,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
2591,GO:0005886,1.99282007851885e-10,1,430,2830,plasma membrane,CC,PTPRS;DLG4;HTRA1;DOCK4;BBS2;F2R;NT5E;TNFRSF6B;APOE;CSMD2;MARVELD1;SYTL1;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;IL20RB;GSN;ADGRL1;FGFBP1;SLC2A3;ADAM19;PTK6;CDC42EP5;GJC2;SEMA4B;LRP1;ALOX15B;OBSCN;NTSR1;EGFR;PRNP;FCGRT;SCN8A;SLC7A8;ANK3;RAPGEF3;FCHO1;TNFSF15;SPTB;DGKA;TSPAN1;SLC16A3;CD9;SLC2A9;SNPH;DNM1;SDK2;PARVB;NOS1;GPSM1;ARAP3;SHANK2;CRTC1;CLCA2;SCN4B;MRC2;ADGRB2;NDRG1;GGT1;ABTB1;COL13A1;MST1R;ARRDC1;EFS;SYT8;RIN1;ARAP1;HBEGF;GAA;CNTN1;EXOC2;EFNB3;EVC;BBS1;CERCAM;SLC27A1;KLF9;REEP2;RAB11FIP4;NISCH;ASAP2;SYNGR1;MAP2K1;SLC16A5;COL6A1;PPL;ABCA2;PKN1;SLC43A1;MC1R;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;DGKQ;TMEM173;SNX9;PLEKHG5;ARL2;SHC1;PHF7;SPRY2;GRB7;MARCKSL1;HDAC11;RAB3B;NLGN2;CD68;SLC12A7;CYBRD1;ITPR3;PRSS8;CAPRIN2;LY6K;PRKCZ;HTR7;PAK1;ABCA7;PRR7;STK39;BLVRB;PEAR1;FGFR3;CEMIP;BRI3;ARVCF;GLDC;NPR2;PLXNB3;CAPNS2;SPRY4;DLG3;ITGB4;MICALL2;SLCO4A1;GRIP2;ZP3;SHROOM4;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;ETV5;LCE1E;ARHGEF4;MUC19;SYNC;MALL;PLXNB1;EREG;NIPSNAP1;SPG11;TMC6;PTPRE;OLFM2;PLCD3;RHOBTB2;ANO8;TNFRSF25;ABCG1;ESYT2;SCART1;ERMAP;LPAR3;S100A13;C5;KIF17;PLGRKT;ANO1;FNDC4;AIP;RASA4;KCNJ15;NLRX1;PKD2;SH3TC2;VAMP2;ST6GALNAC6;SEPT5;LRP11;KCNC4;PI4KAP1;KCNAB2;MAPK3;CSPG4;ITGB5;DEF6;ERRFI1;SEMA5A;IFITM1;VANGL2;GSDMA;RGS14;DNAL4;MYZAP;DYSF;RHOF;PLEK2;SLC22A18;SNTA1;SLITRK6;MVB12B;PI4K2A;PAQR6;KIAA0319L;SDC2;NRSN2;IFNGR2;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;MAP2K2;SAMD3;SLC50A1;SDHA;SLC48A1;LRSAM1;DMTN;LRRC8A;LITAF;ATF4;PROCR;PRSS22;SSH1;LRRC45;LTB4R2;SV2A;TBC1D3E;GPR153;TENM2;IFI6;PKD1;ATXN10;SLC29A4;FLOT1;PSKH1;KCNMA1;UNC5B;SORL1;IL17RD;VLDLR;TPBG;ADGRF1;GPRC5C;GABBR1;SULF2;ROBO3;MAP3K12;LRP5;PTPRU;ATRAID;NDE1;PCSK9;L3MBTL1;AQP3;EPN3;MARK3;TGFBR2;TRPV4;ARHGAP25;ITGA1;IL17RE;PSD4;ANO9;HSD17B7;PDE2A;SMURF2;TRIB3;RAB40B;PEMT;EDA;NOS3;MINK1;PROM2;WNT7A;TRPV1;EPHA1;RHBDF2;SEMA4G;SUCLG2;LZTS2;CROCC;BCR;ATP7B;C19ORF33;CEP112;CPT1C;BCAM;SRR;NBEAL2;MFSD3;TTYH3;PTAFR;RIMS3;ADCY6;ATP2B4;SLC9A3R2;TNFRSF14;GSDMC;ENTPD6;TM7SF2;PLEKHG6;LCE1F;STEAP2;AKT1;ITPR2;CARD11;AMIGO2;SEMA6B;IGFBP2;SEPT6;TSG101;FMNL3;IL17RC;FGFR4;SLC6A9;TCIRG1;STEAP3;SLC6A6;NUCB2;FARP1;CAPN2;RAB25;C1ORF210;PTOV1;PLAU;INSR;WNT3;KRT19;TENM4;GNAL;SLC22A15;LTB4R;TPCN1;ULBP1;ADD3;RABGGTA;ITGB6;HOMER2;C6ORF89;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;BTN3A2;ASIC1;PLB1;GJB4;CAT;MYOF;MAPK10;HFE;JAK3;KIAA1549;MRGPRX3;SCNN1A;CHRM3;ICAM5;ATP12A;SPIRE1;TMEM50B;HGSNAT;BTN3A3;RABAC1;SLC9A7;ADAP1;EPS8L1;EHD3;FYN;ATP8B2;TMEM25;PJA2;SLC38A2;SIRT2;TRPC1;RAB13;MPDZ;TOM1;CELSR1;ADA;CADM4;PLXND1;RHOBTB3;RTN2;ENTPD2;AP2A2;EPS8L2;HDAC8;TGFBR3;PLPP6;RNPEP;VAV3;STX1A;LAMTOR2;EDNRA;EPHB2;MAGI1;LRCH4;ITGA2;SLC39A11;FGFR1;ESYT3;ERBB2;SLC10A6;PAG1;RGS12;OSCP1;C15ORF62;HLA-G;CORO1B;FRS3;MMP17;NET1;GRB10;BSG;APBA1;TMEM8A;IKBKB;NTM;PLEKHA4;HIP1;PLEKHH2;SLC9A5
15515,GO:0071944,4.51789048561152e-10,1,437,2901,cell periphery,CC,PTPRS;DLG4;HTRA1;DOCK4;BBS2;F2R;NT5E;TNFRSF6B;APOE;CSMD2;MARVELD1;SYTL1;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;IL20RB;GSN;ADGRL1;FGFBP1;WIPF1;SLC2A3;ADAM19;PTK6;CDC42EP5;GJC2;SEMA4B;LRP1;ALOX15B;OBSCN;NTSR1;EGFR;PRNP;FCGRT;SCN8A;SLC7A8;ANK3;RAPGEF3;FCHO1;TNFSF15;SPTB;DGKA;TSPAN1;SLC16A3;CD9;SLC2A9;SNPH;DNM1;SDK2;PARVB;NOS1;GPSM1;ARAP3;SHANK2;CRTC1;CLCA2;SCN4B;MRC2;ADGRB2;NDRG1;GGT1;ABTB1;COL13A1;MST1R;ARRDC1;EFS;SYT8;RIN1;ARAP1;HBEGF;GAA;CNTN1;EXOC2;EFNB3;EVC;BBS1;CERCAM;SLC27A1;KLF9;REEP2;RAB11FIP4;NISCH;ASAP2;SYNGR1;MAP2K1;SLC16A5;COL6A1;PPL;ABCA2;PKN1;SLC43A1;MC1R;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;DGKQ;TMEM173;SNX9;PLEKHG5;FAM110C;ARL2;SHC1;PHF7;SPRY2;GRB7;MARCKSL1;HDAC11;RAB3B;NLGN2;CD68;SLC12A7;CYBRD1;ITPR3;PRSS8;CAPRIN2;LY6K;PRKCZ;HTR7;PAK1;ABCA7;PRR7;STK39;BLVRB;PEAR1;FGFR3;CEMIP;BRI3;ARVCF;GLDC;NPR2;PLXNB3;CAPNS2;SPRY4;DLG3;ITGB4;MICALL2;SLCO4A1;GRIP2;ZP3;SHROOM4;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;NID1;ETV5;LCE1E;ARHGEF4;MUC19;SYNC;MALL;PLXNB1;EREG;NIPSNAP1;SPG11;TMC6;PTPRE;OLFM2;PLCD3;RHOBTB2;ANO8;TNFRSF25;ABCG1;ESYT2;SCART1;ERMAP;LPAR3;S100A13;C5;KIF17;PLGRKT;ANO1;FNDC4;AIP;RASA4;KCNJ15;NLRX1;PKD2;SH3TC2;VAMP2;ST6GALNAC6;SEPT5;LRP11;PCLO;KCNC4;PI4KAP1;KCNAB2;MAPK3;CSPG4;ITGB5;DEF6;ERRFI1;SEMA5A;IFITM1;VANGL2;GSDMA;RGS14;DNAL4;MYZAP;DYSF;RHOF;PLEK2;SLC22A18;SNTA1;SLITRK6;MVB12B;PI4K2A;PAQR6;KIAA0319L;SDC2;NRSN2;IFNGR2;PLCD1;ARHGEF2;SEPT10;INPP5D;PDCD1LG2;MAP2K2;SAMD3;SLC50A1;SDHA;SLC48A1;LRSAM1;DMTN;LRRC8A;LITAF;ATF4;PROCR;PRSS22;SSH1;LRRC45;LTB4R2;SV2A;TBC1D3E;GPR153;TENM2;IFI6;PKD1;ATXN10;SLC29A4;FLOT1;PSKH1;KCNMA1;UNC5B;SORL1;IL17RD;VLDLR;TPBG;ADGRF1;GPRC5C;GABBR1;SULF2;ROBO3;MAP3K12;LRP5;PTPRU;ATRAID;NDE1;PCSK9;L3MBTL1;AQP3;EPN3;MARK3;TRIOBP;TGFBR2;TRPV4;ARHGAP25;ITGA1;IL17RE;PSD4;ANO9;HSD17B7;PDE2A;SMURF2;TRIB3;RAB40B;PEMT;EDA;NOS3;MINK1;PROM2;WNT7A;TRPV1;EPHA1;RHBDF2;SEMA4G;SUCLG2;LZTS2;CROCC;BCR;ATP7B;C19ORF33;CEP112;CPT1C;BCAM;SRR;NBEAL2;MFSD3;TTYH3;PTAFR;RIMS3;ADCY6;ATP2B4;SLC9A3R2;TNFRSF14;GSDMC;ENTPD6;TM7SF2;PLEKHG6;LCE1F;STEAP2;AKT1;ITPR2;CARD11;AMIGO2;SEMA6B;IGFBP2;SEPT6;TSG101;FMNL3;IL17RC;FGFR4;SLC6A9;TCIRG1;STEAP3;SLC6A6;NUCB2;FARP1;CAPN2;RAB25;C1ORF210;PTOV1;PLAU;INSR;WNT3;KRT19;TENM4;GNAL;SLC22A15;LTB4R;TPCN1;ULBP1;ADD3;RABGGTA;ITGB6;HOMER2;C6ORF89;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;BTN3A2;ASIC1;PLB1;GJB4;CAT;MYOF;MAPK10;HFE;JAK3;KIAA1549;MRGPRX3;SCNN1A;CHRM3;ICAM5;ATP12A;SPIRE1;TMEM50B;HGSNAT;BTN3A3;RABAC1;SLC9A7;ADAP1;EPS8L1;EHD3;FYN;ATP8B2;TMEM25;PJA2;SLC38A2;SIRT2;TRPC1;RAB13;MPDZ;TOM1;CELSR1;ADA;CADM4;PLXND1;RHOBTB3;RTN2;ENTPD2;AP2A2;EPS8L2;HDAC8;TGFBR3;PLPP6;RNPEP;VAV3;STX1A;LAMTOR2;EDNRA;EPHB2;MAGI1;LRCH4;SEPT8;ITGA2;SLC39A11;FGFR1;ESYT3;ERBB2;SLC10A6;PAG1;RGS12;OSCP1;C15ORF62;HLA-G;CORO1B;FRS3;MMP17;NET1;GRB10;BSG;APBA1;TMEM8A;IKBKB;NTM;PLEKHA4;HIP1;PLEKHH2;SLC9A5
7917,GO:0032501,1.17332967043488e-09,1,593,4175,multicellular organismal process,BP,XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;DOCK4;GAMT;BBS2;F2R;TNFRSF6B;APOE;MARVELD1;BTBD2;ESPN;ZMYND8;NFATC4;SERPINE2;FHL1;S100A6;FOS;IL20RB;GSN;ADGRL1;EGR1;CTNNBIP1;LMF1;THBS3;PGF;ALDH7A1;POSTN;ADAM19;PTK6;ACP5;WWC3;RNF135;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PRNP;SCN8A;NR1D1;ERCC1;FBLN1;ADAMTS7;S100A4;ANK3;TFPI2;DUSP5;IFT140;RAPGEF3;SPTB;LOXL1;DGKA;IGFBP4;KRT15;CD9;SNPH;IDH2;CRTAP;CST3;DNM1;SDK2;MEF2D;NOS1;GPSM1;DDIT3;BRSK1;SHANK2;MICALCL;CRTC1;SCN4B;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;TBC1D8;ARHGEF19;COL13A1;MYH15;SMARCA1;MST1R;ZFP36L1;ADARB1;NUPR1;TCFL5;HBEGF;PHGDH;GAA;CTF1;CNTN1;DHTKD1;TFDP2;EFNB3;OBSL1;MDFI;EVC;BBS1;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;REEP2;RNF165;RAB11FIP4;NISCH;FBXW4;ASH2L;SOX13;CUL7;PRSS3;HMGCL;HYAL1;NAGLU;TXNRD3;WWTR1;SMOC1;MAP2K1;CYP27B1;PCK2;COL6A1;PPL;SDCCAG8;PKN1;MC1R;DDIT4;BTG1;TRNP1;SYNGAP1;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;PBX2;EML2;TMEM173;PLEKHG5;FAM213A;DNAH1;ULK1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;ADM2;SOX12;HDAC11;NLGN2;MYCBPAP;MYH11;ITPR3;LAMA5;UNK;PRSS8;CAPRIN2;TPM2;TTBK2;PRKCZ;HTR7;SERPING1;PAK1;ABCA7;AARS;ELK3;STK39;PABPC1L;FGFR3;CEMIP;KDM3A;MTHFR;FOXQ1;ARVCF;NPR2;SEMA3F;PLXNB3;SPRY4;SALL2;DOCK6;ZSWIM4;DLG3;ITGB4;MICALL2;FBXW8;ETV1;ZP3;SHROOM4;NEURL1;ACVR2B;CCDC88B;RAG1;SPEG;NGFR;EPOR;NID1;ETV5;GSTO1;LCE1E;WDR60;LTBP1;MALL;WNT2B;TRIB2;PLXNB1;EREG;CHD2;TEF;NIPSNAP1;SPG11;SSH3;SPATA20;OLFM2;PLCD3;TNFRSF25;NAB2;PLA2G6;CES3;ABCG1;TRAPPC9;FAM50A;ERMAP;MANF;LPAR3;S100A13;C5;KIF17;PPARA;ANO1;CHAC1;MKNK2;SCMH1;TCF25;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;SH3TC2;HMGA2;AREG;COL8A1;SLIT3;ECM1;B4GAT1;LRP11;PCLO;ACACB;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;CCNI;STK40;VANGL2;DOCK9;SH2D2A;RGS14;KCTD15;FAM20C;TDRKH;PBXIP1;DYSF;SLC22A18;SNTA1;CTSB;SLITRK6;MXRA8;MAPK12;MYH3;NYAP1;SDC2;ARHGAP22;TCTN1;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;TWF2;STMN3;SDHA;DMTN;LRRC8A;LITAF;ANGPTL4;SEMA3B;PTHLH;ATF4;PROCR;ZFPM1;MOSPD3;KDM4C;DOCK11;SSH1;LTB4R2;SLC38A10;METRN;POLM;TENM2;KIF26B;REEP6;ZNF516;PKD1;ATXN10;FLOT1;LTBP3;MDK;TTN;PSKH1;KCNMA1;AZIN2;HSD11B1;UNC5B;HDAC5;IRF5;SORL1;MAP6;PLTP;SRSF5;GSTM2;VLDLR;TPBG;ADGRF1;PRR15;DEAF1;SULF2;ROBO3;NLRP1;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;NEK8;LRP5;PTPRU;WNK4;ATRAID;NDE1;CREBRF;PCSK9;DBNDD1;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;CEP131;DNMT3A;TRIOBP;TGFBR2;TRPV4;TAGLN3;FOXL1;MN1;ITGA1;CMTM7;TMSB4X;PDE2A;SMURF2;APLN;BHLHE40;MLH3;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;WNT7A;HERPUD2;TRPV1;EPHA1;SEMA4G;SHARPIN;GAS6;GLUD1;LZTS2;ECM2;CROCC;BCR;ATP7B;NBR1;TNNI2;SRR;NBEAL2;KIF13B;SPAG16;CAMK1;POLL;PTAFR;RXRA;ZNF358;ADCY6;ATP2B4;SPATA7;PRDM8;CTSH;TNFRSF14;WDR19;MGMT;ASNS;LCE1F;MAPKBP1;AKT1;IGFBP7;ITPR2;CARD11;DGUOK;MICAL1;CRY2;B4GALT2;AMIGO2;LAMB1;SEMA6B;IFT57;SBF2;IGFBP2;SEPT6;TNNT1;CABYR;TSG101;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;ZNF217;TMOD2;ACADVL;FARP1;DNASE2;LMNA;SH2B3;MAB21L2;C9ORF72;TBC1D20;CAPN2;MARK4;RAB25;PLAU;INSR;WNT3;KRT19;TENM4;FOXO4;GNAL;RPS6KA5;CHMP4C;LTB4R;MAGED2;RABGGTA;ITGB6;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;BTN3A2;ASIC1;HOXC5;GJB4;CAT;ZNF160;MYOF;MAPK10;LGALS1;UNC119B;TIMP1;HFE;JAK3;TP73;SCNN1A;MNT;CHRM3;APRT;TFEB;PEX7;SNX17;LSM14B;PHC1;SPIRE1;CSNK1E;TAZ;BTN3A3;BCL6;HSF4;REC8;RNF213;GSTM3;TKFC;EHD3;RPL39L;FYN;PJA2;SLC38A2;LEMD2;SIRT2;TRPC1;SPRED3;PHLDA2;RAB13;CELSR1;ADA;POU2F2;PLXND1;POLR3GL;RHOBTB3;ETNK2;MTA1;ENTPD2;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;RPL29;TGFBR3;TCF7;RNPEP;VAV3;EPAS1;MFNG;EDNRA;LURAP1;EPHB2;PER1;LRCH4;MCTP2;IGF2BP3;ITGA2;FGFR1;WFS1;TMEM223;BLOC1S1;FKBP8;SPATA6;SH3PXD2A;CTH;ERBB2;PLLP;UST;EIF2AK4;UNC119;HLA-G;CORO1B;MMP17;RTL1;GRB10;TSHZ1;TNNI1;CREB3L4;MMP19;ZNF449;KCTD11;BSG;ZMYM3;SDHAF4;TRIM45;DBP;APBA1;ZNF287;PNKD;IKBKB;NTM;CYP4V2;ROBO4;TEAD2;BTBD11;SIX5
10895,GO:0044459,1.17778085950061e-08,1,237,1443,plasma membrane part,CC,PTPRS;DLG4;BBS2;F2R;TNFRSF6B;SYTL1;KCNG1;SERPINE2;S100A6;ADGRL1;SLC2A3;PTK6;GJC2;LRP1;NTSR1;EGFR;PRNP;SCN8A;SLC7A8;ANK3;TNFSF15;SPTB;TSPAN1;SLC16A3;CD9;SLC2A9;SNPH;DNM1;NOS1;SHANK2;CLCA2;SCN4B;MRC2;COL13A1;MST1R;HBEGF;EFNB3;EVC;BBS1;REEP2;RAB11FIP4;SLC16A5;ABCA2;PKN1;SLC43A1;MC1R;SYNGAP1;ITGA6;PITPNM1;SNX9;ARL2;SHC1;SPRY2;NLGN2;SLC12A7;CYBRD1;ITPR3;PRSS8;PRKCZ;HTR7;PAK1;ABCA7;PRR7;STK39;PEAR1;FGFR3;NPR2;PLXNB3;SPRY4;DLG3;ITGB4;SLCO4A1;SHROOM4;NEURL1;ACVR2B;NGFR;EPOR;ARHGEF4;PLXNB1;EREG;NIPSNAP1;OLFM2;PLCD3;TNFRSF25;ABCG1;ESYT2;SCART1;ERMAP;LPAR3;C5;KIF17;PLGRKT;ANO1;RASA4;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;MAPK3;CSPG4;ITGB5;ERRFI1;VANGL2;RGS14;MYZAP;DYSF;PLEK2;SLC22A18;SNTA1;SLITRK6;PI4K2A;IFNGR2;ARHGEF2;PDCD1LG2;MAP2K2;SDHA;DMTN;LITAF;ATF4;PROCR;PRSS22;SSH1;LTB4R2;TENM2;PKD1;SLC29A4;FLOT1;KCNMA1;SORL1;IL17RD;TPBG;GPRC5C;GABBR1;LRP5;PTPRU;NDE1;PCSK9;AQP3;EPN3;TGFBR2;TRPV4;ARHGAP25;ITGA1;IL17RE;PSD4;PDE2A;PEMT;EDA;NOS3;MINK1;PROM2;TRPV1;EPHA1;BCR;ATP7B;CPT1C;BCAM;MFSD3;PTAFR;RIMS3;ADCY6;ATP2B4;SLC9A3R2;TNFRSF14;TM7SF2;PLEKHG6;STEAP2;CARD11;SEMA6B;IGFBP2;SEPT6;IL17RC;FGFR4;SLC6A9;TCIRG1;STEAP3;SLC6A6;FARP1;RAB25;INSR;KRT19;TENM4;GNAL;SLC22A15;LTB4R;ULBP1;ITGB6;HOMER2;EDA2R;ARHGAP44;BTN3A2;ASIC1;PLB1;GJB4;MYOF;HFE;JAK3;MRGPRX3;SCNN1A;CHRM3;ICAM5;ATP12A;SPIRE1;BTN3A3;EPS8L1;EHD3;FYN;PJA2;SLC38A2;TRPC1;RAB13;MPDZ;CELSR1;ADA;CADM4;PLXND1;RTN2;AP2A2;EPS8L2;TGFBR3;STX1A;EDNRA;EPHB2;LRCH4;ITGA2;FGFR1;ESYT3;ERBB2;PAG1;OSCP1;HLA-G;MMP17;BSG;TMEM8A;IKBKB;HIP1
10785,GO:0044282,2.44329077322206e-08,1,69,304,small molecule catabolic process,BP,NT5E;APOE;PRODH;ALDH7A1;TYSND1;CRAT;GLUL;AIG1;NTSR1;HADH;NOS1;ACAD10;PGM1;ALDH4A1;CPT2;MLYCD;HMGCL;HYAL1;CYP27B1;PCK2;CRYL1;GALE;APOBEC3C;PHYH;CEMIP;GLDC;CBS;ETFB;GPT2;APOBEC3F;PPARA;SESN2;BLMH;ACACB;SRD5A3;HIBADH;GALK1;LRP5;ALDOC;ACADS;LONP2;ALDH1L2;NOS3;HEXB;GLUD1;CPT1C;HEXA;ATP2B4;THNSL2;ACOX3;ACAD11;ENTPD6;AKT1;PHYKPL;HAGH;ACADVL;FAAH;UPP1;ALDH1L1;PEX7;SNX17;TKFC;ADA;ENTPD2;CTH;PFKL;NUDT18;PNKD;ACOT8
1252,GO:0003008,7.80016666308325e-08,1,144,804,system process,BP,ACTA2;DLG4;DOCK4;GAMT;BBS2;F2R;APOE;ESPN;SERPINE2;FOS;GSN;CTNNBIP1;ALDH7A1;POSTN;NTSR1;EGFR;PRNP;SCN8A;ANK3;DNM1;NOS1;SHANK2;CRTC1;SCN4B;TBC1D8;ADARB1;HBEGF;GAA;OBSL1;BBS1;REEP2;NISCH;PKN1;SYNGAP1;EML2;SPRY2;BLOC1S4;VEGFB;ADM2;NLGN2;MYH11;ITPR3;TPM2;PRKCZ;HTR7;SERPING1;PAK1;ABCA7;AARS;STK39;CEMIP;MTHFR;NPR2;SHROOM4;RAG1;GSTO1;NIPSNAP1;OLFM2;PLA2G6;PPARA;ANO1;KCNAB2;MAPK3;ITGB5;LAMB2;ERRFI1;THRA;STK40;RGS14;DYSF;SLC22A18;SNTA1;SLITRK6;MYH3;REEP6;MDK;TTN;KCNMA1;GSTM2;VLDLR;ADGRF1;DEAF1;SULF2;CEBPB;LRP5;WNK4;METTL23;AQP3;TRIOBP;TRPV4;ITGA1;PDE2A;APLN;NOS3;HEXB;TRPV1;GAS6;BCR;TNNI2;PTAFR;ADCY6;ATP2B4;SPATA7;WDR19;AKT1;ITPR2;B4GALT2;TNNT1;TMOD2;LMNA;INSR;TENM4;GNAL;LTB4R;MAGED2;RABGGTA;HOMER2;BRAF;ASIC1;GJB4;MYOF;SCNN1A;CHRM3;TAZ;HSF4;EHD3;FYN;PJA2;TRPC1;ADA;EPS8L2;PAIP2;RNPEP;EPAS1;EDNRA;EPHB2;ITGA2;FGFR1;WFS1;EIF2AK4;UNC119;TNNI1;PNKD;CYP4V2
7144,GO:0031012,9.60227728277522e-08,1,57,240,extracellular matrix,CC,HTRA1;APOE;SERPINE2;THBS3;FGFBP1;POSTN;THSD4;TIMP2;VEGFA;FBLN1;ADAMTS7;TFPI2;LOXL1;CRTAP;CST3;ADAMTS13;MMP28;MMP1;LTBP4;SMOC2;SMOC1;COL6A1;ITGA6;MXRA7;LAMA5;ZP3;NID1;LTBP1;WNT2B;COL8A1;SLIT3;ECM1;CSPG4;LAMB2;LTBP2;ADAMTSL1;SLITRK6;SDC2;ANGPTL4;LTBP3;COL4A6;EGFL7;WNT7A;OLFML2A;ECM2;BCAM;EFEMP2;IGFBP7;LAMB1;WNT3;TNXB;LGALS1;TIMP1;ENTPD2;TGFBR3;MMP17;MMP19
4281,GO:0009653,2.83686562183177e-07,1,263,1693,anatomical structure morphogenesis,BP,XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;GAMT;BBS2;F2R;APOE;NFATC4;SERPINE2;FHL1;S100A6;CTNNBIP1;THBS3;PGF;POSTN;WIPF1;CDC42EP5;ACP5;SEMA4B;LRP1;PDCD4;VEGFA;OBSCN;EGFR;ERCC1;FBLN1;ANK3;DUSP5;IFT140;RAPGEF3;CLTCL1;SPTB;CD9;CST3;SDK2;PARVB;MEF2D;NOS1;ARAP3;BRSK1;SHANK2;ADGRB2;ARHGEF19;COL13A1;ZFP36L1;ADARB1;ARAP1;HBEGF;GAA;EFNB3;OBSL1;MDFI;ULK2;RNF165;FBXW4;SOX13;CUL7;HYAL1;NAGLU;ARPIN;WWTR1;MAP2K1;COL6A1;SDCCAG8;PKN1;BTG1;TRNP1;SYNGAP1;ITGA6;PBX2;ULK1;SHC1;SPRY2;GRB7;VEGFB;ADM2;MYH11;LAMA5;UNK;CAPRIN2;TTBK2;PRKCZ;PAK1;ELK3;FGFR3;FOXQ1;SEMA3F;PLXNB3;SYNE3;ZSWIM4;DLG3;ITGB4;MICALL2;FBXW8;ETV1;ZP3;ACVR2B;NGFR;ETV5;WDR60;WNT2B;PLXNB1;EREG;SPG11;SSH3;PLCD3;RHOBTB2;NAB2;LPAR3;S100A13;C5;PPARA;IMPACT;PKD2;STAT6;KLF7;HMGA2;AREG;COL8A1;SLIT3;ECM1;B4GAT1;MAPK3;CSPG4;ITGB5;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;STK40;VANGL2;SH2D2A;FAM20C;RHOF;SLITRK6;MYH3;NYAP1;SDC2;ARHGAP22;MLXIPL;TCTN1;PLCD1;ARHGEF2;TWF2;DMTN;ANGPTL4;SEMA3B;ZFPM1;KDM4C;SSH1;METRN;TENM2;KIF26B;PKD1;FLOT1;TTN;UNC5B;HDAC5;MAP6;VLDLR;DEAF1;SULF2;ROBO3;RFX2;EGFL7;CEBPB;NEK8;LRP5;WNK4;AQP3;TRIOBP;TGFBR2;TRPV4;FOXL1;ITGA1;SMURF2;APLN;EDA;NOS3;AGO4;MINK1;HEXB;WNT7A;EPHA1;SEMA4G;FMNL2;ECM2;BCR;NBEAL2;KIF13B;CAMK1;RXRA;ZNF358;STRADB;CTSH;WDR19;LAMB1;IFT57;TNNT1;FMNL3;FGFR4;IGF2BP2;TMOD2;FARP1;MAB21L2;C9ORF72;TBC1D20;CAPN2;RAB25;INSR;WNT3;KRT19;TENM4;FOXO4;RPS6KA5;MAP2K5;BRAF;ARHGAP44;MYOF;PEX7;CSNK1E;BCL6;RNF213;FYN;SNX1;LEMD2;GDF15;PHLDA2;CELSR1;ADA;PLXND1;RHOBTB3;AP2A2;TGFBR3;TCF7;VAV3;EPAS1;EDNRA;EPHB2;IGF2BP3;ITGA2;FGFR1;FITM2;SH3PXD2A;ERBB2;UST;EIF2AK4;C15ORF62;CORO1B;NET1;GRB10;TSHZ1;TNNI1;MMP19;BSG;ZMYM3;IKBKB;ROBO4;TEAD2
5324,GO:0016054,6.57057707227834e-07,0.999999744172466,47,192,organic acid catabolic process,BP,PRODH;ALDH7A1;TYSND1;CRAT;GLUL;AIG1;HADH;NOS1;ACAD10;ALDH4A1;CPT2;MLYCD;HMGCL;HYAL1;PCK2;CRYL1;PHYH;CEMIP;GLDC;CBS;ETFB;GPT2;PPARA;SESN2;BLMH;ACACB;HIBADH;ACADS;LONP2;ALDH1L2;NOS3;HEXB;GLUD1;CPT1C;HEXA;ATP2B4;THNSL2;ACOX3;ACAD11;AKT1;PHYKPL;ACADVL;FAAH;ALDH1L1;PEX7;CTH;ACOT8
11636,GO:0046395,6.57057707227834e-07,0.999999744172466,47,192,carboxylic acid catabolic process,BP,PRODH;ALDH7A1;TYSND1;CRAT;GLUL;AIG1;HADH;NOS1;ACAD10;ALDH4A1;CPT2;MLYCD;HMGCL;HYAL1;PCK2;CRYL1;PHYH;CEMIP;GLDC;CBS;ETFB;GPT2;PPARA;SESN2;BLMH;ACACB;HIBADH;ACADS;LONP2;ALDH1L2;NOS3;HEXB;GLUD1;CPT1C;HEXA;ATP2B4;THNSL2;ACOX3;ACAD11;AKT1;PHYKPL;ACADVL;FAAH;ALDH1L1;PEX7;CTH;ACOT8
12646,GO:0050877,6.80181322002875e-07,1,81,407,nervous system process,BP,DLG4;BBS2;F2R;APOE;ESPN;SERPINE2;FOS;ALDH7A1;NTSR1;EGFR;PRNP;SCN8A;ANK3;DNM1;SHANK2;CRTC1;ADARB1;GAA;BBS1;REEP2;SYNGAP1;EML2;SPRY2;BLOC1S4;NLGN2;ITPR3;PRKCZ;ABCA7;AARS;CEMIP;SHROOM4;RAG1;NIPSNAP1;OLFM2;PLA2G6;ANO1;KCNAB2;MAPK3;LAMB2;THRA;RGS14;SLITRK6;REEP6;MDK;VLDLR;ADGRF1;DEAF1;CEBPB;METTL23;TRIOBP;HEXB;TRPV1;BCR;PTAFR;SPATA7;WDR19;B4GALT2;TMOD2;INSR;TENM4;GNAL;RABGGTA;HOMER2;BRAF;ASIC1;GJB4;SCNN1A;HSF4;FYN;PJA2;EPS8L2;PAIP2;EPAS1;EPHB2;ITGA2;FGFR1;WFS1;EIF2AK4;UNC119;PNKD;CYP4V2
17028,GO:0099537,1.1557123385498e-06,0.999999627937133,64,298,trans-synaptic signaling,BP,DLG4;F2R;APOE;SYTL1;ZMYND8;NFATC4;SERPINE2;GLUL;NTSR1;EGFR;PRNP;SNPH;DNM1;NOS1;BRSK1;SHANK2;CRTC1;ADARB1;SYT8;NISCH;SYNGR1;SYNGAP1;RAB3B;NLGN2;SLC12A7;MYCBPAP;ITPR3;PRKCZ;HTR7;MCTP1;DLG3;NEURL1;ETV5;SPG11;PLA2G6;LPAR3;VAMP2;SEPT5;PCLO;KCNC4;RGS14;SSH1;SV2A;FLOT1;MINK1;WNT7A;TRPV1;RIMS3;AKT1;SLC6A9;TMOD2;BRAF;ASIC1;CHRM3;FCHSD1;PAIP2;STX1A;EPHB2;EIF2AK4;UNC119;KCTD13;APBA1;PNKD;SNCB
7250,GO:0031226,1.27251888558807e-06,0.999999517220769,134,768,intrinsic component of plasma membrane,CC,PTPRS;DLG4;F2R;TNFRSF6B;KCNG1;SLC2A3;LRP1;NTSR1;EGFR;PRNP;SCN8A;SLC7A8;TNFSF15;SPTB;TSPAN1;SLC16A3;CD9;SLC2A9;SHANK2;CLCA2;SCN4B;MRC2;COL13A1;MST1R;HBEGF;EFNB3;REEP2;SLC16A5;SLC43A1;MC1R;SYNGAP1;ITGA6;NLGN2;SLC12A7;ITPR3;PRSS8;HTR7;FGFR3;NPR2;PLXNB3;DLG3;ITGB4;SLCO4A1;ACVR2B;NGFR;EPOR;PLXNB1;EREG;OLFM2;TNFRSF25;ESYT2;LPAR3;C5;PLGRKT;RASA4;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;CSPG4;ITGB5;SLITRK6;PI4K2A;IFNGR2;PROCR;PRSS22;LTB4R2;TENM2;PKD1;KCNMA1;SORL1;IL17RD;TPBG;GPRC5C;GABBR1;PTPRU;TGFBR2;TRPV4;ITGA1;IL17RE;EDA;PROM2;TRPV1;EPHA1;ATP7B;CPT1C;BCAM;MFSD3;PTAFR;ADCY6;ATP2B4;TNFRSF14;TM7SF2;STEAP2;SEMA6B;IL17RC;FGFR4;SLC6A9;TCIRG1;STEAP3;SLC6A6;INSR;TENM4;SLC22A15;LTB4R;ULBP1;ITGB6;EDA2R;ASIC1;HFE;MRGPRX3;SCNN1A;CHRM3;ICAM5;ATP12A;SLC38A2;TRPC1;CELSR1;CADM4;PLXND1;TGFBR3;STX1A;EDNRA;EPHB2;ITGA2;FGFR1;ESYT3;ERBB2;PAG1;MMP17;BSG;TMEM8A;IKBKB
17027,GO:0099536,1.30247354756254e-06,0.999999579437087,64,299,synaptic signaling,BP,DLG4;F2R;APOE;SYTL1;ZMYND8;NFATC4;SERPINE2;GLUL;NTSR1;EGFR;PRNP;SNPH;DNM1;NOS1;BRSK1;SHANK2;CRTC1;ADARB1;SYT8;NISCH;SYNGR1;SYNGAP1;RAB3B;NLGN2;SLC12A7;MYCBPAP;ITPR3;PRKCZ;HTR7;MCTP1;DLG3;NEURL1;ETV5;SPG11;PLA2G6;LPAR3;VAMP2;SEPT5;PCLO;KCNC4;RGS14;SSH1;SV2A;FLOT1;MINK1;WNT7A;TRPV1;RIMS3;AKT1;SLC6A9;TMOD2;BRAF;ASIC1;CHRM3;FCHSD1;PAIP2;STX1A;EPHB2;EIF2AK4;UNC119;KCTD13;APBA1;PNKD;SNCB
2406,GO:0005578,1.34054040100843e-06,0.999999475056004,45,183,proteinaceous extracellular matrix,CC,POSTN;THSD4;TIMP2;VEGFA;FBLN1;ADAMTS7;TFPI2;LOXL1;CRTAP;CST3;ADAMTS13;MMP28;MMP1;LTBP4;SMOC2;SMOC1;COL6A1;ITGA6;LAMA5;ZP3;NID1;LTBP1;WNT2B;COL8A1;SLIT3;ECM1;LAMB2;LTBP2;ADAMTSL1;SLITRK6;ANGPTL4;COL4A6;WNT7A;OLFML2A;ECM2;EFEMP2;LAMB1;WNT3;TNXB;LGALS1;TIMP1;ENTPD2;TGFBR3;MMP17;MMP19
3453,GO:0007268,2.19268320621447e-06,0.999999092219025,63,296,chemical synaptic transmission,BP,DLG4;F2R;APOE;SYTL1;ZMYND8;NFATC4;SERPINE2;GLUL;NTSR1;EGFR;PRNP;SNPH;DNM1;BRSK1;SHANK2;CRTC1;ADARB1;SYT8;NISCH;SYNGR1;SYNGAP1;RAB3B;NLGN2;SLC12A7;MYCBPAP;ITPR3;PRKCZ;HTR7;MCTP1;DLG3;NEURL1;ETV5;SPG11;PLA2G6;LPAR3;VAMP2;SEPT5;PCLO;KCNC4;RGS14;SSH1;SV2A;FLOT1;MINK1;WNT7A;TRPV1;RIMS3;AKT1;SLC6A9;TMOD2;BRAF;ASIC1;CHRM3;FCHSD1;PAIP2;STX1A;EPHB2;EIF2AK4;UNC119;KCTD13;APBA1;PNKD;SNCB
16910,GO:0098916,2.19268320621447e-06,0.999999092219025,63,296,anterograde trans-synaptic signaling,BP,DLG4;F2R;APOE;SYTL1;ZMYND8;NFATC4;SERPINE2;GLUL;NTSR1;EGFR;PRNP;SNPH;DNM1;BRSK1;SHANK2;CRTC1;ADARB1;SYT8;NISCH;SYNGR1;SYNGAP1;RAB3B;NLGN2;SLC12A7;MYCBPAP;ITPR3;PRKCZ;HTR7;MCTP1;DLG3;NEURL1;ETV5;SPG11;PLA2G6;LPAR3;VAMP2;SEPT5;PCLO;KCNC4;RGS14;SSH1;SV2A;FLOT1;MINK1;WNT7A;TRPV1;RIMS3;AKT1;SLC6A9;TMOD2;BRAF;ASIC1;CHRM3;FCHSD1;PAIP2;STX1A;EPHB2;EIF2AK4;UNC119;KCTD13;APBA1;PNKD;SNCB
11133,GO:0045202,2.52110113088131e-06,0.999998823035157,96,512,synapse,CC,PTPRS;DLG4;F2R;SYTL1;ZMYND8;SERPINE2;ADGRL1;POSTN;FBXO2;GLUL;NTSR1;EGFR;PRNP;NR1D1;ANK3;SNPH;DNM1;SDK2;NOS1;BRSK1;SHANK2;CRTC1;COL13A1;SYT8;SYNGR1;SYNGAP1;NPHP4;RAB3B;NLGN2;LAMA5;PRR7;MCTP1;BLVRB;MTHFR;DLG3;NMNAT2;NEURL1;SYNC;NIPSNAP1;SPG11;OLFM2;DNMBP;VAMP2;SEPT5;PCLO;KCNC4;KCNAB2;LAMB2;BNIP3;RGS14;SNTA1;PI4K2A;ARHGEF2;DMTN;SV2A;TENM2;KCNMA1;GABBR1;NDE1;DBNDD1;PDE2A;RAB40B;MINK1;WNT7A;TRPV1;SHARPIN;DNAJC6;BCR;CEP112;CPT1C;RIMS3;AKT1;MICAL1;SEPT6;SLC6A9;PIAS3;FARP1;ICA1;ADD3;HOMER2;ARHGAP44;ASIC1;CHRM3;FCHSD1;RABAC1;FYN;PJA2;RAB13;MPDZ;STX1A;EPHB2;ITGA2;RGS12;APBA1;SNCB;HIP1
6250,GO:0019838,3.92513164058701e-06,0.999998866308429,26,86,growth factor binding,MF,HTRA1;FGFBP1;EGFR;IGFBP4;LTBP4;COL6A1;ITGA6;SHC1;FGFR3;ITGB4;ACVR2B;NGFR;LTBP1;S100A13;LTBP2;LTBP3;RHBDF1;TGFBR2;RHBDF2;IGFBP7;IGFBP2;FGFR4;INSR;TGFBR3;FGFR1;ERBB2
17718,GO:1901681,5.55541493695449e-06,0.999997946991792,36,142,sulfur compound binding,MF,PTPRS;APOE;SERPINE2;THBS3;PGF;FGFBP1;POSTN;LRP1;VEGFA;ACBD4;COL13A1;HBEGF;DHTKD1;HMGCL;SMOC2;VEGFB;OGDHL;CBS;PNPLA3;ACACB;PC;SEMA5A;LTBP2;MDK;HLCS;GSTM2;ACOT7;ECM2;FGFR4;ACADVL;TNXB;GSTM3;RPL29;TGFBR3;ITGA2;FGFR1
6663,GO:0030030,6.11122487036137e-06,0.999996267676581,170,1045,cell projection organization,BP,PTPRS;DLG4;BBS2;APOE;ESPN;ZMYND8;NFATC4;S100A6;GSN;POSTN;EVI5L;PTK6;CDC42EP5;SEMA4B;LRP1;VEGFA;EGFR;PRNP;ANK3;IFT140;SPTB;NINL;PARVB;BRSK1;SHANK2;CRTC1;ADARB1;ARAP1;CNTN1;EFNB3;OBSL1;BBS1;ULK2;RNF165;CUL7;ARPIN;WWTR1;MAP2K1;SDCCAG8;SYNGAP1;ITGA6;FAM110C;DNAH1;ULK1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;LAMA5;CAPRIN2;TTBK2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;MICALL2;CEP250;FBXW8;ETV1;NEURL1;NGFR;ARHGEF4;WDR60;PLXNB1;SPG11;SSH3;MANF;LPAR3;KIF17;IMPACT;IFT27;KLF7;NUDCD3;AREG;SLIT3;SEPT5;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;PLEK2;CNTRL;SLITRK6;NYAP1;SDC2;TCTN1;PTPDC1;SEPT10;FBF1;TWF2;STMN3;DMTN;SEMA3B;DOCK11;SSH1;METRN;TENM2;ATXN10;FLOT1;UNC5B;MAP6;VLDLR;ADGRF1;ROBO3;RFX2;NDE1;DBNDD1;CEP131;TRIOBP;TRPV4;ITGA1;MINK1;PROM2;WNT7A;SEMA4G;CEP126;ECM2;CROCC;KIF13B;SPAG16;CAMK1;ADCY6;WDR19;TMEM80;AKT1;DGUOK;LAMB1;IFT57;SEPT6;TTC21A;KIF27;FARP1;C9ORF72;MARK4;RAB25;INSR;WNT3;RPS6KA5;BRAF;ARHGAP44;HAUS4;LGALS1;UNC119B;CSNK1E;EPS8L1;EHD3;FYN;SNX1;RAB13;PLXND1;RHOBTB3;EPS8L2;VAV3;EPHB2;SEPT8;ITGA2;FGFR1;BLOC1S1;SPATA6;ERBB2;UST;EIF2AK4;UNC119;C15ORF62;CORO1B;SFI1;GRB10
2592,GO:0005887,6.27709944699148e-06,0.999996530516199,126,730,integral component of plasma membrane,CC,PTPRS;DLG4;F2R;TNFRSF6B;KCNG1;SLC2A3;LRP1;NTSR1;EGFR;SCN8A;SLC7A8;TNFSF15;TSPAN1;SLC16A3;CD9;SLC2A9;SHANK2;CLCA2;SCN4B;MRC2;COL13A1;MST1R;HBEGF;EFNB3;REEP2;SLC16A5;SLC43A1;MC1R;ITGA6;NLGN2;SLC12A7;ITPR3;HTR7;FGFR3;NPR2;PLXNB3;DLG3;ITGB4;SLCO4A1;ACVR2B;NGFR;EPOR;PLXNB1;EREG;OLFM2;TNFRSF25;ESYT2;LPAR3;C5;PLGRKT;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;CSPG4;ITGB5;SLITRK6;PI4K2A;IFNGR2;PROCR;LTB4R2;TENM2;PKD1;KCNMA1;SORL1;IL17RD;TPBG;GPRC5C;GABBR1;PTPRU;TGFBR2;TRPV4;ITGA1;IL17RE;EDA;PROM2;TRPV1;EPHA1;ATP7B;CPT1C;BCAM;MFSD3;PTAFR;ATP2B4;TNFRSF14;TM7SF2;STEAP2;SEMA6B;IL17RC;FGFR4;SLC6A9;TCIRG1;STEAP3;SLC6A6;INSR;TENM4;SLC22A15;LTB4R;ITGB6;EDA2R;ASIC1;HFE;MRGPRX3;SCNN1A;CHRM3;ICAM5;ATP12A;SLC38A2;TRPC1;CELSR1;CADM4;PLXND1;TGFBR3;STX1A;EDNRA;EPHB2;ITGA2;FGFR1;ESYT3;ERBB2;PAG1;MMP17;BSG;TMEM8A;IKBKB
12498,GO:0050662,8.21381842688257e-06,0.999996510793681,49,221,coenzyme binding,MF,XDH;H6PD;PRODH;PYGB;D2HGDH;HADH;ACBD4;IDH2;NOS1;ACAD10;PHGDH;PYGL;DHTKD1;HMGCL;TXNRD3;CRYL1;OGDHL;PHYH;MTHFR;GLDC;CBS;GPT2;PNPLA3;ACACB;PC;HIBADH;SDHA;HLCS;ACOT7;ACADS;MOCOS;NOS3;GLUD1;NUDT6;SRR;THNSL2;ACOX3;ACAD11;TM7SF2;MICAL1;CRY2;PHYKPL;CBR4;ACADVL;TXNRD2;CAT;OGFOD2;SIRT2;CTH
12598,GO:0050806,8.72787195178372e-06,0.999997416393987,25,84,positive regulation of synaptic transmission,BP,DLG4;APOE;SERPINE2;GLUL;NTSR1;EGFR;PRNP;SHANK2;CRTC1;RAB3B;NLGN2;ITPR3;PRKCZ;VAMP2;RGS14;SSH1;FLOT1;WNT7A;RIMS3;BRAF;PAIP2;STX1A;EPHB2;EIF2AK4;KCTD13
7273,GO:0031267,9.78184742565119e-06,0.999994814667343,84,445,small GTPase binding,MF,DLG4;DOCK4;SYTL1;EVI5L;CDC42EP5;OBSCN;EGFR;RAPGEF3;SPTB;ARAP3;NDRG1;TBC1D8;ARHGEF19;RIN1;ARAP1;HBEGF;RGL2;EXOC2;RAB11FIP4;ASAP2;PKN1;SHC2;PLEKHG5;ULK1;SHC1;APPL2;PAK1;FGFR3;MICALL2;NGFR;ARHGEF4;EREG;PLEKHG2;DNMBP;XPOT;TRAPPC9;AGAP1;ALS2CL;ERRFI1;SRGAP3;PLEKHG4;TBC1D14;ARHGEF2;PAK6;DOCK11;TBC1D3E;RABGAP1;ACAP3;WHAMMP3;SORL1;RIN2;PKN3;TRIOBP;FMNL2;PLEKHG3;BCR;RIMS3;PLEKHG6;MICAL1;SBF2;FMNL3;FGFR4;ASAP3;FARP1;C9ORF72;SGSM2;TBC1D20;RABGGTA;ARHGAP44;JAK3;ADAP1;EPS8L1;FYN;ARHGEF17;RHOBTB3;EPS8L2;VAV3;TBC1D16;FGFR1;ERBB2;C15ORF62;FRS3;NET1;KCTD13
3588,GO:0008015,1.2023205644945e-05,0.999994464778717,54,250,blood circulation,BP,DOCK4;BBS2;F2R;APOE;CTNNBIP1;POSTN;NTSR1;EGFR;NOS1;SCN4B;TBC1D8;HBEGF;GAA;NISCH;VEGFB;ADM2;ITPR3;HTR7;SERPING1;STK39;MTHFR;NPR2;GSTO1;PLA2G6;PPARA;THRA;SNTA1;TTN;GSTM2;LRP5;TRPV4;ITGA1;PDE2A;APLN;NOS3;GAS6;BCR;TNNI2;PTAFR;ADCY6;ATP2B4;AKT1;ITPR2;TNNT1;MYOF;CHRM3;TAZ;EHD3;TRPC1;ADA;RNPEP;EPAS1;EDNRA;TNNI1
8216,GO:0032989,1.51608621402044e-05,0.999990833627259,127,744,cellular component morphogenesis,BP,PTPRS;DLG4;APOE;NFATC4;S100A6;POSTN;WIPF1;CDC42EP5;SEMA4B;VEGFA;OBSCN;EGFR;FBLN1;ANK3;SPTB;CD9;PARVB;ARAP3;BRSK1;SHANK2;ADARB1;ARAP1;EFNB3;OBSL1;ULK2;RNF165;CUL7;ARPIN;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;MYH11;LAMA5;UNK;CAPRIN2;TTBK2;PRKCZ;PAK1;SEMA3F;PLXNB3;SYNE3;ZSWIM4;MICALL2;FBXW8;ETV1;NGFR;PLXNB1;SPG11;SSH3;RHOBTB2;LPAR3;S100A13;IMPACT;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;RHOF;SLITRK6;MYH3;NYAP1;SDC2;TCTN1;ARHGEF2;TWF2;DMTN;SEMA3B;ZFPM1;SSH1;METRN;TENM2;FLOT1;TTN;UNC5B;MAP6;VLDLR;ROBO3;RFX2;TRIOBP;ITGA1;AGO4;MINK1;HEXB;WNT7A;EPHA1;SEMA4G;FMNL2;ECM2;NBEAL2;KIF13B;STRADB;WDR19;LAMB1;TNNT1;FMNL3;TMOD2;FARP1;C9ORF72;TBC1D20;RAB25;WNT3;KRT19;TENM4;RPS6KA5;BRAF;ARHGAP44;CSNK1E;BCL6;FYN;SNX1;PLXND1;RHOBTB3;EPHB2;FITM2;ERBB2;UST;EIF2AK4;C15ORF62;CORO1B;NET1;GRB10;ZMYM3
1257,GO:0003013,1.53813757435458e-05,0.999992850502944,54,252,circulatory system process,BP,DOCK4;BBS2;F2R;APOE;CTNNBIP1;POSTN;NTSR1;EGFR;NOS1;SCN4B;TBC1D8;HBEGF;GAA;NISCH;VEGFB;ADM2;ITPR3;HTR7;SERPING1;STK39;MTHFR;NPR2;GSTO1;PLA2G6;PPARA;THRA;SNTA1;TTN;GSTM2;LRP5;TRPV4;ITGA1;PDE2A;APLN;NOS3;GAS6;BCR;TNNI2;PTAFR;ADCY6;ATP2B4;AKT1;ITPR2;TNNT1;MYOF;CHRM3;TAZ;EHD3;TRPC1;ADA;RNPEP;EPAS1;EDNRA;TNNI1
5315,GO:0016042,1.79118657259094e-05,0.99999221696354,45,203,lipid catabolic process,BP,APOE;TYSND1;CRAT;AIG1;HADH;ACAD10;HSD17B14;CPT2;MLYCD;PLD3;CYP27B1;PCK2;PLCH2;PHYH;ETFB;PNPLA3;PLCD3;PLA2G6;CES3;PPARA;SESN2;ACACB;THRA;PLCD1;SRD5A3;FUCA1;HSD11B1;CES2;ACADS;LONP2;HEXB;CPT1C;ACOX3;ACAD11;AKT1;ACADVL;FAAH;PNPLA4;PLB1;PEX7;SNX17;SIRT2;NAGA;CIDEA;ACOT8
322,GO:0000902,1.84243774794571e-05,0.999988834445609,118,687,cell morphogenesis,BP,PTPRS;DLG4;APOE;NFATC4;S100A6;POSTN;WIPF1;CDC42EP5;SEMA4B;VEGFA;EGFR;FBLN1;ANK3;SPTB;PARVB;ARAP3;BRSK1;SHANK2;ADARB1;ARAP1;EFNB3;OBSL1;ULK2;RNF165;CUL7;ARPIN;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;LAMA5;UNK;CAPRIN2;TTBK2;PRKCZ;PAK1;SEMA3F;PLXNB3;SYNE3;ZSWIM4;MICALL2;FBXW8;ETV1;NGFR;PLXNB1;SPG11;SSH3;RHOBTB2;LPAR3;S100A13;IMPACT;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;RHOF;SLITRK6;NYAP1;SDC2;TCTN1;ARHGEF2;TWF2;DMTN;SEMA3B;ZFPM1;SSH1;METRN;TENM2;FLOT1;UNC5B;MAP6;VLDLR;ROBO3;TRIOBP;ITGA1;AGO4;MINK1;HEXB;WNT7A;EPHA1;SEMA4G;FMNL2;ECM2;NBEAL2;KIF13B;STRADB;WDR19;LAMB1;FMNL3;FARP1;C9ORF72;TBC1D20;RAB25;WNT3;TENM4;RPS6KA5;BRAF;ARHGAP44;CSNK1E;BCL6;FYN;SNX1;PLXND1;RHOBTB3;EPHB2;FITM2;ERBB2;UST;EIF2AK4;C15ORF62;CORO1B;NET1;GRB10;ZMYM3
10784,GO:0044281,1.90396097864167e-05,0.999986912755746,226,1501,small molecule metabolic process,BP,XDH;H6PD;DLG4;GAMT;NT5E;ISYNA1;APOE;PRODH;OSBPL5;ACSF2;EGR1;LMF1;ALDH7A1;TYSND1;SLC2A3;ACP5;NAPRT;CRAT;GLUL;AIG1;ALOX15B;NAGS;TIMP2;VEGFA;NTSR1;D2HGDH;NR1D1;SLC7A8;HADH;RAPGEF3;BPHL;SLC16A3;IGFBP4;SLC2A9;IDH2;CRTAP;NOS1;DNPH1;ACAD10;PGM1;GGT1;B3GAT3;PHGDH;GAA;PYCR2;DHTKD1;ALDH4A1;TK2;SLC27A1;NISCH;CPT2;MLYCD;LHPP;PRSS3;HMGCL;UROS;HYAL1;CYP27B1;PCK2;CRYL1;PGLS;DDIT4;PLCH2;DGKQ;AKR7A2;OGDHL;NMRK1;GALE;APOBEC3C;AARS;PHYH;ERO1B;SEC14L2;CEMIP;KDM3A;MTHFR;GLDC;NPR2;CBS;DLG3;NMNAT2;NME4;NEIL1;ABHD14B;ETFB;GSTO1;PPCS;GPT2;PSAT1;PNPLA3;PLCD3;DHRS4;PSPH;ABCG1;CARS;APOBEC3F;ACOT1;PPARA;SESN2;BLMH;PKD2;ACOT11;B4GAT1;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;PC;MACROD1;ACSS2;MVD;FAM20C;MYH3;LTA4H;MLXIPL;PLCD1;INPP5D;SRD5A3;HIBADH;SDHA;PTHLH;ATF4;CHST6;LTB4R2;FUCA1;HLCS;AZIN2;GTPBP1;SORL1;GALK1;PLTP;GSTM2;VLDLR;NADK;GABBR1;ST3GAL3;CES2;ACY1;PTGR2;ACOT7;LRP5;ALDOC;PCSK9;ACADS;LONP2;TMSB4X;MOCOS;HSD17B7;PDE2A;TRIB3;ALDH1L2;PEMT;NOS3;HEXB;SLC27A3;GLUD1;SUCLG2;ALKBH7;MAN2C1;CPT1C;HEXA;SRR;UCKL1;PTAFR;CYP2R1;RXRA;ADCY6;ATP2B4;THNSL2;ACOX3;ACAD11;GSTO2;ASNS;ENTPD6;TM7SF2;AKT1;CARD11;DGUOK;B4GALT2;PHYKPL;ASS1;FGFR4;TCIRG1;HAGH;CBR4;ACADVL;SLC6A6;FAAH;UPP1;MAN2B1;INSR;ACSS1;PNPLA4;ALDH1L1;PLB1;CAT;APRT;MPI;PEX7;SNX17;TAZ;TKFC;SLC37A4;PHLDA2;OSBPL1A;TST;ADA;ENTPD2;FUK;RETSAT;PLPP6;GALNS;NMRAL1;INPP4A;FGFR1;CTH;XYLT2;UST;PFKL;BSG;NUDT18;PNKD;KDSR;CYP4V2;ACOT8
3257,GO:0006928,1.94689857853475e-05,0.99998688086743,197,1263,movement of cell or subcellular component,BP,DOCK4;BBS2;F2R;APOE;ZMYND8;SERPINE2;PGF;POSTN;WIPF1;PTK6;SEMA4B;LRP1;ALOX15B;VEGFA;EGFR;FBLN1;SLC7A8;IFT140;SPTB;TSPAN1;SLC16A3;CD9;IDH2;ARAP3;SCN4B;MMP28;MYH15;EFS;ADARB1;ARAP1;HBEGF;MMP1;EFNB3;PLAT;RNF165;NISCH;PRSS3;HYAL1;ARPIN;MAP2K1;SDCCAG8;PKN1;DDIT4;BTG1;ITGA6;PLEKHG5;FAM110C;DNAH1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;MYH11;LAMA5;UNK;TPM2;TTBK2;PRKCZ;PAK1;MCTP1;CEMIP;SEMA3F;PLXNB3;ELMO3;ZSWIM4;ITGB4;ETV1;ZP3;NEURL1;NGFR;WDR60;PLXNB1;EREG;TNS1;SPG11;RHOBTB2;C5;KIF17;IFT27;KLF7;SLIT3;ECM1;B4GAT1;MAPK3;CSPG4;LAMB2;SEMA5A;IFITM1;VANGL2;DNAL4;RHOF;SNTA1;MYH3;SRGAP3;SDC2;ARHGEF2;INPP5D;KIF21B;DMTN;SEMA3B;PROCR;PAK6;SSH1;LTB4R2;KIF26B;MDK;TTN;UNC5B;HDAC5;SORL1;PLTP;VLDLR;ROBO3;RHBDF1;LRP5;PTPRU;NDE1;PKN3;CEP131;TGFBR2;TRPV4;ITGA1;TMSB4X;SMURF2;NOS3;MINK1;HEXB;WNT7A;PIK3R2;EPHA1;SEMA4G;GAS6;BCR;FYCO1;TNNI2;KIF13B;SPAG16;PTAFR;ATP2B4;CTSH;WDR19;AKT1;LAMB1;IFT57;TTC21A;TNNT1;WDR66;CABYR;KIF27;FMNL3;IL17RC;FGFR4;ASAP3;LMNA;COPG1;RAB25;PLAU;INSR;WNT3;CKLF;FOXO4;RPS6KA5;LYST;MAP2K5;BRAF;TIMP1;JAK3;PEX7;SCYL3;BCL6;FYN;PHLDA2;RAB13;CELSR1;ADA;PLXND1;RHOBTB3;AP2A2;MYO18A;TGFBR3;VAV3;LURAP1;EPHB2;ITGA2;FGFR1;BLOC1S1;ERBB2;CORO1B;NET1;GRB10;TNNI1;BSG;KCTD13;APBA1;ROBO4
3564,GO:0007610,2.01684032824358e-05,0.999989884276584,62,310,behavior,BP,DLG4;BBS2;APOE;ESPN;SERPINE2;FOS;NTSR1;EGFR;PRNP;CST3;DNM1;SHANK2;CRTC1;ADARB1;GAA;EFNB3;NAGLU;SYNGAP1;NPHP4;ADM2;NLGN2;ITPR3;PRKCZ;ABCA7;ETV1;RAG1;ETV5;SPG11;OLFM2;PLA2G6;PPARA;THRA;RGS14;SLITRK6;MDK;VLDLR;ADGRF1;DEAF1;CEBPB;CREBRF;APLN;HEXB;TRPV1;B4GALT2;TMOD2;INSR;HOMER2;BRAF;ASIC1;GJB4;APRT;FYN;PJA2;CELSR1;ADA;MTA1;PAIP2;EPHB2;WFS1;EIF2AK4;MMP17;APBA1
2202,GO:0005088,2.13806768633971e-05,0.99999101970498,40,172,Ras guanyl-nucleotide exchange factor activity,MF,DLG4;OBSCN;EGFR;RAPGEF3;SPTB;ARHGEF19;RIN1;HBEGF;RGL2;SHC2;PLEKHG5;SHC1;FGFR3;ARHGEF4;EREG;PLEKHG2;DNMBP;TRAPPC9;ALS2CL;PLEKHG4;ARHGEF2;DOCK11;RIN2;PLEKHG3;BCR;PLEKHG6;SBF2;FGFR4;FARP1;C9ORF72;JAK3;EPS8L1;FYN;ARHGEF17;EPS8L2;VAV3;FGFR1;ERBB2;FRS3;NET1
6640,GO:0023052,2.1412004179132e-05,0.999983609409096,534,3925,signaling,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;HTRA1;DOCK4;BBS2;F2R;TNFRSF6B;APOE;SYTL1;ZMYND8;NFATC4;SERPINE2;S100A6;FOS;PRODH;IL20RB;GSN;ADGRL1;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;WIPF1;DDIT4L;PTK6;CDC42EP5;WWC3;EDEM1;GLUL;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;RHPN1;PRNP;FCGRT;SCN8A;NR1D1;FBLN1;HADH;S100A4;ANK3;DUSP5;IFT140;RAPGEF3;CLTCL1;TNFSF15;SPTB;DGKA;TSPAN1;IGFBP4;CD9;SNPH;DNM1;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;CRTC1;SCN4B;MRC2;ADGRB2;ERCC6;NDRG1;ADAMTS13;ARHGEF19;MST1R;ARRDC1;HEBP1;EFS;ZFP36L1;ADARB1;SYT8;NUPR1;RIN1;ARAP1;HBEGF;RBL2;RGL2;RPS6KA2;ARHGAP23;MMP1;CTF1;CNTN1;TFDP2;EFNB3;MDFI;EVC;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;RNF165;NISCH;ASAP2;FBXW4;CUL7;EPM2A;NXPH4;SMOC2;WWTR1;SYNGR1;SMOC1;GIGYF1;MAP2K1;CYP27B1;PCK2;PKN1;MC1R;DDIT4;TOM1L2;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;DGKQ;MAML3;PLEKHG5;FAM110C;ARL2;ULK1;SHC1;SPRY2;GRB7;NPHP4;VEGFB;ADM2;RAB3B;NLGN2;PCSK1;PLEKHH3;SLC12A7;MYCBPAP;ITPR3;LAMA5;RALGDS;PITPNC1;APPL2;CAPRIN2;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;MCTP1;ELK3;STK39;PEAR1;FGFR3;KDM3A;NPR2;SEMA3F;PLXNB3;SPRY4;USP20;SALL2;DOCK6;DLG3;ITGB4;ZP3;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;ETV5;GSTO1;ARHGEF4;LTBP1;MUC19;WNT2B;TRIB2;PLXNB1;EREG;SPG11;PTPRE;RMI2;PLCD3;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;DNMBP;ERMAP;MANF;LPAR3;S100A13;AGAP1;MTMR4;C5;PPARA;CHD3;ANO1;CHAC1;SESN2;AIP;MKNK2;RASA4;IFT27;NLRX1;PKD2;STAT6;SH3TC2;ING4;ACOT11;VAMP2;HMGA2;AREG;SLIT3;SEPT5;ECM1;PCLO;KCNC4;PI4KAP1;MAPK3;CSPG4;ITGB5;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;STK40;VANGL2;DOCK9;SH2D2A;RGS14;FAM20C;MYZAP;RHOF;PLEK2;LTBP2;CTSB;MAPK12;MVB12B;NYAP1;SRGAP3;PAQR6;SDC2;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TCTN1;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;SAMD3;STMN3;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;SEMA3B;PTHLH;ATF4;BBC3;PAK6;DOCK11;SSH1;LTB4R2;SV2A;GPR153;ACAP3;TENM2;IFI6;ZNF516;PKD1;NSMCE1;RALGAPA1;FLOT1;MDK;TTN;PSKH1;UNC5B;GTPBP1;IRF5;SORL1;PCBP4;IL17RD;HERPUD1;GSTM2;VLDLR;ADGRF1;GPRC5C;GABBR1;SULF2;ROBO3;NLRP1;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;RIN2;CREBRF;PCSK9;L3MBTL1;PKN3;FBXL15;ISG20;MARK3;TGFBR2;TRPV4;FOXL1;ARHGAP25;IQSEC2;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;CALCOCO1;EDA;CDK5RAP3;NOS3;AGO4;MINK1;LDOC1;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;SHARPIN;GAS6;GLUD1;ERN1;NUDT6;LZTS2;PLEKHG3;BCR;NBR1;BCAM;TADA3;KIF13B;CAMK1;PTAFR;PPP1R15A;RXRA;RIMS3;ADCY6;RAB43;ATP2B4;THNSL2;STRADB;CTSH;TNFRSF14;WDR19;UACA;ASNS;C12ORF66;PLEKHG6;MAPKBP1;AKT1;ITPR2;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;IFT57;IGFBP2;CAPS;TSG101;IL17RC;FGFR4;RASSF9;SLC6A9;ZNF217;TMOD2;TCIRG1;ASAP3;ACADVL;FARP1;LMNA;SH2B3;C9ORF72;CHMP5;ICA1;ARHGAP27;RAB25;IFI27;PLAU;INSR;WNT3;KRT19;TENM4;CKLF;FOXO4;GNAL;RPS6KA5;LTB4R;ITGB6;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;BTN3A2;ASIC1;PIDD1;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;JAK3;MRGPRX3;TP73;MNT;FRAT1;CHRM3;FCHSD1;MIB2;SNX17;CSNK1E;BTN3A3;BCL6;REPS2;RNF213;ADAP1;TKFC;EPS8L1;EHD3;FYN;MAST4;PJA2;LEMD2;ARHGEF17;SIRT2;TRPC1;GDF15;SPRED3;PHLDA2;RAB13;CELSR1;ADA;PLXND1;RHOBTB3;MTA1;TMEM101;ENTPD2;AP2A2;CIDEA;EPS8L2;PAIP2;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;STX1A;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;LURAP1;EPHB2;MAGI1;INPP4A;PER1;LRCH4;MCTP2;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;EIF2AK4;STK32B;UNC119;PAG1;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;FRS3;NET1;GRB10;CREB3L4;KCTD11;BSG;KCTD13;APBA1;PEX11A;CAMKK1;PNKD;DTX3;IKBKB;SNCB;HIP1;TEAD2;BTBD11
17228,GO:0120036,2.41613121277304e-05,0.999984136521446,164,1024,plasma membrane bounded cell projection organization,BP,PTPRS;DLG4;BBS2;APOE;ESPN;ZMYND8;NFATC4;S100A6;GSN;POSTN;EVI5L;PTK6;CDC42EP5;SEMA4B;LRP1;VEGFA;EGFR;PRNP;ANK3;IFT140;SPTB;NINL;PARVB;BRSK1;SHANK2;CRTC1;ADARB1;ARAP1;CNTN1;EFNB3;OBSL1;BBS1;ULK2;RNF165;CUL7;ARPIN;WWTR1;MAP2K1;SDCCAG8;SYNGAP1;ITGA6;DNAH1;ULK1;SHC1;GRB7;NPHP4;BLOC1S4;LAMA5;CAPRIN2;TTBK2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;MICALL2;CEP250;FBXW8;ETV1;NEURL1;NGFR;ARHGEF4;WDR60;PLXNB1;SPG11;SSH3;MANF;LPAR3;KIF17;IMPACT;IFT27;KLF7;NUDCD3;AREG;SLIT3;SEPT5;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;CNTRL;SLITRK6;NYAP1;SDC2;TCTN1;PTPDC1;SEPT10;FBF1;TWF2;STMN3;DMTN;SEMA3B;DOCK11;SSH1;METRN;TENM2;ATXN10;FLOT1;UNC5B;MAP6;VLDLR;ADGRF1;ROBO3;RFX2;NDE1;DBNDD1;CEP131;TRIOBP;TRPV4;ITGA1;MINK1;WNT7A;SEMA4G;CEP126;ECM2;CROCC;KIF13B;SPAG16;CAMK1;ADCY6;WDR19;TMEM80;AKT1;DGUOK;LAMB1;IFT57;SEPT6;TTC21A;KIF27;FARP1;C9ORF72;MARK4;RAB25;INSR;WNT3;RPS6KA5;BRAF;ARHGAP44;HAUS4;LGALS1;UNC119B;CSNK1E;EPS8L1;EHD3;FYN;SNX1;RAB13;PLXND1;EPS8L2;VAV3;EPHB2;SEPT8;FGFR1;BLOC1S1;SPATA6;ERBB2;UST;EIF2AK4;UNC119;C15ORF62;CORO1B;SFI1;GRB10
3374,GO:0007154,2.68798358138677e-05,0.999979301823712,536,3949,cell communication,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;HTRA1;DOCK4;BBS2;F2R;TNFRSF6B;APOE;SYTL1;ZMYND8;NFATC4;SERPINE2;S100A6;FOS;PRODH;IL20RB;GSN;ADGRL1;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;WIPF1;DDIT4L;PTK6;CDC42EP5;WWC3;EDEM1;GLUL;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;RHPN1;PRNP;FCGRT;SCN8A;NR1D1;FBLN1;HADH;S100A4;ANK3;DUSP5;IFT140;RAPGEF3;CLTCL1;TNFSF15;SPTB;DGKA;TSPAN1;IGFBP4;CD9;SNPH;DNM1;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;CRTC1;SCN4B;MRC2;ADGRB2;ERCC6;NDRG1;ADAMTS13;ARHGEF19;MST1R;ARRDC1;HEBP1;EFS;ZFP36L1;ADARB1;SYT8;NUPR1;RIN1;ARAP1;HBEGF;RBL2;RGL2;RPS6KA2;ARHGAP23;MMP1;CTF1;CNTN1;TFDP2;EFNB3;MDFI;EVC;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;RNF165;NISCH;ASAP2;FBXW4;CUL7;EPM2A;NXPH4;SMOC2;WWTR1;SYNGR1;SMOC1;GIGYF1;MAP2K1;CYP27B1;PCK2;PKN1;MC1R;DDIT4;TOM1L2;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;DGKQ;MAML3;PLEKHG5;FAM110C;ARL2;ULK1;SHC1;SPRY2;GRB7;NPHP4;VEGFB;ADM2;RAB3B;NLGN2;PCSK1;PLEKHH3;SLC12A7;MYCBPAP;ITPR3;LAMA5;RALGDS;PITPNC1;APPL2;CAPRIN2;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;MCTP1;ELK3;STK39;PEAR1;FGFR3;KDM3A;NPR2;SEMA3F;PLXNB3;CBS;SPRY4;USP20;SALL2;DOCK6;DLG3;ITGB4;ZP3;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;ETV5;GSTO1;ARHGEF4;LTBP1;MUC19;WNT2B;TRIB2;PLXNB1;EREG;SPG11;PTPRE;RMI2;PLCD3;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;DNMBP;ERMAP;MANF;LPAR3;S100A13;AGAP1;MTMR4;C5;PPARA;CHD3;ANO1;CHAC1;SESN2;AIP;MKNK2;RASA4;IMPACT;IFT27;NLRX1;PKD2;STAT6;SH3TC2;ING4;ACOT11;VAMP2;HMGA2;AREG;SLIT3;SEPT5;ECM1;PCLO;KCNC4;PI4KAP1;MAPK3;CSPG4;ITGB5;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;STK40;VANGL2;DOCK9;SH2D2A;RGS14;FAM20C;MYZAP;RHOF;PLEK2;LTBP2;CTSB;MAPK12;MVB12B;NYAP1;SRGAP3;PAQR6;SDC2;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TCTN1;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;SAMD3;STMN3;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;SEMA3B;PTHLH;ATF4;BBC3;PAK6;DOCK11;SSH1;LTB4R2;SV2A;GPR153;ACAP3;TENM2;IFI6;ZNF516;PKD1;NSMCE1;RALGAPA1;FLOT1;MDK;TTN;PSKH1;UNC5B;GTPBP1;IRF5;SORL1;PCBP4;IL17RD;HERPUD1;GSTM2;VLDLR;ADGRF1;GPRC5C;GABBR1;SULF2;ROBO3;NLRP1;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;RIN2;CREBRF;PCSK9;L3MBTL1;PKN3;FBXL15;AQP3;ISG20;MARK3;TGFBR2;TRPV4;FOXL1;ARHGAP25;IQSEC2;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;MAP1LC3A;PDE2A;SMURF2;APLN;TRIB3;RAB40B;DAP;CALCOCO1;EDA;CDK5RAP3;NOS3;AGO4;MINK1;LDOC1;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;SHARPIN;GAS6;GLUD1;ERN1;NUDT6;LZTS2;PLEKHG3;BCR;NBR1;BCAM;TADA3;KIF13B;CAMK1;PTAFR;PPP1R15A;RXRA;RIMS3;ADCY6;RAB43;ATP2B4;THNSL2;STRADB;CTSH;TNFRSF14;WDR19;UACA;ASNS;C12ORF66;PLEKHG6;MAPKBP1;AKT1;ITPR2;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;IFT57;IGFBP2;CAPS;TSG101;IL17RC;FGFR4;RASSF9;SLC6A9;ZNF217;TMOD2;TCIRG1;ASAP3;ACADVL;FARP1;LMNA;UPP1;SH2B3;C9ORF72;ICA1;ARHGAP27;RAB25;IFI27;PLAU;INSR;WNT3;KRT19;TENM4;CKLF;FOXO4;GNAL;RPS6KA5;LTB4R;ITGB6;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;BTN3A2;ASIC1;GJB4;PIDD1;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;JAK3;MRGPRX3;TP73;MNT;FRAT1;CHRM3;FCHSD1;MIB2;SNX17;CSNK1E;BTN3A3;BCL6;REPS2;RNF213;ADAP1;TKFC;EPS8L1;FYN;MAST4;PJA2;SLC38A2;LEMD2;ARHGEF17;SIRT2;GDF15;SPRED3;PHLDA2;RAB13;CELSR1;ADA;PLXND1;RHOBTB3;MTA1;TMEM101;ENTPD2;AP2A2;CIDEA;EPS8L2;PAIP2;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;STX1A;EPAS1;LAMTOR2;MAP3K10;MFNG;STARD10;EDNRA;LURAP1;EPHB2;MAGI1;INPP4A;PER1;LRCH4;MCTP2;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;EIF2AK4;STK32B;UNC119;PAG1;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;FRS3;NET1;GRB10;CREB3L4;KCTD11;BSG;KCTD13;APBA1;PEX11A;CAMKK1;PNKD;DTX3;IKBKB;SNCB;HIP1;TEAD2;BTBD11
2203,GO:0005089,2.90320045553398e-05,0.999992481970672,19,58,Rho guanyl-nucleotide exchange factor activity,MF,OBSCN;ARHGEF19;RGL2;PLEKHG5;ARHGEF4;PLEKHG2;DNMBP;PLEKHG4;ARHGEF2;DOCK11;PLEKHG3;BCR;PLEKHG6;FARP1;EPS8L1;ARHGEF17;EPS8L2;VAV3;NET1
3496,GO:0007399,2.9982033654063e-05,0.999979011017706,223,1467,nervous system development,BP,PTPRS;DLG4;BBS2;APOE;MARVELD1;BTBD2;ZMYND8;NFATC4;SERPINE2;S100A6;FOS;GSN;ADGRL1;POSTN;PTK6;GJC2;SEMA4B;LRP1;TIMP2;VEGFA;EGFR;SCN8A;ANK3;IFT140;SPTB;CD9;SNPH;IDH2;CST3;SDK2;MEF2D;NOS1;GPSM1;BRSK1;SHANK2;CRTC1;ADGRB2;NDRG1;SMARCA1;ZFP36L1;ADARB1;PHGDH;CTF1;CNTN1;EFNB3;OBSL1;ULK2;RNF165;CUL7;NAGLU;MAP2K1;SDCCAG8;DDIT4;TRNP1;SYNGAP1;PITPNM1;ULK1;SHC1;GRB7;NPHP4;BLOC1S4;SOX12;HDAC11;NLGN2;UNK;CAPRIN2;TTBK2;PRKCZ;PAK1;AARS;SEMA3F;PLXNB3;SALL2;ZSWIM4;DLG3;MICALL2;FBXW8;ETV1;SHROOM4;NEURL1;NGFR;EPOR;ETV5;MALL;WNT2B;PLXNB1;SPG11;SSH3;NAB2;TRAPPC9;MANF;LPAR3;KIF17;CHAC1;IMPACT;IFT27;PKD2;KLF7;SH3TC2;AREG;SLIT3;B4GAT1;PCLO;MAPK3;CSPG4;LAMB2;BNIP3;SEMA5A;THRA;VANGL2;RGS14;SLITRK6;MXRA8;NYAP1;SDC2;TCTN1;ARHGEF2;TWF2;STMN3;SDHA;SEMA3B;KDM4C;SSH1;METRN;TENM2;PKD1;ATXN10;FLOT1;MDK;UNC5B;HDAC5;SORL1;MAP6;VLDLR;TPBG;ADGRF1;DEAF1;SULF2;ROBO3;KDM7A;CEBPB;NDE1;PCSK9;DBNDD1;DNMT3A;TRIOBP;TGFBR2;TRPV4;TAGLN3;ITGA1;HMG20B;CDK5RAP3;MINK1;HEXB;WNT7A;SEMA4G;SHARPIN;GAS6;GLUD1;ECM2;BCR;SRR;KIF13B;CAMK1;ZNF358;ADCY6;ATP2B4;PRDM8;WDR19;AKT1;DGUOK;B4GALT2;AMIGO2;LAMB1;SEMA6B;IFT57;SBF2;FGFR4;TMOD2;FARP1;MAB21L2;C9ORF72;MARK4;WNT3;TENM4;RPS6KA5;BRAF;ARHGAP44;MAPK10;LGALS1;UNC119B;TP73;CHRM3;PEX7;CSNK1E;BCL6;GSTM3;FYN;SLC38A2;LEMD2;SIRT2;RAB13;CELSR1;PLXND1;TCF7;EDNRA;EPHB2;LRCH4;FGFR1;TMEM223;BLOC1S1;FKBP8;ERBB2;PLLP;UST;EIF2AK4;UNC119;GRB10;KCTD11;APBA1;NTM;TEAD2;BTBD11
2397,GO:0005543,3.16644726317001e-05,0.999984130423662,59,294,phospholipid binding,MF,APOE;SYTL1;HS1BP3;OSBPL5;DGKA;ARAP3;SYT8;ARAP1;NISCH;PITPNM1;SNX9;SHC1;GRB7;ITPR3;PITPNC1;MCTP1;SEC14L2;NME4;PNPLA3;ABCG1;ESYT2;LPAR3;AGAP1;SNX29;RASA4;VAMP2;PCLO;OSBPL10;GSDMA;DYSF;PLEK2;PLCD1;TWF2;TECPR1;PLTP;PSD4;MAP1LC3A;PEMT;TRPV1;GAS6;PTAFR;GSDMC;AKT1;ITPR2;WDR45;SBF2;ARHGAP44;MYOF;SNX33;SNX17;ADAP1;SNX1;OSBPL1A;MCTP2;ESYT3;SH3PXD2A;MPPE1;PLEKHA4;HIP1
12659,GO:0050896,3.66474436280004e-05,0.999971331406089,723,5521,response to stimulus,BP,TNIP1;XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;DOCK4;BBS2;F2R;NT5E;TNFRSF6B;APOE;BTBD2;ZMYND8;NFATC4;XPC;SERPINE2;S100A6;FOS;PRODH;IL20RB;GSN;ADGRL1;CITED4;PYGB;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;WIPF1;SLC2A3;FBXO2;DDIT4L;PTK6;TMEM129;CDC42EP5;ACP5;WWC3;NAPRT;EDEM1;RNF135;GLUL;FAM210B;GPX3;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;FCGRT;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;TFPI2;DUSP5;IFT140;RAPGEF3;BPHL;CLTCL1;TNFSF15;SPTB;LOXL1;DGKA;TSPAN1;IGFBP4;CD9;CST3;DNM1;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;DNAJB5;PGM1;CRTC1;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;ABTB1;ARHGEF19;MMP28;MST1R;ARRDC1;HEBP1;EFS;ZFP36L1;ADARB1;NUPR1;RIN1;ARAP1;HBEGF;RBL2;RGL2;RPS6KA2;ARHGAP23;GAA;PYGL;MMP1;PYCR2;CTF1;CNTN1;CYP3A5;TFDP2;EFNB3;RPL13A;MSRB2;MDFI;EVC;BBS1;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;KLF9;RNF165;NISCH;MLYCD;ASAP2;FBXW4;ASH2L;CUL7;EPM2A;PRSS3;HMGCL;UROS;HYAL1;NXPH4;SMOC2;PPP1R14A;TXNRD3;WWTR1;SYNGR1;SMOC1;POLD4;GIGYF1;MAP2K1;CYP27B1;PCK2;COL6A1;PPL;ABCA2;PKN1;MC1R;DDIT4;BTG1;TOM1L2;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PITPNM1;PHF21A;DGKQ;AKR7A2;MAML3;TMEM173;PLEKHG5;DNAJC4;FAM213A;FAM110C;MAGEF1;ULK1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;ADM2;RAB3B;NLGN2;CD68;PLEKHH3;CYBRD1;ITPR3;LAMA5;RALGDS;PITPNC1;APPL2;CIRBP;CAPRIN2;TTBK2;PRKCZ;HTR7;SERPING1;PAK1;ABCA7;APOBEC3C;PRR7;MCTP1;ELK3;STK39;PEAR1;FGFR3;KDM3A;MTHFR;BRI3;PHF1;GLDC;NPR2;SEMA3F;PLXNB3;CBS;SPRY4;FAM3A;USP20;SALL2;DOCK6;ZSWIM4;ITGB4;ETV1;ZP3;NEIL1;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;NGFR;EPOR;ETV5;GSTO1;ARHGEF4;LTBP1;MUC19;WNT2B;NSMCE4A;ACTR1B;TRIB2;PLXNB1;EREG;CHD2;TMC6;PTPRE;RMI2;PLCD3;PLEKHG2;PSPH;RHOBTB2;TMED4;TNFRSF25;PLA2G6;CES3;ABCG1;DNMBP;CARF;SCART1;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;MTMR4;C5;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;ANO1;CHAC1;FNDC4;SESN2;AIP;BLMH;MKNK2;RASA4;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;SH3TC2;ING4;ACOT11;VAMP2;HMGA2;AREG;SLIT3;ECM1;B4GAT1;LRP11;PCLO;PI4KAP1;ACACB;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;BNIP3;ERRFI1;MACROD1;SEMA5A;THRA;IFITM1;STK40;VANGL2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;FAM20C;MYZAP;DYSF;RHOF;PLEK2;SLC22A18;LTBP2;CTSB;SLITRK6;MAPK12;MVB12B;LTA4H;NYAP1;PI4K2A;SRGAP3;PAQR6;PQLC2;SDC2;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TCTN1;C1RL;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;PRAF2;TSPYL2;MAP2K2;TWF2;SAMD3;STMN3;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;UBXN4;MORN4;ATF4;PROCR;ZFPM1;BBC3;PAK6;DOCK11;SSH1;LTB4R2;PRIMPOL;GPR153;POLM;ACAP3;TENM2;FBXO6;IFI6;REEP6;ZNF516;PKD1;FUCA1;NSMCE1;RALGAPA1;FLOT1;MDK;TTN;PSKH1;HLCS;KCNMA1;UNC5B;HDAC5;GTPBP1;IRF5;SORL1;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;ADGRF1;GPRC5C;GABBR1;DEAF1;SULF2;ROBO3;CES2;NLRP1;ACY1;RFX2;ENDOG;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;RIN2;ALDOC;CREBRF;PCSK9;L3MBTL1;PKN3;FBXL15;AQP3;ISG20;LONP2;MARK3;DNMT3A;TGFBR2;TRPV4;FOXL1;ARHGAP25;IQSEC2;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;MAP1LC3A;APOL4;HSD17B7;PDE2A;SMURF2;APLN;TRIB3;RAB40B;DAP;BHLHE40;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;WNT7A;HERPUD2;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;SHARPIN;CCS;GAS6;ERN1;NUDT6;LZTS2;ALKBH7;PLEKHG3;BCR;ATP7B;NBR1;BCAM;SRR;TADA3;NBEAL2;KIF13B;SPAG16;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ADCY6;RAB43;ATP2B4;SPATA7;THNSL2;STRADB;CTSH;TNFRSF14;WDR19;UACA;GSDMC;MGMT;GSTO2;ASNS;ENTPD6;C12ORF66;PLEKHG6;STEAP2;MAPKBP1;AKT1;IGFBP7;ITPR2;CARD11;CDKN1C;MICAL1;CRY2;B4GALT2;CHEK2;HMSD;IFT57;IGFBP2;ASS1;CAPS;TNNT1;TSG101;IL17RC;FGFR4;RASSF9;SLC6A9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;ACADVL;FARP1;LMNA;UPP1;SH2B3;C9ORF72;ARSA;CAPN2;MAN2B1;SPATA18;ARHGAP27;RAB25;IFI27;PLAU;INSR;WNT3;KRT19;NCOA7;TENM4;SLC25A29;CKLF;FOXO4;GNAL;YPEL3;RPS6KA5;ANKZF1;LTB4R;ULBP1;TXNRD2;ITGB6;HOMER2;C6ORF89;LYST;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;BTN3A2;ASIC1;GJB4;FAAP20;PIDD1;CAT;MYOF;MAPK10;DPP7;YPEL5;MPG;LGALS1;TIMP1;HFE;JAK3;MRGPRX3;TP73;SCNN1A;MNT;FRAT1;CHRM3;APRT;TMX4;TFEB;MIB2;SNX17;ENDOV;ICAM5;METTL7A;CSNK1E;HGSNAT;BTN3A3;BCL6;REPS2;HSF4;REC8;RNF213;GSTM3;ADAP1;TKFC;EPS8L1;EHD3;FYN;MAST4;PJA2;SLC38A2;LEMD2;UBXN6;ARHGEF17;SLC25A42;SIRT2;TRPC1;GDF15;SPRED3;PHLDA2;RECQL5;RAB13;TOM1;CELSR1;ADA;POU2F2;PLXND1;RHOBTB3;MTA1;TMEM101;MSH5;ENTPD2;AP2A2;CIDEA;EPS8L2;HDAC8;SLC35F3;ADIRF;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;MFNG;STARD10;EDNRA;CHD6;LURAP1;EPHB2;MAGI1;INPP4A;PER1;LRCH4;MCTP2;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;PLLP;EIF2AK4;STK32B;UNC119;PAG1;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;NET1;HSP90AB4P;GRB10;TNNI1;CREB3L4;MMP19;KCTD11;BSG;SDHAF4;KCTD13;PEX11A;CAMKK1;DTX3;IKBKB;SNCB;HIP1;CYP4V2;TEAD2;BTBD11
6555,GO:0022008,3.71374649111088e-05,0.999975205359878,162,1015,neurogenesis,BP,PTPRS;DLG4;APOE;BTBD2;ZMYND8;NFATC4;SERPINE2;S100A6;GSN;POSTN;PTK6;GJC2;SEMA4B;LRP1;TIMP2;VEGFA;EGFR;ANK3;IFT140;SPTB;CD9;SNPH;IDH2;SDK2;NOS1;BRSK1;SHANK2;CRTC1;NDRG1;SMARCA1;ADARB1;CTF1;CNTN1;EFNB3;OBSL1;ULK2;RNF165;CUL7;NAGLU;MAP2K1;SDCCAG8;DDIT4;SYNGAP1;ULK1;SHC1;GRB7;NPHP4;BLOC1S4;HDAC11;UNK;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;MICALL2;FBXW8;ETV1;NEURL1;NGFR;ETV5;WNT2B;PLXNB1;SPG11;SSH3;NAB2;TRAPPC9;MANF;LPAR3;KIF17;CHAC1;IMPACT;IFT27;KLF7;SH3TC2;AREG;SLIT3;B4GAT1;MAPK3;CSPG4;LAMB2;BNIP3;SEMA5A;VANGL2;RGS14;SLITRK6;MXRA8;NYAP1;SDC2;TCTN1;ARHGEF2;TWF2;STMN3;SEMA3B;KDM4C;SSH1;METRN;TENM2;ATXN10;FLOT1;UNC5B;HDAC5;SORL1;MAP6;VLDLR;ADGRF1;ROBO3;CEBPB;NDE1;PCSK9;DBNDD1;DNMT3A;TRIOBP;TRPV4;ITGA1;HMG20B;CDK5RAP3;MINK1;HEXB;WNT7A;SEMA4G;GAS6;ECM2;KIF13B;CAMK1;ADCY6;PRDM8;AKT1;DGUOK;LAMB1;FARP1;C9ORF72;WNT3;TENM4;RPS6KA5;BRAF;ARHGAP44;MAPK10;LGALS1;UNC119B;TP73;PEX7;CSNK1E;BCL6;FYN;LEMD2;SIRT2;RAB13;CELSR1;PLXND1;EPHB2;FGFR1;BLOC1S1;ERBB2;UST;EIF2AK4;UNC119;GRB10;KCTD11;NTM;BTBD11
12399,GO:0048869,4.05349357162263e-05,0.999969414491452,377,2680,cellular developmental process,BP,XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;BBS2;APOE;BTBD2;ZMYND8;NFATC4;FLNC;SERPINE2;FHL1;S100A6;FOS;GSN;EGR1;CTNNBIP1;PGF;POSTN;WIPF1;PTK6;CDC42EP5;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;NR1D1;ERCC1;FBLN1;ADAMTS7;S100A4;ANK3;IFT140;RAPGEF3;SPTB;KRT15;CD9;SNPH;IDH2;CST3;SDK2;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;BRSK1;DNPH1;SHANK2;MICALCL;CRTC1;MRC2;NDRG1;COL13A1;SMARCA1;MST1R;ZFP36L1;ADARB1;NUPR1;ARAP1;TCFL5;RBL2;CTF1;CNTN1;DHTKD1;EFNB3;OBSL1;MDFI;LTBP4;ULK2;RNF165;ASH2L;SOX13;CUL7;NAGLU;ARPIN;ETV4;TXNRD3;WWTR1;SMOC1;MAP2K1;CYP27B1;PCK2;COL6A1;CCDC71L;PPL;SDCCAG8;DDIT4;BTG1;SYNGAP1;ITGA6;FAM213A;DNAH1;ULK1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;SOX12;HDAC11;MYCBPAP;MYH11;LAMA5;UNK;PRSS8;CAPRIN2;TTBK2;PRKCZ;PAK1;ELK3;PABPC1L;FGFR3;KDM3A;FOXQ1;NPR2;SEMA3F;PLXNB3;SYNE3;ZSWIM4;ITGB4;MICALL2;FBXW8;ETV1;ZP3;NEURL1;ACVR2B;RAG1;SPEG;NGFR;ETV5;LCE1E;WNT2B;TRIB2;PLXNB1;EREG;CHD2;SPG11;SSH3;SPATA20;OLFM2;RHOBTB2;NAB2;ABCG1;TRAPPC9;MANF;LPAR3;S100A13;KIF17;PPARA;CHAC1;IMPACT;IFT27;SATB1;STAT6;KLF7;SH3TC2;HMGA2;AREG;COL8A1;SLIT3;B4GAT1;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;VANGL2;SH2D2A;RGS14;FAM20C;TDRKH;PBXIP1;RHOF;CTSB;SLITRK6;MXRA8;MAPK12;MYH3;NYAP1;SDC2;ARHGAP22;TCTN1;ARHGEF2;INPP5D;TWF2;STMN3;DMTN;LRRC8A;ANGPTL4;SEMA3B;PTHLH;ZFPM1;KDM4C;DOCK11;SSH1;METRN;POLM;TENM2;ZNF516;ATXN10;FLOT1;LTBP3;MDK;TTN;JDP2;UNC5B;HDAC5;SORL1;MAP6;VLDLR;ADGRF1;DEAF1;SULF2;ROBO3;RFX2;EGFL7;CEBPB;LRP5;PTPRU;ATRAID;ALDOC;NDE1;PCSK9;DBNDD1;L3MBTL1;AQP3;CEP131;DNMT3A;TRIOBP;TGFBR2;TRPV4;FOXL1;ITGA1;CMTM7;SLFN5;PDE2A;TRIB3;EDA;HMG20B;CDK5RAP3;AGO4;MINK1;HEXB;WNT7A;TRPV1;EPHA1;SEMA4G;SHARPIN;FMNL2;GAS6;ECM2;NBR1;NBEAL2;KIF13B;SPAG16;CAMK1;TERC;RXRA;ADCY6;PRDM8;STRADB;WDR19;MGMT;LCE1F;AKT1;CARD11;DGUOK;LAMB1;CHEK2;SEMA6B;SEPT6;TNNT1;CABYR;TSG101;FMNL3;FGFR4;TMOD2;ACADVL;FARP1;DNASE2;LMNA;SH2B3;WDFY2;C9ORF72;TBC1D20;UHRF2;CAPN2;RAB25;INSR;WNT3;KRT19;TENM4;FOXO4;YPEL3;RPS6KA5;BRAF;YIPF3;EDA2R;ARHGAP44;CAT;MYOF;MAPK10;LGALS1;UNC119B;JAK3;TP73;MNT;PEX7;CSNK1E;BCL6;HSF4;REC8;GSTM3;FYN;SNX1;LEMD2;SIRT2;GDF15;RAB13;TST;CELSR1;ADA;POU2F2;PLXND1;RHOBTB3;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MFNG;EDNRA;EPHB2;ITGA2;FGFR1;BLOC1S1;FITM2;FKBP8;SPATA6;SH3PXD2A;CTH;ERBB2;UST;EIF2AK4;UNC119;C15ORF62;HLA-G;CORO1B;NET1;GRB10;MMP19;KCTD11;ZMYM3;PEX11A;IKBKB;NTM;DMTF1;HIP1;ROBO4;TEAD2;BTBD11;SIX5
3066,GO:0006635,4.50656027757659e-05,0.999987794430671,19,61,fatty acid beta-oxidation,BP,TYSND1;CRAT;HADH;ACAD10;CPT2;MLYCD;ETFB;PPARA;SESN2;ACACB;ACADS;LONP2;CPT1C;ACOX3;ACAD11;AKT1;ACADVL;PEX7;ACOT8
12295,GO:0048667,4.59116292809513e-05,0.999974793266641,72,382,cell morphogenesis involved in neuron differentiation,BP,PTPRS;DLG4;APOE;NFATC4;S100A6;SEMA4B;VEGFA;ANK3;SPTB;BRSK1;SHANK2;ADARB1;EFNB3;OBSL1;ULK2;RNF165;CUL7;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;UNK;CAPRIN2;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;ETV1;NGFR;PLXNB1;SPG11;SSH3;LPAR3;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;SDC2;TCTN1;TWF2;SEMA3B;SSH1;METRN;FLOT1;UNC5B;MAP6;VLDLR;ROBO3;TRIOBP;MINK1;WNT7A;SEMA4G;ECM2;KIF13B;FARP1;C9ORF72;WNT3;RPS6KA5;BRAF;ARHGAP44;FYN;PLXND1;EPHB2;ERBB2;UST;GRB10
12389,GO:0048856,5.33739928543912e-05,0.999958585179162,492,3612,anatomical structure development,BP,XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;GAMT;BBS2;F2R;TNFRSF6B;APOE;MARVELD1;BTBD2;ZMYND8;NFATC4;FLNC;SERPINE2;FHL1;S100A6;FOS;GSN;ADGRL1;EGR1;CTNNBIP1;THBS3;PGF;POSTN;WIPF1;ADAM19;PTK6;CDC42EP5;ACP5;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;SCN8A;NR1D1;ERCC1;FBLN1;ADAMTS7;S100A4;ANK3;DUSP5;IFT140;RAPGEF3;CLTCL1;SPTB;LOXL1;IGFBP4;KRT15;CD9;SNPH;IDH2;CST3;SDK2;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;BRSK1;DNPH1;SHANK2;MICALCL;CRTC1;ADGRB2;NDRG1;ARHGEF19;COL13A1;MYH15;SMARCA1;MST1R;ZFP36L1;ADARB1;NUPR1;ARAP1;TCFL5;HBEGF;PHGDH;GAA;CTF1;CNTN1;DHTKD1;TFDP2;EFNB3;OBSL1;MDFI;EVC;LTBP4;ULK2;RNF165;RAB11FIP4;FBXW4;ASH2L;SOX13;CUL7;HMGCL;HYAL1;NAGLU;ARPIN;TXNRD3;WWTR1;SMOC1;MAP2K1;CYP27B1;PCK2;COL6A1;PPL;SDCCAG8;PKN1;MC1R;DDIT4;BTG1;TRNP1;SYNGAP1;ITGA6;PHC2;PITPNM1;PBX2;FAM213A;DNAH1;ULK1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;ADM2;SOX12;HDAC11;NLGN2;MYCBPAP;MYH11;LAMA5;UNK;PRSS8;CAPRIN2;TTBK2;PRKCZ;PAK1;AARS;ELK3;PABPC1L;FGFR3;KDM3A;FOXQ1;ARVCF;NPR2;SEMA3F;PLXNB3;SPRY4;SALL2;SYNE3;ZSWIM4;DLG3;ITGB4;MICALL2;FBXW8;ETV1;ZP3;SHROOM4;NEURL1;ACVR2B;RAG1;SPEG;NGFR;EPOR;NID1;ETV5;LCE1E;WDR60;LTBP1;MALL;WNT2B;PLXNB1;EREG;CHD2;TEF;SPG11;SSH3;SPATA20;OLFM2;PLCD3;RHOBTB2;TNFRSF25;NAB2;TRAPPC9;MANF;LPAR3;S100A13;C5;KIF17;PPARA;ANO1;CHAC1;MKNK2;SCMH1;TCF25;IMPACT;IFT27;PKD2;SATB1;STAT6;KLF7;SH3TC2;HMGA2;AREG;COL8A1;SLIT3;ECM1;B4GAT1;PCLO;ACACB;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;STK40;VANGL2;SH2D2A;RGS14;KCTD15;FAM20C;PBXIP1;RHOF;CTSB;SLITRK6;MXRA8;MAPK12;MYH3;NYAP1;SDC2;ARHGAP22;MLXIPL;TCTN1;PLCD1;ARHGEF2;INPP5D;TWF2;STMN3;SDHA;DMTN;LRRC8A;ANGPTL4;SEMA3B;PTHLH;ZFPM1;MOSPD3;KDM4C;DOCK11;SSH1;SLC38A10;METRN;POLM;TENM2;KIF26B;ZNF516;PKD1;ATXN10;FLOT1;MDK;TTN;PSKH1;HSD11B1;UNC5B;HDAC5;SORL1;MAP6;SRSF5;VLDLR;TPBG;ADGRF1;PRR15;DEAF1;SULF2;ROBO3;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;NEK8;LRP5;PTPRU;WNK4;ATRAID;ALDOC;NDE1;PCSK9;DBNDD1;L3MBTL1;FBXL15;AQP3;CEP131;DNMT3A;TRIOBP;TGFBR2;TRPV4;TAGLN3;FOXL1;MN1;ITGA1;CMTM7;PDE2A;SMURF2;APLN;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;WNT7A;TRPV1;EPHA1;SEMA4G;SHARPIN;FMNL2;GAS6;GLUD1;LZTS2;ECM2;BCR;ATP7B;NBR1;SRR;NBEAL2;KIF13B;SPAG16;CAMK1;POLL;RXRA;ZNF358;ADCY6;ATP2B4;PRDM8;STRADB;CTSH;TNFRSF14;WDR19;MGMT;ASNS;LCE1F;AKT1;IGFBP7;CARD11;DGUOK;B4GALT2;AMIGO2;LAMB1;SEMA6B;IFT57;SBF2;TNNT1;CABYR;TSG101;FMNL3;PHF2;FGFR4;IGF2BP2;ZNF217;TMOD2;ACADVL;FARP1;DNASE2;LMNA;SH2B3;MAB21L2;C9ORF72;TBC1D20;CAPN2;MARK4;RAB25;INSR;WNT3;KRT19;TENM4;FOXO4;RPS6KA5;CHMP4C;MAP2K5;BRAF;EDA2R;ARHGAP44;HOXC5;CAT;ZNF160;MYOF;MAPK10;LGALS1;UNC119B;TIMP1;HFE;JAK3;TP73;MNT;CHRM3;APRT;TFEB;PEX7;SNX17;LSM14B;PHC1;CSNK1E;TAZ;BCL6;HSF4;REC8;RNF213;GSTM3;FYN;SLC38A2;SNX1;LEMD2;SIRT2;GDF15;SPRED3;PHLDA2;RAB13;TST;CELSR1;ADA;POU2F2;PLXND1;RHOBTB3;ETNK2;AP2A2;RPL29;TGFBR3;TCF7;VAV3;EPAS1;MFNG;EDNRA;EPHB2;LRCH4;MCTP2;IGF2BP3;ITGA2;FGFR1;WFS1;TMEM223;BLOC1S1;FITM2;FKBP8;SPATA6;SH3PXD2A;CTH;ERBB2;PLLP;UST;EIF2AK4;UNC119;C15ORF62;HLA-G;CORO1B;MMP17;NET1;RTL1;GRB10;TSHZ1;TNNI1;MMP19;KCTD11;BSG;ZMYM3;SDHAF4;TRIM45;DBP;APBA1;IKBKB;NTM;ROBO4;TEAD2;BTBD11;SIX5
12728,GO:0051020,5.78739611112879e-05,0.999965562971645,92,521,GTPase binding,MF,DLG4;DOCK4;SYTL1;EVI5L;CDC42EP5;OBSCN;EGFR;RAPGEF3;SPTB;ARAP3;NDRG1;TBC1D8;ARHGEF19;RIN1;ARAP1;HBEGF;RGL2;EXOC2;RAB11FIP4;ASAP2;PKN1;SHC2;PLEKHG5;ULK1;SHC1;RALGDS;APPL2;PAK1;FGFR3;DOCK6;MICALL2;NGFR;ARHGEF4;EREG;PLEKHG2;DNMBP;XPOT;TRAPPC9;RINL;AGAP1;ALS2CL;BNIP3;ERRFI1;DOCK9;SRGAP3;PLEKHG4;TBC1D14;ARHGEF2;PAK6;DOCK11;TBC1D3E;RABGAP1;ACAP3;WHAMMP3;SORL1;RIN2;PKN3;TRIOBP;IQSEC2;PSD4;FMNL2;PLEKHG3;BCR;RIMS3;PLEKHG6;MICAL1;SBF2;FMNL3;FGFR4;ASAP3;FARP1;C9ORF72;SGSM2;TBC1D20;RABGGTA;ARHGAP44;JAK3;ADAP1;EPS8L1;FYN;ARHGEF17;RHOBTB3;EPS8L2;VAV3;LAMTOR2;TBC1D16;FGFR1;ERBB2;C15ORF62;FRS3;NET1;KCTD13
10385,GO:0043235,5.90084211127913e-05,0.999973560891313,41,185,receptor complex,CC,DLG4;LRP1;EGFR;SHANK2;MST1R;ITGA6;ITPR3;CAPRIN2;FGFR3;PLXNB3;DLG3;ITGB4;ACVR2B;PLXNB1;OLFM2;AIP;ITGB5;VLDLR;GPRC5C;GABBR1;LRP5;TGFBR2;ITGA1;EPHA1;CPT1C;RXRA;TM7SF2;ITPR2;CARD11;FGFR4;INSR;ITGB6;HFE;TRPC1;PLXND1;TGFBR3;EPHB2;ITGA2;FGFR1;ERBB2;IKBKB
7918,GO:0032502,6.0471632353784e-05,0.999952751940165,526,3895,developmental process,BP,XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;GAMT;BBS2;F2R;TNFRSF6B;APOE;MARVELD1;BTBD2;ZMYND8;NFATC4;FLNC;SERPINE2;FHL1;S100A6;FOS;GSN;ADGRL1;CITED4;EGR1;CTNNBIP1;THBS3;PGF;POSTN;WIPF1;ADAM19;PTK6;CDC42EP5;ACP5;WWC3;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PRNP;SCN8A;NR1D1;ERCC1;FBLN1;ADAMTS7;S100A4;ANK3;DUSP5;IFT140;RAPGEF3;CLTCL1;SPTB;LOXL1;IGFBP4;KRT15;CD9;SNPH;IDH2;CST3;SDK2;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;BRSK1;DNPH1;SHANK2;MICALCL;CRTC1;MRC2;ADGRB2;ERCC6;NDRG1;ARHGEF19;COL13A1;MYH15;SMARCA1;MST1R;ZFP36L1;ADARB1;NUPR1;ARAP1;TCFL5;HBEGF;RBL2;PHGDH;GAA;CTF1;CNTN1;DHTKD1;TFDP2;EFNB3;OBSL1;MDFI;EVC;LTBP4;ULK2;RNF165;RAB11FIP4;FBXW4;ASH2L;SOX13;CUL7;HMGCL;HYAL1;NAGLU;ARPIN;ETV4;TXNRD3;WWTR1;SMOC1;MAP2K1;CYP27B1;PCK2;COL6A1;CCDC71L;PPL;SDCCAG8;PKN1;MC1R;DDIT4;BTG1;TRNP1;SYNGAP1;ITGA6;PHC2;PITPNM1;PBX2;FAM213A;DNAH1;ULK1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;ADM2;SOX12;HDAC11;NLGN2;MYCBPAP;MYH11;LAMA5;UNK;PRSS8;CAPRIN2;TTBK2;PRKCZ;SERPING1;PAK1;AARS;ELK3;PABPC1L;FGFR3;KDM3A;FOXQ1;ARVCF;NPR2;SEMA3F;PLXNB3;SPRY4;SALL2;SYNE3;ZSWIM4;DLG3;ITGB4;MICALL2;FBXW8;ETV1;ZP3;SHROOM4;NEURL1;ACVR2B;RAG1;SPEG;NGFR;EPOR;NID1;ETV5;LCE1E;WDR60;LTBP1;MALL;WNT2B;TRIB2;PLXNB1;EREG;CHD2;TEF;SPG11;SSH3;SPATA20;OLFM2;PLCD3;RHOBTB2;TNFRSF25;NAB2;ABCG1;TRAPPC9;MANF;LPAR3;S100A13;C5;KIF17;PPARA;ANO1;CHAC1;MKNK2;SCMH1;TCF25;IMPACT;IFT27;PKD2;SATB1;STAT6;KLF7;SH3TC2;NUDCD3;HMGA2;AREG;COL8A1;SLIT3;ECM1;B4GAT1;PCLO;ACACB;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;STK40;VANGL2;SH2D2A;RGS14;IRF2BPL;KCTD15;FAM20C;TDRKH;PBXIP1;RHOF;CTSB;SLITRK6;MXRA8;MAPK12;MYH3;NYAP1;SDC2;ARHGAP22;MLXIPL;TCTN1;PLCD1;ARHGEF2;INPP5D;TWF2;STMN3;SDHA;DMTN;LRRC8A;LITAF;ANGPTL4;SEMA3B;PTHLH;ZFPM1;MOSPD3;KDM4C;DOCK11;SSH1;SLC38A10;METRN;POLM;TENM2;KIF26B;ZNF516;PKD1;ATXN10;FLOT1;LTBP3;MDK;TTN;PSKH1;HSD11B1;JDP2;UNC5B;HDAC5;SORL1;MAP6;SRSF5;VLDLR;TPBG;ADGRF1;PRR15;DEAF1;SULF2;ROBO3;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;NEK8;LRP5;PTPRU;WNK4;ATRAID;ALDOC;NDE1;PCSK9;DBNDD1;L3MBTL1;FBXL15;AQP3;CEP131;DNMT3A;TRIOBP;TGFBR2;TRPV4;TAGLN3;FOXL1;MN1;ITGA1;CMTM7;SLFN5;PDE2A;SMURF2;APLN;TRIB3;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;WNT7A;TRPV1;EPHA1;SEMA4G;SHARPIN;FMNL2;GAS6;GLUD1;LZTS2;ECM2;BCR;ATP7B;NBR1;SRR;NBEAL2;KIF13B;SPAG16;CAMK1;POLL;TERC;RXRA;ZNF358;ADCY6;ATP2B4;PRDM8;STRADB;CTSH;TNFRSF14;WDR19;MGMT;ASNS;LCE1F;AKT1;IGFBP7;CARD11;DGUOK;B4GALT2;AMIGO2;LAMB1;CHEK2;SEMA6B;IFT57;SBF2;IGFBP2;SEPT6;TNNT1;CABYR;TSG101;FMNL3;PHF2;FGFR4;IGF2BP2;ZNF217;TMOD2;ACADVL;FARP1;DNASE2;LMNA;SH2B3;MAB21L2;WDFY2;C9ORF72;TBC1D20;UHRF2;CAPN2;MARK4;RAB25;INSR;WNT3;KRT19;TENM4;FOXO4;YPEL3;RPS6KA5;CHMP4C;MAP2K5;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;HOXC5;CAT;ZNF160;MYOF;MAPK10;LGALS1;UNC119B;TIMP1;HFE;JAK3;TP73;MNT;CHRM3;APRT;TFEB;PEX7;SNX17;LSM14B;PHC1;CSNK1E;TAZ;BCL6;HSF4;REC8;RNF213;GSTM3;FYN;SLC38A2;SNX1;LEMD2;SIRT2;GDF15;SPRED3;PHLDA2;RAB13;TST;CELSR1;ADA;POU2F2;PLXND1;RHOBTB3;ETNK2;AP2A2;HDAC8;ADIRF;RPL29;TGFBR3;TCF7;VAV3;EPAS1;MFNG;EDNRA;EPHB2;LRCH4;MCTP2;IGF2BP3;ITGA2;FGFR1;WFS1;TMEM223;BLOC1S1;FITM2;FKBP8;SPATA6;SH3PXD2A;CTH;ERBB2;PLLP;UST;EIF2AK4;UNC119;C15ORF62;HLA-G;CORO1B;MMP17;NET1;RTL1;GRB10;TSHZ1;TNNI1;MMP19;KCTD11;BSG;ZMYM3;SDHAF4;TRIM45;DBP;APBA1;PEX11A;IKBKB;NTM;DMTF1;HIP1;ROBO4;TEAD2;BTBD11;SIX5
2199,GO:0005085,6.2030294859116e-05,0.999970252206923,48,229,guanyl-nucleotide exchange factor activity,MF,DLG4;DOCK4;OBSCN;EGFR;RAPGEF3;SPTB;ARHGEF19;RIN1;HBEGF;RGL2;SHC2;PLEKHG5;SHC1;RALGDS;FGFR3;DOCK6;ARHGEF4;EREG;PLEKHG2;DNMBP;TRAPPC9;RINL;ALS2CL;DOCK9;PLEKHG4;ARHGEF2;DOCK11;RIN2;IQSEC2;PSD4;PLEKHG3;BCR;PLEKHG6;SBF2;FGFR4;FARP1;C9ORF72;JAK3;EPS8L1;FYN;ARHGEF17;EPS8L2;VAV3;LAMTOR2;FGFR1;ERBB2;FRS3;NET1
17230,GO:0120039,6.33375493809131e-05,0.999963720783309,80,440,plasma membrane bounded cell projection morphogenesis,BP,PTPRS;DLG4;APOE;NFATC4;S100A6;POSTN;SEMA4B;VEGFA;EGFR;ANK3;SPTB;BRSK1;SHANK2;ADARB1;EFNB3;OBSL1;ULK2;RNF165;CUL7;ARPIN;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;ETV1;NGFR;PLXNB1;SPG11;SSH3;LPAR3;IMPACT;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;NYAP1;SDC2;TCTN1;TWF2;SEMA3B;SSH1;METRN;FLOT1;UNC5B;MAP6;VLDLR;ROBO3;ITGA1;MINK1;WNT7A;SEMA4G;ECM2;KIF13B;FARP1;C9ORF72;WNT3;RPS6KA5;BRAF;ARHGAP44;FYN;SNX1;PLXND1;EPHB2;ERBB2;UST;EIF2AK4;CORO1B;GRB10
10338,GO:0043168,6.65966381036678e-05,0.999950707273761,290,1997,anion binding,MF,XDH;PTPRS;ACTA2;APOE;SYTL1;HS1BP3;SERPINE2;PRODH;OSBPL5;ACSF2;PYGB;THBS3;PGF;FGFBP1;POSTN;PTK6;GLUL;LRP1;NAGS;VEGFA;OBSCN;EGFR;D2HGDH;SCN8A;HADH;NEK9;RAPGEF3;ACBD4;DGKA;DNM1;NOS1;ARAP3;BRSK1;ACAD10;ERCC6;COL13A1;MYH15;SMARCA1;MST1R;SYT8;CUL9;ARAP1;HBEGF;RPS6KA2;PYGL;DHTKD1;TK2;ULK2;MAPK13;CDK18;NISCH;HMGCL;SMOC2;TXNRD3;MAP2K1;PCK2;CRYL1;ABCA2;PKN1;ALPK1;OPLAH;PITPNM1;DGKQ;TUBG2;TMEM173;SNX9;DNAH1;ARL2;ULK1;SHC1;GRB7;VEGFB;OGDHL;RAB3B;MYH11;ITPR3;PITPNC1;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;PHYH;MCTP1;STK39;FGFR3;SEC14L2;CEMIP;MTHFR;GLDC;NPR2;CBS;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;GPT2;PNPLA3;RHOBTB2;ABCG1;ESYT2;LPAR3;AGAP1;CARS;KIF17;PPARA;CHD3;SNX29;SESN2;MKNK2;RASA4;IFT27;NLRX1;VAMP2;SEPT5;PCLO;ACACB;MAPK3;PC;OSBPL10;SEMA5A;STK40;ACSS2;GSDMA;MVD;FAM20C;DYSF;RHOF;PLEK2;LTBP2;TUBE1;MAPK12;MYH3;PI4K2A;PLCD1;SEPT10;MAP2K2;TWF2;SDHA;TECPR1;KIF21B;PAK6;KIF26B;MDK;TTN;PSKH1;HLCS;GTPBP1;GALK1;NTPCR;PLTP;GSTM2;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;ACOT7;WNK4;PKN3;ACADS;LONP2;MARK3;HLTF;TGFBR2;TRPV4;PSD4;SLFN5;MAP1LC3A;MOCOS;PDE2A;TRIB3;RAB40B;ARL10;MLH3;PEMT;NOS3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GAS6;GLUD1;SUCLG2;ERN1;ECM2;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;PTAFR;RXRA;ADCY6;RAB43;ATP2B4;THNSL2;STRADB;ACOX3;ACAD11;GSDMC;ASNS;AKT1;ITPR2;DGUOK;MICAL1;CRY2;CHEK2;PHYKPL;WDR45;SBF2;SEPT6;ASS1;KIF27;FGFR4;CBR4;ACADVL;MARK4;RAB25;INSR;ACSS1;GNAL;RPS6KA5;TNXB;TXNRD2;MAP2K5;BRAF;ARHGAP44;MYOF;MAPK10;JAK3;SNX33;APRT;OGFOD2;SNX17;SCYL3;ATP12A;CSNK1E;GSTM3;ADAP1;TKFC;EHD3;FYN;MAST4;ATP8B2;SNX1;PEX1;SIRT2;TRPC1;RECQL5;RAB13;OSBPL1A;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;RPL29;TGFBR3;MAP3K10;CHD6;EPHB2;MAGI1;SEPT8;MCTP2;ITGA2;FGFR1;ESYT3;SH3PXD2A;CTH;ERBB2;EIF2AK4;STK32B;PFKL;MPPE1;HSP90AB4P;CAMKK1;IKBKB;PLEKHA4;HIP1
5793,GO:0017048,6.69424735095225e-05,0.999972895496602,33,138,Rho GTPase binding,MF,DOCK4;CDC42EP5;OBSCN;ARHGEF19;RGL2;PKN1;PLEKHG5;PAK1;ARHGEF4;PLEKHG2;DNMBP;SRGAP3;PLEKHG4;ARHGEF2;PAK6;DOCK11;WHAMMP3;PKN3;TRIOBP;FMNL2;PLEKHG3;BCR;PLEKHG6;FMNL3;FARP1;ARHGAP44;EPS8L1;ARHGEF17;EPS8L2;VAV3;C15ORF62;NET1;KCTD13
12391,GO:0048858,6.85617984593565e-05,0.999960623968744,80,441,cell projection morphogenesis,BP,PTPRS;DLG4;APOE;NFATC4;S100A6;POSTN;SEMA4B;VEGFA;EGFR;ANK3;SPTB;BRSK1;SHANK2;ADARB1;EFNB3;OBSL1;ULK2;RNF165;CUL7;ARPIN;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;ETV1;NGFR;PLXNB1;SPG11;SSH3;LPAR3;IMPACT;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;NYAP1;SDC2;TCTN1;TWF2;SEMA3B;SSH1;METRN;FLOT1;UNC5B;MAP6;VLDLR;ROBO3;ITGA1;MINK1;WNT7A;SEMA4G;ECM2;KIF13B;FARP1;C9ORF72;WNT3;RPS6KA5;BRAF;ARHGAP44;FYN;SNX1;PLXND1;EPHB2;ERBB2;UST;EIF2AK4;CORO1B;GRB10
6799,GO:0030258,7.22012550952889e-05,0.999966927765293,42,194,lipid modification,BP,APOE;TYSND1;CRAT;EGFR;HADH;DGKA;ACAD10;HBEGF;CYP3A5;CPT2;MLYCD;DGKQ;PHYH;FGFR3;ETFB;EREG;ABCG1;MTMR4;PPARA;SESN2;PI4KAP1;ACACB;PI4K2A;INPP5D;ACADS;LONP2;PIP5KL1;PIK3R2;CPT1C;ACOX3;ACAD11;AKT1;ZFYVE21;FGFR4;ACADVL;PEX7;FYN;PLPP6;FGFR1;ERBB2;CYP4V2;ACOT8
10781,GO:0044273,8.11760128323354e-05,0.999985386539039,12,30,sulfur compound catabolic process,BP,GGT1;MLYCD;HYAL1;CBS;CHAC1;BLMH;CSPG4;ACOT7;HEXB;HEXA;GALNS;CTH
2404,GO:0005576,8.13631337266063e-05,0.999937603356785,383,2786,extracellular region,CC,XDH;PTPRS;ACTA2;HTRA1;GAMT;F2R;NT5E;TNFRSF6B;APOE;SYTL1;XPC;SERPINE2;S100A6;GSN;PYGB;THBS3;PGF;ALDH7A1;FGFBP1;POSTN;SLC2A3;FBXO2;ACP5;THSD4;NAPRT;GLUL;GPX3;SEMA4B;ALOX15B;TIMP2;VEGFA;EGFR;PRNP;ZDHHC1;FBLN1;SLC7A8;ADAMTS7;S100A4;PRDX5;TFPI2;RAPGEF3;BPHL;CLTCL1;TNFSF15;LOXL1;TSPAN1;IGFBP4;KRT15;CD9;NINL;IDH2;CRTAP;CST3;DNM1;DNPH1;PGM1;CGREF1;CLCA2;NDRG1;GGT1;ADAMTS13;FCGBP;MMP28;COL13A1;ARRDC1;HEBP1;B3GAT3;HBEGF;RBL2;PHGDH;ARHGAP23;GAA;PYGL;MMP1;CTF1;CNTN1;PLAT;LTBP4;CTSF;REEP2;RAB11FIP4;PLD3;PRSS3;HYAL1;NXPH4;SMOC2;NAGLU;SMOC1;MAP2K1;PCK2;COL6A1;PPL;CRYL1;PGLS;CAPG;H2AFJ;TOM1L2;DNASE1L1;ITGA6;AKR7A2;MXRA7;SNX9;FAM213A;MAGEF1;ARL2;VEGFB;ADM2;MARCKSL1;HDAC11;RAB3B;PCSK1;PLEKHH3;MYH11;CYBRD1;LAMA5;HSD11B1L;APPL2;PRSS8;TTBK2;LY6K;PRKCZ;THEM6;GALE;SERPING1;SLC37A2;AARS;PABPC1L;BLVRB;FGFR3;SEC14L2;CEMIP;SEMA3F;FAM3A;DLG3;ITGB4;PDZD2;CEP250;ZP3;ABHD14B;NGFR;ELFN2;EPOR;NID1;ETFB;GSTO1;WDR60;LTBP1;MUC19;PPCS;WNT2B;ACTR1B;PLXNB1;EREG;CHD2;PSAT1;SPG11;TMC6;SPATA20;OLFM2;DHRS4;TMED4;TNFRSF25;PLA2G6;CES3;OAF;MANF;S100A13;GSTT1;MTMR4;C5;ANO1;SNX29;FNDC4;BLMH;PKD2;ACOT11;VAMP2;AREG;COL8A1;SLIT3;ECM1;B4GAT1;PCLO;JADE2;MAPK3;CSPG4;ITGB5;LAMB2;SEMA5A;IRF2BPL;FAM20C;DYSF;RHOF;LTBP2;ADAMTSL1;CTSB;SLITRK6;MXRA8;MVB12B;MYH3;LTA4H;KIAA0319L;SDC2;CHMP1B;FAM131A;TCTN1;C1RL;PLCD1;MTMR11;PDCD1LG2;MAP2K2;TWF2;ANGPTL4;SEMA3B;PTHLH;PROCR;PRSS22;IGIP;METRN;FRMD4B;PKD1;FUCA1;ATXN10;FLOT1;LTBP3;MDK;TTN;KCNMA1;SORL1;GALK1;NTPCR;PLTP;GSTM2;VLDLR;PAPLN;ADGRF1;GPRC5C;GABBR1;DEAF1;ST3GAL3;SULF2;CES2;ACY1;COL4A6;EGFL7;PTGR2;ACOT7;ALDOC;PCSK9;CEP131;EPN3;MARK3;ITGA1;CMTM7;IL17RE;TMSB4X;APOL4;APLN;ALDH1L2;EDA;MINK1;HEXB;PROM2;WNT7A;SEMA4G;CCS;GAS6;OLFML2A;ECM2;CROCC;BCR;NBR1;HEXA;BCAM;C1QTNF6;TTYH3;RAB43;THNSL2;SLC9A3R2;EFEMP2;CTSH;UACA;GSTO2;ENTPD6;IGFBP7;CARD11;CRY2;TP73-AS1;LAMB1;HMSD;GAREM2;IGFBP2;ASS1;CAPS;TSG101;KIF27;FGFR4;TMEM256;RASSF9;HAGH;NUCB2;DNASE2;C9ORF72;CHMP5;ARSA;CAPN2;ARMC9;MAN2B1;RAB25;PLAU;INSR;WNT3;KRT19;CKLF;GNAL;CHMP4C;TNXB;MBLAC2;MAGED2;ITGB6;CTDSPL;ALDH1L1;CAT;MYOF;DPP7;YPEL5;LGALS1;C22ORF46;TIMP1;HFE;SCNN1A;TUBGCP6;APRT;MPI;METTL7A;SAT2;GSTM3;TKFC;EPS8L1;TMEM25;PEX1;UBXN6;GDF15;RAB13;OSBPL1A;TOM1;TST;ADA;CADM4;RHOBTB3;NAGA;ENTPD2;EPS8L2;ADIRF;ERV3-1;TGFBR3;RNPEP;VAV3;MAN1B1;STX1A;GALNS;LAMTOR2;MFNG;EPHB2;FGFR1;BLOC1S1;SPATA6;CTH;PLLP;UNC119;PFKL;HLA-G;CORO1B;MMP17;RPL12;MMP19;BSG;LYPLAL1;TRIM45;TMEM8A;KDSR;NTM;ROBO4
10283,GO:0043062,8.19299991148073e-05,0.999959869985991,49,238,extracellular structure organization,BP,HTRA1;APOE;THBS3;POSTN;ADAM19;THSD4;LRP1;TIMP2;FBLN1;LOXL1;CST3;COL13A1;MMP1;HYAL1;SMOC2;COL6A1;ITGA6;MYH11;LAMA5;ABCA7;ERO1B;CAPNS2;ITGB4;NID1;ABCG1;COL8A1;ITGB5;LAMB2;FLOT1;PLTP;SULF2;COL4A6;ITGA1;GAS6;OLFML2A;ECM2;EFEMP2;LAMB1;TSG101;FGFR4;CAPN2;TNXB;ITGB6;TIMP1;ICAM5;ITGA2;SH3PXD2A;MMP19;BSG
12334,GO:0048731,8.3298183077794e-05,0.999935724316824,407,2940,system development,BP,XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;GAMT;BBS2;APOE;MARVELD1;BTBD2;ZMYND8;NFATC4;SERPINE2;FHL1;S100A6;FOS;GSN;ADGRL1;EGR1;CTNNBIP1;THBS3;PGF;POSTN;ADAM19;PTK6;ACP5;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;EGFR;SCN8A;ERCC1;ADAMTS7;S100A4;ANK3;IFT140;RAPGEF3;SPTB;LOXL1;IGFBP4;KRT15;CD9;SNPH;IDH2;CST3;SDK2;MEF2D;NOS1;GPSM1;DDIT3;BRSK1;SHANK2;CRTC1;ADGRB2;NDRG1;ARHGEF19;COL13A1;MYH15;SMARCA1;ZFP36L1;ADARB1;NUPR1;HBEGF;PHGDH;GAA;CTF1;CNTN1;DHTKD1;TFDP2;EFNB3;OBSL1;MDFI;EVC;ULK2;RNF165;RAB11FIP4;FBXW4;ASH2L;SOX13;CUL7;HMGCL;HYAL1;NAGLU;WWTR1;SMOC1;MAP2K1;CYP27B1;PCK2;PPL;SDCCAG8;PKN1;DDIT4;BTG1;TRNP1;SYNGAP1;ITGA6;PITPNM1;FAM213A;ULK1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;ADM2;SOX12;HDAC11;NLGN2;MYH11;LAMA5;UNK;PRSS8;CAPRIN2;TTBK2;PRKCZ;PAK1;AARS;ELK3;FGFR3;FOXQ1;NPR2;SEMA3F;PLXNB3;SPRY4;SALL2;ZSWIM4;DLG3;ITGB4;MICALL2;FBXW8;ETV1;ZP3;SHROOM4;NEURL1;ACVR2B;RAG1;SPEG;NGFR;EPOR;NID1;ETV5;LCE1E;WDR60;LTBP1;MALL;WNT2B;PLXNB1;EREG;CHD2;SPG11;SSH3;PLCD3;NAB2;TRAPPC9;MANF;LPAR3;C5;KIF17;PPARA;CHAC1;MKNK2;TCF25;IMPACT;IFT27;PKD2;SATB1;STAT6;KLF7;SH3TC2;HMGA2;AREG;COL8A1;SLIT3;ECM1;B4GAT1;PCLO;ACACB;KCNAB2;MAPK3;CSPG4;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;STK40;VANGL2;SH2D2A;RGS14;FAM20C;CTSB;SLITRK6;MXRA8;MAPK12;MYH3;NYAP1;SDC2;ARHGAP22;TCTN1;PLCD1;ARHGEF2;INPP5D;TWF2;STMN3;SDHA;DMTN;LRRC8A;ANGPTL4;SEMA3B;PTHLH;ZFPM1;MOSPD3;KDM4C;DOCK11;SSH1;SLC38A10;METRN;POLM;TENM2;KIF26B;ZNF516;PKD1;ATXN10;FLOT1;MDK;TTN;PSKH1;HSD11B1;UNC5B;HDAC5;SORL1;MAP6;SRSF5;VLDLR;TPBG;ADGRF1;DEAF1;SULF2;ROBO3;KDM7A;EGFL7;CEBPB;NEK8;LRP5;PTPRU;WNK4;ATRAID;NDE1;PCSK9;DBNDD1;L3MBTL1;FBXL15;AQP3;DNMT3A;TRIOBP;TGFBR2;TRPV4;TAGLN3;FOXL1;ITGA1;CMTM7;SMURF2;APLN;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;WNT7A;EPHA1;SEMA4G;SHARPIN;GAS6;GLUD1;LZTS2;ECM2;BCR;ATP7B;NBR1;SRR;NBEAL2;KIF13B;CAMK1;POLL;RXRA;ZNF358;ADCY6;ATP2B4;PRDM8;CTSH;WDR19;MGMT;ASNS;LCE1F;AKT1;CARD11;DGUOK;B4GALT2;AMIGO2;LAMB1;SEMA6B;IFT57;SBF2;TSG101;FMNL3;PHF2;FGFR4;TMOD2;FARP1;DNASE2;LMNA;SH2B3;MAB21L2;C9ORF72;TBC1D20;MARK4;INSR;WNT3;KRT19;TENM4;FOXO4;RPS6KA5;MAP2K5;BRAF;ARHGAP44;CAT;ZNF160;MAPK10;LGALS1;UNC119B;TIMP1;HFE;JAK3;TP73;CHRM3;APRT;TFEB;PEX7;SNX17;CSNK1E;TAZ;BCL6;HSF4;REC8;RNF213;GSTM3;FYN;SLC38A2;LEMD2;SIRT2;PHLDA2;RAB13;CELSR1;ADA;POU2F2;PLXND1;RHOBTB3;ETNK2;AP2A2;TGFBR3;TCF7;VAV3;EPAS1;MFNG;EDNRA;EPHB2;LRCH4;ITGA2;FGFR1;WFS1;TMEM223;BLOC1S1;FKBP8;SH3PXD2A;CTH;ERBB2;PLLP;UST;EIF2AK4;UNC119;HLA-G;MMP17;GRB10;TSHZ1;TNNI1;MMP19;KCTD11;BSG;SDHAF4;TRIM45;DBP;APBA1;NTM;ROBO4;TEAD2;BTBD11;SIX5
2108,GO:0004888,8.37073267357566e-05,0.99995518826145,62,324,transmembrane signaling receptor activity,MF,F2R;TNFRSF6B;IL20RB;ADGRL1;NTSR1;EGFR;FCGRT;MRC2;ADGRB2;MST1R;EFNB3;LTBP4;MC1R;HTR7;ABCA7;FGFR3;PLXNB3;ACVR2B;NGFR;EPOR;LTBP1;PLXNB1;PTPRE;TNFRSF25;LPAR3;IFNGR2;LTB4R2;GPR153;UNC5B;SORL1;IL17RD;VLDLR;ADGRF1;GPRC5C;GABBR1;LRP5;PTPRU;TGFBR2;TRPV4;IL17RE;TRPV1;EPHA1;BCAM;PTAFR;CTSH;TNFRSF14;IL17RC;FGFR4;INSR;LTB4R;EDA2R;GPR21;MRGPRX3;CHRM3;CELSR1;PLXND1;TGFBR3;EDNRA;EPHB2;ITGA2;FGFR1;ERBB2
3459,GO:0007275,8.71109459991504e-05,0.999932189471919,452,3303,multicellular organism development,BP,XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;GAMT;BBS2;TNFRSF6B;APOE;MARVELD1;BTBD2;ZMYND8;NFATC4;SERPINE2;FHL1;S100A6;FOS;GSN;ADGRL1;EGR1;CTNNBIP1;THBS3;PGF;POSTN;ADAM19;PTK6;ACP5;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;SCN8A;NR1D1;ERCC1;FBLN1;ADAMTS7;S100A4;ANK3;DUSP5;IFT140;RAPGEF3;SPTB;LOXL1;IGFBP4;KRT15;CD9;SNPH;IDH2;CST3;SDK2;MEF2D;NOS1;GPSM1;DDIT3;BRSK1;SHANK2;MICALCL;CRTC1;ADGRB2;NDRG1;ARHGEF19;COL13A1;MYH15;SMARCA1;MST1R;ZFP36L1;ADARB1;NUPR1;TCFL5;HBEGF;PHGDH;GAA;CTF1;CNTN1;DHTKD1;TFDP2;EFNB3;OBSL1;MDFI;EVC;LTBP4;ULK2;RNF165;RAB11FIP4;FBXW4;ASH2L;SOX13;CUL7;HMGCL;HYAL1;NAGLU;TXNRD3;WWTR1;SMOC1;MAP2K1;CYP27B1;PCK2;COL6A1;PPL;SDCCAG8;PKN1;MC1R;DDIT4;BTG1;TRNP1;SYNGAP1;ITGA6;PHC2;PITPNM1;PBX2;FAM213A;ULK1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;ADM2;SOX12;HDAC11;NLGN2;MYCBPAP;MYH11;LAMA5;UNK;PRSS8;CAPRIN2;TTBK2;PRKCZ;PAK1;AARS;ELK3;FGFR3;FOXQ1;ARVCF;NPR2;SEMA3F;PLXNB3;SPRY4;SALL2;ZSWIM4;DLG3;ITGB4;MICALL2;FBXW8;ETV1;ZP3;SHROOM4;NEURL1;ACVR2B;RAG1;SPEG;NGFR;EPOR;NID1;ETV5;LCE1E;WDR60;LTBP1;MALL;WNT2B;PLXNB1;EREG;CHD2;TEF;SPG11;SSH3;SPATA20;PLCD3;TNFRSF25;NAB2;TRAPPC9;MANF;LPAR3;C5;KIF17;PPARA;ANO1;CHAC1;MKNK2;SCMH1;TCF25;IMPACT;IFT27;PKD2;SATB1;STAT6;KLF7;SH3TC2;HMGA2;AREG;COL8A1;SLIT3;ECM1;B4GAT1;PCLO;ACACB;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;STK40;VANGL2;SH2D2A;RGS14;KCTD15;FAM20C;PBXIP1;CTSB;SLITRK6;MXRA8;MAPK12;MYH3;NYAP1;SDC2;ARHGAP22;TCTN1;PLCD1;ARHGEF2;INPP5D;TWF2;STMN3;SDHA;DMTN;LRRC8A;ANGPTL4;SEMA3B;PTHLH;ZFPM1;MOSPD3;KDM4C;DOCK11;SSH1;SLC38A10;METRN;POLM;TENM2;KIF26B;ZNF516;PKD1;ATXN10;FLOT1;MDK;TTN;PSKH1;HSD11B1;UNC5B;HDAC5;SORL1;MAP6;SRSF5;VLDLR;TPBG;ADGRF1;PRR15;DEAF1;SULF2;ROBO3;ENDOG;KDM7A;EGFL7;CEBPB;NEK8;LRP5;PTPRU;WNK4;ATRAID;NDE1;PCSK9;DBNDD1;L3MBTL1;FBXL15;AQP3;CEP131;DNMT3A;TRIOBP;TGFBR2;TRPV4;TAGLN3;FOXL1;MN1;ITGA1;CMTM7;SMURF2;APLN;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;WNT7A;EPHA1;SEMA4G;SHARPIN;GAS6;GLUD1;LZTS2;ECM2;BCR;ATP7B;NBR1;SRR;NBEAL2;KIF13B;CAMK1;POLL;RXRA;ZNF358;ADCY6;ATP2B4;PRDM8;CTSH;TNFRSF14;WDR19;MGMT;ASNS;LCE1F;AKT1;IGFBP7;CARD11;DGUOK;B4GALT2;AMIGO2;LAMB1;SEMA6B;IFT57;SBF2;TSG101;FMNL3;PHF2;FGFR4;ZNF217;TMOD2;FARP1;DNASE2;LMNA;SH2B3;MAB21L2;C9ORF72;TBC1D20;CAPN2;MARK4;INSR;WNT3;KRT19;TENM4;FOXO4;RPS6KA5;CHMP4C;MAP2K5;BRAF;EDA2R;ARHGAP44;HOXC5;CAT;ZNF160;MAPK10;LGALS1;UNC119B;TIMP1;HFE;JAK3;TP73;MNT;CHRM3;APRT;TFEB;PEX7;SNX17;LSM14B;PHC1;CSNK1E;TAZ;BCL6;HSF4;REC8;RNF213;GSTM3;FYN;SLC38A2;LEMD2;SIRT2;SPRED3;PHLDA2;RAB13;CELSR1;ADA;POU2F2;PLXND1;RHOBTB3;ETNK2;AP2A2;RPL29;TGFBR3;TCF7;VAV3;EPAS1;MFNG;EDNRA;EPHB2;LRCH4;MCTP2;ITGA2;FGFR1;WFS1;TMEM223;BLOC1S1;FKBP8;SPATA6;SH3PXD2A;CTH;ERBB2;PLLP;UST;EIF2AK4;UNC119;HLA-G;MMP17;RTL1;GRB10;TSHZ1;TNNI1;MMP19;KCTD11;BSG;ZMYM3;SDHAF4;TRIM45;DBP;APBA1;IKBKB;NTM;ROBO4;TEAD2;BTBD11;SIX5
6584,GO:0022604,8.98518331545985e-05,0.999951268653918,64,337,regulation of cell morphogenesis,BP,PTPRS;DLG4;APOE;NFATC4;POSTN;WIPF1;CDC42EP5;SEMA4B;VEGFA;FBLN1;PARVB;ARAP3;ARAP1;EFNB3;OBSL1;ULK2;CUL7;ARPIN;MAP2K1;SYNGAP1;CAPRIN2;TTBK2;PAK1;SEMA3F;PLXNB3;SYNE3;ZSWIM4;FBXW8;NGFR;PLXNB1;SSH3;RHOBTB2;LPAR3;S100A13;SEMA5A;RHOF;SDC2;TWF2;DMTN;SEMA3B;SSH1;METRN;TRIOBP;AGO4;HEXB;WNT7A;SEMA4G;FMNL2;KIF13B;FMNL3;WNT3;BRAF;ARHGAP44;CSNK1E;FYN;PLXND1;RHOBTB3;EPHB2;FITM2;UST;C15ORF62;CORO1B;NET1;ZMYM3
10893,GO:0044456,9.85428054627913e-05,0.999943357032071,76,419,synapse part,CC,PTPRS;DLG4;F2R;SYTL1;ZMYND8;ADGRL1;FBXO2;GLUL;NTSR1;PRNP;NR1D1;ANK3;SNPH;DNM1;NOS1;BRSK1;SHANK2;COL13A1;SYT8;SYNGR1;SYNGAP1;RAB3B;NLGN2;LAMA5;PRR7;MCTP1;BLVRB;DLG3;NEURL1;NIPSNAP1;OLFM2;VAMP2;SEPT5;PCLO;KCNC4;KCNAB2;LAMB2;BNIP3;RGS14;PI4K2A;ARHGEF2;DMTN;SV2A;TENM2;KCNMA1;GABBR1;DBNDD1;PDE2A;RAB40B;MINK1;WNT7A;TRPV1;SHARPIN;DNAJC6;BCR;RIMS3;AKT1;MICAL1;SEPT6;SLC6A9;FARP1;ICA1;ADD3;HOMER2;ARHGAP44;CHRM3;RABAC1;FYN;PJA2;RAB13;MPDZ;STX1A;EPHB2;ITGA2;APBA1;HIP1
5782,GO:0017016,0.000101040121806475,0.999942321292206,74,405,Ras GTPase binding,MF,DLG4;DOCK4;SYTL1;EVI5L;CDC42EP5;OBSCN;EGFR;RAPGEF3;SPTB;NDRG1;TBC1D8;ARHGEF19;RIN1;HBEGF;RGL2;EXOC2;RAB11FIP4;PKN1;SHC2;PLEKHG5;ULK1;SHC1;PAK1;FGFR3;MICALL2;NGFR;ARHGEF4;EREG;PLEKHG2;DNMBP;XPOT;TRAPPC9;ALS2CL;SRGAP3;PLEKHG4;TBC1D14;ARHGEF2;PAK6;DOCK11;TBC1D3E;RABGAP1;WHAMMP3;RIN2;PKN3;TRIOBP;FMNL2;PLEKHG3;BCR;RIMS3;PLEKHG6;MICAL1;SBF2;FMNL3;FGFR4;FARP1;C9ORF72;SGSM2;TBC1D20;RABGGTA;ARHGAP44;JAK3;EPS8L1;FYN;ARHGEF17;RHOBTB3;EPS8L2;VAV3;TBC1D16;FGFR1;ERBB2;C15ORF62;FRS3;NET1;KCTD13
11721,GO:0046578,0.000102910434878282,0.999952519973601,41,189,regulation of Ras protein signal transduction,BP,F2R;APOE;TIMP2;OBSCN;ARAP3;ARHGEF19;ARAP1;RGL2;ASAP2;SYNGAP1;PLEKHG5;SPRY2;APPL2;SPRY4;ARHGEF4;PLEKHG2;DNMBP;AGAP1;RASA4;PLEKHG4;ARHGEF2;STMN3;ACAP3;FLOT1;IQSEC2;PSD4;PLEKHG3;BCR;PLEKHG6;ASAP3;FARP1;ARHGAP44;BCL6;ADAP1;EPS8L1;ARHGEF17;EPS8L2;VAV3;EPHB2;NET1;KCTD13
323,GO:0000904,0.00011495541799981,0.999931381032533,85,482,cell morphogenesis involved in differentiation,BP,PTPRS;DLG4;APOE;NFATC4;S100A6;POSTN;SEMA4B;VEGFA;FBLN1;ANK3;SPTB;PARVB;BRSK1;SHANK2;ADARB1;EFNB3;OBSL1;ULK2;RNF165;CUL7;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;LAMA5;UNK;CAPRIN2;PAK1;SEMA3F;PLXNB3;ZSWIM4;MICALL2;FBXW8;ETV1;NGFR;PLXNB1;SPG11;SSH3;LPAR3;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;SDC2;TCTN1;TWF2;DMTN;SEMA3B;ZFPM1;SSH1;METRN;FLOT1;UNC5B;MAP6;VLDLR;ROBO3;TRIOBP;MINK1;WNT7A;EPHA1;SEMA4G;ECM2;NBEAL2;KIF13B;LAMB1;FARP1;C9ORF72;TBC1D20;RAB25;WNT3;RPS6KA5;BRAF;ARHGAP44;FYN;PLXND1;EPHB2;ERBB2;UST;NET1;GRB10
3263,GO:0006936,0.000117557459809545,0.999947260154453,38,170,muscle contraction,BP,ACTA2;DOCK4;GAMT;BBS2;F2R;NOS1;SCN4B;GAA;OBSL1;VEGFB;MYH11;TPM2;HTR7;GSTO1;PLA2G6;ITGB5;DYSF;SNTA1;MYH3;TTN;KCNMA1;GSTM2;SULF2;ITGA1;TRPV1;TNNI2;PTAFR;TNNT1;TMOD2;LTB4R;MYOF;CHRM3;TAZ;EHD3;ADA;EDNRA;ITGA2;TNNI1
12367,GO:0048812,0.000123628391274246,0.999928101302515,77,428,neuron projection morphogenesis,BP,PTPRS;DLG4;APOE;NFATC4;S100A6;POSTN;SEMA4B;VEGFA;EGFR;ANK3;SPTB;BRSK1;SHANK2;ADARB1;EFNB3;OBSL1;ULK2;RNF165;CUL7;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;ETV1;NGFR;PLXNB1;SPG11;SSH3;LPAR3;IMPACT;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;NYAP1;SDC2;TCTN1;TWF2;SEMA3B;SSH1;METRN;FLOT1;UNC5B;MAP6;VLDLR;ROBO3;ITGA1;MINK1;WNT7A;SEMA4G;ECM2;KIF13B;FARP1;C9ORF72;WNT3;RPS6KA5;BRAF;ARHGAP44;FYN;PLXND1;EPHB2;ERBB2;UST;EIF2AK4;GRB10
3451,GO:0007266,0.000131752693604198,0.999943519964739,34,149,Rho protein signal transduction,BP,F2R;APOE;CDC42EP5;OBSCN;ARAP3;ARHGEF19;ARAP1;PLEKHG5;PAK1;NGFR;ARHGEF4;PLEKHG2;RHOBTB2;DNMBP;VANGL2;RHOF;PLEKHG4;ARHGEF2;PAK6;FLOT1;PLEKHG3;BCR;PLEKHG6;FARP1;BCL6;EPS8L1;ARHGEF17;CELSR1;RHOBTB3;EPS8L2;VAV3;C15ORF62;NET1;KCTD13
6729,GO:0030154,0.00013533817651122,0.999896028652698,353,2524,cell differentiation,BP,XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;BBS2;APOE;BTBD2;ZMYND8;NFATC4;FLNC;SERPINE2;FHL1;S100A6;FOS;GSN;EGR1;CTNNBIP1;PGF;POSTN;PTK6;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;NR1D1;ERCC1;FBLN1;ADAMTS7;S100A4;ANK3;IFT140;RAPGEF3;SPTB;KRT15;CD9;SNPH;IDH2;CST3;SDK2;PARVB;MEF2D;NOS1;GPSM1;DDIT3;BRSK1;DNPH1;SHANK2;MICALCL;CRTC1;MRC2;NDRG1;COL13A1;SMARCA1;MST1R;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;CTF1;CNTN1;DHTKD1;EFNB3;OBSL1;MDFI;LTBP4;ULK2;RNF165;ASH2L;SOX13;CUL7;NAGLU;ETV4;TXNRD3;WWTR1;SMOC1;MAP2K1;CYP27B1;PCK2;COL6A1;CCDC71L;PPL;SDCCAG8;DDIT4;BTG1;SYNGAP1;ITGA6;FAM213A;DNAH1;ULK1;SHC1;SPRY2;GRB7;NPHP4;BLOC1S4;SOX12;HDAC11;MYCBPAP;MYH11;LAMA5;UNK;PRSS8;CAPRIN2;PRKCZ;PAK1;ELK3;PABPC1L;FGFR3;KDM3A;FOXQ1;NPR2;SEMA3F;PLXNB3;ZSWIM4;ITGB4;MICALL2;FBXW8;ETV1;ZP3;NEURL1;ACVR2B;RAG1;SPEG;NGFR;ETV5;LCE1E;WNT2B;TRIB2;PLXNB1;EREG;CHD2;SPG11;SSH3;SPATA20;OLFM2;NAB2;ABCG1;TRAPPC9;MANF;LPAR3;KIF17;PPARA;CHAC1;IMPACT;IFT27;SATB1;STAT6;KLF7;SH3TC2;HMGA2;AREG;COL8A1;SLIT3;B4GAT1;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;VANGL2;SH2D2A;RGS14;FAM20C;TDRKH;PBXIP1;CTSB;SLITRK6;MXRA8;MAPK12;MYH3;NYAP1;SDC2;ARHGAP22;TCTN1;ARHGEF2;INPP5D;TWF2;STMN3;DMTN;LRRC8A;ANGPTL4;SEMA3B;PTHLH;ZFPM1;KDM4C;DOCK11;SSH1;METRN;POLM;TENM2;ZNF516;ATXN10;FLOT1;LTBP3;MDK;TTN;JDP2;UNC5B;HDAC5;SORL1;MAP6;VLDLR;ADGRF1;DEAF1;SULF2;ROBO3;RFX2;EGFL7;CEBPB;LRP5;PTPRU;ATRAID;ALDOC;NDE1;PCSK9;DBNDD1;L3MBTL1;AQP3;CEP131;DNMT3A;TRIOBP;TGFBR2;TRPV4;FOXL1;ITGA1;CMTM7;SLFN5;PDE2A;TRIB3;EDA;HMG20B;CDK5RAP3;AGO4;MINK1;HEXB;WNT7A;TRPV1;EPHA1;SEMA4G;SHARPIN;GAS6;ECM2;NBR1;NBEAL2;KIF13B;SPAG16;CAMK1;RXRA;ADCY6;PRDM8;MGMT;LCE1F;AKT1;CARD11;DGUOK;LAMB1;SEMA6B;SEPT6;TNNT1;CABYR;TSG101;FGFR4;TMOD2;ACADVL;FARP1;DNASE2;LMNA;SH2B3;WDFY2;C9ORF72;TBC1D20;UHRF2;CAPN2;RAB25;INSR;WNT3;KRT19;TENM4;FOXO4;RPS6KA5;BRAF;YIPF3;EDA2R;ARHGAP44;CAT;MYOF;MAPK10;LGALS1;UNC119B;JAK3;TP73;PEX7;CSNK1E;BCL6;HSF4;REC8;GSTM3;FYN;LEMD2;SIRT2;GDF15;RAB13;TST;CELSR1;ADA;POU2F2;PLXND1;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MFNG;EDNRA;EPHB2;ITGA2;FGFR1;BLOC1S1;FKBP8;SPATA6;SH3PXD2A;CTH;ERBB2;UST;EIF2AK4;UNC119;HLA-G;NET1;GRB10;MMP19;KCTD11;PEX11A;IKBKB;NTM;DMTF1;HIP1;ROBO4;TEAD2;BTBD11;SIX5
3385,GO:0007165,0.000143415779356234,0.999886740602593,494,3663,signal transduction,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;HTRA1;DOCK4;BBS2;F2R;TNFRSF6B;APOE;ZMYND8;NFATC4;SERPINE2;S100A6;FOS;PRODH;IL20RB;GSN;ADGRL1;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;WIPF1;DDIT4L;PTK6;CDC42EP5;WWC3;EDEM1;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;RHPN1;PRNP;FCGRT;NR1D1;FBLN1;S100A4;ANK3;DUSP5;IFT140;RAPGEF3;CLTCL1;TNFSF15;SPTB;DGKA;TSPAN1;IGFBP4;CD9;DNM1;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;MRC2;ADGRB2;ERCC6;NDRG1;ADAMTS13;ARHGEF19;MST1R;ARRDC1;HEBP1;EFS;ZFP36L1;NUPR1;RIN1;ARAP1;HBEGF;RBL2;RGL2;RPS6KA2;ARHGAP23;MMP1;CTF1;CNTN1;TFDP2;EFNB3;MDFI;EVC;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;RNF165;NISCH;ASAP2;FBXW4;CUL7;EPM2A;NXPH4;SMOC2;WWTR1;SMOC1;GIGYF1;MAP2K1;CYP27B1;PKN1;MC1R;DDIT4;TOM1L2;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;DGKQ;MAML3;PLEKHG5;FAM110C;ULK1;SHC1;SPRY2;GRB7;NPHP4;VEGFB;ADM2;RAB3B;NLGN2;PLEKHH3;ITPR3;LAMA5;RALGDS;PITPNC1;APPL2;CAPRIN2;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;MCTP1;ELK3;STK39;PEAR1;FGFR3;KDM3A;NPR2;SEMA3F;PLXNB3;SPRY4;USP20;SALL2;DOCK6;ITGB4;ZP3;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;GSTO1;ARHGEF4;LTBP1;MUC19;WNT2B;TRIB2;PLXNB1;EREG;PTPRE;RMI2;PLCD3;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;DNMBP;ERMAP;MANF;LPAR3;S100A13;AGAP1;MTMR4;C5;PPARA;CHD3;ANO1;CHAC1;SESN2;AIP;MKNK2;RASA4;IFT27;NLRX1;PKD2;STAT6;SH3TC2;ING4;ACOT11;AREG;SLIT3;ECM1;PCLO;PI4KAP1;MAPK3;CSPG4;ITGB5;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;STK40;VANGL2;DOCK9;SH2D2A;RGS14;FAM20C;MYZAP;RHOF;PLEK2;LTBP2;CTSB;MAPK12;MVB12B;NYAP1;SRGAP3;PAQR6;SDC2;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TCTN1;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;SAMD3;STMN3;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;SEMA3B;PTHLH;ATF4;BBC3;PAK6;DOCK11;SSH1;LTB4R2;GPR153;ACAP3;TENM2;IFI6;ZNF516;PKD1;NSMCE1;RALGAPA1;FLOT1;MDK;TTN;PSKH1;UNC5B;GTPBP1;IRF5;SORL1;PCBP4;IL17RD;HERPUD1;GSTM2;VLDLR;ADGRF1;GPRC5C;GABBR1;SULF2;ROBO3;NLRP1;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;RIN2;CREBRF;PCSK9;L3MBTL1;PKN3;FBXL15;ISG20;MARK3;TGFBR2;TRPV4;FOXL1;ARHGAP25;IQSEC2;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;RAB40B;DAP;CALCOCO1;EDA;CDK5RAP3;NOS3;AGO4;MINK1;LDOC1;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;SHARPIN;GAS6;ERN1;NUDT6;LZTS2;PLEKHG3;BCR;NBR1;BCAM;TADA3;KIF13B;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;RAB43;ATP2B4;THNSL2;STRADB;CTSH;TNFRSF14;WDR19;UACA;ASNS;C12ORF66;PLEKHG6;MAPKBP1;AKT1;ITPR2;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;IFT57;IGFBP2;CAPS;TSG101;IL17RC;FGFR4;RASSF9;ZNF217;TMOD2;TCIRG1;ASAP3;ACADVL;FARP1;LMNA;SH2B3;C9ORF72;ARHGAP27;RAB25;IFI27;PLAU;INSR;WNT3;KRT19;TENM4;CKLF;FOXO4;GNAL;RPS6KA5;LTB4R;ITGB6;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;BTN3A2;ASIC1;PIDD1;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;JAK3;MRGPRX3;TP73;MNT;FRAT1;CHRM3;MIB2;SNX17;CSNK1E;BTN3A3;BCL6;REPS2;RNF213;ADAP1;TKFC;EPS8L1;FYN;MAST4;PJA2;LEMD2;ARHGEF17;SIRT2;GDF15;SPRED3;PHLDA2;RAB13;CELSR1;ADA;PLXND1;RHOBTB3;MTA1;TMEM101;ENTPD2;AP2A2;CIDEA;EPS8L2;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;STX1A;EPAS1;LAMTOR2;MAP3K10;MFNG;STARD10;EDNRA;LURAP1;EPHB2;MAGI1;INPP4A;PER1;LRCH4;MCTP2;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;STK32B;UNC119;PAG1;RGS12;SYVN1;C15ORF62;HLA-G;FRS3;NET1;GRB10;CREB3L4;KCTD11;BSG;KCTD13;PEX11A;CAMKK1;DTX3;IKBKB;HIP1;TEAD2;BTBD11
5274,GO:0015929,0.000154667658365985,0.999987303801951,7,12,hexosaminidase activity,MF,HYAL1;NAGLU;CEMIP;HEXDC;HEXB;HEXA;NAGA
2101,GO:0004871,0.000157920798723327,0.999898233999381,111,673,signal transducer activity,MF,F2R;TNFRSF6B;IL20RB;ADGRL1;NTSR1;EGFR;PRNP;FCGRT;NR1D1;CLTCL1;MRC2;ADGRB2;MST1R;EFNB3;LTBP4;MAPK13;MAP2K1;MC1R;PLCH2;DGKQ;PLEKHG5;SHC1;ITPR3;HTR7;ABCA7;FGFR3;NPR2;PLXNB3;ACVR2B;NGFR;EPOR;LTBP1;PLXNB1;PTPRE;PLCD3;RHOBTB2;TMED4;TNFRSF25;LPAR3;PPARA;AIP;PKD2;STAT6;ECM1;MAPK3;CSPG4;THRA;IFITM1;RGS14;RHOF;MAPK12;PAQR6;IFNGR2;PLCD1;MAP2K2;LITAF;LTB4R2;GPR153;UNC5B;SORL1;IL17RD;VLDLR;ADGRF1;GPRC5C;GABBR1;MAP3K12;LRP5;PTPRU;TGFBR2;TRPV4;IL17RE;MINK1;TRPV1;EPHA1;BCAM;PTAFR;RXRA;CTSH;TNFRSF14;ITPR2;CRY2;IL17RC;FGFR4;SH2B3;INSR;GNAL;LTB4R;TPCN1;BRAF;EDA2R;GPR21;MAPK10;LGALS1;MRGPRX3;CHRM3;MIB2;FYN;CELSR1;PLXND1;RHOBTB3;TMEM101;TGFBR3;MAP3K10;EDNRA;EPHB2;ITGA2;FGFR1;ERBB2;PAG1;RGS12;IKBKB
3565,GO:0007611,0.000158186880097689,0.999934524618647,31,133,learning or memory,BP,DLG4;APOE;FOS;NTSR1;EGFR;PRNP;SHANK2;CRTC1;SYNGAP1;ITPR3;PRKCZ;ABCA7;RAG1;PLA2G6;THRA;RGS14;MDK;VLDLR;ADGRF1;DEAF1;CEBPB;B4GALT2;TMOD2;INSR;BRAF;ASIC1;FYN;PJA2;PAIP2;EPHB2;EIF2AK4
12570,GO:0050770,0.000162448810067845,0.999935021381249,29,121,regulation of axonogenesis,BP,PTPRS;APOE;SEMA4B;VEGFA;EFNB3;ULK2;MAP2K1;SYNGAP1;PAK1;SEMA3F;PLXNB3;ZSWIM4;NGFR;PLXNB1;SSH3;LPAR3;SEMA5A;TWF2;SEMA3B;SSH1;METRN;WNT7A;SEMA4G;KIF13B;WNT3;BRAF;PLXND1;EPHB2;UST
12596,GO:0050804,0.000181740542110213,0.999915316281445,39,183,modulation of chemical synaptic transmission,BP,DLG4;F2R;APOE;ZMYND8;NFATC4;SERPINE2;GLUL;NTSR1;EGFR;PRNP;SHANK2;CRTC1;NISCH;SYNGR1;SYNGAP1;RAB3B;NLGN2;ITPR3;PRKCZ;MCTP1;NEURL1;PLA2G6;VAMP2;SEPT5;KCNC4;RGS14;SSH1;FLOT1;WNT7A;RIMS3;SLC6A9;BRAF;ASIC1;PAIP2;STX1A;EPHB2;EIF2AK4;KCTD13;PNKD
16997,GO:0099177,0.000181740542110213,0.999915316281445,39,183,regulation of trans-synaptic signaling,BP,DLG4;F2R;APOE;ZMYND8;NFATC4;SERPINE2;GLUL;NTSR1;EGFR;PRNP;SHANK2;CRTC1;NISCH;SYNGR1;SYNGAP1;RAB3B;NLGN2;ITPR3;PRKCZ;MCTP1;NEURL1;PLA2G6;VAMP2;SEPT5;KCNC4;RGS14;SSH1;FLOT1;WNT7A;RIMS3;SLC6A9;BRAF;ASIC1;PAIP2;STX1A;EPHB2;EIF2AK4;KCTD13;PNKD
4026,GO:0009062,0.000192339132692629,0.999931979339657,23,89,fatty acid catabolic process,BP,TYSND1;CRAT;AIG1;HADH;ACAD10;CPT2;MLYCD;PCK2;PHYH;ETFB;PPARA;SESN2;ACACB;ACADS;LONP2;CPT1C;ACOX3;ACAD11;AKT1;ACADVL;FAAH;PEX7;ACOT8
3501,GO:0007409,0.000194456538296921,0.999894365105593,58,305,axonogenesis,BP,PTPRS;APOE;S100A6;SEMA4B;VEGFA;ANK3;SPTB;BRSK1;ADARB1;EFNB3;ULK2;RNF165;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;PAK1;SEMA3F;PLXNB3;ZSWIM4;ETV1;NGFR;PLXNB1;SPG11;SSH3;LPAR3;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;TCTN1;TWF2;SEMA3B;SSH1;METRN;FLOT1;UNC5B;VLDLR;ROBO3;WNT7A;SEMA4G;ECM2;KIF13B;C9ORF72;WNT3;RPS6KA5;BRAF;FYN;PLXND1;EPHB2;ERBB2;UST;GRB10
6129,GO:0019395,0.000199758972466739,0.999933285828183,21,78,fatty acid oxidation,BP,TYSND1;CRAT;HADH;ACAD10;CPT2;MLYCD;PHYH;ETFB;PPARA;SESN2;ACACB;ACADS;LONP2;CPT1C;ACOX3;ACAD11;AKT1;ACADVL;PEX7;CYP4V2;ACOT8
17673,GO:1901605,0.000211919156370481,0.99990770193902,33,148,alpha-amino acid metabolic process,BP,GAMT;PRODH;ALDH7A1;GLUL;NAGS;CRTAP;NOS1;GGT1;PHGDH;PYCR2;ALDH4A1;HMGCL;ERO1B;MTHFR;GLDC;CBS;NMNAT2;GPT2;PSAT1;PSPH;BLMH;HIBADH;AZIN2;PEMT;NOS3;GLUD1;SRR;ATP2B4;THNSL2;ASNS;PHYKPL;ASS1;CTH
16752,GO:0098590,0.000214550454806562,0.999862891903974,103,618,plasma membrane region,CC,PTPRS;DLG4;BBS2;F2R;SYTL1;ADGRL1;LRP1;EGFR;SLC7A8;ANK3;CD9;SLC2A9;SNPH;DNM1;NOS1;SHANK2;CLCA2;COL13A1;MST1R;EVC;BBS1;RAB11FIP4;PKN1;ITGA6;PITPNM1;SPRY2;NLGN2;CYBRD1;PRKCZ;PAK1;ABCA7;PRR7;STK39;SPRY4;DLG3;SHROOM4;NEURL1;ARHGEF4;NIPSNAP1;OLFM2;PLCD3;KIF17;ANO1;PKD2;KCNC4;MAPK3;CSPG4;VANGL2;RGS14;PLEK2;SLC22A18;PI4K2A;ARHGEF2;DMTN;ATF4;SSH1;TENM2;PKD1;SLC29A4;FLOT1;KCNMA1;GABBR1;NDE1;AQP3;TGFBR2;TRPV4;PSD4;PDE2A;PEMT;NOS3;MINK1;PROM2;TRPV1;BCR;ATP7B;RIMS3;ATP2B4;SLC9A3R2;PLEKHG6;IGFBP2;SEPT6;TCIRG1;RAB25;INSR;KRT19;HOMER2;PLB1;MYOF;SCNN1A;CHRM3;ATP12A;SPIRE1;EPS8L1;EHD3;PJA2;MPDZ;PLXND1;EPS8L2;STX1A;LRCH4;ERBB2;OSCP1;HIP1
6756,GO:0030198,0.000229676568454584,0.99988718150012,43,209,extracellular matrix organization,BP,HTRA1;THBS3;POSTN;ADAM19;THSD4;LRP1;TIMP2;FBLN1;LOXL1;CST3;COL13A1;MMP1;SMOC2;COL6A1;ITGA6;MYH11;LAMA5;ERO1B;CAPNS2;ITGB4;NID1;COL8A1;ITGB5;LAMB2;FLOT1;SULF2;COL4A6;ITGA1;GAS6;OLFML2A;ECM2;EFEMP2;LAMB1;FGFR4;CAPN2;TNXB;ITGB6;TIMP1;ICAM5;ITGA2;SH3PXD2A;MMP19;BSG
8754,GO:0034440,0.00024196145763613,0.9999178205319,21,79,lipid oxidation,BP,TYSND1;CRAT;HADH;ACAD10;CPT2;MLYCD;PHYH;ETFB;PPARA;SESN2;ACACB;ACADS;LONP2;CPT1C;ACOX3;ACAD11;AKT1;ACADVL;PEX7;CYP4V2;ACOT8
8217,GO:0032990,0.000255443927843121,0.999845518468571,80,459,cell part morphogenesis,BP,PTPRS;DLG4;APOE;NFATC4;S100A6;POSTN;SEMA4B;VEGFA;EGFR;ANK3;SPTB;BRSK1;SHANK2;ADARB1;EFNB3;OBSL1;ULK2;RNF165;CUL7;ARPIN;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;ETV1;NGFR;PLXNB1;SPG11;SSH3;LPAR3;IMPACT;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;NYAP1;SDC2;TCTN1;TWF2;SEMA3B;SSH1;METRN;FLOT1;UNC5B;MAP6;VLDLR;ROBO3;ITGA1;MINK1;WNT7A;SEMA4G;ECM2;KIF13B;FARP1;C9ORF72;WNT3;RPS6KA5;BRAF;ARHGAP44;FYN;SNX1;PLXND1;EPHB2;ERBB2;UST;EIF2AK4;CORO1B;GRB10
4642,GO:0010769,0.00025754399974756,0.999875037503904,41,198,regulation of cell morphogenesis involved in differentiation,BP,PTPRS;APOE;NFATC4;POSTN;SEMA4B;VEGFA;FBLN1;EFNB3;OBSL1;ULK2;CUL7;MAP2K1;SYNGAP1;CAPRIN2;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;NGFR;PLXNB1;SSH3;LPAR3;SEMA5A;SDC2;TWF2;DMTN;SEMA3B;SSH1;METRN;TRIOBP;WNT7A;SEMA4G;KIF13B;WNT3;BRAF;ARHGAP44;PLXND1;EPHB2;UST;NET1
9777,GO:0040011,0.000258026949214823,0.999817688771,167,1096,locomotion,BP,DOCK4;BBS2;F2R;APOE;ZMYND8;SERPINE2;PGF;POSTN;PTK6;SEMA4B;LRP1;ALOX15B;VEGFA;EGFR;FBLN1;SLC7A8;SPTB;TSPAN1;SLC16A3;IDH2;ARAP3;MMP28;EFS;ADARB1;HBEGF;MMP1;EFNB3;PLAT;RNF165;NISCH;PRSS3;HYAL1;ARPIN;MAP2K1;SDCCAG8;PKN1;DDIT4;BTG1;ITGA6;PLEKHG5;FAM110C;DNAH1;SHC1;SPRY2;GRB7;NPHP4;VEGFB;LAMA5;UNK;TTBK2;PRKCZ;PAK1;MCTP1;CEMIP;SEMA3F;PLXNB3;ELMO3;ZSWIM4;ITGB4;ETV1;ZP3;NEURL1;NGFR;PLXNB1;EREG;TNS1;RHOBTB2;PLA2G6;C5;PLGRKT;KLF7;SLIT3;ECM1;B4GAT1;MAPK3;CSPG4;LAMB2;PC;SEMA5A;IFITM1;VANGL2;RHOF;SRGAP3;SDC2;ARHGEF2;INPP5D;DMTN;SEMA3B;PROCR;PAK6;SSH1;LTB4R2;MDK;UNC5B;HDAC5;SORL1;PLTP;VLDLR;ROBO3;RHBDF1;LRP5;PTPRU;NDE1;PKN3;TGFBR2;TRPV4;ITGA1;CMTM7;TMSB4X;SMURF2;NOS3;MINK1;HEXB;WNT7A;PIK3R2;EPHA1;SEMA4G;GAS6;BCR;SPAG16;PTAFR;ATP2B4;CTSH;AKT1;LAMB1;TSG101;FMNL3;IL17RC;FGFR4;ASAP3;LMNA;RAB25;PLAU;INSR;WNT3;CKLF;FOXO4;RPS6KA5;CHMP4C;LYST;MAP2K5;BRAF;TIMP1;JAK3;PEX7;SCYL3;FYN;PHLDA2;RAB13;CELSR1;ADA;PLXND1;RHOBTB3;MYO18A;TGFBR3;VAV3;LURAP1;EPHB2;ITGA2;FGFR1;ERBB2;CORO1B;NET1;GRB10;BSG;KCTD13;ROBO4
3567,GO:0007613,0.000270216107231794,0.999916968371225,18,63,memory,BP,APOE;PRNP;CRTC1;ITPR3;PRKCZ;ABCA7;PLA2G6;RGS14;MDK;VLDLR;ADGRF1;CEBPB;B4GALT2;INSR;ASIC1;PJA2;PAIP2;EIF2AK4
8945,GO:0035023,0.000270924612314443,0.999899072321492,24,95,regulation of Rho protein signal transduction,BP,F2R;APOE;OBSCN;ARAP3;ARHGEF19;ARAP1;PLEKHG5;ARHGEF4;PLEKHG2;DNMBP;PLEKHG4;ARHGEF2;FLOT1;PLEKHG3;BCR;PLEKHG6;FARP1;BCL6;EPS8L1;ARHGEF17;EPS8L2;VAV3;NET1;KCTD13
10240,GO:0042995,0.000273870712022024,0.999801595365867,195,1307,cell projection,CC,PTPRS;ACTA2;DLG4;DOCK4;BBS2;APOE;SYTL1;ESPN;ZMYND8;S100A6;FOS;GSN;ADGRL1;WIPF1;FBXO2;PTK6;GLUL;GJC2;LRP1;RSPH3;TIMP2;NTSR1;PRNP;SCN8A;NR1D1;S100A4;ANK3;IFT140;RAPGEF3;SNPH;CST3;DNM1;PARVB;NOS1;ARAP3;SHANK2;CRTC1;EVC;BBS1;PITPNM3;ARPIN;SYNGR1;SYNGAP1;ITGA6;SNX9;PLEKHG5;DNAH1;ULK1;SPRY2;GRB7;NPHP4;BLOC1S4;CYBRD1;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;ANKS6;PRR7;BLVRB;SPRY4;ORAI2;DLG3;MICALL2;CEP250;NEURL1;NGFR;ARHGEF4;WDR60;SPG11;PSPH;RINL;LPAR3;KIF17;IFT27;PKD2;VAMP2;SEPT5;KCNC4;KCNAB2;MAPK3;CSPG4;DEF6;BNIP3;RGS14;DNAL4;DYSF;PLEK2;CNTRL;PI4K2A;TCTN1;ARHGEF2;FBF1;TWF2;STMN3;KIF21B;DMTN;KLHL24;MORN4;ATF4;SSH1;SV2A;FRMD4B;TENM2;REEP6;PKD1;ATXN10;FLOT1;MDK;AZIN2;MAP6;GABBR1;ROBO3;MAP3K12;NEK8;CEP131;TRIOBP;TRPV4;ITGA1;PSD4;PEMT;MINK1;PROM2;TTLL11;TRPV1;PIP5KL1;EPHA1;SHARPIN;CEP126;CROCC;CPT1C;KIF13B;SPAG16;ADCY6;ATP2B4;SPATA7;WDR19;TMEM80;PLEKHG6;AKT1;MICAL1;IFT57;SEPT6;TTC21A;WDR66;CABYR;KIF27;TMOD2;PIAS3;ASAP3;FARP1;C9ORF72;CAPN2;MARK4;RAB25;INSR;TENM4;HOMER2;BRAF;ARHGAP44;PLB1;MAPK10;UNC119B;SCNN1A;CHRM3;SCYL3;GSTM3;EPS8L1;EHD3;FYN;SLC38A2;SNX1;SIRT2;RAB13;MPDZ;ADA;PLXND1;RHOBTB3;EPS8L2;STX1A;STARD10;EPHB2;MAGI1;ITGA2;WFS1;BLOC1S1;SPATA6;SH3PXD2A;UNC119;RGS12;CORO1B;APBA1;PLEKHH2;TCTEX1D4
9650,GO:0038023,0.00027487660344705,0.999839901443102,69,385,signaling receptor activity,MF,F2R;TNFRSF6B;IL20RB;ADGRL1;NTSR1;EGFR;FCGRT;NR1D1;MRC2;ADGRB2;MST1R;EFNB3;LTBP4;MC1R;HTR7;ABCA7;FGFR3;NPR2;PLXNB3;ACVR2B;NGFR;EPOR;LTBP1;PLXNB1;PTPRE;TNFRSF25;LPAR3;PPARA;THRA;PAQR6;IFNGR2;LTB4R2;GPR153;UNC5B;SORL1;IL17RD;VLDLR;ADGRF1;GPRC5C;GABBR1;LRP5;PTPRU;TGFBR2;TRPV4;IL17RE;TRPV1;EPHA1;BCAM;PTAFR;RXRA;CTSH;TNFRSF14;CRY2;IL17RC;FGFR4;INSR;LTB4R;EDA2R;GPR21;MRGPRX3;CHRM3;CELSR1;PLXND1;TGFBR3;EDNRA;EPHB2;ITGA2;FGFR1;ERBB2
13591,GO:0060089,0.00027487660344705,0.999839901443102,69,385,molecular transducer activity,MF,F2R;TNFRSF6B;IL20RB;ADGRL1;NTSR1;EGFR;FCGRT;NR1D1;MRC2;ADGRB2;MST1R;EFNB3;LTBP4;MC1R;HTR7;ABCA7;FGFR3;NPR2;PLXNB3;ACVR2B;NGFR;EPOR;LTBP1;PLXNB1;PTPRE;TNFRSF25;LPAR3;PPARA;THRA;PAQR6;IFNGR2;LTB4R2;GPR153;UNC5B;SORL1;IL17RD;VLDLR;ADGRF1;GPRC5C;GABBR1;LRP5;PTPRU;TGFBR2;TRPV4;IL17RE;TRPV1;EPHA1;BCAM;PTAFR;RXRA;CTSH;TNFRSF14;CRY2;IL17RC;FGFR4;INSR;LTB4R;EDA2R;GPR21;MRGPRX3;CHRM3;CELSR1;PLXND1;TGFBR3;EDNRA;EPHB2;ITGA2;FGFR1;ERBB2
2377,GO:0005509,0.000278715989176038,0.999839844282376,66,361,calcium ion binding,MF,SYTL1;S100A6;GSN;THBS3;EDEM1;LRP1;ALOX15B;PADI3;FBLN1;S100A4;DGKA;NINL;FKBP9;CGREF1;ADAMTS13;SYT8;LTBP4;RAB11FIP4;PITPNM3;PRSS3;SMOC2;SMOC1;PLCH2;PITPNM1;ITPR3;PPP2R3B;MCTP1;CAPNS2;NID1;LTBP1;PSPH;ESYT2;S100A13;FKBP10;PKD2;SLIT3;PCLO;FAM20C;DYSF;LTBP2;PLCD1;TENM2;LTBP3;TTN;VLDLR;SULF2;EGFL7;GAS6;SRR;NECAB3;EFEMP2;MGMT;ITPR2;CAPS;TNNT1;CABYR;NUCB2;ARSA;CAPN2;BRAF;REPS2;EHD3;CELSR1;MAN1B1;MCTP2;SNCB
3946,GO:0008652,0.000279667143662956,0.999917458128904,17,58,cellular amino acid biosynthetic process,BP,GAMT;GLUL;NAGS;GGT1;PHGDH;PYCR2;CBS;GPT2;PSAT1;PSPH;GLUD1;SRR;ATP2B4;THNSL2;ASNS;ASS1;CTH
17675,GO:1901607,0.00028616034178414,0.99991935969228,16,53,alpha-amino acid biosynthetic process,BP,GAMT;GLUL;NAGS;GGT1;PHGDH;PYCR2;CBS;PSAT1;PSPH;GLUD1;SRR;ATP2B4;THNSL2;ASNS;ASS1;CTH
6750,GO:0030182,0.000323344554727057,0.99977888753724,134,851,neuron differentiation,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;S100A6;POSTN;PTK6;SEMA4B;LRP1;TIMP2;VEGFA;EGFR;ANK3;IFT140;SPTB;SNPH;SDK2;BRSK1;SHANK2;CRTC1;SMARCA1;ADARB1;CTF1;CNTN1;EFNB3;OBSL1;ULK2;RNF165;CUL7;NAGLU;MAP2K1;DDIT4;SYNGAP1;ULK1;SHC1;GRB7;NPHP4;BLOC1S4;UNK;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;MICALL2;FBXW8;ETV1;NEURL1;NGFR;ETV5;WNT2B;PLXNB1;SPG11;SSH3;TRAPPC9;MANF;LPAR3;IMPACT;IFT27;KLF7;AREG;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;NYAP1;SDC2;TCTN1;ARHGEF2;TWF2;STMN3;SEMA3B;KDM4C;SSH1;METRN;TENM2;ATXN10;FLOT1;UNC5B;HDAC5;MAP6;VLDLR;ADGRF1;ROBO3;CEBPB;PCSK9;DBNDD1;DNMT3A;TRIOBP;TRPV4;ITGA1;HMG20B;CDK5RAP3;MINK1;WNT7A;SEMA4G;ECM2;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;LAMB1;FARP1;C9ORF72;WNT3;TENM4;RPS6KA5;BRAF;ARHGAP44;MAPK10;LGALS1;UNC119B;TP73;CSNK1E;BCL6;FYN;RAB13;PLXND1;EPHB2;FGFR1;BLOC1S1;ERBB2;UST;EIF2AK4;UNC119;GRB10;KCTD11;NTM
6639,GO:0023051,0.000337279417399001,0.999738578675401,326,2341,regulation of signaling,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;HTRA1;F2R;APOE;ZMYND8;NFATC4;SERPINE2;GSN;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;DDIT4L;PTK6;WWC3;GLUL;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;NR1D1;FBLN1;HADH;S100A4;DUSP5;IFT140;RAPGEF3;TNFSF15;IGFBP4;DNM1;NOS1;DDIT3;ARAP3;SHANK2;CRTC1;ERCC6;ARHGEF19;MST1R;ARRDC1;ARAP1;HBEGF;RGL2;ARHGAP23;CTF1;TFDP2;MDFI;EVC;LTBP4;RNF165;NISCH;ASAP2;EPM2A;WWTR1;SYNGR1;MAP2K1;CYP27B1;PCK2;PKN1;MC1R;DDIT4;SHC2;SYNGAP1;ITGA6;DGKQ;MAML3;PLEKHG5;FAM110C;ARL2;SHC1;SPRY2;GRB7;NPHP4;VEGFB;ADM2;RAB3B;NLGN2;ITPR3;APPL2;CAPRIN2;PRKCZ;PAK1;ABCA7;MCTP1;STK39;PEAR1;FGFR3;NPR2;SPRY4;USP20;ZP3;NEURL1;ACVR2B;SPPL2B;NGFR;GSTO1;ARHGEF4;LTBP1;WNT2B;TRIB2;PLXNB1;EREG;PTPRE;RMI2;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;DNMBP;MANF;LPAR3;S100A13;AGAP1;MTMR4;C5;CHD3;ANO1;CHAC1;SESN2;AIP;RASA4;NLRX1;PKD2;SH3TC2;VAMP2;AREG;SLIT3;SEPT5;ECM1;KCNC4;MAPK3;CSPG4;BNIP3;ERRFI1;SEMA5A;THRA;STK40;VANGL2;SH2D2A;RGS14;FAM20C;RHOF;MVB12B;SRGAP3;ARHGAP22;PLEKHG4;IFNGR2;TCTN1;ARHGEF2;INPP5D;TSPYL2;MAP2K2;STMN3;DMTN;KLHL24;LITAF;PTHLH;BBC3;PAK6;SSH1;ACAP3;IFI6;RALGAPA1;FLOT1;MDK;UNC5B;SORL1;HERPUD1;GSTM2;SULF2;NLRP1;EGFL7;MAP3K12;NEK8;RHBDF1;LRP5;CREBRF;PCSK9;L3MBTL1;FBXL15;MARK3;TGFBR2;TRPV4;FOXL1;ARHGAP25;IQSEC2;ITGA1;CMTM7;PSD4;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;LMO7;TRIB3;EDA;CDK5RAP3;NOS3;MINK1;LDOC1;WNT7A;PIK3R2;EPHA1;RHBDF2;SHARPIN;GAS6;GLUD1;ERN1;NUDT6;LZTS2;PLEKHG3;BCR;NBR1;PPP1R15A;RIMS3;ATP2B4;THNSL2;STRADB;CTSH;UACA;C12ORF66;PLEKHG6;MAPKBP1;AKT1;ITPR2;CARD11;CDKN1C;CRY2;CHEK2;IGFBP2;TSG101;FGFR4;SLC6A9;TMOD2;ASAP3;FARP1;LMNA;SH2B3;C9ORF72;CHMP5;ICA1;PLAU;INSR;WNT3;CKLF;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;ASIC1;PIDD1;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;TP73;MNT;MIB2;CSNK1E;BCL6;RNF213;ADAP1;TKFC;EPS8L1;EHD3;FYN;PJA2;LEMD2;ARHGEF17;TRPC1;GDF15;SPRED3;PHLDA2;ADA;TMEM101;CIDEA;EPS8L2;PAIP2;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;LURAP1;EPHB2;PER1;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;EIF2AK4;PAG1;RGS12;SYVN1;PFKL;NET1;GRB10;KCTD11;KCTD13;APBA1;PNKD;IKBKB;HIP1
2394,GO:0005539,0.00035868106717574,0.999859838487195,25,104,glycosaminoglycan binding,MF,PTPRS;APOE;SERPINE2;THBS3;PGF;FGFBP1;POSTN;VEGFA;PRNP;COL13A1;HBEGF;LTBP4;SMOC2;VEGFB;CEMIP;SEMA5A;LTBP2;MDK;TGFBR2;ECM2;FGFR4;TNXB;RPL29;TGFBR3;FGFR1
13697,GO:0060291,0.000374840374557395,0.999909402539778,13,39,long-term synaptic potentiation,BP,APOE;SERPINE2;PRNP;SHANK2;CRTC1;ITPR3;PRKCZ;VAMP2;RGS14;BRAF;PAIP2;EPHB2;EIF2AK4
2210,GO:0005102,0.000388573959244169,0.999731669820181,137,886,signaling receptor binding,MF,DLG4;DOCK4;F2R;APOE;SYTL1;NFATC4;SERPINE2;PGF;PTK6;CRAT;SEMA4B;LRP1;TIMP2;VEGFA;EGFR;PRNP;S100A4;PRDX5;TNFSF15;IGFBP4;CD9;DNM1;SHANK2;ADAMTS13;ARAP1;HBEGF;CTF1;EFNB3;BBS1;PLAT;LTBP4;REEP2;NISCH;MLYCD;PITPNM3;HMGCL;NXPH4;PKN1;SHC2;ITGA6;PITPNM1;EML2;SHC1;VEGFB;ADM2;NLGN2;LAMA5;CAPRIN2;KDM3A;SEMA3F;USP20;DLG3;ITGB4;ZP3;WNT2B;PLXNB1;EREG;DHRS4;ERMAP;MANF;S100A13;C5;CHAC1;AIP;PKD2;AREG;SLIT3;ECM1;LAMB2;SEMA5A;DMTN;SEMA3B;PTHLH;KDM4C;FLOT1;MDK;GSTM2;EGFL7;CEBPB;PCSK9;LONP2;TGFBR2;ITGA1;CMTM7;SMURF2;APLN;EDA;WNT7A;PIK3R2;SEMA4G;GAS6;ERN1;NUDT6;ECM2;TADA3;RXRA;THNSL2;SLC9A3R2;ACOX3;SEMA6B;IGFBP2;IL17RC;INSR;WNT3;NCOA7;CKLF;GNAL;TNXB;ULBP1;ITGB6;HOMER2;BTN3A2;PIDD1;CAT;TIMP1;HFE;JAK3;SNX17;ICAM5;BTN3A3;EPS8L1;FYN;SNX1;GDF15;CADM4;TGFBR3;VAV3;EPHB2;ITGA2;FGFR1;ERBB2;PAG1;HLA-G;FRS3;GRB10;HIP1;ACOT8
4348,GO:0009925,0.000395432286232359,0.999937252342347,9,21,basal plasma membrane,CC,EGFR;ANK3;CLCA2;MST1R;ITGA6;SHROOM4;PKD2;ERBB2;OSCP1
12317,GO:0048699,0.000405259728228043,0.99971677297372,146,944,generation of neurons,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;SERPINE2;S100A6;POSTN;PTK6;GJC2;SEMA4B;LRP1;TIMP2;VEGFA;EGFR;ANK3;IFT140;SPTB;SNPH;IDH2;SDK2;NOS1;BRSK1;SHANK2;CRTC1;SMARCA1;ADARB1;CTF1;CNTN1;EFNB3;OBSL1;ULK2;RNF165;CUL7;NAGLU;MAP2K1;SDCCAG8;DDIT4;SYNGAP1;ULK1;SHC1;GRB7;NPHP4;BLOC1S4;UNK;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;MICALL2;FBXW8;ETV1;NEURL1;NGFR;ETV5;WNT2B;PLXNB1;SPG11;SSH3;TRAPPC9;MANF;LPAR3;IMPACT;IFT27;KLF7;AREG;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;RGS14;SLITRK6;NYAP1;SDC2;TCTN1;ARHGEF2;TWF2;STMN3;SEMA3B;KDM4C;SSH1;METRN;TENM2;ATXN10;FLOT1;UNC5B;HDAC5;SORL1;MAP6;VLDLR;ADGRF1;ROBO3;CEBPB;NDE1;PCSK9;DBNDD1;DNMT3A;TRIOBP;TRPV4;ITGA1;HMG20B;CDK5RAP3;MINK1;WNT7A;SEMA4G;GAS6;ECM2;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;LAMB1;FARP1;C9ORF72;WNT3;TENM4;RPS6KA5;BRAF;ARHGAP44;MAPK10;LGALS1;UNC119B;TP73;PEX7;CSNK1E;BCL6;FYN;SIRT2;RAB13;CELSR1;PLXND1;EPHB2;FGFR1;BLOC1S1;ERBB2;UST;EIF2AK4;UNC119;GRB10;KCTD11;NTM
12125,GO:0048251,0.000422359406805873,0.999981344058986,5,7,elastic fiber assembly,BP,THSD4;LOXL1;MYH11;EFEMP2;TNXB
10408,GO:0043269,0.000436551278808785,0.999757891025272,55,297,regulation of ion transport,BP,DLG4;F2R;APOE;KCNG1;SERPINE2;FHL1;GJC2;NTSR1;PRNP;SCN8A;ANK3;NOS1;SHANK2;SCN4B;CNTN1;RAB3B;NLGN2;PRSS8;ABCA7;STK39;CEMIP;GSTO1;PLA2G6;LPAR3;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;SNTA1;KLHL24;ATF4;SV2A;KCNMA1;GSTM2;WNK4;PCSK9;TMSB4X;ANO9;NOS3;MINK1;PTAFR;ATP2B4;AKT1;CRY2;TPCN1;HOMER2;HFE;EHD3;FYN;TRPC1;EPHB2;PER1;FGFR1;WFS1
17222,GO:0120025,0.000446300622014021,0.999674697611858,187,1258,plasma membrane bounded cell projection,CC,PTPRS;ACTA2;DLG4;DOCK4;BBS2;APOE;SYTL1;ESPN;ZMYND8;S100A6;FOS;GSN;ADGRL1;WIPF1;FBXO2;PTK6;GLUL;GJC2;LRP1;TIMP2;NTSR1;PRNP;SCN8A;NR1D1;S100A4;ANK3;IFT140;RAPGEF3;SNPH;CST3;DNM1;PARVB;NOS1;ARAP3;SHANK2;CRTC1;EVC;BBS1;ARPIN;SYNGR1;SYNGAP1;ITGA6;SNX9;PLEKHG5;DNAH1;ULK1;SPRY2;NPHP4;BLOC1S4;CYBRD1;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;ANKS6;PRR7;BLVRB;SPRY4;ORAI2;DLG3;MICALL2;CEP250;NEURL1;NGFR;ARHGEF4;WDR60;SPG11;PSPH;RINL;LPAR3;KIF17;IFT27;PKD2;VAMP2;SEPT5;KCNC4;KCNAB2;MAPK3;CSPG4;DEF6;BNIP3;RGS14;DNAL4;DYSF;PLEK2;CNTRL;PI4K2A;TCTN1;ARHGEF2;FBF1;TWF2;STMN3;KIF21B;DMTN;KLHL24;MORN4;ATF4;SSH1;SV2A;FRMD4B;TENM2;REEP6;PKD1;ATXN10;FLOT1;AZIN2;MAP6;GABBR1;ROBO3;MAP3K12;NEK8;CEP131;TRIOBP;TRPV4;ITGA1;PSD4;PEMT;MINK1;PROM2;TTLL11;TRPV1;EPHA1;SHARPIN;CEP126;CROCC;CPT1C;KIF13B;SPAG16;ADCY6;ATP2B4;SPATA7;WDR19;TMEM80;PLEKHG6;AKT1;MICAL1;IFT57;SEPT6;TTC21A;WDR66;CABYR;KIF27;TMOD2;PIAS3;ASAP3;FARP1;C9ORF72;CAPN2;MARK4;RAB25;INSR;TENM4;HOMER2;BRAF;ARHGAP44;PLB1;MAPK10;UNC119B;SCNN1A;CHRM3;SCYL3;GSTM3;EPS8L1;EHD3;FYN;SLC38A2;SNX1;SIRT2;RAB13;MPDZ;ADA;PLXND1;EPS8L2;STX1A;STARD10;EPHB2;ITGA2;WFS1;BLOC1S1;SPATA6;UNC119;RGS12;CORO1B;APBA1;PLEKHH2;TCTEX1D4
2706,GO:0006082,0.000451055645797856,0.999691048269376,128,822,organic acid metabolic process,BP,GAMT;PRODH;ACSF2;ALDH7A1;TYSND1;SLC2A3;CRAT;GLUL;AIG1;ALOX15B;NAGS;D2HGDH;NR1D1;SLC7A8;HADH;BPHL;SLC16A3;SLC2A9;IDH2;CRTAP;NOS1;ACAD10;PGM1;GGT1;B3GAT3;PHGDH;PYCR2;DHTKD1;ALDH4A1;SLC27A1;CPT2;MLYCD;HMGCL;UROS;HYAL1;PCK2;CRYL1;DDIT4;OGDHL;AARS;PHYH;ERO1B;CEMIP;MTHFR;GLDC;CBS;NMNAT2;ABHD14B;ETFB;GSTO1;GPT2;PSAT1;PNPLA3;PSPH;CARS;ACOT1;PPARA;SESN2;BLMH;ACOT11;B4GAT1;ACACB;MAPK3;CSPG4;PC;ACSS2;LTA4H;MLXIPL;HIBADH;SDHA;ATF4;CHST6;HLCS;AZIN2;GALK1;GSTM2;ST3GAL3;CES2;ACY1;PTGR2;ACOT7;ALDOC;ACADS;LONP2;TRIB3;ALDH1L2;PEMT;NOS3;HEXB;SLC27A3;GLUD1;SUCLG2;ALKBH7;CPT1C;HEXA;SRR;CYP2R1;ATP2B4;THNSL2;ACOX3;ACAD11;GSTO2;ASNS;AKT1;B4GALT2;PHYKPL;ASS1;FGFR4;HAGH;CBR4;ACADVL;SLC6A6;FAAH;INSR;ACSS1;ALDH1L1;PEX7;OSBPL1A;TST;GALNS;CTH;XYLT2;UST;PFKL;BSG;PNKD;CYP4V2;ACOT8
15718,GO:0072329,0.00046358319678058,0.999819290089781,24,100,monocarboxylic acid catabolic process,BP,TYSND1;CRAT;AIG1;HADH;ACAD10;CPT2;MLYCD;PCK2;CRYL1;PHYH;ETFB;PPARA;SESN2;ACACB;ACADS;LONP2;CPT1C;ACOX3;ACAD11;AKT1;ACADVL;FAAH;PEX7;ACOT8
3063,GO:0006629,0.000489339395497904,0.999655309647707,148,970,lipid metabolic process,BP,ISYNA1;APOE;OSBPL5;ACSF2;EGR1;LMF1;TYSND1;CRAT;AIG1;LRP1;ALOX15B;EGFR;NR1D1;HADH;DGKA;ACAD10;GGT1;HBEGF;RBL2;CYP3A5;HSD17B14;SLC27A1;CPT2;MLYCD;PLD3;PITPNM3;HMGCL;ACP6;CYP27B1;PCK2;CCDC71L;CRYL1;ABCA2;LPCAT4;PLCH2;PITPNM1;DGKQ;PHYH;FGFR3;SEC14L2;PLCXD1;ZP3;ETFB;EREG;PNPLA3;PLCD3;DHRS4;PLA2G6;CES3;ABCG1;ESYT2;MTMR4;ACOT1;PPARA;SESN2;ACOT11;ST6GALNAC6;PI4KAP1;ACACB;MAPK3;PC;OSBPL10;THRA;ACSS2;MVD;LTA4H;PI4K2A;SDC2;MLXIPL;PLCD1;INPP5D;SRD5A3;ANGPTL4;FUCA1;HSD11B1;SORL1;PLTP;GSTM2;VLDLR;CES2;PTGR2;ACOT7;LRP5;PCSK9;ACADS;LONP2;APOL4;HSD17B7;TRIB3;PEMT;PIGZ;HEXB;SLC27A3;TRPV1;PIP5KL1;PIK3R2;ALKBH7;CHKB;CPT1C;HEXA;CYP2R1;RXRA;THNSL2;ACOX3;ACAD11;TM7SF2;HINT2;AKT1;ZFYVE21;IGFBP7;FGFR4;CBR4;ACADVL;FAAH;ARSA;ACSS1;PNPLA4;PIGQ;PLB1;CAT;CERS4;PEX7;SNX17;TAZ;FYN;SIRT2;MBOAT2;OSBPL1A;ETNK2;NAGA;CIDEA;RETSAT;PLPP6;VAV3;STARD10;INPP4A;FGFR1;PIGV;ESYT3;FITM2;ERBB2;KDELC2;MPPE1;PEX11A;KDSR;PLEKHA4;CYP4V2;ACOT8
9853,GO:0042127,0.000525319454455303,0.999626338345941,155,1026,regulation of cell proliferation,BP,XDH;HTRA1;F2R;TNFRSF6B;APOE;SERPINE2;S100A6;IL20RB;EGR1;CTNNBIP1;PGF;FGFBP1;FBXO2;PTK6;GLUL;GJC2;ALOX15B;PDCD4;TIMP2;VEGFA;EGFR;PRNP;NR1D1;FBLN1;CD9;IDH2;CST3;MEF2D;CGREF1;NDRG1;TBC1D8;MST1R;ZFP36L1;ADARB1;NUPR1;TCFL5;HBEGF;RPS6KA2;CTF1;MXI1;KLF9;FBXW4;ASH2L;HYAL1;WWTR1;MAP2K1;CYP27B1;MXD4;PKN1;BTG1;TRNP1;SHC1;SPRY2;VEGFB;MARCKSL1;LAMA5;PRKCZ;PAK1;FGFR3;PLXNB3;DLG3;ZP3;NEURL1;CCDC88B;EAPP;SPEG;NGFR;ETV5;PLXNB1;EREG;PLCD3;TNFRSF25;S100A13;PKD2;STAT6;ING4;HMGA2;AREG;SLIT3;ECM1;ERRFI1;SEMA5A;IFITM1;MVD;MLXIPL;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;PTHLH;KDM4C;LTBP3;DEAF1;SULF2;EGFL7;CEBPB;LRP5;PTPRU;ATRAID;CEP131;TGFBR2;ITGA1;APLN;PEMT;NOS3;LDOC1;WNT7A;EPHA1;GAS6;ERN1;LZTS2;PTAFR;CTSH;TNFRSF14;TP53I11;AKT1;IGFBP7;CARD11;CDKN1C;LAMB1;IFT57;IGFBP2;TSG101;FGFR4;TCIRG1;LMNA;MAB21L2;RAB25;PLAU;INSR;WNT3;FOXO4;MAP2K5;BRAF;TIMP1;JAK3;TP73;MTA3;MNT;BCL6;HSF4;FYN;SIRT2;PHLDA2;ADA;TGFBR3;TCF7;VAV3;DHPS;ITGA2;FGFR1;ERBB2;HLA-G;KCTD11;SIX5
6048,GO:0019199,0.000534875444040279,0.999846821875419,15,50,transmembrane receptor protein kinase activity,MF,EGFR;MST1R;EFNB3;LTBP4;FGFR3;ACVR2B;LTBP1;TGFBR2;EPHA1;FGFR4;INSR;TGFBR3;EPHB2;FGFR1;ERBB2
4034,GO:0009070,0.00053500058150675,0.999938875801805,7,14,serine family amino acid biosynthetic process,BP,GGT1;PHGDH;CBS;PSAT1;PSPH;SRR;CTH
1256,GO:0003012,0.000559616242133972,0.999709085407163,44,222,muscle system process,BP,ACTA2;DOCK4;GAMT;BBS2;F2R;GSN;NOS1;SCN4B;GAA;OBSL1;VEGFB;MYH11;TPM2;HTR7;PAK1;GSTO1;PLA2G6;ITGB5;ERRFI1;DYSF;SNTA1;MYH3;TTN;KCNMA1;GSTM2;SULF2;ITGA1;NOS3;TRPV1;TNNI2;PTAFR;ATP2B4;TNNT1;TMOD2;LMNA;LTB4R;MYOF;CHRM3;TAZ;EHD3;ADA;EDNRA;ITGA2;TNNI1
12655,GO:0050890,0.00056669389374635,0.999737098327858,33,155,cognition,BP,DLG4;APOE;FOS;NTSR1;EGFR;PRNP;SHANK2;CRTC1;SYNGAP1;ITPR3;PRKCZ;ABCA7;SHROOM4;RAG1;PLA2G6;THRA;RGS14;MDK;VLDLR;ADGRF1;DEAF1;CEBPB;METTL23;B4GALT2;TMOD2;INSR;BRAF;ASIC1;FYN;PJA2;PAIP2;EPHB2;EIF2AK4
4560,GO:0010646,0.000570127908288506,0.999554357241063,320,2310,regulation of cell communication,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;HTRA1;F2R;APOE;ZMYND8;NFATC4;SERPINE2;GSN;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;DDIT4L;PTK6;WWC3;GLUL;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;NR1D1;FBLN1;HADH;S100A4;ANK3;DUSP5;IFT140;RAPGEF3;TNFSF15;IGFBP4;DNM1;NOS1;DDIT3;ARAP3;SHANK2;CRTC1;ERCC6;ARHGEF19;MST1R;ARRDC1;ARAP1;HBEGF;RGL2;ARHGAP23;CTF1;TFDP2;MDFI;EVC;LTBP4;RNF165;NISCH;ASAP2;EPM2A;WWTR1;SYNGR1;MAP2K1;CYP27B1;PCK2;PKN1;MC1R;DDIT4;SHC2;SYNGAP1;ITGA6;DGKQ;MAML3;PLEKHG5;FAM110C;ARL2;SHC1;SPRY2;GRB7;NPHP4;VEGFB;ADM2;RAB3B;NLGN2;ITPR3;APPL2;CAPRIN2;PRKCZ;PAK1;ABCA7;MCTP1;STK39;PEAR1;FGFR3;SPRY4;USP20;ZP3;NEURL1;ACVR2B;SPPL2B;NGFR;GSTO1;ARHGEF4;LTBP1;WNT2B;TRIB2;PLXNB1;EREG;PTPRE;RMI2;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;DNMBP;MANF;LPAR3;S100A13;AGAP1;MTMR4;C5;CHD3;ANO1;CHAC1;SESN2;AIP;RASA4;NLRX1;PKD2;SH3TC2;VAMP2;AREG;SLIT3;SEPT5;ECM1;KCNC4;MAPK3;CSPG4;BNIP3;ERRFI1;SEMA5A;THRA;STK40;VANGL2;SH2D2A;RGS14;FAM20C;RHOF;MVB12B;SRGAP3;ARHGAP22;PLEKHG4;IFNGR2;TCTN1;ARHGEF2;INPP5D;TSPYL2;MAP2K2;STMN3;DMTN;KLHL24;LITAF;PTHLH;BBC3;PAK6;SSH1;ACAP3;IFI6;RALGAPA1;FLOT1;MDK;UNC5B;SORL1;HERPUD1;GSTM2;SULF2;NLRP1;EGFL7;MAP3K12;NEK8;RHBDF1;LRP5;CREBRF;PCSK9;L3MBTL1;FBXL15;MARK3;TGFBR2;TRPV4;FOXL1;ARHGAP25;IQSEC2;ITGA1;CMTM7;PSD4;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;EDA;CDK5RAP3;NOS3;MINK1;LDOC1;WNT7A;PIK3R2;EPHA1;RHBDF2;SHARPIN;GAS6;GLUD1;ERN1;NUDT6;LZTS2;PLEKHG3;BCR;NBR1;PPP1R15A;RIMS3;ATP2B4;THNSL2;STRADB;CTSH;UACA;C12ORF66;PLEKHG6;MAPKBP1;AKT1;ITPR2;CARD11;CDKN1C;CRY2;CHEK2;IGFBP2;TSG101;FGFR4;SLC6A9;TMOD2;ASAP3;FARP1;LMNA;SH2B3;C9ORF72;ICA1;PLAU;INSR;WNT3;CKLF;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;ASIC1;PIDD1;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;TP73;MNT;MIB2;CSNK1E;BCL6;RNF213;ADAP1;TKFC;EPS8L1;FYN;PJA2;LEMD2;ARHGEF17;GDF15;SPRED3;PHLDA2;ADA;TMEM101;CIDEA;EPS8L2;PAIP2;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;LAMTOR2;MAP3K10;MFNG;STARD10;LURAP1;EPHB2;PER1;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;EIF2AK4;PAG1;RGS12;SYVN1;PFKL;NET1;GRB10;KCTD11;KCTD13;PNKD;IKBKB;HIP1
8907,GO:0034762,0.000602987485409239,0.999670724339281,50,266,regulation of transmembrane transport,BP,DLG4;F2R;KCNG1;FHL1;GJC2;NTSR1;PRNP;SCN8A;ANK3;CLTCL1;NOS1;SHANK2;SCN4B;NLGN2;PRKCZ;PAK1;STK39;CEMIP;NGFR;GSTO1;PLA2G6;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;SNTA1;KLHL24;KCNMA1;AZIN2;GSTM2;WNK4;PCSK9;TMSB4X;ANO9;TRIB3;MINK1;PIK3R2;PTAFR;ATP2B4;AKT1;INSR;TPCN1;BRAF;EHD3;FYN;TRPC1;RTN2;EPHB2;GRB10
3692,GO:0008201,0.000652591130453227,0.999764964794686,20,79,heparin binding,MF,PTPRS;APOE;SERPINE2;THBS3;PGF;FGFBP1;POSTN;VEGFA;COL13A1;HBEGF;SMOC2;VEGFB;LTBP2;MDK;ECM2;FGFR4;TNXB;RPL29;TGFBR3;FGFR1
10719,GO:0044093,0.000669308543556169,0.999507946413743,185,1258,positive regulation of molecular function,BP,XDH;DUSP6;DLG4;DOCK4;F2R;APOE;GSN;EGR1;LMF1;EVI5L;CDC42EP5;LRP1;TIMP2;VEGFA;NTSR1;EGFR;RBCK1;PRNP;FBLN1;ANK3;DUSP5;RAPGEF3;TNFSF15;NOS1;GPSM1;DDIT3;ARAP3;CRTC1;ERCC6;TBC1D8;ARHGEF19;GRAMD4;MST1R;RIN1;ARAP1;B3GAT3;ARHGAP23;SLC27A1;ASAP2;MAP2K1;CYP27B1;PKN1;SHC2;SYNGAP1;ITGA6;DGKQ;TMEM173;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PAK1;STK39;FGFR3;CEMIP;DLG3;NEURL1;ACVR2B;NGFR;GSTO1;PLXNB1;EREG;NAB2;DNMBP;TRAPPC9;RINL;LPAR3;AGAP1;ALS2CL;C5;RASA4;PKD2;HMGA2;MAPK3;CSPG4;ERRFI1;VANGL2;DOCK9;RGS14;DNAL4;MAPK12;SRGAP3;ARHGAP22;PLEKHG4;TBC1D14;ARHGEF2;MAP2K2;BBC3;PAK6;DOCK11;TBC1D3E;RABGAP1;ACAP3;PKD1;RALGAPA1;FLOT1;AZIN2;HDAC5;SORL1;HERPUD1;GSTM2;VLDLR;ADGRF1;NLRP1;MAP3K12;LRP5;WNK4;RIN2;PKIB;TGFBR2;ARHGAP25;ITGA1;TMSB4X;TRIB3;DAP;EDA;NOS3;MINK1;PIK3R2;EPHA1;CCS;GAS6;ERN1;BCR;MAPRE3;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;STRADB;CTSH;PLEKHG6;AKT1;CARD11;IFT57;FGFR4;ASAP3;SGSM2;TBC1D20;ARHGAP27;IFI27;INSR;RPS6KA5;C6ORF89;MAP2K5;BRAF;EDA2R;ARHGAP44;PIDD1;CAT;MAPK10;HFE;TP73;ADAP1;EHD3;FYN;SIRT2;GOLGA2;PLXND1;HDAC8;AVPI1;CIDEB;VAV3;LAMTOR2;MAP3K10;TBC1D16;MFNG;EDNRA;EPHB2;ITGA2;FGFR1;SH3PXD2A;CTH;ERBB2;UNC119;RGS12;C15ORF62;MMP17;HMBOX1;NET1;CAMKK1;IKBKB;HIP1
11116,GO:0045178,0.000669606745506153,0.999838031485204,12,36,basal part of cell,CC,EGFR;ANK3;CLCA2;MST1R;ITGA6;SHROOM4;PKD2;ITGA1;HFE;ITGA2;ERBB2;OSCP1
12294,GO:0048666,0.000675641664301621,0.999543375600659,112,704,neuron development,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;S100A6;POSTN;PTK6;SEMA4B;LRP1;VEGFA;EGFR;ANK3;IFT140;SPTB;BRSK1;SHANK2;CRTC1;ADARB1;CTF1;CNTN1;EFNB3;OBSL1;ULK2;RNF165;CUL7;NAGLU;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;NPHP4;BLOC1S4;UNK;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;MICALL2;FBXW8;ETV1;NEURL1;NGFR;PLXNB1;SPG11;SSH3;MANF;LPAR3;IMPACT;IFT27;KLF7;AREG;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;NYAP1;SDC2;TCTN1;TWF2;STMN3;SEMA3B;SSH1;METRN;TENM2;ATXN10;FLOT1;UNC5B;MAP6;VLDLR;ADGRF1;ROBO3;DBNDD1;TRIOBP;TRPV4;ITGA1;MINK1;WNT7A;SEMA4G;ECM2;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;LAMB1;FARP1;C9ORF72;WNT3;TENM4;RPS6KA5;BRAF;ARHGAP44;MAPK10;LGALS1;FYN;RAB13;PLXND1;EPHB2;FGFR1;BLOC1S1;ERBB2;UST;EIF2AK4;GRB10;NTM
6215,GO:0019752,0.000680213409757817,0.999536161470671,117,749,carboxylic acid metabolic process,BP,GAMT;PRODH;ACSF2;ALDH7A1;TYSND1;SLC2A3;CRAT;GLUL;AIG1;ALOX15B;NAGS;D2HGDH;NR1D1;SLC7A8;HADH;BPHL;SLC16A3;IDH2;CRTAP;NOS1;ACAD10;PGM1;GGT1;PHGDH;PYCR2;DHTKD1;ALDH4A1;SLC27A1;CPT2;MLYCD;HMGCL;UROS;HYAL1;PCK2;CRYL1;DDIT4;OGDHL;AARS;PHYH;ERO1B;CEMIP;MTHFR;GLDC;CBS;NMNAT2;ETFB;GSTO1;GPT2;PSAT1;PNPLA3;PSPH;CARS;ACOT1;PPARA;SESN2;BLMH;ACOT11;ACACB;MAPK3;CSPG4;PC;ACSS2;LTA4H;MLXIPL;HIBADH;SDHA;ATF4;HLCS;AZIN2;GALK1;GSTM2;CES2;ACY1;PTGR2;ACOT7;ALDOC;ACADS;LONP2;TRIB3;ALDH1L2;PEMT;NOS3;HEXB;SLC27A3;GLUD1;SUCLG2;ALKBH7;CPT1C;HEXA;SRR;ATP2B4;THNSL2;ACOX3;ACAD11;GSTO2;ASNS;AKT1;PHYKPL;ASS1;FGFR4;HAGH;CBR4;ACADVL;SLC6A6;FAAH;INSR;ACSS1;ALDH1L1;PEX7;OSBPL1A;CTH;UST;PFKL;BSG;PNKD;CYP4V2;ACOT8
10865,GO:0044421,0.000680403741348849,0.999463298747187,340,2507,extracellular region part,CC,XDH;PTPRS;ACTA2;HTRA1;GAMT;NT5E;TNFRSF6B;APOE;SYTL1;XPC;SERPINE2;S100A6;GSN;PYGB;THBS3;PGF;ALDH7A1;FGFBP1;POSTN;SLC2A3;FBXO2;ACP5;THSD4;NAPRT;GLUL;GPX3;SEMA4B;ALOX15B;TIMP2;VEGFA;EGFR;PRNP;ZDHHC1;FBLN1;SLC7A8;ADAMTS7;S100A4;PRDX5;TFPI2;RAPGEF3;BPHL;CLTCL1;TNFSF15;LOXL1;TSPAN1;IGFBP4;KRT15;CD9;NINL;IDH2;CRTAP;CST3;DNM1;DNPH1;PGM1;NDRG1;GGT1;ADAMTS13;FCGBP;MMP28;ARRDC1;HEBP1;B3GAT3;HBEGF;RBL2;PHGDH;ARHGAP23;GAA;PYGL;MMP1;CTF1;CNTN1;PLAT;LTBP4;CTSF;REEP2;RAB11FIP4;PLD3;PRSS3;HYAL1;SMOC2;NAGLU;SMOC1;MAP2K1;PCK2;COL6A1;PPL;CRYL1;PGLS;CAPG;H2AFJ;TOM1L2;DNASE1L1;ITGA6;AKR7A2;MXRA7;SNX9;FAM213A;MAGEF1;ARL2;VEGFB;MARCKSL1;HDAC11;RAB3B;PCSK1;PLEKHH3;MYH11;CYBRD1;LAMA5;APPL2;PRSS8;TTBK2;PRKCZ;GALE;SERPING1;SLC37A2;AARS;PABPC1L;BLVRB;SEC14L2;SEMA3F;FAM3A;DLG3;ITGB4;CEP250;ZP3;ABHD14B;ELFN2;NID1;ETFB;GSTO1;WDR60;LTBP1;MUC19;PPCS;WNT2B;ACTR1B;EREG;CHD2;PSAT1;SPG11;TMC6;DHRS4;TMED4;PLA2G6;CES3;OAF;MANF;S100A13;GSTT1;MTMR4;C5;ANO1;SNX29;FNDC4;BLMH;PKD2;ACOT11;VAMP2;AREG;COL8A1;SLIT3;ECM1;B4GAT1;PCLO;JADE2;MAPK3;CSPG4;ITGB5;LAMB2;SEMA5A;IRF2BPL;FAM20C;DYSF;RHOF;LTBP2;ADAMTSL1;CTSB;SLITRK6;MXRA8;MVB12B;MYH3;LTA4H;KIAA0319L;SDC2;CHMP1B;TCTN1;C1RL;PLCD1;MTMR11;PDCD1LG2;TWF2;ANGPTL4;SEMA3B;PTHLH;PROCR;METRN;FRMD4B;PKD1;FUCA1;ATXN10;FLOT1;LTBP3;TTN;KCNMA1;SORL1;GALK1;NTPCR;PLTP;GSTM2;VLDLR;GPRC5C;SULF2;CES2;ACY1;COL4A6;EGFL7;PTGR2;ACOT7;ALDOC;PCSK9;CEP131;EPN3;MARK3;ITGA1;CMTM7;TMSB4X;APOL4;APLN;ALDH1L2;MINK1;HEXB;PROM2;WNT7A;SEMA4G;CCS;GAS6;OLFML2A;ECM2;CROCC;BCR;NBR1;HEXA;BCAM;C1QTNF6;TTYH3;RAB43;THNSL2;SLC9A3R2;EFEMP2;CTSH;UACA;GSTO2;ENTPD6;IGFBP7;CARD11;LAMB1;HMSD;GAREM2;IGFBP2;ASS1;CAPS;TSG101;KIF27;TMEM256;RASSF9;HAGH;NUCB2;DNASE2;C9ORF72;CHMP5;ARSA;CAPN2;ARMC9;MAN2B1;RAB25;PLAU;INSR;WNT3;KRT19;CKLF;GNAL;CHMP4C;TNXB;MBLAC2;ITGB6;CTDSPL;ALDH1L1;CAT;MYOF;DPP7;LGALS1;TIMP1;HFE;SCNN1A;TUBGCP6;APRT;MPI;METTL7A;SAT2;GSTM3;TKFC;EPS8L1;PEX1;UBXN6;GDF15;RAB13;OSBPL1A;TOM1;TST;ADA;CADM4;RHOBTB3;NAGA;ENTPD2;EPS8L2;ADIRF;ERV3-1;TGFBR3;RNPEP;VAV3;MAN1B1;GALNS;LAMTOR2;MFNG;BLOC1S1;CTH;PLLP;UNC119;PFKL;CORO1B;MMP17;RPL12;MMP19;BSG;LYPLAL1;TRIM45;TMEM8A;KDSR;ROBO4
10409,GO:0043270,0.000695392570469992,0.999701937938671,27,121,positive regulation of ion transport,BP,F2R;APOE;FHL1;GJC2;NTSR1;ANK3;NOS1;SCN4B;CNTN1;RAB3B;PRSS8;ABCA7;STK39;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;GSTM2;WNK4;TMSB4X;PTAFR;AKT1;EHD3;TRPC1;EPHB2;WFS1
14490,GO:0065009,0.000739221972470396,0.999420861044545,311,2247,regulation of molecular function,BP,XDH;DUSP6;DLG4;DOCK4;F2R;TNFRSF6B;APOE;NFATC4;KCNG1;SERPINE2;FHL1;FOS;GSN;EGR1;CTNNBIP1;LMF1;PGF;PPP1R35;EVI5L;PTK6;CDC42EP5;LRP1;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;FBLN1;PRDX5;ANK3;TFPI2;DUSP5;RAPGEF3;TNFSF15;SPTB;CST3;NOS1;GPSM1;DDIT3;ARAP3;SHANK2;CRTC1;SCN4B;ERCC6;TBC1D8;ARHGEF19;GRAMD4;MST1R;ADARB1;RIN1;ARAP1;B3GAT3;HBEGF;RBL2;RGL2;ARHGAP23;CTF1;MXI1;MDFI;SLC27A1;PHACTR3;ASAP2;PPP1R14A;WWTR1;MAP2K1;CYP27B1;PKN1;SHC2;SYNGAP1;ITGA6;DGKQ;TMEM173;SNX9;PLEKHG5;ARL2;SHC1;SPRY2;VEGFB;ADM2;NLGN2;RALGDS;PRSS8;CAPRIN2;TPM2;TTBK2;PRKCZ;PPP2R3B;SERPING1;PAK1;STK39;FGFR3;CEMIP;PLXNB3;SPRY4;DOCK6;DLG3;ZP3;NEIL1;NEURL1;ACVR2B;RAG1;NGFR;ELFN2;GSTO1;ARHGEF4;TRIB2;PLXNB1;EREG;PLEKHG2;NAB2;PLA2G6;DNMBP;TRAPPC9;RINL;MANF;LPAR3;AGAP1;ALS2CL;C5;PPARA;SESN2;AIP;RASA4;NLRX1;PKD2;VAMP2;HMGA2;AREG;ECM1;ACACB;KCNAB2;MAPK3;CSPG4;TRPT1;ERRFI1;THRA;VANGL2;DOCK9;RGS14;DNAL4;SNTA1;CTSB;MAPK12;SRGAP3;ARHGAP22;PLEKHG4;TBC1D14;ARHGEF2;TSPYL2;MAP2K2;STMN3;KLHL24;ANGPTL4;PTHLH;ZFPM1;BBC3;PAK6;DOCK11;LTB4R2;TBC1D3E;RABGAP1;ACAP3;IFI6;PKD1;RALGAPA1;FLOT1;MDK;TTN;AZIN2;HDAC5;SORL1;HERPUD1;GSTM2;VLDLR;PAPLN;ADGRF1;GABBR1;NLRP1;MAP3K12;LRP5;WNK4;RIN2;NDE1;PCSK9;PKIB;TGFBR2;ARHGAP25;IQSEC2;CSRNP3;ITGA1;CMTM7;PSD4;TMSB4X;ANO9;APLN;TRIB3;DAP;BHLHE40;EDA;CDK5RAP3;NOS3;MINK1;LDOC1;PROM2;ZFP90;WNT7A;TRPV1;PIK3R2;EPHA1;CCS;GAS6;ERN1;NUDT6;PLEKHG3;BCR;MAPRE3;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;THNSL2;STRADB;CTSH;MGMT;PLEKHG6;AKT1;CARD11;CDKN1C;MICAL1;CRY2;HMSD;IFT57;SBF2;SPDYE2;SPDYE2B;TSG101;FGFR4;PIAS3;ASAP3;FARP1;C9ORF72;SGSM2;TBC1D20;ARHGAP27;IFI27;PLAU;INSR;WNT3;CKLF;GNAL;RPS6KA5;C6ORF89;MAP2K5;BRAF;EDA2R;ARHGAP44;PIDD1;CAT;MAPK10;TIMP1;HFE;JAK3;TP73;CSNK1E;BCL6;ADAP1;EPS8L1;EHD3;FYN;ARHGEF17;SIRT2;GDF15;PHLDA2;GOLGA2;PLXND1;EPS8L2;HDAC8;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;LAMTOR2;MAP3K10;TBC1D16;MFNG;EDNRA;EPHB2;ITGA2;FGFR1;WFS1;SH3PXD2A;CTH;ERBB2;EIF2AK4;UNC119;RGS12;C15ORF62;FRS3;SFI1;MMP17;HMBOX1;NET1;CAMKK1;IKBKB;SNCB;HIP1
3557,GO:0007600,0.000754641340295014,0.99961067282241,41,210,sensory perception,BP,BBS2;F2R;ESPN;SERPINE2;ALDH7A1;NTSR1;DNM1;BBS1;REEP2;EML2;SPRY2;NLGN2;ITPR3;CEMIP;NIPSNAP1;OLFM2;ANO1;MAPK3;LAMB2;SLITRK6;REEP6;TRIOBP;HEXB;TRPV1;PTAFR;SPATA7;GNAL;RABGGTA;HOMER2;ASIC1;GJB4;SCNN1A;HSF4;FYN;EPS8L2;EPAS1;ITGA2;FGFR1;WFS1;UNC119;CYP4V2
17724,GO:1901700,0.000802503347204378,0.999424331170964,152,1013,response to oxygen-containing compound,BP,TNIP1;F2R;TNFRSF6B;APOE;NFATC4;FOS;GSN;EGR1;POSTN;PTK6;ACP5;EDEM1;GLUL;FAM210B;GPX3;LRP1;PDCD4;EGFR;PRNP;NR1D1;ERCC1;HADH;PRDX5;RAPGEF3;LOXL1;CD9;CST3;NOS1;ERCC6;ADAMTS13;ZFP36L1;SLC27A1;MAPK13;KLF9;HMGCL;HYAL1;TXNRD3;CYP27B1;PCK2;COL6A1;ABCA2;DDIT4;BTG1;DGKQ;SHC1;PRKCZ;PAK1;MTHFR;GLDC;NEURL1;ACVR2B;NGFR;EREG;PTPRE;PSPH;TNFRSF25;PLA2G6;PPARA;ANO1;SESN2;IMPACT;PKD2;STAT6;VAMP2;AREG;SLIT3;LRP11;MAPK3;BNIP3;ERRFI1;MLXIPL;ARHGEF2;PDCD1LG2;TWF2;DMTN;LITAF;ATF4;SSH1;HLCS;KCNMA1;HDAC5;IRF5;SRSF5;NLRP1;ENDOG;CEBPB;LRP5;PCSK9;AQP3;DNMT3A;TGFBR2;TRPV4;MAP1LC3A;PDE2A;TRIB3;PEMT;NOS3;WNT7A;TRPV1;PIK3R2;CCS;GAS6;ERN1;BCR;SRR;PTAFR;RXRA;ADCY6;ATP2B4;CTSH;TNFRSF14;MGMT;ASNS;AKT1;IGFBP7;ITPR2;CHEK2;IGFBP2;TCIRG1;CAPN2;INSR;WNT3;FOXO4;ANKZF1;TXNRD2;HOMER2;BRAF;GPR21;CAT;LGALS1;TIMP1;JAK3;CHRM3;APRT;FYN;SIRT2;RECQL5;RAB13;ADA;HDAC8;EIF4EBP1;TGFBR3;MAN1B1;LAMTOR2;PER1;ITGA2;PFKL;NET1;GRB10;MMP19;BSG;TEAD2
7603,GO:0031998,0.000816822310459826,0.999922745300959,6,11,regulation of fatty acid beta-oxidation,BP,TYSND1;MLYCD;PPARA;ACACB;LONP2;AKT1
10766,GO:0044242,0.000838201003591514,0.99961135197267,31,147,cellular lipid catabolic process,BP,APOE;TYSND1;CRAT;AIG1;HADH;ACAD10;CPT2;MLYCD;PCK2;PHYH;ETFB;PNPLA3;PPARA;SESN2;ACACB;SRD5A3;FUCA1;ACADS;LONP2;HEXB;CPT1C;ACOX3;ACAD11;AKT1;ACADVL;FAAH;PNPLA4;PEX7;SIRT2;NAGA;ACOT8
7449,GO:0031594,0.000842589625897332,0.999789172020791,12,37,neuromuscular junction,CC,DLG4;F2R;SERPINE2;POSTN;ANK3;SYNGR1;DLG3;SYNC;KCNC4;SNTA1;SV2A;FCHSD1
3747,GO:0008289,0.000857495518291677,0.99946325570705,76,451,lipid binding,MF,APOE;SYTL1;HS1BP3;OSBPL5;ALOX15B;ACBD4;DGKA;ARAP3;SYT8;ARAP1;NISCH;PITPNM3;PITPNM1;SNX9;SHC1;GRB7;ITPR3;PITPNC1;MCTP1;SEC14L2;NME4;PNPLA3;ABCG1;ESYT2;LPAR3;S100A13;AGAP1;PPARA;SNX29;RASA4;ACOT11;VAMP2;PCLO;OSBPL10;GSDMA;DYSF;PLEK2;MVB12B;PAQR6;PLCD1;TWF2;TECPR1;HSD11B1;PLTP;EPN3;PSD4;MAP1LC3A;APOL4;PEMT;PROM2;TRPV1;GAS6;PTAFR;RXRA;GSDMC;AKT1;ITPR2;WDR45;SBF2;ARHGAP44;MYOF;UNC119B;SNX33;SNX17;ADAP1;SNX1;OSBPL1A;AP2A2;STARD10;MCTP2;ESYT3;SH3PXD2A;UNC119;MPPE1;PLEKHA4;HIP1
2383,GO:0005520,0.000862888327467387,0.999888443405536,7,15,insulin-like growth factor binding,MF,HTRA1;IGFBP4;ITGA6;ITGB4;IGFBP7;IGFBP2;INSR
7248,GO:0031224,0.000874799850804714,0.999301241841027,374,2757,intrinsic component of membrane,CC,PTPRS;DLG4;F2R;ST6GALNAC2;NT5E;TNFRSF6B;NYNRIN;CSMD2;MARVELD1;KCNG1;OSBPL5;IL20RB;ADGRL1;LMF1;KIAA1549L;SLC2A3;ADAM19;TMEM129;ACP5;EDEM1;AIG1;FAM210B;GJC2;SEMA4B;LRP1;NTSR1;EGFR;PRNP;ZDHHC1;FCGRT;SCN8A;SLC7A8;TNFSF15;SPTB;TSPAN1;SLC16A3;CD9;SLC2A9;SNPH;SDK2;NOS1;SHANK2;CYYR1;CLCA2;SCN4B;ORAI3;MRC2;ADGRB2;GGT1;COL13A1;GRAMD4;MST1R;ARMCX2;SYT8;B3GAT3;HBEGF;TMEM134;CNTN1;EFNB3;EVC;SLC27A1;REEP2;PLD3;TMEM92;SYNGR1;SLC16A5;ABCA2;SLC43A1;MC1R;LPCAT4;SYNGAP1;ITGA6;MXRA7;TMEM173;DNAJC4;RAB3B;NLGN2;CD68;SLC12A7;CYBRD1;ITPR3;PRSS8;LY6K;HTR7;ABCA7;SLC37A2;PRR7;MCTP1;B4GALNT4;TMTC4;FAM171A2;SLC35E2B;PEAR1;FGFR3;BRI3;NPR2;PLXNB3;TMEM44;TMEM187;ORAI2;SYNE3;DLG3;ITGB4;SLCO4A1;ZP3;ACVR2B;SPPL2B;NGFR;ELFN2;EPOR;MARCH4;SMIM14;MALL;PLXNB1;EREG;TMC6;PTPRE;PNPLA3;OLFM2;ANO8;TMED4;TNFRSF25;ABCG1;ESYT2;SCART1;ERMAP;LPAR3;C5;PLGRKT;ANO1;FNDC4;RASA4;KCNJ15;PKD2;VAMP2;RRNAD1;AREG;ST6GALNAC6;B4GAT1;MARCH9;LRP11;KCNC4;KCNAB2;CSPG4;ITGB5;APCDD1L;BNIP3;SEMA5A;IFITM1;PEX10;VANGL2;SCARA3;DYSF;SLC22A18;SLITRK6;MXRA8;PI4K2A;NAT14;PAQR6;PQLC2;KIAA0319L;SDC2;NRSN2;IFNGR2;PDCD1LG2;PRAF2;SRD5A3;SLC50A1;TECPR1;SLC48A1;LRRC8A;LOC441081;PROCR;MOSPD3;CHST6;PRSS22;LTB4R2;SV2A;SLC38A10;GPR153;TENM2;KRTCAP3;IFI6;REEP6;PKD1;SLC29A4;FLOT1;KCNMA1;HSD11B1;TSNARE1;TMEM128;UNC5B;SORL1;SMIM19;IL17RD;HERPUD1;VLDLR;TPBG;ADGRF1;GPRC5C;GABBR1;ST3GAL3;ROBO3;TMEM175;RHBDF1;LRP5;PTPRU;ATRAID;METTL23;AQP3;TGFBR2;TRPV4;DIRC2;C1ORF115;ITGA1;CMTM7;IL17RE;ANO9;HSD17B7;XKR6;PEMT;EDA;PIGZ;PROM2;SLC27A3;HERPUD2;TRPV1;MARCH2;BNIP3L;EPHA1;RHBDF2;SEMA4G;ERN1;ATP7B;CPT1C;BCAM;MFSD3;TTYH3;PTAFR;ADCY6;ATP2B4;TNFRSF14;TMEM80;TMEM9;ENTPD6;TM7SF2;TP53I11;STEAP2;ITPR2;REEP4;B4GALT2;AMIGO2;SEMA6B;TMEM143;COMTD1;C16ORF58;IL17RC;FGFR4;DNAJC22;TMEM256;SLC6A9;SNN;TCIRG1;STEAP3;SLC6A6;TMEM63C;FAAH;TMEM200A;TBC1D20;C1ORF210;IFI27;INSR;TENM4;SLC25A29;CKLF;SLC22A15;LTB4R;SMIM20;TPCN1;ULBP1;GRAMD1A;ITGB6;C6ORF89;PIGQ;ZDHHC24;YIPF3;EDA2R;GPR21;LETMD1;BTN3A2;ASIC1;RNF215;PLB1;GJB4;MYOF;PAQR4;HFE;KIAA1549;MRGPRX3;SCNN1A;CHRM3;TMX4;C14ORF132;CERS4;ICAM5;ATP12A;TMEM50B;TAZ;HGSNAT;BTN3A3;RABAC1;SLC9A7;SLC37A4;ATP8B2;TMEM25;SLC38A2;LEMD2;SLC25A42;TRPC1;MBOAT2;CELSR1;CADM4;PLXND1;TMEM54;RTN2;TMEM101;ENTPD2;SLC35F3;TMEM139;TGFBR3;PLPP6;MAN1B1;STX1A;MFNG;EDNRA;RNF170;EPHB2;TMCO6;MCTP2;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ESYT3;FITM2;FKBP8;XYLT2;ERBB2;PLLP;SLC10A6;UST;PAG1;SYVN1;HLA-G;MMP17;MPPE1;TMEM200B;FER1L4;RTL1;CREB3L4;BSG;TMEM42;PEX11A;TMEM8A;KDSR;IKBKB;NTM;CYP4V2;ROBO4;XKR9;BTBD11;SLC9A5
12197,GO:0048468,0.000885016655799433,0.999342397805403,190,1291,cell development,BP,PTPRS;ACTA2;DLG4;BBS2;APOE;ZMYND8;NFATC4;FLNC;SERPINE2;S100A6;GSN;POSTN;PTK6;FAM210B;GJC2;SEMA4B;LRP1;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;ERCC1;FBLN1;ANK3;IFT140;RAPGEF3;SPTB;CD9;IDH2;CST3;PARVB;NOS1;BRSK1;SHANK2;CRTC1;NDRG1;ADARB1;CTF1;CNTN1;EFNB3;OBSL1;ULK2;RNF165;CUL7;NAGLU;MAP2K1;SYNGAP1;DNAH1;ULK1;SHC1;GRB7;NPHP4;BLOC1S4;HDAC11;MYH11;LAMA5;UNK;CAPRIN2;PRKCZ;PAK1;PABPC1L;KDM3A;NPR2;SEMA3F;PLXNB3;ZSWIM4;MICALL2;FBXW8;ETV1;ZP3;NEURL1;NGFR;ETV5;PLXNB1;EREG;SPG11;SSH3;MANF;LPAR3;IMPACT;IFT27;KLF7;SH3TC2;AREG;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;RGS14;FAM20C;SLITRK6;MXRA8;MYH3;NYAP1;SDC2;TCTN1;ARHGEF2;TWF2;STMN3;DMTN;SEMA3B;PTHLH;ZFPM1;KDM4C;SSH1;METRN;TENM2;ATXN10;FLOT1;TTN;UNC5B;SORL1;MAP6;VLDLR;ADGRF1;DEAF1;SULF2;ROBO3;RFX2;LRP5;DBNDD1;TRIOBP;TGFBR2;TRPV4;ITGA1;PDE2A;HMG20B;CDK5RAP3;MINK1;HEXB;WNT7A;TRPV1;EPHA1;SEMA4G;ECM2;NBEAL2;KIF13B;SPAG16;CAMK1;ADCY6;PRDM8;AKT1;DGUOK;LAMB1;TNNT1;CABYR;TMOD2;FARP1;LMNA;C9ORF72;TBC1D20;RAB25;WNT3;KRT19;TENM4;RPS6KA5;BRAF;ARHGAP44;MAPK10;LGALS1;TP73;CSNK1E;BCL6;HSF4;REC8;GSTM3;FYN;SIRT2;GDF15;RAB13;POU2F2;PLXND1;TGFBR3;EPAS1;EDNRA;EPHB2;FGFR1;BLOC1S1;ERBB2;UST;EIF2AK4;NET1;GRB10;KCTD11;IKBKB;NTM;SIX5
7235,GO:0031175,0.000909703435636027,0.999389337564553,103,644,neuron projection development,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;S100A6;POSTN;PTK6;SEMA4B;LRP1;VEGFA;EGFR;ANK3;SPTB;BRSK1;SHANK2;CRTC1;ADARB1;CNTN1;EFNB3;OBSL1;ULK2;RNF165;CUL7;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;BLOC1S4;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;MICALL2;FBXW8;ETV1;NEURL1;NGFR;PLXNB1;SPG11;SSH3;MANF;LPAR3;IMPACT;IFT27;KLF7;AREG;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;NYAP1;SDC2;TCTN1;TWF2;STMN3;SEMA3B;SSH1;METRN;ATXN10;FLOT1;UNC5B;MAP6;VLDLR;ADGRF1;ROBO3;DBNDD1;TRIOBP;TRPV4;ITGA1;MINK1;WNT7A;SEMA4G;ECM2;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;LAMB1;FARP1;C9ORF72;WNT3;RPS6KA5;BRAF;ARHGAP44;LGALS1;FYN;RAB13;PLXND1;EPHB2;FGFR1;BLOC1S1;ERBB2;UST;EIF2AK4;GRB10
8909,GO:0034764,0.00092622223077752,0.99961798172937,24,104,positive regulation of transmembrane transport,BP,F2R;GJC2;NTSR1;ANK3;CLTCL1;NOS1;PRKCZ;PAK1;STK39;CEMIP;GSTO1;PKD2;AZIN2;GSTM2;WNK4;TMSB4X;PIK3R2;PTAFR;AKT1;INSR;BRAF;EHD3;TRPC1;EPHB2
3448,GO:0007263,0.000930079197739302,0.999939840597385,5,8,nitric oxide mediated signal transduction,BP,APOE;EGFR;NOS1;NOS3;ATP2B4
3185,GO:0006811,0.000934198955022747,0.999343312378152,131,858,ion transport,BP,DLG4;F2R;APOE;KCNG1;SERPINE2;FHL1;S100A6;OSBPL5;SLC2A3;GJC2;NTSR1;PRNP;SCN8A;SLC7A8;ANK3;SLC16A3;SLC2A9;NOS1;DDIT3;SHANK2;CLCA2;SCN4B;ORAI3;CNTN1;SLC27A1;CPT2;PITPNM3;CYP27B1;SLC16A5;SLC43A1;PITPNM1;RAB3B;NLGN2;SLC12A7;ITPR3;PITPNC1;PRSS8;ABCA7;SLC37A2;STK39;CEMIP;NDUFA4L2;ORAI2;DLG3;SLCO4A1;GSTO1;TMC6;ANO8;PLA2G6;ABCG1;LPAR3;PPARA;ANO1;KCNJ15;PKD2;VAMP2;KCNC4;ACACB;KCNAB2;OSBPL10;SLC22A18;SNTA1;PQLC2;PRAF2;LRRC8A;KLHL24;ATF4;SV2A;SLC38A10;PKD1;KCNMA1;AZIN2;PLTP;GSTM2;TMEM175;WNK4;PCSK9;TRPV4;TMSB4X;ANO9;PDE2A;NOS3;MINK1;TRPV1;CCS;GAS6;ATP7B;MFSD3;TTYH3;PTAFR;RXRA;ATP2B4;STEAP2;AKT1;ITPR2;CRY2;SLC6A9;TCIRG1;STEAP3;SLC6A6;TMEM63C;SLC25A29;SLC22A15;TPCN1;MAGED2;HOMER2;ASIC1;HFE;SCNN1A;ATP12A;SLC9A7;SLC37A4;EHD3;FYN;ATP8B2;SLC38A2;SLC25A42;TRPC1;ADA;STX1A;STARD10;EPHB2;PER1;SLC39A11;FGFR1;WFS1;PLLP;SLC10A6;BSG;APBA1;SLC9A5
10504,GO:0043436,0.000957957768952127,0.999331545168722,125,815,oxoacid metabolic process,BP,GAMT;PRODH;ACSF2;ALDH7A1;TYSND1;SLC2A3;CRAT;GLUL;AIG1;ALOX15B;NAGS;D2HGDH;NR1D1;SLC7A8;HADH;BPHL;SLC16A3;IDH2;CRTAP;NOS1;ACAD10;PGM1;GGT1;B3GAT3;PHGDH;PYCR2;DHTKD1;ALDH4A1;SLC27A1;CPT2;MLYCD;HMGCL;UROS;HYAL1;PCK2;CRYL1;DDIT4;OGDHL;AARS;PHYH;ERO1B;CEMIP;MTHFR;GLDC;CBS;NMNAT2;ABHD14B;ETFB;GSTO1;GPT2;PSAT1;PNPLA3;PSPH;CARS;ACOT1;PPARA;SESN2;BLMH;ACOT11;B4GAT1;ACACB;MAPK3;CSPG4;PC;ACSS2;LTA4H;MLXIPL;HIBADH;SDHA;ATF4;CHST6;HLCS;AZIN2;GALK1;GSTM2;ST3GAL3;CES2;ACY1;PTGR2;ACOT7;ALDOC;ACADS;LONP2;TRIB3;ALDH1L2;PEMT;NOS3;HEXB;SLC27A3;GLUD1;SUCLG2;ALKBH7;CPT1C;HEXA;SRR;ATP2B4;THNSL2;ACOX3;ACAD11;GSTO2;ASNS;AKT1;B4GALT2;PHYKPL;ASS1;FGFR4;HAGH;CBR4;ACADVL;SLC6A6;FAAH;INSR;ACSS1;ALDH1L1;PEX7;OSBPL1A;GALNS;CTH;XYLT2;UST;PFKL;BSG;PNKD;CYP4V2;ACOT8
12400,GO:0048870,0.000978961935428721,0.999299960859254,144,953,cell motility,BP,DOCK4;BBS2;F2R;APOE;ZMYND8;SERPINE2;PGF;POSTN;PTK6;SEMA4B;LRP1;ALOX15B;VEGFA;EGFR;FBLN1;SLC7A8;TSPAN1;SLC16A3;IDH2;ARAP3;MMP28;EFS;ADARB1;HBEGF;MMP1;PLAT;NISCH;PRSS3;HYAL1;ARPIN;MAP2K1;SDCCAG8;PKN1;DDIT4;BTG1;ITGA6;PLEKHG5;FAM110C;DNAH1;SHC1;SPRY2;GRB7;NPHP4;VEGFB;LAMA5;UNK;TTBK2;PRKCZ;PAK1;MCTP1;CEMIP;SEMA3F;PLXNB3;ELMO3;ITGB4;ZP3;NEURL1;PLXNB1;EREG;TNS1;RHOBTB2;C5;ECM1;MAPK3;CSPG4;SEMA5A;IFITM1;VANGL2;RHOF;SRGAP3;SDC2;ARHGEF2;INPP5D;DMTN;SEMA3B;PROCR;PAK6;SSH1;LTB4R2;MDK;HDAC5;SORL1;PLTP;RHBDF1;LRP5;PTPRU;NDE1;PKN3;TGFBR2;TRPV4;ITGA1;TMSB4X;SMURF2;NOS3;MINK1;HEXB;WNT7A;PIK3R2;EPHA1;SEMA4G;GAS6;BCR;SPAG16;PTAFR;ATP2B4;CTSH;AKT1;LAMB1;FMNL3;IL17RC;FGFR4;ASAP3;LMNA;RAB25;PLAU;INSR;CKLF;FOXO4;LYST;MAP2K5;BRAF;TIMP1;JAK3;PEX7;SCYL3;FYN;PHLDA2;RAB13;CELSR1;ADA;PLXND1;RHOBTB3;MYO18A;TGFBR3;VAV3;LURAP1;ITGA2;FGFR1;ERBB2;CORO1B;NET1;BSG;KCTD13;ROBO4
13103,GO:0051674,0.000978961935428721,0.999299960859254,144,953,localization of cell,BP,DOCK4;BBS2;F2R;APOE;ZMYND8;SERPINE2;PGF;POSTN;PTK6;SEMA4B;LRP1;ALOX15B;VEGFA;EGFR;FBLN1;SLC7A8;TSPAN1;SLC16A3;IDH2;ARAP3;MMP28;EFS;ADARB1;HBEGF;MMP1;PLAT;NISCH;PRSS3;HYAL1;ARPIN;MAP2K1;SDCCAG8;PKN1;DDIT4;BTG1;ITGA6;PLEKHG5;FAM110C;DNAH1;SHC1;SPRY2;GRB7;NPHP4;VEGFB;LAMA5;UNK;TTBK2;PRKCZ;PAK1;MCTP1;CEMIP;SEMA3F;PLXNB3;ELMO3;ITGB4;ZP3;NEURL1;PLXNB1;EREG;TNS1;RHOBTB2;C5;ECM1;MAPK3;CSPG4;SEMA5A;IFITM1;VANGL2;RHOF;SRGAP3;SDC2;ARHGEF2;INPP5D;DMTN;SEMA3B;PROCR;PAK6;SSH1;LTB4R2;MDK;HDAC5;SORL1;PLTP;RHBDF1;LRP5;PTPRU;NDE1;PKN3;TGFBR2;TRPV4;ITGA1;TMSB4X;SMURF2;NOS3;MINK1;HEXB;WNT7A;PIK3R2;EPHA1;SEMA4G;GAS6;BCR;SPAG16;PTAFR;ATP2B4;CTSH;AKT1;LAMB1;FMNL3;IL17RC;FGFR4;ASAP3;LMNA;RAB25;PLAU;INSR;CKLF;FOXO4;LYST;MAP2K5;BRAF;TIMP1;JAK3;PEX7;SCYL3;FYN;PHLDA2;RAB13;CELSR1;ADA;PLXND1;RHOBTB3;MYO18A;TGFBR3;VAV3;LURAP1;ITGA2;FGFR1;ERBB2;CORO1B;NET1;BSG;KCTD13;ROBO4
16061,GO:0090066,0.000981165880497377,0.999425179866331,58,326,regulation of anatomical structure size,BP,PTPRS;DOCK4;BBS2;F2R;APOE;GSN;WIPF1;CDC42EP5;SEMA4B;VEGFA;EGFR;SPTB;NOS1;ULK2;ARPIN;CAPG;RAB3B;SLC12A7;HTR7;PAK1;SEMA3F;SSH3;PLEKHG2;PLA2G6;LPAR3;SEMA5A;TWF2;DMTN;LRRC8A;SEMA3B;SSH1;KCNMA1;WHAMMP3;TRIOBP;TRPV4;ITGA1;TMSB4X;APLN;NOS3;WNT7A;SEMA4G;PTAFR;PPP1R15A;ADCY6;AKT1;TMOD2;WNT3;CHRM3;FCHSD1;SPIRE1;EPS8L1;EPS8L2;VAV3;EDNRA;C15ORF62;CORO1B;PEX11A;PLEKHH2
6609,GO:0022838,0.00098469034038366,0.999532247963228,32,153,substrate-specific channel activity,MF,DLG4;KCNG1;SCN8A;CLCA2;SCN4B;ORAI3;ITPR3;ORAI2;DLG3;ANO8;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;LRRC8A;PKD1;KCNMA1;TMEM175;AQP3;TRPV4;ANO9;PDE2A;TRPV1;GAS6;TTYH3;ITPR2;TMEM63C;TPCN1;ASIC1;SCNN1A;TRPC1
7482,GO:0031659,0.000986361597057718,0.999973476998514,4,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2;PKD1;AKT1
12062,GO:0048037,0.00104204150107104,0.999378755344549,61,351,cofactor binding,MF,XDH;H6PD;PRODH;PYGB;D2HGDH;NR1D1;HADH;ACBD4;IDH2;NOS1;ACAD10;HEBP1;PHGDH;PYGL;CYP3A5;DHTKD1;HMGCL;UROS;TXNRD3;CYP27B1;CRYL1;OGDHL;PHYH;MTHFR;GLDC;CBS;GPT2;PNPLA3;ACACB;PC;HIBADH;SDHA;SLC48A1;HLCS;GSTM2;ACOT7;ACADS;MOCOS;NOS3;GLUD1;NUDT6;SRR;CYP2R1;THNSL2;ACOX3;ACAD11;ASNS;TM7SF2;MICAL1;CRY2;PHYKPL;NFU1;CBR4;ACADVL;TXNRD2;CAT;OGFOD2;GSTM3;SIRT2;CTH;CYP4V2
10868,GO:0044425,0.00112063838605683,0.99908489846723,487,3688,membrane part,CC,PTPRS;DLG4;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;NYNRIN;CSMD2;MARVELD1;SYTL1;KCNG1;SERPINE2;S100A6;OSBPL5;IL20RB;ADGRL1;LMF1;KIAA1549L;SLC2A3;ADAM19;PTK6;TMEM129;ACP5;EDEM1;AIG1;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;NTSR1;EGFR;PRNP;ZDHHC1;FCGRT;SCN8A;SLC7A8;ANK3;CLTCL1;FCHO1;TNFSF15;SPTB;TSPAN1;SLC16A3;CD9;SLC2A9;SNPH;DNM1;SDK2;NOS1;GPSM1;SHANK2;CYYR1;CLCA2;SCN4B;ORAI3;MRC2;ADGRB2;GGT1;COL13A1;GRAMD4;MST1R;ARMCX2;SYT8;B3GAT3;HBEGF;TMEM134;CNTN1;CYP3A5;EFNB3;EVC;BBS1;SLC27A1;REEP2;RAB11FIP4;PLD3;TMEM92;SYNGR1;SLC16A5;ABCA2;PKN1;SLC43A1;MC1R;LPCAT4;SYNGAP1;ITGA6;PITPNM1;MXRA7;TMEM173;SNX9;DNAJC4;ARL2;ULK1;SHC1;VPS11;SPRY2;RAB3B;NLGN2;CD68;SLC12A7;CYBRD1;ITPR3;PRSS8;LY6K;PRKCZ;HTR7;PAK1;ABCA7;SLC37A2;PRR7;MCTP1;STK39;B4GALNT4;TMTC4;ERO1B;FAM171A2;SLC35E2B;PEAR1;FGFR3;CEMIP;BRI3;NPR2;PLXNB3;NDUFA4L2;TMEM44;TMEM187;SPRY4;ORAI2;SYNE3;DLG3;ITGB4;SLCO4A1;ZP3;SHROOM4;NEURL1;ACVR2B;SPPL2B;NGFR;ELFN2;EPOR;MARCH4;ARHGEF4;SMIM14;MALL;PLXNB1;EREG;NIPSNAP1;TMC6;PTPRE;PNPLA3;OLFM2;PLCD3;DHRS4;ANO8;TMED4;TNFRSF25;ABCG1;ESYT2;SCART1;ERMAP;LPAR3;C5;KIF17;PLGRKT;ANO1;FNDC4;RASA4;KCNJ15;PKD2;STAT6;VAMP2;RRNAD1;AREG;ST6GALNAC6;AP1G2;B4GAT1;MARCH9;LRP11;KCNC4;KCNAB2;MAPK3;CSPG4;ITGB5;APCDD1L;BNIP3;ERRFI1;SEMA5A;IFITM1;PEX10;VANGL2;SCARA3;RGS14;MYZAP;DYSF;PLEK2;SLC22A18;SNTA1;HOOK2;SLITRK6;MXRA8;MVB12B;PI4K2A;NAT14;PAQR6;PQLC2;KIAA0319L;SDC2;CHMP1B;NRSN2;IFNGR2;ARHGEF2;INPP5D;PDCD1LG2;PRAF2;MAP2K2;SRD5A3;SLC50A1;SDHA;TECPR1;SLC48A1;DMTN;LRRC8A;LITAF;UBXN4;LOC441081;ATF4;PROCR;MOSPD3;CHST6;PRSS22;SSH1;LTB4R2;SV2A;SLC38A10;GPR153;TENM2;KRTCAP3;IFI6;REEP6;PKD1;SLC29A4;FLOT1;PSKH1;KCNMA1;HSD11B1;TSNARE1;TMEM128;UNC5B;SORL1;SMIM19;IL17RD;HERPUD1;VLDLR;TPBG;ADGRF1;GPRC5C;GABBR1;ST3GAL3;ROBO3;TMEM175;RHBDF1;LRP5;PTPRU;ATRAID;NDE1;PCSK9;METTL23;AQP3;EPN3;TGFBR2;TRPV4;ARHGAP25;DIRC2;C1ORF115;ITGA1;CMTM7;IL17RE;PSD4;ANO9;HSD17B7;XKR6;PDE2A;SMURF2;PEMT;EDA;NOS3;MINK1;PIGZ;PROM2;SLC27A3;HERPUD2;TRPV1;MARCH2;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;VPS39;ERN1;BCR;ATP7B;CPT1C;BCAM;MFSD3;TTYH3;NECAB3;PTAFR;CYP2R1;PPP1R15A;RIMS3;ADCY6;ATP2B4;SLC9A3R2;TNFRSF14;TMEM80;TMEM9;ENTPD6;TM7SF2;PLEKHG6;TP53I11;STEAP2;ITPR2;CARD11;REEP4;B4GALT2;AMIGO2;SEMA6B;WDR45;TMEM143;IGFBP2;SEPT6;COMTD1;TSG101;C16ORF58;IL17RC;FGFR4;DNAJC22;TMEM256;SLC6A9;SNN;TCIRG1;STEAP3;SLC6A6;FARP1;TMEM63C;FAAH;COPG1;TMEM200A;ATG2A;TBC1D20;CAPN2;RAB25;C1ORF210;IFI27;INSR;KRT19;TENM4;SLC25A29;CKLF;GNAL;SLC22A15;ANKZF1;CHMP4C;LTB4R;SMIM20;TPCN1;ULBP1;GRAMD1A;ITGB6;HOMER2;C6ORF89;PIGQ;ZDHHC24;YIPF3;EDA2R;GPR21;ARHGAP44;LETMD1;BTN3A2;ASIC1;RNF215;PLB1;GJB4;MYOF;PAQR4;HFE;JAK3;KIAA1549;MRGPRX3;SCNN1A;SNX33;CHRM3;TMX4;C14ORF132;CERS4;ICAM5;ATP12A;SPIRE1;TMEM50B;TAZ;HGSNAT;BTN3A3;RABAC1;SLC9A7;EPS8L1;SLC37A4;EHD3;FYN;ATP8B2;TMEM25;PJA2;SLC38A2;SNX1;LEMD2;UBXN6;SLC25A42;TRPC1;MBOAT2;RAB13;MPDZ;CELSR1;ADA;CADM4;PLXND1;TMEM54;RTN2;TMEM101;ENTPD2;AP2A2;EPS8L2;SLC35F3;TMEM139;RETSAT;TGFBR3;PLPP6;MAN1B1;STX1A;LAMTOR2;MFNG;EDNRA;RNF170;EPHB2;TMCO6;LRCH4;MCTP2;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ESYT3;FITM2;FKBP8;XYLT2;ERBB2;SEC31B;PLLP;SLC10A6;UST;PAG1;SYVN1;OSCP1;HLA-G;MMP17;MPPE1;TMEM200B;FER1L4;TTC19;RTL1;CREB3L4;BSG;SDHAF4;TMEM42;PEX11A;TMEM8A;KDSR;IKBKB;NTM;HIP1;CYP4V2;ROBO4;XKR9;BTBD11;SLC9A5
4420,GO:0010243,0.00118525671344582,0.99919839090687,102,645,response to organonitrogen compound,BP,APOE;FOS;GSN;EGR1;FBXO2;TMEM129;EDEM1;LRP1;EGFR;PRNP;HADH;RAPGEF3;CD9;ADAMTS13;ZFP36L1;SLC27A1;MAPK13;UROS;PCK2;COL6A1;BTG1;DGKQ;SHC1;PRKCZ;PAK1;MTHFR;GLDC;NEURL1;NGFR;EREG;PTPRE;PPARA;SESN2;IMPACT;PKD2;VAMP2;AREG;MAPK3;ERRFI1;ARHGEF2;DMTN;UBXN4;ATF4;SSH1;FBXO6;HLCS;HDAC5;IRF5;HERPUD1;SRSF5;GSTM2;NLRP1;CEBPB;LRP5;PCSK9;DNMT3A;TRPV4;MAP1LC3A;PDE2A;TRIB3;PEMT;TRPV1;PIK3R2;SRR;PTAFR;ADCY6;ATP2B4;MGMT;ASNS;AKT1;ITPR2;TCIRG1;CAPN2;INSR;FOXO4;ANKZF1;HOMER2;BRAF;GPR21;CAT;TIMP1;JAK3;TP73;APRT;FYN;UBXN6;SIRT2;RECQL5;RAB13;ADA;HDAC8;EIF4EBP1;TGFBR3;MAN1B1;LAMTOR2;PER1;ITGA2;WFS1;SYVN1;GRB10;MMP19;BSG
12757,GO:0051056,0.00119270437159025,0.999329681400449,49,265,regulation of small GTPase mediated signal transduction,BP,F2R;APOE;TIMP2;OBSCN;ARAP3;ARHGEF19;ARAP1;RGL2;ARHGAP23;ASAP2;SYNGAP1;PLEKHG5;SPRY2;APPL2;SPRY4;ARHGEF4;PLEKHG2;RHOBTB2;DNMBP;AGAP1;RASA4;RHOF;SRGAP3;ARHGAP22;PLEKHG4;ARHGEF2;STMN3;ACAP3;RALGAPA1;FLOT1;ARHGAP25;IQSEC2;PSD4;PIK3R2;PLEKHG3;BCR;PLEKHG6;ASAP3;FARP1;ARHGAP44;BCL6;ADAP1;EPS8L1;ARHGEF17;EPS8L2;VAV3;EPHB2;NET1;KCTD13
2295,GO:0005261,0.00120399504099192,0.999492733175631,24,105,cation channel activity,MF,KCNG1;SCN8A;SCN4B;ORAI3;ITPR3;ORAI2;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;PKD1;KCNMA1;TMEM175;TRPV4;PDE2A;TRPV1;GAS6;ITPR2;TMEM63C;TPCN1;ASIC1;SCNN1A;TRPC1
12931,GO:0051336,0.0012080538243209,0.999139793326962,135,894,regulation of hydrolase activity,BP,XDH;DOCK4;F2R;TNFRSF6B;SERPINE2;GSN;LMF1;PPP1R35;EVI5L;CDC42EP5;LRP1;TIMP2;VEGFA;EGFR;FBLN1;PRDX5;TFPI2;RAPGEF3;TNFSF15;CST3;NOS1;GPSM1;ARAP3;TBC1D8;ARHGEF19;GRAMD4;RIN1;ARAP1;B3GAT3;ARHGAP23;PHACTR3;ASAP2;PPP1R14A;SYNGAP1;ITGA6;SNX9;ARL2;SPRY2;TPM2;PRKCZ;PPP2R3B;SERPING1;FGFR3;PLXNB3;DLG3;NEIL1;RAG1;NGFR;ELFN2;PLXNB1;DNMBP;RINL;AGAP1;ALS2CL;C5;AIP;RASA4;ECM1;MAPK3;ERRFI1;DOCK9;RGS14;DNAL4;MAPK12;SRGAP3;ARHGAP22;PLEKHG4;TBC1D14;STMN3;ANGPTL4;BBC3;DOCK11;TBC1D3E;RABGAP1;ACAP3;IFI6;RALGAPA1;SORL1;HERPUD1;PAPLN;NLRP1;RIN2;NDE1;ARHGAP25;CSRNP3;ITGA1;TMSB4X;DAP;CDK5RAP3;NOS3;PROM2;PIK3R2;EPHA1;GAS6;ERN1;BCR;PTAFR;PPP1R15A;CTSH;MGMT;PLEKHG6;AKT1;MICAL1;CRY2;HMSD;IFT57;SBF2;ASAP3;FARP1;SGSM2;TBC1D20;ARHGAP27;IFI27;C6ORF89;MAP2K5;ARHGAP44;PIDD1;TIMP1;BCL6;ADAP1;FYN;PLXND1;CIDEB;VAV3;TBC1D16;EDNRA;ITGA2;FGFR1;ERBB2;RGS12;C15ORF62;SFI1;NET1;IKBKB;HIP1
17674,GO:1901606,0.00124078002049793,0.999588053065773,16,60,alpha-amino acid catabolic process,BP,PRODH;ALDH7A1;GLUL;NOS1;ALDH4A1;HMGCL;GLDC;CBS;GPT2;BLMH;HIBADH;NOS3;GLUD1;ATP2B4;THNSL2;PHYKPL
13507,GO:0055114,0.00124689034029915,0.999142436913537,110,716,oxidation-reduction process,BP,XDH;H6PD;NFATC4;PRODH;PYGB;ALDH7A1;TYSND1;CRAT;GPX3;ALOX15B;D2HGDH;NR1D1;HADH;PRDX5;LOXL1;IDH2;NOS1;ACAD10;PGM1;PHGDH;GAA;PYGL;PYCR2;CYP3A5;DHTKD1;ALDH4A1;HSD17B14;PHYHD1;MSRB2;CPT2;MLYCD;TXNRD3;CYP27B1;PCK2;CRYL1;AKR7A2;FAM213A;OGDHL;CYBRD1;HSD11B1L;PHYH;ERO1B;BLVRB;KDM3A;MTHFR;GLDC;NDUFA4L2;CBS;DHRS12;ETFB;GSTO1;DHRS4;PPARA;SESN2;PPP1R3E;ACACB;KCNAB2;BNIP3;STK40;ACSS2;SRD5A3;HIBADH;SDHA;KDM4C;HSD11B1;KDM7A;PTGR2;TSTD1;ALDOC;ACADS;LONP2;HSD17B7;ALDH1L2;NOS3;CCS;GLUD1;SUCLG2;ALKBH7;CPT1C;CYP2R1;ACOX3;ACAD11;GSTO2;TM7SF2;STEAP2;AKT1;MICAL1;PHF2;STEAP3;CBR4;ACADVL;INSR;ACSS1;TXNRD2;ALDH1L1;CAT;TMX4;OGFOD2;PEX7;TAZ;PHLDA2;RETSAT;BLOC1S1;SH3PXD2A;PFKL;TTC19;SDHAF4;KDSR;CYP4V2;ACOT8
16836,GO:0098793,0.00127779845902439,0.99932608018551,40,208,presynapse,CC,PTPRS;DLG4;SYTL1;ADGRL1;GLUL;NTSR1;SNPH;DNM1;BRSK1;SYT8;SYNGR1;RAB3B;NLGN2;MCTP1;BLVRB;VAMP2;SEPT5;PCLO;KCNC4;KCNAB2;PI4K2A;SV2A;GABBR1;DBNDD1;PDE2A;RAB40B;WNT7A;RIMS3;MICAL1;SEPT6;SLC6A9;ICA1;ARHGAP44;CHRM3;RABAC1;RAB13;STX1A;ITGA2;APBA1;HIP1
10292,GO:0043085,0.0012857614809436,0.999065334912749,152,1022,positive regulation of catalytic activity,BP,XDH;DUSP6;DLG4;DOCK4;F2R;APOE;GSN;EGR1;LMF1;EVI5L;CDC42EP5;TIMP2;VEGFA;EGFR;PRNP;FBLN1;DUSP5;RAPGEF3;TNFSF15;NOS1;ARAP3;ERCC6;TBC1D8;ARHGEF19;GRAMD4;MST1R;RIN1;ARAP1;B3GAT3;ARHGAP23;SLC27A1;ASAP2;MAP2K1;CYP27B1;PKN1;SHC2;SYNGAP1;ITGA6;DGKQ;SNX9;SHC1;SPRY2;PRKCZ;PAK1;STK39;FGFR3;CEMIP;DLG3;NEURL1;ACVR2B;NGFR;PLXNB1;EREG;NAB2;DNMBP;RINL;LPAR3;AGAP1;ALS2CL;C5;RASA4;PKD2;MAPK3;CSPG4;ERRFI1;VANGL2;DOCK9;RGS14;DNAL4;MAPK12;SRGAP3;ARHGAP22;PLEKHG4;TBC1D14;MAP2K2;BBC3;PAK6;DOCK11;TBC1D3E;RABGAP1;ACAP3;PKD1;RALGAPA1;AZIN2;SORL1;VLDLR;NLRP1;MAP3K12;RIN2;PKIB;TGFBR2;ARHGAP25;ITGA1;TMSB4X;TRIB3;DAP;NOS3;MINK1;PIK3R2;EPHA1;CCS;GAS6;ERN1;BCR;MAPRE3;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;STRADB;CTSH;PLEKHG6;AKT1;IFT57;FGFR4;ASAP3;SGSM2;TBC1D20;ARHGAP27;IFI27;INSR;C6ORF89;MAP2K5;BRAF;ARHGAP44;PIDD1;MAPK10;TP73;ADAP1;FYN;GOLGA2;AVPI1;CIDEB;VAV3;LAMTOR2;MAP3K10;TBC1D16;EDNRA;EPHB2;ITGA2;FGFR1;SH3PXD2A;ERBB2;UNC119;RGS12;C15ORF62;MMP17;HMBOX1;NET1;CAMKK1;HIP1
8419,GO:0033539,0.00129704050186983,0.999856893682667,6,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACAD10;ETFB;ACADS;ACOX3;ACAD11;ACADVL
5794,GO:0017049,0.00130797952217921,0.999774082151474,8,20,GTP-Rho binding,MF,CDC42EP5;PKN1;WHAMMP3;PKN3;TRIOBP;C15ORF62;NET1;KCTD13
2573,GO:0005861,0.00131925420682183,1,3,3,troponin complex,CC,TNNI2;TNNT1;TNNI1
12496,GO:0050660,0.00133384114321408,0.999553887293003,16,60,flavin adenine dinucleotide binding,MF,XDH;PRODH;D2HGDH;NOS1;ACAD10;TXNRD3;MTHFR;SDHA;ACADS;NOS3;ACOX3;ACAD11;MICAL1;CRY2;ACADVL;TXNRD2
10770,GO:0044255,0.00134562618164583,0.999063525452097,116,751,cellular lipid metabolic process,BP,ISYNA1;APOE;OSBPL5;ACSF2;LMF1;TYSND1;CRAT;AIG1;LRP1;ALOX15B;EGFR;HADH;DGKA;ACAD10;GGT1;HBEGF;CYP3A5;SLC27A1;CPT2;MLYCD;PITPNM3;ACP6;PCK2;CCDC71L;CRYL1;LPCAT4;PLCH2;PITPNM1;DGKQ;PHYH;FGFR3;ZP3;ETFB;EREG;PNPLA3;DHRS4;PLA2G6;ABCG1;ESYT2;MTMR4;ACOT1;PPARA;SESN2;ACOT11;ST6GALNAC6;PI4KAP1;ACACB;MAPK3;OSBPL10;ACSS2;MVD;LTA4H;PI4K2A;SDC2;MLXIPL;PLCD1;INPP5D;SRD5A3;FUCA1;GSTM2;CES2;PTGR2;ACOT7;PCSK9;ACADS;LONP2;TRIB3;PEMT;PIGZ;HEXB;SLC27A3;PIP5KL1;PIK3R2;ALKBH7;CHKB;CPT1C;HEXA;THNSL2;ACOX3;ACAD11;AKT1;ZFYVE21;FGFR4;CBR4;ACADVL;FAAH;ARSA;ACSS1;PNPLA4;PIGQ;PLB1;CAT;CERS4;PEX7;TAZ;FYN;SIRT2;MBOAT2;ETNK2;NAGA;RETSAT;PLPP6;VAV3;STARD10;INPP4A;FGFR1;PIGV;ESYT3;FITM2;ERBB2;KDELC2;MPPE1;KDSR;PLEKHA4;CYP4V2;ACOT8
5575,GO:0016597,0.00134992492855152,0.999665828150948,11,34,amino acid binding,MF,GLUL;NAGS;NOS1;AARS;GLDC;SESN2;NOS3;GLUD1;SRR;THNSL2;ASS1
6987,GO:0030676,0.0014294458435286,0.999839100230848,6,12,Rac guanyl-nucleotide exchange factor activity,MF,ARHGEF4;ARHGEF2;FARP1;EPS8L1;EPS8L2;VAV3
2272,GO:0005216,0.00144462419862959,0.99930444290743,31,150,ion channel activity,MF,DLG4;KCNG1;SCN8A;CLCA2;SCN4B;ORAI3;ITPR3;ORAI2;DLG3;ANO8;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;LRRC8A;PKD1;KCNMA1;TMEM175;TRPV4;ANO9;PDE2A;TRPV1;GAS6;TTYH3;ITPR2;TMEM63C;TPCN1;ASIC1;SCNN1A;TRPC1
14323,GO:0061564,0.0014466148406358,0.999136529746892,58,330,axon development,BP,PTPRS;APOE;S100A6;SEMA4B;VEGFA;ANK3;SPTB;BRSK1;ADARB1;EFNB3;ULK2;RNF165;MAP2K1;SYNGAP1;ULK1;SHC1;GRB7;PAK1;SEMA3F;PLXNB3;ZSWIM4;ETV1;NGFR;PLXNB1;SPG11;SSH3;LPAR3;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SLITRK6;TCTN1;TWF2;SEMA3B;SSH1;METRN;FLOT1;UNC5B;VLDLR;ROBO3;WNT7A;SEMA4G;ECM2;KIF13B;C9ORF72;WNT3;RPS6KA5;BRAF;FYN;PLXND1;EPHB2;ERBB2;UST;GRB10
3188,GO:0006814,0.00146227827891222,0.999348472966624,26,119,sodium ion transport,BP,SERPINE2;SCN8A;ANK3;NOS1;SCN4B;CNTN1;PRSS8;STK39;PKD2;SNTA1;KLHL24;SLC38A10;WNK4;PCSK9;NOS3;ATP2B4;AKT1;MAGED2;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC38A2;PER1;SLC10A6;SLC9A5
19905,GO:2000463,0.00147679691904076,0.999782978578077,7,16,positive regulation of excitatory postsynaptic potential,BP,DLG4;SHANK2;NLGN2;PRKCZ;SSH1;WNT7A;STX1A
1480,GO:0003779,0.00149300314617428,0.99913077017514,53,291,actin binding,MF,ESPN;FLNC;GSN;WIPF1;EGFR;S100A4;SPTB;PARVB;MYH15;MSRB2;OBSL1;PHACTR3;MPRIP;CAPG;MARCKSL1;MYH11;TPM2;SYNE3;MICALL2;SHROOM4;TNS1;SSH3;IMPACT;SNTA1;MYH3;TWF2;DMTN;SSH1;TTN;KCNMA1;TRIOBP;TRPV4;TAGLN3;TMSB4X;NOS3;FMNL2;CROCC;TNNI2;MICAL1;FMNL3;TMOD2;ADD3;HOMER2;MIB2;SPIRE1;FBXO25;EPS8L1;EPS8L2;MYO18A;CORO1B;TNNI1;HIP1;PLEKHH2
6610,GO:0022839,0.00149349960635176,0.999358876657793,24,107,ion gated channel activity,MF,DLG4;KCNG1;SCN8A;CLCA2;SCN4B;ITPR3;DLG3;ANO8;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;KCNMA1;TRPV4;ANO9;TRPV1;GAS6;TTYH3;ITPR2;TMEM63C;TPCN1;ASIC1;SCNN1A
7325,GO:0031344,0.00150125521247333,0.999047501452855,73,437,regulation of cell projection organization,BP,PTPRS;DLG4;APOE;ESPN;ZMYND8;NFATC4;EVI5L;PTK6;CDC42EP5;SEMA4B;LRP1;VEGFA;PRNP;IFT140;SHANK2;CRTC1;ARAP1;CNTN1;EFNB3;OBSL1;ULK2;CUL7;ARPIN;MAP2K1;SYNGAP1;FAM110C;SPRY2;CAPRIN2;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;NEURL1;NGFR;PLXNB1;SSH3;LPAR3;SEMA5A;PLEK2;SDC2;TWF2;DMTN;SEMA3B;DOCK11;SSH1;METRN;TENM2;VLDLR;TRPV4;PROM2;WNT7A;SEMA4G;CROCC;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;WNT3;BRAF;ARHGAP44;LGALS1;EPS8L1;FYN;PLXND1;EPS8L2;EPHB2;ITGA2;FGFR1;UST;C15ORF62;CORO1B
11597,GO:0046320,0.00153348473784841,0.999773085700357,7,16,regulation of fatty acid oxidation,BP,TYSND1;MLYCD;PPARA;ACACB;LONP2;AKT1;ACADVL
3450,GO:0007265,0.00153804369353849,0.999058425693041,63,366,Ras protein signal transduction,BP,F2R;APOE;CDC42EP5;TIMP2;OBSCN;RAPGEF3;ARAP3;ARHGEF19;ARAP1;RGL2;NISCH;ASAP2;SHC2;SYNGAP1;PLEKHG5;SHC1;SPRY2;RAB3B;RALGDS;APPL2;PAK1;SPRY4;NGFR;ARHGEF4;PLEKHG2;RHOBTB2;DNMBP;AGAP1;RASA4;IFT27;VANGL2;RHOF;PLEKHG4;ARHGEF2;SAMD3;STMN3;PAK6;ACAP3;FLOT1;IQSEC2;PSD4;RAB40B;PLEKHG3;BCR;RAB43;PLEKHG6;ASAP3;FARP1;RAB25;ARHGAP44;BCL6;ADAP1;EPS8L1;ARHGEF17;RAB13;CELSR1;RHOBTB3;EPS8L2;VAV3;EPHB2;C15ORF62;NET1;KCTD13
3200,GO:0006836,0.00153985735248038,0.999298639263838,27,126,neurotransmitter transport,BP,SYTL1;GLUL;NTSR1;SNPH;NOS1;BRSK1;SYT8;RAB3B;MCTP1;VAMP2;SEPT5;PCLO;KCNC4;PRAF2;SV2A;APLN;WNT7A;RIMS3;SLC6A9;SLC6A6;ICA1;BRAF;ASIC1;ADA;STX1A;APBA1;PNKD
5894,GO:0018105,0.0015422091004379,0.999177495098717,40,209,peptidyl-serine phosphorylation,BP,VEGFA;EGFR;RAPGEF3;MAPK13;PKN1;DDIT4;DGKQ;ULK1;SPRY2;CAPRIN2;TTBK2;PRKCZ;PAK1;STK39;MKNK2;HMGA2;MAPK3;MAPK12;MLXIPL;MAP2K2;DMTN;PKD1;PSKH1;MAP3K12;PKN3;TGFBR2;GAS6;ERN1;CAMK1;ATP2B4;AKT1;CHEK2;RPS6KA5;BRAF;CSNK1E;MAST4;MAP3K10;STK32B;CAMKK1;IKBKB
9169,GO:0035556,0.00160458725552503,0.998737577149151,275,1981,intracellular signal transduction,BP,TNIP1;XDH;DUSP6;DLG4;DOCK4;F2R;APOE;NFATC4;SERPINE2;PRODH;GSN;ADGRL1;PTK6;CDC42EP5;WWC3;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;RBCK1;PRNP;FBLN1;S100A4;DUSP5;RAPGEF3;TNFSF15;SPTB;DGKA;IGFBP4;NOS1;DDIT3;ARAP3;BRSK1;ADGRB2;ERCC6;NDRG1;ARHGEF19;MST1R;EFS;ZFP36L1;NUPR1;ARAP1;HBEGF;RBL2;RGL2;RPS6KA2;ARHGAP23;CTF1;TFDP2;MAPK13;NISCH;ASAP2;EPM2A;WWTR1;MAP2K1;PKN1;MC1R;DDIT4;SHC2;PLCH2;SYNGAP1;DGKQ;PLEKHG5;FAM110C;SHC1;SPRY2;NPHP4;ADM2;RAB3B;ITPR3;RALGDS;APPL2;PRKCZ;PAK1;ABCA7;MCTP1;STK39;FGFR3;NPR2;SPRY4;DOCK6;ZP3;NGFR;GSTO1;ARHGEF4;TRIB2;PLXNB1;EREG;RMI2;PLCD3;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;DNMBP;LPAR3;S100A13;AGAP1;C5;CHD3;CHAC1;SESN2;AIP;MKNK2;RASA4;IFT27;NLRX1;PKD2;ING4;ACOT11;ECM1;PCLO;PI4KAP1;MAPK3;CSPG4;BNIP3;ERRFI1;SEMA5A;STK40;VANGL2;DOCK9;RGS14;MYZAP;RHOF;PLEK2;MAPK12;NYAP1;SRGAP3;ARHGAP22;MLXIPL;PLEKHG4;PLCD1;ARHGEF2;INPP5D;MAP2K2;SAMD3;STMN3;DMTN;LITAF;PTHLH;ATF4;BBC3;PAK6;DOCK11;ACAP3;PKD1;NSMCE1;RALGAPA1;FLOT1;TTN;PSKH1;UNC5B;SORL1;PCBP4;IL17RD;HERPUD1;GSTM2;ADGRF1;NLRP1;CEBPB;MAP3K12;NEK8;WNK4;RIN2;L3MBTL1;PKN3;MARK3;TRPV4;ARHGAP25;IQSEC2;ITGA1;PSD4;TNFAIP8L1;TMSB4X;PDE2A;TRIB3;RAB40B;CDK5RAP3;NOS3;MINK1;WNT7A;PIK3R2;EPHA1;SHARPIN;GAS6;ERN1;PLEKHG3;BCR;NBR1;CAMK1;PTAFR;PPP1R15A;ADCY6;RAB43;ATP2B4;STRADB;CTSH;UACA;C12ORF66;PLEKHG6;MAPKBP1;AKT1;ITPR2;CARD11;CHEK2;CAPS;TSG101;FGFR4;ASAP3;FARP1;SH2B3;C9ORF72;RAB25;INSR;FOXO4;GNAL;RPS6KA5;HOMER2;MAP2K5;BRAF;EDA2R;ARHGAP44;PIDD1;CAT;MAPK10;LGALS1;JAK3;TP73;MIB2;BCL6;ADAP1;TKFC;EPS8L1;FYN;MAST4;PJA2;LEMD2;ARHGEF17;SIRT2;GDF15;RAB13;CELSR1;ADA;RHOBTB3;TMEM101;EPS8L2;EIF4EBP1;AVPI1;TGFBR3;CIDEB;VAV3;LAMTOR2;MAP3K10;LURAP1;EPHB2;PER1;MCTP2;FGFR1;WFS1;FKBP8;CTH;ERBB2;STK32B;PAG1;SYVN1;C15ORF62;FRS3;NET1;KCTD13;CAMKK1;IKBKB;HIP1;TEAD2
12750,GO:0051049,0.00161564759978452,0.998804893405595,164,1114,regulation of transport,BP,DLG4;F2R;APOE;SYTL1;KCNG1;SERPINE2;FHL1;POSTN;EVI5L;EDEM1;GLUL;GJC2;LRP1;ALOX15B;VEGFA;NTSR1;EGFR;PRNP;SCN8A;NR1D1;HADH;ANK3;RAPGEF3;CLTCL1;TSPAN1;IDH2;DNM1;NOS1;ARAP3;SHANK2;SCN4B;TBC1D8;SYT8;B3GAT3;CNTN1;TFDP2;REEP2;MAP2K1;PCK2;ABCA2;TMEM173;ARL2;VPS11;RAB3B;NLGN2;ITPR3;PRSS8;PRKCZ;PAK1;ABCA7;MCTP1;STK39;CEMIP;MICALL2;ZP3;NGFR;GSTO1;PLA2G6;ABCG1;LPAR3;C5;PPARA;ANO1;STON1;KCNJ15;PKD2;SH3TC2;VAMP2;SEPT5;PCLO;KCNC4;KCNAB2;MAPK3;SNTA1;TBC1D14;MAP2K2;LRSAM1;DMTN;KLHL24;ATF4;BBC3;SV2A;TBC1D3E;RABGAP1;REEP6;FLOT1;TTN;KCNMA1;AZIN2;SORL1;PLTP;GSTM2;NLRP1;RHBDF1;LRP5;WNK4;PCSK9;CEP131;TRPV4;TMSB4X;ANO9;PDE2A;APLN;TRIB3;RAB40B;PEMT;NOS3;MINK1;PROM2;TRPV1;BNIP3L;PIK3R2;RHBDF2;GAS6;GLUD1;DNAJC6;BCR;CAMK1;PTAFR;RIMS3;ATP2B4;MAPKBP1;AKT1;ITPR2;MICAL1;CRY2;TSG101;IL17RC;SGSM2;TBC1D20;ICA1;RAB25;IFI27;INSR;TPCN1;HOMER2;BRAF;ASIC1;HFE;TP73;SNX33;SNX17;EHD3;FYN;TRPC1;RAB13;ADA;RTN2;CIDEA;MYO18A;STX1A;TBC1D16;EPHB2;PER1;ITGA2;FGFR1;WFS1;ERBB2;UNC119;OSCP1;PFKL;GRB10;PNKD;HIP1
679,GO:0001890,0.00162249499648791,0.999284253726705,25,114,placenta development,BP,HTRA1;EGFR;ZFP36L1;MDFI;CUL7;MAP2K1;CYP27B1;FBXW8;EPOR;PLCD3;PKD2;CTSB;PLCD1;PKD1;CEBPB;LDOC1;RXRA;AKT1;KRT19;TFEB;PHLDA2;ADA;ETNK2;EPAS1;BSG
1262,GO:0003018,0.00162440298954151,0.999362169144997,20,84,vascular process in circulatory system,BP,DOCK4;BBS2;F2R;APOE;CTNNBIP1;EGFR;NOS1;HTR7;PLA2G6;TRPV4;ITGA1;PDE2A;APLN;NOS3;BCR;PTAFR;ADCY6;AKT1;CHRM3;EDNRA
5308,GO:0016021,0.00163211187991851,0.998683855259701,363,2691,integral component of membrane,CC,PTPRS;DLG4;F2R;ST6GALNAC2;TNFRSF6B;NYNRIN;CSMD2;MARVELD1;KCNG1;OSBPL5;IL20RB;ADGRL1;LMF1;KIAA1549L;SLC2A3;ADAM19;TMEM129;ACP5;EDEM1;AIG1;FAM210B;GJC2;SEMA4B;LRP1;NTSR1;EGFR;ZDHHC1;FCGRT;SCN8A;SLC7A8;TNFSF15;TSPAN1;SLC16A3;CD9;SLC2A9;SNPH;SDK2;NOS1;SHANK2;CYYR1;CLCA2;SCN4B;ORAI3;MRC2;ADGRB2;GGT1;COL13A1;GRAMD4;MST1R;ARMCX2;SYT8;B3GAT3;HBEGF;TMEM134;EFNB3;EVC;SLC27A1;REEP2;PLD3;TMEM92;SYNGR1;SLC16A5;ABCA2;SLC43A1;MC1R;LPCAT4;ITGA6;MXRA7;TMEM173;DNAJC4;NLGN2;CD68;SLC12A7;CYBRD1;ITPR3;PRSS8;HTR7;ABCA7;SLC37A2;PRR7;MCTP1;B4GALNT4;TMTC4;FAM171A2;SLC35E2B;PEAR1;FGFR3;BRI3;NPR2;PLXNB3;TMEM44;TMEM187;ORAI2;SYNE3;DLG3;ITGB4;SLCO4A1;ZP3;ACVR2B;SPPL2B;NGFR;ELFN2;EPOR;MARCH4;SMIM14;MALL;PLXNB1;EREG;TMC6;PTPRE;PNPLA3;OLFM2;ANO8;TMED4;TNFRSF25;ABCG1;ESYT2;SCART1;ERMAP;LPAR3;C5;PLGRKT;ANO1;FNDC4;KCNJ15;PKD2;VAMP2;RRNAD1;AREG;ST6GALNAC6;B4GAT1;MARCH9;LRP11;KCNC4;KCNAB2;CSPG4;ITGB5;APCDD1L;BNIP3;SEMA5A;IFITM1;PEX10;VANGL2;SCARA3;DYSF;SLC22A18;SLITRK6;MXRA8;PI4K2A;NAT14;PAQR6;PQLC2;KIAA0319L;SDC2;NRSN2;IFNGR2;PDCD1LG2;PRAF2;SRD5A3;SLC50A1;TECPR1;SLC48A1;LRRC8A;LOC441081;PROCR;MOSPD3;CHST6;LTB4R2;SV2A;SLC38A10;GPR153;TENM2;KRTCAP3;IFI6;REEP6;PKD1;SLC29A4;FLOT1;KCNMA1;HSD11B1;TSNARE1;TMEM128;UNC5B;SORL1;SMIM19;IL17RD;HERPUD1;VLDLR;TPBG;ADGRF1;GPRC5C;GABBR1;ST3GAL3;ROBO3;TMEM175;RHBDF1;LRP5;PTPRU;ATRAID;METTL23;AQP3;TGFBR2;TRPV4;DIRC2;C1ORF115;ITGA1;CMTM7;IL17RE;ANO9;HSD17B7;XKR6;PEMT;EDA;PIGZ;PROM2;SLC27A3;HERPUD2;TRPV1;MARCH2;BNIP3L;EPHA1;RHBDF2;SEMA4G;ERN1;ATP7B;CPT1C;BCAM;MFSD3;TTYH3;PTAFR;ADCY6;ATP2B4;TNFRSF14;TMEM80;TMEM9;ENTPD6;TM7SF2;TP53I11;STEAP2;ITPR2;REEP4;B4GALT2;AMIGO2;SEMA6B;TMEM143;COMTD1;C16ORF58;IL17RC;FGFR4;DNAJC22;TMEM256;SLC6A9;SNN;TCIRG1;STEAP3;SLC6A6;TMEM63C;FAAH;TMEM200A;TBC1D20;C1ORF210;IFI27;INSR;TENM4;SLC25A29;CKLF;SLC22A15;LTB4R;SMIM20;TPCN1;GRAMD1A;ITGB6;C6ORF89;PIGQ;ZDHHC24;YIPF3;EDA2R;GPR21;LETMD1;BTN3A2;ASIC1;RNF215;PLB1;GJB4;MYOF;PAQR4;HFE;KIAA1549;MRGPRX3;SCNN1A;CHRM3;TMX4;C14ORF132;CERS4;ICAM5;ATP12A;TMEM50B;TAZ;HGSNAT;BTN3A3;RABAC1;SLC9A7;SLC37A4;ATP8B2;TMEM25;SLC38A2;LEMD2;SLC25A42;TRPC1;MBOAT2;CELSR1;CADM4;PLXND1;TMEM54;RTN2;TMEM101;ENTPD2;SLC35F3;TMEM139;TGFBR3;PLPP6;MAN1B1;STX1A;MFNG;EDNRA;RNF170;EPHB2;TMCO6;MCTP2;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ESYT3;FITM2;FKBP8;XYLT2;ERBB2;PLLP;SLC10A6;UST;PAG1;SYVN1;HLA-G;MMP17;MPPE1;TMEM200B;FER1L4;RTL1;CREB3L4;BSG;TMEM42;PEX11A;TMEM8A;KDSR;IKBKB;CYP4V2;ROBO4;XKR9;BTBD11;SLC9A5
6668,GO:0030036,0.00164358217255769,0.998937291057709,78,469,actin cytoskeleton organization,BP,ESPN;GSN;WIPF1;CDC42EP5;LRP1;OBSCN;RAPGEF3;SPTB;PARVB;ARHGEF19;EFS;ARAP1;MSRB2;OBSL1;NISCH;ARPIN;CAPG;SHC1;NPHP4;MYH11;TPM2;PRKCZ;PAK1;MICALL2;SHROOM4;SSH3;PLEKHG2;RHOBTB2;PI4KAP1;ITGB5;SEMA5A;VANGL2;RHOF;PLEK2;MYH3;ARHGEF2;TWF2;DMTN;PAK6;SSH1;TTN;WHAMMP3;TRIOBP;TRPV4;ARHGAP25;IQSEC2;TMSB4X;MINK1;EPHA1;FMNL2;BCR;MICAL1;TNNT1;FMNL3;TMOD2;ASAP3;C9ORF72;KRT19;TNXB;BRAF;ARHGAP44;FCHSD1;SPIRE1;BCL6;EPS8L1;ARHGEF17;RAB13;CELSR1;RHOBTB3;EPS8L2;MYO18A;LURAP1;C15ORF62;CORO1B;KCTD13;IKBKB;HIP1;PLEKHH2
14840,GO:0070640,0.00165533949929327,1,3,3,vitamin D3 metabolic process,BP,CYP27B1;CYP2R1;FGFR1
6103,GO:0019344,0.00166614309727922,1,3,3,cysteine biosynthetic process,BP,GGT1;CBS;CTH
17101,GO:0102148,0.00167716515637133,1,3,3,N-acetyl-beta-D-galactosaminidase activity,MF,HEXDC;HEXB;HEXA
18391,GO:1903463,0.00168705651522379,1,3,3,regulation of mitotic cell cycle DNA replication,BP,CHEK2;BCL6;FGFR1
6170,GO:0019541,0.00169342113915939,1,3,3,propionate metabolic process,BP,PCK2;ACSS2;ACSS1
13821,GO:0060448,0.00170289275552381,1,3,3,dichotomous subdivision of terminal units involved in lung branching,BP,VANGL2;CTSH;CELSR1
6608,GO:0022836,0.00170934484213113,0.999257687000271,24,108,gated channel activity,MF,DLG4;KCNG1;SCN8A;CLCA2;SCN4B;ITPR3;DLG3;ANO8;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;KCNMA1;TRPV4;ANO9;TRPV1;GAS6;TTYH3;ITPR2;TMEM63C;TPCN1;ASIC1;SCNN1A
4899,GO:0014832,0.00171848822314527,1,3,3,urinary bladder smooth muscle contraction,BP,PLA2G6;KCNMA1;TRPV1
4908,GO:0014848,0.00171848822314527,1,3,3,urinary tract smooth muscle contraction,BP,PLA2G6;KCNMA1;TRPV1
772,GO:0002028,0.00175118017541103,0.999421689315679,15,56,regulation of sodium ion transport,BP,SERPINE2;ANK3;NOS1;SCN4B;CNTN1;PRSS8;STK39;SNTA1;KLHL24;WNK4;PCSK9;NOS3;ATP2B4;AKT1;PER1
10621,GO:0043648,0.00175380402610315,0.999325911888154,19,79,dicarboxylic acid metabolic process,BP,PRODH;GLUL;NAGS;D2HGDH;IDH2;GGT1;ALDH4A1;PCK2;PHYH;MTHFR;NMNAT2;GPT2;SDHA;ALDH1L2;GLUD1;SUCLG2;ASS1;ALDH1L1;ACOT8
2431,GO:0005615,0.00178148523039174,0.998574514154456,322,2397,extracellular space,CC,XDH;PTPRS;ACTA2;HTRA1;GAMT;NT5E;TNFRSF6B;APOE;SYTL1;XPC;SERPINE2;S100A6;GSN;PYGB;PGF;ALDH7A1;FGFBP1;POSTN;SLC2A3;FBXO2;ACP5;THSD4;NAPRT;GLUL;GPX3;SEMA4B;ALOX15B;TIMP2;VEGFA;EGFR;PRNP;ZDHHC1;FBLN1;SLC7A8;ADAMTS7;S100A4;PRDX5;RAPGEF3;BPHL;CLTCL1;TNFSF15;LOXL1;TSPAN1;IGFBP4;KRT15;CD9;IDH2;CRTAP;CST3;DNM1;DNPH1;PGM1;NDRG1;GGT1;ADAMTS13;FCGBP;ARRDC1;HEBP1;B3GAT3;HBEGF;RBL2;PHGDH;ARHGAP23;GAA;PYGL;CTF1;CNTN1;PLAT;LTBP4;CTSF;REEP2;RAB11FIP4;PLD3;PRSS3;HYAL1;NAGLU;MAP2K1;PCK2;COL6A1;PPL;CRYL1;PGLS;CAPG;H2AFJ;TOM1L2;DNASE1L1;AKR7A2;SNX9;FAM213A;MAGEF1;ARL2;VEGFB;MARCKSL1;HDAC11;RAB3B;PCSK1;PLEKHH3;MYH11;CYBRD1;LAMA5;APPL2;PRSS8;TTBK2;PRKCZ;GALE;SERPING1;SLC37A2;AARS;PABPC1L;BLVRB;SEC14L2;SEMA3F;FAM3A;DLG3;ITGB4;CEP250;ZP3;ABHD14B;ELFN2;NID1;ETFB;GSTO1;WDR60;LTBP1;MUC19;PPCS;WNT2B;ACTR1B;EREG;CHD2;PSAT1;SPG11;TMC6;DHRS4;TMED4;PLA2G6;CES3;OAF;MANF;S100A13;GSTT1;MTMR4;C5;ANO1;SNX29;FNDC4;BLMH;PKD2;ACOT11;VAMP2;AREG;COL8A1;SLIT3;ECM1;B4GAT1;PCLO;JADE2;MAPK3;CSPG4;ITGB5;LAMB2;SEMA5A;IRF2BPL;FAM20C;DYSF;RHOF;LTBP2;CTSB;SLITRK6;MXRA8;MVB12B;MYH3;LTA4H;KIAA0319L;CHMP1B;TCTN1;C1RL;PLCD1;MTMR11;PDCD1LG2;TWF2;ANGPTL4;SEMA3B;PTHLH;PROCR;METRN;FRMD4B;PKD1;FUCA1;ATXN10;FLOT1;LTBP3;TTN;KCNMA1;SORL1;GALK1;NTPCR;PLTP;GSTM2;VLDLR;GPRC5C;SULF2;CES2;ACY1;EGFL7;PTGR2;ACOT7;ALDOC;PCSK9;EPN3;MARK3;ITGA1;CMTM7;TMSB4X;APOL4;APLN;ALDH1L2;MINK1;HEXB;PROM2;WNT7A;SEMA4G;CCS;GAS6;ECM2;CROCC;BCR;NBR1;HEXA;BCAM;C1QTNF6;TTYH3;RAB43;THNSL2;SLC9A3R2;EFEMP2;CTSH;UACA;GSTO2;ENTPD6;IGFBP7;CARD11;LAMB1;HMSD;GAREM2;IGFBP2;ASS1;CAPS;TSG101;KIF27;TMEM256;RASSF9;HAGH;NUCB2;DNASE2;C9ORF72;CHMP5;ARSA;CAPN2;ARMC9;MAN2B1;RAB25;PLAU;INSR;WNT3;KRT19;CKLF;GNAL;CHMP4C;TNXB;MBLAC2;ITGB6;CTDSPL;ALDH1L1;CAT;MYOF;DPP7;LGALS1;TIMP1;HFE;SCNN1A;TUBGCP6;APRT;MPI;METTL7A;SAT2;GSTM3;TKFC;EPS8L1;PEX1;UBXN6;GDF15;RAB13;OSBPL1A;TOM1;TST;ADA;CADM4;RHOBTB3;NAGA;ENTPD2;EPS8L2;ADIRF;ERV3-1;TGFBR3;RNPEP;VAV3;GALNS;LAMTOR2;MFNG;BLOC1S1;CTH;PLLP;PFKL;CORO1B;RPL12;MMP19;BSG;LYPLAL1;TMEM8A;KDSR;ROBO4
5054,GO:0015267,0.00179180423907672,0.999101401803542,33,165,channel activity,MF,DLG4;KCNG1;GJC2;SCN8A;CLCA2;SCN4B;ORAI3;ITPR3;ORAI2;DLG3;ANO8;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;LRRC8A;PKD1;KCNMA1;TMEM175;AQP3;TRPV4;ANO9;PDE2A;TRPV1;GAS6;TTYH3;ITPR2;TMEM63C;TPCN1;ASIC1;SCNN1A;TRPC1
6600,GO:0022803,0.00179180423907672,0.999101401803542,33,165,passive transmembrane transporter activity,MF,DLG4;KCNG1;GJC2;SCN8A;CLCA2;SCN4B;ORAI3;ITPR3;ORAI2;DLG3;ANO8;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;LRRC8A;PKD1;KCNMA1;TMEM175;AQP3;TRPV4;ANO9;PDE2A;TRPV1;GAS6;TTYH3;ITPR2;TMEM63C;TPCN1;ASIC1;SCNN1A;TRPC1
8091,GO:0032787,0.0018117128810233,0.998856273373159,69,414,monocarboxylic acid metabolic process,BP,ACSF2;TYSND1;CRAT;AIG1;ALOX15B;D2HGDH;NR1D1;HADH;SLC16A3;IDH2;ACAD10;PGM1;GGT1;DHTKD1;ALDH4A1;SLC27A1;CPT2;MLYCD;PCK2;CRYL1;DDIT4;OGDHL;PHYH;ETFB;PNPLA3;ACOT1;PPARA;SESN2;ACOT11;ACACB;MAPK3;CSPG4;PC;ACSS2;MLXIPL;HLCS;GALK1;GSTM2;CES2;PTGR2;ACOT7;ALDOC;ACADS;LONP2;TRIB3;SLC27A3;ALKBH7;CPT1C;SRR;THNSL2;ACOX3;ACAD11;ASNS;AKT1;FGFR4;HAGH;CBR4;ACADVL;FAAH;INSR;ACSS1;PEX7;OSBPL1A;UST;PFKL;BSG;PNKD;CYP4V2;ACOT8
10896,GO:0044463,0.00184350250185068,0.998671987875876,134,890,cell projection part,CC,DLG4;BBS2;APOE;SYTL1;ESPN;ZMYND8;ADGRL1;FBXO2;GLUL;GJC2;LRP1;TIMP2;NTSR1;PRNP;SCN8A;NR1D1;ANK3;IFT140;DNM1;NOS1;SHANK2;CRTC1;EVC;BBS1;SYNGR1;SYNGAP1;DNAH1;SPRY2;NPHP4;BLOC1S4;CYBRD1;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;PRR7;BLVRB;SPRY4;ORAI2;DLG3;NEURL1;ARHGEF4;WDR60;SPG11;KIF17;IFT27;PKD2;VAMP2;SEPT5;KCNC4;KCNAB2;CSPG4;BNIP3;RGS14;PLEK2;CNTRL;PI4K2A;TCTN1;ARHGEF2;FBF1;TWF2;STMN3;KIF21B;DMTN;MORN4;ATF4;SSH1;SV2A;TENM2;PKD1;ATXN10;AZIN2;MAP6;GABBR1;MAP3K12;NEK8;CEP131;TRIOBP;TRPV4;PSD4;PEMT;MINK1;PROM2;TRPV1;SHARPIN;CEP126;CROCC;CPT1C;KIF13B;SPAG16;ATP2B4;SPATA7;WDR19;TMEM80;AKT1;MICAL1;IFT57;SEPT6;WDR66;CABYR;TMOD2;PIAS3;FARP1;C9ORF72;CAPN2;MARK4;RAB25;INSR;HOMER2;ARHGAP44;PLB1;UNC119B;SCNN1A;CHRM3;GSTM3;EPS8L1;EHD3;FYN;SLC38A2;SIRT2;MPDZ;ADA;PLXND1;EPS8L2;EPHB2;ITGA2;WFS1;BLOC1S1;SPATA6;UNC119;RGS12;APBA1;TCTEX1D4
17229,GO:0120038,0.00184350250185068,0.998671987875876,134,890,plasma membrane bounded cell projection part,CC,DLG4;BBS2;APOE;SYTL1;ESPN;ZMYND8;ADGRL1;FBXO2;GLUL;GJC2;LRP1;TIMP2;NTSR1;PRNP;SCN8A;NR1D1;ANK3;IFT140;DNM1;NOS1;SHANK2;CRTC1;EVC;BBS1;SYNGR1;SYNGAP1;DNAH1;SPRY2;NPHP4;BLOC1S4;CYBRD1;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;PRR7;BLVRB;SPRY4;ORAI2;DLG3;NEURL1;ARHGEF4;WDR60;SPG11;KIF17;IFT27;PKD2;VAMP2;SEPT5;KCNC4;KCNAB2;CSPG4;BNIP3;RGS14;PLEK2;CNTRL;PI4K2A;TCTN1;ARHGEF2;FBF1;TWF2;STMN3;KIF21B;DMTN;MORN4;ATF4;SSH1;SV2A;TENM2;PKD1;ATXN10;AZIN2;MAP6;GABBR1;MAP3K12;NEK8;CEP131;TRIOBP;TRPV4;PSD4;PEMT;MINK1;PROM2;TRPV1;SHARPIN;CEP126;CROCC;CPT1C;KIF13B;SPAG16;ATP2B4;SPATA7;WDR19;TMEM80;AKT1;MICAL1;IFT57;SEPT6;WDR66;CABYR;TMOD2;PIAS3;FARP1;C9ORF72;CAPN2;MARK4;RAB25;INSR;HOMER2;ARHGAP44;PLB1;UNC119B;SCNN1A;CHRM3;GSTM3;EPS8L1;EHD3;FYN;SLC38A2;SIRT2;MPDZ;ADA;PLXND1;EPS8L2;EPHB2;ITGA2;WFS1;BLOC1S1;SPATA6;UNC119;RGS12;APBA1;TCTEX1D4
7599,GO:0031994,0.00192234827675605,0.999834115531636,5,9,insulin-like growth factor I binding,MF,IGFBP4;ITGA6;ITGB4;IGFBP2;INSR
4358,GO:0009966,0.00207078340654836,0.998351834395772,293,2139,regulation of signal transduction,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;HTRA1;F2R;APOE;ZMYND8;NFATC4;SERPINE2;GSN;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;DDIT4L;PTK6;WWC3;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;NR1D1;FBLN1;S100A4;DUSP5;IFT140;TNFSF15;IGFBP4;DNM1;NOS1;DDIT3;ARAP3;SHANK2;ERCC6;ARHGEF19;MST1R;ARRDC1;ARAP1;HBEGF;RGL2;ARHGAP23;CTF1;TFDP2;MDFI;EVC;LTBP4;RNF165;ASAP2;EPM2A;WWTR1;MAP2K1;CYP27B1;PKN1;MC1R;DDIT4;SHC2;SYNGAP1;ITGA6;DGKQ;MAML3;PLEKHG5;FAM110C;SHC1;SPRY2;GRB7;NPHP4;VEGFB;ADM2;NLGN2;APPL2;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;PEAR1;FGFR3;SPRY4;USP20;ZP3;NEURL1;ACVR2B;SPPL2B;NGFR;GSTO1;ARHGEF4;LTBP1;WNT2B;TRIB2;PLXNB1;EREG;PTPRE;RMI2;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;DNMBP;MANF;LPAR3;S100A13;AGAP1;MTMR4;C5;CHD3;CHAC1;SESN2;AIP;RASA4;NLRX1;PKD2;SH3TC2;AREG;SLIT3;ECM1;MAPK3;CSPG4;BNIP3;ERRFI1;SEMA5A;THRA;STK40;VANGL2;SH2D2A;RGS14;FAM20C;RHOF;MVB12B;SRGAP3;ARHGAP22;PLEKHG4;IFNGR2;TCTN1;ARHGEF2;INPP5D;TSPYL2;MAP2K2;STMN3;DMTN;KLHL24;LITAF;PTHLH;BBC3;PAK6;SSH1;ACAP3;IFI6;RALGAPA1;FLOT1;MDK;UNC5B;SORL1;HERPUD1;GSTM2;SULF2;NLRP1;EGFL7;MAP3K12;NEK8;RHBDF1;LRP5;CREBRF;PCSK9;L3MBTL1;FBXL15;MARK3;TGFBR2;TRPV4;FOXL1;ARHGAP25;IQSEC2;ITGA1;CMTM7;PSD4;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;EDA;CDK5RAP3;NOS3;MINK1;LDOC1;WNT7A;PIK3R2;EPHA1;RHBDF2;SHARPIN;GAS6;ERN1;NUDT6;LZTS2;PLEKHG3;BCR;NBR1;PPP1R15A;ATP2B4;THNSL2;STRADB;CTSH;UACA;C12ORF66;PLEKHG6;MAPKBP1;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IGFBP2;TSG101;FGFR4;TMOD2;ASAP3;FARP1;LMNA;SH2B3;C9ORF72;PLAU;INSR;WNT3;CKLF;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;PIDD1;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;TP73;MNT;MIB2;CSNK1E;BCL6;RNF213;ADAP1;TKFC;EPS8L1;FYN;PJA2;LEMD2;ARHGEF17;GDF15;SPRED3;PHLDA2;ADA;TMEM101;CIDEA;EPS8L2;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;LAMTOR2;MAP3K10;MFNG;STARD10;LURAP1;EPHB2;PER1;FGFR1;WFS1;FKBP8;CTH;ERBB2;PAG1;RGS12;SYVN1;NET1;GRB10;KCTD11;KCTD13;IKBKB;HIP1
18044,GO:1902652,0.00208212558994767,0.999098719733933,23,104,secondary alcohol metabolic process,BP,APOE;OSBPL5;LMF1;CYP27B1;DGKQ;SEC14L2;ABCG1;ACACB;MVD;SORL1;VLDLR;LRP5;PCSK9;HSD17B7;CYP2R1;RXRA;TM7SF2;ACADVL;CAT;SNX17;OSBPL1A;PLPP6;FGFR1
4769,GO:0010959,0.00210648543037559,0.998895848614988,36,187,regulation of metal ion transport,BP,F2R;KCNG1;SERPINE2;FHL1;GJC2;NTSR1;PRNP;ANK3;NOS1;SCN4B;CNTN1;PRSS8;STK39;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;VAMP2;KCNAB2;SNTA1;KLHL24;ATF4;GSTM2;WNK4;PCSK9;NOS3;ATP2B4;AKT1;HOMER2;HFE;EHD3;FYN;TRPC1;PER1;WFS1
5510,GO:0016477,0.00216804810255545,0.99843378240561,132,881,cell migration,BP,DOCK4;F2R;APOE;ZMYND8;SERPINE2;PGF;POSTN;PTK6;SEMA4B;LRP1;ALOX15B;VEGFA;EGFR;SLC7A8;TSPAN1;SLC16A3;IDH2;ARAP3;MMP28;EFS;ADARB1;HBEGF;MMP1;PLAT;NISCH;PRSS3;HYAL1;ARPIN;SDCCAG8;PKN1;DDIT4;BTG1;ITGA6;PLEKHG5;FAM110C;SHC1;SPRY2;GRB7;VEGFB;LAMA5;UNK;TTBK2;PRKCZ;PAK1;MCTP1;CEMIP;SEMA3F;PLXNB3;ELMO3;ZP3;PLXNB1;TNS1;RHOBTB2;C5;ECM1;MAPK3;CSPG4;SEMA5A;IFITM1;VANGL2;RHOF;SRGAP3;SDC2;ARHGEF2;INPP5D;DMTN;SEMA3B;PROCR;PAK6;SSH1;LTB4R2;MDK;HDAC5;SORL1;RHBDF1;LRP5;PTPRU;NDE1;PKN3;TGFBR2;TRPV4;ITGA1;TMSB4X;SMURF2;NOS3;MINK1;HEXB;WNT7A;PIK3R2;EPHA1;SEMA4G;GAS6;BCR;PTAFR;CTSH;AKT1;LAMB1;FMNL3;IL17RC;FGFR4;ASAP3;LMNA;RAB25;PLAU;INSR;CKLF;FOXO4;LYST;MAP2K5;BRAF;TIMP1;JAK3;PEX7;SCYL3;FYN;PHLDA2;RAB13;CELSR1;ADA;PLXND1;RHOBTB3;MYO18A;TGFBR3;VAV3;LURAP1;ITGA2;FGFR1;CORO1B;NET1;BSG;KCTD13;ROBO4
598,GO:0001766,0.00231331545826412,0.999881283559631,4,6,membrane raft polarization,BP,MARVELD1;GSN;MALL;PLLP
7437,GO:0031580,0.00231331545826412,0.999881283559631,4,6,membrane raft distribution,BP,MARVELD1;GSN;MALL;PLLP
6772,GO:0030215,0.00232166070146335,0.999619706035919,7,17,semaphorin receptor binding,MF,SEMA4B;SEMA3F;PLXNB1;SEMA5A;SEMA3B;SEMA4G;SEMA6B
18153,GO:1902950,0.00237382993466141,0.999877263962226,4,6,regulation of dendritic spine maintenance,BP,APOE;ZMYND8;PRNP;FYN
4364,GO:0009986,0.0024065950092812,0.998501048291353,62,367,cell surface,CC,F2R;NT5E;SERPINE2;FGFBP1;TIMP2;VEGFA;NTSR1;EGFR;PRNP;ADAMTS7;ANK3;CD9;ADAMTS13;MST1R;HBEGF;PLAT;ITGA6;NLGN2;ABCA7;FGFR3;PLXNB3;ITGB4;NGFR;TNS1;ABCG1;SCART1;ERMAP;AREG;CSPG4;ITGB5;SLITRK6;MXRA8;SDC2;PDCD1LG2;LRRC8A;PROCR;PKD1;TPBG;SULF2;EGFL7;PCSK9;TGFBR2;TRPV4;ITGA1;PROM2;WNT7A;TRPV1;BCAM;ENTPD6;IL17RC;PLAU;INSR;ITGB6;BTN3A2;ASIC1;LGALS1;HFE;BTN3A3;ADA;MYO18A;TGFBR3;ITGA2
16795,GO:0098703,0.00252624490716758,0.999867004828568,4,6,calcium ion import across plasma membrane,BP,PRNP;TRPV1;ATP2B4;FYN
18046,GO:1902656,0.00252624490716758,0.999867004828568,4,6,calcium ion import into cytosol,BP,PRNP;TRPV1;ATP2B4;FYN
12093,GO:0048167,0.00261263446598228,0.998897452472546,21,93,regulation of synaptic plasticity,BP,DLG4;APOE;NFATC4;SERPINE2;PRNP;SHANK2;CRTC1;SYNGR1;SYNGAP1;ITPR3;PRKCZ;MCTP1;NEURL1;VAMP2;RGS14;SSH1;RIMS3;BRAF;PAIP2;EPHB2;EIF2AK4
16590,GO:0097458,0.00268157230788644,0.998034283142653,139,937,neuron part,CC,PTPRS;DLG4;DOCK4;BBS2;APOE;SYTL1;ESPN;ZMYND8;FOS;ADGRL1;FBXO2;GLUL;GJC2;LRP1;TIMP2;NTSR1;PRNP;SCN8A;NR1D1;S100A4;ANK3;IFT140;SNPH;CST3;DNM1;NOS1;BRSK1;SHANK2;CRTC1;SYT8;SYNGR1;SYNGAP1;ULK1;NPHP4;BLOC1S4;RAB3B;NLGN2;ITPR3;PRKCZ;HTR7;PAK1;PRR7;MCTP1;BLVRB;ORAI2;DLG3;MICALL2;NEURL1;NGFR;SPG11;PSPH;LPAR3;KIF17;VAMP2;SEPT5;PCLO;KCNC4;KCNAB2;BNIP3;RGS14;PI4K2A;NRSN2;ARHGEF2;TWF2;STMN3;KIF21B;DMTN;KLHL24;MORN4;ATF4;SSH1;SV2A;TENM2;REEP6;ATXN10;AZIN2;MAP6;HERPUD1;GABBR1;ROBO3;ENDOG;MAP3K12;DBNDD1;TRIOBP;TRPV4;ITGA1;PDE2A;RAB40B;MINK1;WNT7A;TRPV1;EPHA1;SHARPIN;DNAJC6;CROCC;BCR;CPT1C;SRR;KIF13B;RIMS3;ATP2B4;SPATA7;WDR19;MICAL1;IFT57;SEPT6;SLC6A9;TMOD2;PIAS3;FARP1;C9ORF72;CAPN2;ICA1;MARK4;INSR;TENM4;ADD3;HOMER2;BRAF;ARHGAP44;MAPK10;CHRM3;RABAC1;FYN;PJA2;SLC38A2;SIRT2;RAB13;MPDZ;ADA;EPS8L2;STX1A;EPHB2;ITGA2;WFS1;BLOC1S1;RGS12;APBA1;HIP1
1253,GO:0003009,0.00273491167660908,0.999528399877701,7,18,skeletal muscle contraction,BP,GAA;GSTO1;MYH3;GSTM2;TNNI2;TNNT1;TNNI1
4644,GO:0010771,0.00282593152773451,0.998969482348756,16,64,negative regulation of cell morphogenesis involved in differentiation,BP,PTPRS;NFATC4;POSTN;SEMA4B;FBLN1;EFNB3;ULK2;SYNGAP1;SEMA3F;NGFR;SEMA5A;DMTN;SEMA3B;SEMA4G;WNT3;EPHB2
11414,GO:0045860,0.00285498088991293,0.998206742184586,62,370,positive regulation of protein kinase activity,BP,DUSP6;DLG4;F2R;EGR1;VEGFA;EGFR;PRNP;DUSP5;TNFSF15;ERCC6;MST1R;SLC27A1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;SHC1;SPRY2;PRKCZ;PAK1;STK39;CEMIP;DLG3;NEURL1;ACVR2B;EREG;NAB2;LPAR3;C5;PKD2;MAPK3;CSPG4;VANGL2;MAP2K2;PAK6;PKD1;VLDLR;MAP3K12;TGFBR2;ITGA1;MINK1;GAS6;ERN1;MAPRE3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;INSR;MAP2K5;BRAF;MAPK10;TP73;AVPI1;LAMTOR2;MAP3K10;FGFR1;ERBB2;UNC119;CAMKK1
7373,GO:0031434,0.00293324007623642,0.999121481362909,12,42,mitogen-activated protein kinase kinase binding,MF,EGFR;MST1R;FGFR3;TRIB2;TRIB3;EPHA1;FGFR4;INSR;BRAF;EPHB2;FGFR1;ERBB2
7001,GO:0030695,0.00298485831776499,0.998278710439461,45,250,GTPase regulator activity,MF,DOCK4;EVI5L;CDC42EP5;GPSM1;ARAP3;TBC1D8;ARHGEF19;RIN1;ARAP1;ARHGAP23;ASAP2;SYNGAP1;ARL2;RALGDS;APPL2;PLXNB1;RINL;AGAP1;ALS2CL;SESN2;RASA4;ERRFI1;RGS14;SRGAP3;ARHGAP22;TBC1D14;TBC1D3E;RABGAP1;ACAP3;RALGAPA1;RIN2;ARHGAP25;PIK3R2;BCR;PLEKHG6;ASAP3;SGSM2;TBC1D20;ARHGAP27;ARHGAP44;ADAP1;VAV3;TBC1D16;RGS12;C15ORF62
4507,GO:0010562,0.00299306927409269,0.997889053521123,107,700,positive regulation of phosphorus metabolic process,BP,XDH;DUSP6;DLG4;F2R;APOE;EGR1;PTK6;TIMP2;VEGFA;NTSR1;EGFR;PRNP;DUSP5;RAPGEF3;TNFSF15;IGFBP4;NOS1;ERCC6;MST1R;HBEGF;CTF1;CNTN1;SLC27A1;MAP2K1;PKN1;SHC2;ITGA6;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;DLG3;ZP3;NEURL1;ACVR2B;NGFR;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PKD2;AREG;MAPK3;CSPG4;VANGL2;MLXIPL;ARHGEF2;MAP2K2;PTHLH;PAK6;PKD1;FLOT1;VLDLR;MAP3K12;TGFBR2;TRPV4;ITGA1;TMSB4X;APLN;NOS3;MINK1;PROM2;WNT7A;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;STRADB;AKT1;CHEK2;FGFR4;WDFY2;INSR;RPS6KA5;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;TAZ;FYN;GDF15;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;ITGA2;FGFR1;ERBB2;UNC119;CAMKK1
11460,GO:0045937,0.00299306927409269,0.997889053521123,107,700,positive regulation of phosphate metabolic process,BP,XDH;DUSP6;DLG4;F2R;APOE;EGR1;PTK6;TIMP2;VEGFA;NTSR1;EGFR;PRNP;DUSP5;RAPGEF3;TNFSF15;IGFBP4;NOS1;ERCC6;MST1R;HBEGF;CTF1;CNTN1;SLC27A1;MAP2K1;PKN1;SHC2;ITGA6;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;DLG3;ZP3;NEURL1;ACVR2B;NGFR;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PKD2;AREG;MAPK3;CSPG4;VANGL2;MLXIPL;ARHGEF2;MAP2K2;PTHLH;PAK6;PKD1;FLOT1;VLDLR;MAP3K12;TGFBR2;TRPV4;ITGA1;TMSB4X;APLN;NOS3;MINK1;PROM2;WNT7A;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;STRADB;AKT1;CHEK2;FGFR4;WDFY2;INSR;RPS6KA5;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;TAZ;FYN;GDF15;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;ITGA2;FGFR1;ERBB2;UNC119;CAMKK1
9296,GO:0035767,0.00301040530400104,0.999471457015183,7,18,endothelial cell chemotaxis,BP,VEGFA;PLEKHG5;SEMA5A;TMSB4X;RAB13;FGFR1;CORO1B
3191,GO:0006820,0.00304394452088193,0.998122415411546,57,335,anion transport,BP,APOE;OSBPL5;SLC2A3;NTSR1;PRNP;SLC7A8;SLC16A3;SLC2A9;CLCA2;SLC27A1;CPT2;PITPNM3;SLC16A5;SLC43A1;PITPNM1;SLC12A7;PITPNC1;ABCA7;SLC37A2;STK39;SLCO4A1;ANO8;PLA2G6;ABCG1;PPARA;ANO1;VAMP2;ACACB;OSBPL10;PQLC2;PRAF2;LRRC8A;SV2A;SLC38A10;PLTP;WNK4;ANO9;TRPV1;TTYH3;PTAFR;RXRA;AKT1;CRY2;SLC6A9;SLC6A6;SLC25A29;SLC22A15;SLC37A4;ATP8B2;SLC38A2;SLC25A42;STX1A;STARD10;FGFR1;SLC10A6;BSG;APBA1
11868,GO:0046903,0.0030483951457447,0.99774019465409,146,996,secretion,BP,XDH;F2R;SYTL1;SERPINE2;GSN;PYGB;LMF1;POSTN;SLC2A3;NAPRT;GLUL;ALOX15B;TIMP2;VEGFA;NTSR1;EGFR;NR1D1;HADH;RAPGEF3;CD9;SNPH;IDH2;CST3;BRSK1;PGM1;SYT8;GAA;PYGL;EXOC2;LTBP4;NISCH;PRSS3;SYNGR1;PCK2;DNASE1L1;TMEM173;ARL2;VPS11;VEGFB;RAB3B;NLGN2;CD68;ITPR3;PRKCZ;SERPING1;PAK1;MCTP1;STK39;BRI3;ZP3;NEURL1;ACVR2B;ACTR1B;TMC6;OLFM2;PLA2G6;MANF;S100A13;C5;ANO1;VAMP2;SEPT5;ECM1;PCLO;KCNC4;KCNAB2;MAPK3;RHOF;LTBP2;CTSB;LTA4H;PI4K2A;DMTN;SV2A;FUCA1;TTN;NLRP1;RHBDF1;LRP5;WNK4;ALDOC;TRPV4;TMSB4X;APLN;RAB40B;HEXB;WNT7A;TRPV1;RHBDF2;GAS6;GLUD1;BCR;ATP7B;NBEAL2;NECAB3;PTAFR;RIMS3;CTSH;STEAP2;MAPKBP1;ITPR2;CARD11;MICAL1;TSG101;IL17RC;SLC6A9;TCIRG1;STEAP3;COPG1;ARSA;MAN2B1;ICA1;RAB25;PLAU;CKLF;MAGED2;ITGB6;BRAF;ARHGAP44;BTN3A2;ASIC1;CAT;DPP7;YPEL5;TIMP1;HFE;CHRM3;APRT;METTL7A;HGSNAT;SLC38A2;RAB13;TOM1;ADA;POU2F2;AP2A2;CIDEA;MYO18A;STX1A;GALNS;LAMTOR2;STARD10;FGFR1;PFKL;APBA1;PNKD
8910,GO:0034765,0.00305126865761144,0.998315278066928,39,211,regulation of ion transmembrane transport,BP,DLG4;F2R;KCNG1;FHL1;GJC2;NTSR1;PRNP;SCN8A;ANK3;NOS1;SHANK2;SCN4B;NLGN2;STK39;CEMIP;GSTO1;PLA2G6;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;SNTA1;KLHL24;KCNMA1;GSTM2;WNK4;PCSK9;TMSB4X;ANO9;MINK1;PTAFR;ATP2B4;AKT1;TPCN1;EHD3;FYN;TRPC1;EPHB2
13055,GO:0051588,0.003063039863387,0.9990180388782,13,48,regulation of neurotransmitter transport,BP,NTSR1;NOS1;RAB3B;MCTP1;SEPT5;KCNC4;SV2A;APLN;RIMS3;BRAF;ASIC1;STX1A;PNKD
9050,GO:0035296,0.00312839709299448,0.99884462289805,16,65,regulation of tube diameter,BP,DOCK4;BBS2;F2R;APOE;EGFR;NOS1;HTR7;PLA2G6;ITGA1;APLN;NOS3;PTAFR;ADCY6;AKT1;CHRM3;EDNRA
16706,GO:0097746,0.00312839709299448,0.99884462289805,16,65,regulation of blood vessel diameter,BP,DOCK4;BBS2;F2R;APOE;EGFR;NOS1;HTR7;PLA2G6;ITGA1;APLN;NOS3;PTAFR;ADCY6;AKT1;CHRM3;EDNRA
10342,GO:0043173,0.00319537327383668,0.999539345164329,6,14,nucleotide salvage,BP,NAPRT;UCKL1;UPP1;APRT;ADA;FUK
16396,GO:0097060,0.00321009932960281,0.998361443452407,31,157,synaptic membrane,CC,PTPRS;DLG4;F2R;ADGRL1;ANK3;SNPH;DNM1;SHANK2;COL13A1;NLGN2;PRR7;DLG3;NEURL1;NIPSNAP1;OLFM2;RGS14;PI4K2A;TENM2;KCNMA1;GABBR1;PDE2A;MINK1;TRPV1;BCR;RIMS3;HOMER2;CHRM3;PJA2;MPDZ;STX1A;HIP1
16734,GO:0098552,0.00326913145204769,0.99809147711063,46,260,side of membrane,CC,DLG4;SERPINE2;S100A6;PTK6;NTSR1;PRNP;SPTB;CD9;SYNGAP1;ITGA6;SNX9;SHROOM4;SPPL2B;ABCG1;ESYT2;SCART1;ERMAP;RASA4;PKD2;KCNAB2;ERRFI1;MYZAP;PDCD1LG2;MAP2K2;LITAF;PCSK9;TGFBR2;ITGA1;TRPV1;BCAM;FARP1;INSR;GNAL;ITGB6;BTN3A2;HFE;JAK3;BTN3A3;FYN;ADA;TGFBR3;ITGA2;ESYT3;HLA-G;IKBKB;HIP1
4257,GO:0009605,0.00334800355937331,0.9974255084959,189,1334,response to external stimulus,BP,TNIP1;PTPRS;ACTA2;HTRA1;DOCK4;BBS2;F2R;NT5E;TNFRSF6B;APOE;XPC;SERPINE2;FOS;IL20RB;GSN;PGF;POSTN;WIPF1;ACP5;GLUL;SEMA4B;PDCD4;VEGFA;NTSR1;EGFR;NR1D1;ERCC1;SPTB;LOXL1;CD9;CST3;NOS1;DDIT3;CRTC1;GGT1;ADAMTS13;MMP28;MST1R;ADARB1;HBEGF;EFNB3;PLAT;ULK2;MAPK13;RNF165;PRSS3;HMGCL;HYAL1;MAP2K1;CYP27B1;PCK2;PPL;DDIT4;ITGA6;PITPNM1;DGKQ;TMEM173;PLEKHG5;ULK1;SHC1;GRB7;VEGFB;SERPING1;APOBEC3C;STK39;MTHFR;SEMA3F;PLXNB3;CBS;FAM3A;ZSWIM4;ETV1;ZP3;CCDC88B;NGFR;WNT2B;PLXNB1;PSPH;TNFRSF25;PLA2G6;C5;APOBEC3F;PPARA;PLGRKT;ANO1;FNDC4;SESN2;IMPACT;NLRX1;PKD2;SATB1;KLF7;HMGA2;SLIT3;B4GAT1;LRP11;ACACB;MAPK3;LAMB2;BNIP3;SEMA5A;IFITM1;VANGL2;GSDMA;SLITRK6;IFNGR2;PDCD1LG2;LRSAM1;DMTN;LITAF;SEMA3B;ATF4;SSH1;LTB4R2;REEP6;PKD1;TTN;HLCS;UNC5B;HDAC5;IRF5;VLDLR;ROBO3;NLRP1;ENDOG;CEBPB;PCSK9;AQP3;ISG20;DNMT3A;TGFBR2;TRPV4;ITGA1;CMTM7;TMSB4X;MAP1LC3A;PDE2A;DAP;BHLHE40;PEMT;NOS3;TRPV1;BNIP3L;SEMA4G;SHARPIN;GAS6;BCR;SRR;PTAFR;TNFRSF14;GSDMC;MGMT;ASNS;C12ORF66;MAPKBP1;AKT1;CRY2;IGFBP2;IL17RC;UPP1;PLAU;WNT3;CKLF;FOXO4;RPS6KA5;LYST;BRAF;CAT;HFE;BCL6;TKFC;FYN;SLC38A2;SIRT2;RAB13;ADA;PLXND1;MTA1;VAV3;EPHB2;PER1;ITGA2;FGFR1;ERBB2;EIF2AK4;UNC119;CORO1B;GRB10;IKBKB
6679,GO:0030054,0.00348518800964486,0.99745216332823,129,871,cell junction,CC,PTPRS;DLG4;FLNC;FHL1;GSN;ADGRL1;GJC2;LRP1;EGFR;DDB2;ANK3;TSPAN1;CD9;SNPH;SDK2;PARVB;BRSK1;SHANK2;CLCA2;SCN4B;MRC2;NDRG1;COL13A1;RPL13A;OBSL1;MPRIP;SYNGR1;MAP2K1;PPL;SDCCAG8;ITGA6;PLEKHG5;ARL2;GRB7;NPHP4;NLGN2;PRKCZ;PAK1;ABCA7;PRR7;MCTP1;FGFR3;SPRY4;DLG3;ITGB4;MICALL2;PDZD2;SHROOM4;NEURL1;TNS1;OLFM2;DNMBP;NLRX1;PKD2;VAMP2;PCLO;KCNAB2;MAPK3;CSPG4;ITGB5;VANGL2;RGS14;MYZAP;SNTA1;PI4K2A;ARHGAP22;ARHGEF2;FBF1;MAP2K2;KLHL24;PROCR;PAK6;SV2A;FRMD4B;TENM2;FLOT1;CEP68;GABBR1;PTPRU;WNK4;AQP3;TRIOBP;TRPV4;ITGA1;LMO7;MINK1;TRPV1;SHARPIN;BCR;CPT1C;RIMS3;SLC9A3R2;PLEKHG6;AKT1;ZFYVE21;FGFR4;ASAP3;FARP1;CAPN2;ICA1;PLAU;ADD3;ITGB6;HOMER2;ARHGAP44;HOXC5;GJB4;FAAP20;CAT;TP73;UBOX5;CHRM3;RABAC1;EHD3;PJA2;SIRT2;RAB13;MPDZ;ADA;CADM4;STX1A;STARD10;MAGI1;ITGA2;SH3PXD2A;RGS12;CORO1B;RPL12;BSG
3015,GO:0006563,0.00349098638164898,0.999624297713069,5,10,L-serine metabolic process,BP,PHGDH;CBS;PSAT1;PSPH;SRR
8185,GO:0032940,0.00350171517738482,0.997416557019128,137,931,secretion by cell,BP,F2R;SYTL1;SERPINE2;GSN;PYGB;LMF1;POSTN;SLC2A3;NAPRT;GLUL;ALOX15B;TIMP2;VEGFA;NTSR1;EGFR;NR1D1;HADH;RAPGEF3;CD9;SNPH;IDH2;CST3;BRSK1;PGM1;SYT8;GAA;PYGL;EXOC2;LTBP4;NISCH;PRSS3;SYNGR1;PCK2;DNASE1L1;TMEM173;ARL2;VPS11;VEGFB;RAB3B;NLGN2;CD68;ITPR3;PRKCZ;SERPING1;PAK1;MCTP1;BRI3;ZP3;ACVR2B;ACTR1B;TMC6;OLFM2;PLA2G6;MANF;S100A13;C5;ANO1;VAMP2;SEPT5;ECM1;PCLO;KCNC4;KCNAB2;MAPK3;RHOF;LTBP2;CTSB;LTA4H;PI4K2A;DMTN;FUCA1;TTN;NLRP1;RHBDF1;LRP5;ALDOC;TRPV4;TMSB4X;APLN;RAB40B;HEXB;WNT7A;TRPV1;RHBDF2;GAS6;GLUD1;BCR;NBEAL2;NECAB3;PTAFR;RIMS3;CTSH;STEAP2;MAPKBP1;ITPR2;CARD11;MICAL1;TSG101;IL17RC;SLC6A9;TCIRG1;STEAP3;COPG1;ARSA;MAN2B1;ICA1;RAB25;PLAU;CKLF;MAGED2;ITGB6;BRAF;ARHGAP44;BTN3A2;ASIC1;CAT;DPP7;YPEL5;TIMP1;HFE;APRT;METTL7A;HGSNAT;SLC38A2;RAB13;TOM1;POU2F2;AP2A2;CIDEA;MYO18A;STX1A;GALNS;LAMTOR2;FGFR1;PFKL;APBA1;PNKD
13910,GO:0060600,0.00356192004050836,0.999614771072743,5,10,dichotomous subdivision of an epithelial terminal unit,BP,AREG;VANGL2;CTSH;CELSR1;PLXND1
12694,GO:0050954,0.00364545834837499,0.998578950742861,17,72,sensory perception of mechanical stimulus,BP,ESPN;SERPINE2;ALDH7A1;DNM1;EML2;SPRY2;CEMIP;SLITRK6;TRIOBP;HEXB;TRPV1;HOMER2;FYN;EPS8L2;ITGA2;FGFR1;WFS1
3449,GO:0007264,0.00366025888149808,0.997577508304531,74,458,small GTPase mediated signal transduction,BP,DOCK4;F2R;APOE;CDC42EP5;TIMP2;OBSCN;RAPGEF3;ARAP3;ARHGEF19;ARAP1;RGL2;ARHGAP23;NISCH;ASAP2;SHC2;SYNGAP1;PLEKHG5;SHC1;SPRY2;RAB3B;RALGDS;APPL2;PAK1;SPRY4;DOCK6;NGFR;ARHGEF4;PLEKHG2;RHOBTB2;DNMBP;AGAP1;RASA4;IFT27;VANGL2;DOCK9;RHOF;SRGAP3;ARHGAP22;PLEKHG4;ARHGEF2;SAMD3;STMN3;PAK6;DOCK11;ACAP3;RALGAPA1;FLOT1;RIN2;ARHGAP25;IQSEC2;PSD4;RAB40B;PIK3R2;PLEKHG3;BCR;RAB43;PLEKHG6;ASAP3;FARP1;RAB25;ARHGAP44;BCL6;ADAP1;EPS8L1;ARHGEF17;RAB13;CELSR1;RHOBTB3;EPS8L2;VAV3;EPHB2;C15ORF62;NET1;KCTD13
2278,GO:0005229,0.00366949527538218,0.999600231111833,5,10,intracellular calcium activated chloride channel activity,MF,CLCA2;ANO8;ANO1;ANO9;TTYH3
14427,GO:0061778,0.00366949527538218,0.999600231111833,5,10,intracellular chloride channel activity,MF,CLCA2;ANO8;ANO1;ANO9;TTYH3
3186,GO:0006812,0.00374790259322167,0.997421545256291,89,574,cation transport,BP,DLG4;F2R;KCNG1;SERPINE2;FHL1;GJC2;NTSR1;PRNP;SCN8A;SLC7A8;ANK3;SLC2A9;NOS1;DDIT3;SHANK2;SCN4B;ORAI3;CNTN1;CYP27B1;RAB3B;NLGN2;SLC12A7;ITPR3;PRSS8;STK39;CEMIP;NDUFA4L2;ORAI2;GSTO1;PLA2G6;LPAR3;ANO1;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;SLC22A18;SNTA1;PQLC2;KLHL24;ATF4;SLC38A10;PKD1;KCNMA1;AZIN2;GSTM2;TMEM175;WNK4;PCSK9;TRPV4;TMSB4X;PDE2A;NOS3;MINK1;TRPV1;CCS;GAS6;ATP7B;MFSD3;ATP2B4;STEAP2;AKT1;ITPR2;SLC6A9;TCIRG1;STEAP3;TMEM63C;SLC25A29;TPCN1;MAGED2;HOMER2;ASIC1;HFE;SCNN1A;ATP12A;SLC9A7;EHD3;FYN;SLC38A2;SLC25A42;TRPC1;ADA;EPHB2;PER1;SLC39A11;WFS1;SLC10A6;SLC9A5
6662,GO:0030029,0.00380448791436298,0.997424106869619,82,513,actin filament-based process,BP,ESPN;GSN;WIPF1;CDC42EP5;LRP1;OBSCN;RAPGEF3;SPTB;PARVB;SCN4B;ARHGEF19;EFS;ARAP1;MSRB2;OBSL1;NISCH;ARPIN;CAPG;SHC1;NPHP4;MYH11;TPM2;PRKCZ;PAK1;MICALL2;SHROOM4;SSH3;PLEKHG2;RHOBTB2;PI4KAP1;ITGB5;SEMA5A;VANGL2;RHOF;PLEK2;SNTA1;MYH3;ARHGEF2;TWF2;DMTN;PAK6;SSH1;TTN;WHAMMP3;TRIOBP;TRPV4;ARHGAP25;IQSEC2;TMSB4X;MINK1;EPHA1;FMNL2;BCR;TNNI2;MICAL1;TNNT1;FMNL3;TMOD2;ASAP3;C9ORF72;KRT19;TNXB;BRAF;ARHGAP44;FCHSD1;SPIRE1;BCL6;EPS8L1;ARHGEF17;RAB13;CELSR1;RHOBTB3;EPS8L2;MYO18A;LURAP1;C15ORF62;CORO1B;TNNI1;KCTD13;IKBKB;HIP1;PLEKHH2
16853,GO:0098815,0.00382053092464903,0.999174590287416,8,23,modulation of excitatory postsynaptic potential,BP,DLG4;ZMYND8;SHANK2;NLGN2;PRKCZ;SSH1;WNT7A;STX1A
2576,GO:0005865,0.00387309117024311,0.999492046585841,6,11,striated muscle thin filament,CC,TPM2;TTN;TNNI2;TNNT1;TMOD2;TNNI1
5059,GO:0015276,0.0038748174371825,0.998870006097308,11,38,ligand-gated ion channel activity,MF,DLG4;CLCA2;ITPR3;DLG3;KCNJ15;PKD2;TRPV1;ITPR2;TPCN1;ASIC1;SCNN1A
6606,GO:0022834,0.0038748174371825,0.998870006097308,11,38,ligand-gated channel activity,MF,DLG4;CLCA2;ITPR3;DLG3;KCNJ15;PKD2;TRPV1;ITPR2;TPCN1;ASIC1;SCNN1A
6743,GO:0030170,0.00389218459018349,0.99895067835632,10,33,pyridoxal phosphate binding,MF,PYGB;PYGL;GLDC;CBS;GPT2;MOCOS;SRR;THNSL2;PHYKPL;CTH
14646,GO:0070279,0.00389218459018349,0.99895067835632,10,33,vitamin B6 binding,MF,PYGB;PYGL;GLDC;CBS;GPT2;MOCOS;SRR;THNSL2;PHYKPL;CTH
13101,GO:0051668,0.00392312984764016,0.998362410829154,19,84,localization within membrane,BP,DLG4;APOE;MARVELD1;GSN;DNM1;REEP2;SYNGAP1;DLG3;ETV5;MALL;KIF17;SSH1;CEP112;WDR19;TBC1D20;ARHGAP44;SEC31B;PLLP;HIP1
2209,GO:0005096,0.00395295031976281,0.997745924188608,41,226,GTPase activator activity,MF,DOCK4;EVI5L;CDC42EP5;ARAP3;TBC1D8;ARHGEF19;RIN1;ARAP1;ARHGAP23;ASAP2;SYNGAP1;APPL2;PLXNB1;RINL;AGAP1;ALS2CL;RASA4;ERRFI1;RGS14;SRGAP3;ARHGAP22;TBC1D14;TBC1D3E;RABGAP1;ACAP3;RALGAPA1;RIN2;ARHGAP25;PIK3R2;BCR;PLEKHG6;ASAP3;SGSM2;TBC1D20;ARHGAP27;ARHGAP44;ADAP1;VAV3;TBC1D16;RGS12;C15ORF62
3265,GO:0006939,0.00398212549556138,0.998607866264234,14,55,smooth muscle contraction,BP,DOCK4;BBS2;F2R;MYH11;HTR7;PLA2G6;KCNMA1;SULF2;TRPV1;PTAFR;CHRM3;ADA;EDNRA;ITGA2
17722,GO:1901698,0.00401212549904327,0.997126369794138,110,730,response to nitrogen compound,BP,APOE;FOS;GSN;EGR1;FBXO2;TMEM129;EDEM1;LRP1;EGFR;PRNP;HADH;RAPGEF3;CD9;ADAMTS13;ZFP36L1;SLC27A1;MAPK13;UROS;MAP2K1;PCK2;COL6A1;BTG1;DGKQ;TMEM173;SHC1;PRKCZ;PAK1;MTHFR;GLDC;NEURL1;NGFR;EREG;PTPRE;PPARA;SESN2;IMPACT;PKD2;STAT6;VAMP2;AREG;MAPK3;ERRFI1;ARHGEF2;MAP2K2;DMTN;UBXN4;ATF4;SSH1;FBXO6;FLOT1;HLCS;HDAC5;IRF5;HERPUD1;SRSF5;GSTM2;NLRP1;CEBPB;LRP5;PCSK9;DNMT3A;TRPV4;MAP1LC3A;PDE2A;TRIB3;PEMT;AGO4;TRPV1;PIK3R2;SRR;PTAFR;ADCY6;ATP2B4;MGMT;ASNS;AKT1;ITPR2;TCIRG1;CAPN2;INSR;FOXO4;ANKZF1;HOMER2;BRAF;GPR21;CAT;TIMP1;JAK3;TP73;CHRM3;APRT;GSTM3;FYN;UBXN6;SIRT2;RECQL5;RAB13;ADA;HDAC8;EIF4EBP1;TGFBR3;MAN1B1;LAMTOR2;PER1;ITGA2;WFS1;SYVN1;GRB10;MMP19;BSG
12286,GO:0048646,0.00401866703626283,0.997144835944616,105,684,anatomical structure formation involved in morphogenesis,BP,DUSP6;HTRA1;NFATC4;THBS3;PGF;VEGFA;OBSCN;ERCC1;DUSP5;RAPGEF3;CD9;SDK2;NOS1;ADGRB2;OBSL1;HYAL1;MAP2K1;COL6A1;SDCCAG8;PKN1;BTG1;ITGA6;SHC1;SPRY2;VEGFB;ADM2;MYH11;LAMA5;ELK3;ITGB4;ZP3;ACVR2B;NGFR;WNT2B;EREG;PLCD3;C5;PPARA;HMGA2;COL8A1;ECM1;MAPK3;CSPG4;ITGB5;SEMA5A;VANGL2;SH2D2A;FAM20C;MYH3;ARHGAP22;TCTN1;PLCD1;ANGPTL4;ZFPM1;KDM4C;KIF26B;FLOT1;TTN;UNC5B;HDAC5;DEAF1;RFX2;EGFL7;TGFBR2;APLN;EDA;NOS3;WNT7A;EPHA1;NBEAL2;CAMK1;CTSH;LAMB1;IFT57;TNNT1;FMNL3;FGFR4;TMOD2;TBC1D20;CAPN2;WNT3;KRT19;TENM4;FOXO4;MAP2K5;MYOF;BCL6;RNF213;LEMD2;GDF15;CELSR1;ADA;PLXND1;TGFBR3;VAV3;EPAS1;EDNRA;EPHB2;ITGA2;FGFR1;SH3PXD2A;ERBB2;MMP19;ROBO4;TEAD2
8142,GO:0032879,0.00406987326538179,0.996779688276944,234,1687,regulation of localization,BP,DLG4;DOCK4;BBS2;F2R;APOE;SYTL1;ZMYND8;KCNG1;SERPINE2;FHL1;GSN;PGF;POSTN;EVI5L;EDEM1;GLUL;GJC2;SEMA4B;LRP1;ALOX15B;VEGFA;NTSR1;EGFR;PRNP;SCN8A;NR1D1;FBLN1;HADH;ANK3;RAPGEF3;CLTCL1;TSPAN1;CD9;IDH2;DNM1;NOS1;DDIT3;ARAP3;SHANK2;SCN4B;TBC1D8;MMP28;ZFP36L1;ADARB1;SYT8;ARAP1;B3GAT3;HBEGF;CNTN1;TFDP2;REEP2;NISCH;HYAL1;ARPIN;MAP2K1;PCK2;ABCA2;PKN1;ITGA6;TMEM173;FAM110C;ARL2;VPS11;SPRY2;GRB7;VEGFB;RAB3B;NLGN2;ITPR3;LAMA5;PRSS8;TTBK2;PRKCZ;PAK1;ABCA7;MCTP1;STK39;CEMIP;SEMA3F;PLXNB3;ZSWIM4;MICALL2;CEP250;ZP3;NGFR;GSTO1;PLXNB1;EREG;RHOBTB2;PLA2G6;ABCG1;LPAR3;C5;PPARA;ANO1;STON1;SESN2;KCNJ15;PKD2;SH3TC2;VAMP2;SEPT5;ECM1;PCLO;KCNC4;ACACB;KCNAB2;MAPK3;SEMA5A;IFITM1;RHOF;SNTA1;SRGAP3;TBC1D14;ARHGEF2;MAP2K2;LRSAM1;DMTN;KLHL24;SEMA3B;ATF4;BBC3;SSH1;SV2A;TBC1D3E;RABGAP1;REEP6;FLOT1;TTN;KCNMA1;AZIN2;HDAC5;SORL1;PLTP;GSTM2;NLRP1;RHBDF1;LRP5;PTPRU;WNK4;PCSK9;CEP131;TGFBR2;TRPV4;TMSB4X;ANO9;PDE2A;SMURF2;APLN;TRIB3;RAB40B;PEMT;CDK5RAP3;NOS3;MINK1;PROM2;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;GAS6;GLUD1;DNAJC6;LZTS2;ALKBH7;CROCC;BCR;CAMK1;PTAFR;RIMS3;ATP2B4;CTSH;MAPKBP1;AKT1;ITPR2;MICAL1;CRY2;LAMB1;TSG101;IL17RC;LMNA;SGSM2;TBC1D20;ICA1;RAB25;IFI27;PLAU;INSR;WNT3;FOXO4;TPCN1;HOMER2;MAP2K5;BRAF;ASIC1;TIMP1;HFE;TP73;SNX33;SNX17;CSNK1E;BCL6;EHD3;FYN;TRPC1;PHLDA2;RAB13;ADA;PLXND1;RTN2;CIDEA;HDAC8;MYO18A;TGFBR3;STX1A;TBC1D16;EPHB2;PER1;ITGA2;FGFR1;WFS1;FITM2;ERBB2;UNC119;OSCP1;PFKL;CORO1B;GRB10;PNKD;HIP1;ROBO4
3064,GO:0006631,0.00409729072372362,0.997590651417358,45,257,fatty acid metabolic process,BP,ACSF2;TYSND1;CRAT;AIG1;ALOX15B;HADH;ACAD10;GGT1;SLC27A1;CPT2;MLYCD;PCK2;CRYL1;PHYH;ETFB;PNPLA3;ACOT1;PPARA;SESN2;ACOT11;ACACB;MAPK3;ACSS2;MLXIPL;GSTM2;CES2;PTGR2;ACOT7;ACADS;LONP2;TRIB3;SLC27A3;ALKBH7;CPT1C;THNSL2;ACOX3;ACAD11;AKT1;CBR4;ACADVL;FAAH;ACSS1;PEX7;CYP4V2;ACOT8
5380,GO:0016209,0.00434592140601909,0.998529176966284,13,52,antioxidant activity,MF,APOE;GPX3;PRDX5;TXNRD3;FAM213A;GSTO1;GSTT1;SESN2;GSTM2;CCS;GSTO2;TXNRD2;CAT
12571,GO:0050771,0.00438698337780579,0.998605161125167,12,44,negative regulation of axonogenesis,BP,PTPRS;SEMA4B;EFNB3;ULK2;SYNGAP1;SEMA3F;NGFR;SEMA5A;SEMA3B;SEMA4G;WNT3;EPHB2
10294,GO:0043087,0.00445860647088925,0.997159320770251,60,361,regulation of GTPase activity,BP,DOCK4;F2R;EVI5L;CDC42EP5;RAPGEF3;GPSM1;ARAP3;TBC1D8;ARHGEF19;RIN1;ARAP1;ARHGAP23;ASAP2;SYNGAP1;ITGA6;SNX9;ARL2;SPRY2;PLXNB3;PLXNB1;DNMBP;RINL;AGAP1;ALS2CL;RASA4;ERRFI1;DOCK9;RGS14;SRGAP3;ARHGAP22;PLEKHG4;TBC1D14;STMN3;DOCK11;TBC1D3E;RABGAP1;ACAP3;RALGAPA1;RIN2;ARHGAP25;PROM2;PIK3R2;EPHA1;BCR;PLEKHG6;SBF2;ASAP3;SGSM2;TBC1D20;ARHGAP27;ARHGAP44;BCL6;ADAP1;PLXND1;VAV3;TBC1D16;ERBB2;RGS12;C15ORF62;NET1
8485,GO:0033674,0.00449692874664698,0.997059207346062,67,413,positive regulation of kinase activity,BP,DUSP6;DLG4;F2R;EGR1;VEGFA;EGFR;PRNP;DUSP5;TNFSF15;ERCC6;MST1R;SLC27A1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;SHC1;SPRY2;PRKCZ;PAK1;STK39;FGFR3;CEMIP;DLG3;NEURL1;ACVR2B;EREG;NAB2;LPAR3;C5;PKD2;MAPK3;CSPG4;VANGL2;MAP2K2;PAK6;PKD1;VLDLR;MAP3K12;TGFBR2;ITGA1;MINK1;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;FGFR4;INSR;MAP2K5;BRAF;MAPK10;TP73;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2;UNC119;CAMKK1
15738,GO:0072359,0.00467509593800219,0.996670238599566,103,673,circulatory system development,BP,XDH;DUSP6;ACTA2;APOE;NFATC4;EGR1;PGF;ADAM19;LRP1;PDCD4;VEGFA;EGFR;IFT140;RAPGEF3;LOXL1;MEF2D;DDIT3;ADGRB2;ZFP36L1;GAA;TFDP2;OBSL1;CUL7;HYAL1;MAP2K1;BTG1;SHC1;SPRY2;VEGFB;ADM2;MYH11;LAMA5;PAK1;ELK3;FBXW8;ACVR2B;NGFR;EPOR;LTBP1;EREG;PLCD3;C5;PPARA;TCF25;PKD2;HMGA2;COL8A1;ECM1;ACACB;MAPK3;CSPG4;ERRFI1;SEMA5A;VANGL2;SH2D2A;ARHGAP22;PLCD1;ANGPTL4;ZFPM1;MOSPD3;PKD1;TTN;PSKH1;UNC5B;HDAC5;EGFL7;NEK8;LRP5;TGFBR2;FOXL1;APLN;NOS3;WNT7A;EPHA1;RXRA;CTSH;AKT1;IFT57;FMNL3;FGFR4;LMNA;INSR;TENM4;FOXO4;MAP2K5;TP73;SNX17;TAZ;RNF213;LEMD2;PLXND1;TGFBR3;VAV3;EPAS1;EDNRA;EPHB2;FGFR1;CTH;ERBB2;TNNI1;MMP19;ROBO4;TEAD2
17544,GO:1901184,0.00472765336979613,0.998043839011633,18,79,regulation of ERBB signaling pathway,BP,PTK6;EGFR;ARAP1;HBEGF;SHC1;SPRY2;NEURL1;EREG;SH3TC2;ERRFI1;MVB12B;RHBDF1;ITGA1;RHBDF2;AKT1;TSG101;ERBB2;HIP1
19580,GO:1990748,0.00476909616015195,0.998210536154608,15,64,cellular detoxification,BP,APOE;GPX3;PRDX5;TXNRD3;FAM213A;GSTO1;GSTT1;SESN2;GSTM2;NOS3;CCS;GSTO2;TXNRD2;CAT;GSTM3
7851,GO:0032420,0.00483234364297472,0.998900672391658,8,24,stereocilium,CC,DOCK4;BBS2;ESPN;TWF2;MORN4;TRIOBP;HOMER2;EPS8L2
1705,GO:0004252,0.00484133406330372,0.998050427477617,17,74,serine-type endopeptidase activity,MF,HTRA1;TYSND1;MMP1;PLAT;PRSS3;PCSK1;PRSS8;CTSB;C1RL;PRSS22;RHBDF1;PCSK9;LONP2;RHBDF2;CTSH;PLAU;MMP19
13099,GO:0051665,0.00495336096678725,0.999619248346615,4,7,membrane raft localization,BP,MARVELD1;GSN;MALL;PLLP
4027,GO:0009063,0.00497203115223983,0.99799216176295,17,74,cellular amino acid catabolic process,BP,PRODH;ALDH7A1;GLUL;NOS1;ALDH4A1;HMGCL;GLDC;CBS;GPT2;BLMH;HIBADH;NOS3;GLUD1;ATP2B4;THNSL2;PHYKPL;CTH
11373,GO:0045776,0.00500256444131636,0.998855036802306,8,24,negative regulation of blood pressure,BP,NTSR1;NOS1;ADM2;PPARA;APLN;NOS3;PTAFR;RNPEP
5600,GO:0016646,0.00506669594371581,0.999171309683976,6,15,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,PYCR2;ALDH4A1;BLVRB;MTHFR;ALDH1L2;ALDH1L1
7066,GO:0030863,0.00509908160192195,0.997873836984722,18,79,cortical cytoskeleton,CC,DLG4;GSN;WIPF1;RAPGEF3;SPTB;SHROOM4;PCLO;MYZAP;DMTN;FLOT1;TRIOBP;TRPV4;RIMS3;CAPN2;KRT19;HFE;HIP1;PLEKHH2
10670,GO:0043954,0.00517213581173161,0.998809289847693,8,24,cellular component maintenance,BP,F2R;APOE;ZMYND8;PRNP;NLGN2;MTHFR;INSR;FYN
12405,GO:0048875,0.00517880348844565,0.999596637597052,4,7,chemical homeostasis within a tissue,BP,VEGFA;CTSH;HOMER2;EPAS1
7326,GO:0031345,0.00519371365310083,0.997467667699067,25,124,negative regulation of cell projection organization,BP,PTPRS;APOE;NFATC4;EVI5L;SEMA4B;LRP1;PRNP;EFNB3;ULK2;ARPIN;SYNGAP1;SPRY2;SEMA3F;PLXNB3;NGFR;SEMA5A;SEMA3B;TRPV4;SEMA4G;ADCY6;DGUOK;WNT3;LGALS1;FYN;EPHB2
466,GO:0001505,0.00519663486241041,0.997247120811983,31,163,regulation of neurotransmitter levels,BP,SYTL1;ALDH7A1;ACP5;GLUL;NTSR1;SNPH;NOS1;BRSK1;SYT8;RAB3B;MCTP1;GLDC;PKD2;VAMP2;SEPT5;PCLO;KCNC4;NOS3;WNT7A;TRPV1;RIMS3;ATP2B4;AKT1;ASS1;SLC6A9;INSR;BRAF;ASIC1;STX1A;APBA1;PNKD
17025,GO:0099531,0.005202710377599,0.997823510090753,18,80,presynaptic process involved in chemical synaptic transmission,BP,SYTL1;SNPH;BRSK1;SYT8;RAB3B;MCTP1;VAMP2;SEPT5;PCLO;KCNC4;WNT7A;RIMS3;SLC6A9;BRAF;ASIC1;STX1A;APBA1;PNKD
7048,GO:0030835,0.00520393117172476,0.998800680948177,8,24,negative regulation of actin filament depolymerization,BP,GSN;SPTB;CAPG;TWF2;DMTN;TRIOBP;TMOD2;PLEKHH2
16837,GO:0098794,0.00520878420941354,0.996893556608834,45,257,postsynapse,CC,PTPRS;DLG4;F2R;ZMYND8;FBXO2;NTSR1;PRNP;NR1D1;ANK3;DNM1;NOS1;SHANK2;COL13A1;SYNGAP1;NLGN2;PRR7;DLG3;NEURL1;PCLO;KCNAB2;BNIP3;RGS14;ARHGEF2;DMTN;TENM2;KCNMA1;GABBR1;MINK1;TRPV1;SHARPIN;DNAJC6;BCR;AKT1;FARP1;ADD3;HOMER2;ARHGAP44;CHRM3;FYN;PJA2;MPDZ;STX1A;EPHB2;APBA1;HIP1
7856,GO:0032426,0.00523643173288142,0.999590808478651,4,7,stereocilium tip,CC,ESPN;MORN4;HOMER2;EPS8L2
2698,GO:0006066,0.00532791723835057,0.996901136926908,41,232,alcohol metabolic process,BP,ISYNA1;APOE;OSBPL5;LMF1;NTSR1;CYP27B1;PCK2;PLCH2;DGKQ;SEC14L2;PLCD3;DHRS4;ABCG1;ACACB;ACSS2;MVD;PLCD1;INPP5D;SRD5A3;SORL1;GALK1;VLDLR;LRP5;PCSK9;HSD17B7;PTAFR;CYP2R1;RXRA;TM7SF2;ACADVL;ACSS1;PNPLA4;PLB1;CAT;SNX17;TKFC;OSBPL1A;RETSAT;PLPP6;INPP4A;FGFR1
8649,GO:0034220,0.00532834757723988,0.996280781258074,89,580,ion transmembrane transport,BP,DLG4;F2R;KCNG1;FHL1;S100A6;GJC2;NTSR1;PRNP;SCN8A;SLC7A8;ANK3;SLC16A3;SLC2A9;NOS1;DDIT3;SHANK2;CLCA2;SCN4B;ORAI3;CPT2;SLC43A1;NLGN2;SLC12A7;ITPR3;SLC37A2;STK39;CEMIP;NDUFA4L2;ORAI2;DLG3;GSTO1;ANO8;PLA2G6;ANO1;KCNJ15;PKD2;VAMP2;KCNC4;ACACB;KCNAB2;SNTA1;PQLC2;PRAF2;LRRC8A;KLHL24;SLC38A10;PKD1;KCNMA1;GSTM2;TMEM175;WNK4;PCSK9;TRPV4;TMSB4X;ANO9;PDE2A;MINK1;TRPV1;GAS6;ATP7B;MFSD3;TTYH3;PTAFR;ATP2B4;STEAP2;AKT1;ITPR2;SLC6A9;TCIRG1;STEAP3;SLC6A6;TMEM63C;SLC25A29;TPCN1;ASIC1;HFE;SCNN1A;ATP12A;SLC9A7;SLC37A4;EHD3;FYN;ATP8B2;SLC38A2;SLC25A42;TRPC1;EPHB2;SLC39A11;SLC9A5
2176,GO:0005024,0.0053361340133247,0.999580676885888,4,7,transforming growth factor beta-activated receptor activity,MF,LTBP4;LTBP1;TGFBR2;TGFBR3
12256,GO:0048585,0.0055172847658483,0.995792343837885,157,1100,negative regulation of response to stimulus,BP,TNIP1;XDH;DUSP6;PTPRS;HTRA1;BBS2;NT5E;APOE;NFATC4;SERPINE2;IL20RB;EGR1;CTNNBIP1;DDIT4L;PTK6;ACP5;WWC3;SEMA4B;LRP1;PDCD4;TIMP2;EGFR;PRNP;NR1D1;ERCC1;FBLN1;DUSP5;IGFBP4;CD9;DNM1;DDIT3;ARAP3;MMP28;MST1R;ARRDC1;HBEGF;MDFI;PLAT;EPM2A;WWTR1;DDIT4;SYNGAP1;ITGA6;MAGEF1;SPRY2;NPHP4;PRKCZ;SERPING1;MCTP1;STK39;PEAR1;FGFR3;SEMA3F;SPRY4;FAM3A;NEURL1;GSTO1;LTBP1;EREG;PTPRE;MTMR4;C5;PPARA;CHAC1;FNDC4;SESN2;RASA4;NLRX1;PKD2;STAT6;HMGA2;SLIT3;ECM1;ERRFI1;SEMA5A;RGS14;ARHGEF2;INPP5D;STMN3;SEMA3B;ATF4;IFI6;UNC5B;SORL1;HERPUD1;GSTM2;SULF2;NLRP1;EGFL7;CREBRF;MARK3;TGFBR2;ARHGAP25;ITGA1;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;CDK5RAP3;NOS3;PIK3R2;EPHA1;SEMA4G;SHARPIN;GAS6;LZTS2;BCR;TERC;PPP1R15A;ATP2B4;STRADB;C12ORF66;MAPKBP1;AKT1;CRY2;CHEK2;IGFBP2;TSG101;FGFR4;LMNA;PLAU;INSR;WNT3;NCOA7;MAP2K5;BRAF;GPR21;ARHGAP44;HFE;JAK3;TP73;MNT;BCL6;RNF213;TKFC;FYN;LEMD2;SIRT2;RECQL5;ADA;CIDEA;TGFBR3;EPHB2;PER1;FGFR1;WFS1;CTH;ERBB2;RGS12;SYVN1;HLA-G;CORO1B;GRB10;KCTD11;KCTD13
7196,GO:0031094,0.00561934023780643,0.999551580785907,4,7,platelet dense tubular network,CC,F2R;ITPR3;DMTN;ITPR2
6583,GO:0022603,0.00565136591817617,0.995925020144854,106,707,regulation of anatomical structure morphogenesis,BP,XDH;DUSP6;PTPRS;DLG4;APOE;NFATC4;PGF;POSTN;WIPF1;CDC42EP5;SEMA4B;VEGFA;FBLN1;RAPGEF3;CST3;PARVB;ARAP3;ADGRB2;ARHGEF19;ARAP1;EFNB3;OBSL1;ULK2;CUL7;HYAL1;ARPIN;MAP2K1;PKN1;BTG1;SYNGAP1;SPRY2;VEGFB;ADM2;CAPRIN2;TTBK2;PAK1;SEMA3F;PLXNB3;SYNE3;ZSWIM4;FBXW8;NGFR;ETV5;WNT2B;PLXNB1;SSH3;RHOBTB2;LPAR3;S100A13;C5;HMGA2;ECM1;BNIP3;SEMA5A;VANGL2;RHOF;SDC2;TWF2;DMTN;ANGPTL4;SEMA3B;SSH1;METRN;FLOT1;HDAC5;SULF2;TRIOBP;TGFBR2;SMURF2;NOS3;AGO4;HEXB;WNT7A;EPHA1;SEMA4G;FMNL2;BCR;KIF13B;CAMK1;RXRA;CTSH;FMNL3;WNT3;TENM4;FOXO4;MAP2K5;BRAF;ARHGAP44;CSNK1E;BCL6;FYN;GDF15;CELSR1;ADA;PLXND1;RHOBTB3;AP2A2;EPHB2;FGFR1;FITM2;ERBB2;UST;C15ORF62;CORO1B;NET1;ZMYM3
18674,GO:1904062,0.00566724356415296,0.997012055153955,30,158,regulation of cation transmembrane transport,BP,DLG4;F2R;KCNG1;FHL1;GJC2;NTSR1;PRNP;ANK3;NOS1;SHANK2;SCN4B;NLGN2;STK39;CEMIP;GSTO1;PLA2G6;PKD2;VAMP2;KCNAB2;SNTA1;KLHL24;GSTM2;PCSK9;TMSB4X;MINK1;ATP2B4;EHD3;FYN;TRPC1;EPHB2
12254,GO:0048583,0.00568706816854716,0.995298583256292,359,2709,regulation of response to stimulus,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;HTRA1;BBS2;F2R;NT5E;APOE;ZMYND8;NFATC4;SERPINE2;FOS;IL20RB;GSN;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;WIPF1;DDIT4L;PTK6;ACP5;WWC3;EDEM1;RNF135;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;FCGRT;NR1D1;ERCC1;FBLN1;S100A4;DUSP5;IFT140;TNFSF15;IGFBP4;CD9;DNM1;NOS1;DDIT3;ARAP3;SHANK2;ERCC6;GGT1;ARHGEF19;MMP28;MST1R;ARRDC1;ARAP1;HBEGF;RGL2;ARHGAP23;CTF1;TFDP2;MDFI;EVC;PLAT;LTBP4;MAPK13;RNF165;ASAP2;EPM2A;WWTR1;MAP2K1;CYP27B1;PKN1;MC1R;DDIT4;SHC2;SYNGAP1;ITGA6;DGKQ;MAML3;TMEM173;PLEKHG5;FAM110C;MAGEF1;SHC1;SPRY2;GRB7;NPHP4;VEGFB;ADM2;RAB3B;NLGN2;APPL2;CAPRIN2;PRKCZ;SERPING1;PAK1;ABCA7;MCTP1;STK39;PEAR1;FGFR3;SEMA3F;SPRY4;FAM3A;USP20;ZSWIM4;ZP3;NEURL1;ACVR2B;RAG1;SPPL2B;NGFR;GSTO1;ARHGEF4;LTBP1;MUC19;WNT2B;NSMCE4A;TRIB2;PLXNB1;EREG;PTPRE;RMI2;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;DNMBP;ERMAP;MANF;LPAR3;S100A13;AGAP1;MTMR4;C5;APOBEC3F;PPARA;CHD3;ANO1;CHAC1;FNDC4;SESN2;AIP;RASA4;IMPACT;NLRX1;PKD2;STAT6;SH3TC2;HMGA2;AREG;SLIT3;ECM1;MAPK3;CSPG4;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;STK40;VANGL2;SH2D2A;RGS14;FAM20C;RHOF;CTSB;MVB12B;SRGAP3;ARHGAP22;PLEKHG4;IFNGR2;TCTN1;C1RL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;STMN3;LRSAM1;DMTN;KLHL24;LITAF;SEMA3B;PTHLH;ATF4;BBC3;PAK6;SSH1;ACAP3;IFI6;NSMCE1;RALGAPA1;FLOT1;MDK;UNC5B;SORL1;HERPUD1;GSTM2;SULF2;NLRP1;ENDOG;EGFL7;MAP3K12;NEK8;RHBDF1;LRP5;CREBRF;PCSK9;L3MBTL1;FBXL15;MARK3;TGFBR2;TRPV4;FOXL1;ARHGAP25;IQSEC2;ITGA1;CMTM7;PSD4;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;EDA;CDK5RAP3;NOS3;MINK1;LDOC1;WNT7A;PIK3R2;EPHA1;RHBDF2;SEMA4G;SHARPIN;GAS6;ERN1;NUDT6;LZTS2;PLEKHG3;BCR;NBR1;TERC;PTAFR;PPP1R15A;ATP2B4;THNSL2;STRADB;CTSH;UACA;MGMT;C12ORF66;PLEKHG6;MAPKBP1;AKT1;CARD11;CDKN1C;CRY2;CHEK2;HMSD;IGFBP2;TNNT1;TSG101;IL17RC;FGFR4;TMOD2;ASAP3;FARP1;LMNA;SH2B3;C9ORF72;PLAU;INSR;WNT3;NCOA7;CKLF;YPEL3;RPS6KA5;ULBP1;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;BTN3A2;PIDD1;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;JAK3;TP73;MNT;MIB2;ICAM5;CSNK1E;BTN3A3;BCL6;RNF213;ADAP1;TKFC;EPS8L1;FYN;PJA2;LEMD2;ARHGEF17;SIRT2;GDF15;SPRED3;PHLDA2;RECQL5;ADA;TMEM101;CIDEA;EPS8L2;ADIRF;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;LAMTOR2;MAP3K10;MFNG;STARD10;LURAP1;EPHB2;PER1;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;EIF2AK4;PAG1;RGS12;SYVN1;HLA-G;CORO1B;NET1;GRB10;TNNI1;KCTD11;KCTD13;IKBKB;HIP1
4381,GO:0010038,0.00571879993818163,0.996710428592631,39,216,response to metal ion,BP,NFATC4;FOS;GSN;EGFR;D2HGDH;PRNP;ERCC1;ANK3;NDRG1;ADAMTS13;UROS;CYBRD1;ITPR3;CARF;S100A13;RASA4;PKD2;MAPK3;BNIP3;DMTN;ATF4;TTN;KCNMA1;ENDOG;AQP3;DNMT3A;MAP1LC3A;ATP7B;SPAG16;CYP2R1;ENTPD6;AKT1;IGFBP2;BRAF;CAT;HFE;TRPC1;BSG;SNCB
16711,GO:0097755,0.00576316833415344,0.998334595975943,10,35,positive regulation of blood vessel diameter,BP,DOCK4;BBS2;APOE;EGFR;NOS1;PLA2G6;ITGA1;APLN;NOS3;PTAFR
10566,GO:0043547,0.00585976782214225,0.996360228738964,51,301,positive regulation of GTPase activity,BP,DOCK4;F2R;EVI5L;CDC42EP5;RAPGEF3;ARAP3;TBC1D8;ARHGEF19;RIN1;ARAP1;ARHGAP23;ASAP2;SYNGAP1;ITGA6;SNX9;PLXNB1;DNMBP;RINL;AGAP1;ALS2CL;RASA4;ERRFI1;DOCK9;RGS14;SRGAP3;ARHGAP22;PLEKHG4;TBC1D14;DOCK11;TBC1D3E;RABGAP1;ACAP3;RALGAPA1;RIN2;ARHGAP25;PIK3R2;EPHA1;BCR;PLEKHG6;ASAP3;SGSM2;TBC1D20;ARHGAP27;ARHGAP44;ADAP1;VAV3;TBC1D16;ERBB2;RGS12;C15ORF62;NET1
8992,GO:0035150,0.00588372025782169,0.99765693895928,16,69,regulation of tube size,BP,DOCK4;BBS2;F2R;APOE;EGFR;NOS1;HTR7;PLA2G6;ITGA1;APLN;NOS3;PTAFR;ADCY6;AKT1;CHRM3;EDNRA
12649,GO:0050880,0.00588372025782169,0.99765693895928,16,69,regulation of blood vessel size,BP,DOCK4;BBS2;F2R;APOE;EGFR;NOS1;HTR7;PLA2G6;ITGA1;APLN;NOS3;PTAFR;ADCY6;AKT1;CHRM3;EDNRA
13159,GO:0051790,0.00590221947375741,0.999810314804494,3,4,short-chain fatty acid biosynthetic process,BP,ACSS2;THNSL2;ACSS1
3502,GO:0007411,0.0059114126097042,0.996802895698395,32,170,axon guidance,BP,SEMA4B;VEGFA;SPTB;EFNB3;RNF165;SHC1;GRB7;SEMA3F;PLXNB3;ZSWIM4;ETV1;NGFR;PLXNB1;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SEMA3B;UNC5B;VLDLR;ROBO3;SEMA4G;WNT3;RPS6KA5;FYN;PLXND1;EPHB2;ERBB2;GRB10
13123,GO:0051716,0.00596169254548078,0.99494325251145,595,4659,cellular response to stimulus,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;HTRA1;DOCK4;BBS2;F2R;TNFRSF6B;APOE;ZMYND8;NFATC4;XPC;SERPINE2;S100A6;FOS;PRODH;IL20RB;GSN;ADGRL1;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;WIPF1;FBXO2;DDIT4L;PTK6;TMEM129;CDC42EP5;WWC3;EDEM1;GLUL;FAM210B;GPX3;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;DDB2;RHPN1;PRNP;FCGRT;NR1D1;ERCC1;FBLN1;ADAMTS7;S100A4;PRDX5;ANK3;TFPI2;DUSP5;IFT140;RAPGEF3;BPHL;CLTCL1;TNFSF15;SPTB;DGKA;TSPAN1;IGFBP4;CD9;CST3;DNM1;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;ARHGEF19;MMP28;MST1R;ARRDC1;HEBP1;EFS;ZFP36L1;NUPR1;RIN1;ARAP1;HBEGF;RBL2;RGL2;RPS6KA2;ARHGAP23;MMP1;PYCR2;CTF1;CNTN1;CYP3A5;TFDP2;EFNB3;RPL13A;MDFI;EVC;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;KLF9;RNF165;NISCH;ASAP2;FBXW4;ASH2L;CUL7;EPM2A;UROS;HYAL1;NXPH4;SMOC2;PPP1R14A;TXNRD3;WWTR1;SYNGR1;SMOC1;POLD4;GIGYF1;MAP2K1;CYP27B1;PCK2;COL6A1;PKN1;MC1R;DDIT4;TOM1L2;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;DGKQ;AKR7A2;MAML3;TMEM173;PLEKHG5;FAM213A;FAM110C;MAGEF1;ULK1;SHC1;SPRY2;GRB7;NPHP4;VEGFB;ADM2;RAB3B;NLGN2;CD68;PLEKHH3;ITPR3;LAMA5;RALGDS;PITPNC1;APPL2;CAPRIN2;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;MCTP1;ELK3;STK39;PEAR1;FGFR3;KDM3A;PHF1;GLDC;NPR2;SEMA3F;PLXNB3;CBS;SPRY4;USP20;SALL2;DOCK6;ITGB4;ZP3;NEIL1;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;ETV5;GSTO1;ARHGEF4;LTBP1;MUC19;WNT2B;NSMCE4A;TRIB2;PLXNB1;EREG;CHD2;PTPRE;RMI2;PLCD3;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;CES3;ABCG1;DNMBP;CARF;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;MTMR4;C5;PPARA;INO80C;CHD3;ANO1;CHAC1;SESN2;AIP;MKNK2;RASA4;IMPACT;IFT27;NLRX1;PKD2;STAT6;SH3TC2;ING4;ACOT11;VAMP2;HMGA2;AREG;SLIT3;ECM1;PCLO;PI4KAP1;MAPK3;CSPG4;ITGB5;LAMB2;BNIP3;ERRFI1;MACROD1;SEMA5A;THRA;IFITM1;STK40;VANGL2;DOCK9;SH2D2A;RGS14;FAM20C;MYZAP;RHOF;PLEK2;LTBP2;CTSB;MAPK12;MVB12B;NYAP1;SRGAP3;PAQR6;SDC2;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TCTN1;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;TWF2;SAMD3;STMN3;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;SEMA3B;PTHLH;UBXN4;ATF4;BBC3;PAK6;DOCK11;SSH1;LTB4R2;PRIMPOL;GPR153;POLM;ACAP3;TENM2;FBXO6;IFI6;ZNF516;PKD1;NSMCE1;RALGAPA1;FLOT1;MDK;TTN;PSKH1;UNC5B;HDAC5;GTPBP1;IRF5;SORL1;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;ADGRF1;GPRC5C;GABBR1;SULF2;ROBO3;CES2;NLRP1;ACY1;RFX2;ENDOG;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;RIN2;CREBRF;PCSK9;L3MBTL1;PKN3;FBXL15;AQP3;ISG20;MARK3;DNMT3A;TGFBR2;TRPV4;FOXL1;ARHGAP25;IQSEC2;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;MAP1LC3A;PDE2A;SMURF2;APLN;TRIB3;RAB40B;DAP;MLH3;CALCOCO1;EDA;CDK5RAP3;NOS3;AGO4;MINK1;LDOC1;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;SHARPIN;CCS;GAS6;ERN1;NUDT6;LZTS2;ALKBH7;PLEKHG3;BCR;NBR1;BCAM;TADA3;KIF13B;SPAG16;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ADCY6;RAB43;ATP2B4;THNSL2;STRADB;CTSH;TNFRSF14;WDR19;UACA;MGMT;GSTO2;ASNS;C12ORF66;PLEKHG6;MAPKBP1;AKT1;IGFBP7;ITPR2;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;IFT57;IGFBP2;ASS1;CAPS;TSG101;IL17RC;FGFR4;RASSF9;ZNF217;TMOD2;TCIRG1;ASAP3;ACADVL;FARP1;LMNA;UPP1;SH2B3;C9ORF72;CAPN2;SPATA18;ARHGAP27;RAB25;IFI27;PLAU;INSR;WNT3;KRT19;NCOA7;TENM4;CKLF;FOXO4;GNAL;YPEL3;RPS6KA5;ANKZF1;LTB4R;TXNRD2;ITGB6;HOMER2;LYST;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;BTN3A2;ASIC1;FAAP20;PIDD1;CAT;MYOF;MAPK10;MPG;LGALS1;TIMP1;HFE;JAK3;MRGPRX3;TP73;MNT;FRAT1;CHRM3;APRT;TMX4;MIB2;SNX17;ENDOV;CSNK1E;BTN3A3;BCL6;REPS2;HSF4;REC8;RNF213;GSTM3;ADAP1;TKFC;EPS8L1;FYN;MAST4;PJA2;SLC38A2;LEMD2;UBXN6;ARHGEF17;SIRT2;GDF15;SPRED3;PHLDA2;RECQL5;RAB13;CELSR1;ADA;PLXND1;RHOBTB3;MTA1;TMEM101;MSH5;ENTPD2;AP2A2;CIDEA;EPS8L2;HDAC8;ADIRF;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;MAN1B1;STX1A;EPAS1;LAMTOR2;MAP3K10;MFNG;STARD10;EDNRA;CHD6;LURAP1;EPHB2;MAGI1;INPP4A;PER1;LRCH4;MCTP2;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;EIF2AK4;STK32B;UNC119;PAG1;RGS12;SYVN1;C15ORF62;HLA-G;CORO1B;FRS3;NET1;GRB10;CREB3L4;KCTD11;BSG;KCTD13;PEX11A;CAMKK1;DTX3;IKBKB;HIP1;TEAD2;BTBD11
5599,GO:0016645,0.00597337008387919,0.998765147407549,7,20,oxidoreductase activity, acting on the CH-NH group of donors,MF,PRODH;PYCR2;ALDH4A1;BLVRB;MTHFR;ALDH1L2;ALDH1L1
3174,GO:0006790,0.0060031682362009,0.996363375512265,46,271,sulfur compound metabolic process,BP,GAMT;ACSF2;GGT1;B3GAT3;MLYCD;HMGCL;HYAL1;OPLAH;MTHFR;CBS;ABHD14B;GSTO1;GSTT1;ACOT1;CHAC1;BLMH;ACOT11;B4GAT1;ACACB;CSPG4;PC;ACSS2;MVD;CHST6;HLCS;GSTM2;ST3GAL3;ACOT7;TSTD1;PEMT;HEXB;SUCLG2;HEXA;GSTO2;MICAL1;B4GALT2;NFU1;HAGH;CBR4;ACSS1;GSTM3;GALNS;CTH;XYLT2;UST;ACOT8
9562,GO:0036379,0.00601345306075736,0.999080004131649,6,12,myofilament,CC,TPM2;TTN;TNNI2;TNNT1;TMOD2;TNNI1
717,GO:0001944,0.00604459250849884,0.995928873327243,72,453,vasculature development,BP,XDH;ACTA2;APOE;NFATC4;EGR1;PGF;LRP1;PDCD4;VEGFA;RAPGEF3;LOXL1;DDIT3;ADGRB2;ZFP36L1;CUL7;HYAL1;MAP2K1;BTG1;SHC1;SPRY2;VEGFB;ADM2;LAMA5;ELK3;FBXW8;ACVR2B;NGFR;LTBP1;EREG;PLCD3;C5;PKD2;HMGA2;COL8A1;ECM1;CSPG4;ERRFI1;SEMA5A;SH2D2A;ARHGAP22;PLCD1;ANGPTL4;PKD1;UNC5B;HDAC5;EGFL7;LRP5;TGFBR2;APLN;NOS3;WNT7A;EPHA1;CTSH;AKT1;FMNL3;FGFR4;FOXO4;MAP2K5;SNX17;RNF213;PLXND1;TGFBR3;VAV3;EPAS1;EDNRA;EPHB2;FGFR1;CTH;ERBB2;MMP19;ROBO4;TEAD2
16127,GO:0090170,0.00604908177532687,0.999803780661367,3,4,regulation of Golgi inheritance,BP,MAP2K1;MAPK3;MAP2K2
9257,GO:0035694,0.006063287636158,0.999803145301211,3,4,mitochondrial protein catabolic process,BP,BNIP3;BNIP3L;SPATA18
8821,GO:0034618,0.0061866653352764,0.999797602801599,3,4,arginine binding,MF,NAGS;NOS1;NOS3
4029,GO:0009065,0.00624145467086032,0.998698658450898,7,20,glutamine family amino acid catabolic process,BP,PRODH;GLUL;NOS1;ALDH4A1;NOS3;GLUD1;ATP2B4
7638,GO:0032058,0.00624380487114805,0.999795021176534,3,4,positive regulation of translational initiation in response to stress,BP,IMPACT;PPP1R15A;EIF2AK4
9457,GO:0036091,0.00624633595726642,0.999794906604648,3,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2;ATF4;CHD6
3454,GO:0007269,0.00625204350420773,0.997409463802978,17,75,neurotransmitter secretion,BP,SYTL1;SNPH;BRSK1;SYT8;MCTP1;VAMP2;SEPT5;PCLO;KCNC4;WNT7A;RIMS3;SLC6A9;BRAF;ASIC1;STX1A;APBA1;PNKD
17076,GO:0099643,0.00625204350420773,0.997409463802978,17,75,signal release from synapse,BP,SYTL1;SNPH;BRSK1;SYT8;MCTP1;VAMP2;SEPT5;PCLO;KCNC4;WNT7A;RIMS3;SLC6A9;BRAF;ASIC1;STX1A;APBA1;PNKD
4469,GO:0010469,0.00626329438776145,0.996398687877937,38,216,regulation of signaling receptor activity,BP,DLG4;PGF;VEGFA;TNFSF15;SHANK2;HBEGF;CTF1;SHC1;VEGFB;ADM2;NLGN2;ZP3;NEURL1;EREG;MANF;AREG;ERRFI1;KLHL24;PTHLH;MDK;PCSK9;CMTM7;APLN;MINK1;LDOC1;WNT7A;GAS6;NUDT6;THNSL2;TSG101;PLAU;WNT3;CKLF;TIMP1;HFE;GDF15;PHLDA2;EPHB2
10249,GO:0043005,0.00627871891410093,0.995414780035833,112,753,neuron projection,CC,PTPRS;DLG4;DOCK4;BBS2;APOE;ESPN;ZMYND8;FOS;ADGRL1;FBXO2;GLUL;GJC2;LRP1;TIMP2;NTSR1;PRNP;SCN8A;NR1D1;S100A4;ANK3;IFT140;SNPH;CST3;DNM1;NOS1;SHANK2;CRTC1;SYNGR1;SYNGAP1;ULK1;NPHP4;BLOC1S4;PRKCZ;HTR7;PAK1;PRR7;BLVRB;ORAI2;DLG3;MICALL2;NEURL1;NGFR;SPG11;PSPH;LPAR3;KIF17;VAMP2;SEPT5;KCNC4;KCNAB2;BNIP3;RGS14;PI4K2A;ARHGEF2;TWF2;STMN3;KIF21B;KLHL24;MORN4;ATF4;SSH1;SV2A;TENM2;REEP6;ATXN10;AZIN2;MAP6;GABBR1;ROBO3;MAP3K12;TRIOBP;TRPV4;ITGA1;MINK1;TRPV1;EPHA1;SHARPIN;CPT1C;KIF13B;ATP2B4;SPATA7;WDR19;MICAL1;IFT57;SEPT6;TMOD2;PIAS3;FARP1;C9ORF72;CAPN2;MARK4;INSR;TENM4;HOMER2;BRAF;ARHGAP44;MAPK10;CHRM3;FYN;SLC38A2;SIRT2;RAB13;MPDZ;ADA;EPS8L2;STX1A;EPHB2;ITGA2;WFS1;BLOC1S1;RGS12;APBA1
11599,GO:0046322,0.00629301010410023,0.999792790602521,3,4,negative regulation of fatty acid oxidation,BP,ACACB;AKT1;ACADVL
18540,GO:1903795,0.00630093966609048,0.999792430498146,3,4,regulation of inorganic anion transmembrane transport,BP,PRNP;ANO9;PTAFR
3943,GO:0008645,0.00632287350837279,0.997461800296418,16,69,hexose transmembrane transport,BP,SLC2A3;CLTCL1;SLC2A9;PRKCZ;PAK1;NGFR;SESN2;SLC50A1;TRIB3;PIK3R2;AKT1;INSR;BRAF;RTN2;EDNRA;GRB10
6672,GO:0030042,0.00634889690126533,0.998138234998793,10,35,actin filament depolymerization,BP,GSN;SPTB;CAPG;SEMA5A;TWF2;DMTN;TRIOBP;MICAL1;TMOD2;PLEKHH2
1979,GO:0004702,0.00639979952959792,0.99718743600873,19,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,EGFR;MST1R;MAPK13;FGFR3;ACVR2B;MAPK3;MAPK12;MAP3K12;TGFBR2;MINK1;EPHA1;FGFR4;INSR;BRAF;MAPK10;MAP3K10;EPHB2;FGFR1;ERBB2
12841,GO:0051186,0.00642427980398766,0.995722771043127,67,425,cofactor metabolic process,BP,H6PD;GAMT;NT5E;ACSF2;SLC2A3;NAPRT;GPX3;EGFR;D2HGDH;PRDX5;IDH2;PGM1;GGT1;DHTKD1;MLYCD;PRSS3;HMGCL;UROS;PCK2;PGLS;DDIT4;OPLAH;AKR7A2;OGDHL;NMRK1;PHYH;BLVRB;MTHFR;NMNAT2;GSTO1;PPCS;GPT2;PSAT1;GSTT1;ACOT1;PPARA;CHAC1;ACOT11;ACACB;KCNAB2;PC;ACSS2;MVD;MLXIPL;HLCS;GALK1;GSTM2;NADK;ACOT7;ALDOC;MOCOS;ALDH1L2;PEMT;NOS3;SUCLG2;GSTO2;AKT1;NFU1;HAGH;CBR4;INSR;ACSS1;ALDH1L1;CAT;GSTM3;PFKL;ACOT8
5926,GO:0018209,0.00642873378297079,0.996242998099429,40,226,peptidyl-serine modification,BP,VEGFA;EGFR;RAPGEF3;MAPK13;PKN1;DDIT4;DGKQ;ULK1;SPRY2;CAPRIN2;TTBK2;PRKCZ;PAK1;STK39;MKNK2;HMGA2;MAPK3;MAPK12;MLXIPL;MAP2K2;DMTN;PKD1;PSKH1;MAP3K12;PKN3;TGFBR2;GAS6;ERN1;CAMK1;ATP2B4;AKT1;CHEK2;RPS6KA5;BRAF;CSNK1E;MAST4;MAP3K10;STK32B;CAMKK1;IKBKB
10885,GO:0044448,0.00644477149552632,0.996798277003872,25,125,cell cortex part,CC,DLG4;GSN;WIPF1;RAPGEF3;SPTB;EXOC2;PRKCZ;SHROOM4;PKD2;SEPT5;PCLO;MYZAP;SEPT10;DMTN;FLOT1;TRIOBP;TRPV4;RIMS3;SEPT6;CAPN2;KRT19;HFE;SEPT8;HIP1;PLEKHH2
5446,GO:0016323,0.00644911404592017,0.996795936521866,25,125,basolateral plasma membrane,CC,DLG4;LRP1;EGFR;SLC7A8;ANK3;SLC2A9;CLCA2;MST1R;ITGA6;STK39;DLG3;SHROOM4;PKD2;VANGL2;PKD1;FLOT1;AQP3;PROM2;ATP7B;ATP2B4;CHRM3;ATP12A;LRCH4;ERBB2;OSCP1
3269,GO:0006949,0.00645257707842979,0.998261639977376,9,30,syncytium formation,BP,ERCC1;RAPGEF3;NOS1;FLOT1;CAMK1;CAPN2;MYOF;GDF15;SH3PXD2A
19430,GO:1990138,0.00645690724415009,0.996901085948972,23,112,neuron projection extension,BP,PTPRS;APOE;POSTN;SEMA4B;VEGFA;ULK2;ULK1;PRKCZ;PAK1;SEMA3F;PLXNB3;PLXNB1;SPG11;IMPACT;SLIT3;LAMB2;SEMA5A;TWF2;SEMA3B;SEMA4G;C9ORF72;WNT3;EIF2AK4
7843,GO:0032412,0.00645793329993585,0.996789414329785,25,126,regulation of ion transmembrane transporter activity,BP,DLG4;KCNG1;FHL1;NTSR1;PRNP;ANK3;NOS1;SHANK2;SCN4B;NLGN2;STK39;GSTO1;PLA2G6;PKD2;VAMP2;KLHL24;GSTM2;WNK4;PCSK9;TMSB4X;ANO9;MINK1;PTAFR;EHD3;EPHB2
16601,GO:0097485,0.00646252549156683,0.996480815540905,32,171,neuron projection guidance,BP,SEMA4B;VEGFA;SPTB;EFNB3;RNF165;SHC1;GRB7;SEMA3F;PLXNB3;ZSWIM4;ETV1;NGFR;PLXNB1;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SEMA3B;UNC5B;VLDLR;ROBO3;SEMA4G;WNT3;RPS6KA5;FYN;PLXND1;EPHB2;ERBB2;GRB10
8943,GO:0035021,0.00646773820843327,0.999784814718616,3,4,negative regulation of Rac protein signal transduction,BP,ARAP3;STMN3;ARHGAP44
12302,GO:0048675,0.00650475155382601,0.997136641472362,19,87,axon extension,BP,PTPRS;APOE;SEMA4B;VEGFA;ULK2;ULK1;PAK1;SEMA3F;PLXNB3;PLXNB1;SPG11;SLIT3;LAMB2;SEMA5A;TWF2;SEMA3B;SEMA4G;C9ORF72;WNT3
16880,GO:0098869,0.00653231109986775,0.997551514864594,14,60,cellular oxidant detoxification,BP,APOE;GPX3;PRDX5;TXNRD3;FAM213A;GSTO1;GSTT1;SESN2;GSTM2;NOS3;CCS;GSTO2;TXNRD2;CAT
10864,GO:0044420,0.00661373443131925,0.997160603293369,18,81,extracellular matrix component,CC,THSD4;FBLN1;LOXL1;CST3;SMOC2;SMOC1;ITGA6;LAMA5;NID1;LTBP1;COL8A1;LAMB2;COL4A6;EFEMP2;LAMB1;TNXB;TIMP1;ENTPD2
15257,GO:0071466,0.00665741351942633,0.99691509302307,21,102,cellular response to xenobiotic stimulus,BP,EGR1;EGFR;BPHL;GGT1;CYP3A5;PCK2;DDIT4;AKR7A2;GSTO1;CES3;AIP;ERRFI1;GSTM2;CES2;ACY1;PDE2A;CYP2R1;GSTO2;CHEK2;GSTM3;EIF4EBP1
505,GO:0001568,0.00676946630688657,0.995455847212909,69,433,blood vessel development,BP,XDH;ACTA2;APOE;NFATC4;EGR1;PGF;LRP1;VEGFA;RAPGEF3;LOXL1;DDIT3;ADGRB2;ZFP36L1;CUL7;HYAL1;MAP2K1;BTG1;SHC1;SPRY2;VEGFB;ADM2;LAMA5;ELK3;FBXW8;ACVR2B;NGFR;LTBP1;EREG;PLCD3;C5;PKD2;HMGA2;COL8A1;ECM1;CSPG4;SEMA5A;SH2D2A;ARHGAP22;PLCD1;ANGPTL4;PKD1;UNC5B;HDAC5;EGFL7;LRP5;TGFBR2;APLN;NOS3;WNT7A;EPHA1;CTSH;AKT1;FMNL3;FGFR4;FOXO4;MAP2K5;SNX17;RNF213;PLXND1;TGFBR3;VAV3;EPAS1;EDNRA;EPHB2;FGFR1;ERBB2;MMP19;ROBO4;TEAD2
16641,GO:0097553,0.00683652902278102,0.997227425857927,16,70,calcium ion transmembrane import into cytosol,BP,F2R;NTSR1;PRNP;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PKD2;GSTM2;TRPV1;ATP2B4;ITPR2;TPCN1;FYN;TRPC1
12704,GO:0050982,0.00687121480072519,0.998917008273188,6,12,detection of mechanical stimulus,BP,SERPINE2;PKD2;PKD1;TTN;FYN;ITGA2
15117,GO:0071243,0.00692001060617994,0.998761261419711,6,16,cellular response to arsenic-containing substance,BP,MAPK13;UROS;GSTO1;MKNK2;ATF4;GSTO2
3262,GO:0006935,0.00703070910094601,0.99544590731266,58,358,chemotaxis,BP,DOCK4;PGF;SEMA4B;VEGFA;SPTB;MMP28;HBEGF;EFNB3;RNF165;MAP2K1;PLEKHG5;SHC1;GRB7;VEGFB;SEMA3F;PLXNB3;ZSWIM4;ETV1;NGFR;PLXNB1;PLA2G6;C5;PLGRKT;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SEMA3B;LTB4R2;UNC5B;VLDLR;ROBO3;TRPV4;ITGA1;CMTM7;TMSB4X;SEMA4G;GAS6;PTAFR;IL17RC;PLAU;WNT3;CKLF;RPS6KA5;LYST;FYN;RAB13;PLXND1;VAV3;EPHB2;ITGA2;FGFR1;ERBB2;CORO1B;GRB10
9945,GO:0042330,0.00703070910094601,0.99544590731266,58,358,taxis,BP,DOCK4;PGF;SEMA4B;VEGFA;SPTB;MMP28;HBEGF;EFNB3;RNF165;MAP2K1;PLEKHG5;SHC1;GRB7;VEGFB;SEMA3F;PLXNB3;ZSWIM4;ETV1;NGFR;PLXNB1;PLA2G6;C5;PLGRKT;KLF7;SLIT3;B4GAT1;MAPK3;LAMB2;SEMA5A;VANGL2;SEMA3B;LTB4R2;UNC5B;VLDLR;ROBO3;TRPV4;ITGA1;CMTM7;TMSB4X;SEMA4G;GAS6;PTAFR;IL17RC;PLAU;WNT3;CKLF;RPS6KA5;LYST;FYN;RAB13;PLXND1;VAV3;EPHB2;ITGA2;FGFR1;ERBB2;CORO1B;GRB10
4781,GO:0010975,0.00709587036593975,0.995499970357095,53,319,regulation of neuron projection development,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;PTK6;SEMA4B;LRP1;VEGFA;SHANK2;CRTC1;CNTN1;EFNB3;OBSL1;ULK2;CUL7;MAP2K1;SYNGAP1;CAPRIN2;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;NEURL1;NGFR;PLXNB1;SSH3;LPAR3;SEMA5A;SDC2;TWF2;SEMA3B;SSH1;METRN;VLDLR;TRPV4;WNT7A;SEMA4G;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;WNT3;BRAF;ARHGAP44;LGALS1;FYN;PLXND1;EPHB2;FGFR1;UST
13365,GO:0052689,0.00709803437519969,0.99684167298886,19,89,carboxylic ester hydrolase activity,MF,H6PD;BPHL;PGLS;NLGN2;AARS;PNPLA3;PLA2G6;CES3;ACOT1;ACOT11;CES2;ACOT7;FAAH;PNPLA4;PLB1;LYPLAL1;TMEM8A;DTD1;ACOT8
10711,GO:0044070,0.00709820324515124,0.997570742942981,12,47,regulation of anion transport,BP,APOE;NTSR1;PRNP;ABCA7;STK39;PLA2G6;SV2A;ANO9;PTAFR;AKT1;CRY2;FGFR1
16942,GO:0098984,0.00718052019491097,0.996190644442097,29,152,neuron to neuron synapse,CC,PTPRS;DLG4;NTSR1;PRNP;DNM1;NOS1;SHANK2;SYNGAP1;NLGN2;DLG3;NEURL1;PCLO;KCNAB2;BNIP3;RGS14;ARHGEF2;DMTN;MINK1;SHARPIN;DNAJC6;BCR;ADD3;HOMER2;ARHGAP44;CHRM3;FYN;PJA2;MPDZ;STX1A
10786,GO:0044283,0.00720686778131317,0.994967856536214,83,543,small molecule biosynthetic process,BP,XDH;GAMT;NT5E;ISYNA1;APOE;EGR1;GLUL;ALOX15B;NAGS;NTSR1;NR1D1;RAPGEF3;DNPH1;PGM1;GGT1;PHGDH;PYCR2;DHTKD1;TK2;MLYCD;HMGCL;UROS;HYAL1;CYP27B1;PCK2;DDIT4;DGKQ;OGDHL;SEC14L2;CEMIP;KDM3A;CBS;NME4;NEIL1;GPT2;PSAT1;PSPH;ABCG1;PPARA;ACACB;NT5C1B;CSPG4;PC;ACSS2;MVD;LTA4H;MLXIPL;SRD5A3;ATF4;GALK1;PLTP;ACOT7;ALDOC;HSD17B7;PDE2A;TRIB3;GLUD1;SRR;UCKL1;PTAFR;CYP2R1;ATP2B4;THNSL2;ASNS;TM7SF2;ASS1;FGFR4;CBR4;ACADVL;UPP1;INSR;ACSS1;APRT;SLC37A4;OSBPL1A;ADA;ENTPD2;PLPP6;CTH;UST;PFKL;NUDT18;ACOT8
16783,GO:0098657,0.00725012458100909,0.994995969004155,78,502,import into cell,BP,DLG4;APOE;GSN;WIPF1;GLUL;LRP1;VEGFA;NTSR1;PRNP;CLTCL1;FCHO1;TSPAN1;CD9;DNM1;NOS1;ARAP3;MRC2;SYT8;RIN1;SNX9;RAB3B;NLGN2;PAK1;ABCA7;MCTP1;PEAR1;USP20;ELMO3;SPG11;PLA2G6;ESYT2;RINL;SCART1;STON1;MAPK3;SCARA3;HOOK2;LRSAM1;FLOT1;SORL1;VLDLR;TMEM175;LRP5;RIN2;PCSK9;TGFBR2;ARHGAP25;APLN;PROM2;TRPV1;MARCH2;PIK3R2;GAS6;DNAJC6;BCR;ATP2B4;STEAP2;TSG101;STEAP3;C9ORF72;ARHGAP27;HFE;SNX33;SNX17;ICAM5;CSNK1E;SLC9A7;FYN;SNX1;TOM1;RHOBTB3;AP2A2;MYO18A;VAV3;ITGA2;UNC119;HIP1;SLC9A5
5182,GO:0015749,0.00731820085101581,0.997009270817927,16,70,monosaccharide transmembrane transport,BP,SLC2A3;CLTCL1;SLC2A9;PRKCZ;PAK1;NGFR;SESN2;SLC50A1;TRIB3;PIK3R2;AKT1;INSR;BRAF;RTN2;EDNRA;GRB10
11723,GO:0046580,0.00735755171742588,0.997622247607667,11,41,negative regulation of Ras protein signal transduction,BP,TIMP2;ARAP3;SYNGAP1;SPRY2;SPRY4;RASA4;STMN3;ARHGAP44;BCL6;EPHB2;KCTD13
17700,GO:1901657,0.00737019583678959,0.996411434115172,23,116,glycosyl compound metabolic process,BP,DLG4;GAMT;NT5E;TK2;AKR7A2;APOBEC3C;DLG3;NME4;APOBEC3F;MACROD1;FUCA1;GTPBP1;MOCOS;PEMT;UCKL1;CARD11;DGUOK;CBR4;UPP1;APRT;ADA;NAGA;NUDT18
3387,GO:0007167,0.00741775626963131,0.994619530690865,103,689,enzyme linked receptor protein signaling pathway,BP,XDH;DUSP6;HTRA1;FOS;EGR1;PGF;FGFBP1;PTK6;LRP1;PDCD4;VEGFA;EGFR;IGFBP4;DNM1;MST1R;EFS;ARAP1;HBEGF;CTF1;EFNB3;PLAT;LTBP4;MAPK13;RNF165;WWTR1;GIGYF1;DDIT4;SHC2;DGKQ;SHC1;SPRY2;GRB7;VEGFB;PRKCZ;PAK1;FGFR3;NPR2;SPRY4;NEURL1;ACVR2B;NGFR;LTBP1;EREG;PTPRE;MTMR4;SH3TC2;AREG;MAPK3;CSPG4;ITGB5;ERRFI1;SH2D2A;RGS14;FAM20C;LTBP2;MAPK12;MVB12B;SDC2;SULF2;RHBDF1;PTPRU;FBXL15;TGFBR2;ITGA1;SMURF2;APLN;PIK3R2;EPHA1;RHBDF2;GAS6;BCR;AKT1;CDKN1C;IGFBP2;TSG101;FGFR4;TCIRG1;INSR;FOXO4;RPS6KA5;GPR21;MYOF;HFE;JAK3;REPS2;FYN;LEMD2;SIRT2;GDF15;AP2A2;CIDEA;EIF4EBP1;TGFBR3;VAV3;EPHB2;FGFR1;FKBP8;ERBB2;PAG1;FRS3;GRB10;HIP1;BTBD11
2525,GO:0005782,0.00745076064204451,0.997932101360227,9,31,peroxisomal matrix,CC,CRAT;PRDX5;MLYCD;PHYH;LONP2;ACOX3;CAT;PEX7;ACOT8
7556,GO:0031907,0.00745076064204451,0.997932101360227,9,31,microbody lumen,CC,CRAT;PRDX5;MLYCD;PHYH;LONP2;ACOX3;CAT;PEX7;ACOT8
8912,GO:0034767,0.00759874176531647,0.996877000875841,16,71,positive regulation of ion transmembrane transport,BP,F2R;GJC2;NTSR1;ANK3;NOS1;STK39;CEMIP;GSTO1;PKD2;GSTM2;WNK4;TMSB4X;PTAFR;EHD3;TRPC1;EPHB2
2424,GO:0005604,0.00764199530193159,0.996971633299176,15,64,basement membrane,CC,FBLN1;LOXL1;CST3;SMOC2;SMOC1;ITGA6;LAMA5;NID1;COL8A1;LAMB2;COL4A6;EFEMP2;LAMB1;TIMP1;ENTPD2
9888,GO:0042221,0.00766412163970475,0.993616676998107,364,2772,response to chemical,BP,TNIP1;XDH;DUSP6;HTRA1;DOCK4;BBS2;F2R;TNFRSF6B;APOE;NFATC4;XPC;FOS;PRODH;IL20RB;GSN;EGR1;PGF;FGFBP1;POSTN;FBXO2;PTK6;TMEM129;ACP5;EDEM1;GLUL;FAM210B;GPX3;GJC2;SEMA4B;LRP1;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;RBCK1;D2HGDH;PRNP;NR1D1;ERCC1;SLC7A8;ADAMTS7;HADH;PRDX5;ANK3;RAPGEF3;BPHL;TNFSF15;SPTB;LOXL1;CD9;CST3;NOS1;DDIT3;DNAJB5;ERCC6;NDRG1;GGT1;ADAMTS13;MMP28;MST1R;ZFP36L1;NUPR1;HBEGF;MMP1;PYCR2;CTF1;CYP3A5;EFNB3;RPL13A;LTBP4;SLC27A1;MAPK13;KLF9;RNF165;CUL7;HMGCL;UROS;HYAL1;PPP1R14A;TXNRD3;SYNGR1;MAP2K1;CYP27B1;PCK2;COL6A1;ABCA2;DDIT4;BTG1;ITGA6;DGKQ;AKR7A2;TMEM173;PLEKHG5;DNAJC4;FAM213A;SHC1;SPRY2;GRB7;VEGFB;RAB3B;CD68;CYBRD1;ITPR3;LAMA5;PRKCZ;PAK1;STK39;FGFR3;KDM3A;MTHFR;GLDC;NPR2;SEMA3F;PLXNB3;SPRY4;ZSWIM4;ETV1;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;ETV5;GSTO1;LTBP1;PLXNB1;EREG;PTPRE;PSPH;TNFRSF25;PLA2G6;CES3;ABCG1;CARF;MANF;S100A13;GSTT1;MTMR4;C5;PPARA;PLGRKT;ANO1;CHAC1;FNDC4;SESN2;AIP;BLMH;MKNK2;RASA4;IMPACT;PKD2;STAT6;KLF7;VAMP2;HMGA2;AREG;SLIT3;ECM1;B4GAT1;LRP11;ACACB;MAPK3;ITGB5;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;VANGL2;FAM20C;SLC22A18;LTBP2;CTSB;MAPK12;PAQR6;PQLC2;MLXIPL;IFNGR2;ARHGEF2;INPP5D;PDCD1LG2;PRAF2;TSPYL2;MAP2K2;TWF2;DMTN;LITAF;SEMA3B;UBXN4;ATF4;SSH1;LTB4R2;FBXO6;IFI6;FLOT1;MDK;TTN;HLCS;KCNMA1;UNC5B;HDAC5;IRF5;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;SULF2;ROBO3;CES2;NLRP1;ACY1;RFX2;ENDOG;CEBPB;LRP5;PTPRU;CREBRF;PCSK9;FBXL15;AQP3;ISG20;LONP2;DNMT3A;TGFBR2;TRPV4;ITGA1;CMTM7;IL17RE;TMSB4X;MAP1LC3A;PDE2A;SMURF2;APLN;TRIB3;CALCOCO1;PEMT;EDA;CDK5RAP3;NOS3;AGO4;WNT7A;HERPUD2;TRPV1;BNIP3L;PIK3R2;SEMA4G;SHARPIN;CCS;GAS6;ERN1;BCR;ATP7B;SRR;TADA3;SPAG16;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ADCY6;RAB43;ATP2B4;CTSH;TNFRSF14;MGMT;GSTO2;ASNS;ENTPD6;STEAP2;AKT1;IGFBP7;ITPR2;CDKN1C;CRY2;CHEK2;IGFBP2;IL17RC;FGFR4;SLC6A9;SNN;PIAS3;TCIRG1;ACADVL;LMNA;CAPN2;IFI27;PLAU;INSR;WNT3;NCOA7;SLC25A29;CKLF;FOXO4;RPS6KA5;ANKZF1;TXNRD2;HOMER2;LYST;MAP2K5;BRAF;EDA2R;GPR21;GJB4;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;JAK3;TP73;CHRM3;APRT;BCL6;GSTM3;FYN;LEMD2;UBXN6;SLC25A42;SIRT2;TRPC1;GDF15;RECQL5;RAB13;ADA;PLXND1;CIDEA;HDAC8;SLC35F3;ADIRF;EIF4EBP1;TGFBR3;TCF7;VAV3;MAN1B1;STX1A;EPAS1;LAMTOR2;CHD6;EPHB2;PER1;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;PFKL;HLA-G;CORO1B;FRS3;NET1;GRB10;CREB3L4;MMP19;BSG;IKBKB;SNCB;TEAD2
96,GO:0000187,0.00775048537975351,0.996356342444597,21,102,activation of MAPK activity,BP,DUSP6;DUSP5;ERCC6;MAP2K1;PKN1;SHC2;SHC1;STK39;LPAR3;C5;MAPK3;CSPG4;MAP2K2;ITGA1;ERN1;INSR;MAP2K5;MAPK10;TP73;AVPI1;MAP3K10
3307,GO:0007010,0.00792781845872932,0.993962206732831,142,982,cytoskeleton organization,BP,BBS2;APOE;ESPN;GSN;WIPF1;CDC42EP5;LRP1;OBSCN;ANK3;RAPGEF3;SPTB;KRT15;NINL;PARVB;ARAP3;BRSK1;ARHGEF19;EFS;CUL9;ARAP1;MSRB2;OBSL1;NISCH;CUL7;ARPIN;PPL;SDCCAG8;CAPG;EML2;TUBG2;DNAH1;ARL2;SHC1;SPRY2;NPHP4;MYH11;LAMA5;TPM2;TTBK2;PRKCZ;PAK1;SYNE3;MICALL2;CEP250;SHROOM4;NEURL1;CCDC88B;PLXNB1;SSH3;PLEKHG2;RHOBTB2;CHD3;PKD2;SEPT5;PCLO;PI4KAP1;MAPK3;ITGB5;SEMA5A;VANGL2;RGS14;RHOF;PLEK2;TUBE1;HOOK2;MYH3;CHMP1B;ARHGEF2;SEPT10;TWF2;STMN3;DMTN;KLHL24;PAK6;SSH1;PKD1;CEP68;TTN;WHAMMP3;MAP6;NDE1;CEP131;MARK3;TRIOBP;TRPV4;ARHGAP25;IQSEC2;TMSB4X;MINK1;TTLL11;EPHA1;FMNL2;CEP126;CROCC;BCR;GOLGA2P5;SPAG16;MICAL1;CHEK2;SEPT6;TNNT1;FMNL3;TMOD2;ASAP3;LMNA;C9ORF72;CHMP5;CAPN2;GOLGA8A;MARK4;KRT19;CHMP4C;TNXB;ADD3;BRAF;ARHGAP44;HAUS4;TUBGCP6;FCHSD1;SPIRE1;BCL6;EPS8L1;MAST4;EML3;ARHGEF17;RAB13;GOLGA2;CELSR1;RHOBTB3;EPS8L2;MYO18A;LURAP1;SEPT8;FITM2;CCDC69;C15ORF62;CORO1B;ZMYM3;KCTD13;IKBKB;HIP1;PLEKHH2
540,GO:0001659,0.00795945286374314,0.998237039618899,7,21,temperature homeostasis,BP,NTSR1;NR1D1;SLC27A1;APLN;TRPV1;ACADVL;CIDEA
4227,GO:0009409,0.00796288838646542,0.997765572942536,9,31,response to cold,BP,FOS;SLC27A1;CIRBP;ACOT11;LRP11;THRA;ZNF516;ACADVL;EIF2AK4
12759,GO:0051058,0.00798492390505372,0.997223182346619,12,47,negative regulation of small GTPase mediated signal transduction,BP,TIMP2;ARAP3;SYNGAP1;SPRY2;SPRY4;RASA4;STMN3;ARHGAP25;ARHGAP44;BCL6;EPHB2;KCTD13
12939,GO:0051345,0.00799108809963857,0.994370983867496,85,558,positive regulation of hydrolase activity,BP,XDH;DOCK4;F2R;GSN;LMF1;EVI5L;CDC42EP5;VEGFA;EGFR;FBLN1;RAPGEF3;TNFSF15;ARAP3;TBC1D8;ARHGEF19;GRAMD4;RIN1;ARAP1;ARHGAP23;ASAP2;SYNGAP1;ITGA6;SNX9;PRKCZ;FGFR3;NGFR;PLXNB1;DNMBP;RINL;AGAP1;ALS2CL;RASA4;MAPK3;ERRFI1;DOCK9;RGS14;DNAL4;MAPK12;SRGAP3;ARHGAP22;PLEKHG4;TBC1D14;BBC3;DOCK11;TBC1D3E;RABGAP1;ACAP3;RALGAPA1;NLRP1;RIN2;ARHGAP25;ITGA1;TMSB4X;DAP;PIK3R2;EPHA1;ERN1;BCR;PTAFR;PPP1R15A;CTSH;PLEKHG6;AKT1;IFT57;ASAP3;SGSM2;TBC1D20;ARHGAP27;IFI27;C6ORF89;ARHGAP44;PIDD1;ADAP1;FYN;CIDEB;VAV3;TBC1D16;EDNRA;ITGA2;FGFR1;ERBB2;RGS12;C15ORF62;NET1;HIP1
11138,GO:0045211,0.00800070288445375,0.99608028651736,23,114,postsynaptic membrane,CC,PTPRS;DLG4;F2R;ANK3;DNM1;SHANK2;COL13A1;NLGN2;PRR7;DLG3;NEURL1;RGS14;TENM2;KCNMA1;GABBR1;MINK1;TRPV1;BCR;HOMER2;CHRM3;PJA2;MPDZ;HIP1
4033,GO:0009069,0.0080224781885176,0.997746071532672,9,31,serine family amino acid metabolic process,BP,GGT1;PHGDH;GLDC;CBS;PSAT1;PSPH;SRR;THNSL2;CTH
17227,GO:0120035,0.00802866537865292,0.994580627937422,68,430,regulation of plasma membrane bounded cell projection organization,BP,PTPRS;DLG4;APOE;ESPN;ZMYND8;NFATC4;EVI5L;PTK6;CDC42EP5;SEMA4B;LRP1;VEGFA;PRNP;IFT140;SHANK2;CRTC1;ARAP1;CNTN1;EFNB3;OBSL1;ULK2;CUL7;ARPIN;MAP2K1;SYNGAP1;CAPRIN2;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;NEURL1;NGFR;PLXNB1;SSH3;LPAR3;SEMA5A;SDC2;TWF2;DMTN;SEMA3B;DOCK11;SSH1;METRN;TENM2;VLDLR;TRPV4;WNT7A;SEMA4G;CROCC;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;WNT3;BRAF;ARHGAP44;LGALS1;EPS8L1;FYN;PLXND1;EPS8L2;EPHB2;FGFR1;UST;C15ORF62;CORO1B
3693,GO:0008202,0.00805197799180415,0.995405780500385,35,197,steroid metabolic process,BP,APOE;OSBPL5;EGR1;LMF1;NR1D1;CYP3A5;HSD17B14;CYP27B1;DGKQ;SEC14L2;DHRS4;ABCG1;ACACB;MVD;SRD5A3;HSD11B1;SORL1;VLDLR;LRP5;PCSK9;HSD17B7;CYP2R1;RXRA;TM7SF2;HINT2;IGFBP7;FGFR4;ACADVL;CAT;SNX17;OSBPL1A;PLPP6;FGFR1;CYP4V2;ACOT8
17531,GO:1901136,0.00807914626958792,0.995899261466491,25,129,carbohydrate derivative catabolic process,BP,NT5E;FBXO2;EDEM1;RAPGEF3;CST3;HYAL1;NAGLU;APOBEC3C;CEMIP;NEIL1;APOBEC3F;CSPG4;SDC2;FBXO6;FUCA1;PDE2A;HEXB;HEXA;UPP1;HGSNAT;ADA;NAGA;MAN1B1;GALNS;NUDT18
7487,GO:0031667,0.00816872427597109,0.99480014411387,52,316,response to nutrient levels,BP,BBS2;APOE;GSN;POSTN;GLUL;EGFR;ERCC1;CST3;DDIT3;ULK2;HMGCL;CYP27B1;PCK2;DGKQ;ULK1;MTHFR;WNT2B;PSPH;PPARA;SESN2;IMPACT;LRP11;ACACB;MAPK3;ATF4;SSH1;HLCS;PCSK9;AQP3;DNMT3A;TGFBR2;TRPV4;MAP1LC3A;DAP;PEMT;TRPV1;GAS6;MGMT;ASNS;C12ORF66;AKT1;IGFBP2;UPP1;FOXO4;CAT;HFE;FYN;SLC38A2;SIRT2;ADA;ITGA2;EIF2AK4
4367,GO:0009991,0.00818484513433178,0.994719209592182,55,338,response to extracellular stimulus,BP,BBS2;APOE;FOS;GSN;POSTN;GLUL;EGFR;ERCC1;CST3;DDIT3;ULK2;HMGCL;CYP27B1;PCK2;ITGA6;DGKQ;ULK1;MTHFR;CBS;WNT2B;PSPH;PPARA;SESN2;IMPACT;LRP11;ACACB;MAPK3;ATF4;SSH1;HLCS;PCSK9;AQP3;DNMT3A;TGFBR2;TRPV4;MAP1LC3A;DAP;PEMT;TRPV1;GAS6;MGMT;ASNS;C12ORF66;AKT1;IGFBP2;UPP1;FOXO4;CAT;HFE;FYN;SLC38A2;SIRT2;ADA;ITGA2;EIF2AK4
15737,GO:0072358,0.00819267328677801,0.994400594573632,72,459,cardiovascular system development,BP,XDH;ACTA2;APOE;NFATC4;EGR1;PGF;LRP1;PDCD4;VEGFA;RAPGEF3;LOXL1;DDIT3;ADGRB2;ZFP36L1;CUL7;HYAL1;MAP2K1;BTG1;SHC1;SPRY2;VEGFB;ADM2;LAMA5;ELK3;FBXW8;ACVR2B;NGFR;LTBP1;EREG;PLCD3;C5;PKD2;HMGA2;COL8A1;ECM1;CSPG4;ERRFI1;SEMA5A;SH2D2A;ARHGAP22;PLCD1;ANGPTL4;PKD1;UNC5B;HDAC5;EGFL7;LRP5;TGFBR2;APLN;NOS3;WNT7A;EPHA1;CTSH;AKT1;FMNL3;FGFR4;FOXO4;MAP2K5;SNX17;RNF213;PLXND1;TGFBR3;VAV3;EPAS1;EDNRA;EPHB2;FGFR1;CTH;ERBB2;MMP19;ROBO4;TEAD2
6253,GO:0019842,0.00820945165527907,0.99638305252453,18,84,vitamin binding,MF,PYGB;PYGL;DHTKD1;OGDHL;PHYH;SEC14L2;GLDC;CBS;GPT2;ACACB;PC;HLCS;MOCOS;SRR;THNSL2;PHYKPL;OGFOD2;CTH
12621,GO:0050849,0.00826108491272451,0.998789644539658,5,12,negative regulation of calcium-mediated signaling,BP,PRNP;GSTO1;PKD2;GSTM2;ATP2B4
3309,GO:0007015,0.00830105323191156,0.994818565347501,48,282,actin filament organization,BP,ESPN;GSN;WIPF1;CDC42EP5;RAPGEF3;SPTB;EFS;ARAP1;MSRB2;OBSL1;ARPIN;CAPG;TPM2;PAK1;MICALL2;SHROOM4;SSH3;PLEKHG2;RHOBTB2;ITGB5;SEMA5A;RHOF;ARHGEF2;TWF2;DMTN;SSH1;TTN;WHAMMP3;TRIOBP;TRPV4;ARHGAP25;TMSB4X;EPHA1;MICAL1;TMOD2;ASAP3;C9ORF72;BRAF;FCHSD1;SPIRE1;EPS8L1;RHOBTB3;EPS8L2;C15ORF62;CORO1B;KCTD13;HIP1;PLEKHH2
18194,GO:1903019,0.00838833458672628,0.998766233231491,5,12,negative regulation of glycoprotein metabolic process,BP,CST3;HBEGF;ABCA7;JAK3;ACOT8
413,GO:0001101,0.00839368541209209,0.995039705323005,39,224,response to acid chemical,BP,NFATC4;GSN;EGR1;PTK6;VEGFA;EGFR;CD9;HMGCL;COL6A1;MTHFR;GLDC;NEURL1;SESN2;PKD2;LRP11;TWF2;HLCS;CEBPB;AQP3;DNMT3A;PEMT;PTAFR;RXRA;ADCY6;ATP2B4;CTSH;MGMT;ASNS;AKT1;IGFBP7;IGFBP2;CAPN2;WNT3;CAT;FYN;TGFBR3;LAMTOR2;ITGA2;TEAD2
18896,GO:1904659,0.00842398975716317,0.996617536195184,15,65,glucose transmembrane transport,BP,SLC2A3;CLTCL1;SLC2A9;PRKCZ;PAK1;NGFR;SESN2;TRIB3;PIK3R2;AKT1;INSR;BRAF;RTN2;EDNRA;GRB10
16784,GO:0098659,0.00849712648828167,0.99758983970226,9,31,inorganic cation import across plasma membrane,BP,PRNP;TRPV1;ATP2B4;STEAP2;STEAP3;HFE;SLC9A7;FYN;SLC9A5
17050,GO:0099587,0.00849712648828167,0.99758983970226,9,31,inorganic ion import across plasma membrane,BP,PRNP;TRPV1;ATP2B4;STEAP2;STEAP3;HFE;SLC9A7;FYN;SLC9A5
7067,GO:0030864,0.0085196727908782,0.996706873949941,14,59,cortical actin cytoskeleton,CC,GSN;WIPF1;RAPGEF3;SPTB;SHROOM4;MYZAP;FLOT1;TRIOBP;TRPV4;CAPN2;KRT19;HFE;HIP1;PLEKHH2
3825,GO:0008429,0.00855549951258535,0.999140418146157,4,8,phosphatidylethanolamine binding,MF,ESYT2;PLTP;MAP1LC3A;PEMT
1962,GO:0004674,0.00861107699066605,0.99424294233674,64,395,protein serine/threonine kinase activity,MF,OBSCN;EGFR;NEK9;BRSK1;MST1R;RPS6KA2;LTBP4;ULK2;MAPK13;CDK18;MAP2K1;PKN1;ALPK1;ULK1;TTBK2;PRKCZ;PAK1;STK39;FGFR3;ACVR2B;SPEG;LTBP1;MKNK2;HMGA2;MAPK3;STK40;FAM20C;MAPK12;MAP2K2;PAK6;TTN;PSKH1;MAP3K12;NEK8;WNK4;PKN3;MARK3;TGFBR2;MINK1;EPHA1;ERN1;BCR;CAMK1;STRADB;AKT1;CHEK2;FGFR4;MARK4;INSR;RPS6KA5;MAP2K5;BRAF;MAPK10;CSNK1E;MAST4;TGFBR3;MAP3K10;EPHB2;FGFR1;ERBB2;EIF2AK4;STK32B;CAMKK1;IKBKB
6624,GO:0022898,0.0086804909888117,0.995566578591243,25,129,regulation of transmembrane transporter activity,BP,DLG4;KCNG1;FHL1;NTSR1;PRNP;ANK3;NOS1;SHANK2;SCN4B;NLGN2;STK39;GSTO1;PLA2G6;PKD2;VAMP2;KLHL24;GSTM2;WNK4;PCSK9;TMSB4X;ANO9;MINK1;PTAFR;EHD3;EPHB2
4028,GO:0009064,0.00876114630433723,0.996905814646986,12,48,glutamine family amino acid metabolic process,BP,PRODH;GLUL;NAGS;NOS1;GGT1;PYCR2;ALDH4A1;NOS3;GLUD1;ATP2B4;ASNS;ASS1
16840,GO:0098797,0.00877950275626239,0.994526912359789,47,280,plasma membrane protein complex,CC,DLG4;KCNG1;GJC2;LRP1;EGFR;SCN8A;NOS1;SHANK2;SCN4B;COL13A1;EVC;ABCA2;ITGA6;SHC1;ABCA7;DLG3;ITGB4;OLFM2;C5;VAMP2;KCNC4;KCNAB2;ITGB5;SNTA1;SDHA;FLOT1;KCNMA1;GABBR1;LRP5;TGFBR2;ITGA1;CPT1C;CARD11;INSR;KRT19;GNAL;ITGB6;GJB4;HFE;ATP12A;AP2A2;TGFBR3;STX1A;ITGA2;HLA-G;IKBKB;HIP1
13108,GO:0051693,0.00882362880847462,0.998005346291603,7,21,actin filament capping,BP,GSN;SPTB;CAPG;TWF2;DMTN;TRIOBP;TMOD2
10940,GO:0044706,0.00897014213686456,0.995336069784183,26,136,multi-multicellular organism process,BP,SERPINE2;FOS;PGF;FBLN1;CST3;CYP27B1;EPOR;PLA2G6;CTSB;PTHLH;TGFBR2;SMURF2;HEXB;LDOC1;PTAFR;RXRA;AKT1;IGFBP7;IGFBP2;MAGED2;TIMP1;HFE;SLC38A2;RPL29;ITGA2;BSG
6412,GO:0021681,0.00903607020004791,0.999077028140158,4,8,cerebellar granular layer development,BP,SERPINE2;TTBK2;MDK;WNT7A
12595,GO:0050803,0.00909939065742752,0.995652435469787,21,103,regulation of synapse structure or activity,BP,APOE;ZMYND8;NFATC4;ADGRL1;PRNP;DNM1;ADGRB2;SYNGAP1;NLGN2;CAPRIN2;NEURL1;ETV5;SLITRK6;SSH1;TPBG;WNT7A;CAMK1;AMIGO2;ARHGAP44;FYN;EPHB2
4261,GO:0009611,0.00910890710151338,0.993867191837498,65,414,response to wounding,BP,PTPRS;F2R;APOE;SERPINE2;GSN;POSTN;EGFR;FBLN1;TFPI2;DGKA;CD9;CST3;ADAMTS13;ARHGEF19;ZFP36L1;HBEGF;PLAT;MAP2K1;PHF21A;DGKQ;BLOC1S4;ITPR3;SERPING1;PAK1;ELK3;DOCK6;ITGB4;EREG;PPARA;MAPK3;LAMB2;VANGL2;DOCK9;DYSF;DMTN;MORN4;PROCR;ZFPM1;DOCK11;MDK;SULF2;TGFBR2;HMG20B;NOS3;WNT7A;GAS6;AKT1;ITPR2;MICAL1;SH2B3;PLAU;C6ORF89;BRAF;MYOF;LGALS1;TIMP1;EHD3;FYN;CELSR1;ENTPD2;VAV3;ITGA2;ERBB2;PLLP;CORO1B
2570,GO:0005856,0.00914812429688951,0.992665893461587,215,1560,cytoskeleton,CC,ACTA2;DLG4;BBS2;MARVELD1;ESPN;FLNC;H1F0;GSN;WIPF1;CDC42EP5;RSPH3;ALOX15B;CLIP2;ANK3;NEK9;IFT140;RAPGEF3;CLTCL1;SPTB;KRT15;NINL;SNPH;DNM1;PARVB;NOS1;ARAP3;BRSK1;SHANK2;PGM1;ADGRB2;NDRG1;PLEKHH1;MYH15;MST1R;RIN1;OBSL1;EVC;BBS1;REEP2;RAB11FIP4;CUL7;MPRIP;MAP2K1;PPL;SDCCAG8;ABCA2;CAPG;PITPNM1;DGKQ;EML2;TUBG2;FAM110C;DNAH1;ARL2;SPRY2;NPHP4;PLEKHH3;MYH11;CAPRIN2;TPM2;TTBK2;PRKCZ;PAK1;STK39;PHF1;USP20;MICALL2;CEP250;NEIL1;SHROOM4;CCDC88B;SPPL2B;WDR60;SYNC;ACTR1B;TRIB2;TNS1;APBB3;SSH3;PLA2G6;DNMBP;RINL;KIF17;CHD3;CCDC92;IFT27;PKD2;ING4;NUDCD3;ENKD1;SEPT5;PCLO;KCNAB2;MAPK3;DEF6;OSBPL10;VANGL2;RGS14;DNAL4;MYZAP;PBXIP1;DYSF;RHOF;PLEK2;CNTRL;SNTA1;TUBE1;HOOK2;MYH3;TCTN1;ARHGEF2;SEPT10;FBF1;INPP5D;MAP2K2;TWF2;KIF21B;DMTN;ATF4;PROCR;SSH1;LRRC45;FRMD4B;RABGAP1;MYH16;KIF26B;FLOT1;CEP68;TTN;PSKH1;MAP6;NEK8;ALDOC;NDE1;CEP131;TRIOBP;TRPV4;TTC12;TMSB4X;MAP1LC3A;EDA;CDK5RAP3;NOS3;TTLL11;NICN1;CEP126;LZTS2;CROCC;MAPRE3;CEP112;TNNI2;TADA3;KIF13B;SPAG16;RIMS3;SPATA7;WDR19;CCDC15;UACA;GSDMC;PLEKHG6;MAPKBP1;AKT1;REEP4;MICAL1;MZT2B;IFT57;SEPT6;TNNT1;WDR66;CABYR;TSG101;KIF27;IGF2BP2;TMOD2;FARP1;LMNA;FAAH;CAPN2;MARK4;KRT19;ULBP1;ADD3;ITGB6;LYST;MAP2K5;MZT2A;HAUS4;HFE;JAK3;TUBGCP6;SPIRE1;FYN;EML3;PJA2;UBXN6;SIRT2;GOLGA2;RHOBTB3;MTA1;MYO18A;STX1A;LURAP1;SEPT8;SH3PXD2A;UNC119;CCDC69;C15ORF62;CORO1B;SFI1;TTC19;TNNI1;HIP1;PLEKHH2;TCTEX1D4
10485,GO:0043405,0.00915086631542996,0.994376776202747,44,260,regulation of MAP kinase activity,BP,DUSP6;F2R;APOE;PDCD4;VEGFA;EGFR;DUSP5;ERCC6;MST1R;MAP2K1;PKN1;SHC2;SHC1;SPRY2;PAK1;STK39;SPRY4;TRIB2;LPAR3;C5;MAPK3;CSPG4;VANGL2;RGS14;MAP2K2;SORL1;MAP3K12;ITGA1;TRIB3;CDK5RAP3;MINK1;ERN1;TSG101;INSR;MAP2K5;BRAF;MAPK10;TP73;AVPI1;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2
14654,GO:0070293,0.00916614746000861,0.998621110432237,5,12,renal absorption,BP,GSN;WNK4;AQP3;GAS6;MAGED2
9808,GO:0042035,0.00916655794886503,0.996572398535198,13,54,regulation of cytokine biosynthetic process,BP,EGR1;TRIB2;EREG;ERRFI1;INPP5D;ZFPM1;CEBPB;PTAFR;CARD11;IGF2BP2;MAP2K5;IGF2BP3;ZNF287
4708,GO:0010875,0.00921783140713784,0.998611347160638,5,12,positive regulation of cholesterol efflux,BP,APOE;LRP1;ABCA7;ABCG1;PLTP
9049,GO:0035295,0.00938488052908988,0.993193210181909,97,648,tube development,BP,XDH;APOE;NFATC4;SERPINE2;CTNNBIP1;PGF;PTK6;LRP1;VEGFA;EGFR;IFT140;RAPGEF3;ADGRB2;ZFP36L1;CUL7;HYAL1;WWTR1;MAP2K1;SDCCAG8;BTG1;ITGA6;SHC1;SPRY2;VEGFB;ADM2;LAMA5;PAK1;ELK3;SALL2;ITGB4;ACVR2B;NGFR;ETV5;WNT2B;EREG;PLCD3;C5;PKD2;HMGA2;AREG;COL8A1;ECM1;MAPK3;CSPG4;ERRFI1;SEMA5A;THRA;STK40;VANGL2;SH2D2A;ARHGAP22;TCTN1;PLCD1;ANGPTL4;KIF26B;PKD1;HSD11B1;UNC5B;HDAC5;DEAF1;EGFL7;LRP5;WNK4;TGFBR2;FOXL1;APLN;EDA;NOS3;WNT7A;EPHA1;ZNF358;CTSH;WDR19;IFT57;FMNL3;FGFR4;TBC1D20;FOXO4;MAP2K5;CAT;REC8;RNF213;CELSR1;ADA;PLXND1;TGFBR3;TCF7;VAV3;EPAS1;EDNRA;EPHB2;FGFR1;FKBP8;ERBB2;MMP19;ROBO4;TEAD2
17966,GO:1902430,0.00943261895893992,0.999023911024333,4,8,negative regulation of amyloid-beta formation,BP,APOE;PRNP;ABCA7;SORL1
9934,GO:0042310,0.00948173225164669,0.997015654743762,10,37,vasoconstriction,BP,DOCK4;BBS2;F2R;EGFR;HTR7;APLN;PTAFR;AKT1;CHRM3;EDNRA
6765,GO:0030207,0.0095761594676559,0.999004507502799,4,8,chondroitin sulfate catabolic process,BP,HYAL1;CSPG4;HEXB;HEXA
3187,GO:0006813,0.0096199730353879,0.995474460802989,20,97,potassium ion transport,BP,KCNG1;FHL1;PRNP;ANK3;NOS1;SLC12A7;STK39;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;KLHL24;ATF4;KCNMA1;TMEM175;NOS3;ATP12A;SLC9A7;SLC9A5
1963,GO:0004675,0.0096301791339937,0.99853293270617,5,12,transmembrane receptor protein serine/threonine kinase activity,MF,LTBP4;ACVR2B;LTBP1;TGFBR2;TGFBR3
5591,GO:0016627,0.00964872395452821,0.996537795641799,12,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,ACAD10;BLVRB;SRD5A3;SDHA;PTGR2;ACADS;ACOX3;ACAD11;TM7SF2;ACADVL;RETSAT;SDHAF4
7355,GO:0031406,0.00965670166350506,0.99535288903984,21,105,carboxylic acid binding,MF,GLUL;NAGS;NOS1;PYGL;HMGCL;AARS;PHYH;CEMIP;GLDC;PPARA;SESN2;ACACB;PC;HLCS;NOS3;GLUD1;SRR;RXRA;THNSL2;ASS1;OGFOD2
8648,GO:0034219,0.00967438437638494,0.995907398308786,16,72,carbohydrate transmembrane transport,BP,SLC2A3;CLTCL1;SLC2A9;PRKCZ;PAK1;NGFR;SESN2;SLC50A1;TRIB3;PIK3R2;AKT1;INSR;BRAF;RTN2;EDNRA;GRB10
9343,GO:0035869,0.00998674412947767,0.996399388162556,12,49,ciliary transition zone,CC,IFT140;NPHP4;TTBK2;KIF17;TCTN1;CEP131;SPATA7;WDR19;TMEM80;IFT57;UNC119B;UNC119
13883,GO:0060560,0.0099991476485542,0.994545726743524,29,156,developmental growth involved in morphogenesis,BP,PTPRS;APOE;POSTN;SEMA4B;VEGFA;ULK2;ULK1;SPRY2;PRKCZ;PAK1;SEMA3F;PLXNB3;PLXNB1;SPG11;LPAR3;IMPACT;AREG;SLIT3;LAMB2;SEMA5A;VANGL2;TWF2;SEMA3B;KIF26B;TGFBR2;SEMA4G;C9ORF72;WNT3;EIF2AK4
5897,GO:0018108,0.0102671441101055,0.993808427619422,40,229,peptidyl-tyrosine phosphorylation,BP,DLG4;PTK6;VEGFA;EGFR;PRNP;ERCC6;MST1R;HBEGF;CTF1;CNTN1;MAP2K1;DGKQ;SHC1;PRKCZ;FGFR3;DLG3;NEURL1;EREG;AREG;MAPK3;CSPG4;ERRFI1;CNTRL;ARHGEF2;MAP2K2;DMTN;TTN;EPHA1;GAS6;BCR;TSG101;FGFR4;INSR;MAP2K5;JAK3;FYN;EPHB2;FGFR1;ERBB2;UNC119
6423,GO:0021695,0.0103588280915077,0.996945824862679,9,32,cerebellar cortex development,BP,SERPINE2;NAGLU;MAP2K1;TRNP1;TTBK2;AARS;MDK;WNT7A;B4GALT2
7047,GO:0030834,0.0104981012998991,0.996897790408902,9,32,regulation of actin filament depolymerization,BP,GSN;SPTB;CAPG;SEMA5A;TWF2;DMTN;TRIOBP;TMOD2;PLEKHH2
12647,GO:0050878,0.0105814162511639,0.993222122034669,50,307,regulation of body fluid levels,BP,XDH;F2R;APOE;SERPINE2;VEGFA;FBLN1;TFPI2;DGKA;CD9;ADAMTS13;PLAT;PHF21A;DGKQ;BLOC1S4;ITPR3;SERPING1;STK39;DOCK6;NEURL1;MAPK3;DOCK9;DMTN;PROCR;ZFPM1;DOCK11;WNK4;AQP3;TRPV4;APLN;HMG20B;NOS3;GAS6;ATP7B;ADCY6;AKT1;ITPR2;MICAL1;SH2B3;PLAU;SCNN1A;CHRM3;APRT;EHD3;FYN;ADA;ENTPD2;VAV3;EPHB2;ITGA2;WFS1
2531,GO:0005788,0.0106104861342319,0.99393214339717,33,185,endoplasmic reticulum lumen,CC,H6PD;APOE;ADAMTS7;IGFBP4;CRTAP;CST3;ADAMTS13;COL13A1;CERCAM;COL6A1;LTBP1;ANO8;CES3;FKBP10;COL8A1;LAMB2;FAM20C;ADAMTSL1;MXRA8;SDC2;CES2;COL4A6;PCSK9;WNT7A;GAS6;IGFBP7;LAMB1;ARSA;WNT3;LGALS1;TIMP1;WFS1;KDELC2
14147,GO:0061061,0.0106320052445976,0.992882412203623,61,379,muscle structure development,BP,NFATC4;FLNC;FHL1;FOS;EGR1;PDCD4;VEGFA;OBSCN;MEF2D;NOS1;DDIT3;MYH15;ZFP36L1;ADARB1;NUPR1;HBEGF;CTF1;OBSL1;EVC;RNF165;BTG1;MYH11;LAMA5;PAK1;ETV1;NEURL1;SPEG;EREG;CHD2;OLFM2;THRA;VANGL2;MAPK12;MYH3;ZFPM1;FLOT1;TTN;HDAC5;TGFBR2;HMG20B;CAMK1;RXRA;AKT1;TNNT1;TMOD2;LMNA;CAPN2;KRT19;FOXO4;MYOF;LGALS1;TP73;TAZ;LEMD2;SIRT2;GDF15;TGFBR3;EPAS1;FGFR1;CTH;TNNI1
14165,GO:0061098,0.010654660786234,0.997136242053639,8,27,positive regulation of protein tyrosine kinase activity,BP,DLG4;PRNP;ERCC6;DLG3;NEURL1;EREG;GAS6;UNC119
11320,GO:0045664,0.0106931907828867,0.992741843387823,65,413,regulation of neuron differentiation,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;PTK6;SEMA4B;LRP1;TIMP2;VEGFA;SHANK2;CRTC1;CNTN1;EFNB3;OBSL1;ULK2;CUL7;MAP2K1;SYNGAP1;CAPRIN2;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;NEURL1;NGFR;ETV5;PLXNB1;SSH3;LPAR3;IMPACT;SEMA5A;SDC2;ARHGEF2;TWF2;SEMA3B;KDM4C;SSH1;METRN;VLDLR;TRPV4;HMG20B;CDK5RAP3;WNT7A;SEMA4G;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;WNT3;BRAF;ARHGAP44;LGALS1;TP73;CSNK1E;BCL6;FYN;PLXND1;EPHB2;FGFR1;UST;EIF2AK4;KCTD11
9843,GO:0042107,0.010698600458555,0.99572981316426,14,61,cytokine metabolic process,BP,EGR1;TNFSF15;TRIB2;EREG;ERRFI1;INPP5D;ZFPM1;CEBPB;PTAFR;CARD11;IGF2BP2;MAP2K5;IGF2BP3;ZNF287
4341,GO:0009897,0.0107203429121605,0.994788133581233,21,105,external side of plasma membrane,CC,SERPINE2;PRNP;CD9;ITGA6;ABCG1;SCART1;ERMAP;PDCD1LG2;PCSK9;TGFBR2;ITGA1;TRPV1;BCAM;INSR;ITGB6;BTN3A2;HFE;BTN3A3;ADA;TGFBR3;ITGA2
10346,GO:0043177,0.0107727695462032,0.994756586870475,21,106,organic acid binding,MF,GLUL;NAGS;NOS1;PYGL;HMGCL;AARS;PHYH;CEMIP;GLDC;PPARA;SESN2;ACACB;PC;HLCS;NOS3;GLUD1;SRR;RXRA;THNSL2;ASS1;OGFOD2
7146,GO:0031014,0.0109315197135561,1,2,2,troponin T binding,MF,TNNI2;TNNT1
9417,GO:0036003,0.0109733177232809,0.997380103790178,7,22,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,VEGFA;DDIT3;SESN2;ATF4;CEBPB;HSF4;CHD6
6579,GO:0022414,0.0109759641175809,0.991739175349824,119,823,reproductive process,BP,HTRA1;GAMT;BBS2;SERPINE2;FOS;EGR1;PGF;ALOX15B;VEGFA;EGFR;ERCC1;FBLN1;CD9;CRTAP;CST3;MICALCL;GGT1;MST1R;ZFP36L1;SYT8;NUPR1;TCFL5;MDFI;CUL7;TXNRD3;MAP2K1;CYP27B1;BTG1;PHC2;TUBG2;DNAH1;MYCBPAP;PABPC1L;KDM3A;NPR2;FBXW8;ZP3;NEURL1;EPOR;ETV5;WNT2B;EREG;SPATA20;PLCD3;PLA2G6;FAM50A;SCMH1;PKD2;AREG;SLIT3;THRA;CCNI;IRF2BPL;TDRKH;CTSB;PLCD1;PTHLH;PKD1;AZIN2;DEAF1;RFX2;CEBPB;CREBRF;CEP131;DNMT3A;TGFBR2;SMURF2;MLH3;NOS3;AGO4;HEXB;LDOC1;WNT7A;HERPUD2;SPAG16;PTAFR;RXRA;ATP2B4;WDR19;AKT1;IGFBP7;IGFBP2;SEPT6;CABYR;TBC1D20;INSR;WNT3;KRT19;MAGED2;PLB1;TIMP1;HFE;TUBGCP6;TFEB;SPIRE1;BCL6;REC8;RPL39L;SLC38A2;LEMD2;SIRT2;PHLDA2;RAB13;GOLGA2;ADA;RHOBTB3;ETNK2;MSH5;PAIP2;RPL29;TCF7;EPAS1;ITGA2;SPATA6;CREB3L4;MMP19;ZNF449;BSG;SIX5
6593,GO:0022617,0.0109905292777628,0.99578214221952,13,55,extracellular matrix disassembly,BP,HTRA1;LRP1;TIMP2;CST3;MMP1;CAPNS2;NID1;FLOT1;FGFR4;CAPN2;TIMP1;MMP19;BSG
13058,GO:0051591,0.0110123631513191,0.99558850215164,14,61,response to cAMP,BP,FOS;RAPGEF3;ZFP36L1;DGKQ;PKD2;AREG;DMTN;PDE2A;PTAFR;ITPR2;BRAF;PER1;MMP19;BSG
3389,GO:0007169,0.0111041211124009,0.992217294384259,76,496,transmembrane receptor protein tyrosine kinase signaling pathway,BP,XDH;DUSP6;PGF;FGFBP1;PTK6;LRP1;VEGFA;EGFR;IGFBP4;DNM1;MST1R;EFS;ARAP1;HBEGF;EFNB3;PLAT;MAPK13;GIGYF1;DDIT4;SHC2;DGKQ;SHC1;SPRY2;GRB7;VEGFB;PRKCZ;PAK1;FGFR3;SPRY4;NEURL1;NGFR;EREG;PTPRE;SH3TC2;AREG;MAPK3;CSPG4;ERRFI1;SH2D2A;RGS14;FAM20C;MAPK12;MVB12B;SDC2;SULF2;RHBDF1;ITGA1;APLN;PIK3R2;EPHA1;RHBDF2;BCR;AKT1;IGFBP2;TSG101;FGFR4;TCIRG1;INSR;FOXO4;RPS6KA5;GPR21;MYOF;JAK3;REPS2;FYN;SIRT2;AP2A2;EIF4EBP1;VAV3;EPHB2;FGFR1;ERBB2;PAG1;FRS3;GRB10;HIP1
5659,GO:0016773,0.0111185858740363,0.992007099970723,88,578,phosphotransferase activity, alcohol group as acceptor,MF,PTK6;OBSCN;EGFR;NEK9;DGKA;BRSK1;MST1R;HBEGF;RPS6KA2;EFNB3;LTBP4;ULK2;MAPK13;CDK18;MAP2K1;PKN1;ALPK1;DGKQ;ULK1;NMRK1;TTBK2;PRKCZ;PAK1;STK39;FGFR3;NPR2;ACVR2B;SPEG;LTBP1;EREG;MKNK2;HMGA2;PI4KAP1;MAPK3;TRPT1;STK40;FAM20C;CNTRL;MAPK12;PI4K2A;MAP2K2;PAK6;TTN;PSKH1;GALK1;NADK;MAP3K12;NEK8;WNK4;PKN3;MARK3;TGFBR2;MINK1;PIP5KL1;PIK3R2;EPHA1;ERN1;BCR;CHKB;CAMK1;STRADB;AKT1;ZFYVE21;CHEK2;FGFR4;MARK4;INSR;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;CSNK1E;TKFC;FYN;MAST4;ETNK2;FUK;TGFBR3;MAP3K10;EPHB2;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;CAMKK1;IKBKB
12908,GO:0051289,0.0111306973008385,0.995712641622169,13,56,protein homotetramerization,BP,GPX3;CRTC1;PKD2;ACACB;TRPV1;SRR;RXRA;CBR4;CAT;GOLGA2;DHPS;CTH;PFKL
3757,GO:0008305,0.011335045521308,0.997693654917982,6,17,integrin complex,CC,ITGA6;ITGB4;ITGB5;ITGA1;ITGB6;ITGA2
16769,GO:0098636,0.011335045521308,0.997693654917982,6,17,protein complex involved in cell adhesion,CC,ITGA6;ITGB4;ITGB5;ITGA1;ITGB6;ITGA2
4380,GO:0010035,0.0113803148258188,0.992518892075695,55,341,response to inorganic substance,BP,NFATC4;FOS;GSN;EGFR;D2HGDH;PRNP;ERCC1;ANK3;CD9;CST3;ERCC6;NDRG1;ADAMTS13;MAPK13;UROS;TXNRD3;CYBRD1;ITPR3;CARF;S100A13;RASA4;IMPACT;PKD2;STAT6;AREG;LRP11;MAPK3;BNIP3;DMTN;ATF4;TTN;KCNMA1;ENDOG;AQP3;DNMT3A;MAP1LC3A;NOS3;CCS;ATP7B;SPAG16;CYP2R1;ATP2B4;ENTPD6;AKT1;IGFBP2;ANKZF1;TXNRD2;BRAF;CAT;HFE;TRPC1;ADA;NET1;BSG;SNCB
2,GO:0000003,0.0113852679869798,0.991419009089102,119,824,reproduction,BP,HTRA1;GAMT;BBS2;SERPINE2;FOS;EGR1;PGF;ALOX15B;VEGFA;EGFR;ERCC1;FBLN1;CD9;CRTAP;CST3;MICALCL;GGT1;MST1R;ZFP36L1;SYT8;NUPR1;TCFL5;MDFI;CUL7;TXNRD3;MAP2K1;CYP27B1;BTG1;PHC2;TUBG2;DNAH1;MYCBPAP;PABPC1L;KDM3A;NPR2;FBXW8;ZP3;NEURL1;EPOR;ETV5;WNT2B;EREG;SPATA20;PLCD3;PLA2G6;FAM50A;SCMH1;PKD2;AREG;SLIT3;THRA;CCNI;IRF2BPL;TDRKH;CTSB;PLCD1;PTHLH;PKD1;AZIN2;DEAF1;RFX2;CEBPB;CREBRF;CEP131;DNMT3A;TGFBR2;SMURF2;MLH3;NOS3;AGO4;HEXB;LDOC1;WNT7A;HERPUD2;SPAG16;PTAFR;RXRA;ATP2B4;WDR19;AKT1;IGFBP7;IGFBP2;SEPT6;CABYR;TBC1D20;INSR;WNT3;KRT19;MAGED2;PLB1;TIMP1;HFE;TUBGCP6;TFEB;SPIRE1;BCL6;REC8;RPL39L;SLC38A2;LEMD2;SIRT2;PHLDA2;RAB13;GOLGA2;ADA;RHOBTB3;ETNK2;MSH5;PAIP2;RPL29;TCF7;EPAS1;ITGA2;SPATA6;CREB3L4;MMP19;ZNF449;BSG;SIX5
5433,GO:0016301,0.0113986871005704,0.991693339868849,95,632,kinase activity,MF,DLG4;PTK6;NAGS;OBSCN;EGFR;NEK9;DGKA;BRSK1;MST1R;HBEGF;RPS6KA2;EFNB3;TK2;LTBP4;ULK2;MAPK13;CDK18;MAP2K1;PKN1;ALPK1;DGKQ;ULK1;NMRK1;TTBK2;PRKCZ;PAK1;STK39;FGFR3;NPR2;DLG3;NME4;ACVR2B;SPEG;LTBP1;EREG;MKNK2;HMGA2;PI4KAP1;MAPK3;STK40;FAM20C;CNTRL;MAPK12;PI4K2A;MAP2K2;PAK6;TTN;PSKH1;GALK1;NADK;MAP3K12;NEK8;WNK4;PKN3;MARK3;TGFBR2;MINK1;PIP5KL1;PIK3R2;EPHA1;ERN1;BCR;CHKB;UCKL1;CAMK1;STRADB;AKT1;ZFYVE21;CARD11;DGUOK;CHEK2;FGFR4;MARK4;INSR;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;CSNK1E;TKFC;FYN;MAST4;ETNK2;FUK;TGFBR3;MAP3K10;EPHB2;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;CAMKK1;IKBKB
7357,GO:0031410,0.0114090316253193,0.990782680993837,218,1605,cytoplasmic vesicle,CC,PTPRS;DLG4;F2R;APOE;SYTL1;SERPINE2;GSN;PYGB;WIPF1;SLC2A3;NAPRT;LRP1;TIMP2;VEGFA;EGFR;SCN8A;PRDX5;CLTCL1;LOXL1;CD9;CST3;DNM1;DDIT3;BRSK1;PGM1;NDRG1;ARRDC1;SYT8;ARAP1;HBEGF;GAA;PYGL;PLAT;ULK2;RAB11FIP4;NISCH;PRSS3;HYAL1;SYNGR1;MAP2K1;ABCA2;PKN1;CAPG;DNASE1L1;DGKQ;TMEM173;SNX9;PLEKHG5;ULK1;VPS11;VEGFB;RAB3B;CD68;PCSK1;MYH11;ITPR3;APPL2;LY6K;PRKCZ;SERPING1;ABCA7;MCTP1;FGFR3;CEMIP;BRI3;TMEM187;NMNAT2;MICALL2;SPPL2B;NGFR;MALL;ACTR1B;SPG11;TMC6;RHOBTB2;TMED4;ABCG1;RINL;MTMR4;IFT27;PKD2;SH3TC2;VAMP2;AREG;AP1G2;SEPT5;ECM1;KCNAB2;MAPK3;ITGB5;VANGL2;DYSF;RHOF;CTSB;MVB12B;LTA4H;PI4K2A;KIAA0319L;CHMP1B;NRSN2;IFNGR2;TBC1D14;ARHGEF2;PRAF2;MAP2K2;TECPR1;KIF21B;SLC48A1;EHBP1L1;DMTN;LITAF;SV2A;PKD1;FUCA1;FLOT1;AZIN2;SORL1;MAP6;GPRC5C;TMEM175;ALDOC;PCSK9;DBNDD1;CEP131;EPN3;TRPV4;ITGA1;TMSB4X;MAP1LC3A;RAB40B;NOS3;HEXB;PROM2;WNT7A;MARCH2;GAS6;VPS39;ATP7B;FYCO1;NBR1;HEXA;NBEAL2;PTAFR;RAB43;CTSH;TMEM9;STEAP2;ZFYVE21;ITPR2;IGFBP2;SEPT6;TSG101;FGFR4;RASSF9;TCIRG1;STEAP3;PHLDA1;COPG1;WDFY2;C9ORF72;SGSM2;CHMP5;ARSA;MAN2B1;ICA1;RAB25;C1ORF210;PLAU;INSR;WNT3;CHMP4C;TPCN1;MAGED2;YIPF3;ARHGAP44;CAT;MYOF;DPP7;YPEL5;TIMP1;HFE;JAK3;SNX33;APRT;FCHSD1;MIB2;SNX17;METTL7A;SPIRE1;HGSNAT;RABAC1;SLC9A7;EHD3;FYN;SNX1;UBXN6;RAB13;OSBPL1A;MPDZ;TOM1;GOLGA2;ADA;RHOBTB3;AP2A2;RNPEP;STX1A;GALNS;LAMTOR2;TBC1D16;FGFR1;ERBB2;SEC31B;PFKL;HLA-G;BSG;APBA1;HIP1;TCTEX1D4
17678,GO:1901615,0.0115534679829477,0.99245953555274,53,329,organic hydroxy compound metabolic process,BP,ISYNA1;APOE;OSBPL5;LMF1;NTSR1;D2HGDH;NR1D1;CYP27B1;PCK2;PLCH2;DGKQ;SEC14L2;PSAT1;PLCD3;DHRS4;ABCG1;ACACB;ACSS2;MVD;PLCD1;INPP5D;SRD5A3;SORL1;GALK1;PLTP;VLDLR;LRP5;PCSK9;HSD17B7;PTAFR;CYP2R1;RXRA;TM7SF2;FGFR4;HAGH;ACADVL;ACSS1;PNPLA4;PLB1;CAT;SNX17;TKFC;TRPC1;OSBPL1A;RETSAT;PLPP6;EPAS1;INPP4A;FGFR1;PNKD;SNCB;CYP4V2;ACOT8
16273,GO:0090407,0.0115888224121809,0.99185971659982,76,499,organophosphate biosynthetic process,BP,ISYNA1;APOE;NAPRT;TIMP2;NTSR1;DGKA;IDH2;NOS1;PGM1;PYGL;DHTKD1;TK2;SLC27A1;PITPNM3;LHPP;ACP6;CRYL1;DDIT4;LPCAT4;PITPNM1;DGKQ;OGDHL;NMRK1;FGFR3;NPR2;NMNAT2;NME4;ZP3;PPCS;PNPLA3;PLA2G6;MTMR4;PPARA;MVD;PI4K2A;MLXIPL;INPP5D;SRD5A3;PTHLH;LTB4R2;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;MOCOS;PEMT;NOS3;PIGZ;HEXB;PIK3R2;CHKB;UCKL1;PTAFR;ADCY6;DGUOK;FGFR4;TCIRG1;UPP1;INSR;PIGQ;APRT;TAZ;MBOAT2;ADA;ETNK2;FUK;STARD10;INPP4A;FGFR1;PIGV;FITM2;PFKL;MPPE1;PLEKHA4
5141,GO:0015672,0.0116795747335343,0.992790736782298,42,252,monovalent inorganic cation transport,BP,KCNG1;SERPINE2;FHL1;PRNP;SCN8A;ANK3;SLC2A9;NOS1;SCN4B;CNTN1;SLC12A7;PRSS8;STK39;NDUFA4L2;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;SNTA1;KLHL24;ATF4;SLC38A10;KCNMA1;TMEM175;WNK4;PCSK9;TMSB4X;NOS3;MFSD3;ATP2B4;AKT1;TCIRG1;MAGED2;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC38A2;PER1;SLC10A6;SLC9A5
16497,GO:0097237,0.0117094986407716,0.993593289760156,28,155,cellular response to toxic substance,BP,APOE;EGR1;GPX3;PRDX5;CST3;MAPK13;TXNRD3;FAM213A;GSTO1;GSTT1;SESN2;IMPACT;STAT6;BNIP3;GSTM2;ENDOG;DNMT3A;MAP1LC3A;NOS3;CCS;GSTO2;ITPR2;ANKZF1;TXNRD2;CAT;GSTM3;ADIRF;NET1
1167,GO:0002790,0.0117231970457597,0.992250749903187,56,347,peptide secretion,BP,F2R;LMF1;POSTN;GLUL;ALOX15B;EGFR;NR1D1;HADH;RAPGEF3;IDH2;LTBP4;PCK2;ARL2;RAB3B;NLGN2;ITPR3;PRKCZ;ACVR2B;OLFM2;PLA2G6;S100A13;C5;ANO1;PCLO;MAPK3;LTBP2;DMTN;TTN;NLRP1;RHBDF1;LRP5;TRPV4;TMSB4X;APLN;RAB40B;TRPV1;RHBDF2;GAS6;GLUD1;NECAB3;MAPKBP1;ITPR2;CARD11;IL17RC;STEAP3;COPG1;ICA1;ITGB6;BTN3A2;HFE;RAB13;POU2F2;CIDEA;MYO18A;STX1A;PFKL
7685,GO:0032147,0.0117256261533441,0.992857181061103,40,235,activation of protein kinase activity,BP,DUSP6;F2R;VEGFA;EGFR;PRNP;DUSP5;TNFSF15;ERCC6;MAP2K1;PKN1;SHC2;DGKQ;SHC1;PRKCZ;PAK1;STK39;ACVR2B;LPAR3;C5;MAPK3;CSPG4;MAP2K2;PAK6;MAP3K12;TGFBR2;ITGA1;MINK1;GAS6;ERN1;ADCY6;STRADB;AKT1;INSR;MAP2K5;BRAF;MAPK10;TP73;AVPI1;LAMTOR2;MAP3K10
16785,GO:0098660,0.0117940695546355,0.992001021463152,63,404,inorganic ion transmembrane transport,BP,F2R;KCNG1;FHL1;GJC2;NTSR1;PRNP;SCN8A;ANK3;SLC2A9;NOS1;DDIT3;CLCA2;SCN4B;ORAI3;SLC12A7;ITPR3;SLC37A2;STK39;CEMIP;NDUFA4L2;ORAI2;GSTO1;PLA2G6;ANO1;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;SNTA1;KLHL24;PKD1;KCNMA1;GSTM2;TMEM175;PCSK9;TRPV4;TMSB4X;ANO9;PDE2A;TRPV1;GAS6;ATP7B;MFSD3;TTYH3;PTAFR;ATP2B4;STEAP2;ITPR2;TCIRG1;STEAP3;TPCN1;ASIC1;HFE;SCNN1A;ATP12A;SLC9A7;SLC37A4;EHD3;FYN;TRPC1;SLC39A11;SLC9A5
5614,GO:0016672,0.0118000264967432,1,2,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,GSTO1;GSTO2
11113,GO:0045174,0.0118000264967432,1,2,2,glutathione dehydrogenase (ascorbate) activity,MF,GSTO1;GSTO2
12482,GO:0050610,0.0118000264967432,1,2,2,methylarsonate reductase activity,MF,GSTO1;GSTO2
1990,GO:0004714,0.0118648137853602,0.996116227772374,10,38,transmembrane receptor protein tyrosine kinase activity,MF,EGFR;MST1R;EFNB3;FGFR3;EPHA1;FGFR4;INSR;EPHB2;FGFR1;ERBB2
12680,GO:0050922,0.0118857181152786,0.996394948551507,9,33,negative regulation of chemotaxis,BP,SEMA4B;MMP28;SEMA3F;C5;SEMA5A;SEMA3B;SEMA4G;WNT3;CORO1B
18431,GO:1903547,0.0118972516780226,1,2,2,regulation of growth hormone activity,BP,LDOC1;PHLDA2
2193,GO:0005057,0.0119080522173409,0.993933721179065,23,118,signal transducer activity, downstream of receptor,MF,EGFR;MST1R;MAPK13;MAP2K1;FGFR3;ACVR2B;MAPK3;IFITM1;RGS14;MAPK12;MAP3K12;TGFBR2;MINK1;EPHA1;FGFR4;INSR;BRAF;MAPK10;MAP3K10;EPHB2;FGFR1;ERBB2;RGS12
3742,GO:0008283,0.0119260087837373,0.990522544838661,182,1321,cell proliferation,BP,XDH;HTRA1;F2R;TNFRSF6B;APOE;SERPINE2;S100A6;IL20RB;EGR1;CTNNBIP1;PGF;FGFBP1;FBXO2;PTK6;GLUL;GJC2;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;EGFR;PRNP;NR1D1;ERCC1;FBLN1;RAPGEF3;TSPAN1;IGFBP4;CD9;IDH2;CST3;MEF2D;DNPH1;CGREF1;NDRG1;TBC1D8;MST1R;ZFP36L1;ADARB1;NUPR1;TCFL5;HBEGF;RPS6KA2;CTF1;MXI1;KLF9;FBXW4;ASH2L;HYAL1;WWTR1;MAP2K1;CYP27B1;MXD4;PKN1;DDIT4;BTG1;TRNP1;SHC1;SPRY2;VEGFB;MARCKSL1;LAMA5;APPL2;PRKCZ;PAK1;FGFR3;PLXNB3;DLG3;FBXW8;ZP3;NEURL1;CCDC88B;EAPP;SPEG;NGFR;ETV5;WNT2B;PLXNB1;EREG;PLCD3;TNFRSF25;NAB2;S100A13;PKD2;SATB1;STAT6;ING4;HMGA2;AREG;COL8A1;SLIT3;ECM1;CSPG4;ERRFI1;SEMA5A;IFITM1;SH2D2A;MVD;MLXIPL;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;PTHLH;KDM4C;LTBP3;HLCS;DEAF1;SULF2;EGFL7;CEBPB;RHBDF1;LRP5;PTPRU;ATRAID;NDE1;CEP131;ISG20;TGFBR2;ITGA1;APLN;PEMT;CDK5RAP3;NOS3;LDOC1;WNT7A;EPHA1;GAS6;ERN1;LZTS2;PTAFR;RXRA;CTSH;TNFRSF14;TP53I11;AKT1;IGFBP7;CARD11;CDKN1C;LAMB1;IFT57;IGFBP2;TSG101;FGFR4;TCIRG1;LMNA;MAB21L2;UHRF2;RAB25;PLAU;INSR;WNT3;TENM4;CKLF;FOXO4;C6ORF89;MAP2K5;BRAF;TIMP1;JAK3;TP73;MTA3;MNT;CHRM3;BCL6;HSF4;FYN;SIRT2;PHLDA2;ADA;TGFBR3;TCF7;VAV3;EDNRA;DHPS;ITGA2;FGFR1;ERBB2;HLA-G;KCTD11;SIX5
7028,GO:0030810,0.0120265256727297,0.996344934136574,9,33,positive regulation of nucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;MLXIPL;PTHLH;TMSB4X;NOS3;INSR;TAZ
17452,GO:1900373,0.0120265256727297,0.996344934136574,9,33,positive regulation of purine nucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;MLXIPL;PTHLH;TMSB4X;NOS3;INSR;TAZ
16689,GO:0097708,0.0120342500277352,0.990262596488946,218,1607,intracellular vesicle,CC,PTPRS;DLG4;F2R;APOE;SYTL1;SERPINE2;GSN;PYGB;WIPF1;SLC2A3;NAPRT;LRP1;TIMP2;VEGFA;EGFR;SCN8A;PRDX5;CLTCL1;LOXL1;CD9;CST3;DNM1;DDIT3;BRSK1;PGM1;NDRG1;ARRDC1;SYT8;ARAP1;HBEGF;GAA;PYGL;PLAT;ULK2;RAB11FIP4;NISCH;PRSS3;HYAL1;SYNGR1;MAP2K1;ABCA2;PKN1;CAPG;DNASE1L1;DGKQ;TMEM173;SNX9;PLEKHG5;ULK1;VPS11;VEGFB;RAB3B;CD68;PCSK1;MYH11;ITPR3;APPL2;LY6K;PRKCZ;SERPING1;ABCA7;MCTP1;FGFR3;CEMIP;BRI3;TMEM187;NMNAT2;MICALL2;SPPL2B;NGFR;MALL;ACTR1B;SPG11;TMC6;RHOBTB2;TMED4;ABCG1;RINL;MTMR4;IFT27;PKD2;SH3TC2;VAMP2;AREG;AP1G2;SEPT5;ECM1;KCNAB2;MAPK3;ITGB5;VANGL2;DYSF;RHOF;CTSB;MVB12B;LTA4H;PI4K2A;KIAA0319L;CHMP1B;NRSN2;IFNGR2;TBC1D14;ARHGEF2;PRAF2;MAP2K2;TECPR1;KIF21B;SLC48A1;EHBP1L1;DMTN;LITAF;SV2A;PKD1;FUCA1;FLOT1;AZIN2;SORL1;MAP6;GPRC5C;TMEM175;ALDOC;PCSK9;DBNDD1;CEP131;EPN3;TRPV4;ITGA1;TMSB4X;MAP1LC3A;RAB40B;NOS3;HEXB;PROM2;WNT7A;MARCH2;GAS6;VPS39;ATP7B;FYCO1;NBR1;HEXA;NBEAL2;PTAFR;RAB43;CTSH;TMEM9;STEAP2;ZFYVE21;ITPR2;IGFBP2;SEPT6;TSG101;FGFR4;RASSF9;TCIRG1;STEAP3;PHLDA1;COPG1;WDFY2;C9ORF72;SGSM2;CHMP5;ARSA;MAN2B1;ICA1;RAB25;C1ORF210;PLAU;INSR;WNT3;CHMP4C;TPCN1;MAGED2;YIPF3;ARHGAP44;CAT;MYOF;DPP7;YPEL5;TIMP1;HFE;JAK3;SNX33;APRT;FCHSD1;MIB2;SNX17;METTL7A;SPIRE1;HGSNAT;RABAC1;SLC9A7;EHD3;FYN;SNX1;UBXN6;RAB13;OSBPL1A;MPDZ;TOM1;GOLGA2;ADA;RHOBTB3;AP2A2;RNPEP;STX1A;GALNS;LAMTOR2;TBC1D16;FGFR1;ERBB2;SEC31B;PFKL;HLA-G;BSG;APBA1;HIP1;TCTEX1D4
4493,GO:0010523,0.0121232726950515,0.997979221517912,5,13,negative regulation of calcium ion transport into cytosol,BP,NTSR1;NOS1;GSTO1;PKD2;GSTM2
10405,GO:0043266,0.0121704899619663,0.995724517882894,11,44,regulation of potassium ion transport,BP,KCNG1;FHL1;PRNP;ANK3;NOS1;STK39;VAMP2;KCNAB2;KLHL24;ATF4;NOS3
19548,GO:1990617,0.0123083772828571,1,2,2,CHOP-ATF4 complex,CC,DDIT3;ATF4
11550,GO:0046122,0.0123126847595295,1,2,2,purine deoxyribonucleoside metabolic process,BP,DGUOK;ADA
7935,GO:0032535,0.0123701205499698,0.992246379933755,44,264,regulation of cellular component size,BP,PTPRS;APOE;GSN;WIPF1;CDC42EP5;SEMA4B;VEGFA;SPTB;ULK2;ARPIN;CAPG;RAB3B;SLC12A7;PAK1;SEMA3F;SSH3;PLEKHG2;LPAR3;SEMA5A;TWF2;DMTN;LRRC8A;SEMA3B;SSH1;KCNMA1;WHAMMP3;TRIOBP;TRPV4;TMSB4X;WNT7A;SEMA4G;PPP1R15A;AKT1;TMOD2;WNT3;FCHSD1;SPIRE1;EPS8L1;EPS8L2;VAV3;C15ORF62;CORO1B;PEX11A;PLEKHH2
17701,GO:1901658,0.0123756240090307,0.996557702004939,8,28,glycosyl compound catabolic process,BP,NT5E;APOBEC3C;APOBEC3F;FUCA1;UPP1;ADA;NAGA;NUDT18
12600,GO:0050808,0.012396386979321,0.992892674590194,32,179,synapse organization,BP,DLG4;F2R;APOE;ZMYND8;NFATC4;ADGRL1;PRNP;ANK3;SDK2;SHANK2;ADGRB2;NLGN2;CAPRIN2;NEURL1;ETV5;PCLO;LAMB2;SLITRK6;SSH1;TPBG;ADGRF1;WNT7A;CAMK1;AMIGO2;FARP1;INSR;ARHGAP44;FYN;PLXND1;EPHB2;ERBB2;SNCB
9608,GO:0036488,0.0124074693456538,1,2,2,CHOP-C/EBP complex,CC,DDIT3;CEBPB
3694,GO:0008203,0.0124291425081991,0.993985608565779,20,100,cholesterol metabolic process,BP,APOE;OSBPL5;LMF1;DGKQ;SEC14L2;ABCG1;ACACB;MVD;SORL1;VLDLR;LRP5;PCSK9;HSD17B7;RXRA;TM7SF2;ACADVL;CAT;SNX17;OSBPL1A;PLPP6
8590,GO:0034112,0.0124519771657424,0.999228924510365,3,5,positive regulation of homotypic cell-cell adhesion,BP,ANK3;DMTN;LGALS1
12618,GO:0050840,0.0124557400036407,0.996191826072735,9,33,extracellular matrix binding,MF,VEGFA;SMOC1;ITGA6;NID1;ECM1;OLFML2A;BCAM;LGALS1;ITGA2
12723,GO:0051015,0.0124778061784032,0.993523726230452,24,121,actin filament binding,MF,ESPN;FLNC;GSN;WIPF1;EGFR;SPTB;MYH15;OBSL1;CAPG;MYH11;TPM2;SYNE3;MICALL2;SHROOM4;MYH3;TWF2;DMTN;TTN;TRIOBP;TRPV4;TAGLN3;MYO18A;CORO1B;HIP1
12664,GO:0050905,0.012486393561065,0.995596753541288,11,44,neuromuscular process,BP,DLG4;ADARB1;GAA;BLOC1S4;NLGN2;AARS;KCNAB2;SLITRK6;HEXB;BCR;PNKD
708,GO:0001934,0.0124988790906667,0.990898480064079,92,620,positive regulation of protein phosphorylation,BP,XDH;DUSP6;DLG4;F2R;EGR1;PTK6;TIMP2;VEGFA;EGFR;PRNP;DUSP5;RAPGEF3;TNFSF15;IGFBP4;ERCC6;MST1R;HBEGF;CTF1;CNTN1;SLC27A1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;DLG3;NEURL1;ACVR2B;NGFR;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PKD2;AREG;MAPK3;CSPG4;VANGL2;ARHGEF2;MAP2K2;PAK6;PKD1;FLOT1;VLDLR;MAP3K12;TGFBR2;TRPV4;ITGA1;MINK1;PROM2;WNT7A;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;CHEK2;FGFR4;WDFY2;INSR;RPS6KA5;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;FYN;GDF15;AVPI1;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2;UNC119;CAMKK1
12842,GO:0051187,0.0125272534026157,0.99614828986466,9,34,cofactor catabolic process,BP,GPX3;PRDX5;GGT1;BLVRB;CHAC1;ACOT7;ALDH1L2;ALDH1L1;CAT
11656,GO:0046459,0.0125618840087727,0.997886797619495,5,13,short-chain fatty acid metabolic process,BP,PCK2;ACSS2;ACADS;THNSL2;ACSS1
3124,GO:0006706,0.0125869297666846,0.99788149312501,5,13,steroid catabolic process,BP,APOE;HSD17B14;CYP27B1;HSD11B1;SNX17
3942,GO:0008643,0.0126031670512398,0.994028468311457,19,93,carbohydrate transport,BP,SLC2A3;CLTCL1;SLC2A9;PRKCZ;PAK1;SLC37A2;NGFR;SESN2;SLC50A1;AQP3;TRIB3;PIK3R2;AKT1;INSR;BRAF;SLC37A4;RTN2;EDNRA;GRB10
5929,GO:0018212,0.0126271327161961,0.992273391851972,40,232,peptidyl-tyrosine modification,BP,DLG4;PTK6;VEGFA;EGFR;PRNP;ERCC6;MST1R;HBEGF;CTF1;CNTN1;MAP2K1;DGKQ;SHC1;PRKCZ;FGFR3;DLG3;NEURL1;EREG;AREG;MAPK3;CSPG4;ERRFI1;CNTRL;ARHGEF2;MAP2K2;DMTN;TTN;EPHA1;GAS6;BCR;TSG101;FGFR4;INSR;MAP2K5;JAK3;FYN;EPHB2;FGFR1;ERBB2;UNC119
3682,GO:0008188,0.0126667632388603,0.999210428795228,3,5,neuropeptide receptor activity,MF,NTSR1;LTB4R2;LTB4R
9187,GO:0035584,0.0127905495670821,0.99844538647396,4,9,calcium-mediated signaling using intracellular calcium source,BP,ADGRL1;PRNP;DMTN;HOMER2
16878,GO:0098862,0.0129103443315646,0.994165037791017,17,81,cluster of actin-based cell projections,CC,DOCK4;BBS2;ESPN;SHANK2;CYBRD1;ITPR3;RALGDS;SCART1;TWF2;MORN4;TRIOBP;PEMT;ADD3;HOMER2;PLB1;SLC38A2;EPS8L2
17974,GO:1902463,0.0129385906132693,1,2,2,protein localization to cell leading edge,BP,RAB13;CORO1B
6677,GO:0030049,0.0129709070694723,0.997453192305547,6,14,muscle filament sliding,BP,TPM2;MYH3;TTN;TNNI2;TNNT1;TNNI1
8365,GO:0033275,0.0129709070694723,0.997453192305547,6,14,actin-myosin filament sliding,BP,TPM2;MYH3;TTN;TNNI2;TNNT1;TNNI1
10350,GO:0043183,0.0130790592122591,1,2,2,vascular endothelial growth factor receptor 1 binding,MF,VEGFA;VEGFB
5799,GO:0017057,0.0131353350443252,1,2,2,6-phosphogluconolactonase activity,MF,H6PD;PGLS
8108,GO:0032805,0.0131886905033027,1,2,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE;PCSK9
18155,GO:1902952,0.0131985868441655,1,2,2,positive regulation of dendritic spine maintenance,BP,APOE;ZMYND8
11885,GO:0046934,0.0132077190583071,0.99592127349327,9,33,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,EGFR;HBEGF;FGFR3;EREG;PIK3R2;FGFR4;FYN;FGFR1;ERBB2
1582,GO:0003995,0.0132131480698853,0.997747938697157,5,13,acyl-CoA dehydrogenase activity,MF,ACAD10;ACADS;ACOX3;ACAD11;ACADVL
18178,GO:1902994,0.0132341161792935,1,2,2,regulation of phospholipid efflux,BP,APOE;ABCA7
18179,GO:1902995,0.0132341161792935,1,2,2,positive regulation of phospholipid efflux,BP,APOE;ABCA7
14003,GO:0060754,0.0132598032363589,0.99915870764778,3,5,positive regulation of mast cell chemotaxis,BP,PGF;VEGFA;VEGFB
11466,GO:0045947,0.0133222229634514,0.997144494993247,6,18,negative regulation of translational initiation,BP,RPL13A;ATF4;PAIP2B;PAIP2;EIF4EBP1;EIF2AK4
7852,GO:0032421,0.0133266975605415,0.996242041870204,8,28,stereocilium bundle,CC,DOCK4;BBS2;ESPN;TWF2;MORN4;TRIOBP;HOMER2;EPS8L2
12707,GO:0050994,0.0133383570362447,0.996238143772698,8,28,regulation of lipid catabolic process,BP,TYSND1;MLYCD;PPARA;ACACB;THRA;LONP2;AKT1;CIDEA
623,GO:0001807,0.0134019859040937,1,2,2,regulation of type IV hypersensitivity,BP,IL20RB;ZP3
7664,GO:0032102,0.01347650657498,0.992143926486836,33,189,negative regulation of response to external stimulus,BP,PTPRS;HTRA1;BBS2;NT5E;APOE;SERPINE2;IL20RB;ACP5;SEMA4B;PDCD4;CD9;MMP28;PLAT;SERPING1;SEMA3F;FAM3A;C5;PPARA;FNDC4;NLRX1;SEMA5A;SEMA3B;NOS3;SEMA4G;SHARPIN;BCR;MAPKBP1;PLAU;WNT3;TKFC;SIRT2;ADA;CORO1B
12973,GO:0051414,0.0135623759972586,0.999131955232896,3,5,response to cortisol,BP,KLF9;SLIT3;IGFBP7
16398,GO:0097062,0.013598609699602,0.997664860005512,5,13,dendritic spine maintenance,BP,APOE;ZMYND8;PRNP;INSR;FYN
269,GO:0000768,0.013642144773355,0.996136342367417,8,28,syncytium formation by plasma membrane fusion,BP,RAPGEF3;NOS1;FLOT1;CAMK1;CAPN2;MYOF;GDF15;SH3PXD2A
16424,GO:0097113,0.0136435603554684,0.999124735889421,3,5,AMPA glutamate receptor clustering,BP,DLG4;APOE;SSH1
16681,GO:0097688,0.0136435603554684,0.999124735889421,3,5,glutamate receptor clustering,BP,DLG4;APOE;SSH1
524,GO:0001631,0.0136975083733934,1,2,2,cysteinyl leukotriene receptor activity,MF,LTB4R2;LTB4R
525,GO:0001632,0.0136975083733934,1,2,2,leukotriene B4 receptor activity,MF,LTB4R2;LTB4R
2152,GO:0004974,0.0136975083733934,1,2,2,leukotriene receptor activity,MF,LTB4R2;LTB4R
14405,GO:0061737,0.0136975083733934,1,2,2,leukotriene signaling pathway,BP,LTB4R2;LTB4R
8363,GO:0033273,0.0137027379112967,0.994337234495173,14,63,response to vitamin,BP,GSN;POSTN;EGFR;CYP27B1;MTHFR;HLCS;AQP3;DNMT3A;PEMT;GAS6;MGMT;CAT;ADA;ITGA2
20269,GO:2001287,0.0137257509266617,1,2,2,negative regulation of caveolin-mediated endocytosis,BP,PROM2;UNC119
9818,GO:0042058,0.0137313101237299,0.99411691431873,15,69,regulation of epidermal growth factor receptor signaling pathway,BP,PTK6;EGFR;ARAP1;SHC1;SPRY2;NEURL1;EREG;ERRFI1;MVB12B;RHBDF1;ITGA1;RHBDF2;AKT1;TSG101;HIP1
1785,GO:0004416,0.013770888502519,1,2,2,hydroxyacylglutathione hydrolase activity,MF,HAGH;PNKD
6082,GO:0019243,0.013770888502519,1,2,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,HAGH;PNKD
13062,GO:0051596,0.013770888502519,1,2,2,methylglyoxal catabolic process,BP,HAGH;PNKD
14399,GO:0061727,0.013770888502519,1,2,2,methylglyoxal catabolic process to lactate,BP,HAGH;PNKD
9561,GO:0036378,0.0138213858872544,1,2,2,calcitriol biosynthetic process from calciol,BP,CYP27B1;CYP2R1
8315,GO:0033169,0.0138505233673633,0.997610213626961,5,13,histone H3-K9 demethylation,BP,KDM3A;KDM4C;KDM7A;PHF2;HSF4
5379,GO:0016208,0.013864737033525,0.998272566159915,4,9,AMP binding,MF,PYGL;ACSS2;ACSS1;APRT
6298,GO:0019932,0.0138930055094895,0.992202047907351,29,161,second-messenger-mediated signaling,BP,APOE;NFATC4;ADGRL1;EGFR;PRNP;RAPGEF3;NOS1;ADGRB2;MC1R;DGKQ;ADM2;ITPR3;MCTP1;GSTO1;PKD2;PCLO;DMTN;PTHLH;GSTM2;ADGRF1;PDE2A;NOS3;ADCY6;ATP2B4;ITPR2;GNAL;HOMER2;ADA;MCTP2
16712,GO:0097756,0.0139211343712456,0.995308377738144,10,39,negative regulation of blood vessel diameter,BP,DOCK4;BBS2;F2R;EGFR;HTR7;APLN;PTAFR;AKT1;CHRM3;EDNRA
10318,GO:0043129,0.0139542358962238,0.9990969489809,3,5,surfactant homeostasis,BP,VEGFA;CTSH;EPAS1
6102,GO:0019343,0.0139656797714545,1,2,2,cysteine biosynthetic process via cystathionine,BP,CBS;CTH
20231,GO:2001225,0.0139668900954082,0.999095811836056,3,5,regulation of chloride transport,BP,PRNP;ANO9;PTAFR
10239,GO:0042994,0.0139948970993593,0.996966532393999,6,18,cytoplasmic sequestering of transcription factor,BP,MXI1;MDFI;PKD2;THRA;PKD1;TMSB4X
1880,GO:0004563,0.0140524119319175,0.99908811566133,3,5,beta-N-acetylhexosaminidase activity,MF,HEXDC;HEXB;HEXA
5061,GO:0015279,0.0140770745268938,0.999085892726132,3,5,store-operated calcium channel activity,MF,ORAI3;ORAI2;TRPC1
6645,GO:0030001,0.0140774173162502,0.990190706435467,69,450,metal ion transport,BP,F2R;KCNG1;SERPINE2;FHL1;GJC2;NTSR1;PRNP;SCN8A;ANK3;NOS1;DDIT3;SCN4B;ORAI3;CNTN1;CYP27B1;SLC12A7;ITPR3;PRSS8;STK39;CEMIP;ORAI2;GSTO1;PLA2G6;LPAR3;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;SNTA1;KLHL24;ATF4;SLC38A10;PKD1;KCNMA1;GSTM2;TMEM175;WNK4;PCSK9;TRPV4;PDE2A;NOS3;TRPV1;CCS;GAS6;ATP7B;ATP2B4;STEAP2;AKT1;ITPR2;TCIRG1;STEAP3;TPCN1;MAGED2;HOMER2;ASIC1;HFE;SCNN1A;ATP12A;SLC9A7;EHD3;FYN;SLC38A2;TRPC1;PER1;SLC39A11;WFS1;SLC10A6;SLC9A5
18392,GO:1903464,0.0140876725732669,1,2,2,negative regulation of mitotic cell cycle DNA replication,BP,CHEK2;BCL6
16818,GO:0098754,0.0140994602639638,0.993916474733825,15,72,detoxification,BP,APOE;GPX3;PRDX5;TXNRD3;FAM213A;GSTO1;GSTT1;SESN2;GSTM2;NOS3;CCS;GSTO2;TXNRD2;CAT;GSTM3
9886,GO:0042219,0.0141040072361581,0.996937468586806,6,18,cellular modified amino acid catabolic process,BP,PRODH;GGT1;ALDH4A1;CHAC1;ALDH1L2;ALDH1L1
14504,GO:0070032,0.0141325493032209,1,2,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,VAMP2;STX1A
14505,GO:0070033,0.0141325493032209,1,2,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,VAMP2;STX1A
10939,GO:0044703,0.0141397406634333,0.989838258273678,82,548,multi-organism reproductive process,BP,GAMT;BBS2;SERPINE2;FOS;PGF;ERCC1;FBLN1;CD9;CRTAP;CST3;MICALCL;GGT1;MST1R;SYT8;TCFL5;TXNRD3;CYP27B1;BTG1;PHC2;DNAH1;MYCBPAP;PABPC1L;KDM3A;NPR2;ZP3;NEURL1;EPOR;ETV5;EREG;SPATA20;PLA2G6;FAM50A;SCMH1;THRA;CCNI;TDRKH;CTSB;PTHLH;AZIN2;DEAF1;RFX2;CEP131;DNMT3A;TGFBR2;SMURF2;MLH3;NOS3;AGO4;HEXB;LDOC1;HERPUD2;SPAG16;PTAFR;RXRA;ATP2B4;AKT1;IGFBP7;IGFBP2;SEPT6;CABYR;TBC1D20;WNT3;MAGED2;PLB1;TIMP1;HFE;SPIRE1;BCL6;REC8;RPL39L;SLC38A2;SIRT2;ADA;PAIP2;RPL29;ITGA2;SPATA6;CREB3L4;MMP19;ZNF449;BSG;SIX5
5014,GO:0015181,0.0141400234931494,0.999080211743872,3,5,arginine transmembrane transporter activity,MF,TMEM44;PQLC2;SLC25A29
5021,GO:0015189,0.0141400234931494,0.999080211743872,3,5,L-lysine transmembrane transporter activity,MF,TMEM44;PQLC2;SLC25A29
19482,GO:1990393,0.0141671139397901,0.999077763743712,3,5,3M complex,CC,OBSL1;CUL7;FBXW8
1068,GO:0002634,0.0141677740216715,0.999077704072415,3,5,regulation of germinal center formation,BP,PKN1;BCL6;ADA
18154,GO:1902951,0.0141980274632924,1,2,2,negative regulation of dendritic spine maintenance,BP,PRNP;FYN
19308,GO:1905664,0.0141980274632924,1,2,2,regulation of calcium ion import across plasma membrane,BP,PRNP;FYN
9917,GO:0042278,0.0142038628367489,0.994093984353052,14,64,purine nucleoside metabolic process,BP,DLG4;GAMT;NT5E;DLG3;NME4;MACROD1;GTPBP1;MOCOS;PEMT;CARD11;DGUOK;APRT;ADA;NUDT18
12703,GO:0050974,0.014212164552429,0.999073688592251,3,5,detection of mechanical stimulus involved in sensory perception,BP,SERPINE2;FYN;ITGA2
2170,GO:0005007,0.0142308144157785,0.999072000044786,3,5,fibroblast growth factor-activated receptor activity,MF,FGFR3;FGFR4;FGFR1
7687,GO:0032153,0.0142418691196314,0.993870623714127,15,69,cell division site,CC,RAB11FIP4;PKN1;PITPNM1;PLCD3;RHOBTB2;SEPT5;RHOF;SEPT10;SSH1;NDE1;PLEKHG6;SEPT6;TUBGCP6;SPIRE1;SEPT8
3014,GO:0006562,0.0142582701403882,1,2,2,proline catabolic process,BP,PRODH;ALDH4A1
4397,GO:0010133,0.0142582701403882,1,2,2,proline catabolic process to glutamate,BP,PRODH;ALDH4A1
20153,GO:2001028,0.0142646965637427,0.998207088125301,4,9,positive regulation of endothelial cell chemotaxis,BP,VEGFA;SEMA5A;TMSB4X;FGFR1
15960,GO:0080184,0.0142676928037762,1,2,2,response to phenylpropanoid,BP,EGFR;CAT
16371,GO:0097017,0.0143000691466841,1,2,2,renal protein absorption,BP,GSN;GAS6
18150,GO:1902947,0.0143057204020136,0.999065209071563,3,5,regulation of tau-protein kinase activity,BP,EGR1;NAB2;SORL1
7957,GO:0032571,0.0143074126390416,1,2,2,response to vitamin K,BP,POSTN;GAS6
15149,GO:0071307,0.0143074126390416,1,2,2,cellular response to vitamin K,BP,POSTN;GAS6
18145,GO:1902938,0.0143100177004295,1,2,2,regulation of intracellular calcium activated chloride channel activity,BP,PRNP;ANO9
14734,GO:0070435,0.0143130971450039,1,2,2,Shc-EGFR complex,CC,EGFR;SHC1
19433,GO:1990164,0.0143141311950194,1,2,2,histone H2A phosphorylation,BP,HMGA2;RPS6KA5
12701,GO:0050966,0.0143251751126292,1,2,2,detection of mechanical stimulus involved in sensory perception of pain,BP,FYN;ITGA2
8753,GO:0034437,0.0143268403103484,1,2,2,glycoprotein transporter activity,MF,ABCG1;VLDLR
13721,GO:0060319,0.0143297097094399,1,2,2,primitive erythrocyte differentiation,BP,VEGFA;ZFPM1
3679,GO:0008184,0.0143333666566517,1,2,2,glycogen phosphorylase activity,MF,PYGB;PYGL
17106,GO:0102250,0.0143333666566517,1,2,2,linear malto-oligosaccharide phosphorylase activity,MF,PYGB;PYGL
17128,GO:0102499,0.0143333666566517,1,2,2,SHG alpha-glucan phosphorylase activity,MF,PYGB;PYGL
12435,GO:0050253,0.014335364718733,1,2,2,retinyl-palmitate esterase activity,MF,PNPLA4;PLB1
1575,GO:0003987,0.01433771543253,1,2,2,acetate-CoA ligase activity,MF,ACSS2;ACSS1
6137,GO:0019413,0.01433771543253,1,2,2,acetate biosynthetic process,BP,ACSS2;ACSS1
6140,GO:0019427,0.01433771543253,1,2,2,acetyl-CoA biosynthetic process from acetate,BP,ACSS2;ACSS1
6171,GO:0019542,0.01433771543253,1,2,2,propionate biosynthetic process,BP,ACSS2;ACSS1
4291,GO:0009726,0.0143380363149098,1,2,2,detection of endogenous stimulus,BP,ABCG1;PKD2
8634,GO:0034189,0.0143400750940755,1,2,2,very-low-density lipoprotein particle binding,MF,VLDLR;PCSK9
19744,GO:2000182,0.0143404640388715,1,2,2,regulation of progesterone biosynthetic process,BP,EGR1;DGKQ
4538,GO:0010616,0.014342396772761,0.999061878728526,3,5,negative regulation of cardiac muscle adaptation,BP,ERRFI1;ATP2B4;LMNA
18288,GO:1903243,0.014342396772761,0.999061878728526,3,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,ERRFI1;ATP2B4;LMNA
4211,GO:0009374,0.0143525701954129,0.999060954333807,3,5,biotin binding,MF,ACACB;PC;HLCS
13986,GO:0060733,0.0143552879633094,1,2,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,IMPACT;EIF2AK4
15126,GO:0071262,0.0143552879633094,1,2,2,regulation of translational initiation in response to starvation,BP,IMPACT;EIF2AK4
15127,GO:0071264,0.0143552879633094,1,2,2,positive regulation of translational initiation in response to starvation,BP,IMPACT;EIF2AK4
17835,GO:1902083,0.0143665563591846,0.999059683065598,3,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,SNTA1;ATP2B4;NCOA7
19734,GO:2000169,0.0143665563591846,0.999059683065598,3,5,regulation of peptidyl-cysteine S-nitrosylation,BP,SNTA1;ATP2B4;NCOA7
11137,GO:0045210,0.0143688607724132,1,2,2,FasL biosynthetic process,BP,PHLDA1;JAK3
13586,GO:0060083,0.0143738762866629,1,2,2,smooth muscle contraction involved in micturition,BP,KCNMA1;TRPV1
1851,GO:0004517,0.0143745012479731,1,2,2,nitric-oxide synthase activity,MF,NOS1;NOS3
16922,GO:0098936,0.0143892913938303,1,2,2,intrinsic component of postsynaptic membrane,CC,PTPRS;NLGN2
16959,GO:0099055,0.0143892913938303,1,2,2,integral component of postsynaptic membrane,CC,PTPRS;NLGN2
17000,GO:0099240,0.0143892913938303,1,2,2,intrinsic component of synaptic membrane,CC,PTPRS;NLGN2
17077,GO:0099699,0.0143892913938303,1,2,2,integral component of synaptic membrane,CC,PTPRS;NLGN2
4177,GO:0009258,0.0144155135467005,1,2,2,10-formyltetrahydrofolate catabolic process,BP,ALDH1L2;ALDH1L1
5361,GO:0016155,0.0144155135467005,1,2,2,formyltetrahydrofolate dehydrogenase activity,MF,ALDH1L2;ALDH1L1
10341,GO:0043171,0.0144783828365357,0.996307794995189,7,23,peptide catabolic process,BP,RNPEPL1;GGT1;ADAMTS13;CHAC1;LTA4H;CTSH;RNPEP
12258,GO:0048589,0.0145033180509111,0.990086387572114,62,396,developmental growth,BP,DUSP6;PTPRS;GAMT;BBS2;APOE;GSN;THBS3;POSTN;WWC3;SEMA4B;VEGFA;ERCC1;SHANK2;ERCC6;ZFP36L1;ADARB1;EVC;ULK2;WWTR1;ULK1;SPRY2;PRKCZ;PAK1;FGFR3;SEMA3F;PLXNB3;ZP3;ACVR2B;PLXNB1;EREG;SPG11;LPAR3;IMPACT;AREG;SLIT3;ACACB;LAMB2;SEMA5A;STK40;VANGL2;SLITRK6;TWF2;SEMA3B;KIF26B;TGFBR2;WNT7A;SEMA4G;RXRA;AKT1;C9ORF72;INSR;WNT3;TENM4;GPR21;TP73;PHLDA2;ETNK2;TGFBR3;FGFR1;FKBP8;EIF2AK4;APBA1
7604,GO:0031999,0.014575218649734,1,2,2,negative regulation of fatty acid beta-oxidation,BP,ACACB;AKT1
9943,GO:0042327,0.0145764072023942,0.989242167342642,96,654,positive regulation of phosphorylation,BP,XDH;DUSP6;DLG4;F2R;EGR1;PTK6;TIMP2;VEGFA;EGFR;PRNP;DUSP5;RAPGEF3;TNFSF15;IGFBP4;ERCC6;MST1R;HBEGF;CTF1;CNTN1;SLC27A1;MAP2K1;PKN1;SHC2;ITGA6;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;DLG3;NEURL1;ACVR2B;NGFR;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PKD2;AREG;MAPK3;CSPG4;VANGL2;MLXIPL;ARHGEF2;MAP2K2;PAK6;PKD1;FLOT1;VLDLR;MAP3K12;TGFBR2;TRPV4;ITGA1;APLN;MINK1;PROM2;WNT7A;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;CHEK2;FGFR4;WDFY2;INSR;RPS6KA5;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;FYN;GDF15;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2;UNC119;CAMKK1
17289,GO:0140192,0.0146006281047033,1,2,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1;ATP2B4
9793,GO:0040036,0.0146245936888387,0.99626282721277,7,23,regulation of fibroblast growth factor receptor signaling pathway,BP,DUSP6;FGFBP1;SPRY2;SPRY4;FAM20C;SULF2;APLN
9872,GO:0042165,0.014661727094874,0.996788064450938,6,18,neurotransmitter binding,MF,HTR7;GLDC;CBS;NIPSNAP1;SRR;CHRM3
4839,GO:0014051,0.0146887994107025,0.999030254369553,3,5,gamma-aminobutyric acid secretion,BP,NTSR1;SV2A;APBA1
17985,GO:1902495,0.0147133518523719,0.992470438739673,22,114,transmembrane transporter complex,CC,DLG4;KCNG1;SCN8A;NOS1;SHANK2;SCN4B;ABCA2;ABCA7;DLG3;OLFM2;ANO1;VAMP2;KCNC4;KCNAB2;LRRC8A;KCNMA1;HERPUD1;CPT1C;TTYH3;SCNN1A;ATP12A;STX1A
12383,GO:0048846,0.0147402885409334,0.995764638255623,8,28,axon extension involved in axon guidance,BP,SEMA4B;VEGFA;SEMA3F;SLIT3;SEMA5A;SEMA3B;SEMA4G;WNT3
17916,GO:1902284,0.0147402885409334,0.995764638255623,8,28,neuron projection extension involved in neuron projection guidance,BP,SEMA4B;VEGFA;SEMA3F;SLIT3;SEMA5A;SEMA3B;SEMA4G;WNT3
4940,GO:0014909,0.0147413254182256,0.994655209588827,11,45,smooth muscle cell migration,BP,DOCK4;POSTN;LRP1;PLAT;PAK1;SSH1;SORL1;PLAU;FOXO4;ITGA2;CORO1B
4250,GO:0009581,0.0148313284027447,0.994375206288695,12,47,detection of external stimulus,BP,SERPINE2;NTSR1;PITPNM1;ANO1;PKD2;REEP6;PKD1;TTN;TRPV1;FYN;ITGA2;UNC119
5727,GO:0016878,0.0148744351727574,0.996730716675208,6,18,acid-thiol ligase activity,MF,ACSF2;SLC27A1;ACSS2;SLC27A3;SUCLG2;ACSS1
4464,GO:0010464,0.0148976479124227,0.996178585787099,7,23,regulation of mesenchymal cell proliferation,BP,CTNNBIP1;VEGFA;FBXW4;LRP5;TGFBR2;LMNA;FGFR1
13845,GO:0060488,0.0149221149370238,1,2,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,VANGL2;CELSR1
13846,GO:0060489,0.0149221149370238,1,2,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,VANGL2;CELSR1
13847,GO:0060490,0.0149221149370238,1,2,2,lateral sprouting involved in lung morphogenesis,BP,VANGL2;CELSR1
11519,GO:0046068,0.0149842240634248,0.996151804902381,7,23,cGMP metabolic process,BP,APOE;VEGFA;NOS1;NPR2;PDE2A;NOS3;ADCY6
3392,GO:0007173,0.01515828504151,0.992357052746085,21,108,epidermal growth factor receptor signaling pathway,BP,PTK6;EGFR;ARAP1;HBEGF;SHC1;SPRY2;GRB7;NEURL1;EREG;AREG;ERRFI1;MVB12B;RHBDF1;ITGA1;RHBDF2;AKT1;TSG101;RPS6KA5;REPS2;PAG1;HIP1
12380,GO:0048843,0.0151920252647706,0.996644721127747,6,18,negative regulation of axon extension involved in axon guidance,BP,SEMA4B;SEMA3F;SEMA5A;SEMA3B;SEMA4G;WNT3
11216,GO:0045408,0.01519589999281,0.99805234173559,4,9,regulation of interleukin-6 biosynthetic process,BP,EREG;INPP5D;CEBPB;PTAFR
18411,GO:1903522,0.0152826432459679,0.991888808846306,24,128,regulation of blood circulation,BP,DOCK4;F2R;EGFR;NOS1;SCN4B;HBEGF;GAA;ITPR3;NPR2;GSTO1;THRA;SNTA1;GSTM2;APLN;NOS3;PTAFR;ATP2B4;AKT1;ITPR2;CHRM3;EHD3;TRPC1;ADA;EPAS1
6075,GO:0019233,0.0153071449186385,0.99474401811949,10,40,sensory perception of pain,BP,F2R;NTSR1;NLGN2;NIPSNAP1;ANO1;MAPK3;TRPV1;PTAFR;FYN;ITGA2
2296,GO:0005262,0.0153451743049824,0.994094647997912,12,51,calcium channel activity,MF,ORAI3;ITPR3;ORAI2;PKD2;PKD1;TRPV4;PDE2A;TRPV1;GAS6;ITPR2;TPCN1;TRPC1
12599,GO:0050807,0.0154103039118791,0.992528348309645,19,95,regulation of synapse organization,BP,APOE;ZMYND8;NFATC4;ADGRL1;PRNP;ADGRB2;NLGN2;CAPRIN2;NEURL1;ETV5;SLITRK6;SSH1;TPBG;WNT7A;CAMK1;AMIGO2;ARHGAP44;FYN;EPHB2
5861,GO:0017171,0.0154707768084823,0.99249018784028,19,96,serine hydrolase activity,MF,HTRA1;TYSND1;MMP1;PLAT;PRSS3;PCSK1;PRSS8;PLA2G6;CTSB;C1RL;PRSS22;RHBDF1;PCSK9;LONP2;RHBDF2;CTSH;PLAU;DPP7;MMP19
10605,GO:0043619,0.015495833747524,0.998001829486489,4,9,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2;ATF4;EPAS1;CHD6
12896,GO:0051270,0.015515639543381,0.988630552459854,90,610,regulation of cellular component movement,BP,DOCK4;BBS2;F2R;APOE;ZMYND8;SERPINE2;PGF;POSTN;SEMA4B;LRP1;ALOX15B;VEGFA;EGFR;FBLN1;CD9;IDH2;ARAP3;MMP28;ADARB1;ARAP1;HBEGF;NISCH;HYAL1;ARPIN;PKN1;ITGA6;FAM110C;SPRY2;GRB7;VEGFB;LAMA5;TTBK2;PAK1;MCTP1;CEMIP;SEMA3F;PLXNB3;ZSWIM4;ZP3;PLXNB1;EREG;RHOBTB2;C5;ECM1;MAPK3;SEMA5A;IFITM1;RHOF;SRGAP3;ARHGEF2;DMTN;SEMA3B;SSH1;HDAC5;SORL1;PTPRU;TGFBR2;TRPV4;TMSB4X;SMURF2;NOS3;MINK1;WNT7A;EPHA1;SEMA4G;GAS6;BCR;PTAFR;CTSH;AKT1;LAMB1;LMNA;RAB25;PLAU;INSR;WNT3;FOXO4;MAP2K5;BRAF;TIMP1;BCL6;PHLDA2;ADA;PLXND1;TGFBR3;ITGA2;FGFR1;ERBB2;CORO1B;ROBO4
4879,GO:0014745,0.0155157614322033,0.997998462067368,4,9,negative regulation of muscle adaptation,BP,ERRFI1;NOS3;ATP2B4;LMNA
832,GO:0002133,0.0155383307673279,1,2,2,polycystin complex,CC,PKD2;PKD1
15543,GO:0072021,0.0155383307673279,1,2,2,ascending thin limb development,BP,PKD2;PKD1
15634,GO:0072177,0.0155383307673279,1,2,2,mesonephric duct development,BP,PKD2;PKD1
15665,GO:0072218,0.0155383307673279,1,2,2,metanephric ascending thin limb development,BP,PKD2;PKD1
10410,GO:0043271,0.0155614033086614,0.993219932771942,15,70,negative regulation of ion transport,BP,SERPINE2;NTSR1;ANK3;NOS1;STK39;GSTO1;PKD2;ATF4;GSTM2;WNK4;PCSK9;ANO9;NOS3;AKT1;EPHB2
706,GO:0001932,0.0155708782277293,0.987951569253919,133,937,regulation of protein phosphorylation,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;EGR1;PTK6;GJC2;PDCD4;TIMP2;VEGFA;EGFR;PRNP;FBLN1;DUSP5;RAPGEF3;TNFSF15;IGFBP4;ERCC6;MST1R;ADARB1;HBEGF;CTF1;CNTN1;SLC27A1;WWTR1;MAP2K1;PKN1;DDIT4;SHC2;SYNGAP1;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;SPRY4;DLG3;NEURL1;ACVR2B;NGFR;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;SESN2;IMPACT;PKD2;AREG;MAPK3;CSPG4;TRPT1;ERRFI1;STK40;VANGL2;RGS14;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;DMTN;PAK6;PKD1;FLOT1;TTN;SORL1;VLDLR;MAP3K12;LRP5;PKIB;TGFBR2;TRPV4;ITGA1;TRIB3;CDK5RAP3;MINK1;PROM2;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;NBR1;TADA3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;CDKN1C;MICAL1;CHEK2;SPDYE2;SPDYE2B;TSG101;FGFR4;WDFY2;C9ORF72;INSR;RPS6KA5;CTDSPL;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;FYN;LEMD2;SIRT2;GDF15;AVPI1;LAMTOR2;MAP3K10;EPHB2;PER1;FGFR1;FKBP8;ERBB2;EIF2AK4;UNC119;CAMKK1
3540,GO:0007565,0.0155760239353529,0.99184321525749,23,122,female pregnancy,BP,FOS;PGF;FBLN1;CST3;CYP27B1;EPOR;PLA2G6;CTSB;PTHLH;TGFBR2;SMURF2;LDOC1;RXRA;AKT1;IGFBP7;IGFBP2;MAGED2;TIMP1;HFE;SLC38A2;RPL29;ITGA2;BSG
1986,GO:0004709,0.0155958269017114,0.99398422592801,12,51,MAP kinase kinase kinase activity,MF,EGFR;MST1R;FGFR3;MAP3K12;EPHA1;FGFR4;INSR;BRAF;MAP3K10;EPHB2;FGFR1;ERBB2
2620,GO:0005940,0.015704581146856,0.997966485081418,4,9,septin ring,CC,SEPT5;SEPT10;SEPT6;SEPT8
7204,GO:0031105,0.015704581146856,0.997966485081418,4,9,septin complex,CC,SEPT5;SEPT10;SEPT6;SEPT8
7691,GO:0032160,0.015704581146856,0.997966485081418,4,9,septin filament array,CC,SEPT5;SEPT10;SEPT6;SEPT8
5994,GO:0019005,0.0157218286888052,0.993915598555771,12,52,SCF ubiquitin ligase complex,CC,BTBD2;FBXO2;ABTB1;FBXW4;FBXW8;FBXO27;FBXO17;FBXO6;FBXL15;SPSB3;FBXO25;BTBD11
4064,GO:0009119,0.015967411011494,0.992584245882744,17,84,ribonucleoside metabolic process,BP,DLG4;GAMT;NT5E;APOBEC3C;DLG3;NME4;APOBEC3F;GTPBP1;MOCOS;PEMT;UCKL1;CARD11;DGUOK;UPP1;APRT;ADA;NUDT18
5678,GO:0016798,0.0160057011271825,0.992571364438634,17,83,hydrolase activity, acting on glycosyl bonds,MF,EDEM1;DNPH1;GAA;HYAL1;NAGLU;CEMIP;NEIL1;MACROD1;FUCA1;HEXDC;HEXB;MAN2C1;HEXA;MAN2B1;MPG;NAGA;MAN1B1
681,GO:0001892,0.0161668675851068,0.992922529177944,15,70,embryonic placenta development,BP,EGFR;ZFP36L1;MDFI;MAP2K1;FBXW8;PLCD3;PKD2;PLCD1;PKD1;CEBPB;AKT1;KRT19;TFEB;PHLDA2;EPAS1
16297,GO:0090527,0.016168362080766,0.997887410902122,4,9,actin filament reorganization,BP,GSN;EFS;ARAP1;DMTN
5263,GO:0015914,0.0161714786908127,0.99403795489478,11,46,phospholipid transport,BP,APOE;OSBPL5;PITPNM3;PITPNM1;PITPNC1;ABCA7;ABCG1;OSBPL10;PLTP;ATP8B2;STARD10
12045,GO:0048015,0.0165521561502901,0.991737708611254,20,102,phosphatidylinositol-mediated signaling,BP,F2R;SERPINE2;GSN;EGFR;ZFP36L1;RGL2;ZP3;PLXNB1;PI4KAP1;MAPK3;NYAP1;UNC5B;PIK3R2;PTAFR;AKT1;CAT;FYN;SIRT2;FGFR1;ERBB2
3541,GO:0007566,0.0165830432254805,0.994626262492295,9,35,embryo implantation,BP,FBLN1;CST3;TGFBR2;SMURF2;RXRA;IGFBP7;TIMP1;RPL29;BSG
3280,GO:0006970,0.0165882224718868,0.993530594302285,12,52,response to osmotic stress,BP,EGFR;ZFP36L1;MAPK13;PKN1;STK39;PKD2;ERRFI1;ARHGEF2;LRRC8A;KCNMA1;TRPV4;ITGA2
16827,GO:0098772,0.0167517368350446,0.986748381524047,157,1138,molecular function regulator,MF,DLG4;DOCK4;APOE;SERPINE2;PGF;PPP1R35;EVI5L;CDC42EP5;SEMA4B;TIMP2;VEGFA;OBSCN;EGFR;FBLN1;PRDX5;TFPI2;RAPGEF3;TNFSF15;SPTB;CST3;NOS1;GPSM1;ARAP3;SCN4B;ERCC6;TBC1D8;ARHGEF19;RIN1;ARAP1;B3GAT3;HBEGF;RGL2;ARHGAP23;CTF1;PHACTR3;ASAP2;PPP1R14A;MAP2K1;SHC2;SYNGAP1;DGKQ;PLEKHG5;ARL2;SHC1;SPRY2;VEGFB;ADM2;RALGDS;APPL2;PRSS8;PRKCZ;PPP2R3B;SERPING1;FGFR3;SEMA3F;DOCK6;ZP3;ELFN2;ARHGEF4;TRIB2;PLXNB1;EREG;PLEKHG2;DNMBP;TRAPPC9;RINL;MANF;AGAP1;ALS2CL;C5;SESN2;RASA4;AREG;KCNAB2;ERRFI1;DOCK9;RGS14;SNTA1;SRGAP3;ARHGAP22;PLEKHG4;TBC1D14;ARHGEF2;MAP2K2;SAMD3;ANGPTL4;SEMA3B;PTHLH;DOCK11;TBC1D3E;RABGAP1;ACAP3;RALGAPA1;MDK;AZIN2;PAPLN;NLRP1;WNK4;RIN2;PCSK9;PKIB;ARHGAP25;IQSEC2;CMTM7;PSD4;APLN;TRIB3;WNT7A;TRPV1;PIK3R2;SEMA4G;CCS;GAS6;NUDT6;PLEKHG3;BCR;PPP1R15A;ATP2B4;THNSL2;CTSH;PLEKHG6;AKT1;CDKN1C;HMSD;SBF2;FGFR4;PIAS3;ASAP3;FARP1;C9ORF72;SGSM2;TBC1D20;ARHGAP27;WNT3;CKLF;ARHGAP44;TIMP1;JAK3;ADAP1;EPS8L1;FYN;ARHGEF17;GDF15;EPS8L2;VAV3;STX1A;LAMTOR2;TBC1D16;FGFR1;SH3PXD2A;ERBB2;RGS12;C15ORF62;FRS3;MMP17;NET1;SNCB
4941,GO:0014910,0.0168546304041964,0.994121735082217,10,40,regulation of smooth muscle cell migration,BP,DOCK4;POSTN;LRP1;PAK1;SSH1;SORL1;PLAU;FOXO4;ITGA2;CORO1B
2672,GO:0006027,0.0168748740297447,0.994113526333083,10,40,glycosaminoglycan catabolic process,BP,HYAL1;NAGLU;CEMIP;CSPG4;SDC2;FUCA1;HEXB;HEXA;HGSNAT;GALNS
6573,GO:0022407,0.0169040955194716,0.989567422270351,38,227,regulation of cell-cell adhesion,BP,SERPINE2;IL20RB;PRNP;ANK3;CD9;EFNB3;ITGA6;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;PPARA;PDCD1LG2;DMTN;KIF26B;FLOT1;CEBPB;TGFBR2;TRPV4;MINK1;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;ASS1;MAP2K5;LGALS1;HFE;JAK3;BCL6;FYN;ADA;DHPS;ERBB2;PAG1;HLA-G
2489,GO:0005737,0.0171932344649139,0.985280527067015,1021,8368,cytoplasm,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;ISYNA1;APOE;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;CCNG2;PYGB;EGR1;CTNNBIP1;LMF1;THBS3;ALDH7A1;TYSND1;POSTN;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;PTK6;TMEM129;CDC42EP5;ACP5;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;FAM210B;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;RBCK1;RHPN1;D2HGDH;PRNP;ZDHHC1;SCN8A;NR1D1;ERCC1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;SPTB;NPEPL1;LOXL1;DGKA;TSPAN1;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;MICALCL;ACAD10;PGM1;CRTC1;CLCA2;PACS2;NDRG1;ADAMTS13;ABTB1;ARHGEF19;MMP28;COL13A1;GRAMD4;MYH15;MST1R;ARRDC1;ARMCX2;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;HBEGF;RBL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;PYCR2;TMEM134;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;CPT2;MLYCD;ASAP2;FBXW4;PLD3;CUL7;PITPNM3;LHPP;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;MPRIP;NAGLU;OXLD1;PPP1R14A;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;CAPG;DDIT4;ALPK1;OPLAH;LPCAT4;BTG1;SHC2;PLCH2;DNASE1L1;SYNGAP1;PITPNM1;DGKQ;AKR7A2;EML2;TUBG2;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;MARCKSL1;OGDHL;LGALS9B;RAB3B;CD68;PCSK1;MYCBPAP;MYH11;CYBRD1;ITPR3;RALGDS;PITPNC1;UNK;NMRK1;APPL2;CIRBP;CAPRIN2;TPM2;TTBK2;LY6K;PRKCZ;GALE;SERPING1;PAK1;ABCA7;ANKS6;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;FGFR3;FBXO41;SEC14L2;CEMIP;KDM3A;MTHFR;BRI3;ARVCF;PHF1;GLDC;NPR2;PLCXD1;CAPNS2;NDUFA4L2;TMEM44;CBS;TMEM187;SPRY4;USP20;ELMO3;DOCK6;SYNE3;DLG3;NMNAT2;DDX59;MICALL2;NME4;PDZD2;CEP250;GRIP2;FBXW8;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;SPPL2B;EAPP;NGFR;MARCH4;ETFB;GSTO1;LCE1E;ARHGEF4;WDR60;LTBP1;MUC19;SYNC;PPCS;SMIM14;FAM117A;MALL;ACTR1B;TRIB2;GPT2;TNS1;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;SSH3;RMI2;CYHR1;OLFM2;PLCD3;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;SCART1;ERMAP;MANF;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;KIF17;SPATS2;APOBEC3F;ACOT1;PLGRKT;CHD3;ANO1;STON1;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;RASA4;IMPACT;IFT27;NLRX1;PKD2;STAT6;SH3TC2;ING4;NUDCD3;ACOT11;VAMP2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;PCLO;PI4KAP1;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;PEX10;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;MVD;DNAL4;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;ADAMTSL1;SNTA1;TUBE1;PAN2;CTSB;HOOK2;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;SRGAP3;PQLC2;KIAA0319L;SDC2;CHMP1B;FBXO17;NRSN2;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;TCTN1;PTPDC1;PLCD1;ARHGEF2;SEPT10;MTMR11;FBF1;INPP5D;PRAF2;TSPYL2;MAP2K2;SRD5A3;HIBADH;FLYWCH1;TWF2;SAMD3;STMN3;SLC50A1;PGPEP1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;MORN4;ATF4;ZFPM1;MOSPD3;CHST6;BBC3;PAK6;DOCK11;SSH1;LRRC45;PCMTD2;SV2A;SLC38A10;PRIMPOL;FAM193B;FRMD4B;RABGAP1;ACAP3;TENM2;FBXO6;KIF26B;IFI6;REEP6;CBX7;PKD1;FUCA1;ATXN10;RALGAPA1;FLOT1;CEP68;MDK;TTN;PSKH1;HLCS;AZIN2;HSD11B1;TSNARE1;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;NADK;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;RFX2;ENDOG;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;PCSK9;DBNDD1;PKIB;PKN3;FBXL15;METTL23;AQP3;ACADS;FBXL16;CEP131;ISG20;LONP2;EPN3;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;ARHGAP25;IQSEC2;DIRC2;TTC12;ITGA1;IL17RE;TNFAIP8L1;TMSB4X;MAP1LC3A;MOCOS;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;BHLHE40;ALDH1L2;CALCOCO1;PEMT;EDA;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;PROM2;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;RPUSD3;ANGEL1;SHARPIN;CCS;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ALKBH7;CROCC;BCR;KLHDC8B;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;C19ORF33;CEP112;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;SRR;NBEAL2;BOLA1;KIF13B;SPAG16;UCKL1;NECAB3;CAMK1;TERC;PTAFR;CYP2R1;PPP1R15A;RIMS3;ADCY6;TNRC18;RAB43;ATP2B4;SPATA7;STRADB;CTSH;WDR19;ACOX3;ACAD11;PNRC1;FBXL8;UACA;GSDMC;GSTO2;ASNS;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;CRY2;MZT2B;B4GALT2;BEX2;LAMB1;CHEK2;HMSD;IFT57;LACTB2;PHYKPL;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;CAPS;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;KIF27;FMNL3;FGFR4;IGF2BP2;RASSF9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;FARP1;DNASE2;LMNA;ASMTL;FAAH;UPP1;SH2B3;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;ARSA;CAPN2;MAN2B1;GOLGA8A;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;TENM4;SLC25A29;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;HOMER2;C6ORF89;PIGQ;LYST;MAP2K5;ZDHHC24;BRAF;YIPF3;ARHGAP44;LETMD1;ASIC1;ALDH1L1;PIDD1;CAT;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;UNC119B;TIMP1;HFE;JAK3;TP73;MTA3;SCNN1A;TUBGCP6;FRAT1;SNX33;APRT;GLCCI1;FCHSD1;TMX4;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;ENDOV;JOSD2;SCYL3;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;REPS2;RABAC1;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;PJA2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;ARHGEF17;SLC25A42;SIRT2;MBOAT2;GDF15;PHLDA2;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;TST;GOLGA2;HCFC1R1;SH3GLB2;ADA;POU2F2;POLR3GL;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;RETSAT;TGFBR3;CIDEB;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;MAGI1;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ESYT3;BLOC1S1;FITM2;RGPD6;FKBP8;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;KDELC2;UST;EIF2AK4;UNC119;CCDC69;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;SFI1;RPL12;MPPE1;HMBOX1;NET1;TTC19;HSP90AB4P;TRIM2;GRB10;TNNI1;CREB3L4;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;TRIM45;APBA1;PEX11A;TMEM8A;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;BTBD11;SIX5
15440,GO:0071804,0.0172283608389218,0.991935412809271,17,83,cellular potassium ion transport,BP,KCNG1;FHL1;PRNP;ANK3;SLC12A7;STK39;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;KLHL24;KCNMA1;TMEM175;ATP12A;SLC9A7;SLC9A5
15441,GO:0071805,0.0172283608389218,0.991935412809271,17,83,potassium ion transmembrane transport,BP,KCNG1;FHL1;PRNP;ANK3;SLC12A7;STK39;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;KLHL24;KCNMA1;TMEM175;ATP12A;SLC9A7;SLC9A5
4262,GO:0009612,0.0172337288158464,0.990627658092445,25,132,response to mechanical stimulus,BP,XPC;SERPINE2;FOS;POSTN;EGFR;PPL;ETV1;PSPH;PKD2;LRP11;MAPK3;BNIP3;SLITRK6;PKD1;TTN;ENDOG;TGFBR2;TRPV4;PDE2A;ASNS;AKT1;IGFBP2;FYN;SLC38A2;ITGA2
5349,GO:0016125,0.0172841769203776,0.991157428529692,21,110,sterol metabolic process,BP,APOE;OSBPL5;LMF1;DGKQ;SEC14L2;ABCG1;ACACB;MVD;SORL1;VLDLR;LRP5;PCSK9;HSD17B7;RXRA;TM7SF2;ACADVL;CAT;SNX17;OSBPL1A;PLPP6;CYP4V2
4251,GO:0009582,0.0172969995059939,0.993275096358336,12,48,detection of abiotic stimulus,BP,SERPINE2;NTSR1;PITPNM1;ANO1;PKD2;REEP6;PKD1;TTN;TRPV1;FYN;ITGA2;UNC119
7612,GO:0032011,0.0173197414816564,0.993932701137658,10,40,ARF protein signal transduction,BP,ARAP3;ARAP1;ASAP2;APPL2;AGAP1;ACAP3;IQSEC2;PSD4;ASAP3;ADAP1
7613,GO:0032012,0.0173197414816564,0.993932701137658,10,40,regulation of ARF protein signal transduction,BP,ARAP3;ARAP1;ASAP2;APPL2;AGAP1;ACAP3;IQSEC2;PSD4;ASAP3;ADAP1
15120,GO:0071248,0.0173850791189139,0.991447594430701,19,97,cellular response to metal ion,BP,NFATC4;FOS;GSN;EGFR;PRNP;ANK3;CARF;RASA4;PKD2;MAPK3;BNIP3;DMTN;ATF4;ENDOG;MAP1LC3A;SPAG16;AKT1;BRAF;HFE
6847,GO:0030324,0.0174652709134228,0.991060547000535,21,109,lung development,BP,VEGFA;EGFR;MAP2K1;SPRY2;LAMA5;ACVR2B;WNT2B;MAPK3;ERRFI1;THRA;STK40;VANGL2;PKD1;HSD11B1;TGFBR2;NOS3;CTSH;CELSR1;ADA;EPAS1;FGFR1
5839,GO:0017134,0.0175461730422389,0.995941103525093,6,19,fibroblast growth factor binding,MF,FGFBP1;FGFR3;S100A13;FGFR4;TGFBR3;FGFR1
12902,GO:0051281,0.0176337285594082,0.995276705938457,7,24,positive regulation of release of sequestered calcium ion into cytosol,BP,F2R;NTSR1;CEMIP;GSTO1;PKD2;GSTM2;TRPC1
16781,GO:0098655,0.0176604432357961,0.987751944711055,63,412,cation transmembrane transport,BP,DLG4;F2R;KCNG1;FHL1;GJC2;NTSR1;PRNP;SCN8A;ANK3;SLC2A9;NOS1;DDIT3;SHANK2;SCN4B;ORAI3;NLGN2;SLC12A7;ITPR3;STK39;CEMIP;NDUFA4L2;ORAI2;GSTO1;PLA2G6;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;SNTA1;PQLC2;KLHL24;PKD1;KCNMA1;GSTM2;TMEM175;PCSK9;TRPV4;TMSB4X;PDE2A;MINK1;TRPV1;GAS6;ATP7B;MFSD3;ATP2B4;STEAP2;ITPR2;TCIRG1;STEAP3;SLC25A29;TPCN1;ASIC1;HFE;SCNN1A;ATP12A;SLC9A7;EHD3;FYN;TRPC1;EPHB2;SLC39A11;SLC9A5
13554,GO:0060047,0.0176678713898645,0.990502976006304,24,126,heart contraction,BP,NOS1;SCN4B;HBEGF;GAA;VEGFB;ITPR3;NPR2;GSTO1;THRA;SNTA1;TTN;GSTM2;APLN;NOS3;TNNI2;ATP2B4;ITPR2;TNNT1;TAZ;EHD3;TRPC1;ADA;EPAS1;TNNI1
5077,GO:0015318,0.0176678730298616,0.987823372642053,61,396,inorganic molecular entity transmembrane transporter activity,MF,DLG4;KCNG1;SCN8A;SLC7A8;SLC16A3;SLC2A9;CLCA2;SCN4B;ORAI3;SLC27A1;SLC16A5;SLC43A1;SLC12A7;ITPR3;SLC37A2;NDUFA4L2;TMEM44;ORAI2;DLG3;ANO8;ABCG1;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;SLC22A18;PQLC2;LRRC8A;SLC38A10;PKD1;KCNMA1;TMEM175;AQP3;TRPV4;ANO9;PDE2A;TRPV1;GAS6;ATP7B;MFSD3;TTYH3;ATP2B4;ITPR2;SLC6A9;TCIRG1;SLC6A6;TMEM63C;SLC25A29;TPCN1;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC37A4;SLC38A2;TRPC1;SLC39A11;SLC10A6;BSG;SLC9A5
13493,GO:0055090,0.0177150530939012,0.996659303312561,5,14,acylglycerol homeostasis,BP,APOE;SESN2;MLXIPL;ANGPTL4;FITM2
14677,GO:0070328,0.0177150530939012,0.996659303312561,5,14,triglyceride homeostasis,BP,APOE;SESN2;MLXIPL;ANGPTL4;FITM2
10622,GO:0043649,0.0177739271808822,0.996645265675338,5,14,dicarboxylic acid catabolic process,BP,GLUL;ALDH1L2;GLUD1;ALDH1L1;ACOT8
3216,GO:0006865,0.0177917717614702,0.991864660026053,16,77,amino acid transport,BP,NTSR1;SLC7A8;SLC43A1;STK39;VAMP2;PQLC2;PRAF2;SV2A;SLC38A10;TRPV1;SLC6A9;SLC6A6;SLC25A29;SLC38A2;STX1A;APBA1
3592,GO:0008021,0.0179326460170902,0.990960938012106,20,104,synaptic vesicle,CC,PTPRS;DLG4;DNM1;BRSK1;SYT8;SYNGR1;RAB3B;MCTP1;VAMP2;SEPT5;PI4K2A;SV2A;DBNDD1;RAB40B;SEPT6;ICA1;RABAC1;RAB13;STX1A;APBA1
3629,GO:0008092,0.0180180540790114,0.986538280805312,98,668,cytoskeletal protein binding,MF,APOE;ESPN;FLNC;S100A6;GSN;WIPF1;CLIP2;OBSCN;EGFR;PRNP;S100A4;ANK3;SPTB;DNM1;PARVB;BRSK1;NDRG1;MYH15;MSRB2;OBSL1;PHACTR3;MPRIP;CAPG;EML2;FAM110C;MARCKSL1;RAB3B;MYH11;TPM2;TTBK2;SYNE3;MICALL2;SHROOM4;CCDC88B;TNS1;SSH3;KIF17;IMPACT;PKD2;RGS14;DNAL4;SNTA1;HOOK2;MYH3;ARHGEF2;TWF2;STMN3;KIF21B;DMTN;SSH1;RABGAP1;KIF26B;TTN;KCNMA1;MAP6;ALDOC;NDE1;TRIOBP;TRPV4;TAGLN3;TMSB4X;MAP1LC3A;NOS3;FMNL2;CROCC;MAPRE3;TNNI2;KIF13B;REEP4;MICAL1;TNNT1;KIF27;FMNL3;TMOD2;FARP1;CAPN2;MARK4;RAB25;ADD3;HOMER2;TUBGCP6;MIB2;SPIRE1;FBXO25;EPS8L1;FYN;EML3;GOLGA2;EPS8L2;MYO18A;STX1A;MAGI1;SPATA6;CCDC69;CORO1B;TNNI1;HIP1;PLEKHH2
19726,GO:2000145,0.0180316849819586,0.986837445436336,84,568,regulation of cell motility,BP,DOCK4;BBS2;F2R;APOE;ZMYND8;SERPINE2;PGF;POSTN;SEMA4B;LRP1;ALOX15B;VEGFA;EGFR;FBLN1;IDH2;ARAP3;MMP28;ADARB1;HBEGF;NISCH;HYAL1;ARPIN;PKN1;ITGA6;FAM110C;SPRY2;GRB7;VEGFB;LAMA5;TTBK2;PAK1;MCTP1;CEMIP;SEMA3F;PLXNB3;ZP3;PLXNB1;EREG;RHOBTB2;C5;ECM1;MAPK3;SEMA5A;IFITM1;RHOF;SRGAP3;ARHGEF2;DMTN;SEMA3B;SSH1;HDAC5;SORL1;PTPRU;TGFBR2;TRPV4;TMSB4X;SMURF2;NOS3;MINK1;WNT7A;EPHA1;SEMA4G;GAS6;BCR;PTAFR;CTSH;AKT1;LAMB1;LMNA;RAB25;PLAU;INSR;FOXO4;MAP2K5;BRAF;TIMP1;PHLDA2;ADA;PLXND1;ITGA2;FGFR1;ERBB2;CORO1B;ROBO4
6664,GO:0030031,0.0180498224198241,0.987324371680376,67,439,cell projection assembly,BP,BBS2;ESPN;ZMYND8;GSN;EVI5L;CDC42EP5;IFT140;NINL;PARVB;ARAP1;BBS1;WWTR1;SDCCAG8;ITGA6;FAM110C;DNAH1;NPHP4;LAMA5;TTBK2;PLXNB3;CEP250;NEURL1;ARHGEF4;WDR60;SSH3;LPAR3;KIF17;IFT27;NUDCD3;SEPT5;VANGL2;CNTRL;TCTN1;PTPDC1;SEPT10;FBF1;TWF2;DMTN;DOCK11;SSH1;TENM2;ATXN10;RFX2;NDE1;CEP131;CEP126;CROCC;SPAG16;WDR19;TMEM80;IFT57;SEPT6;KIF27;MARK4;HAUS4;UNC119B;CSNK1E;EPS8L1;EHD3;RHOBTB3;EPS8L2;VAV3;SEPT8;SPATA6;UNC119;C15ORF62;SFI1
5516,GO:0016491,0.0180840177623907,0.9869769418085,77,527,oxidoreductase activity,MF,XDH;H6PD;PRODH;ALDH7A1;GPX3;ALOX15B;D2HGDH;HADH;PRDX5;LOXL1;IDH2;NOS1;ACAD10;PHGDH;PYCR2;CYP3A5;DHTKD1;ALDH4A1;HSD17B14;PHYHD1;MSRB2;TXNRD3;CYP27B1;CRYL1;AKR7A2;OGDHL;CYBRD1;HSD11B1L;PHYH;ERO1B;BLVRB;KDM3A;MTHFR;GLDC;NDUFA4L2;CBS;DHRS12;ETFB;GSTO1;DHRS4;GSTT1;SESN2;KCNAB2;SRD5A3;HIBADH;SDHA;KDM4C;HSD11B1;GSTM2;KDM7A;PTGR2;ACADS;HSD17B7;ALDH1L2;NOS3;CCS;GLUD1;ALKBH7;CYP2R1;ACOX3;ACAD11;GSTO2;TM7SF2;STEAP2;MICAL1;PHF2;STEAP3;CBR4;ACADVL;TXNRD2;ALDH1L1;CAT;OGFOD2;RETSAT;SDHAF4;KDSR;CYP4V2
11635,GO:0046394,0.0181084016503901,0.988227115419479,46,286,carboxylic acid biosynthetic process,BP,GAMT;GLUL;ALOX15B;NAGS;NR1D1;PGM1;GGT1;PHGDH;PYCR2;DHTKD1;MLYCD;UROS;HYAL1;DDIT4;OGDHL;CEMIP;CBS;GPT2;PSAT1;PSPH;PPARA;ACACB;CSPG4;ACSS2;LTA4H;MLXIPL;GALK1;ACOT7;ALDOC;TRIB3;GLUD1;SRR;ATP2B4;THNSL2;ASNS;ASS1;FGFR4;CBR4;ACADVL;INSR;ACSS1;OSBPL1A;CTH;UST;PFKL;ACOT8
18049,GO:1902667,0.0181982646215637,0.994526256140107,8,29,regulation of axon guidance,BP,SEMA4B;VEGFA;SEMA3F;ZSWIM4;SEMA5A;SEMA3B;SEMA4G;WNT3
487,GO:0001540,0.0182126083740411,0.993546938561143,10,41,amyloid-beta binding,MF,APOE;FBXO2;PRNP;CST3;APBB3;SORL1;INSR;EPHB2;ITGA2;APBA1
6282,GO:0019897,0.0182874317201448,0.990768942401994,20,103,extrinsic component of plasma membrane,CC,DLG4;SYTL1;SERPINE2;S100A6;PTK6;SNX9;PRSS8;ESYT2;KCNAB2;ERRFI1;MYZAP;PRSS22;PCSK9;EPN3;FARP1;GNAL;JAK3;FYN;ESYT3;HIP1
935,GO:0002335,0.0183976509612547,0.995697221603459,6,19,mature B cell differentiation,BP,DOCK11;CMTM7;LGALS1;ADA;POU2F2;MFNG
18932,GO:1904724,0.0185022711140701,0.993864515668371,9,36,tertiary granule lumen,CC,TIMP2;CST3;PGM1;PRSS3;LTA4H;ALDOC;CTSH;YPEL5;METTL7A
8020,GO:0032673,0.0186249575813816,0.996440910923182,5,14,regulation of interleukin-4 production,BP,IL20RB;PRKCZ;ZP3;ZFPM1;CEBPB
770,GO:0002026,0.0187887917087793,0.996401264745397,5,14,regulation of the force of heart contraction,BP,NOS1;GAA;APLN;NOS3;ATP2B4
11087,GO:0045121,0.0188187558290962,0.988637817233899,34,199,membrane raft,CC,F2R;MARVELD1;NTSR1;EGFR;PRNP;NOS1;CNTN1;LY6K;PRKCZ;MALL;STAT6;MAPK3;PI4K2A;INPP5D;FLOT1;KCNMA1;UNC5B;TGFBR2;ITGA1;SMURF2;NOS3;PROM2;ATP2B4;CARD11;CAPN2;INSR;LTB4R;MYOF;FYN;LAMTOR2;PLLP;PAG1;BSG;IKBKB
4043,GO:0009084,0.0188402360725375,0.996388795644432,5,14,glutamine family amino acid biosynthetic process,BP,GLUL;NAGS;PYCR2;GLUD1;ASS1
13922,GO:0060627,0.0188819207308384,0.987252823685936,54,344,regulation of vesicle-mediated transport,BP,DLG4;APOE;SYTL1;EVI5L;LRP1;VEGFA;TSPAN1;ARAP3;TBC1D8;SYT8;MAP2K1;VPS11;RAB3B;ABCA7;MCTP1;ZP3;PLA2G6;STON1;VAMP2;SEPT5;PCLO;MAPK3;TBC1D14;MAP2K2;LRSAM1;TBC1D3E;RABGAP1;FLOT1;SORL1;PCSK9;APLN;RAB40B;PROM2;GAS6;DNAJC6;BCR;PTAFR;RIMS3;MICAL1;TSG101;SGSM2;TBC1D20;RAB25;BRAF;HFE;SNX33;SNX17;RAB13;MYO18A;STX1A;TBC1D16;ITGA2;UNC119;HIP1
14489,GO:0065008,0.0188858590579359,0.984091472601586,311,2381,regulation of biological quality,BP,XDH;PTPRS;DLG4;DOCK4;BBS2;F2R;APOE;SYTL1;ZMYND8;NFATC4;SERPINE2;FHL1;IL20RB;GSN;ADGRL1;EGR1;CTNNBIP1;ALDH7A1;POSTN;WIPF1;CDC42EP5;ACP5;GLUL;FAM210B;SEMA4B;VEGFA;NTSR1;EGFR;PRNP;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;HADH;PRDX5;ANK3;TFPI2;RAPGEF3;SPTB;DGKA;TSPAN1;CD9;SNPH;CRTAP;DNM1;PARVB;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;CRTC1;SCN4B;ADGRB2;ERCC6;ADAMTS13;ZFP36L1;SYT8;ARAP1;GAA;PYGL;TFDP2;MXI1;HSD17B14;MDFI;BBS1;PLAT;LTBP4;ULK2;SLC27A1;NISCH;ARPIN;TXNRD3;SYNGR1;POLD4;CYP27B1;PCK2;ABCA2;PKN1;CAPG;SYNGAP1;PHF21A;DGKQ;ARL2;VPS11;NPHP4;BLOC1S4;ADM2;RAB3B;NLGN2;PCSK1;SLC12A7;CYBRD1;ITPR3;CIRBP;CAPRIN2;TTBK2;PRKCZ;HTR7;SERPING1;PAK1;ABCA7;AARS;MCTP1;STK39;ERO1B;CEMIP;GLDC;NPR2;SEMA3F;PLXNB3;DOCK6;SYNE3;SLCO4A1;NEURL1;ACVR2B;RAG1;NGFR;ETV5;GSTO1;LTBP1;MALL;PLXNB1;PNPLA3;SSH3;PLEKHG2;DHRS4;RHOBTB2;PLA2G6;ABCG1;LPAR3;S100A13;PPARA;ANO1;SESN2;PKD2;VAMP2;SEPT5;PCLO;KCNC4;ACACB;MAPK3;BNIP3;SEMA5A;THRA;DOCK9;RGS14;RHOF;SNTA1;SLITRK6;PQLC2;MLXIPL;INPP5D;SRD5A3;TWF2;DMTN;LRRC8A;ANGPTL4;SEMA3B;PROCR;ZFPM1;BBC3;DOCK11;SSH1;SV2A;IFI6;PKD1;FLOT1;KCNMA1;HSD11B1;WHAMMP3;SORL1;PCBP4;HERPUD1;GSTM2;TPBG;TEP1;TMEM175;ENDOG;LRP5;WNK4;PCSK9;PKIB;AQP3;TRIOBP;TRPV4;ITGA1;TMSB4X;ANO9;HSD17B7;PDE2A;APLN;HMG20B;NOS3;HEXB;WNT7A;TRPV1;BNIP3L;PIK3R2;SEMA4G;GAS6;GLUD1;ERN1;ALKBH7;CROCC;BCR;ATP7B;TADA3;CAMK1;TERC;PTAFR;CYP2R1;PPP1R15A;RIMS3;ADCY6;ATP2B4;SPATA7;CTSH;ACOX3;STEAP2;AKT1;ITPR2;CARD11;MICAL1;CRY2;AMIGO2;CHEK2;ASS1;FMNL3;FGFR4;IGF2BP2;SLC6A9;TMOD2;PIAS3;TCIRG1;STEAP3;ACADVL;DNASE2;SH2B3;TBC1D20;ICA1;PLAU;INSR;WNT3;COG7;PNPLA4;TPCN1;TXNRD2;HOMER2;BRAF;GPR21;ARHGAP44;LETMD1;ASIC1;PLB1;LGALS1;HFE;JAK3;TP73;SCNN1A;CHRM3;APRT;FCHSD1;TMX4;ATP12A;SPIRE1;CSNK1E;BCL6;SLC9A7;EPS8L1;EHD3;FYN;ZC3H12D;ATP8B2;TRPC1;ADA;PLXND1;RHOBTB3;ENTPD2;CIDEA;EPS8L2;HDAC8;PAIP2;RETSAT;TGFBR3;RNPEP;VAV3;STX1A;EPAS1;EDNRA;DHPS;EPHB2;IGF2BP3;ITGA2;FGFR1;WFS1;FITM2;EIF2AK4;SYVN1;PFKL;C15ORF62;CORO1B;HMBOX1;APBA1;PEX11A;PNKD;DTD1;HIP1;PLEKHH2;SLC9A5
10406,GO:0043267,0.0189222892041777,0.996368887772602,5,14,negative regulation of potassium ion transport,BP,ANK3;NOS1;STK39;ATF4;NOS3
11378,GO:0045785,0.0189634815146632,0.988115502098365,39,236,positive regulation of cell adhesion,BP,VEGFA;ANK3;EFNB3;HYAL1;SMOC2;ITGA6;ARL2;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;NID1;COL8A1;PDCD1LG2;DMTN;KIF26B;FLOT1;TRIOBP;TGFBR2;EPHA1;ECM2;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;BRAF;LGALS1;JAK3;BCL6;FYN;ADA;VAV3;DHPS;ITGA2;ERBB2;HLA-G;NET1
1794,GO:0004435,0.0189670807316499,0.99635801012123,5,14,phosphatidylinositol phospholipase C activity,MF,PLCH2;PLCD3;PLCD1;CHRM3;EDNRA
8097,GO:0032794,0.0190530980059684,0.996337100510791,5,14,GTPase activating protein binding,MF,PLXNB1;RGS14;PLCD1;AKT1;FMNL3
4707,GO:0010874,0.0190613565457383,0.996335091574147,5,14,regulation of cholesterol efflux,BP,APOE;LRP1;ABCA7;ABCG1;PLTP
17438,GO:1900271,0.0190742157423621,0.995501435866561,6,19,regulation of long-term synaptic potentiation,BP,APOE;PRNP;CRTC1;PAIP2;EPHB2;EIF2AK4
5162,GO:0015711,0.0191144804345434,0.987724187406845,43,264,organic anion transport,BP,APOE;OSBPL5;SLC2A3;NTSR1;SLC7A8;SLC16A3;SLC2A9;SLC27A1;CPT2;PITPNM3;SLC16A5;SLC43A1;PITPNM1;PITPNC1;ABCA7;STK39;SLCO4A1;PLA2G6;ABCG1;PPARA;VAMP2;ACACB;OSBPL10;PQLC2;PRAF2;SV2A;SLC38A10;PLTP;TRPV1;RXRA;AKT1;SLC6A9;SLC6A6;SLC25A29;SLC22A15;ATP8B2;SLC38A2;SLC25A42;STX1A;STARD10;SLC10A6;BSG;APBA1
14910,GO:0070820,0.0191505332658884,0.990273489776624,20,105,tertiary granule,CC,SLC2A3;TIMP2;CST3;PGM1;GAA;PRSS3;TMC6;KCNAB2;LTA4H;ALDOC;NBEAL2;PTAFR;CTSH;TCIRG1;PLAU;YPEL5;METTL7A;HGSNAT;AP2A2;LAMTOR2
5323,GO:0016053,0.0191886131639526,0.987475766225335,46,287,organic acid biosynthetic process,BP,GAMT;GLUL;ALOX15B;NAGS;NR1D1;PGM1;GGT1;PHGDH;PYCR2;DHTKD1;MLYCD;UROS;HYAL1;DDIT4;OGDHL;CEMIP;CBS;GPT2;PSAT1;PSPH;PPARA;ACACB;CSPG4;ACSS2;LTA4H;MLXIPL;GALK1;ACOT7;ALDOC;TRIB3;GLUD1;SRR;ATP2B4;THNSL2;ASNS;ASS1;FGFR4;CBR4;ACADVL;INSR;ACSS1;OSBPL1A;CTH;UST;PFKL;ACOT8
12280,GO:0048640,0.019194325558913,0.9916868562721,14,65,negative regulation of developmental growth,BP,PTPRS;BBS2;WWC3;SEMA4B;ULK2;PAK1;FGFR3;SEMA3F;SEMA5A;SEMA3B;TGFBR2;SEMA4G;WNT3;TP73
2522,GO:0005777,0.0192239678646046,0.990232219314161,20,105,peroxisome,CC,XDH;TYSND1;CRAT;PRDX5;IDH2;MLYCD;HMGCL;TMEM173;PHYH;DHRS4;PEX10;MAP2K2;LONP2;ACOX3;ACAD11;CAT;PEX7;PEX1;PEX11A;ACOT8
10063,GO:0042579,0.0192239678646046,0.990232219314161,20,105,microbody,CC,XDH;TYSND1;CRAT;PRDX5;IDH2;MLYCD;HMGCL;TMEM173;PHYH;DHRS4;PEX10;MAP2K2;LONP2;ACOX3;ACAD11;CAT;PEX7;PEX1;PEX11A;ACOT8
2273,GO:0005217,0.0192446621026723,0.9962904385165,5,14,intracellular ligand-gated ion channel activity,MF,ITPR3;PKD2;TRPV1;ITPR2;TPCN1
5060,GO:0015278,0.0192446621026723,0.9962904385165,5,14,calcium-release channel activity,MF,ITPR3;PKD2;TRPV1;ITPR2;TPCN1
5467,GO:0016405,0.0192664962682788,0.996285111724771,5,14,CoA-ligase activity,MF,ACSF2;SLC27A1;ACSS2;SLC27A3;ACSS1
10968,GO:0044782,0.0192904519509141,0.987345160830312,47,293,cilium organization,BP,BBS2;GSN;EVI5L;IFT140;NINL;BBS1;WWTR1;SDCCAG8;DNAH1;NPHP4;LAMA5;TTBK2;CEP250;NEURL1;WDR60;KIF17;IFT27;NUDCD3;SEPT5;VANGL2;CNTRL;TCTN1;PTPDC1;SEPT10;FBF1;ATXN10;RFX2;NDE1;CEP131;CEP126;CROCC;SPAG16;WDR19;TMEM80;IFT57;SEPT6;TTC21A;KIF27;MARK4;HAUS4;UNC119B;CSNK1E;EHD3;SEPT8;SPATA6;UNC119;SFI1
13787,GO:0060402,0.0193216713734565,0.991066842256887,16,78,calcium ion transport into cytosol,BP,F2R;NTSR1;PRNP;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PKD2;GSTM2;TRPV1;ATP2B4;ITPR2;TPCN1;FYN;TRPC1
12220,GO:0048514,0.019366095940504,0.986715850676735,58,373,blood vessel morphogenesis,BP,XDH;APOE;NFATC4;PGF;LRP1;VEGFA;RAPGEF3;ADGRB2;ZFP36L1;CUL7;HYAL1;BTG1;SHC1;SPRY2;VEGFB;ADM2;LAMA5;ELK3;NGFR;EREG;PLCD3;C5;PKD2;HMGA2;COL8A1;ECM1;CSPG4;SEMA5A;SH2D2A;ARHGAP22;PLCD1;ANGPTL4;UNC5B;HDAC5;EGFL7;LRP5;TGFBR2;APLN;NOS3;WNT7A;EPHA1;CTSH;FMNL3;FGFR4;FOXO4;MAP2K5;RNF213;PLXND1;TGFBR3;VAV3;EPAS1;EDNRA;EPHB2;FGFR1;ERBB2;MMP19;ROBO4;TEAD2
7754,GO:0032279,0.0193679827931366,0.989058713883367,27,150,asymmetric synapse,CC,PTPRS;DLG4;PRNP;DNM1;NOS1;SHANK2;SYNGAP1;DLG3;NEURL1;PCLO;KCNAB2;BNIP3;RGS14;ARHGEF2;DMTN;MINK1;SHARPIN;DNAJC6;BCR;ADD3;HOMER2;ARHGAP44;CHRM3;FYN;PJA2;MPDZ;STX1A
7278,GO:0031279,0.0194318698092109,0.995397236251088,6,19,regulation of cyclase activity,BP,TIMP2;NOS1;MAPK3;LTB4R2;GABBR1;NOS3
13393,GO:0052813,0.019432816172666,0.993525517368667,9,35,phosphatidylinositol bisphosphate kinase activity,MF,EGFR;HBEGF;FGFR3;EREG;PIK3R2;FGFR4;FYN;FGFR1;ERBB2
11236,GO:0045494,0.0195643405231385,0.995358520568005,6,19,photoreceptor cell maintenance,BP,BBS2;ERCC6;BBS1;NPHP4;CROCC;SPATA7
15496,GO:0071902,0.0195752487152018,0.987406013924519,43,265,positive regulation of protein serine/threonine kinase activity,BP,DUSP6;F2R;VEGFA;EGFR;DUSP5;TNFSF15;ERCC6;MST1R;SLC27A1;MAP2K1;PKN1;SHC2;SHC1;SPRY2;PAK1;STK39;CEMIP;LPAR3;C5;PKD2;MAPK3;CSPG4;VANGL2;MAP2K2;PKD1;MAP3K12;ITGA1;MINK1;ERN1;MAPRE3;CAMK1;ATP2B4;AKT1;INSR;MAP2K5;BRAF;MAPK10;TP73;AVPI1;LAMTOR2;MAP3K10;FGFR1;ERBB2
1258,GO:0003014,0.0195836724088807,0.991812060003366,13,59,renal system process,BP,F2R;GSN;PKN1;KCNMA1;SULF2;WNK4;AQP3;TRPV1;GAS6;BCR;ADCY6;MAGED2;WFS1
4836,GO:0014047,0.019626457135202,0.99534034400042,6,19,glutamate secretion,BP,NTSR1;VAMP2;TRPV1;SLC38A2;STX1A;APBA1
4124,GO:0009187,0.0196320767135928,0.991789005449897,13,59,cyclic nucleotide metabolic process,BP,APOE;TIMP2;VEGFA;RAPGEF3;NOS1;NPR2;PKD2;PTHLH;LTB4R2;GABBR1;PDE2A;NOS3;ADCY6
14777,GO:0070528,0.0196550595000602,0.99533196956379,6,19,protein kinase C signaling,BP,VEGFA;MC1R;DGKQ;PRKCZ;PLA2G6;FLOT1
12378,GO:0048841,0.0197700318351896,0.994576781831675,7,24,regulation of axon extension involved in axon guidance,BP,SEMA4B;VEGFA;SEMA3F;SEMA5A;SEMA3B;SEMA4G;WNT3
6940,GO:0030574,0.019773547381687,0.992898727777188,10,41,collagen catabolic process,BP,CST3;MRC2;COL13A1;MMP1;COL6A1;COL8A1;CTSB;COL4A6;PHYKPL;MMP19
11413,GO:0045859,0.019787797553787,0.985438823566209,86,582,regulation of protein kinase activity,BP,DUSP6;DLG4;F2R;APOE;EGR1;PTK6;PDCD4;VEGFA;EGFR;PRNP;DUSP5;TNFSF15;ERCC6;MST1R;ADARB1;SLC27A1;WWTR1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;SHC1;SPRY2;PRKCZ;PAK1;STK39;CEMIP;SPRY4;DLG3;NEURL1;ACVR2B;TRIB2;EREG;NAB2;LPAR3;C5;SESN2;PKD2;MAPK3;CSPG4;TRPT1;ERRFI1;VANGL2;RGS14;TSPYL2;MAP2K2;PAK6;PKD1;TTN;SORL1;VLDLR;MAP3K12;LRP5;PKIB;TGFBR2;ITGA1;TRIB3;CDK5RAP3;MINK1;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;CDKN1C;SPDYE2;SPDYE2B;TSG101;INSR;MAP2K5;BRAF;MAPK10;TP73;AVPI1;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2;UNC119;CAMKK1
1397,GO:0003333,0.019827116275921,0.992439222409609,11,47,amino acid transmembrane transport,BP,NTSR1;SLC7A8;SLC43A1;STK39;PQLC2;PRAF2;SLC38A10;SLC6A9;SLC6A6;SLC25A29;SLC38A2
6012,GO:0019068,0.0199556689052791,0.993293997975253,9,36,virion assembly,BP,APOE;PC;CHMP1B;LRSAM1;RAB43;TSG101;TBC1D20;CHMP5;CHMP4C
10238,GO:0042989,0.0199580548740716,0.998253076274452,3,6,sequestering of actin monomers,BP,GSN;TWF2;TMSB4X
4887,GO:0014812,0.0199887702796967,0.991974100888925,12,53,muscle cell migration,BP,DOCK4;POSTN;LRP1;PLAT;PAK1;SSH1;SORL1;PLAU;FOXO4;ITGA2;CORO1B;NET1
18050,GO:1902668,0.0200038868369461,0.995229594104563,6,19,negative regulation of axon guidance,BP,SEMA4B;SEMA3F;SEMA5A;SEMA3B;SEMA4G;WNT3
7327,GO:0031346,0.0200221707913749,0.987172112019733,42,257,positive regulation of cell projection organization,BP,DLG4;APOE;ESPN;ZMYND8;PTK6;CDC42EP5;VEGFA;SHANK2;CRTC1;ARAP1;CNTN1;OBSL1;CUL7;MAP2K1;CAPRIN2;PAK1;PLXNB3;FBXW8;NEURL1;NGFR;PLXNB1;LPAR3;SEMA5A;PLEK2;TWF2;DOCK11;METRN;TENM2;VLDLR;PROM2;CROCC;CAMK1;WNT3;BRAF;EPS8L1;FYN;PLXND1;EPS8L2;ITGA2;FGFR1;C15ORF62;CORO1B
17043,GO:0099565,0.0201507486400296,0.992296515224421,11,47,chemical synaptic transmission, postsynaptic,BP,DLG4;ZMYND8;NTSR1;SHANK2;NLGN2;PRKCZ;SSH1;WNT7A;TRPV1;AKT1;STX1A
16876,GO:0098857,0.0201736457760074,0.987750723617506,34,200,membrane microdomain,CC,F2R;MARVELD1;NTSR1;EGFR;PRNP;NOS1;CNTN1;LY6K;PRKCZ;MALL;STAT6;MAPK3;PI4K2A;INPP5D;FLOT1;KCNMA1;UNC5B;TGFBR2;ITGA1;SMURF2;NOS3;PROM2;ATP2B4;CARD11;CAPN2;INSR;LTB4R;MYOF;FYN;LAMTOR2;PLLP;PAG1;BSG;IKBKB
12175,GO:0048365,0.0203650976582308,0.991800606319879,12,53,Rac GTPase binding,MF,DOCK4;PKN1;PAK1;ARHGEF4;SRGAP3;ARHGEF2;PAK6;FARP1;ARHGAP44;EPS8L1;EPS8L2;VAV3
1960,GO:0004672,0.0203747360412748,0.985418400374704,72,472,protein kinase activity,MF,PTK6;OBSCN;EGFR;NEK9;BRSK1;MST1R;HBEGF;RPS6KA2;EFNB3;LTBP4;ULK2;MAPK13;CDK18;MAP2K1;PKN1;ALPK1;ULK1;TTBK2;PRKCZ;PAK1;STK39;FGFR3;NPR2;ACVR2B;SPEG;LTBP1;EREG;MKNK2;HMGA2;MAPK3;STK40;FAM20C;CNTRL;MAPK12;MAP2K2;PAK6;TTN;PSKH1;MAP3K12;NEK8;WNK4;PKN3;MARK3;TGFBR2;MINK1;EPHA1;ERN1;BCR;CAMK1;STRADB;AKT1;CHEK2;FGFR4;MARK4;INSR;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;CSNK1E;FYN;MAST4;TGFBR3;MAP3K10;EPHB2;FGFR1;ERBB2;EIF2AK4;STK32B;CAMKK1;IKBKB
5181,GO:0015748,0.0204579576162067,0.991052064233449,14,66,organophosphate ester transport,BP,APOE;OSBPL5;PITPNM3;PITPNM1;PITPNC1;ABCA7;SLC37A2;ABCG1;OSBPL10;PLTP;SLC37A4;ATP8B2;SLC25A42;STARD10
10306,GO:0043113,0.0204737805108735,0.99366737736335,8,30,receptor clustering,BP,DLG4;APOE;GSN;SYNGAP1;DLG3;ETV5;SSH1;WDR19
5896,GO:0018107,0.0204883019545823,0.989958352778338,18,91,peptidyl-threonine phosphorylation,BP,MAP2K1;PKN1;DDIT4;DGKQ;ULK1;SPRY2;STK39;CEMIP;DMTN;PSKH1;MAP3K12;TGFBR2;CAMK1;AKT1;CHEK2;SIRT2;MAP3K10;CAMKK1
5780,GO:0017014,0.0205190469065109,0.996970944392322,4,10,protein nitrosylation,BP,NOS1;SNTA1;ATP2B4;NCOA7
5900,GO:0018119,0.0205190469065109,0.996970944392322,4,10,peptidyl-cysteine S-nitrosylation,BP,NOS1;SNTA1;ATP2B4;NCOA7
12857,GO:0051216,0.0205688739370126,0.989479744327924,20,104,cartilage development,BP,BBS2;THBS3;ADAMTS7;MEF2D;EVC;FBXW4;HYAL1;FGFR3;WNT2B;HMGA2;MAPK3;THRA;PTHLH;PKD1;SULF2;TGFBR2;TRPV4;WNT7A;TIMP1;FGFR1
15394,GO:0071688,0.020648619561758,1,3,3,striated muscle myosin thick filament assembly,BP,OBSL1;MYH11;TTN
13686,GO:0060271,0.0206656922945848,0.986445226168907,46,287,cilium assembly,BP,BBS2;GSN;EVI5L;IFT140;NINL;BBS1;WWTR1;SDCCAG8;DNAH1;NPHP4;LAMA5;TTBK2;CEP250;NEURL1;WDR60;KIF17;IFT27;NUDCD3;SEPT5;VANGL2;CNTRL;TCTN1;PTPDC1;SEPT10;FBF1;ATXN10;RFX2;NDE1;CEP131;CEP126;CROCC;SPAG16;WDR19;TMEM80;IFT57;SEPT6;KIF27;MARK4;HAUS4;UNC119B;CSNK1E;EHD3;SEPT8;SPATA6;UNC119;SFI1
12901,GO:0051280,0.020684503301891,0.996938803492061,4,10,negative regulation of release of sequestered calcium ion into cytosol,BP,NTSR1;GSTO1;PKD2;GSTM2
12905,GO:0051284,0.020684503301891,0.996938803492061,4,10,positive regulation of sequestering of calcium ion,BP,NTSR1;GSTO1;PKD2;GSTM2
6575,GO:0022409,0.0207052168598737,0.988512196216162,25,139,positive regulation of cell-cell adhesion,BP,ANK3;EFNB3;ITGA6;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;PDCD1LG2;DMTN;KIF26B;FLOT1;TGFBR2;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;LGALS1;JAK3;BCL6;FYN;ADA;DHPS;HLA-G
13208,GO:0051897,0.0207262031263301,0.990067508192197,17,85,positive regulation of protein kinase B signaling,BP,EGFR;MST1R;HBEGF;MC1R;FAM110C;SPRY2;FGFR3;EREG;SEMA5A;PIK3R2;GAS6;FGFR4;INSR;FYN;FGFR1;ERBB2;HIP1
7315,GO:0031333,0.0207646868965582,0.989799419303396,18,92,negative regulation of protein complex assembly,BP,GSN;CTNNBIP1;SPTB;RPL13A;CAPG;EML2;ULK1;PRKCZ;IMPACT;THRA;ARHGEF2;TWF2;DMTN;SORL1;TRIOBP;TMSB4X;TMOD2;SIRT2
12941,GO:0051347,0.0208553021629998,0.985049053372474,72,481,positive regulation of transferase activity,BP,DUSP6;DLG4;F2R;EGR1;VEGFA;EGFR;PRNP;DUSP5;TNFSF15;ERCC6;MST1R;SLC27A1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;SHC1;SPRY2;PRKCZ;PAK1;STK39;FGFR3;CEMIP;DLG3;NEURL1;ACVR2B;EREG;NAB2;LPAR3;C5;PKD2;MAPK3;CSPG4;VANGL2;MAP2K2;PAK6;PKD1;SORL1;VLDLR;MAP3K12;PKIB;TGFBR2;ITGA1;TRIB3;MINK1;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;FGFR4;INSR;MAP2K5;BRAF;MAPK10;TP73;GOLGA2;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2;UNC119;HMBOX1;CAMKK1
4232,GO:0009416,0.0209566754666171,0.986943442639252,37,223,response to light stimulus,BP,NFATC4;XPC;FOS;EGFR;DDB2;ERCC1;BRSK1;CRTC1;ERCC6;MAPK13;HYAL1;MC1R;SYNGAP1;PITPNM1;NPHP4;CIRBP;RAG1;IMPACT;SCARA3;RGS14;ATF4;PRIMPOL;REEP6;DEAF1;BHLHE40;ASNS;AKT1;CRY2;B4GALT2;BRAF;CAT;MAPK10;TP73;MTA1;PER1;EIF2AK4;UNC119
9820,GO:0042060,0.0210255403274503,0.985761815234298,53,341,wound healing,BP,F2R;APOE;SERPINE2;GSN;POSTN;EGFR;FBLN1;TFPI2;DGKA;CD9;ADAMTS13;ARHGEF19;HBEGF;PLAT;PHF21A;DGKQ;BLOC1S4;ITPR3;SERPING1;PAK1;ELK3;DOCK6;EREG;PPARA;MAPK3;VANGL2;DOCK9;DYSF;DMTN;PROCR;ZFPM1;DOCK11;TGFBR2;HMG20B;NOS3;WNT7A;GAS6;AKT1;ITPR2;MICAL1;SH2B3;PLAU;C6ORF89;MYOF;TIMP1;EHD3;FYN;CELSR1;ENTPD2;VAV3;ITGA2;ERBB2;CORO1B
19384,GO:1905952,0.0211556921936739,0.990384151645174,15,73,regulation of lipid localization,BP,APOE;LRP1;NTSR1;ABCA2;ABCA7;PLA2G6;ABCG1;PPARA;ACACB;PLTP;PCSK9;ALKBH7;AKT1;CIDEA;FITM2
1259,GO:0003015,0.0211760460582454,0.988407376283822,24,128,heart process,BP,NOS1;SCN4B;HBEGF;GAA;VEGFB;ITPR3;NPR2;GSTO1;THRA;SNTA1;TTN;GSTM2;APLN;NOS3;TNNI2;ATP2B4;ITPR2;TNNT1;TAZ;EHD3;TRPC1;ADA;EPAS1;TNNI1
4062,GO:0009116,0.0213251318901313,0.989249467169413,19,100,nucleoside metabolic process,BP,DLG4;GAMT;NT5E;TK2;APOBEC3C;DLG3;NME4;APOBEC3F;MACROD1;GTPBP1;MOCOS;PEMT;UCKL1;CARD11;DGUOK;UPP1;APRT;ADA;NUDT18
13746,GO:0060350,0.0213401176063591,0.993346739967455,8,30,endochondral bone morphogenesis,BP,THBS3;MEF2D;COL13A1;FGFR3;NAB2;TGFBR2;TRPV4;PEX7
14475,GO:0061971,0.0213401176063591,0.993346739967455,8,30,replacement bone morphogenesis,BP,THBS3;MEF2D;COL13A1;FGFR3;NAB2;TGFBR2;TRPV4;PEX7
9025,GO:0035254,0.0214249959576538,0.993315179327539,8,30,glutamate receptor binding,MF,DLG4;PRNP;SHANK2;DLG3;FLOT1;HOMER2;FYN;HIP1
11480,GO:0045981,0.0214803002430209,0.992156475627253,10,42,positive regulation of nucleotide metabolic process,BP,APOE;TIMP2;RAPGEF3;NOS1;MLXIPL;PTHLH;TMSB4X;NOS3;INSR;TAZ
17476,GO:1900544,0.0214803002430209,0.992156475627253,10,42,positive regulation of purine nucleotide metabolic process,BP,APOE;TIMP2;RAPGEF3;NOS1;MLXIPL;PTHLH;TMSB4X;NOS3;INSR;TAZ
9829,GO:0042089,0.0217166320864591,0.990773590080617,13,60,cytokine biosynthetic process,BP,EGR1;TRIB2;EREG;ERRFI1;INPP5D;ZFPM1;CEBPB;PTAFR;CARD11;IGF2BP2;MAP2K5;IGF2BP3;ZNF287
4127,GO:0009190,0.0218766319201252,0.992527801630595,9,36,cyclic nucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;NPR2;PTHLH;LTB4R2;GABBR1;NOS3;ADCY6
13357,GO:0052652,0.0218766319201252,0.992527801630595,9,36,cyclic purine nucleotide metabolic process,BP,APOE;TIMP2;NOS1;NPR2;PTHLH;LTB4R2;GABBR1;NOS3;ADCY6
13488,GO:0055085,0.0220066920620294,0.982919244340614,122,871,transmembrane transport,BP,DLG4;F2R;KCNG1;FHL1;S100A6;SLC2A3;GJC2;NTSR1;PRNP;SCN8A;SLC7A8;ANK3;CLTCL1;SLC16A3;SLC2A9;NOS1;DDIT3;SHANK2;CLCA2;SCN4B;ORAI3;CPT2;SLC16A5;ABCA2;SLC43A1;NLGN2;SLC12A7;ITPR3;PRKCZ;PAK1;ABCA7;SLC37A2;STK39;CEMIP;NDUFA4L2;ORAI2;DLG3;SLCO4A1;NGFR;GSTO1;ANO8;PLA2G6;ABCG1;ANO1;SESN2;KCNJ15;PKD2;VAMP2;KCNC4;ACACB;KCNAB2;PEX10;SLC22A18;SNTA1;PQLC2;PRAF2;SLC50A1;DMTN;LRRC8A;KLHL24;SV2A;SLC38A10;PKD1;SLC29A4;KCNMA1;AZIN2;GSTM2;TMEM175;WNK4;PCSK9;AQP3;TRPV4;TMSB4X;ANO9;PDE2A;TRIB3;MINK1;TRPV1;PIK3R2;GAS6;BCR;ATP7B;MFSD3;TTYH3;PTAFR;ATP2B4;STEAP2;AKT1;ITPR2;SLC6A9;TCIRG1;STEAP3;SLC6A6;TMEM63C;INSR;SLC25A29;SLC22A15;TPCN1;ADD3;BRAF;ASIC1;HFE;SCNN1A;PEX7;ATP12A;SLC9A7;SLC37A4;EHD3;FYN;ATP8B2;SLC38A2;PEX1;SLC25A42;TRPC1;TST;RTN2;EDNRA;EPHB2;SLC39A11;SLC10A6;GRB10;SLC9A5
7593,GO:0031982,0.0220596518064217,0.981098950137501,389,3046,vesicle,CC,PTPRS;ACTA2;DLG4;HTRA1;GAMT;F2R;NT5E;APOE;SYTL1;XPC;SERPINE2;S100A6;GSN;PYGB;ALDH7A1;WIPF1;SLC2A3;FBXO2;ACP5;THSD4;NAPRT;GLUL;GPX3;LRP1;ALOX15B;TIMP2;VEGFA;EGFR;PRNP;ZDHHC1;SCN8A;FBLN1;SLC7A8;S100A4;PRDX5;RAPGEF3;BPHL;CLTCL1;LOXL1;TSPAN1;KRT15;CD9;IDH2;CST3;DNM1;NOS1;DDIT3;BRSK1;DNPH1;PGM1;NDRG1;GGT1;FCGBP;ARRDC1;HEBP1;SYT8;ARAP1;B3GAT3;HBEGF;RBL2;PHGDH;ARHGAP23;GAA;PYGL;CNTN1;PLAT;LTBP4;ULK2;CTSF;REEP2;RAB11FIP4;NISCH;PLD3;PRSS3;HYAL1;NAGLU;SYNGR1;MAP2K1;PCK2;COL6A1;PPL;CRYL1;ABCA2;PKN1;PGLS;CAPG;H2AFJ;TOM1L2;DNASE1L1;DGKQ;AKR7A2;TMEM173;SNX9;PLEKHG5;FAM213A;MAGEF1;ARL2;ULK1;VPS11;VEGFB;MARCKSL1;HDAC11;RAB3B;CD68;PCSK1;MYH11;CYBRD1;ITPR3;LAMA5;APPL2;PRSS8;LY6K;PRKCZ;GALE;SERPING1;ABCA7;SLC37A2;AARS;MCTP1;PABPC1L;BLVRB;FGFR3;SEC14L2;CEMIP;BRI3;TMEM187;ITGB4;NMNAT2;MICALL2;CEP250;ABHD14B;SPPL2B;NGFR;NID1;ETFB;GSTO1;WDR60;MUC19;PPCS;MALL;ACTR1B;CHD2;PSAT1;SPG11;TMC6;DHRS4;RHOBTB2;TMED4;CES3;ABCG1;RINL;OAF;S100A13;GSTT1;MTMR4;C5;ANO1;SNX29;BLMH;IFT27;PKD2;SH3TC2;ACOT11;VAMP2;AREG;COL8A1;AP1G2;SEPT5;ECM1;B4GAT1;PCLO;JADE2;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;SEMA5A;VANGL2;FAM20C;DYSF;RHOF;LTBP2;CTSB;MXRA8;MVB12B;MYH3;LTA4H;PI4K2A;KIAA0319L;CHMP1B;NRSN2;IFNGR2;TBC1D14;C1RL;PLCD1;ARHGEF2;MTMR11;PDCD1LG2;PRAF2;MAP2K2;TWF2;TECPR1;KIF21B;SLC48A1;EHBP1L1;DMTN;LITAF;SEMA3B;PROCR;SV2A;PKD1;FUCA1;FLOT1;LTBP3;TTN;KCNMA1;AZIN2;SORL1;MAP6;GALK1;NTPCR;GSTM2;GPRC5C;TMEM175;ACY1;PTGR2;ACOT7;ALDOC;PCSK9;DBNDD1;CEP131;EPN3;MARK3;TRPV4;ITGA1;TMSB4X;MAP1LC3A;RAB40B;ALDH1L2;NOS3;MINK1;HEXB;PROM2;WNT7A;MARCH2;GAS6;VPS39;DNAJC6;LZTS2;CROCC;BCR;ATP7B;FYCO1;NBR1;HEXA;BCAM;NBEAL2;TTYH3;PTAFR;RAB43;SLC9A3R2;EFEMP2;CTSH;UACA;GSTO2;TMEM9;ENTPD6;STEAP2;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;LAMB1;GAREM2;IGFBP2;SEPT6;ASS1;CAPS;TSG101;KIF27;FGFR4;TMEM256;RASSF9;TCIRG1;HAGH;STEAP3;PHLDA1;NUCB2;DNASE2;COPG1;WDFY2;C9ORF72;SGSM2;CHMP5;ARSA;CAPN2;ARMC9;MAN2B1;ICA1;RAB25;C1ORF210;PLAU;INSR;WNT3;KRT19;GNAL;CHMP4C;TNXB;TPCN1;MBLAC2;MAGED2;ITGB6;CTDSPL;YIPF3;ARHGAP44;ALDH1L1;CAT;MYOF;DPP7;YPEL5;LGALS1;TIMP1;HFE;JAK3;SCNN1A;TUBGCP6;SNX33;APRT;FCHSD1;MIB2;MPI;SNX17;METTL7A;SPIRE1;HGSNAT;RABAC1;SAT2;SLC9A7;GSTM3;TKFC;EPS8L1;EHD3;FYN;SNX1;PEX1;UBXN6;GDF15;RAB13;OSBPL1A;MPDZ;TOM1;TST;GOLGA2;ADA;CADM4;RHOBTB3;NAGA;ENTPD2;AP2A2;EPS8L2;ADIRF;ERV3-1;TGFBR3;RNPEP;VAV3;MAN1B1;STX1A;GALNS;LAMTOR2;TBC1D16;FGFR1;BLOC1S1;CTH;ERBB2;SEC31B;PLLP;PFKL;HLA-G;CORO1B;RPL12;BSG;LYPLAL1;APBA1;TMEM8A;HIP1;ROBO4;TCTEX1D4
9698,GO:0038127,0.0222768600036998,0.98790201735085,23,125,ERBB signaling pathway,BP,PTK6;EGFR;ARAP1;HBEGF;SHC1;SPRY2;GRB7;NEURL1;EREG;SH3TC2;AREG;ERRFI1;MVB12B;RHBDF1;ITGA1;RHBDF2;AKT1;TSG101;RPS6KA5;REPS2;ERBB2;PAG1;HIP1
12047,GO:0048017,0.0222886364033997,0.988494140835401,20,105,inositol lipid-mediated signaling,BP,F2R;SERPINE2;GSN;EGFR;ZFP36L1;RGL2;ZP3;PLXNB1;PI4KAP1;MAPK3;NYAP1;UNC5B;PIK3R2;PTAFR;AKT1;CAT;FYN;SIRT2;FGFR1;ERBB2
3714,GO:0008236,0.0223152650268287,0.988938574297105,18,93,serine-type peptidase activity,MF,HTRA1;TYSND1;MMP1;PLAT;PRSS3;PCSK1;PRSS8;CTSB;C1RL;PRSS22;RHBDF1;PCSK9;LONP2;RHBDF2;CTSH;PLAU;DPP7;MMP19
7017,GO:0030799,0.0224327167339809,0.991749492441028,10,42,regulation of cyclic nucleotide metabolic process,BP,APOE;TIMP2;VEGFA;RAPGEF3;NOS1;PKD2;PTHLH;LTB4R2;GABBR1;NOS3
4231,GO:0009415,0.0224870144795755,0.996583202176424,4,10,response to water,BP,CD9;PKD2;LRP11;ATP2B4
4639,GO:0010766,0.0225424065695968,0.996572118984145,4,10,negative regulation of sodium ion transport,BP,SERPINE2;STK39;WNK4;PCSK9
14703,GO:0070382,0.0225801157512439,0.988103760224047,21,113,exocytic vesicle,CC,PTPRS;DLG4;SYTL1;DNM1;BRSK1;SYT8;SYNGR1;RAB3B;MCTP1;VAMP2;SEPT5;PI4K2A;SV2A;DBNDD1;RAB40B;SEPT6;ICA1;RABAC1;RAB13;STX1A;APBA1
17223,GO:0120031,0.0226722284377584,0.983962743744499,65,429,plasma membrane bounded cell projection assembly,BP,BBS2;ESPN;ZMYND8;GSN;EVI5L;CDC42EP5;IFT140;NINL;PARVB;ARAP1;BBS1;WWTR1;SDCCAG8;ITGA6;DNAH1;NPHP4;LAMA5;TTBK2;PLXNB3;CEP250;NEURL1;ARHGEF4;WDR60;SSH3;LPAR3;KIF17;IFT27;NUDCD3;SEPT5;VANGL2;CNTRL;TCTN1;PTPDC1;SEPT10;FBF1;TWF2;DMTN;DOCK11;SSH1;TENM2;ATXN10;RFX2;NDE1;CEP131;CEP126;CROCC;SPAG16;WDR19;TMEM80;IFT57;SEPT6;KIF27;MARK4;HAUS4;UNC119B;CSNK1E;EPS8L1;EHD3;EPS8L2;VAV3;SEPT8;SPATA6;UNC119;C15ORF62;SFI1
8064,GO:0032753,0.0227164207606074,0.996537241923537,4,10,positive regulation of interleukin-4 production,BP,IL20RB;PRKCZ;ZP3;CEBPB
3662,GO:0008154,0.022888124685089,0.98701196243815,26,147,actin polymerization or depolymerization,BP,GSN;WIPF1;CDC42EP5;SPTB;MSRB2;ARPIN;CAPG;MICALL2;SSH3;PLEKHG2;SEMA5A;TWF2;DMTN;SSH1;WHAMMP3;TRIOBP;TMSB4X;MICAL1;TMOD2;FCHSD1;SPIRE1;EPS8L1;EPS8L2;C15ORF62;CORO1B;PLEKHH2
9891,GO:0042226,0.0230515656832201,0.996469818019903,4,10,interleukin-6 biosynthetic process,BP,EREG;INPP5D;CEBPB;PTAFR
6856,GO:0030334,0.0230998497190221,0.983094582344443,79,536,regulation of cell migration,BP,DOCK4;F2R;APOE;ZMYND8;SERPINE2;PGF;POSTN;SEMA4B;LRP1;ALOX15B;VEGFA;EGFR;IDH2;ARAP3;MMP28;ADARB1;HBEGF;NISCH;HYAL1;ARPIN;ITGA6;FAM110C;SPRY2;GRB7;VEGFB;LAMA5;TTBK2;PAK1;MCTP1;CEMIP;SEMA3F;PLXNB3;ZP3;PLXNB1;RHOBTB2;C5;ECM1;MAPK3;SEMA5A;IFITM1;RHOF;SRGAP3;ARHGEF2;DMTN;SEMA3B;SSH1;HDAC5;SORL1;PTPRU;TGFBR2;TRPV4;TMSB4X;SMURF2;NOS3;MINK1;WNT7A;EPHA1;SEMA4G;GAS6;BCR;PTAFR;CTSH;AKT1;LAMB1;LMNA;RAB25;PLAU;INSR;FOXO4;MAP2K5;BRAF;TIMP1;PHLDA2;ADA;PLXND1;ITGA2;FGFR1;CORO1B;ROBO4
13583,GO:0060079,0.0231949349533491,0.99142152970632,10,42,excitatory postsynaptic potential,BP,DLG4;ZMYND8;SHANK2;NLGN2;PRKCZ;SSH1;WNT7A;TRPV1;AKT1;STX1A
2402,GO:0005548,0.0232316109458576,0.991405699346124,10,42,phospholipid transporter activity,MF,OSBPL5;PITPNM3;PITPNM1;PITPNC1;ABCA7;ABCG1;OSBPL10;PLTP;ANO9;ATP8B2
13247,GO:0051960,0.0232694954916138,0.982898471106251,81,549,regulation of nervous system development,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;SERPINE2;ADGRL1;PTK6;GJC2;SEMA4B;LRP1;TIMP2;VEGFA;IDH2;NOS1;SHANK2;CRTC1;ADGRB2;CNTN1;EFNB3;OBSL1;ULK2;CUL7;MAP2K1;SYNGAP1;NLGN2;CAPRIN2;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;NEURL1;NGFR;ETV5;PLXNB1;SSH3;LPAR3;IMPACT;SEMA5A;VANGL2;RGS14;SLITRK6;SDC2;ARHGEF2;TWF2;SEMA3B;KDM4C;SSH1;METRN;SORL1;VLDLR;TPBG;TRPV4;HMG20B;CDK5RAP3;WNT7A;SEMA4G;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;AMIGO2;WNT3;TENM4;BRAF;ARHGAP44;LGALS1;TP73;CSNK1E;BCL6;FYN;SIRT2;CELSR1;PLXND1;EPHB2;FGFR1;UST;EIF2AK4;KCTD11
10005,GO:0042454,0.0232811251825145,0.995184432245322,5,15,ribonucleoside catabolic process,BP,APOBEC3C;APOBEC3F;UPP1;ADA;NUDT18
8504,GO:0033700,0.0233056029873126,0.997831496332488,3,6,phospholipid efflux,BP,APOE;ABCA7;ABCG1
7280,GO:0031281,0.0233167350677304,0.99641623812717,4,10,positive regulation of cyclase activity,BP,TIMP2;NOS1;MAPK3;NOS3
18176,GO:1902992,0.0233585556529007,0.996407769158904,4,10,negative regulation of amyloid precursor protein catabolic process,BP,APOE;PRNP;ABCA7;SORL1
10486,GO:0043406,0.0233887623556708,0.985737121506605,33,196,positive regulation of MAP kinase activity,BP,DUSP6;F2R;VEGFA;EGFR;DUSP5;ERCC6;MST1R;MAP2K1;PKN1;SHC2;SHC1;PAK1;STK39;LPAR3;C5;MAPK3;CSPG4;VANGL2;MAP2K2;MAP3K12;ITGA1;MINK1;ERN1;INSR;MAP2K5;BRAF;MAPK10;TP73;AVPI1;LAMTOR2;MAP3K10;FGFR1;ERBB2
7840,GO:0032409,0.0233919911826021,0.986866033610201,25,140,regulation of transporter activity,BP,DLG4;KCNG1;FHL1;NTSR1;PRNP;ANK3;NOS1;SHANK2;SCN4B;NLGN2;STK39;GSTO1;PLA2G6;PKD2;VAMP2;KLHL24;GSTM2;WNK4;PCSK9;TMSB4X;ANO9;MINK1;PTAFR;EHD3;EPHB2
13582,GO:0060078,0.0234282461012291,0.99080913043268,11,48,regulation of postsynaptic membrane potential,BP,DLG4;ZMYND8;NTSR1;SHANK2;NLGN2;PRKCZ;SSH1;WNT7A;TRPV1;AKT1;STX1A
12940,GO:0051346,0.023474355643476,0.984614465573433,44,278,negative regulation of hydrolase activity,BP,TNFRSF6B;SERPINE2;PPP1R35;TIMP2;VEGFA;PRDX5;TFPI2;CST3;NOS1;GPSM1;PHACTR3;PPP1R14A;ARL2;SPRY2;PRKCZ;SERPING1;PLXNB3;DLG3;NEIL1;RAG1;NGFR;ELFN2;C5;AIP;RASA4;ECM1;ANGPTL4;IFI6;SORL1;HERPUD1;PAPLN;CSRNP3;NOS3;GAS6;PPP1R15A;AKT1;MICAL1;CRY2;HMSD;FARP1;MAP2K5;TIMP1;SFI1;IKBKB
2671,GO:0006026,0.0235335301513998,0.991275211521584,10,42,aminoglycan catabolic process,BP,HYAL1;NAGLU;CEMIP;CSPG4;SDC2;FUCA1;HEXB;HEXA;HGSNAT;GALNS
4065,GO:0009120,0.0235559801208498,0.997798896948138,3,6,deoxyribonucleoside metabolic process,BP,TK2;DGUOK;ADA
3026,GO:0006575,0.0236417692275968,0.986879751465452,24,135,cellular modified amino acid metabolic process,BP,GAMT;PRODH;OSBPL5;ALDH7A1;CRTAP;GGT1;ALDH4A1;SLC27A1;OPLAH;LPCAT4;ERO1B;MTHFR;GSTO1;GSTT1;CHAC1;OSBPL10;GSTM2;ALDH1L2;PEMT;GSTO2;ASS1;HAGH;ALDH1L1;GSTM3
17768,GO:1901880,0.0236858119895546,0.991209280846053,10,42,negative regulation of protein depolymerization,BP,GSN;SPTB;CAPG;TTBK2;ARHGEF2;TWF2;DMTN;TRIOBP;TMOD2;PLEKHH2
7690,GO:0032156,0.023735586928215,0.996331188411515,4,10,septin cytoskeleton,CC,SEPT5;SEPT10;SEPT6;SEPT8
330,GO:0000921,0.0237365270768242,0.996330996939097,4,10,septin ring assembly,BP,SEPT5;SEPT10;SEPT6;SEPT8
12219,GO:0048513,0.0237654892375343,0.979999582435549,280,2134,animal organ development,BP,XDH;DUSP6;PTPRS;ACTA2;HTRA1;GAMT;BBS2;NFATC4;SERPINE2;FHL1;FOS;EGR1;CTNNBIP1;THBS3;PGF;ADAM19;ACP5;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;VEGFA;EGFR;ERCC1;ADAMTS7;S100A4;IFT140;KRT15;CD9;SNPH;CST3;SDK2;MEF2D;SHANK2;ARHGEF19;COL13A1;MYH15;SMARCA1;ZFP36L1;ADARB1;NUPR1;HBEGF;PHGDH;GAA;CTF1;CNTN1;DHTKD1;TFDP2;OBSL1;MDFI;EVC;RAB11FIP4;FBXW4;ASH2L;SOX13;CUL7;HMGCL;HYAL1;NAGLU;WWTR1;SMOC1;MAP2K1;CYP27B1;PCK2;PPL;PKN1;DDIT4;TRNP1;ITGA6;PITPNM1;FAM213A;SHC1;SPRY2;NPHP4;VEGFB;SOX12;MYH11;LAMA5;PRSS8;TTBK2;PRKCZ;PAK1;AARS;FGFR3;FOXQ1;NPR2;SEMA3F;SPRY4;SALL2;ITGB4;FBXW8;ETV1;ZP3;SHROOM4;NEURL1;ACVR2B;RAG1;SPEG;EPOR;NID1;ETV5;LCE1E;WDR60;LTBP1;WNT2B;PLXNB1;EREG;CHD2;PLCD3;NAB2;TRAPPC9;PPARA;MKNK2;TCF25;IFT27;PKD2;SATB1;STAT6;HMGA2;AREG;COL8A1;SLIT3;ECM1;ACACB;KCNAB2;MAPK3;LAMB2;BNIP3;ERRFI1;SEMA5A;THRA;STK40;VANGL2;FAM20C;CTSB;SLITRK6;MAPK12;MYH3;TCTN1;PLCD1;INPP5D;DMTN;LRRC8A;SEMA3B;PTHLH;ZFPM1;MOSPD3;DOCK11;SLC38A10;POLM;KIF26B;ZNF516;PKD1;FLOT1;MDK;TTN;PSKH1;HSD11B1;HDAC5;SRSF5;VLDLR;DEAF1;SULF2;KDM7A;CEBPB;NEK8;LRP5;PTPRU;WNK4;ATRAID;NDE1;PCSK9;L3MBTL1;FBXL15;AQP3;TRIOBP;TGFBR2;TRPV4;FOXL1;CMTM7;SMURF2;APLN;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;LDOC1;WNT7A;SEMA4G;SHARPIN;GAS6;GLUD1;LZTS2;BCR;ATP7B;NBR1;SRR;NBEAL2;RXRA;ATP2B4;CTSH;WDR19;MGMT;ASNS;LCE1F;AKT1;CARD11;B4GALT2;AMIGO2;LAMB1;IFT57;TSG101;PHF2;DNASE2;LMNA;SH2B3;MAB21L2;TBC1D20;INSR;WNT3;KRT19;TENM4;FOXO4;MAP2K5;BRAF;CAT;ZNF160;LGALS1;TIMP1;HFE;JAK3;TP73;APRT;TFEB;PEX7;SNX17;CSNK1E;TAZ;BCL6;HSF4;REC8;FYN;SLC38A2;LEMD2;SIRT2;PHLDA2;RAB13;CELSR1;ADA;POU2F2;PLXND1;RHOBTB3;ETNK2;AP2A2;TGFBR3;TCF7;EPAS1;MFNG;EDNRA;EPHB2;ITGA2;FGFR1;WFS1;FKBP8;SH3PXD2A;ERBB2;HLA-G;MMP17;TSHZ1;TNNI1;MMP19;BSG;SDHAF4;TRIM45;DBP;TEAD2;SIX5
3465,GO:0007288,0.0237867709849456,0.996320760463619,4,10,sperm axoneme assembly,BP,BBS2;DNAH1;NEURL1;SPAG16
12653,GO:0050885,0.023917845833728,0.993118858151493,7,25,neuromuscular process controlling balance,BP,DLG4;GAA;BLOC1S4;NLGN2;AARS;HEXB;BCR
6885,GO:0030425,0.0239268010307495,0.983487944226368,56,363,dendrite,CC,DLG4;APOE;ZMYND8;FBXO2;LRP1;NTSR1;PRNP;NR1D1;ANK3;DNM1;NOS1;SHANK2;CRTC1;SYNGAP1;HTR7;PAK1;PRR7;DLG3;NEURL1;SPG11;KIF17;KCNC4;BNIP3;RGS14;PI4K2A;ARHGEF2;KIF21B;ATF4;SV2A;TENM2;ATXN10;AZIN2;MAP6;GABBR1;MINK1;TRPV1;SHARPIN;CPT1C;KIF13B;IFT57;PIAS3;FARP1;C9ORF72;CAPN2;INSR;HOMER2;ARHGAP44;CHRM3;FYN;SLC38A2;MPDZ;ADA;EPHB2;WFS1;RGS12;APBA1
16583,GO:0097447,0.0239268010307495,0.983487944226368,56,363,dendritic tree,CC,DLG4;APOE;ZMYND8;FBXO2;LRP1;NTSR1;PRNP;NR1D1;ANK3;DNM1;NOS1;SHANK2;CRTC1;SYNGAP1;HTR7;PAK1;PRR7;DLG3;NEURL1;SPG11;KIF17;KCNC4;BNIP3;RGS14;PI4K2A;ARHGEF2;KIF21B;ATF4;SV2A;TENM2;ATXN10;AZIN2;MAP6;GABBR1;MINK1;TRPV1;SHARPIN;CPT1C;KIF13B;IFT57;PIAS3;FARP1;C9ORF72;CAPN2;INSR;HOMER2;ARHGAP44;CHRM3;FYN;SLC38A2;MPDZ;ADA;EPHB2;WFS1;RGS12;APBA1
7465,GO:0031638,0.0239558300914629,0.992324682549385,8,31,zymogen activation,BP,SERPINE2;GGT1;PLAT;PRSS3;PLGRKT;CTSH;PLAU;CIDEB
14002,GO:0060753,0.0239642103393054,0.997745435527223,3,6,regulation of mast cell chemotaxis,BP,PGF;VEGFA;VEGFB
9233,GO:0035641,0.0241031923804913,0.997727147546115,3,6,locomotory exploration behavior,BP,DLG4;APOE;NLGN2
17720,GO:1901685,0.0243238757106926,0.994825162004638,5,16,glutathione derivative metabolic process,BP,GSTO1;GSTT1;GSTM2;GSTO2;GSTM3
17721,GO:1901687,0.0243238757106926,0.994825162004638,5,16,glutathione derivative biosynthetic process,BP,GSTO1;GSTT1;GSTM2;GSTO2;GSTM3
7600,GO:0031995,0.0243417038324246,0.9976956604858,3,6,insulin-like growth factor II binding,MF,IGFBP4;IGFBP2;INSR
10477,GO:0043395,0.0244261464601902,0.996189864671695,4,10,heparan sulfate proteoglycan binding,MF,PTPRS;LRP1;SEMA5A;ITGA2
2972,GO:0006516,0.0244969354876481,0.994863120205851,5,15,glycoprotein catabolic process,BP,FBXO2;EDEM1;CST3;FBXO6;MAN1B1
20254,GO:2001257,0.0247044728280737,0.988203583244034,16,80,regulation of cation channel activity,BP,DLG4;KCNG1;NTSR1;ANK3;NOS1;SHANK2;NLGN2;GSTO1;PLA2G6;PKD2;VAMP2;KLHL24;GSTM2;MINK1;EHD3;EPHB2
14628,GO:0070244,0.0247498521098607,0.997641480018764,3,6,negative regulation of thymocyte apoptotic process,BP,RAG1;JAK3;ADA
2979,GO:0006525,0.0247995602949306,0.994782420693581,5,15,arginine metabolic process,BP,NAGS;NOS1;NOS3;ATP2B4;ASS1
11554,GO:0046128,0.024845648249335,0.98920991647488,13,62,purine ribonucleoside metabolic process,BP,DLG4;GAMT;NT5E;DLG3;NME4;GTPBP1;MOCOS;PEMT;CARD11;DGUOK;APRT;ADA;NUDT18
11267,GO:0045598,0.0249011036364888,0.988097915448966,16,80,regulation of fat cell differentiation,BP,NR1D1;DDIT3;ZFP36L1;WWTR1;CCDC71L;TRIB2;ZFPM1;JDP2;CEBPB;LRP5;TRPV4;TRIB3;AKT1;WDFY2;SIRT2;ADIRF
17686,GO:1901626,0.0249547700732164,0.997614136342151,3,6,regulation of postsynaptic membrane organization,BP,APOE;ZMYND8;SSH1
19087,GO:1905049,0.0249784560372942,0.997610969683671,3,6,negative regulation of metallopeptidase activity,BP,TIMP2;SORL1;TIMP1
14518,GO:0070059,0.0249813941952458,0.990078602106982,11,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,DDIT3;CHAC1;ATF4;BBC3;HERPUD1;CEBPB;TRIB3;ERN1;PPP1R15A;WFS1;SYVN1
12870,GO:0051235,0.0250560693612239,0.984276551888869,36,219,maintenance of location,BP,F2R;APOE;GSN;NTSR1;ANK3;NOS1;DDIT3;GAA;MXI1;MDFI;ARL2;ITPR3;CEMIP;SYNE3;GSTO1;LTBP1;ABCG1;PPARA;PKD2;ACACB;THRA;TWF2;PKD1;SORL1;GSTM2;TMSB4X;HEXB;TRPV1;ALKBH7;ATP7B;AKT1;ITPR2;TPCN1;TRPC1;CIDEA;FITM2
12897,GO:0051271,0.02507384887572,0.984619439339225,33,197,negative regulation of cellular component movement,BP,APOE;ZMYND8;SEMA4B;LRP1;ALOX15B;FBLN1;CD9;IDH2;ARAP3;MMP28;ADARB1;NISCH;ARPIN;MCTP1;SEMA3F;PLXNB3;C5;SEMA5A;IFITM1;SRGAP3;SEMA3B;HDAC5;PTPRU;EPHA1;SEMA4G;BCR;WNT3;MAP2K5;BRAF;TIMP1;ADA;TGFBR3;CORO1B
15833,GO:0072578,0.0250847933473277,0.997596737615046,3,6,neurotransmitter-gated ion channel clustering,BP,DLG4;APOE;SSH1
3012,GO:0006560,0.0252019597494245,0.997581026947538,3,6,proline metabolic process,BP,PRODH;PYCR2;ALDH4A1
7635,GO:0032055,0.0252690175789025,0.997572021493323,3,6,negative regulation of translation in response to stress,BP,SESN2;ATF4;EIF2AK4
9027,GO:0035256,0.0252721258376607,0.997571603830475,3,6,G-protein coupled glutamate receptor binding,MF,PRNP;HOMER2;FYN
3016,GO:0006564,0.0253432023010399,0.997562047281217,3,6,L-serine biosynthetic process,BP,PHGDH;PSAT1;PSPH
4268,GO:0009629,0.0253968421322772,0.997554827730445,3,6,response to gravity,BP,FOS;PTAFR;STX1A
17637,GO:1901522,0.025420610696046,0.993513680813987,6,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,VEGFA;CARF;SESN2;ATF4;RXRA;CHD6
16050,GO:0090037,0.025428363748163,0.99755058215823,3,6,positive regulation of protein kinase C signaling,BP,VEGFA;MC1R;PLA2G6
4195,GO:0009306,0.0254301036033015,0.982643338321679,52,332,protein secretion,BP,F2R;LMF1;POSTN;GLUL;ALOX15B;EGFR;NR1D1;HADH;RAPGEF3;IDH2;PCK2;ARL2;RAB3B;NLGN2;ITPR3;PRKCZ;ACVR2B;OLFM2;PLA2G6;S100A13;C5;ANO1;PCLO;MAPK3;LTBP2;DMTN;TTN;NLRP1;RHBDF1;LRP5;TRPV4;TMSB4X;RAB40B;RHBDF2;GAS6;GLUD1;NECAB3;MAPKBP1;ITPR2;CARD11;IL17RC;STEAP3;COPG1;ICA1;ITGB6;BTN3A2;RAB13;POU2F2;CIDEA;MYO18A;STX1A;PFKL
6846,GO:0030323,0.0254317438743179,0.986432033445169,21,113,respiratory tube development,BP,VEGFA;EGFR;MAP2K1;SPRY2;LAMA5;ACVR2B;WNT2B;MAPK3;ERRFI1;THRA;STK40;VANGL2;PKD1;HSD11B1;TGFBR2;NOS3;CTSH;CELSR1;ADA;EPAS1;FGFR1
13814,GO:0060440,0.0254669004650169,0.997545388743443,3,6,trachea formation,BP,MAP2K1;MAPK3;TGFBR2
4652,GO:0010801,0.0254674780223165,0.994603309427575,5,15,negative regulation of peptidyl-threonine phosphorylation,BP,DDIT4;DGKQ;SPRY2;DMTN;SIRT2
1873,GO:0004553,0.025496909057753,0.988902329678679,13,61,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,EDEM1;GAA;HYAL1;NAGLU;CEMIP;FUCA1;HEXDC;HEXB;MAN2C1;HEXA;MAN2B1;NAGA;MAN1B1
10526,GO:0043491,0.0255565901078296,0.985342791799409,26,148,protein kinase B signaling,BP,XDH;EGFR;DDIT3;MST1R;ZFP36L1;HBEGF;MC1R;FAM110C;SPRY2;FGFR3;EREG;SESN2;SEMA5A;TRIB3;PIK3R2;GAS6;AKT1;FGFR4;INSR;FOXO4;FYN;LEMD2;SIRT2;FGFR1;ERBB2;HIP1
16101,GO:0090128,0.0255694204475975,0.99753155657502,3,6,regulation of synapse maturation,BP,NFATC4;ADGRL1;NEURL1
12586,GO:0050790,0.025695311488994,0.978755517299564,215,1611,regulation of catalytic activity,BP,XDH;DUSP6;DLG4;DOCK4;F2R;TNFRSF6B;APOE;SERPINE2;GSN;EGR1;LMF1;PPP1R35;EVI5L;PTK6;CDC42EP5;LRP1;PDCD4;TIMP2;VEGFA;EGFR;PRNP;FBLN1;PRDX5;TFPI2;DUSP5;RAPGEF3;TNFSF15;CST3;NOS1;GPSM1;ARAP3;ERCC6;TBC1D8;ARHGEF19;GRAMD4;MST1R;ADARB1;RIN1;ARAP1;B3GAT3;RBL2;ARHGAP23;SLC27A1;PHACTR3;ASAP2;PPP1R14A;WWTR1;MAP2K1;CYP27B1;PKN1;SHC2;SYNGAP1;ITGA6;DGKQ;SNX9;ARL2;SHC1;SPRY2;RALGDS;TPM2;PRKCZ;PPP2R3B;SERPING1;PAK1;STK39;FGFR3;CEMIP;PLXNB3;SPRY4;DLG3;NEIL1;NEURL1;ACVR2B;RAG1;NGFR;ELFN2;TRIB2;PLXNB1;EREG;NAB2;DNMBP;RINL;LPAR3;AGAP1;ALS2CL;C5;SESN2;AIP;RASA4;PKD2;ECM1;ACACB;MAPK3;CSPG4;TRPT1;ERRFI1;VANGL2;DOCK9;RGS14;DNAL4;CTSB;MAPK12;SRGAP3;ARHGAP22;PLEKHG4;TBC1D14;TSPYL2;MAP2K2;STMN3;ANGPTL4;BBC3;PAK6;DOCK11;LTB4R2;TBC1D3E;RABGAP1;ACAP3;IFI6;PKD1;RALGAPA1;TTN;AZIN2;SORL1;HERPUD1;VLDLR;PAPLN;GABBR1;NLRP1;MAP3K12;LRP5;RIN2;NDE1;PKIB;TGFBR2;ARHGAP25;CSRNP3;ITGA1;TMSB4X;TRIB3;DAP;CDK5RAP3;NOS3;MINK1;PROM2;PIK3R2;EPHA1;CCS;GAS6;ERN1;BCR;MAPRE3;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;STRADB;CTSH;MGMT;PLEKHG6;AKT1;CDKN1C;MICAL1;CRY2;HMSD;IFT57;SBF2;SPDYE2;SPDYE2B;TSG101;FGFR4;ASAP3;FARP1;SGSM2;TBC1D20;ARHGAP27;IFI27;INSR;GNAL;C6ORF89;MAP2K5;BRAF;ARHGAP44;PIDD1;MAPK10;TIMP1;TP73;BCL6;ADAP1;FYN;GOLGA2;PLXND1;AVPI1;CIDEB;VAV3;LAMTOR2;MAP3K10;TBC1D16;EDNRA;EPHB2;ITGA2;FGFR1;SH3PXD2A;ERBB2;UNC119;RGS12;C15ORF62;SFI1;MMP17;HMBOX1;NET1;CAMKK1;IKBKB;SNCB;HIP1
13771,GO:0060384,0.0257020021889654,0.994540094955153,5,15,innervation,BP,SERPINE2;ADARB1;RNF165;SLITRK6;SULF2
7636,GO:0032056,0.0257040922864561,0.997513351088,3,6,positive regulation of translation in response to stress,BP,IMPACT;PPP1R15A;EIF2AK4
1927,GO:0004629,0.0257466704755432,0.994528035981467,5,15,phospholipase C activity,MF,PLCH2;PLCD3;PLCD1;CHRM3;EDNRA
3239,GO:0006897,0.0258142981510807,0.98145880422652,68,455,endocytosis,BP,DLG4;APOE;GSN;WIPF1;LRP1;VEGFA;CLTCL1;FCHO1;TSPAN1;CD9;DNM1;ARAP3;MRC2;SYT8;RIN1;SNX9;NLGN2;PAK1;ABCA7;MCTP1;PEAR1;USP20;ELMO3;SPG11;PLA2G6;ESYT2;RINL;SCART1;STON1;MAPK3;SCARA3;HOOK2;LRSAM1;FLOT1;SORL1;VLDLR;TMEM175;LRP5;RIN2;PCSK9;TGFBR2;ARHGAP25;APLN;PROM2;MARCH2;PIK3R2;GAS6;DNAJC6;BCR;STEAP2;TSG101;C9ORF72;ARHGAP27;HFE;SNX33;SNX17;ICAM5;CSNK1E;FYN;SNX1;TOM1;RHOBTB3;AP2A2;MYO18A;VAV3;ITGA2;UNC119;HIP1
16798,GO:0098711,0.0258180542944873,0.997497913965323,3,6,iron ion import across plasma membrane,BP,STEAP2;STEAP3;HFE
2763,GO:0006182,0.0258385255739699,0.994503219138942,5,15,cGMP biosynthetic process,BP,APOE;NOS1;NPR2;NOS3;ADCY6
10475,GO:0043393,0.0258481815162087,0.984660863736457,29,170,regulation of protein binding,BP,APOE;NFATC4;CTNNBIP1;LRP1;GPSM1;TMEM173;CAPRIN2;TTBK2;PPARA;MAPK3;ZFPM1;PKD1;FLOT1;HDAC5;SORL1;HERPUD1;PCSK9;TRIB3;LDOC1;MAPRE3;CAMK1;AKT1;HFE;CSNK1E;PHLDA2;GOLGA2;PLXND1;TGFBR3;MFNG
1250,GO:0003006,0.0258582651096711,0.98172415464158,62,410,developmental process involved in reproduction,BP,HTRA1;BBS2;SERPINE2;ALOX15B;VEGFA;EGFR;ERCC1;CST3;ZFP36L1;NUPR1;MDFI;CUL7;MAP2K1;CYP27B1;DNAH1;PABPC1L;KDM3A;NPR2;FBXW8;ZP3;NEURL1;EPOR;ETV5;WNT2B;EREG;PLCD3;PKD2;AREG;SLIT3;IRF2BPL;CTSB;PLCD1;PKD1;DEAF1;RFX2;CEBPB;NOS3;AGO4;HEXB;LDOC1;WNT7A;SPAG16;RXRA;WDR19;AKT1;CABYR;TBC1D20;INSR;KRT19;TFEB;REC8;SIRT2;PHLDA2;RAB13;ADA;RHOBTB3;ETNK2;TCF7;EPAS1;MMP19;BSG;SIX5
11880,GO:0046928,0.0258628389378237,0.991589318600684,8,31,regulation of neurotransmitter secretion,BP,MCTP1;SEPT5;KCNC4;RIMS3;BRAF;ASIC1;STX1A;PNKD
12588,GO:0050793,0.0258821347059999,0.97856346686999,219,1645,regulation of developmental process,BP,XDH;DUSP6;PTPRS;DLG4;GAMT;BBS2;APOE;ZMYND8;NFATC4;SERPINE2;FOS;ADGRL1;EGR1;CTNNBIP1;PGF;POSTN;WIPF1;PTK6;CDC42EP5;WWC3;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;EGFR;NR1D1;FBLN1;ADAMTS7;RAPGEF3;IDH2;CST3;PARVB;NOS1;DDIT3;ARAP3;SHANK2;CRTC1;ADGRB2;ARHGEF19;ZFP36L1;NUPR1;ARAP1;TCFL5;CNTN1;EFNB3;OBSL1;LTBP4;ULK2;ASH2L;SOX13;CUL7;HYAL1;ARPIN;WWTR1;SMOC1;MAP2K1;CYP27B1;CCDC71L;PKN1;BTG1;SYNGAP1;FAM213A;SPRY2;VEGFB;ADM2;NLGN2;LAMA5;CAPRIN2;TTBK2;PRKCZ;PAK1;FGFR3;KDM3A;NPR2;SEMA3F;PLXNB3;SYNE3;ZSWIM4;FBXW8;ZP3;NEURL1;ACVR2B;RAG1;NGFR;ETV5;WNT2B;TRIB2;PLXNB1;EREG;SSH3;OLFM2;RHOBTB2;NAB2;ABCG1;LPAR3;S100A13;C5;PPARA;IMPACT;STAT6;HMGA2;AREG;ECM1;ACACB;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;VANGL2;RGS14;FAM20C;RHOF;SLITRK6;MAPK12;SDC2;ARHGEF2;INPP5D;TWF2;DMTN;ANGPTL4;SEMA3B;PTHLH;ZFPM1;KDM4C;SSH1;METRN;FLOT1;LTBP3;JDP2;HDAC5;SORL1;VLDLR;TPBG;DEAF1;SULF2;CEBPB;LRP5;ATRAID;L3MBTL1;AQP3;TRIOBP;TGFBR2;TRPV4;SMURF2;TRIB3;HMG20B;CDK5RAP3;NOS3;AGO4;HEXB;WNT7A;TRPV1;EPHA1;SEMA4G;FMNL2;GAS6;BCR;NBR1;KIF13B;CAMK1;TERC;RXRA;ADCY6;CTSH;AKT1;CARD11;DGUOK;AMIGO2;FMNL3;LMNA;WDFY2;INSR;WNT3;TENM4;FOXO4;YPEL3;MAP2K5;BRAF;GPR21;ARHGAP44;LGALS1;TIMP1;JAK3;TP73;CSNK1E;BCL6;HSF4;FYN;SIRT2;GDF15;PHLDA2;CELSR1;ADA;PLXND1;RHOBTB3;AP2A2;HDAC8;ADIRF;TGFBR3;EPHB2;FGFR1;FITM2;CTH;ERBB2;UST;EIF2AK4;C15ORF62;HLA-G;CORO1B;NET1;KCTD11;ZMYM3;IKBKB;TEAD2
5468,GO:0016406,0.0258861922185504,0.997488670436381,3,6,carnitine O-acyltransferase activity,MF,CRAT;CPT2;CPT1C
4441,GO:0010359,0.0259026711145001,0.997486433390234,3,6,regulation of anion channel activity,BP,PRNP;ANO9;PTAFR
6868,GO:0030368,0.0260324720046518,0.997468791774372,3,6,interleukin-17 receptor activity,MF,IL17RD;IL17RE;IL17RC
10758,GO:0044224,0.0260498381324804,0.997466428688417,3,6,juxtaparanode region of axon,CC,DLG4;KCNAB2;SIRT2
2572,GO:0005859,0.0260507442043838,0.996643950501354,4,7,muscle myosin complex,CC,OBSL1;MYH11;MYH3;TTN
16977,GO:0099094,0.0261080868323753,0.991493899554754,8,31,ligand-gated cation channel activity,MF,ITPR3;KCNJ15;PKD2;TRPV1;ITPR2;TPCN1;ASIC1;SCNN1A
1992,GO:0004716,0.0261126605495101,0.997457874641832,3,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR;INSR;ERBB2
4534,GO:0010612,0.0261137766637475,0.997457722590928,3,6,regulation of cardiac muscle adaptation,BP,ERRFI1;ATP2B4;LMNA
18287,GO:1903242,0.0261137766637475,0.997457722590928,3,6,regulation of cardiac muscle hypertrophy in response to stress,BP,ERRFI1;ATP2B4;LMNA
4866,GO:0014731,0.026365544123478,0.997423354093733,3,6,spectrin-associated cytoskeleton,CC,ANK3;SPTB;DMTN
12458,GO:0050431,0.0263768036817909,0.994357279914466,5,15,transforming growth factor beta binding,MF,LTBP4;LTBP1;LTBP3;TGFBR2;TGFBR3
4228,GO:0009410,0.0264022800040133,0.984457895895021,28,164,response to xenobiotic stimulus,BP,EGR1;EGFR;BPHL;GGT1;CYP3A5;PCK2;DDIT4;AKR7A2;GSTO1;CES3;AIP;ERRFI1;HDAC5;GSTM2;CES2;ACY1;DNMT3A;MAP1LC3A;PDE2A;SRR;PTAFR;CYP2R1;GSTO2;CHEK2;HOMER2;GSTM3;ADA;EIF4EBP1
2298,GO:0005272,0.0264184087047469,0.994345963733662,5,15,sodium channel activity,MF,SCN8A;SCN4B;PKD2;ASIC1;SCNN1A
9778,GO:0040012,0.0264440853631509,0.980160314766731,89,616,regulation of locomotion,BP,DOCK4;BBS2;F2R;APOE;ZMYND8;SERPINE2;PGF;POSTN;SEMA4B;LRP1;ALOX15B;VEGFA;EGFR;FBLN1;IDH2;ARAP3;MMP28;ADARB1;HBEGF;NISCH;HYAL1;ARPIN;PKN1;ITGA6;FAM110C;SPRY2;GRB7;VEGFB;LAMA5;TTBK2;PAK1;MCTP1;CEMIP;SEMA3F;PLXNB3;ZSWIM4;ZP3;PLXNB1;EREG;RHOBTB2;C5;ECM1;MAPK3;PC;SEMA5A;IFITM1;RHOF;SRGAP3;ARHGEF2;DMTN;SEMA3B;SSH1;HDAC5;SORL1;PTPRU;TGFBR2;TRPV4;TMSB4X;SMURF2;NOS3;MINK1;WNT7A;EPHA1;SEMA4G;GAS6;BCR;PTAFR;CTSH;AKT1;LAMB1;TSG101;LMNA;RAB25;PLAU;INSR;WNT3;FOXO4;CHMP4C;MAP2K5;BRAF;TIMP1;PHLDA2;ADA;PLXND1;ITGA2;FGFR1;ERBB2;CORO1B;ROBO4
12854,GO:0051208,0.026450223963982,0.987993264320072,14,68,sequestering of calcium ion,BP,F2R;NTSR1;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PKD2;GSTM2;TRPV1;ATP7B;ITPR2;TPCN1;TRPC1
10223,GO:0042953,0.0264667002950138,0.997409506425505,3,6,lipoprotein transport,BP,LRP1;UNC119B;UNC119
11009,GO:0044872,0.0264667002950138,0.997409506425505,3,6,lipoprotein localization,BP,LRP1;UNC119B;UNC119
5209,GO:0015812,0.0264743769080962,0.997408454634063,3,6,gamma-aminobutyric acid transport,BP,NTSR1;SV2A;APBA1
10420,GO:0043292,0.026483522339418,0.985168501318521,24,130,contractile fiber,CC,FLNC;OBSCN;SCN8A;ANK3;CST3;PARVB;NOS1;MYH15;OBSL1;MYH11;TPM2;PAK1;SYNC;MYZAP;MYH3;TWF2;TTN;NBR1;TNNI2;ATP2B4;TNNT1;TMOD2;KRT19;TNNI1
4561,GO:0010647,0.026605799042997,0.97861719915643,156,1144,positive regulation of cell communication,BP,XDH;DUSP6;DLG4;F2R;APOE;NFATC4;SERPINE2;GSN;FGFBP1;PTK6;GLUL;ALOX15B;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;RBCK1;PRNP;S100A4;ANK3;DUSP5;TNFSF15;IGFBP4;NOS1;DDIT3;SHANK2;CRTC1;ERCC6;MST1R;ARAP1;HBEGF;RGL2;CTF1;TFDP2;EVC;RNF165;MAP2K1;CYP27B1;PCK2;PKN1;MC1R;SHC2;MAML3;PLEKHG5;FAM110C;SHC1;SPRY2;GRB7;RAB3B;NLGN2;ITPR3;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;NEURL1;ACVR2B;NGFR;GSTO1;WNT2B;PLXNB1;EREG;TMED4;TNFRSF25;PLA2G6;LPAR3;S100A13;C5;ANO1;PKD2;VAMP2;ECM1;MAPK3;CSPG4;BNIP3;SEMA5A;VANGL2;SH2D2A;RGS14;MAP2K2;DMTN;LITAF;BBC3;SSH1;FLOT1;UNC5B;GSTM2;SULF2;MAP3K12;CREBRF;FBXL15;TRPV4;ITGA1;SMURF2;APLN;EDA;CDK5RAP3;MINK1;WNT7A;PIK3R2;EPHA1;SHARPIN;GAS6;GLUD1;ERN1;RIMS3;CTSH;AKT1;CARD11;CDKN1C;FGFR4;TMOD2;SH2B3;INSR;WNT3;MAP2K5;BRAF;EDA2R;PIDD1;CAT;MAPK10;LGALS1;HFE;TP73;MIB2;CSNK1E;FYN;GDF15;ADA;TMEM101;PAIP2;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;LAMTOR2;MAP3K10;MFNG;STARD10;LURAP1;EPHB2;ITGA2;FGFR1;FKBP8;CTH;ERBB2;EIF2AK4;PAG1;GRB10;KCTD13;IKBKB;HIP1
7809,GO:0032371,0.0266080995804804,0.9921164893426,7,26,regulation of sterol transport,BP,APOE;LRP1;ABCA2;ABCA7;ABCG1;PLTP;PCSK9
7812,GO:0032374,0.0266080995804804,0.9921164893426,7,26,regulation of cholesterol transport,BP,APOE;LRP1;ABCA2;ABCA7;ABCG1;PLTP;PCSK9
12648,GO:0050879,0.0268900704460874,0.992014951383795,7,26,multicellular organismal movement,BP,GAA;GSTO1;MYH3;GSTM2;TNNI2;TNNT1;TNNI1
12650,GO:0050881,0.0268900704460874,0.992014951383795,7,26,musculoskeletal movement,BP,GAA;GSTO1;MYH3;GSTM2;TNNI2;TNNT1;TNNI1
3562,GO:0007606,0.0270589742124282,0.991081970867391,8,32,sensory perception of chemical stimulus,BP,BBS1;REEP2;ITPR3;TRPV1;GNAL;ASIC1;GJB4;SCNN1A
17767,GO:1901879,0.027067244809078,0.988589474246728,12,55,regulation of protein depolymerization,BP,GSN;SPTB;CAPG;TTBK2;SEMA5A;ARHGEF2;TWF2;DMTN;TRIOBP;TRPV4;TMOD2;PLEKHH2
14864,GO:0070679,0.0271011974242675,0.997322141388556,3,6,inositol 1,4,5 trisphosphate binding,MF,ITPR3;ITPR2;TRPC1
7197,GO:0031095,0.0271823418038773,0.997310905806423,3,6,platelet dense tubular network membrane,CC,ITPR3;DMTN;ITPR2
3379,GO:0007159,0.0272224071273348,0.983461189238653,31,185,leukocyte cell-cell adhesion,BP,TNIP1;NT5E;IL20RB;PRNP;EFNB3;CERCAM;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;PPARA;PDCD1LG2;CEBPB;TGFBR2;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;ASS1;LGALS1;HFE;JAK3;BCL6;FYN;ADA;DHPS;ERBB2;PAG1;HLA-G
10296,GO:0043094,0.0272560449608872,0.991004253096173,8,32,cellular metabolic compound salvage,BP,NAPRT;TK2;UCKL1;DGUOK;UPP1;APRT;ADA;FUK
3402,GO:0007186,0.0272981150187613,0.980875851019231,58,383,G-protein coupled receptor signaling pathway,BP,F2R;APOE;ADGRL1;LRP1;OBSCN;NTSR1;DGKA;NOS1;ADGRB2;ARHGEF19;HEBP1;NXPH4;MC1R;DGKQ;PLEKHG5;ADM2;ITPR3;HTR7;USP20;ARHGEF4;PLXNB1;EREG;PLEKHG2;LPAR3;C5;ANO1;AREG;RGS14;ARHGEF2;PTHLH;ATF4;LTB4R2;GPR153;ADGRF1;GPRC5C;GABBR1;PDE2A;APLN;PTAFR;ADCY6;ATP2B4;AKT1;TMOD2;INSR;GNAL;LTB4R;HOMER2;GPR21;MRGPRX3;CHRM3;ARHGEF17;CELSR1;ADA;ENTPD2;VAV3;EDNRA;RGS12;NET1
6067,GO:0019220,0.0273661472956691,0.97788874799799,163,1192,regulation of phosphate metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;EGR1;PPP1R35;PTK6;GJC2;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;PRNP;FBLN1;DUSP5;RAPGEF3;TNFSF15;IGFBP4;NOS1;ERCC6;MST1R;ADARB1;B3GAT3;HBEGF;RBL2;CTF1;CNTN1;SLC27A1;PHACTR3;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;SHC2;SYNGAP1;ITGA6;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PPP2R3B;PAK1;ABCA7;STK39;FGFR3;CEMIP;SPRY4;DLG3;ZP3;NEURL1;ACVR2B;NGFR;ELFN2;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;MTMR4;C5;PPARA;SESN2;IMPACT;PKD2;AREG;MAPK3;CSPG4;TRPT1;ERRFI1;STK40;VANGL2;RGS14;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;DMTN;PTHLH;PAK6;LTB4R2;PKD1;FLOT1;TTN;SORL1;VLDLR;GABBR1;MAP3K12;LRP5;PKIB;TGFBR2;TRPV4;CSRNP3;ITGA1;TMSB4X;APLN;TRIB3;CDK5RAP3;NOS3;MINK1;PROM2;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;NBR1;TADA3;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;STRADB;AKT1;CDKN1C;MICAL1;CRY2;CHEK2;SPDYE2;SPDYE2B;TSG101;FGFR4;FARP1;WDFY2;C9ORF72;INSR;RPS6KA5;CTDSPL;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;TAZ;FYN;LEMD2;SIRT2;GDF15;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;PER1;ITGA2;FGFR1;FKBP8;ERBB2;EIF2AK4;UNC119;SFI1;GRB10;CAMKK1;IKBKB
16994,GO:0099173,0.027389150634501,0.987507647832273,14,68,postsynapse organization,BP,DLG4;APOE;ZMYND8;PRNP;SHANK2;NLGN2;CAPRIN2;ETV5;SSH1;WNT7A;INSR;ARHGAP44;FYN;EPHB2
7257,GO:0031234,0.0274345424680249,0.98748410712076,14,68,extrinsic component of cytoplasmic side of plasma membrane,CC,DLG4;S100A6;PTK6;SNX9;ESYT2;KCNAB2;ERRFI1;MYZAP;FARP1;GNAL;JAK3;FYN;ESYT3;HIP1
16231,GO:0090313,0.0274639724463919,0.991807530853854,7,26,regulation of protein targeting to membrane,BP,PRNP;ANK3;PAK1;CEMIP;DMTN;FYN;ERBB2
10798,GO:0044304,0.0275513459142987,0.990156182669647,9,37,main axon,CC,DLG4;GJC2;SCN8A;ANK3;DNM1;KCNAB2;KIF13B;C9ORF72;SIRT2
16810,GO:0098739,0.0276381415579878,0.989443609424271,10,43,import across plasma membrane,BP,NTSR1;PRNP;TRPV1;ATP2B4;STEAP2;STEAP3;HFE;SLC9A7;FYN;SLC9A5
3273,GO:0006954,0.0276848465646785,0.980779654332481,55,362,inflammatory response,BP,TNIP1;F2R;NT5E;TNFRSF6B;APOE;NFATC4;FOS;IL20RB;CTNNBIP1;ACP5;PDCD4;EGFR;PRDX5;IGFBP4;GGT1;NUPR1;MAPK13;HYAL1;PRKCZ;SERPING1;STK39;ZP3;NGFR;TNFRSF25;C5;PPARA;PLGRKT;FNDC4;NLRX1;ECM1;LTB4R2;HDAC5;NLRP1;CEBPB;TRPV4;IL17RE;TMSB4X;PDE2A;TRPV1;SHARPIN;BCR;PTAFR;TNFRSF14;AKT1;IL17RC;RPS6KA5;LTB4R;ITGB6;HFE;JAK3;BCL6;ADA;PER1;ITGA2;IKBKB
17580,GO:1901293,0.0277543733801234,0.98220183803015,38,236,nucleoside phosphate biosynthetic process,BP,APOE;NAPRT;TIMP2;IDH2;NOS1;PGM1;DHTKD1;TK2;LHPP;DDIT4;OGDHL;NMRK1;NPR2;NMNAT2;NME4;PPCS;PPARA;MLXIPL;PTHLH;LTB4R2;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;NOS3;UCKL1;ADCY6;DGUOK;TCIRG1;UPP1;INSR;APRT;TAZ;ADA;FUK;PFKL
13249,GO:0051962,0.0277573273720896,0.981016435194456,51,328,positive regulation of nervous system development,BP,DLG4;APOE;ZMYND8;SERPINE2;ADGRL1;PTK6;GJC2;TIMP2;VEGFA;SHANK2;CRTC1;ADGRB2;CNTN1;OBSL1;CUL7;MAP2K1;NLGN2;CAPRIN2;PAK1;PLXNB3;FBXW8;NEURL1;NGFR;ETV5;PLXNB1;LPAR3;IMPACT;SEMA5A;RGS14;SLITRK6;ARHGEF2;TWF2;KDM4C;METRN;VLDLR;TPBG;HMG20B;WNT7A;CAMK1;AMIGO2;WNT3;TENM4;BRAF;TP73;CSNK1E;BCL6;FYN;PLXND1;EPHB2;FGFR1;KCTD11
4342,GO:0009898,0.0278820620325181,0.984723639783678,22,121,cytoplasmic side of plasma membrane,CC,DLG4;S100A6;PTK6;NTSR1;SPTB;SYNGAP1;SNX9;SHROOM4;ESYT2;RASA4;KCNAB2;ERRFI1;MYZAP;MAP2K2;LITAF;FARP1;GNAL;JAK3;FYN;ESYT3;IKBKB;HIP1
2243,GO:0005154,0.0279912387200121,0.991616079395126,7,26,epidermal growth factor receptor binding,MF,HBEGF;SHC1;EREG;AREG;SNX1;VAV3;HIP1
6644,GO:0023061,0.0281819076710746,0.981797860231662,39,242,signal release,BP,SYTL1;GLUL;EGFR;NR1D1;HADH;RAPGEF3;SNPH;BRSK1;SYT8;LTBP4;PCK2;ARL2;NLGN2;ITPR3;MCTP1;ACVR2B;PLA2G6;ANO1;VAMP2;SEPT5;PCLO;KCNC4;LRP5;TRPV4;APLN;WNT7A;GLUD1;RIMS3;ITPR2;SLC6A9;ICA1;BRAF;ASIC1;HFE;STX1A;FGFR1;PFKL;APBA1;PNKD
16577,GO:0097435,0.0282800106113146,0.979489332519223,70,467,supramolecular fiber organization,BP,APOE;ESPN;GSN;WIPF1;CDC42EP5;OBSCN;RAPGEF3;SPTB;LOXL1;CST3;EFS;ARAP1;MSRB2;OBSL1;ARPIN;CAPG;EML2;TUBG2;ARL2;MYH11;TPM2;TTBK2;PAK1;MICALL2;SHROOM4;CCDC88B;SSH3;PLEKHG2;RHOBTB2;ITGB5;SEMA5A;RHOF;LTBP2;HOOK2;MYH3;ARHGEF2;TWF2;STMN3;DMTN;KLHL24;SSH1;TTN;WHAMMP3;NDE1;TRIOBP;TRPV4;ARHGAP25;TMSB4X;EPHA1;CEP126;MICAL1;TNNT1;TMOD2;ASAP3;C9ORF72;KRT19;TNXB;BRAF;TUBGCP6;FCHSD1;SPIRE1;EPS8L1;GOLGA2;RHOBTB3;EPS8L2;C15ORF62;CORO1B;KCTD13;HIP1;PLEKHH2
4852,GO:0014069,0.0283363667683585,0.983589424985939,26,148,postsynaptic density,CC,PTPRS;DLG4;PRNP;DNM1;NOS1;SHANK2;SYNGAP1;DLG3;NEURL1;PCLO;KCNAB2;BNIP3;RGS14;ARHGEF2;DMTN;MINK1;SHARPIN;DNAJC6;BCR;ADD3;HOMER2;ARHGAP44;FYN;PJA2;MPDZ;STX1A
8873,GO:0034702,0.0283621458479394,0.985226842159658,19,101,ion channel complex,CC,DLG4;KCNG1;SCN8A;NOS1;SHANK2;SCN4B;DLG3;OLFM2;ANO1;VAMP2;KCNC4;KCNAB2;LRRC8A;KCNMA1;HERPUD1;CPT1C;TTYH3;SCNN1A;STX1A
4105,GO:0009164,0.0284474154641554,0.992471172588112,6,21,nucleoside catabolic process,BP,NT5E;APOBEC3C;APOBEC3F;UPP1;ADA;NUDT18
12553,GO:0050731,0.028495641028715,0.985140223968601,19,102,positive regulation of peptidyl-tyrosine phosphorylation,BP,DLG4;PTK6;VEGFA;PRNP;ERCC6;HBEGF;CTF1;CNTN1;DGKQ;FGFR3;DLG3;NEURL1;EREG;AREG;CSPG4;ARHGEF2;GAS6;FYN;UNC119
3452,GO:0007267,0.0285325081248199,0.977532899353054,126,907,cell-cell signaling,BP,DLG4;F2R;APOE;SYTL1;ZMYND8;NFATC4;SERPINE2;EGR1;CTNNBIP1;PGF;FGFBP1;GLUL;GJC2;LRP1;NTSR1;EGFR;PRNP;NR1D1;HADH;RAPGEF3;IGFBP4;SNPH;DNM1;NOS1;DDIT3;BRSK1;SHANK2;CRTC1;SCN4B;ARHGEF19;ADARB1;SYT8;CTF1;EFNB3;MDFI;LTBP4;NISCH;FBXW4;WWTR1;SYNGR1;PCK2;SYNGAP1;ARL2;NPHP4;RAB3B;NLGN2;PCSK1;SLC12A7;MYCBPAP;ITPR3;CAPRIN2;PRKCZ;HTR7;MCTP1;FGFR3;DLG3;NEURL1;ACVR2B;ETV5;WNT2B;EREG;SPG11;PLA2G6;LPAR3;ANO1;VAMP2;HMGA2;AREG;SEPT5;PCLO;KCNC4;SEMA5A;VANGL2;RGS14;SEMA3B;PTHLH;SSH1;SV2A;FLOT1;SULF2;LRP5;PTPRU;TRPV4;FOXL1;SMURF2;APLN;CALCOCO1;EDA;AGO4;MINK1;WNT7A;TRPV1;GLUD1;LZTS2;RIMS3;AKT1;ITPR2;IGFBP2;SLC6A9;TMOD2;ICA1;WNT3;BRAF;ASIC1;HFE;FRAT1;CHRM3;FCHSD1;CSNK1E;RNF213;GDF15;CELSR1;AP2A2;PAIP2;TCF7;STX1A;EPHB2;FGFR1;EIF2AK4;UNC119;PFKL;GRB10;KCTD13;APBA1;PNKD;SNCB
9947,GO:0042339,0.0285763670790987,0.991402637735305,7,26,keratan sulfate metabolic process,BP,B4GAT1;CHST6;ST3GAL3;HEXB;HEXA;B4GALT2;GALNS
8970,GO:0035091,0.0286591533000372,0.982515532504482,31,184,phosphatidylinositol binding,MF,HS1BP3;OSBPL5;ARAP3;ARAP1;NISCH;PITPNM1;SNX9;GRB7;ITPR3;PITPNC1;ESYT2;SNX29;GSDMA;PLEK2;PLCD1;TWF2;TECPR1;TRPV1;GSDMC;AKT1;ITPR2;WDR45;SBF2;SNX33;SNX17;ADAP1;SNX1;SH3PXD2A;MPPE1;PLEKHA4;HIP1
9253,GO:0035690,0.0286767535437966,0.981564350641054,38,236,cellular response to drug,BP,EGR1;EGFR;PRNP;CST3;MAPK13;KLF9;PPP1R14A;PCK2;DDIT4;IMPACT;STAT6;HMGA2;MAPK3;BNIP3;ERRFI1;ARHGEF2;ATF4;SSH1;GSTM2;ENDOG;DNMT3A;MAP1LC3A;PDE2A;TRPV1;GAS6;PTAFR;ADCY6;ITPR2;CHEK2;ANKZF1;BRAF;CHRM3;FYN;RECQL5;HDAC8;ADIRF;EIF4EBP1;NET1
13901,GO:0060589,0.0288010829287633,0.980759014576809,45,285,nucleoside-triphosphatase regulator activity,MF,DOCK4;EVI5L;CDC42EP5;GPSM1;ARAP3;TBC1D8;ARHGEF19;RIN1;ARAP1;ARHGAP23;ASAP2;SYNGAP1;ARL2;RALGDS;APPL2;PLXNB1;RINL;AGAP1;ALS2CL;SESN2;RASA4;ERRFI1;RGS14;SRGAP3;ARHGAP22;TBC1D14;TBC1D3E;RABGAP1;ACAP3;RALGAPA1;RIN2;ARHGAP25;PIK3R2;BCR;PLEKHG6;ASAP3;SGSM2;TBC1D20;ARHGAP27;ARHGAP44;ADAP1;VAV3;TBC1D16;RGS12;C15ORF62
11322,GO:0045666,0.028809450391263,0.981478313724143,38,234,positive regulation of neuron differentiation,BP,DLG4;APOE;ZMYND8;PTK6;TIMP2;VEGFA;SHANK2;CRTC1;CNTN1;OBSL1;CUL7;MAP2K1;CAPRIN2;PAK1;PLXNB3;FBXW8;NEURL1;NGFR;ETV5;PLXNB1;LPAR3;IMPACT;SEMA5A;ARHGEF2;TWF2;KDM4C;METRN;VLDLR;HMG20B;CAMK1;WNT3;BRAF;CSNK1E;BCL6;FYN;PLXND1;FGFR1;KCTD11
13207,GO:0051896,0.0288262161789883,0.984143964967893,22,122,regulation of protein kinase B signaling,BP,XDH;EGFR;DDIT3;MST1R;HBEGF;MC1R;FAM110C;SPRY2;FGFR3;EREG;SEMA5A;TRIB3;PIK3R2;GAS6;AKT1;FGFR4;INSR;FYN;LEMD2;FGFR1;ERBB2;HIP1
682,GO:0001893,0.0289545847187642,0.991264129889323,7,26,maternal placenta development,BP,CYP27B1;EPOR;CTSB;LDOC1;RXRA;AKT1;BSG
13941,GO:0060674,0.0289654622278289,0.991260140158413,7,26,placenta blood vessel development,BP,MAP2K1;FBXW8;PLCD3;PKD2;PLCD1;PKD1;AKT1
14164,GO:0061097,0.0290053932939658,0.987623044882663,12,56,regulation of protein tyrosine kinase activity,BP,DLG4;PTK6;PRNP;ERCC6;SHC1;DLG3;NEURL1;EREG;ERRFI1;GAS6;TSG101;UNC119
17529,GO:1901099,0.0290341291384491,0.992278260882195,6,21,negative regulation of signal transduction in absence of ligand,BP,IFI6;UNC5B;STRADB;AKT1;MAP2K5;FYN
20242,GO:2001240,0.0290341291384491,0.992278260882195,6,21,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6;UNC5B;STRADB;AKT1;MAP2K5;FYN
7845,GO:0032414,0.0291399239090238,0.988115730121793,11,50,positive regulation of ion transmembrane transporter activity,BP,NTSR1;ANK3;STK39;GSTO1;PKD2;GSTM2;WNK4;TMSB4X;PTAFR;EHD3;EPHB2
9272,GO:0035725,0.0293148293422399,0.986069125135677,15,75,sodium ion transmembrane transport,BP,SCN8A;ANK3;NOS1;SCN4B;STK39;PKD2;SNTA1;KLHL24;PCSK9;ATP2B4;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC9A5
6627,GO:0023014,0.0293398413101042,0.977873248237706,89,621,signal transduction by protein phosphorylation,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;CDC42EP5;PDCD4;TIMP2;VEGFA;EGFR;FBLN1;DUSP5;SPTB;IGFBP4;ERCC6;MST1R;ZFP36L1;HBEGF;MAPK13;MAP2K1;PKN1;SHC2;SYNGAP1;SHC1;SPRY2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;SPRY4;ACVR2B;NGFR;TRIB2;EREG;TNFRSF25;LPAR3;C5;RASA4;MAPK3;CSPG4;ERRFI1;STK40;VANGL2;RGS14;MAPK12;MAP2K2;PAK6;SORL1;IL17RD;MAP3K12;MARK3;TGFBR2;TRPV4;ITGA1;TRIB3;CDK5RAP3;MINK1;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;NBR1;STRADB;CTSH;AKT1;TSG101;FGFR4;INSR;MAP2K5;BRAF;EDA2R;MAPK10;JAK3;TP73;FYN;LEMD2;GDF15;AVPI1;LAMTOR2;MAP3K10;EPHB2;PER1;FGFR1;ERBB2;FRS3;IKBKB
12608,GO:0050819,0.0293690902583074,0.990163573655219,8,32,negative regulation of coagulation,BP,APOE;SERPINE2;CD9;PLAT;SERPING1;PROCR;NOS3;PLAU
10705,GO:0044057,0.0294160703815366,0.98082451891567,40,250,regulation of system process,BP,DOCK4;F2R;NTSR1;EGFR;NOS1;SCN4B;HBEGF;GAA;NLGN2;ITPR3;PAK1;STK39;NPR2;GSTO1;MTMR4;ERRFI1;THRA;SNTA1;GSTM2;WNK4;APLN;NOS3;TRPV1;GAS6;TNNI2;PTAFR;ATP2B4;AKT1;ITPR2;TNNT1;LMNA;TENM4;CHRM3;EHD3;TRPC1;ADA;EPAS1;ITGA2;FGFR1;TNNI1
12257,GO:0048588,0.0294209205185273,0.983099902658646,25,142,developmental cell growth,BP,PTPRS;APOE;POSTN;SEMA4B;VEGFA;ULK2;ULK1;PRKCZ;PAK1;SEMA3F;PLXNB3;PLXNB1;SPG11;LPAR3;IMPACT;SLIT3;LAMB2;SEMA5A;TWF2;SEMA3B;TGFBR2;SEMA4G;C9ORF72;WNT3;EIF2AK4
19472,GO:1990351,0.0294655430495679,0.9837549588807,22,122,transporter complex,CC,DLG4;KCNG1;SCN8A;NOS1;SHANK2;SCN4B;ABCA2;ABCA7;DLG3;OLFM2;ANO1;VAMP2;KCNC4;KCNAB2;LRRC8A;KCNMA1;HERPUD1;CPT1C;TTYH3;SCNN1A;ATP12A;STX1A
12873,GO:0051239,0.029491818180801,0.975298715463477,240,1822,regulation of multicellular organismal process,BP,XDH;DUSP6;PTPRS;DLG4;DOCK4;GAMT;BBS2;F2R;APOE;ZMYND8;NFATC4;SERPINE2;FOS;IL20RB;ADGRL1;EGR1;CTNNBIP1;PGF;POSTN;PTK6;ACP5;WWC3;RNF135;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;PRNP;ADAMTS7;RAPGEF3;CD9;IDH2;CST3;NOS1;DDIT3;SHANK2;CRTC1;SCN4B;ADGRB2;ARHGEF19;ZFP36L1;NUPR1;HBEGF;GAA;CNTN1;EFNB3;OBSL1;PLAT;ULK2;SLC27A1;MAPK13;ASH2L;SOX13;CUL7;HYAL1;WWTR1;SMOC1;MAP2K1;CYP27B1;MC1R;BTG1;SYNGAP1;TMEM173;FAM213A;SPRY2;VEGFB;ADM2;NLGN2;ITPR3;LAMA5;CAPRIN2;PRKCZ;SERPING1;PAK1;ABCA7;STK39;KDM3A;NPR2;SEMA3F;PLXNB3;ZSWIM4;FBXW8;ZP3;NEURL1;ACVR2B;CCDC88B;RAG1;NGFR;ETV5;GSTO1;WNT2B;TRIB2;PLXNB1;EREG;SSH3;ERMAP;LPAR3;MTMR4;C5;IMPACT;NLRX1;STAT6;HMGA2;AREG;ECM1;ACACB;MAPK3;ERRFI1;SEMA5A;THRA;IFITM1;VANGL2;RGS14;FAM20C;SNTA1;SLITRK6;SDC2;ARHGEF2;INPP5D;PDCD1LG2;TWF2;DMTN;LITAF;ANGPTL4;SEMA3B;PTHLH;ATF4;PROCR;ZFPM1;KDM4C;SSH1;METRN;FLOT1;HDAC5;IRF5;SORL1;GSTM2;VLDLR;TPBG;DEAF1;SULF2;NLRP1;CEBPB;LRP5;WNK4;ATRAID;PCSK9;L3MBTL1;AQP3;TGFBR2;TRPV4;TMSB4X;SMURF2;APLN;HMG20B;CDK5RAP3;NOS3;AGO4;WNT7A;TRPV1;EPHA1;SEMA4G;GAS6;BCR;NBR1;TNNI2;KIF13B;CAMK1;PTAFR;RXRA;ADCY6;ATP2B4;CTSH;MAPKBP1;AKT1;ITPR2;CARD11;DGUOK;AMIGO2;TNNT1;IL17RC;IGF2BP2;LMNA;RAB25;PLAU;INSR;WNT3;TENM4;FOXO4;RPS6KA5;MAP2K5;BRAF;GPR21;ARHGAP44;BTN3A2;LGALS1;TIMP1;HFE;JAK3;TP73;CHRM3;CSNK1E;BTN3A3;BCL6;TKFC;EHD3;FYN;SIRT2;TRPC1;PHLDA2;CELSR1;ADA;PLXND1;POLR3GL;AP2A2;CIDEA;HDAC8;TGFBR3;EPAS1;LURAP1;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;CTH;ERBB2;UST;EIF2AK4;HLA-G;TNNI1;KCTD11;ZNF287;IKBKB
7288,GO:0031295,0.0296639529811581,0.990045211719702,8,32,T cell costimulation,BP,EFNB3;PAK1;PDCD1LG2;TNFRSF14;AKT1;CARD11;LGALS1;FYN
16787,GO:0098662,0.0297601956491745,0.979172392560816,56,371,inorganic cation transmembrane transport,BP,F2R;KCNG1;FHL1;GJC2;NTSR1;PRNP;SCN8A;ANK3;SLC2A9;NOS1;DDIT3;SCN4B;ORAI3;SLC12A7;ITPR3;STK39;CEMIP;NDUFA4L2;ORAI2;GSTO1;PLA2G6;KCNJ15;PKD2;VAMP2;KCNC4;KCNAB2;SNTA1;KLHL24;PKD1;KCNMA1;GSTM2;TMEM175;PCSK9;TRPV4;TMSB4X;PDE2A;TRPV1;GAS6;ATP7B;MFSD3;ATP2B4;STEAP2;ITPR2;TCIRG1;STEAP3;TPCN1;ASIC1;HFE;SCNN1A;ATP12A;SLC9A7;EHD3;FYN;TRPC1;SLC39A11;SLC9A5
3706,GO:0008217,0.0297797015920239,0.985415185857911,16,82,regulation of blood pressure,BP,F2R;POSTN;NTSR1;NOS1;NISCH;ADM2;STK39;NPR2;PPARA;LRP5;APLN;NOS3;GAS6;PTAFR;RNPEP;EDNRA
10488,GO:0043408,0.0297876200122151,0.978326147160183,70,474,regulation of MAPK cascade,BP,TNIP1;XDH;DUSP6;F2R;APOE;PDCD4;TIMP2;VEGFA;EGFR;FBLN1;DUSP5;IGFBP4;ERCC6;MST1R;MAP2K1;PKN1;SHC2;SYNGAP1;SHC1;SPRY2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;SPRY4;NGFR;TRIB2;TNFRSF25;LPAR3;C5;MAPK3;CSPG4;ERRFI1;STK40;VANGL2;RGS14;MAP2K2;PAK6;SORL1;MAP3K12;TRPV4;ITGA1;TRIB3;CDK5RAP3;MINK1;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;NBR1;AKT1;TSG101;FGFR4;INSR;MAP2K5;BRAF;EDA2R;MAPK10;TP73;LEMD2;GDF15;AVPI1;LAMTOR2;MAP3K10;EPHB2;PER1;FGFR1;ERBB2
4463,GO:0010463,0.0298030485808759,0.990951883207514,7,26,mesenchymal cell proliferation,BP,CTNNBIP1;VEGFA;FBXW4;LRP5;TGFBR2;LMNA;FGFR1
4288,GO:0009719,0.0298732366034992,0.976068504086535,145,1057,response to endogenous stimulus,BP,DUSP6;HTRA1;BBS2;APOE;FOS;EGR1;PGF;FGFBP1;POSTN;FAM210B;LRP1;PDCD4;TIMP2;EGFR;PRNP;NR1D1;ADAMTS7;HADH;RAPGEF3;CD9;CST3;NOS1;ZFP36L1;LTBP4;SLC27A1;MAPK13;KLF9;RNF165;UROS;HYAL1;PCK2;COL6A1;ABCA2;DDIT4;BTG1;SHC1;SPRY2;PRKCZ;PAK1;FGFR3;KDM3A;SPRY4;NEURL1;ACVR2B;NGFR;LTBP1;EREG;PTPRE;PSPH;ABCG1;MTMR4;PPARA;FNDC4;SESN2;IMPACT;PKD2;VAMP2;AREG;SLIT3;MAPK3;ITGB5;ERRFI1;THRA;FAM20C;LTBP2;CTSB;PAQR6;ARHGEF2;DMTN;ATF4;SSH1;MDK;HDAC5;SRSF5;GSTM2;SULF2;ENDOG;CEBPB;LRP5;PTPRU;CREBRF;PCSK9;FBXL15;DNMT3A;TGFBR2;TRPV4;PDE2A;SMURF2;APLN;TRIB3;CALCOCO1;NOS3;WNT7A;TRPV1;PIK3R2;TADA3;PTAFR;RXRA;ADCY6;ATP2B4;CTSH;ASNS;STEAP2;AKT1;IGFBP7;ITPR2;CDKN1C;CRY2;CHEK2;IGFBP2;FGFR4;PIAS3;TCIRG1;CAPN2;INSR;FOXO4;BRAF;GPR21;CAT;TIMP1;HFE;JAK3;CHRM3;APRT;FYN;LEMD2;SIRT2;GDF15;RECQL5;RAB13;CIDEA;HDAC8;EIF4EBP1;TGFBR3;LAMTOR2;PER1;ITGA2;FGFR1;FKBP8;ERBB2;CORO1B;FRS3;GRB10;MMP19;BSG
3566,GO:0007612,0.029877427386589,0.985766029085896,15,75,learning,BP,DLG4;FOS;NTSR1;SHANK2;SYNGAP1;RAG1;RGS14;DEAF1;B4GALT2;INSR;BRAF;ASIC1;FYN;EPHB2;EIF2AK4
12335,GO:0048732,0.0299618180148041,0.97983054000284,46,294,gland development,BP,XDH;SERPINE2;ALOX15B;VEGFA;EGFR;CST3;HMGCL;MAP2K1;PCK2;LAMA5;NEURL1;RAG1;ETV5;PKD2;STAT6;AREG;MAPK3;THRA;PKD1;MDK;SRSF5;DEAF1;SULF2;CEBPB;LRP5;PCSK9;TGFBR2;APLN;EDA;ATP7B;RXRA;MGMT;ASNS;AKT1;PHF2;INSR;WNT3;BRAF;HFE;APRT;ADA;PLXND1;TGFBR3;ITGA2;FGFR1;DBP
7019,GO:0030801,0.0300306148284775,0.991948316648535,6,21,positive regulation of cyclic nucleotide metabolic process,BP,APOE;TIMP2;RAPGEF3;NOS1;PTHLH;NOS3
6656,GO:0030017,0.0301029340583707,0.983948618642944,20,104,sarcomere,CC,FLNC;OBSCN;SCN8A;ANK3;PARVB;NOS1;OBSL1;TPM2;PAK1;SYNC;MYZAP;MYH3;TTN;NBR1;TNNI2;ATP2B4;TNNT1;TMOD2;KRT19;TNNI1
18807,GO:1904427,0.0301509238920502,0.989012725549924,9,38,positive regulation of calcium ion transmembrane transport,BP,F2R;GJC2;NTSR1;CEMIP;GSTO1;PKD2;GSTM2;EHD3;TRPC1
4198,GO:0009310,0.0301651123189891,0.994786904796959,4,11,amine catabolic process,BP,ALDH7A1;ATP2B4;SAT2;DHPS
11832,GO:0046834,0.0303460139544787,0.985512946198493,15,75,lipid phosphorylation,BP,EGFR;DGKA;HBEGF;DGKQ;FGFR3;EREG;PI4KAP1;PI4K2A;PIP5KL1;PIK3R2;ZFYVE21;FGFR4;FYN;FGFR1;ERBB2
10024,GO:0042493,0.0303516436829728,0.9771821338667,86,600,response to drug,BP,DUSP6;XPC;FOS;GSN;EGR1;PGF;TIMP2;NTSR1;EGFR;PRNP;HADH;CST3;NOS1;MAPK13;KLF9;PPP1R14A;PCK2;ABCA2;DDIT4;DGKQ;VEGFB;RAB3B;STK39;MTHFR;PPARA;BLMH;IMPACT;STAT6;HMGA2;AREG;SLIT3;ACACB;MAPK3;BNIP3;ERRFI1;SLC22A18;PQLC2;ARHGEF2;PRAF2;ATF4;SSH1;MDK;HLCS;KCNMA1;HDAC5;IRF5;GSTM2;NLRP1;ENDOG;DNMT3A;TGFBR2;MAP1LC3A;PDE2A;PEMT;TRPV1;GAS6;SRR;PTAFR;CYP2R1;ADCY6;MGMT;ASNS;IGFBP7;ITPR2;CHEK2;IGFBP2;SLC6A9;SLC25A29;ANKZF1;HOMER2;BRAF;CAT;LGALS1;TP73;CHRM3;FYN;SLC25A42;RECQL5;ADA;HDAC8;SLC35F3;ADIRF;EIF4EBP1;VAV3;ITGA2;NET1
12891,GO:0051261,0.0304573937359401,0.985452706039653,15,75,protein depolymerization,BP,GSN;SPTB;CAPG;TTBK2;SEMA5A;ARHGEF2;TWF2;STMN3;DMTN;TRIOBP;TRPV4;DNAJC6;MICAL1;TMOD2;PLEKHH2
9460,GO:0036094,0.0305374054170375,0.974397853128177,240,1809,small molecule binding,MF,XDH;H6PD;ACTA2;NT5E;APOE;PRODH;OSBPL5;ACSF2;PYGB;SLC2A3;PTK6;GLUL;NAGS;OBSCN;EGFR;D2HGDH;SCN8A;HADH;NEK9;RAPGEF3;DGKA;IDH2;DNM1;NOS1;BRSK1;ACAD10;ERCC6;MYH15;SMARCA1;MST1R;CUL9;PHGDH;RPS6KA2;PYGL;DHTKD1;TK2;ULK2;SLC27A1;MAPK13;CDK18;HMGCL;TXNRD3;MAP2K1;PCK2;CRYL1;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TUBG2;TMEM173;DNAH1;ARL2;ULK1;VPS11;OGDHL;RAB3B;MYH11;ITPR3;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;PHYH;STK39;FGFR3;SEC14L2;CEMIP;MTHFR;GLDC;NPR2;CBS;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;GPT2;RHOBTB2;ABCG1;AGAP1;CARS;KIF17;PPARA;CHD3;SESN2;MKNK2;IFT27;NLRX1;SEPT5;ACACB;NT5C1B;MAPK3;PC;OSBPL10;STK40;ACSS2;MVD;FAM20C;RHOF;TUBE1;MAPK12;MYH3;PI4K2A;SEPT10;MAP2K2;HIBADH;TWF2;SDHA;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GTPBP1;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;ACADS;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;MOCOS;PDE2A;TRIB3;RAB40B;ARL10;MLH3;NOS3;MINK1;PROM2;SLC27A3;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;NUDT6;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;RXRA;ADCY6;MBD1;RAB43;ATP2B4;THNSL2;STRADB;ACOX3;ACAD11;ASNS;TM7SF2;HINT2;AKT1;ITPR2;DGUOK;MICAL1;CRY2;CHEK2;PHYKPL;SEPT6;ASS1;KIF27;FGFR4;CBR4;ACADVL;MARK4;RAB25;INSR;ACSS1;GNAL;RPS6KA5;LTB4R;TXNRD2;MAP2K5;BRAF;CAT;MAPK10;JAK3;APRT;OGFOD2;SCYL3;ATP12A;CSNK1E;ADAP1;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;SIRT2;TRPC1;RECQL5;RAB13;ADA;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;SEPT8;FGFR1;CTH;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;BSG;CAMKK1;IKBKB
479,GO:0001525,0.0305461536290492,0.979140144624932,49,316,angiogenesis,BP,NFATC4;PGF;VEGFA;RAPGEF3;ADGRB2;HYAL1;BTG1;SHC1;SPRY2;VEGFB;ADM2;LAMA5;ELK3;NGFR;EREG;PLCD3;C5;HMGA2;COL8A1;ECM1;CSPG4;SEMA5A;SH2D2A;ARHGAP22;PLCD1;ANGPTL4;UNC5B;HDAC5;EGFL7;TGFBR2;APLN;NOS3;WNT7A;EPHA1;CTSH;FMNL3;FGFR4;FOXO4;MAP2K5;RNF213;PLXND1;VAV3;EPAS1;EDNRA;EPHB2;FGFR1;ERBB2;MMP19;ROBO4
17047,GO:0099572,0.0305592312142638,0.982168331589166,26,149,postsynaptic specialization,CC,PTPRS;DLG4;PRNP;DNM1;NOS1;SHANK2;SYNGAP1;DLG3;NEURL1;PCLO;KCNAB2;BNIP3;RGS14;ARHGEF2;DMTN;MINK1;SHARPIN;DNAJC6;BCR;ADD3;HOMER2;ARHGAP44;FYN;PJA2;MPDZ;STX1A
627,GO:0001817,0.0306068298500663,0.978206799527553,61,409,regulation of cytokine production,BP,PTPRS;F2R;NFATC4;IL20RB;EGR1;POSTN;ACP5;RNF135;ALOX15B;PDCD4;PRNP;DDIT3;MAPK13;MC1R;TMEM173;PRKCZ;ZP3;CCDC88B;TRIB2;EREG;ERMAP;C5;NLRX1;STAT6;MAPK3;ERRFI1;ARHGEF2;INPP5D;PDCD1LG2;LITAF;ATF4;ZFPM1;FLOT1;IRF5;SULF2;NLRP1;CEBPB;TRPV4;TMSB4X;GAS6;PTAFR;MAPKBP1;CARD11;IL17RC;IGF2BP2;RPS6KA5;MAP2K5;BTN3A2;HFE;JAK3;BTN3A3;BCL6;TKFC;POLR3GL;CIDEA;LURAP1;PER1;IGF2BP3;FGFR1;HLA-G;ZNF287
3180,GO:0006805,0.0306345438075975,0.986253484182119,13,64,xenobiotic metabolic process,BP,BPHL;GGT1;CYP3A5;AKR7A2;GSTO1;CES3;AIP;GSTM2;CES2;ACY1;CYP2R1;GSTO2;GSTM3
715,GO:0001941,0.0306370462241313,0.99174612741655,6,21,postsynaptic membrane organization,BP,DLG4;APOE;ZMYND8;NLGN2;ETV5;SSH1
3375,GO:0007155,0.03068064638879,0.97613062569423,111,788,cell adhesion,BP,TNIP1;PTPRS;NT5E;SERPINE2;IL20RB;GSN;ADGRL1;THBS3;POSTN;VEGFA;EGFR;PRNP;FBLN1;ANK3;CD9;SDK2;PARVB;CGREF1;CLCA2;ADAMTS13;COL13A1;EFS;ZFP36L1;CNTN1;EFNB3;CERCAM;HYAL1;SMOC2;COL6A1;ITGA6;ARL2;SHC1;NPHP4;BLOC1S4;NLGN2;LAMA5;PRKCZ;PAK1;ARVCF;PLXNB3;ITGB4;MICALL2;PDZD2;ZP3;CCDC88B;RAG1;NID1;PLXNB1;PPARA;COL8A1;ITGB5;LAMB2;SEMA5A;PDCD1LG2;DMTN;TENM2;KIF26B;PKD1;FLOT1;TPBG;COL4A6;EGFL7;CEBPB;PTPRU;TRIOBP;TGFBR2;TRPV4;ITGA1;LMO7;EDA;MINK1;EPHA1;GAS6;ECM2;BCAM;PTAFR;TNFRSF14;AKT1;IGFBP7;CARD11;AMIGO2;LAMB1;IGFBP2;ASS1;PLAU;TENM4;TNXB;ITGB6;MAP2K5;BRAF;LGALS1;HFE;JAK3;ICAM5;BCL6;FYN;MPDZ;CELSR1;ADA;CADM4;PLXND1;VAV3;DHPS;MAGI1;ITGA2;ERBB2;PAG1;HLA-G;NET1;APBA1;NTM
10386,GO:0043236,0.0307123769502581,0.991720938674905,6,21,laminin binding,MF,ITGA6;NID1;ECM1;BCAM;LGALS1;ITGA2
1989,GO:0004713,0.0308481509099118,0.983214985071505,21,111,protein tyrosine kinase activity,MF,PTK6;EGFR;MST1R;HBEGF;EFNB3;MAP2K1;FGFR3;EREG;CNTRL;MAP2K2;TTN;EPHA1;BCR;FGFR4;INSR;MAP2K5;JAK3;FYN;EPHB2;FGFR1;ERBB2
16397,GO:0097061,0.0308948962571013,0.98728103331753,11,50,dendritic spine organization,BP,DLG4;APOE;ZMYND8;PRNP;SHANK2;CAPRIN2;WNT7A;INSR;ARHGAP44;FYN;EPHB2
8394,GO:0033363,0.0309359681588728,0.991646081041301,6,21,secretory granule organization,BP,F2R;SERPINE2;RFX2;TBC1D20;LYST;BLOC1S1
6185,GO:0019637,0.0309498613568373,0.975752483319201,117,847,organophosphate metabolic process,BP,XDH;H6PD;DLG4;NT5E;ISYNA1;APOE;OSBPL5;NAPRT;TIMP2;VEGFA;NTSR1;EGFR;RAPGEF3;DGKA;IDH2;NOS1;DNPH1;PGM1;HBEGF;PYGL;DHTKD1;TK2;SLC27A1;PITPNM3;LHPP;ACP6;PCK2;CRYL1;PGLS;DDIT4;LPCAT4;PLCH2;PITPNM1;DGKQ;OGDHL;NMRK1;FGFR3;NPR2;DLG3;NMNAT2;NME4;ZP3;NEIL1;ABHD14B;PPCS;EREG;PNPLA3;PLCD3;PLA2G6;MTMR4;PPARA;PKD2;PI4KAP1;NT5C1B;KCNAB2;OSBPL10;MVD;FAM20C;MYH3;PI4K2A;MLXIPL;PLCD1;INPP5D;SRD5A3;SDHA;PTHLH;LTB4R2;GTPBP1;GALK1;NADK;GABBR1;ACOT7;ALDOC;PCSK9;TMSB4X;MOCOS;PDE2A;PEMT;NOS3;PIGZ;HEXB;PIP5KL1;PIK3R2;CHKB;UCKL1;PTAFR;ADCY6;ZFYVE21;CARD11;DGUOK;FGFR4;TCIRG1;UPP1;INSR;PIGQ;PLB1;APRT;MPI;TAZ;TKFC;FYN;MBOAT2;ADA;ETNK2;ENTPD2;FUK;VAV3;STARD10;INPP4A;FGFR1;PIGV;FITM2;ERBB2;PFKL;MPPE1;NUDT18;PLEKHA4
13802,GO:0060425,0.031070317716838,0.988615207268014,9,38,lung morphogenesis,BP,MAP2K1;SPRY2;WNT2B;MAPK3;STK40;VANGL2;TGFBR2;CTSH;CELSR1
12874,GO:0051240,0.0312753589015742,0.975110033535961,134,972,positive regulation of multicellular organismal process,BP,DLG4;BBS2;F2R;APOE;ZMYND8;NFATC4;SERPINE2;FOS;IL20RB;ADGRL1;EGR1;CTNNBIP1;PGF;POSTN;PTK6;RNF135;FAM210B;GJC2;LRP1;ALOX15B;TIMP2;VEGFA;EGFR;RAPGEF3;NOS1;DDIT3;SHANK2;CRTC1;ADGRB2;ZFP36L1;HBEGF;CNTN1;OBSL1;SLC27A1;MAPK13;CUL7;HYAL1;WWTR1;MAP2K1;CYP27B1;BTG1;TMEM173;VEGFB;ADM2;NLGN2;CAPRIN2;PRKCZ;PAK1;ABCA7;PLXNB3;FBXW8;ZP3;NEURL1;ACVR2B;CCDC88B;RAG1;NGFR;ETV5;GSTO1;WNT2B;PLXNB1;EREG;LPAR3;C5;IMPACT;NLRX1;STAT6;HMGA2;ECM1;ACACB;MAPK3;SEMA5A;IFITM1;RGS14;FAM20C;SLITRK6;ARHGEF2;INPP5D;TWF2;DMTN;ANGPTL4;ATF4;ZFPM1;KDM4C;METRN;FLOT1;IRF5;VLDLR;TPBG;SULF2;NLRP1;CEBPB;ATRAID;TGFBR2;TRPV4;TMSB4X;SMURF2;APLN;HMG20B;NOS3;WNT7A;TRPV1;EPHA1;GAS6;CAMK1;PTAFR;CTSH;AKT1;CARD11;AMIGO2;IL17RC;RAB25;WNT3;TENM4;BRAF;GPR21;TP73;CHRM3;CSNK1E;BCL6;TKFC;FYN;SIRT2;ADA;PLXND1;POLR3GL;TGFBR3;LURAP1;EPHB2;ITGA2;FGFR1;CTH;HLA-G;KCTD11
4674,GO:0010827,0.0312894975602782,0.987092186022319,11,50,regulation of glucose transmembrane transport,BP,CLTCL1;PRKCZ;PAK1;NGFR;TRIB3;PIK3R2;AKT1;INSR;BRAF;RTN2;GRB10
12832,GO:0051174,0.0313017312952635,0.974569657893796,164,1205,regulation of phosphorus metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;EGR1;PPP1R35;PTK6;GJC2;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;PRNP;FBLN1;DUSP5;RAPGEF3;TNFSF15;IGFBP4;NOS1;ERCC6;MST1R;ADARB1;B3GAT3;HBEGF;RBL2;CTF1;CNTN1;SLC27A1;PHACTR3;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;SHC2;SYNGAP1;ITGA6;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PPP2R3B;PAK1;ABCA7;STK39;FGFR3;CEMIP;SPRY4;DLG3;ZP3;NEURL1;ACVR2B;NGFR;ELFN2;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;MTMR4;C5;PPARA;SESN2;IMPACT;PKD2;AREG;MAPK3;CSPG4;TRPT1;ERRFI1;STK40;VANGL2;RGS14;FAM20C;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;DMTN;PTHLH;PAK6;LTB4R2;PKD1;FLOT1;TTN;SORL1;VLDLR;GABBR1;MAP3K12;LRP5;PKIB;TGFBR2;TRPV4;CSRNP3;ITGA1;TMSB4X;APLN;TRIB3;CDK5RAP3;NOS3;MINK1;PROM2;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;NBR1;TADA3;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;STRADB;AKT1;CDKN1C;MICAL1;CRY2;CHEK2;SPDYE2;SPDYE2B;TSG101;FGFR4;FARP1;WDFY2;C9ORF72;INSR;RPS6KA5;CTDSPL;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;TAZ;FYN;LEMD2;SIRT2;GDF15;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;PER1;ITGA2;FGFR1;FKBP8;ERBB2;EIF2AK4;UNC119;SFI1;GRB10;CAMKK1;IKBKB
12265,GO:0048608,0.0313615254752917,0.978818963401041,46,295,reproductive structure development,BP,HTRA1;SERPINE2;ALOX15B;VEGFA;EGFR;ERCC1;CST3;ZFP36L1;NUPR1;MDFI;CUL7;MAP2K1;CYP27B1;FBXW8;ZP3;EPOR;WNT2B;EREG;PLCD3;PKD2;SLIT3;CTSB;PLCD1;PKD1;CEBPB;NOS3;AGO4;LDOC1;WNT7A;RXRA;WDR19;AKT1;TBC1D20;INSR;KRT19;TFEB;REC8;PHLDA2;RAB13;ADA;RHOBTB3;ETNK2;TCF7;EPAS1;MMP19;BSG
14970,GO:0070914,0.0314445438032573,0.994492542764868,4,11,UV-damage excision repair,BP,XPC;DDB2;ERCC1;MC1R
7412,GO:0031514,0.0315515296922168,0.984844289061703,15,76,motile cilium,CC,BBS2;DNAH1;IFT27;PKD2;PKD1;SPAG16;ATP2B4;WDR19;SEPT6;WDR66;CABYR;SCNN1A;GSTM3;SPATA6;TCTEX1D4
10718,GO:0044092,0.031792837182731,0.975391871634911,105,750,negative regulation of molecular function,BP,DUSP6;TNFRSF6B;APOE;NFATC4;SERPINE2;CTNNBIP1;PPP1R35;PTK6;PDCD4;TIMP2;VEGFA;RBCK1;PRNP;PRDX5;ANK3;TFPI2;DUSP5;CST3;NOS1;GPSM1;DDIT3;ADARB1;MXI1;MDFI;PHACTR3;PPP1R14A;WWTR1;CYP27B1;PKN1;ARL2;SPRY2;TTBK2;PRKCZ;SERPING1;STK39;PLXNB3;SPRY4;DLG3;NEIL1;RAG1;NGFR;ELFN2;GSTO1;TRIB2;C5;PPARA;AIP;RASA4;NLRX1;PKD2;HMGA2;ECM1;ACACB;MAPK3;ERRFI1;THRA;RGS14;ANGPTL4;ZFPM1;LTB4R2;IFI6;PKD1;SORL1;HERPUD1;GSTM2;PAPLN;GABBR1;LRP5;PCSK9;PKIB;CSRNP3;TMSB4X;ANO9;TRIB3;DAP;BHLHE40;CDK5RAP3;NOS3;ZFP90;EPHA1;GAS6;CAMK1;PPP1R15A;ATP2B4;AKT1;CDKN1C;MICAL1;CRY2;HMSD;TSG101;FARP1;MAP2K5;CAT;TIMP1;HFE;TP73;CSNK1E;GOLGA2;MAP3K10;EPHB2;WFS1;EIF2AK4;SFI1;IKBKB;SNCB
9599,GO:0036477,0.031831562593057,0.976752389784803,70,475,somatodendritic compartment,CC,PTPRS;DLG4;APOE;ZMYND8;FBXO2;GLUL;GJC2;LRP1;TIMP2;NTSR1;PRNP;NR1D1;ANK3;SNPH;CST3;DNM1;NOS1;SHANK2;CRTC1;SYNGAP1;ITPR3;PRKCZ;HTR7;PAK1;PRR7;DLG3;NEURL1;SPG11;KIF17;KCNC4;BNIP3;RGS14;PI4K2A;NRSN2;ARHGEF2;KIF21B;KLHL24;ATF4;SV2A;TENM2;ATXN10;AZIN2;MAP6;GABBR1;ENDOG;ITGA1;MINK1;TRPV1;SHARPIN;CPT1C;SRR;KIF13B;IFT57;PIAS3;FARP1;C9ORF72;CAPN2;INSR;HOMER2;ARHGAP44;CHRM3;FYN;SLC38A2;SIRT2;MPDZ;ADA;EPHB2;WFS1;RGS12;APBA1
6790,GO:0030239,0.031862971540232,0.989371826762476,8,28,myofibril assembly,BP,OBSCN;OBSL1;MYH11;MYH3;TTN;TNNT1;TMOD2;KRT19
4638,GO:0010765,0.0319025994134785,0.991320847406175,6,21,positive regulation of sodium ion transport,BP,ANK3;NOS1;SCN4B;CNTN1;PRSS8;AKT1
16751,GO:0098589,0.0319192933492101,0.97986151221599,34,207,membrane region,CC,F2R;MARVELD1;NTSR1;EGFR;PRNP;NOS1;CNTN1;LY6K;PRKCZ;MALL;STAT6;MAPK3;PI4K2A;INPP5D;FLOT1;KCNMA1;UNC5B;TGFBR2;ITGA1;SMURF2;NOS3;PROM2;ATP2B4;CARD11;CAPN2;INSR;LTB4R;MYOF;FYN;LAMTOR2;PLLP;PAG1;BSG;IKBKB
7022,GO:0030804,0.0321101415748164,0.992633841808917,5,16,positive regulation of cyclic nucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;PTHLH;NOS3
17465,GO:1900449,0.032118015931093,0.991248015437005,6,21,regulation of glutamate receptor signaling pathway,BP,DLG4;SHANK2;NLGN2;KLHL24;MINK1;EPHB2
4506,GO:0010561,0.0321187514196377,0.99433575287887,4,11,negative regulation of glycoprotein biosynthetic process,BP,HBEGF;ABCA7;JAK3;ACOT8
6952,GO:0030613,0.0322085352057953,0.998757561276054,2,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,GSTO1;GSTO2
6953,GO:0030614,0.0322085352057953,0.998757561276054,2,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,GSTO1;GSTO2
10139,GO:0042734,0.0322486487437161,0.98810229482288,9,38,presynaptic membrane,CC,ADGRL1;SNPH;NLGN2;PI4K2A;GABBR1;PDE2A;RIMS3;STX1A;HIP1
4942,GO:0014911,0.0323051431163947,0.991184644620045,6,21,positive regulation of smooth muscle cell migration,BP,DOCK4;POSTN;PAK1;SSH1;FOXO4;ITGA2
16845,GO:0098802,0.0323266876432224,0.983600042283608,17,89,plasma membrane receptor complex,CC,DLG4;SHANK2;ITGA6;DLG3;ITGB4;OLFM2;ITGB5;GABBR1;TGFBR2;ITGA1;CPT1C;CARD11;INSR;ITGB6;HFE;ITGA2;IKBKB
5144,GO:0015680,0.0326021108831438,0.998733788118301,2,3,intracellular copper ion transport,BP,CCS;ATP7B
19341,GO:1905809,0.0326094955720181,0.994220912159303,4,11,negative regulation of synapse organization,BP,APOE;NFATC4;PRNP;FYN
4783,GO:0010977,0.0326108852576582,0.982718173452924,19,103,negative regulation of neuron projection development,BP,PTPRS;APOE;NFATC4;SEMA4B;LRP1;EFNB3;ULK2;SYNGAP1;SEMA3F;NGFR;SEMA5A;SEMA3B;TRPV4;SEMA4G;ADCY6;DGUOK;WNT3;LGALS1;EPHB2
10366,GO:0043204,0.0326536238306694,0.985789542258562,12,57,perikaryon,CC,PTPRS;GLUL;GJC2;NTSR1;NEURL1;PI4K2A;KLHL24;AZIN2;ENDOG;ITGA1;C9ORF72;SIRT2
7756,GO:0032281,0.0327124537300414,0.994196742552667,4,11,AMPA glutamate receptor complex,CC,DLG4;DLG3;OLFM2;CPT1C
8874,GO:0034703,0.0329165270656135,0.98409902162205,15,76,cation channel complex,CC,DLG4;KCNG1;SCN8A;NOS1;SCN4B;DLG3;OLFM2;VAMP2;KCNC4;KCNAB2;KCNMA1;HERPUD1;CPT1C;SCNN1A;STX1A
3614,GO:0008064,0.03293100286661,0.981345360629177,23,131,regulation of actin polymerization or depolymerization,BP,GSN;WIPF1;CDC42EP5;SPTB;ARPIN;CAPG;SSH3;PLEKHG2;SEMA5A;TWF2;DMTN;SSH1;WHAMMP3;TRIOBP;TMSB4X;TMOD2;FCHSD1;SPIRE1;EPS8L1;EPS8L2;C15ORF62;CORO1B;PLEKHH2
8096,GO:0032793,0.0329997432857214,0.994129162089263,4,11,positive regulation of CREB transcription factor activity,BP,VEGFA;CRTC1;ADGRF1;RPS6KA5
12503,GO:0050667,0.0330320649985034,0.994121546147846,4,11,homocysteine metabolic process,BP,MTHFR;CBS;BLMH;CTH
4601,GO:0010721,0.0331335435376002,0.979183141292866,33,201,negative regulation of cell development,BP,PTPRS;APOE;NFATC4;POSTN;SEMA4B;LRP1;FBLN1;IDH2;EFNB3;ULK2;SYNGAP1;PAK1;NPR2;SEMA3F;NGFR;SEMA5A;ARHGEF2;DMTN;SEMA3B;SORL1;TRPV4;WNT7A;TRPV1;SEMA4G;ADCY6;DGUOK;WNT3;LGALS1;TP73;SIRT2;EPHB2;EIF2AK4;KCTD11
19386,GO:1905954,0.0331656142388501,0.986866690270706,10,45,positive regulation of lipid localization,BP,APOE;LRP1;NTSR1;ABCA7;PLA2G6;ABCG1;ACACB;PLTP;CIDEA;FITM2
4494,GO:0010524,0.0332975365059762,0.989582773254926,7,27,positive regulation of calcium ion transport into cytosol,BP,F2R;NTSR1;CEMIP;GSTO1;PKD2;GSTM2;TRPC1
7811,GO:0032373,0.033349913940057,0.992269248276043,5,16,positive regulation of sterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP
7814,GO:0032376,0.033349913940057,0.992269248276043,5,16,positive regulation of cholesterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PLTP
728,GO:0001958,0.0334064494514173,0.992252525475848,5,16,endochondral ossification,BP,MEF2D;COL13A1;FGFR3;NAB2;PEX7
9452,GO:0036075,0.0334064494514173,0.992252525475848,5,16,replacement ossification,BP,MEF2D;COL13A1;FGFR3;NAB2;PEX7
66,GO:0000137,0.0334316316183615,0.994027184341885,4,11,Golgi cis cisterna,CC,GOLGA2P5;NECAB3;GOLGA8A;GOLGA2
7020,GO:0030802,0.0335956827047885,0.989469033082081,7,27,regulation of cyclic nucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;PTHLH;LTB4R2;GABBR1;NOS3
6587,GO:0022610,0.0336784578875197,0.973688823496142,111,791,biological adhesion,BP,TNIP1;PTPRS;NT5E;SERPINE2;IL20RB;GSN;ADGRL1;THBS3;POSTN;VEGFA;EGFR;PRNP;FBLN1;ANK3;CD9;SDK2;PARVB;CGREF1;CLCA2;ADAMTS13;COL13A1;EFS;ZFP36L1;CNTN1;EFNB3;CERCAM;HYAL1;SMOC2;COL6A1;ITGA6;ARL2;SHC1;NPHP4;BLOC1S4;NLGN2;LAMA5;PRKCZ;PAK1;ARVCF;PLXNB3;ITGB4;MICALL2;PDZD2;ZP3;CCDC88B;RAG1;NID1;PLXNB1;PPARA;COL8A1;ITGB5;LAMB2;SEMA5A;PDCD1LG2;DMTN;TENM2;KIF26B;PKD1;FLOT1;TPBG;COL4A6;EGFL7;CEBPB;PTPRU;TRIOBP;TGFBR2;TRPV4;ITGA1;LMO7;EDA;MINK1;EPHA1;GAS6;ECM2;BCAM;PTAFR;TNFRSF14;AKT1;IGFBP7;CARD11;AMIGO2;LAMB1;IGFBP2;ASS1;PLAU;TENM4;TNXB;ITGB6;MAP2K5;BRAF;LGALS1;HFE;JAK3;ICAM5;BCL6;FYN;MPDZ;CELSR1;ADA;CADM4;PLXND1;VAV3;DHPS;MAGI1;ITGA2;ERBB2;PAG1;HLA-G;NET1;APBA1;NTM
4968,GO:0015085,0.0337970272150713,0.98463590604327,13,63,calcium ion transmembrane transporter activity,MF,ORAI3;ITPR3;ORAI2;PKD2;PKD1;TRPV4;PDE2A;TRPV1;GAS6;ATP2B4;ITPR2;TPCN1;TRPC1
6061,GO:0019213,0.0339549810464942,0.985778471780263,11,51,deacetylase activity,MF,PHF21A;HDAC11;CHD3;MACROD1;HDAC5;CES2;HMG20B;MTA3;SIRT2;MTA1;HDAC8
17055,GO:0099604,0.034244175799183,0.99200375505366,5,16,ligand-gated calcium channel activity,MF,ITPR3;PKD2;TRPV1;ITPR2;TPCN1
500,GO:0001556,0.0343155010996214,0.991982490273767,5,16,oocyte maturation,BP,PABPC1L;NPR2;EREG;REC8;SIRT2
6362,GO:0021549,0.034342114781944,0.984938406182976,12,57,cerebellum development,BP,PTPRS;SERPINE2;CNTN1;NAGLU;MAP2K1;TRNP1;TTBK2;PAK1;AARS;MDK;WNT7A;B4GALT2
3156,GO:0006766,0.0343814719920486,0.982398224407789,17,91,vitamin metabolic process,BP,SLC2A3;ACP5;PRSS3;CYP27B1;MTHFR;GSTO1;PSAT1;ACACB;PC;HLCS;PLTP;ALDH1L2;CYP2R1;RXRA;GSTO2;ALDH1L1;FGFR1
17918,GO:1902287,0.0345611981924248,0.993758319136321,4,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,SEMA3F;PLXNB3;PLXNB1;PLXND1
12048,GO:0048018,0.0346184260621223,0.979076409647855,28,170,receptor ligand activity,MF,PGF;SEMA4B;VEGFA;TNFSF15;HBEGF;CTF1;VEGFB;ADM2;SEMA3F;ZP3;EREG;MANF;C5;AREG;SEMA3B;PTHLH;MDK;CMTM7;APLN;WNT7A;SEMA4G;GAS6;NUDT6;THNSL2;WNT3;CKLF;TIMP1;GDF15
4963,GO:0015075,0.0346437001227318,0.974877218741327,65,441,ion transmembrane transporter activity,MF,DLG4;KCNG1;S100A6;SLC2A3;SCN8A;SLC7A8;SLC16A3;SLC2A9;CLCA2;SCN4B;ORAI3;SLC27A1;SLC16A5;SLC43A1;SLC12A7;ITPR3;SLC37A2;NDUFA4L2;TMEM44;ORAI2;DLG3;SLCO4A1;ANO8;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;SLC22A18;PQLC2;LRRC8A;SLC38A10;PKD1;KCNMA1;AZIN2;TMEM175;TRPV4;ANO9;PDE2A;TRPV1;GAS6;ATP7B;MFSD3;TTYH3;ATP2B4;ITPR2;SLC6A9;TCIRG1;SLC6A6;TMEM63C;SLC25A29;SLC22A15;TPCN1;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC37A4;SLC38A2;SLC25A42;TRPC1;SLC39A11;SLC10A6;BSG;SLC9A5
18205,GO:1903037,0.0347560584405931,0.979001647704859,28,167,regulation of leukocyte cell-cell adhesion,BP,IL20RB;PRNP;EFNB3;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;PPARA;PDCD1LG2;CEBPB;TGFBR2;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;ASS1;LGALS1;HFE;JAK3;BCL6;FYN;ADA;DHPS;ERBB2;PAG1;HLA-G
4723,GO:0010890,0.0347633583151675,0.998600264735425,2,3,positive regulation of sequestering of triglyceride,BP,CIDEA;FITM2
4885,GO:0014809,0.0347730862729884,0.998599652441497,2,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,GSTO1;GSTM2
7287,GO:0031294,0.0348352310446179,0.987880407908672,8,33,lymphocyte costimulation,BP,EFNB3;PAK1;PDCD1LG2;TNFRSF14;AKT1;CARD11;LGALS1;FYN
12855,GO:0051209,0.0349382460278855,0.984018874930104,13,64,release of sequestered calcium ion into cytosol,BP,F2R;NTSR1;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PKD2;GSTM2;TRPV1;ITPR2;TPCN1;TRPC1
12904,GO:0051283,0.0349382460278855,0.984018874930104,13,64,negative regulation of sequestering of calcium ion,BP,F2R;NTSR1;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PKD2;GSTM2;TRPV1;ITPR2;TPCN1;TRPC1
2147,GO:0004966,0.0350289967858536,0.998583508931036,2,3,galanin receptor activity,MF,LTB4R2;LTB4R
6073,GO:0019229,0.0351605749306106,0.988868152971566,7,27,regulation of vasoconstriction,BP,DOCK4;F2R;EGFR;APLN;PTAFR;AKT1;CHRM3
9252,GO:0035686,0.0351890048458981,0.998573379930256,2,3,sperm fibrous sheath,CC,CABYR;GSTM3
6917,GO:0030517,0.035201740584598,0.988852259246406,7,27,negative regulation of axon extension,BP,PTPRS;SEMA4B;SEMA3F;SEMA5A;SEMA3B;SEMA4G;WNT3
16421,GO:0097110,0.0353902271894988,0.985827516487569,10,45,scaffold protein binding,MF,DLG4;KRT15;NOS1;MAP2K1;MAPK3;MAP2K2;NOS3;ATP2B4;ITPR2;IKBKB
5512,GO:0016480,0.0354415806129996,0.998557335994707,2,3,negative regulation of transcription by RNA polymerase III,BP,PRDX5;NAB2
8639,GO:0034198,0.0356306866046301,0.98656886841508,9,39,cellular response to amino acid starvation,BP,SESN2;IMPACT;MAPK3;ATF4;MAP1LC3A;DAP;C12ORF66;SLC38A2;EIF2AK4
2425,GO:0005605,0.0356483628229937,0.991582716931772,5,16,basal lamina,CC,LAMA5;NID1;LAMB2;LAMB1;ENTPD2
4106,GO:0009165,0.0357000181949765,0.976784133066884,37,233,nucleotide biosynthetic process,BP,APOE;NAPRT;TIMP2;IDH2;NOS1;PGM1;DHTKD1;TK2;DDIT4;OGDHL;NMRK1;NPR2;NMNAT2;NME4;PPCS;PPARA;MLXIPL;PTHLH;LTB4R2;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;NOS3;UCKL1;ADCY6;DGUOK;TCIRG1;UPP1;INSR;APRT;TAZ;ADA;FUK;PFKL
3553,GO:0007596,0.0357408804825092,0.97721674290098,34,212,blood coagulation,BP,F2R;APOE;SERPINE2;FBLN1;TFPI2;DGKA;CD9;ADAMTS13;PLAT;PHF21A;DGKQ;BLOC1S4;ITPR3;SERPING1;DOCK6;MAPK3;DOCK9;DMTN;PROCR;ZFPM1;DOCK11;HMG20B;NOS3;GAS6;AKT1;ITPR2;MICAL1;SH2B3;PLAU;EHD3;FYN;ENTPD2;VAV3;ITGA2
11268,GO:0045599,0.0358321884269752,0.987462780143874,8,33,negative regulation of fat cell differentiation,BP,DDIT3;WWTR1;TRIB2;ZFPM1;JDP2;TRPV4;TRIB3;SIRT2
15224,GO:0071417,0.0358608181493109,0.974604885945095,56,372,cellular response to organonitrogen compound,BP,EGR1;LRP1;EGFR;PRNP;RAPGEF3;ZFP36L1;MAPK13;UROS;PCK2;COL6A1;SHC1;PRKCZ;PAK1;NEURL1;NGFR;PTPRE;SESN2;IMPACT;PKD2;VAMP2;MAPK3;ERRFI1;ARHGEF2;DMTN;ATF4;SSH1;HDAC5;SRSF5;GSTM2;CEBPB;PCSK9;DNMT3A;PDE2A;TRIB3;TRPV1;PIK3R2;PTAFR;ADCY6;ATP2B4;AKT1;ITPR2;TCIRG1;CAPN2;INSR;FOXO4;GPR21;JAK3;APRT;FYN;SIRT2;RECQL5;RAB13;HDAC8;EIF4EBP1;LAMTOR2;GRB10
16782,GO:0098656,0.0358620001765862,0.978728011293221,26,152,anion transmembrane transport,BP,NTSR1;PRNP;SLC7A8;SLC16A3;CLCA2;CPT2;SLC43A1;SLC12A7;SLC37A2;STK39;ANO1;ACACB;PQLC2;PRAF2;LRRC8A;SLC38A10;ANO9;TTYH3;PTAFR;AKT1;SLC6A9;SLC6A6;SLC25A29;SLC37A4;SLC38A2;SLC25A42
789,GO:0002054,0.0358876289958711,0.998528838046514,2,3,nucleobase binding,MF,PYGL;APRT
791,GO:0002060,0.0358876289958711,0.998528838046514,2,3,purine nucleobase binding,MF,PYGL;APRT
14740,GO:0070458,0.0358905000707448,0.998528653935599,2,3,cellular detoxification of nitrogen compound,BP,GSTM2;GSTM3
2386,GO:0005523,0.035893052003158,0.995649088885627,3,7,tropomyosin binding,MF,S100A6;TNNT1;TMOD2
9774,GO:0040007,0.0360083066652021,0.972442442178886,92,648,growth,BP,DUSP6;PTPRS;HTRA1;GAMT;BBS2;APOE;SERPINE2;FHL1;GSN;THBS3;POSTN;PTK6;WWC3;SEMA4B;ALOX15B;VEGFA;EGFR;ERCC1;IGFBP4;DNPH1;SHANK2;ERCC6;ZFP36L1;ADARB1;HBEGF;EVC;LTBP4;ULK2;HYAL1;WWTR1;CYP27B1;BTG1;ULK1;SHC1;SPRY2;CAPRIN2;PRKCZ;PAK1;FGFR3;SEMA3F;PLXNB3;ZP3;ACVR2B;PLXNB1;EREG;SPG11;LPAR3;SESN2;IMPACT;ING4;HMGA2;AREG;SLIT3;ACACB;LAMB2;SEMA5A;STK40;VANGL2;SLITRK6;TSPYL2;TWF2;SEMA3B;KIF26B;TGFBR2;WNT7A;SEMA4G;GAS6;RXRA;AKT1;IGFBP7;IGFBP2;TSG101;C9ORF72;INSR;WNT3;TENM4;MAP2K5;GPR21;TP73;BCL6;PHLDA2;ETNK2;TGFBR3;LAMTOR2;FGFR1;WFS1;FKBP8;ERBB2;EIF2AK4;NET1;KCTD11;APBA1
81,GO:0000165,0.0361290359308788,0.972596077660152,86,604,MAPK cascade,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;CDC42EP5;PDCD4;TIMP2;VEGFA;EGFR;FBLN1;DUSP5;SPTB;IGFBP4;ERCC6;MST1R;ZFP36L1;HBEGF;MAPK13;MAP2K1;PKN1;SHC2;SYNGAP1;SHC1;SPRY2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;SPRY4;NGFR;TRIB2;EREG;TNFRSF25;LPAR3;C5;RASA4;MAPK3;CSPG4;ERRFI1;STK40;VANGL2;RGS14;MAPK12;MAP2K2;PAK6;SORL1;IL17RD;MAP3K12;MARK3;TRPV4;ITGA1;TRIB3;CDK5RAP3;MINK1;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;NBR1;CTSH;AKT1;TSG101;FGFR4;INSR;MAP2K5;BRAF;EDA2R;MAPK10;JAK3;TP73;FYN;LEMD2;GDF15;AVPI1;LAMTOR2;MAP3K10;EPHB2;PER1;FGFR1;ERBB2;FRS3;IKBKB
5431,GO:0016298,0.0361392249331974,0.982304934549967,15,77,lipase activity,MF,PLD3;PLCH2;PNPLA3;PLCD3;PLA2G6;CES3;PLCD1;CES2;FAAH;PNPLA4;PLB1;CHRM3;EDNRA;LYPLAL1;TMEM8A
13715,GO:0060313,0.0362074045232508,0.99850827885708,2,3,negative regulation of blood vessel remodeling,BP,CST3;BCR
14287,GO:0061458,0.0362503737231753,0.975258776203929,46,298,reproductive system development,BP,HTRA1;SERPINE2;ALOX15B;VEGFA;EGFR;ERCC1;CST3;ZFP36L1;NUPR1;MDFI;CUL7;MAP2K1;CYP27B1;FBXW8;ZP3;EPOR;WNT2B;EREG;PLCD3;PKD2;SLIT3;CTSB;PLCD1;PKD1;CEBPB;NOS3;AGO4;LDOC1;WNT7A;RXRA;WDR19;AKT1;TBC1D20;INSR;KRT19;TFEB;REC8;PHLDA2;RAB13;ADA;RHOBTB3;ETNK2;TCF7;EPAS1;MMP19;BSG
7919,GO:0032504,0.036418699075222,0.973317669539168,68,464,multicellular organism reproduction,BP,GAMT;BBS2;SERPINE2;EGR1;EGFR;ERCC1;CD9;CRTAP;MICALCL;GGT1;TCFL5;TXNRD3;CYP27B1;BTG1;PHC2;DNAH1;MYCBPAP;PABPC1L;KDM3A;NPR2;ZP3;NEURL1;EPOR;ETV5;EREG;SPATA20;PLA2G6;FAM50A;SCMH1;SLIT3;THRA;CCNI;TDRKH;CTSB;AZIN2;DEAF1;RFX2;CREBRF;CEP131;DNMT3A;MLH3;NOS3;AGO4;HEXB;LDOC1;HERPUD2;SPAG16;PTAFR;RXRA;ATP2B4;AKT1;SEPT6;CABYR;TBC1D20;WNT3;SPIRE1;BCL6;REC8;RPL39L;SIRT2;ADA;PAIP2;SPATA6;CREB3L4;MMP19;ZNF449;BSG;SIX5
1697,GO:0004177,0.0364744150089101,0.987192396762423,8,33,aminopeptidase activity,MF,NPEPL1;RNPEPL1;BLMH;LTA4H;CTSH;DPP7;RNPEP;MMP17
14675,GO:0070326,0.0366004957531025,0.99848285914686,2,3,very-low-density lipoprotein particle receptor binding,MF,APOE;PCSK9
11781,GO:0046683,0.0366164668889058,0.981553127952334,16,84,response to organophosphorus,BP,FOS;RAPGEF3;ZFP36L1;DGKQ;PKD2;AREG;DMTN;SSH1;PDE2A;TRPV1;PTAFR;ITPR2;BRAF;PER1;MMP19;BSG
16847,GO:0098805,0.0366964645516383,0.970060308658895,161,1193,whole membrane,CC,PTPRS;DLG4;F2R;APOE;MARVELD1;SLC2A3;FAM210B;LRP1;NTSR1;EGFR;PRNP;BPHL;CLTCL1;TSPAN1;CD9;NOS1;NDRG1;ARMCX2;SYT8;HBEGF;GAA;CNTN1;ULK2;RAB11FIP4;ATG16L2;SYNGR1;CYP27B1;COL6A1;ABCA2;TMEM173;ULK1;VPS11;RAB3B;CD68;CYBRD1;ITPR3;APPL2;LY6K;PRKCZ;ABCA7;MCTP1;CEMIP;BRI3;TMEM44;SYNE3;SPPL2B;MALL;SPG11;TMC6;DHRS4;MTMR4;NLRX1;STAT6;VAMP2;AREG;AP1G2;MARCH9;ACACB;KCNAB2;MAPK3;BNIP3;PEX10;RHOF;MVB12B;PI4K2A;PQLC2;CHMP1B;INPP5D;PRAF2;MAP2K2;TECPR1;SLC48A1;LITAF;SV2A;PKD1;FLOT1;KCNMA1;UNC5B;SORL1;MAP6;VLDLR;TMEM175;ATRAID;PCSK9;DBNDD1;TGFBR2;DIRC2;ITGA1;MAP1LC3A;PDE2A;SMURF2;RAB40B;NOS3;PROM2;WNT7A;MARCH2;BNIP3L;VPS39;CPT1C;NBEAL2;PTAFR;PPP1R15A;RAB43;ATP2B4;TMEM9;C12ORF66;STEAP2;ZFYVE21;ITPR2;CARD11;WDR45;SBF2;TSG101;RASSF9;SNN;TCIRG1;STEAP3;COPG1;ATG2A;CHMP5;CAPN2;MAN2B1;SPATA18;ICA1;IFI27;PLAU;INSR;WNT3;ANKZF1;CHMP4C;LTB4R;TPCN1;LETMD1;CAT;MYOF;SNX17;TMEM50B;HGSNAT;SLC9A7;EHD3;FYN;SNX1;PEX1;UBXN6;RAB13;TOM1;AP2A2;RETSAT;STX1A;LAMTOR2;BLOC1S1;ERBB2;SEC31B;PLLP;PAG1;HLA-G;BSG;PEX11A;TMEM8A;IKBKB;HIP1
7045,GO:0030832,0.0368083850798048,0.978897362833679,23,132,regulation of actin filament length,BP,GSN;WIPF1;CDC42EP5;SPTB;ARPIN;CAPG;SSH3;PLEKHG2;SEMA5A;TWF2;DMTN;SSH1;WHAMMP3;TRIOBP;TMSB4X;TMOD2;FCHSD1;SPIRE1;EPS8L1;EPS8L2;C15ORF62;CORO1B;PLEKHH2
10181,GO:0042802,0.0368550499883736,0.970015345098543,156,1155,identical protein binding,MF,TNIP1;XDH;HTRA1;APOE;S100A6;PGF;PTK6;RNF135;GLUL;VEGFA;NTSR1;EGFR;PADI3;PRNP;FBLN1;S100A4;CST3;DNM1;MEF2D;DDIT3;DNPH1;ARRDC1;UHRF1BP1;PYGL;ALDH4A1;HSD17B14;MDFI;SLC27A1;RAB11FIP4;NISCH;MLYCD;LHPP;HMGCL;MPRIP;WWTR1;CRYL1;PHC2;TMEM173;SNX9;ULK1;GRB7;VEGFB;NLGN2;PCSK1;TPM2;GALE;FGFR3;BRI3;GLDC;NPR2;CBS;ZP3;RAG1;SPPL2B;EPOR;PSPH;NAB2;ABCG1;ESYT2;S100A13;ALS2CL;CARS;APOBEC3F;BLMH;PKD2;STAT6;ACACB;MAPK3;PC;BNIP3;MVD;KCTD15;HOOK2;SDC2;CHMP1B;LRRC8A;ANGPTL4;TENM2;ATXN10;TTN;HLCS;IRF5;GSTM2;ACY1;CEBPB;MAP3K12;ACOT7;PTPRU;NDE1;L3MBTL1;CEP131;DNMT3A;TRPV4;PDE2A;SMURF2;BHLHE40;HEXB;TRPV1;BNIP3L;SHARPIN;GLUD1;OLFML2A;ERN1;MAPRE3;SRR;C1QTNF6;GSTO2;ASNS;AKT1;CHEK2;PHYKPL;SBF2;ASS1;TSG101;TENM4;FOXO4;CHMP4C;TPCN1;HOMER2;BRAF;CAT;LGALS1;TP73;SNX33;PEX7;BCL6;RABAC1;SAT2;SLC9A7;GSTM3;FYN;SNX1;SH3GLB2;CADM4;NAGA;CIDEA;CIDEB;MAP3K10;DHPS;EPHB2;NMRAL1;FGFR1;FKBP8;CTH;ERBB2;PFKL;HLA-G;CORO1B;FRS3;HMBOX1;KCTD11;KCTD13;PEX11A;IKBKB;HIP1;PLEKHH2
8752,GO:0034436,0.0368882456079518,0.998464149082323,2,3,glycoprotein transport,BP,ABCG1;VLDLR
17037,GO:0099550,0.036949754947288,0.998460138421155,2,3,trans-synaptic signaling, modulating synaptic transmission,BP,F2R;EPHB2
12645,GO:0050873,0.0369920718368915,0.989478880440599,6,22,brown fat cell differentiation,BP,ITGA6;BNIP3;ZNF516;CEBPB;TRPV4;PEX11A
8714,GO:0034374,0.0369945469530321,0.998457215318613,2,3,low-density lipoprotein particle remodeling,BP,APOE;ABCG1
13252,GO:0051965,0.037007053207252,0.986967357123092,8,33,positive regulation of synapse assembly,BP,ADGRL1;ADGRB2;NLGN2;SLITRK6;TPBG;WNT7A;AMIGO2;EPHB2
3509,GO:0007422,0.0371055997843899,0.984231835534439,11,51,peripheral nervous system development,BP,SCN8A;ADGRB2;NDRG1;ETV1;NAB2;SH3TC2;LAMB2;AKT1;GSTM3;SIRT2;ERBB2
5229,GO:0015849,0.0371525178118471,0.977197282201111,29,174,organic acid transport,BP,APOE;NTSR1;SLC7A8;SLC16A3;SLC27A1;CPT2;SLC16A5;SLC43A1;STK39;PLA2G6;PPARA;VAMP2;ACACB;PQLC2;PRAF2;SV2A;SLC38A10;TRPV1;RXRA;AKT1;SLC6A9;SLC6A6;SLC25A29;SLC38A2;STX1A;STARD10;SLC10A6;BSG;APBA1
11889,GO:0046942,0.0371525178118471,0.977197282201111,29,174,carboxylic acid transport,BP,APOE;NTSR1;SLC7A8;SLC16A3;SLC27A1;CPT2;SLC16A5;SLC43A1;STK39;PLA2G6;PPARA;VAMP2;ACACB;PQLC2;PRAF2;SV2A;SLC38A10;TRPV1;RXRA;AKT1;SLC6A9;SLC6A6;SLC25A29;SLC38A2;STX1A;STARD10;SLC10A6;BSG;APBA1
14425,GO:0061771,0.0372253926664853,0.998442117338978,2,3,response to caloric restriction,BP,APOE;SIRT2
6730,GO:0030155,0.037252716555272,0.973081974799507,62,418,regulation of cell adhesion,BP,SERPINE2;IL20RB;GSN;POSTN;VEGFA;PRNP;FBLN1;ANK3;CD9;EFNB3;HYAL1;SMOC2;ITGA6;ARL2;LAMA5;PRKCZ;PAK1;PLXNB3;ZP3;CCDC88B;RAG1;NID1;PLXNB1;PPARA;COL8A1;SEMA5A;PDCD1LG2;DMTN;KIF26B;PKD1;FLOT1;CEBPB;TRIOBP;TGFBR2;TRPV4;LMO7;MINK1;EPHA1;ECM2;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;ASS1;PLAU;MAP2K5;BRAF;LGALS1;HFE;JAK3;BCL6;FYN;ADA;PLXND1;VAV3;DHPS;ITGA2;ERBB2;PAG1;HLA-G;NET1
12751,GO:0051050,0.0373815756089055,0.971555043223232,87,608,positive regulation of transport,BP,F2R;APOE;FHL1;POSTN;EDEM1;GLUL;GJC2;LRP1;ALOX15B;VEGFA;NTSR1;EGFR;PRNP;ANK3;RAPGEF3;CLTCL1;TSPAN1;DNM1;NOS1;SCN4B;B3GAT3;CNTN1;TFDP2;PCK2;TMEM173;VPS11;RAB3B;NLGN2;PRSS8;PRKCZ;PAK1;ABCA7;STK39;CEMIP;MICALL2;ZP3;GSTO1;PLA2G6;ABCG1;LPAR3;C5;ANO1;PKD2;VAMP2;MAPK3;BBC3;FLOT1;TTN;AZIN2;SORL1;PLTP;GSTM2;NLRP1;WNK4;PCSK9;CEP131;TRPV4;TMSB4X;APLN;PEMT;TRPV1;PIK3R2;GAS6;GLUD1;BCR;CAMK1;PTAFR;AKT1;TSG101;IL17RC;TBC1D20;INSR;BRAF;HFE;TP73;EHD3;FYN;TRPC1;MYO18A;STX1A;EPHB2;ITGA2;FGFR1;WFS1;ERBB2;OSCP1;HIP1
10153,GO:0042756,0.0374429542559688,0.998427837485713,2,3,drinking behavior,BP,APLN;MMP17
5129,GO:0015629,0.0374475077203269,0.973680516915459,53,346,actin cytoskeleton,CC,ESPN;H1F0;GSN;WIPF1;RAPGEF3;SPTB;PARVB;PGM1;MYH15;MST1R;OBSL1;MPRIP;CAPG;MYH11;TPM2;PRKCZ;PAK1;MICALL2;SHROOM4;SPPL2B;ACTR1B;APBB3;RINL;PKD2;VANGL2;MYZAP;MYH3;ARHGEF2;TWF2;DMTN;MYH16;FLOT1;TTN;TRIOBP;TRPV4;TMSB4X;CROCC;TNNI2;TNNT1;TMOD2;CAPN2;KRT19;ULBP1;HFE;FYN;MYO18A;STX1A;LURAP1;SH3PXD2A;CORO1B;TNNI1;HIP1;PLEKHH2
16232,GO:0090314,0.0374554154449395,0.98931460581657,6,22,positive regulation of protein targeting to membrane,BP,PRNP;ANK3;PAK1;CEMIP;FYN;ERBB2
18341,GO:1903365,0.0375882368349732,0.998418274384397,2,3,regulation of fear response,BP,APOE;RAG1
20101,GO:2000822,0.0375882368349732,0.998418274384397,2,3,regulation of behavioral fear response,BP,APOE;RAG1
3212,GO:0006858,0.0376477166212078,0.99841435286772,2,3,extracellular transport,BP,ARRDC1;TSG101
5810,GO:0017080,0.0376918405079391,0.989230575373872,6,22,sodium channel regulator activity,MF,NOS1;SCN4B;PRSS8;SNTA1;PCSK9;ATP2B4
17687,GO:1901628,0.0377023211687832,0.998410749551198,2,3,positive regulation of postsynaptic membrane organization,BP,APOE;SSH1
4643,GO:0010770,0.0378000403758797,0.979239292923991,20,111,positive regulation of cell morphogenesis involved in differentiation,BP,VEGFA;OBSL1;CUL7;MAP2K1;CAPRIN2;PAK1;PLXNB3;FBXW8;NGFR;PLXNB1;LPAR3;SEMA5A;TWF2;DMTN;METRN;TRIOBP;WNT3;BRAF;PLXND1;NET1
6984,GO:0030672,0.0378672753242324,0.983825090024403,11,52,synaptic vesicle membrane,CC,PTPRS;SYT8;SYNGR1;RAB3B;MCTP1;VAMP2;PI4K2A;SV2A;DBNDD1;ICA1;STX1A
17006,GO:0099501,0.0378672753242324,0.983825090024403,11,52,exocytic vesicle membrane,CC,PTPRS;SYT8;SYNGR1;RAB3B;MCTP1;VAMP2;PI4K2A;SV2A;DBNDD1;ICA1;STX1A
622,GO:0001806,0.0379067490123818,0.998397232104665,2,3,type IV hypersensitivity,BP,IL20RB;ZP3
18676,GO:1904064,0.0379212266998762,0.982421733148199,13,65,positive regulation of cation transmembrane transport,BP,F2R;GJC2;NTSR1;ANK3;NOS1;CEMIP;GSTO1;PKD2;GSTM2;TMSB4X;EHD3;TRPC1;EPHB2
1212,GO:0002883,0.0379455430108471,0.998394662039759,2,3,regulation of hypersensitivity,BP,IL20RB;ZP3
12567,GO:0050767,0.0379550229249616,0.971818319718183,73,501,regulation of neurogenesis,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;SERPINE2;PTK6;GJC2;SEMA4B;LRP1;TIMP2;VEGFA;IDH2;NOS1;SHANK2;CRTC1;CNTN1;EFNB3;OBSL1;ULK2;CUL7;MAP2K1;SYNGAP1;CAPRIN2;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;NEURL1;NGFR;ETV5;PLXNB1;SSH3;LPAR3;IMPACT;SEMA5A;RGS14;SDC2;ARHGEF2;TWF2;SEMA3B;KDM4C;SSH1;METRN;SORL1;VLDLR;TRPV4;HMG20B;CDK5RAP3;WNT7A;SEMA4G;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;WNT3;TENM4;BRAF;ARHGAP44;LGALS1;TP73;CSNK1E;BCL6;FYN;SIRT2;PLXND1;EPHB2;FGFR1;UST;EIF2AK4;KCTD11
12606,GO:0050817,0.0379640872356383,0.975672430901556,34,213,coagulation,BP,F2R;APOE;SERPINE2;FBLN1;TFPI2;DGKA;CD9;ADAMTS13;PLAT;PHF21A;DGKQ;BLOC1S4;ITPR3;SERPING1;DOCK6;MAPK3;DOCK9;DMTN;PROCR;ZFPM1;DOCK11;HMG20B;NOS3;GAS6;AKT1;ITPR2;MICAL1;SH2B3;PLAU;EHD3;FYN;ENTPD2;VAV3;ITGA2
14819,GO:0070588,0.0380223654431073,0.977310282286649,26,153,calcium ion transmembrane transport,BP,F2R;GJC2;NTSR1;PRNP;NOS1;DDIT3;ORAI3;ITPR3;CEMIP;ORAI2;GSTO1;PLA2G6;PKD2;PKD1;GSTM2;TRPV4;PDE2A;TRPV1;GAS6;ATP2B4;ITPR2;TPCN1;ASIC1;EHD3;FYN;TRPC1
12348,GO:0048754,0.0380408965567051,0.979462728103169,19,104,branching morphogenesis of an epithelial tube,BP,NFATC4;CTNNBIP1;PGF;VEGFA;SPRY2;LAMA5;PAK1;ETV5;WNT2B;PKD2;AREG;VANGL2;PKD1;LRP5;TGFBR2;CTSH;CELSR1;PLXND1;EDNRA
19474,GO:1990357,0.0380442426469617,0.998388116276372,2,3,terminal web,CC,KRT19;HFE
4848,GO:0014065,0.0380574029242176,0.980730486092775,16,84,phosphatidylinositol 3-kinase signaling,BP,F2R;SERPINE2;EGFR;ZFP36L1;RGL2;PLXNB1;MAPK3;NYAP1;UNC5B;PIK3R2;AKT1;CAT;FYN;SIRT2;FGFR1;ERBB2
1615,GO:0004046,0.0380918943945741,0.998384952411261,2,3,aminoacylase activity,MF,ACY1;CAT
7255,GO:0031232,0.0381102769590928,0.998383731264101,2,3,extrinsic component of external side of plasma membrane,CC,SERPINE2;PCSK9
2380,GO:0005516,0.0381545230143147,0.9780861688792,23,127,calmodulin binding,MF,OBSCN;EGFR;NOS1;MYH15;MARCKSL1;MYH11;NGFR;PLA2G6;MKNK2;VAMP2;SNTA1;MYH3;TTN;MAP6;TRPV4;NOS3;TRPV1;CAMK1;ATP2B4;ADD3;WFS1;CTH;CAMKK1
19748,GO:2000194,0.0382770608902364,0.995237311444472,3,7,regulation of female gonad development,BP,NUPR1;ZP3;INSR
6929,GO:0030545,0.0382975831229142,0.97619056397264,30,186,receptor regulator activity,MF,PGF;SEMA4B;VEGFA;TNFSF15;HBEGF;CTF1;DGKQ;VEGFB;ADM2;SEMA3F;ZP3;EREG;MANF;C5;AREG;SEMA3B;PTHLH;MDK;PCSK9;CMTM7;APLN;WNT7A;SEMA4G;GAS6;NUDT6;THNSL2;WNT3;CKLF;TIMP1;GDF15
9970,GO:0042383,0.0383296762392865,0.981082100684875,15,77,sarcolemma,CC,FLNC;OBSCN;ANK3;NOS1;COL6A1;SYNC;DYSF;SNTA1;FLOT1;PEMT;ATP2B4;KRT19;SLC38A2;RTN2;BSG
6641,GO:0023056,0.0383616493315801,0.968760048854613,155,1150,positive regulation of signaling,BP,XDH;DUSP6;DLG4;F2R;APOE;NFATC4;SERPINE2;GSN;FGFBP1;PTK6;GLUL;ALOX15B;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;RBCK1;PRNP;S100A4;DUSP5;TNFSF15;IGFBP4;NOS1;DDIT3;SHANK2;CRTC1;ERCC6;MST1R;ARAP1;HBEGF;RGL2;CTF1;TFDP2;EVC;RNF165;MAP2K1;CYP27B1;PCK2;PKN1;MC1R;SHC2;MAML3;PLEKHG5;FAM110C;SHC1;SPRY2;GRB7;RAB3B;NLGN2;ITPR3;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;NEURL1;ACVR2B;NGFR;GSTO1;WNT2B;PLXNB1;EREG;TMED4;TNFRSF25;PLA2G6;LPAR3;S100A13;C5;ANO1;PKD2;VAMP2;ECM1;MAPK3;CSPG4;BNIP3;SEMA5A;VANGL2;SH2D2A;RGS14;MAP2K2;DMTN;LITAF;BBC3;SSH1;FLOT1;UNC5B;GSTM2;SULF2;MAP3K12;CREBRF;FBXL15;TRPV4;ITGA1;SMURF2;APLN;EDA;CDK5RAP3;MINK1;WNT7A;PIK3R2;EPHA1;SHARPIN;GAS6;GLUD1;ERN1;RIMS3;CTSH;AKT1;CARD11;CDKN1C;FGFR4;TMOD2;SH2B3;INSR;WNT3;MAP2K5;BRAF;EDA2R;PIDD1;CAT;MAPK10;LGALS1;HFE;TP73;MIB2;CSNK1E;FYN;GDF15;ADA;TMEM101;PAIP2;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;LAMTOR2;MAP3K10;MFNG;STARD10;LURAP1;EPHB2;ITGA2;FGFR1;FKBP8;CTH;ERBB2;EIF2AK4;PAG1;GRB10;KCTD13;IKBKB;HIP1
1157,GO:0002765,0.0383724172855594,0.998366279472537,2,3,immune response-inhibiting signal transduction,BP,IL20RB;HLA-G
19403,GO:1990037,0.0384307106880273,0.998362389014745,2,3,Lewy body core,CC,ATF4;HERPUD1
10082,GO:0042608,0.0385612986607848,0.998353660985353,2,3,T cell receptor binding,MF,EPS8L1;FYN
11544,GO:0046110,0.0385888658036713,0.99835181625576,2,3,xanthine metabolic process,BP,XDH;ADA
11119,GO:0045182,0.0385960863413271,0.985190531147154,9,40,translation regulator activity,MF,MIF4GD;CIRBP;NEURL1;PAIP2B;IGF2BP2;PAIP2;EIF4EBP1;IGF2BP3;EIF2AK4
3136,GO:0006732,0.0389821099529221,0.973364986048639,45,294,coenzyme metabolic process,BP,H6PD;GAMT;NT5E;ACSF2;SLC2A3;NAPRT;IDH2;PGM1;DHTKD1;MLYCD;HMGCL;PCK2;PGLS;DDIT4;OGDHL;NMRK1;MTHFR;NMNAT2;GSTO1;PPCS;ACOT1;PPARA;ACOT11;ACACB;KCNAB2;PC;ACSS2;MVD;MLXIPL;HLCS;GALK1;NADK;ACOT7;ALDOC;MOCOS;ALDH1L2;PEMT;SUCLG2;GSTO2;CBR4;INSR;ACSS1;ALDH1L1;PFKL;ACOT8
6285,GO:0019900,0.038993670452847,0.970409544631271,84,583,kinase binding,MF,TNIP1;ACTA2;DLG4;DOCK4;WWC3;EGFR;NEK9;DNM1;BRSK1;MICALCL;MST1R;EXOC2;PITPNM3;PKN1;BTG1;TOM1L2;SHC2;PITPNM1;DGKQ;TMEM173;SHC1;SPRY2;GRB7;SLC12A7;PRKCZ;PAK1;STK39;FGFR3;DLG3;CEP250;TRIB2;RHOBTB2;PLA2G6;CSPG4;ERRFI1;RGS14;RHOF;TBC1D14;TWF2;ATF4;SV2A;PKD1;CEP68;TTN;HDAC5;SRSF5;CEBPB;MAP3K12;TGFBR2;TRPV4;TRIB3;CDK5RAP3;PIK3R2;EPHA1;GAS6;MAPRE3;NBR1;KIF13B;PTAFR;PPP1R15A;ADCY6;ATP2B4;AKT1;MICAL1;CHEK2;SPDYE2;SPDYE2B;FGFR4;INSR;BRAF;TP73;PJA2;RAB13;GOLGA2;RHOBTB3;AP2A2;STX1A;EPHB2;PER1;FGFR1;ERBB2;PAG1;PFKL;IKBKB
6642,GO:0023057,0.0391159204411228,0.968733321852818,128,935,negative regulation of signaling,BP,TNIP1;XDH;DUSP6;PTPRS;HTRA1;APOE;NFATC4;SERPINE2;EGR1;CTNNBIP1;DDIT4L;PTK6;WWC3;LRP1;PDCD4;TIMP2;EGFR;PRNP;NR1D1;FBLN1;HADH;DUSP5;IGFBP4;DNM1;DDIT3;ARAP3;SHANK2;MST1R;ARRDC1;HBEGF;MDFI;EPM2A;WWTR1;DDIT4;SYNGAP1;ITGA6;SPRY2;NPHP4;PRKCZ;PEAR1;FGFR3;SPRY4;NEURL1;GSTO1;LTBP1;EREG;PTPRE;PLA2G6;MTMR4;CHAC1;SESN2;RASA4;NLRX1;PKD2;SLIT3;ECM1;ERRFI1;RGS14;ARHGEF2;INPP5D;STMN3;IFI6;UNC5B;SORL1;HERPUD1;GSTM2;SULF2;NLRP1;EGFL7;CREBRF;PCSK9;MARK3;TGFBR2;ARHGAP25;ITGA1;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;CDK5RAP3;NOS3;PIK3R2;EPHA1;GAS6;LZTS2;PPP1R15A;ATP2B4;STRADB;C12ORF66;MAPKBP1;AKT1;CRY2;IGFBP2;TSG101;FGFR4;LMNA;INSR;MAP2K5;BRAF;GPR21;ARHGAP44;ASIC1;HFE;TP73;MNT;BCL6;RNF213;TKFC;FYN;LEMD2;ADA;CIDEA;TGFBR3;EPHB2;PER1;FGFR1;WFS1;CTH;ERBB2;RGS12;SYVN1;PFKL;GRB10;KCTD11;KCTD13;PNKD
3744,GO:0008285,0.0391596176274922,0.971184631007215,68,467,negative regulation of cell proliferation,BP,XDH;F2R;APOE;SERPINE2;IL20RB;CTNNBIP1;FGFBP1;FBXO2;ALOX15B;PDCD4;TIMP2;PRNP;FBLN1;CD9;IDH2;CGREF1;NDRG1;ADARB1;NUPR1;RPS6KA2;MXI1;KLF9;MAP2K1;CYP27B1;MXD4;PKN1;BTG1;SPRY2;PAK1;DLG3;NEURL1;SPEG;NGFR;PLXNB1;EREG;PKD2;ING4;SLIT3;IFITM1;INPP5D;PDCD1LG2;PTHLH;CEBPB;PTPRU;ATRAID;TGFBR2;ITGA1;APLN;PEMT;NOS3;LDOC1;LZTS2;TP53I11;IGFBP7;CDKN1C;IFT57;TSG101;LMNA;FOXO4;TP73;MNT;BCL6;SIRT2;TGFBR3;ERBB2;HLA-G;KCTD11;SIX5
6751,GO:0030183,0.0391615299908426,0.980597381268398,15,78,B cell differentiation,BP,ZFP36L1;RAG1;INPP5D;LRRC8A;DOCK11;POLM;HDAC5;CMTM7;CARD11;LGALS1;JAK3;BCL6;ADA;POU2F2;MFNG
12903,GO:0051282,0.0391664036455251,0.981757248206172,13,65,regulation of sequestering of calcium ion,BP,F2R;NTSR1;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PKD2;GSTM2;TRPV1;ITPR2;TPCN1;TRPC1
5504,GO:0016460,0.0391879669384657,0.991032311304997,5,13,myosin II complex,CC,OBSL1;MYH11;SHROOM4;MYH3;TTN
3175,GO:0006793,0.0391881370744597,0.966374972441691,304,2355,phosphorus metabolic process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;DLG4;F2R;NT5E;ISYNA1;APOE;OSBPL5;ACSF2;EGR1;PPP1R35;PTK6;CDC42EP5;ACP5;NAPRT;GJC2;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PRNP;FBLN1;DUSP5;NEK9;RAPGEF3;TNFSF15;SPTB;DGKA;IGFBP4;IDH2;NOS1;BRSK1;DNPH1;PGM1;ERCC6;MST1R;ZFP36L1;ADARB1;PPM1M;B3GAT3;HBEGF;RBL2;RPS6KA2;PYGL;CTF1;CNTN1;DHTKD1;TK2;ULK2;SLC27A1;MAPK13;CDK18;PHACTR3;MLYCD;PITPNM3;LHPP;HMGCL;PPP1R14A;WWTR1;ACP6;MAP2K1;PCK2;CRYL1;PKN1;PGLS;DDIT4;ALPK1;LPCAT4;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;DGKQ;SNX9;ULK1;SHC1;SPRY2;ADM2;OGDHL;NMRK1;CAPRIN2;TTBK2;PRKCZ;PPP2R3B;PAK1;ABCA7;STK39;FGFR3;CEMIP;NPR2;SPRY4;DLG3;NMNAT2;NME4;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;SPEG;NGFR;ELFN2;PPCS;TRIB2;EREG;PTPRE;PNPLA3;SSH3;PLCD3;PSPH;TNFRSF25;NAB2;PLA2G6;PPM1J;LPAR3;MTMR4;C5;ACOT1;PPARA;SESN2;MKNK2;RASA4;IMPACT;PKD2;ACOT11;HMGA2;AREG;PI4KAP1;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;ERRFI1;OSBPL10;STK40;VANGL2;ACSS2;RGS14;MVD;FAM20C;CNTRL;MAPK12;MYH3;PI4K2A;MLXIPL;PTPDC1;PLCD1;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;SDHA;DMTN;PTHLH;PAK6;SSH1;LTB4R2;PKD1;FLOT1;TTN;PSKH1;GTPBP1;SORL1;GALK1;NTPCR;IL17RD;VLDLR;NADK;GABBR1;MAP3K12;NEK8;ACOT7;LRP5;PTPRU;WNK4;ALDOC;PCSK9;PKIB;PKN3;MARK3;TGFBR2;TRPV4;CSRNP3;ITGA1;TMSB4X;MOCOS;PDE2A;APLN;TRIB3;PEMT;CDK5RAP3;NOS3;MINK1;PIGZ;HEXB;PROM2;WNT7A;PIP5KL1;PIK3R2;EPHA1;GAS6;DNAJC6;SUCLG2;ERN1;BCR;MAPRE3;CHKB;NBR1;TADA3;UCKL1;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;THNSL2;STRADB;CTSH;AKT1;ZFYVE21;CARD11;DGUOK;CDKN1C;MICAL1;CRY2;CHEK2;SPDYE2;SPDYE2B;TSG101;FGFR4;TCIRG1;CBR4;FARP1;UPP1;WDFY2;C9ORF72;MARK4;INSR;ACSS1;RPS6KA5;PIGQ;CTDSPL;MAP2K5;BRAF;EDA2R;PLB1;MAPK10;HFE;JAK3;TP73;APRT;MPI;SCYL3;CSNK1E;TAZ;TKFC;FYN;MAST4;LEMD2;SIRT2;MBOAT2;GDF15;ADA;ETNK2;ENTPD2;FUK;AVPI1;TGFBR3;PLPP6;VAV3;LAMTOR2;MAP3K10;STARD10;EPHB2;INPP4A;PER1;ITGA2;FGFR1;PIGV;FITM2;FKBP8;ERBB2;EIF2AK4;STK32B;UNC119;PFKL;FRS3;SFI1;MPPE1;GRB10;NUDT18;CAMKK1;IKBKB;PLEKHA4;ACOT8
9627,GO:0036510,0.0392225748263738,0.998309194958169,2,3,trimming of terminal mannose on C branch,BP,EDEM1;MAN1B1
2823,GO:0006290,0.0392446260296163,0.995066973468535,3,7,pyrimidine dimer repair,BP,DDB2;ERCC1;ERCC6
8820,GO:0034617,0.0392558854443451,0.998306943213724,2,3,tetrahydrobiopterin binding,MF,NOS1;NOS3
17816,GO:1902022,0.0392564578203984,0.998306904512105,2,3,L-lysine transport,BP,PQLC2;SLC25A29
18360,GO:1903401,0.0392564578203984,0.998306904512105,2,3,L-lysine transmembrane transport,BP,PQLC2;SLC25A29
3569,GO:0007616,0.0392812860531703,0.988662050206758,6,22,long-term memory,BP,APOE;PRNP;PRKCZ;RGS14;PJA2;EIF2AK4
3572,GO:0007619,0.0392831129260088,0.998305101837187,2,3,courtship behavior,BP,THRA;HEXB
6293,GO:0019911,0.039311985321612,0.995055046819446,3,7,structural constituent of myelin sheath,MF,MARVELD1;MALL;PLLP
6787,GO:0030235,0.0393363013234715,0.99505073925251,3,7,nitric-oxide synthase regulator activity,MF,EGFR;ATP2B4;AKT1
16465,GO:0097187,0.0393569606192467,0.998300103753416,2,3,dentinogenesis,BP,HTRA1;FAM20C
4986,GO:0015119,0.0393858963632484,0.998298143835219,2,3,hexose phosphate transmembrane transporter activity,MF,SLC37A2;SLC37A4
5075,GO:0015315,0.0393858963632484,0.998298143835219,2,3,organophosphate:inorganic phosphate antiporter activity,MF,SLC37A2;SLC37A4
5122,GO:0015526,0.0393858963632484,0.998298143835219,2,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,SLC37A2;SLC37A4
14305,GO:0061513,0.0393858963632484,0.998298143835219,2,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,SLC37A2;SLC37A4
16150,GO:0090197,0.0394001629253057,0.995039420722367,3,7,positive regulation of chemokine secretion,BP,POSTN;ALOX15B;C5
14285,GO:0061448,0.0394520314932877,0.976918328917931,24,139,connective tissue development,BP,ACTA2;BBS2;EGR1;THBS3;ADAMTS7;MEF2D;EVC;FBXW4;HYAL1;FGFR3;WNT2B;HMGA2;MAPK3;THRA;PTHLH;ZNF516;PKD1;SULF2;LRP5;TGFBR2;TRPV4;WNT7A;TIMP1;FGFR1
16740,GO:0098562,0.0394584770399567,0.976906244204599,24,140,cytoplasmic side of membrane,CC,DLG4;S100A6;PTK6;NTSR1;SPTB;SYNGAP1;SNX9;SHROOM4;SPPL2B;ESYT2;RASA4;PKD2;KCNAB2;ERRFI1;MYZAP;MAP2K2;LITAF;FARP1;GNAL;JAK3;FYN;ESYT3;IKBKB;HIP1
10496,GO:0043418,0.0394861728529299,0.998291345147591,2,3,homocysteine catabolic process,BP,CBS;BLMH
5318,GO:0016048,0.0394966332780133,0.995022307726568,3,7,detection of temperature stimulus,BP,NTSR1;ANO1;TRPV1
12698,GO:0050961,0.0394966332780133,0.995022307726568,3,7,detection of temperature stimulus involved in sensory perception,BP,NTSR1;ANO1;TRPV1
12700,GO:0050965,0.0394966332780133,0.995022307726568,3,7,detection of temperature stimulus involved in sensory perception of pain,BP,NTSR1;ANO1;TRPV1
7531,GO:0031802,0.0395035126278817,0.998290168480359,2,3,type 5 metabotropic glutamate receptor binding,MF,PRNP;FYN
1708,GO:0004301,0.039509355230518,0.995020049613392,3,7,epoxide hydrolase activity,MF,AKR7A2;LTA4H;RNPEP
4927,GO:0014888,0.0395207693206444,0.98857585207857,6,22,striated muscle adaptation,BP,GSN;ERRFI1;ATP2B4;TNNT1;LMNA;TNNI1
8310,GO:0033159,0.0395582979128113,0.99828644876699,2,3,negative regulation of protein import into nucleus, translocation,BP,PDE2A;GAS6
4035,GO:0009071,0.0395667624550478,0.99500985607114,3,7,serine family amino acid catabolic process,BP,GLDC;CBS;THNSL2
14074,GO:0060935,0.0395822804806504,0.998284819478281,2,3,cardiac fibroblast cell differentiation,BP,PDCD4;TGFBR3
14075,GO:0060936,0.0395822804806504,0.998284819478281,2,3,cardiac fibroblast cell development,BP,PDCD4;TGFBR3
14076,GO:0060938,0.0395822804806504,0.998284819478281,2,3,epicardium-derived cardiac fibroblast cell differentiation,BP,PDCD4;TGFBR3
14077,GO:0060939,0.0395822804806504,0.998284819478281,2,3,epicardium-derived cardiac fibroblast cell development,BP,PDCD4;TGFBR3
6674,GO:0030046,0.0395921663808816,0.998284147695384,2,3,parallel actin filament bundle assembly,BP,ESPN;SPIRE1
7044,GO:0030828,0.0396011252726029,0.995003751358504,3,7,positive regulation of cGMP biosynthetic process,BP,APOE;NOS1;NOS3
2707,GO:0006083,0.0396040006307362,0.99828334338403,2,3,acetate metabolic process,BP,ACSS2;ACSS1
4840,GO:0014052,0.0396404903372142,0.998280862473108,2,3,regulation of gamma-aminobutyric acid secretion,BP,NTSR1;SV2A
12299,GO:0048671,0.0396461001179055,0.998280480947502,2,3,negative regulation of collateral sprouting,BP,PTPRS;ULK2
14435,GO:0061817,0.0396548297176081,0.99827988717677,2,3,endoplasmic reticulum-plasma membrane tethering,BP,ESYT2;ESYT3
11846,GO:0046870,0.0396648482475497,0.998279205639777,2,3,cadmium ion binding,MF,NOS1;NOS3
5062,GO:0015280,0.0396941024811237,0.998277214957949,2,3,ligand-gated sodium channel activity,MF,ASIC1;SCNN1A
12747,GO:0051046,0.0397001111810573,0.971126760568497,63,425,regulation of secretion,BP,F2R;SYTL1;POSTN;GLUL;ALOX15B;NTSR1;EGFR;NR1D1;HADH;RAPGEF3;IDH2;SYT8;PCK2;ARL2;RAB3B;NLGN2;ITPR3;PRKCZ;MCTP1;STK39;ZP3;PLA2G6;C5;ANO1;VAMP2;SEPT5;PCLO;KCNC4;MAPK3;SV2A;TTN;NLRP1;RHBDF1;LRP5;WNK4;TRPV4;TMSB4X;APLN;RAB40B;TRPV1;RHBDF2;GAS6;GLUD1;BCR;PTAFR;RIMS3;MAPKBP1;ITPR2;MICAL1;TSG101;IL17RC;ICA1;BRAF;ASIC1;HFE;RAB13;ADA;CIDEA;MYO18A;STX1A;FGFR1;PFKL;PNKD
12674,GO:0050916,0.0397423944767128,0.998273926894033,2,3,sensory perception of sweet taste,BP,REEP2;ITPR3
4775,GO:0010966,0.0397635163001051,0.998272488022996,2,3,regulation of phosphate transport,BP,CRY2;FGFR1
6735,GO:0030160,0.0397977497537798,0.998270154990604,2,3,GKAP/Homer scaffold activity,MF,SHANK2;HOMER2
6655,GO:0030016,0.0398119828271952,0.977342682567558,22,121,myofibril,CC,FLNC;OBSCN;SCN8A;ANK3;PARVB;NOS1;MYH15;OBSL1;TPM2;PAK1;SYNC;MYZAP;MYH3;TWF2;TTN;NBR1;TNNI2;ATP2B4;TNNT1;TMOD2;KRT19;TNNI1
14951,GO:0070885,0.0398835709624686,0.998264300976339,2,3,negative regulation of calcineurin-NFAT signaling cascade,BP,PRNP;ATP2B4
17181,GO:0106057,0.0398835709624686,0.998264300976339,2,3,negative regulation of calcineurin-mediated signaling,BP,PRNP;ATP2B4
4623,GO:0010749,0.0399273741317132,0.998261310198001,2,3,regulation of nitric oxide mediated signal transduction,BP,EGFR;ATP2B4
9455,GO:0036089,0.0400479209692376,0.99492416774223,3,7,cleavage furrow formation,BP,SNX9;SNX33;SPIRE1
12776,GO:0051094,0.0401688550342905,0.968266737942864,114,822,positive regulation of developmental process,BP,DLG4;BBS2;APOE;ZMYND8;SERPINE2;FOS;ADGRL1;EGR1;CTNNBIP1;PGF;PTK6;FAM210B;GJC2;ALOX15B;TIMP2;VEGFA;RAPGEF3;SHANK2;CRTC1;ADGRB2;ZFP36L1;CNTN1;OBSL1;CUL7;HYAL1;WWTR1;MAP2K1;CYP27B1;CCDC71L;BTG1;VEGFB;ADM2;NLGN2;CAPRIN2;PRKCZ;PAK1;PLXNB3;FBXW8;ZP3;NEURL1;ACVR2B;RAG1;NGFR;ETV5;WNT2B;PLXNB1;OLFM2;LPAR3;C5;IMPACT;STAT6;HMGA2;ECM1;ACACB;BNIP3;SEMA5A;THRA;IFITM1;RGS14;FAM20C;SLITRK6;MAPK12;ARHGEF2;INPP5D;TWF2;DMTN;ANGPTL4;KDM4C;METRN;FLOT1;LTBP3;VLDLR;TPBG;CEBPB;LRP5;ATRAID;TRIOBP;TGFBR2;SMURF2;HMG20B;NOS3;WNT7A;EPHA1;GAS6;CAMK1;CTSH;AKT1;AMIGO2;LMNA;WDFY2;INSR;WNT3;TENM4;YPEL3;BRAF;GPR21;TP73;CSNK1E;BCL6;HSF4;FYN;SIRT2;GDF15;ADA;PLXND1;ADIRF;TGFBR3;EPHB2;FGFR1;CTH;HLA-G;CORO1B;NET1;KCTD11
17172,GO:0106027,0.0401777911049903,0.982669604786974,11,52,neuron projection organization,BP,DLG4;APOE;ZMYND8;PRNP;SHANK2;CAPRIN2;WNT7A;INSR;ARHGAP44;FYN;EPHB2
8126,GO:0032836,0.0402510200117843,0.9948878640125,3,7,glomerular basement membrane development,BP,NID1;LAMB2;SULF2
13011,GO:0051491,0.0402887369908093,0.988298496938291,6,22,positive regulation of filopodium assembly,BP,ESPN;ZMYND8;ARAP1;NEURL1;DOCK11;TENM2
10881,GO:0044444,0.0404021652309745,0.96436899482519,875,7167,cytoplasmic part,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;ISYNA1;APOE;BTBD2;SYTL1;HS1BP3;NFATC4;FLNC;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;ACSF2;PYGB;CTNNBIP1;LMF1;THBS3;ALDH7A1;TYSND1;POSTN;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;PTK6;TMEM129;CDC42EP5;ACP5;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;FAM210B;LRP1;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;RBCK1;RHPN1;D2HGDH;PRNP;ZDHHC1;SCN8A;ERCC1;ADAMTS7;HADH;S100A4;PRDX5;ANK3;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;SPTB;LOXL1;DGKA;TSPAN1;IGFBP4;KRT15;CD9;NINL;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;PARVB;NOS1;GPSM1;DDIT3;ARAP3;BRSK1;DNPH1;SHANK2;DNAJB5;ACAD10;PGM1;CRTC1;CLCA2;PACS2;NDRG1;ADAMTS13;ABTB1;ARHGEF19;COL13A1;GRAMD4;MYH15;MST1R;ARRDC1;ARMCX2;TRIM65;ZFP36L1;ADARB1;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;HBEGF;RBL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;PYCR2;TMEM134;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;RPL13A;MSRB2;OBSL1;TK2;BBS1;PLAT;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;MIF4GD;RAB11FIP4;NISCH;CPT2;MLYCD;ASAP2;FBXW4;PLD3;CUL7;PITPNM3;LHPP;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;MPRIP;NAGLU;OXLD1;PPP1R14A;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;CAPG;DDIT4;OPLAH;LPCAT4;SHC2;DNASE1L1;SYNGAP1;PITPNM1;DGKQ;AKR7A2;TUBG2;TMEM173;SNX9;PLEKHG5;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;OGDHL;LGALS9B;RAB3B;CD68;PCSK1;MYH11;CYBRD1;ITPR3;RALGDS;PITPNC1;NMRK1;APPL2;CIRBP;CAPRIN2;TPM2;TTBK2;LY6K;PRKCZ;GALE;SERPING1;PAK1;ABCA7;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;FGFR3;FBXO41;SEC14L2;CEMIP;MTHFR;BRI3;GLDC;NPR2;CAPNS2;NDUFA4L2;TMEM44;CBS;TMEM187;SPRY4;USP20;DOCK6;SYNE3;DLG3;NMNAT2;MICALL2;NME4;PDZD2;CEP250;GRIP2;FBXW8;SHROOM4;ABHD14B;NEURL1;CCDC88B;SPPL2B;NGFR;MARCH4;ETFB;GSTO1;ARHGEF4;WDR60;LTBP1;MUC19;SYNC;PPCS;SMIM14;MALL;ACTR1B;GPT2;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PNPLA3;RMI2;CYHR1;PLCD3;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;MANF;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;KIF17;SPATS2;APOBEC3F;ACOT1;PLGRKT;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;RASA4;IFT27;NLRX1;PKD2;STAT6;SH3TC2;ING4;ACOT11;VAMP2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;PCLO;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;PEX10;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;MVD;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;CNTRL;ADAMTSL1;TUBE1;PAN2;CTSB;HOOK2;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;SRGAP3;PQLC2;KIAA0319L;SDC2;CHMP1B;FBXO17;NRSN2;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;TCTN1;PLCD1;ARHGEF2;SEPT10;FBF1;INPP5D;PRAF2;MAP2K2;SRD5A3;HIBADH;FLYWCH1;TWF2;SAMD3;STMN3;SLC50A1;PGPEP1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;LRSAM1;DMTN;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;MOSPD3;CHST6;BBC3;DOCK11;SSH1;LRRC45;SV2A;SLC38A10;PRIMPOL;RABGAP1;ACAP3;TENM2;FBXO6;IFI6;REEP6;CBX7;PKD1;FUCA1;ATXN10;FLOT1;CEP68;TTN;PSKH1;HLCS;AZIN2;HSD11B1;TSNARE1;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;NADK;GPRC5C;DHX32;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;ENDOG;MAP3K12;RHBDF1;ACOT7;LRP5;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;PCSK9;DBNDD1;PKN3;FBXL15;ACADS;FBXL16;CEP131;LONP2;EPN3;MARK3;TRIOBP;TGFBR2;TRPV4;ARHGAP25;DIRC2;ITGA1;TMSB4X;MAP1LC3A;MOCOS;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;ALDH1L2;CALCOCO1;PEMT;EDA;CDK5RAP3;NOS3;AGO4;MINK1;PIGZ;HEXB;PROM2;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;RHBDF2;RPUSD3;ANGEL1;SHARPIN;CCS;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;NUDT6;LZTS2;ALKBH7;CROCC;BCR;KLHDC8B;ATP7B;FYCO1;MAN2C1;CHKB;C19ORF33;NBR1;CPT1C;HEXA;GOLGA2P5;TNNI2;NBEAL2;BOLA1;KIF13B;SPAG16;UCKL1;NECAB3;PTAFR;CYP2R1;PPP1R15A;RIMS3;ADCY6;TNRC18;RAB43;ATP2B4;SPATA7;STRADB;CTSH;ACOX3;ACAD11;PNRC1;FBXL8;UACA;GSDMC;GSTO2;ASNS;TMEM9;ENTPD6;C12ORF66;TM7SF2;STEAP2;HINT2;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;MICAL1;CRY2;MZT2B;B4GALT2;LAMB1;CHEK2;IFT57;LACTB2;PHYKPL;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;FMNL3;FGFR4;IGF2BP2;RASSF9;ZNF217;TMOD2;SNN;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;FARP1;DNASE2;LMNA;ASMTL;FAAH;UPP1;SH2B3;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;ARSA;CAPN2;MAN2B1;GOLGA8A;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;SLC25A29;FOXO4;COG7;ANKZF1;CHMP4C;PNPLA4;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;HOMER2;C6ORF89;PIGQ;MAP2K5;ZDHHC24;BRAF;YIPF3;ARHGAP44;LETMD1;ASIC1;ALDH1L1;PIDD1;CAT;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;UNC119B;TIMP1;HFE;JAK3;TP73;TUBGCP6;FRAT1;SNX33;APRT;FCHSD1;TMX4;MIB2;CERS4;MPI;PEX7;SNX17;JOSD2;SCYL3;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;REPS2;RABAC1;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;ZC3H12D;ATP8B2;PJA2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;ARHGEF17;SLC25A42;SIRT2;MBOAT2;GDF15;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;TST;GOLGA2;SH3GLB2;ADA;POLR3GL;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;MYO18A;ADIRF;RPL29;EIF4EBP1;RETSAT;CIDEB;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;TBC1D16;MFNG;STARD10;RNF170;DHPS;EPHB2;NMRAL1;INPP4A;PER1;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ESYT3;BLOC1S1;FITM2;FKBP8;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;KDELC2;UST;EIF2AK4;UNC119;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;SFI1;RPL12;MPPE1;HMBOX1;NET1;TTC19;GRB10;TNNI1;CREB3L4;BSG;LYPLAL1;NUDT18;SDHAF4;TRIM45;APBA1;PEX11A;TMEM8A;CAMKK1;PNKD;DTD1;KDSR;IKBKB;DMTF1;SNCB;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;BTBD11
20271,GO:2001293,0.0404332994109758,0.998226625576855,2,3,malonyl-CoA metabolic process,BP,MLYCD;ACACB
17308,GO:1900006,0.0404851692308293,0.982514957462339,11,52,positive regulation of dendrite development,BP,APOE;ZMYND8;SHANK2;CRTC1;OBSL1;CUL7;CAPRIN2;FBXW8;NEURL1;VLDLR;CAMK1
18545,GO:1903800,0.0405132528797404,0.994840872655365,3,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K1;MAP2K2
12817,GO:0051151,0.0405754703409733,0.994829704066837,3,7,negative regulation of smooth muscle cell differentiation,BP,PDCD4;EREG;FOXO4
10568,GO:0043549,0.0405921295090351,0.968794399968971,91,640,regulation of kinase activity,BP,DUSP6;DLG4;F2R;APOE;EGR1;PTK6;PDCD4;VEGFA;EGFR;PRNP;DUSP5;TNFSF15;ERCC6;MST1R;ADARB1;RBL2;SLC27A1;WWTR1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;SHC1;SPRY2;PRKCZ;PAK1;STK39;FGFR3;CEMIP;SPRY4;DLG3;NEURL1;ACVR2B;TRIB2;EREG;NAB2;LPAR3;C5;SESN2;PKD2;MAPK3;CSPG4;TRPT1;ERRFI1;VANGL2;RGS14;TSPYL2;MAP2K2;PAK6;PKD1;TTN;SORL1;VLDLR;MAP3K12;LRP5;PKIB;TGFBR2;ITGA1;TRIB3;CDK5RAP3;MINK1;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;CDKN1C;SPDYE2;SPDYE2B;TSG101;FGFR4;INSR;MAP2K5;BRAF;MAPK10;TP73;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2;UNC119;CAMKK1
33,GO:0000062,0.0405960501342086,0.98992627853254,5,17,fatty-acyl-CoA binding,MF,ACBD4;HMGCL;PNPLA3;ACOT7;ACADVL
16867,GO:0098839,0.0406027505094511,0.994824804689932,3,7,postsynaptic density membrane,CC,PTPRS;DLG4;DLG3
17070,GO:0099634,0.0406027505094511,0.994824804689932,3,7,postsynaptic specialization membrane,CC,PTPRS;DLG4;DLG3
3584,GO:0007635,0.040645236110267,0.994817171652314,3,7,chemosensory behavior,BP,TRPV1;GJB4;WFS1
1758,GO:0004364,0.0406856199893429,0.989780853975743,5,18,glutathione transferase activity,MF,GSTO1;GSTT1;GSTM2;GSTO2;GSTM3
12266,GO:0048609,0.0407358137143584,0.970026110376092,67,459,multicellular organismal reproductive process,BP,GAMT;BBS2;SERPINE2;EGR1;EGFR;ERCC1;CRTAP;MICALCL;GGT1;TCFL5;TXNRD3;CYP27B1;BTG1;PHC2;DNAH1;MYCBPAP;PABPC1L;KDM3A;NPR2;ZP3;NEURL1;EPOR;ETV5;EREG;SPATA20;PLA2G6;FAM50A;SCMH1;SLIT3;THRA;CCNI;TDRKH;CTSB;AZIN2;DEAF1;RFX2;CREBRF;CEP131;DNMT3A;MLH3;NOS3;AGO4;HEXB;LDOC1;HERPUD2;SPAG16;PTAFR;RXRA;ATP2B4;AKT1;SEPT6;CABYR;TBC1D20;WNT3;SPIRE1;BCL6;REC8;RPL39L;SIRT2;ADA;PAIP2;SPATA6;CREB3L4;MMP19;ZNF449;BSG;SIX5
11677,GO:0046486,0.0407682913588877,0.971700273030507,48,315,glycerolipid metabolic process,BP,APOE;OSBPL5;LMF1;EGFR;DGKA;HBEGF;SLC27A1;PITPNM3;ACP6;PCK2;LPCAT4;PLCH2;PITPNM1;DGKQ;FGFR3;ZP3;EREG;PNPLA3;PLA2G6;MTMR4;PI4KAP1;OSBPL10;PI4K2A;INPP5D;PCSK9;PEMT;PIGZ;PIP5KL1;PIK3R2;CHKB;ZFYVE21;FGFR4;PNPLA4;PIGQ;PLB1;CAT;TAZ;FYN;MBOAT2;ETNK2;STARD10;INPP4A;FGFR1;PIGV;FITM2;ERBB2;MPPE1;PLEKHA4
8193,GO:0032956,0.0408329820974611,0.972993584263044,38,241,regulation of actin cytoskeleton organization,BP,GSN;WIPF1;CDC42EP5;LRP1;RAPGEF3;SPTB;ARHGEF19;ARAP1;ARPIN;CAPG;PAK1;SSH3;PLEKHG2;RHOBTB2;SEMA5A;VANGL2;RHOF;TWF2;DMTN;SSH1;WHAMMP3;TRIOBP;TMSB4X;EPHA1;TMOD2;ASAP3;C9ORF72;BRAF;ARHGAP44;FCHSD1;SPIRE1;EPS8L1;CELSR1;RHOBTB3;EPS8L2;C15ORF62;CORO1B;PLEKHH2
10403,GO:0043260,0.0408443397651678,0.998198255046248,2,3,laminin-11 complex,CC,LAMA5;LAMB2
10402,GO:0043259,0.0408455156273711,0.998198173641784,2,3,laminin-10 complex,CC,LAMA5;LAMB1
46,GO:0000098,0.0409414678845997,0.994763853993831,3,7,sulfur amino acid catabolic process,BP,CBS;BLMH;CTH
9948,GO:0042340,0.0410302731970409,0.994747837545064,3,7,keratan sulfate catabolic process,BP,HEXB;HEXA;GALNS
3284,GO:0006975,0.0410351797933364,0.9947469521785,3,7,DNA damage induced protein phosphorylation,BP,MAPK3;MAPK12;CHEK2
12552,GO:0050730,0.0410945847375839,0.975548797407792,25,148,regulation of peptidyl-tyrosine phosphorylation,BP,DLG4;PTK6;VEGFA;EGFR;PRNP;ERCC6;HBEGF;CTF1;CNTN1;DGKQ;SHC1;PRKCZ;FGFR3;DLG3;NEURL1;EREG;AREG;CSPG4;ERRFI1;ARHGEF2;DMTN;GAS6;TSG101;FYN;UNC119
3365,GO:0007130,0.0411798009571697,0.994720835497937,3,7,synaptonemal complex assembly,BP,MLH3;AGO4;REC8
15510,GO:0071933,0.0413043523451539,0.994698311190194,3,7,Arp2/3 complex binding,MF,SNX9;WHAMMP3;CORO1B
18996,GO:1904861,0.0413416136484531,0.99469156698386,3,7,excitatory synapse assembly,BP,SHANK2;NLGN2;WNT7A
16550,GO:0097371,0.0414890871674735,0.994664848714844,3,7,MDM2/MDM4 family protein binding,MF,PPARA;CDK5RAP3;TP73
4855,GO:0014074,0.0414975096624212,0.97823136978343,17,92,response to purine-containing compound,BP,FOS;RAPGEF3;ZFP36L1;DGKQ;PKD2;AREG;DMTN;SSH1;GSTM2;PDE2A;TRPV1;PTAFR;ITPR2;BRAF;PER1;MMP19;BSG
16417,GO:0097106,0.0415876775871641,0.994646963705719,3,7,postsynaptic density organization,BP,ZMYND8;SHANK2;NLGN2
16973,GO:0099084,0.0415876775871641,0.994646963705719,3,7,postsynaptic specialization organization,BP,ZMYND8;SHANK2;NLGN2
15672,GO:0072235,0.0416912057568258,0.99813926605232,2,3,metanephric distal tubule development,BP,PKD2;PKD1
15673,GO:0072236,0.0416923988640982,0.998139182436983,2,3,metanephric loop of Henle development,BP,PKD2;PKD1
10391,GO:0043244,0.0417541563775011,0.979130630405586,15,78,regulation of protein complex disassembly,BP,GSN;SPTB;CAPG;TTBK2;BNIP3;SEMA5A;ARHGEF2;TWF2;DMTN;TRIOBP;TRPV4;FYCO1;TMOD2;INSR;PLEKHH2
15620,GO:0072156,0.0417607131644549,0.998134392452843,2,3,distal tubule morphogenesis,BP,PKD1;WNK4
8212,GO:0032982,0.0417869315659817,0.994610761298192,3,7,myosin filament,CC,MYH15;MYH11;MYH3
11843,GO:0046854,0.0418774356589386,0.980298586904379,13,65,phosphatidylinositol phosphorylation,BP,EGFR;HBEGF;FGFR3;EREG;PI4KAP1;PI4K2A;PIP5KL1;PIK3R2;ZFYVE21;FGFR4;FYN;FGFR1;ERBB2
8362,GO:0033270,0.0419310395588113,0.994584531479696,3,7,paranode region of axon,CC,GJC2;KIF13B;SIRT2
2275,GO:0005220,0.0420570727896496,0.998113558482857,2,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,ITPR3;ITPR2
5534,GO:0016528,0.0424310048503343,0.98342614868078,9,40,sarcoplasm,CC,XDH;FLNC;GSN;ANK3;NOS1;ITPR3;GSTM2;ITPR2;RTN2
3579,GO:0007626,0.0424950080613104,0.97716784950759,18,99,locomotory behavior,BP,DLG4;APOE;ESPN;NTSR1;DNM1;GAA;EFNB3;NAGLU;NLGN2;ETV5;SPG11;OLFM2;SLITRK6;HEXB;B4GALT2;CELSR1;MTA1;APBA1
10010,GO:0042471,0.0425368724617064,0.980654280027117,12,59,ear morphogenesis,BP,NAGLU;SPRY2;MAPK3;VANGL2;SLITRK6;TRIOBP;BCR;WDR19;CELSR1;EPHB2;FGFR1;TSHZ1
15533,GO:0072006,0.0425405967192205,0.978125701871539,16,85,nephron development,BP,ACTA2;EGR1;CTNNBIP1;PGF;VEGFA;WWTR1;LAMA5;NID1;WNT2B;PKD2;LAMB2;VANGL2;KIF26B;PKD1;SULF2;WNK4
12298,GO:0048670,0.0425998369929853,0.99153847809886,4,12,regulation of collateral sprouting,BP,PTPRS;ULK2;LPAR3;WNT3
3556,GO:0007599,0.0426690099487642,0.972375683515379,34,215,hemostasis,BP,F2R;APOE;SERPINE2;FBLN1;TFPI2;DGKA;CD9;ADAMTS13;PLAT;PHF21A;DGKQ;BLOC1S4;ITPR3;SERPING1;DOCK6;MAPK3;DOCK9;DMTN;PROCR;ZFPM1;DOCK11;HMG20B;NOS3;GAS6;AKT1;ITPR2;MICAL1;SH2B3;PLAU;EHD3;FYN;ENTPD2;VAV3;ITGA2
4360,GO:0009968,0.0427047068565474,0.965941723818499,121,883,negative regulation of signal transduction,BP,TNIP1;XDH;DUSP6;PTPRS;HTRA1;APOE;NFATC4;SERPINE2;EGR1;CTNNBIP1;DDIT4L;PTK6;WWC3;LRP1;PDCD4;TIMP2;EGFR;PRNP;NR1D1;FBLN1;DUSP5;IGFBP4;DNM1;DDIT3;ARAP3;MST1R;ARRDC1;HBEGF;MDFI;EPM2A;WWTR1;DDIT4;SYNGAP1;ITGA6;SPRY2;NPHP4;PRKCZ;PEAR1;FGFR3;SPRY4;NEURL1;GSTO1;LTBP1;EREG;PTPRE;MTMR4;CHAC1;SESN2;RASA4;NLRX1;PKD2;SLIT3;ECM1;ERRFI1;RGS14;ARHGEF2;INPP5D;STMN3;IFI6;UNC5B;SORL1;HERPUD1;GSTM2;SULF2;NLRP1;EGFL7;CREBRF;MARK3;TGFBR2;ARHGAP25;ITGA1;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;CDK5RAP3;NOS3;PIK3R2;EPHA1;GAS6;LZTS2;PPP1R15A;ATP2B4;STRADB;C12ORF66;MAPKBP1;AKT1;CRY2;IGFBP2;TSG101;FGFR4;LMNA;INSR;MAP2K5;BRAF;GPR21;ARHGAP44;HFE;TP73;MNT;BCL6;RNF213;TKFC;FYN;LEMD2;ADA;CIDEA;TGFBR3;EPHB2;PER1;FGFR1;WFS1;CTH;ERBB2;RGS12;SYVN1;GRB10;KCTD11;KCTD13
6782,GO:0030226,0.0428626289277321,0.998056484563043,2,3,apolipoprotein receptor activity,MF,LRP1;ABCA7
11997,GO:0047617,0.0429715711476543,0.991440122228581,4,12,acyl-CoA hydrolase activity,MF,ACOT1;ACOT11;ACOT7;ACOT8
7996,GO:0032633,0.0430463277284258,0.9891410605445,5,17,interleukin-4 production,BP,IL20RB;PRKCZ;ZP3;ZFPM1;CEBPB
13615,GO:0060143,0.0430924157632266,0.991408083338409,4,12,positive regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3;FLOT1;CAMK1;GDF15
12095,GO:0048169,0.0431515920668278,0.989107017171299,5,17,regulation of long-term neuronal synaptic plasticity,BP,DLG4;SYNGR1;SYNGAP1;NEURL1;EPHB2
12665,GO:0050906,0.0432057241682723,0.985536316496729,7,29,detection of stimulus involved in sensory perception,BP,SERPINE2;NTSR1;ANO1;REEP6;TRPV1;FYN;ITGA2
7663,GO:0032101,0.0432371938284635,0.968297131786546,64,440,regulation of response to external stimulus,BP,TNIP1;PTPRS;HTRA1;BBS2;F2R;NT5E;APOE;SERPINE2;IL20RB;PGF;ACP5;SEMA4B;PDCD4;VEGFA;EGFR;CD9;GGT1;MMP28;PLAT;MAPK13;MAP2K1;CYP27B1;TMEM173;VEGFB;SERPING1;STK39;SEMA3F;FAM3A;ZSWIM4;ZP3;C5;APOBEC3F;PPARA;FNDC4;NLRX1;MAPK3;SEMA5A;LRSAM1;DMTN;SEMA3B;NLRP1;TGFBR2;TRPV4;TMSB4X;PDE2A;NOS3;SEMA4G;SHARPIN;GAS6;BCR;MAPKBP1;IL17RC;PLAU;WNT3;BRAF;BCL6;TKFC;SIRT2;ADA;PER1;ITGA2;FGFR1;EIF2AK4;CORO1B
20151,GO:2001026,0.0433413193142372,0.991341992629035,4,12,regulation of endothelial cell chemotaxis,BP,VEGFA;SEMA5A;TMSB4X;FGFR1
3148,GO:0006749,0.0434528020278452,0.982863188366019,9,42,glutathione metabolic process,BP,GGT1;OPLAH;GSTO1;GSTT1;CHAC1;GSTM2;GSTO2;HAGH;GSTM3
8938,GO:0035004,0.044049970373533,0.982671134844122,9,40,phosphatidylinositol 3-kinase activity,MF,EGFR;HBEGF;FGFR3;EREG;PIK3R2;FGFR4;FYN;FGFR1;ERBB2
4279,GO:0009650,0.0441159584865276,0.991135445112199,4,12,UV protection,BP,ERCC1;MC1R;SCARA3;CAT
5558,GO:0016575,0.0441394514052407,0.977749621264183,15,79,histone deacetylation,BP,VEGFA;PHF21A;HDAC11;CHD3;JDP2;HDAC5;HMG20B;TADA3;C6ORF89;MTA3;BCL6;SIRT2;MTA1;HDAC8;PER1
3403,GO:0007187,0.0441676794868195,0.977733424371383,15,79,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,NOS1;MC1R;ADM2;HTR7;LPAR3;PTHLH;LTB4R2;ADGRF1;GABBR1;ADCY6;ATP2B4;GNAL;LTB4R;CHRM3;EDNRA
18619,GO:1903959,0.0442209837188952,0.988759741037369,5,17,regulation of anion transmembrane transport,BP,PRNP;STK39;ANO9;PTAFR;AKT1
14710,GO:0070403,0.0442851180768561,0.991090168624289,4,12,NAD+ binding,MF,HADH;CRYL1;GLUD1;SIRT2
11796,GO:0046710,0.0443100420680652,0.991083492382188,4,12,GDP metabolic process,BP,DLG4;DLG3;CARD11;NUDT18
2770,GO:0006195,0.044529633388934,0.983599086058543,8,35,purine nucleotide catabolic process,BP,XDH;NT5E;RAPGEF3;DNPH1;NT5C1B;PDE2A;ADA;NUDT18
7155,GO:0031034,0.0445354022540842,0.996770766264267,3,4,myosin filament assembly,BP,OBSL1;MYH11;TTN
13972,GO:0060712,0.0446279374622259,0.990998222710748,4,12,spongiotrophoblast layer development,BP,ZFP36L1;FBXW8;AKT1;PHLDA2
12724,GO:0051016,0.0446786615419593,0.990984596868629,4,12,barbed-end actin filament capping,BP,GSN;CAPG;TWF2;TRIOBP
9722,GO:0038191,0.0446830167981954,0.988608902053423,5,17,neuropilin binding,MF,SEMA4B;SEMA3F;SEMA5A;SEMA3B;SEMA4G
7480,GO:0031657,0.0447039903123392,0.990977790824434,4,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2;PKD1;AKT1
1984,GO:0004707,0.0447131138438477,0.99097533892212,4,12,MAP kinase activity,MF,MAPK13;MAPK3;MAPK12;MAPK10
4562,GO:0010648,0.0447223373832704,0.964074574206868,127,932,negative regulation of cell communication,BP,TNIP1;XDH;DUSP6;PTPRS;HTRA1;APOE;NFATC4;SERPINE2;EGR1;CTNNBIP1;DDIT4L;PTK6;WWC3;LRP1;PDCD4;TIMP2;EGFR;PRNP;NR1D1;FBLN1;HADH;DUSP5;IGFBP4;DNM1;DDIT3;ARAP3;SHANK2;MST1R;ARRDC1;HBEGF;MDFI;EPM2A;WWTR1;DDIT4;SYNGAP1;ITGA6;SPRY2;NPHP4;PRKCZ;PEAR1;FGFR3;SPRY4;NEURL1;GSTO1;LTBP1;EREG;PTPRE;PLA2G6;MTMR4;CHAC1;SESN2;RASA4;NLRX1;PKD2;SLIT3;ECM1;ERRFI1;RGS14;ARHGEF2;INPP5D;STMN3;IFI6;UNC5B;SORL1;HERPUD1;GSTM2;SULF2;NLRP1;EGFL7;CREBRF;MARK3;TGFBR2;ARHGAP25;ITGA1;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;CDK5RAP3;NOS3;PIK3R2;EPHA1;GAS6;LZTS2;PPP1R15A;ATP2B4;STRADB;C12ORF66;MAPKBP1;AKT1;CRY2;IGFBP2;TSG101;FGFR4;LMNA;INSR;MAP2K5;BRAF;GPR21;ARHGAP44;ASIC1;HFE;TP73;MNT;BCL6;RNF213;TKFC;FYN;LEMD2;ADA;CIDEA;TGFBR3;EPHB2;PER1;FGFR1;WFS1;CTH;ERBB2;RGS12;SYVN1;PFKL;GRB10;KCTD11;KCTD13;PNKD
18552,GO:1903825,0.0449652749078723,0.977275120464593,15,79,organic acid transmembrane transport,BP,NTSR1;SLC7A8;SLC16A3;CPT2;SLC43A1;STK39;ACACB;PQLC2;PRAF2;SLC38A10;AKT1;SLC6A9;SLC6A6;SLC25A29;SLC38A2
19080,GO:1905039,0.0449652749078723,0.977275120464593,15,79,carboxylic acid transmembrane transport,BP,NTSR1;SLC7A8;SLC16A3;CPT2;SLC43A1;STK39;ACACB;PQLC2;PRAF2;SLC38A10;AKT1;SLC6A9;SLC6A6;SLC25A29;SLC38A2
7466,GO:0031639,0.0450424302588022,0.99088671782939,4,12,plasminogen activation,BP,SERPINE2;PLAT;PLGRKT;PLAU
5164,GO:0015718,0.0452145156019521,0.976544181084854,16,86,monocarboxylic acid transport,BP,APOE;NTSR1;SLC16A3;SLC27A1;CPT2;SLC16A5;PLA2G6;PPARA;ACACB;SV2A;RXRA;AKT1;STARD10;SLC10A6;BSG;APBA1
2053,GO:0004806,0.0453083872057474,0.990814978526198,4,12,triglyceride lipase activity,MF,PNPLA3;CES3;CES2;PNPLA4
3190,GO:0006817,0.0453294322416472,0.990809295413619,4,12,phosphate ion transport,BP,SLC37A2;CRY2;SLC37A4;FGFR1
1985,GO:0004708,0.0453410498509439,0.990806157730306,4,12,MAP kinase kinase activity,MF,MAP2K1;MAPK3;MAP2K2;MAPK10
15444,GO:0071813,0.0454564778788553,0.990774967377216,4,12,lipoprotein particle binding,MF,APOE;SORL1;VLDLR;PCSK9
15445,GO:0071814,0.0454564778788553,0.990774967377216,4,12,protein-lipid complex binding,MF,APOE;SORL1;VLDLR;PCSK9
12508,GO:0050673,0.0454947296922266,0.969465561387833,39,251,epithelial cell proliferation,BP,XDH;HTRA1;APOE;PGF;GLUL;VEGFA;EGFR;NR1D1;IGFBP4;ZFP36L1;KLF9;HYAL1;MAP2K1;VEGFB;PLXNB3;NGFR;EREG;STAT6;AREG;COL8A1;ECM1;ERRFI1;SEMA5A;DEAF1;SULF2;EGFL7;CEBPB;APLN;WNT7A;ERN1;AKT1;CDKN1C;LAMB1;IFT57;C6ORF89;MAP2K5;TGFBR3;FGFR1;ERBB2
9794,GO:0040037,0.0455817235461696,0.990741092205671,4,12,negative regulation of fibroblast growth factor receptor signaling pathway,BP,SPRY2;SPRY4;SULF2;APLN
7205,GO:0031106,0.04602175322772,0.990621814510642,4,12,septin ring organization,BP,SEPT5;SEPT10;SEPT6;SEPT8
4897,GO:0014829,0.0460799576517106,0.990606006604725,4,12,vascular smooth muscle contraction,BP,DOCK4;BBS2;CHRM3;EDNRA
6455,GO:0021782,0.046205237860842,0.97791205550564,13,66,glial cell development,BP,GSN;LRP1;EGFR;CD9;NDRG1;HDAC11;SH3TC2;LAMB2;MXRA8;PRDM8;AKT1;TENM4;SIRT2
5673,GO:0016790,0.0462114247778628,0.984295271174576,7,29,thiolester hydrolase activity,MF,ACOT1;ACOT11;ACOT7;HAGH;LYPLAL1;PNKD;ACOT8
18000,GO:1902531,0.0462167012922746,0.961697917477122,174,1306,regulation of intracellular signal transduction,BP,TNIP1;XDH;DUSP6;F2R;APOE;SERPINE2;PTK6;WWC3;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;RBCK1;PRNP;FBLN1;S100A4;DUSP5;TNFSF15;IGFBP4;NOS1;DDIT3;ARAP3;ERCC6;ARHGEF19;MST1R;ARAP1;HBEGF;RGL2;ARHGAP23;CTF1;ASAP2;EPM2A;MAP2K1;PKN1;MC1R;DDIT4;SHC2;SYNGAP1;DGKQ;PLEKHG5;FAM110C;SHC1;SPRY2;APPL2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;SPRY4;NGFR;GSTO1;ARHGEF4;TRIB2;PLXNB1;EREG;RMI2;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;PLA2G6;DNMBP;LPAR3;S100A13;AGAP1;C5;CHD3;SESN2;AIP;RASA4;NLRX1;PKD2;ECM1;MAPK3;CSPG4;ERRFI1;SEMA5A;STK40;VANGL2;RGS14;RHOF;SRGAP3;ARHGAP22;PLEKHG4;ARHGEF2;MAP2K2;STMN3;LITAF;PAK6;ACAP3;RALGAPA1;FLOT1;UNC5B;SORL1;HERPUD1;GSTM2;NLRP1;MAP3K12;NEK8;L3MBTL1;MARK3;TRPV4;ARHGAP25;IQSEC2;ITGA1;PSD4;TNFAIP8L1;TMSB4X;PDE2A;TRIB3;CDK5RAP3;MINK1;WNT7A;PIK3R2;EPHA1;SHARPIN;GAS6;ERN1;PLEKHG3;BCR;NBR1;ATP2B4;UACA;C12ORF66;PLEKHG6;MAPKBP1;AKT1;CARD11;CHEK2;TSG101;FGFR4;ASAP3;FARP1;C9ORF72;INSR;MAP2K5;BRAF;EDA2R;ARHGAP44;CAT;MAPK10;LGALS1;TP73;MIB2;BCL6;ADAP1;TKFC;EPS8L1;FYN;PJA2;LEMD2;ARHGEF17;GDF15;ADA;TMEM101;EPS8L2;AVPI1;VAV3;LAMTOR2;MAP3K10;LURAP1;EPHB2;PER1;FGFR1;WFS1;CTH;ERBB2;SYVN1;NET1;KCTD13;IKBKB;HIP1
12122,GO:0048246,0.0462239881506607,0.987966129543121,5,18,macrophage chemotaxis,BP,MMP28;C5;MAPK3;TRPV4;CKLF
3386,GO:0007166,0.0462858343761438,0.960656571273214,242,1858,cell surface receptor signaling pathway,BP,XDH;DUSP6;DLG4;HTRA1;BBS2;TNFRSF6B;APOE;ZMYND8;NFATC4;SERPINE2;FOS;IL20RB;ADGRL1;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;WIPF1;PTK6;SEMA4B;LRP1;PDCD4;VEGFA;NTSR1;EGFR;RBCK1;PRNP;FCGRT;IFT140;TNFSF15;TSPAN1;IGFBP4;CD9;DNM1;DDIT3;SHANK2;ADGRB2;ADAMTS13;ARHGEF19;MST1R;ARRDC1;EFS;ARAP1;HBEGF;MMP1;CTF1;CNTN1;EFNB3;MDFI;EVC;PLAT;LTBP4;SLC27A1;MAPK13;RNF165;FBXW4;WWTR1;GIGYF1;DDIT4;SHC2;ITGA6;DGKQ;MAML3;SHC1;SPRY2;GRB7;NPHP4;VEGFB;NLGN2;LAMA5;CAPRIN2;TTBK2;PRKCZ;PAK1;ABCA7;PEAR1;FGFR3;NPR2;SEMA3F;PLXNB3;SPRY4;ITGB4;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;GSTO1;LTBP1;MUC19;WNT2B;PLXNB1;EREG;PTPRE;TNFRSF25;PLA2G6;ERMAP;MTMR4;C5;CHAC1;AIP;MKNK2;IFT27;STAT6;SH3TC2;AREG;SLIT3;ECM1;MAPK3;CSPG4;ITGB5;ERRFI1;IFITM1;VANGL2;SH2D2A;RGS14;FAM20C;LTBP2;MAPK12;MVB12B;SDC2;IFNGR2;TCTN1;ARHGEF2;INPP5D;PDCD1LG2;DMTN;KLHL24;SEMA3B;SSH1;IFI6;MDK;UNC5B;IRF5;IL17RD;VLDLR;ADGRF1;SULF2;ROBO3;EGFL7;RHBDF1;LRP5;PTPRU;CREBRF;FBXL15;ISG20;TGFBR2;FOXL1;ITGA1;IL17RE;TMSB4X;SMURF2;APLN;CALCOCO1;EDA;NOS3;AGO4;MINK1;WNT7A;TRPV1;PIK3R2;EPHA1;RHBDF2;SEMA4G;SHARPIN;GAS6;LZTS2;BCR;PTAFR;STRADB;TNFRSF14;WDR19;AKT1;CARD11;CDKN1C;IFT57;IGFBP2;TSG101;IL17RC;FGFR4;TCIRG1;LMNA;IFI27;INSR;WNT3;KRT19;FOXO4;RPS6KA5;ITGB6;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;BTN3A2;PIDD1;MYOF;MAPK10;TIMP1;HFE;JAK3;FRAT1;MIB2;CSNK1E;BTN3A3;BCL6;REPS2;RNF213;ADAP1;FYN;LEMD2;SIRT2;GDF15;CELSR1;ADA;PLXND1;AP2A2;CIDEA;EIF4EBP1;TGFBR3;TCF7;VAV3;STX1A;MAP3K10;MFNG;EPHB2;MAGI1;ITGA2;FGFR1;FKBP8;ERBB2;PAG1;HLA-G;FRS3;GRB10;KCTD11;BSG;DTX3;IKBKB;HIP1;BTBD11
7878,GO:0032454,0.0462921038896567,0.99054832887216,4,12,histone demethylase activity (H3-K9 specific),MF,KDM3A;KDM4C;KDM7A;PHF2
12572,GO:0050772,0.0465233733872724,0.977736812737695,13,66,positive regulation of axonogenesis,BP,VEGFA;MAP2K1;PAK1;PLXNB3;NGFR;PLXNB1;LPAR3;SEMA5A;TWF2;METRN;WNT3;BRAF;PLXND1
534,GO:0001653,0.0467579175732089,0.984067453936584,7,29,peptide receptor activity,MF,F2R;NTSR1;MC1R;NPR2;LTB4R2;LTB4R;EDNRA
9941,GO:0042325,0.0467583376774716,0.961971004319486,141,1038,regulation of phosphorylation,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;EGR1;PTK6;GJC2;PDCD4;TIMP2;VEGFA;EGFR;PRNP;FBLN1;DUSP5;RAPGEF3;TNFSF15;IGFBP4;ERCC6;MST1R;ADARB1;HBEGF;RBL2;CTF1;CNTN1;SLC27A1;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;SHC2;SYNGAP1;ITGA6;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;SPRY4;DLG3;NEURL1;ACVR2B;NGFR;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PPARA;SESN2;IMPACT;PKD2;AREG;MAPK3;CSPG4;TRPT1;ERRFI1;STK40;VANGL2;RGS14;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;DMTN;PAK6;PKD1;FLOT1;TTN;SORL1;VLDLR;MAP3K12;LRP5;PKIB;TGFBR2;TRPV4;ITGA1;APLN;TRIB3;CDK5RAP3;MINK1;PROM2;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;NBR1;TADA3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;CDKN1C;MICAL1;CHEK2;SPDYE2;SPDYE2B;TSG101;FGFR4;WDFY2;C9ORF72;INSR;RPS6KA5;CTDSPL;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;FYN;LEMD2;SIRT2;GDF15;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;PER1;FGFR1;FKBP8;ERBB2;EIF2AK4;UNC119;GRB10;CAMKK1;IKBKB
3743,GO:0008284,0.0468733205444031,0.964558101654488,76,535,positive regulation of cell proliferation,BP,HTRA1;F2R;S100A6;EGR1;PGF;FGFBP1;GLUL;GJC2;VEGFA;EGFR;CST3;MEF2D;TBC1D8;MST1R;HBEGF;CTF1;FBXW4;ASH2L;HYAL1;WWTR1;SHC1;VEGFB;MARCKSL1;PRKCZ;PAK1;FGFR3;PLXNB3;ZP3;CCDC88B;EAPP;ETV5;EREG;S100A13;HMGA2;AREG;ECM1;SEMA5A;MVD;MLXIPL;PDCD1LG2;PTHLH;KDM4C;LTBP3;EGFL7;LRP5;CEP131;TGFBR2;APLN;WNT7A;EPHA1;GAS6;ERN1;PTAFR;CTSH;AKT1;CARD11;LAMB1;IGFBP2;FGFR4;TCIRG1;MAB21L2;RAB25;INSR;MAP2K5;TIMP1;JAK3;MTA3;BCL6;HSF4;ADA;TGFBR3;VAV3;DHPS;ITGA2;FGFR1;ERBB2
17917,GO:1902285,0.0469471422558969,0.990369643384397,4,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,SEMA3F;PLXNB3;PLXNB1;PLXND1
6810,GO:0030276,0.047015843409592,0.980120461151232,10,47,clathrin binding,MF,SYTL1;LRP1;CLTCL1;SYT8;TOM1L2;CEMIP;DNAJC6;TOM1;AP2A2;HIP1
7828,GO:0032391,0.0470465594094108,0.985693885766481,6,23,photoreceptor connecting cilium,CC,IFT140;NPHP4;KIF17;SPATA7;WDR19;IFT57
5584,GO:0016614,0.0471954098615464,0.97478243574655,17,95,oxidoreductase activity, acting on CH-OH group of donors,MF,XDH;H6PD;D2HGDH;HADH;IDH2;PHGDH;HSD17B14;CRYL1;AKR7A2;DHRS4;KCNAB2;HIBADH;HSD11B1;PTGR2;HSD17B7;CBR4;KDSR
7844,GO:0032413,0.0473903898719081,0.982320334357614,8,35,negative regulation of ion transmembrane transporter activity,BP,ANK3;STK39;GSTO1;PKD2;GSTM2;PCSK9;ANO9;EPHB2
2989,GO:0006536,0.047574115529501,0.985493038722583,6,23,glutamate metabolic process,BP,PRODH;GLUL;NAGS;GGT1;ALDH4A1;GLUD1
10877,GO:0044438,0.0476457868949112,0.976355289552002,14,74,microbody part,CC,CRAT;PRDX5;MLYCD;PHYH;DHRS4;PEX10;MAP2K2;LONP2;ACOX3;CAT;PEX7;PEX1;PEX11A;ACOT8
10878,GO:0044439,0.0476457868949112,0.976355289552002,14,74,peroxisomal part,CC,CRAT;PRDX5;MLYCD;PHYH;DHRS4;PEX10;MAP2K2;LONP2;ACOX3;CAT;PEX7;PEX1;PEX11A;ACOT8
3768,GO:0008324,0.0479803202673967,0.966560371695722,46,305,cation transmembrane transporter activity,MF,KCNG1;SCN8A;SLC7A8;SLC2A9;SCN4B;ORAI3;SLC12A7;ITPR3;NDUFA4L2;TMEM44;ORAI2;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;SLC22A18;PQLC2;PKD1;KCNMA1;AZIN2;TMEM175;TRPV4;PDE2A;TRPV1;GAS6;ATP7B;MFSD3;ATP2B4;ITPR2;SLC6A9;TCIRG1;SLC6A6;TMEM63C;SLC25A29;TPCN1;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC38A2;SLC25A42;TRPC1;SLC39A11;SLC10A6;SLC9A5
6841,GO:0030317,0.0480999297510336,0.983505232566235,7,29,flagellated sperm motility,BP,BBS2;DNAH1;NPHP4;NEURL1;PLTP;SPAG16;ATP2B4
11848,GO:0046873,0.0483159029993476,0.968836830840577,32,199,metal ion transmembrane transporter activity,MF,KCNG1;SCN8A;SCN4B;ORAI3;SLC12A7;ITPR3;ORAI2;KCNJ15;PKD2;KCNC4;KCNAB2;PKD1;KCNMA1;TMEM175;TRPV4;PDE2A;TRPV1;GAS6;ATP7B;ATP2B4;ITPR2;SLC6A9;SLC6A6;TPCN1;ASIC1;SCNN1A;ATP12A;SLC9A7;TRPC1;SLC39A11;SLC10A6;SLC9A5
10389,GO:0043242,0.0483454631972034,0.979455852069867,10,47,negative regulation of protein complex disassembly,BP,GSN;SPTB;CAPG;TTBK2;ARHGEF2;TWF2;DMTN;TRIOBP;TMOD2;PLEKHH2
11451,GO:0045926,0.0486484125851431,0.969903479550091,27,165,negative regulation of growth,BP,PTPRS;BBS2;SERPINE2;FHL1;PTK6;WWC3;SEMA4B;ALOX15B;ULK2;HYAL1;CYP27B1;BTG1;CAPRIN2;PAK1;FGFR3;SEMA3F;SESN2;ING4;SLIT3;SEMA5A;TSPYL2;SEMA3B;TGFBR2;SEMA4G;WNT3;TP73;BCL6
3658,GO:0008144,0.0489809555344693,0.959402993409165,170,1264,drug binding,MF,ACTA2;ACSF2;PYGB;PTK6;GLUL;OBSCN;EGFR;SCN8A;NEK9;DGKA;FKBP9;NOS1;BRSK1;ERCC6;MYH15;SMARCA1;MST1R;CUL9;RPS6KA2;PYGL;CYP3A5;TK2;ULK2;MAPK13;CDK18;MAP2K1;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TMEM173;DNAH1;ULK1;MYH11;ITPR3;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;GLDC;NPR2;CBS;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;GPT2;ABCG1;CARS;FKBP10;KIF17;PPARA;CHD3;MKNK2;NLRX1;ACACB;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;MAPK12;MYH3;PI4K2A;MAP2K2;TWF2;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;MOCOS;PDE2A;TRIB3;MLH3;NOS3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;ATP2B4;THNSL2;STRADB;ASNS;AKT1;DGUOK;CHEK2;PHYKPL;ASS1;KIF27;FGFR4;MARK4;INSR;ACSS1;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;CHRM3;APRT;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;RECQL5;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;FGFR1;FKBP8;CTH;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
2262,GO:0005178,0.0491011780597258,0.975548968189838,14,73,integrin binding,MF,TIMP2;EGFR;CD9;ADAMTS13;LTBP4;NISCH;ITGA6;LAMA5;LAMB2;ECM2;TNXB;ITGB6;ICAM5;ITGA2
16970,GO:0099081,0.0492110396562602,0.962126436072725,85,597,supramolecular polymer,CC,ESPN;FLNC;WIPF1;THSD4;CLIP2;OBSCN;SCN8A;ANK3;KRT15;NINL;SNPH;CST3;DNM1;PARVB;NOS1;SHANK2;NDRG1;MYH15;OBSL1;REEP2;COL6A1;EML2;TUBG2;FAM110C;DNAH1;SPRY2;MYH11;TPM2;PRKCZ;PAK1;SHROOM4;LTBP1;SYNC;KIF17;PKD2;ENKD1;COL8A1;KCNAB2;RGS14;DNAL4;MYZAP;PBXIP1;TUBE1;HOOK2;MYH3;ARHGEF2;FBF1;MAP2K2;TWF2;KIF21B;DMTN;KIF26B;TTN;MAP6;COL4A6;NDE1;TRPV4;TMSB4X;MAP1LC3A;CDK5RAP3;TTLL11;NICN1;LZTS2;MAPRE3;NBR1;TNNI2;KIF13B;ATP2B4;REEP4;MICAL1;TNNT1;KIF27;TMOD2;LMNA;KRT19;TNXB;HAUS4;TUBGCP6;FYN;EML3;SIRT2;GOLGA2;MTA1;CORO1B;TNNI1
8739,GO:0034405,0.0492333898575433,0.983027348964277,7,29,response to fluid shear stress,BP,TFPI2;PKD2;PKD1;NOS3;AKT1;ASS1;MAP2K5
10476,GO:0043394,0.049583528681223,0.984722494935587,6,23,proteoglycan binding,MF,PTPRS;LRP1;NID1;SEMA5A;CTSB;ITGA2
10886,GO:0044449,0.0495979746452475,0.971456734352587,21,117,contractile fiber part,CC,FLNC;OBSCN;SCN8A;ANK3;PARVB;NOS1;OBSL1;MYH11;TPM2;PAK1;SYNC;MYZAP;MYH3;TTN;NBR1;TNNI2;ATP2B4;TNNT1;TMOD2;KRT19;TNNI1
9935,GO:0042311,0.0499472319208813,0.986707779018039,5,18,vasodilation,BP,BBS2;APOE;NOS1;ITGA1;NOS3
3291,GO:0006986,0.050252077349411,0.969121655695188,26,158,response to unfolded protein,BP,TMEM129;EDEM1;DDIT3;DNAJB5;CUL7;DNAJC4;SHC1;MANF;CHAC1;TSPYL2;UBXN4;ATF4;FBXO6;HERPUD1;CREBRF;CDK5RAP3;HERPUD2;ERN1;PPP1R15A;ASNS;ACADVL;LMNA;WFS1;CTH;SYVN1;CREB3L4
11837,GO:0046847,0.0504104365921861,0.979597267720613,9,41,filopodium assembly,BP,ESPN;ZMYND8;ARAP1;ITGA6;NEURL1;ARHGEF4;DMTN;DOCK11;TENM2
16969,GO:0099080,0.0508948052909806,0.960758672382823,85,598,supramolecular complex,CC,ESPN;FLNC;WIPF1;THSD4;CLIP2;OBSCN;SCN8A;ANK3;KRT15;NINL;SNPH;CST3;DNM1;PARVB;NOS1;SHANK2;NDRG1;MYH15;OBSL1;REEP2;COL6A1;EML2;TUBG2;FAM110C;DNAH1;SPRY2;MYH11;TPM2;PRKCZ;PAK1;SHROOM4;LTBP1;SYNC;KIF17;PKD2;ENKD1;COL8A1;KCNAB2;RGS14;DNAL4;MYZAP;PBXIP1;TUBE1;HOOK2;MYH3;ARHGEF2;FBF1;MAP2K2;TWF2;KIF21B;DMTN;KIF26B;TTN;MAP6;COL4A6;NDE1;TRPV4;TMSB4X;MAP1LC3A;CDK5RAP3;TTLL11;NICN1;LZTS2;MAPRE3;NBR1;TNNI2;KIF13B;ATP2B4;REEP4;MICAL1;TNNT1;KIF27;TMOD2;LMNA;KRT19;TNXB;HAUS4;TUBGCP6;FYN;EML3;SIRT2;GOLGA2;MTA1;CORO1B;TNNI1
4675,GO:0010828,0.0509387904786274,0.982303183240353,7,29,positive regulation of glucose transmembrane transport,BP,CLTCL1;PRKCZ;PAK1;PIK3R2;AKT1;INSR;BRAF
16759,GO:0098609,0.0509727221639819,0.962334025401903,63,434,cell-cell adhesion,BP,TNIP1;NT5E;SERPINE2;IL20RB;ADGRL1;EGFR;PRNP;ANK3;CD9;SDK2;COL13A1;ZFP36L1;EFNB3;CERCAM;ITGA6;SHC1;NPHP4;BLOC1S4;NLGN2;PRKCZ;PAK1;ARVCF;PLXNB3;ZP3;CCDC88B;RAG1;PPARA;ITGB5;PDCD1LG2;DMTN;TENM2;KIF26B;PKD1;FLOT1;CEBPB;PTPRU;TGFBR2;TRPV4;MINK1;GAS6;PTAFR;TNFRSF14;AKT1;CARD11;AMIGO2;LAMB1;IGFBP2;ASS1;TENM4;MAP2K5;LGALS1;HFE;JAK3;ICAM5;BCL6;FYN;CELSR1;ADA;CADM4;DHPS;ERBB2;PAG1;HLA-G
13693,GO:0060284,0.051111783237751,0.960827840097402,81,571,regulation of cell development,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;SERPINE2;POSTN;PTK6;GJC2;SEMA4B;LRP1;TIMP2;VEGFA;FBLN1;IDH2;NOS1;SHANK2;CRTC1;CNTN1;EFNB3;OBSL1;ULK2;CUL7;MAP2K1;SYNGAP1;CAPRIN2;PAK1;NPR2;SEMA3F;PLXNB3;ZSWIM4;FBXW8;NEURL1;NGFR;ETV5;PLXNB1;SSH3;LPAR3;IMPACT;SEMA5A;RGS14;SDC2;ARHGEF2;TWF2;DMTN;SEMA3B;KDM4C;SSH1;METRN;SORL1;VLDLR;TRIOBP;TRPV4;HMG20B;CDK5RAP3;WNT7A;TRPV1;SEMA4G;KIF13B;CAMK1;ADCY6;AKT1;DGUOK;WNT3;TENM4;BRAF;ARHGAP44;LGALS1;TP73;CSNK1E;BCL6;FYN;SIRT2;PLXND1;EPHB2;FGFR1;UST;EIF2AK4;NET1;KCTD11;IKBKB
4802,GO:0012505,0.0513114257406417,0.955020679038551,400,3164,endomembrane system,CC,XDH;H6PD;PTPRS;DLG4;DOCK4;F2R;ST6GALNAC2;APOE;SYTL1;HS1BP3;SERPINE2;S100A6;FOS;OSBPL5;H1F0;GSN;PYGB;LMF1;POSTN;EVI5L;SLC2A3;FBXO2;ADAM19;TMEM129;CDC42EP5;NAPRT;EDEM1;CRAT;GLUL;AIG1;LRP1;TIMP2;VEGFA;NTSR1;EGFR;PRNP;ZDHHC1;ADAMTS7;ANK3;RAPGEF3;CLTCL1;FCHO1;SPTB;LOXL1;SLC16A3;IGFBP4;CD9;SLC2A9;FKBP9;CRTAP;CST3;DNM1;NOS1;GPSM1;DDIT3;BRSK1;PGM1;CLCA2;PACS2;NDRG1;ADAMTS13;TBC1D8;COL13A1;SYT8;ARAP1;B3GAT3;GAA;PYGL;CYP3A5;OBSL1;PLAT;CERCAM;SLC27A1;REEP2;RAB11FIP4;NISCH;ASAP2;PLD3;KLHDC2;CUL7;PITPNM3;PRSS3;TXNRD3;SYNGR1;MAP2K1;COL6A1;ABCA2;PKN1;LPCAT4;DNASE1L1;PITPNM1;DGKQ;AKR7A2;TMEM173;SNX9;ARL2;ULK1;VPS11;PHF7;VEGFB;RAB3B;CD68;PCSK1;ITPR3;APPL2;LY6K;PRKCZ;SERPING1;PAK1;ABCA7;SLC37A2;MCTP1;B4GALNT4;ERO1B;FGFR3;CEMIP;BRI3;TMEM187;SYNE3;NMNAT2;MICALL2;PDZD2;FBXW8;CCDC88B;SPPL2B;NGFR;MARCH4;LTBP1;MUC19;SMIM14;MALL;ACTR1B;TMC6;PNPLA3;DHRS4;ANO8;TMED4;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;MANF;FKBP10;MTMR4;CHAC1;FNDC4;IFT27;PKD2;STAT6;SH3TC2;VAMP2;AREG;ST6GALNAC6;COL8A1;AP1G2;SEPT5;ECM1;B4GAT1;MARCH9;ACACB;KCNAB2;MAPK3;CSPG4;LAMB2;BNIP3;SCARA3;DOCK9;FAM20C;DYSF;RHOF;SLC22A18;ADAMTSL1;CTSB;MXRA8;MVB12B;LTA4H;PI4K2A;KIAA0319L;SDC2;CHMP1B;NRSN2;IFNGR2;TBC1D14;ARHGEF2;PDCD1LG2;PRAF2;MAP2K2;SRD5A3;STMN3;SLC50A1;SLC48A1;EHBP1L1;DMTN;LITAF;SEMA3B;PTHLH;UBXN4;MOSPD3;CHST6;SV2A;TBC1D3E;SLC38A10;RABGAP1;TENM2;FBXO6;REEP6;PKD1;FUCA1;FLOT1;PSKH1;AZIN2;HSD11B1;TSNARE1;HDAC5;SORL1;MAP6;IL17RD;HERPUD1;GSTM2;VLDLR;TPBG;ST3GAL3;SULF2;CES2;TMEM175;COL4A6;RHBDF1;LRP5;ATRAID;ALDOC;PCSK9;DBNDD1;PKN3;CEP131;EPN3;ITGA1;TMSB4X;MAP1LC3A;HSD17B7;PDE2A;RAB40B;PEMT;EDA;CDK5RAP3;NOS3;MINK1;PIGZ;HEXB;SLC27A3;WNT7A;MARCH2;BNIP3L;RHBDF2;ANGEL1;GAS6;VPS39;ERN1;ATP7B;FYCO1;NBR1;CPT1C;HEXA;GOLGA2P5;NBEAL2;NECAB3;PTAFR;CYP2R1;PPP1R15A;TNRC18;RAB43;SLC9A3R2;CTSH;TMEM9;ENTPD6;TM7SF2;STEAP2;ZFYVE21;IGFBP7;ITPR2;REEP4;B4GALT2;LAMB1;CHEK2;IFT57;SEPT6;TSG101;FMNL3;FGFR4;RASSF9;TCIRG1;STEAP3;NUCB2;LMNA;FAAH;COPG1;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;ARSA;CAPN2;MAN2B1;GOLGA8A;ICA1;RAB25;C1ORF210;IFI27;PLAU;INSR;WNT3;COG7;CHMP4C;TPCN1;ULBP1;MAGED2;C6ORF89;PIGQ;ZDHHC24;YIPF3;ARHGAP44;ASIC1;PIDD1;CAT;MYOF;DPP7;YPEL5;LGALS1;TIMP1;HFE;JAK3;TP73;SNX33;APRT;FCHSD1;TMX4;MIB2;CERS4;SNX17;SCYL3;METTL7A;TMEM50B;HGSNAT;BCL6;RABAC1;SLC9A7;SLC37A4;EHD3;FYN;ATP8B2;PJA2;SNX1;LEMD2;UBXN6;MBOAT2;GDF15;RAB13;OSBPL1A;TOM1;GOLGA2;RHOBTB3;MTA1;RTN2;ENTPD2;AP2A2;MYO18A;RETSAT;RNPEP;MAN1B1;STX1A;GALNS;LAMTOR2;TBC1D16;MFNG;RNF170;MCTP2;SLC39A11;PIGV;WFS1;ESYT3;FITM2;FKBP8;XYLT2;ERBB2;SEC31B;KDELC2;UST;SYVN1;PFKL;HLA-G;MPPE1;CREB3L4;BSG;APBA1;KDSR;HIP1;CYP4V2;TCTEX1D4
2408,GO:0005581,0.0513193644172315,0.980535497723851,8,35,collagen trimer,CC,COL13A1;COL6A1;COL8A1;SCARA3;COL4A6;EDA;C1QTNF6;TNXB
17210,GO:0110053,0.0514117040033999,0.967150966799496,30,187,regulation of actin filament organization,BP,GSN;WIPF1;CDC42EP5;RAPGEF3;SPTB;ARAP1;ARPIN;CAPG;PAK1;SSH3;PLEKHG2;SEMA5A;TWF2;DMTN;SSH1;WHAMMP3;TRIOBP;TMSB4X;EPHA1;TMOD2;ASAP3;C9ORF72;BRAF;FCHSD1;SPIRE1;EPS8L1;EPS8L2;C15ORF62;CORO1B;PLEKHH2
15291,GO:0071526,0.0515403418696653,0.982046291842956,7,29,semaphorin-plexin signaling pathway,BP,SEMA4B;SEMA3F;PLXNB3;PLXNB1;SEMA3B;SEMA4G;PLXND1
8199,GO:0032963,0.0518488705237088,0.97394967885541,14,74,collagen metabolic process,BP,F2R;CST3;MRC2;COL13A1;MMP1;COL6A1;COL8A1;ERRFI1;CTSB;COL4A6;PHYKPL;TNXB;ITGA2;MMP19
8847,GO:0034656,0.0520111344950059,0.980155364515029,8,36,nucleobase-containing small molecule catabolic process,BP,NT5E;APOBEC3C;APOBEC3F;ENTPD6;UPP1;ADA;ENTPD2;NUDT18
3789,GO:0008360,0.0520827997374912,0.969793275169661,21,122,regulation of cell shape,BP,WIPF1;CDC42EP5;VEGFA;PARVB;ARAP3;ARAP1;TTBK2;PLXNB3;SYNE3;PLXNB1;RHOBTB2;S100A13;RHOF;DMTN;HEXB;FMNL3;CSNK1E;FYN;PLXND1;RHOBTB3;C15ORF62
12744,GO:0051043,0.0520953314577785,0.985968365873137,5,18,regulation of membrane protein ectodomain proteolysis,BP,APOE;TIMP2;SNX9;TIMP1;SNX33
2180,GO:0005031,0.0521144994099972,0.985961724688239,5,18,tumor necrosis factor-activated receptor activity,MF,TNFRSF6B;NGFR;TNFRSF25;TNFRSF14;EDA2R
2182,GO:0005035,0.0521144994099972,0.985961724688239,5,18,death receptor activity,MF,TNFRSF6B;NGFR;TNFRSF25;TNFRSF14;EDA2R
12800,GO:0051129,0.0522619336878755,0.960700755853029,70,489,negative regulation of cellular component organization,BP,PTPRS;DLG4;APOE;ESPN;NFATC4;GSN;CTNNBIP1;POSTN;EVI5L;SEMA4B;LRP1;PRNP;ERCC1;FBLN1;RAPGEF3;SPTB;CST3;ARAP1;EFNB3;RPL13A;ULK2;ARPIN;CAPG;TOM1L2;SYNGAP1;EML2;ULK1;SPRY2;TTBK2;PRKCZ;MCTP1;KDM3A;PHF1;SEMA3F;PLXNB3;NGFR;IMPACT;BNIP3;SEMA5A;THRA;ARHGEF2;TWF2;LRSAM1;DMTN;SEMA3B;KDM4C;SORL1;PCSK9;TRIOBP;TRPV4;TMSB4X;PROM2;SEMA4G;ADCY6;AKT1;DGUOK;PHF2;TMOD2;LMNA;WNT3;LGALS1;SNX33;FYN;SIRT2;HDAC8;EPHB2;UNC119;CORO1B;IKBKB;PLEKHH2
3404,GO:0007188,0.0523161104553868,0.973680236396125,14,74,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,NOS1;MC1R;ADM2;HTR7;PTHLH;LTB4R2;ADGRF1;GABBR1;ADCY6;ATP2B4;GNAL;LTB4R;CHRM3;EDNRA
3561,GO:0007605,0.0524684931118004,0.974370414523,13,68,sensory perception of sound,BP,ESPN;ALDH7A1;DNM1;EML2;SPRY2;CEMIP;SLITRK6;TRIOBP;HEXB;HOMER2;EPS8L2;FGFR1;WFS1
7806,GO:0032368,0.0526057097493897,0.976142519631596,11,55,regulation of lipid transport,BP,APOE;LRP1;NTSR1;ABCA2;ABCA7;PLA2G6;ABCG1;PPARA;PLTP;PCSK9;AKT1
13872,GO:0060541,0.0528159528661059,0.968885255156135,22,129,respiratory system development,BP,VEGFA;EGFR;MAP2K1;SPRY2;LAMA5;ACVR2B;WNT2B;MAPK3;ERRFI1;THRA;STK40;VANGL2;PKD1;HSD11B1;TGFBR2;EDA;NOS3;CTSH;CELSR1;ADA;EPAS1;FGFR1
4353,GO:0009953,0.0528760015855326,0.97712026252908,10,48,dorsal/ventral pattern formation,BP,DUSP6;DDIT3;MDFI;TCTN1;LRP5;FBXL15;WNT7A;WDR19;WNT3;FKBP8
11482,GO:0045987,0.0529394745941398,0.985675175466886,5,18,positive regulation of smooth muscle contraction,BP,F2R;PTAFR;CHRM3;ADA;ITGA2
9617,GO:0036499,0.0530199445446693,0.985647149998307,5,18,PERK-mediated unfolded protein response,BP,DDIT3;ATF4;HERPUD1;PPP1R15A;ASNS
9809,GO:0042036,0.0531724789218402,0.985593990115822,5,18,negative regulation of cytokine biosynthetic process,BP,TRIB2;ERRFI1;INPP5D;ZFPM1;MAP2K5
13717,GO:0060315,0.0532074925056437,0.991962408857921,3,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,GSTO1;PKD2;GSTM2
10573,GO:0043555,0.0533604887972426,0.985528401235047,5,18,regulation of translation in response to stress,BP,SESN2;IMPACT;ATF4;PPP1R15A;EIF2AK4
3183,GO:0006809,0.0534554086462219,0.978064946968958,9,42,nitric oxide biosynthetic process,BP,ACP5;NOS1;PKD2;NOS3;TRPV1;ATP2B4;AKT1;ASS1;INSR
13786,GO:0060401,0.0534930224063507,0.971573744881109,16,88,cytosolic calcium ion transport,BP,F2R;NTSR1;PRNP;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PKD2;GSTM2;TRPV1;ATP2B4;ITPR2;TPCN1;FYN;TRPC1
12816,GO:0051150,0.0535925925017566,0.985447330425055,5,18,regulation of smooth muscle cell differentiation,BP,PDCD4;EREG;OLFM2;FOXO4;CTH
4709,GO:0010876,0.0537961456542674,0.964224307890691,35,224,lipid localization,BP,APOE;OSBPL5;LRP1;NTSR1;SLC27A1;CPT2;PITPNM3;ABCA2;PITPNM1;PITPNC1;ABCA7;NME4;PLA2G6;ABCG1;ESYT2;PPARA;ACACB;OSBPL10;SORL1;PLTP;VLDLR;PCSK9;ANO9;APOL4;HEXB;ALKBH7;RXRA;AKT1;ATP8B2;OSBPL1A;CIDEA;STARD10;ESYT3;FITM2;SLC10A6
8715,GO:0034375,0.0539128931084933,0.991811094529498,3,8,high-density lipoprotein particle remodeling,BP,APOE;ABCG1;PLTP
4271,GO:0009636,0.0539373259488293,0.961911444508714,47,318,response to toxic substance,BP,APOE;FOS;GSN;EGR1;GPX3;GJC2;SLC7A8;PRDX5;BPHL;CST3;ERCC6;ADAMTS13;NUPR1;MAPK13;TXNRD3;FAM213A;GSTO1;GSTT1;PPARA;SESN2;BLMH;IMPACT;STAT6;AREG;MAPK3;BNIP3;KCNMA1;GSTM2;ENDOG;DNMT3A;MAP1LC3A;PEMT;NOS3;CCS;MGMT;GSTO2;ASNS;ITPR2;SNN;ANKZF1;TXNRD2;CAT;GSTM3;FYN;ADA;ADIRF;NET1
13225,GO:0051928,0.0539440931240502,0.975430319862208,11,55,positive regulation of calcium ion transport,BP,F2R;GJC2;NTSR1;CEMIP;GSTO1;LPAR3;PKD2;GSTM2;EHD3;TRPC1;WFS1
6326,GO:0020037,0.0539696846736348,0.97541666874058,11,55,heme binding,MF,NR1D1;NOS1;HEBP1;CYP3A5;CYP27B1;CBS;SLC48A1;NOS3;CYP2R1;CAT;CYP4V2
13555,GO:0060048,0.0541267527409485,0.973551669736432,13,64,cardiac muscle contraction,BP,NOS1;SCN4B;GAA;VEGFB;GSTO1;SNTA1;TTN;GSTM2;TNNI2;TNNT1;TAZ;EHD3;TNNI1
12590,GO:0050795,0.0542146093014225,0.982802864157277,6,24,regulation of behavior,BP,DLG4;APOE;RAG1;MDK;ADA;EIF2AK4
10872,GO:0044430,0.0542552691248003,0.955108829116774,159,1186,cytoskeletal part,CC,BBS2;ESPN;GSN;WIPF1;CLIP2;NEK9;IFT140;RAPGEF3;CLTCL1;SPTB;KRT15;NINL;SNPH;DNM1;BRSK1;SHANK2;ADGRB2;NDRG1;MYH15;MST1R;OBSL1;EVC;BBS1;REEP2;RAB11FIP4;CUL7;MAP2K1;SDCCAG8;ABCA2;CAPG;PITPNM1;EML2;TUBG2;FAM110C;DNAH1;ARL2;SPRY2;NPHP4;MYH11;CAPRIN2;TPM2;TTBK2;PRKCZ;PAK1;PHF1;USP20;MICALL2;CEP250;NEIL1;SHROOM4;CCDC88B;SPPL2B;WDR60;SYNC;ACTR1B;PLA2G6;KIF17;CHD3;CCDC92;IFT27;PKD2;NUDCD3;ENKD1;SEPT5;KCNAB2;VANGL2;RGS14;DNAL4;MYZAP;PBXIP1;DYSF;CNTRL;TUBE1;HOOK2;MYH3;ARHGEF2;SEPT10;FBF1;MAP2K2;TWF2;KIF21B;DMTN;ATF4;PROCR;LRRC45;RABGAP1;MYH16;KIF26B;FLOT1;CEP68;TTN;PSKH1;MAP6;NEK8;NDE1;CEP131;TRIOBP;TRPV4;TTC12;TMSB4X;MAP1LC3A;CDK5RAP3;TTLL11;NICN1;CEP126;LZTS2;CROCC;MAPRE3;CEP112;TNNI2;TADA3;KIF13B;SPAG16;SPATA7;CCDC15;GSDMC;PLEKHG6;MAPKBP1;AKT1;REEP4;MICAL1;MZT2B;IFT57;SEPT6;TNNT1;WDR66;TSG101;KIF27;TMOD2;LMNA;CAPN2;MARK4;KRT19;ITGB6;MAP2K5;MZT2A;HAUS4;HFE;TUBGCP6;FYN;EML3;UBXN6;SIRT2;GOLGA2;MTA1;MYO18A;STX1A;LURAP1;SEPT8;SH3PXD2A;UNC119;CCDC69;CORO1B;SFI1;TTC19;TNNI1;HIP1;PLEKHH2;TCTEX1D4
3176,GO:0006796,0.0543161805193167,0.953041176297214,293,2283,phosphate-containing compound metabolic process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;DLG4;F2R;NT5E;ISYNA1;APOE;OSBPL5;EGR1;PPP1R35;PTK6;CDC42EP5;ACP5;NAPRT;GJC2;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PRNP;FBLN1;DUSP5;NEK9;RAPGEF3;TNFSF15;SPTB;DGKA;IGFBP4;IDH2;NOS1;BRSK1;DNPH1;PGM1;ERCC6;MST1R;ZFP36L1;ADARB1;PPM1M;B3GAT3;HBEGF;RBL2;RPS6KA2;PYGL;CTF1;CNTN1;DHTKD1;TK2;ULK2;SLC27A1;MAPK13;CDK18;PHACTR3;PITPNM3;LHPP;PPP1R14A;WWTR1;ACP6;MAP2K1;PCK2;CRYL1;PKN1;PGLS;DDIT4;ALPK1;LPCAT4;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;DGKQ;SNX9;ULK1;SHC1;SPRY2;ADM2;OGDHL;NMRK1;CAPRIN2;TTBK2;PRKCZ;PPP2R3B;PAK1;ABCA7;STK39;FGFR3;CEMIP;NPR2;SPRY4;DLG3;NMNAT2;NME4;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;SPEG;NGFR;ELFN2;PPCS;TRIB2;EREG;PTPRE;PNPLA3;SSH3;PLCD3;PSPH;TNFRSF25;NAB2;PLA2G6;PPM1J;LPAR3;MTMR4;C5;PPARA;SESN2;MKNK2;RASA4;IMPACT;PKD2;HMGA2;AREG;PI4KAP1;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;ERRFI1;OSBPL10;STK40;VANGL2;RGS14;MVD;FAM20C;CNTRL;MAPK12;MYH3;PI4K2A;MLXIPL;PTPDC1;PLCD1;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;SDHA;DMTN;PTHLH;PAK6;SSH1;LTB4R2;PKD1;FLOT1;TTN;PSKH1;GTPBP1;SORL1;GALK1;NTPCR;IL17RD;VLDLR;NADK;GABBR1;MAP3K12;NEK8;ACOT7;LRP5;PTPRU;WNK4;ALDOC;PCSK9;PKIB;PKN3;MARK3;TGFBR2;TRPV4;CSRNP3;ITGA1;TMSB4X;MOCOS;PDE2A;APLN;TRIB3;PEMT;CDK5RAP3;NOS3;MINK1;PIGZ;HEXB;PROM2;WNT7A;PIP5KL1;PIK3R2;EPHA1;GAS6;DNAJC6;ERN1;BCR;MAPRE3;CHKB;NBR1;TADA3;UCKL1;CAMK1;PTAFR;PPP1R15A;ADCY6;ATP2B4;THNSL2;STRADB;CTSH;AKT1;ZFYVE21;CARD11;DGUOK;CDKN1C;MICAL1;CRY2;CHEK2;SPDYE2;SPDYE2B;TSG101;FGFR4;TCIRG1;FARP1;UPP1;WDFY2;C9ORF72;MARK4;INSR;RPS6KA5;PIGQ;CTDSPL;MAP2K5;BRAF;EDA2R;PLB1;MAPK10;HFE;JAK3;TP73;APRT;MPI;SCYL3;CSNK1E;TAZ;TKFC;FYN;MAST4;LEMD2;SIRT2;MBOAT2;GDF15;ADA;ETNK2;ENTPD2;FUK;AVPI1;TGFBR3;PLPP6;VAV3;LAMTOR2;MAP3K10;STARD10;EPHB2;INPP4A;PER1;ITGA2;FGFR1;PIGV;FITM2;FKBP8;ERBB2;EIF2AK4;STK32B;UNC119;PFKL;FRS3;SFI1;MPPE1;GRB10;NUDT18;CAMKK1;IKBKB;PLEKHA4
6286,GO:0019901,0.0543522732256498,0.958638624701182,75,523,protein kinase binding,MF,TNIP1;ACTA2;DOCK4;EGFR;NEK9;DNM1;BRSK1;MICALCL;MST1R;EXOC2;PITPNM3;PKN1;TOM1L2;SHC2;PITPNM1;TMEM173;SHC1;SPRY2;GRB7;SLC12A7;PRKCZ;PAK1;STK39;FGFR3;CEP250;TRIB2;RHOBTB2;PLA2G6;CSPG4;ERRFI1;RGS14;RHOF;TBC1D14;TWF2;ATF4;SV2A;PKD1;CEP68;TTN;HDAC5;SRSF5;MAP3K12;TGFBR2;TRPV4;TRIB3;CDK5RAP3;PIK3R2;EPHA1;GAS6;MAPRE3;NBR1;KIF13B;PTAFR;PPP1R15A;ADCY6;ATP2B4;AKT1;MICAL1;CHEK2;SPDYE2;SPDYE2B;FGFR4;INSR;BRAF;TP73;PJA2;RAB13;GOLGA2;RHOBTB3;AP2A2;EPHB2;FGFR1;ERBB2;PAG1;IKBKB
6301,GO:0019935,0.0544214929563862,0.973266176577054,13,68,cyclic-nucleotide-mediated signaling,BP,APOE;RAPGEF3;NOS1;MC1R;DGKQ;ADM2;PCLO;PTHLH;ADGRF1;PDE2A;ADCY6;ATP2B4;GNAL
9012,GO:0035239,0.0547174459820716,0.958263204143116,76,534,tube morphogenesis,BP,XDH;APOE;NFATC4;CTNNBIP1;PGF;LRP1;VEGFA;EGFR;RAPGEF3;ADGRB2;ZFP36L1;CUL7;HYAL1;SDCCAG8;BTG1;SHC1;SPRY2;VEGFB;ADM2;LAMA5;PAK1;ELK3;ACVR2B;NGFR;ETV5;WNT2B;EREG;PLCD3;C5;PKD2;HMGA2;AREG;COL8A1;ECM1;CSPG4;SEMA5A;VANGL2;SH2D2A;ARHGAP22;TCTN1;PLCD1;ANGPTL4;KIF26B;PKD1;UNC5B;HDAC5;DEAF1;EGFL7;LRP5;WNK4;TGFBR2;APLN;EDA;NOS3;WNT7A;EPHA1;CTSH;IFT57;FMNL3;FGFR4;FOXO4;MAP2K5;RNF213;CELSR1;PLXND1;TGFBR3;TCF7;VAV3;EPAS1;EDNRA;EPHB2;FGFR1;ERBB2;MMP19;ROBO4;TEAD2
17666,GO:1901575,0.0547860289011945,0.953610159721806,211,1627,organic substance catabolic process,BP,XDH;NT5E;APOE;BTBD2;SERPINE2;GID4;PRODH;H1F0;PYGB;ALDH7A1;TYSND1;FBXO2;TMEM129;EDEM1;CRAT;GLUL;AIG1;LRP1;TIMP2;NTSR1;EGFR;RBCK1;NR1D1;ADAMTS7;HADH;RAPGEF3;RNPEPL1;CST3;NOS1;DDIT3;DNPH1;ACAD10;PGM1;GGT1;ADAMTS13;ABTB1;ARRDC1;ZFP36L1;CUL9;GAA;PYGL;CYP3A5;DHTKD1;ALDH4A1;HSD17B14;RPL13A;CTSF;RNF165;CPT2;MLYCD;FBXW4;PLD3;CUL7;HMGCL;HYAL1;NAGLU;WWTR1;CYP27B1;PCK2;CRYL1;DDIT4;PLCH2;DNASE1L1;SNX9;MAGEF1;VPS11;OGDHL;CIRBP;GALE;APOBEC3C;PHYH;BLVRB;CEMIP;GLDC;CBS;USP20;NEIL1;ETFB;TRIB2;GPT2;PNPLA3;RNF44;PLCD3;PLA2G6;CES3;APOBEC3F;PPARA;CHAC1;SESN2;BLMH;ACACB;NT5C1B;CSPG4;BNIP3;THRA;PAN2;CTSB;MVB12B;LTA4H;SDC2;MLXIPL;PLCD1;SRD5A3;HIBADH;LRSAM1;UBXN4;FBXO6;PKD1;FUCA1;AZIN2;HSD11B1;GTPBP1;SORL1;GALK1;PCBP4;HERPUD1;VLDLR;CES2;ENDOG;RHBDF1;ACOT7;LRP5;ATRAID;ALDOC;PCSK9;FBXL15;ACADS;ISG20;LONP2;PDE2A;SMURF2;TRIB3;ALDH1L2;CDK5RAP3;NOS3;AGO4;HEXB;BNIP3L;SHARPIN;GLUD1;ERN1;MAN2C1;CPT1C;HEXA;ATP2B4;THNSL2;CTSH;ACOX3;ACAD11;PNRC1;ENTPD6;AKT1;CHEK2;PHYKPL;TSG101;IGF2BP2;TCIRG1;HAGH;ACADVL;DNASE2;FAAH;UPP1;SPSB3;CAPN2;MAN2B1;SPATA18;INSR;ANKZF1;CHMP4C;PNPLA4;ALDH1L1;PLB1;TIMP1;HFE;SNX33;PEX7;SNX17;CSNK1E;HGSNAT;SAT2;RNF213;TKFC;FYN;ZC3H12D;SNX1;UBXN6;SIRT2;TST;ADA;NAGA;MTA1;ENTPD2;AP2A2;CIDEA;RPL29;RNPEP;MAN1B1;GALNS;DHPS;IGF2BP3;WFS1;CTH;SYVN1;PFKL;RPL12;LYPLAL1;NUDT18;KCTD13;PNKD;ACOT8;BTBD11
788,GO:0002053,0.0548602773998061,0.985002617162012,5,18,positive regulation of mesenchymal cell proliferation,BP,VEGFA;FBXW4;LRP5;TGFBR2;FGFR1
6803,GO:0030262,0.0550582693701141,0.982466696727506,6,24,apoptotic nuclear changes,BP,H1F0;ENDOG;CDK5RAP3;SHARPIN;DNASE2;CIDEA
1782,GO:0004407,0.0552459578917274,0.977184548367228,9,42,histone deacetylase activity,MF,PHF21A;HDAC11;CHD3;HDAC5;HMG20B;MTA3;SIRT2;MTA1;HDAC8
8105,GO:0032802,0.0557710336980302,0.987623924824949,4,13,low-density lipoprotein particle receptor catabolic process,BP,APOE;VLDLR;PCSK9;AP2A2
18193,GO:1903018,0.0558110201948956,0.980115609758413,7,30,regulation of glycoprotein metabolic process,BP,CST3;HBEGF;ABCA7;NECAB3;JAK3;GOLGA2;ACOT8
12957,GO:0051384,0.0559440477948127,0.97006889412106,16,89,response to glucocorticoid,BP,FOS;EGFR;ZFP36L1;KLF9;PCK2;DDIT4;AREG;SLIT3;ERRFI1;MDK;PTPRU;CREBRF;PTAFR;IGFBP7;IGFBP2;EIF4EBP1
5356,GO:0016137,0.0561072667916727,0.987524027289081,4,13,glycoside metabolic process,BP,AKR7A2;FUCA1;CBR4;NAGA
5427,GO:0016290,0.0561554966622333,0.991324202953807,3,8,palmitoyl-CoA hydrolase activity,MF,ACOT1;ACOT7;ACOT8
12859,GO:0051220,0.0561760374410123,0.982019101852487,6,24,cytoplasmic sequestering of protein,BP,MXI1;MDFI;PKD2;THRA;PKD1;TMSB4X
3416,GO:0007204,0.0563132377331902,0.966559333236148,22,131,positive regulation of cytosolic calcium ion concentration,BP,DLG4;F2R;NTSR1;PRNP;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;PKD1;GSTM2;TRPV4;TRPV1;ATP2B4;ITPR2;TPCN1;FYN;TRPC1;EDNRA
2257,GO:0005172,0.0563775999140394,0.991275502994115,3,8,vascular endothelial growth factor receptor binding,MF,PGF;VEGFA;VEGFB
1463,GO:0003720,0.0564061642735684,0.991269233539601,3,8,telomerase activity,MF,TEP1;TERC;HMBOX1
1561,GO:0003964,0.0564061642735684,0.991269233539601,3,8,RNA-directed DNA polymerase activity,MF,TEP1;TERC;HMBOX1
11812,GO:0046777,0.0564371771918647,0.964234954958348,28,172,protein autophosphorylation,BP,PTK6;VEGFA;EGFR;ULK2;ULK1;PAK1;STK39;FGFR3;MKNK2;IMPACT;MAPK3;ERRFI1;MAP2K2;MAP3K12;MINK1;EPHA1;ERN1;BCR;AKT1;CHEK2;FGFR4;INSR;JAK3;FYN;MAP3K10;FGFR1;ERBB2;EIF2AK4
7264,GO:0031253,0.0566785357092593,0.962888026622654,32,202,cell projection membrane,CC,BBS2;SYTL1;SHANK2;EVC;BBS1;SPRY2;CYBRD1;PAK1;ABCA7;SPRY4;ARHGEF4;PKD2;KCNC4;CSPG4;PLEK2;ARHGEF2;DMTN;ATF4;PKD1;TRPV4;PSD4;PEMT;PROM2;TRPV1;RAB25;INSR;PLB1;SCNN1A;EPS8L1;EHD3;PLXND1;EPS8L2
12688,GO:0050930,0.0566953858044308,0.991205673864177,3,8,induction of positive chemotaxis,BP,PGF;VEGFA;VEGFB
13614,GO:0060142,0.056734256038373,0.987337160951619,4,13,regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3;FLOT1;CAMK1;GDF15
4722,GO:0010889,0.056820054646353,0.991178231722293,3,8,regulation of sequestering of triglyceride,BP,PPARA;CIDEA;FITM2
11679,GO:0046488,0.0568445153005064,0.964617164475474,26,159,phosphatidylinositol metabolic process,BP,EGFR;HBEGF;SLC27A1;PITPNM3;PLCH2;PITPNM1;FGFR3;ZP3;EREG;MTMR4;PI4KAP1;PI4K2A;INPP5D;PIGZ;PIP5KL1;PIK3R2;ZFYVE21;FGFR4;PIGQ;FYN;INPP4A;FGFR1;PIGV;ERBB2;MPPE1;PLEKHA4
13599,GO:0060119,0.0568479558163061,0.981748842498545,6,24,inner ear receptor cell development,BP,NAGLU;IFT27;VANGL2;SLITRK6;TRIOBP;FGFR1
11601,GO:0046324,0.0568699856804846,0.976380685908094,9,42,regulation of glucose import,BP,CLTCL1;PRKCZ;PAK1;NGFR;PIK3R2;AKT1;INSR;RTN2;GRB10
13253,GO:0051966,0.0569988759478723,0.981688016327045,6,24,regulation of synaptic transmission, glutamatergic,BP,SERPINE2;GLUL;EGFR;SHANK2;NLGN2;PLA2G6
6755,GO:0030195,0.0570510626254481,0.979570927149001,7,30,negative regulation of blood coagulation,BP,APOE;SERPINE2;CD9;PLAT;SERPING1;NOS3;PLAU
17331,GO:1900047,0.0570510626254481,0.979570927149001,7,30,negative regulation of hemostasis,BP,APOE;SERPINE2;CD9;PLAT;SERPING1;NOS3;PLAU
16695,GO:0097722,0.0570750695148019,0.97956035247338,7,30,sperm motility,BP,BBS2;DNAH1;NPHP4;NEURL1;PLTP;SPAG16;ATP2B4
1038,GO:0002551,0.0571843752217995,0.991097883114476,3,8,mast cell chemotaxis,BP,PGF;VEGFA;VEGFB
15494,GO:0071900,0.0573060558836836,0.957993649347553,57,392,regulation of protein serine/threonine kinase activity,BP,DUSP6;F2R;APOE;PDCD4;VEGFA;EGFR;DUSP5;TNFSF15;ERCC6;MST1R;SLC27A1;MAP2K1;PKN1;SHC2;SHC1;SPRY2;PAK1;STK39;CEMIP;SPRY4;TRIB2;LPAR3;C5;SESN2;PKD2;MAPK3;CSPG4;VANGL2;RGS14;MAP2K2;PKD1;SORL1;MAP3K12;LRP5;PKIB;ITGA1;TRIB3;CDK5RAP3;MINK1;ERN1;MAPRE3;CAMK1;ATP2B4;AKT1;CDKN1C;TSG101;INSR;MAP2K5;BRAF;MAPK10;TP73;AVPI1;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2
14304,GO:0061512,0.0575067935765434,0.979369992617473,7,30,protein localization to cilium,BP,BBS2;IFT140;BBS1;TCTN1;CROCC;SPATA7;TTC21A
6126,GO:0019388,0.0576074815593866,0.991004281843621,3,8,galactose catabolic process,BP,PGM1;GALE;GALK1
4966,GO:0015079,0.0576565317444898,0.973437341630046,11,55,potassium ion transmembrane transporter activity,MF,KCNG1;SLC12A7;KCNJ15;PKD2;KCNC4;KCNAB2;KCNMA1;TMEM175;ATP12A;SLC9A7;SLC9A5
19086,GO:1905048,0.0577820622825419,0.987023191702019,4,13,regulation of metallopeptidase activity,BP,TIMP2;MAPK3;SORL1;TIMP1
13644,GO:0060193,0.0578631512966595,0.979212590893754,7,30,positive regulation of lipase activity,BP,LMF1;EGFR;PRKCZ;FGFR3;PTAFR;EDNRA;FGFR1
16149,GO:0090196,0.0579686025928986,0.990924149229481,3,8,regulation of chemokine secretion,BP,POSTN;ALOX15B;C5
3076,GO:0006650,0.0580218512384225,0.959861328714193,41,270,glycerophospholipid metabolic process,BP,OSBPL5;EGFR;DGKA;HBEGF;SLC27A1;PITPNM3;ACP6;LPCAT4;PLCH2;PITPNM1;DGKQ;FGFR3;ZP3;EREG;PNPLA3;PLA2G6;MTMR4;PI4KAP1;OSBPL10;PI4K2A;INPP5D;PEMT;PIGZ;PIP5KL1;PIK3R2;CHKB;ZFYVE21;FGFR4;PIGQ;PLB1;TAZ;FYN;MBOAT2;ETNK2;STARD10;INPP4A;FGFR1;PIGV;ERBB2;MPPE1;PLEKHA4
4488,GO:0010518,0.0580601286617186,0.981259027573447,6,24,positive regulation of phospholipase activity,BP,EGFR;PRKCZ;FGFR3;PTAFR;EDNRA;FGFR1
13060,GO:0051593,0.0581058548404122,0.990893634212785,3,8,response to folic acid,BP,GSN;MTHFR;MGMT
3281,GO:0006971,0.0581299464988999,0.990888274625728,3,8,hypotonic response,BP,STK39;TRPV4;ITGA2
9958,GO:0042362,0.0582208758632043,0.99086803691459,3,8,fat-soluble vitamin biosynthetic process,BP,CYP27B1;PLTP;CYP2R1
11417,GO:0045869,0.0582292992803016,0.990866161437361,3,8,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,APOBEC3C;APOBEC3F;HMGA2
7043,GO:0030826,0.0582491834223376,0.990861733742455,3,8,regulation of cGMP biosynthetic process,BP,APOE;NOS1;NOS3
12094,GO:0048168,0.058270929485146,0.979032175169554,7,30,regulation of neuronal synaptic plasticity,BP,DLG4;APOE;SYNGR1;SYNGAP1;MCTP1;NEURL1;EPHB2
12692,GO:0050951,0.0583452264419803,0.990840337849894,3,8,sensory perception of temperature stimulus,BP,NTSR1;ANO1;TRPV1
5825,GO:0017110,0.0584277866806368,0.986828661814383,4,13,nucleoside-diphosphatase activity,MF,ENTPD6;SLC25A42;ENTPD2;NUDT18
7444,GO:0031589,0.0585854232426056,0.960742003974569,35,225,cell-substrate adhesion,BP,THBS3;POSTN;VEGFA;FBLN1;PARVB;ADAMTS13;COL13A1;SMOC2;ITGA6;ARL2;LAMA5;PRKCZ;ITGB4;MICALL2;NID1;COL8A1;ITGB5;DMTN;PKD1;TRIOBP;ITGA1;EDA;MINK1;EPHA1;GAS6;ECM2;BCAM;LAMB1;PLAU;ITGB6;BRAF;LGALS1;BCL6;ITGA2;NET1
2663,GO:0006013,0.0587024045036421,0.990760629237992,3,8,mannose metabolic process,BP,MAN2C1;MAN2B1;MPI
5658,GO:0016772,0.0587066564854255,0.953119491440642,107,775,transferase activity, transferring phosphorus-containing groups,MF,DLG4;PTK6;NAGS;OBSCN;EGFR;NEK9;DGKA;BRSK1;MST1R;HBEGF;RPS6KA2;EFNB3;TK2;LTBP4;ULK2;MAPK13;CDK18;POLD4;MAP2K1;PKN1;ALPK1;DGKQ;ULK1;NMRK1;TTBK2;PRKCZ;PAK1;STK39;FGFR3;NPR2;DLG3;NMNAT2;NME4;ACVR2B;SPEG;LTBP1;EREG;MKNK2;HMGA2;PI4KAP1;MAPK3;TRPT1;STK40;FAM20C;CNTRL;MAPK12;PI4K2A;MAP2K2;PAK6;PRIMPOL;POLM;TTN;PSKH1;GALK1;NADK;TEP1;MAP3K12;NEK8;WNK4;PKN3;MARK3;TGFBR2;MINK1;PIP5KL1;PIK3R2;EPHA1;ERN1;BCR;CHKB;UCKL1;CAMK1;POLL;TERC;STRADB;AKT1;ZFYVE21;CARD11;DGUOK;CHEK2;FGFR4;MARK4;INSR;RPS6KA5;MAP2K5;BRAF;POLR2J2;MAPK10;JAK3;CSNK1E;TKFC;FYN;MAST4;POLR3GL;ETNK2;FUK;TGFBR3;MAP3K10;EPHB2;POLR2J3;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HMBOX1;CAMKK1;IKBKB
14481,GO:0062013,0.0587087121839846,0.96770175137223,17,96,positive regulation of small molecule metabolic process,BP,APOE;TIMP2;NTSR1;NR1D1;RAPGEF3;NOS1;MLYCD;ABCG1;PPARA;MLXIPL;PTHLH;TMSB4X;NOS3;PTAFR;AKT1;INSR;TAZ
6741,GO:0030168,0.0587195506530973,0.967067558041038,18,103,platelet activation,BP,F2R;APOE;SERPINE2;DGKA;CD9;ADAMTS13;DGKQ;BLOC1S4;ITPR3;MAPK3;DMTN;NOS3;GAS6;AKT1;ITPR2;FYN;ENTPD2;VAV3
3787,GO:0008356,0.0588528422478933,0.986700179088701,4,13,asymmetric cell division,BP,ETV5;RGS14;ARHGEF2;GOLGA2
15258,GO:0071467,0.059054070489145,0.986639234304442,4,13,cellular response to pH,BP,HYAL1;IMPACT;TRPV1;ASIC1
3383,GO:0007163,0.0592646739256485,0.962950788908764,26,159,establishment or maintenance of cell polarity,BP,DLG4;GSN;PARVB;BRSK1;SDCCAG8;SPRY2;PRKCZ;PAK1;DLG3;RHOBTB2;VANGL2;RHOF;ARHGEF2;FBF1;FRMD4B;KIF26B;PKD1;NDE1;MARK3;WNT7A;LMNA;MARK4;RHOBTB3;MYO18A;LRCH4;UST
14092,GO:0060976,0.0592845450703863,0.978582328088174,7,30,coronary vasculature development,BP,VEGFA;VEGFB;LTBP1;APLN;SNX17;PLXND1;TGFBR3
2650,GO:0005996,0.0593416380624663,0.961247074471484,31,197,monosaccharide metabolic process,BP,H6PD;SLC2A3;NR1D1;IGFBP4;PGM1;GAA;NISCH;MLYCD;PCK2;CRYL1;DGKQ;GALE;GSTO1;PPARA;ACACB;PC;ATF4;FUCA1;GALK1;LRP5;ALDOC;MAN2C1;GSTO2;AKT1;MAN2B1;INSR;MPI;TKFC;SLC37A4;PHLDA2;PFKL
15837,GO:0072584,0.0593622249539387,0.990612809265861,3,8,caveolin-mediated endocytosis,BP,MAPK3;PROM2;UNC119
13491,GO:0055088,0.0594409523991989,0.970367182574772,13,69,lipid homeostasis,BP,APOE;ABCA2;MALL;PNPLA3;ABCG1;SESN2;MLXIPL;ANGPTL4;LRP5;PCSK9;ACOX3;PNPLA4;FITM2
15962,GO:0085029,0.0594584510766079,0.980690428917492,6,24,extracellular matrix assembly,BP,THSD4;LOXL1;MYH11;GAS6;EFEMP2;TNXB
13056,GO:0051589,0.059510931983817,0.986500584456426,4,13,negative regulation of neurotransmitter transport,BP,NOS1;BRAF;ASIC1;PNKD
5142,GO:0015677,0.0595397459777219,0.99057291254354,3,8,copper ion import,BP,ATP7B;STEAP2;STEAP3
6771,GO:0030214,0.0596085228305066,0.98647091644208,4,13,hyaluronan catabolic process,BP,HYAL1;CEMIP;HEXB;HEXA
14046,GO:0060856,0.0596548521341996,0.990547014546992,3,8,establishment of blood-brain barrier,BP,MXRA8;WNT7A;TRPV1
7630,GO:0032049,0.059737391051657,0.990528430079133,3,8,cardiolipin biosynthetic process,BP,SLC27A1;PLA2G6;TAZ
9821,GO:0042063,0.0597919121620269,0.961873562535791,28,174,gliogenesis,BP,SERPINE2;GSN;GJC2;LRP1;EGFR;CD9;IDH2;NDRG1;MAP2K1;HDAC11;ETV5;NAB2;SH3TC2;AREG;MAPK3;CSPG4;LAMB2;BNIP3;MXRA8;METRN;HEXB;PRDM8;AKT1;LAMB1;TENM4;TP73;SIRT2;ERBB2
6671,GO:0030041,0.0598893124607154,0.964654173341057,21,125,actin filament polymerization,BP,GSN;WIPF1;CDC42EP5;SPTB;MSRB2;ARPIN;CAPG;MICALL2;PLEKHG2;TWF2;DMTN;WHAMMP3;TRIOBP;TMSB4X;TMOD2;FCHSD1;SPIRE1;EPS8L1;EPS8L2;C15ORF62;CORO1B
626,GO:0001816,0.0598895183382775,0.955167824467273,64,449,cytokine production,BP,PTPRS;F2R;NFATC4;IL20RB;EGR1;POSTN;ACP5;RNF135;ALOX15B;PDCD4;PRNP;DDIT3;MAPK13;MC1R;TMEM173;PRKCZ;ZP3;CCDC88B;TRIB2;EREG;ERMAP;S100A13;C5;NLRX1;STAT6;MAPK3;ERRFI1;ARHGEF2;INPP5D;PDCD1LG2;LITAF;ATF4;ZFPM1;FLOT1;LTBP3;IRF5;SULF2;NLRP1;CEBPB;TRPV4;TMSB4X;GAS6;PTAFR;MAPKBP1;CARD11;IL17RC;IGF2BP2;RPS6KA5;ITGB6;MAP2K5;BTN3A2;HFE;JAK3;BTN3A3;BCL6;TKFC;POLR3GL;CIDEA;LURAP1;PER1;IGF2BP3;FGFR1;HLA-G;ZNF287
13009,GO:0051489,0.0599101551551056,0.978303698890445,7,30,regulation of filopodium assembly,BP,ESPN;ZMYND8;ARAP1;NEURL1;DMTN;DOCK11;TENM2
13255,GO:0051968,0.0600678875258765,0.986331028083467,4,13,positive regulation of synaptic transmission, glutamatergic,BP,GLUL;EGFR;SHANK2;NLGN2
9609,GO:0036490,0.0601007126888887,0.990446487219658,3,8,regulation of translation in response to endoplasmic reticulum stress,BP,SESN2;PPP1R15A;EIF2AK4
5010,GO:0015174,0.0601407479775727,0.990437444062662,3,8,basic amino acid transmembrane transporter activity,MF,TMEM44;PQLC2;SLC25A29
10251,GO:0043008,0.0601546249802973,0.990434308897186,3,8,ATP-dependent protein binding,MF,PRNP;PLA2G6;STX1A
1877,GO:0004559,0.0602913487877008,0.986262835777582,4,13,alpha-mannosidase activity,MF,EDEM1;MAN2C1;MAN2B1;MAN1B1
3887,GO:0008526,0.060309562838353,0.990399282403004,3,8,phosphatidylinositol transporter activity,MF,PITPNM3;PITPNM1;PITPNC1
12652,GO:0050884,0.0603345542164931,0.990393628850914,3,8,neuromuscular process controlling posture,BP,ADARB1;GAA;PNKD
7697,GO:0032185,0.0603509068216972,0.986244645094603,4,13,septin cytoskeleton organization,BP,SEPT5;SEPT10;SEPT6;SEPT8
335,GO:0000931,0.0605209501340851,0.990351429071139,3,8,gamma-tubulin large complex,CC,MZT2B;MZT2A;TUBGCP6
3735,GO:0008274,0.0605209501340851,0.990351429071139,3,8,gamma-tubulin ring complex,CC,MZT2B;MZT2A;TUBGCP6
15158,GO:0071320,0.0605231460449351,0.978029969203566,7,30,cellular response to cAMP,BP,RAPGEF3;ZFP36L1;PKD2;DMTN;PDE2A;PTAFR;ITPR2
7137,GO:0030991,0.0605408895581191,0.990346911340146,3,8,intraciliary transport particle A,CC,IFT140;WDR19;TTC21A
6565,GO:0022037,0.0605624122795511,0.970730320184064,12,62,metencephalon development,BP,PTPRS;SERPINE2;CNTN1;NAGLU;MAP2K1;TRNP1;TTBK2;PAK1;AARS;MDK;WNT7A;B4GALT2
19470,GO:1990316,0.0606885767736978,0.990313428555499,3,8,Atg1/ULK1 kinase complex,CC,ULK1;SESN2;C9ORF72
3192,GO:0006821,0.0608690734870714,0.974322585213049,9,43,chloride transport,BP,PRNP;CLCA2;SLC12A7;ANO8;ANO1;WNK4;ANO9;TTYH3;PTAFR
11881,GO:0046929,0.0608883747089134,0.990268073025953,3,8,negative regulation of neurotransmitter secretion,BP,BRAF;ASIC1;PNKD
1435,GO:0003416,0.061132590306377,0.986005285577898,4,13,endochondral bone growth,BP,THBS3;EVC;FGFR3;TGFBR2
11387,GO:0045807,0.0612053170233657,0.967589949495697,15,83,positive regulation of endocytosis,BP,APOE;LRP1;VEGFA;TSPAN1;ABCA7;FLOT1;PCSK9;APLN;GAS6;BCR;TSG101;HFE;MYO18A;ITGA2;HIP1
4633,GO:0010760,0.061227409599048,0.995263154820226,2,4,negative regulation of macrophage chemotaxis,BP,MMP28;C5
19260,GO:1905522,0.061227409599048,0.995263154820226,2,4,negative regulation of macrophage migration,BP,MMP28;C5
14911,GO:0070821,0.0612858729279951,0.974111970614296,9,43,tertiary granule membrane,CC,SLC2A3;GAA;TMC6;KCNAB2;NBEAL2;PTAFR;PLAU;HGSNAT;LAMTOR2
8877,GO:0034706,0.0612915673077891,0.990176340953722,3,8,sodium channel complex,CC,SCN8A;SCN4B;SCNN1A
5927,GO:0018210,0.0613124997095089,0.965421272266522,18,103,peptidyl-threonine modification,BP,MAP2K1;PKN1;DDIT4;DGKQ;ULK1;SPRY2;STK39;CEMIP;DMTN;PSKH1;MAP3K12;TGFBR2;CAMK1;AKT1;CHEK2;SIRT2;MAP3K10;CAMKK1
147,GO:0000302,0.0615442375536369,0.961335794272214,26,163,response to reactive oxygen species,BP,APOE;FOS;EGFR;PRDX5;CST3;ERCC6;MAPK13;HYAL1;TXNRD3;SESN2;IMPACT;PKD2;STAT6;AREG;MAPK3;BNIP3;ENDOG;MAP1LC3A;NOS3;CCS;AKT1;ANKZF1;TXNRD2;CAT;ADA;NET1
3267,GO:0006941,0.0618271159628546,0.967313359089706,15,79,striated muscle contraction,BP,NOS1;SCN4B;GAA;OBSL1;VEGFB;GSTO1;SNTA1;MYH3;TTN;GSTM2;TNNI2;TNNT1;TAZ;EHD3;TNNI1
10400,GO:0043256,0.0619907738636815,0.990016614923871,3,8,laminin complex,CC,LAMA5;LAMB2;LAMB1
5373,GO:0016192,0.062064885969766,0.947640797362551,189,1439,vesicle-mediated transport,BP,DLG4;BBS2;APOE;SYTL1;OSBPL5;GSN;PYGB;LMF1;EVI5L;WIPF1;SLC2A3;NAPRT;LRP1;TIMP2;VEGFA;FCGRT;ANK3;CLTCL1;FCHO1;SPTB;TSPAN1;CD9;SNPH;CST3;DNM1;ARAP3;PGM1;MRC2;TBC1D8;SYT8;RIN1;ARAP1;GAA;PYGL;EXOC2;BBS1;RAB11FIP4;ASAP2;PRSS3;SYNGR1;MAP2K1;DNASE1L1;TMEM173;SNX9;VPS11;BLOC1S4;VEGFB;RAB3B;NLGN2;CD68;APPL2;SERPING1;PAK1;ABCA7;MCTP1;PEAR1;BRI3;USP20;ELMO3;MICALL2;ZP3;ACTR1B;SPG11;TMC6;TMED4;PLA2G6;ESYT2;TRAPPC9;RINL;SCART1;MANF;S100A13;AGAP1;KIF17;STON1;VAMP2;AREG;AP1G2;SEPT5;ECM1;PCLO;KCNAB2;MAPK3;SCARA3;DYSF;RHOF;CTSB;HOOK2;MVB12B;LTA4H;PI4K2A;TBC1D14;MAP2K2;LRSAM1;DMTN;TBC1D3E;RABGAP1;ACAP3;FUCA1;FLOT1;TTN;TSNARE1;WHAMMP3;SORL1;VLDLR;TMEM175;LRP5;RIN2;ALDOC;PCSK9;TGFBR2;ARHGAP25;TMSB4X;APLN;RAB40B;HEXB;PROM2;MARCH2;PIK3R2;GAS6;VPS39;DNAJC6;BCR;NBEAL2;PTAFR;RIMS3;RAB43;CTSH;STEAP2;ZFYVE21;MICAL1;TSG101;RASSF9;TCIRG1;ASAP3;COPG1;C9ORF72;SGSM2;TBC1D20;CHMP5;ARSA;MAN2B1;ARHGAP27;RAB25;PLAU;COG7;CHMP4C;MAGED2;LYST;BRAF;ARHGAP44;CAT;DPP7;YPEL5;TIMP1;HFE;SNX33;APRT;SNX17;ICAM5;METTL7A;SPIRE1;TMEM50B;CSNK1E;HGSNAT;ADAP1;EHD3;FYN;SNX1;UBXN6;RAB13;OSBPL1A;TOM1;GOLGA2;RHOBTB3;AP2A2;MYO18A;VAV3;STX1A;GALNS;LAMTOR2;TBC1D16;ITGA2;BLOC1S1;SEC31B;UNC119;PFKL;MPPE1;HIP1
7050,GO:0030837,0.0620720237286132,0.975346023330642,8,37,negative regulation of actin filament polymerization,BP,GSN;SPTB;CAPG;TWF2;DMTN;TRIOBP;TMSB4X;TMOD2
15541,GO:0072017,0.0624946848572726,0.989900995291917,3,8,distal tubule development,BP,PKD2;PKD1;WNK4
15009,GO:0070977,0.0625714664101398,0.989883341022498,3,8,bone maturation,BP,THBS3;FGFR3;PLXNB1
18417,GO:1903530,0.0626485416937153,0.95367719613934,58,398,regulation of secretion by cell,BP,F2R;SYTL1;POSTN;GLUL;ALOX15B;NTSR1;EGFR;NR1D1;HADH;RAPGEF3;IDH2;SYT8;PCK2;ARL2;RAB3B;NLGN2;ITPR3;PRKCZ;MCTP1;ZP3;PLA2G6;C5;ANO1;VAMP2;SEPT5;PCLO;KCNC4;MAPK3;TTN;NLRP1;RHBDF1;LRP5;TRPV4;TMSB4X;APLN;RAB40B;RHBDF2;GAS6;GLUD1;BCR;PTAFR;RIMS3;MAPKBP1;ITPR2;MICAL1;TSG101;IL17RC;ICA1;BRAF;ASIC1;HFE;RAB13;CIDEA;MYO18A;STX1A;FGFR1;PFKL;PNKD
8757,GO:0034447,0.062760266335213,0.995074621982033,2,4,very-low-density lipoprotein particle clearance,BP,APOE;VLDLR
11186,GO:0045334,0.0627860645633958,0.97500159878682,8,37,clathrin-coated endocytic vesicle,CC,APOE;EGFR;CLTCL1;CD9;HBEGF;CEMIP;AP2A2;HIP1
8427,GO:0033558,0.0628605903242508,0.973313422068156,9,43,protein deacetylase activity,MF,PHF21A;HDAC11;CHD3;HDAC5;HMG20B;MTA3;SIRT2;MTA1;HDAC8
3114,GO:0006694,0.062931599637322,0.962626899191435,21,126,steroid biosynthetic process,BP,APOE;EGR1;NR1D1;HSD17B14;CYP27B1;DGKQ;SEC14L2;ABCG1;ACACB;MVD;SRD5A3;HSD11B1;HSD17B7;CYP2R1;TM7SF2;HINT2;IGFBP7;FGFR4;OSBPL1A;PLPP6;ACOT8
4331,GO:0009887,0.0633177489019516,0.950302131603748,89,638,animal organ morphogenesis,BP,ACTA2;HTRA1;GAMT;BBS2;FHL1;CTNNBIP1;THBS3;PGF;ACP5;PDCD4;VEGFA;EGFR;IFT140;SDK2;MEF2D;SHANK2;ARHGEF19;COL13A1;ADARB1;GAA;MDFI;HYAL1;NAGLU;WWTR1;MAP2K1;ITGA6;SPRY2;LAMA5;FGFR3;ITGB4;ACVR2B;ETV5;WDR60;WNT2B;EREG;NAB2;PPARA;PKD2;STAT6;AREG;COL8A1;SLIT3;MAPK3;ERRFI1;THRA;STK40;VANGL2;FAM20C;SLITRK6;ZFPM1;KIF26B;PKD1;TTN;SULF2;CEBPB;NEK8;LRP5;WNK4;AQP3;TRIOBP;TGFBR2;TRPV4;SMURF2;EDA;WNT7A;BCR;RXRA;CTSH;WDR19;LAMB1;IFT57;TBC1D20;INSR;BRAF;PEX7;LEMD2;PHLDA2;CELSR1;PLXND1;AP2A2;TGFBR3;TCF7;EPHB2;ITGA2;FGFR1;TSHZ1;TNNI1;BSG;TEAD2
7076,GO:0030879,0.0639020434295515,0.964423951806082,17,97,mammary gland development,BP,XDH;VEGFA;NEURL1;ETV5;STAT6;AREG;DEAF1;CEBPB;LRP5;TGFBR2;APLN;ATP7B;MGMT;AKT1;WNT3;APRT;ITGA2
8721,GO:0034382,0.0639662939067289,0.99492429690152,2,4,chylomicron remnant clearance,BP,APOE;LMF1
15456,GO:0071830,0.0639662939067289,0.99492429690152,2,4,triglyceride-rich lipoprotein particle clearance,BP,APOE;LMF1
18206,GO:1903038,0.0639725838468822,0.968765017121765,12,63,negative regulation of leukocyte cell-cell adhesion,BP,IL20RB;PRNP;PPARA;PDCD1LG2;CEBPB;ASS1;HFE;JAK3;BCL6;ERBB2;PAG1;HLA-G
4853,GO:0014070,0.0641225500746257,0.949766573089283,87,628,response to organic cyclic compound,BP,DUSP6;NFATC4;FOS;GSN;EGR1;POSTN;FAM210B;EGFR;NR1D1;RAPGEF3;CST3;ZFP36L1;KLF9;MAP2K1;CYP27B1;PCK2;ABCA2;DDIT4;ITGA6;DGKQ;TMEM173;PAK1;KDM3A;MTHFR;GLDC;PSPH;PPARA;IMPACT;PKD2;AREG;SLIT3;ACACB;MAPK3;ERRFI1;THRA;PAQR6;MAP2K2;DMTN;ATF4;SSH1;FLOT1;MDK;HLCS;HDAC5;GSTM2;ENDOG;CEBPB;PTPRU;CREBRF;AQP3;LONP2;DNMT3A;TGFBR2;MAP1LC3A;PDE2A;CALCOCO1;AGO4;WNT7A;TRPV1;SRR;TADA3;PTAFR;RXRA;ADCY6;ATP2B4;MGMT;ASNS;AKT1;IGFBP7;ITPR2;CRY2;CHEK2;IGFBP2;HOMER2;BRAF;CAT;LGALS1;SIRT2;RECQL5;ADA;CIDEA;HDAC8;EIF4EBP1;PER1;ITGA2;MMP19;BSG
10490,GO:0043410,0.0641253921015324,0.953792898674907,49,333,positive regulation of MAPK cascade,BP,XDH;DUSP6;F2R;TIMP2;VEGFA;EGFR;DUSP5;IGFBP4;ERCC6;MST1R;MAP2K1;PKN1;SHC2;SHC1;SPRY2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;NGFR;TNFRSF25;LPAR3;C5;MAPK3;CSPG4;VANGL2;MAP2K2;MAP3K12;TRPV4;ITGA1;MINK1;WNT7A;EPHA1;GAS6;ERN1;FGFR4;INSR;MAP2K5;BRAF;EDA2R;MAPK10;TP73;AVPI1;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2
18207,GO:1903039,0.0642234489757528,0.96231325482601,20,119,positive regulation of leukocyte cell-cell adhesion,BP,EFNB3;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;PDCD1LG2;TGFBR2;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;LGALS1;JAK3;BCL6;FYN;ADA;DHPS;HLA-G
7436,GO:0031579,0.0642738191632157,0.98142448795125,5,19,membrane raft organization,BP,MARVELD1;GSN;MALL;FLOT1;PLLP
3377,GO:0007157,0.0643339535210224,0.981402025719515,5,19,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ADGRL1;TENM2;AMIGO2;TENM4;CADM4
6299,GO:0019933,0.0646416419929258,0.96838384875647,12,63,cAMP-mediated signaling,BP,RAPGEF3;NOS1;MC1R;DGKQ;ADM2;PCLO;PTHLH;ADGRF1;PDE2A;ADCY6;ATP2B4;GNAL
8425,GO:0033555,0.0646753872259334,0.976063876294216,7,31,multicellular organismal response to stress,BP,APOE;NOS1;RAG1;LRP11;MDK;DEAF1;TRPV1
8911,GO:0034766,0.0648411678589491,0.970769590493051,10,50,negative regulation of ion transmembrane transport,BP,NTSR1;ANK3;STK39;GSTO1;PKD2;GSTM2;PCSK9;ANO9;AKT1;EPHB2
9438,GO:0036042,0.064991703613934,0.99479511355076,2,4,long-chain fatty acyl-CoA binding,MF,PNPLA3;ACOT7
12892,GO:0051262,0.0650384481622463,0.962288587566481,19,117,protein tetramerization,BP,GPX3;DNM1;CRTC1;HMGCL;DHRS4;PKD2;ACACB;TRPV1;SRR;RXRA;SBF2;CBR4;INSR;CAT;TP73;GOLGA2;DHPS;CTH;PFKL
122,GO:0000253,0.0650916042635329,0.994782460692561,2,4,3-keto sterol reductase activity,MF,DHRS4;HSD17B7
12607,GO:0050818,0.0651879580682629,0.970584113926806,10,50,regulation of coagulation,BP,F2R;APOE;SERPINE2;CD9;PLAT;SERPING1;DMTN;PROCR;NOS3;PLAU
18476,GO:1903649,0.0652117529908099,0.981073375872923,5,19,regulation of cytoplasmic transport,BP,MAP2K1;VPS11;MAPK3;MAP2K2;SORL1
11456,GO:0045933,0.0654001810602501,0.978107580729431,6,25,positive regulation of muscle contraction,BP,F2R;GSTO1;PTAFR;CHRM3;ADA;ITGA2
6982,GO:0030669,0.0655357894011954,0.978050428528809,6,25,clathrin-coated endocytic vesicle membrane,CC,APOE;EGFR;CD9;HBEGF;AP2A2;HIP1
5586,GO:0016616,0.0656637374568462,0.964824596760884,15,85,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,H6PD;HADH;IDH2;PHGDH;HSD17B14;CRYL1;AKR7A2;DHRS4;KCNAB2;HIBADH;HSD11B1;PTGR2;HSD17B7;CBR4;KDSR
11356,GO:0045742,0.0656692344003329,0.97799415520696,6,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,PTK6;ARAP1;NEURL1;EREG;AKT1;HIP1
9699,GO:0038128,0.0658656241519789,0.975519347028075,7,31,ERBB2 signaling pathway,BP,PTK6;EGFR;HBEGF;SHC1;GRB7;EREG;ERBB2
5983,GO:0018916,0.0661254772481773,0.994650817956131,2,4,nitrobenzene metabolic process,BP,GSTM2;GSTM3
4225,GO:0009407,0.0661825373557582,0.994643515493573,2,4,toxin catabolic process,BP,GSTO1;GSTO2
12159,GO:0048306,0.0662160683400289,0.973262539852812,8,38,calcium-dependent protein binding,MF,S100A6;S100A4;SYT8;VAMP2;VLDLR;TSG101;STX1A;WFS1
13815,GO:0060441,0.0662357315865696,0.980688203759583,5,19,epithelial tube branching involved in lung morphogenesis,BP,SPRY2;WNT2B;VANGL2;CTSH;CELSR1
2375,GO:0005506,0.0662464740752,0.964491254517505,15,84,iron ion binding,MF,XDH;ACP5;ALOX15B;NOS1;CYP3A5;CYP27B1;PHYH;KDM3A;KDM7A;NOS3;CYP2R1;NFU1;PHF2;OGFOD2;CYP4V2
10331,GO:0043153,0.0663898776324571,0.980630055086246,5,19,entrainment of circadian clock by photoperiod,BP,CRTC1;BHLHE40;CRY2;MTA1;PER1
4865,GO:0014722,0.0664776224756873,0.994605689288574,2,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,GSTO1;GSTM2
10364,GO:0043202,0.0665879226222501,0.966172651969732,13,70,lysosomal lumen,CC,GAA;CTSF;HYAL1;NAGLU;CSPG4;CTSB;SDC2;FUCA1;HEXB;HEXA;ARSA;MAN2B1;GALNS
17009,GO:0099512,0.066634030064046,0.947998258193359,83,591,supramolecular fiber,CC,ESPN;FLNC;WIPF1;THSD4;CLIP2;OBSCN;SCN8A;ANK3;KRT15;NINL;SNPH;CST3;DNM1;PARVB;NOS1;SHANK2;NDRG1;MYH15;OBSL1;REEP2;COL6A1;EML2;TUBG2;FAM110C;DNAH1;SPRY2;MYH11;TPM2;PRKCZ;PAK1;SHROOM4;LTBP1;SYNC;KIF17;PKD2;ENKD1;KCNAB2;RGS14;DNAL4;MYZAP;PBXIP1;TUBE1;HOOK2;MYH3;ARHGEF2;FBF1;MAP2K2;TWF2;KIF21B;DMTN;KIF26B;TTN;MAP6;NDE1;TRPV4;TMSB4X;MAP1LC3A;CDK5RAP3;TTLL11;NICN1;LZTS2;MAPRE3;NBR1;TNNI2;KIF13B;ATP2B4;REEP4;MICAL1;TNNT1;KIF27;TMOD2;LMNA;KRT19;TNXB;HAUS4;TUBGCP6;FYN;EML3;SIRT2;GOLGA2;MTA1;CORO1B;TNNI1
3605,GO:0008047,0.0667660175430277,0.950538843712947,57,395,enzyme activator activity,MF,DOCK4;APOE;EVI5L;CDC42EP5;FBLN1;ARAP3;ERCC6;TBC1D8;ARHGEF19;RIN1;ARAP1;B3GAT3;ARHGAP23;ASAP2;MAP2K1;SYNGAP1;DGKQ;SPRY2;APPL2;PLXNB1;RINL;AGAP1;ALS2CL;RASA4;ERRFI1;RGS14;SRGAP3;ARHGAP22;TBC1D14;MAP2K2;TBC1D3E;RABGAP1;ACAP3;RALGAPA1;AZIN2;NLRP1;RIN2;ARHGAP25;PIK3R2;CCS;GAS6;BCR;PPP1R15A;CTSH;PLEKHG6;ASAP3;SGSM2;TBC1D20;ARHGAP27;ARHGAP44;ADAP1;VAV3;TBC1D16;SH3PXD2A;RGS12;C15ORF62;MMP17
10183,GO:0042805,0.0669269840210972,0.981351650110431,5,15,actinin binding,MF,OBSL1;MICALL2;PKD2;TTN;MAGI1
1204,GO:0002864,0.0669646385858577,0.994543034114731,2,4,regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB;ZP3
3770,GO:0008328,0.0669904257586013,0.980403096701509,5,19,ionotropic glutamate receptor complex,CC,DLG4;SHANK2;DLG3;OLFM2;CPT1C
16886,GO:0098878,0.0669904257586013,0.980403096701509,5,19,neurotransmitter receptor complex,CC,DLG4;SHANK2;DLG3;OLFM2;CPT1C
12196,GO:0048408,0.0670713439444043,0.994529268832432,2,4,epidermal growth factor binding,MF,EGFR;SHC1
16178,GO:0090238,0.0671798860070733,0.994515252787436,2,4,positive regulation of arachidonic acid secretion,BP,NTSR1;PLA2G6
20256,GO:2001259,0.0671877721685812,0.974911481283063,7,31,positive regulation of cation channel activity,BP,NTSR1;ANK3;GSTO1;PKD2;GSTM2;EHD3;EPHB2
7842,GO:0032411,0.0672821192209253,0.968068837830707,11,57,positive regulation of transporter activity,BP,NTSR1;ANK3;STK39;GSTO1;PKD2;GSTM2;WNK4;TMSB4X;PTAFR;EHD3;EPHB2
17007,GO:0099503,0.0676058130675335,0.947099387888834,84,611,secretory vesicle,CC,PTPRS;DLG4;SYTL1;SERPINE2;GSN;PYGB;SLC2A3;NAPRT;TIMP2;VEGFA;LOXL1;CD9;CST3;DNM1;BRSK1;PGM1;SYT8;GAA;PYGL;PLAT;PRSS3;SYNGR1;DNASE1L1;TMEM173;VEGFB;RAB3B;CD68;PCSK1;ITPR3;LY6K;SERPING1;MCTP1;BRI3;ACTR1B;TMC6;VAMP2;SEPT5;ECM1;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;SV2A;FUCA1;ALDOC;DBNDD1;CEP131;ITGA1;TMSB4X;RAB40B;HEXB;GAS6;HEXA;NBEAL2;PTAFR;CTSH;ITPR2;SEPT6;TCIRG1;ARSA;MAN2B1;ICA1;PLAU;MAGED2;CAT;DPP7;YPEL5;TIMP1;APRT;METTL7A;HGSNAT;RABAC1;RAB13;TOM1;AP2A2;RNPEP;STX1A;GALNS;LAMTOR2;PFKL;BSG;APBA1;TCTEX1D4
7653,GO:0032091,0.0680897476679455,0.964247453390649,14,78,negative regulation of protein binding,BP,NFATC4;CTNNBIP1;GPSM1;TTBK2;PPARA;MAPK3;ZFPM1;SORL1;PCSK9;CAMK1;AKT1;HFE;CSNK1E;GOLGA2
14535,GO:0070086,0.0681396720628935,0.994390709811276,2,4,ubiquitin-dependent endocytosis,BP,LRSAM1;TSG101
6036,GO:0019136,0.0682692456258411,0.99437381293604,2,4,deoxynucleoside kinase activity,MF,TK2;DGUOK
6688,GO:0030072,0.0683099815566354,0.957974656273085,23,141,peptide hormone secretion,BP,GLUL;EGFR;NR1D1;HADH;RAPGEF3;LTBP4;PCK2;ARL2;NLGN2;ITPR3;ACVR2B;PLA2G6;ANO1;PCLO;LRP5;TRPV4;APLN;GLUD1;ITPR2;ICA1;HFE;STX1A;PFKL
17530,GO:1901135,0.0683224518504008,0.944314564798307,121,907,carbohydrate derivative metabolic process,BP,TNIP1;H6PD;DLG4;GAMT;ST6GALNAC2;NT5E;APOE;LMF1;FBXO2;EDEM1;TIMP2;VEGFA;ADAMTS7;RAPGEF3;CST3;NOS1;PGM1;ADAMTS13;B3GAT3;HBEGF;PYGL;DHTKD1;TK2;HYAL1;NAGLU;ACP6;CRYL1;PGLS;DDIT4;AKR7A2;VEGFB;OGDHL;ABCA7;APOBEC3C;CEMIP;NPR2;DLG3;NME4;NEIL1;ABHD14B;MUC19;PPCS;ESYT2;APOBEC3F;PPARA;PKD2;ST6GALNAC6;B4GAT1;CSPG4;MACROD1;VANGL2;MVD;FAM20C;ADAMTSL1;MYH3;SDC2;MLXIPL;SRD5A3;SDHA;PTHLH;CHST6;LTB4R2;FBXO6;FUCA1;GTPBP1;GALK1;NADK;GABBR1;ST3GAL3;SULF2;ACOT7;ALDOC;FOXL1;TMSB4X;MOCOS;PDE2A;PEMT;NOS3;PIGZ;HEXB;MAN2C1;HEXA;UCKL1;NECAB3;ADCY6;AKT1;CARD11;DGUOK;B4GALT2;TCIRG1;CBR4;PHLDA1;UPP1;ARSA;MAN2B1;INSR;COG7;PIGQ;JAK3;APRT;MPI;TAZ;HGSNAT;TKFC;GOLGA2;ADA;NAGA;FUK;MAN1B1;GALNS;MFNG;PIGV;ESYT3;XYLT2;KDELC2;UST;SYVN1;PFKL;MPPE1;NUDT18;ACOT8
5198,GO:0015800,0.068413356547217,0.974345232765465,7,31,acidic amino acid transport,BP,NTSR1;VAMP2;PRAF2;TRPV1;SLC38A2;STX1A;APBA1
15725,GO:0072341,0.0684546153195738,0.968776738921952,10,51,modified amino acid binding,MF,OSBPL5;MTHFR;CBS;OSBPL10;GSDMA;PLCD1;GSTM2;GAS6;GSDMC;GSTM3
13027,GO:0051541,0.0685945087995719,0.99433131030332,2,4,elastin metabolic process,BP,CST3;HBEGF
9884,GO:0042182,0.0686017562940829,0.99433036184419,2,4,ketone catabolic process,BP,HAGH;PNKD
5153,GO:0015695,0.0686738641384498,0.976718560067393,6,25,organic cation transport,BP,SLC7A8;SLC22A18;AZIN2;SLC25A29;SLC38A2;SLC25A42
3619,GO:0008076,0.0688185126283482,0.974157458155312,7,31,voltage-gated potassium channel complex,CC,DLG4;KCNG1;VAMP2;KCNC4;KCNAB2;KCNMA1;STX1A
17053,GO:0099601,0.0688378819608072,0.976648460211514,6,25,regulation of neurotransmitter receptor activity,BP,DLG4;SHANK2;NLGN2;KLHL24;MINK1;EPHB2
6283,GO:0019898,0.0688466527725856,0.954733155782971,30,190,extrinsic component of membrane,CC,DLG4;SYTL1;SERPINE2;S100A6;PTK6;ALOX15B;PRNP;SNX9;ULK1;PRSS8;STK39;ESYT2;KCNAB2;ERRFI1;MYZAP;PRSS22;PCSK9;EPN3;PIK3R2;WDR45;FARP1;ATG2A;GNAL;JAK3;SNX33;FYN;SNX1;UBXN6;ESYT3;HIP1
8095,GO:0032792,0.0688549587345488,0.994297187180099,2,4,negative regulation of CREB transcription factor activity,BP,DDIT3;EIF2AK4
19836,GO:2000344,0.0689292819341772,0.994287435023638,2,4,positive regulation of acrosome reaction,BP,ZP3;PLB1
4398,GO:0010138,0.0689559711656482,0.994283931470552,2,4,pyrimidine ribonucleotide salvage,BP,UCKL1;UPP1
10743,GO:0044206,0.0689559711656482,0.994283931470552,2,4,UMP salvage,BP,UCKL1;UPP1
8132,GO:0032868,0.0690047916879318,0.954602363423833,30,192,response to insulin,BP,EGR1;HADH;ZFP36L1;SLC27A1;PCK2;SHC1;PRKCZ;PAK1;NGFR;PTPRE;PPARA;SESN2;VAMP2;ERRFI1;HDAC5;SRSF5;PCSK9;TRPV4;TRIB3;PIK3R2;AKT1;TCIRG1;INSR;FOXO4;GPR21;CAT;APRT;RAB13;EIF4EBP1;GRB10
4219,GO:0009397,0.069049227957583,0.994271682880095,2,4,folic acid-containing compound catabolic process,BP,ALDH1L2;ALDH1L1
10051,GO:0042560,0.069049227957583,0.994271682880095,2,4,pteridine-containing compound catabolic process,BP,ALDH1L2;ALDH1L1
8442,GO:0033591,0.0693414356110125,0.994233237442811,2,4,response to L-ascorbic acid,BP,CAT;ITGA2
4631,GO:0010758,0.0693987096168983,0.983127588705607,4,14,regulation of macrophage chemotaxis,BP,MMP28;C5;MAPK3;TRPV4
11561,GO:0046135,0.069694437181832,0.983030868129338,4,14,pyrimidine nucleoside catabolic process,BP,NT5E;APOBEC3C;APOBEC3F;UPP1
2290,GO:0005249,0.0697825945648676,0.976243766573578,6,25,voltage-gated potassium channel activity,MF,KCNG1;KCNJ15;PKD2;KCNC4;KCNAB2;KCNMA1
4079,GO:0009137,0.069853133628279,0.994165672687689,2,4,purine nucleoside diphosphate catabolic process,BP,ENTPD2;NUDT18
4118,GO:0009181,0.069853133628279,0.994165672687689,2,4,purine ribonucleoside diphosphate catabolic process,BP,ENTPD2;NUDT18
4924,GO:0014883,0.069857775100025,0.994165058422497,2,4,transition between fast and slow fiber,BP,TNNT1;TNNI1
90,GO:0000179,0.0698606916471826,0.99416467242567,2,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,RRNAD1;TFB1M
1813,GO:0004466,0.0700006219565487,0.994146141342876,2,4,long-chain-acyl-CoA dehydrogenase activity,MF,ACAD11;ACADVL
5820,GO:0017099,0.0700006219565487,0.994146141342876,2,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,ACAD11;ACADVL
18402,GO:1903510,0.0701988734268943,0.962997270455519,14,77,mucopolysaccharide metabolic process,BP,B3GAT3;HYAL1;CEMIP;B4GAT1;CSPG4;CHST6;ST3GAL3;HEXB;HEXA;AKT1;B4GALT2;GALNS;XYLT2;UST
10780,GO:0044272,0.0702033597766587,0.956662161641846,23,142,sulfur compound biosynthetic process,BP,GGT1;MLYCD;OPLAH;CBS;GSTO1;GSTT1;CHAC1;B4GAT1;ACACB;CSPG4;ACSS2;CHST6;GSTM2;ST3GAL3;GSTO2;B4GALT2;HAGH;CBR4;ACSS1;GSTM3;CTH;XYLT2;UST
18831,GO:1904491,0.0702898709420333,0.994107763244804,2,4,protein localization to ciliary transition zone,BP,TCTN1;SPATA7
7758,GO:0032287,0.0703401418251514,0.988047186159026,3,8,peripheral nervous system myelin maintenance,BP,NDRG1;SH3TC2;AKT1
6876,GO:0030388,0.070447241500933,0.994086841935424,2,4,fructose 1,6-bisphosphate metabolic process,BP,ALDOC;PFKL
3149,GO:0006750,0.0704612972459013,0.982779343844195,4,14,glutathione biosynthetic process,BP,GGT1;OPLAH;CHAC1;HAGH
4047,GO:0009092,0.0704716081124799,0.994083599978435,2,4,homoserine metabolic process,BP,CBS;CTH
6104,GO:0019346,0.0704716081124799,0.994083599978435,2,4,transsulfuration,BP,CBS;CTH
1082,GO:0002666,0.070497955470277,0.994080093704321,2,4,positive regulation of T cell tolerance induction,BP,TGFBR2;HLA-G
4222,GO:0009403,0.0706904152895682,0.994054456796353,2,4,toxin biosynthetic process,BP,CBS;CTH
14906,GO:0070814,0.0706904152895682,0.994054456796353,2,4,hydrogen sulfide biosynthetic process,BP,CBS;CTH
1023,GO:0002524,0.0707272875423852,0.99404954023455,2,4,hypersensitivity,BP,IL20RB;ZP3
5426,GO:0016289,0.0707760100812681,0.982675822566338,4,14,CoA hydrolase activity,MF,ACOT1;ACOT11;ACOT7;ACOT8
1902,GO:0004591,0.0708645046992207,0.994031229701753,2,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,DHTKD1;OGDHL
7154,GO:0031033,0.0708658592138974,0.991022219380827,3,5,myosin filament organization,BP,OBSL1;MYH11;TTN
12950,GO:0051371,0.0710608299329007,0.99098644254125,3,5,muscle alpha-actinin binding,MF,OBSL1;PKD2;TTN
545,GO:0001665,0.0711735449408726,0.993989910325084,2,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC2;ST6GALNAC6
11140,GO:0045214,0.0712217675337396,0.976270374840301,6,21,sarcomere organization,BP,OBSCN;OBSL1;MYH3;TTN;TNNT1;KRT19
3119,GO:0006701,0.071224617981445,0.993983071025039,2,4,progesterone biosynthetic process,BP,EGR1;DGKQ
10723,GO:0044107,0.0712249343975731,0.993983028643596,2,4,cellular alcohol metabolic process,BP,CYP27B1;CYP2R1
10724,GO:0044108,0.0712249343975731,0.993983028643596,2,4,cellular alcohol biosynthetic process,BP,CYP27B1;CYP2R1
12401,GO:0048871,0.0713973573485652,0.952518261933793,31,200,multicellular organismal homeostasis,BP,BBS2;F2R;IL20RB;ACP5;VEGFA;NTSR1;EGFR;NR1D1;CRTC1;ERCC6;BBS1;SLC27A1;NPHP4;STK39;ACACB;INPP5D;AQP3;TRPV4;APLN;TRPV1;CROCC;ADCY6;SPATA7;CTSH;ACADVL;HOMER2;HFE;SCNN1A;CIDEA;EPAS1;WFS1
18500,GO:1903715,0.0715438935512604,0.993940247290548,2,4,regulation of aerobic respiration,BP,BNIP3;TRPV4
5163,GO:0015712,0.0715678994726576,0.993937022631906,2,4,hexose phosphate transport,BP,SLC37A2;SLC37A4
5183,GO:0015760,0.0715678994726576,0.993937022631906,2,4,glucose-6-phosphate transport,BP,SLC37A2;SLC37A4
1711,GO:0004305,0.0717645549278948,0.993910581126249,2,4,ethanolamine kinase activity,MF,CHKB;ETNK2
14511,GO:0070044,0.071840181739466,0.99390040067322,2,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,VAMP2;STX1A
20268,GO:2001286,0.0718711716616266,0.993896227064745,2,4,regulation of caveolin-mediated endocytosis,BP,PROM2;UNC119
1940,GO:0004645,0.0719077252598627,0.993891302725897,2,4,phosphorylase activity,MF,PYGB;PYGL
12359,GO:0048786,0.0719835293783268,0.978491026697829,5,19,presynaptic active zone,CC,PCLO;SV2A;RIMS3;ARHGAP44;STX1A
2123,GO:0004920,0.0720064365183139,0.993877997023361,2,4,interleukin-10 receptor activity,MF,IL20RB;IFNGR2
3143,GO:0006741,0.0720137436593269,0.993877011613227,2,4,NADP biosynthetic process,BP,IDH2;NADK
7637,GO:0032057,0.0721120014456584,0.993863754958589,2,4,negative regulation of translational initiation in response to stress,BP,ATF4;EIF2AK4
18152,GO:1902949,0.0721294592487566,0.993861398429302,2,4,positive regulation of tau-protein kinase activity,BP,EGR1;NAB2
15433,GO:0071797,0.0721808697571557,0.993854456762113,2,4,LUBAC complex,CC,RBCK1;SHARPIN
16548,GO:0097367,0.0722012976120086,0.938342036388233,207,1582,carbohydrate derivative binding,MF,PTPRS;ACTA2;APOE;SERPINE2;ACSF2;THBS3;PGF;FGFBP1;POSTN;PTK6;GLUL;LRP1;VEGFA;OBSCN;EGFR;PRNP;SCN8A;NEK9;RAPGEF3;DGKA;DNM1;NOS1;BRSK1;ERCC6;COL13A1;MYH15;SMARCA1;MST1R;CUL9;HBEGF;RPS6KA2;PYGL;TK2;LTBP4;ULK2;MAPK13;CDK18;SMOC2;MAP2K1;PCK2;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TUBG2;TMEM173;DNAH1;ARL2;ULK1;VEGFB;RAB3B;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;CEMIP;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;NID1;ACTR1B;CHD2;PNPLA3;RHOBTB2;ABCG1;AGAP1;CARS;KIF17;CHD3;MKNK2;IFT27;NLRX1;SEPT5;ACACB;MAPK3;PC;SEMA5A;STK40;ACSS2;MVD;FAM20C;RHOF;LTBP2;TUBE1;CTSB;MAPK12;MYH3;PI4K2A;SEPT10;MAP2K2;TWF2;KIF21B;PAK6;KIF26B;MDK;TTN;PSKH1;HLCS;GTPBP1;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;PDE2A;TRIB3;RAB40B;ARL10;MLH3;NOS3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;ECM2;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;PTAFR;ADCY6;RAB43;ATP2B4;STRADB;ASNS;AKT1;DGUOK;CHEK2;SEPT6;ASS1;KIF27;FGFR4;MARK4;RAB25;INSR;ACSS1;GNAL;RPS6KA5;TNXB;MAP2K5;BRAF;MAPK10;JAK3;APRT;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;RECQL5;RAB13;ADA;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;RPL29;TGFBR3;MAP3K10;CHD6;EPHB2;MAGI1;SEPT8;ITGA2;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;MPPE1;HSP90AB4P;CAMKK1;IKBKB
12147,GO:0048289,0.0722233848833964,0.993848713869048,2,4,isotype switching to IgE isotypes,BP,STAT6;BCL6
12150,GO:0048293,0.0722233848833964,0.993848713869048,2,4,regulation of isotype switching to IgE isotypes,BP,STAT6;BCL6
18020,GO:1902576,0.0722781913345407,0.993841307582045,2,4,negative regulation of nuclear cell cycle DNA replication,BP,CHEK2;BCL6
16429,GO:0097119,0.0724815339167353,0.993813798356976,2,4,postsynaptic density protein 95 clustering,BP,ZMYND8;NLGN2
11105,GO:0045159,0.0725071821657581,0.993810325123516,2,4,myosin II binding,MF,GSN;TRIOBP
9399,GO:0035977,0.0725353309630329,0.9938065123927,2,4,protein deglycosylation involved in glycoprotein catabolic process,BP,EDEM1;MAN1B1
16592,GO:0097466,0.0725353309630329,0.9938065123927,2,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,EDEM1;MAN1B1
18788,GO:1904382,0.0725353309630329,0.9938065123927,2,4,mannose trimming involved in glycoprotein ERAD pathway,BP,EDEM1;MAN1B1
18872,GO:1904587,0.0725353309630329,0.9938065123927,2,4,response to glycoprotein,BP,EDEM1;MAN1B1
4893,GO:0014824,0.0725883520936961,0.993799328229795,2,4,artery smooth muscle contraction,BP,BBS2;EDNRA
14736,GO:0070444,0.0726017057680038,0.99379751834346,2,4,oligodendrocyte progenitor proliferation,BP,GJC2;SIRT2
14737,GO:0070445,0.0726017057680038,0.99379751834346,2,4,regulation of oligodendrocyte progenitor proliferation,BP,GJC2;SIRT2
1304,GO:0003150,0.0726386047837575,0.993792516171193,2,4,muscular septum morphogenesis,BP,VANGL2;TGFBR3
6149,GO:0019470,0.0726394271467541,0.993792404670519,2,4,4-hydroxyproline catabolic process,BP,PRODH;ALDH4A1
18553,GO:1903826,0.072663039926962,0.993789202780586,2,4,arginine transmembrane transport,BP,PQLC2;SLC25A29
12119,GO:0048243,0.0726907092465224,0.993785450001964,2,4,norepinephrine secretion,BP,NISCH;STX1A
10309,GO:0043117,0.0726960891560289,0.993784720223969,2,4,positive regulation of vascular permeability,BP,TRPV4;PDE2A
14655,GO:0070294,0.0727035984995728,0.993783701534806,2,4,renal sodium ion absorption,BP,WNK4;MAGED2
13065,GO:0051599,0.0727398964855551,0.993778776565688,2,4,response to hydrostatic pressure,BP,PKD2;ATP2B4
16561,GO:0097396,0.0728184801390585,0.993768108978136,2,4,response to interleukin-17,BP,IL17RE;IL17RC
16562,GO:0097398,0.0728184801390585,0.993768108978136,2,4,cellular response to interleukin-17,BP,IL17RE;IL17RC
16563,GO:0097400,0.0728184801390585,0.993768108978136,2,4,interleukin-17-mediated signaling pathway,BP,IL17RE;IL17RC
13926,GO:0060633,0.0728395077151237,0.99376525330955,2,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;THRA
19724,GO:2000143,0.0728395077151237,0.99376525330955,2,4,negative regulation of DNA-templated transcription, initiation,BP,CTNNBIP1;THRA
13577,GO:0060073,0.0728438534406237,0.993764663070591,2,4,micturition,BP,KCNMA1;TRPV1
1646,GO:0004095,0.0728452487275882,0.99376447355726,2,4,carnitine O-palmitoyltransferase activity,MF,CPT2;CPT1C
5477,GO:0016416,0.0728452487275882,0.99376447355726,2,4,O-palmitoyltransferase activity,MF,CPT2;CPT1C
17925,GO:1902305,0.0728963445517359,0.969948542535069,8,38,regulation of sodium ion transmembrane transport,BP,ANK3;NOS1;SCN4B;STK39;SNTA1;KLHL24;PCSK9;ATP2B4
17312,GO:1900019,0.0729046338244426,0.993756405550579,2,4,regulation of protein kinase C activity,BP,EGFR;CEMIP
17313,GO:1900020,0.0729046338244426,0.993756405550579,2,4,positive regulation of protein kinase C activity,BP,EGFR;CEMIP
12096,GO:0048170,0.0729327859449214,0.993752579401127,2,4,positive regulation of long-term neuronal synaptic plasticity,BP,NEURL1;EPHB2
17733,GO:1901727,0.0729673793083147,0.99374787656662,2,4,positive regulation of histone deacetylase activity,BP,VEGFA;C6ORF89
13720,GO:0060318,0.0729740915480101,0.993746963902946,2,4,definitive erythrocyte differentiation,BP,ZFPM1;TGFBR3
18078,GO:1902744,0.0730108098591939,0.993741970388434,2,4,negative regulation of lamellipodium organization,BP,ARPIN;PLXNB3
15919,GO:0075044,0.0730421929932061,0.993737701195153,2,4,autophagy of host cells involved in interaction with symbiont,BP,ULK2;ULK1
15920,GO:0075071,0.0730421929932061,0.993737701195153,2,4,autophagy involved in symbiotic interaction,BP,ULK2;ULK1
16797,GO:0098706,0.0730481906271881,0.993736885179394,2,4,ferric iron import across plasma membrane,BP,STEAP2;STEAP3
9702,GO:0038132,0.073101862439226,0.993729580938695,2,4,neuregulin binding,MF,ITGA6;ITGB4
10438,GO:0043313,0.0731137390256889,0.993727964193767,2,4,regulation of neutrophil degranulation,BP,BCR;PTAFR
18012,GO:1902563,0.0731137390256889,0.993727964193767,2,4,regulation of neutrophil activation,BP,BCR;PTAFR
609,GO:0001778,0.073203276150659,0.993715770361847,2,4,plasma membrane repair,BP,DYSF;MYOF
4704,GO:0010871,0.0732049887082522,0.993715537042564,2,4,negative regulation of receptor biosynthetic process,BP,NR1D1;PPARA
3505,GO:0007416,0.0732322256693866,0.961147062661778,14,77,synapse assembly,BP,ADGRL1;SDK2;SHANK2;ADGRB2;NLGN2;PCLO;SLITRK6;TPBG;ADGRF1;WNT7A;AMIGO2;FARP1;PLXND1;EPHB2
16768,GO:0098634,0.0732474789085021,0.993709747080942,2,4,cell-matrix adhesion mediator activity,MF,ITGA1;ITGA2
16770,GO:0098639,0.0732474789085021,0.993709747080942,2,4,collagen binding involved in cell-matrix adhesion,MF,ITGA1;ITGA2
15794,GO:0072522,0.0732710488413578,0.951860273082553,29,187,purine-containing compound biosynthetic process,BP,NT5E;APOE;TIMP2;NOS1;PGM1;DHTKD1;DDIT4;OGDHL;NPR2;NME4;PPCS;PPARA;MLXIPL;PTHLH;LTB4R2;GALK1;GABBR1;ACOT7;ALDOC;TMSB4X;NOS3;ADCY6;DGUOK;TCIRG1;INSR;APRT;TAZ;ADA;PFKL
6884,GO:0030424,0.0733223279288081,0.946102406272931,52,358,axon,CC,PTPRS;DLG4;ADGRL1;GLUL;GJC2;TIMP2;NTSR1;SCN8A;ANK3;CST3;DNM1;SHANK2;SYNGR1;ULK1;BLOC1S4;PRKCZ;PAK1;BLVRB;ORAI2;DLG3;SPG11;LPAR3;SEPT5;KCNC4;KCNAB2;TWF2;STMN3;KIF21B;KLHL24;SSH1;SV2A;TENM2;AZIN2;MAP6;ROBO3;MAP3K12;TRPV4;MINK1;CPT1C;KIF13B;MICAL1;SEPT6;TMOD2;C9ORF72;INSR;CHRM3;SLC38A2;SIRT2;STX1A;EPHB2;ITGA2;BLOC1S1
6580,GO:0022417,0.0733583279273036,0.986790534179081,3,9,protein maturation by protein folding,BP,ERO1B;AIP;WFS1
11802,GO:0046717,0.0734133938512085,0.966072113248131,10,51,acid secretion,BP,NTSR1;PLA2G6;VAMP2;SV2A;TRPV1;SLC6A9;SLC38A2;STX1A;STARD10;APBA1
12977,GO:0051425,0.0734489451094621,0.993682265699382,2,4,PTB domain binding,MF,INPP5D;INSR
19527,GO:1990535,0.073450257601745,0.993682086512475,2,4,neuron projection maintenance,BP,PRNP;INSR
18156,GO:1902953,0.0734600450774082,0.993680750222819,2,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,SORL1;TBC1D20
7755,GO:0032280,0.0735113354993394,0.993673745701347,2,4,symmetric synapse,CC,NTSR1;NLGN2
12685,GO:0050927,0.0736569981263085,0.98172016694035,4,14,positive regulation of positive chemotaxis,BP,PGF;VEGFA;VEGFB;ITGA2
7569,GO:0031941,0.0737332287948809,0.974403393555038,6,26,filamentous actin,CC,ESPN;PRKCZ;PAK1;SHROOM4;PKD2;TMSB4X
6168,GO:0019534,0.073757433639847,0.993640094803433,2,4,toxin transmembrane transporter activity,MF,SLC7A8;ABCG1
16418,GO:0097107,0.0738171022392997,0.993631925317278,2,4,postsynaptic density assembly,BP,SHANK2;NLGN2
16793,GO:0098698,0.0738171022392997,0.993631925317278,2,4,postsynaptic specialization assembly,BP,SHANK2;NLGN2
12163,GO:0048313,0.0738459316009049,0.981656996119061,4,14,Golgi inheritance,BP,MAP2K1;MAPK3;MAP2K2;GOLGA2
3327,GO:0007040,0.0740916974145991,0.965699085515847,10,51,lysosome organization,BP,GAA;NAGLU;VPS11;SPG11;HOOK2;TMEM175;HEXB;CHMP5;LYST;TFEB
15958,GO:0080171,0.0740916974145991,0.965699085515847,10,51,lytic vacuole organization,BP,GAA;NAGLU;VPS11;SPG11;HOOK2;TMEM175;HEXB;CHMP5;LYST;TFEB
8222,GO:0033002,0.0741504103499272,0.956352727441,19,113,muscle cell proliferation,BP,CTNNBIP1;PDCD4;EGFR;MEF2D;HBEGF;PAK1;EREG;TGFBR2;APLN;ERN1;PTAFR;RXRA;AKT1;TENM4;TP73;TGFBR3;ITGA2;FGFR1;SIX5
4500,GO:0010544,0.0741527361745132,0.9815542844784,4,14,negative regulation of platelet activation,BP,APOE;SERPINE2;CD9;NOS3
931,GO:0002329,0.0742765438397599,0.99356888353954,2,4,pre-B cell differentiation,BP,RAG1;LRRC8A
12079,GO:0048104,0.0743082299580329,0.993564526788009,2,4,establishment of body hair or bristle planar orientation,BP,VANGL2;CELSR1
12080,GO:0048105,0.0743082299580329,0.993564526788009,2,4,establishment of body hair planar orientation,BP,VANGL2;CELSR1
12642,GO:0050870,0.0743580950225362,0.956196601168302,19,114,positive regulation of T cell activation,BP,EFNB3;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;PDCD1LG2;TGFBR2;TNFRSF14;AKT1;CARD11;IGFBP2;LGALS1;JAK3;BCL6;FYN;ADA;DHPS;HLA-G
10574,GO:0043558,0.0743649913605026,0.981483131896583,4,14,regulation of translational initiation in response to stress,BP,IMPACT;ATF4;PPP1R15A;EIF2AK4
16877,GO:0098858,0.0745120326892773,0.955447893971824,20,120,actin-based cell projection,CC,ACTA2;DOCK4;BBS2;SYTL1;ESPN;RAPGEF3;ITGA6;DEF6;TWF2;MORN4;TENM2;TRIOBP;TRPV4;PROM2;KIF13B;PLEKHG6;FARP1;HOMER2;EPS8L2;STARD10
10290,GO:0043083,0.0745263152246915,0.993534509289542,2,4,synaptic cleft,CC,LAMA5;LAMB2
1322,GO:0003175,0.0745463019507529,0.993531755552956,2,4,tricuspid valve development,BP,ZFPM1;TGFBR2
1330,GO:0003186,0.0745463019507529,0.993531755552956,2,4,tricuspid valve morphogenesis,BP,ZFPM1;TGFBR2
8709,GO:0034368,0.0746448241978651,0.986458709795145,3,9,protein-lipid complex remodeling,BP,APOE;ABCG1;PLTP
8710,GO:0034369,0.0746448241978651,0.986458709795145,3,9,plasma lipoprotein particle remodeling,BP,APOE;ABCG1;PLTP
9881,GO:0042178,0.0746769657630202,0.986450385645934,3,9,xenobiotic catabolic process,BP,GSTO1;GSTM2;GSTM3
14712,GO:0070405,0.0747238254378798,0.973968547804099,6,26,ammonium ion binding,MF,PITPNM1;HTR7;ESYT2;PLTP;CHRM3;SAT2
5696,GO:0016829,0.0747980743336038,0.954601990315732,21,129,lyase activity,MF,GLUL;MLYCD;HMGCL;UROS;PCK2;GLDC;NPR2;CBS;NEIL1;CHAC1;HMGA2;MVD;AZIN2;ALDOC;SRR;POLL;ADCY6;THNSL2;PHYKPL;TKFC;CTH
7041,GO:0030823,0.0748015502011522,0.981336546471978,4,14,regulation of cGMP metabolic process,BP,APOE;VEGFA;NOS1;NOS3
4536,GO:0010614,0.0748106281551594,0.981333494882033,4,14,negative regulation of cardiac muscle hypertrophy,BP,PAK1;ERRFI1;ATP2B4;LMNA
4875,GO:0014741,0.0748106281551594,0.981333494882033,4,14,negative regulation of muscle hypertrophy,BP,PAK1;ERRFI1;ATP2B4;LMNA
17659,GO:1901565,0.0748637401636927,0.938303491779435,130,979,organonitrogen compound catabolic process,BP,XDH;NT5E;APOE;BTBD2;SERPINE2;GID4;PRODH;ALDH7A1;FBXO2;TMEM129;EDEM1;GLUL;LRP1;TIMP2;EGFR;RBCK1;NR1D1;ADAMTS7;RAPGEF3;RNPEPL1;CST3;NOS1;DDIT3;DNPH1;GGT1;ADAMTS13;ABTB1;ARRDC1;CUL9;CYP3A5;ALDH4A1;CTSF;RNF165;FBXW4;CUL7;HMGCL;HYAL1;NAGLU;WWTR1;SNX9;MAGEF1;VPS11;APOBEC3C;BLVRB;CEMIP;GLDC;CBS;USP20;NEIL1;TRIB2;GPT2;RNF44;APOBEC3F;CHAC1;BLMH;NT5C1B;CSPG4;BNIP3;CTSB;MVB12B;LTA4H;SDC2;HIBADH;LRSAM1;UBXN4;FBXO6;PKD1;FUCA1;AZIN2;SORL1;HERPUD1;VLDLR;RHBDF1;ATRAID;PCSK9;FBXL15;LONP2;PDE2A;SMURF2;TRIB3;ALDH1L2;CDK5RAP3;NOS3;HEXB;BNIP3L;SHARPIN;GLUD1;HEXA;ATP2B4;THNSL2;CTSH;AKT1;CHEK2;PHYKPL;TSG101;TCIRG1;UPP1;SPSB3;CAPN2;SPATA18;ANKZF1;CHMP4C;ALDH1L1;TIMP1;HFE;SNX33;CSNK1E;HGSNAT;SAT2;RNF213;FYN;SNX1;UBXN6;SIRT2;TST;ADA;NAGA;MTA1;AP2A2;RNPEP;MAN1B1;GALNS;DHPS;WFS1;CTH;SYVN1;LYPLAL1;NUDT18;KCTD13;BTBD11
6255,GO:0019852,0.0749029544990925,0.986391811639245,3,9,L-ascorbic acid metabolic process,BP,SLC2A3;GSTO1;GSTO2
10000,GO:0042446,0.0750027833858952,0.966879754338093,9,45,hormone biosynthetic process,BP,EGR1;HSD17B14;CYP27B1;DGKQ;SRD5A3;HSD11B1;HSD17B7;CYP2R1;HFE
20255,GO:2001258,0.0750453758504431,0.977108239371402,5,20,negative regulation of cation channel activity,BP,ANK3;GSTO1;PKD2;GSTM2;EPHB2
6694,GO:0030100,0.0751284143079609,0.952242192645449,25,157,regulation of endocytosis,BP,DLG4;APOE;LRP1;VEGFA;TSPAN1;ARAP3;ABCA7;MCTP1;STON1;LRSAM1;FLOT1;PCSK9;APLN;PROM2;GAS6;DNAJC6;BCR;TSG101;HFE;SNX33;SNX17;MYO18A;ITGA2;UNC119;HIP1
2938,GO:0006468,0.0751956570247707,0.936515208272621,173,1315,protein phosphorylation,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;EGR1;PTK6;CDC42EP5;GJC2;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PRNP;FBLN1;DUSP5;NEK9;RAPGEF3;TNFSF15;SPTB;IGFBP4;BRSK1;ERCC6;MST1R;ZFP36L1;ADARB1;HBEGF;RPS6KA2;CTF1;CNTN1;ULK2;SLC27A1;MAPK13;CDK18;WWTR1;MAP2K1;PKN1;DDIT4;ALPK1;SHC2;SYNGAP1;DGKQ;SNX9;ULK1;SHC1;SPRY2;ADM2;CAPRIN2;TTBK2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;NPR2;SPRY4;DLG3;NEURL1;ACVR2B;SPEG;NGFR;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;SESN2;MKNK2;RASA4;IMPACT;PKD2;HMGA2;AREG;MAPK3;CSPG4;TRPT1;ERRFI1;STK40;VANGL2;RGS14;FAM20C;CNTRL;MAPK12;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;DMTN;PAK6;PKD1;FLOT1;TTN;PSKH1;SORL1;IL17RD;VLDLR;MAP3K12;NEK8;LRP5;WNK4;PKIB;PKN3;MARK3;TGFBR2;TRPV4;ITGA1;TRIB3;CDK5RAP3;MINK1;PROM2;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;BCR;MAPRE3;NBR1;TADA3;CAMK1;ADCY6;ATP2B4;STRADB;CTSH;AKT1;DGUOK;CDKN1C;MICAL1;CHEK2;SPDYE2;SPDYE2B;TSG101;FGFR4;WDFY2;C9ORF72;MARK4;INSR;RPS6KA5;CTDSPL;MAP2K5;BRAF;EDA2R;MAPK10;HFE;JAK3;TP73;SCYL3;CSNK1E;FYN;MAST4;LEMD2;SIRT2;GDF15;AVPI1;TGFBR3;LAMTOR2;MAP3K10;EPHB2;PER1;FGFR1;FKBP8;ERBB2;EIF2AK4;STK32B;UNC119;FRS3;CAMKK1;IKBKB
11360,GO:0045746,0.075248109220841,0.971036990974321,7,32,negative regulation of Notch signaling pathway,BP,EGFR;ARRDC1;PEAR1;NEURL1;CHAC1;EGFL7;BCL6
8993,GO:0035162,0.0753905782302904,0.981138252310061,4,14,embryonic hemopoiesis,BP,VEGFA;ZFPM1;TGFBR2;SH2B3
10501,GO:0043433,0.075755443033251,0.954593495720922,20,121,negative regulation of DNA binding transcription factor activity,BP,CTNNBIP1;RBCK1;PRNP;DDIT3;MXI1;MDFI;NLRX1;PKD2;THRA;PKD1;TMSB4X;DAP;BHLHE40;CDK5RAP3;GAS6;MAP2K5;CAT;MAP3K10;WFS1;EIF2AK4
3282,GO:0006972,0.0758698770892264,0.980976464212867,4,14,hyperosmotic response,BP,PKN1;ERRFI1;ARHGEF2;TRPV4
3525,GO:0007507,0.0759396063105536,0.944048991434518,52,354,heart development,BP,DUSP6;NFATC4;ADAM19;PDCD4;VEGFA;EGFR;IFT140;MEF2D;ZFP36L1;GAA;TFDP2;OBSL1;MAP2K1;SHC1;VEGFB;MYH11;PAK1;ACVR2B;EPOR;LTBP1;PPARA;TCF25;PKD2;ACACB;MAPK3;VANGL2;ZFPM1;MOSPD3;PKD1;TTN;PSKH1;NEK8;TGFBR2;FOXL1;APLN;RXRA;IFT57;LMNA;INSR;TENM4;MAP2K5;TP73;SNX17;TAZ;LEMD2;PLXND1;TGFBR3;EDNRA;FGFR1;ERBB2;TNNI1;TEAD2
15985,GO:0086023,0.0760865988394287,0.993318154172676,2,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1;ATP2B4
9449,GO:0036066,0.0762257921602041,0.980856073360157,4,14,protein O-linked fucosylation,BP,ADAMTS7;ADAMTS13;ADAMTSL1;MFNG
11559,GO:0046133,0.0762601469398334,0.986038331082119,3,9,pyrimidine ribonucleoside catabolic process,BP,APOBEC3C;APOBEC3F;UPP1
11224,GO:0045428,0.0765211152095441,0.970429274151983,7,32,regulation of nitric oxide biosynthetic process,BP,ACP5;PKD2;TRPV1;ATP2B4;AKT1;ASS1;INSR
12752,GO:0051051,0.0766091919108097,0.946234678891416,39,263,negative regulation of transport,BP,DLG4;F2R;SERPINE2;NTSR1;HADH;ANK3;IDH2;NOS1;MCTP1;STK39;GSTO1;PKD2;LRSAM1;DMTN;ATF4;GSTM2;RHBDF1;WNK4;PCSK9;TMSB4X;ANO9;PDE2A;NOS3;PROM2;RHBDF2;GAS6;BCR;MAPKBP1;AKT1;BRAF;ASIC1;SNX33;ADA;CIDEA;EPHB2;UNC119;PFKL;GRB10;PNKD
1604,GO:0004029,0.0766432492527293,0.980714593392315,4,14,aldehyde dehydrogenase (NAD) activity,MF,ALDH7A1;ALDH4A1;ALDH1L2;ALDH1L1
11600,GO:0046323,0.0766506393037165,0.964285320233392,10,51,glucose import,BP,CLTCL1;PRKCZ;PAK1;NGFR;SESN2;PIK3R2;AKT1;INSR;RTN2;GRB10
5269,GO:0015923,0.0766911258370533,0.980698348842373,4,14,mannosidase activity,MF,EDEM1;MAN2C1;MAN2B1;MAN1B1
4698,GO:0010863,0.0768868803856951,0.980631889148806,4,14,positive regulation of phospholipase C activity,BP,EGFR;PTAFR;EDNRA;FGFR1
19843,GO:2000352,0.0769333415529411,0.980616105888913,4,14,negative regulation of endothelial cell apoptotic process,BP,SEMA5A;ANGPTL4;GAS6;BRAF
3219,GO:0006869,0.0769582351293038,0.948436076496653,31,201,lipid transport,BP,APOE;OSBPL5;LRP1;NTSR1;SLC27A1;CPT2;PITPNM3;ABCA2;PITPNM1;PITPNC1;ABCA7;NME4;PLA2G6;ABCG1;ESYT2;PPARA;ACACB;OSBPL10;SORL1;PLTP;VLDLR;PCSK9;ANO9;APOL4;RXRA;AKT1;ATP8B2;OSBPL1A;STARD10;ESYT3;SLC10A6
3254,GO:0006921,0.0771391077325681,0.972901301526857,6,26,cellular component disassembly involved in execution phase of apoptosis,BP,H1F0;ENDOG;CDK5RAP3;SHARPIN;DNASE2;CIDEA
17723,GO:1901699,0.0772268624689086,0.941345750793799,63,445,cellular response to nitrogen compound,BP,EGR1;LRP1;EGFR;PRNP;RAPGEF3;ZFP36L1;MAPK13;UROS;MAP2K1;PCK2;COL6A1;TMEM173;SHC1;PRKCZ;PAK1;NEURL1;NGFR;PTPRE;SESN2;IMPACT;PKD2;STAT6;VAMP2;MAPK3;ERRFI1;ARHGEF2;MAP2K2;DMTN;ATF4;SSH1;FLOT1;HDAC5;SRSF5;GSTM2;CEBPB;PCSK9;DNMT3A;PDE2A;TRIB3;AGO4;TRPV1;PIK3R2;PTAFR;ADCY6;ATP2B4;AKT1;ITPR2;TCIRG1;CAPN2;INSR;FOXO4;GPR21;JAK3;CHRM3;APRT;FYN;SIRT2;RECQL5;RAB13;HDAC8;EIF4EBP1;LAMTOR2;GRB10
14482,GO:0062014,0.0773090830758511,0.960950651556637,12,65,negative regulation of small molecule metabolic process,BP,APOE;CYP27B1;DDIT4;PPARA;ACACB;MLXIPL;LTB4R2;GABBR1;TRIB3;ATP2B4;AKT1;ACADVL
12569,GO:0050769,0.0774563928330411,0.944398797464771,44,298,positive regulation of neurogenesis,BP,DLG4;APOE;ZMYND8;SERPINE2;PTK6;GJC2;TIMP2;VEGFA;SHANK2;CRTC1;CNTN1;OBSL1;CUL7;MAP2K1;CAPRIN2;PAK1;PLXNB3;FBXW8;NEURL1;NGFR;ETV5;PLXNB1;LPAR3;IMPACT;SEMA5A;RGS14;ARHGEF2;TWF2;KDM4C;METRN;VLDLR;HMG20B;CAMK1;WNT3;TENM4;BRAF;TP73;CSNK1E;BCL6;FYN;PLXND1;EPHB2;FGFR1;KCTD11
16501,GO:0097242,0.0774662753035819,0.980434804782047,4,14,amyloid-beta clearance,BP,APOE;LRP1;ABCA7;INSR
4782,GO:0010976,0.0775172839045602,0.948788191490149,29,186,positive regulation of neuron projection development,BP,DLG4;APOE;ZMYND8;PTK6;VEGFA;SHANK2;CRTC1;CNTN1;OBSL1;CUL7;MAP2K1;CAPRIN2;PAK1;PLXNB3;FBXW8;NEURL1;NGFR;PLXNB1;LPAR3;SEMA5A;TWF2;METRN;VLDLR;CAMK1;WNT3;BRAF;FYN;PLXND1;FGFR1
11633,GO:0046390,0.0775418284336476,0.948751585702056,29,188,ribose phosphate biosynthetic process,BP,APOE;TIMP2;NOS1;PGM1;PYGL;DHTKD1;DDIT4;OGDHL;NPR2;NME4;PPCS;PPARA;MLXIPL;PTHLH;LTB4R2;GALK1;GABBR1;ACOT7;ALDOC;TMSB4X;NOS3;UCKL1;ADCY6;TCIRG1;UPP1;INSR;APRT;TAZ;PFKL
11265,GO:0045596,0.077616995314195,0.941574723365308,59,417,negative regulation of cell differentiation,BP,XDH;PTPRS;APOE;NFATC4;POSTN;SEMA4B;LRP1;PDCD4;EGFR;FBLN1;ADAMTS7;IDH2;DDIT3;ZFP36L1;EFNB3;ULK2;WWTR1;SYNGAP1;PAK1;NPR2;SEMA3F;NGFR;TRIB2;EREG;ABCG1;PPARA;AREG;SEMA5A;ARHGEF2;INPP5D;DMTN;SEMA3B;PTHLH;ZFPM1;JDP2;HDAC5;SORL1;LRP5;TRPV4;TRIB3;WNT7A;TRPV1;SEMA4G;NBR1;ADCY6;DGUOK;WNT3;FOXO4;LGALS1;JAK3;TP73;BCL6;SIRT2;HDAC8;EPHB2;ERBB2;EIF2AK4;HLA-G;KCTD11
14698,GO:0070374,0.0776545669998404,0.953997775406092,19,114,positive regulation of ERK1 and ERK2 cascade,BP,F2R;EGFR;MST1R;MAP2K1;SHC1;SPRY2;PRKCZ;ABCA7;FGFR3;MAPK3;TRPV4;EPHA1;GAS6;FGFR4;INSR;BRAF;EPHB2;FGFR1;ERBB2
16879,GO:0098868,0.0776718535903888,0.980364741084282,4,14,bone growth,BP,THBS3;EVC;FGFR3;TGFBR2
11583,GO:0046209,0.077728700488558,0.965426803501184,9,45,nitric oxide metabolic process,BP,ACP5;NOS1;PKD2;NOS3;TRPV1;ATP2B4;AKT1;ASS1;INSR
17676,GO:1901611,0.0779308385800594,0.985599196303082,3,9,phosphatidylglycerol binding,MF,PITPNC1;NME4;PLTP
4748,GO:0010927,0.0779912213972669,0.960768057688804,12,60,cellular component assembly involved in morphogenesis,BP,OBSCN;CD9;OBSL1;MYH11;MYH3;TTN;RFX2;TNNT1;TMOD2;TBC1D20;KRT19;TENM4
15795,GO:0072523,0.0780986618975748,0.967235268509598,8,39,purine-containing compound catabolic process,BP,XDH;NT5E;RAPGEF3;DNPH1;NT5C1B;PDE2A;ADA;NUDT18
606,GO:0001775,0.0782283133086782,0.936140866139877,115,861,cell activation,BP,F2R;APOE;SERPINE2;IL20RB;GSN;PYGB;EGR1;SLC2A3;NAPRT;LRP1;TIMP2;EGFR;PRNP;ERCC1;DGKA;CD9;CST3;PGM1;NDRG1;ADAMTS13;ZFP36L1;GAA;PYGL;EFNB3;SOX13;PRSS3;SYNGR1;PKN1;DNASE1L1;DGKQ;TMEM173;BLOC1S4;CD68;ITPR3;PRKCZ;PAK1;BRI3;ZP3;CCDC88B;RAG1;ACTR1B;TMC6;S100A13;SATB1;STAT6;VAMP2;KCNAB2;MAPK3;RHOF;CTSB;LTA4H;PI4K2A;INPP5D;PDCD1LG2;DMTN;LRRC8A;ZFPM1;DOCK11;POLM;FUCA1;HDAC5;CEBPB;ALDOC;TGFBR2;CMTM7;NOS3;HEXB;WNT7A;TRPV1;GAS6;BCR;NBEAL2;KIF13B;PTAFR;CTSH;TNFRSF14;AKT1;ITPR2;CARD11;IGFBP2;TCIRG1;ARSA;MAN2B1;PLAU;ULBP1;BRAF;CAT;DPP7;YPEL5;LGALS1;TIMP1;HFE;JAK3;APRT;METTL7A;HGSNAT;BCL6;FYN;TOM1;ADA;POU2F2;ENTPD2;AP2A2;MYO18A;TCF7;VAV3;GALNS;LAMTOR2;MFNG;DHPS;ERBB2;EIF2AK4;PAG1;PFKL;HLA-G
15260,GO:0071470,0.0782811040691024,0.972393264129098,6,26,cellular response to osmotic stress,BP,ZFP36L1;STK39;PKD2;ERRFI1;ARHGEF2;TRPV4
3550,GO:0007588,0.0783150212685537,0.975805498700583,5,20,excretion,BP,SLC22A18;MDK;KCNMA1;AQP3;TRPV1
13642,GO:0060191,0.0784895860264457,0.965019150502149,9,45,regulation of lipase activity,BP,LMF1;LRP1;EGFR;PRKCZ;FGFR3;ANGPTL4;PTAFR;EDNRA;FGFR1
4294,GO:0009743,0.0787364282236807,0.950719566547969,23,144,response to carbohydrate,BP,EGR1;GLUL;NR1D1;ERCC1;CST3;ZFP36L1;MAPK13;PCK2;ACVR2B;PLA2G6;ANO1;SESN2;VAMP2;MLXIPL;ENDOG;LRP5;TGFBR2;GAS6;ERN1;CAT;LGALS1;ITGA2;PFKL
12933,GO:0051339,0.0788306091273217,0.975598417604582,5,20,regulation of lyase activity,BP,TIMP2;NOS1;LTB4R2;GABBR1;NOS3
3531,GO:0007520,0.0788436527896603,0.975593172945689,5,20,myoblast fusion,BP,NOS1;FLOT1;CAPN2;MYOF;GDF15
19506,GO:1990440,0.0788674561186303,0.985351090205697,3,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,DDIT3;ATF4;CEBPB
16629,GO:0097531,0.0789930109494829,0.985317726880303,3,9,mast cell migration,BP,PGF;VEGFA;VEGFB
4487,GO:0010517,0.0790163715473356,0.969230310611787,7,32,regulation of phospholipase activity,BP,LRP1;EGFR;PRKCZ;FGFR3;PTAFR;EDNRA;FGFR1
2981,GO:0006527,0.0790492108946761,0.985302785050182,3,9,arginine catabolic process,BP,NOS1;NOS3;ATP2B4
10381,GO:0043230,0.0793776995270039,0.931034955199338,257,2038,extracellular organelle,CC,PTPRS;ACTA2;HTRA1;GAMT;NT5E;APOE;SYTL1;XPC;SERPINE2;S100A6;GSN;PYGB;ALDH7A1;SLC2A3;FBXO2;ACP5;THSD4;NAPRT;GLUL;GPX3;ALOX15B;TIMP2;PRNP;ZDHHC1;FBLN1;SLC7A8;S100A4;PRDX5;RAPGEF3;BPHL;CLTCL1;TSPAN1;KRT15;CD9;IDH2;CST3;DNM1;DNPH1;PGM1;NDRG1;GGT1;FCGBP;ARRDC1;HEBP1;B3GAT3;RBL2;PHGDH;ARHGAP23;GAA;PYGL;CNTN1;PLAT;LTBP4;CTSF;REEP2;PLD3;PRSS3;HYAL1;NAGLU;MAP2K1;PCK2;COL6A1;PPL;CRYL1;PGLS;CAPG;H2AFJ;TOM1L2;DNASE1L1;AKR7A2;SNX9;FAM213A;MAGEF1;ARL2;MARCKSL1;HDAC11;RAB3B;MYH11;CYBRD1;LAMA5;APPL2;PRSS8;PRKCZ;GALE;SERPING1;SLC37A2;AARS;PABPC1L;BLVRB;SEC14L2;ITGB4;CEP250;ABHD14B;NID1;ETFB;GSTO1;WDR60;MUC19;PPCS;ACTR1B;CHD2;PSAT1;SPG11;TMC6;DHRS4;TMED4;CES3;OAF;S100A13;GSTT1;C5;ANO1;SNX29;BLMH;PKD2;ACOT11;VAMP2;COL8A1;ECM1;B4GAT1;PCLO;JADE2;MAPK3;CSPG4;ITGB5;LAMB2;SEMA5A;FAM20C;DYSF;RHOF;LTBP2;CTSB;MXRA8;MVB12B;MYH3;LTA4H;KIAA0319L;CHMP1B;C1RL;PLCD1;MTMR11;PDCD1LG2;TWF2;SEMA3B;PROCR;PKD1;FUCA1;FLOT1;LTBP3;TTN;KCNMA1;SORL1;GALK1;NTPCR;GSTM2;GPRC5C;ACY1;PTGR2;ACOT7;ALDOC;EPN3;MARK3;ITGA1;ALDH1L2;MINK1;HEXB;PROM2;WNT7A;GAS6;CROCC;BCR;NBR1;HEXA;BCAM;TTYH3;RAB43;SLC9A3R2;EFEMP2;CTSH;UACA;GSTO2;ENTPD6;IGFBP7;CARD11;LAMB1;GAREM2;IGFBP2;ASS1;CAPS;TSG101;KIF27;TMEM256;RASSF9;HAGH;NUCB2;DNASE2;CHMP5;ARSA;CAPN2;ARMC9;MAN2B1;RAB25;PLAU;INSR;WNT3;KRT19;GNAL;CHMP4C;TNXB;MBLAC2;ITGB6;CTDSPL;ALDH1L1;CAT;MYOF;DPP7;LGALS1;TIMP1;SCNN1A;TUBGCP6;APRT;MPI;METTL7A;SAT2;GSTM3;TKFC;EPS8L1;PEX1;UBXN6;GDF15;RAB13;OSBPL1A;TOM1;TST;CADM4;RHOBTB3;NAGA;ENTPD2;EPS8L2;ADIRF;ERV3-1;TGFBR3;RNPEP;VAV3;MAN1B1;GALNS;LAMTOR2;BLOC1S1;CTH;PLLP;PFKL;CORO1B;RPL12;BSG;LYPLAL1;TMEM8A;ROBO4
18437,GO:1903561,0.0793776995270039,0.931034955199338,257,2038,extracellular vesicle,CC,PTPRS;ACTA2;HTRA1;GAMT;NT5E;APOE;SYTL1;XPC;SERPINE2;S100A6;GSN;PYGB;ALDH7A1;SLC2A3;FBXO2;ACP5;THSD4;NAPRT;GLUL;GPX3;ALOX15B;TIMP2;PRNP;ZDHHC1;FBLN1;SLC7A8;S100A4;PRDX5;RAPGEF3;BPHL;CLTCL1;TSPAN1;KRT15;CD9;IDH2;CST3;DNM1;DNPH1;PGM1;NDRG1;GGT1;FCGBP;ARRDC1;HEBP1;B3GAT3;RBL2;PHGDH;ARHGAP23;GAA;PYGL;CNTN1;PLAT;LTBP4;CTSF;REEP2;PLD3;PRSS3;HYAL1;NAGLU;MAP2K1;PCK2;COL6A1;PPL;CRYL1;PGLS;CAPG;H2AFJ;TOM1L2;DNASE1L1;AKR7A2;SNX9;FAM213A;MAGEF1;ARL2;MARCKSL1;HDAC11;RAB3B;MYH11;CYBRD1;LAMA5;APPL2;PRSS8;PRKCZ;GALE;SERPING1;SLC37A2;AARS;PABPC1L;BLVRB;SEC14L2;ITGB4;CEP250;ABHD14B;NID1;ETFB;GSTO1;WDR60;MUC19;PPCS;ACTR1B;CHD2;PSAT1;SPG11;TMC6;DHRS4;TMED4;CES3;OAF;S100A13;GSTT1;C5;ANO1;SNX29;BLMH;PKD2;ACOT11;VAMP2;COL8A1;ECM1;B4GAT1;PCLO;JADE2;MAPK3;CSPG4;ITGB5;LAMB2;SEMA5A;FAM20C;DYSF;RHOF;LTBP2;CTSB;MXRA8;MVB12B;MYH3;LTA4H;KIAA0319L;CHMP1B;C1RL;PLCD1;MTMR11;PDCD1LG2;TWF2;SEMA3B;PROCR;PKD1;FUCA1;FLOT1;LTBP3;TTN;KCNMA1;SORL1;GALK1;NTPCR;GSTM2;GPRC5C;ACY1;PTGR2;ACOT7;ALDOC;EPN3;MARK3;ITGA1;ALDH1L2;MINK1;HEXB;PROM2;WNT7A;GAS6;CROCC;BCR;NBR1;HEXA;BCAM;TTYH3;RAB43;SLC9A3R2;EFEMP2;CTSH;UACA;GSTO2;ENTPD6;IGFBP7;CARD11;LAMB1;GAREM2;IGFBP2;ASS1;CAPS;TSG101;KIF27;TMEM256;RASSF9;HAGH;NUCB2;DNASE2;CHMP5;ARSA;CAPN2;ARMC9;MAN2B1;RAB25;PLAU;INSR;WNT3;KRT19;GNAL;CHMP4C;TNXB;MBLAC2;ITGB6;CTDSPL;ALDH1L1;CAT;MYOF;DPP7;LGALS1;TIMP1;SCNN1A;TUBGCP6;APRT;MPI;METTL7A;SAT2;GSTM3;TKFC;EPS8L1;PEX1;UBXN6;GDF15;RAB13;OSBPL1A;TOM1;TST;CADM4;RHOBTB3;NAGA;ENTPD2;EPS8L2;ADIRF;ERV3-1;TGFBR3;RNPEP;VAV3;MAN1B1;GALNS;LAMTOR2;BLOC1S1;CTH;PLLP;PFKL;CORO1B;RPL12;BSG;LYPLAL1;TMEM8A;ROBO4
2619,GO:0005938,0.0794113887200337,0.945587535893949,34,223,cell cortex,CC,DLG4;GSN;WIPF1;RAPGEF3;SPTB;GPSM1;EXOC2;FAM110C;PRKCZ;SHROOM4;RHOBTB2;PKD2;SEPT5;PCLO;MYZAP;RHOF;SEPT10;SAMD3;DMTN;FLOT1;TRIOBP;TRPV4;RIMS3;ITPR2;SEPT6;CAPN2;KRT19;ADD3;HFE;SPIRE1;RHOBTB3;SEPT8;HIP1;PLEKHH2
8876,GO:0034705,0.079440543264073,0.96902548544285,7,32,potassium channel complex,CC,DLG4;KCNG1;VAMP2;KCNC4;KCNAB2;KCNMA1;STX1A
6619,GO:0022857,0.0795659003223365,0.938124070506792,74,534,transmembrane transporter activity,MF,DLG4;KCNG1;S100A6;SLC2A3;GJC2;SCN8A;SLC7A8;SLC16A3;SLC2A9;CLCA2;SCN4B;ORAI3;SLC27A1;SLC16A5;ABCA2;SLC43A1;SLC12A7;ITPR3;ABCA7;SLC37A2;NDUFA4L2;TMEM44;ORAI2;DLG3;SLCO4A1;ANO8;ABCG1;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;SLC22A18;PQLC2;SLC50A1;SLC48A1;LRRC8A;SV2A;SLC38A10;PKD1;SLC29A4;KCNMA1;AZIN2;TMEM175;AQP3;TRPV4;ANO9;PDE2A;TRPV1;GAS6;ATP7B;MFSD3;TTYH3;ATP2B4;ITPR2;SLC6A9;TCIRG1;SLC6A6;TMEM63C;SLC25A29;SLC22A15;TPCN1;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC37A4;SLC38A2;SLC25A42;TRPC1;SLC39A11;SLC10A6;BSG;SLC9A5
3240,GO:0006898,0.0795691887845225,0.948600839434882,26,165,receptor-mediated endocytosis,BP,DLG4;APOE;LRP1;VEGFA;CLTCL1;FCHO1;CD9;DNM1;ARAP3;SNX9;SCART1;SCARA3;FLOT1;SORL1;VLDLR;PCSK9;TGFBR2;APLN;DNAJC6;ARHGAP27;HFE;SNX17;SNX1;AP2A2;UNC119;HIP1
595,GO:0001763,0.0798062959122905,0.950577778184786,22,135,morphogenesis of a branching structure,BP,NFATC4;CTNNBIP1;PGF;VEGFA;COL13A1;SPRY2;LAMA5;PAK1;ETV5;WNT2B;PKD2;AREG;VANGL2;PKD1;LRP5;TGFBR2;RXRA;CTSH;CELSR1;PLXND1;EDNRA;FGFR1
16786,GO:0098661,0.0798074893500404,0.964310935788989,9,45,inorganic anion transmembrane transport,BP,PRNP;CLCA2;SLC12A7;SLC37A2;ANO1;ANO9;TTYH3;PTAFR;SLC37A4
7042,GO:0030825,0.0799686879121389,0.985057624911281,3,9,positive regulation of cGMP metabolic process,BP,APOE;NOS1;NOS3
8359,GO:0033267,0.0800623000878812,0.944462006527331,36,239,axon part,CC,DLG4;ADGRL1;GLUL;GJC2;TIMP2;NTSR1;SCN8A;ANK3;DNM1;SHANK2;SYNGR1;BLOC1S4;PRKCZ;BLVRB;ORAI2;DLG3;SEPT5;KCNC4;KCNAB2;TWF2;STMN3;KIF21B;SSH1;SV2A;TENM2;MAP3K12;TRPV4;KIF13B;MICAL1;SEPT6;TMOD2;C9ORF72;CHRM3;SIRT2;ITGA2;BLOC1S1
7046,GO:0030833,0.0802318199756879,0.952249926638193,19,115,regulation of actin filament polymerization,BP,GSN;WIPF1;CDC42EP5;SPTB;ARPIN;CAPG;PLEKHG2;TWF2;DMTN;WHAMMP3;TRIOBP;TMSB4X;TMOD2;FCHSD1;SPIRE1;EPS8L1;EPS8L2;C15ORF62;CORO1B
17023,GO:0099528,0.0804662947516366,0.984924399407341,3,9,G-protein coupled neurotransmitter receptor activity,MF,HTR7;GABBR1;CHRM3
784,GO:0002043,0.080479165567816,0.984920948372004,3,9,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA;NGFR;SEMA5A
14181,GO:0061138,0.0806340498554539,0.950624717497275,21,128,morphogenesis of a branching epithelium,BP,NFATC4;CTNNBIP1;PGF;VEGFA;SPRY2;LAMA5;PAK1;ETV5;WNT2B;PKD2;AREG;VANGL2;PKD1;LRP5;TGFBR2;RXRA;CTSH;CELSR1;PLXND1;EDNRA;FGFR1
12943,GO:0051349,0.0807143581665093,0.984857841249919,3,9,positive regulation of lyase activity,BP,TIMP2;NOS1;NOS3
9476,GO:0036126,0.0807444061737953,0.965876782059784,8,39,sperm flagellum,CC,DNAH1;IFT27;ATP2B4;SEPT6;CABYR;GSTM3;SPATA6;TCTEX1D4
16698,GO:0097729,0.0807444061737953,0.965876782059784,8,39,9+2 motile cilium,CC,DNAH1;IFT27;ATP2B4;SEPT6;CABYR;GSTM3;SPATA6;TCTEX1D4
14978,GO:0070932,0.0807640648881562,0.974817901043889,5,20,histone H3 deacetylation,BP,HDAC11;HDAC5;SIRT2;HDAC8;PER1
5844,GO:0017145,0.080877747760477,0.971230039503355,6,26,stem cell division,BP,WWTR1;ETV5;VANGL2;ARHGEF2;WNT7A;FGFR1
18675,GO:1904063,0.0809681107477413,0.965761411256256,8,39,negative regulation of cation transmembrane transport,BP,NTSR1;ANK3;STK39;GSTO1;PKD2;GSTM2;PCSK9;EPHB2
18169,GO:1902969,0.0810484028041669,0.984768062753363,3,9,mitotic DNA replication,BP,CHEK2;BCL6;FGFR1
10800,GO:0044306,0.0810493300439756,0.956251999396989,14,79,neuron projection terminus,CC,DLG4;GLUL;NTSR1;SYNGR1;BLVRB;VAMP2;SEPT5;KCNC4;KCNAB2;SV2A;MICAL1;SEPT6;CHRM3;ITGA2
16430,GO:0097120,0.0810494703153795,0.974702158882687,5,20,receptor localization to synapse,BP,DLG4;DLG3;KIF17;CEP112;ARHGAP44
13813,GO:0060439,0.0810794520900407,0.984759709113277,3,9,trachea morphogenesis,BP,MAP2K1;MAPK3;TGFBR2
8293,GO:0033138,0.0811651345124978,0.960071475037783,11,59,positive regulation of peptidyl-serine phosphorylation,BP,VEGFA;EGFR;RAPGEF3;SPRY2;CAPRIN2;PAK1;GAS6;CAMK1;ATP2B4;AKT1;BRAF
17162,GO:0106003,0.0811871238177311,0.984730729074955,3,9,amyloid-beta complex,CC,APOE;PRNP;INSR
9675,GO:0038083,0.0812802799168708,0.968133742495573,7,32,peptidyl-tyrosine autophosphorylation,BP,PTK6;VEGFA;EGFR;MAPK3;INSR;JAK3;FYN
4466,GO:0010466,0.0816638982283815,0.949227460305272,22,139,negative regulation of peptidase activity,BP,TNFRSF6B;SERPINE2;TIMP2;VEGFA;PRDX5;TFPI2;CST3;SERPING1;RAG1;NGFR;C5;ECM1;IFI6;SORL1;HERPUD1;PAPLN;GAS6;AKT1;MICAL1;HMSD;MAP2K5;TIMP1
14953,GO:0070887,0.0816827721087576,0.928799683085602,268,2112,cellular response to chemical stimulus,BP,TNIP1;XDH;DUSP6;HTRA1;DOCK4;BBS2;TNFRSF6B;APOE;NFATC4;FOS;PRODH;IL20RB;GSN;EGR1;PGF;FGFBP1;POSTN;PTK6;EDEM1;FAM210B;GPX3;LRP1;PDCD4;VEGFA;EGFR;RBCK1;PRNP;NR1D1;ADAMTS7;PRDX5;ANK3;RAPGEF3;BPHL;TNFSF15;CST3;NOS1;DDIT3;NDRG1;GGT1;ADAMTS13;MMP28;MST1R;ZFP36L1;HBEGF;MMP1;PYCR2;CTF1;CYP3A5;RPL13A;LTBP4;SLC27A1;MAPK13;KLF9;RNF165;CUL7;UROS;HYAL1;PPP1R14A;TXNRD3;SYNGR1;MAP2K1;CYP27B1;PCK2;COL6A1;DDIT4;ITGA6;AKR7A2;TMEM173;PLEKHG5;FAM213A;SHC1;SPRY2;VEGFB;CD68;LAMA5;PRKCZ;PAK1;FGFR3;KDM3A;GLDC;NPR2;PLXNB3;SPRY4;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;ETV5;GSTO1;LTBP1;EREG;PTPRE;TNFRSF25;PLA2G6;CES3;CARF;GSTT1;MTMR4;C5;PPARA;ANO1;SESN2;AIP;MKNK2;RASA4;IMPACT;PKD2;STAT6;VAMP2;HMGA2;SLIT3;ECM1;MAPK3;ITGB5;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;FAM20C;LTBP2;CTSB;MAPK12;PAQR6;MLXIPL;IFNGR2;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;TWF2;DMTN;LITAF;ATF4;SSH1;IFI6;FLOT1;HDAC5;IRF5;IL17RD;HERPUD1;SRSF5;GSTM2;SULF2;CES2;ACY1;RFX2;ENDOG;CEBPB;LRP5;CREBRF;PCSK9;FBXL15;AQP3;ISG20;DNMT3A;TGFBR2;TRPV4;ITGA1;IL17RE;TMSB4X;MAP1LC3A;PDE2A;SMURF2;APLN;TRIB3;CALCOCO1;EDA;CDK5RAP3;NOS3;AGO4;WNT7A;TRPV1;BNIP3L;PIK3R2;SHARPIN;CCS;GAS6;ERN1;BCR;TADA3;SPAG16;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ADCY6;RAB43;ATP2B4;CTSH;TNFRSF14;MGMT;GSTO2;ASNS;AKT1;IGFBP7;ITPR2;CDKN1C;CRY2;CHEK2;IGFBP2;IL17RC;FGFR4;TCIRG1;ACADVL;LMNA;CAPN2;IFI27;INSR;WNT3;NCOA7;CKLF;FOXO4;RPS6KA5;ANKZF1;TXNRD2;LYST;MAP2K5;BRAF;EDA2R;GPR21;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;JAK3;CHRM3;APRT;BCL6;GSTM3;FYN;LEMD2;SIRT2;GDF15;RECQL5;RAB13;CIDEA;HDAC8;ADIRF;EIF4EBP1;TGFBR3;TCF7;VAV3;STX1A;EPAS1;LAMTOR2;CHD6;PER1;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;HLA-G;CORO1B;FRS3;NET1;GRB10;CREB3L4;IKBKB;TEAD2
16598,GO:0097479,0.081894245479824,0.955724289941611,14,79,synaptic vesicle localization,BP,SYTL1;SNPH;DNM1;SYT8;BLOC1S4;NLGN2;SPG11;VAMP2;SEPT5;PCLO;RIMS3;BRAF;STX1A;BLOC1S1
6762,GO:0030204,0.0820231013644857,0.970713431820175,6,26,chondroitin sulfate metabolic process,BP,B3GAT3;HYAL1;CSPG4;HEXB;HEXA;XYLT2
13059,GO:0051592,0.0820765717688185,0.95465305668864,15,82,response to calcium ion,BP,FOS;EGFR;ITPR3;CARF;RASA4;PKD2;DMTN;TTN;KCNMA1;ENDOG;AQP3;SPAG16;ENTPD6;BRAF;TRPC1
4201,GO:0009313,0.0822158179382059,0.984452951856479,3,9,oligosaccharide catabolic process,BP,HEXB;MAN2C1;MAN2B1
6094,GO:0019318,0.0822158396340684,0.946218781727656,27,173,hexose metabolic process,BP,H6PD;NR1D1;IGFBP4;PGM1;GAA;NISCH;MLYCD;PCK2;DGKQ;GALE;PPARA;ACACB;PC;ATF4;FUCA1;GALK1;LRP5;ALDOC;MAN2C1;AKT1;MAN2B1;INSR;MPI;TKFC;SLC37A4;PHLDA2;PFKL
12487,GO:0050651,0.0822200278264515,0.984451811713922,3,9,dermatan sulfate proteoglycan biosynthetic process,BP,B3GAT3;CSPG4;UST
9974,GO:0042398,0.0822222790664302,0.967569661347877,7,33,cellular modified amino acid biosynthetic process,BP,GAMT;ALDH7A1;GGT1;SLC27A1;OPLAH;CHAC1;HAGH
5514,GO:0016485,0.0822271812296994,0.947703328645346,24,152,protein processing,BP,SERPINE2;GSN;TYSND1;PRNP;GGT1;ADAMTS13;PLAT;PRSS3;PCSK1;SERPING1;ERO1B;SPPL2B;C5;PLGRKT;CHAC1;RHBDF1;PCSK9;LONP2;RHBDF2;GAS6;CTSH;CAPN2;PLAU;CIDEB
13632,GO:0060170,0.082238407774466,0.962997590565294,9,45,ciliary membrane,CC,BBS2;SHANK2;EVC;BBS1;PKD2;PKD1;PROM2;SCNN1A;EHD3
11603,GO:0046326,0.0823430030334458,0.970568759599545,6,26,positive regulation of glucose import,BP,CLTCL1;PRKCZ;PAK1;PIK3R2;AKT1;INSR
17417,GO:1900221,0.0824391058498575,0.984392442309267,3,9,regulation of amyloid-beta clearance,BP,APOE;LRP1;ABCA7
13578,GO:0060074,0.0825241024821119,0.984369388640829,3,9,synapse maturation,BP,NFATC4;ADGRL1;NEURL1
20241,GO:2001239,0.082590295962896,0.967389554178056,7,33,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6;UNC5B;STRADB;AKT1;MAP2K5;FYN;FGFR1
4636,GO:0010763,0.0826109436561775,0.984345823211977,3,9,positive regulation of fibroblast migration,BP,PAK1;DMTN;AKT1
19456,GO:1990253,0.0827103080063596,0.984318845255183,3,9,cellular response to leucine starvation,BP,SESN2;IMPACT;EIF2AK4
12368,GO:0048813,0.0828085005044929,0.952156749487563,17,100,dendrite morphogenesis,BP,DLG4;NFATC4;SHANK2;OBSL1;CUL7;CAPRIN2;FBXW8;KLF7;SDC2;MAP6;VLDLR;MINK1;WNT7A;FARP1;ARHGAP44;FYN;EPHB2
3458,GO:0007274,0.0831833569317528,0.984190202181133,3,9,neuromuscular synaptic transmission,BP,ADARB1;ETV5;FCHSD1
5710,GO:0016849,0.0832467178128462,0.984172945485251,3,9,phosphorus-oxygen lyase activity,MF,NPR2;ADCY6;TKFC
12361,GO:0048788,0.0832498566725399,0.992289257964362,2,4,cytoskeleton of presynaptic active zone,CC,PCLO;RIMS3
17045,GO:0099569,0.0832498566725399,0.992289257964362,2,4,presynaptic cytoskeleton,CC,PCLO;RIMS3
8174,GO:0032922,0.0834157972686182,0.962358251811785,9,45,circadian regulation of gene expression,BP,NR1D1;NGFR;PPARA;ATF4;BHLHE40;CRY2;CSNK1E;MTA1;PER1
2462,GO:0005677,0.0834221141992967,0.984125143220223,3,9,chromatin silencing complex,CC,BAHCC1;TNRC18;SIRT2
2289,GO:0005248,0.0835051230271426,0.984102503705169,3,9,voltage-gated sodium channel activity,MF,SCN8A;SCN4B;PKD2
18947,GO:1904754,0.0837052491454158,0.984047878728664,3,9,positive regulation of vascular associated smooth muscle cell migration,BP,DOCK4;PAK1;SSH1
5503,GO:0016459,0.0840527491345411,0.964546907379456,8,35,myosin complex,CC,MYH15;OBSL1;MYH11;SHROOM4;MYH3;MYH16;TTN;MYO18A
6065,GO:0019218,0.0840934368285842,0.954313391941943,14,80,regulation of steroid metabolic process,BP,APOE;EGR1;LMF1;NR1D1;CYP27B1;DGKQ;SEC14L2;ABCG1;ACACB;MVD;TM7SF2;IGFBP7;FGFR4;ACADVL
4362,GO:0009975,0.0841004336725291,0.983939832288818,3,9,cyclase activity,MF,NPR2;ADCY6;TKFC
14695,GO:0070371,0.0842153705511465,0.944301634774591,28,181,ERK1 and ERK2 cascade,BP,TNIP1;DUSP6;F2R;EGFR;FBLN1;MST1R;ZFP36L1;MAP2K1;SHC1;SPRY2;PRKCZ;ABCA7;FGFR3;SPRY4;MAPK3;ERRFI1;RGS14;MAP2K2;TRPV4;EPHA1;GAS6;CTSH;FGFR4;INSR;BRAF;EPHB2;FGFR1;ERBB2
7808,GO:0032370,0.0843348480690827,0.966532853058037,7,33,positive regulation of lipid transport,BP,APOE;LRP1;NTSR1;ABCA7;PLA2G6;ABCG1;PLTP
12668,GO:0050909,0.0845392477267342,0.977682461498225,4,15,sensory perception of taste,BP,REEP2;ITPR3;ASIC1;SCNN1A
19258,GO:1905517,0.0846905770609214,0.973019928807012,5,21,macrophage migration,BP,MMP28;C5;MAPK3;TRPV4;CKLF
12601,GO:0050810,0.0849401441558714,0.95635579406424,12,66,regulation of steroid biosynthetic process,BP,APOE;EGR1;NR1D1;CYP27B1;DGKQ;SEC14L2;ABCG1;ACACB;MVD;TM7SF2;IGFBP7;FGFR4
9034,GO:0035265,0.0850178854609636,0.951633627965796,16,93,organ growth,BP,DUSP6;THBS3;WWC3;EVC;SPRY2;PAK1;FGFR3;ACVR2B;ACACB;TGFBR2;RXRA;AKT1;TENM4;TP73;TGFBR3;FGFR1
17616,GO:1901379,0.0850506169411882,0.963642276183739,8,39,regulation of potassium ion transmembrane transport,BP,KCNG1;FHL1;PRNP;ANK3;STK39;VAMP2;KCNAB2;KLHL24
15732,GO:0072350,0.0850649491850158,0.966172898565933,7,33,tricarboxylic acid metabolic process,BP,IDH2;DHTKD1;OGDHL;SDHA;GLUD1;SUCLG2;ASS1
7263,GO:0031252,0.0852498328499505,0.938312611140044,44,300,cell leading edge,CC,ACTA2;S100A6;GSN;WIPF1;PTK6;RAPGEF3;PARVB;ARAP3;ARPIN;SNX9;PLEKHG5;SPRY2;PRKCZ;PAK1;ABCA7;SPRY4;ITGB4;ARHGEF4;RINL;PKD2;KCNC4;CSPG4;DYSF;PLEK2;ARHGEF2;TWF2;ATF4;SSH1;FRMD4B;FLOT1;TRPV4;PSD4;TRPV1;ASAP3;INSR;ARHGAP44;SCYL3;EPS8L1;SNX1;RAB13;PLXND1;EPS8L2;CORO1B;PLEKHH2
3589,GO:0008016,0.0853101018132423,0.949618400257466,18,108,regulation of heart contraction,BP,NOS1;SCN4B;HBEGF;GAA;ITPR3;NPR2;GSTO1;THRA;SNTA1;GSTM2;APLN;NOS3;ATP2B4;ITPR2;EHD3;TRPC1;ADA;EPAS1
11513,GO:0046058,0.0853208938770754,0.963501076162829,8,39,cAMP metabolic process,BP,TIMP2;RAPGEF3;PKD2;PTHLH;LTB4R2;GABBR1;PDE2A;ADCY6
13745,GO:0060349,0.0854853892868174,0.959267182640723,10,52,bone morphogenesis,BP,THBS3;ACP5;MEF2D;COL13A1;FGFR3;NAB2;LRP5;TGFBR2;TRPV4;PEX7
149,GO:0000305,0.0855540326020445,0.972661477858896,5,21,response to oxygen radical,BP,ERCC6;TXNRD3;NOS3;CCS;TXNRD2
3405,GO:0007189,0.0855770119682271,0.963367170393185,8,39,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;MC1R;ADM2;PTHLH;ADGRF1;ADCY6;ATP2B4;GNAL
17661,GO:1901567,0.0859526807343683,0.972495577731451,5,21,fatty acid derivative binding,MF,ACBD4;HMGCL;PNPLA3;ACOT7;ACADVL
2183,GO:0005041,0.0859741910613836,0.983424296577106,3,9,low-density lipoprotein particle receptor activity,MF,LRP1;SORL1;VLDLR
12635,GO:0050863,0.0860435079252673,0.942952876476209,28,182,regulation of T cell activation,BP,IL20RB;GSN;PRNP;EFNB3;SOX13;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;PDCD1LG2;CEBPB;TGFBR2;TNFRSF14;AKT1;CARD11;IGFBP2;BRAF;LGALS1;HFE;JAK3;BCL6;FYN;ADA;DHPS;ERBB2;PAG1;HLA-G
10631,GO:0043679,0.0862981367563637,0.955536514894244,12,66,axon terminus,CC,GLUL;NTSR1;SYNGR1;BLVRB;SEPT5;KCNC4;KCNAB2;SV2A;MICAL1;SEPT6;CHRM3;ITGA2
7350,GO:0031401,0.0865610696082914,0.929546018273389,106,789,positive regulation of protein modification process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;EGR1;PTK6;TIMP2;VEGFA;EGFR;PRNP;DUSP5;RAPGEF3;TNFSF15;IGFBP4;NOS1;ERCC6;MST1R;NUPR1;HBEGF;CTF1;CNTN1;SLC27A1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;PHF1;DLG3;NEURL1;ACVR2B;NGFR;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PKD2;AREG;MAPK3;CSPG4;VANGL2;ARHGEF2;MAP2K2;PAK6;PKD1;FLOT1;JDP2;VLDLR;MAP3K12;TGFBR2;TRPV4;ITGA1;TRIB3;CDK5RAP3;MINK1;PROM2;WNT7A;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;PPP1R15A;ADCY6;ATP2B4;STRADB;AKT1;CHEK2;FGFR4;PIAS3;WDFY2;INSR;RPS6KA5;C6ORF89;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;BCL6;FYN;GDF15;GOLGA2;MTA1;AVPI1;LAMTOR2;MAP3K10;EPHB2;FGFR1;WFS1;ERBB2;UNC119;CAMKK1
19259,GO:1905521,0.086872513794483,0.976845823713507,4,15,regulation of macrophage migration,BP,MMP28;C5;MAPK3;TRPV4
2316,GO:0005319,0.0870094272135751,0.952475101030102,14,80,lipid transporter activity,MF,APOE;OSBPL5;SLC27A1;PITPNM3;PITPNM1;PITPNC1;ABCA7;ABCG1;OSBPL10;PLTP;ANO9;ATP8B2;OSBPL1A;SLC10A6
2514,GO:0005768,0.0876493652157609,0.929661314285716,92,678,endosome,CC,F2R;APOE;LRP1;EGFR;CLTCL1;CST3;DDIT3;NDRG1;RAB11FIP4;NISCH;MAP2K1;ABCA2;PKN1;DGKQ;SNX9;ULK1;VPS11;CD68;APPL2;PRKCZ;ABCA7;MCTP1;NMNAT2;MICALL2;SPPL2B;NGFR;ABCG1;MTMR4;IFT27;SH3TC2;AP1G2;MAPK3;DYSF;CTSB;MVB12B;PI4K2A;CHMP1B;TBC1D14;PRAF2;MAP2K2;SLC48A1;EHBP1L1;LITAF;FLOT1;SORL1;TMEM175;PCSK9;MAP1LC3A;RAB40B;MARCH2;VPS39;ATP7B;FYCO1;NBR1;RAB43;CTSH;TMEM9;STEAP2;ZFYVE21;TSG101;FGFR4;RASSF9;TCIRG1;STEAP3;WDFY2;C9ORF72;CHMP5;RAB25;C1ORF210;INSR;CHMP4C;TPCN1;ARHGAP44;HFE;JAK3;SNX33;FCHSD1;MIB2;SNX17;SLC9A7;EHD3;FYN;SNX1;UBXN6;RAB13;OSBPL1A;TOM1;AP2A2;LAMTOR2;TBC1D16;ERBB2;HLA-G
10502,GO:0043434,0.0879806721248974,0.936406018815186,43,295,response to peptide hormone,BP,EGR1;HADH;ZFP36L1;SLC27A1;PCK2;BTG1;SHC1;PRKCZ;PAK1;NGFR;EREG;PTPRE;PPARA;SESN2;VAMP2;AREG;MAPK3;ERRFI1;HDAC5;SRSF5;LRP5;PCSK9;TRPV4;TRIB3;TRPV1;PIK3R2;ADCY6;AKT1;TCIRG1;INSR;FOXO4;BRAF;GPR21;CAT;TIMP1;JAK3;APRT;FYN;RAB13;EIF4EBP1;TGFBR3;GRB10;BSG
12222,GO:0048518,0.0880042219695583,0.921181960527617,483,3888,positive regulation of biological process,BP,TNIP1;XDH;DUSP6;PTPRS;ACTA2;DLG4;HTRA1;DOCK4;BBS2;F2R;APOE;ESPN;ZMYND8;NFATC4;SERPINE2;FHL1;S100A6;FOS;PRODH;IL20RB;GSN;ADGRL1;CITED4;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;WIPF1;PTK6;CDC42EP5;EDEM1;RNF135;GLUL;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;DDB2;PRNP;NR1D1;ERCC1;FBLN1;S100A4;ANK3;DUSP5;RAPGEF3;CLTCL1;TNFSF15;TSPAN1;IGFBP4;CST3;DNM1;MEF2D;NOS1;GPSM1;DDIT3;DNPH1;SHANK2;CRTC1;SCN4B;ADGRB2;ERCC6;NDRG1;TBC1D8;ARHGEF19;TCEA2;GRAMD4;SMARCA1;MST1R;TRIM65;ZFP36L1;ADARB1;NUPR1;ARAP1;B3GAT3;HBEGF;RBL2;RGL2;RPS6KA2;MMP1;CTF1;CNTN1;TFDP2;EFNB3;OBSL1;EVC;SLC27A1;MAPK13;RNF165;RAB11FIP4;MLYCD;FBXW4;ASH2L;CUL7;EPM2A;HYAL1;SMOC2;ARPIN;ETV4;WWTR1;MAP2K1;CYP27B1;PCK2;CCDC71L;PKN1;MC1R;DDIT4;BTG1;SHC2;ITGA6;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;PLEKHG5;FAM110C;MAGEF1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;VEGFB;ADM2;MARCKSL1;SOX12;RAB3B;NLGN2;ITPR3;PRSS8;CIRBP;CAPRIN2;PRKCZ;SERPING1;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;CEMIP;KDM3A;PHF1;SEMA3F;PLXNB3;SALL2;DLG3;MICALL2;CEP250;FBXW8;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;EAPP;NGFR;NID1;ETV5;GSTO1;ARHGEF4;MUC19;WNT2B;NSMCE4A;TRIB2;PLXNB1;EREG;TEF;OLFM2;PLEKHG2;TMED4;TNFRSF25;NAB2;PLA2G6;ABCG1;TRAPPC9;CARF;ERMAP;LPAR3;S100A13;C5;PPARA;PLGRKT;ANO1;SESN2;IMPACT;NLRX1;PKD2;STAT6;KLF7;ING4;VAMP2;HMGA2;AREG;COL8A1;ECM1;ACACB;MAPK3;CSPG4;PC;BNIP3;SEMA5A;THRA;IFITM1;VANGL2;SH2D2A;RGS14;MVD;IRF2BPL;FAM20C;PLEK2;CTSB;SLITRK6;MAPK12;MVB12B;NAT14;ZXDC;MLXIPL;C1RL;ARHGEF2;INPP5D;PDCD1LG2;MAP2K2;TWF2;SLC50A1;LRSAM1;DMTN;LITAF;ANGPTL4;SEMA3B;PTHLH;ATF4;ZFPM1;BBC3;KDM4C;PAK6;DOCK11;SSH1;METRN;TENM2;KIF26B;ZNF516;PKD1;NSMCE1;FLOT1;LTBP3;MDK;TTN;KCNMA1;AZIN2;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;PCBP4;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;TPBG;ADGRF1;DEAF1;SULF2;NLRP1;PEG3;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;LRP5;WNK4;ATRAID;CREBRF;PCSK9;PKIB;FBXL15;METTL23;AQP3;CEP131;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;CSRNP3;ITGA1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;SEMA4G;SHARPIN;CCS;GAS6;GLUD1;ERN1;ECM2;CROCC;BCR;MAPRE3;FYCO1;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;RIMS3;ADCY6;ATP2B4;STRADB;CTSH;TNFRSF14;MGMT;ASNS;AKT1;CARD11;CDKN1C;AMIGO2;LAMB1;CHEK2;HMSD;IFT57;IGFBP2;ASS1;TSG101;PHF2;IL17RC;FGFR4;TMOD2;PIAS3;TCIRG1;LMNA;SH2B3;MAB21L2;WDFY2;C9ORF72;TBC1D20;UHRF2;MARK4;RAB25;IFI27;PLAU;INSR;WNT3;NCOA7;NELFCD;TENM4;FOXO4;YPEL3;RPS6KA5;CHMP4C;TPCN1;C6ORF89;MAP2K5;BRAF;EDA2R;GPR21;BTN3A2;PLB1;PIDD1;CAT;MAPK10;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;SNX33;CHRM3;TFEB;MIB2;SPIRE1;CSNK1E;TAZ;BTN3A3;BCL6;HSF4;TKFC;EPS8L1;EHD3;FYN;ZC3H12D;SNX1;ARHGEF17;SIRT2;TRPC1;GDF15;GOLGA2;ADA;POU2F2;PLXND1;POLR3GL;MTA1;TMEM101;CIDEA;EPS8L2;PAIP2;MYO18A;ADIRF;EIF4EBP1;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;EPAS1;LAMTOR2;MAP3K10;MFNG;STARD10;CHD6;LURAP1;DHPS;EPHB2;PER1;ITGA2;FGFR1;WFS1;FITM2;FKBP8;CTH;ERBB2;EIF2AK4;UNC119;PAG1;OSCP1;C15ORF62;HLA-G;CORO1B;HMBOX1;NET1;GRB10;CREB3L4;KCTD11;KCTD13;DBP;ZNF287;CAMKK1;IKBKB;HIP1;TEAD2;SIX5
12406,GO:0048878,0.0886396994808487,0.929253143785187,87,642,chemical homeostasis,BP,DLG4;F2R;APOE;FHL1;VEGFA;NTSR1;EGFR;PRNP;NR1D1;SLC7A8;ANK3;NOS1;DDIT3;PYGL;CYP27B1;PCK2;ABCA2;SLC12A7;CYBRD1;ITPR3;ERO1B;CEMIP;NGFR;GSTO1;MALL;PNPLA3;PLA2G6;ABCG1;LPAR3;ANO1;SESN2;PKD2;MAPK3;BNIP3;PQLC2;MLXIPL;ANGPTL4;SV2A;IFI6;PKD1;KCNMA1;HERPUD1;GSTM2;TMEM175;ENDOG;LRP5;WNK4;PCSK9;AQP3;TRPV4;HEXB;TRPV1;PIK3R2;GAS6;ERN1;ATP7B;ADCY6;ATP2B4;CTSH;ACOX3;STEAP2;AKT1;ITPR2;CRY2;FGFR4;TCIRG1;STEAP3;TBC1D20;INSR;PNPLA4;TPCN1;HOMER2;GPR21;LETMD1;LGALS1;HFE;SCNN1A;ATP12A;SLC9A7;FYN;TRPC1;EPAS1;EDNRA;DHPS;WFS1;FITM2;SLC9A5
9393,GO:0035966,0.0886999346581927,0.941477680494844,27,175,response to topologically incorrect protein,BP,TMEM129;EDEM1;DDIT3;DNAJB5;CUL7;DNAJC4;SHC1;MANF;CHAC1;TSPYL2;UBXN4;ATF4;FBXO6;HERPUD1;CREBRF;CDK5RAP3;HERPUD2;ERN1;PPP1R15A;ASNS;ACADVL;LMNA;ANKZF1;WFS1;CTH;SYVN1;CREB3L4
17579,GO:1901292,0.0887741689373327,0.944934902730899,21,131,nucleoside phosphate catabolic process,BP,XDH;NT5E;RAPGEF3;DNPH1;PGM1;DHTKD1;DDIT4;OGDHL;NEIL1;PPARA;NT5C1B;MLXIPL;GALK1;ALDOC;PDE2A;UPP1;INSR;ADA;ENTPD2;PFKL;NUDT18
18539,GO:1903793,0.0888785966721143,0.971270127253451,5,21,positive regulation of anion transport,BP,APOE;NTSR1;ABCA7;PLA2G6;PTAFR
6794,GO:0030246,0.0889802149620049,0.945527831061084,20,123,carbohydrate binding,MF,ADGRL1;SLC2A3;FBXO2;MRC2;GAA;PYGL;CNTN1;LGALS9C;LGALS9B;PHYH;ZP3;FBXO6;PKD1;GALK1;MAN2C1;MAN2B1;LGALS1;OGFOD2;PFKL;BSG
3551,GO:0007589,0.0894018565021931,0.956969283017778,10,53,body fluid secretion,BP,XDH;VEGFA;STK39;NEURL1;WNK4;APLN;ATP7B;CHRM3;APRT;ADA
14521,GO:0070062,0.0896363337637892,0.921825656156325,255,2029,extracellular exosome,CC,PTPRS;ACTA2;HTRA1;GAMT;NT5E;APOE;SYTL1;XPC;S100A6;GSN;PYGB;ALDH7A1;SLC2A3;FBXO2;ACP5;THSD4;NAPRT;GLUL;GPX3;ALOX15B;TIMP2;PRNP;ZDHHC1;FBLN1;SLC7A8;S100A4;PRDX5;RAPGEF3;BPHL;CLTCL1;TSPAN1;KRT15;CD9;IDH2;CST3;DNM1;DNPH1;PGM1;NDRG1;GGT1;FCGBP;ARRDC1;HEBP1;B3GAT3;RBL2;PHGDH;ARHGAP23;GAA;PYGL;CNTN1;PLAT;LTBP4;CTSF;REEP2;PLD3;PRSS3;HYAL1;NAGLU;MAP2K1;PCK2;COL6A1;PPL;CRYL1;PGLS;CAPG;H2AFJ;TOM1L2;DNASE1L1;AKR7A2;SNX9;FAM213A;MAGEF1;ARL2;MARCKSL1;HDAC11;RAB3B;MYH11;CYBRD1;LAMA5;APPL2;PRSS8;PRKCZ;GALE;SERPING1;SLC37A2;AARS;PABPC1L;BLVRB;SEC14L2;ITGB4;CEP250;ABHD14B;NID1;ETFB;GSTO1;WDR60;MUC19;PPCS;ACTR1B;CHD2;PSAT1;SPG11;TMC6;DHRS4;TMED4;CES3;OAF;S100A13;GSTT1;C5;ANO1;SNX29;BLMH;PKD2;ACOT11;VAMP2;COL8A1;ECM1;B4GAT1;PCLO;JADE2;MAPK3;CSPG4;ITGB5;LAMB2;SEMA5A;FAM20C;DYSF;RHOF;LTBP2;CTSB;MXRA8;MVB12B;MYH3;LTA4H;KIAA0319L;CHMP1B;C1RL;PLCD1;MTMR11;PDCD1LG2;TWF2;SEMA3B;PROCR;PKD1;FUCA1;FLOT1;LTBP3;TTN;KCNMA1;SORL1;GALK1;NTPCR;GSTM2;GPRC5C;ACY1;PTGR2;ACOT7;ALDOC;EPN3;MARK3;ITGA1;ALDH1L2;MINK1;HEXB;PROM2;WNT7A;GAS6;CROCC;BCR;NBR1;HEXA;BCAM;TTYH3;RAB43;SLC9A3R2;EFEMP2;CTSH;UACA;GSTO2;ENTPD6;IGFBP7;CARD11;LAMB1;GAREM2;IGFBP2;ASS1;CAPS;TSG101;KIF27;TMEM256;RASSF9;HAGH;NUCB2;DNASE2;CHMP5;ARSA;CAPN2;ARMC9;MAN2B1;RAB25;PLAU;INSR;WNT3;KRT19;GNAL;CHMP4C;TNXB;MBLAC2;ITGB6;CTDSPL;ALDH1L1;CAT;MYOF;DPP7;LGALS1;TIMP1;SCNN1A;TUBGCP6;APRT;MPI;METTL7A;SAT2;GSTM3;TKFC;EPS8L1;PEX1;UBXN6;GDF15;RAB13;OSBPL1A;TOM1;TST;CADM4;RHOBTB3;NAGA;ENTPD2;EPS8L2;ADIRF;ERV3-1;TGFBR3;RNPEP;VAV3;GALNS;LAMTOR2;BLOC1S1;CTH;PLLP;PFKL;CORO1B;RPL12;BSG;LYPLAL1;TMEM8A;ROBO4
993,GO:0002455,0.0898391590313793,0.97576949669483,4,15,humoral immune response mediated by circulating immunoglobulin,BP,SERPING1;ZP3;C5;C1RL
17546,GO:1901186,0.0902193944051073,0.966804300485751,6,27,positive regulation of ERBB signaling pathway,BP,PTK6;ARAP1;NEURL1;EREG;AKT1;HIP1
918,GO:0002313,0.0903218668429022,0.975593046420055,4,15,mature B cell differentiation involved in immune response,BP,DOCK11;LGALS1;ADA;MFNG
4371,GO:0010001,0.0905553599222447,0.943707986228714,21,130,glial cell differentiation,BP,SERPINE2;GSN;LRP1;EGFR;CD9;NDRG1;MAP2K1;HDAC11;NAB2;SH3TC2;MAPK3;LAMB2;BNIP3;MXRA8;METRN;PRDM8;AKT1;TENM4;TP73;SIRT2;ERBB2
3157,GO:0006767,0.0906865588190227,0.952827195831241,12,67,water-soluble vitamin metabolic process,BP,SLC2A3;ACP5;PRSS3;MTHFR;GSTO1;PSAT1;ACACB;PC;HLCS;ALDH1L2;GSTO2;ALDH1L1
2975,GO:0006520,0.0908149113265503,0.934980490010309,40,276,cellular amino acid metabolic process,BP,GAMT;PRODH;ALDH7A1;GLUL;NAGS;SLC7A8;BPHL;CRTAP;NOS1;GGT1;PHGDH;PYCR2;ALDH4A1;HMGCL;AARS;ERO1B;MTHFR;GLDC;CBS;NMNAT2;GPT2;PSAT1;PSPH;CARS;BLMH;HIBADH;ATF4;AZIN2;ACY1;PEMT;NOS3;GLUD1;SRR;ATP2B4;THNSL2;ASNS;PHYKPL;ASS1;SLC6A6;CTH
4199,GO:0009311,0.0908304691569139,0.956146811592834,10,53,oligosaccharide metabolic process,BP,ST6GALNAC2;GAA;ST6GALNAC6;ST3GAL3;HEXB;MAN2C1;MAN2B1;BRAF;NAGA;MAN1B1
13336,GO:0052547,0.0908329095693488,0.934669905925717,41,286,regulation of peptidase activity,BP,XDH;F2R;TNFRSF6B;SERPINE2;GSN;TIMP2;VEGFA;FBLN1;PRDX5;TFPI2;TNFSF15;CST3;GRAMD4;SERPING1;RAG1;NGFR;C5;ECM1;MAPK3;MAPK12;BBC3;IFI6;SORL1;HERPUD1;PAPLN;NLRP1;DAP;GAS6;CTSH;MGMT;AKT1;MICAL1;HMSD;IFT57;IFI27;MAP2K5;PIDD1;TIMP1;FYN;CIDEB;HIP1
8727,GO:0034389,0.0908540107390726,0.975398099997722,4,15,lipid particle organization,BP,PNPLA3;TBC1D20;CIDEA;FITM2
15279,GO:0071495,0.0909571706721058,0.9248905562323,120,901,cellular response to endogenous stimulus,BP,DUSP6;HTRA1;BBS2;FOS;EGR1;PGF;FGFBP1;POSTN;FAM210B;LRP1;PDCD4;EGFR;PRNP;NR1D1;ADAMTS7;RAPGEF3;ZFP36L1;LTBP4;SLC27A1;MAPK13;KLF9;RNF165;UROS;HYAL1;PCK2;COL6A1;DDIT4;SHC1;SPRY2;PRKCZ;PAK1;FGFR3;KDM3A;SPRY4;NEURL1;ACVR2B;NGFR;LTBP1;PTPRE;MTMR4;PPARA;SESN2;IMPACT;PKD2;VAMP2;SLIT3;MAPK3;ITGB5;ERRFI1;THRA;FAM20C;LTBP2;CTSB;PAQR6;ARHGEF2;DMTN;ATF4;SSH1;HDAC5;SRSF5;GSTM2;SULF2;CEBPB;CREBRF;PCSK9;FBXL15;DNMT3A;TGFBR2;PDE2A;SMURF2;APLN;TRIB3;CALCOCO1;WNT7A;TRPV1;PIK3R2;TADA3;PTAFR;RXRA;ADCY6;ATP2B4;CTSH;ASNS;AKT1;IGFBP7;ITPR2;CDKN1C;CRY2;CHEK2;IGFBP2;FGFR4;TCIRG1;CAPN2;INSR;FOXO4;BRAF;GPR21;HFE;JAK3;CHRM3;APRT;FYN;LEMD2;SIRT2;GDF15;RECQL5;RAB13;CIDEA;HDAC8;EIF4EBP1;TGFBR3;LAMTOR2;PER1;ITGA2;FGFR1;FKBP8;ERBB2;CORO1B;FRS3;GRB10
554,GO:0001676,0.0910140620050174,0.954230949403943,11,60,long-chain fatty acid metabolic process,BP,AIG1;ALOX15B;SLC27A1;PNPLA3;ACOT1;MAPK3;GSTM2;ACOT7;SLC27A3;FAAH;ACOT8
4267,GO:0009628,0.0914010539534433,0.924803827074054,115,861,response to abiotic stimulus,BP,NFATC4;XPC;SERPINE2;FOS;EGR1;PGF;POSTN;VEGFA;NTSR1;EGFR;DDB2;ERCC1;CD9;CST3;NOS1;BRSK1;CRTC1;ERCC6;NDRG1;ZFP36L1;PLAT;SLC27A1;MAPK13;HYAL1;PPL;PKN1;MC1R;DDIT4;SYNGAP1;PITPNM1;NPHP4;VEGFB;CIRBP;PAK1;STK39;MTHFR;ETV1;RAG1;PSPH;S100A13;PPARA;ANO1;IMPACT;PKD2;ACOT11;HMGA2;LRP11;MAPK3;BNIP3;ERRFI1;THRA;SCARA3;RGS14;SLITRK6;ARHGEF2;LRRC8A;ANGPTL4;ATF4;PRIMPOL;REEP6;ZNF516;PKD1;TTN;KCNMA1;DEAF1;ENDOG;LRP5;AQP3;DNMT3A;TGFBR2;TRPV4;PDE2A;BHLHE40;NOS3;TRPV1;BNIP3L;TERC;PTAFR;CYP2R1;ATP2B4;MGMT;ASNS;AKT1;IGFBP7;ITPR2;CRY2;B4GALT2;CHEK2;IGFBP2;ACADVL;LMNA;CAPN2;PLAU;BRAF;ASIC1;CAT;MYOF;MAPK10;TP73;HSF4;FYN;SLC38A2;SIRT2;ADA;MTA1;ADIRF;TGFBR3;STX1A;EPAS1;EDNRA;PER1;ITGA2;EIF2AK4;UNC119;NET1
11447,GO:0045922,0.0914652216558374,0.975173639310508,4,15,negative regulation of fatty acid metabolic process,BP,ACACB;TRIB3;AKT1;ACADVL
4504,GO:0010559,0.0916011412535338,0.966157728356487,6,27,regulation of glycoprotein biosynthetic process,BP,HBEGF;ABCA7;NECAB3;JAK3;GOLGA2;ACOT8
12684,GO:0050926,0.091686381055292,0.975092276646258,4,15,regulation of positive chemotaxis,BP,PGF;VEGFA;VEGFB;ITGA2
3074,GO:0006644,0.0917892572496821,0.931978068432721,49,342,phospholipid metabolic process,BP,ISYNA1;OSBPL5;EGFR;DGKA;HBEGF;SLC27A1;PITPNM3;ACP6;LPCAT4;PLCH2;PITPNM1;DGKQ;FGFR3;ZP3;EREG;PNPLA3;PLA2G6;MTMR4;PI4KAP1;OSBPL10;MVD;PI4K2A;PLCD1;INPP5D;SRD5A3;PCSK9;PEMT;PIGZ;HEXB;PIP5KL1;PIK3R2;CHKB;ZFYVE21;FGFR4;PIGQ;PLB1;TAZ;FYN;MBOAT2;ETNK2;VAV3;STARD10;INPP4A;FGFR1;PIGV;FITM2;ERBB2;MPPE1;PLEKHA4
18197,GO:1903026,0.0918528891557563,0.989650358799241,2,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,DDIT3;TMSB4X
12160,GO:0048308,0.0918667530283125,0.975025862673947,4,15,organelle inheritance,BP,MAP2K1;MAPK3;MAP2K2;GOLGA2
10076,GO:0042594,0.0919108120687062,0.942049494135884,22,138,response to starvation,BP,GLUL;DDIT3;ULK2;HMGCL;PCK2;ULK1;WNT2B;SESN2;IMPACT;LRP11;MAPK3;ATF4;PCSK9;MAP1LC3A;DAP;GAS6;ASNS;C12ORF66;UPP1;HFE;SLC38A2;EIF2AK4
13812,GO:0060438,0.0923193737662741,0.974858981354542,4,15,trachea development,BP,MAP2K1;MAPK3;TGFBR2;EDA
18002,GO:1902533,0.092423064090433,0.925867920190046,89,658,positive regulation of intracellular signal transduction,BP,XDH;DUSP6;F2R;PTK6;PDCD4;TIMP2;VEGFA;EGFR;RBCK1;S100A4;DUSP5;TNFSF15;IGFBP4;NOS1;DDIT3;ERCC6;MST1R;HBEGF;RGL2;CTF1;MAP2K1;PKN1;MC1R;SHC2;PLEKHG5;FAM110C;SHC1;SPRY2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;NGFR;GSTO1;PLXNB1;EREG;TMED4;TNFRSF25;PLA2G6;LPAR3;S100A13;C5;PKD2;ECM1;MAPK3;CSPG4;SEMA5A;VANGL2;MAP2K2;LITAF;UNC5B;GSTM2;MAP3K12;TRPV4;ITGA1;CDK5RAP3;MINK1;WNT7A;PIK3R2;EPHA1;SHARPIN;GAS6;ERN1;AKT1;CARD11;FGFR4;INSR;MAP2K5;BRAF;EDA2R;CAT;MAPK10;LGALS1;TP73;MIB2;FYN;ADA;TMEM101;AVPI1;LAMTOR2;MAP3K10;LURAP1;EPHB2;FGFR1;CTH;ERBB2;IKBKB;HIP1
11753,GO:0046632,0.0925721694815716,0.955140232510429,10,53,alpha-beta T cell differentiation,BP,PRKCZ;SATB1;STAT6;ZFPM1;TGFBR2;BRAF;JAK3;BCL6;ADA;TCF7
2721,GO:0006103,0.0927567179204508,0.974697428951704,4,15,2-oxoglutarate metabolic process,BP,D2HGDH;IDH2;PHYH;GPT2
15115,GO:0071241,0.0928380408777686,0.943632200555751,19,117,cellular response to inorganic substance,BP,NFATC4;FOS;GSN;EGFR;PRNP;ANK3;CARF;RASA4;PKD2;MAPK3;BNIP3;DMTN;ATF4;ENDOG;MAP1LC3A;SPAG16;AKT1;BRAF;HFE
17695,GO:1901652,0.0928642086016501,0.931337871593354,48,335,response to peptide,BP,EGR1;LRP1;PRNP;HADH;ZFP36L1;SLC27A1;PCK2;BTG1;SHC1;PRKCZ;PAK1;NGFR;EREG;PTPRE;PPARA;SESN2;VAMP2;AREG;MAPK3;ERRFI1;ARHGEF2;HDAC5;IRF5;SRSF5;NLRP1;LRP5;PCSK9;TRPV4;TRIB3;TRPV1;PIK3R2;ADCY6;AKT1;TCIRG1;INSR;FOXO4;BRAF;GPR21;CAT;TIMP1;JAK3;APRT;FYN;RAB13;EIF4EBP1;TGFBR3;GRB10;BSG
8588,GO:0034110,0.0928859406176281,0.969569732116205,5,21,regulation of homotypic cell-cell adhesion,BP,SERPINE2;ANK3;CD9;DMTN;LGALS1
14915,GO:0070828,0.0928982783528798,0.974645073533718,4,15,heterochromatin organization,BP,BAHCC1;MTHFR;HMGA2;TNRC18
16200,GO:0090276,0.0929612923452871,0.943547389355586,19,117,regulation of peptide hormone secretion,BP,GLUL;EGFR;NR1D1;HADH;RAPGEF3;PCK2;ARL2;NLGN2;ITPR3;PLA2G6;ANO1;LRP5;APLN;GLUD1;ITPR2;ICA1;HFE;STX1A;PFKL
7075,GO:0030878,0.0930872998876632,0.974575116264907,4,15,thyroid gland development,BP,MAP2K1;MAPK3;THRA;BRAF
13069,GO:0051604,0.0932566420495711,0.936240525148045,31,208,protein maturation,BP,SERPINE2;GSN;LMF1;TYSND1;PRNP;GGT1;ADAMTS13;PLAT;PRSS3;MAGEF1;PCSK1;SERPING1;ERO1B;SPPL2B;C5;PLGRKT;CHAC1;AIP;SORL1;RHBDF1;PCSK9;LONP2;RHBDF2;GAS6;CTSH;NFU1;CAPN2;PLAU;CIDEB;DHPS;WFS1
12875,GO:0051241,0.0932868037803227,0.924950562823424,91,676,negative regulation of multicellular organismal process,BP,XDH;PTPRS;DOCK4;BBS2;F2R;APOE;NFATC4;SERPINE2;IL20RB;ACP5;WWC3;RNF135;SEMA4B;LRP1;PDCD4;EGFR;PRNP;ADAMTS7;CD9;IDH2;CST3;DDIT3;ADGRB2;ZFP36L1;EFNB3;PLAT;ULK2;MC1R;SYNGAP1;SPRY2;SERPING1;PAK1;STK39;NPR2;SEMA3F;NGFR;TRIB2;NLRX1;AREG;ECM1;ERRFI1;SEMA5A;ARHGEF2;INPP5D;PDCD1LG2;SEMA3B;PTHLH;PROCR;ZFPM1;HDAC5;SORL1;LRP5;WNK4;PCSK9;TGFBR2;TRPV4;TMSB4X;APLN;NOS3;WNT7A;SEMA4G;GAS6;BCR;NBR1;ADCY6;ATP2B4;MAPKBP1;DGUOK;TNNT1;LMNA;PLAU;WNT3;FOXO4;RPS6KA5;MAP2K5;LGALS1;TIMP1;HFE;JAK3;TP73;BCL6;SIRT2;ADA;CIDEA;HDAC8;EPHB2;FGFR1;ERBB2;EIF2AK4;HLA-G;KCTD11
12965,GO:0051393,0.0933663188776916,0.976293089175355,4,11,alpha-actinin binding,MF,OBSL1;PKD2;TTN;MAGI1
4277,GO:0009648,0.0935903919323431,0.969268224832607,5,21,photoperiodism,BP,CRTC1;BHLHE40;CRY2;MTA1;PER1
10046,GO:0042552,0.0935915677036967,0.948285109109952,14,80,myelination,BP,MARVELD1;SCN8A;CD9;NDRG1;MALL;NAB2;SH3TC2;HEXB;AKT1;SBF2;TENM4;SIRT2;ERBB2;PLLP
7174,GO:0031065,0.0937602544009921,0.974325603922644,4,15,positive regulation of histone deacetylation,BP,VEGFA;JDP2;C6ORF89;BCL6
16464,GO:0097186,0.0939008975438356,0.974273368733268,4,15,amelogenesis,BP,ITGA6;ITGB4;PPARA;FAM20C
6657,GO:0030018,0.0939150438030078,0.949587609473343,13,69,Z disc,CC,FLNC;OBSCN;SCN8A;ANK3;PARVB;NOS1;OBSL1;PAK1;SYNC;MYZAP;TTN;ATP2B4;KRT19
11434,GO:0045907,0.0939159717212199,0.974267768331111,4,15,positive regulation of vasoconstriction,BP,F2R;EGFR;PTAFR;AKT1
7967,GO:0032590,0.0939399717127224,0.974258851058543,4,15,dendrite membrane,CC,KCNC4;ATF4;TRPV1;INSR
17681,GO:1901618,0.0941045566196633,0.97419767499538,4,15,organic hydroxy compound transmembrane transporter activity,MF,SLC16A3;ABCG1;AQP3;SLC10A6
1923,GO:0004620,0.0941243465341168,0.952373280928909,11,60,phospholipase activity,MF,PLD3;PLCH2;PNPLA3;PLCD3;PLA2G6;PLCD1;PLB1;CHRM3;EDNRA;LYPLAL1;TMEM8A
15517,GO:0071949,0.0942469827928354,0.968986509789362,5,21,FAD binding,MF,PRODH;D2HGDH;ACOX3;MICAL1;CRY2
616,GO:0001786,0.0945280543801468,0.964778441281902,6,27,phosphatidylserine binding,MF,OSBPL5;OSBPL10;GSDMA;PLCD1;GAS6;GSDMC
12168,GO:0048333,0.0945538143084511,0.974030473086887,4,15,mesodermal cell differentiation,BP,ITGB4;HMGA2;ITGA2;FGFR1
7172,GO:0031063,0.0947388510094195,0.968775034002082,5,21,regulation of histone deacetylation,BP,VEGFA;JDP2;TADA3;C6ORF89;BCL6
18336,GO:1903358,0.0949001380974637,0.973901367742226,4,15,regulation of Golgi organization,BP,MAP2K1;MAPK3;MAP2K2;EHD3
2602,GO:0005901,0.094907114817526,0.953784222892138,10,53,caveola,CC,F2R;NOS1;MAPK3;FLOT1;KCNMA1;TGFBR2;NOS3;ATP2B4;INSR;MYOF
14495,GO:0070006,0.094935674985397,0.973888109553545,4,15,metalloaminopeptidase activity,MF,RNPEPL1;LTA4H;RNPEP;MMP17
12264,GO:0048599,0.0950167813746656,0.964546862852566,6,27,oocyte development,BP,PABPC1L;NPR2;ZP3;EREG;REC8;SIRT2
2751,GO:0006164,0.0950207889200021,0.93681115359582,27,177,purine nucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;PGM1;DHTKD1;DDIT4;OGDHL;NPR2;NME4;PPCS;PPARA;MLXIPL;PTHLH;LTB4R2;GALK1;GABBR1;ACOT7;ALDOC;TMSB4X;NOS3;ADCY6;TCIRG1;INSR;APRT;TAZ;ADA;PFKL
7747,GO:0032272,0.095033139800369,0.955786528106356,9,47,negative regulation of protein polymerization,BP,GSN;SPTB;CAPG;EML2;TWF2;DMTN;TRIOBP;TMSB4X;TMOD2
6761,GO:0030203,0.0952249297402337,0.942886160284298,18,109,glycosaminoglycan metabolic process,BP,B3GAT3;HYAL1;NAGLU;CEMIP;B4GAT1;CSPG4;SDC2;CHST6;FUCA1;ST3GAL3;HEXB;HEXA;AKT1;B4GALT2;HGSNAT;GALNS;XYLT2;UST
12490,GO:0050654,0.0952939338182405,0.964415376577265,6,27,chondroitin sulfate proteoglycan metabolic process,BP,B3GAT3;HYAL1;CSPG4;HEXB;HEXA;XYLT2
16310,GO:0090568,0.0953536792999176,0.964387017026597,6,27,nuclear transcriptional repressor complex,CC,BAHCC1;APPL2;SALL2;CHD3;TNRC18;SIRT2
3758,GO:0008306,0.095836618717299,0.957827894534901,8,40,associative learning,BP,FOS;SYNGAP1;RAG1;RGS14;DEAF1;B4GALT2;BRAF;ASIC1
5230,GO:0015850,0.0958754127699466,0.943368885462315,17,103,organic hydroxy compound transport,BP,APOE;OSBPL5;LRP1;SLC16A3;NOS1;NISCH;ABCA2;RAB3B;ABCA7;ABCG1;PLTP;PCSK9;AQP3;RXRA;OSBPL1A;STX1A;SLC10A6
15098,GO:0071214,0.0960913254872263,0.932900597211459,34,229,cellular response to abiotic stimulus,BP,NFATC4;XPC;EGR1;EGFR;DDB2;ERCC1;ZFP36L1;MAPK13;HYAL1;MC1R;STK39;IMPACT;PKD2;HMGA2;MAPK3;BNIP3;ERRFI1;ARHGEF2;ATF4;TRPV4;PDE2A;TRPV1;PTAFR;MGMT;AKT1;CRY2;CHEK2;ASIC1;TP73;SLC38A2;ADIRF;ITGA2;EIF2AK4;NET1
17159,GO:0104004,0.0960913254872263,0.932900597211459,34,229,cellular response to environmental stimulus,BP,NFATC4;XPC;EGR1;EGFR;DDB2;ERCC1;ZFP36L1;MAPK13;HYAL1;MC1R;STK39;IMPACT;PKD2;HMGA2;MAPK3;BNIP3;ERRFI1;ARHGEF2;ATF4;TRPV4;PDE2A;TRPV1;PTAFR;MGMT;AKT1;CRY2;CHEK2;ASIC1;TP73;SLC38A2;ADIRF;ITGA2;EIF2AK4;NET1
160,GO:0000332,0.0961682625734916,1,1,1,template for synthesis of G-rich strand of telomere DNA activity,MF,TERC
238,GO:0000496,0.0961682625734916,1,1,1,base pairing,MF,TERC
239,GO:0000497,0.0961682625734916,1,1,1,base pairing with DNA,MF,TERC
1464,GO:0003721,0.0961682625734916,1,1,1,telomerase RNA reverse transcriptase activity,MF,TERC
12549,GO:0050727,0.0962473047771969,0.935893453219275,27,178,regulation of inflammatory response,BP,TNIP1;NT5E;APOE;IL20RB;ACP5;PDCD4;EGFR;GGT1;MAPK13;SERPING1;STK39;ZP3;C5;PPARA;FNDC4;NLRX1;NLRP1;TRPV4;TMSB4X;PDE2A;SHARPIN;BCR;IL17RC;BCL6;ADA;PER1;ITGA2
4093,GO:0009151,0.0965718323544739,0.979833032430683,3,10,purine deoxyribonucleotide metabolic process,BP,DGUOK;ADA;NUDT18
6623,GO:0022890,0.0965853281991364,0.930783841195992,39,268,inorganic cation transmembrane transporter activity,MF,KCNG1;SCN8A;SLC2A9;SCN4B;ORAI3;SLC12A7;ITPR3;NDUFA4L2;ORAI2;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;SLC22A18;PKD1;KCNMA1;TMEM175;TRPV4;PDE2A;TRPV1;GAS6;ATP7B;MFSD3;ATP2B4;ITPR2;SLC6A9;TCIRG1;SLC6A6;TMEM63C;TPCN1;ASIC1;SCNN1A;ATP12A;SLC9A7;TRPC1;SLC39A11;SLC10A6;SLC9A5
15190,GO:0071363,0.0967377364535174,0.925365874289564,63,452,cellular response to growth factor stimulus,BP,XDH;DUSP6;HTRA1;FOS;EGR1;FGFBP1;POSTN;PDCD4;VEGFA;EGFR;ADAMTS7;NOS1;ZFP36L1;LTBP4;RNF165;HYAL1;DDIT4;SHC1;SPRY2;PRKCZ;FGFR3;SPRY4;ACVR2B;NGFR;LTBP1;MTMR4;MAPK3;ITGB5;ERRFI1;FAM20C;LTBP2;TWF2;SULF2;FBXL15;TGFBR2;PDE2A;SMURF2;APLN;WNT7A;TRPV1;GAS6;ERN1;AKT1;CDKN1C;FGFR4;INSR;MAP2K5;BRAF;CAT;MYOF;HFE;FYN;LEMD2;SIRT2;GDF15;CIDEA;TGFBR3;FGFR1;FKBP8;ERBB2;CORO1B;FRS3;GRB10
15677,GO:0072243,0.0967814706115747,0.973196806731829,4,15,metanephric nephron epithelium development,BP,WWTR1;PKD2;LAMB2;PKD1
12039,GO:0048009,0.0969560072904141,0.967817168831618,5,21,insulin-like growth factor receptor signaling pathway,BP,IGFBP4;GIGYF1;AKT1;IGFBP2;GRB10
6614,GO:0022843,0.0970864649719755,0.957152860706886,8,40,voltage-gated cation channel activity,MF,KCNG1;KCNJ15;PKD2;KCNC4;KCNAB2;KCNMA1;GAS6;TPCN1
15134,GO:0071277,0.0973073393673518,0.957033336763963,8,40,cellular response to calcium ion,BP,FOS;CARF;RASA4;PKD2;DMTN;ENDOG;SPAG16;BRAF
8568,GO:0034061,0.0973406727097264,0.959880410226289,7,34,DNA polymerase activity,MF,POLD4;PRIMPOL;POLM;TEP1;POLL;TERC;HMBOX1
15796,GO:0072524,0.0973543806862888,0.938888889973793,21,132,pyridine-containing compound metabolic process,BP,H6PD;NT5E;NAPRT;IDH2;PGM1;DHTKD1;PCK2;PGLS;DDIT4;OGDHL;NMRK1;NMNAT2;PSAT1;PPARA;KCNAB2;MLXIPL;GALK1;NADK;ALDOC;INSR;PFKL
4020,GO:0009056,0.0973732895087706,0.914906182711689,251,1986,catabolic process,BP,XDH;NT5E;APOE;BTBD2;SERPINE2;GID4;PRODH;H1F0;PYGB;ALDH7A1;TYSND1;FBXO2;TMEM129;EDEM1;CRAT;GLUL;AIG1;GPX3;LRP1;TIMP2;NTSR1;EGFR;RBCK1;NR1D1;ADAMTS7;HADH;PRDX5;RAPGEF3;RNPEPL1;CST3;NOS1;GPSM1;DDIT3;DNPH1;ACAD10;PGM1;PACS2;MRC2;GGT1;ADAMTS13;ABTB1;COL13A1;ARRDC1;TRIM65;ZFP36L1;CUL9;GAA;PYGL;MMP1;CYP3A5;DHTKD1;ALDH4A1;HSD17B14;RPL13A;ULK2;CTSF;RNF165;CPT2;MLYCD;FBXW4;PLD3;CUL7;EPM2A;ATG16L2;HMGCL;HYAL1;NAGLU;WWTR1;CYP27B1;PCK2;COL6A1;CRYL1;DDIT4;PLCH2;DNASE1L1;SNX9;MAGEF1;ULK1;VPS11;OGDHL;CIRBP;GALE;APOBEC3C;PHYH;BLVRB;CEMIP;GLDC;CBS;USP20;ITGB4;NEIL1;ETFB;GSTO1;TRIB2;GPT2;PNPLA3;RNF44;PLCD3;PLA2G6;CES3;APOBEC3F;PPARA;CHAC1;SESN2;BLMH;COL8A1;ACACB;NT5C1B;MAPK3;CSPG4;BNIP3;THRA;PAN2;CTSB;MVB12B;LTA4H;SDC2;MLXIPL;TBC1D14;PLCD1;SRD5A3;HIBADH;TECPR1;LRSAM1;UBXN4;FBXO6;PKD1;FUCA1;AZIN2;HSD11B1;GTPBP1;SORL1;GALK1;PCBP4;HERPUD1;GSTM2;VLDLR;CES2;COL4A6;ENDOG;RHBDF1;ACOT7;LRP5;ATRAID;ALDOC;PCSK9;FBXL15;ACADS;ISG20;LONP2;MAP1LC3A;PDE2A;SMURF2;TRIB3;DAP;ALDH1L2;CDK5RAP3;NOS3;AGO4;HEXB;BNIP3L;PIK3R2;SHARPIN;VPS39;GLUD1;ERN1;FYCO1;MAN2C1;NBR1;CPT1C;HEXA;CYP2R1;ATP2B4;THNSL2;CTSH;ACOX3;ACAD11;PNRC1;GSTO2;ENTPD6;AKT1;CHEK2;PHYKPL;WDR45;TSG101;IGF2BP2;TCIRG1;HAGH;ACADVL;DNASE2;FAAH;UPP1;SPSB3;ATG2A;C9ORF72;CAPN2;MAN2B1;SPATA18;INSR;ANKZF1;CHMP4C;PNPLA4;TPCN1;ALDH1L1;PLB1;CAT;TIMP1;HFE;SNX33;TFEB;PEX7;SNX17;CSNK1E;HGSNAT;SAT2;RNF213;GSTM3;TKFC;FYN;ZC3H12D;SNX1;UBXN6;SIRT2;TST;GOLGA2;ADA;NAGA;MTA1;ENTPD2;AP2A2;CIDEA;RPL29;RNPEP;MAN1B1;GALNS;LAMTOR2;DHPS;IGF2BP3;WFS1;CTH;EIF2AK4;SYVN1;PFKL;RPL12;MMP19;LYPLAL1;NUDT18;KCTD13;PNKD;ACOT8;BTBD11
6753,GO:0030193,0.0974662426440379,0.954413920866729,9,47,regulation of blood coagulation,BP,F2R;APOE;SERPINE2;CD9;PLAT;SERPING1;DMTN;NOS3;PLAU
17330,GO:1900046,0.0974662426440379,0.954413920866729,9,47,regulation of hemostasis,BP,F2R;APOE;SERPINE2;CD9;PLAT;SERPING1;DMTN;NOS3;PLAU
14101,GO:0060993,0.0975475957903461,0.950313753264247,11,60,kidney morphogenesis,BP,CTNNBIP1;PGF;VEGFA;WWTR1;LAMA5;WNT2B;PKD2;VANGL2;KIF26B;PKD1;WNK4
4889,GO:0014819,0.0976511148617517,0.988588906872897,2,5,regulation of skeletal muscle contraction,BP,GSTO1;GSTM2
4179,GO:0009260,0.0976779735998186,0.934321269998316,28,185,ribonucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;PGM1;DHTKD1;DDIT4;OGDHL;NPR2;NME4;PPCS;PPARA;MLXIPL;PTHLH;LTB4R2;GALK1;GABBR1;ACOT7;ALDOC;TMSB4X;NOS3;UCKL1;ADCY6;TCIRG1;UPP1;INSR;APRT;TAZ;PFKL
18645,GO:1904018,0.0978035800880589,0.941098096935413,18,110,positive regulation of vasculature development,BP,EGR1;PGF;VEGFA;RAPGEF3;HYAL1;BTG1;VEGFB;ADM2;C5;HMGA2;ECM1;SEMA5A;ANGPTL4;TGFBR2;NOS3;EPHA1;CTSH;CTH
7926,GO:0032515,0.0979130379324592,0.959586304372121,7,34,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R35;PHACTR3;PPP1R14A;ELFN2;PPP1R15A;CRY2;IKBKB
4959,GO:0015038,0.0979251943571377,0.988537715514381,2,5,glutathione disulfide oxidoreductase activity,MF,GSTO1;GSTO2
12638,GO:0050866,0.0980358158868874,0.941907858305923,17,103,negative regulation of cell activation,BP,APOE;SERPINE2;IL20RB;PRNP;CD9;PKN1;INPP5D;PDCD1LG2;CEBPB;NOS3;BCR;HFE;JAK3;BCL6;ERBB2;PAG1;HLA-G
6715,GO:0030133,0.0983419792100693,0.930070461720779,37,253,transport vesicle,CC,PTPRS;DLG4;SYTL1;CLTCL1;DNM1;BRSK1;SYT8;SYNGR1;RAB3B;PCSK1;MCTP1;FGFR3;TMEM187;VAMP2;AREG;AP1G2;SEPT5;PI4K2A;NRSN2;SV2A;AZIN2;MAP6;DBNDD1;RAB40B;STEAP2;SEPT6;FGFR4;RASSF9;COPG1;ICA1;YIPF3;RABAC1;RAB13;STX1A;SEC31B;HLA-G;APBA1
14266,GO:0061387,0.0983754113863293,0.946555041625965,13,74,regulation of extent of cell growth,BP,PTPRS;APOE;SEMA4B;VEGFA;ULK2;PAK1;SEMA3F;LPAR3;SEMA5A;TWF2;SEMA3B;SEMA4G;WNT3
6878,GO:0030395,0.0984389559768711,1,1,1,lactose binding,MF,LGALS1
8595,GO:0034117,0.0984389559768711,1,1,1,erythrocyte aggregation,BP,LGALS1
8596,GO:0034118,0.0984389559768711,1,1,1,regulation of erythrocyte aggregation,BP,LGALS1
8597,GO:0034120,0.0984389559768711,1,1,1,positive regulation of erythrocyte aggregation,BP,LGALS1
12059,GO:0048030,0.0984389559768711,1,1,1,disaccharide binding,MF,LGALS1
9976,GO:0042402,0.0984557859852163,0.979264683771082,3,10,cellular biogenic amine catabolic process,BP,ALDH7A1;SAT2;DHPS
7199,GO:0031099,0.0987475453320241,0.939524683952599,19,118,regeneration,BP,PTPRS;APOE;GSN;PGF;POSTN;EGFR;MAP2K1;ULK1;LAMB2;SRSF5;SULF2;CEBPB;PTPRU;TGFBR2;WNT7A;GAS6;BRAF;HFE;TGFBR3
8708,GO:0034367,0.0988226006706894,0.979153415687283,3,10,protein-containing complex remodeling,BP,APOE;ABCG1;PLTP
4492,GO:0010522,0.0989917204142114,0.9513296633287,10,54,regulation of calcium ion transport into cytosol,BP,F2R;NTSR1;PRNP;NOS1;CEMIP;GSTO1;PKD2;GSTM2;FYN;TRPC1
12447,GO:0050337,0.099017532240021,1,1,1,thiosulfate-thiol sulfurtransferase activity,MF,TSTD1
7688,GO:0032154,0.0990529548271257,0.953514387934655,9,47,cleavage furrow,CC,RAB11FIP4;PKN1;PITPNM1;PLCD3;SSH1;NDE1;PLEKHG6;SEPT6;SPIRE1
12289,GO:0048661,0.0990554902682191,0.951292130756841,10,54,positive regulation of smooth muscle cell proliferation,BP,EGFR;MEF2D;HBEGF;PAK1;EREG;TGFBR2;ERN1;PTAFR;AKT1;ITGA2
12339,GO:0048739,0.0992712413569974,0.982961740219633,3,6,cardiac muscle fiber development,BP,VEGFA;MYH11;TTN
11869,GO:0046906,0.0994327820574478,0.949118134036044,11,61,tetrapyrrole binding,MF,NR1D1;NOS1;HEBP1;CYP3A5;CYP27B1;CBS;SLC48A1;NOS3;CYP2R1;CAT;CYP4V2
16188,GO:0090257,0.0995144745923933,0.938991468694877,19,118,regulation of muscle system process,BP,DOCK4;F2R;NOS1;PAK1;GSTO1;MTMR4;ERRFI1;GSTM2;NOS3;TNNI2;PTAFR;ATP2B4;TNNT1;LMNA;CHRM3;EHD3;ADA;ITGA2;TNNI1
3042,GO:0006598,0.0997841345143452,0.988188102086073,2,5,polyamine catabolic process,BP,SAT2;DHPS
19160,GO:1905271,0.0998971527057736,1,1,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,TMSB4X
19161,GO:1905273,0.0998971527057736,1,1,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,TMSB4X
16250,GO:0090343,0.100076394068979,0.978771605147945,3,10,positive regulation of cell aging,BP,HMGA2;LMNA;YPEL3
5685,GO:0016810,0.10015688264947,0.939457081749975,18,111,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,PADI3;ADARB1;OPLAH;PHF21A;HDAC11;APOBEC3C;APOBEC3F;CHD3;HDAC5;ACY1;HMG20B;FAAH;CAT;MTA3;SIRT2;ADA;MTA1;HDAC8
12708,GO:0050995,0.100182455712874,0.978739201257585,3,10,negative regulation of lipid catabolic process,BP,ACACB;AKT1;CIDEA
18130,GO:1902904,0.100214506921809,0.942664349435059,15,89,negative regulation of supramolecular fiber organization,BP,GSN;SPTB;ARAP1;ARPIN;CAPG;EML2;TTBK2;ARHGEF2;TWF2;DMTN;TRIOBP;TMSB4X;TMOD2;CORO1B;PLEKHH2
12811,GO:0051145,0.100245843542309,0.958382702601639,7,34,smooth muscle cell differentiation,BP,NFATC4;PDCD4;VEGFA;EREG;OLFM2;FOXO4;CTH
14932,GO:0070851,0.100360652954247,0.943844785023976,14,82,growth factor receptor binding,MF,PGF;VEGFA;HBEGF;SHC1;VEGFB;EREG;AREG;ECM1;ERN1;FYN;SNX1;VAV3;FRS3;HIP1
4290,GO:0009725,0.100413289808602,0.919265210621796,87,643,response to hormone,BP,BBS2;FOS;EGR1;PGF;POSTN;FAM210B;TIMP2;EGFR;NR1D1;HADH;CST3;NOS1;ZFP36L1;SLC27A1;KLF9;PCK2;ABCA2;DDIT4;BTG1;SHC1;PRKCZ;PAK1;KDM3A;NGFR;EREG;PTPRE;PSPH;ABCG1;PPARA;SESN2;VAMP2;AREG;SLIT3;MAPK3;ERRFI1;THRA;CTSB;PAQR6;MDK;HDAC5;SRSF5;ENDOG;LRP5;PTPRU;CREBRF;PCSK9;DNMT3A;TGFBR2;TRPV4;TRIB3;CALCOCO1;NOS3;WNT7A;TRPV1;PIK3R2;TADA3;PTAFR;RXRA;ADCY6;CTSH;ASNS;STEAP2;AKT1;IGFBP7;CRY2;CHEK2;IGFBP2;PIAS3;TCIRG1;INSR;FOXO4;BRAF;GPR21;CAT;TIMP1;JAK3;CHRM3;APRT;FYN;RAB13;EIF4EBP1;TGFBR3;PER1;ITGA2;GRB10;MMP19;BSG
16953,GO:0099024,0.100436007418142,0.958284242860623,7,34,plasma membrane invagination,BP,GSN;SNX9;ABCA7;ARHGAP25;SNX33;SPIRE1;ITGA2
3306,GO:0007009,0.100470141878348,0.948543309857909,11,60,plasma membrane organization,BP,GSN;ANK3;NDRG1;SNX9;SH3TC2;DYSF;FLOT1;ANO9;AKT1;MYOF;SNX33
4705,GO:0010872,0.101243460420264,0.987910710391932,2,5,regulation of cholesterol esterification,BP,APOE;ABCG1
710,GO:0001936,0.10125915052537,0.94467790112252,13,75,regulation of endothelial cell proliferation,BP,XDH;APOE;PGF;VEGFA;VEGFB;PLXNB3;NGFR;ECM1;SEMA5A;EGFL7;APLN;AKT1;FGFR1
7951,GO:0032559,0.101272018859124,0.914172282875774,154,1168,adenyl ribonucleotide binding,MF,ACTA2;ACSF2;PTK6;GLUL;OBSCN;EGFR;SCN8A;NEK9;RAPGEF3;DGKA;BRSK1;ERCC6;MYH15;SMARCA1;MST1R;CUL9;RPS6KA2;PYGL;TK2;ULK2;MAPK13;CDK18;MAP2K1;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TMEM173;DNAH1;ULK1;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;ABCG1;CARS;KIF17;CHD3;MKNK2;NLRX1;ACACB;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;MAPK12;MYH3;PI4K2A;MAP2K2;TWF2;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;PDE2A;TRIB3;MLH3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;ATP2B4;STRADB;ASNS;AKT1;DGUOK;CHEK2;ASS1;KIF27;FGFR4;MARK4;INSR;ACSS1;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;APRT;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;RECQL5;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
5535,GO:0016529,0.101364657994446,0.957802678661187,7,34,sarcoplasmic reticulum,CC,XDH;ANK3;NOS1;ITPR3;GSTM2;ITPR2;RTN2
12799,GO:0051128,0.101385712357134,0.911713858412971,230,1799,regulation of cellular component organization,BP,PTPRS;DLG4;HTRA1;APOE;ESPN;ZMYND8;NFATC4;SERPINE2;FHL1;GSN;ADGRL1;CTNNBIP1;POSTN;EVI5L;WIPF1;PTK6;CDC42EP5;SEMA4B;LRP1;VEGFA;EGFR;DDB2;PRNP;ERCC1;FBLN1;IFT140;RAPGEF3;SPTB;TSPAN1;IGFBP4;CST3;PARVB;NOS1;ARAP3;DNPH1;SHANK2;CRTC1;ADGRB2;TBC1D8;ARHGEF19;CUL9;ARAP1;HBEGF;MMP1;CNTN1;TFDP2;EFNB3;RPL13A;OBSL1;LTBP4;ULK2;CUL7;HYAL1;ARPIN;MAP2K1;CYP27B1;CAPG;BTG1;TOM1L2;SYNGAP1;EML2;SNX9;FAM110C;ARL2;ULK1;VPS11;SPRY2;NPHP4;NLGN2;CAPRIN2;TTBK2;PRKCZ;PAK1;ABCA7;MCTP1;KDM3A;MTHFR;PHF1;SEMA3F;PLXNB3;SYNE3;ZSWIM4;MICALL2;CEP250;FBXW8;NEURL1;NGFR;ETV5;PLXNB1;EREG;SSH3;RMI2;PLEKHG2;RHOBTB2;PLA2G6;LPAR3;S100A13;STON1;SESN2;IMPACT;SLIT3;MAPK3;BNIP3;SEMA5A;THRA;VANGL2;RHOF;PLEK2;SLITRK6;SDC2;CHMP1B;TBC1D14;ARHGEF2;TSPYL2;MAP2K2;TWF2;STMN3;LRSAM1;DMTN;SEMA3B;BBC3;KDM4C;DOCK11;SSH1;TBC1D3E;METRN;RABGAP1;TENM2;PKD1;FLOT1;JDP2;WHAMMP3;SORL1;VLDLR;TPBG;ENDOG;LRP5;PCSK9;PKIB;L3MBTL1;CEP131;TRIOBP;TRPV4;TMSB4X;APLN;PEMT;AGO4;HEXB;PROM2;WNT7A;BNIP3L;EPHA1;SEMA4G;FMNL2;GAS6;DNAJC6;CROCC;BCR;FYCO1;TADA3;KIF13B;CAMK1;PPP1R15A;ADCY6;AKT1;IGFBP7;DGUOK;AMIGO2;IGFBP2;TSG101;FMNL3;PHF2;FGFR4;TMOD2;ASAP3;LMNA;C9ORF72;SGSM2;CHMP5;UHRF2;CAPN2;INSR;WNT3;RPS6KA5;CHMP4C;C6ORF89;MAP2K5;BRAF;ARHGAP44;LGALS1;HFE;TP73;SNX33;FCHSD1;SNX17;SPIRE1;CSNK1E;BCL6;EPS8L1;EHD3;FYN;SIRT2;GDF15;CELSR1;PLXND1;RHOBTB3;CIDEA;EPS8L2;HDAC8;MYO18A;CIDEB;STX1A;LAMTOR2;TBC1D16;EPHB2;ITGA2;FGFR1;FITM2;ERBB2;UST;UNC119;OSCP1;C15ORF62;CORO1B;HMBOX1;NET1;ZMYM3;IKBKB;HIP1;PLEKHH2
12775,GO:0051093,0.101494517315026,0.919572658069199,76,558,negative regulation of developmental process,BP,XDH;PTPRS;BBS2;APOE;NFATC4;POSTN;WWC3;SEMA4B;LRP1;PDCD4;EGFR;FBLN1;ADAMTS7;RAPGEF3;IDH2;CST3;DDIT3;ADGRB2;ZFP36L1;EFNB3;ULK2;ARPIN;WWTR1;SYNGAP1;SPRY2;PAK1;FGFR3;NPR2;SEMA3F;NGFR;TRIB2;EREG;ABCG1;PPARA;HMGA2;AREG;ECM1;BNIP3;SEMA5A;ARHGEF2;INPP5D;DMTN;SEMA3B;PTHLH;ZFPM1;JDP2;HDAC5;SORL1;LRP5;TGFBR2;TRPV4;TRIB3;WNT7A;TRPV1;SEMA4G;GAS6;BCR;NBR1;TERC;ADCY6;DGUOK;WNT3;FOXO4;MAP2K5;LGALS1;TIMP1;JAK3;TP73;BCL6;SIRT2;HDAC8;EPHB2;ERBB2;EIF2AK4;HLA-G;KCTD11
8034,GO:0032693,0.101626309705659,0.978296443509759,3,10,negative regulation of interleukin-10 production,BP,TRIB2;PDCD1LG2;JAK3
18252,GO:1903169,0.101808088514266,0.944327203785203,13,75,regulation of calcium ion transmembrane transport,BP,F2R;GJC2;NTSR1;PRNP;NOS1;CEMIP;GSTO1;PLA2G6;PKD2;GSTM2;EHD3;FYN;TRPC1
8125,GO:0032835,0.101954240662434,0.957496303817306,7,34,glomerulus development,BP,ACTA2;EGR1;WWTR1;NID1;LAMB2;VANGL2;SULF2
17263,GO:0140056,0.101960161029981,0.933461775321066,24,155,organelle localization by membrane tethering,BP,NINL;SNPH;EXOC2;SDCCAG8;VPS11;NPHP4;RAB3B;TTBK2;CEP250;ESYT2;CNTRL;TCTN1;FBF1;TSNARE1;NDE1;CEP131;RAB40B;MARK4;HAUS4;CSNK1E;RAB13;STX1A;ESYT3;SFI1
3189,GO:0006816,0.10209262692882,0.929562398394805,31,207,calcium ion transport,BP,F2R;GJC2;NTSR1;PRNP;NOS1;DDIT3;ORAI3;CYP27B1;ITPR3;CEMIP;ORAI2;GSTO1;PLA2G6;LPAR3;PKD2;PKD1;GSTM2;TRPV4;PDE2A;NOS3;TRPV1;GAS6;ATP2B4;ITPR2;TPCN1;HOMER2;ASIC1;EHD3;FYN;TRPC1;WFS1
15571,GO:0072078,0.102098007165875,0.951778479419434,9,47,nephron tubule morphogenesis,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B;PKD1;WNK4
10298,GO:0043096,0.10213172032579,0.987740608210306,2,5,purine nucleobase salvage,BP,APRT;ADA
790,GO:0002055,0.102133030107566,1,1,1,adenine binding,MF,APRT
1586,GO:0003999,0.102133030107566,1,1,1,adenine phosphoribosyltransferase activity,MF,APRT
7010,GO:0030730,0.10231069204221,0.97808551798056,3,10,sequestering of triglyceride,BP,PPARA;CIDEA;FITM2
11688,GO:0046500,0.102329667713955,0.978079660022095,3,10,S-adenosylmethionine metabolic process,BP,GAMT;MTHFR;PEMT
12568,GO:0050768,0.102385454745986,0.931350753402308,27,177,negative regulation of neurogenesis,BP,PTPRS;APOE;NFATC4;SEMA4B;LRP1;IDH2;EFNB3;ULK2;SYNGAP1;SEMA3F;NGFR;SEMA5A;ARHGEF2;SEMA3B;SORL1;TRPV4;WNT7A;SEMA4G;ADCY6;DGUOK;WNT3;LGALS1;TP73;SIRT2;EPHB2;EIF2AK4;KCTD11
3889,GO:0008528,0.102478805281474,0.960806717031702,6,28,G-protein coupled peptide receptor activity,MF,F2R;NTSR1;MC1R;LTB4R2;LTB4R;EDNRA
4107,GO:0009166,0.102557382102972,0.935982557691976,20,126,nucleotide catabolic process,BP,XDH;NT5E;RAPGEF3;DNPH1;PGM1;DHTKD1;DDIT4;OGDHL;NEIL1;PPARA;NT5C1B;MLXIPL;GALK1;ALDOC;PDE2A;UPP1;INSR;ADA;PFKL;NUDT18
767,GO:0002021,0.102724417177601,0.977957678963316,3,10,response to dietary excess,BP,APOE;TRPV4;TRPV1
18077,GO:1902743,0.102810605614575,0.957050416131702,7,34,regulation of lamellipodium organization,BP,ARPIN;PLXNB3;SSH3;TWF2;DMTN;SSH1;CORO1B
4591,GO:0010711,0.102813971404738,1,1,1,negative regulation of collagen catabolic process,BP,CST3
13711,GO:0060309,0.102813971404738,1,1,1,elastin catabolic process,BP,CST3
13712,GO:0060310,0.102813971404738,1,1,1,regulation of elastin catabolic process,BP,CST3
13713,GO:0060311,0.102813971404738,1,1,1,negative regulation of elastin catabolic process,BP,CST3
4886,GO:0014810,0.102987614531561,1,1,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,GSTO1
11404,GO:0045838,0.1030172339662,0.977867050164482,3,10,positive regulation of membrane potential,BP,ANK3;AKT1;PIAS3
3321,GO:0007031,0.103330228748048,0.960391524735945,6,28,peroxisome organization,BP,PEX10;LONP2;PEX7;PEX1;PEX11A;ACOT8
7395,GO:0031467,0.103535963926877,0.987469754780076,2,5,Cul7-RING ubiquitin ligase complex,CC,CUL7;FBXW8
19916,GO:2000483,0.103557016358511,0.987465676087126,2,5,negative regulation of interleukin-8 secretion,BP,TMSB4X;MAPKBP1
6967,GO:0030638,0.1036285046069,0.987451821994304,2,5,polyketide metabolic process,BP,AKR7A2;CBR4
6971,GO:0030647,0.1036285046069,0.987451821994304,2,5,aminoglycoside antibiotic metabolic process,BP,AKR7A2;CBR4
10921,GO:0044597,0.1036285046069,0.987451821994304,2,5,daunorubicin metabolic process,BP,AKR7A2;CBR4
10922,GO:0044598,0.1036285046069,0.987451821994304,2,5,doxorubicin metabolic process,BP,AKR7A2;CBR4
15204,GO:0071385,0.103885952489356,0.953344328296262,8,41,cellular response to glucocorticoid stimulus,BP,EGFR;ZFP36L1;KLF9;PCK2;DDIT4;ERRFI1;CREBRF;EIF4EBP1
3287,GO:0006979,0.103903964094021,0.923220216861648,45,318,response to oxidative stress,BP,APOE;FOS;PRODH;NAPRT;GPX3;EGFR;PRNP;ERCC1;PRDX5;CST3;ERCC6;PYCR2;MSRB2;MAPK13;HYAL1;TXNRD3;BTG1;MCTP1;NEIL1;ETV5;SESN2;IMPACT;PKD2;STAT6;AREG;MAPK3;BNIP3;SCARA3;RGS14;ATF4;ENDOG;MAP1LC3A;NOS3;CCS;MGMT;AKT1;NCOA7;ANKZF1;TXNRD2;CAT;SIRT2;ADA;EPAS1;CHD6;NET1
6578,GO:0022412,0.103931864356731,0.929644073962331,28,185,cellular process involved in reproduction in multicellular organism,BP,BBS2;ERCC1;CD9;DNAH1;PABPC1L;KDM3A;NPR2;ZP3;NEURL1;ETV5;EREG;SLIT3;TDRKH;DEAF1;RFX2;DNMT3A;MLH3;AGO4;HEXB;SPAG16;AKT1;CABYR;TBC1D20;SPIRE1;REC8;SIRT2;ZNF449;SIX5
7841,GO:0032410,0.104115104908628,0.953217922796642,8,41,negative regulation of transporter activity,BP,ANK3;STK39;GSTO1;PKD2;GSTM2;PCSK9;ANO9;EPHB2
26,GO:0000050,0.104174332943218,0.977507707348639,3,10,urea cycle,BP,NAGS;ASS1;NMRAL1
6184,GO:0019627,0.104174332943218,0.977507707348639,3,10,urea metabolic process,BP,NAGS;ASS1;NMRAL1
3558,GO:0007601,0.104323948537646,0.941260274408862,14,82,visual perception,BP,BBS2;BBS1;EML2;OLFM2;LAMB2;SLITRK6;REEP6;SPATA7;RABGGTA;HSF4;EPAS1;WFS1;UNC119;CYP4V2
12693,GO:0050953,0.104323948537646,0.941260274408862,14,82,sensory perception of light stimulus,BP,BBS2;BBS1;EML2;OLFM2;LAMB2;SLITRK6;REEP6;SPATA7;RABGGTA;HSF4;EPAS1;WFS1;UNC119;CYP4V2
5682,GO:0016803,0.104348013894408,0.977453603086583,3,10,ether hydrolase activity,MF,AKR7A2;LTA4H;RNPEP
10080,GO:0042602,0.104391731313842,1,1,1,riboflavin reductase (NADPH) activity,MF,BLVRB
551,GO:0001673,0.104413674317499,0.977433137541773,3,10,male germ cell nucleus,CC,TCFL5;MLH3;REC8
3277,GO:0006958,0.104556175738342,0.977388700241111,3,10,complement activation, classical pathway,BP,SERPING1;C5;C1RL
7408,GO:0031507,0.104679690023825,0.977350160188103,3,10,heterochromatin assembly,BP,BAHCC1;HMGA2;TNRC18
16148,GO:0090195,0.104809648332388,0.97730958570683,3,10,chemokine secretion,BP,POSTN;ALOX15B;C5
10351,GO:0043184,0.104940850071581,0.987196404723796,2,5,vascular endothelial growth factor receptor 2 binding,MF,VEGFA;VEGFB
10343,GO:0043174,0.105066454998126,0.969691493879059,4,16,nucleoside salvage,BP,TK2;UCKL1;UPP1;APRT
14905,GO:0070813,0.105128564862764,0.987159701485204,2,5,hydrogen sulfide metabolic process,BP,CBS;CTH
6881,GO:0030421,0.105132383967618,1,1,1,defecation,BP,MDK
4030,GO:0009066,0.105151837398342,0.952645141495076,8,41,aspartate family amino acid metabolic process,BP,ALDH7A1;MTHFR;NMNAT2;THNSL2;ASNS;PHYKPL;ASS1;CTH
11072,GO:0045091,0.105181207719884,0.977193446575294,3,10,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,APOBEC3C;APOBEC3F;HMGA2
4236,GO:0009438,0.105304983296225,0.987125168480721,2,5,methylglyoxal metabolic process,BP,HAGH;PNKD
16177,GO:0090237,0.105311372695537,0.987123917088615,2,5,regulation of arachidonic acid secretion,BP,NTSR1;PLA2G6
10813,GO:0044324,0.105351960118692,1,1,1,regulation of transcription involved in anterior/posterior axis specification,BP,DDIT3
19665,GO:2000016,0.105351960118692,1,1,1,negative regulation of determination of dorsal identity,BP,DDIT3
82,GO:0000166,0.105429364363421,0.908558904384729,210,1628,nucleotide binding,MF,XDH;H6PD;ACTA2;NT5E;PRODH;ACSF2;PTK6;GLUL;OBSCN;EGFR;D2HGDH;SCN8A;HADH;NEK9;RAPGEF3;DGKA;IDH2;DNM1;NOS1;BRSK1;ACAD10;ERCC6;MYH15;SMARCA1;MST1R;CUL9;PHGDH;RPS6KA2;PYGL;TK2;ULK2;SLC27A1;MAPK13;CDK18;TXNRD3;MAP2K1;PCK2;CRYL1;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TUBG2;TMEM173;DNAH1;ARL2;ULK1;VPS11;RAB3B;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;MTHFR;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;RHOBTB2;ABCG1;AGAP1;CARS;KIF17;CHD3;MKNK2;IFT27;NLRX1;SEPT5;ACACB;NT5C1B;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;RHOF;TUBE1;MAPK12;MYH3;PI4K2A;SEPT10;MAP2K2;HIBADH;TWF2;SDHA;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GTPBP1;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;ACADS;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;PDE2A;TRIB3;RAB40B;ARL10;MLH3;NOS3;MINK1;SLC27A3;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;NUDT6;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;MBD1;RAB43;ATP2B4;STRADB;ACOX3;ACAD11;ASNS;TM7SF2;HINT2;AKT1;DGUOK;MICAL1;CRY2;CHEK2;SEPT6;ASS1;KIF27;FGFR4;CBR4;ACADVL;MARK4;RAB25;INSR;ACSS1;GNAL;RPS6KA5;LTB4R;TXNRD2;MAP2K5;BRAF;CAT;MAPK10;JAK3;APRT;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;SIRT2;RECQL5;RAB13;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;SEPT8;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
9398,GO:0035976,0.105660498072493,0.98705546498541,2,5,transcription factor AP-1 complex,CC,FOS;DDIT3
10459,GO:0043369,0.105688645800049,0.97703451511957,3,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,STAT6;ZFPM1;BRAF
10347,GO:0043178,0.10573801457872,0.949607082684858,9,48,alcohol binding,MF,APOE;OSBPL5;ITPR3;ABCG1;OSBPL10;PROM2;ITPR2;ADAP1;TRPC1
7739,GO:0032262,0.106045505397484,0.986979808360607,2,5,pyrimidine nucleotide salvage,BP,UCKL1;UPP1
7032,GO:0030814,0.106090284894977,0.959038389043625,6,28,regulation of cAMP metabolic process,BP,TIMP2;RAPGEF3;PKD2;PTHLH;LTB4R2;GABBR1
12970,GO:0051410,0.106191031327829,0.98695116529615,2,5,detoxification of nitrogen compound,BP,GSTM2;GSTM3
3985,GO:0008859,0.106199937238702,1,1,1,exoribonuclease II activity,MF,ISG20
50,GO:0000104,0.106235917220602,0.986942325540994,2,5,succinate dehydrogenase activity,MF,SDHA;SDHAF4
2499,GO:0005749,0.106235917220602,0.986942325540994,2,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,SDHA;SDHAF4
3676,GO:0008177,0.106235917220602,0.986942325540994,2,5,succinate dehydrogenase (ubiquinone) activity,MF,SDHA;SDHAF4
11159,GO:0045257,0.106235917220602,0.986942325540994,2,5,succinate dehydrogenase complex (ubiquinone),CC,SDHA;SDHAF4
11164,GO:0045273,0.106235917220602,0.986942325540994,2,5,respiratory chain complex II,CC,SDHA;SDHAF4
11168,GO:0045281,0.106235917220602,0.986942325540994,2,5,succinate dehydrogenase complex,CC,SDHA;SDHAF4
11170,GO:0045283,0.106235917220602,0.986942325540994,2,5,fumarate reductase complex,CC,SDHA;SDHAF4
4898,GO:0014831,0.106267097264979,0.986936183574795,2,5,gastro-intestinal system smooth muscle contraction,BP,SULF2;PTAFR
8172,GO:0032919,0.106360081083705,1,1,1,spermine acetylation,BP,SAT2
8173,GO:0032920,0.106360081083705,1,1,1,putrescine acetylation,BP,SAT2
11581,GO:0046204,0.106360081083705,1,1,1,nor-spermidine metabolic process,BP,SAT2
16402,GO:0097067,0.106419392122081,0.976804993830222,3,10,cellular response to thyroid hormone stimulus,BP,KLF9;CTSB;CTSH
13014,GO:0051494,0.106424563995865,0.937281032643327,16,97,negative regulation of cytoskeleton organization,BP,ESPN;GSN;SPTB;ARAP1;ARPIN;CAPG;EML2;TTBK2;ARHGEF2;TWF2;DMTN;TRIOBP;TMSB4X;TMOD2;CORO1B;PLEKHH2
5633,GO:0016723,0.106501016177392,0.976779308911728,3,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,CYBRD1;STEAP2;STEAP3
17150,GO:0102991,0.106584390030539,0.986873615892751,2,5,myristoyl-CoA hydrolase activity,MF,ACOT1;ACOT7
17440,GO:1900273,0.10685313179429,0.976668398253325,3,10,positive regulation of long-term synaptic potentiation,BP,CRTC1;EPHB2;EIF2AK4
270,GO:0000773,0.106871081821953,1,1,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,PEMT
1912,GO:0004608,0.106871081821953,1,1,1,phosphatidylethanolamine N-methyltransferase activity,MF,PEMT
15945,GO:0080101,0.106871081821953,1,1,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,PEMT
8011,GO:0032653,0.106884039470597,0.963208746579943,5,22,regulation of interleukin-10 production,BP,IL20RB;PRKCZ;TRIB2;PDCD1LG2;JAK3
10880,GO:0044441,0.106903643629912,0.922674099234018,39,269,ciliary part,CC,BBS2;IFT140;SHANK2;EVC;BBS1;DNAH1;NPHP4;TTBK2;WDR60;KIF17;IFT27;PKD2;CNTRL;TCTN1;FBF1;PKD1;NEK8;CEP131;PROM2;CEP126;CROCC;SPAG16;ATP2B4;SPATA7;WDR19;TMEM80;AKT1;IFT57;SEPT6;WDR66;CABYR;MARK4;UNC119B;SCNN1A;GSTM3;EHD3;SPATA6;UNC119;TCTEX1D4
17904,GO:1902259,0.106920249522151,0.976647237151106,3,10,regulation of delayed rectifier potassium channel activity,BP,KCNG1;ANK3;VAMP2
17366,GO:1900120,0.107002129013368,0.968929192597108,4,16,regulation of receptor binding,BP,PCSK9;LDOC1;HFE;PHLDA2
17575,GO:1901265,0.107071548009293,0.907077418297972,210,1629,nucleoside phosphate binding,MF,XDH;H6PD;ACTA2;NT5E;PRODH;ACSF2;PTK6;GLUL;OBSCN;EGFR;D2HGDH;SCN8A;HADH;NEK9;RAPGEF3;DGKA;IDH2;DNM1;NOS1;BRSK1;ACAD10;ERCC6;MYH15;SMARCA1;MST1R;CUL9;PHGDH;RPS6KA2;PYGL;TK2;ULK2;SLC27A1;MAPK13;CDK18;TXNRD3;MAP2K1;PCK2;CRYL1;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TUBG2;TMEM173;DNAH1;ARL2;ULK1;VPS11;RAB3B;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;MTHFR;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;RHOBTB2;ABCG1;AGAP1;CARS;KIF17;CHD3;MKNK2;IFT27;NLRX1;SEPT5;ACACB;NT5C1B;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;RHOF;TUBE1;MAPK12;MYH3;PI4K2A;SEPT10;MAP2K2;HIBADH;TWF2;SDHA;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GTPBP1;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;ACADS;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;PDE2A;TRIB3;RAB40B;ARL10;MLH3;NOS3;MINK1;SLC27A3;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;NUDT6;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;MBD1;RAB43;ATP2B4;STRADB;ACOX3;ACAD11;ASNS;TM7SF2;HINT2;AKT1;DGUOK;MICAL1;CRY2;CHEK2;SEPT6;ASS1;KIF27;FGFR4;CBR4;ACADVL;MARK4;RAB25;INSR;ACSS1;GNAL;RPS6KA5;LTB4R;TXNRD2;MAP2K5;BRAF;CAT;MAPK10;JAK3;APRT;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;SIRT2;RECQL5;RAB13;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;SEPT8;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
3044,GO:0006601,0.107097625533527,1,1,1,creatine biosynthetic process,BP,GAMT
7011,GO:0030731,0.107097625533527,1,1,1,guanidinoacetate N-methyltransferase activity,MF,GAMT
7094,GO:0030899,0.10713233778707,1,1,1,calcium-dependent ATPase activity,MF,TNNT1
7383,GO:0031444,0.10713233778707,1,1,1,slow-twitch skeletal muscle fiber contraction,BP,TNNT1
3079,GO:0006655,0.107184153941103,0.976563970072691,3,10,phosphatidylglycerol biosynthetic process,BP,SLC27A1;PLA2G6;TAZ
1672,GO:0004138,0.107184335475218,1,1,1,deoxyguanosine kinase activity,MF,DGUOK
3931,GO:0008617,0.107184335475218,1,1,1,guanosine metabolic process,BP,DGUOK
4614,GO:0010737,0.107231919276569,0.964149174772617,5,18,protein kinase A signaling,BP,MC1R;AIP;TTN;PJA2;RAB13
19812,GO:2000311,0.107316774820608,0.97652208800437,3,10,regulation of AMPA receptor activity,BP,SHANK2;NLGN2;MINK1
12491,GO:0050655,0.107318506361786,0.976521541012485,3,10,dermatan sulfate proteoglycan metabolic process,BP,B3GAT3;CSPG4;UST
3150,GO:0006751,0.107342340022632,0.986723666969355,2,5,glutathione catabolic process,BP,GGT1;CHAC1
13553,GO:0060046,0.107377727899736,0.986716649247602,2,5,regulation of acrosome reaction,BP,ZP3;PLB1
19257,GO:1905516,0.107382867930136,0.986715629810827,2,5,positive regulation of fertilization,BP,ZP3;PLB1
6204,GO:0019722,0.107411211252913,0.937845250104397,15,90,calcium-mediated signaling,BP,NFATC4;ADGRL1;EGFR;PRNP;NOS1;ADGRB2;MCTP1;GSTO1;PKD2;DMTN;GSTM2;ATP2B4;HOMER2;ADA;MCTP2
4223,GO:0009404,0.107443224811672,0.968754707008984,4,16,toxin metabolic process,BP,CBS;GSTO1;GSTO2;CTH
7200,GO:0031100,0.10744326175077,0.946241533016221,10,55,animal organ regeneration,BP,PGF;EGFR;SRSF5;SULF2;CEBPB;PTPRU;TGFBR2;GAS6;HFE;TGFBR3
998,GO:0002467,0.107560644240713,0.976445007798703,3,10,germinal center formation,BP,PKN1;BCL6;ADA
6044,GO:0019184,0.107564688394569,0.968706608970493,4,16,nonribosomal peptide biosynthetic process,BP,GGT1;OPLAH;CHAC1;HAGH
14599,GO:0070193,0.107578456111847,0.976439374646837,3,10,synaptonemal complex organization,BP,MLH3;AGO4;REC8
8106,GO:0032803,0.107596746470659,0.986673182716668,2,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE;PCSK9
17532,GO:1901137,0.107608855284589,0.914535747749258,75,551,carbohydrate derivative biosynthetic process,BP,TNIP1;ST6GALNAC2;NT5E;APOE;LMF1;TIMP2;ADAMTS7;NOS1;PGM1;ADAMTS13;B3GAT3;HBEGF;PYGL;DHTKD1;TK2;HYAL1;CRYL1;DDIT4;VEGFB;OGDHL;ABCA7;CEMIP;NPR2;NME4;MUC19;PPCS;PPARA;ST6GALNAC6;B4GAT1;CSPG4;VANGL2;MVD;ADAMTSL1;SDC2;MLXIPL;SRD5A3;PTHLH;CHST6;LTB4R2;GALK1;GABBR1;ST3GAL3;ACOT7;ALDOC;FOXL1;TMSB4X;NOS3;PIGZ;HEXA;UCKL1;NECAB3;ADCY6;B4GALT2;TCIRG1;PHLDA1;UPP1;INSR;COG7;PIGQ;JAK3;APRT;MPI;TAZ;GOLGA2;ADA;FUK;MAN1B1;MFNG;PIGV;XYLT2;UST;SYVN1;PFKL;MPPE1;ACOT8
3947,GO:0008654,0.107655167945559,0.92396819643273,34,231,phospholipid biosynthetic process,BP,ISYNA1;DGKA;SLC27A1;PITPNM3;ACP6;LPCAT4;PITPNM1;DGKQ;FGFR3;ZP3;PNPLA3;PLA2G6;MTMR4;MVD;PI4K2A;INPP5D;SRD5A3;PEMT;PIGZ;HEXB;PIK3R2;CHKB;FGFR4;PIGQ;TAZ;MBOAT2;ETNK2;STARD10;INPP4A;FGFR1;PIGV;FITM2;MPPE1;PLEKHA4
20171,GO:2001057,0.107717616717044,0.94846074984555,9,48,reactive nitrogen species metabolic process,BP,ACP5;NOS1;PKD2;NOS3;TRPV1;ATP2B4;AKT1;ASS1;INSR
18454,GO:1903587,0.107865808690856,0.986619706143103,2,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA;NGFR
8341,GO:0033216,0.107990070558321,0.986594979734482,2,5,ferric iron import,BP,STEAP2;STEAP3
19714,GO:2000116,0.108033108958058,0.926508294205219,28,189,regulation of cysteine-type endopeptidase activity,BP,XDH;F2R;TNFRSF6B;GSN;VEGFA;PRDX5;TNFSF15;CST3;GRAMD4;RAG1;NGFR;BBC3;IFI6;HERPUD1;NLRP1;DAP;GAS6;CTSH;MGMT;AKT1;MICAL1;IFT57;IFI27;MAP2K5;PIDD1;FYN;CIDEB;HIP1
18620,GO:1903960,0.108371255576688,0.976188187342531,3,10,negative regulation of anion transmembrane transport,BP,STK39;ANO9;AKT1
266,GO:0000737,0.108395126482809,0.962525571594894,5,22,DNA catabolic process, endonucleolytic,BP,H1F0;DNASE1L1;ENDOG;DNASE2;CIDEA
7268,GO:0031260,0.108406246870361,1,1,1,pseudopodium membrane,CC,RAB25
16962,GO:0099068,0.108416236232723,0.976173909030367,3,10,postsynapse assembly,BP,SHANK2;NLGN2;WNT7A
1524,GO:0003905,0.108456050506489,1,1,1,alkylbase DNA N-glycosylase activity,MF,MPG
3956,GO:0008725,0.108456050506489,1,1,1,DNA-3-methyladenine glycosylase activity,MF,MPG
10638,GO:0043733,0.108456050506489,1,1,1,DNA-3-methylbase glycosylase activity,MF,MPG
10657,GO:0043916,0.108456050506489,1,1,1,DNA-7-methylguanine glycosylase activity,MF,MPG
13395,GO:0052821,0.108456050506489,1,1,1,DNA-7-methyladenine glycosylase activity,MF,MPG
13396,GO:0052822,0.108456050506489,1,1,1,DNA-3-methylguanine glycosylase activity,MF,MPG
8392,GO:0033344,0.108518311851733,0.962469732109806,5,22,cholesterol efflux,BP,APOE;LRP1;ABCA7;ABCG1;PLTP
5726,GO:0016877,0.108597580261716,0.95779970931804,6,28,ligase activity, forming carbon-sulfur bonds,MF,ACSF2;SLC27A1;ACSS2;SLC27A3;SUCLG2;ACSS1
3125,GO:0006707,0.108603754494247,0.98647259509382,2,5,cholesterol catabolic process,BP,APOE;SNX17
5351,GO:0016127,0.108603754494247,0.98647259509382,2,5,sterol catabolic process,BP,APOE;SNX17
19995,GO:2000646,0.108981316427586,0.986397076416999,2,5,positive regulation of receptor catabolic process,BP,APOE;PCSK9
6300,GO:0019934,0.108981889451345,0.986396961673681,2,5,cGMP-mediated signaling,BP,APOE;PDE2A
7722,GO:0032226,0.109107888712382,0.986371721864914,2,5,positive regulation of synaptic transmission, dopaminergic,BP,RAB3B;FLOT1
17549,GO:1901193,0.109127512499871,1,1,1,regulation of formation of translation preinitiation complex,BP,RPL13A
17550,GO:1901194,0.109127512499871,1,1,1,negative regulation of formation of translation preinitiation complex,BP,RPL13A
18909,GO:1904689,0.109127512499871,1,1,1,negative regulation of cytoplasmic translational initiation,BP,RPL13A
11266,GO:0045597,0.109152973077362,0.91247453490142,81,597,positive regulation of cell differentiation,BP,DLG4;APOE;ZMYND8;SERPINE2;FOS;CTNNBIP1;PTK6;FAM210B;GJC2;ALOX15B;TIMP2;VEGFA;SHANK2;CRTC1;ZFP36L1;CNTN1;OBSL1;CUL7;WWTR1;MAP2K1;CYP27B1;CCDC71L;BTG1;CAPRIN2;PRKCZ;PAK1;PLXNB3;FBXW8;NEURL1;ACVR2B;RAG1;NGFR;ETV5;PLXNB1;OLFM2;LPAR3;IMPACT;SEMA5A;THRA;IFITM1;RGS14;FAM20C;MAPK12;ARHGEF2;INPP5D;TWF2;DMTN;KDM4C;METRN;FLOT1;LTBP3;VLDLR;CEBPB;LRP5;ATRAID;TRIOBP;TGFBR2;HMG20B;GAS6;CAMK1;AKT1;WDFY2;WNT3;TENM4;BRAF;TP73;CSNK1E;BCL6;HSF4;FYN;SIRT2;GDF15;ADA;PLXND1;ADIRF;EPHB2;FGFR1;CTH;HLA-G;NET1;KCTD11
3395,GO:0007176,0.109161493874392,0.962177822788894,5,22,regulation of epidermal growth factor-activated receptor activity,BP,SHC1;NEURL1;EREG;ERRFI1;TSG101
7266,GO:0031256,0.109177628111923,0.933201244616456,18,111,leading edge membrane,CC,SPRY2;PAK1;ABCA7;SPRY4;ARHGEF4;KCNC4;CSPG4;PLEK2;ARHGEF2;ATF4;TRPV4;PSD4;TRPV1;INSR;ARHGAP44;EPS8L1;PLXND1;EPS8L2
465,GO:0001504,0.109232027671772,0.968044173267597,4,16,neurotransmitter uptake,BP,GLUL;NTSR1;NOS1;RAB3B
1018,GO:0002517,0.109285942751747,0.986336022376842,2,5,T cell tolerance induction,BP,TGFBR2;HLA-G
1081,GO:0002664,0.109285942751747,0.986336022376842,2,5,regulation of T cell tolerance induction,BP,TGFBR2;HLA-G
3457,GO:0007272,0.109330790736713,0.937968987396925,14,82,ensheathment of neurons,BP,MARVELD1;SCN8A;CD9;NDRG1;MALL;NAB2;SH3TC2;HEXB;AKT1;SBF2;TENM4;SIRT2;ERBB2;PLLP
3791,GO:0008366,0.109330790736713,0.937968987396925,14,82,axon ensheathment,BP,MARVELD1;SCN8A;CD9;NDRG1;MALL;NAB2;SH3TC2;HEXB;AKT1;SBF2;TENM4;SIRT2;ERBB2;PLLP
4369,GO:0009994,0.109336628019057,0.957432893939223,6,28,oocyte differentiation,BP,PABPC1L;NPR2;ZP3;EREG;REC8;SIRT2
5344,GO:0016101,0.10933895678699,0.947518059137497,9,48,diterpenoid metabolic process,BP,APOE;LRP1;EGFR;DHRS4;SDC2;PNPLA4;PLB1;RETSAT;CYP4V2
15797,GO:0072525,0.109353299619721,0.935290449785908,16,97,pyridine-containing compound biosynthetic process,BP,NAPRT;IDH2;PGM1;DHTKD1;DDIT4;OGDHL;NMRK1;NMNAT2;PSAT1;PPARA;MLXIPL;GALK1;NADK;ALDOC;INSR;PFKL
4010,GO:0009008,0.109378799972012,0.986317389718749,2,5,DNA-methyltransferase activity,MF,DNMT3A;MGMT
1075,GO:0002645,0.109587647612242,0.986275445035509,2,5,positive regulation of tolerance induction,BP,TGFBR2;HLA-G
10978,GO:0044795,0.109591902928866,1,1,1,trans-Golgi network to recycling endosome transport,BP,RAB13
8534,GO:0033882,0.109623601513892,1,1,1,choloyl-CoA hydrolase activity,MF,ACOT8
11146,GO:0045222,0.109623601513892,1,1,1,CD4 biosynthetic process,BP,ACOT8
11147,GO:0045223,0.109623601513892,1,1,1,regulation of CD4 biosynthetic process,BP,ACOT8
11148,GO:0045225,0.109623601513892,1,1,1,negative regulation of CD4 biosynthetic process,BP,ACOT8
13394,GO:0052815,0.109623601513892,1,1,1,medium-chain acyl-CoA hydrolase activity,MF,ACOT8
12235,GO:0048537,0.109627331153584,0.986267469180808,2,5,mucosal-associated lymphoid tissue development,BP,FOXL1;ADA
12238,GO:0048541,0.109627331153584,0.986267469180808,2,5,Peyer's patch development,BP,FOXL1;ADA
3979,GO:0008823,0.10963358594653,0.986266211881238,2,5,cupric reductase activity,MF,STEAP2;STEAP3
13419,GO:0052851,0.10963358594653,0.986266211881238,2,5,ferric-chelate reductase (NADPH) activity,MF,STEAP2;STEAP3
13927,GO:0060638,0.109740527403089,0.986244707978014,2,5,mesenchymal-epithelial cell signaling,BP,WNT2B;FGFR1
8704,GO:0034363,0.109938225839738,1,1,1,intermediate-density lipoprotein particle,CC,APOE
8706,GO:0034365,0.109938225839738,1,1,1,discoidal high-density lipoprotein particle,CC,APOE
8712,GO:0034371,0.109938225839738,1,1,1,chylomicron remodeling,BP,APOE
11871,GO:0046911,0.109938225839738,1,1,1,metal chelating activity,MF,APOE
16355,GO:0090731,0.109938225839738,1,1,1,cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
17689,GO:1901630,0.109938225839738,1,1,1,negative regulation of presynaptic membrane organization,BP,APOE
18183,GO:1903000,0.109938225839738,1,1,1,regulation of lipid transport across blood brain barrier,BP,APOE
18184,GO:1903002,0.109938225839738,1,1,1,positive regulation of lipid transport across blood brain barrier,BP,APOE
19349,GO:1905853,0.109938225839738,1,1,1,regulation of heparan sulfate binding,BP,APOE
19350,GO:1905855,0.109938225839738,1,1,1,positive regulation of heparan sulfate binding,BP,APOE
19351,GO:1905858,0.109938225839738,1,1,1,regulation of heparan sulfate proteoglycan binding,BP,APOE
19352,GO:1905860,0.109938225839738,1,1,1,positive regulation of heparan sulfate proteoglycan binding,BP,APOE
19360,GO:1905890,0.109938225839738,1,1,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
828,GO:0002116,0.109953412417793,0.97568423247952,3,10,semaphorin receptor complex,CC,PLXNB3;PLXNB1;PLXND1
5851,GO:0017154,0.109953412417793,0.97568423247952,3,10,semaphorin receptor activity,MF,PLXNB3;PLXNB1;PLXND1
16513,GO:0097283,0.110001068722889,0.986192261139047,2,5,keratinocyte apoptotic process,BP,GSN;ZFP36L1
17862,GO:1902172,0.110001068722889,0.986192261139047,2,5,regulation of keratinocyte apoptotic process,BP,GSN;ZFP36L1
8558,GO:0034038,0.110078394670278,1,1,1,deoxyhypusine synthase activity,MF,DHPS
494,GO:0001547,0.110200449204471,0.986152071458666,2,5,antral ovarian follicle growth,BP,ZP3;EREG
17304,GO:0150034,0.110265314420693,0.925438333851059,27,178,distal axon,CC,ADGRL1;GLUL;TIMP2;NTSR1;SHANK2;SYNGR1;BLVRB;ORAI2;DLG3;SEPT5;KCNC4;KCNAB2;TWF2;STMN3;KIF21B;SSH1;SV2A;TENM2;MAP3K12;TRPV4;MICAL1;SEPT6;TMOD2;C9ORF72;CHRM3;SIRT2;ITGA2
14673,GO:0070324,0.110290902921689,0.986133822877227,2,5,thyroid hormone binding,MF,THRA;CTSH
5322,GO:0016052,0.110496508192492,0.929462953312698,21,134,carbohydrate catabolic process,BP,PYGB;PGM1;GAA;PYGL;DHTKD1;CRYL1;DDIT4;OGDHL;GALE;PPARA;MLXIPL;GALK1;LRP5;ALDOC;HEXB;MAN2C1;MAN2B1;INSR;TKFC;NAGA;PFKL
7281,GO:0031282,0.11064328275613,0.986062639361996,2,5,regulation of guanylate cyclase activity,BP,NOS1;NOS3
7282,GO:0031284,0.11064328275613,0.986062639361996,2,5,positive regulation of guanylate cyclase activity,BP,NOS1;NOS3
11386,GO:0045806,0.110685661183749,0.952774582486534,7,35,negative regulation of endocytosis,BP,DLG4;MCTP1;LRSAM1;PCSK9;PROM2;SNX33;UNC119
11946,GO:0047184,0.110687443269491,0.986053708193365,2,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,LPCAT4;TAZ
2980,GO:0006526,0.110690979840952,0.986052992845312,2,5,arginine biosynthetic process,BP,NAGS;ASS1
15251,GO:0071458,0.110767508187775,0.986037509696026,2,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,SPPL2B;PKD2
9358,GO:0035897,0.110770903648655,0.986036822568247,2,5,proteolysis in other organism,BP,MAP2K1;MAP2K2
9418,GO:0036004,0.110780859874619,1,1,1,GAF domain binding,MF,AIP
5307,GO:0016020,0.110781169605279,0.899527369225656,699,5739,membrane,CC,PTPRS;DLG4;HTRA1;DOCK4;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;NYNRIN;APOE;CSMD2;MARVELD1;SYTL1;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;IL20RB;GSN;ADGRL1;PYGB;LMF1;PGF;FGFBP1;TYSND1;KIAA1549L;SLC2A3;FBXO2;ADAM19;PTK6;TMEM129;CDC42EP5;ACP5;EDEM1;CRAT;AIG1;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;VEGFA;OBSCN;NTSR1;EGFR;PRNP;ZDHHC1;FCGRT;SCN8A;SLC7A8;HADH;ANK3;RAPGEF3;BPHL;CLTCL1;FCHO1;TNFSF15;SPTB;DGKA;TSPAN1;SLC16A3;CD9;SLC2A9;SNPH;IDH2;CST3;DNM1;SDK2;PARVB;NOS1;GPSM1;ARAP3;SHANK2;CYYR1;CRTC1;CLCA2;SCN4B;ORAI3;MRC2;ADGRB2;NDRG1;GGT1;TBC1D8;ABTB1;COL13A1;GRAMD4;MST1R;ARRDC1;ARMCX2;EFS;SYT8;RIN1;ARAP1;B3GAT3;HBEGF;GAA;TMEM134;CNTN1;EXOC2;CYP3A5;EFNB3;RPL13A;EVC;BBS1;ULK2;CERCAM;SLC27A1;KLF9;REEP2;RAB11FIP4;NISCH;CPT2;ASAP2;PLD3;KLHDC2;PITPNM3;TMEM92;ATG16L2;HMGCL;SYNGR1;MAP2K1;CYP27B1;SLC16A5;COL6A1;PPL;ABCA2;PKN1;SLC43A1;MC1R;LPCAT4;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;DGKQ;MXRA7;TMEM173;SNX9;PLEKHG5;DNAJC4;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;VEGFB;MARCKSL1;HDAC11;RAB3B;NLGN2;CD68;SLC12A7;MYCBPAP;CYBRD1;ITPR3;APPL2;PRSS8;CAPRIN2;LY6K;PRKCZ;HTR7;PAK1;ABCA7;SLC37A2;AARS;PRR7;MCTP1;STK39;B4GALNT4;TMTC4;ERO1B;FAM171A2;BLVRB;SLC35E2B;PEAR1;FGFR3;CEMIP;KDM3A;BRI3;ARVCF;GLDC;NPR2;PLXNB3;CAPNS2;NDUFA4L2;TMEM44;TMEM187;SPRY4;ORAI2;SYNE3;DLG3;ITGB4;NMNAT2;MICALL2;SLCO4A1;NME4;GRIP2;ZP3;SHROOM4;NEURL1;ACVR2B;CCDC88B;SPPL2B;NGFR;ELFN2;EPOR;MARCH4;ETV5;LCE1E;ARHGEF4;MUC19;SYNC;SMIM14;MALL;ACTR1B;PLXNB1;EREG;NIPSNAP1;SPG11;TMC6;PTPRE;PNPLA3;OLFM2;PLCD3;DHRS4;RHOBTB2;ANO8;TMED4;TNFRSF25;PLA2G6;ABCG1;ESYT2;TRAPPC9;SCART1;ERMAP;LPAR3;S100A13;AGAP1;MTMR4;C5;KIF17;PLGRKT;ANO1;STON1;FNDC4;AIP;RASA4;KCNJ15;NLRX1;PKD2;STAT6;SH3TC2;VAMP2;RRNAD1;AREG;ST6GALNAC6;AP1G2;SEPT5;B4GAT1;MARCH9;LRP11;PCLO;KCNC4;PI4KAP1;ACACB;KCNAB2;MAPK3;CSPG4;ITGB5;APCDD1L;DEF6;BNIP3;ERRFI1;SEMA5A;IFITM1;PEX10;VANGL2;GSDMA;SCARA3;DOCK9;RGS14;DNAL4;MYZAP;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;SNTA1;HOOK2;SLITRK6;MXRA8;MVB12B;PI4K2A;NAT14;PAQR6;PQLC2;KIAA0319L;SDC2;CHMP1B;NRSN2;IFNGR2;TCTN1;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;PRAF2;MAP2K2;SRD5A3;SAMD3;SLC50A1;SDHA;TECPR1;SLC48A1;EHBP1L1;LRSAM1;DMTN;LRRC8A;LITAF;UBXN4;LOC441081;ATF4;PROCR;MOSPD3;CHST6;PRSS22;SSH1;LRRC45;LTB4R2;SV2A;TBC1D3E;SLC38A10;GPR153;ACAP3;TENM2;KRTCAP3;IFI6;REEP6;PKD1;ATXN10;SLC29A4;FLOT1;PSKH1;KCNMA1;AZIN2;HSD11B1;TSNARE1;TMEM128;UNC5B;WHAMMP3;GTPBP1;SORL1;MAP6;GALK1;NTPCR;SMIM19;IL17RD;HERPUD1;VLDLR;TPBG;ADGRF1;GPRC5C;GABBR1;ST3GAL3;SULF2;ROBO3;TMEM175;MAP3K12;RHBDF1;LRP5;PTPRU;WNK4;ATRAID;NDE1;PCSK9;DBNDD1;L3MBTL1;METTL23;AQP3;LONP2;EPN3;MARK3;HLTF;TGFBR2;TRPV4;ARHGAP25;DIRC2;C1ORF115;ITGA1;CMTM7;IL17RE;PSD4;ANO9;MAP1LC3A;APOL4;HSD17B7;XKR6;PDE2A;SMURF2;TRIB3;RAB40B;PEMT;EDA;CDK5RAP3;NOS3;AGO4;MINK1;PIGZ;HEXB;PROM2;SLC27A3;WNT7A;HERPUD2;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;VPS39;SUCLG2;ERN1;LZTS2;CROCC;BCR;ATP7B;FYCO1;C19ORF33;CEP112;NBR1;CPT1C;HEXA;GOLGA2P5;BCAM;SRR;NBEAL2;MFSD3;TTYH3;NECAB3;PTAFR;CYP2R1;PPP1R15A;RIMS3;ADCY6;TNRC18;RAB43;ATP2B4;SLC9A3R2;TNFRSF14;ACOX3;ACAD11;TMEM80;GSDMC;MGMT;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;TP53I11;LCE1F;STEAP2;AKT1;ZFYVE21;ITPR2;CARD11;REEP4;B4GALT2;AMIGO2;SEMA6B;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;COMTD1;TSG101;C16ORF58;FMNL3;IL17RC;FGFR4;DNAJC22;TMEM256;RASSF9;SLC6A9;SNN;TCIRG1;ASAP3;STEAP3;ACADVL;SLC6A6;NUCB2;FARP1;LMNA;TMEM63C;FAAH;COPG1;TMEM200A;ATG2A;C9ORF72;TBC1D20;CHMP5;CAPN2;MAN2B1;GOLGA8A;SPATA18;ICA1;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;KRT19;NELFCD;TENM4;SLC25A29;CKLF;GNAL;COG7;SLC22A15;ANKZF1;CHMP4C;PNPLA4;LTB4R;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;GRAMD1A;RABGGTA;ITGB6;HOMER2;C6ORF89;PIGQ;ZDHHC24;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;LETMD1;BTN3A2;ASIC1;RNF215;PLB1;GJB4;CAT;MYOF;PAQR4;MAPK10;HFE;JAK3;KIAA1549;MRGPRX3;SCNN1A;TUBGCP6;SNX33;CHRM3;TMX4;C14ORF132;CERS4;SNX17;ICAM5;METTL7A;ATP12A;SPIRE1;TMEM50B;TAZ;HGSNAT;BTN3A3;RABAC1;RNF213;SLC9A7;ADAP1;EPS8L1;SLC37A4;EHD3;FYN;ATP8B2;TMEM25;PJA2;SLC38A2;SNX1;PEX1;LEMD2;UBXN6;SLC25A42;SIRT2;TRPC1;MBOAT2;SPRED3;PHLDA2;RAB13;MPDZ;TOM1;TST;GOLGA2;CELSR1;ADA;CADM4;PLXND1;TMEM54;RHOBTB3;RTN2;TMEM101;ENTPD2;AP2A2;EPS8L2;HDAC8;MYO18A;SLC35F3;RPL29;TMEM139;RETSAT;TGFBR3;PLPP6;RNPEP;VAV3;MAN1B1;STX1A;LAMTOR2;MFNG;STARD10;EDNRA;RNF170;EPHB2;TMCO6;MAGI1;LRCH4;MCTP2;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ESYT3;BLOC1S1;FITM2;FKBP8;XYLT2;ERBB2;SEC31B;PLLP;SLC10A6;UST;PAG1;RGS12;SYVN1;OSCP1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;MMP17;RPL12;MPPE1;NET1;TMEM200B;FER1L4;TTC19;RTL1;GRB10;CREB3L4;BSG;SDHAF4;APBA1;TMEM42;PEX11A;TMEM8A;PNKD;KDSR;IKBKB;NTM;PLEKHA4;HIP1;CYP4V2;PLEKHH2;ROBO4;XKR9;BTBD11;SLC9A5
5007,GO:0015171,0.11079006641987,0.946671453709416,9,48,amino acid transmembrane transporter activity,MF,SLC7A8;SLC43A1;TMEM44;PQLC2;SLC38A10;SLC6A9;SLC6A6;SLC25A29;SLC38A2
16102,GO:0090129,0.110811826347812,0.986028540105825,2,5,positive regulation of synapse maturation,BP,ADGRL1;NEURL1
13908,GO:0060598,0.11082585020109,1,1,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,AREG
1784,GO:0004415,0.110830355919664,0.986024789198957,2,5,hyalurononglucosaminidase activity,MF,HYAL1;CEMIP
7558,GO:0031915,0.110837605993786,0.986023321468974,2,5,positive regulation of synaptic plasticity,BP,SSH1;EPHB2
12677,GO:0050919,0.110859628874844,0.956674546049674,6,28,negative chemotaxis,BP,SEMA4B;SEMA3F;SLIT3;SEMA5A;SEMA3B;SEMA4G
2945,GO:0006476,0.110880250608197,0.935516789682639,15,90,protein deacetylation,BP,VEGFA;PHF21A;HDAC11;CHD3;JDP2;HDAC5;HMG20B;TADA3;C6ORF89;MTA3;BCL6;SIRT2;MTA1;HDAC8;PER1
9083,GO:0035360,0.110898428475342,0.986011005899917,2,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;STARD10
12251,GO:0048568,0.110899154255562,0.919513422741446,39,269,embryonic organ development,BP,VEGFA;EGFR;ERCC1;IFT140;ZFP36L1;MDFI;HYAL1;NAGLU;MAP2K1;SPRY2;FBXW8;WDR60;PLCD3;PKD2;MAPK3;VANGL2;SLITRK6;PLCD1;ZFPM1;PKD1;CEBPB;TRIOBP;TGFBR2;BCR;WDR19;AKT1;IFT57;SH2B3;KRT19;TFEB;PHLDA2;CELSR1;ADA;TCF7;EPAS1;EPHB2;FGFR1;TSHZ1;TEAD2
11931,GO:0047045,0.110900607222623,1,1,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,HSD17B14
9419,GO:0036005,0.110911951842318,0.986008267040253,2,5,response to macrophage colony-stimulating factor,BP,MST1R;PDE2A
9420,GO:0036006,0.110911951842318,0.986008267040253,2,5,cellular response to macrophage colony-stimulating factor stimulus,BP,MST1R;PDE2A
19092,GO:1905063,0.110985682702362,0.985993330664477,2,5,regulation of vascular smooth muscle cell differentiation,BP,PDCD4;CTH
6651,GO:0030010,0.11109079867055,0.932939055121446,17,104,establishment of cell polarity,BP,GSN;BRSK1;SDCCAG8;SPRY2;PRKCZ;PAK1;ARHGEF2;FBF1;FRMD4B;KIF26B;PKD1;NDE1;MARK3;WNT7A;MARK4;MYO18A;UST
17604,GO:1901342,0.111095541090406,0.924229563154152,28,186,regulation of vasculature development,BP,XDH;EGR1;PGF;PDCD4;VEGFA;RAPGEF3;ADGRB2;HYAL1;BTG1;SPRY2;VEGFB;ADM2;NGFR;C5;HMGA2;ECM1;SEMA5A;ANGPTL4;HDAC5;TGFBR2;NOS3;EPHA1;CTSH;FOXO4;MAP2K5;PLXND1;CTH;ERBB2
768,GO:0002024,0.111102599352781,0.985969632502117,2,5,diet induced thermogenesis,BP,TRPV4;TRPV1
17463,GO:1900425,0.111108075014042,0.985968522227555,2,5,negative regulation of defense response to bacterium,BP,MAPKBP1;SIRT2
15489,GO:0071895,0.111178005003283,0.985954339719095,2,5,odontoblast differentiation,BP,FAM20C;CEBPB
17402,GO:1900193,0.111183942506616,0.985953135266271,2,5,regulation of oocyte maturation,BP,NPR2;SIRT2
9299,GO:0035771,0.111198033628558,0.985950276643026,2,5,interleukin-4-mediated signaling pathway,BP,STAT6;JAK3
1930,GO:0004632,0.111233478325103,1,1,1,phosphopantothenate--cysteine ligase activity,MF,PPCS
1526,GO:0003908,0.111255462574806,1,1,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,MGMT
14568,GO:0070141,0.111284861547173,0.985932656930089,2,5,response to UV-A,BP,EGFR;AKT1
16387,GO:0097049,0.111326194560045,0.985924266212597,2,5,motor neuron apoptotic process,BP,ADARB1;MAP3K12
1285,GO:0003096,0.111355879240104,0.98591823888949,2,5,renal sodium ion transport,BP,WNK4;MAGED2
2640,GO:0005977,0.111376396962211,0.94387123230344,10,55,glycogen metabolic process,BP,PYGB;NR1D1;PGM1;GAA;PYGL;PPP1R3E;STK40;AKT1;INSR;PHLDA2
2704,GO:0006073,0.111376396962211,0.94387123230344,10,55,cellular glucan metabolic process,BP,PYGB;NR1D1;PGM1;GAA;PYGL;PPP1R3E;STK40;AKT1;INSR;PHLDA2
10703,GO:0044042,0.111376396962211,0.94387123230344,10,55,glucan metabolic process,BP,PYGB;NR1D1;PGM1;GAA;PYGL;PPP1R3E;STK40;AKT1;INSR;PHLDA2
4445,GO:0010385,0.111443065027956,0.985900530218853,2,5,double-stranded methylated DNA binding,MF,EGR1;MBD1
5970,GO:0018455,0.111459388713028,1,1,1,alcohol dehydrogenase [NAD(P)+] activity,MF,DHRS4
7132,GO:0030976,0.111586436011734,0.985871389944965,2,5,thiamine pyrophosphate binding,MF,DHTKD1;OGDHL
2968,GO:0006509,0.111590094419037,0.952291530371363,7,35,membrane protein ectodomain proteolysis,BP,APOE;ADAM19;TIMP2;SNX9;SPPL2B;TIMP1;SNX33
19605,GO:1990822,0.111614186034056,0.985865746915218,2,5,basic amino acid transmembrane transport,BP,PQLC2;SLC25A29
5572,GO:0016594,0.111637721920064,0.985860960124283,2,5,glycine binding,MF,GLDC;SRR
4332,GO:0009888,0.111638861065894,0.904684329914816,160,1234,tissue development,BP,XDH;DUSP6;PTPRS;ACTA2;BBS2;NFATC4;SERPINE2;FOS;GSN;EGR1;CTNNBIP1;THBS3;PGF;POSTN;PTK6;SEMA4B;ALOX15B;PDCD4;VEGFA;EGFR;ADAMTS7;S100A4;DUSP5;IFT140;RAPGEF3;KRT15;CST3;MEF2D;DNPH1;ARHGEF19;MYH15;ZFP36L1;ADARB1;NUPR1;HBEGF;GAA;OBSL1;EVC;FBXW4;CUL7;HYAL1;WWTR1;MAP2K1;CYP27B1;PCK2;COL6A1;PPL;BTG1;ITGA6;SPRY2;MYH11;LAMA5;PRSS8;PAK1;FGFR3;FOXQ1;SEMA3F;SALL2;DLG3;ITGB4;FBXW8;NEURL1;ACVR2B;EPOR;ETV5;LCE1E;WNT2B;EREG;NAB2;PPARA;PKD2;SATB1;STAT6;HMGA2;AREG;COL8A1;ECM1;MAPK3;ITGB5;LAMB2;ERRFI1;THRA;VANGL2;FAM20C;CTSB;SLITRK6;TCTN1;SEMA3B;PTHLH;ZFPM1;KIF26B;ZNF516;PKD1;FLOT1;TTN;DEAF1;SULF2;CEBPB;LRP5;WNK4;ATRAID;ALDOC;FBXL15;AQP3;TRIOBP;TGFBR2;TRPV4;FOXL1;PDE2A;SMURF2;EDA;HMG20B;WNT7A;SEMA4G;SHARPIN;GAS6;NBR1;RXRA;ZNF358;CTSH;WDR19;MGMT;LCE1F;AKT1;LAMB1;IFT57;TSG101;ACADVL;LMNA;TBC1D20;RAB25;INSR;WNT3;KRT19;TENM4;EDA2R;CAT;TIMP1;TP73;TAZ;GSTM3;LEMD2;SIRT2;PHLDA2;RAB13;TST;CELSR1;ADA;PLXND1;AP2A2;TGFBR3;TCF7;EDNRA;ITGA2;FGFR1;FKBP8;TNNI1;BSG;IKBKB;TEAD2
6783,GO:0030228,0.111675778666829,0.975131588585527,3,10,lipoprotein particle receptor activity,MF,LRP1;SORL1;VLDLR
16384,GO:0097039,0.11168771335654,0.985850790555365,2,5,protein linear polyubiquitination,BP,RBCK1;SHARPIN
9779,GO:0040013,0.111704813677567,0.922186430177338,31,209,negative regulation of locomotion,BP,APOE;ZMYND8;SEMA4B;LRP1;ALOX15B;FBLN1;IDH2;ARAP3;MMP28;ADARB1;NISCH;ARPIN;MCTP1;SEMA3F;PLXNB3;C5;SEMA5A;IFITM1;SRGAP3;SEMA3B;HDAC5;PTPRU;EPHA1;SEMA4G;BCR;WNT3;MAP2K5;BRAF;TIMP1;ADA;CORO1B
6111,GO:0019362,0.111752539799692,0.929422461096433,20,127,pyridine nucleotide metabolic process,BP,H6PD;NT5E;NAPRT;IDH2;PGM1;DHTKD1;PCK2;PGLS;DDIT4;OGDHL;NMRK1;NMNAT2;PPARA;KCNAB2;MLXIPL;GALK1;NADK;ALDOC;INSR;PFKL
11684,GO:0046496,0.111752539799692,0.929422461096433,20,127,nicotinamide nucleotide metabolic process,BP,H6PD;NT5E;NAPRT;IDH2;PGM1;DHTKD1;PCK2;PGLS;DDIT4;OGDHL;NMRK1;NMNAT2;PPARA;KCNAB2;MLXIPL;GALK1;NADK;ALDOC;INSR;PFKL
5244,GO:0015874,0.111758814276016,0.985836321662729,2,5,norepinephrine transport,BP,NISCH;STX1A
13595,GO:0060099,0.111783202226813,0.985831357384649,2,5,regulation of phagocytosis, engulfment,BP,ABCA7;ITGA2
13596,GO:0060100,0.111783202226813,0.985831357384649,2,5,positive regulation of phagocytosis, engulfment,BP,ABCA7;ITGA2
19122,GO:1905155,0.111783202226813,0.985831357384649,2,5,positive regulation of membrane invagination,BP,ABCA7;ITGA2
4499,GO:0010543,0.111799450349064,0.96097433760043,5,22,regulation of platelet activation,BP,APOE;SERPINE2;CD9;DMTN;NOS3
9361,GO:0035902,0.111824718790826,0.967006026012551,4,16,response to immobilization stress,BP,FOS;ERCC1;LRP11;FOXO4
16141,GO:0090188,0.111843776002138,0.985819024268922,2,5,negative regulation of pancreatic juice secretion,BP,STK39;WNK4
16947,GO:0099003,0.111856538732013,0.934859083326476,15,90,vesicle-mediated transport in synapse,BP,SYTL1;SNPH;DNM1;SYT8;BLOC1S4;NLGN2;SPG11;VAMP2;SEPT5;PCLO;DNAJC6;RIMS3;BRAF;STX1A;BLOC1S1
13656,GO:0060215,0.112016878463885,0.985783755805178,2,5,primitive hemopoiesis,BP,VEGFA;ZFPM1
1267,GO:0003056,0.112061882411942,0.985774580739978,2,5,regulation of vascular smooth muscle contraction,BP,DOCK4;CHRM3
4578,GO:0010668,0.112070678664953,0.985772787146058,2,5,ectodermal cell differentiation,BP,ITGA6;EDA2R
4057,GO:0009110,0.112103348189049,0.966893877960029,4,16,vitamin biosynthetic process,BP,CYP27B1;PSAT1;PLTP;CYP2R1
1557,GO:0003958,0.112105276504009,0.98576573160861,2,5,NADPH-hemoprotein reductase activity,MF,NOS1;NOS3
5056,GO:0015271,0.112106374709418,0.985765507628361,2,5,outward rectifier potassium channel activity,MF,PKD2;KCNMA1
4175,GO:0009256,0.112149263130086,0.985756759369091,2,5,10-formyltetrahydrofolate metabolic process,BP,ALDH1L2;ALDH1L1
498,GO:0001554,0.112171892947259,0.985752142524847,2,5,luteolysis,BP,SLIT3;MMP19
16493,GO:0097229,0.112182703967775,1,1,1,sperm end piece,CC,CABYR
13047,GO:0051575,0.112221191592836,0.985742082714272,2,5,5'-deoxyribose-5-phosphate lyase activity,MF,HMGA2;POLL
18595,GO:1903909,0.112258621118907,0.98573444297739,2,5,regulation of receptor clustering,BP,GSN;SSH1
15299,GO:0071542,0.112287341614969,0.966819759177425,4,16,dopaminergic neuron differentiation,BP,VEGFA;MANF;WNT3;CSNK1E
13975,GO:0060716,0.112291652608997,0.966818021975798,4,16,labyrinthine layer blood vessel development,BP,FBXW8;PLCD3;PLCD1;AKT1
5375,GO:0016198,0.112325915264053,0.985720703404402,2,5,axon choice point recognition,BP,EFNB3;ROBO3
6896,GO:0030479,0.112374107177151,0.985710860676162,2,5,actin cortical patch,CC,WIPF1;HIP1
14369,GO:0061645,0.112374107177151,0.985710860676162,2,5,endocytic patch,CC,WIPF1;HIP1
17184,GO:0106070,0.112376504101962,0.985710371055875,2,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;ATP2B4
14667,GO:0070314,0.112384215807425,0.985708795738186,2,5,G1 to G0 transition,BP,RAB11FIP4;CYP27B1
11225,GO:0045429,0.112444829346582,0.9606783830202,5,22,positive regulation of nitric oxide biosynthetic process,BP,PKD2;TRPV1;AKT1;ASS1;INSR
18799,GO:1904407,0.112444829346582,0.9606783830202,5,22,positive regulation of nitric oxide metabolic process,BP,PKD2;TRPV1;AKT1;ASS1;INSR
3874,GO:0008509,0.112513434030008,0.923154832559945,28,186,anion transmembrane transporter activity,MF,SLC2A3;SLC7A8;SLC16A3;SLC2A9;CLCA2;SLC27A1;SLC16A5;SLC43A1;SLC12A7;SLC37A2;TMEM44;SLCO4A1;ANO8;ANO1;PQLC2;LRRC8A;SLC38A10;ANO9;TTYH3;SLC6A9;SLC6A6;SLC25A29;SLC22A15;SLC37A4;SLC38A2;SLC25A42;SLC10A6;BSG
15281,GO:0071498,0.112517531454276,0.966726961959203,4,16,cellular response to fluid shear stress,BP,TFPI2;PKD2;ASS1;MAP2K5
2086,GO:0004852,0.112566480800928,1,1,1,uroporphyrinogen-III synthase activity,MF,UROS
15225,GO:0071418,0.112566480800928,1,1,1,cellular response to amine stimulus,BP,UROS
6132,GO:0019402,0.11263399819264,1,1,1,galactitol metabolic process,BP,GALK1
14356,GO:0061623,0.11263399819264,1,1,1,glycolytic process from galactose,BP,GALK1
16487,GO:0097223,0.112642182178137,0.934294005391633,15,91,sperm part,CC,LOXL1;SYT8;DNAH1;LY6K;IFT27;CEP131;ITGA1;HEXB;ATP2B4;SEPT6;CABYR;GSTM3;SPATA6;BSG;TCTEX1D4
6033,GO:0019118,0.112647464507389,1,1,1,phenanthrene-epoxide hydrolase activity,MF,AKR7A2
6034,GO:0019119,0.112647464507389,1,1,1,phenanthrene-9,10-epoxide hydrolase activity,MF,AKR7A2
4762,GO:0010951,0.112700872592576,0.927811358141772,21,137,negative regulation of endopeptidase activity,BP,TNFRSF6B;SERPINE2;TIMP2;VEGFA;PRDX5;TFPI2;CST3;SERPING1;RAG1;NGFR;C5;IFI6;SORL1;HERPUD1;PAPLN;GAS6;AKT1;MICAL1;HMSD;MAP2K5;TIMP1
13006,GO:0051480,0.112720579769504,0.92702119590202,22,142,regulation of cytosolic calcium ion concentration,BP,DLG4;F2R;NTSR1;PRNP;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;PKD1;GSTM2;TRPV4;TRPV1;ATP2B4;ITPR2;TPCN1;FYN;TRPC1;EDNRA
7632,GO:0032051,0.11275168301903,0.98563364936489,2,5,clathrin light chain binding,MF,CLTCL1;HIP1
10807,GO:0044317,0.112754747658536,1,1,1,rod spherule,CC,REEP6
696,GO:0001917,0.112766092191815,0.960530838169049,5,22,photoreceptor inner segment,CC,DNM1;NOS1;SHANK2;REEP6;CROCC
10553,GO:0043533,0.112782476847882,0.985627344827916,2,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ITPR3;ADAP1
12210,GO:0048489,0.112848890312623,0.93715189118273,13,76,synaptic vesicle transport,BP,SYTL1;SNPH;DNM1;SYT8;BLOC1S4;SPG11;VAMP2;SEPT5;PCLO;RIMS3;BRAF;STX1A;BLOC1S1
16599,GO:0097480,0.112848890312623,0.93715189118273,13,76,establishment of synaptic vesicle localization,BP,SYTL1;SNPH;DNM1;SYT8;BLOC1S4;SPG11;VAMP2;SEPT5;PCLO;RIMS3;BRAF;STX1A;BLOC1S1
625,GO:0001809,0.113006337649597,1,1,1,positive regulation of type IV hypersensitivity,BP,ZP3
13834,GO:0060467,0.113006337649597,1,1,1,negative regulation of fertilization,BP,ZP3
19847,GO:2000359,0.113006337649597,1,1,1,regulation of binding of sperm to zona pellucida,BP,ZP3
19848,GO:2000360,0.113006337649597,1,1,1,negative regulation of binding of sperm to zona pellucida,BP,ZP3
19867,GO:2000387,0.113006337649597,1,1,1,regulation of antral ovarian follicle growth,BP,ZP3
19868,GO:2000388,0.113006337649597,1,1,1,positive regulation of antral ovarian follicle growth,BP,ZP3
10390,GO:0043243,0.113079062949169,0.960386960057766,5,22,positive regulation of protein complex disassembly,BP,BNIP3;SEMA5A;TRPV4;FYCO1;INSR
14774,GO:0070524,0.113259805806636,1,1,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,HSD11B1
10360,GO:0043198,0.113274501737621,0.960297042671318,5,22,dendritic shaft,CC,ZMYND8;NTSR1;SYNGAP1;DLG3;ARHGEF2
9814,GO:0042048,0.113497684533381,0.985480602202833,2,5,olfactory behavior,BP,GJB4;WFS1
5840,GO:0017136,0.113597353701098,0.966290628199515,4,16,NAD-dependent histone deacetylase activity,MF,HDAC11;HDAC5;SIRT2;HDAC8
4950,GO:0015018,0.11364647575425,1,1,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,B3GAT3
4094,GO:0009152,0.113649989099816,0.923470896561518,26,173,purine ribonucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;PGM1;DHTKD1;DDIT4;OGDHL;NPR2;NME4;PPCS;PPARA;MLXIPL;PTHLH;LTB4R2;GALK1;GABBR1;ACOT7;ALDOC;TMSB4X;NOS3;ADCY6;TCIRG1;INSR;APRT;TAZ;PFKL
17810,GO:1902003,0.113654740533917,0.966267392328353,4,16,regulation of amyloid-beta formation,BP,APOE;PRNP;ABCA7;SORL1
6574,GO:0022408,0.113770447031257,0.932238596842036,16,98,negative regulation of cell-cell adhesion,BP,SERPINE2;IL20RB;PRNP;CD9;PPARA;PDCD1LG2;CEBPB;TRPV4;ASS1;MAP2K5;HFE;JAK3;BCL6;ERBB2;PAG1;HLA-G
18659,GO:1904036,0.113817489463398,0.960046939945578,5,22,negative regulation of epithelial cell apoptotic process,BP,SEMA5A;ANGPTL4;GAS6;BRAF;WFS1
4851,GO:0014068,0.11394258276507,0.951029883309005,7,35,positive regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;RGL2;PLXNB1;UNC5B;CAT;FYN;FGFR1
19842,GO:2000351,0.114011590407118,0.959957434490367,5,22,regulation of endothelial cell apoptotic process,BP,PDCD4;SEMA5A;ANGPTL4;GAS6;BRAF
6698,GO:0030108,0.114057179385449,1,1,1,HLA-A specific activating MHC class I receptor activity,MF,CTSH
7832,GO:0032397,0.114057179385449,1,1,1,activating MHC class I receptor activity,MF,CTSH
13084,GO:0051643,0.11409546946206,0.985357488049456,2,5,endoplasmic reticulum localization,BP,ESYT2;ESYT3
4976,GO:0015101,0.114130663077491,0.966074509147558,4,16,organic cation transmembrane transporter activity,MF,SLC7A8;AZIN2;SLC25A29;SLC25A42
2191,GO:0005053,0.114194733706395,1,1,1,peroxisome matrix targeting signal-2 binding,MF,PEX7
3582,GO:0007632,0.114221740913322,0.950879674081222,7,35,visual behavior,BP,SYNGAP1;NPHP4;RAG1;RGS14;DEAF1;B4GALT2;BRAF
5749,GO:0016903,0.114240616446923,0.950869513764584,7,35,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,XDH;ALDH7A1;DHTKD1;ALDH4A1;OGDHL;ALDH1L2;ALDH1L1
12315,GO:0048696,0.114312903205439,1,1,1,regulation of collateral sprouting in absence of injury,BP,WNT3
12316,GO:0048697,0.114312903205439,1,1,1,positive regulation of collateral sprouting in absence of injury,BP,WNT3
13569,GO:0060064,0.114312903205439,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
19250,GO:1905474,0.114312903205439,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
16996,GO:0099175,0.114327705738148,0.950822629166022,7,35,regulation of postsynapse organization,BP,APOE;ZMYND8;PRNP;CAPRIN2;SSH1;ARHGAP44;FYN
12418,GO:0050104,0.114371481828631,1,1,1,L-gulonate 3-dehydrogenase activity,MF,CRYL1
10395,GO:0043250,0.114394818469215,1,1,1,sodium-dependent organic anion transmembrane transporter activity,MF,SLC10A6
10396,GO:0043251,0.114394818469215,1,1,1,sodium-dependent organic anion transport,BP,SLC10A6
1787,GO:0004419,0.114400644151236,1,1,1,hydroxymethylglutaryl-CoA lyase activity,MF,HMGCL
4121,GO:0009184,0.114579552008248,1,1,1,purine deoxyribonucleoside diphosphate catabolic process,BP,NUDT18
4129,GO:0009192,0.114579552008248,1,1,1,deoxyribonucleoside diphosphate catabolic process,BP,NUDT18
10944,GO:0044716,0.114579552008248,1,1,1,8-oxo-GDP phosphatase activity,MF,NUDT18
10945,GO:0044717,0.114579552008248,1,1,1,8-hydroxy-dADP phosphatase activity,MF,NUDT18
11512,GO:0046057,0.114579552008248,1,1,1,dADP catabolic process,BP,NUDT18
11518,GO:0046067,0.114579552008248,1,1,1,dGDP catabolic process,BP,NUDT18
11798,GO:0046712,0.114579552008248,1,1,1,GDP catabolic process,BP,NUDT18
7369,GO:0031430,0.114632619945854,0.967834746195202,4,12,M band,CC,OBSCN;OBSL1;TTN;NBR1
9465,GO:0036114,0.114710164427896,1,1,1,medium-chain fatty-acyl-CoA catabolic process,BP,ACOT7
9466,GO:0036115,0.114710164427896,1,1,1,fatty-acyl-CoA catabolic process,BP,ACOT7
9467,GO:0036116,0.114710164427896,1,1,1,long-chain fatty-acyl-CoA catabolic process,BP,ACOT7
17472,GO:1900533,0.114710164427896,1,1,1,palmitic acid metabolic process,BP,ACOT7
17473,GO:1900535,0.114710164427896,1,1,1,palmitic acid biosynthetic process,BP,ACOT7
1070,GO:0002636,0.114794364035765,1,1,1,positive regulation of germinal center formation,BP,ADA
2749,GO:0006157,0.114794364035765,1,1,1,deoxyadenosine catabolic process,BP,ADA
9939,GO:0042321,0.114794364035765,1,1,1,negative regulation of circadian sleep/wake cycle, sleep,BP,ADA
9940,GO:0042323,0.114794364035765,1,1,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADA
11534,GO:0046090,0.114794364035765,1,1,1,deoxyadenosine metabolic process,BP,ADA
11545,GO:0046111,0.114794364035765,1,1,1,xanthine biosynthetic process,BP,ADA
11551,GO:0046124,0.114794364035765,1,1,1,purine deoxyribonucleoside catabolic process,BP,ADA
13630,GO:0060167,0.114794364035765,1,1,1,regulation of adenosine receptor signaling pathway,BP,ADA
13631,GO:0060169,0.114794364035765,1,1,1,negative regulation of adenosine receptor signaling pathway,BP,ADA
13790,GO:0060407,0.114794364035765,1,1,1,negative regulation of penile erection,BP,ADA
14633,GO:0070256,0.114794364035765,1,1,1,negative regulation of mucus secretion,BP,ADA
11370,GO:0045766,0.114801843587747,0.931530174491525,16,98,positive regulation of angiogenesis,BP,PGF;VEGFA;RAPGEF3;HYAL1;BTG1;VEGFB;ADM2;C5;HMGA2;ECM1;SEMA5A;ANGPTL4;TGFBR2;NOS3;EPHA1;CTSH
11791,GO:0046697,0.114887532189597,0.965767092832926,4,16,decidualization,BP,CYP27B1;EPOR;CTSB;BSG
13054,GO:0051586,0.114894373995058,1,1,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13236,GO:0051944,0.114894373995058,1,1,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
3245,GO:0006906,0.114981912205803,0.928055651779736,19,120,vesicle fusion,BP,SYTL1;EVI5L;TBC1D8;SYT8;VPS11;SPG11;VAMP2;DYSF;TBC1D14;TBC1D3E;RABGAP1;TSNARE1;TMEM175;VPS39;SGSM2;RAB13;VAV3;STX1A;TBC1D16
3759,GO:0008307,0.115049011823334,0.955407145735166,6,24,structural constituent of muscle,MF,OBSCN;OBSL1;MYH11;TPM2;TTN;KRT19
12678,GO:0050920,0.115140584576747,0.927918741531103,19,121,regulation of chemotaxis,BP,PGF;SEMA4B;VEGFA;MMP28;VEGFB;SEMA3F;ZSWIM4;C5;MAPK3;SEMA5A;SEMA3B;TRPV4;TMSB4X;SEMA4G;GAS6;WNT3;ITGA2;FGFR1;CORO1B
8562,GO:0034045,0.115179839049604,0.965648147076305,4,16,phagophore assembly site membrane,CC,ULK2;ULK1;WDR45;ATG2A
11226,GO:0045444,0.115184394696207,0.925221049501905,22,142,fat cell differentiation,BP,BBS2;NR1D1;DDIT3;ZFP36L1;WWTR1;CCDC71L;ITGA6;TRIB2;HMGA2;BNIP3;ZFPM1;ZNF516;JDP2;CEBPB;LRP5;TRPV4;TRIB3;AKT1;WDFY2;SIRT2;ADIRF;PEX11A
20217,GO:2001199,0.11526195011681,1,1,1,negative regulation of dendritic cell differentiation,BP,HLA-G
9106,GO:0035418,0.115266900794088,0.959377285949574,5,22,protein localization to synapse,BP,DLG4;NLGN2;PCLO;WNT7A;ARHGAP44
16104,GO:0090131,0.115267233788107,1,1,1,mesenchyme migration,BP,ACTA2
3436,GO:0007229,0.115312849587628,0.939260565533111,11,62,integrin-mediated signaling pathway,BP,ADAMTS13;ITGA6;LAMA5;ITGB4;ITGB5;DMTN;ITGA1;ITGB6;TIMP1;VAV3;ITGA2
8291,GO:0033135,0.11556916996968,0.933747010131838,14,84,regulation of peptidyl-serine phosphorylation,BP,VEGFA;EGFR;RAPGEF3;DDIT4;SPRY2;CAPRIN2;PAK1;MLXIPL;DMTN;GAS6;CAMK1;ATP2B4;AKT1;BRAF
17441,GO:1900274,0.115569861184459,0.965489248388217,4,16,regulation of phospholipase C activity,BP,EGFR;PTAFR;EDNRA;FGFR1
2297,GO:0005267,0.115582740464424,0.950145850432241,7,35,potassium channel activity,MF,KCNG1;KCNJ15;PKD2;KCNC4;KCNAB2;KCNMA1;TMEM175
1565,GO:0003974,0.115592891291092,1,1,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,GALE
1569,GO:0003978,0.115592891291092,1,1,1,UDP-glucose 4-epimerase activity,MF,GALE
4405,GO:0010164,0.115623160526815,1,1,1,response to cesium ion,BP,CYP2R1
6861,GO:0030343,0.115623160526815,1,1,1,vitamin D3 25-hydroxylase activity,MF,CYP2R1
14841,GO:0070643,0.115623160526815,1,1,1,vitamin D 25-hydroxylase activity,MF,CYP2R1
3547,GO:0007584,0.115700328311433,0.924824350847423,22,143,response to nutrient,BP,GSN;POSTN;EGFR;ERCC1;HMGCL;CYP27B1;DGKQ;MTHFR;SSH1;HLCS;AQP3;DNMT3A;TGFBR2;PEMT;TRPV1;GAS6;MGMT;IGFBP2;CAT;FYN;ADA;ITGA2
11264,GO:0045595,0.115702908818119,0.901564667540293,149,1151,regulation of cell differentiation,BP,XDH;DUSP6;PTPRS;DLG4;APOE;ZMYND8;NFATC4;SERPINE2;FOS;CTNNBIP1;POSTN;PTK6;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;EGFR;NR1D1;FBLN1;ADAMTS7;IDH2;NOS1;DDIT3;SHANK2;CRTC1;ZFP36L1;TCFL5;CNTN1;EFNB3;OBSL1;LTBP4;ULK2;ASH2L;SOX13;CUL7;WWTR1;SMOC1;MAP2K1;CYP27B1;CCDC71L;BTG1;SYNGAP1;FAM213A;SPRY2;CAPRIN2;PRKCZ;PAK1;KDM3A;NPR2;SEMA3F;PLXNB3;ZSWIM4;FBXW8;NEURL1;ACVR2B;RAG1;NGFR;ETV5;TRIB2;PLXNB1;EREG;SSH3;OLFM2;ABCG1;LPAR3;PPARA;IMPACT;AREG;ERRFI1;SEMA5A;THRA;IFITM1;RGS14;FAM20C;MAPK12;SDC2;ARHGEF2;INPP5D;TWF2;DMTN;SEMA3B;PTHLH;ZFPM1;KDM4C;SSH1;METRN;FLOT1;LTBP3;JDP2;HDAC5;SORL1;VLDLR;CEBPB;LRP5;ATRAID;L3MBTL1;AQP3;TRIOBP;TGFBR2;TRPV4;TRIB3;HMG20B;CDK5RAP3;AGO4;WNT7A;TRPV1;SEMA4G;GAS6;NBR1;KIF13B;CAMK1;ADCY6;AKT1;CARD11;DGUOK;WDFY2;WNT3;TENM4;FOXO4;BRAF;ARHGAP44;LGALS1;JAK3;TP73;CSNK1E;BCL6;HSF4;FYN;SIRT2;GDF15;ADA;PLXND1;HDAC8;ADIRF;EPHB2;FGFR1;CTH;ERBB2;UST;EIF2AK4;HLA-G;NET1;KCTD11;IKBKB;TEAD2
3424,GO:0007215,0.115913987161805,0.949966873758792,7,35,glutamate receptor signaling pathway,BP,DLG4;SHANK2;NLGN2;KLHL24;MINK1;HOMER2;EPHB2
12120,GO:0048244,0.116098900955152,1,1,1,phytanoyl-CoA dioxygenase activity,MF,PHYH
16408,GO:0097089,0.116098900955152,1,1,1,methyl-branched fatty acid metabolic process,BP,PHYH
12078,GO:0048103,0.116126872851446,0.965261939415571,4,16,somatic stem cell division,BP,VANGL2;ARHGEF2;WNT7A;FGFR1
4412,GO:0010189,0.116214564910583,1,1,1,vitamin E biosynthetic process,BP,PLTP
9957,GO:0042360,0.116214564910583,1,1,1,vitamin E metabolic process,BP,PLTP
18684,GO:1904121,0.116214564910583,1,1,1,phosphatidylethanolamine transporter activity,MF,PLTP
11784,GO:0046686,0.116232531473353,0.946230472631498,8,43,response to cadmium ion,BP,FOS;GSN;EGFR;PRNP;ERCC1;MAPK3;AKT1;CAT
9471,GO:0036120,0.116267355106846,0.965204540519991,4,16,cellular response to platelet-derived growth factor stimulus,BP,HYAL1;ERRFI1;FYN;CORO1B
9112,GO:0035438,0.11632788004079,1,1,1,cyclic-di-GMP binding,MF,TMEM173
14301,GO:0061507,0.11632788004079,1,1,1,cyclic-GMP-AMP binding,MF,TMEM173
12003,GO:0047658,0.116390304420681,1,1,1,alpha-amino-acid esterase activity,MF,BPHL
6792,GO:0030241,0.116405647992539,1,2,2,skeletal muscle myosin thick filament assembly,BP,MYH11;TTN
9240,GO:0035659,0.116530187891746,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
11110,GO:0045167,0.116530187891746,1,1,1,asymmetric protein localization involved in cell fate determination,BP,WNT7A
19016,GO:1904889,0.116530187891746,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
19017,GO:1904891,0.116530187891746,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
4320,GO:0009822,0.116538800649875,1,1,1,alkaloid catabolic process,BP,CYP3A5
16494,GO:0097231,0.116555980138221,1,1,1,cell motility in response to calcium ion,BP,SPAG16
19567,GO:1990716,0.116555980138221,1,1,1,axonemal central apparatus,CC,SPAG16
14268,GO:0061395,0.11656882444686,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,ATF4
18822,GO:1904464,0.116716112085758,1,1,1,regulation of matrix metallopeptidase secretion,BP,IDH2
18823,GO:1904465,0.116716112085758,1,1,1,negative regulation of matrix metallopeptidase secretion,BP,IDH2
19591,GO:1990773,0.116716112085758,1,1,1,matrix metallopeptidase secretion,BP,IDH2
14975,GO:0070925,0.116716821594228,0.905409100486502,86,638,organelle assembly,BP,BBS2;GSN;EVI5L;OBSCN;IFT140;NINL;SHANK2;PACS2;OBSL1;BBS1;ULK2;ATG16L2;WWTR1;SDCCAG8;TUBG2;DNAH1;ULK1;VPS11;GRB7;NPHP4;NLGN2;MYH11;LAMA5;CIRBP;TTBK2;CEP250;NEURL1;WDR60;SPG11;KIF17;IFT27;NUDCD3;SEPT5;VANGL2;CNTRL;MYH3;CHMP1B;TBC1D14;TCTN1;PTPDC1;ARHGEF2;SEPT10;FBF1;LRSAM1;ATXN10;TTN;TMEM175;RFX2;NDE1;CEP131;MAP1LC3A;CEP126;CROCC;GOLGA2P5;SPAG16;WDR19;TMEM80;CHEK2;IFT57;WDR45;SEPT6;TNNT1;TSG101;KIF27;TMOD2;ATG2A;C9ORF72;TBC1D20;CHMP5;GOLGA8A;MARK4;KRT19;CHMP4C;HAUS4;UNC119B;TUBGCP6;CSNK1E;EHD3;GOLGA2;SEPT8;SPATA6;SH3PXD2A;UNC119;CCDC69;SFI1;RPL12
15133,GO:0071276,0.116772831986028,0.958449957131719,5,23,cellular response to cadmium ion,BP,FOS;GSN;EGFR;MAPK3;AKT1
1559,GO:0003962,0.116794081070531,1,1,1,cystathionine gamma-synthase activity,MF,CTH
1662,GO:0004123,0.116794081070531,1,1,1,cystathionine gamma-lyase activity,MF,CTH
5939,GO:0018272,0.116794081070531,1,1,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,CTH
9355,GO:0035887,0.116794081070531,1,1,1,aortic smooth muscle cell differentiation,BP,CTH
10901,GO:0044524,0.116794081070531,1,1,1,protein sulfhydration,BP,CTH
10908,GO:0044540,0.116794081070531,1,1,1,L-cystine L-cysteine-lyase (deaminating),MF,CTH
12033,GO:0047982,0.116794081070531,1,1,1,homocysteine desulfhydrase activity,MF,CTH
15129,GO:0071266,0.116794081070531,1,1,1,'de novo' L-methionine biosynthetic process,BP,CTH
15954,GO:0080146,0.116794081070531,1,1,1,L-cysteine desulfhydrase activity,MF,CTH
18982,GO:1904829,0.116794081070531,1,1,1,regulation of aortic smooth muscle cell differentiation,BP,CTH
18983,GO:1904831,0.116794081070531,1,1,1,positive regulation of aortic smooth muscle cell differentiation,BP,CTH
5686,GO:0016811,0.116800920886054,0.936287448516566,12,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,PHF21A;HDAC11;CHD3;HDAC5;ACY1;HMG20B;FAAH;CAT;MTA3;SIRT2;MTA1;HDAC8
15523,GO:0071963,0.116806263495347,1,1,1,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
16488,GO:0097224,0.11681436565003,1,1,1,sperm connecting piece,CC,SPATA6
3601,GO:0008038,0.116833895192914,0.958649969001001,5,22,neuron recognition,BP,EFNB3;SEMA5A;ROBO3;EPHB2;NTM
11783,GO:0046685,0.116908940278912,0.953459415865926,6,29,response to arsenic-containing substance,BP,MAPK13;UROS;GSTO1;MKNK2;ATF4;GSTO2
969,GO:0002416,0.11693796988722,1,1,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,FCGRT
6218,GO:0019770,0.11693796988722,1,1,1,IgG receptor activity,MF,FCGRT
6265,GO:0019864,0.11693796988722,1,1,1,IgG binding,MF,FCGRT
17,GO:0000032,0.117027295652136,1,1,1,cell wall mannoprotein biosynthetic process,BP,MPI
1820,GO:0004476,0.117027295652136,1,1,1,mannose-6-phosphate isomerase activity,MF,MPI
2689,GO:0006056,0.117027295652136,1,1,1,mannoprotein metabolic process,BP,MPI
2690,GO:0006057,0.117027295652136,1,1,1,mannoprotein biosynthetic process,BP,MPI
7407,GO:0031506,0.117027295652136,1,1,1,cell wall glycoprotein biosynthetic process,BP,MPI
10044,GO:0042546,0.117027295652136,1,1,1,cell wall biogenesis,BP,MPI
10702,GO:0044038,0.117027295652136,1,1,1,cell wall macromolecule biosynthetic process,BP,MPI
14348,GO:0061611,0.117027295652136,1,1,1,mannose to fructose-6-phosphate metabolic process,BP,MPI
14820,GO:0070589,0.117027295652136,1,1,1,cellular component macromolecule biosynthetic process,BP,MPI
1687,GO:0004163,0.117221906304901,1,1,1,diphosphomevalonate decarboxylase activity,MF,MVD
2085,GO:0004850,0.11730122662991,1,1,1,uridine phosphorylase activity,MF,UPP1
2783,GO:0006218,0.11730122662991,1,1,1,uridine catabolic process,BP,UPP1
11543,GO:0046108,0.11730122662991,1,1,1,uridine metabolic process,BP,UPP1
13353,GO:0052642,0.117315458491454,1,1,1,lysophosphatidic acid phosphatase activity,MF,ACP6
20280,GO:2001311,0.117315458491454,1,1,1,lysobisphosphatidic acid metabolic process,BP,ACP6
28,GO:0000053,0.11741000842029,1,1,1,argininosuccinate metabolic process,BP,ASS1
1619,GO:0004055,0.11741000842029,1,1,1,argininosuccinate synthase activity,MF,ASS1
13479,GO:0055074,0.117459761393005,0.918247925161703,30,203,calcium ion homeostasis,BP,DLG4;F2R;APOE;NTSR1;PRNP;NOS1;DDIT3;CYP27B1;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;BNIP3;SV2A;PKD1;HERPUD1;GSTM2;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;ITPR2;TPCN1;FYN;TRPC1;EDNRA;WFS1
2112,GO:0004900,0.117574952615327,1,1,1,erythropoietin receptor activity,MF,EPOR
9708,GO:0038162,0.117574952615327,1,1,1,erythropoietin-mediated signaling pathway,BP,EPOR
4997,GO:0015143,0.117684465754276,1,1,1,urate transmembrane transporter activity,MF,SLC2A9
5180,GO:0015747,0.117684465754276,1,1,1,urate transport,BP,SLC2A9
15769,GO:0072428,0.117684465754276,1,1,1,signal transduction involved in intra-S DNA damage checkpoint,BP,CHEK2
17726,GO:1901702,0.117684465754276,1,1,1,salt transmembrane transporter activity,MF,SLC2A9
18605,GO:1903925,0.117684465754276,1,1,1,response to bisphenol A,BP,CHEK2
18606,GO:1903926,0.117684465754276,1,1,1,cellular response to bisphenol A,BP,CHEK2
20004,GO:2000656,0.11775321249794,1,1,1,regulation of apolipoprotein binding,BP,MAPK3
20005,GO:2000657,0.11775321249794,1,1,1,negative regulation of apolipoprotein binding,BP,MAPK3
3380,GO:0007160,0.117799417226888,0.922510278491437,23,149,cell-matrix adhesion,BP,THBS3;POSTN;VEGFA;ADAMTS13;COL13A1;ITGA6;LAMA5;PRKCZ;ITGB4;NID1;ITGB5;DMTN;PKD1;ITGA1;EDA;MINK1;EPHA1;ECM2;BCAM;PLAU;ITGB6;BCL6;ITGA2
5213,GO:0015819,0.117808240861254,1,1,1,lysine transport,BP,PQLC2
664,GO:0001868,0.117835347411763,1,1,1,regulation of complement activation, lectin pathway,BP,SERPING1
665,GO:0001869,0.117835347411763,1,1,1,negative regulation of complement activation, lectin pathway,BP,SERPING1
15912,GO:0072740,0.117844322880795,1,1,1,cellular response to anisomycin,BP,MAPK13
1648,GO:0004098,0.117903396722522,1,1,1,cerebroside-sulfatase activity,MF,ARSA
3607,GO:0008049,0.117926657094402,1,1,1,male courtship behavior,BP,HEXB
11944,GO:0047166,0.117972550328337,1,1,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,LPCAT4
8189,GO:0032945,0.1179726220206,0.9453373507119,8,42,negative regulation of mononuclear cell proliferation,BP,IL20RB;PRNP;PKN1;INPP5D;PDCD1LG2;CEBPB;ERBB2;HLA-G
12507,GO:0050672,0.1179726220206,0.9453373507119,8,42,negative regulation of lymphocyte proliferation,BP,IL20RB;PRNP;PKN1;INPP5D;PDCD1LG2;CEBPB;ERBB2;HLA-G
11862,GO:0046890,0.117973849177466,0.924927007903266,20,128,regulation of lipid biosynthetic process,BP,APOE;EGR1;NR1D1;SLC27A1;CYP27B1;DGKQ;SEC14L2;ZP3;PLA2G6;ABCG1;ACACB;MVD;MLXIPL;TRIB3;TM7SF2;AKT1;IGFBP7;FGFR4;ACADVL;FITM2
1640,GO:0004085,0.118000811517951,1,1,1,butyryl-CoA dehydrogenase activity,MF,ACADS
6181,GO:0019605,0.118000811517951,1,1,1,butyrate metabolic process,BP,ACADS
11621,GO:0046359,0.118000811517951,1,1,1,butyrate catabolic process,BP,ACADS
13422,GO:0052890,0.118000811517951,1,1,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,ACADS
18466,GO:1903621,0.118134666631331,1,1,1,protein localization to photoreceptor connecting cilium,BP,SPATA7
1066,GO:0002625,0.11813731933094,1,1,1,regulation of T cell antigen processing and presentation,BP,HFE
1067,GO:0002626,0.11813731933094,1,1,1,negative regulation of T cell antigen processing and presentation,BP,HFE
4393,GO:0010106,0.11813731933094,1,1,1,cellular response to iron ion starvation,BP,HFE
18747,GO:1904282,0.11813731933094,1,1,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,HFE
18748,GO:1904283,0.11813731933094,1,1,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,HFE
20211,GO:2001186,0.11813731933094,1,1,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,HFE
11906,GO:0046970,0.118142615344143,1,1,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,SIRT2
14275,GO:0061433,0.118142615344143,1,1,1,cellular response to caloric restriction,BP,SIRT2
14738,GO:0070446,0.118142615344143,1,1,1,negative regulation of oligodendrocyte progenitor proliferation,BP,SIRT2
1915,GO:0004611,0.118248450157987,1,1,1,phosphoenolpyruvate carboxykinase activity,MF,PCK2
1916,GO:0004613,0.118248450157987,1,1,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,PCK2
6172,GO:0019543,0.118248450157987,1,1,1,propionate catabolic process,BP,PCK2
11604,GO:0046327,0.118248450157987,1,1,1,glycerol biosynthetic process from pyruvate,BP,PCK2
6724,GO:0030145,0.118285324055891,0.94515871060898,8,42,manganese ion binding,MF,GLUL;NPEPL1;PPM1M;HMGCL;PCK2;FAM20C;PRIMPOL;MPPE1
3832,GO:0008442,0.11830556926112,1,1,1,3-hydroxyisobutyrate dehydrogenase activity,MF,HIBADH
6538,GO:0021956,0.118396468705913,1,1,1,central nervous system interneuron axonogenesis,BP,TCTN1
1864,GO:0004531,0.118447152461338,1,1,1,deoxyribonuclease II activity,MF,DNASE2
13224,GO:0051926,0.118482020717992,0.952657004356315,6,29,negative regulation of calcium ion transport,BP,NTSR1;NOS1;GSTO1;PKD2;GSTM2;NOS3
1920,GO:0004617,0.118500848582118,1,1,1,phosphoglycerate dehydrogenase activity,MF,PHGDH
624,GO:0001808,0.118590887998756,1,1,1,negative regulation of type IV hypersensitivity,BP,IL20RB
1205,GO:0002865,0.118590887998756,1,1,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
1213,GO:0002884,0.118590887998756,1,1,1,negative regulation of hypersensitivity,BP,IL20RB
1579,GO:0003991,0.118714923651383,1,1,1,acetylglutamate kinase activity,MF,NAGS
1611,GO:0004042,0.118714923651383,1,1,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,NAGS
17152,GO:0103045,0.118714923651383,1,1,1,methione N-acyltransferase activity,MF,NAGS
1810,GO:0004463,0.118718752787244,1,1,1,leukotriene-A4 hydrolase activity,MF,LTA4H
10084,GO:0042610,0.118730176743087,1,1,1,CD8 receptor binding,MF,FYN
19228,GO:1905429,0.118730176743087,1,1,1,response to glycine,BP,FYN
19229,GO:1905430,0.118730176743087,1,1,1,cellular response to glycine,BP,FYN
7547,GO:0031883,0.118818187484881,1,1,1,taste receptor binding,MF,REEP2
5804,GO:0017064,0.118832280289496,1,1,1,fatty acid amide hydrolase activity,MF,FAAH
17094,GO:0102077,0.118832280289496,1,1,1,oleamide hydrolase activity,MF,FAAH
17158,GO:0103073,0.118832280289496,1,1,1,anandamide amidohydrolase activity,MF,FAAH
5001,GO:0015152,0.1188392659167,1,1,1,glucose-6-phosphate transmembrane transporter activity,MF,SLC37A4
7620,GO:0032028,0.1188392659167,1,1,1,myosin head/neck binding,MF,STX1A
2045,GO:0004795,0.118866806063154,1,1,1,threonine synthase activity,MF,THNSL2
4046,GO:0009088,0.118866806063154,1,1,1,threonine biosynthetic process,BP,THNSL2
11622,GO:0046360,0.118866806063154,1,1,1,2-oxobutyrate biosynthetic process,BP,THNSL2
11623,GO:0046361,0.118866806063154,1,1,1,2-oxobutyrate metabolic process,BP,THNSL2
1942,GO:0004648,0.118885369353047,1,1,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,PSAT1
7348,GO:0031399,0.118958436628553,0.89800730189666,163,1259,regulation of protein modification process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;EGR1;PPP1R35;FBXO2;PTK6;GJC2;PDCD4;TIMP2;VEGFA;EGFR;PRNP;FBLN1;DUSP5;RAPGEF3;TNFSF15;IGFBP4;CRTAP;NOS1;ERCC6;MST1R;ADARB1;NUPR1;B3GAT3;HBEGF;CTF1;CNTN1;SLC27A1;PHACTR3;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;SHC2;SYNGAP1;DGKQ;SNX9;SHC1;SPRY2;CAPRIN2;PRKCZ;PPP2R3B;PAK1;ABCA7;STK39;FGFR3;CEMIP;KDM3A;MTHFR;PHF1;SPRY4;DLG3;NEURL1;ACVR2B;NGFR;ELFN2;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;SESN2;IMPACT;PKD2;AREG;MAPK3;CSPG4;TRPT1;ERRFI1;STK40;VANGL2;RGS14;SNTA1;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;DMTN;KDM4C;PAK6;PKD1;FLOT1;TTN;JDP2;SORL1;HERPUD1;VLDLR;MAP3K12;LRP5;PKIB;TGFBR2;TRPV4;ITGA1;TRIB3;HMG20B;CDK5RAP3;MINK1;PROM2;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;NBR1;TADA3;CAMK1;PPP1R15A;ADCY6;ATP2B4;STRADB;HINT2;AKT1;CDKN1C;MICAL1;CRY2;CHEK2;SPDYE2;SPDYE2B;TSG101;FGFR4;PIAS3;WDFY2;C9ORF72;INSR;NCOA7;RPS6KA5;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;MAPK10;HFE;TP73;BCL6;FYN;LEMD2;SIRT2;GDF15;GOLGA2;MTA1;HDAC8;AVPI1;LAMTOR2;MAP3K10;EPHB2;PER1;FGFR1;WFS1;FKBP8;ERBB2;EIF2AK4;UNC119;CAMKK1;IKBKB
12417,GO:0050080,0.119103061540371,1,1,1,malonyl-CoA decarboxylase activity,MF,MLYCD
20272,GO:2001294,0.119103061540371,1,1,1,malonyl-CoA catabolic process,BP,MLYCD
1950,GO:0004657,0.119169566035805,1,1,1,proline dehydrogenase activity,MF,PRODH
3642,GO:0008118,0.11918289696725,1,1,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,ST3GAL3
1583,GO:0003996,0.119241452183933,1,1,1,acyl-CoA ligase activity,MF,ACSF2
10094,GO:0042628,0.119266154187134,1,1,1,mating plug formation,BP,SERPINE2
11176,GO:0045297,0.119266154187134,1,1,1,post-mating behavior,BP,SERPINE2
14171,GO:0061107,0.119266154187134,1,1,1,seminal vesicle development,BP,SERPINE2
14172,GO:0061108,0.119266154187134,1,1,1,seminal vesicle epithelium development,BP,SERPINE2
1846,GO:0004512,0.119269299910396,1,1,1,inositol-3-phosphate synthase activity,MF,ISYNA1
5723,GO:0016872,0.119269299910396,1,1,1,intramolecular lyase activity,MF,ISYNA1
14047,GO:0060857,0.119297825770054,1,1,1,establishment of glial blood-brain barrier,BP,MXRA8
15011,GO:0070981,0.119389546614439,1,1,1,L-asparagine biosynthetic process,BP,ASNS
15012,GO:0070982,0.119389546614439,1,1,1,L-asparagine metabolic process,BP,ASNS
16134,GO:0090181,0.119407638211722,0.941502033885322,9,49,regulation of cholesterol metabolic process,BP,APOE;LMF1;DGKQ;SEC14L2;ABCG1;ACACB;MVD;TM7SF2;ACADVL
10125,GO:0042709,0.1194322782281,1,1,1,succinate-CoA ligase complex,CC,SUCLG2
11155,GO:0045244,0.1194322782281,1,1,1,succinate-CoA ligase complex (GDP-forming),CC,SUCLG2
13029,GO:0051543,0.119435135759059,1,1,1,regulation of elastin biosynthetic process,BP,HBEGF
13030,GO:0051545,0.119435135759059,1,1,1,negative regulation of elastin biosynthetic process,BP,HBEGF
1897,GO:0004584,0.119442169043722,1,1,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,PIGV
5940,GO:0018277,0.119442169043722,1,1,1,protein deamination,BP,LOXL1
24,GO:0000048,0.119445626909863,1,1,1,peptidyltransferase activity,MF,GGT1
1248,GO:0002951,0.119445626909863,1,1,1,leukotriene-C(4) hydrolase,MF,GGT1
10650,GO:0043890,0.119453097710264,1,1,1,N-acetylgalactosamine-6-sulfatase activity,MF,GALNS
9615,GO:0036497,0.119464923313136,1,1,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,PPP1R15A
17930,GO:1902310,0.119464923313136,1,1,1,positive regulation of peptidyl-serine dephosphorylation,BP,PPP1R15A
18598,GO:1903916,0.119464923313136,1,1,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,PPP1R15A
18599,GO:1903917,0.119464923313136,1,1,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,PPP1R15A
4025,GO:0009061,0.119485942627744,1,1,1,anaerobic respiration,BP,SDHA
11165,GO:0045274,0.119485942627744,1,1,1,plasma membrane respiratory chain complex II,CC,SDHA
11169,GO:0045282,0.119485942627744,1,1,1,plasma membrane succinate dehydrogenase complex,CC,SDHA
4391,GO:0010070,0.119506388801548,1,1,1,zygote asymmetric cell division,BP,RGS14
839,GO:0002153,0.119512278009596,1,1,1,steroid receptor RNA activator RNA binding,MF,THRA
11450,GO:0045925,0.119512278009596,1,1,1,positive regulation of female receptivity,BP,THRA
18927,GO:1904719,0.119537487831714,1,1,1,positive regulation of AMPA glutamate receptor clustering,BP,SSH1
3955,GO:0008721,0.1195660671396,1,1,1,D-serine ammonia-lyase activity,MF,SRR
5713,GO:0016855,0.1195660671396,1,1,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,SRR
5898,GO:0018114,0.1195660671396,1,1,1,threonine racemase activity,MF,SRR
6874,GO:0030378,0.1195660671396,1,1,1,serine racemase activity,MF,SRR
9553,GO:0036361,0.1195660671396,1,1,1,racemase activity, acting on amino acids and derivatives,MF,SRR
11641,GO:0046416,0.1195660671396,1,1,1,D-amino acid metabolic process,BP,SRR
11646,GO:0046437,0.1195660671396,1,1,1,D-amino acid biosynthetic process,BP,SRR
12004,GO:0047661,0.1195660671396,1,1,1,amino-acid racemase activity,MF,SRR
14588,GO:0070178,0.1195660671396,1,1,1,D-serine metabolic process,BP,SRR
14589,GO:0070179,0.1195660671396,1,1,1,D-serine biosynthetic process,BP,SRR
1839,GO:0004498,0.119574168404699,1,1,1,calcidiol 1-monooxygenase activity,MF,CYP27B1
16372,GO:0097018,0.119585018275888,1,1,1,renal albumin absorption,BP,GAS6
17379,GO:1900141,0.119585018275888,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
17380,GO:1900142,0.119585018275888,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
19931,GO:2000532,0.119585018275888,1,1,1,regulation of renal albumin absorption,BP,GAS6
19932,GO:2000533,0.119585018275888,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
9519,GO:0036266,0.119609374995834,1,1,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,ANKZF1
15873,GO:0072671,0.119609374995834,1,1,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,ANKZF1
4624,GO:0010750,0.119614669247559,1,1,1,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
7861,GO:0032431,0.119614669247559,1,1,1,activation of phospholipase A2 activity,BP,EGFR
8445,GO:0033594,0.119614669247559,1,1,1,response to hydroxyisoflavone,BP,EGFR
10250,GO:0043006,0.119614669247559,1,1,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
16604,GO:0097489,0.119614669247559,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
15519,GO:0071953,0.119623417724711,1,1,1,elastic fiber,CC,FBLN1
1806,GO:0004458,0.119626139016797,1,1,1,D-lactate dehydrogenase (cytochrome) activity,MF,D2HGDH
2001,GO:0004728,0.119626139016797,1,1,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,MAP2K1
5745,GO:0016898,0.119626139016797,1,1,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,D2HGDH
6159,GO:0019516,0.119626139016797,1,1,1,lactate oxidation,BP,D2HGDH
1661,GO:0004122,0.119629841227826,1,1,1,cystathionine beta-synthase activity,MF,CBS
2988,GO:0006535,0.119629841227826,1,1,1,cysteine biosynthetic process from serine,BP,CBS
4048,GO:0009093,0.119629841227826,1,1,1,cysteine catabolic process,BP,CBS
5609,GO:0016662,0.119629841227826,1,1,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,CBS
6147,GO:0019448,0.119629841227826,1,1,1,L-cysteine catabolic process,BP,CBS
12455,GO:0050421,0.119629841227826,1,1,1,nitrite reductase (NO-forming) activity,MF,CBS
14502,GO:0070025,0.119629841227826,1,1,1,carbon monoxide binding,MF,CBS
16849,GO:0098809,0.119629841227826,1,1,1,nitrite reductase activity,MF,CBS
19447,GO:1990188,0.119636683586708,1,1,1,euchromatin binding,MF,ASH2L
2416,GO:0005591,0.119636944669388,1,1,1,collagen type VIII trimer,CC,COL8A1
2422,GO:0005598,0.119636944669388,1,1,1,short-chain collagen trimer,CC,COL8A1
7111,GO:0030935,0.119636944669388,1,1,1,sheet-forming collagen trimer,CC,COL8A1
16776,GO:0098646,0.119636944669388,1,1,1,collagen sheet,CC,COL8A1
9570,GO:0036403,0.119637074336419,1,1,1,arachidonate 8(S)-lipoxygenase activity,MF,ALOX15B
5343,GO:0016095,0.11964443830811,1,1,1,polyprenol catabolic process,BP,SRD5A3
17117,GO:0102389,0.11964443830811,1,1,1,polyprenol reductase activity,MF,SRD5A3
11002,GO:0044855,0.11965465485838,1,1,1,plasma membrane raft distribution,BP,GSN
11003,GO:0044856,0.11965465485838,1,1,1,plasma membrane raft localization,BP,GSN
11005,GO:0044858,0.11965465485838,1,1,1,plasma membrane raft polarization,BP,GSN
18594,GO:1903906,0.11965465485838,1,1,1,regulation of plasma membrane raft polarization,BP,GSN
3727,GO:0008265,0.119654702038183,1,1,1,Mo-molybdopterin cofactor sulfurase activity,MF,MOCOS
17146,GO:0102867,0.119654702038183,1,1,1,molybdenum cofactor sulfurtransferase activity,MF,MOCOS
3992,GO:0008894,0.119654795876074,1,1,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,ENTPD6
11710,GO:0046541,0.119655345077974,1,1,1,saliva secretion,BP,CHRM3
9499,GO:0036179,0.119656465970678,1,1,1,osteoclast maturation,BP,FAM20C
15304,GO:0071547,0.119657200387357,1,1,1,piP-body,CC,TDRKH
1879,GO:0004561,0.119658459735144,1,1,1,alpha-N-acetylglucosaminidase activity,MF,NAGLU
9491,GO:0036153,0.119660682675971,1,1,1,triglyceride acyl-chain remodeling,BP,PNPLA3
12893,GO:0051264,0.119660682675971,1,1,1,mono-olein transacylation activity,MF,PNPLA3
12894,GO:0051265,0.119660682675971,1,1,1,diolein transacylation activity,MF,PNPLA3
1645,GO:0004092,0.119661869523358,1,1,1,carnitine O-acetyltransferase activity,MF,CRAT
1296,GO:0003131,0.119662351762705,1,1,1,mesodermal-endodermal cell signaling,BP,HMGA2
7160,GO:0031049,0.119662351762705,1,1,1,programmed DNA elimination,BP,HMGA2
7162,GO:0031052,0.119662351762705,1,1,1,chromosome breakage,BP,HMGA2
9136,GO:0035501,0.119662351762705,1,1,1,MH1 domain binding,MF,HMGA2
9400,GO:0035978,0.119662351762705,1,1,1,histone H2A-S139 phosphorylation,BP,HMGA2
20027,GO:2000685,0.119662351762705,1,1,1,positive regulation of cellular response to X-ray,BP,HMGA2
12269,GO:0048619,0.1196634807238,1,1,1,embryonic hindgut morphogenesis,BP,TCF7
17987,GO:1902499,0.119664038680398,1,1,1,positive regulation of protein autoubiquitination,BP,MTA1
5464,GO:0016402,0.11966446389805,1,1,1,pristanoyl-CoA oxidase activity,MF,ACOX3
13969,GO:0060709,0.119665773814798,1,1,1,glycogen cell differentiation involved in embryonic placenta development,BP,AKT1
17079,GO:0100002,0.119665773814798,1,1,1,negative regulation of protein kinase activity by protein phosphorylation,BP,AKT1
1764,GO:0004371,0.119667911432258,1,1,1,glycerone kinase activity,MF,TKFC
1850,GO:0004516,0.119667911432258,1,1,1,nicotinate phosphoribosyltransferase activity,MF,NAPRT
3839,GO:0008453,0.119667911432258,1,1,1,alanine-glyoxylate transaminase activity,MF,PHYKPL
3970,GO:0008792,0.119667911432258,1,1,1,arginine decarboxylase activity,MF,AZIN2
4101,GO:0009159,0.119667911432258,1,1,1,deoxyribonucleoside monophosphate catabolic process,BP,DNPH1
5028,GO:0015203,0.119667911432258,1,1,1,polyamine transmembrane transporter activity,MF,AZIN2
5118,GO:0015489,0.119667911432258,1,1,1,putrescine transmembrane transporter activity,MF,AZIN2
5228,GO:0015847,0.119667911432258,1,1,1,putrescine transport,BP,AZIN2
6108,GO:0019357,0.119667911432258,1,1,1,nicotinate nucleotide biosynthetic process,BP,NAPRT
6109,GO:0019358,0.119667911432258,1,1,1,nicotinate nucleotide salvage,BP,NAPRT
6114,GO:0019365,0.119667911432258,1,1,1,pyridine nucleotide salvage,BP,NAPRT
7655,GO:0032093,0.119667911432258,1,1,1,SAM domain binding,MF,L3MBTL1
8256,GO:0033058,0.119667911432258,1,1,1,directional locomotion,BP,ARPIN
8457,GO:0033608,0.119667911432258,1,1,1,formyl-CoA transferase activity,MF,SUGCT
8548,GO:0034012,0.119667911432258,1,1,1,FAD-AMP lyase (cyclizing) activity,MF,TKFC
8699,GO:0034355,0.119667911432258,1,1,1,NAD salvage,BP,NAPRT
9188,GO:0035585,0.119667911432258,1,1,1,calcium-mediated signaling using extracellular calcium source,BP,DMTN
9707,GO:0038161,0.119667911432258,1,1,1,prolactin signaling pathway,BP,CREBRF
10221,GO:0042946,0.119667911432258,1,1,1,glucoside transport,BP,SLC50A1
10222,GO:0042947,0.119667911432258,1,1,1,glucoside transmembrane transporter activity,MF,SLC50A1
10953,GO:0044736,0.119667911432258,1,1,1,acid-sensing ion channel activity,MF,ASIC1
11120,GO:0045183,0.119667911432258,1,1,1,translation factor activity, non-nucleic acid binding,MF,NEURL1
11685,GO:0046497,0.119667911432258,1,1,1,nicotinate nucleotide metabolic process,BP,NAPRT
11971,GO:0047369,0.119667911432258,1,1,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,SUGCT
12424,GO:0050144,0.119667911432258,1,1,1,nucleoside deoxyribosyltransferase activity,MF,DNPH1
12436,GO:0050262,0.119667911432258,1,1,1,ribosylnicotinamide kinase activity,MF,NMRK1
12451,GO:0050354,0.119667911432258,1,1,1,triokinase activity,MF,TKFC
12673,GO:0050915,0.119667911432258,1,1,1,sensory perception of sour taste,BP,ASIC1
14061,GO:0060912,0.119667911432258,1,1,1,cardiac cell fate specification,BP,TENM4
14269,GO:0061400,0.119667911432258,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,CARF
14423,GO:0061769,0.119667911432258,1,1,1,ribosylnicotinate kinase activity,MF,NMRK1
14797,GO:0070560,0.119667911432258,1,1,1,protein secretion by platelet,BP,DMTN
14868,GO:0070694,0.119667911432258,1,1,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,DNPH1
16764,GO:0098629,0.119667911432258,1,1,1,trans-Golgi network membrane organization,BP,AZIN2
17395,GO:1900170,0.119667911432258,1,1,1,negative regulation of glucocorticoid mediated signaling pathway,BP,CREBRF
17875,GO:1902211,0.119667911432258,1,1,1,regulation of prolactin signaling pathway,BP,CREBRF
17876,GO:1902213,0.119667911432258,1,1,1,positive regulation of prolactin signaling pathway,BP,CREBRF
19938,GO:2000543,0.119667911432258,1,1,1,positive regulation of gastrulation,BP,TENM4
193,GO:0000412,0.119668121232131,1,1,1,histone peptidyl-prolyl isomerization,BP,FKBP10
18146,GO:1902939,0.119668650386454,1,1,1,negative regulation of intracellular calcium activated chloride channel activity,BP,ANO9
14418,GO:0061760,0.119672536100008,1,1,1,antifungal innate immune response,BP,FAM3A
19076,GO:1905034,0.119672536100008,1,1,1,regulation of antifungal innate immune response,BP,FAM3A
19077,GO:1905035,0.119672536100008,1,1,1,negative regulation of antifungal innate immune response,BP,FAM3A
2649,GO:0005991,0.119675986569861,1,1,1,trehalose metabolic process,BP,BRAF
14719,GO:0070413,0.119675986569861,1,1,1,trehalose metabolism in response to stress,BP,BRAF
4289,GO:0009720,0.119679569666252,1,1,1,detection of hormone stimulus,BP,ABCG1
8561,GO:0034041,0.119679569666252,1,1,1,sterol-transporting ATPase activity,MF,ABCG1
7692,GO:0032173,0.119681528339105,1,1,1,septin collar,CC,SEPT6
1406,GO:0003342,0.119684010237741,1,1,1,proepicardium development,BP,ZFP36L1
1407,GO:0003343,0.119684010237741,1,1,1,septum transversum development,BP,ZFP36L1
16564,GO:0097403,0.119684010237741,1,1,1,cellular response to raffinose,BP,ZFP36L1
17650,GO:1901545,0.119684010237741,1,1,1,response to raffinose,BP,ZFP36L1
3827,GO:0008431,0.119688538915541,1,1,1,vitamin E binding,MF,SEC14L2
2423,GO:0005600,0.119689757179772,1,1,1,collagen type XIII trimer,CC,COL13A1
7112,GO:0030936,0.119689757179772,1,1,1,transmembrane collagen trimer,CC,COL13A1
2155,GO:0004980,0.119694762161656,1,1,1,melanocyte-stimulating hormone receptor activity,MF,MC1R
10686,GO:0043990,0.119694912444543,1,1,1,histone H2A-S1 phosphorylation,BP,RPS6KA5
9889,GO:0042222,0.119700745130478,1,1,1,interleukin-1 biosynthetic process,BP,EGR1
11209,GO:0045360,0.119700745130478,1,1,1,regulation of interleukin-1 biosynthetic process,BP,EGR1
11210,GO:0045362,0.119700745130478,1,1,1,positive regulation of interleukin-1 biosynthetic process,BP,EGR1
12546,GO:0050720,0.119700745130478,1,1,1,interleukin-1 beta biosynthetic process,BP,EGR1
12547,GO:0050722,0.119700745130478,1,1,1,regulation of interleukin-1 beta biosynthetic process,BP,EGR1
12548,GO:0050725,0.119700745130478,1,1,1,positive regulation of interleukin-1 beta biosynthetic process,BP,EGR1
15704,GO:0072303,0.119700745130478,1,1,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,EGR1
2181,GO:0005034,0.119704624138468,1,1,1,osmosensor activity,MF,TRPV4
6696,GO:0030103,0.119704624138468,1,1,1,vasopressin secretion,BP,TRPV4
16609,GO:0097497,0.119704624138468,1,1,1,blood vessel endothelial cell delamination,BP,TRPV4
18386,GO:1903444,0.119704624138468,1,1,1,negative regulation of brown fat cell differentiation,BP,TRPV4
18521,GO:1903759,0.119704624138468,1,1,1,signal transduction involved in regulation of aerobic respiration,BP,TRPV4
15023,GO:0070995,0.119705105083049,1,1,1,NADPH oxidation,BP,KCNAB2
19399,GO:1990031,0.119705105083049,1,1,1,pinceau fiber,CC,KCNAB2
14540,GO:0070095,0.119707365931687,1,1,1,fructose-6-phosphate binding,MF,PFKL
3519,GO:0007495,0.119709078790875,1,1,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,FOXL1
1958,GO:0004668,0.119711053657556,1,1,1,protein-arginine deiminase activity,MF,PADI3
5892,GO:0018101,0.119711053657556,1,1,1,protein citrullination,BP,PADI3
9572,GO:0036414,0.119711053657556,1,1,1,histone citrullination,BP,PADI3
2307,GO:0005295,0.119714887602596,1,1,1,neutral amino acid:sodium symporter activity,MF,SLC6A9
5094,GO:0015375,0.119714887602596,1,1,1,glycine:sodium symporter activity,MF,SLC6A9
7509,GO:0031704,0.119714887602596,1,1,1,apelin receptor binding,MF,APLN
10478,GO:0043396,0.119714887602596,1,1,1,corticotropin-releasing hormone secretion,BP,APLN
10479,GO:0043397,0.119714887602596,1,1,1,regulation of corticotropin-releasing hormone secretion,BP,APLN
13005,GO:0051466,0.119714887602596,1,1,1,positive regulation of corticotropin-releasing hormone secretion,BP,APLN
13525,GO:0060012,0.119714887602596,1,1,1,synaptic transmission, glycinergic,BP,SLC6A9
13594,GO:0060092,0.119714887602596,1,1,1,regulation of synaptic transmission, glycinergic,BP,SLC6A9
13639,GO:0060183,0.119714887602596,1,1,1,apelin receptor signaling pathway,BP,APLN
14314,GO:0061536,0.119714887602596,1,1,1,glycine secretion,BP,SLC6A9
14315,GO:0061537,0.119714887602596,1,1,1,glycine secretion, neurotransmission,BP,SLC6A9
18649,GO:1904022,0.119714887602596,1,1,1,positive regulation of G-protein coupled receptor internalization,BP,APLN
19526,GO:1990523,0.119716066498863,1,1,1,bone regeneration,BP,POSTN
1335,GO:0003195,0.11971912208158,1,1,1,tricuspid valve formation,BP,ZFPM1
9836,GO:0042097,0.11971912208158,1,1,1,interleukin-4 biosynthetic process,BP,ZFPM1
11214,GO:0045402,0.11971912208158,1,1,1,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
11215,GO:0045403,0.11971912208158,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
13763,GO:0060375,0.11971912208158,1,1,1,regulation of mast cell differentiation,BP,ZFPM1
13764,GO:0060377,0.11971912208158,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
1495,GO:0003842,0.119720147986838,1,1,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,ALDH4A1
9160,GO:0035538,0.119721435308945,1,1,1,carbohydrate response element binding,MF,MLXIPL
15963,GO:0085032,0.119724980487164,1,1,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,TNIP1
19221,GO:1905407,0.119726199400698,1,1,1,regulation of creatine transmembrane transporter activity,BP,STK39
19222,GO:1905408,0.119726199400698,1,1,1,negative regulation of creatine transmembrane transporter activity,BP,STK39
13156,GO:0051786,0.119731466609017,1,1,1,all-trans-retinol 13,14-reductase activity,MF,RETSAT
4917,GO:0014859,0.119733591238048,1,1,1,negative regulation of skeletal muscle cell proliferation,BP,SIX5
18066,GO:1902723,0.119733591238048,1,1,1,negative regulation of skeletal muscle satellite cell proliferation,BP,SIX5
5762,GO:0016941,0.119754833551678,1,1,1,natriuretic peptide receptor activity,MF,NPR2
13692,GO:0060283,0.119754833551678,1,1,1,negative regulation of oocyte development,BP,NPR2
17403,GO:1900194,0.119754833551678,1,1,1,negative regulation of oocyte maturation,BP,NPR2
19358,GO:1905880,0.119754833551678,1,1,1,negative regulation of oogenesis,BP,NPR2
3962,GO:0008753,0.119756104381456,1,1,1,NADPH dehydrogenase (quinone) activity,MF,CBR4
1749,GO:0004352,0.11976173251306,1,1,1,glutamate dehydrogenase (NAD+) activity,MF,GLUD1
1750,GO:0004353,0.11976173251306,1,1,1,glutamate dehydrogenase [NAD(P)+] activity,MF,GLUD1
5596,GO:0016639,0.11976173251306,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,GLUD1
3707,GO:0008218,0.119761913973746,1,1,1,bioluminescence,BP,SDC2
17812,GO:1902010,0.119762639703308,1,1,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
9678,GO:0038086,0.119768345335497,1,1,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,VEGFA
9680,GO:0038091,0.119768345335497,1,1,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,VEGFA
16630,GO:0097532,0.119768345335497,1,1,1,stress response to acid chemical,BP,VEGFA
16631,GO:0097533,0.119768345335497,1,1,1,cellular stress response to acid chemical,BP,VEGFA
18444,GO:1903570,0.119768345335497,1,1,1,regulation of protein kinase D signaling,BP,VEGFA
18445,GO:1903572,0.119768345335497,1,1,1,positive regulation of protein kinase D signaling,BP,VEGFA
19397,GO:1990026,0.119770512561569,1,1,1,hippocampal mossy fiber expansion,CC,MICAL1
1612,GO:0004043,0.11977617691241,1,1,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,ALDH7A1
3974,GO:0008802,0.11977617691241,1,1,1,betaine-aldehyde dehydrogenase activity,MF,ALDH7A1
6089,GO:0019285,0.11977617691241,1,1,1,glycine betaine biosynthetic process from choline,BP,ALDH7A1
7386,GO:0031455,0.11977617691241,1,1,1,glycine betaine metabolic process,BP,ALDH7A1
7387,GO:0031456,0.11977617691241,1,1,1,glycine betaine biosynthetic process,BP,ALDH7A1
3994,GO:0008900,0.119779393435852,1,1,1,potassium:proton exchanging ATPase activity,MF,ATP12A
812,GO:0002086,0.11978347671664,1,1,1,diaphragm contraction,BP,GAA
1889,GO:0004574,0.11978347671664,1,1,1,oligo-1,6-glucosidase activity,MF,GAA
2646,GO:0005985,0.11978347671664,1,1,1,sucrose metabolic process,BP,GAA
10349,GO:0043181,0.11978347671664,1,1,1,vacuolar sequestering,BP,GAA
54,GO:0000111,0.119785769440591,1,1,1,nucleotide-excision repair factor 2 complex,CC,XPC
11063,GO:0045081,0.119785857383723,1,1,1,negative regulation of interleukin-10 biosynthetic process,BP,TRIB2
7816,GO:0032378,0.11979014315035,1,1,1,negative regulation of intracellular lipid transport,BP,PCSK9
7819,GO:0032381,0.11979014315035,1,1,1,negative regulation of intracellular sterol transport,BP,PCSK9
7822,GO:0032384,0.11979014315035,1,1,1,negative regulation of intracellular cholesterol transport,BP,PCSK9
19287,GO:1905596,0.11979014315035,1,1,1,negative regulation of low-density lipoprotein particle receptor binding,BP,PCSK9
19289,GO:1905598,0.11979014315035,1,1,1,negative regulation of low-density lipoprotein receptor activity,BP,PCSK9
19292,GO:1905601,0.11979014315035,1,1,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9
3842,GO:0008456,0.119804741646308,1,1,1,alpha-N-acetylgalactosaminidase activity,MF,NAGA
15917,GO:0072755,0.119810115721286,1,1,1,cellular response to benomyl,BP,IMPACT
17656,GO:1901561,0.119810115721286,1,1,1,response to benomyl,BP,IMPACT
483,GO:0001534,0.119811236713054,1,1,1,radial spoke,CC,WDR66
484,GO:0001536,0.119811236713054,1,1,1,radial spoke stalk,CC,WDR66
17039,GO:0099552,0.119817041995503,1,1,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,F2R
17040,GO:0099553,0.119817041995503,1,1,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,F2R
17375,GO:1900134,0.119817041995503,1,1,1,negative regulation of renin secretion into blood stream,BP,F2R
2145,GO:0004962,0.119819788488777,1,1,1,endothelin receptor activity,MF,EDNRA
16029,GO:0086100,0.119819788488777,1,1,1,endothelin receptor signaling pathway,BP,EDNRA
1767,GO:0004375,0.119820241010475,1,1,1,glycine dehydrogenase (decarboxylating) activity,MF,GLDC
5598,GO:0016642,0.119820241010475,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,GLDC
9513,GO:0036255,0.119820241010475,1,1,1,response to methylamine,BP,GLDC
14647,GO:0070280,0.119820241010475,1,1,1,pyridoxal binding,MF,GLDC
18385,GO:1903442,0.119820241010475,1,1,1,response to lipoic acid,BP,GLDC
15501,GO:0071914,0.119822184132617,1,1,1,prominosome,CC,PROM2
15292,GO:0071528,0.119828674583696,1,1,1,tRNA re-export from nucleus,BP,XPOT
7532,GO:0031811,0.119830408646754,1,1,1,G-protein coupled nucleotide receptor binding,MF,DLG4
7533,GO:0031812,0.119830408646754,1,1,1,P2Y1 nucleotide receptor binding,MF,DLG4
1600,GO:0004021,0.119833714836365,1,1,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,GPT2
2977,GO:0006522,0.119833714836365,1,1,1,alanine metabolic process,BP,GPT2
2978,GO:0006524,0.119833714836365,1,1,1,alanine catabolic process,BP,GPT2
4038,GO:0009078,0.119833714836365,1,1,1,pyruvate family amino acid metabolic process,BP,GPT2
4039,GO:0009080,0.119833714836365,1,1,1,pyruvate family amino acid catabolic process,BP,GPT2
10201,GO:0042851,0.119833714836365,1,1,1,L-alanine metabolic process,BP,GPT2
10202,GO:0042853,0.119833714836365,1,1,1,L-alanine catabolic process,BP,GPT2
12002,GO:0047635,0.119833714836365,1,1,1,alanine-oxo-acid transaminase activity,MF,GPT2
9951,GO:0042352,0.119834110995463,1,1,1,GDP-L-fucose salvage,BP,FUK
12430,GO:0050201,0.119834110995463,1,1,1,fucokinase activity,MF,FUK
19443,GO:1990175,0.119834897491934,1,1,1,EH domain binding,MF,EPN3
2007,GO:0004736,0.119845697440987,1,1,1,pyruvate carboxylase activity,MF,PC
9524,GO:0036290,0.119845806296893,1,1,1,protein trans-autophosphorylation,BP,ERN1
19471,GO:1990332,0.119845806296893,1,1,1,Ire1 complex,CC,ERN1
19538,GO:1990579,0.119845806296893,1,1,1,peptidyl-serine trans-autophosphorylation,BP,ERN1
19551,GO:1990630,0.119845806296893,1,1,1,IRE1-RACK1-PP2A complex,CC,ERN1
5859,GO:0017168,0.119846987195924,1,1,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,OPLAH
19566,GO:1990715,0.119849759327817,1,1,1,mRNA CDS binding,MF,UNK
14828,GO:0070615,0.11985221658472,1,1,1,nucleosome-dependent ATPase activity,MF,SMARCA1
16300,GO:0090537,0.11985221658472,1,1,1,CERF complex,CC,SMARCA1
4842,GO:0014054,0.119856145048748,1,1,1,positive regulation of gamma-aminobutyric acid secretion,BP,NTSR1
5517,GO:0016492,0.119856145048748,1,1,1,G-protein coupled neurotensin receptor activity,MF,NTSR1
12695,GO:0050955,0.119856763578034,1,1,1,thermoception,BP,TRPV1
12697,GO:0050960,0.119856763578034,1,1,1,detection of temperature stimulus involved in thermoception,BP,TRPV1
12702,GO:0050968,0.119856763578034,1,1,1,detection of chemical stimulus involved in sensory perception of pain,BP,TRPV1
13825,GO:0060454,0.119856763578034,1,1,1,positive regulation of gastric acid secretion,BP,TRPV1
16162,GO:0090210,0.119856763578034,1,1,1,regulation of establishment of blood-brain barrier,BP,TRPV1
16163,GO:0090212,0.119856763578034,1,1,1,negative regulation of establishment of blood-brain barrier,BP,TRPV1
16650,GO:0097603,0.119856763578034,1,1,1,temperature-gated ion channel activity,MF,TRPV1
17672,GO:1901594,0.119856763578034,1,1,1,response to capsazepine,BP,TRPV1
19716,GO:2000118,0.119857007554318,1,1,1,regulation of sodium-dependent phosphate transport,BP,CRY2
2159,GO:0004992,0.119857088445729,1,1,1,platelet activating factor receptor activity,MF,PTAFR
10440,GO:0043315,0.119857088445729,1,1,1,positive regulation of neutrophil degranulation,BP,PTAFR
15124,GO:0071258,0.119857088445729,1,1,1,cellular response to gravity,BP,PTAFR
18014,GO:1902565,0.119857088445729,1,1,1,positive regulation of neutrophil activation,BP,PTAFR
18147,GO:1902941,0.119857088445729,1,1,1,regulation of voltage-gated chloride channel activity,BP,PTAFR
18148,GO:1902943,0.119857088445729,1,1,1,positive regulation of voltage-gated chloride channel activity,BP,PTAFR
18542,GO:1903797,0.119857088445729,1,1,1,positive regulation of inorganic anion transmembrane transport,BP,PTAFR
18755,GO:1904298,0.119857088445729,1,1,1,regulation of transcytosis,BP,PTAFR
18756,GO:1904300,0.119857088445729,1,1,1,positive regulation of transcytosis,BP,PTAFR
18757,GO:1904301,0.119857088445729,1,1,1,regulation of maternal process involved in parturition,BP,PTAFR
18758,GO:1904303,0.119857088445729,1,1,1,positive regulation of maternal process involved in parturition,BP,PTAFR
18763,GO:1904316,0.119857088445729,1,1,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,PTAFR
18764,GO:1904317,0.119857088445729,1,1,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,PTAFR
13519,GO:0060005,0.119859895147487,1,1,1,vestibular reflex,BP,SLITRK6
13520,GO:0060007,0.119859895147487,1,1,1,linear vestibuloocular reflex,BP,SLITRK6
1041,GO:0002560,0.119860686558329,1,1,1,basophil mediated immunity,BP,PI4K2A
1042,GO:0002561,0.119860686558329,1,1,1,basophil degranulation,BP,PI4K2A
8477,GO:0033644,0.119860686558329,1,1,1,host cell membrane,CC,PI4K2A
10755,GO:0044218,0.119860686558329,1,1,1,other organism cell membrane,CC,PI4K2A
10757,GO:0044221,0.119860686558329,1,1,1,host cell synapse,CC,PI4K2A
10760,GO:0044231,0.119860686558329,1,1,1,host cell presynaptic membrane,CC,PI4K2A
10783,GO:0044279,0.119860686558329,1,1,1,other organism membrane,CC,PI4K2A
15817,GO:0072556,0.119860686558329,1,1,1,other organism presynaptic membrane,CC,PI4K2A
15438,GO:0071802,0.119861177386365,1,1,1,negative regulation of podosome assembly,BP,ARHGEF2
1660,GO:0004118,0.119861794013822,1,1,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,PDE2A
4906,GO:0014846,0.119864283363237,1,1,1,esophagus smooth muscle contraction,BP,SULF2
17868,GO:1902178,0.119867365353979,1,1,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,FGFR3
9258,GO:0035695,0.11986771195609,1,1,1,mitophagy by induced vacuole formation,BP,SPATA18
1751,GO:0004356,0.119870275483202,1,1,1,glutamate-ammonia ligase activity,MF,GLUL
2994,GO:0006542,0.119870275483202,1,1,1,glutamine biosynthetic process,BP,GLUL
5381,GO:0016211,0.119870275483202,1,1,1,ammonia ligase activity,MF,GLUL
6194,GO:0019676,0.119870275483202,1,1,1,ammonia assimilation cycle,BP,GLUL
9662,GO:0038039,0.11987035445567,1,1,1,G-protein coupled receptor heterodimeric complex,CC,GABBR1
958,GO:0002380,0.119874341634173,1,1,1,immunoglobulin secretion involved in immune response,BP,POU2F2
16457,GO:0097168,0.119875800119272,1,1,1,mesenchymal stem cell proliferation,BP,LTBP3
17972,GO:1902460,0.119875800119272,1,1,1,regulation of mesenchymal stem cell proliferation,BP,LTBP3
17973,GO:1902462,0.119875800119272,1,1,1,positive regulation of mesenchymal stem cell proliferation,BP,LTBP3
10122,GO:0042700,0.119876334643348,1,1,1,luteinizing hormone signaling pathway,BP,EREG
12090,GO:0048160,0.119876334643348,1,1,1,primary follicle stage,BP,EREG
16426,GO:0097116,0.11987648175028,1,1,1,gephyrin clustering involved in postsynaptic density assembly,BP,NLGN2
1017,GO:0002514,0.119876654707713,1,1,1,B cell tolerance induction,BP,TGFBR2
1076,GO:0002649,0.119876654707713,1,1,1,regulation of tolerance induction to self antigen,BP,TGFBR2
1077,GO:0002651,0.119876654707713,1,1,1,positive regulation of tolerance induction to self antigen,BP,TGFBR2
1079,GO:0002661,0.119876654707713,1,1,1,regulation of B cell tolerance induction,BP,TGFBR2
1080,GO:0002663,0.119876654707713,1,1,1,positive regulation of B cell tolerance induction,BP,TGFBR2
2178,GO:0005026,0.119876654707713,1,1,1,transforming growth factor beta receptor activity, type II,MF,TGFBR2
19181,GO:1905317,0.119876654707713,1,1,1,inferior endocardial cushion morphogenesis,BP,TGFBR2
4453,GO:0010430,0.119876905701681,1,1,1,fatty acid omega-oxidation,BP,CYP4V2
17231,GO:0120043,0.119877046967772,1,1,1,stereocilium shaft,CC,TRIOBP
17232,GO:0120044,0.119877046967772,1,1,1,stereocilium base,CC,TRIOBP
3467,GO:0007290,0.119877113359996,1,1,1,spermatid nucleus elongation,BP,KDM3A
11590,GO:0046293,0.119877113359996,1,1,1,formaldehyde biosynthetic process,BP,KDM3A
2174,GO:0005011,0.119877127737671,1,1,1,macrophage colony-stimulating factor receptor activity,MF,MST1R
17034,GO:0099545,0.119877181614456,1,1,1,trans-synaptic signaling by trans-synaptic complex,BP,EPHB2
17041,GO:0099557,0.119877181614456,1,1,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,EPHB2
17173,GO:0106028,0.119877181614456,1,1,1,neuron projection retraction,BP,EPHB2
17466,GO:1900450,0.119877181614456,1,1,1,negative regulation of glutamate receptor signaling pathway,BP,EPHB2
18960,GO:1904782,0.119877181614456,1,1,1,negative regulation of NMDA glutamate receptor activity,BP,EPHB2
7388,GO:0031460,0.119877181677877,1,1,1,glycine betaine transport,BP,SLC38A2
6374,GO:0021566,0.119877190763715,1,1,1,hypoglossal nerve development,BP,ADARB1
6396,GO:0021618,0.119877190763715,1,1,1,hypoglossal nerve morphogenesis,BP,ADARB1
6669,GO:0030037,0.119877213841006,1,1,1,actin filament reorganization involved in cell cycle,BP,ARAP1
2184,GO:0005042,0.11987727012808,1,1,1,netrin receptor activity,MF,UNC5B
11535,GO:0046092,0.119877398112207,1,1,1,deoxycytidine metabolic process,BP,TK2
1292,GO:0003127,0.119877451194465,1,1,1,detection of nodal flow,BP,PKD2
12352,GO:0048763,0.119877451194465,1,1,1,calcium-induced calcium release activity,MF,PKD2
15256,GO:0071464,0.119877451194465,1,1,1,cellular response to hydrostatic pressure,BP,PKD2
15559,GO:0072055,0.119877451194465,1,1,1,renal cortex development,BP,PKD2
15560,GO:0072059,0.119877451194465,1,1,1,cortical collecting duct development,BP,PKD2
15646,GO:0072194,0.119877451194465,1,1,1,kidney smooth muscle tissue development,BP,PKD2
15657,GO:0072208,0.119877451194465,1,1,1,metanephric smooth muscle tissue development,BP,PKD2
15661,GO:0072214,0.119877451194465,1,1,1,metanephric cortex development,BP,PKD2
15666,GO:0072219,0.119877451194465,1,1,1,metanephric cortical collecting duct development,BP,PKD2
3090,GO:0006666,0.119878683118378,1,1,1,3-keto-sphinganine metabolic process,BP,KDSR
11994,GO:0047560,0.119878683118378,1,1,1,3-dehydrosphinganine reductase activity,MF,KDSR
15206,GO:0071387,0.119878697495405,1,1,1,cellular response to cortisol stimulus,BP,KLF9
4951,GO:0015019,0.119879054004353,1,1,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,HGSNAT
19801,GO:2000297,0.119880658079454,1,1,1,negative regulation of synapse maturation,BP,NFATC4
11144,GO:0045219,0.119885825291919,1,1,1,regulation of FasL biosynthetic process,BP,JAK3
11145,GO:0045221,0.119885825291919,1,1,1,negative regulation of FasL biosynthetic process,BP,JAK3
18962,GO:1904784,0.119887800484569,1,1,1,NLRP1 inflammasome complex assembly,BP,NLRP1
2407,GO:0005579,0.119888174413249,1,1,1,membrane attack complex,CC,C5
11489,GO:0045994,0.119889817090642,1,1,1,positive regulation of translational initiation by iron,BP,RXRA
9746,GO:0039520,0.119890977469781,1,1,1,induction by virus of host autophagy,BP,EIF2AK4
13933,GO:0060665,0.119897935868642,1,1,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,FGFR1
16199,GO:0090272,0.119897935868642,1,1,1,negative regulation of fibroblast growth factor production,BP,FGFR1
18393,GO:1903465,0.119897935868642,1,1,1,positive regulation of mitotic cell cycle DNA replication,BP,FGFR1
20107,GO:2000830,0.119897935868642,1,1,1,positive regulation of parathyroid hormone secretion,BP,FGFR1
2089,GO:0004855,0.119907972469722,1,1,1,xanthine oxidase activity,MF,XDH
5637,GO:0016727,0.119907972469722,1,1,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,XDH
20226,GO:2001213,0.119907972469722,1,1,1,negative regulation of vasculogenesis,BP,XDH
8858,GO:0034676,0.119909889931423,1,1,1,integrin alpha6-beta4 complex,CC,ITGA6
12303,GO:0048677,0.1199181442328,1,1,1,axon extension involved in regeneration,BP,LAMB2
15678,GO:0072244,0.1199181442328,1,1,1,metanephric glomerular epithelium development,BP,LAMB2
15679,GO:0072248,0.1199181442328,1,1,1,metanephric glomerular visceral epithelial cell differentiation,BP,LAMB2
15680,GO:0072249,0.1199181442328,1,1,1,metanephric glomerular visceral epithelial cell development,BP,LAMB2
15691,GO:0072274,0.1199181442328,1,1,1,metanephric glomerular basement membrane development,BP,LAMB2
15712,GO:0072312,0.1199181442328,1,1,1,metanephric glomerular epithelial cell differentiation,BP,LAMB2
15713,GO:0072313,0.1199181442328,1,1,1,metanephric glomerular epithelial cell development,BP,LAMB2
6467,GO:0021812,0.11992365585687,1,1,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,LAMB1
10401,GO:0043257,0.11992365585687,1,1,1,laminin-8 complex,CC,LAMB1
7025,GO:0030807,0.119943611667513,1,1,1,positive regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7040,GO:0030822,0.119943611667513,1,1,1,positive regulation of cAMP catabolic process,BP,RAPGEF3
8283,GO:0033123,0.119943611667513,1,1,1,positive regulation of purine nucleotide catabolic process,BP,RAPGEF3
1632,GO:0004077,0.119945871158067,1,1,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,HLCS
1633,GO:0004078,0.119945871158067,1,1,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,HLCS
1634,GO:0004079,0.119945871158067,1,1,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,HLCS
1635,GO:0004080,0.119945871158067,1,1,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,HLCS
4194,GO:0009305,0.119945871158067,1,1,1,protein biotinylation,BP,HLCS
5938,GO:0018271,0.119945871158067,1,1,1,biotin-protein ligase activity,MF,HLCS
14903,GO:0070781,0.119945871158067,1,1,1,response to biotin,BP,HLCS
15072,GO:0071110,0.119945871158067,1,1,1,histone biotinylation,BP,HLCS
9317,GO:0035811,0.119990837587037,1,1,1,negative regulation of urine volume,BP,ADCY6
13576,GO:0060072,0.119999454043244,1,1,1,large conductance calcium-activated potassium channel activity,MF,KCNMA1
14556,GO:0070123,0.120039655197864,1,1,1,transforming growth factor beta receptor activity, type III,MF,TGFBR3
2338,GO:0005368,0.120064040338913,1,1,1,taurine transmembrane transporter activity,MF,SLC6A6
2339,GO:0005369,0.120064040338913,1,1,1,taurine:sodium symporter activity,MF,SLC6A6
5173,GO:0015734,0.120064040338913,1,1,1,taurine transport,BP,SLC6A6
8625,GO:0034164,0.120108296678304,1,1,1,negative regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
16926,GO:0098948,0.120108296678304,1,1,1,intrinsic component of postsynaptic specialization membrane,CC,PTPRS
16960,GO:0099060,0.120108296678304,1,1,1,integral component of postsynaptic specialization membrane,CC,PTPRS
16961,GO:0099061,0.120108296678304,1,1,1,integral component of postsynaptic density membrane,CC,PTPRS
16989,GO:0099146,0.120108296678304,1,1,1,intrinsic component of postsynaptic density membrane,CC,PTPRS
5964,GO:0018400,0.120108632686521,1,1,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,CRTAP
4716,GO:0010883,0.120115837812018,0.9518200474331,6,29,regulation of lipid storage,BP,ABCG1;PPARA;ACACB;ALKBH7;CIDEA;FITM2
17517,GO:1901074,0.120183207482501,1,1,1,regulation of engulfment of apoptotic cell,BP,ABCA7
17518,GO:1901076,0.120183207482501,1,1,1,positive regulation of engulfment of apoptotic cell,BP,ABCA7
18041,GO:1902630,0.120230929392343,1,1,1,regulation of membrane hyperpolarization,BP,CRTC1
18042,GO:1902631,0.120230929392343,1,1,1,negative regulation of membrane hyperpolarization,BP,CRTC1
12888,GO:0051258,0.120231786542538,0.916096369370034,30,204,protein polymerization,BP,GSN;WIPF1;CDC42EP5;SPTB;DNM1;MSRB2;ARPIN;CAPG;EML2;TUBG2;ARL2;PAK1;MICALL2;PLEKHG2;TWF2;DMTN;WHAMMP3;NDE1;TRIOBP;TRPV4;TMSB4X;TMOD2;TUBGCP6;FCHSD1;SPIRE1;EPS8L1;GOLGA2;EPS8L2;C15ORF62;CORO1B
8738,GO:0034404,0.120236398415478,0.919163889012473,25,167,nucleobase-containing small molecule biosynthetic process,BP,XDH;NT5E;RAPGEF3;DNPH1;PGM1;DHTKD1;TK2;DDIT4;OGDHL;NME4;NEIL1;PPARA;NT5C1B;MLXIPL;GALK1;ALDOC;PDE2A;UCKL1;UPP1;INSR;APRT;ADA;ENTPD2;PFKL;NUDT18
5754,GO:0016920,0.120277262423031,1,1,1,pyroglutamyl-peptidase activity,MF,PGPEP1
16915,GO:0098923,0.120307140019634,1,1,1,retrograde trans-synaptic signaling by soluble gas,BP,NOS1
16916,GO:0098924,0.120307140019634,1,1,1,retrograde trans-synaptic signaling by nitric oxide,BP,NOS1
16991,GO:0099163,0.120307140019634,1,1,1,synaptic signaling by nitric oxide,BP,NOS1
17033,GO:0099543,0.120307140019634,1,1,1,trans-synaptic signaling by soluble gas,BP,NOS1
17036,GO:0099548,0.120307140019634,1,1,1,trans-synaptic signaling by nitric oxide,BP,NOS1
17292,GO:0140196,0.120307140019634,1,1,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
1831,GO:0004489,0.120310372669204,1,1,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,MTHFR
8364,GO:0033274,0.120310372669204,1,1,1,response to vitamin B2,BP,MTHFR
16893,GO:0098888,0.120361797451512,1,1,1,extrinsic component of presynaptic membrane,CC,HIP1
16894,GO:0098890,0.120361797451512,1,1,1,extrinsic component of postsynaptic membrane,CC,HIP1
17001,GO:0099243,0.120361797451512,1,1,1,extrinsic component of synaptic membrane,CC,HIP1
18198,GO:1903027,0.120538066493836,1,1,1,regulation of opsonization,BP,MYO18A
18199,GO:1903028,0.120538066493836,1,1,1,positive regulation of opsonization,BP,MYO18A
16266,GO:0090389,0.120569617979068,1,1,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,SPG11
9651,GO:0038024,0.120609452790124,0.943827067631331,8,42,cargo receptor activity,MF,LRP1;ABCA7;SCART1;SCARA3;SORL1;VLDLR;AP2A2;HIP1
8391,GO:0033343,0.120718277144558,1,1,1,positive regulation of collagen binding,BP,ITGA2
8927,GO:0034976,0.120793515264137,0.913223580717797,35,242,response to endoplasmic reticulum stress,BP,FBXO2;TMEM129;EDEM1;DDIT3;CUL7;SHC1;PLA2G6;CHAC1;SESN2;TSPYL2;UBXN4;ATF4;BBC3;FBXO6;FLOT1;HERPUD1;CEBPB;CREBRF;TRIB3;CDK5RAP3;PIK3R2;ERN1;PPP1R15A;ASNS;ACADVL;LMNA;ANKZF1;TMX4;UBXN6;MAN1B1;WFS1;CTH;EIF2AK4;SYVN1;CREB3L4
18658,GO:1904035,0.120819871844455,0.943706165477416,8,42,regulation of epithelial cell apoptotic process,BP,GSN;PDCD4;ZFP36L1;SEMA5A;ANGPTL4;GAS6;BRAF;WFS1
3221,GO:0006874,0.120841453112838,0.916188190844192,29,196,cellular calcium ion homeostasis,BP,DLG4;F2R;APOE;NTSR1;PRNP;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;BNIP3;SV2A;PKD1;HERPUD1;GSTM2;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;ITPR2;TPCN1;FYN;TRPC1;EDNRA;WFS1
12782,GO:0051100,0.120870447220784,0.923795313848099,19,122,negative regulation of binding,BP,NFATC4;CTNNBIP1;GPSM1;DDIT3;MDFI;TTBK2;PPARA;HMGA2;MAPK3;ZFPM1;SORL1;PCSK9;TMSB4X;ZFP90;CAMK1;AKT1;HFE;CSNK1E;GOLGA2
6213,GO:0019748,0.120956802661602,0.947092814534793,7,36,secondary metabolic process,BP,AKR7A2;CBS;GSTO1;GSTO2;CBR4;TRPC1;CTH
18388,GO:1903450,0.121264870054903,1,1,1,regulation of G1 to G0 transition,BP,RAB11FIP4
18389,GO:1903452,0.121264870054903,1,1,1,positive regulation of G1 to G0 transition,BP,RAB11FIP4
5772,GO:0016999,0.121347578379837,0.928301142511977,15,93,antibiotic metabolic process,BP,GPX3;EGFR;PRDX5;IDH2;DHTKD1;PCK2;AKR7A2;OGDHL;KDM3A;ACSS2;SDHA;SUCLG2;CBR4;ACSS1;CAT
1485,GO:0003824,0.121357099302842,0.890036647703156,534,4344,catalytic activity,MF,XDH;DUSP6;H6PD;PTPRS;DLG4;HTRA1;GAMT;ST6GALNAC2;NT5E;ISYNA1;GID4;PRODH;ACSF2;PYGB;ALDH7A1;TYSND1;SUGCT;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;ACP5;THSD4;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;GPX3;ALOX15B;NAGS;OBSCN;EGFR;PADI3;RBCK1;DDB2;D2HGDH;ZDHHC1;ERCC1;ADAMTS7;HADH;PRDX5;DUSP5;NEK9;BPHL;NPEPL1;LOXL1;DGKA;RNPEPL1;IDH2;FKBP9;DNM1;NOS1;HAGHL;BRSK1;DNPH1;ACAD10;PGM1;CLCA2;ERCC6;GGT1;ADAMTS13;MMP28;MYH15;SMARCA1;MST1R;ADARB1;PPM1M;B3GAT3;HBEGF;PHGDH;RPS6KA2;GAA;PYGL;MMP1;PYCR2;CYP3A5;DHTKD1;ALDH4A1;HSD17B14;PHYHD1;EFNB3;MSRB2;TK2;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;RNF165;CDK18;CPT2;MLYCD;FBXW4;PLD3;ASH2L;LHPP;PRSS3;HMGCL;UROS;HYAL1;NAGLU;TXNRD3;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;CRYL1;ABCA2;PKN1;PGLS;ALPK1;OPLAH;LPCAT4;PLCH2;DNASE1L1;PHF21A;DGKQ;AKR7A2;TUBG2;DNAH1;ARL2;ULK1;OGDHL;HDAC11;RAB3B;NLGN2;PCSK1;MYH11;CYBRD1;HSD11B1L;NMRK1;PRSS8;TTBK2;PRKCZ;PPP2R3B;GALE;PAK1;ABCA7;APOBEC3C;AARS;PHYH;STK39;B4GALNT4;ERO1B;BLVRB;FGFR3;FBXO41;CEMIP;KDM3A;MTHFR;KLHL29;GLDC;NPR2;PLCXD1;CAPNS2;NDUFA4L2;CBS;USP20;DHRS12;DLG3;NMNAT2;DDX59;NME4;FBXW8;NSUN5P2;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;SPEG;MARCH4;NSUN7;ETFB;GSTO1;WDR60;LTBP1;PPCS;EREG;CHD2;GPT2;PSAT1;PTPRE;PNPLA3;RNF44;SSH3;SPATA20;PLCD3;DHRS4;PSPH;RHOBTB2;PLA2G6;UNKL;CES3;PPM1J;ABCG1;GSTT1;AGAP1;CARS;FKBP10;MTMR4;KIF17;APOBEC3F;ACOT1;CHD3;CHAC1;SESN2;BLMH;MKNK2;IFT27;ACOT11;RRNAD1;HMGA2;ST6GALNAC6;SEPT5;B4GAT1;MARCH9;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;TRPT1;PC;FBXO27;MACROD1;STK40;ACSS2;MVD;DNAL4;FAM20C;RHOF;CNTRL;ADAMTSL1;FAHD2B;TUBE1;PAN2;CTSB;MAPK12;MYH3;LTA4H;PI4K2A;NAT14;FBXO17;PTPDC1;C1RL;PLCD1;SEPT10;INPP5D;MAP2K2;SRD5A3;HIBADH;PGPEP1;SDHA;KIF21B;FAM86C2P;LRSAM1;KLHL24;CHST6;KDM4C;PAK6;PRSS22;SSH1;PCMTD2;PRIMPOL;POLM;MYH16;FBXO6;KIF26B;FUCA1;NSMCE1;TTN;PSKH1;HLCS;AZIN2;HSD11B1;HDAC5;GTPBP1;GALK1;TFB1M;NTPCR;GSTM2;PAPLN;NADK;DHX32;TEP1;ST3GAL3;SULF2;CES2;ACY1;ENDOG;KDM7A;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;PTPRU;TSTD1;WNK4;ALDOC;PCSK9;PKN3;FBXL15;METTL23;ACADS;FBXL16;ISG20;LONP2;MARK3;HLTF;DNMT3A;TGFBR2;MOCOS;HSD17B7;PDE2A;SMURF2;LMO7;RAB40B;ALDH1L2;MLH3;PEMT;HMG20B;NOS3;HEXDC;MINK1;PIGZ;HEXB;SLC27A3;TTLL11;MARCH2;PIP5KL1;PIK3R2;EPHA1;RHBDF2;RPUSD3;SHARPIN;CCS;GLUD1;DNAJC6;SUCLG2;ERN1;NUDT6;ALKBH7;BCR;KLHDC8B;ATP7B;MAN2C1;CHKB;CPT1C;EXD3;HEXA;FAHD2A;SRR;TADA3;NUDT8;KIF13B;UCKL1;CAMK1;POLL;TERC;CYP2R1;ADCY6;RAB43;ATP2B4;THNSL2;PRDM8;STRADB;CTSH;ACOX3;ACAD11;FBXL8;MGMT;GSTO2;ASNS;ENTPD6;TM7SF2;STEAP2;HINT2;AKT1;ZFYVE21;CARD11;DGUOK;MICAL1;B4GALT2;CHEK2;LACTB2;PHYKPL;SEPT6;ASS1;TNNT1;COMTD1;KIF27;PHF2;FGFR4;PIAS3;TCIRG1;HAGH;STEAP3;CBR4;ACADVL;DNASE2;ASMTL;FAAH;UPP1;SPSB3;UHRF2;ARSA;CAPN2;MAN2B1;MARK4;RAB25;PLAU;INSR;ACSS1;GNAL;RPS6KA5;ANKZF1;PNPLA4;MBLAC2;RABGGTA;TXNRD2;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;CPSF4;POLR2J2;ALDH1L1;PLB1;CAT;MAPK10;DPP7;MPG;JAK3;MTA3;UBOX5;CHRM3;APRT;TMX4;OGFOD2;MIB2;CERS4;MPI;ENDOV;JOSD2;METTL7A;ATP12A;CSNK1E;TAZ;HGSNAT;SAT2;RNF213;GSTM3;TKFC;FBXO25;FYN;MAST4;ZC3H12D;ATP8B2;PJA2;PEX1;SLC25A42;SIRT2;MBOAT2;RECQL5;RAB13;TST;ADA;POLR3GL;RHOBTB3;ETNK2;NAGA;MTA1;MSH5;ENTPD2;FUK;HDAC8;RETSAT;TGFBR3;PLPP6;RNPEP;MAN1B1;GALNS;MAP3K10;MFNG;EDNRA;CHD6;RNF170;DHPS;EPHB2;POLR2J3;INPP4A;SEPT8;FGFR1;DIP2C;PIGV;FKBP8;CTH;XYLT2;ERBB2;KDELC2;UST;EIF2AK4;STK32B;SYVN1;PFKL;MMP17;MPPE1;HMBOX1;TRIM2;MMP19;KCTD11;LYPLAL1;NUDT18;SDHAF4;KCTD13;TMEM8A;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;CYP4V2;ACOT8
309,GO:0000821,0.121433058556232,1,1,1,regulation of arginine metabolic process,BP,ATP2B4
8351,GO:0033241,0.121433058556232,1,1,1,regulation of cellular amine catabolic process,BP,ATP2B4
8352,GO:0033242,0.121433058556232,1,1,1,negative regulation of cellular amine catabolic process,BP,ATP2B4
9607,GO:0036487,0.121433058556232,1,1,1,nitric-oxide synthase inhibitor activity,MF,ATP2B4
15479,GO:0071878,0.121433058556232,1,1,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,ATP2B4
16809,GO:0098736,0.121433058556232,1,1,1,negative regulation of the force of heart contraction,BP,ATP2B4
17293,GO:0140199,0.121433058556232,1,1,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,ATP2B4
17339,GO:1900081,0.121433058556232,1,1,1,regulation of arginine catabolic process,BP,ATP2B4
17340,GO:1900082,0.121433058556232,1,1,1,negative regulation of arginine catabolic process,BP,ATP2B4
18290,GO:1903248,0.121433058556232,1,1,1,regulation of citrulline biosynthetic process,BP,ATP2B4
18291,GO:1903249,0.121433058556232,1,1,1,negative regulation of citrulline biosynthetic process,BP,ATP2B4
19795,GO:2000283,0.121433058556232,1,1,1,negative regulation of cellular amino acid biosynthetic process,BP,ATP2B4
3427,GO:0007218,0.121448436283885,0.962717020600749,4,17,neuropeptide signaling pathway,BP,NTSR1;NXPH4;LTB4R2;LTB4R
2172,GO:0005009,0.121636222051497,1,1,1,insulin-activated receptor activity,MF,INSR
1741,GO:0004344,0.121688223193518,1,1,1,glucose dehydrogenase activity,MF,H6PD
12030,GO:0047936,0.121688223193518,1,1,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,H6PD
12130,GO:0048259,0.121862014710856,0.937385173229285,10,56,regulation of receptor-mediated endocytosis,BP,DLG4;VEGFA;ARAP3;FLOT1;PCSK9;APLN;DNAJC6;HFE;UNC119;HIP1
4600,GO:0010720,0.122101342473767,0.907639755855074,48,341,positive regulation of cell development,BP,DLG4;APOE;ZMYND8;SERPINE2;PTK6;GJC2;TIMP2;VEGFA;SHANK2;CRTC1;CNTN1;OBSL1;CUL7;MAP2K1;CAPRIN2;PAK1;PLXNB3;FBXW8;NEURL1;NGFR;ETV5;PLXNB1;LPAR3;IMPACT;SEMA5A;RGS14;ARHGEF2;TWF2;DMTN;KDM4C;METRN;VLDLR;TRIOBP;HMG20B;CAMK1;WNT3;TENM4;BRAF;TP73;CSNK1E;BCL6;FYN;SIRT2;PLXND1;EPHB2;FGFR1;NET1;KCTD11
8701,GO:0034358,0.122173711535302,0.962412343576937,4,17,plasma lipoprotein particle,CC,APOE;SORL1;PLTP;VLDLR
19594,GO:1990777,0.122173711535302,0.962412343576937,4,17,lipoprotein particle,CC,APOE;SORL1;PLTP;VLDLR
8022,GO:0032675,0.12239367485272,0.934727555099278,11,63,regulation of interleukin-6 production,BP,F2R;MAPK13;EREG;NLRX1;ARHGEF2;INPP5D;CEBPB;TRPV4;GAS6;PTAFR;IL17RC
4564,GO:0010650,0.122560166498703,1,1,1,positive regulation of cell communication by electrical coupling,BP,ANK3
15865,GO:0072658,0.122560166498703,1,1,1,maintenance of protein location in membrane,BP,ANK3
15867,GO:0072660,0.122560166498703,1,1,1,maintenance of protein location in plasma membrane,BP,ANK3
17493,GO:1900827,0.122560166498703,1,1,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
15741,GO:0072363,0.122632152676899,1,1,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
15744,GO:0072366,0.122632152676899,1,1,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
3264,GO:0006937,0.12269715792111,0.930575736876305,13,78,regulation of muscle contraction,BP,DOCK4;F2R;NOS1;GSTO1;GSTM2;TNNI2;PTAFR;TNNT1;CHRM3;EHD3;ADA;ITGA2;TNNI1
11811,GO:0046755,0.123104585361469,0.955462232503622,5,23,viral budding,BP,CHMP1B;LRSAM1;TSG101;CHMP5;CHMP4C
12967,GO:0051402,0.123115237676231,0.917737784414159,24,159,neuron apoptotic process,BP,F2R;APOE;LRP1;PRNP;DDIT3;ADARB1;SYNGAP1;AARS;NGFR;BNIP3;ATF4;MDK;UNC5B;NLRP1;CEBPB;MAP3K12;PCSK9;ITGA1;BRAF;TP73;FYN;WFS1;TRIM2;SNCB
12497,GO:0050661,0.123315351931889,0.945795838975911,7,36,NADP binding,MF,H6PD;NOS1;MTHFR;NOS3;TM7SF2;CBR4;CAT
18129,GO:1902903,0.123523699217833,0.910625156608967,36,250,regulation of supramolecular fiber organization,BP,APOE;GSN;WIPF1;CDC42EP5;RAPGEF3;SPTB;ARAP1;ARPIN;CAPG;EML2;ARL2;TTBK2;PAK1;SSH3;PLEKHG2;SEMA5A;ARHGEF2;TWF2;DMTN;SSH1;WHAMMP3;TRIOBP;TRPV4;TMSB4X;EPHA1;TMOD2;ASAP3;C9ORF72;BRAF;FCHSD1;SPIRE1;EPS8L1;EPS8L2;C15ORF62;CORO1B;PLEKHH2
15024,GO:0070997,0.123698239691118,0.911375329821539,34,235,neuron death,BP,F2R;APOE;FOS;EGR1;LRP1;PRNP;DDIT3;ADARB1;DDIT4;SYNGAP1;AARS;NGFR;PPARA;BNIP3;ATF4;SSH1;MDK;UNC5B;SORL1;NLRP1;ENDOG;CEBPB;MAP3K12;PCSK9;ITGA1;AKT1;NCOA7;BRAF;TP73;FYN;MAGI1;WFS1;TRIM2;SNCB
5841,GO:0017137,0.123773560632037,0.917261071368249,24,158,Rab GTPase binding,MF,SYTL1;EVI5L;NDRG1;TBC1D8;RIN1;RAB11FIP4;ULK1;MICALL2;NGFR;TRAPPC9;ALS2CL;TBC1D14;TBC1D3E;RABGAP1;RIN2;RIMS3;MICAL1;SBF2;C9ORF72;SGSM2;TBC1D20;RABGGTA;RHOBTB3;TBC1D16
18086,GO:1902769,0.123849330684631,1,1,1,regulation of choline O-acetyltransferase activity,BP,SORL1
18087,GO:1902771,0.123849330684631,1,1,1,positive regulation of choline O-acetyltransferase activity,BP,SORL1
18151,GO:1902948,0.123849330684631,1,1,1,negative regulation of tau-protein kinase activity,BP,SORL1
18158,GO:1902955,0.123849330684631,1,1,1,positive regulation of early endosome to recycling endosome transport,BP,SORL1
18181,GO:1902997,0.123849330684631,1,1,1,negative regulation of neurofibrillary tangle assembly,BP,SORL1
16862,GO:0098831,0.124161771571665,0.983221264092657,2,5,presynaptic active zone cytoplasmic component,CC,PCLO;RIMS3
3068,GO:0006637,0.124190158862424,0.929582575605628,13,78,acyl-CoA metabolic process,BP,ACSF2;MLYCD;HMGCL;ACOT1;ACOT11;ACACB;ACSS2;MVD;ACOT7;SUCLG2;CBR4;ACSS1;ACOT8
9093,GO:0035383,0.124190158862424,0.929582575605628,13,78,thioester metabolic process,BP,ACSF2;MLYCD;HMGCL;ACOT1;ACOT11;ACACB;ACSS2;MVD;ACOT7;SUCLG2;CBR4;ACSS1;ACOT8
16187,GO:0090251,0.124499280303205,1,1,1,protein localization involved in establishment of planar polarity,BP,CELSR1
15577,GO:0072088,0.12465442383787,0.93835813425885,9,49,nephron epithelium morphogenesis,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B;PKD1;WNK4
14241,GO:0061333,0.124688411033389,0.938337659483081,9,49,renal tubule morphogenesis,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B;PKD1;WNK4
9200,GO:0035601,0.12503644570174,0.924406072003476,16,99,protein deacylation,BP,VEGFA;PHF21A;HDAC11;CHD3;JDP2;HDAC5;HMG20B;TADA3;C6ORF89;MTA3;BCL6;SIRT2;MTA1;HDAC8;PER1;LYPLAL1
507,GO:0001570,0.125106747550861,0.938085528093361,9,49,vasculogenesis,BP,XDH;VEGFA;ZFP36L1;CUL7;EGFL7;TGFBR2;WNT7A;TGFBR3;TEAD2
19458,GO:1990256,0.125125110942054,1,1,1,signal clustering,BP,SEMA5A
8205,GO:0032970,0.125202985649886,0.908461220419382,38,265,regulation of actin filament-based process,BP,GSN;WIPF1;CDC42EP5;LRP1;RAPGEF3;SPTB;ARHGEF19;ARAP1;ARPIN;CAPG;PAK1;SSH3;PLEKHG2;RHOBTB2;SEMA5A;VANGL2;RHOF;TWF2;DMTN;SSH1;WHAMMP3;TRIOBP;TMSB4X;EPHA1;TMOD2;ASAP3;C9ORF72;BRAF;ARHGAP44;FCHSD1;SPIRE1;EPS8L1;CELSR1;RHOBTB3;EPS8L2;C15ORF62;CORO1B;PLEKHH2
12505,GO:0050670,0.125212678435074,0.921759564261075,18,115,regulation of lymphocyte proliferation,BP,IL20RB;PRNP;PKN1;ZP3;CCDC88B;INPP5D;PDCD1LG2;CEBPB;TGFBR2;CARD11;IGFBP2;JAK3;BCL6;ADA;VAV3;DHPS;ERBB2;HLA-G
4056,GO:0009109,0.125746812799703,0.96981052597378,3,11,coenzyme catabolic process,BP,ACOT7;ALDH1L2;ALDH1L1
709,GO:0001935,0.126210051711291,0.926535874362175,14,85,endothelial cell proliferation,BP,XDH;APOE;PGF;VEGFA;VEGFB;PLXNB3;NGFR;ECM1;SEMA5A;EGFL7;APLN;ERN1;AKT1;FGFR1
13726,GO:0060326,0.126247247637475,0.916968738621029,22,147,cell chemotaxis,BP,DOCK4;PGF;VEGFA;MMP28;HBEGF;PLEKHG5;VEGFB;PLXNB3;C5;MAPK3;SEMA5A;TRPV4;ITGA1;TMSB4X;GAS6;IL17RC;CKLF;LYST;RAB13;VAV3;FGFR1;CORO1B
4103,GO:0009162,0.126346061843413,0.969601467416696,3,11,deoxyribonucleoside monophosphate metabolic process,BP,DNPH1;TK2;DGUOK
6835,GO:0030308,0.12639854842477,0.91980956080589,19,122,negative regulation of cell growth,BP,PTPRS;SERPINE2;FHL1;SEMA4B;ULK2;HYAL1;CYP27B1;BTG1;CAPRIN2;PAK1;SEMA3F;SESN2;SLIT3;SEMA5A;TSPYL2;SEMA3B;SEMA4G;WNT3;BCL6
3533,GO:0007528,0.126605738583144,0.948460031471727,6,29,neuromuscular junction development,BP,F2R;ANK3;SHANK2;ETV5;LAMB2;ERBB2
3460,GO:0007276,0.126878233806354,0.902610820589201,52,375,gamete generation,BP,GAMT;BBS2;ERCC1;CRTAP;MICALCL;GGT1;TCFL5;TXNRD3;BTG1;PHC2;DNAH1;MYCBPAP;PABPC1L;KDM3A;NPR2;ZP3;NEURL1;ETV5;EREG;SPATA20;FAM50A;SCMH1;CCNI;TDRKH;AZIN2;DEAF1;RFX2;CEP131;DNMT3A;MLH3;NOS3;AGO4;HEXB;HERPUD2;SPAG16;ATP2B4;AKT1;SEPT6;CABYR;TBC1D20;WNT3;SPIRE1;BCL6;REC8;RPL39L;SIRT2;PAIP2;SPATA6;CREB3L4;MMP19;ZNF449;SIX5
8411,GO:0033500,0.126959006484911,0.916479063909492,22,145,carbohydrate homeostasis,BP,NR1D1;PYGL;PCK2;ERO1B;NGFR;PLA2G6;ANO1;MLXIPL;ENDOG;LRP5;TRPV4;PIK3R2;GAS6;ERN1;AKT1;CRY2;FGFR4;INSR;GPR21;LGALS1;DHPS;WFS1
10075,GO:0042593,0.126959006484911,0.916479063909492,22,145,glucose homeostasis,BP,NR1D1;PYGL;PCK2;ERO1B;NGFR;PLA2G6;ANO1;MLXIPL;ENDOG;LRP5;TRPV4;PIK3R2;GAS6;ERN1;AKT1;CRY2;FGFR4;INSR;GPR21;LGALS1;DHPS;WFS1
3129,GO:0006720,0.12713767015016,0.929512153546739,12,71,isoprenoid metabolic process,BP,APOE;LRP1;EGFR;PHYH;DHRS4;MVD;SDC2;SRD5A3;PNPLA4;PLB1;RETSAT;CYP4V2
5156,GO:0015698,0.12713772222928,0.925904884284038,14,85,inorganic anion transport,BP,PRNP;CLCA2;SLC12A7;SLC37A2;ANO8;ANO1;LRRC8A;WNK4;ANO9;TTYH3;PTAFR;CRY2;SLC37A4;FGFR1
2516,GO:0005770,0.127182644097313,0.911879186407377,28,190,late endosome,CC,F2R;EGFR;CLTCL1;CST3;DDIT3;MAP2K1;VPS11;NMNAT2;MAPK3;DYSF;MVB12B;CHMP1B;MAP2K2;LITAF;PCSK9;MAP1LC3A;VPS39;ATP7B;FYCO1;NBR1;CTSH;TMEM9;TSG101;STEAP3;CHMP4C;UBXN6;OSBPL1A;LAMTOR2
5319,GO:0016049,0.127278900429037,0.903367869107063,48,344,cell growth,BP,PTPRS;HTRA1;APOE;SERPINE2;FHL1;POSTN;SEMA4B;VEGFA;EGFR;IGFBP4;DNPH1;HBEGF;LTBP4;ULK2;HYAL1;CYP27B1;BTG1;ULK1;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;PLXNB1;SPG11;LPAR3;SESN2;IMPACT;SLIT3;LAMB2;SEMA5A;TSPYL2;TWF2;SEMA3B;TGFBR2;SEMA4G;AKT1;IGFBP7;IGFBP2;TSG101;C9ORF72;WNT3;MAP2K5;BCL6;LAMTOR2;ERBB2;EIF2AK4;NET1
10013,GO:0042474,0.127327995038531,0.969257836659971,3,11,middle ear morphogenesis,BP,NAGLU;FGFR1;TSHZ1
6938,GO:0030554,0.127434486195504,0.890837437679501,154,1180,adenyl nucleotide binding,MF,ACTA2;ACSF2;PTK6;GLUL;OBSCN;EGFR;SCN8A;NEK9;RAPGEF3;DGKA;BRSK1;ERCC6;MYH15;SMARCA1;MST1R;CUL9;RPS6KA2;PYGL;TK2;ULK2;MAPK13;CDK18;MAP2K1;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TMEM173;DNAH1;ULK1;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;ABCG1;CARS;KIF17;CHD3;MKNK2;NLRX1;ACACB;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;MAPK12;MYH3;PI4K2A;MAP2K2;TWF2;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;PDE2A;TRIB3;MLH3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;ATP2B4;STRADB;ASNS;AKT1;DGUOK;CHEK2;ASS1;KIF27;FGFR4;MARK4;INSR;ACSS1;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;APRT;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;RECQL5;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
10299,GO:0043097,0.127660594428229,0.969141142648532,3,11,pyrimidine nucleoside salvage,BP,TK2;UCKL1;UPP1
2780,GO:0006213,0.12786838661531,0.94314075585001,7,37,pyrimidine nucleoside metabolic process,BP,NT5E;TK2;APOBEC3C;NME4;APOBEC3F;UCKL1;UPP1
8395,GO:0033364,0.128144064020296,1,1,1,mast cell secretory granule organization,BP,LYST
11354,GO:0045740,0.128163394800484,0.9393425653469,8,43,positive regulation of DNA replication,BP,EGFR;CST3;SHC1;EREG;AREG;INSR;FGFR1;KCTD13
14930,GO:0070848,0.128236319891261,0.898819140041635,64,469,response to growth factor,BP,XDH;DUSP6;HTRA1;FOS;EGR1;FGFBP1;POSTN;PDCD4;VEGFA;EGFR;ADAMTS7;NOS1;ZFP36L1;LTBP4;RNF165;HYAL1;DDIT4;SHC1;SPRY2;PRKCZ;FGFR3;SPRY4;ACVR2B;NGFR;LTBP1;MTMR4;FNDC4;MAPK3;ITGB5;ERRFI1;FAM20C;LTBP2;TWF2;SULF2;FBXL15;TGFBR2;PDE2A;SMURF2;APLN;WNT7A;TRPV1;GAS6;ERN1;AKT1;CDKN1C;FGFR4;INSR;MAP2K5;BRAF;CAT;MYOF;HFE;FYN;LEMD2;SIRT2;GDF15;CIDEA;TGFBR3;FGFR1;FKBP8;ERBB2;CORO1B;FRS3;GRB10
5619,GO:0016684,0.128237815784112,0.94726818475708,6,31,oxidoreductase activity, acting on peroxide as acceptor,MF,GPX3;PRDX5;GSTT1;SESN2;GSTM2;CAT
13716,GO:0060314,0.128427351505065,0.959754775259989,4,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,NOS1;GSTO1;PKD2;GSTM2
10293,GO:0043086,0.12873476910857,0.896977906485136,72,537,negative regulation of catalytic activity,BP,DUSP6;TNFRSF6B;APOE;SERPINE2;PPP1R35;PTK6;PDCD4;TIMP2;VEGFA;PRNP;PRDX5;TFPI2;DUSP5;CST3;NOS1;GPSM1;ADARB1;PHACTR3;PPP1R14A;WWTR1;CYP27B1;PKN1;ARL2;SPRY2;PRKCZ;SERPING1;PLXNB3;SPRY4;DLG3;NEIL1;RAG1;NGFR;ELFN2;TRIB2;C5;AIP;RASA4;ECM1;ACACB;ERRFI1;RGS14;ANGPTL4;LTB4R2;IFI6;SORL1;HERPUD1;PAPLN;GABBR1;LRP5;PKIB;CSRNP3;TRIB3;CDK5RAP3;NOS3;EPHA1;GAS6;PPP1R15A;ATP2B4;AKT1;CDKN1C;MICAL1;CRY2;HMSD;TSG101;FARP1;MAP2K5;TIMP1;TP73;EPHB2;SFI1;IKBKB;SNCB
10457,GO:0043367,0.128810926502846,0.942745950822948,7,36,CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ;SATB1;STAT6;ZFPM1;BRAF;JAK3;BCL6
6054,GO:0019206,0.129002803323848,0.968668684522079,3,11,nucleoside kinase activity,MF,TK2;UCKL1;DGUOK
8908,GO:0034763,0.129016184905995,0.93042702997748,11,64,negative regulation of transmembrane transport,BP,NTSR1;ANK3;STK39;GSTO1;PKD2;GSTM2;PCSK9;ANO9;AKT1;EPHB2;GRB10
8585,GO:0034104,0.129038813233363,0.968655975107055,3,11,negative regulation of tissue remodeling,BP,CST3;INPP5D;BCR
6143,GO:0019433,0.129059234359607,0.96864876684411,3,11,triglyceride catabolic process,BP,APOE;PNPLA3;PNPLA4
4278,GO:0009649,0.129310103240873,0.952480551405775,5,23,entrainment of circadian clock,BP,CRTC1;BHLHE40;CRY2;MTA1;PER1
7721,GO:0032225,0.129396121546773,0.968529770042919,3,11,regulation of synaptic transmission, dopaminergic,BP,RAB3B;FLOT1;PNKD
15697,GO:0072287,0.129478045723084,1,1,1,metanephric distal tubule morphogenesis,BP,PKD1
15470,GO:0071868,0.129487556608745,0.952394518928067,5,23,cellular response to monoamine stimulus,BP,MAPK3;ATF4;ADCY6;ATP2B4;SIRT2
15472,GO:0071870,0.129487556608745,0.952394518928067,5,23,cellular response to catecholamine stimulus,BP,MAPK3;ATF4;ADCY6;ATP2B4;SIRT2
5728,GO:0016879,0.129491234780219,0.938564980989287,8,43,ligase activity, forming carbon-nitrogen bonds,MF,NAPRT;GLUL;PPCS;ACACB;HLCS;TTLL11;ASNS;ASS1
4658,GO:0010811,0.129652699398765,0.925928301966486,13,78,positive regulation of cell-substrate adhesion,BP,VEGFA;SMOC2;ITGA6;ARL2;PRKCZ;NID1;COL8A1;DMTN;TRIOBP;EPHA1;ECM2;BRAF;NET1
19379,GO:1905939,0.129764195000258,0.96839958053516,3,11,regulation of gonad development,BP,NUPR1;ZP3;INSR
15486,GO:0071889,0.129829474296172,0.952228631732175,5,23,14-3-3 protein binding,MF,ZFP36L1;DDIT4;PRKCZ;KIF13B;AKT1
2838,GO:0006309,0.129859003234063,0.959138748201231,4,17,apoptotic DNA fragmentation,BP,H1F0;ENDOG;DNASE2;CIDEA
2711,GO:0006089,0.130043493519211,0.968300667973157,3,11,lactate metabolic process,BP,D2HGDH;HAGH;PNKD
1988,GO:0004712,0.130307258103056,0.941908857101652,7,36,protein serine/threonine/tyrosine kinase activity,MF,RPS6KA2;MAP2K1;ACVR2B;MAPK3;MAP2K2;AKT1;MAPK10
13798,GO:0060420,0.130324228746769,0.941899346965014,7,36,regulation of heart growth,BP,DUSP6;PAK1;ACACB;TGFBR2;TP73;TGFBR3;FGFR1
506,GO:0001569,0.130759093916065,0.951776816327532,5,23,branching involved in blood vessel morphogenesis,BP,NFATC4;VEGFA;TGFBR2;PLXND1;EDNRA
478,GO:0001523,0.130769054304473,0.937814647592539,8,43,retinoid metabolic process,BP,APOE;LRP1;DHRS4;SDC2;PNPLA4;PLB1;RETSAT;CYP4V2
9232,GO:0035640,0.13088673642191,0.968001392225025,3,11,exploration behavior,BP,DLG4;APOE;NLGN2
9264,GO:0035710,0.130896460428683,0.937739725559597,8,43,CD4-positive, alpha-beta T cell activation,BP,PRKCZ;SATB1;STAT6;ZFPM1;TGFBR2;BRAF;JAK3;BCL6
4359,GO:0009967,0.130938832988778,0.888633159007037,137,1060,positive regulation of signal transduction,BP,XDH;DUSP6;DLG4;F2R;NFATC4;GSN;FGFBP1;PTK6;ALOX15B;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;RBCK1;S100A4;DUSP5;TNFSF15;IGFBP4;NOS1;DDIT3;SHANK2;ERCC6;MST1R;ARAP1;HBEGF;RGL2;CTF1;TFDP2;EVC;RNF165;MAP2K1;CYP27B1;PKN1;MC1R;SHC2;MAML3;PLEKHG5;FAM110C;SHC1;SPRY2;GRB7;NLGN2;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;NEURL1;ACVR2B;NGFR;GSTO1;WNT2B;PLXNB1;EREG;TMED4;TNFRSF25;PLA2G6;LPAR3;S100A13;C5;PKD2;ECM1;MAPK3;CSPG4;BNIP3;SEMA5A;VANGL2;SH2D2A;MAP2K2;DMTN;LITAF;BBC3;SSH1;FLOT1;UNC5B;GSTM2;SULF2;MAP3K12;CREBRF;FBXL15;TRPV4;ITGA1;SMURF2;EDA;CDK5RAP3;MINK1;WNT7A;PIK3R2;EPHA1;SHARPIN;GAS6;ERN1;CTSH;AKT1;CARD11;CDKN1C;FGFR4;TMOD2;SH2B3;INSR;WNT3;MAP2K5;BRAF;EDA2R;PIDD1;CAT;MAPK10;LGALS1;HFE;TP73;MIB2;CSNK1E;FYN;GDF15;ADA;TMEM101;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;LAMTOR2;MAP3K10;MFNG;STARD10;LURAP1;EPHB2;FGFR1;FKBP8;CTH;ERBB2;PAG1;GRB10;IKBKB;HIP1
15836,GO:0072583,0.130998706572073,0.941521083901236,7,36,clathrin-dependent endocytosis,BP,FCHO1;DNM1;ARAP3;DNAJC6;AP2A2;UNC119;HIP1
2662,GO:0006012,0.131099230752909,0.967925823208438,3,11,galactose metabolic process,BP,PGM1;GALE;GALK1
12296,GO:0048668,0.131174166769038,0.958570362374002,4,17,collateral sprouting,BP,PTPRS;ULK2;LPAR3;WNT3
16515,GO:0097286,0.131175163745213,0.967898804400488,3,11,iron ion import,BP,STEAP2;STEAP3;HFE
5764,GO:0016964,0.131221205201873,1,1,1,alpha-2 macroglobulin receptor activity,MF,LRP1
2387,GO:0005524,0.131283272896721,0.887591777879375,150,1149,ATP binding,MF,ACTA2;ACSF2;PTK6;GLUL;OBSCN;EGFR;SCN8A;NEK9;DGKA;BRSK1;ERCC6;MYH15;SMARCA1;MST1R;CUL9;RPS6KA2;PYGL;TK2;ULK2;MAPK13;CDK18;MAP2K1;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;DNAH1;ULK1;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;ABCG1;CARS;KIF17;CHD3;MKNK2;NLRX1;ACACB;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;MAPK12;MYH3;PI4K2A;MAP2K2;TWF2;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;TRIB3;MLH3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;ATP2B4;STRADB;ASNS;AKT1;DGUOK;CHEK2;ASS1;KIF27;FGFR4;MARK4;INSR;ACSS1;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;RECQL5;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
10371,GO:0043218,0.131443396486869,0.967803297962189,3,11,compact myelin,CC,SIRT2;MPDZ;PLLP
15513,GO:0071941,0.131544794026562,0.967767169101906,3,11,nitrogen cycle metabolic process,BP,NAGS;ASS1;NMRAL1
14627,GO:0070243,0.131642973705617,0.967732173496104,3,11,regulation of thymocyte apoptotic process,BP,RAG1;JAK3;ADA
13928,GO:0060644,0.131653589151611,0.967728388895176,3,11,mammary gland epithelial cell differentiation,BP,CEBPB;MGMT;AKT1
12745,GO:0051044,0.131866180409175,0.967652564025366,3,11,positive regulation of membrane protein ectodomain proteolysis,BP,APOE;SNX9;SNX33
19990,GO:2000641,0.131936540374007,0.958239795751783,4,17,regulation of early endosome to late endosome transport,BP,MAP2K1;VPS11;MAPK3;MAP2K2
9766,GO:0039692,0.131954738811844,0.967620959833577,3,11,single stranded viral RNA replication via double stranded DNA intermediate,BP,APOBEC3C;APOBEC3F;HMGA2
13057,GO:0051590,0.132028323151302,0.958199944976064,4,17,positive regulation of neurotransmitter transport,BP,NTSR1;RAB3B;APLN;STX1A
426,GO:0001134,0.132588457522112,0.950884323877787,5,23,transcription factor activity, transcription factor recruiting,MF,NR1D1;PPARA;THRA;DMTF1;TEAD2
10448,GO:0043325,0.132674661543784,0.957918988366141,4,17,phosphatidylinositol-3,4-bisphosphate binding,MF,ARAP3;PLEK2;AKT1;HIP1
13598,GO:0060117,0.132886954664274,0.967287631391274,3,11,auditory receptor cell development,BP,SLITRK6;TRIOBP;FGFR1
10829,GO:0044342,0.132933818059167,0.967270843578952,3,11,type B pancreatic cell proliferation,BP,NR1D1;IGFBP4;ERRFI1
8188,GO:0032944,0.132956926327207,0.916163074372797,18,116,regulation of mononuclear cell proliferation,BP,IL20RB;PRNP;PKN1;ZP3;CCDC88B;INPP5D;PDCD1LG2;CEBPB;TGFBR2;CARD11;IGFBP2;JAK3;BCL6;ADA;VAV3;DHPS;ERBB2;HLA-G
2166,GO:0005003,0.132968078521212,0.967258568618167,3,11,ephrin receptor activity,MF,EFNB3;EPHA1;EPHB2
2168,GO:0005005,0.132968078521212,0.967258568618167,3,11,transmembrane-ephrin receptor activity,MF,EFNB3;EPHA1;EPHB2
4454,GO:0010447,0.133037788871441,0.967233587641176,3,11,response to acidic pH,BP,IMPACT;TRPV1;ASIC1
1774,GO:0004385,0.133191339814764,0.967178538870287,3,11,guanylate kinase activity,MF,DLG4;DLG3;CARD11
16806,GO:0098732,0.133191413292122,0.918643260977081,16,100,macromolecule deacylation,BP,VEGFA;PHF21A;HDAC11;CHD3;JDP2;HDAC5;HMG20B;TADA3;C6ORF89;MTA3;BCL6;SIRT2;MTA1;HDAC8;PER1;LYPLAL1
2837,GO:0006308,0.133204129447026,0.944803877991824,6,30,DNA catabolic process,BP,H1F0;DNASE1L1;ENDOG;ISG20;DNASE2;CIDEA
3593,GO:0008022,0.133224953139629,0.910092034326133,24,160,protein C-terminus binding,MF,DLG4;ERCC1;FBLN1;DNM1;ERCC6;MIF4GD;MAP2K1;EML2;DLG3;CEP250;NEIL1;ECM1;ATF4;CALCOCO1;MAPRE3;BCAM;SLC9A3R2;PIAS3;SNX17;RABAC1;PEX1;MPDZ;MAGI1;ERBB2
15112,GO:0071230,0.133392783098665,0.932955820276438,9,50,cellular response to amino acid stimulus,BP,EGFR;COL6A1;NEURL1;SESN2;CEBPB;DNMT3A;CAPN2;FYN;LAMTOR2
5843,GO:0017144,0.133487259369617,0.89322245892156,70,528,drug metabolic process,BP,GAMT;NT5E;EGR1;ACP5;GPX3;EGFR;PRDX5;IDH2;NOS1;PGM1;GGT1;PYCR2;CYP3A5;DHTKD1;PRSS3;HMGCL;CYP27B1;PCK2;DDIT4;DGKQ;AKR7A2;OGDHL;KDM3A;MTHFR;GLDC;CBS;PSAT1;PPARA;PKD2;ACACB;CSPG4;PC;ACSS2;FAM20C;MYH3;MLXIPL;SDHA;HLCS;GALK1;NADK;ALDOC;TMSB4X;ALDH1L2;PEMT;NOS3;TRPV1;SUCLG2;SRR;CYP2R1;ATP2B4;CTSH;ASNS;AKT1;ASS1;TCIRG1;CBR4;INSR;ACSS1;ALDH1L1;CAT;APRT;TAZ;SAT2;ADA;CTH;UST;PFKL;PNKD;SNCB;ACOT8
6125,GO:0019377,0.133490025011922,0.967071367419536,3,11,glycolipid catabolic process,BP,FUCA1;HEXB;NAGA
20200,GO:2001171,0.133586693773727,0.957521568605607,4,17,positive regulation of ATP biosynthetic process,BP,MLXIPL;TMSB4X;INSR;TAZ
12042,GO:0048012,0.133750079684556,0.966977958816845,3,11,hepatocyte growth factor receptor signaling pathway,BP,MST1R;PAK1;SIRT2
2987,GO:0006534,0.133771467632551,0.966970272449186,3,11,cysteine metabolic process,BP,GGT1;CBS;CTH
6826,GO:0030296,0.133807728788849,0.966957239559137,3,11,protein tyrosine kinase activator activity,MF,ERCC6;DGKQ;GAS6
7583,GO:0031960,0.133930106084024,0.918086228318434,16,101,response to corticosteroid,BP,FOS;EGFR;ZFP36L1;KLF9;PCK2;DDIT4;AREG;SLIT3;ERRFI1;MDK;PTPRU;CREBRF;PTAFR;IGFBP7;IGFBP2;EIF4EBP1
7689,GO:0032155,0.134047603519391,0.92968375313532,10,57,cell division site part,CC,RAB11FIP4;PKN1;PITPNM1;PLCD3;SSH1;NDE1;PLEKHG6;SEPT6;TUBGCP6;SPIRE1
12711,GO:0050998,0.134194285657735,0.966818193948221,3,11,nitric-oxide synthase binding,MF,DNM1;SNTA1;ATP2B4
3158,GO:0006768,0.134203604246164,0.966814839535357,3,11,biotin metabolic process,BP,ACACB;PC;HLCS
3228,GO:0006884,0.134336283240153,0.957194086361185,4,17,cell volume homeostasis,BP,SLC12A7;LRRC8A;KCNMA1;TRPV4
4229,GO:0009411,0.134341206906044,0.914006069931736,19,123,response to UV,BP,NFATC4;XPC;EGFR;DDB2;ERCC1;BRSK1;ERCC6;MAPK13;HYAL1;MC1R;CIRBP;IMPACT;SCARA3;ATF4;PRIMPOL;AKT1;CAT;TP73;EIF2AK4
3075,GO:0006646,0.134457652678096,0.966723344567248,3,11,phosphatidylethanolamine biosynthetic process,BP,SLC27A1;CHKB;ETNK2
3060,GO:0006625,0.134817858386286,0.956983292263266,4,17,protein targeting to peroxisome,BP,PEX10;LONP2;PEX7;PEX1
15868,GO:0072662,0.134817858386286,0.956983292263266,4,17,protein localization to peroxisome,BP,PEX10;LONP2;PEX7;PEX1
15869,GO:0072663,0.134817858386286,0.956983292263266,4,17,establishment of protein localization to peroxisome,BP,PEX10;LONP2;PEX7;PEX1
4595,GO:0010715,0.134905626373607,0.966561795793631,3,11,regulation of extracellular matrix disassembly,BP,LRP1;CST3;FGFR4
3570,GO:0007617,0.134977378542936,0.966535895314308,3,11,mating behavior,BP,SERPINE2;THRA;HEXB
16049,GO:0090036,0.135158830625579,0.966470365357954,3,11,regulation of protein kinase C signaling,BP,VEGFA;MC1R;PLA2G6
8928,GO:0034979,0.135368724752617,0.956741782645361,4,17,NAD-dependent protein deacetylase activity,MF,HDAC11;HDAC5;SIRT2;HDAC8
3266,GO:0006940,0.135382896593024,0.943641311803691,6,30,regulation of smooth muscle contraction,BP,DOCK4;F2R;PTAFR;CHRM3;ADA;ITGA2
5396,GO:0016239,0.135426948151206,0.92880923392678,10,57,positive regulation of macroautophagy,BP,GPSM1;EPM2A;ULK1;SESN2;MAPK3;BNIP3;LRSAM1;BNIP3L;FYCO1;C9ORF72
7181,GO:0031078,0.135454452578316,0.966363508909923,3,11,histone deacetylase activity (H3-K14 specific),MF,HDAC11;HDAC5;HDAC8
7625,GO:0032041,0.135454452578316,0.966363508909923,3,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,HDAC11;HDAC5;HDAC8
5337,GO:0016079,0.135568304262815,0.931618332729924,9,50,synaptic vesicle exocytosis,BP,SYTL1;SNPH;SYT8;VAMP2;SEPT5;PCLO;RIMS3;BRAF;STX1A
4351,GO:0009950,0.135571568939693,0.966321143123948,3,11,dorsal/ventral axis specification,BP,MDFI;LRP5;WNT3
7136,GO:0030990,0.135591899990064,0.943529469185112,6,30,intraciliary transport particle,CC,IFT140;KIF17;IFT27;WDR19;IFT57;TTC21A
3359,GO:0007098,0.135602899714823,0.915535642818492,17,108,centrosome cycle,BP,BRSK1;SDCCAG8;ARL2;CEP250;CHD3;PKD2;TUBE1;CHMP1B;CEP68;NDE1;CEP131;CROCC;CHMP5;CHMP4C;HAUS4;TUBGCP6;GOLGA2
12509,GO:0050678,0.135658170575986,0.903461904338592,31,214,regulation of epithelial cell proliferation,BP,XDH;HTRA1;APOE;PGF;GLUL;VEGFA;EGFR;NR1D1;ZFP36L1;KLF9;HYAL1;VEGFB;PLXNB3;NGFR;EREG;ECM1;ERRFI1;SEMA5A;DEAF1;SULF2;EGFL7;APLN;WNT7A;AKT1;CDKN1C;LAMB1;IFT57;MAP2K5;TGFBR3;FGFR1;ERBB2
12835,GO:0051179,0.135672670973735,0.876688496362988,528,4306,localization,BP,XDH;DLG4;DOCK4;BBS2;F2R;APOE;MARVELD1;SYTL1;ZMYND8;KCNG1;SERPINE2;FHL1;S100A6;OSBPL5;GSN;PYGB;LMF1;PGF;POSTN;EVI5L;WIPF1;SLC2A3;PTK6;TMEM129;NAPRT;EDEM1;GLUL;GJC2;SEMA4B;LRP1;ALOX15B;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;FBLN1;SLC7A8;HADH;ANK3;IFT140;RAPGEF3;CLTCL1;FCHO1;SPTB;TSPAN1;SLC16A3;CD9;NINL;SLC2A9;SNPH;IDH2;CST3;DNM1;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;PGM1;CLCA2;SCN4B;PACS2;ORAI3;MRC2;TBC1D8;MMP28;ARRDC1;EFS;ZFP36L1;ADARB1;SYT8;RIN1;ARAP1;B3GAT3;HBEGF;GAA;PYGL;MMP1;CNTN1;EXOC2;TFDP2;MXI1;RPL13A;OBSL1;MDFI;BBS1;PLAT;LTBP4;SLC27A1;REEP2;RAB11FIP4;NISCH;CPT2;ASAP2;PITPNM3;ATG16L2;PRSS3;HYAL1;ARPIN;SYNGR1;MAP2K1;CYP27B1;PCK2;SLC16A5;SDCCAG8;ABCA2;PKN1;SLC43A1;DDIT4;BTG1;TOM1L2;DNASE1L1;SYNGAP1;ITGA6;PITPNM1;TMEM173;SNX9;PLEKHG5;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;RAB3B;NLGN2;CD68;SLC12A7;ITPR3;LAMA5;PITPNC1;UNK;APPL2;PRSS8;TTBK2;PRKCZ;SERPING1;PAK1;ABCA7;SLC37A2;MCTP1;STK39;PABPC1L;PEAR1;CEMIP;BRI3;SEMA3F;PLXNB3;NDUFA4L2;USP20;ORAI2;ELMO3;SYNE3;ZSWIM4;DLG3;ITGB4;MICALL2;SLCO4A1;NME4;CEP250;ZP3;NEURL1;ACVR2B;CCDC88B;NGFR;ETV5;GSTO1;WDR60;LTBP1;MALL;ACTR1B;PLXNB1;EREG;TNS1;SPG11;TMC6;OLFM2;RHOBTB2;ANO8;TMED4;PLA2G6;ABCG1;ESYT2;XPOT;TRAPPC9;RINL;SCART1;MANF;LPAR3;S100A13;AGAP1;C5;KIF17;PPARA;ANO1;STON1;SESN2;AIP;KCNJ15;IFT27;PKD2;SH3TC2;NUDCD3;VAMP2;AREG;AP1G2;SEPT5;ECM1;PCLO;KCNC4;ACACB;KCNAB2;MAPK3;CSPG4;BNIP3;OSBPL10;SEMA5A;THRA;IFITM1;PEX10;VANGL2;SCARA3;RGS14;DYSF;RHOF;SLC22A18;CNTRL;LTBP2;SNTA1;CTSB;HOOK2;EIF2D;MVB12B;LTA4H;PI4K2A;SRGAP3;PQLC2;SDC2;CHMP1B;TBC1D14;TCTN1;ARHGEF2;SEPT10;FBF1;INPP5D;PRAF2;MAP2K2;TWF2;SLC50A1;SLC48A1;LRSAM1;DMTN;LRRC8A;KLHL24;SEMA3B;ATF4;PROCR;BBC3;PAK6;SSH1;LTB4R2;SV2A;TBC1D3E;SLC38A10;RABGAP1;ACAP3;REEP6;PKD1;FUCA1;SLC29A4;FLOT1;CEP68;MDK;TTN;KCNMA1;AZIN2;TSNARE1;HDAC5;WHAMMP3;SORL1;MAP6;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;TMEM175;NLRP1;RHBDF1;LRP5;PTPRU;WNK4;RIN2;ALDOC;NDE1;PCSK9;PKN3;AQP3;CEP131;LONP2;TGFBR2;TRPV4;ARHGAP25;ITGA1;TMSB4X;ANO9;APOL4;PDE2A;SMURF2;APLN;TRIB3;RAB40B;MLH3;PEMT;CDK5RAP3;NOS3;MINK1;HEXB;PROM2;WNT7A;TRPV1;MARCH2;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;CCS;GAS6;VPS39;GLUD1;DNAJC6;LZTS2;ALKBH7;CROCC;BCR;MAPRE3;ATP7B;FYCO1;CEP112;NBEAL2;MFSD3;KIF13B;SPAG16;TTYH3;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;RIMS3;RAB43;ATP2B4;SPATA7;STRADB;CTSH;WDR19;C12ORF66;STEAP2;MAPKBP1;AKT1;ZFYVE21;ITPR2;CARD11;MICAL1;CRY2;LAMB1;IFT57;WDR45;SEPT6;TTC21A;TSG101;FMNL3;IL17RC;FGFR4;IGF2BP2;RASSF9;SLC6A9;TCIRG1;ASAP3;STEAP3;SLC6A6;LMNA;TMEM63C;COPG1;C9ORF72;SGSM2;TBC1D20;CHMP5;ARSA;MAN2B1;ICA1;MARK4;ARHGAP27;RAB25;IFI27;PLAU;INSR;WNT3;SLC25A29;CKLF;FOXO4;COG7;SLC22A15;CHMP4C;TPCN1;ADD3;MAGED2;ITGB6;HOMER2;LYST;MAP2K5;ZDHHC24;BRAF;ARHGAP44;CPSF4;BTN3A2;ASIC1;CAT;HAUS4;DPP7;YPEL5;UNC119B;TIMP1;HFE;JAK3;TP73;SCNN1A;SNX33;CHRM3;APRT;PEX7;SNX17;ICAM5;SCYL3;METTL7A;ATP12A;SPIRE1;TMEM50B;CSNK1E;HGSNAT;BCL6;SLC9A7;ADAP1;SLC37A4;EHD3;FYN;ATP8B2;SLC38A2;SNX1;PEX1;LEMD2;UBXN6;SLC25A42;TRPC1;PHLDA2;RAB13;OSBPL1A;TOM1;TST;GOLGA2;CELSR1;ADA;POU2F2;PLXND1;RHOBTB3;RTN2;AP2A2;CIDEA;HDAC8;MYO18A;SLC35F3;RPL29;TGFBR3;VAV3;STX1A;GALNS;LAMTOR2;TBC1D16;STARD10;EDNRA;LURAP1;EPHB2;TMCO6;PER1;SEPT8;IGF2BP3;ITGA2;SLC39A11;FGFR1;WFS1;ESYT3;BLOC1S1;FITM2;RGPD6;ERBB2;SEC31B;PLLP;SLC10A6;UNC119;SYVN1;OSCP1;PFKL;CORO1B;SFI1;RPL12;MPPE1;NET1;GRB10;BSG;KCTD13;APBA1;PNKD;IKBKB;HIP1;ROBO4;SLC9A5
7027,GO:0030809,0.135724271307021,0.956585686530421,4,17,negative regulation of nucleotide biosynthetic process,BP,DDIT4;PPARA;LTB4R2;GABBR1
17451,GO:1900372,0.135724271307021,0.956585686530421,4,17,negative regulation of purine nucleotide biosynthetic process,BP,DDIT4;PPARA;LTB4R2;GABBR1
11365,GO:0045761,0.135849255848915,0.966220618639434,3,11,regulation of adenylate cyclase activity,BP,TIMP2;LTB4R2;GABBR1
1284,GO:0003094,0.135905819949175,0.966200129348539,3,11,glomerular filtration,BP,F2R;SULF2;GAS6
14696,GO:0070372,0.136023915740884,0.907159839010247,25,168,regulation of ERK1 and ERK2 cascade,BP,TNIP1;DUSP6;F2R;EGFR;FBLN1;MST1R;MAP2K1;SHC1;SPRY2;PRKCZ;ABCA7;FGFR3;SPRY4;MAPK3;ERRFI1;RGS14;TRPV4;EPHA1;GAS6;FGFR4;INSR;BRAF;EPHB2;FGFR1;ERBB2
6027,GO:0019098,0.136197883655333,0.956377490283787,4,17,reproductive behavior,BP,SERPINE2;THRA;CREBRF;HEXB
4459,GO:0010457,0.136376180625516,0.966029583373605,3,11,centriole-centriole cohesion,BP,CEP250;CEP68;CROCC
7031,GO:0030813,0.136792733046276,0.965878299333318,3,11,positive regulation of nucleotide catabolic process,BP,RAPGEF3;MLXIPL;INSR
15545,GO:0072028,0.136857822512533,0.93082295261695,9,50,nephron morphogenesis,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B;PKD1;WNK4
463,GO:0001502,0.136903201331565,0.965838140240938,3,11,cartilage condensation,BP,THRA;PKD1;WNT7A
16812,GO:0098743,0.136903201331565,0.965838140240938,3,11,cell aggregation,BP,THRA;PKD1;WNT7A
9065,GO:0035330,0.136935552820797,0.965826376240779,3,11,regulation of hippo signaling,BP,WWC3;NEK8;MARK3
7349,GO:0031400,0.137254284940287,0.891557786572583,62,457,negative regulation of protein modification process,BP,TNIP1;XDH;DUSP6;APOE;PPP1R35;PTK6;PDCD4;PRNP;FBLN1;DUSP5;CRTAP;ADARB1;PHACTR3;PPP1R14A;WWTR1;PKN1;DDIT4;DGKQ;SPRY2;PRKCZ;STK39;KDM3A;PHF1;SPRY4;ELFN2;TRIB2;IMPACT;ERRFI1;RGS14;SNTA1;MLXIPL;DMTN;KDM4C;SORL1;LRP5;PKIB;TRIB3;HMG20B;CDK5RAP3;PIK3R2;EPHA1;PPP1R15A;ATP2B4;HINT2;AKT1;CDKN1C;MICAL1;CRY2;TSG101;PIAS3;C9ORF72;NCOA7;CTDSPL;TP73;FYN;LEMD2;SIRT2;HDAC8;EPHB2;PER1;FKBP8;IKBKB
6063,GO:0019216,0.137281784428878,0.899146758093189,37,260,regulation of lipid metabolic process,BP,APOE;EGR1;LMF1;TYSND1;NR1D1;RBL2;SLC27A1;CPT2;MLYCD;CYP27B1;DGKQ;FGFR3;SEC14L2;ZP3;PLA2G6;ABCG1;MTMR4;PPARA;ACACB;THRA;MVD;MLXIPL;ANGPTL4;LONP2;TRIB3;PIK3R2;RXRA;TM7SF2;AKT1;IGFBP7;FGFR4;ACADVL;TAZ;CIDEA;VAV3;FITM2;PEX11A
12510,GO:0050679,0.137311149582385,0.913006813568309,18,116,positive regulation of epithelial cell proliferation,BP,HTRA1;PGF;GLUL;VEGFA;EGFR;HYAL1;VEGFB;PLXNB3;ECM1;SEMA5A;EGFL7;APLN;WNT7A;AKT1;LAMB1;MAP2K5;FGFR1;ERBB2
11238,GO:0045499,0.137638532065933,0.955742331542238,4,17,chemorepellent activity,MF,SEMA4B;SEMA3F;SEMA3B;SEMA4G
17979,GO:1902475,0.137779418145698,0.942355524373917,6,30,L-alpha-amino acid transmembrane transport,BP,NTSR1;SLC7A8;SLC43A1;PQLC2;PRAF2;SLC25A29
12499,GO:0050663,0.137880952931213,0.913866742218949,17,109,cytokine secretion,BP,F2R;POSTN;ALOX15B;PRKCZ;S100A13;C5;MAPK3;NLRP1;TRPV4;TMSB4X;GAS6;MAPKBP1;CARD11;IL17RC;ITGB6;BTN3A2;CIDEA
2673,GO:0006029,0.137913301093225,0.92722745009553,10,57,proteoglycan metabolic process,BP,B3GAT3;HYAL1;CSPG4;VANGL2;SULF2;FOXL1;HEXB;HEXA;XYLT2;UST
3511,GO:0007431,0.137917534966946,0.942281198281189,6,30,salivary gland development,BP,EGFR;CST3;LAMA5;EDA;PLXND1;FGFR1
5374,GO:0016197,0.138133524966323,0.904773010578693,26,176,endosomal transport,BP,CLTCL1;RAB11FIP4;SNX9;MICALL2;MVB12B;TBC1D14;SORL1;VPS39;ZFYVE21;TSG101;RASSF9;SGSM2;CHMP5;CHMP4C;LYST;ARHGAP44;SNX33;SNX17;TMEM50B;EHD3;SNX1;UBXN6;RAB13;TOM1;RHOBTB3;BLOC1S1
9470,GO:0036119,0.138257790791332,0.955468451347968,4,17,response to platelet-derived growth factor,BP,HYAL1;ERRFI1;FYN;CORO1B
7493,GO:0031674,0.138315285967769,0.920286436739419,13,74,I band,CC,FLNC;OBSCN;SCN8A;ANK3;PARVB;NOS1;OBSL1;PAK1;SYNC;MYZAP;TTN;ATP2B4;KRT19
7195,GO:0031093,0.138346109413164,0.937221085358857,7,37,platelet alpha granule lumen,CC,VEGFA;VEGFB;SERPING1;TMSB4X;GAS6;MAGED2;TIMP1
7258,GO:0031235,0.138583019501868,0.965225451840764,3,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,SPTB;SYNGAP1;RASA4
2705,GO:0006081,0.138708807473868,0.926642625452783,10,58,cellular aldehyde metabolic process,BP,H6PD;ALDH7A1;IDH2;ALDH4A1;PGLS;AKR7A2;KDM3A;HAGH;TKFC;PNKD
9057,GO:0035308,0.138820554024434,0.936949807795003,7,37,negative regulation of protein dephosphorylation,BP,PPP1R35;PHACTR3;PPP1R14A;ELFN2;PPP1R15A;CRY2;IKBKB
12364,GO:0048799,0.139079838590004,0.965043520886192,3,11,animal organ maturation,BP,THBS3;FGFR3;PLXNB1
15656,GO:0072207,0.139264882134368,0.955021943989384,4,17,metanephric epithelium development,BP,WWTR1;PKD2;LAMB2;PKD1
14107,GO:0060999,0.139360037925896,0.941503482181293,6,30,positive regulation of dendritic spine development,BP,APOE;ZMYND8;SHANK2;CAPRIN2;NEURL1;CAMK1
18242,GO:1903136,0.13963223831522,0.97813541352704,2,6,cuprous ion binding,MF,PRNP;SNCB
12322,GO:0048705,0.139695096720339,0.90896940328055,20,130,skeletal system morphogenesis,BP,THBS3;ACP5;IFT140;MEF2D;COL13A1;MDFI;HYAL1;FGFR3;ACVR2B;WDR60;NAB2;THRA;PKD1;LRP5;TGFBR2;TRPV4;WNT7A;WDR19;PEX7;FGFR1
536,GO:0001655,0.140057543828439,0.899996751082496,31,213,urogenital system development,BP,ACTA2;EGR1;CTNNBIP1;PGF;ALOX15B;VEGFA;IFT140;WWTR1;ITGA6;LAMA5;ITGB4;ACVR2B;NID1;WNT2B;PKD2;LAMB2;VANGL2;KIF26B;PKD1;SULF2;WNK4;PCSK9;LZTS2;RXRA;CTSH;CAT;TP73;EPHB2;FGFR1;WFS1;MMP17
12040,GO:0048010,0.140064258421958,0.920878988165752,12,72,vascular endothelial growth factor receptor signaling pathway,BP,PGF;VEGFA;MAPK13;SHC2;VEGFB;SH2D2A;MAPK12;PIK3R2;MYOF;FYN;VAV3;GRB10
15203,GO:0071384,0.140745731196665,0.931774173375688,8,44,cellular response to corticosteroid stimulus,BP,EGFR;ZFP36L1;KLF9;PCK2;DDIT4;ERRFI1;CREBRF;EIF4EBP1
3578,GO:0007625,0.140981553273938,0.977792604733832,2,6,grooming behavior,BP,DLG4;APRT
9039,GO:0035272,0.141081668539276,0.935653163850715,7,37,exocrine system development,BP,EGFR;CST3;LAMA5;EDA;INSR;PLXND1;FGFR1
4833,GO:0014044,0.141116646533617,0.946665155785973,5,23,Schwann cell development,BP,NDRG1;SH3TC2;LAMB2;AKT1;SIRT2
12890,GO:0051260,0.14123809308329,0.899023814245226,31,216,protein homooligomerization,BP,APOE;KCNG1;TYSND1;GLUL;GPX3;PRNP;CRTC1;ITPR3;PKD2;KCNC4;ACACB;KCTD15;ANGPTL4;ATXN10;FLOT1;TRPV1;SHARPIN;SRR;RXRA;CBR4;ASIC1;CAT;HSF4;RNF213;EHD3;GOLGA2;DHPS;CTH;PFKL;KCTD11;KCTD13
11040,GO:0045055,0.141408190721944,0.886630626204589,69,513,regulated exocytosis,BP,SYTL1;GSN;PYGB;SLC2A3;NAPRT;TIMP2;VEGFA;CD9;SNPH;CST3;PGM1;SYT8;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;VEGFB;CD68;SERPING1;BRI3;ZP3;ACTR1B;TMC6;MANF;S100A13;VAMP2;SEPT5;ECM1;PCLO;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;DMTN;FUCA1;TTN;ALDOC;TMSB4X;HEXB;GAS6;BCR;NBEAL2;PTAFR;RIMS3;CTSH;STEAP2;MICAL1;TCIRG1;ARSA;MAN2B1;PLAU;MAGED2;BRAF;CAT;DPP7;YPEL5;TIMP1;APRT;METTL7A;HGSNAT;TOM1;AP2A2;STX1A;GALNS;LAMTOR2;PFKL
3078,GO:0006654,0.141574983262948,0.940304182045881,6,30,phosphatidic acid biosynthetic process,BP,DGKA;SLC27A1;ACP6;LPCAT4;DGKQ;PNPLA3
3244,GO:0006904,0.141585842868787,0.935363192996485,7,37,vesicle docking involved in exocytosis,BP,SNPH;EXOC2;VPS11;RAB3B;RAB40B;RAB13;STX1A
17226,GO:0120034,0.141982640391932,0.919590517067626,12,72,positive regulation of plasma membrane bounded cell projection assembly,BP,ESPN;ZMYND8;CDC42EP5;ARAP1;NEURL1;TWF2;DOCK11;TENM2;CROCC;EPS8L1;EPS8L2;C15ORF62
712,GO:0001938,0.142098223276006,0.924470343039078,10,58,positive regulation of endothelial cell proliferation,BP,PGF;VEGFA;VEGFB;PLXNB3;ECM1;SEMA5A;EGFL7;APLN;AKT1;FGFR1
5260,GO:0015909,0.142318721909497,0.934941133984821,7,37,long-chain fatty acid transport,BP,APOE;NTSR1;SLC27A1;CPT2;PLA2G6;ACACB;AKT1
12046,GO:0048016,0.142526384811771,0.939787140355412,6,30,inositol phosphate-mediated signaling,BP,NFATC4;PRNP;ADGRB2;ITPR3;ATP2B4;ITPR2
5226,GO:0015844,0.142796012175013,0.945561776081915,5,24,monoamine transport,BP,NOS1;NISCH;RAB3B;SLC29A4;STX1A
4077,GO:0009135,0.142852672844319,0.913288133881929,15,94,purine nucleoside diphosphate metabolic process,BP,DLG4;PGM1;DHTKD1;DDIT4;OGDHL;DLG3;PPARA;MLXIPL;GALK1;ALDOC;CARD11;INSR;ENTPD2;PFKL;NUDT18
4116,GO:0009179,0.142852672844319,0.913288133881929,15,94,purine ribonucleoside diphosphate metabolic process,BP,DLG4;PGM1;DHTKD1;DDIT4;OGDHL;DLG3;PPARA;MLXIPL;GALK1;ALDOC;CARD11;INSR;ENTPD2;PFKL;NUDT18
14852,GO:0070664,0.142898716096966,0.930477970370014,8,44,negative regulation of leukocyte proliferation,BP,IL20RB;PRNP;PKN1;INPP5D;PDCD1LG2;CEBPB;ERBB2;HLA-G
11752,GO:0046631,0.143079754866003,0.921193074121464,11,65,alpha-beta T cell activation,BP,PRKCZ;SATB1;STAT6;ZFPM1;TGFBR2;BRAF;HFE;JAK3;BCL6;ADA;TCF7
7986,GO:0032613,0.143183391226299,0.945366201276344,5,24,interleukin-10 production,BP,IL20RB;PRKCZ;TRIB2;PDCD1LG2;JAK3
5012,GO:0015179,0.143575870539299,0.934215636146198,7,37,L-amino acid transmembrane transporter activity,MF,SLC7A8;SLC43A1;TMEM44;PQLC2;SLC6A9;SLC25A29;SLC38A2
2285,GO:0005244,0.143731778761751,0.920762629656002,11,65,voltage-gated ion channel activity,MF,KCNG1;SCN8A;SCN4B;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;KCNMA1;GAS6;TPCN1
6605,GO:0022832,0.143731778761751,0.920762629656002,11,65,voltage-gated channel activity,MF,KCNG1;SCN8A;SCN4B;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;KCNMA1;GAS6;TPCN1
3194,GO:0006825,0.143777953197354,0.952626699329034,4,18,copper ion transport,BP,CCS;ATP7B;STEAP2;STEAP3
3790,GO:0008361,0.143832915359838,0.907025411493728,19,123,regulation of cell size,BP,PTPRS;APOE;SEMA4B;VEGFA;ULK2;SLC12A7;PAK1;SEMA3F;LPAR3;SEMA5A;TWF2;LRRC8A;SEMA3B;KCNMA1;TRPV4;SEMA4G;AKT1;WNT3;VAV3
13512,GO:0055123,0.143895969718082,0.916200117820752,13,79,digestive system development,BP,PTK6;EGFR;ITGA6;ITGB4;ACVR2B;VANGL2;PKD1;TGFBR2;FOXL1;WDR19;INSR;ADA;TCF7
17008,GO:0099504,0.143966916122702,0.916151378818012,13,79,synaptic vesicle cycle,BP,SYTL1;SNPH;DNM1;SYT8;NLGN2;VAMP2;SEPT5;PCLO;WNT7A;DNAJC6;RIMS3;BRAF;STX1A
10117,GO:0042692,0.143998533469936,0.897527031120561,30,202,muscle cell differentiation,BP,NFATC4;FLNC;PDCD4;VEGFA;OBSCN;NOS1;OBSL1;MYH11;PAK1;SPEG;EREG;OLFM2;THRA;MAPK12;MYH3;FLOT1;TTN;HDAC5;CAMK1;RXRA;AKT1;TNNT1;TMOD2;LMNA;CAPN2;KRT19;FOXO4;MYOF;GDF15;CTH
2604,GO:0005903,0.14403154619207,0.923225602122542,10,58,brush border,CC,ESPN;SHANK2;CYBRD1;ITPR3;RALGDS;SCART1;PEMT;ADD3;PLB1;SLC38A2
2041,GO:0004791,0.144187994379597,0.97696913681708,2,6,thioredoxin-disulfide reductase activity,MF,TXNRD3;TXNRD2
4097,GO:0009155,0.144657543538924,0.976847506418031,2,6,purine deoxyribonucleotide catabolic process,BP,ADA;NUDT18
11269,GO:0045600,0.144659397344479,0.933588802826841,7,37,positive regulation of fat cell differentiation,BP,ZFP36L1;CCDC71L;CEBPB;LRP5;AKT1;WDFY2;ADIRF
6110,GO:0019359,0.144800859490545,0.911908742131808,15,94,nicotinamide nucleotide biosynthetic process,BP,NAPRT;IDH2;PGM1;DHTKD1;DDIT4;OGDHL;NMRK1;NMNAT2;PPARA;MLXIPL;GALK1;NADK;ALDOC;INSR;PFKL
6112,GO:0019363,0.144800859490545,0.911908742131808,15,94,pyridine nucleotide biosynthetic process,BP,NAPRT;IDH2;PGM1;DHTKD1;DDIT4;OGDHL;NMRK1;NMNAT2;PPARA;MLXIPL;GALK1;NADK;ALDOC;INSR;PFKL
20183,GO:2001138,0.1448338627688,0.97680176460676,2,6,regulation of phospholipid transport,BP,APOE;ABCA7
20184,GO:2001140,0.1448338627688,0.97680176460676,2,6,positive regulation of phospholipid transport,BP,APOE;ABCA7
15453,GO:0071825,0.144835707961389,0.944529821416344,5,24,protein-lipid complex subunit organization,BP,APOE;SNX9;ABCA7;ABCG1;PLTP
6708,GO:0030125,0.144976194053113,0.944458546699135,5,24,clathrin vesicle coat,CC,EGFR;CLTCL1;AP1G2;AP2A2;HIP1
15530,GO:0072001,0.145788659527453,0.89737549354475,28,191,renal system development,BP,ACTA2;EGR1;CTNNBIP1;PGF;VEGFA;IFT140;WWTR1;ITGA6;LAMA5;ITGB4;ACVR2B;NID1;WNT2B;PKD2;LAMB2;VANGL2;KIF26B;PKD1;SULF2;WNK4;PCSK9;LZTS2;CTSH;CAT;TP73;FGFR1;WFS1;MMP17
6572,GO:0022406,0.145859940828244,0.900398898988868,24,162,membrane docking,BP,NINL;SNPH;EXOC2;SDCCAG8;VPS11;NPHP4;RAB3B;TTBK2;CEP250;ESYT2;CNTRL;TCTN1;FBF1;TSNARE1;NDE1;CEP131;RAB40B;MARK4;HAUS4;CSNK1E;RAB13;STX1A;ESYT3;SFI1
11686,GO:0046498,0.145915770575942,0.976520268864106,2,6,S-adenosylhomocysteine metabolic process,BP,GAMT;PEMT
16647,GO:0097581,0.146099692986692,0.919195621250073,11,65,lamellipodium organization,BP,PARVB;ARPIN;PLXNB3;ARHGEF4;SSH3;TWF2;DMTN;SSH1;SNX1;VAV3;CORO1B
16210,GO:0090287,0.146147491940312,0.899346191830761,25,169,regulation of cellular response to growth factor stimulus,BP,XDH;DUSP6;HTRA1;FGFBP1;VEGFA;LTBP4;RNF165;SPRY2;SPRY4;LTBP1;MTMR4;FAM20C;SULF2;FBXL15;TGFBR2;SMURF2;APLN;CDKN1C;MYOF;LEMD2;CIDEA;TGFBR3;FGFR1;FKBP8;GRB10
456,GO:0001302,0.146194111888964,0.976447620610712,2,6,replicative cell aging,BP,ERCC1;CHEK2
1097,GO:0002686,0.146293223918432,0.951482420145295,4,18,negative regulation of leukocyte migration,BP,MMP28;C5;BCR;ADA
4913,GO:0014855,0.146555605349784,0.932488424704001,7,37,striated muscle cell proliferation,BP,TGFBR2;RXRA;TENM4;TP73;TGFBR3;FGFR1;SIX5
10653,GO:0043901,0.146619620116328,0.906140900427285,18,118,negative regulation of multi-organism process,BP,TNIP1;HTRA1;GSN;APOBEC3C;NPR2;FAM3A;ZP3;APOBEC3F;NLRX1;HMGA2;IFITM1;ISG20;MAPKBP1;TIMP1;TKFC;SIRT2;ADA;EIF2AK4
2668,GO:0006022,0.146767684590994,0.906092426207702,18,116,aminoglycan metabolic process,BP,B3GAT3;HYAL1;NAGLU;CEMIP;B4GAT1;CSPG4;SDC2;CHST6;FUCA1;ST3GAL3;HEXB;HEXA;AKT1;B4GALT2;HGSNAT;GALNS;XYLT2;UST
4593,GO:0010713,0.146959500430816,0.976247369933562,2,6,negative regulation of collagen metabolic process,BP,CST3;ERRFI1
13610,GO:0060135,0.14700783114702,0.927989059388066,8,44,maternal process involved in female pregnancy,BP,CYP27B1;EPOR;PLA2G6;CTSB;LDOC1;RXRA;AKT1;BSG
7658,GO:0032096,0.147054441675673,0.976222481029091,2,6,negative regulation of response to food,BP,BBS2;PPARA
7661,GO:0032099,0.147054441675673,0.976222481029091,2,6,negative regulation of appetite,BP,BBS2;PPARA
12115,GO:0048232,0.147202397345147,0.889746363112437,40,286,male gamete generation,BP,GAMT;BBS2;ERCC1;CRTAP;MICALCL;GGT1;TCFL5;TXNRD3;BTG1;PHC2;DNAH1;MYCBPAP;KDM3A;NEURL1;ETV5;SPATA20;FAM50A;SCMH1;CCNI;TDRKH;AZIN2;RFX2;CEP131;DNMT3A;MLH3;AGO4;HERPUD2;SPAG16;ATP2B4;SEPT6;CABYR;TBC1D20;BCL6;REC8;RPL39L;PAIP2;SPATA6;CREB3L4;ZNF449;SIX5
7127,GO:0030968,0.147216020805627,0.905732021785073,18,117,endoplasmic reticulum unfolded protein response,BP,EDEM1;DDIT3;CUL7;SHC1;TSPYL2;ATF4;HERPUD1;CREBRF;CDK5RAP3;ERN1;PPP1R15A;ASNS;ACADVL;LMNA;WFS1;CTH;SYVN1;CREB3L4
8191,GO:0032947,0.147458340265245,0.915891842954861,12,72,protein-containing complex scaffold activity,MF,WWC3;SHANK2;GRIP2;SEPT5;RGS14;SEPT10;SLC9A3R2;SEPT6;HOMER2;LAMTOR2;MAGI1;SEPT8
13013,GO:0051493,0.147582778722219,0.884714248482813,54,395,regulation of cytoskeleton organization,BP,ESPN;GSN;WIPF1;CDC42EP5;LRP1;RAPGEF3;SPTB;ARHGEF19;ARAP1;ARPIN;CAPG;EML2;ARL2;TTBK2;PAK1;CEP250;PLXNB1;SSH3;PLEKHG2;RHOBTB2;MAPK3;SEMA5A;VANGL2;RHOF;CHMP1B;ARHGEF2;TWF2;STMN3;DMTN;SSH1;PKD1;WHAMMP3;CEP131;TRIOBP;TRPV4;TMSB4X;EPHA1;TMOD2;ASAP3;C9ORF72;CHMP5;CAPN2;CHMP4C;BRAF;ARHGAP44;FCHSD1;SPIRE1;EPS8L1;CELSR1;RHOBTB3;EPS8L2;C15ORF62;CORO1B;PLEKHH2
8703,GO:0034362,0.147759334775577,0.976037353641736,2,6,low-density lipoprotein particle,CC,APOE;SORL1
4128,GO:0009191,0.147767606254049,0.976035177739404,2,6,ribonucleoside diphosphate catabolic process,BP,ENTPD2;NUDT18
5918,GO:0018198,0.147891852310974,0.931566360740152,7,38,peptidyl-cysteine modification,BP,ZDHHC1;NOS1;RAB3B;SNTA1;ATP2B4;NCOA7;ZDHHC24
12023,GO:0047844,0.148014427399165,0.975970210887723,2,6,deoxycytidine deaminase activity,MF,APOBEC3C;APOBEC3F
2617,GO:0005929,0.148199124144561,0.886305759319423,47,340,cilium,CC,BBS2;IFT140;SHANK2;EVC;BBS1;DNAH1;NPHP4;TTBK2;ANKS6;CEP250;WDR60;KIF17;IFT27;PKD2;DNAL4;CNTRL;TCTN1;FBF1;PKD1;NEK8;CEP131;TRPV4;PROM2;TTLL11;CEP126;CROCC;SPAG16;ADCY6;ATP2B4;SPATA7;WDR19;TMEM80;AKT1;IFT57;SEPT6;TTC21A;WDR66;CABYR;KIF27;MARK4;UNC119B;SCNN1A;GSTM3;EHD3;SPATA6;UNC119;TCTEX1D4
10814,GO:0044325,0.148242838739853,0.913152063877892,13,80,ion channel binding,MF,FHL1;PRNP;ANK3;NOS1;SCN4B;PACS2;PKD2;SNTA1;PKD1;HERPUD1;RIMS3;FYN;STX1A
5594,GO:0016635,0.148310506484736,0.97589218198772,2,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,SDHA;SDHAF4
15469,GO:0071867,0.148547240828129,0.942638282731351,5,24,response to monoamine,BP,MAPK3;ATF4;ADCY6;ATP2B4;SIRT2
15471,GO:0071869,0.148547240828129,0.942638282731351,5,24,response to catecholamine,BP,MAPK3;ATF4;ADCY6;ATP2B4;SIRT2
4230,GO:0009414,0.1485689077685,0.975823996588567,2,6,response to water deprivation,BP,CD9;LRP11
12226,GO:0048522,0.14874200165957,0.865131296540913,429,3475,positive regulation of cellular process,BP,TNIP1;XDH;DUSP6;DLG4;HTRA1;DOCK4;F2R;APOE;ESPN;ZMYND8;NFATC4;SERPINE2;S100A6;FOS;PRODH;GSN;ADGRL1;CITED4;EGR1;CTNNBIP1;PGF;FGFBP1;POSTN;WIPF1;PTK6;CDC42EP5;EDEM1;GLUL;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;DDB2;PRNP;NR1D1;ERCC1;FBLN1;S100A4;ANK3;DUSP5;RAPGEF3;TNFSF15;TSPAN1;IGFBP4;CST3;MEF2D;NOS1;GPSM1;DDIT3;DNPH1;SHANK2;CRTC1;ADGRB2;ERCC6;NDRG1;TBC1D8;ARHGEF19;TCEA2;GRAMD4;SMARCA1;MST1R;TRIM65;ZFP36L1;NUPR1;ARAP1;HBEGF;RBL2;RGL2;RPS6KA2;MMP1;CTF1;CNTN1;TFDP2;EFNB3;OBSL1;EVC;SLC27A1;RNF165;RAB11FIP4;MLYCD;FBXW4;ASH2L;CUL7;EPM2A;HYAL1;ARPIN;ETV4;WWTR1;MAP2K1;CYP27B1;PCK2;CCDC71L;PKN1;MC1R;DDIT4;BTG1;SHC2;ITGA6;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;PLEKHG5;FAM110C;MAGEF1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;VEGFB;MARCKSL1;SOX12;RAB3B;NLGN2;ITPR3;CIRBP;CAPRIN2;PRKCZ;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;CEMIP;KDM3A;PHF1;SEMA3F;PLXNB3;SALL2;DLG3;MICALL2;FBXW8;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;EAPP;NGFR;ETV5;GSTO1;ARHGEF4;WNT2B;NSMCE4A;TRIB2;PLXNB1;EREG;TEF;OLFM2;PLEKHG2;TMED4;TNFRSF25;NAB2;PLA2G6;CARF;LPAR3;S100A13;C5;PPARA;PLGRKT;ANO1;SESN2;IMPACT;PKD2;STAT6;KLF7;ING4;VAMP2;HMGA2;AREG;ECM1;ACACB;MAPK3;CSPG4;BNIP3;SEMA5A;THRA;IFITM1;VANGL2;SH2D2A;RGS14;MVD;IRF2BPL;FAM20C;PLEK2;SLITRK6;MAPK12;NAT14;ZXDC;MLXIPL;ARHGEF2;INPP5D;PDCD1LG2;MAP2K2;TWF2;LRSAM1;DMTN;LITAF;SEMA3B;PTHLH;ATF4;ZFPM1;BBC3;KDM4C;PAK6;DOCK11;SSH1;METRN;TENM2;ZNF516;PKD1;NSMCE1;FLOT1;LTBP3;MDK;TTN;KCNMA1;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;PCBP4;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;DEAF1;SULF2;NLRP1;PEG3;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;LRP5;ATRAID;CREBRF;PCSK9;PKIB;FBXL15;METTL23;CEP131;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;CSRNP3;ITGA1;TMSB4X;SMURF2;APLN;TRIB3;DAP;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;SEMA4G;SHARPIN;GAS6;GLUD1;ERN1;CROCC;BCR;MAPRE3;FYCO1;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;RIMS3;ADCY6;ATP2B4;STRADB;CTSH;TNFRSF14;MGMT;ASNS;AKT1;CARD11;CDKN1C;AMIGO2;LAMB1;CHEK2;IFT57;IGFBP2;ASS1;TSG101;PHF2;IL17RC;FGFR4;TMOD2;PIAS3;TCIRG1;LMNA;SH2B3;MAB21L2;WDFY2;C9ORF72;UHRF2;MARK4;RAB25;IFI27;PLAU;INSR;WNT3;NCOA7;TENM4;FOXO4;YPEL3;RPS6KA5;TPCN1;C6ORF89;MAP2K5;BRAF;EDA2R;PIDD1;CAT;MAPK10;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;SNX33;TFEB;MIB2;SPIRE1;CSNK1E;TAZ;BCL6;HSF4;EPS8L1;FYN;ZC3H12D;ARHGEF17;SIRT2;TRPC1;GDF15;GOLGA2;ADA;POU2F2;PLXND1;MTA1;TMEM101;EPS8L2;PAIP2;MYO18A;ADIRF;EIF4EBP1;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;EPAS1;LAMTOR2;MAP3K10;MFNG;STARD10;CHD6;LURAP1;DHPS;EPHB2;PER1;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;EIF2AK4;UNC119;PAG1;OSCP1;C15ORF62;HLA-G;CORO1B;HMBOX1;NET1;GRB10;CREB3L4;KCTD11;KCTD13;DBP;ZNF287;CAMKK1;IKBKB;HIP1;TEAD2;SIX5
1580,GO:0003993,0.148744082952877,0.975777726748509,2,6,acid phosphatase activity,MF,ACP5;ACP6
13250,GO:0051963,0.14878109158592,0.926908949109531,8,44,regulation of synapse assembly,BP,ADGRL1;ADGRB2;NLGN2;SLITRK6;TPBG;WNT7A;AMIGO2;EPHB2
13797,GO:0060419,0.148845857643557,0.923238874121121,9,51,heart growth,BP,DUSP6;PAK1;ACACB;TGFBR2;RXRA;TENM4;TP73;TGFBR3;FGFR1
9338,GO:0035864,0.148855451648179,0.975748291236725,2,6,response to potassium ion,BP,ADAMTS13;CARF
2747,GO:0006152,0.148865630295381,0.975745600206866,2,6,purine nucleoside catabolic process,BP,ADA;NUDT18
11556,GO:0046130,0.148865630295381,0.975745600206866,2,6,purine ribonucleoside catabolic process,BP,ADA;NUDT18
13714,GO:0060312,0.148916391030341,0.975732178229433,2,6,regulation of blood vessel remodeling,BP,CST3;BCR
2389,GO:0005527,0.149023356240528,0.960670237893419,3,12,macrolide binding,MF,FKBP9;FKBP10;FKBP8
2390,GO:0005528,0.149023356240528,0.960670237893419,3,12,FK506 binding,MF,FKBP9;FKBP10;FKBP8
17439,GO:1900272,0.149033823943956,0.975701115158195,2,6,negative regulation of long-term synaptic potentiation,BP,APOE;PRNP
2589,GO:0005884,0.149038809154465,0.914758769692579,12,73,actin filament,CC,ESPN;WIPF1;TPM2;PRKCZ;PAK1;SHROOM4;PKD2;TWF2;DMTN;TMSB4X;FYN;CORO1B
9064,GO:0035329,0.149121992709574,0.930992287083015,7,37,hippo signaling,BP,WWC3;WWTR1;NPHP4;NEK8;MARK3;PJA2;TEAD2
4890,GO:0014820,0.149212087481248,0.97565392964801,2,6,tonic smooth muscle contraction,BP,BBS2;EDNRA
3461,GO:0007281,0.149423109528811,0.901653428813288,20,132,germ cell development,BP,BBS2;ERCC1;DNAH1;PABPC1L;KDM3A;NPR2;ZP3;NEURL1;ETV5;EREG;DEAF1;RFX2;HEXB;SPAG16;AKT1;CABYR;TBC1D20;REC8;SIRT2;SIX5
4827,GO:0014037,0.149574326194301,0.935921756060117,6,30,Schwann cell differentiation,BP,NDRG1;NAB2;SH3TC2;LAMB2;AKT1;SIRT2
11355,GO:0045741,0.14961290673582,0.975547695276015,2,6,positive regulation of epidermal growth factor-activated receptor activity,BP,NEURL1;EREG
7078,GO:0030881,0.149666257268046,0.975533540534222,2,6,beta-2-microglobulin binding,MF,FCGRT;HFE
11263,GO:0045591,0.149728498171087,0.975517022715913,2,6,positive regulation of regulatory T cell differentiation,BP,BCL6;HLA-G
16263,GO:0090385,0.149730686854775,0.975516441786847,2,6,phagosome-lysosome fusion,BP,SPG11;TMEM175
2712,GO:0006090,0.149820706489959,0.906684928479484,16,102,pyruvate metabolic process,BP,SLC16A3;PGM1;DHTKD1;PCK2;DDIT4;OGDHL;PPARA;PC;MLXIPL;GALK1;ALDOC;SRR;HAGH;INSR;PFKL;BSG
15956,GO:0080154,0.149993244281004,0.975446711021893,2,6,regulation of fertilization,BP,ZP3;PLB1
10144,GO:0042744,0.150020572606653,0.960285056662665,3,12,hydrogen peroxide catabolic process,BP,GPX3;PRDX5;CAT
792,GO:0002062,0.150221426271059,0.919212989239872,10,58,chondrocyte differentiation,BP,ADAMTS7;MEF2D;FGFR3;WNT2B;HMGA2;PTHLH;SULF2;TGFBR2;WNT7A;FGFR1
18089,GO:1902774,0.150228282733836,0.975384218613701,2,6,late endosome to lysosome transport,BP,VPS39;C9ORF72
5490,GO:0016433,0.150298645905361,0.975365497439782,2,6,rRNA (adenine) methyltransferase activity,MF,RRNAD1;TFB1M
11678,GO:0046487,0.150559853767991,0.975295947203146,2,6,glyoxylate metabolic process,BP,IDH2;ALDH4A1
13337,GO:0052548,0.150811970240041,0.888084785047293,37,268,regulation of endopeptidase activity,BP,XDH;F2R;TNFRSF6B;SERPINE2;GSN;TIMP2;VEGFA;PRDX5;TFPI2;TNFSF15;CST3;GRAMD4;SERPING1;RAG1;NGFR;C5;BBC3;IFI6;SORL1;HERPUD1;PAPLN;NLRP1;DAP;GAS6;CTSH;MGMT;AKT1;MICAL1;HMSD;IFT57;IFI27;MAP2K5;PIDD1;TIMP1;FYN;CIDEB;HIP1
18253,GO:1903170,0.150843544561646,0.949391113908783,4,18,negative regulation of calcium ion transmembrane transport,BP,NTSR1;GSTO1;PKD2;GSTM2
5668,GO:0016783,0.150931681268911,0.959931986264545,3,12,sulfurtransferase activity,MF,TSTD1;MOCOS;TST
11983,GO:0047484,0.151157215159593,0.975136583669278,2,6,regulation of response to osmotic stress,BP,ARHGEF2;TRPV4
9962,GO:0042368,0.151328521706839,0.975090803676071,2,6,vitamin D biosynthetic process,BP,CYP27B1;CYP2R1
16055,GO:0090045,0.151351560020666,0.975084644227657,2,6,positive regulation of deacetylase activity,BP,VEGFA;C6ORF89
12881,GO:0051251,0.151409999531154,0.897001637338854,23,156,positive regulation of lymphocyte activation,BP,EFNB3;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;STAT6;INPP5D;PDCD1LG2;TGFBR2;GAS6;TNFRSF14;AKT1;CARD11;IGFBP2;LGALS1;JAK3;BCL6;FYN;ADA;VAV3;DHPS;HLA-G
2656,GO:0006002,0.151422554190896,0.975065659454581,2,6,fructose 6-phosphate metabolic process,BP,MPI;PFKL
16802,GO:0098722,0.151451743843068,0.975057852004755,2,6,asymmetric stem cell division,BP,ETV5;ARHGEF2
16364,GO:0097006,0.15147280296173,0.921479007284651,9,52,regulation of plasma lipoprotein particle levels,BP,APOE;LMF1;ABCA7;CES3;ABCG1;PLTP;VLDLR;PCSK9;AP2A2
3804,GO:0008395,0.151630584513796,0.975009994609089,2,6,steroid hydroxylase activity,MF,CYP3A5;CYP2R1
2139,GO:0004953,0.151717802837584,0.974986641251712,2,6,icosanoid receptor activity,MF,LTB4R2;LTB4R
10012,GO:0042473,0.151719809390971,0.97498610387471,2,6,outer ear morphogenesis,BP,MAPK3;FGFR1
20068,GO:2000766,0.151777030386364,0.974970777433267,2,6,negative regulation of cytoplasmic translation,BP,RPL13A;UNK
5206,GO:0015809,0.15195769320582,0.97492236177183,2,6,arginine transport,BP,PQLC2;SLC25A29
16409,GO:0097090,0.151972758822407,0.974918322583595,2,6,presynaptic membrane organization,BP,APOE;NLGN2
13751,GO:0060359,0.152056541633733,0.915157626572492,11,66,response to ammonium ion,BP,GLDC;MAPK3;ATF4;HDAC5;DNMT3A;MAP1LC3A;SRR;PTAFR;HOMER2;CHRM3;ADA
11313,GO:0045657,0.152172456006441,0.974864756784792,2,6,positive regulation of monocyte differentiation,BP,CTNNBIP1;ZFP36L1
13612,GO:0060137,0.152197410888704,0.974858059648941,2,6,maternal process involved in parturition,BP,LDOC1;PTAFR
11218,GO:0045410,0.152268229970289,0.974839049883787,2,6,positive regulation of interleukin-6 biosynthetic process,BP,EREG;PTAFR
10699,GO:0044033,0.152292420102291,0.97483255521797,2,6,multi-organism metabolic process,BP,MAP2K1;MAP2K2
2829,GO:0006298,0.152496761183916,0.934103974797601,6,31,mismatch repair,BP,XPC;ERCC1;POLD4;MLH3;TP73;MSH5
19515,GO:1990459,0.152500527425615,0.974776652742194,2,6,transferrin receptor binding,MF,HFE;SNX1
7936,GO:0032536,0.152507386407922,0.974774809376248,2,6,regulation of cell projection size,BP,TWF2;WNT7A
18413,GO:1903524,0.152517786942253,0.934092246277248,6,31,positive regulation of blood circulation,BP,F2R;EGFR;APLN;PTAFR;AKT1;ADA
543,GO:0001662,0.152643172855918,0.948556522484804,4,18,behavioral fear response,BP,APOE;RAG1;MDK;DEAF1
867,GO:0002209,0.152643172855918,0.948556522484804,4,18,behavioral defense response,BP,APOE;RAG1;MDK;DEAF1
10078,GO:0042596,0.152643172855918,0.948556522484804,4,18,fear response,BP,APOE;RAG1;MDK;DEAF1
12797,GO:0051126,0.152701408014214,0.974722642309751,2,6,negative regulation of actin nucleation,BP,ARPIN;CORO1B
16128,GO:0090174,0.152756619261995,0.900332327826406,19,125,organelle membrane fusion,BP,SYTL1;EVI5L;TBC1D8;SYT8;VPS11;SPG11;VAMP2;DYSF;TBC1D14;TBC1D3E;RABGAP1;TSNARE1;TMEM175;VPS39;SGSM2;RAB13;VAV3;STX1A;TBC1D16
11531,GO:0046085,0.152888364492015,0.974672332191917,2,6,adenosine metabolic process,BP,NT5E;ADA
1587,GO:0004000,0.153446536666302,0.974521878570265,2,6,adenosine deaminase activity,MF,ADARB1;ADA
401,GO:0001078,0.153506723660033,0.904014657255937,16,102,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NFATC4;NR1D1;TCFL5;RBL2;FOXQ1;HES2;PPARA;HMGA2;MLXIPL;ZFPM1;JDP2;CEBPB;BHLHE40;ZFP90;ZNF217;TSHZ1
6370,GO:0021561,0.153691046707078,0.974455854108084,2,6,facial nerve development,BP,ADARB1;SEMA3F
6393,GO:0021610,0.153691046707078,0.974455854108084,2,6,facial nerve morphogenesis,BP,ADARB1;SEMA3F
15259,GO:0071468,0.153728462318402,0.974445744544984,2,6,cellular response to acidic pH,BP,IMPACT;TRPV1
13848,GO:0060491,0.153790947714287,0.899558493486613,19,125,regulation of cell projection assembly,BP,ESPN;ZMYND8;EVI5L;CDC42EP5;IFT140;ARAP1;FAM110C;PLXNB3;NEURL1;SSH3;TWF2;DMTN;DOCK11;SSH1;TENM2;CROCC;EPS8L1;EPS8L2;C15ORF62
2984,GO:0006531,0.153880179640701,0.974404733895642,2,6,aspartate metabolic process,BP,NMNAT2;ASS1
15777,GO:0072497,0.153881782944558,0.974404300360022,2,6,mesenchymal stem cell differentiation,BP,LTBP3;WNT3
3423,GO:0007214,0.153884079669182,0.974403679317182,2,6,gamma-aminobutyric acid signaling pathway,BP,ATF4;GABBR1
15282,GO:0071499,0.154055252315065,0.974357375826329,2,6,cellular response to laminar fluid shear stress,BP,ASS1;MAP2K5
17978,GO:1902474,0.15406841495206,0.97435381378169,2,6,positive regulation of protein localization to synapse,BP,NLGN2;WNT7A
1447,GO:0003680,0.154127611523284,0.974337791568736,2,6,AT DNA binding,MF,H1F0;HMGA2
19616,GO:1990845,0.154145730609004,0.974332886597497,2,6,adaptive thermogenesis,BP,TRPV4;TRPV1
13531,GO:0060020,0.154168170367177,0.97432681144348,2,6,Bergmann glial cell differentiation,BP,MAP2K1;MAPK3
6414,GO:0021683,0.154231394952251,0.974309691302589,2,6,cerebellar granular layer morphogenesis,BP,SERPINE2;WNT7A
13690,GO:0060281,0.154299866141102,0.974291145074788,2,6,regulation of oocyte development,BP,NPR2;SIRT2
19357,GO:1905879,0.154299866141102,0.974291145074788,2,6,regulation of oogenesis,BP,NPR2;SIRT2
18803,GO:1904415,0.154303886156805,0.974290056031838,2,6,regulation of xenophagy,BP,MAPK3;LRSAM1
18804,GO:1904417,0.154303886156805,0.974290056031838,2,6,positive regulation of xenophagy,BP,MAPK3;LRSAM1
19823,GO:2000323,0.154318947247029,0.974285975732929,2,6,negative regulation of glucocorticoid receptor signaling pathway,BP,CRY2;PER1
11392,GO:0045820,0.154319168985682,0.974285915658223,2,6,negative regulation of glycolytic process,BP,DDIT4;PPARA
12851,GO:0051198,0.154319168985682,0.974285915658223,2,6,negative regulation of coenzyme metabolic process,BP,DDIT4;PPARA
3552,GO:0007595,0.154329169276701,0.933079804654751,6,31,lactation,BP,XDH;VEGFA;NEURL1;APLN;ATP7B;APRT
5474,GO:0016413,0.154455225354044,0.974249043395273,2,6,O-acetyltransferase activity,MF,CRAT;LPCAT4
4720,GO:0010887,0.154467762681473,0.974245644573953,2,6,negative regulation of cholesterol storage,BP,ABCG1;PPARA
16139,GO:0090186,0.154499569552794,0.974237021009407,2,6,regulation of pancreatic juice secretion,BP,STK39;WNK4
15651,GO:0072201,0.154558424230708,0.974221060978327,2,6,negative regulation of mesenchymal cell proliferation,BP,CTNNBIP1;LMNA
2701,GO:0006069,0.154586589070978,0.974213421857085,2,6,ethanol oxidation,BP,ACSS2;ACSS1
8030,GO:0032689,0.154646038377062,0.947622716525288,4,18,negative regulation of interferon-gamma production,BP,IL20RB;PRNP;PDCD1LG2;GAS6
2991,GO:0006538,0.154665672570002,0.974191967045322,2,6,glutamate catabolic process,BP,GLUL;GLUD1
14290,GO:0061469,0.154668641622923,0.974191161415856,2,6,regulation of type B pancreatic cell proliferation,BP,NR1D1;ERRFI1
10973,GO:0044788,0.154757878489836,0.947570419097694,4,18,modulation by host of viral process,BP,APOE;PC;TBC1D20;EIF2AK4
6096,GO:0019320,0.154785604484216,0.927511746824422,7,38,hexose catabolic process,BP,PGM1;GALE;GALK1;LRP5;ALDOC;TKFC;PFKL
14936,GO:0070857,0.15479344285459,0.974157288031678,2,6,regulation of bile acid biosynthetic process,BP,NR1D1;FGFR4
19120,GO:1905153,0.154853888572735,0.97414087523743,2,6,regulation of membrane invagination,BP,ABCA7;ITGA2
5339,GO:0016081,0.154861706576573,0.974138752099725,2,6,synaptic vesicle docking,BP,SNPH;STX1A
1793,GO:0004430,0.154888380183276,0.974131507789848,2,6,1-phosphatidylinositol 4-kinase activity,MF,PI4KAP1;PI4K2A
3886,GO:0008525,0.154890983162437,0.974130800798727,2,6,phosphatidylcholine transporter activity,MF,ABCA7;PLTP
14880,GO:0070728,0.154902142829644,0.974127769646957,2,6,leucine binding,MF,SESN2;GLUD1
2645,GO:0005984,0.154908827810316,0.974125953823379,2,6,disaccharide metabolic process,BP,GAA;BRAF
16504,GO:0097264,0.15497348831163,0.974108387503303,2,6,self proteolysis,BP,TENM2;TENM4
2028,GO:0004771,0.1549872189072,0.974104656668354,2,6,sterol esterase activity,MF,CES3;CES2
3571,GO:0007618,0.15500215669914,0.94745613601954,4,18,mating,BP,SERPINE2;THRA;HEXB;ADA
11142,GO:0045217,0.155106427414804,0.974072256223366,2,6,cell-cell junction maintenance,BP,F2R;NLGN2
13985,GO:0060732,0.155108377280704,0.974071726115543,2,6,positive regulation of inositol phosphate biosynthetic process,BP,NTSR1;PTAFR
15669,GO:0072224,0.155133917185761,0.974064782190477,2,6,metanephric glomerulus development,BP,EGR1;LAMB2
14658,GO:0070300,0.15525718272084,0.947336742131552,4,18,phosphatidic acid binding,MF,PITPNM1;PITPNC1;PLCD1;PLTP
8498,GO:0033689,0.155342230857876,0.974008115632189,2,6,negative regulation of osteoblast proliferation,BP,PLXNB1;ATRAID
17533,GO:1901142,0.155409933816013,0.97398968755087,2,6,insulin metabolic process,BP,ERO1B;ERN1
489,GO:0001542,0.155549897663448,0.973951573386142,2,6,ovulation from ovarian follicle,BP,NOS3;MMP19
13584,GO:0060080,0.155563013220528,0.973948000631355,2,6,inhibitory postsynaptic potential,BP,NTSR1;NLGN2
16442,GO:0097151,0.155563013220528,0.973948000631355,2,6,positive regulation of inhibitory postsynaptic potential,BP,NTSR1;NLGN2
16859,GO:0098828,0.155563013220528,0.973948000631355,2,6,modulation of inhibitory postsynaptic potential,BP,NTSR1;NLGN2
9523,GO:0036289,0.15556790098915,0.973946669121891,2,6,peptidyl-serine autophosphorylation,BP,MAP2K2;ERN1
2714,GO:0006094,0.155584843005682,0.918857145910491,9,52,gluconeogenesis,BP,NR1D1;PGM1;PCK2;DGKQ;PPARA;PC;ATF4;ALDOC;SLC37A4
10355,GO:0043190,0.155604788625195,0.973936619394903,2,6,ATP-binding cassette (ABC) transporter complex,CC,ABCA2;ABCA7
11433,GO:0045906,0.155697170118295,0.97391144369317,2,6,negative regulation of vasoconstriction,BP,DOCK4;APLN
3443,GO:0007256,0.155744103833707,0.973898649460592,2,6,activation of JNKK activity,BP,ERCC6;MAP3K10
8376,GO:0033293,0.155842735064285,0.932043153022554,6,32,monocarboxylic acid binding,MF,PYGL;PPARA;ACACB;PC;HLCS;RXRA
12640,GO:0050868,0.155887774046172,0.91542028531481,10,59,negative regulation of T cell activation,BP,IL20RB;PRNP;PDCD1LG2;CEBPB;HFE;JAK3;BCL6;ERBB2;PAG1;HLA-G
12749,GO:0051048,0.155903163678266,0.900675670780781,17,111,negative regulation of secretion,BP,F2R;HADH;IDH2;STK39;RHBDF1;WNK4;TMSB4X;RHBDF2;GAS6;BCR;MAPKBP1;BRAF;ASIC1;ADA;CIDEA;PFKL;PNKD
3948,GO:0008655,0.155964233608326,0.957962099329958,3,12,pyrimidine-containing compound salvage,BP,TK2;UCKL1;UPP1
3477,GO:0007340,0.156054546769981,0.957926444673111,3,12,acrosome reaction,BP,SYT8;ZP3;PLB1
9489,GO:0036151,0.156083425872954,0.946949346527341,4,18,phosphatidylcholine acyl-chain remodeling,BP,LPCAT4;PLA2G6;PLB1;MBOAT2
7243,GO:0031210,0.156114306761065,0.95790284621079,3,12,phosphatidylcholine binding,MF,PITPNM1;ESYT2;PLTP
12710,GO:0050997,0.156114306761065,0.95790284621079,3,12,quaternary ammonium group binding,MF,PITPNM1;ESYT2;PLTP
3528,GO:0007517,0.156178962271928,0.885935796005698,33,227,muscle organ development,BP,FHL1;FOS;EGR1;MEF2D;MYH15;ADARB1;NUPR1;HBEGF;CTF1;EVC;LAMA5;PAK1;ETV1;NEURL1;SPEG;CHD2;VANGL2;MAPK12;MYH3;ZFPM1;FLOT1;TTN;TGFBR2;HMG20B;RXRA;FOXO4;TP73;TAZ;LEMD2;SIRT2;TGFBR3;FGFR1;TNNI1
5402,GO:0016247,0.156236960139804,0.909775343048013,12,74,channel regulator activity,MF,NOS1;SCN4B;PRSS8;PRKCZ;KCNAB2;SNTA1;WNK4;PCSK9;TRPV1;ATP2B4;PIAS3;STX1A
9020,GO:0035249,0.15630302943149,0.931972011870613,6,31,synaptic transmission, glutamatergic,BP,SERPINE2;GLUL;EGFR;SHANK2;NLGN2;PLA2G6
7859,GO:0032429,0.156496931818485,0.973693067082215,2,6,regulation of phospholipase A2 activity,BP,LRP1;EGFR
19770,GO:2000241,0.156575433282722,0.909542466280382,12,74,regulation of reproductive process,BP,NUPR1;NPR2;ZP3;SMURF2;PTAFR;RXRA;INSR;PLB1;TIMP1;SIRT2;PHLDA2;ADA
17731,GO:1901725,0.156640874990832,0.973653681928132,2,6,regulation of histone deacetylase activity,BP,VEGFA;C6ORF89
6742,GO:0030169,0.156641179910026,0.973653598471135,2,6,low-density lipoprotein particle binding,MF,SORL1;PCSK9
6295,GO:0019915,0.156663745817148,0.921942669132203,8,45,lipid storage,BP,APOE;ABCG1;PPARA;ACACB;HEXB;ALKBH7;CIDEA;FITM2
16772,GO:0098642,0.156663961858452,0.973647362688254,2,6,network-forming collagen trimer,CC,COL8A1;COL4A6
16775,GO:0098645,0.156663961858452,0.973647362688254,2,6,collagen network,CC,COL8A1;COL4A6
16779,GO:0098651,0.156663961858452,0.973647362688254,2,6,basement membrane collagen trimer,CC,COL8A1;COL4A6
546,GO:0001666,0.15679381042405,0.884224257307559,35,251,response to hypoxia,BP,EGR1;PGF;POSTN;VEGFA;CST3;NOS1;NDRG1;ZFP36L1;PLAT;DDIT4;VEGFB;PAK1;MTHFR;PPARA;BNIP3;ANGPTL4;KCNMA1;ENDOG;AQP3;DNMT3A;TGFBR2;BNIP3L;TERC;AKT1;ITPR2;LMNA;CAPN2;PLAU;CAT;SIRT2;ADA;TGFBR3;EPAS1;EDNRA;ITGA2
17498,GO:1901016,0.156835438672577,0.931672399704518,6,31,regulation of potassium ion transmembrane transporter activity,BP,KCNG1;FHL1;ANK3;STK39;VAMP2;KLHL24
2517,GO:0005771,0.156854124167168,0.938076345405713,5,25,multivesicular body,CC,EGFR;CST3;CTSH;TSG101;STEAP3
16230,GO:0090312,0.156907381034726,0.946562144125811,4,18,positive regulation of protein deacetylation,BP,VEGFA;JDP2;C6ORF89;BCL6
5811,GO:0017081,0.156957904427182,0.957569222021231,3,12,chloride channel regulator activity,MF,WNK4;TRPV1;STX1A
474,GO:0001518,0.157014095404009,0.973551447555592,2,6,voltage-gated sodium channel complex,CC,SCN8A;SCN4B
929,GO:0002327,0.157015685733577,0.973551011568687,2,6,immature B cell differentiation,BP,RAG1;LRRC8A
18140,GO:1902930,0.157173718385417,0.917839130748385,9,52,regulation of alcohol biosynthetic process,BP,APOE;NTSR1;CYP27B1;SEC14L2;ABCG1;ACACB;MVD;PTAFR;TM7SF2
6833,GO:0030306,0.157178748304022,0.973506292128014,2,6,ADP-ribosylation factor binding,MF,RAB11FIP4;SORL1
13241,GO:0051954,0.157212805305571,0.957468231438584,3,12,positive regulation of amine transport,BP,NTSR1;RAB3B;STX1A
3898,GO:0008542,0.157230881676879,0.931449643571941,6,31,visual learning,BP,SYNGAP1;RAG1;RGS14;DEAF1;B4GALT2;BRAF
4758,GO:0010942,0.157268820562448,0.873527593677259,66,496,positive regulation of cell death,BP,XDH;DUSP6;F2R;NFATC4;FOS;PRODH;GSN;EGR1;LRP1;PDCD4;OBSCN;NTSR1;RBCK1;PRNP;TNFSF15;DDIT3;ARHGEF19;GRAMD4;NUPR1;RPS6KA2;TFDP2;DDIT4;BTG1;ITGA6;PLEKHG5;NEURL1;NGFR;ARHGEF4;PLEKHG2;PLA2G6;ING4;HMGA2;BNIP3;ARHGEF2;INPP5D;ATF4;BBC3;SSH1;KCNMA1;IRF5;NLRP1;ENDOG;PCSK9;DNMT3A;CSRNP3;ITGA1;DAP;TRPV1;BNIP3L;CTSH;AKT1;CHEK2;IFT57;MARK4;IFI27;PIDD1;TP73;BCL6;FYN;ARHGEF17;SIRT2;CIDEB;VAV3;MAP3K10;NET1;HIP1
7924,GO:0032510,0.157303956948455,0.97347193246327,2,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,LYST;UBXN6
678,GO:0001889,0.157435440588013,0.901116402296275,16,103,liver development,BP,EGFR;HMGCL;PCK2;PKD2;PKD1;SRSF5;SULF2;CEBPB;PCSK9;ASNS;PHF2;HFE;ADA;TGFBR3;ITGA2;DBP
14200,GO:0061180,0.157560715673805,0.917590761621392,9,52,mammary gland epithelium development,BP,ETV5;STAT6;AREG;DEAF1;CEBPB;LRP5;MGMT;AKT1;WNT3
3408,GO:0007193,0.157673384261634,0.931200154902111,6,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,HTR7;GABBR1;ADCY6;GNAL;CHRM3;EDNRA
8045,GO:0032717,0.157693292455193,0.957277633938597,3,12,negative regulation of interleukin-8 production,BP,TMSB4X;MAPKBP1;MAP2K5
10007,GO:0042461,0.157758456530869,0.946161276430348,4,18,photoreceptor cell development,BP,VEGFA;IFT140;NAGLU;NPHP4
9269,GO:0035721,0.157766060199451,0.957248742485785,3,12,intraciliary retrograde transport,BP,IFT140;WDR19;TTC21A
10418,GO:0043281,0.157818268776886,0.890165443500317,25,174,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;TNFRSF6B;GSN;VEGFA;PRDX5;TNFSF15;GRAMD4;RAG1;NGFR;BBC3;IFI6;HERPUD1;NLRP1;DAP;GAS6;CTSH;MGMT;AKT1;MICAL1;IFT57;IFI27;MAP2K5;PIDD1;HIP1
17419,GO:1900223,0.157927161332142,0.973300634699102,2,6,positive regulation of amyloid-beta clearance,BP,LRP1;ABCA7
1595,GO:0004016,0.157932736197593,0.97329910026503,2,6,adenylate cyclase activity,MF,NPR2;ADCY6
1773,GO:0004383,0.157932736197593,0.97329910026503,2,6,guanylate cyclase activity,MF,NPR2;ADCY6
3618,GO:0008074,0.157932736197593,0.97329910026503,2,6,guanylate cyclase complex, soluble,CC,NPR2;ADCY6
10584,GO:0043574,0.158097734873403,0.946001211445739,4,18,peroxisomal transport,BP,PEX10;LONP2;PEX7;PEX1
6304,GO:0019953,0.158421321206513,0.874159562068496,59,438,sexual reproduction,BP,GAMT;BBS2;SERPINE2;ERCC1;CD9;CRTAP;MICALCL;GGT1;MST1R;SYT8;TCFL5;TXNRD3;BTG1;PHC2;DNAH1;MYCBPAP;PABPC1L;KDM3A;NPR2;ZP3;NEURL1;ETV5;EREG;SPATA20;FAM50A;SCMH1;THRA;CCNI;TDRKH;AZIN2;DEAF1;RFX2;CEP131;DNMT3A;MLH3;NOS3;AGO4;HEXB;HERPUD2;SPAG16;ATP2B4;AKT1;SEPT6;CABYR;TBC1D20;WNT3;PLB1;SPIRE1;BCL6;REC8;RPL39L;SIRT2;ADA;PAIP2;SPATA6;CREB3L4;MMP19;ZNF449;SIX5
12550,GO:0050728,0.158454187032347,0.91078191006261,11,67,negative regulation of inflammatory response,BP,NT5E;APOE;IL20RB;ACP5;PDCD4;PPARA;FNDC4;NLRX1;SHARPIN;BCR;ADA
18893,GO:1904645,0.158522891929183,0.945800421174804,4,18,response to amyloid-beta,BP,LRP1;PRNP;NGFR;FYN
18533,GO:1903779,0.1588085021809,0.925119903040924,7,38,regulation of cardiac conduction,BP,NOS1;ITPR3;NPR2;ATP2B4;ITPR2;EHD3;TRPC1
11668,GO:0046473,0.158901302291903,0.930506604607971,6,31,phosphatidic acid metabolic process,BP,DGKA;SLC27A1;ACP6;LPCAT4;DGKQ;PNPLA3
7034,GO:0030816,0.15891268596426,0.956792578680536,3,12,positive regulation of cAMP metabolic process,BP,TIMP2;RAPGEF3;PTHLH
13545,GO:0060038,0.15892215441442,0.93049481130532,6,31,cardiac muscle cell proliferation,BP,TGFBR2;RXRA;TENM4;TP73;TGFBR3;FGFR1
3364,GO:0007129,0.159032143369515,0.945559609107701,4,18,synapsis,BP,MLH3;AGO4;REC8;MSH5
159,GO:0000323,0.15915461244973,0.87128370808566,69,518,lytic vacuole,CC,PYGB;ACP5;NAPRT;LRP1;ANK3;TSPAN1;CST3;GAA;CTSF;HYAL1;NAGLU;SYNGR1;COL6A1;ABCA2;VPS11;CD68;CYBRD1;BRI3;TMEM44;SPPL2B;SPG11;S100A13;MARCH9;CSPG4;CTSB;PI4K2A;PQLC2;SDC2;TECPR1;SLC48A1;LITAF;BBC3;FUCA1;FLOT1;VLDLR;TMEM175;ATRAID;PCSK9;DIRC2;MAP1LC3A;HEXB;MARCH2;VPS39;FYCO1;NBR1;HEXA;CTSH;TMEM9;C12ORF66;TCIRG1;DNASE2;C9ORF72;ARSA;CAPN2;MAN2B1;TPCN1;CAT;DPP7;HGSNAT;SNX1;UBXN6;TOM1;ADA;NAGA;AP2A2;GALNS;LAMTOR2;BLOC1S1;TMEM8A
2510,GO:0005764,0.15915461244973,0.87128370808566,69,518,lysosome,CC,PYGB;ACP5;NAPRT;LRP1;ANK3;TSPAN1;CST3;GAA;CTSF;HYAL1;NAGLU;SYNGR1;COL6A1;ABCA2;VPS11;CD68;CYBRD1;BRI3;TMEM44;SPPL2B;SPG11;S100A13;MARCH9;CSPG4;CTSB;PI4K2A;PQLC2;SDC2;TECPR1;SLC48A1;LITAF;BBC3;FUCA1;FLOT1;VLDLR;TMEM175;ATRAID;PCSK9;DIRC2;MAP1LC3A;HEXB;MARCH2;VPS39;FYCO1;NBR1;HEXA;CTSH;TMEM9;C12ORF66;TCIRG1;DNASE2;C9ORF72;ARSA;CAPN2;MAN2B1;TPCN1;CAT;DPP7;HGSNAT;SNX1;UBXN6;TOM1;ADA;NAGA;AP2A2;GALNS;LAMTOR2;BLOC1S1;TMEM8A
7274,GO:0031268,0.159598498312154,0.95651892250214,3,12,pseudopodium organization,BP,CDC42EP5;RAB25;C15ORF62
4615,GO:0010738,0.159657763552919,0.956495245467562,3,12,regulation of protein kinase A signaling,BP,MC1R;AIP;PJA2
10307,GO:0043114,0.159915645863752,0.945141032185189,4,18,regulation of vascular permeability,BP,CTNNBIP1;TRPV4;PDE2A;BCR
8811,GO:0034599,0.159926716771534,0.884685108088012,30,212,cellular response to oxidative stress,BP,FOS;PRODH;GPX3;EGFR;PRDX5;CST3;PYCR2;MAPK13;ETV5;SESN2;IMPACT;PKD2;STAT6;MAPK3;BNIP3;ATF4;ENDOG;MAP1LC3A;NOS3;CCS;MGMT;AKT1;NCOA7;ANKZF1;TXNRD2;CAT;SIRT2;EPAS1;CHD6;NET1
16492,GO:0097228,0.160079003217274,0.956326824549515,3,12,sperm principal piece,CC,IFT27;ATP2B4;CABYR
2638,GO:0005975,0.160199193543522,0.872383362692272,60,446,carbohydrate metabolic process,BP,H6PD;ST6GALNAC2;ISYNA1;PYGB;SLC2A3;NTSR1;NR1D1;IGFBP4;IDH2;PGM1;B3GAT3;GAA;PYGL;DHTKD1;NISCH;MLYCD;HYAL1;PCK2;CRYL1;PGLS;DDIT4;DGKQ;AKR7A2;OGDHL;GALE;GSTO1;PPARA;PPP1R3E;ST6GALNAC6;ACACB;PC;STK40;MLXIPL;ATF4;CHST6;FUCA1;GALK1;ST3GAL3;LRP5;ALDOC;HEXDC;HEXB;MAN2C1;HEXA;PTAFR;GSTO2;AKT1;B4GALT2;MAN2B1;INSR;PIGQ;BRAF;MPI;TKFC;SLC37A4;PHLDA2;NAGA;FUK;MAN1B1;PFKL
14674,GO:0070325,0.160343955334498,0.944937751269131,4,18,lipoprotein particle receptor binding,MF,APOE;LRP1;PCSK9;SNX17
3793,GO:0008374,0.160378728849703,0.924181222650536,7,38,O-acyltransferase activity,MF,CRAT;CPT2;LPCAT4;PNPLA3;CPT1C;TAZ;MBOAT2
12202,GO:0048477,0.160464088033257,0.919578849332964,8,45,oogenesis,BP,ERCC1;PABPC1L;NPR2;ZP3;EREG;HEXB;REC8;SIRT2
11669,GO:0046474,0.160473291485946,0.885706306390586,28,194,glycerophospholipid biosynthetic process,BP,DGKA;SLC27A1;PITPNM3;ACP6;LPCAT4;PITPNM1;DGKQ;FGFR3;ZP3;PNPLA3;PLA2G6;MTMR4;PI4K2A;INPP5D;PEMT;PIGZ;PIK3R2;CHKB;FGFR4;PIGQ;TAZ;ETNK2;STARD10;INPP4A;FGFR1;PIGV;MPPE1;PLEKHA4
12379,GO:0048842,0.160729560157318,0.972524623043462,2,6,positive regulation of axon extension involved in axon guidance,BP,VEGFA;SEMA5A
7130,GO:0030971,0.160834137145301,0.919347818571187,8,45,receptor tyrosine kinase binding,MF,DOCK4;PITPNM3;SHC2;PITPNM1;SHC1;PIK3R2;GAS6;PAG1
5543,GO:0016553,0.160858719577235,0.956014468231944,3,12,base conversion or substitution editing,BP,ADARB1;APOBEC3C;APOBEC3F
4122,GO:0009185,0.16114182109376,0.900110697281271,15,96,ribonucleoside diphosphate metabolic process,BP,DLG4;PGM1;DHTKD1;DDIT4;OGDHL;DLG3;PPARA;MLXIPL;GALK1;ALDOC;CARD11;INSR;ENTPD2;PFKL;NUDT18
6979,GO:0030665,0.161244832879394,0.90888968557297,11,67,clathrin-coated vesicle membrane,CC,APOE;EGFR;CLTCL1;CD9;HBEGF;CEMIP;VAMP2;AP1G2;RASSF9;AP2A2;HIP1
453,GO:0001227,0.161267600115924,0.88842987793168,24,163,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NFATC4;NR1D1;TCFL5;RBL2;MXI1;FOXQ1;HES2;PPARA;SATB1;HMGA2;MLXIPL;ZFPM1;JDP2;DEAF1;CEBPB;MXD3;BHLHE40;ZFP90;ZNF217;MNT;BCL6;TCF7;HMBOX1;TSHZ1
10289,GO:0043073,0.16143985686298,0.955781149735583,3,12,germ cell nucleus,CC,TCFL5;MLH3;REC8
12445,GO:0050321,0.161633443905968,0.955703329948068,3,12,tau-protein kinase activity,MF,BRSK1;TTBK2;MARK4
6705,GO:0030122,0.161916992748624,0.955589258818356,3,12,AP-2 adaptor complex,CC,EGFR;AP2A2;HIP1
6150,GO:0019471,0.161960944188095,0.955571567911861,3,12,4-hydroxyproline metabolic process,BP,PRODH;ALDH4A1;ERO1B
7654,GO:0032092,0.161985582234065,0.905804867080221,12,74,positive regulation of protein binding,BP,APOE;LRP1;TMEM173;CAPRIN2;PKD1;FLOT1;HERPUD1;TRIB3;MAPRE3;HFE;PLXND1;MFNG
18001,GO:1902532,0.161995229620836,0.872746079020496,53,391,negative regulation of intracellular signal transduction,BP,TNIP1;XDH;DUSP6;APOE;SERPINE2;WWC3;PDCD4;TIMP2;PRNP;FBLN1;DUSP5;DDIT3;ARAP3;EPM2A;DDIT4;SYNGAP1;SPRY2;SPRY4;GSTO1;SESN2;RASA4;NLRX1;PKD2;ERRFI1;RGS14;ARHGEF2;STMN3;SORL1;HERPUD1;GSTM2;NLRP1;MARK3;ARHGAP25;TNFAIP8L1;TMSB4X;PDE2A;TRIB3;CDK5RAP3;PIK3R2;ATP2B4;C12ORF66;MAPKBP1;AKT1;ARHGAP44;TP73;BCL6;TKFC;LEMD2;EPHB2;PER1;WFS1;SYVN1;KCTD13
17511,GO:1901068,0.162062177369476,0.918460423965854,8,46,guanosine-containing compound metabolic process,BP,DLG4;DLG3;NME4;GTPBP1;MOCOS;CARD11;DGUOK;NUDT18
13239,GO:0051952,0.162358122041167,0.935170877793102,5,25,regulation of amine transport,BP,NTSR1;RAB3B;STK39;SV2A;STX1A
6079,GO:0019239,0.162362200957524,0.935168710650136,5,25,deaminase activity,MF,ADARB1;APOBEC3C;APOBEC3F;RPUSD3;ADA
7227,GO:0031143,0.162466397800971,0.955367937693324,3,12,pseudopodium,CC,MAPK3;CAPN2;RAB25
4051,GO:0009100,0.16319862333002,0.875644347050295,42,303,glycoprotein metabolic process,BP,TNIP1;ST6GALNAC2;LMF1;FBXO2;EDEM1;ADAMTS7;CST3;ADAMTS13;B3GAT3;HBEGF;HYAL1;VEGFB;ABCA7;MUC19;ST6GALNAC6;B4GAT1;CSPG4;VANGL2;MVD;ADAMTSL1;SRD5A3;FBXO6;ST3GAL3;SULF2;FOXL1;HEXB;MAN2C1;HEXA;NECAB3;B4GALT2;PHLDA1;MAN2B1;COG7;JAK3;MPI;GOLGA2;MAN1B1;MFNG;XYLT2;UST;SYVN1;ACOT8
5547,GO:0016558,0.16327697973837,0.955040690799934,3,12,protein import into peroxisome matrix,BP,PEX10;PEX7;PEX1
19912,GO:2000479,0.163346049207927,0.955012766864177,3,12,regulation of cAMP-dependent protein kinase activity,BP,SESN2;PKIB;ATP2B4
15306,GO:0071549,0.163744167625894,0.93443328337125,5,25,cellular response to dexamethasone stimulus,BP,EGFR;PCK2;DDIT4;ERRFI1;EIF4EBP1
15784,GO:0072507,0.163891656769274,0.88018818360055,32,227,divalent inorganic cation homeostasis,BP,DLG4;F2R;APOE;NTSR1;EGFR;PRNP;ANK3;NOS1;DDIT3;CYP27B1;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;BNIP3;SV2A;PKD1;HERPUD1;GSTM2;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;ITPR2;TPCN1;FYN;TRPC1;EDNRA;WFS1
8902,GO:0034755,0.16411126211359,0.954702987930743,3,12,iron ion transmembrane transport,BP,STEAP2;STEAP3;HFE
3859,GO:0008483,0.164358988447865,0.954602539429556,3,12,transaminase activity,MF,GPT2;PSAT1;PHYKPL
8356,GO:0033262,0.164451644172533,0.954564948855784,3,12,regulation of nuclear cell cycle DNA replication,BP,CHEK2;BCL6;FGFR1
1405,GO:0003341,0.164594445568288,0.933979628784871,5,25,cilium movement,BP,BBS2;DNAH1;SPAG16;WDR66;CABYR
18142,GO:1902932,0.164605086445799,0.954502672698508,3,12,positive regulation of alcohol biosynthetic process,BP,NTSR1;ABCG1;PTAFR
3468,GO:0007292,0.164608428998733,0.903982595417246,12,74,female gamete generation,BP,ERCC1;PABPC1L;NPR2;ZP3;EREG;MLH3;NOS3;HEXB;SPIRE1;REC8;SIRT2;MMP19
17133,GO:0102567,0.16468663074187,0.954469564718119,3,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,PLA2G6;PLB1;TMEM8A
17134,GO:0102568,0.16468663074187,0.954469564718119,3,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,PLA2G6;PLB1;TMEM8A
5072,GO:0015299,0.164692342580365,0.954467245320089,3,12,solute:proton antiporter activity,MF,SLC22A18;SLC9A7;SLC9A5
7008,GO:0030728,0.164743747161182,0.954446369641329,3,12,ovulation,BP,EREG;NOS3;MMP19
14851,GO:0070663,0.164823602744424,0.892540736972822,18,120,regulation of leukocyte proliferation,BP,IL20RB;PRNP;PKN1;ZP3;CCDC88B;INPP5D;PDCD1LG2;CEBPB;TGFBR2;CARD11;IGFBP2;JAK3;BCL6;ADA;VAV3;DHPS;ERBB2;HLA-G
3231,GO:0006887,0.164934693767478,0.864398227294624,79,599,exocytosis,BP,SYTL1;GSN;PYGB;SLC2A3;NAPRT;TIMP2;VEGFA;CD9;SNPH;CST3;PGM1;SYT8;GAA;PYGL;EXOC2;PRSS3;SYNGR1;DNASE1L1;TMEM173;VPS11;VEGFB;RAB3B;CD68;SERPING1;PAK1;BRI3;ZP3;ACTR1B;TMC6;PLA2G6;MANF;S100A13;VAMP2;SEPT5;ECM1;PCLO;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;DMTN;FUCA1;TTN;ALDOC;TMSB4X;RAB40B;HEXB;GAS6;BCR;NBEAL2;PTAFR;RIMS3;CTSH;STEAP2;MICAL1;TSG101;TCIRG1;ARSA;MAN2B1;RAB25;PLAU;MAGED2;BRAF;ARHGAP44;CAT;DPP7;YPEL5;TIMP1;APRT;METTL7A;HGSNAT;RAB13;TOM1;AP2A2;STX1A;GALNS;LAMTOR2;PFKL
17315,GO:1900025,0.165101106547979,0.954301149779552,3,12,negative regulation of substrate adhesion-dependent cell spreading,BP,POSTN;FBLN1;DMTN
5655,GO:0016765,0.165154390215394,0.91640127437272,8,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,GSTO1;GSTT1;GSTM2;GSTO2;RABGGTA;GSTM3;DHPS;CTH
8978,GO:0035102,0.165325197381749,0.954210002088021,3,12,PRC1 complex,CC,PHC2;CBX7;PHC1
7911,GO:0032495,0.165415376366843,0.954173304010875,3,12,response to muramyl dipeptide,BP,ARHGEF2;IRF5;NLRP1
9488,GO:0036150,0.165487984051093,0.954143748901437,3,12,phosphatidylserine acyl-chain remodeling,BP,OSBPL5;LPCAT4;OSBPL10
3028,GO:0006577,0.165514076512493,0.954133126249862,3,12,amino-acid betaine metabolic process,BP,ALDH7A1;CRAT;CPT1C
3860,GO:0008484,0.165556077872577,0.954116024991231,3,12,sulfuric ester hydrolase activity,MF,SULF2;ARSA;GALNS
11122,GO:0045185,0.16557994296363,0.898796543654484,14,89,maintenance of protein location,BP,GSN;ANK3;MXI1;MDFI;ARL2;SYNE3;LTBP1;PKD2;THRA;TWF2;PKD1;SORL1;TMSB4X;AKT1
5595,GO:0016638,0.165756079105111,0.954034561356826,3,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,LOXL1;GLDC;GLUD1
11625,GO:0046365,0.165779754186184,0.916123201934735,8,46,monosaccharide catabolic process,BP,PGM1;CRYL1;GALE;GALK1;LRP5;ALDOC;TKFC;PFKL
16479,GO:0097205,0.165903684285735,0.953974406381583,3,12,renal filtration,BP,F2R;SULF2;GAS6
11459,GO:0045936,0.165969443637055,0.86766631300782,59,439,negative regulation of phosphate metabolic process,BP,TNIP1;XDH;DUSP6;APOE;PPP1R35;PTK6;PDCD4;PRNP;FBLN1;DUSP5;ADARB1;SLC27A1;PHACTR3;PPP1R14A;WWTR1;PKN1;DDIT4;DGKQ;SPRY2;PRKCZ;STK39;SPRY4;DLG3;ELFN2;TRIB2;PPARA;IMPACT;ERRFI1;RGS14;MLXIPL;DMTN;LTB4R2;SORL1;GABBR1;LRP5;PKIB;CSRNP3;TRIB3;CDK5RAP3;PIK3R2;EPHA1;PPP1R15A;AKT1;CDKN1C;MICAL1;CRY2;TSG101;FARP1;C9ORF72;CTDSPL;TP73;LEMD2;SIRT2;EPHB2;PER1;FKBP8;SFI1;GRB10;IKBKB
1976,GO:0004697,0.16619968508194,0.95385368968245,3,12,protein kinase C activity,MF,PKN1;PRKCZ;PKN3
7998,GO:0032635,0.166199974972901,0.905510576474439,11,67,interleukin-6 production,BP,F2R;MAPK13;EREG;NLRX1;ARHGEF2;INPP5D;CEBPB;TRPV4;GAS6;PTAFR;IL17RC
10585,GO:0043576,0.166288418098143,0.953817480094366,3,12,regulation of respiratory gaseous exchange,BP,NTSR1;NLGN2;APLN
6681,GO:0030056,0.166289922758279,0.970957213875452,2,6,hemidesmosome,CC,ITGA6;ITGB4
3253,GO:0006919,0.166425352610528,0.902593173530466,12,76,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;TNFSF15;NGFR;BBC3;NLRP1;DAP;CTSH;IFT57;IFI27;PIDD1;HIP1
18935,GO:1904738,0.166489166439315,0.95373552259712,3,12,vascular associated smooth muscle cell migration,BP,DOCK4;PAK1;SSH1
18945,GO:1904752,0.166489166439315,0.95373552259712,3,12,regulation of vascular associated smooth muscle cell migration,BP,DOCK4;PAK1;SSH1
1387,GO:0003299,0.16718666365386,0.953450359115647,3,12,muscle hypertrophy in response to stress,BP,ERRFI1;ATP2B4;LMNA
4926,GO:0014887,0.16718666365386,0.953450359115647,3,12,cardiac muscle adaptation,BP,ERRFI1;ATP2B4;LMNA
4934,GO:0014898,0.16718666365386,0.953450359115647,3,12,cardiac muscle hypertrophy in response to stress,BP,ERRFI1;ATP2B4;LMNA
4664,GO:0010817,0.167277416169891,0.873571542272746,39,282,regulation of hormone levels,BP,EGR1;GLUL;EGFR;NR1D1;HADH;RAPGEF3;HSD17B14;LTBP4;CYP27B1;PCK2;DGKQ;ARL2;NLGN2;PCSK1;ITPR3;ERO1B;SLCO4A1;ACVR2B;DHRS4;PLA2G6;ANO1;PCLO;SRD5A3;HSD11B1;LRP5;TRPV4;HSD17B7;APLN;GLUD1;CYP2R1;ITPR2;ICA1;PNPLA4;PLB1;HFE;RETSAT;STX1A;FGFR1;PFKL
17475,GO:1900543,0.16744383898401,0.932452893708861,5,25,negative regulation of purine nucleotide metabolic process,BP,DDIT4;PPARA;MLXIPL;LTB4R2;GABBR1
2757,GO:0006171,0.167814146939974,0.932253748145577,5,25,cAMP biosynthetic process,BP,TIMP2;PTHLH;LTB4R2;GABBR1;ADCY6
816,GO:0002090,0.167841386940366,0.932239092297539,5,25,regulation of receptor internalization,BP,DLG4;VEGFA;FLOT1;PCSK9;APLN
16201,GO:0090277,0.1678633037049,0.910817425495541,9,53,positive regulation of peptide hormone secretion,BP,GLUL;EGFR;PCK2;NLGN2;PLA2G6;ANO1;APLN;GLUD1;HFE
742,GO:0001974,0.167968152289195,0.932170877220244,5,25,blood vessel remodeling,BP,CST3;ACVR2B;NOS3;BCR;EPAS1
15111,GO:0071229,0.167993393742245,0.887506472938601,20,134,cellular response to acid chemical,BP,NFATC4;EGR1;PTK6;VEGFA;EGFR;COL6A1;NEURL1;SESN2;PKD2;TWF2;CEBPB;DNMT3A;PTAFR;ADCY6;AKT1;CAPN2;WNT3;FYN;LAMTOR2;TEAD2
8220,GO:0032994,0.168205337663045,0.940761948805101,4,19,protein-lipid complex,CC,APOE;SORL1;PLTP;VLDLR
6857,GO:0030335,0.168463160644762,0.870796851779749,43,313,positive regulation of cell migration,BP,DOCK4;F2R;PGF;POSTN;SEMA4B;VEGFA;EGFR;HBEGF;HYAL1;ITGA6;FAM110C;SPRY2;GRB7;VEGFB;PAK1;CEMIP;SEMA3F;ZP3;MAPK3;SEMA5A;ARHGEF2;DMTN;SEMA3B;SSH1;TGFBR2;TRPV4;TMSB4X;SMURF2;NOS3;WNT7A;EPHA1;SEMA4G;GAS6;PTAFR;CTSH;AKT1;LAMB1;RAB25;PLAU;INSR;FOXO4;ITGA2;FGFR1
6858,GO:0030336,0.168510346423055,0.882708062375292,24,165,negative regulation of cell migration,BP,APOE;ZMYND8;LRP1;ALOX15B;IDH2;ARAP3;MMP28;ADARB1;NISCH;ARPIN;MCTP1;PLXNB3;C5;IFITM1;SRGAP3;HDAC5;PTPRU;EPHA1;BCR;MAP2K5;BRAF;TIMP1;ADA;CORO1B
15305,GO:0071548,0.16864047200634,0.924737544728359,6,32,response to dexamethasone,BP,EGFR;PCK2;DDIT4;ERRFI1;PTAFR;EIF4EBP1
7193,GO:0031091,0.168694452043632,0.91027383507924,9,53,platelet alpha granule,CC,SERPINE2;VEGFA;CD9;VEGFB;SERPING1;TMSB4X;GAS6;MAGED2;TIMP1
15659,GO:0072210,0.168720617349863,0.931765555963801,5,25,metanephric nephron development,BP,EGR1;PKD2;LAMB2;KIF26B;PKD1
9281,GO:0035735,0.168808780921438,0.918937300473657,7,39,intraciliary transport involved in cilium assembly,BP,IFT140;WDR60;KIF17;IFT27;CEP131;WDR19;IFT57
8631,GO:0034185,0.168851002746273,0.95276738612693,3,12,apolipoprotein binding,MF,LRP1;VLDLR;PCSK9
3597,GO:0008028,0.168896468184001,0.93167073287867,5,25,monocarboxylic acid transmembrane transporter activity,MF,SLC16A3;SLC27A1;SLC16A5;SLC10A6;BSG
12288,GO:0048660,0.168969142171914,0.898495551129942,13,82,regulation of smooth muscle cell proliferation,BP,CTNNBIP1;PDCD4;EGFR;MEF2D;HBEGF;PAK1;EREG;TGFBR2;APLN;ERN1;PTAFR;AKT1;ITGA2
2326,GO:0005342,0.169120107325523,0.896244465410714,14,89,organic acid transmembrane transporter activity,MF,SLC7A8;SLC16A3;SLC27A1;SLC16A5;SLC43A1;TMEM44;PQLC2;SLC38A10;SLC6A9;SLC6A6;SLC25A29;SLC38A2;SLC10A6;BSG
11890,GO:0046943,0.169120107325523,0.896244465410714,14,89,carboxylic acid transmembrane transporter activity,MF,SLC7A8;SLC16A3;SLC27A1;SLC16A5;SLC43A1;TMEM44;PQLC2;SLC38A10;SLC6A9;SLC6A6;SLC25A29;SLC38A2;SLC10A6;BSG
6722,GO:0030141,0.169185383214033,0.862114541409811,71,541,secretory granule,CC,SERPINE2;GSN;PYGB;SLC2A3;NAPRT;TIMP2;VEGFA;LOXL1;CD9;CST3;PGM1;SYT8;GAA;PYGL;PLAT;PRSS3;SYNGR1;DNASE1L1;TMEM173;VEGFB;RAB3B;CD68;PCSK1;ITPR3;LY6K;SERPING1;BRI3;ACTR1B;TMC6;VAMP2;ECM1;KCNAB2;RHOF;CTSB;LTA4H;FUCA1;ALDOC;CEP131;ITGA1;TMSB4X;RAB40B;HEXB;GAS6;HEXA;NBEAL2;PTAFR;CTSH;ITPR2;TCIRG1;ARSA;MAN2B1;ICA1;PLAU;MAGED2;CAT;DPP7;YPEL5;TIMP1;APRT;METTL7A;HGSNAT;RAB13;TOM1;AP2A2;RNPEP;STX1A;GALNS;LAMTOR2;PFKL;BSG;TCTEX1D4
12900,GO:0051279,0.169434833748721,0.91381052046035,8,46,regulation of release of sequestered calcium ion into cytosol,BP,F2R;NTSR1;NOS1;CEMIP;GSTO1;PKD2;GSTM2;TRPC1
4521,GO:0010591,0.169571330589245,0.931306480460182,5,25,regulation of lamellipodium assembly,BP,PLXNB3;SSH3;TWF2;DMTN;SSH1
9860,GO:0042136,0.169791546269663,0.909555200717756,9,53,neurotransmitter biosynthetic process,BP,ACP5;NOS1;PKD2;NOS3;TRPV1;ATP2B4;AKT1;ASS1;INSR
6769,GO:0030212,0.169866393497868,0.931147047892048,5,25,hyaluronan metabolic process,BP,HYAL1;CEMIP;HEXB;HEXA;AKT1
2730,GO:0006112,0.169913939761886,0.905999620443523,10,60,energy reserve metabolic process,BP,PYGB;NR1D1;PGM1;GAA;PYGL;PPP1R3E;STK40;AKT1;INSR;PHLDA2
4508,GO:0010563,0.170583112169331,0.863680861467458,59,440,negative regulation of phosphorus metabolic process,BP,TNIP1;XDH;DUSP6;APOE;PPP1R35;PTK6;PDCD4;PRNP;FBLN1;DUSP5;ADARB1;SLC27A1;PHACTR3;PPP1R14A;WWTR1;PKN1;DDIT4;DGKQ;SPRY2;PRKCZ;STK39;SPRY4;DLG3;ELFN2;TRIB2;PPARA;IMPACT;ERRFI1;RGS14;MLXIPL;DMTN;LTB4R2;SORL1;GABBR1;LRP5;PKIB;CSRNP3;TRIB3;CDK5RAP3;PIK3R2;EPHA1;PPP1R15A;AKT1;CDKN1C;MICAL1;CRY2;TSG101;FARP1;C9ORF72;CTDSPL;TP73;LEMD2;SIRT2;EPHB2;PER1;FKBP8;SFI1;GRB10;IKBKB
19772,GO:2000243,0.170685040791811,0.923552445145521,6,32,positive regulation of reproductive process,BP,ZP3;SMURF2;PTAFR;INSR;PLB1;SIRT2
11022,GO:0045017,0.170766603159285,0.875949857063839,30,211,glycerolipid biosynthetic process,BP,DGKA;SLC27A1;PITPNM3;ACP6;PCK2;LPCAT4;PITPNM1;DGKQ;FGFR3;ZP3;PNPLA3;PLA2G6;MTMR4;PI4K2A;INPP5D;PEMT;PIGZ;PIK3R2;CHKB;FGFR4;PIGQ;TAZ;ETNK2;STARD10;INPP4A;FGFR1;PIGV;FITM2;MPPE1;PLEKHA4
6193,GO:0019674,0.170898474262283,0.912880359390764,8,46,NAD metabolic process,BP,NT5E;NAPRT;PCK2;NMRK1;NMNAT2;NADK;ALDOC;PFKL
3414,GO:0007200,0.171258933617361,0.923218919269821,6,32,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,F2R;LPAR3;ANO1;LTB4R2;LTB4R;CHRM3
3130,GO:0006721,0.171363325396024,0.908523438663893,9,53,terpenoid metabolic process,BP,APOE;LRP1;EGFR;DHRS4;SDC2;PNPLA4;PLB1;RETSAT;CYP4V2
17044,GO:0099568,0.171661614150523,0.86690291094291,46,336,cytoplasmic region,CC,DLG4;GSN;WIPF1;IFT140;RAPGEF3;SPTB;GPSM1;EXOC2;BBS1;FAM110C;DNAH1;BLOC1S4;PRKCZ;SHROOM4;RHOBTB2;KIF17;PKD2;SEPT5;PCLO;MYZAP;RHOF;SEPT10;SAMD3;DMTN;FLOT1;TRIOBP;TRPV4;SPAG16;RIMS3;SPATA7;ITPR2;IFT57;SEPT6;WDR66;CAPN2;KRT19;ADD3;HFE;SPIRE1;ADA;RHOBTB3;SEPT8;BLOC1S1;HIP1;PLEKHH2;TCTEX1D4
4104,GO:0009163,0.172247745483288,0.916684742514279,7,40,nucleoside biosynthetic process,BP,NT5E;TK2;NME4;UCKL1;UPP1;APRT;ADA
4967,GO:0015081,0.172836655962776,0.900946737581232,11,67,sodium ion transmembrane transporter activity,MF,SCN8A;SCN4B;PKD2;SLC6A9;SLC6A6;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC10A6;SLC9A5
628,GO:0001818,0.172980644886155,0.880160205847131,23,159,negative regulation of cytokine production,BP,PTPRS;IL20RB;ACP5;RNF135;PDCD4;PRNP;MC1R;TRIB2;NLRX1;ERRFI1;INPP5D;PDCD1LG2;ZFPM1;TMSB4X;GAS6;MAPKBP1;RPS6KA5;MAP2K5;HFE;JAK3;BCL6;CIDEA;FGFR1
18646,GO:1904019,0.173078206993248,0.903864695738547,10,60,epithelial cell apoptotic process,BP,GSN;PDCD4;ZFP36L1;SEMA5A;ANGPTL4;DNMT3A;TGFBR2;GAS6;BRAF;WFS1
13597,GO:0060113,0.173228972839579,0.922071082775084,6,32,inner ear receptor cell differentiation,BP,NAGLU;IFT27;VANGL2;SLITRK6;TRIOBP;FGFR1
14528,GO:0070076,0.173613262796365,0.929113288784308,5,25,histone lysine demethylation,BP,KDM3A;KDM4C;KDM7A;PHF2;HSF4
6916,GO:0030516,0.173716527100117,0.900338445739569,11,67,regulation of axon extension,BP,PTPRS;APOE;SEMA4B;VEGFA;PAK1;SEMA3F;SEMA5A;TWF2;SEMA3B;SEMA4G;WNT3
1838,GO:0004497,0.17374869121672,0.915913769666644,7,39,monooxygenase activity,MF,NOS1;CYP3A5;CYP27B1;NOS3;CYP2R1;MICAL1;CYP4V2
19715,GO:2000117,0.173754839757712,0.897448004520722,12,76,negative regulation of cysteine-type endopeptidase activity,BP,TNFRSF6B;VEGFA;PRDX5;CST3;RAG1;NGFR;IFI6;HERPUD1;GAS6;AKT1;MICAL1;MAP2K5
4202,GO:0009314,0.174074026268088,0.864842731272801,46,338,response to radiation,BP,NFATC4;XPC;FOS;EGR1;EGFR;DDB2;ERCC1;BRSK1;CRTC1;ERCC6;MAPK13;HYAL1;MC1R;SYNGAP1;PITPNM1;NPHP4;CIRBP;RAG1;IMPACT;HMGA2;SCARA3;RGS14;ATF4;PRIMPOL;REEP6;DEAF1;LRP5;DNMT3A;BHLHE40;CYP2R1;MGMT;ASNS;AKT1;CRY2;B4GALT2;CHEK2;BRAF;CAT;MAPK10;TP73;MTA1;ADIRF;PER1;EIF2AK4;UNC119;NET1
15573,GO:0072080,0.174310171153026,0.903030771492757,10,60,nephron tubule development,BP,CTNNBIP1;PGF;VEGFA;WWTR1;LAMA5;WNT2B;PKD2;KIF26B;PKD1;WNK4
10120,GO:0042698,0.174479843248871,0.915463940176895,7,39,ovulation cycle,BP,EGR1;EGFR;ZP3;EREG;SLIT3;NOS3;MMP19
11000,GO:0044853,0.174515187852318,0.902891846999951,10,60,plasma membrane raft,CC,F2R;NOS1;MAPK3;FLOT1;KCNMA1;TGFBR2;NOS3;ATP2B4;INSR;MYOF
4757,GO:0010941,0.174883118036327,0.848067253259024,150,1184,regulation of cell death,BP,XDH;DUSP6;F2R;TNFRSF6B;APOE;HS1BP3;NFATC4;FOS;PRODH;GSN;EGR1;LRP1;PDCD4;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;PRDX5;TNFSF15;CST3;DDIT3;NDRG1;ARHGEF19;GRAMD4;MST1R;ZFP36L1;NUPR1;RGL2;RPS6KA2;TFDP2;MAP2K1;DDIT4;BTG1;SYNGAP1;ITGA6;PLEKHG5;SHC1;SPRY2;PRKCZ;PAK1;AARS;STK39;FGFR3;NME4;NEURL1;RAG1;NGFR;ARHGEF4;PLEKHG2;TNFRSF25;PLA2G6;PPARA;IMPACT;ING4;HMGA2;BNIP3;SEMA5A;THRA;STK40;CTSB;ARHGEF2;INPP5D;MAP2K2;ANGPTL4;ATF4;BBC3;PAK6;SSH1;IFI6;MDK;KCNMA1;UNC5B;IRF5;SORL1;HERPUD1;NLRP1;ENDOG;CEBPB;MAP3K12;LRP5;PCSK9;DNMT3A;CSRNP3;ITGA1;TNFAIP8L1;DAP;NOS3;AGO4;MINK1;WNT7A;TRPV1;BNIP3L;EPHA1;GAS6;STRADB;CTSH;TNFRSF14;MGMT;ASNS;AKT1;CARD11;MICAL1;BEX2;AMIGO2;CHEK2;IFT57;FGFR4;STEAP3;LMNA;MARK4;IFI27;INSR;NCOA7;RABGGTA;MAP2K5;BRAF;PIDD1;CAT;LGALS1;TIMP1;JAK3;TP73;MNT;BCL6;FYN;ARHGEF17;SIRT2;GDF15;ADA;CIDEA;MYO18A;CIDEB;TCF7;VAV3;MAP3K10;EPHB2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;NET1;TRIM2;IKBKB;SNCB;HIP1;TEAD2
14769,GO:0070509,0.174976764888023,0.921048962761757,6,32,calcium ion import,BP,PRNP;PKD2;TRPV4;TRPV1;ATP2B4;FYN
4067,GO:0009124,0.175236857957593,0.881876532346922,20,136,nucleoside monophosphate biosynthetic process,BP,PGM1;DHTKD1;TK2;LHPP;DDIT4;OGDHL;PPARA;MLXIPL;GALK1;ALDOC;TMSB4X;UCKL1;DGUOK;TCIRG1;UPP1;INSR;APRT;TAZ;ADA;PFKL
5832,GO:0017124,0.175329138219266,0.889695023211902,15,97,SH3 domain binding,MF,DOCK4;ESPN;WIPF1;ADAM19;SHANK2;EFS;SYNGAP1;ELMO3;ERRFI1;SH2D2A;INPP5D;DNAJC6;MICAL1;CABYR;ARHGAP27
8102,GO:0032799,0.175358707797898,0.93724026459816,4,19,low-density lipoprotein receptor particle metabolic process,BP,APOE;VLDLR;PCSK9;AP2A2
3624,GO:0008083,0.175397717690051,0.899026480603887,11,69,growth factor activity,MF,PGF;VEGFA;HBEGF;VEGFB;EREG;MANF;AREG;MDK;NUDT6;TIMP1;GDF15
13485,GO:0055081,0.175417870968742,0.920790441808806,6,32,anion homeostasis,BP,APOE;SLC12A7;ABCG1;PQLC2;MLXIPL;FGFR4
8133,GO:0032869,0.175426147980995,0.878258114954378,23,158,cellular response to insulin stimulus,BP,ZFP36L1;PCK2;SHC1;PRKCZ;PAK1;NGFR;PTPRE;VAMP2;ERRFI1;HDAC5;SRSF5;PCSK9;TRIB3;PIK3R2;AKT1;TCIRG1;INSR;FOXO4;GPR21;APRT;RAB13;EIF4EBP1;GRB10
5459,GO:0016358,0.175730807224526,0.877005658521983,24,165,dendrite development,BP,PTPRS;DLG4;APOE;ZMYND8;NFATC4;SHANK2;CRTC1;OBSL1;CUL7;SYNGAP1;CAPRIN2;FBXW8;NEURL1;KLF7;SDC2;MAP6;VLDLR;MINK1;WNT7A;CAMK1;FARP1;ARHGAP44;FYN;EPHB2
3576,GO:0007623,0.176021160019437,0.881298636748586,20,135,circadian rhythm,BP,EGFR;NR1D1;CST3;CRTC1;HEBP1;KLF9;NAGLU;HTR7;NGFR;PPARA;ATF4;BHLHE40;CRY2;ASS1;MAPK10;CSNK1E;ADA;MTA1;PER1;DBP
10182,GO:0042803,0.1765069391239,0.856117099071044,69,525,protein homodimerization activity,MF,XDH;APOE;S100A6;PGF;VEGFA;NTSR1;MEF2D;DDIT3;DNPH1;PYGL;SLC27A1;RAB11FIP4;LHPP;HMGCL;WWTR1;CRYL1;TMEM173;SNX9;VEGFB;TPM2;GALE;GLDC;CBS;RAG1;SPPL2B;PSPH;ABCG1;S100A13;CARS;PKD2;BNIP3;MVD;TENM2;HLCS;GSTM2;CEBPB;MAP3K12;ACOT7;CEP131;PDE2A;BHLHE40;HEXB;BNIP3L;OLFML2A;ERN1;SRR;ASNS;AKT1;CHEK2;SBF2;TSG101;TENM4;CHMP4C;HOMER2;CAT;LGALS1;PEX7;SLC9A7;GSTM3;SNX1;CADM4;NAGA;CIDEA;MAP3K10;FGFR1;HLA-G;PEX11A;IKBKB;HIP1
6289,GO:0019904,0.176537248338822,0.855077791402509,74,563,protein domain specific binding,MF,DLG4;DOCK4;ESPN;CTNNBIP1;WIPF1;ADAM19;ERCC1;RAPGEF3;DDIT3;SHANK2;EFS;TFDP2;CAPG;SYNGAP1;VPS11;PRKCZ;PLXNB3;ELMO3;DLG3;CEP250;ARHGEF4;PPARA;AIP;PKD2;HMGA2;ERRFI1;THRA;SH2D2A;SNTA1;ZXDC;SDC2;CHMP1B;INPP5D;MAP2K2;STMN3;LITAF;ATF4;PKD1;CEP68;NLRP1;NDE1;L3MBTL1;EPN3;TRPV4;PDE2A;DAP;BHLHE40;CALCOCO1;ANGEL1;DNAJC6;SRR;TADA3;RXRA;ATP2B4;CARD11;MICAL1;CABYR;ICA1;ARHGAP27;INSR;WNT3;HOMER2;SCNN1A;FYN;POU2F2;PLXND1;AP2A2;TGFBR3;STX1A;FKBP8;PAG1;WBP1;KCTD13;TEAD2
8186,GO:0032941,0.176818337400031,0.936513782143336,4,19,secretion by tissue,BP,STK39;WNK4;CHRM3;ADA
14114,GO:0061008,0.176898239784894,0.886662779277437,16,105,hepaticobiliary system development,BP,EGFR;HMGCL;PCK2;PKD2;PKD1;SRSF5;SULF2;CEBPB;PCSK9;ASNS;PHF2;HFE;ADA;TGFBR3;ITGA2;DBP
12506,GO:0050671,0.177134166996999,0.89781958515819,11,69,positive regulation of lymphocyte proliferation,BP,ZP3;CCDC88B;PDCD1LG2;TGFBR2;CARD11;IGFBP2;JAK3;BCL6;ADA;VAV3;DHPS
9840,GO:0042102,0.177244513078986,0.908695869685525,8,47,positive regulation of T cell proliferation,BP,ZP3;CCDC88B;PDCD1LG2;TGFBR2;CARD11;IGFBP2;JAK3;DHPS
1181,GO:0002828,0.177540407105929,0.936153412178715,4,19,regulation of type 2 immune response,BP,PRKCZ;STAT6;ECM1;BCL6
11321,GO:0045665,0.17759241868846,0.878817020075236,21,143,negative regulation of neuron differentiation,BP,PTPRS;APOE;NFATC4;SEMA4B;LRP1;EFNB3;ULK2;SYNGAP1;SEMA3F;NGFR;SEMA5A;SEMA3B;TRPV4;SEMA4G;ADCY6;DGUOK;WNT3;LGALS1;TP73;EPHB2;EIF2AK4
14581,GO:0070167,0.177661718817923,0.913499424924329,7,39,regulation of biomineral tissue development,BP,CYP27B1;ACVR2B;ECM1;FAM20C;ATRAID;GAS6;NBR1
10547,GO:0043523,0.177825011540865,0.879874534015813,20,136,regulation of neuron apoptotic process,BP,F2R;APOE;LRP1;PRNP;DDIT3;SYNGAP1;AARS;ATF4;MDK;UNC5B;CEBPB;MAP3K12;PCSK9;ITGA1;BRAF;TP73;FYN;WFS1;TRIM2;SNCB
1908,GO:0004601,0.178253025319144,0.926034308147651,5,27,peroxidase activity,MF,GPX3;PRDX5;GSTT1;GSTM2;CAT
13942,GO:0060675,0.17825783019745,0.913130133905903,7,39,ureteric bud morphogenesis,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B
15628,GO:0072171,0.17825783019745,0.913130133905903,7,39,mesonephric tubule morphogenesis,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B
13248,GO:0051961,0.1783242640321,0.872152313109841,27,189,negative regulation of nervous system development,BP,PTPRS;APOE;NFATC4;SEMA4B;LRP1;IDH2;EFNB3;ULK2;SYNGAP1;SEMA3F;NGFR;SEMA5A;ARHGEF2;SEMA3B;SORL1;TRPV4;WNT7A;SEMA4G;ADCY6;DGUOK;WNT3;LGALS1;TP73;SIRT2;EPHB2;EIF2AK4;KCTD11
12217,GO:0048511,0.178371525881165,0.872114219171621,27,189,rhythmic process,BP,EGR1;EGFR;NR1D1;CST3;CRTC1;HEBP1;KLF9;NAGLU;HTR7;ZP3;NGFR;EREG;TEF;PPARA;SLIT3;ATF4;BHLHE40;NOS3;CRY2;ASS1;MAPK10;CSNK1E;ADA;MTA1;PER1;MMP19;DBP
3462,GO:0007283,0.17893327780324,0.864330920388814,38,276,spermatogenesis,BP,GAMT;BBS2;ERCC1;CRTAP;MICALCL;GGT1;TCFL5;TXNRD3;BTG1;PHC2;DNAH1;MYCBPAP;KDM3A;NEURL1;ETV5;SPATA20;FAM50A;SCMH1;CCNI;TDRKH;AZIN2;RFX2;CEP131;DNMT3A;HERPUD2;SPAG16;ATP2B4;SEPT6;CABYR;TBC1D20;BCL6;REC8;RPL39L;PAIP2;SPATA6;CREB3L4;ZNF449;SIX5
12879,GO:0051249,0.179027264396145,0.8665081781682,34,245,regulation of lymphocyte activation,BP,IL20RB;GSN;PRNP;ZFP36L1;EFNB3;SOX13;PKN1;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;STAT6;INPP5D;PDCD1LG2;CEBPB;TGFBR2;GAS6;TNFRSF14;AKT1;CARD11;IGFBP2;BRAF;LGALS1;HFE;JAK3;BCL6;FYN;ADA;VAV3;DHPS;ERBB2;PAG1;HLA-G
8756,GO:0034446,0.179057585249815,0.896553387991645,11,68,substrate adhesion-dependent cell spreading,BP,POSTN;FBLN1;PARVB;LAMA5;MICALL2;DMTN;TRIOBP;EPHA1;LAMB1;BRAF;NET1
7035,GO:0030817,0.179871945267437,0.934985355463299,4,19,regulation of cAMP biosynthetic process,BP,TIMP2;PTHLH;LTB4R2;GABBR1
12287,GO:0048659,0.180116958956182,0.890442231395367,13,83,smooth muscle cell proliferation,BP,CTNNBIP1;PDCD4;EGFR;MEF2D;HBEGF;PAK1;EREG;TGFBR2;APLN;ERN1;PTAFR;AKT1;ITGA2
12637,GO:0050865,0.180465619650967,0.861093099875419,42,308,regulation of cell activation,BP,APOE;SERPINE2;IL20RB;GSN;PRNP;CD9;ZFP36L1;EFNB3;SOX13;PKN1;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;STAT6;INPP5D;PDCD1LG2;DMTN;CEBPB;TGFBR2;NOS3;GAS6;BCR;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;BRAF;LGALS1;HFE;JAK3;BCL6;FYN;ADA;MYO18A;VAV3;DHPS;ERBB2;PAG1;HLA-G
334,GO:0000930,0.181010376808743,0.93441256763148,4,19,gamma-tubulin complex,CC,TUBG2;MZT2B;MZT2A;TUBGCP6
1201,GO:0002861,0.181083259715052,0.965013812068041,2,7,regulation of inflammatory response to antigenic stimulus,BP,IL20RB;ZP3
10057,GO:0042572,0.181154879854739,0.93433974770176,4,19,retinol metabolic process,BP,DHRS4;PNPLA4;PLB1;RETSAT
10370,GO:0043217,0.1811813148719,0.947597303244559,3,12,myelin maintenance,BP,NDRG1;SH3TC2;AKT1
15851,GO:0072604,0.181522479357217,0.934154385313727,4,19,interleukin-6 secretion,BP,F2R;TRPV4;GAS6;IL17RC
3117,GO:0006699,0.181626429115029,0.934101938181759,4,19,bile acid biosynthetic process,BP,NR1D1;FGFR4;OSBPL1A;ACOT8
12591,GO:0050796,0.181660426857185,0.883054149038181,16,106,regulation of insulin secretion,BP,GLUL;NR1D1;HADH;RAPGEF3;PCK2;ARL2;NLGN2;ITPR3;PLA2G6;ANO1;LRP5;GLUD1;ITPR2;ICA1;STX1A;PFKL
8046,GO:0032720,0.182061804460575,0.924178526636053,5,26,negative regulation of tumor necrosis factor production,BP,ACP5;MC1R;ERRFI1;GAS6;CIDEA
1100,GO:0002689,0.182092867028634,0.964694010885349,2,7,negative regulation of leukocyte chemotaxis,BP,MMP28;C5
5625,GO:0016709,0.182125594726854,0.93384990118296,4,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,NOS1;CYP27B1;NOS3;MICAL1
10474,GO:0043392,0.182229668029368,0.910499858779119,7,40,negative regulation of DNA binding,BP,CTNNBIP1;DDIT3;MDFI;PPARA;HMGA2;TMSB4X;ZFP90
1176,GO:0002823,0.182529202495421,0.933645887393418,4,19,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL20RB;HFE;JAK3;BCL6
3590,GO:0008017,0.182849562618926,0.866089498472197,30,212,microtubule binding,MF,CLIP2;PRNP;DNM1;NDRG1;MYH15;EML2;MYH11;TTBK2;CCDC88B;KIF17;RGS14;HOOK2;MYH3;ARHGEF2;KIF21B;KIF26B;MAP6;NDE1;TRPV4;MAP1LC3A;MAPRE3;KIF13B;REEP4;KIF27;MARK4;TUBGCP6;EML3;GOLGA2;MYO18A;CCDC69
2659,GO:0006006,0.182961139935824,0.875886386864348,20,136,glucose metabolic process,BP,H6PD;NR1D1;IGFBP4;PGM1;GAA;NISCH;MLYCD;PCK2;DGKQ;PPARA;ACACB;PC;ATF4;LRP5;ALDOC;AKT1;INSR;SLC37A4;PHLDA2;PFKL
11786,GO:0046688,0.183004711608963,0.933008849386818,4,20,response to copper ion,BP,PRNP;S100A13;MAP1LC3A;ATP7B
8463,GO:0033619,0.183040529312844,0.900671409031476,9,54,membrane protein proteolysis,BP,APOE;ADAM19;TIMP2;SNX9;SPPL2B;NGFR;CTSH;TIMP1;SNX33
3705,GO:0008216,0.183190790046865,0.964344824581841,2,7,spermidine metabolic process,BP,SAT2;DHPS
8702,GO:0034361,0.183528028171344,0.964237273565592,2,7,very-low-density lipoprotein particle,CC,APOE;VLDLR
8724,GO:0034385,0.183528028171344,0.964237273565592,2,7,triglyceride-rich plasma lipoprotein particle,CC,APOE;VLDLR
4849,GO:0014066,0.18367912406169,0.896548686180167,10,61,regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;SERPINE2;EGFR;RGL2;PLXNB1;MAPK3;UNC5B;CAT;FYN;FGFR1
19915,GO:2000482,0.183920995290666,0.945697465217578,3,13,regulation of interleukin-8 secretion,BP,F2R;TMSB4X;MAPKBP1
6287,GO:0019902,0.1840825548897,0.873741039102463,21,143,phosphatase binding,MF,DLG4;PPP1R35;EGFR;PHACTR3;DLG3;MTMR4;PPARA;STAT6;MAPK3;ITGA1;PIK3R2;PPP1R15A;ATP2B4;SLC9A3R2;AKT1;CRY2;SBF2;JAK3;ERBB2;SFI1;TCTEX1D4
15536,GO:0072009,0.184142264505707,0.892995410568539,11,68,nephron epithelium development,BP,CTNNBIP1;PGF;VEGFA;WWTR1;LAMA5;WNT2B;PKD2;LAMB2;KIF26B;PKD1;WNK4
684,GO:0001895,0.184189299281847,0.915393481695671,6,33,retina homeostasis,BP,BBS2;ERCC6;BBS1;NPHP4;CROCC;SPATA7
9775,GO:0040008,0.184307119809158,0.851756573871015,59,444,regulation of growth,BP,DUSP6;PTPRS;HTRA1;GAMT;BBS2;APOE;SERPINE2;FHL1;PTK6;WWC3;SEMA4B;ALOX15B;VEGFA;EGFR;IGFBP4;DNPH1;HBEGF;LTBP4;ULK2;HYAL1;CYP27B1;BTG1;SHC1;CAPRIN2;PAK1;FGFR3;SEMA3F;ZP3;LPAR3;SESN2;ING4;HMGA2;SLIT3;ACACB;SEMA5A;TSPYL2;TWF2;SEMA3B;TGFBR2;SEMA4G;GAS6;AKT1;IGFBP7;IGFBP2;TSG101;INSR;WNT3;MAP2K5;GPR21;TP73;BCL6;PHLDA2;TGFBR3;LAMTOR2;FGFR1;WFS1;ERBB2;NET1;KCTD11
5548,GO:0016559,0.184309506859058,0.963987514032389,2,7,peroxisome fission,BP,PEX11A;ACOT8
1115,GO:0002704,0.184323121112319,0.922915995005169,5,26,negative regulation of leukocyte mediated immunity,BP,IL20RB;BCR;HFE;JAK3;BCL6
4998,GO:0015144,0.184362864027779,0.932716480884512,4,19,carbohydrate transmembrane transporter activity,MF,SLC2A3;SLC2A9;SLC50A1;AQP3
8837,GO:0034644,0.184411205440688,0.892730407315757,11,69,cellular response to UV,BP,NFATC4;XPC;DDB2;ERCC1;MAPK13;HYAL1;MC1R;IMPACT;ATF4;TP73;EIF2AK4
12566,GO:0050766,0.184501934111833,0.922815901714338,5,26,positive regulation of phagocytosis,BP,ABCA7;GAS6;BCR;MYO18A;ITGA2
7185,GO:0031083,0.184502526792002,0.945443829492049,3,13,BLOC-1 complex,CC,BLOC1S4;PI4K2A;BLOC1S1
7329,GO:0031348,0.184512115222151,0.87914062322369,17,114,negative regulation of defense response,BP,HTRA1;NT5E;APOE;IL20RB;ACP5;PDCD4;SERPING1;FAM3A;PPARA;FNDC4;NLRX1;SHARPIN;BCR;MAPKBP1;TKFC;SIRT2;ADA
19804,GO:2000300,0.184722948609995,0.932533481399261,4,19,regulation of synaptic vesicle exocytosis,BP,SEPT5;RIMS3;BRAF;STX1A
3356,GO:0007095,0.184936923174458,0.932424661114338,4,19,mitotic G2 DNA damage checkpoint,BP,BRSK1;HMGA2;CDK5RAP3;FOXO4
8460,GO:0033613,0.185142422091497,0.899261286469767,9,54,activating transcription factor binding,MF,FOS;MEF2D;RBL2;DGKQ;ZFPM1;ZNF516;BHLHE40;IFI27;WFS1
8749,GO:0034433,0.185191067569617,0.963704875506531,2,7,steroid esterification,BP,APOE;ABCG1
8750,GO:0034434,0.185191067569617,0.963704875506531,2,7,sterol esterification,BP,APOE;ABCG1
8751,GO:0034435,0.185191067569617,0.963704875506531,2,7,cholesterol esterification,BP,APOE;ABCG1
10300,GO:0043101,0.185422835259034,0.945041559684935,3,13,purine-containing compound salvage,BP,DGUOK;APRT;ADA
4345,GO:0009914,0.185444463577696,0.868218788939833,25,175,hormone transport,BP,GLUL;EGFR;NR1D1;HADH;RAPGEF3;LTBP4;PCK2;ARL2;NLGN2;ITPR3;SLCO4A1;ACVR2B;PLA2G6;ANO1;PCLO;LRP5;TRPV4;APLN;GLUD1;ITPR2;ICA1;HFE;STX1A;FGFR1;PFKL
6734,GO:0030159,0.185456865371856,0.932160000799441,4,19,receptor signaling complex scaffold activity,MF,SHANK2;GRIP2;RGS14;HOMER2
10337,GO:0043167,0.185629981295027,0.829590486587092,535,4370,ion binding,MF,XDH;PTPRS;ACTA2;ZC3H6;NT5E;APOE;SYTL1;ZMYND8;HS1BP3;SERPINE2;FHL1;S100A6;PRODH;OSBPL5;GSN;ACSF2;PYGB;EGR1;THBS3;PGF;FGFBP1;POSTN;ADAM19;ZNF862;PTK6;TMEM129;ACP5;EDEM1;RNF135;GLUL;LRP1;ALOX15B;NAGS;TIMP2;VEGFA;OBSCN;EGFR;PADI3;ZSCAN18;RBCK1;D2HGDH;PRNP;SCN8A;NR1D1;FBLN1;ADAMTS7;HADH;S100A4;NEK9;RAPGEF3;ZKSCAN1;ACBD4;NPEPL1;LOXL1;DGKA;RNPEPL1;NINL;IDH2;FKBP9;DNM1;NOS1;HAGHL;ARAP3;BRSK1;ACAD10;PGM1;CGREF1;CLCA2;ERCC6;ADAMTS13;TCEA2;MMP28;ZCCHC24;COL13A1;MYH15;SMARCA1;MST1R;TRIM65;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;ARAP1;B3GAT3;HBEGF;RPS6KA2;PYGL;MMP1;CYP3A5;DHTKD1;PHYHD1;MSRB2;TK2;LTBP4;ULK2;MAPK13;KLF9;RNF165;RAB11FIP4;CDK18;NISCH;ASAP2;ASH2L;PITPNM3;LHPP;PRSS3;HMGCL;SMOC2;TXNRD3;SMOC1;MAP2K1;CYP27B1;PCK2;CRYL1;ABCA2;PKN1;ALPK1;OPLAH;PLCH2;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;TUBG2;TMEM173;SNX9;THAP8;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;GRB7;VEGFB;OGDHL;RAB3B;MYH11;CYBRD1;ITPR3;PITPNC1;UNK;NMRK1;CAPRIN2;TTBK2;PRKCZ;PPP2R3B;HTR7;PAK1;ABCA7;APOBEC3C;AARS;PHYH;MCTP1;STK39;FGFR3;SEC14L2;CEMIP;KDM3A;MTHFR;PHF1;GLDC;NPR2;CAPNS2;CBS;USP20;SALL2;ZSWIM4;NMNAT2;DDX59;MICALL2;NME4;NEIL1;NEURL1;ACVR2B;RAG1;SPEG;MARCH4;NID1;LTBP1;ACTR1B;CHD2;GPT2;PNPLA3;RNF44;CYHR1;PLCD3;PSPH;RHOBTB2;UNKL;ABCG1;ESYT2;LPAR3;S100A13;AGAP1;CARS;FKBP10;MTMR4;KIF17;APOBEC3F;PPARA;CHD3;SNX29;SESN2;MKNK2;RASA4;IFT27;NLRX1;PKD2;KLF7;ING4;VAMP2;SLIT3;SEPT5;B4GAT1;MARCH9;PCLO;JADE2;ACACB;NT5C1B;MAPK3;PC;OSBPL10;SEMA5A;THRA;PEX10;STK40;ACSS2;GSDMA;MVD;IRF2BPL;FAM20C;DYSF;RHOF;PLEK2;LTBP2;FAHD2B;TUBE1;PAN2;ZSCAN30;MAPK12;MYH3;LTA4H;PI4K2A;ZXDC;PLCD1;ARHGEF2;SEPT10;MAP2K2;FLYWCH1;TWF2;SDHA;TECPR1;KIF21B;LRSAM1;LITAF;ZFPM1;KDM4C;PAK6;ZNF467;PRIMPOL;POLM;ACAP3;TENM2;KIF26B;ZNF516;NSMCE1;LTBP3;MDK;TTN;PSKH1;HLCS;KCNMA1;HDAC5;GTPBP1;GALK1;NTPCR;PLTP;GSTM2;VLDLR;NADK;DHX32;DEAF1;TEP1;SULF2;NLRP1;PEG3;ACY1;GLI4;ENDOG;KDM7A;EGFL7;MAP3K12;NEK8;ACOT7;WNK4;ZNF251;L3MBTL1;PKN3;ACADS;ISG20;LONP2;MARK3;HLTF;DNMT3A;TGFBR2;TRPV4;ITGA1;PSD4;SLFN5;MAP1LC3A;MOCOS;PDE2A;LMO7;TRIB3;RAB40B;ARL10;MLH3;PEMT;NOS3;MINK1;ZFP90;TTLL11;TRPV1;MARCH2;PIP5KL1;EPHA1;ZNF558;ZNF662;SHARPIN;CCS;GAS6;GLUD1;SUCLG2;ERN1;ECM2;ALKBH7;BCR;ATP7B;FYCO1;MAN2C1;CHKB;NBR1;EXD3;FAHD2A;SRR;NUDT8;KIF13B;UCKL1;NECAB3;CAMK1;POLL;PTAFR;CYP2R1;RXRA;ZNF358;ADCY6;ZNF362;MBD1;RAB43;ATP2B4;THNSL2;PRDM8;EFEMP2;STRADB;ACOX3;ACAD11;GSDMC;MGMT;ASNS;STEAP2;AKT1;ZFYVE21;ITPR2;DGUOK;MICAL1;CRY2;B4GALT2;CHEK2;LACTB2;PHYKPL;WDR45;SBF2;SEPT6;ASS1;CAPS;TNNT1;NFU1;CABYR;KIF27;PHF2;FGFR4;ZNF217;SNN;PIAS3;ASAP3;HAGH;STEAP3;CBR4;ACADVL;NUCB2;ZNF25;LENG9;WDFY2;UHRF2;ARSA;CAPN2;MAN2B1;MARK4;RAB25;INSR;ACSS1;GNAL;YPEL3;RPS6KA5;ANKZF1;TNXB;MBLAC2;RABGGTA;TXNRD2;CTDSPL;MAP2K5;BRAF;ARHGAP44;ZNF554;CPSF4;RNF215;FAAP20;CAT;ZNF160;MYOF;MAPK10;YPEL5;ZFP28;TIMP1;JAK3;TP73;MTA3;SNX33;UBOX5;CHRM3;ZNF846;APRT;OGFOD2;MIB2;MPI;SNX17;ENDOV;PHC1;SCYL3;ATP12A;CSNK1E;BCL6;REPS2;SAT2;RNF213;GSTM3;ADAP1;TKFC;EHD3;FYN;MAST4;ZC3H12D;ATP8B2;PJA2;SNX1;PEX1;SIRT2;TRPC1;ANKMY1;RECQL5;RAB13;OSBPL1A;CELSR1;ADA;RHOBTB3;ETNK2;MTA1;MSH5;ENTPD2;FUK;HDAC8;MYO18A;RPL29;TGFBR3;RNPEP;VAV3;MAN1B1;GALNS;MAP3K10;MFNG;CHD6;RNF170;EPHB2;MAGI1;SEPT8;MCTP2;ITGA2;FGFR1;ZNF333;ESYT3;FKBP8;SH3PXD2A;CTH;ERBB2;EIF2AK4;STK32B;SYVN1;PFKL;MMP17;MPPE1;HSP90AB4P;TRIM2;TSHZ1;TNNI1;MMP19;ZNF449;IRF2BP2;ZMYM3;NUDT18;TRIM45;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;DTD1;IKBKB;SNCB;PLEKHA4;HIP1;CYP4V2
8150,GO:0032890,0.185766812340287,0.922106785523846,5,26,regulation of organic acid transport,BP,NTSR1;STK39;PLA2G6;SV2A;AKT1
19727,GO:2000146,0.185770778209919,0.867956544352692,25,175,negative regulation of cell motility,BP,APOE;ZMYND8;LRP1;ALOX15B;FBLN1;IDH2;ARAP3;MMP28;ADARB1;NISCH;ARPIN;MCTP1;PLXNB3;C5;IFITM1;SRGAP3;HDAC5;PTPRU;EPHA1;BCR;MAP2K5;BRAF;TIMP1;ADA;CORO1B
4807,GO:0014003,0.186081755315276,0.921929927802449,5,26,oligodendrocyte development,BP,GSN;CD9;HDAC11;PRDM8;TENM4
3684,GO:0008191,0.186091560850623,0.963415189900721,2,7,metalloendopeptidase inhibitor activity,MF,TIMP2;TIMP1
17680,GO:1901617,0.186186612687672,0.869692019384985,23,160,organic hydroxy compound biosynthetic process,BP,ISYNA1;APOE;NTSR1;NR1D1;CYP27B1;PCK2;DGKQ;SEC14L2;PSAT1;ABCG1;ACACB;MVD;SRD5A3;PLTP;HSD17B7;PTAFR;CYP2R1;TM7SF2;FGFR4;TRPC1;OSBPL1A;PLPP6;ACOT8
10004,GO:0042451,0.186206319887526,0.931373147757209,4,20,purine nucleoside biosynthetic process,BP,NT5E;NME4;APRT;ADA
11555,GO:0046129,0.186206319887526,0.931373147757209,4,20,purine ribonucleoside biosynthetic process,BP,NT5E;NME4;APRT;ADA
11479,GO:0045980,0.186235586407562,0.921843500603847,5,26,negative regulation of nucleotide metabolic process,BP,DDIT4;PPARA;MLXIPL;LTB4R2;GABBR1
17989,GO:1902510,0.186410082948141,0.963312486070593,2,7,regulation of apoptotic DNA fragmentation,BP,ENDOG;CIDEA
6118,GO:0019370,0.186650029893399,0.963235036345731,2,7,leukotriene biosynthetic process,BP,GGT1;LTA4H
2271,GO:0005215,0.186981416262605,0.843367406081375,88,679,transporter activity,MF,DLG4;APOE;KCNG1;S100A6;OSBPL5;SLC2A3;GJC2;LRP1;SCN8A;SLC7A8;SLC16A3;SLC2A9;CLCA2;SCN4B;ORAI3;SLC27A1;PITPNM3;SLC16A5;ABCA2;SLC43A1;PITPNM1;SLC12A7;ITPR3;PITPNC1;ABCA7;SLC37A2;NDUFA4L2;TMEM44;ORAI2;DLG3;SLCO4A1;ANO8;ABCG1;ANO1;KCNJ15;PKD2;KCNC4;KCNAB2;OSBPL10;SLC22A18;PQLC2;SLC50A1;SLC48A1;LRRC8A;SV2A;SLC38A10;PKD1;SLC29A4;KCNMA1;AZIN2;PLTP;VLDLR;TMEM175;AQP3;TRPV4;ANO9;PDE2A;TRPV1;GAS6;ATP7B;MFSD3;TTYH3;ATP2B4;STEAP2;ITPR2;RASSF9;SLC6A9;TCIRG1;SLC6A6;TMEM63C;SLC25A29;SLC22A15;TPCN1;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC37A4;ATP8B2;SLC38A2;SLC25A42;TRPC1;OSBPL1A;STARD10;SLC39A11;SLC10A6;BSG;SLC9A5
2546,GO:0005815,0.187327125097411,0.844407181480978,80,611,microtubule organizing center,CC,BBS2;NEK9;IFT140;NINL;BRSK1;ADGRB2;NDRG1;OBSL1;EVC;BBS1;RAB11FIP4;CUL7;MAP2K1;SDCCAG8;ABCA2;CAPG;PITPNM1;TUBG2;FAM110C;ARL2;NPHP4;CAPRIN2;TTBK2;PRKCZ;PHF1;USP20;CEP250;NEIL1;CCDC88B;SPPL2B;WDR60;ACTR1B;PLA2G6;KIF17;CHD3;CCDC92;IFT27;PKD2;RGS14;DYSF;CNTRL;TUBE1;HOOK2;FBF1;ATF4;PROCR;LRRC45;RABGAP1;FLOT1;CEP68;PSKH1;NEK8;NDE1;CEP131;TRIOBP;TTC12;CDK5RAP3;CEP126;LZTS2;CROCC;CEP112;SPATA7;CCDC15;GSDMC;PLEKHG6;AKT1;MZT2B;IFT57;TSG101;MARK4;ITGB6;MZT2A;HAUS4;TUBGCP6;UBXN6;SIRT2;UNC119;SFI1;TTC19;TCTEX1D4
14240,GO:0061326,0.187722594335507,0.89376179979197,10,61,renal tubule development,BP,CTNNBIP1;PGF;VEGFA;WWTR1;LAMA5;WNT2B;PKD2;KIF26B;PKD1;WNK4
1709,GO:0004303,0.187765341773732,0.962874117784729,2,7,estradiol 17-beta-dehydrogenase activity,MF,HSD17B14;HSD17B7
4805,GO:0012510,0.187849972583216,0.943975507615518,3,13,trans-Golgi network transport vesicle membrane,CC,CLTCL1;AP1G2;RASSF9
7106,GO:0030915,0.18792350858127,0.962822811937119,2,7,Smc5-Smc6 complex,CC,NSMCE4A;NSMCE1
17183,GO:0106068,0.18792350858127,0.962822811937119,2,7,SUMO ligase complex,CC,NSMCE4A;NSMCE1
16453,GO:0097164,0.187928860455037,0.87336404219358,19,130,ammonium ion metabolic process,BP,ALDH7A1;CRAT;SLC27A1;LPCAT4;AKR7A2;PLA2G6;AZIN2;PEMT;CHKB;CPT1C;CBR4;PLB1;SAT2;MBOAT2;STARD10;DHPS;PNKD;KDSR;SNCB
2782,GO:0006216,0.188070559791871,0.962775084441254,2,7,cytidine catabolic process,BP,APOBEC3C;APOBEC3F
4361,GO:0009972,0.188070559791871,0.962775084441254,2,7,cytidine deamination,BP,APOBEC3C;APOBEC3F
11533,GO:0046087,0.188070559791871,0.962775084441254,2,7,cytidine metabolic process,BP,APOBEC3C;APOBEC3F
9956,GO:0042359,0.188094649049676,0.943867627082772,3,13,vitamin D metabolic process,BP,CYP27B1;CYP2R1;FGFR1
8672,GO:0034284,0.188492595075681,0.872926037148015,19,130,response to monosaccharide,BP,EGR1;GLUL;NR1D1;PCK2;ACVR2B;PLA2G6;ANO1;SESN2;VAMP2;MLXIPL;ENDOG;LRP5;TGFBR2;GAS6;ERN1;CAT;LGALS1;ITGA2;PFKL
4378,GO:0010033,0.188509679614482,0.830528684260129,267,2159,response to organic substance,BP,TNIP1;XDH;DUSP6;HTRA1;BBS2;F2R;TNFRSF6B;APOE;NFATC4;FOS;IL20RB;GSN;EGR1;PGF;FGFBP1;POSTN;FBXO2;PTK6;TMEM129;ACP5;EDEM1;GLUL;FAM210B;GPX3;LRP1;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;RBCK1;PRNP;NR1D1;ERCC1;ADAMTS7;HADH;RAPGEF3;TNFSF15;LOXL1;CD9;CST3;NOS1;DDIT3;DNAJB5;ADAMTS13;MST1R;ZFP36L1;MMP1;CTF1;RPL13A;LTBP4;SLC27A1;MAPK13;KLF9;RNF165;CUL7;HMGCL;UROS;HYAL1;SYNGR1;MAP2K1;CYP27B1;PCK2;COL6A1;ABCA2;DDIT4;BTG1;ITGA6;DGKQ;TMEM173;DNAJC4;SHC1;SPRY2;CD68;LAMA5;PRKCZ;PAK1;FGFR3;KDM3A;MTHFR;GLDC;NPR2;SPRY4;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;GSTO1;LTBP1;EREG;PTPRE;PSPH;TNFRSF25;PLA2G6;ABCG1;MANF;MTMR4;PPARA;ANO1;CHAC1;FNDC4;SESN2;AIP;IMPACT;PKD2;STAT6;VAMP2;AREG;SLIT3;ECM1;ACACB;MAPK3;ITGB5;ERRFI1;THRA;IFITM1;FAM20C;LTBP2;CTSB;MAPK12;PAQR6;MLXIPL;IFNGR2;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;TWF2;DMTN;LITAF;UBXN4;ATF4;SSH1;FBXO6;IFI6;FLOT1;MDK;HLCS;KCNMA1;HDAC5;IRF5;IL17RD;HERPUD1;SRSF5;GSTM2;SULF2;NLRP1;RFX2;ENDOG;CEBPB;LRP5;PTPRU;CREBRF;PCSK9;FBXL15;AQP3;ISG20;LONP2;DNMT3A;TGFBR2;TRPV4;IL17RE;TMSB4X;MAP1LC3A;PDE2A;SMURF2;APLN;TRIB3;CALCOCO1;PEMT;EDA;CDK5RAP3;NOS3;AGO4;WNT7A;HERPUD2;TRPV1;PIK3R2;SHARPIN;GAS6;ERN1;BCR;SRR;TADA3;PTAFR;PPP1R15A;RXRA;ADCY6;RAB43;ATP2B4;CTSH;TNFRSF14;MGMT;ASNS;STEAP2;AKT1;IGFBP7;ITPR2;CDKN1C;CRY2;CHEK2;IGFBP2;IL17RC;FGFR4;PIAS3;TCIRG1;ACADVL;LMNA;CAPN2;IFI27;INSR;WNT3;FOXO4;RPS6KA5;ANKZF1;HOMER2;MAP2K5;BRAF;EDA2R;GPR21;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;JAK3;TP73;CHRM3;APRT;BCL6;FYN;LEMD2;UBXN6;SIRT2;GDF15;RECQL5;RAB13;ADA;CIDEA;HDAC8;EIF4EBP1;TGFBR3;TCF7;MAN1B1;STX1A;LAMTOR2;PER1;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;PFKL;HLA-G;CORO1B;FRS3;GRB10;CREB3L4;MMP19;BSG;IKBKB;TEAD2
7738,GO:0032261,0.188650637690614,0.96258655559431,2,7,purine nucleotide salvage,BP,APRT;ADA
13622,GO:0060155,0.188669827844629,0.962580311682516,2,7,platelet dense granule organization,BP,F2R;BLOC1S1
19256,GO:1905515,0.188740471120786,0.901224739851459,8,47,non-motile cilium assembly,BP,BBS2;IFT140;BBS1;CEP250;VANGL2;CEP126;TMEM80;IFT57
5773,GO:0017000,0.18897023620502,0.943480951824255,3,13,antibiotic biosynthetic process,BP,KDM3A;ACSS2;ACSS1
17808,GO:1901998,0.188971828162113,0.912522421985655,6,33,toxin transport,BP,SLC7A8;DNM1;ABCG1;BNIP3;RAB40B;RAB43
464,GO:0001503,0.189094301352196,0.858800956256286,33,237,ossification,BP,CTNNBIP1;THBS3;EGFR;MEF2D;MRC2;COL13A1;WWTR1;SMOC1;CYP27B1;COL6A1;FGFR3;NPR2;ACVR2B;PLXNB1;NAB2;AREG;ECM1;MAPK3;THRA;IFITM1;FAM20C;PTHLH;CEBPB;LRP5;ATRAID;FBXL15;MN1;NBR1;AKT1;WNT3;CAT;PEX7;HDAC8
13952,GO:0060688,0.189154409764645,0.912412302258373,6,33,regulation of morphogenesis of a branching structure,BP,PGF;VEGFA;ETV5;WNT2B;RXRA;FGFR1
4957,GO:0015036,0.189251372073037,0.912151971860276,6,34,disulfide oxidoreductase activity,MF,TXNRD3;ERO1B;GSTO1;CCS;GSTO2;TXNRD2
10977,GO:0044794,0.189502178172161,0.943245564100295,3,13,positive regulation by host of viral process,BP,APOE;PC;TBC1D20
4241,GO:0009445,0.189558270325345,0.962290748213377,2,7,putrescine metabolic process,BP,AZIN2;SAT2
13718,GO:0060316,0.189599364907627,0.962277331331668,2,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,GSTO1;GSTM2
8190,GO:0032946,0.189764082688766,0.888879193812866,11,70,positive regulation of mononuclear cell proliferation,BP,ZP3;CCDC88B;PDCD1LG2;TGFBR2;CARD11;IGFBP2;JAK3;BCL6;ADA;VAV3;DHPS
2205,GO:0005092,0.189999387284547,0.943025223208033,3,13,GDP-dissociation inhibitor activity,MF,GPSM1;SESN2;RGS14
10286,GO:0043067,0.190018592093374,0.834931691454829,140,1107,regulation of programmed cell death,BP,XDH;DUSP6;F2R;TNFRSF6B;APOE;HS1BP3;NFATC4;GSN;EGR1;LRP1;PDCD4;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;PRDX5;TNFSF15;CST3;DDIT3;NDRG1;ARHGEF19;GRAMD4;MST1R;ZFP36L1;NUPR1;RGL2;RPS6KA2;TFDP2;MAP2K1;BTG1;SYNGAP1;ITGA6;PLEKHG5;SHC1;SPRY2;PRKCZ;PAK1;AARS;STK39;FGFR3;NME4;NEURL1;RAG1;NGFR;ARHGEF4;PLEKHG2;TNFRSF25;PLA2G6;ING4;HMGA2;BNIP3;SEMA5A;THRA;STK40;CTSB;ARHGEF2;INPP5D;MAP2K2;ANGPTL4;ATF4;BBC3;PAK6;IFI6;MDK;KCNMA1;UNC5B;IRF5;HERPUD1;NLRP1;ENDOG;CEBPB;MAP3K12;LRP5;PCSK9;CSRNP3;ITGA1;TNFAIP8L1;DAP;NOS3;AGO4;MINK1;WNT7A;TRPV1;BNIP3L;EPHA1;GAS6;STRADB;CTSH;TNFRSF14;MGMT;ASNS;AKT1;CARD11;MICAL1;BEX2;AMIGO2;CHEK2;IFT57;FGFR4;STEAP3;LMNA;MARK4;IFI27;INSR;RABGGTA;MAP2K5;BRAF;PIDD1;CAT;LGALS1;TIMP1;JAK3;TP73;MNT;BCL6;FYN;ARHGEF17;SIRT2;GDF15;ADA;CIDEA;MYO18A;CIDEB;TCF7;VAV3;MAP3K10;EPHB2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;NET1;TRIM2;IKBKB;SNCB;HIP1
10021,GO:0042490,0.190021620677702,0.911888752509386,6,33,mechanoreceptor differentiation,BP,NAGLU;IFT27;VANGL2;SLITRK6;TRIOBP;FGFR1
7746,GO:0032271,0.190613549843213,0.867303201485901,22,153,regulation of protein polymerization,BP,GSN;WIPF1;CDC42EP5;SPTB;ARPIN;CAPG;EML2;ARL2;PAK1;PLEKHG2;TWF2;DMTN;WHAMMP3;TRIOBP;TMSB4X;TMOD2;FCHSD1;SPIRE1;EPS8L1;EPS8L2;C15ORF62;CORO1B
7476,GO:0031649,0.190639742185364,0.942740987391955,3,13,heat generation,BP,SLC27A1;APLN;TRPV1
18141,GO:1902931,0.190711953871605,0.961913304145966,2,7,negative regulation of alcohol biosynthetic process,BP,APOE;CYP27B1
13585,GO:0060081,0.190851120451383,0.961867664430123,2,7,membrane hyperpolarization,BP,CRTC1;PRKCZ
17895,GO:1902236,0.190918064042445,0.942617286953762,3,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,HERPUD1;WFS1;SYVN1
16302,GO:0090543,0.190941220514889,0.919186250212443,5,26,Flemming body,CC,EXOC2;CAPG;CNTRL;TSG101;CHMP4C
1909,GO:0004602,0.191040472616508,0.941922091429248,3,14,glutathione peroxidase activity,MF,GPX3;GSTT1;GSTM2
8420,GO:0033540,0.191186780691145,0.942497762995716,3,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,CRAT;ACOX3;ACOT8
5672,GO:0016788,0.191354070702168,0.842176272490869,73,558,hydrolase activity, acting on ester bonds,MF,DUSP6;H6PD;PTPRS;NT5E;ACP5;ERCC1;DUSP5;BPHL;PPM1M;PLD3;LHPP;ACP6;MAP2K1;PGLS;PLCH2;DNASE1L1;NLGN2;PPP2R3B;AARS;PLCXD1;NEIL1;RAG1;PTPRE;PNPLA3;SSH3;PLCD3;PSPH;PLA2G6;CES3;PPM1J;MTMR4;ACOT1;ACOT11;NT5C1B;PAN2;MYH3;PTPDC1;PLCD1;INPP5D;SSH1;NTPCR;SULF2;CES2;ENDOG;ACOT7;PTPRU;ISG20;PDE2A;DNAJC6;ERN1;EXD3;LACTB2;HAGH;DNASE2;FAAH;ARSA;PNPLA4;CTDSPL;CPSF4;PLB1;CHRM3;ENDOV;ZC3H12D;PLPP6;GALNS;EDNRA;INPP4A;MPPE1;LYPLAL1;TMEM8A;PNKD;DTD1;ACOT8
981,GO:0002438,0.191446243686918,0.961672227994837,2,7,acute inflammatory response to antigenic stimulus,BP,IL20RB;ZP3
3314,GO:0007020,0.191466679710619,0.918887910734701,5,26,microtubule nucleation,BP,EML2;TUBG2;NDE1;TUBGCP6;GOLGA2
12727,GO:0051019,0.191481612105611,0.918879427854979,5,26,mitogen-activated protein kinase binding,MF,TNIP1;MICALCL;CDK5RAP3;NBR1;PTAFR
3512,GO:0007435,0.19154358855225,0.91884421713167,5,26,salivary gland morphogenesis,BP,EGFR;LAMA5;EDA;PLXND1;FGFR1
12814,GO:0051148,0.191651385548147,0.918782963628966,5,26,negative regulation of muscle cell differentiation,BP,PDCD4;PAK1;EREG;HDAC5;FOXO4
4717,GO:0010884,0.191691894641018,0.942272844533787,3,13,positive regulation of lipid storage,BP,ACACB;CIDEA;FITM2
10006,GO:0042455,0.191716534659989,0.910658399940076,6,34,ribonucleoside biosynthetic process,BP,NT5E;NME4;UCKL1;UPP1;APRT;ADA
6582,GO:0022602,0.191772459648556,0.918714149449328,5,26,ovulation cycle process,BP,ZP3;EREG;SLIT3;NOS3;MMP19
16367,GO:0097011,0.19185839605208,0.961536626252368,2,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,NPR2;AKT1
16368,GO:0097012,0.19185839605208,0.961536626252368,2,7,response to granulocyte macrophage colony-stimulating factor,BP,NPR2;AKT1
12278,GO:0048638,0.191886367424915,0.860261294746402,28,198,regulation of developmental growth,BP,DUSP6;PTPRS;GAMT;BBS2;APOE;WWC3;SEMA4B;VEGFA;ULK2;PAK1;FGFR3;SEMA3F;ZP3;LPAR3;ACACB;SEMA5A;TWF2;SEMA3B;TGFBR2;SEMA4G;AKT1;INSR;WNT3;GPR21;TP73;PHLDA2;TGFBR3;FGFR1
10914,GO:0044550,0.192162511816662,0.942062997948786,3,13,secondary metabolite biosynthetic process,BP,CBS;TRPC1;CTH
7745,GO:0032270,0.192328535159964,0.833055292304928,137,1081,positive regulation of cellular protein metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;GSN;EGR1;PTK6;EDEM1;LRP1;TIMP2;VEGFA;EGFR;PRNP;FBLN1;DUSP5;RAPGEF3;TNFSF15;IGFBP4;NOS1;ERCC6;GRAMD4;MST1R;NUPR1;HBEGF;CTF1;CNTN1;SLC27A1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;MAGEF1;SHC1;VPS11;SPRY2;CIRBP;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;PHF1;DLG3;NEURL1;ACVR2B;NGFR;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PLGRKT;IMPACT;PKD2;AREG;MAPK3;CSPG4;VANGL2;MAPK12;ARHGEF2;MAP2K2;BBC3;PAK6;PKD1;FLOT1;JDP2;HERPUD1;VLDLR;NLRP1;MAP3K12;PCSK9;TGFBR2;TRPV4;ITGA1;TRIB3;DAP;CDK5RAP3;MINK1;PROM2;WNT7A;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;AKT1;CHEK2;IFT57;FGFR4;PIAS3;WDFY2;IFI27;INSR;RPS6KA5;C6ORF89;MAP2K5;BRAF;EDA2R;PIDD1;MAPK10;HFE;TP73;SNX33;CSNK1E;BCL6;FYN;SIRT2;GDF15;GOLGA2;MTA1;AVPI1;CIDEB;LAMTOR2;MAP3K10;EPHB2;ITGA2;FGFR1;WFS1;ERBB2;EIF2AK4;UNC119;CAMKK1;HIP1
17725,GO:1901701,0.192359372346131,0.838083241533641,91,705,cellular response to oxygen-containing compound,BP,TNIP1;NFATC4;FOS;EGR1;PTK6;FAM210B;LRP1;PDCD4;EGFR;PRNP;NR1D1;PRDX5;RAPGEF3;CST3;ADAMTS13;ZFP36L1;MAPK13;KLF9;CYP27B1;PCK2;COL6A1;DDIT4;SHC1;PRKCZ;PAK1;NEURL1;NGFR;PTPRE;PLA2G6;ANO1;SESN2;IMPACT;PKD2;STAT6;VAMP2;MAPK3;BNIP3;ERRFI1;MLXIPL;ARHGEF2;PDCD1LG2;TWF2;DMTN;LITAF;ATF4;SSH1;HDAC5;SRSF5;ENDOG;CEBPB;LRP5;PCSK9;DNMT3A;MAP1LC3A;PDE2A;TRIB3;NOS3;TRPV1;PIK3R2;CCS;GAS6;ERN1;BCR;PTAFR;ADCY6;ATP2B4;AKT1;ITPR2;CHEK2;TCIRG1;CAPN2;INSR;WNT3;FOXO4;ANKZF1;GPR21;LGALS1;JAK3;CHRM3;APRT;FYN;SIRT2;RECQL5;RAB13;HDAC8;EIF4EBP1;LAMTOR2;ITGA2;NET1;GRB10;TEAD2
10011,GO:0042472,0.192448019355717,0.898785814472696,8,47,inner ear morphogenesis,BP,SPRY2;VANGL2;SLITRK6;TRIOBP;BCR;CELSR1;EPHB2;FGFR1
13680,GO:0060263,0.192558978930827,0.961305654616237,2,7,regulation of respiratory burst,BP,BCR;INSR
6183,GO:0019626,0.192690714574527,0.961262156733338,2,7,short-chain fatty acid catabolic process,BP,PCK2;ACADS
4076,GO:0009134,0.192780167788363,0.961232608093617,2,7,nucleoside diphosphate catabolic process,BP,ENTPD2;NUDT18
11916,GO:0046983,0.192786692366438,0.835537654336548,107,848,protein dimerization activity,MF,XDH;APOE;S100A6;FOS;PGF;ZNF862;VEGFA;NTSR1;EGFR;PRDX5;DNM1;MEF2D;DDIT3;DNPH1;TCFL5;PYGL;MXI1;SLC27A1;RAB11FIP4;LHPP;HMGCL;WWTR1;MXD4;CRYL1;H2AFJ;TMEM173;SNX9;VEGFB;TPM2;GALE;GLDC;CBS;RAG1;SPPL2B;HES2;PSPH;ABCG1;S100A13;CARS;ANO1;PKD2;BNIP3;MVD;MLXIPL;ATF4;TENM2;NSMCE1;RALGAPA1;FLOT1;HLCS;JDP2;GSTM2;CEBPB;MAP3K12;ACOT7;CEP131;MXD3;PDE2A;BHLHE40;HMG20B;HEXB;BNIP3L;PIK3R2;OLFML2A;SUCLG2;ERN1;HEXA;SRR;RXRA;ASNS;AKT1;CHEK2;SBF2;CABYR;TSG101;CAPN2;TENM4;CHMP4C;RABGGTA;HOMER2;BRAF;POLR2J2;CAT;LGALS1;MNT;TFEB;PEX7;SLC9A7;GSTM3;SNX1;CELSR1;CADM4;NAGA;CIDEA;STX1A;EPAS1;MAP3K10;POLR2J3;ITGA2;FGFR1;ERBB2;HLA-G;PEX11A;IKBKB;HIP1;TEAD2;BTBD11
5680,GO:0016801,0.192818903445004,0.941769849944884,3,13,hydrolase activity, acting on ether bonds,MF,AKR7A2;LTA4H;RNPEP
13242,GO:0051955,0.193000294109876,0.94168874437642,3,13,regulation of amino acid transport,BP,NTSR1;STK39;SV2A
14704,GO:0070383,0.193075168360588,0.961135093102368,2,7,DNA cytosine deamination,BP,APOBEC3C;APOBEC3F
5544,GO:0016554,0.193124290816395,0.961118844979882,2,7,cytidine to uridine editing,BP,APOBEC3C;APOBEC3F
6711,GO:0030128,0.193381105632883,0.941518336831655,3,13,clathrin coat of endocytic vesicle,CC,EGFR;AP2A2;HIP1
10548,GO:0043524,0.193687896814294,0.878065240726964,14,92,negative regulation of neuron apoptotic process,BP,F2R;APOE;LRP1;SYNGAP1;AARS;MDK;UNC5B;CEBPB;MAP3K12;BRAF;TP73;FYN;WFS1;SNCB
11290,GO:0045628,0.193792213612269,0.960897626742083,2,7,regulation of T-helper 2 cell differentiation,BP,PRKCZ;BCL6
10332,GO:0043154,0.193848554188527,0.885978812628512,11,70,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNFRSF6B;VEGFA;PRDX5;RAG1;NGFR;IFI6;HERPUD1;GAS6;AKT1;MICAL1;MAP2K5
5657,GO:0016769,0.193887079208991,0.941291639260932,3,13,transferase activity, transferring nitrogenous groups,MF,GPT2;PSAT1;PHYKPL
2277,GO:0005227,0.193898486643847,0.941286524541037,3,13,calcium activated cation channel activity,MF,ANO1;KCNMA1;TMEM63C
16567,GO:0097413,0.193900111098258,0.960861839889884,2,7,Lewy body,CC,ATF4;HERPUD1
4650,GO:0010799,0.193959588337397,0.909500720417345,6,33,regulation of peptidyl-threonine phosphorylation,BP,DDIT4;DGKQ;SPRY2;CEMIP;DMTN;SIRT2
12746,GO:0051045,0.194031312770289,0.960818304577388,2,7,negative regulation of membrane protein ectodomain proteolysis,BP,TIMP2;TIMP1
9354,GO:0035886,0.19403931529862,0.94122336812789,3,13,vascular smooth muscle cell differentiation,BP,PDCD4;VEGFA;CTH
11557,GO:0046131,0.194057941836277,0.917129104731938,5,27,pyrimidine ribonucleoside metabolic process,BP,APOBEC3C;NME4;APOBEC3F;UCKL1;UPP1
14036,GO:0060840,0.19410613672816,0.893197940206775,9,54,artery development,BP,APOE;LRP1;VEGFA;LOXL1;ACVR2B;LTBP1;PKD2;SNX17;PLXND1
3488,GO:0007369,0.19412386987714,0.870133832688931,18,121,gastrulation,BP,DUSP6;DUSP5;COL6A1;ITGB4;ACVR2B;HMGA2;COL8A1;ITGB5;VANGL2;LRP5;TGFBR2;APLN;LAMB1;WNT3;TENM4;MAP2K5;ITGA2;FGFR1
16792,GO:0098693,0.194430152102923,0.909214204625139,6,33,regulation of synaptic vesicle cycle,BP,DNM1;NLGN2;SEPT5;RIMS3;BRAF;STX1A
2286,GO:0005245,0.194516246277098,0.941009297376279,3,13,voltage-gated calcium channel activity,MF,PKD2;GAS6;TPCN1
8076,GO:0032769,0.194517493629565,0.960656797835616,2,7,negative regulation of monooxygenase activity,BP,CYP27B1;ATP2B4
15265,GO:0071476,0.19468195891338,0.960602098337746,2,7,cellular hypotonic response,BP,STK39;TRPV4
5320,GO:0016050,0.194791432843497,0.848437479231947,43,318,vesicle organization,BP,DLG4;F2R;SYTL1;SERPINE2;EVI5L;DNM1;TBC1D8;SYT8;SNX9;VPS11;BLOC1S4;SPG11;TRAPPC9;ALS2CL;VAMP2;AREG;DYSF;HOOK2;PI4K2A;CHMP1B;TBC1D14;TBC1D3E;RABGAP1;TSNARE1;TMEM175;RFX2;VPS39;TSG101;SGSM2;TBC1D20;CHMP5;CHMP4C;LYST;SNX33;SNX1;RAB13;GOLGA2;MYO18A;VAV3;STX1A;TBC1D16;BLOC1S1;SEC31B
7815,GO:0032377,0.194808215012953,0.960560084538922,2,7,regulation of intracellular lipid transport,BP,ABCA2;PCSK9
7818,GO:0032380,0.194808215012953,0.960560084538922,2,7,regulation of intracellular sterol transport,BP,ABCA2;PCSK9
7821,GO:0032383,0.194808215012953,0.960560084538922,2,7,regulation of intracellular cholesterol transport,BP,ABCA2;PCSK9
7473,GO:0031646,0.194817713840669,0.940873836219608,3,13,positive regulation of neurological system process,BP,PTAFR;TENM4;ITGA2
3382,GO:0007162,0.194836212988073,0.861669130080582,24,168,negative regulation of cell adhesion,BP,SERPINE2;IL20RB;POSTN;PRNP;FBLN1;CD9;PLXNB3;PLXNB1;PPARA;SEMA5A;PDCD1LG2;DMTN;CEBPB;TRPV4;ASS1;MAP2K5;LGALS1;HFE;JAK3;BCL6;PLXND1;ERBB2;PAG1;HLA-G
7134,GO:0030983,0.194870097581896,0.940850286528335,3,13,mismatched DNA binding,MF,XPC;MLH3;MSH5
11153,GO:0045239,0.194892929802514,0.940840020973321,3,13,tricarboxylic acid cycle enzyme complex,CC,DHTKD1;OGDHL;SUCLG2
7488,GO:0031668,0.194994724584047,0.859502519138638,26,184,cellular response to extracellular stimulus,BP,FOS;POSTN;GLUL;CYP27B1;ITGA6;ULK1;CBS;WNT2B;SESN2;IMPACT;MAPK3;ATF4;SSH1;PCSK9;AQP3;MAP1LC3A;DAP;TRPV1;GAS6;ASNS;C12ORF66;UPP1;HFE;FYN;SLC38A2;EIF2AK4
15811,GO:0072542,0.195018342911395,0.96049011809162,2,7,protein phosphatase activator activity,MF,B3GAT3;PPP1R15A
3600,GO:0008037,0.195024274666355,0.888596456520487,10,62,cell recognition,BP,EFNB3;LAMA5;PEAR1;ZP3;ST6GALNAC6;SEMA5A;ROBO3;CADM4;EPHB2;NTM
11711,GO:0046543,0.195095527125568,0.960464404538164,2,7,development of secondary female sexual characteristics,BP,AREG;IRF2BPL
15749,GO:0072378,0.195110800535107,0.960459315417021,2,7,blood coagulation, fibrin clot formation,BP,FBLN1;SERPING1
5387,GO:0016229,0.195120186935574,0.92675268555821,4,20,steroid dehydrogenase activity,MF,HSD17B14;SRD5A3;HSD11B1;HSD17B7
819,GO:0002093,0.195136705570976,0.960450683175486,2,7,auditory receptor cell morphogenesis,BP,SLITRK6;TRIOBP
827,GO:0002115,0.195297144795471,0.940658174301694,3,13,store-operated calcium entry,BP,ORAI3;ORAI2;HOMER2
7246,GO:0031214,0.195318958711328,0.885008711162777,11,69,biomineral tissue development,BP,CYP27B1;FGFR3;ACVR2B;PPARA;ECM1;FAM20C;PTHLH;ATRAID;FBXL15;GAS6;NBR1
13445,GO:0055006,0.195355123459988,0.897457899160588,8,43,cardiac cell development,BP,PDCD4;VEGFA;OBSL1;MYH11;PAK1;TTN;LMNA;TGFBR3
910,GO:0002295,0.195670959094244,0.960272474084505,2,7,T-helper cell lineage commitment,BP,STAT6;ZFPM1
10463,GO:0043373,0.195670959094244,0.960272474084505,2,7,CD4-positive, alpha-beta T cell lineage commitment,BP,STAT6;ZFPM1
9328,GO:0035845,0.195728434225911,0.960253281654329,2,7,photoreceptor cell outer segment organization,BP,IFT140;NPHP4
9855,GO:0042129,0.195750296597309,0.878917159917129,13,85,regulation of T cell proliferation,BP,IL20RB;PRNP;ZP3;CCDC88B;PDCD1LG2;CEBPB;TGFBR2;CARD11;IGFBP2;JAK3;DHPS;ERBB2;HLA-G
13661,GO:0060228,0.195786724472102,0.989353116287536,1,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOE
2327,GO:0005343,0.195846398192046,0.940410749940983,3,13,organic acid:sodium symporter activity,MF,SLC6A9;SLC6A6;SLC10A6
11311,GO:0045655,0.195992271762235,0.940344974133778,3,13,regulation of monocyte differentiation,BP,CTNNBIP1;ZFP36L1;INPP5D
4632,GO:0010759,0.196005426637341,0.960160730487538,2,7,positive regulation of macrophage chemotaxis,BP,MAPK3;TRPV4
945,GO:0002360,0.196302082516002,0.94020518899587,3,13,T cell lineage commitment,BP,STAT6;ZFPM1;BRAF
3184,GO:0006810,0.196798098235623,0.820102923562507,409,3348,transport,BP,XDH;DLG4;BBS2;F2R;APOE;SYTL1;KCNG1;SERPINE2;FHL1;S100A6;OSBPL5;GSN;PYGB;LMF1;POSTN;EVI5L;WIPF1;SLC2A3;TMEM129;NAPRT;EDEM1;GLUL;GJC2;LRP1;ALOX15B;TIMP2;VEGFA;NTSR1;EGFR;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;SLC7A8;HADH;ANK3;IFT140;RAPGEF3;CLTCL1;FCHO1;SPTB;TSPAN1;SLC16A3;CD9;SLC2A9;SNPH;IDH2;CST3;DNM1;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;PGM1;CLCA2;SCN4B;ORAI3;MRC2;TBC1D8;ARRDC1;ZFP36L1;SYT8;RIN1;ARAP1;B3GAT3;GAA;PYGL;CNTN1;EXOC2;TFDP2;RPL13A;BBS1;LTBP4;SLC27A1;REEP2;RAB11FIP4;NISCH;CPT2;ASAP2;PITPNM3;ATG16L2;PRSS3;SYNGR1;MAP2K1;CYP27B1;PCK2;SLC16A5;ABCA2;SLC43A1;TOM1L2;DNASE1L1;PITPNM1;TMEM173;SNX9;ARL2;VPS11;BLOC1S4;VEGFB;RAB3B;NLGN2;CD68;SLC12A7;ITPR3;PITPNC1;APPL2;PRSS8;PRKCZ;SERPING1;PAK1;ABCA7;SLC37A2;MCTP1;STK39;PEAR1;CEMIP;BRI3;NDUFA4L2;USP20;ORAI2;ELMO3;DLG3;MICALL2;SLCO4A1;NME4;ZP3;NEURL1;ACVR2B;CCDC88B;NGFR;GSTO1;WDR60;ACTR1B;SPG11;TMC6;OLFM2;ANO8;TMED4;PLA2G6;ABCG1;ESYT2;XPOT;TRAPPC9;RINL;SCART1;MANF;LPAR3;S100A13;AGAP1;C5;KIF17;PPARA;ANO1;STON1;SESN2;AIP;KCNJ15;IFT27;PKD2;SH3TC2;VAMP2;AREG;AP1G2;SEPT5;ECM1;PCLO;KCNC4;ACACB;KCNAB2;MAPK3;BNIP3;OSBPL10;PEX10;SCARA3;RGS14;DYSF;RHOF;SLC22A18;LTBP2;SNTA1;CTSB;HOOK2;EIF2D;MVB12B;LTA4H;PI4K2A;PQLC2;CHMP1B;TBC1D14;ARHGEF2;PRAF2;MAP2K2;SLC50A1;SLC48A1;LRSAM1;DMTN;LRRC8A;KLHL24;ATF4;BBC3;SV2A;TBC1D3E;SLC38A10;RABGAP1;ACAP3;REEP6;PKD1;FUCA1;SLC29A4;FLOT1;TTN;KCNMA1;AZIN2;TSNARE1;WHAMMP3;SORL1;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;TMEM175;NLRP1;RHBDF1;LRP5;WNK4;RIN2;ALDOC;NDE1;PCSK9;AQP3;CEP131;LONP2;TGFBR2;TRPV4;ARHGAP25;TMSB4X;ANO9;APOL4;PDE2A;APLN;TRIB3;RAB40B;PEMT;NOS3;MINK1;HEXB;PROM2;WNT7A;TRPV1;MARCH2;BNIP3L;PIK3R2;RHBDF2;CCS;GAS6;VPS39;GLUD1;DNAJC6;ALKBH7;BCR;ATP7B;FYCO1;NBEAL2;MFSD3;KIF13B;TTYH3;NECAB3;CAMK1;PTAFR;RXRA;RIMS3;RAB43;ATP2B4;STRADB;CTSH;WDR19;STEAP2;MAPKBP1;AKT1;ZFYVE21;ITPR2;CARD11;MICAL1;CRY2;IFT57;TTC21A;TSG101;IL17RC;IGF2BP2;RASSF9;SLC6A9;TCIRG1;ASAP3;STEAP3;SLC6A6;TMEM63C;COPG1;C9ORF72;SGSM2;TBC1D20;CHMP5;ARSA;MAN2B1;ICA1;ARHGAP27;RAB25;IFI27;PLAU;INSR;SLC25A29;CKLF;COG7;SLC22A15;CHMP4C;TPCN1;ADD3;MAGED2;ITGB6;HOMER2;LYST;ZDHHC24;BRAF;ARHGAP44;CPSF4;BTN3A2;ASIC1;CAT;DPP7;YPEL5;UNC119B;TIMP1;HFE;TP73;SCNN1A;SNX33;CHRM3;APRT;PEX7;SNX17;ICAM5;METTL7A;ATP12A;SPIRE1;TMEM50B;CSNK1E;HGSNAT;BCL6;SLC9A7;ADAP1;SLC37A4;EHD3;FYN;ATP8B2;SLC38A2;SNX1;PEX1;UBXN6;SLC25A42;TRPC1;RAB13;OSBPL1A;TOM1;TST;GOLGA2;ADA;POU2F2;RHOBTB3;RTN2;AP2A2;CIDEA;MYO18A;SLC35F3;RPL29;VAV3;STX1A;GALNS;LAMTOR2;TBC1D16;STARD10;EDNRA;EPHB2;TMCO6;PER1;IGF2BP3;ITGA2;SLC39A11;FGFR1;WFS1;ESYT3;BLOC1S1;RGPD6;ERBB2;SEC31B;PLLP;SLC10A6;UNC119;SYVN1;OSCP1;PFKL;RPL12;MPPE1;GRB10;BSG;APBA1;PNKD;HIP1;SLC9A5
9435,GO:0036037,0.196905897746196,0.959859213382153,2,7,CD8-positive, alpha-beta T cell activation,BP,SATB1;HFE
16727,GO:0098533,0.196956402192314,0.939909567895049,3,13,ATPase dependent transmembrane transport complex,CC,ABCA2;ABCA7;ATP12A
4628,GO:0010755,0.197004447468532,0.959826154859078,2,7,regulation of plasminogen activation,BP,SERPINE2;PLGRKT
6095,GO:0019319,0.197110434211363,0.891037638838894,9,55,hexose biosynthetic process,BP,NR1D1;PGM1;PCK2;DGKQ;PPARA;PC;ATF4;ALDOC;SLC37A4
10847,GO:0044387,0.197174534960497,0.959769071242434,2,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,ADARB1;CDK5RAP3
5357,GO:0016139,0.197326148368213,0.959718158167706,2,7,glycoside catabolic process,BP,FUCA1;NAGA
9933,GO:0042308,0.197327430526648,0.959717727489035,2,7,negative regulation of protein import into nucleus,BP,PDE2A;GAS6
18874,GO:1904590,0.197327430526648,0.959717727489035,2,7,negative regulation of protein import,BP,PDE2A;GAS6
12661,GO:0050900,0.197329340967171,0.853317816125263,31,225,leukocyte migration,BP,PGF;VEGFA;SLC7A8;SLC16A3;MMP28;MMP1;ITGA6;SHC1;GRB7;VEGFB;ZP3;C5;ECM1;MAPK3;SDC2;INPP5D;PROCR;TRPV4;ITGA1;PIK3R2;GAS6;BCR;PTAFR;IL17RC;CKLF;LYST;FYN;ADA;VAV3;ITGA2;BSG
1550,GO:0003951,0.197342984900747,0.939734658174724,3,13,NAD+ kinase activity,MF,DGKA;DGKQ;NADK
425,GO:0001133,0.197438614034769,0.939691361815633,3,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,NR1D1;PPARA;THRA
7631,GO:0032050,0.197496648448421,0.95966086945234,2,7,clathrin heavy chain binding,MF,LRP1;CEMIP
13747,GO:0060351,0.197540883149812,0.939645046520227,3,13,cartilage development involved in endochondral bone morphogenesis,BP,THBS3;TGFBR2;TRPV4
10141,GO:0042738,0.19762779527046,0.959616779579285,2,7,exogenous drug catabolic process,BP,NOS1;CYP2R1
11157,GO:0045252,0.197714989612545,0.959587454409156,2,7,oxoglutarate dehydrogenase complex,CC,DHTKD1;OGDHL
27,GO:0000052,0.197742702280309,0.959578132161857,2,7,citrulline metabolic process,BP,ATP2B4;ASS1
15263,GO:0071474,0.19774692778717,0.9595767106643,2,7,cellular hyperosmotic response,BP,ERRFI1;ARHGEF2
10681,GO:0043983,0.197777850629297,0.959566307289325,2,7,histone H4-K12 acetylation,BP,ING4;JADE2
15262,GO:0071472,0.197961582048814,0.959504470572908,2,7,cellular response to salt stress,BP,ZFP36L1;TRPV4
18538,GO:1903792,0.197977538591701,0.93944714821329,3,13,negative regulation of anion transport,BP,STK39;ANO9;AKT1
3409,GO:0007194,0.198039667201863,0.959478177796508,2,7,negative regulation of adenylate cyclase activity,BP,LTB4R2;GABBR1
7279,GO:0031280,0.198039667201863,0.959478177796508,2,7,negative regulation of cyclase activity,BP,LTB4R2;GABBR1
3925,GO:0008610,0.198059594651787,0.837585309491081,67,511,lipid biosynthetic process,BP,ISYNA1;APOE;EGR1;ALOX15B;NR1D1;DGKA;HSD17B14;SLC27A1;MLYCD;PITPNM3;ACP6;CYP27B1;PCK2;LPCAT4;PITPNM1;DGKQ;FGFR3;SEC14L2;ZP3;PNPLA3;PLA2G6;ABCG1;MTMR4;ST6GALNAC6;ACACB;ACSS2;MVD;PI4K2A;MLXIPL;INPP5D;SRD5A3;HSD11B1;ACOT7;HSD17B7;TRIB3;PEMT;PIGZ;HEXB;PIK3R2;CHKB;CYP2R1;THNSL2;TM7SF2;HINT2;AKT1;IGFBP7;FGFR4;CBR4;ACADVL;ACSS1;PIGQ;CERS4;PEX7;TAZ;MBOAT2;OSBPL1A;ETNK2;PLPP6;STARD10;INPP4A;FGFR1;PIGV;FITM2;MPPE1;KDSR;PLEKHA4;ACOT8
13379,GO:0052742,0.198094034702497,0.906974915992297,6,33,phosphatidylinositol kinase activity,MF,FGFR3;PI4KAP1;PI4K2A;PIK3R2;FGFR4;FGFR1
5328,GO:0016064,0.198239481661412,0.890264290325227,9,55,immunoglobulin mediated immune response,BP,ERCC1;SERPING1;ZP3;C5;STAT6;C1RL;INPP5D;BCL6;POU2F2
6205,GO:0019724,0.198239481661412,0.890264290325227,9,55,B cell mediated immunity,BP,ERCC1;SERPING1;ZP3;C5;STAT6;C1RL;INPP5D;BCL6;POU2F2
7117,GO:0030949,0.198661975871033,0.95926836995649,2,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,VEGFA;GRB10
2955,GO:0006489,0.198695552597049,0.959257036389214,2,7,dolichyl diphosphate biosynthetic process,BP,MVD;SRD5A3
11662,GO:0046465,0.198695552597049,0.959257036389214,2,7,dolichyl diphosphate metabolic process,BP,MVD;SRD5A3
11400,GO:0045834,0.198938956280945,0.879319999751004,12,77,positive regulation of lipid metabolic process,BP,APOE;NR1D1;MLYCD;FGFR3;ZP3;PLA2G6;ABCG1;PPARA;MLXIPL;AKT1;TAZ;VAV3
13223,GO:0051924,0.199059720073552,0.86794495066965,17,115,regulation of calcium ion transport,BP,F2R;GJC2;NTSR1;PRNP;NOS1;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;GSTM2;NOS3;HOMER2;EHD3;FYN;TRPC1;WFS1
14762,GO:0070493,0.199071556173369,0.959130025804541,2,7,thrombin-activated receptor signaling pathway,BP,F2R;DGKQ
6649,GO:0030007,0.199179045456587,0.959093685367956,2,7,cellular potassium ion homeostasis,BP,KCNMA1;ATP12A
18735,GO:1904251,0.199193216705403,0.959088893245332,2,7,regulation of bile acid metabolic process,BP,NR1D1;FGFR4
9081,GO:0035358,0.199304763872155,0.959051164158392,2,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;STARD10
19822,GO:2000322,0.199353102615255,0.959034809643981,2,7,regulation of glucocorticoid receptor signaling pathway,BP,CRY2;PER1
17977,GO:1902473,0.199457088864871,0.958999618220158,2,7,regulation of protein localization to synapse,BP,NLGN2;WNT7A
9691,GO:0038110,0.199515178718822,0.958979953517389,2,7,interleukin-2-mediated signaling pathway,BP,SHC1;JAK3
8720,GO:0034381,0.199659635712962,0.905799731068361,6,34,plasma lipoprotein particle clearance,BP,APOE;LMF1;CES3;VLDLR;PCSK9;AP2A2
2603,GO:0005902,0.199665444303065,0.893863253915033,8,48,microvillus,CC,BBS2;SYTL1;ESPN;RAPGEF3;PROM2;KIF13B;PLEKHG6;STARD10
9610,GO:0036491,0.199788848247389,0.958887255230203,2,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,PPP1R15A;EIF2AK4
10108,GO:0042659,0.199833124134471,0.958872249407838,2,7,regulation of cell fate specification,BP,DUSP6;FGFR1
1626,GO:0004065,0.199957174506689,0.95883019403889,2,7,arylsulfatase activity,MF,SULF2;ARSA
3320,GO:0007030,0.200085588198253,0.867191339849373,17,114,Golgi organization,BP,OBSL1;CUL7;MAP2K1;FBXW8;TMED4;MAPK3;PI4K2A;MAP2K2;GOLGA2P5;RAB43;TBC1D20;GOLGA8A;COG7;EHD3;ATP8B2;GOLGA2;MYO18A
10278,GO:0043046,0.200103460752547,0.958780576304875,2,7,DNA methylation involved in gamete generation,BP,TDRKH;DNMT3A
1886,GO:0004571,0.200104941366065,0.958780073973909,2,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,EDEM1;MAN1B1
5643,GO:0016742,0.200127411355777,0.958772450205856,2,7,hydroxymethyl-, formyl- and related transferase activity,MF,ALDH1L2;ALDH1L1
14582,GO:0070168,0.200137644554182,0.95876897801489,2,7,negative regulation of biomineral tissue development,BP,ECM1;GAS6
6818,GO:0030285,0.200144310515688,0.95876671614239,2,7,integral component of synaptic vesicle membrane,CC,PTPRS;SV2A
7580,GO:0031957,0.200154592391445,0.958763227223774,2,7,very long-chain fatty acid-CoA ligase activity,MF,SLC27A1;SLC27A3
9349,GO:0035878,0.200199485760979,0.958747992186358,2,7,nail development,BP,ITGA6;ITGB4
8570,GO:0034063,0.200230949853257,0.93842208102899,3,13,stress granule assembly,BP,GRB7;CIRBP;C9ORF72
2292,GO:0005251,0.200344813792456,0.95869865681794,2,7,delayed rectifier potassium channel activity,MF,KCNG1;KCNC4
7152,GO:0031023,0.200419325634189,0.866893570777738,17,115,microtubule organizing center organization,BP,BRSK1;SDCCAG8;ARL2;CEP250;CHD3;PKD2;TUBE1;CHMP1B;CEP68;NDE1;CEP131;CROCC;CHMP5;CHMP4C;HAUS4;TUBGCP6;GOLGA2
5099,GO:0015386,0.200567426449678,0.958623035488712,2,7,potassium:proton antiporter activity,MF,SLC9A7;SLC9A5
4744,GO:0010919,0.200632648100631,0.958600868360925,2,7,regulation of inositol phosphate biosynthetic process,BP,NTSR1;PTAFR
8684,GO:0034331,0.200639394688865,0.958598575078047,2,7,cell junction maintenance,BP,F2R;NLGN2
3518,GO:0007494,0.200646265743921,0.958596239430007,2,7,midgut development,BP,EGFR;FOXL1
9095,GO:0035385,0.200652283039333,0.958594193949768,2,7,Roundabout signaling pathway,BP,SLIT3;ROBO3
19999,GO:2000650,0.2007411998243,0.958563963035188,2,7,negative regulation of sodium ion transmembrane transporter activity,BP,STK39;PCSK9
4983,GO:0015114,0.201169761729686,0.958418121274511,2,7,phosphate ion transmembrane transporter activity,MF,SLC37A2;SLC37A4
9407,GO:0035988,0.201194581154751,0.958409668274156,2,7,chondrocyte proliferation,BP,FGFR3;HMGA2
19728,GO:2000147,0.201234570566674,0.842908811788552,43,319,positive regulation of cell motility,BP,DOCK4;F2R;PGF;POSTN;SEMA4B;VEGFA;EGFR;HBEGF;HYAL1;ITGA6;FAM110C;SPRY2;GRB7;VEGFB;PAK1;CEMIP;SEMA3F;ZP3;MAPK3;SEMA5A;ARHGEF2;DMTN;SEMA3B;SSH1;TGFBR2;TRPV4;TMSB4X;SMURF2;NOS3;WNT7A;EPHA1;SEMA4G;GAS6;PTAFR;CTSH;AKT1;LAMB1;RAB25;PLAU;INSR;FOXO4;ITGA2;FGFR1
8112,GO:0032809,0.20136885414355,0.958350293328509,2,7,neuronal cell body membrane,CC,KCNC4;INSR
10793,GO:0044298,0.20136885414355,0.958350293328509,2,7,cell body membrane,CC,KCNC4;INSR
1630,GO:0004074,0.201428859365618,0.988693068150681,1,2,biliverdin reductase activity,MF,BLVRB
9227,GO:0035634,0.201671611868549,0.988664171120494,1,2,response to stilbenoid,BP,CIDEA
6766,GO:0030208,0.201709572252155,0.958234103964937,2,7,dermatan sulfate biosynthetic process,BP,CSPG4;UST
286,GO:0000791,0.201773430419931,0.912675479500765,5,27,euchromatin,CC,H1F0;ASH2L;TRNP1;DNMT3A;TCF7
17545,GO:1901185,0.201790137514277,0.892442095061667,8,48,negative regulation of ERBB signaling pathway,BP,EGFR;HBEGF;SPRY2;EREG;ERRFI1;ITGA1;TSG101;ERBB2
2194,GO:0005068,0.201902243475044,0.958168338204962,2,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,SHC1;PAG1
4770,GO:0010960,0.201974669500086,0.95814360489894,2,7,magnesium ion homeostasis,BP,EGFR;ANK3
16030,GO:0086103,0.202097347060343,0.958101696302349,2,7,G-protein coupled receptor signaling pathway involved in heart process,BP,NOS1;ATP2B4
12780,GO:0051098,0.202394927224534,0.844489605155572,38,281,regulation of binding,BP,APOE;NFATC4;CTNNBIP1;LRP1;GPSM1;DDIT3;MDFI;TMEM173;CAPRIN2;TTBK2;PPARA;HMGA2;MAPK3;ZFPM1;PKD1;FLOT1;HDAC5;SORL1;HERPUD1;PCSK9;TMSB4X;TRIB3;LDOC1;ZFP90;MAPRE3;CAMK1;AKT1;HFE;CSNK1E;SIRT2;PHLDA2;GOLGA2;PLXND1;HDAC8;TGFBR3;MFNG;ITGA2;HMBOX1
6869,GO:0030371,0.202717389335144,0.922738313562878,4,20,translation repressor activity,MF,CIRBP;PAIP2B;PAIP2;EIF4EBP1
15624,GO:0072163,0.202817206444811,0.883123032907738,10,62,mesonephric epithelium development,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B;PKD1;CAT;FGFR1
15625,GO:0072164,0.202817206444811,0.883123032907738,10,62,mesonephric tubule development,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B;PKD1;CAT;FGFR1
18435,GO:1903556,0.202939098216859,0.911996628636592,5,27,negative regulation of tumor necrosis factor superfamily cytokine production,BP,ACP5;MC1R;ERRFI1;GAS6;CIDEA
10140,GO:0042737,0.203215450776954,0.879191172638166,11,71,drug catabolic process,BP,NT5E;GPX3;PRDX5;NOS1;CYP3A5;PCK2;GLDC;CYP2R1;CTSH;CAT;ADA
1024,GO:0002526,0.203277828502362,0.886688963990877,9,56,acute inflammatory response,BP,IL20RB;CTNNBIP1;NUPR1;SERPING1;ZP3;C5;CEBPB;TRPV1;HFE
15188,GO:0071361,0.203415673963394,0.957650182810564,2,7,cellular response to ethanol,BP,DNMT3A;ITPR2
15633,GO:0072176,0.203467173903886,0.957632501824575,2,7,nephric duct development,BP,PKD2;PKD1
1678,GO:0004145,0.203765003958993,0.988413260622112,1,2,diamine N-acetyltransferase activity,MF,SAT2
6238,GO:0019809,0.203765003958993,0.988413260622112,1,2,spermidine binding,MF,SAT2
8170,GO:0032917,0.203765003958993,0.988413260622112,1,2,polyamine acetylation,BP,SAT2
8171,GO:0032918,0.203765003958993,0.988413260622112,1,2,spermidine acetylation,BP,SAT2
19960,GO:2000586,0.203860483466774,0.957497364494184,2,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1;HIP1
16570,GO:0097421,0.203929353687743,0.911418703342258,5,27,liver regeneration,BP,EGFR;SRSF5;SULF2;CEBPB;HFE
17224,GO:0120032,0.204043980015111,0.862332511672739,18,123,regulation of plasma membrane bounded cell projection assembly,BP,ESPN;ZMYND8;EVI5L;CDC42EP5;IFT140;ARAP1;PLXNB3;NEURL1;SSH3;TWF2;DMTN;DOCK11;SSH1;TENM2;CROCC;EPS8L1;EPS8L2;C15ORF62
5697,GO:0016830,0.204137010588001,0.896376602115676,7,41,carbon-carbon lyase activity,MF,GLUL;MLYCD;HMGCL;PCK2;MVD;AZIN2;ALDOC
17557,GO:1901215,0.204405865688,0.86042981683138,19,131,negative regulation of neuron death,BP,F2R;APOE;LRP1;SYNGAP1;AARS;PPARA;ATF4;MDK;UNC5B;SORL1;CEBPB;MAP3K12;AKT1;NCOA7;BRAF;TP73;FYN;WFS1;SNCB
11234,GO:0045475,0.204486742316014,0.957281800875991,2,7,locomotor rhythm,BP,NAGLU;MTA1
161,GO:0000333,0.204612353486644,0.988310823089858,1,2,telomerase catalytic core complex,CC,TERC
6815,GO:0030282,0.204787960193558,0.885754301020737,9,55,bone mineralization,BP,CYP27B1;FGFR3;ACVR2B;ECM1;FAM20C;PTHLH;ATRAID;FBXL15;NBR1
1926,GO:0004623,0.204999901847447,0.92151860620074,4,20,phospholipase A2 activity,MF,PNPLA3;PLA2G6;PLB1;TMEM8A
10230,GO:0042981,0.205120038948617,0.821223080594562,138,1095,regulation of apoptotic process,BP,XDH;DUSP6;F2R;TNFRSF6B;APOE;HS1BP3;NFATC4;GSN;EGR1;LRP1;PDCD4;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;PRDX5;TNFSF15;DDIT3;NDRG1;ARHGEF19;GRAMD4;MST1R;ZFP36L1;NUPR1;RGL2;RPS6KA2;TFDP2;MAP2K1;BTG1;SYNGAP1;ITGA6;PLEKHG5;SHC1;SPRY2;PRKCZ;PAK1;AARS;STK39;FGFR3;NME4;NEURL1;RAG1;NGFR;ARHGEF4;PLEKHG2;TNFRSF25;PLA2G6;ING4;HMGA2;BNIP3;SEMA5A;THRA;STK40;CTSB;ARHGEF2;INPP5D;MAP2K2;ANGPTL4;ATF4;BBC3;PAK6;IFI6;MDK;KCNMA1;UNC5B;IRF5;HERPUD1;NLRP1;ENDOG;CEBPB;MAP3K12;LRP5;PCSK9;CSRNP3;ITGA1;TNFAIP8L1;DAP;NOS3;AGO4;MINK1;WNT7A;TRPV1;BNIP3L;EPHA1;GAS6;STRADB;CTSH;TNFRSF14;MGMT;ASNS;AKT1;CARD11;MICAL1;BEX2;AMIGO2;CHEK2;IFT57;FGFR4;STEAP3;LMNA;IFI27;INSR;RABGGTA;MAP2K5;BRAF;PIDD1;CAT;LGALS1;TIMP1;JAK3;TP73;MNT;BCL6;FYN;ARHGEF17;SIRT2;GDF15;ADA;CIDEA;MYO18A;CIDEB;TCF7;VAV3;MAP3K10;EPHB2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;NET1;TRIM2;IKBKB;SNCB;HIP1
10662,GO:0043931,0.205613779220599,0.956892667053493,2,7,ossification involved in bone maturation,BP,THBS3;PLXNB1
15748,GO:0072376,0.205804006153928,0.921087423417281,4,20,protein activation cascade,BP,FBLN1;SERPING1;C5;C1RL
18051,GO:1902669,0.206032714629893,0.956747627884613,2,7,positive regulation of axon guidance,BP,VEGFA;SEMA5A
14411,GO:0061744,0.206248625702783,0.988111579192822,1,2,motor behavior,BP,ADARB1
17702,GO:1901659,0.206471559367998,0.894694836327284,7,42,glycosyl compound biosynthetic process,BP,NT5E;TK2;NME4;UCKL1;UPP1;APRT;ADA
18175,GO:1902991,0.206761292258067,0.920573087531568,4,20,regulation of amyloid precursor protein catabolic process,BP,APOE;PRNP;ABCA7;SORL1
14104,GO:0060996,0.206851822876745,0.876643186325016,11,70,dendritic spine development,BP,PTPRS;DLG4;APOE;ZMYND8;SHANK2;CAPRIN2;NEURL1;WNT7A;CAMK1;ARHGAP44;EPHB2
12573,GO:0050773,0.206951092040813,0.865804119028975,15,100,regulation of dendrite development,BP,PTPRS;APOE;ZMYND8;NFATC4;SHANK2;CRTC1;OBSL1;CUL7;CAPRIN2;FBXW8;NEURL1;SDC2;VLDLR;CAMK1;ARHGAP44
3151,GO:0006753,0.20706016266502,0.830879844591509,62,481,nucleoside phosphate metabolic process,BP,XDH;H6PD;DLG4;NT5E;APOE;NAPRT;TIMP2;VEGFA;RAPGEF3;IDH2;NOS1;DNPH1;PGM1;DHTKD1;TK2;LHPP;PCK2;PGLS;DDIT4;OGDHL;NMRK1;NPR2;DLG3;NMNAT2;NME4;NEIL1;ABHD14B;PPCS;PPARA;PKD2;NT5C1B;KCNAB2;FAM20C;MYH3;MLXIPL;SDHA;PTHLH;LTB4R2;GTPBP1;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;MOCOS;PDE2A;NOS3;UCKL1;ADCY6;CARD11;DGUOK;TCIRG1;UPP1;INSR;APRT;TAZ;ADA;ENTPD2;FUK;PFKL;NUDT18
12898,GO:0051272,0.207092453448386,0.837388056125011,44,328,positive regulation of cellular component movement,BP,DOCK4;F2R;PGF;POSTN;SEMA4B;VEGFA;EGFR;HBEGF;HYAL1;ITGA6;FAM110C;SPRY2;GRB7;VEGFB;PAK1;CEMIP;SEMA3F;ZP3;MAPK3;SEMA5A;ARHGEF2;DMTN;SEMA3B;SSH1;TGFBR2;TRPV4;TMSB4X;SMURF2;NOS3;WNT7A;EPHA1;SEMA4G;GAS6;PTAFR;CTSH;AKT1;LAMB1;RAB25;PLAU;INSR;FOXO4;BCL6;ITGA2;FGFR1
7422,GO:0031532,0.207348968357827,0.873089790056171,12,78,actin cytoskeleton reorganization,BP,GSN;RAPGEF3;PARVB;EFS;ARAP1;SHC1;PRKCZ;PAK1;MICALL2;DMTN;TRPV4;MINK1
3417,GO:0007205,0.207572439036077,0.920136409386287,4,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,F2R;LRP1;DGKA;DGKQ
3543,GO:0007568,0.207581184931681,0.846383944011317,29,210,aging,BP,FOS;GSN;LRP1;PDCD4;TIMP2;PRNP;ERCC1;RNF165;MAP2K1;SERPING1;HMGA2;INPP5D;LITAF;ENDOG;DNMT3A;TGFBR2;SRR;TERC;AKT1;CHEK2;IGFBP2;LMNA;FOXO4;YPEL3;CAT;TIMP1;MNT;BCL6;ADA
9783,GO:0040017,0.207806454132279,0.835867195459037,46,344,positive regulation of locomotion,BP,DOCK4;F2R;PGF;POSTN;SEMA4B;VEGFA;EGFR;HBEGF;HYAL1;ITGA6;FAM110C;SPRY2;GRB7;VEGFB;PAK1;CEMIP;SEMA3F;ZP3;MAPK3;PC;SEMA5A;ARHGEF2;DMTN;SEMA3B;SSH1;TGFBR2;TRPV4;TMSB4X;SMURF2;NOS3;WNT7A;EPHA1;SEMA4G;GAS6;PTAFR;CTSH;AKT1;LAMB1;TSG101;RAB25;PLAU;INSR;FOXO4;CHMP4C;ITGA2;FGFR1
7319,GO:0031338,0.20788928866948,0.888337193729606,8,48,regulation of vesicle fusion,BP,EVI5L;TBC1D8;VPS11;TBC1D14;TBC1D3E;RABGAP1;SGSM2;TBC1D16
859,GO:0002192,0.208191113966545,0.987872591607191,1,2,IRES-dependent translational initiation of linear mRNA,BP,EIF4EBP1
17201,GO:0110017,0.208191113966545,0.987872591607191,1,2,cap-independent translational initiation of linear mRNA,BP,EIF4EBP1
1173,GO:0002820,0.208271849303136,0.919759250817154,4,20,negative regulation of adaptive immune response,BP,IL20RB;HFE;JAK3;BCL6
11010,GO:0044877,0.208337952643371,0.824516476747077,86,663,protein-containing complex binding,MF,DLG4;APOE;ESPN;FLNC;GSN;WIPF1;RNF135;LRP1;TIMP2;EGFR;DDB2;PRNP;FCGRT;FBLN1;FCHO1;SPTB;CD9;CRTAP;MRC2;ERCC6;ADAMTS13;MYH15;SMARCA1;OBSL1;LTBP4;NISCH;CAPG;ITGA6;SNX9;ULK1;SHC1;ADM2;MYH11;LAMA5;TPM2;PAK1;MTHFR;PHF1;SYNE3;MICALL2;SHROOM4;ACVR2B;NID1;IMPACT;HMGA2;LAMB2;CTSB;MYH3;PI4K2A;TWF2;DMTN;TTN;WHAMMP3;SORL1;VLDLR;PCSK9;L3MBTL1;CEP131;TRIOBP;TRPV4;TAGLN3;ITGA1;ECM2;TERC;CDKN1C;TSG101;SMARCD2;INSR;GNAL;TNXB;ITGB6;LETMD1;ICAM5;EPS8L1;FYN;SNX1;PEX1;RECQL5;MYO18A;TGFBR3;EPHB2;ITGA2;CORO1B;HMBOX1;GRB10;HIP1
6588,GO:0022612,0.208392755395949,0.869531894637057,13,85,gland morphogenesis,BP,EGFR;LAMA5;ETV5;STAT6;AREG;SULF2;CEBPB;LRP5;TGFBR2;EDA;RXRA;PLXND1;FGFR1
9526,GO:0036293,0.208394126012058,0.84120216415337,35,259,response to decreased oxygen levels,BP,EGR1;PGF;POSTN;VEGFA;CST3;NOS1;NDRG1;ZFP36L1;PLAT;DDIT4;VEGFB;PAK1;MTHFR;PPARA;BNIP3;ANGPTL4;KCNMA1;ENDOG;AQP3;DNMT3A;TGFBR2;BNIP3L;TERC;AKT1;ITPR2;LMNA;CAPN2;PLAU;CAT;SIRT2;ADA;TGFBR3;EPAS1;EDNRA;ITGA2
10746,GO:0044209,0.208667353076913,0.987813590996825,1,2,AMP salvage,BP,APRT
12880,GO:0051250,0.208831004757328,0.871997387325468,12,78,negative regulation of lymphocyte activation,BP,IL20RB;PRNP;PKN1;INPP5D;PDCD1LG2;CEBPB;HFE;JAK3;BCL6;ERBB2;PAG1;HLA-G
2643,GO:0005980,0.208957154497524,0.919389129981244,4,20,glycogen catabolic process,BP,PYGB;PGM1;GAA;PYGL
4173,GO:0009251,0.208957154497524,0.919389129981244,4,20,glucan catabolic process,BP,PYGB;PGM1;GAA;PYGL
18917,GO:1904705,0.209202749585812,0.908322128474818,5,27,regulation of vascular smooth muscle cell proliferation,BP,PDCD4;MEF2D;PAK1;APLN;ERN1
19621,GO:1990874,0.209202749585812,0.908322128474818,5,27,vascular smooth muscle cell proliferation,BP,PDCD4;MEF2D;PAK1;APLN;ERN1
15973,GO:0086010,0.209400643740918,0.919149309848454,4,20,membrane depolarization during action potential,BP,SCN8A;ANK3;SCN4B;TPCN1
6907,GO:0030506,0.209429616299487,0.934172002945142,3,13,ankyrin binding,MF,FLNC;OBSCN;SPTB
698,GO:0001919,0.209468397297678,0.919112650877908,4,20,regulation of receptor recycling,BP,ARAP1;PCSK9;CHMP5;TBC1D16
517,GO:0001588,0.209470815376963,0.987713686124279,1,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,GPR21
2138,GO:0004952,0.209470815376963,0.987713686124279,1,2,dopamine neurotransmitter receptor activity,MF,GPR21
19874,GO:2000395,0.209618588189488,0.987695261667625,1,2,regulation of ubiquitin-dependent endocytosis,BP,TSG101
19875,GO:2000397,0.209618588189488,0.987695261667625,1,2,positive regulation of ubiquitin-dependent endocytosis,BP,TSG101
9877,GO:0042171,0.209695714938223,0.918989617495061,4,20,lysophosphatidic acid acyltransferase activity,MF,LPCAT4;PNPLA3;TAZ;MBOAT2
15349,GO:0071617,0.209695714938223,0.918989617495061,4,20,lysophospholipid acyltransferase activity,MF,LPCAT4;PNPLA3;TAZ;MBOAT2
6661,GO:0030027,0.209972860238845,0.85176387849254,22,154,lamellipodium,CC,ACTA2;GSN;RAPGEF3;PARVB;ARAP3;ARPIN;PLEKHG5;PAK1;PKD2;CSPG4;DYSF;PLEK2;TWF2;SSH1;FLOT1;TRPV4;SCYL3;SNX1;RAB13;PLXND1;CORO1B;PLEKHH2
3288,GO:0006982,0.21007303877651,0.987638502993709,1,2,response to lipid hydroperoxide,BP,GPX3
8711,GO:0034370,0.210100937067629,0.98763501384456,1,2,triglyceride-rich lipoprotein particle remodeling,BP,APOE
8713,GO:0034372,0.210100937067629,0.98763501384456,1,2,very-low-density lipoprotein particle remodeling,BP,APOE
5266,GO:0015918,0.21021776902263,0.881870539124561,9,56,sterol transport,BP,APOE;OSBPL5;LRP1;ABCA2;ABCA7;ABCG1;PLTP;PCSK9;OSBPL1A
6689,GO:0030073,0.210389194716299,0.857312023499362,18,124,insulin secretion,BP,GLUL;NR1D1;HADH;RAPGEF3;PCK2;ARL2;NLGN2;ITPR3;ACVR2B;PLA2G6;ANO1;PCLO;LRP5;GLUD1;ITPR2;ICA1;STX1A;PFKL
16470,GO:0097194,0.210456676322906,0.873947188242504,11,71,execution phase of apoptosis,BP,H1F0;SATB1;BBC3;ENDOG;CDK5RAP3;SHARPIN;AKT1;DNASE2;SIRT2;CIDEA;CIDEB
18091,GO:1902803,0.210559769141663,0.918521392982459,4,20,regulation of synaptic vesicle transport,BP,SEPT5;RIMS3;BRAF;STX1A
4237,GO:0009439,0.210717071055032,0.987557814674094,1,2,cyanate metabolic process,BP,TST
4238,GO:0009440,0.210717071055032,0.987557814674094,1,2,cyanate catabolic process,BP,TST
4423,GO:0010256,0.210781788841871,0.832446307994142,48,358,endomembrane system organization,BP,F2R;SERPINE2;GSN;ANK3;NEK9;DNM1;NDRG1;OBSL1;REEP2;CUL7;SYNGR1;MAP2K1;SNX9;VPS11;FBXW8;TMED4;ALS2CL;SH3TC2;MAPK3;DYSF;HOOK2;PI4K2A;CHMP1B;MAP2K2;FLOT1;RFX2;ANO9;GOLGA2P5;RAB43;AKT1;REEP4;TSG101;LMNA;TBC1D20;CHMP5;GOLGA8A;COG7;CHMP4C;LYST;MYOF;SNX33;EHD3;ATP8B2;LEMD2;GOLGA2;MYO18A;BLOC1S1;SEC31B
20100,GO:2000821,0.211023820891807,0.987519279267546,1,2,regulation of grooming behavior,BP,DLG4
18759,GO:1904304,0.2110477381689,0.987516271843633,1,2,regulation of gastro-intestinal system smooth muscle contraction,BP,PTAFR
18760,GO:1904306,0.2110477381689,0.987516271843633,1,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,PTAFR
20024,GO:2000678,0.211136487648765,0.932641436036058,3,14,negative regulation of transcription regulatory region DNA binding,BP,DDIT3;PPARA;TMSB4X
2381,GO:0005518,0.211314376140314,0.891688392435722,7,41,collagen binding,MF,MRC2;PAK1;NID1;CTSB;ITGA1;ECM2;ITGA2
19550,GO:1990622,0.211468059948482,0.987463352837667,1,2,CHOP-ATF3 complex,CC,DDIT3
11100,GO:0045143,0.21153097438837,0.906944861078949,5,27,homologous chromosome segregation,BP,MLH3;AGO4;REC8;LEMD2;MSH5
6331,GO:0021510,0.21161272667067,0.885812881604357,8,48,spinal cord development,BP,PTPRS;ADARB1;SOX12;PKD2;TCTN1;PKD1;VLDLR;AKT1
11369,GO:0045765,0.211763941576821,0.84788000722669,24,170,regulation of angiogenesis,BP,PGF;VEGFA;RAPGEF3;ADGRB2;HYAL1;BTG1;SPRY2;VEGFB;ADM2;NGFR;C5;HMGA2;ECM1;SEMA5A;ANGPTL4;HDAC5;TGFBR2;NOS3;EPHA1;CTSH;FOXO4;MAP2K5;PLXND1;ERBB2
17253,GO:0140029,0.212011990347975,0.880617269827029,9,56,exocytic process,BP,SNPH;EXOC2;VPS11;RAB3B;SEPT5;DMTN;RAB40B;RAB13;STX1A
10414,GO:0043277,0.212088644295264,0.906614053274828,5,27,apoptotic cell clearance,BP,LRP1;ABCA7;PEAR1;SPG11;GAS6
5703,GO:0016838,0.212103369915977,0.987383127216435,1,2,carbon-oxygen lyase activity, acting on phosphates,MF,THNSL2
17457,GO:1900390,0.212267214594809,0.987362390484761,1,2,regulation of iron ion import,BP,HFE
18812,GO:1904432,0.212267214594809,0.987362390484761,1,2,regulation of ferrous iron binding,BP,HFE
18813,GO:1904434,0.212267214594809,0.987362390484761,1,2,positive regulation of ferrous iron binding,BP,HFE
18814,GO:1904435,0.212267214594809,0.987362390484761,1,2,regulation of transferrin receptor binding,BP,HFE
18815,GO:1904437,0.212267214594809,0.987362390484761,1,2,positive regulation of transferrin receptor binding,BP,HFE
10943,GO:0044715,0.212339673155545,0.987353213767628,1,2,8-oxo-dGDP phosphatase activity,MF,NUDT18
3878,GO:0008514,0.212400213785118,0.854097078515189,19,131,organic anion transmembrane transporter activity,MF,SLC2A3;SLC7A8;SLC16A3;SLC2A9;SLC27A1;SLC16A5;SLC43A1;TMEM44;SLCO4A1;PQLC2;SLC38A10;SLC6A9;SLC6A6;SLC25A29;SLC22A15;SLC38A2;SLC25A42;SLC10A6;BSG
6424,GO:0021696,0.212433283005667,0.917503086220728,4,20,cerebellar cortex morphogenesis,BP,SERPINE2;MAP2K1;TRNP1;WNT7A
10843,GO:0044375,0.212488570645685,0.987334344447003,1,2,regulation of peroxisome size,BP,PEX11A
9823,GO:0042073,0.212584556253938,0.885015395937744,8,49,intraciliary transport,BP,IFT140;WDR60;KIF17;IFT27;CEP131;WDR19;IFT57;TTC21A
7830,GO:0032393,0.212618126857114,0.98731791328902,1,2,MHC class I receptor activity,MF,CTSH
996,GO:0002460,0.21275431689483,0.853781635116268,19,132,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL20RB;ERCC1;PKN1;PRKCZ;SERPING1;ZP3;SCART1;C5;STAT6;C1RL;INPP5D;CTSH;BTN3A2;HFE;JAK3;BTN3A3;BCL6;ADA;POU2F2
6053,GO:0019205,0.212804445281932,0.890540491436616,7,42,nucleobase-containing compound kinase activity,MF,DLG4;TK2;DLG3;NME4;UCKL1;CARD11;DGUOK
6889,GO:0030431,0.212975417473721,0.931766985559259,3,14,sleep,BP,FOS;CST3;ADA
6214,GO:0019751,0.213070300181661,0.865962676557734,13,86,polyol metabolic process,BP,ISYNA1;NTSR1;CYP27B1;PCK2;PLCH2;PLCD3;PLCD1;INPP5D;GALK1;PTAFR;CYP2R1;TKFC;INPP4A
1139,GO:0002731,0.213093879877699,0.98725747219855,1,2,negative regulation of dendritic cell cytokine production,BP,JAK3
564,GO:0001706,0.213157596147628,0.890475758982593,7,41,endoderm formation,BP,DUSP6;DUSP5;COL6A1;HMGA2;COL8A1;ITGB5;LAMB1
3039,GO:0006595,0.21317712829272,0.931670812044593,3,14,polyamine metabolic process,BP,AZIN2;SAT2;DHPS
14503,GO:0070026,0.213195801283952,0.987244502727353,1,2,nitric oxide binding,MF,CBS
13978,GO:0060720,0.213616219955901,0.987190925928509,1,2,spongiotrophoblast cell proliferation,BP,PHLDA2
13979,GO:0060721,0.213616219955901,0.987190925928509,1,2,regulation of spongiotrophoblast cell proliferation,BP,PHLDA2
13980,GO:0060722,0.213616219955901,0.987190925928509,1,2,cell proliferation involved in embryonic placenta development,BP,PHLDA2
13981,GO:0060723,0.213616219955901,0.987190925928509,1,2,regulation of cell proliferation involved in embryonic placenta development,BP,PHLDA2
16164,GO:0090214,0.213616219955901,0.987190925928509,1,2,spongiotrophoblast layer developmental growth,BP,PHLDA2
11580,GO:0046203,0.213664659820924,0.987184744772709,1,2,spermidine catabolic process,BP,DHPS
7698,GO:0032190,0.213773702484226,0.987170824259595,1,2,acrosin binding,MF,ZP3
9314,GO:0035803,0.213773702484226,0.987170824259595,1,2,egg coat formation,BP,ZP3
11928,GO:0047025,0.213836732833404,0.987162773844788,1,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,CBR4
103,GO:0000215,0.213965051720461,0.987146375791083,1,2,tRNA 2'-phosphotransferase activity,MF,TRPT1
6830,GO:0030301,0.214248290871316,0.883880338163141,8,49,cholesterol transport,BP,APOE;OSBPL5;LRP1;ABCA2;ABCA7;ABCG1;PLTP;PCSK9
19794,GO:2000282,0.214398246461641,0.987090929985945,1,2,regulation of cellular amino acid biosynthetic process,BP,ATP2B4
1254,GO:0003010,0.214457346701451,0.987083355143176,1,2,voluntary skeletal muscle contraction,BP,TNNT1
4864,GO:0014721,0.214457346701451,0.987083355143176,1,2,twitch skeletal muscle contraction,BP,TNNT1
4259,GO:0009608,0.214611185728578,0.987063625929145,1,2,response to symbiont,BP,PTAFR
4260,GO:0009609,0.214611185728578,0.987063625929145,1,2,response to symbiotic bacterium,BP,PTAFR
13474,GO:0055065,0.21478552839881,0.831191272964729,43,323,metal ion homeostasis,BP,DLG4;F2R;APOE;NTSR1;EGFR;PRNP;SLC7A8;ANK3;NOS1;DDIT3;CYP27B1;SLC12A7;CYBRD1;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;BNIP3;SV2A;PKD1;KCNMA1;HERPUD1;GSTM2;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;STEAP2;ITPR2;STEAP3;TPCN1;LETMD1;HFE;SCNN1A;ATP12A;FYN;TRPC1;EPAS1;EDNRA;WFS1
8818,GO:0034614,0.214821391114905,0.855548011115611,17,118,cellular response to reactive oxygen species,BP,FOS;EGFR;PRDX5;CST3;MAPK13;IMPACT;PKD2;STAT6;MAPK3;BNIP3;ENDOG;MAP1LC3A;NOS3;CCS;AKT1;ANKZF1;NET1
17512,GO:1901069,0.21494406744091,0.987020877067002,1,2,guanosine-containing compound catabolic process,BP,NUDT18
2192,GO:0005055,0.215524282609323,0.986946175159365,1,2,laminin receptor activity,MF,BCAM
3623,GO:0008081,0.215554693141471,0.878133654056816,9,56,phosphoric diester hydrolase activity,MF,PLD3;PLCH2;PLCXD1;PLCD3;PLCD1;PDE2A;CHRM3;EDNRA;MPPE1
9406,GO:0035987,0.215659213374177,0.895802183789356,6,34,endodermal cell differentiation,BP,DUSP6;COL6A1;HMGA2;COL8A1;ITGB5;LAMB1
732,GO:0001963,0.215681508122422,0.930472545565295,3,14,synaptic transmission, dopaminergic,BP,RAB3B;FLOT1;PNKD
9825,GO:0042078,0.2157104317727,0.986922157420689,1,2,germ-line stem cell division,BP,ETV5
12081,GO:0048133,0.2157104317727,0.986922157420689,1,2,male germ-line stem cell asymmetric division,BP,ETV5
16805,GO:0098728,0.2157104317727,0.986922157420689,1,2,germline stem cell asymmetric division,BP,ETV5
6718,GO:0030136,0.215795835429463,0.853041118913403,18,124,clathrin-coated vesicle,CC,APOE;LRP1;EGFR;CLTCL1;CD9;HBEGF;SNX9;VPS11;CEMIP;MALL;VAMP2;AP1G2;EPN3;STEAP2;RASSF9;RAB13;AP2A2;HIP1
15832,GO:0072577,0.215903887180656,0.904341388449064,5,27,endothelial cell apoptotic process,BP,PDCD4;SEMA5A;ANGPTL4;GAS6;BRAF
19475,GO:1990379,0.215947111497054,0.986891584016586,1,2,lipid transport across blood brain barrier,BP,APOE
7026,GO:0030808,0.215991372144098,0.863762668449746,13,86,regulation of nucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;DDIT4;PPARA;MLXIPL;PTHLH;LTB4R2;GABBR1;TMSB4X;NOS3;INSR;TAZ
17450,GO:1900371,0.215991372144098,0.863762668449746,13,86,regulation of purine nucleotide biosynthetic process,BP,APOE;TIMP2;NOS1;DDIT4;PPARA;MLXIPL;PTHLH;LTB4R2;GABBR1;TMSB4X;NOS3;INSR;TAZ
17408,GO:1900208,0.215999635130481,0.986884793743163,1,2,regulation of cardiolipin metabolic process,BP,TAZ
17409,GO:1900210,0.215999635130481,0.986884793743163,1,2,positive regulation of cardiolipin metabolic process,BP,TAZ
4710,GO:0010877,0.216107161096865,0.986870886554588,1,2,lipid transport involved in lipid storage,BP,APOE
19253,GO:1905477,0.21614322024129,0.861019633768822,14,94,positive regulation of protein localization to membrane,BP,LRP1;EGFR;PRNP;ANK3;TFDP2;PAK1;CEMIP;BBC3;SSH1;AKT1;TP73;FYN;EPHB2;ERBB2
15852,GO:0072606,0.216228786207797,0.930209654708,3,14,interleukin-8 secretion,BP,F2R;TMSB4X;MAPKBP1
3413,GO:0007198,0.216380285772773,0.986835523734484,1,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,HTR7
14189,GO:0061152,0.216620341017387,0.986804398206128,1,2,trachea submucosa development,BP,EDA
14190,GO:0061153,0.216620341017387,0.986804398206128,1,2,trachea gland development,BP,EDA
4880,GO:0014802,0.216731387715493,0.986789985858055,1,2,terminal cisterna,CC,RTN2
633,GO:0001823,0.21681441707878,0.873050501722748,10,63,mesonephros development,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B;PKD1;CAT;FGFR1
11973,GO:0047374,0.216851478133387,0.986774389753297,1,2,methylumbelliferyl-acetate deacetylase activity,MF,CES2
18123,GO:1902893,0.216948455479626,0.903716282841968,5,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4;FOS;NGFR;PPARA;APLN
16425,GO:0097114,0.217032607796856,0.986750846829675,1,2,NMDA glutamate receptor clustering,BP,APOE
11399,GO:0045833,0.217154105594006,0.881891320423131,8,49,negative regulation of lipid metabolic process,BP,APOE;SLC27A1;CYP27B1;ACACB;TRIB3;AKT1;ACADVL;CIDEA
10014,GO:0042475,0.217221490520208,0.876961014641968,9,56,odontogenesis of dentin-containing tooth,BP,HTRA1;ITGA6;LAMA5;ITGB4;ACVR2B;PPARA;FAM20C;EDA;BSG
17688,GO:1901629,0.217463137196408,0.986694792366279,1,2,regulation of presynaptic membrane organization,BP,APOE
1732,GO:0004332,0.21747236314526,0.986693589693634,1,2,fructose-bisphosphate aldolase activity,MF,ALDOC
5560,GO:0016577,0.217544478277799,0.903359049371115,5,27,histone demethylation,BP,KDM3A;KDM4C;KDM7A;PHF2;HSF4
5610,GO:0016667,0.217551587971513,0.881485296043067,8,50,oxidoreductase activity, acting on a sulfur group of donors,MF,MSRB2;TXNRD3;ERO1B;GSTO1;SESN2;CCS;GSTO2;TXNRD2
13129,GO:0051725,0.217655192805157,0.986669743780298,1,2,protein de-ADP-ribosylation,BP,MACROD1
1497,GO:0003845,0.217690085017082,0.986665190152993,1,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,HSD11B1
13836,GO:0060478,0.217778045136575,0.986653706966849,1,2,acrosomal vesicle exocytosis,BP,ZP3
19851,GO:2000367,0.217778045136575,0.986653706966849,1,2,regulation of acrosomal vesicle exocytosis,BP,ZP3
19852,GO:2000368,0.217778045136575,0.986653706966849,1,2,positive regulation of acrosomal vesicle exocytosis,BP,ZP3
10612,GO:0043627,0.217884444027539,0.881390096662669,8,49,response to estrogen,BP,CITED4;ASH2L;CYP27B1;TGFBR2;WNT7A;IGFBP2;KRT19;GSTM3
10359,GO:0043197,0.218049351371191,0.857221516670062,15,101,dendritic spine,CC,DLG4;ZMYND8;FBXO2;NTSR1;NR1D1;DNM1;NOS1;SHANK2;NEURL1;RGS14;TENM2;TRPV1;FARP1;ARHGAP44;APBA1
19500,GO:1990425,0.21816031183538,0.98660373714833,1,2,ryanodine receptor complex,CC,NOS1
3166,GO:0006780,0.218211708294759,0.986597010560225,1,2,uroporphyrinogen III biosynthetic process,BP,UROS
11690,GO:0046502,0.218211708294759,0.986597010560225,1,2,uroporphyrinogen III metabolic process,BP,UROS
936,GO:0002337,0.218236397973198,0.986593778582785,1,2,B-1a B cell differentiation,BP,CMTM7
12639,GO:0050867,0.21835301337879,0.841299372949365,25,180,positive regulation of cell activation,BP,EFNB3;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;STAT6;INPP5D;PDCD1LG2;DMTN;TGFBR2;GAS6;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;LGALS1;JAK3;BCL6;FYN;ADA;VAV3;DHPS;HLA-G
17558,GO:1901216,0.218558813803075,0.871697909596941,10,64,positive regulation of neuron death,BP,FOS;EGR1;PRNP;DDIT3;DDIT4;ATF4;SSH1;PCSK9;ITGA1;FYN
14009,GO:0060764,0.218608588353937,0.986545003967613,1,2,cell-cell signaling involved in mammary gland development,BP,LRP5
12255,GO:0048584,0.218715596166744,0.805790723084073,179,1435,positive regulation of response to stimulus,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;F2R;NFATC4;GSN;PGF;FGFBP1;WIPF1;PTK6;EDEM1;ALOX15B;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;RBCK1;PRNP;NR1D1;S100A4;DUSP5;TNFSF15;IGFBP4;NOS1;DDIT3;SHANK2;ERCC6;MST1R;ARAP1;HBEGF;RGL2;CTF1;TFDP2;EVC;MAPK13;RNF165;MAP2K1;CYP27B1;PKN1;MC1R;SHC2;MAML3;TMEM173;PLEKHG5;FAM110C;SHC1;SPRY2;GRB7;VEGFB;RAB3B;NLGN2;CAPRIN2;PRKCZ;SERPING1;PAK1;ABCA7;STK39;FGFR3;ZP3;NEURL1;ACVR2B;NGFR;GSTO1;MUC19;WNT2B;NSMCE4A;PLXNB1;EREG;TMED4;TNFRSF25;PLA2G6;ERMAP;LPAR3;S100A13;C5;ANO1;NLRX1;PKD2;STAT6;HMGA2;ECM1;MAPK3;CSPG4;BNIP3;SEMA5A;VANGL2;SH2D2A;CTSB;C1RL;INPP5D;MAP2K2;LRSAM1;DMTN;LITAF;BBC3;SSH1;NSMCE1;FLOT1;UNC5B;HERPUD1;GSTM2;SULF2;ENDOG;MAP3K12;CREBRF;FBXL15;TGFBR2;TRPV4;ITGA1;TMSB4X;PDE2A;SMURF2;EDA;CDK5RAP3;MINK1;WNT7A;PIK3R2;EPHA1;SHARPIN;GAS6;ERN1;PTAFR;PPP1R15A;CTSH;MGMT;AKT1;CARD11;CDKN1C;HMSD;IL17RC;FGFR4;TMOD2;SH2B3;INSR;WNT3;YPEL3;RPS6KA5;MAP2K5;BRAF;EDA2R;BTN3A2;PIDD1;CAT;MAPK10;LGALS1;HFE;TP73;MIB2;CSNK1E;BTN3A3;TKFC;FYN;GDF15;ADA;TMEM101;AVPI1;TGFBR3;CIDEB;VAV3;STX1A;LAMTOR2;MAP3K10;MFNG;STARD10;LURAP1;EPHB2;ITGA2;FGFR1;FKBP8;CTH;ERBB2;EIF2AK4;PAG1;GRB10;IKBKB;HIP1
4486,GO:0010513,0.218738694608769,0.986527930232222,1,2,positive regulation of phosphatidylinositol biosynthetic process,BP,ZP3
3873,GO:0008508,0.218745484793023,0.986527038825716,1,2,bile acid:sodium symporter activity,MF,SLC10A6
15719,GO:0072330,0.218778115788827,0.837926658465913,28,203,monocarboxylic acid biosynthetic process,BP,ALOX15B;NR1D1;PGM1;DHTKD1;MLYCD;DDIT4;OGDHL;PPARA;ACACB;CSPG4;ACSS2;MLXIPL;GALK1;ACOT7;ALDOC;TRIB3;SRR;THNSL2;ASNS;FGFR4;CBR4;ACADVL;INSR;ACSS1;OSBPL1A;UST;PFKL;ACOT8
15152,GO:0071313,0.218830282668531,0.986515903860722,1,2,cellular response to caffeine,BP,GSTM2
15223,GO:0071415,0.218830282668531,0.986515903860722,1,2,cellular response to purine-containing compound,BP,GSTM2
1735,GO:0004335,0.218865907287544,0.986511224373972,1,2,galactokinase activity,MF,GALK1
13018,GO:0051499,0.218867147898808,0.986511061396419,1,2,D-aminoacyl-tRNA deacylase activity,MF,DTD1
13019,GO:0051500,0.218867147898808,0.986511061396419,1,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,DTD1
14355,GO:0061622,0.218872260185523,0.986510389789883,1,2,glycolytic process through glucose-1-phosphate,BP,GALK1
1544,GO:0003941,0.219172612787888,0.986470898937698,1,2,L-serine ammonia-lyase activity,MF,SRR
19750,GO:2000196,0.219320330062431,0.986451452861604,1,2,positive regulation of female gonad development,BP,ZP3
19866,GO:2000386,0.219320330062431,0.986451452861604,1,2,positive regulation of ovarian follicle development,BP,ZP3
1214,GO:0002885,0.21934571077542,0.986448110054587,1,2,positive regulation of hypersensitivity,BP,ZP3
3398,GO:0007181,0.219431299411795,0.986436834026814,1,2,transforming growth factor beta receptor complex assembly,BP,TGFBR3
1875,GO:0004557,0.219611063905241,0.986413133348459,1,2,alpha-galactosidase activity,MF,NAGA
2033,GO:0004776,0.219731623539899,0.986397225289862,1,2,succinate-CoA ligase (GDP-forming) activity,MF,SUCLG2
17386,GO:1900150,0.219825513931092,0.98638482898615,1,2,regulation of defense response to fungus,BP,FAM3A
11462,GO:0045940,0.219869894919175,0.928451166813189,3,14,positive regulation of steroid metabolic process,BP,APOE;NR1D1;ABCG1
9614,GO:0036496,0.219878190615889,0.986377871309122,1,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,PPP1R15A
1130,GO:0002719,0.219902158606026,0.928435511622728,3,14,negative regulation of cytokine production involved in immune response,BP,HFE;JAK3;BCL6
7555,GO:0031906,0.220132152238369,0.986344299137165,1,2,late endosome lumen,CC,CTSH
16602,GO:0097486,0.220132152238369,0.986344299137165,1,2,multivesicular body lumen,CC,CTSH
4660,GO:0010813,0.220270601225914,0.986325977318974,1,2,neuropeptide catabolic process,BP,CTSH
11821,GO:0046813,0.220277578935591,0.986325053546885,1,2,receptor-mediated virion attachment to host cell,BP,GAS6
19045,GO:1904954,0.220383493038885,0.98631102734408,1,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3
12227,GO:0048523,0.220434923853125,0.797795853267297,400,3282,negative regulation of cellular process,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;ZC3H6;HTRA1;F2R;TNFRSF6B;APOE;ESPN;ZMYND8;NFATC4;XPC;SERPINE2;FHL1;IL20RB;GSN;EGR1;CTNNBIP1;FGFBP1;POSTN;PPP1R35;EVI5L;FBXO2;DDIT4L;PTK6;ACP5;WWC3;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;RBCK1;PRNP;NR1D1;ERCC1;FBLN1;ADAMTS7;HADH;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;RAPGEF3;SPTB;IGFBP4;CD9;IDH2;CRTAP;CST3;DNM1;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;DNAJB5;CGREF1;NDRG1;MMP28;MST1R;ARRDC1;ZFP36L1;ADARB1;NUPR1;ARAP1;TCFL5;HBEGF;RBL2;RGL2;RPS6KA2;TFDP2;MXI1;EFNB3;RPL13A;MDFI;PLAT;ULK2;SLC27A1;KLF9;NISCH;PHACTR3;EPM2A;HYAL1;ARPIN;PPP1R14A;WWTR1;MAP2K1;CYP27B1;MXD4;PKN1;CAPG;DDIT4;H2AFJ;BTG1;TOM1L2;SYNGAP1;ITGA6;PHF21A;DGKQ;EML2;MAGEF1;ULK1;SHC1;SPRY2;GRB7;NPHP4;ITPR3;UNK;CIRBP;CAPRIN2;TTBK2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;MCTP1;ELK3;STK39;PEAR1;FGFR3;CEMIP;KDM3A;FOXQ1;PHF1;NPR2;SEMA3F;PLXNB3;SPRY4;SALL2;DLG3;ZP3;NEIL1;NEURL1;ACVR2B;RAG1;EAPP;SPEG;NGFR;ELFN2;GSTO1;LTBP1;TRIB2;HES2;PLXNB1;EREG;PTPRE;NAB2;PLA2G6;ABCG1;MTMR4;C5;APOBEC3F;PPARA;CHAC1;SESN2;RASA4;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;ING4;HMGA2;AREG;SLIT3;ECM1;ACACB;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;STK40;RGS14;IRF2BPL;PBXIP1;SNTA1;MAPK12;SRGAP3;MLXIPL;TBC1D14;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;TWF2;STMN3;LRSAM1;DMTN;ANGPTL4;SEMA3B;PTHLH;ATF4;ZFPM1;KDM4C;LTB4R2;TENM2;FBXO6;IFI6;CBX7;PKD1;MDK;JDP2;UNC5B;HDAC5;WHAMMP3;SORL1;PCBP4;HERPUD1;GSTM2;VLDLR;PAPLN;GABBR1;DEAF1;SULF2;NLRP1;PEG3;EGFL7;CEBPB;MAP3K12;RHBDF1;LRP5;PTPRU;ATRAID;CREBRF;PCSK9;PKIB;L3MBTL1;MARK3;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;ARHGAP25;CSRNP3;ITGA1;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;PEMT;HMG20B;CDK5RAP3;NOS3;AGO4;LDOC1;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;GAS6;ERN1;LZTS2;BCR;NBR1;TERC;PPP1R15A;RXRA;ADCY6;MBD1;TNRC18;ATP2B4;STRADB;CTSH;MGMT;ASNS;C12ORF66;TP53I11;PAIP2B;HINT2;MAPKBP1;AKT1;IGFBP7;ITPR2;DGUOK;CDKN1C;MICAL1;CRY2;AMIGO2;CHEK2;HMSD;IFT57;IGFBP2;ASS1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;TMOD2;PIAS3;ACADVL;FARP1;LMNA;C9ORF72;UHRF2;IFI27;INSR;WNT3;NCOA7;NELFCD;FOXO4;RPS6KA5;CHMP4C;TPCN1;CTDSPL;MAP2K5;BRAF;GPR21;ARHGAP44;ASIC1;PIDD1;CAT;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;MNT;SNX33;PHC1;BCL6;HSF4;RNF213;TKFC;FYN;ZC3H12D;LEMD2;SIRT2;TRPC1;RECQL5;GOLGA2;ADA;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;MYO18A;EIF4EBP1;TGFBR3;TCF7;LAMTOR2;MAP3K10;EPHB2;PER1;IGF2BP3;FGFR1;WFS1;FKBP8;CTH;ERBB2;EIF2AK4;UNC119;PAG1;RGS12;SYVN1;PFKL;HLA-G;CORO1B;SFI1;HMBOX1;GRB10;TSHZ1;KCTD11;KCTD13;PNKD;IKBKB;SNCB;PLEKHH2;TEAD2;ACOT8;SIX5
13050,GO:0051582,0.220472491339379,0.9862992350042,1,2,positive regulation of neurotransmitter uptake,BP,RAB3B
2006,GO:0004735,0.22048246594705,0.986297913002954,1,2,pyrroline-5-carboxylate reductase activity,MF,PYCR2
10825,GO:0044338,0.220488230057925,0.986297149014037,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
16691,GO:0097711,0.220492240792291,0.857690428107203,14,94,ciliary basal body-plasma membrane docking,BP,NINL;SDCCAG8;NPHP4;TTBK2;CEP250;CNTRL;TCTN1;FBF1;NDE1;CEP131;MARK4;HAUS4;CSNK1E;SFI1
8180,GO:0032929,0.220537635966918,0.986290599647876,1,2,negative regulation of superoxide anion generation,BP,ACP5
919,GO:0002314,0.220539837690512,0.986290307740848,1,2,germinal center B cell differentiation,BP,ADA
2631,GO:0005960,0.220542357160926,0.986289973702251,1,2,glycine cleavage complex,CC,GLDC
11511,GO:0046056,0.220544472448568,0.986289693247839,1,2,dADP metabolic process,BP,NUDT18
9464,GO:0036112,0.220643189786172,0.986276601240474,1,2,medium-chain fatty-acyl-CoA metabolic process,BP,ACOT7
13568,GO:0060061,0.220673358893053,0.986272598766617,1,2,Spemann organizer formation,BP,WNT3
2748,GO:0006154,0.220689490661861,0.986270458326506,1,2,adenosine catabolic process,BP,ADA
11541,GO:0046103,0.220689490661861,0.986270458326506,1,2,inosine biosynthetic process,BP,ADA
4882,GO:0014806,0.220750063172919,0.986262419588899,1,2,smooth muscle hyperplasia,BP,NOS3
5074,GO:0015307,0.220859403186728,0.986247902038927,1,2,drug:proton antiporter activity,MF,SLC22A18
11740,GO:0046618,0.220859403186728,0.986247902038927,1,2,drug export,BP,SLC22A18
18456,GO:1903589,0.220939666969843,0.986237239537784,1,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA
8072,GO:0032764,0.220941824761483,0.986236952825145,1,2,negative regulation of mast cell cytokine production,BP,BCL6
11125,GO:0045188,0.220943268689099,0.986236760963995,1,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADA
8896,GO:0034739,0.220952000246725,0.986235600730339,1,2,histone deacetylase activity (H4-K16 specific),MF,SIRT2
13744,GO:0060348,0.221076597721635,0.850703365170192,17,116,bone development,BP,THBS3;ACP5;MEF2D;COL13A1;FGFR3;NPR2;PLXNB1;NAB2;FAM20C;ZFPM1;SLC38A10;SULF2;LRP5;TGFBR2;TRPV4;PEX7;TRIM45
4074,GO:0009132,0.221149924222439,0.852572723925973,16,110,nucleoside diphosphate metabolic process,BP,DLG4;PGM1;DHTKD1;DDIT4;OGDHL;DLG3;NME4;PPARA;MLXIPL;GALK1;ALDOC;CARD11;INSR;ENTPD2;PFKL;NUDT18
1158,GO:0002767,0.221165157937959,0.986207259531555,1,2,immune response-inhibiting cell surface receptor signaling pathway,BP,HLA-G
10487,GO:0043407,0.221183057624972,0.869801574350478,10,64,negative regulation of MAP kinase activity,BP,DUSP6;APOE;PDCD4;DUSP5;SPRY2;SPRY4;RGS14;SORL1;CDK5RAP3;TP73
10358,GO:0043196,0.221260763284954,0.986194537225381,1,2,varicosity,CC,DNM1
5592,GO:0016628,0.221329401570637,0.912166009225929,4,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,BLVRB;SRD5A3;PTGR2;TM7SF2
14267,GO:0061394,0.22135528655332,0.986181952378084,1,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,ATF4
12483,GO:0050613,0.221358450342853,0.986181531038132,1,2,delta14-sterol reductase activity,MF,TM7SF2
3581,GO:0007631,0.22143482615456,0.891901542753719,6,35,feeding behavior,BP,FOS;ADM2;APLN;FYN;EIF2AK4;MMP17
2480,GO:0005719,0.221438958140977,0.91210491432581,4,21,nuclear euchromatin,CC,H1F0;ASH2L;TRNP1;TCF7
12132,GO:0048261,0.221453929040462,0.927681032840269,3,14,negative regulation of receptor-mediated endocytosis,BP,DLG4;PCSK9;UNC119
2046,GO:0004797,0.221477869629756,0.986165621963678,1,2,thymidine kinase activity,MF,TK2
1649,GO:0004103,0.221613533934387,0.986147536134937,1,2,choline kinase activity,MF,CHKB
1061,GO:0002589,0.221633182684981,0.986144915588829,1,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,HFE
1062,GO:0002590,0.221633182684981,0.986144915588829,1,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,HFE
19286,GO:1905595,0.221758948239631,0.986128135631886,1,2,regulation of low-density lipoprotein particle receptor binding,BP,PCSK9
19558,GO:1990667,0.221758948239631,0.986128135631886,1,2,PCSK9-AnxA2 complex,CC,PCSK9
3437,GO:0007231,0.221793864997552,0.986123474908333,1,2,osmosensory signaling pathway,BP,TRPV4
13226,GO:0051930,0.221825921792035,0.927499726018199,3,14,regulation of sensory perception of pain,BP,F2R;NTSR1;PTAFR
13227,GO:0051931,0.221825921792035,0.927499726018199,3,14,regulation of sensory perception,BP,F2R;NTSR1;PTAFR
18196,GO:1903025,0.221875260024057,0.949534913046424,2,8,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,DDIT3;TMSB4X
14697,GO:0070373,0.221883289603269,0.878636436347335,8,49,negative regulation of ERK1 and ERK2 cascade,BP,TNIP1;DUSP6;FBLN1;SPRY2;SPRY4;ERRFI1;RGS14;EPHB2
6130,GO:0019400,0.221971626123511,0.927428664112095,3,14,alditol metabolic process,BP,PCK2;GALK1;TKFC
2237,GO:0005146,0.221982630400736,0.986098262944943,1,2,leukemia inhibitory factor receptor binding,MF,CTF1
6342,GO:0021523,0.222172807940126,0.986072836133476,1,2,somatic motor neuron differentiation,BP,TCTN1
19541,GO:1990590,0.222175619128749,0.986072460078852,1,2,ATF1-ATF4 transcription factor complex,CC,ATF4
1802,GO:0004450,0.222186676132047,0.986070980920196,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH2
2716,GO:0006097,0.222186676132047,0.986070980920196,1,2,glyoxylate cycle,BP,IDH2
1238,GO:0002933,0.222237682426694,0.986064156362892,1,2,lipid hydroxylation,BP,CYP3A5
17086,GO:0101020,0.222237682426694,0.986064156362892,1,2,estrogen 16-alpha-hydroxylase activity,MF,CYP3A5
19393,GO:1990005,0.222254209094506,0.986061944715717,1,2,granular vesicle,CC,AZIN2
19210,GO:1905384,0.222266404036107,0.986060312625182,1,2,regulation of protein localization to presynapse,BP,WNT7A
19211,GO:1905386,0.222266404036107,0.986060312625182,1,2,positive regulation of protein localization to presynapse,BP,WNT7A
5958,GO:0018352,0.222303210097499,0.986055386087874,1,2,protein-pyridoxal-5-phosphate linkage,BP,CTH
1168,GO:0002791,0.222331113517887,0.828075164219838,37,271,regulation of peptide secretion,BP,F2R;POSTN;GLUL;ALOX15B;EGFR;NR1D1;HADH;RAPGEF3;IDH2;PCK2;ARL2;NLGN2;ITPR3;PRKCZ;PLA2G6;C5;ANO1;MAPK3;TTN;NLRP1;RHBDF1;LRP5;TRPV4;TMSB4X;APLN;RHBDF2;GAS6;GLUD1;MAPKBP1;ITPR2;IL17RC;ICA1;HFE;CIDEA;MYO18A;STX1A;PFKL
13571,GO:0060066,0.222335397889912,0.986051076902469,1,2,oviduct development,BP,WNT7A
7225,GO:0031133,0.222360932630123,0.98604765786673,1,2,regulation of axon diameter,BP,WNT7A
17864,GO:1902174,0.222457280410882,0.986034752868535,1,2,positive regulation of keratinocyte apoptotic process,BP,GSN
12720,GO:0051012,0.222470266891896,0.986033012918092,1,2,microtubule sliding,BP,SPAG16
18868,GO:1904580,0.222490411490994,0.986030313667741,1,2,regulation of intracellular mRNA localization,BP,ZFP36L1
18869,GO:1904582,0.222490411490994,0.986030313667741,1,2,positive regulation of intracellular mRNA localization,BP,ZFP36L1
629,GO:0001819,0.22252069076585,0.82985960983609,34,252,positive regulation of cytokine production,BP,F2R;NFATC4;IL20RB;EGR1;POSTN;RNF135;ALOX15B;DDIT3;MAPK13;TMEM173;PRKCZ;ZP3;CCDC88B;EREG;C5;NLRX1;STAT6;MAPK3;ARHGEF2;ATF4;ZFPM1;FLOT1;IRF5;SULF2;NLRP1;CEBPB;TRPV4;PTAFR;CARD11;IL17RC;TKFC;POLR3GL;LURAP1;HLA-G
4436,GO:0010324,0.222549799396388,0.884066616003172,7,42,membrane invagination,BP,GSN;SNX9;ABCA7;ARHGAP25;SNX33;SPIRE1;ITGA2
19648,GO:1990967,0.222596527488495,0.986016089904004,1,2,multi-organism toxin transport,BP,RAB40B
8086,GO:0032782,0.222770920789228,0.98599269643279,1,2,bile acid secretion,BP,STARD10
6217,GO:0019763,0.222795994769312,0.985989331134561,1,2,immunoglobulin receptor activity,MF,FCGRT
15824,GO:0072566,0.222798823952402,0.985988951387673,1,2,chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19831,GO:2000338,0.222798823952402,0.985988951387673,1,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19832,GO:2000340,0.222798823952402,0.985988951387673,1,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
9763,GO:0039656,0.222824142759207,0.985985552712579,1,2,modulation by virus of host gene expression,BP,CPSF4
11813,GO:0046778,0.222824142759207,0.985985552712579,1,2,modification by virus of host mRNA processing,BP,CPSF4
10112,GO:0042663,0.222854785726725,0.985981438722282,1,2,regulation of endodermal cell fate specification,BP,DUSP6
19497,GO:1990418,0.222910358240463,0.985973976053134,1,2,response to insulin-like growth factor stimulus,BP,AKT1
3826,GO:0008430,0.222921133882515,0.985972528763139,1,2,selenium binding,MF,GPX3
8269,GO:0033084,0.222944420587186,0.985969400807244,1,2,regulation of immature T cell proliferation in thymus,BP,ERBB2
8272,GO:0033088,0.222944420587186,0.985969400807244,1,2,negative regulation of immature T cell proliferation in thymus,BP,ERBB2
7090,GO:0030895,0.222991905208071,0.985963021272401,1,2,apolipoprotein B mRNA editing enzyme complex,CC,APOBEC3F
12152,GO:0048295,0.223008778023189,0.98596075402205,1,2,positive regulation of isotype switching to IgE isotypes,BP,STAT6
5006,GO:0015168,0.223017333732443,0.985959604286587,1,2,glycerol transmembrane transporter activity,MF,AQP3
5052,GO:0015254,0.223017333732443,0.985959604286587,1,2,glycerol channel activity,MF,AQP3
5195,GO:0015793,0.223017333732443,0.985959604286587,1,2,glycerol transport,BP,AQP3
15578,GO:0072089,0.22303821145365,0.864724781329899,11,71,stem cell proliferation,BP,VEGFA;FBLN1;ZFP36L1;WNT2B;HMGA2;ARHGEF2;LTBP3;NDE1;WNT3;FGFR1;KCTD11
3205,GO:0006844,0.223100357062404,0.985948444650602,1,2,acyl carnitine transport,BP,SLC25A29
5040,GO:0015227,0.223100357062404,0.985948444650602,1,2,acyl carnitine transmembrane transporter activity,MF,SLC25A29
17597,GO:1901329,0.223108692911473,0.985947323904049,1,2,regulation of odontoblast differentiation,BP,CEBPB
19745,GO:2000191,0.223213364772514,0.926821988598055,3,14,regulation of fatty acid transport,BP,NTSR1;PLA2G6;AKT1
1941,GO:0004647,0.223226877358298,0.985931428667002,1,2,phosphoserine phosphatase activity,MF,PSPH
16345,GO:0090677,0.223238066998422,0.985929923186131,1,2,reversible differentiation,BP,OLFM2
16346,GO:0090678,0.223238066998422,0.985929923186131,1,2,cell dedifferentiation involved in phenotypic switching,BP,OLFM2
19132,GO:1905174,0.223238066998422,0.985929923186131,1,2,regulation of vascular smooth muscle cell dedifferentiation,BP,OLFM2
19642,GO:1990936,0.223238066998422,0.985929923186131,1,2,vascular smooth muscle cell dedifferentiation,BP,OLFM2
18200,GO:1903031,0.223266774163703,0.985926060437663,1,2,regulation of microtubule plus-end binding,BP,MAPRE3
18201,GO:1903033,0.223266774163703,0.985926060437663,1,2,positive regulation of microtubule plus-end binding,BP,MAPRE3
17404,GO:1900195,0.223277503195276,0.985924616617493,1,2,positive regulation of oocyte maturation,BP,SIRT2
2062,GO:0004817,0.223277914535704,0.985924561261169,1,2,cysteine-tRNA ligase activity,MF,CARS
2910,GO:0006423,0.223277914535704,0.985924561261169,1,2,cysteinyl-tRNA aminoacylation,BP,CARS
2153,GO:0004977,0.2232849609494,0.985923612968004,1,2,melanocortin receptor activity,MF,MC1R
9831,GO:0042091,0.223376526545018,0.985911286945365,1,2,interleukin-10 biosynthetic process,BP,TRIB2
11056,GO:0045074,0.223376526545018,0.985911286945365,1,2,regulation of interleukin-10 biosynthetic process,BP,TRIB2
1647,GO:0004096,0.223418486513708,0.985905636495392,1,2,catalase activity,MF,CAT
15911,GO:0072739,0.223418764749271,0.985905599023129,1,2,response to anisomycin,BP,MAPK13
20075,GO:2000777,0.223487156255085,0.985896386456915,1,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,SIRT2
9626,GO:0036509,0.223535213349034,0.98588991096103,1,2,trimming of terminal mannose on B branch,BP,MAN1B1
9628,GO:0036511,0.223535213349034,0.98588991096103,1,2,trimming of first mannose on A branch,BP,MAN1B1
9629,GO:0036512,0.223535213349034,0.98588991096103,1,2,trimming of second mannose on A branch,BP,MAN1B1
19974,GO:2000616,0.22353779255215,0.985889563376312,1,2,negative regulation of histone H3-K9 acetylation,BP,HDAC8
15897,GO:0072709,0.223542224176124,0.985888966139862,1,2,cellular response to sorbitol,BP,MAPK13
15953,GO:0080144,0.223562517810809,0.98588623104555,1,2,amino acid homeostasis,BP,PQLC2
1878,GO:0004560,0.223563411856195,0.985886110542794,1,2,alpha-L-fucosidase activity,MF,FUCA1
5273,GO:0015928,0.223563411856195,0.985886110542794,1,2,fucosidase activity,MF,FUCA1
20106,GO:2000828,0.223613796721727,0.985879318540025,1,2,regulation of parathyroid hormone secretion,BP,FGFR1
15801,GO:0072529,0.223686685748093,0.899349160692426,5,28,pyrimidine-containing compound catabolic process,BP,NT5E;APOBEC3C;NEIL1;APOBEC3F;UPP1
18127,GO:1902897,0.223720065707502,0.985864987140761,1,2,regulation of postsynaptic density protein 95 clustering,BP,ZMYND8
19355,GO:1905874,0.223720065707502,0.985864987140761,1,2,regulation of postsynaptic density organization,BP,ZMYND8
3563,GO:0007608,0.223766617885283,0.92655107334729,3,14,sensory perception of smell,BP,BBS1;GNAL;GJB4
16271,GO:0090402,0.22380912962624,0.985852969655431,1,2,oncogene-induced cell senescence,BP,HMGA2
9468,GO:0036117,0.223840108088125,0.98584878834127,1,2,hyaluranon cable,CC,HYAL1
6665,GO:0030032,0.223842610577143,0.877281503165604,8,49,lamellipodium assembly,BP,PARVB;PLXNB3;ARHGEF4;SSH3;TWF2;DMTN;SSH1;VAV3
10208,GO:0042903,0.223846868438454,0.985847875770562,1,2,tubulin deacetylase activity,MF,SIRT2
19554,GO:1990641,0.223858203740507,0.985846345558275,1,2,response to iron ion starvation,BP,HFE
2115,GO:0004906,0.223907015864516,0.985839755078883,1,2,interferon-gamma receptor activity,MF,IFNGR2
19226,GO:1905424,0.223962406817838,0.985832274234592,1,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,CSNK1E
19227,GO:1905426,0.223962406817838,0.985832274234592,1,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,CSNK1E
8658,GO:0034242,0.223984124260342,0.985829340565834,1,2,negative regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
4413,GO:0010193,0.223988564980785,0.985828740655206,1,2,response to ozone,BP,CAT
2733,GO:0006116,0.224006782357163,0.985826279462691,1,2,NADH oxidation,BP,PCK2
7666,GO:0032104,0.224066756973885,0.926403944214011,3,14,regulation of response to extracellular stimulus,BP,BBS2;CYP27B1;PPARA
7669,GO:0032107,0.224066756973885,0.926403944214011,3,14,regulation of response to nutrient levels,BP,BBS2;CYP27B1;PPARA
12960,GO:0051387,0.224143812705696,0.985807758697996,1,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
14968,GO:0070905,0.224214230906468,0.98579823576523,1,2,serine binding,MF,THNSL2
3141,GO:0006739,0.224277296018697,0.898989798917386,5,28,NADP metabolic process,BP,H6PD;IDH2;PGLS;KCNAB2;NADK
11532,GO:0046086,0.224283145339987,0.985788912681648,1,2,adenosine biosynthetic process,BP,NT5E
14801,GO:0070564,0.224286020898712,0.985788523586419,1,2,positive regulation of vitamin D receptor signaling pathway,BP,CYP27B1
13811,GO:0060437,0.224297150057729,0.985787017629826,1,2,lung growth,BP,SPRY2
10706,GO:0044058,0.224341563945043,0.926269135544552,3,14,regulation of digestive system process,BP,STK39;WNK4;TRPV1
3419,GO:0007207,0.224363228421259,0.985778074284492,1,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,CHRM3
3928,GO:0008614,0.224415091795222,0.985771052622889,1,2,pyridoxine metabolic process,BP,PSAT1
3929,GO:0008615,0.224415091795222,0.985771052622889,1,2,pyridoxine biosynthetic process,BP,PSAT1
1808,GO:0004461,0.224452929525728,0.9857659286189,1,2,lactose synthase activity,MF,B4GALT2
1610,GO:0004040,0.224453842582051,0.985765804959362,1,2,amidase activity,MF,FAAH
4588,GO:0010701,0.224472753152902,0.985763243675383,1,2,positive regulation of norepinephrine secretion,BP,STX1A
896,GO:0002276,0.224475261837726,0.98576290387465,1,2,basophil activation involved in immune response,BP,PI4K2A
11249,GO:0045575,0.224475261837726,0.98576290387465,1,2,basophil activation,BP,PI4K2A
16391,GO:0097055,0.224538612614685,0.985754321500944,1,2,agmatine biosynthetic process,BP,AZIN2
17539,GO:1901162,0.224538612614685,0.985754321500944,1,2,primary amino compound biosynthetic process,BP,AZIN2
11851,GO:0046879,0.224609224070907,0.837275464280302,24,172,hormone secretion,BP,GLUL;EGFR;NR1D1;HADH;RAPGEF3;LTBP4;PCK2;ARL2;NLGN2;ITPR3;ACVR2B;PLA2G6;ANO1;PCLO;LRP5;TRPV4;APLN;GLUD1;ITPR2;ICA1;HFE;STX1A;FGFR1;PFKL
13647,GO:0060199,0.22461626109041,0.985743798156725,1,2,clathrin-sculpted glutamate transport vesicle,CC,VAMP2
13650,GO:0060203,0.22461626109041,0.985743798156725,1,2,clathrin-sculpted glutamate transport vesicle membrane,CC,VAMP2
542,GO:0001661,0.224640578047704,0.985740501682925,1,2,conditioned taste aversion,BP,FOS
14739,GO:0070447,0.224644928018514,0.985739911943256,1,2,positive regulation of oligodendrocyte progenitor proliferation,BP,GJC2
16500,GO:0097241,0.224646738089278,0.985739666541987,1,2,hematopoietic stem cell migration to bone marrow,BP,GAS6
15079,GO:0071149,0.224647880127074,0.98573951170841,1,2,TEAD-2-YAP complex,CC,TEAD2
1505,GO:0003865,0.224650789358977,0.985739117280358,1,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,SRD5A3
8514,GO:0033765,0.224650789358977,0.985739117280358,1,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,SRD5A3
9248,GO:0035671,0.224650789358977,0.985739117280358,1,2,enone reductase activity,MF,SRD5A3
12016,GO:0047751,0.224650789358977,0.985739117280358,1,2,cholestenone 5-alpha-reductase activity,MF,SRD5A3
19589,GO:1990769,0.224655976781397,0.985738413964285,1,2,proximal neuron projection,CC,GJC2
19540,GO:1990589,0.224664283514376,0.985737287687863,1,2,ATF4-CREB1 transcription factor complex,CC,ATF4
1627,GO:0004066,0.224683287886936,0.985734710771604,1,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,ASNS
2983,GO:0006529,0.224683287886936,0.985734710771604,1,2,asparagine biosynthetic process,BP,ASNS
15948,GO:0080121,0.224706173350973,0.985731607244103,1,2,AMP transport,BP,SLC25A42
13800,GO:0060423,0.224707479972919,0.985731430039843,1,2,foregut regionalization,BP,WNT2B
13801,GO:0060424,0.224707479972919,0.985731430039843,1,2,lung field specification,BP,WNT2B
13849,GO:0060492,0.224707479972919,0.985731430039843,1,2,lung induction,BP,WNT2B
18711,GO:1904207,0.224715723735436,0.98573031199072,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
18712,GO:1904209,0.224715723735436,0.98573031199072,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
13268,GO:0051990,0.224749439063992,0.985725738877031,1,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,D2HGDH
3388,GO:0007168,0.224758989608982,0.985724443299316,1,2,receptor guanylyl cyclase signaling pathway,BP,NPR2
12285,GO:0048645,0.224760886213297,0.889764164377274,6,35,animal organ formation,BP,MAP2K1;WNT2B;MAPK3;TGFBR2;LEMD2;FGFR1
5363,GO:0016165,0.224801995673704,0.98571860849091,1,2,linoleate 13S-lipoxygenase activity,MF,ALOX15B
17186,GO:0106072,0.224818829387311,0.98571632422345,1,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,ATP2B4
16033,GO:0089709,0.224821964861939,0.985715898729171,1,2,L-histidine transmembrane transport,BP,SLC25A29
19834,GO:2000342,0.224831711581317,0.985714576021233,1,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,MAP2K5
8934,GO:0034991,0.224893248131721,0.985706223411937,1,2,nuclear meiotic cohesin complex,CC,REC8
4874,GO:0014740,0.224928455841344,0.985701443277415,1,2,negative regulation of muscle hyperplasia,BP,NOS3
14099,GO:0060988,0.224940269138681,0.985699839188046,1,2,lipid tube assembly,BP,SNX9
5797,GO:0017055,0.224960251128272,0.985697125665825,1,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
16821,GO:0098758,0.224964159686169,0.985696594855694,1,2,response to interleukin-8,BP,EGR1
16822,GO:0098759,0.224964159686169,0.985696594855694,1,2,cellular response to interleukin-8,BP,EGR1
2169,GO:0005006,0.224965144341586,0.985696461130709,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
16739,GO:0098560,0.224971428392232,0.985695607683712,1,2,cytoplasmic side of late endosome membrane,CC,LITAF
9963,GO:0042369,0.224976310356987,0.985694944636298,1,2,vitamin D catabolic process,BP,CYP27B1
14078,GO:0060940,0.224983649621295,0.985693947816203,1,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,PDCD4
19536,GO:1990575,0.224987013843358,0.985693490873774,1,2,mitochondrial L-ornithine transmembrane transport,BP,SLC25A29
6084,GO:0019254,0.224988637715493,0.985693270309858,1,2,carnitine metabolic process, CoA-linked,BP,CRAT
19701,GO:2000097,0.224992852217943,0.985692697862211,1,2,regulation of smooth muscle cell-matrix adhesion,BP,PLAU
1545,GO:0003943,0.225000366230261,0.985691677216266,1,2,N-acetylgalactosamine-4-sulfatase activity,MF,GALNS
4514,GO:0010572,0.225011201202075,0.985690205403815,1,2,positive regulation of platelet activation,BP,DMTN
17734,GO:1901731,0.225011201202075,0.985690205403815,1,2,positive regulation of platelet aggregation,BP,DMTN
1748,GO:0004351,0.225012144465592,0.985690077267685,1,2,glutamate decarboxylase activity,MF,GLUL
9098,GO:0035402,0.225022739024707,0.985688638022174,1,2,histone kinase activity (H3-T11 specific),MF,PKN1
9103,GO:0035407,0.225022739024707,0.985688638022174,1,2,histone H3-T11 phosphorylation,BP,PKN1
5116,GO:0015467,0.225022941478343,0.985688610518522,1,2,G-protein activated inward rectifier potassium channel activity,MF,KCNJ15
5532,GO:0016524,0.225024245032096,0.985688433428023,1,2,latrotoxin receptor activity,MF,ADGRL1
6015,GO:0019075,0.225024245032096,0.985688433428023,1,2,virus maturation,BP,MVB12B
9721,GO:0038190,0.225026313675457,0.985688152395831,1,2,VEGF-activated neuropilin signaling pathway,BP,VEGFA
17934,GO:1902336,0.225026313675457,0.985688152395831,1,2,positive regulation of retinal ganglion cell axon guidance,BP,VEGFA
6209,GO:0019732,0.225028316571126,0.985687880292804,1,2,antifungal humoral response,BP,FAM3A
7214,GO:0031117,0.225036068655577,0.985686827106933,1,2,positive regulation of microtubule depolymerization,BP,TRPV4
20026,GO:2000683,0.225039539592119,0.985686355536717,1,2,regulation of cellular response to X-ray,BP,HMGA2
18519,GO:1903756,0.225039700832876,0.985686333629927,1,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8
18520,GO:1903758,0.225039700832876,0.985686333629927,1,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8
13588,GO:0060086,0.225043452709048,0.985685823880213,1,2,circadian temperature homeostasis,BP,NR1D1
9274,GO:0035727,0.225045895005454,0.985685492051341,1,2,lysophosphatidic acid binding,MF,PNPLA3
11288,GO:0045626,0.2250474104412,0.985685286150611,1,2,negative regulation of T-helper 1 cell differentiation,BP,JAK3
15288,GO:0071505,0.225052467476973,0.985684599044027,1,2,response to mycophenolic acid,BP,EGR1
15289,GO:0071506,0.225052467476973,0.985684599044027,1,2,cellular response to mycophenolic acid,BP,EGR1
20232,GO:2001226,0.225056865301694,0.985684001490118,1,2,negative regulation of chloride transport,BP,ANO9
7938,GO:0032542,0.22505999180423,0.985683576668349,1,2,sulfiredoxin activity,MF,SESN2
15684,GO:0072262,0.22506548951771,0.985682829634693,1,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,EGR1
15702,GO:0072301,0.22506548951771,0.985682829634693,1,2,regulation of metanephric glomerular mesangial cell proliferation,BP,EGR1
15367,GO:0071642,0.22507478910657,0.985681565948802,1,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,TRPV4
2623,GO:0005945,0.225099303390641,0.985678234492026,1,2,6-phosphofructokinase complex,CC,PFKL
18581,GO:1903892,0.225103206623522,0.985677704007529,1,2,negative regulation of ATF6-mediated unfolded protein response,BP,WFS1
4766,GO:0010956,0.225105282066867,0.985677421931529,1,2,negative regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1
14281,GO:0061441,0.225122380738626,0.985675097910529,1,2,renal artery morphogenesis,BP,PKD2
514,GO:0001579,0.225124875587099,0.985674758797254,1,2,medium-chain fatty acid transport,BP,SLC27A1
4784,GO:0010979,0.225125764399495,0.98567463798396,1,2,regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
4785,GO:0010980,0.225125764399495,0.98567463798396,1,2,positive regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
12308,GO:0048682,0.225127300095475,0.98567442924062,1,2,sprouting of injured axon,BP,LAMB2
19093,GO:1905064,0.225127554834939,0.985674394614363,1,2,negative regulation of vascular smooth muscle cell differentiation,BP,PDCD4
15219,GO:0071403,0.225129981831846,0.985674064714698,1,2,cellular response to high density lipoprotein particle stimulus,BP,ABCG1
5254,GO:0015888,0.225131374239955,0.985673875443851,1,2,thiamine transport,BP,SLC35F3
20016,GO:2000669,0.225135378521049,0.98567333113176,1,2,negative regulation of dendritic cell apoptotic process,BP,GAS6
18647,GO:1904020,0.22513685680975,0.985673130181263,1,2,regulation of G-protein coupled receptor internalization,BP,APLN
17031,GO:0099541,0.225142914089687,0.985672306770949,1,2,trans-synaptic signaling by lipid,BP,F2R
17032,GO:0099542,0.225142914089687,0.985672306770949,1,2,trans-synaptic signaling by endocannabinoid,BP,F2R
12183,GO:0048382,0.225142951689674,0.985672301659629,1,2,mesendoderm development,BP,ZFP36L1
9135,GO:0035500,0.225145252770715,0.985671988849773,1,2,MH2 domain binding,MF,HMGA2
15303,GO:0071546,0.225149917160597,0.985671354758861,1,2,pi-body,CC,TDRKH
9554,GO:0036363,0.225153376458257,0.985670884481437,1,2,transforming growth factor beta activation,BP,LTBP3
13809,GO:0060434,0.22516037633042,0.98566993285051,1,2,bronchus morphogenesis,BP,TGFBR2
7860,GO:0032430,0.225161640107663,0.985669761036463,1,2,positive regulation of phospholipase A2 activity,BP,EGFR
1671,GO:0004137,0.225176005577629,0.985667807928569,1,2,deoxycytidine kinase activity,MF,TK2
15793,GO:0072521,0.225176854551834,0.818523156034761,51,395,purine-containing compound metabolic process,BP,XDH;DLG4;GAMT;NT5E;APOE;TIMP2;VEGFA;RAPGEF3;SLC2A9;NOS1;DNPH1;PGM1;DHTKD1;DDIT4;OGDHL;NPR2;DLG3;NME4;ABHD14B;PPCS;PPARA;PKD2;NT5C1B;MACROD1;FAM20C;MYH3;MLXIPL;SDHA;PTHLH;LTB4R2;GTPBP1;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;MOCOS;PDE2A;PEMT;NOS3;ADCY6;CARD11;DGUOK;TCIRG1;INSR;APRT;TAZ;ADA;PFKL;NUDT18
7520,GO:0031749,0.225177612520799,0.985667589441579,1,2,D2 dopamine receptor binding,MF,DNM1
12466,GO:0050473,0.225178804072423,0.98566742743179,1,2,arachidonate 15-lipoxygenase activity,MF,ALOX15B
8520,GO:0033842,0.225181924365973,0.985667003174955,1,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,B4GALNT4
6925,GO:0030538,0.2251833782589,0.985666805491079,1,2,embryonic genitalia morphogenesis,BP,TCF7
3755,GO:0008300,0.225185859977054,0.985666468051697,1,2,isoprenoid catabolic process,BP,SRD5A3
6136,GO:0019408,0.225187800898266,0.985666204141327,1,2,dolichol biosynthetic process,BP,SRD5A3
18961,GO:1904783,0.225188156644754,0.985666155769562,1,2,positive regulation of NMDA glutamate receptor activity,BP,EPHB2
17642,GO:1901529,0.225190795724277,0.985665796924294,1,2,positive regulation of anion channel activity,BP,PTAFR
3412,GO:0007197,0.225191309748742,0.985665727029926,1,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,CHRM3
5750,GO:0016907,0.225191309748742,0.985665727029926,1,2,G-protein coupled acetylcholine receptor activity,MF,CHRM3
5085,GO:0015349,0.225194498157727,0.985665293482331,1,2,thyroid hormone transmembrane transporter activity,MF,SLCO4A1
10228,GO:0042978,0.225199001369827,0.985664681140203,1,2,ornithine decarboxylase activator activity,MF,AZIN2
17911,GO:1902269,0.225199001369827,0.985664681140203,1,2,positive regulation of polyamine transmembrane transport,BP,AZIN2
17699,GO:1901656,0.225202157975407,0.985664251899318,1,2,glycoside transport,BP,SLC50A1
14513,GO:0070051,0.225202290371605,0.985664233895705,1,2,fibrinogen binding,MF,FBLN1
5729,GO:0016880,0.225202405539708,0.985664218234793,1,2,acid-ammonia (or amide) ligase activity,MF,GLUL
1440,GO:0003430,0.225203560523938,0.985664061175977,1,2,growth plate cartilage chondrocyte growth,BP,TGFBR2
19946,GO:2000563,0.225205579533605,0.985663786621524,1,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,TGFBR2
16891,GO:0098886,0.225209141419651,0.985663302252249,1,2,modification of dendritic spine,BP,ARHGAP44
19872,GO:2000393,0.225209331194184,0.985663276445151,1,2,negative regulation of lamellipodium morphogenesis,BP,ARPIN
16660,GO:0097632,0.225210411482997,0.985663129538204,1,2,extrinsic component of phagophore assembly site membrane,CC,ULK1
16638,GO:0097543,0.2252121517842,0.98566289287529,1,2,ciliary inversin compartment,CC,NEK8
5058,GO:0015275,0.225212502673624,0.985662845157683,1,2,stretch-activated, cation-selective, calcium channel activity,MF,TRPV4
17286,GO:0140135,0.225212502673624,0.985662845157683,1,2,mechanosensitive cation channel activity,MF,TRPV4
12151,GO:0048294,0.225215453298095,0.985662443897565,1,2,negative regulation of isotype switching to IgE isotypes,BP,BCL6
9334,GO:0035860,0.225217314743906,0.985662190753309,1,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,SULF2
2106,GO:0004886,0.225218971016149,0.98566196550913,1,2,9-cis retinoic acid receptor activity,MF,RXRA
2593,GO:0005889,0.225220215375419,0.985661796281625,1,2,potassium:proton exchanging ATPase complex,CC,ATP12A
15701,GO:0072300,0.225237385594454,0.985659461089581,1,2,positive regulation of metanephric glomerulus development,BP,EGR1
4272,GO:0009637,0.225238822413703,0.985659265668886,1,2,response to blue light,BP,CRY2
4304,GO:0009785,0.225238822413703,0.985659265668886,1,2,blue light signaling pathway,BP,CRY2
4329,GO:0009882,0.225238822413703,0.985659265668886,1,2,blue light photoreceptor activity,MF,CRY2
15272,GO:0071483,0.225238822413703,0.985659265668886,1,2,cellular response to blue light,BP,CRY2
12999,GO:0051458,0.225249833455481,0.985657768014834,1,2,corticotropin secretion,BP,APLN
13000,GO:0051459,0.225249833455481,0.985657768014834,1,2,regulation of corticotropin secretion,BP,APLN
13001,GO:0051461,0.225249833455481,0.985657768014834,1,2,positive regulation of corticotropin secretion,BP,APLN
11217,GO:0045409,0.225252658836431,0.98565738370959,1,2,negative regulation of interleukin-6 biosynthetic process,BP,INPP5D
3615,GO:0008065,0.225259116887883,0.985656505270534,1,2,establishment of blood-nerve barrier,BP,GSTM3
10900,GO:0044501,0.225260169156773,0.985656362135596,1,2,modulation of signal transduction in other organism,BP,TNIP1
13271,GO:0052027,0.225260169156773,0.985656362135596,1,2,modulation by symbiont of host signal transduction pathway,BP,TNIP1
13305,GO:0052250,0.225260169156773,0.985656362135596,1,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,TNIP1
6138,GO:0019417,0.225260994918909,0.985656249810674,1,2,sulfur oxidation,BP,MICAL1
9795,GO:0040038,0.22526105207242,0.985656242036299,1,2,polar body extrusion after meiotic divisions,BP,SPIRE1
14845,GO:0070649,0.22526105207242,0.985656242036299,1,2,formin-nucleated actin cable assembly,BP,SPIRE1
17199,GO:0110009,0.22526105207242,0.985656242036299,1,2,formin-nucleated actin cable organization,BP,SPIRE1
14514,GO:0070052,0.225275250534954,0.985654310601043,1,2,collagen V binding,MF,ECM2
10812,GO:0044323,0.225276094097799,0.985654195845464,1,2,retinoic acid-responsive element binding,MF,RXRA
9178,GO:0035574,0.225278294665545,0.98565389648474,1,2,histone H4-K20 demethylation,BP,KDM7A
9179,GO:0035575,0.225278294665545,0.98565389648474,1,2,histone demethylase activity (H4-K20 specific),MF,KDM7A
8378,GO:0033300,0.225284961428956,0.985652989530473,1,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A3
14920,GO:0070837,0.225284961428956,0.985652989530473,1,2,dehydroascorbic acid transport,BP,SLC2A3
9652,GO:0038025,0.225298232152315,0.985651184068759,1,2,reelin receptor activity,MF,VLDLR
14899,GO:0070777,0.225299386310715,0.985651027041164,1,2,D-aspartate transport,BP,NTSR1
14901,GO:0070779,0.225299386310715,0.985651027041164,1,2,D-aspartate import across plasma membrane,BP,NTSR1
9991,GO:0042426,0.225302125515321,0.985650654358184,1,2,choline catabolic process,BP,ALDH7A1
15255,GO:0071462,0.225305984482828,0.985650129316264,1,2,cellular response to water stimulus,BP,PKD2
12,GO:0000023,0.225309232733612,0.985649687358551,1,2,maltose metabolic process,BP,GAA
1876,GO:0004558,0.225309232733612,0.985649687358551,1,2,alpha-1,4-glucosidase activity,MF,GAA
7874,GO:0032450,0.225309232733612,0.985649687358551,1,2,maltose alpha-glucosidase activity,MF,GAA
1255,GO:0003011,0.225310346431085,0.98564953582689,1,2,involuntary skeletal muscle contraction,BP,GAA
11315,GO:0045659,0.225313765790873,0.985649070576942,1,2,negative regulation of neutrophil differentiation,BP,INPP5D
19557,GO:1990666,0.225318545549858,0.985648420211992,1,2,PCSK9-LDLR complex,CC,PCSK9
19502,GO:1990428,0.225322640906799,0.98564786295782,1,2,miRNA transport,BP,TGFBR2
3534,GO:0007529,0.225329617981686,0.985646913560818,1,2,establishment of synaptic specificity at neuromuscular junction,BP,F2R
18949,GO:1904761,0.225329972060734,0.985646865379034,1,2,negative regulation of myofibroblast differentiation,BP,PDCD4
12177,GO:0048369,0.225331265577152,0.985646689361079,1,2,lateral mesoderm morphogenesis,BP,FGFR1
12178,GO:0048370,0.225331265577152,0.985646689361079,1,2,lateral mesoderm formation,BP,FGFR1
12179,GO:0048371,0.225331265577152,0.985646689361079,1,2,lateral mesodermal cell differentiation,BP,FGFR1
12180,GO:0048372,0.225331265577152,0.985646689361079,1,2,lateral mesodermal cell fate commitment,BP,FGFR1
12181,GO:0048377,0.225331265577152,0.985646689361079,1,2,lateral mesodermal cell fate specification,BP,FGFR1
12182,GO:0048378,0.225331265577152,0.985646689361079,1,2,regulation of lateral mesodermal cell fate specification,BP,FGFR1
8852,GO:0034665,0.225334061868376,0.985646308845728,1,2,integrin alpha1-beta1 complex,CC,ITGA1
153,GO:0000309,0.225348797023598,0.985644303612123,1,2,nicotinamide-nucleotide adenylyltransferase activity,MF,NMNAT2
6107,GO:0019355,0.225348797023598,0.985644303612123,1,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,NMNAT2
8826,GO:0034627,0.225348797023598,0.985644303612123,1,2,'de novo' NAD biosynthetic process,BP,NMNAT2
8827,GO:0034628,0.225348797023598,0.985644303612123,1,2,'de novo' NAD biosynthetic process from aspartate,BP,NMNAT2
16420,GO:0097109,0.225351496588234,0.985643936224617,1,2,neuroligin family protein binding,MF,DLG4
12463,GO:0050436,0.225354164861009,0.985643573090397,1,2,microfibril binding,MF,LTBP1
8865,GO:0034685,0.225358901153925,0.985642928499575,1,2,integrin alphav-beta6 complex,CC,ITGB6
2771,GO:0006196,0.225361616817686,0.985642558900979,1,2,AMP catabolic process,BP,NT5E
3463,GO:0007284,0.225367106030442,0.985641811809194,1,2,spermatogonial cell division,BP,ZNF449
2146,GO:0004965,0.225372278838901,0.985641107760362,1,2,G-protein coupled GABA receptor activity,MF,GABBR1
1107,GO:0002696,0.225381147165965,0.836613769918389,24,173,positive regulation of leukocyte activation,BP,EFNB3;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;STAT6;INPP5D;PDCD1LG2;TGFBR2;GAS6;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;LGALS1;JAK3;BCL6;FYN;ADA;VAV3;DHPS;HLA-G
16934,GO:0098971,0.225381888571549,0.985639799768767,1,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,KIF17
3837,GO:0008449,0.225381973481199,0.985639788211333,1,2,N-acetylglucosamine-6-sulfatase activity,MF,SULF2
13619,GO:0060151,0.225385505774818,0.985639307409581,1,2,peroxisome localization,BP,PEX1
13620,GO:0060152,0.225385505774818,0.985639307409581,1,2,microtubule-based peroxisome localization,BP,PEX1
9158,GO:0035526,0.225388302725144,0.985638926693335,1,2,retrograde transport, plasma membrane to Golgi,BP,RAB43
15969,GO:0086006,0.225388761316207,0.985638864270172,1,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,SCN4B
6486,GO:0021847,0.225389988053523,0.985638697286481,1,2,ventricular zone neuroblast division,BP,FGFR1
9206,GO:0035607,0.225389988053523,0.985638697286481,1,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,FGFR1
16940,GO:0098982,0.22539400813657,0.985638150064493,1,2,GABA-ergic synapse,CC,NLGN2
16941,GO:0098983,0.22539400813657,0.985638150064493,1,2,symmetric, GABA-ergic, inhibitory synapse,CC,NLGN2
16661,GO:0097635,0.225394085303512,0.985638139560246,1,2,extrinsic component of autophagosome membrane,CC,ULK1
13641,GO:0060187,0.225396446924638,0.985637818085838,1,2,cell pole,CC,VANGL2
15500,GO:0071910,0.22539837893452,0.98563755508899,1,2,determination of liver left/right asymmetry,BP,PKD2
9694,GO:0038113,0.225400561447883,0.985637257988794,1,2,interleukin-9-mediated signaling pathway,BP,JAK3
15066,GO:0071104,0.225400561447883,0.985637257988794,1,2,response to interleukin-9,BP,JAK3
15183,GO:0071355,0.225400561447883,0.985637257988794,1,2,cellular response to interleukin-9,BP,JAK3
2927,GO:0006447,0.225400735458875,0.985637234300975,1,2,regulation of translational initiation by iron,BP,RXRA
3276,GO:0006957,0.225403009892685,0.985636924683875,1,2,complement activation, alternative pathway,BP,C5
495,GO:0001550,0.225404813665678,0.985636679134822,1,2,ovarian cumulus expansion,BP,EREG
12092,GO:0048165,0.225404813665678,0.985636679134822,1,2,fused antrum stage,BP,EREG
9745,GO:0039519,0.22540485481458,0.985636673533161,1,2,modulation by virus of host autophagy,BP,EIF2AK4
5441,GO:0016314,0.225405046186968,0.985636647481325,1,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,INPP5D
17765,GO:1901873,0.225412254271485,0.985635666213937,1,2,regulation of post-translational protein modification,BP,CRTAP
17766,GO:1901874,0.225412254271485,0.985635666213937,1,2,negative regulation of post-translational protein modification,BP,CRTAP
7262,GO:0031251,0.225414657278613,0.985635339073883,1,2,PAN complex,CC,PAN2
17487,GO:1900747,0.225417015014416,0.985635018092804,1,2,negative regulation of vascular endothelial growth factor signaling pathway,BP,XDH
18006,GO:1902548,0.225417015014416,0.985635018092804,1,2,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
2088,GO:0004854,0.225419801048593,0.985634638798114,1,2,xanthine dehydrogenase activity,MF,XDH
4061,GO:0009115,0.225419801048593,0.985634638798114,1,2,xanthine catabolic process,BP,XDH
5636,GO:0016726,0.225419801048593,0.985634638798114,1,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,XDH
7634,GO:0032053,0.225423051246417,0.985634196304358,1,2,ciliary basal body organization,BP,CROCC
18997,GO:1904862,0.225428463520463,0.985633459440483,1,2,inhibitory synapse assembly,BP,NLGN2
14244,GO:0061341,0.225433230570624,0.985632810404013,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,VANGL2
14246,GO:0061346,0.225433230570624,0.985632810404013,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,VANGL2
2427,GO:0005607,0.225433920490321,0.985632716469674,1,2,laminin-2 complex,CC,LAMB1
2718,GO:0006099,0.225434037326996,0.898284837134771,5,28,tricarboxylic acid cycle,BP,IDH2;DHTKD1;OGDHL;SDHA;SUCLG2
8431,GO:0033564,0.225444215228215,0.985631314773454,1,2,anterior/posterior axon guidance,BP,UNC5B
18286,GO:1903238,0.225448699731679,0.985630704154544,1,2,positive regulation of leukocyte tethering or rolling,BP,PTAFR
5784,GO:0017018,0.225458846561317,0.985629322487602,1,2,myosin phosphatase activity,MF,MYH3
9325,GO:0035838,0.225460221210162,0.985629135299509,1,2,growing cell tip,CC,PI4K2A
6013,GO:0019072,0.225464605638196,0.985628538255778,1,2,viral genome packaging,BP,PC
6014,GO:0019074,0.225464605638196,0.985628538255778,1,2,viral RNA genome packaging,BP,PC
5303,GO:0016013,0.22546565792823,0.98562839495946,1,2,syntrophin complex,CC,SNTA1
14203,GO:0061187,0.225467073901344,0.985628202137086,1,2,regulation of chromatin silencing at rDNA,BP,PHF2
14204,GO:0061188,0.225467073901344,0.985628202137086,1,2,negative regulation of chromatin silencing at rDNA,BP,PHF2
16072,GO:0090080,0.225481244064539,0.985626272411676,1,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,FGFR1
18883,GO:1904612,0.225482466892351,0.985626105877291,1,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,PDE2A
18884,GO:1904613,0.225482466892351,0.985626105877291,1,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,PDE2A
14146,GO:0061055,0.225486271383513,0.985625587744436,1,2,myotome development,BP,WDR19
4523,GO:0010593,0.225511657656264,0.985622130121811,1,2,negative regulation of lamellipodium assembly,BP,PLXNB3
8857,GO:0034673,0.225537696827118,0.985618583083221,1,2,inhibin-betaglycan-ActRII complex,CC,TGFBR3
17197,GO:0106104,0.225560546324709,0.985615470130204,1,2,regulation of glutamate receptor clustering,BP,SSH1
18926,GO:1904717,0.225560546324709,0.985615470130204,1,2,regulation of AMPA glutamate receptor clustering,BP,SSH1
1468,GO:0003726,0.22556574952947,0.985614761206342,1,2,double-stranded RNA adenosine deaminase activity,MF,ADARB1
8864,GO:0034684,0.225574942872013,0.985613508587459,1,2,integrin alphav-beta5 complex,CC,ITGB5
2302,GO:0005287,0.225583104678209,0.985612396466376,1,2,high-affinity basic amino acid transmembrane transporter activity,MF,SLC25A29
2303,GO:0005289,0.225583104678209,0.985612396466376,1,2,high-affinity arginine transmembrane transporter activity,MF,SLC25A29
2305,GO:0005292,0.225583104678209,0.985612396466376,1,2,high-affinity lysine transmembrane transporter activity,MF,SLC25A29
3608,GO:0008050,0.225590742950443,0.985611355637387,1,2,female courtship behavior,BP,THRA
11449,GO:0045924,0.225590742950443,0.985611355637387,1,2,regulation of female receptivity,BP,THRA
5442,GO:0016316,0.225591190755648,0.98561129461588,1,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,INPP4A
5856,GO:0017161,0.225591190755648,0.98561129461588,1,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,INPP4A
8810,GO:0034597,0.225591190755648,0.98561129461588,1,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,INPP4A
13400,GO:0052828,0.225591190755648,0.98561129461588,1,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,INPP4A
13074,GO:0051611,0.22562087440073,0.985607249358636,1,2,regulation of serotonin uptake,BP,NOS1
13075,GO:0051612,0.22562087440073,0.985607249358636,1,2,negative regulation of serotonin uptake,BP,NOS1
6541,GO:0021965,0.225634798401991,0.985605351587125,1,2,spinal cord ventral commissure morphogenesis,BP,ADARB1
911,GO:0002296,0.22564007008457,0.985604633046146,1,2,T-helper 1 cell lineage commitment,BP,STAT6
11520,GO:0046069,0.225640373148565,0.985604591737293,1,2,cGMP catabolic process,BP,PDE2A
16351,GO:0090722,0.225651760919172,0.985603039488998,1,2,receptor-receptor interaction,MF,FGFR1
18992,GO:1904849,0.225651760919172,0.985603039488998,1,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
19940,GO:2000546,0.225651760919172,0.985603039488998,1,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
19897,GO:2000427,0.225662693898535,0.985601549143142,1,2,positive regulation of apoptotic cell clearance,BP,ABCA7
10439,GO:0043314,0.225671082032097,0.985600405642373,1,2,negative regulation of neutrophil degranulation,BP,BCR
18013,GO:1902564,0.225671082032097,0.985600405642373,1,2,negative regulation of neutrophil activation,BP,BCR
20093,GO:2000809,0.225674559061066,0.985599931626066,1,2,positive regulation of synaptic vesicle clustering,BP,NLGN2
7084,GO:0030888,0.22568427371674,0.889168687569166,6,35,regulation of B cell proliferation,BP,PKN1;INPP5D;CARD11;BCL6;ADA;VAV3
8786,GO:0034499,0.225694730711248,0.985597181490921,1,2,late endosome to Golgi transport,BP,SGSM2
15520,GO:0071955,0.225694746411059,0.985597179350318,1,2,recycling endosome to Golgi transport,BP,TBC1D14
17491,GO:1900756,0.225750307989909,0.985589602727254,1,2,protein processing in phagocytic vesicle,BP,GSN
18602,GO:1903921,0.225750307989909,0.985589602727254,1,2,regulation of protein processing in phagocytic vesicle,BP,GSN
18603,GO:1903923,0.225750307989909,0.985589602727254,1,2,positive regulation of protein processing in phagocytic vesicle,BP,GSN
16123,GO:0090164,0.225772017107473,0.985586641760478,1,2,asymmetric Golgi ribbon formation,BP,MYO18A
14916,GO:0070829,0.225773724763083,0.985586408833964,1,2,heterochromatin maintenance,BP,MTHFR
10040,GO:0042539,0.225773818570501,0.985586396038435,1,2,hypotonic salinity response,BP,TRPV4
15266,GO:0071477,0.225773818570501,0.985586396038435,1,2,cellular hypotonic salinity response,BP,TRPV4
13257,GO:0051971,0.225796151611135,0.985583349582873,1,2,positive regulation of transmission of nerve impulse,BP,ITGA2
17416,GO:1900220,0.225814896468985,0.985580792309763,1,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,PLXNB1
19962,GO:2000588,0.22581675590774,0.98558053862117,1,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,HIP1
2477,GO:0005712,0.225837401793112,0.98557772167326,1,2,chiasma,CC,MLH3
6558,GO:0022011,0.225884643645478,0.910069440115167,4,20,myelination in peripheral nervous system,BP,NDRG1;SH3TC2;AKT1;SIRT2
7763,GO:0032292,0.225884643645478,0.910069440115167,4,20,peripheral nervous system axon ensheathment,BP,NDRG1;SH3TC2;AKT1;SIRT2
8389,GO:0033341,0.225885721314437,0.985571127680859,1,2,regulation of collagen binding,BP,ITGA2
3710,GO:0008228,0.225977773501743,0.985558560907252,1,2,opsonization,BP,MYO18A
2218,GO:0005119,0.225982088714246,0.98555797165079,1,2,smoothened binding,MF,BBS1
16264,GO:0090386,0.22599608199147,0.985556060728842,1,2,phagosome maturation involved in apoptotic cell clearance,BP,SPG11
16265,GO:0090387,0.22599608199147,0.985556060728842,1,2,phagolysosome assembly involved in apoptotic cell clearance,BP,SPG11
1025,GO:0002528,0.226022855351642,0.985552404158245,1,2,regulation of vascular permeability involved in acute inflammatory response,BP,CTNNBIP1
5632,GO:0016722,0.226080297943931,0.925414028493817,3,14,oxidoreductase activity, oxidizing metal ions,MF,CYBRD1;STEAP2;STEAP3
9672,GO:0038064,0.226084118899547,0.985544035112374,1,2,collagen receptor activity,MF,ITGA2
13109,GO:0051694,0.226130336910848,0.98553771957306,1,2,pointed-end actin filament capping,BP,TMOD2
13028,GO:0051542,0.226132718297128,0.985537394121936,1,2,elastin biosynthetic process,BP,HBEGF
5204,GO:0015807,0.226162911101758,0.881641712160681,7,42,L-amino acid transport,BP,NTSR1;SLC7A8;SLC43A1;PQLC2;PRAF2;SLC6A9;SLC25A29
3664,GO:0008157,0.226172425352819,0.925368616442457,3,14,protein phosphatase 1 binding,MF,PHACTR3;PPP1R15A;TCTEX1D4
45,GO:0000097,0.226313835028801,0.925298891512174,3,14,sulfur amino acid biosynthetic process,BP,GGT1;CBS;CTH
18541,GO:1903796,0.226536467728748,0.985482155686395,1,2,negative regulation of inorganic anion transmembrane transport,BP,ANO9
1742,GO:0004345,0.226575726369101,0.985476778181306,1,2,glucose-6-phosphate dehydrogenase activity,MF,H6PD
1591,GO:0004008,0.226644279722082,0.985467385278376,1,2,copper-exporting ATPase activity,MF,ATP7B
10632,GO:0043682,0.226644279722082,0.985467385278376,1,2,copper-transporting ATPase activity,MF,ATP7B
13517,GO:0060003,0.226644279722082,0.985467385278376,1,2,copper ion export,BP,ATP7B
2414,GO:0005589,0.226723394292065,0.985456541027946,1,2,collagen type VI trimer,CC,COL6A1
16777,GO:0098647,0.226723394292065,0.985456541027946,1,2,collagen beaded filament,CC,COL6A1
12675,GO:0050917,0.226725204321237,0.985456292873083,1,2,sensory perception of umami taste,BP,ITPR3
308,GO:0000820,0.226762300996346,0.985451206390736,1,2,regulation of glutamine family amino acid metabolic process,BP,ATP2B4
11367,GO:0045763,0.226762300996346,0.985451206390736,1,2,negative regulation of cellular amino acid metabolic process,BP,ATP2B4
4625,GO:0010751,0.226795044607274,0.985446715935089,1,2,negative regulation of nitric oxide mediated signal transduction,BP,ATP2B4
7489,GO:0031669,0.226861647736759,0.836648025584836,23,164,cellular response to nutrient levels,BP,POSTN;GLUL;CYP27B1;ULK1;WNT2B;SESN2;IMPACT;MAPK3;ATF4;SSH1;PCSK9;AQP3;MAP1LC3A;DAP;TRPV1;GAS6;ASNS;C12ORF66;UPP1;HFE;FYN;SLC38A2;EIF2AK4
2198,GO:0005080,0.226878608611353,0.888397135047718,6,35,protein kinase C binding,MF,PKN1;TWF2;HDAC5;TRPV4;ADCY6;AKT1
7629,GO:0032048,0.226927955511346,0.92499580115611,3,14,cardiolipin metabolic process,BP,SLC27A1;PLA2G6;TAZ
4416,GO:0010224,0.227015496821377,0.924952558581345,3,14,response to UV-B,BP,XPC;ERCC6;HYAL1
1333,GO:0003192,0.227027053800693,0.985414875639282,1,2,mitral valve formation,BP,ZFPM1
1318,GO:0003169,0.227070280345489,0.985408938974749,1,2,coronary vein morphogenesis,BP,VEGFA
14080,GO:0060948,0.227070280345489,0.985408938974749,1,2,cardiac vascular smooth muscle cell development,BP,VEGFA
14277,GO:0061437,0.227108616107885,0.924906550310976,3,14,renal system vasculature development,BP,ACTA2;EGR1;PKD2
14280,GO:0061440,0.227108616107885,0.924906550310976,3,14,kidney vasculature development,BP,ACTA2;EGR1;PKD2
6949,GO:0030594,0.227116273019286,0.908919521032634,4,21,neurotransmitter receptor activity,MF,HTR7;GABBR1;GPR21;CHRM3
20072,GO:2000773,0.227143330943092,0.924889395713403,3,14,negative regulation of cellular senescence,BP,HMGA2;TERC;BCL6
10097,GO:0042632,0.227315690636163,0.888114396424994,6,35,cholesterol homeostasis,BP,APOE;ABCA2;MALL;ABCG1;LRP5;PCSK9
13495,GO:0055092,0.227315690636163,0.888114396424994,6,35,sterol homeostasis,BP,APOE;ABCA2;MALL;ABCG1;LRP5;PCSK9
6721,GO:0030140,0.227369591660291,0.897101887305654,5,28,trans-Golgi network transport vesicle,CC,CLTCL1;AP1G2;STEAP2;RASSF9;RAB13
2428,GO:0005608,0.227424476616031,0.985360242454087,1,2,laminin-3 complex,CC,LAMB2
3270,GO:0006950,0.227578408780381,0.792323188301566,324,2654,response to stress,BP,TNIP1;XDH;DUSP6;PTPRS;HTRA1;F2R;NT5E;TNFRSF6B;APOE;BTBD2;NFATC4;XPC;SERPINE2;FOS;PRODH;IL20RB;GSN;EGR1;CTNNBIP1;PGF;POSTN;FBXO2;PTK6;TMEM129;CDC42EP5;ACP5;NAPRT;EDEM1;RNF135;GLUL;GPX3;PDCD4;VEGFA;EGFR;DDB2;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;TFPI2;DGKA;IGFBP4;CD9;CST3;NOS1;DDIT3;BRSK1;DNAJB5;ERCC6;NDRG1;GGT1;ADAMTS13;ABTB1;ARHGEF19;MST1R;ZFP36L1;ADARB1;NUPR1;HBEGF;RBL2;RPS6KA2;PYCR2;TFDP2;RPL13A;MSRB2;PLAT;ULK2;SLC27A1;MAPK13;MLYCD;ASH2L;CUL7;HMGCL;HYAL1;TXNRD3;POLD4;MAP2K1;CYP27B1;PCK2;PKN1;MC1R;DDIT4;BTG1;PHF21A;DGKQ;TMEM173;DNAJC4;MAGEF1;ULK1;SHC1;BLOC1S4;VEGFB;ITPR3;CIRBP;PRKCZ;SERPING1;PAK1;APOBEC3C;MCTP1;ELK3;STK39;MTHFR;PHF1;CBS;FAM3A;DOCK6;ITGB4;ZP3;NEIL1;CCDC88B;RAG1;NGFR;ETV5;MUC19;WNT2B;NSMCE4A;EREG;CHD2;RMI2;TNFRSF25;PLA2G6;MANF;C5;APOBEC3F;PPARA;PLGRKT;INO80C;ANO1;CHAC1;FNDC4;SESN2;IMPACT;NLRX1;PKD2;STAT6;ING4;ACOT11;HMGA2;AREG;ECM1;LRP11;MAPK3;LAMB2;BNIP3;ERRFI1;MACROD1;THRA;IFITM1;VANGL2;GSDMA;SCARA3;DOCK9;RGS14;DYSF;CTSB;MAPK12;IFNGR2;C1RL;ARHGEF2;TSPYL2;MAP2K2;LRSAM1;DMTN;LRRC8A;ANGPTL4;UBXN4;MORN4;ATF4;PROCR;ZFPM1;BBC3;PAK6;DOCK11;LTB4R2;PRIMPOL;POLM;FBXO6;IFI6;ZNF516;PKD1;NSMCE1;FLOT1;MDK;KCNMA1;HDAC5;IRF5;PCBP4;HERPUD1;GSTM2;DEAF1;SULF2;NLRP1;ENDOG;CEBPB;MAP3K12;CREBRF;PCSK9;AQP3;ISG20;DNMT3A;TGFBR2;TRPV4;IL17RE;TMSB4X;MAP1LC3A;PDE2A;TRIB3;DAP;MLH3;HMG20B;CDK5RAP3;NOS3;MINK1;WNT7A;HERPUD2;TRPV1;BNIP3L;PIK3R2;SHARPIN;CCS;GAS6;ERN1;ALKBH7;BCR;NBR1;POLL;TERC;PTAFR;PPP1R15A;RAB43;ATP2B4;STRADB;TNFRSF14;GSDMC;MGMT;ASNS;C12ORF66;MAPKBP1;AKT1;IGFBP7;ITPR2;CARD11;MICAL1;CHEK2;ASS1;IL17RC;TCIRG1;ACADVL;LMNA;UPP1;SH2B3;CAPN2;SPATA18;IFI27;PLAU;NCOA7;FOXO4;YPEL3;RPS6KA5;ANKZF1;LTB4R;ULBP1;TXNRD2;ITGB6;C6ORF89;LYST;MAP2K5;BRAF;EDA2R;FAAP20;PIDD1;CAT;MYOF;MAPK10;MPG;LGALS1;TIMP1;HFE;JAK3;TP73;TMX4;ENDOV;CSNK1E;BCL6;HSF4;REC8;GSTM3;TKFC;EHD3;FYN;SLC38A2;UBXN6;SIRT2;RECQL5;CELSR1;ADA;MTA1;MSH5;ENTPD2;TGFBR3;CIDEB;VAV3;MAN1B1;EPAS1;MAP3K10;EDNRA;CHD6;PER1;ITGA2;WFS1;CTH;ERBB2;PLLP;EIF2AK4;SYVN1;HLA-G;CORO1B;NET1;HSP90AB4P;CREB3L4;SDHAF4;IKBKB;BTBD11
15747,GO:0072369,0.227640714929637,0.985330467639412,1,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
15141,GO:0071286,0.227754209390271,0.985314826307573,1,2,cellular response to magnesium ion,BP,ANK3
13021,GO:0051525,0.227809767068761,0.985307166122665,1,2,NFAT protein binding,MF,PPARA
19034,GO:1904928,0.227909390024088,0.985293424610003,1,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,LRP5
6628,GO:0023016,0.228030540034545,0.985276703907429,1,2,signal transduction by trans-phosphorylation,BP,STK39
4856,GO:0014075,0.228054917110324,0.908389212087023,4,21,response to amine,BP,ADAMTS13;UROS;GLDC;ITGA2
18163,GO:1902960,0.228451564378856,0.985218511484226,1,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
19152,GO:1905246,0.228451564378856,0.985218511484226,1,2,negative regulation of aspartic-type peptidase activity,BP,SORL1
3792,GO:0008373,0.228484418972502,0.924225551509342,3,14,sialyltransferase activity,MF,ST6GALNAC2;ST6GALNAC6;ST3GAL3
16615,GO:0097503,0.228484418972502,0.924225551509342,3,14,sialylation,BP,ST6GALNAC2;ST6GALNAC6;ST3GAL3
8633,GO:0034188,0.228560128503081,0.985203484960025,1,2,apolipoprotein A-I receptor activity,MF,ABCA7
16304,GO:0090554,0.228560128503081,0.985203484960025,1,2,phosphatidylcholine-translocating ATPase activity,MF,ABCA7
16305,GO:0090556,0.228560128503081,0.985203484960025,1,2,phosphatidylserine-translocating ATPase activity,MF,ABCA7
15739,GO:0072361,0.228591103846183,0.985199196022223,1,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
16789,GO:0098679,0.228591103846183,0.985199196022223,1,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
14853,GO:0070665,0.228647576730265,0.860401830497679,11,73,positive regulation of leukocyte proliferation,BP,ZP3;CCDC88B;PDCD1LG2;TGFBR2;CARD11;IGFBP2;JAK3;BCL6;ADA;VAV3;DHPS
16203,GO:0090279,0.228660754180223,0.924138100223498,3,14,regulation of calcium ion import,BP,PRNP;PKD2;FYN
18180,GO:1902996,0.228702073777681,0.985183824987035,1,2,regulation of neurofibrillary tangle assembly,BP,SORL1
3603,GO:0008045,0.228766054519224,0.924085859570457,3,14,motor neuron axon guidance,BP,RNF165;SEMA3F;ERBB2
11611,GO:0046337,0.228768463823867,0.924084664128318,3,14,phosphatidylethanolamine metabolic process,BP,SLC27A1;CHKB;ETNK2
18165,GO:1902962,0.228835407542323,0.985165344202474,1,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
18166,GO:1902963,0.228835407542323,0.985165344202474,1,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
15742,GO:0072364,0.229051566588736,0.985135355507879,1,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
19337,GO:1905793,0.229178579084442,0.98511771841781,1,2,protein localization to pericentriolar material,BP,NUDCD3
18543,GO:1903798,0.229197490663629,0.923871676960245,3,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K1;MAP2K2
932,GO:0002331,0.229242358938391,0.985108857386797,1,2,pre-B cell allelic exclusion,BP,RAG1
12962,GO:0051389,0.229251137476517,0.985107637536084,1,2,inactivation of MAPKK activity,BP,EPHB2
1577,GO:0003989,0.229336715983427,0.985095742710675,1,2,acetyl-CoA carboxylase activity,MF,ACACB
20273,GO:2001295,0.229336715983427,0.985095742710675,1,2,malonyl-CoA biosynthetic process,BP,ACACB
6974,GO:0030658,0.22935904477354,0.842156326519642,18,126,transport vesicle membrane,CC,PTPRS;CLTCL1;SYT8;SYNGR1;RAB3B;MCTP1;VAMP2;AREG;AP1G2;PI4K2A;SV2A;MAP6;DBNDD1;RASSF9;ICA1;STX1A;SEC31B;HLA-G
18157,GO:1902954,0.229467993484423,0.985077485523945,1,2,regulation of early endosome to recycling endosome transport,BP,SORL1
6525,GO:0021934,0.22954319268101,0.985067021592523,1,2,hindbrain tangential cell migration,BP,TTBK2
6526,GO:0021935,0.22954319268101,0.985067021592523,1,2,cerebellar granule cell precursor tangential migration,BP,TTBK2
9080,GO:0035357,0.229549800338397,0.923696606196862,3,14,peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;RXRA;STARD10
8497,GO:0033688,0.22955995802098,0.923691556347652,3,14,regulation of osteoblast proliferation,BP,PLXNB1;LRP5;ATRAID
12790,GO:0051119,0.229591452325194,0.923675898280342,3,14,sugar transmembrane transporter activity,MF,SLC2A3;SLC2A9;SLC50A1
13459,GO:0055022,0.229646259306274,0.923648646909293,3,14,negative regulation of cardiac muscle tissue growth,BP,PAK1;TGFBR2;TP73
14176,GO:0061117,0.229646259306274,0.923648646909293,3,14,negative regulation of heart growth,BP,PAK1;TGFBR2;TP73
18451,GO:1903580,0.229808713640331,0.907395587314601,4,21,positive regulation of ATP metabolic process,BP,MLXIPL;TMSB4X;INSR;TAZ
13480,GO:0055075,0.22994537533163,0.923499854032579,3,14,potassium ion homeostasis,BP,SLC12A7;KCNMA1;ATP12A
414,GO:0001102,0.230063867212233,0.886332015649402,6,35,RNA polymerase II activating transcription factor binding,MF,FOS;MEF2D;RBL2;ZFPM1;BHLHE40;IFI27
16589,GO:0097457,0.230135736021929,0.984984423236484,1,2,hippocampal mossy fiber,CC,MICAL1
9846,GO:0042110,0.230192074424175,0.821900755218569,36,268,T cell activation,BP,IL20RB;GSN;EGR1;PRNP;ZFP36L1;EFNB3;SOX13;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;SATB1;STAT6;PDCD1LG2;ZFPM1;CEBPB;TGFBR2;KIF13B;TNFRSF14;AKT1;CARD11;IGFBP2;BRAF;LGALS1;HFE;JAK3;BCL6;FYN;ADA;TCF7;DHPS;ERBB2;EIF2AK4;PAG1;HLA-G
18372,GO:1903428,0.230350255615936,0.895272015585632,5,28,positive regulation of reactive oxygen species biosynthetic process,BP,PKD2;TRPV1;AKT1;ASS1;INSR
377,GO:0001010,0.230352301053,0.923297255499093,3,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,NR1D1;PPARA;THRA
2384,GO:0005521,0.23050484767425,0.923221253756139,3,14,lamin binding,MF,PRNP;BNIP3L;IFI27
8869,GO:0034695,0.230578814030226,0.923184391959963,3,14,response to prostaglandin E,BP,ADCY6;AKT1;TGFBR3
13657,GO:0060216,0.230614641506536,0.923166534599266,3,14,definitive hemopoiesis,BP,ZFPM1;BCR;TGFBR3
9089,GO:0035373,0.230667606813105,0.984910061197913,1,2,chondroitin sulfate proteoglycan binding,MF,SEMA5A
9856,GO:0042130,0.230672575491813,0.885936143621455,6,35,negative regulation of T cell proliferation,BP,IL20RB;PRNP;PDCD1LG2;CEBPB;ERBB2;HLA-G
5698,GO:0016831,0.230778979027455,0.895008001433758,5,28,carboxy-lyase activity,MF,GLUL;MLYCD;PCK2;MVD;AZIN2
11366,GO:0045762,0.230790512490801,0.984892847690073,1,2,positive regulation of adenylate cyclase activity,BP,TIMP2
3406,GO:0007190,0.231068063779792,0.922940400665896,3,14,activation of adenylate cyclase activity,BP,ADCY6;GNAL;EDNRA
12583,GO:0050786,0.231117177829857,0.944738413953566,2,9,RAGE receptor binding,MF,S100A4;S100A13
15580,GO:0072092,0.231233363285787,0.984830731574323,1,2,ureteric bud invasion,BP,KIF26B
8644,GO:0034205,0.231522055212149,0.906421394127946,4,21,amyloid-beta formation,BP,APOE;PRNP;ABCA7;SORL1
9674,GO:0038066,0.231897593979257,0.894318178634877,5,28,p38MAPK cascade,BP,XDH;VEGFA;ZFP36L1;MINK1;PER1
19786,GO:2000272,0.231919550748907,0.906194888946447,4,21,negative regulation of signaling receptor activity,BP,ERRFI1;TSG101;HFE;EPHB2
17394,GO:1900169,0.232140448297731,0.984703045951047,1,2,regulation of glucocorticoid mediated signaling pathway,BP,CREBRF
6064,GO:0019217,0.232207781422435,0.866181197638344,9,57,regulation of fatty acid metabolic process,BP,TYSND1;MLYCD;PPARA;ACACB;MLXIPL;LONP2;TRIB3;AKT1;ACADVL
1048,GO:0002576,0.232397084816141,0.85453205537194,12,76,platelet degranulation,BP,VEGFA;CD9;VEGFB;SERPING1;MANF;ECM1;DMTN;TTN;TMSB4X;GAS6;MAGED2;TIMP1
14286,GO:0061450,0.232539509410701,0.945450697965482,2,8,trophoblast cell migration,BP,SMURF2;TIMP1
17540,GO:1901163,0.232539509410701,0.945450697965482,2,8,regulation of trophoblast cell migration,BP,SMURF2;TIMP1
16850,GO:0098810,0.232708345391329,0.945384905573498,2,8,neurotransmitter reuptake,BP,NOS1;RAB3B
13739,GO:0060341,0.232845040405748,0.803661246993448,79,615,regulation of cellular localization,BP,F2R;ZMYND8;GSN;EDEM1;LRP1;NTSR1;EGFR;PRNP;NR1D1;ANK3;RAPGEF3;DNM1;NOS1;ZFP36L1;B3GAT3;TFDP2;REEP2;MAP2K1;ABCA2;TMEM173;VPS11;RAB3B;NLGN2;TTBK2;PAK1;MCTP1;CEMIP;MICALL2;CEP250;NGFR;GSTO1;PLA2G6;ANO1;SESN2;PKD2;SH3TC2;VAMP2;SEPT5;KCNC4;KCNAB2;MAPK3;MAP2K2;DMTN;BBC3;SSH1;REEP6;SORL1;GSTM2;LRP5;PCSK9;CEP131;PDE2A;PEMT;CDK5RAP3;BNIP3L;GAS6;LZTS2;CROCC;CAMK1;RIMS3;AKT1;TSG101;LMNA;TBC1D20;IFI27;BRAF;ASIC1;HFE;TP73;SNX33;CSNK1E;FYN;TRPC1;HDAC8;STX1A;EPHB2;ERBB2;OSCP1;PNKD
13210,GO:0051899,0.232862115781899,0.870853576088221,8,50,membrane depolarization,BP,FHL1;NTSR1;SCN8A;ANK3;SCN4B;PRKCZ;IFI6;TPCN1
15674,GO:0072237,0.233032232373216,0.984576918432221,1,2,metanephric proximal tubule development,BP,PKD1
670,GO:0001881,0.233156613843896,0.893540107046143,5,28,receptor recycling,BP,ARAP1;PCSK9;CHMP5;EHD3;TBC1D16
7092,GO:0030897,0.233314235575705,0.921816450318915,3,14,HOPS complex,CC,VPS11;HOOK2;VPS39
15671,GO:0072234,0.23333567357304,0.921805693229067,3,14,metanephric nephron tubule development,BP,WWTR1;PKD2;PKD1
9493,GO:0036156,0.233624376001497,0.984492843083015,1,2,inner dynein arm,CC,DNAH1
6269,GO:0019869,0.23370673365978,0.944995130308468,2,8,chloride channel inhibitor activity,MF,WNK4;STX1A
3137,GO:0006733,0.233939617380418,0.835052013957908,20,142,oxidoreduction coenzyme metabolic process,BP,H6PD;NT5E;NAPRT;IDH2;PGM1;DHTKD1;PCK2;PGLS;DDIT4;OGDHL;NMRK1;NMNAT2;PPARA;KCNAB2;MLXIPL;GALK1;NADK;ALDOC;INSR;PFKL
3121,GO:0006703,0.234047971332556,0.944861626729254,2,8,estrogen biosynthetic process,BP,HSD17B14;HSD17B7
10362,GO:0043200,0.234269436469967,0.852803475825795,12,80,response to amino acid,BP,EGFR;COL6A1;MTHFR;NEURL1;SESN2;CEBPB;DNMT3A;PEMT;ASNS;CAPN2;FYN;LAMTOR2
1663,GO:0004126,0.234338674719068,0.944747780170918,2,8,cytidine deaminase activity,MF,APOBEC3C;APOBEC3F
5461,GO:0016362,0.234355930433946,0.984388612843148,1,2,activin receptor activity, type II,MF,ACVR2B
18467,GO:1903624,0.234362842066825,0.94473831093725,2,8,regulation of DNA catabolic process,BP,ENDOG;CIDEA
12593,GO:0050801,0.234377901047214,0.808888837819928,55,423,ion homeostasis,BP,DLG4;F2R;APOE;FHL1;NTSR1;EGFR;PRNP;SLC7A8;ANK3;NOS1;DDIT3;CYP27B1;SLC12A7;CYBRD1;ITPR3;CEMIP;GSTO1;PLA2G6;ABCG1;LPAR3;PKD2;MAPK3;BNIP3;PQLC2;MLXIPL;SV2A;IFI6;PKD1;KCNMA1;HERPUD1;GSTM2;TMEM175;WNK4;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;STEAP2;ITPR2;FGFR4;TCIRG1;STEAP3;TPCN1;LETMD1;HFE;SCNN1A;ATP12A;SLC9A7;FYN;TRPC1;EPAS1;EDNRA;WFS1;SLC9A5
7198,GO:0031098,0.23459717447795,0.82188411548099,31,228,stress-activated protein kinase signaling cascade,BP,XDH;CDC42EP5;PDCD4;VEGFA;EGFR;ERCC6;ZFP36L1;MAPK13;MAP2K1;PKN1;PAK1;STK39;MAPK3;VANGL2;MAP2K2;PAK6;MAP3K12;TRPV4;MINK1;WNT7A;ERN1;NBR1;STRADB;AKT1;MAP2K5;EDA2R;MAPK10;TP73;MAP3K10;PER1;IKBKB
3683,GO:0008190,0.23467361135356,0.944616481113452,2,8,eukaryotic initiation factor 4E binding,MF,ANGEL1;EIF4EBP1
5904,GO:0018146,0.234713856898157,0.904597382364252,4,21,keratan sulfate biosynthetic process,BP,B4GAT1;CHST6;ST3GAL3;B4GALT2
11742,GO:0046620,0.235065717904898,0.864123018975155,9,57,regulation of organ growth,BP,DUSP6;WWC3;PAK1;ACACB;TGFBR2;AKT1;TP73;TGFBR3;FGFR1
539,GO:0001658,0.235097672671485,0.88304652158768,6,35,branching involved in ureteric bud morphogenesis,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2
9533,GO:0036303,0.235136743875175,0.920899944296862,3,14,lymph vessel morphogenesis,BP,VEGFA;ACVR2B;PKD1
19127,GO:1905167,0.23537997851687,0.98424203809559,1,2,positive regulation of lysosomal protein catabolic process,BP,LRP1
11179,GO:0045321,0.235410170881361,0.798049284841978,97,767,leukocyte activation,BP,IL20RB;GSN;PYGB;EGR1;SLC2A3;NAPRT;TIMP2;PRNP;ERCC1;CST3;PGM1;NDRG1;ZFP36L1;GAA;PYGL;EFNB3;SOX13;PRSS3;SYNGR1;PKN1;DNASE1L1;TMEM173;CD68;PRKCZ;PAK1;BRI3;ZP3;CCDC88B;RAG1;ACTR1B;TMC6;S100A13;SATB1;STAT6;VAMP2;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;INPP5D;PDCD1LG2;LRRC8A;ZFPM1;DOCK11;POLM;FUCA1;HDAC5;CEBPB;ALDOC;TGFBR2;CMTM7;HEXB;TRPV1;GAS6;BCR;NBEAL2;KIF13B;PTAFR;CTSH;TNFRSF14;AKT1;CARD11;IGFBP2;TCIRG1;ARSA;MAN2B1;PLAU;ULBP1;BRAF;CAT;DPP7;YPEL5;LGALS1;HFE;JAK3;APRT;METTL7A;HGSNAT;BCL6;FYN;TOM1;ADA;POU2F2;AP2A2;MYO18A;TCF7;VAV3;GALNS;LAMTOR2;MFNG;DHPS;ERBB2;EIF2AK4;PAG1;PFKL;HLA-G
131,GO:0000272,0.235686254554607,0.904039318605635,4,21,polysaccharide catabolic process,BP,PYGB;PGM1;GAA;PYGL
10767,GO:0044247,0.235686254554607,0.904039318605635,4,21,cellular polysaccharide catabolic process,BP,PYGB;PGM1;GAA;PYGL
17556,GO:1901214,0.235762389772733,0.823607874758421,28,205,regulation of neuron death,BP,F2R;APOE;FOS;EGR1;LRP1;PRNP;DDIT3;DDIT4;SYNGAP1;AARS;PPARA;ATF4;SSH1;MDK;UNC5B;SORL1;CEBPB;MAP3K12;PCSK9;ITGA1;AKT1;NCOA7;BRAF;TP73;FYN;WFS1;TRIM2;SNCB
3070,GO:0006639,0.236026382661734,0.858858769416268,10,65,acylglycerol metabolic process,BP,APOE;LMF1;DGKA;PCK2;DGKQ;PNPLA3;PCSK9;PNPLA4;CAT;FITM2
19954,GO:2000574,0.236116799032415,0.94404914656663,2,8,regulation of microtubule motor activity,BP,DNAL4;NDE1
7772,GO:0032305,0.236186722483509,0.944021593325837,2,8,positive regulation of icosanoid secretion,BP,NTSR1;PLA2G6
19747,GO:2000193,0.236186722483509,0.944021593325837,2,8,positive regulation of fatty acid transport,BP,NTSR1;PLA2G6
3082,GO:0006658,0.236267151339753,0.903705411679625,4,21,phosphatidylserine metabolic process,BP,OSBPL5;SLC27A1;LPCAT4;OSBPL10
547,GO:0001667,0.236425871850955,0.816520265789693,36,268,ameboidal-type cell migration,BP,APOE;SEMA4B;VEGFA;HBEGF;PRSS3;HYAL1;PKN1;PLEKHG5;LAMA5;PAK1;SEMA3F;TNS1;SEMA5A;DMTN;SEMA3B;LTB4R2;HDAC5;LRP5;PKN3;TGFBR2;TMSB4X;SMURF2;NOS3;WNT7A;SEMA4G;CTSH;AKT1;RAB25;MAP2K5;BRAF;TIMP1;RAB13;PLXND1;ITGA2;FGFR1;CORO1B
6775,GO:0030218,0.236484692528111,0.851118052658156,12,80,erythrocyte differentiation,BP,FAM210B;VEGFA;ZFP36L1;THRA;INPP5D;DMTN;ZFPM1;DNASE2;JAK3;BCL6;TGFBR3;EPAS1
14642,GO:0070269,0.236967349122782,0.943713577457152,2,8,pyroptosis,BP,GSDMA;GSDMC
11704,GO:0046530,0.236997453995005,0.891155607121105,5,28,photoreceptor cell differentiation,BP,VEGFA;IFT140;SDK2;NAGLU;NPHP4
3312,GO:0007018,0.237010918432477,0.819823440792784,31,228,microtubule-based movement,BP,BBS2;IFT140;MYH15;DNAH1;BLOC1S4;MYH11;PRKCZ;WDR60;SPG11;KIF17;IFT27;DNAL4;MYH3;KIF21B;KIF26B;NDE1;CEP131;FYCO1;KIF13B;SPAG16;WDR19;IFT57;TTC21A;WDR66;CABYR;KIF27;COPG1;AP2A2;MYO18A;BLOC1S1;APBA1
3573,GO:0007620,0.237057443584855,0.943677979859481,2,8,copulation,BP,SERPINE2;ADA
2605,GO:0005905,0.237298929643544,0.862509500620183,9,57,clathrin-coated pit,CC,LRP1;EGFR;CLTCL1;FCHO1;CEMIP;VLDLR;EPN3;AP2A2;HIP1
4742,GO:0010917,0.237412816213867,0.943537469097354,2,8,negative regulation of mitochondrial membrane potential,BP,BNIP3;BNIP3L
11403,GO:0045837,0.237412816213867,0.943537469097354,2,8,negative regulation of membrane potential,BP,BNIP3;BNIP3L
4098,GO:0009156,0.237489281291217,0.835573730392038,18,127,ribonucleoside monophosphate biosynthetic process,BP,PGM1;DHTKD1;LHPP;DDIT4;OGDHL;PPARA;MLXIPL;GALK1;ALDOC;TMSB4X;UCKL1;TCIRG1;UPP1;INSR;APRT;TAZ;ADA;PFKL
7660,GO:0032098,0.237764246406554,0.943398363353327,2,8,regulation of appetite,BP,BBS2;PPARA
2518,GO:0005773,0.237834808498239,0.799560859148358,77,600,vacuole,CC,PYGB;ACP5;NAPRT;LRP1;ANK3;TSPAN1;CST3;MST1R;GAA;CTSF;ATG16L2;HYAL1;NAGLU;SYNGR1;COL6A1;ABCA2;ULK1;VPS11;CD68;CYBRD1;BRI3;TMEM44;SPPL2B;SPG11;S100A13;MARCH9;CSPG4;CTSB;PI4K2A;PQLC2;SDC2;TBC1D14;TECPR1;SLC48A1;LITAF;BBC3;FUCA1;FLOT1;VLDLR;TMEM175;PEG3;ATRAID;PCSK9;DIRC2;MAP1LC3A;HEXB;MARCH2;VPS39;FYCO1;MAN2C1;NBR1;HEXA;CTSH;TMEM9;C12ORF66;SBF2;TCIRG1;DNASE2;C9ORF72;ARSA;CAPN2;MAN2B1;TPCN1;CAT;DPP7;TMEM50B;HGSNAT;SNX1;UBXN6;TOM1;ADA;NAGA;AP2A2;GALNS;LAMTOR2;BLOC1S1;TMEM8A
9362,GO:0035904,0.237839742758296,0.881245574872105,6,35,aorta development,BP,LRP1;LOXL1;LTBP1;PKD2;SNX17;PLXND1
9026,GO:0035255,0.237978563163137,0.902719378922745,4,21,ionotropic glutamate receptor binding,MF,DLG4;SHANK2;DLG3;FLOT1
7667,GO:0032105,0.238197933549212,0.943226487228341,2,8,negative regulation of response to extracellular stimulus,BP,BBS2;PPARA
7670,GO:0032108,0.238197933549212,0.943226487228341,2,8,negative regulation of response to nutrient levels,BP,BBS2;PPARA
7657,GO:0032095,0.23834430442272,0.943168425886086,2,8,regulation of response to food,BP,BBS2;PPARA
7479,GO:0031652,0.238450384760166,0.943126330120905,2,8,positive regulation of heat generation,BP,SLC27A1;APLN
10052,GO:0042562,0.23862261149723,0.872999439760689,7,43,hormone binding,MF,EGFR;SHC1;NPR2;THRA;CTSH;INSR;CHRM3
12249,GO:0048565,0.238929048430868,0.852791265718402,11,72,digestive tract development,BP,PTK6;EGFR;ITGA6;ITGB4;ACVR2B;VANGL2;PKD1;TGFBR2;FOXL1;ADA;TCF7
12878,GO:0051248,0.238955101672773,0.79280587558341,111,886,negative regulation of protein metabolic process,BP,TNIP1;XDH;DUSP6;TNFRSF6B;APOE;SERPINE2;PPP1R35;PTK6;PDCD4;TIMP2;VEGFA;EGFR;PRNP;FBLN1;PRDX5;TFPI2;DUSP5;CRTAP;CST3;ZFP36L1;ADARB1;HBEGF;RPL13A;PLAT;PHACTR3;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;DGKQ;SPRY2;GRB7;UNK;CIRBP;CAPRIN2;PRKCZ;SERPING1;ABCA7;STK39;KDM3A;PHF1;SPRY4;RAG1;NGFR;ELFN2;TRIB2;C5;CHAC1;SESN2;IMPACT;ECM1;ERRFI1;RGS14;SNTA1;MLXIPL;INPP5D;MAP2K2;DMTN;ATF4;ZFPM1;KDM4C;IFI6;AZIN2;SORL1;HERPUD1;PAPLN;LRP5;ATRAID;PKIB;TRIB3;HMG20B;CDK5RAP3;AGO4;PIK3R2;EPHA1;GAS6;PPP1R15A;ATP2B4;PAIP2B;HINT2;AKT1;CDKN1C;MICAL1;CRY2;HMSD;TSG101;IGF2BP2;PIAS3;C9ORF72;NCOA7;CTDSPL;MAP2K5;TIMP1;HFE;JAK3;TP73;FYN;ZC3H12D;LEMD2;SIRT2;HDAC8;PAIP2;EIF4EBP1;EPHB2;PER1;IGF2BP3;FKBP8;EIF2AK4;IKBKB;ACOT8
3323,GO:0007033,0.239439116718413,0.830556204188787,20,142,vacuole organization,BP,PACS2;GAA;ULK2;ATG16L2;NAGLU;ULK1;VPS11;SPG11;HOOK2;TBC1D14;LRSAM1;TMEM175;MAP1LC3A;HEXB;WDR45;ATG2A;C9ORF72;CHMP5;LYST;TFEB
1106,GO:0002695,0.239782867974119,0.845449744089822,13,88,negative regulation of leukocyte activation,BP,IL20RB;PRNP;PKN1;INPP5D;PDCD1LG2;CEBPB;BCR;HFE;JAK3;BCL6;ERBB2;PAG1;HLA-G
12676,GO:0050918,0.239945715003743,0.879628923890129,6,36,positive chemotaxis,BP,PGF;VEGFA;VEGFB;PLXNB3;SEMA5A;ITGA2
1283,GO:0003093,0.239968810336435,0.942522247136184,2,8,regulation of glomerular filtration,BP,F2R;GAS6
303,GO:0000813,0.240291363796595,0.942393556282809,2,8,ESCRT I complex,CC,MVB12B;TSG101
13828,GO:0060457,0.240322029355133,0.942381314774225,2,8,negative regulation of digestive system process,BP,STK39;WNK4
17926,GO:1902306,0.240442981077446,0.942333020207149,2,8,negative regulation of sodium ion transmembrane transport,BP,STK39;PCSK9
1121,GO:0002710,0.240644361412126,0.942252571255114,2,8,negative regulation of T cell mediated immunity,BP,IL20RB;HFE
3655,GO:0008140,0.240659943131837,0.942246344456586,2,8,cAMP response element binding protein binding,MF,DDIT3;CRTC1
3716,GO:0008238,0.24081525837773,0.855316764371894,10,65,exopeptidase activity,MF,NPEPL1;RNPEPL1;GGT1;BLMH;LTA4H;PGPEP1;CTSH;DPP7;RNPEP;MMP17
12620,GO:0050848,0.240932925363675,0.871411250284754,7,43,regulation of calcium-mediated signaling,BP,PRNP;NOS1;GSTO1;PKD2;GSTM2;ATP2B4;ADA
3719,GO:0008242,0.24100754533758,0.942107356757128,2,8,omega peptidase activity,MF,GGT1;PGPEP1
5590,GO:0016624,0.241327790166987,0.941979175329309,2,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,DHTKD1;OGDHL
10803,GO:0044309,0.241406815036556,0.838840123024365,15,103,neuron spine,CC,DLG4;ZMYND8;FBXO2;NTSR1;NR1D1;DNM1;NOS1;SHANK2;NEURL1;RGS14;TENM2;TRPV1;FARP1;ARHGAP44;APBA1
10620,GO:0043647,0.241483658422273,0.864767057598681,8,50,inositol phosphate metabolic process,BP,ISYNA1;NTSR1;PLCH2;PLCD3;PLCD1;INPP5D;PTAFR;INPP4A
9191,GO:0035588,0.241642336395626,0.941853151126029,2,8,G-protein coupled purinergic receptor signaling pathway,BP,PTAFR;ADA
4918,GO:0014866,0.241863494435127,0.955667819557839,2,4,skeletal myofibril assembly,BP,MYH11;TTN
16884,GO:0098876,0.241864029477835,0.854538359859203,10,65,vesicle-mediated transport to the plasma membrane,BP,BBS2;OSBPL5;ANK3;EXOC2;BBS1;VAMP2;VPS39;STEAP2;ARHGAP44;SNX17
1182,GO:0002829,0.241904047678404,0.941748202016621,2,8,negative regulation of type 2 immune response,BP,STAT6;BCL6
15424,GO:0071772,0.24207955596224,0.840883174234762,14,95,response to BMP,BP,HTRA1;EGR1;PDCD4;ADAMTS7;RNF165;ACVR2B;MAPK3;FBXL15;SMURF2;HFE;LEMD2;GDF15;TGFBR3;FKBP8
15425,GO:0071773,0.24207955596224,0.840883174234762,14,95,cellular response to BMP stimulus,BP,HTRA1;EGR1;PDCD4;ADAMTS7;RNF165;ACVR2B;MAPK3;FBXL15;SMURF2;HFE;LEMD2;GDF15;TGFBR3;FKBP8
15845,GO:0072593,0.242134321990083,0.825254606818188,22,160,reactive oxygen species metabolic process,BP,XDH;ACP5;GPX3;EGFR;PRDX5;NOS1;DDIT4;SESN2;PKD2;BNIP3;TGFBR2;NOS3;TRPV1;CCS;BCR;ATP2B4;AKT1;ASS1;INSR;CAT;SIRT2;SH3PXD2A
3818,GO:0008420,0.242275669497013,0.941599031741567,2,8,CTD phosphatase activity,MF,PPM1M;CTDSPL
3709,GO:0008227,0.24240557773128,0.941546845758984,2,8,G-protein coupled amine receptor activity,MF,HTR7;CHRM3
16527,GO:0097327,0.242502586524201,0.850009976672981,11,73,response to antineoplastic agent,BP,EGR1;EGFR;MAPK13;PCK2;DDIT4;ERRFI1;PTAFR;ASNS;RECQL5;ADIRF;EIF4EBP1
10635,GO:0043691,0.242531264773425,0.94149633558288,2,8,reverse cholesterol transport,BP,APOE;ABCG1
19261,GO:1905523,0.242593776720348,0.941471206455141,2,8,positive regulation of macrophage migration,BP,MAPK3;TRPV4
10373,GO:0043220,0.242981833013374,0.941315103664359,2,8,Schmidt-Lanterman incisure,CC,SIRT2;MPDZ
986,GO:0002443,0.243209374965427,0.798004190920234,64,500,leukocyte mediated immunity,BP,IL20RB;GSN;PYGB;SLC2A3;NAPRT;TIMP2;ERCC1;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;PRKCZ;SERPING1;BRI3;ZP3;ACTR1B;TMC6;SCART1;S100A13;C5;STAT6;VAMP2;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;C1RL;INPP5D;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;ULBP1;LYST;BTN3A2;CAT;DPP7;YPEL5;HFE;JAK3;APRT;METTL7A;HGSNAT;BTN3A3;BCL6;TOM1;POU2F2;AP2A2;GALNS;LAMTOR2;PFKL
5627,GO:0016712,0.243279603511284,0.941195193437757,2,8,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,CYP3A5;CYP2R1
12818,GO:0051152,0.243495948526788,0.941108003784855,2,8,positive regulation of smooth muscle cell differentiation,BP,OLFM2;CTH
8066,GO:0032755,0.243627952232539,0.869551875669027,7,43,positive regulation of interleukin-6 production,BP,F2R;MAPK13;EREG;ARHGEF2;TRPV4;PTAFR;IL17RC
4868,GO:0014733,0.243654333009514,0.941044136141013,2,8,regulation of skeletal muscle adaptation,BP,TNNT1;TNNI1
5200,GO:0015802,0.243685051298314,0.941031745564967,2,8,basic amino acid transport,BP,PQLC2;SLC25A29
7628,GO:0032045,0.24387418019952,0.940955432469327,2,8,guanyl-nucleotide exchange factor complex,CC,ULK1;C9ORF72
2670,GO:0006024,0.243936271898476,0.845418969897779,12,80,glycosaminoglycan biosynthetic process,BP,B3GAT3;HYAL1;CEMIP;B4GAT1;CSPG4;SDC2;CHST6;ST3GAL3;HEXA;B4GALT2;XYLT2;UST
578,GO:0001731,0.243997064272551,0.940905825250614,2,8,formation of translation preinitiation complex,BP,RPL13A;EIF2D
3122,GO:0006704,0.244004598370969,0.940902783192361,2,8,glucocorticoid biosynthetic process,BP,DGKQ;HSD11B1
15060,GO:0071071,0.244283100206638,0.940790282558465,2,8,regulation of phospholipid biosynthetic process,BP,SLC27A1;ZP3
8785,GO:0034498,0.244355572280227,0.940760991744487,2,8,early endosome to Golgi transport,BP,EHD3;SNX1
11492,GO:0046007,0.244448089338795,0.940723589948469,2,8,negative regulation of activated T cell proliferation,BP,PRNP;PDCD1LG2
4964,GO:0015077,0.244584382501817,0.821841647176587,23,168,monovalent inorganic cation transmembrane transporter activity,MF,KCNG1;SCN8A;SLC2A9;SCN4B;SLC12A7;NDUFA4L2;KCNJ15;PKD2;KCNC4;KCNAB2;SLC22A18;KCNMA1;TMEM175;MFSD3;SLC6A9;TCIRG1;SLC6A6;ASIC1;SCNN1A;ATP12A;SLC9A7;SLC10A6;SLC9A5
7021,GO:0030803,0.244643052832537,0.940644737469623,2,8,negative regulation of cyclic nucleotide biosynthetic process,BP,LTB4R2;GABBR1
7036,GO:0030818,0.244643052832537,0.940644737469623,2,8,negative regulation of cAMP biosynthetic process,BP,LTB4R2;GABBR1
18208,GO:1903044,0.244895743455784,0.940542467276159,2,8,protein localization to membrane raft,BP,REEP2;FLOT1
9271,GO:0035723,0.244946946317143,0.940521734555095,2,8,interleukin-15-mediated signaling pathway,BP,SHC1;JAK3
15178,GO:0071350,0.244946946317143,0.940521734555095,2,8,cellular response to interleukin-15,BP,SHC1;JAK3
1303,GO:0003149,0.24512071852053,0.940451347635158,2,8,membranous septum morphogenesis,BP,VANGL2;TGFBR2
10875,GO:0044433,0.245149679837464,0.784904975011263,130,1040,cytoplasmic vesicle part,CC,PTPRS;DLG4;APOE;GSN;PYGB;SLC2A3;NAPRT;LRP1;TIMP2;VEGFA;EGFR;CLTCL1;CD9;CST3;PGM1;NDRG1;SYT8;HBEGF;GAA;PYGL;ULK2;RAB11FIP4;PRSS3;SYNGR1;ABCA2;DNASE1L1;TMEM173;SNX9;VPS11;VEGFB;RAB3B;CD68;PCSK1;ITPR3;APPL2;SERPING1;ABCA7;MCTP1;CEMIP;BRI3;SPPL2B;ACTR1B;TMC6;MTMR4;PKD2;VAMP2;AREG;AP1G2;ECM1;KCNAB2;DYSF;RHOF;CTSB;MVB12B;LTA4H;PI4K2A;CHMP1B;IFNGR2;PRAF2;SLC48A1;LITAF;SV2A;PKD1;FUCA1;SORL1;MAP6;GPRC5C;TMEM175;ALDOC;PCSK9;DBNDD1;TMSB4X;RAB40B;NOS3;HEXB;WNT7A;MARCH2;GAS6;VPS39;NBEAL2;PTAFR;RAB43;CTSH;TMEM9;STEAP2;ZFYVE21;ITPR2;TSG101;RASSF9;TCIRG1;STEAP3;COPG1;CHMP5;ARSA;MAN2B1;ICA1;PLAU;INSR;WNT3;CHMP4C;TPCN1;MAGED2;CAT;MYOF;DPP7;YPEL5;TIMP1;SNX33;APRT;SNX17;METTL7A;SPIRE1;HGSNAT;SLC9A7;EHD3;SNX1;UBXN6;RAB13;TOM1;ADA;AP2A2;STX1A;GALNS;LAMTOR2;ERBB2;SEC31B;PFKL;HLA-G;BSG;HIP1
553,GO:0001675,0.24515191600606,0.940438707041257,2,8,acrosome assembly,BP,RFX2;TBC1D20
7188,GO:0031086,0.245412679118973,0.940333003866515,2,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,ZFP36L1;PNRC1
3085,GO:0006661,0.245440614169893,0.831114225095848,17,119,phosphatidylinositol biosynthetic process,BP,SLC27A1;PITPNM3;PITPNM1;FGFR3;ZP3;MTMR4;PI4K2A;INPP5D;PIGZ;PIK3R2;FGFR4;PIGQ;INPP4A;FGFR1;PIGV;MPPE1;PLEKHA4
8286,GO:0033129,0.245597335416923,0.940258100421489,2,8,positive regulation of histone phosphorylation,BP,MAPK3;RPS6KA5
3006,GO:0006554,0.245828750034172,0.940164170363478,2,8,lysine catabolic process,BP,ALDH7A1;PHYKPL
19044,GO:1904953,0.245837402898158,0.940160656920177,2,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;CSNK1E
11239,GO:0045503,0.245897454262076,0.915405666035804,3,14,dynein light chain binding,MF,GLUL;DNAH1;WDR60
3161,GO:0006775,0.246038635700549,0.897576652474779,4,22,fat-soluble vitamin metabolic process,BP,CYP27B1;PLTP;CYP2R1;FGFR1
4912,GO:0014854,0.246082495794666,0.940061099863723,2,8,response to inactivity,BP,MTMR4;CAT
14857,GO:0070669,0.246168136984798,0.940026294734628,2,8,response to interleukin-2,BP,SHC1;JAK3
15180,GO:0071352,0.246168136984798,0.940026294734628,2,8,cellular response to interleukin-2,BP,SHC1;JAK3
12592,GO:0050798,0.246174721610592,0.885078980669603,5,29,activated T cell proliferation,BP,PRNP;SATB1;PDCD1LG2;IGFBP2;FYN
5854,GO:0017158,0.24621520754682,0.867760066786988,7,43,regulation of calcium ion-dependent exocytosis,BP,SYTL1;SYT8;ZP3;SEPT5;RIMS3;BRAF;STX1A
12176,GO:0048368,0.246215674532747,0.940006971244071,2,8,lateral mesoderm development,BP,FGFR1;TEAD2
5155,GO:0015697,0.246256816739978,0.939990245126558,2,8,quaternary ammonium group transport,BP,SLC25A29;SLC38A2
6732,GO:0030157,0.246587575457548,0.939855700865514,2,8,pancreatic juice secretion,BP,STK39;WNK4
7030,GO:0030812,0.246615355018646,0.939844394667158,2,8,negative regulation of nucleotide catabolic process,BP,DDIT4;PPARA
632,GO:0001822,0.246677188376579,0.817636041531411,25,181,kidney development,BP,ACTA2;EGR1;CTNNBIP1;PGF;VEGFA;WWTR1;LAMA5;ACVR2B;NID1;WNT2B;PKD2;LAMB2;VANGL2;KIF26B;PKD1;SULF2;WNK4;PCSK9;LZTS2;CTSH;CAT;TP73;FGFR1;WFS1;MMP17
480,GO:0001527,0.246812384690551,0.9397641767064,2,8,microfibril,CC,THSD4;LTBP1
4747,GO:0010923,0.246822843957834,0.846736163663313,11,73,negative regulation of phosphatase activity,BP,PPP1R35;PHACTR3;PPP1R14A;DLG3;ELFN2;CSRNP3;PPP1R15A;CRY2;FARP1;SFI1;IKBKB
1436,GO:0003417,0.246948573958852,0.939708700944224,2,8,growth plate cartilage development,BP,THBS3;TGFBR2
9110,GO:0035435,0.247141983848944,0.939629877214154,2,8,phosphate ion transmembrane transport,BP,SLC37A2;SLC37A4
14942,GO:0070863,0.247154192653921,0.939624899988196,2,8,positive regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1
5098,GO:0015385,0.247243286848933,0.939588572903971,2,8,sodium:proton antiporter activity,MF,SLC9A7;SLC9A5
8151,GO:0032891,0.247265478192661,0.939579523119123,2,8,negative regulation of organic acid transport,BP,STK39;AKT1
8674,GO:0034308,0.247279372791927,0.874750169528722,6,36,primary alcohol metabolic process,BP,DHRS4;ACSS2;ACSS1;PNPLA4;PLB1;RETSAT
15474,GO:0071872,0.247459599980746,0.939500332850987,2,8,cellular response to epinephrine stimulus,BP,ATP2B4;SIRT2
1185,GO:0002832,0.247647129400994,0.874504042344876,6,36,negative regulation of response to biotic stimulus,BP,HTRA1;FAM3A;NLRX1;MAPKBP1;TKFC;SIRT2
13187,GO:0051864,0.247671926407274,0.939413662625665,2,8,histone demethylase activity (H3-K36 specific),MF,KDM4C;KDM7A
14788,GO:0070544,0.247671926407274,0.939413662625665,2,8,histone H3-K36 demethylation,BP,KDM4C;KDM7A
1676,GO:0004143,0.247772590364139,0.93937255272679,2,8,diacylglycerol kinase activity,MF,DGKA;DGKQ
5733,GO:0016885,0.247781043717849,0.939369099910754,2,8,ligase activity, forming carbon-carbon bonds,MF,ACACB;PC
2276,GO:0005225,0.247975645759239,0.939289589186256,2,8,volume-sensitive anion channel activity,MF,LRRC8A;TTYH3
15389,GO:0071679,0.248097005873768,0.939239979941739,2,8,commissural neuron axon guidance,BP,VEGFA;EPHB2
920,GO:0002315,0.248099674479824,0.939238888871084,2,8,marginal zone B cell differentiation,BP,DOCK11;MFNG
19630,GO:1990909,0.248103287626011,0.939237411607334,2,8,Wnt signalosome,CC,LRP5;WNT3
6763,GO:0030205,0.248196802101046,0.939199171828653,2,8,dermatan sulfate metabolic process,BP,CSPG4;UST
9066,GO:0035331,0.248279202047104,0.939165467990432,2,8,negative regulation of hippo signaling,BP,WWC3;MARK3
9837,GO:0042098,0.248310146564976,0.8332519828791,15,105,T cell proliferation,BP,IL20RB;PRNP;ZP3;CCDC88B;SATB1;PDCD1LG2;CEBPB;TGFBR2;CARD11;IGFBP2;JAK3;FYN;DHPS;ERBB2;HLA-G
4481,GO:0010508,0.248589547719502,0.83570025207297,14,96,positive regulation of autophagy,BP,GPSM1;TRIM65;EPM2A;ULK1;SESN2;MAPK3;BNIP3;LRSAM1;BNIP3L;FYCO1;C9ORF72;TPCN1;TFEB;EIF2AK4
7618,GO:0032026,0.248677103777118,0.939002596685384,2,8,response to magnesium ion,BP,ANK3;ENTPD6
17458,GO:1900402,0.24884220706561,0.938934958027745,2,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,NR1D1;PPARA
12082,GO:0048143,0.249027595382698,0.938858968783044,2,8,astrocyte activation,BP,LRP1;EGFR
17502,GO:1901020,0.249051198348572,0.912997439590741,3,15,negative regulation of calcium ion transmembrane transporter activity,BP,GSTO1;PKD2;GSTM2
6408,GO:0021675,0.249104124604262,0.86575150628418,7,43,nerve development,BP,SERPINE2;ADARB1;RNF165;SEMA3F;SLITRK6;SULF2;EPHB2
2430,GO:0005614,0.249210709413483,0.938783869875075,2,8,interstitial matrix,CC,SMOC2;ECM2
18765,GO:1904321,0.249281685173516,0.938754750033726,2,8,response to forskolin,BP,ADCY6;HDAC8
18766,GO:1904322,0.249281685173516,0.938754750033726,2,8,cellular response to forskolin,BP,ADCY6;HDAC8
13466,GO:0055037,0.249390488487241,0.822335742433348,20,143,recycling endosome,CC,NDRG1;RAB11FIP4;NISCH;ULK1;MCTP1;MICALL2;ABCG1;SH3TC2;TBC1D14;SORL1;RASSF9;RAB25;C1ORF210;ARHGAP44;HFE;FCHSD1;SLC9A7;EHD3;RAB13;HLA-G
11598,GO:0046321,0.249559818359124,0.938640577653887,2,8,positive regulation of fatty acid oxidation,BP,MLYCD;PPARA
707,GO:0001933,0.249582053411076,0.800741216494276,43,326,negative regulation of protein phosphorylation,BP,TNIP1;XDH;DUSP6;APOE;PTK6;PDCD4;PRNP;FBLN1;DUSP5;ADARB1;WWTR1;PKN1;DDIT4;DGKQ;SPRY2;PRKCZ;STK39;SPRY4;TRIB2;IMPACT;ERRFI1;RGS14;MLXIPL;DMTN;SORL1;LRP5;PKIB;TRIB3;CDK5RAP3;PIK3R2;EPHA1;AKT1;CDKN1C;MICAL1;TSG101;C9ORF72;CTDSPL;TP73;LEMD2;SIRT2;EPHB2;PER1;FKBP8
5222,GO:0015837,0.249989485671861,0.882650688014322,5,29,amine transport,BP,NTSR1;RAB3B;STK39;SV2A;STX1A
4980,GO:0015108,0.250555903940964,0.872552350137022,6,36,chloride transmembrane transporter activity,MF,CLCA2;SLC12A7;ANO8;ANO1;ANO9;TTYH3
9368,GO:0035914,0.250756196205223,0.872417637742541,6,36,skeletal muscle cell differentiation,BP,FOS;EGR1;MEF2D;NUPR1;HMG20B;LEMD2
3069,GO:0006638,0.251127801949344,0.847518734656022,10,66,neutral lipid metabolic process,BP,APOE;LMF1;DGKA;PCK2;DGKQ;PNPLA3;PCSK9;PNPLA4;CAT;FITM2
15481,GO:0071880,0.251467012911666,0.937855095937298,2,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1;ATP2B4
11085,GO:0045117,0.251621441817568,0.91164400640636,3,15,azole transport,BP,SLC25A29;ADA;SLC35F3
12932,GO:0051338,0.251712869511519,0.783740584036233,93,730,regulation of transferase activity,BP,DUSP6;DLG4;F2R;APOE;EGR1;PTK6;PDCD4;VEGFA;EGFR;PRNP;DUSP5;TNFSF15;ERCC6;MST1R;ADARB1;RBL2;SLC27A1;WWTR1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;SHC1;SPRY2;PRKCZ;PAK1;STK39;FGFR3;CEMIP;SPRY4;DLG3;NEURL1;ACVR2B;TRIB2;EREG;NAB2;LPAR3;C5;SESN2;PKD2;MAPK3;CSPG4;TRPT1;ERRFI1;VANGL2;RGS14;TSPYL2;MAP2K2;PAK6;PKD1;TTN;SORL1;VLDLR;MAP3K12;LRP5;PKIB;TGFBR2;ITGA1;TRIB3;CDK5RAP3;MINK1;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;ADCY6;ATP2B4;STRADB;AKT1;CDKN1C;SPDYE2;SPDYE2B;TSG101;FGFR4;INSR;MAP2K5;BRAF;MAPK10;TP73;GOLGA2;AVPI1;VAV3;LAMTOR2;MAP3K10;EPHB2;FGFR1;ERBB2;UNC119;HMBOX1;CAMKK1
19787,GO:2000273,0.251733758413409,0.894205204538475,4,22,positive regulation of signaling receptor activity,BP,NEURL1;EREG;HFE;EPHB2
11351,GO:0045737,0.251909033058644,0.881422774781359,5,29,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR;PKD2;PKD1;MAPRE3;AKT1
3585,GO:0007638,0.252121409148882,0.937584540764907,2,8,mechanosensory behavior,BP,ETV1;SLITRK6
13489,GO:0055086,0.252198336802079,0.788423194802071,69,547,nucleobase-containing small molecule metabolic process,BP,XDH;H6PD;DLG4;GAMT;NT5E;APOE;NAPRT;TIMP2;VEGFA;RAPGEF3;IDH2;NOS1;DNPH1;PGM1;DHTKD1;TK2;LHPP;PCK2;PGLS;DDIT4;OGDHL;NMRK1;APOBEC3C;NPR2;DLG3;NMNAT2;NME4;NEIL1;ABHD14B;PPCS;APOBEC3F;PPARA;PKD2;NT5C1B;KCNAB2;MACROD1;FAM20C;MYH3;MLXIPL;SDHA;PTHLH;LTB4R2;GTPBP1;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;MOCOS;PDE2A;PEMT;NOS3;UCKL1;ADCY6;ENTPD6;CARD11;DGUOK;TCIRG1;UPP1;INSR;APRT;MPI;TAZ;ADA;ENTPD2;FUK;PFKL;NUDT18
6428,GO:0021700,0.252233177558159,0.819984762895642,20,143,developmental maturation,BP,DLG4;NFATC4;ADGRL1;THBS3;FAM210B;VEGFA;DDIT3;PABPC1L;FGFR3;NPR2;NEURL1;PLXNB1;EREG;FAM20C;CABYR;REC8;SIRT2;POU2F2;EPAS1;FGFR1
18143,GO:1902936,0.252287653343602,0.84664694618245,10,66,phosphatidylinositol bisphosphate binding,MF,ARAP3;GSDMA;PLEK2;PLCD1;TWF2;GSDMC;AKT1;WDR45;ADAP1;HIP1
12622,GO:0050850,0.252344505582135,0.893841419158045,4,22,positive regulation of calcium-mediated signaling,BP,GSTO1;PKD2;GSTM2;ADA
12535,GO:0050708,0.252839316748156,0.802998186076315,35,259,regulation of protein secretion,BP,F2R;POSTN;GLUL;ALOX15B;EGFR;NR1D1;HADH;RAPGEF3;IDH2;PCK2;ARL2;NLGN2;ITPR3;PRKCZ;PLA2G6;C5;ANO1;MAPK3;TTN;NLRP1;RHBDF1;LRP5;TRPV4;TMSB4X;RHBDF2;GAS6;GLUD1;MAPKBP1;ITPR2;IL17RC;ICA1;CIDEA;MYO18A;STX1A;PFKL
11855,GO:0046883,0.25287756318307,0.819417512794335,20,144,regulation of hormone secretion,BP,GLUL;EGFR;NR1D1;HADH;RAPGEF3;PCK2;ARL2;NLGN2;ITPR3;PLA2G6;ANO1;LRP5;APLN;GLUD1;ITPR2;ICA1;HFE;STX1A;FGFR1;PFKL
3575,GO:0007622,0.253108906496864,0.893385503699563,4,22,rhythmic behavior,BP,CST3;NAGLU;ADA;MTA1
12218,GO:0048512,0.253108906496864,0.893385503699563,4,22,circadian behavior,BP,CST3;NAGLU;ADA;MTA1
12877,GO:0051247,0.253143396447872,0.776205971891067,143,1148,positive regulation of protein metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;GSN;EGR1;PTK6;EDEM1;LRP1;TIMP2;VEGFA;EGFR;PRNP;FBLN1;DUSP5;RAPGEF3;TNFSF15;IGFBP4;NOS1;ERCC6;GRAMD4;MST1R;NUPR1;HBEGF;CTF1;CNTN1;SLC27A1;MAP2K1;PKN1;SHC2;DGKQ;SNX9;MAGEF1;SHC1;VPS11;SPRY2;CIRBP;CAPRIN2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;PHF1;DLG3;NEURL1;ACVR2B;NGFR;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PLGRKT;IMPACT;PKD2;AREG;MAPK3;CSPG4;VANGL2;MAPK12;ARHGEF2;MAP2K2;ZFPM1;BBC3;PAK6;PKD1;FLOT1;JDP2;SORL1;HERPUD1;VLDLR;NLRP1;MAP3K12;PCSK9;TGFBR2;TRPV4;ITGA1;SMURF2;TRIB3;DAP;PEMT;CDK5RAP3;MINK1;PROM2;WNT7A;EPHA1;GAS6;ERN1;MAPRE3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;AKT1;CARD11;CHEK2;IFT57;FGFR4;PIAS3;WDFY2;IFI27;INSR;RPS6KA5;C6ORF89;MAP2K5;BRAF;EDA2R;PIDD1;MAPK10;HFE;TP73;SNX33;CSNK1E;BCL6;FYN;SNX1;SIRT2;GDF15;GOLGA2;MTA1;AVPI1;CIDEB;LAMTOR2;MAP3K10;EPHB2;ITGA2;FGFR1;WFS1;ERBB2;EIF2AK4;UNC119;CAMKK1;HIP1
11281,GO:0045619,0.253161761264715,0.832022392901094,14,97,regulation of lymphocyte differentiation,BP,ZFP36L1;SOX13;PRKCZ;RAG1;INPP5D;TGFBR2;GAS6;CARD11;BRAF;JAK3;BCL6;ADA;ERBB2;HLA-G
14105,GO:0060997,0.253687002865334,0.870441689504227,6,36,dendritic spine morphogenesis,BP,DLG4;SHANK2;CAPRIN2;WNT7A;ARHGAP44;EPHB2
11115,GO:0045177,0.253836932693526,0.807198468484451,29,214,apical part of cell,CC,EGFR;CD9;SLC2A9;SHANK2;PLAT;ITPR3;PRKCZ;STK39;SHROOM4;ANO1;CSPG4;VANGL2;SLC22A18;REEP6;SLC29A4;KCNMA1;TRPV4;EDA;PROM2;SRR;SLC9A3R2;IGFBP2;TCIRG1;HOMER2;PLB1;HFE;SCNN1A;MPDZ;ERBB2
10236,GO:0042987,0.253838691055989,0.880184337913417,5,29,amyloid precursor protein catabolic process,BP,APOE;PRNP;ABCA7;ABCG1;SORL1
9867,GO:0042149,0.254084933364107,0.870172720238947,6,36,cellular response to glucose starvation,BP,SESN2;IMPACT;ATF4;ASNS;C12ORF66;UPP1
2294,GO:0005254,0.254673926138579,0.879647032152272,5,29,chloride channel activity,MF,CLCA2;ANO8;ANO1;ANO9;TTYH3
17485,GO:1900745,0.255063469612668,0.909818864684172,3,15,positive regulation of p38MAPK cascade,BP,XDH;VEGFA;MINK1
11758,GO:0046637,0.255219154747725,0.879295877058039,5,29,regulation of alpha-beta T cell differentiation,BP,PRKCZ;TGFBR2;JAK3;BCL6;ADA
7686,GO:0032148,0.255324358200195,0.892060316366464,4,22,activation of protein kinase B activity,BP,PRKCZ;GAS6;AKT1;INSR
14973,GO:0070920,0.255331769505222,0.909675990199673,3,15,regulation of production of small RNA involved in gene silencing by RNA,BP,EGFR;MAP2K1;MAP2K2
12138,GO:0048268,0.255346496798123,0.909668145108429,3,15,clathrin coat assembly,BP,CLTCL1;FCHO1;HIP1
9534,GO:0036309,0.255765156252483,0.981159047375551,1,2,protein localization to M-band,BP,OBSCN
14622,GO:0070233,0.255798806587082,0.909427074953577,3,15,negative regulation of T cell apoptotic process,BP,RAG1;JAK3;ADA
15781,GO:0072503,0.255855702249399,0.805425403229639,29,216,cellular divalent inorganic cation homeostasis,BP,DLG4;F2R;APOE;NTSR1;PRNP;NOS1;DDIT3;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;BNIP3;SV2A;PKD1;HERPUD1;GSTM2;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;ITPR2;TPCN1;FYN;TRPC1;EDNRA;WFS1
15455,GO:0071827,0.255969238437774,0.891673511882928,4,22,plasma lipoprotein particle organization,BP,APOE;ABCA7;ABCG1;PLTP
16919,GO:0098928,0.255970341656137,0.981126393430961,1,2,presynaptic signal transduction,BP,PCLO
17021,GO:0099526,0.255970341656137,0.981126393430961,1,2,presynapse to nucleus signaling pathway,BP,PCLO
14106,GO:0060998,0.256452579912348,0.853882126312189,8,51,regulation of dendritic spine development,BP,PTPRS;APOE;ZMYND8;SHANK2;CAPRIN2;NEURL1;CAMK1;ARHGAP44
11284,GO:0045622,0.256685983509512,0.908953505783243,3,15,regulation of T-helper cell differentiation,BP,PRKCZ;JAK3;BCL6
4592,GO:0010712,0.256703244872095,0.891232664784898,4,22,regulation of collagen metabolic process,BP,F2R;CST3;ERRFI1;ITGA2
13601,GO:0060122,0.256994142778536,0.90878878759424,3,15,inner ear receptor cell stereocilium organization,BP,IFT27;VANGL2;TRIOBP
17871,GO:1902188,0.257094200047302,0.908735279766454,3,15,positive regulation of viral release from host cell,BP,PC;TSG101;CHMP4C
10533,GO:0043502,0.257266802936058,0.853291684349532,8,51,regulation of muscle adaptation,BP,PAK1;MTMR4;ERRFI1;NOS3;ATP2B4;TNNT1;LMNA;TNNI1
2536,GO:0005794,0.257432805354671,0.772198113116875,143,1143,Golgi apparatus,CC,DOCK4;F2R;ST6GALNAC2;APOE;H1F0;LMF1;POSTN;ADAM19;EDEM1;NTSR1;EGFR;PRNP;ZDHHC1;ANK3;CLTCL1;SPTB;DNM1;GPSM1;ARAP1;B3GAT3;OBSL1;ASAP2;CUL7;MAP2K1;PITPNM1;AKR7A2;TMEM173;SNX9;ARL2;PHF7;ABCA7;B4GALNT4;FGFR3;NMNAT2;FBXW8;CCDC88B;SPPL2B;MARCH4;MUC19;MALL;TMC6;TMED4;ABCG1;DNMBP;TRAPPC9;CHAC1;IFT27;VAMP2;AREG;ST6GALNAC6;AP1G2;B4GAT1;MARCH9;MAPK3;CSPG4;SCARA3;FAM20C;PI4K2A;KIAA0319L;SDC2;IFNGR2;TBC1D14;ARHGEF2;MAP2K2;STMN3;SLC50A1;LITAF;PTHLH;CHST6;SLC38A10;TENM2;PKD1;PSKH1;AZIN2;HDAC5;SORL1;MAP6;IL17RD;ST3GAL3;SULF2;RHBDF1;PCSK9;PKN3;PDE2A;NOS3;MINK1;WNT7A;ANGEL1;GAS6;ATP7B;FYCO1;GOLGA2P5;NECAB3;PPP1R15A;RAB43;ENTPD6;STEAP2;B4GALT2;CHEK2;IFT57;FMNL3;FGFR4;NUCB2;COPG1;TBC1D20;CAPN2;GOLGA8A;ICA1;WNT3;COG7;C6ORF89;ZDHHC24;YIPF3;ASIC1;PIDD1;CAT;DPP7;TP73;SNX17;SCYL3;TMEM50B;BCL6;RABAC1;SLC9A7;ATP8B2;PJA2;SNX1;GDF15;RAB13;GOLGA2;RHOBTB3;MYO18A;MAN1B1;MFNG;SLC39A11;XYLT2;UST;HLA-G;MPPE1;CREB3L4;BSG;APBA1;HIP1
3275,GO:0006956,0.257609231176261,0.908459662225218,3,15,complement activation,BP,SERPING1;C5;C1RL
2708,GO:0006084,0.257880062512016,0.87757747208713,5,29,acetyl-CoA metabolic process,BP,MLYCD;ACACB;ACSS2;MVD;ACSS1
11467,GO:0045948,0.258016955988291,0.890442093395546,4,22,positive regulation of translational initiation,BP,IMPACT;PPP1R15A;RXRA;EIF2AK4
7803,GO:0032365,0.258137796138023,0.877410619445941,5,29,intracellular lipid transport,BP,CPT2;ABCA2;ABCG1;ACACB;PCSK9
18450,GO:1903579,0.258228864230552,0.908127638271109,3,15,negative regulation of ATP metabolic process,BP,DDIT4;PPARA;MLXIPL
16741,GO:0098563,0.258425516353737,0.908022166337446,3,15,intrinsic component of synaptic vesicle membrane,CC,PTPRS;RAB3B;SV2A
5555,GO:0016572,0.258663201629299,0.877070256683061,5,29,histone phosphorylation,BP,PKN1;HMGA2;MAPK3;MAP3K12;RPS6KA5
12812,GO:0051146,0.259092483305969,0.812780354125611,21,147,striated muscle cell differentiation,BP,FLNC;VEGFA;OBSCN;NOS1;OBSL1;MYH11;PAK1;THRA;MYH3;FLOT1;TTN;HDAC5;RXRA;AKT1;TNNT1;TMOD2;LMNA;CAPN2;KRT19;MYOF;GDF15
16401,GO:0097066,0.259096778923545,0.907661787578701,3,15,response to thyroid hormone,BP,KLF9;CTSB;CTSH
9211,GO:0035612,0.259244236062317,0.934605234245102,2,8,AP-2 adaptor complex binding,MF,FCHO1;HIP1
10135,GO:0042730,0.25944935612405,0.907472280319522,3,15,fibrinolysis,BP,PLAT;SERPING1;PLAU
17503,GO:1901021,0.259738988303382,0.889402787701834,4,22,positive regulation of calcium ion transmembrane transporter activity,BP,GSTO1;PKD2;GSTM2;EHD3
818,GO:0002092,0.260253539236728,0.907039471395356,3,15,positive regulation of receptor internalization,BP,VEGFA;PCSK9;APLN
4187,GO:0009268,0.260486639899648,0.888950490815182,4,22,response to pH,BP,HYAL1;IMPACT;TRPV1;ASIC1
680,GO:0001891,0.260719414908964,0.906788377716598,3,15,phagocytic cup,CC,ABCA7;PEAR1;ARHGAP25
11323,GO:0045667,0.260751501869669,0.835985166963036,11,74,regulation of osteoblast differentiation,BP,CTNNBIP1;SMOC1;ACVR2B;AREG;IFITM1;FAM20C;CEBPB;LRP5;ATRAID;NBR1;HDAC8
8942,GO:0035020,0.260928156299359,0.906675786210726,3,15,regulation of Rac protein signal transduction,BP,ARAP3;STMN3;ARHGAP44
17399,GO:1900181,0.26113598879865,0.906563632161441,3,15,negative regulation of protein localization to nucleus,BP,PDE2A;GAS6;LZTS2
7456,GO:0031623,0.261832885966154,0.844232859911957,9,59,receptor internalization,BP,DLG4;LRP1;VEGFA;CD9;DNM1;FLOT1;PCSK9;APLN;SNX1
18418,GO:1903531,0.262156186570804,0.824796243582155,14,98,negative regulation of secretion by cell,BP,F2R;HADH;IDH2;RHBDF1;TMSB4X;RHBDF2;GAS6;BCR;MAPKBP1;BRAF;ASIC1;CIDEA;PFKL;PNKD
6390,GO:0021602,0.262233559212552,0.905970469433487,3,15,cranial nerve morphogenesis,BP,ADARB1;SEMA3F;EPHB2
6284,GO:0019899,0.262241252559461,0.762495838391066,225,1822,enzyme binding,MF,TNIP1;ACTA2;DLG4;DOCK4;BTBD2;SYTL1;EGR1;TYSND1;PPP1R35;EVI5L;CDC42EP5;WWC3;LRP1;TIMP2;OBSCN;EGFR;PRNP;NEK9;RAPGEF3;SPTB;CST3;DNM1;MEF2D;ARAP3;BRSK1;MICALCL;NDRG1;TBC1D8;ABTB1;ARHGEF19;MST1R;ARRDC1;UHRF1BP1;CUL9;RIN1;ARAP1;HBEGF;RGL2;EXOC2;RAB11FIP4;PHACTR3;ASAP2;CUL7;PITPNM3;PKN1;MC1R;BTG1;TOM1L2;SHC2;PITPNM1;DGKQ;TMEM173;SNX9;PLEKHG5;ULK1;SHC1;SPRY2;GRB7;SLC12A7;RALGDS;APPL2;PRKCZ;PAK1;STK39;FGFR3;GLDC;CBS;DOCK6;DLG3;MICALL2;CEP250;ZP3;NGFR;ARHGEF4;TRIB2;EREG;PLEKHG2;RHOBTB2;PLA2G6;DNMBP;XPOT;TRAPPC9;RINL;AGAP1;ALS2CL;MTMR4;PPARA;PKD2;STAT6;ECM1;MAPK3;CSPG4;BNIP3;ERRFI1;DOCK9;RGS14;RHOF;SLC22A18;SNTA1;SRGAP3;PLEKHG4;TBC1D14;ARHGEF2;TWF2;ATF4;BBC3;KDM4C;PAK6;DOCK11;SV2A;TBC1D3E;RABGAP1;ACAP3;PKD1;ATXN10;FLOT1;CEP68;TTN;HLCS;HDAC5;WHAMMP3;SORL1;SRSF5;GSTM2;TEP1;NLRP1;CEBPB;MAP3K12;RIN2;PKN3;LONP2;HLTF;TRIOBP;TGFBR2;TRPV4;IQSEC2;ITGA1;PSD4;TMSB4X;MAP1LC3A;TRIB3;CDK5RAP3;PIK3R2;EPHA1;FMNL2;GAS6;ERN1;PLEKHG3;BCR;MAPRE3;NBR1;KIF13B;TERC;PTAFR;PPP1R15A;RXRA;RIMS3;ADCY6;ATP2B4;SLC9A3R2;TNFRSF14;PLEKHG6;AKT1;MICAL1;CRY2;CHEK2;SBF2;SPDYE2;SPDYE2B;TSG101;FMNL3;FGFR4;PIAS3;TCIRG1;ASAP3;FARP1;C9ORF72;SGSM2;TBC1D20;INSR;FOXO4;RABGGTA;BRAF;ARHGAP44;CAT;TIMP1;JAK3;TP73;UBOX5;PEX7;GSTM3;ADAP1;EPS8L1;FYN;PJA2;ARHGEF17;SIRT2;RECQL5;RAB13;GOLGA2;RCOR2;RHOBTB3;AP2A2;EPS8L2;VAV3;STX1A;EPAS1;LAMTOR2;TBC1D16;EPHB2;PER1;FGFR1;WFS1;ERBB2;PAG1;SYVN1;PFKL;C15ORF62;FRS3;SFI1;NET1;KCTD13;IKBKB;TCTEX1D4;BTBD11
9490,GO:0036152,0.263114609444789,0.905493258709461,3,15,phosphatidylethanolamine acyl-chain remodeling,BP,LPCAT4;PLA2G6;MBOAT2
15875,GO:0072673,0.263185834714853,0.905454639026137,3,15,lamellipodium morphogenesis,BP,ARPIN;SNX1;CORO1B
11757,GO:0046636,0.26321061589729,0.905441200752376,3,15,negative regulation of alpha-beta T cell activation,BP,HFE;JAK3;BCL6
2376,GO:0005507,0.26367232071034,0.863184022869915,6,38,copper ion binding,MF,PRNP;LOXL1;S100A13;CCS;ATP7B;SNCB
2951,GO:0006482,0.264030457981864,0.873576131978097,5,29,protein demethylation,BP,KDM3A;KDM4C;KDM7A;PHF2;HSF4
3703,GO:0008214,0.264030457981864,0.873576131978097,5,29,protein dealkylation,BP,KDM3A;KDM4C;KDM7A;PHF2;HSF4
12144,GO:0048284,0.264134161755939,0.810015850825432,20,145,organelle fusion,BP,SYTL1;EVI5L;TBC1D8;SYT8;VPS11;SPG11;VAMP2;BNIP3;DYSF;TBC1D14;TBC1D3E;RABGAP1;TSNARE1;TMEM175;VPS39;SGSM2;RAB13;VAV3;STX1A;TBC1D16
11041,GO:0045056,0.264164094547765,0.904923582513086,3,15,transcytosis,BP,LRP1;FCGRT;PTAFR
10305,GO:0043112,0.264182045456114,0.813679231657109,18,129,receptor metabolic process,BP,DLG4;APOE;LRP1;VEGFA;NR1D1;CD9;DNM1;ARAP1;PPARA;FLOT1;VLDLR;PCSK9;APLN;CHMP5;EHD3;SNX1;AP2A2;TBC1D16
5564,GO:0016581,0.264329528097631,0.904833660246816,3,15,NuRD complex,CC,APPL2;SALL2;CHD3
16303,GO:0090545,0.264329528097631,0.904833660246816,3,15,CHD-type complex,CC,APPL2;SALL2;CHD3
2854,GO:0006346,0.264392228805864,0.904799570235781,3,15,methylation-dependent chromatin silencing,BP,DNMT3A;MBD1;UHRF2
4470,GO:0010470,0.264396340126943,0.886574815400357,4,22,regulation of gastrulation,BP,DUSP6;TENM4;MAP2K5;FGFR1
13804,GO:0060428,0.264412650008291,0.886564868115153,4,22,lung epithelium development,BP,MAP2K1;ERRFI1;THRA;PKD1
11283,GO:0045621,0.264956583559029,0.84753710953173,8,52,positive regulation of lymphocyte differentiation,BP,PRKCZ;RAG1;INPP5D;TGFBR2;GAS6;BCL6;ADA;HLA-G
12907,GO:0051287,0.264961508455768,0.847533498422477,8,52,NAD binding,MF,HADH;IDH2;PHGDH;CRYL1;HIBADH;GLUD1;NUDT6;SIRT2
13550,GO:0060043,0.265152017278402,0.886113612114371,4,22,regulation of cardiac muscle cell proliferation,BP,TGFBR2;TP73;TGFBR3;FGFR1
10846,GO:0044381,0.265305022771965,0.904302746997657,3,15,glucose import in response to insulin stimulus,BP,PAK1;NGFR;PIK3R2
20263,GO:2001273,0.265305022771965,0.904302746997657,3,15,regulation of glucose import in response to insulin stimulus,BP,PAK1;NGFR;PIK3R2
17809,GO:1902001,0.265440715826571,0.904228804162908,3,15,fatty acid transmembrane transport,BP,CPT2;ACACB;AKT1
12796,GO:0051125,0.265523872619178,0.885886421335887,4,22,regulation of actin nucleation,BP,GSN;WIPF1;ARPIN;CORO1B
10884,GO:0044447,0.265711597704851,0.904081126177318,3,15,axoneme part,CC,DNAH1;SPAG16;WDR66
11743,GO:0046621,0.2658897809948,0.88566270893691,4,22,negative regulation of organ growth,BP,WWC3;PAK1;TGFBR2;TP73
5853,GO:0017157,0.266020627937228,0.814250300554567,17,121,regulation of exocytosis,BP,SYTL1;SYT8;RAB3B;ZP3;PLA2G6;VAMP2;SEPT5;PCLO;RAB40B;BCR;PTAFR;RIMS3;MICAL1;TSG101;BRAF;RAB13;STX1A
4580,GO:0010675,0.266874366818697,0.827432768634184,12,82,regulation of cellular carbohydrate metabolic process,BP,NTSR1;NR1D1;IGFBP4;MLYCD;DDIT4;DGKQ;PPARA;ACACB;PTAFR;AKT1;INSR;PHLDA2
486,GO:0001539,0.267106573175485,0.90331920528504,3,15,cilium or flagellum-dependent cell motility,BP,BBS2;DNAH1;SPAG16
13694,GO:0060285,0.267106573175485,0.90331920528504,3,15,cilium-dependent cell motility,BP,BBS2;DNAH1;SPAG16
15627,GO:0072170,0.267265962434129,0.903231997673296,3,15,metanephric tubule development,BP,WWTR1;PKD2;PKD1
3548,GO:0007585,0.267658105500424,0.860660688317709,6,37,respiratory gaseous exchange,BP,NTSR1;GAA;NLGN2;STK40;APLN;EDNRA
4063,GO:0009117,0.267800777060759,0.776983786383691,60,476,nucleotide metabolic process,BP,XDH;H6PD;DLG4;NT5E;APOE;NAPRT;TIMP2;VEGFA;RAPGEF3;IDH2;NOS1;DNPH1;PGM1;DHTKD1;TK2;PCK2;PGLS;DDIT4;OGDHL;NMRK1;NPR2;DLG3;NMNAT2;NME4;NEIL1;ABHD14B;PPCS;PPARA;PKD2;NT5C1B;KCNAB2;FAM20C;MYH3;MLXIPL;SDHA;PTHLH;LTB4R2;GTPBP1;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;MOCOS;PDE2A;NOS3;UCKL1;ADCY6;CARD11;DGUOK;TCIRG1;UPP1;INSR;APRT;TAZ;ADA;FUK;PFKL;NUDT18
2526,GO:0005783,0.268261569457564,0.760352081367051,163,1322,endoplasmic reticulum,CC,XDH;H6PD;DLG4;APOE;HS1BP3;FOS;OSBPL5;LMF1;FBXO2;TMEM129;EDEM1;CRAT;GLUL;NTSR1;EGFR;PRNP;ZDHHC1;ADAMTS7;ANK3;IGFBP4;FKBP9;CRTAP;CST3;NOS1;GPSM1;PACS2;ADAMTS13;COL13A1;CYP3A5;CERCAM;SLC27A1;REEP2;PLD3;TXNRD3;MAP2K1;COL6A1;LPCAT4;DNASE1L1;PITPNM1;TMEM173;ULK1;ITPR3;SLC37A2;MCTP1;ERO1B;FGFR3;CEMIP;SYNE3;PDZD2;CCDC88B;SPPL2B;LTBP1;SMIM14;TMC6;PNPLA3;DHRS4;ANO8;TMED4;CES3;ABCG1;ESYT2;TRAPPC9;MANF;FKBP10;FNDC4;PKD2;AREG;COL8A1;LAMB2;BNIP3;SCARA3;FAM20C;ADAMTSL1;MXRA8;SDC2;IFNGR2;MAP2K2;SRD5A3;SEMA3B;UBXN4;MOSPD3;SV2A;TENM2;FBXO6;REEP6;PSKH1;HSD11B1;SORL1;HERPUD1;GSTM2;TPBG;SULF2;CES2;COL4A6;RHBDF1;LRP5;PCSK9;HSD17B7;PDE2A;PEMT;EDA;PIGZ;SLC27A3;WNT7A;MARCH2;BNIP3L;RHBDF2;ANGEL1;GAS6;ERN1;CPT1C;NBEAL2;NECAB3;CYP2R1;PPP1R15A;TM7SF2;IGFBP7;ITPR2;REEP4;LAMB1;FGFR4;NUCB2;FAAH;COPG1;TBC1D20;ARSA;CAPN2;WNT3;ULBP1;PIGQ;ZDHHC24;CAT;LGALS1;TIMP1;TMX4;CERS4;METTL7A;TMEM50B;SLC37A4;ATP8B2;PJA2;LEMD2;MBOAT2;RTN2;ENTPD2;RETSAT;MAN1B1;RNF170;MCTP2;PIGV;WFS1;ESYT3;FITM2;FKBP8;XYLT2;SEC31B;KDELC2;SYVN1;HLA-G;MPPE1;CREB3L4;KDSR;CYP4V2
6411,GO:0021680,0.26842189842112,0.90259861759741,3,15,cerebellar Purkinje cell layer development,BP,NAGLU;AARS;B4GALT2
12279,GO:0048639,0.268735064373259,0.816815683482482,15,105,positive regulation of developmental growth,BP,BBS2;VEGFA;PAK1;ZP3;LPAR3;ACACB;SEMA5A;TWF2;TGFBR2;AKT1;INSR;WNT3;GPR21;TGFBR3;FGFR1
14921,GO:0070838,0.268947042325815,0.791286675930987,32,240,divalent metal ion transport,BP,F2R;GJC2;NTSR1;PRNP;NOS1;DDIT3;ORAI3;CYP27B1;ITPR3;CEMIP;ORAI2;GSTO1;PLA2G6;LPAR3;PKD2;PKD1;GSTM2;TRPV4;PDE2A;NOS3;TRPV1;GAS6;ATP2B4;ITPR2;TPCN1;HOMER2;ASIC1;EHD3;FYN;TRPC1;SLC39A11;WFS1
992,GO:0002449,0.269038066449615,0.809616999403886,18,130,lymphocyte mediated immunity,BP,IL20RB;ERCC1;PRKCZ;SERPING1;ZP3;SCART1;C5;STAT6;C1RL;INPP5D;CTSH;ULBP1;LYST;BTN3A2;HFE;BTN3A3;BCL6;POU2F2
363,GO:0000982,0.269272681571686,0.787794567759334,36,271,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NFATC4;FOS;EGR1;NR1D1;MEF2D;DDIT3;TCFL5;RBL2;ETV4;SOX12;ELK3;FOXQ1;ETV1;HES2;TEF;CARF;PPARA;KLF7;HMGA2;MLXIPL;LITAF;ATF4;ZFPM1;ZNF467;JDP2;CEBPB;HLTF;BHLHE40;ZFP90;ZNF217;TP73;TFEB;POU2F2;EPAS1;TSHZ1;DBP
9971,GO:0042391,0.270638378928329,0.795929916093517,26,193,regulation of membrane potential,BP,DLG4;ZMYND8;FHL1;NTSR1;SCN8A;ANK3;SHANK2;CRTC1;SCN4B;NLGN2;PRKCZ;BNIP3;SNTA1;SSH1;IFI6;KCNMA1;WNT7A;TRPV1;BNIP3L;RIMS3;AKT1;PIAS3;TPCN1;ASIC1;EHD3;STX1A
2127,GO:0004930,0.270836639597882,0.806172342163176,19,138,G-protein coupled receptor activity,MF,F2R;ADGRL1;NTSR1;ADGRB2;MC1R;HTR7;LPAR3;LTB4R2;GPR153;ADGRF1;GPRC5C;GABBR1;PTAFR;LTB4R;GPR21;MRGPRX3;CHRM3;CELSR1;EDNRA
6692,GO:0030098,0.271563263537702,0.793971248557876,27,201,lymphocyte differentiation,BP,EGR1;ZFP36L1;SOX13;PRKCZ;RAG1;SATB1;STAT6;INPP5D;LRRC8A;ZFPM1;DOCK11;POLM;HDAC5;TGFBR2;CMTM7;GAS6;CARD11;BRAF;LGALS1;JAK3;BCL6;ADA;POU2F2;TCF7;MFNG;ERBB2;HLA-G
19853,GO:2000369,0.271751229020836,0.900765263474732,3,15,regulation of clathrin-dependent endocytosis,BP,ARAP3;DNAJC6;UNC119
10876,GO:0044437,0.271811618409816,0.774100214842655,58,452,vacuolar part,CC,PYGB;NAPRT;LRP1;TSPAN1;GAA;CTSF;ATG16L2;HYAL1;NAGLU;SYNGR1;COL6A1;ABCA2;ULK1;VPS11;CD68;CYBRD1;BRI3;TMEM44;SPPL2B;SPG11;MARCH9;CSPG4;CTSB;PI4K2A;PQLC2;SDC2;TECPR1;SLC48A1;LITAF;FUCA1;FLOT1;VLDLR;TMEM175;ATRAID;PCSK9;DIRC2;MAP1LC3A;HEXB;MARCH2;VPS39;HEXA;TMEM9;C12ORF66;SBF2;TCIRG1;ARSA;MAN2B1;TPCN1;DPP7;TMEM50B;HGSNAT;UBXN6;TOM1;AP2A2;GALNS;LAMTOR2;BLOC1S1;TMEM8A
1105,GO:0002694,0.271890734836079,0.784715572559065,37,282,regulation of leukocyte activation,BP,IL20RB;GSN;PRNP;ZFP36L1;EFNB3;SOX13;PKN1;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;STAT6;INPP5D;PDCD1LG2;CEBPB;TGFBR2;GAS6;BCR;PTAFR;TNFRSF14;AKT1;CARD11;IGFBP2;BRAF;LGALS1;HFE;JAK3;BCL6;FYN;ADA;MYO18A;VAV3;DHPS;ERBB2;PAG1;HLA-G
14787,GO:0070542,0.272561162438507,0.841934426112583,8,52,response to fatty acid,BP,NFATC4;HMGCL;GLDC;PTAFR;ADCY6;AKT1;CAT;TGFBR3
11228,GO:0045446,0.272778242295185,0.830948092669461,10,67,endothelial cell differentiation,BP,XDH;PTPRS;RAPGEF3;BTG1;LAMA5;ACVR2B;PDE2A;WNT7A;GSTM3;IKBKB
6576,GO:0022410,0.273388260467191,0.926873830700752,2,9,circadian sleep/wake cycle process,BP,CST3;ADA
12594,GO:0050802,0.273388260467191,0.926873830700752,2,9,circadian sleep/wake cycle, sleep,BP,CST3;ADA
13442,GO:0055002,0.273680561047606,0.822393650155896,12,78,striated muscle cell development,BP,FLNC;VEGFA;OBSCN;OBSL1;MYH11;PAK1;MYH3;TTN;TNNT1;TMOD2;LMNA;KRT19
13971,GO:0060711,0.273693599509181,0.856471709699534,6,37,labyrinthine layer development,BP,ZFP36L1;MAP2K1;FBXW8;PLCD3;PLCD1;AKT1
5852,GO:0017156,0.27376972651173,0.83018417982243,10,67,calcium ion regulated exocytosis,BP,SYTL1;SNPH;SYT8;ZP3;VAMP2;SEPT5;PCLO;RIMS3;BRAF;STX1A
5259,GO:0015908,0.273917558458258,0.84092949178702,8,52,fatty acid transport,BP,APOE;NTSR1;SLC27A1;CPT2;PLA2G6;PPARA;ACACB;AKT1
13246,GO:0051959,0.273942704100908,0.880700360275703,4,22,dynein light intermediate chain binding,MF,DNAH1;CCDC88B;DNAL4;HOOK2
11624,GO:0046364,0.274103281821865,0.834880517472189,9,60,monosaccharide biosynthetic process,BP,NR1D1;PGM1;PCK2;DGKQ;PPARA;PC;ATF4;ALDOC;SLC37A4
4149,GO:0009215,0.274393215142084,0.926421690673309,2,9,purine deoxyribonucleoside triphosphate metabolic process,BP,DGUOK;ADA
5438,GO:0016310,0.274552042657321,0.751920533420719,202,1641,phosphorylation,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;EGR1;PTK6;CDC42EP5;GJC2;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PRNP;FBLN1;DUSP5;NEK9;RAPGEF3;TNFSF15;SPTB;DGKA;IGFBP4;BRSK1;PGM1;ERCC6;MST1R;ZFP36L1;ADARB1;HBEGF;RBL2;RPS6KA2;CTF1;CNTN1;DHTKD1;TK2;ULK2;SLC27A1;MAPK13;CDK18;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;ALPK1;SHC2;SYNGAP1;ITGA6;DGKQ;SNX9;ULK1;SHC1;SPRY2;ADM2;OGDHL;NMRK1;CAPRIN2;TTBK2;PRKCZ;PAK1;ABCA7;STK39;FGFR3;CEMIP;NPR2;SPRY4;DLG3;NME4;NEURL1;ACVR2B;SPEG;NGFR;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PPARA;SESN2;MKNK2;RASA4;IMPACT;PKD2;HMGA2;AREG;PI4KAP1;MAPK3;CSPG4;TRPT1;ERRFI1;STK40;VANGL2;RGS14;FAM20C;CNTRL;MAPK12;PI4K2A;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SDHA;DMTN;PAK6;PKD1;FLOT1;TTN;PSKH1;SORL1;GALK1;IL17RD;VLDLR;NADK;MAP3K12;NEK8;LRP5;WNK4;ALDOC;PKIB;PKN3;MARK3;TGFBR2;TRPV4;ITGA1;APLN;TRIB3;CDK5RAP3;MINK1;PROM2;WNT7A;PIP5KL1;PIK3R2;EPHA1;GAS6;ERN1;BCR;MAPRE3;CHKB;NBR1;TADA3;UCKL1;CAMK1;ADCY6;ATP2B4;STRADB;CTSH;AKT1;ZFYVE21;DGUOK;CDKN1C;MICAL1;CHEK2;SPDYE2;SPDYE2B;TSG101;FGFR4;WDFY2;C9ORF72;MARK4;INSR;RPS6KA5;CTDSPL;MAP2K5;BRAF;EDA2R;MAPK10;HFE;JAK3;TP73;SCYL3;CSNK1E;TAZ;TKFC;FYN;MAST4;LEMD2;SIRT2;GDF15;ETNK2;FUK;AVPI1;TGFBR3;VAV3;LAMTOR2;MAP3K10;EPHB2;PER1;FGFR1;FKBP8;ERBB2;EIF2AK4;STK32B;UNC119;PFKL;FRS3;GRB10;CAMKK1;IKBKB
1096,GO:0002685,0.274916035991453,0.814402954951024,14,100,regulation of leukocyte migration,BP,PGF;VEGFA;MMP28;VEGFB;ZP3;C5;ECM1;MAPK3;TRPV4;GAS6;BCR;PTAFR;ADA;ITGA2
5117,GO:0015485,0.274940736275818,0.866050508025689,5,30,cholesterol binding,MF,APOE;OSBPL5;ABCG1;OSBPL10;PROM2
8003,GO:0032642,0.275855137622937,0.846381744363913,7,45,regulation of chemokine production,BP,EGR1;POSTN;ALOX15B;C5;ZFPM1;TRPV4;MAP2K5
7491,GO:0031672,0.275864763403272,0.881969810778598,4,18,A band,CC,OBSCN;OBSL1;TTN;NBR1
15566,GO:0072073,0.276571462162943,0.816292284145536,13,90,kidney epithelium development,BP,CTNNBIP1;PGF;VEGFA;WWTR1;LAMA5;WNT2B;PKD2;LAMB2;KIF26B;PKD1;WNK4;CAT;FGFR1
6909,GO:0030509,0.276874170491562,0.816049074646888,13,90,BMP signaling pathway,BP,HTRA1;EGR1;PDCD4;RNF165;ACVR2B;MAPK3;FBXL15;SMURF2;HFE;LEMD2;GDF15;TGFBR3;FKBP8
17010,GO:0099513,0.276938902957175,0.768722352838754,60,467,polymeric cytoskeletal fiber,CC,ESPN;WIPF1;CLIP2;KRT15;NINL;SNPH;DNM1;SHANK2;NDRG1;REEP2;EML2;TUBG2;FAM110C;DNAH1;SPRY2;TPM2;PRKCZ;PAK1;SHROOM4;SYNC;KIF17;PKD2;ENKD1;KCNAB2;RGS14;DNAL4;PBXIP1;TUBE1;HOOK2;ARHGEF2;FBF1;MAP2K2;TWF2;KIF21B;DMTN;KIF26B;MAP6;NDE1;TRPV4;TMSB4X;MAP1LC3A;CDK5RAP3;TTLL11;NICN1;LZTS2;MAPRE3;KIF13B;REEP4;MICAL1;KIF27;LMNA;KRT19;HAUS4;TUBGCP6;FYN;EML3;SIRT2;GOLGA2;MTA1;CORO1B
11803,GO:0046718,0.277027362989526,0.823138244510505,11,76,viral entry into host cell,BP,GSN;EGFR;EFNB3;ITGB5;IFITM1;CTSB;GAS6;TNFRSF14;ITGB6;LGALS1;ITGA2
12712,GO:0050999,0.27702978962504,0.864654834162468,5,30,regulation of nitric-oxide synthase activity,BP,APOE;EGFR;NOS3;ATP2B4;AKT1
15787,GO:0072511,0.27714750329916,0.78408396734675,32,241,divalent inorganic cation transport,BP,F2R;GJC2;NTSR1;PRNP;NOS1;DDIT3;ORAI3;CYP27B1;ITPR3;CEMIP;ORAI2;GSTO1;PLA2G6;LPAR3;PKD2;PKD1;GSTM2;TRPV4;PDE2A;NOS3;TRPV1;GAS6;ATP2B4;ITPR2;TPCN1;HOMER2;ASIC1;EHD3;FYN;TRPC1;SLC39A11;WFS1
4186,GO:0009267,0.277446832429462,0.807099503152544,16,114,cellular response to starvation,BP,GLUL;WNT2B;SESN2;IMPACT;MAPK3;ATF4;PCSK9;MAP1LC3A;DAP;GAS6;ASNS;C12ORF66;UPP1;HFE;SLC38A2;EIF2AK4
7086,GO:0030890,0.278569137726176,0.877342941231686,4,23,positive regulation of B cell proliferation,BP,CARD11;BCL6;ADA;VAV3
20073,GO:2000774,0.279158346998406,0.924260375804641,2,9,positive regulation of cellular senescence,BP,HMGA2;YPEL3
6891,GO:0030433,0.279202425759308,0.825878582327525,10,68,ubiquitin-dependent ERAD pathway,BP,FBXO2;TMEM129;EDEM1;UBXN4;FBXO6;HERPUD1;ANKZF1;MAN1B1;WFS1;SYVN1
4096,GO:0009154,0.2793976873987,0.876822157694184,4,23,purine ribonucleotide catabolic process,BP,NT5E;RAPGEF3;PDE2A;NUDT18
7249,GO:0031225,0.279420192013387,0.825607828543062,10,69,anchored component of membrane,CC,NT5E;PRNP;CNTN1;RAB3B;PRSS8;LY6K;PRSS22;ULBP1;MMP17;NTM
134,GO:0000281,0.279659531963928,0.830655714285743,9,60,mitotic cytokinesis,BP,ANK3;CUL7;SNX9;SEPT5;SEPT10;SEPT6;SNX33;SEPT8;UNC119
15280,GO:0071496,0.279799430889555,0.782654593789137,31,234,cellular response to external stimulus,BP,FOS;POSTN;GLUL;EGFR;CYP27B1;ITGA6;ULK1;CBS;WNT2B;SESN2;IMPACT;MAPK3;BNIP3;ATF4;SSH1;PCSK9;AQP3;MAP1LC3A;PDE2A;DAP;TRPV1;GAS6;ASNS;C12ORF66;AKT1;UPP1;HFE;FYN;SLC38A2;ITGA2;EIF2AK4
530,GO:0001649,0.27988668205265,0.798580260426284,19,138,osteoblast differentiation,BP,CTNNBIP1;MEF2D;MRC2;WWTR1;SMOC1;COL6A1;ACVR2B;AREG;IFITM1;FAM20C;PTHLH;CEBPB;LRP5;ATRAID;NBR1;AKT1;WNT3;CAT;HDAC8
10489,GO:0043409,0.280323557541431,0.800207972906871,18,130,negative regulation of MAPK cascade,BP,TNIP1;DUSP6;APOE;PDCD4;FBLN1;DUSP5;SPRY2;SPRY4;ERRFI1;RGS14;SORL1;CDK5RAP3;PIK3R2;AKT1;TP73;LEMD2;EPHB2;PER1
3311,GO:0007017,0.280514946525406,0.760452703227498,77,606,microtubule-based process,BP,BBS2;IFT140;NINL;BRSK1;MYH15;CUL9;OBSL1;CUL7;SDCCAG8;EML2;TUBG2;DNAH1;ARL2;SPRY2;BLOC1S4;MYH11;TTBK2;PRKCZ;PAK1;CEP250;NEURL1;CCDC88B;WDR60;SPG11;KIF17;CHD3;IFT27;PKD2;RGS14;DNAL4;TUBE1;HOOK2;MYH3;CHMP1B;ARHGEF2;STMN3;KIF21B;KIF26B;PKD1;CEP68;MAP6;NDE1;CEP131;MARK3;TRPV4;TTLL11;CEP126;CROCC;FYCO1;GOLGA2P5;KIF13B;SPAG16;WDR19;CHEK2;IFT57;TTC21A;WDR66;CABYR;KIF27;LMNA;COPG1;CHMP5;GOLGA8A;MARK4;CHMP4C;HAUS4;TUBGCP6;SPIRE1;EML3;PEX1;GOLGA2;AP2A2;MYO18A;BLOC1S1;ERBB2;CCDC69;APBA1
44,GO:0000096,0.280563641017797,0.862283240125611,5,30,sulfur amino acid metabolic process,BP,GGT1;MTHFR;CBS;BLMH;CTH
9844,GO:0042108,0.280617601732359,0.86224692286783,5,30,positive regulation of cytokine biosynthetic process,BP,EGR1;EREG;ZFPM1;PTAFR;CARD11
12300,GO:0048672,0.280623022351006,0.923590254571258,2,9,positive regulation of collateral sprouting,BP,LPAR3;WNT3
9659,GO:0038034,0.280649468758217,0.835767447437635,8,53,signal transduction in absence of ligand,BP,MKNK2;IFI6;UNC5B;STRADB;AKT1;MAP2K5;FYN;FGFR1
16468,GO:0097192,0.280649468758217,0.835767447437635,8,53,extrinsic apoptotic signaling pathway in absence of ligand,BP,MKNK2;IFI6;UNC5B;STRADB;AKT1;MAP2K5;FYN;FGFR1
1501,GO:0003857,0.280743914527079,0.923534821990391,2,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,HADH;CRYL1
19833,GO:2000341,0.281151212443348,0.923347927362002,2,9,regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MAP2K5
994,GO:0002456,0.281178927736442,0.835371186753497,8,53,T cell mediated immunity,BP,IL20RB;PRKCZ;ZP3;SCART1;CTSH;BTN3A2;HFE;BTN3A3
7153,GO:0031032,0.281765277364523,0.79921713572584,18,125,actomyosin structure organization,BP,OBSCN;RAPGEF3;ARAP1;OBSL1;MYH11;PAK1;ITGB5;MYH3;TTN;EPHA1;TNNT1;TMOD2;ASAP3;KRT19;BRAF;MYO18A;LURAP1;KCTD13
11096,GO:0045136,0.282325379062069,0.922807963711264,2,9,development of secondary sexual characteristics,BP,AREG;IRF2BPL
11053,GO:0045071,0.282498037373111,0.84136876115896,7,46,negative regulation of viral genome replication,BP,TNIP1;APOBEC3C;APOBEC3F;HMGA2;IFITM1;ISG20;EIF2AK4
12969,GO:0051409,0.28284595179556,0.922568007248027,2,9,response to nitrosative stress,BP,DUSP6;DDIT3
4099,GO:0009157,0.282925730917828,0.922531202842133,2,9,deoxyribonucleoside monophosphate biosynthetic process,BP,TK2;DGUOK
7770,GO:0032303,0.283140068068528,0.922432282853332,2,9,regulation of icosanoid secretion,BP,NTSR1;PLA2G6
9832,GO:0042092,0.283267318844411,0.874379528062214,4,23,type 2 immune response,BP,PRKCZ;STAT6;ECM1;BCL6
20164,GO:2001044,0.283621871870145,0.92220970944544,2,9,regulation of integrin-mediated signaling pathway,BP,DMTN;TIMP1
11861,GO:0046889,0.283821042129607,0.840582915879984,7,45,positive regulation of lipid biosynthetic process,BP,APOE;NR1D1;ZP3;PLA2G6;ABCG1;MLXIPL;AKT1
2096,GO:0004864,0.284370532455527,0.873680015855753,4,23,protein phosphatase inhibitor activity,MF,PPP1R35;PHACTR3;PPP1R14A;ELFN2
13048,GO:0051580,0.28444551385785,0.921828536922216,2,9,regulation of neurotransmitter uptake,BP,NOS1;RAB3B
17737,GO:1901741,0.284805331360171,0.921661746337812,2,9,positive regulation of myoblast fusion,BP,FLOT1;GDF15
14692,GO:0070365,0.284866401126998,0.921633421566484,2,9,hepatocyte differentiation,BP,PCK2;ITGA2
11767,GO:0046651,0.284943799517355,0.792375940509857,20,148,lymphocyte proliferation,BP,IL20RB;PRNP;PKN1;ZP3;CCDC88B;SATB1;INPP5D;PDCD1LG2;CEBPB;TGFBR2;CARD11;IGFBP2;JAK3;BCL6;FYN;ADA;VAV3;DHPS;ERBB2;HLA-G
8033,GO:0032692,0.284989508643112,0.892552075681126,3,16,negative regulation of interleukin-1 production,BP,ACP5;ERRFI1;GAS6
17474,GO:1900542,0.285284803026697,0.800562704879748,16,115,regulation of purine nucleotide metabolic process,BP,APOE;TIMP2;VEGFA;RAPGEF3;NOS1;DDIT4;PPARA;PKD2;MLXIPL;PTHLH;LTB4R2;GABBR1;TMSB4X;NOS3;INSR;TAZ
11578,GO:0046185,0.285402858180149,0.921384403349824,2,9,aldehyde catabolic process,BP,HAGH;PNKD
7477,GO:0031650,0.285418084121879,0.92137733026624,2,9,regulation of heat generation,BP,SLC27A1;APLN
548,GO:0001669,0.285435584796978,0.832176095025436,8,53,acrosomal vesicle,CC,LOXL1;SYT8;LY6K;CEP131;ITGA1;HEXB;BSG;TCTEX1D4
3071,GO:0006641,0.285468484681903,0.832151335678861,8,53,triglyceride metabolic process,BP,APOE;LMF1;PCK2;PNPLA3;PCSK9;PNPLA4;CAT;FITM2
574,GO:0001726,0.285508234266632,0.793837577274044,19,138,ruffle,CC,S100A6;GSN;WIPF1;PTK6;ARAP3;SNX9;SPRY2;PAK1;ABCA7;SPRY4;ARHGEF4;RINL;ARHGEF2;FRMD4B;TRPV4;PSD4;ASAP3;EPS8L1;EPS8L2
13522,GO:0060009,0.285585874492105,0.921299365104651,2,9,Sertoli cell development,BP,CST3;RAB13
8075,GO:0032768,0.285770136985228,0.847737238428244,6,38,regulation of monooxygenase activity,BP,APOE;EGFR;CYP27B1;NOS3;ATP2B4;AKT1
654,GO:0001845,0.285909301284598,0.921148981051361,2,9,phagolysosome assembly,BP,SPG11;TMEM175
10002,GO:0042448,0.286005655641109,0.921104153320506,2,9,progesterone metabolic process,BP,EGR1;DGKQ
7037,GO:0030819,0.286069100903413,0.921074629701723,2,9,positive regulation of cAMP biosynthetic process,BP,TIMP2;PTHLH
745,GO:0001977,0.286125840936846,0.92104822195122,2,9,renal system process involved in regulation of blood volume,BP,F2R;GAS6
2926,GO:0006446,0.286136927424325,0.820374549101628,10,69,regulation of translational initiation,BP,RPL13A;MIF4GD;IMPACT;ATF4;PPP1R15A;RXRA;PAIP2B;PAIP2;EIF4EBP1;EIF2AK4
3236,GO:0006893,0.286183142598309,0.838851718242172,7,45,Golgi to plasma membrane transport,BP,BBS2;OSBPL5;ANK3;EXOC2;BBS1;VAMP2;STEAP2
17484,GO:1900744,0.286276167272096,0.87246844517737,4,23,regulation of p38MAPK cascade,BP,XDH;VEGFA;MINK1;PER1
4068,GO:0009125,0.286356973361707,0.92094060671812,2,9,nucleoside monophosphate catabolic process,BP,NT5E;DNPH1
3368,GO:0007140,0.286408530823923,0.872384136898276,4,23,male meiotic nuclear division,BP,TDRKH;MLH3;AGO4;REC8
11048,GO:0045064,0.286411039629123,0.920915423648257,2,9,T-helper 2 cell differentiation,BP,PRKCZ;BCL6
19385,GO:1905953,0.286629840878514,0.872243130002375,4,23,negative regulation of lipid localization,BP,ABCG1;PPARA;PCSK9;AKT1
6809,GO:0030275,0.286913225470795,0.891448841330358,3,16,LRR domain binding,MF,DDIT3;ZXDC;ATF4
504,GO:0001562,0.286942218421225,0.92066781233361,2,9,response to protozoan,BP,CCDC88B;LYST
10196,GO:0042832,0.286942218421225,0.92066781233361,2,9,defense response to protozoan,BP,CCDC88B;LYST
501,GO:0001558,0.287462929977976,0.770852191356248,37,284,regulation of cell growth,BP,PTPRS;HTRA1;APOE;SERPINE2;FHL1;SEMA4B;VEGFA;EGFR;IGFBP4;DNPH1;HBEGF;LTBP4;ULK2;HYAL1;CYP27B1;BTG1;CAPRIN2;PAK1;SEMA3F;LPAR3;SESN2;SLIT3;SEMA5A;TSPYL2;TWF2;SEMA3B;SEMA4G;AKT1;IGFBP7;IGFBP2;TSG101;WNT3;MAP2K5;BCL6;LAMTOR2;ERBB2;NET1
1998,GO:0004725,0.287786278733584,0.814640604852204,11,76,protein tyrosine phosphatase activity,MF,DUSP6;PTPRS;DUSP5;MAP2K1;PTPRE;SSH3;MTMR4;PTPDC1;SSH1;PTPRU;DNAJC6
3909,GO:0008574,0.287883492459377,0.871443316934094,4,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,WDR60;KIF17;DNAL4;KIF27
12944,GO:0051350,0.288062866709796,0.920144237701729,2,9,negative regulation of lyase activity,BP,LTB4R2;GABBR1
2786,GO:0006222,0.288301373866825,0.920032598883875,2,9,UMP biosynthetic process,BP,UCKL1;UPP1
4112,GO:0009173,0.288301373866825,0.920032598883875,2,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,UCKL1;UPP1
4113,GO:0009174,0.288301373866825,0.920032598883875,2,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,UCKL1;UPP1
11508,GO:0046049,0.288301373866825,0.920032598883875,2,9,UMP metabolic process,BP,UCKL1;UPP1
10149,GO:0042752,0.288431208939754,0.818682999078376,10,68,regulation of circadian rhythm,BP,NR1D1;CRTC1;PPARA;BHLHE40;CRY2;MAPK10;CSNK1E;ADA;MTA1;PER1
3723,GO:0008253,0.288441971295987,0.919966755007266,2,9,5'-nucleotidase activity,MF,NT5E;NT5C1B
9857,GO:0042133,0.288530997720225,0.814048951095378,11,76,neurotransmitter metabolic process,BP,ALDH7A1;ACP5;NOS1;GLDC;PKD2;NOS3;TRPV1;ATP2B4;AKT1;ASS1;INSR
946,GO:0002363,0.288535805761743,0.91992279689917,2,9,alpha-beta T cell lineage commitment,BP,STAT6;ZFPM1
4297,GO:0009749,0.2885771303146,0.795385465942187,17,124,response to glucose,BP,EGR1;GLUL;NR1D1;PCK2;ACVR2B;PLA2G6;ANO1;SESN2;VAMP2;MLXIPL;ENDOG;LRP5;TGFBR2;GAS6;ERN1;LGALS1;PFKL
95,GO:0000186,0.288648485366564,0.837039166491544,7,45,activation of MAPKK activity,BP,F2R;EGFR;ERCC6;MAP3K12;BRAF;LAMTOR2;MAP3K10
8719,GO:0034380,0.288656165612182,0.919866396153521,2,9,high-density lipoprotein particle assembly,BP,APOE;ABCA7
7276,GO:0031272,0.288686653903641,0.919852106377209,2,9,regulation of pseudopodium assembly,BP,CDC42EP5;C15ORF62
7277,GO:0031274,0.288686653903641,0.919852106377209,2,9,positive regulation of pseudopodium assembly,BP,CDC42EP5;C15ORF62
10580,GO:0043567,0.288780516885855,0.919808105618487,2,9,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4;IGFBP2
10669,GO:0043951,0.288922256435528,0.919741640154605,2,9,negative regulation of cAMP-mediated signaling,BP,PDE2A;ATP2B4
14626,GO:0070242,0.288936952475782,0.89028338662188,3,16,thymocyte apoptotic process,BP,RAG1;JAK3;ADA
19993,GO:2000644,0.289115659861063,0.919650906779529,2,9,regulation of receptor catabolic process,BP,APOE;PCSK9
11768,GO:0046653,0.289126433885251,0.890174009775354,3,16,tetrahydrofolate metabolic process,BP,MTHFR;ALDH1L2;ALDH1L1
734,GO:0001965,0.289288571518346,0.890080382214951,3,16,G-protein alpha-subunit binding,MF,F2R;LPAR3;RGS14
12536,GO:0050709,0.289464965852646,0.817767548219657,10,69,negative regulation of protein secretion,BP,F2R;HADH;IDH2;RHBDF1;TMSB4X;RHBDF2;GAS6;MAPKBP1;CIDEA;PFKL
9100,GO:0035404,0.289724885222004,0.919364782598396,2,9,histone-serine phosphorylation,BP,HMGA2;RPS6KA5
4618,GO:0010743,0.289738119570755,0.889820619933353,3,16,regulation of macrophage derived foam cell differentiation,BP,ALOX15B;ABCG1;PPARA
11658,GO:0046461,0.289769752662539,0.889802332118463,3,16,neutral lipid catabolic process,BP,APOE;PNPLA3;PNPLA4
11661,GO:0046464,0.289769752662539,0.889802332118463,3,16,acylglycerol catabolic process,BP,APOE;PNPLA3;PNPLA4
7201,GO:0031102,0.289789886417329,0.844874246663793,6,38,neuron projection regeneration,BP,PTPRS;APOE;MAP2K1;ULK1;LAMB2;BRAF
13045,GO:0051573,0.28997604622265,0.919246686355461,2,9,negative regulation of histone H3-K9 methylation,BP,KDM3A;KDM4C
9427,GO:0036019,0.290321216463444,0.889483322422436,3,16,endolysosome,CC,CTSB;PCSK9;AP2A2
10062,GO:0042578,0.2903553726684,0.769826319396702,35,267,phosphoric ester hydrolase activity,MF,DUSP6;PTPRS;NT5E;ACP5;DUSP5;PPM1M;PLD3;LHPP;ACP6;MAP2K1;PLCH2;PPP2R3B;PLCXD1;PTPRE;SSH3;PLCD3;PSPH;PPM1J;MTMR4;NT5C1B;MYH3;PTPDC1;PLCD1;INPP5D;SSH1;NTPCR;PTPRU;PDE2A;DNAJC6;CTDSPL;CHRM3;PLPP6;EDNRA;INPP4A;MPPE1
4070,GO:0009127,0.290357488992731,0.796291230542665,16,116,purine nucleoside monophosphate biosynthetic process,BP,PGM1;DHTKD1;LHPP;DDIT4;OGDHL;PPARA;MLXIPL;GALK1;ALDOC;TMSB4X;TCIRG1;INSR;APRT;TAZ;ADA;PFKL
4109,GO:0009168,0.290357488992731,0.796291230542665,16,116,purine ribonucleoside monophosphate biosynthetic process,BP,PGM1;DHTKD1;LHPP;DDIT4;OGDHL;PPARA;MLXIPL;GALK1;ALDOC;TMSB4X;TCIRG1;INSR;APRT;TAZ;ADA;PFKL
16052,GO:0090042,0.290377123898957,0.919057932158712,2,9,tubulin deacetylation,BP,TADA3;SIRT2
10232,GO:0042983,0.290465070707405,0.919016515398912,2,9,amyloid precursor protein biosynthetic process,BP,ABCA7;NECAB3
10233,GO:0042984,0.290465070707405,0.919016515398912,2,9,regulation of amyloid precursor protein biosynthetic process,BP,ABCA7;NECAB3
16244,GO:0090331,0.290606364778585,0.91894995515761,2,9,negative regulation of platelet aggregation,BP,SERPINE2;CD9
4511,GO:0010566,0.290899115671242,0.91881196613846,2,9,regulation of ketone biosynthetic process,BP,EGR1;DGKQ
11020,GO:0045010,0.290900102551948,0.844080650582748,6,38,actin nucleation,BP,GSN;WIPF1;ARPIN;WHAMMP3;SPIRE1;CORO1B
17769,GO:1901881,0.290915830262362,0.918804084363375,2,9,positive regulation of protein depolymerization,BP,SEMA5A;TRPV4
13441,GO:0055001,0.290943303269033,0.804895578280997,13,87,muscle cell development,BP,NFATC4;FLNC;VEGFA;OBSCN;OBSL1;MYH11;PAK1;MYH3;TTN;TNNT1;TMOD2;LMNA;KRT19
10155,GO:0042759,0.291072726280912,0.918730082565284,2,9,long-chain fatty acid biosynthetic process,BP,ALOX15B;ACOT7
8771,GO:0034464,0.291101395893011,0.9187165568188,2,9,BBSome,CC,BBS2;BBS1
8965,GO:0035082,0.291259649809132,0.869280471413066,4,23,axoneme assembly,BP,BBS2;DNAH1;NEURL1;SPAG16
15595,GO:0072109,0.291271289137821,0.91863638306392,2,9,glomerular mesangium development,BP,ACTA2;EGR1
1074,GO:0002643,0.29128328724664,0.91863071968307,2,9,regulation of tolerance induction,BP,TGFBR2;HLA-G
3456,GO:0007271,0.291294655466984,0.918625353454131,2,9,synaptic transmission, cholinergic,BP,APOE;CHRM3
3542,GO:0007567,0.291394259407467,0.918578329578775,2,9,parturition,BP,LDOC1;PTAFR
2443,GO:0005652,0.291542935949123,0.918508114535688,2,9,nuclear lamina,CC,HLCS;LMNA
14665,GO:0070307,0.291617407404028,0.918472933503071,2,9,lens fiber cell development,BP,WNT7A;TBC1D20
10093,GO:0042627,0.291646186510872,0.967215008725626,1,3,chylomicron,CC,APOE
4706,GO:0010873,0.291721937433674,0.967196563834096,1,3,positive regulation of cholesterol esterification,BP,APOE
5473,GO:0016411,0.291727846681086,0.868979508908072,4,23,acylglycerol O-acyltransferase activity,MF,LPCAT4;PNPLA3;TAZ;MBOAT2
379,GO:0001012,0.29184509638744,0.756607383972537,56,436,RNA polymerase II regulatory region DNA binding,MF,ZC3H6;ZMYND8;NFATC4;FOS;EGR1;NR1D1;MEF2D;DDIT3;TCFL5;RBL2;TFDP2;MXI1;SOX13;ETV4;PHF21A;PBX2;ELK3;KDM3A;FOXQ1;SALL2;ETV1;ETV5;HES2;TEF;CARF;PPARA;SATB1;STAT6;KLF7;HMGA2;THRA;MLXIPL;LITAF;ATF4;ZFPM1;JDP2;DEAF1;RFX2;CEBPB;CREBRF;HLTF;MXD3;BHLHE40;RXRA;ZNF217;SMARCD2;TP73;MNT;TFEB;BCL6;HSF4;POU2F2;PER1;CREB3L4;DBP;SIX5
19508,GO:1990442,0.291900502509889,0.96715306035164,1,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,DDIT3
14860,GO:0070672,0.291974325707631,0.918304223523581,2,9,response to interleukin-15,BP,SHC1;JAK3
3415,GO:0007202,0.292043392706334,0.918271557787257,2,9,activation of phospholipase C activity,BP,EGFR;EDNRA
17679,GO:1901616,0.292098060576142,0.843222946029942,6,38,organic hydroxy compound catabolic process,BP,APOE;NTSR1;CYP27B1;SRD5A3;SNX17;TKFC
18840,GO:1904526,0.292351872795206,0.918125585500934,2,9,regulation of microtubule binding,BP,TTBK2;MAPRE3
8309,GO:0033158,0.292438557894532,0.88825504530387,3,16,regulation of protein import into nucleus, translocation,BP,TMEM173;PDE2A;GAS6
10151,GO:0042754,0.292456510594927,0.918076043444809,2,9,negative regulation of circadian rhythm,BP,CRY2;ADA
8317,GO:0033173,0.292500754804904,0.868482128533508,4,23,calcineurin-NFAT signaling cascade,BP,NFATC4;PRNP;ADGRB2;ATP2B4
4620,GO:0010745,0.29258854427235,0.918013510507334,2,9,negative regulation of macrophage derived foam cell differentiation,BP,ABCG1;PPARA
9448,GO:0036065,0.29259563249646,0.868421026174324,4,23,fucosylation,BP,ADAMTS7;ADAMTS13;ADAMTSL1;MFNG
6839,GO:0030315,0.292723262798492,0.854020695020557,5,30,T-tubule,CC,ANK3;NOS1;DYSF;ATP2B4;RTN2
3005,GO:0006553,0.292778417959913,0.91792354470346,2,9,lysine metabolic process,BP,ALDH7A1;PHYKPL
16152,GO:0090199,0.29292882856785,0.8423935907852,6,39,regulation of release of cytochrome c from mitochondria,BP,PLA2G6;BNIP3;BBC3;AKT1;LMNA;CIDEB
2334,GO:0005355,0.29301303324722,0.917812315827951,2,9,glucose transmembrane transporter activity,MF,SLC2A3;SLC2A9
20076,GO:2000778,0.293119543377819,0.88785884261353,3,16,positive regulation of interleukin-6 secretion,BP,F2R;TRPV4;IL17RC
11285,GO:0045623,0.293281600649029,0.917684904210711,2,9,negative regulation of T-helper cell differentiation,BP,JAK3;BCL6
13581,GO:0060077,0.293286337655004,0.91768265609054,2,9,inhibitory synapse,CC,NLGN2;CEP112
12848,GO:0051195,0.293330694387902,0.917661603580506,2,9,negative regulation of cofactor metabolic process,BP,DDIT4;PPARA
13876,GO:0060546,0.293360808943423,0.917647309232824,2,9,negative regulation of necroptotic process,BP,RBCK1;ARHGEF2
20199,GO:2001170,0.293386108138276,0.917635299675672,2,9,negative regulation of ATP biosynthetic process,BP,DDIT4;PPARA
19811,GO:2000310,0.293538384766515,0.917562996498455,2,9,regulation of NMDA receptor activity,BP,DLG4;EPHB2
14580,GO:0070166,0.293575328155463,0.917545450766666,2,9,enamel mineralization,BP,PPARA;FAM20C
4718,GO:0010885,0.29359740870514,0.917534963093499,2,9,regulation of cholesterol storage,BP,ABCG1;PPARA
7120,GO:0030952,0.293616559536334,0.887569318107894,3,16,establishment or maintenance of cytoskeleton polarity,BP,RHOBTB2;RHOF;LMNA
13782,GO:0060397,0.293686130415358,0.917492816359475,2,9,JAK-STAT cascade involved in growth hormone signaling pathway,BP,MAPK3;JAK3
2392,GO:0005536,0.293698201693635,0.917487081190937,2,9,glucose binding,MF,SLC2A3;PYGL
11941,GO:0047144,0.293767966538457,0.917453931660268,2,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,LPCAT4;MBOAT2
12989,GO:0051446,0.293867042016695,0.917406844165755,2,9,positive regulation of meiotic cell cycle,BP,INSR;SIRT2
5270,GO:0015924,0.293938570065016,0.917372841305731,2,9,mannosyl-oligosaccharide mannosidase activity,MF,EDEM1;MAN1B1
1814,GO:0004467,0.294059070181164,0.917315543406958,2,9,long-chain fatty acid-CoA ligase activity,MF,SLC27A1;SLC27A3
15564,GO:0072070,0.294077690390054,0.917306687826654,2,9,loop of Henle development,BP,PKD2;PKD1
19676,GO:2000042,0.294226077987067,0.917236100361194,2,9,negative regulation of double-strand break repair via homologous recombination,BP,MAGEF1;RECQL5
2354,GO:0005451,0.294226083790109,0.917236097600383,2,9,monovalent cation:proton antiporter activity,MF,SLC9A7;SLC9A5
19871,GO:2000392,0.294241670846961,0.917228681256808,2,9,regulation of lamellipodium morphogenesis,BP,ARPIN;CORO1B
15473,GO:0071871,0.294291728613323,0.917204861599887,2,9,response to epinephrine,BP,ATP2B4;SIRT2
19424,GO:1990126,0.294352988747805,0.887139776161959,3,16,retrograde transport, endosome to plasma membrane,BP,VPS39;ARHGAP44;SNX17
6602,GO:0022821,0.294378394681025,0.91716361454724,2,9,potassium ion antiporter activity,MF,SLC9A7;SLC9A5
16801,GO:0098719,0.294385313950646,0.917160321039445,2,9,sodium ion import across plasma membrane,BP,SLC9A7;SLC9A5
19596,GO:1990782,0.294483552317515,0.825329829561005,8,53,protein tyrosine kinase binding,MF,DOCK4;PITPNM3;SHC2;PITPNM1;SHC1;PIK3R2;GAS6;PAG1
6935,GO:0030551,0.294585049461822,0.887004283675152,3,16,cyclic nucleotide binding,MF,RAPGEF3;TMEM173;PDE2A
13911,GO:0060601,0.294699006078069,0.917010942186154,2,9,lateral sprouting from an epithelium,BP,VANGL2;CELSR1
10593,GO:0043589,0.294736390585623,0.916993131447979,2,9,skin morphogenesis,BP,ERRFI1;ITGA2
10356,GO:0043194,0.294901576410532,0.916914412162724,2,9,axon initial segment,CC,SCN8A;ANK3
15436,GO:0071800,0.294982533388823,0.88677205368585,3,16,podosome assembly,BP,GSN;ARHGEF2;SH3PXD2A
2772,GO:0006198,0.295024389573798,0.916855862937051,2,9,cAMP catabolic process,BP,RAPGEF3;PDE2A
10667,GO:0043949,0.295027895228276,0.886745538794348,3,16,regulation of cAMP-mediated signaling,BP,NOS1;PDE2A;ATP2B4
7170,GO:0031061,0.295212480521108,0.88663761918828,3,16,negative regulation of histone methylation,BP,KDM3A;PHF1;KDM4C
14294,GO:0061478,0.295320303263353,0.916714711507904,2,9,response to platelet aggregation inhibitor,BP,ADCY6;HDAC8
7594,GO:0031983,0.295464745235406,0.769722040320129,30,232,vesicle lumen,CC,APOE;GSN;PYGB;NAPRT;TIMP2;VEGFA;EGFR;PYGL;DNASE1L1;VEGFB;PCSK1;SERPING1;ACTR1B;ECM1;FUCA1;ALDOC;TMSB4X;HEXB;GAS6;CTSH;ARSA;MAN2B1;MAGED2;CAT;DPP7;TIMP1;APRT;ADA;GALNS;PFKL
5267,GO:0015919,0.295716359214081,0.886342810244253,3,16,peroxisomal membrane transport,BP,PEX10;PEX7;PEX1
8187,GO:0032943,0.295718112856135,0.783151604841723,20,149,mononuclear cell proliferation,BP,IL20RB;PRNP;PKN1;ZP3;CCDC88B;SATB1;INPP5D;PDCD1LG2;CEBPB;TGFBR2;CARD11;IGFBP2;JAK3;BCL6;FYN;ADA;VAV3;DHPS;ERBB2;HLA-G
18478,GO:1903651,0.295998047550102,0.916391003828595,2,9,positive regulation of cytoplasmic transport,BP,VPS11;SORL1
3464,GO:0007286,0.296021968735168,0.812604151210056,10,69,spermatid development,BP,BBS2;DNAH1;KDM3A;NEURL1;RFX2;SPAG16;CABYR;TBC1D20;REC8;SIX5
17969,GO:1902445,0.296271053349521,0.966077747582635,1,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,ALKBH7
11345,GO:0045725,0.296284729592185,0.916253900321465,2,9,positive regulation of glycogen biosynthetic process,BP,AKT1;INSR
11114,GO:0045176,0.296419232907591,0.916189538865617,2,9,apical protein localization,BP,VANGL2;CELSR1
16243,GO:0090330,0.296437346252181,0.885920437768839,3,16,regulation of platelet aggregation,BP,SERPINE2;CD9;DMTN
4243,GO:0009447,0.296453091755865,0.966032519625814,1,3,putrescine catabolic process,BP,SAT2
17991,GO:1902512,0.296609773277638,0.965993563400745,1,3,positive regulation of apoptotic DNA fragmentation,BP,ENDOG
16963,GO:0099072,0.296748277282347,0.885738091036167,3,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,DLG4;DNM1;ARHGAP44
462,GO:0001501,0.296815283483156,0.76037419409204,40,307,skeletal system development,BP,BBS2;THBS3;POSTN;ACP5;ADAMTS7;IFT140;IGFBP4;MEF2D;COL13A1;MDFI;EVC;FBXW4;HYAL1;FGFR3;NPR2;ACVR2B;WDR60;WNT2B;PLXNB1;NAB2;HMGA2;MAPK3;THRA;FAM20C;PTHLH;ZFPM1;SLC38A10;PKD1;DEAF1;SULF2;LRP5;TGFBR2;TRPV4;HEXB;WNT7A;WDR19;TIMP1;PEX7;FGFR1;TRIM45
2719,GO:0006101,0.296842676052351,0.850856291716475,5,31,citrate metabolic process,BP,IDH2;DHTKD1;OGDHL;SDHA;SUCLG2
11560,GO:0046134,0.296925266515609,0.865159796639734,4,24,pyrimidine nucleoside biosynthetic process,BP,TK2;NME4;UCKL1;UPP1
12860,GO:0051222,0.296957910877334,0.7609531610385,39,297,positive regulation of protein transport,BP,F2R;POSTN;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;ANK3;RAPGEF3;B3GAT3;PCK2;TMEM173;VPS11;NLGN2;PRKCZ;PAK1;CEMIP;MICALL2;PLA2G6;C5;ANO1;VAMP2;MAPK3;TTN;SORL1;NLRP1;CEP131;TRPV4;PEMT;GAS6;GLUD1;CAMK1;TSG101;IL17RC;FYN;MYO18A;ERBB2;OSCP1
20170,GO:2001056,0.297257059511981,0.790421034699893,16,118,positive regulation of cysteine-type endopeptidase activity,BP,XDH;F2R;GSN;TNFSF15;GRAMD4;NGFR;BBC3;NLRP1;DAP;CTSH;IFT57;IFI27;PIDD1;FYN;CIDEB;HIP1
922,GO:0002317,0.29727305736552,0.965828359200587,1,3,plasma cell differentiation,BP,LGALS1
8360,GO:0033268,0.29736391966834,0.915736842031794,2,9,node of Ranvier,CC,SCN8A;ANK3
2750,GO:0006163,0.297605524188009,0.755401232865111,47,374,purine nucleotide metabolic process,BP,XDH;DLG4;NT5E;APOE;TIMP2;VEGFA;RAPGEF3;NOS1;DNPH1;PGM1;DHTKD1;DDIT4;OGDHL;NPR2;DLG3;NME4;ABHD14B;PPCS;PPARA;PKD2;NT5C1B;FAM20C;MYH3;MLXIPL;SDHA;PTHLH;LTB4R2;GTPBP1;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;MOCOS;PDE2A;NOS3;ADCY6;CARD11;DGUOK;TCIRG1;INSR;APRT;TAZ;ADA;PFKL;NUDT18
15819,GO:0072558,0.297629363779021,0.965739420245496,1,3,NLRP1 inflammasome complex,CC,NLRP1
9306,GO:0035791,0.297716348704762,0.915567664129786,2,9,platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1;HIP1
1574,GO:0003986,0.297781380943255,0.965701433449741,1,3,acetyl-CoA hydrolase activity,MF,ACOT8
19860,GO:2000379,0.297868866770655,0.822597736294654,8,54,positive regulation of reactive oxygen species metabolic process,BP,XDH;EGFR;PKD2;TGFBR2;TRPV1;AKT1;ASS1;INSR
3322,GO:0007032,0.297882394818047,0.81113263022598,10,69,endosome organization,BP,DNM1;VPS11;ALS2CL;HOOK2;PI4K2A;CHMP1B;TSG101;CHMP5;CHMP4C;SNX33
2755,GO:0006168,0.297901151507579,0.965671487216703,1,3,adenine salvage,BP,APRT
11529,GO:0046083,0.297901151507579,0.965671487216703,1,3,adenine metabolic process,BP,APRT
11530,GO:0046084,0.297901151507579,0.965671487216703,1,3,adenine biosynthetic process,BP,APRT
17541,GO:1901164,0.298253356399765,0.965583336662089,1,3,negative regulation of trophoblast cell migration,BP,TIMP1
6902,GO:0030500,0.29836322018688,0.838713804791218,6,38,regulation of bone mineralization,BP,CYP27B1;ACVR2B;ECM1;FAM20C;ATRAID;NBR1
12716,GO:0051005,0.298564185706932,0.965505431564842,1,3,negative regulation of lipoprotein lipase activity,BP,ANGPTL4
8822,GO:0034620,0.298651756857511,0.784662279594686,18,132,cellular response to unfolded protein,BP,EDEM1;DDIT3;CUL7;SHC1;TSPYL2;ATF4;HERPUD1;CREBRF;CDK5RAP3;ERN1;PPP1R15A;ASNS;ACADVL;LMNA;WFS1;CTH;SYVN1;CREB3L4
14365,GO:0061640,0.298680632791952,0.810500377200645,10,69,cytoskeleton-dependent cytokinesis,BP,ANK3;CUL7;SNX9;SEPT5;SEPT10;SEPT6;SNX33;SPIRE1;SEPT8;UNC119
5538,GO:0016532,0.298708619129676,0.965469196162006,1,3,superoxide dismutase copper chaperone activity,MF,CCS
14221,GO:0061298,0.298853652090332,0.915020634174221,2,9,retina vasculature development in camera-type eye,BP,ACVR2B;LRP5
11254,GO:0045580,0.29887332232673,0.80569425067914,11,77,regulation of T cell differentiation,BP,SOX13;PRKCZ;RAG1;TGFBR2;CARD11;BRAF;JAK3;BCL6;ADA;ERBB2;HLA-G
6237,GO:0019808,0.299106625874331,0.965369228911712,1,3,polyamine binding,MF,SAT2
9376,GO:0035928,0.29946457950128,0.965279176984892,1,3,rRNA import into mitochondrion,BP,TST
2519,GO:0005774,0.299646110630337,0.755283994080472,44,342,vacuolar membrane,CC,LRP1;TSPAN1;GAA;ATG16L2;SYNGR1;COL6A1;ABCA2;ULK1;VPS11;CD68;CYBRD1;BRI3;TMEM44;SPPL2B;SPG11;MARCH9;PI4K2A;PQLC2;TECPR1;SLC48A1;LITAF;FLOT1;VLDLR;TMEM175;ATRAID;PCSK9;DIRC2;MAP1LC3A;MARCH2;VPS39;TMEM9;C12ORF66;SBF2;TCIRG1;MAN2B1;TPCN1;TMEM50B;HGSNAT;UBXN6;TOM1;AP2A2;LAMTOR2;BLOC1S1;TMEM8A
18657,GO:1904031,0.299937254951999,0.848711107428596,5,31,positive regulation of cyclin-dependent protein kinase activity,BP,EGFR;PKD2;PKD1;MAPRE3;AKT1
11515,GO:0046061,0.299987240091651,0.965147442518126,1,3,dATP catabolic process,BP,ADA
13819,GO:0060445,0.300705910814158,0.883406829020168,3,16,branching involved in salivary gland morphogenesis,BP,LAMA5;PLXND1;FGFR1
10313,GO:0043123,0.300849346537124,0.780674246798099,19,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,F2R;RBCK1;S100A4;PLEKHG5;TMED4;S100A13;ECM1;LITAF;SHARPIN;AKT1;CARD11;EDA2R;LGALS1;MIB2;FYN;TMEM101;LURAP1;CTH;IKBKB
10312,GO:0043122,0.301029515617728,0.772098446695154,24,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;F2R;RBCK1;S100A4;PLEKHG5;TMED4;S100A13;NLRX1;ECM1;LITAF;NLRP1;SHARPIN;MAPKBP1;AKT1;CARD11;EDA2R;LGALS1;MIB2;FYN;TMEM101;LURAP1;PER1;CTH;IKBKB
6288,GO:0019903,0.301033116487563,0.792992382533687,14,100,protein phosphatase binding,MF,DLG4;EGFR;PHACTR3;DLG3;MTMR4;STAT6;ITGA1;PIK3R2;PPP1R15A;ATP2B4;AKT1;JAK3;ERBB2;TCTEX1D4
400,GO:0001077,0.301182504678132,0.773491808116799,23,171,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,FOS;EGR1;MEF2D;DDIT3;ETV4;SOX12;ELK3;ETV1;TEF;CARF;PPARA;KLF7;HMGA2;LITAF;ATF4;ZNF467;CEBPB;HLTF;TP73;TFEB;POU2F2;EPAS1;DBP
16774,GO:0098644,0.301523683867209,0.882922736564117,3,16,complex of collagen trimers,CC,COL8A1;COL4A6;TNXB
1203,GO:0002863,0.301956883324352,0.964648368121053,1,3,positive regulation of inflammatory response to antigenic stimulus,BP,ZP3
1206,GO:0002866,0.301956883324352,0.964648368121053,1,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,ZP3
20206,GO:2001181,0.302046403095688,0.964625586253194,1,3,positive regulation of interleukin-10 secretion,BP,PRKCZ
11568,GO:0046164,0.302343252420281,0.847036220445982,5,31,alcohol catabolic process,BP,APOE;NTSR1;SRD5A3;SNX17;TKFC
18508,GO:1903725,0.302514777707779,0.826542911979202,7,46,regulation of phospholipid metabolic process,BP,SLC27A1;FGFR3;ZP3;MTMR4;PIK3R2;TAZ;VAV3
6738,GO:0030165,0.302558509733863,0.812829344271471,9,61,PDZ domain binding,MF,DLG4;DOCK4;DLG3;SNTA1;SDC2;MAP2K2;SRR;ATP2B4;TGFBR3
12058,GO:0048029,0.302920741240141,0.826238290206678,7,46,monosaccharide binding,MF,SLC2A3;PYGL;PHYH;GALK1;OGFOD2;PFKL;BSG
9942,GO:0042326,0.303057562131697,0.751610300882104,45,350,negative regulation of phosphorylation,BP,TNIP1;XDH;DUSP6;APOE;PTK6;PDCD4;PRNP;FBLN1;DUSP5;ADARB1;WWTR1;PKN1;DDIT4;DGKQ;SPRY2;PRKCZ;STK39;SPRY4;TRIB2;PPARA;IMPACT;ERRFI1;RGS14;MLXIPL;DMTN;SORL1;LRP5;PKIB;TRIB3;CDK5RAP3;PIK3R2;EPHA1;AKT1;CDKN1C;MICAL1;TSG101;C9ORF72;CTDSPL;TP73;LEMD2;SIRT2;EPHB2;PER1;FKBP8;GRB10
14137,GO:0061045,0.303277865173121,0.825970187212542,7,46,negative regulation of wound healing,BP,APOE;SERPINE2;CD9;PLAT;SERPING1;NOS3;PLAU
7150,GO:0031021,0.303306726380739,0.964303930618268,1,3,interphase microtubule organizing center,CC,WDR60
8587,GO:0034109,0.303352350614881,0.818393181894826,8,54,homotypic cell-cell adhesion,BP,SERPINE2;ANK3;CD9;BLOC1S4;DMTN;PTPRU;GAS6;LGALS1
538,GO:0001657,0.30344121116028,0.812137787776851,9,61,ureteric bud development,BP,CTNNBIP1;PGF;VEGFA;LAMA5;WNT2B;PKD2;KIF26B;CAT;FGFR1
1290,GO:0003105,0.303570608152932,0.964236366726911,1,3,negative regulation of glomerular filtration,BP,F2R
4119,GO:0009182,0.303818689656267,0.964172779762389,1,3,purine deoxyribonucleoside diphosphate metabolic process,BP,NUDT18
11517,GO:0046066,0.303818689656267,0.964172779762389,1,3,dGDP metabolic process,BP,NUDT18
19998,GO:2000649,0.303854460813339,0.845981079891012,5,31,regulation of sodium ion transmembrane transporter activity,BP,ANK3;SCN4B;STK39;KLHL24;PCSK9
19209,GO:1905383,0.304016611248179,0.964122001861076,1,3,protein localization to presynapse,BP,WNT7A
3199,GO:0006835,0.304254887037021,0.825236093202227,7,46,dicarboxylic acid transport,BP,NTSR1;VAMP2;PRAF2;TRPV1;SLC38A2;STX1A;APBA1
4596,GO:0010716,0.304280402134072,0.964054259024442,1,3,negative regulation of extracellular matrix disassembly,BP,CST3
6683,GO:0030060,0.304308526076697,0.964047032217013,1,3,L-malate dehydrogenase activity,MF,PHGDH
1169,GO:0002792,0.304489563458226,0.805777230949971,10,70,negative regulation of peptide secretion,BP,F2R;HADH;IDH2;RHBDF1;TMSB4X;RHBDF2;GAS6;MAPKBP1;CIDEA;PFKL
18364,GO:1903409,0.304775499218022,0.810964469673318,9,62,reactive oxygen species biosynthetic process,BP,ACP5;NOS1;PKD2;NOS3;TRPV1;ATP2B4;AKT1;ASS1;INSR
4590,GO:0010710,0.304822649110142,0.963914770987248,1,3,regulation of collagen catabolic process,BP,CST3
9728,GO:0038202,0.304899814745774,0.845249785269553,5,31,TORC1 signaling,BP,DGKQ;SESN2;C12ORF66;CARD11;C9ORF72
2042,GO:0004792,0.305086442195379,0.963846797629512,1,3,thiosulfate sulfurtransferase activity,MF,TST
2221,GO:0005125,0.305175033385975,0.800436649943064,11,79,cytokine activity,MF,VEGFA;TNFSF15;CTF1;C5;AREG;CMTM7;WNT7A;THNSL2;CKLF;TIMP1;GDF15
10203,GO:0042866,0.305359198793005,0.800467357169975,11,77,pyruvate biosynthetic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;PPARA;MLXIPL;GALK1;ALDOC;SRR;INSR;PFKL
1792,GO:0004427,0.305380335234644,0.963770979490531,1,3,inorganic diphosphatase activity,MF,LHPP
18065,GO:1902722,0.305448658179939,0.96375334022547,1,3,positive regulation of prolactin secretion,BP,EGFR
6210,GO:0019740,0.30554872408433,0.963727496599754,1,3,nitrogen utilization,BP,GLUL
9237,GO:0035651,0.305601368139878,0.963713896072043,1,3,AP-3 adaptor complex binding,MF,PI4K2A
18284,GO:1903236,0.305691273005982,0.963690662315036,1,3,regulation of leukocyte tethering or rolling,BP,PTAFR
13685,GO:0060268,0.305885327153558,0.963640483809025,1,3,negative regulation of respiratory burst,BP,BCR
2452,GO:0005665,0.305898411866546,0.879567197204241,3,17,DNA-directed RNA polymerase II, core complex,CC,POLR2J2;CHD6;POLR2J3
11017,GO:0045007,0.306066798371215,0.963593522051523,1,3,depurination,BP,MPG
15382,GO:0071672,0.306213407482508,0.963555555946822,1,3,negative regulation of smooth muscle cell chemotaxis,BP,CORO1B
13684,GO:0060267,0.306324453771956,0.96352678372037,1,3,positive regulation of respiratory burst,BP,INSR
7389,GO:0031461,0.306429141702569,0.772133140775416,21,157,cullin-RING ubiquitin ligase complex,CC,BTBD2;FBXO2;DDB2;ABTB1;CUL9;FBXW4;CUL7;KLHL29;ZSWIM4;FBXW8;FBXO27;DCAF10;FBXO17;KLHL24;FBXO6;FBXL15;KLHDC8B;SPSB3;FBXO25;KCTD13;BTBD11
9658,GO:0038033,0.306607203434611,0.963453462522664,1,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,VEGFA
19664,GO:2000015,0.306755705510594,0.963414918958386,1,3,regulation of determination of dorsal identity,BP,DDIT3
18672,GO:1904058,0.306829564468858,0.963395740022138,1,3,positive regulation of sensory perception of pain,BP,PTAFR
9339,GO:0035865,0.306931064870282,0.963369373772155,1,3,cellular response to potassium ion,BP,CARF
4657,GO:0010810,0.306946467996457,0.775485099817199,19,140,regulation of cell-substrate adhesion,BP,POSTN;VEGFA;FBLN1;SMOC2;ITGA6;ARL2;PRKCZ;NID1;COL8A1;DMTN;TRIOBP;MINK1;EPHA1;ECM2;PLAU;BRAF;LGALS1;BCL6;NET1
9661,GO:0038037,0.306965281969189,0.963360482845531,1,3,G-protein coupled receptor dimeric complex,CC,GABBR1
16672,GO:0097648,0.306965281969189,0.963360482845531,1,3,G-protein coupled receptor complex,CC,GABBR1
4017,GO:0009051,0.306969301633659,0.963359438297702,1,3,pentose-phosphate shunt, oxidative branch,BP,PGLS
10831,GO:0044344,0.306973350660106,0.785001709446771,15,109,cellular response to fibroblast growth factor stimulus,BP,DUSP6;FGFBP1;POSTN;ZFP36L1;HYAL1;SPRY2;FGFR3;SPRY4;MAPK3;FAM20C;SULF2;APLN;FGFR4;FGFR1;FRS3
6266,GO:0019865,0.307076889607306,0.963331474019405,1,3,immunoglobulin binding,MF,FCGRT
18202,GO:1903034,0.307104495926442,0.787880698366402,14,101,regulation of response to wounding,BP,PTPRS;F2R;APOE;SERPINE2;CD9;HBEGF;PLAT;MAP2K1;SERPING1;DMTN;TGFBR2;NOS3;PLAU;BRAF
2544,GO:0005813,0.307141363667156,0.742539949427498,56,440,centrosome,CC,NEK9;IFT140;BRSK1;ADGRB2;NDRG1;OBSL1;BBS1;RAB11FIP4;CUL7;SDCCAG8;TUBG2;ARL2;NPHP4;CAPRIN2;PHF1;USP20;CEP250;CCDC88B;SPPL2B;WDR60;ACTR1B;CHD3;CCDC92;IFT27;RGS14;CNTRL;TUBE1;HOOK2;FBF1;ATF4;PROCR;LRRC45;RABGAP1;FLOT1;CEP68;NEK8;NDE1;CEP131;TTC12;CDK5RAP3;CEP126;CROCC;CEP112;CCDC15;PLEKHG6;MZT2B;IFT57;MARK4;ITGB6;MZT2A;HAUS4;TUBGCP6;SIRT2;UNC119;SFI1;TTC19
18241,GO:1903135,0.307162670036714,0.963309168947485,1,3,cupric ion binding,MF,PRNP
2691,GO:0006059,0.307190553765309,0.963301916753434,1,3,hexitol metabolic process,BP,GALK1
14030,GO:0060830,0.307415220997644,0.963243452895168,1,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,WDR19
17847,GO:1902109,0.307445442606981,0.963235584312072,1,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BNIP3
4180,GO:0009261,0.307607833795321,0.85814317357805,4,24,ribonucleotide catabolic process,BP,NT5E;RAPGEF3;PDE2A;NUDT18
13455,GO:0055017,0.307684362721725,0.822652188377816,7,46,cardiac muscle tissue growth,BP,PAK1;TGFBR2;RXRA;TENM4;TP73;TGFBR3;FGFR1
8903,GO:0034756,0.307723440305226,0.963163157451216,1,3,regulation of iron ion transport,BP,HFE
17085,GO:0101006,0.30775096788347,0.963155981104358,1,3,protein histidine phosphatase activity,MF,LHPP
16603,GO:0097487,0.307774268615603,0.963149906037628,1,3,multivesicular body, internal vesicle,CC,EGFR
535,GO:0001654,0.307938986524586,0.759796092813854,29,220,eye development,BP,VEGFA;EGFR;IFT140;CST3;SDK2;MYH15;RAB11FIP4;NAGLU;SMOC1;NPHP4;SALL2;ACVR2B;WNT2B;COL8A1;LAMB2;SLITRK6;LRP5;TGFBR2;WNT7A;RXRA;ATP2B4;WDR19;MAB21L2;TBC1D20;HSF4;EPHB2;FKBP8;SDHAF4;SIX5
16574,GO:0097428,0.308040433442657,0.909020313197552,2,10,protein maturation by iron-sulfur cluster transfer,BP,MAGEF1;NFU1
5546,GO:0016557,0.308292824812856,0.963014552909231,1,3,peroxisome membrane biogenesis,BP,PEX11A
454,GO:0001228,0.308317300738367,0.754585318623988,34,260,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,FOS;EGR1;MEF2D;DDIT3;TFDP2;ETV4;ZNF76;PBX2;SOX12;ELK3;SALL2;ETV1;ETV5;TEF;CARF;PPARA;STAT6;KLF7;HMGA2;LITAF;ATF4;ZNF467;IRF5;CEBPB;CREBRF;HLTF;CSRNP3;FOXO4;TP73;TFEB;POU2F2;EPAS1;CREB3L4;DBP
16911,GO:0098917,0.308365782426118,0.962995486072579,1,3,retrograde trans-synaptic signaling,BP,NOS1
13458,GO:0055021,0.308509491736631,0.842715664561434,5,31,regulation of cardiac muscle tissue growth,BP,PAK1;TGFBR2;TP73;TGFBR3;FGFR1
3018,GO:0006566,0.308663047762468,0.962917738408146,1,3,threonine metabolic process,BP,THNSL2
20216,GO:2001198,0.308717277752247,0.962903544546715,1,3,regulation of dendritic cell differentiation,BP,HLA-G
10748,GO:0044211,0.308751562295144,0.962894569443575,1,3,CTP salvage,BP,UCKL1
9405,GO:0035986,0.308900034033374,0.962855687305006,1,3,senescence-associated heterochromatin focus assembly,BP,HMGA2
3252,GO:0006915,0.308956710509222,0.721197739140166,170,1390,apoptotic process,BP,XDH;DUSP6;F2R;TNFRSF6B;APOE;HS1BP3;NFATC4;PRODH;H1F0;GSN;EGR1;LRP1;ALOX15B;PDCD4;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;PRDX5;TNFSF15;CST3;MEF2D;DDIT3;PACS2;ERCC6;NDRG1;ARHGEF19;GRAMD4;MST1R;ZFP36L1;ADARB1;NUPR1;RGL2;RPS6KA2;TFDP2;NISCH;MAP2K1;PKN1;DDIT4;BTG1;SYNGAP1;ITGA6;TMEM173;PLEKHG5;SHC1;SPRY2;PRKCZ;PAK1;AARS;STK39;FGFR3;ELMO3;NME4;NEURL1;RAG1;NGFR;ARHGEF4;PLEKHG2;TNFRSF25;PLA2G6;CHAC1;MKNK2;SATB1;ING4;HMGA2;SLIT3;MAPK3;BNIP3;SEMA5A;THRA;STK40;GSDMA;CTSB;ARHGEF2;INPP5D;MAP2K2;ANGPTL4;ATF4;BBC3;PAK6;IFI6;MDK;KCNMA1;UNC5B;IRF5;HERPUD1;NLRP1;PEG3;ENDOG;CEBPB;MAP3K12;LRP5;PCSK9;DNMT3A;TGFBR2;CSRNP3;ITGA1;TNFAIP8L1;TRIB3;DAP;CDK5RAP3;NOS3;AGO4;MINK1;WNT7A;TRPV1;BNIP3L;EPHA1;SHARPIN;GAS6;ERN1;PPP1R15A;STRADB;CTSH;TNFRSF14;UACA;MGMT;ASNS;HINT2;AKT1;CARD11;MICAL1;BEX2;AMIGO2;CHEK2;IFT57;FGFR4;STEAP3;PHLDA1;DNASE2;LMNA;IFI27;INSR;RABGGTA;MAP2K5;BRAF;EDA2R;PIDD1;CAT;LGALS1;TIMP1;JAK3;TP73;MNT;BCL6;FYN;ARHGEF17;SIRT2;GDF15;PHLDA2;ADA;CIDEA;MYO18A;CIDEB;VAV3;MAP3K10;EPHB2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;NET1;TRIM2;IKBKB;SNCB;HIP1
6090,GO:0019287,0.308970045269302,0.962837344252423,1,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,MVD
10302,GO:0043103,0.309033676539805,0.962820668122843,1,3,hypoxanthine salvage,BP,ADA
15514,GO:0071942,0.30922679688465,0.962770029170021,1,3,XPC complex,CC,XPC
14122,GO:0061028,0.309330628335731,0.842137269112538,5,31,establishment of endothelial barrier,BP,PTPRS;RAPGEF3;PDE2A;WNT7A;IKBKB
13803,GO:0060426,0.309410432317282,0.962721839548559,1,3,lung vasculature development,BP,ERRFI1
1056,GO:0002584,0.309412345320395,0.962721337344362,1,3,negative regulation of antigen processing and presentation of peptide antigen,BP,HFE
12968,GO:0051403,0.309550319131742,0.760656871860495,27,205,stress-activated MAPK cascade,BP,XDH;CDC42EP5;PDCD4;VEGFA;EGFR;ERCC6;ZFP36L1;MAPK13;MAP2K1;PKN1;PAK1;MAPK3;VANGL2;MAP2K2;MAP3K12;TRPV4;MINK1;WNT7A;ERN1;NBR1;AKT1;EDA2R;MAPK10;TP73;MAP3K10;PER1;IKBKB
12214,GO:0048499,0.309606039687965,0.962670467758797,1,3,synaptic vesicle membrane organization,BP,SYNGR1
12111,GO:0048210,0.309658902844136,0.962656577291598,1,3,Golgi vesicle fusion to target membrane,BP,RAB13
9949,GO:0042350,0.309766860480234,0.962628200567189,1,3,GDP-L-fucose biosynthetic process,BP,FUK
1554,GO:0003955,0.309778379836122,0.962625171946418,1,3,NAD(P)H dehydrogenase (quinone) activity,MF,CBR4
2160,GO:0004993,0.30979779688952,0.962620066568001,1,3,G-protein coupled serotonin receptor activity,MF,HTR7
3420,GO:0007210,0.30979779688952,0.962620066568001,1,3,serotonin receptor signaling pathway,BP,HTR7
10345,GO:0043176,0.30979779688952,0.962620066568001,1,3,amine binding,MF,HTR7
12952,GO:0051378,0.30979779688952,0.962620066568001,1,3,serotonin binding,MF,HTR7
16788,GO:0098664,0.30979779688952,0.962620066568001,1,3,G-protein coupled serotonin receptor signaling pathway,BP,HTR7
17051,GO:0099589,0.30979779688952,0.962620066568001,1,3,serotonin receptor activity,MF,HTR7
15285,GO:0071502,0.309905198937636,0.962591819616219,1,3,cellular response to temperature stimulus,BP,TRPV1
7557,GO:0031914,0.310049112149055,0.962553950395291,1,3,negative regulation of synaptic plasticity,BP,RGS14
13254,GO:0051967,0.310171897748386,0.962521622783169,1,3,negative regulation of synaptic transmission, glutamatergic,BP,PLA2G6
4863,GO:0014719,0.310205955041574,0.962512653087499,1,3,skeletal muscle satellite cell activation,BP,WNT7A
16549,GO:0097368,0.310358946899733,0.962472343857702,1,3,establishment of Sertoli cell barrier,BP,RAB13
8717,GO:0034378,0.310384502100774,0.962465608256372,1,3,chylomicron assembly,BP,APOE
11589,GO:0046292,0.310597869992329,0.96240934285757,1,3,formaldehyde metabolic process,BP,KDM3A
10480,GO:0043398,0.310799810739244,0.962356044929697,1,3,HLH domain binding,MF,PKD2
18503,GO:1903719,0.310827163473489,0.962348822330141,1,3,regulation of I-kappaB phosphorylation,BP,AKT1
18504,GO:1903721,0.310827163473489,0.962348822330141,1,3,positive regulation of I-kappaB phosphorylation,BP,AKT1
16211,GO:0090288,0.310963498831902,0.787996355297321,13,93,negative regulation of cellular response to growth factor stimulus,BP,XDH;HTRA1;SPRY2;SPRY4;LTBP1;MTMR4;SULF2;TGFBR2;SMURF2;APLN;LEMD2;CIDEA;TGFBR3
10685,GO:0043988,0.311008524690219,0.962300912451039,1,3,histone H3-S28 phosphorylation,BP,RPS6KA5
2982,GO:0006528,0.311069233421108,0.962284867084834,1,3,asparagine metabolic process,BP,ASNS
8898,GO:0034751,0.311099111522136,0.962276968796862,1,3,aryl hydrocarbon receptor complex,CC,AIP
9478,GO:0036132,0.311238755361337,0.962240040927168,1,3,13-prostaglandin reductase activity,MF,PTGR2
11990,GO:0047522,0.311238755361337,0.962240040927168,1,3,15-oxoprostaglandin 13-oxidase activity,MF,PTGR2
17288,GO:0140161,0.311258344801835,0.962234858923504,1,3,monocarboxylate:sodium symporter activity,MF,SLC10A6
13914,GO:0060605,0.311272262810735,0.962231176930818,1,3,tube lumen cavitation,BP,EDA
13931,GO:0060662,0.311272262810735,0.962231176930818,1,3,salivary gland cavitation,BP,EDA
12938,GO:0051344,0.311373719511967,0.962204330268186,1,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,AIP
1608,GO:0004033,0.311405269206737,0.876239686358431,3,17,aldo-keto reductase (NADP) activity,MF,AKR7A2;DHRS4;KCNAB2
8513,GO:0033764,0.311473678493693,0.876198117227038,3,17,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B14;HSD11B1;HSD17B7
11549,GO:0046121,0.311674346648078,0.962124714476624,1,3,deoxyribonucleoside catabolic process,BP,ADA
18455,GO:1903588,0.311784012704905,0.962095646692115,1,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
10701,GO:0044036,0.311791951467663,0.962093541953508,1,3,cell wall macromolecule metabolic process,BP,MPI
15308,GO:0071554,0.311791951467663,0.962093541953508,1,3,cell wall organization or biogenesis,BP,MPI
254,GO:0000720,0.311810393749465,0.962088652236845,1,3,pyrimidine dimer repair by nucleotide-excision repair,BP,ERCC1
13749,GO:0060353,0.311938583121707,0.962054654284475,1,3,regulation of cell adhesion molecule production,BP,FLOT1
13750,GO:0060355,0.311938583121707,0.962054654284475,1,3,positive regulation of cell adhesion molecule production,BP,FLOT1
702,GO:0001923,0.311967330746554,0.962047027461916,1,3,B-1 B cell differentiation,BP,CMTM7
1133,GO:0002725,0.312024671919483,0.962031811986136,1,3,negative regulation of T cell cytokine production,BP,HFE
9999,GO:0042445,0.31233051012028,0.777696157030378,16,118,hormone metabolic process,BP,EGR1;HSD17B14;CYP27B1;DGKQ;PCSK1;ERO1B;DHRS4;SRD5A3;HSD11B1;HSD17B7;CYP2R1;PNPLA4;PLB1;HFE;RETSAT;FGFR1
2391,GO:0005534,0.312383903549105,0.961936407789022,1,3,galactose binding,MF,GALK1
15062,GO:0071073,0.312402358409876,0.961931502749127,1,3,positive regulation of phospholipid biosynthetic process,BP,ZP3
5689,GO:0016814,0.312424003212882,0.854937409526402,4,24,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,ADARB1;APOBEC3C;APOBEC3F;ADA
4296,GO:0009746,0.312451293739515,0.775089484074177,17,126,response to hexose,BP,EGR1;GLUL;NR1D1;PCK2;ACVR2B;PLA2G6;ANO1;SESN2;VAMP2;MLXIPL;ENDOG;LRP5;TGFBR2;GAS6;ERN1;LGALS1;PFKL
3017,GO:0006565,0.312584838702884,0.961882981946647,1,3,L-serine catabolic process,BP,CBS
2031,GO:0004774,0.312627170062123,0.96187172097644,1,3,succinate-CoA ligase activity,MF,SUCLG2
5901,GO:0018125,0.312644643286411,0.961867072182767,1,3,peptidyl-cysteine methylation,BP,RAB3B
5705,GO:0016841,0.312656201269153,0.961863996969087,1,3,ammonia-lyase activity,MF,SRR
6060,GO:0019212,0.312670367312775,0.854772715967783,4,24,phosphatase inhibitor activity,MF,PPP1R35;PHACTR3;PPP1R14A;ELFN2
544,GO:0001664,0.312779656481933,0.774763303850826,17,127,G-protein coupled receptor binding,MF,DLG4;PRNP;DNM1;ARAP1;BBS1;REEP2;USP20;ITGB4;WNT2B;C5;APLN;WNT7A;WNT3;CKLF;GNAL;HOMER2;FYN
14786,GO:0070541,0.312853562924267,0.961811462624574,1,3,response to platinum ion,BP,UROS
135,GO:0000285,0.312865930264616,0.961808169222057,1,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
663,GO:0001867,0.312870217256335,0.961807027563941,1,3,complement activation, lectin pathway,BP,SERPING1
18690,GO:1904154,0.312871705564137,0.96180663121157,1,3,positive regulation of retrograde protein transport, ER to cytosol,BP,EDEM1
11755,GO:0046634,0.31299316534715,0.82778189925543,6,39,regulation of alpha-beta T cell activation,BP,PRKCZ;TGFBR2;HFE;JAK3;BCL6;ADA
11291,GO:0045629,0.313018481797217,0.961767531172312,1,3,negative regulation of T-helper 2 cell differentiation,BP,BCL6
1522,GO:0003896,0.313064568098493,0.961755249257293,1,3,DNA primase activity,MF,PRIMPOL
12672,GO:0050913,0.313073675099412,0.906482992155491,2,10,sensory perception of bitter taste,BP,REEP2;ITPR3
2998,GO:0006546,0.313087834980949,0.961749047788622,1,3,glycine catabolic process,BP,GLDC
6148,GO:0019464,0.313087834980949,0.961749047788622,1,3,glycine decarboxylation via glycine cleavage system,BP,GLDC
16927,GO:0098953,0.313148634174014,0.961732839787062,1,3,receptor diffusion trapping,BP,DLG4
16933,GO:0098970,0.313148634174014,0.961732839787062,1,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,DLG4
17066,GO:0099628,0.313148634174014,0.961732839787062,1,3,neurotransmitter receptor diffusion trapping,BP,DLG4
10310,GO:0043120,0.313183777941887,0.96172346921936,1,3,tumor necrosis factor binding,MF,TNFRSF25
1982,GO:0004705,0.313192889758022,0.961721039466198,1,3,JUN kinase activity,MF,MAPK10
5751,GO:0016909,0.313192889758022,0.961721039466198,1,3,SAP kinase activity,MF,MAPK10
10037,GO:0042536,0.313220772998279,0.961713603565583,1,3,negative regulation of tumor necrosis factor biosynthetic process,BP,ERRFI1
18891,GO:1904636,0.313295397562746,0.961693698485229,1,3,response to ionomycin,BP,NFATC4
18892,GO:1904637,0.313295397562746,0.961693698485229,1,3,cellular response to ionomycin,BP,NFATC4
8271,GO:0033087,0.313503248882994,0.961638224700342,1,3,negative regulation of immature T cell proliferation,BP,ERBB2
18530,GO:1903774,0.313517999897381,0.961634285971272,1,3,positive regulation of viral budding via host ESCRT complex,BP,TSG101
6009,GO:0019062,0.313552892180427,0.961624968285937,1,3,virion attachment to host cell,BP,GAS6
10935,GO:0044650,0.313552892180427,0.961624968285937,1,3,adhesion of symbiont to host cell,BP,GAS6
13182,GO:0051835,0.3135645590484,0.961621852449829,1,3,positive regulation of synapse structural plasticity,BP,CAMK1
2618,GO:0005930,0.313587706321015,0.804010517318878,9,62,axoneme,CC,IFT140;BBS1;DNAH1;KIF17;SPAG16;SPATA7;IFT57;WDR66;TCTEX1D4
19926,GO:2000514,0.313782529145044,0.854028382803986,4,24,regulation of CD4-positive, alpha-beta T cell activation,BP,PRKCZ;TGFBR2;JAK3;BCL6
11540,GO:0046102,0.313836539405817,0.961549173001248,1,3,inosine metabolic process,BP,ADA
12297,GO:0048669,0.313867118190508,0.961540996549374,1,3,collateral sprouting in absence of injury,BP,WNT3
4319,GO:0009820,0.313887657185923,0.961535504055494,1,3,alkaloid metabolic process,BP,CYP3A5
10826,GO:0044339,0.31394912149439,0.961519064627695,1,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
17401,GO:1900186,0.314045850994381,0.961493184640056,1,3,negative regulation of clathrin-dependent endocytosis,BP,UNC119
14520,GO:0070061,0.314059888473317,0.961489428054867,1,3,fructose binding,MF,PFKL
10404,GO:0043262,0.314069978195934,0.961486727798907,1,3,adenosine-diphosphatase activity,MF,SLC25A42
3935,GO:0008626,0.314113686740067,0.961475029031161,1,3,granzyme-mediated apoptotic signaling pathway,BP,BNIP3
2669,GO:0006023,0.314174234977266,0.789081591026488,12,85,aminoglycan biosynthetic process,BP,B3GAT3;HYAL1;CEMIP;B4GAT1;CSPG4;SDC2;CHST6;ST3GAL3;HEXA;B4GALT2;XYLT2;UST
13788,GO:0060405,0.314181437974859,0.961456890980708,1,3,regulation of penile erection,BP,ADA
8070,GO:0032762,0.314207177245404,0.961449998855281,1,3,mast cell cytokine production,BP,BCL6
8071,GO:0032763,0.314207177245404,0.961449998855281,1,3,regulation of mast cell cytokine production,BP,BCL6
1848,GO:0004514,0.314250218877901,0.961438472098763,1,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,NAPRT
15729,GO:0072347,0.31434310366321,0.826784405680787,6,39,response to anesthetic,BP,HDAC5;DNMT3A;MAP1LC3A;SRR;HOMER2;ADA
8441,GO:0033590,0.314348055815848,0.961412263300837,1,3,response to cobalamin,BP,EGFR
19584,GO:1990756,0.314366130233618,0.961407420327132,1,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,ARRDC1
6780,GO:0030224,0.31436637430406,0.85363707304638,4,24,monocyte differentiation,BP,CTNNBIP1;VEGFA;ZFP36L1;INPP5D
18240,GO:1903131,0.31436637430406,0.85363707304638,4,24,mononuclear cell differentiation,BP,CTNNBIP1;VEGFA;ZFP36L1;INPP5D
967,GO:0002414,0.314532846102437,0.961362732444658,1,3,immunoglobulin transcytosis in epithelial cells,BP,FCGRT
11569,GO:0046165,0.31466872972474,0.77846059293101,15,110,alcohol biosynthetic process,BP,ISYNA1;APOE;NTSR1;CYP27B1;PCK2;SEC14L2;ABCG1;ACACB;MVD;SRD5A3;HSD17B7;PTAFR;CYP2R1;TM7SF2;PLPP6
11542,GO:0046104,0.314682075491523,0.961322705789174,1,3,thymidine metabolic process,BP,TK2
11552,GO:0046125,0.314682075491523,0.961322705789174,1,3,pyrimidine deoxyribonucleoside metabolic process,BP,TK2
12772,GO:0051090,0.314694436191861,0.744833119276166,39,304,regulation of DNA binding transcription factor activity,BP,FOS;CTNNBIP1;VEGFA;RBCK1;PRNP;DDIT3;CRTC1;MXI1;MDFI;PRKCZ;TRAPPC9;NLRX1;PKD2;MAPK3;THRA;ARHGEF2;PKD1;HDAC5;ADGRF1;LRP5;TMSB4X;DAP;BHLHE40;EDA;CDK5RAP3;GAS6;AKT1;CARD11;RPS6KA5;MAP2K5;EDA2R;PIDD1;CAT;MAPK10;MAP3K10;WFS1;CTH;EIF2AK4;IKBKB
181,GO:0000394,0.314705156031208,0.874227984204091,3,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,TRPT1;ERN1;CPSF4
53,GO:0000110,0.314821112499109,0.961285390856776,1,3,nucleotide-excision repair factor 1 complex,CC,ERCC1
8519,GO:0033829,0.314836095934713,0.961281368310083,1,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,MFNG
7933,GO:0032532,0.3148703399176,0.961272174026671,1,3,regulation of microvillus length,BP,TWF2
19291,GO:1905600,0.314909234093866,0.961261729627749,1,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9
18632,GO:1903976,0.314933611855551,0.961255182525222,1,3,negative regulation of glial cell migration,BP,IDH2
320,GO:0000839,0.314934776530208,0.96125486971369,1,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,SYVN1
18771,GO:1904340,0.314963172629647,0.961247242548247,1,3,positive regulation of dopaminergic neuron differentiation,BP,CSNK1E
19048,GO:1904958,0.314963172629647,0.961247242548247,1,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,CSNK1E
16826,GO:0098771,0.315079532342988,0.738423271345781,49,387,inorganic ion homeostasis,BP,DLG4;F2R;APOE;NTSR1;EGFR;PRNP;SLC7A8;ANK3;NOS1;DDIT3;CYP27B1;SLC12A7;CYBRD1;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;MAPK3;BNIP3;SV2A;PKD1;KCNMA1;HERPUD1;GSTM2;TMEM175;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;STEAP2;ITPR2;FGFR4;TCIRG1;STEAP3;TPCN1;LETMD1;HFE;SCNN1A;ATP12A;SLC9A7;FYN;TRPC1;EPAS1;EDNRA;WFS1;SLC9A5
19577,GO:1990743,0.315085906815196,0.961214266027263,1,3,protein sialylation,BP,ST6GALNAC2
10717,GO:0044091,0.315133564039033,0.853122292797288,4,24,membrane biogenesis,BP,ANK3;NLGN2;FLOT1;PEX11A
4629,GO:0010756,0.315202785657756,0.961182847278721,1,3,positive regulation of plasminogen activation,BP,PLGRKT
6612,GO:0022841,0.315210669988951,0.961180727311717,1,3,potassium ion leak channel activity,MF,TMEM175
9217,GO:0035620,0.31527099908804,0.961164503538045,1,3,ceramide transporter activity,MF,PLTP
9703,GO:0038145,0.315335452794424,0.961147166129806,1,3,macrophage colony-stimulating factor signaling pathway,BP,MST1R
3478,GO:0007341,0.315371087597301,0.961137578751764,1,3,penetration of zona pellucida,BP,HEXB
4900,GO:0014834,0.31544561971037,0.961117521699225,1,3,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A
7402,GO:0031493,0.315463227145417,0.961112782533568,1,3,nucleosomal histone binding,MF,L3MBTL1
10147,GO:0042748,0.315466753504466,0.961111833347987,1,3,circadian sleep/wake cycle, non-REM sleep,BP,ADA
14139,GO:0061047,0.315506240025283,0.961101203872851,1,3,positive regulation of branching involved in lung morphogenesis,BP,WNT2B
6024,GO:0019087,0.315522749949762,0.961096759014477,1,3,transformation of host cell by virus,BP,INSR
7668,GO:0032106,0.315576039633885,0.961082410128832,1,3,positive regulation of response to extracellular stimulus,BP,CYP27B1
7671,GO:0032109,0.315576039633885,0.961082410128832,1,3,positive regulation of response to nutrient levels,BP,CYP27B1
19094,GO:1905065,0.315578025751897,0.961081875282038,1,3,positive regulation of vascular smooth muscle cell differentiation,BP,CTH
13561,GO:0060054,0.315618851740608,0.961070880183443,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A
1919,GO:0004616,0.315635238429924,0.961066466465203,1,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,HIBADH
14656,GO:0070295,0.315635958326507,0.961066272555956,1,3,renal water absorption,BP,AQP3
5405,GO:0016254,0.315643181326185,0.873653708805243,3,17,preassembly of GPI anchor in ER membrane,BP,PIGZ;PIGQ;PIGV
2098,GO:0004866,0.315655356821158,0.791828084731211,11,80,endopeptidase inhibitor activity,MF,SERPINE2;TIMP2;PRDX5;TFPI2;CST3;SERPING1;C5;PAPLN;GAS6;HMSD;TIMP1
6880,GO:0030414,0.315655356821158,0.791828084731211,11,80,peptidase inhibitor activity,MF,SERPINE2;TIMP2;PRDX5;TFPI2;CST3;SERPING1;C5;PAPLN;GAS6;HMSD;TIMP1
19573,GO:1990737,0.315688448710166,0.961052132349154,1,3,response to manganese-induced endoplasmic reticulum stress,BP,ATF4
1993,GO:0004719,0.315771309741038,0.96102980449955,1,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,PCMTD2
18376,GO:1903432,0.315799053963586,0.852675212002233,4,24,regulation of TORC1 signaling,BP,DGKQ;SESN2;C12ORF66;C9ORF72
3899,GO:0008543,0.315863385433988,0.787606785491049,12,86,fibroblast growth factor receptor signaling pathway,BP,DUSP6;FGFBP1;SPRY2;FGFR3;SPRY4;MAPK3;FAM20C;SULF2;APLN;FGFR4;FGFR1;FRS3
7619,GO:0032027,0.315911017931964,0.960992141350492,1,3,myosin light chain binding,MF,SPATA6
9485,GO:0036146,0.31595898753957,0.960979204516395,1,3,cellular response to mycotoxin,BP,EGR1
9137,GO:0035502,0.315977193935554,0.960974293801291,1,3,metanephric part of ureteric bud development,BP,PKD2
18365,GO:1903416,0.31600433882503,0.960966971473117,1,3,response to glycoside,BP,CHEK2
13484,GO:0055080,0.316012662587067,0.738084107746971,48,379,cation homeostasis,BP,DLG4;F2R;APOE;NTSR1;EGFR;PRNP;SLC7A8;ANK3;NOS1;DDIT3;CYP27B1;SLC12A7;CYBRD1;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;MAPK3;BNIP3;SV2A;PKD1;KCNMA1;HERPUD1;GSTM2;TMEM175;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;STEAP2;ITPR2;TCIRG1;STEAP3;TPCN1;LETMD1;HFE;SCNN1A;ATP12A;SLC9A7;FYN;TRPC1;EPAS1;EDNRA;WFS1;SLC9A5
13668,GO:0060244,0.316031071868671,0.960959759443893,1,3,negative regulation of cell proliferation involved in contact inhibition,BP,PAK1
14185,GO:0061146,0.316038481191513,0.96095776042006,1,3,Peyer's patch morphogenesis,BP,FOXL1
14532,GO:0070081,0.316056506949597,0.960952896844887,1,3,clathrin-sculpted monoamine transport vesicle,CC,VAMP2
14533,GO:0070083,0.316056506949597,0.960952896844887,1,3,clathrin-sculpted monoamine transport vesicle membrane,CC,VAMP2
11220,GO:0045415,0.316067399899113,0.960949957616457,1,3,negative regulation of interleukin-8 biosynthetic process,BP,MAP2K5
8265,GO:0033080,0.316075364317368,0.960947808506431,1,3,immature T cell proliferation in thymus,BP,ERBB2
8507,GO:0033745,0.316093947156703,0.960942793860001,1,3,L-methionine-(R)-S-oxide reductase activity,MF,MSRB2
15534,GO:0072007,0.316100285331198,0.960941083393429,1,3,mesangial cell differentiation,BP,ACTA2
15535,GO:0072008,0.316100285331198,0.960941083393429,1,3,glomerular mesangial cell differentiation,BP,ACTA2
15617,GO:0072143,0.316100285331198,0.960941083393429,1,3,mesangial cell development,BP,ACTA2
15618,GO:0072144,0.316100285331198,0.960941083393429,1,3,glomerular mesangial cell development,BP,ACTA2
18729,GO:1904238,0.316100285331198,0.960941083393429,1,3,pericyte cell differentiation,BP,ACTA2
3813,GO:0008410,0.316106250220153,0.96093947362386,1,3,CoA-transferase activity,MF,SUGCT
17928,GO:1902308,0.316121205434096,0.960935437424511,1,3,regulation of peptidyl-serine dephosphorylation,BP,PPP1R15A
2732,GO:0006114,0.316121673615824,0.960935311064872,1,3,glycerol biosynthetic process,BP,PCK2
15421,GO:0071733,0.316131397217304,0.960932686665575,1,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1
16155,GO:0090202,0.316131397217304,0.960932686665575,1,3,gene looping,BP,ZFPM1
16314,GO:0090579,0.316131397217304,0.960932686665575,1,3,dsDNA loop formation,BP,ZFPM1
16106,GO:0090135,0.316138025202769,0.960930897712814,1,3,actin filament branching,BP,CORO1B
5029,GO:0015204,0.316161296889278,0.960924616091058,1,3,urea transmembrane transporter activity,MF,AQP3
5224,GO:0015840,0.316161296889278,0.960924616091058,1,3,urea transport,BP,AQP3
3524,GO:0007501,0.316171613926202,0.960921831067923,1,3,mesodermal cell fate specification,BP,FGFR1
10110,GO:0042661,0.316171613926202,0.960921831067923,1,3,regulation of mesodermal cell fate specification,BP,FGFR1
19329,GO:1905770,0.316171613926202,0.960921831067923,1,3,regulation of mesodermal cell differentiation,BP,FGFR1
19367,GO:1905902,0.316171613926202,0.960921831067923,1,3,regulation of mesoderm formation,BP,FGFR1
8344,GO:0033227,0.316221622916142,0.960908329768482,1,3,dsRNA transport,BP,FLOT1
7867,GO:0032437,0.316268466096871,0.9608956806568,1,3,cuticular plate,CC,TRIOBP
19680,GO:2000049,0.316274558082345,0.960894035453483,1,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,FLOT1
13637,GO:0060179,0.316348502509875,0.960874062725739,1,3,male mating behavior,BP,HEXB
18092,GO:1902804,0.316373889295415,0.960867204243836,1,3,negative regulation of synaptic vesicle transport,BP,BRAF
19805,GO:2000301,0.316373889295415,0.960867204243836,1,3,negative regulation of synaptic vesicle exocytosis,BP,BRAF
12522,GO:0050692,0.31638051068157,0.960865415296105,1,3,DBD domain binding,MF,RXRA
9402,GO:0035983,0.31641423684147,0.960856302502772,1,3,response to trichostatin A,BP,HDAC8
9403,GO:0035984,0.31641423684147,0.960856302502772,1,3,cellular response to trichostatin A,BP,HDAC8
9359,GO:0035898,0.316555607648686,0.960818090476426,1,3,parathyroid hormone secretion,BP,FGFR1
5011,GO:0015175,0.316569735700388,0.852156835084078,4,24,neutral amino acid transmembrane transporter activity,MF,SLC7A8;SLC43A1;SLC6A9;SLC38A2
2058,GO:0004813,0.316604767483282,0.960804797564411,1,3,alanine-tRNA ligase activity,MF,AARS
2906,GO:0006419,0.316604767483282,0.960804797564411,1,3,alanyl-tRNA aminoacylation,BP,AARS
2229,GO:0005134,0.316631416102162,0.960797590609449,1,3,interleukin-2 receptor binding,MF,ECM1
13691,GO:0060282,0.316634857300931,0.960796659901152,1,3,positive regulation of oocyte development,BP,SIRT2
19359,GO:1905881,0.316634857300931,0.960796659901152,1,3,positive regulation of oogenesis,BP,SIRT2
18666,GO:1904047,0.316638885714912,0.960795570357552,1,3,S-adenosyl-L-methionine binding,MF,CBS
1584,GO:0003997,0.316662126137124,0.96078928429434,1,3,acyl-CoA oxidase activity,MF,ACOX3
11949,GO:0047192,0.31676476504416,0.960761515397704,1,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,LPCAT4
995,GO:0002457,0.316775779193344,0.96075853483299,1,3,T cell antigen processing and presentation,BP,HFE
12469,GO:0050501,0.31678066969245,0.960757211360471,1,3,hyaluronan synthase activity,MF,HYAL1
9469,GO:0036118,0.316876053985869,0.960731393057027,1,3,hyaluranon cable assembly,BP,HYAL1
17352,GO:1900104,0.316876053985869,0.960731393057027,1,3,regulation of hyaluranon cable assembly,BP,HYAL1
17353,GO:1900106,0.316876053985869,0.960731393057027,1,3,positive regulation of hyaluranon cable assembly,BP,HYAL1
9498,GO:0036166,0.316895311192606,0.960726179357822,1,3,phenotypic switching,BP,OLFM2
17425,GO:1900239,0.316895311192606,0.960726179357822,1,3,regulation of phenotypic switching,BP,OLFM2
5660,GO:0016774,0.316996487571306,0.960698780099914,1,3,phosphotransferase activity, carboxyl group as acceptor,MF,NAGS
6010,GO:0019064,0.317018578763741,0.960692796145141,1,3,fusion of virus membrane with host plasma membrane,BP,GAS6
9764,GO:0039663,0.317018578763741,0.960692796145141,1,3,membrane fusion involved in viral entry into host cell,BP,GAS6
10981,GO:0044800,0.317018578763741,0.960692796145141,1,3,multi-organism membrane fusion,BP,GAS6
11314,GO:0045658,0.317027435165423,0.960690397014196,1,3,regulation of neutrophil differentiation,BP,INPP5D
9799,GO:0042015,0.317038774561788,0.960687325132362,1,3,interleukin-20 binding,MF,IL20RB
6445,GO:0021769,0.317049887074371,0.9606843145758,1,3,orbitofrontal cortex development,BP,FGFR1
11441,GO:0045916,0.317065105501431,0.960680191439722,1,3,negative regulation of complement activation,BP,SERPING1
19781,GO:2000258,0.317065105501431,0.960680191439722,1,3,negative regulation of protein activation cascade,BP,SERPING1
18510,GO:1903727,0.31711595106082,0.851789031218237,4,24,positive regulation of phospholipid metabolic process,BP,FGFR3;ZP3;TAZ;VAV3
4989,GO:0015129,0.317146088667418,0.960658246313955,1,3,lactate transmembrane transporter activity,MF,SLC16A3
4767,GO:0010957,0.317178511544738,0.960649458202155,1,3,negative regulation of vitamin D biosynthetic process,BP,CYP27B1
11563,GO:0046137,0.317178511544738,0.960649458202155,1,3,negative regulation of vitamin metabolic process,BP,CYP27B1
1898,GO:0004586,0.317182958606412,0.960648252750159,1,3,ornithine decarboxylase activity,MF,AZIN2
8401,GO:0033387,0.317182958606412,0.960648252750159,1,3,putrescine biosynthetic process from ornithine,BP,AZIN2
2665,GO:0006015,0.317206589183689,0.960641846911326,1,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,PYGL
11634,GO:0046391,0.317206589183689,0.960641846911326,1,3,5-phosphoribose 1-diphosphate metabolic process,BP,PYGL
14270,GO:0061408,0.317212538394564,0.960640234086128,1,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,HSF4
1268,GO:0003057,0.317214771856964,0.960639628586514,1,3,regulation of the force of heart contraction by chemical signal,BP,NOS3
9350,GO:0035879,0.317220607250324,0.960638046564554,1,3,plasma membrane lactate transport,BP,SLC16A3
13827,GO:0060456,0.317226008783003,0.960636582132072,1,3,positive regulation of digestive system process,BP,TRPV1
20011,GO:2000664,0.317258305705194,0.960627825301583,1,3,positive regulation of interleukin-5 secretion,BP,PRKCZ
20014,GO:2000667,0.317258305705194,0.960627825301583,1,3,positive regulation of interleukin-13 secretion,BP,PRKCZ
19943,GO:2000553,0.317271534020229,0.960624238306776,1,3,positive regulation of T-helper 2 cell cytokine production,BP,PRKCZ
4844,GO:0014061,0.317315777108146,0.96061223992531,1,3,regulation of norepinephrine secretion,BP,STX1A
7760,GO:0032289,0.317337189318249,0.960606432321209,1,3,central nervous system myelin formation,BP,TENM4
9765,GO:0039689,0.317359375775354,0.960600414183017,1,3,negative stranded viral RNA replication,BP,ATG16L2
11397,GO:0045829,0.317375816754602,0.960595954169542,1,3,negative regulation of isotype switching,BP,BCL6
13243,GO:0051956,0.317389589240588,0.960592217818868,1,3,negative regulation of amino acid transport,BP,STK39
17574,GO:1901264,0.317418993540414,0.807329794845138,8,55,carbohydrate derivative transport,BP,SLC37A2;ABCG1;SLC50A1;SLC29A4;VLDLR;SLC37A4;SLC25A42;ADA
14630,GO:0070252,0.317423029189886,0.808165789139097,8,50,actin-mediated cell contraction,BP,SCN4B;TPM2;SNTA1;MYH3;TTN;TNNI2;TNNT1;TNNI1
14938,GO:0070859,0.317449023413718,0.960576091453937,1,3,positive regulation of bile acid biosynthetic process,BP,NR1D1
18737,GO:1904253,0.317449023413718,0.960576091453937,1,3,positive regulation of bile acid metabolic process,BP,NR1D1
5041,GO:0015228,0.317452422757949,0.96057516898628,1,3,coenzyme A transmembrane transporter activity,MF,SLC25A42
5248,GO:0015880,0.317452422757949,0.96057516898628,1,3,coenzyme A transport,BP,SLC25A42
9074,GO:0035349,0.317452422757949,0.96057516898628,1,3,coenzyme A transmembrane transport,BP,SLC25A42
15064,GO:0071077,0.317452422757949,0.96057516898628,1,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,SLC25A42
15068,GO:0071106,0.317452422757949,0.96057516898628,1,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,SLC25A42
15949,GO:0080122,0.317452422757949,0.96057516898628,1,3,AMP transmembrane transporter activity,MF,SLC25A42
1016,GO:0002513,0.317537411239258,0.960552101806095,1,3,tolerance induction to self antigen,BP,TGFBR2
9559,GO:0036374,0.317551366332573,0.960548313413726,1,3,glutathione hydrolase activity,MF,GGT1
17148,GO:0102953,0.317551366332573,0.960548313413726,1,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,GGT1
17157,GO:0103068,0.317551366332573,0.960548313413726,1,3,leukotriene C4 gamma-glutamyl transferase activity,MF,GGT1
17738,GO:1901748,0.317551366332573,0.960548313413726,1,3,leukotriene D4 metabolic process,BP,GGT1
17739,GO:1901750,0.317551366332573,0.960548313413726,1,3,leukotriene D4 biosynthetic process,BP,GGT1
923,GO:0002318,0.317555224540446,0.960547265987022,1,3,myeloid progenitor cell differentiation,BP,BRAF
14436,GO:0061819,0.317578164858454,0.960541037806023,1,3,telomeric DNA-containing double minutes formation,BP,ERCC1
19325,GO:1905764,0.317578164858454,0.960541037806023,1,3,regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19326,GO:1905765,0.317578164858454,0.960541037806023,1,3,negative regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19544,GO:1990599,0.317578164858454,0.960541037806023,1,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
13807,GO:0060431,0.317579872257777,0.960540574232281,1,3,primary lung bud formation,BP,WNT2B
12869,GO:0051234,0.3175995412886,0.704284086946029,413,3432,establishment of localization,BP,XDH;DLG4;BBS2;F2R;APOE;SYTL1;KCNG1;SERPINE2;FHL1;S100A6;OSBPL5;GSN;PYGB;LMF1;POSTN;EVI5L;WIPF1;SLC2A3;TMEM129;NAPRT;EDEM1;GLUL;GJC2;LRP1;ALOX15B;TIMP2;VEGFA;NTSR1;EGFR;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;SLC7A8;HADH;ANK3;IFT140;RAPGEF3;CLTCL1;FCHO1;SPTB;TSPAN1;SLC16A3;CD9;SLC2A9;SNPH;IDH2;CST3;DNM1;NOS1;DDIT3;ARAP3;BRSK1;SHANK2;PGM1;CLCA2;SCN4B;ORAI3;MRC2;TBC1D8;ARRDC1;ZFP36L1;SYT8;RIN1;ARAP1;B3GAT3;GAA;PYGL;CNTN1;EXOC2;TFDP2;RPL13A;BBS1;LTBP4;SLC27A1;REEP2;RAB11FIP4;NISCH;CPT2;ASAP2;PITPNM3;ATG16L2;PRSS3;SYNGR1;MAP2K1;CYP27B1;PCK2;SLC16A5;ABCA2;SLC43A1;TOM1L2;DNASE1L1;PITPNM1;TMEM173;SNX9;ARL2;VPS11;SPRY2;BLOC1S4;VEGFB;RAB3B;NLGN2;CD68;SLC12A7;ITPR3;PITPNC1;APPL2;PRSS8;PRKCZ;SERPING1;PAK1;ABCA7;SLC37A2;MCTP1;STK39;PEAR1;CEMIP;BRI3;NDUFA4L2;USP20;ORAI2;ELMO3;SYNE3;DLG3;MICALL2;SLCO4A1;NME4;ZP3;NEURL1;ACVR2B;CCDC88B;NGFR;GSTO1;WDR60;ACTR1B;SPG11;TMC6;OLFM2;ANO8;TMED4;PLA2G6;ABCG1;ESYT2;XPOT;TRAPPC9;RINL;SCART1;MANF;LPAR3;S100A13;AGAP1;C5;KIF17;PPARA;ANO1;STON1;SESN2;AIP;KCNJ15;IFT27;PKD2;SH3TC2;VAMP2;AREG;AP1G2;SEPT5;ECM1;PCLO;KCNC4;ACACB;KCNAB2;MAPK3;BNIP3;OSBPL10;PEX10;SCARA3;RGS14;DYSF;RHOF;SLC22A18;LTBP2;SNTA1;CTSB;HOOK2;EIF2D;MVB12B;LTA4H;PI4K2A;PQLC2;CHMP1B;TBC1D14;ARHGEF2;PRAF2;MAP2K2;SLC50A1;SLC48A1;LRSAM1;DMTN;LRRC8A;KLHL24;ATF4;BBC3;SV2A;TBC1D3E;SLC38A10;RABGAP1;ACAP3;REEP6;PKD1;FUCA1;SLC29A4;FLOT1;TTN;KCNMA1;AZIN2;TSNARE1;WHAMMP3;SORL1;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;TMEM175;NLRP1;RHBDF1;LRP5;WNK4;RIN2;ALDOC;NDE1;PCSK9;AQP3;CEP131;LONP2;TGFBR2;TRPV4;ARHGAP25;TMSB4X;ANO9;APOL4;PDE2A;APLN;TRIB3;RAB40B;PEMT;NOS3;MINK1;HEXB;PROM2;WNT7A;TRPV1;MARCH2;BNIP3L;PIK3R2;RHBDF2;CCS;GAS6;VPS39;GLUD1;DNAJC6;ALKBH7;CROCC;BCR;ATP7B;FYCO1;NBEAL2;MFSD3;KIF13B;TTYH3;NECAB3;CAMK1;PTAFR;RXRA;RIMS3;RAB43;ATP2B4;STRADB;CTSH;WDR19;STEAP2;MAPKBP1;AKT1;ZFYVE21;ITPR2;CARD11;MICAL1;CRY2;IFT57;TTC21A;TSG101;IL17RC;IGF2BP2;RASSF9;SLC6A9;TCIRG1;ASAP3;STEAP3;SLC6A6;TMEM63C;COPG1;C9ORF72;SGSM2;TBC1D20;CHMP5;ARSA;MAN2B1;ICA1;ARHGAP27;RAB25;IFI27;PLAU;INSR;SLC25A29;CKLF;COG7;SLC22A15;CHMP4C;TPCN1;ADD3;MAGED2;ITGB6;HOMER2;LYST;ZDHHC24;BRAF;ARHGAP44;CPSF4;BTN3A2;ASIC1;CAT;DPP7;YPEL5;UNC119B;TIMP1;HFE;TP73;SCNN1A;SNX33;CHRM3;APRT;PEX7;SNX17;ICAM5;METTL7A;ATP12A;SPIRE1;TMEM50B;CSNK1E;HGSNAT;BCL6;SLC9A7;ADAP1;SLC37A4;EHD3;FYN;ATP8B2;SLC38A2;SNX1;PEX1;LEMD2;UBXN6;SLC25A42;TRPC1;RAB13;OSBPL1A;TOM1;TST;GOLGA2;ADA;POU2F2;RHOBTB3;RTN2;AP2A2;CIDEA;MYO18A;SLC35F3;RPL29;VAV3;STX1A;GALNS;LAMTOR2;TBC1D16;STARD10;EDNRA;EPHB2;TMCO6;PER1;IGF2BP3;ITGA2;SLC39A11;FGFR1;WFS1;ESYT3;BLOC1S1;RGPD6;ERBB2;SEC31B;PLLP;SLC10A6;UNC119;SYVN1;OSCP1;PFKL;RPL12;MPPE1;GRB10;BSG;APBA1;PNKD;HIP1;SLC9A5
841,GO:0002155,0.317604229376974,0.960533960711966,1,3,regulation of thyroid hormone mediated signaling pathway,BP,THRA
18621,GO:1903961,0.317620505517281,0.960529540997181,1,3,positive regulation of anion transmembrane transport,BP,PTAFR
11724,GO:0046581,0.317633398817137,0.960526039669328,1,3,intercellular canaliculus,CC,STARD10
16738,GO:0098559,0.317654453442151,0.960520321640833,1,3,cytoplasmic side of early endosome membrane,CC,LITAF
9689,GO:0038108,0.317678004213806,0.960513925124627,1,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,BBS2
4872,GO:0014738,0.317702766238313,0.960507198962113,1,3,regulation of muscle hyperplasia,BP,NOS3
13049,GO:0051581,0.317707760081147,0.960505842391296,1,3,negative regulation of neurotransmitter uptake,BP,NOS1
293,GO:0000798,0.317773952890162,0.960487858588162,1,3,nuclear cohesin complex,CC,REC8
16502,GO:0097252,0.317775897870687,0.960487330086451,1,3,oligodendrocyte apoptotic process,BP,GAS6
14699,GO:0070375,0.317776611443468,0.960487136189064,1,3,ERK5 cascade,BP,MAP2K5
703,GO:0001927,0.317784386836555,0.960485023364775,1,3,exocyst assembly,BP,EXOC2
19543,GO:1990597,0.317798046161106,0.960481311524772,1,3,AIP1-IRE1 complex,CC,ERN1
19546,GO:1990604,0.317801848633741,0.960480278188442,1,3,IRE1-TRAF2-ASK1 complex,CC,ERN1
15020,GO:0070991,0.317804004046921,0.960479692439877,1,3,medium-chain-acyl-CoA dehydrogenase activity,MF,ACAD11
15668,GO:0072223,0.3178152488951,0.960476636489605,1,3,metanephric glomerular mesangium development,BP,EGR1
15675,GO:0072239,0.3178152488951,0.960476636489605,1,3,metanephric glomerulus vasculature development,BP,EGR1
7128,GO:0030969,0.31781736139026,0.96047606237284,1,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,ERN1
14516,GO:0070054,0.31781736139026,0.96047606237284,1,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,ERN1
14517,GO:0070055,0.31781736139026,0.96047606237284,1,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,ERN1
4792,GO:0010989,0.317818690074262,0.960475701271352,1,3,negative regulation of low-density lipoprotein particle clearance,BP,PCSK9
1509,GO:0003872,0.317822701792749,0.960474610979522,1,3,6-phosphofructokinase activity,MF,PFKL
4961,GO:0015057,0.317825171774578,0.960473939687073,1,3,thrombin-activated receptor activity,MF,F2R
10188,GO:0042819,0.317828865869343,0.960472935691892,1,3,vitamin B6 biosynthetic process,BP,PSAT1
11715,GO:0046548,0.317852288830071,0.960466569358854,1,3,retinal rod cell development,BP,NAGLU
7366,GO:0031427,0.317854405983471,0.960465993889087,1,3,response to methotrexate,BP,ASNS
17393,GO:1900165,0.31786735532479,0.960462473981741,1,3,negative regulation of interleukin-6 secretion,BP,GAS6
4295,GO:0009744,0.317868126832541,0.960462264263482,1,3,response to sucrose,BP,ERCC1
8673,GO:0034285,0.317868126832541,0.960462264263482,1,3,response to disaccharide,BP,ERCC1
14225,GO:0061302,0.31787102119382,0.960461477486451,1,3,smooth muscle cell-matrix adhesion,BP,PLAU
9959,GO:0042363,0.317897822099323,0.960454191727914,1,3,fat-soluble vitamin catabolic process,BP,CYP27B1
803,GO:0002074,0.317906897975523,0.96045172429327,1,3,extraocular skeletal muscle development,BP,MYH15
19516,GO:1990460,0.317911197097808,0.96045055547021,1,3,leptin receptor binding,MF,SNX1
10852,GO:0044393,0.317917724058183,0.960448780914976,1,3,microspike,CC,PROM2
17374,GO:1900133,0.317923764245693,0.960447138661647,1,3,regulation of renin secretion into blood stream,BP,F2R
141,GO:0000293,0.317926945300375,0.960446273755518,1,3,ferric-chelate reductase activity,MF,CYBRD1
9302,GO:0035787,0.317936927063664,0.960443559711993,1,3,cell migration involved in kidney development,BP,VANGL2
4442,GO:0010360,0.317941351505338,0.960442356670007,1,3,negative regulation of anion channel activity,BP,ANO9
16190,GO:0090259,0.317943595317119,0.960441746550912,1,3,regulation of retinal ganglion cell axon guidance,BP,VEGFA
5945,GO:0018298,0.317945149717416,0.960441323887685,1,3,protein-chromophore linkage,BP,CRY2
20018,GO:2000671,0.317945277492606,0.960441289143606,1,3,regulation of motor neuron apoptotic process,BP,MAP3K12
20019,GO:2000672,0.317945277492606,0.960441289143606,1,3,negative regulation of motor neuron apoptotic process,BP,MAP3K12
3799,GO:0008381,0.317945279587232,0.960441288574135,1,3,mechanosensitive ion channel activity,MF,TRPV4
6827,GO:0030297,0.317950490487551,0.960439871636924,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,DGKQ
10950,GO:0044729,0.317951157018638,0.960439690392999,1,3,hemi-methylated DNA-binding,MF,EGR1
699,GO:0001920,0.317956431176046,0.96043825622059,1,3,negative regulation of receptor recycling,BP,PCSK9
18841,GO:1904527,0.317956518502259,0.960438232474214,1,3,negative regulation of microtubule binding,BP,TTBK2
9048,GO:0035290,0.317962357015019,0.960436644803125,1,3,trunk segmentation,BP,SEMA3F
9605,GO:0036484,0.317962357015019,0.960436644803125,1,3,trunk neural crest cell migration,BP,SEMA3F
9606,GO:0036486,0.317962357015019,0.960436644803125,1,3,ventral trunk neural crest cell migration,BP,SEMA3F
17543,GO:1901166,0.317962357015019,0.960436644803125,1,3,neural crest cell migration involved in autonomic nervous system development,BP,SEMA3F
4819,GO:0014022,0.317962648961397,0.960436565412941,1,3,neural plate elongation,BP,VANGL2
6554,GO:0022007,0.317962648961397,0.960436565412941,1,3,convergent extension involved in neural plate elongation,BP,VANGL2
15480,GO:0071879,0.317968728269491,0.96043491222012,1,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
5342,GO:0016094,0.317970531588972,0.960434421821646,1,3,polyprenol biosynthetic process,BP,SRD5A3
667,GO:0001875,0.317971755984637,0.960434088854959,1,3,lipopolysaccharide receptor activity,MF,PTAFR
13,GO:0000026,0.317975715328824,0.960433012124784,1,3,alpha-1,2-mannosyltransferase activity,MF,PIGZ
8988,GO:0035136,0.31797789850325,0.851207935414015,4,24,forelimb morphogenesis,BP,RNF165;WNT7A;ZNF358;WNT3
15699,GO:0072298,0.317978045633944,0.960432378398151,1,3,regulation of metanephric glomerulus development,BP,EGR1
4603,GO:0010724,0.317981300722389,0.960431493166409,1,3,regulation of definitive erythrocyte differentiation,BP,ZFPM1
10219,GO:0042940,0.317986859334273,0.960429981456942,1,3,D-amino acid transport,BP,NTSR1
18331,GO:1903348,0.317989450825433,0.960429276668213,1,3,positive regulation of bicellular tight junction assembly,BP,NPHP4
8994,GO:0035166,0.317994442989433,0.960427918965277,1,3,post-embryonic hemopoiesis,BP,ERCC1
10824,GO:0044336,0.318001895436656,0.960425892095434,1,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,TCF7
13762,GO:0060374,0.318005139813254,0.960425009690955,1,3,mast cell differentiation,BP,ZFPM1
14931,GO:0070849,0.318009712120664,0.82406594194472,6,39,response to epidermal growth factor,BP,EGFR;ZFP36L1;MAPK3;ERRFI1;AKT1;ERBB2
10627,GO:0043654,0.318018721643551,0.960421315582598,1,3,recognition of apoptotic cell,BP,PEAR1
19414,GO:1990075,0.31802211503342,0.960420392585824,1,3,periciliary membrane compartment,CC,KIF17
3800,GO:0008384,0.318033943740468,0.96041717509626,1,3,IkappaB kinase activity,MF,IKBKB
8872,GO:0034699,0.31804479248832,0.960414224025728,1,3,response to luteinizing hormone,BP,TGFBR3
18682,GO:1904116,0.31806051238688,0.960409947675571,1,3,response to vasopressin,BP,ADCY6
18683,GO:1904117,0.31806051238688,0.960409947675571,1,3,cellular response to vasopressin,BP,ADCY6
186,GO:0000404,0.318060747396738,0.960409883742706,1,3,heteroduplex DNA loop binding,MF,XPC
6675,GO:0030047,0.318061291811545,0.960409735638307,1,3,actin modification,BP,TRIOBP
10828,GO:0044341,0.318068540811923,0.960407763563599,1,3,sodium-dependent phosphate transport,BP,CRY2
19415,GO:1990086,0.318091374936638,0.960401551208283,1,3,lens fiber cell apoptotic process,BP,TGFBR2
14676,GO:0070327,0.318091854229923,0.960401420803455,1,3,thyroid hormone transport,BP,SLCO4A1
9646,GO:0038007,0.318101313128648,0.96039884719808,1,3,netrin-activated signaling pathway,BP,UNC5B
16031,GO:0089700,0.318102446005419,0.960398538954917,1,3,protein kinase D signaling,BP,VEGFA
1983,GO:0004706,0.318107832248971,0.960397073398576,1,3,JUN kinase kinase kinase activity,MF,MAP3K10
1376,GO:0003274,0.318111202463568,0.960396156372132,1,3,endocardial cushion fusion,BP,TGFBR2
5752,GO:0016917,0.318114077356036,0.960395374111621,1,3,GABA receptor activity,MF,GABBR1
6322,GO:0020016,0.318128141848368,0.960391547019644,1,3,ciliary pocket,CC,EHD3
6323,GO:0020018,0.318128141848368,0.960391547019644,1,3,ciliary pocket membrane,CC,EHD3
18596,GO:1903911,0.31813260163031,0.960390333421566,1,3,positive regulation of receptor clustering,BP,SSH1
15716,GO:0072320,0.318133932019008,0.960389971391248,1,3,volume-sensitive chloride channel activity,MF,TTYH3
9262,GO:0035701,0.318171004136607,0.960379882398783,1,3,hematopoietic stem cell migration,BP,GAS6
17622,GO:1901387,0.318177508006726,0.960378112245411,1,3,positive regulation of voltage-gated calcium channel activity,BP,EHD3
4981,GO:0015111,0.318179490956564,0.960377572538236,1,3,iodide transmembrane transporter activity,MF,ANO1
9653,GO:0038026,0.318180462402257,0.960377308134441,1,3,reelin-mediated signaling pathway,BP,VLDLR
9579,GO:0036446,0.318184803848798,0.960376126485903,1,3,myofibroblast differentiation,BP,PDCD4
18948,GO:1904760,0.318184803848798,0.960376126485903,1,3,regulation of myofibroblast differentiation,BP,PDCD4
6784,GO:0030229,0.318185077032183,0.960376052130547,1,3,very-low-density lipoprotein particle receptor activity,MF,VLDLR
3196,GO:0006828,0.318194297968184,0.960373542317568,1,3,manganese ion transport,BP,TRPC1
19813,GO:2000312,0.318230467700985,0.960363696498179,1,3,regulation of kainate selective glutamate receptor activity,BP,KLHL24
1520,GO:0003886,0.318233044199353,0.960362995090082,1,3,DNA (cytosine-5-)-methyltransferase activity,MF,DNMT3A
8082,GO:0032776,0.318233044199353,0.960362995090082,1,3,DNA methylation on cytosine,BP,DNMT3A
16098,GO:0090116,0.318233044199353,0.960362995090082,1,3,C-5 methylation of cytosine,BP,DNMT3A
12807,GO:0051138,0.318240024032016,0.960361094911657,1,3,positive regulation of NK T cell differentiation,BP,TGFBR2
1849,GO:0004515,0.318243199802738,0.960360230327132,1,3,nicotinate-nucleotide adenylyltransferase activity,MF,NMNAT2
11259,GO:0045586,0.3182468055156,0.960359248679776,1,3,regulation of gamma-delta T cell differentiation,BP,SOX13
5338,GO:0016080,0.318248422339796,0.960358808498207,1,3,synaptic vesicle targeting,BP,SEPT5
8624,GO:0034163,0.318261872553892,0.960355146555724,1,3,regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
14842,GO:0070644,0.318266956955415,0.960353762229093,1,3,vitamin D response element binding,MF,RXRA
11886,GO:0046935,0.318270431236652,0.960352816272278,1,3,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R2
71,GO:0000147,0.318271406123958,0.960352550833342,1,3,actin cortical patch assembly,BP,WIPF1
10854,GO:0044396,0.318271406123958,0.960352550833342,1,3,actin cortical patch organization,BP,WIPF1
13100,GO:0051666,0.318271406123958,0.960352550833342,1,3,actin cortical patch localization,BP,WIPF1
13638,GO:0060180,0.318278277035971,0.960350680014916,1,3,female mating behavior,BP,THRA
6494,GO:0021869,0.318281805365099,0.960349719297968,1,3,forebrain ventricular zone progenitor cell division,BP,FGFR1
7902,GO:0032484,0.318288975709886,0.960347766865835,1,3,Ral protein signal transduction,BP,RGL2
7903,GO:0032485,0.318288975709886,0.960347766865835,1,3,regulation of Ral protein signal transduction,BP,RGL2
14257,GO:0061364,0.318310684110934,0.960341855479736,1,3,apoptotic process involved in luteolysis,BP,SLIT3
16597,GO:0097475,0.31831370048679,0.960341034053056,1,3,motor neuron migration,BP,VEGFA
19065,GO:1904996,0.318315999025323,0.960340408102763,1,3,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,PTAFR
7139,GO:0030997,0.318334690605741,0.960335317693385,1,3,regulation of centriole-centriole cohesion,BP,CEP250
15357,GO:0071630,0.318371609648415,0.960325262131072,1,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,ANKZF1
18592,GO:1903903,0.318377523009562,0.960323651380583,1,3,regulation of establishment of T cell polarity,BP,GSN
19895,GO:2000425,0.318405847678496,0.960315935437299,1,3,regulation of apoptotic cell clearance,BP,ABCA7
16921,GO:0098935,0.318407186534804,0.960315570696561,1,3,dendritic transport,BP,KIF17
16923,GO:0098937,0.318407186534804,0.960315570696561,1,3,anterograde dendritic transport,BP,KIF17
6937,GO:0030553,0.318439243731753,0.960306836849813,1,3,cGMP binding,MF,PDE2A
11666,GO:0046470,0.318446662279599,0.806525400149487,8,55,phosphatidylcholine metabolic process,BP,SLC27A1;LPCAT4;PLA2G6;PEMT;CHKB;PLB1;MBOAT2;STARD10
9295,GO:0035766,0.318448855933823,0.960304217823806,1,3,cell chemotaxis to fibroblast growth factor,BP,FGFR1
9297,GO:0035768,0.318448855933823,0.960304217823806,1,3,endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
18991,GO:1904847,0.318448855933823,0.960304217823806,1,3,regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
19939,GO:2000544,0.318448855933823,0.960304217823806,1,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
17167,GO:0106017,0.318451636714804,0.960303460128284,1,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,INPP4A
16949,GO:0099010,0.318463879068253,0.960300124281512,1,3,modification of postsynaptic structure,BP,ARHGAP44
13073,GO:0051610,0.31846532162265,0.960299731197312,1,3,serotonin uptake,BP,NOS1
7023,GO:0030805,0.318470698971046,0.960298265894083,1,3,regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7038,GO:0030820,0.318470698971046,0.960298265894083,1,3,regulation of cAMP catabolic process,BP,RAPGEF3
8281,GO:0033121,0.318470698971046,0.960298265894083,1,3,regulation of purine nucleotide catabolic process,BP,RAPGEF3
14663,GO:0070305,0.318483372376087,0.960294812321052,1,3,response to cGMP,BP,PDE2A
15159,GO:0071321,0.318483372376087,0.960294812321052,1,3,cellular response to cGMP,BP,PDE2A
20091,GO:2000807,0.318525014392743,0.960283463384468,1,3,regulation of synaptic vesicle clustering,BP,NLGN2
9142,GO:0035509,0.31854463155286,0.960278116340064,1,3,negative regulation of myosin-light-chain-phosphatase activity,BP,IKBKB
18330,GO:1903347,0.31854463155286,0.960278116340064,1,3,negative regulation of bicellular tight junction assembly,BP,IKBKB
17343,GO:1900086,0.318549022758961,0.960276919371628,1,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,VEGFA
6686,GO:0030070,0.318557679017853,0.960274559759076,1,3,insulin processing,BP,ERO1B
7905,GO:0032487,0.318587091968878,0.960266541450697,1,3,regulation of Rap protein signal transduction,BP,TIMP2
12914,GO:0051295,0.318637304359651,0.960252850754576,1,3,establishment of meiotic spindle localization,BP,SPIRE1
16808,GO:0098735,0.318654174071634,0.960248250502078,1,3,positive regulation of the force of heart contraction,BP,NOS1
8853,GO:0034666,0.318721541318506,0.960229876771027,1,3,integrin alpha2-beta1 complex,CC,ITGA2
3272,GO:0006953,0.318747480565529,0.871745531063515,3,17,acute-phase response,BP,CEBPB;TRPV1;HFE
7853,GO:0032422,0.31875163527495,0.960221667320404,1,3,purine-rich negative regulatory element binding,MF,ELK3
14226,GO:0061303,0.318829230564918,0.960200495146603,1,3,cornea development in camera-type eye,BP,WNT2B
329,GO:0000920,0.318830883026621,0.871694101929167,3,17,cell separation after cytokinesis,BP,CHMP1B;CHMP5;CHMP4C
18359,GO:1903400,0.318841919182277,0.96019703237161,1,3,L-arginine transmembrane transport,BP,SLC25A29
19598,GO:1990785,0.318960881400178,0.960164558394078,1,3,response to water-immersion restraint stress,BP,FOXO4
10795,GO:0044300,0.319020432335156,0.960148296433358,1,3,cerebellar mossy fiber,CC,DLG4
2405,GO:0005577,0.319026530939157,0.96014663082524,1,3,fibrinogen complex,CC,FBLN1
8560,GO:0034040,0.319107160064724,0.960124606073224,1,3,lipid-transporting ATPase activity,MF,ABCG1
6400,GO:0021631,0.319113826549683,0.960122784724233,1,3,optic nerve morphogenesis,BP,EPHB2
17185,GO:0106071,0.319154772502226,0.960111596804513,1,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1
17986,GO:1902498,0.319225769181428,0.960092193514876,1,3,regulation of protein autoubiquitination,BP,MTA1
2541,GO:0005801,0.319478359524503,0.813487112630678,7,47,cis-Golgi network,CC,B3GAT3;AZIN2;ANGEL1;GOLGA2P5;GOLGA8A;GOLGA2;MPPE1
20055,GO:2000741,0.319516183971435,0.960012765170025,1,3,positive regulation of mesenchymal stem cell differentiation,BP,LTBP3
18913,GO:1904694,0.319536260498432,0.96000727077743,1,3,negative regulation of vascular smooth muscle contraction,BP,DOCK4
13863,GO:0060528,0.31954737101247,0.960004229942661,1,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,RXRA
6733,GO:0030158,0.31960190477322,0.959989302614165,1,3,protein xylosyltransferase activity,MF,XYLT2
8952,GO:0035035,0.31965614288613,0.85007410312551,4,24,histone acetyltransferase binding,MF,EGR1;CEBPB;SIRT2;EPAS1
16694,GO:0097720,0.319657729624085,0.850073029604665,4,24,calcineurin-mediated signaling,BP,NFATC4;PRNP;ADGRB2;ATP2B4
16196,GO:0090269,0.319722650280543,0.959956239600313,1,3,fibroblast growth factor production,BP,FGFR1
16197,GO:0090270,0.319722650280543,0.959956239600313,1,3,regulation of fibroblast growth factor production,BP,FGFR1
7088,GO:0030893,0.319728378022598,0.959954670803843,1,3,meiotic cohesin complex,CC,REC8
8547,GO:0033993,0.319951689512484,0.724809279738141,73,584,response to lipid,BP,TNIP1;F2R;TNFRSF6B;NFATC4;FOS;POSTN;PTK6;ACP5;FAM210B;PDCD4;NTSR1;EGFR;NR1D1;LOXL1;CST3;NOS1;ADAMTS13;ZFP36L1;KLF9;HMGCL;CYP27B1;PCK2;ABCA2;DDIT4;PAK1;KDM3A;GLDC;NGFR;PSPH;TNFRSF25;ABCG1;PPARA;AREG;SLIT3;MAPK3;ERRFI1;THRA;PAQR6;PDCD1LG2;TWF2;LITAF;MDK;HDAC5;ENDOG;CEBPB;PTPRU;CREBRF;AQP3;DNMT3A;TGFBR2;CALCOCO1;NOS3;WNT7A;BCR;SRR;TADA3;PTAFR;RXRA;ADCY6;CTSH;TNFRSF14;AKT1;IGFBP7;CRY2;IGFBP2;WNT3;CAT;HDAC8;EIF4EBP1;TGFBR3;PER1;ITGA2;TEAD2
3334,GO:0007050,0.320038755378933,0.750090294361822,28,215,cell cycle arrest,BP,PRNP;DDIT3;CGREF1;RBL2;TFDP2;MAP2K1;PPP2R3B;PKD2;ING4;HMGA2;MAPK12;MLXIPL;PKD1;WHAMMP3;PCBP4;GAS6;ERN1;PPP1R15A;STRADB;CDKN1C;CHEK2;TSG101;UHRF2;FOXO4;PIDD1;TP73;LAMTOR2;EIF2AK4
18440,GO:1903566,0.320074087004784,0.959859915375315,1,3,positive regulation of protein localization to cilium,BP,CROCC
15069,GO:0071107,0.320098755372866,0.959853148927963,1,3,response to parathyroid hormone,BP,ITGA2
14095,GO:0060979,0.320323439970834,0.959791487497606,1,3,vasculogenesis involved in coronary vascular morphogenesis,BP,TGFBR3
19617,GO:1990851,0.320350991762376,0.959783922433544,1,3,Wnt-Frizzled-LRP5/6 complex,CC,LRP5
310,GO:0000822,0.320407000350271,0.959768541203235,1,3,inositol hexakisphosphate binding,MF,ITPR3
2426,GO:0005606,0.320717538776094,0.959683196812638,1,3,laminin-1 complex,CC,LAMB1
2600,GO:0005899,0.320813197130333,0.959656885621661,1,3,insulin receptor complex,CC,INSR
1332,GO:0003190,0.320869449170143,0.959641408517223,1,3,atrioventricular valve formation,BP,ZFPM1
6759,GO:0030201,0.320937382715618,0.849206340106454,4,24,heparan sulfate proteoglycan metabolic process,BP,B3GAT3;VANGL2;SULF2;XYLT2
20182,GO:2001137,0.321175365802971,0.959557177209089,1,3,positive regulation of endocytic recycling,BP,SORL1
4635,GO:0010762,0.321184558192768,0.84903871800229,4,24,regulation of fibroblast migration,BP,PAK1;DMTN;AKT1;BRAF
18173,GO:1902988,0.321204286624308,0.959549208721733,1,3,neurofibrillary tangle assembly,BP,SORL1
2606,GO:0005911,0.321276031114906,0.73887369445958,39,302,cell-cell junction,CC,GJC2;ANK3;SCN4B;NDRG1;COL13A1;OBSL1;PPL;SDCCAG8;ITGA6;PLEKHG5;NPHP4;PRKCZ;PAK1;DLG3;MICALL2;PDZD2;SHROOM4;PKD2;VANGL2;ARHGEF2;FBF1;MAP2K2;KLHL24;SV2A;FRMD4B;FLOT1;PTPRU;WNK4;AQP3;AKT1;FGFR4;ADD3;GJB4;SIRT2;RAB13;MPDZ;CADM4;STARD10;MAGI1
1631,GO:0004075,0.321529748811472,0.959459470443715,1,3,biotin carboxylase activity,MF,ACACB
9054,GO:0035305,0.321566019367123,0.787165800279344,11,78,negative regulation of dephosphorylation,BP,PPP1R35;PHACTR3;PPP1R14A;DLG3;ELFN2;CSRNP3;PPP1R15A;CRY2;FARP1;SFI1;IKBKB
19706,GO:2000107,0.321691421602498,0.833010596779616,5,32,negative regulation of leukocyte apoptotic process,BP,RAG1;GAS6;JAK3;BCL6;ADA
7966,GO:0032589,0.321785590284008,0.848630838978912,4,24,neuron projection membrane,CC,KCNC4;ATF4;TRPV1;INSR
4136,GO:0009201,0.322144253181376,0.772064547316157,15,111,ribonucleoside triphosphate biosynthetic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;MLXIPL;GALK1;ALDOC;TMSB4X;UCKL1;TCIRG1;INSR;TAZ;PFKL
10797,GO:0044302,0.322296002324487,0.959247727030004,1,3,dentate gyrus mossy fiber,CC,MICAL1
16378,GO:0097028,0.322363027908146,0.869508233664861,3,17,dendritic cell differentiation,BP,TGFBR2;GAS6;HLA-G
2429,GO:0005610,0.322635915903851,0.959153586281451,1,3,laminin-5 complex,CC,LAMA5
5835,GO:0017127,0.322694373455321,0.901541122752274,2,10,cholesterol transporter activity,MF,APOE;ABCG1
16326,GO:0090630,0.322716491094058,0.791105025703065,10,70,activation of GTPase activity,BP,EVI5L;TBC1D8;PLEKHG4;TBC1D14;TBC1D3E;RABGAP1;RALGAPA1;EPHA1;SGSM2;TBC1D16
7945,GO:0032553,0.322892302436696,0.707371113513756,177,1433,ribonucleotide binding,MF,ACTA2;ACSF2;PTK6;GLUL;OBSCN;EGFR;SCN8A;NEK9;RAPGEF3;DGKA;DNM1;NOS1;BRSK1;ERCC6;MYH15;SMARCA1;MST1R;CUL9;RPS6KA2;PYGL;TK2;ULK2;MAPK13;CDK18;MAP2K1;PCK2;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TUBG2;TMEM173;DNAH1;ARL2;ULK1;RAB3B;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;RHOBTB2;ABCG1;AGAP1;CARS;KIF17;CHD3;MKNK2;IFT27;NLRX1;SEPT5;ACACB;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;RHOF;TUBE1;MAPK12;MYH3;PI4K2A;SEPT10;MAP2K2;TWF2;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GTPBP1;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;PDE2A;TRIB3;RAB40B;ARL10;MLH3;NOS3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;RAB43;ATP2B4;STRADB;ASNS;AKT1;DGUOK;CHEK2;SEPT6;ASS1;KIF27;FGFR4;MARK4;RAB25;INSR;ACSS1;GNAL;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;APRT;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;RECQL5;RAB13;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;SEPT8;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
11818,GO:0046790,0.323112650290743,0.959021334254271,1,3,virion binding,MF,TSG101
15581,GO:0072093,0.323352806563081,0.958954615423027,1,3,metanephric renal vesicle formation,BP,KIF26B
6714,GO:0030132,0.323399730715634,0.868863771170969,3,17,clathrin coat of coated pit,CC,EGFR;AP2A2;HIP1
3247,GO:0006909,0.323891190364285,0.758743982994542,20,150,phagocytosis,BP,GSN;WIPF1;LRP1;PAK1;ABCA7;PEAR1;ELMO3;SPG11;PLA2G6;MAPK3;TMEM175;ARHGAP25;PIK3R2;GAS6;BCR;ICAM5;FYN;MYO18A;VAV3;ITGA2
10774,GO:0044262,0.324364686818027,0.750107633455992,25,190,cellular carbohydrate metabolic process,BP,ISYNA1;PYGB;NTSR1;NR1D1;IGFBP4;IDH2;PGM1;GAA;PYGL;MLYCD;PCK2;DDIT4;DGKQ;PPARA;PPP1R3E;ACACB;STK40;GALK1;PTAFR;AKT1;INSR;BRAF;TKFC;PHLDA2;FUK
10483,GO:0043402,0.324374090041789,0.958670165377058,1,3,glucocorticoid mediated signaling pathway,BP,CREBRF
7442,GO:0031587,0.32465216808544,0.958592511517201,1,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
358,GO:0000977,0.324662621561468,0.726769868650278,55,433,RNA polymerase II regulatory region sequence-specific DNA binding,MF,ZC3H6;ZMYND8;NFATC4;FOS;EGR1;NR1D1;MEF2D;DDIT3;TCFL5;TFDP2;MXI1;SOX13;ETV4;PHF21A;PBX2;ELK3;KDM3A;FOXQ1;SALL2;ETV1;ETV5;HES2;TEF;CARF;PPARA;SATB1;STAT6;KLF7;HMGA2;THRA;MLXIPL;LITAF;ATF4;ZFPM1;JDP2;DEAF1;RFX2;CEBPB;CREBRF;HLTF;MXD3;BHLHE40;RXRA;ZNF217;SMARCD2;TP73;MNT;TFEB;BCL6;HSF4;POU2F2;PER1;CREB3L4;DBP;SIX5
2973,GO:0006517,0.325067033939352,0.830577599336455,5,32,protein deglycosylation,BP,EDEM1;MAN2C1;MAN2B1;MAN1B1;SYVN1
9186,GO:0035583,0.325112103441572,0.958463882733724,1,3,sequestering of TGFbeta in extracellular matrix,BP,LTBP1
2836,GO:0006307,0.325618199841753,0.900015226418912,2,10,DNA dealkylation involved in DNA repair,BP,MGMT;MPG
7471,GO:0031644,0.326139223737545,0.829802293400785,5,32,regulation of neurological system process,BP,F2R;NTSR1;PTAFR;TENM4;ITGA2
7804,GO:0032366,0.32628372153782,0.867064024639194,3,17,intracellular sterol transport,BP,ABCA2;ABCG1;PCSK9
7805,GO:0032367,0.32628372153782,0.867064024639194,3,17,intracellular cholesterol transport,BP,ABCA2;ABCG1;PCSK9
12534,GO:0050707,0.326512824734496,0.774861514633298,13,95,regulation of cytokine secretion,BP,F2R;POSTN;ALOX15B;PRKCZ;C5;MAPK3;NLRP1;TRPV4;TMSB4X;GAS6;MAPKBP1;IL17RC;CIDEA
4854,GO:0014072,0.326676119269747,0.866818362343814,3,17,response to isoquinoline alkaloid,BP,MAP1LC3A;SRR;ADA
10415,GO:0043278,0.326676119269747,0.866818362343814,3,17,response to morphine,BP,MAP1LC3A;SRR;ADA
11859,GO:0046887,0.326906242525129,0.787584661611438,10,71,positive regulation of hormone secretion,BP,GLUL;EGFR;PCK2;NLGN2;PLA2G6;ANO1;APLN;GLUD1;HFE;FGFR1
2818,GO:0006285,0.326959712058354,0.89931135574373,2,10,base-excision repair, AP site formation,BP,NEIL1;MPG
891,GO:0002265,0.32702806580821,0.957925486527332,1,3,astrocyte activation involved in immune response,BP,LRP1
7097,GO:0030902,0.327045947343819,0.778324912880253,12,86,hindbrain development,BP,PTPRS;SERPINE2;CNTN1;NAGLU;MAP2K1;TRNP1;TTBK2;PAK1;AARS;MDK;WNT7A;B4GALT2
10458,GO:0043368,0.327103938928226,0.866550308971025,3,17,positive T cell selection,BP,STAT6;ZFPM1;BRAF
1965,GO:0004677,0.327731295004244,0.957726835368486,1,3,DNA-dependent protein kinase activity,MF,HMGA2
56,GO:0000118,0.327799015537594,0.799161723054944,8,55,histone deacetylase complex,CC,PHF21A;HDAC11;APPL2;SALL2;CHD3;HDAC5;ZNF217;HDAC8
15690,GO:0072273,0.328113669943985,0.865916765387984,3,17,metanephric nephron morphogenesis,BP,PKD2;KIF26B;PKD1
17635,GO:1901505,0.328143815390924,0.828349508321707,5,32,carbohydrate derivative transmembrane transporter activity,MF,SLC37A2;SLC50A1;SLC29A4;SLC37A4;SLC25A42
7224,GO:0031128,0.328196588441108,0.86586468363945,3,17,developmental induction,BP,WNT2B;WNT3;FGFR1
19670,GO:2000026,0.328329561783937,0.703919851794108,155,1267,regulation of multicellular organismal development,BP,XDH;DUSP6;PTPRS;DLG4;APOE;ZMYND8;NFATC4;SERPINE2;FOS;ADGRL1;EGR1;CTNNBIP1;PGF;PTK6;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;EGFR;ADAMTS7;RAPGEF3;IDH2;NOS1;DDIT3;SHANK2;CRTC1;ADGRB2;ARHGEF19;ZFP36L1;NUPR1;CNTN1;EFNB3;OBSL1;ULK2;ASH2L;SOX13;CUL7;HYAL1;WWTR1;MAP2K1;CYP27B1;BTG1;SYNGAP1;FAM213A;SPRY2;VEGFB;ADM2;NLGN2;LAMA5;CAPRIN2;PRKCZ;PAK1;SEMA3F;PLXNB3;ZSWIM4;FBXW8;ZP3;NEURL1;ACVR2B;RAG1;NGFR;ETV5;WNT2B;PLXNB1;SSH3;LPAR3;C5;IMPACT;STAT6;HMGA2;ECM1;ACACB;ERRFI1;SEMA5A;VANGL2;RGS14;FAM20C;SLITRK6;SDC2;ARHGEF2;INPP5D;TWF2;ANGPTL4;SEMA3B;PTHLH;ZFPM1;KDM4C;SSH1;METRN;FLOT1;HDAC5;SORL1;VLDLR;TPBG;DEAF1;SULF2;CEBPB;ATRAID;L3MBTL1;AQP3;TGFBR2;TRPV4;SMURF2;HMG20B;CDK5RAP3;NOS3;AGO4;WNT7A;EPHA1;SEMA4G;GAS6;NBR1;KIF13B;CAMK1;RXRA;ADCY6;CTSH;AKT1;CARD11;DGUOK;AMIGO2;INSR;WNT3;TENM4;FOXO4;MAP2K5;BRAF;ARHGAP44;LGALS1;TIMP1;JAK3;TP73;CSNK1E;BCL6;FYN;SIRT2;PHLDA2;CELSR1;ADA;PLXND1;AP2A2;TGFBR3;EPHB2;FGFR1;CTH;ERBB2;UST;EIF2AK4;HLA-G;KCTD11;IKBKB
562,GO:0001704,0.328369864030198,0.781558333494942,11,78,formation of primary germ layer,BP,DUSP6;DUSP5;COL6A1;ITGB4;HMGA2;COL8A1;ITGB5;LAMB1;WNT3;ITGA2;FGFR1
16229,GO:0090311,0.328644529807104,0.827985964375537,5,32,regulation of protein deacetylation,BP,VEGFA;JDP2;TADA3;C6ORF89;BCL6
4233,GO:0009435,0.328734718705021,0.827920454567981,5,32,NAD biosynthetic process,BP,NAPRT;NMRK1;NMNAT2;ALDOC;PFKL
17698,GO:1901655,0.328934585486826,0.791610978728715,9,63,cellular response to ketone,BP,EGFR;KLF9;PCK2;DDIT4;ERRFI1;ADCY6;AKT1;HDAC8;EIF4EBP1
12715,GO:0051004,0.328943268123003,0.898266276961913,2,10,regulation of lipoprotein lipase activity,BP,LMF1;ANGPTL4
877,GO:0002237,0.328965295095682,0.743278414550548,27,209,response to molecule of bacterial origin,BP,TNIP1;F2R;TNFRSF6B;FOS;ACP5;PDCD4;NR1D1;LOXL1;NOS1;ADAMTS13;CYP27B1;PCK2;NGFR;TNFRSF25;MAPK3;PDCD1LG2;LITAF;HDAC5;IRF5;CEBPB;NOS3;BCR;SRR;PTAFR;TNFRSF14;AKT1;SIRT2
11023,GO:0045019,0.329158253916304,0.898152696005873,2,10,negative regulation of nitric oxide biosynthetic process,BP,ACP5;ATP2B4
18798,GO:1904406,0.329158253916304,0.898152696005873,2,10,negative regulation of nitric oxide metabolic process,BP,ACP5;ATP2B4
10546,GO:0043522,0.329178847245366,0.89814181297569,2,10,leucine zipper domain binding,MF,DDIT3;ATF4
12559,GO:0050750,0.329285043424489,0.865180234988862,3,17,low-density lipoprotein particle receptor binding,MF,APOE;PCSK9;SNX17
8583,GO:0034101,0.329312282514422,0.776350284828891,12,87,erythrocyte homeostasis,BP,FAM210B;VEGFA;ZFP36L1;THRA;INPP5D;DMTN;ZFPM1;DNASE2;JAK3;BCL6;TGFBR3;EPAS1
18919,GO:1904707,0.329650632316205,0.864950017288463,3,17,positive regulation of vascular smooth muscle cell proliferation,BP,MEF2D;PAK1;ERN1
1260,GO:0003016,0.329677104456884,0.86493334095514,3,17,respiratory system process,BP,GAA;NLGN2;STK40
15271,GO:0071482,0.329840518134758,0.775908487357008,12,87,cellular response to light stimulus,BP,NFATC4;XPC;DDB2;ERCC1;MAPK13;HYAL1;MC1R;IMPACT;ATF4;CRY2;TP73;EIF2AK4
18412,GO:1903523,0.330119531666895,0.864654503221944,3,17,negative regulation of blood circulation,BP,DOCK4;F2R;APLN
18894,GO:1904646,0.330219862181376,0.864591236973266,3,17,cellular response to amyloid-beta,BP,LRP1;PRNP;NGFR
7744,GO:0032269,0.330220178867469,0.708360231074798,104,849,negative regulation of cellular protein metabolic process,BP,TNIP1;XDH;DUSP6;TNFRSF6B;APOE;SERPINE2;PPP1R35;PTK6;PDCD4;TIMP2;VEGFA;EGFR;PRNP;FBLN1;PRDX5;TFPI2;DUSP5;CRTAP;CST3;ZFP36L1;ADARB1;RPL13A;PLAT;PHACTR3;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;DGKQ;SPRY2;GRB7;UNK;CIRBP;CAPRIN2;PRKCZ;SERPING1;STK39;KDM3A;PHF1;SPRY4;RAG1;NGFR;ELFN2;TRIB2;C5;CHAC1;SESN2;IMPACT;ECM1;ERRFI1;RGS14;SNTA1;MLXIPL;MAP2K2;DMTN;ATF4;KDM4C;IFI6;SORL1;HERPUD1;PAPLN;LRP5;ATRAID;PKIB;TRIB3;HMG20B;CDK5RAP3;AGO4;PIK3R2;EPHA1;GAS6;PPP1R15A;ATP2B4;PAIP2B;HINT2;AKT1;CDKN1C;MICAL1;CRY2;HMSD;TSG101;IGF2BP2;PIAS3;C9ORF72;NCOA7;CTDSPL;MAP2K5;TIMP1;HFE;TP73;FYN;ZC3H12D;LEMD2;SIRT2;HDAC8;PAIP2;EIF4EBP1;EPHB2;PER1;IGF2BP3;FKBP8;EIF2AK4;IKBKB
19251,GO:1905475,0.330230583814232,0.759749078569991,17,127,regulation of protein localization to membrane,BP,ZMYND8;GSN;LRP1;EGFR;PRNP;ANK3;TFDP2;PAK1;CEMIP;DMTN;BBC3;SSH1;AKT1;TP73;FYN;EPHB2;ERBB2
290,GO:0000795,0.330432537020528,0.864457087996627,3,17,synaptonemal complex,CC,MLH3;REC8;MSH5
16974,GO:0099086,0.330432537020528,0.864457087996627,3,17,synaptonemal structure,CC,MLH3;REC8;MSH5
905,GO:0002287,0.330461313684408,0.826664666540351,5,32,alpha-beta T cell activation involved in immune response,BP,PRKCZ;STAT6;ZFPM1;JAK3;BCL6
908,GO:0002293,0.330461313684408,0.826664666540351,5,32,alpha-beta T cell differentiation involved in immune response,BP,PRKCZ;STAT6;ZFPM1;JAK3;BCL6
909,GO:0002294,0.330461313684408,0.826664666540351,5,32,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,PRKCZ;STAT6;ZFPM1;JAK3;BCL6
9833,GO:0042093,0.330461313684408,0.826664666540351,5,32,T-helper cell differentiation,BP,PRKCZ;STAT6;ZFPM1;JAK3;BCL6
3350,GO:0007084,0.330746098189481,0.897311922709404,2,10,mitotic nuclear envelope reassembly,BP,REEP4;LMNA
17735,GO:1901739,0.330822871409861,0.897271186585632,2,10,regulation of myoblast fusion,BP,FLOT1;GDF15
645,GO:0001836,0.330883956962078,0.804306612465466,7,49,release of cytochrome c from mitochondria,BP,PLA2G6;BNIP3;BBC3;IFI6;AKT1;LMNA;CIDEB
8496,GO:0033687,0.330911914858068,0.864154507179135,3,17,osteoblast proliferation,BP,PLXNB1;LRP5;ATRAID
12979,GO:0051428,0.330915661472669,0.897221941498066,2,10,peptide hormone receptor binding,MF,PTHLH;FYN
16369,GO:0097014,0.331007087457261,0.789938094024732,9,63,ciliary plasm,CC,IFT140;BBS1;DNAH1;KIF17;SPAG16;SPATA7;IFT57;WDR66;TCTEX1D4
17367,GO:1900121,0.331016205676111,0.897168568352768,2,10,negative regulation of receptor binding,BP,PCSK9;HFE
11498,GO:0046033,0.331242863041907,0.897048200060253,2,10,AMP metabolic process,BP,NT5E;APRT
11448,GO:0045923,0.331322642525182,0.863895033710948,3,17,positive regulation of fatty acid metabolic process,BP,MLYCD;PPARA;MLXIPL
2993,GO:0006541,0.331480945957508,0.863794971689195,3,17,glutamine metabolic process,BP,GLUL;GLUD1;ASNS
10104,GO:0042641,0.331528161138586,0.796203852830019,8,55,actomyosin,CC,MST1R;MICALL2;SHROOM4;VANGL2;MYO18A;STX1A;LURAP1;CORO1B
8044,GO:0032715,0.331632844643122,0.863698929132393,3,17,negative regulation of interleukin-6 production,BP,NLRX1;INPP5D;GAS6
15017,GO:0070988,0.331849742713609,0.795948203815348,8,55,demethylation,BP,CYP3A5;APOBEC3C;KDM3A;APOBEC3F;KDM4C;KDM7A;PHF2;HSF4
13999,GO:0060749,0.33192405380328,0.896686040062666,2,10,mammary gland alveolus development,BP,VEGFA;AREG
14262,GO:0061377,0.33192405380328,0.896686040062666,2,10,mammary gland lobule development,BP,VEGFA;AREG
11857,GO:0046885,0.33202354384415,0.86345176761265,3,17,regulation of hormone biosynthetic process,BP,EGR1;CYP27B1;DGKQ
13795,GO:0060415,0.332413965866392,0.804360520638915,7,43,muscle tissue morphogenesis,BP,ADARB1;VANGL2;ZFPM1;TTN;RXRA;TGFBR3;TNNI1
19022,GO:1904896,0.332665015211055,0.89629140718012,2,10,ESCRT complex disassembly,BP,CHMP1B;CHMP5
19024,GO:1904903,0.332665015211055,0.89629140718012,2,10,ESCRT III complex disassembly,BP,CHMP1B;CHMP5
774,GO:0002031,0.332794705121473,0.896222260345628,2,10,G-protein coupled receptor internalization,BP,DNM1;APLN
8946,GO:0035024,0.333043055315809,0.862805928705535,3,17,negative regulation of Rho protein signal transduction,BP,ARAP3;BCL6;KCTD13
5280,GO:0015937,0.333189174475768,0.89601180438286,2,10,coenzyme A biosynthetic process,BP,PPCS;ACOT7
12948,GO:0051354,0.333456797925554,0.89586890578659,2,10,negative regulation of oxidoreductase activity,BP,CYP27B1;ATP2B4
17314,GO:1900024,0.333518199281832,0.812169355773003,6,40,regulation of substrate adhesion-dependent cell spreading,BP,POSTN;FBLN1;DMTN;TRIOBP;BRAF;NET1
9618,GO:0036500,0.333548404571997,0.895819970317259,2,10,ATF6-mediated unfolded protein response,BP,DDIT3;WFS1
15792,GO:0072520,0.333680061587266,0.895749620870606,2,10,seminiferous tubule development,BP,TBC1D20;REC8
8346,GO:0033234,0.333713991570203,0.895731487053061,2,10,negative regulation of protein sumoylation,BP,HMG20B;PIAS3
12641,GO:0050869,0.333760922235655,0.862350409624456,3,17,negative regulation of B cell activation,BP,PKN1;INPP5D;BCL6
8901,GO:0034754,0.333901395212578,0.787468001949161,9,64,cellular hormone metabolic process,BP,EGR1;HSD17B14;DGKQ;DHRS4;SRD5A3;HSD17B7;PNPLA4;PLB1;RETSAT
5542,GO:0016540,0.333950755479709,0.895604906663583,2,10,protein autoprocessing,BP,PCSK9;CAPN2
2723,GO:0006105,0.333996052218641,0.895580681358602,2,10,succinate metabolic process,BP,SDHA;SUCLG2
52,GO:0000109,0.334014438333812,0.895570847443113,2,10,nucleotide-excision repair complex,CC,XPC;ERCC1
10775,GO:0044264,0.334207657439773,0.781604174072503,10,71,cellular polysaccharide metabolic process,BP,PYGB;NR1D1;PGM1;GAA;PYGL;PPP1R3E;STK40;AKT1;INSR;PHLDA2
3713,GO:0008235,0.33440686390749,0.823783183917471,5,32,metalloexopeptidase activity,MF,NPEPL1;RNPEPL1;LTA4H;RNPEP;MMP17
2293,GO:0005253,0.334438199598733,0.81147035533716,6,40,anion channel activity,MF,CLCA2;ANO8;ANO1;LRRC8A;ANO9;TTYH3
189,GO:0000407,0.33475082557017,0.823531206614486,5,32,phagophore assembly site,CC,ULK2;ULK1;NBR1;WDR45;ATG2A
9190,GO:0035587,0.334767226296402,0.895167830885122,2,10,purinergic receptor signaling pathway,BP,PTAFR;ADA
6059,GO:0019211,0.335208838691308,0.89493105815592,2,10,phosphatase activator activity,MF,B3GAT3;PPP1R15A
2439,GO:0005640,0.33544129505598,0.86128166229051,3,17,nuclear outer membrane,CC,ITPR3;SYNE3;RETSAT
3289,GO:0006983,0.335444683724748,0.894804502957294,2,10,ER overload response,BP,DDIT3;WFS1
18370,GO:1903426,0.335521901964115,0.800871528487859,7,48,regulation of reactive oxygen species biosynthetic process,BP,ACP5;PKD2;TRPV1;ATP2B4;AKT1;ASS1;INSR
8660,GO:0034244,0.335775775298092,0.894626713967778,2,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,EAPP;RECQL5
11231,GO:0045454,0.3359467052428,0.792377923204985,8,57,cell redox homeostasis,BP,PRDX5;NOS1;DDIT3;TXNRD3;ERO1B;NOS3;TXNRD2;TMX4
12324,GO:0048708,0.335955970459938,0.810315350888,6,40,astrocyte differentiation,BP,SERPINE2;LRP1;EGFR;MAP2K1;MAPK3;LAMB2
7617,GO:0032025,0.336129936199161,0.894436376642001,2,10,response to cobalt ion,BP,D2HGDH;BNIP3
11772,GO:0046658,0.33626608899452,0.838195544015984,4,25,anchored component of plasma membrane,CC,PRNP;PRSS8;PRSS22;ULBP1
9753,GO:0039532,0.336287556218752,0.894351613237805,2,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,NLRX1;TKFC
2612,GO:0005922,0.336501212988918,0.894236662402826,2,10,connexin complex,CC,GJC2;GJB4
6456,GO:0021783,0.336586038633313,0.894191008055293,2,10,preganglionic parasympathetic fiber development,BP,ADARB1;SEMA3F
11674,GO:0046479,0.337028597843976,0.893952661935597,2,10,glycosphingolipid catabolic process,BP,HEXB;NAGA
13877,GO:0060547,0.337243765303619,0.893836686913812,2,10,negative regulation of necrotic cell death,BP,RBCK1;ARHGEF2
14121,GO:0061025,0.337411046178657,0.741449291374795,23,176,membrane fusion,BP,SYTL1;EVI5L;CD9;DNM1;TBC1D8;SYT8;VPS11;SPG11;VAMP2;BNIP3;DYSF;TBC1D14;TBC1D3E;RABGAP1;TSNARE1;TMEM175;GAS6;VPS39;SGSM2;RAB13;VAV3;STX1A;TBC1D16
4799,GO:0010998,0.337411642742941,0.893746158558441,2,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,IMPACT;EIF2AK4
199,GO:0000421,0.337665823999433,0.837218831942032,4,25,autophagosome membrane,CC,ATG16L2;ULK1;TECPR1;MAP1LC3A
6243,GO:0019825,0.337746893781285,0.893565261777441,2,10,oxygen binding,MF,CYP3A5;CBS
10634,GO:0043687,0.337764638229993,0.722975065472929,40,317,post-translational protein modification,BP,APOE;FBXO2;DDB2;IGFBP4;CRTAP;CST3;CUL9;OBSL1;FBXW4;CUL7;LY6K;FBXO41;FBXW8;LTBP1;ANO8;LAMB2;FBXO27;DCAF10;FAM20C;MXRA8;SDC2;FBXO17;FBXO6;PCSK9;FBXL15;FBXL16;LMO7;GAS6;FBXL8;IGFBP7;LAMB1;SPSB3;ARSA;RABGGTA;LGALS1;TIMP1;RAB13;EPAS1;WFS1;NTM
13451,GO:0055012,0.337789413349035,0.89354230816716,2,10,ventricular cardiac muscle cell differentiation,BP,RXRA;LMNA
17894,GO:1902235,0.338084726520569,0.836926096725459,4,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,DDIT3;HERPUD1;WFS1;SYVN1
13700,GO:0060294,0.338338742985413,0.893245544522904,2,10,cilium movement involved in cell motility,BP,BBS2;SPAG16
7018,GO:0030800,0.338357209707846,0.893235561317545,2,10,negative regulation of cyclic nucleotide metabolic process,BP,LTB4R2;GABBR1
7033,GO:0030815,0.338357209707846,0.893235561317545,2,10,negative regulation of cAMP metabolic process,BP,LTB4R2;GABBR1
17499,GO:1901017,0.338398681971363,0.893213139550065,2,10,negative regulation of potassium ion transmembrane transporter activity,BP,ANK3;STK39
17617,GO:1901380,0.338398681971363,0.893213139550065,2,10,negative regulation of potassium ion transmembrane transport,BP,ANK3;STK39
19040,GO:1904948,0.338447302735392,0.893186850077638,2,10,midbrain dopaminergic neuron differentiation,BP,WNT3;CSNK1E
509,GO:0001573,0.338492112611516,0.893162618393831,2,10,ganglioside metabolic process,BP,ST6GALNAC6;HEXB
7129,GO:0030970,0.33852869060747,0.836615630914094,4,25,retrograde protein transport, ER to cytosol,BP,TMEM129;EDEM1;HERPUD1;SYVN1
18403,GO:1903513,0.33852869060747,0.836615630914094,4,25,endoplasmic reticulum to cytosol transport,BP,TMEM129;EDEM1;HERPUD1;SYVN1
11766,GO:0046649,0.338596485048843,0.716692066909619,49,389,lymphocyte activation,BP,IL20RB;GSN;EGR1;PRNP;ERCC1;ZFP36L1;EFNB3;SOX13;PKN1;PRKCZ;PAK1;ZP3;CCDC88B;RAG1;SATB1;STAT6;INPP5D;PDCD1LG2;LRRC8A;ZFPM1;DOCK11;POLM;HDAC5;CEBPB;TGFBR2;CMTM7;GAS6;KIF13B;TNFRSF14;AKT1;CARD11;IGFBP2;ULBP1;BRAF;LGALS1;HFE;JAK3;BCL6;FYN;ADA;POU2F2;TCF7;VAV3;MFNG;DHPS;ERBB2;EIF2AK4;PAG1;HLA-G
4410,GO:0010181,0.338791280056831,0.893000770388627,2,10,FMN binding,MF,NOS1;NOS3
15829,GO:0072574,0.338838665295213,0.89297512433387,2,10,hepatocyte proliferation,BP,SULF2;CEBPB
15830,GO:0072575,0.338838665295213,0.89297512433387,2,10,epithelial cell proliferation involved in liver morphogenesis,BP,SULF2;CEBPB
3290,GO:0006984,0.338890321222414,0.808075893882526,6,40,ER-nucleus signaling pathway,BP,DDIT3;ATF4;HERPUD1;PPP1R15A;ASNS;WFS1
432,GO:0001161,0.338985002018054,0.892895904500587,2,10,intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6;BCL6
10750,GO:0044213,0.338985002018054,0.892895904500587,2,10,intronic transcription regulatory region DNA binding,MF,ZC3H6;BCL6
12580,GO:0050780,0.339065623742637,0.892852247544738,2,10,dopamine receptor binding,MF,DLG4;DNM1
5000,GO:0015149,0.339484212947134,0.892625441328706,2,10,hexose transmembrane transporter activity,MF,SLC2A3;SLC2A9
10253,GO:0043010,0.33972561622866,0.736367330928894,25,191,camera-type eye development,BP,VEGFA;EGFR;IFT140;SDK2;MYH15;RAB11FIP4;NPHP4;ACVR2B;WNT2B;COL8A1;LAMB2;SLITRK6;LRP5;TGFBR2;WNT7A;RXRA;ATP2B4;WDR19;MAB21L2;TBC1D20;HSF4;EPHB2;FKBP8;SDHAF4;SIX5
10461,GO:0043371,0.339830072768369,0.892437866967578,2,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,JAK3;BCL6
13551,GO:0060044,0.339950980085141,0.892372256371432,2,10,negative regulation of cardiac muscle cell proliferation,BP,TGFBR2;TP73
16835,GO:0098792,0.339960353373324,0.892367169127377,2,10,xenophagy,BP,MAPK3;LRSAM1
19274,GO:1905564,0.339980849105249,0.892356044898573,2,10,positive regulation of vascular endothelial cell proliferation,BP,APLN;FGFR1
8448,GO:0033598,0.340207112932547,0.835439883705735,4,25,mammary gland epithelial cell proliferation,BP,STAT6;AREG;DEAF1;CEBPB
9811,GO:0042043,0.34039495198174,0.892131167629187,2,10,neurexin family protein binding,MF,SYTL1;NLGN2
5133,GO:0015645,0.340433168308176,0.892110402894117,2,10,fatty acid ligase activity,MF,SLC27A1;SLC27A3
2511,GO:0005765,0.340452556272785,0.722028720485276,38,298,lysosomal membrane,CC,LRP1;TSPAN1;GAA;SYNGR1;COL6A1;ABCA2;VPS11;CD68;CYBRD1;BRI3;TMEM44;SPPL2B;SPG11;MARCH9;PI4K2A;PQLC2;TECPR1;SLC48A1;LITAF;FLOT1;VLDLR;TMEM175;ATRAID;PCSK9;DIRC2;MARCH2;VPS39;TMEM9;C12ORF66;TCIRG1;TPCN1;HGSNAT;UBXN6;TOM1;AP2A2;LAMTOR2;BLOC1S1;TMEM8A
16874,GO:0098852,0.340452556272785,0.722028720485276,38,298,lytic vacuole membrane,CC,LRP1;TSPAN1;GAA;SYNGR1;COL6A1;ABCA2;VPS11;CD68;CYBRD1;BRI3;TMEM44;SPPL2B;SPG11;MARCH9;PI4K2A;PQLC2;TECPR1;SLC48A1;LITAF;FLOT1;VLDLR;TMEM175;ATRAID;PCSK9;DIRC2;MARCH2;VPS39;TMEM9;C12ORF66;TCIRG1;TPCN1;HGSNAT;UBXN6;TOM1;AP2A2;LAMTOR2;BLOC1S1;TMEM8A
2319,GO:0005328,0.340533766256113,0.892055734003628,2,10,neurotransmitter:sodium symporter activity,MF,SLC6A9;SLC6A6
14611,GO:0070208,0.340598488912656,0.892020554054026,2,10,protein heterotrimerization,BP,COL6A1;C1QTNF6
7797,GO:0032355,0.340694968646264,0.771117295145675,11,80,response to estradiol,BP,POSTN;FAM210B;EGFR;CST3;AREG;ENDOG;DNMT3A;WNT7A;IGFBP2;CAT;ITGA2
19996,GO:2000647,0.340718733325397,0.891955180523715,2,10,negative regulation of stem cell proliferation,BP,FBLN1;KCTD11
148,GO:0000303,0.340723799435227,0.857143881097714,3,18,response to superoxide,BP,ERCC6;NOS3;CCS
7577,GO:0031953,0.340841490755552,0.891888420920407,2,10,negative regulation of protein autophosphorylation,BP,IMPACT;ERRFI1
2248,GO:0005161,0.340897069143608,0.891858188946374,2,10,platelet-derived growth factor receptor binding,MF,VEGFA;ERN1
8566,GO:0034058,0.341005640852256,0.891799119309985,2,10,endosomal vesicle fusion,BP,VPS11;VPS39
13518,GO:0060004,0.341095911523479,0.89174999462914,2,10,reflex,BP,SATB1;SLITRK6
14093,GO:0060977,0.341186700412246,0.891700577014928,2,10,coronary vasculature morphogenesis,BP,VEGFA;TGFBR3
14500,GO:0070016,0.341307787335568,0.891634650723895,2,10,armadillo repeat domain binding,MF,CTNNBIP1;CALCOCO1
12142,GO:0048278,0.341484052725975,0.788088774330392,8,56,vesicle docking,BP,SNPH;EXOC2;VPS11;RAB3B;TSNARE1;RAB40B;RAB13;STX1A
11729,GO:0046596,0.341489407143383,0.856648721173298,3,18,regulation of viral entry into host cell,BP,GSN;IFITM1;LGALS1
7085,GO:0030889,0.34191026217913,0.891306340984,2,10,negative regulation of B cell proliferation,BP,PKN1;INPP5D
15114,GO:0071236,0.341976168217731,0.758173461770972,14,104,cellular response to antibiotic,BP,EGR1;CST3;MAPK13;IMPACT;STAT6;BNIP3;ENDOG;DNMT3A;MAP1LC3A;ADCY6;ITPR2;ANKZF1;HDAC8;NET1
11324,GO:0045668,0.342059770752224,0.834138373195307,4,25,negative regulation of osteoblast differentiation,BP,AREG;LRP5;NBR1;HDAC8
12725,GO:0051017,0.342079992248333,0.754968355549569,15,111,actin filament bundle assembly,BP,ESPN;RAPGEF3;ARAP1;PAK1;RHOBTB2;ITGB5;RHOF;DMTN;TRIOBP;EPHA1;ASAP3;BRAF;SPIRE1;CORO1B;KCTD13
11393,GO:0045821,0.342146785661634,0.891177319085167,2,10,positive regulation of glycolytic process,BP,MLXIPL;INSR
12850,GO:0051197,0.342146785661634,0.891177319085167,2,10,positive regulation of coenzyme metabolic process,BP,MLXIPL;INSR
3209,GO:0006853,0.342155401850817,0.891172617609928,2,10,carnitine shuttle,BP,CPT2;ACACB
100,GO:0000212,0.342385951783857,0.891046779986391,2,10,meiotic spindle organization,BP,TUBG2;GOLGA2
10270,GO:0043034,0.342388829589993,0.856826059503649,3,17,costamere,CC,FLNC;ANK3;KRT19
15579,GO:0072091,0.342484079723118,0.805321602194563,6,40,regulation of stem cell proliferation,BP,VEGFA;FBLN1;ZFP36L1;HMGA2;LTBP3;KCTD11
16639,GO:0097546,0.342587334283642,0.833767042319635,4,25,ciliary base,CC,NPHP4;WDR60;NEK8;CEP126
3152,GO:0006754,0.34265449688618,0.761111953217429,13,96,ATP biosynthetic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;PPARA;MLXIPL;GALK1;ALDOC;TMSB4X;TCIRG1;INSR;TAZ;PFKL
9578,GO:0036445,0.342703553856094,0.890873312194562,2,10,neuronal stem cell division,BP,ARHGEF2;FGFR1
13470,GO:0055057,0.342703553856094,0.890873312194562,2,10,neuroblast division,BP,ARHGEF2;FGFR1
885,GO:0002252,0.342731821133166,0.698719910334699,92,749,immune effector process,BP,HTRA1;IL20RB;GSN;PYGB;WIPF1;SLC2A3;NAPRT;LRP1;TIMP2;ERCC1;CST3;PGM1;ADARB1;GAA;PYGL;PRSS3;SYNGR1;PKN1;DDIT4;DNASE1L1;TMEM173;CD68;PRKCZ;SERPING1;PAK1;APOBEC3C;BRI3;ZP3;ACTR1B;TMC6;PLA2G6;SCART1;S100A13;C5;APOBEC3F;NLRX1;STAT6;VAMP2;KCNAB2;MAPK3;BNIP3;IFITM1;RHOF;CTSB;LTA4H;PI4K2A;C1RL;INPP5D;ZFPM1;DOCK11;FUCA1;IRF5;ALDOC;ISG20;HEXB;BNIP3L;PIK3R2;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;ULBP1;LYST;BTN3A2;CAT;DPP7;YPEL5;LGALS1;HFE;JAK3;APRT;METTL7A;HGSNAT;BTN3A3;BCL6;TKFC;FYN;TOM1;ADA;POU2F2;AP2A2;MYO18A;VAV3;GALNS;LAMTOR2;MFNG;EIF2AK4;PFKL
14945,GO:0070875,0.342836587577079,0.890800611998713,2,10,positive regulation of glycogen metabolic process,BP,AKT1;INSR
4154,GO:0009220,0.342939382420007,0.85570896513941,3,18,pyrimidine ribonucleotide biosynthetic process,BP,NME4;UCKL1;UPP1
11558,GO:0046132,0.342939382420007,0.85570896513941,3,18,pyrimidine ribonucleoside biosynthetic process,BP,NME4;UCKL1;UPP1
7313,GO:0031331,0.342972836105331,0.721343343818786,36,281,positive regulation of cellular catabolic process,BP,APOE;EDEM1;LRP1;RAPGEF3;GPSM1;TRIM65;ZFP36L1;EPM2A;SNX9;MAGEF1;ULK1;VPS11;TRIB2;PPARA;SESN2;MAPK3;BNIP3;MLXIPL;LRSAM1;GTPBP1;HERPUD1;ENDOG;PCSK9;TRIB3;BNIP3L;FYCO1;AKT1;C9ORF72;INSR;TPCN1;SNX33;TFEB;CSNK1E;ZC3H12D;SIRT2;EIF2AK4
10576,GO:0043560,0.343096720108497,0.890658386859586,2,10,insulin receptor substrate binding,MF,PRKCZ;INSR
18124,GO:1902894,0.34313672643442,0.890636505767247,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4;PPARA
2165,GO:0005001,0.343377745104807,0.890504637740115,2,10,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRE;PTPRU
6047,GO:0019198,0.343377745104807,0.890504637740115,2,10,transmembrane receptor protein phosphatase activity,MF,PTPRE;PTPRU
12551,GO:0050729,0.343529372563659,0.779495713494396,9,65,positive regulation of inflammatory response,BP,TNIP1;PDCD4;EGFR;MAPK13;ZP3;TRPV4;PDE2A;IL17RC;ITGA2
13710,GO:0060307,0.343695249907948,0.890330803972272,2,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
14274,GO:0061430,0.343841769549476,0.890250539252996,2,10,bone trabecula morphogenesis,BP,THBS3;PLXNB1
7947,GO:0032555,0.343985459523716,0.687249586963703,175,1422,purine ribonucleotide binding,MF,ACTA2;ACSF2;PTK6;GLUL;OBSCN;EGFR;SCN8A;NEK9;RAPGEF3;DGKA;DNM1;BRSK1;ERCC6;MYH15;SMARCA1;MST1R;CUL9;RPS6KA2;PYGL;TK2;ULK2;MAPK13;CDK18;MAP2K1;PCK2;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TUBG2;TMEM173;DNAH1;ARL2;ULK1;RAB3B;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;RHOBTB2;ABCG1;AGAP1;CARS;KIF17;CHD3;MKNK2;IFT27;NLRX1;SEPT5;ACACB;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;RHOF;TUBE1;MAPK12;MYH3;PI4K2A;SEPT10;MAP2K2;TWF2;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GTPBP1;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;PDE2A;TRIB3;RAB40B;ARL10;MLH3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;RAB43;ATP2B4;STRADB;ASNS;AKT1;DGUOK;CHEK2;SEPT6;ASS1;KIF27;FGFR4;MARK4;RAB25;INSR;ACSS1;GNAL;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;APRT;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;RECQL5;RAB13;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;SEPT8;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
10256,GO:0043015,0.344309082268249,0.832552975713851,4,25,gamma-tubulin binding,MF,BRSK1;NDRG1;MARK4;TUBGCP6
1481,GO:0003785,0.344425854188087,0.854742865554665,3,18,actin monomer binding,MF,TWF2;TMSB4X;NOS3
4183,GO:0009264,0.344455515660526,0.854723560015079,3,18,deoxyribonucleotide catabolic process,BP,NEIL1;ADA;NUDT18
3249,GO:0006911,0.34486206497348,0.8321623339647,4,25,phagocytosis, engulfment,BP,GSN;ABCA7;ARHGAP25;ITGA2
3738,GO:0008277,0.344863247170582,0.767622206849972,11,80,regulation of G-protein coupled receptor protein signaling pathway,BP,DNM1;NOS1;DGKQ;USP20;RGS14;APLN;ATP2B4;TMOD2;HOMER2;ADA;RGS12
9847,GO:0042113,0.345078500465275,0.742097645476949,19,144,B cell activation,BP,ERCC1;ZFP36L1;PKN1;RAG1;STAT6;INPP5D;LRRC8A;DOCK11;POLM;HDAC5;CMTM7;CARD11;LGALS1;JAK3;BCL6;ADA;POU2F2;VAV3;MFNG
8956,GO:0035051,0.345173189533484,0.763347383626682,12,83,cardiocyte differentiation,BP,PDCD4;VEGFA;EGFR;OBSL1;MYH11;PAK1;MAPK3;TTN;RXRA;LMNA;TENM4;TGFBR3
3775,GO:0008333,0.345361137200631,0.793129522472025,7,48,endosome to lysosome transport,BP,VPS11;HOOK2;VPS39;TSG101;CHMP5;LYST;UBXN6
2864,GO:0006359,0.345446273966608,0.831749256139427,4,25,regulation of transcription by RNA polymerase III,BP,PRDX5;ZNF76;NAB2;ERBB2
2247,GO:0005160,0.345674200340138,0.831587990734781,4,25,transforming growth factor beta receptor binding,MF,TGFBR2;SMURF2;GDF15;TGFBR3
2742,GO:0006140,0.345896862401352,0.748704201186565,16,120,regulation of nucleotide metabolic process,BP,APOE;TIMP2;VEGFA;RAPGEF3;NOS1;DDIT4;PPARA;PKD2;MLXIPL;PTHLH;LTB4R2;GABBR1;TMSB4X;NOS3;INSR;TAZ
9767,GO:0039694,0.346106058503574,0.831282275175334,4,25,viral RNA genome replication,BP,ATG16L2;APOBEC3C;APOBEC3F;HMGA2
15426,GO:0071774,0.346182848904575,0.751357646546045,15,112,response to fibroblast growth factor,BP,DUSP6;FGFBP1;POSTN;ZFP36L1;HYAL1;SPRY2;FGFR3;SPRY4;MAPK3;FAM20C;SULF2;APLN;FGFR4;FGFR1;FRS3
10416,GO:0043279,0.34629278741772,0.777355822889827,9,64,response to alkaloid,BP,HDAC5;GSTM2;DNMT3A;MAP1LC3A;TRPV1;SRR;HOMER2;RECQL5;ADA
8135,GO:0032872,0.347196112942302,0.736204004870548,21,160,regulation of stress-activated MAPK cascade,BP,XDH;PDCD4;VEGFA;EGFR;ERCC6;MAP2K1;PKN1;PAK1;MAPK3;VANGL2;MAP2K2;TRPV4;MINK1;WNT7A;ERN1;NBR1;AKT1;EDA2R;TP73;MAP3K10;PER1
7416,GO:0031526,0.347363922494804,0.830390617677607,4,25,brush border membrane,CC,SHANK2;CYBRD1;PEMT;PLB1
12304,GO:0048678,0.347523015924528,0.791224982723726,7,49,response to axon injury,BP,PTPRS;CST3;MAP2K1;LAMB2;MORN4;BRAF;LGALS1
11667,GO:0046471,0.34767276768336,0.83017141304216,4,25,phosphatidylglycerol metabolic process,BP,SLC27A1;LPCAT4;PLA2G6;TAZ
8047,GO:0032722,0.347845006478545,0.813508601200442,5,33,positive regulation of chemokine production,BP,EGR1;POSTN;ALOX15B;C5;TRPV4
15160,GO:0071322,0.348116066549099,0.760329591521668,12,89,cellular response to carbohydrate stimulus,BP,NR1D1;ZFP36L1;MAPK13;PCK2;PLA2G6;ANO1;MLXIPL;ENDOG;LRP5;GAS6;ERN1;LGALS1
8183,GO:0032934,0.349046653525077,0.812609558500797,5,33,sterol binding,MF,APOE;OSBPL5;ABCG1;OSBPL10;PROM2
4141,GO:0009206,0.34905111292142,0.75201455809803,14,105,purine ribonucleoside triphosphate biosynthetic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;MLXIPL;GALK1;ALDOC;TMSB4X;TCIRG1;INSR;TAZ;PFKL
12198,GO:0048469,0.349901874267974,0.758891067868754,12,88,cell maturation,BP,FAM210B;VEGFA;PABPC1L;NPR2;EREG;FAM20C;CABYR;REC8;SIRT2;POU2F2;EPAS1;FGFR1
15309,GO:0071556,0.35032956935493,0.850878964374903,3,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,SPPL2B;PKD2;HLA-G
16735,GO:0098553,0.35032956935493,0.850878964374903,3,18,lumenal side of endoplasmic reticulum membrane,CC,SPPL2B;PKD2;HLA-G
17799,GO:1901985,0.350443854879009,0.811562294611733,5,33,positive regulation of protein acetylation,BP,RAPGEF3;NOS1;MAPK3;CAMK1;RPS6KA5
2385,GO:0005522,0.350881651682969,0.886360279655859,2,10,profilin binding,MF,WIPF1;PCLO
10143,GO:0042743,0.350920647357245,0.827394657104203,4,26,hydrogen peroxide metabolic process,BP,GPX3;EGFR;PRDX5;CAT
12575,GO:0050775,0.35101572907041,0.827791795609526,4,25,positive regulation of dendrite morphogenesis,BP,OBSL1;CUL7;CAPRIN2;FBXW8
16607,GO:0097493,0.351090518775686,0.89794844139199,2,6,structural molecule activity conferring elasticity,MF,OBSL1;TTN
13886,GO:0060563,0.351302886758669,0.810917391677373,5,33,neuroepithelial cell differentiation,BP,FAM20C;SLITRK6;CEBPB;TRIOBP;FGFR1
12131,GO:0048260,0.351495130515733,0.810772961649516,5,33,positive regulation of receptor-mediated endocytosis,BP,VEGFA;PCSK9;APLN;HFE;HIP1
6383,GO:0021587,0.352565422028008,0.82668437259653,4,25,cerebellum morphogenesis,BP,SERPINE2;MAP2K1;TRNP1;WNT7A
3428,GO:0007219,0.352748552458459,0.740034667896146,17,128,Notch signaling pathway,BP,POSTN;EGFR;ARRDC1;CNTN1;MAML3;PEAR1;NEURL1;CHAC1;MDK;EGFL7;TGFBR2;KRT19;MIB2;BCL6;PLXND1;MFNG;DTX3
10015,GO:0042476,0.353158315530921,0.76062677072184,11,80,odontogenesis,BP,HTRA1;ITGA6;LAMA5;ITGB4;ACVR2B;PPARA;FAM20C;AQP3;EDA;LAMB1;BSG
8705,GO:0034364,0.35321850031703,0.883561261454331,2,11,high-density lipoprotein particle,CC,APOE;PLTP
7876,GO:0032452,0.353225296236944,0.826211992802269,4,25,histone demethylase activity,MF,KDM3A;KDM4C;KDM7A;PHF2
12240,GO:0048546,0.353294869033831,0.826162159345265,4,25,digestive tract morphogenesis,BP,EGFR;ACVR2B;VANGL2;TCF7
14610,GO:0070207,0.353425151246831,0.848835741773432,3,18,protein homotrimerization,BP,ATXN10;ASIC1;HSF4
7184,GO:0031082,0.353441015305223,0.84882524026101,3,18,BLOC complex,CC,BLOC1S4;PI4K2A;BLOC1S1
15221,GO:0071407,0.353459158068042,0.701298636108424,52,414,cellular response to organic cyclic compound,BP,NFATC4;EGR1;FAM210B;EGFR;NR1D1;RAPGEF3;ZFP36L1;KLF9;MAP2K1;CYP27B1;PCK2;DDIT4;ITGA6;TMEM173;PAK1;KDM3A;PPARA;IMPACT;PKD2;MAPK3;ERRFI1;THRA;PAQR6;MAP2K2;DMTN;ATF4;SSH1;FLOT1;GSTM2;CEBPB;CREBRF;PDE2A;CALCOCO1;AGO4;TRPV1;TADA3;PTAFR;RXRA;ADCY6;ATP2B4;MGMT;AKT1;ITPR2;CRY2;CHEK2;LGALS1;SIRT2;RECQL5;HDAC8;EIF4EBP1;PER1;ITGA2
590,GO:0001755,0.353690597298228,0.809120777392782,5,33,neural crest cell migration,BP,SEMA4B;LAMA5;SEMA3F;SEMA3B;SEMA4G
10262,GO:0043025,0.35384107402164,0.713098043853374,34,267,neuronal cell body,CC,PTPRS;APOE;GLUL;GJC2;LRP1;TIMP2;NTSR1;SNPH;CST3;SHANK2;CRTC1;ITPR3;PRKCZ;DLG3;NEURL1;KCNC4;PI4K2A;NRSN2;ARHGEF2;KLHL24;SV2A;ATXN10;AZIN2;ENDOG;ITGA1;TRPV1;SRR;C9ORF72;INSR;HOMER2;SLC38A2;SIRT2;ADA;EPHB2
15136,GO:0071280,0.353871736072564,0.883190846136048,2,11,cellular response to copper ion,BP,PRNP;MAP1LC3A
19043,GO:1904951,0.354333673640819,0.706319821966535,42,329,positive regulation of establishment of protein localization,BP,F2R;POSTN;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;ANK3;RAPGEF3;B3GAT3;TFDP2;PCK2;TMEM173;VPS11;NLGN2;PRKCZ;PAK1;CEMIP;MICALL2;PLA2G6;C5;ANO1;VAMP2;MAPK3;BBC3;TTN;SORL1;NLRP1;CEP131;TRPV4;PEMT;GAS6;GLUD1;CAMK1;TSG101;IL17RC;TP73;FYN;MYO18A;ERBB2;OSCP1
7964,GO:0032587,0.354567193362367,0.764586872193544,10,72,ruffle membrane,CC,SPRY2;PAK1;ABCA7;SPRY4;ARHGEF4;ARHGEF2;TRPV4;PSD4;EPS8L1;EPS8L2
1695,GO:0004175,0.355227571854981,0.717027708122016,29,228,endopeptidase activity,MF,HTRA1;TYSND1;ADAM19;ADAMTS7;CLCA2;ADAMTS13;MMP28;MMP1;PLAT;CTSF;PRSS3;PCSK1;PRSS8;CAPNS2;USP20;SPPL2B;BLMH;CTSB;C1RL;PRSS22;RHBDF1;PCSK9;LONP2;RHBDF2;CTSH;CAPN2;PLAU;MMP17;MMP19
14331,GO:0061572,0.355360637904281,0.743369361894964,15,112,actin filament bundle organization,BP,ESPN;RAPGEF3;ARAP1;PAK1;RHOBTB2;ITGB5;RHOF;DMTN;TRIOBP;EPHA1;ASAP3;BRAF;SPIRE1;CORO1B;KCTD13
7588,GO:0031968,0.355536800771295,0.728682833682103,21,162,organelle outer membrane,CC,FAM210B;BPHL;ARMCX2;CYP27B1;TMEM173;ULK1;ITPR3;SYNE3;NLRX1;ACACB;BNIP3;PDE2A;BNIP3L;CPT1C;PPP1R15A;SNN;SPATA18;IFI27;ANKZF1;LETMD1;RETSAT
876,GO:0002230,0.355963000303094,0.847151803736292,3,18,positive regulation of defense response to virus by host,BP,TMEM173;APOBEC3F;EIF2AK4
853,GO:0002183,0.35642732583172,0.846842846924052,3,18,cytoplasmic translational initiation,BP,RPL13A;EIF2D;EIF4EBP1
14487,GO:0065005,0.356587845466502,0.846735976896306,3,18,protein-lipid complex assembly,BP,APOE;SNX9;ABCA7
8334,GO:0033198,0.356849489871978,0.846561712053637,3,18,response to ATP,BP,DGKQ;SSH1;TRPV1
11244,GO:0045540,0.356860620300633,0.793922533821738,6,41,regulation of cholesterol biosynthetic process,BP,APOE;SEC14L2;ABCG1;ACACB;MVD;TM7SF2
3286,GO:0006978,0.357208419005649,0.84632251398328,3,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ING4;CHEK2;TP73
14350,GO:0061615,0.357315367296356,0.846251210475927,3,18,glycolytic process through fructose-6-phosphate,BP,GALK1;ALDOC;PFKL
14353,GO:0061620,0.357315367296356,0.846251210475927,3,18,glycolytic process through glucose-6-phosphate,BP,GALK1;ALDOC;PFKL
883,GO:0002250,0.357530251309202,0.720229711218079,25,194,adaptive immune response,BP,IL20RB;ERCC1;PKN1;PRKCZ;SERPING1;PRR7;ZP3;RAG1;SCART1;C5;STAT6;C1RL;INPP5D;CTSH;BTN3A2;HFE;JAK3;TFEB;BTN3A3;BCL6;FYN;ADA;POU2F2;EIF2AK4;PAG1
14660,GO:0070302,0.358304107108982,0.726235895648159,21,161,regulation of stress-activated protein kinase signaling cascade,BP,XDH;PDCD4;VEGFA;EGFR;ERCC6;MAP2K1;PKN1;PAK1;MAPK3;VANGL2;MAP2K2;TRPV4;MINK1;WNT7A;ERN1;NBR1;AKT1;EDA2R;TP73;MAP3K10;PER1
683,GO:0001894,0.358443511243417,0.73765942910422,16,121,tissue homeostasis,BP,BBS2;F2R;IL20RB;ACP5;VEGFA;EGFR;ERCC6;BBS1;NPHP4;STK39;INPP5D;CROCC;SPATA7;CTSH;HOMER2;EPAS1
2398,GO:0005544,0.358465249888555,0.80551011320251,5,33,calcium-dependent phospholipid binding,MF,SYTL1;SYT8;ESYT2;PCLO;DYSF
16918,GO:0098927,0.358841103667042,0.792369815486367,6,41,vesicle-mediated transport between endosomal compartments,BP,MAP2K1;VPS11;MAPK3;HOOK2;MAP2K2;SORL1
4678,GO:0010831,0.358994465329545,0.845129879987343,3,18,positive regulation of myotube differentiation,BP,THRA;FLOT1;GDF15
12305,GO:0048679,0.3590099721264,0.845119507989869,3,18,regulation of axon regeneration,BP,PTPRS;MAP2K1;BRAF
13651,GO:0060205,0.359347044188105,0.713200175001364,29,231,cytoplasmic vesicle lumen,CC,APOE;GSN;PYGB;NAPRT;TIMP2;VEGFA;PYGL;DNASE1L1;VEGFB;PCSK1;SERPING1;ACTR1B;ECM1;FUCA1;ALDOC;TMSB4X;HEXB;GAS6;CTSH;ARSA;MAN2B1;MAGED2;CAT;DPP7;TIMP1;APRT;ADA;GALNS;PFKL
12542,GO:0050715,0.359397554434334,0.766389553125905,9,65,positive regulation of cytokine secretion,BP,F2R;POSTN;ALOX15B;PRKCZ;C5;MAPK3;NLRP1;TRPV4;IL17RC
12221,GO:0048515,0.359520720444753,0.760311199365025,10,73,spermatid differentiation,BP,BBS2;DNAH1;KDM3A;NEURL1;RFX2;SPAG16;CABYR;TBC1D20;REC8;SIX5
10460,GO:0043370,0.359879956041618,0.844537125936757,3,18,regulation of CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ;JAK3;BCL6
20239,GO:2001237,0.359943662077618,0.759954601853976,10,73,negative regulation of extrinsic apoptotic signaling pathway,BP,ITGA6;ARHGEF2;IFI6;UNC5B;NOS3;STRADB;AKT1;LMNA;MAP2K5;FYN
10357,GO:0043195,0.360002593063758,0.791457398922661,6,41,terminal bouton,CC,NTSR1;SYNGR1;BLVRB;SEPT5;SV2A;MICAL1
11770,GO:0046655,0.360169549027743,0.844343059142037,3,18,folic acid metabolic process,BP,MTHFR;ALDH1L2;ALDH1L1
3370,GO:0007143,0.360176711852461,0.844338257753629,3,18,female meiotic nuclear division,BP,EREG;MLH3;SPIRE1
2505,GO:0005759,0.360220418350905,0.696968690499915,48,393,mitochondrial matrix,CC,PRODH;ACSF2;ALDH7A1;NAGS;D2HGDH;HADH;PRDX5;IDH2;ACAD10;PYCR2;DHTKD1;ALDH4A1;TK2;MLYCD;HMGCL;ACP6;PCK2;ARL2;SHC1;OGDHL;GLDC;NME4;ETFB;GPT2;PC;ACSS2;HIBADH;PRIMPOL;TFB1M;ACADS;PDE2A;ALDH1L2;RPUSD3;GLUD1;SUCLG2;ALKBH7;DGUOK;LACTB2;PHYKPL;HAGH;CBR4;ACADVL;ACSS1;TXNRD2;MPG;TST;BLOC1S1;SDHAF4
393,GO:0001055,0.360672315768978,0.879300345977239,2,11,RNA polymerase II activity,MF,POLR2J2;POLR2J3
7656,GO:0032094,0.361081997549215,0.843730913578237,3,18,response to food,BP,BBS2;PPARA;AKT1
9425,GO:0036017,0.361153685723897,0.941795975654061,1,4,response to erythropoietin,BP,EPOR
9426,GO:0036018,0.361153685723897,0.941795975654061,1,4,cellular response to erythropoietin,BP,EPOR
14349,GO:0061614,0.361240811797449,0.803400150177106,5,33,pri-miRNA transcription by RNA polymerase II,BP,NFATC4;FOS;NGFR;PPARA;APLN
15218,GO:0071402,0.361400249382461,0.843517160947798,3,18,cellular response to lipoprotein particle stimulus,BP,APOE;CD9;ABCG1
5131,GO:0015631,0.361428130103705,0.705188234929721,35,275,tubulin binding,MF,CLIP2;PRNP;DNM1;BRSK1;NDRG1;MYH15;EML2;FAM110C;MYH11;TTBK2;CCDC88B;KIF17;RGS14;HOOK2;MYH3;ARHGEF2;STMN3;KIF21B;RABGAP1;KIF26B;MAP6;NDE1;TRPV4;MAP1LC3A;MAPRE3;KIF13B;REEP4;KIF27;MARK4;TUBGCP6;FYN;EML3;GOLGA2;MYO18A;CCDC69
4634,GO:0010761,0.361464981811146,0.803229383298029,5,33,fibroblast migration,BP,PAK1;TNS1;DMTN;AKT1;BRAF
3179,GO:0006801,0.36169906494113,0.802722777663227,5,34,superoxide metabolic process,BP,ACP5;EGFR;NOS3;CCS;SH3PXD2A
7068,GO:0030865,0.36219729936222,0.789729703176539,6,41,cortical cytoskeleton organization,BP,WIPF1;TRPV4;FMNL2;RAB13;RHOBTB3;IKBKB
3499,GO:0007405,0.362516136637196,0.802427934350754,5,33,neuroblast proliferation,BP,VEGFA;ARHGEF2;NDE1;FGFR1;KCTD11
11325,GO:0045669,0.362529610290238,0.789467690921848,6,41,positive regulation of osteoblast differentiation,BP,CTNNBIP1;ACVR2B;IFITM1;FAM20C;CEBPB;ATRAID
65,GO:0000132,0.362634167871529,0.842687215059948,3,18,establishment of mitotic spindle orientation,BP,SPRY2;ARHGEF2;NDE1
4087,GO:0009145,0.362761682132307,0.740037762093946,14,106,purine nucleoside triphosphate biosynthetic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;MLXIPL;GALK1;ALDOC;TMSB4X;TCIRG1;INSR;TAZ;PFKL
14754,GO:0070482,0.362863120155744,0.70379807877769,35,279,response to oxygen levels,BP,EGR1;PGF;POSTN;VEGFA;CST3;NOS1;NDRG1;ZFP36L1;PLAT;DDIT4;VEGFB;PAK1;MTHFR;PPARA;BNIP3;ANGPTL4;KCNMA1;ENDOG;AQP3;DNMT3A;TGFBR2;BNIP3L;TERC;AKT1;ITPR2;LMNA;CAPN2;PLAU;CAT;SIRT2;ADA;TGFBR3;EPAS1;EDNRA;ITGA2
10422,GO:0043295,0.362893033996309,0.878016335472748,2,11,glutathione binding,MF,GSTM2;GSTM3
17489,GO:1900750,0.362893033996309,0.878016335472748,2,11,oligopeptide binding,MF,GSTM2;GSTM3
11016,GO:0045006,0.363030092647693,0.877936869175115,2,11,DNA deamination,BP,APOBEC3C;APOBEC3F
9582,GO:0036452,0.363199668365093,0.81852860471461,4,26,ESCRT complex,CC,MVB12B;CHMP1B;TSG101;CHMP4C
11452,GO:0045927,0.363249743870246,0.71990857386619,22,170,positive regulation of growth,BP,BBS2;VEGFA;EGFR;DNPH1;HBEGF;HYAL1;PAK1;ZP3;LPAR3;ACACB;SEMA5A;TWF2;TGFBR2;AKT1;INSR;WNT3;MAP2K5;GPR21;TGFBR3;FGFR1;WFS1;ERBB2
14618,GO:0070229,0.363371771322625,0.818403119431621,4,26,negative regulation of lymphocyte apoptotic process,BP,RAG1;JAK3;BCL6;ADA
9458,GO:0036092,0.36363284381945,0.801575229177841,5,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGFR3;PIK3R2;FGFR4;INPP4A;FGFR1
12395,GO:0048864,0.36376890197245,0.769791153542164,8,57,stem cell development,BP,SEMA4B;LAMA5;SEMA3F;MAPK3;SEMA3B;WNT7A;SEMA4G;EDNRA
14133,GO:0061041,0.363947768665183,0.751351693617184,11,81,regulation of wound healing,BP,F2R;APOE;SERPINE2;CD9;HBEGF;PLAT;SERPING1;DMTN;TGFBR2;NOS3;PLAU
16079,GO:0090087,0.363954250704918,0.687450774871414,61,488,regulation of peptide transport,BP,F2R;POSTN;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;NR1D1;HADH;ANK3;RAPGEF3;IDH2;B3GAT3;PCK2;TMEM173;ARL2;VPS11;NLGN2;ITPR3;PRKCZ;PAK1;CEMIP;MICALL2;PLA2G6;C5;ANO1;SH3TC2;VAMP2;MAPK3;DMTN;TTN;SORL1;NLRP1;RHBDF1;LRP5;CEP131;TRPV4;TMSB4X;PDE2A;APLN;PEMT;BNIP3L;RHBDF2;GAS6;GLUD1;CAMK1;MAPKBP1;ITPR2;TSG101;IL17RC;ICA1;IFI27;HFE;FYN;CIDEA;MYO18A;STX1A;ERBB2;OSCP1;PFKL
18203,GO:1903035,0.364290094234836,0.769361531813187,8,57,negative regulation of response to wounding,BP,PTPRS;APOE;SERPINE2;CD9;PLAT;SERPING1;NOS3;PLAU
10145,GO:0042745,0.365125470496532,0.876718791954291,2,11,circadian sleep/wake cycle,BP,CST3;ADA
6871,GO:0030374,0.365310976813921,0.768519320471045,8,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,NR1D1;PKN1;PPARA;THRA;CALCOCO1;TADA3;TSG101;NCOA7
1367,GO:0003254,0.365854254312075,0.816589316839433,4,26,regulation of membrane depolarization,BP,FHL1;NTSR1;ANK3;IFI6
19644,GO:1990939,0.366186262448093,0.79962052638319,5,33,ATP-dependent microtubule motor activity,MF,DNAH1;WDR60;KIF17;DNAL4;KIF27
18313,GO:1903305,0.366192640603586,0.754669139827519,10,73,regulation of regulated secretory pathway,BP,SYTL1;SYT8;ZP3;SEPT5;BCR;PTAFR;RIMS3;MICAL1;BRAF;STX1A
8868,GO:0034694,0.366207356907814,0.840273178224754,3,18,response to prostaglandin,BP,ADCY6;AKT1;TGFBR3
2709,GO:0006085,0.366356535999548,0.840172047874539,3,18,acetyl-CoA biosynthetic process,BP,MLYCD;ACSS2;ACSS1
12362,GO:0048791,0.366374407133202,0.840159930954323,3,18,calcium ion-regulated exocytosis of neurotransmitter,BP,SYTL1;SYT8;RIMS3
7977,GO:0032602,0.366502728021511,0.775797061256429,7,50,chemokine production,BP,EGR1;POSTN;ALOX15B;C5;ZFPM1;TRPV4;MAP2K5
6518,GO:0021904,0.366575638870168,0.84002346511274,3,18,dorsal/ventral neural tube patterning,BP,TCTN1;WDR19;FKBP8
8179,GO:0032928,0.366776465335911,0.875754829787399,2,11,regulation of superoxide anion generation,BP,ACP5;EGFR
4394,GO:0010107,0.367027021264625,0.839717175580084,3,18,potassium ion import,BP,SLC12A7;KCNJ15;ATP12A
4765,GO:0010955,0.367392091726476,0.815462189285395,4,26,negative regulation of protein processing,BP,SERPINE2;PRNP;SERPING1;CHAC1
18320,GO:1903318,0.367392091726476,0.815462189285395,4,26,negative regulation of protein maturation,BP,SERPINE2;PRNP;SERPING1;CHAC1
12889,GO:0051259,0.367989394530357,0.690284476121777,47,382,protein complex oligomerization,BP,APOE;KCNG1;TYSND1;GLUL;GPX3;PRNP;DNM1;DDIT3;CRTC1;MMP1;HMGCL;COL6A1;SNX9;ITPR3;PRKCZ;DHRS4;PKD2;KCNC4;ACACB;KCTD15;ANGPTL4;ATXN10;FLOT1;SORL1;TRPV1;SHARPIN;NBR1;SRR;C1QTNF6;RXRA;SBF2;CBR4;INSR;BRAF;ASIC1;CAT;TP73;HGSNAT;HSF4;RNF213;EHD3;GOLGA2;DHPS;CTH;PFKL;KCTD11;KCTD13
9143,GO:0035510,0.36800406503607,0.815012905910385,4,26,DNA dealkylation,BP,APOBEC3C;APOBEC3F;MGMT;MPG
589,GO:0001754,0.368227152046188,0.838901582131957,3,18,eye photoreceptor cell differentiation,BP,VEGFA;SDK2;NAGLU
19673,GO:2000036,0.368368515345298,0.838805395344135,3,18,regulation of stem cell population maintenance,BP,KDM3A;HMGA2;KDM4C
6981,GO:0030667,0.368549332385593,0.71017840549755,25,195,secretory granule membrane,CC,SLC2A3;CD9;GAA;SYNGR1;TMEM173;CD68;ITPR3;BRI3;TMC6;VAMP2;KCNAB2;RHOF;RAB40B;NBEAL2;PTAFR;ITPR2;TCIRG1;ICA1;PLAU;HGSNAT;RAB13;TOM1;AP2A2;LAMTOR2;BSG
10811,GO:0044322,0.36890487224224,0.814350796948024,4,26,endoplasmic reticulum quality control compartment,CC,EDEM1;FBXO6;MAN1B1;SYVN1
1644,GO:0004090,0.369187414596333,0.93889815021229,1,4,carbonyl reductase (NADPH) activity,MF,DHRS4
1521,GO:0003887,0.36920257744714,0.814131775048905,4,26,DNA-directed DNA polymerase activity,MF,POLD4;PRIMPOL;POLM;POLL
4714,GO:0010881,0.369671790253938,0.874055362377241,2,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,GSTO1;GSTM2
9510,GO:0036230,0.369890040523541,0.689724960901339,45,364,granulocyte activation,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;BRI3;ACTR1B;TMC6;VAMP2;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;APRT;METTL7A;HGSNAT;TOM1;AP2A2;GALNS;LAMTOR2;PFKL
10287,GO:0043068,0.369958563744211,0.68296032539719,58,470,positive regulation of programmed cell death,BP,XDH;DUSP6;F2R;NFATC4;GSN;PDCD4;OBSCN;NTSR1;RBCK1;PRNP;TNFSF15;DDIT3;ARHGEF19;GRAMD4;NUPR1;RPS6KA2;TFDP2;BTG1;ITGA6;PLEKHG5;NEURL1;NGFR;ARHGEF4;PLEKHG2;PLA2G6;ING4;HMGA2;BNIP3;ARHGEF2;INPP5D;ATF4;BBC3;KCNMA1;IRF5;NLRP1;ENDOG;PCSK9;CSRNP3;ITGA1;DAP;TRPV1;BNIP3L;CTSH;AKT1;CHEK2;IFT57;MARK4;IFI27;PIDD1;TP73;BCL6;ARHGEF17;SIRT2;CIDEB;VAV3;MAP3K10;NET1;HIP1
12038,GO:0048008,0.369966763536289,0.783575366997005,6,41,platelet-derived growth factor receptor signaling pathway,BP,LRP1;VEGFA;PLAT;RGS14;BCR;HIP1
14464,GO:0061900,0.370341992074288,0.837459996314893,3,18,glial cell activation,BP,LRP1;EGFR;TRPV1
15181,GO:0071353,0.370466893222648,0.813200491111226,4,26,cellular response to interleukin-4,BP,ADAMTS13;STAT6;JAK3;TCF7
3696,GO:0008206,0.370758566860795,0.812985388038793,4,26,bile acid metabolic process,BP,NR1D1;FGFR4;OSBPL1A;ACOT8
5447,GO:0016324,0.370807412265718,0.71306733973382,22,170,apical plasma membrane,CC,EGFR;CD9;SLC2A9;SHANK2;PRKCZ;STK39;SHROOM4;ANO1;CSPG4;VANGL2;SLC22A18;SLC29A4;KCNMA1;TRPV4;PROM2;SLC9A3R2;IGFBP2;TCIRG1;PLB1;SCNN1A;MPDZ;ERBB2
5316,GO:0016043,0.370881271618382,0.650834359375238,548,4592,cellular component organization,BP,PTPRS;DLG4;HTRA1;BBS2;F2R;APOE;MARVELD1;SYTL1;ESPN;ZMYND8;NFATC4;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;H1F0;GSN;ADGRL1;CTNNBIP1;THBS3;TYSND1;POSTN;EVI5L;WIPF1;ADAM19;PTK6;CDC42EP5;THSD4;GLUL;GPX3;SEMA4B;LRP1;TIMP2;VEGFA;OBSCN;EGFR;PADI3;DDB2;PRNP;ERCC1;FBLN1;ANK3;BAHCC1;NEK9;IFT140;RAPGEF3;CLTCL1;FCHO1;SPTB;LOXL1;TSPAN1;IGFBP4;KRT15;CD9;NINL;IDH2;CST3;DNM1;SDK2;PARVB;NOS1;DDIT3;ARAP3;BRSK1;DNPH1;SHANK2;CRTC1;PACS2;ADGRB2;NDRG1;TBC1D8;ARHGEF19;COL13A1;SMARCA1;EFS;ADARB1;SYT8;CUL9;ARAP1;HBEGF;RBL2;GAA;MMP1;CNTN1;EXOC2;TFDP2;EFNB3;RPL13A;MSRB2;OBSL1;BBS1;LTBP4;ULK2;REEP2;RNF165;NISCH;ASH2L;CUL7;ATG16L2;HMGCL;HYAL1;SMOC2;NAGLU;ARPIN;WWTR1;SYNGR1;POLD4;MAP2K1;CYP27B1;COL6A1;PPL;SDCCAG8;PKN1;CAPG;H2AFJ;BTG1;TOM1L2;SYNGAP1;ITGA6;PHF21A;DGKQ;EML2;TUBG2;SNX9;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;BLOC1S4;SOX12;HDAC11;RAB3B;NLGN2;SLC12A7;MYH11;ITPR3;LAMA5;UNK;CIRBP;CAPRIN2;TPM2;TTBK2;PRKCZ;PAK1;ABCA7;MCTP1;PABPC1L;ERO1B;BRD3;KDM3A;MTHFR;PHF1;SEMA3F;PLXNB3;CAPNS2;SYNE3;ZSWIM4;ITGB4;MICALL2;CEP250;FBXW8;ETV1;SHROOM4;NEURL1;CCDC88B;RAG1;NGFR;NID1;ETV5;ARHGEF4;WDR60;MALL;PLXNB1;EREG;CHD2;TNS1;SPG11;PNPLA3;SSH3;RMI2;PLEKHG2;DHRS4;RHOBTB2;TMED4;PLA2G6;ABCG1;TRAPPC9;MANF;LPAR3;S100A13;ALS2CL;FKBP10;KIF17;INO80C;CHD3;STON1;SPC24;SESN2;AIP;SCMH1;IMPACT;IFT27;PKD2;SATB1;KLF7;SH3TC2;ING4;NUDCD3;VAMP2;HMGA2;AREG;COL8A1;SLIT3;SEPT5;B4GAT1;PCLO;KCNC4;PI4KAP1;JADE2;ACACB;MAPK3;ITGB5;LAMB2;BNIP3;SEMA5A;THRA;PEX10;VANGL2;ACSS2;RGS14;KCTD15;TDRKH;DYSF;RHOF;PLEK2;CNTRL;LTBP2;TUBE1;HOOK2;SLITRK6;EIF2D;MYH3;NYAP1;PI4K2A;SDC2;CHMP1B;TBC1D14;TCTN1;PTPDC1;ARHGEF2;SEPT10;FBF1;TSPYL2;MAP2K2;H1FX;TWF2;STMN3;TECPR1;LRSAM1;DMTN;LRRC8A;KLHL24;ANGPTL4;SEMA3B;ZFPM1;BBC3;KDM4C;PAK6;DOCK11;SSH1;TBC1D3E;PRIMPOL;METRN;RABGAP1;TENM2;IFI6;CBX7;PKD1;ATXN10;FLOT1;CEP68;TTN;HLCS;KCNMA1;AZIN2;TSNARE1;JDP2;UNC5B;HDAC5;WHAMMP3;SORL1;MAP6;TFB1M;PLTP;SRSF5;VLDLR;TPBG;ADGRF1;TEP1;SULF2;ROBO3;TMEM175;NLRP1;COL4A6;RFX2;ENDOG;KDM7A;MAP3K12;LRP5;NDE1;PCSK9;DBNDD1;PKIB;L3MBTL1;CEP131;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TRPV4;ARHGAP25;IQSEC2;ITGA1;TMSB4X;ANO9;MAP1LC3A;APLN;MLH3;PEMT;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;PROM2;WNT7A;TTLL11;TRPV1;BNIP3L;EPHA1;SEMA4G;SHARPIN;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;OLFML2A;CEP126;ECM2;ALKBH7;CROCC;BCR;FYCO1;NBR1;GOLGA2P5;SRR;TADA3;NBEAL2;C1QTNF6;KIF13B;SPAG16;CAMK1;TERC;PPP1R15A;RXRA;ADCY6;MBD1;TNRC18;RAB43;SLC9A3R2;EFEMP2;STRADB;WDR19;TMEM80;AKT1;IGFBP7;DGUOK;REEP4;MICAL1;AMIGO2;LAMB1;CHEK2;IFT57;PSMG4;WDR45;SBF2;IGFBP2;SEPT6;TTC21A;TNNT1;NFU1;TSG101;KIF27;FMNL3;PHF2;FGFR4;TMOD2;TCIRG1;ASAP3;CBR4;FARP1;DNASE2;LMNA;ATG2A;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;CAPN2;GOLGA8A;SMARCD2;SPATA18;MARK4;RAB25;INSR;WNT3;KRT19;TENM4;COG7;RPS6KA5;CHMP4C;TNXB;SMIM20;ADD3;RABGGTA;ITGB6;C6ORF89;LYST;MAP2K5;BRAF;ARHGAP44;ASIC1;CAT;MYOF;HAUS4;LGALS1;UNC119B;TIMP1;HFE;TP73;MTA3;TUBGCP6;FRAT1;SNX33;FCHSD1;TFEB;PEX7;SNX17;PHC1;ICAM5;SPIRE1;CSNK1E;TAZ;HGSNAT;BCL6;REPS2;HSF4;REC8;RNF213;EPS8L1;EHD3;FYN;MAST4;EML3;ATP8B2;SNX1;PEX1;LEMD2;ARHGEF17;SIRT2;GDF15;RECQL5;RAB13;GOLGA2;CELSR1;PLXND1;RHOBTB3;MTA1;MSH5;AP2A2;CIDEA;EPS8L2;HDAC8;MYO18A;TGFBR3;CIDEB;TCF7;VAV3;STX1A;EPAS1;LAMTOR2;TBC1D16;CHD6;LURAP1;DHPS;EPHB2;MAGI1;PER1;SEPT8;ITGA2;FGFR1;BLOC1S1;FITM2;SPATA6;SH3PXD2A;CTH;ERBB2;SEC31B;PLLP;UST;EIF2AK4;UNC119;CCDC69;OSCP1;PFKL;C15ORF62;CORO1B;SFI1;RPL12;HMBOX1;NET1;TTC19;GRB10;MMP19;KCTD11;BSG;ZMYM3;SDHAF4;KCTD13;APBA1;PEX11A;IKBKB;SNCB;HIP1;PLEKHH2;TEAD2;ACOT8
7405,GO:0031501,0.371550626152822,0.938029400114511,1,4,mannosyltransferase complex,CC,PIGV
2245,GO:0005158,0.371780501110859,0.836476245992538,3,18,insulin receptor binding,MF,SHC1;SNX1;GRB10
561,GO:0001702,0.37179005096751,0.836469706523023,3,18,gastrulation with mouth forming second,BP,ACVR2B;LRP5;TENM4
5704,GO:0016840,0.371866678011271,0.87275939163706,2,11,carbon-nitrogen lyase activity,MF,CHAC1;SRR
14849,GO:0070661,0.371929086017356,0.715846320836583,20,156,leukocyte proliferation,BP,IL20RB;PRNP;PKN1;ZP3;CCDC88B;SATB1;INPP5D;PDCD1LG2;CEBPB;TGFBR2;CARD11;IGFBP2;JAK3;BCL6;FYN;ADA;VAV3;DHPS;ERBB2;HLA-G
9372,GO:0035924,0.371964102987034,0.812095301285754,4,26,cellular response to vascular endothelial growth factor stimulus,BP,XDH;VEGFA;ERN1;AKT1
8032,GO:0032691,0.371994770306848,0.872683555824301,2,11,negative regulation of interleukin-1 beta production,BP,ACP5;ERRFI1
5611,GO:0016668,0.372235179207608,0.872541163331615,2,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD3;TXNRD2
11573,GO:0046173,0.372775239852013,0.78108607985235,6,42,polyol biosynthetic process,BP,ISYNA1;NTSR1;CYP27B1;PCK2;PTAFR;CYP2R1
7930,GO:0032527,0.372899285551244,0.794110389226481,5,34,protein exit from endoplasmic reticulum,BP,TMEM129;EDEM1;SORL1;HERPUD1;SYVN1
18204,GO:1903036,0.372922471905108,0.794092422941117,5,34,positive regulation of response to wounding,BP,F2R;HBEGF;DMTN;TGFBR2;BRAF
5202,GO:0015804,0.373178620512236,0.811196906129486,4,26,neutral amino acid transport,BP,SLC7A8;SLC43A1;SLC6A9;SLC38A2
2039,GO:0004784,0.373285023745001,0.937387051834195,1,4,superoxide dismutase activity,MF,CCS
5631,GO:0016721,0.373285023745001,0.937387051834195,1,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,CCS
15825,GO:0072567,0.373558156074202,0.871756155296292,2,11,chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MAP2K5
11042,GO:0045058,0.37363270479077,0.810860581328295,4,26,T cell selection,BP,STAT6;ZFPM1;CARD11;BRAF
11256,GO:0045582,0.37399985352866,0.780106465061737,6,42,positive regulation of T cell differentiation,BP,PRKCZ;RAG1;TGFBR2;BCL6;ADA;HLA-G
10417,GO:0043280,0.374274891776191,0.729804194113999,14,108,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;GSN;TNFSF15;GRAMD4;NGFR;BBC3;NLRP1;DAP;CTSH;IFT57;IFI27;PIDD1;HIP1
6358,GO:0021545,0.374383484292883,0.810303987995721,4,26,cranial nerve development,BP,ADARB1;SEMA3F;SLITRK6;EPHB2
6139,GO:0019418,0.374554223477511,0.936914431446509,1,4,sulfide oxidation,BP,TSTD1
14615,GO:0070221,0.374554223477511,0.936914431446509,1,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,TSTD1
890,GO:0002263,0.37477784782655,0.678383830783461,58,472,cell activation involved in immune response,BP,GSN;PYGB;SLC2A3;NAPRT;LRP1;TIMP2;ERCC1;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;PRKCZ;BRI3;ACTR1B;TMC6;S100A13;STAT6;VAMP2;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;ZFPM1;DOCK11;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;LGALS1;JAK3;APRT;METTL7A;HGSNAT;BCL6;TOM1;ADA;AP2A2;GALNS;LAMTOR2;MFNG;EIF2AK4;PFKL
12207,GO:0048486,0.375086250882369,0.870846447357722,2,11,parasympathetic nervous system development,BP,ADARB1;SEMA3F
11696,GO:0046514,0.375166710459061,0.870798459121799,2,11,ceramide catabolic process,BP,HEXB;NAGA
8342,GO:0033218,0.37527129914393,0.703977591255096,25,197,amide binding,MF,APOE;FBXO2;PRNP;SLC7A8;RNPEPL1;CST3;CEMIP;NPR2;APBB3;ACACB;PC;LTA4H;HLCS;SORL1;PLTP;GSTM2;RXRA;INSR;PEX7;GSTM3;RNPEP;EPHB2;ITGA2;HLA-G;APBA1
357,GO:0000976,0.375772786871385,0.675850229664329,62,498,transcription regulatory region sequence-specific DNA binding,MF,ZC3H6;ZMYND8;NFATC4;FOS;EGR1;NR1D1;BAHCC1;MEF2D;DDIT3;TCFL5;TFDP2;MXI1;SOX13;ETV4;PHF21A;PBX2;SOX12;ELK3;KDM3A;FOXQ1;SALL2;ETV1;ETV5;HES2;CHD2;TEF;CARF;PPARA;SATB1;STAT6;KLF7;HMGA2;THRA;MLXIPL;LITAF;ATF4;ZFPM1;ZNF516;JDP2;DEAF1;RFX2;CEBPB;CREBRF;HLTF;MXD3;BHLHE40;RXRA;TNRC18;CRY2;ZNF217;SMARCD2;TP73;MNT;TFEB;BCL6;HSF4;POU2F2;MTA1;PER1;CREB3L4;DBP;SIX5
19366,GO:1905898,0.375898667766459,0.791781564590222,5,34,positive regulation of response to endoplasmic reticulum stress,BP,EDEM1;DDIT3;HERPUD1;ERN1;PPP1R15A
18918,GO:1904706,0.375909557023061,0.870354985192355,2,11,negative regulation of vascular smooth muscle cell proliferation,BP,PDCD4;APLN
8333,GO:0033197,0.375914501238853,0.870352030989688,2,11,response to vitamin E,BP,CAT;ADA
17319,GO:1900029,0.375989842506335,0.870307009906693,2,11,positive regulation of ruffle assembly,BP,EPS8L1;EPS8L2
1223,GO:0002901,0.376198662929496,0.936298850609792,1,4,mature B cell apoptotic process,BP,ADA
1227,GO:0002905,0.376198662929496,0.936298850609792,1,4,regulation of mature B cell apoptotic process,BP,ADA
1228,GO:0002906,0.376198662929496,0.936298850609792,1,4,negative regulation of mature B cell apoptotic process,BP,ADA
13209,GO:0051898,0.37633116906905,0.791444972310435,5,34,negative regulation of protein kinase B signaling,BP,XDH;DDIT3;TRIB3;AKT1;LEMD2
3549,GO:0007586,0.376486480159703,0.77811277405126,6,42,digestion,BP,PRSS3;ADM2;STK39;WNK4;TRPV1;CHRM3
6712,GO:0030130,0.376698421143309,0.869883208046348,2,11,clathrin coat of trans-Golgi network vesicle,CC,CLTCL1;AP1G2
594,GO:0001759,0.376705158950148,0.869879174838258,2,11,organ induction,BP,WNT2B;FGFR1
6848,GO:0030325,0.376737553946584,0.869859782527361,2,11,adrenal gland development,BP,MDK;INSR
5130,GO:0015630,0.376926288874289,0.661487260402481,118,964,microtubule cytoskeleton,CC,BBS2;CLIP2;NEK9;IFT140;CLTCL1;NINL;SNPH;DNM1;BRSK1;ADGRB2;NDRG1;OBSL1;EVC;BBS1;REEP2;RAB11FIP4;CUL7;MAP2K1;SDCCAG8;ABCA2;CAPG;PITPNM1;EML2;TUBG2;FAM110C;DNAH1;ARL2;SPRY2;NPHP4;CAPRIN2;TTBK2;PRKCZ;PHF1;USP20;CEP250;NEIL1;CCDC88B;SPPL2B;WDR60;ACTR1B;PLA2G6;KIF17;CHD3;CCDC92;IFT27;PKD2;NUDCD3;ENKD1;SEPT5;KCNAB2;RGS14;DNAL4;PBXIP1;DYSF;CNTRL;TUBE1;HOOK2;ARHGEF2;SEPT10;FBF1;MAP2K2;KIF21B;ATF4;PROCR;LRRC45;RABGAP1;KIF26B;FLOT1;CEP68;PSKH1;MAP6;NEK8;NDE1;CEP131;TRIOBP;TRPV4;TTC12;MAP1LC3A;CDK5RAP3;TTLL11;NICN1;CEP126;LZTS2;CROCC;MAPRE3;CEP112;TADA3;KIF13B;SPATA7;CCDC15;GSDMC;PLEKHG6;MAPKBP1;AKT1;REEP4;MZT2B;IFT57;SEPT6;TSG101;KIF27;MARK4;ITGB6;LYST;MAP2K5;MZT2A;HAUS4;TUBGCP6;EML3;UBXN6;SIRT2;GOLGA2;MTA1;SEPT8;UNC119;CCDC69;SFI1;TTC19;TCTEX1D4
11744,GO:0046622,0.377028472664673,0.808337985339691,4,26,positive regulation of organ growth,BP,ACACB;AKT1;TGFBR3;FGFR1
10987,GO:0044818,0.377257741484126,0.808167194775074,4,26,mitotic G2/M transition checkpoint,BP,BRSK1;HMGA2;CDK5RAP3;FOXO4
13091,GO:0051651,0.37729314737021,0.745091096685937,10,74,maintenance of location in cell,BP,APOE;GSN;ANK3;GAA;ARL2;SYNE3;TWF2;SORL1;TMSB4X;AKT1
10074,GO:0042592,0.377348462864183,0.659180354574291,132,1091,homeostatic process,BP,DLG4;BBS2;F2R;APOE;FHL1;IL20RB;ACP5;FAM210B;VEGFA;NTSR1;EGFR;PRNP;NR1D1;ERCC1;SLC7A8;PRDX5;ANK3;NOS1;DDIT3;CRTC1;ERCC6;ZFP36L1;GAA;PYGL;BBS1;SLC27A1;TXNRD3;POLD4;CYP27B1;PCK2;ABCA2;PKN1;NPHP4;SLC12A7;CYBRD1;ITPR3;STK39;ERO1B;CEMIP;RAG1;NGFR;GSTO1;MALL;PNPLA3;PLA2G6;ABCG1;LPAR3;ANO1;SESN2;PKD2;ACACB;MAPK3;BNIP3;THRA;PQLC2;MLXIPL;INPP5D;DMTN;LRRC8A;ANGPTL4;ZFPM1;DOCK11;SV2A;IFI6;PKD1;KCNMA1;HERPUD1;GSTM2;TEP1;TMEM175;ENDOG;LRP5;WNK4;PCSK9;PKIB;AQP3;TRPV4;APLN;NOS3;HEXB;TRPV1;PIK3R2;GAS6;ERN1;CROCC;BCR;ATP7B;TERC;ADCY6;ATP2B4;SPATA7;CTSH;ACOX3;STEAP2;AKT1;ITPR2;CARD11;CRY2;FGFR4;TCIRG1;STEAP3;ACADVL;DNASE2;TBC1D20;INSR;PNPLA4;TPCN1;TXNRD2;HOMER2;GPR21;LETMD1;LGALS1;HFE;JAK3;SCNN1A;TMX4;ATP12A;BCL6;SLC9A7;FYN;TRPC1;ADA;CIDEA;HDAC8;TGFBR3;EPAS1;EDNRA;DHPS;WFS1;FITM2;HMBOX1;SLC9A5
11521,GO:0046070,0.377649902515399,0.935752554989334,1,4,dGTP metabolic process,BP,DGUOK
1275,GO:0003071,0.377748232092124,0.869254043948517,2,11,renal system process involved in regulation of systemic arterial blood pressure,BP,F2R;GAS6
13008,GO:0051482,0.377813882598735,0.869214648385763,2,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,F2R;LPAR3
14827,GO:0070613,0.377863183731038,0.766512293795893,7,50,regulation of protein processing,BP,SERPINE2;GSN;PRNP;SERPING1;C5;PLGRKT;CHAC1
6268,GO:0019867,0.378051822457652,0.708292670760786,21,164,outer membrane,CC,FAM210B;BPHL;ARMCX2;CYP27B1;TMEM173;ULK1;ITPR3;SYNE3;NLRX1;ACACB;BNIP3;PDE2A;BNIP3L;CPT1C;PPP1R15A;SNN;SPATA18;IFI27;ANKZF1;LETMD1;RETSAT
1202,GO:0002862,0.378063779472877,0.935596234597352,1,4,negative regulation of inflammatory response to antigenic stimulus,BP,IL20RB
3479,GO:0007342,0.378125267857531,0.935572990739494,1,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,CD9
19662,GO:2000010,0.37817038459257,0.869000614925805,2,11,positive regulation of protein localization to cell surface,BP,AKT1;SNX33
15157,GO:0071318,0.378176469071827,0.868996960460473,2,11,cellular response to ATP,BP,SSH1;TRPV1
16143,GO:0090190,0.378210010333717,0.868976813961559,2,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,VEGFA;WNT2B
10231,GO:0042982,0.378240451272699,0.776702837605074,6,42,amyloid precursor protein metabolic process,BP,APOE;PRNP;ABCA7;ABCG1;SORL1;NECAB3
9394,GO:0035967,0.378348175565673,0.712246773947132,19,147,cellular response to topologically incorrect protein,BP,EDEM1;DDIT3;CUL7;SHC1;TSPYL2;ATF4;HERPUD1;CREBRF;CDK5RAP3;ERN1;PPP1R15A;ASNS;ACADVL;LMNA;ANKZF1;WFS1;CTH;SYVN1;CREB3L4
14746,GO:0070470,0.378417633892068,0.935462400206933,1,4,plasma membrane respiratory chain,CC,SDHA
8035,GO:0032695,0.378421603394584,0.868849685214882,2,11,negative regulation of interleukin-12 production,BP,ACP5;JAK3
18333,GO:1903350,0.378540407062247,0.868778278869292,2,11,response to dopamine,BP,MAPK3;ATF4
18334,GO:1903351,0.378540407062247,0.868778278869292,2,11,cellular response to dopamine,BP,MAPK3;ATF4
16844,GO:0098801,0.378631563636713,0.868723476473253,2,11,regulation of renal system process,BP,F2R;GAS6
11632,GO:0046386,0.378782190625088,0.830890370087079,3,19,deoxyribose phosphate catabolic process,BP,NEIL1;ADA;NUDT18
4052,GO:0009101,0.37899093836424,0.691806790312046,32,252,glycoprotein biosynthetic process,BP,TNIP1;ST6GALNAC2;LMF1;ADAMTS7;ADAMTS13;B3GAT3;HBEGF;VEGFB;ABCA7;MUC19;ST6GALNAC6;B4GAT1;CSPG4;VANGL2;MVD;ADAMTSL1;SRD5A3;ST3GAL3;FOXL1;NECAB3;B4GALT2;PHLDA1;COG7;JAK3;MPI;GOLGA2;MAN1B1;MFNG;XYLT2;UST;SYVN1;ACOT8
2699,GO:0006067,0.379407090640988,0.868256774024333,2,11,ethanol metabolic process,BP,ACSS2;ACSS1
4881,GO:0014805,0.379699488291728,0.934976153799499,1,4,smooth muscle adaptation,BP,NOS3
7270,GO:0031262,0.379706722865357,0.934973403160421,1,4,Ndc80 complex,CC,SPC24
2702,GO:0006071,0.379711505623735,0.868073354067911,2,11,glycerol metabolic process,BP,PCK2;TKFC
9214,GO:0035615,0.379901666176735,0.867958711215007,2,11,clathrin adaptor activity,MF,AP2A2;HIP1
16815,GO:0098748,0.379901666176735,0.867958711215007,2,11,endocytic adaptor activity,MF,AP2A2;HIP1
11278,GO:0045616,0.379966000998519,0.788608375083078,5,34,regulation of keratinocyte differentiation,BP,ALOX15B;ZFP36L1;CYP27B1;ERRFI1;AQP3
19956,GO:2000580,0.380010294602264,0.934857918643657,1,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,DNAL4
19957,GO:2000582,0.380010294602264,0.934857918643657,1,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,DNAL4
2654,GO:0006000,0.380029341600061,0.867881711006161,2,11,fructose metabolic process,BP,ALDOC;TKFC
16153,GO:0090200,0.380415087301735,0.80534277860039,4,27,positive regulation of release of cytochrome c from mitochondria,BP,PLA2G6;BNIP3;BBC3;CIDEB
12100,GO:0048185,0.380537937317123,0.867574756799776,2,11,activin binding,MF,ACVR2B;TGFBR3
907,GO:0002292,0.380626198143113,0.788091664414698,5,34,T cell differentiation involved in immune response,BP,PRKCZ;STAT6;ZFPM1;JAK3;BCL6
3722,GO:0008252,0.380826222108145,0.867400608776449,2,11,nucleotidase activity,MF,NT5E;NT5C1B
7275,GO:0031269,0.380954711206916,0.867322953656982,2,11,pseudopodium assembly,BP,CDC42EP5;C15ORF62
523,GO:0001618,0.380972522486191,0.774500613839445,6,42,virus receptor activity,MF,EGFR;EFNB3;ITGB5;TNFRSF14;ITGB6;ITGA2
17160,GO:0104005,0.380972522486191,0.774500613839445,6,42,hijacked molecular function,MF,EGFR;EFNB3;ITGB5;TNFRSF14;ITGB6;ITGA2
10692,GO:0044003,0.381002602449492,0.78779686125478,5,34,modification by symbiont of host morphology or physiology,BP,TNIP1;RXRA;INSR;CPSF4;EIF2AK4
10532,GO:0043501,0.381017193159734,0.867285183113859,2,11,skeletal muscle adaptation,BP,TNNT1;TNNI1
8330,GO:0033189,0.38117975160732,0.867186890720455,2,11,response to vitamin A,BP,DNMT3A;CAT
8089,GO:0032785,0.381424457771967,0.867038858096203,2,11,negative regulation of DNA-templated transcription, elongation,BP,EAPP;RECQL5
917,GO:0002312,0.381428949352952,0.76357337201885,7,50,B cell activation involved in immune response,BP,ERCC1;STAT6;DOCK11;LGALS1;BCL6;ADA;MFNG
10531,GO:0043500,0.381518243085944,0.754865401183815,8,58,muscle adaptation,BP,GSN;PAK1;ERRFI1;NOS3;ATP2B4;TNNT1;LMNA;TNNI1
12089,GO:0048156,0.381651131003363,0.86690166044343,2,11,tau protein binding,MF,APOE;FYN
8653,GO:0034236,0.381901507321731,0.866750033509799,2,11,protein kinase A catalytic subunit binding,MF,PJA2;RAB13
1055,GO:0002583,0.382008149916071,0.934094759620854,1,4,regulation of antigen processing and presentation of peptide antigen,BP,HFE
15975,GO:0086012,0.382103908991661,0.86662739644638,2,11,membrane depolarization during cardiac muscle cell action potential,BP,ANK3;SCN4B
7880,GO:0032456,0.382182441068727,0.786871831130116,5,34,endocytic recycling,BP,RAB11FIP4;MICALL2;SORL1;EHD3;RAB13
13492,GO:0055089,0.3822588960045,0.866533450044367,2,11,fatty acid homeostasis,BP,APOE;MLXIPL
16514,GO:0097284,0.382273838784933,0.866524390622261,2,11,hepatocyte apoptotic process,BP,GSN;DNMT3A
5434,GO:0016303,0.38240609608133,0.80431616625593,4,26,1-phosphatidylinositol-3-kinase activity,MF,FGFR3;PIK3R2;FGFR4;FGFR1
7906,GO:0032488,0.382516780462237,0.866377057996582,2,11,Cdc42 protein signal transduction,BP,APOE;RHOBTB3
8589,GO:0034111,0.382554841531169,0.866353968357846,2,11,negative regulation of homotypic cell-cell adhesion,BP,SERPINE2;CD9
12861,GO:0051223,0.38261668299055,0.670562078885948,59,474,regulation of protein transport,BP,F2R;POSTN;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;NR1D1;HADH;ANK3;RAPGEF3;IDH2;B3GAT3;PCK2;TMEM173;ARL2;VPS11;NLGN2;ITPR3;PRKCZ;PAK1;CEMIP;MICALL2;PLA2G6;C5;ANO1;SH3TC2;VAMP2;MAPK3;DMTN;TTN;SORL1;NLRP1;RHBDF1;LRP5;CEP131;TRPV4;TMSB4X;PDE2A;PEMT;BNIP3L;RHBDF2;GAS6;GLUD1;CAMK1;MAPKBP1;ITPR2;TSG101;IL17RC;ICA1;IFI27;FYN;CIDEA;MYO18A;STX1A;ERBB2;OSCP1;PFKL
5774,GO:0017001,0.382681124077994,0.803640337982731,4,27,antibiotic catabolic process,BP,GPX3;PRDX5;PCK2;CAT
1479,GO:0003777,0.3827717012356,0.735119804301952,11,81,microtubule motor activity,MF,MYH15;DNAH1;MYH11;WDR60;KIF17;DNAL4;MYH3;KIF21B;KIF26B;KIF13B;KIF27
13052,GO:0051584,0.382779356029945,0.9337987074863,1,4,regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13234,GO:0051940,0.382779356029945,0.9337987074863,1,4,regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
844,GO:0002161,0.382957216109864,0.86610974628861,2,11,aminoacyl-tRNA editing activity,MF,AARS;DTD1
17188,GO:0106074,0.382957216109864,0.86610974628861,2,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,AARS;DTD1
6900,GO:0030496,0.38298743888798,0.705863689950049,20,155,midbody,CC,EXOC2;RAB11FIP4;PKN1;CAPG;PITPNM1;CNTRL;CHMP1B;SSH1;TRIOBP;CEP126;KLHDC8B;MAPRE3;MICAL1;SEPT6;TSG101;CHMP4C;C6ORF89;SIRT2;CCDC69;TTC19
12325,GO:0048709,0.383117293273939,0.753521043255649,8,58,oligodendrocyte differentiation,BP,GSN;CD9;HDAC11;BNIP3;PRDM8;TENM4;TP73;ERBB2
1493,GO:0003839,0.383133011911098,0.933662672856489,1,4,gamma-glutamylcyclotransferase activity,MF,CHAC1
9375,GO:0035927,0.383368836420044,0.933571867048375,1,4,RNA import into mitochondrion,BP,TST
674,GO:0001885,0.383446906324928,0.772499754290493,6,42,endothelial cell development,BP,PTPRS;RAPGEF3;PDE2A;WNT7A;GSTM3;IKBKB
7782,GO:0032331,0.38346756533725,0.865799666227466,2,11,negative regulation of chondrocyte differentiation,BP,ADAMTS7;PTHLH
11154,GO:0045240,0.383566324839568,0.865739619857378,2,11,dihydrolipoyl dehydrogenase complex,CC,DHTKD1;OGDHL
2263,GO:0005179,0.383593454614044,0.827527493893422,3,19,hormone activity,MF,ADM2;PTHLH;APLN
9859,GO:0042135,0.38382962359339,0.865579466581377,2,11,neurotransmitter catabolic process,BP,ALDH7A1;GLDC
18469,GO:1903626,0.383882418704148,0.933373844658829,1,4,positive regulation of DNA catabolic process,BP,ENDOG
7810,GO:0032372,0.383949047606162,0.933348127951728,1,4,negative regulation of sterol transport,BP,PCSK9
7813,GO:0032375,0.383949047606162,0.933348127951728,1,4,negative regulation of cholesterol transport,BP,PCSK9
6770,GO:0030213,0.38400115899251,0.865475077304478,2,11,hyaluronan biosynthetic process,BP,HYAL1;CEMIP
4725,GO:0010893,0.384032297041596,0.865456123614796,2,11,positive regulation of steroid biosynthetic process,BP,NR1D1;ABCG1
3917,GO:0008593,0.384059286208211,0.739271281608213,10,74,regulation of Notch signaling pathway,BP,POSTN;EGFR;ARRDC1;MAML3;PEAR1;NEURL1;CHAC1;EGFL7;BCL6;MFNG
14761,GO:0070492,0.384187325263055,0.933256110198235,1,4,oligosaccharide binding,MF,LGALS1
16558,GO:0097386,0.384207337324271,0.865349551805222,2,11,glial cell projection,CC,GLUL;SIRT2
15831,GO:0072576,0.384557611975105,0.86513616244193,2,11,liver morphogenesis,BP,SULF2;CEBPB
17087,GO:0101023,0.384708924562059,0.865043929296657,2,11,vascular endothelial cell proliferation,BP,APLN;FGFR1
19272,GO:1905562,0.384708924562059,0.865043929296657,2,11,regulation of vascular endothelial cell proliferation,BP,APLN;FGFR1
804,GO:0002076,0.384729814748403,0.865031193111559,2,11,osteoblast development,BP,PTHLH;LRP5
18740,GO:1904262,0.384976934044098,0.864880485173101,2,11,negative regulation of TORC1 signaling,BP,SESN2;C12ORF66
12247,GO:0048562,0.385106984009102,0.701899684676798,21,163,embryonic organ morphogenesis,BP,IFT140;MDFI;HYAL1;NAGLU;SPRY2;WDR60;PKD2;MAPK3;VANGL2;SLITRK6;TRIOBP;TGFBR2;BCR;WDR19;IFT57;CELSR1;TCF7;EPHB2;FGFR1;TSHZ1;TEAD2
9133,GO:0035497,0.385149856142907,0.864774976672464,2,11,cAMP response element binding,MF,HMGA2;CREB3L4
4999,GO:0015145,0.385214644180246,0.864735435533621,2,11,monosaccharide transmembrane transporter activity,MF,SLC2A3;SLC2A9
6198,GO:0019693,0.385221702869538,0.674013398726671,47,386,ribose phosphate metabolic process,BP,H6PD;DLG4;NT5E;APOE;TIMP2;VEGFA;RAPGEF3;NOS1;PGM1;PYGL;DHTKD1;PGLS;DDIT4;OGDHL;NPR2;DLG3;NME4;ABHD14B;PPCS;PPARA;PKD2;FAM20C;MYH3;MLXIPL;SDHA;PTHLH;LTB4R2;GTPBP1;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;MOCOS;PDE2A;NOS3;UCKL1;ADCY6;CARD11;TCIRG1;UPP1;INSR;APRT;TAZ;PFKL;NUDT18
17350,GO:1900102,0.385228454246877,0.864727006283757,2,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,PPP1R15A;WFS1
12225,GO:0048521,0.385370256495598,0.932798131366024,1,4,negative regulation of behavior,BP,ADA
4711,GO:0010878,0.385495228491155,0.86456412334423,2,11,cholesterol storage,BP,ABCG1;PPARA
16750,GO:0098588,0.385524834166482,0.646411253326307,183,1513,bounding membrane of organelle,CC,PTPRS;DLG4;BBS2;ST6GALNAC2;APOE;SLC2A3;EDEM1;FAM210B;LRP1;EGFR;BPHL;CLTCL1;TSPAN1;CD9;NOS1;GPSM1;SHANK2;NDRG1;ARMCX2;SYT8;ARAP1;B3GAT3;HBEGF;GAA;EVC;BBS1;RAB11FIP4;ASAP2;ATG16L2;SYNGR1;CYP27B1;COL6A1;ABCA2;PITPNM1;TMEM173;ULK1;VPS11;RAB3B;CD68;CYBRD1;ITPR3;APPL2;ABCA7;MCTP1;B4GALNT4;CEMIP;BRI3;TMEM44;SYNE3;NMNAT2;SPPL2B;MARCH4;MALL;SPG11;TMC6;DHRS4;ABCG1;TRAPPC9;MTMR4;NLRX1;PKD2;VAMP2;AREG;ST6GALNAC6;AP1G2;B4GAT1;MARCH9;ACACB;KCNAB2;BNIP3;PEX10;SCARA3;RHOF;MVB12B;PI4K2A;PQLC2;KIAA0319L;CHMP1B;IFNGR2;PRAF2;MAP2K2;SLC50A1;TECPR1;SLC48A1;DMTN;LITAF;CHST6;SV2A;PKD1;FLOT1;AZIN2;WHAMMP3;SORL1;MAP6;IL17RD;VLDLR;ST3GAL3;TMEM175;RHBDF1;ATRAID;PCSK9;DBNDD1;DIRC2;MAP1LC3A;PDE2A;RAB40B;NOS3;PROM2;WNT7A;MARCH2;BNIP3L;VPS39;ATP7B;CPT1C;GOLGA2P5;NBEAL2;PTAFR;PPP1R15A;RAB43;TMEM9;ENTPD6;C12ORF66;STEAP2;ZFYVE21;ITPR2;B4GALT2;SBF2;TSG101;RASSF9;SNN;TCIRG1;STEAP3;COPG1;TBC1D20;CHMP5;MAN2B1;GOLGA8A;SPATA18;ICA1;IFI27;PLAU;INSR;WNT3;COG7;ANKZF1;CHMP4C;TPCN1;C6ORF89;LETMD1;CAT;SCNN1A;SNX17;TMEM50B;HGSNAT;SLC9A7;EHD3;PJA2;SNX1;PEX1;UBXN6;RAB13;TOM1;GOLGA2;RHOBTB3;AP2A2;MYO18A;RETSAT;MAN1B1;STX1A;LAMTOR2;MFNG;BLOC1S1;XYLT2;ERBB2;SEC31B;UST;HLA-G;MPPE1;CREB3L4;BSG;PEX11A;TMEM8A;HIP1
4235,GO:0009437,0.385710330971887,0.864432717408068,2,11,carnitine metabolic process,BP,CRAT;CPT1C
11760,GO:0046639,0.385826214429698,0.864361897664112,2,11,negative regulation of alpha-beta T cell differentiation,BP,JAK3;BCL6
8800,GO:0034552,0.385839087927722,0.932616087337375,1,4,respiratory chain complex II assembly,BP,SDHAF4
8801,GO:0034553,0.385839087927722,0.932616087337375,1,4,mitochondrial respiratory chain complex II assembly,BP,SDHAF4
11495,GO:0046030,0.386204807647533,0.864130398354746,2,11,inositol trisphosphate phosphatase activity,MF,INPP5D;INPP4A
11613,GO:0046339,0.38629482120177,0.864075328250275,2,11,diacylglycerol metabolic process,BP,DGKA;DGKQ
10412,GO:0043274,0.386369294871742,0.86402975690432,2,11,phospholipase binding,MF,DGKQ;PRKCZ
3927,GO:0008612,0.386404415684575,0.93239617132549,1,4,peptidyl-lysine modification to peptidyl-hypusine,BP,DHPS
6585,GO:0022605,0.386413304405407,0.932392710035892,1,4,mammalian oogenesis stage,BP,EREG
3328,GO:0007041,0.386427362098659,0.72710994284615,12,90,lysosomal transport,BP,VPS11;HOOK2;SORL1;PCSK9;VPS39;TSG101;C9ORF72;CHMP5;LYST;HGSNAT;EHD3;UBXN6
18374,GO:1903430,0.386503933535878,0.932357412605753,1,4,negative regulation of cell maturation,BP,NPR2
20081,GO:2000786,0.386504821884817,0.863946806499323,2,11,positive regulation of autophagosome assembly,BP,ULK1;LRSAM1
16121,GO:0090161,0.386604088884179,0.863886033133786,2,11,Golgi ribbon formation,BP,GOLGA2;MYO18A
6936,GO:0030552,0.386927757943555,0.863687780921816,2,11,cAMP binding,MF,RAPGEF3;PDE2A
4148,GO:0009214,0.387269883149345,0.863478065690548,2,11,cyclic nucleotide catabolic process,BP,RAPGEF3;PDE2A
16587,GO:0097452,0.387409065691431,0.932004267149249,1,4,GAIT complex,CC,RPL13A
15477,GO:0071875,0.387431835661862,0.863378735592881,2,11,adrenergic receptor signaling pathway,BP,NOS1;ATP2B4
7148,GO:0031017,0.387563185092716,0.931944023216209,1,4,exocrine pancreas development,BP,INSR
10146,GO:0042747,0.387810473109103,0.931847291797078,1,4,circadian sleep/wake cycle, REM sleep,BP,CST3
7438,GO:0031581,0.387934224893294,0.863070373779357,2,11,hemidesmosome assembly,BP,ITGA6;ITGB4
8772,GO:0034465,0.387950667372031,0.931792414537533,1,4,response to carbon monoxide,BP,KCNMA1
12781,GO:0051099,0.38798827545201,0.705834960497329,18,140,positive regulation of binding,BP,APOE;LRP1;GPSM1;TMEM173;CAPRIN2;HMGA2;PKD1;FLOT1;HERPUD1;TRIB3;MAPRE3;HFE;SIRT2;PLXND1;HDAC8;MFNG;ITGA2;HMBOX1
10610,GO:0043625,0.388018927415122,0.931765685160086,1,4,delta DNA polymerase complex,CC,POLD4
2737,GO:0006121,0.388109068021323,0.931730377868013,1,4,mitochondrial electron transport, succinate to ubiquinone,BP,SDHA
17907,GO:1902262,0.388244981628251,0.931677120406647,1,4,apoptotic process involved in blood vessel morphogenesis,BP,LRP5
10164,GO:0042772,0.388487281976636,0.824077074984887,3,19,DNA damage response, signal transduction resulting in transcription,BP,ING4;CHEK2;TP73
10768,GO:0044248,0.388538689500808,0.641387877144467,215,1797,cellular catabolic process,BP,XDH;NT5E;APOE;BTBD2;GID4;PRODH;H1F0;PYGB;ALDH7A1;TYSND1;FBXO2;TMEM129;EDEM1;CRAT;GLUL;AIG1;GPX3;LRP1;TIMP2;RBCK1;NR1D1;ADAMTS7;HADH;PRDX5;RAPGEF3;RNPEPL1;CST3;NOS1;GPSM1;DDIT3;DNPH1;ACAD10;PGM1;PACS2;GGT1;ADAMTS13;ABTB1;ARRDC1;TRIM65;ZFP36L1;CUL9;GAA;PYGL;CYP3A5;DHTKD1;ALDH4A1;RPL13A;ULK2;CTSF;RNF165;CPT2;MLYCD;FBXW4;CUL7;EPM2A;ATG16L2;HMGCL;HYAL1;WWTR1;CYP27B1;PCK2;CRYL1;DDIT4;DNASE1L1;SNX9;MAGEF1;ULK1;VPS11;OGDHL;CIRBP;APOBEC3C;PHYH;BLVRB;CEMIP;GLDC;CBS;USP20;ITGB4;NEIL1;ETFB;GSTO1;TRIB2;GPT2;PNPLA3;RNF44;APOBEC3F;PPARA;CHAC1;SESN2;BLMH;ACACB;NT5C1B;MAPK3;CSPG4;BNIP3;PAN2;CTSB;MVB12B;LTA4H;MLXIPL;TBC1D14;SRD5A3;HIBADH;TECPR1;LRSAM1;UBXN4;FBXO6;PKD1;FUCA1;GTPBP1;GALK1;PCBP4;HERPUD1;GSTM2;VLDLR;ENDOG;RHBDF1;ACOT7;ATRAID;ALDOC;PCSK9;FBXL15;ACADS;ISG20;LONP2;MAP1LC3A;PDE2A;SMURF2;TRIB3;DAP;ALDH1L2;CDK5RAP3;NOS3;AGO4;HEXB;BNIP3L;PIK3R2;SHARPIN;VPS39;GLUD1;ERN1;FYCO1;NBR1;CPT1C;HEXA;CYP2R1;ATP2B4;THNSL2;CTSH;ACOX3;ACAD11;PNRC1;GSTO2;ENTPD6;AKT1;CHEK2;PHYKPL;WDR45;TSG101;IGF2BP2;TCIRG1;HAGH;ACADVL;DNASE2;FAAH;UPP1;SPSB3;ATG2A;C9ORF72;CAPN2;SPATA18;INSR;ANKZF1;CHMP4C;PNPLA4;TPCN1;ALDH1L1;CAT;TIMP1;HFE;SNX33;TFEB;PEX7;CSNK1E;RNF213;GSTM3;TKFC;ZC3H12D;UBXN6;SIRT2;TST;GOLGA2;ADA;NAGA;MTA1;ENTPD2;AP2A2;CIDEA;RPL29;RNPEP;MAN1B1;GALNS;LAMTOR2;IGF2BP3;WFS1;CTH;EIF2AK4;SYVN1;PFKL;RPL12;NUDT18;KCTD13;PNKD;ACOT8;BTBD11
1704,GO:0004222,0.388563747353803,0.748925244674876,8,58,metalloendopeptidase activity,MF,ADAM19;ADAMTS7;CLCA2;ADAMTS13;MMP28;MMP1;MMP17;MMP19
4308,GO:0009790,0.388585669941562,0.657251125167482,82,666,embryo development,BP,DUSP6;DLG4;VEGFA;EGFR;ERCC1;DUSP5;IFT140;ZFP36L1;MDFI;FBXW4;HYAL1;NAGLU;MAP2K1;COL6A1;PBX2;SPRY2;LAMA5;SEMA3F;SALL2;DLG3;ITGB4;FBXW8;ZP3;ACVR2B;WDR60;WNT2B;PLCD3;C5;PKD2;HMGA2;COL8A1;MAPK3;ITGB5;VANGL2;SLITRK6;MYH3;TCTN1;PLCD1;ZFPM1;KDM4C;PKD1;DEAF1;SULF2;ENDOG;CEBPB;LRP5;DNMT3A;TRIOBP;TGFBR2;APLN;NOS3;WNT7A;BCR;RXRA;ZNF358;WDR19;AKT1;LAMB1;IFT57;SH2B3;MAB21L2;CAPN2;INSR;WNT3;KRT19;TENM4;MAP2K5;TFEB;PHLDA2;CELSR1;ADA;ETNK2;TCF7;EPAS1;EDNRA;EPHB2;ITGA2;FGFR1;FKBP8;TSHZ1;APBA1;TEAD2
15355,GO:0071625,0.388602638535087,0.8626595631326,2,11,vocalization behavior,BP,DLG4;SHANK2
12714,GO:0051001,0.38882861994752,0.931448131891791,1,4,negative regulation of nitric-oxide synthase activity,BP,ATP2B4
15278,GO:0071494,0.388908114778201,0.931416905808536,1,4,cellular response to UV-C,BP,IMPACT
7649,GO:0032079,0.388920898801161,0.931411883343067,1,4,positive regulation of endodeoxyribonuclease activity,BP,AKT1
12134,GO:0048263,0.388972047915012,0.931391786096974,1,4,determination of dorsal identity,BP,DDIT3
4189,GO:0009298,0.389021821087595,0.931372225992891,1,4,GDP-mannose biosynthetic process,BP,MPI
1103,GO:0002692,0.389029339712613,0.93136927098798,1,4,negative regulation of cellular extravasation,BP,BCR
12263,GO:0048598,0.389063136733277,0.670469186636939,47,377,embryonic morphogenesis,BP,DUSP6;DUSP5;IFT140;ZFP36L1;MDFI;FBXW4;HYAL1;NAGLU;COL6A1;PBX2;SPRY2;LAMA5;ITGB4;ACVR2B;WDR60;WNT2B;PKD2;HMGA2;COL8A1;MAPK3;ITGB5;VANGL2;SLITRK6;MYH3;TCTN1;DEAF1;LRP5;TRIOBP;TGFBR2;APLN;WNT7A;BCR;ZNF358;WDR19;LAMB1;IFT57;MAB21L2;WNT3;TENM4;MAP2K5;CELSR1;TCF7;EPHB2;ITGA2;FGFR1;TSHZ1;TEAD2
17064,GO:0099625,0.389120818367678,0.862340658866296,2,11,ventricular cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
15381,GO:0071671,0.389279518956058,0.931270899633523,1,4,regulation of smooth muscle cell chemotaxis,BP,CORO1B
14179,GO:0061135,0.389517405523152,0.728856704329328,11,85,endopeptidase regulator activity,MF,SERPINE2;TIMP2;PRDX5;TFPI2;CST3;SERPING1;C5;PAPLN;GAS6;HMSD;TIMP1
17062,GO:0099623,0.389697333002195,0.86198541381701,2,11,regulation of cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
4383,GO:0010040,0.389770950094156,0.931077414094786,1,4,response to iron(II) ion,BP,MAP1LC3A
11645,GO:0046434,0.390035373936849,0.695416777948879,22,173,organophosphate catabolic process,BP,XDH;NT5E;NTSR1;RAPGEF3;DNPH1;PGM1;DHTKD1;DDIT4;OGDHL;NEIL1;PPARA;NT5C1B;MLXIPL;GALK1;ALDOC;PDE2A;UPP1;INSR;ADA;ENTPD2;PFKL;NUDT18
9404,GO:0035985,0.390078564747658,0.930956129691633,1,4,senescence-associated heterochromatin focus,CC,HMGA2
12306,GO:0048680,0.390216591872248,0.93090166643637,1,4,positive regulation of axon regeneration,BP,BRAF
14808,GO:0070572,0.390216591872248,0.93090166643637,1,4,positive regulation of neuron projection regeneration,BP,BRAF
952,GO:0002371,0.390349088203339,0.930849360606969,1,4,dendritic cell cytokine production,BP,JAK3
1138,GO:0002730,0.390349088203339,0.930849360606969,1,4,regulation of dendritic cell cytokine production,BP,JAK3
267,GO:0000738,0.390393393508001,0.930831864666744,1,4,DNA catabolic process, exonucleolytic,BP,ISG20
10468,GO:0043380,0.390450935370373,0.930809137598442,1,4,regulation of memory T cell differentiation,BP,BCL6
7138,GO:0030992,0.390454086682273,0.822681873107023,3,19,intraciliary transport particle B,CC,KIF17;IFT27;IFT57
6739,GO:0030166,0.390540746276547,0.766729999697445,6,42,proteoglycan biosynthetic process,BP,B3GAT3;CSPG4;VANGL2;FOXL1;XYLT2;UST
14195,GO:0061158,0.390780521534932,0.861316705735069,2,11,3'-UTR-mediated mRNA destabilization,BP,ZFP36L1;ZC3H12D
17492,GO:1900825,0.390833761493401,0.930657817006013,1,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
18786,GO:1904380,0.390874193491118,0.822383227582783,3,19,endoplasmic reticulum mannose trimming,BP,EDEM1;MAN1B1;SYVN1
3762,GO:0008310,0.390969953743357,0.930603934742885,1,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,ISG20
13161,GO:0051792,0.391012344968239,0.930587158065183,1,4,medium-chain fatty acid biosynthetic process,BP,ACOT7
2574,GO:0005862,0.391272114031686,0.930484297609601,1,4,muscle thin filament tropomyosin,CC,TPM2
11539,GO:0046101,0.391279499089227,0.930481371981523,1,4,hypoxanthine biosynthetic process,BP,ADA
11011,GO:0044878,0.391292214178403,0.930476334656473,1,4,mitotic cytokinesis checkpoint,BP,CHMP4C
10229,GO:0042979,0.391411898064402,0.930428908552446,1,4,ornithine decarboxylase regulator activity,MF,AZIN2
17909,GO:1902267,0.391411898064402,0.930428908552446,1,4,regulation of polyamine transmembrane transport,BP,AZIN2
15458,GO:0071838,0.391458042808696,0.930410617835298,1,4,cell proliferation in bone marrow,BP,HMGA2
19924,GO:2000508,0.39146691846509,0.930407099388381,1,4,regulation of dendritic cell chemotaxis,BP,GAS6
19925,GO:2000510,0.39146691846509,0.930407099388381,1,4,positive regulation of dendritic cell chemotaxis,BP,GAS6
1231,GO:0002920,0.391515642038907,0.821926805001636,3,19,regulation of humoral immune response,BP,SERPING1;ZP3;C5
13452,GO:0055013,0.391587986768586,0.767012285022506,6,38,cardiac muscle cell development,BP,VEGFA;OBSL1;MYH11;PAK1;TTN;LMNA
15814,GO:0072553,0.391643584589298,0.930337043349345,1,4,terminal button organization,BP,NLGN2
19845,GO:2000354,0.391782012792388,0.930282119928286,1,4,regulation of ovarian follicle development,BP,ZP3
11292,GO:0045630,0.391831042551436,0.930262660237637,1,4,positive regulation of T-helper 2 cell differentiation,BP,PRKCZ
1086,GO:0002674,0.39189099324673,0.930238861516276,1,4,negative regulation of acute inflammatory response,BP,IL20RB
17586,GO:1901300,0.392004221520568,0.930193899422422,1,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
1805,GO:0004457,0.392128891539836,0.930144373188774,1,4,lactate dehydrogenase activity,MF,D2HGDH
1050,GO:0002578,0.392244123782626,0.930098576885592,1,4,negative regulation of antigen processing and presentation,BP,HFE
404,GO:0001085,0.392308986217054,0.713852650869822,14,107,RNA polymerase II transcription factor binding,MF,BBS2;FOS;ERCC1;MEF2D;RBL2;BBS1;PPARA;ATF4;ZFPM1;HDAC5;BHLHE40;IFI27;MTA1;TEAD2
3517,GO:0007492,0.392332633047424,0.745729758942646,8,58,endoderm development,BP,DUSP6;DUSP5;ZFP36L1;COL6A1;HMGA2;COL8A1;ITGB5;LAMB1
2743,GO:0006144,0.392394523406448,0.821300593716416,3,19,purine nucleobase metabolic process,BP,XDH;APRT;ADA
11626,GO:0046368,0.392426539637032,0.930026042128636,1,4,GDP-L-fucose metabolic process,BP,FUK
1956,GO:0004663,0.392452564973234,0.93001568977801,1,4,Rab geranylgeranyltransferase activity,MF,RABGGTA
16251,GO:0090344,0.392513722713283,0.821215587960089,3,19,negative regulation of cell aging,BP,HMGA2;TERC;BCL6
4838,GO:0014049,0.39252552899967,0.92998666112052,1,4,positive regulation of glutamate secretion,BP,NTSR1
16159,GO:0090207,0.392554684613007,0.821186372260494,3,19,regulation of triglyceride metabolic process,BP,APOE;LMF1;FITM2
10315,GO:0043125,0.392669710752457,0.929929276684144,1,4,ErbB-3 class receptor binding,MF,ERBB2
571,GO:0001714,0.392684995481205,0.929923191647668,1,4,endodermal cell fate specification,BP,DUSP6
13111,GO:0051701,0.392713195869062,0.696915385836047,20,157,interaction with host,BP,TNIP1;GSN;EGFR;EXOC2;EFNB3;ITGB5;PC;IFITM1;CTSB;GAS6;RXRA;TNFRSF14;TSG101;INSR;CHMP4C;ITGB6;CPSF4;LGALS1;ITGA2;EIF2AK4
9755,GO:0039534,0.392753325881063,0.929895984488548,1,4,negative regulation of MDA-5 signaling pathway,BP,TKFC
16161,GO:0090209,0.392802042644327,0.929876582916175,1,4,negative regulation of triglyceride metabolic process,BP,APOE
8506,GO:0033743,0.392883101522361,0.929844293658789,1,4,peptide-methionine (R)-S-oxide reductase activity,MF,MSRB2
19371,GO:1905908,0.393062917144725,0.929772632503402,1,4,positive regulation of amyloid fibril formation,BP,APOE
9597,GO:0036475,0.393172667293031,0.820745344541951,3,19,neuron death in response to oxidative stress,BP,ATF4;ENDOG;NCOA7
6131,GO:0019401,0.393530833764663,0.929585943553728,1,4,alditol biosynthetic process,BP,PCK2
4806,GO:0014002,0.393543700445487,0.820480322250653,3,19,astrocyte development,BP,LRP1;EGFR;LAMB2
11915,GO:0046982,0.393652748420209,0.669239219543409,42,349,protein heterodimerization activity,MF,FOS;PGF;VEGFA;NTSR1;EGFR;MEF2D;DDIT3;H2AFJ;VEGFB;TPM2;ABCG1;BNIP3;MLXIPL;ATF4;TENM2;RALGAPA1;FLOT1;JDP2;CEBPB;BHLHE40;HMG20B;HEXB;BNIP3L;PIK3R2;SUCLG2;HEXA;RXRA;CABYR;CAPN2;TENM4;RABGGTA;HOMER2;BRAF;SNX1;STX1A;EPAS1;ITGA2;ERBB2;IKBKB;HIP1;TEAD2;BTBD11
9616,GO:0036498,0.393656156405061,0.737105981966609,9,67,IRE1-mediated unfolded protein response,BP,EDEM1;CUL7;SHC1;TSPYL2;ERN1;ACADVL;LMNA;WFS1;SYVN1
2340,GO:0005372,0.393747893552203,0.929499237113173,1,4,water transmembrane transporter activity,MF,AQP3
5050,GO:0015250,0.393747893552203,0.929499237113173,1,4,water channel activity,MF,AQP3
5087,GO:0015355,0.393770497077267,0.929490204140646,1,4,secondary active monocarboxylate transmembrane transporter activity,MF,SLC10A6
32,GO:0000060,0.39377750702665,0.77736811639539,5,35,protein import into nucleus, translocation,BP,TMEM173;PDE2A;GAS6;AKT1;BCL6
15135,GO:0071279,0.393822227041336,0.929469528770343,1,4,cellular response to cobalt ion,BP,BNIP3
7115,GO:0030947,0.393829227630135,0.820276256852544,3,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,VEGFA;MYOF;GRB10
14545,GO:0070100,0.394124901366954,0.929348481064355,1,4,negative regulation of chemokine-mediated signaling pathway,BP,SLIT3
10372,GO:0043219,0.394137591451771,0.929343403147842,1,4,lateral loop,CC,SIRT2
12284,GO:0048644,0.394378985794045,0.75367815634442,7,46,muscle organ morphogenesis,BP,ADARB1;VANGL2;ZFPM1;TTN;RXRA;TGFBR3;TNNI1
898,GO:0002278,0.394403460447804,0.929236964158655,1,4,eosinophil activation involved in immune response,BP,VAMP2
990,GO:0002447,0.394403460447804,0.929236964158655,1,4,eosinophil mediated immunity,BP,VAMP2
10433,GO:0043307,0.394403460447804,0.929236964158655,1,4,eosinophil activation,BP,VAMP2
10434,GO:0043308,0.394403460447804,0.929236964158655,1,4,eosinophil degranulation,BP,VAMP2
17905,GO:1902260,0.394430675256579,0.929226063284335,1,4,negative regulation of delayed rectifier potassium channel activity,BP,ANK3
15151,GO:0071312,0.394457660142591,0.819826754977967,3,19,cellular response to alkaloid,BP,GSTM2;TRPV1;RECQL5
4484,GO:0010511,0.394560721004383,0.929173959190092,1,4,regulation of phosphatidylinositol biosynthetic process,BP,ZP3
11502,GO:0046037,0.394656719399239,0.819684268771986,3,19,GMP metabolic process,BP,DLG4;DLG3;CARD11
14000,GO:0060750,0.394666934593614,0.929131386068597,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,AREG
17316,GO:1900026,0.394669434579797,0.79453577444937,4,27,positive regulation of substrate adhesion-dependent cell spreading,BP,DMTN;TRIOBP;BRAF;NET1
4987,GO:0015125,0.394708233409657,0.929114828170644,1,4,bile acid transmembrane transporter activity,MF,SLC10A6
19941,GO:2000551,0.39495718984243,0.929014963542024,1,4,regulation of T-helper 2 cell cytokine production,BP,PRKCZ
10154,GO:0042758,0.39502153069163,0.928989140148154,1,4,long-chain fatty acid catabolic process,BP,AIG1
3013,GO:0006561,0.395059434320316,0.928973924689779,1,4,proline biosynthetic process,BP,PYCR2
13513,GO:0055129,0.395059434320316,0.928973924689779,1,4,L-proline biosynthetic process,BP,PYCR2
10494,GO:0043415,0.395141523536247,0.928940965117364,1,4,positive regulation of skeletal muscle tissue regeneration,BP,TGFBR2
10495,GO:0043416,0.395141523536247,0.928940965117364,1,4,regulation of skeletal muscle tissue regeneration,BP,TGFBR2
14007,GO:0060762,0.395185205395357,0.928923422589799,1,4,regulation of branching involved in mammary gland duct morphogenesis,BP,ETV5
1812,GO:0004465,0.395200209603726,0.92891739631756,1,4,lipoprotein lipase activity,MF,PNPLA3
17796,GO:1901981,0.395202918484924,0.711261838985811,14,107,phosphatidylinositol phosphate binding,MF,OSBPL5;ARAP3;ARAP1;GSDMA;PLEK2;PLCD1;TWF2;TECPR1;GSDMC;AKT1;WDR45;ADAP1;PLEKHA4;HIP1
12667,GO:0050908,0.39522444995785,0.928907659782331,1,4,detection of light stimulus involved in visual perception,BP,REEP6
12699,GO:0050962,0.39522444995785,0.928907659782331,1,4,detection of light stimulus involved in sensory perception,BP,REEP6
6746,GO:0030175,0.395284809711535,0.735833788152739,9,66,filopodium,CC,ACTA2;RAPGEF3;ITGA6;DEF6;TWF2;MORN4;TENM2;TRPV4;FARP1
7907,GO:0032489,0.395307908921278,0.928874130804581,1,4,regulation of Cdc42 protein signal transduction,BP,APOE
19660,GO:2000008,0.395343670363288,0.794018821762489,4,27,regulation of protein localization to cell surface,BP,KCNAB2;AKT1;HFE;SNX33
8201,GO:0032965,0.395363225513714,0.819178148460833,3,19,regulation of collagen biosynthetic process,BP,F2R;ERRFI1;ITGA2
3445,GO:0007258,0.395416624992105,0.928830440295907,1,4,JUN phosphorylation,BP,MAPK10
14971,GO:0070915,0.395578684348207,0.928765281480714,1,4,lysophosphatidic acid receptor activity,MF,LPAR3
6216,GO:0019755,0.395593303481272,0.928759401784545,1,4,one-carbon compound transport,BP,AQP3
8268,GO:0033083,0.39564632037193,0.928738076300359,1,4,regulation of immature T cell proliferation,BP,ERBB2
10856,GO:0044406,0.395705630810703,0.928714214616034,1,4,adhesion of symbiont to host,BP,GAS6
13177,GO:0051823,0.395727924578389,0.928705244141957,1,4,regulation of synapse structural plasticity,BP,CAMK1
2635,GO:0005968,0.395733628541745,0.92870294889228,1,4,Rab-protein geranylgeranyltransferase complex,CC,RABGGTA
12717,GO:0051006,0.395743752702687,0.928698874862059,1,4,positive regulation of lipoprotein lipase activity,BP,LMF1
14258,GO:0061365,0.395743752702687,0.928698874862059,1,4,positive regulation of triglyceride lipase activity,BP,LMF1
4630,GO:0010757,0.395745214695808,0.928698286534417,1,4,negative regulation of plasminogen activation,BP,SERPINE2
15189,GO:0071362,0.395783863236658,0.928682732696358,1,4,cellular response to ether,BP,NFATC4
4662,GO:0010815,0.395831428405171,0.92866358753747,1,4,bradykinin catabolic process,BP,CTSH
3653,GO:0008138,0.395840601961098,0.775720027049006,5,35,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP6;DUSP5;SSH3;PTPDC1;SSH1
128,GO:0000268,0.395890956558423,0.928639622745583,1,4,peroxisome targeting sequence binding,MF,PEX7
17711,GO:1901673,0.395904571785464,0.818789916402711,3,19,regulation of mitotic spindle assembly,BP,CHMP1B;CHMP5;CHMP4C
13881,GO:0060558,0.396024561407884,0.928585818059326,1,4,regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1
2667,GO:0006021,0.396084987278092,0.928561475396872,1,4,inositol biosynthetic process,BP,ISYNA1
888,GO:0002260,0.396121561807478,0.76190520071105,6,43,lymphocyte homeostasis,BP,PKN1;RAG1;DOCK11;AKT1;JAK3;ADA
4935,GO:0014900,0.396137296988022,0.928540398190342,1,4,muscle hyperplasia,BP,NOS3
6537,GO:0021955,0.3961568159783,0.818608890178119,3,19,central nervous system neuron axonogenesis,BP,ADARB1;TCTN1;EPHB2
20210,GO:2001185,0.396198451106826,0.928515752410569,1,4,regulation of CD8-positive, alpha-beta T cell activation,BP,HFE
16608,GO:0097494,0.396327568196993,0.928463699505082,1,4,regulation of vesicle size,BP,RAB3B
17817,GO:1902023,0.396348996667155,0.928455058452834,1,4,L-arginine transport,BP,SLC25A29
12734,GO:0051026,0.396368719769254,0.928447104519843,1,4,chiasma assembly,BP,MSH5
4929,GO:0014891,0.396414353402753,0.928428699286025,1,4,striated muscle atrophy,BP,GSN
10291,GO:0043084,0.396417424336058,0.928427460593244,1,4,penile erection,BP,ADA
3088,GO:0006664,0.396588069345573,0.713739294719463,13,100,glycolipid metabolic process,BP,ESYT2;ST6GALNAC6;FUCA1;PIGZ;HEXB;HEXA;ARSA;PIGQ;NAGA;PIGV;ESYT3;KDELC2;MPPE1
18401,GO:1903509,0.396588069345573,0.713739294719463,13,100,liposaccharide metabolic process,BP,ESYT2;ST6GALNAC6;FUCA1;PIGZ;HEXB;HEXA;ARSA;PIGQ;NAGA;PIGV;ESYT3;KDELC2;MPPE1
3025,GO:0006574,0.396636323517568,0.928339131094391,1,4,valine catabolic process,BP,HIBADH
10684,GO:0043987,0.396716346704836,0.928306823532034,1,4,histone H3-S10 phosphorylation,BP,RPS6KA5
9429,GO:0036021,0.39674026398038,0.928297165717137,1,4,endolysosome lumen,CC,CTSB
1216,GO:0002887,0.396746868894878,0.928294498505324,1,4,negative regulation of myeloid leukocyte mediated immunity,BP,BCR
16456,GO:0097167,0.396792373654961,0.928276120995842,1,4,circadian regulation of translation,BP,PER1
15409,GO:0071709,0.396808787300659,0.818140621486026,3,19,membrane assembly,BP,ANK3;NLGN2;FLOT1
19107,GO:1905098,0.39686360991438,0.928247345722673,1,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,GPSM1
12237,GO:0048539,0.396872195174167,0.928243877297709,1,4,bone marrow development,BP,LRP5
510,GO:0001574,0.396903903443809,0.928231066329412,1,4,ganglioside biosynthetic process,BP,ST6GALNAC6
3115,GO:0006695,0.39692383820137,0.741660603204721,8,59,cholesterol biosynthetic process,BP,APOE;SEC14L2;ABCG1;ACACB;MVD;HSD17B7;TM7SF2;PLPP6
17249,GO:0140007,0.397008144544672,0.928188940208229,1,4,KICSTOR complex,CC,C12ORF66
13228,GO:0051932,0.397011613334395,0.817994834909297,3,19,synaptic transmission, GABAergic,BP,DNM1;NISCH;NLGN2
14273,GO:0061428,0.397040168169964,0.928175995678583,1,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,SIRT2
19047,GO:1904956,0.397101414393129,0.928151234815193,1,4,regulation of midbrain dopaminergic neuron differentiation,BP,CSNK1E
9574,GO:0036438,0.397129026632287,0.92814006989936,1,4,maintenance of lens transparency,BP,STK39
6611,GO:0022840,0.397171137450764,0.92812304046019,1,4,leak channel activity,MF,TMEM175
6613,GO:0022842,0.397171137450764,0.92812304046019,1,4,narrow pore channel activity,MF,TMEM175
2437,GO:0005638,0.397354621992453,0.928048810862255,1,4,lamin filament,CC,LMNA
11001,GO:0044854,0.397406542211952,0.928027797647111,1,4,plasma membrane raft assembly,BP,FLOT1
11004,GO:0044857,0.397406542211952,0.928027797647111,1,4,plasma membrane raft organization,BP,FLOT1
4388,GO:0010046,0.397450755760926,0.928009900483961,1,4,response to mycotoxin,BP,EGR1
13534,GO:0060023,0.397450788155793,0.928009887369979,1,4,soft palate development,BP,TSHZ1
6801,GO:0030260,0.397485294824868,0.717173799995182,12,92,entry into host cell,BP,GSN;EGFR;EXOC2;EFNB3;ITGB5;IFITM1;CTSB;GAS6;TNFRSF14;ITGB6;LGALS1;ITGA2
10857,GO:0044409,0.397485294824868,0.717173799995182,12,92,entry into host,BP,GSN;EGFR;EXOC2;EFNB3;ITGB5;IFITM1;CTSB;GAS6;TNFRSF14;ITGB6;LGALS1;ITGA2
13171,GO:0051806,0.397485294824868,0.717173799995182,12,92,entry into cell of other organism involved in symbiotic interaction,BP,GSN;EGFR;EXOC2;EFNB3;ITGB5;IFITM1;CTSB;GAS6;TNFRSF14;ITGB6;LGALS1;ITGA2
13178,GO:0051828,0.397485294824868,0.717173799995182,12,92,entry into other organism involved in symbiotic interaction,BP,GSN;EGFR;EXOC2;EFNB3;ITGB5;IFITM1;CTSB;GAS6;TNFRSF14;ITGB6;LGALS1;ITGA2
4834,GO:0014045,0.39749132316401,0.927993476812392,1,4,establishment of endothelial blood-brain barrier,BP,WNT7A
6556,GO:0022009,0.39749132316401,0.927993476812392,1,4,central nervous system vasculogenesis,BP,WNT7A
14138,GO:0061046,0.397552328742084,0.927968774390788,1,4,regulation of branching involved in lung morphogenesis,BP,WNT2B
1286,GO:0003097,0.397584988506259,0.927955547615582,1,4,renal water transport,BP,AQP3
4956,GO:0015035,0.397623593729113,0.816836270981642,3,20,protein disulfide oxidoreductase activity,MF,TXNRD3;ERO1B;CCS
3109,GO:0006689,0.397662501546222,0.927924149820606,1,4,ganglioside catabolic process,BP,HEXB
13256,GO:0051969,0.397718526916206,0.927901450636743,1,4,regulation of transmission of nerve impulse,BP,ITGA2
1547,GO:0003945,0.397749032791519,0.927889089041452,1,4,N-acetyllactosamine synthase activity,MF,B4GALT2
1288,GO:0003100,0.397771113682786,0.927880140599024,1,4,regulation of systemic arterial blood pressure by endothelin,BP,NOS3
9069,GO:0035335,0.397876548759003,0.727159769310144,10,75,peptidyl-tyrosine dephosphorylation,BP,DUSP6;PTPRS;DUSP5;PTPRE;SSH3;MTMR4;PTPDC1;SSH1;PTPRU;DNAJC6
15602,GO:0072126,0.397899745066958,0.92782799809072,1,4,positive regulation of glomerular mesangial cell proliferation,BP,EGR1
14666,GO:0070309,0.397932022571449,0.927814910287698,1,4,lens fiber cell morphogenesis,BP,TBC1D20
15695,GO:0072284,0.397946492601921,0.927809042537274,1,4,metanephric S-shaped body morphogenesis,BP,PKD2
12729,GO:0051021,0.397948799816561,0.927808106910078,1,4,GDP-dissociation inhibitor binding,MF,PLXNB3
12730,GO:0051022,0.397948799816561,0.927808106910078,1,4,Rho GDP-dissociation inhibitor binding,MF,PLXNB3
16233,GO:0090315,0.397956617432693,0.927804936635282,1,4,negative regulation of protein targeting to membrane,BP,DMTN
8681,GO:0034316,0.397995949443836,0.927788985030015,1,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,CORO1B
6415,GO:0021684,0.398001611362818,0.927786688585516,1,4,cerebellar granular layer formation,BP,WNT7A
6430,GO:0021707,0.398001611362818,0.927786688585516,1,4,cerebellar granule cell differentiation,BP,WNT7A
727,GO:0001957,0.398075938204899,0.92775653780701,1,4,intramembranous ossification,BP,MN1
9451,GO:0036072,0.398075938204899,0.92775653780701,1,4,direct ossification,BP,MN1
14609,GO:0070206,0.398142150561393,0.773876126234961,5,35,protein trimerization,BP,COL6A1;ATXN10;C1QTNF6;ASIC1;HSF4
19840,GO:2000348,0.398218955516537,0.927698500672283,1,4,regulation of CD40 signaling pathway,BP,SHARPIN
2107,GO:0004887,0.398255447648776,0.927683687351321,1,4,thyroid hormone receptor activity,MF,THRA
15896,GO:0072708,0.398277529000333,0.92767472291112,1,4,response to sorbitol,BP,MAPK13
5809,GO:0017076,0.398329756233391,0.634568776518831,175,1436,purine nucleotide binding,MF,ACTA2;ACSF2;PTK6;GLUL;OBSCN;EGFR;SCN8A;NEK9;RAPGEF3;DGKA;DNM1;BRSK1;ERCC6;MYH15;SMARCA1;MST1R;CUL9;RPS6KA2;PYGL;TK2;ULK2;MAPK13;CDK18;MAP2K1;PCK2;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TUBG2;TMEM173;DNAH1;ARL2;ULK1;RAB3B;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;RHOBTB2;ABCG1;AGAP1;CARS;KIF17;CHD3;MKNK2;IFT27;NLRX1;SEPT5;ACACB;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;RHOF;TUBE1;MAPK12;MYH3;PI4K2A;SEPT10;MAP2K2;TWF2;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GTPBP1;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;PDE2A;TRIB3;RAB40B;ARL10;MLH3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;RAB43;ATP2B4;STRADB;ASNS;AKT1;DGUOK;CHEK2;SEPT6;ASS1;KIF27;FGFR4;MARK4;RAB25;INSR;ACSS1;GNAL;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;APRT;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;RECQL5;RAB13;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;SEPT8;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
14159,GO:0061086,0.398373202688332,0.927635873974612,1,4,negative regulation of histone H3-K27 methylation,BP,PHF1
711,GO:0001937,0.398404290096013,0.816992403737521,3,19,negative regulation of endothelial cell proliferation,BP,XDH;APOE;NGFR
18319,GO:1903317,0.398410433566347,0.749217988825222,7,51,regulation of protein maturation,BP,SERPINE2;GSN;PRNP;SERPING1;C5;PLGRKT;CHAC1
13664,GO:0060232,0.398423990016411,0.927615246180537,1,4,delamination,BP,TRPV4
8999,GO:0035184,0.398458779886889,0.927601113811009,1,4,histone threonine kinase activity,MF,PKN1
9101,GO:0035405,0.398458779886889,0.927601113811009,1,4,histone-threonine phosphorylation,BP,PKN1
18430,GO:1903546,0.398527751743238,0.927573090943603,1,4,protein localization to photoreceptor outer segment,BP,SPATA7
3870,GO:0008504,0.398538686963531,0.927568647408301,1,4,monoamine transmembrane transporter activity,MF,SLC29A4
14278,GO:0061438,0.398573970231666,0.927554308870321,1,4,renal system vasculature morphogenesis,BP,PKD2
14279,GO:0061439,0.398573970231666,0.927554308870321,1,4,kidney vasculature morphogenesis,BP,PKD2
3218,GO:0006868,0.398598291236921,0.927544424189213,1,4,glutamine transport,BP,SLC38A2
5019,GO:0015186,0.398598291236921,0.927544424189213,1,4,L-glutamine transmembrane transporter activity,MF,SLC38A2
15343,GO:0071608,0.398622866304475,0.927534435400383,1,4,macrophage inflammatory protein-1 alpha production,BP,TRPV4
15365,GO:0071640,0.398622866304475,0.927534435400383,1,4,regulation of macrophage inflammatory protein 1 alpha production,BP,TRPV4
17422,GO:1900226,0.39871682719576,0.927496236144459,1,4,negative regulation of NLRP3 inflammasome complex assembly,BP,SIRT2
12212,GO:0048495,0.398722826713935,0.927493796650692,1,4,Roundabout binding,MF,SLIT3
9282,GO:0035739,0.398754192266183,0.927481042117927,1,4,CD4-positive, alpha-beta T cell proliferation,BP,TGFBR2
19944,GO:2000561,0.398754192266183,0.927481042117927,1,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,TGFBR2
2655,GO:0006001,0.39879104180715,0.927466055788179,1,4,fructose catabolic process,BP,TKFC
14357,GO:0061624,0.39879104180715,0.927466055788179,1,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,TKFC
1124,GO:0002713,0.398803738399903,0.927460891768912,1,4,negative regulation of B cell mediated immunity,BP,BCL6
1219,GO:0002890,0.398803738399903,0.927460891768912,1,4,negative regulation of immunoglobulin mediated immune response,BP,BCL6
11095,GO:0045134,0.398804895895526,0.927460420975453,1,4,uridine-diphosphatase activity,MF,ENTPD6
1768,GO:0004376,0.3988744618836,0.927432122595686,1,4,glycolipid mannosyltransferase activity,MF,PIGV
10982,GO:0044803,0.398913018027836,0.927416435593555,1,4,multi-organism membrane organization,BP,GAS6
4763,GO:0010952,0.398954309632237,0.693331791436672,19,151,positive regulation of peptidase activity,BP,XDH;F2R;GSN;FBLN1;TNFSF15;GRAMD4;NGFR;MAPK3;MAPK12;BBC3;NLRP1;DAP;CTSH;IFT57;IFI27;PIDD1;FYN;CIDEB;HIP1
5786,GO:0017022,0.39895914563199,0.759566098019704,6,43,myosin binding,MF,GSN;RAB3B;TRIOBP;RAB25;STX1A;SPATA6
14143,GO:0061052,0.399012138180297,0.927376097775813,1,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,PAK1
14858,GO:0070670,0.399012278364533,0.791196842884997,4,27,response to interleukin-4,BP,ADAMTS13;STAT6;JAK3;TCF7
5169,GO:0015727,0.39901891244874,0.92737334041959,1,4,lactate transport,BP,SLC16A3
9347,GO:0035873,0.39901891244874,0.92737334041959,1,4,lactate transmembrane transport,BP,SLC16A3
3083,GO:0006659,0.399022146837373,0.927372023891215,1,4,phosphatidylserine biosynthetic process,BP,SLC27A1
7100,GO:0030905,0.399060227598212,0.927356522349433,1,4,retromer, tubulation complex,CC,SNX1
15850,GO:0072603,0.39906350815565,0.927355186836207,1,4,interleukin-5 secretion,BP,PRKCZ
20009,GO:2000662,0.39906350815565,0.927355186836207,1,4,regulation of interleukin-5 secretion,BP,PRKCZ
1454,GO:0003696,0.399111656405338,0.927335583954612,1,4,satellite DNA binding,MF,MLH3
18279,GO:1903224,0.399159757496883,0.927315996992278,1,4,regulation of endodermal cell differentiation,BP,DUSP6
9720,GO:0038189,0.399165520773523,0.927313649942467,1,4,neuropilin signaling pathway,BP,VEGFA
19148,GO:1905232,0.39919760564243,0.927300582766639,1,4,cellular response to L-glutamate,BP,FYN
1179,GO:0002826,0.399243324350276,0.927281960428534,1,4,negative regulation of T-helper 1 type immune response,BP,JAK3
19987,GO:2000637,0.399246407627009,0.81638506506282,3,19,positive regulation of gene silencing by miRNA,BP,EGFR;MAP2K1;MAP2K2
6728,GO:0030151,0.399247572979174,0.927280229708478,1,4,molybdenum ion binding,MF,MOCOS
12792,GO:0051121,0.399257788745202,0.927276068112844,1,4,hepoxilin metabolic process,BP,ALOX15B
12793,GO:0051122,0.399257788745202,0.927276068112844,1,4,hepoxilin biosynthetic process,BP,ALOX15B
14773,GO:0070522,0.399262704987799,0.927274065330606,1,4,ERCC4-ERCC1 complex,CC,ERCC1
3913,GO:0008585,0.399266912392033,0.73225749811225,9,67,female gonad development,BP,VEGFA;NUPR1;ZP3;EREG;SLIT3;CEBPB;NOS3;INSR;MMP19
9293,GO:0035754,0.399272795709403,0.927269954458845,1,4,B cell chemotaxis,BP,GAS6
12360,GO:0048787,0.399273518632894,0.927269659940547,1,4,presynaptic active zone membrane,CC,STX1A
12393,GO:0048861,0.399286961717134,0.927264183107164,1,4,leukemia inhibitory factor signaling pathway,BP,CTF1
5440,GO:0016312,0.399308807492062,0.927255282395864,1,4,inositol bisphosphate phosphatase activity,MF,INPP4A
1170,GO:0002793,0.399358220153966,0.690977752916726,20,153,positive regulation of peptide secretion,BP,F2R;POSTN;GLUL;ALOX15B;EGFR;PCK2;NLGN2;PRKCZ;PLA2G6;C5;ANO1;MAPK3;TTN;NLRP1;TRPV4;APLN;GLUD1;IL17RC;HFE;MYO18A
1437,GO:0003418,0.399364807999288,0.927232462795176,1,4,growth plate cartilage chondrocyte differentiation,BP,TGFBR2
1441,GO:0003431,0.399364807999288,0.927232462795176,1,4,growth plate cartilage chondrocyte development,BP,TGFBR2
15918,GO:0072757,0.399365907814819,0.92723201458787,1,4,cellular response to camptothecin,BP,RECQL5
9873,GO:0042166,0.399399934337877,0.927218146923121,1,4,acetylcholine binding,MF,CHRM3
1289,GO:0003104,0.399404063323654,0.927216464024462,1,4,positive regulation of glomerular filtration,BP,GAS6
18837,GO:1904505,0.399404570911413,0.927216257139363,1,4,regulation of telomere maintenance in response to DNA damage,BP,ERCC1
18838,GO:1904506,0.399404570911413,0.927216257139363,1,4,negative regulation of telomere maintenance in response to DNA damage,BP,ERCC1
12270,GO:0048625,0.399415625801846,0.927211751242184,1,4,myoblast fate commitment,BP,EPAS1
150,GO:0000306,0.399429325901416,0.92720616693564,1,4,extrinsic component of vacuolar membrane,CC,ULK1
7615,GO:0032021,0.399439990993817,0.927201819546141,1,4,NELF complex,CC,NELFCD
8783,GO:0034485,0.39945448898924,0.927195909499609,1,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,INPP5D
16743,GO:0098574,0.399466666290203,0.927190945243984,1,4,cytoplasmic side of lysosomal membrane,CC,LITAF
18811,GO:1904431,0.399483118090226,0.927184238092284,1,4,positive regulation of t-circle formation,BP,ERCC1
3715,GO:0008237,0.399497538109075,0.71121382264532,13,99,metallopeptidase activity,MF,ADAM19;ADAMTS7;NPEPL1;RNPEPL1;CLCA2;ADAMTS13;MMP28;MMP1;LTA4H;ACY1;RNPEP;MMP17;MMP19
8635,GO:0034190,0.399526464190003,0.927166564700164,1,4,apolipoprotein receptor binding,MF,PCSK9
4517,GO:0010575,0.399533919290697,0.816177504435748,3,19,positive regulation of vascular endothelial growth factor production,BP,C5;ATF4;SULF2
2794,GO:0006241,0.399538541405585,0.854386872913779,2,12,CTP biosynthetic process,BP,NME4;UCKL1
11501,GO:0046036,0.399538541405585,0.854386872913779,2,12,CTP metabolic process,BP,NME4;UCKL1
8042,GO:0032713,0.39954638832382,0.927158440191004,1,4,negative regulation of interleukin-4 production,BP,ZFPM1
6200,GO:0019695,0.399552927239546,0.927155773679959,1,4,choline metabolic process,BP,ALDH7A1
1696,GO:0004176,0.399557178969188,0.927154039830174,1,4,ATP-dependent peptidase activity,MF,LONP2
18580,GO:1903891,0.399557695372002,0.927153829240034,1,4,regulation of ATF6-mediated unfolded protein response,BP,WFS1
1917,GO:0004614,0.399564246239965,0.927151157749581,1,4,phosphoglucomutase activity,MF,PGM1
14555,GO:0070122,0.399573123258819,0.92714753754144,1,4,isopeptidase activity,MF,GGT1
14651,GO:0070290,0.399578684609735,0.927145269465255,1,4,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,PLD3
3474,GO:0007320,0.399589585449471,0.927140823667627,1,4,insemination,BP,SERPINE2
18099,GO:1902816,0.399596561957356,0.927137978280587,1,4,regulation of protein localization to microtubule,BP,TTBK2
18100,GO:1902817,0.399596561957356,0.927137978280587,1,4,negative regulation of protein localization to microtubule,BP,TTBK2
4328,GO:0009881,0.399600105266959,0.927136533106193,1,4,photoreceptor activity,MF,CRY2
757,GO:0001999,0.399616398414902,0.927129887552222,1,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,F2R
758,GO:0002001,0.399616398414902,0.927129887552222,1,4,renin secretion into blood stream,BP,F2R
15061,GO:0071072,0.399621039979134,0.927127994309265,1,4,negative regulation of phospholipid biosynthetic process,BP,SLC27A1
1459,GO:0003708,0.399631239199817,0.927123834052053,1,4,retinoic acid receptor activity,MF,RXRA
1494,GO:0003841,0.399632294255753,0.816106461423403,3,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,LPCAT4;TAZ;MBOAT2
14339,GO:0061588,0.399661087263423,0.927111658193247,1,4,calcium activated phospholipid scrambling,BP,ANO9
14340,GO:0061589,0.399661087263423,0.927111658193247,1,4,calcium activated phosphatidylserine scrambling,BP,ANO9
14341,GO:0061590,0.399661087263423,0.927111658193247,1,4,calcium activated phosphatidylcholine scrambling,BP,ANO9
14342,GO:0061591,0.399661087263423,0.927111658193247,1,4,calcium activated galactosylceramide scrambling,BP,ANO9
16491,GO:0097227,0.3996799653876,0.927103956626604,1,4,sperm annulus,CC,SEPT6
16938,GO:0098976,0.399685690307447,0.92710162097408,1,4,excitatory chemical synaptic transmission,BP,SSH1
10989,GO:0044821,0.399691184721275,0.927099379319732,1,4,meiotic telomere tethering at nuclear periphery,BP,LEMD2
14602,GO:0070197,0.399691184721275,0.927099379319732,1,4,meiotic attachment of telomere to nuclear envelope,BP,LEMD2
16499,GO:0097240,0.399691184721275,0.927099379319732,1,4,chromosome attachment to the nuclear envelope,BP,LEMD2
10976,GO:0044793,0.399694840625082,0.927097887731442,1,4,negative regulation by host of viral process,BP,EIF2AK4
10991,GO:0044828,0.399694840625082,0.927097887731442,1,4,negative regulation by host of viral genome replication,BP,EIF2AK4
2990,GO:0006537,0.39970682361315,0.927092998606388,1,4,glutamate biosynthetic process,BP,GLUD1
8337,GO:0033206,0.399727087923756,0.927084730192606,1,4,meiotic cytokinesis,BP,SPIRE1
8614,GO:0034144,0.399728543423277,0.927084136285136,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
16605,GO:0097490,0.399747612048588,0.92707635517334,1,4,sympathetic neuron projection extension,BP,SEMA3F
16606,GO:0097491,0.399747612048588,0.92707635517334,1,4,sympathetic neuron projection guidance,BP,SEMA3F
7119,GO:0030951,0.399763294114272,0.927069955588881,1,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,LMNA
13540,GO:0060029,0.399772166135911,0.927066334913155,1,4,convergent extension involved in organogenesis,BP,VANGL2
20021,GO:2000675,0.399779855517272,0.927063196782901,1,4,negative regulation of type B pancreatic cell apoptotic process,BP,WFS1
10608,GO:0043622,0.399786664697017,0.927060417803801,1,4,cortical microtubule organization,BP,TRPV4
11807,GO:0046726,0.399787100693447,0.927060239861613,1,4,positive regulation by virus of viral protein levels in host cell,BP,TBC1D20
249,GO:0000710,0.399787146134122,0.927060221316041,1,4,meiotic mismatch repair,BP,ERCC1
18524,GO:1903763,0.399788607219682,0.927059625004701,1,4,gap junction channel activity involved in cell communication by electrical coupling,MF,GJC2
1434,GO:0003415,0.399821051394363,0.927046382814983,1,4,chondrocyte hypertrophy,BP,TGFBR2
6895,GO:0030478,0.399824622731685,0.927044925071436,1,4,actin cap,CC,GSN
15108,GO:0071225,0.399824739763096,0.927044877301283,1,4,cellular response to muramyl dipeptide,BP,ARHGEF2
20078,GO:2000780,0.399826039180797,0.815966509594474,3,19,negative regulation of double-strand break repair,BP,MAGEF1;HMGA2;RECQL5
6371,GO:0021562,0.399836626914316,0.927040025087806,1,4,vestibulocochlear nerve development,BP,SLITRK6
17881,GO:1902219,0.399844441839556,0.927036835006079,1,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,ARHGEF2
14293,GO:0061476,0.399858748203085,0.927030994870335,1,4,response to anticoagulant,BP,EGR1
15286,GO:0071503,0.399858748203085,0.927030994870335,1,4,response to heparin,BP,EGR1
15287,GO:0071504,0.399858748203085,0.927030994870335,1,4,cellular response to heparin,BP,EGR1
1975,GO:0004694,0.399863890487227,0.927028895618855,1,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,EIF2AK4
16386,GO:0097048,0.399887519183319,0.927019249116972,1,4,dendritic cell apoptotic process,BP,GAS6
20015,GO:2000668,0.399887519183319,0.927019249116972,1,4,regulation of dendritic cell apoptotic process,BP,GAS6
2744,GO:0006145,0.399916441243991,0.927007440500963,1,4,purine nucleobase catabolic process,BP,XDH
6401,GO:0021636,0.399930593895506,0.927001661668579,1,4,trigeminal nerve morphogenesis,BP,SEMA3F
6402,GO:0021637,0.399930593895506,0.927001661668579,1,4,trigeminal nerve structural organization,BP,SEMA3F
9695,GO:0038114,0.399949209336535,0.926994060150012,1,4,interleukin-21-mediated signaling pathway,BP,JAK3
16819,GO:0098756,0.399949209336535,0.926994060150012,1,4,response to interleukin-21,BP,JAK3
16820,GO:0098757,0.399949209336535,0.926994060150012,1,4,cellular response to interleukin-21,BP,JAK3
661,GO:0001865,0.399988094089888,0.926978180176349,1,4,NK T cell differentiation,BP,TGFBR2
12806,GO:0051136,0.399988094089888,0.926978180176349,1,4,regulation of NK T cell differentiation,BP,TGFBR2
14501,GO:0070022,0.399988198063355,0.926978137712219,1,4,transforming growth factor beta receptor complex,CC,TGFBR2
11764,GO:0046643,0.399992018814763,0.926976577255861,1,4,regulation of gamma-delta T cell activation,BP,SOX13
10387,GO:0043237,0.399999324018134,0.92697359363575,1,4,laminin-1 binding,MF,NID1
4555,GO:0010641,0.400013358427621,0.92696786143384,1,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,HIP1
12194,GO:0048406,0.400067935664634,0.926945567296767,1,4,nerve growth factor binding,MF,NGFR
5372,GO:0016191,0.400076886530818,0.926941910573183,1,4,synaptic vesicle uncoating,BP,DNAJC6
13471,GO:0055059,0.400099333439116,0.926932739771428,1,4,asymmetric neuroblast division,BP,ARHGEF2
17341,GO:1900084,0.400102837021627,0.926931308299982,1,4,regulation of peptidyl-tyrosine autophosphorylation,BP,VEGFA
9231,GO:0035639,0.400119159500385,0.633150818275511,171,1403,purine ribonucleoside triphosphate binding,MF,ACTA2;ACSF2;PTK6;GLUL;OBSCN;EGFR;SCN8A;NEK9;DGKA;DNM1;BRSK1;ERCC6;MYH15;SMARCA1;MST1R;CUL9;RPS6KA2;PYGL;TK2;ULK2;MAPK13;CDK18;MAP2K1;PCK2;ABCA2;PKN1;ALPK1;OPLAH;DGKQ;TUBG2;DNAH1;ARL2;ULK1;RAB3B;MYH11;NMRK1;TTBK2;PRKCZ;PAK1;ABCA7;AARS;STK39;FGFR3;NPR2;NMNAT2;DDX59;NME4;ACVR2B;SPEG;ACTR1B;CHD2;RHOBTB2;ABCG1;AGAP1;CARS;KIF17;CHD3;MKNK2;IFT27;NLRX1;SEPT5;ACACB;MAPK3;PC;STK40;ACSS2;MVD;FAM20C;RHOF;TUBE1;MAPK12;MYH3;PI4K2A;SEPT10;MAP2K2;TWF2;KIF21B;PAK6;KIF26B;TTN;PSKH1;HLCS;GTPBP1;GALK1;NTPCR;NADK;DHX32;TEP1;NLRP1;MAP3K12;NEK8;WNK4;PKN3;LONP2;MARK3;HLTF;TGFBR2;TRPV4;SLFN5;TRIB3;RAB40B;ARL10;MLH3;MINK1;TTLL11;TRPV1;PIP5KL1;EPHA1;GLUD1;SUCLG2;ERN1;BCR;ATP7B;FYCO1;CHKB;SRR;KIF13B;UCKL1;CAMK1;ADCY6;RAB43;ATP2B4;STRADB;ASNS;AKT1;DGUOK;CHEK2;SEPT6;ASS1;KIF27;FGFR4;MARK4;RAB25;INSR;ACSS1;GNAL;RPS6KA5;MAP2K5;BRAF;MAPK10;JAK3;SCYL3;ATP12A;CSNK1E;TKFC;EHD3;FYN;MAST4;ATP8B2;PEX1;RECQL5;RAB13;RHOBTB3;ETNK2;MSH5;ENTPD2;FUK;MYO18A;MAP3K10;CHD6;EPHB2;MAGI1;SEPT8;FGFR1;ERBB2;EIF2AK4;STK32B;PFKL;HSP90AB4P;CAMKK1;IKBKB
16410,GO:0097091,0.400125808056247,0.926921922508562,1,4,synaptic vesicle clustering,BP,NLGN2
11993,GO:0047555,0.400130832229698,0.926919869569343,1,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,PDE2A
14914,GO:0070827,0.40013111229926,0.926919755128405,1,4,chromatin maintenance,BP,MTHFR
4621,GO:0010746,0.40014020984367,0.926916037664655,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
4622,GO:0010748,0.40014020984367,0.926916037664655,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
7503,GO:0031697,0.400170191444629,0.926903785668165,1,4,beta-1 adrenergic receptor binding,MF,DLG4
5369,GO:0016185,0.400174436292347,0.926902050906087,1,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM1
16871,GO:0098844,0.400174436292347,0.926902050906087,1,4,postsynaptic endocytic zone membrane,CC,DNM1
16889,GO:0098884,0.400174436292347,0.926902050906087,1,4,postsynaptic neurotransmitter receptor internalization,BP,DNM1
14245,GO:0061343,0.400175868971123,0.926901465400624,1,4,cell adhesion involved in heart morphogenesis,BP,TGFBR2
9108,GO:0035426,0.400182520651432,0.926898746961363,1,4,extracellular matrix-cell signaling,BP,LRP5
16317,GO:0090599,0.40022762707206,0.926880311004576,1,4,alpha-glucosidase activity,MF,GAA
1427,GO:0003402,0.400258744760371,0.926867590856836,1,4,planar cell polarity pathway involved in axis elongation,BP,VANGL2
14299,GO:0061502,0.400344702400989,0.926832446332994,1,4,early endosome to recycling endosome transport,BP,SORL1
19914,GO:2000481,0.400348045985552,0.926831079067526,1,4,positive regulation of cAMP-dependent protein kinase activity,BP,ATP2B4
5376,GO:0016199,0.400354736098676,0.926828343284902,1,4,axon midline choice point recognition,BP,ROBO3
11383,GO:0045794,0.400370074566716,0.926822070697302,1,4,negative regulation of cell volume,BP,KCNMA1
3604,GO:0008046,0.400426006149715,0.926799194932506,1,4,axon guidance receptor activity,MF,EPHB2
5216,GO:0015822,0.400496484931686,0.926770363098667,1,4,ornithine transport,BP,SLC25A29
18335,GO:1903352,0.400496484931686,0.926770363098667,1,4,L-ornithine transmembrane transport,BP,SLC25A29
13719,GO:0060317,0.400505908678768,0.815475028233379,3,19,cardiac epithelial to mesenchymal transition,BP,PDCD4;TGFBR2;TGFBR3
14227,GO:0061304,0.400522988591882,0.926759519014267,1,4,retinal blood vessel morphogenesis,BP,LRP5
2715,GO:0006096,0.400534554320099,0.724833612661817,10,75,glycolytic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;PPARA;MLXIPL;GALK1;ALDOC;INSR;PFKL
8349,GO:0033239,0.400551072360364,0.926748027332442,1,4,negative regulation of cellular amine metabolic process,BP,ATP2B4
10500,GO:0043426,0.400559274471613,0.92674467087442,1,4,MRF binding,MF,BHLHE40
6760,GO:0030202,0.400560278461127,0.926744260016475,1,4,heparin metabolic process,BP,XYLT2
6768,GO:0030210,0.400560278461127,0.926744260016475,1,4,heparin biosynthetic process,BP,XYLT2
15991,GO:0086036,0.400575266170347,0.926738126495574,1,4,regulation of cardiac muscle cell membrane potential,BP,EHD3
11749,GO:0046627,0.400632079514408,0.789945919427838,4,27,negative regulation of insulin receptor signaling pathway,BP,PRKCZ;PTPRE;GPR21;GRB10
12801,GO:0051130,0.400667737626225,0.639765600209062,110,905,positive regulation of cellular component organization,BP,DLG4;APOE;ESPN;ZMYND8;GSN;ADGRL1;WIPF1;PTK6;CDC42EP5;LRP1;VEGFA;DDB2;ERCC1;RAPGEF3;TSPAN1;NOS1;SHANK2;CRTC1;ADGRB2;ARAP1;MMP1;CNTN1;TFDP2;OBSL1;CUL7;HYAL1;ARPIN;MAP2K1;SNX9;ARL2;ULK1;VPS11;NPHP4;NLGN2;CAPRIN2;PAK1;ABCA7;PHF1;PLXNB3;MICALL2;FBXW8;NEURL1;NGFR;PLXNB1;EREG;PLA2G6;LPAR3;MAPK3;BNIP3;SEMA5A;PLEK2;SLITRK6;TWF2;LRSAM1;DMTN;BBC3;DOCK11;SSH1;METRN;TENM2;FLOT1;JDP2;WHAMMP3;VLDLR;TPBG;ENDOG;LRP5;PCSK9;PKIB;TRIOBP;TRPV4;APLN;PEMT;PROM2;WNT7A;EPHA1;GAS6;CROCC;BCR;FYCO1;CAMK1;PPP1R15A;AMIGO2;TSG101;INSR;WNT3;RPS6KA5;C6ORF89;BRAF;HFE;TP73;SPIRE1;BCL6;EPS8L1;FYN;SIRT2;GDF15;PLXND1;EPS8L2;MYO18A;CIDEB;EPHB2;ITGA2;FGFR1;OSCP1;C15ORF62;CORO1B;HMBOX1;NET1;HIP1
7267,GO:0031258,0.400678260240887,0.815350341099186,3,19,lamellipodium membrane,CC,CSPG4;PLEK2;PLXND1
3656,GO:0008142,0.400710345272535,0.92668283275982,1,4,oxysterol binding,MF,OSBPL5
9664,GO:0038044,0.400802176917024,0.9266452272702,1,4,transforming growth factor-beta secretion,BP,ITGB6
3515,GO:0007442,0.40080839880569,0.926642678943977,1,4,hindgut morphogenesis,BP,TCF7
19494,GO:1990414,0.400817071456983,0.926639126755977,1,4,replication-born double-strand break repair via sister chromatid exchange,BP,RECQL5
15888,GO:0072687,0.400884702063341,0.92661142260392,1,4,meiotic spindle,CC,SIRT2
5159,GO:0015705,0.400962987680706,0.9265793456169,1,4,iodide transport,BP,ANO1
20053,GO:2000739,0.401054206731478,0.926541958246926,1,4,regulation of mesenchymal stem cell differentiation,BP,LTBP3
4801,GO:0012501,0.401120211924668,0.631580659151994,178,1483,programmed cell death,BP,XDH;DUSP6;F2R;TNFRSF6B;APOE;HS1BP3;NFATC4;PRODH;H1F0;GSN;EGR1;LRP1;ALOX15B;PDCD4;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;PRDX5;TNFSF15;KRT15;CST3;MEF2D;DDIT3;PACS2;ERCC6;NDRG1;ARHGEF19;GRAMD4;MST1R;ZFP36L1;ADARB1;NUPR1;RGL2;RPS6KA2;PYGL;TFDP2;NISCH;MAP2K1;PPL;PKN1;DDIT4;BTG1;SYNGAP1;ITGA6;TMEM173;PLEKHG5;SHC1;SPRY2;PRSS8;PRKCZ;PAK1;AARS;STK39;FGFR3;ELMO3;NME4;NEURL1;RAG1;NGFR;ARHGEF4;PLEKHG2;TNFRSF25;PLA2G6;CHAC1;MKNK2;SATB1;ING4;HMGA2;SLIT3;MAPK3;BNIP3;SEMA5A;THRA;STK40;GSDMA;CTSB;ARHGEF2;INPP5D;MAP2K2;ANGPTL4;ATF4;BBC3;PAK6;IFI6;MDK;KCNMA1;UNC5B;IRF5;HERPUD1;NLRP1;PEG3;ENDOG;CEBPB;MAP3K12;LRP5;PCSK9;DNMT3A;TGFBR2;CSRNP3;ITGA1;TNFAIP8L1;TRIB3;DAP;CDK5RAP3;NOS3;AGO4;MINK1;WNT7A;TRPV1;BNIP3L;EPHA1;SHARPIN;GAS6;ERN1;ALKBH7;PPP1R15A;STRADB;CTSH;TNFRSF14;UACA;GSDMC;MGMT;ASNS;HINT2;AKT1;CARD11;MICAL1;BEX2;AMIGO2;CHEK2;IFT57;FGFR4;STEAP3;PHLDA1;DNASE2;LMNA;MARK4;IFI27;INSR;KRT19;RABGGTA;MAP2K5;BRAF;EDA2R;PIDD1;CAT;LGALS1;TIMP1;JAK3;TP73;MNT;BCL6;FYN;ARHGEF17;SIRT2;GDF15;PHLDA2;ADA;CIDEA;MYO18A;CIDEB;VAV3;MAP3K10;EPHB2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;NET1;TRIM2;IKBKB;SNCB;HIP1
14079,GO:0060947,0.40116218201582,0.926497687804156,1,4,cardiac vascular smooth muscle cell differentiation,BP,VEGFA
6080,GO:0019240,0.401304685874879,0.926439235060276,1,4,citrulline biosynthetic process,BP,ATP2B4
15267,GO:0071478,0.401377764634021,0.693594989337081,18,141,cellular response to radiation,BP,NFATC4;XPC;EGR1;DDB2;ERCC1;MAPK13;HYAL1;MC1R;IMPACT;HMGA2;ATF4;MGMT;CRY2;CHEK2;TP73;ADIRF;EIF2AK4;NET1
9654,GO:0038027,0.401415082423923,0.92639393233467,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ABCA7
8974,GO:0035095,0.401431321739109,0.926387266846508,1,4,behavioral response to nicotine,BP,PPARA
12486,GO:0050650,0.401447960366434,0.814793043720855,3,19,chondroitin sulfate proteoglycan biosynthetic process,BP,B3GAT3;CSPG4;XYLT2
18438,GO:1903564,0.401513868573305,0.926353379381647,1,4,regulation of protein localization to cilium,BP,CROCC
15539,GO:0072014,0.401623308396135,0.926308436733781,1,4,proximal tubule development,BP,PKD1
16224,GO:0090306,0.401638306972763,0.926302276076571,1,4,spindle assembly involved in meiosis,BP,GOLGA2
5005,GO:0015166,0.401739097464124,0.926260868123387,1,4,polyol transmembrane transporter activity,MF,AQP3
7912,GO:0032496,0.401819215264671,0.679380658158461,25,200,response to lipopolysaccharide,BP,TNIP1;F2R;TNFRSF6B;FOS;ACP5;PDCD4;NR1D1;LOXL1;NOS1;ADAMTS13;CYP27B1;PCK2;NGFR;TNFRSF25;MAPK3;PDCD1LG2;LITAF;HDAC5;CEBPB;NOS3;BCR;SRR;PTAFR;TNFRSF14;AKT1
18125,GO:1902895,0.401935232623771,0.814439847647152,3,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,FOS;NGFR;APLN
13494,GO:0055091,0.402212094587809,0.926066352381436,1,4,phospholipid homeostasis,BP,ABCG1
15745,GO:0072367,0.402345861856712,0.926011283943624,1,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,PPARA
13853,GO:0060509,0.402545139881578,0.925929199116234,1,4,Type I pneumocyte differentiation,BP,THRA
18906,GO:1904684,0.402681857449195,0.925872850852508,1,4,negative regulation of metalloendopeptidase activity,BP,SORL1
3401,GO:0007185,0.402831961807724,0.925810954476149,1,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,PTPRU
4958,GO:0015037,0.403034409424349,0.85215618461304,2,12,peptide disulfide oxidoreductase activity,MF,GSTO1;GSTO2
5366,GO:0016176,0.403057205030599,0.925718013789235,1,4,superoxide-generating NADPH oxidase activator activity,MF,SH3PXD2A
10581,GO:0043568,0.403152638929436,0.925678613640977,1,4,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
15372,GO:0071651,0.403279284738182,0.925626307470392,1,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,TRPV4
11816,GO:0046785,0.403323328386771,0.736178285324161,8,59,microtubule polymerization,BP,EML2;TUBG2;ARL2;PAK1;NDE1;TRPV4;TUBGCP6;GOLGA2
14131,GO:0061038,0.40338465870473,0.925582769339647,1,4,uterus morphogenesis,BP,WNT7A
3500,GO:0007406,0.403568490161176,0.925506776343414,1,4,negative regulation of neuroblast proliferation,BP,KCTD11
9632,GO:0036515,0.403765301966292,0.925425363897633,1,4,serotonergic neuron axon guidance,BP,VANGL2
6736,GO:0030162,0.403765822723459,0.648642685555085,63,520,regulation of proteolysis,BP,TNIP1;XDH;F2R;TNFRSF6B;APOE;BTBD2;SERPINE2;GSN;EDEM1;TIMP2;VEGFA;PRNP;FBLN1;PRDX5;TFPI2;TNFSF15;CST3;ABTB1;GRAMD4;PLAT;LTBP4;SNX9;MAGEF1;SERPING1;RAG1;NGFR;TRIB2;C5;PLGRKT;CHAC1;ECM1;MAPK3;MAPK12;BBC3;IFI6;PKD1;SORL1;HERPUD1;PAPLN;NLRP1;RHBDF1;TRIB3;DAP;GAS6;CTSH;MGMT;AKT1;MICAL1;HMSD;IFT57;FGFR4;IFI27;MAP2K5;PIDD1;TIMP1;HFE;SNX33;CSNK1E;FYN;SIRT2;CIDEB;HIP1;BTBD11
15876,GO:0072674,0.403818506178973,0.925403346122458,1,4,multinuclear osteoclast differentiation,BP,SH3PXD2A
15877,GO:0072675,0.403818506178973,0.925403346122458,1,4,osteoclast fusion,BP,SH3PXD2A
3810,GO:0008406,0.403821413658957,0.691357279085165,18,141,gonad development,BP,VEGFA;ERCC1;CST3;NUPR1;ZP3;WNT2B;EREG;SLIT3;CEBPB;NOS3;AGO4;WDR19;TBC1D20;INSR;REC8;RAB13;RHOBTB3;MMP19
18774,GO:1904352,0.403885075798535,0.925375791565961,1,4,positive regulation of protein catabolic process in the vacuole,BP,LRP1
13817,GO:0060443,0.403951827125729,0.769196660658496,5,35,mammary gland morphogenesis,BP,ETV5;STAT6;AREG;LRP5;TGFBR2
19682,GO:2000051,0.403955507509382,0.925346631503595,1,4,negative regulation of non-canonical Wnt signaling pathway,BP,RNF213
7981,GO:0032608,0.404027606033799,0.755368220065695,6,43,interferon-beta production,BP,PTPRS;RNF135;TMEM173;NLRX1;FLOT1;IRF5
4734,GO:0010906,0.40403459368991,0.728116887541655,9,67,regulation of glucose metabolic process,BP,NR1D1;IGFBP4;MLYCD;DGKQ;PPARA;ACACB;AKT1;INSR;PHLDA2
447,GO:0001221,0.404148112009672,0.769037934773889,5,35,transcription cofactor binding,MF,NR1D1;PPARA;CHD6;PER1;TEAD2
12577,GO:0050777,0.404302619057026,0.715923541802192,11,84,negative regulation of immune response,BP,IL20RB;SERPING1;FAM3A;NLRX1;STAT6;INPP5D;BCR;HFE;JAK3;BCL6;HLA-G
9683,GO:0038094,0.4043636021406,0.735283704914798,8,59,Fc-gamma receptor signaling pathway,BP,WIPF1;FCGRT;PAK1;PLA2G6;MAPK3;PIK3R2;FYN;VAV3
5588,GO:0016620,0.404464467873334,0.786974227619979,4,27,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH7A1;ALDH4A1;ALDH1L2;ALDH1L1
4216,GO:0009394,0.40488836101404,0.786185352860309,4,28,2'-deoxyribonucleotide metabolic process,BP,NEIL1;DGUOK;ADA;NUDT18
10284,GO:0043065,0.405162580125913,0.649851706718129,57,467,positive regulation of apoptotic process,BP,XDH;DUSP6;F2R;NFATC4;GSN;PDCD4;OBSCN;NTSR1;RBCK1;PRNP;TNFSF15;DDIT3;ARHGEF19;GRAMD4;NUPR1;RPS6KA2;TFDP2;BTG1;ITGA6;PLEKHG5;NEURL1;NGFR;ARHGEF4;PLEKHG2;PLA2G6;ING4;HMGA2;BNIP3;ARHGEF2;INPP5D;ATF4;BBC3;KCNMA1;IRF5;NLRP1;ENDOG;PCSK9;CSRNP3;ITGA1;DAP;TRPV1;BNIP3L;CTSH;AKT1;CHEK2;IFT57;IFI27;PIDD1;TP73;BCL6;ARHGEF17;SIRT2;CIDEB;VAV3;MAP3K10;NET1;HIP1
113,GO:0000242,0.405171922538656,0.812086088651182,3,19,pericentriolar material,CC,TUBG2;WDR60;TUBE1
10314,GO:0043124,0.405246770173881,0.768148747924261,5,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;NLRX1;NLRP1;MAPKBP1;PER1
6975,GO:0030659,0.405253965880526,0.647646969477213,62,506,cytoplasmic vesicle membrane,CC,PTPRS;DLG4;APOE;SLC2A3;LRP1;EGFR;CLTCL1;CD9;SYT8;HBEGF;GAA;ULK2;SYNGR1;TMEM173;SNX9;RAB3B;CD68;ITPR3;MCTP1;CEMIP;BRI3;TMC6;PKD2;VAMP2;AREG;AP1G2;KCNAB2;DYSF;RHOF;PI4K2A;IFNGR2;SV2A;MAP6;GPRC5C;DBNDD1;RAB40B;NOS3;WNT7A;NBEAL2;PTAFR;RAB43;ITPR2;RASSF9;TCIRG1;COPG1;ICA1;PLAU;WNT3;MYOF;SNX33;SNX17;SPIRE1;HGSNAT;RAB13;TOM1;AP2A2;STX1A;LAMTOR2;SEC31B;HLA-G;BSG;HIP1
6346,GO:0021532,0.405285988631935,0.786335000122222,4,27,neural tube patterning,BP,IFT140;TCTN1;WDR19;FKBP8
10782,GO:0044275,0.405387532272071,0.768034730915468,5,35,cellular carbohydrate catabolic process,BP,PYGB;PGM1;GAA;PYGL;TKFC
3271,GO:0006952,0.405571426699839,0.63498448155594,110,914,defense response,BP,TNIP1;PTPRS;HTRA1;F2R;NT5E;TNFRSF6B;APOE;NFATC4;FOS;IL20RB;GSN;EGR1;CTNNBIP1;PTK6;ACP5;RNF135;PDCD4;EGFR;NR1D1;PRDX5;IGFBP4;CST3;GGT1;ADAMTS13;MST1R;ADARB1;NUPR1;RPL13A;MAPK13;HYAL1;CYP27B1;DDIT4;TMEM173;SHC1;PRKCZ;SERPING1;PAK1;APOBEC3C;STK39;FAM3A;ZP3;CCDC88B;RAG1;NGFR;MUC19;EREG;TNFRSF25;PLA2G6;C5;APOBEC3F;PPARA;PLGRKT;FNDC4;NLRX1;ECM1;MAPK3;BNIP3;IFITM1;GSDMA;CTSB;IFNGR2;C1RL;ARHGEF2;LRSAM1;LTB4R2;IFI6;FLOT1;MDK;HDAC5;IRF5;DEAF1;NLRP1;CEBPB;ISG20;TRPV4;IL17RE;TMSB4X;PDE2A;TRPV1;BNIP3L;SHARPIN;BCR;PTAFR;RAB43;TNFRSF14;GSDMC;MAPKBP1;AKT1;CARD11;IL17RC;TCIRG1;IFI27;RPS6KA5;LTB4R;ULBP1;ITGB6;LYST;HFE;JAK3;BCL6;TKFC;FYN;SIRT2;ADA;PER1;ITGA2;EIF2AK4;HLA-G;SDHAF4;IKBKB
10437,GO:0043312,0.405669689018913,0.657203259883793,43,352,neutrophil degranulation,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;BRI3;ACTR1B;TMC6;KCNAB2;RHOF;CTSB;LTA4H;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;APRT;METTL7A;HGSNAT;TOM1;AP2A2;GALNS;LAMTOR2;PFKL
5066,GO:0015293,0.4062331761322,0.719827450829374,10,75,symporter activity,MF,SLC16A3;SLC2A9;SLC16A5;SLC12A7;SLC22A18;MFSD3;SLC6A9;SLC6A6;SLC38A2;SLC10A6
15102,GO:0071219,0.406342704763697,0.701102108055889,14,109,cellular response to molecule of bacterial origin,BP,TNIP1;PDCD4;NR1D1;ADAMTS13;MAPK3;PDCD1LG2;LITAF;HDAC5;CEBPB;NOS3;BCR;PTAFR;AKT1;SIRT2
2537,GO:0005795,0.406514317035968,0.697557786467811,15,116,Golgi stack,CC,ARAP1;ASAP2;PITPNM1;B4GALNT4;MARCH4;DNMBP;MARCH9;SORL1;ST3GAL3;SULF2;GOLGA2P5;NECAB3;B4GALT2;GOLGA8A;GOLGA2
16700,GO:0097731,0.406878602145771,0.742054238126979,7,51,9+0 non-motile cilium,CC,IFT140;SHANK2;NPHP4;KIF17;SPATA7;WDR19;IFT57
16702,GO:0097733,0.406878602145771,0.742054238126979,7,51,photoreceptor cell cilium,CC,IFT140;SHANK2;NPHP4;KIF17;SPATA7;WDR19;IFT57
3381,GO:0007161,0.407184700390732,0.924002040749754,1,4,calcium-independent cell-matrix adhesion,BP,PKD1
11730,GO:0046597,0.407945971301418,0.848992873582667,2,12,negative regulation of viral entry into host cell,BP,GSN;IFITM1
17845,GO:1902107,0.408169616982638,0.712489464707442,11,84,positive regulation of leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1;PRKCZ;RAG1;INPP5D;TGFBR2;GAS6;BCL6;ADA;HLA-G
6379,GO:0021575,0.408281242870245,0.78399777433081,4,27,hindbrain morphogenesis,BP,SERPINE2;MAP2K1;TRNP1;WNT7A
4803,GO:0012506,0.40832031009969,0.643913923579147,64,523,vesicle membrane,CC,PTPRS;DLG4;APOE;SLC2A3;LRP1;EGFR;CLTCL1;CD9;NOS1;SYT8;HBEGF;GAA;ULK2;SYNGR1;DGKQ;TMEM173;SNX9;RAB3B;CD68;ITPR3;MCTP1;CEMIP;BRI3;TMC6;PKD2;VAMP2;AREG;AP1G2;KCNAB2;DYSF;RHOF;PI4K2A;IFNGR2;SV2A;MAP6;GPRC5C;DBNDD1;RAB40B;NOS3;WNT7A;NBEAL2;PTAFR;RAB43;ITPR2;RASSF9;TCIRG1;COPG1;ICA1;PLAU;WNT3;MYOF;SNX33;SNX17;SPIRE1;HGSNAT;RAB13;TOM1;AP2A2;STX1A;LAMTOR2;SEC31B;HLA-G;BSG;HIP1
4581,GO:0010676,0.408348365964213,0.765631576523514,5,35,positive regulation of cellular carbohydrate metabolic process,BP,NTSR1;PPARA;PTAFR;AKT1;INSR
2195,GO:0005070,0.409288959472224,0.764866192641009,5,35,SH3/SH2 adaptor activity,MF,GRB7;SH2D2A;VAV3;PAG1;GRB10
947,GO:0002366,0.409404428382163,0.645769404442527,57,469,leukocyte activation involved in immune response,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;ERCC1;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;PRKCZ;BRI3;ACTR1B;TMC6;S100A13;STAT6;VAMP2;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;ZFPM1;DOCK11;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;LGALS1;JAK3;APRT;METTL7A;HGSNAT;BCL6;TOM1;ADA;AP2A2;GALNS;LAMTOR2;MFNG;EIF2AK4;PFKL
7441,GO:0031585,0.40961060571848,0.922982046551284,1,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
9447,GO:0036064,0.409854312158529,0.706137991170561,12,92,ciliary basal body,CC,BBS2;IFT140;EVC;BBS1;NPHP4;TTBK2;KIF17;PKD2;SPATA7;AKT1;IFT57;MARK4
6887,GO:0030427,0.410173615096966,0.691081080418688,16,124,site of polarized growth,CC,ADGRL1;TIMP2;SHANK2;ORAI2;DLG3;PI4K2A;TWF2;STMN3;KIF21B;SSH1;TENM2;MAP3K12;TRPV4;TMOD2;C9ORF72;SIRT2
20150,GO:2001025,0.411164443407072,0.846901373889438,2,12,positive regulation of response to drug,BP,RAB3B;ENDOG
4152,GO:0009218,0.411186055682012,0.806929646351191,3,20,pyrimidine ribonucleotide metabolic process,BP,NME4;UCKL1;UPP1
5613,GO:0016671,0.411674071164305,0.846568839200297,2,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRB2;ERO1B
7218,GO:0031122,0.411841252928172,0.737825053516034,7,51,cytoplasmic microtubule organization,BP,TUBG2;CCDC88B;HOOK2;STMN3;TRPV4;CEP126;TUBGCP6
6680,GO:0030055,0.412803194989523,0.649714105192459,44,361,cell-substrate junction,CC,FLNC;FHL1;GSN;LRP1;EGFR;CD9;PARVB;MRC2;RPL13A;MPRIP;MAP2K1;ITGA6;ARL2;GRB7;PAK1;FGFR3;SPRY4;ITGB4;TNS1;MAPK3;CSPG4;ITGB5;ARHGAP22;ARHGEF2;MAP2K2;PROCR;FLOT1;TRIOBP;TRPV4;ITGA1;LMO7;SLC9A3R2;ZFYVE21;ASAP3;CAPN2;PLAU;ITGB6;CAT;UBOX5;EHD3;ITGA2;CORO1B;RPL12;BSG
6717,GO:0030135,0.413041881332231,0.667388210170214,26,208,coated vesicle,CC,APOE;LRP1;EGFR;CLTCL1;CD9;HBEGF;SNX9;VPS11;CEMIP;MALL;TMED4;VAMP2;AREG;AP1G2;VANGL2;PCSK9;EPN3;STEAP2;RASSF9;COPG1;RAB13;GOLGA2;AP2A2;SEC31B;HLA-G;HIP1
2269,GO:0005201,0.413191221735383,0.761680757783408,5,35,extracellular matrix structural constituent,MF,FBLN1;TFPI2;COL4A6;EFEMP2;LAMB1
10425,GO:0043299,0.413475290791343,0.647762613926463,46,378,leukocyte degranulation,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;BRI3;ACTR1B;TMC6;S100A13;VAMP2;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;APRT;METTL7A;HGSNAT;TOM1;AP2A2;GALNS;LAMTOR2;PFKL
3111,GO:0006691,0.4135319290629,0.84535342967922,2,12,leukotriene metabolic process,BP,GGT1;LTA4H
902,GO:0002283,0.413546932105189,0.649687252739743,43,353,neutrophil activation involved in immune response,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;BRI3;ACTR1B;TMC6;KCNAB2;RHOF;CTSB;LTA4H;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;APRT;METTL7A;HGSNAT;TOM1;AP2A2;GALNS;LAMTOR2;PFKL
15150,GO:0071310,0.413756961690641,0.616728029677881,215,1796,cellular response to organic substance,BP,TNIP1;XDH;DUSP6;HTRA1;BBS2;TNFRSF6B;NFATC4;FOS;IL20RB;GSN;EGR1;PGF;FGFBP1;POSTN;PTK6;EDEM1;FAM210B;LRP1;PDCD4;VEGFA;EGFR;RBCK1;PRNP;NR1D1;ADAMTS7;RAPGEF3;TNFSF15;NOS1;DDIT3;ADAMTS13;MST1R;ZFP36L1;MMP1;CTF1;RPL13A;LTBP4;SLC27A1;MAPK13;KLF9;RNF165;CUL7;UROS;HYAL1;SYNGR1;MAP2K1;CYP27B1;PCK2;COL6A1;DDIT4;ITGA6;TMEM173;SHC1;SPRY2;CD68;LAMA5;PRKCZ;PAK1;FGFR3;KDM3A;GLDC;NPR2;SPRY4;NEURL1;ACVR2B;SPPL2B;NGFR;EPOR;GSTO1;LTBP1;EREG;PTPRE;TNFRSF25;PLA2G6;MTMR4;PPARA;ANO1;SESN2;AIP;IMPACT;PKD2;STAT6;VAMP2;SLIT3;ECM1;MAPK3;ITGB5;ERRFI1;THRA;IFITM1;FAM20C;LTBP2;CTSB;MAPK12;PAQR6;MLXIPL;IFNGR2;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;TWF2;DMTN;LITAF;ATF4;SSH1;IFI6;FLOT1;HDAC5;IRF5;IL17RD;HERPUD1;SRSF5;GSTM2;SULF2;RFX2;ENDOG;CEBPB;LRP5;CREBRF;PCSK9;FBXL15;ISG20;DNMT3A;TGFBR2;IL17RE;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;CALCOCO1;EDA;CDK5RAP3;NOS3;AGO4;WNT7A;TRPV1;PIK3R2;SHARPIN;GAS6;ERN1;BCR;TADA3;PTAFR;PPP1R15A;RXRA;ADCY6;RAB43;ATP2B4;CTSH;TNFRSF14;MGMT;ASNS;AKT1;IGFBP7;ITPR2;CDKN1C;CRY2;CHEK2;IGFBP2;IL17RC;FGFR4;TCIRG1;ACADVL;LMNA;CAPN2;IFI27;INSR;WNT3;FOXO4;RPS6KA5;ANKZF1;MAP2K5;BRAF;EDA2R;GPR21;CAT;MYOF;MAPK10;LGALS1;TIMP1;HFE;JAK3;CHRM3;APRT;BCL6;FYN;LEMD2;SIRT2;GDF15;RECQL5;RAB13;CIDEA;HDAC8;EIF4EBP1;TGFBR3;TCF7;STX1A;LAMTOR2;PER1;ITGA2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;HLA-G;CORO1B;FRS3;GRB10;CREB3L4;IKBKB;TEAD2
17365,GO:1900119,0.413958617681228,0.845073591892792,2,12,positive regulation of execution phase of apoptosis,BP,ENDOG;SIRT2
5679,GO:0016799,0.41420168460737,0.804695006172792,3,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,DNPH1;NEIL1;MPG
1225,GO:0002903,0.414656931975798,0.844615048753231,2,12,negative regulation of B cell apoptotic process,BP,BCL6;ADA
6703,GO:0030120,0.415049515148383,0.734883159996986,7,52,vesicle coat,CC,EGFR;CLTCL1;AP1G2;COPG1;AP2A2;SEC31B;HIP1
16316,GO:0090596,0.415135234137895,0.680949166798892,18,141,sensory organ morphogenesis,BP,VEGFA;SDK2;NAGLU;SPRY2;WNT2B;COL8A1;MAPK3;VANGL2;SLITRK6;LRP5;TRIOBP;BCR;WDR19;TBC1D20;CELSR1;EPHB2;FGFR1;TSHZ1
18045,GO:1902653,0.41584395661422,0.725188469415117,8,60,secondary alcohol biosynthetic process,BP,APOE;SEC14L2;ABCG1;ACACB;MVD;HSD17B7;TM7SF2;PLPP6
10038,GO:0042537,0.416138871202665,0.843639624318104,2,12,benzene-containing compound metabolic process,BP,GSTM2;GSTM3
3154,GO:0006757,0.417384321956227,0.709842493317004,10,76,ATP generation from ADP,BP,PGM1;DHTKD1;DDIT4;OGDHL;PPARA;MLXIPL;GALK1;ALDOC;INSR;PFKL
3027,GO:0006576,0.4182587753072,0.775662301974759,4,28,cellular biogenic amine metabolic process,BP,ALDH7A1;AZIN2;SAT2;DHPS
8009,GO:0032651,0.418507141352717,0.75698234386304,5,36,regulation of interleukin-1 beta production,BP,F2R;EGR1;ACP5;ERRFI1;NLRP1
19771,GO:2000242,0.418669840271749,0.775335490683393,4,28,negative regulation of reproductive process,BP,NPR2;ZP3;TIMP1;ADA
2520,GO:0005775,0.41891498777554,0.682955831161492,16,126,vacuolar lumen,CC,PYGB;NAPRT;GAA;CTSF;HYAL1;NAGLU;CSPG4;CTSB;SDC2;FUCA1;HEXB;HEXA;ARSA;MAN2B1;DPP7;GALNS
305,GO:0000815,0.419083923964059,0.841691788921699,2,12,ESCRT III complex,CC,CHMP1B;CHMP4C
5049,GO:0015248,0.419163414694846,0.800992884655259,3,20,sterol transporter activity,MF,APOE;ABCG1;OSBPL1A
2581,GO:0005874,0.419172340255337,0.645835344719792,41,331,microtubule,CC,CLIP2;NINL;SNPH;DNM1;NDRG1;REEP2;EML2;TUBG2;FAM110C;DNAH1;SPRY2;KIF17;ENKD1;KCNAB2;RGS14;DNAL4;PBXIP1;TUBE1;HOOK2;ARHGEF2;MAP2K2;KIF21B;KIF26B;MAP6;NDE1;TRPV4;MAP1LC3A;CDK5RAP3;TTLL11;NICN1;LZTS2;MAPRE3;KIF13B;REEP4;KIF27;HAUS4;TUBGCP6;EML3;SIRT2;GOLGA2;MTA1
9769,GO:0039702,0.419355360442182,0.800849031499348,3,20,viral budding via host ESCRT complex,BP,CHMP1B;TSG101;CHMP4C
15082,GO:0071158,0.419451441265304,0.707890384630451,10,77,positive regulation of cell cycle arrest,BP,RBL2;TFDP2;PKD2;HMGA2;PCBP4;CHEK2;UHRF2;FOXO4;PIDD1;TP73
1308,GO:0003158,0.419527437259448,0.707933573994245,10,76,endothelium development,BP,XDH;PTPRS;RAPGEF3;BTG1;LAMA5;ACVR2B;PDE2A;WNT7A;GSTM3;IKBKB
13232,GO:0051937,0.419768716403757,0.800539082119551,3,20,catecholamine transport,BP,NISCH;RAB3B;STX1A
12467,GO:0050482,0.420343541320068,0.84085486994538,2,12,arachidonic acid secretion,BP,NTSR1;PLA2G6
18622,GO:1903963,0.420343541320068,0.84085486994538,2,12,arachidonate transport,BP,NTSR1;PLA2G6
8878,GO:0034707,0.420510040057579,0.84074407288191,2,12,chloride channel complex,CC,ANO1;TTYH3
4385,GO:0010042,0.4207112149122,0.840610147058525,2,12,response to manganese ion,BP,D2HGDH;ATF4
11339,GO:0045717,0.420715509669185,0.840607287321527,2,12,negative regulation of fatty acid biosynthetic process,BP,TRIB3;ACADVL
5064,GO:0015291,0.42079950785488,0.681275041378484,16,125,secondary active transmembrane transporter activity,MF,SLC7A8;SLC16A3;SLC2A9;SLC16A5;SLC12A7;SLC37A2;SLCO4A1;SLC22A18;MFSD3;SLC6A9;SLC6A6;SLC9A7;SLC37A4;SLC38A2;SLC10A6;SLC9A5
5674,GO:0016791,0.420807991093061,0.660087877743861,26,208,phosphatase activity,MF,DUSP6;PTPRS;NT5E;ACP5;DUSP5;PPM1M;LHPP;ACP6;MAP2K1;PPP2R3B;PTPRE;SSH3;PSPH;PPM1J;MTMR4;NT5C1B;MYH3;PTPDC1;INPP5D;SSH1;NTPCR;PTPRU;DNAJC6;CTDSPL;PLPP6;INPP4A
10894,GO:0044458,0.420937109841071,0.840459694909306,2,12,motile cilium assembly,BP,IFT57;SPATA6
9428,GO:0036020,0.421168914522018,0.840305230016364,2,12,endolysosome membrane,CC,PCSK9;AP2A2
4548,GO:0010634,0.421310131431019,0.691382500799916,13,101,positive regulation of epithelial cell migration,BP,VEGFA;HBEGF;HYAL1;SEMA5A;TGFBR2;TMSB4X;NOS3;WNT7A;CTSH;AKT1;RAB25;ITGA2;FGFR1
7960,GO:0032580,0.421495588574045,0.712655617019989,9,68,Golgi cisterna membrane,CC,ARAP1;ASAP2;PITPNM1;B4GALNT4;ST3GAL3;GOLGA2P5;B4GALT2;GOLGA8A;GOLGA2
1085,GO:0002673,0.421622071941239,0.772982582498353,4,28,regulation of acute inflammatory response,BP,IL20RB;SERPING1;ZP3;C5
560,GO:0001701,0.421861384081211,0.652562920770249,31,249,in utero embryonic development,BP,VEGFA;EGFR;ZFP36L1;MDFI;MAP2K1;FBXW8;ZP3;PLCD3;C5;PKD2;TCTN1;PLCD1;KDM4C;PKD1;ENDOG;CEBPB;TGFBR2;NOS3;RXRA;WDR19;AKT1;CAPN2;KRT19;TFEB;PHLDA2;ADA;ETNK2;EPAS1;EDNRA;FGFR1;APBA1
773,GO:0002029,0.421924254008564,0.839801364336699,2,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,DNM1;APLN
6568,GO:0022401,0.421924254008564,0.839801364336699,2,12,negative adaptation of signaling pathway,BP,DNM1;APLN
14659,GO:0070301,0.422053418831299,0.71203118764345,9,69,cellular response to hydrogen peroxide,BP,CST3;MAPK13;IMPACT;STAT6;BNIP3;ENDOG;MAP1LC3A;ANKZF1;NET1
14178,GO:0061134,0.422082049226404,0.686592118623271,14,112,peptidase regulator activity,MF,SERPINE2;TIMP2;FBLN1;PRDX5;TFPI2;CST3;SERPING1;C5;PAPLN;NLRP1;GAS6;CTSH;HMSD;TIMP1
13521,GO:0060008,0.422195450944809,0.8396202550866,2,12,Sertoli cell differentiation,BP,CST3;RAB13
10537,GO:0043508,0.422276083341489,0.839566387068142,2,12,negative regulation of JUN kinase activity,BP,PDCD4;TP73
11472,GO:0045956,0.422295381735805,0.839553493009684,2,12,positive regulation of calcium ion-dependent exocytosis,BP,ZP3;STX1A
12756,GO:0051055,0.423184369328336,0.753112829633833,5,36,negative regulation of lipid biosynthetic process,BP,APOE;SLC27A1;CYP27B1;TRIB3;ACADVL
4495,GO:0010528,0.423218706762167,0.83893595092177,2,12,regulation of transposition,BP,APOBEC3C;APOBEC3F
4496,GO:0010529,0.423218706762167,0.83893595092177,2,12,negative regulation of transposition,BP,APOBEC3C;APOBEC3F
1102,GO:0002691,0.423239587115473,0.838921971353784,2,12,regulation of cellular extravasation,BP,BCR;PTAFR
6892,GO:0030449,0.423302076026755,0.83888013073849,2,12,regulation of complement activation,BP,SERPING1;C5
19780,GO:2000257,0.423302076026755,0.83888013073849,2,12,regulation of protein activation cascade,BP,SERPING1;C5
7118,GO:0030950,0.423792889183684,0.838551300779868,2,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOBTB2;RHOF
15437,GO:0071801,0.423800976052818,0.838545879896948,2,12,regulation of podosome assembly,BP,GSN;ARHGEF2
14888,GO:0070742,0.423843289866386,0.838517514069197,2,12,C2H2 zinc finger domain binding,MF,HMGA2;ZXDC
11759,GO:0046638,0.423963546009116,0.797381190447526,3,20,positive regulation of alpha-beta T cell differentiation,BP,PRKCZ;TGFBR2;ADA
3080,GO:0006656,0.42418031094241,0.770935469581614,4,28,phosphatidylcholine biosynthetic process,BP,SLC27A1;PEMT;CHKB;STARD10
8345,GO:0033233,0.424232489556263,0.797177953678778,3,20,regulation of protein sumoylation,BP,EGR1;HMG20B;PIAS3
15187,GO:0071360,0.424389332768663,0.838151231323325,2,12,cellular response to exogenous dsRNA,BP,TMEM173;FLOT1
4032,GO:0009068,0.424575712141669,0.838026109955005,2,12,aspartate family amino acid catabolic process,BP,ALDH7A1;PHYKPL
11358,GO:0045744,0.424885324277677,0.770369972915387,4,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,DNM1;APLN;ATP2B4;ADA
9870,GO:0042159,0.425025931446017,0.837723657847969,2,12,lipoprotein catabolic process,BP,APOE;LYPLAL1
17501,GO:1901019,0.425038082743143,0.737441627106938,6,44,regulation of calcium ion transmembrane transporter activity,BP,NOS1;GSTO1;PLA2G6;PKD2;GSTM2;EHD3
17083,GO:0101003,0.425096116385943,0.751524483157604,5,36,ficolin-1-rich granule membrane,CC,SLC2A3;GAA;NBEAL2;TCIRG1;AP2A2
8666,GO:0034260,0.425184288402751,0.751451132296648,5,36,negative regulation of GTPase activity,BP,GPSM1;ARL2;SPRY2;PLXNB3;RASA4
10990,GO:0044827,0.425677778848289,0.837285232556849,2,12,modulation by host of viral genome replication,BP,TBC1D20;EIF2AK4
15538,GO:0072012,0.425852525615107,0.83716759486665,2,12,glomerulus vasculature development,BP,ACTA2;EGR1
1118,GO:0002707,0.42590138100098,0.795914706476114,3,20,negative regulation of lymphocyte mediated immunity,BP,IL20RB;HFE;BCL6
15941,GO:0080025,0.426067047164496,0.795789110957684,3,20,phosphatidylinositol-3,5-bisphosphate binding,MF,PLEK2;WDR45;HIP1
2246,GO:0005159,0.426110130462359,0.836994097018117,2,12,insulin-like growth factor receptor binding,MF,SHC1;INSR
12713,GO:0051000,0.426137145759184,0.836975896521571,2,12,positive regulation of nitric-oxide synthase activity,BP,APOE;AKT1
5783,GO:0017017,0.426178118644029,0.836948290621768,2,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP6;DUSP5
15525,GO:0071985,0.426299331396272,0.769234037074428,4,28,multivesicular body sorting pathway,BP,CHMP5;LYST;TMEM50B;UBXN6
5605,GO:0016653,0.426325836526608,0.836848743918857,2,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NOS1;NOS3
7923,GO:0032509,0.426385594683991,0.795547512598031,3,20,endosome transport via multivesicular body sorting pathway,BP,LYST;TMEM50B;UBXN6
4432,GO:0010288,0.426718046821407,0.795295228399554,3,20,response to lead ion,BP,DNMT3A;MAP1LC3A;CAT
1112,GO:0002701,0.426780544618327,0.795247785425877,3,20,negative regulation of production of molecular mediator of immune response,BP,HFE;JAK3;BCL6
16334,GO:0090661,0.42679091174017,0.910688765372063,1,5,box H/ACA telomerase RNP complex,CC,TERC
4721,GO:0010888,0.426913265536705,0.836452562848312,2,12,negative regulation of lipid storage,BP,ABCG1;PPARA
4617,GO:0010742,0.427044548196504,0.795047320722369,3,20,macrophage derived foam cell differentiation,BP,ALOX15B;ABCG1;PPARA
16070,GO:0090077,0.427044548196504,0.795047320722369,3,20,foam cell differentiation,BP,ALOX15B;ABCG1;PPARA
14806,GO:0070570,0.427080421383659,0.795020074324265,3,20,regulation of neuron projection regeneration,BP,PTPRS;MAP2K1;BRAF
2110,GO:0004896,0.427122923491344,0.7356629484072,6,44,cytokine receptor activity,MF,IL20RB;EPOR;IFNGR2;IL17RD;IL17RE;IL17RC
4764,GO:0010954,0.427277592972538,0.836206596308829,2,12,positive regulation of protein processing,BP,GSN;PLGRKT
8983,GO:0035115,0.42728365231025,0.794865684934327,3,20,embryonic forelimb morphogenesis,BP,WNT7A;ZNF358;WNT3
5537,GO:0016531,0.427326454524608,0.910436478717106,1,5,copper chaperone activity,MF,CCS
1015,GO:0002507,0.427395976728604,0.836126630874467,2,12,tolerance induction,BP,TGFBR2;HLA-G
18420,GO:1903533,0.427789846887744,0.689766167268181,12,94,regulation of protein targeting,BP,PRNP;ANK3;VPS11;PAK1;CEMIP;MICALL2;DMTN;PEMT;BNIP3L;FYN;ERBB2;OSCP1
16477,GO:0097201,0.427795821093658,0.835856394513124,2,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,IMPACT;SIRT2
8284,GO:0033127,0.42782894056165,0.835834000145707,2,12,regulation of histone phosphorylation,BP,MAPK3;RPS6KA5
11047,GO:0045063,0.427945658726057,0.835755066163382,2,12,T-helper 1 cell differentiation,BP,STAT6;JAK3
6050,GO:0019201,0.428123269528015,0.794227281849752,3,20,nucleotide kinase activity,MF,DLG4;DLG3;CARD11
16627,GO:0097529,0.428274455393956,0.694165429853869,11,87,myeloid leukocyte migration,BP,PGF;VEGFA;MMP28;VEGFB;C5;MAPK3;TRPV4;ITGA1;IL17RC;CKLF;VAV3
11828,GO:0046827,0.428426138635391,0.793996771066013,3,20,positive regulation of protein export from nucleus,BP,RAPGEF3;GAS6;CAMK1
15100,GO:0071216,0.428485128837432,0.67406754829093,16,127,cellular response to biotic stimulus,BP,TNIP1;PDCD4;NR1D1;DDIT3;ADAMTS13;MAPK3;PDCD1LG2;LITAF;HDAC5;CEBPB;NOS3;BCR;PTAFR;AKT1;SIRT2;WFS1
10022,GO:0042491,0.428501152454309,0.793939660391536,3,20,inner ear auditory receptor cell differentiation,BP,SLITRK6;TRIOBP;FGFR1
11606,GO:0046329,0.428594562457306,0.767385197953359,4,28,negative regulation of JNK cascade,BP,PDCD4;AKT1;TP73;PER1
4190,GO:0009299,0.428640172049448,0.793833800565504,3,20,mRNA transcription,BP,DDIT3;EREG;ATF4
18314,GO:1903306,0.428757179992244,0.835205702684528,2,12,negative regulation of regulated secretory pathway,BP,BCR;BRAF
3326,GO:0007039,0.428762154894183,0.835202331937145,2,12,protein catabolic process in the vacuole,BP,LRP1;TCIRG1
12462,GO:0050435,0.428891797740082,0.767145320196751,4,28,amyloid-beta metabolic process,BP,APOE;PRNP;ABCA7;SORL1
17337,GO:1900077,0.428932506040065,0.767112459329684,4,28,negative regulation of cellular response to insulin stimulus,BP,PRKCZ;PTPRE;GPR21;GRB10
19927,GO:2000515,0.428974344798581,0.835058528937392,2,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,JAK3;BCL6
8784,GO:0034497,0.428987756743487,0.835049437334433,2,12,protein localization to phagophore assembly site,BP,PACS2;WDR45
12813,GO:0051147,0.429035613079089,0.688715422235681,12,93,regulation of muscle cell differentiation,BP,PDCD4;PAK1;EREG;OLFM2;THRA;MAPK12;FLOT1;HDAC5;CAMK1;FOXO4;GDF15;CTH
4816,GO:0014015,0.429042557014266,0.748233249908367,5,36,positive regulation of gliogenesis,BP,SERPINE2;GJC2;ETV5;TENM4;TP73
10716,GO:0044090,0.429139905850193,0.834946281097052,2,12,positive regulation of vacuole organization,BP,ULK1;LRSAM1
11986,GO:0047496,0.42927850721383,0.748035943822181,5,36,vesicle transport along microtubule,BP,BLOC1S4;PRKCZ;NDE1;FYCO1;BLOC1S1
10008,GO:0042462,0.429281848868789,0.834850014065054,2,12,eye photoreceptor cell development,BP,VEGFA;NAGLU
17309,GO:1900015,0.42935643403,0.793287988354575,3,20,regulation of cytokine production involved in inflammatory response,BP,PDCD4;IL17RC;PER1
12374,GO:0048821,0.429379884467634,0.793270107196019,3,20,erythrocyte development,BP,FAM210B;DMTN;BCL6
19613,GO:1990837,0.429401437888792,0.623180589915252,65,531,sequence-specific double-stranded DNA binding,MF,ZC3H6;ZMYND8;NFATC4;FOS;H1F0;EGR1;NR1D1;BAHCC1;MEF2D;DDIT3;TCFL5;TFDP2;MXI1;SOX13;ETV4;PHF21A;PBX2;SOX12;ELK3;KDM3A;FOXQ1;SALL2;ETV1;ETV5;HES2;CHD2;TEF;CARF;PPARA;SATB1;STAT6;KLF7;HMGA2;THRA;MLXIPL;TSPYL2;LITAF;ATF4;ZFPM1;ZNF516;JDP2;DEAF1;RFX2;CEBPB;CREBRF;HLTF;MXD3;BHLHE40;MLH3;RXRA;TNRC18;CRY2;ZNF217;SMARCD2;TP73;MNT;TFEB;BCL6;HSF4;POU2F2;MTA1;PER1;CREB3L4;DBP;SIX5
8039,GO:0032703,0.429435158135592,0.834746005301814,2,12,negative regulation of interleukin-2 production,BP,IL20RB;PRNP
12330,GO:0048714,0.429493139107493,0.834706660646258,2,12,positive regulation of oligodendrocyte differentiation,BP,TENM4;TP73
16958,GO:0099054,0.429717209917397,0.834554564810733,2,12,presynapse assembly,BP,NLGN2;WNT7A
12597,GO:0050805,0.429768752565527,0.747625800074551,5,36,negative regulation of synaptic transmission,BP,SHANK2;PLA2G6;BRAF;ASIC1;PNKD
5300,GO:0016010,0.429803386955312,0.834496049632371,2,12,dystrophin-associated glycoprotein complex,CC,SNTA1;KRT19
16336,GO:0090665,0.429803386955312,0.834496049632371,2,12,glycoprotein complex,CC,SNTA1;KRT19
6713,GO:0030131,0.429820453345866,0.766395200885234,4,28,clathrin adaptor complex,CC,EGFR;AP1G2;AP2A2;HIP1
8790,GO:0034505,0.429918826006724,0.834417648218573,2,12,tooth mineralization,BP,PPARA;FAM20C
13552,GO:0060045,0.429947686121612,0.83439804458415,2,12,positive regulation of cardiac muscle cell proliferation,BP,TGFBR3;FGFR1
11255,GO:0045581,0.429953694242394,0.792832349993088,3,20,negative regulation of T cell differentiation,BP,JAK3;BCL6;ERBB2
8305,GO:0033151,0.430363334473464,0.834115574672331,2,12,V(D)J recombination,BP,RAG1;TCF7
11251,GO:0045577,0.430407768815776,0.792485635374966,3,20,regulation of B cell differentiation,BP,ZFP36L1;INPP5D;CARD11
8819,GO:0034616,0.430422036722662,0.834075660940387,2,12,response to laminar fluid shear stress,BP,ASS1;MAP2K5
13923,GO:0060628,0.430501447821552,0.834021658514006,2,12,regulation of ER to Golgi vesicle-mediated transport,BP,SORL1;TBC1D20
7608,GO:0032007,0.430554797785181,0.746967648595813,5,36,negative regulation of TOR signaling,BP,EPM2A;DDIT4;SESN2;TNFAIP8L1;C12ORF66
15191,GO:0071364,0.4305551979578,0.746967313364265,5,36,cellular response to epidermal growth factor stimulus,BP,EGFR;ZFP36L1;ERRFI1;AKT1;ERBB2
7767,GO:0032300,0.430615099736922,0.833944355051519,2,12,mismatch repair complex,CC,MLH3;MSH5
11270,GO:0045601,0.431120386778575,0.791940966676695,3,20,regulation of endothelial cell differentiation,BP,XDH;BTG1;IKBKB
1402,GO:0003338,0.431169293152965,0.791903562327375,3,20,metanephros morphogenesis,BP,PKD2;KIF26B;PKD1
15201,GO:0071380,0.431571227548453,0.83329327050032,2,12,cellular response to prostaglandin E stimulus,BP,ADCY6;AKT1
20265,GO:2001275,0.431643580449888,0.833243946641339,2,12,positive regulation of glucose import in response to insulin stimulus,BP,PAK1;PIK3R2
16133,GO:0090179,0.431835065686789,0.833113371827718,2,12,planar cell polarity pathway involved in neural tube closure,BP,VANGL2;CELSR1
7982,GO:0032609,0.431897864040778,0.720103227870152,7,53,interferon-gamma production,BP,IL20RB;PRNP;ZP3;PDCD1LG2;ZFPM1;GAS6;BTN3A2
4797,GO:0010996,0.431941258461718,0.833040935259373,2,12,response to auditory stimulus,BP,XPC;SLITRK6
16103,GO:0090130,0.432121052420862,0.650912106501785,25,201,tissue migration,BP,ACTA2;APOE;VEGFA;HBEGF;PRSS3;HYAL1;PKN1;PLEKHG5;SEMA5A;LTB4R2;HDAC5;PKN3;TGFBR2;TMSB4X;NOS3;WNT7A;CTSH;AKT1;RAB25;MAP2K5;RAB13;PLXND1;ITGA2;FGFR1;CORO1B
7796,GO:0032354,0.432166892341022,0.832886970300986,2,12,response to follicle-stimulating hormone,BP,ASNS;TGFBR3
3510,GO:0007423,0.432196286083901,0.635756814395981,38,308,sensory organ development,BP,VEGFA;EGFR;IFT140;CST3;SDK2;MYH15;RAB11FIP4;NAGLU;SMOC1;SPRY2;NPHP4;SALL2;ACVR2B;WNT2B;IFT27;COL8A1;MAPK3;LAMB2;VANGL2;SLITRK6;LRP5;TRIOBP;TGFBR2;WNT7A;BCR;RXRA;ATP2B4;WDR19;MAB21L2;TBC1D20;HSF4;CELSR1;EPHB2;FGFR1;FKBP8;TSHZ1;SDHAF4;SIX5
12679,GO:0050921,0.432363779073247,0.696199595951,10,78,positive regulation of chemotaxis,BP,PGF;VEGFA;VEGFB;MAPK3;SEMA5A;TRPV4;TMSB4X;GAS6;ITGA2;FGFR1
4953,GO:0015026,0.43238337054953,0.790974020634343,3,20,coreceptor activity,MF,NGFR;LRP5;TGFBR3
11415,GO:0045861,0.432444284956091,0.648964031682505,26,213,negative regulation of proteolysis,BP,TNFRSF6B;SERPINE2;TIMP2;VEGFA;PRNP;PRDX5;TFPI2;CST3;PLAT;SERPING1;RAG1;NGFR;C5;CHAC1;ECM1;IFI6;SORL1;HERPUD1;PAPLN;GAS6;AKT1;MICAL1;HMSD;MAP2K5;TIMP1;HFE
14598,GO:0070192,0.432459000295386,0.745370516873358,5,36,chromosome organization involved in meiotic cell cycle,BP,MLH3;AGO4;REC8;LEMD2;MSH5
13818,GO:0060444,0.432518004204703,0.790870822161386,3,20,branching involved in mammary gland duct morphogenesis,BP,ETV5;AREG;LRP5
13617,GO:0060148,0.432939331854647,0.790547716579469,3,20,positive regulation of posttranscriptional gene silencing,BP,EGFR;MAP2K1;MAP2K2
12798,GO:0051127,0.43294210403726,0.832357423544663,2,12,positive regulation of actin nucleation,BP,GSN;WIPF1
6950,GO:0030595,0.433049001729514,0.680428959312899,13,104,leukocyte chemotaxis,BP,PGF;VEGFA;MMP28;VEGFB;C5;MAPK3;TRPV4;ITGA1;GAS6;IL17RC;CKLF;LYST;VAV3
2582,GO:0005875,0.433170228083903,0.672989191858916,15,118,microtubule associated complex,CC,CLIP2;EML2;DNAH1;WDR60;ACTR1B;KIF17;NUDCD3;DNAL4;KIF21B;RABGAP1;KIF26B;NDE1;KIF13B;KIF27;HAUS4
18482,GO:1903671,0.433334008753005,0.790244839226506,3,20,negative regulation of sprouting angiogenesis,BP,NGFR;HDAC5;MAP2K5
19481,GO:1990391,0.43339272666208,0.744585937773929,5,36,DNA repair complex,CC,XPC;ERCC1;PHF21A;MLH3;MSH5
5071,GO:0015298,0.434015791757177,0.789721157214242,3,20,solute:cation antiporter activity,MF,SLC22A18;SLC9A7;SLC9A5
3797,GO:0008379,0.434060455034096,0.907225806211128,1,5,thioredoxin peroxidase activity,MF,PRDX5
12041,GO:0048011,0.43414585358152,0.789621187110434,3,20,neurotrophin TRK receptor signaling pathway,BP,DDIT4;SPRY2;NGFR
3538,GO:0007548,0.434208635679965,0.656188092249274,21,168,sex differentiation,BP,VEGFA;ERCC1;CST3;NUPR1;ZP3;WNT2B;EREG;SLIT3;PKD1;CEBPB;NOS3;AGO4;WNT7A;WDR19;TBC1D20;INSR;REC8;RAB13;RHOBTB3;TCF7;MMP19
1098,GO:0002687,0.434284433343136,0.701002803799415,9,70,positive regulation of leukocyte migration,BP,PGF;VEGFA;VEGFB;ZP3;MAPK3;TRPV4;GAS6;PTAFR;ITGA2
1458,GO:0003707,0.434414652834057,0.74372617183397,5,36,steroid hormone receptor activity,MF,NR1D1;PPARA;THRA;PAQR6;RXRA
1099,GO:0002688,0.434452673063142,0.708518928168181,8,62,regulation of leukocyte chemotaxis,BP,PGF;VEGFA;MMP28;VEGFB;C5;MAPK3;TRPV4;GAS6
15144,GO:0071295,0.434473409091122,0.789369318753095,3,20,cellular response to vitamin,BP,POSTN;CYP27B1;GAS6
11713,GO:0046545,0.434586269104834,0.700861263670481,9,69,development of primary female sexual characteristics,BP,VEGFA;NUPR1;ZP3;EREG;SLIT3;CEBPB;NOS3;INSR;MMP19
4946,GO:0015012,0.434643239551289,0.789238675411585,3,20,heparan sulfate proteoglycan biosynthetic process,BP,B3GAT3;VANGL2;XYLT2
14037,GO:0060841,0.434853431408769,0.831048030404315,2,12,venous blood vessel development,BP,VEGFA;ACVR2B
2579,GO:0005871,0.435260164556345,0.728679204305161,6,44,kinesin complex,CC,KIF17;KIF21B;KIF26B;NDE1;KIF13B;KIF27
1478,GO:0003774,0.435371390836334,0.682928463206476,12,93,motor activity,MF,MYH15;DNAH1;MYH11;WDR60;KIF17;DNAL4;MYH3;KIF21B;MYH16;KIF26B;KIF13B;KIF27
7921,GO:0032507,0.435634964620722,0.70762249428641,8,61,maintenance of protein location in cell,BP,GSN;ANK3;ARL2;SYNE3;TWF2;SORL1;TMSB4X;AKT1
1282,GO:0003091,0.43567155603893,0.788446832228461,3,20,renal water homeostasis,BP,AQP3;ADCY6;WFS1
718,GO:0001945,0.435685911185468,0.788435768454806,3,20,lymph vessel development,BP,VEGFA;ACVR2B;PKD1
17338,GO:1900078,0.43607530113891,0.788135555946211,3,20,positive regulation of cellular response to insulin stimulus,BP,PRKCZ;PAK1;PIK3R2
17078,GO:0099738,0.436258600179065,0.761166990417569,4,28,cell cortex region,CC,PRKCZ;PKD2;PCLO;RIMS3
16736,GO:0098554,0.436787465904827,0.828333072097099,2,13,cytoplasmic side of endoplasmic reticulum membrane,CC,SPPL2B;PKD2
3444,GO:0007257,0.436787847845441,0.760735039339106,4,28,activation of JUN kinase activity,BP,ERCC6;PKN1;ERN1;MAP3K10
5154,GO:0015696,0.437283248682237,0.726685578638646,6,45,ammonium transport,BP,NOS1;RAB3B;AZIN2;SLC25A29;SLC38A2;ADA
9621,GO:0036503,0.437304615481077,0.686052460662144,11,86,ERAD pathway,BP,FBXO2;TMEM129;EDEM1;UBXN4;FBXO6;HERPUD1;ANKZF1;UBXN6;MAN1B1;WFS1;SYVN1
9838,GO:0042100,0.438023013508625,0.726045550031925,6,45,B cell proliferation,BP,PKN1;INPP5D;CARD11;BCL6;ADA;VAV3
9033,GO:0035264,0.438371284543112,0.67567464829814,13,102,multicellular organism growth,BP,GAMT;BBS2;ERCC1;ERCC6;ZFP36L1;ADARB1;WWTR1;STK40;SLITRK6;GPR21;ETNK2;FKBP8;APBA1
2615,GO:0005925,0.438522678090876,0.625690236982,43,356,focal adhesion,CC,FLNC;FHL1;GSN;LRP1;EGFR;CD9;PARVB;MRC2;RPL13A;MPRIP;MAP2K1;ITGA6;ARL2;GRB7;PAK1;FGFR3;SPRY4;TNS1;MAPK3;CSPG4;ITGB5;ARHGAP22;ARHGEF2;MAP2K2;PROCR;FLOT1;TRIOBP;TRPV4;ITGA1;LMO7;SLC9A3R2;ZFYVE21;ASAP3;CAPN2;PLAU;ITGB6;CAT;UBOX5;EHD3;ITGA2;CORO1B;RPL12;BSG
5724,GO:0016874,0.438949256026757,0.66139433182784,17,135,ligase activity,MF,ACSF2;NAPRT;GLUL;SLC27A1;AARS;PPCS;CARS;ACACB;PC;ACSS2;HLCS;SLC27A3;TTLL11;SUCLG2;ASNS;ASS1;ACSS1
4084,GO:0009142,0.439486486280615,0.667007068968326,15,120,nucleoside triphosphate biosynthetic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;MLXIPL;GALK1;ALDOC;TMSB4X;UCKL1;TCIRG1;INSR;TAZ;PFKL
11097,GO:0045137,0.44057528521345,0.657120850440172,18,144,development of primary sexual characteristics,BP,VEGFA;ERCC1;CST3;NUPR1;ZP3;WNT2B;EREG;SLIT3;CEBPB;NOS3;AGO4;WDR19;TBC1D20;INSR;REC8;RAB13;RHOBTB3;MMP19
9882,GO:0042180,0.440761487693068,0.652035553087236,20,163,cellular ketone metabolic process,BP,EGR1;TYSND1;NR1D1;MLYCD;DGKQ;AKR7A2;DHRS4;PPARA;ACACB;MLXIPL;LONP2;TRIB3;ATP2B4;AKT1;FGFR4;HAGH;CBR4;ACADVL;PNKD;KDSR
7005,GO:0030705,0.440792192408935,0.654426006840604,19,152,cytoskeleton-dependent intracellular transport,BP,IFT140;BLOC1S4;PRKCZ;CCDC88B;WDR60;SPG11;KIF17;IFT27;HOOK2;NDE1;CEP131;FYCO1;KIF13B;WDR19;IFT57;TTC21A;COPG1;BLOC1S1;APBA1
18590,GO:1903901,0.440954593530016,0.702728164132568,8,62,negative regulation of viral life cycle,BP,TNIP1;GSN;APOBEC3C;APOBEC3F;HMGA2;IFITM1;ISG20;EIF2AK4
7559,GO:0031929,0.441647503505074,0.67708141205616,12,94,TOR signaling,BP,EPM2A;DDIT4;DGKQ;SESN2;TNFAIP8L1;GAS6;C12ORF66;AKT1;CARD11;C9ORF72;EIF4EBP1;LAMTOR2
18589,GO:1903900,0.441927701061049,0.66829318908417,14,112,regulation of viral life cycle,BP,TNIP1;GSN;ADARB1;APOBEC3C;APOBEC3F;HMGA2;PC;IFITM1;ISG20;TSG101;TBC1D20;CHMP4C;LGALS1;EIF2AK4
12915,GO:0051298,0.442083210978485,0.701874647013643,8,61,centrosome duplication,BP,BRSK1;PKD2;CHMP1B;NDE1;CEP131;CHMP5;CHMP4C;TUBGCP6
6980,GO:0030666,0.442522990807623,0.667740111548648,14,112,endocytic vesicle membrane,CC,DLG4;APOE;LRP1;EGFR;CD9;HBEGF;NOS3;WNT7A;RAB43;TCIRG1;WNT3;AP2A2;HLA-G;HIP1
4144,GO:0009209,0.443218052451806,0.823841219940688,2,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,NME4;UCKL1
16249,GO:0090342,0.443235768948346,0.735927805354875,5,37,regulation of cell aging,BP,HMGA2;TERC;LMNA;YPEL3;BCL6
17658,GO:1901564,0.443332340237811,0.57925164004264,580,4910,organonitrogen compound metabolic process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;DLG4;HTRA1;GAMT;F2R;ST6GALNAC2;NT5E;TNFRSF6B;APOE;BTBD2;ZMYND8;SERPINE2;GID4;PRODH;OSBPL5;GSN;EGR1;LMF1;ALDH7A1;TYSND1;PPP1R35;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;THSD4;NAPRT;EDEM1;CRAT;RNF135;GLUL;GJC2;LRP1;NAGS;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PADI3;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;FBLN1;SLC7A8;ADAMTS7;PRDX5;TFPI2;DUSP5;NEK9;RAPGEF3;BPHL;TNFSF15;SPTB;NPEPL1;LOXL1;RNPEPL1;IGFBP4;SLC2A9;IDH2;FKBP9;CRTAP;CST3;NOS1;DDIT3;BRSK1;DNPH1;PGM1;CLCA2;ERCC6;GGT1;ADAMTS13;ABTB1;MMP28;GRAMD4;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;B3GAT3;HBEGF;PHGDH;RPS6KA2;MMP1;PYCR2;CTF1;CNTN1;CYP3A5;DHTKD1;ALDH4A1;RPL13A;MSRB2;OBSL1;TK2;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;RNF165;MIF4GD;CDK18;PHACTR3;FBXW4;ASH2L;CUL7;LHPP;PRSS3;HMGCL;UROS;HYAL1;NAGLU;PPP1R14A;WWTR1;MAP2K1;PCK2;PKN1;PGLS;DDIT4;ALPK1;OPLAH;LPCAT4;BTG1;SHC2;SYNGAP1;PHF21A;DGKQ;SNX9;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;OGDHL;HDAC11;RAB3B;PCSK1;UNK;NMRK1;PRSS8;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;STK39;ERO1B;BLVRB;FGFR3;FBXO41;CEMIP;KDM3A;MTHFR;KLHL29;PHF1;GLDC;NPR2;CAPNS2;CBS;SPRY4;USP20;DLG3;NMNAT2;NME4;FBXW8;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;SPEG;NGFR;ELFN2;MARCH4;ETFB;GSTO1;LCE1E;LTBP1;MUC19;PPCS;TRIB2;EREG;GPT2;PSAT1;PTPRE;RNF44;SSH3;PSPH;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;PPM1J;ABCG1;ESYT2;LPAR3;GSTT1;CARS;FKBP10;MTMR4;C5;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;BLMH;MKNK2;RASA4;IMPACT;PKD2;SATB1;ING4;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;MARCH9;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;LAMB2;PC;FBXO27;BNIP3;ERRFI1;MACROD1;OSBPL10;DCAF10;PEX10;STK40;VANGL2;RGS14;MVD;FAM20C;CNTRL;ADAMTSL1;SNTA1;CTSB;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;SDC2;FBXO17;MLXIPL;PTPDC1;C1RL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;HIBADH;PGPEP1;SDHA;LRSAM1;DMTN;KLHL24;PTHLH;UBXN4;ATF4;ZFPM1;CHST6;BBC3;KDM4C;PAK6;PRSS22;SSH1;LTB4R2;PCMTD2;TENM2;FBXO6;IFI6;PKD1;FUCA1;NSMCE1;FLOT1;TTN;PSKH1;HLCS;AZIN2;JDP2;HDAC5;GTPBP1;SORL1;GALK1;IL17RD;HERPUD1;GSTM2;VLDLR;PAPLN;NADK;GABBR1;ST3GAL3;SULF2;NLRP1;ACY1;KDM7A;CEBPB;MAP3K12;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;WNK4;ATRAID;ALDOC;PCSK9;PKIB;PKN3;FBXL15;FBXL16;LONP2;MARK3;HLTF;TRIOBP;TGFBR2;TRPV4;FOXL1;ITGA1;TMSB4X;MOCOS;APOL4;PDE2A;SMURF2;LMO7;TRIB3;RAB40B;DAP;ALDH1L2;PEMT;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;PIGZ;HEXB;PROM2;WNT7A;TTLL11;MARCH2;BNIP3L;PIK3R2;EPHA1;RHBDF2;SHARPIN;GAS6;GLUD1;DNAJC6;ERN1;BCR;KLHDC8B;MAPRE3;MAN2C1;CHKB;NBR1;CPT1C;HEXA;SRR;TADA3;UCKL1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;THNSL2;STRADB;CTSH;FBXL8;MGMT;GSTO2;ASNS;PAIP2B;LCE1F;HINT2;AKT1;IGFBP7;CARD11;DGUOK;CDKN1C;MICAL1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;PHYKPL;WDR45;IGFBP2;ASS1;SPDYE2;SPDYE2B;NFU1;TSG101;PHF2;FGFR4;IGF2BP2;PIAS3;TCIRG1;HAGH;PHLDA1;SLC6A6;UPP1;SPSB3;WDFY2;C9ORF72;UHRF2;ARSA;CAPN2;MAN2B1;SPATA18;MARK4;IFI27;PLAU;INSR;NCOA7;TENM4;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;ALDH1L1;PLB1;PIDD1;CAT;MAPK10;DPP7;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;SNX33;UBOX5;CHRM3;APRT;MIB2;CERS4;MPI;LSM14B;JOSD2;PHC1;SCYL3;CSNK1E;TAZ;HGSNAT;BCL6;HSF4;SAT2;RNF213;GSTM3;FBXO25;RPL39L;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;UBXN6;SIRT2;MBOAT2;GDF15;RAB13;TST;GOLGA2;ADA;NAGA;MTA1;AP2A2;HDAC8;PAIP2;RPL29;EIF4EBP1;AVPI1;TGFBR3;CIDEB;RNPEP;MAN1B1;GALNS;EPAS1;LAMTOR2;MAP3K10;MFNG;STARD10;RNF170;DHPS;EPHB2;NMRAL1;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ESYT3;BLOC1S1;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;STK32B;UNC119;SYVN1;PFKL;FRS3;MMP17;RPL12;MPPE1;TRIM2;MMP19;KCTD11;LYPLAL1;NUDT18;KCTD13;ZNF287;CAMKK1;PNKD;DTX3;KDSR;IKBKB;NTM;SNCB;HIP1;ACOT8;BTBD11
8915,GO:0034774,0.443502074373785,0.636937077176276,27,223,secretory granule lumen,CC,GSN;PYGB;NAPRT;TIMP2;VEGFA;PYGL;DNASE1L1;VEGFB;PCSK1;SERPING1;ACTR1B;ECM1;FUCA1;ALDOC;TMSB4X;HEXB;GAS6;CTSH;ARSA;MAN2B1;MAGED2;CAT;DPP7;TIMP1;APRT;GALNS;PFKL
4937,GO:0014902,0.443787539818833,0.709645904813895,7,53,myotube differentiation,BP,NOS1;THRA;FLOT1;HDAC5;CAPN2;MYOF;GDF15
7616,GO:0032024,0.443788543145601,0.721038566748298,6,45,positive regulation of insulin secretion,BP,GLUL;PCK2;NLGN2;PLA2G6;ANO1;GLUD1
13188,GO:0051865,0.44393830804843,0.709512448506546,7,53,protein autoubiquitination,BP,DDB2;RAG1;LRSAM1;KLHL24;UHRF2;RNF213;MTA1
19859,GO:2000378,0.444091711636852,0.735198089173913,5,37,negative regulation of reactive oxygen species metabolic process,BP,ACP5;BNIP3;BCR;ATP2B4;SIRT2
17082,GO:0101002,0.444252857713697,0.653573770244429,18,146,ficolin-1-rich granule,CC,GSN;SLC2A3;TIMP2;CST3;PGM1;GAA;PYGL;ACTR1B;CTSB;LTA4H;ALDOC;NBEAL2;CTSH;TCIRG1;CAT;YPEL5;AP2A2;PFKL
9903,GO:0042262,0.444308553696969,0.902201517144774,1,5,DNA protection,BP,CBS
904,GO:0002286,0.44448519285629,0.720431316543976,6,45,T cell activation involved in immune response,BP,PRKCZ;STAT6;ZFPM1;JAK3;BCL6;EIF2AK4
10792,GO:0044297,0.444846363437235,0.623548365025673,38,311,cell body,CC,PTPRS;ACTA2;APOE;GLUL;GJC2;LRP1;TIMP2;NTSR1;SNPH;CST3;SHANK2;CRTC1;PITPNM3;PITPNM1;ITPR3;PRKCZ;DLG3;NEURL1;KCNC4;PI4K2A;NRSN2;ARHGEF2;KLHL24;SV2A;ATXN10;AZIN2;ENDOG;ITGA1;TRPV1;SRR;C9ORF72;INSR;HOMER2;BRAF;SLC38A2;SIRT2;ADA;EPHB2
3107,GO:0006687,0.445300716648662,0.708305509639876,7,53,glycosphingolipid metabolic process,BP,ESYT2;ST6GALNAC6;HEXB;HEXA;ARSA;NAGA;ESYT3
7490,GO:0031670,0.445322937222944,0.719700433166504,6,45,cellular response to nutrient,BP,POSTN;CYP27B1;SSH1;TRPV1;GAS6;FYN
2614,GO:0005924,0.446141185356294,0.618318428350559,43,357,cell-substrate adherens junction,CC,FLNC;FHL1;GSN;LRP1;EGFR;CD9;PARVB;MRC2;RPL13A;MPRIP;MAP2K1;ITGA6;ARL2;GRB7;PAK1;FGFR3;SPRY4;TNS1;MAPK3;CSPG4;ITGB5;ARHGAP22;ARHGEF2;MAP2K2;PROCR;FLOT1;TRIOBP;TRPV4;ITGA1;LMO7;SLC9A3R2;ZFYVE21;ASAP3;CAPN2;PLAU;ITGB6;CAT;UBOX5;EHD3;ITGA2;CORO1B;RPL12;BSG
3324,GO:0007034,0.446458780855795,0.660562406728451,15,119,vacuolar transport,BP,VPS11;HOOK2;CHMP1B;SORL1;PCSK9;VPS39;TSG101;C9ORF72;CHMP5;CHMP4C;LYST;TMEM50B;HGSNAT;EHD3;UBXN6
12001,GO:0047631,0.446832622259405,0.900938105633991,1,5,ADP-ribose diphosphatase activity,MF,NUDT6
9515,GO:0036258,0.446834305195251,0.752003335513102,4,29,multivesicular body assembly,BP,CHMP1B;TSG101;CHMP5;CHMP4C
7206,GO:0031109,0.447333935962514,0.676865456564972,11,86,microtubule polymerization or depolymerization,BP,EML2;TUBG2;ARL2;TTBK2;PAK1;ARHGEF2;STMN3;NDE1;TRPV4;TUBGCP6;GOLGA2
7985,GO:0032612,0.447410939748466,0.706241601519973,7,54,interleukin-1 production,BP,F2R;EGR1;ACP5;S100A13;ERRFI1;NLRP1;GAS6
12530,GO:0050703,0.447598726233017,0.900552587009465,1,5,interleukin-1 alpha secretion,BP,S100A13
12537,GO:0050710,0.447661549869234,0.751316826709294,4,29,negative regulation of cytokine secretion,BP,TMSB4X;GAS6;MAPKBP1;CIDEA
7234,GO:0031167,0.448534775333142,0.777683743611236,3,21,rRNA methylation,BP,NSUN5P2;RRNAD1;TFB1M
8468,GO:0033627,0.448736910391986,0.731224089337387,5,37,cell adhesion mediated by integrin,BP,ITGA6;PLAU;ITGB6;ADA;ITGA2
10148,GO:0042749,0.448750959512451,0.899970958257631,1,5,regulation of circadian sleep/wake cycle,BP,ADA
11124,GO:0045187,0.448750959512451,0.899970958257631,1,5,regulation of circadian sleep/wake cycle, sleep,BP,ADA
11514,GO:0046060,0.448981386980319,0.899854382015561,1,5,dATP metabolic process,BP,ADA
6774,GO:0030217,0.449035036128145,0.651874917404735,17,136,T cell differentiation,BP,EGR1;ZFP36L1;SOX13;PRKCZ;RAG1;SATB1;STAT6;ZFPM1;TGFBR2;CARD11;BRAF;JAK3;BCL6;ADA;TCF7;ERBB2;HLA-G
5641,GO:0016740,0.449512317413526,0.580871975822536,227,1892,transferase activity,MF,DLG4;GAMT;ST6GALNAC2;GID4;PYGB;SUGCT;FBXO2;ZNF862;PTK6;TMEM129;NAPRT;CRAT;RNF135;NAGS;OBSCN;EGFR;RBCK1;DDB2;ZDHHC1;NEK9;DGKA;BRSK1;DNPH1;GGT1;MST1R;B3GAT3;HBEGF;RPS6KA2;PYGL;EFNB3;TK2;LTBP4;ULK2;MAPK13;RNF165;CDK18;CPT2;FBXW4;ASH2L;HYAL1;POLD4;MAP2K1;PKN1;ALPK1;LPCAT4;DGKQ;ULK1;NMRK1;TTBK2;PRKCZ;PAK1;STK39;B4GALNT4;FGFR3;FBXO41;KLHL29;NPR2;DLG3;NMNAT2;NME4;FBXW8;NSUN5P2;NEURL1;ACVR2B;RAG1;SPEG;MARCH4;NSUN7;GSTO1;LTBP1;EREG;GPT2;PSAT1;PNPLA3;RNF44;UNKL;GSTT1;MKNK2;RRNAD1;HMGA2;ST6GALNAC6;B4GAT1;MARCH9;PI4KAP1;JADE2;MAPK3;TRPT1;FBXO27;STK40;FAM20C;CNTRL;MAPK12;PI4K2A;NAT14;FBXO17;MAP2K2;FAM86C2P;LRSAM1;KLHL24;CHST6;PAK6;PCMTD2;PRIMPOL;POLM;FBXO6;NSMCE1;TTN;PSKH1;GALK1;TFB1M;GSTM2;NADK;TEP1;ST3GAL3;MAP3K12;NEK8;TSTD1;WNK4;PKN3;FBXL15;METTL23;FBXL16;MARK3;HLTF;DNMT3A;TGFBR2;MOCOS;SMURF2;LMO7;ALDH1L2;PEMT;MINK1;PIGZ;HEXB;MARCH2;PIP5KL1;PIK3R2;EPHA1;SHARPIN;ERN1;BCR;KLHDC8B;CHKB;CPT1C;HEXA;TADA3;UCKL1;CAMK1;POLL;TERC;PRDM8;STRADB;FBXL8;MGMT;GSTO2;AKT1;ZFYVE21;CARD11;DGUOK;B4GALT2;CHEK2;PHYKPL;COMTD1;FGFR4;PIAS3;ASMTL;UPP1;SPSB3;UHRF2;MARK4;INSR;RPS6KA5;RABGGTA;PIGQ;MAP2K5;ZDHHC24;BRAF;POLR2J2;ALDH1L1;MAPK10;JAK3;UBOX5;APRT;MIB2;CERS4;METTL7A;CSNK1E;TAZ;HGSNAT;SAT2;RNF213;GSTM3;TKFC;FBXO25;FYN;MAST4;PJA2;MBOAT2;TST;POLR3GL;ETNK2;FUK;TGFBR3;MAP3K10;MFNG;RNF170;DHPS;EPHB2;POLR2J3;FGFR1;PIGV;CTH;XYLT2;ERBB2;KDELC2;UST;EIF2AK4;STK32B;SYVN1;PFKL;HMBOX1;TRIM2;KCTD11;KCTD13;CAMKK1;DTX3;IKBKB
12402,GO:0048872,0.449603959265238,0.641554446481488,21,170,homeostasis of number of cells,BP,F2R;IL20RB;FAM210B;VEGFA;ZFP36L1;PKN1;RAG1;THRA;INPP5D;DMTN;ZFPM1;DOCK11;BCR;AKT1;CARD11;DNASE2;JAK3;BCL6;ADA;TGFBR3;EPAS1
12935,GO:0051341,0.449678612801039,0.704223579464761,7,54,regulation of oxidoreductase activity,BP,APOE;EGFR;CYP27B1;NOS3;CCS;ATP2B4;AKT1
3223,GO:0006878,0.449700994856662,0.819250560001643,2,13,cellular copper ion homeostasis,BP,PRNP;ATP7B
3171,GO:0006787,0.450364354628044,0.899152894943202,1,5,porphyrin-containing compound catabolic process,BP,BLVRB
8232,GO:0033015,0.450364354628044,0.899152894943202,1,5,tetrapyrrole catabolic process,BP,BLVRB
9874,GO:0042167,0.450364354628044,0.899152894943202,1,5,heme catabolic process,BP,BLVRB
11566,GO:0046149,0.450364354628044,0.899152894943202,1,5,pigment catabolic process,BP,BLVRB
3222,GO:0006875,0.450605955319096,0.621706691628483,34,280,cellular metal ion homeostasis,BP,DLG4;F2R;APOE;NTSR1;PRNP;NOS1;DDIT3;CYBRD1;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;BNIP3;SV2A;PKD1;KCNMA1;HERPUD1;GSTM2;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;ITPR2;TPCN1;LETMD1;HFE;ATP12A;FYN;TRPC1;EDNRA;WFS1
5449,GO:0016328,0.450714851225407,0.714979429026802,6,45,lateral plasma membrane,CC,ANK3;ARL2;VANGL2;SNTA1;PKD1;RAB13
895,GO:0002275,0.451942564187851,0.610641041453941,46,383,myeloid cell activation involved in immune response,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;BRI3;ACTR1B;TMC6;S100A13;VAMP2;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;APRT;METTL7A;HGSNAT;TOM1;AP2A2;GALNS;LAMTOR2;PFKL
4756,GO:0010940,0.452066063512615,0.89828542606198,1,5,positive regulation of necrotic cell death,BP,BNIP3
15105,GO:0071222,0.452078800876788,0.662814452591774,13,104,cellular response to lipopolysaccharide,BP,TNIP1;PDCD4;NR1D1;ADAMTS13;MAPK3;PDCD1LG2;LITAF;HDAC5;CEBPB;NOS3;BCR;PTAFR;AKT1
9309,GO:0035795,0.452495168447233,0.898065932151313,1,5,negative regulation of mitochondrial membrane permeability,BP,BNIP3
19318,GO:1905709,0.452495168447233,0.898065932151313,1,5,negative regulation of membrane permeability,BP,BNIP3
16221,GO:0090303,0.452561997168208,0.747233428139533,4,29,positive regulation of wound healing,BP,F2R;HBEGF;DMTN;TGFBR2
17363,GO:1900117,0.453105620587816,0.774061421570313,3,21,regulation of execution phase of apoptosis,BP,ENDOG;SIRT2;CIDEA
3690,GO:0008199,0.453408330552984,0.897597825209946,1,5,ferric iron binding,MF,ACP5
3634,GO:0008106,0.453436203557258,0.816577023108563,2,13,alcohol dehydrogenase (NADP+) activity,MF,AKR7A2;DHRS4
814,GO:0002088,0.453880229910799,0.712194286310056,6,45,lens development in camera-type eye,BP,WNT2B;SLITRK6;TGFBR2;WNT7A;TBC1D20;SIX5
6196,GO:0019682,0.453900665621094,0.773428539299987,3,21,glyceraldehyde-3-phosphate metabolic process,BP,H6PD;PGLS;TKFC
15283,GO:0071500,0.454035496518065,0.897275528819737,1,5,cellular response to nitrosative stress,BP,DDIT3
4123,GO:0009186,0.454156107167638,0.897213473286885,1,5,deoxyribonucleoside diphosphate metabolic process,BP,NUDT18
19955,GO:2000576,0.45422664107921,0.897177171653056,1,5,positive regulation of microtubule motor activity,BP,DNAL4
2752,GO:0006165,0.454300655931481,0.670341905996289,11,87,nucleoside diphosphate phosphorylation,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;MLXIPL;GALK1;ALDOC;INSR;PFKL
5671,GO:0016787,0.454405251449319,0.576588555045577,217,1819,hydrolase activity,MF,DUSP6;H6PD;PTPRS;HTRA1;NT5E;TYSND1;ADAM19;ACP5;THSD4;EDEM1;AIG1;PADI3;ERCC1;ADAMTS7;DUSP5;BPHL;NPEPL1;RNPEPL1;DNM1;HAGHL;DNPH1;ACAD10;CLCA2;ERCC6;GGT1;ADAMTS13;MMP28;MYH15;SMARCA1;ADARB1;PPM1M;GAA;MMP1;PLAT;CTSF;PLD3;LHPP;PRSS3;HYAL1;NAGLU;ACP6;MAP2K1;ABCA2;PGLS;OPLAH;PLCH2;DNASE1L1;PHF21A;AKR7A2;TUBG2;DNAH1;ARL2;HDAC11;RAB3B;NLGN2;PCSK1;MYH11;PRSS8;PPP2R3B;ABCA7;APOBEC3C;AARS;CEMIP;PLCXD1;CAPNS2;USP20;DDX59;NEIL1;ABHD14B;RAG1;SPPL2B;WDR60;CHD2;PTPRE;PNPLA3;SSH3;PLCD3;PSPH;RHOBTB2;PLA2G6;CES3;PPM1J;ABCG1;AGAP1;MTMR4;KIF17;APOBEC3F;ACOT1;CHD3;BLMH;IFT27;ACOT11;SEPT5;NT5C1B;MACROD1;DNAL4;RHOF;ADAMTSL1;FAHD2B;TUBE1;PAN2;CTSB;MYH3;LTA4H;PTPDC1;C1RL;PLCD1;SEPT10;INPP5D;PGPEP1;KIF21B;PRSS22;SSH1;MYH16;KIF26B;FUCA1;HDAC5;GTPBP1;NTPCR;PAPLN;DHX32;SULF2;CES2;ACY1;ENDOG;RHBDF1;ACOT7;PTPRU;PCSK9;ISG20;LONP2;HLTF;PDE2A;RAB40B;MLH3;HMG20B;HEXDC;HEXB;RHBDF2;RPUSD3;DNAJC6;ERN1;NUDT6;ATP7B;MAN2C1;EXD3;HEXA;FAHD2A;TADA3;NUDT8;KIF13B;RAB43;ATP2B4;CTSH;ENTPD6;HINT2;LACTB2;SEPT6;TNNT1;KIF27;TCIRG1;HAGH;DNASE2;ASMTL;FAAH;ARSA;CAPN2;MAN2B1;RAB25;PLAU;GNAL;ANKZF1;PNPLA4;MBLAC2;CTDSPL;CPSF4;PLB1;CAT;DPP7;MPG;MTA3;CHRM3;ENDOV;JOSD2;ATP12A;RNF213;ZC3H12D;ATP8B2;PEX1;SLC25A42;SIRT2;RECQL5;RAB13;ADA;RHOBTB3;NAGA;MTA1;MSH5;ENTPD2;HDAC8;PLPP6;RNPEP;MAN1B1;GALNS;EDNRA;CHD6;INPP4A;SEPT8;MMP17;MPPE1;MMP19;LYPLAL1;NUDT18;TMEM8A;PNKD;DTD1;ACOT8
596,GO:0001764,0.454554436476494,0.670203447315745,11,86,neuron migration,BP,VEGFA;SDCCAG8;DDIT4;UNK;ARHGEF2;NDE1;GAS6;PEX7;FYN;CELSR1;FGFR1
4789,GO:0010985,0.454643088744991,0.896962671053298,1,5,negative regulation of lipoprotein particle clearance,BP,PCSK9
2696,GO:0006064,0.455221029795059,0.896664513919047,1,5,glucuronate catabolic process,BP,CRYL1
6186,GO:0019640,0.455221029795059,0.896664513919047,1,5,glucuronate catabolic process to xylulose 5-phosphate,BP,CRYL1
12825,GO:0051167,0.455221029795059,0.896664513919047,1,5,xylulose 5-phosphate metabolic process,BP,CRYL1
17537,GO:1901159,0.455221029795059,0.896664513919047,1,5,xylulose 5-phosphate biosynthetic process,BP,CRYL1
1525,GO:0003906,0.455302717025104,0.815233173927166,2,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1;HMGA2
2753,GO:0006166,0.455421685883546,0.896560866915905,1,5,purine ribonucleoside salvage,BP,APRT
11245,GO:0045541,0.455821272517864,0.896354265297569,1,5,negative regulation of cholesterol biosynthetic process,BP,APOE
16158,GO:0090206,0.455821272517864,0.896354265297569,1,5,negative regulation of cholesterol metabolic process,BP,APOE
415,GO:0001103,0.45629975029387,0.744099675177087,4,29,RNA polymerase II repressing transcription factor binding,MF,BBS2;BBS1;PPARA;MTA1
16154,GO:0090201,0.456450904304451,0.814403891686956,2,13,negative regulation of release of cytochrome c from mitochondria,BP,AKT1;LMNA
9916,GO:0042277,0.456501406911191,0.634950483518034,21,171,peptide binding,MF,APOE;FBXO2;PRNP;SLC7A8;RNPEPL1;CST3;CEMIP;NPR2;APBB3;LTA4H;SORL1;GSTM2;RXRA;INSR;PEX7;GSTM3;RNPEP;EPHB2;ITGA2;HLA-G;APBA1
2754,GO:0006167,0.456722801446264,0.895887166378661,1,5,AMP biosynthetic process,BP,APRT
17276,GO:0140097,0.456776300666038,0.632672695411259,22,179,catalytic activity, acting on DNA,MF,ERCC1;SMARCA1;POLD4;DNASE1L1;NEIL1;CHD2;CHD3;HMGA2;PRIMPOL;POLM;TEP1;ENDOG;ISG20;DNMT3A;POLL;TERC;MGMT;DNASE2;MPG;ENDOV;RECQL5;HMBOX1
4677,GO:0010830,0.456849469399112,0.743637383230116,4,29,regulation of myotube differentiation,BP,THRA;FLOT1;HDAC5;GDF15
4151,GO:0009217,0.456992626845536,0.895747102103799,1,5,purine deoxyribonucleoside triphosphate catabolic process,BP,ADA
9591,GO:0036465,0.457088115139582,0.724020656657765,5,37,synaptic vesicle recycling,BP,DNM1;SYT8;NLGN2;WNT7A;DNAJC6
11348,GO:0045730,0.457148144449068,0.813899334934973,2,13,respiratory burst,BP,BCR;INSR
7393,GO:0031465,0.45722928390077,0.895624155526156,1,5,Cul4B-RING E3 ubiquitin ligase complex,CC,DDB2
105,GO:0000220,0.457257371306443,0.89560955753836,1,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,TCIRG1
2660,GO:0006007,0.457374547803959,0.770653376906475,3,21,glucose catabolic process,BP,LRP5;ALDOC;PFKL
7648,GO:0032077,0.457559311872401,0.895452545761831,1,5,positive regulation of deoxyribonuclease activity,BP,AKT1
11129,GO:0045197,0.457636820289468,0.742974624250916,4,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,DLG4;DLG3;VANGL2;LRCH4
5667,GO:0016782,0.457780886320013,0.708503879754993,6,46,transferase activity, transferring sulfur-containing groups,MF,SUGCT;CHST6;TSTD1;MOCOS;TST;UST
14741,GO:0070459,0.457858159445328,0.895296992777966,1,5,prolactin secretion,BP,EGFR
16234,GO:0090316,0.457876645066184,0.638170439332899,19,154,positive regulation of intracellular protein transport,BP,EDEM1;PRNP;ANK3;RAPGEF3;B3GAT3;TMEM173;VPS11;PAK1;CEMIP;MICALL2;VAMP2;SORL1;CEP131;PEMT;GAS6;CAMK1;FYN;ERBB2;OSCP1
857,GO:0002190,0.457891324952057,0.895279720644219,1,5,cap-independent translational initiation,BP,EIF4EBP1
3670,GO:0008171,0.457932195713411,0.770206398009485,3,21,O-methyltransferase activity,MF,PCMTD2;COMTD1;ASMTL
4616,GO:0010739,0.457948461703113,0.895249960310702,1,5,positive regulation of protein kinase A signaling,BP,MC1R
9159,GO:0035529,0.457988070784339,0.895229326268009,1,5,NADH pyrophosphatase activity,MF,NUDT6
20204,GO:2001179,0.458061804615898,0.895190908241588,1,5,regulation of interleukin-10 secretion,BP,PRKCZ
2401,GO:0005547,0.458066563369328,0.742612572313236,4,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,ARAP3;ARAP1;AKT1;ADAP1
10551,GO:0043531,0.458458980219711,0.742281774474906,4,29,ADP binding,MF,ABCG1;GLUD1;ERN1;MYO18A
3521,GO:0007498,0.458619743391339,0.678938091552834,9,70,mesoderm development,BP,VEGFA;ZFP36L1;ITGB4;ACVR2B;HMGA2;WNT3;ITGA2;FGFR1;TEAD2
2368,GO:0005496,0.458642780336784,0.696198862345029,7,54,steroid binding,MF,APOE;OSBPL5;ABCG1;OSBPL10;PAQR6;HSD11B1;PROM2
8152,GO:0032892,0.458729759320227,0.812752073154389,2,13,positive regulation of organic acid transport,BP,NTSR1;PLA2G6
19390,GO:1990000,0.458891190917418,0.81263476167429,2,13,amyloid fibril formation,BP,APOE;GSN
365,GO:0000987,0.458979736335301,0.611691177464836,36,294,proximal promoter sequence-specific DNA binding,MF,NFATC4;FOS;NR1D1;MEF2D;DDIT3;TCFL5;ETV4;ELK3;FOXQ1;ETV1;HES2;CARF;PPARA;STAT6;KLF7;HMGA2;MLXIPL;LITAF;ATF4;ZFPM1;ZNF516;JDP2;RFX2;CEBPB;HLTF;BHLHE40;RXRA;ZNF217;SMARCD2;TP73;TFEB;HSF4;POU2F2;PER1;CREB3L4;SIX5
7633,GO:0032052,0.459397389108166,0.894493448364658,1,5,bile acid binding,MF,PYGL
3568,GO:0007614,0.45955615256754,0.894410341692044,1,5,short-term memory,BP,MDK
4168,GO:0009240,0.459738335881876,0.89431492363048,1,5,isopentenyl diphosphate biosynthetic process,BP,MVD
11680,GO:0046490,0.459738335881876,0.89431492363048,1,5,isopentenyl diphosphate metabolic process,BP,MVD
8455,GO:0033605,0.459831649324961,0.894266029423487,1,5,positive regulation of catecholamine secretion,BP,STX1A
4302,GO:0009757,0.459831847338378,0.894265925648208,1,5,hexose mediated signaling,BP,MLXIPL
4411,GO:0010182,0.459831847338378,0.894265925648208,1,5,sugar mediated signaling pathway,BP,MLXIPL
4422,GO:0010255,0.459831847338378,0.894265925648208,1,5,glucose mediated signaling pathway,BP,MLXIPL
13151,GO:0051781,0.460006334148572,0.69497156250706,7,54,positive regulation of cell division,BP,PGF;VEGFA;VEGFB;EREG;MDK;CAT;SIRT2
12557,GO:0050747,0.460021173520299,0.894166677995683,1,5,positive regulation of lipoprotein metabolic process,BP,PEMT
6197,GO:0019692,0.460129679406081,0.74042318624552,4,30,deoxyribose phosphate metabolic process,BP,NEIL1;DGUOK;ADA;NUDT18
18216,GO:1903054,0.460680091754646,0.893820794677012,1,5,negative regulation of extracellular matrix organization,BP,CST3
12205,GO:0048484,0.460795195834269,0.893760298842234,1,5,enteric nervous system development,BP,EDNRA
11787,GO:0046689,0.46095620194211,0.89367564073538,1,5,response to mercury ion,BP,BSG
6105,GO:0019348,0.461007830076953,0.893648485096191,1,5,dolichol metabolic process,BP,SRD5A3
6566,GO:0022038,0.461046376226422,0.811064809644116,2,13,corpus callosum development,BP,PTPRS;EPHB2
5127,GO:0015605,0.461333411000019,0.767471209604476,3,21,organophosphate ester transmembrane transporter activity,MF,SLC37A2;SLC37A4;SLC25A42
1233,GO:0002922,0.461346883377138,0.893470036824508,1,5,positive regulation of humoral immune response,BP,ZP3
12209,GO:0048488,0.461407835689484,0.739790071020128,4,29,synaptic vesicle endocytosis,BP,DNM1;SYT8;NLGN2;DNAJC6
3700,GO:0008211,0.4614091877244,0.810799824004705,2,13,glucocorticoid metabolic process,BP,DGKQ;HSD11B1
9238,GO:0035655,0.461415269572582,0.893434020848585,1,5,interleukin-18-mediated signaling pathway,BP,AKT1
15179,GO:0071351,0.461415269572582,0.893434020848585,1,5,cellular response to interleukin-18,BP,AKT1
4060,GO:0009113,0.461440773874777,0.810776745035048,2,13,purine nucleobase biosynthetic process,BP,APRT;ADA
15863,GO:0072656,0.461487818722478,0.893395803836057,1,5,maintenance of protein location in mitochondrion,BP,AKT1
19928,GO:2000516,0.461498978022892,0.810734213185542,2,13,positive regulation of CD4-positive, alpha-beta T cell activation,BP,PRKCZ;TGFBR2
12517,GO:0050687,0.461562379139069,0.767286523735782,3,21,negative regulation of defense response to virus,BP,HTRA1;NLRX1;TKFC
13966,GO:0060706,0.461755062463602,0.767131050972302,3,21,cell differentiation involved in embryonic placenta development,BP,MDFI;AKT1;KRT19
6912,GO:0030512,0.461791420987321,0.693362192899324,7,54,negative regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP1;MTMR4;TGFBR2;SMURF2;CIDEA;TGFBR3
9079,GO:0035356,0.461803165041023,0.893229584764142,1,5,cellular triglyceride homeostasis,BP,FITM2
7971,GO:0032594,0.461882133674741,0.767028492324363,3,21,protein transport within lipid bilayer,BP,REEP2;ARHGAP44;HIP1
7398,GO:0031489,0.461946159236191,0.810407269854132,2,13,myosin V binding,MF,RAB3B;RAB25
17462,GO:1900424,0.462018781014762,0.810354145843423,2,13,regulation of defense response to bacterium,BP,MAPKBP1;SIRT2
19678,GO:2000047,0.462056236990798,0.893096069549261,1,5,regulation of cell-cell adhesion mediated by cadherin,BP,FLOT1
19063,GO:1904994,0.462094348541988,0.893075953388288,1,5,regulation of leukocyte adhesion to vascular endothelial cell,BP,PTAFR
11352,GO:0045738,0.462096280735626,0.766855606307259,3,21,negative regulation of DNA repair,BP,MAGEF1;HMGA2;RECQL5
13213,GO:0051902,0.462109812763104,0.893067790309024,1,5,negative regulation of mitochondrial depolarization,BP,IFI6
18699,GO:1904180,0.462109812763104,0.893067790309024,1,5,negative regulation of membrane depolarization,BP,IFI6
12133,GO:0048262,0.462125294510678,0.89305961758722,1,5,determination of dorsal/ventral asymmetry,BP,DDIT3
10707,GO:0044060,0.462258939994424,0.766724246668445,3,21,regulation of endocrine process,BP,F2R;APLN;FGFR1
15380,GO:0071670,0.462405226270348,0.892911773606041,1,5,smooth muscle cell chemotaxis,BP,CORO1B
18529,GO:1903772,0.462483218385011,0.89287055911816,1,5,regulation of viral budding via host ESCRT complex,BP,TSG101
16365,GO:0097009,0.462595035880633,0.8099323211628,2,13,energy homeostasis,BP,CRTC1;ACACB
9868,GO:0042157,0.462595275204798,0.641931755289021,16,130,lipoprotein metabolic process,BP,APOE;LRP1;ZDHHC1;LY6K;PPARA;PCSK9;APOL4;PEMT;PIGZ;WDR45;PIGQ;ZDHHC24;PIGV;MPPE1;LYPLAL1;NTM
7596,GO:0031985,0.462619249849592,0.662617397129623,11,87,Golgi cisterna,CC,ARAP1;ASAP2;PITPNM1;B4GALNT4;SORL1;ST3GAL3;GOLGA2P5;NECAB3;B4GALT2;GOLGA8A;GOLGA2
10119,GO:0042695,0.462874692373841,0.892663532074391,1,5,thelarche,BP,AREG
13995,GO:0060744,0.462874692373841,0.892663532074391,1,5,mammary gland branching involved in thelarche,BP,AREG
13590,GO:0060088,0.462951956498924,0.892622641204173,1,5,auditory receptor cell stereocilium organization,BP,TRIOBP
19565,GO:1990712,0.462964759037712,0.892615864685397,1,5,HFE-transferrin receptor complex,CC,HFE
4425,GO:0010259,0.46307490722363,0.766064757764596,3,21,multicellular organism aging,BP,ERCC1;RNF165;INPP5D
12137,GO:0048266,0.463076002753001,0.89255697052964,1,5,behavioral response to pain,BP,TRPV1
11538,GO:0046100,0.463163079105932,0.892510856398928,1,5,hypoxanthine metabolic process,BP,ADA
3554,GO:0007597,0.46320176175501,0.89249036663698,1,5,blood coagulation, intrinsic pathway,BP,SERPING1
11088,GO:0045123,0.463208451232147,0.765956738753324,3,21,cellular extravasation,BP,ITGA1;BCR;PTAFR
8473,GO:0033632,0.463252467510602,0.892463504533393,1,5,regulation of cell-cell adhesion mediated by integrin,BP,ADA
16084,GO:0090092,0.463257816414589,0.638361333871114,17,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;LTBP4;RNF165;WWTR1;ACVR2B;LTBP1;MTMR4;FBXL15;TGFBR2;SMURF2;CDKN1C;HFE;LEMD2;GDF15;CIDEA;TGFBR3;FKBP8
8023,GO:0032677,0.463338789551944,0.718255588806483,5,38,regulation of interleukin-8 production,BP,F2R;DDIT3;TMSB4X;MAPKBP1;MAP2K5
4823,GO:0014032,0.463413499241217,0.691897169389366,7,54,neural crest cell development,BP,SEMA4B;LAMA5;SEMA3F;MAPK3;SEMA3B;SEMA4G;EDNRA
9679,GO:0038089,0.463432406466112,0.892368144302619,1,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,VEGFA
8029,GO:0032688,0.4636068954399,0.809190404057161,2,13,negative regulation of interferon-beta production,BP,PTPRS;NLRX1
15364,GO:0071639,0.463749082716561,0.892200186151475,1,5,positive regulation of monocyte chemotactic protein-1 production,BP,TRPV4
11879,GO:0046923,0.463773649655964,0.892187149303986,1,5,ER retention sequence binding,MF,CEMIP
4031,GO:0009067,0.463796980518254,0.765480413996532,3,21,aspartate family amino acid biosynthetic process,BP,THNSL2;ASNS;CTH
1800,GO:0004448,0.463821839343537,0.892161573698103,1,5,isocitrate dehydrogenase activity,MF,IDH2
2720,GO:0006102,0.46382790909972,0.89215835202982,1,5,isocitrate metabolic process,BP,IDH2
16142,GO:0090189,0.46385265629334,0.809009971098913,2,13,regulation of branching involved in ureteric bud morphogenesis,BP,VEGFA;WNT2B
7440,GO:0031584,0.463908857858573,0.892115380620628,1,5,activation of phospholipase D activity,BP,PRKCZ
17542,GO:1901165,0.463931412506293,0.892103405574347,1,5,positive regulation of trophoblast cell migration,BP,SMURF2
7622,GO:0032036,0.463984602536007,0.892075161744998,1,5,myosin heavy chain binding,MF,STX1A
16897,GO:0098902,0.464013573933472,0.892059775964086,1,5,regulation of membrane depolarization during action potential,BP,ANK3
725,GO:0001955,0.464106724965991,0.892010296818825,1,5,blood vessel maturation,BP,DDIT3
18908,GO:1904688,0.46411155343244,0.89200773166946,1,5,regulation of cytoplasmic translational initiation,BP,RPL13A
4322,GO:0009838,0.464158878482185,0.891982587959551,1,5,abscission,BP,CHMP4C
8270,GO:0033085,0.464169944421263,0.891976708104562,1,5,negative regulation of T cell differentiation in thymus,BP,ERBB2
9473,GO:0036123,0.464266410341517,0.891925442404086,1,5,histone H3-K9 dimethylation,BP,KDM3A
2084,GO:0004849,0.464294556465629,0.891910481509602,1,5,uridine kinase activity,MF,UCKL1
7418,GO:0031528,0.464339822799268,0.808652030019528,2,13,microvillus membrane,CC,SYTL1;PROM2
17829,GO:1902047,0.46437139216371,0.891869633140956,1,5,polyamine transmembrane transport,BP,AZIN2
10467,GO:0043379,0.46438992700214,0.891859777923496,1,5,memory T cell differentiation,BP,BCL6
16349,GO:0090713,0.46438992700214,0.891859777923496,1,5,immunological memory process,BP,BCL6
16350,GO:0090715,0.46438992700214,0.891859777923496,1,5,immunological memory formation process,BP,BCL6
1109,GO:0002698,0.464400176778282,0.673492543275991,9,71,negative regulation of immune effector process,BP,HTRA1;IL20RB;SERPING1;NLRX1;BCR;HFE;JAK3;BCL6;TKFC
15465,GO:0071863,0.464417757162958,0.891844979163535,1,5,regulation of cell proliferation in bone marrow,BP,HMGA2
15466,GO:0071864,0.464417757162958,0.891844979163535,1,5,positive regulation of cell proliferation in bone marrow,BP,HMGA2
17359,GO:1900113,0.464472279405399,0.891815983020823,1,5,negative regulation of histone H3-K9 trimethylation,BP,KDM4C
6643,GO:0023058,0.464537193132241,0.808506910776905,2,13,adaptation of signaling pathway,BP,DNM1;APLN
5370,GO:0016188,0.464571986112033,0.891762943779754,1,5,synaptic vesicle maturation,BP,DLG4
3926,GO:0008611,0.46457481267489,0.891761439937974,1,5,ether lipid biosynthetic process,BP,PEX7
11692,GO:0046504,0.46457481267489,0.891761439937974,1,5,glycerol ether biosynthetic process,BP,PEX7
17634,GO:1901503,0.46457481267489,0.891761439937974,1,5,ether biosynthetic process,BP,PEX7
10083,GO:0042609,0.464654232121268,0.891719180131746,1,5,CD4 receptor binding,MF,FYN
8340,GO:0033211,0.464838535651063,0.891621069422238,1,5,adiponectin-activated signaling pathway,BP,SLC27A1
19138,GO:1905206,0.464881926020352,0.891597962957269,1,5,positive regulation of hydrogen peroxide-induced cell death,BP,ENDOG
2185,GO:0005044,0.464914746085741,0.764574466779508,3,21,scavenger receptor activity,MF,LRP1;SCART1;SCARA3
20166,GO:2001046,0.464958078426971,0.89155740218861,1,5,positive regulation of integrin-mediated signaling pathway,BP,DMTN
1132,GO:0002724,0.465036275139168,0.808139688204997,2,13,regulation of T cell cytokine production,BP,PRKCZ;HFE
17178,GO:0106049,0.46504155575912,0.891512928684924,1,5,regulation of cellular response to osmotic stress,BP,ARHGEF2
17880,GO:1902218,0.46504155575912,0.891512928684924,1,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,ARHGEF2
14943,GO:0070873,0.465077410476957,0.764442489447412,3,21,regulation of glycogen metabolic process,BP,AKT1;INSR;PHLDA2
6886,GO:0030426,0.465090661669703,0.642962753205886,15,120,growth cone,CC,ADGRL1;TIMP2;SHANK2;ORAI2;DLG3;TWF2;STMN3;KIF21B;SSH1;TENM2;MAP3K12;TRPV4;TMOD2;C9ORF72;SIRT2
3394,GO:0007175,0.465143924693658,0.808060430144314,2,13,negative regulation of epidermal growth factor-activated receptor activity,BP,ERRFI1;TSG101
1954,GO:0004661,0.465172033931816,0.891443391289928,1,5,protein geranylgeranyltransferase activity,MF,RABGGTA
5165,GO:0015721,0.465197904506573,0.808020680292884,2,13,bile acid and bile salt transport,BP,RXRA;SLC10A6
5608,GO:0016661,0.465232317133073,0.891411254049171,1,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,CBS
4837,GO:0014048,0.465268031721064,0.891392211537928,1,5,regulation of glutamate secretion,BP,NTSR1
3440,GO:0007252,0.465284644076942,0.807956797358373,2,13,I-kappaB phosphorylation,BP,AKT1;IKBKB
5700,GO:0016833,0.465286707471318,0.891382253033358,1,5,oxo-acid-lyase activity,MF,HMGCL
11271,GO:0045602,0.465290984990812,0.891379972045424,1,5,negative regulation of endothelial cell differentiation,BP,XDH
448,GO:0001222,0.465451729353468,0.807833708063367,2,13,transcription corepressor binding,MF,NR1D1;PER1
7434,GO:0031573,0.465467709715022,0.80782193332552,2,13,intra-S DNA damage checkpoint,BP,XPC;CHEK2
13799,GO:0060421,0.465508262593796,0.7640927473099,3,21,positive regulation of heart growth,BP,ACACB;TGFBR3;FGFR1
7929,GO:0032526,0.465582860787011,0.67240146854104,9,71,response to retinoic acid,BP,PTK6;TWF2;AQP3;RXRA;CTSH;IGFBP7;IGFBP2;WNT3;TEAD2
3004,GO:0006552,0.465736866381008,0.891142035010964,1,5,leucine catabolic process,BP,HMGCL
7873,GO:0032449,0.465910639153589,0.891049212789891,1,5,CBM complex,CC,CARD11
8028,GO:0032687,0.465964147854636,0.891020620326643,1,5,negative regulation of interferon-alpha production,BP,PTPRS
741,GO:0001973,0.466055478977067,0.89097180617429,1,5,adenosine receptor signaling pathway,BP,ADA
2492,GO:0005741,0.46610592355244,0.632806727270252,18,147,mitochondrial outer membrane,CC,FAM210B;BPHL;ARMCX2;CYP27B1;TMEM173;ULK1;NLRX1;ACACB;BNIP3;PDE2A;BNIP3L;CPT1C;PPP1R15A;SNN;SPATA18;IFI27;ANKZF1;LETMD1
4456,GO:0010453,0.466265153396333,0.807233859897844,2,13,regulation of cell fate commitment,BP,DUSP6;FGFR1
20157,GO:2001033,0.466280974502179,0.890851223896128,1,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2
10652,GO:0043900,0.46630966009498,0.606454281926646,34,283,regulation of multi-organism process,BP,TNIP1;HTRA1;APOE;GSN;ADARB1;EXOC2;TMEM173;APOBEC3C;NPR2;FAM3A;ZP3;APOBEC3F;NLRX1;HMGA2;MAPK3;PC;IFITM1;MVB12B;LRSAM1;ISG20;SMURF2;PTAFR;MAPKBP1;TSG101;TBC1D20;NELFCD;CHMP4C;PLB1;LGALS1;TIMP1;TKFC;SIRT2;ADA;EIF2AK4
8969,GO:0035090,0.466424437777128,0.890774462871034,1,5,maintenance of apical/basal cell polarity,BP,LRCH4
11131,GO:0045199,0.466424437777128,0.890774462871034,1,5,maintenance of epithelial cell apical/basal polarity,BP,LRCH4
12843,GO:0051188,0.466725317303665,0.611882927078545,29,239,cofactor biosynthetic process,BP,NAPRT;IDH2;PGM1;GGT1;DHTKD1;MLYCD;UROS;DDIT4;OPLAH;OGDHL;NMRK1;NMNAT2;PPCS;PSAT1;PPARA;CHAC1;ACACB;ACSS2;MLXIPL;GALK1;NADK;ACOT7;ALDOC;MOCOS;HAGH;CBR4;INSR;ACSS1;PFKL
881,GO:0002248,0.466797084189448,0.890574912356087,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,F2R
14001,GO:0060751,0.466800616557576,0.890573019660566,1,5,branch elongation involved in mammary gland duct branching,BP,AREG
18548,GO:1903817,0.466908911064876,0.890514983480595,1,5,negative regulation of voltage-gated potassium channel activity,BP,ANK3
2113,GO:0004904,0.466914350314287,0.890512068008526,1,5,interferon receptor activity,MF,IFNGR2
13748,GO:0060352,0.466929315426435,0.890504046337889,1,5,cell adhesion molecule production,BP,FLOT1
2820,GO:0006287,0.467093551743085,0.890415986567933,1,5,base-excision repair, gap-filling,BP,POLL
10039,GO:0042538,0.467115050983542,0.890404455770908,1,5,hyperosmotic salinity response,BP,TRPV4
10549,GO:0043525,0.467180798183784,0.714887463729225,5,38,positive regulation of neuron apoptotic process,BP,PRNP;DDIT3;ATF4;PCSK9;ITGA1
13841,GO:0060484,0.467242480446862,0.890336094708842,1,5,lung-associated mesenchyme development,BP,FGFR1
8592,GO:0034114,0.467307397026303,0.806463790153495,2,13,regulation of heterotypic cell-cell adhesion,BP,FLOT1;MAP2K5
8273,GO:0033089,0.467390151634268,0.890256840142033,1,5,positive regulation of T cell differentiation in thymus,BP,ADA
4551,GO:0010637,0.467390805558493,0.890256489102716,1,5,negative regulation of mitochondrial fusion,BP,BNIP3
520,GO:0001608,0.467519434143419,0.890187424219466,1,5,G-protein coupled nucleotide receptor activity,MF,PTAFR
9192,GO:0035589,0.467519434143419,0.890187424219466,1,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,PTAFR
11029,GO:0045028,0.467519434143419,0.890187424219466,1,5,G-protein coupled purinergic nucleotide receptor activity,MF,PTAFR
9851,GO:0042119,0.467545158116167,0.597478394300656,43,360,neutrophil activation,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;BRI3;ACTR1B;TMC6;KCNAB2;RHOF;CTSB;LTA4H;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;APRT;METTL7A;HGSNAT;TOM1;AP2A2;GALNS;LAMTOR2;PFKL
11287,GO:0045625,0.467570029897258,0.89016024997894,1,5,regulation of T-helper 1 cell differentiation,BP,JAK3
16320,GO:0090611,0.467613158235069,0.890137082943865,1,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,CHMP4C
5448,GO:0016327,0.467709966916546,0.80616590220391,2,13,apicolateral plasma membrane,CC,KRT19;MPDZ
16480,GO:0097208,0.467716548298993,0.8900815324955,1,5,alveolar lamellar body,CC,CTSH
3671,GO:0008172,0.467722351548919,0.89007841393153,1,5,S-methyltransferase activity,MF,MGMT
6944,GO:0030579,0.467760331614744,0.890058002671299,1,5,ubiquitin-dependent SMAD protein catabolic process,BP,SMURF2
13879,GO:0060556,0.467800938147161,0.890036177170103,1,5,regulation of vitamin D biosynthetic process,BP,CYP27B1
11989,GO:0047499,0.46781389191554,0.890029214093536,1,5,calcium-independent phospholipase A2 activity,MF,PLA2G6
3425,GO:0007216,0.46784978056587,0.890009921261171,1,5,G-protein coupled glutamate receptor signaling pathway,BP,HOMER2
2807,GO:0006269,0.467854572449475,0.890007345100685,1,5,DNA replication, synthesis of RNA primer,BP,PRIMPOL
13070,GO:0051606,0.467938512534737,0.640384511163997,15,118,detection of stimulus,BP,SERPINE2;NTSR1;POLD4;PITPNM1;ABCG1;ANO1;PKD2;HMGA2;REEP6;PKD1;TTN;TRPV1;FYN;ITGA2;UNC119
13463,GO:0055026,0.467944796690199,0.762110215017246,3,21,negative regulation of cardiac muscle tissue development,BP,PAK1;TGFBR2;TP73
11435,GO:0045910,0.468016765150671,0.762051535262743,3,21,negative regulation of DNA recombination,BP,MAGEF1;BCL6;RECQL5
17663,GO:1901569,0.468030234853921,0.889912880328482,1,5,fatty acid derivative catabolic process,BP,ACOT7
8202,GO:0032966,0.468049310766249,0.889902618836359,1,5,negative regulation of collagen biosynthetic process,BP,ERRFI1
2639,GO:0005976,0.468054916322178,0.663374536912988,10,79,polysaccharide metabolic process,BP,PYGB;NR1D1;PGM1;GAA;PYGL;PPP1R3E;STK40;AKT1;INSR;PHLDA2
8264,GO:0033079,0.468090777971165,0.889880310276476,1,5,immature T cell proliferation,BP,ERBB2
8037,GO:0032700,0.468118678884755,0.889865298466769,1,5,negative regulation of interleukin-17 production,BP,PRNP
12243,GO:0048550,0.468175401295475,0.88983477544393,1,5,negative regulation of pinocytosis,BP,PROM2
1928,GO:0004630,0.468270617239848,0.889783526234496,1,5,phospholipase D activity,MF,PLD3
7191,GO:0031089,0.468339368504137,0.889746511799193,1,5,platelet dense granule lumen,CC,ECM1
7665,GO:0032103,0.468362437331768,0.625694742270835,20,165,positive regulation of response to external stimulus,BP,TNIP1;PGF;PDCD4;VEGFA;EGFR;MAPK13;CYP27B1;VEGFB;ZP3;MAPK3;SEMA5A;LRSAM1;TRPV4;TMSB4X;PDE2A;GAS6;IL17RC;BRAF;ITGA2;FGFR1
16722,GO:0098519,0.468489504888214,0.889665653063106,1,5,nucleotide phosphatase activity, acting on free nucleotides,MF,NTPCR
864,GO:0002200,0.468513757415267,0.687274476544433,7,54,somatic diversification of immune receptors,BP,ERCC1;RAG1;STAT6;POLM;POLL;BCL6;TCF7
18609,GO:1903936,0.468539166406661,0.889638898454931,1,5,cellular response to sodium arsenite,BP,MAPK13
4242,GO:0009446,0.468565938012749,0.889624473798054,1,5,putrescine biosynthetic process,BP,AZIN2
8421,GO:0033549,0.468711565854181,0.805423673403157,2,13,MAP kinase phosphatase activity,MF,DUSP6;DUSP5
10602,GO:0043615,0.468886456970009,0.88945168168428,1,5,astrocyte cell migration,BP,HEXB
10464,GO:0043374,0.468914963995531,0.88943630501744,1,5,CD8-positive, alpha-beta T cell differentiation,BP,SATB1
10427,GO:0043301,0.4690163840244,0.889381587872447,1,5,negative regulation of leukocyte degranulation,BP,BCR
10023,GO:0042492,0.469050086670108,0.889363401053755,1,5,gamma-delta T cell differentiation,BP,SOX13
3527,GO:0007512,0.469139226039092,0.88931528978923,1,5,adult heart development,BP,MEF2D
2346,GO:0005391,0.469218014412397,0.88927275397175,1,5,sodium:potassium-exchanging ATPase activity,MF,ATP12A
3904,GO:0008556,0.469218014412397,0.88927275397175,1,5,potassium-transporting ATPase activity,MF,ATP12A
6392,GO:0021604,0.46921958948979,0.889271903517054,1,5,cranial nerve structural organization,BP,SEMA3F
6394,GO:0021612,0.46921958948979,0.889271903517054,1,5,facial nerve structural organization,BP,SEMA3F
319,GO:0000836,0.469255899751252,0.889252296868743,1,5,Hrd1p ubiquitin ligase complex,CC,SYVN1
19587,GO:1990763,0.469257952542383,0.889251188342781,1,5,arrestin family protein binding,MF,ARRDC1
16058,GO:0090051,0.46933268259674,0.804962624038524,2,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,HDAC5;MAP2K5
14130,GO:0061037,0.469380944610245,0.804926774735687,2,13,negative regulation of cartilage development,BP,ADAMTS7;PTHLH
8652,GO:0034235,0.469458878540707,0.8891426517485,1,5,GPI anchor binding,MF,MPPE1
7973,GO:0032596,0.469464022132583,0.889139872367159,1,5,protein transport into membrane raft,BP,REEP2
12523,GO:0050693,0.469468928740382,0.88913722100168,1,5,LBD domain binding,MF,RXRA
7519,GO:0031748,0.469509232051362,0.889115440868017,1,5,D1 dopamine receptor binding,MF,DLG4
9131,GO:0035493,0.469531721639381,0.804814753589366,2,13,SNARE complex assembly,BP,VPS11;STX1A
16657,GO:0097629,0.46971570379323,0.889003818795466,1,5,extrinsic component of omegasome membrane,CC,ULK1
18321,GO:1903319,0.469775792285381,0.804633344956086,2,13,positive regulation of protein maturation,BP,GSN;PLGRKT
359,GO:0000978,0.469782272733498,0.602140109656459,35,287,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NFATC4;FOS;NR1D1;MEF2D;DDIT3;TCFL5;ETV4;ELK3;FOXQ1;ETV1;HES2;CARF;PPARA;STAT6;KLF7;HMGA2;MLXIPL;LITAF;ATF4;ZFPM1;JDP2;RFX2;CEBPB;HLTF;BHLHE40;RXRA;ZNF217;SMARCD2;TP73;TFEB;HSF4;POU2F2;PER1;CREB3L4;SIX5
8439,GO:0033578,0.469788036469683,0.888964697280108,1,5,protein glycosylation in Golgi,BP,LMF1
19654,GO:2000002,0.469790185313812,0.888963534928825,1,5,negative regulation of DNA damage checkpoint,BP,CHEK2
11640,GO:0046415,0.469869314852078,0.888920726742322,1,5,urate metabolic process,BP,SLC2A9
4952,GO:0015020,0.469871830707903,0.804561938027228,2,13,glucuronosyltransferase activity,MF,B3GAT3;B4GAT1
13266,GO:0051987,0.469879116367721,0.888915423485612,1,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,SIRT2
9392,GO:0035965,0.469934602492337,0.888885398789757,1,5,cardiolipin acyl-chain remodeling,BP,TAZ
17927,GO:1902307,0.470048203992251,0.80443076315979,2,13,positive regulation of sodium ion transmembrane transport,BP,ANK3;NOS1
11219,GO:0045414,0.470147772209771,0.888769999160351,1,5,regulation of interleukin-8 biosynthetic process,BP,MAP2K5
18587,GO:1903898,0.470148370633969,0.888769675099278,1,5,negative regulation of PERK-mediated unfolded protein response,BP,PPP1R15A
16238,GO:0090324,0.470148847164596,0.888769417038194,1,5,negative regulation of oxidative phosphorylation,BP,MLXIPL
10827,GO:0044340,0.470153349156603,0.8887669790295,1,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,WNT3
6179,GO:0019563,0.470157602571422,0.88876467560559,1,5,glycerol catabolic process,BP,TKFC
4178,GO:0009259,0.470159417343379,0.594172377725853,44,372,ribonucleotide metabolic process,BP,DLG4;NT5E;APOE;TIMP2;VEGFA;RAPGEF3;NOS1;PGM1;DHTKD1;DDIT4;OGDHL;NPR2;DLG3;NME4;ABHD14B;PPCS;PPARA;PKD2;FAM20C;MYH3;MLXIPL;SDHA;PTHLH;LTB4R2;GTPBP1;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;MOCOS;PDE2A;NOS3;UCKL1;ADCY6;CARD11;TCIRG1;UPP1;INSR;APRT;TAZ;PFKL;NUDT18
15855,GO:0072611,0.470187419804131,0.888748527313831,1,5,interleukin-13 secretion,BP,PRKCZ
20012,GO:2000665,0.470187419804131,0.888748527313831,1,5,regulation of interleukin-13 secretion,BP,PRKCZ
17069,GO:0099632,0.470231656798184,0.804294272175877,2,13,protein transport within plasma membrane,BP,ARHGAP44;HIP1
17071,GO:0099637,0.470231656798184,0.804294272175877,2,13,neurotransmitter receptor transport,BP,ARHGAP44;HIP1
3756,GO:0008301,0.470256201960155,0.804276006362156,2,13,DNA binding, bending,MF,HMGA2;FOXL1
5210,GO:0015813,0.470265382871959,0.804269173949312,2,13,L-glutamate transmembrane transport,BP,NTSR1;PRAF2
14209,GO:0061200,0.470286137822893,0.888695053123954,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,VAMP2
14210,GO:0061202,0.470286137822893,0.888695053123954,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,VAMP2
5020,GO:0015187,0.470338778227825,0.88866653171873,1,5,glycine transmembrane transporter activity,MF,SLC6A9
7494,GO:0031681,0.470360761107197,0.888654619638946,1,5,G-protein beta-subunit binding,MF,F2R
13031,GO:0051546,0.470375202898708,0.804187436082179,2,13,keratinocyte migration,BP,HBEGF;LTB4R2
18754,GO:1904294,0.470401550232136,0.804167823279177,2,13,positive regulation of ERAD pathway,BP,EDEM1;HERPUD1
648,GO:0001839,0.470604043527995,0.88852273445092,1,5,neural plate morphogenesis,BP,VANGL2
1232,GO:0002921,0.470606879292417,0.888521196563992,1,5,negative regulation of humoral immune response,BP,SERPING1
19169,GO:1905288,0.470631141157361,0.888508038342958,1,5,vascular associated smooth muscle cell apoptotic process,BP,PDCD4
19243,GO:1905459,0.470631141157361,0.888508038342958,1,5,regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4
19244,GO:1905461,0.470631141157361,0.888508038342958,1,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4
2946,GO:0006477,0.470637465153567,0.888504608408569,1,5,protein sulfation,BP,UST
12564,GO:0050764,0.470663678505647,0.711820174241834,5,38,regulation of phagocytosis,BP,ABCA7;GAS6;BCR;MYO18A;ITGA2
10187,GO:0042816,0.470743459733052,0.888447110130163,1,5,vitamin B6 metabolic process,BP,PSAT1
2324,GO:0005337,0.470766692083197,0.888434504838333,1,5,nucleoside transmembrane transporter activity,MF,SLC29A4
5234,GO:0015858,0.470766692083197,0.888434504838333,1,5,nucleoside transport,BP,SLC29A4
17694,GO:1901642,0.470766692083197,0.888434504838333,1,5,nucleoside transmembrane transport,BP,SLC29A4
9492,GO:0036155,0.470892020389153,0.888366488831101,1,5,acylglycerol acyl-chain remodeling,BP,PNPLA3
5047,GO:0015245,0.470917523319803,0.888352645013929,1,5,fatty acid transmembrane transporter activity,MF,SLC27A1
18537,GO:1903789,0.470931869530708,0.888344856943473,1,5,regulation of amino acid transmembrane transport,BP,STK39
1442,GO:0003433,0.470940579802158,0.888340128257291,1,5,chondrocyte development involved in endochondral bone morphogenesis,BP,TGFBR2
10156,GO:0042760,0.470959672081055,0.888329762857543,1,5,very long-chain fatty acid catabolic process,BP,ACADVL
5789,GO:0017034,0.471032255559242,0.888290350848707,1,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF3
13240,GO:0051953,0.471069670567788,0.888270031389026,1,5,negative regulation of amine transport,BP,STK39
16099,GO:0090118,0.471085423779418,0.888261475363561,1,5,receptor-mediated endocytosis involved in cholesterol transport,BP,PCSK9
15728,GO:0072345,0.471093987088549,0.888256824207995,1,5,NAADP-sensitive calcium-release channel activity,MF,TPCN1
13469,GO:0055056,0.471096324639482,0.888255554545804,1,5,D-glucose transmembrane transporter activity,MF,SLC2A3
13956,GO:0060693,0.471146649375465,0.888228217924456,1,5,regulation of branching involved in salivary gland morphogenesis,BP,FGFR1
17467,GO:1900451,0.471175991034067,0.888212277408099,1,5,positive regulation of glutamate receptor signaling pathway,BP,EPHB2
2878,GO:0006382,0.471191119185675,0.88820405811639,1,5,adenosine to inosine editing,BP,ADARB1
9374,GO:0035926,0.471198510279387,0.888200042309577,1,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN
13900,GO:0060586,0.471218396771138,0.888189236911996,1,5,multicellular organismal iron ion homeostasis,BP,HFE
15714,GO:0072318,0.471226055858489,0.888185075142252,1,5,clathrin coat disassembly,BP,DNAJC6
4374,GO:0010009,0.471234959405783,0.888180237022307,1,5,cytoplasmic side of endosome membrane,CC,LITAF
3029,GO:0006578,0.471253011644441,0.88817042716674,1,5,amino-acid betaine biosynthetic process,BP,ALDH7A1
1413,GO:0003352,0.471253212495923,0.888170318024056,1,5,regulation of cilium movement,BP,BBS2
1414,GO:0003356,0.471253212495923,0.888170318024056,1,5,regulation of cilium beat frequency,BP,BBS2
13701,GO:0060295,0.471253212495923,0.888170318024056,1,5,regulation of cilium movement involved in cell motility,BP,BBS2
13702,GO:0060296,0.471253212495923,0.888170318024056,1,5,regulation of cilium beat frequency involved in ciliary motility,BP,BBS2
17815,GO:1902019,0.471253212495923,0.888170318024056,1,5,regulation of cilium-dependent cell motility,BP,BBS2
1798,GO:0004445,0.471267953789247,0.888162306967309,1,5,inositol-polyphosphate 5-phosphatase activity,MF,INPP5D
16095,GO:0090110,0.47131621390407,0.803486289566141,2,13,cargo loading into COPII-coated vesicle,BP,TBC1D20;SEC31B
6271,GO:0019871,0.47132756152794,0.888129909735494,1,5,sodium channel inhibitor activity,MF,PCSK9
12440,GO:0050291,0.471331908273803,0.88812754700474,1,5,sphingosine N-acyltransferase activity,MF,CERS4
16892,GO:0098887,0.4713674846869,0.888108207797005,1,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,ARHGAP44
11647,GO:0046439,0.471373354635379,0.888105016702448,1,5,L-cysteine metabolic process,BP,CBS
17657,GO:1901563,0.471392742840467,0.888094476232278,1,5,response to camptothecin,BP,RECQL5
11547,GO:0046113,0.471399308971805,0.888090906388359,1,5,nucleobase catabolic process,BP,XDH
1994,GO:0004720,0.471404867284246,0.888087884408338,1,5,protein-lysine 6-oxidase activity,MF,LOXL1
13977,GO:0060718,0.471471678079824,0.888051556123026,1,5,chorionic trophoblast cell differentiation,BP,HTRA1
8807,GO:0034594,0.47147882405495,0.888047670058708,1,5,phosphatidylinositol trisphosphate phosphatase activity,MF,INPP5D
2215,GO:0005113,0.47152470235795,0.888022718779859,1,5,patched binding,MF,BBS1
19873,GO:2000394,0.471554413711446,0.888006558102767,1,5,positive regulation of lamellipodium morphogenesis,BP,CORO1B
11060,GO:0045078,0.471596900490155,0.887983445935822,1,5,positive regulation of interferon-gamma biosynthetic process,BP,ZFPM1
13483,GO:0055078,0.47160948354228,0.803267495449176,2,13,sodium ion homeostasis,BP,SCNN1A;ATP12A
16581,GO:0097443,0.471611646326375,0.8879754236939,1,5,sorting endosome,CC,CLTCL1
9387,GO:0035947,0.471632136465678,0.887964275748985,1,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,NR1D1
11246,GO:0045542,0.471632255526181,0.887964210964701,1,5,positive regulation of cholesterol biosynthetic process,BP,ABCG1
4679,GO:0010832,0.471634076967841,0.887963219947515,1,5,negative regulation of myotube differentiation,BP,HDAC5
15979,GO:0086016,0.471638715731132,0.887960696048283,1,5,AV node cell action potential,BP,SCN4B
15988,GO:0086027,0.471638715731132,0.887960696048283,1,5,AV node cell to bundle of His cell signaling,BP,SCN4B
8842,GO:0034650,0.471644365757501,0.887957621881237,1,5,cortisol metabolic process,BP,DGKQ
8843,GO:0034651,0.471644365757501,0.887957621881237,1,5,cortisol biosynthetic process,BP,DGKQ
19690,GO:2000064,0.471644365757501,0.887957621881237,1,5,regulation of cortisol biosynthetic process,BP,DGKQ
18369,GO:1903423,0.471653984468272,0.887952388236052,1,5,positive regulation of synaptic vesicle recycling,BP,DNM1
8735,GO:0034398,0.471679989167983,0.887938237982248,1,5,telomere tethering at nuclear periphery,BP,LEMD2
7057,GO:0030853,0.471709285015087,0.887922295493331,1,5,negative regulation of granulocyte differentiation,BP,INPP5D
13539,GO:0060028,0.471715249714983,0.887919049379879,1,5,convergent extension involved in axis elongation,BP,VANGL2
5635,GO:0016725,0.471796588761225,0.887874776952092,1,5,oxidoreductase activity, acting on CH or CH2 groups,MF,XDH
5262,GO:0015911,0.471818654726932,0.88786276460173,1,5,plasma membrane long-chain fatty acid transport,BP,AKT1
19071,GO:1905007,0.471821141073761,0.8878614110159,1,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
473,GO:0001517,0.471837243273549,0.887852644652534,1,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,CHST6
4212,GO:0009378,0.47185166470436,0.887844792945204,1,5,four-way junction helicase activity,MF,RECQL5
813,GO:0002087,0.471856335189107,0.887842250037832,1,5,regulation of respiratory gaseous exchange by neurological system process,BP,NLGN2
4724,GO:0010891,0.47185697496832,0.887841901695317,1,5,negative regulation of sequestering of triglyceride,BP,PPARA
6072,GO:0019228,0.471872326464287,0.803071288411144,2,13,neuronal action potential,BP,SCN8A;ANK3
12906,GO:0051286,0.471899240404078,0.887818887956337,1,5,cell tip,CC,PI4K2A
3120,GO:0006702,0.471902714779555,0.887816996003573,1,5,androgen biosynthetic process,BP,SRD5A3
13831,GO:0060462,0.47191972510054,0.88780773282191,1,5,lung lobe development,BP,TGFBR2
13832,GO:0060463,0.47191972510054,0.88780773282191,1,5,lung lobe morphogenesis,BP,TGFBR2
10974,GO:0044789,0.471932396766134,0.887800831991653,1,5,modulation by host of viral release from host cell,BP,PC
10975,GO:0044791,0.471932396766134,0.887800831991653,1,5,positive regulation by host of viral release from host cell,BP,PC
10311,GO:0043121,0.471981455891198,0.887774112395991,1,5,neurotrophin binding,MF,NGFR
10668,GO:0043950,0.47203378025011,0.887745609855546,1,5,positive regulation of cAMP-mediated signaling,BP,NOS1
15310,GO:0071557,0.472056865643642,0.887733033091481,1,5,histone H3-K27 demethylation,BP,KDM7A
15311,GO:0071558,0.472056865643642,0.887733033091481,1,5,histone demethylase activity (H3-K27 specific),MF,KDM7A
19746,GO:2000192,0.472074031022379,0.887723680921678,1,5,negative regulation of fatty acid transport,BP,AKT1
9496,GO:0036159,0.47209765420848,0.887710809532019,1,5,inner dynein arm assembly,BP,DNAH1
5687,GO:0016812,0.472154760048601,0.887679690724691,1,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,OPLAH
15505,GO:0071922,0.472175526114837,0.887668373234364,1,5,regulation of cohesin loading,BP,HDAC8
7910,GO:0032494,0.47217801949947,0.887667014293914,1,5,response to peptidoglycan,BP,IRF5
19741,GO:2000178,0.472265490548391,0.802777600072581,2,13,negative regulation of neural precursor cell proliferation,BP,SIRT2;KCTD11
16416,GO:0097105,0.472281829238182,0.887610426492418,1,5,presynaptic membrane assembly,BP,NLGN2
7904,GO:0032486,0.472314490254189,0.802740981212756,2,13,Rap protein signal transduction,BP,TIMP2;RAPGEF3
9140,GO:0035507,0.472362123048336,0.887566644751756,1,5,regulation of myosin-light-chain-phosphatase activity,BP,IKBKB
840,GO:0002154,0.47241457022646,0.887538040916216,1,5,thyroid hormone mediated signaling pathway,BP,THRA
600,GO:0001768,0.472422465675507,0.887533734458409,1,5,establishment of T cell polarity,BP,GSN
11117,GO:0045179,0.472430890560491,0.887529139110769,1,5,apical cortex,CC,PRKCZ
16415,GO:0097104,0.472465908484815,0.887510037287578,1,5,postsynaptic membrane assembly,BP,NLGN2
4922,GO:0014877,0.472484091631624,0.887500117784758,1,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,MTMR4
4930,GO:0014894,0.472484091631624,0.887500117784758,1,5,response to denervation involved in regulation of muscle adaptation,BP,MTMR4
16987,GO:0099132,0.47250225341219,0.729862221785671,4,30,ATP hydrolysis coupled cation transmembrane transport,BP,ATP7B;ATP2B4;TCIRG1;ATP12A
16594,GO:0097470,0.472509026591345,0.887486514013175,1,5,ribbon synapse,CC,NPHP4
7882,GO:0032459,0.472533990100279,0.729834895175425,4,30,regulation of protein oligomerization,BP,APOE;MMP1;SNX9;SORL1
14310,GO:0061525,0.472665980379576,0.88740086014144,1,5,hindgut development,BP,TCF7
8572,GO:0034067,0.472674261040654,0.758239197473,3,21,protein localization to Golgi apparatus,BP,OBSL1;SORL1;COG7
14272,GO:0061419,0.472686706505677,0.887389546166682,1,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,VEGFA
3432,GO:0007224,0.47281086370465,0.647864601230873,12,96,smoothened signaling pathway,BP,SERPINE2;IFT140;EVC;TTBK2;IFT27;TCTN1;TGFBR2;WDR19;IFT57;MAP3K10;FKBP8;KCTD11
11118,GO:0045180,0.472827978943783,0.887312408664186,1,5,basal cortex,CC,PKD2
19140,GO:1905208,0.472836222016664,0.802350846285575,2,13,negative regulation of cardiocyte differentiation,BP,EGFR;PAK1
13934,GO:0060666,0.473085428258162,0.88717174780381,1,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,PLXND1
10399,GO:0043255,0.473088912270621,0.6831066823796,7,54,regulation of carbohydrate biosynthetic process,BP,NTSR1;NR1D1;DGKQ;PPARA;PTAFR;AKT1;INSR
11247,GO:0045545,0.473133211373222,0.887145628289293,1,5,syndecan binding,MF,SEMA5A
13708,GO:0060304,0.473167098656205,0.887127102208558,1,5,regulation of phosphatidylinositol dephosphorylation,BP,MTMR4
16329,GO:0090649,0.473470476663116,0.88696115804747,1,5,response to oxygen-glucose deprivation,BP,AQP3
16330,GO:0090650,0.473470476663116,0.88696115804747,1,5,cellular response to oxygen-glucose deprivation,BP,AQP3
12847,GO:0051194,0.473472129931235,0.801874764826197,2,13,positive regulation of cofactor metabolic process,BP,MLXIPL;INSR
16333,GO:0090659,0.473476873263171,0.801871211312449,2,13,walking behavior,BP,EFNB3;SPG11
10636,GO:0043696,0.473523917648453,0.886931910001893,1,5,dedifferentiation,BP,OLFM2
10637,GO:0043697,0.473523917648453,0.886931910001893,1,5,cell dedifferentiation,BP,OLFM2
9059,GO:0035313,0.473534671139393,0.801827908675992,2,13,wound healing, spreading of epidermal cells,BP,HBEGF;WNT7A
8732,GO:0034394,0.473679216624672,0.709153682963776,5,38,protein localization to cell surface,BP,KCNAB2;PTPRU;AKT1;HFE;SNX33
11312,GO:0045656,0.473717994908948,0.886825650770206,1,5,negative regulation of monocyte differentiation,BP,INPP5D
2476,GO:0005697,0.474020161643863,0.756421498867019,3,22,telomerase holoenzyme complex,CC,TEP1;TERC;HMBOX1
16131,GO:0090177,0.474152398501513,0.801364779336802,2,13,establishment of planar polarity involved in neural tube closure,BP,VANGL2;CELSR1
16132,GO:0090178,0.474152398501513,0.801364779336802,2,13,regulation of establishment of planar polarity involved in neural tube closure,BP,VANGL2;CELSR1
4585,GO:0010694,0.474207790046872,0.886557193622452,1,5,positive regulation of alkaline phosphatase activity,BP,ITGA2
13944,GO:0060677,0.474315766498082,0.886497955820019,1,5,ureteric bud elongation,BP,KIF26B
2412,GO:0005587,0.474327389778639,0.886491577879307,1,5,collagen type IV trimer,CC,COL4A6
10821,GO:0044332,0.474344474847659,0.886482202515778,1,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,LRP5
6425,GO:0021697,0.474346421742736,0.801219192145846,2,13,cerebellar cortex formation,BP,MAP2K1;WNT7A
987,GO:0002444,0.474367435439332,0.58872923787613,46,386,myeloid leukocyte mediated immunity,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;BRI3;ACTR1B;TMC6;S100A13;VAMP2;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;APRT;METTL7A;HGSNAT;TOM1;AP2A2;GALNS;LAMTOR2;PFKL
9514,GO:0036257,0.47440743877719,0.728219621311926,4,30,multivesicular body organization,BP,CHMP1B;TSG101;CHMP5;CHMP4C
1327,GO:0003181,0.474486134744097,0.801114321038691,2,13,atrioventricular valve morphogenesis,BP,ZFPM1;TGFBR2
15396,GO:0071692,0.474575123040656,0.886355585781558,1,5,protein localization to extracellular region,BP,LTBP1
15397,GO:0071694,0.474575123040656,0.886355585781558,1,5,maintenance of protein location in extracellular region,BP,LTBP1
7605,GO:0032000,0.474686313777108,0.8862945135705,1,5,positive regulation of fatty acid beta-oxidation,BP,PPARA
18959,GO:1904781,0.475026182626334,0.88610770569358,1,5,positive regulation of protein localization to centrosome,BP,CEP250
18835,GO:1904502,0.475109254991486,0.886062014781926,1,5,regulation of lipophagy,BP,SESN2
18836,GO:1904504,0.475109254991486,0.886062014781926,1,5,positive regulation of lipophagy,BP,SESN2
9631,GO:0036514,0.475143749440888,0.886043038861985,1,5,dopaminergic neuron axon guidance,BP,VANGL2
19038,GO:1904938,0.475143749440888,0.886043038861985,1,5,planar cell polarity pathway involved in axon guidance,BP,VANGL2
16034,GO:0089717,0.475159974344924,0.88603411258051,1,5,spanning component of membrane,CC,NLGN2
10423,GO:0043296,0.47519406458488,0.641070517132971,13,104,apical junction complex,CC,ANK3;NPHP4;PRKCZ;DLG3;MICALL2;SHROOM4;ARHGEF2;FBF1;FRMD4B;WNK4;RAB13;MPDZ;MAGI1
6924,GO:0030534,0.475259562696371,0.671395571089694,8,63,adult behavior,BP,BBS2;NTSR1;DNM1;SHANK2;EFNB3;PPARA;SLITRK6;HOMER2
11024,GO:0045022,0.475444860068547,0.707587752484845,5,38,early endosome to late endosome transport,BP,MAP2K1;VPS11;MAPK3;HOOK2;MAP2K2
14606,GO:0070201,0.475515421990274,0.579296441886624,62,513,regulation of establishment of protein localization,BP,F2R;POSTN;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;NR1D1;HADH;ANK3;RAPGEF3;IDH2;B3GAT3;TFDP2;PCK2;TMEM173;ARL2;VPS11;NLGN2;ITPR3;PRKCZ;PAK1;CEMIP;MICALL2;PLA2G6;C5;ANO1;SH3TC2;VAMP2;MAPK3;DMTN;BBC3;TTN;SORL1;NLRP1;RHBDF1;LRP5;CEP131;TRPV4;TMSB4X;PDE2A;PEMT;BNIP3L;RHBDF2;GAS6;GLUD1;CAMK1;MAPKBP1;ITPR2;TSG101;IL17RC;ICA1;IFI27;TP73;FYN;CIDEA;MYO18A;STX1A;ERBB2;OSCP1;PFKL
10575,GO:0043559,0.475582052594904,0.885801741944226,1,5,insulin binding,MF,INSR
1592,GO:0004012,0.475888086757131,0.800060314765035,2,13,phospholipid-translocating ATPase activity,MF,ABCA7;ATP8B2
5775,GO:0017002,0.476312700527487,0.885398760645462,1,5,activin-activated receptor activity,MF,ACVR2B
15655,GO:0072205,0.47637691053117,0.885363301948841,1,5,metanephric collecting duct development,BP,PKD1
19961,GO:2000587,0.476377612725886,0.885362914129303,1,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1
11438,GO:0045913,0.476402187958475,0.691832553413602,6,46,positive regulation of carbohydrate metabolic process,BP,NTSR1;PPARA;MLXIPL;PTAFR;AKT1;INSR
12268,GO:0048617,0.476733324003156,0.885166349368692,1,5,embryonic foregut morphogenesis,BP,ACVR2B
10874,GO:0044432,0.477057584891734,0.564213799210369,114,958,endoplasmic reticulum part,CC,H6PD;APOE;OSBPL5;LMF1;TMEM129;EDEM1;EGFR;ADAMTS7;IGFBP4;CRTAP;CST3;NOS1;GPSM1;ADAMTS13;COL13A1;CYP3A5;CERCAM;REEP2;PLD3;COL6A1;LPCAT4;PITPNM1;TMEM173;ULK1;ITPR3;SLC37A2;MCTP1;ERO1B;SPPL2B;LTBP1;SMIM14;TMC6;PNPLA3;DHRS4;ANO8;TMED4;CES3;ABCG1;ESYT2;FKBP10;PKD2;AREG;COL8A1;LAMB2;SCARA3;FAM20C;ADAMTSL1;MXRA8;SDC2;IFNGR2;SRD5A3;UBXN4;MOSPD3;FBXO6;REEP6;PSKH1;HSD11B1;HERPUD1;CES2;COL4A6;RHBDF1;PCSK9;HSD17B7;PEMT;EDA;PIGZ;WNT7A;MARCH2;RHBDF2;GAS6;ERN1;CPT1C;NECAB3;CYP2R1;PPP1R15A;TM7SF2;IGFBP7;ITPR2;REEP4;LAMB1;FAAH;COPG1;TBC1D20;ARSA;CAPN2;WNT3;PIGQ;LGALS1;TIMP1;CERS4;TMEM50B;SLC37A4;ATP8B2;PJA2;MBOAT2;RTN2;ENTPD2;RETSAT;MAN1B1;RNF170;PIGV;WFS1;ESYT3;FITM2;FKBP8;XYLT2;SEC31B;KDELC2;SYVN1;HLA-G;MPPE1;CREB3L4;KDSR;CYP4V2
1045,GO:0002568,0.477162185977784,0.884929069067853,1,5,somatic diversification of T cell receptor genes,BP,TCF7
1092,GO:0002681,0.477162185977784,0.884929069067853,1,5,somatic recombination of T cell receptor gene segments,BP,TCF7
8307,GO:0033153,0.477162185977784,0.884929069067853,1,5,T cell receptor V(D)J recombination,BP,TCF7
15196,GO:0071375,0.477167939726814,0.60452056908048,27,222,cellular response to peptide hormone stimulus,BP,ZFP36L1;PCK2;SHC1;PRKCZ;PAK1;NGFR;PTPRE;VAMP2;MAPK3;ERRFI1;HDAC5;SRSF5;PCSK9;TRIB3;PIK3R2;ADCY6;AKT1;TCIRG1;INSR;FOXO4;GPR21;JAK3;APRT;FYN;RAB13;EIF4EBP1;GRB10
14869,GO:0070695,0.477464965810236,0.884761354467166,1,5,FHF complex,CC,HOOK2
11109,GO:0045165,0.47789350702335,0.630714587623004,15,121,cell fate commitment,BP,DUSP6;SPRY2;SOX12;WNT2B;STAT6;ARHGEF2;ZFPM1;CEBPB;WNT7A;WNT3;TENM4;BRAF;EPAS1;FGFR1;FKBP8
8010,GO:0032652,0.477969912513002,0.690171681892198,6,47,regulation of interleukin-1 production,BP,F2R;EGR1;ACP5;ERRFI1;NLRP1;GAS6
14148,GO:0061072,0.478468193433729,0.884204508304794,1,5,iris morphogenesis,BP,WNT2B
3586,GO:0008009,0.47866192413452,0.796635734412191,2,14,chemokine activity,MF,C5;CKLF
8007,GO:0032649,0.478674182726702,0.689532827352344,6,47,regulation of interferon-gamma production,BP,IL20RB;PRNP;ZP3;PDCD1LG2;ZFPM1;GAS6
10224,GO:0042954,0.478976771321743,0.883921548493715,1,5,lipoprotein transporter activity,MF,LRP1
3708,GO:0008219,0.479363093141019,0.55391314863231,186,1570,cell death,BP,XDH;DUSP6;F2R;TNFRSF6B;APOE;HS1BP3;NFATC4;FOS;PRODH;H1F0;GSN;EGR1;LRP1;ALOX15B;PDCD4;VEGFA;OBSCN;NTSR1;EGFR;RBCK1;PRNP;PRDX5;TNFSF15;KRT15;CST3;MEF2D;DDIT3;PACS2;ERCC6;NDRG1;ARHGEF19;GRAMD4;MST1R;ZFP36L1;ADARB1;NUPR1;RGL2;RPS6KA2;PYGL;TFDP2;NISCH;MAP2K1;PPL;PKN1;DDIT4;BTG1;SYNGAP1;ITGA6;TMEM173;PLEKHG5;SHC1;SPRY2;PRSS8;PRKCZ;PAK1;AARS;STK39;FGFR3;ELMO3;NME4;NEURL1;RAG1;NGFR;ARHGEF4;PLEKHG2;TNFRSF25;PLA2G6;PPARA;CHAC1;MKNK2;IMPACT;SATB1;ING4;HMGA2;SLIT3;MAPK3;BNIP3;SEMA5A;THRA;STK40;GSDMA;CTSB;ARHGEF2;INPP5D;MAP2K2;ANGPTL4;ATF4;BBC3;PAK6;SSH1;IFI6;MDK;KCNMA1;UNC5B;IRF5;SORL1;HERPUD1;NLRP1;PEG3;ENDOG;CEBPB;MAP3K12;LRP5;PCSK9;DNMT3A;TGFBR2;CSRNP3;ITGA1;TNFAIP8L1;TRIB3;DAP;CDK5RAP3;NOS3;AGO4;MINK1;WNT7A;TRPV1;BNIP3L;EPHA1;SHARPIN;GAS6;ERN1;ALKBH7;PPP1R15A;STRADB;CTSH;TNFRSF14;UACA;GSDMC;MGMT;ASNS;HINT2;AKT1;CARD11;MICAL1;BEX2;AMIGO2;CHEK2;IFT57;FGFR4;STEAP3;PHLDA1;DNASE2;LMNA;MARK4;IFI27;INSR;KRT19;NCOA7;RABGGTA;MAP2K5;BRAF;EDA2R;PIDD1;CAT;LGALS1;TIMP1;JAK3;TP73;MNT;BCL6;FYN;ARHGEF17;SIRT2;GDF15;PHLDA2;ADA;CIDEA;MYO18A;CIDEB;VAV3;MAP3K10;EPHB2;MAGI1;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;NET1;TRIM2;IKBKB;SNCB;HIP1;TEAD2
2268,GO:0005200,0.480658862964123,0.651463288475431,10,80,structural constituent of cytoskeleton,MF,ANK3;SPTB;KRT15;PPL;TUBG2;TUBE1;KRT19;ADD3;TUBGCP6;HIP1
12643,GO:0050871,0.481578448195106,0.686892961207398,6,47,positive regulation of B cell activation,BP,STAT6;INPP5D;CARD11;BCL6;ADA;VAV3
12043,GO:0048013,0.481668425814038,0.657313721883716,9,72,ephrin receptor signaling pathway,BP,DNM1;EFNB3;PAK1;SDC2;EPHA1;FYN;AP2A2;VAV3;EPHB2
12718,GO:0051010,0.481720265372315,0.795642779014998,2,13,microtubule plus-end binding,MF,CLIP2;TTBK2
12815,GO:0051149,0.48174992069134,0.67496825828062,7,55,positive regulation of muscle cell differentiation,BP,OLFM2;THRA;MAPK12;FLOT1;CAMK1;GDF15;CTH
16699,GO:0097730,0.482155786406309,0.664999931847338,8,63,non-motile cilium,CC,IFT140;SHANK2;NPHP4;KIF17;PKD2;SPATA7;WDR19;IFT57
11496,GO:0046031,0.482180931151395,0.650029397209573,10,80,ADP metabolic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;PPARA;MLXIPL;GALK1;ALDOC;INSR;PFKL
565,GO:0001707,0.48323610387197,0.700636630671913,5,38,mesoderm formation,BP,ITGB4;HMGA2;WNT3;ITGA2;FGFR1
7868,GO:0032438,0.483314189403304,0.748693890557487,3,22,melanosome organization,BP,BLOC1S4;LYST;BLOC1S1
614,GO:0001783,0.483514695527557,0.748525882445921,3,22,B cell apoptotic process,BP,PKN1;BCL6;ADA
14638,GO:0070265,0.483561781756663,0.700027572214232,5,39,necrotic cell death,BP,RBCK1;PYGL;BNIP3;ARHGEF2;ALKBH7
989,GO:0002446,0.484201527507134,0.581135206112232,43,362,neutrophil mediated immunity,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;CST3;PGM1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;BRI3;ACTR1B;TMC6;KCNAB2;RHOF;CTSB;LTA4H;FUCA1;ALDOC;HEXB;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;APRT;METTL7A;HGSNAT;TOM1;AP2A2;GALNS;LAMTOR2;PFKL
4143,GO:0009208,0.484852906761716,0.79189443064274,2,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,NME4;UCKL1
13443,GO:0055003,0.484985725869877,0.8019462107818,2,9,cardiac myofibril assembly,BP,OBSL1;TTN
9182,GO:0035579,0.48547623537358,0.67152702919116,7,55,specific granule membrane,CC,SLC2A3;TMC6;KCNAB2;PLAU;HGSNAT;TOM1;LAMTOR2
11663,GO:0046466,0.485586488132,0.746786668638643,3,22,membrane lipid catabolic process,BP,FUCA1;HEXB;NAGA
4778,GO:0010970,0.486437587234864,0.619076033249106,16,131,transport along microtubule,BP,IFT140;BLOC1S4;PRKCZ;WDR60;SPG11;KIF17;IFT27;NDE1;CEP131;FYCO1;WDR19;IFT57;TTC21A;COPG1;BLOC1S1;APBA1
16981,GO:0099111,0.486437587234864,0.619076033249106,16,131,microtubule-based transport,BP,IFT140;BLOC1S4;PRKCZ;WDR60;SPG11;KIF17;IFT27;NDE1;CEP131;FYCO1;WDR19;IFT57;TTC21A;COPG1;BLOC1S1;APBA1
17336,GO:1900076,0.486483743579856,0.670594313552161,7,55,regulation of cellular response to insulin stimulus,BP,PRKCZ;PAK1;NGFR;PTPRE;PIK3R2;GPR21;GRB10
4055,GO:0009108,0.487082895372713,0.601430762343917,23,190,coenzyme biosynthetic process,BP,NAPRT;IDH2;PGM1;DHTKD1;MLYCD;DDIT4;OGDHL;NMRK1;NMNAT2;PPCS;PPARA;ACACB;ACSS2;MLXIPL;GALK1;NADK;ACOT7;ALDOC;MOCOS;CBR4;INSR;ACSS1;PFKL
6002,GO:0019048,0.487768923773104,0.71657588591886,4,30,modulation by virus of host morphology or physiology,BP,RXRA;INSR;CPSF4;EIF2AK4
613,GO:0001782,0.488104064908919,0.744665321014165,3,22,B cell homeostasis,BP,PKN1;DOCK11;ADA
12856,GO:0051213,0.488579683683665,0.650818059876528,9,72,dioxygenase activity,MF,ALOX15B;PHYHD1;PHYH;KDM3A;KDM4C;KDM7A;ALKBH7;PHF2;OGFOD2
11038,GO:0045053,0.488643974322536,0.878456332201841,1,5,protein retention in Golgi apparatus,BP,SORL1
15404,GO:0071702,0.488713589570854,0.541869020104077,229,1935,organic substance transport,BP,BBS2;F2R;APOE;SYTL1;OSBPL5;LMF1;POSTN;EVI5L;SLC2A3;TMEM129;EDEM1;GLUL;LRP1;ALOX15B;NTSR1;EGFR;PRNP;ZDHHC1;NR1D1;SLC7A8;HADH;ANK3;RAPGEF3;CLTCL1;SLC16A3;SLC2A9;IDH2;NOS1;TBC1D8;ARRDC1;ZFP36L1;B3GAT3;EXOC2;RPL13A;BBS1;LTBP4;SLC27A1;REEP2;NISCH;CPT2;PITPNM3;ATG16L2;SYNGR1;PCK2;SLC16A5;ABCA2;SLC43A1;TOM1L2;PITPNM1;TMEM173;SNX9;ARL2;VPS11;RAB3B;NLGN2;ITPR3;PITPNC1;PRKCZ;PAK1;ABCA7;SLC37A2;STK39;CEMIP;MICALL2;SLCO4A1;NME4;ACVR2B;NGFR;OLFM2;TMED4;PLA2G6;ABCG1;ESYT2;XPOT;RINL;S100A13;AGAP1;C5;KIF17;PPARA;ANO1;SESN2;AIP;IFT27;SH3TC2;VAMP2;AP1G2;PCLO;ACACB;MAPK3;OSBPL10;PEX10;SLC22A18;LTBP2;HOOK2;EIF2D;MVB12B;PQLC2;CHMP1B;TBC1D14;ARHGEF2;PRAF2;SLC50A1;SLC48A1;LRSAM1;DMTN;SV2A;TBC1D3E;SLC38A10;RABGAP1;PKD1;SLC29A4;FLOT1;TTN;AZIN2;TSNARE1;SORL1;HERPUD1;PLTP;SRSF5;VLDLR;NLRP1;RHBDF1;LRP5;PCSK9;AQP3;CEP131;LONP2;TGFBR2;TRPV4;TMSB4X;ANO9;APOL4;PDE2A;APLN;TRIB3;RAB40B;PEMT;TRPV1;BNIP3L;PIK3R2;RHBDF2;GAS6;VPS39;GLUD1;BCR;KIF13B;NECAB3;CAMK1;RXRA;RAB43;STRADB;MAPKBP1;AKT1;ITPR2;CARD11;TSG101;IL17RC;IGF2BP2;RASSF9;SLC6A9;TCIRG1;STEAP3;SLC6A6;COPG1;SGSM2;CHMP5;ICA1;RAB25;IFI27;INSR;SLC25A29;COG7;SLC22A15;CHMP4C;ITGB6;LYST;ZDHHC24;BRAF;ARHGAP44;CPSF4;BTN3A2;UNC119B;HFE;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;BCL6;SLC37A4;EHD3;FYN;ATP8B2;SLC38A2;SNX1;PEX1;SLC25A42;RAB13;OSBPL1A;TOM1;TST;ADA;POU2F2;RTN2;AP2A2;CIDEA;MYO18A;SLC35F3;RPL29;STX1A;TBC1D16;STARD10;EDNRA;TMCO6;IGF2BP3;ESYT3;ERBB2;SEC31B;SLC10A6;UNC119;SYVN1;OSCP1;PFKL;RPL12;GRB10;BSG;APBA1;HIP1
7742,GO:0032266,0.488781472240924,0.715684631382021,4,30,phosphatidylinositol-3-phosphate binding,MF,TECPR1;WDR45;PLEKHA4;HIP1
8935,GO:0034992,0.489088184040553,0.878201216317679,1,5,microtubule organizing center attachment site,CC,SYNE3
8936,GO:0034993,0.489088184040553,0.878201216317679,1,5,meiotic nuclear membrane microtubule tethering complex,CC,SYNE3
16209,GO:0090286,0.489088184040553,0.878201216317679,1,5,cytoskeletal anchoring at nuclear membrane,BP,SYNE3
17192,GO:0106083,0.489088184040553,0.878201216317679,1,5,nuclear membrane protein complex,CC,SYNE3
17195,GO:0106094,0.489088184040553,0.878201216317679,1,5,nuclear membrane microtubule tethering complex,CC,SYNE3
16693,GO:0097718,0.489143544345591,0.715365627100455,4,30,disordered domain specific binding,MF,FYN;AP2A2;FKBP8;TEAD2
635,GO:0001825,0.489450437457137,0.743527277856947,3,22,blastocyst formation,BP,ZP3;KDM4C;ADA
5350,GO:0016126,0.489558228774715,0.657931372685621,8,64,sterol biosynthetic process,BP,APOE;SEC14L2;ABCG1;ACACB;MVD;HSD17B7;TM7SF2;PLPP6
2103,GO:0004879,0.489949598381048,0.714654874208821,4,30,nuclear receptor activity,MF,NR1D1;PPARA;THRA;RXRA
16725,GO:0098531,0.489949598381048,0.714654874208821,4,30,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,NR1D1;PPARA;THRA;RXRA
9624,GO:0036507,0.490189358034976,0.742901634142052,3,22,protein demannosylation,BP,EDEM1;MAN1B1;SYVN1
9625,GO:0036508,0.490189358034976,0.742901634142052,3,22,protein alpha-1,2-demannosylation,BP,EDEM1;MAN1B1;SYVN1
12912,GO:0051293,0.490196037137413,0.714437413161514,4,30,establishment of spindle localization,BP,SPRY2;ARHGEF2;NDE1;SPIRE1
13792,GO:0060412,0.49082309179769,0.713883754952887,4,30,ventricular septum morphogenesis,BP,VANGL2;ZFPM1;TGFBR2;TGFBR3
2882,GO:0006388,0.491165132089373,0.786998189382718,2,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,TRPT1;CPSF4
10555,GO:0043535,0.491465567880472,0.656141742397252,8,64,regulation of blood vessel endothelial cell migration,BP,APOE;VEGFA;HDAC5;TMSB4X;NOS3;AKT1;MAP2K5;FGFR1
10246,GO:0043001,0.491772422884005,0.713044623228187,4,30,Golgi to plasma membrane protein transport,BP,BBS2;ANK3;BBS1;VAMP2
4092,GO:0009150,0.492445132257525,0.573707390854688,42,358,purine ribonucleotide metabolic process,BP,DLG4;NT5E;APOE;TIMP2;VEGFA;RAPGEF3;NOS1;PGM1;DHTKD1;DDIT4;OGDHL;NPR2;DLG3;NME4;ABHD14B;PPCS;PPARA;PKD2;FAM20C;MYH3;MLXIPL;SDHA;PTHLH;LTB4R2;GTPBP1;GALK1;NADK;GABBR1;ACOT7;ALDOC;TMSB4X;MOCOS;PDE2A;NOS3;ADCY6;CARD11;TCIRG1;INSR;APRT;TAZ;PFKL;NUDT18
1172,GO:0002819,0.49297585154985,0.639695349547561,10,81,regulation of adaptive immune response,BP,IL20RB;PKN1;PRKCZ;ZP3;STAT6;HFE;JAK3;BCL6;ADA;EIF2AK4
2543,GO:0005811,0.4930208505665,0.654680000004296,8,64,lipid droplet,CC,PITPNM1;PNPLA3;EDA;ATG2A;PNPLA4;METTL7A;CIDEA;CIDEB
11850,GO:0046875,0.493321282772587,0.740241484827928,3,22,ephrin receptor binding,MF,EFNB3;SHC1;FYN
15209,GO:0071392,0.493392931682184,0.740180470366433,3,22,cellular response to estradiol stimulus,BP,FAM210B;EGFR;ITGA2
4516,GO:0010574,0.493434311088406,0.740145229444636,3,22,regulation of vascular endothelial growth factor production,BP,C5;ATF4;SULF2
8292,GO:0033137,0.493627564799525,0.739980612894101,3,22,negative regulation of peptidyl-serine phosphorylation,BP,DDIT4;MLXIPL;DMTN
16090,GO:0090102,0.493892876882696,0.739754531828644,3,22,cochlea development,BP,IFT27;VANGL2;SLITRK6
8128,GO:0032839,0.493904599629807,0.739744540249772,3,22,dendrite cytoplasm,CC,DLG4;KIF17;ADA
3135,GO:0006730,0.493945396051058,0.739709766999609,3,22,one-carbon metabolic process,BP,MTHFR;ALDH1L2;ALDH1L1
9194,GO:0035591,0.493961592858435,0.663641058821599,7,55,signaling adaptor activity,MF,SHC1;GRB7;SH2D2A;SH2B3;VAV3;PAG1;GRB10
3949,GO:0008656,0.495007985578753,0.783986436469486,2,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,NLRP1;CTSH
9819,GO:0042059,0.495014631805274,0.689676663296008,5,39,negative regulation of epidermal growth factor receptor signaling pathway,BP,EGFR;SPRY2;ERRFI1;ITGA1;TSG101
12947,GO:0051353,0.495799301268112,0.709025460063772,4,31,positive regulation of oxidoreductase activity,BP,APOE;CYP27B1;CCS;AKT1
9773,GO:0040001,0.495972849122162,0.737978745939569,3,22,establishment of mitotic spindle localization,BP,SPRY2;ARHGEF2;NDE1
17275,GO:0140096,0.496239943148911,0.535938132360249,203,1700,catalytic activity, acting on a protein,MF,DUSP6;PTPRS;HTRA1;GID4;TYSND1;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;THSD4;RNF135;OBSCN;EGFR;RBCK1;DDB2;ZDHHC1;ADAMTS7;DUSP5;NEK9;NPEPL1;LOXL1;RNPEPL1;FKBP9;BRSK1;CLCA2;GGT1;ADAMTS13;MMP28;MST1R;PPM1M;HBEGF;RPS6KA2;MMP1;EFNB3;PLAT;LTBP4;ULK2;CTSF;MAPK13;RNF165;CDK18;FBXW4;ASH2L;LHPP;PRSS3;MAP2K1;PKN1;ALPK1;PHF21A;ULK1;HDAC11;PCSK1;PRSS8;TTBK2;PRKCZ;PPP2R3B;PAK1;STK39;B4GALNT4;ERO1B;FGFR3;FBXO41;KDM3A;KLHL29;NPR2;CAPNS2;USP20;FBXW8;NEURL1;ACVR2B;RAG1;SPPL2B;SPEG;MARCH4;LTBP1;EREG;PTPRE;RNF44;SSH3;UNKL;PPM1J;FKBP10;MTMR4;CHD3;BLMH;MKNK2;HMGA2;MAPK3;FBXO27;STK40;FAM20C;CNTRL;ADAMTSL1;CTSB;MAPK12;MYH3;LTA4H;FBXO17;PTPDC1;C1RL;MAP2K2;PGPEP1;LRSAM1;KLHL24;KDM4C;PAK6;PRSS22;SSH1;PCMTD2;FBXO6;NSMCE1;TTN;PSKH1;HLCS;HDAC5;PAPLN;ACY1;KDM7A;MAP3K12;NEK8;RHBDF1;PTPRU;WNK4;PCSK9;PKN3;FBXL15;FBXL16;LONP2;MARK3;HLTF;TGFBR2;SMURF2;LMO7;HMG20B;MINK1;TTLL11;MARCH2;EPHA1;RHBDF2;SHARPIN;DNAJC6;ERN1;BCR;KLHDC8B;TADA3;CAMK1;STRADB;CTSH;FBXL8;AKT1;CHEK2;PHF2;FGFR4;PIAS3;SPSB3;UHRF2;CAPN2;MARK4;PLAU;INSR;RPS6KA5;ANKZF1;RABGGTA;CTDSPL;MAP2K5;ZDHHC24;BRAF;MAPK10;DPP7;JAK3;MTA3;UBOX5;TMX4;MIB2;JOSD2;CSNK1E;RNF213;FBXO25;FYN;MAST4;PJA2;SIRT2;MTA1;HDAC8;TGFBR3;RNPEP;MAP3K10;EPHB2;FGFR1;FKBP8;XYLT2;ERBB2;EIF2AK4;STK32B;SYVN1;MMP17;TRIM2;MMP19;LYPLAL1;KCTD13;CAMKK1;IKBKB
5536,GO:0016530,0.496253444916495,0.869745802264164,1,6,metallochaperone activity,MF,CCS
5137,GO:0015662,0.496531984439184,0.737500359839097,3,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,ATP7B;ATP2B4;ATP12A
1967,GO:0004683,0.496989296490512,0.737108769632542,3,22,calmodulin-dependent protein kinase activity,MF,MKNK2;CAMK1;CAMKK1
4761,GO:0010950,0.497644150043469,0.608071609192257,16,134,positive regulation of endopeptidase activity,BP,XDH;F2R;GSN;TNFSF15;GRAMD4;NGFR;BBC3;NLRP1;DAP;CTSH;IFT57;IFI27;PIDD1;FYN;CIDEB;HIP1
956,GO:0002377,0.497645917328635,0.650320116695735,8,64,immunoglobulin production,BP,ERCC1;PKN1;STAT6;POLM;POLL;CARD11;BCL6;POU2F2
2213,GO:0005109,0.497802099790521,0.736412060786024,3,22,frizzled binding,MF,WNT2B;WNT7A;WNT3
6913,GO:0030513,0.49824996737573,0.736027771107201,3,22,positive regulation of BMP signaling pathway,BP,RNF165;FBXL15;FKBP8
4545,GO:0010631,0.498608450205306,0.58833502995378,24,199,epithelial cell migration,BP,APOE;VEGFA;HBEGF;PRSS3;HYAL1;PKN1;PLEKHG5;SEMA5A;LTB4R2;HDAC5;PKN3;TGFBR2;TMSB4X;NOS3;WNT7A;CTSH;AKT1;RAB25;MAP2K5;RAB13;PLXND1;ITGA2;FGFR1;CORO1B
14155,GO:0061082,0.498681653940956,0.781085232492162,2,14,myeloid leukocyte cytokine production,BP,GAS6;BCL6
10081,GO:0042605,0.498861201826932,0.780942883746568,2,14,peptide antigen binding,MF,SLC7A8;HLA-G
2613,GO:0005923,0.499149872573777,0.627863265818857,11,89,bicellular tight junction,CC,ANK3;NPHP4;PRKCZ;DLG3;MICALL2;ARHGEF2;FRMD4B;WNK4;RAB13;MPDZ;MAGI1
8055,GO:0032733,0.499612046930772,0.780347039231901,2,14,positive regulation of interleukin-10 production,BP,IL20RB;PRKCZ
5712,GO:0016854,0.499722144864656,0.780259593157825,2,14,racemase and epimerase activity,MF,GALE;SRR
6813,GO:0030279,0.499756230097165,0.685348313622259,5,39,negative regulation of ossification,BP,AREG;ECM1;LRP5;NBR1;HDAC8
2729,GO:0006111,0.499766785430844,0.734724204619707,3,22,regulation of gluconeogenesis,BP,NR1D1;DGKQ;PPARA
324,GO:0000910,0.500173585300345,0.602665209355368,17,140,cytokinesis,BP,ANK3;RAB11FIP4;CUL7;SNX9;PAK1;RHOBTB2;SEPT5;RHOF;SEPT10;PAK6;SEPT6;CHMP4C;SNX33;SPIRE1;SEPT8;UNC119;TTC19
12554,GO:0050732,0.500583847954679,0.684590233712837,5,39,negative regulation of peptidyl-tyrosine phosphorylation,BP,PTK6;PRKCZ;ERRFI1;DMTN;TSG101
1175,GO:0002822,0.501023085570787,0.638890183004478,9,73,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL20RB;PKN1;PRKCZ;ZP3;STAT6;HFE;JAK3;BCL6;ADA
17843,GO:1902105,0.501048512593017,0.596392884546898,19,157,regulation of leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1;SOX13;FAM213A;PRKCZ;RAG1;INPP5D;ZFPM1;CEBPB;TGFBR2;GAS6;CARD11;BRAF;JAK3;BCL6;ADA;ERBB2;HLA-G
11455,GO:0045932,0.501203032083882,0.779081491833989,2,14,negative regulation of muscle contraction,BP,DOCK4;TNNT1
12459,GO:0050432,0.501273073821605,0.779025683511085,2,14,catecholamine secretion,BP,NISCH;STX1A
18562,GO:1903845,0.501548310566695,0.656339736350108,7,56,negative regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;LTBP1;MTMR4;TGFBR2;SMURF2;CIDEA;TGFBR3
7211,GO:0031114,0.501798803985447,0.732972850126383,3,22,regulation of microtubule depolymerization,BP,TTBK2;ARHGEF2;TRPV4
2542,GO:0005802,0.501954316723675,0.593084813683346,20,166,trans-Golgi network,CC,POSTN;CLTCL1;ARAP1;SNX9;NMNAT2;MARCH4;TRAPPC9;CHAC1;VAMP2;MARCH9;PI4K2A;AZIN2;SORL1;ATP7B;RAB43;COG7;SLC9A7;RAB13;RHOBTB3;MYO18A
10319,GO:0043130,0.50223876411481,0.645818363516712,8,65,ubiquitin binding,MF,RBCK1;SHARPIN;NBR1;TSG101;UBTD1;MARK4;FAAP20;SIRT2
8760,GO:0034451,0.502723272509106,0.732174163728241,3,22,centriolar satellite,CC,SDCCAG8;FLOT1;CEP131
12252,GO:0048569,0.502805847042852,0.777802408383107,2,14,post-embryonic animal organ development,BP,VEGFA;ERCC1
10624,GO:0043651,0.503273080658027,0.777428764099254,2,14,linoleic acid metabolic process,BP,ALOX15B;GSTM2
4909,GO:0014850,0.503601715751024,0.777165744858916,2,14,response to muscle activity,BP,POSTN;ITGA2
6754,GO:0030194,0.503626292613082,0.777146068034799,2,14,positive regulation of blood coagulation,BP,F2R;DMTN
17332,GO:1900048,0.503626292613082,0.777146068034799,2,14,positive regulation of hemostasis,BP,F2R;DMTN
4822,GO:0014031,0.503840046985867,0.654180522712667,7,56,mesenchymal cell development,BP,SEMA4B;LAMA5;SEMA3F;MAPK3;SEMA3B;SEMA4G;EDNRA
4072,GO:0009129,0.503881759401637,0.776941477314349,2,14,pyrimidine nucleoside monophosphate metabolic process,BP,UCKL1;UPP1
4073,GO:0009130,0.503881759401637,0.776941477314349,2,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,UCKL1;UPP1
7807,GO:0032369,0.503923387792121,0.77690812918583,2,14,negative regulation of lipid transport,BP,PCSK9;AKT1
20071,GO:2000772,0.504440795532274,0.701285763270928,4,31,regulation of cellular senescence,BP,HMGA2;TERC;YPEL3;BCL6
4280,GO:0009651,0.504509545705251,0.776438265435033,2,14,response to salt stress,BP,ZFP36L1;TRPV4
10173,GO:0042789,0.504946655843255,0.776087515938544,2,14,mRNA transcription by RNA polymerase II,BP,DDIT3;ATF4
14213,GO:0061213,0.504952284468744,0.776082997351753,2,14,positive regulation of mesonephros development,BP,VEGFA;WNT2B
6019,GO:0019081,0.50515512350326,0.775920126520932,2,14,viral translation,BP,EIF2D;EIF2AK4
8012,GO:0032655,0.505246833561032,0.700559115747894,4,31,regulation of interleukin-12 production,BP,ACP5;IRF5;JAK3;HLA-G
14473,GO:0061951,0.505668248800969,0.679916072901423,5,39,establishment of protein localization to plasma membrane,BP,BBS2;ANK3;BBS1;VAMP2;ARHGAP44
12541,GO:0050714,0.505779764291025,0.594523962258826,18,145,positive regulation of protein secretion,BP,F2R;POSTN;GLUL;ALOX15B;EGFR;PCK2;NLGN2;PRKCZ;PLA2G6;C5;ANO1;MAPK3;TTN;NLRP1;TRPV4;GLUD1;IL17RC;MYO18A
555,GO:0001678,0.505839254213278,0.621232361093502,11,91,cellular glucose homeostasis,BP,NR1D1;PCK2;PLA2G6;ANO1;MLXIPL;ENDOG;LRP5;PIK3R2;GAS6;ERN1;LGALS1
18270,GO:1903204,0.506065891852394,0.775187996755713,2,14,negative regulation of oxidative stress-induced neuron death,BP,ATF4;NCOA7
11280,GO:0045618,0.50626708476688,0.775026084308294,2,14,positive regulation of keratinocyte differentiation,BP,ALOX15B;CYP27B1
255,GO:0000722,0.50657451539761,0.77477854873084,2,14,telomere maintenance via recombination,BP,ERCC1;TEP1
6534,GO:0021952,0.50672952984379,0.774653676657424,2,14,central nervous system projection neuron axonogenesis,BP,ADARB1;EPHB2
7372,GO:0031433,0.506751223853483,1.00000000000006,1,1,telethonin binding,MF,TTN
9413,GO:0035995,0.506751223853483,1.00000000000006,1,1,detection of muscle stretch,BP,TTN
6812,GO:0030278,0.506957816905291,0.60622041748576,14,115,regulation of ossification,BP,CTNNBIP1;SMOC1;CYP27B1;ACVR2B;AREG;ECM1;MAPK3;IFITM1;FAM20C;CEBPB;LRP5;ATRAID;NBR1;HDAC8
4594,GO:0010714,0.507286125997172,0.774204987889111,2,14,positive regulation of collagen metabolic process,BP,F2R;ITGA2
8203,GO:0032967,0.507286125997172,0.774204987889111,2,14,positive regulation of collagen biosynthetic process,BP,F2R;ITGA2
11873,GO:0046914,0.507644852955639,0.539307543823938,87,734,transition metal ion binding,MF,XDH;S100A6;EGR1;ACP5;GLUL;ALOX15B;TIMP2;PRNP;NR1D1;S100A4;NPEPL1;LOXL1;RNPEPL1;NOS1;ADAMTS13;TCEA2;MMP28;ZCCHC24;TRIM65;PPM1M;MMP1;CYP3A5;MSRB2;RNF165;HMGCL;CYP27B1;PCK2;PHC2;APOBEC3C;PHYH;KDM3A;USP20;ZSWIM4;NEIL1;RAG1;MARCH4;CYHR1;S100A13;APOBEC3F;PPARA;CHD3;KLF7;MARCH9;THRA;PEX10;FAM20C;LTA4H;ARHGEF2;LITAF;KDM4C;PRIMPOL;KDM7A;L3MBTL1;HLTF;MOCOS;NOS3;MARCH2;CCS;ATP7B;NBR1;CYP2R1;RXRA;MBD1;LACTB2;NFU1;PHF2;PIAS3;RABGGTA;CPSF4;TIMP1;MTA3;OGFOD2;MIB2;MPI;PHC1;SIRT2;ADA;MTA1;RNPEP;MMP17;MPPE1;TRIM2;MMP19;ZMYM3;TRIM45;SNCB;CYP4V2
11050,GO:0045066,0.508089692742815,0.773556319320769,2,14,regulatory T cell differentiation,BP,BCL6;HLA-G
11261,GO:0045589,0.508089692742815,0.773556319320769,2,14,regulation of regulatory T cell differentiation,BP,BCL6;HLA-G
9896,GO:0042246,0.508147004960854,0.697937897632956,4,31,tissue regeneration,BP,GSN;POSTN;TGFBR2;WNT7A
3097,GO:0006677,0.508295220966891,0.773390240482673,2,14,glycosylceramide metabolic process,BP,ST6GALNAC6;NAGA
16993,GO:0099172,0.508485975120452,0.773236038354359,2,14,presynapse organization,BP,NLGN2;WNT7A
15312,GO:0071559,0.508497217259583,0.586662833898871,20,166,response to transforming growth factor beta,BP,HTRA1;FOS;POSTN;ZFP36L1;LTBP4;PRKCZ;LTBP1;MTMR4;FNDC4;ITGB5;LTBP2;TGFBR2;PDE2A;SMURF2;WNT7A;CDKN1C;FYN;GDF15;CIDEA;TGFBR3
19783,GO:2000269,0.508693627326546,0.77306810871124,2,14,regulation of fibroblast apoptotic process,BP,BTG1;GAS6
15799,GO:0072527,0.508797070719355,0.639424769319809,8,66,pyrimidine-containing compound metabolic process,BP,NT5E;TK2;APOBEC3C;NME4;NEIL1;APOBEC3F;UCKL1;UPP1
6777,GO:0030220,0.508851202686137,0.772940629597766,2,14,platelet formation,BP,ZFPM1;NBEAL2
7626,GO:0032042,0.508871541615787,0.772924172367884,2,14,mitochondrial DNA metabolic process,BP,SESN2;PRIMPOL
3794,GO:0008375,0.508879187774155,0.66141109248075,6,48,acetylglucosaminyltransferase activity,MF,B4GAT1;HEXB;HEXA;PIGQ;MFNG;XYLT2
16105,GO:0090132,0.509168161644541,0.577915143734771,24,200,epithelium migration,BP,APOE;VEGFA;HBEGF;PRSS3;HYAL1;PKN1;PLEKHG5;SEMA5A;LTB4R2;HDAC5;PKN3;TGFBR2;TMSB4X;NOS3;WNT7A;CTSH;AKT1;RAB25;MAP2K5;RAB13;PLXND1;ITGA2;FGFR1;CORO1B
3506,GO:0007417,0.509189082062014,0.542832386404672,70,587,central nervous system development,BP,PTPRS;BBS2;SERPINE2;GSN;GJC2;LRP1;TIMP2;EGFR;CD9;SNPH;CST3;SHANK2;SMARCA1;ADARB1;PHGDH;CNTN1;NAGLU;MAP2K1;DDIT4;TRNP1;PITPNM1;SOX12;HDAC11;TTBK2;PAK1;AARS;SEMA3F;SHROOM4;NEURL1;EPOR;WNT2B;TRAPPC9;PKD2;MAPK3;LAMB2;BNIP3;SEMA5A;THRA;TCTN1;PKD1;MDK;VLDLR;KDM7A;NDE1;TGFBR2;TAGLN3;CDK5RAP3;WNT7A;SHARPIN;GLUD1;BCR;SRR;ATP2B4;PRDM8;AKT1;B4GALT2;AMIGO2;LAMB1;FGFR4;WNT3;TENM4;TP73;CSNK1E;FYN;SLC38A2;SIRT2;CELSR1;EPHB2;FGFR1;ERBB2
5435,GO:0016307,0.509190479431328,0.772666015805564,2,14,phosphatidylinositol phosphate kinase activity,MF,PIP5KL1;ZFYVE21
11112,GO:0045171,0.509350992470907,0.660967917592226,6,48,intercellular bridge,CC,NINL;GSTM2;CEP131;GSTM3;UNC119;TRIM45
11359,GO:0045745,0.509539323419602,0.772383462290236,2,14,positive regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;TMOD2
15495,GO:0071901,0.509563898726615,0.603613708100806,14,116,negative regulation of protein serine/threonine kinase activity,BP,DUSP6;APOE;PDCD4;DUSP5;SPRY2;SPRY4;RGS14;SORL1;LRP5;PKIB;CDK5RAP3;AKT1;CDKN1C;TP73
2515,GO:0005769,0.509860228409876,0.567050072932723,31,259,early endosome,CC,F2R;APOE;LRP1;EGFR;NISCH;MAP2K1;VPS11;APPL2;ABCA7;MTMR4;MAPK3;DYSF;MVB12B;PI4K2A;MAP2K2;LITAF;FLOT1;SORL1;PCSK9;STEAP2;TSG101;WDFY2;C1ORF210;HFE;MIB2;SNX17;SNX1;UBXN6;TOM1;TBC1D16;HLA-G
5498,GO:0016446,0.51013408629993,0.771901263269839,2,14,somatic hypermutation of immunoglobulin genes,BP,POLM;POLL
18556,GO:1903829,0.510150800496959,0.563382289291514,34,285,positive regulation of cellular protein localization,BP,EDEM1;LRP1;EGFR;PRNP;ANK3;RAPGEF3;B3GAT3;TFDP2;TMEM173;VPS11;PAK1;CEMIP;MICALL2;CEP250;NGFR;SESN2;VAMP2;BBC3;SSH1;SORL1;CEP131;PEMT;CDK5RAP3;GAS6;CROCC;CAMK1;AKT1;TSG101;TP73;SNX33;FYN;EPHB2;ERBB2;OSCP1
6601,GO:0022804,0.510313181518052,0.576784752585446,24,200,active transmembrane transporter activity,MF,SLC7A8;SLC16A3;SLC2A9;SLC16A5;ABCA2;SLC12A7;ABCA7;SLC37A2;SLCO4A1;ABCG1;SLC22A18;SLC29A4;ATP7B;MFSD3;ATP2B4;SLC6A9;TCIRG1;SLC6A6;ATP12A;SLC9A7;SLC37A4;SLC38A2;SLC10A6;SLC9A5
4745,GO:0010921,0.510336478112727,0.595790840878448,16,132,regulation of phosphatase activity,BP,PPP1R35;B3GAT3;PHACTR3;PPP1R14A;PPP2R3B;DLG3;ELFN2;CSRNP3;ITGA1;CDK5RAP3;PPP1R15A;CRY2;FARP1;ITGA2;SFI1;IKBKB
16524,GO:0097320,0.510603623703532,0.771520181337523,2,14,plasma membrane tubulation,BP,SNX9;SNX33
15652,GO:0072202,0.511009592900992,0.771190401377595,2,14,cell differentiation involved in metanephros development,BP,WWTR1;LAMB2
5622,GO:0016705,0.511068632804591,0.616263562777626,11,90,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,NOS1;CYP3A5;CYP27B1;PHYH;KDM4C;KDM7A;NOS3;CYP2R1;MICAL1;OGFOD2;CYP4V2
7999,GO:0032637,0.511186132102693,0.674496551226931,5,40,interleukin-8 production,BP,F2R;DDIT3;TMSB4X;MAPKBP1;MAP2K5
14950,GO:0070884,0.511192050766067,0.771042097966957,2,14,regulation of calcineurin-NFAT signaling cascade,BP,PRNP;ATP2B4
17180,GO:0106056,0.511192050766067,0.771042097966957,2,14,regulation of calcineurin-mediated signaling,BP,PRNP;ATP2B4
10213,GO:0042921,0.511392047204705,0.770879476419127,2,14,glucocorticoid receptor signaling pathway,BP,CRY2;PER1
4418,GO:0010226,0.511405749728988,0.770868332194582,2,14,response to lithium ion,BP,NFATC4;IGFBP2
16832,GO:0098787,0.511570479471982,0.770734333879479,2,14,mRNA cleavage involved in mRNA processing,BP,ERN1;CPSF4
15166,GO:0071333,0.511614088777172,0.621599414256459,10,83,cellular response to glucose stimulus,BP,NR1D1;PCK2;PLA2G6;ANO1;MLXIPL;ENDOG;LRP5;GAS6;ERN1;LGALS1
6958,GO:0030620,0.511683567400909,0.860186691567635,1,6,U2 snRNA binding,MF,ISG20
12250,GO:0048566,0.511699168300391,0.770629621873746,2,14,embryonic digestive tract development,BP,ADA;TCF7
7927,GO:0032516,0.511785029851188,0.770559742632963,2,14,positive regulation of phosphoprotein phosphatase activity,BP,ITGA1;PPP1R15A
8967,GO:0035088,0.511899101282848,0.694531100571985,4,31,establishment or maintenance of apical/basal cell polarity,BP,DLG4;DLG3;VANGL2;LRCH4
14218,GO:0061245,0.511899101282848,0.694531100571985,4,31,establishment or maintenance of bipolar cell polarity,BP,DLG4;DLG3;VANGL2;LRCH4
537,GO:0001656,0.512180970049213,0.646278738918577,7,56,metanephros development,BP,EGR1;WWTR1;PKD2;LAMB2;KIF26B;PKD1;CTSH
5808,GO:0017075,0.512306418732022,0.770135145810778,2,14,syntaxin-1 binding,MF,SNPH;VAMP2
10810,GO:0044321,0.512408315734602,0.770052113168674,2,14,response to leptin,BP,BBS2;NR1D1
15200,GO:0071379,0.512605833922087,0.769891113334644,2,14,cellular response to prostaglandin stimulus,BP,ADCY6;AKT1
7284,GO:0031290,0.512621778354706,0.769878114011379,2,14,retinal ganglion cell axon guidance,BP,VEGFA;EPHB2
1129,GO:0002718,0.512670716684685,0.673116205006505,5,40,regulation of cytokine production involved in immune response,BP,PRKCZ;MAPK3;HFE;JAK3;BCL6
1101,GO:0002690,0.513246883572385,0.657067494913636,6,49,positive regulation of leukocyte chemotaxis,BP,PGF;VEGFA;VEGFB;MAPK3;TRPV4;GAS6
12736,GO:0051029,0.513379761494122,0.85910825644282,1,6,rRNA transport,BP,TST
7983,GO:0032610,0.513720710918272,0.858890812104657,1,6,interleukin-1 alpha production,BP,S100A13
10424,GO:0043297,0.514075814938141,0.656516933176071,6,48,apical junction assembly,BP,ARL2;NPHP4;MICALL2;FBF1;RAB13;IKBKB
12170,GO:0048339,0.514103114207955,0.768668575555312,2,14,paraxial mesoderm development,BP,FGFR1;TEAD2
4181,GO:0009262,0.514220856555226,0.691983106734652,4,32,deoxyribonucleotide metabolic process,BP,NEIL1;DGUOK;ADA;NUDT18
13051,GO:0051583,0.514290251692449,0.858527080013262,1,6,dopamine uptake involved in synaptic transmission,BP,RAB3B
13230,GO:0051934,0.514290251692449,0.858527080013262,1,6,catecholamine uptake involved in synaptic transmission,BP,RAB3B
16286,GO:0090493,0.514290251692449,0.858527080013262,1,6,catecholamine uptake,BP,RAB3B
16287,GO:0090494,0.514290251692449,0.858527080013262,1,6,dopamine uptake,BP,RAB3B
4024,GO:0009060,0.514307965183787,0.63386033646285,8,68,aerobic respiration,BP,IDH2;DHTKD1;OGDHL;BNIP3;SDHA;SUCLG2;CAT;BLOC1S1
9898,GO:0042249,0.514502905838016,0.768341519967674,2,14,establishment of planar polarity of embryonic epithelium,BP,VANGL2;CELSR1
12347,GO:0048753,0.514829184083886,0.720901045060709,3,23,pigment granule organization,BP,BLOC1S4;LYST;BLOC1S1
12615,GO:0050832,0.514848542218502,0.766801397389995,2,15,defense response to fungus,BP,FAM3A;IL17RC
2939,GO:0006469,0.515094582818211,0.57202798981311,24,201,negative regulation of protein kinase activity,BP,DUSP6;APOE;PTK6;PDCD4;DUSP5;ADARB1;WWTR1;PKN1;SPRY2;SPRY4;TRIB2;ERRFI1;RGS14;SORL1;LRP5;PKIB;TRIB3;CDK5RAP3;EPHA1;AKT1;CDKN1C;TSG101;TP73;EPHB2
1607,GO:0004032,0.515586617999974,0.857696825970596,1,6,alditol:NADP+ 1-oxidoreductase activity,MF,AKR7A2
6786,GO:0030234,0.515696568124268,0.531259490777867,87,737,enzyme regulator activity,MF,DOCK4;APOE;SERPINE2;PPP1R35;EVI5L;CDC42EP5;TIMP2;EGFR;FBLN1;PRDX5;TFPI2;CST3;GPSM1;ARAP3;ERCC6;TBC1D8;ARHGEF19;RIN1;ARAP1;B3GAT3;ARHGAP23;PHACTR3;ASAP2;PPP1R14A;MAP2K1;SYNGAP1;DGKQ;ARL2;SPRY2;RALGDS;APPL2;PPP2R3B;SERPING1;ELFN2;TRIB2;PLXNB1;RINL;AGAP1;ALS2CL;C5;SESN2;RASA4;ERRFI1;RGS14;SRGAP3;ARHGAP22;TBC1D14;MAP2K2;SAMD3;ANGPTL4;TBC1D3E;RABGAP1;ACAP3;RALGAPA1;AZIN2;PAPLN;NLRP1;RIN2;PKIB;ARHGAP25;TRIB3;PIK3R2;CCS;GAS6;BCR;PPP1R15A;ATP2B4;CTSH;PLEKHG6;AKT1;CDKN1C;HMSD;SBF2;ASAP3;SGSM2;TBC1D20;ARHGAP27;ARHGAP44;TIMP1;ADAP1;VAV3;TBC1D16;SH3PXD2A;RGS12;C15ORF62;MMP17;SNCB
2097,GO:0004865,0.515866512670828,0.85751714046216,1,6,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14A
4088,GO:0009146,0.516039185450146,0.857406212898186,1,6,purine nucleoside triphosphate catabolic process,BP,ADA
11184,GO:0045332,0.516150080251404,0.766991247017411,2,14,phospholipid translocation,BP,ABCA7;ATP8B2
6485,GO:0021846,0.516985161527089,0.766304978339941,2,14,cell proliferation in forebrain,BP,WNT7A;FGFR1
9360,GO:0035900,0.517162250070017,0.856683324716855,1,6,response to isolation stress,BP,LGALS1
4340,GO:0009896,0.517214585984034,0.551638879175752,39,327,positive regulation of catabolic process,BP,APOE;EDEM1;LRP1;RAPGEF3;GPSM1;TRIM65;ZFP36L1;EPM2A;SNX9;MAGEF1;ULK1;VPS11;TRIB2;PPARA;SESN2;MAPK3;BNIP3;MLXIPL;LRSAM1;GTPBP1;SORL1;HERPUD1;ENDOG;PCSK9;SMURF2;TRIB3;BNIP3L;FYCO1;AKT1;C9ORF72;INSR;TPCN1;SNX33;TFEB;CSNK1E;ZC3H12D;SNX1;SIRT2;EIF2AK4
3504,GO:0007413,0.517671398824353,0.765740166782386,2,14,axonal fasciculation,BP,SEMA5A;EPHB2
17174,GO:0106030,0.517671398824353,0.765740166782386,2,14,neuron projection fasciculation,BP,SEMA5A;EPHB2
12526,GO:0050699,0.517742629817244,0.718322267179608,3,23,WW domain binding,MF,LITAF;SCNN1A;WBP1
3704,GO:0008215,0.517773778040202,0.856288666837981,1,6,spermine metabolic process,BP,SAT2
17797,GO:1901983,0.518184286191328,0.640361034962045,7,57,regulation of protein acetylation,BP,RAPGEF3;NOS1;MAPK3;CAMK1;HINT2;RPS6KA5;HDAC8
11731,GO:0046598,0.51832867501152,0.855929925154979,1,6,positive regulation of viral entry into host cell,BP,LGALS1
5654,GO:0016763,0.518479715992739,0.667690916562023,5,40,transferase activity, transferring pentosyl groups,MF,NAPRT;DNPH1;UPP1;APRT;XYLT2
6521,GO:0021915,0.518945023892874,0.590703362075707,15,124,neural tube development,BP,IFT140;ZFP36L1;SALL2;PKD2;VANGL2;TCTN1;PKD1;DEAF1;ZNF358;WDR19;IFT57;CELSR1;TCF7;FKBP8;TEAD2
14776,GO:0070527,0.519263234846335,0.66695619902493,5,40,platelet aggregation,BP,SERPINE2;CD9;BLOC1S4;DMTN;GAS6
1430,GO:0003407,0.519540091064506,0.687538614005715,4,31,neural retina development,BP,SDK2;RAB11FIP4;ATP2B4;SDHAF4
17696,GO:1901653,0.51958549425808,0.558600463869454,30,252,cellular response to peptide,BP,LRP1;PRNP;ZFP36L1;PCK2;SHC1;PRKCZ;PAK1;NGFR;PTPRE;VAMP2;MAPK3;ERRFI1;ARHGEF2;HDAC5;SRSF5;PCSK9;TRIB3;PIK3R2;ADCY6;AKT1;TCIRG1;INSR;FOXO4;GPR21;JAK3;APRT;FYN;RAB13;EIF4EBP1;GRB10
10556,GO:0043536,0.519612552473844,0.666628411756902,5,40,positive regulation of blood vessel endothelial cell migration,BP,VEGFA;TMSB4X;NOS3;AKT1;FGFR1
19758,GO:2000210,0.519676890281576,0.855055794036519,1,6,positive regulation of anoikis,BP,CHEK2
12344,GO:0048747,0.520091667186257,0.689129481617853,4,27,muscle fiber development,BP,FLNC;VEGFA;MYH11;TTN
488,GO:0001541,0.520133724954,0.666139101804702,5,40,ovarian follicle development,BP,VEGFA;ZP3;EREG;CEBPB;MMP19
4019,GO:0009055,0.520207558870151,0.612853383991847,10,87,electron transfer activity,MF,XDH;PHGDH;ALDH4A1;TXNRD3;AKR7A2;GLDC;NDUFA4L2;ETFB;SDHA;TXNRD2
6548,GO:0021987,0.520577930070032,0.613003714822522,10,82,cerebral cortex development,BP,PTPRS;BBS2;LRP1;EGFR;TRAPPC9;BNIP3;MDK;NDE1;LAMB1;SLC38A2
6676,GO:0030048,0.520677798696195,0.620531973342457,9,69,actin filament-based movement,BP,WIPF1;SCN4B;TPM2;SNTA1;MYH3;TTN;TNNI2;TNNT1;TNNI1
5145,GO:0015682,0.521071103215382,0.685692520924812,4,32,ferric iron transport,BP,STEAP2;TCIRG1;STEAP3;HFE
15788,GO:0072512,0.521071103215382,0.685692520924812,4,32,trivalent inorganic cation transport,BP,STEAP2;TCIRG1;STEAP3;HFE
2965,GO:0006506,0.521084927717137,0.685679765965655,4,32,GPI anchor biosynthetic process,BP,PIGZ;PIGQ;PIGV;MPPE1
18700,GO:1904181,0.521191519507895,0.854069516245619,1,6,positive regulation of membrane depolarization,BP,ANK3
3155,GO:0006760,0.521297793442476,0.715159126585087,3,23,folic acid-containing compound metabolic process,BP,MTHFR;ALDH1L2;ALDH1L1
17510,GO:1901033,0.52152405312548,0.85385237742385,1,6,positive regulation of response to reactive oxygen species,BP,ENDOG
19408,GO:1990050,0.522123106054784,0.853460656478608,1,6,phosphatidic acid transporter activity,MF,PLTP
2341,GO:0005375,0.522421399165237,0.853265338657599,1,6,copper ion transmembrane transporter activity,MF,ATP7B
9109,GO:0035434,0.522421399165237,0.853265338657599,1,6,copper ion transmembrane transport,BP,ATP7B
8941,GO:0035019,0.522823933535443,0.647978709032973,6,49,somatic stem cell population maintenance,BP,VANGL2;LRP5;WNT7A;EPHA1;BRAF;EPAS1
6863,GO:0030346,0.522934094900367,0.852929222928881,1,6,protein phosphatase 2B binding,MF,ATP2B4
15853,GO:0072608,0.522940255437529,0.852925181017505,1,6,interleukin-10 secretion,BP,PRKCZ
10557,GO:0043537,0.523152553864244,0.713501723942732,3,23,negative regulation of blood vessel endothelial cell migration,BP,APOE;HDAC5;MAP2K5
18975,GO:1904813,0.523184244768941,0.594250697722988,13,110,ficolin-1-rich granule lumen,CC,GSN;TIMP2;CST3;PGM1;PYGL;ACTR1B;CTSB;LTA4H;ALDOC;CTSH;CAT;YPEL5;PFKL
17677,GO:1901612,0.523314665063397,0.85267939098255,1,6,cardiolipin binding,MF,NME4
15320,GO:0071569,0.523391640383582,0.85262882436926,1,6,protein ufmylation,BP,CDK5RAP3
4421,GO:0010248,0.523771396752493,0.852379183313879,1,6,establishment or maintenance of transmembrane electrochemical gradient,BP,ATP12A
20023,GO:2000677,0.524192305339881,0.682806645957917,4,32,regulation of transcription regulatory region DNA binding,BP,DDIT3;PPARA;HMGA2;TMSB4X
7792,GO:0032350,0.524341010557446,0.712437136387188,3,23,regulation of hormone metabolic process,BP,EGR1;CYP27B1;DGKQ
19858,GO:2000377,0.52440683306888,0.593117131171645,13,109,regulation of reactive oxygen species metabolic process,BP,XDH;ACP5;EGFR;PKD2;BNIP3;TGFBR2;TRPV1;BCR;ATP2B4;AKT1;ASS1;INSR;SIRT2
4301,GO:0009756,0.524416800767281,0.851954257924767,1,6,carbohydrate mediated signaling,BP,MLXIPL
1027,GO:0002534,0.524487988856226,0.712305336424209,3,23,cytokine production involved in inflammatory response,BP,PDCD4;IL17RC;PER1
16870,GO:0098843,0.524516430039169,0.851888589780522,1,6,postsynaptic endocytic zone,CC,DNM1
3106,GO:0006686,0.52460296554436,0.85183153608456,1,6,sphingomyelin biosynthetic process,BP,PEMT
4515,GO:0010573,0.524604577885981,0.712200765402871,3,23,vascular endothelial growth factor production,BP,C5;ATF4;SULF2
7207,GO:0031110,0.524662550833673,0.634137083637825,7,57,regulation of microtubule polymerization or depolymerization,BP,EML2;ARL2;TTBK2;PAK1;ARHGEF2;STMN3;TRPV4
17368,GO:1900122,0.524807302916666,0.851696755528843,1,6,positive regulation of receptor binding,BP,HFE
12369,GO:0048814,0.52494902107939,0.633860902714288,7,57,regulation of dendrite morphogenesis,BP,NFATC4;OBSL1;CUL7;CAPRIN2;FBXW8;SDC2;ARHGAP44
18227,GO:1903078,0.525010200217289,0.661545629897669,5,40,positive regulation of protein localization to plasma membrane,BP,LRP1;EGFR;PRNP;AKT1;EPHB2
14917,GO:0070830,0.525117807934112,0.661443958325237,5,40,bicellular tight junction assembly,BP,ARL2;NPHP4;MICALL2;RAB13;IKBKB
5585,GO:0016615,0.525348775563945,0.85133920028016,1,6,malate dehydrogenase activity,MF,PHGDH
5341,GO:0016093,0.525566906048874,0.851194995701202,1,6,polyprenol metabolic process,BP,SRD5A3
4326,GO:0009855,0.525651270073264,0.615009624581811,9,74,determination of bilateral symmetry,BP,IFT140;DDIT3;ACVR2B;PKD2;VANGL2;PSKH1;NEK8;TGFBR2;IFT57
10365,GO:0043203,0.525688965450039,0.851114261786032,1,6,axon hillock,CC,PRKCZ
8793,GO:0034511,0.525714039391,0.85109767342197,1,6,U3 snoRNA binding,MF,ISG20
13824,GO:0060453,0.525730438828922,0.851086823244026,1,6,regulation of gastric acid secretion,BP,TRPV1
12936,GO:0051342,0.5259406345932,0.850947706359451,1,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,AIP
15556,GO:0072050,0.526148185868092,0.85081025342384,1,6,S-shaped body morphogenesis,BP,PKD2
4777,GO:0010968,0.526176969242188,0.850791184573409,1,6,regulation of microtubule nucleation,BP,EML2
10264,GO:0043028,0.526251313803647,0.680896105511775,4,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,PRDX5;NLRP1;GAS6;CTSH
7970,GO:0032593,0.526345918862968,0.850679222953801,1,6,insulin-responsive compartment,CC,RAB13
6973,GO:0030656,0.526413315342874,0.850634543956609,1,6,regulation of vitamin metabolic process,BP,CYP27B1
6141,GO:0019430,0.526458044668724,0.757144620478472,2,15,removal of superoxide radicals,BP,NOS3;CCS
5827,GO:0017112,0.526518502437133,0.644446577950135,6,49,Rab guanyl-nucleotide exchange factor activity,MF,RIN1;TRAPPC9;ALS2CL;RIN2;SBF2;C9ORF72
5688,GO:0016813,0.52662217250228,0.850496029251767,1,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,PADI3
3371,GO:0007144,0.52681944021295,0.85036512085257,1,6,female meiosis I,BP,MLH3
10835,GO:0044351,0.527109652610573,0.85017239250835,1,6,macropinocytosis,BP,SNX33
12913,GO:0051294,0.527111207223377,0.70994779532541,3,23,establishment of spindle orientation,BP,SPRY2;ARHGEF2;NDE1
8723,GO:0034384,0.527129878393075,0.850158954418502,1,6,high-density lipoprotein particle clearance,BP,APOE
19431,GO:1990144,0.527289032005065,0.850053183647685,1,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,BNIP3
7920,GO:0032506,0.527572580337995,0.709532125787408,3,23,cytokinetic process,BP,SNX9;SNX33;SPIRE1
4791,GO:0010988,0.527722438071926,0.849764892881557,1,6,regulation of low-density lipoprotein particle clearance,BP,PCSK9
15162,GO:0071326,0.527866783860279,0.605663983279167,10,84,cellular response to monosaccharide stimulus,BP,NR1D1;PCK2;PLA2G6;ANO1;MLXIPL;ENDOG;LRP5;GAS6;ERN1;LGALS1
15164,GO:0071331,0.527866783860279,0.605663983279167,10,84,cellular response to hexose stimulus,BP,NR1D1;PCK2;PLA2G6;ANO1;MLXIPL;ENDOG;LRP5;GAS6;ERN1;LGALS1
14643,GO:0070273,0.52793618903364,0.709204319979354,3,23,phosphatidylinositol-4-phosphate binding,MF,OSBPL5;GSDMA;GSDMC
14019,GO:0060789,0.52802699747624,0.849562083023128,1,6,hair follicle placode formation,BP,EDA
3752,GO:0008297,0.528081981799402,0.849525448514961,1,6,single-stranded DNA exodeoxyribonuclease activity,MF,ISG20
880,GO:0002246,0.528102281965018,0.849511921554358,1,6,wound healing involved in inflammatory response,BP,F2R
5227,GO:0015846,0.528310524590416,0.849373112039022,1,6,polyamine transport,BP,AZIN2
1120,GO:0002709,0.528342965675264,0.67894974615851,4,32,regulation of T cell mediated immunity,BP,IL20RB;PRKCZ;ZP3;HFE
6031,GO:0019104,0.528462534787291,0.755454514459594,2,15,DNA N-glycosylase activity,MF,NEIL1;MPG
7889,GO:0032466,0.528509548973809,0.849240366043493,1,6,negative regulation of cytokinesis,BP,CHMP4C
6903,GO:0030501,0.528564544693795,0.708637386183072,3,23,positive regulation of bone mineralization,BP,ACVR2B;FAM20C;ATRAID
14583,GO:0070169,0.528564544693795,0.708637386183072,3,23,positive regulation of biomineral tissue development,BP,ACVR2B;FAM20C;ATRAID
1301,GO:0003143,0.528658286253165,0.658091329883939,5,40,embryonic heart tube morphogenesis,BP,PKD2;VANGL2;TGFBR2;IFT57;TEAD2
766,GO:0002020,0.528827220352018,0.599109352732604,11,88,protease binding,MF,TYSND1;LRP1;TIMP2;PRNP;CST3;ECM1;FLOT1;TTN;LONP2;TIMP1;SYVN1
17398,GO:1900180,0.528920515498047,0.604735687032317,10,83,regulation of protein localization to nucleus,BP,TMEM173;NGFR;SESN2;PDE2A;CDK5RAP3;GAS6;LZTS2;AKT1;LMNA;FYN
20163,GO:2001040,0.528944792444948,0.848949789251048,1,6,positive regulation of cellular response to drug,BP,ENDOG
14381,GO:0061676,0.529002194062482,0.848911438499506,1,6,importin-alpha family protein binding,MF,GOLGA2
3201,GO:0006837,0.529048523893214,0.84888048013302,1,6,serotonin transport,BP,NOS1
2722,GO:0006104,0.52912117251027,0.848831926439608,1,6,succinyl-CoA metabolic process,BP,SUCLG2
13244,GO:0051957,0.529165109860434,0.848802556388235,1,6,positive regulation of amino acid transport,BP,NTSR1
1449,GO:0003684,0.529260481641215,0.619682308367693,8,66,damaged DNA binding,MF,XPC;DDB2;ERCC1;NEIL1;CRY2;MPG;TP73;MSH5
6364,GO:0021554,0.529270714053646,0.848731949104775,1,6,optic nerve development,BP,EPHB2
11062,GO:0045080,0.529446120786139,0.848614622170162,1,6,positive regulation of chemokine biosynthetic process,BP,EGR1
5955,GO:0018344,0.529520536939666,0.848564827662457,1,6,protein geranylgeranylation,BP,RABGGTA
17697,GO:1901654,0.529535510815068,0.580122618912623,15,126,response to ketone,BP,FOS;EGFR;KLF9;PCK2;DDIT4;PSPH;SLIT3;ERRFI1;PTAFR;ADCY6;AKT1;IGFBP7;HDAC8;EIF4EBP1;TGFBR3
6930,GO:0030546,0.529588665201804,0.848519230854377,1,6,receptor activator activity,MF,DGKQ
16406,GO:0097084,0.529720838800213,0.848430743272308,1,6,vascular smooth muscle cell development,BP,VEGFA
16328,GO:0090647,0.529729264655796,0.848425101140942,1,6,modulation of age-related behavioral decline,BP,PRNP
1426,GO:0003401,0.52976801816838,0.707549961182067,3,23,axis elongation,BP,SPRY2;AREG;VANGL2
11357,GO:0045743,0.529853912681194,0.848341617506032,1,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,FGFBP1
3748,GO:0008290,0.529862680610227,0.84833574396955,1,6,F-actin capping protein complex,CC,CAPG
19997,GO:2000648,0.530063439593246,0.707282706707233,3,23,positive regulation of stem cell proliferation,BP,VEGFA;HMGA2;LTBP3
19381,GO:1905941,0.530070496477344,0.848196485164453,1,6,positive regulation of gonad development,BP,ZP3
14544,GO:0070099,0.530137678490146,0.848151447477189,1,6,regulation of chemokine-mediated signaling pathway,BP,SLIT3
19158,GO:1905268,0.530205580857883,0.656621576178732,5,40,negative regulation of chromatin organization,BP,KDM3A;PHF1;KDM4C;PHF2;HDAC8
16611,GO:0097499,0.530268542619352,0.848063692309282,1,6,protein localization to non-motile cilium,BP,SPATA7
16124,GO:0090166,0.530313418408466,0.848033591465394,1,6,Golgi disassembly,BP,GOLGA2
14574,GO:0070160,0.530327104697516,0.5973399924789,11,91,occluding junction,CC,ANK3;NPHP4;PRKCZ;DLG3;MICALL2;ARHGEF2;FRMD4B;WNK4;RAB13;MPDZ;MAGI1
18215,GO:1903053,0.530477467720132,0.706907941672368,3,23,regulation of extracellular matrix organization,BP,LRP1;CST3;FGFR4
9754,GO:0039533,0.530634787426443,0.847817911848458,1,6,regulation of MDA-5 signaling pathway,BP,TKFC
522,GO:0001614,0.530672807428796,0.84779238182545,1,6,purinergic nucleotide receptor activity,MF,PTAFR
5521,GO:0016502,0.530672807428796,0.84779238182545,1,6,nucleotide receptor activity,MF,PTAFR
12167,GO:0048332,0.53073662457932,0.656116505171951,5,40,mesoderm morphogenesis,BP,ITGB4;HMGA2;WNT3;ITGA2;FGFR1
16690,GO:0097709,0.53074210905252,0.847745839031425,1,6,connective tissue replacement,BP,F2R
2521,GO:0005776,0.530790787581534,0.602898270755485,10,83,autophagosome,CC,ATG16L2;ULK1;VPS11;TBC1D14;TECPR1;PEG3;MAP1LC3A;FYCO1;NBR1;C9ORF72
6685,GO:0030062,0.53082471656563,0.847690347402764,1,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,SUCLG2
12146,GO:0048286,0.530843139868574,0.706576740641913,3,23,lung alveolus development,BP,ERRFI1;STK40;ADA
7677,GO:0032135,0.531017460254981,0.847560818285413,1,6,DNA insertion or deletion binding,MF,XPC
9286,GO:0035745,0.531018076037708,0.84756040434005,1,6,T-helper 2 cell cytokine production,BP,PRKCZ
19784,GO:2000270,0.531061843813682,0.847530980693785,1,6,negative regulation of fibroblast apoptotic process,BP,GAS6
13543,GO:0060033,0.53107637648976,0.847521209994976,1,6,anatomical structure regression,BP,LRP5
503,GO:0001561,0.531108724669913,0.847499459942962,1,6,fatty acid alpha-oxidation,BP,PHYH
13796,GO:0060416,0.531152021675388,0.706296825626002,3,23,response to growth hormone,BP,MAPK3;AKT1;JAK3
4746,GO:0010922,0.531163741524854,0.706286202137831,3,23,positive regulation of phosphatase activity,BP,ITGA1;PPP1R15A;ITGA2
5436,GO:0016308,0.53118632290391,0.847447276357168,1,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,PIP5KL1
5271,GO:0015925,0.531301642291008,0.847369703460305,1,6,galactosidase activity,MF,NAGA
18185,GO:1903003,0.531315934999194,0.84736008719246,1,6,positive regulation of protein deubiquitination,BP,TNIP1
11672,GO:0046477,0.53133866693031,0.847344792086394,1,6,glycosylceramide catabolic process,BP,NAGA
3163,GO:0006777,0.531350988542835,0.847336501099914,1,6,Mo-molybdopterin cofactor biosynthetic process,BP,MOCOS
6203,GO:0019720,0.531350988542835,0.847336501099914,1,6,Mo-molybdopterin cofactor metabolic process,BP,MOCOS
6704,GO:0030121,0.531363777155262,0.847327895540398,1,6,AP-1 adaptor complex,CC,AP1G2
10234,GO:0042985,0.531367057901919,0.84732568784964,1,6,negative regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
11895,GO:0046951,0.531417287301763,0.847291884592325,1,6,ketone body biosynthetic process,BP,HMGCL
11376,GO:0045779,0.531493483995156,0.84724059620393,1,6,negative regulation of bone resorption,BP,INPP5D
9770,GO:0039706,0.531498389321863,0.847237294002559,1,6,co-receptor binding,MF,HFE
11068,GO:0045086,0.53149963327918,0.847236456577595,1,6,positive regulation of interleukin-2 biosynthetic process,BP,CARD11
7987,GO:0032615,0.531567623289985,0.675938132444719,4,32,interleukin-12 production,BP,ACP5;IRF5;JAK3;HLA-G
18631,GO:1903975,0.531587579028879,0.847177244184282,1,6,regulation of glial cell migration,BP,IDH2
15524,GO:0071971,0.53183634703889,0.847009668326565,1,6,extracellular exosome assembly,BP,TSG101
18432,GO:1903551,0.53183634703889,0.847009668326565,1,6,regulation of extracellular exosome assembly,BP,TSG101
3159,GO:0006771,0.531971381301985,0.846918653803256,1,6,riboflavin metabolic process,BP,ACP5
17052,GO:0099590,0.531972888980234,0.846917637404723,1,6,neurotransmitter receptor internalization,BP,DNM1
3407,GO:0007191,0.532113478972375,0.846822838691324,1,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,GNAL
4735,GO:0010907,0.532128951953878,0.705410601416412,3,23,positive regulation of glucose metabolic process,BP,PPARA;AKT1;INSR
9229,GO:0035637,0.532135616231043,0.595556475051451,11,91,multicellular organismal signaling,BP,SCN8A;ANK3;NOS1;SCN4B;ITPR3;NPR2;ATP2B4;ITPR2;EHD3;TRPC1;ITGA2
17834,GO:1902075,0.532137871948059,0.846806386633623,1,6,cellular response to salt,BP,MAPK13
568,GO:0001710,0.53216992139982,0.846784768775785,1,6,mesodermal cell fate commitment,BP,FGFR1
15905,GO:0072719,0.5321908194403,0.846770671597737,1,6,cellular response to cisplatin,BP,ADIRF
18608,GO:1903935,0.532224116447413,0.846748208631034,1,6,response to sodium arsenite,BP,MAPK13
8178,GO:0032927,0.532273917447414,0.846714607490958,1,6,positive regulation of activin receptor signaling pathway,BP,ACVR2B
8611,GO:0034141,0.53227864057412,0.846711420503384,1,6,positive regulation of toll-like receptor 3 signaling pathway,BP,FLOT1
5593,GO:0016634,0.532288623277389,0.846704684393846,1,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,ACOX3
3717,GO:0008239,0.532288695789533,0.846704635462418,1,6,dipeptidyl-peptidase activity,MF,DPP7
18842,GO:1904528,0.532317431323077,0.846685244224058,1,6,positive regulation of microtubule binding,BP,MAPRE3
12216,GO:0048505,0.53241351859154,0.846620390740324,1,6,regulation of timing of cell differentiation,BP,SERPINE2
15142,GO:0071287,0.532451198502655,0.846594953828648,1,6,cellular response to manganese ion,BP,ATF4
4573,GO:0010663,0.532469240443633,0.846582773082952,1,6,positive regulation of striated muscle cell apoptotic process,BP,BNIP3
4576,GO:0010666,0.532469240443633,0.846582773082952,1,6,positive regulation of cardiac muscle cell apoptotic process,BP,BNIP3
12721,GO:0051013,0.532490838050521,0.846568190909043,1,6,microtubule severing,BP,TTLL11
16146,GO:0090193,0.532554495152193,0.846525205721072,1,6,positive regulation of glomerulus development,BP,EGR1
6637,GO:0023035,0.53255848098875,0.846522513966413,1,6,CD40 signaling pathway,BP,SHARPIN
1492,GO:0003836,0.532622140224481,0.846479518619695,1,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,ST3GAL3
11746,GO:0046624,0.532684927197257,0.846437104370359,1,6,sphingolipid transporter activity,MF,PLTP
15277,GO:0071493,0.532686156538775,0.846436273834775,1,6,cellular response to UV-B,BP,HYAL1
4637,GO:0010764,0.532690366415813,0.846433429657028,1,6,negative regulation of fibroblast migration,BP,BRAF
10029,GO:0042500,0.53270239363231,0.846425303912401,1,6,aspartic endopeptidase activity, intramembrane cleaving,MF,SPPL2B
13646,GO:0060198,0.532770489818078,0.846379291718872,1,6,clathrin-sculpted vesicle,CC,VAMP2
15693,GO:0072282,0.532878300695719,0.846306425348205,1,6,metanephric nephron tubule morphogenesis,BP,PKD1
12408,GO:0048934,0.532898785388412,0.846292577647674,1,6,peripheral nervous system neuron differentiation,BP,ETV1
12409,GO:0048935,0.532898785388412,0.846292577647674,1,6,peripheral nervous system neuron development,BP,ETV1
318,GO:0000835,0.532906128514056,0.846287613475169,1,6,ER ubiquitin ligase complex,CC,SYVN1
389,GO:0001042,0.532997522850673,0.84622581900159,1,6,RNA polymerase I core binding,MF,ERBB2
13822,GO:0060449,0.532997906112147,0.846225559831108,1,6,bud elongation involved in lung branching,BP,SPRY2
5836,GO:0017128,0.533022227890072,0.846209112273719,1,6,phospholipid scramblase activity,MF,ANO9
9223,GO:0035627,0.533042668999873,0.846195288083129,1,6,ceramide transport,BP,PLTP
19106,GO:1905097,0.533053747413564,0.846187795472554,1,6,regulation of guanyl-nucleotide exchange factor activity,BP,GPSM1
3455,GO:0007270,0.533072376083379,0.846175195863542,1,6,neuron-neuron synaptic transmission,BP,TMOD2
15171,GO:0071340,0.533117645204003,0.84614457491539,1,6,skeletal muscle acetylcholine-gated channel clustering,BP,ETV5
3198,GO:0006833,0.533180956904391,0.846101742631031,1,6,water transport,BP,AQP3
18332,GO:1903349,0.533200239988437,0.846088695426679,1,6,omegasome membrane,CC,ULK1
8104,GO:0032801,0.533248645853567,0.674362887609854,4,32,receptor catabolic process,BP,APOE;VLDLR;PCSK9;AP2A2
17792,GO:1901977,0.533255111177432,0.846051564692285,1,6,negative regulation of cell cycle checkpoint,BP,CHEK2
17730,GO:1901724,0.533308898526733,0.846015161456494,1,6,positive regulation of cell proliferation involved in kidney development,BP,EGR1
5134,GO:0015651,0.533417002917848,0.845941978744453,1,6,quaternary ammonium group transmembrane transporter activity,MF,SLC25A29
15116,GO:0071242,0.533462913520683,0.67416184197111,4,32,cellular response to ammonium ion,BP,MAPK3;ATF4;PTAFR;CHRM3
18769,GO:1904338,0.533495708995215,0.845888682712828,1,6,regulation of dopaminergic neuron differentiation,BP,CSNK1E
1390,GO:0003306,0.533527187097655,0.845867363715053,1,6,Wnt signaling pathway involved in heart development,BP,VANGL2
5115,GO:0015464,0.533528695404999,0.845866342140131,1,6,acetylcholine receptor activity,MF,CHRM3
4655,GO:0010807,0.533542291014342,0.845857133655826,1,6,regulation of synaptic vesicle priming,BP,STX1A
8499,GO:0033690,0.533551634461562,0.845850805000789,1,6,positive regulation of osteoblast proliferation,BP,LRP5
6133,GO:0019405,0.533552335543969,0.845850330122357,1,6,alditol catabolic process,BP,TKFC
12722,GO:0051014,0.533577958616883,0.845832973732253,1,6,actin filament severing,BP,GSN
5223,GO:0015838,0.533637313537364,0.845792763176987,1,6,amino-acid betaine transport,BP,SLC38A2
8229,GO:0033010,0.53367645565802,0.845766242061198,1,6,paranodal junction,CC,SIRT2
9892,GO:0042228,0.533690088536795,0.845757004250822,1,6,interleukin-8 biosynthetic process,BP,MAP2K5
14885,GO:0070739,0.533712766691341,0.845741636401746,1,6,protein-glutamic acid ligase activity,MF,TTLL11
14886,GO:0070740,0.533712766691341,0.845741636401746,1,6,tubulin-glutamic acid ligase activity,MF,TTLL11
9023,GO:0035252,0.533747217298261,0.845718288960253,1,6,UDP-xylosyltransferase activity,MF,XYLT2
9921,GO:0042285,0.533747217298261,0.845718288960253,1,6,xylosyltransferase activity,MF,XYLT2
10126,GO:0042711,0.533760460581241,0.845709313241408,1,6,maternal behavior,BP,CREBRF
7645,GO:0032074,0.533772574141232,0.84570110289049,1,6,negative regulation of nuclease activity,BP,NEIL1
11402,GO:0045836,0.533817323253839,0.845670770167555,1,6,positive regulation of meiotic nuclear division,BP,SIRT2
5211,GO:0015816,0.533862725742811,0.845639990407667,1,6,glycine transport,BP,SLC6A9
13951,GO:0060687,0.533867776024328,0.845636566407118,1,6,regulation of branching involved in prostate gland morphogenesis,BP,RXRA
3248,GO:0006910,0.533974048345184,0.845564503645841,1,6,phagocytosis, recognition,BP,PEAR1
9611,GO:0036492,0.534003138562447,0.845544773706281,1,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,EIF2AK4
13970,GO:0060710,0.53406497944001,0.845502825488687,1,6,chorio-allantoic fusion,BP,ZFP36L1
19069,GO:1905005,0.534071177581847,0.845498620705767,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
8287,GO:0033130,0.534097201564541,0.845480965337977,1,6,acetylcholine receptor binding,MF,DLG4
3390,GO:0007171,0.534171833993072,0.845430325065782,1,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,DGKQ
15715,GO:0072319,0.534213812012249,0.845401836784428,1,6,vesicle uncoating,BP,DNAJC6
1331,GO:0003188,0.534229165319444,0.845391416410594,1,6,heart valve formation,BP,ZFPM1
10047,GO:0042554,0.534360169208469,0.750442551779966,2,15,superoxide anion generation,BP,ACP5;EGFR
6789,GO:0030238,0.534380623266732,0.845288595355539,1,6,male sex determination,BP,INSR
13233,GO:0051938,0.534405462624913,0.845271728079641,1,6,L-glutamate import,BP,NTSR1
16799,GO:0098712,0.534405462624913,0.845271728079641,1,6,L-glutamate import across plasma membrane,BP,NTSR1
6904,GO:0030502,0.534425943557658,0.845257819468041,1,6,negative regulation of bone mineralization,BP,ECM1
12840,GO:0051185,0.534430776637286,0.845254537199592,1,6,coenzyme transmembrane transporter activity,MF,SLC25A42
14160,GO:0061087,0.534463337354534,0.845232423124157,1,6,positive regulation of histone H3-K27 methylation,BP,PHF1
9090,GO:0035374,0.534474227331753,0.845225026560549,1,6,chondroitin sulfate binding,MF,PTPRS
11054,GO:0045072,0.534525589893322,0.84519013742859,1,6,regulation of interferon-gamma biosynthetic process,BP,ZFPM1
14799,GO:0070562,0.534573695407424,0.845157455849792,1,6,regulation of vitamin D receptor signaling pathway,BP,CYP27B1
14569,GO:0070142,0.534580803459832,0.845152626434536,1,6,synaptic vesicle budding,BP,DNM1
15526,GO:0071986,0.534590428867418,0.845146086488748,1,6,Ragulator complex,CC,LAMTOR2
9288,GO:0035748,0.534622567580963,0.84512424860669,1,6,myelin sheath abaxonal region,CC,PRKCZ
17258,GO:0140035,0.534639733517523,0.845112583690181,1,6,ubiquitination-like modification-dependent protein binding,MF,FAAP20
17259,GO:0140036,0.534639733517523,0.845112583690181,1,6,ubiquitin-dependent protein binding,MF,FAAP20
8025,GO:0032680,0.534661859374634,0.614257819358128,8,67,regulation of tumor necrosis factor production,BP,NFATC4;ACP5;MC1R;ERRFI1;ARHGEF2;GAS6;PTAFR;CIDEA
19933,GO:2000535,0.534663755022082,0.845096259146436,1,6,regulation of entry of bacterium into host cell,BP,EXOC2
17072,GO:0099638,0.534686051224908,0.845081106034514,1,6,endosome to plasma membrane protein transport,BP,ARHGAP44
17073,GO:0099639,0.534686051224908,0.845081106034514,1,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,ARHGAP44
336,GO:0000932,0.534750610982578,0.605972026300194,9,75,P-body,CC,BTBD2;ZFP36L1;APOBEC3C;APOBEC3F;PAN2;AGO4;PNRC1;C9ORF72;ZC3H12D
7202,GO:0031103,0.53480539946285,0.672900854780697,4,32,axon regeneration,BP,PTPRS;MAP2K1;LAMB2;BRAF
17703,GO:1901660,0.534814676172747,0.844993669236912,1,6,calcium ion export,BP,ATP2B4
10565,GO:0043546,0.534823185260341,0.844987883733062,1,6,molybdopterin cofactor binding,MF,XDH
5573,GO:0016595,0.534880998075729,0.844948571708841,1,6,glutamate binding,MF,GLUL
16157,GO:0090205,0.534890486708955,0.844942118906458,1,6,positive regulation of cholesterol metabolic process,BP,ABCG1
3833,GO:0008443,0.534922850541164,0.844920108290609,1,6,phosphofructokinase activity,MF,PFKL
7779,GO:0032328,0.534948489370159,0.844902669833329,1,6,alanine transport,BP,SLC38A2
332,GO:0000923,0.534962266097167,0.844893298928482,1,6,equatorial microtubule organizing center,CC,TUBGCP6
12974,GO:0051415,0.534962266097167,0.844893298928482,1,6,microtubule nucleation by interphase microtubule organizing center,BP,TUBGCP6
7573,GO:0031946,0.534972885476297,0.844886075382572,1,6,regulation of glucocorticoid biosynthetic process,BP,DGKQ
14319,GO:0061549,0.534992520128553,0.844872718833216,1,6,sympathetic ganglion development,BP,SEMA3F
9162,GO:0035542,0.535003745793517,0.844865082179429,1,6,regulation of SNARE complex assembly,BP,VPS11
6368,GO:0021559,0.535027199698279,0.844849126008166,1,6,trigeminal nerve development,BP,SEMA3F
17601,GO:1901339,0.53505288288951,0.844831651918766,1,6,regulation of store-operated calcium channel activity,BP,PLA2G6
8196,GO:0032959,0.535056096254429,0.844829465542716,1,6,inositol trisphosphate biosynthetic process,BP,PTAFR
4415,GO:0010216,0.53510160571745,0.844798498645712,1,6,maintenance of DNA methylation,BP,UHRF2
8930,GO:0034983,0.535111524888378,0.844791748592699,1,6,peptidyl-lysine deacetylation,BP,SIRT2
8940,GO:0035014,0.535129137251217,0.844779762781468,1,6,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R2
6077,GO:0019237,0.535187336390366,0.844740151792472,1,6,centromeric DNA binding,MF,MLH3
2524,GO:0005779,0.535211542126173,0.749714161998323,2,15,integral component of peroxisomal membrane,CC,PEX10;PEX11A
7254,GO:0031231,0.535211542126173,0.749714161998323,2,15,intrinsic component of peroxisomal membrane,CC,PEX10;PEX11A
15653,GO:0072203,0.535215993306221,0.844720645037522,1,6,cell proliferation involved in metanephros development,BP,EGR1
10211,GO:0042908,0.535290751089067,0.844669749564617,1,6,xenobiotic transport,BP,SLC6A6
10212,GO:0042910,0.535290751089067,0.844669749564617,1,6,xenobiotic transmembrane transporter activity,MF,SLC6A6
2253,GO:0005168,0.535313627514192,0.844654172906199,1,6,neurotrophin TRKA receptor binding,MF,SHC1
15504,GO:0071921,0.535365759247629,0.844618672190718,1,6,cohesin loading,BP,HDAC8
16010,GO:0086067,0.535365915866775,0.844618565531056,1,6,AV node cell to bundle of His cell communication,BP,SCN4B
13472,GO:0055062,0.535387587704388,0.844603805786706,1,6,phosphate ion homeostasis,BP,FGFR4
15782,GO:0072505,0.535387587704388,0.844603805786706,1,6,divalent inorganic anion homeostasis,BP,FGFR4
15783,GO:0072506,0.535387587704388,0.844603805786706,1,6,trivalent inorganic anion homeostasis,BP,FGFR4
13034,GO:0051549,0.535505582972515,0.844523427561712,1,6,positive regulation of keratinocyte migration,BP,HBEGF
14222,GO:0061299,0.535518770228302,0.844514442660548,1,6,retina vasculature morphogenesis in camera-type eye,BP,LRP5
7968,GO:0032591,0.535576879612417,0.844474846630622,1,6,dendritic spine membrane,CC,TRPV1
10277,GO:0043045,0.535588183215537,0.8444671434978,1,6,DNA methylation involved in embryo development,BP,DNMT3A
17649,GO:1901538,0.535588183215537,0.8444671434978,1,6,changes to DNA methylation involved in embryo development,BP,DNMT3A
1658,GO:0004115,0.535615240737673,0.844448703393488,1,6,3',5'-cyclic-AMP phosphodiesterase activity,MF,PDE2A
4919,GO:0014870,0.535637406674311,0.844433595867393,1,6,response to muscle inactivity,BP,MTMR4
5095,GO:0015377,0.535638742434534,0.844432685428979,1,6,cation:chloride symporter activity,MF,SLC12A7
5097,GO:0015379,0.535638742434534,0.844432685428979,1,6,potassium:chloride symporter activity,MF,SLC12A7
5520,GO:0016500,0.535730552697135,0.844370099840895,1,6,protein-hormone receptor activity,MF,INSR
12211,GO:0048490,0.535731750484024,0.749268491786272,2,15,anterograde synaptic vesicle transport,BP,BLOC1S4;BLOC1S1
17011,GO:0099514,0.535731750484024,0.749268491786272,2,15,synaptic vesicle cytoskeletal transport,BP,BLOC1S4;BLOC1S1
17014,GO:0099517,0.535731750484024,0.749268491786272,2,15,synaptic vesicle transport along microtubule,BP,BLOC1S4;BLOC1S1
17980,GO:1902476,0.535823433105379,0.671943076939149,4,32,chloride transmembrane transport,BP,CLCA2;SLC12A7;ANO1;TTYH3
599,GO:0001767,0.535906631742222,0.844250021462178,1,6,establishment of lymphocyte polarity,BP,GSN
17528,GO:1901098,0.535968626456229,0.844207728667773,1,6,positive regulation of autophagosome maturation,BP,FYCO1
5482,GO:0016421,0.535995735654539,0.84418923230764,1,6,CoA carboxylase activity,MF,ACACB
11364,GO:0045760,0.536045485635932,0.844155284440661,1,6,positive regulation of action potential,BP,ANK3
16088,GO:0090100,0.53612189657591,0.61297553366221,8,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,RNF165;ACVR2B;FBXL15;CDKN1C;HFE;GDF15;TGFBR3;FKBP8
19299,GO:1905634,0.536129113010763,0.844098208297496,1,6,regulation of protein localization to chromatin,BP,HDAC8
1347,GO:0003214,0.536307068082913,0.843976705459561,1,6,cardiac left ventricle morphogenesis,BP,TGFBR2
3399,GO:0007182,0.536310183185556,0.84397457797421,1,6,common-partner SMAD protein phosphorylation,BP,TGFBR2
13447,GO:0055008,0.536711104804537,0.651834504643786,5,36,cardiac muscle tissue morphogenesis,BP,ZFPM1;TTN;RXRA;TGFBR3;TNNI1
6977,GO:0030662,0.536760354912284,0.572881899487531,15,127,coated vesicle membrane,CC,APOE;EGFR;CLTCL1;CD9;HBEGF;CEMIP;VAMP2;AREG;AP1G2;RASSF9;COPG1;AP2A2;SEC31B;HLA-G;HIP1
1353,GO:0003223,0.536893950698978,0.843575539565021,1,6,ventricular compact myocardium morphogenesis,BP,TGFBR3
18905,GO:1904683,0.537036103213787,0.84347826470938,1,6,regulation of metalloendopeptidase activity,BP,SORL1
6498,GO:0021873,0.537176339910874,0.843382260332792,1,6,forebrain neuroblast division,BP,FGFR1
13659,GO:0060219,0.537203090879012,0.843363942369142,1,6,camera-type eye photoreceptor cell differentiation,BP,SDK2
14242,GO:0061337,0.537224619453421,0.611893549233112,8,66,cardiac conduction,BP,NOS1;SCN4B;ITPR3;NPR2;ATP2B4;ITPR2;EHD3;TRPC1
18167,GO:1902965,0.537374751106303,0.843246361617475,1,6,regulation of protein localization to early endosome,BP,SORL1
18168,GO:1902966,0.537374751106303,0.843246361617475,1,6,positive regulation of protein localization to early endosome,BP,SORL1
4513,GO:0010571,0.537388454429382,0.843236972761365,1,6,positive regulation of nuclear cell cycle DNA replication,BP,FGFR1
11051,GO:0045069,0.537498012925273,0.60314362534504,9,76,regulation of viral genome replication,BP,TNIP1;ADARB1;APOBEC3C;APOBEC3F;HMGA2;IFITM1;ISG20;TBC1D20;EIF2AK4
9184,GO:0035581,0.537504995782046,0.843157108689576,1,6,sequestering of extracellular ligand from receptor,BP,LTBP1
12795,GO:0051124,0.537522293556258,0.843145252409472,1,6,synaptic growth at neuromuscular junction,BP,SHANK2
9824,GO:0042074,0.537555811119528,0.843122276977593,1,6,cell migration involved in gastrulation,BP,LRP5
4715,GO:0010882,0.537681922348227,0.747593641815587,2,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,GSTO1;GSTM2
14397,GO:0061724,0.537704368942897,0.843020416678386,1,6,lipophagy,BP,SESN2
12199,GO:0048471,0.537729628840941,0.518168099298837,60,510,perinuclear region of cytoplasm,CC,S100A6;GSN;THBS3;EGFR;S100A4;PRDX5;TSPAN1;CST3;NOS1;NDRG1;TMEM134;OBSL1;RAB11FIP4;CUL7;TMEM173;PLEKHG5;RAB3B;PRKCZ;PRR7;USP20;DOCK6;CEP250;FBXW8;NEURL1;SYNC;CYHR1;S100A13;VAMP2;DEF6;GSDMA;CTSB;MAP2K2;TWF2;DMTN;ATXN10;AZIN2;MAP6;TSTD1;ATRAID;PCSK9;PKN3;EPN3;PDE2A;APLN;RAB40B;ANGEL1;ATP7B;LAMB1;CAPN2;PTOV1;HFE;SPIRE1;EHD3;SIRT2;CIDEB;NMRAL1;ITGA2;ERBB2;CORO1B;APBA1
18958,GO:1904779,0.537792782209875,0.842959773687216,1,6,regulation of protein localization to centrosome,BP,CEP250
10285,GO:0043066,0.537860316269166,0.513390001637344,72,613,negative regulation of apoptotic process,BP,F2R;TNFRSF6B;APOE;LRP1;PDCD4;VEGFA;NTSR1;EGFR;PRNP;PRDX5;MST1R;RGL2;SYNGAP1;ITGA6;SHC1;SPRY2;PRKCZ;AARS;FGFR3;RAG1;NGFR;HMGA2;BNIP3;SEMA5A;STK40;ARHGEF2;ANGPTL4;IFI6;MDK;UNC5B;HERPUD1;CEBPB;MAP3K12;NOS3;AGO4;WNT7A;BNIP3L;EPHA1;GAS6;STRADB;CTSH;MGMT;ASNS;AKT1;MICAL1;AMIGO2;FGFR4;LMNA;INSR;MAP2K5;BRAF;PIDD1;CAT;TIMP1;JAK3;TP73;MNT;BCL6;FYN;ADA;CIDEA;MYO18A;TCF7;EPHB2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;IKBKB;SNCB
15125,GO:0071260,0.537929632599356,0.621075474462798,7,58,cellular response to mechanical stimulus,BP,EGFR;MAPK3;BNIP3;PDE2A;AKT1;SLC38A2;ITGA2
4249,GO:0009566,0.537954183310204,0.611028030273373,8,67,fertilization,BP,CD9;MST1R;SYT8;ZP3;TDRKH;HEXB;PLB1;REC8
8981,GO:0035112,0.538145727235112,0.842717527643802,1,6,genitalia morphogenesis,BP,TCF7
15546,GO:0072033,0.538642236234921,0.842376312810098,1,6,renal vesicle formation,BP,KIF26B
6458,GO:0021785,0.538646339183343,0.842373491038946,1,6,branchiomotor neuron axon guidance,BP,SEMA3F
5194,GO:0015791,0.538718711343223,0.842323711983139,1,6,polyol transport,BP,AQP3
11416,GO:0045862,0.538753074515439,0.535808156697976,33,282,positive regulation of proteolysis,BP,TNIP1;XDH;F2R;APOE;GSN;EDEM1;FBLN1;TNFSF15;GRAMD4;SNX9;MAGEF1;NGFR;TRIB2;PLGRKT;MAPK3;MAPK12;BBC3;HERPUD1;NLRP1;TRIB3;DAP;CTSH;AKT1;IFT57;FGFR4;IFI27;PIDD1;SNX33;CSNK1E;FYN;SIRT2;CIDEB;HIP1
2817,GO:0006284,0.538753179766975,0.64814285680764,5,41,base-excision repair,BP,ERCC6;NEIL1;HMGA2;POLL;MPG
1072,GO:0002638,0.538849399848503,0.842233794481405,1,6,negative regulation of immunoglobulin production,BP,BCL6
14032,GO:0060836,0.538955477162956,0.842160784386376,1,6,lymphatic endothelial cell differentiation,BP,ACVR2B
1703,GO:0004198,0.539367863420312,0.746140478153545,2,15,calcium-dependent cysteine-type endopeptidase activity,MF,CAPNS2;CAPN2
4713,GO:0010880,0.539451805893763,0.746067998306735,2,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,GSTO1;GSTM2
16637,GO:0097542,0.53948320798688,0.647440862486704,5,41,ciliary tip,CC,IFT140;WDR60;IFT27;WDR19;IFT57
17605,GO:1901343,0.540175192067594,0.608992844693086,8,66,negative regulation of vasculature development,BP,XDH;PDCD4;ADGRB2;SPRY2;NGFR;HDAC5;FOXO4;MAP2K5
15351,GO:0071621,0.540196645366751,0.63079318154763,6,51,granulocyte chemotaxis,BP,MAPK3;TRPV4;ITGA1;IL17RC;CKLF;VAV3
11409,GO:0045843,0.540284792877966,0.667730003094341,4,32,negative regulation of striated muscle tissue development,BP,PAK1;TGFBR2;TP73;SIRT2
17763,GO:1901862,0.540284792877966,0.667730003094341,4,32,negative regulation of muscle tissue development,BP,PAK1;TGFBR2;TP73;SIRT2
3514,GO:0007440,0.540542318204337,0.841065840110974,1,6,foregut morphogenesis,BP,ACVR2B
19125,GO:1905165,0.540640881804408,0.840997658489942,1,6,regulation of lysosomal protein catabolic process,BP,LRP1
3628,GO:0008091,0.54073898321436,0.840929776661676,1,6,spectrin,CC,SPTB
3065,GO:0006633,0.540817082996853,0.586773065539937,11,93,fatty acid biosynthetic process,BP,ALOX15B;MLYCD;ACACB;ACSS2;MLXIPL;ACOT7;TRIB3;THNSL2;CBR4;ACADVL;ACSS1
4755,GO:0010939,0.540877107700007,0.696739287460643,3,24,regulation of necrotic cell death,BP,RBCK1;BNIP3;ARHGEF2
8266,GO:0033081,0.540895286780497,0.744819737095153,2,15,regulation of T cell differentiation in thymus,BP,ADA;ERBB2
7251,GO:0031227,0.54099219553869,0.568657362355375,15,127,intrinsic component of endoplasmic reticulum membrane,CC,EDEM1;SLC37A2;SPPL2B;ESYT2;PKD2;ERN1;TM7SF2;SLC37A4;RTN2;WFS1;ESYT3;FITM2;FKBP8;SYVN1;HLA-G
5279,GO:0015936,0.541133969797136,0.7446129891316,2,15,coenzyme A metabolic process,BP,PPCS;ACOT7
7247,GO:0031223,0.541175594359721,0.840627419946566,1,6,auditory behavior,BP,SLITRK6
18373,GO:1903429,0.541552646446152,0.744250093359871,2,15,regulation of cell maturation,BP,NPR2;SIRT2
3396,GO:0007178,0.54157341389863,0.54385109468623,25,211,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;FOS;EGR1;PDCD4;LTBP4;RNF165;WWTR1;PRKCZ;ACVR2B;LTBP1;MTMR4;MAPK3;ITGB5;LTBP2;FBXL15;TGFBR2;SMURF2;CDKN1C;HFE;LEMD2;GDF15;CIDEA;TGFBR3;FKBP8;BTBD11
4313,GO:0009799,0.542281078930692,0.598540803314994,9,75,specification of symmetry,BP,IFT140;DDIT3;ACVR2B;PKD2;VANGL2;PSKH1;NEK8;TGFBR2;IFT57
7167,GO:0031057,0.542290906044536,0.66582713611872,4,32,negative regulation of histone modification,BP,KDM3A;PHF1;KDM4C;HDAC8
12609,GO:0050820,0.542448967669136,0.743472175356646,2,15,positive regulation of coagulation,BP,F2R;DMTN
4858,GO:0014704,0.542467261583096,0.665659606989371,4,32,intercalated disc,CC,ANK3;SCN4B;OBSL1;PAK1
15683,GO:0072257,0.542643962925834,0.839607668447256,1,6,metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
15707,GO:0072307,0.542643962925834,0.839607668447256,1,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
10569,GO:0043550,0.542827172737763,0.665317583573446,4,32,regulation of lipid kinase activity,BP,RBL2;FGFR3;PIK3R2;VAV3
4824,GO:0014033,0.543212679389704,0.615898080790881,7,58,neural crest cell differentiation,BP,SEMA4B;LAMA5;SEMA3F;MAPK3;SEMA3B;SEMA4G;EDNRA
9676,GO:0038084,0.543440810611002,0.742609739197409,2,15,vascular endothelial growth factor signaling pathway,BP,XDH;VEGFA
12223,GO:0048519,0.544308893038939,0.480182373057732,426,3630,negative regulation of biological process,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;ZC3H6;HTRA1;DOCK4;BBS2;F2R;NT5E;TNFRSF6B;APOE;ESPN;ZMYND8;NFATC4;XPC;SERPINE2;FHL1;IL20RB;GSN;EGR1;CTNNBIP1;FGFBP1;POSTN;PPP1R35;EVI5L;FBXO2;DDIT4L;PTK6;ACP5;WWC3;RNF135;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;RBCK1;PRNP;NR1D1;ERCC1;FBLN1;ADAMTS7;HADH;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;RAPGEF3;SPTB;IGFBP4;CD9;IDH2;CRTAP;CST3;DNM1;NOS1;GPSM1;DDIT3;ARAP3;BRSK1;SHANK2;DNAJB5;CGREF1;CRTC1;ADGRB2;NDRG1;MMP28;MST1R;ARRDC1;ZFP36L1;ADARB1;NUPR1;ARAP1;TCFL5;HBEGF;RBL2;RGL2;RPS6KA2;TFDP2;MXI1;EFNB3;RPL13A;MDFI;PLAT;ULK2;SLC27A1;KLF9;NISCH;PHACTR3;EPM2A;HYAL1;ARPIN;PPP1R14A;WWTR1;MAP2K1;CYP27B1;MXD4;PKN1;MC1R;CAPG;DDIT4;H2AFJ;BTG1;TOM1L2;SYNGAP1;ITGA6;PHF21A;DGKQ;EML2;MAGEF1;ARL2;ULK1;SHC1;SPRY2;GRB7;NPHP4;ITPR3;UNK;CIRBP;CAPRIN2;TTBK2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;MCTP1;ELK3;STK39;PEAR1;FGFR3;CEMIP;KDM3A;FOXQ1;PHF1;NPR2;SEMA3F;PLXNB3;SPRY4;FAM3A;SALL2;DLG3;ZP3;NEIL1;NEURL1;ACVR2B;RAG1;EAPP;SPEG;NGFR;ELFN2;GSTO1;LTBP1;TRIB2;HES2;PLXNB1;EREG;PTPRE;NAB2;PLA2G6;ABCG1;MTMR4;C5;APOBEC3F;PPARA;CHAC1;FNDC4;SESN2;RASA4;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;ING4;HMGA2;AREG;SLIT3;ECM1;ACACB;PC;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;STK40;RGS14;IRF2BPL;TDRKH;PBXIP1;SNTA1;PAN2;MAPK12;SRGAP3;MLXIPL;TBC1D14;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;TWF2;STMN3;LRSAM1;DMTN;ANGPTL4;SEMA3B;PTHLH;ATF4;PROCR;ZFPM1;KDM4C;LTB4R2;TENM2;FBXO6;IFI6;CBX7;PKD1;MDK;AZIN2;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;SORL1;PCBP4;HERPUD1;GSTM2;VLDLR;PAPLN;GABBR1;DEAF1;SULF2;NLRP1;PEG3;EGFL7;CEBPB;MAP3K12;RHBDF1;LRP5;PTPRU;WNK4;ATRAID;CREBRF;PCSK9;PKIB;L3MBTL1;ISG20;MARK3;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;ARHGAP25;CSRNP3;ITGA1;TNFAIP8L1;TMSB4X;ANO9;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;PEMT;HMG20B;CDK5RAP3;NOS3;AGO4;LDOC1;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;SEMA4G;SHARPIN;GAS6;ERN1;LZTS2;BCR;NBR1;TERC;PPP1R15A;RXRA;ADCY6;MBD1;TNRC18;ATP2B4;STRADB;CTSH;PNRC1;MGMT;ASNS;C12ORF66;TP53I11;PAIP2B;HINT2;MAPKBP1;AKT1;IGFBP7;ITPR2;DGUOK;CDKN1C;MICAL1;CRY2;AMIGO2;CHEK2;HMSD;IFT57;IGFBP2;ASS1;TNNT1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;TMOD2;PIAS3;ACADVL;FARP1;LMNA;C9ORF72;UHRF2;IFI27;PLAU;INSR;WNT3;NCOA7;NELFCD;FOXO4;RPS6KA5;CHMP4C;TPCN1;CTDSPL;MAP2K5;BRAF;GPR21;ARHGAP44;ASIC1;PIDD1;CAT;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;MNT;SNX33;PHC1;BCL6;HSF4;RNF213;TKFC;FYN;ZC3H12D;LEMD2;SIRT2;TRPC1;RECQL5;GOLGA2;ADA;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;MYO18A;RPL29;EIF4EBP1;TGFBR3;TCF7;LAMTOR2;MAP3K10;EPHB2;PER1;IGF2BP3;FGFR1;WFS1;FKBP8;CTH;ERBB2;EIF2AK4;UNC119;PAG1;RGS12;SYVN1;PFKL;HLA-G;CORO1B;SFI1;RPL12;HMBOX1;GRB10;TSHZ1;KCTD11;KCTD13;PNKD;IKBKB;SNCB;PLEKHH2;TEAD2;ACOT8;SIX5
3313,GO:0007019,0.544316693672899,0.663900300573341,4,32,microtubule depolymerization,BP,TTBK2;ARHGEF2;STMN3;TRPV4
11887,GO:0046939,0.544689086142438,0.5829179684423,11,93,nucleotide phosphorylation,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;MLXIPL;GALK1;ALDOC;INSR;PFKL
3110,GO:0006690,0.544782006227125,0.614174724501968,7,59,icosanoid metabolic process,BP,ALOX15B;GGT1;MAPK3;LTA4H;CES2;PTGR2;FAAH
16261,GO:0090382,0.544875340235327,0.662944609818118,4,33,phagosome maturation,BP,SPG11;TMEM175;RAB43;TCIRG1
979,GO:0002433,0.544893689863939,0.61424480555143,7,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,WIPF1;PAK1;PLA2G6;MAPK3;PIK3R2;FYN;VAV3
9685,GO:0038096,0.544893689863939,0.61424480555143,7,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,WIPF1;PAK1;PLA2G6;MAPK3;PIK3R2;FYN;VAV3
7700,GO:0032196,0.545181621572933,0.741091943178919,2,15,transposition,BP,APOBEC3C;APOBEC3F
4892,GO:0014823,0.54533620633066,0.641790022379259,5,41,response to activity,BP,POSTN;HADH;HDAC5;CAT;ITGA2
23,GO:0000045,0.54545647260049,0.588280623747013,10,84,autophagosome assembly,BP,PACS2;ULK2;ATG16L2;ULK1;TBC1D14;LRSAM1;MAP1LC3A;WDR45;ATG2A;C9ORF72
4571,GO:0010661,0.545926252623696,0.740441104181109,2,15,positive regulation of muscle cell apoptotic process,BP,PDCD4;BNIP3
5662,GO:0016776,0.545944011196299,0.661924515193174,4,33,phosphotransferase activity, phosphate group as acceptor,MF,DLG4;DLG3;NME4;CARD11
10630,GO:0043666,0.54602904615766,0.587710365543654,10,84,regulation of phosphoprotein phosphatase activity,BP,PPP1R35;B3GAT3;PHACTR3;PPP1R14A;PPP2R3B;ELFN2;ITGA1;PPP1R15A;CRY2;IKBKB
13888,GO:0060571,0.546124188754101,0.740267937841635,2,15,morphogenesis of an epithelial fold,BP,EGFR;WNT2B
14621,GO:0070232,0.546272756357923,0.691743751170584,3,24,regulation of T cell apoptotic process,BP,RAG1;JAK3;ADA
9549,GO:0036344,0.546546199166474,0.739898510872712,2,15,platelet morphogenesis,BP,ZFPM1;NBEAL2
1277,GO:0003073,0.546654416298773,0.64051177955576,5,41,regulation of systemic arterial blood pressure,BP,F2R;POSTN;NTSR1;NOS3;GAS6
4943,GO:0014912,0.546792225511839,0.739682997236667,2,15,negative regulation of smooth muscle cell migration,BP,LRP1;CORO1B
2964,GO:0006505,0.546898736450228,0.661011927556344,4,33,GPI anchor metabolic process,BP,PIGZ;PIGQ;PIGV;MPPE1
8006,GO:0032648,0.547008226971572,0.640168346991923,5,41,regulation of interferon-beta production,BP,PTPRS;RNF135;NLRX1;FLOT1;IRF5
13878,GO:0060548,0.547364286184968,0.501323255437896,80,683,negative regulation of cell death,BP,F2R;TNFRSF6B;APOE;LRP1;PDCD4;VEGFA;NTSR1;EGFR;RBCK1;PRNP;PRDX5;CST3;MST1R;RGL2;SYNGAP1;ITGA6;SHC1;SPRY2;PRKCZ;AARS;FGFR3;RAG1;NGFR;PPARA;IMPACT;HMGA2;BNIP3;SEMA5A;STK40;ARHGEF2;ANGPTL4;ATF4;IFI6;MDK;UNC5B;SORL1;HERPUD1;CEBPB;MAP3K12;NOS3;AGO4;WNT7A;BNIP3L;EPHA1;GAS6;STRADB;CTSH;MGMT;ASNS;AKT1;MICAL1;AMIGO2;FGFR4;LMNA;INSR;NCOA7;MAP2K5;BRAF;PIDD1;CAT;TIMP1;JAK3;TP73;MNT;BCL6;FYN;ADA;CIDEA;MYO18A;TCF7;EPHB2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;IKBKB;SNCB;TEAD2
13912,GO:0060602,0.548040623474372,0.738587806285002,2,15,branch elongation of an epithelium,BP,SPRY2;AREG
6647,GO:0030003,0.548253970521316,0.520415792982036,39,334,cellular cation homeostasis,BP,DLG4;F2R;APOE;NTSR1;PRNP;NOS1;DDIT3;CYBRD1;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;MAPK3;BNIP3;SV2A;PKD1;KCNMA1;HERPUD1;GSTM2;TMEM175;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;ITPR2;TCIRG1;TPCN1;LETMD1;HFE;ATP12A;SLC9A7;FYN;TRPC1;EDNRA;WFS1;SLC9A5
15004,GO:0070971,0.548319081129972,0.73834315173526,2,15,endoplasmic reticulum exit site,CC,SEC31B;MPPE1
5792,GO:0017046,0.548387237758585,0.738283248336816,2,15,peptide hormone binding,MF,NPR2;INSR
1995,GO:0004721,0.548520049061655,0.554586022168463,17,144,phosphoprotein phosphatase activity,MF,DUSP6;PTPRS;DUSP5;PPM1M;LHPP;MAP2K1;PPP2R3B;PTPRE;SSH3;PPM1J;MTMR4;MYH3;PTPDC1;SSH1;PTPRU;DNAJC6;CTDSPL
13741,GO:0060343,0.548602135456811,0.738094320048532,2,15,trabecula formation,BP,THBS3;TGFBR3
1044,GO:0002566,0.54865942363168,0.738043941297304,2,15,somatic diversification of immune receptors via somatic mutation,BP,POLM;POLL
10679,GO:0043981,0.548757544044479,0.737957641718539,2,15,histone H4-K5 acetylation,BP,ING4;JADE2
10680,GO:0043982,0.548757544044479,0.737957641718539,2,15,histone H4-K8 acetylation,BP,ING4;JADE2
15184,GO:0071356,0.548907926157514,0.539877076565128,23,199,cellular response to tumor necrosis factor,BP,TNFRSF6B;POSTN;RBCK1;ADAMTS7;TNFSF15;ADAMTS13;ZFP36L1;HYAL1;PCK2;SPPL2B;NGFR;TNFRSF25;MAPK3;ARHGEF2;TMSB4X;EDA;TRPV1;SHARPIN;GAS6;TNFRSF14;AKT1;EDA2R;IKBKB
7724,GO:0032228,0.549561938442364,0.737249521633395,2,15,regulation of synaptic transmission, GABAergic,BP,NISCH;NLGN2
10407,GO:0043268,0.54970179355667,0.737126289875879,2,15,positive regulation of potassium ion transport,BP,FHL1;STK39
2200,GO:0005086,0.549916728863794,0.736936835445085,2,15,ARF guanyl-nucleotide exchange factor activity,MF,IQSEC2;PSD4
11756,GO:0046635,0.550017208048354,0.688251692647431,3,24,positive regulation of alpha-beta T cell activation,BP,PRKCZ;TGFBR2;ADA
2538,GO:0005796,0.550146846604951,0.621511529229464,6,49,Golgi lumen,CC,MUC19;CSPG4;SDC2;WNT7A;GAS6;WNT3
13487,GO:0055083,0.550195823197142,0.736690707648866,2,15,monovalent inorganic anion homeostasis,BP,SLC12A7;FGFR4
10032,GO:0042531,0.550781588345868,0.657288171824998,4,33,positive regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;CTF1;FGFR3;FYN
10749,GO:0044212,0.550879380919763,0.500288334729018,72,609,transcription regulatory region DNA binding,MF,ZC3H6;ZMYND8;NFATC4;FOS;EGR1;NR1D1;PRDX5;BAHCC1;MEF2D;DDIT3;TCFL5;RBL2;TFDP2;MXI1;ASH2L;SOX13;ETV4;PHF21A;PBX2;SOX12;ELK3;KDM3A;FOXQ1;SALL2;ETV1;ETV5;HES2;CHD2;TEF;CARF;PPARA;SATB1;STAT6;KLF7;HMGA2;THRA;MLXIPL;LITAF;ATF4;ZFPM1;ZNF516;JDP2;HDAC5;IRF5;DEAF1;RFX2;CEBPB;CREBRF;HLTF;MXD3;BHLHE40;CALCOCO1;RXRA;TNRC18;CRY2;ZNF217;SMARCD2;TP73;MNT;TFEB;BCL6;HSF4;POU2F2;RCOR2;MTA1;TCF7;PER1;CREB3L4;DBP;DMTF1;TEAD2;SIX5
13781,GO:0060396,0.550918266627889,0.736052966312333,2,15,growth hormone receptor signaling pathway,BP,MAPK3;JAK3
17771,GO:1901889,0.551362339830444,0.735660504620287,2,15,negative regulation of cell junction assembly,BP,DMTN;IKBKB
3495,GO:0007398,0.551434377713958,0.735596806630661,2,15,ectoderm development,BP,ITGA6;EDA2R
13842,GO:0060485,0.551901213291128,0.545704057168869,19,161,mesenchyme development,BP,ACTA2;SEMA4B;PDCD4;S100A4;ZFP36L1;CUL7;WWTR1;LAMA5;SEMA3F;PKD2;HMGA2;MAPK3;SEMA3B;TGFBR2;SEMA4G;TGFBR3;EDNRA;FGFR1;TEAD2
13174,GO:0051817,0.552261052869252,0.588489597238776,9,76,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,TNIP1;APOE;HMGA2;PC;RXRA;TBC1D20;INSR;CPSF4;EIF2AK4
3544,GO:0007569,0.55272637444238,0.580914169954541,10,85,cell aging,BP,PDCD4;ERCC1;MAP2K1;HMGA2;TERC;CHEK2;LMNA;YPEL3;MNT;BCL6
1320,GO:0003171,0.552765441607609,0.7344182036555,2,15,atrioventricular valve development,BP,ZFPM1;TGFBR2
11833,GO:0046835,0.55344997098075,0.685032004282828,3,24,carbohydrate phosphorylation,BP,GALK1;TKFC;FUK
11490,GO:0045995,0.553831563821648,0.579911524789453,10,84,regulation of embryonic development,BP,DUSP6;LAMA5;WNT2B;VANGL2;INSR;TENM4;MAP2K5;PHLDA2;CELSR1;FGFR1
10710,GO:0044068,0.554125830007673,0.684396024619583,3,24,modulation by symbiont of host cellular process,BP,TNIP1;CPSF4;EIF2AK4
14166,GO:0061099,0.554225979081044,0.684301726778886,3,24,negative regulation of protein tyrosine kinase activity,BP,PTK6;ERRFI1;TSG101
7209,GO:0031112,0.554268890795581,0.6842613175992,3,24,positive regulation of microtubule polymerization or depolymerization,BP,ARL2;PAK1;TRPV4
8643,GO:0034204,0.55429908911546,0.73305636188781,2,15,lipid translocation,BP,ABCA7;ATP8B2
7825,GO:0032387,0.554300148380165,0.632757928260203,5,42,negative regulation of intracellular transport,BP,DMTN;PCSK9;PDE2A;GAS6;BRAF
20148,GO:2001023,0.554524054419778,0.632538490454946,5,42,regulation of response to drug,BP,RAB3B;STK39;HMGA2;ENDOG;ADIRF
6117,GO:0019369,0.555343785311932,0.683248209708957,3,24,arachidonic acid metabolic process,BP,ALOX15B;MAPK3;FAAH
18419,GO:1903532,0.555458548999986,0.528257461604519,26,218,positive regulation of secretion by cell,BP,F2R;POSTN;GLUL;ALOX15B;NTSR1;EGFR;PCK2;NLGN2;PRKCZ;ZP3;PLA2G6;C5;ANO1;MAPK3;TTN;NLRP1;TRPV4;APLN;GLUD1;PTAFR;TSG101;IL17RC;HFE;MYO18A;STX1A;FGFR1
4810,GO:0014009,0.555548943466884,0.68305464767476,3,24,glial cell proliferation,BP,IDH2;ETV5;AREG
3274,GO:0006955,0.555767345899892,0.481441534760259,143,1226,immune response,BP,TNIP1;PTPRS;TNFRSF6B;FOS;IL20RB;GSN;PYGB;EGR1;WIPF1;SLC2A3;PTK6;NAPRT;RNF135;LRP1;TIMP2;RBCK1;PRNP;FCGRT;NR1D1;ERCC1;TNFSF15;CST3;PGM1;ADAMTS13;MST1R;ADARB1;GAA;PYGL;RPL13A;PRSS3;SYNGR1;CYP27B1;PKN1;DNASE1L1;TMEM173;SHC1;CD68;PRKCZ;SERPING1;PAK1;APOBEC3C;PRR7;BRI3;FAM3A;ZP3;RAG1;SPPL2B;NGFR;MUC19;ACTR1B;EREG;TMC6;TNFRSF25;PLA2G6;SCART1;ERMAP;S100A13;C5;APOBEC3F;NLRX1;STAT6;VAMP2;ECM1;KCNAB2;MAPK3;IFITM1;RHOF;CTSB;LTA4H;PI4K2A;IFNGR2;C1RL;ARHGEF2;INPP5D;PDCD1LG2;ZFPM1;DOCK11;IFI6;FUCA1;FLOT1;GTPBP1;IRF5;NLRP1;CEBPB;ALDOC;ISG20;APLN;EDA;HEXB;PIK3R2;GAS6;BCR;NBEAL2;PTAFR;RAB43;CTSH;TNFRSF14;CARD11;HMSD;TCIRG1;ARSA;MAN2B1;IFI27;PLAU;RPS6KA5;LTB4R;ULBP1;LYST;BRAF;BTN3A2;CAT;MAPK10;DPP7;YPEL5;LGALS1;HFE;JAK3;APRT;TFEB;ICAM5;METTL7A;HGSNAT;BTN3A3;BCL6;TKFC;FYN;SIRT2;TOM1;ADA;POU2F2;AP2A2;TGFBR3;TCF7;VAV3;GALNS;LAMTOR2;MFNG;EIF2AK4;PAG1;PFKL;HLA-G;SDHAF4;IKBKB
12204,GO:0048483,0.556229130838061,0.682412454930657,3,24,autonomic nervous system development,BP,ADARB1;SEMA3F;EDNRA
395,GO:0001067,0.556943394120214,0.494151587551154,72,610,regulatory region nucleic acid binding,MF,ZC3H6;ZMYND8;NFATC4;FOS;EGR1;NR1D1;PRDX5;BAHCC1;MEF2D;DDIT3;TCFL5;RBL2;TFDP2;MXI1;ASH2L;SOX13;ETV4;PHF21A;PBX2;SOX12;ELK3;KDM3A;FOXQ1;SALL2;ETV1;ETV5;HES2;CHD2;TEF;CARF;PPARA;SATB1;STAT6;KLF7;HMGA2;THRA;MLXIPL;LITAF;ATF4;ZFPM1;ZNF516;JDP2;HDAC5;IRF5;DEAF1;RFX2;CEBPB;CREBRF;HLTF;MXD3;BHLHE40;CALCOCO1;RXRA;TNRC18;CRY2;ZNF217;SMARCD2;TP73;MNT;TFEB;BCL6;HSF4;POU2F2;RCOR2;MTA1;TCF7;PER1;CREB3L4;DBP;DMTF1;TEAD2;SIX5
2481,GO:0005720,0.557138215813374,0.651149246476565,4,33,nuclear heterochromatin,CC,SATB1;DNMT3A;UHRF2;SIRT2
16521,GO:0097306,0.558181368567466,0.629246523485956,5,41,cellular response to alcohol,BP,DNMT3A;ADCY6;AKT1;ITPR2;RECQL5
6305,GO:0019955,0.558604036439766,0.600471254987281,7,59,cytokine binding,MF,IL20RB;LTBP4;LTBP1;TNFRSF25;LTBP3;TGFBR2;TGFBR3
4977,GO:0015103,0.558635656034137,0.582101563896708,9,76,inorganic anion transmembrane transporter activity,MF,CLCA2;SLC12A7;SLC37A2;ANO8;ANO1;LRRC8A;ANO9;TTYH3;SLC37A4
7984,GO:0032611,0.55921012975489,0.627932202427288,5,42,interleukin-1 beta production,BP,F2R;EGR1;ACP5;ERRFI1;NLRP1
13504,GO:0055106,0.560221171685254,0.72654449535854,2,16,ubiquitin-protein transferase regulator activity,MF,TRIB2;TRIB3
13477,GO:0055070,0.560319434040903,0.726455801903865,2,16,copper ion homeostasis,BP,PRNP;ATP7B
13486,GO:0055082,0.560491785770977,0.500237975591056,50,430,cellular chemical homeostasis,BP,DLG4;F2R;APOE;NTSR1;PRNP;NR1D1;NOS1;DDIT3;PCK2;CYBRD1;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;ANO1;PKD2;MAPK3;BNIP3;MLXIPL;SV2A;PKD1;KCNMA1;HERPUD1;GSTM2;TMEM175;ENDOG;LRP5;TRPV4;HEXB;TRPV1;PIK3R2;GAS6;ERN1;ATP7B;ATP2B4;ITPR2;TCIRG1;TPCN1;LETMD1;LGALS1;HFE;ATP12A;SLC9A7;FYN;TRPC1;EDNRA;WFS1;FITM2;SLC9A5
4135,GO:0009200,0.561004304702136,0.725837147398132,2,16,deoxyribonucleoside triphosphate metabolic process,BP,DGUOK;ADA
6819,GO:0030286,0.561937848748505,0.646478577412141,4,33,dynein complex,CC,DNAH1;WDR60;NUDCD3;DNAL4
5471,GO:0016409,0.562541939260313,0.64588854776427,4,33,palmitoyltransferase activity,MF,ZDHHC1;CPT2;CPT1C;ZDHHC24
948,GO:0002367,0.562670879472463,0.608647461818863,6,51,cytokine production involved in immune response,BP,PRKCZ;MAPK3;GAS6;HFE;JAK3;BCL6
3315,GO:0007021,0.562706400193423,0.821341149733239,1,7,tubulin complex assembly,BP,ARL2
3780,GO:0008347,0.563279207922584,0.645167780290674,4,33,glial cell migration,BP,IDH2;CSPG4;HEXB;LAMB1
894,GO:0002274,0.563533470984969,0.497132473006186,50,432,myeloid leukocyte activation,BP,GSN;PYGB;SLC2A3;NAPRT;TIMP2;CST3;PGM1;NDRG1;GAA;PYGL;PRSS3;SYNGR1;DNASE1L1;TMEM173;CD68;BRI3;ACTR1B;TMC6;S100A13;VAMP2;KCNAB2;RHOF;CTSB;LTA4H;PI4K2A;FUCA1;ALDOC;TGFBR2;HEXB;TRPV1;BCR;NBEAL2;PTAFR;CTSH;TCIRG1;ARSA;MAN2B1;PLAU;CAT;DPP7;YPEL5;APRT;METTL7A;HGSNAT;TOM1;AP2A2;MYO18A;GALNS;LAMTOR2;PFKL
10288,GO:0043069,0.563721976707676,0.486911694451129,73,626,negative regulation of programmed cell death,BP,F2R;TNFRSF6B;APOE;LRP1;PDCD4;VEGFA;NTSR1;EGFR;RBCK1;PRNP;PRDX5;MST1R;RGL2;SYNGAP1;ITGA6;SHC1;SPRY2;PRKCZ;AARS;FGFR3;RAG1;NGFR;HMGA2;BNIP3;SEMA5A;STK40;ARHGEF2;ANGPTL4;IFI6;MDK;UNC5B;HERPUD1;CEBPB;MAP3K12;NOS3;AGO4;WNT7A;BNIP3L;EPHA1;GAS6;STRADB;CTSH;MGMT;ASNS;AKT1;MICAL1;AMIGO2;FGFR4;LMNA;INSR;MAP2K5;BRAF;PIDD1;CAT;TIMP1;JAK3;TP73;MNT;BCL6;FYN;ADA;CIDEA;MYO18A;TCF7;EPHB2;FGFR1;WFS1;FKBP8;CTH;ERBB2;SYVN1;IKBKB;SNCB
18591,GO:1903902,0.563842104062492,0.607478192390906,6,51,positive regulation of viral life cycle,BP,ADARB1;PC;TSG101;TBC1D20;CHMP4C;LGALS1
8584,GO:0034103,0.564349166882125,0.622850411463846,5,42,regulation of tissue remodeling,BP,EGFR;CST3;INPP5D;LRP5;BCR
10369,GO:0043209,0.564615109110706,0.541293048115226,16,138,myelin sheath,CC,GSN;GLUL;GJC2;DNM1;NDRG1;CNTN1;ITPR3;PRKCZ;SDHA;TAGLN3;ASS1;EHD3;SIRT2;MPDZ;ERBB2;PLLP
12876,GO:0051246,0.564645061898012,0.465348506277389,236,2014,regulation of protein metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;TNFRSF6B;APOE;BTBD2;SERPINE2;GSN;EGR1;PPP1R35;FBXO2;PTK6;EDEM1;GJC2;LRP1;PDCD4;TIMP2;VEGFA;EGFR;PRNP;FBLN1;PRDX5;TFPI2;DUSP5;RAPGEF3;TNFSF15;IGFBP4;CRTAP;CST3;NOS1;ERCC6;ABTB1;GRAMD4;MST1R;ZFP36L1;ADARB1;NUPR1;B3GAT3;HBEGF;CTF1;CNTN1;RPL13A;PLAT;LTBP4;SLC27A1;MIF4GD;PHACTR3;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;SHC2;SYNGAP1;DGKQ;SNX9;MAGEF1;SHC1;VPS11;SPRY2;GRB7;UNK;CIRBP;CAPRIN2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;STK39;FGFR3;CEMIP;KDM3A;MTHFR;PHF1;SPRY4;DLG3;NEURL1;ACVR2B;RAG1;NGFR;ELFN2;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PLGRKT;CHAC1;SESN2;MKNK2;IMPACT;PKD2;AREG;ECM1;MAPK3;CSPG4;TRPT1;ERRFI1;STK40;VANGL2;RGS14;SNTA1;MAPK12;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;DMTN;ATF4;ZFPM1;BBC3;KDM4C;PAK6;SSH1;IFI6;PKD1;FLOT1;TTN;AZIN2;JDP2;SORL1;HERPUD1;VLDLR;PAPLN;NLRP1;CEBPB;MAP3K12;RHBDF1;LRP5;ATRAID;PCSK9;PKIB;TGFBR2;TRPV4;ITGA1;SMURF2;TRIB3;DAP;PEMT;HMG20B;CDK5RAP3;AGO4;MINK1;PROM2;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;NBR1;TADA3;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;MGMT;PAIP2B;HINT2;AKT1;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;IFT57;SPDYE2;SPDYE2B;TSG101;FGFR4;IGF2BP2;PIAS3;WDFY2;C9ORF72;IFI27;INSR;NCOA7;RPS6KA5;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;PIDD1;MAPK10;TIMP1;HFE;JAK3;TP73;SNX33;LSM14B;CSNK1E;BCL6;FYN;ZC3H12D;SNX1;LEMD2;SIRT2;GDF15;GOLGA2;MTA1;HDAC8;PAIP2;EIF4EBP1;AVPI1;CIDEB;LAMTOR2;MAP3K10;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;FKBP8;ERBB2;EIF2AK4;UNC119;ZNF287;CAMKK1;IKBKB;HIP1;ACOT8;BTBD11
7069,GO:0030866,0.565345172562186,0.643144186441007,4,33,cortical actin cytoskeleton organization,BP,WIPF1;FMNL2;RAB13;IKBKB
8428,GO:0033559,0.56564900683855,0.593234598752185,7,60,unsaturated fatty acid metabolic process,BP,ALOX15B;MAPK3;GSTM2;CES2;PTGR2;FAAH;ACOT8
12276,GO:0048635,0.565680131787843,0.642815558865218,4,33,negative regulation of muscle organ development,BP,PAK1;TGFBR2;TP73;SIRT2
6791,GO:0030240,0.565814786766478,0.883729133182223,1,2,skeletal muscle thin filament assembly,BP,TTN
2099,GO:0004867,0.565956389606894,0.620966217202894,5,43,serine-type endopeptidase inhibitor activity,MF,SERPINE2;TFPI2;SERPING1;PAPLN;HMSD
12356,GO:0048769,0.566357752997467,0.883447927119731,1,2,sarcomerogenesis,BP,TTN
10060,GO:0042575,0.566680496893691,0.720677489454619,2,16,DNA polymerase complex,CC,POLD4;TERC
5709,GO:0016846,0.566681609778256,0.818333342495208,1,7,carbon-sulfur lyase activity,MF,CTH
10042,GO:0042542,0.567188322689417,0.554737569112271,12,104,response to hydrogen peroxide,BP,CST3;MAPK13;IMPACT;STAT6;AREG;BNIP3;ENDOG;MAP1LC3A;ANKZF1;CAT;ADA;NET1
4406,GO:0010165,0.567676984107302,0.640853330914632,4,33,response to X-ray,BP,ERCC1;ERCC6;HMGA2;TP73
10398,GO:0043254,0.567884012034031,0.500497751840515,39,335,regulation of protein complex assembly,BP,APOE;GSN;CTNNBIP1;WIPF1;CDC42EP5;VEGFA;DDB2;ERCC1;SPTB;MMP1;RPL13A;ARPIN;CAPG;EML2;SNX9;ARL2;ULK1;VPS11;PRKCZ;PAK1;PLEKHG2;IMPACT;THRA;ARHGEF2;TWF2;DMTN;WHAMMP3;SORL1;TRIOBP;TMSB4X;TMOD2;FCHSD1;SPIRE1;EPS8L1;SIRT2;EPS8L2;STX1A;C15ORF62;CORO1B
11227,GO:0045445,0.568057402698173,0.603257357813746,6,51,myoblast differentiation,BP,DDIT3;ZFP36L1;BTG1;MAPK12;LGALS1;EPAS1
6690,GO:0030091,0.568212837902588,0.817165375956235,1,7,protein repair,BP,MSRB2
2523,GO:0005778,0.568301859574192,0.603011974801741,6,51,peroxisomal membrane,CC,DHRS4;PEX10;MAP2K2;CAT;PEX1;PEX11A
7552,GO:0031903,0.568301859574192,0.603011974801741,6,51,microbody membrane,CC,DHRS4;PEX10;MAP2K2;CAT;PEX1;PEX11A
3438,GO:0007249,0.568537776652784,0.518151823178985,24,207,I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;F2R;RBCK1;S100A4;PLEKHG5;TMED4;S100A13;NLRX1;ECM1;LITAF;NLRP1;SHARPIN;MAPKBP1;AKT1;CARD11;EDA2R;LGALS1;MIB2;FYN;TMEM101;LURAP1;PER1;CTH;IKBKB
7433,GO:0031572,0.568714533688603,0.639831657771751,4,33,G2 DNA damage checkpoint,BP,BRSK1;HMGA2;CDK5RAP3;FOXO4
8134,GO:0032870,0.568829393977061,0.489067807166274,55,470,cellular response to hormone stimulus,BP,BBS2;FOS;PGF;FAM210B;EGFR;NR1D1;ZFP36L1;SLC27A1;KLF9;PCK2;DDIT4;SHC1;PRKCZ;PAK1;KDM3A;NGFR;PTPRE;PPARA;VAMP2;SLIT3;MAPK3;ERRFI1;THRA;CTSB;PAQR6;HDAC5;SRSF5;CREBRF;PCSK9;TRIB3;CALCOCO1;PIK3R2;TADA3;RXRA;ADCY6;CTSH;ASNS;AKT1;IGFBP7;CRY2;CHEK2;IGFBP2;TCIRG1;INSR;FOXO4;GPR21;JAK3;CHRM3;APRT;FYN;RAB13;EIF4EBP1;PER1;ITGA2;GRB10
2937,GO:0006465,0.568977572696931,0.718572992696864,2,16,signal peptide processing,BP,SPPL2B;GAS6
18434,GO:1903555,0.56944236441816,0.579326174801872,8,69,regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;ACP5;MC1R;ERRFI1;ARHGEF2;GAS6;PTAFR;CIDEA
3944,GO:0008649,0.569714645771694,0.71789569295418,2,16,rRNA methyltransferase activity,MF,RRNAD1;TFB1M
17279,GO:0140102,0.569714645771694,0.71789569295418,2,16,catalytic activity, acting on a rRNA,MF,RRNAD1;TFB1M
5524,GO:0016505,0.569854226529706,0.71776732080299,2,16,peptidase activator activity involved in apoptotic process,MF,NLRP1;CTSH
11491,GO:0046006,0.569883441178707,0.668725482877182,3,25,regulation of activated T cell proliferation,BP,PRNP;PDCD1LG2;IGFBP2
15313,GO:0071560,0.570017171099733,0.527235169477873,19,163,cellular response to transforming growth factor beta stimulus,BP,HTRA1;FOS;POSTN;ZFP36L1;LTBP4;PRKCZ;LTBP1;MTMR4;ITGB5;LTBP2;TGFBR2;PDE2A;SMURF2;WNT7A;CDKN1C;FYN;GDF15;CIDEA;TGFBR3
5862,GO:0017176,0.570074547510651,0.815738259788779,1,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,PIGQ
15464,GO:0071855,0.571063505659029,0.814976994181323,1,7,neuropeptide receptor binding,MF,APLN
2586,GO:0005881,0.571483547500823,0.599812163199109,6,51,cytoplasmic microtubule,CC,CLIP2;SNPH;REEP2;TUBG2;ENKD1;TRPV4
16811,GO:0098742,0.571587139605973,0.550414797665336,12,102,cell-cell adhesion via plasma-membrane adhesion molecules,BP,ADGRL1;SDK2;ARVCF;PLXNB3;TENM2;PKD1;TGFBR2;AMIGO2;TENM4;MAP2K5;CELSR1;CADM4
11824,GO:0046823,0.571638007492282,0.716123669876312,2,16,negative regulation of nucleocytoplasmic transport,BP,PDE2A;GAS6
11027,GO:0045026,0.571681086370431,0.71608390372952,2,16,plasma membrane fusion,BP,CD9;STX1A
3118,GO:0006700,0.571761316584419,0.716009834162197,2,16,C21-steroid hormone biosynthetic process,BP,EGR1;DGKQ
7884,GO:0032461,0.571764225321851,0.716007148558459,2,16,positive regulation of protein oligomerization,BP,MMP1;SNX9
3691,GO:0008200,0.571889704877728,0.666783462391176,3,25,ion channel inhibitor activity,MF,WNK4;PCSK9;STX1A
983,GO:0002440,0.572007060938879,0.545164708860034,13,112,production of molecular mediator of immune response,BP,ERCC1;PKN1;PRKCZ;STAT6;MAPK3;POLM;GAS6;POLL;CARD11;HFE;JAK3;BCL6;POU2F2
6192,GO:0019673,0.572098528412828,0.814177907685903,1,7,GDP-mannose metabolic process,BP,MPI
17015,GO:0099518,0.572125776619835,0.615099783820764,5,42,vesicle cytoskeletal trafficking,BP,BLOC1S4;PRKCZ;NDE1;FYCO1;BLOC1S1
4139,GO:0009204,0.573157990364271,0.813357444150681,1,7,deoxyribonucleoside triphosphate catabolic process,BP,ADA
11773,GO:0046660,0.573167927527872,0.567277360072264,9,77,female sex differentiation,BP,VEGFA;NUPR1;ZP3;EREG;SLIT3;CEBPB;NOS3;INSR;MMP19
7646,GO:0032075,0.573495333554346,0.714406104114756,2,16,positive regulation of nuclease activity,BP,ERN1;AKT1
3699,GO:0008210,0.573627808087734,0.714283357847968,2,16,estrogen metabolic process,BP,HSD17B14;HSD17B7
16539,GO:0097352,0.574051949384469,0.634139619252255,4,34,autophagosome maturation,BP,TECPR1;MAP1LC3A;FYCO1;TSG101
4884,GO:0014808,0.574103609182068,0.713842233060996,2,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,GSTO1;GSTM2
18404,GO:1903514,0.574103609182068,0.713842233060996,2,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,GSTO1;GSTM2
16520,GO:0097305,0.574130514256119,0.542994838362064,13,112,response to alcohol,BP,GSN;ABCA2;DNMT3A;TGFBR2;PEMT;ADCY6;MGMT;AKT1;ITPR2;CAT;FYN;RECQL5;TGFBR3
14391,GO:0061702,0.574339552650696,0.812439421768279,1,7,inflammasome complex,CC,NLRP1
3441,GO:0007253,0.57465098495495,0.812196924015627,1,7,cytoplasmic sequestering of NF-kappaB,BP,TMSB4X
5070,GO:0015297,0.574692141707038,0.596573842985404,6,51,antiporter activity,MF,SLC7A8;SLC37A2;SLC22A18;SLC9A7;SLC37A4;SLC9A5
11372,GO:0045773,0.574861440868125,0.63374902123482,4,33,positive regulation of axon extension,BP,VEGFA;PAK1;SEMA5A;TWF2
19835,GO:2000343,0.575010430510865,0.811916766076941,1,7,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
6247,GO:0019829,0.575140257795531,0.633057951260083,4,34,cation-transporting ATPase activity,MF,ATP7B;ATP2B4;TCIRG1;ATP12A
4264,GO:0009617,0.575693928401514,0.497164271239449,34,298,response to bacterium,BP,TNIP1;F2R;TNFRSF6B;FOS;ACP5;PDCD4;NR1D1;LOXL1;NOS1;ADAMTS13;CYP27B1;PCK2;SHC1;NGFR;TNFRSF25;PLA2G6;MAPK3;GSDMA;PDCD1LG2;LITAF;HDAC5;IRF5;NLRP1;CEBPB;NOS3;BCR;SRR;PTAFR;TNFRSF14;GSDMC;MAPKBP1;AKT1;LYST;SIRT2
6279,GO:0019888,0.575696105009342,0.583076548581916,7,60,protein phosphatase regulator activity,MF,PPP1R35;B3GAT3;PHACTR3;PPP1R14A;PPP2R3B;ELFN2;PPP1R15A
8716,GO:0034377,0.575721863213726,0.712338819866142,2,16,plasma lipoprotein particle assembly,BP,APOE;ABCA7
8722,GO:0034383,0.575783769270906,0.662996423008242,3,25,low-density lipoprotein particle clearance,BP,CES3;PCSK9;AP2A2
5706,GO:0016842,0.576006772285773,0.811138660407005,1,7,amidine-lyase activity,MF,CHAC1
1474,GO:0003746,0.576016163234815,0.712064889853044,2,16,translation elongation factor activity,MF,ABTB1;GTPBP1
16519,GO:0097300,0.576310557783173,0.631892998922561,4,34,programmed necrotic cell death,BP,RBCK1;PYGL;ARHGEF2;ALKBH7
7607,GO:0032006,0.576498059214435,0.563880993688975,9,77,regulation of TOR signaling,BP,EPM2A;DDIT4;DGKQ;SESN2;TNFAIP8L1;GAS6;C12ORF66;C9ORF72;LAMTOR2
8143,GO:0032880,0.576620809872865,0.471399641083646,81,690,regulation of protein localization,BP,F2R;ZMYND8;GSN;POSTN;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;NR1D1;HADH;ANK3;RAPGEF3;IDH2;B3GAT3;TFDP2;PCK2;TMEM173;ARL2;VPS11;NLGN2;ITPR3;TTBK2;PRKCZ;PAK1;CEMIP;MICALL2;CEP250;NGFR;PLA2G6;C5;ANO1;SESN2;SH3TC2;VAMP2;KCNAB2;MAPK3;DMTN;BBC3;SSH1;TTN;SORL1;NLRP1;RHBDF1;LRP5;CEP131;TRPV4;TMSB4X;PDE2A;PEMT;CDK5RAP3;WNT7A;BNIP3L;RHBDF2;GAS6;GLUD1;LZTS2;CROCC;CAMK1;MAPKBP1;AKT1;ITPR2;TSG101;IL17RC;LMNA;ICA1;IFI27;HFE;TP73;SNX33;CSNK1E;FYN;CIDEA;HDAC8;MYO18A;STX1A;EPHB2;ERBB2;OSCP1;PFKL
15398,GO:0071695,0.576688613698893,0.55049639279917,11,94,anatomical structure maturation,BP,THBS3;FAM210B;DDIT3;PABPC1L;FGFR3;NPR2;PLXNB1;EREG;FAM20C;REC8;SIRT2
19369,GO:1905906,0.576718070669838,0.810581775597317,1,7,regulation of amyloid fibril formation,BP,APOE
12118,GO:0048240,0.576902696967174,0.810437040000424,1,7,sperm capacitation,BP,CABYR
10508,GO:0043457,0.577202350131421,0.710959194156753,2,16,regulation of cellular respiration,BP,BNIP3;TRPV4
11605,GO:0046328,0.577333750977819,0.531745893039261,15,129,regulation of JNK cascade,BP,PDCD4;EGFR;ERCC6;PKN1;PAK1;VANGL2;TRPV4;MINK1;WNT7A;ERN1;AKT1;EDA2R;TP73;MAP3K10;PER1
3865,GO:0008494,0.577536279741784,0.809939756343872,1,7,translation activator activity,MF,MIF4GD
6957,GO:0030619,0.577562078540186,0.809919487989778,1,7,U1 snRNA binding,MF,ISG20
4619,GO:0010744,0.577840940447148,0.809700307758548,1,7,positive regulation of macrophage derived foam cell differentiation,BP,ALOX15B
4058,GO:0009111,0.577891301377762,0.809660705976451,1,7,vitamin catabolic process,BP,CYP27B1
6779,GO:0030223,0.577948481162632,0.809615735067604,1,7,neutrophil differentiation,BP,INPP5D
15341,GO:0071605,0.578236847292303,0.809388825631883,1,7,monocyte chemotactic protein-1 production,BP,TRPV4
15362,GO:0071637,0.578236847292303,0.809388825631883,1,7,regulation of monocyte chemotactic protein-1 production,BP,TRPV4
749,GO:0001990,0.578427816981894,0.709814168204196,2,16,regulation of systemic arterial blood pressure by hormone,BP,F2R;NOS3
11762,GO:0046641,0.578468290667166,0.809206569284071,1,7,positive regulation of alpha-beta T cell proliferation,BP,TGFBR2
7216,GO:0031119,0.578711331271216,0.809015047749146,1,7,tRNA pseudouridine synthesis,BP,RPUSD3
15840,GO:0072588,0.578833061203288,0.805882578144892,1,8,box H/ACA RNP complex,CC,TERC
11484,GO:0045989,0.57897954752301,0.80880352940765,1,7,positive regulation of striated muscle contraction,BP,GSTO1
14215,GO:0061217,0.579032980071721,0.709247708627767,2,16,regulation of mesonephros development,BP,VEGFA;WNT2B
4392,GO:0010092,0.579071675078104,0.709211465412651,2,16,specification of animal organ identity,BP,WNT2B;FGFR1
4726,GO:0010894,0.579197654726573,0.709093448947187,2,16,negative regulation of steroid biosynthetic process,BP,APOE;CYP27B1
11461,GO:0045939,0.579197654726573,0.709093448947187,2,16,negative regulation of steroid metabolic process,BP,APOE;CYP27B1
3043,GO:0006600,0.579401796991495,0.80847020291494,1,7,creatine metabolic process,BP,GAMT
889,GO:0002262,0.579487152533225,0.542173028200302,12,104,myeloid cell homeostasis,BP,FAM210B;VEGFA;ZFP36L1;THRA;INPP5D;DMTN;ZFPM1;DNASE2;JAK3;BCL6;TGFBR3;EPAS1
7180,GO:0031077,0.579493179078402,0.808398011193958,1,7,post-embryonic camera-type eye development,BP,VEGFA
14632,GO:0070255,0.579560035933627,0.808345182171212,1,7,regulation of mucus secretion,BP,ADA
3168,GO:0006782,0.579729486510578,0.808211239332523,1,7,protoporphyrinogen IX biosynthetic process,BP,UROS
14616,GO:0070227,0.579873370564544,0.59110007898997,6,52,lymphocyte apoptotic process,BP,PKN1;RAG1;AKT1;JAK3;BCL6;ADA
7643,GO:0032071,0.579965064782047,0.808024915487389,1,7,regulation of endodeoxyribonuclease activity,BP,AKT1
4382,GO:0010039,0.580093733811254,0.658777569758768,3,25,response to iron ion,BP,CYBRD1;MAP1LC3A;HFE
13497,GO:0055094,0.580761869204498,0.707625667294157,2,16,response to lipoprotein particle,BP,APOE;CD9
10353,GO:0043186,0.580864190429621,0.807312599066433,1,7,P granule,CC,TDRKH
11237,GO:0045495,0.580864190429621,0.807312599066433,1,7,pole plasm,CC,TDRKH
13699,GO:0060293,0.580864190429621,0.807312599066433,1,7,germ plasm,CC,TDRKH
3246,GO:0006907,0.580967480275326,0.707432395573021,2,16,pinocytosis,BP,PROM2;SNX33
11804,GO:0046719,0.581095048691973,0.807129403874361,1,7,regulation by virus of viral protein levels in host cell,BP,TBC1D20
8527,GO:0033866,0.581165517696363,0.707246168980958,2,16,nucleoside bisphosphate biosynthetic process,BP,PPCS;ACOT7
8551,GO:0034030,0.581165517696363,0.707246168980958,2,16,ribonucleoside bisphosphate biosynthetic process,BP,PPCS;ACOT7
8554,GO:0034033,0.581165517696363,0.707246168980958,2,16,purine nucleoside bisphosphate biosynthetic process,BP,PPCS;ACOT7
10606,GO:0043620,0.581315817837224,0.540142973433137,12,106,regulation of DNA-templated transcription in response to stress,BP,EGR1;VEGFA;DDIT3;SESN2;IMPACT;RGS14;ATF4;CEBPB;HSF4;SIRT2;EPAS1;CHD6
4743,GO:0010918,0.581318340842626,0.80695209522507,1,7,positive regulation of mitochondrial membrane potential,BP,AKT1
3475,GO:0007338,0.581484568391904,0.589459859628604,6,52,single fertilization,BP,CD9;MST1R;SYT8;ZP3;HEXB;PLB1
12634,GO:0050862,0.581519972230315,0.806791887336763,1,7,positive regulation of T cell receptor signaling pathway,BP,ADA
13667,GO:0060242,0.58156151554596,0.806758867039407,1,7,contact inhibition,BP,PAK1
16765,GO:0098631,0.581567238574052,0.626637333571539,4,34,cell adhesion mediator activity,MF,PLXNB3;ITGA1;BCAM;ITGA2
381,GO:0001016,0.581661132108985,0.806679671476613,1,7,RNA polymerase III regulatory region DNA binding,MF,PRDX5
15137,GO:0071281,0.581683632583961,0.806661780318743,1,7,cellular response to iron ion,BP,HFE
17349,GO:1900101,0.581781663025596,0.6571174500457,3,25,regulation of endoplasmic reticulum unfolded protein response,BP,ERN1;PPP1R15A;WFS1
109,GO:0000226,0.581999144328499,0.478346763294751,50,428,microtubule cytoskeleton organization,BP,BBS2;NINL;BRSK1;CUL9;OBSL1;CUL7;SDCCAG8;EML2;TUBG2;DNAH1;ARL2;SPRY2;TTBK2;PRKCZ;PAK1;CEP250;NEURL1;CCDC88B;CHD3;PKD2;RGS14;TUBE1;HOOK2;CHMP1B;ARHGEF2;STMN3;PKD1;CEP68;MAP6;NDE1;CEP131;MARK3;TRPV4;TTLL11;CEP126;CROCC;GOLGA2P5;SPAG16;CHEK2;LMNA;CHMP5;GOLGA8A;MARK4;CHMP4C;HAUS4;TUBGCP6;SPIRE1;EML3;GOLGA2;CCDC69
13355,GO:0052650,0.582078412571586,0.806347681538871,1,7,NADP-retinol dehydrogenase activity,MF,DHRS4
11282,GO:0045620,0.582263184391787,0.656643046657981,3,25,negative regulation of lymphocyte differentiation,BP,JAK3;BCL6;ERBB2
15128,GO:0071265,0.582330306306809,0.806147078160535,1,7,L-methionine biosynthetic process,BP,CTH
15080,GO:0071156,0.5825511348253,0.544303155284286,11,96,regulation of cell cycle arrest,BP,RBL2;TFDP2;PKD2;HMGA2;MLXIPL;PCBP4;CHEK2;UHRF2;FOXO4;PIDD1;TP73
559,GO:0001696,0.582603071979874,0.805929686434955,1,7,gastric acid secretion,BP,TRPV1
18777,GO:1904355,0.58270288588055,0.705798015383411,2,16,positive regulation of telomere capping,BP,MAPK3;PKIB
10587,GO:0043583,0.582823344002492,0.53407574994361,13,112,ear development,BP,NAGLU;SPRY2;IFT27;MAPK3;VANGL2;SLITRK6;TRIOBP;BCR;WDR19;CELSR1;EPHB2;FGFR1;TSHZ1
19163,GO:1905276,0.583099556803677,0.705423651401887,2,16,regulation of epithelial tube formation,BP,VANGL2;CELSR1
6910,GO:0030510,0.583288076863682,0.587841239242388,6,51,regulation of BMP signaling pathway,BP,HTRA1;RNF165;FBXL15;SMURF2;LEMD2;FKBP8
5730,GO:0016881,0.583321201127396,0.705214343930828,2,16,acid-amino acid ligase activity,MF,PPCS;TTLL11
9060,GO:0035315,0.583578795217466,0.655345034524411,3,25,hair cell differentiation,BP,SLITRK6;TRIOBP;FGFR1
8122,GO:0032825,0.583596498783837,0.805136470345244,1,7,positive regulation of natural killer cell differentiation,BP,GAS6
11676,GO:0046485,0.583815798452085,0.804961057366614,1,7,ether lipid metabolic process,BP,PEX7
6276,GO:0019885,0.583934814913405,0.804865811731024,1,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,HFE
13677,GO:0060259,0.584072535121811,0.804755556720068,1,7,regulation of feeding behavior,BP,EIF2AK4
11055,GO:0045073,0.584147818361581,0.804695268297949,1,7,regulation of chemokine biosynthetic process,BP,EGR1
12087,GO:0048148,0.58416610069635,0.804680625415621,1,7,behavioral response to cocaine,BP,HOMER2
7468,GO:0031641,0.584204839680227,0.654726412593823,3,25,regulation of myelination,BP,AKT1;TENM4;SIRT2
449,GO:0001223,0.584207771678093,0.70437620612479,2,16,transcription coactivator binding,MF,PPARA;TEAD2
12077,GO:0048102,0.584312340780077,0.804563469155678,1,7,autophagic cell death,BP,BNIP3
12748,GO:0051047,0.584338711425376,0.497167371111246,27,230,positive regulation of secretion,BP,F2R;POSTN;GLUL;ALOX15B;NTSR1;EGFR;PCK2;NLGN2;PRKCZ;ZP3;PLA2G6;C5;ANO1;MAPK3;TTN;NLRP1;TRPV4;APLN;TRPV1;GLUD1;PTAFR;TSG101;IL17RC;HFE;MYO18A;STX1A;FGFR1
3081,GO:0006657,0.584347615712803,0.804535202120439,1,7,CDP-choline pathway,BP,CHKB
16557,GO:0097384,0.584374959734642,0.804513288402562,1,7,cellular lipid biosynthetic process,BP,PEX7
12862,GO:0051224,0.584462238775706,0.536979310447395,12,105,negative regulation of protein transport,BP,F2R;HADH;IDH2;DMTN;RHBDF1;TMSB4X;PDE2A;RHBDF2;GAS6;MAPKBP1;CIDEA;PFKL
15662,GO:0072215,0.584544215986456,0.704057758261653,2,16,regulation of metanephros development,BP,EGR1;WWTR1
2957,GO:0006491,0.584544522278835,0.704057468256725,2,16,N-glycan processing,BP,EDEM1;MAN1B1
13160,GO:0051791,0.584579738047694,0.80434912184432,1,7,medium-chain fatty acid metabolic process,BP,ACOT7
16315,GO:0090594,0.584605776379359,0.804328240421461,1,7,inflammatory response to wounding,BP,F2R
9792,GO:0040034,0.584691192019719,0.804259730272951,1,7,regulation of development, heterochronic,BP,SERPINE2
1925,GO:0004622,0.584693262729488,0.703916616582371,2,16,lysophospholipase activity,MF,PLB1;LYPLAL1
5292,GO:0015980,0.584702022929686,0.501380125567882,24,215,energy derivation by oxidation of organic compounds,BP,NFATC4;PYGB;D2HGDH;NR1D1;IDH2;PGM1;GAA;PYGL;DHTKD1;OGDHL;ETFB;PPP1R3E;BNIP3;STK40;SDHA;SUCLG2;AKT1;ACADVL;INSR;CAT;TAZ;PHLDA2;BLOC1S1;SDHAF4
9752,GO:0039531,0.584727897772523,0.703883812561265,2,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,NLRX1;TKFC
5055,GO:0015269,0.584732454876393,0.804226628059225,1,7,calcium-activated potassium channel activity,MF,KCNMA1
3003,GO:0006551,0.584743455307319,0.804217802535494,1,7,leucine metabolic process,BP,HMGCL
5699,GO:0016832,0.584777189944935,0.804190735840582,1,7,aldehyde-lyase activity,MF,ALDOC
10992,GO:0044829,0.584827144521405,0.80415065032471,1,7,positive regulation by host of viral genome replication,BP,TBC1D20
3771,GO:0008329,0.584840278629272,0.804140110031973,1,7,signaling pattern recognition receptor activity,MF,PTAFR
9719,GO:0038187,0.584840278629272,0.804140110031973,1,7,pattern recognition receptor activity,MF,PTAFR
5567,GO:0016589,0.58492919335299,0.80406874418048,1,7,NURF complex,CC,SMARCA1
19088,GO:1905050,0.584942599645098,0.804057982248936,1,7,positive regulation of metallopeptidase activity,BP,MAPK3
6142,GO:0019432,0.584960371789268,0.653979019523106,3,25,triglyceride biosynthetic process,BP,PCK2;PNPLA3;FITM2
2250,GO:0005165,0.585008738159029,0.804004883242541,1,7,neurotrophin receptor binding,MF,SHC1
2252,GO:0005167,0.585008738159029,0.804004883242541,1,7,neurotrophin TRK receptor binding,MF,SHC1
4928,GO:0014889,0.58518787935703,0.803861009094863,1,7,muscle atrophy,BP,GSN
8594,GO:0034116,0.58519876603272,0.803852263229223,1,7,positive regulation of heterotypic cell-cell adhesion,BP,FLOT1
17364,GO:1900118,0.585425938628648,0.803669699564495,1,7,negative regulation of execution phase of apoptosis,BP,CIDEA
17486,GO:1900746,0.585432852189069,0.803664141692597,1,7,regulation of vascular endothelial growth factor signaling pathway,BP,XDH
18005,GO:1902547,0.585432852189069,0.803664141692597,1,7,regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
9835,GO:0042095,0.58548971052214,0.803618428545683,1,7,interferon-gamma biosynthetic process,BP,ZFPM1
4439,GO:0010340,0.585493267094979,0.803615568867806,1,7,carboxyl-O-methyltransferase activity,MF,PCMTD2
13270,GO:0051998,0.585493267094979,0.803615568867806,1,7,protein carboxyl O-methyltransferase activity,MF,PCMTD2
2095,GO:0004862,0.585503549599414,0.803607301008663,1,7,cAMP-dependent protein kinase inhibitor activity,MF,PKIB
136,GO:0000287,0.585507857683293,0.513901862949933,18,156,magnesium ion binding,MF,GLUL;IDH2;BRSK1;PGM1;RPS6KA2;LHPP;HMGCL;PSPH;NT5C1B;MAPK12;PI4K2A;ERN1;SRR;RPS6KA5;ENDOV;MAST4;ATP8B2;NUDT18
19913,GO:2000480,0.58555996371644,0.803561935681099,1,7,negative regulation of cAMP-dependent protein kinase activity,BP,PKIB
10072,GO:0042589,0.58558275496851,0.803543606010855,1,7,zymogen granule membrane,CC,VAMP2
13104,GO:0051683,0.585692874733793,0.803455025966668,1,7,establishment of Golgi localization,BP,COPG1
9757,GO:0039536,0.585698892221346,0.803450184697479,1,7,negative regulation of RIG-I signaling pathway,BP,NLRX1
7778,GO:0032324,0.585723636425441,0.803430276263345,1,7,molybdopterin cofactor biosynthetic process,BP,MOCOS
10564,GO:0043545,0.585723636425441,0.803430276263345,1,7,molybdopterin cofactor metabolic process,BP,MOCOS
12844,GO:0051189,0.585723636425441,0.803430276263345,1,7,prosthetic group metabolic process,BP,MOCOS
5462,GO:0016363,0.58590661184484,0.540934736640533,11,95,nuclear matrix,CC,PHACTR3;DGKQ;PRKCZ;XPOT;SATB1;HLCS;TEP1;CEBPB;DNMT3A;MBD1;RGS12
7581,GO:0031958,0.585946742252347,0.702727977460122,2,16,corticosteroid receptor signaling pathway,BP,CRY2;PER1
9189,GO:0035586,0.58597387674899,0.803228859752428,1,7,purinergic receptor activity,MF,PTAFR
3037,GO:0006591,0.586029837958212,0.803183796892743,1,7,ornithine metabolic process,BP,AZIN2
11058,GO:0045076,0.586235581839741,0.803018058047649,1,7,regulation of interleukin-2 biosynthetic process,BP,CARD11
541,GO:0001660,0.586268199124353,0.802991773765231,1,7,fever generation,BP,TRPV1
3936,GO:0008627,0.586270851956419,0.802989635900874,1,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,ARHGEF2
5578,GO:0016601,0.58634901341941,0.621823608936985,4,34,Rac protein signal transduction,BP,ARAP3;NISCH;STMN3;ARHGAP44
8001,GO:0032640,0.586599668025157,0.561663323919722,8,70,tumor necrosis factor production,BP,NFATC4;ACP5;MC1R;ERRFI1;ARHGEF2;GAS6;PTAFR;CIDEA
9839,GO:0042101,0.586668648314556,0.802668872340822,1,7,T cell receptor complex,CC,CARD11
16053,GO:0090043,0.58672532710756,0.802623139042195,1,7,regulation of tubulin deacetylation,BP,TADA3
7049,GO:0030836,0.586735760737318,0.802614719470079,1,7,positive regulation of actin filament depolymerization,BP,SEMA5A
9193,GO:0035590,0.586962450850309,0.802431725337583,1,7,purinergic nucleotide receptor signaling pathway,BP,PTAFR
3765,GO:0008318,0.586984518576682,0.802413904846445,1,7,protein prenyltransferase activity,MF,RABGGTA
17772,GO:1901890,0.587000404910006,0.651956480768003,3,25,positive regulation of cell junction assembly,BP,VEGFA;NPHP4;FLOT1
15199,GO:0071378,0.587004288386024,0.701722851315923,2,16,cellular response to growth hormone stimulus,BP,MAPK3;JAK3
9181,GO:0035578,0.587034123787389,0.561215841197069,8,70,azurophil granule lumen,CC,PYGB;NAPRT;FUCA1;HEXB;ARSA;MAN2B1;DPP7;GALNS
8593,GO:0034115,0.58703724042878,0.802371325393133,1,7,negative regulation of heterotypic cell-cell adhesion,BP,MAP2K5
14818,GO:0070587,0.58703724042878,0.802371325393133,1,7,regulation of cell-cell adhesion involved in gastrulation,BP,MAP2K5
11233,GO:0045472,0.587065090716656,0.802348830179774,1,7,response to ether,BP,NFATC4
2288,GO:0005247,0.587155816873226,0.802275536244952,1,7,voltage-gated chloride channel activity,MF,ANO1
16122,GO:0090162,0.587210487772444,0.651747827320947,3,25,establishment of epithelial cell polarity,BP,FBF1;FRMD4B;MYO18A
18775,GO:1904353,0.587211630106079,0.651746692569475,3,25,regulation of telomere capping,BP,ERCC1;MAPK3;PKIB
12839,GO:0051184,0.587268505350664,0.701471403848466,2,16,cofactor transmembrane transporter activity,MF,SLC48A1;SLC25A42
9983,GO:0042415,0.58733106910129,0.802133902264827,1,7,norepinephrine metabolic process,BP,EPAS1
20225,GO:2001212,0.587374855686838,0.802098503861187,1,7,regulation of vasculogenesis,BP,XDH
16126,GO:0090169,0.587538165359631,0.651422240332859,3,25,regulation of spindle assembly,BP,CHMP1B;CHMP5;CHMP4C
11894,GO:0046950,0.58757078922119,0.801940049892404,1,7,cellular ketone body metabolic process,BP,HMGCL
17885,GO:1902224,0.58757078922119,0.801940049892404,1,7,ketone body metabolic process,BP,HMGCL
10535,GO:0043506,0.587612742147384,0.560760912067528,8,69,regulation of JUN kinase activity,BP,PDCD4;ERCC6;PKN1;PAK1;VANGL2;ERN1;TP73;MAP3K10
20094,GO:2000810,0.587628227524928,0.701128856440425,2,16,regulation of bicellular tight junction assembly,BP,NPHP4;IKBKB
11841,GO:0046851,0.587683070783326,0.801849205541853,1,7,negative regulation of bone remodeling,BP,INPP5D
12097,GO:0048172,0.587705724664748,0.801830873219859,1,7,regulation of short-term neuronal synaptic plasticity,BP,SYNGR1
18222,GO:1903071,0.587724944685864,0.801815318747769,1,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,HERPUD1
13913,GO:0060603,0.587757466342638,0.65120424388027,3,25,mammary gland duct morphogenesis,BP,ETV5;AREG;LRP5
14679,GO:0070330,0.587794622649106,0.801758922122441,1,7,aromatase activity,MF,CYP3A5
20080,GO:2000785,0.587867673095918,0.62028821013167,4,34,regulation of autophagosome assembly,BP,ULK1;TBC1D14;LRSAM1;C9ORF72
3442,GO:0007254,0.587961144774229,0.511370611670445,18,156,JNK cascade,BP,CDC42EP5;PDCD4;EGFR;ERCC6;PKN1;PAK1;VANGL2;MAP3K12;TRPV4;MINK1;WNT7A;ERN1;AKT1;EDA2R;MAPK10;TP73;MAP3K10;PER1
10308,GO:0043116,0.587996975294386,0.801595075014289,1,7,negative regulation of vascular permeability,BP,PDE2A
6825,GO:0030295,0.588016903461748,0.582779727496042,6,52,protein kinase activator activity,MF,ERCC6;MAP2K1;DGKQ;SPRY2;MAP2K2;GAS6
15140,GO:0071285,0.588038600694517,0.801561358492537,1,7,cellular response to lithium ion,BP,NFATC4
10132,GO:0042726,0.588081758840699,0.801526396131224,1,7,flavin-containing compound metabolic process,BP,ACP5
11858,GO:0046886,0.588117902678432,0.801497112664154,1,7,positive regulation of hormone biosynthetic process,BP,EGR1
4920,GO:0014874,0.588178659276401,0.801447881171773,1,7,response to stimulus involved in regulation of muscle adaptation,BP,MTMR4
15596,GO:0072110,0.588180709620236,0.801446219612864,1,7,glomerular mesangial cell proliferation,BP,EGR1
15600,GO:0072124,0.588180709620236,0.801446219612864,1,7,regulation of glomerular mesangial cell proliferation,BP,EGR1
14720,GO:0070417,0.588236842710293,0.801400726558515,1,7,cellular response to cold,BP,EIF2AK4
817,GO:0002091,0.588369404636996,0.801293262214871,1,7,negative regulation of receptor internalization,BP,DLG4
7104,GO:0030913,0.588383809816389,0.801281581827135,1,7,paranodal junction assembly,BP,CD9
19681,GO:2000050,0.588443612023186,0.70035150275623,2,16,regulation of non-canonical Wnt signaling pathway,BP,CSNK1E;RNF213
7189,GO:0031087,0.588459314521405,0.801220351081663,1,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,PNRC1
566,GO:0001708,0.588494541878677,0.619653501807169,4,34,cell fate specification,BP,DUSP6;TENM4;FGFR1;FKBP8
8057,GO:0032736,0.588513790657539,0.801176165140649,1,7,positive regulation of interleukin-13 production,BP,PRKCZ
16116,GO:0090154,0.588517952684726,0.801172789007116,1,7,positive regulation of sphingolipid biosynthetic process,BP,PLA2G6
19808,GO:2000304,0.588517952684726,0.801172789007116,1,7,positive regulation of ceramide biosynthetic process,BP,PLA2G6
5831,GO:0017121,0.588619597398613,0.801090324568972,1,7,phospholipid scrambling,BP,ANO9
3487,GO:0007368,0.588677503089011,0.559662930473049,8,69,determination of left/right symmetry,BP,IFT140;ACVR2B;PKD2;VANGL2;PSKH1;NEK8;TGFBR2;IFT57
17061,GO:0099622,0.588785517423597,0.700025172585994,2,16,cardiac muscle cell membrane repolarization,BP,SCN4B;SNTA1
16299,GO:0090533,0.588852595961208,0.80090120042926,1,7,cation-transporting ATPase complex,CC,ATP12A
15630,GO:0072173,0.588882104830971,0.80087723901414,1,7,metanephric tubule morphogenesis,BP,PKD1
7726,GO:0032230,0.58890874224135,0.800855607476039,1,7,positive regulation of synaptic transmission, GABAergic,BP,NLGN2
9560,GO:0036376,0.588932353007555,0.800836432390413,1,7,sodium ion export across plasma membrane,BP,ATP12A
19517,GO:1990462,0.58912610118408,0.800679033227014,1,7,omegasome,CC,ULK1
2216,GO:0005114,0.589134859886419,0.800671915640782,1,7,type II transforming growth factor beta receptor binding,MF,TGFBR3
7307,GO:0031325,0.589148896298995,0.439642729432026,255,2175,positive regulation of cellular metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;NFATC4;FOS;GSN;CITED4;EGR1;PTK6;EDEM1;LRP1;TIMP2;VEGFA;NTSR1;EGFR;PRNP;NR1D1;ERCC1;FBLN1;DUSP5;RAPGEF3;TNFSF15;IGFBP4;CST3;MEF2D;NOS1;GPSM1;DDIT3;CRTC1;ERCC6;TCEA2;GRAMD4;SMARCA1;MST1R;TRIM65;ZFP36L1;NUPR1;ARAP1;HBEGF;CTF1;CNTN1;TFDP2;SLC27A1;MLYCD;ASH2L;EPM2A;ETV4;WWTR1;MAP2K1;PKN1;MC1R;SHC2;ITGA6;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;MAGEF1;ULK1;SHC1;VPS11;SPRY2;SOX12;CIRBP;CAPRIN2;PRKCZ;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;CEMIP;KDM3A;PHF1;SALL2;DLG3;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;TRIB2;EREG;TEF;TNFRSF25;NAB2;PLA2G6;CARF;LPAR3;C5;PPARA;PLGRKT;SESN2;IMPACT;PKD2;STAT6;KLF7;HMGA2;AREG;ACACB;MAPK3;CSPG4;BNIP3;THRA;VANGL2;IRF2BPL;MAPK12;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LRSAM1;LITAF;PTHLH;ATF4;ZFPM1;BBC3;PAK6;ZNF516;PKD1;FLOT1;MDK;JDP2;HDAC5;GTPBP1;IRF5;HERPUD1;SRSF5;VLDLR;DEAF1;NLRP1;PEG3;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;LRP5;CREBRF;PCSK9;PKIB;METTL23;HLTF;TGFBR2;TRPV4;CSRNP3;ITGA1;TMSB4X;APLN;TRIB3;DAP;CALCOCO1;PEMT;CDK5RAP3;NOS3;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;FYCO1;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;MGMT;AKT1;CARD11;CDKN1C;CHEK2;IFT57;ASS1;PHF2;FGFR4;PIAS3;WDFY2;C9ORF72;IFI27;INSR;NCOA7;FOXO4;RPS6KA5;TPCN1;C6ORF89;MAP2K5;BRAF;EDA2R;PIDD1;MAPK10;HFE;TP73;SNX33;TFEB;CSNK1E;TAZ;BCL6;HSF4;FYN;ZC3H12D;SIRT2;GDF15;GOLGA2;POU2F2;PLXND1;MTA1;ADIRF;AVPI1;CIDEB;VAV3;EPAS1;LAMTOR2;MAP3K10;CHD6;EPHB2;PER1;ITGA2;FGFR1;WFS1;ERBB2;EIF2AK4;UNC119;HMBOX1;CREB3L4;KCTD13;DBP;ZNF287;CAMKK1;IKBKB;HIP1;TEAD2;SIX5
14060,GO:0060911,0.589205674343028,0.800614362997504,1,7,cardiac cell fate commitment,BP,TENM4
9043,GO:0035280,0.589309163068681,0.800530233810165,1,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,AGO4
6670,GO:0030038,0.589342782776401,0.558976322725997,8,69,contractile actin filament bundle assembly,BP,RAPGEF3;ARAP1;PAK1;ITGB5;EPHA1;ASAP3;BRAF;KCTD13
10330,GO:0043149,0.589342782776401,0.558976322725997,8,69,stress fiber assembly,BP,RAPGEF3;ARAP1;PAK1;ITGB5;EPHA1;ASAP3;BRAF;KCTD13
1145,GO:0002741,0.589380548825978,0.800472187325123,1,7,positive regulation of cytokine secretion involved in immune response,BP,MAPK3
19837,GO:2000345,0.589414487052523,0.800444586623996,1,7,regulation of hepatocyte proliferation,BP,SULF2
1104,GO:0002693,0.58961974013721,0.800277603688287,1,7,positive regulation of cellular extravasation,BP,PTAFR
4554,GO:0010640,0.589656708324794,0.699192673739763,2,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,LRP1;HIP1
13997,GO:0060746,0.589680062759557,0.800228509431592,1,7,parental behavior,BP,CREBRF
13976,GO:0060717,0.589969518911653,0.799992812114253,1,7,chorion development,BP,HTRA1
4273,GO:0009642,0.590034135497408,0.799940169199311,1,7,response to light intensity,BP,CAT
14044,GO:0060850,0.590034786328623,0.799939638916885,1,7,regulation of transcription involved in cell fate commitment,BP,CEBPB
14096,GO:0060982,0.590059500499704,0.799919501706517,1,7,coronary artery morphogenesis,BP,VEGFA
7508,GO:0031702,0.590075972785568,0.799906079213716,1,7,type 1 angiotensin receptor binding,MF,ARAP1
2283,GO:0005242,0.590078804512205,0.799903771706249,1,7,inward rectifier potassium channel activity,MF,KCNJ15
7,GO:0000014,0.590114138018042,0.799874977675636,1,7,single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
10061,GO:0042577,0.590118914198924,0.799871085237579,1,7,lipid phosphatase activity,MF,PLPP6
18059,GO:1902692,0.590126411976798,0.698743237685812,2,16,regulation of neuroblast proliferation,BP,VEGFA;KCTD11
3430,GO:0007221,0.590134885998487,0.698735125495968,2,16,positive regulation of transcription of Notch receptor target,BP,MAML3;PLXND1
4903,GO:0014841,0.590162082925901,0.799835901603554,1,7,skeletal muscle satellite cell proliferation,BP,SIX5
4904,GO:0014842,0.590162082925901,0.799835901603554,1,7,regulation of skeletal muscle satellite cell proliferation,BP,SIX5
4914,GO:0014856,0.590162082925901,0.799835901603554,1,7,skeletal muscle cell proliferation,BP,SIX5
4915,GO:0014857,0.590162082925901,0.799835901603554,1,7,regulation of skeletal muscle cell proliferation,BP,SIX5
8339,GO:0033210,0.590196474553097,0.799807868366148,1,7,leptin-mediated signaling pathway,BP,BBS2
12838,GO:0051182,0.590201188119406,0.799804026033836,1,7,coenzyme transport,BP,SLC25A42
4349,GO:0009931,0.590253462213344,0.799761410506761,1,7,calcium-dependent protein serine/threonine kinase activity,MF,MKNK2
12959,GO:0051386,0.590258834799892,0.799757030233728,1,7,regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
19861,GO:2000380,0.590303586055331,0.799720541839286,1,7,regulation of mesoderm development,BP,FGFR1
14812,GO:0070577,0.590401222128193,0.69848009258555,2,16,lysine-acetylated histone binding,MF,ZMYND8;BRD3
17256,GO:0140033,0.590401222128193,0.69848009258555,2,16,acetylation-dependent protein binding,MF,ZMYND8;BRD3
18384,GO:1903441,0.590406106198208,0.799636933046195,1,7,protein localization to ciliary membrane,BP,BBS2
1987,GO:0004711,0.590414562232902,0.799630035734727,1,7,ribosomal protein S6 kinase activity,MF,RPS6KA2
2280,GO:0005231,0.590441462877924,0.799608092633743,1,7,excitatory extracellular ligand-gated ion channel activity,MF,TRPV1
15370,GO:0071649,0.59046480801959,0.799589048391258,1,7,regulation of chemokine (C-C motif) ligand 5 production,BP,TRPV4
18809,GO:1904429,0.590508935695346,0.799553046865371,1,7,regulation of t-circle formation,BP,ERCC1
6908,GO:0030507,0.59051412453123,0.698371941323386,2,16,spectrin binding,MF,ANK3;DMTN
11471,GO:0045955,0.590555029799012,0.799515436089113,1,7,negative regulation of calcium ion-dependent exocytosis,BP,BRAF
7793,GO:0032351,0.590595515057408,0.799482397716252,1,7,negative regulation of hormone metabolic process,BP,CYP27B1
7795,GO:0032353,0.590595515057408,0.799482397716252,1,7,negative regulation of hormone biosynthetic process,BP,CYP27B1
2301,GO:0005283,0.590597291782459,0.799480947713776,1,7,amino acid:sodium symporter activity,MF,SLC6A9
427,GO:0001135,0.590633279492786,0.799451576182309,1,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,DMTF1
2547,GO:0005816,0.590640424518678,0.799445744371128,1,7,spindle pole body,CC,TUBGCP6
5044,GO:0015232,0.590644568985198,0.799442361578124,1,7,heme transporter activity,MF,SLC48A1
5252,GO:0015886,0.590644568985198,0.799442361578124,1,7,heme transport,BP,SLC48A1
19785,GO:2000271,0.590650763560131,0.799437305370277,1,7,positive regulation of fibroblast apoptotic process,BP,BTG1
18375,GO:1903431,0.590653747526571,0.799434869729775,1,7,positive regulation of cell maturation,BP,SIRT2
1433,GO:0003413,0.59067120238457,0.799420621908409,1,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,TGFBR2
8065,GO:0032754,0.590679874262125,0.799413543075565,1,7,positive regulation of interleukin-5 production,BP,PRKCZ
187,GO:0000405,0.590723622800939,0.799377828511558,1,7,bubble DNA binding,MF,XPC
3378,GO:0007158,0.590726961351382,0.799375102866677,1,7,neuron cell-cell adhesion,BP,NLGN2
13538,GO:0060027,0.590746220902818,0.799359378538144,1,7,convergent extension involved in gastrulation,BP,VANGL2
11381,GO:0045792,0.590749516491444,0.799356687788868,1,7,negative regulation of cell size,BP,AKT1
6702,GO:0030119,0.590772886508312,0.5959167002691,5,43,AP-type membrane coat adaptor complex,CC,EGFR;AP1G2;VPS39;AP2A2;HIP1
4090,GO:0009148,0.590806585377998,0.696958536629399,2,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,NME4;UCKL1
13709,GO:0060306,0.590809212758047,0.698089157299641,2,16,regulation of membrane repolarization,BP,SCN4B;SNTA1
12244,GO:0048557,0.590862427922264,0.799264483393766,1,7,embryonic digestive tract morphogenesis,BP,TCF7
10326,GO:0043140,0.590945359995778,0.799196741058043,1,7,ATP-dependent 3'-5' DNA helicase activity,MF,RECQL5
8574,GO:0034085,0.591046961500688,0.79911372644321,1,7,establishment of sister chromatid cohesion,BP,HDAC8
5272,GO:0015926,0.591062385706415,0.799101121779532,1,7,glucosidase activity,MF,GAA
17297,GO:0150011,0.591088968792526,0.79907939674516,1,7,regulation of neuron projection arborization,BP,DLG4
17298,GO:0150012,0.591088968792526,0.79907939674516,1,7,positive regulation of neuron projection arborization,BP,DLG4
8696,GO:0034350,0.591105839390012,0.799065608373641,1,7,regulation of glial cell apoptotic process,BP,GAS6
8697,GO:0034351,0.591105839390012,0.799065608373641,1,7,negative regulation of glial cell apoptotic process,BP,GAS6
733,GO:0001964,0.591120435893435,0.799053678076225,1,7,startle response,BP,SLITRK6
9094,GO:0035384,0.591252127448489,0.595425469097086,5,43,thioester biosynthetic process,BP,MLYCD;ACACB;ACSS2;CBR4;ACSS1
15348,GO:0071616,0.591252127448489,0.595425469097086,5,43,acyl-CoA biosynthetic process,BP,MLYCD;ACACB;ACSS2;CBR4;ACSS1
5069,GO:0015296,0.591287996437533,0.798916687879383,1,7,anion:cation symporter activity,MF,SLC12A7
17538,GO:1901160,0.591369706056476,0.798849861391498,1,7,primary amino compound metabolic process,BP,AZIN2
16306,GO:0090557,0.591371008180922,0.79884879631564,1,7,establishment of endothelial intestinal barrier,BP,PTPRS
17993,GO:1902514,0.591401194316573,0.798824104364779,1,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1
15752,GO:0072383,0.59162027278545,0.798644835307093,1,7,plus-end-directed vesicle transport along microtubule,BP,FYCO1
2588,GO:0005883,0.591634293054952,0.798633358807406,1,7,neurofilament,CC,SHANK2
7875,GO:0032451,0.591783914171851,0.616314059736591,4,34,demethylase activity,MF,KDM3A;KDM4C;KDM7A;PHF2
2440,GO:0005641,0.591986173562545,0.798345168169881,1,7,nuclear envelope lumen,CC,SORL1
1328,GO:0003183,0.591992375758721,0.798340085911267,1,7,mitral valve morphogenesis,BP,ZFPM1
6798,GO:0030252,0.592340059497607,0.798055036916767,1,7,growth hormone secretion,BP,LTBP4
19078,GO:1905037,0.592444696662069,0.540223726753157,10,87,autophagosome organization,BP,PACS2;ULK2;ATG16L2;ULK1;TBC1D14;LRSAM1;MAP1LC3A;WDR45;ATG2A;C9ORF72
4583,GO:0010692,0.592764087116641,0.797707006224617,1,7,regulation of alkaline phosphatase activity,BP,ITGA2
295,GO:0000800,0.592783188495489,0.797691318193364,1,7,lateral element,CC,REC8
2512,GO:0005766,0.593075888702978,0.519131113493173,14,123,primary lysosome,CC,PYGB;NAPRT;GAA;SYNGR1;CD68;BRI3;FUCA1;HEXB;HEXA;ARSA;MAN2B1;DPP7;TOM1;GALNS
10065,GO:0042582,0.593075888702978,0.519131113493173,14,123,azurophil granule,CC,PYGB;NAPRT;GAA;SYNGR1;CD68;BRI3;FUCA1;HEXB;HEXA;ARSA;MAN2B1;DPP7;TOM1;GALNS
15076,GO:0071141,0.593220586555173,0.797331842593742,1,7,SMAD protein complex,CC,HMGA2
4510,GO:0010565,0.593602556057517,0.518525360986638,14,124,regulation of cellular ketone metabolic process,BP,EGR1;TYSND1;NR1D1;MLYCD;DGKQ;PPARA;ACACB;MLXIPL;LONP2;TRIB3;ATP2B4;AKT1;FGFR4;ACADVL
13092,GO:0051653,0.593648610050188,0.61441429453635,4,34,spindle localization,BP,SPRY2;ARHGEF2;NDE1;SPIRE1
13742,GO:0060346,0.593880131917807,0.796788928350287,1,7,bone trabecula formation,BP,THBS3
15245,GO:0071450,0.593981820893883,0.693898011428607,2,17,cellular response to oxygen radical,BP,NOS3;CCS
15246,GO:0071451,0.593981820893883,0.693898011428607,2,17,cellular response to superoxide,BP,NOS3;CCS
18554,GO:1903827,0.59609165939983,0.465051524977386,48,415,regulation of cellular protein localization,BP,ZMYND8;GSN;EDEM1;LRP1;EGFR;PRNP;ANK3;RAPGEF3;B3GAT3;TFDP2;TMEM173;VPS11;TTBK2;PAK1;CEMIP;MICALL2;CEP250;NGFR;SESN2;SH3TC2;VAMP2;KCNAB2;DMTN;BBC3;SSH1;SORL1;CEP131;PDE2A;PEMT;CDK5RAP3;BNIP3L;GAS6;LZTS2;CROCC;CAMK1;AKT1;TSG101;LMNA;IFI27;HFE;TP73;SNX33;CSNK1E;FYN;HDAC8;EPHB2;ERBB2;OSCP1
13548,GO:0060041,0.596557276693403,0.543083015318543,9,78,retina development in camera-type eye,BP,IFT140;SDK2;RAB11FIP4;NPHP4;ACVR2B;LAMB2;LRP5;ATP2B4;SDHAF4
2571,GO:0005858,0.59669249592389,0.794462147889379,1,7,axonemal dynein complex,CC,DNAH1
17844,GO:1902106,0.596714270728077,0.573809956548131,6,52,negative regulation of leukocyte differentiation,BP,INPP5D;ZFPM1;JAK3;BCL6;ERBB2;HLA-G
12358,GO:0048771,0.597546169899437,0.528783063586804,11,96,tissue remodeling,BP,F2R;ACP5;EGFR;CST3;ACVR2B;CSPG4;INPP5D;LRP5;NOS3;BCR;EPAS1
14620,GO:0070231,0.598331759883335,0.609221794345674,4,35,T cell apoptotic process,BP,RAG1;AKT1;JAK3;ADA
6720,GO:0030139,0.599126100255619,0.486606092744022,24,210,endocytic vesicle,CC,DLG4;APOE;GSN;LRP1;EGFR;CLTCL1;CD9;HBEGF;RAB11FIP4;PLEKHG5;VPS11;CEMIP;ITGB5;DYSF;NOS3;WNT7A;RAB43;TCIRG1;WNT3;EHD3;RAB13;AP2A2;HLA-G;HIP1
18118,GO:1902883,0.599284252596998,0.608242807782123,4,35,negative regulation of response to oxidative stress,BP,MCTP1;ATF4;AKT1;NCOA7
6618,GO:0022853,0.599423196823224,0.608099892103085,4,35,active ion transmembrane transporter activity,MF,ATP7B;ATP2B4;TCIRG1;ATP12A
10091,GO:0042625,0.599423196823224,0.608099892103085,4,35,ATPase coupled ion transmembrane transporter activity,MF,ATP7B;ATP2B4;TCIRG1;ATP12A
5701,GO:0016835,0.599479204413653,0.5707253234924,6,53,carbon-oxygen lyase activity,MF,UROS;CBS;NEIL1;HMGA2;POLL;THNSL2
5403,GO:0016248,0.600104059361593,0.638185271552284,3,26,channel inhibitor activity,MF,WNK4;PCSK9;STX1A
12338,GO:0048738,0.60021112705451,0.508269587240912,15,126,cardiac muscle tissue development,BP,VEGFA;OBSL1;MYH11;PAK1;ZFPM1;TTN;TGFBR2;RXRA;LMNA;TENM4;TP73;TAZ;TGFBR3;FGFR1;TNNI1
5046,GO:0015238,0.600254108952649,0.557625764790436,7,61,drug transmembrane transporter activity,MF,TMEM44;SLC22A18;PQLC2;SLC6A9;SLC25A29;SLC38A2;SLC25A42
977,GO:0002431,0.600584199205119,0.557281619856497,7,61,Fc receptor mediated stimulatory signaling pathway,BP,WIPF1;PAK1;PLA2G6;MAPK3;PIK3R2;FYN;VAV3
3447,GO:0007260,0.601361279074736,0.584711289834635,5,44,tyrosine phosphorylation of STAT protein,BP,PTK6;CTF1;FGFR3;JAK3;FYN
16236,GO:0090322,0.602172087313862,0.68591495482738,2,17,regulation of superoxide metabolic process,BP,ACP5;EGFR
7371,GO:0031432,0.602531565860211,0.789569964385658,1,7,titin binding,MF,OBSCN
8816,GO:0034612,0.603358006946631,0.482131395658026,24,213,response to tumor necrosis factor,BP,TNFRSF6B;POSTN;RBCK1;ADAMTS7;TNFSF15;ADAMTS13;ZFP36L1;HYAL1;PCK2;SPPL2B;NGFR;TNFRSF25;MAPK3;ARHGEF2;ENDOG;TMSB4X;EDA;TRPV1;SHARPIN;GAS6;TNFRSF14;AKT1;EDA2R;IKBKB
1224,GO:0002902,0.603452976581069,0.684654811903367,2,17,regulation of B cell apoptotic process,BP,BCL6;ADA
1184,GO:0002831,0.603635510577732,0.522338928891122,11,97,regulation of response to biotic stimulus,BP,HTRA1;TMEM173;FAM3A;APOBEC3F;NLRX1;MAPK3;LRSAM1;MAPKBP1;TKFC;SIRT2;EIF2AK4
3711,GO:0008233,0.604131897861831,0.460081970614231,43,375,peptidase activity,MF,HTRA1;TYSND1;ADAM19;THSD4;ADAMTS7;NPEPL1;RNPEPL1;CLCA2;GGT1;ADAMTS13;MMP28;MMP1;PLAT;CTSF;PRSS3;PCSK1;PRSS8;CAPNS2;USP20;SPPL2B;BLMH;ADAMTSL1;CTSB;LTA4H;C1RL;PGPEP1;PRSS22;PAPLN;ACY1;RHBDF1;PCSK9;LONP2;RHBDF2;TADA3;CTSH;CAPN2;PLAU;ANKZF1;DPP7;JOSD2;RNPEP;MMP17;MMP19
12783,GO:0051101,0.604212083821446,0.527761686498819,10,89,regulation of DNA binding,BP,CTNNBIP1;DDIT3;MDFI;PPARA;HMGA2;TMSB4X;ZFP90;SIRT2;HDAC8;ITGA2
4059,GO:0009112,0.604230075073851,0.603138838946249,4,35,nucleobase metabolic process,BP,XDH;UCKL1;APRT;ADA
3268,GO:0006942,0.604347716558684,0.581604678015715,5,44,regulation of striated muscle contraction,BP,NOS1;GSTO1;GSTM2;EHD3;TNNI1
3032,GO:0006584,0.604485228510218,0.63372359020117,3,26,catecholamine metabolic process,BP,EPAS1;PNKD;SNCB
4286,GO:0009712,0.604485228510218,0.63372359020117,3,26,catechol-containing compound metabolic process,BP,EPAS1;PNKD;SNCB
2713,GO:0006091,0.604851240256156,0.460763240098778,41,365,generation of precursor metabolites and energy,BP,XDH;NFATC4;PYGB;D2HGDH;NR1D1;IDH2;PGM1;PHGDH;GAA;PYGL;DHTKD1;ALDH4A1;HMGCL;TXNRD3;DDIT4;AKR7A2;OGDHL;GLDC;NDUFA4L2;ETFB;PPARA;PPP1R3E;BNIP3;STK40;ACSS2;MLXIPL;SDHA;GALK1;ALDOC;SUCLG2;AKT1;ACADVL;INSR;ACSS1;TXNRD2;CAT;TAZ;PHLDA2;BLOC1S1;PFKL;SDHAF4
10887,GO:0044450,0.605540213026337,0.495927072034692,17,148,microtubule organizing center part,CC,SDCCAG8;CAPG;TUBG2;TTBK2;CEP250;WDR60;CCDC92;TUBE1;FBF1;FLOT1;CEP131;CROCC;MZT2B;MZT2A;TUBGCP6;SIRT2;SFI1
19743,GO:2000181,0.605582885296635,0.552055725388178,7,61,negative regulation of blood vessel morphogenesis,BP,XDH;ADGRB2;SPRY2;NGFR;HDAC5;FOXO4;MAP2K5
8308,GO:0033157,0.605591398487245,0.479886428857394,24,210,regulation of intracellular protein transport,BP,EDEM1;PRNP;ANK3;RAPGEF3;B3GAT3;TMEM173;VPS11;PAK1;CEMIP;MICALL2;SH3TC2;VAMP2;DMTN;SORL1;CEP131;PDE2A;PEMT;BNIP3L;GAS6;CAMK1;IFI27;FYN;ERBB2;OSCP1
1868,GO:0004536,0.605972612972168,0.55147683357272,7,62,deoxyribonuclease activity,MF,ERCC1;DNASE1L1;NEIL1;ENDOG;ISG20;DNASE2;ENDOV
13221,GO:0051920,0.606307005567431,0.783043519491648,1,8,peroxiredoxin activity,MF,PRDX5
14591,GO:0070181,0.606342421116781,0.783012892859783,1,8,small ribosomal subunit rRNA binding,MF,CIRBP
2717,GO:0006098,0.606601522940347,0.681543737710651,2,17,pentose-phosphate shunt,BP,H6PD;PGLS
3138,GO:0006734,0.60661222359467,0.631546281094813,3,26,NADH metabolic process,BP,PCK2;ALDOC;PFKL
9880,GO:0042177,0.606639688035267,0.519105706805044,11,98,negative regulation of protein catabolic process,BP,SERPINE2;TIMP2;EGFR;CST3;AZIN2;ATRAID;CDK5RAP3;TIMP1;HFE;FYN;SIRT2
3689,GO:0008198,0.606698633223001,0.681447476533586,2,17,ferrous iron binding,MF,ACP5;PHYH
8077,GO:0032770,0.607160632896544,0.680989264476611,2,17,positive regulation of monooxygenase activity,BP,APOE;AKT1
8962,GO:0035066,0.607392075704878,0.630746134765576,3,26,positive regulation of histone acetylation,BP,NOS1;MAPK3;RPS6KA5
10450,GO:0043330,0.607509146806704,0.630625931394618,3,26,response to exogenous dsRNA,BP,TMEM173;MAPK3;FLOT1
7553,GO:0031904,0.607735478020603,0.680418550208716,2,17,endosome lumen,CC,CTSB;CTSH
3421,GO:0007212,0.607961384025125,0.630161384116002,3,26,dopamine receptor signaling pathway,BP,ADCY6;GNAL;GPR21
3530,GO:0007519,0.607989346088962,0.52389681244246,10,88,skeletal muscle tissue development,BP,FOS;EGR1;MEF2D;MYH15;NUPR1;NEURL1;FLOT1;HMG20B;TAZ;LEMD2
903,GO:0002285,0.608075702189899,0.517682935806875,11,97,lymphocyte activation involved in immune response,BP,ERCC1;PRKCZ;STAT6;ZFPM1;DOCK11;LGALS1;JAK3;BCL6;ADA;MFNG;EIF2AK4
7051,GO:0030838,0.608714680912263,0.538506797097682,8,71,positive regulation of actin filament polymerization,BP,GSN;WIPF1;CDC42EP5;ARPIN;WHAMMP3;SPIRE1;C15ORF62;CORO1B
14657,GO:0070296,0.609148779759826,0.679012656349909,2,17,sarcoplasmic reticulum calcium ion transport,BP,GSTO1;GSTM2
12290,GO:0048662,0.609337242246269,0.628746017245621,3,26,negative regulation of smooth muscle cell proliferation,BP,CTNNBIP1;PDCD4;APLN
7055,GO:0030851,0.609352620383287,0.678809561250153,2,17,granulocyte differentiation,BP,INPP5D;ZFPM1
14251,GO:0061351,0.60954517190192,0.529372936641071,9,79,neural precursor cell proliferation,BP,GJC2;VEGFA;TRNP1;ARHGEF2;NDE1;WNT7A;SIRT2;FGFR1;KCTD11
2789,GO:0006228,0.609707355676046,0.780088634698102,1,8,UTP biosynthetic process,BP,NME4
11395,GO:0045823,0.610353763818888,0.677810895368092,2,17,positive regulation of heart contraction,BP,APLN;ADA
15800,GO:0072528,0.610438059309396,0.596302144668995,4,36,pyrimidine-containing compound biosynthetic process,BP,TK2;NME4;UCKL1;UPP1
959,GO:0002381,0.610556071208586,0.596559918472424,4,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,ERCC1;STAT6;BCL6;POU2F2
8200,GO:0032964,0.610990732065898,0.627040940258409,3,26,collagen biosynthetic process,BP,F2R;ERRFI1;ITGA2
7775,GO:0032309,0.611446307409966,0.676718806672614,2,17,icosanoid secretion,BP,NTSR1;PLA2G6
3220,GO:0006873,0.611457037980068,0.455606280712891,39,342,cellular ion homeostasis,BP,DLG4;F2R;APOE;NTSR1;PRNP;NOS1;DDIT3;CYBRD1;ITPR3;CEMIP;GSTO1;PLA2G6;LPAR3;PKD2;MAPK3;BNIP3;SV2A;PKD1;KCNMA1;HERPUD1;GSTM2;TMEM175;TRPV4;HEXB;TRPV1;ATP7B;ATP2B4;ITPR2;TCIRG1;TPCN1;LETMD1;HFE;ATP12A;SLC9A7;FYN;TRPC1;EDNRA;WFS1;SLC9A5
15215,GO:0071398,0.611921500931611,0.595132382863256,4,35,cellular response to fatty acid,BP,NFATC4;PTAFR;ADCY6;AKT1
12836,GO:0051180,0.611941722267786,0.676222823193739,2,17,vitamin transport,BP,SLC2A3;SLC35F3
9887,GO:0042220,0.612243378132212,0.625746220565554,3,26,response to cocaine,BP,HDAC5;DNMT3A;HOMER2
16071,GO:0090079,0.612540008988066,0.675623204212825,2,17,translation regulator activity, nucleic acid binding,MF,MIF4GD;PAIP2B
16380,GO:0097035,0.612627536053793,0.625348641667641,3,26,regulation of membrane lipid distribution,BP,ABCA7;ANO9;ATP8B2
573,GO:0001725,0.612707880211447,0.572847434148103,5,44,stress fiber,CC,MST1R;MICALL2;SHROOM4;VANGL2;CORO1B
16622,GO:0097517,0.612707880211447,0.572847434148103,5,44,contractile actin filament bundle,CC,MST1R;MICALL2;SHROOM4;VANGL2;CORO1B
20063,GO:2000757,0.612733440818319,0.675429190418103,2,17,negative regulation of peptidyl-lysine acetylation,BP,HINT2;HDAC8
11657,GO:0046460,0.612749815486055,0.625222039200986,3,26,neutral lipid biosynthetic process,BP,PCK2;PNPLA3;FITM2
11660,GO:0046463,0.612749815486055,0.625222039200986,3,26,acylglycerol biosynthetic process,BP,PCK2;PNPLA3;FITM2
6006,GO:0019058,0.612896074751773,0.464623087105406,29,255,viral life cycle,BP,TNIP1;APOE;GSN;EGFR;ADARB1;EFNB3;ATG16L2;APOBEC3C;APOBEC3F;HMGA2;ITGB5;PC;IFITM1;CTSB;MVB12B;CHMP1B;LRSAM1;ISG20;GAS6;RAB43;TNFRSF14;TSG101;TBC1D20;CHMP5;CHMP4C;ITGB6;LGALS1;ITGA2;EIF2AK4
3139,GO:0006735,0.613015640511847,0.675146009037422,2,17,NADH regeneration,BP,ALDOC;PFKL
14354,GO:0061621,0.613015640511847,0.675146009037422,2,17,canonical glycolysis,BP,ALDOC;PFKL
14395,GO:0061718,0.613015640511847,0.675146009037422,2,17,glucose catabolic process to pyruvate,BP,ALDOC;PFKL
6849,GO:0030326,0.613017176038981,0.518601444761585,10,88,embryonic limb morphogenesis,BP,IFT140;FBXW4;PBX2;MYH3;LRP5;WNT7A;ZNF358;WDR19;WNT3;FGFR1
8982,GO:0035113,0.613017176038981,0.518601444761585,10,88,embryonic appendage morphogenesis,BP,IFT140;FBXW4;PBX2;MYH3;LRP5;WNT7A;ZNF358;WDR19;WNT3;FGFR1
10263,GO:0043027,0.613274074960501,0.674886537415314,2,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,PRDX5;GAS6
1452,GO:0003690,0.613482846388645,0.437015976859613,70,603,double-stranded DNA binding,MF,ZC3H6;ZMYND8;NFATC4;XPC;FOS;H1F0;EGR1;EGFR;NR1D1;BAHCC1;MEF2D;DDIT3;TCFL5;TFDP2;MXI1;SOX13;ETV4;PHF21A;PBX2;SOX12;ELK3;KDM3A;FOXQ1;SALL2;ETV1;ETV5;HES2;CHD2;TEF;CARF;PPARA;SATB1;STAT6;KLF7;HMGA2;THRA;MLXIPL;TSPYL2;LITAF;ATF4;ZFPM1;ZNF516;JDP2;DEAF1;RFX2;CEBPB;CREBRF;HLTF;MXD3;BHLHE40;MLH3;RXRA;MBD1;TNRC18;CRY2;ZNF217;SMARCD2;TP73;MNT;TFEB;BCL6;HSF4;POU2F2;MTA1;MSH5;PER1;HMBOX1;CREB3L4;DBP;SIX5
5515,GO:0016486,0.613494977072282,0.674664643995036,2,17,peptide hormone processing,BP,PCSK1;ERO1B
11334,GO:0045687,0.614030360209564,0.623894739317807,3,26,positive regulation of glial cell differentiation,BP,SERPINE2;TENM4;TP73
4533,GO:0010611,0.61409420535917,0.592855322482844,4,35,regulation of cardiac muscle hypertrophy,BP,PAK1;ERRFI1;ATP2B4;LMNA
4877,GO:0014743,0.61409420535917,0.592855322482844,4,35,regulation of muscle hypertrophy,BP,PAK1;ERRFI1;ATP2B4;LMNA
12636,GO:0050864,0.614183660943142,0.532737860341455,8,71,regulation of B cell activation,BP,ZFP36L1;PKN1;STAT6;INPP5D;CARD11;BCL6;ADA;VAV3
8050,GO:0032728,0.614252298463667,0.623664422070882,3,26,positive regulation of interferon-beta production,BP,RNF135;FLOT1;IRF5
3007,GO:0006555,0.614784403308244,0.673367502067521,2,17,methionine metabolic process,BP,MTHFR;CTH
13496,GO:0055093,0.614792773868114,0.673359070645536,2,17,response to hyperoxia,BP,BNIP3;CAT
9329,GO:0035850,0.614985687568073,0.622902764908051,3,26,epithelial cell differentiation involved in kidney development,BP,ACTA2;WWTR1;LAMB2
720,GO:0001947,0.615212291701092,0.591680879077079,4,35,heart looping,BP,PKD2;VANGL2;TGFBR2;IFT57
4702,GO:0010869,0.615307697140402,0.672840135764171,2,17,regulation of receptor biosynthetic process,BP,NR1D1;PPARA
13042,GO:0051570,0.615400585857378,0.672746467282289,2,17,regulation of histone H3-K9 methylation,BP,KDM3A;KDM4C
1021,GO:0002521,0.615494401848043,0.456098028212208,34,297,leukocyte differentiation,BP,FOS;EGR1;CTNNBIP1;VEGFA;ZFP36L1;SOX13;FAM213A;PRKCZ;RAG1;SATB1;STAT6;FAM20C;INPP5D;LRRC8A;ZFPM1;DOCK11;POLM;HDAC5;CEBPB;TGFBR2;CMTM7;GAS6;CARD11;BRAF;LGALS1;JAK3;BCL6;ADA;POU2F2;TCF7;MFNG;SH3PXD2A;ERBB2;HLA-G
13666,GO:0060236,0.616259939994677,0.590578782755229,4,35,regulation of mitotic spindle organization,BP,CHMP1B;PKD1;CHMP5;CHMP4C
1477,GO:0003756,0.616345925771956,0.671792215272374,2,17,protein disulfide isomerase activity,MF,ERO1B;TMX4
5720,GO:0016864,0.616345925771956,0.671792215272374,2,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,ERO1B;TMX4
6056,GO:0019208,0.61662945154717,0.530148001576128,8,71,phosphatase regulator activity,MF,PPP1R35;B3GAT3;PHACTR3;PPP1R14A;PPP2R3B;ELFN2;PPP1R15A;SBF2
19735,GO:2000171,0.616713334964219,0.671420862077702,2,17,negative regulation of dendrite development,BP,PTPRS;NFATC4
10964,GO:0044773,0.616724719042889,0.50847908932007,11,98,mitotic DNA damage checkpoint,BP,XPC;BRSK1;RBL2;TFDP2;HMGA2;PCBP4;CDK5RAP3;CHEK2;FOXO4;PIDD1;TP73
10654,GO:0043902,0.617158959360323,0.486654066625564,16,143,positive regulation of multi-organism process,BP,APOE;ADARB1;ZP3;MAPK3;PC;MVB12B;LRSAM1;SMURF2;PTAFR;TSG101;TBC1D20;NELFCD;CHMP4C;PLB1;LGALS1;SIRT2
13673,GO:0060251,0.617336121827544,0.670790774845164,2,17,regulation of glial cell proliferation,BP,IDH2;ETV5
15608,GO:0072132,0.617387163931124,0.620402480323524,3,26,mesenchyme morphogenesis,BP,ACTA2;TGFBR2;FGFR1
14020,GO:0060795,0.617398563559572,0.670727558462467,2,17,cell fate commitment involved in formation of primary germ layer,BP,DUSP6;FGFR1
10833,GO:0044346,0.617489569683181,0.67063540937381,2,17,fibroblast apoptotic process,BP,BTG1;GAS6
14198,GO:0061178,0.61763142321309,0.588749628284696,4,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;PLA2G6;ANO1;LRP5
10570,GO:0043551,0.617637965666357,0.620140806405399,3,26,regulation of phosphatidylinositol 3-kinase activity,BP,FGFR3;PIK3R2;VAV3
11445,GO:0045920,0.618082108727917,0.670035023813657,2,17,negative regulation of exocytosis,BP,BCR;BRAF
2611,GO:0005921,0.618281164810936,0.669833174246087,2,17,gap junction,CC,GJC2;GJB4
13421,GO:0052866,0.61828588473844,0.61946431509391,3,26,phosphatidylinositol phosphate phosphatase activity,MF,MTMR4;INPP5D;INPP4A
825,GO:0002102,0.618380273948985,0.619365705051122,3,26,podosome,CC,GSN;ARHGEF2;SH3PXD2A
13460,GO:0055023,0.618507182843128,0.669603888222512,2,17,positive regulation of cardiac muscle tissue growth,BP,TGFBR3;FGFR1
18660,GO:1904037,0.61864152864925,0.669467551449509,2,17,positive regulation of epithelial cell apoptotic process,BP,GSN;PDCD4
2092,GO:0004859,0.618802355058662,0.772041052299725,1,8,phospholipase inhibitor activity,MF,SNCB
8195,GO:0032958,0.61890091848621,0.669204215244973,2,17,inositol phosphate biosynthetic process,BP,NTSR1;PTAFR
3882,GO:0008519,0.618993593813783,0.669110097262755,2,17,ammonium transmembrane transporter activity,MF,AZIN2;SLC25A29
10626,GO:0043653,0.619251826824381,0.771637835934163,1,8,mitochondrial fragmentation involved in apoptotic process,BP,BNIP3
12229,GO:0048525,0.619598305193009,0.526860541839849,8,72,negative regulation of viral process,BP,TNIP1;GSN;APOBEC3C;APOBEC3F;HMGA2;IFITM1;ISG20;EIF2AK4
6914,GO:0030514,0.619723525275178,0.617960774976446,3,26,negative regulation of BMP signaling pathway,BP,HTRA1;SMURF2;LEMD2
5067,GO:0015294,0.619901000265489,0.549248704766865,6,53,solute:cation symporter activity,MF,SLC2A9;SLC12A7;MFSD3;SLC6A9;SLC6A6;SLC10A6
6338,GO:0021517,0.61994897657665,0.668138838136856,2,17,ventral spinal cord development,BP,TCTN1;VLDLR
3278,GO:0006959,0.620266961970301,0.517376568742832,9,85,humoral immune response,BP,PRSS3;SERPING1;FAM3A;ZP3;PLA2G6;C5;C1RL;TFEB;POU2F2
5293,GO:0015985,0.620281568011136,0.770712090147709,1,8,energy coupled proton transport, down electrochemical gradient,BP,TCIRG1
5294,GO:0015986,0.620281568011136,0.770712090147709,1,8,ATP synthesis coupled proton transport,BP,TCIRG1
8181,GO:0032930,0.620376716986858,0.77062641138192,1,8,positive regulation of superoxide anion generation,BP,EGFR
736,GO:0001968,0.620439414411779,0.667639538368027,2,17,fibronectin binding,MF,VEGFA;FBLN1
12789,GO:0051117,0.620652172401339,0.548239760693448,6,54,ATPase binding,MF,PKD2;SNTA1;BBC3;TCIRG1;WFS1;SYVN1
3587,GO:0008013,0.621490373506281,0.535071864311054,7,62,beta-catenin binding,MF,CTNNBIP1;ASH2L;PTPRU;CALCOCO1;SLC9A3R2;FOXO4;TCF7
15296,GO:0071539,0.621581218935641,0.616012805586779,3,26,protein localization to centrosome,BP,CEP250;NUDCD3;CEP131
10571,GO:0043552,0.621599492285849,0.66645657232306,2,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,FGFR3;VAV3
11504,GO:0046039,0.621763707978775,0.615230798471533,3,27,GTP metabolic process,BP,NME4;GTPBP1;MOCOS
5781,GO:0017015,0.621788405203216,0.516295312392482,9,80,regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP4;LTBP1;MTMR4;TGFBR2;SMURF2;CDKN1C;CIDEA;TGFBR3
2855,GO:0006348,0.621790298137807,0.769350746680956,1,8,chromatin silencing at telomere,BP,SIRT2
8321,GO:0033179,0.62205168522167,0.769114290667997,1,8,proton-transporting V-type ATPase, V0 domain,CC,TCIRG1
14877,GO:0070723,0.622159188312942,0.665884863614142,2,17,response to cholesterol,BP,ABCA2;TGFBR2
631,GO:0001821,0.622533192384068,0.768678241889413,1,8,histamine secretion,BP,ADA
14631,GO:0070254,0.622534154842644,0.768677369687599,1,8,mucus secretion,BP,ADA
6764,GO:0030206,0.622596428400711,0.665437799122236,2,17,chondroitin sulfate biosynthetic process,BP,CSPG4;XYLT2
4373,GO:0010008,0.622622359804234,0.441611520794875,42,368,endosome membrane,CC,EGFR;NDRG1;RAB11FIP4;ABCA2;VPS11;CD68;APPL2;ABCA7;SPPL2B;MTMR4;AP1G2;MVB12B;PI4K2A;CHMP1B;PRAF2;SLC48A1;LITAF;SORL1;TMEM175;PCSK9;MARCH2;VPS39;TMEM9;STEAP2;ZFYVE21;TSG101;TCIRG1;STEAP3;CHMP5;INSR;CHMP4C;TPCN1;SNX17;SLC9A7;EHD3;SNX1;UBXN6;RAB13;AP2A2;LAMTOR2;ERBB2;HLA-G
793,GO:0002063,0.623110172762289,0.66491201766899,2,17,chondrocyte development,BP,SULF2;TGFBR2
10957,GO:0044754,0.623858696568975,0.767474738354022,1,8,autolysosome,CC,MAP1LC3A
7925,GO:0032511,0.624585828956866,0.766812571409212,1,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,TMEM50B
16968,GO:0099078,0.625193156633906,0.766258437866379,1,8,BORC complex,CC,BLOC1S1
4185,GO:0009266,0.625713585002698,0.466778911302999,20,177,response to temperature stimulus,BP,FOS;NTSR1;NOS1;SLC27A1;CIRBP;ANO1;ACOT11;LRP11;MAPK3;THRA;ZNF516;TRPV4;NOS3;TRPV1;AKT1;IGFBP7;ACADVL;MYOF;HSF4;EIF2AK4
6017,GO:0019079,0.625880447129981,0.498670786351565,11,99,viral genome replication,BP,TNIP1;ADARB1;ATG16L2;APOBEC3C;APOBEC3F;HMGA2;IFITM1;ISG20;GAS6;TBC1D20;EIF2AK4
1049,GO:0002577,0.625946377098336,0.765569837375399,1,8,regulation of antigen processing and presentation,BP,HFE
16980,GO:0099106,0.625979240693458,0.542550613429448,6,54,ion channel regulator activity,MF,PRKCZ;KCNAB2;WNK4;PCSK9;PIAS3;STX1A
12085,GO:0048146,0.62610087631652,0.579760981502955,4,36,positive regulation of fibroblast proliferation,BP,S100A6;EGFR;EREG;GAS6
14772,GO:0070513,0.626465610188782,0.76509427648729,1,8,death domain binding,MF,DAP
6257,GO:0019855,0.626539824636514,0.765026245831862,1,8,calcium channel inhibitor activity,MF,STX1A
15392,GO:0071682,0.626826240904408,0.764763557827933,1,8,endocytic vesicle lumen,CC,APOE
2578,GO:0005869,0.626896280990597,0.764699287137705,1,8,dynactin complex,CC,ACTR1B
1854,GO:0004520,0.626933363291803,0.557460647378836,5,45,endodeoxyribonuclease activity,MF,ERCC1;DNASE1L1;NEIL1;DNASE2;ENDOV
16614,GO:0097502,0.626985277507854,0.609718758118372,3,27,mannosylation,BP,B4GAT1;PIGZ;PIGV
12518,GO:0050688,0.62784980979824,0.540544794830408,6,54,regulation of defense response to virus,BP,HTRA1;TMEM173;APOBEC3F;NLRX1;TKFC;EIF2AK4
10625,GO:0043652,0.628704850360013,0.763035180294852,1,8,engulfment of apoptotic cell,BP,ABCA7
19917,GO:2000484,0.628912993074812,0.7628431044173,1,8,positive regulation of interleukin-8 secretion,BP,F2R
5717,GO:0016861,0.62932263352527,0.762464746918809,1,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,MPI
12538,GO:0050711,0.629607730002393,0.762201157749175,1,8,negative regulation of interleukin-1 secretion,BP,GAS6
9807,GO:0042033,0.629682320514722,0.762132158376716,1,8,chemokine biosynthetic process,BP,EGR1
12560,GO:0050755,0.629682320514722,0.762132158376716,1,8,chemokine metabolic process,BP,EGR1
18446,GO:1903573,0.629965927626924,0.575623961482081,4,36,negative regulation of response to endoplasmic reticulum stress,BP,HERPUD1;PPP1R15A;WFS1;SYVN1
18509,GO:1903726,0.630013300388926,0.761825808419817,1,8,negative regulation of phospholipid metabolic process,BP,SLC27A1
8137,GO:0032874,0.630339384834071,0.488681583743613,12,107,positive regulation of stress-activated MAPK cascade,BP,XDH;VEGFA;ERCC6;PKN1;PAK1;VANGL2;TRPV4;MINK1;WNT7A;ERN1;EDA2R;MAP3K10
17560,GO:1901223,0.630428681515431,0.761440922799657,1,8,negative regulation of NIK/NF-kappaB signaling,BP,TMSB4X
10559,GO:0043539,0.630483792778082,0.605999806507564,3,27,protein serine/threonine kinase activator activity,MF,MAP2K1;SPRY2;MAP2K2
2930,GO:0006450,0.6304938424952,0.656219348013656,2,18,regulation of translational fidelity,BP,AARS;DTD1
11018,GO:0045008,0.630550015142932,0.761328409689356,1,8,depyrimidination,BP,NEIL1
6744,GO:0030173,0.630608592440789,0.574933928648344,4,36,integral component of Golgi membrane,CC,B4GAT1;STEAP2;TBC1D20;MFNG
3255,GO:0006924,0.630773888862736,0.761120707123133,1,8,activation-induced cell death of T cells,BP,AKT1
14848,GO:0070652,0.630789324039154,0.76110638192507,1,8,HAUS complex,CC,HAUS4
7570,GO:0031943,0.631058269181572,0.760856674562375,1,8,regulation of glucocorticoid metabolic process,BP,DGKQ
9412,GO:0035994,0.631101745435578,0.662794859020334,2,13,response to muscle stretch,BP,FOS;TTN
4071,GO:0009128,0.631394022728979,0.76054466489998,1,8,purine nucleoside monophosphate catabolic process,BP,NT5E
4100,GO:0009158,0.631394022728979,0.76054466489998,1,8,ribonucleoside monophosphate catabolic process,BP,NT5E
4110,GO:0009169,0.631394022728979,0.76054466489998,1,8,purine ribonucleoside monophosphate catabolic process,BP,NT5E
10034,GO:0042533,0.63140571360518,0.760533795320907,1,8,tumor necrosis factor biosynthetic process,BP,ERRFI1
10035,GO:0042534,0.63140571360518,0.760533795320907,1,8,regulation of tumor necrosis factor biosynthetic process,BP,ERRFI1
16946,GO:0098993,0.631430999909045,0.760510284152809,1,8,anchored component of synaptic vesicle membrane,CC,RAB3B
9415,GO:0035999,0.631535629107584,0.760412981794794,1,8,tetrahydrofolate interconversion,BP,MTHFR
6701,GO:0030118,0.631836210975872,0.55219025460237,5,45,clathrin coat,CC,EGFR;CLTCL1;AP1G2;AP2A2;HIP1
12556,GO:0050746,0.631934997649114,0.760041308887514,1,8,regulation of lipoprotein metabolic process,BP,PEMT
1008,GO:0002483,0.632321431799446,0.759681264415859,1,8,antigen processing and presentation of endogenous peptide antigen,BP,HFE
9284,GO:0035743,0.632371002034379,0.759635050209831,1,8,CD4-positive, alpha-beta T cell cytokine production,BP,PRKCZ
10604,GO:0043618,0.632420175074878,0.491516911042572,11,101,regulation of transcription from RNA polymerase II promoter in response to stress,BP,EGR1;VEGFA;DDIT3;SESN2;IMPACT;ATF4;CEBPB;HSF4;SIRT2;EPAS1;CHD6
14861,GO:0070673,0.632632809391803,0.759390857904868,1,8,response to interleukin-18,BP,AKT1
3292,GO:0006987,0.632824991760012,0.75921148829358,1,8,activation of signaling protein activity involved in unfolded protein response,BP,ERN1
12136,GO:0048265,0.633066725397153,0.75898572932194,1,8,response to pain,BP,TRPV1
13743,GO:0060347,0.633216553721805,0.758845722932742,1,8,heart trabecula formation,BP,TGFBR3
17310,GO:1900016,0.633280487775829,0.758785961572845,1,8,negative regulation of cytokine production involved in inflammatory response,BP,PDCD4
4859,GO:0014706,0.633537751411009,0.448934447416417,25,216,striated muscle tissue development,BP,FOS;EGR1;VEGFA;MEF2D;MYH15;NUPR1;OBSL1;MYH11;PAK1;NEURL1;ZFPM1;FLOT1;TTN;TGFBR2;HMG20B;RXRA;LMNA;TENM4;TP73;TAZ;LEMD2;SIRT2;TGFBR3;FGFR1;TNNI1
13674,GO:0060252,0.633581812144433,0.758504154435453,1,8,positive regulation of glial cell proliferation,BP,ETV5
12992,GO:0051451,0.633690170412917,0.758402754613591,1,8,myoblast migration,BP,NET1
11375,GO:0045778,0.633739161915838,0.534201894997984,6,54,positive regulation of ossification,BP,CTNNBIP1;ACVR2B;IFITM1;FAM20C;CEBPB;ATRAID
11302,GO:0045646,0.633799841980643,0.571498357358583,4,36,regulation of erythrocyte differentiation,BP,FAM210B;ZFP36L1;INPP5D;ZFPM1
7824,GO:0032386,0.633847534056312,0.434885467210971,36,317,regulation of intracellular transport,BP,EDEM1;PRNP;ANK3;RAPGEF3;B3GAT3;REEP2;MAP2K1;ABCA2;TMEM173;VPS11;PAK1;CEMIP;MICALL2;SH3TC2;VAMP2;SEPT5;MAPK3;MAP2K2;DMTN;REEP6;SORL1;PCSK9;CEP131;PDE2A;PEMT;BNIP3L;GAS6;CAMK1;RIMS3;TBC1D20;IFI27;BRAF;FYN;STX1A;ERBB2;OSCP1
13557,GO:0060050,0.633916832065611,0.758190545665725,1,8,positive regulation of protein glycosylation,BP,GOLGA2
9315,GO:0035809,0.633978795435167,0.758132509058497,1,8,regulation of urine volume,BP,ADCY6
20064,GO:2000758,0.634041061689188,0.602196979382232,3,27,positive regulation of peptidyl-lysine acetylation,BP,NOS1;MAPK3;RPS6KA5
2331,GO:0005347,0.634179980396748,0.757944001890808,1,8,ATP transmembrane transporter activity,MF,SLC25A42
9995,GO:0042438,0.634541990595742,0.757604527448307,1,8,melanin biosynthetic process,BP,TRPC1
2395,GO:0005540,0.634591961357791,0.757557639511202,1,8,hyaluronic acid binding,MF,CEMIP
8484,GO:0033673,0.634701126499293,0.449246323723329,24,213,negative regulation of kinase activity,BP,DUSP6;APOE;PTK6;PDCD4;DUSP5;ADARB1;WWTR1;PKN1;SPRY2;SPRY4;TRIB2;ERRFI1;RGS14;SORL1;LRP5;PKIB;TRIB3;CDK5RAP3;EPHA1;AKT1;CDKN1C;TSG101;TP73;EPHB2
8094,GO:0032790,0.63477295682001,0.757387753353351,1,8,ribosome disassembly,BP,EIF2D
2996,GO:0006544,0.63491601359016,0.757253414271255,1,8,glycine metabolic process,BP,GLDC
740,GO:0001972,0.635020473119556,0.757155285225047,1,8,retinoic acid binding,MF,RXRA
5497,GO:0016445,0.635096064394821,0.548668281507857,5,45,somatic diversification of immunoglobulins,BP,ERCC1;STAT6;POLM;POLL;BCL6
12076,GO:0048096,0.635129816010848,0.75705253697293,1,8,chromatin-mediated maintenance of transcription,BP,PABPC1L
1043,GO:0002562,0.635182239415307,0.548574984062861,5,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,ERCC1;RAG1;STAT6;BCL6;TCF7
5496,GO:0016444,0.635182239415307,0.548574984062861,5,45,somatic cell DNA recombination,BP,ERCC1;RAG1;STAT6;BCL6;TCF7
11303,GO:0045647,0.63522767462075,0.756960552790052,1,8,negative regulation of erythrocyte differentiation,BP,ZFP36L1
13088,GO:0051648,0.635244017876494,0.452399740384532,22,195,vesicle localization,BP,BBS2;SYTL1;SNPH;DNM1;SYT8;BLOC1S4;NLGN2;PRKCZ;SPG11;TRAPPC9;VAMP2;AREG;SEPT5;PCLO;NDE1;FYCO1;RIMS3;TBC1D20;BRAF;GOLGA2;STX1A;BLOC1S1
5857,GO:0017162,0.635252480925979,0.756937231461297,1,8,aryl hydrocarbon receptor binding,MF,AIP
14228,GO:0061307,0.635268696062253,0.756921986104326,1,8,cardiac neural crest cell differentiation involved in heart development,BP,MAPK3
14229,GO:0061308,0.635268696062253,0.756921986104326,1,8,cardiac neural crest cell development involved in heart development,BP,MAPK3
4659,GO:0010812,0.63546277175163,0.54827119644597,5,45,negative regulation of cell-substrate adhesion,BP,POSTN;FBLN1;DMTN;LGALS1;BCL6
13808,GO:0060433,0.635608820414583,0.756602038615205,1,8,bronchus development,BP,TGFBR2
15407,GO:0071706,0.635731374297524,0.509438209514258,8,73,tumor necrosis factor superfamily cytokine production,BP,NFATC4;ACP5;MC1R;ERRFI1;ARHGEF2;GAS6;PTAFR;CIDEA
6834,GO:0030307,0.635737445661405,0.478159621902216,13,117,positive regulation of cell growth,BP,VEGFA;EGFR;DNPH1;HBEGF;HYAL1;PAK1;LPAR3;SEMA5A;TWF2;AKT1;WNT3;MAP2K5;ERBB2
13687,GO:0060272,0.635776830320584,0.75644387912987,1,8,embryonic skeletal joint morphogenesis,BP,HYAL1
19041,GO:1904949,0.635777905647352,0.501191047869643,9,81,ATPase complex,CC,SMARCA1;ABCA2;APPL2;ABCA7;SALL2;INO80C;CHD3;SMARCD2;ATP12A
15239,GO:0071439,0.635808273788862,0.756414270646559,1,8,clathrin complex,CC,CLTCL1
6319,GO:0019992,0.635905730101848,0.756322484587446,1,8,diacylglycerol binding,MF,PLTP
4814,GO:0014013,0.635970036951478,0.519356018583917,7,63,regulation of gliogenesis,BP,SERPINE2;GJC2;IDH2;ETV5;TENM4;TP73;SIRT2
17716,GO:1901679,0.636099386304439,0.756140018921136,1,8,nucleotide transmembrane transport,BP,SLC25A42
6557,GO:0022010,0.636115588794879,0.756124748063933,1,8,central nervous system myelination,BP,TENM4
7762,GO:0032291,0.636115588794879,0.756124748063933,1,8,axon ensheathment in central nervous system,BP,TENM4
10816,GO:0044327,0.636287947033883,0.755962255965318,1,8,dendritic spine head,CC,DNM1
13454,GO:0055015,0.636463104305107,0.755797041971519,1,8,ventricular cardiac muscle cell development,BP,LMNA
6325,GO:0020027,0.636469777127605,0.755790746292543,1,8,hemoglobin metabolic process,BP,CAT
14817,GO:0070586,0.636477449211515,0.755783507679828,1,8,cell-cell adhesion involved in gastrulation,BP,MAP2K5
16173,GO:0090232,0.636576956057697,0.755689608385931,1,8,positive regulation of spindle checkpoint,BP,NDRG1
16362,GO:0097001,0.636650574756074,0.75562012094108,1,8,ceramide binding,MF,PLTP
3024,GO:0006573,0.636775163534264,0.755502489953193,1,8,valine metabolic process,BP,HIBADH
16137,GO:0090184,0.636794304459929,0.599238751529473,3,27,positive regulation of kidney development,BP,EGR1;VEGFA;WNT2B
4549,GO:0010635,0.636826122187303,0.75545436491083,1,8,regulation of mitochondrial fusion,BP,BNIP3
2812,GO:0006275,0.636847269180553,0.486923902702009,11,99,regulation of DNA replication,BP,EGFR;CST3;SHC1;EREG;AREG;TSPYL2;CHEK2;INSR;BCL6;FGFR1;KCTD13
750,GO:0001991,0.636972189789972,0.755316380202509,1,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,F2R
16136,GO:0090183,0.637023849010413,0.568012052628368,4,36,regulation of kidney development,BP,EGR1;VEGFA;WWTR1;WNT2B
20253,GO:2001256,0.637084134700397,0.755210590442238,1,8,regulation of store-operated calcium entry,BP,HOMER2
9535,GO:0036310,0.637098415547352,0.755197092343147,1,8,annealing helicase activity,MF,SMARCA1
16245,GO:0090335,0.637175412823514,0.755124305749574,1,8,regulation of brown fat cell differentiation,BP,TRPV4
13869,GO:0060537,0.637242635615353,0.443414475000341,26,225,muscle tissue development,BP,FOS;EGR1;VEGFA;MEF2D;MYH15;NUPR1;OBSL1;MYH11;PAK1;NEURL1;PKD2;ZFPM1;FLOT1;TTN;TGFBR2;HMG20B;RXRA;LMNA;TENM4;TP73;TAZ;LEMD2;SIRT2;TGFBR3;FGFR1;TNNI1
9960,GO:0042364,0.637299463787482,0.755007004514019,1,8,water-soluble vitamin biosynthetic process,BP,PSAT1
8882,GO:0034713,0.637301887188438,0.755004712553002,1,8,type I transforming growth factor beta receptor binding,MF,TGFBR2
1490,GO:0003831,0.63739229348406,0.754919198200843,1,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT2
8303,GO:0033148,0.637398638109175,0.754913196047374,1,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,PAK1
1305,GO:0003151,0.637426631116446,0.546141574589488,5,45,outflow tract morphogenesis,BP,VEGFA;ZFPM1;TGFBR2;PLXND1;TGFBR3
17651,GO:1901550,0.637606980208069,0.7547160385915,1,8,regulation of endothelial cell development,BP,IKBKB
18243,GO:1903140,0.637606980208069,0.7547160385915,1,8,regulation of establishment of endothelial barrier,BP,IKBKB
433,GO:0001162,0.637719139318549,0.754609851369999,1,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6
8609,GO:0034139,0.637738497494012,0.754591520426558,1,8,regulation of toll-like receptor 3 signaling pathway,BP,FLOT1
2222,GO:0005126,0.637754789382448,0.468013135609427,15,137,cytokine receptor binding,MF,PGF;VEGFA;TNFSF15;CTF1;SHC1;VEGFB;C5;ECM1;TGFBR2;SMURF2;EDA;CKLF;PIDD1;GDF15;TGFBR3
17013,GO:0099516,0.637775847373477,0.567196626917535,4,36,ion antiporter activity,MF,SLC37A2;SLC9A7;SLC37A4;SLC9A5
2393,GO:0005537,0.637794079717755,0.754538881934363,1,8,mannose binding,MF,BSG
14479,GO:0062009,0.63789397264988,0.754444258206019,1,8,secondary palate development,BP,TSHZ1
11602,GO:0046325,0.637909032341999,0.754429990515834,1,8,negative regulation of glucose import,BP,GRB10
15344,GO:0071609,0.63809622304162,0.754252592384483,1,8,chemokine (C-C motif) ligand 5 production,BP,TRPV4
16388,GO:0097050,0.638120268941146,0.754229797434101,1,8,type B pancreatic cell apoptotic process,BP,WFS1
20020,GO:2000674,0.638120268941146,0.754229797434101,1,8,regulation of type B pancreatic cell apoptotic process,BP,WFS1
15802,GO:0072530,0.63813727238442,0.75421367761082,1,8,purine-containing compound transmembrane transport,BP,SLC25A42
4965,GO:0015078,0.638141028256718,0.506578690916959,8,75,proton transmembrane transporter activity,MF,SLC2A9;NDUFA4L2;SLC22A18;MFSD3;TCIRG1;ATP12A;SLC9A7;SLC9A5
19486,GO:1990403,0.638179714773299,0.75417343736448,1,8,embryonic brain development,BP,IFT140
10709,GO:0044065,0.638189491366179,0.754164167334038,1,8,regulation of respiratory system process,BP,NLGN2
7103,GO:0030911,0.638190352719754,0.754163350598101,1,8,TPR domain binding,MF,PDE2A
18162,GO:1902959,0.638251102676414,0.754105742297475,1,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
19151,GO:1905245,0.638251102676414,0.754105742297475,1,8,regulation of aspartic-type peptidase activity,BP,SORL1
14108,GO:0061000,0.638302678131126,0.754056826088897,1,8,negative regulation of dendritic spine development,BP,PTPRS
19844,GO:2000353,0.638349078153241,0.754012812220995,1,8,positive regulation of endothelial cell apoptotic process,BP,PDCD4
705,GO:0001931,0.638392505773469,0.753971612537809,1,8,uropod,CC,FLOT1
7265,GO:0031254,0.638392505773469,0.753971612537809,1,8,cell trailing edge,CC,FLOT1
10788,GO:0044291,0.638436697845242,0.545044227262919,5,45,cell-cell contact zone,CC,ANK3;SCN4B;OBSL1;PAK1;FLOT1
19042,GO:1904950,0.638444641685009,0.479845508032653,12,109,negative regulation of establishment of protein localization,BP,F2R;HADH;IDH2;DMTN;RHBDF1;TMSB4X;PDE2A;RHBDF2;GAS6;MAPKBP1;CIDEA;PFKL
2333,GO:0005351,0.638622365876942,0.753753458467138,1,8,carbohydrate:proton symporter activity,MF,SLC2A9
9714,GO:0038179,0.638667640199618,0.597218451624903,3,27,neurotrophin signaling pathway,BP,DDIT4;SPRY2;NGFR
5891,GO:0018095,0.638688087903347,0.753691056746318,1,8,protein polyglutamylation,BP,TTLL11
12656,GO:0050891,0.638735205541999,0.544719661513323,5,45,multicellular organismal water homeostasis,BP,AQP3;TRPV4;ADCY6;SCNN1A;WFS1
3227,GO:0006883,0.638736802107357,0.753644795939317,1,8,cellular sodium ion homeostasis,BP,ATP12A
13851,GO:0060502,0.638763310690222,0.753619619667474,1,8,epithelial cell proliferation involved in lung morphogenesis,BP,MAP2K1
10394,GO:0043249,0.638913377462905,0.753477058738646,1,8,erythrocyte maturation,BP,FAM210B
16120,GO:0090160,0.638922799775868,0.753468105630797,1,8,Golgi to lysosome transport,BP,EHD3
7507,GO:0031701,0.638938122812616,0.75345354511709,1,8,angiotensin receptor binding,MF,ARAP1
2284,GO:0005243,0.638945123773137,0.753446892331459,1,8,gap junction channel activity,MF,GJC2
15081,GO:0071157,0.638954600147182,0.647338443384425,2,18,negative regulation of cell cycle arrest,BP,MLXIPL;CHEK2
18572,GO:1903867,0.639139291649955,0.753262327132095,1,8,extraembryonic membrane development,BP,HTRA1
15540,GO:0072015,0.6392438522024,0.753162894667565,1,8,glomerular visceral epithelial cell development,BP,LAMB2
15710,GO:0072310,0.6392438522024,0.753162894667565,1,8,glomerular epithelial cell development,BP,LAMB2
10623,GO:0043650,0.639280843348097,0.753127710509172,1,8,dicarboxylic acid biosynthetic process,BP,GLUD1
2438,GO:0005639,0.639281626190415,0.753126965867587,1,8,integral component of nuclear inner membrane,CC,LEMD2
7253,GO:0031229,0.639281626190415,0.753126965867587,1,8,intrinsic component of nuclear inner membrane,CC,LEMD2
10890,GO:0044453,0.639281626190415,0.753126965867587,1,8,nuclear membrane part,CC,LEMD2
5084,GO:0015347,0.639302596159889,0.753107018545187,1,8,sodium-independent organic anion transmembrane transporter activity,MF,SLCO4A1
4694,GO:0010857,0.639306324820684,0.753103471593819,1,8,calcium-dependent protein kinase activity,MF,MKNK2
513,GO:0001578,0.639418881805667,0.543975850108094,5,45,microtubule bundle formation,BP,BBS2;DNAH1;NEURL1;SPAG16;MARK4
649,GO:0001840,0.639486140719445,0.752932373208999,1,8,neural plate development,BP,VANGL2
8803,GO:0034587,0.639526525823036,0.752893933726061,1,8,piRNA metabolic process,BP,TDRKH
11272,GO:0045603,0.639588544622502,0.752834894029888,1,8,positive regulation of endothelial cell differentiation,BP,BTG1
16044,GO:0090030,0.639642996267457,0.752783049250621,1,8,regulation of steroid hormone biosynthetic process,BP,DGKQ
20180,GO:2001135,0.639745363044195,0.752685561127079,1,8,regulation of endocytic recycling,BP,SORL1
18371,GO:1903427,0.639751313112439,0.646494482982651,2,18,negative regulation of reactive oxygen species biosynthetic process,BP,ACP5;ATP2B4
14318,GO:0061548,0.639787742541131,0.752645192912769,1,8,ganglion development,BP,SEMA3F
19992,GO:2000643,0.639828151611681,0.752606696994151,1,8,positive regulation of early endosome to late endosome transport,BP,VPS11
8194,GO:0032957,0.639876493158104,0.75256063823856,1,8,inositol trisphosphate metabolic process,BP,PTAFR
2785,GO:0006221,0.639907240509129,0.595320729854769,3,28,pyrimidine nucleotide biosynthetic process,BP,NME4;UCKL1;UPP1
9171,GO:0035562,0.639930961581935,0.752508734200199,1,8,negative regulation of chromatin binding,BP,NFATC4
1420,GO:0003373,0.640087590220558,0.752359434022396,1,8,dynamin family protein polymerization involved in membrane fission,BP,DNM1
1421,GO:0003374,0.640087590220558,0.752359434022396,1,8,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM1
11750,GO:0046628,0.640116703434271,0.752331675511602,1,8,positive regulation of insulin receptor signaling pathway,BP,PRKCZ
5439,GO:0016311,0.640134139252373,0.424038789569675,41,360,dephosphorylation,BP,DUSP6;PTPRS;NT5E;PPP1R35;ACP5;DUSP5;PPM1M;B3GAT3;PHACTR3;LHPP;PPP1R14A;ACP6;PPP2R3B;DLG3;ELFN2;PTPRE;SSH3;PSPH;PPM1J;MTMR4;NT5C1B;MYH3;PTPDC1;INPP5D;SSH1;NTPCR;PTPRU;CSRNP3;ITGA1;CDK5RAP3;DNAJC6;PPP1R15A;THNSL2;CRY2;FARP1;CTDSPL;PLPP6;INPP4A;ITGA2;SFI1;IKBKB
13354,GO:0052646,0.640199387764426,0.752252825899726,1,8,alditol phosphate metabolic process,BP,ACP6
13635,GO:0060174,0.640221553575528,0.752231684878738,1,8,limb bud formation,BP,WNT3
5114,GO:0015459,0.640269387428485,0.595486214862341,3,27,potassium channel regulator activity,MF,PRKCZ;KCNAB2;PIAS3
8809,GO:0034596,0.640273282469562,0.752182342281635,1,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,INPP4A
12976,GO:0051418,0.640302484982051,0.752154483639537,1,8,microtubule nucleation by microtubule organizing center,BP,TUBGCP6
14335,GO:0061577,0.64031947180753,0.752138277446532,1,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1
15113,GO:0071233,0.640353617637725,0.752105698379467,1,8,cellular response to leucine,BP,SESN2
13993,GO:0060742,0.640498436575263,0.751967488549939,1,8,epithelial cell differentiation involved in prostate gland development,BP,RXRA
13032,GO:0051547,0.640506815182584,0.751959490542721,1,8,regulation of keratinocyte migration,BP,HBEGF
12195,GO:0048407,0.640539458425504,0.751928328274063,1,8,platelet-derived growth factor binding,MF,COL6A1
14480,GO:0062012,0.640540607649184,0.426014550305643,38,337,regulation of small molecule metabolic process,BP,APOE;EGR1;LMF1;TYSND1;TIMP2;VEGFA;NTSR1;NR1D1;RAPGEF3;IGFBP4;NOS1;MLYCD;CYP27B1;DDIT4;DGKQ;SEC14L2;ABCG1;PPARA;PKD2;ACACB;MVD;MLXIPL;PTHLH;LTB4R2;GABBR1;LONP2;TMSB4X;TRIB3;NOS3;PTAFR;ATP2B4;TM7SF2;AKT1;FGFR4;ACADVL;INSR;TAZ;PHLDA2
7565,GO:0031936,0.640593576663602,0.751876658802236,1,8,negative regulation of chromatin silencing,BP,PHF2
7396,GO:0031468,0.6406162053496,0.645576790679056,2,18,nuclear envelope reassembly,BP,REEP4;LMNA
15755,GO:0072386,0.640618006534953,0.751853331690378,1,8,plus-end-directed organelle transport along microtubule,BP,FYCO1
3739,GO:0008278,0.640672966633663,0.751800846442767,1,8,cohesin complex,CC,REC8
15003,GO:0070970,0.640739265748105,0.751737521650483,1,8,interleukin-2 secretion,BP,CARD11
14525,GO:0070070,0.640749742548315,0.751727513748373,1,8,proton-transporting V-type ATPase complex assembly,BP,TCIRG1
14527,GO:0070072,0.640749742548315,0.751727513748373,1,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,TCIRG1
9673,GO:0038065,0.640769204264511,0.751708922252725,1,8,collagen-activated signaling pathway,BP,ITGA2
16226,GO:0090308,0.640793909241049,0.751685320435449,1,8,regulation of methylation-dependent chromatin silencing,BP,UHRF2
10335,GO:0043162,0.640827848403963,0.645351987543733,2,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,MVB12B;TSG101
1321,GO:0003174,0.640862000766675,0.75162026067684,1,8,mitral valve development,BP,ZFPM1
13860,GO:0060525,0.640927559618082,0.751557608694128,1,8,prostate glandular acinus development,BP,RXRA
7470,GO:0031643,0.640974445739421,0.751512794193964,1,8,positive regulation of myelination,BP,TENM4
8144,GO:0032881,0.64104838106873,0.594642144214287,3,27,regulation of polysaccharide metabolic process,BP,AKT1;INSR;PHLDA2
5577,GO:0016600,0.641059619562967,0.751431368120121,1,8,flotillin complex,CC,FLOT1
6070,GO:0019226,0.641096138435017,0.594590362767646,3,27,transmission of nerve impulse,BP,SCN8A;ANK3;ITGA2
15512,GO:0071936,0.641196212199401,0.751300743752185,1,8,coreceptor activity involved in Wnt signaling pathway,MF,LRP5
15552,GO:0072044,0.641203296156448,0.751293967911479,1,8,collecting duct development,BP,PKD1
17798,GO:1901984,0.641236876511685,0.644917258476886,2,18,negative regulation of protein acetylation,BP,HINT2;HDAC8
11098,GO:0045141,0.641282944861884,0.751217773935453,1,8,meiotic telomere clustering,BP,LEMD2
16167,GO:0090220,0.641282944861884,0.751217773935453,1,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,LEMD2
2345,GO:0005388,0.641368541376167,0.751135870525773,1,8,calcium-transporting ATPase activity,MF,ATP2B4
18776,GO:1904354,0.641395422344421,0.751110145157645,1,8,negative regulation of telomere capping,BP,ERCC1
12988,GO:0051445,0.641401434022979,0.594259248602673,3,27,regulation of meiotic cell cycle,BP,NPR2;INSR;SIRT2
18149,GO:1902946,0.641572103983118,0.750941009090111,1,8,protein localization to early endosome,BP,SORL1
7208,GO:0031111,0.641653738729324,0.593985483851779,3,27,negative regulation of microtubule polymerization or depolymerization,BP,EML2;TTBK2;ARHGEF2
18772,GO:1904350,0.641905293405951,0.750621813461427,1,8,regulation of protein catabolic process in the vacuole,BP,LRP1
10367,GO:0043207,0.641944205545801,0.411661895995537,59,524,response to external biotic stimulus,BP,TNIP1;ACTA2;HTRA1;F2R;TNFRSF6B;FOS;WIPF1;ACP5;PDCD4;NR1D1;LOXL1;NOS1;ADAMTS13;MST1R;ADARB1;PRSS3;HYAL1;CYP27B1;PCK2;DDIT4;TMEM173;SHC1;APOBEC3C;FAM3A;CCDC88B;NGFR;TNFRSF25;PLA2G6;APOBEC3F;NLRX1;HMGA2;MAPK3;BNIP3;IFITM1;GSDMA;IFNGR2;PDCD1LG2;LRSAM1;LITAF;HDAC5;IRF5;NLRP1;CEBPB;ISG20;NOS3;BNIP3L;BCR;SRR;PTAFR;TNFRSF14;GSDMC;MAPKBP1;AKT1;IL17RC;LYST;TKFC;SIRT2;EIF2AK4;IKBKB
13116,GO:0051707,0.641944205545801,0.411661895995537,59,524,response to other organism,BP,TNIP1;ACTA2;HTRA1;F2R;TNFRSF6B;FOS;WIPF1;ACP5;PDCD4;NR1D1;LOXL1;NOS1;ADAMTS13;MST1R;ADARB1;PRSS3;HYAL1;CYP27B1;PCK2;DDIT4;TMEM173;SHC1;APOBEC3C;FAM3A;CCDC88B;NGFR;TNFRSF25;PLA2G6;APOBEC3F;NLRX1;HMGA2;MAPK3;BNIP3;IFITM1;GSDMA;IFNGR2;PDCD1LG2;LRSAM1;LITAF;HDAC5;IRF5;NLRP1;CEBPB;ISG20;NOS3;BNIP3L;BCR;SRR;PTAFR;TNFRSF14;GSDMC;MAPKBP1;AKT1;IL17RC;LYST;TKFC;SIRT2;EIF2AK4;IKBKB
723,GO:0001953,0.642656748551792,0.592896061176447,3,27,negative regulation of cell-matrix adhesion,BP,POSTN;DMTN;BCL6
12337,GO:0048736,0.642985815997692,0.466282072969322,14,125,appendage development,BP,IFT140;RNF165;FBXW4;SMOC1;ITGA6;PBX2;ITGB4;MYH3;LRP5;WNT7A;ZNF358;WDR19;WNT3;FGFR1
13634,GO:0060173,0.642985815997692,0.466282072969322,14,125,limb development,BP,IFT140;RNF165;FBXW4;SMOC1;ITGA6;PBX2;ITGB4;MYH3;LRP5;WNT7A;ZNF358;WDR19;WNT3;FGFR1
2490,GO:0005739,0.642986889657157,0.390487610108573,162,1426,mitochondrion,CC,HS1BP3;XPC;PRODH;ACSF2;ALDH7A1;SUGCT;CRAT;GLUL;FAM210B;NAGS;NTSR1;D2HGDH;HADH;PRDX5;BPHL;SNPH;IDH2;DNM1;NOS1;ACAD10;PACS2;GRAMD4;ARMCX2;PYCR2;DHTKD1;TFDP2;ALDH4A1;MSRB2;TK2;SLC27A1;CPT2;MLYCD;HMGCL;UROS;OXLD1;TXNRD3;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;PPL;DDIT4;TMEM173;ARL2;ULK1;SHC1;OGDHL;CAPRIN2;AARS;PHYH;ELK3;GLDC;NDUFA4L2;NME4;ETFB;GPT2;NIPSNAP1;DHRS4;TNFRSF25;PLA2G6;ABCG1;PLGRKT;SESN2;NLRX1;SLIT3;ACACB;MAPK3;PC;BNIP3;MACROD1;ACSS2;TDRKH;CTSB;MAPK12;PI4K2A;MAP2K2;HIBADH;SDHA;BBC3;PRIMPOL;IFI6;HLCS;AZIN2;TFB1M;DHX32;ENDOG;ACOT7;LRP5;TSTD1;ALDOC;ACADS;PDE2A;ALDH1L2;PEMT;SLC27A3;BNIP3L;RPUSD3;GLUD1;SUCLG2;ERN1;NUDT6;ALKBH7;ATP7B;NBR1;CPT1C;BOLA1;PPP1R15A;TNRC18;SPATA7;ACOX3;ACAD11;GSDMC;HINT2;AKT1;DGUOK;LACTB2;PHYKPL;TMEM143;ASS1;COMTD1;NFU1;ZNF217;SNN;TCIRG1;HAGH;CBR4;ACADVL;SPATA18;IFI27;ACSS1;SLC25A29;ANKZF1;PNPLA4;SMIM20;TXNRD2;BRAF;LETMD1;ALDH1L1;CAT;MAPK10;MPG;TP73;TAZ;FYN;HSDL1;SLC25A42;SIRT2;TST;CIDEA;TMEM223;BLOC1S1;FITM2;FKBP8;C15ORF62;TTC19;CREB3L4;BSG;SDHAF4;PNKD;SNCB;ACOT8
8056,GO:0032735,0.643216471719211,0.642808286524899,2,18,positive regulation of interleukin-12 production,BP,IRF5;HLA-G
14662,GO:0070304,0.643536323972066,0.474428607887351,12,108,positive regulation of stress-activated protein kinase signaling cascade,BP,XDH;VEGFA;ERCC6;PKN1;PAK1;VANGL2;TRPV4;MINK1;WNT7A;ERN1;EDA2R;MAP3K10
9985,GO:0042417,0.643716990091461,0.642273743501872,2,18,dopamine metabolic process,BP,PNKD;SNCB
11840,GO:0046850,0.643734765646827,0.591723204439342,3,27,regulation of bone remodeling,BP,EGFR;INPP5D;LRP5
8278,GO:0033116,0.643867221172142,0.522990252583381,6,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,AREG;AZIN2;WHAMMP3;TBC1D20;GOLGA2;MPPE1
3912,GO:0008584,0.644136922743627,0.485011781723024,10,91,male gonad development,BP,ERCC1;CST3;NUPR1;WNT2B;AGO4;TBC1D20;INSR;REC8;RAB13;RHOBTB3
3310,GO:0007016,0.644518032695186,0.748108090381117,1,8,cytoskeletal anchoring at plasma membrane,BP,ANK3
615,GO:0001784,0.645031740737379,0.590309422436593,3,27,phosphotyrosine residue binding,MF,SHC1;MAPK3;PIK3R2
22,GO:0000041,0.645082725745122,0.499160950566419,8,74,transition metal ion transport,BP,CCS;ATP7B;STEAP2;TCIRG1;STEAP3;HFE;TRPC1;SLC39A11
7059,GO:0030855,0.645241495361974,0.412707211094963,50,443,epithelial cell differentiation,BP,XDH;PTPRS;ACTA2;PTK6;ALOX15B;VEGFA;RAPGEF3;KRT15;CST3;DNPH1;ZFP36L1;WWTR1;MAP2K1;CYP27B1;PCK2;PPL;BTG1;LAMA5;PRSS8;ACVR2B;LCE1E;EREG;LAMB2;ERRFI1;THRA;FAM20C;CTSB;SLITRK6;CEBPB;ALDOC;AQP3;TRIOBP;PDE2A;WNT7A;SHARPIN;RXRA;MGMT;LCE1F;AKT1;TSG101;ACADVL;TBC1D20;RAB25;KRT19;GSTM3;RAB13;TST;ITGA2;FGFR1;IKBKB
12831,GO:0051173,0.645602062582794,0.382588019416151,243,2090,positive regulation of nitrogen compound metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;APOE;NFATC4;FOS;GSN;CITED4;EGR1;PTK6;EDEM1;LRP1;TIMP2;VEGFA;EGFR;PRNP;NR1D1;ERCC1;FBLN1;DUSP5;RAPGEF3;TNFSF15;IGFBP4;CST3;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;GRAMD4;SMARCA1;MST1R;ZFP36L1;NUPR1;HBEGF;CTF1;CNTN1;TFDP2;SLC27A1;ASH2L;ETV4;WWTR1;MAP2K1;PKN1;MC1R;SHC2;ITGA6;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;MAGEF1;SHC1;VPS11;SPRY2;SOX12;CIRBP;CAPRIN2;PRKCZ;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;CEMIP;KDM3A;PHF1;SALL2;DLG3;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;TRIB2;EREG;TEF;TNFRSF25;NAB2;PLA2G6;CARF;LPAR3;C5;PPARA;PLGRKT;SESN2;IMPACT;PKD2;STAT6;KLF7;HMGA2;AREG;MAPK3;CSPG4;THRA;VANGL2;IRF2BPL;MAPK12;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;BBC3;PAK6;ZNF516;PKD1;FLOT1;MDK;JDP2;HDAC5;GTPBP1;IRF5;SORL1;HERPUD1;SRSF5;VLDLR;DEAF1;NLRP1;PEG3;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;LRP5;CREBRF;PCSK9;PKIB;METTL23;HLTF;TGFBR2;TRPV4;CSRNP3;ITGA1;TMSB4X;SMURF2;APLN;TRIB3;DAP;CALCOCO1;PEMT;CDK5RAP3;NOS3;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;MGMT;AKT1;CARD11;CDKN1C;CHEK2;IFT57;ASS1;PHF2;FGFR4;PIAS3;WDFY2;IFI27;INSR;NCOA7;FOXO4;RPS6KA5;C6ORF89;MAP2K5;BRAF;EDA2R;PIDD1;MAPK10;HFE;TP73;SNX33;TFEB;CSNK1E;TAZ;BCL6;HSF4;FYN;ZC3H12D;SNX1;SIRT2;GDF15;GOLGA2;POU2F2;PLXND1;MTA1;ADIRF;AVPI1;CIDEB;EPAS1;LAMTOR2;MAP3K10;CHD6;EPHB2;PER1;ITGA2;FGFR1;WFS1;ERBB2;EIF2AK4;UNC119;HMBOX1;CREB3L4;KCTD13;DBP;ZNF287;CAMKK1;IKBKB;HIP1;TEAD2;SIX5
5933,GO:0018230,0.64567269186306,0.640179995226016,2,18,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC1;ZDHHC24
5934,GO:0018231,0.64567269186306,0.640179995226016,2,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC1;ZDHHC24
2540,GO:0005798,0.64618544125975,0.459010519267576,15,136,Golgi-associated vesicle,CC,CLTCL1;SPPL2B;TMED4;AREG;AP1G2;VANGL2;PKD1;PCSK9;STEAP2;RASSF9;COPG1;RAB13;GOLGA2;SEC31B;HLA-G
8103,GO:0032800,0.646320459579185,0.63948470859283,2,18,receptor biosynthetic process,BP,NR1D1;PPARA
20238,GO:2001236,0.646480622272366,0.466532576855803,13,118,regulation of extrinsic apoptotic signaling pathway,BP,RBCK1;ITGA6;ARHGEF2;IFI6;UNC5B;NOS3;STRADB;AKT1;LMNA;MAP2K5;PIDD1;FYN;FGFR1
7483,GO:0031663,0.647034632528006,0.556714838881251,4,37,lipopolysaccharide-mediated signaling pathway,BP,MAPK3;NOS3;PTAFR;AKT1
9785,GO:0040019,0.647101447460152,0.638645237949877,2,18,positive regulation of embryonic development,BP,WNT2B;TENM4
10761,GO:0044232,0.647194781422983,0.63854482763742,2,18,organelle membrane contact site,CC,ESYT2;ESYT3
18269,GO:1903203,0.647617326265418,0.638090013268067,2,18,regulation of oxidative stress-induced neuron death,BP,ATF4;NCOA7
13722,GO:0060322,0.647626616409199,0.407624822178658,55,481,head development,BP,PTPRS;BBS2;SERPINE2;GJC2;LRP1;EGFR;CD9;SNPH;CST3;SHANK2;SMARCA1;PHGDH;CNTN1;NAGLU;MAP2K1;DDIT4;TRNP1;PITPNM1;TTBK2;PAK1;AARS;SHROOM4;NEURL1;EPOR;WNT2B;TRAPPC9;MAPK3;BNIP3;SEMA5A;THRA;MYH3;TCTN1;MDK;KDM7A;NDE1;TGFBR2;CDK5RAP3;WNT7A;SHARPIN;GLUD1;BCR;SRR;ATP2B4;B4GALT2;AMIGO2;LAMB1;WNT3;BRAF;CSNK1E;FYN;SLC38A2;SIRT2;EDNRA;EPHB2;FGFR1
19255,GO:1905508,0.647674125178229,0.587419890118854,3,27,protein localization to microtubule organizing center,BP,CEP250;NUDCD3;CEP131
7166,GO:0031056,0.648534314572006,0.464374719176479,13,117,regulation of histone modification,BP,VEGFA;NOS1;KDM3A;MTHFR;PHF1;MAPK3;KDM4C;JDP2;TADA3;RPS6KA5;C6ORF89;BCL6;HDAC8
4575,GO:0010665,0.648925742580685,0.636679247001996,2,18,regulation of cardiac muscle cell apoptotic process,BP,RGL2;BNIP3
8984,GO:0035116,0.648928018198925,0.636676790174601,2,18,embryonic hindlimb morphogenesis,BP,WNT7A;WNT3
11574,GO:0046174,0.648980242891594,0.636620403729261,2,18,polyol catabolic process,BP,NTSR1;TKFC
3779,GO:0008344,0.649083512861401,0.554459253156629,4,37,adult locomotory behavior,BP,NTSR1;DNM1;EFNB3;SLITRK6
10983,GO:0044804,0.649193979854127,0.636389573118511,2,18,autophagy of nucleus,BP,WDR45;ATG2A
5073,GO:0015301,0.649740550636454,0.6357988433962,2,18,anion:anion antiporter activity,MF,SLC37A2;SLC37A4
5068,GO:0015295,0.6498385991741,0.635692805238269,2,18,solute:proton symporter activity,MF,SLC2A9;MFSD3
7362,GO:0031418,0.650025316655719,0.635490815569179,2,18,L-ascorbic acid binding,MF,PHYH;OGFOD2
14954,GO:0070888,0.65030771324144,0.635185178191769,2,18,E-box binding,MF,BHLHE40;PER1
16089,GO:0090101,0.650687937447736,0.493161810281998,8,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;LTBP1;MTMR4;TGFBR2;SMURF2;LEMD2;CIDEA;TGFBR3
74,GO:0000151,0.651154932427847,0.423001904043299,30,267,ubiquitin ligase complex,CC,BTBD2;FBXO2;RBCK1;DDB2;ABTB1;CUL9;FBXW4;CUL7;PHC2;KLHL29;ZSWIM4;FBXW8;FBXO27;DCAF10;FBXO17;KLHL24;FBXO6;CBX7;FBXL15;SMURF2;LMO7;SHARPIN;KLHDC8B;SPSB3;MIB2;PHC1;FBXO25;SYVN1;KCTD13;BTBD11
13885,GO:0060562,0.651460695610211,0.429742454965088,25,222,epithelial tube morphogenesis,BP,NFATC4;CTNNBIP1;PGF;VEGFA;SPRY2;LAMA5;PAK1;ETV5;WNT2B;PKD2;AREG;VANGL2;TCTN1;KIF26B;PKD1;DEAF1;LRP5;WNK4;TGFBR2;CTSH;IFT57;CELSR1;PLXND1;EDNRA;TEAD2
12820,GO:0051154,0.65183317761485,0.633531194415829,2,18,negative regulation of striated muscle cell differentiation,BP,PAK1;HDAC5
18561,GO:1903844,0.651836833563405,0.483629700685143,9,82,regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;LTBP4;LTBP1;MTMR4;TGFBR2;SMURF2;CDKN1C;CIDEA;TGFBR3
16165,GO:0090218,0.651853434464203,0.633509197098487,2,18,positive regulation of lipid kinase activity,BP,FGFR3;VAV3
3317,GO:0007026,0.652083601674798,0.633259191531558,2,18,negative regulation of microtubule depolymerization,BP,TTBK2;ARHGEF2
5119,GO:0015491,0.652888245595544,0.632384292402396,2,18,cation:cation antiporter activity,MF,SLC9A7;SLC9A5
19014,GO:1904886,0.652993025416382,0.632270260692204,2,18,beta-catenin destruction complex disassembly,BP,LRP5;FRAT1
11607,GO:0046330,0.653561140892982,0.474745717354151,10,91,positive regulation of JNK cascade,BP,ERCC6;PKN1;PAK1;VANGL2;TRPV4;MINK1;WNT7A;ERN1;EDA2R;MAP3K10
3210,GO:0006855,0.653599087784616,0.528135328193621,5,46,drug transmembrane transport,BP,NTSR1;SLC22A18;PQLC2;PRAF2;SLC25A29
11793,GO:0046703,0.653638687462868,0.736243688970566,1,9,natural killer cell lectin-like receptor binding,MF,ULBP1
18783,GO:1904377,0.653983095692057,0.52770972822252,5,46,positive regulation of protein localization to cell periphery,BP,LRP1;EGFR;PRNP;AKT1;EPHB2
17482,GO:1900739,0.654023754587255,0.579859093663708,3,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2;BBC3;TP73
17483,GO:1900740,0.654023754587255,0.579859093663708,3,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2;BBC3;TP73
13774,GO:0060389,0.654519659751449,0.548443266889446,4,37,pathway-restricted SMAD protein phosphorylation,BP,TGFBR2;HFE;GDF15;TGFBR3
4671,GO:0010824,0.654529423927181,0.548432419977939,4,37,regulation of centrosome duplication,BP,CHMP1B;CEP131;CHMP5;CHMP4C
18131,GO:1902905,0.654632193110264,0.446545176809875,16,145,positive regulation of supramolecular fiber organization,BP,APOE;GSN;WIPF1;CDC42EP5;RAPGEF3;ARPIN;ARL2;PAK1;SEMA5A;WHAMMP3;TRPV4;EPHA1;BRAF;SPIRE1;C15ORF62;CORO1B
2764,GO:0006183,0.654874061964874,0.735006267584288,1,9,GTP biosynthetic process,BP,NME4
8136,GO:0032873,0.654999496819851,0.547910045643246,4,37,negative regulation of stress-activated MAPK cascade,BP,PDCD4;AKT1;TP73;PER1
14661,GO:0070303,0.654999496819851,0.547910045643246,4,37,negative regulation of stress-activated protein kinase signaling cascade,BP,PDCD4;AKT1;TP73;PER1
12858,GO:0051219,0.655054620997871,0.498333220809774,7,64,phosphoprotein binding,MF,PLAT;SHC1;PKD2;LRP11;MAPK3;TRPV1;PIK3R2
2641,GO:0005978,0.655132763427009,0.547761888808017,4,37,glycogen biosynthetic process,BP,NR1D1;PGM1;AKT1;INSR
4172,GO:0009250,0.655132763427009,0.547761888808017,4,37,glucan biosynthetic process,BP,NR1D1;PGM1;AKT1;INSR
7328,GO:0031347,0.655426299636495,0.401447256961041,51,452,regulation of defense response,BP,TNIP1;PTPRS;HTRA1;NT5E;APOE;IL20RB;ACP5;RNF135;PDCD4;EGFR;NR1D1;GGT1;MAPK13;TMEM173;SERPING1;PAK1;STK39;FAM3A;ZP3;RAG1;MUC19;EREG;C5;APOBEC3F;PPARA;FNDC4;NLRX1;MAPK3;CTSB;IFNGR2;LRSAM1;FLOT1;NLRP1;TRPV4;TMSB4X;PDE2A;SHARPIN;BCR;MAPKBP1;CARD11;IL17RC;RPS6KA5;BCL6;TKFC;FYN;SIRT2;ADA;PER1;ITGA2;EIF2AK4;IKBKB
6581,GO:0022600,0.655677568971719,0.547155922563109,4,37,digestive system process,BP,STK39;WNK4;TRPV1;CHRM3
11509,GO:0046051,0.656431330688348,0.733440113049268,1,9,UTP metabolic process,BP,NME4
9997,GO:0042440,0.656931863524756,0.524177480289976,5,47,pigment metabolic process,BP,UROS;BLVRB;APRT;TRPC1;ADA
13461,GO:0055024,0.656989818953287,0.52437024381032,5,46,regulation of cardiac muscle tissue development,BP,PAK1;TGFBR2;TP73;TGFBR3;FGFR1
5796,GO:0017053,0.657010710121599,0.486208264323279,8,73,transcriptional repressor complex,CC,BAHCC1;APPL2;SALL2;CHD3;ZFPM1;TNRC18;SIRT2;RCOR2
7650,GO:0032088,0.657479720092587,0.495494501031559,7,65,negative regulation of NF-kappaB transcription factor activity,BP,RBCK1;NLRX1;TMSB4X;DAP;CDK5RAP3;MAP2K5;CAT
10265,GO:0043029,0.657603264058758,0.575882156678646,3,28,T cell homeostasis,BP,RAG1;AKT1;JAK3
18315,GO:1903307,0.657916384917262,0.575533171501374,3,28,positive regulation of regulated secretory pathway,BP,ZP3;PTAFR;STX1A
13016,GO:0051496,0.658043540399198,0.544518960247885,4,37,positive regulation of stress fiber assembly,BP,RAPGEF3;PAK1;EPHA1;BRAF
3494,GO:0007389,0.658181270034807,0.418101149149407,28,249,pattern specification process,BP,DUSP6;CTNNBIP1;IFT140;DDIT3;MDFI;SYNGAP1;PBX2;SEMA3F;ACVR2B;WNT2B;SCMH1;PKD2;VANGL2;TCTN1;PSKH1;NEK8;LRP5;FBXL15;TGFBR2;WNT7A;WDR19;IFT57;WNT3;CELSR1;MFNG;FGFR1;FKBP8;TSHZ1
9930,GO:0042304,0.65823244895437,0.575180726156489,3,28,regulation of fatty acid biosynthetic process,BP,MLXIPL;TRIB3;ACADVL
11714,GO:0046546,0.658242433484494,0.469521431506391,10,92,development of primary male sexual characteristics,BP,ERCC1;CST3;NUPR1;WNT2B;AGO4;TBC1D20;INSR;REC8;RAB13;RHOBTB3
12236,GO:0048538,0.658474420022361,0.544037784771207,4,37,thymus development,BP,MAP2K1;RAG1;MAPK3;BRAF
955,GO:0002376,0.658587956008825,0.370766251520866,213,1853,immune system process,BP,TNIP1;PTPRS;HTRA1;TNFRSF6B;FOS;IL20RB;GSN;PYGB;EGR1;CTNNBIP1;PGF;WIPF1;SLC2A3;PTK6;NAPRT;RNF135;FAM210B;LRP1;TIMP2;VEGFA;RBCK1;PRNP;FCGRT;NR1D1;ERCC1;SLC7A8;TNFSF15;SLC16A3;CST3;PGM1;NDRG1;GGT1;ADAMTS13;MMP28;MST1R;ZFP36L1;ADARB1;GAA;PYGL;MMP1;DHTKD1;EFNB3;RPL13A;CTSF;ASH2L;SOX13;PRSS3;SYNGR1;MAP2K1;CYP27B1;PKN1;DDIT4;DNASE1L1;ITGA6;TMEM173;FAM213A;SHC1;GRB7;VEGFB;RAB3B;CD68;PTMS;PRKCZ;SERPING1;PAK1;APOBEC3C;PRR7;BRI3;FAM3A;ZP3;CCDC88B;RAG1;SPPL2B;NGFR;MUC19;WNT2B;ACTR1B;EREG;CHD2;TMC6;TNFRSF25;PLA2G6;SCART1;ERMAP;S100A13;C5;APOBEC3F;MKNK2;NLRX1;SATB1;STAT6;VAMP2;ECM1;KCNAB2;MAPK3;ITGB5;BNIP3;THRA;IFITM1;FAM20C;RHOF;CTSB;LTA4H;PI4K2A;SDC2;IFNGR2;C1RL;ARHGEF2;INPP5D;PDCD1LG2;DMTN;LRRC8A;PROCR;ZFPM1;DOCK11;POLM;IFI6;FUCA1;FLOT1;HDAC5;GTPBP1;IRF5;NLRP1;CEBPB;LRP5;ALDOC;L3MBTL1;AQP3;ISG20;TGFBR2;TRPV4;FOXL1;ITGA1;CMTM7;APLN;EDA;AGO4;HEXB;TRPV1;BNIP3L;PIK3R2;GAS6;BCR;NBEAL2;KIF13B;POLL;PTAFR;RAB43;CTSH;TNFRSF14;AKT1;CARD11;HMSD;IGFBP2;IL17RC;TCIRG1;DNASE2;SH2B3;ARSA;MAN2B1;IFI27;PLAU;CKLF;RPS6KA5;LTB4R;ULBP1;LYST;BRAF;BTN3A2;CAT;ZNF160;MAPK10;DPP7;YPEL5;LGALS1;HFE;JAK3;TP73;APRT;TFEB;ICAM5;METTL7A;TAZ;HGSNAT;BTN3A3;BCL6;TKFC;FYN;SIRT2;OSBPL1A;TOM1;ADA;POU2F2;AP2A2;MYO18A;TGFBR3;TCF7;VAV3;GALNS;EPAS1;LAMTOR2;MFNG;DHPS;ITGA2;SH3PXD2A;ERBB2;EIF2AK4;PAG1;PFKL;HLA-G;BSG;SDHAF4;IKBKB
12863,GO:0051225,0.658600280209146,0.463217793262645,11,100,spindle assembly,BP,TUBG2;CHMP1B;GOLGA2P5;CHEK2;CHMP5;GOLGA8A;CHMP4C;HAUS4;TUBGCP6;GOLGA2;CCDC69
11317,GO:0045661,0.658633994310689,0.574732699101852,3,28,regulation of myoblast differentiation,BP,DDIT3;ZFP36L1;BTG1
6700,GO:0030117,0.659103216218887,0.468575506019592,10,92,membrane coat,CC,EGFR;CLTCL1;DNM1;AP1G2;CHMP1B;VPS39;COPG1;AP2A2;SEC31B;HIP1
12200,GO:0048475,0.659103216218887,0.468575506019592,10,92,coated membrane,CC,EGFR;CLTCL1;DNM1;AP1G2;CHMP1B;VPS39;COPG1;AP2A2;SEC31B;HIP1
9087,GO:0035371,0.659666891822081,0.624957723883798,2,18,microtubule plus-end,CC,CLIP2;MAPRE3
1249,GO:0003002,0.659753229101103,0.426151389902991,22,197,regionalization,BP,DUSP6;CTNNBIP1;IFT140;DDIT3;MDFI;PBX2;SEMA3F;ACVR2B;WNT2B;SCMH1;VANGL2;TCTN1;LRP5;FBXL15;WNT7A;WDR19;IFT57;WNT3;CELSR1;FGFR1;FKBP8;TSHZ1
5941,GO:0018279,0.659884978813995,0.542106207127293,4,38,protein N-linked glycosylation via asparagine,BP,ST6GALNAC2;ST6GALNAC6;ST3GAL3;SYVN1
14261,GO:0061371,0.660177198678083,0.542133387666687,4,37,determination of heart left/right asymmetry,BP,PKD2;VANGL2;TGFBR2;IFT57
4401,GO:0010155,0.660968870004405,0.728836265416709,1,9,regulation of proton transport,BP,TMSB4X
13090,GO:0051650,0.661444677088949,0.42632709878025,21,189,establishment of vesicle localization,BP,BBS2;SYTL1;SNPH;DNM1;SYT8;BLOC1S4;PRKCZ;SPG11;TRAPPC9;VAMP2;AREG;SEPT5;PCLO;NDE1;FYCO1;RIMS3;TBC1D20;BRAF;GOLGA2;STX1A;BLOC1S1
13780,GO:0060395,0.661459574872506,0.54069615437538,4,37,SMAD protein signal transduction,BP,FOS;WWTR1;GDF15;BTBD11
16056,GO:0090049,0.661566993485415,0.571451305799203,3,28,regulation of cell migration involved in sprouting angiogenesis,BP,VEGFA;HDAC5;MAP2K5
9180,GO:0035577,0.662080990144206,0.518428740209311,5,47,azurophil granule membrane,CC,GAA;SYNGR1;CD68;BRI3;TOM1
11326,GO:0045670,0.662117563370746,0.539957699784439,4,37,regulation of osteoclast differentiation,BP,FOS;FAM213A;INPP5D;CEBPB
607,GO:0001776,0.66230469367459,0.502422478692937,6,56,leukocyte homeostasis,BP,PKN1;RAG1;DOCK11;AKT1;JAK3;ADA
10086,GO:0042612,0.662583938771836,0.727182950848106,1,9,MHC class I protein complex,CC,HLA-G
3508,GO:0007420,0.662799791156806,0.393696437792046,51,449,brain development,BP,PTPRS;BBS2;SERPINE2;GJC2;LRP1;EGFR;CD9;SNPH;CST3;SHANK2;SMARCA1;PHGDH;CNTN1;NAGLU;MAP2K1;DDIT4;TRNP1;PITPNM1;TTBK2;PAK1;AARS;SHROOM4;NEURL1;EPOR;WNT2B;TRAPPC9;BNIP3;SEMA5A;THRA;TCTN1;MDK;KDM7A;NDE1;TGFBR2;CDK5RAP3;WNT7A;SHARPIN;GLUD1;BCR;SRR;ATP2B4;B4GALT2;AMIGO2;LAMB1;WNT3;CSNK1E;FYN;SLC38A2;SIRT2;EPHB2;FGFR1
6577,GO:0022411,0.662822039006254,0.392564867788008,53,474,cellular component disassembly,BP,HTRA1;H1F0;GSN;LRP1;TIMP2;NEK9;SPTB;CST3;MMP1;CAPG;TTBK2;CAPNS2;NID1;BNIP3;SEMA5A;EIF2D;CHMP1B;ARHGEF2;TWF2;STMN3;TECPR1;DMTN;FLOT1;ENDOG;LRP5;TRIOBP;TRPV4;MAP1LC3A;CDK5RAP3;BNIP3L;SHARPIN;DNAJC6;FYCO1;MICAL1;WDR45;TSG101;FGFR4;TMOD2;DNASE2;LMNA;ATG2A;CHMP5;CAPN2;SMARCD2;SPATA18;INSR;TIMP1;FRAT1;GOLGA2;CIDEA;MMP19;BSG;PLEKHH2
13114,GO:0051704,0.663234100275475,0.368050692807148,181,1585,multi-organism process,BP,TNIP1;ACTA2;DLG4;HTRA1;GAMT;BBS2;F2R;TNFRSF6B;APOE;SERPINE2;FOS;GSN;PGF;WIPF1;ACP5;PDCD4;EGFR;RBCK1;NR1D1;ERCC1;FBLN1;LOXL1;CD9;CRTAP;CST3;NOS1;SHANK2;MICALCL;CRTC1;PACS2;GGT1;ADAMTS13;MST1R;ADARB1;SYT8;TCFL5;MMP1;EXOC2;EFNB3;RPL13A;ULK2;RAB11FIP4;CUL7;ATG16L2;PRSS3;HYAL1;TXNRD3;MAP2K1;CYP27B1;PCK2;DDIT4;BTG1;PHC2;TMEM173;DNAH1;ULK1;SHC1;MYCBPAP;APOBEC3C;PABPC1L;KDM3A;NPR2;FAM3A;ZP3;NEURL1;CCDC88B;NGFR;EPOR;ETV5;EREG;SPATA20;TNFRSF25;PLA2G6;FAM50A;APOBEC3F;SCMH1;NLRX1;SATB1;HMGA2;AP1G2;MAPK3;ITGB5;PC;BNIP3;THRA;IFITM1;CCNI;GSDMA;TDRKH;CTSB;EIF2D;MVB12B;CHMP1B;IFNGR2;PDCD1LG2;MAP2K2;LRSAM1;LITAF;PTHLH;AZIN2;HDAC5;IRF5;DEAF1;NLRP1;RFX2;CEBPB;CEP131;ISG20;DNMT3A;TGFBR2;SMURF2;RAB40B;MLH3;NOS3;AGO4;HEXB;LDOC1;HERPUD2;BNIP3L;GAS6;BCR;SRR;SPAG16;UCKL1;PTAFR;RXRA;RAB43;ATP2B4;TNFRSF14;GSDMC;MAPKBP1;AKT1;IGFBP7;IGFBP2;SEPT6;CABYR;TSG101;IL17RC;TBC1D20;CHMP5;INSR;WNT3;KRT19;NELFCD;CHMP4C;ULBP1;MAGED2;ITGB6;LYST;CPSF4;PLB1;LGALS1;TIMP1;HFE;TP73;SPIRE1;BCL6;REC8;TKFC;RPL39L;FYN;SLC38A2;SIRT2;MPDZ;ADA;AP2A2;PAIP2;RPL29;CHD6;ITGA2;FKBP8;SPATA6;EIF2AK4;RPL12;CREB3L4;MMP19;ZNF449;BSG;IKBKB;ACOT8;SIX5
13184,GO:0051851,0.663493051570014,0.516845720248602,5,47,modification by host of symbiont morphology or physiology,BP,APOE;HMGA2;PC;TBC1D20;EIF2AK4
4252,GO:0009583,0.663585276013095,0.569184173109361,3,28,detection of light stimulus,BP,PITPNM1;REEP6;UNC119
3745,GO:0008286,0.663905210346458,0.457309575759892,11,101,insulin receptor signaling pathway,BP,SHC1;PRKCZ;PTPRE;PIK3R2;AKT1;TCIRG1;INSR;FOXO4;GPR21;EIF4EBP1;GRB10
10561,GO:0043542,0.664365422061499,0.439247952366803,15,137,endothelial cell migration,BP,APOE;VEGFA;PRSS3;PLEKHG5;SEMA5A;HDAC5;TMSB4X;NOS3;WNT7A;AKT1;MAP2K5;RAB13;PLXND1;FGFR1;CORO1B
9117,GO:0035455,0.664401128638225,0.618700399187836,2,19,response to interferon-alpha,BP,IFITM1;GAS6
13501,GO:0055102,0.664527463758516,0.725183118748534,1,9,lipase inhibitor activity,MF,SNCB
2501,GO:0005751,0.664788872208749,0.722511496507649,1,10,mitochondrial respiratory chain complex IV,CC,NDUFA4L2
8319,GO:0033177,0.66480477140385,0.724896857499804,1,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,TCIRG1
241,GO:0000506,0.66505282396179,0.724640600805928,1,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,PIGQ
13870,GO:0060538,0.665244842565247,0.461805164633466,10,92,skeletal muscle organ development,BP,FOS;EGR1;MEF2D;MYH15;NUPR1;NEURL1;FLOT1;HMG20B;TAZ;LEMD2
7168,GO:0031058,0.665464947367948,0.476712267078612,8,74,positive regulation of histone modification,BP,VEGFA;NOS1;PHF1;MAPK3;JDP2;RPS6KA5;C6ORF89;BCL6
1006,GO:0002480,0.665862398657234,0.723802966252947,1,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,HLA-G
3086,GO:0006662,0.666589693515943,0.723048784062391,1,9,glycerol ether metabolic process,BP,PEX7
10713,GO:0044087,0.666592885532187,0.379812809212488,76,666,regulation of cellular component biogenesis,BP,APOE;ESPN;ZMYND8;GSN;ADGRL1;CTNNBIP1;EVI5L;WIPF1;CDC42EP5;VEGFA;DDB2;ERCC1;IFT140;RAPGEF3;SPTB;ADGRB2;ARAP1;MMP1;RPL13A;HYAL1;ARPIN;CAPG;EML2;SNX9;FAM110C;ARL2;ULK1;VPS11;NPHP4;NLGN2;PRKCZ;PAK1;PLXNB3;NEURL1;SSH3;PLEKHG2;PLA2G6;IMPACT;THRA;SLITRK6;CHMP1B;TBC1D14;ARHGEF2;TWF2;LRSAM1;DMTN;DOCK11;SSH1;TENM2;FLOT1;WHAMMP3;SORL1;TPBG;TRIOBP;TMSB4X;WNT7A;EPHA1;CROCC;AMIGO2;TSG101;TMOD2;ASAP3;C9ORF72;CHMP5;CHMP4C;BRAF;FCHSD1;SPIRE1;EPS8L1;SIRT2;EPS8L2;STX1A;EPHB2;C15ORF62;CORO1B;IKBKB
980,GO:0002437,0.666636185201287,0.616202552928637,2,19,inflammatory response to antigenic stimulus,BP,IL20RB;ZP3
2100,GO:0004869,0.666679444419539,0.565162401582142,3,29,cysteine-type endopeptidase inhibitor activity,MF,PRDX5;CST3;GAS6
11979,GO:0047429,0.667007544915551,0.722614764682258,1,9,nucleoside-triphosphate diphosphatase activity,MF,ASMTL
13072,GO:0051608,0.667819406199715,0.721769983499031,1,9,histamine transport,BP,ADA
14750,GO:0070475,0.667910916800704,0.72167463734089,1,9,rRNA base methylation,BP,NSUN5P2
13449,GO:0055010,0.668126029264608,0.564056199791428,3,28,ventricular cardiac muscle tissue morphogenesis,BP,RXRA;TGFBR3;TNNI1
12323,GO:0048706,0.668135798913226,0.473736614990565,8,74,embryonic skeletal system development,BP,IFT140;MDFI;HYAL1;WDR60;DEAF1;SULF2;TGFBR2;WDR19
14760,GO:0070491,0.668224323204308,0.495789840317522,6,56,repressing transcription factor binding,MF,BBS2;ZMYND8;BBS1;PPARA;HDAC5;MTA1
11273,GO:0045604,0.668533454230543,0.511171985787658,5,47,regulation of epidermal cell differentiation,BP,ALOX15B;ZFP36L1;CYP27B1;ERRFI1;AQP3
17400,GO:1900182,0.668724871828803,0.495226915852831,6,56,positive regulation of protein localization to nucleus,BP,TMEM173;NGFR;SESN2;CDK5RAP3;AKT1;FYN
17559,GO:1901222,0.669038450588108,0.510601538231594,5,47,regulation of NIK/NF-kappaB signaling,BP,PDCD4;EGFR;TNFSF15;TMSB4X;UACA
14497,GO:0070011,0.669161410543986,0.394031222593442,40,358,peptidase activity, acting on L-amino acid peptides,MF,HTRA1;TYSND1;ADAM19;ADAMTS7;NPEPL1;RNPEPL1;CLCA2;GGT1;ADAMTS13;MMP28;MMP1;PLAT;CTSF;PRSS3;PCSK1;PRSS8;CAPNS2;USP20;SPPL2B;BLMH;CTSB;LTA4H;C1RL;PGPEP1;PRSS22;ACY1;RHBDF1;PCSK9;LONP2;RHBDF2;TADA3;CTSH;CAPN2;PLAU;ANKZF1;DPP7;JOSD2;RNPEP;MMP17;MMP19
9301,GO:0035774,0.670533896386414,0.611819695130018,2,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,PLA2G6;ANO1
3650,GO:0008134,0.670537979713313,0.38253271311841,57,504,transcription factor binding,MF,BBS2;ZMYND8;NFATC4;FOS;GPX3;NR1D1;ERCC1;MEF2D;DDIT3;CRTC1;SMARCA1;RBL2;TFDP2;MDFI;BBS1;HYAL1;PKN1;DGKQ;PBX2;TMEM173;HDAC11;KDM3A;TRIB2;HES2;APBB3;NAB2;PPARA;AIP;HMGA2;THRA;MLXIPL;ARHGEF2;ATF4;ZFPM1;KDM4C;ZNF516;HDAC5;CEBPB;METTL23;BHLHE40;CDK5RAP3;TADA3;RXRA;IFI27;NCOA7;FOXO4;TP73;SIRT2;RCOR2;MTA1;HDAC8;EPAS1;MAP3K10;CHD6;PER1;WFS1;TEAD2
19719,GO:2000134,0.670972206460012,0.455367101250794,10,93,negative regulation of G1/S transition of mitotic cell cycle,BP,FHL1;GJC2;RBL2;TFDP2;PKD2;PCBP4;CHEK2;CTDSPL;PIDD1;TP73
12403,GO:0048873,0.670993612717789,0.611300493190745,2,19,homeostasis of number of cells within a tissue,BP,F2R;IL20RB
3751,GO:0008296,0.671090405748528,0.718346095933459,1,9,3'-5'-exodeoxyribonuclease activity,MF,ISG20
8960,GO:0035064,0.671340574918559,0.492279934109135,6,56,methylated histone binding,MF,ZMYND8;PHF1;ING4;KDM7A;L3MBTL1;PHF2
17257,GO:0140034,0.671340574918559,0.492279934109135,6,56,methylation-dependent protein binding,MF,ZMYND8;PHF1;ING4;KDM7A;L3MBTL1;PHF2
11286,GO:0045624,0.671349229728144,0.718073782139027,1,9,positive regulation of T-helper cell differentiation,BP,PRKCZ
6120,GO:0019372,0.671756591082493,0.717644773858655,1,9,lipoxygenase pathway,BP,ALOX15B
7452,GO:0031616,0.67176399384702,0.717636973012556,1,9,spindle pole centrosome,CC,NDE1
7642,GO:0032070,0.671797202877538,0.717601976108145,1,9,regulation of deoxyribonuclease activity,BP,AKT1
13874,GO:0060544,0.671859442710512,0.6103213242213,2,19,regulation of necroptotic process,BP,RBCK1;ARHGEF2
17283,GO:0140112,0.672454285006231,0.609647627086292,2,19,extracellular vesicle biogenesis,BP,ARRDC1;TSG101
13036,GO:0051561,0.672652579267197,0.716699382759355,1,9,positive regulation of mitochondrial calcium ion concentration,BP,BNIP3
11275,GO:0045606,0.672894144630694,0.609148938989907,2,19,positive regulation of epidermal cell differentiation,BP,ALOX15B;CYP27B1
10536,GO:0043507,0.672975079750135,0.490433867789569,6,56,positive regulation of JUN kinase activity,BP,ERCC6;PKN1;PAK1;VANGL2;ERN1;MAP3K10
6726,GO:0030149,0.673072121495749,0.608947033350375,2,19,sphingolipid catabolic process,BP,HEXB;NAGA
2725,GO:0006107,0.67307219603623,0.716255781042067,1,9,oxaloacetate metabolic process,BP,PCK2
12351,GO:0048762,0.673139058475461,0.429640079027551,15,137,mesenchymal cell differentiation,BP,SEMA4B;PDCD4;S100A4;CUL7;WWTR1;LAMA5;SEMA3F;HMGA2;MAPK3;SEMA3B;TGFBR2;SEMA4G;TGFBR3;EDNRA;FGFR1
950,GO:0002369,0.673337402232803,0.608645951644135,2,19,T cell cytokine production,BP,PRKCZ;HFE
8436,GO:0033572,0.673423974554636,0.557489694607043,3,29,transferrin transport,BP,TCIRG1;STEAP3;HFE
17584,GO:1901298,0.673668308587571,0.715624662914277,1,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
7743,GO:0032268,0.673754347415333,0.354791269721283,219,1901,regulation of cellular protein metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;F2R;TNFRSF6B;APOE;SERPINE2;GSN;EGR1;PPP1R35;FBXO2;PTK6;EDEM1;GJC2;LRP1;PDCD4;TIMP2;VEGFA;EGFR;PRNP;FBLN1;PRDX5;TFPI2;DUSP5;RAPGEF3;TNFSF15;IGFBP4;CRTAP;CST3;NOS1;ERCC6;GRAMD4;MST1R;ZFP36L1;ADARB1;NUPR1;B3GAT3;HBEGF;CTF1;CNTN1;RPL13A;PLAT;SLC27A1;MIF4GD;PHACTR3;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;SHC2;SYNGAP1;DGKQ;SNX9;MAGEF1;SHC1;VPS11;SPRY2;GRB7;UNK;CIRBP;CAPRIN2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;STK39;FGFR3;CEMIP;KDM3A;MTHFR;PHF1;SPRY4;DLG3;NEURL1;ACVR2B;RAG1;NGFR;ELFN2;TRIB2;EREG;TNFRSF25;NAB2;PLA2G6;LPAR3;C5;PLGRKT;CHAC1;SESN2;MKNK2;IMPACT;PKD2;AREG;ECM1;MAPK3;CSPG4;TRPT1;ERRFI1;STK40;VANGL2;RGS14;SNTA1;MAPK12;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;DMTN;ATF4;BBC3;KDM4C;PAK6;SSH1;IFI6;PKD1;FLOT1;TTN;JDP2;SORL1;HERPUD1;VLDLR;PAPLN;NLRP1;MAP3K12;RHBDF1;LRP5;ATRAID;PCSK9;PKIB;TGFBR2;TRPV4;ITGA1;TRIB3;DAP;HMG20B;CDK5RAP3;AGO4;MINK1;PROM2;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;NBR1;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;PAIP2B;HINT2;AKT1;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;IFT57;SPDYE2;SPDYE2B;TSG101;FGFR4;IGF2BP2;PIAS3;WDFY2;C9ORF72;IFI27;INSR;NCOA7;RPS6KA5;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;PIDD1;MAPK10;TIMP1;HFE;TP73;SNX33;LSM14B;CSNK1E;BCL6;FYN;ZC3H12D;LEMD2;SIRT2;GDF15;GOLGA2;MTA1;HDAC8;PAIP2;EIF4EBP1;AVPI1;CIDEB;LAMTOR2;MAP3K10;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;FKBP8;ERBB2;EIF2AK4;UNC119;CAMKK1;IKBKB;HIP1
8120,GO:0032823,0.673840053708859,0.715442629062925,1,9,regulation of natural killer cell differentiation,BP,GAS6
15413,GO:0071715,0.673996488394282,0.607897221994635,2,19,icosanoid transport,BP,NTSR1;PLA2G6
17665,GO:1901571,0.673996488394282,0.607897221994635,2,19,fatty acid derivative transport,BP,NTSR1;PLA2G6
5803,GO:0017062,0.674009953149081,0.715262461874441,1,9,respiratory chain complex III assembly,BP,TTC19
8799,GO:0034551,0.674009953149081,0.715262461874441,1,9,mitochondrial respiratory chain complex III assembly,BP,TTC19
10484,GO:0043403,0.674632009158145,0.607174320985066,2,19,skeletal muscle tissue regeneration,BP,TGFBR2;WNT7A
11689,GO:0046501,0.674685796863624,0.714544890809205,1,9,protoporphyrinogen IX metabolic process,BP,UROS
11546,GO:0046112,0.674950770903583,0.606811382669412,2,19,nucleobase biosynthetic process,BP,APRT;ADA
18498,GO:1903708,0.675245219069751,0.439518168841514,12,111,positive regulation of hemopoiesis,BP,FOS;CTNNBIP1;FAM210B;ZFP36L1;PRKCZ;RAG1;INPP5D;TGFBR2;GAS6;BCL6;ADA;HLA-G
14347,GO:0061608,0.675281230105263,0.713911523264843,1,9,nuclear import signal receptor activity,MF,TMCO6
9815,GO:0042053,0.675321920707811,0.713868200192896,1,9,regulation of dopamine metabolic process,BP,PNKD
9822,GO:0042069,0.675321920707811,0.713868200192896,1,9,regulation of catecholamine metabolic process,BP,PNKD
18511,GO:1903729,0.675555406743456,0.713619509502546,1,9,regulation of plasma membrane organization,BP,GSN
10254,GO:0043011,0.675667270404175,0.713500301291127,1,9,myeloid dendritic cell differentiation,BP,TGFBR2
8955,GO:0035050,0.675853719830366,0.502867051505428,5,47,embryonic heart tube development,BP,PKD2;VANGL2;TGFBR2;IFT57;TEAD2
597,GO:0001765,0.675901595601244,0.713250465169082,1,9,membrane raft assembly,BP,FLOT1
13675,GO:0060253,0.675930436635571,0.713219703236212,1,9,negative regulation of glial cell proliferation,BP,IDH2
10998,GO:0044849,0.675936060755004,0.713213704233094,1,9,estrous cycle,BP,EGR1
408,GO:0001094,0.675995229977557,0.713150585034459,1,9,TFIID-class transcription factor binding,MF,ERCC1
7331,GO:0031362,0.676253233618218,0.712875230509634,1,9,anchored component of external side of plasma membrane,CC,PRNP
13222,GO:0051923,0.67629225602314,0.712833565794628,1,9,sulfation,BP,UST
3801,GO:0008385,0.676331456255829,0.7127917064365,1,9,IkappaB kinase complex,CC,IKBKB
12574,GO:0050774,0.676632342730718,0.712470250170431,1,9,negative regulation of dendrite morphogenesis,BP,NFATC4
5722,GO:0016868,0.676641214681393,0.712460767417339,1,9,intramolecular transferase activity, phosphotransferases,MF,PGM1
17715,GO:1901678,0.676862420841028,0.712224252662254,1,9,iron coordination entity transport,BP,SLC48A1
16235,GO:0090317,0.67691556367308,0.553484197617599,3,29,negative regulation of intracellular protein transport,BP,DMTN;PDE2A;GAS6
6049,GO:0019200,0.676919639176622,0.604564474822013,2,19,carbohydrate kinase activity,MF,GALK1;PFKL
10714,GO:0044088,0.677092942050057,0.522605078379128,4,38,regulation of vacuole organization,BP,ULK1;TBC1D14;LRSAM1;C9ORF72
12662,GO:0050901,0.677206942765311,0.711855584068298,1,9,leukocyte tethering or rolling,BP,PTAFR
4558,GO:0010644,0.677476315822947,0.603927564926649,2,19,cell communication by electrical coupling,BP,GJC2;ANK3
17225,GO:0120033,0.677563960590867,0.603827222757492,2,19,negative regulation of plasma membrane bounded cell projection assembly,BP,EVI5L;PLXNB3
10049,GO:0042558,0.677645939688112,0.552643414037828,3,29,pteridine-containing compound metabolic process,BP,MTHFR;ALDH1L2;ALDH1L1
15694,GO:0072283,0.677719222711926,0.71130671427719,1,9,metanephric renal vesicle morphogenesis,BP,KIF26B
1134,GO:0002726,0.677737185993461,0.711287453070536,1,9,positive regulation of T cell cytokine production,BP,PRKCZ
9751,GO:0039530,0.677911846356362,0.711100120099459,1,9,MDA-5 signaling pathway,BP,TKFC
5035,GO:0015217,0.677963693478924,0.711044492793073,1,9,ADP transmembrane transporter activity,MF,SLC25A42
5239,GO:0015866,0.677963693478924,0.711044492793073,1,9,ADP transport,BP,SLC25A42
8472,GO:0033631,0.677987553572233,0.711018890228798,1,9,cell-cell adhesion mediated by integrin,BP,ADA
5240,GO:0015867,0.677997541521002,0.711008172343317,1,9,ATP transport,BP,SLC25A42
18220,GO:1903069,0.678173093404174,0.710819739828613,1,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,HERPUD1
11343,GO:0045723,0.678243646568688,0.710743982824128,1,9,positive regulation of fatty acid biosynthetic process,BP,MLXIPL
10071,GO:0042588,0.678262749007191,0.710723468750956,1,9,zymogen granule,CC,VAMP2
14940,GO:0070861,0.678288474588944,0.602997065174606,2,19,regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1
17814,GO:1902018,0.678349351334545,0.710630452322172,1,9,negative regulation of cilium assembly,BP,EVI5L
3031,GO:0006582,0.67836137410666,0.710617537239166,1,9,melanin metabolic process,BP,TRPC1
8731,GO:0034393,0.678373886744825,0.71060409545065,1,9,positive regulation of smooth muscle cell apoptotic process,BP,PDCD4
7056,GO:0030852,0.678520714788701,0.710446327731944,1,9,regulation of granulocyte differentiation,BP,INPP5D
19703,GO:2000104,0.678586065642994,0.602655729214507,2,19,negative regulation of DNA-dependent DNA replication,BP,CHEK2;BCL6
11751,GO:0046629,0.678688906681281,0.710265521310161,1,9,gamma-delta T cell activation,BP,SOX13
3891,GO:0008532,0.678728491828839,0.710222954338087,1,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B4GAT1
10659,GO:0043922,0.678914237965457,0.710023150828942,1,9,negative regulation by host of viral transcription,BP,HMGA2
9784,GO:0040018,0.678926145775287,0.602265406965416,2,19,positive regulation of multicellular organism growth,BP,BBS2;GPR21
2553,GO:0005829,0.679082541392838,0.342576304172429,477,4110,cytosol,CC,TNIP1;XDH;DUSP6;ACTA2;DLG4;HTRA1;DOCK4;GAMT;BBS2;NT5E;ISYNA1;BTBD2;NFATC4;FLNC;SERPINE2;FHL1;S100A6;FOS;OSBPL5;GSN;CTNNBIP1;ALDH7A1;WIPF1;FBXO2;PTK6;CDC42EP5;ACP5;WWC3;NAPRT;RNF135;GLUL;ALOX15B;PDCD4;OBSCN;PADI3;RBCK1;RHPN1;PRNP;ERCC1;PRDX5;ANK3;NEK9;CLTCL1;FCHO1;SPTB;DGKA;KRT15;NINL;IDH2;PARVB;NOS1;GPSM1;DDIT3;ARAP3;DNPH1;SHANK2;DNAJB5;PGM1;CRTC1;CLCA2;NDRG1;ABTB1;ARHGEF19;TRIM65;ZFP36L1;ADARB1;CUL9;NUPR1;RIN1;ARAP1;RBL2;PHGDH;RPS6KA2;ARHGAP23;PYGL;EXOC2;DHTKD1;MXI1;HSD17B14;RPL13A;MSRB2;OBSL1;BBS1;ULK2;SLC27A1;MAPK13;KLF9;MIF4GD;NISCH;MLYCD;ASAP2;FBXW4;CUL7;PITPNM3;LHPP;UROS;MPRIP;PPP1R14A;WWTR1;POLD4;MAP2K1;PCK2;PPL;SDCCAG8;CRYL1;PKN1;PGLS;DDIT4;OPLAH;SHC2;SYNGAP1;PITPNM1;DGKQ;AKR7A2;TUBG2;SNX9;PLEKHG5;ARL2;ULK1;SHC1;PHF7;SPRY2;GRB7;NPHP4;LGALS9C;BLOC1S4;OGDHL;LGALS9B;RAB3B;MYH11;RALGDS;PITPNC1;NMRK1;APPL2;CAPRIN2;TPM2;TTBK2;PRKCZ;GALE;PAK1;AARS;STK39;BLVRB;FBXO41;SEC14L2;MTHFR;GLDC;NPR2;CAPNS2;CBS;SPRY4;USP20;DOCK6;DLG3;MICALL2;CEP250;GRIP2;FBXW8;ABHD14B;NGFR;ETFB;GSTO1;ARHGEF4;SYNC;PPCS;ACTR1B;PSAT1;SPG11;APBB3;RMI2;PLCD3;PLEKHG2;CCDC106;PSPH;RHOBTB2;TNFRSF25;PLA2G6;UNKL;CES3;XPOT;TRAPPC9;MANF;S100A13;GSTT1;AGAP1;ALS2CL;CARS;MTMR4;KIF17;SPATS2;ACOT1;CHAC1;SPC24;SESN2;AIP;BLMH;RASA4;STAT6;ING4;ACOT11;VAMP2;ACACB;NT5C1B;KCNAB2;MAPK3;PC;FBXO27;DEF6;ERRFI1;OSBPL10;THRA;STK40;ACSS2;GSDMA;DOCK9;SH2D2A;MVD;PBXIP1;RHOF;CNTRL;PAN2;HOOK2;EIF2D;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;SRGAP3;CHMP1B;FBXO17;ARHGAP22;MLXIPL;TBC1D14;TCTN1;PLCD1;ARHGEF2;FBF1;INPP5D;MAP2K2;FLYWCH1;PGPEP1;LRSAM1;DMTN;LITAF;PTHLH;UBXN4;NOL4L;DOCK11;SSH1;LRRC45;RABGAP1;ACAP3;FBXO6;CBX7;ATXN10;CEP68;TTN;HLCS;AZIN2;HDAC5;GTPBP1;IRF5;GALK1;PCBP4;SRSF5;GSTM2;NADK;NLRP1;ACY1;ENDOG;MAP3K12;ACOT7;TSTD1;WNK4;RIN2;ALDOC;NDE1;FBXL15;FBXL16;CEP131;MARK3;TGFBR2;ARHGAP25;TMSB4X;MAP1LC3A;MOCOS;PDE2A;SMURF2;LMO7;TRIB3;CALCOCO1;CDK5RAP3;NOS3;AGO4;MINK1;TTLL11;TRPV1;PIP5KL1;BNIP3L;PIK3R2;ANGEL1;SHARPIN;CCS;FMNL2;DNAJC6;LZTS2;CROCC;BCR;KLHDC8B;FYCO1;MAN2C1;CHKB;C19ORF33;NBR1;TNNI2;KIF13B;UCKL1;PPP1R15A;ADCY6;TNRC18;SPATA7;STRADB;CTSH;FBXL8;UACA;GSDMC;GSTO2;ASNS;STEAP2;AKT1;ZFYVE21;CARD11;DGUOK;MICAL1;CRY2;MZT2B;WDR45;SBF2;ASS1;TNNT1;NFU1;CABYR;TSG101;FMNL3;IGF2BP2;RASSF9;ASAP3;HAGH;PHLDA1;ACADVL;NUCB2;FARP1;LMNA;ASMTL;UPP1;SH2B3;SPSB3;COPG1;ATG2A;CHMP5;CAPN2;GOLGA8A;ICA1;MARK4;ARHGAP27;KRT19;FOXO4;CHMP4C;PNPLA4;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;HOMER2;MAP2K5;BRAF;ARHGAP44;ALDH1L1;PIDD1;CAT;MZT2A;HAUS4;MAPK10;DPP7;LGALS1;UNC119B;JAK3;TP73;TUBGCP6;FRAT1;SNX33;APRT;MIB2;MPI;PEX7;SNX17;JOSD2;SPIRE1;CSNK1E;TAZ;REPS2;RNF213;GSTM3;ADAP1;TKFC;EPS8L1;EHD3;RPL39L;FYN;SNX1;PEX1;UBXN6;ARHGEF17;SIRT2;RECQL5;RAB13;OSBPL1A;TOM1;SH3GLB2;ADA;POLR3GL;RHOBTB3;ETNK2;MTA1;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;ADIRF;RPL29;EIF4EBP1;CIDEB;VAV3;STX1A;EPAS1;TBC1D16;STARD10;DHPS;EPHB2;NMRAL1;INPP4A;PER1;MCTP2;IGF2BP3;FGFR1;BLOC1S1;FKBP8;SH3PXD2A;CTH;ERBB2;EIF2AK4;UNC119;RGS12;PFKL;CORO1B;SFI1;RPL12;HMBOX1;NET1;GRB10;TNNI1;LYPLAL1;NUDT18;TRIM45;APBA1;CAMKK1;DTD1;IKBKB;DMTF1;SNCB;HIP1;PLEKHH2;TEAD2;BTBD11
287,GO:0000792,0.6791323718771,0.471090191221057,7,66,heterochromatin,CC,PHC2;SATB1;HMGA2;KDM4C;DNMT3A;UHRF2;SIRT2
14141,GO:0061050,0.679315658284352,0.709590980516,1,9,regulation of cell growth involved in cardiac muscle cell development,BP,PAK1
6355,GO:0021542,0.679407346885327,0.70949219721108,1,9,dentate gyrus development,BP,MDK
15778,GO:0072498,0.679418276747744,0.709480419851213,1,9,embryonic skeletal joint development,BP,HYAL1
1281,GO:0003085,0.679482823695677,0.709410860288348,1,9,negative regulation of systemic arterial blood pressure,BP,NTSR1
7641,GO:0032069,0.679503538510184,0.550500454782286,3,29,regulation of nuclease activity,BP,NEIL1;ERN1;AKT1
810,GO:0002084,0.679523888587554,0.709366599536279,1,9,protein depalmitoylation,BP,LYPLAL1
12521,GO:0050691,0.679612571782717,0.55037446838317,3,29,regulation of defense response to virus by host,BP,TMEM173;APOBEC3F;EIF2AK4
18079,GO:1902745,0.679633336498845,0.601452878779169,2,19,positive regulation of lamellipodium organization,BP,TWF2;CORO1B
14813,GO:0070578,0.679840829232368,0.709024814463092,1,9,RISC-loading complex,CC,AGO4
3279,GO:0006968,0.679978609818565,0.601055753874647,2,19,cellular defense response,BP,TCIRG1;HLA-G
6706,GO:0030123,0.680090213394305,0.708755658996325,1,9,AP-3 adaptor complex,CC,VPS39
8233,GO:0033017,0.680127632903501,0.60088426545007,2,19,sarcoplasmic reticulum membrane,CC,NOS1;ITPR2
14390,GO:0061700,0.680139765491116,0.708702155029081,1,9,GATOR2 complex,CC,SESN2
5953,GO:0018342,0.680188368640507,0.708649668165102,1,9,protein prenylation,BP,RABGGTA
16540,GO:0097354,0.680188368640507,0.708649668165102,1,9,prenylation,BP,RABGGTA
17358,GO:1900112,0.680247341965817,0.708585972471722,1,9,regulation of histone H3-K9 trimethylation,BP,KDM4C
8613,GO:0034143,0.680255685738606,0.708576959673456,1,9,regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
9781,GO:0040015,0.680261895283941,0.70857025208876,1,9,negative regulation of multicellular organism growth,BP,BBS2
16145,GO:0090192,0.680302295493944,0.7085266085875,1,9,regulation of glomerulus development,BP,EGR1
7060,GO:0030856,0.680310646978264,0.444946682671446,10,93,regulation of epithelial cell differentiation,BP,XDH;ALOX15B;ZFP36L1;WWTR1;CYP27B1;BTG1;ERRFI1;CEBPB;AQP3;IKBKB
17311,GO:1900017,0.680385448007345,0.708436764452161,1,9,positive regulation of cytokine production involved in inflammatory response,BP,IL17RC
1453,GO:0003691,0.680398551467723,0.708422604511691,1,9,double-stranded telomeric DNA binding,MF,HMBOX1
1143,GO:0002739,0.680433279053936,0.708385074357046,1,9,regulation of cytokine secretion involved in immune response,BP,MAPK3
12837,GO:0051181,0.68051507825223,0.549330765781926,3,29,cofactor transport,BP,SLC48A1;SLC25A29;SLC25A42
265,GO:0000733,0.680539673138004,0.708270070400274,1,9,DNA strand renaturation,BP,SMARCA1
726,GO:0001956,0.680539879528917,0.708269847273508,1,9,positive regulation of neurotransmitter secretion,BP,STX1A
17830,GO:1902065,0.680579393668362,0.708227126346231,1,9,response to L-glutamate,BP,FYN
16731,GO:0098542,0.680647387351188,0.392474328210267,29,267,defense response to other organism,BP,HTRA1;ACP5;ADARB1;DDIT4;TMEM173;SHC1;APOBEC3C;FAM3A;CCDC88B;PLA2G6;APOBEC3F;NLRX1;MAPK3;BNIP3;IFITM1;GSDMA;LRSAM1;IRF5;NLRP1;CEBPB;ISG20;BNIP3L;GSDMC;MAPKBP1;IL17RC;LYST;TKFC;SIRT2;EIF2AK4
12241,GO:0048548,0.680803503596467,0.707984735330534,1,9,regulation of pinocytosis,BP,PROM2
14974,GO:0070922,0.680818727048153,0.707968264313484,1,9,small RNA loading onto RISC,BP,AGO4
4563,GO:0010649,0.680866115923376,0.707916987217253,1,9,regulation of cell communication by electrical coupling,BP,ANK3
7794,GO:0032352,0.680918013071374,0.707860823799964,1,9,positive regulation of hormone metabolic process,BP,EGR1
5916,GO:0018196,0.68096007589251,0.51781709942547,4,39,peptidyl-asparagine modification,BP,ST6GALNAC2;ST6GALNAC6;ST3GAL3;SYVN1
15904,GO:0072718,0.680993942477329,0.707778637173929,1,9,response to cisplatin,BP,ADIRF
7212,GO:0031115,0.681045437733228,0.707722887895557,1,9,negative regulation of microtubule polymerization,BP,EML2
18586,GO:1903897,0.681091674776786,0.707672824060525,1,9,regulation of PERK-mediated unfolded protein response,BP,PPP1R15A
5755,GO:0016922,0.681173301581107,0.599679505469608,2,19,ligand-dependent nuclear receptor binding,MF,TADA3;RXRA
13473,GO:0055064,0.681207047693154,0.707547872842418,1,9,chloride ion homeostasis,BP,SLC12A7
9024,GO:0035253,0.681225759351882,0.70752760376286,1,9,ciliary rootlet,CC,CROCC
9004,GO:0035196,0.68123286477316,0.517841914155065,4,38,production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K1;MAP2K2;AGO4
13382,GO:0052745,0.681355710100555,0.599469083329,2,19,inositol phosphate phosphatase activity,MF,INPP5D;INPP4A
10092,GO:0042626,0.681424447483009,0.468489669901484,7,66,ATPase activity, coupled to transmembrane movement of substances,MF,ABCA2;ABCA7;ABCG1;ATP7B;ATP2B4;TCIRG1;ATP12A
17284,GO:0140115,0.681501402393378,0.707228889728386,1,9,export across plasma membrane,BP,ATP12A
14664,GO:0070306,0.681519380233774,0.599280211158247,2,19,lens fiber cell differentiation,BP,WNT7A;TBC1D20
7932,GO:0032530,0.681535957383804,0.707191425545461,1,9,regulation of microvillus organization,BP,TWF2
18805,GO:1904424,0.681590661776058,0.707132107837117,1,9,regulation of GTP binding,BP,GPSM1
11972,GO:0047372,0.68159854074799,0.707123563635825,1,9,acylglycerol lipase activity,MF,FAAH
14979,GO:0070933,0.6817239901212,0.70698749593496,1,9,histone H4 deacetylation,BP,SIRT2
8476,GO:0033643,0.681843671048844,0.706857638407971,1,9,host cell part,CC,PI4K2A
10958,GO:0044764,0.681884438314331,0.547744202960729,3,29,multi-organism cellular process,BP,NLRX1;GAS6;TKFC
10226,GO:0042975,0.681941083019048,0.706751909837492,1,9,peroxisome proliferator activated receptor binding,MF,NFATC4
14158,GO:0061085,0.681969399677727,0.706721169977585,1,9,regulation of histone H3-K27 methylation,BP,PHF1
16169,GO:0090224,0.681983760513558,0.516974951321907,4,38,regulation of spindle organization,BP,CHMP1B;PKD1;CHMP5;CHMP4C
4850,GO:0014067,0.681985785439628,0.706703380841089,1,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2
4089,GO:0009147,0.68200609877687,0.597791850253559,2,20,pyrimidine nucleoside triphosphate metabolic process,BP,NME4;UCKL1
9276,GO:0035729,0.682054292272717,0.70662899743575,1,9,cellular response to hepatocyte growth factor stimulus,BP,SIRT2
3397,GO:0007179,0.682140613362732,0.423286584078467,14,129,transforming growth factor beta receptor signaling pathway,BP,HTRA1;FOS;LTBP4;PRKCZ;LTBP1;MTMR4;ITGB5;LTBP2;TGFBR2;SMURF2;CDKN1C;GDF15;CIDEA;TGFBR3
13816,GO:0060442,0.682247539607709,0.706419092858712,1,9,branching involved in prostate gland morphogenesis,BP,RXRA
5175,GO:0015740,0.682256411443318,0.706409453453884,1,9,C4-dicarboxylate transport,BP,NTSR1
8964,GO:0035068,0.682302722826956,0.706359131260945,1,9,micro-ribonucleoprotein complex,CC,AGO4
16932,GO:0098969,0.682376126266814,0.706279356731691,1,9,neurotransmitter receptor transport to postsynaptic membrane,BP,ARHGAP44
18423,GO:1903539,0.682376126266814,0.706279356731691,1,9,protein localization to postsynaptic membrane,BP,ARHGAP44
18424,GO:1903540,0.682376126266814,0.706279356731691,1,9,establishment of protein localization to postsynaptic membrane,BP,ARHGAP44
7443,GO:0031588,0.682401283583838,0.70625201193056,1,9,nucleotide-activated protein kinase complex,CC,SESN2
10910,GO:0044546,0.682409026463696,0.706243595385057,1,9,NLRP3 inflammasome complex assembly,BP,SIRT2
17421,GO:1900225,0.682409026463696,0.706243595385057,1,9,regulation of NLRP3 inflammasome complex assembly,BP,SIRT2
10142,GO:0042742,0.682416671651577,0.442161870393807,10,98,defense response to bacterium,BP,ACP5;SHC1;PLA2G6;GSDMA;NLRP1;CEBPB;GSDMC;MAPKBP1;LYST;SIRT2
15568,GO:0072075,0.682553187383259,0.706086857000836,1,9,metanephric mesenchyme development,BP,PKD2
14798,GO:0070561,0.682625670172272,0.706008025402851,1,9,vitamin D receptor signaling pathway,BP,CYP27B1
10339,GO:0043169,0.682662888852891,0.341076444267088,346,2969,cation binding,MF,XDH;ZC3H6;NT5E;APOE;SYTL1;ZMYND8;FHL1;S100A6;GSN;EGR1;THBS3;POSTN;ADAM19;ZNF862;TMEM129;ACP5;EDEM1;RNF135;GLUL;LRP1;ALOX15B;NAGS;TIMP2;OBSCN;PADI3;ZSCAN18;RBCK1;PRNP;NR1D1;FBLN1;ADAMTS7;S100A4;NEK9;ZKSCAN1;NPEPL1;LOXL1;DGKA;RNPEPL1;NINL;IDH2;FKBP9;NOS1;HAGHL;ARAP3;BRSK1;PGM1;CGREF1;CLCA2;ADAMTS13;TCEA2;MMP28;ZCCHC24;TRIM65;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;ARAP1;B3GAT3;RPS6KA2;PYGL;MMP1;CYP3A5;DHTKD1;PHYHD1;MSRB2;LTBP4;KLF9;RNF165;RAB11FIP4;ASAP2;ASH2L;PITPNM3;LHPP;PRSS3;HMGCL;SMOC2;SMOC1;CYP27B1;PCK2;PLCH2;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;THAP8;VPS11;PHF7;OGDHL;CYBRD1;ITPR3;UNK;NMRK1;CAPRIN2;PRKCZ;PPP2R3B;HTR7;APOBEC3C;AARS;PHYH;MCTP1;KDM3A;PHF1;GLDC;CAPNS2;CBS;USP20;SALL2;ZSWIM4;DDX59;MICALL2;NME4;NEIL1;NEURL1;ACVR2B;RAG1;MARCH4;NID1;LTBP1;RNF44;CYHR1;PLCD3;PSPH;UNKL;ESYT2;S100A13;AGAP1;CARS;FKBP10;MTMR4;APOBEC3F;PPARA;CHD3;SESN2;MKNK2;RASA4;PKD2;KLF7;ING4;SLIT3;B4GAT1;MARCH9;PCLO;JADE2;ACACB;NT5C1B;PC;THRA;PEX10;ACSS2;IRF2BPL;FAM20C;DYSF;LTBP2;FAHD2B;PAN2;ZSCAN30;MAPK12;LTA4H;PI4K2A;ZXDC;PLCD1;ARHGEF2;MAP2K2;FLYWCH1;LRSAM1;LITAF;ZFPM1;KDM4C;ZNF467;PRIMPOL;POLM;ACAP3;TENM2;ZNF516;NSMCE1;LTBP3;TTN;KCNMA1;HDAC5;PLTP;VLDLR;NADK;DEAF1;SULF2;PEG3;ACY1;GLI4;ENDOG;KDM7A;EGFL7;NEK8;ZNF251;L3MBTL1;ISG20;HLTF;DNMT3A;TGFBR2;ITGA1;MOCOS;PDE2A;LMO7;NOS3;ZFP90;TRPV1;MARCH2;ZNF558;ZNF662;SHARPIN;CCS;GAS6;GLUD1;SUCLG2;ERN1;ALKBH7;ATP7B;FYCO1;MAN2C1;NBR1;EXD3;FAHD2A;SRR;NUDT8;NECAB3;POLL;CYP2R1;RXRA;ZNF358;ADCY6;ZNF362;MBD1;ATP2B4;THNSL2;PRDM8;EFEMP2;MGMT;STEAP2;ZFYVE21;ITPR2;MICAL1;B4GALT2;CHEK2;LACTB2;CAPS;TNNT1;NFU1;CABYR;PHF2;ZNF217;SNN;PIAS3;ASAP3;HAGH;STEAP3;NUCB2;ZNF25;LENG9;WDFY2;UHRF2;ARSA;CAPN2;MAN2B1;ACSS1;GNAL;YPEL3;RPS6KA5;ANKZF1;MBLAC2;RABGGTA;CTDSPL;MAP2K5;BRAF;ZNF554;CPSF4;RNF215;FAAP20;CAT;ZNF160;YPEL5;ZFP28;TIMP1;TP73;MTA3;UBOX5;CHRM3;ZNF846;APRT;OGFOD2;MIB2;MPI;ENDOV;PHC1;ATP12A;BCL6;REPS2;SAT2;RNF213;ADAP1;TKFC;EHD3;FYN;MAST4;ZC3H12D;ATP8B2;PJA2;SIRT2;ANKMY1;CELSR1;ADA;MTA1;HDAC8;RNPEP;VAV3;MAN1B1;GALNS;MFNG;RNF170;MCTP2;ITGA2;ZNF333;ESYT3;FKBP8;STK32B;SYVN1;PFKL;MMP17;MPPE1;TRIM2;TSHZ1;TNNI1;MMP19;ZNF449;IRF2BP2;ZMYM3;NUDT18;TRIM45;ZNF667;ZNF287;PNKD;DTX3;DTD1;SNCB;CYP4V2
11342,GO:0045722,0.6827045310254,0.705922238092221,1,9,positive regulation of gluconeogenesis,BP,PPARA
2279,GO:0005230,0.682738685223946,0.705885077941233,1,9,extracellular ligand-gated ion channel activity,MF,TRPV1
15861,GO:0072643,0.68283462114347,0.705780678719552,1,9,interferon-gamma secretion,BP,BTN3A2
2350,GO:0005416,0.682891303659482,0.705718981995869,1,9,amino acid:cation symporter activity,MF,SLC6A9
7997,GO:0032634,0.682916138716542,0.705691946773569,1,9,interleukin-5 production,BP,PRKCZ
8021,GO:0032674,0.682916138716542,0.705691946773569,1,9,regulation of interleukin-5 production,BP,PRKCZ
13363,GO:0052659,0.682976364877008,0.705626376952988,1,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,INPP5D
2642,GO:0005979,0.683029693170883,0.597534379785739,2,19,regulation of glycogen biosynthetic process,BP,AKT1;INSR
4772,GO:0010962,0.683029693170883,0.597534379785739,2,19,regulation of glucan biosynthetic process,BP,AKT1;INSR
17245,GO:0120103,0.683148879292001,0.705438491961365,1,9,centriolar subdistal appendage,CC,CNTRL
360,GO:0000979,0.683172628512148,0.546248409051679,3,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,FOS;KDM3A;CEBPB
19117,GO:1905146,0.683286963731607,0.705288036204545,1,9,lysosomal protein catabolic process,BP,LRP1
12382,GO:0048845,0.683412892501148,0.705150772155754,1,9,venous blood vessel morphogenesis,BP,VEGFA
14639,GO:0070266,0.683552448550652,0.5458067697252,3,29,necroptotic process,BP,RBCK1;PYGL;ARHGEF2
9119,GO:0035457,0.683754363448549,0.704778309544582,1,9,cellular response to interferon-alpha,BP,GAS6
8311,GO:0033160,0.683781676086195,0.704748501948358,1,9,positive regulation of protein import into nucleus, translocation,BP,TMEM173
8736,GO:0034399,0.683833882244594,0.42543576343804,13,120,nuclear periphery,CC,PHACTR3;DGKQ;PRKCZ;XPOT;SATB1;ATF4;HLCS;TEP1;CEBPB;DNMT3A;MBD1;LMNA;RGS12
2409,GO:0005583,0.68403517652702,0.704471730963399,1,9,fibrillar collagen trimer,CC,TNXB
16773,GO:0098643,0.68403517652702,0.704471730963399,1,9,banded collagen fibril,CC,TNXB
9538,GO:0036314,0.684253291466307,0.596116046913333,2,19,response to sterol,BP,ABCA2;TGFBR2
8734,GO:0034397,0.68431472290813,0.704166284842354,1,9,telomere localization,BP,LEMD2
7748,GO:0032273,0.684411182316924,0.440254548457852,10,94,positive regulation of protein polymerization,BP,GSN;WIPF1;CDC42EP5;ARPIN;ARL2;PAK1;WHAMMP3;SPIRE1;C15ORF62;CORO1B
19309,GO:1905666,0.684452925521054,0.704015185486608,1,9,regulation of protein localization to endosome,BP,SORL1
19310,GO:1905668,0.684452925521054,0.704015185486608,1,9,positive regulation of protein localization to endosome,BP,SORL1
9118,GO:0035456,0.684607203568753,0.594775509851494,2,20,response to interferon-beta,BP,TMEM173;IFITM1
12381,GO:0048844,0.684620805745083,0.513922893264918,4,38,artery morphogenesis,BP,APOE;LRP1;VEGFA;PKD2
3777,GO:0008340,0.685342594450148,0.703041029158716,1,9,determination of adult lifespan,BP,INPP5D
12321,GO:0048704,0.685667597167107,0.47578615842908,6,57,embryonic skeletal system morphogenesis,BP,IFT140;MDFI;HYAL1;WDR60;TGFBR2;WDR19
3625,GO:0008088,0.685678141277564,0.491349386075563,5,48,axo-dendritic transport,BP,BLOC1S4;SPG11;KIF17;BLOC1S1;APBA1
194,GO:0000413,0.685934723025267,0.542527980588409,3,30,protein peptidyl-prolyl isomerization,BP,FKBP9;FKBP10;FKBP8
1476,GO:0003755,0.685934723025267,0.542527980588409,3,30,peptidyl-prolyl cis-trans isomerase activity,MF,FKBP9;FKBP10;FKBP8
6652,GO:0030011,0.686303529858384,0.701985981812836,1,9,maintenance of cell polarity,BP,LRCH4
8262,GO:0033077,0.686473991100235,0.490430229777198,5,48,T cell differentiation in thymus,BP,ZFP36L1;RAG1;CARD11;ADA;ERBB2
7759,GO:0032288,0.686538066267113,0.593458198686734,2,19,myelin assembly,BP,CD9;TENM4
17869,GO:1902186,0.686764915227464,0.54206032650917,3,29,regulation of viral release from host cell,BP,PC;TSG101;CHMP4C
12123,GO:0048247,0.687126621359977,0.591838716025105,2,20,lymphocyte chemotaxis,BP,GAS6;CKLF
11826,GO:0046825,0.687833454810096,0.509848123695812,4,39,regulation of protein export from nucleus,BP,RAPGEF3;GAS6;CAMK1;IFI27
15637,GO:0072182,0.687868691067882,0.70026115504583,1,9,regulation of nephron tubule epithelial cell differentiation,BP,WWTR1
12774,GO:0051092,0.688008047728343,0.42515944874558,12,113,positive regulation of NF-kappaB transcription factor activity,BP,RBCK1;PRKCZ;TRAPPC9;ARHGEF2;EDA;CARD11;RPS6KA5;EDA2R;PIDD1;CAT;CTH;IKBKB
7862,GO:0032432,0.688032988444144,0.488626953303731,5,48,actin filament bundle,CC,MST1R;MICALL2;SHROOM4;VANGL2;CORO1B
10879,GO:0044440,0.688720049067577,0.370242747504808,44,395,endosomal part,CC,EGFR;NDRG1;RAB11FIP4;ABCA2;VPS11;CD68;APPL2;ABCA7;SPPL2B;MTMR4;AP1G2;CTSB;MVB12B;PI4K2A;CHMP1B;PRAF2;SLC48A1;LITAF;SORL1;TMEM175;PCSK9;MARCH2;VPS39;CTSH;TMEM9;STEAP2;ZFYVE21;TSG101;TCIRG1;STEAP3;CHMP5;INSR;CHMP4C;TPCN1;SNX17;SLC9A7;EHD3;SNX1;UBXN6;RAB13;AP2A2;LAMTOR2;ERBB2;HLA-G
5297,GO:0015991,0.689268000685311,0.589330762035682,2,20,ATP hydrolysis coupled proton transport,BP,TCIRG1;ATP12A
9052,GO:0035303,0.689642680465556,0.405140595863117,17,156,regulation of dephosphorylation,BP,PPP1R35;B3GAT3;PHACTR3;PPP1R14A;PPP2R3B;DLG3;ELFN2;MTMR4;CSRNP3;ITGA1;CDK5RAP3;PPP1R15A;CRY2;FARP1;ITGA2;SFI1;IKBKB
16628,GO:0097530,0.69030588994406,0.470086494972789,6,59,granulocyte migration,BP,MAPK3;TRPV4;ITGA1;IL17RC;CKLF;VAV3
10579,GO:0043565,0.690900184037578,0.351624084163494,86,754,sequence-specific DNA binding,MF,ZC3H6;ZMYND8;NFATC4;FOS;H1F0;EGR1;NR1D1;BAHCC1;MEF2D;DDIT3;TCFL5;TFDP2;MXI1;SOX13;ETV4;PHF21A;ZNF76;PBX2;SOX12;ELK3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;RAG1;ETV5;HES2;CHD2;TEF;CARF;PPARA;SATB1;STAT6;KLF7;HMGA2;THRA;MLXIPL;TSPYL2;LITAF;ATF4;ZFPM1;ZNF516;JDP2;IRF5;DEAF1;RFX2;CEBPB;CREBRF;HLTF;MXD3;FOXL1;CSRNP3;BHLHE40;MLH3;CALCOCO1;ZFP90;ZNF558;RXRA;MBD1;TNRC18;CRY2;ZNF217;ZNF25;SMARCD2;FOXO4;ZNF554;HOXC5;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;POU2F2;MTA1;TCF7;EPAS1;PER1;HMBOX1;CREB3L4;DBP;DMTF1;TEAD2;SIX5
19365,GO:1905897,0.691626130359215,0.456687604506433,7,67,regulation of response to endoplasmic reticulum stress,BP,EDEM1;DDIT3;HERPUD1;ERN1;PPP1R15A;WFS1;SYVN1
3632,GO:0008097,0.691873492948689,0.693234977675346,1,10,5S rRNA binding,MF,TST
13735,GO:0060337,0.692279475305154,0.455793182316427,7,68,type I interferon signaling pathway,BP,EGR1;IFITM1;IFI6;IRF5;ISG20;IFI27;HLA-G
15185,GO:0071357,0.692279475305154,0.455793182316427,7,68,cellular response to type I interferon,BP,EGR1;IFITM1;IFI6;IRF5;ISG20;IFI27;HLA-G
13532,GO:0060021,0.692427479402032,0.467998307390948,6,57,roof of mouth development,BP,ACVR2B;TGFBR2;WNT7A;TGFBR3;EPHB2;TSHZ1
11836,GO:0046839,0.692487599503487,0.535336758301057,3,29,phospholipid dephosphorylation,BP,MTMR4;INPP5D;PLPP6
14306,GO:0061515,0.693290954762546,0.482518274404396,5,48,myeloid cell development,BP,FAM210B;FAM20C;DMTN;ZFPM1;BCL6
16312,GO:0090575,0.694537213365944,0.409368186749709,14,131,RNA polymerase II transcription factor complex,CC,FOS;NR1D1;ERCC1;DDIT3;TFDP2;MXI1;PPARA;THRA;ATF4;CEBPB;MXD3;TADA3;RXRA;TEAD2
2577,GO:0005868,0.69461465778173,0.583020932780057,2,20,cytoplasmic dynein complex,CC,WDR60;NUDCD3
5737,GO:0016889,0.69549922575065,0.581970366245557,2,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,NEIL1;DNASE2
4066,GO:0009123,0.695700836815581,0.376067913008505,29,271,nucleoside monophosphate metabolic process,BP,DLG4;NT5E;DNPH1;PGM1;DHTKD1;TK2;LHPP;DDIT4;OGDHL;DLG3;PPARA;FAM20C;MYH3;MLXIPL;SDHA;GALK1;NADK;ALDOC;TMSB4X;UCKL1;CARD11;DGUOK;TCIRG1;UPP1;INSR;APRT;TAZ;ADA;PFKL
6697,GO:0030104,0.695833118694629,0.479549841062355,5,48,water homeostasis,BP,AQP3;TRPV4;ADCY6;SCNN1A;WFS1
15385,GO:0071675,0.695904352274741,0.581488579107989,2,20,regulation of mononuclear cell migration,BP,MAPK3;TRPV4
7096,GO:0030901,0.695951177032135,0.463729056316718,6,58,midbrain development,BP,KDM7A;GLUD1;WNT3;CSNK1E;SIRT2;FGFR1
10527,GO:0043492,0.696188913822497,0.441741503467153,8,76,ATPase activity, coupled to movement of substances,MF,ABCA2;ABCA7;ABCG1;ATP7B;ATP2B4;TCIRG1;ATP12A;ATP8B2
10965,GO:0044774,0.696269353970577,0.420939338353857,11,104,mitotic DNA integrity checkpoint,BP,XPC;BRSK1;RBL2;TFDP2;HMGA2;PCBP4;CDK5RAP3;CHEK2;FOXO4;PIDD1;TP73
16536,GO:0097345,0.696586002861967,0.4784299965388,5,49,mitochondrial outer membrane permeabilization,BP,TFDP2;BNIP3;BBC3;BNIP3L;TP73
1380,GO:0003281,0.69659611833989,0.478656986171357,5,48,ventricular septum development,BP,LTBP1;VANGL2;ZFPM1;TGFBR2;TGFBR3
6057,GO:0019209,0.696871756907809,0.462659162293018,6,58,kinase activator activity,MF,ERCC6;MAP2K1;DGKQ;SPRY2;MAP2K2;GAS6
11167,GO:0045277,0.697099630444357,0.685197005732656,1,11,respiratory chain complex IV,CC,NDUFA4L2
12528,GO:0050701,0.697270749364502,0.529160592444334,3,30,interleukin-1 secretion,BP,S100A13;NLRP1;GAS6
2249,GO:0005164,0.69776703675322,0.579268281257487,2,20,tumor necrosis factor receptor binding,MF,TNFSF15;EDA
653,GO:0001844,0.698207595265456,0.528044537945361,3,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2;BBC3;TP73
8127,GO:0032838,0.698554168754931,0.408830855981996,13,122,plasma membrane bounded cell projection cytoplasm,CC,DLG4;IFT140;BBS1;DNAH1;BLOC1S4;KIF17;SPAG16;SPATA7;IFT57;WDR66;ADA;BLOC1S1;TCTEX1D4
4258,GO:0009607,0.698837689426795,0.350722228651804,61,551,response to biotic stimulus,BP,TNIP1;ACTA2;HTRA1;F2R;TNFRSF6B;FOS;WIPF1;ACP5;PDCD4;NR1D1;LOXL1;NOS1;DDIT3;ADAMTS13;MST1R;ADARB1;PRSS3;HYAL1;CYP27B1;PCK2;DDIT4;TMEM173;SHC1;APOBEC3C;FAM3A;CCDC88B;NGFR;TNFRSF25;PLA2G6;APOBEC3F;NLRX1;HMGA2;MAPK3;BNIP3;IFITM1;GSDMA;IFNGR2;PDCD1LG2;LRSAM1;LITAF;HDAC5;IRF5;NLRP1;CEBPB;ISG20;NOS3;BNIP3L;BCR;SRR;PTAFR;TNFRSF14;GSDMC;MAPKBP1;AKT1;IL17RC;LYST;TKFC;SIRT2;WFS1;EIF2AK4;IKBKB
1306,GO:0003156,0.698893808791758,0.577921066259781,2,20,regulation of animal organ formation,BP,WNT2B;FGFR1
1122,GO:0002711,0.699334602386804,0.577393188076898,2,20,positive regulation of T cell mediated immunity,BP,PRKCZ;ZP3
15866,GO:0072659,0.699339244456019,0.38692761681046,20,184,protein localization to plasma membrane,BP,BBS2;LRP1;EGFR;PRNP;ANK3;PACS2;BBS1;LAMA5;PRKCZ;VAMP2;FLOT1;RAB40B;GAS6;AKT1;ARHGAP44;EHD3;RAB13;EPHB2;BSG;IKBKB
6822,GO:0030291,0.699497877401551,0.52650457235221,3,30,protein serine/threonine kinase inhibitor activity,MF,SPRY2;PKIB;CDKN1C
1174,GO:0002821,0.700071338551618,0.474340022291053,5,49,positive regulation of adaptive immune response,BP,PRKCZ;ZP3;STAT6;ADA;EIF2AK4
6716,GO:0030134,0.700162359066699,0.446691841427881,7,68,COPII-coated ER to Golgi transport vesicle,CC,TMED4;AREG;VANGL2;PCSK9;GOLGA2;SEC31B;HLA-G
15186,GO:0071359,0.700181465343077,0.458802921745757,6,58,cellular response to dsRNA,BP,EGFR;MAP2K1;TMEM173;MAP2K2;FLOT1;AGO4
7892,GO:0032469,0.700674505073402,0.575785635877928,2,20,endoplasmic reticulum calcium ion homeostasis,BP,HERPUD1;WFS1
14484,GO:0065002,0.700711292014889,0.47335827625453,5,50,intracellular protein transmembrane transport,BP,PEX10;BCR;PEX7;PEX1;RTN2
11691,GO:0046503,0.70128493897886,0.52436618970536,3,30,glycerolipid catabolic process,BP,APOE;PNPLA3;PNPLA4
59,GO:0000122,0.701462625191366,0.345437440149196,68,603,negative regulation of transcription by RNA polymerase II,BP,ZMYND8;NFATC4;EGR1;CTNNBIP1;WWC3;VEGFA;NR1D1;DDIT3;DNAJB5;TCFL5;MXI1;MDFI;WWTR1;MXD4;PHF21A;FOXQ1;SALL2;ACVR2B;EAPP;HES2;PPARA;TCF25;IMPACT;SATB1;STAT6;HMGA2;THRA;IRF2BPL;MLXIPL;ZFPM1;TENM2;CBX7;JDP2;HDAC5;VLDLR;DEAF1;PEG3;CEBPB;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;BHLHE40;ZFP90;TRPV1;RXRA;MBD1;CRY2;ZNF217;IFI27;MAP2K5;TP73;MNT;BCL6;HSF4;SIRT2;RECQL5;RCOR2;HDAC8;TCF7;PER1;FGFR1;WFS1;HMBOX1;TSHZ1
13475,GO:0055067,0.701930229755855,0.427040520583501,9,86,monovalent inorganic cation homeostasis,BP,SLC12A7;MAPK3;KCNMA1;TMEM175;TCIRG1;SCNN1A;ATP12A;SLC9A7;SLC9A5
12260,GO:0048593,0.701977227011832,0.444728821782409,7,67,camera-type eye morphogenesis,BP,VEGFA;SDK2;WNT2B;COL8A1;LRP5;TBC1D20;EPHB2
9300,GO:0035773,0.702416053528228,0.49235253684144,4,40,insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;PLA2G6;ANO1;LRP5
75,GO:0000152,0.702452334468776,0.492309356322721,4,40,nuclear ubiquitin ligase complex,CC,CUL7;PHC2;CBX7;PHC1
12617,GO:0050839,0.702620122572596,0.355931030078116,43,389,cell adhesion molecule binding,MF,ADGRL1;POSTN;TIMP2;EGFR;ANK3;CD9;NDRG1;ADAMTS13;LTBP4;NISCH;MPRIP;PPL;CAPG;ITGA6;SNX9;NLGN2;LAMA5;ESYT2;LAMB2;DOCK9;H1FX;TWF2;PAK6;TENM2;CCS;FMNL2;ECM2;SLC9A3R2;CHMP5;TENM4;TNXB;ITGB6;ICAM5;EPS8L1;SNX1;GOLGA2;SH3GLB2;CADM4;EPS8L2;RPL29;ITGA2;CORO1B;BSG
4042,GO:0009083,0.702886862453746,0.573121650381046,2,20,branched-chain amino acid catabolic process,BP,HMGCL;HIBADH
14617,GO:0070228,0.703050463700654,0.491597150863805,4,40,regulation of lymphocyte apoptotic process,BP,RAG1;JAK3;BCL6;ADA
3295,GO:0006995,0.703275968076344,0.680201344079534,1,10,cellular response to nitrogen starvation,BP,MAP1LC3A
10577,GO:0043562,0.703275968076344,0.680201344079534,1,10,cellular response to nitrogen levels,BP,MAP1LC3A
2954,GO:0006488,0.703327904469008,0.57258912379761,2,20,dolichol-linked oligosaccharide biosynthetic process,BP,MVD;SRD5A3
5913,GO:0018193,0.703596599558217,0.334110071007846,107,939,peptidyl-amino acid modification,BP,DLG4;ST6GALNAC2;EGR1;PTK6;VEGFA;EGFR;PADI3;PRNP;ZDHHC1;RAPGEF3;FKBP9;CRTAP;NOS1;ERCC6;MST1R;HBEGF;CTF1;CNTN1;MAPK13;ASH2L;MAP2K1;PKN1;DDIT4;DGKQ;ULK1;SHC1;SPRY2;RAB3B;CAPRIN2;TTBK2;PRKCZ;PAK1;STK39;FGFR3;CEMIP;KDM3A;PHF1;DLG3;NEURL1;EREG;FKBP10;MKNK2;ING4;HMGA2;AREG;ST6GALNAC6;JADE2;MAPK3;CSPG4;ERRFI1;CNTRL;SNTA1;MAPK12;MLXIPL;ARHGEF2;MAP2K2;DMTN;KDM4C;PKD1;TTN;PSKH1;ST3GAL3;MAP3K12;PKN3;TGFBR2;HMG20B;TTLL11;EPHA1;GAS6;ERN1;BCR;TADA3;CAMK1;ATP2B4;HINT2;AKT1;CHEK2;TSG101;FGFR4;PIAS3;INSR;NCOA7;RPS6KA5;MAP2K5;ZDHHC24;BRAF;JAK3;CSNK1E;FYN;MAST4;SIRT2;MTA1;HDAC8;MAP3K10;DHPS;EPHB2;PER1;FGFR1;BLOC1S1;FKBP8;CTH;ERBB2;STK32B;UNC119;SYVN1;CAMKK1;IKBKB
15946,GO:0080111,0.703604169970314,0.572255306633295,2,20,DNA demethylation,BP,APOBEC3C;APOBEC3F
1412,GO:0003351,0.705078923276744,0.678100166764419,1,10,epithelial cilium movement,BP,CABYR
6005,GO:0019054,0.705120815013456,0.570419325172551,2,20,modulation by virus of host process,BP,CPSF4;EIF2AK4
11644,GO:0046427,0.705584934895259,0.488572388406101,4,40,positive regulation of JAK-STAT cascade,BP,PTK6;CTF1;FGFR3;FYN
12853,GO:0051205,0.705709148413905,0.488423857536596,4,40,protein insertion into membrane,BP,EGFR;TFDP2;BBC3;TP73
3900,GO:0008544,0.706266658435351,0.363360312262108,30,278,epidermis development,BP,ALOX15B;EGFR;KRT15;ZFP36L1;MAP2K1;CYP27B1;PPL;LAMA5;PRSS8;FOXQ1;LCE1E;EREG;NAB2;PPARA;SATB1;ERRFI1;VANGL2;SLITRK6;PTHLH;AQP3;TRIOBP;EDA;SHARPIN;LCE1F;TSG101;INSR;KRT19;EDA2R;CELSR1;FGFR1
11565,GO:0046148,0.706271757346504,0.487750767981486,4,40,pigment biosynthetic process,BP,UROS;APRT;TRPC1;ADA
6586,GO:0022607,0.706444366463838,0.319299987194524,254,2215,cellular component assembly,BP,DLG4;BBS2;APOE;ESPN;ZMYND8;FLNC;KCNG1;XPC;H1F0;GSN;ADGRL1;CTNNBIP1;TYSND1;EVI5L;WIPF1;CDC42EP5;THSD4;GLUL;GPX3;VEGFA;OBSCN;DDB2;PRNP;ERCC1;ANK3;BAHCC1;IFT140;RAPGEF3;CLTCL1;FCHO1;SPTB;LOXL1;CD9;NINL;DNM1;SDK2;PARVB;DDIT3;SHANK2;CRTC1;PACS2;ADGRB2;ARAP1;MMP1;EXOC2;RPL13A;MSRB2;OBSL1;BBS1;ULK2;ASH2L;ATG16L2;HMGCL;HYAL1;ARPIN;WWTR1;COL6A1;SDCCAG8;CAPG;ITGA6;DGKQ;EML2;TUBG2;SNX9;FAM110C;DNAH1;ARL2;ULK1;VPS11;GRB7;NPHP4;SOX12;NLGN2;MYH11;ITPR3;LAMA5;CIRBP;TTBK2;PRKCZ;PAK1;ABCA7;PLXNB3;ITGB4;MICALL2;CEP250;NEURL1;ARHGEF4;WDR60;TNS1;SPG11;SSH3;PLEKHG2;DHRS4;RHOBTB2;TRAPPC9;LPAR3;KIF17;IMPACT;IFT27;PKD2;NUDCD3;VAMP2;HMGA2;AREG;SEPT5;PCLO;KCNC4;ACACB;MAPK3;ITGB5;THRA;VANGL2;KCTD15;RHOF;CNTRL;SLITRK6;EIF2D;MYH3;CHMP1B;TBC1D14;TCTN1;PTPDC1;ARHGEF2;SEPT10;FBF1;TSPYL2;H1FX;TWF2;LRSAM1;DMTN;ANGPTL4;DOCK11;SSH1;TENM2;ATXN10;FLOT1;TTN;WHAMMP3;SORL1;SRSF5;TPBG;ADGRF1;TMEM175;NLRP1;RFX2;NDE1;CEP131;TRIOBP;TRPV4;TMSB4X;MAP1LC3A;MLH3;AGO4;WNT7A;TRPV1;EPHA1;SHARPIN;GAS6;CEP126;CROCC;NBR1;GOLGA2P5;SRR;C1QTNF6;SPAG16;RXRA;TNRC18;SLC9A3R2;EFEMP2;WDR19;TMEM80;AMIGO2;CHEK2;IFT57;PSMG4;WDR45;SBF2;SEPT6;TNNT1;NFU1;TSG101;KIF27;TMOD2;TCIRG1;ASAP3;CBR4;FARP1;ATG2A;C9ORF72;TBC1D20;CHMP5;GOLGA8A;MARK4;INSR;KRT19;TENM4;CHMP4C;TNXB;SMIM20;RABGGTA;BRAF;ASIC1;CAT;HAUS4;UNC119B;HFE;TP73;TUBGCP6;FCHSD1;SPIRE1;CSNK1E;TAZ;HGSNAT;REPS2;HSF4;REC8;RNF213;EPS8L1;EHD3;SIRT2;RAB13;GOLGA2;PLXND1;RHOBTB3;MSH5;EPS8L2;TGFBR3;TCF7;VAV3;STX1A;DHPS;EPHB2;MAGI1;SEPT8;ITGA2;SPATA6;SH3PXD2A;CTH;SEC31B;UNC119;CCDC69;PFKL;C15ORF62;CORO1B;SFI1;RPL12;TTC19;KCTD11;SDHAF4;KCTD13;APBA1;IKBKB;HIP1;TEAD2
4572,GO:0010662,0.706452320344592,0.568802724176755,2,20,regulation of striated muscle cell apoptotic process,BP,RGL2;BNIP3
4569,GO:0010659,0.706570693101661,0.56865879077597,2,20,cardiac muscle cell apoptotic process,BP,RGL2;BNIP3
4582,GO:0010677,0.70679895156569,0.568381144268297,2,20,negative regulation of cellular carbohydrate metabolic process,BP,DDIT4;PPARA
481,GO:0001530,0.706994376715691,0.675855600406566,1,10,lipopolysaccharide binding,MF,PTAFR
7900,GO:0032482,0.706996502565167,0.450635955461393,6,59,Rab protein signal transduction,BP,RAB3B;IFT27;RAB40B;RAB43;RAB25;RAB13
13149,GO:0051775,0.70700716068671,0.675840577186741,1,10,response to redox state,BP,SIRT2
5715,GO:0016859,0.707119530203856,0.516864322321794,3,31,cis-trans isomerase activity,MF,FKBP9;FKBP10;FKBP8
11094,GO:0045132,0.707262701141295,0.465841972198289,5,49,meiotic chromosome segregation,BP,MLH3;AGO4;REC8;LEMD2;MSH5
6840,GO:0030316,0.707360913510691,0.450385218659501,6,58,osteoclast differentiation,BP,FOS;FAM213A;FAM20C;INPP5D;CEBPB;SH3PXD2A
16489,GO:0097225,0.7075923617448,0.675152263750999,1,10,sperm midpiece,CC,IFT27
18095,GO:1902807,0.707738867734511,0.413560124978316,10,96,negative regulation of cell cycle G1/S phase transition,BP,FHL1;GJC2;RBL2;TFDP2;PKD2;PCBP4;CHEK2;CTDSPL;PIDD1;TP73
13643,GO:0060192,0.70802687738057,0.674640415419682,1,10,negative regulation of lipase activity,BP,ANGPTL4
2958,GO:0006493,0.708027220481151,0.420116015321508,9,85,protein O-linked glycosylation,BP,ST6GALNAC2;ADAMTS7;ADAMTS13;VEGFB;MUC19;B4GAT1;ADAMTSL1;ST3GAL3;MFNG
17273,GO:0140078,0.7082661966253,0.674358222374718,1,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1
17274,GO:0140080,0.7082661966253,0.674358222374718,1,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,NEIL1
2513,GO:0005767,0.708474041130631,0.67411298056358,1,10,secondary lysosome,CC,MAP1LC3A
10499,GO:0043425,0.708524843140491,0.566277577484425,2,20,bHLH transcription factor binding,MF,BHLHE40;MAP3K10
18117,GO:1902882,0.708714024897827,0.448612289672281,6,59,regulation of response to oxidative stress,BP,MCTP1;SESN2;ATF4;ENDOG;AKT1;NCOA7
11241,GO:0045505,0.708908498813338,0.565808945443663,2,20,dynein intermediate chain binding,MF,DNAH1;DNAL4
9121,GO:0035459,0.708922464265839,0.565791879742371,2,20,cargo loading into vesicle,BP,TBC1D20;SEC31B
13723,GO:0060323,0.709236614091723,0.514772964623615,3,30,head morphogenesis,BP,MYH3;WNT3;BRAF
7564,GO:0031935,0.709487446228757,0.565101060990446,2,20,regulation of chromatin silencing,BP,PHF2;UHRF2
9865,GO:0042147,0.709849017738427,0.435398362887166,7,68,retrograde transport, endosome to Golgi,BP,CLTCL1;TBC1D14;ZFYVE21;SGSM2;EHD3;SNX1;RHOBTB3
10462,GO:0043372,0.710671914989333,0.671510387765182,1,10,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ
4265,GO:0009620,0.710732413631978,0.562712393861631,2,21,response to fungus,BP,FAM3A;IL17RC
11422,GO:0045879,0.710736906626621,0.56357043623221,2,20,negative regulation of smoothened signaling pathway,BP,SERPINE2;KCTD11
8979,GO:0035107,0.71076469335867,0.404415915921455,11,104,appendage morphogenesis,BP,IFT140;RNF165;FBXW4;PBX2;MYH3;LRP5;WNT7A;ZNF358;WDR19;WNT3;FGFR1
8980,GO:0035108,0.71076469335867,0.404415915921455,11,104,limb morphogenesis,BP,IFT140;RNF165;FBXW4;PBX2;MYH3;LRP5;WNT7A;ZNF358;WDR19;WNT3;FGFR1
8871,GO:0034698,0.711020563885479,0.563222395129867,2,20,response to gonadotropin,BP,ASNS;TGFBR3
4462,GO:0010460,0.711070532732557,0.67103654961426,1,10,positive regulation of heart rate,BP,ADA
10095,GO:0042629,0.711188820278565,0.670895833041582,1,10,mast cell granule,CC,S100A13
15822,GO:0072562,0.711639309614028,0.481301156614705,4,40,blood microparticle,CC,APOE;GSN;SERPING1;ANGPTL4
2784,GO:0006220,0.711873787144279,0.480709411468928,4,41,pyrimidine nucleotide metabolic process,BP,NME4;NEIL1;UCKL1;UPP1
1278,GO:0003081,0.712242411370847,0.66964028474301,1,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,F2R
5295,GO:0015988,0.712465773093539,0.560580693948042,2,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,TCIRG1;ATP12A
19661,GO:2000009,0.712537812896993,0.669287554007663,1,10,negative regulation of protein localization to cell surface,BP,SNX33
9038,GO:0035270,0.712986475379592,0.43171413749571,7,68,endocrine system development,BP,MAP2K1;MAPK3;THRA;MDK;AKT1;INSR;BRAF
1523,GO:0003899,0.713065168543928,0.479270312658527,4,41,DNA-directed 5'-3' RNA polymerase activity,MF,PRIMPOL;POLR2J2;POLR3GL;POLR2J3
5732,GO:0016884,0.713079173931167,0.668640326213008,1,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,ASNS
1183,GO:0002830,0.713201624618291,0.668493785091492,1,10,positive regulation of type 2 immune response,BP,PRKCZ
2587,GO:0005882,0.713433471758667,0.431188182885404,7,68,intermediate filament,CC,KRT15;SHANK2;SYNC;FBF1;MICAL1;LMNA;KRT19
8026,GO:0032682,0.713493677723733,0.668144059388859,1,10,negative regulation of chemokine production,BP,MAP2K5
7252,GO:0031228,0.713664014586536,0.478855015043036,4,40,intrinsic component of Golgi membrane,CC,B4GAT1;STEAP2;TBC1D20;MFNG
16383,GO:0097038,0.71366996228564,0.667932816443193,1,10,perinuclear endoplasmic reticulum,CC,CAPN2
17896,GO:1902237,0.713723132653628,0.667869080314048,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,DDIT3
8347,GO:0033235,0.713773308515429,0.667808924506414,1,10,positive regulation of protein sumoylation,BP,PIAS3
15663,GO:0072216,0.713927178628396,0.66762439377558,1,10,positive regulation of metanephros development,BP,EGR1
11481,GO:0045986,0.713977561102974,0.667563953591777,1,10,negative regulation of smooth muscle contraction,BP,DOCK4
9834,GO:0042094,0.714065287645931,0.66745869284258,1,10,interleukin-2 biosynthetic process,BP,CARD11
3422,GO:0007213,0.714214083665746,0.667280093658272,1,10,G-protein coupled acetylcholine receptor signaling pathway,BP,CHRM3
7462,GO:0031629,0.714318825777049,0.667154324778683,1,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,STX1A
17005,GO:0099500,0.714318825777049,0.667154324778683,1,10,vesicle fusion to plasma membrane,BP,STX1A
5714,GO:0016857,0.714336541844048,0.667133048373919,1,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,GALE
12239,GO:0048545,0.714401655835069,0.355665109189351,29,266,response to steroid hormone,BP,FOS;EGFR;NR1D1;ZFP36L1;KLF9;PCK2;ABCA2;DDIT4;PAK1;KDM3A;PPARA;AREG;SLIT3;ERRFI1;THRA;PAQR6;MDK;PTPRU;CREBRF;TGFBR2;CALCOCO1;TADA3;PTAFR;RXRA;IGFBP7;CRY2;IGFBP2;EIF4EBP1;PER1
7640,GO:0032060,0.714417558603778,0.667035735661659,1,10,bleb assembly,BP,LPAR3
8088,GO:0032784,0.714817279014572,0.477458426937463,4,40,regulation of DNA-templated transcription, elongation,BP,ERCC6;TCEA2;EAPP;RECQL5
11253,GO:0045579,0.714990855696238,0.666346453341471,1,10,positive regulation of B cell differentiation,BP,INPP5D
2595,GO:0005891,0.715368045836037,0.665892311167759,1,10,voltage-gated calcium channel complex,CC,NOS1
4752,GO:0010934,0.715580058886599,0.665636820574851,1,10,macrophage cytokine production,BP,GAS6
15484,GO:0071887,0.715617168162854,0.428476016199604,7,69,leukocyte apoptotic process,BP,PKN1;RAG1;GAS6;AKT1;JAK3;BCL6;ADA
10789,GO:0044292,0.715850668022093,0.665310483212301,1,10,dendrite terminus,CC,IFT57
16335,GO:0090662,0.71623058617566,0.555924213314647,2,21,ATP hydrolysis coupled transmembrane transport,BP,TCIRG1;ATP12A
16986,GO:0099131,0.71623058617566,0.555924213314647,2,21,ATP hydrolysis coupled ion transmembrane transport,BP,TCIRG1;ATP12A
639,GO:0001829,0.716254000248021,0.664823601898726,1,10,trophectodermal cell differentiation,BP,ADA
11319,GO:0045663,0.71679678376403,0.664167458266903,1,10,positive regulation of myoblast differentiation,BP,BTG1
15018,GO:0070989,0.716813659762776,0.66414704070607,1,10,oxidative demethylation,BP,CYP3A5
7142,GO:0031010,0.717004744248896,0.663915783957302,1,10,ISWI-type complex,CC,SMARCA1
3852,GO:0008474,0.717016524001553,0.6639015233989,1,10,palmitoyl-(protein) hydrolase activity,MF,LYPLAL1
16758,GO:0098599,0.717016524001553,0.6639015233989,1,10,palmitoyl hydrolase activity,MF,LYPLAL1
16807,GO:0098734,0.717016524001553,0.6639015233989,1,10,macromolecule depalmitoylation,BP,LYPLAL1
13967,GO:0060707,0.717038828143008,0.663874520658352,1,10,trophoblast giant cell differentiation,BP,MDFI
19973,GO:2000615,0.717046708150163,0.663864980215783,1,10,regulation of histone H3-K9 acetylation,BP,HDAC8
15930,GO:0075522,0.717151481124152,0.663738108709547,1,10,IRES-dependent viral translational initiation,BP,EIF2D
569,GO:0001711,0.71723880175972,0.663632340271488,1,10,endodermal cell fate commitment,BP,DUSP6
6747,GO:0030176,0.717275739156272,0.387459987483527,13,124,integral component of endoplasmic reticulum membrane,CC,EDEM1;SLC37A2;SPPL2B;PKD2;ERN1;TM7SF2;SLC37A4;RTN2;WFS1;FITM2;FKBP8;SYVN1;HLA-G
10497,GO:0043422,0.717478654822119,0.663341672880442,1,10,protein kinase B binding,MF,SRSF5
20198,GO:2001169,0.71783959553654,0.437789248278783,6,59,regulation of ATP biosynthetic process,BP,DDIT4;PPARA;MLXIPL;TMSB4X;INSR;TAZ
12885,GO:0051255,0.717953894637804,0.66276513608828,1,10,spindle midzone assembly,BP,CCDC69
9630,GO:0036513,0.717956718541505,0.662761707828148,1,10,Derlin-1 retrotranslocation complex,CC,SYVN1
17662,GO:1901568,0.718049931928437,0.401568610307128,10,97,fatty acid derivative metabolic process,BP,ALOX15B;GGT1;HMGCL;MAPK3;LTA4H;CES2;PTGR2;ACOT7;CBR4;FAAH
11240,GO:0045504,0.718075166611107,0.662617884138327,1,10,dynein heavy chain binding,MF,WDR60
11090,GO:0045125,0.718200226735779,0.66246597668673,1,10,bioactive lipid receptor activity,MF,LPAR3
2802,GO:0006264,0.718255605802878,0.662398690983549,1,10,mitochondrial DNA replication,BP,PRIMPOL
17793,GO:1901978,0.718414448625002,0.662205634859501,1,10,positive regulation of cell cycle checkpoint,BP,NDRG1
8013,GO:0032656,0.718980781857598,0.661516573051503,1,10,regulation of interleukin-13 production,BP,PRKCZ
2554,GO:0005832,0.718985588704807,0.661510719534735,1,10,chaperonin-containing T-complex,CC,FYCO1
12971,GO:0051412,0.719049076600151,0.661433399572694,1,10,response to corticosterone,BP,FOS
5651,GO:0016755,0.719101911506755,0.661369042382623,1,10,transferase activity, transferring amino-acyl groups,MF,GGT1
20000,GO:2000651,0.71943426958537,0.66096397036297,1,10,positive regulation of sodium ion transmembrane transporter activity,BP,ANK3
4962,GO:0015074,0.719447937276125,0.660947303816529,1,10,DNA integration,BP,NYNRIN
806,GO:0002080,0.719502485552752,0.660880780215276,1,10,acrosomal membrane,CC,BSG
13889,GO:0060572,0.719515627347402,0.660864751698435,1,10,morphogenesis of an epithelial bud,BP,WNT2B
20052,GO:2000738,0.719753000234854,0.660575129189784,1,10,positive regulation of stem cell differentiation,BP,LTBP3
19683,GO:2000052,0.719802198585836,0.660515075774435,1,10,positive regulation of non-canonical Wnt signaling pathway,BP,CSNK1E
12231,GO:0048532,0.719832125162192,0.660478541914951,1,10,anatomical structure arrangement,BP,SEMA3F
5652,GO:0016757,0.719847799194271,0.36001496523392,22,205,transferase activity, transferring glycosyl groups,MF,ST6GALNAC2;PYGB;NAPRT;DNPH1;B3GAT3;PYGL;HYAL1;B4GALNT4;ST6GALNAC6;B4GAT1;ST3GAL3;PIGZ;HEXB;HEXA;B4GALT2;UPP1;PIGQ;APRT;MFNG;PIGV;XYLT2;KDELC2
321,GO:0000900,0.719865121623787,0.660438256604753,1,10,translation repressor activity, mRNA regulatory element binding,MF,PAIP2B
9547,GO:0036342,0.719873472549946,0.660428060345711,1,10,post-anal tail morphogenesis,BP,VANGL2
10397,GO:0043252,0.71994460153093,0.660341203437578,1,10,sodium-independent organic anion transport,BP,SLCO4A1
7538,GO:0031848,0.72008644263037,0.660167943518757,1,10,protection from non-homologous end joining at telomere,BP,ERCC1
12990,GO:0051447,0.720292541380686,0.659916061445171,1,10,negative regulation of meiotic cell cycle,BP,NPR2
17913,GO:1902275,0.720335948323894,0.376658533448618,15,141,regulation of chromatin organization,BP,VEGFA;NOS1;KDM3A;MTHFR;PHF1;MAPK3;KDM4C;JDP2;TADA3;PHF2;UHRF2;RPS6KA5;C6ORF89;BCL6;HDAC8
13012,GO:0051492,0.720423605247094,0.43470266173446,6,59,regulation of stress fiber assembly,BP,RAPGEF3;ARAP1;PAK1;EPHA1;ASAP3;BRAF
16885,GO:0098877,0.720433256221012,0.659743998647015,1,10,neurotransmitter receptor transport to plasma membrane,BP,ARHGAP44
11465,GO:0045945,0.720446805861992,0.659727426642015,1,10,positive regulation of transcription by RNA polymerase III,BP,ERBB2
7141,GO:0031005,0.720524952690631,0.659631835389007,1,10,filamin binding,MF,MICALL2
12709,GO:0050996,0.72052499761764,0.659631780426999,1,10,positive regulation of lipid catabolic process,BP,PPARA
91,GO:0000182,0.720528446666245,0.659627560944385,1,10,rDNA binding,MF,TSPYL2
10809,GO:0044320,0.720554175784263,0.659596083193427,1,10,cellular response to leptin stimulus,BP,BBS2
5597,GO:0016641,0.720657614907525,0.659469508312377,1,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,LOXL1
8700,GO:0034356,0.720694659850221,0.659424168171023,1,10,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NAPRT
4409,GO:0010172,0.72070381684744,0.659412959940917,1,10,embryonic body morphogenesis,BP,MAB21L2
2666,GO:0006020,0.72095270830057,0.65910819740756,1,10,inositol metabolic process,BP,ISYNA1
3697,GO:0008207,0.721055042618781,0.54990351910058,2,21,C21-steroid hormone metabolic process,BP,EGR1;DGKQ
2211,GO:0005104,0.721069221892447,0.658965450871395,1,10,fibroblast growth factor receptor binding,MF,FRS3
17526,GO:1901096,0.721127846026594,0.658893608740456,1,10,regulation of autophagosome maturation,BP,FYCO1
17169,GO:0106019,0.721156800390221,0.658858121379034,1,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,INPP4A
3782,GO:0008349,0.721280402153741,0.658706596653689,1,10,MAP kinase kinase kinase kinase activity,MF,MINK1
10363,GO:0043201,0.721409480155711,0.658548298704886,1,10,response to leucine,BP,SESN2
20062,GO:2000756,0.721505736050735,0.448541386679359,5,50,regulation of peptidyl-lysine acetylation,BP,NOS1;MAPK3;HINT2;RPS6KA5;HDAC8
14100,GO:0060992,0.721766179969697,0.658110533004075,1,10,response to fungicide,BP,IMPACT
6976,GO:0030660,0.721892243474506,0.403689683916964,9,88,Golgi-associated vesicle membrane,CC,CLTCL1;SPPL2B;AREG;AP1G2;PKD1;RASSF9;COPG1;SEC31B;HLA-G
16635,GO:0097539,0.722186413412765,0.657594194330551,1,10,ciliary transition fiber,CC,FBF1
12376,GO:0048839,0.722498198898297,0.396476160566706,10,96,inner ear development,BP,NAGLU;SPRY2;IFT27;VANGL2;SLITRK6;TRIOBP;BCR;CELSR1;EPHB2;FGFR1
7074,GO:0030877,0.722756076711532,0.656893213323099,1,10,beta-catenin destruction complex,CC,CTNNBIP1
6349,GO:0021535,0.7229795030539,0.656617956268279,1,10,cell migration in hindbrain,BP,TTBK2
8640,GO:0034199,0.723248217255453,0.656286661112782,1,10,activation of protein kinase A activity,BP,ADCY6
5533,GO:0016525,0.72344082011905,0.431086213985201,6,59,negative regulation of angiogenesis,BP,ADGRB2;SPRY2;NGFR;HDAC5;FOXO4;MAP2K5
14534,GO:0070085,0.723454277278766,0.356003582002578,22,204,glycosylation,BP,ST6GALNAC2;LMF1;ADAMTS7;ADAMTS13;B3GAT3;VEGFB;MUC19;ST6GALNAC6;B4GAT1;MVD;ADAMTSL1;SRD5A3;ST3GAL3;PIGZ;B4GALT2;COG7;MPI;GOLGA2;MAN1B1;MFNG;PIGV;SYVN1
2607,GO:0005912,0.723616847121504,0.329563021360748,49,447,adherens junction,CC,FLNC;FHL1;GSN;LRP1;EGFR;CD9;PARVB;MRC2;NDRG1;RPL13A;MPRIP;MAP2K1;ITGA6;ARL2;GRB7;PAK1;FGFR3;SPRY4;SHROOM4;TNS1;MAPK3;CSPG4;ITGB5;ARHGAP22;ARHGEF2;MAP2K2;KLHL24;PROCR;FRMD4B;FLOT1;TRIOBP;TRPV4;ITGA1;LMO7;SLC9A3R2;ZFYVE21;ASAP3;CAPN2;PLAU;ITGB6;CAT;UBOX5;EHD3;CADM4;MAGI1;ITGA2;CORO1B;RPL12;BSG
11737,GO:0046605,0.723715884365149,0.445863165734614,5,50,regulation of centrosome cycle,BP,CEP250;CHMP1B;CEP131;CHMP5;CHMP4C
10473,GO:0043388,0.723830342222192,0.466151027596119,4,41,positive regulation of DNA binding,BP,HMGA2;SIRT2;HDAC8;ITGA2
13793,GO:0060413,0.724085170332688,0.655253077118699,1,10,atrial septum morphogenesis,BP,ZFPM1
19020,GO:1904894,0.724120262717807,0.465794791855872,4,41,positive regulation of STAT cascade,BP,PTK6;CTF1;FGFR3;FYN
6347,GO:0021533,0.724888193622719,0.654258950864905,1,10,cell differentiation in hindbrain,BP,WNT7A
11779,GO:0046677,0.725043640542099,0.352384100172098,23,216,response to antibiotic,BP,GSN;EGR1;CST3;MAPK13;UROS;HYAL1;IMPACT;STAT6;AREG;BNIP3;ENDOG;DNMT3A;MAP1LC3A;PEMT;ADCY6;MGMT;ITPR2;ANKZF1;CAT;FYN;ADA;HDAC8;NET1
16076,GO:0090084,0.725269194962186,0.653786439836156,1,10,negative regulation of inclusion body assembly,BP,SORL1
15621,GO:0072160,0.725314813318432,0.653729828504376,1,10,nephron tubule epithelial cell differentiation,BP,WWTR1
4160,GO:0009226,0.725654321343834,0.544106965213598,2,21,nucleotide-sugar biosynthetic process,BP,MPI;FUK
1265,GO:0003044,0.725681581534023,0.544072441494426,2,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,F2R;NOS3
2824,GO:0006293,0.725758999912334,0.543974384043384,2,21,nucleotide-excision repair, preincision complex stabilization,BP,DDB2;ERCC1
2826,GO:0006295,0.725758999912334,0.543974384043384,2,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,DDB2;ERCC1
12520,GO:0050690,0.725913525265352,0.543778615782143,2,21,regulation of defense response to virus by virus,BP,FYN;AP2A2
794,GO:0002064,0.726059377975553,0.370079561837438,15,142,epithelial cell development,BP,PTPRS;ACTA2;RAPGEF3;CST3;LAMB2;SLITRK6;TRIOBP;PDE2A;WNT7A;TBC1D20;RAB25;GSTM3;RAB13;FGFR1;IKBKB
10715,GO:0044089,0.726083373521865,0.33110975281495,42,382,positive regulation of cellular component biogenesis,BP,ESPN;ZMYND8;GSN;ADGRL1;WIPF1;CDC42EP5;VEGFA;DDB2;ERCC1;RAPGEF3;ADGRB2;ARAP1;MMP1;HYAL1;ARPIN;SNX9;ARL2;ULK1;NPHP4;NLGN2;PAK1;NEURL1;SLITRK6;TWF2;LRSAM1;DOCK11;TENM2;FLOT1;WHAMMP3;TPBG;WNT7A;EPHA1;CROCC;AMIGO2;TSG101;BRAF;SPIRE1;EPS8L1;EPS8L2;EPHB2;C15ORF62;CORO1B
16466,GO:0097190,0.726507552341871,0.325382464253965,51,466,apoptotic signaling pathway,BP,TNFRSF6B;NFATC4;PRODH;GSN;RBCK1;DDIT3;ERCC6;NUPR1;TFDP2;DDIT4;ITGA6;FGFR3;NGFR;TNFRSF25;PLA2G6;CHAC1;MKNK2;BNIP3;ARHGEF2;ATF4;BBC3;IFI6;UNC5B;HERPUD1;CEBPB;TRIB3;DAP;NOS3;BNIP3L;ERN1;PPP1R15A;STRADB;CTSH;TNFRSF14;UACA;AKT1;CHEK2;LMNA;IFI27;MAP2K5;EDA2R;PIDD1;TP73;MNT;FYN;CIDEB;FGFR1;WFS1;CTH;SYVN1;HIP1
2879,GO:0006383,0.726566454400233,0.442177384216364,5,51,transcription by RNA polymerase III,BP,PRDX5;ZNF76;NAB2;POLR3GL;ERBB2
8053,GO:0032731,0.726640030370018,0.542857351835912,2,21,positive regulation of interleukin-1 beta production,BP,EGR1;NLRP1
4653,GO:0010803,0.72680527243385,0.441886397280467,5,51,regulation of tumor necrosis factor-mediated signaling pathway,BP,RBCK1;SPPL2B;SHARPIN;GAS6;IKBKB
12719,GO:0051011,0.728033703304308,0.650341683216308,1,10,microtubule minus-end binding,MF,TUBGCP6
5888,GO:0018065,0.728231689508414,0.647816598175026,1,11,protein-cofactor linkage,BP,CTH
2956,GO:0006490,0.729215294119269,0.539580329277321,2,21,oligosaccharide-lipid intermediate biosynthetic process,BP,MVD;SRD5A3
12057,GO:0048027,0.72933001845709,0.538637935595212,2,22,mRNA 5'-UTR binding,MF,IGF2BP2;IGF2BP3
11232,GO:0045471,0.729377852409875,0.411978960087557,7,70,response to ethanol,BP,GSN;DNMT3A;PEMT;MGMT;ITPR2;CAT;FYN
18026,GO:1902600,0.729695663050116,0.40192935842006,8,82,proton transmembrane transport,BP,SLC2A9;NDUFA4L2;TMSB4X;MFSD3;TCIRG1;ATP12A;SLC9A7;SLC9A5
6206,GO:0019725,0.729741055228977,0.317923863732889,60,545,cellular homeostasis,BP,DLG4;F2R;APOE;NTSR1;PRNP;NR1D1;PRDX5;NOS1;DDIT3;GAA;TXNRD3;POLD4;PCK2;SLC12A7;CYBRD1;ITPR3;ERO1B;CEMIP;GSTO1;PLA2G6;LPAR3;ANO1;PKD2;MAPK3;BNIP3;MLXIPL;LRRC8A;SV2A;PKD1;KCNMA1;HERPUD1;GSTM2;TMEM175;ENDOG;LRP5;TRPV4;NOS3;HEXB;TRPV1;PIK3R2;GAS6;ERN1;ATP7B;ATP2B4;ITPR2;TCIRG1;TPCN1;TXNRD2;LETMD1;LGALS1;HFE;TMX4;ATP12A;SLC9A7;FYN;TRPC1;EDNRA;WFS1;FITM2;SLC9A5
4815,GO:0014014,0.729851888082501,0.538767512191657,2,21,negative regulation of gliogenesis,BP,IDH2;SIRT2
12587,GO:0050792,0.730190305154947,0.359321883085072,17,163,regulation of viral process,BP,TNIP1;APOE;GSN;ADARB1;APOBEC3C;APOBEC3F;HMGA2;PC;IFITM1;MVB12B;ISG20;TSG101;TBC1D20;NELFCD;CHMP4C;LGALS1;EIF2AK4
19188,GO:1905332,0.730241668599455,0.538269291366711,2,21,positive regulation of morphogenesis of an epithelium,BP,VEGFA;WNT2B
8017,GO:0032663,0.730349583256247,0.488180344954449,3,31,regulation of interleukin-2 production,BP,IL20RB;PRNP;CARD11
13508,GO:0055117,0.730603362976817,0.45778815129158,4,41,regulation of cardiac muscle contraction,BP,NOS1;GSTO1;GSTM2;EHD3
17848,GO:1902110,0.730749180170284,0.437067356782057,5,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TFDP2;BNIP3;BBC3;BNIP3L;TP73
14120,GO:0061024,0.731220121818504,0.311745425712233,74,664,membrane organization,BP,DLG4;APOE;MARVELD1;SYTL1;ZMYND8;GSN;EVI5L;EGFR;ANK3;NEK9;CLTCL1;FCHO1;CD9;DNM1;NDRG1;TBC1D8;SYT8;TFDP2;REEP2;SYNGR1;SNX9;VPS11;NLGN2;ABCA7;ETV5;MALL;SPG11;TRAPPC9;SH3TC2;VAMP2;AREG;BNIP3;DYSF;TBC1D14;BBC3;SSH1;TBC1D3E;RABGAP1;FLOT1;AZIN2;TSNARE1;TMEM175;ARHGAP25;ANO9;BNIP3L;GAS6;VPS39;DNAJC6;ALKBH7;AKT1;REEP4;LMNA;SGSM2;TBC1D20;ARHGAP44;MYOF;TP73;SNX33;SPIRE1;TAZ;REPS2;ATP8B2;LEMD2;RAB13;GOLGA2;AP2A2;MYO18A;VAV3;STX1A;TBC1D16;ITGA2;SEC31B;PLLP;HIP1
781,GO:0002040,0.731557132339632,0.409498000046362,7,69,sprouting angiogenesis,BP,PGF;VEGFA;NGFR;SEMA5A;HDAC5;MAP2K5;RNF213
11463,GO:0045943,0.731884387508549,0.536165028910267,2,21,positive regulation of transcription by RNA polymerase I,BP,ATF4;ERBB2
9749,GO:0039528,0.732377639316043,0.535531759524667,2,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,NLRX1;TKFC
12654,GO:0050886,0.732386464925775,0.455572266844725,4,41,endocrine process,BP,F2R;APLN;NOS3;FGFR1
17660,GO:1901566,0.732472557001029,0.296679342591352,170,1518,organonitrogen compound biosynthetic process,BP,TNIP1;GAMT;ST6GALNAC2;NT5E;APOE;EGR1;LMF1;ALDH7A1;NAPRT;GLUL;NAGS;TIMP2;EGFR;ZDHHC1;ADAMTS7;IDH2;NOS1;PGM1;GGT1;ADAMTS13;ABTB1;ZFP36L1;B3GAT3;HBEGF;PHGDH;PYCR2;DHTKD1;RPL13A;TK2;SLC27A1;MIF4GD;UROS;HYAL1;MAP2K1;DDIT4;OPLAH;GRB7;VEGFB;OGDHL;PCSK1;UNK;NMRK1;CIRBP;CAPRIN2;LY6K;ABCA7;AARS;CEMIP;NPR2;CBS;NMNAT2;NME4;NEURL1;GSTO1;MUC19;PPCS;TRIB2;EREG;GPT2;PSAT1;PSPH;PLA2G6;GSTT1;CARS;PPARA;CHAC1;SESN2;MKNK2;IMPACT;ST6GALNAC6;B4GAT1;MAPK3;CSPG4;VANGL2;MVD;ADAMTSL1;EIF2D;SDC2;MLXIPL;INPP5D;MAP2K2;SRD5A3;PTHLH;ATF4;ZFPM1;CHST6;LTB4R2;AZIN2;GTPBP1;GALK1;GSTM2;NADK;GABBR1;ST3GAL3;CEBPB;ACOT7;ALDOC;FOXL1;TMSB4X;MOCOS;PEMT;NOS3;AGO4;PIGZ;GLUD1;CHKB;HEXA;SRR;UCKL1;NECAB3;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;THNSL2;GSTO2;ASNS;PAIP2B;AKT1;CARD11;DGUOK;B4GALT2;WDR45;ASS1;IGF2BP2;TCIRG1;HAGH;PHLDA1;UPP1;INSR;COG7;PIGQ;MAP2K5;ZDHHC24;JAK3;APRT;CERS4;MPI;LSM14B;TAZ;GSTM3;RPL39L;ZC3H12D;GOLGA2;ADA;PAIP2;RPL29;EIF4EBP1;MAN1B1;MFNG;STARD10;DHPS;NMRAL1;PER1;IGF2BP3;ITGA2;PIGV;CTH;XYLT2;ERBB2;UST;EIF2AK4;SYVN1;PFKL;RPL12;MPPE1;KDSR;NTM;ACOT8
13112,GO:0051702,0.732851453862683,0.434488057031829,5,51,interaction with symbiont,BP,APOE;HMGA2;PC;TBC1D20;EIF2AK4
9170,GO:0035561,0.733209529440518,0.534462220407214,2,21,regulation of chromatin binding,BP,NFATC4;HMBOX1
6911,GO:0030511,0.733492812854123,0.53409757878878,2,21,positive regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN1C;TGFBR3
18563,GO:1903846,0.733492812854123,0.53409757878878,2,21,positive regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN1C;TGFBR3
8005,GO:0032647,0.733630737183199,0.533919963487463,2,21,regulation of interferon-alpha production,BP,PTPRS;IRF5
15730,GO:0072348,0.733667639459614,0.533872432880162,2,21,sulfur compound transport,BP,SLC6A6;SLC35F3
8599,GO:0034122,0.733825785135228,0.533668696969774,2,21,negative regulation of toll-like receptor signaling pathway,BP,PTPRS;NR1D1
11748,GO:0046626,0.734191632923442,0.453322857443646,4,41,regulation of insulin receptor signaling pathway,BP,PRKCZ;PTPRE;GPR21;GRB10
7161,GO:0031050,0.734499846354553,0.452938178331616,4,41,dsRNA fragmentation,BP,EGFR;MAP2K1;MAP2K2;AGO4
14972,GO:0070918,0.734499846354553,0.452938178331616,4,41,production of small RNA involved in gene silencing by RNA,BP,EGFR;MAP2K1;MAP2K2;AGO4
19677,GO:2000045,0.73467524441175,0.363501211919034,14,135,regulation of G1/S transition of mitotic cell cycle,BP,FHL1;GJC2;EGFR;RBL2;TFDP2;HYAL1;PKD2;PKD1;PCBP4;AKT1;CHEK2;CTDSPL;PIDD1;TP73
16268,GO:0090398,0.734966019283133,0.431886222843103,5,51,cellular senescence,BP,MAP2K1;HMGA2;TERC;YPEL3;BCL6
5092,GO:0015370,0.735152648561846,0.48210513096462,3,31,solute:sodium symporter activity,MF,SLC6A9;SLC6A6;SLC10A6
9037,GO:0035269,0.735229410190642,0.638927179640477,1,11,protein O-linked mannosylation,BP,B4GAT1
5925,GO:0018208,0.735426574874232,0.451485837302066,4,42,peptidyl-proline modification,BP,FKBP9;CRTAP;FKBP10;FKBP8
14969,GO:0070911,0.735459200272443,0.481265088171807,3,32,global genome nucleotide-excision repair,BP,XPC;DDB2;ERCC1
11089,GO:0045124,0.735575897003522,0.531409478791094,2,21,regulation of bone resorption,BP,EGFR;INPP5D
4408,GO:0010171,0.735757457566405,0.451366693210152,4,41,body morphogenesis,BP,MYH3;MAB21L2;WNT3;BRAF
11845,GO:0046856,0.736252135577778,0.53053426396292,2,21,phosphatidylinositol dephosphorylation,BP,MTMR4;INPP5D
3908,GO:0008569,0.736745089262044,0.63929673332913,1,10,ATP-dependent microtubule motor activity, minus-end-directed,MF,DNAH1
15972,GO:0086009,0.736885023799806,0.529714010153359,2,21,membrane repolarization,BP,SCN4B;SNTA1
18210,GO:1903046,0.737089291275209,0.368798727103362,12,116,meiotic cell cycle process,BP,ERCC1;TUBG2;EREG;TDRKH;MLH3;AGO4;SPIRE1;REC8;LEMD2;SIRT2;GOLGA2;MSH5
10567,GO:0043548,0.73736694128992,0.529088677898439,2,21,phosphatidylinositol 3-kinase binding,MF,INSR;FYN
13724,GO:0060324,0.737514984391682,0.449165477218311,4,41,face development,BP,MAP2K1;MAPK3;MYH3;BRAF
3195,GO:0006826,0.737633044308948,0.448722720717037,4,42,iron ion transport,BP,STEAP2;TCIRG1;STEAP3;HFE
14194,GO:0061157,0.73795770639561,0.528321226719088,2,21,mRNA destabilization,BP,ZFP36L1;ZC3H12D
1853,GO:0004519,0.738594369754264,0.37179553112239,11,108,endonuclease activity,MF,ERCC1;DNASE1L1;NEIL1;RAG1;ENDOG;ERN1;LACTB2;DNASE2;CPSF4;ENDOV;ZC3H12D
4525,GO:0010595,0.738616700690691,0.400847193384863,7,70,positive regulation of endothelial cell migration,BP,VEGFA;SEMA5A;TMSB4X;NOS3;WNT7A;AKT1;FGFR1
795,GO:0002065,0.739606913329985,0.399646981487964,7,70,columnar/cuboidal epithelial cell differentiation,BP,PTK6;FAM20C;SLITRK6;CEBPB;TRIOBP;RXRA;FGFR1
12852,GO:0051204,0.739614596728969,0.475964187528567,3,32,protein insertion into mitochondrial membrane,BP,TFDP2;BBC3;TP73
1343,GO:0003208,0.739693240128557,0.446429111011097,4,41,cardiac ventricle morphogenesis,BP,TGFBR2;RXRA;TGFBR3;TNNI1
4157,GO:0009223,0.7403927244191,0.632246690303666,1,11,pyrimidine deoxyribonucleotide catabolic process,BP,NEIL1
17704,GO:1901661,0.740402949661698,0.524329960357131,2,22,quinone metabolic process,BP,AKR7A2;CBR4
4085,GO:0009143,0.74060440930982,0.631970567362424,1,11,nucleoside triphosphate catabolic process,BP,ADA
3687,GO:0008194,0.740975762049825,0.374583001482967,10,98,UDP-glycosyltransferase activity,MF,B3GAT3;HYAL1;B4GALNT4;B4GAT1;HEXB;HEXA;B4GALT2;PIGQ;MFNG;XYLT2
10912,GO:0044548,0.741193778324553,0.631200855160859,1,11,S100 protein binding,MF,S100A6
13805,GO:0060429,0.741558784100413,0.296632641956067,91,817,epithelium development,BP,XDH;PTPRS;ACTA2;NFATC4;SERPINE2;CTNNBIP1;PGF;PTK6;ALOX15B;VEGFA;EGFR;IFT140;RAPGEF3;KRT15;CST3;DNPH1;ARHGEF19;ZFP36L1;HBEGF;WWTR1;MAP2K1;CYP27B1;PCK2;PPL;BTG1;SPRY2;LAMA5;PRSS8;PAK1;FOXQ1;SALL2;DLG3;ACVR2B;ETV5;LCE1E;WNT2B;EREG;PKD2;STAT6;AREG;LAMB2;ERRFI1;THRA;VANGL2;FAM20C;CTSB;SLITRK6;TCTN1;KIF26B;PKD1;DEAF1;CEBPB;LRP5;WNK4;ALDOC;AQP3;TRIOBP;TGFBR2;PDE2A;SMURF2;EDA;WNT7A;SHARPIN;RXRA;ZNF358;CTSH;WDR19;MGMT;LCE1F;AKT1;IFT57;TSG101;ACADVL;TBC1D20;RAB25;WNT3;KRT19;CAT;GSTM3;RAB13;TST;CELSR1;PLXND1;AP2A2;TCF7;EDNRA;ITGA2;FGFR1;FKBP8;IKBKB;TEAD2
14006,GO:0060761,0.741855159644124,0.443409453481189,4,42,negative regulation of response to cytokine stimulus,BP,SLIT3;ECM1;GAS6;MAP2K5
4788,GO:0010984,0.742524345332535,0.629458063195279,1,11,regulation of lipoprotein particle clearance,BP,PCSK9
10031,GO:0042509,0.742659867988303,0.442392874814777,4,42,regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;CTF1;FGFR3;FYN
252,GO:0000717,0.742685393867637,0.521338478165023,2,22,nucleotide-excision repair, DNA duplex unwinding,BP,XPC;DDB2
9291,GO:0035751,0.742817896215056,0.629072615863183,1,11,regulation of lysosomal lumen pH,BP,TMEM175
2371,GO:0005501,0.743017056791675,0.628810911590774,1,11,retinoid binding,MF,RXRA
17461,GO:1900409,0.743466302441694,0.628220003063903,1,11,positive regulation of cellular response to oxidative stress,BP,ENDOG
18119,GO:1902884,0.743466302441694,0.628220003063903,1,11,positive regulation of response to oxidative stress,BP,ENDOG
18275,GO:1903209,0.743466302441694,0.628220003063903,1,11,positive regulation of oxidative stress-induced cell death,BP,ENDOG
16,GO:0000030,0.74380536615824,0.519865221876453,2,22,mannosyltransferase activity,MF,PIGZ;PIGV
11182,GO:0045324,0.74383684249631,0.627732009585637,1,11,late endosome to vacuole transport,BP,TMEM50B
5508,GO:0016471,0.743896270186311,0.627653693257759,1,11,vacuolar proton-transporting V-type ATPase complex,CC,TCIRG1
7399,GO:0031490,0.744379894987369,0.376682735020181,9,92,chromatin DNA binding,MF,H1F0;KDM3A;HMGA2;THRA;RXRA;SMARCD2;BCL6;LEMD2;PER1
1996,GO:0004722,0.744390027860523,0.40526325999436,6,61,protein serine/threonine phosphatase activity,MF,PPM1M;PPP2R3B;PPM1J;MTMR4;MYH3;CTDSPL
11882,GO:0046930,0.74445854397472,0.626912002136404,1,11,pore complex,CC,C5
1153,GO:0002761,0.744501234786207,0.393694169092649,7,70,regulation of myeloid leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1;FAM213A;INPP5D;ZFPM1;CEBPB
76,GO:0000153,0.744544958619749,0.626797900400953,1,11,cytoplasmic ubiquitin ligase complex,CC,SYVN1
2833,GO:0006304,0.744573936772846,0.38429903858422,8,80,DNA modification,BP,FOS;APOBEC3C;NEIL1;APOBEC3F;TDRKH;DNMT3A;MGMT;MPG
2208,GO:0005095,0.744583747944253,0.626746673262675,1,11,GTPase inhibitor activity,MF,ARL2
4451,GO:0010421,0.744631259924827,0.626683918283407,1,11,hydrogen peroxide-mediated programmed cell death,BP,ENDOG
16593,GO:0097468,0.744631259924827,0.626683918283407,1,11,programmed cell death in response to reactive oxygen species,BP,ENDOG
8114,GO:0032813,0.744726545565585,0.469389739214614,3,32,tumor necrosis factor receptor superfamily binding,MF,TNFSF15;EDA;PIDD1
2094,GO:0004861,0.744895025587132,0.626335364636774,1,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1C
2465,GO:0005682,0.745089567413812,0.51817155994591,2,22,U5 snRNP,CC,TEP1;MAPKBP1
10554,GO:0043534,0.745153664613209,0.383598039836023,8,80,blood vessel endothelial cell migration,BP,APOE;VEGFA;HDAC5;TMSB4X;NOS3;AKT1;MAP2K5;FGFR1
8569,GO:0034062,0.745160840027351,0.438945313681468,4,43,5'-3' RNA polymerase activity,MF,PRIMPOL;POLR2J2;POLR3GL;POLR2J3
16707,GO:0097747,0.745160840027351,0.438945313681468,4,43,RNA polymerase activity,MF,PRIMPOL;POLR2J2;POLR3GL;POLR2J3
14063,GO:0060914,0.745409805831957,0.625654298244796,1,11,heart formation,BP,LEMD2
8015,GO:0032660,0.745424849133629,0.625634379497468,1,11,regulation of interleukin-17 production,BP,PRNP
12527,GO:0050700,0.745442484550673,0.625611027375441,1,11,CARD domain binding,MF,CARD11
16077,GO:0090085,0.745919298932347,0.624979171481142,1,11,regulation of protein deubiquitination,BP,TNIP1
18340,GO:1903364,0.746063708267393,0.358202721209996,12,117,positive regulation of cellular protein catabolic process,BP,APOE;EDEM1;LRP1;MAGEF1;VPS11;TRIB2;HERPUD1;PCSK9;TRIB3;AKT1;CSNK1E;SIRT2
2695,GO:0006063,0.746146138067044,0.624678249678338,1,11,uronic acid metabolic process,BP,CRYL1
6180,GO:0019585,0.746146138067044,0.624678249678338,1,11,glucuronate metabolic process,BP,CRYL1
1087,GO:0002675,0.746297002370783,0.624477999491543,1,11,positive regulation of acute inflammatory response,BP,ZP3
11761,GO:0046640,0.746710634896883,0.623928488922717,1,11,regulation of alpha-beta T cell proliferation,BP,TGFBR2
6274,GO:0019883,0.747084496371649,0.62343121545076,1,11,antigen processing and presentation of endogenous antigen,BP,HFE
12773,GO:0051091,0.747570317943982,0.334540349161849,19,182,positive regulation of DNA binding transcription factor activity,BP,VEGFA;RBCK1;DDIT3;CRTC1;PRKCZ;TRAPPC9;ARHGEF2;HDAC5;ADGRF1;LRP5;EDA;AKT1;CARD11;RPS6KA5;EDA2R;PIDD1;CAT;CTH;IKBKB
9462,GO:0036109,0.747643522442004,0.622686591793822,1,11,alpha-linolenic acid metabolic process,BP,ACOT8
965,GO:0002407,0.747665208919934,0.622657679672263,1,11,dendritic cell chemotaxis,BP,GAS6
12822,GO:0051156,0.747835174816001,0.514534763829908,2,22,glucose 6-phosphate metabolic process,BP,H6PD;PGLS
10195,GO:0042827,0.748117300441298,0.622054519677744,1,11,platelet dense granule,CC,ECM1
1178,GO:0002825,0.748136729687176,0.622028579325082,1,11,regulation of T-helper 1 type immune response,BP,JAK3
2400,GO:0005546,0.74834649625855,0.435172997536936,4,42,phosphatidylinositol-4,5-bisphosphate binding,MF,GSDMA;PLCD1;TWF2;GSDMC
16361,GO:0095500,0.748509475021673,0.621530620732314,1,11,acetylcholine receptor signaling pathway,BP,CHRM3
18558,GO:1903831,0.748509475021673,0.621530620732314,1,11,signal transduction involved in cellular response to ammonium ion,BP,CHRM3
19115,GO:1905144,0.748509475021673,0.621530620732314,1,11,response to acetylcholine,BP,CHRM3
19116,GO:1905145,0.748509475021673,0.621530620732314,1,11,cellular response to acetylcholine,BP,CHRM3
12629,GO:0050857,0.748542088083823,0.621487025151535,1,11,positive regulation of antigen receptor-mediated signaling pathway,BP,ADA
3754,GO:0008299,0.748817833046888,0.513227894881837,2,22,isoprenoid biosynthetic process,BP,MVD;SRD5A3
3235,GO:0006892,0.748904722583629,0.371505499878626,9,89,post-Golgi vesicle-mediated transport,BP,BBS2;OSBPL5;ANK3;EXOC2;BBS1;VAMP2;SORL1;STEAP2;EHD3
3466,GO:0007289,0.748943838108923,0.620949627036721,1,11,spermatid nucleus differentiation,BP,KDM3A
12158,GO:0048305,0.748990758622294,0.620886820929985,1,11,immunoglobulin secretion,BP,POU2F2
7140,GO:0031000,0.749017032727097,0.620851647412286,1,11,response to caffeine,BP,GSTM2
9521,GO:0036270,0.749017032727097,0.620851647412286,1,11,response to diuretic,BP,GSTM2
586,GO:0001741,0.749038527671663,0.62082286971564,1,11,XY body,CC,DNMT3A
13446,GO:0055007,0.749123867550868,0.388598968623203,7,66,cardiac muscle cell differentiation,BP,VEGFA;OBSL1;MYH11;PAK1;TTN;RXRA;LMNA
19159,GO:1905269,0.749334729133526,0.378528960684124,8,80,positive regulation of chromatin organization,BP,VEGFA;NOS1;PHF1;MAPK3;JDP2;RPS6KA5;C6ORF89;BCL6
12307,GO:0048681,0.74934118319424,0.620417469148964,1,11,negative regulation of axon regeneration,BP,PTPRS
1155,GO:0002763,0.749472771416506,0.463232177876938,3,32,positive regulation of myeloid leukocyte differentiation,BP,FOS;CTNNBIP1;ZFP36L1
16225,GO:0090307,0.749587702121592,0.398835284746649,6,61,mitotic spindle assembly,BP,CHMP1B;CHEK2;CHMP5;CHMP4C;TUBGCP6;GOLGA2
13556,GO:0060049,0.749606095453496,0.620062315600893,1,11,regulation of protein glycosylation,BP,GOLGA2
7988,GO:0032616,0.749759525842692,0.619856487611073,1,11,interleukin-13 production,BP,PRKCZ
10937,GO:0044666,0.749824343186723,0.61976950551683,1,11,MLL3/4 complex,CC,ASH2L
143,GO:0000295,0.749895026628965,0.619674631630034,1,11,adenine nucleotide transmembrane transporter activity,MF,SLC25A42
2330,GO:0005346,0.749895026628965,0.619674631630034,1,11,purine ribonucleotide transmembrane transporter activity,MF,SLC25A42
5034,GO:0015216,0.749895026628965,0.619674631630034,1,11,purine nucleotide transmembrane transporter activity,MF,SLC25A42
14416,GO:0061756,0.749955078927279,0.619594011061766,1,11,leukocyte adhesion to vascular endothelial cell,BP,PTAFR
12327,GO:0048711,0.75010775262464,0.61938897872156,1,11,positive regulation of astrocyte differentiation,BP,SERPINE2
13510,GO:0055119,0.750179515154841,0.619292572371045,1,11,relaxation of cardiac muscle,BP,GSTM2
7098,GO:0030903,0.750180962964444,0.619290627150917,1,11,notochord development,BP,TEAD2
4045,GO:0009086,0.750266615963793,0.619175531883508,1,11,methionine biosynthetic process,BP,CTH
15570,GO:0072077,0.750384390934337,0.619017223592244,1,11,renal vesicle morphogenesis,BP,KIF26B
15576,GO:0072087,0.750384390934337,0.619017223592244,1,11,renal vesicle development,BP,KIF26B
17317,GO:1900027,0.750539839241322,0.51093102103223,2,22,regulation of ruffle assembly,BP,EPS8L1;EPS8L2
14018,GO:0060788,0.750891776321538,0.618334561089071,1,11,ectodermal placode formation,BP,EDA
15400,GO:0071697,0.750891776321538,0.618334561089071,1,11,ectodermal placode morphogenesis,BP,EDA
4676,GO:0010829,0.750969657022448,0.61822968203434,1,11,negative regulation of glucose transmembrane transport,BP,GRB10
80,GO:0000164,0.751190759794693,0.617931794133335,1,11,protein phosphatase type 1 complex,CC,PPP1R15A
9030,GO:0035259,0.751624059203952,0.617347429228403,1,11,glucocorticoid receptor binding,MF,CEBPB
11045,GO:0045061,0.751641225133274,0.617324262512041,1,11,thymic T cell selection,BP,CARD11
5736,GO:0016888,0.751645459646529,0.617318547530534,1,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,ENDOV
17089,GO:0101031,0.751661939970333,0.617296304651673,1,11,chaperone complex,CC,FYCO1
17361,GO:1900115,0.7517303283327,0.617203991355478,1,11,extracellular regulation of signal transduction,BP,LTBP1
17362,GO:1900116,0.7517303283327,0.617203991355478,1,11,extracellular negative regulation of signal transduction,BP,LTBP1
18094,GO:1902806,0.751788895205697,0.340162811911815,15,146,regulation of cell cycle G1/S phase transition,BP,FHL1;GJC2;EGFR;RBL2;TFDP2;HYAL1;PKD2;PKD1;PCBP4;ATP2B4;AKT1;CHEK2;CTDSPL;PIDD1;TP73
1657,GO:0004114,0.751823802576316,0.61707778470585,1,11,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE2A
9053,GO:0035304,0.75198997642738,0.361362742403509,10,99,regulation of protein dephosphorylation,BP,PPP1R35;B3GAT3;PHACTR3;PPP1R14A;PPP2R3B;ELFN2;ITGA1;PPP1R15A;CRY2;IKBKB
20156,GO:2001032,0.751997479825654,0.616843193409638,1,11,regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2
11747,GO:0046625,0.752093522393337,0.616713411807314,1,11,sphingolipid binding,MF,PLTP
7194,GO:0031092,0.75219879781705,0.616571109786441,1,11,platelet alpha granule membrane,CC,CD9
16269,GO:0090399,0.752261331036719,0.616486561050242,1,11,replicative senescence,BP,CHEK2
11577,GO:0046184,0.752346580823752,0.616371271868352,1,11,aldehyde biosynthetic process,BP,KDM3A
4337,GO:0009893,0.7523951729921,0.270785954253397,270,2358,positive regulation of metabolic process,BP,TNIP1;XDH;DUSP6;ACTA2;DLG4;F2R;APOE;NFATC4;FOS;GSN;CITED4;EGR1;PTK6;EDEM1;GJC2;LRP1;TIMP2;VEGFA;NTSR1;EGFR;PRNP;NR1D1;ERCC1;FBLN1;ANK3;DUSP5;RAPGEF3;TNFSF15;IGFBP4;CST3;MEF2D;NOS1;GPSM1;DDIT3;CRTC1;ERCC6;TCEA2;GRAMD4;SMARCA1;MST1R;TRIM65;ZFP36L1;NUPR1;ARAP1;HBEGF;CTF1;CNTN1;TFDP2;SLC27A1;MLYCD;ASH2L;EPM2A;ETV4;WWTR1;MAP2K1;CYP27B1;PKN1;MC1R;SHC2;ITGA6;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;MAGEF1;ULK1;SHC1;VPS11;SPRY2;ADM2;SOX12;CIRBP;CAPRIN2;PRKCZ;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;CEMIP;KDM3A;PHF1;SALL2;DLG3;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;TRIB2;EREG;TEF;TNFRSF25;NAB2;PLA2G6;ABCG1;CARF;LPAR3;C5;PPARA;PLGRKT;SESN2;IMPACT;PKD2;STAT6;KLF7;HMGA2;AREG;ACACB;MAPK3;CSPG4;BNIP3;THRA;VANGL2;IRF2BPL;MAPK12;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;SLC50A1;LRSAM1;LITAF;PTHLH;ATF4;ZFPM1;BBC3;KDM4C;PAK6;ZNF516;PKD1;FLOT1;MDK;TTN;JDP2;HDAC5;GTPBP1;IRF5;SORL1;HERPUD1;SRSF5;VLDLR;DEAF1;NLRP1;PEG3;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;LRP5;CREBRF;PCSK9;PKIB;METTL23;HLTF;TGFBR2;TRPV4;CSRNP3;ITGA1;TMSB4X;SMURF2;APLN;TRIB3;DAP;CALCOCO1;PEMT;EDA;CDK5RAP3;NOS3;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;CCS;GAS6;ERN1;MAPRE3;FYCO1;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;MGMT;AKT1;CARD11;CDKN1C;CHEK2;IFT57;ASS1;PHF2;FGFR4;PIAS3;WDFY2;C9ORF72;IFI27;INSR;WNT3;NCOA7;FOXO4;RPS6KA5;TPCN1;C6ORF89;MAP2K5;BRAF;EDA2R;PIDD1;MAPK10;HFE;TP73;SNX33;TFEB;CSNK1E;TAZ;BCL6;HSF4;FYN;ZC3H12D;SNX1;SIRT2;GDF15;GOLGA2;POU2F2;PLXND1;MTA1;ADIRF;AVPI1;CIDEB;VAV3;EPAS1;LAMTOR2;MAP3K10;CHD6;EPHB2;PER1;ITGA2;FGFR1;WFS1;ERBB2;EIF2AK4;UNC119;HMBOX1;CREB3L4;KCTD13;DBP;ZNF287;CAMKK1;IKBKB;HIP1;TEAD2;SIX5
954,GO:0002374,0.752474244658731,0.616198566583928,1,11,cytokine secretion involved in immune response,BP,MAPK3
15087,GO:0071168,0.752562643961322,0.508221934094005,2,22,protein localization to chromatin,BP,LEMD2;HDAC8
7147,GO:0031016,0.752638741545807,0.429681174948573,4,42,pancreas development,BP,ACVR2B;AKT1;INSR;WFS1
9225,GO:0035631,0.75266385558422,0.615941933004504,1,11,CD40 receptor complex,CC,IKBKB
18076,GO:1902742,0.752676159031863,0.508069552719379,2,22,apoptotic process involved in development,BP,SLIT3;LRP5
17728,GO:1901722,0.75269481761379,0.615900012433119,1,11,regulation of cell proliferation involved in kidney development,BP,EGR1
4040,GO:0009081,0.752890147228289,0.507782194798174,2,22,branched-chain amino acid metabolic process,BP,HMGCL;HIBADH
3630,GO:0008093,0.753033027559263,0.615441837423107,1,11,cytoskeletal adaptor activity,MF,OBSL1
14236,GO:0061318,0.753071390116185,0.615389837253285,1,11,renal filtration cell differentiation,BP,LAMB2
15598,GO:0072112,0.753071390116185,0.615389837253285,1,11,glomerular visceral epithelial cell differentiation,BP,LAMB2
15711,GO:0072311,0.753071390116185,0.615389837253285,1,11,glomerular epithelial cell differentiation,BP,LAMB2
20030,GO:2000696,0.753090188532862,0.615364353886514,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,WWTR1
16833,GO:0098789,0.753119230656804,0.615324981121785,1,11,pre-mRNA cleavage required for polyadenylation,BP,CPSF4
3535,GO:0007530,0.75315729261528,0.615273374711213,1,11,sex determination,BP,INSR
9373,GO:0035925,0.753380003090918,0.6149712905878,1,11,mRNA 3'-UTR AU-rich region binding,MF,ZFP36L1
12318,GO:0048701,0.753424437679758,0.458065553494761,3,32,embryonic cranial skeleton morphogenesis,BP,IFT140;TGFBR2;WDR19
7213,GO:0031116,0.753460496985417,0.507015635093158,2,22,positive regulation of microtubule polymerization,BP,ARL2;PAK1
10388,GO:0043240,0.753485475965899,0.614828154892121,1,11,Fanconi anaemia nuclear complex,CC,FAAP20
3330,GO:0007043,0.753492755978071,0.37346427530866,8,80,cell-cell junction assembly,BP,CD9;ARL2;NPHP4;MICALL2;FBF1;TRPV4;RAB13;IKBKB
2347,GO:0005402,0.753528346114149,0.614769963118101,1,11,carbohydrate:cation symporter activity,MF,SLC2A9
5340,GO:0016082,0.75359742528663,0.614676179114622,1,11,synaptic vesicle priming,BP,STX1A
16035,GO:0089718,0.753786192928738,0.614419800341805,1,11,amino acid import across plasma membrane,BP,NTSR1
9275,GO:0035728,0.75385299867032,0.614329030902288,1,11,response to hepatocyte growth factor,BP,SIRT2
6158,GO:0019511,0.753992103465427,0.614139968113005,1,11,peptidyl-proline hydroxylation,BP,CRTAP
14123,GO:0061029,0.754052077846172,0.614058429512862,1,11,eyelid development in camera-type eye,BP,EGFR
14649,GO:0070286,0.754059988462185,0.614047673450344,1,11,axonemal dynein complex assembly,BP,DNAH1
9486,GO:0036148,0.754094182017052,0.614001177459767,1,11,phosphatidylglycerol acyl-chain remodeling,BP,LPCAT4
5495,GO:0016442,0.754115871203041,0.613971682215858,1,11,RISC complex,CC,AGO4
7314,GO:0031332,0.754115871203041,0.613971682215858,1,11,RNAi effector complex,CC,AGO4
1337,GO:0003198,0.754408189519335,0.613573964016686,1,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
20046,GO:2000726,0.754420700862048,0.613556933498407,1,11,negative regulation of cardiac muscle cell differentiation,BP,PAK1
13380,GO:0052743,0.754426203551805,0.613549442992752,1,11,inositol tetrakisphosphate phosphatase activity,MF,INPP5D
11377,GO:0045780,0.754474141103069,0.613484182889683,1,11,positive regulation of bone resorption,BP,EGFR
11842,GO:0046852,0.754474141103069,0.613484182889683,1,11,positive regulation of bone remodeling,BP,EGFR
19740,GO:2000177,0.754852550167966,0.426834251766715,4,42,regulation of neural precursor cell proliferation,BP,GJC2;VEGFA;SIRT2;KCTD11
10163,GO:0042771,0.754871052062439,0.426530443438315,4,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,NUPR1;DDIT4;CHEK2;TP73
1356,GO:0003229,0.754993666086819,0.456003684234958,3,32,ventricular cardiac muscle tissue development,BP,RXRA;TGFBR3;TNNI1
6496,GO:0021871,0.754995129649148,0.612774307584102,1,11,forebrain regionalization,BP,WNT2B
2841,GO:0006312,0.754996093607189,0.504947016885074,2,22,mitotic recombination,BP,ERCC1;TEP1
13537,GO:0060026,0.755197397084793,0.612498398806583,1,11,convergent extension,BP,VANGL2
13352,GO:0052629,0.755288001409386,0.612374751338973,1,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,MTMR4
1251,GO:0003007,0.755561159596745,0.333011018521308,16,149,heart morphogenesis,BP,PDCD4;VEGFA;GAA;PKD2;VANGL2;ZFPM1;TTN;TGFBR2;RXRA;IFT57;INSR;LEMD2;PLXND1;TGFBR3;TNNI1;TEAD2
19742,GO:2000179,0.755580423924642,0.504158033601861,2,22,positive regulation of neural precursor cell proliferation,BP,GJC2;VEGFA
1991,GO:0004715,0.755679980636508,0.455100078169357,3,32,non-membrane spanning protein tyrosine kinase activity,MF,PTK6;JAK3;FYN
4568,GO:0010658,0.755990820987785,0.50360329745757,2,22,striated muscle cell apoptotic process,BP,RGL2;BNIP3
7980,GO:0032607,0.756082540105208,0.503479251990837,2,22,interferon-alpha production,BP,PTPRS;IRF5
11304,GO:0045648,0.756136712855771,0.503405974375729,2,22,positive regulation of erythrocyte differentiation,BP,FAM210B;INPP5D
16578,GO:0097440,0.756144977374708,0.611203521925482,1,11,apical dendrite,CC,NEURL1
4556,GO:0010642,0.756196685390949,0.611132753077319,1,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,LRP1
719,GO:0001946,0.7562984993746,0.610993374842373,1,11,lymphangiogenesis,BP,ACVR2B
8369,GO:0033280,0.756340018032451,0.503130892859614,2,22,response to vitamin D,BP,CYP27B1;AQP3
15270,GO:0071481,0.756377145748641,0.610885681798021,1,11,cellular response to X-ray,BP,HMGA2
15460,GO:0071840,0.756412812718166,0.262057046831002,554,4801,cellular component organization or biogenesis,BP,PTPRS;DLG4;HTRA1;BBS2;F2R;APOE;MARVELD1;SYTL1;ESPN;ZMYND8;NFATC4;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;H1F0;GSN;ADGRL1;CTNNBIP1;THBS3;TYSND1;POSTN;EVI5L;WIPF1;ADAM19;PTK6;CDC42EP5;THSD4;GLUL;GPX3;SEMA4B;LRP1;TIMP2;VEGFA;OBSCN;EGFR;PADI3;DDB2;PRNP;ERCC1;FBLN1;ANK3;BAHCC1;NEK9;IFT140;RAPGEF3;CLTCL1;FCHO1;SPTB;LOXL1;TSPAN1;IGFBP4;KRT15;CD9;NINL;IDH2;CST3;DNM1;SDK2;PARVB;NOS1;DDIT3;ARAP3;BRSK1;DNPH1;SHANK2;CRTC1;PACS2;ADGRB2;NDRG1;TBC1D8;ARHGEF19;COL13A1;SMARCA1;ARRDC1;EFS;ADARB1;SYT8;CUL9;ARAP1;HBEGF;RBL2;GAA;MMP1;CNTN1;EXOC2;TFDP2;EFNB3;RPL13A;MSRB2;OBSL1;BBS1;LTBP4;ULK2;REEP2;RNF165;NISCH;ASH2L;CUL7;ATG16L2;HMGCL;HYAL1;SMOC2;NAGLU;ARPIN;WWTR1;SYNGR1;POLD4;MAP2K1;CYP27B1;COL6A1;PPL;SDCCAG8;PKN1;CAPG;H2AFJ;BTG1;TOM1L2;SYNGAP1;ITGA6;PHF21A;DGKQ;EML2;TUBG2;SNX9;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;BLOC1S4;SOX12;HDAC11;RAB3B;NLGN2;SLC12A7;MYH11;ITPR3;LAMA5;UNK;CIRBP;CAPRIN2;TPM2;TTBK2;PRKCZ;PAK1;ABCA7;MCTP1;PABPC1L;ERO1B;BRD3;KDM3A;MTHFR;PHF1;SEMA3F;PLXNB3;CAPNS2;SYNE3;ZSWIM4;ITGB4;MICALL2;CEP250;FBXW8;ETV1;NSUN5P2;SHROOM4;NEURL1;CCDC88B;RAG1;NGFR;NID1;ETV5;ARHGEF4;WDR60;MALL;PLXNB1;EREG;CHD2;TNS1;SPG11;PNPLA3;SSH3;RMI2;PLEKHG2;DHRS4;RHOBTB2;TMED4;PLA2G6;ABCG1;TRAPPC9;MANF;LPAR3;S100A13;ALS2CL;FKBP10;KIF17;INO80C;CHD3;STON1;SPC24;SESN2;AIP;SCMH1;IMPACT;IFT27;PKD2;SATB1;KLF7;SH3TC2;ING4;NUDCD3;VAMP2;RRNAD1;HMGA2;AREG;COL8A1;SLIT3;SEPT5;B4GAT1;PCLO;KCNC4;PI4KAP1;JADE2;ACACB;MAPK3;ITGB5;LAMB2;BNIP3;SEMA5A;THRA;PEX10;VANGL2;ACSS2;RGS14;KCTD15;TDRKH;DYSF;RHOF;PLEK2;CNTRL;LTBP2;TUBE1;HOOK2;SLITRK6;EIF2D;MYH3;NYAP1;PI4K2A;SDC2;CHMP1B;TBC1D14;TCTN1;PTPDC1;ARHGEF2;SEPT10;FBF1;TSPYL2;MAP2K2;H1FX;TWF2;STMN3;TECPR1;LRSAM1;DMTN;LRRC8A;KLHL24;ANGPTL4;SEMA3B;ZFPM1;BBC3;KDM4C;PAK6;DOCK11;SSH1;TBC1D3E;PRIMPOL;METRN;RABGAP1;TENM2;IFI6;CBX7;PKD1;ATXN10;FLOT1;CEP68;TTN;HLCS;KCNMA1;AZIN2;TSNARE1;JDP2;UNC5B;HDAC5;WHAMMP3;SORL1;MAP6;TFB1M;PLTP;SRSF5;VLDLR;TPBG;ADGRF1;TEP1;SULF2;ROBO3;TMEM175;NLRP1;COL4A6;RFX2;ENDOG;KDM7A;MAP3K12;LRP5;NDE1;PCSK9;DBNDD1;PKIB;L3MBTL1;CEP131;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TRPV4;ARHGAP25;IQSEC2;ITGA1;TMSB4X;ANO9;MAP1LC3A;APLN;MLH3;PEMT;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;PROM2;WNT7A;TTLL11;TRPV1;BNIP3L;EPHA1;SEMA4G;SHARPIN;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;OLFML2A;CEP126;ECM2;ALKBH7;CROCC;BCR;FYCO1;NBR1;GOLGA2P5;SRR;TADA3;NBEAL2;C1QTNF6;KIF13B;SPAG16;CAMK1;TERC;PPP1R15A;RXRA;ADCY6;MBD1;TNRC18;RAB43;SLC9A3R2;EFEMP2;STRADB;WDR19;TMEM80;AKT1;IGFBP7;DGUOK;REEP4;MICAL1;AMIGO2;LAMB1;CHEK2;IFT57;PSMG4;WDR45;SBF2;IGFBP2;SEPT6;TTC21A;TNNT1;NFU1;TSG101;KIF27;FMNL3;PHF2;FGFR4;TMOD2;TCIRG1;ASAP3;CBR4;FARP1;DNASE2;LMNA;ATG2A;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;CAPN2;GOLGA8A;SMARCD2;SPATA18;MARK4;RAB25;INSR;WNT3;KRT19;TENM4;COG7;RPS6KA5;CHMP4C;TNXB;SMIM20;ADD3;RABGGTA;ITGB6;C6ORF89;LYST;MAP2K5;BRAF;ARHGAP44;ASIC1;CAT;MYOF;HAUS4;LGALS1;UNC119B;TIMP1;HFE;TP73;MTA3;TUBGCP6;FRAT1;SNX33;FCHSD1;TFEB;MPI;PEX7;SNX17;PHC1;ICAM5;SPIRE1;CSNK1E;TAZ;HGSNAT;BCL6;REPS2;HSF4;REC8;RNF213;EPS8L1;EHD3;FYN;MAST4;EML3;ATP8B2;SNX1;PEX1;LEMD2;ARHGEF17;SIRT2;GDF15;RECQL5;RAB13;GOLGA2;CELSR1;PLXND1;RHOBTB3;MTA1;MSH5;AP2A2;CIDEA;EPS8L2;HDAC8;MYO18A;RPL29;TGFBR3;CIDEB;TCF7;VAV3;STX1A;EPAS1;LAMTOR2;TBC1D16;CHD6;LURAP1;DHPS;EPHB2;MAGI1;PER1;SEPT8;ITGA2;FGFR1;BLOC1S1;FITM2;SPATA6;SH3PXD2A;CTH;ERBB2;SEC31B;PLLP;UST;EIF2AK4;UNC119;CCDC69;OSCP1;PFKL;C15ORF62;CORO1B;SFI1;RPL12;HMBOX1;NET1;TTC19;GRB10;MMP19;KCTD11;BSG;ZMYM3;SDHAF4;KCTD13;APBA1;PEX11A;IKBKB;SNCB;HIP1;PLEKHH2;TEAD2;ACOT8
5523,GO:0016504,0.756806155377529,0.453190728851055,3,33,peptidase activator activity,MF,FBLN1;NLRP1;CTSH
4170,GO:0009247,0.757184554592514,0.403673095449005,5,53,glycolipid biosynthetic process,BP,ST6GALNAC6;PIGZ;PIGQ;PIGV;MPPE1
8989,GO:0035137,0.75737310463264,0.501731181252987,2,22,hindlimb morphogenesis,BP,WNT7A;WNT3
17460,GO:1900408,0.759188566255967,0.450038734613162,3,33,negative regulation of cellular response to oxidative stress,BP,ATF4;AKT1;NCOA7
18268,GO:1903202,0.759188566255967,0.450038734613162,3,33,negative regulation of oxidative stress-induced cell death,BP,ATF4;AKT1;NCOA7
15891,GO:0072698,0.760069647964432,0.420085853020957,4,42,protein localization to microtubule cytoskeleton,BP,TTBK2;CEP250;NUDCD3;CEP131
11464,GO:0045944,0.760383497704802,0.276995466272791,88,789,positive regulation of transcription by RNA polymerase II,BP,TNIP1;NFATC4;FOS;CITED4;EGR1;VEGFA;EGFR;NR1D1;MEF2D;NOS1;DDIT3;CRTC1;TCEA2;TFDP2;ASH2L;ETV4;WWTR1;MC1R;ITGA6;ZNF76;PBX2;MAML3;TMEM173;SOX12;CAPRIN2;ELK3;KDM3A;SALL2;ETV1;ABHD14B;EAPP;NGFR;ETV5;TEF;CARF;PPARA;SESN2;PKD2;STAT6;KLF7;HMGA2;MAPK3;THRA;IRF2BPL;MLXIPL;ARHGEF2;LITAF;ATF4;ZFPM1;PKD1;HDAC5;IRF5;PEG3;RFX2;CEBPB;LRP5;CREBRF;METTL23;HLTF;CSRNP3;APLN;CALCOCO1;CDK5RAP3;HEXB;WNT7A;PIK3R2;CAMK1;RXRA;AKT1;NCOA7;FOXO4;RPS6KA5;MAP2K5;TP73;TFEB;HSF4;SIRT2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;PER1;CREB3L4;DBP;IKBKB;TEAD2;SIX5
1111,GO:0002700,0.760479836959842,0.373764455211453,7,72,regulation of production of molecular mediator of immune response,BP,PKN1;PRKCZ;STAT6;MAPK3;HFE;JAK3;BCL6
8831,GO:0034637,0.760923225923523,0.384508701666229,6,62,cellular carbohydrate biosynthetic process,BP,ISYNA1;NR1D1;PGM1;PCK2;AKT1;INSR
12579,GO:0050779,0.761254129740154,0.496444340595745,2,22,RNA destabilization,BP,ZFP36L1;ZC3H12D
18056,GO:1902686,0.76206422610037,0.397450804854506,5,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,TFDP2;BNIP3;BBC3;BNIP3L;TP73
7826,GO:0032388,0.762225032253105,0.315526712584697,20,192,positive regulation of intracellular transport,BP,EDEM1;PRNP;ANK3;RAPGEF3;B3GAT3;TMEM173;VPS11;PAK1;CEMIP;MICALL2;VAMP2;SORL1;CEP131;PEMT;GAS6;CAMK1;TBC1D20;FYN;ERBB2;OSCP1
8526,GO:0033865,0.763058300270437,0.444889896685591,3,33,nucleoside bisphosphate metabolic process,BP,ABHD14B;PPCS;ACOT7
8532,GO:0033875,0.763058300270437,0.444889896685591,3,33,ribonucleoside bisphosphate metabolic process,BP,ABHD14B;PPCS;ACOT7
8553,GO:0034032,0.763058300270437,0.444889896685591,3,33,purine nucleoside bisphosphate metabolic process,BP,ABHD14B;PPCS;ACOT7
251,GO:0000715,0.763104407507739,0.493164650907851,2,23,nucleotide-excision repair, DNA damage recognition,BP,XPC;DDB2
8689,GO:0034340,0.763120956843379,0.370355317119699,7,73,response to type I interferon,BP,EGR1;IFITM1;IFI6;IRF5;ISG20;IFI27;HLA-G
4546,GO:0010632,0.763237405897419,0.323788813899699,16,155,regulation of epithelial cell migration,BP,APOE;VEGFA;HBEGF;HYAL1;SEMA5A;HDAC5;TGFBR2;TMSB4X;NOS3;WNT7A;CTSH;AKT1;RAB25;MAP2K5;ITGA2;FGFR1
10949,GO:0044728,0.763537533994233,0.381211443199804,6,62,DNA methylation or demethylation,BP,FOS;APOBEC3C;APOBEC3F;TDRKH;DNMT3A;MGMT
10085,GO:0042611,0.763629941921617,0.598815264888567,1,12,MHC protein complex,CC,HLA-G
10393,GO:0043248,0.763765051976976,0.598625448622295,1,12,proteasome assembly,BP,PSMG4
1871,GO:0004550,0.765413088659363,0.596303673085996,1,12,nucleoside diphosphate kinase activity,MF,NME4
1388,GO:0003300,0.765706463525287,0.393870999387601,5,48,cardiac muscle hypertrophy,BP,PAK1;ERRFI1;TTN;ATP2B4;LMNA
4933,GO:0014897,0.765706463525287,0.393870999387601,5,48,striated muscle hypertrophy,BP,PAK1;ERRFI1;TTN;ATP2B4;LMNA
12821,GO:0051155,0.766244354795101,0.440623397358055,3,33,positive regulation of striated muscle cell differentiation,BP,THRA;FLOT1;GDF15
2091,GO:0004857,0.767024317373636,0.303040142224814,24,232,enzyme inhibitor activity,MF,SERPINE2;PPP1R35;TIMP2;PRDX5;TFPI2;CST3;PHACTR3;PPP1R14A;ARL2;SPRY2;SERPING1;ELFN2;TRIB2;C5;ANGPTL4;PAPLN;PKIB;TRIB3;GAS6;ATP2B4;CDKN1C;HMSD;TIMP1;SNCB
7729,GO:0032233,0.767124576631383,0.410591548843899,4,43,positive regulation of actin filament bundle assembly,BP,RAPGEF3;PAK1;EPHA1;BRAF
2081,GO:0004842,0.767294283491471,0.286208407855988,41,379,ubiquitin-protein transferase activity,MF,GID4;FBXO2;TMEM129;RNF135;RBCK1;DDB2;RNF165;FBXW4;FBXO41;KLHL29;FBXW8;NEURL1;RAG1;MARCH4;RNF44;UNKL;FBXO27;FBXO17;LRSAM1;KLHL24;FBXO6;NSMCE1;FBXL15;FBXL16;HLTF;SMURF2;LMO7;MARCH2;SHARPIN;KLHDC8B;FBXL8;SPSB3;UHRF2;UBOX5;MIB2;RNF213;FBXO25;PJA2;SYVN1;TRIM2;KCTD13
3663,GO:0008156,0.767928375225586,0.438358221344214,3,33,negative regulation of DNA replication,BP,TSPYL2;CHEK2;BCL6
15406,GO:0071705,0.767936945490075,0.25781124469867,192,1703,nitrogen compound transport,BP,BBS2;F2R;APOE;SYTL1;LMF1;POSTN;EVI5L;TMEM129;EDEM1;GLUL;LRP1;ALOX15B;NTSR1;EGFR;PRNP;ZDHHC1;NR1D1;SLC7A8;HADH;ANK3;RAPGEF3;CLTCL1;SLC2A9;IDH2;NOS1;TBC1D8;ARRDC1;ZFP36L1;B3GAT3;EXOC2;RPL13A;BBS1;LTBP4;REEP2;NISCH;ATG16L2;SYNGR1;PCK2;SLC43A1;TOM1L2;PITPNM1;TMEM173;SNX9;ARL2;VPS11;RAB3B;NLGN2;ITPR3;PRKCZ;PAK1;STK39;CEMIP;MICALL2;ACVR2B;NGFR;OLFM2;TMED4;PLA2G6;ABCG1;XPOT;RINL;S100A13;AGAP1;C5;KIF17;ANO1;AIP;IFT27;SH3TC2;VAMP2;AP1G2;PCLO;MAPK3;PEX10;LTBP2;HOOK2;EIF2D;MVB12B;PQLC2;CHMP1B;TBC1D14;ARHGEF2;PRAF2;SLC48A1;LRSAM1;DMTN;SV2A;TBC1D3E;SLC38A10;RABGAP1;PKD1;SLC29A4;FLOT1;TTN;AZIN2;TSNARE1;SORL1;HERPUD1;PLTP;SRSF5;VLDLR;NLRP1;RHBDF1;LRP5;AQP3;CEP131;LONP2;TGFBR2;TRPV4;TMSB4X;PDE2A;APLN;RAB40B;PEMT;TRPV1;BNIP3L;PIK3R2;RHBDF2;GAS6;VPS39;GLUD1;BCR;KIF13B;NECAB3;CAMK1;RAB43;STRADB;MAPKBP1;AKT1;ITPR2;CARD11;TSG101;IL17RC;IGF2BP2;RASSF9;SLC6A9;TCIRG1;STEAP3;SLC6A6;COPG1;SGSM2;CHMP5;ICA1;RAB25;IFI27;SLC25A29;COG7;CHMP4C;ITGB6;LYST;ZDHHC24;ARHGAP44;CPSF4;BTN3A2;UNC119B;HFE;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;BCL6;EHD3;FYN;SLC38A2;SNX1;PEX1;SLC25A42;RAB13;TOM1;TST;ADA;POU2F2;RTN2;AP2A2;CIDEA;MYO18A;SLC35F3;RPL29;STX1A;TBC1D16;TMCO6;IGF2BP3;ERBB2;SEC31B;UNC119;SYVN1;OSCP1;PFKL;RPL12;APBA1;HIP1
16842,GO:0098799,0.76800257876812,0.592631330110902,1,12,outer mitochondrial membrane protein complex,CC,ANKZF1
15145,GO:0071300,0.768021939909032,0.409412040748448,4,43,cellular response to retinoic acid,BP,PTK6;TWF2;WNT3;TEAD2
8246,GO:0033036,0.768042805787664,0.254756426387554,258,2266,macromolecule localization,BP,DLG4;BBS2;F2R;APOE;MARVELD1;SYTL1;ZMYND8;OSBPL5;GSN;LMF1;POSTN;EVI5L;TMEM129;EDEM1;GLUL;LRP1;ALOX15B;OBSCN;NTSR1;EGFR;PRNP;ZDHHC1;NR1D1;HADH;ANK3;IFT140;RAPGEF3;CLTCL1;IDH2;DDIT3;PACS2;TBC1D8;ARRDC1;ZFP36L1;B3GAT3;EXOC2;TFDP2;MXI1;RPL13A;OBSL1;MDFI;BBS1;SLC27A1;REEP2;CPT2;PITPNM3;ATG16L2;SYNGR1;PCK2;ABCA2;TOM1L2;SYNGAP1;PITPNM1;TMEM173;SNX9;ARL2;ULK1;VPS11;RAB3B;NLGN2;ITPR3;LAMA5;PITPNC1;TTBK2;PRKCZ;PAK1;ABCA7;CEMIP;SYNE3;DLG3;MICALL2;NME4;CEP250;ACVR2B;NGFR;ETV5;LTBP1;MALL;OLFM2;TMED4;PLA2G6;ABCG1;ESYT2;XPOT;RINL;S100A13;AGAP1;C5;KIF17;PPARA;ANO1;SESN2;AIP;IFT27;PKD2;SH3TC2;NUDCD3;VAMP2;AP1G2;SEPT5;PCLO;ACACB;KCNAB2;MAPK3;OSBPL10;THRA;PEX10;VANGL2;LTBP2;HOOK2;EIF2D;MVB12B;CHMP1B;TBC1D14;TCTN1;ARHGEF2;SEPT10;PRAF2;TWF2;LRSAM1;DMTN;BBC3;SSH1;TBC1D3E;RABGAP1;PKD1;FLOT1;CEP68;TTN;TSNARE1;SORL1;HERPUD1;PLTP;SRSF5;VLDLR;NLRP1;RHBDF1;LRP5;PTPRU;WNK4;PCSK9;CEP131;LONP2;TGFBR2;TRPV4;TMSB4X;ANO9;APOL4;PDE2A;RAB40B;MLH3;PEMT;CDK5RAP3;HEXB;WNT7A;BNIP3L;PIK3R2;RHBDF2;GAS6;VPS39;GLUD1;LZTS2;ALKBH7;CROCC;BCR;MAPRE3;KIF13B;NECAB3;CAMK1;PPP1R15A;RXRA;RAB43;SPATA7;STRADB;WDR19;C12ORF66;MAPKBP1;AKT1;ITPR2;CARD11;WDR45;SEPT6;TTC21A;TSG101;IL17RC;IGF2BP2;RASSF9;TCIRG1;STEAP3;LMNA;COPG1;SGSM2;CHMP5;ICA1;RAB25;IFI27;COG7;CHMP4C;ITGB6;LYST;ZDHHC24;BRAF;ARHGAP44;CPSF4;BTN3A2;UNC119B;HFE;TP73;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;CSNK1E;BCL6;EHD3;FYN;ATP8B2;SNX1;PEX1;LEMD2;RAB13;OSBPL1A;TOM1;TST;CELSR1;POU2F2;RTN2;AP2A2;CIDEA;HDAC8;MYO18A;RPL29;STX1A;LAMTOR2;TBC1D16;STARD10;EPHB2;TMCO6;SEPT8;IGF2BP3;ITGA2;ESYT3;FITM2;ERBB2;SEC31B;PLLP;SLC10A6;UNC119;SYVN1;OSCP1;PFKL;CORO1B;RPL12;BSG;APBA1;IKBKB;HIP1
4526,GO:0010596,0.768194558400536,0.437999536505718,3,33,negative regulation of endothelial cell migration,BP,APOE;HDAC5;MAP2K5
7694,GO:0032182,0.768959832201722,0.354210236718463,8,82,ubiquitin-like protein binding,MF,RBCK1;SHARPIN;NBR1;TSG101;UBTD1;MARK4;FAAP20;SIRT2
6016,GO:0019076,0.768999749285299,0.43691346241904,3,33,viral release from host cell,BP,PC;TSG101;CHMP4C
9356,GO:0035890,0.768999749285299,0.43691346241904,3,33,exit from host,BP,PC;TSG101;CHMP4C
9357,GO:0035891,0.768999749285299,0.43691346241904,3,33,exit from host cell,BP,PC;TSG101;CHMP4C
13285,GO:0052126,0.768999749285299,0.43691346241904,3,33,movement in host environment,BP,PC;TSG101;CHMP4C
13294,GO:0052192,0.768999749285299,0.43691346241904,3,33,movement in environment of other organism involved in symbiotic interaction,BP,PC;TSG101;CHMP4C
18481,GO:1903670,0.76907305401358,0.408028277966706,4,43,regulation of sprouting angiogenesis,BP,VEGFA;NGFR;HDAC5;MAP2K5
7713,GO:0032212,0.769430349419992,0.436331990076779,3,33,positive regulation of telomere maintenance via telomerase,BP,MAPK3;PKIB;HMBOX1
13259,GO:0051973,0.769526197781846,0.436202495867295,3,33,positive regulation of telomerase activity,BP,MAPK3;PKIB;HMBOX1
865,GO:0002204,0.769582021425024,0.436127065786303,3,33,somatic recombination of immunoglobulin genes involved in immune response,BP,ERCC1;STAT6;BCL6
866,GO:0002208,0.769582021425024,0.436127065786303,3,33,somatic diversification of immunoglobulins involved in immune response,BP,ERCC1;STAT6;BCL6
11126,GO:0045190,0.769582021425024,0.436127065786303,3,33,isotype switching,BP,ERCC1;STAT6;BCL6
10603,GO:0043616,0.76963715715819,0.436052557599075,3,33,keratinocyte proliferation,BP,ZFP36L1;KLF9;EREG
1872,GO:0004551,0.769715832627335,0.590185208782829,1,12,nucleotide diphosphatase activity,MF,NUDT6
14575,GO:0070161,0.770000951282059,0.278144463186485,50,464,anchoring junction,CC,FLNC;FHL1;GSN;LRP1;EGFR;CD9;PARVB;MRC2;NDRG1;RPL13A;MPRIP;MAP2K1;PPL;ITGA6;ARL2;GRB7;PAK1;FGFR3;SPRY4;SHROOM4;TNS1;MAPK3;CSPG4;ITGB5;ARHGAP22;ARHGEF2;MAP2K2;KLHL24;PROCR;FRMD4B;FLOT1;TRIOBP;TRPV4;ITGA1;LMO7;SLC9A3R2;ZFYVE21;ASAP3;CAPN2;PLAU;ITGB6;CAT;UBOX5;EHD3;CADM4;MAGI1;ITGA2;CORO1B;RPL12;BSG
390,GO:0001046,0.770006430574974,0.361851907360929,7,72,core promoter sequence-specific DNA binding,MF,FOS;NR1D1;KDM3A;CHD2;ATF4;CEBPB;MTA1
1131,GO:0002720,0.77020255916027,0.483333308566204,2,23,positive regulation of cytokine production involved in immune response,BP,PRKCZ;MAPK3
2804,GO:0006266,0.770239618716812,0.483281569653197,2,23,DNA ligation,BP,POLD4;MGMT
7899,GO:0032481,0.77040438956361,0.37234474278628,6,63,positive regulation of type I interferon production,BP,RNF135;TMEM173;STAT6;FLOT1;IRF5;POLR3GL
77,GO:0000154,0.770495291413961,0.434493731438486,3,34,rRNA modification,BP,NSUN5P2;RRNAD1;TFB1M
20161,GO:2001038,0.770810400705781,0.482484157260522,2,23,regulation of cellular response to drug,BP,HMGA2;ENDOG
14113,GO:0061005,0.771455961097209,0.433590441750705,3,33,cell differentiation involved in kidney development,BP,ACTA2;WWTR1;LAMB2
2795,GO:0006244,0.77148837579826,0.587640532039087,1,12,pyrimidine nucleotide catabolic process,BP,NEIL1
2403,GO:0005575,0.771895643021569,0.279488212503485,1376,11703,cellular_component,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;NYNRIN;APOE;CSMD2;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;IL20RB;H1F0;GSN;ADGRL1;CITED4;ACSF2;CCNG2;PYGB;EGR1;CTNNBIP1;LMF1;THBS3;VWA5A;PGF;ALDH7A1;FGFBP1;TYSND1;POSTN;KIAA1549L;EVI5L;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;THSD4;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;FAM210B;GPX3;GJC2;SEMA4B;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;TFPI2;SH3TC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;DGKA;TSPAN1;SLC16A3;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;SDK2;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;CYYR1;MICALCL;ACAD10;PGM1;CGREF1;CRTC1;CLCA2;SCN4B;PACS2;ORAI3;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;FCGBP;TBC1D8;ABTB1;ARHGEF19;TCEA2;KHNYN;MMP28;PLEKHH1;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;ARMCX2;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;MMP1;PYCR2;CTF1;TMEM134;CNTN1;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;LTBP4;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;PLD3;KLHDC2;ASH2L;SOX13;CUL7;PITPNM3;LHPP;TMEM92;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;NXPH4;MPRIP;SMOC2;NAGLU;OXLD1;ARPIN;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;SMOC1;ACP6;POLD4;GIGYF1;MAP2K1;CYP27B1;PCK2;SLC16A5;MXD4;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;SLC43A1;MC1R;CAPG;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MXRA7;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;DNAJC4;FAM213A;FAM110C;MAGEF1;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;ADM2;R3HDM2;MARCKSL1;OGDHL;LGALS9B;SOX12;HDAC11;RAB3B;NLGN2;CD68;PCSK1;PLEKHH3;SLC12A7;PTMS;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;UNK;NMRK1;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;C22ORF23;TTBK2;LY6K;PRKCZ;THEM6;PPP2R3B;HTR7;GALE;SERPING1;PAK1;ABCA7;ANKS6;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;PABPC1L;B4GALNT4;TMTC4;ERO1B;FAM171A2;BLVRB;SLC35E2B;PEAR1;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;BRI3;FOXQ1;ARVCF;KLHL29;PHF1;GLDC;NPR2;SEMA3F;PLCXD1;PLXNB3;CAPNS2;NDUFA4L2;TMEM44;CBS;TMEM187;SPRY4;FAM3A;USP20;SALL2;ORAI2;ELMO3;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;NMNAT2;DDX59;WDR27;MICALL2;SLCO4A1;NME4;PDZD2;CEP250;GRIP2;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;EPOR;MARCH4;NID1;ETV5;ETFB;GSTO1;LCE1E;ARHGEF4;WDR60;LTBP1;MUC19;SYNC;PPCS;SMIM14;FAM117A;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;PLXNB1;EREG;CHD2;GPT2;TEF;TNS1;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;SPATA20;OLFM2;PLCD3;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;OAF;SCART1;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;C5;KIF17;SPATS2;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;ANO1;SNX29;STON1;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;R3HDM4;SH3TC2;ING4;NUDCD3;ACOT11;VAMP2;RRNAD1;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;LRP11;PCLO;KCNC4;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;APCDD1L;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;SEMA5A;THRA;IFITM1;DCAF10;PEX10;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;LTBP2;ADAMTSL1;SNTA1;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;SLITRK6;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;NYAP1;PI4K2A;NAT14;SRGAP3;ZXDC;PAQR6;PQLC2;KIAA0319L;SDC2;CHMP1B;FBXO17;NRSN2;ARHGAP22;MLXIPL;FAM131A;IFNGR2;TBC1D14;TCTN1;PTPDC1;C1RL;PLCD1;ARHGEF2;SEPT10;MTMR11;FBF1;INPP5D;PDCD1LG2;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;SAMD3;STMN3;SLC50A1;PGPEP1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;UBXN4;LOC441081;NOL4L;MORN4;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;DOCK11;SSH1;LRRC45;LTB4R2;PCMTD2;SV2A;TBC1D3E;IGIP;FAM214B;SLC38A10;PRIMPOL;FAM193B;METRN;FRMD4B;RABGAP1;GPR153;POLM;ACAP3;TENM2;KRTCAP3;MYH16;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;ATXN10;RALGAPA1;SLC29A4;FLOT1;LTBP3;CEP68;MDK;TTN;PSKH1;HLCS;KCNMA1;AZIN2;HSD11B1;TSNARE1;TMEM128;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;NTPCR;SMIM19;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;TPBG;PAPLN;ADGRF1;NADK;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;ROBO3;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;ACADS;FBXL16;CEP131;ISG20;LONP2;EPN3;MARK3;DGCR6L;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;DIRC2;CSRNP3;TTC12;C1ORF115;MN1;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;SLFN5;ANO9;MAP1LC3A;MOCOS;APOL4;HSD17B7;XKR6;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;ARL10;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;HERPUD2;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;NICN1;ZNF558;RPUSD3;ANGEL1;SEMA4G;ZNF662;SHARPIN;CCS;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;OLFML2A;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ECM2;ESRG;ALKBH7;CROCC;BCR;KLHDC8B;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;C19ORF33;CEP112;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;BCAM;SRR;TADA3;NBEAL2;C1QTNF6;BOLA1;MFSD3;KIF13B;SPAG16;TTYH3;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;THNSL2;PRDM8;SLC9A3R2;EFEMP2;STRADB;CTSH;TNFRSF14;WDR19;ACOX3;ACAD11;PNRC1;TMEM80;FBXL8;CCDC15;UACA;GSDMC;MGMT;GSTO2;ASNS;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;TP53I11;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;SWT1;CRY2;MZT2B;B4GALT2;TP73-AS1;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;GAREM2;SEMA6B;IFT57;LACTB2;PHYKPL;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;TTC21A;CAPS;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;C16ORF58;KIF27;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;DNAJC22;TMEM256;RASSF9;SLC6A9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;SLC6A6;NUCB2;ZNF25;FARP1;DNASE2;LMNA;TMEM63C;ASMTL;FAAH;UPP1;SH2B3;MAB21L2;SPSB3;COPG1;TMEM200A;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;ARMC9;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;CKLF;FOXO4;GNAL;COG7;YPEL3;SLC22A15;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;LTB4R;SMIM20;TPCN1;ULBP1;ADD3;MBLAC2;MAGED2;GRAMD1A;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;BTN3A2;ASIC1;ALDH1L1;HOXC5;RNF215;PLB1;GJB4;FAAP20;PIDD1;CAT;ZNF160;MZT2A;MYOF;HAUS4;PAQR4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;UNC119B;C22ORF46;TIMP1;HFE;JAK3;KIAA1549;MRGPRX3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;CHRM3;ZNF846;APRT;GLCCI1;FCHSD1;TMX4;TFEB;MIB2;C14ORF132;CERS4;MPI;PEX7;SNX17;ENDOV;JOSD2;PHC1;ICAM5;SCYL3;METTL7A;ATP12A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BTN3A3;BCL6;REPS2;RABAC1;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;TMEM25;PJA2;SLC38A2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;ARHGEF17;SLC25A42;SIRT2;TRPC1;MBOAT2;GDF15;SPRED3;PHLDA2;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;FAM220A;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;CADM4;POU2F2;PLXND1;RCOR2;POLR3GL;TMEM54;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;TMEM101;MSH5;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;SLC35F3;ADIRF;RPL29;TMEM139;EIF4EBP1;ERV3-1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;TMCO6;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;DIP2C;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;RGPD6;FKBP8;SPATA6;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;PLLP;SLC10A6;KDELC2;UST;EIF2AK4;STK32B;UNC119;PAG1;CCDC69;RGS12;SYVN1;OSCP1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;MMP17;RPL12;MPPE1;HMBOX1;NET1;TMEM200B;FER1L4;TTC19;WBP1;HSP90AB4P;RTL1;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;TRIM45;KCTD13;DBP;APBA1;TMEM42;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;ROBO4;TEAD2;XKR9;ACOT8;TCTEX1D4;BTBD11;SLC9A5;SIX5
1589,GO:0004003,0.772039740215299,0.43279842188609,3,33,ATP-dependent DNA helicase activity,MF,CHD2;CHD3;RECQL5
13211,GO:0051900,0.772062589714264,0.586813134221939,1,12,regulation of mitochondrial depolarization,BP,IFI6
18899,GO:1904668,0.772158422007349,0.586674901312941,1,12,positive regulation of ubiquitin protein ligase activity,BP,GOLGA2
5103,GO:0015399,0.772205784043342,0.358962171355246,7,73,primary active transmembrane transporter activity,MF,ABCA2;ABCA7;ABCG1;ATP7B;ATP2B4;TCIRG1;ATP12A
5104,GO:0015405,0.772205784043342,0.358962171355246,7,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCA2;ABCA7;ABCG1;ATP7B;ATP2B4;TCIRG1;ATP12A
7576,GO:0031952,0.772480025973361,0.432200514012647,3,33,regulation of protein autophosphorylation,BP,VEGFA;IMPACT;ERRFI1
13592,GO:0060090,0.77260043618972,0.31559605855965,15,147,molecular adaptor activity,MF,ANK3;ARRDC1;OBSL1;SHC1;VPS11;GRB7;SH2D2A;GAS6;SH2B3;AP2A2;VAV3;STX1A;PAG1;GRB10;HIP1
7390,GO:0031462,0.772744494488024,0.585828613007735,1,12,Cul2-RING ubiquitin ligase complex,CC,ZSWIM4
16952,GO:0099023,0.772769739805722,0.36932455342502,6,63,tethering complex,CC,EXOC2;VPS11;TRAPPC9;HOOK2;VPS39;COG7
13678,GO:0060260,0.773519671701162,0.47868520135016,2,23,regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;THRA
3040,GO:0006596,0.773567025481052,0.584638233039226,1,12,polyamine biosynthetic process,BP,AZIN2
19615,GO:1990841,0.773748453682896,0.43047525565456,3,33,promoter-specific chromatin binding,MF,EGR1;RBL2;FOXO4
6648,GO:0030004,0.773788199093838,0.356964573837602,7,73,cellular monovalent inorganic cation homeostasis,BP,MAPK3;KCNMA1;TMEM175;TCIRG1;ATP12A;SLC9A7;SLC9A5
6251,GO:0019840,0.773793705601138,0.584309633438902,1,12,isoprenoid binding,MF,RXRA
8759,GO:0034450,0.774090378297957,0.583879215100528,1,12,ubiquitin-ubiquitin ligase activity,MF,UBOX5
1702,GO:0004197,0.774184680254832,0.356463449701388,7,73,cysteine-type endopeptidase activity,MF,CTSF;CAPNS2;USP20;BLMH;CTSB;CTSH;CAPN2
10079,GO:0042599,0.774409373210916,0.58341596006052,1,12,lamellar body,CC,CTSH
8117,GO:0032816,0.774465002298001,0.583335125715592,1,12,positive regulation of natural killer cell activation,BP,GAS6
8875,GO:0034704,0.774600869678567,0.477162661549126,2,23,calcium channel complex,CC,NOS1;HERPUD1
3369,GO:0007141,0.774635135183279,0.583087818062984,1,12,male meiosis I,BP,REC8
97,GO:0000188,0.774869527089513,0.476783762572901,2,23,inactivation of MAPK activity,BP,DUSP6;DUSP5
9322,GO:0035821,0.774894864534651,0.339337074669891,9,94,modification of morphology or physiology of other organism,BP,TNIP1;APOE;HMGA2;PC;RXRA;TBC1D20;INSR;CPSF4;EIF2AK4
12460,GO:0050433,0.774967770364931,0.582603909381022,1,12,regulation of catecholamine secretion,BP,STX1A
6201,GO:0019706,0.775028362133118,0.47655964260493,2,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC1;ZDHHC24
6202,GO:0019707,0.775028362133118,0.47655964260493,2,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC1;ZDHHC24
11697,GO:0046519,0.775601146101394,0.581681079181266,1,12,sphingoid metabolic process,BP,KDSR
7105,GO:0030914,0.775634537333268,0.581632376591366,1,12,STAGA complex,CC,TADA3
6290,GO:0019905,0.775668243753384,0.365610547172515,6,63,syntaxin binding,MF,SYTL1;SNPH;SYT8;VPS11;VAMP2;GOLGA2
9120,GO:0035458,0.77580217813087,0.581387787043444,1,12,cellular response to interferon-beta,BP,TMEM173
10255,GO:0043014,0.775841978310993,0.475410348756126,2,23,alpha-tubulin binding,MF,FAM110C;TRPV4
6986,GO:0030674,0.775850227470904,0.318443991555072,13,129,protein binding, bridging,MF,ANK3;ARRDC1;OBSL1;SHC1;VPS11;GRB7;SH2D2A;AP2A2;VAV3;STX1A;PAG1;GRB10;HIP1
17846,GO:1902108,0.775876388233221,0.379408650477898,5,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TFDP2;BNIP3;BBC3;BNIP3L;TP73
11127,GO:0045191,0.77596400509058,0.475237794340763,2,23,regulation of isotype switching,BP,STAT6;BCL6
7286,GO:0031293,0.775995934723913,0.475192635736678,2,23,membrane protein intracellular domain proteolysis,BP,SPPL2B;NGFR
16478,GO:0097202,0.776144964200731,0.580887253437222,1,12,activation of cysteine-type endopeptidase activity,BP,CIDEB
7256,GO:0031233,0.776170061176956,0.580850585616143,1,12,intrinsic component of external side of plasma membrane,CC,PRNP
15442,GO:0071806,0.776176985703241,0.378832273368236,5,55,protein transmembrane transport,BP,PEX10;BCR;PEX7;PEX1;RTN2
3914,GO:0008589,0.776232302798146,0.379135357818777,5,53,regulation of smoothened signaling pathway,BP,SERPINE2;IFT140;EVC;TCTN1;KCTD11
12101,GO:0048188,0.776430553776423,0.580469821368561,1,12,Set1C/COMPASS complex,CC,ASH2L
362,GO:0000981,0.776522509264986,0.261424018132307,79,713,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,NFATC4;FOS;EGR1;ZSCAN18;NR1D1;MEF2D;DDIT3;TSC22D1;ZFP36L1;TCFL5;RBL2;TFDP2;MXI1;KLF9;SOX13;ETV4;MXD4;ZNF76;PBX2;THAP8;SOX12;ELK3;FOXQ1;SALL2;ETV1;ETV5;HES2;TEF;UNKL;CARF;PPARA;SATB1;STAT6;KLF7;HMGA2;THRA;MLXIPL;LITAF;ATF4;ZFPM1;ZNF467;JDP2;IRF5;DEAF1;PEG3;RFX2;CEBPB;CREBRF;HLTF;MXD3;FOXL1;CSRNP3;BHLHE40;ZFP90;BOLA1;RXRA;ZNF217;ZNF25;FOXO4;HOXC5;ZNF160;KIAA1549;TP73;MNT;TFEB;BCL6;HSF4;POU2F2;RCOR2;TCF7;EPAS1;HMBOX1;TSHZ1;CREB3L4;ZMYM3;DBP;DMTF1;TEAD2;SIX5
8600,GO:0034123,0.77674105575107,0.580015546026812,1,12,positive regulation of toll-like receptor signaling pathway,BP,FLOT1
15213,GO:0071396,0.777071842948823,0.275233874223888,41,382,cellular response to lipid,BP,TNIP1;NFATC4;PTK6;FAM210B;PDCD4;EGFR;NR1D1;ADAMTS13;ZFP36L1;KLF9;CYP27B1;PCK2;DDIT4;PAK1;KDM3A;PPARA;MAPK3;ERRFI1;THRA;PAQR6;PDCD1LG2;TWF2;LITAF;HDAC5;CEBPB;CREBRF;CALCOCO1;NOS3;BCR;TADA3;PTAFR;RXRA;ADCY6;AKT1;CRY2;WNT3;HDAC8;EIF4EBP1;PER1;ITGA2;TEAD2
10451,GO:0043331,0.777591301367761,0.352147467859528,7,73,response to dsRNA,BP,EGFR;MAP2K1;TMEM173;MAPK3;MAP2K2;FLOT1;AGO4
3559,GO:0007602,0.777619191657511,0.472892527050675,2,23,phototransduction,BP,PITPNM1;UNC119
12624,GO:0050852,0.777761610364461,0.312481669375404,14,141,T cell receptor signaling pathway,BP,RBCK1;PRNP;PAK1;ERMAP;INPP5D;PIK3R2;CARD11;BRAF;BTN3A2;BTN3A3;FYN;ADA;PAG1;IKBKB
20067,GO:2000765,0.777788072282023,0.472652741308204,2,23,regulation of cytoplasmic translation,BP,RPL13A;UNK
18688,GO:1904152,0.777790821677066,0.578476374622415,1,12,regulation of retrograde protein transport, ER to cytosol,BP,EDEM1
3760,GO:0008308,0.777875675262919,0.578351737096286,1,12,voltage-gated anion channel activity,MF,ANO1
2366,GO:0005484,0.77795564158076,0.424325346416833,3,34,SNAP receptor activity,MF,VAMP2;TSNARE1;STX1A
722,GO:0001952,0.777964209938054,0.34296335671698,8,82,regulation of cell-matrix adhesion,BP,POSTN;VEGFA;PRKCZ;DMTN;MINK1;EPHA1;PLAU;BCL6
13892,GO:0060575,0.777984426874161,0.57819194758972,1,12,intestinal epithelial cell differentiation,BP,PTK6
4932,GO:0014896,0.778012260128204,0.377657156023808,5,49,muscle hypertrophy,BP,PAK1;ERRFI1;TTN;ATP2B4;LMNA
11437,GO:0045912,0.778240217106687,0.472010308919135,2,23,negative regulation of carbohydrate metabolic process,BP,DDIT4;PPARA
3753,GO:0008298,0.778553514104185,0.577354879979663,1,12,intracellular mRNA localization,BP,ZFP36L1
12329,GO:0048713,0.778951508741193,0.470998328863063,2,23,regulation of oligodendrocyte differentiation,BP,TENM4;TP73
7496,GO:0031683,0.779002962068721,0.576692714695922,1,12,G-protein beta/gamma-subunit complex binding,MF,GNAL
16115,GO:0090153,0.779047460986773,0.576627103392312,1,12,regulation of sphingolipid biosynthetic process,BP,PLA2G6
19079,GO:1905038,0.779047460986773,0.576627103392312,1,12,regulation of membrane lipid metabolic process,BP,PLA2G6
19807,GO:2000303,0.779047460986773,0.576627103392312,1,12,regulation of ceramide biosynthetic process,BP,PLA2G6
9812,GO:0042044,0.779326713740285,0.576215147126944,1,12,fluid transport,BP,AQP3
11801,GO:0046716,0.779459846440017,0.576018619177119,1,12,muscle cell cellular homeostasis,BP,GAA
16110,GO:0090141,0.779628753317203,0.575769161763581,1,12,positive regulation of mitochondrial fission,BP,BNIP3
13155,GO:0051785,0.779799572313548,0.393506929760171,4,44,positive regulation of nuclear division,BP,EREG;LRP5;INSR;SIRT2
15723,GO:0072337,0.779807011073606,0.575505748046493,1,12,modified amino acid transport,BP,SLC38A2
2535,GO:0005793,0.779829695296594,0.327261450966567,10,102,endoplasmic reticulum-Golgi intermediate compartment,CC,TMED4;AREG;AZIN2;WHAMMP3;NUCB2;COPG1;TBC1D20;GOLGA2;MYO18A;MPPE1
5238,GO:0015865,0.779859858676003,0.575427625638582,1,12,purine nucleotide transport,BP,SLC25A42
5241,GO:0015868,0.779859858676003,0.575427625638582,1,12,purine ribonucleotide transport,BP,SLC25A42
13020,GO:0051503,0.779859858676003,0.575427625638582,1,12,adenine nucleotide transport,BP,SLC25A42
2436,GO:0005637,0.780062890559301,0.393153832170714,4,44,nuclear inner membrane,CC,ERN1;TM7SF2;IFI27;LEMD2
10655,GO:0043903,0.780144366454323,0.29869545991146,18,178,regulation of symbiosis, encompassing mutualism through parasitism,BP,TNIP1;APOE;GSN;ADARB1;EXOC2;APOBEC3C;APOBEC3F;HMGA2;PC;IFITM1;MVB12B;ISG20;TSG101;TBC1D20;NELFCD;CHMP4C;LGALS1;EIF2AK4
12365,GO:0048806,0.78014475363441,0.469296971278663,2,23,genitalia development,BP,PKD1;TCF7
25,GO:0000049,0.780156066900164,0.373804754033177,5,54,tRNA binding,MF,AARS;XPOT;CARS;EIF2AK4;DTD1
2318,GO:0005326,0.780210822747147,0.469202633026552,2,23,neurotransmitter transporter activity,MF,SLC6A9;SLC6A6
4270,GO:0009635,0.780451543580401,0.5745520606752,1,12,response to herbicide,BP,MAPK13
15302,GO:0071545,0.780619042601811,0.574303897435966,1,12,inositol phosphate catabolic process,BP,NTSR1
9968,GO:0042379,0.780629613666321,0.467293736525995,2,25,chemokine receptor binding,MF,C5;CKLF
13844,GO:0060487,0.780640226837664,0.574272501810167,1,12,lung epithelial cell differentiation,BP,THRA
2967,GO:0006508,0.780667978004161,0.24803739142079,140,1256,proteolysis,BP,TNIP1;XDH;HTRA1;F2R;TNFRSF6B;APOE;BTBD2;SERPINE2;GID4;GSN;TYSND1;FBXO2;ADAM19;TMEM129;THSD4;EDEM1;RNF135;TIMP2;VEGFA;RBCK1;DDB2;PRNP;NR1D1;FBLN1;ADAMTS7;PRDX5;TFPI2;TNFSF15;NPEPL1;RNPEPL1;CST3;DDIT3;CLCA2;GGT1;ADAMTS13;ABTB1;MMP28;GRAMD4;ARRDC1;CUL9;MMP1;PLAT;LTBP4;CTSF;RNF165;FBXW4;CUL7;PRSS3;WWTR1;MAP2K1;SNX9;MAGEF1;PCSK1;PRSS8;SERPING1;ERO1B;CAPNS2;USP20;RAG1;SPPL2B;NGFR;TRIB2;RNF44;C5;PLGRKT;INO80C;CHAC1;BLMH;ECM1;MAPK3;ADAMTSL1;CTSB;MAPK12;MVB12B;LTA4H;C1RL;MAP2K2;PGPEP1;UBXN4;BBC3;PRSS22;TENM2;FBXO6;IFI6;PKD1;SORL1;HERPUD1;PAPLN;NLRP1;ACY1;RHBDF1;PCSK9;FBXL15;LONP2;SMURF2;TRIB3;DAP;RHBDF2;SHARPIN;GAS6;TADA3;CTSH;MGMT;AKT1;MICAL1;HMSD;IFT57;TSG101;FGFR4;SPSB3;CAPN2;IFI27;PLAU;TENM4;FOXO4;ANKZF1;CHMP4C;MAP2K5;PIDD1;DPP7;TIMP1;HFE;SNX33;JOSD2;CSNK1E;RNF213;FYN;UBXN6;SIRT2;MTA1;CIDEB;RNPEP;MAN1B1;WFS1;SYVN1;MMP17;MMP19;KCTD13;HIP1;BTBD11
15399,GO:0071696,0.780704893270903,0.574176651202748,1,12,ectodermal placode development,BP,EDA
15220,GO:0071404,0.780731102152994,0.574137797927309,1,12,cellular response to low-density lipoprotein particle stimulus,BP,CD9
275,GO:0000778,0.780781670965599,0.574062823140438,1,12,condensed nuclear chromosome kinetochore,CC,REC8
10675,GO:0043970,0.780809516657168,0.574021533124044,1,12,histone H3-K9 acetylation,BP,HDAC8
9172,GO:0035563,0.781008614205613,0.573726200977979,1,12,positive regulation of chromatin binding,BP,HMBOX1
4577,GO:0010667,0.781076737222291,0.573625107182911,1,12,negative regulation of cardiac muscle cell apoptotic process,BP,RGL2
10324,GO:0043138,0.781083851692227,0.573614548114178,1,12,3'-5' DNA helicase activity,MF,RECQL5
771,GO:0002027,0.78125800262912,0.391549319399214,4,44,regulation of heart rate,BP,SCN4B;SNTA1;ADA;EPAS1
8806,GO:0034593,0.781315786234703,0.467622775008803,2,23,phosphatidylinositol bisphosphate phosphatase activity,MF,MTMR4;INPP4A
1386,GO:0003298,0.781434484801422,0.573093851451469,1,12,physiological muscle hypertrophy,BP,PAK1
1389,GO:0003301,0.781434484801422,0.573093851451469,1,12,physiological cardiac muscle hypertrophy,BP,PAK1
14140,GO:0061049,0.781434484801422,0.573093851451469,1,12,cell growth involved in cardiac muscle cell development,BP,PAK1
1655,GO:0004112,0.781602230314345,0.572844539261723,1,12,cyclic-nucleotide phosphodiesterase activity,MF,PDE2A
17833,GO:1902074,0.781833116300381,0.572501165019115,1,12,response to salt,BP,MAPK13
13186,GO:0051861,0.781951269433624,0.572325348996451,1,12,glycolipid binding,MF,MPPE1
12387,GO:0048854,0.782150308640716,0.466426940483732,2,23,brain morphogenesis,BP,BBS2;SHANK2
1325,GO:0003179,0.782236690394964,0.466303028613053,2,23,heart valve morphogenesis,BP,ZFPM1;TGFBR2
14526,GO:0070071,0.782252629871353,0.571876612136969,1,12,proton-transporting two-sector ATPase complex assembly,BP,TCIRG1
16091,GO:0090103,0.782340249301542,0.571746062103215,1,12,cochlea morphogenesis,BP,VANGL2
15537,GO:0072010,0.782669400941699,0.57125530885699,1,12,glomerular epithelium development,BP,LAMB2
15567,GO:0072074,0.782765983658143,0.571111209022914,1,12,kidney mesenchyme development,BP,PKD2
3482,GO:0007350,0.782813462747036,0.571040354606225,1,12,blastoderm segmentation,BP,SEMA3F
2374,GO:0005504,0.782918757327869,0.56912230774088,1,13,fatty acid binding,MF,PPARA
11396,GO:0045824,0.783029850344401,0.417327780607553,3,34,negative regulation of innate immune response,BP,SERPING1;FAM3A;NLRX1
16285,GO:0090482,0.783031441674085,0.570714919579802,1,12,vitamin transmembrane transporter activity,MF,SLC2A3
16111,GO:0090148,0.783082477445499,0.570638691988162,1,12,membrane fission,BP,DNM1
10295,GO:0043090,0.783088966423038,0.570628999086063,1,12,amino acid import,BP,NTSR1
5830,GO:0017119,0.783181626955044,0.570490565434451,1,12,Golgi transport complex,CC,COG7
17042,GO:0099563,0.783404986222468,0.57015669995932,1,12,modification of synaptic structure,BP,ARHGAP44
7863,GO:0032433,0.783421446776303,0.570132086115112,1,12,filopodium tip,CC,MORN4
13467,GO:0055038,0.783478937257469,0.355384437882057,6,64,recycling endosome membrane,CC,NDRG1;RAB11FIP4;SLC9A7;EHD3;RAB13;HLA-G
13206,GO:0051895,0.783592564394624,0.569876132800715,1,12,negative regulation of focal adhesion assembly,BP,DMTN
13267,GO:0051988,0.783666652585607,0.569765269879003,1,12,regulation of attachment of spindle microtubules to kinetochore,BP,SIRT2
17861,GO:1902170,0.783676279763454,0.569750862174213,1,12,cellular response to reactive nitrogen species,BP,STAT6
16107,GO:0090136,0.783725176184958,0.569677678569795,1,12,epithelial cell-cell adhesion,BP,ITGB5
13085,GO:0051645,0.783751752544596,0.569637896721546,1,12,Golgi localization,BP,COPG1
1471,GO:0003730,0.783849439731153,0.368939975413093,5,54,mRNA 3'-UTR binding,MF,ZFP36L1;CIRBP;PCBP4;IGF2BP2;IGF2BP3
3580,GO:0007628,0.784095031512721,0.569123740372323,1,12,adult walking behavior,BP,EFNB3
17264,GO:0140058,0.784107967107677,0.569104354585571,1,12,neuron projection arborization,BP,DLG4
1867,GO:0004535,0.784152930916151,0.569036963786709,1,12,poly(A)-specific ribonuclease activity,MF,PAN2
2399,GO:0005545,0.784310571898956,0.568800617726575,1,12,1-phosphatidylinositol binding,MF,SNX9
14111,GO:0061003,0.784311276905034,0.568799560465127,1,12,positive regulation of dendritic spine morphogenesis,BP,CAPRIN2
9332,GO:0035855,0.784337422042724,0.568760350207949,1,12,megakaryocyte development,BP,ZFPM1
787,GO:0002052,0.784546892557141,0.568446084834455,1,12,positive regulation of neuroblast proliferation,BP,VEGFA
16528,GO:0097329,0.784714420438308,0.568194592610944,1,12,response to antimetabolite,BP,ASNS
9041,GO:0035278,0.785052054646208,0.567687324446687,1,12,miRNA mediated inhibition of translation,BP,AGO4
9791,GO:0040033,0.785052054646208,0.567687324446687,1,12,negative regulation of translation, ncRNA-mediated,BP,AGO4
11476,GO:0045974,0.785052054646208,0.567687324446687,1,12,regulation of translation, ncRNA-mediated,BP,AGO4
9875,GO:0042168,0.785433022806406,0.461014991231445,2,24,heme metabolic process,BP,UROS;BLVRB
4312,GO:0009798,0.78552835361313,0.366719703766517,5,54,axis specification,BP,DDIT3;MDFI;LRP5;WNT7A;WNT3
1071,GO:0002637,0.786365296533216,0.412691357522304,3,34,regulation of immunoglobulin production,BP,PKN1;STAT6;BCL6
3940,GO:0008637,0.786407942780029,0.318975480749694,10,104,apoptotic mitochondrial changes,BP,TFDP2;PLA2G6;BNIP3;BBC3;IFI6;BNIP3L;AKT1;LMNA;TP73;CIDEB
12666,GO:0050907,0.786822892058461,0.563245433716157,1,13,detection of chemical stimulus involved in sensory perception,BP,TRPV1
7029,GO:0030811,0.787667812393214,0.363882279891815,5,54,regulation of nucleotide catabolic process,BP,RAPGEF3;DDIT4;PPARA;MLXIPL;INSR
17513,GO:1901070,0.787855032471195,0.561679389356423,1,13,guanosine-containing compound biosynthetic process,BP,NME4
2834,GO:0006305,0.788188583834293,0.382181780416994,4,44,DNA alkylation,BP,FOS;TDRKH;DNMT3A;MGMT
2835,GO:0006306,0.788188583834293,0.382181780416994,4,44,DNA methylation,BP,FOS;TDRKH;DNMT3A;MGMT
2727,GO:0006109,0.788233314261276,0.303388678487891,13,130,regulation of carbohydrate metabolic process,BP,NTSR1;NR1D1;IGFBP4;MLYCD;DDIT4;DGKQ;PPARA;ACACB;MLXIPL;PTAFR;AKT1;INSR;PHLDA2
19705,GO:2000106,0.788851739949084,0.362125789535462,5,55,regulation of leukocyte apoptotic process,BP,RAG1;GAS6;JAK3;BCL6;ADA
9308,GO:0035794,0.78969051247295,0.361009008230529,5,55,positive regulation of mitochondrial membrane permeability,BP,TFDP2;BNIP3;BBC3;BNIP3L;TP73
19319,GO:1905710,0.78969051247295,0.361009008230529,5,55,positive regulation of membrane permeability,BP,TFDP2;BNIP3;BBC3;BNIP3L;TP73
6650,GO:0030008,0.789710822174536,0.558850479397623,1,13,TRAPP complex,CC,TRAPPC9
11774,GO:0046661,0.790814326536126,0.313549276721584,10,103,male sex differentiation,BP,ERCC1;CST3;NUPR1;WNT2B;AGO4;TBC1D20;INSR;REC8;RAB13;RHOBTB3
14263,GO:0061383,0.790822435660789,0.406449496700611,3,34,trabecula morphogenesis,BP,THBS3;PLXNB1;TGFBR3
11778,GO:0046676,0.791227713138064,0.45258267152341,2,24,negative regulation of insulin secretion,BP,HADH;PFKL
16202,GO:0090278,0.791227713138064,0.45258267152341,2,24,negative regulation of peptide hormone secretion,BP,HADH;PFKL
17202,GO:0110020,0.791743594588583,0.34460043951551,6,64,regulation of actomyosin structure organization,BP,RAPGEF3;ARAP1;PAK1;EPHA1;ASAP3;BRAF
9828,GO:0042088,0.791974454727434,0.451487757975678,2,24,T-helper 1 type immune response,BP,STAT6;JAK3
1484,GO:0003823,0.792204388177763,0.451150232859349,2,24,antigen binding,MF,SLC7A8;HLA-G
8257,GO:0033059,0.792638851919104,0.375858730770011,4,45,cellular pigmentation,BP,BBS2;BLOC1S4;LYST;BLOC1S1
5653,GO:0016758,0.792755090901621,0.291304808227527,15,150,transferase activity, transferring hexosyl groups,MF,PYGB;B3GAT3;PYGL;HYAL1;B4GALNT4;B4GAT1;PIGZ;HEXB;HEXA;B4GALT2;PIGQ;MFNG;PIGV;XYLT2;KDELC2
12628,GO:0050856,0.793477259486718,0.449278470388951,2,24,regulation of T cell receptor signaling pathway,BP,PRNP;ADA
9529,GO:0036296,0.793628095002511,0.449056296711669,2,24,response to increased oxygen levels,BP,BNIP3;CAT
17251,GO:0140013,0.793779813945656,0.309837824597123,10,103,meiotic nuclear division,BP,EREG;TDRKH;MLH3;AGO4;SPIRE1;REC8;LEMD2;SIRT2;GOLGA2;MSH5
1177,GO:0002824,0.793930211787317,0.374088277090267,4,45,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,PRKCZ;ZP3;STAT6;ADA
8090,GO:0032786,0.794034786506693,0.448456867942772,2,24,positive regulation of DNA-templated transcription, elongation,BP,ERCC6;EAPP
13082,GO:0051641,0.794120335836374,0.227623902243829,246,2178,cellular localization,BP,DLG4;BBS2;F2R;APOE;MARVELD1;SYTL1;ZMYND8;GSN;LMF1;EVI5L;WIPF1;TMEM129;EDEM1;LRP1;OBSCN;NTSR1;EGFR;PRNP;ZDHHC1;NR1D1;ANK3;IFT140;RAPGEF3;CLTCL1;SPTB;NINL;SNPH;DNM1;NOS1;DDIT3;BRSK1;PACS2;TBC1D8;ZFP36L1;SYT8;B3GAT3;GAA;EXOC2;TFDP2;RPL13A;OBSL1;BBS1;REEP2;RAB11FIP4;CPT2;SYNGR1;MAP2K1;SDCCAG8;ABCA2;TOM1L2;SYNGAP1;TMEM173;SNX9;ARL2;VPS11;SPRY2;NPHP4;BLOC1S4;RAB3B;NLGN2;ITPR3;LAMA5;TTBK2;PRKCZ;PAK1;ABCA7;MCTP1;PABPC1L;CEMIP;SYNE3;DLG3;MICALL2;CEP250;CCDC88B;NGFR;ETV5;GSTO1;WDR60;MALL;SPG11;TMED4;PLA2G6;ABCG1;ESYT2;XPOT;TRAPPC9;S100A13;KIF17;ANO1;SESN2;AIP;IFT27;PKD2;SH3TC2;NUDCD3;VAMP2;AREG;AP1G2;SEPT5;PCLO;KCNC4;ACACB;KCNAB2;MAPK3;PEX10;RGS14;CNTRL;LTBP2;HOOK2;EIF2D;MVB12B;CHMP1B;TBC1D14;TCTN1;ARHGEF2;SEPT10;FBF1;MAP2K2;TWF2;LRSAM1;DMTN;BBC3;SSH1;TBC1D3E;RABGAP1;REEP6;PKD1;FLOT1;CEP68;TSNARE1;WHAMMP3;SORL1;MAP6;HERPUD1;SRSF5;GSTM2;LRP5;PTPRU;NDE1;PCSK9;CEP131;LONP2;TMSB4X;PDE2A;RAB40B;PEMT;CDK5RAP3;WNT7A;TRPV1;BNIP3L;CCS;GAS6;VPS39;DNAJC6;LZTS2;CROCC;BCR;ATP7B;FYCO1;CEP112;KIF13B;CAMK1;PPP1R15A;RIMS3;RAB43;ATP2B4;SPATA7;STRADB;WDR19;C12ORF66;AKT1;ZFYVE21;ITPR2;IFT57;WDR45;SEPT6;TTC21A;TSG101;RASSF9;SLC6A9;LMNA;COPG1;SGSM2;TBC1D20;CHMP5;MARK4;RAB25;IFI27;COG7;CHMP4C;TPCN1;LYST;ZDHHC24;BRAF;ARHGAP44;CPSF4;ASIC1;HAUS4;HFE;TP73;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;CSNK1E;BCL6;EHD3;FYN;SNX1;PEX1;LEMD2;UBXN6;TRPC1;RAB13;TOM1;GOLGA2;CELSR1;RHOBTB3;RTN2;AP2A2;HDAC8;RPL29;STX1A;LAMTOR2;TBC1D16;EPHB2;TMCO6;SEPT8;ESYT3;BLOC1S1;RGPD6;ERBB2;SEC31B;PLLP;SYVN1;OSCP1;CORO1B;SFI1;RPL12;MPPE1;BSG;APBA1;PNKD;IKBKB;HIP1
10671,GO:0043966,0.79441356547255,0.354693937748544,5,55,histone H3 acetylation,BP,ING4;JADE2;TADA3;HDAC8;PER1
1,GO:0000002,0.794770721327138,0.447370708935907,2,24,mitochondrial genome maintenance,BP,SESN2;PRIMPOL
5513,GO:0016482,0.794922048612775,0.29516208523744,13,131,cytosolic transport,BP,CLTCL1;MAP2K1;VPS11;MAPK3;HOOK2;TBC1D14;MAP2K2;SORL1;ZFYVE21;SGSM2;EHD3;SNX1;RHOBTB3
2971,GO:0006515,0.795162402700882,0.446791864993756,2,24,protein quality control for misfolded or incompletely synthesized proteins,BP,LONP2;ANKZF1
17507,GO:1901030,0.795285561381871,0.399772516080793,3,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TFDP2;BBC3;TP73
21,GO:0000038,0.795518638413515,0.446264941529638,2,24,very long-chain fatty acid metabolic process,BP,ACOT1;ACADVL
7551,GO:0031902,0.796900610348217,0.305853394634377,10,104,late endosome membrane,CC,VPS11;MVB12B;CHMP1B;LITAF;VPS39;TMEM9;TSG101;CHMP4C;UBXN6;LAMTOR2
14097,GO:0060986,0.796945963455598,0.444149288463307,2,24,endocrine hormone secretion,BP,APLN;FGFR1
12228,GO:0048524,0.797072079092157,0.311442996148861,9,95,positive regulation of viral process,BP,APOE;ADARB1;PC;MVB12B;TSG101;TBC1D20;NELFCD;CHMP4C;LGALS1
7062,GO:0030858,0.797788414362679,0.396213532618396,3,35,positive regulation of epithelial cell differentiation,BP,ALOX15B;CYP27B1;BTG1
13462,GO:0055025,0.798445674416171,0.441918653828551,2,24,positive regulation of cardiac muscle tissue development,BP,TGFBR3;FGFR1
5982,GO:0018904,0.798457241263978,0.545285384836094,1,13,ether metabolic process,BP,PEX7
8299,GO:0033144,0.798594314435115,0.441697139043738,2,24,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,CRY2;PER1
1379,GO:0003279,0.798652613844071,0.324930788154094,7,74,cardiac septum development,BP,LTBP1;VANGL2;ZFPM1;TGFBR2;SNX17;PLXND1;TGFBR3
4683,GO:0010837,0.798957802885412,0.441155112015588,2,24,regulation of keratinocyte proliferation,BP,ZFP36L1;KLF9
1026,GO:0002532,0.798996234810889,0.394489818611219,3,35,production of molecular mediator involved in inflammatory response,BP,PDCD4;IL17RC;PER1
61,GO:0000124,0.800031086724614,0.542802893678318,1,13,SAGA complex,CC,TADA3
6231,GO:0019787,0.800120035377976,0.248002489707476,43,403,ubiquitin-like protein transferase activity,MF,GID4;FBXO2;ZNF862;TMEM129;RNF135;RBCK1;DDB2;RNF165;FBXW4;FBXO41;KLHL29;FBXW8;NEURL1;RAG1;MARCH4;RNF44;UNKL;FBXO27;FBXO17;LRSAM1;KLHL24;FBXO6;NSMCE1;FBXL15;FBXL16;HLTF;SMURF2;LMO7;MARCH2;SHARPIN;KLHDC8B;FBXL8;PIAS3;SPSB3;UHRF2;UBOX5;MIB2;RNF213;FBXO25;PJA2;SYVN1;TRIM2;KCTD13
9436,GO:0036038,0.800205403217894,0.542527142713788,1,13,MKS complex,CC,TCTN1
8332,GO:0033194,0.800471885478762,0.542105287556089,1,13,response to hydroperoxide,BP,GPX3
8300,GO:0033145,0.800544163141014,0.541990804170574,1,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,PAK1
18107,GO:1902850,0.800688969982111,0.291843893429377,12,122,microtubule cytoskeleton organization involved in mitosis,BP,TUBG2;SPRY2;CHMP1B;ARHGEF2;PKD1;NDE1;CEP126;CHEK2;CHMP5;CHMP4C;TUBGCP6;GOLGA2
4197,GO:0009309,0.800694817430107,0.541752088988481,1,13,amine biosynthetic process,BP,AZIN2
9975,GO:0042401,0.800694817430107,0.541752088988481,1,13,cellular biogenic amine biosynthetic process,BP,AZIN2
7990,GO:0032620,0.80087210943785,0.541471013229938,1,13,interleukin-17 production,BP,PRNP
11867,GO:0046902,0.801076341179574,0.332000699084618,6,66,regulation of mitochondrial membrane permeability,BP,TFDP2;BNIP3;BBC3;BNIP3L;ALKBH7;TP73
6682,GO:0030057,0.801306201763625,0.437641932057793,2,24,desmosome,CC,PPL;KLHL24
14709,GO:0070402,0.80136816029244,0.540683705185831,1,13,NADPH binding,MF,CBR4
15965,GO:0086002,0.801752125961998,0.436972613679039,2,24,cardiac muscle cell action potential involved in contraction,BP,SCN4B;SNTA1
4363,GO:0009982,0.802271241653246,0.539247049400633,1,13,pseudouridine synthase activity,MF,RPUSD3
4102,GO:0009161,0.802412570863126,0.259158586452995,26,259,ribonucleoside monophosphate metabolic process,BP,DLG4;NT5E;PGM1;DHTKD1;LHPP;DDIT4;OGDHL;DLG3;PPARA;FAM20C;MYH3;MLXIPL;SDHA;GALK1;NADK;ALDOC;TMSB4X;UCKL1;CARD11;TCIRG1;UPP1;INSR;APRT;TAZ;ADA;PFKL
3376,GO:0007156,0.802536416536767,0.330328537772404,6,64,homophilic cell adhesion via plasma membrane adhesion molecules,BP,SDK2;PLXNB3;PKD1;AMIGO2;CELSR1;CADM4
1217,GO:0002888,0.802609555511564,0.538707737155693,1,13,positive regulation of myeloid leukocyte mediated immunity,BP,PTAFR
4165,GO:0009235,0.802728686063256,0.538517684619809,1,13,cobalamin metabolic process,BP,PRSS3
11754,GO:0046633,0.803089687108186,0.537941308986334,1,13,alpha-beta T cell proliferation,BP,TGFBR2
11427,GO:0045898,0.803175834268346,0.537803663803743,1,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
10252,GO:0043009,0.80322320560631,0.243932485029997,44,412,chordate embryonic development,BP,VEGFA;EGFR;IFT140;ZFP36L1;MDFI;HYAL1;MAP2K1;SALL2;FBXW8;ZP3;WDR60;PLCD3;C5;PKD2;VANGL2;TCTN1;PLCD1;KDM4C;PKD1;DEAF1;SULF2;ENDOG;CEBPB;TGFBR2;NOS3;RXRA;ZNF358;WDR19;AKT1;IFT57;CAPN2;KRT19;TFEB;PHLDA2;CELSR1;ADA;ETNK2;TCF7;EPAS1;EDNRA;FGFR1;FKBP8;APBA1;TEAD2
3104,GO:0006684,0.803570045780467,0.537173292380805,1,13,sphingomyelin metabolic process,BP,PEMT
18780,GO:1904358,0.803642217771189,0.387821142499252,3,35,positive regulation of telomere maintenance via telomere lengthening,BP,MAPK3;PKIB;HMBOX1
10428,GO:0043302,0.803981592553207,0.536514317202289,1,13,positive regulation of leukocyte degranulation,BP,PTAFR
7499,GO:0031690,0.804417864189231,0.535814764486622,1,13,adrenergic receptor binding,MF,DLG4
15864,GO:0072657,0.804462307254022,0.240913940267226,47,452,protein localization to membrane,BP,DLG4;BBS2;APOE;ZMYND8;GSN;LRP1;EGFR;PRNP;ZDHHC1;ANK3;PACS2;TFDP2;RPL13A;BBS1;REEP2;SYNGAP1;NLGN2;LAMA5;PRKCZ;PAK1;CEMIP;SYNE3;DLG3;ETV5;VAMP2;DMTN;BBC3;SSH1;FLOT1;RAB40B;GAS6;WDR19;AKT1;ZDHHC24;BRAF;ARHGAP44;TP73;EHD3;FYN;RAB13;RPL29;STX1A;EPHB2;ERBB2;RPL12;BSG;IKBKB
8664,GO:0034249,0.80457853590889,0.260610081298827,23,230,negative regulation of cellular amide metabolic process,BP,APOE;EGFR;PRNP;ZFP36L1;RPL13A;MAP2K1;GRB7;UNK;CIRBP;CAPRIN2;ABCA7;SESN2;MAP2K2;ATF4;SORL1;AGO4;PAIP2B;IGF2BP2;ZC3H12D;PAIP2;EIF4EBP1;IGF2BP3;EIF2AK4
8215,GO:0032988,0.804866762275385,0.535093901933104,1,13,ribonucleoprotein complex disassembly,BP,EIF2D
17351,GO:1900103,0.804929319196348,0.534993359175927,1,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,ERN1
4417,GO:0010225,0.804994533754433,0.53488852264102,1,13,response to UV-C,BP,IMPACT
11230,GO:0045453,0.805020238508536,0.385831375081342,3,35,bone resorption,BP,ACP5;EGFR;INPP5D
7883,GO:0032460,0.805056693363903,0.534788575869546,1,13,negative regulation of protein oligomerization,BP,SORL1
4699,GO:0010866,0.805405321232781,0.534227630365569,1,13,regulation of triglyceride biosynthetic process,BP,FITM2
13017,GO:0051497,0.805578811434089,0.533948239306856,1,13,negative regulation of stress fiber assembly,BP,ARAP1
14807,GO:0070571,0.805895179810813,0.533438337638249,1,13,negative regulation of neuron projection regeneration,BP,PTPRS
588,GO:0001750,0.805909194286105,0.384544887778936,3,35,photoreceptor outer segment,CC,IFT140;SHANK2;WDR19
2940,GO:0006470,0.80601899124269,0.256275415527294,25,243,protein dephosphorylation,BP,DUSP6;PTPRS;PPP1R35;DUSP5;PPM1M;B3GAT3;PHACTR3;LHPP;PPP1R14A;PPP2R3B;ELFN2;PTPRE;SSH3;PPM1J;MTMR4;MYH3;PTPDC1;SSH1;PTPRU;ITGA1;DNAJC6;PPP1R15A;CRY2;CTDSPL;IKBKB
7562,GO:0031932,0.806031982225833,0.533217681290644,1,13,TORC2 complex,CC,SESN2
14637,GO:0070262,0.806271098240854,0.532831754762094,1,13,peptidyl-serine dephosphorylation,BP,PPP1R15A
4505,GO:0010560,0.806293828077293,0.532795053356369,1,13,positive regulation of glycoprotein biosynthetic process,BP,GOLGA2
10820,GO:0044331,0.806324358540103,0.532745752037583,1,13,cell-cell adhesion mediated by cadherin,BP,FLOT1
11446,GO:0045921,0.806334709142548,0.3383762883804,5,56,positive regulation of exocytosis,BP,ZP3;PLA2G6;PTAFR;TSG101;STX1A
19477,GO:1990381,0.806507127350663,0.532450507137709,1,13,ubiquitin-specific protease binding,MF,SYVN1
4443,GO:0010369,0.806565749085715,0.532355771226908,1,13,chromocenter,CC,SCMH1
11328,GO:0045672,0.80672774357612,0.532093882497433,1,13,positive regulation of osteoclast differentiation,BP,FOS
18655,GO:1904029,0.806835290115266,0.313984194184354,7,76,regulation of cyclin-dependent protein kinase activity,BP,EGFR;PKD2;PKD1;CDK5RAP3;MAPRE3;AKT1;CDKN1C
13837,GO:0060479,0.806935090990263,0.531758466233025,1,13,lung cell differentiation,BP,THRA
8728,GO:0034390,0.807056481121733,0.531561990771619,1,13,smooth muscle cell apoptotic process,BP,PDCD4
8729,GO:0034391,0.807056481121733,0.531561990771619,1,13,regulation of smooth muscle cell apoptotic process,BP,PDCD4
9333,GO:0035859,0.807206292593753,0.531319403717891,1,13,Seh1-associated complex,CC,SESN2
12531,GO:0050704,0.807426276711533,0.427762129730409,2,25,regulation of interleukin-1 secretion,BP,NLRP1;GAS6
3361,GO:0007100,0.807439305094997,0.530941848186641,1,13,mitotic centrosome separation,BP,NDE1
12206,GO:0048485,0.807479587597558,0.530876547568345,1,13,sympathetic nervous system development,BP,SEMA3F
3108,GO:0006688,0.80771909955191,0.530488100212199,1,13,glycosphingolipid biosynthetic process,BP,ST6GALNAC6
2679,GO:0006044,0.807786187999797,0.530379238185931,1,13,N-acetylglucosamine metabolic process,BP,CHST6
7164,GO:0031054,0.807918596694519,0.53016431127686,1,13,pre-miRNA processing,BP,AGO4
18367,GO:1903421,0.807922903120619,0.530157319445735,1,13,regulation of synaptic vesicle recycling,BP,DNM1
9756,GO:0039535,0.807954332810413,0.530106287718447,1,13,regulation of RIG-I signaling pathway,BP,NLRX1
4579,GO:0010669,0.808198595880386,0.529709499013274,1,13,epithelial structure maintenance,BP,CROCC
19704,GO:2000105,0.808235775857325,0.529649074081161,1,13,positive regulation of DNA-dependent DNA replication,BP,FGFR1
11329,GO:0045682,0.8082507627184,0.322413451903393,6,66,regulation of epidermis development,BP,ALOX15B;ZFP36L1;CYP27B1;NAB2;ERRFI1;AQP3
10392,GO:0043247,0.808282690325077,0.529572817862258,1,13,telomere maintenance in response to DNA damage,BP,ERCC1
5528,GO:0016514,0.808335950465361,0.529486232596313,1,13,SWI/SNF complex,CC,SMARCD2
16651,GO:0097617,0.808344134207059,0.529472926873113,1,13,annealing activity,MF,SMARCA1
4339,GO:0009895,0.808410504872641,0.259233517607252,21,208,negative regulation of catabolic process,BP,SERPINE2;TIMP2;EGFR;CST3;DDIT4;CIRBP;PPARA;ACACB;TBC1D14;AZIN2;ATRAID;DAP;CDK5RAP3;ATP2B4;AKT1;TIMP1;HFE;FYN;SIRT2;GOLGA2;CIDEA
17620,GO:1901385,0.808437624846393,0.52932089697622,1,13,regulation of voltage-gated calcium channel activity,BP,EHD3
15237,GO:0071437,0.808573641934078,0.529099627192688,1,13,invadopodium,CC,PAK1
13195,GO:0051881,0.808698063677443,0.353099054094388,4,47,regulation of mitochondrial membrane potential,BP,BNIP3;IFI6;BNIP3L;AKT1
1358,GO:0003231,0.808786310470146,0.311513719637174,7,75,cardiac ventricle development,BP,LTBP1;VANGL2;ZFPM1;TGFBR2;RXRA;TGFBR3;TNNI1
700,GO:0001921,0.808806930234906,0.528719882578831,1,13,positive regulation of receptor recycling,BP,ARAP1
4685,GO:0010839,0.809028733739793,0.528358555944529,1,13,negative regulation of keratinocyte proliferation,BP,KLF9
6436,GO:0021756,0.80903175184915,0.528353637465311,1,13,striatum development,BP,BBS2
2658,GO:0006004,0.80927566804295,0.527955972359609,1,13,fucose metabolic process,BP,FUCA1
8947,GO:0035025,0.809302991564604,0.527911405492242,1,13,positive regulation of Rho protein signal transduction,BP,F2R
8695,GO:0034349,0.809398265993296,0.527755973087681,1,13,glial cell apoptotic process,BP,GAS6
2856,GO:0006349,0.809500350796309,0.527589374666924,1,13,regulation of gene expression by genetic imprinting,BP,DNMT3A
18356,GO:1903392,0.809560407837849,0.527491337102946,1,13,negative regulation of adherens junction organization,BP,DMTN
9088,GO:0035372,0.80958215478297,0.527455832330164,1,13,protein localization to microtubule,BP,TTBK2
1374,GO:0003272,0.809784599196292,0.527125189863243,1,13,endocardial cushion formation,BP,TGFBR2
8808,GO:0034595,0.809857310475552,0.527006378953282,1,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,INPP5D
5552,GO:0016569,0.810138633343847,0.237147932086455,42,396,covalent chromatin modification,BP,ZMYND8;VEGFA;PADI3;DDB2;NOS1;ASH2L;PKN1;PHF21A;HDAC11;KDM3A;MTHFR;PHF1;RAG1;FKBP10;CHD3;SATB1;ING4;HMGA2;JADE2;MAPK3;KDM4C;HLCS;JDP2;HDAC5;KDM7A;MAP3K12;DNMT3A;HMG20B;TADA3;MBD1;PHF2;UHRF2;RPS6KA5;C6ORF89;MTA3;PHC1;BCL6;HSF4;SIRT2;MTA1;HDAC8;PER1
14031,GO:0060831,0.810194210697784,0.526455499885527,1,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,WDR19
12942,GO:0051348,0.81031516043903,0.252474697889733,24,236,negative regulation of transferase activity,BP,DUSP6;APOE;PTK6;PDCD4;DUSP5;ADARB1;WWTR1;PKN1;SPRY2;SPRY4;TRIB2;ERRFI1;RGS14;SORL1;LRP5;PKIB;TRIB3;CDK5RAP3;EPHA1;AKT1;CDKN1C;TSG101;TP73;EPHB2
13081,GO:0051640,0.810555167486475,0.230348753459069,56,522,organelle localization,BP,BBS2;SYTL1;NINL;SNPH;DNM1;SYT8;EXOC2;SDCCAG8;VPS11;SPRY2;NPHP4;BLOC1S4;RAB3B;NLGN2;TTBK2;PRKCZ;PABPC1L;CEP250;SPG11;ESYT2;TRAPPC9;S100A13;VAMP2;AREG;SEPT5;PCLO;CNTRL;CHMP1B;TCTN1;ARHGEF2;FBF1;TSNARE1;MAP6;NDE1;CEP131;RAB40B;CROCC;FYCO1;RIMS3;COPG1;TBC1D20;CHMP5;MARK4;CHMP4C;BRAF;HAUS4;SPIRE1;CSNK1E;PEX1;LEMD2;RAB13;GOLGA2;STX1A;ESYT3;BLOC1S1;SFI1
5721,GO:0016866,0.810835702864345,0.422550034053826,2,25,intramolecular transferase activity,MF,PGM1;RPUSD3
13570,GO:0060065,0.811021140576846,0.525100690632833,1,13,uterus development,BP,WNT7A
9434,GO:0036035,0.811030646687509,0.525085094146256,1,13,osteoclast development,BP,FAM20C
8961,GO:0035065,0.812213027345464,0.348360994159339,4,46,regulation of histone acetylation,BP,NOS1;MAPK3;RPS6KA5;HDAC8
6356,GO:0021543,0.812545645851496,0.281140029393478,11,114,pallium development,BP,PTPRS;BBS2;LRP1;EGFR;TRAPPC9;BNIP3;MDK;NDE1;ATP2B4;LAMB1;SLC38A2
7727,GO:0032231,0.813802637932704,0.314925533336207,6,66,regulation of actin filament bundle assembly,BP,RAPGEF3;ARAP1;PAK1;EPHA1;ASAP3;BRAF
15202,GO:0071383,0.814166182766226,0.255889972937742,19,189,cellular response to steroid hormone stimulus,BP,EGFR;NR1D1;ZFP36L1;KLF9;PCK2;DDIT4;PAK1;KDM3A;PPARA;ERRFI1;THRA;PAQR6;CREBRF;CALCOCO1;TADA3;RXRA;CRY2;EIF4EBP1;PER1
7306,GO:0031324,0.814358985804033,0.207390706151494,212,1891,negative regulation of cellular metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;ZC3H6;TNFRSF6B;APOE;ZMYND8;NFATC4;SERPINE2;EGR1;CTNNBIP1;PPP1R35;PTK6;ACP5;WWC3;PDCD4;TIMP2;VEGFA;EGFR;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;BAHCC1;TFPI2;DUSP5;CRTAP;CST3;DDIT3;DNAJB5;ZFP36L1;ADARB1;TCFL5;HBEGF;TFDP2;MXI1;RPL13A;MDFI;PLAT;SLC27A1;PHACTR3;PPP1R14A;WWTR1;MAP2K1;CYP27B1;MXD4;PKN1;DDIT4;H2AFJ;PHF21A;DGKQ;MAGEF1;SHC1;SPRY2;GRB7;UNK;CIRBP;CAPRIN2;PRKCZ;SERPING1;ABCA7;ELK3;STK39;KDM3A;FOXQ1;PHF1;SPRY4;SALL2;DLG3;ZP3;NEIL1;ACVR2B;RAG1;EAPP;NGFR;ELFN2;TRIB2;HES2;EREG;NAB2;C5;PPARA;CHAC1;SESN2;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;ECM1;ACACB;BNIP3;ERRFI1;THRA;RGS14;IRF2BPL;PBXIP1;SNTA1;MLXIPL;TBC1D14;INPP5D;TSPYL2;MAP2K2;DMTN;ATF4;ZFPM1;KDM4C;LTB4R2;TENM2;IFI6;CBX7;JDP2;HDAC5;SORL1;HERPUD1;VLDLR;PAPLN;GABBR1;DEAF1;PEG3;CEBPB;LRP5;ATRAID;PCSK9;PKIB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;CSRNP3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;HMG20B;CDK5RAP3;AGO4;ZFP90;TRPV1;PIK3R2;EPHA1;GAS6;BCR;PPP1R15A;RXRA;MBD1;TNRC18;ATP2B4;PAIP2B;HINT2;AKT1;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;TSG101;PHF2;IGF2BP2;ZNF217;PIAS3;ACADVL;FARP1;C9ORF72;UHRF2;IFI27;NCOA7;NELFCD;RPS6KA5;CTDSPL;MAP2K5;TIMP1;HFE;JAK3;TP73;MTA3;MNT;BCL6;HSF4;FYN;ZC3H12D;LEMD2;SIRT2;RECQL5;GOLGA2;RCOR2;MTA1;HDAC8;PAIP2;EIF4EBP1;TCF7;MAP3K10;EPHB2;PER1;IGF2BP3;FGFR1;WFS1;FKBP8;EIF2AK4;SFI1;HMBOX1;GRB10;TSHZ1;IKBKB;ACOT8;SIX5
8659,GO:0034243,0.814367330827486,0.417105325649778,2,25,regulation of transcription elongation from RNA polymerase II promoter,BP,EAPP;RECQL5
2952,GO:0006486,0.815572119772312,0.252361309969389,20,198,protein glycosylation,BP,ST6GALNAC2;LMF1;ADAMTS7;ADAMTS13;B3GAT3;VEGFB;MUC19;ST6GALNAC6;B4GAT1;MVD;ADAMTSL1;SRD5A3;ST3GAL3;B4GALT2;COG7;MPI;GOLGA2;MAN1B1;MFNG;SYVN1
10492,GO:0043413,0.815572119772312,0.252361309969389,20,198,macromolecule glycosylation,BP,ST6GALNAC2;LMF1;ADAMTS7;ADAMTS13;B3GAT3;VEGFB;MUC19;ST6GALNAC6;B4GAT1;MVD;ADAMTSL1;SRD5A3;ST3GAL3;B4GALT2;COG7;MPI;GOLGA2;MAN1B1;MFNG;SYVN1
4512,GO:0010569,0.815649984474511,0.415116161520728,2,25,regulation of double-strand break repair via homologous recombination,BP,MAGEF1;RECQL5
6928,GO:0030544,0.815684222513598,0.369898394252922,3,36,Hsp70 protein binding,MF,MVD;ERN1;HDAC8
13917,GO:0060612,0.81575883988015,0.414947057086306,2,25,adipose tissue development,BP,ZNF516;LRP5
10808,GO:0044319,0.815775513195514,0.414921151456413,2,25,wound healing, spreading of cells,BP,HBEGF;WNT7A
16294,GO:0090505,0.815775513195514,0.414921151456413,2,25,epiboly involved in wound healing,BP,HBEGF;WNT7A
14109,GO:0061001,0.815852998544795,0.414800747100039,2,25,regulation of dendritic spine morphogenesis,BP,CAPRIN2;ARHGAP44
7210,GO:0031113,0.816398291666537,0.368842839812329,3,36,regulation of microtubule polymerization,BP,EML2;ARL2;PAK1
3366,GO:0007131,0.816451558063285,0.368764038283593,3,36,reciprocal meiotic recombination,BP,MLH3;REC8;MSH5
9324,GO:0035825,0.816451558063285,0.368764038283593,3,36,homologous recombination,BP,MLH3;REC8;MSH5
1108,GO:0002697,0.816690811165952,0.250965899468455,20,200,regulation of immune effector process,BP,HTRA1;IL20RB;PKN1;TMEM173;PRKCZ;SERPING1;ZP3;C5;APOBEC3F;NLRX1;STAT6;MAPK3;BCR;PTAFR;HFE;JAK3;BCL6;TKFC;MYO18A;EIF2AK4
8280,GO:0033120,0.817390594161322,0.412406709257901,2,25,positive regulation of RNA splicing,BP,SRSF5;ERN1
8598,GO:0034121,0.817802061734548,0.366763244637466,3,36,regulation of toll-like receptor signaling pathway,BP,PTPRS;NR1D1;FLOT1
12063,GO:0048038,0.818007008101137,0.511923366019454,1,14,quinone binding,MF,CBR4
17849,GO:1902115,0.818067509270514,0.263102116407743,14,143,regulation of organelle assembly,BP,GSN;EVI5L;IFT140;ULK1;VPS11;CHMP1B;TBC1D14;ARHGEF2;LRSAM1;CROCC;TSG101;C9ORF72;CHMP5;CHMP4C
7781,GO:0032330,0.818813920079867,0.410182450822969,2,25,regulation of chondrocyte differentiation,BP,ADAMTS7;PTHLH
4654,GO:0010804,0.818845987837042,0.51051000569321,1,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
1448,GO:0003682,0.819162655444186,0.224729556741393,46,436,chromatin binding,MF,ZMYND8;NFATC4;FOS;H1F0;EGR1;EGFR;BAHCC1;ERCC6;SMARCA1;NUPR1;RBL2;ASH2L;PKN1;PHF21A;PBX2;BRD3;KDM3A;PHF1;SATB1;HMGA2;THRA;KDM4C;PRIMPOL;JDP2;HDAC5;CEBPB;L3MBTL1;DNMT3A;MLH3;CALCOCO1;HMG20B;RXRA;TNRC18;SMARCD2;FOXO4;TP73;MTA3;MNT;BCL6;REC8;LEMD2;SIRT2;MTA1;HDAC8;PER1;TSHZ1
8145,GO:0032885,0.819298784917566,0.409422945838129,2,25,regulation of polysaccharide biosynthetic process,BP,AKT1;INSR
14371,GO:0061647,0.819369753792433,0.364433703187585,3,36,histone H3-K9 modification,BP,KDM3A;KDM4C;HDAC8
9876,GO:0042169,0.819902437555704,0.408476086317984,2,25,SH2 domain binding,MF,TRPV4;PAG1
12511,GO:0050680,0.82001305200089,0.288429044290563,8,86,negative regulation of epithelial cell proliferation,BP,XDH;APOE;KLF9;NGFR;EREG;CDKN1C;IFT57;TGFBR3
16817,GO:0098751,0.820190839483895,0.408023210146503,2,25,bone cell development,BP,FAM20C;ZFPM1
13549,GO:0060042,0.820879710190798,0.406940159207044,2,25,retina morphogenesis in camera-type eye,BP,SDK2;LRP5
13196,GO:0051882,0.821145891747659,0.506614571590475,1,14,mitochondrial depolarization,BP,IFI6
634,GO:0001824,0.821281094585579,0.335188697130259,4,47,blastocyst development,BP,ZP3;KDM4C;CAPN2;ADA
11178,GO:0045309,0.821368877233028,0.361452100785602,3,36,protein phosphorylated amino acid binding,MF,SHC1;MAPK3;PIK3R2
2827,GO:0006296,0.821383723961276,0.361103655789168,3,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,DDB2;ERCC1;POLD4
14824,GO:0070603,0.821515591061576,0.304294400834485,6,67,SWI/SNF superfamily-type complex,CC,SMARCA1;APPL2;SALL2;INO80C;CHD3;SMARCD2
8338,GO:0033209,0.821642504433495,0.261645984108583,13,138,tumor necrosis factor-mediated signaling pathway,BP,TNFRSF6B;RBCK1;TNFSF15;SPPL2B;NGFR;TNFRSF25;TMSB4X;EDA;SHARPIN;GAS6;TNFRSF14;EDA2R;IKBKB
3331,GO:0007044,0.821758361055523,0.294105733922335,7,76,cell-substrate junction assembly,BP,VEGFA;ITGA6;LAMA5;ITGB4;TNS1;DMTN;ITGA2
15964,GO:0086001,0.822286926360738,0.360078721862238,3,36,cardiac muscle cell action potential,BP,ANK3;SCN4B;SNTA1
11299,GO:0045639,0.822503015863685,0.315826808952282,5,57,positive regulation of myeloid cell differentiation,BP,FOS;CTNNBIP1;FAM210B;ZFP36L1;INPP5D
12930,GO:0051321,0.822570842677012,0.254607009279837,15,153,meiotic cell cycle,BP,ERCC1;TUBG2;NPR2;EREG;TDRKH;MLH3;AGO4;INSR;TUBGCP6;SPIRE1;REC8;LEMD2;SIRT2;GOLGA2;MSH5
604,GO:0001773,0.82257682065302,0.504175300931893,1,14,myeloid dendritic cell activation,BP,TGFBR2
19582,GO:1990752,0.823970791319447,0.402057237903075,2,25,microtubule end,CC,CLIP2;MAPRE3
5742,GO:0016894,0.824128466797615,0.401227931841472,2,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,NEIL1;DNASE2
4366,GO:0009988,0.824415970481394,0.400771684375567,2,26,cell-cell recognition,BP,ZP3;ST6GALNAC6
14118,GO:0061014,0.824520001986533,0.356727096343138,3,36,positive regulation of mRNA catabolic process,BP,ZFP36L1;GTPBP1;ZC3H12D
716,GO:0001942,0.825556273493511,0.298742642995883,6,67,hair follicle development,BP,EGFR;LAMA5;FOXQ1;VANGL2;EDA;CELSR1
15269,GO:0071480,0.825598155646617,0.398892161812952,2,26,cellular response to gamma radiation,BP,EGR1;CHEK2
8067,GO:0032757,0.82566191997584,0.398790625123573,2,26,positive regulation of interleukin-8 production,BP,F2R;DDIT3
7432,GO:0031571,0.825816197581541,0.298263364813072,6,68,mitotic G1 DNA damage checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1;TP73
10988,GO:0044819,0.825816197581541,0.298263364813072,6,68,mitotic G1/S transition checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1;TP73
7414,GO:0031519,0.825847575351938,0.328587633440719,4,47,PcG protein complex,CC,PHC2;PHF1;CBX7;PHC1
6948,GO:0030593,0.825956239850202,0.35393114838019,3,38,neutrophil chemotaxis,BP,ITGA1;CKLF;VAV3
5620,GO:0016701,0.826076873123404,0.498157501651353,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,ALOX15B
5621,GO:0016702,0.826076873123404,0.498157501651353,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,ALOX15B
11318,GO:0045662,0.826210914662773,0.497925573843007,1,14,negative regulation of myoblast differentiation,BP,DDIT3
10138,GO:0042733,0.826324286811944,0.327895327072516,4,47,embryonic digit morphogenesis,BP,IFT140;FBXW4;LRP5;WNT7A
8366,GO:0033276,0.826419883155588,0.497563785180257,1,14,transcription factor TFTC complex,CC,TADA3
12830,GO:0051172,0.826485629619281,0.194998731644486,198,1776,negative regulation of nitrogen compound metabolic process,BP,TNIP1;XDH;DUSP6;ZC3H6;TNFRSF6B;APOE;ZMYND8;NFATC4;SERPINE2;EGR1;CTNNBIP1;PPP1R35;PTK6;ACP5;WWC3;PDCD4;TIMP2;VEGFA;EGFR;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;BAHCC1;TFPI2;DUSP5;CRTAP;CST3;DDIT3;DNAJB5;ZFP36L1;ADARB1;TCFL5;HBEGF;TFDP2;MXI1;RPL13A;MDFI;PLAT;PHACTR3;PPP1R14A;WWTR1;MAP2K1;MXD4;PKN1;DDIT4;H2AFJ;PHF21A;DGKQ;MAGEF1;SHC1;SPRY2;GRB7;UNK;CIRBP;CAPRIN2;PRKCZ;SERPING1;ABCA7;ELK3;STK39;KDM3A;FOXQ1;PHF1;SPRY4;SALL2;ZP3;NEIL1;ACVR2B;RAG1;EAPP;NGFR;ELFN2;TRIB2;HES2;EREG;NAB2;C5;PPARA;CHAC1;SESN2;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;ECM1;ERRFI1;THRA;RGS14;IRF2BPL;PBXIP1;SNTA1;MLXIPL;INPP5D;TSPYL2;MAP2K2;DMTN;ATF4;ZFPM1;KDM4C;LTB4R2;TENM2;IFI6;CBX7;AZIN2;JDP2;HDAC5;SORL1;HERPUD1;VLDLR;PAPLN;GABBR1;DEAF1;PEG3;CEBPB;LRP5;ATRAID;PKIB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;HMG20B;CDK5RAP3;AGO4;ZFP90;TRPV1;PIK3R2;EPHA1;GAS6;PPP1R15A;RXRA;MBD1;TNRC18;ATP2B4;PAIP2B;HINT2;AKT1;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;TSG101;PHF2;IGF2BP2;ZNF217;PIAS3;C9ORF72;UHRF2;IFI27;NCOA7;NELFCD;RPS6KA5;CTDSPL;MAP2K5;TIMP1;HFE;JAK3;TP73;MTA3;MNT;BCL6;HSF4;FYN;ZC3H12D;LEMD2;SIRT2;RECQL5;RCOR2;MTA1;HDAC8;PAIP2;EIF4EBP1;TCF7;MAP3K10;EPHB2;PER1;IGF2BP3;FGFR1;WFS1;FKBP8;EIF2AK4;HMBOX1;TSHZ1;IKBKB;ACOT8;SIX5
18425,GO:1903541,0.826601791006504,0.497248631177178,1,14,regulation of exosomal secretion,BP,TSG101
18427,GO:1903543,0.826601791006504,0.497248631177178,1,14,positive regulation of exosomal secretion,BP,TSG101
610,GO:0001779,0.827139243566366,0.496316323888815,1,14,natural killer cell differentiation,BP,GAS6
9883,GO:0042181,0.827228718845301,0.396290536061298,2,26,ketone biosynthetic process,BP,EGR1;DGKQ
12632,GO:0050860,0.827313931317243,0.496012918155595,1,14,negative regulation of T cell receptor signaling pathway,BP,PRNP
12545,GO:0050718,0.827367177583762,0.495920400586455,1,14,positive regulation of interleukin-1 beta secretion,BP,NLRP1
13925,GO:0060632,0.827454805398194,0.495768106008298,1,14,regulation of microtubule-based movement,BP,BBS2
1855,GO:0004521,0.827473708120978,0.326012271747827,4,48,endoribonuclease activity,MF,ERN1;LACTB2;CPSF4;ENDOV
808,GO:0002082,0.827735242805442,0.495280398817848,1,14,regulation of oxidative phosphorylation,BP,MLXIPL
5905,GO:0018149,0.82789419564026,0.350437948570528,3,40,peptide cross-linking,BP,ABCA7;LCE1E;LCE1F
8612,GO:0034142,0.827908362959875,0.494979086460058,1,14,toll-like receptor 4 signaling pathway,BP,NR1D1
17813,GO:1902017,0.82794746621762,0.351227559953422,3,37,regulation of cilium assembly,BP,EVI5L;IFT140;CROCC
13152,GO:0051782,0.828017160171816,0.494789633097147,1,14,negative regulation of cell division,BP,CHMP4C
17825,GO:1902042,0.828083269926247,0.394922760084163,2,26,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,ARHGEF2;NOS3
3698,GO:0008209,0.828229096446231,0.494420370907666,1,14,androgen metabolic process,BP,SRD5A3
10592,GO:0043588,0.828352000004822,0.229638965001301,25,250,skin development,BP,ALOX15B;EGFR;KRT15;ZFP36L1;MAP2K1;CYP27B1;PPL;ITGA6;LAMA5;PRSS8;FOXQ1;ITGB4;LCE1E;EREG;ERRFI1;VANGL2;PKD1;AQP3;EDA;SHARPIN;LCE1F;TSG101;KRT19;CELSR1;ITGA2
2457,GO:0005671,0.828441465793893,0.494050077796484,1,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,TADA3
11609,GO:0046332,0.828653988057757,0.307155085204043,5,57,SMAD binding,MF,FOS;HMGA2;TGFBR2;SMURF2;TGFBR3
6710,GO:0030127,0.828749264807355,0.493512899061553,1,14,COPII vesicle coat,CC,SEC31B
6604,GO:0022829,0.828809013115029,0.493408557244891,1,14,wide pore channel activity,MF,GJC2
5855,GO:0017160,0.828894137817497,0.49325986124238,1,14,Ral GTPase binding,MF,EXOC2
7728,GO:0032232,0.828995478977427,0.493082780103382,1,14,negative regulation of actin filament bundle assembly,BP,ARAP1
16172,GO:0090231,0.829079288608096,0.492936285323751,1,14,regulation of spindle checkpoint,BP,NDRG1
7953,GO:0032561,0.829522143548571,0.224017114757318,29,285,guanyl ribonucleotide binding,MF,DNM1;PCK2;TUBG2;TMEM173;ARL2;RAB3B;NPR2;RHOBTB2;AGAP1;IFT27;SEPT5;RHOF;TUBE1;SEPT10;GTPBP1;PDE2A;RAB40B;ARL10;GLUD1;SUCLG2;RAB43;SEPT6;RAB25;INSR;GNAL;EHD3;RAB13;RHOBTB3;SEPT8
10590,GO:0043586,0.82991643883923,0.491470610252638,1,14,tongue development,BP,EGFR
11703,GO:0046527,0.829921090784533,0.491462453551025,1,14,glucosyltransferase activity,MF,KDELC2
8995,GO:0035173,0.829975340015304,0.491367323276821,1,14,histone kinase activity,MF,PKN1
4522,GO:0010592,0.830236131961652,0.49090974930265,1,14,positive regulation of lamellipodium assembly,BP,TWF2
2219,GO:0005123,0.830327385400939,0.490749540329246,1,14,death receptor binding,MF,PIDD1
8963,GO:0035067,0.830509713386194,0.490429281407009,1,14,negative regulation of histone acetylation,BP,HDAC8
12916,GO:0051299,0.830534728622582,0.490385326034038,1,14,centrosome separation,BP,NDE1
5884,GO:0018027,0.830637528851776,0.490204650345993,1,14,peptidyl-lysine dimethylation,BP,KDM3A
3238,GO:0006896,0.830641232687297,0.490198139475452,1,14,Golgi to vacuole transport,BP,EHD3
18267,GO:1903201,0.830655252484048,0.321367067647972,4,48,regulation of oxidative stress-induced cell death,BP,ATF4;ENDOG;AKT1;NCOA7
1701,GO:0004190,0.830854662149504,0.489822813166267,1,14,aspartic-type endopeptidase activity,MF,SPPL2B
14492,GO:0070001,0.830854662149504,0.489822813166267,1,14,aspartic-type peptidase activity,MF,SPPL2B
12259,GO:0048592,0.830862667207318,0.273893126077022,8,87,eye morphogenesis,BP,VEGFA;SDK2;NAGLU;WNT2B;COL8A1;LRP5;TBC1D20;EPHB2
7992,GO:0032623,0.830896551751616,0.346745549824545,3,37,interleukin-2 production,BP,IL20RB;PRNP;CARD11
4524,GO:0010594,0.831011492007251,0.261917133097927,10,107,regulation of endothelial cell migration,BP,APOE;VEGFA;SEMA5A;HDAC5;TMSB4X;NOS3;WNT7A;AKT1;MAP2K5;FGFR1
15231,GO:0071425,0.831018222545777,0.48953499184187,1,14,hematopoietic stem cell proliferation,BP,WNT2B
20079,GO:2000781,0.831042772017149,0.489491777114452,1,14,positive regulation of double-strand break repair,BP,MGMT
7419,GO:0031529,0.831091268997536,0.34644862751756,3,37,ruffle organization,BP,EPS8L1;EPS8L2;CORO1B
18752,GO:1904292,0.83118269083187,0.389936780368288,2,26,regulation of ERAD pathway,BP,EDEM1;HERPUD1
9474,GO:0036124,0.831225784012381,0.48916950027436,1,14,histone H3-K9 trimethylation,BP,KDM4C
7550,GO:0031901,0.831360581515524,0.261460186268552,10,107,early endosome membrane,CC,EGFR;APPL2;ABCA7;MTMR4;PI4K2A;LITAF;TSG101;SNX1;UBXN6;HLA-G
12283,GO:0048643,0.831434028379121,0.488802535572921,1,14,positive regulation of skeletal muscle tissue development,BP,FLOT1
15597,GO:0072111,0.831568681749796,0.488565107201853,1,14,cell proliferation involved in kidney development,BP,EGR1
10954,GO:0044743,0.831576635667978,0.345402576668562,3,38,protein transmembrane import into intracellular organelle,BP,PEX10;PEX7;PEX1
8250,GO:0033043,0.831576789141954,0.195799272574895,111,1012,regulation of organelle organization,BP,ESPN;ZMYND8;GSN;EVI5L;WIPF1;CDC42EP5;LRP1;VEGFA;ERCC1;IFT140;RAPGEF3;SPTB;NOS1;TBC1D8;ARHGEF19;CUL9;ARAP1;TFDP2;OBSL1;CUL7;ARPIN;MAP2K1;CAPG;TOM1L2;EML2;ARL2;ULK1;VPS11;TTBK2;PAK1;KDM3A;MTHFR;PHF1;MICALL2;CEP250;PLXNB1;EREG;SSH3;RMI2;PLEKHG2;RHOBTB2;PLA2G6;MAPK3;BNIP3;SEMA5A;VANGL2;RHOF;CHMP1B;TBC1D14;ARHGEF2;MAP2K2;TWF2;STMN3;LRSAM1;DMTN;BBC3;KDM4C;SSH1;TBC1D3E;RABGAP1;PKD1;JDP2;WHAMMP3;LRP5;PKIB;L3MBTL1;CEP131;TRIOBP;TRPV4;TMSB4X;PEMT;BNIP3L;EPHA1;CROCC;FYCO1;TADA3;AKT1;TSG101;PHF2;TMOD2;ASAP3;LMNA;C9ORF72;SGSM2;CHMP5;UHRF2;CAPN2;INSR;RPS6KA5;CHMP4C;C6ORF89;BRAF;ARHGAP44;TP73;FCHSD1;SPIRE1;BCL6;EPS8L1;EHD3;SIRT2;CELSR1;RHOBTB3;EPS8L2;HDAC8;CIDEB;TBC1D16;OSCP1;C15ORF62;CORO1B;HMBOX1;PLEKHH2
8680,GO:0034315,0.831792176457378,0.488170778040691,1,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,CORO1B
17281,GO:0140104,0.831908071517915,0.388231408871554,2,27,molecular carrier activity,MF,CCS;TMCO6
605,GO:0001774,0.831979261587101,0.487840448220381,1,14,microglial cell activation,BP,TRPV1
1123,GO:0002712,0.83199474830082,0.388623871522325,2,26,regulation of B cell mediated immunity,BP,STAT6;BCL6
1218,GO:0002889,0.83199474830082,0.388623871522325,2,26,regulation of immunoglobulin mediated immune response,BP,STAT6;BCL6
8623,GO:0034162,0.832000685062715,0.48780260749306,1,14,toll-like receptor 9 signaling pathway,BP,PTPRS
15147,GO:0071305,0.832031903417147,0.487747460715588,1,14,cellular response to vitamin D,BP,CYP27B1
8926,GO:0034975,0.83206211712642,0.487694082800162,1,14,protein folding in endoplasmic reticulum,BP,ERO1B
17561,GO:1901224,0.832337650733945,0.344545100334466,3,37,positive regulation of NIK/NF-kappaB signaling,BP,PDCD4;EGFR;TNFSF15
5257,GO:0015893,0.832444974078915,0.265329631287806,9,98,drug transport,BP,NTSR1;RAB3B;SLC22A18;PQLC2;PRAF2;SLC6A9;SLC25A29;SLC25A42;SLC35F3
10845,GO:0044380,0.832538995844028,0.318813629205045,4,47,protein localization to cytoskeleton,BP,TTBK2;CEP250;NUDCD3;CEP131
16075,GO:0090083,0.832576979667347,0.486783603376256,1,14,regulation of inclusion body assembly,BP,SORL1
69,GO:0000145,0.832705152113859,0.486556684478723,1,14,exocyst,CC,EXOC2
17387,GO:1900151,0.832708560068151,0.486550649558299,1,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1
17389,GO:1900153,0.832708560068151,0.486550649558299,1,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1
4697,GO:0010862,0.832729875774818,0.387432968361342,2,26,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,HFE;GDF15
4570,GO:0010660,0.832753835841605,0.343908351242699,3,37,regulation of muscle cell apoptotic process,BP,PDCD4;RGL2;BNIP3
13039,GO:0051567,0.832828284664302,0.387273374783712,2,26,histone H3-K9 methylation,BP,KDM3A;KDM4C
783,GO:0002042,0.832846080638573,0.343767142761106,3,37,cell migration involved in sprouting angiogenesis,BP,VEGFA;HDAC5;MAP2K5
1795,GO:0004438,0.833189656745081,0.485697971140428,1,14,phosphatidylinositol-3-phosphatase activity,MF,MTMR4
13381,GO:0052744,0.833189656745081,0.485697971140428,1,14,phosphatidylinositol monophosphate phosphatase activity,MF,MTMR4
17168,GO:0106018,0.833213271670282,0.485656079212943,1,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,MTMR4
2936,GO:0006464,0.833379806462776,0.183397250165987,351,3086,cellular protein modification process,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;F2R;ST6GALNAC2;APOE;ZMYND8;GID4;EGR1;LMF1;PPP1R35;FBXO2;ZNF862;PTK6;TMEM129;CDC42EP5;EDEM1;RNF135;GJC2;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PADI3;RBCK1;DDB2;PRNP;ZDHHC1;FBLN1;ADAMTS7;DUSP5;NEK9;RAPGEF3;TNFSF15;SPTB;LOXL1;IGFBP4;FKBP9;CRTAP;CST3;NOS1;BRSK1;ERCC6;ADAMTS13;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;B3GAT3;HBEGF;RPS6KA2;CTF1;CNTN1;OBSL1;PLAT;ULK2;SLC27A1;MAPK13;RNF165;CDK18;PHACTR3;FBXW4;ASH2L;CUL7;LHPP;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;ALPK1;BTG1;SHC2;SYNGAP1;PHF21A;DGKQ;SNX9;MAGEF1;ULK1;SHC1;SPRY2;VEGFB;ADM2;HDAC11;RAB3B;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;PAK1;ABCA7;STK39;ERO1B;FGFR3;FBXO41;CEMIP;KDM3A;MTHFR;KLHL29;PHF1;NPR2;SPRY4;USP20;DLG3;FBXW8;NEURL1;ACVR2B;RAG1;SPEG;NGFR;ELFN2;MARCH4;ETFB;LCE1E;LTBP1;MUC19;TRIB2;EREG;PTPRE;RNF44;SSH3;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;PPM1J;LPAR3;FKBP10;MTMR4;C5;INO80C;CHD3;SESN2;BLMH;MKNK2;RASA4;IMPACT;PKD2;SATB1;ING4;HMGA2;AREG;ST6GALNAC6;B4GAT1;MARCH9;JADE2;MAPK3;CSPG4;TRPT1;LAMB2;FBXO27;ERRFI1;MACROD1;DCAF10;PEX10;STK40;VANGL2;RGS14;MVD;FAM20C;CNTRL;ADAMTSL1;SNTA1;MXRA8;MAPK12;MYH3;SDC2;FBXO17;MLXIPL;PTPDC1;ARHGEF2;TSPYL2;MAP2K2;SRD5A3;LRSAM1;DMTN;KLHL24;KDM4C;PAK6;SSH1;PCMTD2;FBXO6;PKD1;NSMCE1;FLOT1;TTN;PSKH1;HLCS;JDP2;HDAC5;SORL1;IL17RD;HERPUD1;VLDLR;ST3GAL3;KDM7A;MAP3K12;NEK8;LRP5;PTPRU;WNK4;PCSK9;PKIB;PKN3;FBXL15;FBXL16;MARK3;HLTF;TRIOBP;TGFBR2;TRPV4;ITGA1;SMURF2;LMO7;TRIB3;RAB40B;HMG20B;CDK5RAP3;MINK1;PIGZ;PROM2;WNT7A;TTLL11;MARCH2;PIK3R2;EPHA1;SHARPIN;GAS6;DNAJC6;ERN1;BCR;KLHDC8B;MAPRE3;MAN2C1;NBR1;TADA3;CAMK1;PPP1R15A;ADCY6;ATP2B4;STRADB;CTSH;FBXL8;LCE1F;HINT2;AKT1;IGFBP7;DGUOK;CDKN1C;MICAL1;CRY2;B4GALT2;LAMB1;CHEK2;WDR45;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;PIAS3;SPSB3;WDFY2;C9ORF72;UHRF2;ARSA;MAN2B1;MARK4;INSR;NCOA7;FOXO4;COG7;RPS6KA5;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;MAPK10;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;UBOX5;CHRM3;MIB2;MPI;JOSD2;PHC1;SCYL3;CSNK1E;BCL6;HSF4;RNF213;FBXO25;FYN;MAST4;PJA2;LEMD2;SIRT2;GDF15;RAB13;GOLGA2;MTA1;HDAC8;AVPI1;TGFBR3;MAN1B1;EPAS1;LAMTOR2;MAP3K10;MFNG;RNF170;DHPS;EPHB2;PER1;FGFR1;PIGV;WFS1;BLOC1S1;FKBP8;CTH;ERBB2;UST;EIF2AK4;STK32B;UNC119;SYVN1;FRS3;MPPE1;TRIM2;KCTD11;LYPLAL1;KCTD13;CAMKK1;DTX3;IKBKB;NTM
9502,GO:0036211,0.833379806462776,0.183397250165987,351,3086,protein modification process,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;F2R;ST6GALNAC2;APOE;ZMYND8;GID4;EGR1;LMF1;PPP1R35;FBXO2;ZNF862;PTK6;TMEM129;CDC42EP5;EDEM1;RNF135;GJC2;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PADI3;RBCK1;DDB2;PRNP;ZDHHC1;FBLN1;ADAMTS7;DUSP5;NEK9;RAPGEF3;TNFSF15;SPTB;LOXL1;IGFBP4;FKBP9;CRTAP;CST3;NOS1;BRSK1;ERCC6;ADAMTS13;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;B3GAT3;HBEGF;RPS6KA2;CTF1;CNTN1;OBSL1;PLAT;ULK2;SLC27A1;MAPK13;RNF165;CDK18;PHACTR3;FBXW4;ASH2L;CUL7;LHPP;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;ALPK1;BTG1;SHC2;SYNGAP1;PHF21A;DGKQ;SNX9;MAGEF1;ULK1;SHC1;SPRY2;VEGFB;ADM2;HDAC11;RAB3B;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;PAK1;ABCA7;STK39;ERO1B;FGFR3;FBXO41;CEMIP;KDM3A;MTHFR;KLHL29;PHF1;NPR2;SPRY4;USP20;DLG3;FBXW8;NEURL1;ACVR2B;RAG1;SPEG;NGFR;ELFN2;MARCH4;ETFB;LCE1E;LTBP1;MUC19;TRIB2;EREG;PTPRE;RNF44;SSH3;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;PPM1J;LPAR3;FKBP10;MTMR4;C5;INO80C;CHD3;SESN2;BLMH;MKNK2;RASA4;IMPACT;PKD2;SATB1;ING4;HMGA2;AREG;ST6GALNAC6;B4GAT1;MARCH9;JADE2;MAPK3;CSPG4;TRPT1;LAMB2;FBXO27;ERRFI1;MACROD1;DCAF10;PEX10;STK40;VANGL2;RGS14;MVD;FAM20C;CNTRL;ADAMTSL1;SNTA1;MXRA8;MAPK12;MYH3;SDC2;FBXO17;MLXIPL;PTPDC1;ARHGEF2;TSPYL2;MAP2K2;SRD5A3;LRSAM1;DMTN;KLHL24;KDM4C;PAK6;SSH1;PCMTD2;FBXO6;PKD1;NSMCE1;FLOT1;TTN;PSKH1;HLCS;JDP2;HDAC5;SORL1;IL17RD;HERPUD1;VLDLR;ST3GAL3;KDM7A;MAP3K12;NEK8;LRP5;PTPRU;WNK4;PCSK9;PKIB;PKN3;FBXL15;FBXL16;MARK3;HLTF;TRIOBP;TGFBR2;TRPV4;ITGA1;SMURF2;LMO7;TRIB3;RAB40B;HMG20B;CDK5RAP3;MINK1;PIGZ;PROM2;WNT7A;TTLL11;MARCH2;PIK3R2;EPHA1;SHARPIN;GAS6;DNAJC6;ERN1;BCR;KLHDC8B;MAPRE3;MAN2C1;NBR1;TADA3;CAMK1;PPP1R15A;ADCY6;ATP2B4;STRADB;CTSH;FBXL8;LCE1F;HINT2;AKT1;IGFBP7;DGUOK;CDKN1C;MICAL1;CRY2;B4GALT2;LAMB1;CHEK2;WDR45;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;PIAS3;SPSB3;WDFY2;C9ORF72;UHRF2;ARSA;MAN2B1;MARK4;INSR;NCOA7;FOXO4;COG7;RPS6KA5;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;MAPK10;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;UBOX5;CHRM3;MIB2;MPI;JOSD2;PHC1;SCYL3;CSNK1E;BCL6;HSF4;RNF213;FBXO25;FYN;MAST4;PJA2;LEMD2;SIRT2;GDF15;RAB13;GOLGA2;MTA1;HDAC8;AVPI1;TGFBR3;MAN1B1;EPAS1;LAMTOR2;MAP3K10;MFNG;RNF170;DHPS;EPHB2;PER1;FGFR1;PIGV;WFS1;BLOC1S1;FKBP8;CTH;ERBB2;UST;EIF2AK4;STK32B;UNC119;SYVN1;FRS3;MPPE1;TRIM2;KCTD11;LYPLAL1;KCTD13;CAMKK1;DTX3;IKBKB;NTM
16293,GO:0090504,0.833417435922046,0.386317075110571,2,26,epiboly,BP,HBEGF;WNT7A
12343,GO:0048745,0.833514766511419,0.485120929045071,1,14,smooth muscle tissue development,BP,PKD2
15753,GO:0072384,0.833519258076962,0.28758083244713,6,68,organelle transport along microtubule,BP,BLOC1S4;PRKCZ;NDE1;FYCO1;COPG1;BLOC1S1
5499,GO:0016447,0.833590807392967,0.342626087229714,3,37,somatic recombination of immunoglobulin gene segments,BP,ERCC1;STAT6;BCL6
7448,GO:0031593,0.833712542820004,0.342439392596069,3,37,polyubiquitin modification-dependent protein binding,MF,TNIP1;SHARPIN;FAAP20
14670,GO:0070317,0.833883262712486,0.342177492378044,3,37,negative regulation of G0 to G1 transition,BP,TFDP2;FOXO4;PHC1
20230,GO:2001224,0.833898696401554,0.484438622782625,1,14,positive regulation of neuron migration,BP,ARHGEF2
1381,GO:0003283,0.834216728949892,0.483872717199433,1,14,atrial septum development,BP,ZFPM1
815,GO:0002089,0.834342106945601,0.483649443150451,1,14,lens morphogenesis in camera-type eye,BP,TBC1D20
5991,GO:0019001,0.834925027968066,0.217586442300588,29,286,guanyl nucleotide binding,MF,DNM1;PCK2;TUBG2;TMEM173;ARL2;RAB3B;NPR2;RHOBTB2;AGAP1;IFT27;SEPT5;RHOF;TUBE1;SEPT10;GTPBP1;PDE2A;RAB40B;ARL10;GLUD1;SUCLG2;RAB43;SEPT6;RAB25;INSR;GNAL;EHD3;RAB13;RHOBTB3;SEPT8
13580,GO:0060076,0.835245770937409,0.482037221741945,1,14,excitatory synapse,CC,DLG4
2435,GO:0005635,0.835338979111642,0.209748747017594,39,376,nuclear envelope,CC,S100A6;EGFR;PRNP;SLC16A3;SLC2A9;CST3;CLCA2;KLHDC2;ITPR3;PRKCZ;PAK1;SYNE3;TMC6;XPOT;STAT6;MAPK3;BNIP3;SLC22A18;UBXN4;SORL1;ATRAID;RAB40B;BNIP3L;ERN1;TNRC18;TM7SF2;NUCB2;LMNA;C9ORF72;TBC1D20;IFI27;INSR;MYOF;CERS4;LEMD2;MTA1;RETSAT;STX1A;CREB3L4
12819,GO:0051153,0.835669188625616,0.297000762307307,5,58,regulation of striated muscle cell differentiation,BP,PAK1;THRA;FLOT1;HDAC5;GDF15
5986,GO:0018958,0.835791037164132,0.313809860930507,4,48,phenol-containing compound metabolic process,BP,TRPC1;EPAS1;PNKD;SNCB
70,GO:0000146,0.835966372582479,0.480747848291105,1,14,microfilament motor activity,MF,MYH3
10969,GO:0044783,0.836438531235666,0.283383595874274,6,69,G1 DNA damage checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1;TP73
467,GO:0001508,0.836545411608616,0.283348878041036,6,68,action potential,BP,NTSR1;SCN8A;ANK3;SCN4B;SNTA1;TPCN1
1319,GO:0003170,0.836855833664921,0.380706645050651,2,26,heart valve development,BP,ZFPM1;TGFBR2
15384,GO:0071674,0.836963263700083,0.379998853485174,2,27,mononuclear cell migration,BP,MAPK3;TRPV4
11654,GO:0046456,0.837057347152203,0.379844607774089,2,27,icosanoid biosynthetic process,BP,GGT1;LTA4H
3285,GO:0006977,0.837107001846182,0.29478860611444,5,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1
9869,GO:0042158,0.837469968654324,0.253320299053674,10,109,lipoprotein biosynthetic process,BP,APOE;ZDHHC1;LY6K;PIGZ;WDR45;PIGQ;ZDHHC24;PIGV;MPPE1;NTM
7309,GO:0031327,0.837473054863439,0.187223004916662,132,1204,negative regulation of cellular biosynthetic process,BP,ZC3H6;ZMYND8;NFATC4;EGR1;CTNNBIP1;ACP5;WWC3;PDCD4;VEGFA;EGFR;NR1D1;PRDX5;BAHCC1;DDIT3;DNAJB5;ZFP36L1;TCFL5;HBEGF;TFDP2;MXI1;RPL13A;MDFI;SLC27A1;WWTR1;MAP2K1;CYP27B1;MXD4;DDIT4;H2AFJ;PHF21A;SHC1;GRB7;UNK;CIRBP;CAPRIN2;ABCA7;ELK3;FOXQ1;SALL2;ZP3;ACVR2B;EAPP;TRIB2;HES2;EREG;NAB2;PPARA;SESN2;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;ERRFI1;THRA;IRF2BPL;PBXIP1;MLXIPL;INPP5D;TSPYL2;MAP2K2;ATF4;ZFPM1;LTB4R2;TENM2;CBX7;JDP2;HDAC5;VLDLR;GABBR1;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;AGO4;ZFP90;TRPV1;GAS6;RXRA;MBD1;TNRC18;ATP2B4;PAIP2B;CDKN1C;CRY2;CHEK2;TSG101;PHF2;IGF2BP2;ZNF217;ACADVL;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;JAK3;TP73;MTA3;MNT;BCL6;HSF4;ZC3H12D;SIRT2;RECQL5;RCOR2;MTA1;HDAC8;PAIP2;EIF4EBP1;TCF7;MAP3K10;PER1;IGF2BP3;FGFR1;WFS1;EIF2AK4;HMBOX1;TSHZ1;ACOT8;SIX5
2865,GO:0006360,0.83810595420301,0.293351725315735,5,59,transcription by RNA polymerase I,BP,ERCC6;MAPK3;ATF4;ERBB2;DMTF1
7179,GO:0031076,0.838119583071505,0.378631890609181,2,26,embryonic camera-type eye development,BP,IFT140;WDR19
730,GO:0001960,0.838255812998109,0.335133118820561,3,38,negative regulation of cytokine-mediated signaling pathway,BP,SLIT3;ECM1;GAS6
5642,GO:0016741,0.838376489174442,0.228021140426377,18,184,transferase activity, transferring one-carbon groups,MF,GAMT;ASH2L;NSUN5P2;NSUN7;RRNAD1;FAM86C2P;PCMTD2;TFB1M;METTL23;DNMT3A;ALDH1L2;PEMT;PRDM8;MGMT;COMTD1;ASMTL;ALDH1L1;METTL7A
8069,GO:0032760,0.838471424625281,0.334799123661224,3,38,positive regulation of tumor necrosis factor production,BP,NFATC4;ARHGEF2;PTAFR
3229,GO:0006885,0.838555335755613,0.280412190436913,6,69,regulation of pH,BP,MAPK3;TMEM175;TCIRG1;ATP12A;SLC9A7;SLC9A5
3112,GO:0006692,0.839314021390007,0.376133473880597,2,27,prostanoid metabolic process,BP,CES2;PTGR2
3113,GO:0006693,0.839314021390007,0.376133473880597,2,27,prostaglandin metabolic process,BP,CES2;PTGR2
391,GO:0001047,0.839432087234568,0.246354125337647,11,117,core promoter binding,MF,FOS;NR1D1;KDM3A;CHD2;HMGA2;ATF4;HDAC5;CEBPB;CALCOCO1;MTA1;TCF7
14477,GO:0061982,0.83983258285914,0.278614427639168,6,69,meiosis I cell cycle process,BP,ERCC1;MLH3;AGO4;REC8;LEMD2;MSH5
441,GO:0001190,0.840717584979314,0.30649079492198,4,48,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,FOS;CITED4;SOX12;PPARA
17247,GO:0120111,0.840750387400985,0.289535952606291,5,59,neuron projection cytoplasm,CC,DLG4;BLOC1S4;KIF17;ADA;BLOC1S1
2877,GO:0006379,0.840788778558097,0.373696282957239,2,27,mRNA cleavage,BP,ERN1;CPSF4
3446,GO:0007259,0.840860377223775,0.26023099480927,8,89,JAK-STAT cascade,BP,PTK6;CTF1;FGFR3;PKD2;MAPK3;PKD1;JAK3;FYN
11349,GO:0045732,0.841267531490492,0.226410227522872,17,175,positive regulation of protein catabolic process,BP,APOE;EDEM1;LRP1;SNX9;MAGEF1;VPS11;TRIB2;SORL1;HERPUD1;PCSK9;SMURF2;TRIB3;AKT1;SNX33;CSNK1E;SNX1;SIRT2
2830,GO:0006301,0.841343102596828,0.305358212841208,4,49,postreplication repair,BP,POLD4;PRIMPOL;NSMCE1;FAAP20
88,GO:0000177,0.841887482135414,0.468631180150421,1,15,cytoplasmic exosome (RNase complex),CC,GTPBP1
11406,GO:0045840,0.841967386910071,0.329361557570099,3,38,positive regulation of mitotic nuclear division,BP,EREG;LRP5;INSR
13791,GO:0060411,0.842567153231458,0.303724991468157,4,48,cardiac septum morphogenesis,BP,VANGL2;ZFPM1;TGFBR2;TGFBR3
9980,GO:0042407,0.842568793539163,0.467381675842552,1,15,cristae formation,BP,TAZ
8054,GO:0032732,0.842833791482801,0.370300897517522,2,27,positive regulation of interleukin-1 production,BP,EGR1;NLRP1
8213,GO:0032984,0.842855141418824,0.209948361038094,27,274,protein-containing complex disassembly,BP,GSN;SPTB;CAPG;TTBK2;BNIP3;SEMA5A;EIF2D;CHMP1B;ARHGEF2;TWF2;STMN3;TECPR1;DMTN;LRP5;TRIOBP;TRPV4;MAP1LC3A;DNAJC6;FYCO1;MICAL1;TSG101;TMOD2;CHMP5;SMARCD2;INSR;FRAT1;PLEKHH2
7143,GO:0031011,0.842885567547975,0.466799662085443,1,15,Ino80 complex,CC,INO80C
8335,GO:0033202,0.842885567547975,0.466799662085443,1,15,DNA helicase complex,CC,INO80C
8469,GO:0033628,0.842906893360938,0.370179182597082,2,27,regulation of cell adhesion mediated by integrin,BP,PLAU;ADA
5243,GO:0015872,0.842996602050547,0.466595497050885,1,15,dopamine transport,BP,RAB3B
17508,GO:1901031,0.843644399135406,0.368949904142228,2,27,regulation of response to reactive oxygen species,BP,SESN2;ENDOG
8355,GO:0033260,0.84374003086377,0.301768349091255,4,49,nuclear DNA replication,BP,POLD4;CHEK2;BCL6;FGFR1
10607,GO:0043621,0.843956569178975,0.302527741205082,4,44,protein self-association,MF,VAMP2;DMTN;TTN;PCSK9
10980,GO:0044798,0.844138761921017,0.227337126049215,15,157,nuclear transcription factor complex,CC,NFATC4;FOS;NR1D1;ERCC1;DDIT3;TFDP2;MXI1;PPARA;THRA;ATF4;CEBPB;MXD3;TADA3;RXRA;TEAD2
1186,GO:0002833,0.844152116497695,0.36810222960792,2,27,positive regulation of response to biotic stimulus,BP,MAPK3;LRSAM1
3476,GO:0007339,0.844488491132999,0.463844209428636,1,15,binding of sperm to zona pellucida,BP,ZP3
2851,GO:0006342,0.844495209919512,0.248696340083079,9,107,chromatin silencing,BP,BAHCC1;H2AFJ;HDAC5;DNMT3A;MBD1;TNRC18;PHF2;UHRF2;SIRT2
1215,GO:0002886,0.845347715466652,0.366101521914106,2,27,regulation of myeloid leukocyte mediated immunity,BP,BCR;PTAFR
724,GO:0001954,0.845492700955787,0.323835566659306,3,38,positive regulation of cell-matrix adhesion,BP,VEGFA;PRKCZ;EPHA1
4069,GO:0009126,0.845531683489019,0.209971740830143,24,248,purine nucleoside monophosphate metabolic process,BP,DLG4;NT5E;PGM1;DHTKD1;LHPP;DDIT4;OGDHL;DLG3;PPARA;FAM20C;MYH3;MLXIPL;SDHA;GALK1;NADK;ALDOC;TMSB4X;CARD11;TCIRG1;INSR;APRT;TAZ;ADA;PFKL
4108,GO:0009167,0.845531683489019,0.209971740830143,24,248,purine ribonucleoside monophosphate metabolic process,BP,DLG4;NT5E;PGM1;DHTKD1;LHPP;DDIT4;OGDHL;DLG3;PPARA;FAM20C;MYH3;MLXIPL;SDHA;GALK1;NADK;ALDOC;TMSB4X;CARD11;TCIRG1;INSR;APRT;TAZ;ADA;PFKL
3631,GO:0008094,0.845543624215011,0.261254920841591,7,79,DNA-dependent ATPase activity,MF,ERCC6;SMARCA1;CHD2;CHD3;RECQL5;MSH5;CHD6
3335,GO:0007051,0.845851469918827,0.225185490554717,15,156,spindle organization,BP,TUBG2;CHD3;RGS14;CHMP1B;PKD1;CEP126;GOLGA2P5;CHEK2;CHMP5;GOLGA8A;CHMP4C;HAUS4;TUBGCP6;GOLGA2;CCDC69
6709,GO:0030126,0.845904324818377,0.4612191881794,1,15,COPI vesicle coat,CC,COPG1
7475,GO:0031648,0.845916853682184,0.323167763328112,3,38,protein destabilization,BP,GSN;PRNP;CTSH
10426,GO:0043300,0.84616880357525,0.364723791119348,2,27,regulation of leukocyte degranulation,BP,BCR;PTAFR
6931,GO:0030547,0.846187539919643,0.460692446779854,1,15,receptor inhibitor activity,MF,PCSK9
16828,GO:0098773,0.846300369062608,0.269453653504234,6,69,skin epidermis development,BP,EGFR;LAMA5;FOXQ1;VANGL2;EDA;CELSR1
10873,GO:0044431,0.846315084186345,0.184479119266127,77,716,Golgi apparatus part,CC,ST6GALNAC2;POSTN;EDEM1;EGFR;CLTCL1;GPSM1;ARAP1;B3GAT3;ASAP2;PITPNM1;SNX9;ABCA7;B4GALNT4;NMNAT2;SPPL2B;MARCH4;MUC19;MALL;ABCG1;DNMBP;TRAPPC9;CHAC1;VAMP2;AREG;ST6GALNAC6;AP1G2;B4GAT1;MARCH9;CSPG4;SCARA3;PI4K2A;KIAA0319L;SDC2;IFNGR2;SLC50A1;LITAF;CHST6;PKD1;AZIN2;SORL1;IL17RD;ST3GAL3;SULF2;RHBDF1;NOS3;WNT7A;ANGEL1;GAS6;ATP7B;GOLGA2P5;NECAB3;RAB43;ENTPD6;STEAP2;B4GALT2;COPG1;TBC1D20;GOLGA8A;ICA1;WNT3;COG7;C6ORF89;TMEM50B;SLC9A7;PJA2;RAB13;GOLGA2;RHOBTB3;MYO18A;MAN1B1;MFNG;XYLT2;UST;HLA-G;MPPE1;CREB3L4;BSG
6570,GO:0022404,0.846327693488664,0.269414746623055,6,69,molting cycle process,BP,EGFR;LAMA5;FOXQ1;VANGL2;EDA;CELSR1
6571,GO:0022405,0.846327693488664,0.269414746623055,6,69,hair cycle process,BP,EGFR;LAMA5;FOXQ1;VANGL2;EDA;CELSR1
15250,GO:0071456,0.846799283525647,0.226491218502872,14,150,cellular response to hypoxia,BP,EGR1;VEGFA;NDRG1;ZFP36L1;BNIP3;ENDOG;AQP3;DNMT3A;BNIP3L;TERC;AKT1;LMNA;SIRT2;EPAS1
5956,GO:0018345,0.846988305918058,0.36334567704424,2,27,protein palmitoylation,BP,ZDHHC1;ZDHHC24
5478,GO:0016417,0.847053744300017,0.363235501170187,2,27,S-acyltransferase activity,MF,ZDHHC1;ZDHHC24
5392,GO:0016234,0.847136845414354,0.268261812351194,6,69,inclusion body,CC,EDEM1;PRNP;ATF4;HERPUD1;STRADB;SNCB
3357,GO:0007096,0.847221441507097,0.458764839236621,1,15,regulation of exit from mitosis,BP,SIRT2
20259,GO:2001269,0.847305423732597,0.458607938146137,1,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,GSN
1159,GO:0002768,0.847578876341753,0.206410414351883,25,251,immune response-regulating cell surface receptor signaling pathway,BP,FOS;WIPF1;RBCK1;PRNP;FCGRT;SHC1;PAK1;MUC19;PLA2G6;ERMAP;MAPK3;INPP5D;PIK3R2;CARD11;RPS6KA5;BRAF;BTN3A2;MAPK10;BTN3A3;FYN;ADA;VAV3;PAG1;HLA-G;IKBKB
10413,GO:0043276,0.84767364915662,0.362190824825939,2,27,anoikis,BP,AKT1;CHEK2
20025,GO:2000679,0.847966111300062,0.457371890700304,1,15,positive regulation of transcription regulatory region DNA binding,BP,HMGA2
5623,GO:0016706,0.848181396563354,0.319591570268956,3,38,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,PHYH;KDM4C;KDM7A
5033,GO:0015215,0.848279065326591,0.456785340371773,1,15,nucleotide transmembrane transporter activity,MF,SLC25A42
8204,GO:0032968,0.84854690326868,0.456282805480375,1,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,EAPP
9545,GO:0036336,0.848604109953543,0.456175405605015,1,15,dendritic cell migration,BP,GAS6
8493,GO:0033683,0.848628889433278,0.318599476449085,3,39,nucleotide-excision repair, DNA incision,BP,DDB2;ERCC1;POLD4
16057,GO:0090050,0.848654820761302,0.456080181956809,1,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,VEGFA
15771,GO:0072431,0.848675601680215,0.277853538220928,5,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1
17955,GO:1902400,0.848675601680215,0.277853538220928,5,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1
10064,GO:0042581,0.848775459389633,0.243308437058248,9,100,specific granule,CC,SLC2A3;TIMP2;DNASE1L1;TMC6;KCNAB2;PLAU;HGSNAT;TOM1;LAMTOR2
4310,GO:0009792,0.849246327853734,0.190921444625589,44,422,embryo development ending in birth or egg hatching,BP,VEGFA;EGFR;IFT140;ZFP36L1;MDFI;HYAL1;MAP2K1;SALL2;FBXW8;ZP3;WDR60;PLCD3;C5;PKD2;VANGL2;TCTN1;PLCD1;KDM4C;PKD1;DEAF1;SULF2;ENDOG;CEBPB;TGFBR2;NOS3;RXRA;ZNF358;WDR19;AKT1;IFT57;CAPN2;KRT19;TFEB;PHLDA2;CELSR1;ADA;ETNK2;TCF7;EPAS1;EDNRA;FGFR1;FKBP8;APBA1;TEAD2
16685,GO:0097696,0.849483278840672,0.248355977548098,8,90,STAT cascade,BP,PTK6;CTF1;FGFR3;PKD2;MAPK3;PKD1;JAK3;FYN
1952,GO:0004659,0.849514412876163,0.454463315218921,1,15,prenyltransferase activity,MF,RABGGTA
18195,GO:1903020,0.849660513447627,0.454187988044796,1,15,positive regulation of glycoprotein metabolic process,BP,GOLGA2
3073,GO:0006643,0.849681855714838,0.215771107872816,17,177,membrane lipid metabolic process,BP,PLA2G6;ESYT2;ST6GALNAC6;FUCA1;PEMT;PIGZ;HEXB;HEXA;ARSA;PIGQ;CERS4;NAGA;PIGV;ESYT3;KDELC2;MPPE1;KDSR
6208,GO:0019731,0.849708141455415,0.451807400030619,1,17,antibacterial humoral response,BP,PLA2G6
15352,GO:0071622,0.849791531548672,0.3581205591236,2,28,regulation of granulocyte chemotaxis,BP,MAPK3;TRPV4
289,GO:0000794,0.849923014860974,0.264750538872648,6,65,condensed nuclear chromosome,CC,TTN;MLH3;ADD3;REC8;MSH5;RGS12
10185,GO:0042809,0.850075695030122,0.453404754722002,1,15,vitamin D receptor binding,MF,RXRA
5455,GO:0016339,0.850244540369002,0.453085882376993,1,15,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ARVCF
6317,GO:0019985,0.850359794929272,0.315851494572143,3,39,translesion synthesis,BP,POLD4;PRIMPOL;FAAP20
94,GO:0000185,0.85039693857056,0.452797897968619,1,15,activation of MAPKKK activity,BP,MINK1
15428,GO:0071786,0.850447954894891,0.45270145649544,1,15,endoplasmic reticulum tubular network organization,BP,REEP2
20077,GO:2000779,0.850489045108564,0.291569034668886,4,49,regulation of double-strand break repair,BP,MAGEF1;HMGA2;MGMT;RECQL5
13015,GO:0051495,0.850499124642117,0.219186060922631,15,158,positive regulation of cytoskeleton organization,BP,GSN;WIPF1;CDC42EP5;RAPGEF3;ARPIN;ARL2;PAK1;SEMA5A;WHAMMP3;TRPV4;EPHA1;BRAF;SPIRE1;C15ORF62;CORO1B
15982,GO:0086019,0.850550551451547,0.452507451667373,1,15,cell-cell signaling involved in cardiac conduction,BP,SCN4B
13698,GO:0060292,0.850626200479214,0.452364355416323,1,15,long term synaptic depression,BP,SHANK2
4574,GO:0010664,0.850763823863564,0.452103925484365,1,15,negative regulation of striated muscle cell apoptotic process,BP,RGL2
9395,GO:0035970,0.850804714302946,0.452026521040953,1,15,peptidyl-threonine dephosphorylation,BP,DUSP5
4254,GO:0009593,0.850817809012379,0.356377527655344,2,28,detection of chemical stimulus,BP,ABCG1;TRPV1
13775,GO:0060390,0.851074599848104,0.45151533715818,1,15,regulation of SMAD protein signal transduction,BP,WWTR1
9750,GO:0039529,0.851272339704901,0.451140473601477,1,15,RIG-I signaling pathway,BP,NLRX1
7708,GO:0032206,0.851468933074276,0.290076768950715,4,49,positive regulation of telomere maintenance,BP,ERCC1;MAPK3;PKIB;HMBOX1
18436,GO:1903557,0.851499330850009,0.314036448196527,3,39,positive regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;ARHGEF2;PTAFR
5814,GO:0017085,0.851649233676552,0.450425207806559,1,15,response to insecticide,BP,MAPK13
8682,GO:0034329,0.851656712734081,0.213321306889424,17,175,cell junction assembly,BP,FLNC;VEGFA;CD9;ITGA6;ARL2;NPHP4;LAMA5;ITGB4;MICALL2;TNS1;FBF1;DMTN;FLOT1;TRPV4;RAB13;ITGA2;IKBKB
2344,GO:0005385,0.85205862119992,0.449647125288448,1,15,zinc ion transmembrane transporter activity,MF,SLC39A11
15322,GO:0071577,0.85205862119992,0.449647125288448,1,15,zinc ion transmembrane transport,BP,SLC39A11
6757,GO:0030199,0.852174840609287,0.354552201759214,2,27,collagen fibril organization,BP,LOXL1;TNXB
459,GO:0001325,0.852583260691529,0.448648237344289,1,15,formation of extrachromosomal circular DNA,BP,ERCC1
16331,GO:0090656,0.852583260691529,0.448648237344289,1,15,t-circle formation,BP,ERCC1
16358,GO:0090737,0.852583260691529,0.448648237344289,1,15,telomere maintenance via telomere trimming,BP,ERCC1
15410,GO:0071711,0.852623141944301,0.44857222445653,1,15,basement membrane organization,BP,NID1
5321,GO:0016051,0.852744667318735,0.216305256474327,15,158,carbohydrate biosynthetic process,BP,ISYNA1;NTSR1;NR1D1;PGM1;PCK2;DGKQ;PPARA;ST6GALNAC6;PC;ATF4;ALDOC;PTAFR;AKT1;INSR;SLC37A4
17826,GO:1902043,0.852883896258713,0.44807494949324,1,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PIDD1
15968,GO:0086005,0.85330977397083,0.447261718651988,1,15,ventricular cardiac muscle cell action potential,BP,SNTA1
14718,GO:0070412,0.853752857549971,0.446414239467935,1,15,R-SMAD binding,MF,FOS
7333,GO:0031369,0.854057099895486,0.350843614516209,2,28,translation initiation factor binding,MF,ANGEL1;EIF4EBP1
9929,GO:0042303,0.854235835660142,0.248977124114586,7,80,molting cycle,BP,EGFR;LAMA5;FOXQ1;VANGL2;EDA;CELSR1;PER1
10098,GO:0042633,0.854235835660142,0.248977124114586,7,80,hair cycle,BP,EGFR;LAMA5;FOXQ1;VANGL2;EDA;CELSR1;PER1
4686,GO:0010842,0.854262573607955,0.445437550320324,1,15,retina layer formation,BP,SDK2
11426,GO:0045893,0.854292893105925,0.170269690577719,115,1053,positive regulation of transcription, DNA-templated,BP,TNIP1;F2R;NFATC4;FOS;CITED4;EGR1;VEGFA;EGFR;NR1D1;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;SMARCA1;TFDP2;ASH2L;ETV4;WWTR1;MAP2K1;MC1R;ITGA6;ZNF76;PBX2;MAML3;TMEM173;SHC1;SOX12;CAPRIN2;ELK3;PABPC1L;SEC14L2;KDM3A;PHF1;SALL2;ETV1;ZP3;ABHD14B;EAPP;NGFR;ETV5;TEF;CARF;PPARA;SESN2;PKD2;STAT6;KLF7;HMGA2;MAPK3;THRA;IRF2BPL;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LITAF;ATF4;ZFPM1;ZNF516;PKD1;MDK;HDAC5;IRF5;DEAF1;PEG3;RFX2;KDM7A;CEBPB;LRP5;CREBRF;METTL23;HLTF;CSRNP3;APLN;CALCOCO1;CDK5RAP3;HEXB;ZFP90;WNT7A;PIK3R2;MAPRE3;TNNI2;TADA3;CAMK1;RXRA;AKT1;CDKN1C;CHEK2;PHF2;INSR;NCOA7;FOXO4;RPS6KA5;MAP2K5;TP73;TFEB;HSF4;SIRT2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;PER1;ERBB2;HMBOX1;CREB3L4;DBP;ZNF287;IKBKB;TEAD2;SIX5
18400,GO:1903508,0.854292893105925,0.170269690577719,115,1053,positive regulation of nucleic acid-templated transcription,BP,TNIP1;F2R;NFATC4;FOS;CITED4;EGR1;VEGFA;EGFR;NR1D1;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;SMARCA1;TFDP2;ASH2L;ETV4;WWTR1;MAP2K1;MC1R;ITGA6;ZNF76;PBX2;MAML3;TMEM173;SHC1;SOX12;CAPRIN2;ELK3;PABPC1L;SEC14L2;KDM3A;PHF1;SALL2;ETV1;ZP3;ABHD14B;EAPP;NGFR;ETV5;TEF;CARF;PPARA;SESN2;PKD2;STAT6;KLF7;HMGA2;MAPK3;THRA;IRF2BPL;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LITAF;ATF4;ZFPM1;ZNF516;PKD1;MDK;HDAC5;IRF5;DEAF1;PEG3;RFX2;KDM7A;CEBPB;LRP5;CREBRF;METTL23;HLTF;CSRNP3;APLN;CALCOCO1;CDK5RAP3;HEXB;ZFP90;WNT7A;PIK3R2;MAPRE3;TNNI2;TADA3;CAMK1;RXRA;AKT1;CDKN1C;CHEK2;PHF2;INSR;NCOA7;FOXO4;RPS6KA5;MAP2K5;TP73;TFEB;HSF4;SIRT2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;PER1;ERBB2;HMBOX1;CREB3L4;DBP;ZNF287;IKBKB;TEAD2;SIX5
8654,GO:0034237,0.854493862334626,0.444993743942787,1,15,protein kinase A regulatory subunit binding,MF,PJA2
6773,GO:0030216,0.854757502508917,0.213605774390946,15,162,keratinocyte differentiation,BP,ALOX15B;KRT15;ZFP36L1;MAP2K1;CYP27B1;PPL;PRSS8;LCE1E;EREG;ERRFI1;AQP3;SHARPIN;LCE1F;TSG101;KRT19
16308,GO:0090559,0.854787641763594,0.257071805174768,6,71,regulation of membrane permeability,BP,TFDP2;BNIP3;BBC3;BNIP3L;ALKBH7;TP73
4334,GO:0009890,0.855092232443835,0.167774351611295,133,1220,negative regulation of biosynthetic process,BP,ZC3H6;APOE;ZMYND8;NFATC4;EGR1;CTNNBIP1;ACP5;WWC3;PDCD4;VEGFA;EGFR;NR1D1;PRDX5;BAHCC1;DDIT3;DNAJB5;ZFP36L1;TCFL5;HBEGF;TFDP2;MXI1;RPL13A;MDFI;SLC27A1;WWTR1;MAP2K1;CYP27B1;MXD4;DDIT4;H2AFJ;PHF21A;SHC1;GRB7;UNK;CIRBP;CAPRIN2;ABCA7;ELK3;FOXQ1;SALL2;ZP3;ACVR2B;EAPP;TRIB2;HES2;EREG;NAB2;PPARA;SESN2;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;ERRFI1;THRA;IRF2BPL;PBXIP1;MLXIPL;INPP5D;TSPYL2;MAP2K2;ATF4;ZFPM1;LTB4R2;TENM2;CBX7;JDP2;HDAC5;VLDLR;GABBR1;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;AGO4;ZFP90;TRPV1;GAS6;RXRA;MBD1;TNRC18;ATP2B4;PAIP2B;CDKN1C;CRY2;CHEK2;TSG101;PHF2;IGF2BP2;ZNF217;ACADVL;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;JAK3;TP73;MTA3;MNT;BCL6;HSF4;ZC3H12D;SIRT2;RECQL5;RCOR2;MTA1;HDAC8;PAIP2;EIF4EBP1;TCF7;MAP3K10;PER1;IGF2BP3;FGFR1;WFS1;EIF2AK4;HMBOX1;TSHZ1;ACOT8;SIX5
11081,GO:0045111,0.855194760381589,0.234568252335315,9,100,intermediate filament cytoskeleton,CC,KRT15;SHANK2;SYNC;ING4;FBF1;MICAL1;LMNA;KRT19;PJA2
6853,GO:0030330,0.855652319796301,0.233883634338276,9,101,DNA damage response, signal transduction by p53 class mediator,BP,NDRG1;RBL2;TFDP2;SESN2;ING4;PCBP4;CHEK2;PIDD1;TP73
5711,GO:0016853,0.856004079903537,0.22422420576024,11,122,isomerase activity,MF,ISYNA1;FKBP9;PGM1;GALE;ERO1B;FKBP10;RPUSD3;SRR;TMX4;MPI;FKBP8
1114,GO:0002703,0.856209383649181,0.233121034822112,9,101,regulation of leukocyte mediated immunity,BP,IL20RB;PRKCZ;ZP3;STAT6;BCR;PTAFR;HFE;JAK3;BCL6
5377,GO:0016202,0.856671521569701,0.245531520577504,7,80,regulation of striated muscle tissue development,BP,PAK1;FLOT1;TGFBR2;TP73;SIRT2;TGFBR3;FGFR1
17762,GO:1901861,0.856671521569701,0.245531520577504,7,80,regulation of muscle tissue development,BP,PAK1;FLOT1;TGFBR2;TP73;SIRT2;TGFBR3;FGFR1
4437,GO:0010332,0.856768228617461,0.281770120520956,4,50,response to gamma radiation,BP,EGR1;ERCC6;CHEK2;TP73
9270,GO:0035722,0.856902228260822,0.305100661409369,3,40,interleukin-12-mediated signaling pathway,BP,PDCD4;GSTO1;AIP
15177,GO:0071349,0.856902228260822,0.305100661409369,3,40,cellular response to interleukin-12,BP,PDCD4;GSTO1;AIP
18053,GO:1902680,0.856960765025332,0.167307897299302,115,1054,positive regulation of RNA biosynthetic process,BP,TNIP1;F2R;NFATC4;FOS;CITED4;EGR1;VEGFA;EGFR;NR1D1;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;SMARCA1;TFDP2;ASH2L;ETV4;WWTR1;MAP2K1;MC1R;ITGA6;ZNF76;PBX2;MAML3;TMEM173;SHC1;SOX12;CAPRIN2;ELK3;PABPC1L;SEC14L2;KDM3A;PHF1;SALL2;ETV1;ZP3;ABHD14B;EAPP;NGFR;ETV5;TEF;CARF;PPARA;SESN2;PKD2;STAT6;KLF7;HMGA2;MAPK3;THRA;IRF2BPL;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LITAF;ATF4;ZFPM1;ZNF516;PKD1;MDK;HDAC5;IRF5;DEAF1;PEG3;RFX2;KDM7A;CEBPB;LRP5;CREBRF;METTL23;HLTF;CSRNP3;APLN;CALCOCO1;CDK5RAP3;HEXB;ZFP90;WNT7A;PIK3R2;MAPRE3;TNNI2;TADA3;CAMK1;RXRA;AKT1;CDKN1C;CHEK2;PHF2;INSR;NCOA7;FOXO4;RPS6KA5;MAP2K5;TP73;TFEB;HSF4;SIRT2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;PER1;ERBB2;HMBOX1;CREB3L4;DBP;ZNF287;IKBKB;TEAD2;SIX5
17743,GO:1901798,0.857110432288439,0.438720516950813,1,16,positive regulation of signal transduction by p53 class mediator,BP,CDK5RAP3
2214,GO:0005112,0.857268703091192,0.439638632345187,1,15,Notch binding,MF,CHAC1
8051,GO:0032729,0.857340370213094,0.34518368182766,2,28,positive regulation of interferon-gamma production,BP,ZP3;ZFPM1
796,GO:0002066,0.857357037943943,0.304630774640073,3,39,columnar/cuboidal epithelial cell development,BP,SLITRK6;TRIOBP;FGFR1
19416,GO:1990089,0.857462587507762,0.30446011699705,3,39,response to nerve growth factor,BP,TRPV1;AKT1;BRAF
19417,GO:1990090,0.857462587507762,0.30446011699705,3,39,cellular response to nerve growth factor stimulus,BP,TRPV1;AKT1;BRAF
9879,GO:0042176,0.857486132838535,0.189607655799419,30,300,regulation of protein catabolic process,BP,APOE;SERPINE2;EDEM1;LRP1;TIMP2;EGFR;CST3;SNX9;MAGEF1;VPS11;TRIB2;PKD1;AZIN2;SORL1;HERPUD1;RHBDF1;ATRAID;PCSK9;SMURF2;TRIB3;CDK5RAP3;AKT1;CHEK2;TIMP1;HFE;SNX33;CSNK1E;FYN;SNX1;SIRT2
12103,GO:0048194,0.857586109184358,0.253021953596179,6,71,Golgi vesicle budding,BP,TRAPPC9;AREG;TBC1D20;GOLGA2;MYO18A;SEC31B
1094,GO:0002683,0.857689474800827,0.192948075110953,26,265,negative regulation of immune system process,BP,PTPRS;HTRA1;IL20RB;PRNP;NR1D1;MMP28;ZFP36L1;PKN1;SERPING1;FAM3A;C5;NLRX1;STAT6;INPP5D;PDCD1LG2;ZFPM1;CEBPB;BCR;HFE;JAK3;BCL6;TKFC;ADA;ERBB2;PAG1;HLA-G
4480,GO:0010507,0.857968536972777,0.264109413378241,5,60,negative regulation of autophagy,BP,TBC1D14;DAP;AKT1;SIRT2;GOLGA2
8683,GO:0034330,0.858404305689497,0.199552414251633,20,204,cell junction organization,BP,F2R;FLNC;VEGFA;CD9;SDK2;ITGA6;ARL2;NPHP4;NLGN2;LAMA5;ITGB4;MICALL2;TNS1;FBF1;DMTN;FLOT1;TRPV4;RAB13;ITGA2;IKBKB
12512,GO:0050681,0.858530300645941,0.30273140788006,3,39,androgen receptor binding,MF,PKN1;KDM3A;KDM4C
12084,GO:0048145,0.858672742402434,0.262926224682649,5,61,regulation of fibroblast proliferation,BP,S100A6;EGFR;NUPR1;EREG;GAS6
15764,GO:0072413,0.858831922302606,0.262688473312791,5,61,signal transduction involved in mitotic cell cycle checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1
17956,GO:1902402,0.858831922302606,0.262688473312791,5,61,signal transduction involved in mitotic DNA damage checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1
17957,GO:1902403,0.858831922302606,0.262688473312791,5,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1
9841,GO:0042104,0.858939353910097,0.435160719170885,1,16,positive regulation of activated T cell proliferation,BP,IGFBP2
5716,GO:0016860,0.858960016027969,0.30177031347377,3,40,intramolecular oxidoreductase activity,MF,ERO1B;TMX4;MPI
11847,GO:0046872,0.859335834722094,0.155999030812573,332,2927,metal ion binding,MF,XDH;ZC3H6;NT5E;APOE;SYTL1;ZMYND8;FHL1;S100A6;GSN;EGR1;THBS3;POSTN;ADAM19;ZNF862;TMEM129;ACP5;EDEM1;RNF135;GLUL;LRP1;ALOX15B;TIMP2;OBSCN;PADI3;ZSCAN18;RBCK1;PRNP;NR1D1;FBLN1;ADAMTS7;S100A4;NEK9;ZKSCAN1;NPEPL1;LOXL1;DGKA;RNPEPL1;NINL;IDH2;FKBP9;NOS1;HAGHL;ARAP3;BRSK1;PGM1;CGREF1;CLCA2;ADAMTS13;TCEA2;MMP28;ZCCHC24;TRIM65;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;ARAP1;B3GAT3;RPS6KA2;MMP1;CYP3A5;PHYHD1;MSRB2;LTBP4;KLF9;RNF165;RAB11FIP4;ASAP2;ASH2L;PITPNM3;LHPP;PRSS3;HMGCL;SMOC2;SMOC1;CYP27B1;PCK2;PLCH2;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;THAP8;VPS11;PHF7;OGDHL;CYBRD1;ITPR3;UNK;NMRK1;CAPRIN2;PRKCZ;PPP2R3B;APOBEC3C;AARS;PHYH;MCTP1;KDM3A;PHF1;CAPNS2;CBS;USP20;SALL2;ZSWIM4;DDX59;MICALL2;NME4;NEIL1;NEURL1;ACVR2B;RAG1;MARCH4;NID1;LTBP1;RNF44;CYHR1;PLCD3;PSPH;UNKL;ESYT2;S100A13;AGAP1;CARS;FKBP10;MTMR4;APOBEC3F;PPARA;CHD3;MKNK2;RASA4;PKD2;KLF7;ING4;SLIT3;B4GAT1;MARCH9;PCLO;JADE2;ACACB;NT5C1B;PC;THRA;PEX10;IRF2BPL;FAM20C;DYSF;LTBP2;FAHD2B;PAN2;ZSCAN30;MAPK12;LTA4H;PI4K2A;ZXDC;PLCD1;ARHGEF2;MAP2K2;FLYWCH1;LRSAM1;LITAF;ZFPM1;KDM4C;ZNF467;PRIMPOL;POLM;ACAP3;TENM2;ZNF516;NSMCE1;LTBP3;TTN;KCNMA1;HDAC5;VLDLR;NADK;DEAF1;SULF2;PEG3;ACY1;GLI4;ENDOG;KDM7A;EGFL7;NEK8;ZNF251;L3MBTL1;ISG20;HLTF;DNMT3A;TGFBR2;ITGA1;MOCOS;PDE2A;LMO7;NOS3;ZFP90;TRPV1;MARCH2;ZNF558;ZNF662;SHARPIN;CCS;GAS6;SUCLG2;ERN1;ALKBH7;ATP7B;FYCO1;MAN2C1;NBR1;EXD3;FAHD2A;SRR;NUDT8;NECAB3;POLL;CYP2R1;RXRA;ZNF358;ADCY6;ZNF362;MBD1;ATP2B4;PRDM8;EFEMP2;MGMT;STEAP2;ZFYVE21;ITPR2;MICAL1;B4GALT2;CHEK2;LACTB2;CAPS;TNNT1;NFU1;CABYR;PHF2;ZNF217;SNN;PIAS3;ASAP3;HAGH;STEAP3;NUCB2;ZNF25;LENG9;WDFY2;UHRF2;ARSA;CAPN2;MAN2B1;GNAL;YPEL3;RPS6KA5;ANKZF1;MBLAC2;RABGGTA;CTDSPL;MAP2K5;BRAF;ZNF554;CPSF4;RNF215;FAAP20;CAT;ZNF160;YPEL5;ZFP28;TIMP1;TP73;MTA3;UBOX5;ZNF846;OGFOD2;MIB2;MPI;ENDOV;PHC1;ATP12A;BCL6;REPS2;RNF213;ADAP1;TKFC;EHD3;FYN;MAST4;ZC3H12D;ATP8B2;PJA2;SIRT2;ANKMY1;CELSR1;ADA;MTA1;HDAC8;RNPEP;VAV3;MAN1B1;GALNS;MFNG;RNF170;MCTP2;ITGA2;ZNF333;ESYT3;FKBP8;STK32B;SYVN1;PFKL;MMP17;MPPE1;TRIM2;TSHZ1;TNNI1;MMP19;ZNF449;IRF2BP2;ZMYM3;NUDT18;TRIM45;ZNF667;ZNF287;PNKD;DTX3;DTD1;SNCB;CYP4V2
9055,GO:0035306,0.859698306752981,0.300835332822318,3,39,positive regulation of dephosphorylation,BP,ITGA1;PPP1R15A;ITGA2
19689,GO:2000060,0.859746637483547,0.24107912488516,7,81,positive regulation of ubiquitin-dependent protein catabolic process,BP,MAGEF1;TRIB2;HERPUD1;TRIB3;AKT1;CSNK1E;SIRT2
6443,GO:0021766,0.85976175242121,0.277144112861894,4,50,hippocampus development,BP,PTPRS;BBS2;MDK;ATP2B4
3659,GO:0008146,0.86083400603534,0.339103579956094,2,28,sulfotransferase activity,MF,CHST6;UST
1237,GO:0002931,0.861032894341193,0.33875563459024,2,28,response to ischemia,BP,EGR1;MLYCD
17866,GO:1902176,0.861050081035155,0.431021142041921,1,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1
11874,GO:0046915,0.86105801565596,0.338711672068683,2,28,transition metal ion transmembrane transporter activity,MF,ATP7B;SLC39A11
1666,GO:0004129,0.861436223645764,0.428229435008922,1,18,cytochrome-c oxidase activity,MF,NDUFA4L2
4945,GO:0015002,0.861436223645764,0.428229435008922,1,18,heme-copper terminal oxidase activity,MF,NDUFA4L2
5616,GO:0016676,0.861436223645764,0.428229435008922,1,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,NDUFA4L2
15878,GO:0072676,0.861659945767432,0.297376146075663,3,40,lymphocyte migration,BP,ECM1;GAS6;CKLF
4350,GO:0009948,0.862577233271549,0.336047163305095,2,28,anterior/posterior axis specification,BP,DDIT3;WNT3
19110,GO:1905114,0.862892333993518,0.174888153397694,44,428,cell surface receptor signaling pathway involved in cell-cell signaling,BP,DLG4;APOE;ZMYND8;NFATC4;EGR1;CTNNBIP1;LRP1;NTSR1;IGFBP4;DDIT3;SHANK2;ARHGEF19;MDFI;FBXW4;WWTR1;NPHP4;NLGN2;CAPRIN2;PRKCZ;WNT2B;VANGL2;SSH1;SULF2;LRP5;PTPRU;FOXL1;SMURF2;CALCOCO1;EDA;AGO4;WNT7A;TRPV1;LZTS2;AKT1;IGFBP2;WNT3;FRAT1;CSNK1E;RNF213;CELSR1;AP2A2;TCF7;STX1A;GRB10
19139,GO:1905207,0.863472890857927,0.334470859862122,2,28,regulation of cardiocyte differentiation,BP,EGFR;PAK1
5398,GO:0016241,0.863787233331506,0.204443950556839,14,150,regulation of macroautophagy,BP,GPSM1;EPM2A;ULK1;SESN2;MAPK3;BNIP3;TBC1D14;LRSAM1;BNIP3L;ERN1;FYCO1;AKT1;C9ORF72;LAMTOR2
5920,GO:0018200,0.8640461334744,0.425086689247793,1,16,peptidyl-glutamic acid modification,BP,TTLL11
4670,GO:0010823,0.86423091883391,0.293165517520315,3,40,negative regulation of mitochondrion organization,BP,BNIP3;AKT1;LMNA
12623,GO:0050851,0.864281995143075,0.201281010602902,15,162,antigen receptor-mediated signaling pathway,BP,RBCK1;PRNP;PAK1;ERMAP;INPP5D;PIK3R2;CARD11;BRAF;BTN3A2;BTN3A3;FYN;ADA;VAV3;PAG1;IKBKB
14090,GO:0060972,0.865191278777074,0.422799987036754,1,16,left/right pattern formation,BP,IFT57
12275,GO:0048634,0.865207714824248,0.233266745894649,7,81,regulation of muscle organ development,BP,PAK1;FLOT1;TGFBR2;TP73;SIRT2;TGFBR3;FGFR1
672,GO:0001883,0.865297952599604,0.181770978465879,28,283,purine nucleoside binding,MF,DNM1;PCK2;TUBG2;ARL2;RAB3B;NPR2;RHOBTB2;AGAP1;IFT27;SEPT5;RHOF;TUBE1;SEPT10;GTPBP1;RAB40B;ARL10;GLUD1;SUCLG2;RAB43;SEPT6;RAB25;INSR;GNAL;EHD3;RAB13;ADA;RHOBTB3;SEPT8
16069,GO:0090075,0.865558062643784,0.422065386018732,1,16,relaxation of muscle,BP,GSTM2
12630,GO:0050858,0.865957430737386,0.42126431441553,1,16,negative regulation of antigen receptor-mediated signaling pathway,BP,PRNP
10180,GO:0042800,0.865971597803149,0.421235874215557,1,16,histone methyltransferase activity (H3-K4 specific),MF,ASH2L
2825,GO:0006294,0.865989495667334,0.329574521656678,2,29,nucleotide-excision repair, preincision complex assembly,BP,XPC;DDB2
2849,GO:0006337,0.86615970515188,0.420858100105813,1,16,nucleosome disassembly,BP,SMARCD2
1117,GO:0002706,0.866326881223226,0.240147188746553,6,72,regulation of lymphocyte mediated immunity,BP,IL20RB;PRKCZ;ZP3;STAT6;HFE;BCL6
3213,GO:0006862,0.866462593411362,0.420249221430666,1,16,nucleotide transport,BP,SLC25A42
8176,GO:0032925,0.866502092938546,0.420169763982364,1,16,regulation of activin receptor signaling pathway,BP,ACVR2B
406,GO:0001091,0.86662044865075,0.419931604575361,1,16,RNA polymerase II basal transcription factor binding,MF,ERCC1
13071,GO:0051607,0.866675783936602,0.198188204826918,15,161,defense response to virus,BP,HTRA1;ADARB1;DDIT4;TMEM173;APOBEC3C;APOBEC3F;NLRX1;BNIP3;IFITM1;IRF5;ISG20;BNIP3L;LYST;TKFC;EIF2AK4
3769,GO:0008327,0.866748135803369,0.419674542809355,1,16,methyl-CpG binding,MF,MBD1
18008,GO:1902555,0.866813471270384,0.32811058890193,2,29,endoribonuclease complex,CC,AGO4;ERN1
19196,GO:1905348,0.866813471270384,0.32811058890193,2,29,endonuclease complex,CC,AGO4;ERN1
6233,GO:0019789,0.86683384136117,0.41950192602442,1,16,SUMO transferase activity,MF,PIAS3
72,GO:0000149,0.866958035578503,0.223840480379858,8,92,SNARE binding,MF,SYTL1;SNPH;SYT8;VPS11;VAMP2;TSNARE1;GOLGA2;STX1A
11398,GO:0045830,0.867127207326018,0.418910622562789,1,16,positive regulation of isotype switching,BP,STAT6
6749,GO:0030178,0.867237881507299,0.199824571620697,14,153,negative regulation of Wnt signaling pathway,BP,APOE;NFATC4;EGR1;CTNNBIP1;LRP1;IGFBP4;DDIT3;MDFI;WWTR1;NPHP4;LZTS2;IGFBP2;RNF213;GRB10
9590,GO:0036464,0.867284621385194,0.197393467446703,15,161,cytoplasmic ribonucleoprotein granule,CC,BTBD2;ZFP36L1;PITPNM1;GRB7;CIRBP;APOBEC3C;APOBEC3F;TDRKH;PAN2;TSTD1;AGO4;CTSH;PNRC1;C9ORF72;ZC3H12D
4188,GO:0009295,0.867286481436859,0.288127203684214,3,40,nucleoid,CC,TFB1M;ACADVL;MPG
10106,GO:0042645,0.867286481436859,0.288127203684214,3,40,mitochondrial nucleoid,CC,TFB1M;ACADVL;MPG
9727,GO:0038201,0.867680510917152,0.417793515735484,1,16,TOR complex,CC,SESN2
1462,GO:0003714,0.867838828561759,0.192555468759041,17,179,transcription corepressor activity,MF,ZMYND8;NR1D1;DDIT3;MXI1;WWTR1;MXD4;ELK3;NAB2;PBXIP1;TRIB3;BHLHE40;TSG101;MNT;HSF4;RCOR2;MTA1;MAP3K10
19653,GO:2000001,0.868045027989133,0.417056219215828,1,16,regulation of DNA damage checkpoint,BP,CHEK2
3164,GO:0006778,0.868050882722071,0.325905508032411,2,29,porphyrin-containing compound metabolic process,BP,UROS;BLVRB
12083,GO:0048144,0.868273700725781,0.248332242027533,5,62,fibroblast proliferation,BP,S100A6;EGFR;NUPR1;EREG;GAS6
20146,GO:2001021,0.86844820953375,0.24806681220036,5,62,negative regulation of response to DNA damage stimulus,BP,ERCC1;MAGEF1;HMGA2;CHEK2;RECQL5
2563,GO:0005847,0.868489502663899,0.416155744053459,1,16,mRNA cleavage and polyadenylation specificity factor complex,CC,CPSF4
14859,GO:0070671,0.868603472943453,0.285697848265411,3,41,response to interleukin-12,BP,PDCD4;GSTO1;AIP
17514,GO:1901071,0.868753911242986,0.415619311859484,1,16,glucosamine-containing compound metabolic process,BP,CHST6
9786,GO:0040020,0.868947108222229,0.415226995100771,1,16,regulation of meiotic nuclear division,BP,SIRT2
3439,GO:0007250,0.869123155559268,0.414869239208044,1,16,activation of NF-kappaB-inducing kinase activity,BP,TNFSF15
7866,GO:0032436,0.869144118092684,0.235987575619716,6,72,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,TRIB2;HERPUD1;TRIB3;AKT1;CSNK1E;SIRT2
11079,GO:0045109,0.869326417132756,0.414455865892091,1,16,intermediate filament organization,BP,KLHL24
6341,GO:0021522,0.869530747481503,0.414039979483246,1,16,spinal cord motor neuron differentiation,BP,TCTN1
4344,GO:0009913,0.869617153978378,0.188390120331002,18,193,epidermal cell differentiation,BP,ALOX15B;KRT15;ZFP36L1;MAP2K1;CYP27B1;PPL;PRSS8;LCE1E;EREG;ERRFI1;SLITRK6;AQP3;TRIOBP;SHARPIN;LCE1F;TSG101;KRT19;FGFR1
8976,GO:0035098,0.869847297042737,0.413395012747614,1,16,ESC/E(Z) complex,CC,PHF1
6357,GO:0021544,0.869861903439198,0.413365232568764,1,16,subpallium development,BP,BBS2
14231,GO:0061311,0.870048536145835,0.412984563519756,1,16,cell surface receptor signaling pathway involved in heart development,BP,VANGL2
7374,GO:0031435,0.870073784762998,0.412933042752975,1,16,mitogen-activated protein kinase kinase kinase binding,MF,TGFBR2
1302,GO:0003148,0.870174323309742,0.412727838140503,1,16,outflow tract septum morphogenesis,BP,TGFBR2
11695,GO:0046513,0.870283600710462,0.283148616537986,3,40,ceramide biosynthetic process,BP,PLA2G6;ST6GALNAC6;CERS4
4567,GO:0010657,0.870314720686482,0.283096729337057,3,40,muscle cell apoptotic process,BP,PDCD4;RGL2;BNIP3
8049,GO:0032727,0.870373822339824,0.412320404054769,1,16,positive regulation of interferon-alpha production,BP,IRF5
2621,GO:0005942,0.870493791494017,0.412075235165213,1,16,phosphatidylinositol 3-kinase complex,CC,PIK3R2
10186,GO:0042813,0.870841548789324,0.411363888715454,1,16,Wnt-activated receptor activity,MF,LRP5
7391,GO:0031463,0.871049921105537,0.25926355965727,4,51,Cul3-RING ubiquitin ligase complex,CC,KLHL29;KLHL24;KLHDC8B;KCTD13
4528,GO:0010604,0.871067027512619,0.145108819671242,247,2213,positive regulation of macromolecule metabolic process,BP,TNIP1;XDH;DUSP6;ACTA2;DLG4;F2R;APOE;NFATC4;FOS;GSN;CITED4;EGR1;PTK6;EDEM1;GJC2;LRP1;TIMP2;VEGFA;EGFR;PRNP;NR1D1;ERCC1;FBLN1;ANK3;DUSP5;RAPGEF3;TNFSF15;IGFBP4;CST3;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;GRAMD4;SMARCA1;MST1R;ZFP36L1;NUPR1;ARAP1;HBEGF;CTF1;CNTN1;TFDP2;SLC27A1;ASH2L;ETV4;WWTR1;MAP2K1;PKN1;MC1R;SHC2;ITGA6;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;MAGEF1;SHC1;VPS11;SPRY2;ADM2;SOX12;CIRBP;CAPRIN2;PRKCZ;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;CEMIP;KDM3A;PHF1;SALL2;DLG3;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;TRIB2;EREG;TEF;TNFRSF25;NAB2;PLA2G6;CARF;LPAR3;C5;PPARA;PLGRKT;SESN2;IMPACT;PKD2;STAT6;KLF7;HMGA2;AREG;MAPK3;CSPG4;THRA;VANGL2;IRF2BPL;MAPK12;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;SLC50A1;LITAF;ATF4;ZFPM1;BBC3;KDM4C;PAK6;ZNF516;PKD1;FLOT1;MDK;TTN;JDP2;HDAC5;GTPBP1;IRF5;SORL1;HERPUD1;SRSF5;VLDLR;DEAF1;NLRP1;PEG3;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;LRP5;CREBRF;PCSK9;PKIB;METTL23;HLTF;TGFBR2;TRPV4;CSRNP3;ITGA1;SMURF2;APLN;TRIB3;DAP;CALCOCO1;PEMT;EDA;CDK5RAP3;MINK1;HEXB;PROM2;ZFP90;WNT7A;PIK3R2;EPHA1;GAS6;ERN1;MAPRE3;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;MGMT;AKT1;CARD11;CDKN1C;CHEK2;IFT57;PHF2;FGFR4;PIAS3;WDFY2;IFI27;INSR;WNT3;NCOA7;FOXO4;RPS6KA5;C6ORF89;MAP2K5;BRAF;EDA2R;PIDD1;MAPK10;HFE;TP73;SNX33;TFEB;CSNK1E;BCL6;HSF4;FYN;ZC3H12D;SNX1;SIRT2;GDF15;GOLGA2;POU2F2;PLXND1;MTA1;ADIRF;AVPI1;CIDEB;EPAS1;LAMTOR2;MAP3K10;CHD6;EPHB2;PER1;ITGA2;FGFR1;WFS1;ERBB2;EIF2AK4;UNC119;HMBOX1;CREB3L4;KCTD13;DBP;ZNF287;CAMKK1;IKBKB;HIP1;TEAD2;SIX5
15268,GO:0071479,0.871177913411039,0.243903041395548,5,62,cellular response to ionizing radiation,BP,EGR1;HMGA2;MGMT;CHEK2;NET1
10009,GO:0042470,0.871338254831081,0.217563349504896,8,93,melanosome,CC,SYTL1;SYNGR1;CAPG;MYH11;CTSB;FLOT1;SGSM2;BSG
12357,GO:0048770,0.871338254831081,0.217563349504896,8,93,pigment granule,CC,SYTL1;SYNGR1;CAPG;MYH11;CTSB;FLOT1;SGSM2;BSG
6699,GO:0030111,0.871534592339164,0.176865900926624,25,257,regulation of Wnt signaling pathway,BP,APOE;NFATC4;EGR1;CTNNBIP1;LRP1;IGFBP4;DDIT3;MDFI;WWTR1;NPHP4;CAPRIN2;WNT2B;VANGL2;SULF2;LRP5;FOXL1;SMURF2;EDA;WNT7A;LZTS2;IGFBP2;WNT3;CSNK1E;RNF213;GRB10
11825,GO:0046824,0.871741813639062,0.258164336193374,4,51,positive regulation of nucleocytoplasmic transport,BP,RAPGEF3;TMEM173;GAS6;CAMK1
11410,GO:0045844,0.87180391018154,0.280609074373162,3,40,positive regulation of striated muscle tissue development,BP,FLOT1;TGFBR3;FGFR1
12277,GO:0048636,0.87180391018154,0.280609074373162,3,40,positive regulation of muscle organ development,BP,FLOT1;TGFBR3;FGFR1
17764,GO:1901863,0.87180391018154,0.280609074373162,3,40,positive regulation of muscle tissue development,BP,FLOT1;TGFBR3;FGFR1
11327,GO:0045671,0.871880099758156,0.409233552150209,1,16,negative regulation of osteoclast differentiation,BP,INPP5D
4475,GO:0010494,0.871992735839528,0.280292986921256,3,40,cytoplasmic stress granule,CC,GRB7;CIRBP;C9ORF72
8679,GO:0034314,0.872252112947191,0.318358752581737,2,29,Arp2/3 complex-mediated actin nucleation,BP,WHAMMP3;CORO1B
19595,GO:1990778,0.872393919869257,0.181802236355986,20,208,protein localization to cell periphery,BP,BBS2;LRP1;EGFR;PRNP;ANK3;PACS2;BBS1;LAMA5;PRKCZ;VAMP2;FLOT1;RAB40B;GAS6;AKT1;ARHGAP44;EHD3;RAB13;EPHB2;BSG;IKBKB
11839,GO:0046849,0.872422948040762,0.25708057296436,4,51,bone remodeling,BP,ACP5;EGFR;INPP5D;LRP5
6207,GO:0019730,0.872442405735371,0.278433092475079,3,45,antimicrobial humoral response,BP,PRSS3;FAM3A;PLA2G6
2728,GO:0006110,0.872580293070099,0.256829987943308,4,51,regulation of glycolytic process,BP,DDIT4;PPARA;MLXIPL;INSR
6249,GO:0019835,0.872806152230301,0.406246066587724,1,17,cytolysis,BP,C5
10936,GO:0044665,0.872914708024266,0.317159911124692,2,29,MLL1/2 complex,CC,ASH2L;INO80C
15170,GO:0071339,0.872914708024266,0.317159911124692,2,29,MLL1 complex,CC,ASH2L;INO80C
7169,GO:0031060,0.873029623759117,0.256113912840895,4,51,regulation of histone methylation,BP,KDM3A;MTHFR;PHF1;KDM4C
1047,GO:0002573,0.873312739496759,0.200844276678915,11,122,myeloid leukocyte differentiation,BP,FOS;CTNNBIP1;VEGFA;ZFP36L1;FAM213A;FAM20C;INPP5D;ZFPM1;CEBPB;TGFBR2;SH3PXD2A
6625,GO:0022900,0.873849961240641,0.19642582542826,12,141,electron transport chain,BP,XDH;D2HGDH;PHGDH;ALDH4A1;TXNRD3;AKR7A2;GLDC;NDUFA4L2;ETFB;SDHA;TXNRD2;TAZ
6169,GO:0019538,0.87410950161085,0.138631805186147,477,4214,protein metabolic process,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;HTRA1;F2R;ST6GALNAC2;TNFRSF6B;APOE;BTBD2;ZMYND8;SERPINE2;GID4;GSN;EGR1;LMF1;TYSND1;PPP1R35;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;CDC42EP5;THSD4;EDEM1;RNF135;GJC2;LRP1;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PADI3;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;FBLN1;ADAMTS7;PRDX5;TFPI2;DUSP5;NEK9;RAPGEF3;TNFSF15;SPTB;NPEPL1;LOXL1;RNPEPL1;IGFBP4;FKBP9;CRTAP;CST3;NOS1;DDIT3;BRSK1;CLCA2;ERCC6;GGT1;ADAMTS13;ABTB1;MMP28;GRAMD4;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;B3GAT3;HBEGF;RPS6KA2;MMP1;CTF1;CNTN1;RPL13A;MSRB2;OBSL1;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;RNF165;MIF4GD;CDK18;PHACTR3;FBXW4;ASH2L;CUL7;LHPP;PRSS3;HYAL1;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;ALPK1;BTG1;SHC2;SYNGAP1;PHF21A;DGKQ;SNX9;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;HDAC11;RAB3B;PCSK1;UNK;PRSS8;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;AARS;STK39;ERO1B;FGFR3;FBXO41;CEMIP;KDM3A;MTHFR;KLHL29;PHF1;NPR2;CAPNS2;SPRY4;USP20;DLG3;FBXW8;NEURL1;ACVR2B;RAG1;SPPL2B;SPEG;NGFR;ELFN2;MARCH4;ETFB;LCE1E;LTBP1;MUC19;TRIB2;EREG;PTPRE;RNF44;SSH3;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;PPM1J;ABCG1;LPAR3;CARS;FKBP10;MTMR4;C5;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;BLMH;MKNK2;RASA4;IMPACT;PKD2;SATB1;ING4;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;MARCH9;JADE2;MAPK3;CSPG4;TRPT1;LAMB2;FBXO27;BNIP3;ERRFI1;MACROD1;DCAF10;PEX10;STK40;VANGL2;RGS14;MVD;FAM20C;CNTRL;ADAMTSL1;SNTA1;CTSB;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;SDC2;FBXO17;MLXIPL;PTPDC1;C1RL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;PGPEP1;LRSAM1;DMTN;KLHL24;UBXN4;ATF4;ZFPM1;BBC3;KDM4C;PAK6;PRSS22;SSH1;PCMTD2;TENM2;FBXO6;IFI6;PKD1;NSMCE1;FLOT1;TTN;PSKH1;HLCS;AZIN2;JDP2;HDAC5;GTPBP1;SORL1;IL17RD;HERPUD1;VLDLR;PAPLN;ST3GAL3;SULF2;NLRP1;ACY1;KDM7A;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;ATRAID;PCSK9;PKIB;PKN3;FBXL15;FBXL16;LONP2;MARK3;HLTF;TRIOBP;TGFBR2;TRPV4;FOXL1;ITGA1;MOCOS;APOL4;SMURF2;LMO7;TRIB3;RAB40B;DAP;PEMT;HMG20B;CDK5RAP3;AGO4;MINK1;PIGZ;HEXB;PROM2;WNT7A;TTLL11;MARCH2;BNIP3L;PIK3R2;EPHA1;RHBDF2;SHARPIN;GAS6;DNAJC6;ERN1;BCR;KLHDC8B;MAPRE3;MAN2C1;NBR1;HEXA;TADA3;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;FBXL8;MGMT;PAIP2B;LCE1F;HINT2;AKT1;IGFBP7;CARD11;DGUOK;CDKN1C;MICAL1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;WDR45;IGFBP2;SPDYE2;SPDYE2B;NFU1;TSG101;PHF2;FGFR4;IGF2BP2;PIAS3;TCIRG1;PHLDA1;SPSB3;WDFY2;C9ORF72;UHRF2;ARSA;CAPN2;MAN2B1;SPATA18;MARK4;IFI27;PLAU;INSR;NCOA7;TENM4;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;PIDD1;CAT;MAPK10;DPP7;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;SNX33;UBOX5;CHRM3;MIB2;MPI;LSM14B;JOSD2;PHC1;SCYL3;CSNK1E;BCL6;HSF4;RNF213;FBXO25;RPL39L;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;UBXN6;SIRT2;GDF15;RAB13;GOLGA2;MTA1;AP2A2;HDAC8;PAIP2;RPL29;EIF4EBP1;AVPI1;TGFBR3;CIDEB;RNPEP;MAN1B1;EPAS1;LAMTOR2;MAP3K10;MFNG;RNF170;DHPS;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;BLOC1S1;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;STK32B;UNC119;SYVN1;FRS3;MMP17;RPL12;MPPE1;TRIM2;MMP19;KCTD11;LYPLAL1;KCTD13;ZNF287;CAMKK1;DTX3;IKBKB;NTM;HIP1;ACOT8;BTBD11
3633,GO:0008104,0.874198942082644,0.142233540880287,228,2056,protein localization,BP,DLG4;BBS2;F2R;APOE;MARVELD1;SYTL1;ZMYND8;GSN;LMF1;POSTN;EVI5L;TMEM129;EDEM1;GLUL;LRP1;ALOX15B;OBSCN;EGFR;PRNP;ZDHHC1;NR1D1;HADH;ANK3;IFT140;RAPGEF3;CLTCL1;IDH2;DDIT3;PACS2;TBC1D8;ARRDC1;B3GAT3;EXOC2;TFDP2;MXI1;RPL13A;OBSL1;MDFI;BBS1;REEP2;ATG16L2;SYNGR1;PCK2;TOM1L2;SYNGAP1;PITPNM1;TMEM173;SNX9;ARL2;ULK1;VPS11;RAB3B;NLGN2;ITPR3;LAMA5;TTBK2;PRKCZ;PAK1;ABCA7;CEMIP;SYNE3;DLG3;MICALL2;CEP250;ACVR2B;NGFR;ETV5;LTBP1;MALL;OLFM2;TMED4;PLA2G6;ABCG1;XPOT;RINL;S100A13;AGAP1;C5;KIF17;ANO1;SESN2;AIP;IFT27;PKD2;SH3TC2;NUDCD3;VAMP2;AP1G2;SEPT5;PCLO;KCNAB2;MAPK3;THRA;PEX10;VANGL2;LTBP2;HOOK2;EIF2D;MVB12B;CHMP1B;TBC1D14;TCTN1;ARHGEF2;SEPT10;PRAF2;TWF2;LRSAM1;DMTN;BBC3;SSH1;TBC1D3E;RABGAP1;PKD1;FLOT1;CEP68;TTN;TSNARE1;SORL1;HERPUD1;SRSF5;VLDLR;NLRP1;RHBDF1;LRP5;PTPRU;WNK4;CEP131;LONP2;TRPV4;TMSB4X;PDE2A;RAB40B;MLH3;PEMT;CDK5RAP3;WNT7A;BNIP3L;PIK3R2;RHBDF2;GAS6;VPS39;GLUD1;LZTS2;CROCC;BCR;MAPRE3;KIF13B;NECAB3;CAMK1;PPP1R15A;RAB43;SPATA7;STRADB;WDR19;C12ORF66;MAPKBP1;AKT1;ITPR2;CARD11;WDR45;SEPT6;TTC21A;TSG101;IL17RC;RASSF9;TCIRG1;STEAP3;LMNA;COPG1;SGSM2;CHMP5;ICA1;RAB25;IFI27;COG7;CHMP4C;ITGB6;LYST;ZDHHC24;BRAF;ARHGAP44;CPSF4;BTN3A2;UNC119B;HFE;TP73;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;CSNK1E;BCL6;EHD3;FYN;SNX1;PEX1;LEMD2;RAB13;TOM1;CELSR1;POU2F2;RTN2;AP2A2;CIDEA;HDAC8;MYO18A;RPL29;STX1A;LAMTOR2;TBC1D16;EPHB2;TMCO6;SEPT8;ITGA2;ERBB2;SEC31B;PLLP;UNC119;SYVN1;OSCP1;PFKL;CORO1B;RPL12;BSG;APBA1;IKBKB;HIP1
5413,GO:0016266,0.874204448585191,0.27683626241055,3,39,O-glycan processing,BP,ST6GALNAC2;MUC19;ST3GAL3
2453,GO:0005666,0.874217207136499,0.403326137850817,1,17,DNA-directed RNA polymerase III complex,CC,POLR3GL
39,GO:0000079,0.874293578629894,0.228236176105904,6,73,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR;PKD2;PKD1;CDK5RAP3;MAPRE3;AKT1
20236,GO:2001234,0.874490157012631,0.187893210283412,15,163,negative regulation of apoptotic signaling pathway,BP,ITGA6;ARHGEF2;IFI6;UNC5B;HERPUD1;NOS3;STRADB;AKT1;LMNA;MAP2K5;MNT;FYN;WFS1;CTH;SYVN1
1340,GO:0003205,0.8746193108556,0.207511918793738,9,102,cardiac chamber development,BP,LTBP1;VANGL2;ZFPM1;TGFBR2;RXRA;SNX17;PLXND1;TGFBR3;TNNI1
4448,GO:0010390,0.875080442821794,0.313224766270787,2,29,histone monoubiquitination,BP,DDB2;RAG1
10512,GO:0043467,0.875600495884021,0.211475572807716,8,93,regulation of generation of precursor metabolites and energy,BP,DDIT4;PPARA;BNIP3;MLXIPL;TRPV4;AKT1;INSR;PHLDA2
8591,GO:0034113,0.875893333367313,0.311741097475845,2,29,heterotypic cell-cell adhesion,BP,FLOT1;MAP2K5
3731,GO:0008270,0.876212447369111,0.154003428850188,60,576,zinc ion binding,MF,S100A6;EGR1;TIMP2;NR1D1;RNPEPL1;ADAMTS13;TCEA2;MMP28;ZCCHC24;TRIM65;MMP1;MSRB2;RNF165;PHC2;APOBEC3C;USP20;ZSWIM4;NEIL1;RAG1;MARCH4;CYHR1;S100A13;APOBEC3F;PPARA;CHD3;KLF7;MARCH9;THRA;PEX10;LTA4H;ARHGEF2;LITAF;KDM4C;KDM7A;L3MBTL1;HLTF;MARCH2;CCS;NBR1;RXRA;MBD1;LACTB2;PHF2;PIAS3;RABGGTA;CPSF4;TIMP1;MTA3;MIB2;MPI;PHC1;SIRT2;ADA;MTA1;RNPEP;MMP17;TRIM2;MMP19;ZMYM3;TRIM45
11347,GO:0045727,0.876384825271512,0.204919820510173,9,104,positive regulation of translation,BP,CIRBP;IMPACT;MAPK3;PTAFR;PPP1R15A;RXRA;ITGA2;ERBB2;EIF2AK4
11389,GO:0045814,0.876619638513433,0.199796198140004,10,121,negative regulation of gene expression, epigenetic,BP,BAHCC1;H2AFJ;PHF1;HDAC5;DNMT3A;MBD1;TNRC18;PHF2;UHRF2;SIRT2
11425,GO:0045892,0.877031833880234,0.146979943140751,95,894,negative regulation of transcription, DNA-templated,BP,ZC3H6;ZMYND8;NFATC4;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;NR1D1;PRDX5;BAHCC1;DDIT3;DNAJB5;TCFL5;TFDP2;MXI1;MDFI;WWTR1;MXD4;H2AFJ;PHF21A;SHC1;ELK3;FOXQ1;SALL2;ZP3;ACVR2B;EAPP;HES2;EREG;NAB2;PPARA;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;THRA;IRF2BPL;PBXIP1;MLXIPL;ZFPM1;TENM2;CBX7;JDP2;HDAC5;VLDLR;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;ZFP90;TRPV1;GAS6;RXRA;MBD1;TNRC18;CDKN1C;CRY2;TSG101;PHF2;ZNF217;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;TP73;MTA3;MNT;BCL6;HSF4;SIRT2;RECQL5;RCOR2;HDAC8;TCF7;MAP3K10;PER1;FGFR1;WFS1;HMBOX1;TSHZ1;SIX5
9036,GO:0035268,0.8770643355017,0.397383019038525,1,17,protein mannosylation,BP,B4GAT1
16895,GO:0098900,0.877225961780848,0.309300880622102,2,29,regulation of action potential,BP,NTSR1;ANK3
12755,GO:0051054,0.877243164145914,0.180328982778987,17,181,positive regulation of DNA metabolic process,BP,EGFR;ERCC1;CST3;SHC1;EREG;STAT6;AREG;MAPK3;ENDOG;PKIB;MGMT;AKT1;FGFR4;INSR;FGFR1;HMBOX1;KCTD13
1154,GO:0002762,0.877539025035033,0.308726181876621,2,29,negative regulation of myeloid leukocyte differentiation,BP,INPP5D;ZFPM1
18449,GO:1903578,0.877836078306011,0.222926197375098,6,73,regulation of ATP metabolic process,BP,DDIT4;PPARA;MLXIPL;TMSB4X;INSR;TAZ
7885,GO:0032462,0.877979948406545,0.395456912846323,1,17,regulation of protein homooligomerization,BP,APOE
5615,GO:0016675,0.878028346954058,0.393547967623738,1,19,oxidoreductase activity, acting on a heme group of donors,MF,NDUFA4L2
15966,GO:0086003,0.878050799581893,0.307785517654037,2,29,cardiac muscle cell contraction,BP,SCN4B;SNTA1
6536,GO:0021954,0.878215623161667,0.269550261037673,3,41,central nervous system neuron development,BP,ADARB1;TCTN1;EPHB2
16097,GO:0090114,0.878292699459642,0.232826267828835,5,63,COPII-coated vesicle budding,BP,TRAPPC9;AREG;TBC1D20;GOLGA2;SEC31B
12543,GO:0050716,0.879526009322699,0.392187925422253,1,17,positive regulation of interleukin-1 secretion,BP,NLRP1
16839,GO:0098796,0.879674740467799,0.146680166735418,76,729,membrane protein complex,CC,DLG4;KCNG1;GJC2;LRP1;EGFR;SCN8A;CLTCL1;DNM1;NOS1;SHANK2;SCN4B;COL13A1;EVC;ABCA2;ITGA6;SHC1;VPS11;ABCA7;NDUFA4L2;SYNE3;DLG3;ITGB4;OLFM2;C5;ANO1;VAMP2;AP1G2;KCNC4;KCNAB2;ITGB5;SNTA1;HOOK2;MVB12B;CHMP1B;SDHA;LRRC8A;FLOT1;KCNMA1;TSNARE1;HERPUD1;GABBR1;LRP5;TGFBR2;ITGA1;PIK3R2;VPS39;ERN1;CPT1C;TTYH3;CARD11;TSG101;TCIRG1;COPG1;INSR;KRT19;GNAL;ANKZF1;CHMP4C;ITGB6;PIGQ;GJB4;HFE;SCNN1A;ATP12A;SNX1;AP2A2;TGFBR3;STX1A;LAMTOR2;ITGA2;SEC31B;SYVN1;HLA-G;SDHAF4;IKBKB;HIP1
9931,GO:0042306,0.879806955765108,0.266838801375811,3,41,regulation of protein import into nucleus,BP,TMEM173;PDE2A;GAS6
5915,GO:0018195,0.88002978893495,0.391118176814274,1,17,peptidyl-arginine modification,BP,PADI3
9817,GO:0042056,0.880096462441844,0.39002103933959,1,18,chemoattractant activity,MF,VEGFA
19712,GO:2000113,0.880337137316551,0.140764871461145,120,1116,negative regulation of cellular macromolecule biosynthetic process,BP,ZC3H6;ZMYND8;NFATC4;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;EGFR;NR1D1;PRDX5;BAHCC1;DDIT3;DNAJB5;ZFP36L1;TCFL5;HBEGF;TFDP2;MXI1;RPL13A;MDFI;WWTR1;MAP2K1;MXD4;H2AFJ;PHF21A;SHC1;GRB7;UNK;CIRBP;CAPRIN2;ABCA7;ELK3;FOXQ1;SALL2;ZP3;ACVR2B;EAPP;HES2;EREG;NAB2;PPARA;SESN2;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;THRA;IRF2BPL;PBXIP1;MLXIPL;TSPYL2;MAP2K2;ATF4;ZFPM1;TENM2;CBX7;JDP2;HDAC5;VLDLR;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;AGO4;ZFP90;TRPV1;GAS6;RXRA;MBD1;TNRC18;PAIP2B;CDKN1C;CRY2;CHEK2;TSG101;PHF2;IGF2BP2;ZNF217;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;JAK3;TP73;MTA3;MNT;BCL6;HSF4;ZC3H12D;SIRT2;RECQL5;RCOR2;HDAC8;PAIP2;EIF4EBP1;TCF7;MAP3K10;PER1;IGF2BP3;FGFR1;WFS1;EIF2AK4;HMBOX1;TSHZ1;ACOT8;SIX5
8501,GO:0033692,0.880516202151972,0.243915934020587,4,52,cellular polysaccharide biosynthetic process,BP,NR1D1;PGM1;AKT1;INSR
16834,GO:0098791,0.880552899043743,0.146970574288984,69,657,Golgi subcompartment,CC,ST6GALNAC2;POSTN;EDEM1;EGFR;CLTCL1;GPSM1;ARAP1;B3GAT3;ASAP2;PITPNM1;SNX9;ABCA7;B4GALNT4;NMNAT2;SPPL2B;MARCH4;MALL;ABCG1;DNMBP;TRAPPC9;CHAC1;VAMP2;AREG;ST6GALNAC6;AP1G2;B4GAT1;MARCH9;SCARA3;PI4K2A;KIAA0319L;IFNGR2;SLC50A1;LITAF;CHST6;PKD1;AZIN2;SORL1;IL17RD;ST3GAL3;SULF2;RHBDF1;NOS3;ATP7B;GOLGA2P5;NECAB3;RAB43;ENTPD6;STEAP2;B4GALT2;COPG1;TBC1D20;GOLGA8A;ICA1;COG7;C6ORF89;TMEM50B;SLC9A7;PJA2;RAB13;GOLGA2;RHOBTB3;MYO18A;MAN1B1;MFNG;XYLT2;UST;HLA-G;CREB3L4;BSG
16703,GO:0097734,0.881002158967783,0.389047009785076,1,17,extracellular exosome biogenesis,BP,TSG101
19446,GO:1990182,0.881002158967783,0.389047009785076,1,17,exosomal secretion,BP,TSG101
8449,GO:0033599,0.881220903542942,0.388579913460677,1,17,regulation of mammary gland epithelial cell proliferation,BP,DEAF1
14669,GO:0070316,0.881325679658951,0.264240623231753,3,41,regulation of G0 to G1 transition,BP,TFDP2;FOXO4;PHC1
2774,GO:0006206,0.881428351523877,0.388136541973671,1,17,pyrimidine nucleobase metabolic process,BP,UCKL1
11331,GO:0045684,0.881724739261674,0.300584182353522,2,30,positive regulation of epidermis development,BP,ALOX15B;CYP27B1
11579,GO:0046189,0.881874665474768,0.387181335636251,1,17,phenol-containing compound biosynthetic process,BP,TRPC1
11332,GO:0045685,0.881977781833463,0.263121872042268,3,41,regulation of glial cell differentiation,BP,SERPINE2;TENM4;TP73
14465,GO:0061912,0.882022606650639,0.263044900161844,3,41,selective autophagy,BP,SESN2;MAPK3;LRSAM1
86,GO:0000175,0.882071251456922,0.299939388525495,2,30,3'-5'-exoribonuclease activity,MF,PAN2;ISG20
7404,GO:0031498,0.882204961498742,0.386473272993212,1,17,chromatin disassembly,BP,SMARCD2
18461,GO:1903599,0.882326893618343,0.386211634644131,1,17,positive regulation of autophagy of mitochondrion,BP,BNIP3
11250,GO:0045576,0.882364001183264,0.299394092971606,2,30,mast cell activation,BP,NDRG1;S100A13
12986,GO:0051443,0.882587697152206,0.298977085313804,2,30,positive regulation of ubiquitin-protein transferase activity,BP,TRIB3;GOLGA2
18897,GO:1904666,0.883116294694098,0.383559686966364,1,18,regulation of ubiquitin protein ligase activity,BP,GOLGA2
9150,GO:0035518,0.883235937967941,0.384256769790195,1,17,histone H2A monoubiquitination,BP,DDB2
8230,GO:0033013,0.88344682160919,0.260368367616239,3,42,tetrapyrrole metabolic process,BP,PRSS3;UROS;BLVRB
12326,GO:0048710,0.883466438699722,0.383759887177385,1,17,regulation of astrocyte differentiation,BP,SERPINE2
10515,GO:0043473,0.883919813116458,0.213635823227026,6,74,pigmentation,BP,BBS2;MC1R;BLOC1S4;EDA;LYST;BLOC1S1
2388,GO:0005525,0.884092217567098,0.15934761735876,27,278,GTP binding,MF,DNM1;PCK2;TUBG2;ARL2;RAB3B;NPR2;RHOBTB2;AGAP1;IFT27;SEPT5;RHOF;TUBE1;SEPT10;GTPBP1;RAB40B;ARL10;GLUD1;SUCLG2;RAB43;SEPT6;RAB25;INSR;GNAL;EHD3;RAB13;RHOBTB3;SEPT8
17459,GO:1900407,0.88425212722498,0.237681065620326,4,53,regulation of cellular response to oxidative stress,BP,ATF4;ENDOG;AKT1;NCOA7
8608,GO:0034138,0.884483784485569,0.381560993229627,1,17,toll-like receptor 3 signaling pathway,BP,FLOT1
2862,GO:0006356,0.884766436931804,0.294900188104131,2,30,regulation of transcription by RNA polymerase I,BP,ATF4;ERBB2
5664,GO:0016779,0.884935877787935,0.184675990678705,11,126,nucleotidyltransferase activity,MF,POLD4;NMNAT2;PRIMPOL;POLM;TEP1;POLL;TERC;POLR2J2;POLR3GL;POLR2J3;HMBOX1
6466,GO:0021801,0.885272366974469,0.379849961112968,1,17,cerebral cortex radial glia guided migration,BP,LAMB1
6564,GO:0022030,0.885272366974469,0.379849961112968,1,17,telencephalon glial cell migration,BP,LAMB1
7400,GO:0031491,0.885335915851356,0.221499441764378,5,66,nucleosome binding,MF,SMARCA1;PHF1;HMGA2;L3MBTL1;SMARCD2
3197,GO:0006829,0.88542370829002,0.379520925313402,1,17,zinc ion transport,BP,SLC39A11
6336,GO:0021515,0.885455162292403,0.379452513359839,1,17,cell differentiation in spinal cord,BP,TCTN1
17850,GO:1902116,0.885479741481554,0.293559336332351,2,30,negative regulation of organelle assembly,BP,EVI5L;ARHGEF2
13992,GO:0060740,0.885817231313211,0.378664352890885,1,17,prostate gland epithelium morphogenesis,BP,RXRA
19723,GO:2000142,0.885901156331731,0.292765743406237,2,30,regulation of DNA-templated transcription, initiation,BP,CTNNBIP1;THRA
5394,GO:0016236,0.885935783698431,0.157893314905237,26,269,macroautophagy,BP,GPSM1;PACS2;ULK2;EPM2A;ATG16L2;ULK1;SESN2;MAPK3;BNIP3;TBC1D14;TECPR1;LRSAM1;MAP1LC3A;BNIP3L;ERN1;FYCO1;NBR1;AKT1;WDR45;TSG101;TCIRG1;ATG2A;C9ORF72;CHMP4C;UBXN6;LAMTOR2
1339,GO:0003203,0.885953134294804,0.378368199113409,1,17,endocardial cushion morphogenesis,BP,TGFBR2
15032,GO:0071011,0.886126491932289,0.291966799202601,2,31,precatalytic spliceosome,CC,TEP1;MAPKBP1
12868,GO:0051233,0.88612965226163,0.29233500310529,2,30,spindle midzone,CC,UNC119;CCDC69
9595,GO:0036473,0.886494896114587,0.219883474217344,5,64,cell death in response to oxidative stress,BP,PRODH;ATF4;ENDOG;AKT1;NCOA7
19606,GO:1990823,0.886798626862546,0.209243945159696,6,74,response to leukemia inhibitory factor,BP,SYNGR1;SPRY2;KDM3A;GLDC;RFX2;CTH
19609,GO:1990830,0.886798626862546,0.209243945159696,6,74,cellular response to leukemia inhibitory factor,BP,SYNGR1;SPRY2;KDM3A;GLDC;RFX2;CTH
7609,GO:0032008,0.886816581106545,0.291038173351949,2,30,positive regulation of TOR signaling,BP,GAS6;LAMTOR2
16025,GO:0086091,0.886833713938494,0.376445069113029,1,17,regulation of heart rate by cardiac conduction,BP,SCN4B
7310,GO:0031328,0.886940825600322,0.131839116213021,142,1305,positive regulation of cellular biosynthetic process,BP,TNIP1;F2R;APOE;NFATC4;FOS;CITED4;EGR1;TIMP2;VEGFA;NTSR1;EGFR;NR1D1;RAPGEF3;CST3;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;SMARCA1;TFDP2;ASH2L;ETV4;WWTR1;MAP2K1;MC1R;ITGA6;ZNF76;PBX2;MAML3;TMEM173;SHC1;SOX12;CIRBP;CAPRIN2;ELK3;PABPC1L;SEC14L2;KDM3A;PHF1;SALL2;ETV1;ZP3;ABHD14B;EAPP;NGFR;ETV5;EREG;TEF;PLA2G6;CARF;PPARA;SESN2;IMPACT;PKD2;STAT6;KLF7;HMGA2;AREG;MAPK3;THRA;IRF2BPL;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;ZNF516;PKD1;MDK;HDAC5;IRF5;DEAF1;PEG3;RFX2;KDM7A;CEBPB;LRP5;CREBRF;PKIB;METTL23;HLTF;CSRNP3;TMSB4X;APLN;CALCOCO1;PEMT;CDK5RAP3;NOS3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;MAPRE3;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;AKT1;CARD11;CDKN1C;CHEK2;ASS1;PHF2;FGFR4;INSR;NCOA7;FOXO4;RPS6KA5;MAP2K5;TP73;TFEB;TAZ;HSF4;SIRT2;GOLGA2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;PER1;ITGA2;FGFR1;ERBB2;EIF2AK4;HMBOX1;CREB3L4;KCTD13;DBP;ZNF287;IKBKB;TEAD2;SIX5
6968,GO:0030641,0.88698930611941,0.219102998257396,5,64,regulation of cellular pH,BP,MAPK3;TMEM175;TCIRG1;SLC9A7;SLC9A5
9056,GO:0035307,0.887060219965711,0.290577531262337,2,30,positive regulation of protein dephosphorylation,BP,ITGA1;PPP1R15A
17254,GO:0140030,0.887129038256538,0.185351521928962,10,114,modification-dependent protein binding,MF,TNIP1;ZMYND8;BRD3;PHF1;ING4;KDM7A;L3MBTL1;SHARPIN;PHF2;FAAP20
12332,GO:0048729,0.888056406491525,0.144224233939182,46,448,tissue morphogenesis,BP,ACTA2;NFATC4;CTNNBIP1;PGF;VEGFA;EGFR;ARHGEF19;ADARB1;HBEGF;SPRY2;LAMA5;PAK1;FOXQ1;DLG3;ITGB4;ETV5;WNT2B;PKD2;HMGA2;AREG;VANGL2;TCTN1;ZFPM1;KIF26B;PKD1;TTN;DEAF1;LRP5;WNK4;TGFBR2;FOXL1;SMURF2;WNT7A;RXRA;CTSH;IFT57;WNT3;CELSR1;PLXND1;AP2A2;TGFBR3;EDNRA;ITGA2;FGFR1;TNNI1;TEAD2
477,GO:0001522,0.888468853922143,0.371901496630393,1,18,pseudouridine synthesis,BP,RPUSD3
16469,GO:0097193,0.888764532364149,0.157167953010246,23,243,intrinsic apoptotic signaling pathway,BP,NFATC4;PRODH;DDIT3;ERCC6;NUPR1;DDIT4;CHAC1;BNIP3;ARHGEF2;ATF4;BBC3;HERPUD1;CEBPB;TRIB3;ERN1;PPP1R15A;AKT1;CHEK2;EDA2R;TP73;CIDEB;WFS1;SYVN1
4263,GO:0009615,0.88883258165282,0.159347214524021,21,223,response to virus,BP,ACTA2;HTRA1;MST1R;ADARB1;HYAL1;DDIT4;TMEM173;APOBEC3C;APOBEC3F;NLRX1;HMGA2;BNIP3;IFITM1;IFNGR2;IRF5;ISG20;BNIP3L;LYST;TKFC;EIF2AK4;IKBKB
10960,GO:0044769,0.8889240934033,0.370897493248414,1,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,TCIRG1
11898,GO:0046961,0.8889240934033,0.370897493248414,1,18,proton-transporting ATPase activity, rotational mechanism,MF,TCIRG1
6460,GO:0021795,0.889144417264357,0.286622214052999,2,30,cerebral cortex cell migration,BP,EGFR;LAMB1
9527,GO:0036294,0.889862537136362,0.16951827058308,14,157,cellular response to decreased oxygen levels,BP,EGR1;VEGFA;NDRG1;ZFP36L1;BNIP3;ENDOG;AQP3;DNMT3A;BNIP3L;TERC;AKT1;LMNA;SIRT2;EPAS1
5553,GO:0016570,0.890175366912858,0.14446936648858,39,388,histone modification,BP,ZMYND8;VEGFA;PADI3;DDB2;NOS1;ASH2L;PKN1;PHF21A;HDAC11;KDM3A;MTHFR;PHF1;RAG1;FKBP10;CHD3;SATB1;ING4;HMGA2;JADE2;MAPK3;KDM4C;HLCS;JDP2;HDAC5;KDM7A;MAP3K12;HMG20B;TADA3;PHF2;RPS6KA5;C6ORF89;MTA3;PHC1;BCL6;HSF4;SIRT2;MTA1;HDAC8;PER1
13258,GO:0051972,0.890332221398043,0.248394187741151,3,42,regulation of telomerase activity,BP,MAPK3;PKIB;HMBOX1
4153,GO:0009219,0.890357799693375,0.367722479787578,1,18,pyrimidine deoxyribonucleotide metabolic process,BP,NEIL1
8953,GO:0035036,0.891092653164011,0.366087360828013,1,18,sperm-egg recognition,BP,ZP3
11025,GO:0045023,0.891489432507561,0.246359713710046,3,42,G0 to G1 transition,BP,TFDP2;FOXO4;PHC1
2454,GO:0005667,0.891499305411096,0.15175913227456,25,260,transcription factor complex,CC,NFATC4;FOS;NR1D1;ERCC1;DDIT3;RBL2;TFDP2;MXI1;WWTR1;PBX2;PPARA;THRA;MLXIPL;ATF4;ZFPM1;DEAF1;CEBPB;MXD3;TADA3;RXRA;TP73;RCOR2;TCF7;EPAS1;TEAD2
3296,GO:0006996,0.891743882347813,0.120889801908899,346,3091,organelle organization,BP,DLG4;BBS2;F2R;APOE;SYTL1;ESPN;ZMYND8;XPC;SERPINE2;H1F0;GSN;EVI5L;WIPF1;CDC42EP5;LRP1;VEGFA;OBSCN;PADI3;DDB2;ERCC1;ANK3;BAHCC1;NEK9;IFT140;RAPGEF3;SPTB;KRT15;NINL;IDH2;DNM1;PARVB;NOS1;ARAP3;BRSK1;SHANK2;PACS2;TBC1D8;ARHGEF19;SMARCA1;EFS;SYT8;CUL9;ARAP1;RBL2;GAA;TFDP2;MSRB2;OBSL1;BBS1;ULK2;REEP2;NISCH;ASH2L;CUL7;ATG16L2;HMGCL;NAGLU;ARPIN;WWTR1;POLD4;MAP2K1;PPL;SDCCAG8;PKN1;CAPG;H2AFJ;TOM1L2;PHF21A;EML2;TUBG2;SNX9;DNAH1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;BLOC1S4;HDAC11;NLGN2;MYH11;LAMA5;CIRBP;TPM2;TTBK2;PRKCZ;PAK1;PABPC1L;BRD3;KDM3A;MTHFR;PHF1;SYNE3;MICALL2;CEP250;FBXW8;SHROOM4;NEURL1;CCDC88B;RAG1;WDR60;PLXNB1;EREG;CHD2;SPG11;PNPLA3;SSH3;RMI2;PLEKHG2;RHOBTB2;TMED4;PLA2G6;TRAPPC9;ALS2CL;FKBP10;KIF17;INO80C;CHD3;SPC24;SESN2;AIP;SCMH1;IFT27;PKD2;SATB1;ING4;NUDCD3;VAMP2;HMGA2;AREG;SEPT5;PCLO;PI4KAP1;JADE2;MAPK3;ITGB5;BNIP3;SEMA5A;PEX10;VANGL2;ACSS2;RGS14;TDRKH;DYSF;RHOF;PLEK2;CNTRL;TUBE1;HOOK2;EIF2D;MYH3;PI4K2A;CHMP1B;TBC1D14;TCTN1;PTPDC1;ARHGEF2;SEPT10;FBF1;TSPYL2;MAP2K2;H1FX;TWF2;STMN3;LRSAM1;DMTN;KLHL24;ZFPM1;BBC3;KDM4C;PAK6;SSH1;TBC1D3E;PRIMPOL;RABGAP1;IFI6;CBX7;PKD1;ATXN10;CEP68;TTN;HLCS;TSNARE1;JDP2;HDAC5;WHAMMP3;MAP6;TFB1M;TEP1;TMEM175;RFX2;KDM7A;MAP3K12;LRP5;NDE1;PKIB;L3MBTL1;CEP131;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TRPV4;ARHGAP25;IQSEC2;TMSB4X;MAP1LC3A;MLH3;PEMT;HMG20B;NOS3;AGO4;MINK1;HEXB;TTLL11;BNIP3L;EPHA1;SHARPIN;FMNL2;VPS39;GLUD1;CEP126;ALKBH7;CROCC;BCR;FYCO1;GOLGA2P5;TADA3;SPAG16;TERC;MBD1;TNRC18;RAB43;WDR19;TMEM80;AKT1;REEP4;MICAL1;CHEK2;IFT57;WDR45;SEPT6;TTC21A;TNNT1;TSG101;KIF27;FMNL3;PHF2;TMOD2;TCIRG1;ASAP3;LMNA;ATG2A;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;CAPN2;GOLGA8A;SMARCD2;SPATA18;MARK4;INSR;KRT19;COG7;RPS6KA5;CHMP4C;TNXB;SMIM20;ADD3;C6ORF89;LYST;BRAF;ARHGAP44;HAUS4;UNC119B;TP73;MTA3;TUBGCP6;SNX33;FCHSD1;TFEB;PEX7;PHC1;SPIRE1;CSNK1E;TAZ;BCL6;HSF4;REC8;EPS8L1;EHD3;MAST4;EML3;ATP8B2;SNX1;PEX1;LEMD2;ARHGEF17;SIRT2;RECQL5;RAB13;GOLGA2;CELSR1;RHOBTB3;MTA1;MSH5;CIDEA;EPS8L2;HDAC8;MYO18A;CIDEB;VAV3;STX1A;EPAS1;TBC1D16;CHD6;LURAP1;PER1;SEPT8;BLOC1S1;FITM2;SPATA6;SH3PXD2A;SEC31B;UNC119;CCDC69;OSCP1;C15ORF62;CORO1B;SFI1;RPL12;HMBOX1;TTC19;ZMYM3;SDHAF4;KCTD13;PEX11A;IKBKB;HIP1;PLEKHH2;ACOT8
14592,GO:0070182,0.891808956098152,0.364488416500135,1,18,DNA polymerase binding,MF,TERC
18189,GO:1903008,0.891893257926468,0.187630886784639,8,96,organelle disassembly,BP,BNIP3;EIF2D;MAP1LC3A;BNIP3L;WDR45;ATG2A;SPATA18;GOLGA2
11185,GO:0045333,0.892194202018649,0.168584736550364,13,153,cellular respiration,BP,NFATC4;D2HGDH;IDH2;DHTKD1;OGDHL;ETFB;BNIP3;SDHA;SUCLG2;CAT;TAZ;BLOC1S1;SDHAF4
3336,GO:0007052,0.892363112231674,0.18203863464801,9,105,mitotic spindle organization,BP,TUBG2;CHMP1B;PKD1;CEP126;CHEK2;CHMP5;CHMP4C;TUBGCP6;GOLGA2
8115,GO:0032814,0.892762251742621,0.362352579314915,1,18,regulation of natural killer cell activation,BP,GAS6
1095,GO:0002684,0.892977514679362,0.133711622873173,63,611,positive regulation of immune system process,BP,TNIP1;PTPRS;FOS;CTNNBIP1;PGF;WIPF1;FAM210B;VEGFA;RBCK1;PRNP;NR1D1;ZFP36L1;EFNB3;TMEM173;VEGFB;PRKCZ;SERPING1;PAK1;ZP3;CCDC88B;RAG1;MUC19;EREG;PLA2G6;ERMAP;C5;NLRX1;STAT6;MAPK3;CTSB;C1RL;INPP5D;PDCD1LG2;FLOT1;AQP3;TGFBR2;TRPV4;PIK3R2;GAS6;PTAFR;TNFRSF14;AKT1;CARD11;HMSD;IGFBP2;RPS6KA5;BRAF;BTN3A2;LGALS1;JAK3;BTN3A3;BCL6;TKFC;FYN;ADA;MYO18A;VAV3;DHPS;ITGA2;EIF2AK4;PAG1;HLA-G;IKBKB
6440,GO:0021762,0.893049849243517,0.278769229682037,2,31,substantia nigra development,BP,GLUD1;SIRT2
3169,GO:0006783,0.89323464210135,0.361290844497922,1,18,heme biosynthetic process,BP,UROS
14882,GO:0070734,0.893276982018055,0.361195573090639,1,18,histone H3-K27 methylation,BP,PHF1
4086,GO:0009144,0.893552026305067,0.152019345581099,22,240,purine nucleoside triphosphate metabolic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;FAM20C;MYH3;MLXIPL;SDHA;GTPBP1;GALK1;NADK;ALDOC;TMSB4X;MOCOS;DGUOK;TCIRG1;INSR;TAZ;ADA;PFKL
6978,GO:0030663,0.89356098203079,0.36055606364474,1,18,COPI-coated vesicle membrane,CC,COPG1
8243,GO:0033032,0.89379517262037,0.360028104559898,1,18,regulation of myeloid cell apoptotic process,BP,THRA
8214,GO:0032986,0.893836738479898,0.359934340780373,1,18,protein-DNA complex disassembly,BP,SMARCD2
3241,GO:0006900,0.894006301124635,0.190485334985434,7,86,vesicle budding from membrane,BP,DNM1;TRAPPC9;AREG;TBC1D20;GOLGA2;MYO18A;SEC31B
3667,GO:0008168,0.894037362865434,0.15987851668769,16,175,methyltransferase activity,MF,GAMT;ASH2L;NSUN5P2;NSUN7;RRNAD1;FAM86C2P;PCMTD2;TFB1M;METTL23;DNMT3A;PEMT;PRDM8;MGMT;COMTD1;ASMTL;METTL7A
17505,GO:1901028,0.894045950040725,0.241633197806551,3,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TFDP2;BBC3;TP73
20149,GO:2001024,0.894505336388325,0.358423726081418,1,18,negative regulation of response to drug,BP,STK39
2959,GO:0006497,0.89468243064564,0.178582898416583,9,107,protein lipidation,BP,ZDHHC1;LY6K;PIGZ;WDR45;PIGQ;ZDHHC24;PIGV;MPPE1;NTM
10491,GO:0043412,0.894785510870327,0.117377652708025,365,3245,macromolecule modification,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;F2R;ST6GALNAC2;APOE;ZMYND8;GID4;FOS;EGR1;LMF1;PPP1R35;FBXO2;ZNF862;PTK6;TMEM129;CDC42EP5;EDEM1;RNF135;GJC2;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PADI3;RBCK1;DDB2;PRNP;ZDHHC1;FBLN1;ADAMTS7;DUSP5;NEK9;RAPGEF3;TNFSF15;SPTB;LOXL1;IGFBP4;FKBP9;CRTAP;CST3;NOS1;BRSK1;ERCC6;ADAMTS13;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;B3GAT3;HBEGF;RPS6KA2;CTF1;CNTN1;OBSL1;PLAT;ULK2;SLC27A1;MAPK13;RNF165;CDK18;PHACTR3;FBXW4;ASH2L;CUL7;LHPP;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;ALPK1;BTG1;SHC2;SYNGAP1;PHF21A;DGKQ;SNX9;MAGEF1;ULK1;SHC1;SPRY2;VEGFB;ADM2;HDAC11;RAB3B;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;PAK1;ABCA7;APOBEC3C;AARS;STK39;ERO1B;FGFR3;FBXO41;CEMIP;KDM3A;MTHFR;KLHL29;PHF1;NPR2;SPRY4;USP20;DLG3;FBXW8;NSUN5P2;NEIL1;NEURL1;ACVR2B;RAG1;SPEG;NGFR;ELFN2;MARCH4;ETFB;LCE1E;LTBP1;MUC19;TRIB2;EREG;PTPRE;RNF44;SSH3;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;PPM1J;LPAR3;FKBP10;MTMR4;C5;APOBEC3F;INO80C;CHD3;SESN2;BLMH;MKNK2;RASA4;IMPACT;PKD2;SATB1;ING4;RRNAD1;HMGA2;AREG;ST6GALNAC6;B4GAT1;MARCH9;JADE2;MAPK3;CSPG4;TRPT1;LAMB2;FBXO27;ERRFI1;MACROD1;DCAF10;PEX10;STK40;VANGL2;RGS14;MVD;FAM20C;TDRKH;CNTRL;ADAMTSL1;SNTA1;MXRA8;MAPK12;MYH3;SDC2;FBXO17;MLXIPL;PTPDC1;ARHGEF2;TSPYL2;MAP2K2;SRD5A3;LRSAM1;DMTN;KLHL24;KDM4C;PAK6;SSH1;PCMTD2;FBXO6;PKD1;NSMCE1;FLOT1;TTN;PSKH1;HLCS;JDP2;HDAC5;SORL1;TFB1M;IL17RD;HERPUD1;VLDLR;ST3GAL3;KDM7A;MAP3K12;NEK8;LRP5;PTPRU;WNK4;PCSK9;PKIB;PKN3;FBXL15;FBXL16;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;ITGA1;SMURF2;LMO7;TRIB3;RAB40B;HMG20B;CDK5RAP3;MINK1;PIGZ;PROM2;WNT7A;TTLL11;MARCH2;PIK3R2;EPHA1;RPUSD3;SHARPIN;GAS6;DNAJC6;ERN1;BCR;KLHDC8B;MAPRE3;MAN2C1;NBR1;TADA3;CAMK1;PPP1R15A;ADCY6;MBD1;ATP2B4;STRADB;CTSH;FBXL8;MGMT;LCE1F;HINT2;AKT1;IGFBP7;DGUOK;CDKN1C;MICAL1;CRY2;B4GALT2;LAMB1;CHEK2;WDR45;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;PIAS3;SPSB3;WDFY2;C9ORF72;UHRF2;ARSA;MAN2B1;MARK4;INSR;NCOA7;FOXO4;COG7;RPS6KA5;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;MAPK10;MPG;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;UBOX5;CHRM3;MIB2;MPI;JOSD2;PHC1;SCYL3;CSNK1E;BCL6;HSF4;RNF213;FBXO25;FYN;MAST4;PJA2;LEMD2;SIRT2;GDF15;RAB13;GOLGA2;MTA1;HDAC8;AVPI1;TGFBR3;MAN1B1;EPAS1;LAMTOR2;MAP3K10;MFNG;RNF170;DHPS;EPHB2;PER1;FGFR1;PIGV;WFS1;BLOC1S1;FKBP8;CTH;ERBB2;UST;EIF2AK4;STK32B;UNC119;SYVN1;FRS3;MPPE1;TRIM2;KCTD11;LYPLAL1;KCTD13;CAMKK1;DTX3;IKBKB;NTM
2287,GO:0005246,0.89480856051478,0.357737134357484,1,18,calcium channel regulator activity,MF,STX1A
17770,GO:1901888,0.895086620459649,0.20620005841451,5,64,regulation of cell junction assembly,BP,VEGFA;NPHP4;DMTN;FLOT1;IKBKB
11052,GO:0045070,0.895185978396926,0.27463645737067,2,31,positive regulation of viral genome replication,BP,ADARB1;TBC1D20
38,GO:0000077,0.895290545323739,0.164506383766393,13,146,DNA damage checkpoint,BP,XPC;BRSK1;RBL2;TFDP2;HMGA2;FBXO6;PCBP4;CDK5RAP3;CHEK2;FOXO4;PIDD1;TP73;EIF2AK4
8556,GO:0034035,0.895397577102363,0.356400742896575,1,18,purine ribonucleoside bisphosphate metabolic process,BP,ABHD14B
12456,GO:0050427,0.895397577102363,0.356400742896575,1,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,ABHD14B
1862,GO:0004529,0.895494153739474,0.356181286206225,1,18,exodeoxyribonuclease activity,MF,ISG20
5743,GO:0016895,0.895494153739474,0.356181286206225,1,18,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,ISG20
7238,GO:0031201,0.895512266750432,0.239028372205947,3,43,SNARE complex,CC,VAMP2;TSNARE1;STX1A
13884,GO:0060561,0.895787726386643,0.355513596416054,1,18,apoptotic process involved in morphogenesis,BP,LRP5
7585,GO:0031965,0.895847348589053,0.147137498661187,24,251,nuclear membrane,CC,EGFR;PRNP;SLC16A3;CST3;CLCA2;KLHDC2;ITPR3;PAK1;SYNE3;TMC6;STAT6;ERN1;TNRC18;TM7SF2;LMNA;C9ORF72;TBC1D20;IFI27;MYOF;CERS4;LEMD2;RETSAT;STX1A;CREB3L4
17287,GO:0140142,0.895887250473906,0.355287041791049,1,18,nucleocytoplasmic carrier activity,MF,TMCO6
7942,GO:0032550,0.896220571730849,0.144073275852234,27,281,purine ribonucleoside binding,MF,DNM1;PCK2;TUBG2;ARL2;RAB3B;NPR2;RHOBTB2;AGAP1;IFT27;SEPT5;RHOF;TUBE1;SEPT10;GTPBP1;RAB40B;ARL10;GLUD1;SUCLG2;RAB43;SEPT6;RAB25;INSR;GNAL;EHD3;RAB13;RHOBTB3;SEPT8
13035,GO:0051560,0.896258573513445,0.35444086867636,1,18,mitochondrial calcium ion homeostasis,BP,BNIP3
567,GO:0001709,0.896289364145551,0.354370638903888,1,18,cell fate determination,BP,WNT7A
16461,GO:0097178,0.896311781348143,0.272446467827128,2,31,ruffle assembly,BP,EPS8L1;EPS8L2
9228,GO:0035635,0.896447075027472,0.354010765389912,1,18,entry of bacterium into host cell,BP,EXOC2
4335,GO:0009891,0.89687410523528,0.120677064610344,143,1319,positive regulation of biosynthetic process,BP,TNIP1;F2R;APOE;NFATC4;FOS;CITED4;EGR1;TIMP2;VEGFA;NTSR1;EGFR;NR1D1;RAPGEF3;CST3;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;SMARCA1;TFDP2;ASH2L;ETV4;WWTR1;MAP2K1;MC1R;ITGA6;ZNF76;PBX2;MAML3;TMEM173;SHC1;SOX12;CIRBP;CAPRIN2;ELK3;PABPC1L;SEC14L2;KDM3A;PHF1;SALL2;ETV1;ZP3;ABHD14B;EAPP;NGFR;ETV5;EREG;TEF;PLA2G6;ABCG1;CARF;PPARA;SESN2;IMPACT;PKD2;STAT6;KLF7;HMGA2;AREG;MAPK3;THRA;IRF2BPL;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;ZNF516;PKD1;MDK;HDAC5;IRF5;DEAF1;PEG3;RFX2;KDM7A;CEBPB;LRP5;CREBRF;PKIB;METTL23;HLTF;CSRNP3;TMSB4X;APLN;CALCOCO1;PEMT;CDK5RAP3;NOS3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;MAPRE3;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;AKT1;CARD11;CDKN1C;CHEK2;ASS1;PHF2;FGFR4;INSR;NCOA7;FOXO4;RPS6KA5;MAP2K5;TP73;TFEB;TAZ;HSF4;SIRT2;GOLGA2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;PER1;ITGA2;FGFR1;ERBB2;EIF2AK4;HMBOX1;CREB3L4;KCTD13;DBP;ZNF287;IKBKB;TEAD2;SIX5
4553,GO:0010639,0.89689399159685,0.143230507224769,27,280,negative regulation of organelle organization,BP,ESPN;GSN;EVI5L;ERCC1;SPTB;ARAP1;ARPIN;CAPG;TOM1L2;EML2;TTBK2;KDM3A;PHF1;BNIP3;ARHGEF2;TWF2;DMTN;KDM4C;TRIOBP;TMSB4X;AKT1;PHF2;TMOD2;LMNA;HDAC8;CORO1B;PLEKHH2
13973,GO:0060713,0.896919291879044,0.352931692911632,1,18,labyrinthine layer morphogenesis,BP,ZFP36L1
1125,GO:0002714,0.89708533820211,0.352551706278641,1,18,positive regulation of B cell mediated immunity,BP,STAT6
1220,GO:0002891,0.89708533820211,0.352551706278641,1,18,positive regulation of immunoglobulin mediated immune response,BP,STAT6
17791,GO:1901976,0.897308315597937,0.270500997748799,2,31,regulation of cell cycle checkpoint,BP,NDRG1;CHEK2
13193,GO:0051879,0.897405833585735,0.270310266935993,2,31,Hsp90 protein binding,MF,ERN1;HDAC8
12884,GO:0051254,0.89740932467907,0.121558217714416,120,1115,positive regulation of RNA metabolic process,BP,TNIP1;F2R;NFATC4;FOS;CITED4;EGR1;VEGFA;EGFR;NR1D1;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;TFDP2;ASH2L;ETV4;WWTR1;MAP2K1;MC1R;ITGA6;ZNF76;PBX2;MAML3;TMEM173;SHC1;SOX12;CAPRIN2;ELK3;PABPC1L;SEC14L2;KDM3A;PHF1;SALL2;ETV1;ZP3;ABHD14B;EAPP;NGFR;ETV5;TEF;CARF;PPARA;SESN2;PKD2;STAT6;KLF7;HMGA2;MAPK3;THRA;IRF2BPL;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LITAF;ATF4;ZFPM1;ZNF516;PKD1;MDK;HDAC5;GTPBP1;IRF5;SRSF5;DEAF1;PEG3;RFX2;KDM7A;CEBPB;LRP5;CREBRF;METTL23;HLTF;CSRNP3;APLN;CALCOCO1;CDK5RAP3;HEXB;ZFP90;WNT7A;PIK3R2;ERN1;MAPRE3;TNNI2;TADA3;CAMK1;RXRA;AKT1;CDKN1C;CHEK2;PHF2;INSR;NCOA7;FOXO4;RPS6KA5;MAP2K5;TP73;TFEB;HSF4;ZC3H12D;SIRT2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;PER1;ERBB2;HMBOX1;CREB3L4;DBP;ZNF287;IKBKB;TEAD2;SIX5
7931,GO:0032528,0.897522686293921,0.351549486077558,1,18,microvillus organization,BP,TWF2
13067,GO:0051602,0.897590977549811,0.351392810353201,1,18,response to electrical stimulus,BP,S100A13
1698,GO:0004180,0.897731789417695,0.351069601536079,1,18,carboxypeptidase activity,MF,BLMH
16109,GO:0090140,0.897738378444623,0.351054472496267,1,18,regulation of mitochondrial fission,BP,BNIP3
6439,GO:0021761,0.897817349973817,0.201693699422652,5,65,limbic system development,BP,PTPRS;BBS2;MDK;ATP2B4;FGFR1
2564,GO:0005849,0.897819411292063,0.350868375990464,1,18,mRNA cleavage factor complex,CC,CPSF4
11344,GO:0045724,0.897867069163767,0.350758894799911,1,18,positive regulation of cilium assembly,BP,CROCC
3349,GO:0007080,0.898034949141851,0.234521648573442,3,43,mitotic metaphase plate congression,BP,CHMP1B;CHMP5;CHMP4C
671,GO:0001882,0.898436828949459,0.140513425857184,28,291,nucleoside binding,MF,DNM1;PCK2;TUBG2;ARL2;RAB3B;NPR2;RHOBTB2;AGAP1;IFT27;SEPT5;RHOF;TUBE1;SEPT10;GTPBP1;RAB40B;ARL10;GLUD1;SUCLG2;RAB43;SEPT6;RAB25;INSR;GNAL;EHD3;RAB13;ADA;RHOBTB3;SEPT8
13478,GO:0055072,0.898585885353113,0.200351006713751,5,66,iron ion homeostasis,BP,CYBRD1;STEAP2;STEAP3;HFE;EPAS1
9780,GO:0040014,0.898616972758515,0.233477263568712,3,43,regulation of multicellular organism growth,BP,GAMT;BBS2;GPR21
3096,GO:0006672,0.898776235660287,0.200141034172785,5,65,ceramide metabolic process,BP,PLA2G6;ST6GALNAC6;HEXB;CERS4;NAGA
15290,GO:0071514,0.898978312635363,0.348199320688999,1,18,genetic imprinting,BP,DNMT3A
17719,GO:1901682,0.899003147527579,0.348141968058025,1,18,sulfur compound transmembrane transporter activity,MF,SLC6A6
15887,GO:0072686,0.899132360093168,0.182698387868212,7,86,mitotic spindle,CC,CAPG;EML2;PKD2;TADA3;MAPKBP1;SIRT2;GOLGA2
15785,GO:0072509,0.899181283711909,0.347730395737387,1,18,divalent inorganic cation transmembrane transporter activity,MF,SLC39A11
7175,GO:0031069,0.899183777903016,0.347724630666758,1,18,hair follicle morphogenesis,BP,FOXQ1
2482,GO:0005721,0.899282222822626,0.347497032364094,1,18,pericentric heterochromatin,CC,KDM4C
5582,GO:0016605,0.899456364410055,0.182203541230744,7,86,PML body,CC,MKNK2;SATB1;RGS14;TENM2;ISG20;CHEK2;LRCH4
13855,GO:0060512,0.899497458133242,0.346999062133494,1,18,prostate gland morphogenesis,BP,RXRA
14923,GO:0070841,0.899605130361938,0.346749765051081,1,18,inclusion body assembly,BP,SORL1
15340,GO:0071604,0.899624608244763,0.34670465402065,1,18,transforming growth factor beta production,BP,LTBP3
12920,GO:0051303,0.899894634717071,0.198325731031145,5,65,establishment of chromosome localization,BP,CHMP1B;NDE1;CHMP5;CHMP4C;LEMD2
6068,GO:0019221,0.899923222405254,0.127826942142251,53,529,cytokine-mediated signaling pathway,BP,BBS2;TNFRSF6B;FOS;IL20RB;EGR1;PDCD4;VEGFA;RBCK1;TNFSF15;MST1R;MMP1;CTF1;SLC27A1;SHC1;LAMA5;SPPL2B;NGFR;EPOR;GSTO1;EREG;TNFRSF25;AIP;STAT6;SLIT3;ECM1;MAPK3;IFITM1;IFNGR2;INPP5D;IFI6;IRF5;IL17RD;CREBRF;ISG20;IL17RE;TMSB4X;EDA;SHARPIN;GAS6;PTAFR;TNFRSF14;AKT1;IL17RC;IFI27;RPS6KA5;EDA2R;TIMP1;JAK3;BCL6;FYN;STX1A;HLA-G;IKBKB
19713,GO:2000114,0.899939027036031,0.345975893707983,1,18,regulation of establishment of cell polarity,BP,GSN
9422,GO:0036010,0.899999732728684,0.345835067831643,1,18,protein localization to endosome,BP,SORL1
8998,GO:0035176,0.900154145851654,0.264908800253621,2,31,social behavior,BP,DLG4;SHANK2
13113,GO:0051703,0.900154145851654,0.264908800253621,2,31,intraspecies interaction between organisms,BP,DLG4;SHANK2
13023,GO:0051537,0.900974372087037,0.342727432906553,1,19,2 iron, 2 sulfur cluster binding,MF,XDH
1344,GO:0003209,0.901006984284097,0.343492634752437,1,18,cardiac atrium morphogenesis,BP,ZFPM1
3089,GO:0006665,0.901323408062938,0.161582718886459,11,127,sphingolipid metabolic process,BP,PLA2G6;ESYT2;ST6GALNAC6;PEMT;HEXB;HEXA;ARSA;CERS4;NAGA;ESYT3;KDSR
10204,GO:0042886,0.901331519298913,0.114562298597337,166,1535,amide transport,BP,BBS2;F2R;APOE;SYTL1;LMF1;POSTN;EVI5L;TMEM129;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;ZDHHC1;NR1D1;HADH;ANK3;RAPGEF3;CLTCL1;IDH2;TBC1D8;ARRDC1;B3GAT3;EXOC2;RPL13A;BBS1;LTBP4;REEP2;ATG16L2;SYNGR1;PCK2;TOM1L2;PITPNM1;TMEM173;SNX9;ARL2;VPS11;RAB3B;NLGN2;ITPR3;PRKCZ;PAK1;CEMIP;MICALL2;ACVR2B;NGFR;OLFM2;TMED4;PLA2G6;ABCG1;XPOT;RINL;S100A13;AGAP1;C5;KIF17;ANO1;AIP;IFT27;SH3TC2;VAMP2;AP1G2;PCLO;MAPK3;PEX10;LTBP2;HOOK2;EIF2D;MVB12B;CHMP1B;TBC1D14;ARHGEF2;PRAF2;LRSAM1;DMTN;TBC1D3E;RABGAP1;PKD1;TTN;TSNARE1;SORL1;HERPUD1;PLTP;SRSF5;VLDLR;NLRP1;RHBDF1;LRP5;AQP3;CEP131;LONP2;TRPV4;TMSB4X;PDE2A;APLN;RAB40B;PEMT;TRPV1;BNIP3L;PIK3R2;RHBDF2;GAS6;VPS39;GLUD1;BCR;KIF13B;NECAB3;CAMK1;RAB43;STRADB;MAPKBP1;AKT1;ITPR2;CARD11;TSG101;IL17RC;RASSF9;TCIRG1;STEAP3;COPG1;SGSM2;CHMP5;ICA1;RAB25;IFI27;COG7;CHMP4C;ITGB6;LYST;ZDHHC24;ARHGAP44;CPSF4;BTN3A2;UNC119B;HFE;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;BCL6;EHD3;FYN;SNX1;PEX1;RAB13;TOM1;POU2F2;RTN2;AP2A2;CIDEA;MYO18A;RPL29;STX1A;TBC1D16;TMCO6;ERBB2;SEC31B;UNC119;SYVN1;OSCP1;PFKL;RPL12;APBA1;HIP1
13087,GO:0051647,0.901388748756725,0.342601942441466,1,18,nucleus localization,BP,PABPC1L
2963,GO:0006501,0.901430768695689,0.262044836719574,2,32,C-terminal protein lipidation,BP,LY6K;NTM
18512,GO:1903747,0.902084439493217,0.172374432692673,8,98,regulation of establishment of protein localization to mitochondrion,BP,TFDP2;VPS11;MICALL2;BBC3;PEMT;BNIP3L;TP73;OSCP1
8146,GO:0032886,0.902183590095491,0.150694558938388,15,166,regulation of microtubule-based process,BP,BBS2;EML2;ARL2;TTBK2;PAK1;CEP250;CHMP1B;ARHGEF2;STMN3;PKD1;CEP131;TRPV4;CHMP5;CHMP4C;ERBB2
6737,GO:0030163,0.902527488326262,0.120102711199997,77,741,protein catabolic process,BP,APOE;BTBD2;SERPINE2;GID4;FBXO2;TMEM129;EDEM1;LRP1;TIMP2;EGFR;RBCK1;NR1D1;ADAMTS7;CST3;DDIT3;ABTB1;ARRDC1;CUL9;CTSF;RNF165;FBXW4;CUL7;WWTR1;SNX9;MAGEF1;VPS11;USP20;TRIB2;RNF44;BNIP3;CTSB;MVB12B;LRSAM1;UBXN4;FBXO6;PKD1;AZIN2;SORL1;HERPUD1;VLDLR;RHBDF1;ATRAID;PCSK9;FBXL15;LONP2;SMURF2;TRIB3;CDK5RAP3;BNIP3L;SHARPIN;CTSH;AKT1;CHEK2;TSG101;TCIRG1;SPSB3;CAPN2;SPATA18;ANKZF1;CHMP4C;TIMP1;HFE;SNX33;CSNK1E;RNF213;FYN;SNX1;UBXN6;SIRT2;MTA1;AP2A2;MAN1B1;WFS1;SYVN1;LYPLAL1;KCTD13;BTBD11
7737,GO:0032259,0.902653392193271,0.135899330733963,27,282,methylation,BP,GAMT;FOS;ASH2L;BTG1;RAB3B;KDM3A;MTHFR;PHF1;NSUN5P2;NSUN7;ETFB;GSTO1;SATB1;RRNAD1;TDRKH;FAM86C2P;KDM4C;PCMTD2;TFB1M;METTL23;DNMT3A;PEMT;PRDM8;MGMT;COMTD1;ASMTL;METTL7A
4503,GO:0010558,0.902690482293552,0.115291334399995,124,1162,negative regulation of macromolecule biosynthetic process,BP,ZC3H6;ZMYND8;NFATC4;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;EGFR;NR1D1;PRDX5;BAHCC1;DDIT3;DNAJB5;ZFP36L1;TCFL5;HBEGF;TFDP2;MXI1;RPL13A;MDFI;WWTR1;MAP2K1;MXD4;H2AFJ;PHF21A;SHC1;GRB7;UNK;CIRBP;CAPRIN2;ABCA7;ELK3;FOXQ1;SALL2;ZP3;ACVR2B;EAPP;TRIB2;HES2;EREG;NAB2;PPARA;SESN2;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;ERRFI1;THRA;IRF2BPL;PBXIP1;MLXIPL;INPP5D;TSPYL2;MAP2K2;ATF4;ZFPM1;TENM2;CBX7;JDP2;HDAC5;VLDLR;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;AGO4;ZFP90;TRPV1;GAS6;RXRA;MBD1;TNRC18;PAIP2B;CDKN1C;CRY2;CHEK2;TSG101;PHF2;IGF2BP2;ZNF217;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;JAK3;TP73;MTA3;MNT;BCL6;HSF4;ZC3H12D;SIRT2;RECQL5;RCOR2;MTA1;HDAC8;PAIP2;EIF4EBP1;TCF7;MAP3K10;PER1;IGF2BP3;FGFR1;WFS1;EIF2AK4;HMBOX1;TSHZ1;ACOT8;SIX5
200,GO:0000422,0.903018739478232,0.183781846487311,6,77,autophagy of mitochondrion,BP,BNIP3;MAP1LC3A;BNIP3L;WDR45;ATG2A;SPATA18
14398,GO:0061726,0.903018739478232,0.183781846487311,6,77,mitochondrion disassembly,BP,BNIP3;MAP1LC3A;BNIP3L;WDR45;ATG2A;SPATA18
2266,GO:0005198,0.903068376281117,0.124582268318681,51,516,structural molecule activity,MF,APOE;MARVELD1;WWC3;OBSCN;FBLN1;ANK3;TFPI2;CLTCL1;SPTB;KRT15;SHANK2;RPL13A;OBSL1;PPL;TUBG2;NPHP4;MYH11;TPM2;GRIP2;LCE1E;SYNC;MALL;SEPT5;LAMB2;RGS14;SNTA1;TUBE1;SEPT10;TTN;COL4A6;CROCC;SLC9A3R2;EFEMP2;LCE1F;LAMB1;SEPT6;LMNA;COPG1;KRT19;ADD3;HOMER2;TUBGCP6;RPL39L;RPL29;LAMTOR2;MAGI1;SEPT8;SEC31B;PLLP;RPL12;HIP1
2813,GO:0006278,0.903379077205309,0.192542971816707,5,66,RNA-dependent DNA biosynthetic process,BP,MAPK3;TEP1;PKIB;TERC;HMBOX1
7898,GO:0032480,0.904086834978639,0.223383145189282,3,44,negative regulation of type I interferon production,BP,PTPRS;RNF135;NLRX1
5744,GO:0016896,0.904096453457624,0.256735423789423,2,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,PAN2;ISG20
18323,GO:1903321,0.904303000786139,0.190934660821909,5,67,negative regulation of protein modification by small protein conjugation or removal,BP,HMG20B;AKT1;PIAS3;FYN;HDAC8
19464,GO:1990266,0.904325962091992,0.222763781562168,3,45,neutrophil migration,BP,ITGA1;CKLF;VAV3
1341,GO:0003206,0.904558875561179,0.181415943262353,6,76,cardiac chamber morphogenesis,BP,VANGL2;ZFPM1;TGFBR2;RXRA;TGFBR3;TNNI1
18225,GO:1903076,0.904587191917621,0.190561001584949,5,66,regulation of protein localization to plasma membrane,BP,LRP1;EGFR;PRNP;AKT1;EPHB2
12918,GO:0051301,0.905123759541453,0.122150136685353,51,505,cell division,BP,CCNG2;PGF;VEGFA;ANK3;NEK9;RAB11FIP4;CUL7;WWTR1;SNX9;VEGFB;PAK1;ETV5;EREG;RHOBTB2;SPC24;HMGA2;SEPT5;VANGL2;RGS14;RHOF;CNTRL;CHMP1B;ARHGEF2;SEPT10;PAK6;MDK;NDE1;TRIOBP;WNT7A;LZTS2;KLHDC8B;MAPRE3;REEP4;CHEK2;SEPT6;TSG101;CHMP5;MARK4;CHMP4C;CAT;HAUS4;SNX33;SPIRE1;SIRT2;RECQL5;GOLGA2;SEPT8;FGFR1;UNC119;TTC19;ZNF449
3325,GO:0007035,0.905376730737257,0.332364225932129,1,19,vacuolar acidification,BP,TCIRG1
18555,GO:1903828,0.90573882055722,0.179467219818907,6,77,negative regulation of cellular protein localization,BP,TTBK2;DMTN;PDE2A;GAS6;LZTS2;SNX33
5276,GO:0015932,0.906141330332381,0.252628528827922,2,32,nucleobase-containing compound transmembrane transporter activity,MF,SLC29A4;SLC25A42
9684,GO:0038095,0.906388807640082,0.161269498565005,9,110,Fc-epsilon receptor signaling pathway,BP,FOS;SHC1;PAK1;MAPK3;PIK3R2;CARD11;MAPK10;VAV3;IKBKB
9071,GO:0035337,0.90641541822346,0.252075774685674,2,32,fatty-acyl-CoA metabolic process,BP,ACOT7;CBR4
17824,GO:1902041,0.906545485668435,0.218881589795728,3,44,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,ARHGEF2;NOS3;PIDD1
12411,GO:0050000,0.907034496968113,0.1865283846238,5,66,chromosome localization,BP,CHMP1B;NDE1;CHMP5;CHMP4C;LEMD2
15937,GO:0080008,0.90720919989516,0.250471877323653,2,32,Cul4-RING E3 ubiquitin ligase complex,CC,DDB2;DCAF10
5221,GO:0015833,0.907290161655268,0.107990746239655,164,1521,peptide transport,BP,BBS2;F2R;APOE;SYTL1;LMF1;POSTN;EVI5L;TMEM129;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;ZDHHC1;NR1D1;HADH;ANK3;RAPGEF3;CLTCL1;IDH2;TBC1D8;ARRDC1;B3GAT3;EXOC2;RPL13A;BBS1;LTBP4;REEP2;ATG16L2;SYNGR1;PCK2;TOM1L2;PITPNM1;TMEM173;SNX9;ARL2;VPS11;RAB3B;NLGN2;ITPR3;PRKCZ;PAK1;CEMIP;MICALL2;ACVR2B;NGFR;OLFM2;TMED4;PLA2G6;ABCG1;XPOT;RINL;S100A13;AGAP1;C5;KIF17;ANO1;AIP;IFT27;SH3TC2;VAMP2;AP1G2;PCLO;MAPK3;PEX10;LTBP2;HOOK2;EIF2D;MVB12B;CHMP1B;TBC1D14;ARHGEF2;PRAF2;LRSAM1;DMTN;TBC1D3E;RABGAP1;PKD1;TTN;TSNARE1;SORL1;HERPUD1;SRSF5;VLDLR;NLRP1;RHBDF1;LRP5;CEP131;LONP2;TRPV4;TMSB4X;PDE2A;APLN;RAB40B;PEMT;TRPV1;BNIP3L;PIK3R2;RHBDF2;GAS6;VPS39;GLUD1;BCR;KIF13B;NECAB3;CAMK1;RAB43;STRADB;MAPKBP1;AKT1;ITPR2;CARD11;TSG101;IL17RC;RASSF9;TCIRG1;STEAP3;COPG1;SGSM2;CHMP5;ICA1;RAB25;IFI27;COG7;CHMP4C;ITGB6;LYST;ZDHHC24;ARHGAP44;CPSF4;BTN3A2;UNC119B;HFE;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;BCL6;EHD3;FYN;SNX1;PEX1;RAB13;TOM1;POU2F2;RTN2;AP2A2;CIDEA;MYO18A;RPL29;STX1A;TBC1D16;TMCO6;ERBB2;SEC31B;UNC119;SYVN1;OSCP1;PFKL;RPL12;APBA1;HIP1
1156,GO:0002764,0.907321433089644,0.125703940190086,34,349,immune response-regulating signaling pathway,BP,TNIP1;PTPRS;FOS;IL20RB;WIPF1;RBCK1;PRNP;FCGRT;NR1D1;SHC1;PAK1;MUC19;PLA2G6;ERMAP;NLRX1;MAPK3;CTSB;INPP5D;FLOT1;PIK3R2;CTSH;CARD11;RPS6KA5;BRAF;BTN3A2;MAPK10;BTN3A3;TKFC;FYN;ADA;VAV3;PAG1;HLA-G;IKBKB
8586,GO:0034105,0.907341366618689,0.32766910946879,1,19,positive regulation of tissue remodeling,BP,EGFR
4447,GO:0010389,0.907343788944717,0.14179892740192,16,180,regulation of G2/M transition of mitotic cell cycle,BP,FHL1;NINL;BRSK1;SDCCAG8;CEP250;HMGA2;CNTRL;NDE1;CEP131;CDK5RAP3;FOXO4;CHMP4C;HAUS4;MTA3;CSNK1E;SFI1
18276,GO:1903214,0.907366072653137,0.185888381663059,5,67,regulation of protein targeting to mitochondrion,BP,VPS11;MICALL2;PEMT;BNIP3L;OSCP1
16467,GO:0097191,0.907594512342798,0.143213002498989,15,169,extrinsic apoptotic signaling pathway,BP,RBCK1;ITGA6;FGFR3;MKNK2;ARHGEF2;IFI6;UNC5B;NOS3;STRADB;AKT1;LMNA;MAP2K5;PIDD1;FYN;FGFR1
2556,GO:0005834,0.907647070711003,0.326934533007394,1,19,heterotrimeric G-protein complex,CC,GNAL
19201,GO:1905360,0.907647070711003,0.326934533007394,1,19,GTPase complex,CC,GNAL
10849,GO:0044389,0.907719134362195,0.129411387585973,27,284,ubiquitin-like protein ligase binding,MF,BTBD2;EGFR;ABTB1;ARRDC1;CUL9;CUL7;MC1R;TMEM173;SNX9;CBS;DLG3;NGFR;TRIB2;SLC22A18;CEBPB;HLTF;TRIOBP;MAP1LC3A;TRIB3;CDK5RAP3;TNFRSF14;CHEK2;TSG101;UBOX5;PER1;WFS1;BTBD11
5469,GO:0016407,0.907759058123826,0.169293462650577,7,88,acetyltransferase activity,MF,CRAT;NAGS;LPCAT4;NAT14;TADA3;HGSNAT;SAT2
2953,GO:0006487,0.907824563672313,0.176070280866795,6,78,protein N-linked glycosylation,BP,ST6GALNAC2;ST6GALNAC6;MVD;SRD5A3;ST3GAL3;SYVN1
1457,GO:0003705,0.907839027078524,0.197725623550589,4,55,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,MEF2D;CEBPB;BHLHE40;TEAD2
14289,GO:0061462,0.908055982781555,0.248755813929347,2,32,protein localization to lysosome,BP,SORL1;C12ORF66
16242,GO:0090329,0.908078856573046,0.216057163966106,3,44,regulation of DNA-dependent DNA replication,BP,CHEK2;BCL6;FGFR1
12108,GO:0048207,0.908128668112486,0.197099241671156,4,56,vesicle targeting, rough ER to cis-Golgi,BP,TRAPPC9;AREG;TBC1D20;GOLGA2
12109,GO:0048208,0.908128668112486,0.197099241671156,4,56,COPII vesicle coating,BP,TRAPPC9;AREG;TBC1D20;GOLGA2
14488,GO:0065007,0.90830024287661,0.101812782588,912,7902,biological regulation,BP,TNIP1;XDH;DUSP6;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;NT5E;TNFRSF6B;APOE;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;KCNG1;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;IL20RB;GSN;ADGRL1;CITED4;CCNG2;EGR1;CTNNBIP1;LMF1;PGF;ALDH7A1;FGFBP1;TYSND1;POSTN;PPP1R35;EVI5L;WIPF1;FBXO2;DDIT4L;ZNF862;PTK6;CDC42EP5;ACP5;WWC3;EDEM1;RNF135;GLUL;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;ZSCAN18;RBCK1;DDB2;RHPN1;PRNP;FCGRT;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;IFT140;RAPGEF3;CLTCL1;TNFSF15;ZKSCAN1;SPTB;DGKA;TSPAN1;IGFBP4;CD9;NINL;SNPH;IDH2;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;CGREF1;CRTC1;SCN4B;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;TBC1D8;ABTB1;ARHGEF19;TCEA2;MMP28;GRAMD4;SMARCA1;MST1R;ARRDC1;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;RPS6KA2;ARHGAP23;GAA;PYGL;MMP1;CTF1;CNTN1;EXOC2;TFDP2;MXI1;HSD17B14;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;EVC;BBS1;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;ASH2L;SOX13;CUL7;EPM2A;HYAL1;NXPH4;SMOC2;ARPIN;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;SMOC1;POLD4;GIGYF1;MAP2K1;CYP27B1;PCK2;MXD4;CCDC71L;SDCCAG8;ABCA2;PKN1;MC1R;CAPG;DDIT4;H2AFJ;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;PBX2;EML2;MAML3;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;THAP8;MAGEF1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;ADM2;MARCKSL1;SOX12;HDAC11;RAB3B;NLGN2;PCSK1;PLEKHH3;SLC12A7;CYBRD1;ITPR3;LAMA5;RALGDS;PITPNC1;UNK;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;TTBK2;PRKCZ;PPP2R3B;HTR7;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;MCTP1;ELK3;STK39;PABPC1L;ERO1B;PEAR1;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;PHF1;GLDC;NPR2;SEMA3F;PLXNB3;SPRY4;FAM3A;USP20;SALL2;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;MICALL2;SLCO4A1;NME4;CEP250;FBXW8;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;EPOR;NID1;ETV5;GSTO1;ARHGEF4;LTBP1;MUC19;MALL;WNT2B;NSMCE4A;TRIB2;HES2;PLXNB1;EREG;CHD2;TEF;APBB3;PTPRE;PNPLA3;SSH3;RMI2;OLFM2;PLCD3;PLEKHG2;DHRS4;RHOBTB2;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;TRAPPC9;RINL;CARF;ERMAP;MANF;LPAR3;S100A13;AGAP1;ALS2CL;MTMR4;C5;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;ANO1;STON1;CHAC1;FNDC4;SESN2;AIP;MKNK2;RASA4;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;SH3TC2;ING4;ACOT11;VAMP2;HMGA2;AREG;COL8A1;SLIT3;SEPT5;ECM1;PCLO;KCNC4;PI4KAP1;ACACB;KCNAB2;MAPK3;CSPG4;TRPT1;ITGB5;PC;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;CCNI;STK40;VANGL2;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;FAM20C;MYZAP;TDRKH;PBXIP1;RHOF;PLEK2;CNTRL;LTBP2;SNTA1;PAN2;CTSB;ZSCAN30;SLITRK6;MAPK12;MVB12B;NYAP1;NAT14;SRGAP3;ZXDC;PAQR6;PQLC2;SDC2;CHMP1B;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TBC1D14;TCTN1;C1RL;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;SRD5A3;TWF2;SAMD3;STMN3;SLC50A1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;ATF4;PROCR;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;DOCK11;SSH1;LTB4R2;SV2A;TBC1D3E;METRN;RABGAP1;GPR153;ACAP3;TENM2;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;NSMCE1;RALGAPA1;FLOT1;LTBP3;MDK;TTN;PSKH1;KCNMA1;AZIN2;HSD11B1;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;TPBG;PAPLN;ADGRF1;GPRC5C;GABBR1;DEAF1;TEP1;SULF2;ROBO3;TMEM175;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;RIN2;ATRAID;NDE1;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;CEP131;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;CSRNP3;MN1;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;ANO9;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;SEMA4G;ZNF662;SHARPIN;CCS;FMNL2;GAS6;GLUD1;DNAJC6;ERN1;NUDT6;LZTS2;ECM2;ALKBH7;CROCC;PLEKHG3;BCR;MAPRE3;ATP7B;FYCO1;NBR1;TNNI2;BCAM;TADA3;BOLA1;KIF13B;NECAB3;CAMK1;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;THNSL2;PRDM8;STRADB;CTSH;TNFRSF14;WDR19;ACOX3;PNRC1;UACA;MGMT;ASNS;C12ORF66;TM7SF2;PLEKHG6;TP53I11;PAIP2B;STEAP2;HINT2;MAPKBP1;AKT1;IGFBP7;ITPR2;CARD11;DGUOK;CDKN1C;MICAL1;CRY2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;IFT57;SBF2;IGFBP2;ASS1;SPDYE2;SPDYE2B;CAPS;TNNT1;TSG101;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;RASSF9;SLC6A9;ZNF217;TMOD2;PIAS3;TCIRG1;ASAP3;STEAP3;ACADVL;ZNF25;FARP1;DNASE2;LMNA;SH2B3;MAB21L2;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;CAPN2;SMARCD2;ICA1;MARK4;ARHGAP27;RAB25;IFI27;PTOV1;PLAU;INSR;WNT3;KRT19;NCOA7;NELFCD;TENM4;CKLF;FOXO4;GNAL;COG7;YPEL3;RPS6KA5;CHMP4C;PNPLA4;LTB4R;TPCN1;ULBP1;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;ZNF554;CPSF4;LETMD1;BTN3A2;ASIC1;HOXC5;PLB1;PIDD1;CAT;ZNF160;MYOF;HAUS4;MAPK10;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;MRGPRX3;TP73;MTA3;SCNN1A;MNT;FRAT1;SNX33;CHRM3;ZNF846;APRT;FCHSD1;TMX4;TFEB;MIB2;SNX17;LSM14B;PHC1;ICAM5;ATP12A;SPIRE1;CSNK1E;TAZ;BTN3A3;BCL6;REPS2;HSF4;RNF213;SLC9A7;ADAP1;TKFC;EPS8L1;EHD3;FYN;MAST4;ZC3H12D;ATP8B2;PJA2;SNX1;LEMD2;ARHGEF17;SIRT2;TRPC1;GDF15;SPRED3;PHLDA2;RECQL5;RAB13;GOLGA2;CELSR1;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;RHOBTB3;MTA1;RTN2;TMEM101;ENTPD2;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;RETSAT;TGFBR3;CIDEB;TCF7;RNPEP;VAV3;STX1A;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;LURAP1;DHPS;EPHB2;MAGI1;INPP4A;PER1;LRCH4;MCTP2;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FITM2;FKBP8;SH3PXD2A;CTH;ERBB2;UST;EIF2AK4;STK32B;UNC119;PAG1;RGS12;SYVN1;OSCP1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;MMP17;RPL12;HMBOX1;NET1;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;KCTD13;DBP;APBA1;PEX11A;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;DTD1;IKBKB;DMTF1;SNCB;HIP1;PLEKHH2;ROBO4;TEAD2;ACOT8;BTBD11;SLC9A5;SIX5
3351,GO:0007088,0.908563548362772,0.148369391515264,12,139,regulation of mitotic nuclear division,BP,CUL9;OBSL1;CUL7;TOM1L2;EREG;CHMP1B;LRP5;L3MBTL1;CHMP5;INSR;CHMP4C;SIRT2
14523,GO:0070064,0.908648489448032,0.324520585295349,1,19,proline-rich region binding,MF,RABAC1
4779,GO:0010971,0.908662463360618,0.324486817578608,1,19,positive regulation of G2/M transition of mitotic cell cycle,BP,MTA3
127,GO:0000266,0.908692644834694,0.247462098079834,2,32,mitochondrial fission,BP,DNM1;BNIP3
19757,GO:2000209,0.908863533246311,0.324000680856961,1,19,regulation of anoikis,BP,CHEK2
8061,GO:0032743,0.908971263852741,0.323740018920819,1,19,positive regulation of interleukin-2 production,BP,CARD11
14767,GO:0070507,0.909184293325219,0.145094119945814,13,148,regulation of microtubule cytoskeleton organization,BP,EML2;ARL2;TTBK2;PAK1;CEP250;CHMP1B;ARHGEF2;STMN3;PKD1;CEP131;TRPV4;CHMP5;CHMP4C
9070,GO:0035336,0.909261014949237,0.323038264308159,1,19,long-chain fatty-acyl-CoA metabolic process,BP,ACOT7
603,GO:0001772,0.909282947418952,0.322985105088602,1,19,immunological synapse,CC,CARD11
11436,GO:0045911,0.909436416194639,0.322612972624666,1,19,positive regulation of DNA recombination,BP,STAT6
12585,GO:0050789,0.909442737426181,0.100388320922464,865,7509,regulation of biological process,BP,TNIP1;XDH;DUSP6;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;NT5E;TNFRSF6B;APOE;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;KCNG1;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;IL20RB;GSN;ADGRL1;CITED4;CCNG2;EGR1;CTNNBIP1;LMF1;PGF;FGFBP1;TYSND1;POSTN;PPP1R35;EVI5L;WIPF1;FBXO2;DDIT4L;ZNF862;PTK6;CDC42EP5;ACP5;WWC3;EDEM1;RNF135;GLUL;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;ZSCAN18;RBCK1;DDB2;RHPN1;PRNP;FCGRT;SCN8A;NR1D1;ERCC1;FBLN1;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;IFT140;RAPGEF3;CLTCL1;TNFSF15;ZKSCAN1;SPTB;DGKA;TSPAN1;IGFBP4;CD9;NINL;IDH2;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;CGREF1;CRTC1;SCN4B;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;TBC1D8;ABTB1;ARHGEF19;TCEA2;MMP28;GRAMD4;SMARCA1;MST1R;ARRDC1;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;RPS6KA2;ARHGAP23;GAA;MMP1;CTF1;CNTN1;EXOC2;TFDP2;MXI1;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;EVC;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;ASH2L;SOX13;CUL7;EPM2A;HYAL1;NXPH4;SMOC2;ARPIN;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;SMOC1;GIGYF1;MAP2K1;CYP27B1;PCK2;MXD4;CCDC71L;SDCCAG8;ABCA2;PKN1;MC1R;CAPG;DDIT4;H2AFJ;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;PBX2;EML2;MAML3;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;THAP8;MAGEF1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;VEGFB;ADM2;MARCKSL1;SOX12;HDAC11;RAB3B;NLGN2;PLEKHH3;ITPR3;LAMA5;RALGDS;PITPNC1;UNK;APPL2;PRSS8;CIRBP;CAPRIN2;TTBK2;PRKCZ;PPP2R3B;HTR7;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;MCTP1;ELK3;STK39;PABPC1L;ERO1B;PEAR1;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;PHF1;NPR2;SEMA3F;PLXNB3;SPRY4;FAM3A;USP20;SALL2;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;MICALL2;NME4;CEP250;FBXW8;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;EPOR;NID1;ETV5;GSTO1;ARHGEF4;LTBP1;MUC19;WNT2B;NSMCE4A;TRIB2;HES2;PLXNB1;EREG;CHD2;TEF;APBB3;PTPRE;SSH3;RMI2;OLFM2;PLCD3;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;TRAPPC9;CARF;ERMAP;MANF;LPAR3;S100A13;AGAP1;MTMR4;C5;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;ANO1;STON1;CHAC1;FNDC4;SESN2;AIP;MKNK2;RASA4;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;SH3TC2;ING4;ACOT11;VAMP2;HMGA2;AREG;COL8A1;SLIT3;SEPT5;ECM1;PCLO;KCNC4;PI4KAP1;ACACB;KCNAB2;MAPK3;CSPG4;TRPT1;ITGB5;PC;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;CCNI;STK40;VANGL2;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;FAM20C;MYZAP;TDRKH;PBXIP1;RHOF;PLEK2;CNTRL;LTBP2;SNTA1;PAN2;CTSB;ZSCAN30;SLITRK6;MAPK12;MVB12B;NYAP1;NAT14;SRGAP3;ZXDC;PAQR6;SDC2;CHMP1B;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TBC1D14;TCTN1;C1RL;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;TWF2;SAMD3;STMN3;SLC50A1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;ATF4;PROCR;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;DOCK11;SSH1;LTB4R2;SV2A;TBC1D3E;METRN;RABGAP1;GPR153;ACAP3;TENM2;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;NSMCE1;RALGAPA1;FLOT1;LTBP3;MDK;TTN;PSKH1;KCNMA1;AZIN2;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;TPBG;PAPLN;ADGRF1;GPRC5C;GABBR1;DEAF1;SULF2;ROBO3;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;RIN2;ATRAID;NDE1;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;CEP131;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;CSRNP3;MN1;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;ANO9;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;SEMA4G;ZNF662;SHARPIN;CCS;FMNL2;GAS6;GLUD1;DNAJC6;ERN1;NUDT6;LZTS2;ECM2;ALKBH7;CROCC;PLEKHG3;BCR;MAPRE3;FYCO1;NBR1;TNNI2;BCAM;TADA3;BOLA1;KIF13B;NECAB3;CAMK1;TERC;PTAFR;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;THNSL2;PRDM8;STRADB;CTSH;TNFRSF14;WDR19;PNRC1;UACA;MGMT;ASNS;C12ORF66;TM7SF2;PLEKHG6;TP53I11;PAIP2B;HINT2;MAPKBP1;AKT1;IGFBP7;ITPR2;CARD11;DGUOK;CDKN1C;MICAL1;CRY2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;IFT57;IGFBP2;ASS1;SPDYE2;SPDYE2B;CAPS;TNNT1;TSG101;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;RASSF9;SLC6A9;ZNF217;TMOD2;PIAS3;TCIRG1;ASAP3;STEAP3;ACADVL;ZNF25;FARP1;LMNA;SH2B3;MAB21L2;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;CAPN2;SMARCD2;ICA1;MARK4;ARHGAP27;RAB25;IFI27;PTOV1;PLAU;INSR;WNT3;KRT19;NCOA7;NELFCD;TENM4;CKLF;FOXO4;GNAL;YPEL3;RPS6KA5;CHMP4C;LTB4R;TPCN1;ULBP1;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;ZNF554;CPSF4;BTN3A2;ASIC1;HOXC5;PLB1;PIDD1;CAT;ZNF160;MYOF;HAUS4;MAPK10;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;MRGPRX3;TP73;MTA3;MNT;FRAT1;SNX33;CHRM3;ZNF846;FCHSD1;TMX4;TFEB;MIB2;SNX17;LSM14B;PHC1;ICAM5;SPIRE1;CSNK1E;TAZ;BTN3A3;BCL6;REPS2;HSF4;RNF213;ADAP1;TKFC;EPS8L1;EHD3;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;ARHGEF17;SIRT2;TRPC1;GDF15;SPRED3;PHLDA2;RECQL5;RAB13;GOLGA2;CELSR1;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;RHOBTB3;MTA1;RTN2;TMEM101;ENTPD2;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;STX1A;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;LURAP1;DHPS;EPHB2;MAGI1;INPP4A;PER1;LRCH4;MCTP2;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FITM2;FKBP8;CTH;ERBB2;UST;EIF2AK4;STK32B;UNC119;PAG1;RGS12;SYVN1;OSCP1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;RPL12;HMBOX1;NET1;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;KCTD13;DBP;APBA1;PEX11A;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;IKBKB;DMTF1;SNCB;HIP1;PLEKHH2;ROBO4;TEAD2;ACOT8;BTBD11;SIX5
20147,GO:2001022,0.909845404361639,0.181776066543156,5,67,positive regulation of response to DNA damage stimulus,BP,EGFR;NSMCE4A;HMGA2;NSMCE1;MGMT
3363,GO:0007127,0.909944565497451,0.18161106864544,5,67,meiosis I,BP,MLH3;AGO4;REC8;LEMD2;MSH5
762,GO:0002011,0.910170745454098,0.212182502881585,3,44,morphogenesis of an epithelial sheet,BP,HBEGF;VANGL2;WNT7A
445,GO:0001205,0.910273603066688,0.320578014013219,1,19,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,MEF2D
78,GO:0000159,0.910667458407837,0.31961776203092,1,19,protein phosphatase type 2A complex,CC,PPP2R3B
17280,GO:0140103,0.910755070355087,0.319403902893037,1,19,catalytic activity, acting on a glycoprotein,MF,B4GALNT4
7941,GO:0032549,0.910834199251015,0.12540553426341,27,285,ribonucleoside binding,MF,DNM1;PCK2;TUBG2;ARL2;RAB3B;NPR2;RHOBTB2;AGAP1;IFT27;SEPT5;RHOF;TUBE1;SEPT10;GTPBP1;RAB40B;ARL10;GLUD1;SUCLG2;RAB43;SEPT6;RAB25;INSR;GNAL;EHD3;RAB13;RHOBTB3;SEPT8
5386,GO:0016226,0.911352065091572,0.31720034907161,1,20,iron-sulfur cluster assembly,BP,NFU1
7232,GO:0031163,0.911352065091572,0.31720034907161,1,20,metallo-sulfur cluster assembly,BP,NFU1
5603,GO:0016651,0.911364055179485,0.170070235778041,6,83,oxidoreductase activity, acting on NAD(P)H,MF,NOS1;TXNRD3;DHRS4;NOS3;CBR4;TXNRD2
14778,GO:0070530,0.91137850952151,0.317879419199301,1,19,K63-linked polyubiquitin modification-dependent protein binding,MF,FAAP20
16896,GO:0098901,0.911522182056881,0.317527430907411,1,19,regulation of cardiac muscle cell action potential,BP,ANK3
18007,GO:1902554,0.912107713055418,0.169191525225139,6,78,serine/threonine protein kinase complex,CC,ULK1;SESN2;TGFBR2;ERN1;C9ORF72;IKBKB
1119,GO:0002708,0.912523796868078,0.207616686929115,3,45,positive regulation of lymphocyte mediated immunity,BP,PRKCZ;ZP3;STAT6
2863,GO:0006357,0.912635606365177,0.101663080568728,173,1592,regulation of transcription by RNA polymerase II,BP,TNIP1;ZC3H6;HTRA1;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;NR1D1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;TCEA2;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MDFI;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MXD4;ABCA2;PKN1;MC1R;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SOX12;CAPRIN2;ELK3;BRD3;KDM3A;FOXQ1;SALL2;ETV1;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;CHD2;TEF;UNKL;CARF;PPARA;CHD3;SESN2;TCF25;IMPACT;PKD2;SATB1;STAT6;KLF7;HMGA2;ECM1;MAPK3;THRA;IRF2BPL;MLXIPL;ARHGEF2;LITAF;ATF4;ZFPM1;KDM4C;TENM2;CBX7;PKD1;JDP2;HDAC5;IRF5;VLDLR;DEAF1;PEG3;RFX2;CEBPB;LRP5;CREBRF;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;PDE2A;SMURF2;APLN;TRIB3;BHLHE40;CALCOCO1;CDK5RAP3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;MBD1;ATP2B4;AKT1;CRY2;ZNF217;ZNF25;SMARCD2;IFI27;NCOA7;FOXO4;RPS6KA5;MAP2K5;HOXC5;ZNF160;HFE;KIAA1549;TP73;MNT;TFEB;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;CHD6;PER1;FGFR1;WFS1;FKBP8;ERBB2;HMBOX1;TSHZ1;CREB3L4;ZMYM3;DBP;IKBKB;DMTF1;TEAD2;SIX5
11458,GO:0045935,0.912929806632812,0.102922291783655,137,1274,positive regulation of nucleobase-containing compound metabolic process,BP,TNIP1;F2R;APOE;NFATC4;FOS;CITED4;EGR1;TIMP2;VEGFA;EGFR;NR1D1;ERCC1;RAPGEF3;CST3;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;TFDP2;ASH2L;ETV4;WWTR1;MAP2K1;MC1R;ITGA6;ZNF76;PBX2;MAML3;TMEM173;SHC1;SOX12;CAPRIN2;ELK3;PABPC1L;SEC14L2;KDM3A;PHF1;SALL2;ETV1;ZP3;ABHD14B;EAPP;NGFR;ETV5;EREG;TEF;CARF;PPARA;SESN2;PKD2;STAT6;KLF7;HMGA2;AREG;MAPK3;THRA;IRF2BPL;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;ZNF516;PKD1;MDK;HDAC5;GTPBP1;IRF5;SRSF5;DEAF1;PEG3;RFX2;ENDOG;KDM7A;CEBPB;LRP5;CREBRF;PKIB;METTL23;HLTF;CSRNP3;TMSB4X;APLN;CALCOCO1;CDK5RAP3;NOS3;HEXB;ZFP90;WNT7A;PIK3R2;ERN1;MAPRE3;TNNI2;TADA3;CAMK1;RXRA;MGMT;AKT1;CDKN1C;CHEK2;PHF2;FGFR4;INSR;NCOA7;FOXO4;RPS6KA5;MAP2K5;TP73;TFEB;TAZ;HSF4;ZC3H12D;SIRT2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;PER1;FGFR1;ERBB2;HMBOX1;CREB3L4;KCTD13;DBP;ZNF287;IKBKB;TEAD2;SIX5
9298,GO:0035770,0.913013491169549,0.135702426245992,15,170,ribonucleoprotein granule,CC,BTBD2;ZFP36L1;PITPNM1;GRB7;CIRBP;APOBEC3C;APOBEC3F;TDRKH;PAN2;TSTD1;AGO4;CTSH;PNRC1;C9ORF72;ZC3H12D
8318,GO:0033176,0.913106763492407,0.31288683978703,1,20,proton-transporting V-type ATPase complex,CC,TCIRG1
3232,GO:0006888,0.91312426760068,0.1355486326697,15,170,ER to Golgi vesicle-mediated transport,BP,LMF1;ANK3;SPTB;TMED4;TRAPPC9;AREG;WHAMMP3;SORL1;GAS6;COPG1;TBC1D20;COG7;GOLGA2;SEC31B;MPPE1
19953,GO:2000573,0.913173714600952,0.188290432510887,4,56,positive regulation of DNA biosynthetic process,BP,MAPK3;PKIB;FGFR4;HMBOX1
6802,GO:0030261,0.913566208282498,0.238907185957931,2,28,chromosome condensation,BP,HMGA2;TTN
14152,GO:0061077,0.913832926948896,0.175022401760495,5,68,chaperone-mediated protein folding,BP,FKBP9;CRTAP;FKBP10;FYCO1;FKBP8
8462,GO:0033617,0.913893007728015,0.3109417401632,1,20,mitochondrial respiratory chain complex IV assembly,BP,SMIM20
4159,GO:0009225,0.913919535765508,0.23642132182504,2,33,nucleotide-sugar metabolic process,BP,MPI;FUK
11860,GO:0046888,0.914081298655676,0.236085849351295,2,33,negative regulation of hormone secretion,BP,HADH;PFKL
18873,GO:1904589,0.914119550268933,0.204623100300311,3,45,regulation of protein import,BP,TMEM173;PDE2A;GAS6
7229,GO:0031146,0.914434485967482,0.173847085163879,5,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,FBXO2;FBXW4;WWTR1;FBXO6;FBXL15
12576,GO:0050776,0.914445661388692,0.109283326239965,58,574,regulation of immune response,BP,TNIP1;PTPRS;FOS;IL20RB;WIPF1;RNF135;RBCK1;PRNP;FCGRT;NR1D1;PKN1;TMEM173;SHC1;PRKCZ;SERPING1;PAK1;FAM3A;ZP3;SPPL2B;MUC19;EREG;PLA2G6;ERMAP;C5;NLRX1;STAT6;ECM1;MAPK3;IFITM1;CTSB;IFNGR2;C1RL;INPP5D;FLOT1;PIK3R2;BCR;PTAFR;CTSH;CARD11;HMSD;RPS6KA5;ULBP1;BRAF;BTN3A2;MAPK10;HFE;JAK3;ICAM5;BTN3A3;BCL6;TKFC;FYN;ADA;VAV3;EIF2AK4;PAG1;HLA-G;IKBKB
6597,GO:0022625,0.915125032902769,0.184121888958688,4,63,cytosolic large ribosomal subunit,CC,RPL13A;RPL39L;RPL29;RPL12
692,GO:0001913,0.915586288402988,0.306726404744759,1,20,T cell mediated cytotoxicity,BP,CTSH
19879,GO:2000404,0.91572396721279,0.306382063893897,1,20,regulation of T cell migration,BP,ECM1
3610,GO:0008053,0.915870489420146,0.306015339416635,1,20,mitochondrial fusion,BP,BNIP3
731,GO:0001961,0.916082012776921,0.231919552185379,2,33,positive regulation of cytokine-mediated signaling pathway,BP,CREBRF;GAS6
18514,GO:1903749,0.916462500176199,0.155537645740003,7,90,positive regulation of establishment of protein localization to mitochondrion,BP,TFDP2;VPS11;MICALL2;BBC3;PEMT;TP73;OSCP1
15173,GO:0071345,0.916487992024278,0.103880071420714,76,744,cellular response to cytokine stimulus,BP,BBS2;TNFRSF6B;FOS;IL20RB;GSN;EGR1;POSTN;PDCD4;VEGFA;RBCK1;ADAMTS7;TNFSF15;ADAMTS13;MST1R;ZFP36L1;MMP1;CTF1;RPL13A;SLC27A1;MAPK13;HYAL1;SYNGR1;PCK2;TMEM173;SHC1;SPRY2;LAMA5;KDM3A;GLDC;NPR2;SPPL2B;NGFR;EPOR;GSTO1;EREG;TNFRSF25;AIP;STAT6;SLIT3;ECM1;MAPK3;IFITM1;IFNGR2;ARHGEF2;INPP5D;IFI6;IRF5;IL17RD;RFX2;CEBPB;CREBRF;ISG20;IL17RE;TMSB4X;PDE2A;EDA;TRPV1;SHARPIN;GAS6;PTAFR;RAB43;TNFRSF14;AKT1;IL17RC;IFI27;RPS6KA5;EDA2R;TIMP1;JAK3;BCL6;FYN;TCF7;STX1A;CTH;HLA-G;IKBKB
20257,GO:2001267,0.91667068593355,0.304007701028894,1,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,GSN
10972,GO:0044786,0.916717541864242,0.181913186698676,4,57,cell cycle DNA replication,BP,POLD4;CHEK2;BCL6;FGFR1
417,GO:0001105,0.916964131673065,0.230072447792669,2,33,RNA polymerase II transcription coactivator activity,MF,CITED4;SOX12
5777,GO:0017004,0.916981573758278,0.229753898801522,2,34,cytochrome complex assembly,BP,SMIM20;TTC19
8665,GO:0034250,0.917042971536971,0.141749383692261,10,121,positive regulation of cellular amide metabolic process,BP,CIRBP;PLA2G6;IMPACT;MAPK3;PTAFR;PPP1R15A;RXRA;ITGA2;ERBB2;EIF2AK4
5557,GO:0016574,0.917220130791371,0.198762483447918,3,45,histone ubiquitination,BP,DDB2;RAG1;PHC1
18271,GO:1903205,0.917286947294554,0.302455907658818,1,20,regulation of hydrogen peroxide-induced cell death,BP,ENDOG
18214,GO:1903052,0.917851275717689,0.14824546140343,8,100,positive regulation of proteolysis involved in cellular protein catabolic process,BP,EDEM1;MAGEF1;TRIB2;HERPUD1;TRIB3;AKT1;CSNK1E;SIRT2
12958,GO:0051385,0.917881780289867,0.300953381886456,1,20,response to mineralocorticoid,BP,FOS
7013,GO:0030742,0.917887088348799,0.300939953079671,1,20,GTP-dependent protein binding,MF,RAB3B
11076,GO:0045103,0.917929716129052,0.228043324652357,2,33,intermediate filament-based process,BP,SYNC;KLHL24
12533,GO:0050706,0.917995122152795,0.300666559029005,1,20,regulation of interleukin-1 beta secretion,BP,NLRP1
8690,GO:0034341,0.918490571405252,0.139561418418561,10,122,response to interferon-gamma,BP,GSN;ADAMTS13;RPL13A;CYP27B1;IFITM1;IFNGR2;IRF5;PTAFR;RAB43;HLA-G
7312,GO:0031330,0.918624024822962,0.12626339886685,16,181,negative regulation of cellular catabolic process,BP,TIMP2;CST3;DDIT4;CIRBP;PPARA;ACACB;TBC1D14;ATRAID;DAP;CDK5RAP3;ATP2B4;AKT1;TIMP1;HFE;SIRT2;GOLGA2
13728,GO:0060330,0.918976243284701,0.298176652356204,1,20,regulation of response to interferon-gamma,BP,IFNGR2
13732,GO:0060334,0.918976243284701,0.298176652356204,1,20,regulation of interferon-gamma-mediated signaling pathway,BP,IFNGR2
8153,GO:0032897,0.919139430880276,0.297761273702026,1,20,negative regulation of viral transcription,BP,HMGA2
5847,GO:0017148,0.919194600210934,0.121467159988721,19,215,negative regulation of translation,BP,EGFR;ZFP36L1;RPL13A;MAP2K1;GRB7;UNK;CIRBP;CAPRIN2;SESN2;MAP2K2;ATF4;AGO4;PAIP2B;IGF2BP2;ZC3H12D;PAIP2;EIF4EBP1;IGF2BP3;EIF2AK4
15101,GO:0071218,0.919447496990199,0.296976151703437,1,20,cellular response to misfolded protein,BP,ANKZF1
4804,GO:0012507,0.919499534769123,0.194252206997327,3,46,ER to Golgi transport vesicle membrane,CC,AREG;SEC31B;HLA-G
9906,GO:0042267,0.919856312842593,0.223692883036778,2,34,natural killer cell mediated cytotoxicity,BP,ULBP1;LYST
3811,GO:0008408,0.919902171031165,0.19348132912028,3,46,3'-5' exonuclease activity,MF,PAN2;ISG20;EXD3
7099,GO:0030904,0.920068586111599,0.295389405675502,1,20,retromer complex,CC,SNX1
6245,GO:0019827,0.920075272988817,0.137224366855338,10,121,stem cell population maintenance,BP,KDM3A;HMGA2;VANGL2;KDM4C;LRP5;WNT7A;EPHA1;ZNF358;BRAF;EPAS1
7836,GO:0032402,0.920524075410616,0.294222423109056,1,20,melanosome transport,BP,BBS2
13215,GO:0051904,0.920524075410616,0.294222423109056,1,20,pigment granule transport,BP,BBS2
4955,GO:0015031,0.920613731390862,0.093141806904224,161,1503,protein transport,BP,BBS2;F2R;APOE;SYTL1;LMF1;POSTN;EVI5L;TMEM129;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;ZDHHC1;NR1D1;HADH;ANK3;RAPGEF3;CLTCL1;IDH2;TBC1D8;ARRDC1;B3GAT3;EXOC2;RPL13A;BBS1;REEP2;ATG16L2;SYNGR1;PCK2;TOM1L2;PITPNM1;TMEM173;SNX9;ARL2;VPS11;RAB3B;NLGN2;ITPR3;PRKCZ;PAK1;CEMIP;MICALL2;ACVR2B;NGFR;OLFM2;TMED4;PLA2G6;ABCG1;XPOT;RINL;S100A13;AGAP1;C5;KIF17;ANO1;AIP;IFT27;SH3TC2;VAMP2;AP1G2;PCLO;MAPK3;PEX10;LTBP2;HOOK2;EIF2D;MVB12B;CHMP1B;TBC1D14;ARHGEF2;PRAF2;LRSAM1;DMTN;TBC1D3E;RABGAP1;PKD1;TTN;TSNARE1;SORL1;HERPUD1;SRSF5;VLDLR;NLRP1;RHBDF1;LRP5;CEP131;LONP2;TRPV4;TMSB4X;PDE2A;RAB40B;PEMT;BNIP3L;PIK3R2;RHBDF2;GAS6;VPS39;GLUD1;BCR;KIF13B;NECAB3;CAMK1;RAB43;STRADB;MAPKBP1;AKT1;ITPR2;CARD11;TSG101;IL17RC;RASSF9;TCIRG1;STEAP3;COPG1;SGSM2;CHMP5;ICA1;RAB25;IFI27;COG7;CHMP4C;ITGB6;LYST;ZDHHC24;ARHGAP44;CPSF4;BTN3A2;UNC119B;HFE;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;BCL6;EHD3;FYN;SNX1;PEX1;RAB13;TOM1;POU2F2;RTN2;AP2A2;CIDEA;MYO18A;RPL29;STX1A;TBC1D16;TMCO6;ERBB2;SEC31B;UNC119;SYVN1;OSCP1;PFKL;RPL12;APBA1;HIP1
277,GO:0000780,0.920627526158116,0.293956985934287,1,20,condensed nuclear chromosome, centromeric region,CC,REC8
10791,GO:0044295,0.920645599192369,0.293910598648941,1,20,axonal growth cone,CC,C9ORF72
4083,GO:0009141,0.920650403185564,0.115574226717027,23,257,nucleoside triphosphate metabolic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;FAM20C;MYH3;MLXIPL;SDHA;GTPBP1;GALK1;NADK;ALDOC;TMSB4X;MOCOS;UCKL1;DGUOK;TCIRG1;INSR;TAZ;ADA;PFKL
14524,GO:0070069,0.920666872934008,0.292601291510842,1,22,cytochrome complex,CC,NDUFA4L2
18134,GO:1902911,0.920807405398335,0.148626104108277,7,90,protein kinase complex,CC,ULK1;SESN2;TGFBR2;ERN1;C9ORF72;INSR;IKBKB
92,GO:0000183,0.920815296647566,0.220490938349109,2,39,chromatin silencing at rDNA,BP,PHF2;SIRT2
8973,GO:0035094,0.921146098122427,0.292624220244489,1,20,response to nicotine,BP,PPARA
13205,GO:0051894,0.921294318237396,0.292242608742813,1,20,positive regulation of focal adhesion assembly,BP,VEGFA
3626,GO:0008089,0.921428612399173,0.220348718795206,2,34,anterograde axonal transport,BP,BLOC1S4;BLOC1S1
7578,GO:0031954,0.921446652294789,0.291850091261815,1,20,positive regulation of protein autophosphorylation,BP,VEGFA
1865,GO:0004532,0.921485814505074,0.220226658057692,2,34,exoribonuclease activity,MF,PAN2;ISG20
3226,GO:0006882,0.921767006730195,0.290366812358583,1,21,cellular zinc ion homeostasis,BP,ATP7B
13476,GO:0055069,0.921767006730195,0.290366812358583,1,21,zinc ion homeostasis,BP,ATP7B
12333,GO:0048730,0.921903521743231,0.290670964835879,1,20,epidermis morphogenesis,BP,FOXQ1
5902,GO:0018126,0.92208459485069,0.290202838395429,1,20,protein hydroxylation,BP,CRTAP
1116,GO:0002705,0.922114554091472,0.172146910891003,4,58,positive regulation of leukocyte mediated immunity,BP,PRKCZ;ZP3;STAT6;PTAFR
8141,GO:0032878,0.922513357618705,0.289092547422695,1,20,regulation of establishment or maintenance of cell polarity,BP,GSN
3594,GO:0008023,0.922763587893181,0.187972697335684,3,46,transcription elongation factor complex,CC,ERCC6;TCEA2;NELFCD
9365,GO:0035909,0.922898086280564,0.288094101528621,1,20,aorta morphogenesis,BP,LRP1
5647,GO:0016747,0.923357880564955,0.121186814983641,15,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,CRAT;NAGS;ZDHHC1;CPT2;LPCAT4;PNPLA3;NAT14;CPT1C;TADA3;ZDHHC24;CERS4;TAZ;HGSNAT;SAT2;MBOAT2
442,GO:0001191,0.923500736001219,0.215909102298708,2,34,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,ZMYND8;BHLHE40
5472,GO:0016410,0.923588973205592,0.150277387366585,6,80,N-acyltransferase activity,MF,NAGS;NAT14;TADA3;CERS4;HGSNAT;SAT2
12626,GO:0050854,0.923660441096811,0.2155653749595,2,34,regulation of antigen receptor-mediated signaling pathway,BP,PRNP;ADA
12764,GO:0051082,0.923755525935599,0.1389566633036,8,102,unfolded protein binding,MF,DNAJB5;DNAJC4;ERO1B;AIP;NUDCD3;FYCO1;SYVN1;HSP90AB4P
13778,GO:0060393,0.923880931748585,0.215090452267438,2,34,regulation of pathway-restricted SMAD protein phosphorylation,BP,HFE;GDF15
2463,GO:0005680,0.923952450138797,0.284693830392473,1,21,anaphase-promoting complex,CC,CUL7
16262,GO:0090383,0.924102909236419,0.284300800301177,1,21,phagosome acidification,BP,TCIRG1
16804,GO:0098727,0.924628384980694,0.130348032923156,10,122,maintenance of cell number,BP,KDM3A;HMGA2;VANGL2;KDM4C;LRP5;WNT7A;EPHA1;ZNF358;BRAF;EPAS1
1446,GO:0003678,0.924908033753315,0.183808820806716,3,46,DNA helicase activity,MF,CHD2;CHD3;RECQL5
17745,GO:1901800,0.925101597730217,0.141676822167152,7,91,positive regulation of proteasomal protein catabolic process,BP,EDEM1;TRIB2;HERPUD1;TRIB3;AKT1;CSNK1E;SIRT2
19015,GO:1904888,0.925382984145792,0.182882398506314,3,46,cranial skeletal system development,BP,IFT140;TGFBR2;WDR19
14506,GO:0070034,0.925596970164709,0.280380448031058,1,21,telomerase RNA binding,MF,TEP1
2866,GO:0006361,0.925855813951715,0.210562053756504,2,35,transcription initiation from RNA polymerase I promoter,BP,MAPK3;DMTF1
10771,GO:0044257,0.92599136517828,0.0943182230692113,64,634,cellular protein catabolic process,BP,APOE;BTBD2;GID4;FBXO2;TMEM129;EDEM1;LRP1;RBCK1;NR1D1;ADAMTS7;DDIT3;ABTB1;ARRDC1;CUL9;CTSF;RNF165;FBXW4;CUL7;WWTR1;MAGEF1;VPS11;USP20;TRIB2;RNF44;BNIP3;CTSB;MVB12B;UBXN4;FBXO6;PKD1;HERPUD1;VLDLR;RHBDF1;ATRAID;PCSK9;FBXL15;LONP2;SMURF2;TRIB3;CDK5RAP3;BNIP3L;SHARPIN;CTSH;AKT1;CHEK2;TSG101;TCIRG1;SPSB3;CAPN2;SPATA18;ANKZF1;CHMP4C;HFE;CSNK1E;RNF213;UBXN6;SIRT2;MTA1;AP2A2;MAN1B1;WFS1;SYVN1;KCTD13;BTBD11
9,GO:0000018,0.926058514686506,0.16499097880646,4,58,regulation of DNA recombination,BP,MAGEF1;STAT6;BCL6;RECQL5
4134,GO:0009199,0.926239578944253,0.109827889293117,21,239,ribonucleoside triphosphate metabolic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;FAM20C;MYH3;MLXIPL;SDHA;GTPBP1;GALK1;NADK;ALDOC;TMSB4X;MOCOS;UCKL1;TCIRG1;INSR;TAZ;PFKL
10722,GO:0044106,0.926356544778854,0.145497402890335,6,83,cellular amine metabolic process,BP,ALDH7A1;AZIN2;ATP2B4;SAT2;DHPS;PNKD
5393,GO:0016235,0.926378400232698,0.209680822223071,2,34,aggresome,CC,EDEM1;STRADB
6563,GO:0022029,0.926383872047512,0.209668908273418,2,34,telencephalon cell migration,BP,EGFR;LAMB1
1113,GO:0002702,0.926529764040459,0.180488372004306,3,47,positive regulation of production of molecular mediator of immune response,BP,PRKCZ;STAT6;MAPK3
7298,GO:0031307,0.926582345663106,0.277777189921496,1,21,integral component of mitochondrial outer membrane,CC,BNIP3
10513,GO:0043470,0.926676079672701,0.163862522376766,4,58,regulation of carbohydrate catabolic process,BP,DDIT4;PPARA;MLXIPL;INSR
18497,GO:1903707,0.926729339526405,0.138905127095608,7,94,negative regulation of hemopoiesis,BP,ZFP36L1;INPP5D;ZFPM1;JAK3;BCL6;ERBB2;HLA-G
6280,GO:0019894,0.926970722617226,0.208389551834393,2,34,kinesin binding,MF,TTBK2;CROCC
17664,GO:1901570,0.927063796430754,0.163052401597955,4,59,fatty acid derivative biosynthetic process,BP,GGT1;HMGCL;LTA4H;CBR4
3165,GO:0006779,0.927147929121301,0.276276540529128,1,21,porphyrin-containing compound biosynthetic process,BP,UROS
8239,GO:0033028,0.927269235121304,0.275954065762334,1,21,myeloid cell apoptotic process,BP,THRA
3058,GO:0006623,0.927274037486512,0.207727074913533,2,34,protein targeting to vacuole,BP,SORL1;TMEM50B
3346,GO:0007076,0.927456747942428,0.279545573059251,1,16,mitotic chromosome condensation,BP,TTN
7458,GO:0031625,0.927582135823933,0.104909499479012,25,271,ubiquitin protein ligase binding,MF,BTBD2;EGFR;ABTB1;ARRDC1;CUL9;CUL7;MC1R;TMEM173;SNX9;CBS;DLG3;NGFR;TRIB2;SLC22A18;HLTF;TRIOBP;MAP1LC3A;TRIB3;TNFRSF14;CHEK2;TSG101;UBOX5;PER1;WFS1;BTBD11
18052,GO:1902679,0.927746195369508,0.0885886616111399,96,927,negative regulation of RNA biosynthetic process,BP,ZC3H6;ZMYND8;NFATC4;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;NR1D1;PRDX5;BAHCC1;DDIT3;DNAJB5;TCFL5;TFDP2;MXI1;MDFI;WWTR1;MXD4;H2AFJ;PHF21A;SHC1;ELK3;FOXQ1;SALL2;ZP3;ACVR2B;EAPP;HES2;EREG;NAB2;PPARA;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;THRA;IRF2BPL;PBXIP1;MLXIPL;ZFPM1;TENM2;CBX7;JDP2;HDAC5;VLDLR;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;ZFP90;TRPV1;GAS6;RXRA;MBD1;TNRC18;CDKN1C;CRY2;TSG101;PHF2;ZNF217;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;TP73;MTA3;MNT;BCL6;HSF4;SIRT2;RECQL5;RCOR2;MTA1;HDAC8;TCF7;MAP3K10;PER1;FGFR1;WFS1;HMBOX1;TSHZ1;SIX5
18399,GO:1903507,0.927746195369508,0.0885886616111399,96,927,negative regulation of nucleic acid-templated transcription,BP,ZC3H6;ZMYND8;NFATC4;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;NR1D1;PRDX5;BAHCC1;DDIT3;DNAJB5;TCFL5;TFDP2;MXI1;MDFI;WWTR1;MXD4;H2AFJ;PHF21A;SHC1;ELK3;FOXQ1;SALL2;ZP3;ACVR2B;EAPP;HES2;EREG;NAB2;PPARA;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;THRA;IRF2BPL;PBXIP1;MLXIPL;ZFPM1;TENM2;CBX7;JDP2;HDAC5;VLDLR;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;ZFP90;TRPV1;GAS6;RXRA;MBD1;TNRC18;CDKN1C;CRY2;TSG101;PHF2;ZNF217;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;TP73;MTA3;MNT;BCL6;HSF4;SIRT2;RECQL5;RCOR2;MTA1;HDAC8;TCF7;MAP3K10;PER1;FGFR1;WFS1;HMBOX1;TSHZ1;SIX5
12394,GO:0048863,0.927959441265185,0.111755530926897,17,200,stem cell differentiation,BP,SEMA4B;LAMA5;KDM3A;SEMA3F;CHD2;HMGA2;MAPK3;SEMA3B;KDM4C;LTBP3;WNT7A;SEMA4G;WNT3;FOXO4;TP73;EDNRA;TEAD2
9682,GO:0038093,0.928034620749804,0.117963866509521,13,155,Fc receptor signaling pathway,BP,FOS;WIPF1;FCGRT;SHC1;PAK1;PLA2G6;MAPK3;PIK3R2;CARD11;MAPK10;FYN;VAV3;IKBKB
5817,GO:0017091,0.928089056889858,0.273768937077256,1,21,AU-rich element binding,MF,ZFP36L1
2093,GO:0004860,0.928520342470165,0.149703673941719,5,70,protein kinase inhibitor activity,MF,SPRY2;TRIB2;PKIB;TRIB3;CDKN1C
16292,GO:0090503,0.928793033710898,0.204144745788611,2,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,PAN2;ISG20
10609,GO:0043624,0.929388616897431,0.112518999729389,15,179,cellular protein complex disassembly,BP,GSN;SPTB;CAPG;TTBK2;SEMA5A;ARHGEF2;TWF2;STMN3;DMTN;TRIOBP;TRPV4;DNAJC6;MICAL1;TMOD2;PLEKHH2
4519,GO:0010586,0.929390673530447,0.270278846188329,1,21,miRNA metabolic process,BP,AGO4
12184,GO:0048384,0.929416143683806,0.270210294466804,1,21,retinoic acid receptor signaling pathway,BP,RXRA
7829,GO:0032392,0.92944436388431,0.140428957645437,6,81,DNA geometric change,BP,XPC;DDB2;SMARCA1;CHD2;CHD3;RECQL5
20235,GO:2001233,0.929575009303334,0.10038752666243,28,303,regulation of apoptotic signaling pathway,BP,NFATC4;GSN;RBCK1;DDIT3;TFDP2;ITGA6;PLA2G6;BNIP3;ARHGEF2;BBC3;IFI6;UNC5B;HERPUD1;NOS3;STRADB;CTSH;AKT1;LMNA;MAP2K5;PIDD1;TP73;MNT;FYN;CIDEB;FGFR1;WFS1;CTH;SYVN1
418,GO:0001106,0.929716403248532,0.269401409469948,1,21,RNA polymerase II transcription corepressor activity,MF,ZMYND8
3481,GO:0007346,0.929722179245036,0.0909951184230804,57,572,regulation of mitotic cell cycle,BP,XPC;FHL1;GJC2;TIMP2;EGFR;NINL;BRSK1;ZFP36L1;CUL9;RBL2;TFDP2;OBSL1;CUL7;HYAL1;MAP2K1;SDCCAG8;BTG1;TOM1L2;PAK1;STK39;CEP250;EREG;PKD2;HMGA2;CNTRL;CHMP1B;MAP2K2;PAK6;PKD1;PCBP4;LRP5;NDE1;L3MBTL1;CEP131;CDK5RAP3;MINK1;STRADB;ASNS;AKT1;CDKN1C;CHEK2;CHMP5;INSR;FOXO4;CHMP4C;CTDSPL;MAP2K5;PIDD1;HAUS4;TP73;MTA3;CSNK1E;BCL6;SIRT2;EIF4EBP1;FGFR1;SFI1
2379,GO:0005515,0.929729396850092,0.0787803742311754,956,8308,protein binding,MF,TNIP1;XDH;PTPRS;ACTA2;DLG4;HTRA1;DOCK4;BBS2;F2R;TNFRSF6B;ISYNA1;APOE;BTBD2;SYTL1;ESPN;ZMYND8;NFATC4;FLNC;XPC;SERPINE2;FHL1;S100A6;FOS;IL20RB;H1F0;GSN;ADGRL1;LRRC20;ACSF2;PYGB;EGR1;CTNNBIP1;PGF;ALDH7A1;FGFBP1;TYSND1;POSTN;PPP1R35;EVI5L;WIPF1;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;CDC42EP5;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;GPX3;SEMA4B;LRP1;RSPH3;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;RBCK1;DDB2;RHPN1;PRNP;FCGRT;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;S100A4;PRDX5;ANK3;DUSP5;NEK9;IFT140;RAPGEF3;CLTCL1;FCHO1;TNFSF15;ZKSCAN1;SPTB;TSPAN1;SLC16A3;IGFBP4;KRT15;CD9;NINL;SNPH;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;MICALCL;PGM1;CRTC1;SCN4B;PACS2;ORAI3;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;FCGBP;TBC1D8;ABTB1;ARHGEF19;TCEA2;COL13A1;MYH15;SMARCA1;MST1R;ARRDC1;EFS;ZFP36L1;ADARB1;UHRF1BP1;SYT8;CUL9;JMJD7;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;RPS6KA2;PYGL;CTF1;TMEM134;CNTN1;EXOC2;TFDP2;MXI1;ALDH4A1;HSD17B14;PHYHD1;EFNB3;MSRB2;OBSL1;MDFI;BBS1;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;MLYCD;ASAP2;FBXW4;PLD3;ASH2L;SOX13;CUL7;PITPNM3;LHPP;EPM2A;PRSS3;HMGCL;PCED1A;HYAL1;NXPH4;MPRIP;ARPIN;ETV4;WWTR1;SYNGR1;SMOC1;POLD4;GIGYF1;MAP2K1;PCK2;MXD4;COL6A1;PPL;SDCCAG8;CRYL1;PKN1;PGLS;MC1R;CAPG;DDIT4;H2AFJ;BTG1;TOM1L2;SHC2;SYNGAP1;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;AKR7A2;PBX2;EML2;TMEM173;SNX9;PLEKHG5;DNAJC4;FAM110C;THAP8;MAGEF1;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;FAM102A;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;ADM2;MARCKSL1;OGDHL;LGALS9B;HDAC11;RAB3B;NLGN2;PCSK1;SLC12A7;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;PITPNC1;NMRK1;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;C22ORF23;TTBK2;PCED1B;PRKCZ;PPP2R3B;GALE;SERPING1;PAK1;ANKS6;APOBEC3C;PHYH;ELK3;STK39;ERO1B;FGFR3;BRD3;CEMIP;KDM3A;BRI3;NATD1;ARVCF;PHF1;GLDC;NPR2;SEMA3F;FAM167A;PLXNB3;CBS;SPRY4;USP20;SALL2;ORAI2;ELMO3;DOCK6;SYNE3;DLG3;ITGB4;WDR27;MICALL2;NME4;CEP250;GRIP2;FBXW8;ETV1;ZP3;NEIL1;SHROOM4;ABHD14B;ACVR2B;CCDC88B;RAG1;SPPL2B;SPEG;NGFR;EPOR;NID1;ETV5;ETFB;GSTO1;ARHGEF4;WDR60;LTBP1;SMIM14;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;PLXNB1;EREG;CHD2;TEF;TNS1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;SSH3;CYHR1;OLFM2;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;TNFRSF25;NAB2;PLA2G6;UNKL;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;ALS2CL;CARS;MTMR4;C5;KIF17;APOBEC3F;PPARA;PLGRKT;CHD3;ANO1;CHAC1;CCDC92;SPC24;SESN2;AIP;BLMH;MKNK2;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;WDR90;PKD2;SATB1;STAT6;ING4;NUDCD3;VAMP2;HMGA2;AREG;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;LRP11;PCLO;JADE2;ACACB;MAPK3;CSPG4;ITGB5;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;SEMA5A;THRA;IFITM1;PEX10;STK40;VANGL2;SCARA3;DOCK9;SH2D2A;RGS14;MVD;DNAL4;KCTD15;FAM20C;MYZAP;PBXIP1;DYSF;RHOF;SLC22A18;CNTRL;LTBP2;SNTA1;PAN2;CTSB;HOOK2;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;SRGAP3;ZXDC;KIAA0319L;SDC2;CHMP1B;FBXO17;ARHGAP22;MLXIPL;PLEKHG4;TBC1D14;PLCD1;ARHGEF2;SEPT10;FBF1;INPP5D;PRAF2;TSPYL2;MAP2K2;H1FX;TWF2;SAMD3;STMN3;SDHA;TECPR1;KIF21B;SLC48A1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;UBXN4;NOL4L;MORN4;ATF4;PROCR;ZFPM1;BBC3;KDM4C;PAK6;DOCK11;SSH1;LRRC45;SV2A;TBC1D3E;FAM214B;PRIMPOL;RABGAP1;POLM;ACAP3;TENM2;ERICH2;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;NSMCE1;ATXN10;RALGAPA1;FLOT1;LTBP3;CEP68;MDK;TTN;PSKH1;HLCS;KCNMA1;AZIN2;TSNARE1;TMEM128;JDP2;UNC5B;HDAC5;WHAMMP3;IRF5;SORL1;MAP6;TFB1M;HERPUD1;SRSF5;GSTM2;VLDLR;NADK;DHX32;GABBR1;DEAF1;TEP1;ROBO3;NLRP1;ACY1;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;L3MBTL1;PKN3;FBXL15;METTL23;CEP131;LONP2;EPN3;MARK3;CCDC57;DGCR6L;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;IQSEC2;RSRP1;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;ANO9;MAP1LC3A;MOCOS;PDE2A;SMURF2;APLN;TRIB3;TYMSOS;DAP;BHLHE40;MLH3;CALCOCO1;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;WNT7A;HERPUD2;TRPV1;MARCH2;BNIP3L;PIK3R2;EPHA1;RHBDF2;RPUSD3;ANGEL1;SEMA4G;SHARPIN;CCS;FMNL2;GAS6;GLUD1;DNAJC6;OLFML2A;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ECM2;CROCC;PLEKHG3;BCR;MAPRE3;ATP7B;FYCO1;NBR1;CPT1C;HEXA;TNNI2;BCAM;SRR;TADA3;C1QTNF6;BOLA1;KIF13B;UCKL1;NECAB3;CAMK1;TERC;PTAFR;PPP1R15A;RXRA;RIMS3;ADCY6;MBD1;RAB43;ATP2B4;SPATA7;THNSL2;PRDM8;SLC9A3R2;EFEMP2;STRADB;CTSH;TNFRSF14;WDR19;ACOX3;PNRC1;FBXL8;UACA;GSTO2;ASNS;PLEKHG6;PAIP2B;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;REEP4;CDKN1C;MICAL1;CRY2;MZT2B;BEX2;AMIGO2;LAMB1;CHEK2;SEMA6B;KIAA0930;IFT57;LACTB2;PHYKPL;SBF2;IGFBP2;SEPT6;ASS1;SPDYE2;SPDYE2B;TNNT1;COMTD1;NFU1;CABYR;TSG101;KIF27;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;RASSF9;ZNF217;TMOD2;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;NUCB2;FARP1;LMNA;ASMTL;FAAH;SH2B3;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;UBTD1;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;IFI27;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;CKLF;FOXO4;GNAL;COG7;RPS6KA5;ANKZF1;CHMP4C;TNXB;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;GRAMD1A;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;EDA2R;ARHGAP44;CPSF4;POLR2J2;LETMD1;BTN3A2;ASIC1;FAAP20;PIDD1;CAT;MYOF;HAUS4;MAPK10;YPEL5;MPG;LGALS1;UNC119B;TIMP1;HFE;JAK3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;CHRM3;ZNF846;TFEB;MIB2;PEX7;SNX17;PHC1;ICAM5;SCYL3;SPIRE1;CSNK1E;BTN3A3;BCL6;REPS2;RABAC1;SAT2;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;EHD3;RPL39L;FYN;ZC3H12D;EML3;GPATCH2L;TMEM25;PJA2;SLC38A2;SNX1;PEX1;LEMD2;UBXN6;ARHGEF17;SIRT2;TRPC1;GDF15;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;GOLGA2;CELSR1;SH3GLB2;ADA;CADM4;POU2F2;PLXND1;RCOR2;POLR3GL;RHOBTB3;NAGA;MTA1;RTN2;MSH5;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;RPL29;TMEM139;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;STX1A;EPAS1;LAMTOR2;MAP3K10;TBC1D16;STARD10;EDNRA;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;TMCO6;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;IGF2BP3;ITGA2;FGFR1;WFS1;ESYT3;BLOC1S1;FKBP8;SPATA6;SH3PXD2A;CTH;ERBB2;PLLP;UNC119;PAG1;CCDC69;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;RPL12;MPPE1;HMBOX1;NET1;TTC19;WBP1;HSP90AB4P;TRIM2;GRB10;TNNI1;ZNF449;KCTD11;BSG;NUDT18;KCTD13;APBA1;PEX11A;TMEM8A;CAMKK1;PNKD;DTX3;IKBKB;NTM;HIP1;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;BTBD11;SIX5
2545,GO:0005814,0.929825093795587,0.125604204036281,9,112,centriole,CC,SDCCAG8;CAPG;TTBK2;CEP250;CCDC92;FBF1;CROCC;SIRT2;SFI1
3342,GO:0007063,0.930101066427996,0.268363116300689,1,21,regulation of sister chromatid cohesion,BP,HDAC8
7835,GO:0032401,0.93011344867046,0.268329655824709,1,21,establishment of melanosome localization,BP,BBS2
13216,GO:0051905,0.93011344867046,0.268329655824709,1,21,establishment of pigment granule localization,BP,BBS2
3937,GO:0008630,0.930227469736093,0.133255133766522,7,93,intrinsic apoptotic signaling pathway in response to DNA damage,BP,NFATC4;ERCC6;NUPR1;DDIT4;CHEK2;TP73;CIDEB
12589,GO:0050794,0.930288821861095,0.0776975807584528,817,7118,regulation of cellular process,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;ZC3H6;HTRA1;DOCK4;BBS2;F2R;TNFRSF6B;APOE;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;KCNG1;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;IL20RB;GSN;ADGRL1;CITED4;CCNG2;EGR1;CTNNBIP1;LMF1;PGF;FGFBP1;TYSND1;POSTN;PPP1R35;EVI5L;WIPF1;FBXO2;DDIT4L;ZNF862;PTK6;CDC42EP5;ACP5;WWC3;EDEM1;GLUL;FAM210B;GJC2;SEMA4B;LRP1;ALOX15B;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;ZSCAN18;RBCK1;DDB2;RHPN1;PRNP;FCGRT;NR1D1;ERCC1;FBLN1;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;IFT140;RAPGEF3;CLTCL1;TNFSF15;ZKSCAN1;SPTB;DGKA;TSPAN1;IGFBP4;CD9;NINL;IDH2;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;CGREF1;CRTC1;MRC2;ADGRB2;ERCC6;NDRG1;ADAMTS13;TBC1D8;ARHGEF19;TCEA2;MMP28;GRAMD4;SMARCA1;MST1R;ARRDC1;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;RPS6KA2;ARHGAP23;MMP1;CTF1;CNTN1;TFDP2;MXI1;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;EVC;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;RAB11FIP4;NISCH;PHACTR3;MLYCD;ASAP2;FBXW4;ASH2L;SOX13;CUL7;EPM2A;HYAL1;NXPH4;SMOC2;ARPIN;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;SMOC1;GIGYF1;MAP2K1;CYP27B1;PCK2;MXD4;CCDC71L;SDCCAG8;ABCA2;PKN1;MC1R;CAPG;DDIT4;H2AFJ;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;SYNGAP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;PBX2;EML2;MAML3;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;THAP8;MAGEF1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;VEGFB;ADM2;MARCKSL1;SOX12;HDAC11;RAB3B;NLGN2;PLEKHH3;ITPR3;LAMA5;RALGDS;PITPNC1;UNK;APPL2;CIRBP;CAPRIN2;TTBK2;PRKCZ;PPP2R3B;HTR7;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;MCTP1;ELK3;STK39;PABPC1L;ERO1B;PEAR1;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;PHF1;NPR2;SEMA3F;PLXNB3;SPRY4;USP20;SALL2;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;MICALL2;NME4;CEP250;FBXW8;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;EPOR;ETV5;GSTO1;ARHGEF4;LTBP1;MUC19;WNT2B;NSMCE4A;TRIB2;HES2;PLXNB1;EREG;CHD2;TEF;APBB3;PTPRE;SSH3;RMI2;OLFM2;PLCD3;PLEKHG2;RHOBTB2;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;ABCG1;DNMBP;TRAPPC9;CARF;ERMAP;MANF;LPAR3;S100A13;AGAP1;MTMR4;C5;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;ANO1;STON1;CHAC1;SESN2;AIP;MKNK2;RASA4;SCMH1;TCF25;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;SH3TC2;ING4;ACOT11;VAMP2;HMGA2;AREG;SLIT3;SEPT5;ECM1;PCLO;KCNC4;PI4KAP1;ACACB;KCNAB2;MAPK3;CSPG4;TRPT1;ITGB5;BNIP3;ERRFI1;SEMA5A;THRA;IFITM1;CCNI;STK40;VANGL2;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;FAM20C;MYZAP;PBXIP1;RHOF;PLEK2;CNTRL;LTBP2;SNTA1;CTSB;ZSCAN30;SLITRK6;MAPK12;MVB12B;NYAP1;NAT14;SRGAP3;ZXDC;PAQR6;SDC2;CHMP1B;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TBC1D14;TCTN1;PLCD1;ARHGEF2;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;TWF2;SAMD3;STMN3;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;ATF4;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;DOCK11;SSH1;LTB4R2;TBC1D3E;METRN;RABGAP1;GPR153;ACAP3;TENM2;FBXO6;IFI6;ZNF516;CBX7;PKD1;NSMCE1;RALGAPA1;FLOT1;LTBP3;MDK;TTN;PSKH1;KCNMA1;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;PAPLN;ADGRF1;GPRC5C;GABBR1;DEAF1;SULF2;ROBO3;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;RIN2;ATRAID;NDE1;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;CEP131;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;CSRNP3;MN1;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;RAB40B;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;SEMA4G;ZNF662;SHARPIN;FMNL2;GAS6;GLUD1;DNAJC6;ERN1;NUDT6;LZTS2;CROCC;PLEKHG3;BCR;MAPRE3;FYCO1;NBR1;TNNI2;BCAM;TADA3;BOLA1;KIF13B;NECAB3;CAMK1;TERC;PTAFR;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;THNSL2;PRDM8;STRADB;CTSH;TNFRSF14;WDR19;PNRC1;UACA;MGMT;ASNS;C12ORF66;PLEKHG6;TP53I11;PAIP2B;HINT2;MAPKBP1;AKT1;IGFBP7;ITPR2;CARD11;DGUOK;CDKN1C;MICAL1;CRY2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;IFT57;IGFBP2;ASS1;SPDYE2;SPDYE2B;CAPS;TSG101;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;RASSF9;SLC6A9;ZNF217;TMOD2;PIAS3;TCIRG1;ASAP3;STEAP3;ACADVL;ZNF25;FARP1;LMNA;SH2B3;MAB21L2;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;CAPN2;SMARCD2;ICA1;MARK4;ARHGAP27;RAB25;IFI27;PTOV1;PLAU;INSR;WNT3;KRT19;NCOA7;NELFCD;TENM4;CKLF;FOXO4;GNAL;YPEL3;RPS6KA5;CHMP4C;LTB4R;TPCN1;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;GPR21;ARHGAP44;ZNF554;CPSF4;BTN3A2;ASIC1;HOXC5;PIDD1;CAT;ZNF160;MYOF;HAUS4;MAPK10;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;MRGPRX3;TP73;MTA3;MNT;FRAT1;SNX33;CHRM3;ZNF846;FCHSD1;TMX4;TFEB;MIB2;SNX17;LSM14B;PHC1;SPIRE1;CSNK1E;TAZ;BTN3A3;BCL6;REPS2;HSF4;RNF213;ADAP1;TKFC;EPS8L1;EHD3;FYN;MAST4;ZC3H12D;PJA2;LEMD2;ARHGEF17;SIRT2;TRPC1;GDF15;SPRED3;PHLDA2;RECQL5;RAB13;GOLGA2;CELSR1;ADA;POU2F2;PLXND1;RCOR2;RHOBTB3;MTA1;TMEM101;ENTPD2;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;STX1A;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;LURAP1;DHPS;EPHB2;MAGI1;INPP4A;PER1;LRCH4;MCTP2;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FITM2;FKBP8;CTH;ERBB2;UST;EIF2AK4;STK32B;UNC119;PAG1;RGS12;SYVN1;OSCP1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;HMBOX1;NET1;TRIM2;GRB10;TSHZ1;CREB3L4;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;KCTD13;DBP;PEX11A;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;IKBKB;DMTF1;SNCB;HIP1;PLEKHH2;ROBO4;TEAD2;ACOT8;BTBD11;SIX5
3258,GO:0006929,0.93038984165069,0.267582141615503,1,21,substrate-dependent cell migration,BP,ITGA2
7365,GO:0031424,0.930429767622613,0.132796297978256,7,96,keratinization,BP,KRT15;PPL;PRSS8;LCE1E;SHARPIN;LCE1F;KRT19
9006,GO:0035198,0.930480761577826,0.267335986152671,1,21,miRNA binding,MF,AGO4
4354,GO:0009954,0.930538494465667,0.267179614053748,1,21,proximal/distal pattern formation,BP,PBX2
4651,GO:0010800,0.930712928333445,0.266706836358051,1,21,positive regulation of peptidyl-threonine phosphorylation,BP,CEMIP
3057,GO:0006622,0.930885580907095,0.266238418378039,1,21,protein targeting to lysosome,BP,SORL1
11423,GO:0045880,0.931141985081259,0.265541914514049,1,21,positive regulation of smoothened signaling pathway,BP,EVC
6464,GO:0021799,0.931182517377746,0.265431716838319,1,21,cerebral cortex radially oriented cell migration,BP,LAMB1
16291,GO:0090502,0.931236461784009,0.155268017948807,4,60,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,ERN1;LACTB2;CPSF4;ENDOV
3304,GO:0007007,0.931359510282775,0.264371062331091,1,22,inner mitochondrial membrane organization,BP,TAZ
10344,GO:0043175,0.931400376436716,0.198380313049232,2,35,RNA polymerase core enzyme binding,MF,RECQL5;ERBB2
5846,GO:0017147,0.931581010944697,0.264346928332959,1,21,Wnt-protein binding,MF,LRP5
4414,GO:0010212,0.93193209937929,0.116549233978926,11,134,response to ionizing radiation,BP,EGR1;ERCC1;ERCC6;HMGA2;DNMT3A;CYP2R1;MGMT;CHEK2;TP73;MTA1;NET1
10672,GO:0043967,0.931959867343886,0.154018551653513,4,59,histone H4 acetylation,BP,ING4;JADE2;TADA3;PER1
130,GO:0000271,0.931985309158659,0.153971230396906,4,59,polysaccharide biosynthetic process,BP,NR1D1;PGM1;AKT1;INSR
7054,GO:0030850,0.932639682412625,0.19561730770632,2,35,prostate gland development,BP,ALOX15B;RXRA
89,GO:0000178,0.933083223503498,0.259658998283096,1,22,exosome (RNase complex),CC,GTPBP1
19198,GO:1905354,0.933083223503498,0.259658998283096,1,22,exoribonuclease complex,CC,GTPBP1
9576,GO:0036442,0.933143938024292,0.259492157425608,1,22,proton-exporting ATPase activity,MF,TCIRG1
15721,GO:0072332,0.933413697746242,0.140951057973214,5,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,NUPR1;DDIT4;CHEK2;EDA2R;TP73
11141,GO:0045216,0.933437115344178,0.106812994428898,15,173,cell-cell junction organization,BP,F2R;VEGFA;CD9;SDK2;ARL2;NPHP4;NLGN2;LAMA5;MICALL2;FBF1;DMTN;TRPV4;RAB13;ITGA2;IKBKB
7849,GO:0032418,0.933460018442232,0.166599868242234,3,48,lysosome localization,BP,S100A13;MAP6;BLOC1S1
3242,GO:0006901,0.933496759270913,0.151059817589921,4,60,vesicle coating,BP,TRAPPC9;AREG;TBC1D20;GOLGA2
4352,GO:0009952,0.933518308326687,0.116763142720394,10,123,anterior/posterior pattern specification,BP,CTNNBIP1;DDIT3;ACVR2B;WNT2B;SCMH1;VANGL2;LRP5;WNT3;CELSR1;TSHZ1
11361,GO:0045747,0.933568937884038,0.193535566580651,2,35,positive regulation of Notch signaling pathway,BP,MAML3;MFNG
4543,GO:0010628,0.933712200581354,0.0788953748426149,145,1361,positive regulation of gene expression,BP,TNIP1;ACTA2;F2R;NFATC4;FOS;GSN;CITED4;EGR1;GJC2;VEGFA;EGFR;NR1D1;ANK3;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;SMARCA1;CNTN1;TFDP2;ASH2L;ETV4;WWTR1;MAP2K1;MC1R;ITGA6;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SHC1;SPRY2;ADM2;SOX12;CIRBP;CAPRIN2;ELK3;PABPC1L;SEC14L2;KDM3A;PHF1;SALL2;ETV1;ZP3;ABHD14B;EAPP;NGFR;ETV5;TEF;CARF;PPARA;PLGRKT;SESN2;IMPACT;PKD2;STAT6;KLF7;HMGA2;MAPK3;THRA;IRF2BPL;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;SLC50A1;LITAF;ATF4;ZFPM1;KDM4C;ZNF516;PKD1;MDK;TTN;HDAC5;IRF5;SRSF5;DEAF1;PEG3;RFX2;KDM7A;CEBPB;LRP5;CREBRF;METTL23;HLTF;TRPV4;CSRNP3;APLN;CALCOCO1;EDA;CDK5RAP3;HEXB;ZFP90;WNT7A;PIK3R2;GAS6;ERN1;MAPRE3;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;CTSH;AKT1;CDKN1C;CHEK2;PHF2;FGFR4;PIAS3;INSR;WNT3;NCOA7;FOXO4;RPS6KA5;MAP2K5;BRAF;HFE;TP73;TFEB;HSF4;SIRT2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;EPHB2;PER1;ITGA2;ERBB2;EIF2AK4;HMBOX1;CREB3L4;DBP;ZNF287;IKBKB;TEAD2;SIX5
7922,GO:0032508,0.934162447977282,0.139689216226772,5,71,DNA duplex unwinding,BP,XPC;DDB2;CHD2;CHD3;RECQL5
11308,GO:0045652,0.934434566008543,0.148888074642377,4,65,regulation of megakaryocyte differentiation,BP,ASH2L;ZFPM1;L3MBTL1;AGO4
16113,GO:0090150,0.934721894050634,0.0966637798172768,23,265,establishment of protein localization to membrane,BP,BBS2;EGFR;PRNP;ZDHHC1;ANK3;TFDP2;RPL13A;BBS1;REEP2;PAK1;CEMIP;SYNE3;VAMP2;DMTN;BBC3;ZDHHC24;BRAF;ARHGAP44;TP73;FYN;RPL29;ERBB2;RPL12
875,GO:0002228,0.934872082818536,0.190372007411886,2,36,natural killer cell mediated immunity,BP,ULBP1;LYST
11121,GO:0045184,0.934901512733602,0.0766970945430971,169,1584,establishment of protein localization,BP,DLG4;BBS2;F2R;APOE;SYTL1;LMF1;POSTN;EVI5L;TMEM129;EDEM1;GLUL;LRP1;ALOX15B;EGFR;PRNP;ZDHHC1;NR1D1;HADH;ANK3;RAPGEF3;CLTCL1;IDH2;DDIT3;TBC1D8;ARRDC1;B3GAT3;EXOC2;TFDP2;RPL13A;BBS1;REEP2;ATG16L2;SYNGR1;PCK2;TOM1L2;PITPNM1;TMEM173;SNX9;ARL2;VPS11;RAB3B;NLGN2;ITPR3;PRKCZ;PAK1;CEMIP;SYNE3;MICALL2;ACVR2B;NGFR;OLFM2;TMED4;PLA2G6;ABCG1;XPOT;RINL;S100A13;AGAP1;C5;KIF17;ANO1;AIP;IFT27;SH3TC2;VAMP2;AP1G2;PCLO;MAPK3;PEX10;LTBP2;HOOK2;EIF2D;MVB12B;CHMP1B;TBC1D14;ARHGEF2;PRAF2;LRSAM1;DMTN;BBC3;TBC1D3E;RABGAP1;PKD1;TTN;TSNARE1;SORL1;HERPUD1;SRSF5;VLDLR;NLRP1;RHBDF1;LRP5;CEP131;LONP2;TRPV4;TMSB4X;PDE2A;RAB40B;PEMT;BNIP3L;PIK3R2;RHBDF2;GAS6;VPS39;GLUD1;BCR;KIF13B;NECAB3;CAMK1;RAB43;STRADB;MAPKBP1;AKT1;ITPR2;CARD11;TSG101;IL17RC;RASSF9;TCIRG1;STEAP3;COPG1;SGSM2;CHMP5;ICA1;RAB25;IFI27;COG7;CHMP4C;ITGB6;LYST;ZDHHC24;BRAF;ARHGAP44;CPSF4;BTN3A2;UNC119B;HFE;TP73;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;BCL6;EHD3;FYN;SNX1;PEX1;RAB13;TOM1;POU2F2;RTN2;AP2A2;CIDEA;MYO18A;RPL29;STX1A;TBC1D16;TMCO6;ITGA2;ERBB2;SEC31B;UNC119;SYVN1;OSCP1;PFKL;RPL12;APBA1;HIP1
9596,GO:0036474,0.935288804180366,0.253559499952159,1,22,cell death in response to hydrogen peroxide,BP,ENDOG
7297,GO:0031306,0.935398545471289,0.253253910803585,1,22,intrinsic component of mitochondrial outer membrane,CC,BNIP3
2533,GO:0005790,0.935460626864628,0.253080947600475,1,22,smooth endoplasmic reticulum,CC,SYVN1
5702,GO:0016836,0.935704848216904,0.188489045860187,2,36,hydro-lyase activity,MF,UROS;CBS
4547,GO:0010633,0.935896091240294,0.161683368058074,3,48,negative regulation of epithelial cell migration,BP,APOE;HDAC5;MAP2K5
8991,GO:0035148,0.936378582767786,0.1152615011275,9,114,tube formation,BP,VEGFA;SDCCAG8;VANGL2;TCTN1;DEAF1;EDA;IFT57;CELSR1;TEAD2
15951,GO:0080134,0.93690255589495,0.077425378483979,102,983,regulation of response to stress,BP,TNIP1;XDH;PTPRS;HTRA1;F2R;NT5E;APOE;SERPINE2;IL20RB;ACP5;EDEM1;RNF135;PDCD4;VEGFA;EGFR;NR1D1;ERCC1;CD9;DDIT3;ERCC6;GGT1;HBEGF;PLAT;MAPK13;MAP2K1;PKN1;TMEM173;MAGEF1;SERPING1;PAK1;MCTP1;STK39;FAM3A;ZP3;RAG1;MUC19;NSMCE4A;EREG;C5;APOBEC3F;PPARA;FNDC4;SESN2;IMPACT;NLRX1;HMGA2;MAPK3;ERRFI1;VANGL2;CTSB;IFNGR2;ARHGEF2;MAP2K2;LRSAM1;DMTN;ATF4;NSMCE1;FLOT1;HERPUD1;NLRP1;ENDOG;TGFBR2;TRPV4;TMSB4X;PDE2A;NOS3;MINK1;WNT7A;SHARPIN;ERN1;BCR;NBR1;TERC;PPP1R15A;ATP2B4;MGMT;MAPKBP1;AKT1;CARD11;CHEK2;IL17RC;LMNA;PLAU;NCOA7;YPEL3;RPS6KA5;BRAF;EDA2R;TP73;BCL6;TKFC;FYN;SIRT2;RECQL5;ADA;MAP3K10;PER1;ITGA2;WFS1;EIF2AK4;SYVN1;IKBKB
12998,GO:0051457,0.93703450623361,0.248674235288239,1,22,maintenance of protein location in nucleus,BP,ARL2
14088,GO:0060969,0.937192304786386,0.248230080998067,1,22,negative regulation of gene silencing,BP,PHF2
1073,GO:0002639,0.937269317551182,0.248013157838889,1,22,positive regulation of immunoglobulin production,BP,STAT6
15762,GO:0072401,0.937387829867891,0.133862345596213,5,72,signal transduction involved in DNA integrity checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1
15766,GO:0072422,0.937387829867891,0.133862345596213,5,72,signal transduction involved in DNA damage checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1
10099,GO:0042634,0.937397770296489,0.247651114732463,1,22,regulation of hair cycle,BP,PER1
13158,GO:0051788,0.937529842322313,0.247278572801697,1,22,response to misfolded protein,BP,ANKZF1
5391,GO:0016233,0.937546369110436,0.157956339655771,3,51,telomere capping,BP,ERCC1;MAPK3;PKIB
4140,GO:0009205,0.937597300763705,0.0951451040477213,20,233,purine ribonucleoside triphosphate metabolic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;NME4;PPARA;FAM20C;MYH3;MLXIPL;SDHA;GTPBP1;GALK1;NADK;ALDOC;TMSB4X;MOCOS;TCIRG1;INSR;TAZ;PFKL
19450,GO:1990204,0.937627967339418,0.126141374001132,6,88,oxidoreductase complex,CC,DHTKD1;OGDHL;GLDC;SDHA;CBR4;SDHAF4
15198,GO:0071377,0.937742292236181,0.246678669683205,1,22,cellular response to glucagon stimulus,BP,ADCY6
7431,GO:0031570,0.938028103076466,0.103257852367541,13,156,DNA integrity checkpoint,BP,XPC;BRSK1;RBL2;TFDP2;HMGA2;FBXO6;PCBP4;CDK5RAP3;CHEK2;FOXO4;PIDD1;TP73;EIF2AK4
1423,GO:0003382,0.938054918916848,0.245794463245299,1,22,epithelial cell morphogenesis,BP,RAB25
8175,GO:0032924,0.938181881256824,0.245434885802729,1,22,activin receptor signaling pathway,BP,ACVR2B
13937,GO:0060669,0.938261682390565,0.245208731651747,1,22,embryonic placenta morphogenesis,BP,ZFP36L1
3622,GO:0008080,0.938306058648111,0.13221176554575,5,72,N-acetyltransferase activity,MF,NAGS;NAT14;TADA3;HGSNAT;SAT2
9021,GO:0035250,0.938472575891436,0.244610526474628,1,22,UDP-galactosyltransferase activity,MF,B4GALT2
4253,GO:0009584,0.938582586657016,0.244298166869774,1,22,detection of visible light,BP,REEP6
4566,GO:0010656,0.938637011035594,0.244143557723068,1,22,negative regulation of muscle cell apoptotic process,BP,RGL2
10161,GO:0042769,0.938680412473598,0.181489994147667,2,37,DNA damage response, detection of DNA damage,BP,POLD4;HMGA2
68,GO:0000139,0.938704727326914,0.0798329549989814,58,582,Golgi membrane,CC,ST6GALNAC2;EDEM1;EGFR;GPSM1;ARAP1;B3GAT3;ASAP2;PITPNM1;ABCA7;B4GALNT4;NMNAT2;SPPL2B;MARCH4;MALL;ABCG1;TRAPPC9;AREG;ST6GALNAC6;AP1G2;B4GAT1;MARCH9;SCARA3;KIAA0319L;IFNGR2;SLC50A1;LITAF;CHST6;PKD1;SORL1;IL17RD;ST3GAL3;RHBDF1;NOS3;ATP7B;GOLGA2P5;RAB43;ENTPD6;STEAP2;B4GALT2;COPG1;TBC1D20;GOLGA8A;ICA1;COG7;C6ORF89;TMEM50B;SLC9A7;PJA2;GOLGA2;RHOBTB3;MYO18A;MAN1B1;MFNG;XYLT2;UST;HLA-G;CREB3L4;BSG
20045,GO:2000725,0.938753154228535,0.243813442141796,1,22,regulation of cardiac muscle cell differentiation,BP,PAK1
6058,GO:0019210,0.938866414165862,0.131202077876839,5,72,kinase inhibitor activity,MF,SPRY2;TRIB2;PKIB;TRIB3;CDKN1C
8817,GO:0034613,0.93890996476188,0.0726110756538364,154,1456,cellular protein localization,BP,DLG4;BBS2;APOE;SYTL1;ZMYND8;GSN;EVI5L;TMEM129;EDEM1;LRP1;OBSCN;EGFR;PRNP;ZDHHC1;ANK3;IFT140;RAPGEF3;CLTCL1;DDIT3;PACS2;TBC1D8;B3GAT3;TFDP2;RPL13A;OBSL1;BBS1;REEP2;SYNGR1;TOM1L2;SYNGAP1;TMEM173;SNX9;ARL2;VPS11;RAB3B;NLGN2;LAMA5;TTBK2;PRKCZ;PAK1;ABCA7;CEMIP;SYNE3;DLG3;MICALL2;CEP250;NGFR;ETV5;TMED4;XPOT;SESN2;AIP;IFT27;SH3TC2;NUDCD3;VAMP2;AP1G2;SEPT5;KCNAB2;PEX10;LTBP2;EIF2D;TBC1D14;TCTN1;ARHGEF2;SEPT10;TWF2;LRSAM1;DMTN;BBC3;SSH1;TBC1D3E;RABGAP1;PKD1;FLOT1;CEP68;TSNARE1;SORL1;HERPUD1;SRSF5;PTPRU;CEP131;LONP2;TMSB4X;PDE2A;RAB40B;PEMT;CDK5RAP3;BNIP3L;GAS6;VPS39;LZTS2;CROCC;BCR;KIF13B;CAMK1;PPP1R15A;RAB43;SPATA7;STRADB;WDR19;C12ORF66;AKT1;WDR45;SEPT6;TTC21A;TSG101;RASSF9;LMNA;COPG1;SGSM2;RAB25;IFI27;COG7;ZDHHC24;BRAF;ARHGAP44;CPSF4;HFE;TP73;SNX33;PEX7;SNX17;TMEM50B;CSNK1E;BCL6;EHD3;FYN;SNX1;PEX1;LEMD2;RAB13;TOM1;CELSR1;RTN2;AP2A2;HDAC8;RPL29;STX1A;LAMTOR2;TBC1D16;EPHB2;TMCO6;SEPT8;ERBB2;SEC31B;SYVN1;OSCP1;CORO1B;RPL12;BSG;APBA1;IKBKB;HIP1
5735,GO:0016887,0.938994109994347,0.0857302814310269,33,348,ATPase activity,MF,ERCC6;SMARCA1;ABCA2;DNAH1;ABCA7;DDX59;WDR60;CHD2;ABCG1;KIF17;CHD3;DNAL4;MYH3;KIF21B;KIF26B;DHX32;LONP2;HLTF;MLH3;ATP7B;KIF13B;ATP2B4;TNNT1;KIF27;TCIRG1;ATP12A;RNF213;ATP8B2;PEX1;RECQL5;RHOBTB3;MSH5;CHD6
16749,GO:0098586,0.939031190971178,0.18089521512614,2,36,cellular response to virus,BP,NLRX1;TKFC
18357,GO:1903393,0.939059789056701,0.242940739598505,1,22,positive regulation of adherens junction organization,BP,VEGFA
1537,GO:0003924,0.93915264389476,0.0930394229913552,20,227,GTPase activity,MF,DNM1;TUBG2;ARL2;RAB3B;RHOBTB2;AGAP1;IFT27;SEPT5;RHOF;TUBE1;SEPT10;GTPBP1;RAB40B;RAB43;SEPT6;RAB25;GNAL;RAB13;RHOBTB3;SEPT8
7379,GO:0031440,0.93918284987941,0.242590030142421,1,22,regulation of mRNA 3'-end processing,BP,ZFP36L1
19252,GO:1905476,0.93923222289957,0.242449246663509,1,22,negative regulation of protein localization to membrane,BP,DMTN
12994,GO:0051453,0.939433696821241,0.139764757220813,4,61,regulation of intracellular pH,BP,TMEM175;TCIRG1;SLC9A7;SLC9A5
242,GO:0000578,0.939476621686753,0.241751719790487,1,22,embryonic axis specification,BP,WNT7A
2487,GO:0005732,0.93957366130952,0.240496910515723,1,24,small nucleolar ribonucleoprotein complex,CC,TERC
11664,GO:0046467,0.939603125776125,0.110086701615497,9,116,membrane lipid biosynthetic process,BP,PLA2G6;ST6GALNAC6;PEMT;PIGZ;PIGQ;CERS4;PIGV;MPPE1;KDSR
8581,GO:0034097,0.940022935203592,0.075300650033668,82,811,response to cytokine,BP,BBS2;TNFRSF6B;FOS;IL20RB;GSN;EGR1;POSTN;ACP5;PDCD4;TIMP2;VEGFA;RBCK1;ADAMTS7;TNFSF15;ADAMTS13;MST1R;ZFP36L1;MMP1;CTF1;RPL13A;SLC27A1;MAPK13;HYAL1;SYNGR1;CYP27B1;PCK2;TMEM173;SHC1;SPRY2;LAMA5;KDM3A;MTHFR;GLDC;NPR2;SPPL2B;NGFR;EPOR;GSTO1;EREG;TNFRSF25;AIP;STAT6;SLIT3;ECM1;MAPK3;IFITM1;IFNGR2;ARHGEF2;INPP5D;IFI6;IRF5;IL17RD;RFX2;ENDOG;CEBPB;CREBRF;ISG20;IL17RE;TMSB4X;PDE2A;EDA;TRPV1;SHARPIN;GAS6;PTAFR;RAB43;TNFRSF14;AKT1;IL17RC;IFI27;RPS6KA5;MAP2K5;EDA2R;TIMP1;JAK3;BCL6;FYN;TCF7;STX1A;CTH;HLA-G;IKBKB
13083,GO:0051642,0.940072032943429,0.24004789093596,1,22,centrosome localization,BP,NDE1
14879,GO:0070727,0.940300455863114,0.070985889376917,155,1466,cellular macromolecule localization,BP,DLG4;BBS2;APOE;SYTL1;ZMYND8;GSN;EVI5L;TMEM129;EDEM1;LRP1;OBSCN;EGFR;PRNP;ZDHHC1;ANK3;IFT140;RAPGEF3;CLTCL1;DDIT3;PACS2;TBC1D8;ZFP36L1;B3GAT3;TFDP2;RPL13A;OBSL1;BBS1;REEP2;SYNGR1;TOM1L2;SYNGAP1;TMEM173;SNX9;ARL2;VPS11;RAB3B;NLGN2;LAMA5;TTBK2;PRKCZ;PAK1;ABCA7;CEMIP;SYNE3;DLG3;MICALL2;CEP250;NGFR;ETV5;TMED4;XPOT;SESN2;AIP;IFT27;SH3TC2;NUDCD3;VAMP2;AP1G2;SEPT5;KCNAB2;PEX10;LTBP2;EIF2D;TBC1D14;TCTN1;ARHGEF2;SEPT10;TWF2;LRSAM1;DMTN;BBC3;SSH1;TBC1D3E;RABGAP1;PKD1;FLOT1;CEP68;TSNARE1;SORL1;HERPUD1;SRSF5;PTPRU;CEP131;LONP2;TMSB4X;PDE2A;RAB40B;PEMT;CDK5RAP3;BNIP3L;GAS6;VPS39;LZTS2;CROCC;BCR;KIF13B;CAMK1;PPP1R15A;RAB43;SPATA7;STRADB;WDR19;C12ORF66;AKT1;WDR45;SEPT6;TTC21A;TSG101;RASSF9;LMNA;COPG1;SGSM2;RAB25;IFI27;COG7;ZDHHC24;BRAF;ARHGAP44;CPSF4;HFE;TP73;SNX33;PEX7;SNX17;TMEM50B;CSNK1E;BCL6;EHD3;FYN;SNX1;PEX1;LEMD2;RAB13;TOM1;CELSR1;RTN2;AP2A2;HDAC8;RPL29;STX1A;LAMTOR2;TBC1D16;EPHB2;TMCO6;SEPT8;ERBB2;SEC31B;SYVN1;OSCP1;CORO1B;RPL12;BSG;APBA1;IKBKB;HIP1
1357,GO:0003230,0.940541919762741,0.238698729599964,1,22,cardiac atrium development,BP,ZFPM1
14128,GO:0061035,0.940628588020496,0.177205881670762,2,36,regulation of cartilage development,BP,ADAMTS7;PTHLH
646,GO:0001837,0.940730526895012,0.115797421226739,7,94,epithelial to mesenchymal transition,BP,PDCD4;S100A4;CUL7;WWTR1;HMGA2;TGFBR2;TGFBR3
4327,GO:0009880,0.940758527707371,0.176904525730271,2,36,embryonic pattern specification,BP,SEMA3F;WNT7A
5967,GO:0018410,0.940787993754217,0.176627390708118,2,37,C-terminal protein amino acid modification,BP,LY6K;NTM
17610,GO:1901361,0.941453595493132,0.076907453480985,55,571,organic cyclic compound catabolic process,BP,XDH;NT5E;APOE;PRODH;H1F0;RAPGEF3;DNPH1;PGM1;ZFP36L1;DHTKD1;ALDH4A1;HSD17B14;RPL13A;CYP27B1;DDIT4;DNASE1L1;OGDHL;CIRBP;APOBEC3C;BLVRB;NEIL1;APOBEC3F;PPARA;NT5C1B;PAN2;MLXIPL;HSD11B1;GTPBP1;GALK1;PCBP4;ENDOG;ALDOC;ISG20;PDE2A;ALDH1L2;AGO4;ERN1;PNRC1;ENTPD6;AKT1;IGF2BP2;DNASE2;UPP1;INSR;ALDH1L1;SNX17;ZC3H12D;ADA;ENTPD2;CIDEA;RPL29;IGF2BP3;PFKL;RPL12;NUDT18
15760,GO:0072395,0.942145053660878,0.125195989766969,5,73,signal transduction involved in cell cycle checkpoint,BP,RBL2;TFDP2;PCBP4;CHEK2;PIDD1
18681,GO:1904115,0.942183856873392,0.173379534202038,2,37,axon cytoplasm,CC,BLOC1S4;BLOC1S1
2828,GO:0006297,0.94222347608575,0.233332356785805,1,23,nucleotide-excision repair, DNA gap filling,BP,POLD4
9692,GO:0038111,0.942299050568762,0.232229113236816,1,25,interleukin-7-mediated signaling pathway,BP,JAK3
16823,GO:0098760,0.942299050568762,0.232229113236816,1,25,response to interleukin-7,BP,JAK3
16824,GO:0098761,0.942299050568762,0.232229113236816,1,25,cellular response to interleukin-7,BP,JAK3
17865,GO:1902175,0.942328583439203,0.233026981757451,1,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1
12919,GO:0051302,0.942535896559581,0.10539661961098,9,116,regulation of cell division,BP,PGF;VEGFA;RAB11FIP4;VEGFB;EREG;MDK;CHMP4C;CAT;SIRT2
16537,GO:0097346,0.942992177342474,0.231094189085948,1,23,INO80-type complex,CC,INO80C
13731,GO:0060333,0.943048440346473,0.132744775822204,4,62,interferon-gamma-mediated signaling pathway,BP,IFNGR2;IRF5;PTAFR;HLA-G
5788,GO:0017025,0.943164073210977,0.230592160447733,1,23,TBP-class protein binding,MF,THRA
14543,GO:0070098,0.943229225813467,0.230401732396647,1,23,chemokine-mediated signaling pathway,BP,SLIT3
975,GO:0002429,0.943386004727735,0.0871195900165369,20,228,immune response-activating cell surface receptor signaling pathway,BP,WIPF1;RBCK1;PRNP;PAK1;MUC19;PLA2G6;ERMAP;MAPK3;INPP5D;PIK3R2;CARD11;RPS6KA5;BRAF;BTN3A2;BTN3A3;FYN;ADA;VAV3;PAG1;IKBKB
6719,GO:0030137,0.943482131041444,0.229661771335126,1,23,COPI-coated vesicle,CC,COPG1
18618,GO:1903955,0.943661420495033,0.131559131844519,4,62,positive regulation of protein targeting to mitochondrion,BP,VPS11;MICALL2;PEMT;OSCP1
12910,GO:0051291,0.943899500791537,0.110226073639446,7,100,protein heterooligomerization,BP,COL6A1;ITPR3;PRKCZ;C1QTNF6;CBR4;INSR;BRAF
14005,GO:0060760,0.944178870963934,0.168698602981389,2,37,positive regulation of response to cytokine stimulus,BP,CREBRF;GAS6
20237,GO:2001235,0.944249695287172,0.0956171606928461,12,150,positive regulation of apoptotic signaling pathway,BP,NFATC4;GSN;RBCK1;DDIT3;TFDP2;PLA2G6;BNIP3;BBC3;CTSH;PIDD1;TP73;CIDEB
10482,GO:0043401,0.944487880624477,0.0953058869158817,12,147,steroid hormone mediated signaling pathway,BP,NR1D1;PAK1;KDM3A;PPARA;THRA;PAQR6;CREBRF;CALCOCO1;TADA3;RXRA;CRY2;PER1
18083,GO:1902751,0.944697101850444,0.226089732315754,1,23,positive regulation of cell cycle G2/M phase transition,BP,MTA3
17344,GO:1900087,0.944751336784948,0.225929609347225,1,23,positive regulation of G1/S transition of mitotic cell cycle,BP,HYAL1
3332,GO:0007045,0.944768775716002,0.129489387171398,4,61,cell-substrate adherens junction assembly,BP,VEGFA;LAMA5;DMTN;ITGA2
12066,GO:0048041,0.944768775716002,0.129489387171398,4,61,focal adhesion assembly,BP,VEGFA;LAMA5;DMTN;ITGA2
4780,GO:0010972,0.94506151139909,0.113238454266428,6,87,negative regulation of G2/M transition of mitotic cell cycle,BP,FHL1;BRSK1;HMGA2;CDK5RAP3;FOXO4;CHMP4C
13089,GO:0051649,0.945267539921159,0.0646772720295734,177,1667,establishment of localization in cell,BP,BBS2;F2R;APOE;SYTL1;LMF1;EVI5L;TMEM129;EDEM1;NTSR1;PRNP;ZDHHC1;NR1D1;ANK3;IFT140;RAPGEF3;CLTCL1;SPTB;SNPH;DNM1;NOS1;DDIT3;BRSK1;TBC1D8;SYT8;B3GAT3;TFDP2;RPL13A;REEP2;RAB11FIP4;CPT2;SYNGR1;MAP2K1;ABCA2;TOM1L2;TMEM173;SNX9;VPS11;SPRY2;BLOC1S4;RAB3B;NLGN2;ITPR3;PRKCZ;PAK1;MCTP1;CEMIP;MICALL2;CCDC88B;NGFR;GSTO1;WDR60;SPG11;TMED4;PLA2G6;ABCG1;XPOT;TRAPPC9;S100A13;KIF17;ANO1;AIP;IFT27;PKD2;SH3TC2;VAMP2;AREG;AP1G2;SEPT5;PCLO;KCNC4;ACACB;MAPK3;PEX10;RGS14;LTBP2;HOOK2;EIF2D;MVB12B;CHMP1B;TBC1D14;ARHGEF2;MAP2K2;DMTN;BBC3;TBC1D3E;RABGAP1;REEP6;PKD1;TSNARE1;WHAMMP3;SORL1;HERPUD1;SRSF5;GSTM2;LRP5;NDE1;PCSK9;CEP131;LONP2;PDE2A;RAB40B;PEMT;WNT7A;TRPV1;BNIP3L;CCS;GAS6;VPS39;DNAJC6;BCR;ATP7B;FYCO1;KIF13B;CAMK1;RIMS3;RAB43;ATP2B4;STRADB;WDR19;AKT1;ZFYVE21;ITPR2;IFT57;TTC21A;TSG101;RASSF9;SLC6A9;COPG1;SGSM2;TBC1D20;CHMP5;RAB25;IFI27;COG7;CHMP4C;TPCN1;LYST;ZDHHC24;BRAF;ARHGAP44;CPSF4;ASIC1;TP73;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;BCL6;EHD3;FYN;SNX1;PEX1;LEMD2;UBXN6;TRPC1;RAB13;TOM1;GOLGA2;RHOBTB3;RTN2;AP2A2;RPL29;STX1A;TBC1D16;TMCO6;BLOC1S1;RGPD6;ERBB2;SEC31B;SYVN1;OSCP1;RPL12;MPPE1;APBA1;PNKD;HIP1
18483,GO:1903672,0.945331681677278,0.224212569142907,1,23,positive regulation of sprouting angiogenesis,BP,VEGFA
10658,GO:0043921,0.945416866916975,0.223959973650357,1,23,modulation by host of viral transcription,BP,HMGA2
13311,GO:0052312,0.945416866916975,0.223959973650357,1,23,modulation of transcription in other organism involved in symbiotic interaction,BP,HMGA2
13329,GO:0052472,0.945416866916975,0.223959973650357,1,23,modulation by host of symbiont transcription,BP,HMGA2
11984,GO:0047485,0.945468820948048,0.107696450191013,7,96,protein N-terminus binding,MF,ZMYND8;NTSR1;ERCC6;EXOC2;MAP2K1;PIAS3;STX1A
6351,GO:0021537,0.945685118243255,0.0917598844088472,13,158,telencephalon development,BP,PTPRS;BBS2;LRP1;EGFR;TRAPPC9;BNIP3;TCTN1;MDK;NDE1;ATP2B4;LAMB1;SLC38A2;EPHB2
104,GO:0000217,0.945707150705898,0.223098123192016,1,23,DNA secondary structure binding,MF,XPC
7834,GO:0032400,0.945861758276321,0.222638406376457,1,23,melanosome localization,BP,BBS2
13191,GO:0051875,0.945861758276321,0.222638406376457,1,23,pigment granule localization,BP,BBS2
15247,GO:0071453,0.945899996784804,0.0898975151500372,14,171,cellular response to oxygen levels,BP,EGR1;VEGFA;NDRG1;ZFP36L1;BNIP3;ENDOG;AQP3;DNMT3A;BNIP3L;TERC;AKT1;LMNA;SIRT2;EPAS1
7897,GO:0032479,0.945948638963442,0.10300501960526,8,107,regulation of type I interferon production,BP,PTPRS;RNF135;TMEM173;NLRX1;STAT6;FLOT1;IRF5;POLR3GL
9183,GO:0035580,0.946160848352487,0.163811563895544,2,38,specific granule lumen,CC,TIMP2;DNASE1L1
6504,GO:0021885,0.946199205355895,0.16391001614046,2,37,forebrain cell migration,BP,EGFR;LAMB1
12726,GO:0051018,0.946391885136251,0.163450727318468,2,37,protein kinase A binding,MF,PJA2;RAB13
1146,GO:0002753,0.946472896559932,0.139534984218316,3,50,cytoplasmic pattern recognition receptor signaling pathway,BP,NLRX1;TKFC;IKBKB
14264,GO:0061384,0.946493144797701,0.220756015717012,1,23,heart trabecula morphogenesis,BP,TGFBR3
4300,GO:0009755,0.946781315324094,0.0901021497725283,13,158,hormone-mediated signaling pathway,BP,NR1D1;SLC27A1;PAK1;KDM3A;PPARA;THRA;PAQR6;CREBRF;CALCOCO1;TADA3;RXRA;CRY2;PER1
5507,GO:0016469,0.946913428002253,0.219048162268763,1,24,proton-transporting two-sector ATPase complex,CC,TCIRG1
10510,GO:0043462,0.946993899624256,0.138321424430055,3,51,regulation of ATPase activity,BP,TPM2;DNAL4;TMSB4X
1336,GO:0003197,0.947218461222314,0.218583576486178,1,23,endocardial cushion development,BP,TGFBR2
3893,GO:0008535,0.947737685017948,0.216573465062753,1,24,respiratory chain complex IV assembly,BP,SMIM20
18781,GO:1904375,0.948330582809336,0.11374345649916,5,74,regulation of protein localization to cell periphery,BP,LRP1;EGFR;PRNP;AKT1;EPHB2
15174,GO:0071346,0.948458694460947,0.0987950835998616,8,108,cellular response to interferon-gamma,BP,GSN;ADAMTS13;RPL13A;IFNGR2;IRF5;PTAFR;RAB43;HLA-G
4196,GO:0009308,0.94856737313463,0.106983586208861,6,88,amine metabolic process,BP,ALDH7A1;AZIN2;ATP2B4;SAT2;DHPS;PNKD
15847,GO:0072595,0.948633568476798,0.157886879364054,2,38,maintenance of protein localization in organelle,BP,ARL2;AKT1
7979,GO:0032606,0.949280600104093,0.0974193631573559,8,108,type I interferon production,BP,PTPRS;RNF135;TMEM173;NLRX1;STAT6;FLOT1;IRF5;POLR3GL
7293,GO:0031301,0.949480671610727,0.089420042452846,11,140,integral component of organelle membrane,CC,PTPRS;B4GAT1;BNIP3;PEX10;PQLC2;SV2A;STEAP2;TBC1D20;LEMD2;MFNG;PEX11A
12086,GO:0048147,0.949534887248491,0.211128419033072,1,24,negative regulation of fibroblast proliferation,BP,NUPR1
19773,GO:2000249,0.949784374459188,0.210367097970757,1,24,regulation of actin cytoskeleton reorganization,BP,RAPGEF3
12909,GO:0051290,0.949873645424154,0.154099625870248,2,43,protein heterotetramerization,BP,CBR4;INSR
14445,GO:0061844,0.950058263371329,0.208406872798115,1,27,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,FAM3A
8231,GO:0033014,0.950359363096468,0.208607352237493,1,24,tetrapyrrole biosynthetic process,BP,UROS
1869,GO:0004540,0.950627561665117,0.103337577749594,6,87,ribonuclease activity,MF,PAN2;ISG20;ERN1;LACTB2;CPSF4;ENDOV
9245,GO:0035666,0.950715429971398,0.207513987696966,1,24,TRIF-dependent toll-like receptor signaling pathway,BP,IKBKB
10595,GO:0043601,0.950904471542506,0.206932367026396,1,24,nuclear replisome,CC,POLD4
12529,GO:0050702,0.951015531497454,0.206590301797555,1,24,interleukin-1 beta secretion,BP,NLRP1
11074,GO:0045095,0.951056401985873,0.206464351549167,1,24,keratin filament,CC,FBF1
10266,GO:0043030,0.95119974829508,0.206022308609324,1,24,regulation of macrophage activation,BP,MYO18A
13115,GO:0051705,0.951330203021086,0.151335760788407,2,38,multi-organism behavior,BP,DLG4;SHANK2
4598,GO:0010718,0.951422622081068,0.151109520186046,2,38,positive regulation of epithelial to mesenchymal transition,BP,WWTR1;TGFBR2
18986,GO:1904837,0.951427798155478,0.150607324311058,2,41,beta-catenin-TCF complex assembly,BP,ASH2L;TCF7
1147,GO:0002755,0.951511853567564,0.205058269597427,1,24,MyD88-dependent toll-like receptor signaling pathway,BP,TNIP1
688,GO:0001909,0.951541126192454,0.128478185176742,3,52,leukocyte mediated cytotoxicity,BP,CTSH;ULBP1;LYST
11499,GO:0046034,0.951601292381857,0.0779354036523363,17,208,ATP metabolic process,BP,PGM1;DHTKD1;DDIT4;OGDHL;PPARA;FAM20C;MYH3;MLXIPL;SDHA;GALK1;NADK;ALDOC;TMSB4X;TCIRG1;INSR;TAZ;PFKL
3303,GO:0007006,0.951607127153937,0.0970277085110707,7,99,mitochondrial membrane organization,BP,TFDP2;BNIP3;BBC3;BNIP3L;ALKBH7;TP73;TAZ
12232,GO:0048534,0.951618711853406,0.0635620198771166,60,616,hematopoietic or lymphoid organ development,BP,FOS;EGR1;CTNNBIP1;FAM210B;VEGFA;ERCC1;ZFP36L1;DHTKD1;ASH2L;SOX13;MAP2K1;PKN1;FAM213A;PRKCZ;RAG1;WNT2B;CHD2;MKNK2;SATB1;STAT6;KCNAB2;MAPK3;THRA;FAM20C;INPP5D;DMTN;LRRC8A;ZFPM1;DOCK11;POLM;HDAC5;CEBPB;LRP5;L3MBTL1;TGFBR2;FOXL1;CMTM7;AGO4;GAS6;BCR;NBEAL2;CARD11;DNASE2;SH2B3;BRAF;ZNF160;LGALS1;JAK3;TP73;TAZ;BCL6;ADA;POU2F2;TGFBR3;TCF7;EPAS1;MFNG;SH3PXD2A;ERBB2;HLA-G
6695,GO:0030101,0.951775998151836,0.150071925103524,2,39,natural killer cell activation,BP,GAS6;ULBP1
5646,GO:0016746,0.951792750566769,0.0787187691765543,16,191,transferase activity, transferring acyl groups,MF,CRAT;NAGS;ZDHHC1;GGT1;CPT2;LPCAT4;PNPLA3;NAT14;CPT1C;TADA3;ZDHHC24;CERS4;TAZ;HGSNAT;SAT2;MBOAT2
7711,GO:0032210,0.951861514056458,0.127884622202125,3,51,regulation of telomere maintenance via telomerase,BP,MAPK3;PKIB;HMBOX1
3660,GO:0008150,0.951923958083597,0.0597856196979956,1310,11234,biological_process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;NYNRIN;APOE;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;GID4;FOS;PRODH;OSBPL5;IL20RB;H1F0;GSN;ADGRL1;CITED4;ACSF2;CCNG2;PYGB;EGR1;CTNNBIP1;LMF1;THBS3;PGF;ALDH7A1;FGFBP1;TYSND1;POSTN;PPP1R35;EVI5L;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;THSD4;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;FAM210B;GPX3;GJC2;SEMA4B;LRP1;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;TFPI2;SH3TC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;DGKA;TSPAN1;SLC16A3;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;SDK2;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;CYYR1;MICALCL;ACAD10;PGM1;CGREF1;CRTC1;CLCA2;SCN4B;PACS2;ORAI3;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;TBC1D8;ABTB1;ARHGEF19;TCEA2;KHNYN;MMP28;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;MMP1;PYCR2;CTF1;CNTN1;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;PHYHD1;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;LTBP4;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;PLD3;ASH2L;SOX13;CUL7;PITPNM3;LHPP;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;NXPH4;SMOC2;NAGLU;ARPIN;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;SMOC1;ACP6;POLD4;GIGYF1;MAP2K1;CYP27B1;PCK2;SLC16A5;MXD4;COL6A1;CCDC71L;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;SLC43A1;MC1R;CAPG;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;DNAJC4;FAM213A;FAM110C;THAP8;MAGEF1;DNAH1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;ADM2;MARCKSL1;OGDHL;SOX12;HDAC11;RAB3B;NLGN2;CD68;PCSK1;PLEKHH3;SLC12A7;PTMS;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;UNK;NMRK1;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;C22ORF23;TTBK2;LY6K;PRKCZ;PPP2R3B;HTR7;GALE;SERPING1;PAK1;ABCA7;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;PABPC1L;ERO1B;BLVRB;PEAR1;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;BRI3;FOXQ1;ARVCF;KLHL29;PHF1;GLDC;NPR2;SEMA3F;PLCXD1;PLXNB3;CAPNS2;NDUFA4L2;CBS;TMEM187;SPRY4;FAM3A;USP20;DHRS12;SALL2;ORAI2;ELMO3;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;NMNAT2;DDX59;MICALL2;SLCO4A1;NME4;PDZD2;CEP250;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;EPOR;MARCH4;NID1;ETV5;NSUN7;ETFB;GSTO1;LCE1E;ARHGEF4;WDR60;LTBP1;MUC19;SYNC;PPCS;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;PLXNB1;EREG;CHD2;GPT2;TEF;TNS1;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;SPATA20;OLFM2;PLCD3;PLEKHG2;DHRS4;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;PPM1J;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;SCART1;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;C5;KIF17;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;ANO1;STON1;CHAC1;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;PPP1R3E;SH3TC2;ING4;NUDCD3;ACOT11;VAMP2;RRNAD1;HMGA2;AREG;ST6GALNAC6;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;LRP11;PCLO;KCNC4;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;ITGB5;LAMB2;PC;FBXO27;BNIP3;ERRFI1;MACROD1;OSBPL10;SEMA5A;THRA;IFITM1;DCAF10;PEX10;CCNI;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;KCTD15;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;LTBP2;ADAMTSL1;SNTA1;FAHD2B;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;SLITRK6;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;NYAP1;PI4K2A;NAT14;SRGAP3;ZXDC;PAQR6;PQLC2;SDC2;CHMP1B;FBXO17;NRSN2;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TBC1D14;TCTN1;PTPDC1;C1RL;PLCD1;ARHGEF2;SEPT10;FBF1;INPP5D;PDCD1LG2;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;TWF2;SAMD3;STMN3;SLC50A1;PGPEP1;SDHA;TECPR1;KIF21B;FAM86C2P;SLC48A1;EHBP1L1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;UBXN4;MORN4;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;DOCK11;SSH1;LTB4R2;PCMTD2;SV2A;TBC1D3E;SLC38A10;PRIMPOL;METRN;FRMD4B;RABGAP1;GPR153;POLM;ACAP3;TENM2;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;ATXN10;RALGAPA1;SLC29A4;FLOT1;LTBP3;CEP68;MDK;TTN;PSKH1;HLCS;KCNMA1;AZIN2;HSD11B1;TSNARE1;TMEM128;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;NTPCR;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;TPBG;PAPLN;ADGRF1;NADK;PRR15;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;ROBO3;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;ACADS;FBXL16;CEP131;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;CSRNP3;TTC12;MN1;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;SLFN5;ANO9;MAP1LC3A;MOCOS;APOL4;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;HERPUD2;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;RPUSD3;SEMA4G;ZNF662;SHARPIN;CCS;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;OLFML2A;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ECM2;ALKBH7;CROCC;PLEKHG3;BCR;KLHDC8B;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;C19ORF33;CEP112;NBR1;CPT1C;EXD3;HEXA;FAHD2A;GOLGA2P5;TNNI2;BCAM;SRR;TADA3;NBEAL2;C1QTNF6;BOLA1;MFSD3;KIF13B;SPAG16;TTYH3;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;THNSL2;PRDM8;SLC9A3R2;EFEMP2;STRADB;CTSH;TNFRSF14;WDR19;ACOX3;ACAD11;PNRC1;TMEM80;FBXL8;UACA;GSDMC;MGMT;GSTO2;ASNS;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;TP53I11;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;SWT1;CRY2;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;SEMA6B;IFT57;LACTB2;PSMG4;PHYKPL;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;SPDYE2;SPDYE2B;TTC21A;CAPS;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;KIF27;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;TMEM256;RASSF9;SLC6A9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;SLC6A6;ZNF25;FARP1;DNASE2;LMNA;TMEM63C;ASMTL;FAAH;UPP1;SH2B3;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;CKLF;FOXO4;GNAL;COG7;YPEL3;SLC22A15;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;LTB4R;SMIM20;TPCN1;ULBP1;ADD3;MBLAC2;MAGED2;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;BTN3A2;ASIC1;ALDH1L1;HOXC5;PLB1;GJB4;FAAP20;PIDD1;CAT;ZNF160;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;UNC119B;TIMP1;HFE;JAK3;KIAA1549;MRGPRX3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;CHRM3;ZNF846;APRT;FCHSD1;TMX4;TFEB;OGFOD2;MIB2;CERS4;MPI;PEX7;SNX17;LSM14B;ENDOV;JOSD2;PHC1;ICAM5;SCYL3;METTL7A;ATP12A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BTN3A3;BCL6;REPS2;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;PJA2;SLC38A2;SNX1;PEX1;LEMD2;UBXN6;ARHGEF17;SLC25A42;SIRT2;TRPC1;MBOAT2;GDF15;SPRED3;PHLDA2;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;TST;GOLGA2;CELSR1;ADA;CADM4;POU2F2;PLXND1;RCOR2;POLR3GL;TMEM54;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;TMEM101;MSH5;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;SLC35F3;ADIRF;RPL29;EIF4EBP1;AVPI1;ERV3-1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;TMCO6;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;DIP2C;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;RGPD6;FKBP8;SPATA6;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;PLLP;SLC10A6;KDELC2;UST;EIF2AK4;STK32B;UNC119;PAG1;CCDC69;RGS12;SYVN1;OSCP1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;MMP17;RPL12;MPPE1;HMBOX1;NET1;TTC19;WBP1;HSP90AB4P;RTL1;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;ROBO4;TEAD2;ACOT8;BTBD11;SLC9A5;SIX5
41,GO:0000083,0.951939487043771,0.203733829750249,1,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,TFDP2
13157,GO:0051787,0.951963814470035,0.203658360141517,1,24,misfolded protein binding,MF,EDEM1
6855,GO:0030332,0.95222804860409,0.202837775522557,1,24,cyclin binding,MF,CDK5RAP3
20104,GO:2000826,0.952276246982513,0.202687923023305,1,24,regulation of heart morphogenesis,BP,TGFBR2
482,GO:0001533,0.952508486562191,0.126103706441746,3,55,cornified envelope,CC,PPL;LCE1E;LCE1F
12104,GO:0048199,0.952518962242621,0.113964505865153,4,64,vesicle targeting, to, from or within Golgi,BP,TRAPPC9;AREG;TBC1D20;GOLGA2
6781,GO:0030225,0.952604736026507,0.201665209904356,1,24,macrophage differentiation,BP,VEGFA
2941,GO:0006471,0.952628183934321,0.201592112864726,1,24,protein ADP-ribosylation,BP,SIRT2
12234,GO:0048536,0.95280357228125,0.201044951677259,1,24,spleen development,BP,PKN1
3938,GO:0008631,0.952958636291252,0.147162555738174,2,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PRODH;AKT1
6254,GO:0019843,0.953073192899702,0.124875851083607,3,55,rRNA binding,MF,CIRBP;TST;RPL12
4226,GO:0009408,0.953132488977666,0.0836510179845715,11,140,response to heat,BP,NOS1;ANO1;LRP11;MAPK3;TRPV4;NOS3;TRPV1;AKT1;IGFBP7;MYOF;HSF4
3301,GO:0007004,0.953456658755582,0.112080375089918,4,64,telomere maintenance via telomerase,BP,MAPK3;PKIB;TERC;HMBOX1
14444,GO:0061842,0.953508981473168,0.198837075480935,1,24,microtubule organizing center localization,BP,NDE1
10871,GO:0044429,0.953533093841824,0.0588854608764501,84,851,mitochondrial part,CC,PRODH;ACSF2;ALDH7A1;CRAT;FAM210B;NAGS;D2HGDH;HADH;PRDX5;BPHL;SNPH;IDH2;DNM1;ACAD10;GRAMD4;ARMCX2;PYCR2;DHTKD1;ALDH4A1;TK2;CPT2;MLYCD;HMGCL;ACP6;CYP27B1;PCK2;TMEM173;ARL2;ULK1;SHC1;OGDHL;GLDC;NDUFA4L2;NME4;ETFB;GPT2;NIPSNAP1;NLRX1;ACACB;PC;BNIP3;ACSS2;HIBADH;SDHA;PRIMPOL;TFB1M;ACADS;PDE2A;ALDH1L2;PEMT;SLC27A3;BNIP3L;RPUSD3;GLUD1;SUCLG2;ALKBH7;CPT1C;PPP1R15A;ACAD11;DGUOK;LACTB2;PHYKPL;SNN;HAGH;CBR4;ACADVL;SPATA18;IFI27;ACSS1;SLC25A29;ANKZF1;SMIM20;TXNRD2;LETMD1;CAT;MPG;TAZ;SLC25A42;TST;CIDEA;BLOC1S1;FKBP8;TTC19;SDHAF4
20228,GO:2001222,0.953598268335797,0.198556786040395,1,24,regulation of neuron migration,BP,ARHGEF2
652,GO:0001843,0.953655037654967,0.103675787457368,5,75,neural tube closure,BP,VANGL2;DEAF1;IFT57;CELSR1;TEAD2
13915,GO:0060606,0.953655037654967,0.103675787457368,5,75,tube closure,BP,VANGL2;DEAF1;IFT57;CELSR1;TEAD2
13481,GO:0055076,0.953943024353572,0.0929209090998037,7,100,transition metal ion homeostasis,BP,PRNP;CYBRD1;ATP7B;STEAP2;STEAP3;HFE;EPAS1
7589,GO:0031970,0.953944622586934,0.102981010706062,5,78,organelle envelope lumen,CC,ARL2;NME4;SORL1;CAT;BLOC1S1
18338,GO:1903362,0.954102965413756,0.0743132078115265,17,203,regulation of cellular protein catabolic process,BP,APOE;EDEM1;LRP1;MAGEF1;VPS11;TRIB2;PKD1;HERPUD1;RHBDF1;ATRAID;PCSK9;TRIB3;CDK5RAP3;AKT1;HFE;CSNK1E;SIRT2
10089,GO:0042623,0.954157381932292,0.0684032758765477,26,289,ATPase activity, coupled,MF,ERCC6;SMARCA1;ABCA2;DNAH1;ABCA7;DDX59;WDR60;CHD2;ABCG1;KIF17;CHD3;DNAL4;MYH3;DHX32;LONP2;ATP7B;ATP2B4;TNNT1;KIF27;TCIRG1;ATP12A;ATP8B2;PEX1;RECQL5;MSH5;CHD6
13672,GO:0060249,0.954347439122597,0.0685952448106636,25,284,anatomical structure homeostasis,BP,BBS2;F2R;IL20RB;ACP5;VEGFA;EGFR;ERCC1;ERCC6;GAA;BBS1;POLD4;NPHP4;STK39;MAPK3;INPP5D;TEP1;PKIB;CROCC;TERC;SPATA7;CTSH;HOMER2;HDAC8;EPAS1;HMBOX1
9848,GO:0042116,0.954369947478175,0.143664932778978,2,39,macrophage activation,BP,TRPV1;MYO18A
2942,GO:0006473,0.954725174169378,0.0778990107730156,13,162,protein acetylation,BP,RAPGEF3;NOS1;NUPR1;ING4;JADE2;MAPK3;TADA3;CAMK1;HINT2;RPS6KA5;HDAC8;PER1;BLOC1S1
3354,GO:0007093,0.954827408390838,0.0792245721017806,12,152,mitotic cell cycle checkpoint,BP,XPC;BRSK1;RBL2;TFDP2;HMGA2;PCBP4;CDK5RAP3;CHEK2;FOXO4;CHMP4C;PIDD1;TP73
2876,GO:0006378,0.955082438713947,0.14188830455525,2,39,mRNA polyadenylation,BP,PABPC1L;CPSF4
15880,GO:0072678,0.95529026892661,0.192817935040472,1,25,T cell migration,BP,ECM1
11380,GO:0045787,0.955601966580392,0.0659533604278921,27,302,positive regulation of cell cycle,BP,PTK6;EGFR;RBL2;TFDP2;RAB11FIP4;HYAL1;EREG;PKD2;HMGA2;MLXIPL;PKD1;PCBP4;LRP5;MAPRE3;ASNS;AKT1;CHEK2;UHRF2;INSR;FOXO4;C6ORF89;PIDD1;TP73;MTA3;SIRT2;EIF4EBP1;FGFR1
14,GO:0000027,0.955806158093169,0.190816467887017,1,26,ribosomal large subunit assembly,BP,RPL12
8085,GO:0032781,0.955807915014967,0.13991529575048,2,40,positive regulation of ATPase activity,BP,DNAL4;TMSB4X
13153,GO:0051783,0.955848424848233,0.0776209047560759,12,152,regulation of nuclear division,BP,CUL9;OBSL1;CUL7;TOM1L2;EREG;CHMP1B;LRP5;L3MBTL1;CHMP5;INSR;CHMP4C;SIRT2
42,GO:0000086,0.955915967696398,0.0699971176473803,19,225,G2/M transition of mitotic cell cycle,BP,FHL1;NINL;BRSK1;SDCCAG8;CEP250;HMGA2;CNTRL;NDE1;FBXL15;CEP131;CDK5RAP3;CHEK2;PHLDA1;FOXO4;CHMP4C;HAUS4;MTA3;CSNK1E;SFI1
7401,GO:0031492,0.955940032381435,0.139294988136411,2,42,nucleosomal DNA binding,MF,HMGA2;SMARCD2
15870,GO:0072665,0.955954682135091,0.118823419163926,3,52,protein localization to vacuole,BP,SORL1;C12ORF66;TMEM50B
650,GO:0001841,0.956012866836853,0.0935714132105194,6,87,neural tube formation,BP,VANGL2;TCTN1;DEAF1;IFT57;CELSR1;TEAD2
2532,GO:0005789,0.9560541797626,0.0562130926450933,79,791,endoplasmic reticulum membrane,CC,OSBPL5;LMF1;TMEM129;EDEM1;EGFR;NOS1;GPSM1;CYP3A5;REEP2;PLD3;LPCAT4;PITPNM1;TMEM173;ULK1;ITPR3;SLC37A2;MCTP1;ERO1B;SPPL2B;SMIM14;TMC6;PNPLA3;DHRS4;TMED4;ABCG1;ESYT2;PKD2;AREG;SCARA3;IFNGR2;SRD5A3;UBXN4;MOSPD3;REEP6;PSKH1;HSD11B1;HERPUD1;RHBDF1;HSD17B7;PEMT;EDA;PIGZ;MARCH2;RHBDF2;ERN1;CPT1C;NECAB3;CYP2R1;PPP1R15A;TM7SF2;ITPR2;REEP4;FAAH;COPG1;TBC1D20;PIGQ;CERS4;TMEM50B;SLC37A4;ATP8B2;PJA2;MBOAT2;RTN2;ENTPD2;RETSAT;MAN1B1;RNF170;PIGV;WFS1;ESYT3;FITM2;FKBP8;XYLT2;SEC31B;SYVN1;HLA-G;CREB3L4;KDSR;CYP4V2
6725,GO:0030148,0.956075105236161,0.0990065907271338,5,76,sphingolipid biosynthetic process,BP,PLA2G6;ST6GALNAC6;PEMT;CERS4;KDSR
18081,GO:1902749,0.956197535623134,0.0721361319595853,16,195,regulation of cell cycle G2/M phase transition,BP,FHL1;NINL;BRSK1;SDCCAG8;CEP250;HMGA2;CNTRL;NDE1;CEP131;CDK5RAP3;FOXO4;CHMP4C;HAUS4;MTA3;CSNK1E;SFI1
4502,GO:0010557,0.956683763958868,0.0528522081369248,130,1246,positive regulation of macromolecule biosynthetic process,BP,TNIP1;F2R;NFATC4;FOS;CITED4;EGR1;VEGFA;EGFR;NR1D1;CST3;MEF2D;NOS1;DDIT3;CRTC1;ERCC6;TCEA2;SMARCA1;TFDP2;ASH2L;ETV4;WWTR1;MAP2K1;MC1R;ITGA6;ZNF76;PBX2;MAML3;TMEM173;SHC1;SOX12;CIRBP;CAPRIN2;ELK3;PABPC1L;SEC14L2;KDM3A;PHF1;SALL2;ETV1;ZP3;ABHD14B;EAPP;NGFR;ETV5;EREG;TEF;CARF;PPARA;SESN2;IMPACT;PKD2;STAT6;KLF7;HMGA2;AREG;MAPK3;THRA;IRF2BPL;NAT14;ZXDC;MLXIPL;ARHGEF2;MAP2K2;LITAF;ATF4;ZFPM1;ZNF516;PKD1;MDK;HDAC5;IRF5;DEAF1;PEG3;RFX2;KDM7A;CEBPB;LRP5;CREBRF;PKIB;METTL23;HLTF;CSRNP3;APLN;CALCOCO1;CDK5RAP3;HEXB;ZFP90;WNT7A;PIK3R2;MAPRE3;TNNI2;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;AKT1;CARD11;CDKN1C;CHEK2;PHF2;FGFR4;INSR;NCOA7;FOXO4;RPS6KA5;MAP2K5;TP73;TFEB;HSF4;SIRT2;GOLGA2;POU2F2;PLXND1;ADIRF;EPAS1;CHD6;PER1;ITGA2;FGFR1;ERBB2;EIF2AK4;HMBOX1;CREB3L4;KCTD13;DBP;ZNF287;IKBKB;TEAD2;SIX5
2832,GO:0006303,0.956742152550724,0.105234034413122,4,67,double-strand break repair via nonhomologous end joining,BP,ERCC1;HMGA2;POLM;POLL
1093,GO:0002682,0.956840864386517,0.0543161527186546,93,923,regulation of immune system process,BP,TNIP1;PTPRS;HTRA1;FOS;IL20RB;GSN;CTNNBIP1;PGF;WIPF1;RNF135;FAM210B;VEGFA;RBCK1;PRNP;FCGRT;NR1D1;GGT1;MMP28;ZFP36L1;EFNB3;ASH2L;SOX13;PKN1;TMEM173;FAM213A;SHC1;VEGFB;PRKCZ;SERPING1;PAK1;FAM3A;ZP3;CCDC88B;RAG1;SPPL2B;MUC19;EREG;PLA2G6;ERMAP;C5;APOBEC3F;NLRX1;STAT6;ECM1;MAPK3;IFITM1;CTSB;IFNGR2;C1RL;INPP5D;PDCD1LG2;ZFPM1;FLOT1;CEBPB;L3MBTL1;AQP3;TGFBR2;TRPV4;AGO4;PIK3R2;GAS6;BCR;PTAFR;CTSH;TNFRSF14;AKT1;CARD11;HMSD;IGFBP2;RPS6KA5;ULBP1;BRAF;BTN3A2;MAPK10;LGALS1;HFE;JAK3;TP73;ICAM5;BTN3A3;BCL6;TKFC;FYN;ADA;MYO18A;VAV3;DHPS;ITGA2;ERBB2;EIF2AK4;PAG1;HLA-G;IKBKB
10162,GO:0042770,0.95685729577122,0.0818217752065713,9,121,signal transduction in response to DNA damage,BP,NDRG1;RBL2;TFDP2;SESN2;ING4;PCBP4;CHEK2;PIDD1;TP73
11893,GO:0046949,0.957199251076082,0.186706307714364,1,25,fatty-acyl-CoA biosynthetic process,BP,CBR4
12127,GO:0048255,0.957636582182482,0.185293266300092,1,25,mRNA stabilization,BP,CIRBP
7965,GO:0032588,0.95772578545289,0.103340472759449,4,65,trans-Golgi network membrane,CC,ATP7B;RAB43;COG7;RHOBTB3
3243,GO:0006903,0.957735904609512,0.0957637017673979,5,77,vesicle targeting,BP,TRAPPC9;AREG;SEPT5;TBC1D20;GOLGA2
7706,GO:0032204,0.957813516322009,0.0956595458794282,5,76,regulation of telomere maintenance,BP,ERCC1;MAPK3;PKIB;HDAC8;HMBOX1
297,GO:0000803,0.957867510605806,0.184545139643057,1,25,sex chromosome,CC,DNMT3A
2875,GO:0006376,0.957884112651422,0.184491301743063,1,25,mRNA splice site selection,BP,SRSF5
8416,GO:0033522,0.957993604966119,0.184136055850581,1,25,histone H2A ubiquitination,BP,DDB2
13725,GO:0060325,0.958013192703836,0.184072470955498,1,25,face morphogenesis,BP,MYH3
2970,GO:0006513,0.958040387658289,0.102694519970813,4,65,protein monoubiquitination,BP,DDB2;NEURL1;RAG1;TSG101
4386,GO:0010043,0.958107991968999,0.183412260248372,1,26,response to zinc ion,BP,D2HGDH
7061,GO:0030857,0.958165939585763,0.183576287902408,1,25,negative regulation of epithelial cell differentiation,BP,XDH
98,GO:0000209,0.95817608546436,0.0637420880626594,24,275,protein polyubiquitination,BP,FBXO2;TMEM129;RBCK1;DDB2;RNF165;FBXW4;FBXO41;FBXW8;UNKL;BLMH;FBXO27;FBXO17;LRSAM1;FBXO6;FBXL15;FBXL16;SMURF2;LMO7;SHARPIN;FBXL8;UBOX5;MIB2;RNF213;SYVN1
14802,GO:0070566,0.958244266229169,0.183321615597257,1,25,adenylyltransferase activity,MF,NMNAT2
264,GO:0000732,0.958671619236844,0.181929280981763,1,25,strand displacement,BP,RMI2
15070,GO:0071108,0.958690094269358,0.181868980064136,1,25,protein K48-linked deubiquitination,BP,USP20
14782,GO:0070536,0.958837766381087,0.181386666289955,1,25,protein K63-linked deubiquitination,BP,USP20
11353,GO:0045739,0.959058272846846,0.1316831442139,2,40,positive regulation of DNA repair,BP,EGFR;MGMT
3050,GO:0006612,0.959058642756528,0.0723959835952938,12,164,protein targeting to membrane,BP,PRNP;ZDHHC1;ANK3;RPL13A;PAK1;CEMIP;DMTN;ZDHHC24;FYN;RPL29;ERBB2;RPL12
7292,GO:0031300,0.959089667814987,0.072471396911947,12,154,intrinsic component of organelle membrane,CC,PTPRS;RAB3B;B4GAT1;BNIP3;PEX10;PQLC2;SV2A;STEAP2;TBC1D20;LEMD2;MFNG;PEX11A
12926,GO:0051310,0.95961064068622,0.11057251434518,3,53,metaphase plate congression,BP,CHMP1B;CHMP5;CHMP4C
2188,GO:0005048,0.959645775152484,0.130177463473077,2,40,signal sequence binding,MF,CEMIP;PEX7
15871,GO:0072666,0.959908691420868,0.129501833114446,2,40,establishment of protein localization to vacuole,BP,SORL1;TMEM50B
19528,GO:1990542,0.960616281470516,0.0972550185472589,4,67,mitochondrial transmembrane transport,BP,CPT2;ACACB;SLC25A29;TST
16858,GO:0098827,0.960681333874823,0.0505522351256068,79,795,endoplasmic reticulum subcompartment,CC,OSBPL5;LMF1;TMEM129;EDEM1;EGFR;NOS1;GPSM1;CYP3A5;REEP2;PLD3;LPCAT4;PITPNM1;TMEM173;ULK1;ITPR3;SLC37A2;MCTP1;ERO1B;SPPL2B;SMIM14;TMC6;PNPLA3;DHRS4;TMED4;ABCG1;ESYT2;PKD2;AREG;SCARA3;IFNGR2;SRD5A3;UBXN4;MOSPD3;REEP6;PSKH1;HSD11B1;HERPUD1;RHBDF1;HSD17B7;PEMT;EDA;PIGZ;MARCH2;RHBDF2;ERN1;CPT1C;NECAB3;CYP2R1;PPP1R15A;TM7SF2;ITPR2;REEP4;FAAH;COPG1;TBC1D20;PIGQ;CERS4;TMEM50B;SLC37A4;ATP8B2;PJA2;MBOAT2;RTN2;ENTPD2;RETSAT;MAN1B1;RNF170;PIGV;WFS1;ESYT3;FITM2;FKBP8;XYLT2;SEC31B;SYVN1;HLA-G;CREB3L4;KDSR;CYP4V2
4460,GO:0010458,0.961177053569745,0.17332456646755,1,26,exit from mitosis,BP,SIRT2
2839,GO:0006310,0.961398880669588,0.0626992935634866,18,215,DNA recombination,BP,ERCC1;MAGEF1;RAG1;NSMCE4A;RMI2;INO80C;STAT6;POLM;NSMCE1;TEP1;ENDOG;MLH3;POLL;BCL6;REC8;RECQL5;MSH5;TCF7
14743,GO:0070461,0.9614660904216,0.172361215809215,1,26,SAGA-type complex,CC,TADA3
10194,GO:0042826,0.961598128993057,0.0831583723064019,6,89,histone deacetylase binding,MF,MEF2D;UHRF1BP1;PKN1;HDAC5;CEBPB;SIRT2
6535,GO:0021953,0.961615088024288,0.0831266135583025,6,89,central nervous system neuron differentiation,BP,ADARB1;TCTN1;WNT7A;WNT3;CSNK1E;EPHB2
7089,GO:0030894,0.961626266361436,0.171826336540631,1,26,replisome,CC,POLD4
20245,GO:2001243,0.96175000300198,0.0878602233129954,5,79,negative regulation of intrinsic apoptotic signaling pathway,BP,ARHGEF2;HERPUD1;AKT1;WFS1;SYVN1
17803,GO:1901990,0.961793438782675,0.055704752495186,32,356,regulation of mitotic cell cycle phase transition,BP,XPC;FHL1;GJC2;EGFR;NINL;BRSK1;ZFP36L1;RBL2;TFDP2;HYAL1;SDCCAG8;CEP250;PKD2;HMGA2;CNTRL;PKD1;PCBP4;NDE1;CEP131;CDK5RAP3;AKT1;CHEK2;FOXO4;CHMP4C;CTDSPL;PIDD1;HAUS4;TP73;MTA3;CSNK1E;SIRT2;SFI1
899,GO:0002279,0.961800792401949,0.171242706588339,1,26,mast cell activation involved in immune response,BP,S100A13
10429,GO:0043303,0.961800792401949,0.171242706588339,1,26,mast cell degranulation,BP,S100A13
1148,GO:0002756,0.961860886564071,0.171041545282161,1,26,MyD88-independent toll-like receptor signaling pathway,BP,IKBKB
4200,GO:0009312,0.961867714980032,0.171018681063052,1,26,oligosaccharide biosynthetic process,BP,ST6GALNAC6
12390,GO:0048857,0.962193439251429,0.12344398986508,2,41,neural nucleus development,BP,GLUD1;SIRT2
14004,GO:0060759,0.962535467829837,0.0701618514095812,10,134,regulation of response to cytokine stimulus,BP,RBCK1;SPPL2B;SLIT3;ECM1;IFNGR2;CREBRF;SHARPIN;GAS6;MAP2K5;IKBKB
16920,GO:0098930,0.962671221498735,0.122195601279299,2,41,axonal transport,BP,BLOC1S4;BLOC1S1
872,GO:0002224,0.962676354654889,0.0811025432253087,6,90,toll-like receptor signaling pathway,BP,TNIP1;PTPRS;NR1D1;CTSB;FLOT1;IKBKB
13264,GO:0051984,0.96281508397831,0.16783346189206,1,26,positive regulation of chromosome segregation,BP,SIRT2
7149,GO:0031018,0.96289483657801,0.167564125411292,1,26,endocrine pancreas development,BP,AKT1
3796,GO:0008378,0.962926953553599,0.167455608668346,1,26,galactosyltransferase activity,MF,B4GALT2
9878,GO:0042175,0.96296645810221,0.0476771136544103,80,806,nuclear outer membrane-endoplasmic reticulum membrane network,CC,OSBPL5;LMF1;TMEM129;EDEM1;EGFR;NOS1;GPSM1;CYP3A5;REEP2;PLD3;LPCAT4;PITPNM1;TMEM173;ULK1;ITPR3;SLC37A2;MCTP1;ERO1B;SYNE3;SPPL2B;SMIM14;TMC6;PNPLA3;DHRS4;TMED4;ABCG1;ESYT2;PKD2;AREG;SCARA3;IFNGR2;SRD5A3;UBXN4;MOSPD3;REEP6;PSKH1;HSD11B1;HERPUD1;RHBDF1;HSD17B7;PEMT;EDA;PIGZ;MARCH2;RHBDF2;ERN1;CPT1C;NECAB3;CYP2R1;PPP1R15A;TM7SF2;ITPR2;REEP4;FAAH;COPG1;TBC1D20;PIGQ;CERS4;TMEM50B;SLC37A4;ATP8B2;PJA2;MBOAT2;RTN2;ENTPD2;RETSAT;MAN1B1;RNF170;PIGV;WFS1;ESYT3;FITM2;FKBP8;XYLT2;SEC31B;SYVN1;HLA-G;CREB3L4;KDSR;CYP4V2
16575,GO:0097431,0.963058519970061,0.167010754639054,1,26,mitotic spindle pole,CC,MAPKBP1
13125,GO:0051721,0.963232432731671,0.166421932095088,1,26,protein phosphatase 2A binding,MF,AKT1
9932,GO:0042307,0.963426826156591,0.165762702511073,1,26,positive regulation of protein import into nucleus,BP,TMEM173
7290,GO:0031297,0.96353109093581,0.165408653146458,1,26,replication fork processing,BP,PRIMPOL
886,GO:0002253,0.963563086047456,0.0532982891451828,32,355,activation of immune response,BP,TNIP1;PTPRS;WIPF1;RBCK1;PRNP;NR1D1;TMEM173;SERPING1;PAK1;MUC19;PLA2G6;ERMAP;C5;NLRX1;MAPK3;CTSB;C1RL;INPP5D;FLOT1;PIK3R2;CARD11;HMSD;RPS6KA5;BRAF;BTN3A2;BTN3A3;TKFC;FYN;ADA;VAV3;PAG1;IKBKB
10616,GO:0043631,0.963744235678232,0.119377262354676,2,41,RNA polyadenylation,BP,PABPC1L;CPSF4
4478,GO:0010501,0.964432028592831,0.117559829847505,2,41,RNA secondary structure unwinding,BP,DDX59;AGO4
5739,GO:0016891,0.964465598686921,0.161914195636139,1,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,ENDOV
16063,GO:0090068,0.965168004950029,0.0570598160919172,18,218,positive regulation of cell cycle process,BP,RBL2;TFDP2;RAB11FIP4;HYAL1;EREG;PKD2;HMGA2;PCBP4;LRP5;CHEK2;UHRF2;INSR;FOXO4;PIDD1;TP73;MTA3;SIRT2;FGFR1
7865,GO:0032435,0.965318533852632,0.158983833457369,1,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,HFE
3672,GO:0008173,0.96547140834249,0.0969930432936079,3,55,RNA methyltransferase activity,MF,NSUN5P2;RRNAD1;TFB1M
7703,GO:0032201,0.965487233554613,0.158401548988784,1,27,telomere maintenance via semi-conservative replication,BP,POLD4
19876,GO:2000401,0.965507862903835,0.158330282922117,1,27,regulation of lymphocyte migration,BP,ECM1
6278,GO:0019887,0.965780834960492,0.0630924171722564,11,146,protein kinase regulator activity,MF,ERCC6;MAP2K1;DGKQ;SPRY2;TRIB2;MAP2K2;SAMD3;PKIB;TRIB3;GAS6;CDKN1C
12760,GO:0051059,0.965845308451618,0.157162624863939,1,27,NF-kappaB binding,MF,CDK5RAP3
1852,GO:0004518,0.965928058727075,0.059186726710584,14,178,nuclease activity,MF,ERCC1;DNASE1L1;NEIL1;RAG1;PAN2;ENDOG;ISG20;ERN1;EXD3;LACTB2;DNASE2;CPSF4;ENDOV;ZC3H12D
2549,GO:0005819,0.96593791385423,0.0519339262784608,26,297,spindle,CC,CLTCL1;RAB11FIP4;CAPG;EML2;TUBG2;FAM110C;WDR60;PKD2;RGS14;ARHGEF2;FBF1;NDE1;TADA3;PLEKHG6;MAPKBP1;AKT1;MZT2B;SEPT6;MAP2K5;MZT2A;HAUS4;TUBGCP6;SIRT2;GOLGA2;UNC119;CCDC69
11823,GO:0046822,0.966174130047914,0.0744427882346283,6,91,regulation of nucleocytoplasmic transport,BP,RAPGEF3;TMEM173;PDE2A;GAS6;CAMK1;IFI27
991,GO:0002448,0.96638911053795,0.155273229380097,1,27,mast cell mediated immunity,BP,S100A13
411,GO:0001098,0.966439398302963,0.112081195668362,2,42,basal transcription machinery binding,MF,ERCC1;RECQL5
412,GO:0001099,0.966439398302963,0.112081195668362,2,42,basal RNA polymerase II transcription machinery binding,MF,ERCC1;RECQL5
263,GO:0000731,0.966783502693333,0.0841804645145122,4,68,DNA synthesis involved in DNA repair,BP,POLD4;RMI2;PRIMPOL;FAAP20
2676,GO:0006040,0.966847438201696,0.153673340811119,1,27,amino sugar metabolic process,BP,CHST6
371,GO:0000993,0.966895226522111,0.15350612820372,1,27,RNA polymerase II core binding,MF,RECQL5
851,GO:0002181,0.966906306448945,0.0773986663850065,5,85,cytoplasmic translation,BP,RPL13A;UNK;EIF2D;RPL29;EIF4EBP1
12102,GO:0048193,0.966984002427864,0.0500969694222476,27,308,Golgi vesicle transport,BP,BBS2;OSBPL5;LMF1;ANK3;SPTB;EXOC2;BBS1;TMED4;TRAPPC9;VAMP2;AREG;TBC1D14;WHAMMP3;SORL1;GAS6;STEAP2;COPG1;SGSM2;TBC1D20;COG7;EHD3;SNX1;RAB13;GOLGA2;MYO18A;SEC31B;MPPE1
3347,GO:0007077,0.967285387934834,0.109802742584023,2,42,mitotic nuclear envelope disassembly,BP,NEK9;LMNA
5284,GO:0015949,0.967344546013951,0.151655562274993,1,28,nucleobase-containing small molecule interconversion,BP,NME4
11454,GO:0045931,0.967415809577487,0.0659484841922676,8,114,positive regulation of mitotic cell cycle,BP,HYAL1;EREG;LRP5;ASNS;INSR;MTA3;EIF4EBP1;FGFR1
20251,GO:2001252,0.967861363192601,0.0596427625192148,11,146,positive regulation of chromosome organization,BP,VEGFA;ERCC1;NOS1;PHF1;MAPK3;JDP2;PKIB;RPS6KA5;C6ORF89;BCL6;HMBOX1
288,GO:0000793,0.968354344525167,0.0553897734567211,14,174,condensed chromosome,CC,NSMCE4A;SPC24;NSMCE1;TTN;CEBPB;NDE1;L3MBTL1;MLH3;SEPT6;PHF2;ADD3;REC8;MSH5;RGS12
13094,GO:0051656,0.968654689560868,0.0465609778265349,31,348,establishment of organelle localization,BP,BBS2;SYTL1;SNPH;DNM1;SYT8;SPRY2;BLOC1S4;PRKCZ;SPG11;TRAPPC9;S100A13;VAMP2;AREG;SEPT5;PCLO;CHMP1B;ARHGEF2;NDE1;CROCC;FYCO1;RIMS3;COPG1;TBC1D20;CHMP5;CHMP4C;BRAF;SPIRE1;LEMD2;GOLGA2;STX1A;BLOC1S1
12849,GO:0051196,0.968721151743537,0.0799988704120317,4,68,regulation of coenzyme metabolic process,BP,DDIT4;PPARA;MLXIPL;INSR
729,GO:0001959,0.968798289611883,0.0613310217957946,9,126,regulation of cytokine-mediated signaling pathway,BP,RBCK1;SPPL2B;SLIT3;ECM1;IFNGR2;CREBRF;SHARPIN;GAS6;IKBKB
2504,GO:0005758,0.968866232139433,0.0795496204797325,4,71,mitochondrial intermembrane space,CC,ARL2;NME4;CAT;BLOC1S1
4818,GO:0014020,0.968872144364939,0.0735890019569839,5,80,primary neural tube formation,BP,VANGL2;DEAF1;IFT57;CELSR1;TEAD2
5541,GO:0016538,0.968889061857916,0.146191480719251,1,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1C
17804,GO:1901991,0.968985432504147,0.0526485165492787,16,202,negative regulation of mitotic cell cycle phase transition,BP,FHL1;GJC2;BRSK1;ZFP36L1;RBL2;TFDP2;PKD2;HMGA2;PCBP4;CDK5RAP3;CHEK2;FOXO4;CHMP4C;CTDSPL;PIDD1;TP73
14271,GO:0061418,0.96941405697195,0.078359181297274,4,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,EGR1;VEGFA;SIRT2;EPAS1
11379,GO:0045786,0.969537199663818,0.0420163103118829,50,533,negative regulation of cell cycle,BP,XPC;FHL1;GJC2;ALOX15B;PDCD4;TIMP2;EGFR;PRNP;DDIT3;BRSK1;CGREF1;NDRG1;ZFP36L1;NUPR1;RBL2;RPS6KA2;TFDP2;MAP2K1;BTG1;TOM1L2;PPP2R3B;NPR2;PKD2;ING4;HMGA2;MAPK12;MLXIPL;TSPYL2;FBXO6;PKD1;WHAMMP3;PCBP4;CDK5RAP3;GAS6;ERN1;PPP1R15A;STRADB;CDKN1C;CHEK2;TSG101;UHRF2;FOXO4;CHMP4C;CTDSPL;PIDD1;TP73;PHC1;BCL6;LAMTOR2;EIF2AK4
12794,GO:0051123,0.969648485910648,0.143474354256363,1,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
4669,GO:0010822,0.970003627106033,0.0574869071153348,10,138,positive regulation of mitochondrion organization,BP,TFDP2;VPS11;MICALL2;PLA2G6;BNIP3;BBC3;PEMT;TP73;CIDEB;OSCP1
3678,GO:0008180,0.970345856402086,0.140960943017126,1,28,COP9 signalosome,CC,FLOT1
16766,GO:0098632,0.970368246414252,0.140879951273936,1,28,cell-cell adhesion mediator activity,MF,PLXNB3
3712,GO:0008234,0.970530681856637,0.0551534672916003,11,148,cysteine-type peptidase activity,MF,CTSF;CAPNS2;USP20;BLMH;CTSB;PGPEP1;TADA3;CTSH;CAPN2;ANKZF1;JOSD2
18318,GO:1903313,0.97088148591236,0.0841138168917222,3,56,positive regulation of mRNA metabolic process,BP,ZFP36L1;GTPBP1;ZC3H12D
18656,GO:1904030,0.970905999809757,0.138929126335145,1,28,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN1C
3319,GO:0007029,0.970926420553758,0.0997188849741685,2,43,endoplasmic reticulum organization,BP,REEP2;SEC31B
5450,GO:0016331,0.971031434104877,0.0594191942691397,8,115,morphogenesis of embryonic epithelium,BP,LAMA5;WNT2B;VANGL2;TCTN1;DEAF1;IFT57;CELSR1;TEAD2
7300,GO:0031312,0.97122874276371,0.137753083271965,1,28,extrinsic component of organelle membrane,CC,ULK1
11722,GO:0046579,0.971267531660112,0.137611474086556,1,28,positive regulation of Ras protein signal transduction,BP,F2R
4479,GO:0010506,0.971350247920431,0.0452897103963724,23,271,regulation of autophagy,BP,GPSM1;TRIM65;ULK2;EPM2A;ULK1;SESN2;MAPK3;BNIP3;TBC1D14;LRSAM1;DAP;BNIP3L;PIK3R2;ERN1;FYCO1;AKT1;C9ORF72;TPCN1;TFEB;SIRT2;GOLGA2;LAMTOR2;EIF2AK4
14476,GO:0061980,0.971466987634013,0.136882398432878,1,28,regulatory RNA binding,MF,AGO4
10778,GO:0044270,0.971516256987268,0.0394121267069463,50,546,cellular nitrogen compound catabolic process,BP,XDH;NT5E;H1F0;RAPGEF3;DNPH1;PGM1;ZFP36L1;CYP3A5;DHTKD1;RPL13A;DDIT4;DNASE1L1;OGDHL;CIRBP;APOBEC3C;BLVRB;NEIL1;APOBEC3F;PPARA;NT5C1B;PAN2;MLXIPL;GTPBP1;GALK1;PCBP4;ENDOG;ALDOC;ISG20;PDE2A;ALDH1L2;AGO4;ERN1;PNRC1;ENTPD6;AKT1;IGF2BP2;DNASE2;UPP1;INSR;ALDH1L1;ZC3H12D;TST;ADA;ENTPD2;CIDEA;RPL29;IGF2BP3;PFKL;RPL12;NUDT18
3923,GO:0008608,0.971533717009209,0.136638140269564,1,28,attachment of spindle microtubules to kinetochore,BP,SIRT2
869,GO:0002220,0.971606995289302,0.0638493288363025,6,94,innate immune response activating cell surface receptor signaling pathway,BP,PAK1;MUC19;CARD11;RPS6KA5;FYN;IKBKB
871,GO:0002223,0.971606995289302,0.0638493288363025,6,94,stimulatory C-type lectin receptor signaling pathway,BP,PAK1;MUC19;CARD11;RPS6KA5;FYN;IKBKB
7346,GO:0031397,0.971617429160748,0.0822129689821425,3,58,negative regulation of protein ubiquitination,BP,AKT1;FYN;HDAC8
11792,GO:0046700,0.971679357206151,0.0391984619239101,50,546,heterocycle catabolic process,BP,XDH;NT5E;PRODH;H1F0;RAPGEF3;DNPH1;PGM1;ZFP36L1;DHTKD1;ALDH4A1;RPL13A;DDIT4;DNASE1L1;OGDHL;CIRBP;APOBEC3C;BLVRB;NEIL1;APOBEC3F;PPARA;NT5C1B;PAN2;MLXIPL;GTPBP1;GALK1;PCBP4;ENDOG;ALDOC;ISG20;PDE2A;ALDH1L2;AGO4;ERN1;PNRC1;ENTPD6;AKT1;IGF2BP2;DNASE2;UPP1;INSR;ALDH1L1;ZC3H12D;ADA;ENTPD2;CIDEA;RPL29;IGF2BP3;PFKL;RPL12;NUDT18
2867,GO:0006362,0.971946217052833,0.134884597930226,1,29,transcription elongation from RNA polymerase I promoter,BP,ERCC6
7457,GO:0031624,0.972187713681454,0.134235084286905,1,28,ubiquitin conjugating enzyme binding,MF,PPARA
5311,GO:0016032,0.972461885473246,0.0369056682532847,64,678,viral process,BP,TNIP1;APOE;GSN;EGFR;RBCK1;FBLN1;CRTC1;PACS2;ADARB1;MMP1;EFNB3;RPL13A;RAB11FIP4;CUL7;ATG16L2;TMEM173;SHC1;APOBEC3C;APOBEC3F;NLRX1;SATB1;HMGA2;AP1G2;MAPK3;ITGB5;PC;BNIP3;IFITM1;CTSB;EIF2D;MVB12B;CHMP1B;LRSAM1;NLRP1;ISG20;BNIP3L;GAS6;UCKL1;RXRA;RAB43;TNFRSF14;SEPT6;TSG101;TBC1D20;CHMP5;INSR;KRT19;NELFCD;CHMP4C;ULBP1;ITGB6;CPSF4;LGALS1;TP73;FYN;MPDZ;AP2A2;RPL29;CHD6;ITGA2;FKBP8;EIF2AK4;RPL12;ACOT8
6691,GO:0030097,0.972534265564108,0.0375740966687504,55,587,hemopoiesis,BP,FOS;EGR1;CTNNBIP1;FAM210B;VEGFA;ERCC1;ZFP36L1;DHTKD1;ASH2L;SOX13;FAM213A;PRKCZ;RAG1;WNT2B;CHD2;MKNK2;SATB1;STAT6;KCNAB2;THRA;FAM20C;INPP5D;DMTN;LRRC8A;ZFPM1;DOCK11;POLM;HDAC5;CEBPB;L3MBTL1;TGFBR2;CMTM7;AGO4;GAS6;BCR;NBEAL2;CARD11;DNASE2;SH2B3;BRAF;ZNF160;LGALS1;JAK3;TP73;TAZ;BCL6;ADA;POU2F2;TGFBR3;TCF7;EPAS1;MFNG;SH3PXD2A;ERBB2;HLA-G
10882,GO:0044445,0.972699150662317,0.0475071868263149,15,203,cytosolic part,CC,RPL13A;BLOC1S4;NPR2;EIF2D;PI4K2A;NLRP1;FYCO1;ADCY6;RPL39L;RPL29;BLOC1S1;EIF2AK4;PFKL;RPL12;IKBKB
18247,GO:1903146,0.973011852655887,0.0937777507991687,2,44,regulation of autophagy of mitochondrion,BP,BNIP3;BNIP3L
3067,GO:0006636,0.97309558096241,0.130635508289291,1,29,unsaturated fatty acid biosynthetic process,BP,ALOX15B
5606,GO:0016655,0.973332081923453,0.0924368061075289,2,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,DHRS4;CBR4
2057,GO:0004812,0.973804794951856,0.091531430553904,2,44,aminoacyl-tRNA ligase activity,MF,AARS;CARS
5725,GO:0016875,0.973804794951856,0.091531430553904,2,44,ligase activity, forming carbon-oxygen bonds,MF,AARS;CARS
7956,GO:0032570,0.973859483794804,0.127781809448568,1,29,response to progesterone,BP,FOS
18082,GO:1902750,0.974384645697325,0.0582929379035771,6,97,negative regulation of cell cycle G2/M phase transition,BP,FHL1;BRSK1;HMGA2;CDK5RAP3;FOXO4;CHMP4C
12625,GO:0050853,0.97438611973299,0.125800248761234,1,29,B cell receptor signaling pathway,BP,VAV3
6915,GO:0030515,0.974427837970737,0.125428214345766,1,30,snoRNA binding,MF,ISG20
18875,GO:1904591,0.974478011760437,0.125453278012366,1,29,positive regulation of protein import,BP,TMEM173
10524,GO:0043489,0.974512845569047,0.125321655824035,1,29,RNA stabilization,BP,CIRBP
13204,GO:0051893,0.974693158462308,0.0889962521127755,2,44,regulation of focal adhesion assembly,BP,VEGFA;DMTN
16094,GO:0090109,0.974693158462308,0.0889962521127755,2,44,regulation of cell-substrate junction assembly,BP,VEGFA;DMTN
5399,GO:0016242,0.974829289381263,0.124123545675022,1,29,negative regulation of macroautophagy,BP,AKT1
8686,GO:0034333,0.974841067300409,0.06638278734971,4,70,adherens junction assembly,BP,VEGFA;LAMA5;DMTN;ITGA2
14745,GO:0070469,0.974942478896446,0.0658775213858679,4,78,respiratory chain,CC,NDUFA4L2;SDHA;TTC19;SDHAF4
12281,GO:0048641,0.975129488122341,0.122982904260803,1,29,regulation of skeletal muscle tissue development,BP,FLOT1
18324,GO:1903322,0.975129502083568,0.054052305852859,7,107,positive regulation of protein modification by small protein conjugation or removal,BP,TNIP1;TRIB3;CDK5RAP3;PIAS3;GOLGA2;MTA1;WFS1
2815,GO:0006282,0.97526703035341,0.0602498979861382,5,83,regulation of DNA repair,BP,EGFR;MAGEF1;HMGA2;MGMT;RECQL5
7864,GO:0032434,0.975284107485096,0.0537557375843554,7,107,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,TRIB2;HERPUD1;TRIB3;AKT1;HFE;CSNK1E;SIRT2
2868,GO:0006363,0.975300746604658,0.122119060531269,1,30,termination of RNA polymerase I transcription,BP,DMTF1
18778,GO:1904356,0.97537522751417,0.0729936507329337,3,58,regulation of telomere maintenance via telomere lengthening,BP,MAPK3;PKIB;HMBOX1
10205,GO:0042887,0.975379279338312,0.121819707536608,1,30,amide transmembrane transporter activity,MF,AQP3
11175,GO:0045296,0.975507721269132,0.0384935789393203,25,297,cadherin binding,MF,EGFR;ANK3;NDRG1;MPRIP;PPL;CAPG;ITGA6;SNX9;ESYT2;DOCK9;H1FX;TWF2;PAK6;CCS;FMNL2;SLC9A3R2;CHMP5;EPS8L1;SNX1;GOLGA2;SH3GLB2;EPS8L2;RPL29;CORO1B;BSG
6055,GO:0019207,0.975539867522534,0.0455323539362046,12,162,kinase regulator activity,MF,ERCC6;MAP2K1;DGKQ;SPRY2;TRIB2;MAP2K2;SAMD3;PKIB;TRIB3;PIK3R2;GAS6;CDKN1C
1469,GO:0003727,0.975571560206959,0.0646940739567213,4,71,single-stranded RNA binding,MF,THRA;AGO4;LACTB2;ENDOV
5962,GO:0018394,0.975759876799771,0.0474734475463888,10,140,peptidyl-lysine acetylation,BP,NOS1;ING4;JADE2;MAPK3;TADA3;HINT2;RPS6KA5;HDAC8;PER1;BLOC1S1
11390,GO:0045815,0.975773760507756,0.0640327785850757,4,77,positive regulation of gene expression, epigenetic,BP,ERCC6;PABPC1L;SLC50A1;PHF2
4529,GO:0010605,0.975835324337301,0.028939863727325,211,2015,negative regulation of macromolecule metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;ZC3H6;BBS2;TNFRSF6B;APOE;ZMYND8;NFATC4;SERPINE2;EGR1;CTNNBIP1;PPP1R35;PTK6;WWC3;PDCD4;TIMP2;VEGFA;EGFR;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;BAHCC1;TFPI2;DUSP5;CRTAP;CST3;DDIT3;DNAJB5;ZFP36L1;ADARB1;TCFL5;HBEGF;RBL2;TFDP2;MXI1;RPL13A;MDFI;PLAT;PHACTR3;PPP1R14A;WWTR1;MAP2K1;MXD4;PKN1;DDIT4;H2AFJ;PHF21A;DGKQ;MAGEF1;SHC1;SPRY2;GRB7;UNK;CIRBP;CAPRIN2;PRKCZ;SERPING1;ABCA7;ELK3;STK39;KDM3A;FOXQ1;PHF1;SPRY4;SALL2;ZP3;NEIL1;ACVR2B;RAG1;EAPP;NGFR;ELFN2;TRIB2;HES2;EREG;NAB2;C5;PPARA;CHAC1;SESN2;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;SLIT3;ECM1;ACACB;PC;ERRFI1;THRA;RGS14;IRF2BPL;TDRKH;PBXIP1;SNTA1;PAN2;MLXIPL;INPP5D;TSPYL2;MAP2K2;DMTN;ATF4;ZFPM1;KDM4C;TENM2;IFI6;CBX7;AZIN2;JDP2;HDAC5;GTPBP1;SORL1;PCBP4;HERPUD1;VLDLR;PAPLN;DEAF1;PEG3;CEBPB;LRP5;ATRAID;PCSK9;PKIB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;HMG20B;CDK5RAP3;AGO4;ZFP90;TRPV1;PIK3R2;EPHA1;GAS6;ERN1;PPP1R15A;RXRA;MBD1;TNRC18;ATP2B4;PNRC1;PAIP2B;HINT2;AKT1;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;TSG101;PHF2;IGF2BP2;ZNF217;PIAS3;C9ORF72;UHRF2;IFI27;NCOA7;NELFCD;RPS6KA5;CTDSPL;MAP2K5;TIMP1;HFE;JAK3;TP73;MTA3;MNT;BCL6;HSF4;FYN;ZC3H12D;LEMD2;SIRT2;RECQL5;RCOR2;MTA1;HDAC8;PAIP2;RPL29;EIF4EBP1;TCF7;MAP3K10;EPHB2;PER1;IGF2BP3;FGFR1;WFS1;FKBP8;EIF2AK4;RPL12;HMBOX1;TSHZ1;IKBKB;ACOT8;SIX5
6569,GO:0022402,0.976346903393663,0.0298450170550614,115,1136,cell cycle process,BP,XPC;FHL1;GJC2;EGFR;PRNP;ERCC1;ANK3;NEK9;NINL;DDIT3;BRSK1;CGREF1;ZFP36L1;CUL9;ARAP1;RBL2;TFDP2;OBSL1;RAB11FIP4;CUL7;HYAL1;POLD4;MAP2K1;CYP27B1;SDCCAG8;TOM1L2;TUBG2;SNX9;ARL2;SPRY2;PPP2R3B;PAK1;CEP250;EREG;RMI2;RHOBTB2;CHD3;SPC24;PKD2;ING4;HMGA2;SEPT5;RGS14;TDRKH;RHOF;CNTRL;TUBE1;MAPK12;CHMP1B;MLXIPL;ARHGEF2;SEPT10;PAK6;PKD1;CEP68;TTN;WHAMMP3;PCBP4;LRP5;NDE1;L3MBTL1;FBXL15;CEP131;MLH3;CDK5RAP3;AGO4;GAS6;ERN1;CEP126;CROCC;GOLGA2P5;PPP1R15A;ATP2B4;STRADB;AKT1;REEP4;CDKN1C;CHEK2;SEPT6;TSG101;PHLDA1;LMNA;CHMP5;UHRF2;GOLGA8A;INSR;FOXO4;CHMP4C;CTDSPL;PIDD1;HAUS4;TP73;MTA3;TUBGCP6;SNX33;PHC1;SPIRE1;CSNK1E;BCL6;REC8;LEMD2;SIRT2;RECQL5;GOLGA2;MSH5;HDAC8;EIF4EBP1;LAMTOR2;SEPT8;FGFR1;EIF2AK4;UNC119;CCDC69;SFI1;TTC19
8424,GO:0033554,0.97638696788198,0.0288066672046263,167,1613,cellular response to stress,BP,XDH;PTPRS;APOE;NFATC4;XPC;FOS;PRODH;EGR1;FBXO2;TMEM129;CDC42EP5;EDEM1;GLUL;GPX3;PDCD4;VEGFA;EGFR;DDB2;ERCC1;PRDX5;TFPI2;CST3;DDIT3;BRSK1;ERCC6;NDRG1;ZFP36L1;NUPR1;RBL2;RPS6KA2;PYCR2;TFDP2;MAPK13;ASH2L;CUL7;POLD4;MAP2K1;PKN1;MC1R;DDIT4;MAGEF1;ULK1;SHC1;PAK1;STK39;PHF1;CBS;NEIL1;ETV5;WNT2B;NSMCE4A;CHD2;RMI2;PLA2G6;INO80C;ANO1;CHAC1;SESN2;IMPACT;PKD2;STAT6;ING4;HMGA2;MAPK3;LAMB2;BNIP3;ERRFI1;MACROD1;VANGL2;RGS14;MAPK12;ARHGEF2;TSPYL2;MAP2K2;UBXN4;ATF4;BBC3;PAK6;PRIMPOL;POLM;FBXO6;NSMCE1;FLOT1;PCBP4;HERPUD1;GSTM2;ENDOG;CEBPB;MAP3K12;CREBRF;PCSK9;AQP3;DNMT3A;TRPV4;MAP1LC3A;TRIB3;DAP;MLH3;CDK5RAP3;NOS3;MINK1;WNT7A;TRPV1;BNIP3L;PIK3R2;CCS;GAS6;ERN1;ALKBH7;NBR1;POLL;TERC;PPP1R15A;STRADB;MGMT;ASNS;C12ORF66;AKT1;CHEK2;ASS1;ACADVL;LMNA;UPP1;SPATA18;NCOA7;FOXO4;YPEL3;ANKZF1;TXNRD2;MAP2K5;BRAF;EDA2R;FAAP20;PIDD1;CAT;MYOF;MAPK10;MPG;HFE;TP73;TMX4;ENDOV;CSNK1E;BCL6;HSF4;REC8;GSTM3;SLC38A2;UBXN6;SIRT2;RECQL5;MTA1;MSH5;CIDEB;VAV3;MAN1B1;EPAS1;MAP3K10;CHD6;PER1;WFS1;CTH;EIF2AK4;SYVN1;NET1;CREB3L4;IKBKB
14029,GO:0060828,0.976460705396721,0.0415333759132239,15,196,regulation of canonical Wnt signaling pathway,BP,APOE;EGR1;IGFBP4;DDIT3;WWTR1;NPHP4;CAPRIN2;WNT2B;SULF2;LRP5;SMURF2;EDA;WNT7A;LZTS2;IGFBP2
3746,GO:0008287,0.976610786729728,0.083364869283391,2,45,protein serine/threonine phosphatase complex,CC,PPP2R3B;PPP1R15A
18305,GO:1903293,0.976610786729728,0.083364869283391,2,45,phosphatase complex,CC,PPP2R3B;PPP1R15A
13574,GO:0060070,0.976629382658997,0.0390479111613964,19,237,canonical Wnt signaling pathway,BP,APOE;EGR1;IGFBP4;DDIT3;WWTR1;NPHP4;CAPRIN2;WNT2B;SULF2;LRP5;PTPRU;SMURF2;EDA;WNT7A;LZTS2;IGFBP2;WNT3;FRAT1;TCF7
259,GO:0000726,0.976632262763362,0.0621787087802538,4,74,non-recombinational repair,BP,ERCC1;HMGA2;POLM;POLL
761,GO:0002009,0.976652957480085,0.0345810800196044,35,394,morphogenesis of an epithelium,BP,NFATC4;CTNNBIP1;PGF;VEGFA;EGFR;ARHGEF19;HBEGF;SPRY2;LAMA5;PAK1;FOXQ1;DLG3;ETV5;WNT2B;PKD2;AREG;VANGL2;TCTN1;KIF26B;PKD1;DEAF1;LRP5;WNK4;TGFBR2;SMURF2;WNT7A;RXRA;CTSH;IFT57;CELSR1;PLXND1;AP2A2;EDNRA;FGFR1;TEAD2
2850,GO:0006338,0.976832382596679,0.0443468011185108,11,155,chromatin remodeling,BP,BAHCC1;SMARCA1;PABPC1L;INO80C;SCMH1;SATB1;HMGA2;HDAC5;HMG20B;TNRC18;SMARCD2
6919,GO:0030520,0.976844780899939,0.0826822128658598,2,45,intracellular estrogen receptor signaling pathway,BP,PAK1;TADA3
18096,GO:1902808,0.977019186047221,0.115504539733546,1,30,positive regulation of cell cycle G1/S phase transition,BP,HYAL1
7330,GO:0031349,0.977062893607537,0.0362121046783374,25,298,positive regulation of defense response,BP,TNIP1;PTPRS;PDCD4;EGFR;NR1D1;MAPK13;TMEM173;PAK1;ZP3;MUC19;EREG;NLRX1;MAPK3;CTSB;LRSAM1;FLOT1;TRPV4;PDE2A;CARD11;IL17RC;RPS6KA5;TKFC;FYN;ITGA2;IKBKB
3234,GO:0006891,0.977096809541709,0.11520250303501,1,30,intra-Golgi vesicle-mediated transport,BP,COPG1
17800,GO:1901987,0.977216342765564,0.034142310532432,33,378,regulation of cell cycle phase transition,BP,XPC;FHL1;GJC2;EGFR;NINL;BRSK1;ZFP36L1;RBL2;TFDP2;HYAL1;SDCCAG8;CEP250;PKD2;HMGA2;CNTRL;PKD1;PCBP4;NDE1;CEP131;CDK5RAP3;ATP2B4;AKT1;CHEK2;FOXO4;CHMP4C;CTDSPL;PIDD1;HAUS4;TP73;MTA3;CSNK1E;SIRT2;SFI1
1974,GO:0004693,0.977251294598643,0.114600533446997,1,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDK18
19186,GO:1905330,0.977301436305389,0.0447215497893062,10,143,regulation of morphogenesis of an epithelium,BP,VEGFA;ARHGEF19;ETV5;WNT2B;VANGL2;SMURF2;RXRA;CELSR1;AP2A2;FGFR1
8512,GO:0033762,0.977350428546303,0.114213639440408,1,30,response to glucagon,BP,ADCY6
2901,GO:0006413,0.977433731060883,0.041363089675516,13,185,translational initiation,BP,RPL13A;MIF4GD;IMPACT;EIF2D;ATF4;PPP1R15A;RXRA;PAIP2B;PAIP2;RPL29;EIF4EBP1;EIF2AK4;RPL12
7595,GO:0031984,0.977548966637866,0.0280644210738498,129,1269,organelle subcompartment,CC,ST6GALNAC2;OSBPL5;LMF1;POSTN;TMEM129;EDEM1;EGFR;CLTCL1;NOS1;GPSM1;ARAP1;B3GAT3;CYP3A5;REEP2;ASAP2;PLD3;LPCAT4;PITPNM1;TMEM173;SNX9;ULK1;ITPR3;ABCA7;SLC37A2;MCTP1;B4GALNT4;ERO1B;NMNAT2;SPPL2B;MARCH4;SMIM14;MALL;TMC6;PNPLA3;DHRS4;TMED4;ABCG1;DNMBP;ESYT2;TRAPPC9;CHAC1;PKD2;VAMP2;AREG;ST6GALNAC6;AP1G2;B4GAT1;MARCH9;SCARA3;PI4K2A;KIAA0319L;IFNGR2;SRD5A3;SLC50A1;LITAF;UBXN4;MOSPD3;CHST6;REEP6;PKD1;PSKH1;AZIN2;HSD11B1;SORL1;IL17RD;HERPUD1;ST3GAL3;SULF2;RHBDF1;HSD17B7;PEMT;EDA;NOS3;PIGZ;MARCH2;RHBDF2;ERN1;ATP7B;CPT1C;GOLGA2P5;NECAB3;CYP2R1;PPP1R15A;RAB43;ENTPD6;TM7SF2;STEAP2;ITPR2;REEP4;B4GALT2;FAAH;COPG1;TBC1D20;GOLGA8A;ICA1;COG7;C6ORF89;PIGQ;CERS4;TMEM50B;SLC9A7;SLC37A4;ATP8B2;PJA2;MBOAT2;RAB13;GOLGA2;RHOBTB3;RTN2;ENTPD2;MYO18A;RETSAT;MAN1B1;MFNG;RNF170;PIGV;WFS1;ESYT3;FITM2;FKBP8;XYLT2;SEC31B;UST;SYVN1;HLA-G;CREB3L4;BSG;KDSR;CYP4V2
16846,GO:0098803,0.977605928811676,0.0670318031644571,3,66,respiratory chain complex,CC,NDUFA4L2;SDHA;SDHAF4
7192,GO:0031090,0.977607896036211,0.026684675240284,234,2217,organelle membrane,CC,PTPRS;DLG4;BBS2;ST6GALNAC2;APOE;PRODH;SLC2A3;FBXO2;EDEM1;CRAT;FAM210B;LRP1;EGFR;PRNP;HADH;BPHL;CLTCL1;TSPAN1;SLC16A3;CD9;SNPH;IDH2;CST3;DNM1;NOS1;GPSM1;SHANK2;CLCA2;NDRG1;GRAMD4;ARMCX2;SYT8;ARAP1;B3GAT3;HBEGF;GAA;CYP3A5;EVC;BBS1;ULK2;RAB11FIP4;CPT2;ASAP2;KLHDC2;ATG16L2;HMGCL;SYNGR1;CYP27B1;COL6A1;ABCA2;PITPNM1;DGKQ;TMEM173;SNX9;ULK1;VPS11;RAB3B;CD68;CYBRD1;ITPR3;APPL2;PAK1;ABCA7;MCTP1;B4GALNT4;CEMIP;BRI3;NDUFA4L2;TMEM44;SYNE3;NMNAT2;NME4;SPPL2B;MARCH4;MALL;NIPSNAP1;SPG11;TMC6;DHRS4;ABCG1;TRAPPC9;MTMR4;NLRX1;PKD2;STAT6;VAMP2;AREG;ST6GALNAC6;AP1G2;B4GAT1;MARCH9;ACACB;KCNAB2;BNIP3;PEX10;SCARA3;DYSF;RHOF;MVB12B;PI4K2A;PQLC2;KIAA0319L;CHMP1B;IFNGR2;PRAF2;MAP2K2;SLC50A1;SDHA;TECPR1;SLC48A1;DMTN;LITAF;CHST6;SV2A;PKD1;FLOT1;AZIN2;WHAMMP3;SORL1;MAP6;IL17RD;VLDLR;GPRC5C;ST3GAL3;TMEM175;RHBDF1;ATRAID;PCSK9;DBNDD1;DIRC2;MAP1LC3A;PDE2A;RAB40B;PEMT;NOS3;PROM2;SLC27A3;WNT7A;MARCH2;BNIP3L;VPS39;ERN1;ATP7B;CPT1C;GOLGA2P5;NBEAL2;PTAFR;CYP2R1;PPP1R15A;TNRC18;RAB43;ACAD11;TMEM9;ENTPD6;C12ORF66;TM7SF2;STEAP2;ZFYVE21;ITPR2;B4GALT2;SBF2;TSG101;RASSF9;SNN;TCIRG1;STEAP3;ACADVL;LMNA;FAAH;COPG1;C9ORF72;TBC1D20;CHMP5;MAN2B1;GOLGA8A;SPATA18;ICA1;IFI27;PLAU;INSR;WNT3;SLC25A29;COG7;ANKZF1;CHMP4C;SMIM20;TPCN1;C6ORF89;LETMD1;CAT;MYOF;SCNN1A;SNX33;CERS4;SNX17;SPIRE1;TMEM50B;TAZ;HGSNAT;SLC9A7;EHD3;PJA2;SNX1;PEX1;LEMD2;UBXN6;SLC25A42;RAB13;TOM1;TST;GOLGA2;RHOBTB3;AP2A2;MYO18A;RETSAT;MAN1B1;STX1A;LAMTOR2;MFNG;BLOC1S1;FKBP8;XYLT2;ERBB2;SEC31B;UST;HLA-G;MPPE1;TTC19;CREB3L4;BSG;SDHAF4;PEX11A;TMEM8A;HIP1
10712,GO:0044085,0.977650294822104,0.0264367075777563,263,2478,cellular component biogenesis,BP,DLG4;BBS2;APOE;ESPN;ZMYND8;FLNC;KCNG1;XPC;H1F0;GSN;ADGRL1;CTNNBIP1;TYSND1;EVI5L;WIPF1;CDC42EP5;THSD4;GLUL;GPX3;VEGFA;OBSCN;DDB2;PRNP;ERCC1;ANK3;BAHCC1;IFT140;RAPGEF3;CLTCL1;FCHO1;SPTB;LOXL1;CD9;NINL;DNM1;SDK2;PARVB;DDIT3;SHANK2;CRTC1;PACS2;ADGRB2;ARRDC1;ARAP1;MMP1;EXOC2;RPL13A;MSRB2;OBSL1;BBS1;ULK2;ASH2L;ATG16L2;HMGCL;HYAL1;ARPIN;WWTR1;COL6A1;SDCCAG8;CAPG;ITGA6;DGKQ;EML2;TUBG2;SNX9;FAM110C;DNAH1;ARL2;ULK1;VPS11;GRB7;NPHP4;SOX12;NLGN2;MYH11;ITPR3;LAMA5;CIRBP;TTBK2;PRKCZ;PAK1;ABCA7;PLXNB3;ITGB4;MICALL2;CEP250;NSUN5P2;NEURL1;ARHGEF4;WDR60;TNS1;SPG11;SSH3;PLEKHG2;DHRS4;RHOBTB2;PLA2G6;TRAPPC9;LPAR3;KIF17;IMPACT;IFT27;PKD2;NUDCD3;VAMP2;RRNAD1;HMGA2;AREG;SEPT5;PCLO;KCNC4;ACACB;MAPK3;ITGB5;THRA;VANGL2;KCTD15;RHOF;CNTRL;SLITRK6;EIF2D;MYH3;CHMP1B;TBC1D14;TCTN1;PTPDC1;ARHGEF2;SEPT10;FBF1;TSPYL2;H1FX;TWF2;LRSAM1;DMTN;ANGPTL4;DOCK11;SSH1;TENM2;ATXN10;FLOT1;TTN;WHAMMP3;SORL1;TFB1M;SRSF5;TPBG;ADGRF1;TMEM175;NLRP1;RFX2;NDE1;CEP131;ISG20;TRIOBP;TRPV4;TMSB4X;MAP1LC3A;MLH3;AGO4;WNT7A;TRPV1;EPHA1;SHARPIN;GAS6;CEP126;CROCC;NBR1;GOLGA2P5;SRR;C1QTNF6;SPAG16;RXRA;TNRC18;SLC9A3R2;EFEMP2;WDR19;TMEM80;AMIGO2;CHEK2;IFT57;PSMG4;WDR45;SBF2;SEPT6;TNNT1;NFU1;TSG101;KIF27;TMOD2;TCIRG1;ASAP3;CBR4;FARP1;ATG2A;C9ORF72;TBC1D20;CHMP5;GOLGA8A;MARK4;INSR;KRT19;TENM4;CHMP4C;TNXB;SMIM20;RABGGTA;BRAF;ASIC1;CAT;HAUS4;UNC119B;HFE;TP73;TUBGCP6;FCHSD1;MPI;SPIRE1;CSNK1E;TAZ;HGSNAT;REPS2;HSF4;REC8;RNF213;EPS8L1;EHD3;SIRT2;RAB13;GOLGA2;PLXND1;RHOBTB3;MSH5;EPS8L2;RPL29;TGFBR3;TCF7;VAV3;STX1A;DHPS;EPHB2;MAGI1;SEPT8;ITGA2;SPATA6;SH3PXD2A;CTH;SEC31B;UNC119;CCDC69;PFKL;C15ORF62;CORO1B;SFI1;RPL12;TTC19;KCTD11;SDHAF4;KCTD13;APBA1;PEX11A;IKBKB;HIP1;TEAD2
20240,GO:2001238,0.97765072126663,0.0802363356071236,2,46,positive regulation of extrinsic apoptotic signaling pathway,BP,RBCK1;PIDD1
7171,GO:0031062,0.977779389836554,0.11253399184324,1,30,positive regulation of histone methylation,BP,PHF1
797,GO:0002067,0.97780355531691,0.112439099853567,1,30,glandular epithelial cell differentiation,BP,RXRA
10855,GO:0044403,0.977876505058969,0.0297707908067187,67,713,symbiont process,BP,TNIP1;APOE;GSN;EGFR;RBCK1;FBLN1;CRTC1;PACS2;ADARB1;MMP1;EXOC2;EFNB3;RPL13A;ULK2;RAB11FIP4;CUL7;ATG16L2;TMEM173;ULK1;SHC1;APOBEC3C;APOBEC3F;NLRX1;SATB1;HMGA2;AP1G2;MAPK3;ITGB5;PC;BNIP3;IFITM1;CTSB;EIF2D;MVB12B;CHMP1B;LRSAM1;NLRP1;ISG20;BNIP3L;GAS6;UCKL1;RXRA;RAB43;TNFRSF14;SEPT6;TSG101;TBC1D20;CHMP5;INSR;KRT19;NELFCD;CHMP4C;ULBP1;ITGB6;CPSF4;LGALS1;TP73;FYN;MPDZ;AP2A2;RPL29;CHD6;ITGA2;FKBP8;EIF2AK4;RPL12;ACOT8
17851,GO:1902117,0.977919721713541,0.0665458384009384,3,59,positive regulation of organelle assembly,BP,ULK1;LRSAM1;CROCC
9173,GO:0035567,0.977944074810523,0.0449377780735053,9,132,non-canonical Wnt signaling pathway,BP,ARHGEF19;VANGL2;SMURF2;AGO4;WNT7A;CSNK1E;RNF213;CELSR1;AP2A2
10777,GO:0044267,0.978113459390238,0.0252745672879947,429,3926,cellular protein metabolic process,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;F2R;ST6GALNAC2;TNFRSF6B;APOE;BTBD2;ZMYND8;SERPINE2;GID4;GSN;EGR1;LMF1;PPP1R35;FBXO2;ZNF862;PTK6;TMEM129;CDC42EP5;EDEM1;RNF135;GJC2;LRP1;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PADI3;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;FBLN1;ADAMTS7;PRDX5;TFPI2;DUSP5;NEK9;RAPGEF3;TNFSF15;SPTB;LOXL1;IGFBP4;FKBP9;CRTAP;CST3;NOS1;DDIT3;BRSK1;ERCC6;GGT1;ADAMTS13;ABTB1;GRAMD4;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;B3GAT3;HBEGF;RPS6KA2;MMP1;CTF1;CNTN1;RPL13A;MSRB2;OBSL1;PLAT;ULK2;SLC27A1;CTSF;MAPK13;RNF165;MIF4GD;CDK18;PHACTR3;FBXW4;ASH2L;CUL7;LHPP;PPP1R14A;WWTR1;MAP2K1;PKN1;DDIT4;ALPK1;BTG1;SHC2;SYNGAP1;PHF21A;DGKQ;SNX9;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;HDAC11;RAB3B;UNK;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;AARS;STK39;ERO1B;FGFR3;FBXO41;CEMIP;KDM3A;MTHFR;KLHL29;PHF1;NPR2;SPRY4;USP20;DLG3;FBXW8;NEURL1;ACVR2B;RAG1;SPPL2B;SPEG;NGFR;ELFN2;MARCH4;ETFB;LCE1E;LTBP1;MUC19;TRIB2;EREG;PTPRE;RNF44;SSH3;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;PPM1J;LPAR3;CARS;FKBP10;MTMR4;C5;PLGRKT;INO80C;CHD3;CHAC1;SESN2;BLMH;MKNK2;RASA4;IMPACT;PKD2;SATB1;ING4;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;MARCH9;JADE2;MAPK3;CSPG4;TRPT1;LAMB2;FBXO27;BNIP3;ERRFI1;MACROD1;DCAF10;PEX10;STK40;VANGL2;RGS14;MVD;FAM20C;CNTRL;ADAMTSL1;SNTA1;CTSB;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;SDC2;FBXO17;MLXIPL;PTPDC1;ARHGEF2;TSPYL2;MAP2K2;SRD5A3;LRSAM1;DMTN;KLHL24;UBXN4;ATF4;BBC3;KDM4C;PAK6;SSH1;PCMTD2;FBXO6;IFI6;PKD1;NSMCE1;FLOT1;TTN;PSKH1;HLCS;JDP2;HDAC5;GTPBP1;SORL1;IL17RD;HERPUD1;VLDLR;PAPLN;ST3GAL3;NLRP1;KDM7A;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;ATRAID;PCSK9;PKIB;PKN3;FBXL15;FBXL16;LONP2;MARK3;HLTF;TRIOBP;TGFBR2;TRPV4;ITGA1;MOCOS;SMURF2;LMO7;TRIB3;RAB40B;DAP;HMG20B;CDK5RAP3;AGO4;MINK1;PIGZ;HEXB;PROM2;WNT7A;TTLL11;MARCH2;BNIP3L;PIK3R2;EPHA1;SHARPIN;GAS6;DNAJC6;ERN1;BCR;KLHDC8B;MAPRE3;MAN2C1;NBR1;TADA3;CAMK1;PTAFR;PPP1R15A;RXRA;ADCY6;ATP2B4;STRADB;CTSH;FBXL8;PAIP2B;LCE1F;HINT2;AKT1;IGFBP7;DGUOK;CDKN1C;MICAL1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;WDR45;IGFBP2;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;IGF2BP2;PIAS3;TCIRG1;SPSB3;WDFY2;C9ORF72;UHRF2;ARSA;CAPN2;MAN2B1;SPATA18;MARK4;IFI27;INSR;NCOA7;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;PIDD1;MAPK10;LGALS1;TIMP1;HFE;JAK3;TP73;MTA3;SNX33;UBOX5;CHRM3;MIB2;MPI;LSM14B;JOSD2;PHC1;SCYL3;CSNK1E;BCL6;HSF4;RNF213;FBXO25;RPL39L;FYN;MAST4;ZC3H12D;PJA2;LEMD2;UBXN6;SIRT2;GDF15;RAB13;GOLGA2;MTA1;AP2A2;HDAC8;PAIP2;RPL29;EIF4EBP1;AVPI1;TGFBR3;CIDEB;MAN1B1;EPAS1;LAMTOR2;MAP3K10;MFNG;RNF170;DHPS;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;BLOC1S1;FKBP8;CTH;ERBB2;UST;EIF2AK4;STK32B;UNC119;SYVN1;FRS3;RPL12;MPPE1;TRIM2;KCTD11;LYPLAL1;KCTD13;CAMKK1;DTX3;IKBKB;NTM;HIP1;BTBD11
3230,GO:0006886,0.978351221795674,0.0281633116464579,89,917,intracellular protein transport,BP,SYTL1;EVI5L;TMEM129;EDEM1;PRNP;ZDHHC1;ANK3;RAPGEF3;CLTCL1;TBC1D8;B3GAT3;RPL13A;REEP2;SYNGR1;TOM1L2;TMEM173;SNX9;VPS11;RAB3B;PAK1;CEMIP;MICALL2;NGFR;TMED4;XPOT;AIP;IFT27;SH3TC2;VAMP2;AP1G2;PEX10;LTBP2;EIF2D;TBC1D14;ARHGEF2;DMTN;TBC1D3E;RABGAP1;PKD1;TSNARE1;SORL1;HERPUD1;SRSF5;CEP131;LONP2;PDE2A;RAB40B;PEMT;BNIP3L;GAS6;VPS39;BCR;KIF13B;CAMK1;RAB43;STRADB;AKT1;RASSF9;COPG1;SGSM2;RAB25;IFI27;COG7;ZDHHC24;ARHGAP44;CPSF4;SNX33;PEX7;SNX17;TMEM50B;BCL6;FYN;SNX1;PEX1;RAB13;TOM1;RTN2;AP2A2;RPL29;STX1A;TBC1D16;TMCO6;ERBB2;SEC31B;SYVN1;OSCP1;RPL12;APBA1;HIP1
3251,GO:0006914,0.978395674214212,0.0316920529205141,38,426,autophagy,BP,GPSM1;PACS2;TRIM65;ULK2;EPM2A;ATG16L2;ULK1;VPS11;ITGB4;SESN2;MAPK3;BNIP3;TBC1D14;TECPR1;LRSAM1;MAP1LC3A;DAP;BNIP3L;PIK3R2;VPS39;ERN1;FYCO1;NBR1;AKT1;WDR45;TSG101;TCIRG1;ATG2A;C9ORF72;SPATA18;CHMP4C;TPCN1;TFEB;UBXN6;SIRT2;GOLGA2;LAMTOR2;EIF2AK4
14466,GO:0061919,0.978395674214212,0.0316920529205141,38,426,process utilizing autophagic mechanism,BP,GPSM1;PACS2;TRIM65;ULK2;EPM2A;ATG16L2;ULK1;VPS11;ITGB4;SESN2;MAPK3;BNIP3;TBC1D14;TECPR1;LRSAM1;MAP1LC3A;DAP;BNIP3L;PIK3R2;VPS39;ERN1;FYCO1;NBR1;AKT1;WDR45;TSG101;TCIRG1;ATG2A;C9ORF72;SPATA18;CHMP4C;TPCN1;TFEB;UBXN6;SIRT2;GOLGA2;LAMTOR2;EIF2AK4
5325,GO:0016055,0.978528344558718,0.0321231882357018,34,387,Wnt signaling pathway,BP,APOE;NFATC4;EGR1;CTNNBIP1;LRP1;IGFBP4;DDIT3;ARHGEF19;MDFI;FBXW4;WWTR1;NPHP4;CAPRIN2;WNT2B;VANGL2;SULF2;LRP5;PTPRU;FOXL1;SMURF2;CALCOCO1;EDA;AGO4;WNT7A;LZTS2;IGFBP2;WNT3;FRAT1;CSNK1E;RNF213;CELSR1;AP2A2;TCF7;GRB10
10995,GO:0044839,0.978566671861252,0.0360446211316793,19,239,cell cycle G2/M phase transition,BP,FHL1;NINL;BRSK1;SDCCAG8;CEP250;HMGA2;CNTRL;NDE1;FBXL15;CEP131;CDK5RAP3;CHEK2;PHLDA1;FOXO4;CHMP4C;HAUS4;MTA3;CSNK1E;SFI1
7406,GO:0031503,0.978618909353593,0.0369039708947027,17,217,protein-containing complex localization,BP,DLG4;IFT140;DNM1;DLG3;WDR60;XPOT;KIF17;IFT27;SRSF5;CEP131;CEP112;WDR19;IFT57;TTC21A;ARHGAP44;CPSF4;HIP1
6879,GO:0030397,0.97877045923639,0.0769240588198517,2,46,membrane disassembly,BP,NEK9;LMNA
12763,GO:0051081,0.97877045923639,0.0769240588198517,2,46,nuclear envelope disassembly,BP,NEK9;LMNA
6776,GO:0030219,0.978869899151362,0.0569165383854751,4,78,megakaryocyte differentiation,BP,ASH2L;ZFPM1;L3MBTL1;AGO4
3224,GO:0006879,0.978902189771676,0.0764552580239577,2,47,cellular iron ion homeostasis,BP,CYBRD1;HFE
331,GO:0000922,0.979050618680705,0.0416179906394866,10,142,spindle pole,CC,FAM110C;WDR60;RGS14;FBF1;NDE1;PLEKHG6;MAPKBP1;TUBGCP6;GOLGA2;UNC119
4365,GO:0009987,0.979408586431224,0.0249757739126843,1213,10492,cellular process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;NYNRIN;APOE;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;GID4;FOS;PRODH;OSBPL5;IL20RB;H1F0;GSN;ADGRL1;CITED4;ACSF2;CCNG2;PYGB;EGR1;CTNNBIP1;LMF1;THBS3;PGF;ALDH7A1;FGFBP1;TYSND1;POSTN;PPP1R35;EVI5L;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;THSD4;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;FAM210B;GPX3;GJC2;SEMA4B;LRP1;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;TNFSF15;ZKSCAN1;SPTB;LOXL1;DGKA;TSPAN1;SLC16A3;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;SDK2;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;MICALCL;ACAD10;PGM1;CGREF1;CRTC1;SCN4B;PACS2;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;TBC1D8;ABTB1;ARHGEF19;TCEA2;MMP28;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;MMP1;PYCR2;CTF1;CNTN1;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;ASH2L;SOX13;CUL7;PITPNM3;LHPP;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;NXPH4;SMOC2;NAGLU;ARPIN;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;SMOC1;ACP6;POLD4;GIGYF1;MAP2K1;CYP27B1;PCK2;MXD4;COL6A1;CCDC71L;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;MC1R;CAPG;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;DNAJC4;FAM213A;FAM110C;THAP8;MAGEF1;DNAH1;ARL2;ULK1;SHC1;VPS11;SPRY2;GRB7;NPHP4;BLOC1S4;VEGFB;ADM2;MARCKSL1;OGDHL;SOX12;HDAC11;RAB3B;NLGN2;CD68;PCSK1;PLEKHH3;SLC12A7;PTMS;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;PITPNC1;UNK;NMRK1;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;TTBK2;LY6K;PRKCZ;PPP2R3B;HTR7;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;PHYH;MCTP1;ELK3;STK39;PABPC1L;ERO1B;BLVRB;PEAR1;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;BRI3;FOXQ1;KLHL29;PHF1;GLDC;NPR2;SEMA3F;PLXNB3;CAPNS2;NDUFA4L2;CBS;SPRY4;USP20;SALL2;ELMO3;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;NMNAT2;DDX59;MICALL2;NME4;CEP250;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;EPOR;MARCH4;NID1;ETV5;ETFB;GSTO1;LCE1E;ARHGEF4;WDR60;LTBP1;MUC19;SYNC;PPCS;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;PLXNB1;EREG;CHD2;GPT2;TEF;TNS1;PSAT1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;SPATA20;OLFM2;PLCD3;PLEKHG2;DHRS4;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;PPM1J;ABCG1;DNMBP;ESYT2;TRAPPC9;CARF;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;C5;KIF17;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;ANO1;STON1;CHAC1;SPC24;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;PPP1R3E;SH3TC2;ING4;NUDCD3;ACOT11;VAMP2;RRNAD1;HMGA2;AREG;ST6GALNAC6;COL8A1;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;PCLO;KCNC4;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;ITGB5;LAMB2;PC;FBXO27;BNIP3;ERRFI1;MACROD1;OSBPL10;SEMA5A;THRA;IFITM1;DCAF10;PEX10;CCNI;STK40;VANGL2;ACSS2;GSDMA;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;KCTD15;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;CNTRL;LTBP2;ADAMTSL1;SNTA1;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;SLITRK6;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;NYAP1;PI4K2A;NAT14;SRGAP3;ZXDC;PAQR6;SDC2;CHMP1B;FBXO17;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TBC1D14;TCTN1;PTPDC1;PLCD1;ARHGEF2;SEPT10;FBF1;INPP5D;PDCD1LG2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;TWF2;SAMD3;STMN3;SDHA;TECPR1;KIF21B;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;UBXN4;ATF4;PROCR;ZFPM1;CHST6;BBC3;KDM4C;PAK6;ZNF467;DOCK11;SSH1;LTB4R2;PCMTD2;SV2A;TBC1D3E;PRIMPOL;METRN;FRMD4B;RABGAP1;GPR153;POLM;ACAP3;TENM2;FBXO6;KIF26B;IFI6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;ATXN10;RALGAPA1;FLOT1;LTBP3;CEP68;MDK;TTN;PSKH1;HLCS;KCNMA1;AZIN2;TSNARE1;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;NTPCR;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;TPBG;PAPLN;ADGRF1;NADK;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;ROBO3;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;ACADS;FBXL16;CEP131;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;CSRNP3;TTC12;MN1;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;SLFN5;ANO9;MAP1LC3A;MOCOS;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;RPUSD3;SEMA4G;ZNF662;SHARPIN;CCS;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;OLFML2A;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ECM2;ALKBH7;CROCC;PLEKHG3;BCR;KLHDC8B;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;BCAM;SRR;TADA3;NBEAL2;C1QTNF6;BOLA1;KIF13B;SPAG16;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;THNSL2;PRDM8;SLC9A3R2;EFEMP2;STRADB;CTSH;TNFRSF14;WDR19;ACOX3;ACAD11;PNRC1;TMEM80;FBXL8;UACA;GSDMC;MGMT;GSTO2;ASNS;ENTPD6;C12ORF66;PLEKHG6;TP53I11;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;SWT1;CRY2;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;SEMA6B;IFT57;LACTB2;PSMG4;PHYKPL;WDR45;SBF2;IGFBP2;SEPT6;ASS1;SPDYE2;SPDYE2B;TTC21A;CAPS;TNNT1;NFU1;WDR66;CABYR;TSG101;KIF27;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;RASSF9;SLC6A9;ZNF217;TMOD2;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;SLC6A6;ZNF25;FARP1;DNASE2;LMNA;FAAH;UPP1;SH2B3;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;CKLF;FOXO4;GNAL;COG7;YPEL3;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;LTB4R;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;BTN3A2;ASIC1;ALDH1L1;HOXC5;PLB1;GJB4;FAAP20;PIDD1;CAT;ZNF160;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;UNC119B;TIMP1;HFE;JAK3;KIAA1549;MRGPRX3;TP73;MTA3;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;CHRM3;ZNF846;APRT;FCHSD1;TMX4;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;LSM14B;ENDOV;JOSD2;PHC1;ICAM5;SCYL3;METTL7A;ATP12A;SPIRE1;CSNK1E;TAZ;HGSNAT;BTN3A3;BCL6;REPS2;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;PJA2;SLC38A2;SNX1;PEX1;LEMD2;UBXN6;ARHGEF17;SIRT2;TRPC1;MBOAT2;GDF15;SPRED3;PHLDA2;RECQL5;RAB13;OSBPL1A;TOM1;TST;GOLGA2;CELSR1;ADA;CADM4;POU2F2;PLXND1;RCOR2;POLR3GL;RHOBTB3;ETNK2;NAGA;MTA1;TMEM101;MSH5;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;SPATA6;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;PLLP;KDELC2;UST;EIF2AK4;STK32B;UNC119;PAG1;CCDC69;RGS12;SYVN1;OSCP1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;RPL12;MPPE1;HMBOX1;NET1;TTC19;HSP90AB4P;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;KCTD13;DBP;APBA1;PEX11A;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;ROBO4;TEAD2;ACOT8;BTBD11;SLC9A5;SIX5
4336,GO:0009892,0.979447569801434,0.0245993975307222,227,2164,negative regulation of metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;ZC3H6;BBS2;TNFRSF6B;APOE;ZMYND8;NFATC4;SERPINE2;EGR1;CTNNBIP1;PPP1R35;PTK6;ACP5;WWC3;PDCD4;TIMP2;VEGFA;EGFR;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;BAHCC1;TFPI2;DUSP5;CRTAP;CST3;DDIT3;DNAJB5;ZFP36L1;ADARB1;TCFL5;HBEGF;RBL2;TFDP2;MXI1;RPL13A;MDFI;PLAT;SLC27A1;PHACTR3;PPP1R14A;WWTR1;MAP2K1;CYP27B1;MXD4;PKN1;DDIT4;H2AFJ;PHF21A;DGKQ;MAGEF1;SHC1;SPRY2;GRB7;UNK;CIRBP;CAPRIN2;PRKCZ;SERPING1;ABCA7;ELK3;STK39;KDM3A;FOXQ1;PHF1;SPRY4;SALL2;DLG3;ZP3;NEIL1;ACVR2B;RAG1;EAPP;NGFR;ELFN2;TRIB2;HES2;EREG;NAB2;C5;PPARA;CHAC1;SESN2;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;SLIT3;ECM1;ACACB;PC;BNIP3;ERRFI1;THRA;RGS14;IRF2BPL;TDRKH;PBXIP1;SNTA1;PAN2;MLXIPL;TBC1D14;INPP5D;TSPYL2;MAP2K2;DMTN;ATF4;ZFPM1;KDM4C;LTB4R2;TENM2;IFI6;CBX7;AZIN2;JDP2;HDAC5;GTPBP1;SORL1;PCBP4;HERPUD1;VLDLR;PAPLN;GABBR1;DEAF1;PEG3;CEBPB;LRP5;ATRAID;PCSK9;PKIB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;CSRNP3;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;HMG20B;CDK5RAP3;AGO4;ZFP90;TRPV1;PIK3R2;EPHA1;GAS6;ERN1;BCR;PPP1R15A;RXRA;MBD1;TNRC18;ATP2B4;PNRC1;PAIP2B;HINT2;AKT1;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;TSG101;PHF2;IGF2BP2;ZNF217;PIAS3;ACADVL;FARP1;C9ORF72;UHRF2;IFI27;NCOA7;NELFCD;RPS6KA5;CTDSPL;MAP2K5;TIMP1;HFE;JAK3;TP73;MTA3;MNT;BCL6;HSF4;FYN;ZC3H12D;LEMD2;SIRT2;RECQL5;GOLGA2;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;RPL29;EIF4EBP1;TCF7;MAP3K10;EPHB2;PER1;IGF2BP3;FGFR1;WFS1;FKBP8;EIF2AK4;SFI1;RPL12;HMBOX1;GRB10;TSHZ1;IKBKB;ACOT8;SIX5
10259,GO:0043022,0.979605639456814,0.0743535323096251,2,47,ribosome binding,MF,IMPACT;LETMD1
7316,GO:0031334,0.979671789563096,0.0363138736204486,15,197,positive regulation of protein complex assembly,BP,GSN;WIPF1;CDC42EP5;VEGFA;DDB2;ERCC1;MMP1;ARPIN;SNX9;ARL2;PAK1;WHAMMP3;SPIRE1;C15ORF62;CORO1B
16595,GO:0097472,0.97998019840991,0.10358981573841,1,31,cyclin-dependent protein kinase activity,MF,CDK18
10334,GO:0043161,0.979982528136152,0.0304012750233617,32,371,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,BTBD2;GID4;FBXO2;TMEM129;EDEM1;RBCK1;DDIT3;ABTB1;RNF165;FBXW4;WWTR1;TRIB2;RNF44;UBXN4;FBXO6;HERPUD1;FBXL15;SMURF2;TRIB3;SHARPIN;AKT1;SPSB3;ANKZF1;HFE;CSNK1E;SIRT2;MTA1;MAN1B1;WFS1;SYVN1;KCTD13;BTBD11
2534,GO:0005791,0.979998137050413,0.0610862370305322,3,62,rough endoplasmic reticulum,CC,GLUL;SYNE3;PCSK9
14723,GO:0070423,0.980165005275635,0.102842832417607,1,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,IKBKB
16008,GO:0086065,0.980181748012973,0.102775065482663,1,31,cell communication involved in cardiac conduction,BP,SCN4B
11453,GO:0045930,0.980186130746113,0.0324441682874221,22,272,negative regulation of mitotic cell cycle,BP,XPC;FHL1;GJC2;TIMP2;EGFR;BRSK1;ZFP36L1;RBL2;TFDP2;BTG1;TOM1L2;PKD2;HMGA2;PCBP4;CDK5RAP3;CHEK2;FOXO4;CHMP4C;CTDSPL;PIDD1;TP73;BCL6
15862,GO:0072655,0.980277107240856,0.0383270392538219,11,157,establishment of protein localization to mitochondrion,BP,DDIT3;TFDP2;VPS11;MICALL2;AIP;BBC3;PEMT;BNIP3L;AKT1;TP73;OSCP1
14641,GO:0070268,0.980295976460043,0.0536499029723629,4,76,cornification,BP,KRT15;PPL;PRSS8;KRT19
17305,GO:0198738,0.980304695410823,0.0296156734088858,34,389,cell-cell signaling by wnt,BP,APOE;NFATC4;EGR1;CTNNBIP1;LRP1;IGFBP4;DDIT3;ARHGEF19;MDFI;FBXW4;WWTR1;NPHP4;CAPRIN2;WNT2B;VANGL2;SULF2;LRP5;PTPRU;FOXL1;SMURF2;CALCOCO1;EDA;AGO4;WNT7A;LZTS2;IGFBP2;WNT3;FRAT1;CSNK1E;RNF213;CELSR1;AP2A2;TCF7;GRB10
8663,GO:0034248,0.980371736509319,0.0290746654671715,37,424,regulation of cellular amide metabolic process,BP,APOE;EGFR;PRNP;ZFP36L1;RPL13A;MIF4GD;MAP2K1;GRB7;UNK;CIRBP;CAPRIN2;ABCA7;NEURL1;PLA2G6;SESN2;MKNK2;IMPACT;MAPK3;MAP2K2;ATF4;SORL1;AGO4;PTAFR;PPP1R15A;RXRA;PAIP2B;AKT1;IGF2BP2;LSM14B;ZC3H12D;PAIP2;EIF4EBP1;PER1;IGF2BP3;ITGA2;ERBB2;EIF2AK4
468,GO:0001510,0.980425500388535,0.0600222913766351,3,61,RNA methylation,BP,NSUN5P2;RRNAD1;TFB1M
8301,GO:0033146,0.980436486568659,0.101742072337785,1,31,regulation of intracellular estrogen receptor signaling pathway,BP,PAK1
1020,GO:0002520,0.980459397463401,0.0267842120166602,61,653,immune system development,BP,FOS;EGR1;CTNNBIP1;FAM210B;VEGFA;ERCC1;ZFP36L1;DHTKD1;ASH2L;SOX13;MAP2K1;PKN1;FAM213A;PRKCZ;RAG1;WNT2B;CHD2;MKNK2;SATB1;STAT6;KCNAB2;MAPK3;THRA;FAM20C;INPP5D;DMTN;LRRC8A;ZFPM1;DOCK11;POLM;HDAC5;CEBPB;LRP5;L3MBTL1;TGFBR2;FOXL1;CMTM7;AGO4;GAS6;BCR;NBEAL2;POLL;CARD11;DNASE2;SH2B3;BRAF;ZNF160;LGALS1;JAK3;TP73;TAZ;BCL6;ADA;POU2F2;TGFBR3;TCF7;EPAS1;MFNG;SH3PXD2A;ERBB2;HLA-G
18322,GO:1903320,0.980496726587345,0.035570386197401,14,188,regulation of protein modification by small protein conjugation or removal,BP,TNIP1;EGR1;FBXO2;HERPUD1;TRIB3;HMG20B;CDK5RAP3;AKT1;PIAS3;FYN;GOLGA2;MTA1;HDAC8;WFS1
6277,GO:0019886,0.980500281088506,0.053227980528103,4,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,CTSF;ACTR1B;OSBPL1A;AP2A2
12754,GO:0051053,0.980538702707867,0.0434820010683643,7,109,negative regulation of DNA metabolic process,BP,ERCC1;MAGEF1;HMGA2;TSPYL2;CHEK2;BCL6;RECQL5
5990,GO:0018995,0.980612986759454,0.0595353971921374,3,61,host,CC,MVB12B;PI4K2A;TSG101
10629,GO:0043657,0.980612986759454,0.0595353971921374,3,61,host cell,CC,MVB12B;PI4K2A;TSG101
10752,GO:0044215,0.980612986759454,0.0595353971921374,3,61,other organism,CC,MVB12B;PI4K2A;TSG101
10753,GO:0044216,0.980612986759454,0.0595353971921374,3,61,other organism cell,CC,MVB12B;PI4K2A;TSG101
10754,GO:0044217,0.980612986759454,0.0595353971921374,3,61,other organism part,CC,MVB12B;PI4K2A;TSG101
12985,GO:0051438,0.980736949133625,0.0708706995578634,2,48,regulation of ubiquitin-protein transferase activity,BP,TRIB3;GOLGA2
14362,GO:0061630,0.980738703877114,0.0345641721280755,15,197,ubiquitin protein ligase activity,MF,GID4;TMEM129;RNF165;NEURL1;RAG1;RNF44;LRSAM1;FBXO6;HLTF;SMURF2;UHRF2;UBOX5;MIB2;PJA2;SYVN1
4680,GO:0010833,0.980802454120765,0.0525168859028601,4,74,telomere maintenance via telomere lengthening,BP,MAPK3;PKIB;TERC;HMBOX1
6983,GO:0030670,0.980898677375473,0.0587502534572014,3,62,phagocytic vesicle membrane,CC,RAB43;TCIRG1;HLA-G
3333,GO:0007049,0.980989175170765,0.0234459430828321,159,1541,cell cycle,BP,MARVELD1;XPC;FHL1;CCNG2;PTK6;GJC2;ALOX15B;PDCD4;TIMP2;EGFR;PRNP;ERCC1;ANK3;NEK9;CLTCL1;NINL;DDIT3;BRSK1;CGREF1;NDRG1;ZFP36L1;ADARB1;CUL9;NUPR1;ARAP1;RBL2;RPS6KA2;TFDP2;OBSL1;MAPK13;RAB11FIP4;CUL7;HYAL1;POLD4;MAP2K1;CYP27B1;SDCCAG8;BTG1;TOM1L2;TRNP1;TUBG2;SNX9;ARL2;SPRY2;APPL2;PPP2R3B;PAK1;STK39;NPR2;CEP250;EREG;RMI2;RHOBTB2;CHD3;SPC24;PKD2;ING4;HMGA2;SEPT5;MAPK3;CCNI;RGS14;TDRKH;RHOF;CNTRL;TUBE1;MAPK12;CHMP1B;MLXIPL;ARHGEF2;SEPT10;TSPYL2;MAP2K2;PAK6;RABGAP1;FBXO6;PKD1;CEP68;TTN;WHAMMP3;PCBP4;SRSF5;LRP5;NDE1;L3MBTL1;FBXL15;CEP131;DNMT3A;TRIOBP;MLH3;HMG20B;CDK5RAP3;AGO4;MINK1;GAS6;ERN1;CEP126;LZTS2;CROCC;BCR;KLHDC8B;MAPRE3;GOLGA2P5;TADA3;CAMK1;PPP1R15A;ATP2B4;STRADB;ASNS;AKT1;REEP4;CDKN1C;BEX2;CHEK2;SEPT6;TSG101;STEAP3;PHLDA1;LMNA;CHMP5;UHRF2;GOLGA8A;MARK4;INSR;FOXO4;CHMP4C;C6ORF89;CTDSPL;MAP2K5;PIDD1;HAUS4;TP73;MTA3;TUBGCP6;MNT;SNX33;PHC1;SPIRE1;CSNK1E;BCL6;REC8;LEMD2;SIRT2;RECQL5;GOLGA2;MSH5;HDAC8;EIF4EBP1;AVPI1;LAMTOR2;SEPT8;FGFR1;EIF2AK4;UNC119;CCDC69;SFI1;TTC19;KCTD11;DMTF1
6598,GO:0022626,0.981086390225875,0.0444688029423458,6,110,cytosolic ribosome,CC,RPL13A;EIF2D;RPL39L;RPL29;EIF2AK4;RPL12
8298,GO:0033143,0.981133485077897,0.0581791250608992,3,61,regulation of intracellular steroid hormone receptor signaling pathway,BP,PAK1;CRY2;PER1
12208,GO:0048487,0.98126047355601,0.0982129607255024,1,32,beta-tubulin binding,MF,TRPV4
9029,GO:0035258,0.981294063925648,0.051356044023241,4,74,steroid hormone receptor binding,MF,PKN1;KDM3A;KDM4C;CEBPB
10562,GO:0043543,0.981296958848658,0.033639983769125,15,198,protein acylation,BP,ZDHHC1;RAPGEF3;NOS1;NUPR1;ING4;JADE2;MAPK3;TADA3;CAMK1;HINT2;RPS6KA5;ZDHHC24;HDAC8;PER1;BLOC1S1
3669,GO:0008170,0.981345218426607,0.0512349673270096,4,74,N-methyltransferase activity,MF,ASH2L;RRNAD1;TFB1M;PEMT
2608,GO:0005913,0.981441301775722,0.0510074024090595,4,74,cell-cell adherens junction,CC,NDRG1;ITGA6;FLOT1;CADM4
870,GO:0002221,0.981561300602918,0.0396780426273351,8,122,pattern recognition receptor signaling pathway,BP,TNIP1;PTPRS;NR1D1;NLRX1;CTSB;FLOT1;TKFC;IKBKB
5551,GO:0016567,0.981588021909114,0.0249835504323435,67,709,protein ubiquitination,BP,GID4;FBXO2;TMEM129;RNF135;RBCK1;DDB2;ARRDC1;CUL9;RNF165;FBXW4;CUL7;WWTR1;MAGEF1;FBXO41;KLHL29;FBXW8;NEURL1;RAG1;MARCH4;RNF44;UNKL;BLMH;MARCH9;JADE2;FBXO27;DCAF10;PEX10;FBXO17;LRSAM1;KLHL24;FBXO6;NSMCE1;HERPUD1;FBXL15;FBXL16;HLTF;SMURF2;LMO7;TRIB3;RAB40B;CDK5RAP3;MARCH2;SHARPIN;KLHDC8B;FBXL8;AKT1;TSG101;SPSB3;UHRF2;UBOX5;MIB2;PHC1;RNF213;FBXO25;FYN;PJA2;GOLGA2;MTA1;HDAC8;EPAS1;RNF170;WFS1;SYVN1;TRIM2;KCTD11;KCTD13;DTX3
18355,GO:1903391,0.98176050561998,0.0678155323147022,2,47,regulation of adherens junction organization,BP,VEGFA;DMTN
8437,GO:0033574,0.981770499897139,0.0961113297412854,1,32,response to testosterone,BP,PSPH
4309,GO:0009791,0.981967395391435,0.0497579567870291,4,74,post-embryonic development,BP,VEGFA;ERCC1;ACVR2B;ETNK2
1461,GO:0003713,0.982204202272041,0.029668044752076,21,261,transcription coactivator activity,MF,NFATC4;CITED4;NR1D1;WWTR1;PKN1;MAML3;SOX12;PPARA;AIP;KLF7;ING4;THRA;CALCOCO1;TADA3;RXRA;TSG101;PHF2;SMARCD2;NCOA7;MNT;MTA1
3894,GO:0008536,0.982333059466012,0.0937749991651531,1,32,Ran GTPase binding,MF,XPOT
1110,GO:0002699,0.982362778520151,0.0419528226145649,6,100,positive regulation of immune effector process,BP,PRKCZ;ZP3;STAT6;MAPK3;PTAFR;MYO18A
7435,GO:0031577,0.982375562599184,0.0935976885000264,1,32,spindle checkpoint,BP,NDRG1
15491,GO:0071897,0.98245391169592,0.0329258635042082,13,178,DNA biosynthetic process,BP,TK2;POLD4;RMI2;MAPK3;PRIMPOL;POLM;TEP1;PKIB;POLL;TERC;FGFR4;FAAP20;HMBOX1
647,GO:0001838,0.982515241432548,0.0416485577207356,6,99,embryonic epithelial tube formation,BP,VANGL2;TCTN1;DEAF1;IFT57;CELSR1;TEAD2
9346,GO:0035872,0.982523469900858,0.0929797805819321,1,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,IKBKB
9530,GO:0036297,0.982646987689804,0.0650135244838543,2,48,interstrand cross-link repair,BP,ERCC1;FAAP20
15175,GO:0071347,0.982653304151008,0.0375388652725613,8,125,cellular response to interleukin-1,BP,EGR1;ADAMTS7;MAPK13;HYAL1;MAPK3;CEBPB;RPS6KA5;IKBKB
17947,GO:1902373,0.982662961253798,0.0923957683079487,1,32,negative regulation of mRNA catabolic process,BP,CIRBP
2899,GO:0006409,0.982683899532274,0.0923079989360263,1,32,tRNA export from nucleus,BP,XPOT
15235,GO:0071431,0.982683899532274,0.0923079989360263,1,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,XPOT
12614,GO:0050830,0.982706302720717,0.0918007445133687,1,35,defense response to Gram-positive bacterium,BP,ACP5
12758,GO:0051057,0.982823552648063,0.0917218836841392,1,32,positive regulation of small GTPase mediated signal transduction,BP,F2R
11015,GO:0045005,0.982843333787719,0.0916387625421381,1,32,DNA-dependent DNA replication maintenance of fidelity,BP,PRIMPOL
2822,GO:0006289,0.982854629385332,0.0388042697607669,7,113,nucleotide-excision repair,BP,XPC;DDB2;ERCC1;ERCC6;POLD4;NEIL1;POLL
11077,GO:0045104,0.983008411805192,0.090944114847882,1,32,intermediate filament cytoskeleton organization,BP,KLHL24
9335,GO:0035861,0.98303419815623,0.0908354467243871,1,32,site of double-strand break,CC,PHF1
2844,GO:0006325,0.983049701663593,0.0233820364702039,61,660,chromatin organization,BP,ZMYND8;H1F0;VEGFA;PADI3;DDB2;BAHCC1;NOS1;SMARCA1;RBL2;ASH2L;PKN1;H2AFJ;PHF21A;HDAC11;PABPC1L;BRD3;KDM3A;MTHFR;PHF1;RAG1;CHD2;FKBP10;INO80C;CHD3;SCMH1;SATB1;ING4;HMGA2;JADE2;MAPK3;TSPYL2;H1FX;ZFPM1;KDM4C;CBX7;HLCS;JDP2;HDAC5;KDM7A;MAP3K12;L3MBTL1;HLTF;DNMT3A;HMG20B;TADA3;MBD1;TNRC18;PHF2;UHRF2;SMARCD2;RPS6KA5;C6ORF89;MTA3;PHC1;BCL6;HSF4;SIRT2;MTA1;HDAC8;CHD6;PER1
3596,GO:0008026,0.98312390451505,0.0431149283703821,5,87,ATP-dependent helicase activity,MF,DDX59;CHD2;CHD3;DHX32;RECQL5
14507,GO:0070035,0.98312390451505,0.0431149283703821,5,87,purine NTP-dependent helicase activity,MF,DDX59;CHD2;CHD3;DHX32;RECQL5
4021,GO:0009057,0.983198421895626,0.02153389422677,111,1126,macromolecule catabolic process,BP,APOE;BTBD2;SERPINE2;GID4;H1F0;PYGB;FBXO2;TMEM129;EDEM1;LRP1;TIMP2;EGFR;RBCK1;NR1D1;ADAMTS7;CST3;DDIT3;PGM1;ABTB1;ARRDC1;ZFP36L1;CUL9;GAA;PYGL;RPL13A;CTSF;RNF165;FBXW4;CUL7;HYAL1;NAGLU;WWTR1;DNASE1L1;SNX9;MAGEF1;VPS11;CIRBP;CEMIP;USP20;TRIB2;RNF44;CSPG4;BNIP3;PAN2;CTSB;MVB12B;SDC2;LRSAM1;UBXN4;FBXO6;PKD1;FUCA1;AZIN2;GTPBP1;SORL1;PCBP4;HERPUD1;VLDLR;ENDOG;RHBDF1;ATRAID;PCSK9;FBXL15;ISG20;LONP2;SMURF2;TRIB3;CDK5RAP3;AGO4;HEXB;BNIP3L;SHARPIN;ERN1;HEXA;CTSH;PNRC1;AKT1;CHEK2;TSG101;IGF2BP2;TCIRG1;DNASE2;SPSB3;CAPN2;SPATA18;ANKZF1;CHMP4C;TIMP1;HFE;SNX33;CSNK1E;HGSNAT;RNF213;FYN;ZC3H12D;SNX1;UBXN6;SIRT2;MTA1;AP2A2;CIDEA;RPL29;MAN1B1;GALNS;IGF2BP3;WFS1;SYVN1;RPL12;LYPLAL1;KCTD13;BTBD11
12883,GO:0051253,0.983389928509229,0.0216172479973136,97,992,negative regulation of RNA metabolic process,BP,ZC3H6;ZMYND8;NFATC4;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;NR1D1;PRDX5;BAHCC1;DDIT3;DNAJB5;TCFL5;TFDP2;MXI1;MDFI;WWTR1;MXD4;H2AFJ;PHF21A;SHC1;CIRBP;ELK3;FOXQ1;SALL2;ZP3;ACVR2B;EAPP;HES2;EREG;NAB2;PPARA;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;THRA;IRF2BPL;PBXIP1;MLXIPL;ZFPM1;TENM2;CBX7;JDP2;HDAC5;VLDLR;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;ZFP90;TRPV1;GAS6;RXRA;MBD1;TNRC18;CDKN1C;CRY2;TSG101;PHF2;ZNF217;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;TP73;MTA3;MNT;BCL6;HSF4;SIRT2;RECQL5;RCOR2;MTA1;HDAC8;TCF7;MAP3K10;PER1;FGFR1;WFS1;HMBOX1;TSHZ1;SIX5
7095,GO:0030900,0.983407180575883,0.028811417461452,18,230,forebrain development,BP,PTPRS;BBS2;LRP1;EGFR;WNT2B;TRAPPC9;BNIP3;SEMA5A;TCTN1;MDK;NDE1;WNT7A;ATP2B4;LAMB1;FYN;SLC38A2;EPHB2;FGFR1
1011,GO:0002495,0.983570839775551,0.0458609284506183,4,76,antigen processing and presentation of peptide antigen via MHC class II,BP,CTSF;ACTR1B;OSBPL1A;AP2A2
3431,GO:0007223,0.983615681671136,0.0883733674473913,1,32,Wnt signaling pathway, calcium modulating pathway,BP,AGO4
14816,GO:0070585,0.983852150317123,0.0319534422833657,11,160,protein localization to mitochondrion,BP,DDIT3;TFDP2;VPS11;MICALL2;AIP;BBC3;PEMT;BNIP3L;AKT1;TP73;OSCP1
5677,GO:0016796,0.98398628118448,0.0607665496981473,2,49,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,PAN2;ISG20
2905,GO:0006418,0.984279126998821,0.0598422999253305,2,49,tRNA aminoacylation for protein translation,BP,AARS;CARS
11875,GO:0046916,0.984411341130613,0.0437759734072293,4,78,cellular transition metal ion homeostasis,BP,PRNP;CYBRD1;ATP7B;HFE
4476,GO:0010498,0.984490732812542,0.0233948172952282,36,416,proteasomal protein catabolic process,BP,BTBD2;GID4;FBXO2;TMEM129;EDEM1;RBCK1;NR1D1;DDIT3;ABTB1;RNF165;FBXW4;WWTR1;TRIB2;RNF44;UBXN4;FBXO6;PKD1;HERPUD1;RHBDF1;FBXL15;SMURF2;TRIB3;SHARPIN;AKT1;SPSB3;ANKZF1;HFE;CSNK1E;UBXN6;SIRT2;MTA1;MAN1B1;WFS1;SYVN1;KCTD13;BTBD11
1149,GO:0002757,0.984599531608137,0.0245670247781535,27,325,immune response-activating signal transduction,BP,TNIP1;PTPRS;WIPF1;RBCK1;PRNP;NR1D1;PAK1;MUC19;PLA2G6;ERMAP;NLRX1;MAPK3;CTSB;INPP5D;FLOT1;PIK3R2;CARD11;RPS6KA5;BRAF;BTN3A2;BTN3A3;TKFC;FYN;ADA;VAV3;PAG1;IKBKB
1005,GO:0002479,0.984669650560396,0.0486030042145081,3,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5;HLA-G;IKBKB
6350,GO:0021536,0.984693551300601,0.0836107006032544,1,33,diencephalon development,BP,SEMA5A
12846,GO:0051193,0.984727568683774,0.0430519812198307,4,76,regulation of cofactor metabolic process,BP,DDIT4;PPARA;MLXIPL;INSR
3297,GO:0006997,0.98473307457115,0.0334913726599961,8,124,nucleus organization,BP,NEK9;KDM3A;CHMP1B;REEP4;LMNA;CHMP5;CHMP4C;LEMD2
12738,GO:0051031,0.984762936141,0.0833104939109173,1,33,tRNA transport,BP,XPOT
10850,GO:0044390,0.984823894678553,0.0830464576228337,1,33,ubiquitin-like protein conjugating enzyme binding,MF,PPARA
1014,GO:0002504,0.985017579385026,0.0423192524588304,4,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,CTSF;ACTR1B;OSBPL1A;AP2A2
3795,GO:0008376,0.985020103040024,0.0821947592346363,1,33,acetylgalactosaminyltransferase activity,MF,B4GALNT4
11642,GO:0046425,0.985054313503752,0.0422292772046291,4,77,regulation of JAK-STAT cascade,BP,PTK6;CTF1;FGFR3;FYN
17801,GO:1901988,0.985100626127635,0.0268313131701591,16,215,negative regulation of cell cycle phase transition,BP,FHL1;GJC2;BRSK1;ZFP36L1;RBL2;TFDP2;PKD2;HMGA2;PCBP4;CDK5RAP3;CHEK2;FOXO4;CHMP4C;CTDSPL;PIDD1;TP73
6693,GO:0030099,0.985107133776436,0.0246222267419074,23,289,myeloid cell differentiation,BP,FOS;CTNNBIP1;FAM210B;VEGFA;ZFP36L1;ASH2L;FAM213A;THRA;FAM20C;INPP5D;DMTN;ZFPM1;CEBPB;L3MBTL1;TGFBR2;AGO4;NBEAL2;DNASE2;JAK3;BCL6;TGFBR3;EPAS1;SH3PXD2A
399,GO:0001076,0.985166308926556,0.030438319771464,10,147,transcription factor activity, RNA polymerase II transcription factor binding,MF,ZMYND8;FOS;CITED4;NR1D1;SOX12;PPARA;THRA;ATF4;BHLHE40;DMTF1
3934,GO:0008625,0.985296824877588,0.0469639378751955,3,64,extrinsic apoptotic signaling pathway via death domain receptors,BP,ARHGEF2;NOS3;PIDD1
5569,GO:0016591,0.985559832529903,0.0351155010055212,6,103,DNA-directed RNA polymerase II, holoenzyme,CC,ERCC1;TADA3;POLR2J2;RECQL5;CHD6;POLR2J3
285,GO:0000790,0.985629030412925,0.0235893331231706,24,303,nuclear chromatin,CC,H1F0;NR1D1;MEF2D;SMARCA1;ASH2L;H2AFJ;TRNP1;APPL2;SALL2;INO80C;CHD3;SATB1;STAT6;KDM4C;CBX7;CEBPB;DNMT3A;CALCOCO1;RXRA;UHRF2;SMARCD2;SIRT2;POLR3GL;TCF7
9973,GO:0042393,0.985639529650942,0.0280102993458136,12,172,histone binding,MF,ZMYND8;PKN1;PHF21A;BRD3;PHF1;RAG1;CHD2;ING4;KDM7A;L3MBTL1;PHF2;UHRF2
19687,GO:2000058,0.985667717818208,0.0316282977182521,8,126,regulation of ubiquitin-dependent protein catabolic process,BP,MAGEF1;TRIB2;HERPUD1;TRIB3;AKT1;HFE;CSNK1E;SIRT2
14375,GO:0061659,0.985719939507261,0.0262416564027781,15,202,ubiquitin-like protein ligase activity,MF,GID4;TMEM129;RNF165;NEURL1;RAG1;RNF44;LRSAM1;FBXO6;HLTF;SMURF2;UHRF2;UBOX5;MIB2;PJA2;SYVN1
10739,GO:0044183,0.985883898866116,0.0782866790244392,1,34,protein binding involved in protein folding,MF,FYCO1
11298,GO:0045638,0.98611450521511,0.0446338227243821,3,67,negative regulation of myeloid cell differentiation,BP,ZFP36L1;INPP5D;ZFPM1
4954,GO:0015030,0.986125158273118,0.0538288579937502,2,51,Cajal body,CC,ISG20;TERC
18339,GO:1903363,0.986131070596973,0.0446471141054048,3,65,negative regulation of cellular protein catabolic process,BP,ATRAID;CDK5RAP3;HFE
19018,GO:1904892,0.986347193948221,0.0390185460991709,4,78,regulation of STAT cascade,BP,PTK6;CTF1;FGFR3;FYN
10863,GO:0044419,0.986416109849836,0.0186685765597072,67,729,interspecies interaction between organisms,BP,TNIP1;APOE;GSN;EGFR;RBCK1;FBLN1;CRTC1;PACS2;ADARB1;MMP1;EXOC2;EFNB3;RPL13A;ULK2;RAB11FIP4;CUL7;ATG16L2;TMEM173;ULK1;SHC1;APOBEC3C;APOBEC3F;NLRX1;SATB1;HMGA2;AP1G2;MAPK3;ITGB5;PC;BNIP3;IFITM1;CTSB;EIF2D;MVB12B;CHMP1B;LRSAM1;NLRP1;ISG20;BNIP3L;GAS6;UCKL1;RXRA;RAB43;TNFRSF14;SEPT6;TSG101;TBC1D20;CHMP5;INSR;KRT19;NELFCD;CHMP4C;ULBP1;ITGB6;CPSF4;LGALS1;TP73;FYN;MPDZ;AP2A2;RPL29;CHD6;ITGA2;FKBP8;EIF2AK4;RPL12;ACOT8
2948,GO:0006479,0.986542632947867,0.0278551601909901,10,149,protein methylation,BP,ASH2L;BTG1;RAB3B;KDM3A;MTHFR;PHF1;ETFB;SATB1;KDM4C;PCMTD2
3702,GO:0008213,0.986542632947867,0.0278551601909901,10,149,protein alkylation,BP,ASH2L;BTG1;RAB3B;KDM3A;MTHFR;PHF1;ETFB;SATB1;KDM4C;PCMTD2
7347,GO:0031398,0.986662363696635,0.0350119726118377,5,91,positive regulation of protein ubiquitination,BP,TRIB3;CDK5RAP3;GOLGA2;MTA1;WFS1
2456,GO:0005669,0.986968698551431,0.0733443040822399,1,35,transcription factor TFIID complex,CC,ERCC1
16082,GO:0090090,0.986976505277528,0.0289972644818591,8,129,negative regulation of canonical Wnt signaling pathway,BP,APOE;EGR1;IGFBP4;DDIT3;WWTR1;NPHP4;LZTS2;IGFBP2
5741,GO:0016893,0.987049505717702,0.0729809675884546,1,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,ENDOV
2497,GO:0005746,0.987164891248822,0.0416009236732508,3,72,mitochondrial respiratory chain,CC,NDUFA4L2;SDHA;SDHAF4
10073,GO:0042590,0.987313849379341,0.0412847288740335,3,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGB5;HLA-G;IKBKB
15632,GO:0072175,0.987421496135219,0.0310695294701188,6,103,epithelial tube formation,BP,VANGL2;TCTN1;DEAF1;IFT57;CELSR1;TEAD2
14795,GO:0070555,0.987438809871339,0.0270182744230673,9,141,response to interleukin-1,BP,EGR1;ADAMTS7;MAPK13;HYAL1;MTHFR;MAPK3;CEBPB;RPS6KA5;IKBKB
2560,GO:0005844,0.987466382128374,0.0408331391023031,3,69,polysome,CC,UNK;IMPACT;EIF2AK4
276,GO:0000779,0.98755952893111,0.030754994271325,6,104,condensed chromosome, centromeric region,CC,SPC24;CEBPB;NDE1;SEPT6;PHF2;REC8
274,GO:0000777,0.987770332058134,0.0324245908058189,5,92,condensed chromosome kinetochore,CC,SPC24;NDE1;SEPT6;PHF2;REC8
1443,GO:0003674,0.987951938430492,0.0159817688038598,1315,11315,molecular_function,MF,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;NYNRIN;APOE;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;GID4;FOS;PRODH;OSBPL5;IL20RB;H1F0;GSN;ADGRL1;LRRC20;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;THBS3;PGF;ALDH7A1;FGFBP1;TYSND1;POSTN;PPP1R35;EVI5L;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;THSD4;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;GPX3;GJC2;SEMA4B;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;TNFSF15;ZKSCAN1;ACBD4;SPTB;NPEPL1;LOXL1;DGKA;TSPAN1;SLC16A3;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;HAGHL;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;CYYR1;MICALCL;ACAD10;PGM1;CGREF1;CRTC1;CLCA2;SCN4B;PACS2;ORAI3;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;FCGBP;TBC1D8;ABTB1;ARHGEF19;TCEA2;KHNYN;MMP28;ZCCHC24;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;UHRF1BP1;PPM1M;SYT8;CUL9;JMJD7;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;MMP1;PYCR2;CTF1;TMEM134;CNTN1;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;PHYHD1;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;TK2;BBS1;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;PLD3;ASH2L;SOX13;CUL7;PITPNM3;LHPP;EPM2A;PRSS3;HMGCL;UROS;PCED1A;HYAL1;NXPH4;MPRIP;SMOC2;NAGLU;ARPIN;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;SMOC1;ACP6;POLD4;GIGYF1;MAP2K1;CYP27B1;PCK2;SLC16A5;MXD4;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;SLC43A1;MC1R;CAPG;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;DNAJC4;FAM213A;FAM110C;THAP8;MAGEF1;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;FAM102A;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;ADM2;R3HDM2;MARCKSL1;OGDHL;LGALS9B;SOX12;HDAC11;RAB3B;NLGN2;PCSK1;SLC12A7;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;UNK;NMRK1;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;C22ORF23;TTBK2;PCED1B;PRKCZ;PPP2R3B;HTR7;GALE;SERPING1;PAK1;ABCA7;ANKS6;SLC37A2;APOBEC3C;AARS;PHYH;MCTP1;ELK3;STK39;PABPC1L;B4GALNT4;ERO1B;BLVRB;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;BRI3;NATD1;FOXQ1;ARVCF;KLHL29;PHF1;GLDC;NPR2;SEMA3F;PLCXD1;FAM167A;PLXNB3;CAPNS2;NDUFA4L2;TMEM44;CBS;TMEM187;SPRY4;FAM3A;USP20;DHRS12;SALL2;ORAI2;ELMO3;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;NMNAT2;DDX59;WDR27;MICALL2;SLCO4A1;NME4;CEP250;GRIP2;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;SPEG;NGFR;ELFN2;EPOR;MARCH4;NID1;ETV5;NSUN7;ETFB;GSTO1;LCE1E;ARHGEF4;WDR60;LTBP1;SYNC;PPCS;SMIM14;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;PLXNB1;EREG;CHD2;GPT2;TEF;TNS1;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;SPATA20;OLFM2;PLCD3;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;PPM1J;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;SCART1;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;C5;KIF17;SPATS2;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;ANO1;SNX29;CHAC1;CCDC92;SPC24;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;WDR90;PKD2;SATB1;STAT6;KLF7;R3HDM4;ING4;NUDCD3;ACOT11;VAMP2;RRNAD1;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;LRP11;PCLO;KCNC4;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;ITGB5;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;SEMA5A;THRA;IFITM1;PEX10;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;KCTD15;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;LTBP2;ADAMTSL1;SNTA1;FAHD2B;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;SRGAP3;ZXDC;PAQR6;PQLC2;KIAA0319L;SDC2;CHMP1B;FBXO17;NRSN2;ARHGAP22;MLXIPL;PLEKHG4;IFNGR2;TBC1D14;PTPDC1;C1RL;PLCD1;ARHGEF2;SEPT10;FBF1;INPP5D;PDCD1LG2;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;SAMD3;STMN3;SLC50A1;PGPEP1;SDHA;TECPR1;KIF21B;FAM86C2P;SLC48A1;EHBP1L1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;UBXN4;NOL4L;MORN4;ATF4;PROCR;ZFPM1;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;DOCK11;SSH1;LRRC45;LTB4R2;PCMTD2;SV2A;TBC1D3E;FAM214B;SLC38A10;PRIMPOL;RABGAP1;GPR153;POLM;ACAP3;TENM2;ERICH2;MYH16;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;ATXN10;RALGAPA1;SLC29A4;FLOT1;LTBP3;CEP68;MDK;TTN;PSKH1;HLCS;KCNMA1;AZIN2;HSD11B1;TSNARE1;TMEM128;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;NTPCR;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;PAPLN;ADGRF1;NADK;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;ROBO3;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;ACADS;FBXL16;CEP131;ISG20;LONP2;EPN3;MARK3;CCDC57;DGCR6L;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;RSRP1;CSRNP3;MN1;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;SLFN5;ANO9;MAP1LC3A;MOCOS;APOL4;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;TYMSOS;RAB40B;DAP;ARL10;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;HERPUD2;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;RPUSD3;ANGEL1;SEMA4G;ZNF662;SHARPIN;CCS;FMNL2;GAS6;GLUD1;DNAJC6;OLFML2A;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ECM2;ALKBH7;CROCC;PLEKHG3;BCR;KLHDC8B;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;NBR1;CPT1C;EXD3;HEXA;FAHD2A;TNNI2;BCAM;SRR;TADA3;C1QTNF6;BOLA1;MFSD3;NUDT8;KIF13B;TTYH3;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;THNSL2;PRDM8;SLC9A3R2;EFEMP2;STRADB;CTSH;TNFRSF14;WDR19;ACOX3;ACAD11;PNRC1;FBXL8;UACA;GSDMC;MGMT;GSTO2;ASNS;TMEM9;ENTPD6;TM7SF2;PLEKHG6;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;SEMA6B;KIAA0930;IFT57;LACTB2;PHYKPL;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;SPDYE2;SPDYE2B;CAPS;TNNT1;COMTD1;NFU1;CABYR;TSG101;KIF27;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;TMEM256;RASSF9;SLC6A9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;SLC6A6;NUCB2;ZNF25;FARP1;DNASE2;LMNA;TMEM63C;ASMTL;FAAH;UPP1;SH2B3;LENG9;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;UBTD1;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;IFI27;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;CKLF;FOXO4;GNAL;COG7;YPEL3;SLC22A15;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;LTB4R;SMIM20;TPCN1;ULBP1;ADD3;MBLAC2;MAGED2;GRAMD1A;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;BTN3A2;ASIC1;ALDH1L1;HOXC5;RNF215;PLB1;FAAP20;PIDD1;CAT;ZNF160;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;UNC119B;TIMP1;HFE;JAK3;KIAA1549;MRGPRX3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;CHRM3;ZNF846;APRT;TMX4;TFEB;OGFOD2;MIB2;CERS4;MPI;PEX7;SNX17;LSM14B;ENDOV;JOSD2;PHC1;ICAM5;SCYL3;METTL7A;ATP12A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BTN3A3;BCL6;REPS2;RABAC1;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;GPATCH2L;TMEM25;PJA2;SLC38A2;SNX1;PEX1;LEMD2;UBXN6;ARHGEF17;SLC25A42;SIRT2;TRPC1;MBOAT2;GDF15;ANKMY1;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;TST;GOLGA2;CELSR1;SH3GLB2;ADA;CADM4;POU2F2;PLXND1;RCOR2;POLR3GL;TMEM54;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;TMEM101;MSH5;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;TMEM139;EIF4EBP1;AVPI1;ERV3-1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;TMCO6;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;DIP2C;PIGV;WFS1;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;SPATA6;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;PLLP;SLC10A6;KDELC2;UST;EIF2AK4;STK32B;UNC119;PAG1;CCDC69;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;MMP17;RPL12;MPPE1;HMBOX1;NET1;TTC19;WBP1;HSP90AB4P;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;BTBD11;SLC9A5;SIX5
2904,GO:0006417,0.987958002345857,0.0188312131942162,32,386,regulation of translation,BP,EGFR;ZFP36L1;RPL13A;MIF4GD;MAP2K1;GRB7;UNK;CIRBP;CAPRIN2;NEURL1;SESN2;MKNK2;IMPACT;MAPK3;MAP2K2;ATF4;AGO4;PTAFR;PPP1R15A;RXRA;PAIP2B;AKT1;IGF2BP2;LSM14B;ZC3H12D;PAIP2;EIF4EBP1;PER1;IGF2BP3;ITGA2;ERBB2;EIF2AK4
8846,GO:0034655,0.988253555212873,0.0172779691305565,45,521,nucleobase-containing compound catabolic process,BP,XDH;NT5E;H1F0;RAPGEF3;DNPH1;PGM1;ZFP36L1;DHTKD1;RPL13A;DDIT4;DNASE1L1;OGDHL;CIRBP;APOBEC3C;NEIL1;APOBEC3F;PPARA;NT5C1B;PAN2;MLXIPL;GTPBP1;GALK1;PCBP4;ENDOG;ALDOC;ISG20;PDE2A;AGO4;ERN1;PNRC1;ENTPD6;AKT1;IGF2BP2;DNASE2;UPP1;INSR;ZC3H12D;ADA;ENTPD2;CIDEA;RPL29;IGF2BP3;PFKL;RPL12;NUDT18
15936,GO:0075733,0.988336217202547,0.0465068262134146,2,52,intracellular transport of virus,BP,MVB12B;TSG101
16356,GO:0090734,0.988441660712623,0.0666308719156722,1,35,site of DNA damage,CC,PHF1
5993,GO:0019003,0.988444474062174,0.0461442258230397,2,52,GDP binding,MF,RAB3B;SUCLG2
10273,GO:0043039,0.988447180234615,0.0461351533844929,2,52,tRNA aminoacylation,BP,AARS;CARS
7707,GO:0032205,0.98851498601643,0.066291457995447,1,35,negative regulation of telomere maintenance,BP,ERCC1
138,GO:0000289,0.988517811173388,0.0662783703466141,1,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,PAN2
9871,GO:0042162,0.988551641978559,0.0661215880364935,1,35,telomeric DNA binding,MF,HMBOX1
3298,GO:0006998,0.98910958803929,0.0320086389291156,4,80,nuclear envelope organization,BP,NEK9;REEP4;LMNA;LEMD2
1000,GO:0002474,0.989168300448502,0.0318084401834616,4,83,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGB5;HFE;HLA-G;IKBKB
36,GO:0000075,0.989172644258145,0.0203194614480114,15,207,cell cycle checkpoint,BP,XPC;BRSK1;NDRG1;RBL2;TFDP2;HMGA2;FBXO6;PCBP4;CDK5RAP3;CHEK2;FOXO4;CHMP4C;PIDD1;TP73;EIF2AK4
6497,GO:0021872,0.98939648989015,0.0620748121743764,1,36,forebrain generation of neurons,BP,FGFR1
4668,GO:0010821,0.989399978787863,0.0207228341784504,13,187,regulation of mitochondrion organization,BP,TFDP2;VPS11;MICALL2;PLA2G6;BNIP3;BBC3;PEMT;BNIP3L;AKT1;LMNA;TP73;CIDEB;OSCP1
14386,GO:0061695,0.98947771441258,0.0188690574787735,18,241,transferase complex, transferring phosphorus-containing groups,CC,ERCC1;POLD4;ULK1;SESN2;TGFBR2;PIK3R2;ERN1;TADA3;TERC;C9ORF72;INSR;POLR2J2;RECQL5;POLR3GL;CHD6;POLR2J3;PFKL;IKBKB
2933,GO:0006457,0.98961551770436,0.0195424801739241,15,210,protein folding,BP,FKBP9;CRTAP;DNAJB5;LTBP4;DNAJC4;ERO1B;FKBP10;AIP;NUDCD3;TTC12;FYCO1;TMX4;WFS1;FKBP8;HSP90AB4P
12578,GO:0050778,0.989648657853596,0.0157968946557308,38,444,positive regulation of immune response,BP,TNIP1;PTPRS;WIPF1;RBCK1;PRNP;NR1D1;TMEM173;PRKCZ;SERPING1;PAK1;ZP3;MUC19;EREG;PLA2G6;ERMAP;C5;NLRX1;STAT6;MAPK3;CTSB;C1RL;INPP5D;FLOT1;PIK3R2;PTAFR;CARD11;HMSD;RPS6KA5;BRAF;BTN3A2;BTN3A3;TKFC;FYN;ADA;VAV3;EIF2AK4;PAG1;IKBKB
10272,GO:0043038,0.989661999836404,0.0419809092170742,2,53,amino acid activation,BP,AARS;CARS
5790,GO:0017038,0.989772234695138,0.0210593658789543,11,165,protein import,BP,APOE;TMEM173;PEX10;PDE2A;GAS6;AKT1;SNX33;PEX7;BCL6;PEX1;TMCO6
686,GO:0001906,0.989792195523558,0.0342033844512333,3,70,cell killing,BP,CTSH;ULBP1;LYST
19688,GO:2000059,0.989799035804172,0.0600803132340856,1,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,HFE
12993,GO:0051452,0.989867662556027,0.0597537946904952,1,37,intracellular pH reduction,BP,TCIRG1
2870,GO:0006366,0.989868732835643,0.0125872671044347,180,1758,transcription by RNA polymerase II,BP,TNIP1;ZC3H6;HTRA1;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;NR1D1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MDFI;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MXD4;ABCA2;PKN1;MC1R;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SOX12;CAPRIN2;ELK3;BRD3;KDM3A;FOXQ1;SALL2;ETV1;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;CHD2;TEF;UNKL;CARF;PPARA;CHD3;SESN2;TCF25;IMPACT;PKD2;SATB1;STAT6;KLF7;HMGA2;ECM1;MAPK3;THRA;IRF2BPL;MLXIPL;ARHGEF2;LITAF;ATF4;ZFPM1;KDM4C;TENM2;ZNF516;CBX7;PKD1;JDP2;HDAC5;IRF5;SRSF5;VLDLR;DEAF1;PEG3;RFX2;CEBPB;LRP5;CREBRF;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;PDE2A;SMURF2;APLN;TRIB3;BHLHE40;CALCOCO1;CDK5RAP3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;MBD1;ATP2B4;AKT1;CRY2;ZNF217;ZNF25;SMARCD2;IFI27;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;CPSF4;POLR2J2;HOXC5;ZNF160;HFE;KIAA1549;TP73;MNT;TFEB;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;CHD6;POLR2J3;PER1;FGFR1;WFS1;FKBP8;ERBB2;HMBOX1;TSHZ1;CREB3L4;ZMYM3;DBP;IKBKB;DMTF1;TEAD2;SIX5
14522,GO:0070063,0.989872226316736,0.0412603295924453,2,53,RNA polymerase binding,MF,RECQL5;ERBB2
3963,GO:0008757,0.989882548150773,0.0230918107586592,8,130,S-adenosylmethionine-dependent methyltransferase activity,MF,GAMT;ASH2L;NSUN5P2;RRNAD1;PCMTD2;TFB1M;DNMT3A;PEMT
11870,GO:0046907,0.990031762444021,0.0126405276842628,145,1456,intracellular transport,BP,BBS2;APOE;SYTL1;LMF1;EVI5L;TMEM129;EDEM1;PRNP;ZDHHC1;ANK3;IFT140;RAPGEF3;CLTCL1;SPTB;SNPH;DNM1;TBC1D8;SYT8;B3GAT3;RPL13A;REEP2;RAB11FIP4;CPT2;SYNGR1;MAP2K1;ABCA2;TOM1L2;TMEM173;SNX9;VPS11;BLOC1S4;RAB3B;PRKCZ;PAK1;CEMIP;MICALL2;CCDC88B;NGFR;WDR60;SPG11;TMED4;ABCG1;XPOT;TRAPPC9;S100A13;KIF17;AIP;IFT27;SH3TC2;VAMP2;AREG;AP1G2;SEPT5;PCLO;ACACB;MAPK3;PEX10;RGS14;LTBP2;HOOK2;EIF2D;MVB12B;TBC1D14;ARHGEF2;MAP2K2;DMTN;TBC1D3E;RABGAP1;REEP6;PKD1;TSNARE1;WHAMMP3;SORL1;HERPUD1;SRSF5;NDE1;PCSK9;CEP131;LONP2;PDE2A;RAB40B;PEMT;BNIP3L;CCS;GAS6;VPS39;BCR;ATP7B;FYCO1;KIF13B;CAMK1;RIMS3;RAB43;STRADB;WDR19;AKT1;ZFYVE21;IFT57;TTC21A;TSG101;RASSF9;COPG1;SGSM2;TBC1D20;CHMP5;RAB25;IFI27;COG7;CHMP4C;LYST;ZDHHC24;BRAF;ARHGAP44;CPSF4;SNX33;PEX7;SNX17;SPIRE1;TMEM50B;BCL6;EHD3;FYN;SNX1;PEX1;UBXN6;RAB13;TOM1;GOLGA2;RHOBTB3;RTN2;AP2A2;RPL29;STX1A;TBC1D16;TMCO6;BLOC1S1;RGPD6;ERBB2;SEC31B;SYVN1;OSCP1;RPL12;MPPE1;APBA1;HIP1
10959,GO:0044766,0.990046435396165,0.0335106517762681,3,68,multi-organism transport,BP,MVB12B;RAB40B;TSG101
18021,GO:1902579,0.990046435396165,0.0335106517762681,3,68,multi-organism localization,BP,MVB12B;RAB40B;TSG101
6145,GO:0019439,0.990215754455647,0.0143591336892749,48,555,aromatic compound catabolic process,BP,XDH;NT5E;H1F0;RAPGEF3;DNPH1;PGM1;ZFP36L1;DHTKD1;RPL13A;DDIT4;DNASE1L1;OGDHL;CIRBP;APOBEC3C;BLVRB;NEIL1;APOBEC3F;PPARA;NT5C1B;PAN2;MLXIPL;GTPBP1;GALK1;PCBP4;ENDOG;ALDOC;ISG20;PDE2A;ALDH1L2;AGO4;ERN1;PNRC1;ENTPD6;AKT1;IGF2BP2;DNASE2;UPP1;INSR;ALDH1L1;ZC3H12D;ADA;ENTPD2;CIDEA;RPL29;IGF2BP3;PFKL;RPL12;NUDT18
5506,GO:0016462,0.99043927013644,0.0134573687230601,63,684,pyrophosphatase activity,MF,DNM1;ERCC6;MYH15;SMARCA1;LHPP;ABCA2;TUBG2;DNAH1;ARL2;RAB3B;MYH11;ABCA7;DDX59;WDR60;CHD2;RHOBTB2;ABCG1;AGAP1;KIF17;CHD3;IFT27;SEPT5;DNAL4;RHOF;TUBE1;MYH3;SEPT10;KIF21B;MYH16;KIF26B;GTPBP1;NTPCR;DHX32;LONP2;HLTF;RAB40B;MLH3;NUDT6;ATP7B;KIF13B;RAB43;ATP2B4;ENTPD6;SEPT6;TNNT1;KIF27;TCIRG1;ASMTL;RAB25;GNAL;ATP12A;RNF213;ATP8B2;PEX1;SLC25A42;RECQL5;RAB13;RHOBTB3;MSH5;ENTPD2;CHD6;SEPT8;NUDT18
5880,GO:0018023,0.990483129768806,0.0568020867162732,1,37,peptidyl-lysine trimethylation,BP,KDM4C
582,GO:0001736,0.990583721875622,0.0239553573885665,6,109,establishment of planar polarity,BP,ARHGEF19;DLG3;VANGL2;SMURF2;CELSR1;AP2A2
3384,GO:0007164,0.990583721875622,0.0239553573885665,6,109,establishment of tissue polarity,BP,ARHGEF19;DLG3;VANGL2;SMURF2;CELSR1;AP2A2
16399,GO:0097064,0.990655089313964,0.055969640463845,1,37,ncRNA export from nucleus,BP,XPOT
583,GO:0001738,0.990666675927615,0.0224710836600236,7,121,morphogenesis of a polarized epithelium,BP,ARHGEF19;LAMA5;DLG3;VANGL2;SMURF2;CELSR1;AP2A2
13130,GO:0051726,0.990682679648867,0.0123945946972796,96,998,regulation of cell cycle,BP,XPC;FHL1;CCNG2;PTK6;GJC2;ALOX15B;PDCD4;TIMP2;EGFR;PRNP;NINL;DDIT3;BRSK1;CGREF1;NDRG1;ZFP36L1;ADARB1;CUL9;NUPR1;RBL2;RPS6KA2;TFDP2;OBSL1;RAB11FIP4;CUL7;HYAL1;MAP2K1;SDCCAG8;BTG1;TOM1L2;TRNP1;PPP2R3B;PAK1;STK39;NPR2;CEP250;EREG;RMI2;PKD2;ING4;HMGA2;CCNI;CNTRL;MAPK12;CHMP1B;MLXIPL;TSPYL2;MAP2K2;PAK6;FBXO6;PKD1;WHAMMP3;PCBP4;SRSF5;LRP5;NDE1;L3MBTL1;CEP131;CDK5RAP3;MINK1;GAS6;ERN1;BCR;MAPRE3;PPP1R15A;ATP2B4;STRADB;ASNS;AKT1;CDKN1C;BEX2;CHEK2;TSG101;CHMP5;UHRF2;INSR;FOXO4;CHMP4C;C6ORF89;CTDSPL;MAP2K5;PIDD1;HAUS4;TP73;MTA3;MNT;PHC1;CSNK1E;BCL6;SIRT2;HDAC8;EIF4EBP1;LAMTOR2;FGFR1;EIF2AK4;SFI1
4247,GO:0009451,0.990713363048096,0.0213603383259084,8,132,RNA modification,BP,ADARB1;APOBEC3C;AARS;NSUN5P2;APOBEC3F;RRNAD1;TFB1M;RPUSD3
5806,GO:0017069,0.99072493182936,0.0555520331752505,1,38,snRNA binding,MF,ISG20
14180,GO:0061136,0.990739296945462,0.0198035924848482,10,155,regulation of proteasomal protein catabolic process,BP,EDEM1;TRIB2;PKD1;HERPUD1;RHBDF1;TRIB3;AKT1;HFE;CSNK1E;SIRT2
5556,GO:0016573,0.99098895187203,0.020792382826952,8,131,histone acetylation,BP,NOS1;ING4;JADE2;MAPK3;TADA3;RPS6KA5;HDAC8;PER1
12978,GO:0051427,0.990989229772037,0.0199856046075184,9,143,hormone receptor binding,MF,PKN1;KDM3A;PTHLH;KDM4C;CEBPB;TADA3;RXRA;NCOA7;FYN
12753,GO:0051052,0.991033887855295,0.014898367079435,26,324,regulation of DNA metabolic process,BP,EGFR;ERCC1;CST3;MAGEF1;SHC1;EREG;STAT6;HMGA2;AREG;MAPK3;TSPYL2;ENDOG;PKIB;MGMT;AKT1;CHEK2;FGFR4;UHRF2;INSR;BCL6;RECQL5;CIDEA;HDAC8;FGFR1;HMBOX1;KCTD13
5691,GO:0016817,0.991047333268509,0.0126354123262838,63,686,hydrolase activity, acting on acid anhydrides,MF,DNM1;ERCC6;MYH15;SMARCA1;LHPP;ABCA2;TUBG2;DNAH1;ARL2;RAB3B;MYH11;ABCA7;DDX59;WDR60;CHD2;RHOBTB2;ABCG1;AGAP1;KIF17;CHD3;IFT27;SEPT5;DNAL4;RHOF;TUBE1;MYH3;SEPT10;KIF21B;MYH16;KIF26B;GTPBP1;NTPCR;DHX32;LONP2;HLTF;RAB40B;MLH3;NUDT6;ATP7B;KIF13B;RAB43;ATP2B4;ENTPD6;SEPT6;TNNT1;KIF27;TCIRG1;ASMTL;RAB25;GNAL;ATP12A;RNF213;ATP8B2;PEX1;SLC25A42;RECQL5;RAB13;RHOBTB3;MSH5;ENTPD2;CHD6;SEPT8;NUDT18
5692,GO:0016818,0.991047333268509,0.0126354123262838,63,686,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,DNM1;ERCC6;MYH15;SMARCA1;LHPP;ABCA2;TUBG2;DNAH1;ARL2;RAB3B;MYH11;ABCA7;DDX59;WDR60;CHD2;RHOBTB2;ABCG1;AGAP1;KIF17;CHD3;IFT27;SEPT5;DNAL4;RHOF;TUBE1;MYH3;SEPT10;KIF21B;MYH16;KIF26B;GTPBP1;NTPCR;DHX32;LONP2;HLTF;RAB40B;MLH3;NUDT6;ATP7B;KIF13B;RAB43;ATP2B4;ENTPD6;SEPT6;TNNT1;KIF27;TCIRG1;ASMTL;RAB25;GNAL;ATP12A;RNF213;ATP8B2;PEX1;SLC25A42;RECQL5;RAB13;RHOBTB3;MSH5;ENTPD2;CHD6;SEPT8;NUDT18
11411,GO:0045851,0.991075331698207,0.0538435524148206,1,38,pH reduction,BP,TCIRG1
9669,GO:0038061,0.991097269861619,0.0227767802473046,6,110,NIK/NF-kappaB signaling,BP,PDCD4;EGFR;TNFSF15;TMSB4X;UACA;AKT1
1860,GO:0004527,0.991294346357818,0.0298286082461883,3,69,exonuclease activity,MF,PAN2;ISG20;EXD3
17252,GO:0140014,0.991341577330389,0.0157474897110168,18,238,mitotic nuclear division,BP,CUL9;OBSL1;CUL7;TOM1L2;TUBG2;EREG;CHMP1B;TTN;LRP5;NDE1;L3MBTL1;CHEK2;CHMP5;INSR;CHMP4C;TUBGCP6;SIRT2;GOLGA2
16193,GO:0090263,0.991403088418654,0.0220760555391388,6,110,positive regulation of canonical Wnt signaling pathway,BP,CAPRIN2;WNT2B;SULF2;SMURF2;EDA;WNT7A
12145,GO:0048285,0.991526314593746,0.0137986408542403,29,352,organelle fission,BP,DNM1;CUL9;OBSL1;CUL7;TOM1L2;TUBG2;EREG;BNIP3;TDRKH;CHMP1B;TTN;LRP5;NDE1;L3MBTL1;MLH3;AGO4;CHEK2;CHMP5;INSR;CHMP4C;TUBGCP6;SPIRE1;REC8;LEMD2;SIRT2;GOLGA2;MSH5;PEX11A;ACOT8
12610,GO:0050821,0.991593192758354,0.0195161833561759,8,133,protein stabilization,BP,TSPAN1;CRTAP;FLOT1;CHEK2;COG7;WFS1;SYVN1;HIP1
17805,GO:1901992,0.991596651677132,0.0351740116215496,2,55,positive regulation of mitotic cell cycle phase transition,BP,HYAL1;MTA3
11819,GO:0046794,0.9916481863842,0.0349910571441762,2,55,transport of virus,BP,MVB12B;TSG101
6599,GO:0022627,0.9916721613036,0.0505820882377427,1,43,cytosolic small ribosomal subunit,CC,EIF2D
6921,GO:0030522,0.9917265569771,0.0155624984009869,16,221,intracellular receptor signaling pathway,BP,ALOX15B;NR1D1;CYP27B1;PAK1;KDM3A;PPARA;NLRX1;THRA;CALCOCO1;TADA3;RXRA;CRY2;TKFC;STARD10;PER1;IKBKB
4338,GO:0009894,0.99177386002051,0.0114442759392527,71,768,regulation of catabolic process,BP,APOE;SERPINE2;TYSND1;EDEM1;LRP1;TIMP2;EGFR;RAPGEF3;CST3;GPSM1;TRIM65;ZFP36L1;ULK2;MLYCD;EPM2A;DDIT4;SNX9;MAGEF1;ULK1;VPS11;CIRBP;TRIB2;PPARA;SESN2;ACACB;MAPK3;BNIP3;THRA;MLXIPL;TBC1D14;LRSAM1;PKD1;AZIN2;GTPBP1;SORL1;PCBP4;HERPUD1;ENDOG;RHBDF1;ATRAID;PCSK9;LONP2;SMURF2;TRIB3;DAP;CDK5RAP3;BNIP3L;PIK3R2;ERN1;FYCO1;ATP2B4;AKT1;CHEK2;IGF2BP2;C9ORF72;INSR;TPCN1;TIMP1;HFE;SNX33;TFEB;CSNK1E;FYN;ZC3H12D;SNX1;SIRT2;GOLGA2;CIDEA;LAMTOR2;IGF2BP3;EIF2AK4
8277,GO:0033108,0.991875036017042,0.0246503717763972,4,89,mitochondrial respiratory chain complex assembly,BP,SMIM20;TAZ;TTC19;SDHAF4
17946,GO:1902369,0.991929860014774,0.0496119655743138,1,38,negative regulation of RNA catabolic process,BP,CIRBP
6748,GO:0030177,0.992219807982222,0.0181841875594408,8,135,positive regulation of Wnt signaling pathway,BP,CAPRIN2;WNT2B;SULF2;SMURF2;EDA;WNT7A;WNT3;CSNK1E
8975,GO:0035097,0.992312584702109,0.0267629370545246,3,70,histone methyltransferase complex,CC,ASH2L;PHF1;INO80C
10493,GO:0043414,0.992337344362393,0.0142553591928271,17,234,macromolecule methylation,BP,FOS;ASH2L;BTG1;RAB3B;KDM3A;MTHFR;PHF1;NSUN5P2;ETFB;SATB1;RRNAD1;TDRKH;KDM4C;PCMTD2;TFB1M;DNMT3A;MGMT
13575,GO:0060071,0.99241077828247,0.0211916676659044,5,99,Wnt signaling pathway, planar cell polarity pathway,BP,ARHGEF19;VANGL2;SMURF2;CELSR1;AP2A2
2082,GO:0004843,0.992455085148442,0.0263318262619726,3,70,thiol-dependent ubiquitin-specific protease activity,MF,USP20;ANKZF1;JOSD2
14960,GO:0070897,0.992505652606318,0.0466388081668218,1,39,DNA-templated transcriptional preinitiation complex assembly,BP,THRA
19791,GO:2000278,0.992791479954867,0.0222403206562878,4,84,regulation of DNA biosynthetic process,BP,MAPK3;PKIB;FGFR4;HMBOX1
5961,GO:0018393,0.992870810233545,0.0168039640162293,8,134,internal peptidyl-lysine acetylation,BP,NOS1;ING4;JADE2;MAPK3;TADA3;RPS6KA5;HDAC8;PER1
4552,GO:0010638,0.993106183040025,0.0104449928508595,44,511,positive regulation of organelle organization,BP,GSN;WIPF1;CDC42EP5;VEGFA;ERCC1;RAPGEF3;NOS1;TFDP2;ARPIN;ARL2;ULK1;VPS11;PAK1;PHF1;MICALL2;EREG;PLA2G6;MAPK3;BNIP3;SEMA5A;LRSAM1;BBC3;JDP2;WHAMMP3;LRP5;PKIB;TRPV4;PEMT;EPHA1;CROCC;FYCO1;INSR;RPS6KA5;C6ORF89;BRAF;TP73;SPIRE1;BCL6;SIRT2;CIDEB;OSCP1;C15ORF62;CORO1B;HMBOX1
8789,GO:0034504,0.993113827160072,0.0136198327954888,14,203,protein localization to nucleus,BP,TMEM173;ARL2;ABCA7;NGFR;SESN2;PDE2A;CDK5RAP3;GAS6;LZTS2;AKT1;LMNA;BCL6;FYN;TMCO6
12461,GO:0050434,0.99313762821726,0.0433350094753665,1,40,positive regulation of viral transcription,BP,NELFCD
5756,GO:0016925,0.9931973836846,0.0211217202277228,4,85,protein sumoylation,BP,EGR1;HMG20B;PIAS3;MTA1
8348,GO:0033238,0.993244970679265,0.0291143721456385,2,59,regulation of cellular amine metabolic process,BP,ATP2B4;PNKD
2816,GO:0006283,0.993272424040443,0.0237877709739579,3,73,transcription-coupled nucleotide-excision repair,BP,ERCC1;ERCC6;POLD4
19671,GO:2000027,0.99328982525781,0.0139151640303748,12,183,regulation of organ morphogenesis,BP,VEGFA;ARHGEF19;ETV5;WNT2B;VANGL2;SULF2;TGFBR2;SMURF2;RXRA;CELSR1;AP2A2;FGFR1
2845,GO:0006333,0.993302243358141,0.0152101345515098,9,156,chromatin assembly or disassembly,BP,H1F0;BAHCC1;CHD3;HMGA2;TSPYL2;H1FX;TNRC18;SMARCD2;HDAC8
133,GO:0000280,0.993405237003405,0.0112581152126964,25,316,nuclear division,BP,CUL9;OBSL1;CUL7;TOM1L2;TUBG2;EREG;TDRKH;CHMP1B;TTN;LRP5;NDE1;L3MBTL1;MLH3;AGO4;CHEK2;CHMP5;INSR;CHMP4C;TUBGCP6;SPIRE1;REC8;LEMD2;SIRT2;GOLGA2;MSH5
5554,GO:0016571,0.993424330474201,0.0173564860105739,6,111,histone methylation,BP,ASH2L;KDM3A;MTHFR;PHF1;SATB1;KDM4C
10897,GO:0044464,0.993529842290788,0.00850391780580718,1285,11098,cell part,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;APOE;CSMD2;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;IL20RB;H1F0;GSN;ADGRL1;CITED4;ACSF2;CCNG2;PYGB;EGR1;CTNNBIP1;LMF1;THBS3;VWA5A;ALDH7A1;FGFBP1;TYSND1;POSTN;EVI5L;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;FAM210B;GJC2;SEMA4B;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;ERCC1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;DGKA;TSPAN1;SLC16A3;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;SDK2;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;MICALCL;ACAD10;PGM1;CRTC1;CLCA2;SCN4B;PACS2;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;TBC1D8;ABTB1;ARHGEF19;TCEA2;MMP28;PLEKHH1;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;ARMCX2;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;PYCR2;TMEM134;CNTN1;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;PLD3;KLHDC2;ASH2L;SOX13;CUL7;PITPNM3;LHPP;TMEM92;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;MPRIP;NAGLU;OXLD1;ARPIN;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;SLC16A5;MXD4;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;SLC43A1;MC1R;CAPG;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;ADM2;R3HDM2;MARCKSL1;OGDHL;LGALS9B;SOX12;HDAC11;RAB3B;NLGN2;CD68;PCSK1;PLEKHH3;SLC12A7;PTMS;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;UNK;NMRK1;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;TTBK2;LY6K;PRKCZ;PPP2R3B;HTR7;GALE;SERPING1;PAK1;ABCA7;ANKS6;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;PEAR1;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;BRI3;FOXQ1;ARVCF;KLHL29;PHF1;GLDC;NPR2;PLCXD1;PLXNB3;CAPNS2;NDUFA4L2;TMEM44;CBS;TMEM187;SPRY4;USP20;SALL2;ORAI2;ELMO3;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;NMNAT2;DDX59;WDR27;MICALL2;SLCO4A1;NME4;PDZD2;CEP250;GRIP2;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;EPOR;MARCH4;NID1;ETV5;ETFB;GSTO1;LCE1E;ARHGEF4;WDR60;LTBP1;MUC19;SYNC;PPCS;SMIM14;FAM117A;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;PLXNB1;EREG;CHD2;GPT2;TEF;TNS1;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;OLFM2;PLCD3;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;SCART1;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;C5;KIF17;SPATS2;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;ANO1;STON1;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;R3HDM4;SH3TC2;ING4;NUDCD3;ACOT11;VAMP2;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;LRP11;PCLO;KCNC4;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;SEMA5A;THRA;IFITM1;DCAF10;PEX10;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;LTBP2;ADAMTSL1;SNTA1;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;SLITRK6;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;NYAP1;PI4K2A;NAT14;SRGAP3;ZXDC;PAQR6;PQLC2;KIAA0319L;SDC2;CHMP1B;FBXO17;NRSN2;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;TCTN1;PTPDC1;PLCD1;ARHGEF2;SEPT10;MTMR11;FBF1;INPP5D;PDCD1LG2;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;SAMD3;STMN3;SLC50A1;PGPEP1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;MORN4;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;DOCK11;SSH1;LRRC45;LTB4R2;PCMTD2;SV2A;TBC1D3E;FAM214B;SLC38A10;PRIMPOL;FAM193B;FRMD4B;RABGAP1;GPR153;POLM;ACAP3;TENM2;MYH16;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;ATXN10;RALGAPA1;SLC29A4;FLOT1;CEP68;MDK;TTN;PSKH1;HLCS;KCNMA1;AZIN2;HSD11B1;TSNARE1;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;ADGRF1;NADK;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;ROBO3;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;ACADS;FBXL16;CEP131;ISG20;LONP2;EPN3;MARK3;DGCR6L;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;DIRC2;CSRNP3;TTC12;ITGA1;IL17RE;PSD4;TNFAIP8L1;TMSB4X;SLFN5;ANO9;MAP1LC3A;MOCOS;APOL4;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;ARL10;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;NICN1;ZNF558;RPUSD3;ANGEL1;SEMA4G;ZNF662;SHARPIN;CCS;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ESRG;ALKBH7;CROCC;BCR;KLHDC8B;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;C19ORF33;CEP112;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;BCAM;SRR;TADA3;NBEAL2;BOLA1;MFSD3;KIF13B;SPAG16;TTYH3;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;PRDM8;SLC9A3R2;STRADB;CTSH;TNFRSF14;WDR19;ACOX3;ACAD11;PNRC1;TMEM80;FBXL8;CCDC15;UACA;GSDMC;MGMT;GSTO2;ASNS;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;SWT1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;SEMA6B;IFT57;LACTB2;PHYKPL;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;TTC21A;CAPS;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;KIF27;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;RASSF9;SLC6A9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;SLC6A6;NUCB2;ZNF25;FARP1;DNASE2;LMNA;ASMTL;FAAH;UPP1;SH2B3;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;FOXO4;GNAL;COG7;YPEL3;SLC22A15;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;LTB4R;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;BTN3A2;ASIC1;ALDH1L1;HOXC5;PLB1;GJB4;FAAP20;PIDD1;CAT;ZNF160;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;UNC119B;TIMP1;HFE;JAK3;KIAA1549;MRGPRX3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;CHRM3;ZNF846;APRT;GLCCI1;FCHSD1;TMX4;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;ENDOV;JOSD2;PHC1;ICAM5;SCYL3;METTL7A;ATP12A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BTN3A3;BCL6;REPS2;RABAC1;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;TMEM25;PJA2;SLC38A2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;ARHGEF17;SLC25A42;SIRT2;TRPC1;MBOAT2;GDF15;PHLDA2;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;FAM220A;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;CADM4;POU2F2;PLXND1;RCOR2;POLR3GL;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;MSH5;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;TMCO6;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;RGPD6;FKBP8;SPATA6;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;PLLP;SLC10A6;KDELC2;UST;EIF2AK4;STK32B;UNC119;PAG1;CCDC69;RGS12;SYVN1;OSCP1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;MMP17;RPL12;MPPE1;HMBOX1;NET1;TTC19;HSP90AB4P;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;BTBD11;SLC9A5;SIX5
5826,GO:0017111,0.993584381422527,0.0092985491151039,58,646,nucleoside-triphosphatase activity,MF,DNM1;ERCC6;MYH15;SMARCA1;ABCA2;TUBG2;DNAH1;ARL2;RAB3B;MYH11;ABCA7;DDX59;WDR60;CHD2;RHOBTB2;ABCG1;AGAP1;KIF17;CHD3;IFT27;SEPT5;DNAL4;RHOF;TUBE1;MYH3;SEPT10;KIF21B;MYH16;KIF26B;GTPBP1;NTPCR;DHX32;LONP2;HLTF;RAB40B;MLH3;ATP7B;KIF13B;RAB43;ATP2B4;ENTPD6;SEPT6;TNNT1;KIF27;TCIRG1;RAB25;GNAL;ATP12A;RNF213;ATP8B2;PEX1;RECQL5;RAB13;RHOBTB3;MSH5;ENTPD2;CHD6;SEPT8
1150,GO:0002758,0.993617875476612,0.0129699717744225,13,194,innate immune response-activating signal transduction,BP,TNIP1;PTPRS;NR1D1;PAK1;MUC19;NLRX1;CTSB;FLOT1;CARD11;RPS6KA5;TKFC;FYN;IKBKB
11457,GO:0045934,0.993626745312352,0.00849119332688861,105,1097,negative regulation of nucleobase-containing compound metabolic process,BP,ZC3H6;ZMYND8;NFATC4;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;NR1D1;ERCC1;PRDX5;BAHCC1;DDIT3;DNAJB5;TCFL5;TFDP2;MXI1;MDFI;WWTR1;MXD4;DDIT4;H2AFJ;PHF21A;MAGEF1;SHC1;CIRBP;ELK3;FOXQ1;SALL2;ZP3;NEIL1;ACVR2B;EAPP;HES2;EREG;NAB2;PPARA;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;THRA;IRF2BPL;PBXIP1;MLXIPL;TSPYL2;ZFPM1;LTB4R2;TENM2;CBX7;JDP2;HDAC5;VLDLR;GABBR1;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;TRIB3;DAP;BHLHE40;ZFP90;TRPV1;GAS6;RXRA;MBD1;TNRC18;CDKN1C;CRY2;CHEK2;TSG101;PHF2;ZNF217;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;TP73;MTA3;MNT;BCL6;HSF4;SIRT2;RECQL5;RCOR2;MTA1;HDAC8;TCF7;MAP3K10;PER1;FGFR1;WFS1;HMBOX1;TSHZ1;SIX5
20250,GO:2001251,0.993634730661966,0.0168569145120222,6,111,negative regulation of chromosome organization,BP,ERCC1;KDM3A;PHF1;KDM4C;PHF2;HDAC8
283,GO:0000786,0.993641190534187,0.0225124798974984,3,84,nucleosome,CC,H1F0;H2AFJ;H1FX
16223,GO:0090305,0.993643004313405,0.0117912295757854,18,250,nucleic acid phosphodiester bond hydrolysis,BP,H1F0;DDB2;ERCC1;POLD4;DNASE1L1;RAG1;PAN2;ENDOG;ISG20;ERN1;EXD3;PNRC1;LACTB2;DNASE2;CPSF4;ENDOV;ZC3H12D;CIDEA
16129,GO:0090175,0.993661683311001,0.0180365507849239,5,101,regulation of establishment of planar polarity,BP,ARHGEF19;VANGL2;SMURF2;CELSR1;AP2A2
5881,GO:0018024,0.993777233529487,0.0399887922111301,1,40,histone-lysine N-methyltransferase activity,MF,ASH2L
3045,GO:0006605,0.993938432939715,0.0101189422226181,28,366,protein targeting,BP,PRNP;ZDHHC1;ANK3;RPL13A;SYNGR1;VPS11;PAK1;CEMIP;MICALL2;AIP;PEX10;LTBP2;DMTN;SORL1;LONP2;PEMT;BNIP3L;KIF13B;RASSF9;ZDHHC24;PEX7;TMEM50B;FYN;PEX1;RPL29;ERBB2;OSCP1;RPL12
2800,GO:0006260,0.993955020836607,0.0110937027383077,19,259,DNA replication,BP,EGFR;CST3;POLD4;SHC1;PTMS;EREG;RMI2;ING4;AREG;TSPYL2;PRIMPOL;POLL;CHEK2;INSR;BCL6;RECQL5;FGFR1;KCTD13;DTD1
13025,GO:0051539,0.993955659062293,0.0389903156652424,1,41,4 iron, 4 sulfur cluster binding,MF,NFU1
2367,GO:0005488,0.993980233789857,0.00741869360843667,1163,10131,binding,MF,TNIP1;XDH;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;BBS2;F2R;NT5E;TNFRSF6B;ISYNA1;NYNRIN;APOE;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;IL20RB;H1F0;GSN;ADGRL1;LRRC20;ACSF2;PYGB;EGR1;CTNNBIP1;THBS3;PGF;ALDH7A1;FGFBP1;TYSND1;POSTN;PPP1R35;EVI5L;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;GPX3;SEMA4B;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;IFT140;RAPGEF3;CLTCL1;FCHO1;TNFSF15;ZKSCAN1;ACBD4;SPTB;NPEPL1;LOXL1;DGKA;TSPAN1;SLC16A3;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;HAGHL;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;MICALCL;ACAD10;PGM1;CGREF1;CRTC1;CLCA2;SCN4B;PACS2;ORAI3;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;FCGBP;TBC1D8;ABTB1;ARHGEF19;TCEA2;KHNYN;MMP28;ZCCHC24;COL13A1;MYH15;SMARCA1;MST1R;ARRDC1;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;UHRF1BP1;PPM1M;SYT8;CUL9;JMJD7;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;PHGDH;RPS6KA2;GAA;PYGL;MMP1;CTF1;TMEM134;CNTN1;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;PHYHD1;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;TK2;BBS1;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;MLYCD;ASAP2;FBXW4;PLD3;ASH2L;SOX13;CUL7;PITPNM3;LHPP;EPM2A;PRSS3;HMGCL;UROS;PCED1A;HYAL1;NXPH4;MPRIP;SMOC2;ARPIN;ETV4;TXNRD3;WWTR1;SYNGR1;SMOC1;POLD4;GIGYF1;MAP2K1;CYP27B1;PCK2;MXD4;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;MC1R;CAPG;DDIT4;H2AFJ;ALPK1;OPLAH;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;TUBG2;TMEM173;SNX9;PLEKHG5;DNAJC4;FAM110C;THAP8;MAGEF1;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;FAM102A;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;ADM2;R3HDM2;MARCKSL1;OGDHL;LGALS9B;SOX12;HDAC11;RAB3B;NLGN2;PCSK1;SLC12A7;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;PITPNC1;UNK;NMRK1;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;C22ORF23;TTBK2;PCED1B;PRKCZ;PPP2R3B;HTR7;GALE;SERPING1;PAK1;ABCA7;ANKS6;APOBEC3C;AARS;PHYH;MCTP1;ELK3;STK39;PABPC1L;ERO1B;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;BRI3;NATD1;FOXQ1;ARVCF;PHF1;GLDC;NPR2;SEMA3F;FAM167A;PLXNB3;CAPNS2;CBS;SPRY4;USP20;SALL2;ORAI2;ELMO3;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;NMNAT2;DDX59;WDR27;MICALL2;NME4;CEP250;GRIP2;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;SPEG;NGFR;EPOR;MARCH4;NID1;ETV5;NSUN7;ETFB;GSTO1;ARHGEF4;WDR60;LTBP1;SMIM14;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;PLXNB1;EREG;CHD2;GPT2;TEF;TNS1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;OLFM2;PLCD3;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;TNFRSF25;NAB2;PLA2G6;UNKL;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;C5;KIF17;SPATS2;APOBEC3F;PPARA;PLGRKT;CHD3;ANO1;SNX29;CHAC1;CCDC92;SPC24;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;WDR90;PKD2;SATB1;STAT6;KLF7;R3HDM4;ING4;NUDCD3;ACOT11;VAMP2;HMGA2;AREG;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;LRP11;PCLO;JADE2;ACACB;NT5C1B;MAPK3;CSPG4;ITGB5;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;SEMA5A;THRA;IFITM1;PEX10;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;KCTD15;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;LTBP2;SNTA1;FAHD2B;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;EIF2D;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;SRGAP3;ZXDC;PAQR6;KIAA0319L;SDC2;CHMP1B;FBXO17;ARHGAP22;MLXIPL;PLEKHG4;TBC1D14;PLCD1;ARHGEF2;SEPT10;FBF1;INPP5D;PRAF2;TSPYL2;MAP2K2;H1FX;HIBADH;FLYWCH1;TWF2;SAMD3;STMN3;SDHA;TECPR1;KIF21B;SLC48A1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;ANGPTL4;SEMA3B;PTHLH;UBXN4;NOL4L;MORN4;ATF4;PROCR;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;DOCK11;SSH1;LRRC45;SV2A;TBC1D3E;FAM214B;PRIMPOL;RABGAP1;POLM;ACAP3;TENM2;ERICH2;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;NSMCE1;ATXN10;RALGAPA1;FLOT1;LTBP3;CEP68;MDK;TTN;PSKH1;HLCS;KCNMA1;AZIN2;HSD11B1;TSNARE1;TMEM128;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;NTPCR;PCBP4;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;NADK;DHX32;GABBR1;DEAF1;TEP1;SULF2;ROBO3;NLRP1;PEG3;ACY1;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;L3MBTL1;PKN3;FBXL15;METTL23;ACADS;CEP131;ISG20;LONP2;EPN3;MARK3;CCDC57;DGCR6L;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;IQSEC2;RSRP1;CSRNP3;ITGA1;CMTM7;IL17RE;PSD4;TNFAIP8L1;TMSB4X;SLFN5;ANO9;MAP1LC3A;MOCOS;APOL4;PDE2A;SMURF2;APLN;LMO7;TRIB3;TYMSOS;RAB40B;DAP;ARL10;BHLHE40;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;HERPUD2;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;RPUSD3;ANGEL1;SEMA4G;ZNF662;SHARPIN;CCS;FMNL2;GAS6;GLUD1;DNAJC6;OLFML2A;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ECM2;ALKBH7;CROCC;PLEKHG3;BCR;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;NBR1;CPT1C;EXD3;HEXA;FAHD2A;TNNI2;BCAM;SRR;TADA3;C1QTNF6;BOLA1;NUDT8;KIF13B;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;THNSL2;PRDM8;SLC9A3R2;EFEMP2;STRADB;CTSH;TNFRSF14;WDR19;ACOX3;ACAD11;PNRC1;FBXL8;UACA;GSDMC;MGMT;GSTO2;ASNS;TM7SF2;PLEKHG6;PAIP2B;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;SEMA6B;KIAA0930;IFT57;LACTB2;PHYKPL;WDR45;SBF2;IGFBP2;SEPT6;ASS1;SPDYE2;SPDYE2B;CAPS;TNNT1;COMTD1;NFU1;CABYR;TSG101;KIF27;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;RASSF9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;ZNF25;FARP1;DNASE2;LMNA;ASMTL;FAAH;SH2B3;LENG9;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;UBTD1;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;IFI27;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;CKLF;FOXO4;GNAL;COG7;YPEL3;RPS6KA5;ANKZF1;CHMP4C;TNXB;LTB4R;SMIM20;TPCN1;ULBP1;ADD3;MBLAC2;MAGED2;GRAMD1A;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;EDA2R;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;BTN3A2;ASIC1;HOXC5;RNF215;FAAP20;PIDD1;CAT;ZNF160;MYOF;HAUS4;MAPK10;YPEL5;MPG;LGALS1;ZFP28;UNC119B;TIMP1;HFE;JAK3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;CHRM3;ZNF846;APRT;TFEB;OGFOD2;MIB2;CERS4;MPI;PEX7;SNX17;LSM14B;ENDOV;PHC1;ICAM5;SCYL3;ATP12A;SPIRE1;CSNK1E;BTN3A3;BCL6;REPS2;RABAC1;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;GPATCH2L;TMEM25;PJA2;SLC38A2;SNX1;PEX1;LEMD2;UBXN6;ARHGEF17;SIRT2;TRPC1;GDF15;ANKMY1;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;TST;GOLGA2;CELSR1;SH3GLB2;ADA;CADM4;POU2F2;PLXND1;RCOR2;POLR3GL;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;MSH5;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;RPL29;TMEM139;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;TMCO6;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;ESYT3;BLOC1S1;FKBP8;SPATA6;SH3PXD2A;CTH;ERBB2;PLLP;EIF2AK4;STK32B;UNC119;PAG1;CCDC69;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;MMP17;RPL12;MPPE1;HMBOX1;NET1;TTC19;WBP1;HSP90AB4P;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;NUDT18;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTX3;DTD1;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;BTBD11;SIX5
7311,GO:0031329,0.994127053238736,0.00844996393548057,62,691,regulation of cellular catabolic process,BP,APOE;TYSND1;EDEM1;LRP1;TIMP2;RAPGEF3;CST3;GPSM1;TRIM65;ZFP36L1;ULK2;MLYCD;EPM2A;DDIT4;SNX9;MAGEF1;ULK1;VPS11;CIRBP;TRIB2;PPARA;SESN2;ACACB;MAPK3;BNIP3;MLXIPL;TBC1D14;LRSAM1;PKD1;GTPBP1;PCBP4;HERPUD1;ENDOG;RHBDF1;ATRAID;PCSK9;LONP2;TRIB3;DAP;CDK5RAP3;BNIP3L;PIK3R2;ERN1;FYCO1;ATP2B4;AKT1;IGF2BP2;C9ORF72;INSR;TPCN1;TIMP1;HFE;SNX33;TFEB;CSNK1E;ZC3H12D;SIRT2;GOLGA2;CIDEA;LAMTOR2;IGF2BP3;EIF2AK4
6626,GO:0022904,0.994140828185741,0.0184329345982287,4,94,respiratory electron transport chain,BP,D2HGDH;ETFB;SDHA;TAZ
7345,GO:0031396,0.99418456962178,0.0129226379043765,10,162,regulation of protein ubiquitination,BP,FBXO2;HERPUD1;TRIB3;CDK5RAP3;AKT1;FYN;GOLGA2;MTA1;HDAC8;WFS1
10594,GO:0043596,0.994239359591603,0.0374752228211628,1,41,nuclear replication fork,CC,POLD4
15952,GO:0080135,0.994299235454598,0.00864133037317245,46,535,regulation of cellular response to stress,BP,XDH;PTPRS;EDEM1;PDCD4;VEGFA;EGFR;ERCC1;DDIT3;ERCC6;MAP2K1;PKN1;MAGEF1;PAK1;NSMCE4A;IMPACT;HMGA2;MAPK3;VANGL2;ARHGEF2;MAP2K2;ATF4;NSMCE1;HERPUD1;ENDOG;TRPV4;MINK1;WNT7A;ERN1;NBR1;TERC;PPP1R15A;MGMT;AKT1;CHEK2;NCOA7;YPEL3;BRAF;EDA2R;TP73;BCL6;RECQL5;MAP3K10;PER1;WFS1;EIF2AK4;SYVN1
3046,GO:0006606,0.994386161694254,0.0150455261279673,6,113,protein import into nucleus,BP,TMEM173;PDE2A;GAS6;AKT1;BCL6;TMCO6
11814,GO:0046782,0.994395096409842,0.0248197612423657,2,59,regulation of viral transcription,BP,HMGA2;NELFCD
13465,GO:0055029,0.994400887467361,0.014145032922803,7,127,nuclear DNA-directed RNA polymerase complex,CC,ERCC1;TADA3;POLR2J2;RECQL5;POLR3GL;CHD6;POLR2J3
18011,GO:1902562,0.994428056730433,0.0364589528751319,1,41,H4 histone acetyltransferase complex,CC,TADA3
6918,GO:0030518,0.994560653205046,0.0146238957202908,6,113,intracellular steroid hormone receptor signaling pathway,BP,PAK1;KDM3A;CALCOCO1;TADA3;CRY2;PER1
9587,GO:0036459,0.994579659492042,0.017262398477184,4,87,thiol-dependent ubiquitinyl hydrolase activity,MF,USP20;TADA3;ANKZF1;JOSD2
17084,GO:0101005,0.994579659492042,0.017262398477184,4,87,ubiquitinyl hydrolase activity,MF,USP20;TADA3;ANKZF1;JOSD2
2433,GO:0005623,0.994583800206184,0.00716082592736756,1285,11103,cell,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;APOE;CSMD2;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;KCNG1;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;IL20RB;H1F0;GSN;ADGRL1;CITED4;ACSF2;CCNG2;PYGB;EGR1;CTNNBIP1;LMF1;THBS3;VWA5A;ALDH7A1;FGFBP1;TYSND1;POSTN;EVI5L;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;FAM210B;GJC2;SEMA4B;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;ZDHHC1;FCGRT;SCN8A;NR1D1;ERCC1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;DGKA;TSPAN1;SLC16A3;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;SDK2;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;MICALCL;ACAD10;PGM1;CRTC1;CLCA2;SCN4B;PACS2;MRC2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;TBC1D8;ABTB1;ARHGEF19;TCEA2;MMP28;PLEKHH1;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;ARMCX2;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;PYCR2;TMEM134;CNTN1;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;EFNB3;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;PLD3;KLHDC2;ASH2L;SOX13;CUL7;PITPNM3;LHPP;TMEM92;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;MPRIP;NAGLU;OXLD1;ARPIN;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;SLC16A5;MXD4;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;SLC43A1;MC1R;CAPG;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;ADM2;R3HDM2;MARCKSL1;OGDHL;LGALS9B;SOX12;HDAC11;RAB3B;NLGN2;CD68;PCSK1;PLEKHH3;SLC12A7;PTMS;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;UNK;NMRK1;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;TTBK2;LY6K;PRKCZ;PPP2R3B;HTR7;GALE;SERPING1;PAK1;ABCA7;ANKS6;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;PEAR1;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;BRI3;FOXQ1;ARVCF;KLHL29;PHF1;GLDC;NPR2;PLCXD1;PLXNB3;CAPNS2;NDUFA4L2;TMEM44;CBS;TMEM187;SPRY4;USP20;SALL2;ORAI2;ELMO3;DOCK6;SYNE3;ZSWIM4;DLG3;ITGB4;NMNAT2;DDX59;WDR27;MICALL2;SLCO4A1;NME4;PDZD2;CEP250;GRIP2;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;EPOR;MARCH4;NID1;ETV5;ETFB;GSTO1;LCE1E;ARHGEF4;WDR60;LTBP1;MUC19;SYNC;PPCS;SMIM14;FAM117A;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;PLXNB1;EREG;CHD2;GPT2;TEF;TNS1;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;OLFM2;PLCD3;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;SCART1;ERMAP;MANF;LPAR3;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;C5;KIF17;SPATS2;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;ANO1;STON1;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;KCNJ15;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;R3HDM4;SH3TC2;ING4;NUDCD3;ACOT11;VAMP2;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;LRP11;PCLO;KCNC4;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;SEMA5A;THRA;IFITM1;DCAF10;PEX10;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;LTBP2;ADAMTSL1;SNTA1;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;SLITRK6;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;NYAP1;PI4K2A;NAT14;SRGAP3;ZXDC;PAQR6;PQLC2;KIAA0319L;SDC2;CHMP1B;FBXO17;NRSN2;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;TCTN1;PTPDC1;PLCD1;ARHGEF2;SEPT10;MTMR11;FBF1;INPP5D;PDCD1LG2;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;SAMD3;STMN3;SLC50A1;PGPEP1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;MORN4;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;DOCK11;SSH1;LRRC45;LTB4R2;PCMTD2;SV2A;TBC1D3E;FAM214B;SLC38A10;PRIMPOL;FAM193B;FRMD4B;RABGAP1;GPR153;POLM;ACAP3;TENM2;MYH16;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;ATXN10;RALGAPA1;SLC29A4;FLOT1;CEP68;MDK;TTN;PSKH1;HLCS;KCNMA1;AZIN2;HSD11B1;TSNARE1;JDP2;UNC5B;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;ADGRF1;NADK;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;ROBO3;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;EGFL7;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;ACADS;FBXL16;CEP131;ISG20;LONP2;EPN3;MARK3;DGCR6L;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;DIRC2;CSRNP3;TTC12;ITGA1;IL17RE;PSD4;TNFAIP8L1;TMSB4X;SLFN5;ANO9;MAP1LC3A;MOCOS;APOL4;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;ARL10;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;NICN1;ZNF558;RPUSD3;ANGEL1;SEMA4G;ZNF662;SHARPIN;CCS;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ESRG;ALKBH7;CROCC;BCR;KLHDC8B;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;C19ORF33;CEP112;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;BCAM;SRR;TADA3;NBEAL2;BOLA1;MFSD3;KIF13B;SPAG16;TTYH3;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;PRDM8;SLC9A3R2;STRADB;CTSH;TNFRSF14;WDR19;ACOX3;ACAD11;PNRC1;TMEM80;FBXL8;CCDC15;UACA;GSDMC;MGMT;GSTO2;ASNS;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;SWT1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;SEMA6B;IFT57;LACTB2;PHYKPL;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;TTC21A;CAPS;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;KIF27;FMNL3;PHF2;IL17RC;FGFR4;IGF2BP2;RASSF9;SLC6A9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;SLC6A6;NUCB2;ZNF25;FARP1;DNASE2;LMNA;ASMTL;FAAH;UPP1;SH2B3;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;FOXO4;GNAL;COG7;YPEL3;SLC22A15;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;LTB4R;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;EDA2R;GPR21;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;BTN3A2;ASIC1;ALDH1L1;HOXC5;PLB1;GJB4;FAAP20;PIDD1;CAT;ZNF160;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;UNC119B;TIMP1;HFE;JAK3;KIAA1549;MRGPRX3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;CHRM3;ZNF846;APRT;GLCCI1;FCHSD1;TMX4;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;ENDOV;JOSD2;PHC1;ICAM5;SCYL3;METTL7A;ATP12A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BTN3A3;BCL6;REPS2;RABAC1;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;TMEM25;PJA2;SLC38A2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;ARHGEF17;SLC25A42;SIRT2;TRPC1;MBOAT2;GDF15;PHLDA2;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;FAM220A;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;CADM4;POU2F2;PLXND1;RCOR2;POLR3GL;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;MSH5;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;EDNRA;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;TMCO6;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;RGPD6;FKBP8;SPATA6;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;PLLP;SLC10A6;KDELC2;UST;EIF2AK4;STK32B;UNC119;PAG1;CCDC69;RGS12;SYVN1;OSCP1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;MMP17;RPL12;MPPE1;HMBOX1;NET1;TTC19;HSP90AB4P;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;BTBD11;SLC9A5;SIX5
2944,GO:0006475,0.994729484707695,0.0127556779220794,8,138,internal protein amino acid acetylation,BP,NOS1;ING4;JADE2;MAPK3;TADA3;RPS6KA5;HDAC8;PER1
7220,GO:0031124,0.994752431839068,0.0167655417445589,4,88,mRNA 3'-end processing,BP,ZFP36L1;PABPC1L;SRSF5;CPSF4
1775,GO:0004386,0.994835146403204,0.0125261103963619,8,137,helicase activity,MF,SMARCA1;DDX59;CHD2;CHD3;DHX32;HLTF;RECQL5;CHD6
11405,GO:0045839,0.994846457128896,0.0341346900461892,1,42,negative regulation of mitotic nuclear division,BP,TOM1L2
202,GO:0000428,0.994847307255043,0.0131153464724488,7,128,DNA-directed RNA polymerase complex,CC,ERCC1;TADA3;POLR2J2;RECQL5;POLR3GL;CHD6;POLR2J3
14485,GO:0065003,0.994925801475954,0.00659381960889905,138,1419,protein-containing complex assembly,BP,DLG4;APOE;KCNG1;XPC;H1F0;GSN;CTNNBIP1;TYSND1;WIPF1;CDC42EP5;GLUL;GPX3;VEGFA;DDB2;PRNP;ERCC1;CLTCL1;FCHO1;SPTB;DNM1;DDIT3;CRTC1;MMP1;EXOC2;RPL13A;MSRB2;OBSL1;ASH2L;HMGCL;ARPIN;COL6A1;CAPG;DGKQ;EML2;TUBG2;SNX9;DNAH1;ARL2;ULK1;VPS11;GRB7;SOX12;MYH11;ITPR3;CIRBP;PRKCZ;PAK1;ABCA7;MICALL2;PLEKHG2;DHRS4;TRAPPC9;IMPACT;PKD2;VAMP2;AREG;SEPT5;KCNC4;ACACB;MAPK3;THRA;KCTD15;EIF2D;ARHGEF2;SEPT10;TSPYL2;H1FX;TWF2;DMTN;ANGPTL4;ATXN10;FLOT1;TTN;WHAMMP3;SORL1;SRSF5;NLRP1;NDE1;TRIOBP;TRPV4;TMSB4X;AGO4;TRPV1;SHARPIN;NBR1;SRR;C1QTNF6;RXRA;SLC9A3R2;PSMG4;SBF2;SEPT6;TMOD2;TCIRG1;CBR4;C9ORF72;TBC1D20;INSR;SMIM20;RABGGTA;BRAF;ASIC1;CAT;HFE;TP73;TUBGCP6;FCHSD1;SPIRE1;TAZ;HGSNAT;REPS2;HSF4;RNF213;EPS8L1;EHD3;SIRT2;GOLGA2;EPS8L2;TGFBR3;TCF7;STX1A;DHPS;MAGI1;SEPT8;SH3PXD2A;CTH;SEC31B;PFKL;C15ORF62;CORO1B;RPL12;TTC19;KCTD11;SDHAF4;KCTD13;APBA1;HIP1;TEAD2
257,GO:0000724,0.994957396408987,0.0147036997374285,5,101,double-strand break repair via homologous recombination,BP,MAGEF1;NSMCE1;POLL;REC8;RECQL5
8219,GO:0032993,0.995008485487326,0.0116091024621074,9,163,protein-DNA complex,CC,FOS;H1F0;DDIT3;NUPR1;POLD4;H2AFJ;SOX12;HMGA2;H1FX
8815,GO:0034605,0.995057406303829,0.0134101006870811,6,114,cellular response to heat,BP,ANO1;MAPK3;TRPV4;TRPV1;MYOF;HSF4
868,GO:0002218,0.995080010145054,0.00996423273735953,14,209,activation of innate immune response,BP,TNIP1;PTPRS;NR1D1;TMEM173;PAK1;MUC19;NLRX1;CTSB;FLOT1;CARD11;RPS6KA5;TKFC;FYN;IKBKB
1590,GO:0004004,0.995132895531727,0.0219880055308651,2,59,ATP-dependent RNA helicase activity,MF,DDX59;DHX32
18212,GO:1903050,0.995259046715849,0.010376167388228,11,176,regulation of proteolysis involved in cellular protein catabolic process,BP,EDEM1;MAGEF1;TRIB2;PKD1;HERPUD1;RHBDF1;TRIB3;AKT1;HFE;CSNK1E;SIRT2
13022,GO:0051536,0.995291882068357,0.0213331226415975,2,61,iron-sulfur cluster binding,MF,XDH;NFU1
13026,GO:0051540,0.995291882068357,0.0213331226415975,2,61,metal cluster binding,MF,XDH;NFU1
40,GO:0000082,0.995301147709171,0.00935435491228651,15,221,G1/S transition of mitotic cell cycle,BP,FHL1;GJC2;EGFR;RBL2;TFDP2;HYAL1;PKD2;PKD1;PCBP4;AKT1;CHEK2;CTDSPL;PIDD1;TP73;EIF4EBP1
20246,GO:2001244,0.995331015195416,0.0313713007870448,1,44,positive regulation of intrinsic apoptotic signaling pathway,BP,DDIT3
8922,GO:0034968,0.995342750941731,0.0150739763299513,4,89,histone lysine methylation,BP,ASH2L;KDM3A;PHF1;KDM4C
17744,GO:1901799,0.9953916952263,0.0310702231588601,1,43,negative regulation of proteasomal protein catabolic process,BP,HFE
258,GO:0000725,0.995398080092259,0.0135418315283292,5,102,recombinational repair,BP,MAGEF1;NSMCE1;POLL;REC8;RECQL5
13068,GO:0051603,0.995412255389264,0.00688938474508481,51,591,proteolysis involved in cellular protein catabolic process,BP,BTBD2;GID4;FBXO2;TMEM129;EDEM1;RBCK1;NR1D1;ADAMTS7;DDIT3;ABTB1;ARRDC1;CUL9;CTSF;RNF165;FBXW4;CUL7;WWTR1;MAGEF1;USP20;TRIB2;RNF44;CTSB;MVB12B;UBXN4;FBXO6;PKD1;HERPUD1;RHBDF1;FBXL15;LONP2;SMURF2;TRIB3;SHARPIN;CTSH;AKT1;TSG101;SPSB3;CAPN2;ANKZF1;CHMP4C;HFE;CSNK1E;RNF213;UBXN6;SIRT2;MTA1;MAN1B1;WFS1;SYVN1;KCTD13;BTBD11
16624,GO:0097525,0.995540984193417,0.0203411539333124,2,62,spliceosomal snRNP complex,CC,TEP1;MAPKBP1
7077,GO:0030880,0.995552875252749,0.0114680253848973,7,130,RNA polymerase complex,CC,ERCC1;TADA3;POLR2J2;RECQL5;POLR3GL;CHD6;POLR2J3
10996,GO:0044843,0.995562963797318,0.00870326793277183,16,233,cell cycle G1/S phase transition,BP,FHL1;GJC2;EGFR;RBL2;TFDP2;HYAL1;PKD2;PKD1;PCBP4;ATP2B4;AKT1;CHEK2;CTDSPL;PIDD1;TP73;EIF4EBP1
1466,GO:0003724,0.995653285838721,0.0199315387361022,2,60,RNA helicase activity,MF,DDX59;DHX32
3680,GO:0008186,0.995653930067265,0.0199289925386242,2,60,RNA-dependent ATPase activity,MF,DDX59;DHX32
15720,GO:0072331,0.995670626858866,0.00836037611048779,17,245,signal transduction by p53 class mediator,BP,NDRG1;NUPR1;RBL2;TFDP2;DDIT4;RMI2;CHD3;SESN2;ING4;PCBP4;L3MBTL1;CDK5RAP3;AKT1;CHEK2;EDA2R;PIDD1;TP73
11297,GO:0045637,0.995675736005462,0.00952296870860834,11,181,regulation of myeloid cell differentiation,BP,FOS;CTNNBIP1;FAM210B;ZFP36L1;ASH2L;FAM213A;INPP5D;ZFPM1;CEBPB;L3MBTL1;AGO4
7474,GO:0031647,0.995934130950324,0.0083427389059885,14,212,regulation of protein stability,BP,GSN;PRNP;TSPAN1;CRTAP;VPS11;FLOT1;TADA3;CTSH;CHEK2;COG7;HDAC8;WFS1;SYVN1;HIP1
14765,GO:0070498,0.995981224846955,0.0131962211989158,4,93,interleukin-1-mediated signaling pathway,BP,EGR1;MAPK3;RPS6KA5;IKBKB
780,GO:0002039,0.996037421532298,0.0183866595593754,2,61,p53 binding,MF,TEP1;TP73
11187,GO:0045335,0.996064607208343,0.0117536143244912,5,105,phagocytic vesicle,CC,GSN;ITGB5;RAB43;TCIRG1;HLA-G
18496,GO:1903706,0.996068840761688,0.00696956520495023,24,327,regulation of hemopoiesis,BP,FOS;CTNNBIP1;FAM210B;ZFP36L1;ASH2L;SOX13;FAM213A;PRKCZ;RAG1;INPP5D;ZFPM1;CEBPB;L3MBTL1;TGFBR2;AGO4;GAS6;CARD11;BRAF;JAK3;TP73;BCL6;ADA;ERBB2;HLA-G
9028,GO:0035257,0.996197262578401,0.00994700552485779,7,130,nuclear hormone receptor binding,MF,PKN1;KDM3A;KDM4C;CEBPB;TADA3;RXRA;NCOA7
3061,GO:0006626,0.996217444447699,0.0105094859489897,6,120,protein targeting to mitochondrion,BP,VPS11;MICALL2;AIP;PEMT;BNIP3L;OSCP1
278,GO:0000781,0.996324153571309,0.00916128820965184,8,146,chromosome, telomeric region,CC,ERCC1;NSMCE4A;NSMCE1;TEP1;TERC;CHEK2;SIRT2;HMBOX1
6273,GO:0019882,0.996349523294206,0.00840894370783631,10,170,antigen processing and presentation,BP,CTSF;RAB3B;ACTR1B;ITGB5;CTSH;HFE;OSBPL1A;AP2A2;HLA-G;IKBKB
4597,GO:0010717,0.996423470649898,0.0168130998440451,2,62,regulation of epithelial to mesenchymal transition,BP,WWTR1;TGFBR2
282,GO:0000785,0.99646420746454,0.00574380646627841,36,456,chromatin,CC,H1F0;NR1D1;BAHCC1;MEF2D;SMARCA1;RBL2;ASH2L;H2AFJ;TRNP1;PHC2;APPL2;KDM3A;SALL2;INO80C;CHD3;SATB1;STAT6;HMGA2;H1FX;KDM4C;CBX7;HLCS;CEBPB;L3MBTL1;DNMT3A;CALCOCO1;RXRA;TNRC18;UHRF2;CAPN2;SMARCD2;TP73;LEMD2;SIRT2;POLR3GL;TCF7
13040,GO:0051568,0.996477511849328,0.0247661896189231,1,45,histone H3-K4 methylation,BP,ASH2L
12769,GO:0051087,0.996581177746098,0.0130948516379349,3,79,chaperone binding,MF,PRNP;DNAJB5;SYVN1
11069,GO:0045087,0.996669644077162,0.00516492589806363,46,552,innate immune response,BP,TNIP1;PTPRS;GSN;EGR1;PTK6;RNF135;NR1D1;ADAMTS13;MST1R;ADARB1;RPL13A;CYP27B1;TMEM173;SERPING1;PAK1;APOBEC3C;FAM3A;MUC19;EREG;C5;APOBEC3F;NLRX1;IFITM1;CTSB;IFNGR2;C1RL;ARHGEF2;IFI6;FLOT1;IRF5;NLRP1;ISG20;PTAFR;RAB43;CARD11;IFI27;RPS6KA5;ULBP1;LYST;JAK3;TKFC;FYN;SIRT2;HLA-G;SDHAF4;IKBKB
8685,GO:0034332,0.996845767381567,0.0106377720304389,4,92,adherens junction organization,BP,VEGFA;LAMA5;DMTN;ITGA2
367,GO:0000989,0.996854806221768,0.00495531629489323,43,518,transcription factor activity, transcription factor binding,MF,ZMYND8;NFATC4;FOS;CITED4;NR1D1;DDIT3;TFDP2;MXI1;WWTR1;MXD4;PKN1;BTG1;PHF21A;MAML3;SOX12;ELK3;NAB2;PPARA;AIP;KLF7;ING4;HMGA2;THRA;PBXIP1;ATF4;TRIB3;BHLHE40;CALCOCO1;TADA3;RXRA;CRY2;TSG101;PHF2;SMARCD2;NCOA7;MNT;HSF4;RCOR2;MTA1;MAP3K10;PER1;DMTF1;TEAD2
60,GO:0000123,0.996862174032013,0.0121401970768181,3,79,histone acetyltransferase complex,CC,ING4;JADE2;TADA3
10986,GO:0044815,0.996926213176974,0.0118459029280121,3,91,DNA packaging complex,CC,H1F0;H2AFJ;H1FX
4544,GO:0010629,0.997005981349144,0.00395009509541985,137,1430,negative regulation of gene expression,BP,XDH;ZC3H6;BBS2;ZMYND8;NFATC4;SERPINE2;EGR1;CTNNBIP1;WWC3;PDCD4;VEGFA;EGFR;PRNP;NR1D1;PRDX5;BAHCC1;DDIT3;DNAJB5;ZFP36L1;TCFL5;RBL2;TFDP2;MXI1;RPL13A;MDFI;WWTR1;MAP2K1;MXD4;H2AFJ;PHF21A;DGKQ;SHC1;GRB7;UNK;CIRBP;CAPRIN2;SERPING1;ELK3;FOXQ1;PHF1;SALL2;ZP3;ACVR2B;EAPP;HES2;EREG;NAB2;PPARA;CHAC1;SESN2;SCMH1;TCF25;IMPACT;SATB1;STAT6;ING4;HMGA2;SLIT3;ACACB;PC;THRA;IRF2BPL;TDRKH;PBXIP1;PAN2;MLXIPL;MAP2K2;ATF4;ZFPM1;TENM2;CBX7;JDP2;HDAC5;GTPBP1;PCBP4;VLDLR;DEAF1;PEG3;CEBPB;L3MBTL1;DNMT3A;TRPV4;MXD3;TAGLN3;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;AGO4;ZFP90;TRPV1;GAS6;ERN1;RXRA;MBD1;TNRC18;PNRC1;PAIP2B;AKT1;CDKN1C;CRY2;TSG101;PHF2;IGF2BP2;ZNF217;UHRF2;IFI27;NELFCD;RPS6KA5;MAP2K5;TP73;MTA3;MNT;BCL6;HSF4;FYN;ZC3H12D;SIRT2;RECQL5;RCOR2;HDAC8;PAIP2;RPL29;EIF4EBP1;TCF7;MAP3K10;PER1;IGF2BP3;FGFR1;WFS1;EIF2AK4;RPL12;HMBOX1;TSHZ1;SIX5
132,GO:0000278,0.997098600129565,0.00409329591201508,83,906,mitotic cell cycle,BP,XPC;FHL1;GJC2;TIMP2;EGFR;ANK3;NEK9;CLTCL1;NINL;BRSK1;ZFP36L1;CUL9;RBL2;TFDP2;OBSL1;CUL7;HYAL1;MAP2K1;SDCCAG8;BTG1;TOM1L2;TUBG2;SNX9;SPRY2;PAK1;STK39;CEP250;EREG;PKD2;HMGA2;SEPT5;RGS14;CNTRL;TUBE1;CHMP1B;ARHGEF2;SEPT10;MAP2K2;PAK6;PKD1;TTN;PCBP4;LRP5;NDE1;L3MBTL1;FBXL15;CEP131;DNMT3A;CDK5RAP3;MINK1;CEP126;TADA3;STRADB;ASNS;AKT1;REEP4;CDKN1C;CHEK2;SEPT6;PHLDA1;LMNA;CHMP5;INSR;FOXO4;CHMP4C;CTDSPL;MAP2K5;PIDD1;HAUS4;TP73;MTA3;TUBGCP6;SNX33;CSNK1E;BCL6;SIRT2;RECQL5;GOLGA2;EIF4EBP1;SEPT8;FGFR1;UNC119;SFI1
12034,GO:0048002,0.997110613235447,0.00734310958187048,8,149,antigen processing and presentation of peptide antigen,BP,CTSF;ACTR1B;ITGB5;HFE;OSBPL1A;AP2A2;HLA-G;IKBKB
10597,GO:0043603,0.997115493663922,0.00409047739206697,80,905,cellular amide metabolic process,BP,TNIP1;APOE;NAGS;EGFR;PRNP;RNPEPL1;GGT1;ADAMTS13;ABTB1;ZFP36L1;RPL13A;MIF4GD;MAP2K1;OPLAH;GRB7;PCSK1;UNK;CIRBP;CAPRIN2;ABCA7;AARS;ERO1B;MTHFR;NEURL1;SPPL2B;GSTO1;PLA2G6;GSTT1;CARS;CHAC1;SESN2;MKNK2;IMPACT;ST6GALNAC6;ACACB;MAPK3;PC;EIF2D;LTA4H;MAP2K2;ATF4;HLCS;GTPBP1;SORL1;GSTM2;ALDH1L2;PEMT;AGO4;HEXB;GAS6;PTAFR;PPP1R15A;RXRA;CTSH;GSTO2;ASNS;PAIP2B;AKT1;ASS1;IGF2BP2;HAGH;ALDH1L1;CERS4;LSM14B;GSTM3;RPL39L;ZC3H12D;NAGA;PAIP2;RPL29;EIF4EBP1;RNPEP;DHPS;NMRAL1;PER1;IGF2BP3;ITGA2;ERBB2;EIF2AK4;RPL12
10379,GO:0043228,0.997144332446142,0.00347792741856417,342,3269,non-membrane-bounded organelle,CC,ACTA2;DLG4;DOCK4;BBS2;MARVELD1;BTBD2;ESPN;FLNC;XPC;H1F0;GSN;WIPF1;CDC42EP5;RSPH3;ALOX15B;CLIP2;OBSCN;SCN8A;NR1D1;ERCC1;ANK3;BAHCC1;NEK9;IFT140;RAPGEF3;CLTCL1;SPTB;KRT15;NINL;SNPH;CST3;DNM1;PARVB;MEF2D;NOS1;ARAP3;BRSK1;SHANK2;PGM1;ADGRB2;ERCC6;NDRG1;ABTB1;PLEKHH1;MYH15;SMARCA1;MST1R;ZFP36L1;ADARB1;RIN1;RBL2;MXI1;RPL13A;OBSL1;EVC;BBS1;REEP2;MIF4GD;RAB11FIP4;CPT2;ASH2L;CUL7;MPRIP;ETV4;POLD4;MAP2K1;PPL;SDCCAG8;ABCA2;CAPG;H2AFJ;TRNP1;PHC2;PITPNM1;DGKQ;EML2;TUBG2;FAM110C;DNAH1;ARL2;SPRY2;GRB7;NPHP4;PLEKHH3;MYH11;ITPR3;APPL2;CIRBP;CAPRIN2;TPM2;TTBK2;PRKCZ;PAK1;APOBEC3C;STK39;KDM3A;PHF1;USP20;SALL2;DDX59;MICALL2;CEP250;NSUN5P2;NEIL1;SHROOM4;ABHD14B;CCDC88B;SPPL2B;WDR60;SYNC;NSMCE4A;ACTR1B;TRIB2;CHD2;TNS1;SPG11;APBB3;PNPLA3;SSH3;PLA2G6;DNMBP;RINL;CARF;S100A13;FKBP10;KIF17;APOBEC3F;INO80C;CHD3;CCDC92;SPC24;SCMH1;IFT27;PKD2;SATB1;STAT6;ING4;NUDCD3;HMGA2;ENKD1;SEPT5;PCLO;KCNAB2;MAPK3;DEF6;OSBPL10;VANGL2;RGS14;DNAL4;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;CNTRL;SNTA1;TUBE1;PAN2;CTSB;HOOK2;EIF2D;MYH3;TCTN1;ARHGEF2;SEPT10;FBF1;INPP5D;TSPYL2;MAP2K2;H1FX;TWF2;SDHA;KIF21B;DMTN;ATF4;PROCR;KDM4C;PAK6;SSH1;LRRC45;FRMD4B;RABGAP1;MYH16;KIF26B;CBX7;NSMCE1;FLOT1;CEP68;TTN;PSKH1;HLCS;MAP6;TFB1M;SRSF5;DEAF1;TEP1;KDM7A;CEBPB;NEK8;TSTD1;ALDOC;NDE1;L3MBTL1;CEP131;ISG20;HLTF;DNMT3A;TRIOBP;TRPV4;TTC12;TMSB4X;MAP1LC3A;MLH3;CALCOCO1;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;LDOC1;TTLL11;NICN1;CEP126;LZTS2;CROCC;MAPRE3;CEP112;NBR1;TNNI2;TADA3;KIF13B;SPAG16;TERC;RXRA;RIMS3;MBD1;TNRC18;ATP2B4;SPATA7;CTSH;WDR19;PNRC1;CCDC15;UACA;GSDMC;PLEKHG6;HINT2;MAPKBP1;AKT1;REEP4;MICAL1;MZT2B;CHEK2;IFT57;SEPT6;TNNT1;WDR66;CABYR;TSG101;KIF27;PHF2;IGF2BP2;TMOD2;PHLDA1;ACADVL;FARP1;LMNA;FAAH;ATG2A;C9ORF72;UHRF2;CAPN2;SMARCD2;MARK4;KRT19;COG7;YPEL3;PNPLA4;ULBP1;ADD3;MAGED2;ITGB6;C6ORF89;LYST;MAP2K5;ZNF554;GJB4;FAAP20;MZT2A;HAUS4;MPG;HFE;JAK3;TP73;TUBGCP6;ENDOV;METTL7A;SPIRE1;BCL6;REC8;RNF213;RPL39L;FYN;ZC3H12D;EML3;PJA2;LEMD2;UBXN6;SIRT2;RECQL5;GOLGA2;POLR3GL;RHOBTB3;MTA1;MSH5;CIDEA;HDAC8;MYO18A;RPL29;CIDEB;TCF7;STX1A;LURAP1;SEPT8;FGFR1;SH3PXD2A;EIF2AK4;UNC119;CCDC69;RGS12;C15ORF62;CORO1B;SFI1;RPL12;HMBOX1;TTC19;TNNI1;DTD1;HIP1;PLEKHH2;TCTEX1D4
10383,GO:0043232,0.997144332446142,0.00347792741856417,342,3269,intracellular non-membrane-bounded organelle,CC,ACTA2;DLG4;DOCK4;BBS2;MARVELD1;BTBD2;ESPN;FLNC;XPC;H1F0;GSN;WIPF1;CDC42EP5;RSPH3;ALOX15B;CLIP2;OBSCN;SCN8A;NR1D1;ERCC1;ANK3;BAHCC1;NEK9;IFT140;RAPGEF3;CLTCL1;SPTB;KRT15;NINL;SNPH;CST3;DNM1;PARVB;MEF2D;NOS1;ARAP3;BRSK1;SHANK2;PGM1;ADGRB2;ERCC6;NDRG1;ABTB1;PLEKHH1;MYH15;SMARCA1;MST1R;ZFP36L1;ADARB1;RIN1;RBL2;MXI1;RPL13A;OBSL1;EVC;BBS1;REEP2;MIF4GD;RAB11FIP4;CPT2;ASH2L;CUL7;MPRIP;ETV4;POLD4;MAP2K1;PPL;SDCCAG8;ABCA2;CAPG;H2AFJ;TRNP1;PHC2;PITPNM1;DGKQ;EML2;TUBG2;FAM110C;DNAH1;ARL2;SPRY2;GRB7;NPHP4;PLEKHH3;MYH11;ITPR3;APPL2;CIRBP;CAPRIN2;TPM2;TTBK2;PRKCZ;PAK1;APOBEC3C;STK39;KDM3A;PHF1;USP20;SALL2;DDX59;MICALL2;CEP250;NSUN5P2;NEIL1;SHROOM4;ABHD14B;CCDC88B;SPPL2B;WDR60;SYNC;NSMCE4A;ACTR1B;TRIB2;CHD2;TNS1;SPG11;APBB3;PNPLA3;SSH3;PLA2G6;DNMBP;RINL;CARF;S100A13;FKBP10;KIF17;APOBEC3F;INO80C;CHD3;CCDC92;SPC24;SCMH1;IFT27;PKD2;SATB1;STAT6;ING4;NUDCD3;HMGA2;ENKD1;SEPT5;PCLO;KCNAB2;MAPK3;DEF6;OSBPL10;VANGL2;RGS14;DNAL4;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;CNTRL;SNTA1;TUBE1;PAN2;CTSB;HOOK2;EIF2D;MYH3;TCTN1;ARHGEF2;SEPT10;FBF1;INPP5D;TSPYL2;MAP2K2;H1FX;TWF2;SDHA;KIF21B;DMTN;ATF4;PROCR;KDM4C;PAK6;SSH1;LRRC45;FRMD4B;RABGAP1;MYH16;KIF26B;CBX7;NSMCE1;FLOT1;CEP68;TTN;PSKH1;HLCS;MAP6;TFB1M;SRSF5;DEAF1;TEP1;KDM7A;CEBPB;NEK8;TSTD1;ALDOC;NDE1;L3MBTL1;CEP131;ISG20;HLTF;DNMT3A;TRIOBP;TRPV4;TTC12;TMSB4X;MAP1LC3A;MLH3;CALCOCO1;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;LDOC1;TTLL11;NICN1;CEP126;LZTS2;CROCC;MAPRE3;CEP112;NBR1;TNNI2;TADA3;KIF13B;SPAG16;TERC;RXRA;RIMS3;MBD1;TNRC18;ATP2B4;SPATA7;CTSH;WDR19;PNRC1;CCDC15;UACA;GSDMC;PLEKHG6;HINT2;MAPKBP1;AKT1;REEP4;MICAL1;MZT2B;CHEK2;IFT57;SEPT6;TNNT1;WDR66;CABYR;TSG101;KIF27;PHF2;IGF2BP2;TMOD2;PHLDA1;ACADVL;FARP1;LMNA;FAAH;ATG2A;C9ORF72;UHRF2;CAPN2;SMARCD2;MARK4;KRT19;COG7;YPEL3;PNPLA4;ULBP1;ADD3;MAGED2;ITGB6;C6ORF89;LYST;MAP2K5;ZNF554;GJB4;FAAP20;MZT2A;HAUS4;MPG;HFE;JAK3;TP73;TUBGCP6;ENDOV;METTL7A;SPIRE1;BCL6;REC8;RNF213;RPL39L;FYN;ZC3H12D;EML3;PJA2;LEMD2;UBXN6;SIRT2;RECQL5;GOLGA2;POLR3GL;RHOBTB3;MTA1;MSH5;CIDEA;HDAC8;MYO18A;RPL29;CIDEB;TCF7;STX1A;LURAP1;SEPT8;FGFR1;SH3PXD2A;EIF2AK4;UNC119;CCDC69;RGS12;C15ORF62;CORO1B;SFI1;RPL12;HMBOX1;TTC19;TNNI1;DTD1;HIP1;PLEKHH2;TCTEX1D4
3052,GO:0006614,0.997183683131815,0.0109632415349589,3,91,SRP-dependent cotranslational protein targeting to membrane,BP,RPL13A;RPL29;RPL12
7871,GO:0032446,0.997193647878953,0.0040689238390612,70,789,protein modification by small protein conjugation,BP,GID4;EGR1;FBXO2;TMEM129;RNF135;RBCK1;DDB2;ARRDC1;CUL9;RNF165;FBXW4;CUL7;WWTR1;MAGEF1;FBXO41;KLHL29;FBXW8;NEURL1;RAG1;MARCH4;RNF44;UNKL;BLMH;MARCH9;JADE2;FBXO27;DCAF10;PEX10;FBXO17;LRSAM1;KLHL24;FBXO6;NSMCE1;HERPUD1;FBXL15;FBXL16;HLTF;SMURF2;LMO7;TRIB3;RAB40B;HMG20B;CDK5RAP3;MARCH2;SHARPIN;KLHDC8B;FBXL8;AKT1;TSG101;PIAS3;SPSB3;UHRF2;UBOX5;MIB2;PHC1;RNF213;FBXO25;FYN;PJA2;GOLGA2;MTA1;HDAC8;EPAS1;RNF170;WFS1;SYVN1;TRIM2;KCTD11;KCTD13;DTX3
3651,GO:0008135,0.997265346547088,0.0107372093890514,3,81,translation factor activity, RNA binding,MF,ABTB1;EIF2D;GTPBP1
13154,GO:0051784,0.997281638267529,0.0198677484471192,1,47,negative regulation of nuclear division,BP,TOM1L2
2934,GO:0006458,0.997356821665061,0.0194026863748738,1,47,'de novo' protein folding,BP,FYCO1
5879,GO:0018022,0.997408396511975,0.00891000787451334,4,95,peptidyl-lysine methylation,BP,ASH2L;KDM3A;PHF1;KDM4C
5502,GO:0016458,0.997441693802224,0.00529323731673675,15,237,gene silencing,BP,EGFR;BAHCC1;MAP2K1;H2AFJ;SCMH1;TDRKH;MAP2K2;HDAC5;DNMT3A;AGO4;MBD1;TNRC18;PHF2;UHRF2;SIRT2
5421,GO:0016279,0.997455939206404,0.0187859211087271,1,47,protein-lysine N-methyltransferase activity,MF,ASH2L
16290,GO:0090501,0.997457561807466,0.00731934057834343,6,124,RNA phosphodiester bond hydrolysis,BP,PAN2;ISG20;ERN1;LACTB2;CPSF4;ENDOV
416,GO:0001104,0.997477107228189,0.00999731757204411,3,81,RNA polymerase II transcription cofactor activity,MF,ZMYND8;CITED4;SOX12
366,GO:0000988,0.997511934274461,0.00395887460603188,43,523,transcription factor activity, protein binding,MF,ZMYND8;NFATC4;FOS;CITED4;NR1D1;DDIT3;TFDP2;MXI1;WWTR1;MXD4;PKN1;BTG1;PHF21A;MAML3;SOX12;ELK3;NAB2;PPARA;AIP;KLF7;ING4;HMGA2;THRA;PBXIP1;ATF4;TRIB3;BHLHE40;CALCOCO1;TADA3;RXRA;CRY2;TSG101;PHF2;SMARCD2;NCOA7;MNT;HSF4;RCOR2;MTA1;MAP3K10;PER1;DMTF1;TEAD2
17802,GO:1901989,0.997535050814259,0.0121273943192924,2,66,positive regulation of cell cycle phase transition,BP,HYAL1;MTA3
10276,GO:0043044,0.997562182030919,0.0119841439720197,2,69,ATP-dependent chromatin remodeling,BP,SMARCA1;SMARCD2
1455,GO:0003697,0.997599592273891,0.00831446891597676,4,96,single-stranded DNA binding,MF,XPC;ERCC1;MLH3;CRY2
2871,GO:0006367,0.997743211843132,0.0058513297506897,8,150,transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;NR1D1;WWTR1;MAML3;PPARA;THRA;RXRA;TEAD2
1473,GO:0003743,0.997749952418802,0.0168908414770336,1,49,translation initiation factor activity,MF,EIF2D
1456,GO:0003700,0.997755913718403,0.00309854821797193,102,1089,DNA binding transcription factor activity,MF,ZC3H6;NFATC4;FOS;EGR1;ZSCAN18;NR1D1;ZKSCAN1;MEF2D;DDIT3;TSC22D1;ZFP36L1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;KLF9;SOX13;ETV4;MXD4;ZNF76;PBX2;THAP8;SOX12;ELK3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ETV5;HES2;TEF;UNKL;CARF;PPARA;TCF25;SATB1;STAT6;KLF7;HMGA2;THRA;ZSCAN30;ZXDC;MLXIPL;LITAF;ATF4;ZFPM1;ZNF467;ZNF516;JDP2;IRF5;DEAF1;PEG3;GLI4;RFX2;CEBPB;CREBRF;ZNF251;L3MBTL1;HLTF;MXD3;FOXL1;CSRNP3;BHLHE40;ZFP90;ZNF558;TADA3;BOLA1;RXRA;ZNF358;ZNF217;ZNF25;FOXO4;ZNF554;HOXC5;ZNF160;ZFP28;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;POU2F2;RCOR2;MTA1;TCF7;EPAS1;ZNF333;HMBOX1;TSHZ1;CREB3L4;ZNF449;ZMYM3;DBP;ZNF287;DMTF1;TEAD2;SIX5
5420,GO:0016278,0.99776158191286,0.0168359968872012,1,48,lysine N-methyltransferase activity,MF,ASH2L
20145,GO:2001020,0.997828908759062,0.00540218029987782,9,162,regulation of response to DNA damage stimulus,BP,EGFR;ERCC1;MAGEF1;NSMCE4A;HMGA2;NSMCE1;MGMT;CHEK2;RECQL5
2976,GO:0006521,0.99784046130177,0.0162769558476954,1,51,regulation of cellular amino acid metabolic process,BP,ATP2B4
20244,GO:2001242,0.997915235669945,0.00610338220939085,6,127,regulation of intrinsic apoptotic signaling pathway,BP,DDIT3;ARHGEF2;HERPUD1;AKT1;WFS1;SYVN1
14982,GO:0070936,0.997932232753598,0.0157213311347677,1,49,protein K48-linked ubiquitination,BP,SYVN1
6228,GO:0019783,0.997932579608177,0.0072677864889582,4,97,ubiquitin-like protein-specific protease activity,MF,USP20;TADA3;ANKZF1;JOSD2
256,GO:0000723,0.997958660694944,0.00533145943065909,8,153,telomere maintenance,BP,ERCC1;POLD4;MAPK3;TEP1;PKIB;TERC;HDAC8;HMBOX1
6923,GO:0030532,0.997966650528211,0.0102263754356003,2,69,small nuclear ribonucleoprotein complex,CC,TEP1;MAPKBP1
1460,GO:0003712,0.998003534484848,0.00332956780982693,36,457,transcription cofactor activity,MF,ZMYND8;NFATC4;CITED4;NR1D1;DDIT3;TFDP2;MXI1;WWTR1;MXD4;PKN1;BTG1;PHF21A;MAML3;SOX12;ELK3;NAB2;PPARA;AIP;KLF7;ING4;THRA;PBXIP1;TRIB3;BHLHE40;CALCOCO1;TADA3;RXRA;TSG101;PHF2;SMARCD2;NCOA7;MNT;HSF4;RCOR2;MTA1;MAP3K10
7403,GO:0031497,0.998015943207721,0.00582121621272728,6,134,chromatin assembly,BP,H1F0;BAHCC1;HMGA2;TSPYL2;H1FX;TNRC18
1004,GO:0002478,0.99804223316276,0.0054067517058354,7,141,antigen processing and presentation of exogenous peptide antigen,BP,CTSF;ACTR1B;ITGB5;OSBPL1A;AP2A2;HLA-G;IKBKB
2447,GO:0005657,0.998082067782421,0.00972328625054055,2,68,replication fork,CC,POLD4;BCL6
2873,GO:0006369,0.998128099378016,0.00951126205933219,2,69,termination of RNA polymerase II transcription,BP,SRSF5;CPSF4
10523,GO:0043488,0.998150801303897,0.00513122036914051,7,141,regulation of mRNA stability,BP,ZFP36L1;CIRBP;PCBP4;AKT1;IGF2BP2;ZC3H12D;IGF2BP3
7888,GO:0032465,0.998193772319936,0.00922491291950235,2,68,regulation of cytokinesis,BP,RAB11FIP4;CHMP4C
4424,GO:0010257,0.998212122448055,0.0138036240553315,1,55,NADH dehydrogenase complex assembly,BP,TAZ
8211,GO:0032981,0.998212122448055,0.0138036240553315,1,55,mitochondrial respiratory chain complex I assembly,BP,TAZ
361,GO:0000980,0.998212174796296,0.0138737737050984,1,50,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,SMARCD2
3202,GO:0006839,0.998229761457855,0.00367497419878638,16,249,mitochondrial transport,BP,TFDP2;CPT2;VPS11;MICALL2;AIP;ACACB;BNIP3;BBC3;PEMT;BNIP3L;ALKBH7;SLC25A29;TP73;SLC25A42;TST;OSCP1
8251,GO:0033044,0.99823223859877,0.00348920516990508,19,278,regulation of chromosome organization,BP,VEGFA;ERCC1;NOS1;KDM3A;MTHFR;PHF1;RMI2;MAPK3;KDM4C;JDP2;PKIB;TADA3;PHF2;UHRF2;RPS6KA5;C6ORF89;BCL6;HDAC8;HMBOX1
9816,GO:0042054,0.998235397066697,0.0137198665313743,1,50,histone methyltransferase activity,MF,ASH2L
8252,GO:0033045,0.998279381421707,0.00883332527047563,2,69,regulation of sister chromatid segregation,BP,RMI2;HDAC8
20050,GO:2000736,0.998292835852472,0.00549408199917339,5,121,regulation of stem cell differentiation,BP,KDM3A;KDM4C;LTBP3;TP73;TEAD2
3051,GO:0006613,0.998327062059816,0.00688299800142707,3,96,cotranslational protein targeting to membrane,BP,RPL13A;RPL29;RPL12
9901,GO:0042255,0.998357249358552,0.0128522794707557,1,54,ribosome assembly,BP,RPL12
4760,GO:0010948,0.998421243466407,0.00308825646412143,20,295,negative regulation of cell cycle process,BP,FHL1;GJC2;BRSK1;ZFP36L1;RBL2;TFDP2;TOM1L2;PKD2;HMGA2;MLXIPL;PCBP4;CDK5RAP3;CHEK2;FOXO4;CHMP4C;CTDSPL;PIDD1;TP73;PHC1;BCL6
1781,GO:0004402,0.998453627291269,0.0122423589988236,1,51,histone acetyltransferase activity,MF,TADA3
6275,GO:0019884,0.998493386530836,0.00424780982995418,7,144,antigen processing and presentation of exogenous antigen,BP,CTSF;ACTR1B;ITGB5;OSBPL1A;AP2A2;HLA-G;IKBKB
14144,GO:0061053,0.998559726541671,0.0115192186450368,1,51,somite development,BP,WDR19
2799,GO:0006259,0.99857091939842,0.00209971011980015,74,845,DNA metabolic process,BP,NT5E;NYNRIN;XPC;FOS;H1F0;EGFR;DDB2;ERCC1;IGFBP4;CST3;ERCC6;SMARCA1;TK2;POLD4;MC1R;DNASE1L1;MAGEF1;SHC1;PTMS;APOBEC3C;CBS;NEIL1;RAG1;NSMCE4A;EREG;RMI2;APOBEC3F;INO80C;SESN2;STAT6;ING4;HMGA2;AREG;MAPK3;TDRKH;TSPYL2;PRIMPOL;POLM;FBXO6;NSMCE1;TEP1;ENDOG;PKIB;ISG20;DNMT3A;MLH3;POLL;TERC;MBD1;MGMT;AKT1;CHEK2;FGFR4;DNASE2;UHRF2;INSR;FAAP20;MPG;TP73;ENDOV;CSNK1E;BCL6;REC8;RECQL5;MTA1;MSH5;CIDEA;HDAC8;MYO18A;TCF7;FGFR1;HMBOX1;KCTD13;DTD1
2831,GO:0006302,0.998680899312214,0.00315858481743436,11,194,double-strand break repair,BP,ERCC1;MAGEF1;HMGA2;POLM;NSMCE1;POLL;MGMT;CHEK2;REC8;RECQL5;MTA1
116,GO:0000245,0.998690975067767,0.0105892468256708,1,53,spliceosomal complex assembly,BP,SRSF5
137,GO:0000288,0.998696665113858,0.00690228634751541,2,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;PAN2
10776,GO:0044265,0.998707737085797,0.00186220379762284,85,961,cellular macromolecule catabolic process,BP,APOE;BTBD2;GID4;H1F0;FBXO2;TMEM129;EDEM1;LRP1;RBCK1;NR1D1;ADAMTS7;CST3;DDIT3;ABTB1;ARRDC1;ZFP36L1;CUL9;RPL13A;CTSF;RNF165;FBXW4;CUL7;WWTR1;DNASE1L1;MAGEF1;VPS11;CIRBP;USP20;TRIB2;RNF44;BNIP3;PAN2;CTSB;MVB12B;UBXN4;FBXO6;PKD1;GTPBP1;PCBP4;HERPUD1;VLDLR;ENDOG;RHBDF1;ATRAID;PCSK9;FBXL15;ISG20;LONP2;SMURF2;TRIB3;CDK5RAP3;AGO4;BNIP3L;SHARPIN;ERN1;CTSH;PNRC1;AKT1;CHEK2;TSG101;IGF2BP2;TCIRG1;DNASE2;SPSB3;CAPN2;SPATA18;ANKZF1;CHMP4C;HFE;CSNK1E;RNF213;ZC3H12D;UBXN6;SIRT2;MTA1;AP2A2;CIDEA;RPL29;MAN1B1;IGF2BP3;WFS1;SYVN1;RPL12;KCTD13;BTBD11
4509,GO:0010564,0.998763573715073,0.00195357300904869,51,620,regulation of cell cycle process,BP,XPC;FHL1;GJC2;EGFR;NINL;BRSK1;ZFP36L1;CUL9;RBL2;TFDP2;OBSL1;RAB11FIP4;CUL7;HYAL1;SDCCAG8;TOM1L2;CEP250;EREG;RMI2;PKD2;HMGA2;CNTRL;CHMP1B;MLXIPL;PKD1;PCBP4;LRP5;NDE1;L3MBTL1;CEP131;CDK5RAP3;ATP2B4;AKT1;CHEK2;CHMP5;UHRF2;INSR;FOXO4;CHMP4C;CTDSPL;PIDD1;HAUS4;TP73;MTA3;PHC1;CSNK1E;BCL6;SIRT2;HDAC8;FGFR1;SFI1
7260,GO:0031248,0.998767022543909,0.00526034484578641,3,88,protein acetyltransferase complex,CC,ING4;JADE2;TADA3
17983,GO:1902493,0.998767022543909,0.00526034484578641,3,88,acetyltransferase complex,CC,ING4;JADE2;TADA3
11070,GO:0045088,0.998788443302771,0.00244040746907108,19,286,regulation of innate immune response,BP,TNIP1;PTPRS;RNF135;NR1D1;TMEM173;SERPING1;PAK1;FAM3A;MUC19;EREG;NLRX1;CTSB;IFNGR2;FLOT1;CARD11;RPS6KA5;TKFC;FYN;IKBKB
13263,GO:0051983,0.998791001932855,0.00516860679104342,3,88,regulation of chromosome segregation,BP,RMI2;SIRT2;HDAC8
11071,GO:0045089,0.99879392509063,0.00261410604223499,15,241,positive regulation of innate immune response,BP,TNIP1;PTPRS;NR1D1;TMEM173;PAK1;MUC19;EREG;NLRX1;CTSB;FLOT1;CARD11;RPS6KA5;TKFC;FYN;IKBKB
10167,GO:0042775,0.998801137240182,0.00638183654185174,2,79,mitochondrial ATP synthesis coupled electron transport,BP,SDHA;TAZ
14402,GO:0061733,0.998803272416636,0.00980315278314257,1,53,peptide-lysine-N-acetyltransferase activity,MF,TADA3
3049,GO:0006611,0.998812085831848,0.00308651819641967,9,170,protein export from nucleus,BP,RAPGEF3;XPOT;PKD1;SRSF5;GAS6;CAMK1;STRADB;IFI27;CPSF4
3737,GO:0008276,0.998816650985997,0.00633816714259837,2,72,protein methyltransferase activity,MF,ASH2L;PCMTD2
8788,GO:0034502,0.998831384340817,0.0062683920542837,2,72,protein localization to chromosome,BP,LEMD2;HDAC8
18211,GO:1903047,0.998832999150254,0.00176522321821013,65,756,mitotic cell cycle process,BP,XPC;FHL1;GJC2;EGFR;ANK3;NEK9;NINL;BRSK1;ZFP36L1;CUL9;RBL2;TFDP2;OBSL1;CUL7;HYAL1;SDCCAG8;TOM1L2;TUBG2;SNX9;SPRY2;CEP250;EREG;PKD2;HMGA2;SEPT5;CNTRL;CHMP1B;ARHGEF2;SEPT10;PKD1;TTN;PCBP4;LRP5;NDE1;L3MBTL1;FBXL15;CEP131;CDK5RAP3;CEP126;AKT1;REEP4;CHEK2;SEPT6;PHLDA1;LMNA;CHMP5;INSR;FOXO4;CHMP4C;CTDSPL;PIDD1;HAUS4;TP73;MTA3;TUBGCP6;SNX33;CSNK1E;BCL6;SIRT2;GOLGA2;EIF4EBP1;SEPT8;FGFR1;UNC119;SFI1
7177,GO:0031072,0.998862824818236,0.00422681114131683,4,103,heat shock protein binding,MF,MVD;METTL23;ERN1;HDAC8
2735,GO:0006119,0.998878344590197,0.00481253660820939,3,96,oxidative phosphorylation,BP,MLXIPL;SDHA;TAZ
10165,GO:0042773,0.99893186104642,0.00575864092284706,2,80,ATP synthesis coupled electron transport,BP,SDHA;TAZ
8879,GO:0034708,0.998938693869867,0.00459358042151428,3,90,methyltransferase complex,CC,ASH2L;PHF1;INO80C
14117,GO:0061013,0.998944610572486,0.0028954420462965,8,160,regulation of mRNA catabolic process,BP,ZFP36L1;CIRBP;GTPBP1;PCBP4;AKT1;IGF2BP2;ZC3H12D;IGF2BP3
18213,GO:1903051,0.998947128380354,0.00876025943122552,1,55,negative regulation of proteolysis involved in cellular protein catabolic process,BP,HFE
12828,GO:0051170,0.99897412700697,0.00318440881534499,6,133,import into nucleus,BP,TMEM173;PDE2A;GAS6;AKT1;BCL6;TMCO6
11036,GO:0045047,0.99897872827788,0.00441389249563082,3,101,protein targeting to ER,BP,RPL13A;RPL29;RPL12
5277,GO:0015934,0.998979574032033,0.0038125809877918,4,115,large ribosomal subunit,CC,RPL13A;RPL39L;RPL29;RPL12
19452,GO:1990234,0.998995842106154,0.00154883364633606,60,715,transferase complex,CC,BTBD2;FBXO2;RBCK1;DDB2;ERCC1;ABTB1;CUL9;DHTKD1;FBXW4;ASH2L;CUL7;POLD4;PHC2;ULK1;OGDHL;KLHL29;PHF1;ZSWIM4;FBXW8;NSMCE4A;INO80C;SESN2;ING4;JADE2;FBXO27;DCAF10;FBXO17;KLHL24;FBXO6;CBX7;NSMCE1;FBXL15;TGFBR2;SMURF2;LMO7;PIK3R2;SHARPIN;ERN1;KLHDC8B;TADA3;TERC;SPSB3;C9ORF72;INSR;RABGGTA;PIGQ;POLR2J2;MIB2;PHC1;FBXO25;RECQL5;POLR3GL;CHD6;POLR2J3;PIGV;SYVN1;PFKL;KCTD13;IKBKB;BTBD11
10522,GO:0043487,0.998999392495148,0.00291109650975494,7,148,regulation of RNA stability,BP,ZFP36L1;CIRBP;PCBP4;AKT1;IGF2BP2;ZC3H12D;IGF2BP3
2890,GO:0006400,0.999008585514467,0.00541181258209157,2,74,tRNA modification,BP,AARS;RPUSD3
2860,GO:0006354,0.999059005515801,0.0031934130659198,5,121,DNA-templated transcription, elongation,BP,ERCC6;TCEA2;EAPP;NELFCD;RECQL5
2969,GO:0006511,0.999090523112246,0.00153030145670694,40,515,ubiquitin-dependent protein catabolic process,BP,BTBD2;GID4;FBXO2;TMEM129;EDEM1;RBCK1;DDIT3;ABTB1;ARRDC1;CUL9;RNF165;FBXW4;CUL7;WWTR1;MAGEF1;USP20;TRIB2;RNF44;MVB12B;UBXN4;FBXO6;HERPUD1;FBXL15;SMURF2;TRIB3;SHARPIN;AKT1;TSG101;SPSB3;ANKZF1;HFE;CSNK1E;RNF213;SIRT2;MTA1;MAN1B1;WFS1;SYVN1;KCTD13;BTBD11
12493,GO:0050657,0.999103467818889,0.00237519124425537,9,173,nucleic acid transport,BP,ZFP36L1;XPOT;FLOT1;SRSF5;TGFBR2;IGF2BP2;CPSF4;TST;IGF2BP3
12494,GO:0050658,0.999103467818889,0.00237519124425537,9,173,RNA transport,BP,ZFP36L1;XPOT;FLOT1;SRSF5;TGFBR2;IGF2BP2;CPSF4;TST;IGF2BP3
273,GO:0000776,0.999147036701151,0.00291923781915049,5,121,kinetochore,CC,SPC24;NDE1;SEPT6;PHF2;REC8
10664,GO:0043933,0.999175629813838,0.00110392716904996,158,1668,protein-containing complex subunit organization,BP,DLG4;APOE;KCNG1;XPC;H1F0;GSN;CTNNBIP1;TYSND1;WIPF1;CDC42EP5;GLUL;GPX3;VEGFA;DDB2;PRNP;ERCC1;CLTCL1;FCHO1;SPTB;LOXL1;DNM1;DDIT3;CRTC1;MMP1;EXOC2;RPL13A;MSRB2;OBSL1;ASH2L;HMGCL;ARPIN;COL6A1;CAPG;DGKQ;EML2;TUBG2;SNX9;DNAH1;ARL2;ULK1;VPS11;GRB7;SOX12;MYH11;ITPR3;CIRBP;TTBK2;PRKCZ;PAK1;ABCA7;MICALL2;PLEKHG2;DHRS4;ABCG1;TRAPPC9;IMPACT;PKD2;VAMP2;AREG;SEPT5;KCNC4;ACACB;MAPK3;BNIP3;SEMA5A;THRA;KCTD15;EIF2D;CHMP1B;ARHGEF2;SEPT10;TSPYL2;H1FX;TWF2;STMN3;TECPR1;DMTN;ANGPTL4;ATXN10;FLOT1;TTN;WHAMMP3;SORL1;PLTP;SRSF5;NLRP1;LRP5;NDE1;TRIOBP;TRPV4;TMSB4X;MAP1LC3A;AGO4;TRPV1;SHARPIN;DNAJC6;FYCO1;NBR1;SRR;C1QTNF6;RXRA;SLC9A3R2;MICAL1;PSMG4;SBF2;SEPT6;TSG101;TMOD2;TCIRG1;CBR4;C9ORF72;TBC1D20;CHMP5;SMARCD2;INSR;TNXB;SMIM20;RABGGTA;BRAF;ASIC1;CAT;HFE;TP73;TUBGCP6;FRAT1;FCHSD1;SPIRE1;TAZ;HGSNAT;REPS2;HSF4;RNF213;EPS8L1;EHD3;SIRT2;GOLGA2;EPS8L2;TGFBR3;TCF7;STX1A;DHPS;MAGI1;SEPT8;SH3PXD2A;CTH;SEC31B;PFKL;C15ORF62;CORO1B;RPL12;TTC19;KCTD11;SDHAF4;KCTD13;APBA1;HIP1;PLEKHH2;TEAD2
16843,GO:0098800,0.999177284898074,0.003636964662978,3,99,inner mitochondrial membrane protein complex,CC,NDUFA4L2;SDHA;SDHAF4
2583,GO:0005876,0.999192047934725,0.00695928530901539,1,56,spindle microtubule,CC,TUBG2
7702,GO:0032200,0.999198008287691,0.00224188211057751,8,166,telomere organization,BP,ERCC1;POLD4;MAPK3;TEP1;PKIB;TERC;HDAC8;HMBOX1
14087,GO:0060968,0.999199381241971,0.002748962498337,5,127,regulation of gene silencing,BP,EGFR;MAP2K1;MAP2K2;PHF2;UHRF2
2974,GO:0006518,0.999213101719362,0.00120811224064502,64,782,peptide metabolic process,BP,TNIP1;APOE;EGFR;PRNP;RNPEPL1;GGT1;ADAMTS13;ABTB1;ZFP36L1;RPL13A;MIF4GD;MAP2K1;OPLAH;GRB7;PCSK1;UNK;CIRBP;CAPRIN2;ABCA7;AARS;ERO1B;NEURL1;SPPL2B;GSTO1;GSTT1;CARS;CHAC1;SESN2;MKNK2;IMPACT;MAPK3;EIF2D;LTA4H;MAP2K2;ATF4;GTPBP1;SORL1;GSTM2;AGO4;GAS6;PTAFR;PPP1R15A;RXRA;CTSH;GSTO2;PAIP2B;AKT1;IGF2BP2;HAGH;LSM14B;GSTM3;RPL39L;ZC3H12D;PAIP2;RPL29;EIF4EBP1;RNPEP;DHPS;PER1;IGF2BP3;ITGA2;ERBB2;EIF2AK4;RPL12
15848,GO:0072599,0.999261434229248,0.0032925118448314,3,104,establishment of protein localization to endoplasmic reticulum,BP,RPL13A;RPL29;RPL12
12871,GO:0051236,0.99930607494695,0.00187028559196315,9,176,establishment of RNA localization,BP,ZFP36L1;XPOT;FLOT1;SRSF5;TGFBR2;IGF2BP2;CPSF4;TST;IGF2BP3
9787,GO:0040029,0.999307386435433,0.00145940328365667,18,290,regulation of gene expression, epigenetic,BP,EGFR;BAHCC1;ERCC6;MAP2K1;H2AFJ;PABPC1L;PHF1;MAP2K2;SLC50A1;HDAC5;DNMT3A;AGO4;MBD1;TNRC18;PHF2;UHRF2;SIRT2;MTA1
17248,GO:0120114,0.999325516199206,0.00383033323287329,2,79,Sm-like protein family complex,CC,TEP1;MAPKBP1
93,GO:0000184,0.999326779699603,0.00260857175005192,4,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,RPL13A;PNRC1;RPL29;RPL12
3233,GO:0006890,0.999327525576361,0.00382531116573852,2,77,retrograde vesicle-mediated transport, Golgi to ER,BP,COPG1;COG7
2858,GO:0006352,0.999330922511878,0.00167207044285039,11,205,DNA-templated transcription, initiation,BP,CTNNBIP1;NR1D1;WWTR1;MAML3;PPARA;MAPK3;THRA;NAT14;RXRA;DMTF1;TEAD2
6920,GO:0030521,0.999348708631855,0.00575865675652627,1,58,androgen receptor signaling pathway,BP,KDM3A
6302,GO:0019941,0.999397943556745,0.00102920818094146,40,523,modification-dependent protein catabolic process,BP,BTBD2;GID4;FBXO2;TMEM129;EDEM1;RBCK1;DDIT3;ABTB1;ARRDC1;CUL9;RNF165;FBXW4;CUL7;WWTR1;MAGEF1;USP20;TRIB2;RNF44;MVB12B;UBXN4;FBXO6;HERPUD1;FBXL15;SMURF2;TRIB3;SHARPIN;AKT1;TSG101;SPSB3;ANKZF1;HFE;CSNK1E;RNF213;SIRT2;MTA1;MAN1B1;WFS1;SYVN1;KCTD13;BTBD11
1470,GO:0003729,0.99945841257073,0.00148321337191225,9,180,mRNA binding,MF,ZFP36L1;ADARB1;RPL13A;UNK;CIRBP;PCBP4;IGF2BP2;PAIP2;IGF2BP3
2872,GO:0006368,0.999471678037892,0.00244064565813459,3,97,transcription elongation from RNA polymerase II promoter,BP,EAPP;NELFCD;RECQL5
8645,GO:0034212,0.999496155591965,0.00459370675855741,1,60,peptide N-acetyltransferase activity,MF,TADA3
240,GO:0000502,0.99950521386394,0.00450901130251697,1,63,proteasome complex,CC,WFS1
18317,GO:1903312,0.999509722111209,0.00448528784424502,1,60,negative regulation of mRNA metabolic process,BP,CIRBP
9045,GO:0035282,0.999535741904523,0.00427615778772388,1,60,segmentation,BP,SEMA3F
7587,GO:0031967,0.999538622949784,0.000687433921537131,83,973,organelle envelope,CC,S100A6;PRODH;CRAT;FAM210B;EGFR;PRNP;HADH;BPHL;SLC16A3;SLC2A9;SNPH;IDH2;CST3;DNM1;CLCA2;GRAMD4;ARMCX2;CPT2;KLHDC2;HMGCL;CYP27B1;TMEM173;ARL2;ULK1;ITPR3;PRKCZ;PAK1;NDUFA4L2;SYNE3;NME4;NIPSNAP1;TMC6;XPOT;NLRX1;STAT6;ACACB;MAPK3;BNIP3;SLC22A18;SDHA;UBXN4;SORL1;ATRAID;PDE2A;RAB40B;PEMT;SLC27A3;BNIP3L;ERN1;CPT1C;PPP1R15A;TNRC18;ACAD11;TM7SF2;SNN;ACADVL;NUCB2;LMNA;C9ORF72;TBC1D20;SPATA18;IFI27;INSR;SLC25A29;ANKZF1;SMIM20;LETMD1;CAT;MYOF;CERS4;TAZ;LEMD2;SLC25A42;TST;MTA1;CIDEA;RETSAT;STX1A;BLOC1S1;FKBP8;TTC19;CREB3L4;SDHAF4
7591,GO:0031975,0.999538622949784,0.000687433921537131,83,973,envelope,CC,S100A6;PRODH;CRAT;FAM210B;EGFR;PRNP;HADH;BPHL;SLC16A3;SLC2A9;SNPH;IDH2;CST3;DNM1;CLCA2;GRAMD4;ARMCX2;CPT2;KLHDC2;HMGCL;CYP27B1;TMEM173;ARL2;ULK1;ITPR3;PRKCZ;PAK1;NDUFA4L2;SYNE3;NME4;NIPSNAP1;TMC6;XPOT;NLRX1;STAT6;ACACB;MAPK3;BNIP3;SLC22A18;SDHA;UBXN4;SORL1;ATRAID;PDE2A;RAB40B;PEMT;SLC27A3;BNIP3L;ERN1;CPT1C;PPP1R15A;TNRC18;ACAD11;TM7SF2;SNN;ACADVL;NUCB2;LMNA;C9ORF72;TBC1D20;SPATA18;IFI27;INSR;SLC25A29;ANKZF1;SMIM20;LETMD1;CAT;MYOF;CERS4;TAZ;LEMD2;SLC25A42;TST;MTA1;CIDEA;RETSAT;STX1A;BLOC1S1;FKBP8;TTC19;CREB3L4;SDHAF4
14083,GO:0060964,0.99954798126594,0.002112865560345,3,103,regulation of gene silencing by miRNA,BP,EGFR;MAP2K1;MAP2K2
5278,GO:0015935,0.999556067405572,0.00408354776665005,1,68,small ribosomal subunit,CC,EIF2D
2491,GO:0005740,0.999560600672905,0.000732143239371407,47,617,mitochondrial envelope,CC,PRODH;CRAT;FAM210B;HADH;BPHL;SNPH;IDH2;DNM1;GRAMD4;ARMCX2;CPT2;HMGCL;CYP27B1;TMEM173;ARL2;ULK1;NDUFA4L2;NME4;NIPSNAP1;NLRX1;ACACB;BNIP3;SDHA;PDE2A;PEMT;SLC27A3;BNIP3L;CPT1C;PPP1R15A;ACAD11;SNN;ACADVL;SPATA18;IFI27;SLC25A29;ANKZF1;SMIM20;LETMD1;CAT;TAZ;SLC25A42;TST;CIDEA;BLOC1S1;FKBP8;TTC19;SDHAF4
19205,GO:1905369,0.999564637463752,0.00402723165558629,1,64,endopeptidase complex,CC,WFS1
3302,GO:0007005,0.99956970261339,0.00076903358275382,35,484,mitochondrion organization,BP,IDH2;DNM1;TFDP2;HMGCL;VPS11;MICALL2;PLA2G6;SESN2;AIP;BNIP3;ACSS2;BBC3;PRIMPOL;IFI6;TFB1M;MAP1LC3A;PEMT;NOS3;BNIP3L;SHARPIN;GLUD1;ALKBH7;AKT1;WDR45;LMNA;ATG2A;SPATA18;SMIM20;TP73;TAZ;CIDEB;EPAS1;OSCP1;TTC19;SDHAF4
5275,GO:0015931,0.999576495137839,0.00108874605370355,11,207,nucleobase-containing compound transport,BP,ZFP36L1;XPOT;SLC29A4;FLOT1;SRSF5;TGFBR2;IGF2BP2;CPSF4;SLC25A42;TST;IGF2BP3
16851,GO:0098813,0.999591067591367,0.000941832126813449,15,251,nuclear chromosome segregation,BP,TUBG2;RMI2;SPC24;CHMP1B;TTN;NDE1;MLH3;AGO4;CHMP5;CHMP4C;REC8;LEMD2;SIRT2;MSH5;HDAC8
15005,GO:0070972,0.999595292602994,0.00163552965847808,4,125,protein localization to endoplasmic reticulum,BP,RPL13A;PPP1R15A;RPL29;RPL12
7586,GO:0031966,0.999611970729931,0.000662494048014941,43,577,mitochondrial membrane,CC,PRODH;CRAT;FAM210B;HADH;BPHL;SNPH;IDH2;DNM1;GRAMD4;ARMCX2;CPT2;HMGCL;CYP27B1;TMEM173;ULK1;NDUFA4L2;NME4;NIPSNAP1;NLRX1;ACACB;BNIP3;SDHA;PDE2A;PEMT;SLC27A3;BNIP3L;CPT1C;PPP1R15A;ACAD11;SNN;ACADVL;SPATA18;IFI27;SLC25A29;ANKZF1;SMIM20;LETMD1;TAZ;SLC25A42;TST;FKBP8;TTC19;SDHAF4
19204,GO:1905368,0.999612749893294,0.00232331016941004,2,85,peptidase complex,CC,TADA3;WFS1
10617,GO:0043632,0.999625825773358,0.00065102011926699,40,532,modification-dependent macromolecule catabolic process,BP,BTBD2;GID4;FBXO2;TMEM129;EDEM1;RBCK1;DDIT3;ABTB1;ARRDC1;CUL9;RNF165;FBXW4;CUL7;WWTR1;MAGEF1;USP20;TRIB2;RNF44;MVB12B;UBXN4;FBXO6;HERPUD1;FBXL15;SMURF2;TRIB3;SHARPIN;AKT1;TSG101;SPSB3;ANKZF1;HFE;CSNK1E;RNF213;SIRT2;MTA1;MAN1B1;WFS1;SYVN1;KCTD13;BTBD11
430,GO:0001158,0.999658866437048,0.00325311166572342,1,63,enhancer sequence-specific DNA binding,MF,SMARCD2
13616,GO:0060147,0.999665887099057,0.00160355685664852,3,106,regulation of posttranscriptional gene silencing,BP,EGFR;MAP2K1;MAP2K2
14085,GO:0060966,0.999665887099057,0.00160355685664852,3,106,regulation of gene silencing by RNA,BP,EGFR;MAP2K1;MAP2K2
1467,GO:0003725,0.9996735063992,0.00312985438292882,1,63,double-stranded RNA binding,MF,AGO4
10963,GO:0044772,0.999675758351418,0.000586009324448543,35,483,mitotic cell cycle phase transition,BP,XPC;FHL1;GJC2;EGFR;NINL;BRSK1;ZFP36L1;RBL2;TFDP2;HYAL1;SDCCAG8;CEP250;PKD2;HMGA2;CNTRL;PKD1;PCBP4;NDE1;FBXL15;CEP131;CDK5RAP3;AKT1;CHEK2;PHLDA1;FOXO4;CHMP4C;CTDSPL;PIDD1;HAUS4;TP73;MTA3;CSNK1E;SIRT2;EIF4EBP1;SFI1
17278,GO:0140101,0.99968543332765,0.00130242878894604,4,117,catalytic activity, acting on a tRNA,MF,AARS;CARS;TRPT1;DTD1
9912,GO:0042273,0.999687542287165,0.00300051561801965,1,67,ribosomal large subunit biogenesis,BP,RPL12
17741,GO:1901796,0.999688416921762,0.000984556743673468,7,160,regulation of signal transduction by p53 class mediator,BP,RMI2;CHD3;L3MBTL1;CDK5RAP3;AKT1;CHEK2;TP73
7969,GO:0032592,0.999695773146498,0.00293566011135234,1,65,integral component of mitochondrial membrane,CC,BNIP3
272,GO:0000775,0.999714864034513,0.000854903874400964,8,173,chromosome, centromeric region,CC,SPC24;KDM4C;CEBPB;NDE1;DNMT3A;SEPT6;PHF2;REC8
12826,GO:0051168,0.999718040166858,0.00080464234028055,9,187,nuclear export,BP,RAPGEF3;XPOT;PKD1;SRSF5;GAS6;CAMK1;STRADB;IFI27;CPSF4
16742,GO:0098573,0.999732437941314,0.00261874575556626,1,66,intrinsic component of mitochondrial membrane,CC,BNIP3
7219,GO:0031123,0.999742488619239,0.00108304272942062,4,119,RNA 3'-end processing,BP,ZFP36L1;PABPC1L;SRSF5;CPSF4
2432,GO:0005622,0.999744813736854,0.000343441363109421,1200,10530,intracellular,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;ISYNA1;APOE;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;ADGRL1;CITED4;ACSF2;CCNG2;PYGB;EGR1;CTNNBIP1;LMF1;THBS3;VWA5A;ALDH7A1;TYSND1;POSTN;EVI5L;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;FAM210B;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;ZDHHC1;SCN8A;NR1D1;ERCC1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;DGKA;TSPAN1;SLC16A3;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;MICALCL;ACAD10;PGM1;CRTC1;CLCA2;PACS2;ADGRB2;ERCC6;NDRG1;ADAMTS13;TBC1D8;ABTB1;ARHGEF19;TCEA2;MMP28;PLEKHH1;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;ARMCX2;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RGL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;PYCR2;TMEM134;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;PLD3;KLHDC2;ASH2L;SOX13;CUL7;PITPNM3;LHPP;TMEM92;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;MPRIP;NAGLU;OXLD1;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;MC1R;CAPG;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TOM1L2;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;ADM2;R3HDM2;MARCKSL1;OGDHL;LGALS9B;SOX12;HDAC11;RAB3B;CD68;PCSK1;PLEKHH3;PTMS;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;UNK;NMRK1;APPL2;CIRBP;CAPRIN2;TPM2;TTBK2;LY6K;PRKCZ;PPP2R3B;GALE;SERPING1;PAK1;ABCA7;ANKS6;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;BRI3;FOXQ1;ARVCF;KLHL29;PHF1;GLDC;NPR2;PLCXD1;CAPNS2;NDUFA4L2;TMEM44;CBS;TMEM187;SPRY4;USP20;SALL2;ELMO3;DOCK6;SYNE3;ZSWIM4;DLG3;NMNAT2;DDX59;WDR27;MICALL2;NME4;PDZD2;CEP250;GRIP2;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;MARCH4;ETV5;ETFB;GSTO1;LCE1E;ARHGEF4;WDR60;LTBP1;MUC19;SYNC;PPCS;SMIM14;FAM117A;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;PLXNB1;EREG;CHD2;GPT2;TEF;TNS1;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;OLFM2;PLCD3;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;SCART1;ERMAP;MANF;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;KIF17;SPATS2;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;ANO1;STON1;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;R3HDM4;SH3TC2;ING4;NUDCD3;ACOT11;VAMP2;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;PCLO;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;LTBP2;ADAMTSL1;SNTA1;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;NYAP1;PI4K2A;NAT14;SRGAP3;ZXDC;PQLC2;KIAA0319L;SDC2;CHMP1B;FBXO17;NRSN2;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;TCTN1;PTPDC1;PLCD1;ARHGEF2;SEPT10;MTMR11;FBF1;INPP5D;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;SAMD3;STMN3;SLC50A1;PGPEP1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;MORN4;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;DOCK11;SSH1;LRRC45;LTB4R2;PCMTD2;SV2A;TBC1D3E;FAM214B;SLC38A10;PRIMPOL;FAM193B;FRMD4B;RABGAP1;POLM;ACAP3;TENM2;MYH16;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;ATXN10;RALGAPA1;FLOT1;CEP68;MDK;TTN;PSKH1;HLCS;AZIN2;HSD11B1;TSNARE1;JDP2;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;ADGRF1;NADK;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;ACADS;FBXL16;CEP131;ISG20;LONP2;EPN3;MARK3;DGCR6L;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;DIRC2;CSRNP3;TTC12;ITGA1;IL17RE;TNFAIP8L1;TMSB4X;SLFN5;ANO9;MAP1LC3A;MOCOS;APOL4;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;ARL10;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;NICN1;ZNF558;RPUSD3;ANGEL1;ZNF662;SHARPIN;CCS;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ESRG;ALKBH7;CROCC;BCR;KLHDC8B;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;C19ORF33;CEP112;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;SRR;TADA3;NBEAL2;BOLA1;KIF13B;SPAG16;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;PRDM8;SLC9A3R2;STRADB;CTSH;WDR19;ACOX3;ACAD11;PNRC1;FBXL8;CCDC15;UACA;GSDMC;MGMT;GSTO2;ASNS;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;SWT1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;IFT57;LACTB2;PHYKPL;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;CAPS;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;KIF27;FMNL3;PHF2;FGFR4;IGF2BP2;RASSF9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;ZNF25;FARP1;DNASE2;LMNA;ASMTL;FAAH;UPP1;SH2B3;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;FOXO4;GNAL;COG7;YPEL3;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;EDA2R;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;ASIC1;ALDH1L1;HOXC5;GJB4;FAAP20;PIDD1;CAT;ZNF160;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;UNC119B;TIMP1;HFE;JAK3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;ZNF846;APRT;GLCCI1;FCHSD1;TMX4;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;ENDOV;JOSD2;PHC1;SCYL3;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;REPS2;RABAC1;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;PJA2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;ARHGEF17;SLC25A42;SIRT2;MBOAT2;GDF15;PHLDA2;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;FAM220A;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;POU2F2;RCOR2;POLR3GL;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;MSH5;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;RETSAT;TGFBR3;CIDEB;TCF7;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;TMCO6;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;RGPD6;FKBP8;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;KDELC2;UST;EIF2AK4;STK32B;UNC119;PAG1;CCDC69;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;FRS3;SFI1;RPL12;MPPE1;HMBOX1;NET1;TTC19;HSP90AB4P;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;BTBD11;SIX5
3598,GO:0008033,0.999754504981631,0.00103611037925797,4,120,tRNA processing,BP,AARS;TRPT1;RPUSD3;CPSF4
2843,GO:0006323,0.999762604195258,0.000763111066639025,7,166,DNA packaging,BP,H1F0;BAHCC1;HMGA2;TSPYL2;H1FX;TTN;TNRC18
4191,GO:0009301,0.999764524425826,0.00233698477725606,1,67,snRNA transcription,BP,POU2F2
10176,GO:0042795,0.999764524425826,0.00233698477725606,1,67,snRNA transcription by RNA polymerase II,BP,POU2F2
3341,GO:0007062,0.999777976463329,0.000944706039834926,4,120,sister chromatid cohesion,BP,SPC24;NDE1;REC8;HDAC8
12735,GO:0051028,0.999794797210099,0.000783106012459602,5,135,mRNA transport,BP,ZFP36L1;SRSF5;IGF2BP2;CPSF4;IGF2BP3
15065,GO:0071103,0.99980660616044,0.000487191714124211,13,245,DNA conformation change,BP,XPC;H1F0;DDB2;BAHCC1;SMARCA1;CHD2;CHD3;HMGA2;TSPYL2;H1FX;TTN;TNRC18;RECQL5
12921,GO:0051304,0.999809801435933,0.00193231730335735,1,68,chromosome separation,BP,RECQL5
2859,GO:0006353,0.999811750607118,0.000950007802926982,3,107,DNA-templated transcription, termination,BP,SRSF5;CPSF4;DMTF1
110,GO:0000228,0.999827064736482,0.000319925196800581,35,493,nuclear chromosome,CC,H1F0;NR1D1;ERCC1;MEF2D;SMARCA1;ASH2L;POLD4;H2AFJ;TRNP1;APPL2;SALL2;INO80C;CHD3;SATB1;STAT6;HMGA2;KDM4C;CBX7;TTN;CEBPB;DNMT3A;MLH3;CALCOCO1;RXRA;UHRF2;SMARCD2;ADD3;REC8;SIRT2;POLR3GL;MSH5;HDAC8;TCF7;RGS12;HMBOX1
5923,GO:0018205,0.999833532668805,0.000357797723420588,21,337,peptidyl-lysine modification,BP,EGR1;NOS1;ASH2L;KDM3A;PHF1;ING4;JADE2;MAPK3;KDM4C;HMG20B;TADA3;HINT2;PIAS3;RPS6KA5;SIRT2;MTA1;HDAC8;DHPS;PER1;BLOC1S1;CTH
3339,GO:0007059,0.999839033780541,0.000364697367528521,18,299,chromosome segregation,BP,TUBG2;RMI2;SPC24;RGS14;CHMP1B;TTN;NEK8;NDE1;MLH3;AGO4;CHMP5;CHMP4C;REC8;LEMD2;SIRT2;RECQL5;MSH5;HDAC8
2846,GO:0006334,0.999840796233123,0.000811749586798659,3,116,nucleosome assembly,BP,H1F0;TSPYL2;H1FX
2801,GO:0006261,0.999845966051543,0.00059981492913794,5,138,DNA-dependent DNA replication,BP,POLD4;PRIMPOL;CHEK2;BCL6;FGFR1
3283,GO:0006974,0.999866978464431,0.000220054212937664,58,739,cellular response to DNA damage stimulus,BP,NFATC4;XPC;EGFR;DDB2;ERCC1;DDIT3;BRSK1;ERCC6;NDRG1;NUPR1;RBL2;TFDP2;ASH2L;POLD4;MC1R;DDIT4;MAGEF1;PHF1;NEIL1;NSMCE4A;CHD2;RMI2;INO80C;SESN2;ING4;HMGA2;MAPK3;MACROD1;MAPK12;PRIMPOL;POLM;FBXO6;NSMCE1;PCBP4;MLH3;CDK5RAP3;ALKBH7;POLL;PPP1R15A;MGMT;AKT1;CHEK2;SPATA18;FOXO4;FAAP20;PIDD1;MPG;TP73;ENDOV;CSNK1E;BCL6;REC8;RECQL5;MTA1;MSH5;CIDEB;VAV3;EIF2AK4
8823,GO:0034622,0.999867107511161,0.000210825906752077,71,880,cellular protein-containing complex assembly,BP,XPC;H1F0;GSN;WIPF1;CDC42EP5;DDB2;CLTCL1;FCHO1;SPTB;DNM1;EXOC2;RPL13A;MSRB2;OBSL1;ARPIN;CAPG;DGKQ;EML2;TUBG2;SNX9;DNAH1;ARL2;VPS11;GRB7;SOX12;MYH11;CIRBP;PAK1;MICALL2;PLEKHG2;SEPT5;THRA;EIF2D;SEPT10;TSPYL2;H1FX;TWF2;DMTN;TTN;WHAMMP3;SRSF5;NDE1;TRIOBP;TRPV4;TMSB4X;AGO4;PSMG4;SEPT6;TMOD2;TCIRG1;C9ORF72;TBC1D20;SMIM20;TUBGCP6;FCHSD1;SPIRE1;TAZ;EPS8L1;SIRT2;GOLGA2;EPS8L2;TGFBR3;STX1A;SEPT8;SEC31B;C15ORF62;CORO1B;RPL12;TTC19;SDHAF4;HIP1
3906,GO:0008565,0.999869561476743,0.00137684335805454,1,72,protein transporter activity,MF,LRP1
10961,GO:0044770,0.999874919955205,0.00023234110478764,36,510,cell cycle phase transition,BP,XPC;FHL1;GJC2;EGFR;NINL;BRSK1;ZFP36L1;RBL2;TFDP2;HYAL1;SDCCAG8;CEP250;PKD2;HMGA2;CNTRL;PKD1;PCBP4;NDE1;FBXL15;CEP131;CDK5RAP3;ATP2B4;AKT1;CHEK2;PHLDA1;FOXO4;CHMP4C;CTDSPL;PIDD1;HAUS4;TP73;MTA3;CSNK1E;SIRT2;EIF4EBP1;SFI1
10258,GO:0043021,0.999877282452436,0.000641180486251919,3,110,ribonucleoprotein complex binding,MF,RNF135;IMPACT;LETMD1
13658,GO:0060218,0.999885386907468,0.000767015401564567,2,100,hematopoietic stem cell differentiation,BP,CHD2;TP73
17320,GO:1900034,0.999894680558183,0.00113740634694198,1,72,regulation of cellular response to heat,BP,MAPK3
10598,GO:0043604,0.999899370362833,0.000169687958507471,55,733,amide biosynthetic process,BP,TNIP1;NAGS;EGFR;GGT1;ABTB1;ZFP36L1;RPL13A;MIF4GD;MAP2K1;OPLAH;GRB7;PCSK1;UNK;CIRBP;CAPRIN2;AARS;NEURL1;PLA2G6;CARS;CHAC1;SESN2;MKNK2;IMPACT;ST6GALNAC6;MAPK3;EIF2D;MAP2K2;ATF4;GTPBP1;PEMT;AGO4;PTAFR;PPP1R15A;RXRA;ASNS;PAIP2B;AKT1;ASS1;IGF2BP2;HAGH;CERS4;LSM14B;RPL39L;ZC3H12D;PAIP2;RPL29;EIF4EBP1;DHPS;NMRAL1;PER1;IGF2BP3;ITGA2;ERBB2;EIF2AK4;RPL12
15034,GO:0071013,0.999912333529667,0.000602298775197769,2,96,catalytic step 2 spliceosome,CC,TEP1;MAPKBP1
9003,GO:0035195,0.999913751506812,0.000392695866195223,4,134,gene silencing by miRNA,BP,EGFR;MAP2K1;MAP2K2;AGO4
6018,GO:0019080,0.999915889989938,0.000288028219291012,7,184,viral gene expression,BP,RPL13A;HMGA2;EIF2D;NELFCD;RPL29;EIF2AK4;RPL12
9062,GO:0035326,0.999917240801552,0.000915110601633997,1,74,enhancer binding,MF,SMARCD2
5581,GO:0016604,0.999917852539871,0.000143239269027617,49,651,nuclear body,CC,NFATC4;H1F0;PTK6;OBSCN;NR1D1;CRTC1;KLHDC2;LHPP;WWTR1;DGKQ;MAML3;PHF7;NSMCE4A;RMI2;MKNK2;SATB1;RGS14;EIF2D;FLYWCH1;TENM2;PSKH1;HDAC5;SRSF5;CREBRF;ISG20;SMURF2;BHLHE40;HMG20B;AGO4;BNIP3L;NBR1;TERC;MBD1;WDR19;CRY2;CHEK2;ZNF217;PIAS3;LMNA;FOXO4;FAAP20;UBOX5;HSF4;TCF7;EPAS1;LRCH4;HMBOX1;KCTD13;PLEKHH2
8893,GO:0034728,0.999922668239263,0.000354324177160337,4,139,nucleosome organization,BP,H1F0;TSPYL2;H1FX;SMARCD2
35,GO:0000070,0.999926300581177,0.000302094927112438,5,141,mitotic sister chromatid segregation,BP,TUBG2;CHMP1B;TTN;CHMP5;CHMP4C
2442,GO:0005643,0.999933231860301,0.000753503056598938,1,76,nuclear pore,CC,XPOT
6594,GO:0022618,0.999935807410929,0.000210241833513987,8,193,ribonucleoprotein complex assembly,BP,RPL13A;GRB7;CIRBP;EIF2D;SRSF5;AGO4;C9ORF72;RPL12
17277,GO:0140098,0.99994297916175,0.000132632984214233,19,331,catalytic activity, acting on RNA,MF,AARS;DDX59;NSUN5P2;CARS;RRNAD1;TRPT1;PAN2;PRIMPOL;TFB1M;DHX32;ISG20;ERN1;LACTB2;CPSF4;POLR2J2;ENDOV;POLR3GL;POLR2J3;DTD1
10891,GO:0044454,0.99994532912059,0.000109978359702092,30,462,nuclear chromosome part,CC,H1F0;NR1D1;ERCC1;MEF2D;SMARCA1;ASH2L;POLD4;H2AFJ;TRNP1;APPL2;SALL2;INO80C;CHD3;SATB1;STAT6;KDM4C;CBX7;CEBPB;DNMT3A;MLH3;CALCOCO1;RXRA;UHRF2;SMARCD2;REC8;SIRT2;POLR3GL;MSH5;TCF7;HMBOX1
307,GO:0000819,0.999948307997877,0.000155300046560291,10,215,sister chromatid segregation,BP,TUBG2;RMI2;SPC24;CHMP1B;TTN;NDE1;CHMP5;CHMP4C;REC8;HDAC8
12514,GO:0050684,0.999951411729383,0.000350798271123302,2,99,regulation of mRNA processing,BP,ZFP36L1;CPSF4
7158,GO:0031047,0.999951663296876,0.000202932484167185,5,155,gene silencing by RNA,BP,EGFR;MAP2K1;TDRKH;MAP2K2;AGO4
14844,GO:0070647,0.999952127744613,7.67521398553233e-05,77,950,protein modification by small protein conjugation or removal,BP,TNIP1;GID4;EGR1;FBXO2;ZNF862;TMEM129;RNF135;RBCK1;DDB2;ARRDC1;CUL9;RNF165;FBXW4;CUL7;WWTR1;MAGEF1;FBXO41;KLHL29;USP20;FBXW8;NEURL1;RAG1;MARCH4;RNF44;UNKL;INO80C;BLMH;MARCH9;JADE2;FBXO27;DCAF10;PEX10;FBXO17;LRSAM1;KLHL24;FBXO6;NSMCE1;HERPUD1;FBXL15;FBXL16;HLTF;SMURF2;LMO7;TRIB3;RAB40B;HMG20B;CDK5RAP3;MARCH2;SHARPIN;KLHDC8B;TADA3;FBXL8;AKT1;TSG101;PIAS3;SPSB3;UHRF2;FOXO4;UBOX5;MIB2;JOSD2;PHC1;RNF213;FBXO25;FYN;PJA2;GOLGA2;MTA1;HDAC8;EPAS1;RNF170;WFS1;SYVN1;TRIM2;KCTD11;KCTD13;DTX3
531,GO:0001650,0.999952997722368,0.000264106969381289,3,118,fibrillar center,CC,INO80C;PAK6;DEAF1
9002,GO:0035194,0.999953261226616,0.000221981357233651,4,140,posttranscriptional gene silencing by RNA,BP,EGFR;MAP2K1;MAP2K2;AGO4
10519,GO:0043484,0.999955910087223,0.000320763634880156,2,100,regulation of RNA splicing,BP,SRSF5;ERN1
879,GO:0002244,0.999956168500913,0.000185047154480763,5,158,hematopoietic progenitor cell differentiation,BP,DHTKD1;CHD2;KCNAB2;BRAF;TP73
16791,GO:0098687,0.999957838669786,0.000103344971003459,17,312,chromosomal region,CC,ERCC1;NSMCE4A;SPC24;SCMH1;KDM4C;NSMCE1;TEP1;CEBPB;NDE1;DNMT3A;TERC;CHEK2;SEPT6;PHF2;REC8;SIRT2;HMBOX1
5494,GO:0016441,0.999958059831601,0.000200644903457943,4,141,posttranscriptional gene silencing,BP,EGFR;MAP2K1;MAP2K2;AGO4
2893,GO:0006403,0.999959365506039,0.00012939515147038,9,209,RNA localization,BP,ZFP36L1;XPOT;FLOT1;SRSF5;TGFBR2;IGF2BP2;CPSF4;TST;IGF2BP3
8396,GO:0033365,0.999961554478303,6.69463284780962e-05,54,728,protein localization to organelle,BP,BBS2;OBSCN;IFT140;DDIT3;TFDP2;RPL13A;OBSL1;BBS1;TMEM173;ARL2;VPS11;TTBK2;ABCA7;MICALL2;CEP250;NGFR;SESN2;AIP;NUDCD3;PEX10;TCTN1;LRSAM1;BBC3;CEP68;SORL1;CEP131;LONP2;PDE2A;PEMT;CDK5RAP3;BNIP3L;GAS6;LZTS2;CROCC;PPP1R15A;SPATA7;C12ORF66;AKT1;TTC21A;TSG101;LMNA;COG7;TP73;PEX7;TMEM50B;BCL6;FYN;PEX1;LEMD2;HDAC8;RPL29;TMCO6;OSCP1;RPL12
15232,GO:0071426,0.999964289600392,0.000204601527218459,3,121,ribonucleoprotein complex export from nucleus,BP,XPOT;SRSF5;CPSF4
4531,GO:0010608,0.999967097564327,6.54959253448005e-05,33,505,posttranscriptional regulation of gene expression,BP,EGFR;ZFP36L1;RPL13A;MIF4GD;MAP2K1;GRB7;UNK;CIRBP;CAPRIN2;NEURL1;SESN2;MKNK2;IMPACT;MAPK3;MAP2K2;ATF4;PCBP4;AGO4;PTAFR;PPP1R15A;RXRA;PAIP2B;AKT1;IGF2BP2;LSM14B;ZC3H12D;PAIP2;EIF4EBP1;PER1;IGF2BP3;ITGA2;ERBB2;EIF2AK4
1472,GO:0003735,0.999967272647471,0.000158619158055253,4,154,structural constituent of ribosome,MF,RPL13A;RPL39L;RPL29;RPL12
2896,GO:0006406,0.99996734874932,0.000243144219881352,2,103,mRNA export from nucleus,BP,SRSF5;CPSF4
15233,GO:0071427,0.99996734874932,0.000243144219881352,2,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,SRSF5;CPSF4
15086,GO:0071166,0.999968082616077,0.000184325994612343,3,122,ribonucleoprotein complex localization,BP,XPOT;SRSF5;CPSF4
5332,GO:0016073,0.99996996143799,0.000364332744392705,1,84,snRNA metabolic process,BP,POU2F2
10275,GO:0043043,0.999970252851635,5.39453644747626e-05,47,672,peptide biosynthetic process,BP,TNIP1;EGFR;GGT1;ABTB1;ZFP36L1;RPL13A;MIF4GD;MAP2K1;OPLAH;GRB7;PCSK1;UNK;CIRBP;CAPRIN2;AARS;NEURL1;CARS;CHAC1;SESN2;MKNK2;IMPACT;MAPK3;EIF2D;MAP2K2;ATF4;GTPBP1;AGO4;PTAFR;PPP1R15A;RXRA;PAIP2B;AKT1;IGF2BP2;HAGH;LSM14B;RPL39L;ZC3H12D;PAIP2;RPL29;EIF4EBP1;DHPS;PER1;IGF2BP3;ITGA2;ERBB2;EIF2AK4;RPL12
5583,GO:0016607,0.999972781962426,6.52706420097737e-05,19,339,nuclear speck,CC,NFATC4;LHPP;DGKQ;MAML3;PHF7;RMI2;PSKH1;HDAC5;SRSF5;SMURF2;BNIP3L;MBD1;CRY2;ZNF217;PIAS3;LMNA;FOXO4;HSF4;EPAS1
10867,GO:0044424,0.999974039285351,3.60576131240187e-05,1177,10409,intracellular part,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;ISYNA1;APOE;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;CCNG2;PYGB;EGR1;CTNNBIP1;LMF1;THBS3;VWA5A;ALDH7A1;TYSND1;POSTN;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;DDIT4L;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;FAM210B;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;RHPN1;D2HGDH;PRNP;ZDHHC1;SCN8A;NR1D1;ERCC1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;ZKSCAN1;SPTB;NPEPL1;LOXL1;DGKA;TSPAN1;SLC16A3;RNPEPL1;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;MICALCL;ACAD10;PGM1;CRTC1;CLCA2;PACS2;ADGRB2;ERCC6;NDRG1;ADAMTS13;ABTB1;ARHGEF19;TCEA2;MMP28;PLEKHH1;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;ARMCX2;HEBP1;TRIM65;EFS;ZFP36L1;ADARB1;PPM1M;SYT8;CUL9;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;PYCR2;TMEM134;EXOC2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;FBXW4;PLD3;KLHDC2;ASH2L;SOX13;CUL7;PITPNM3;LHPP;TMEM92;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;MPRIP;NAGLU;OXLD1;PPP1R14A;ETV4;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;CAPG;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;NPHP4;LGALS9C;BLOC1S4;VEGFB;R3HDM2;MARCKSL1;OGDHL;LGALS9B;SOX12;HDAC11;RAB3B;CD68;PCSK1;PLEKHH3;PTMS;MYCBPAP;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;UNK;NMRK1;APPL2;CIRBP;CAPRIN2;TPM2;TTBK2;LY6K;PRKCZ;PPP2R3B;GALE;SERPING1;PAK1;ABCA7;ANKS6;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;BRI3;FOXQ1;ARVCF;KLHL29;PHF1;GLDC;NPR2;PLCXD1;CAPNS2;NDUFA4L2;TMEM44;CBS;TMEM187;SPRY4;USP20;SALL2;ELMO3;DOCK6;SYNE3;ZSWIM4;DLG3;NMNAT2;DDX59;WDR27;MICALL2;NME4;PDZD2;CEP250;GRIP2;FBXW8;ETV1;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;ACVR2B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;MARCH4;ETV5;ETFB;GSTO1;LCE1E;ARHGEF4;WDR60;LTBP1;MUC19;SYNC;PPCS;SMIM14;FAM117A;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;CHD2;GPT2;TEF;TNS1;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;OLFM2;PLCD3;PLEKHG2;DHRS4;CCDC106;PSPH;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;SCART1;ERMAP;MANF;S100A13;GSTT1;AGAP1;ALS2CL;CARS;FKBP10;MTMR4;KIF17;SPATS2;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;ANO1;STON1;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;IMPACT;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;R3HDM4;SH3TC2;ING4;NUDCD3;ACOT11;VAMP2;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;PCLO;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;PC;FBXO27;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;GSDMA;SCARA3;DOCK9;SH2D2A;RGS14;MVD;IRF2BPL;DNAL4;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;ADAMTSL1;SNTA1;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;SRGAP3;ZXDC;PQLC2;KIAA0319L;SDC2;CHMP1B;FBXO17;NRSN2;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;TCTN1;PTPDC1;PLCD1;ARHGEF2;SEPT10;MTMR11;FBF1;INPP5D;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;SAMD3;STMN3;SLC50A1;PGPEP1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;LRSAM1;DMTN;LRRC8A;KLHL24;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;MORN4;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;DOCK11;SSH1;LRRC45;LTB4R2;PCMTD2;SV2A;FAM214B;SLC38A10;PRIMPOL;FAM193B;FRMD4B;RABGAP1;POLM;ACAP3;TENM2;MYH16;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;ATXN10;RALGAPA1;FLOT1;CEP68;MDK;TTN;PSKH1;HLCS;AZIN2;HSD11B1;TSNARE1;JDP2;HDAC5;WHAMMP3;GTPBP1;IRF5;SORL1;MAP6;GALK1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;NADK;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;TSTD1;WNK4;RIN2;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;AQP3;ACADS;FBXL16;CEP131;ISG20;LONP2;EPN3;MARK3;DGCR6L;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;ARHGAP25;IQSEC2;DIRC2;CSRNP3;TTC12;ITGA1;IL17RE;TNFAIP8L1;TMSB4X;SLFN5;MAP1LC3A;MOCOS;APOL4;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;NICN1;ZNF558;RPUSD3;ANGEL1;ZNF662;SHARPIN;CCS;FMNL2;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ESRG;ALKBH7;CROCC;BCR;KLHDC8B;MAPRE3;ATP7B;FYCO1;MAN2C1;CHKB;C19ORF33;CEP112;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;SRR;TADA3;NBEAL2;BOLA1;KIF13B;SPAG16;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;PRDM8;SLC9A3R2;STRADB;CTSH;WDR19;ACOX3;ACAD11;PNRC1;FBXL8;CCDC15;UACA;GSDMC;MGMT;GSTO2;ASNS;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;SWT1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;HMSD;IFT57;LACTB2;PHYKPL;WDR45;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;CAPS;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;KIF27;FMNL3;PHF2;FGFR4;IGF2BP2;RASSF9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;ZNF25;FARP1;DNASE2;LMNA;ASMTL;FAAH;UPP1;SH2B3;MAB21L2;SPSB3;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;FOXO4;GNAL;COG7;YPEL3;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;ASIC1;ALDH1L1;HOXC5;GJB4;FAAP20;PIDD1;CAT;ZNF160;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;UNC119B;TIMP1;HFE;JAK3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;ZNF846;APRT;GLCCI1;FCHSD1;TMX4;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;ENDOV;JOSD2;PHC1;SCYL3;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;REPS2;RABAC1;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;EML3;ATP8B2;PJA2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;ARHGEF17;SLC25A42;SIRT2;MBOAT2;GDF15;PHLDA2;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;FAM220A;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;POU2F2;RCOR2;POLR3GL;RHOBTB3;ETNK2;NAGA;MTA1;RTN2;MSH5;ENTPD2;FUK;AP2A2;CIDEA;EPS8L2;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;RETSAT;TGFBR3;CIDEB;TCF7;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;CHD6;RNF170;LURAP1;DHPS;EPHB2;NMRAL1;MAGI1;POLR2J3;INPP4A;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;RGPD6;FKBP8;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;KDELC2;UST;EIF2AK4;UNC119;CCDC69;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;SFI1;RPL12;MPPE1;HMBOX1;NET1;TTC19;HSP90AB4P;TRIM2;GRB10;TSHZ1;TNNI1;CREB3L4;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;BTBD11;SIX5
15454,GO:0071826,0.999976696051561,8.06483457274173e-05,8,204,ribonucleoprotein complex subunit organization,BP,RPL13A;GRB7;CIRBP;EIF2D;SRSF5;AGO4;C9ORF72;RPL12
10892,GO:0044455,0.999978481252177,9.48767986072408e-05,5,166,mitochondrial membrane part,CC,NDUFA4L2;BNIP3;SDHA;ANKZF1;SDHAF4
6021,GO:0019083,0.999981335290027,8.29330139537431e-05,5,170,viral transcription,BP,RPL13A;HMGA2;NELFCD;RPL29;RPL12
17282,GO:0140110,0.999983538153907,2.48272254566539e-05,122,1406,transcription regulator activity,MF,ZC3H6;ZMYND8;NFATC4;FOS;CITED4;EGR1;ZSCAN18;NR1D1;ZKSCAN1;MEF2D;DDIT3;TSC22D1;ZFP36L1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;KLF9;SOX13;ETV4;WWTR1;MXD4;PKN1;BTG1;PHF21A;ZNF76;PBX2;MAML3;THAP8;SOX12;ELK3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ETV5;HES2;TEF;NAB2;UNKL;CARF;PPARA;AIP;TCF25;SATB1;STAT6;KLF7;ING4;HMGA2;THRA;PBXIP1;ZSCAN30;ZXDC;MLXIPL;LITAF;ATF4;ZFPM1;ZNF467;ZNF516;JDP2;IRF5;DEAF1;PEG3;GLI4;RFX2;CEBPB;CREBRF;ZNF251;L3MBTL1;HLTF;MXD3;FOXL1;CSRNP3;TRIB3;BHLHE40;CALCOCO1;ZFP90;ZNF558;TADA3;BOLA1;RXRA;ZNF358;CRY2;TSG101;PHF2;ZNF217;ZNF25;SMARCD2;NCOA7;FOXO4;ZNF554;HOXC5;ZNF160;ZFP28;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;POU2F2;RCOR2;MTA1;TCF7;EPAS1;MAP3K10;PER1;ZNF333;HMBOX1;TSHZ1;CREB3L4;ZNF449;ZMYM3;DBP;ZNF287;DMTF1;TEAD2;SIX5
17821,GO:1902036,0.99998377992394,0.000206695137669166,1,95,regulation of hematopoietic stem cell differentiation,BP,TP73
281,GO:0000784,0.999987755927955,9.79582927118374e-05,2,114,nuclear chromosome, telomeric region,CC,ERCC1;HMBOX1
3250,GO:0006913,0.999987790867409,3.308230130182e-05,15,301,nucleocytoplasmic transport,BP,RAPGEF3;TMEM173;XPOT;RGS14;PKD1;SRSF5;PDE2A;GAS6;CAMK1;STRADB;AKT1;IFI27;CPSF4;BCL6;TMCO6
2814,GO:0006281,0.999989770023503,2.17805078374266e-05,30,484,DNA repair,BP,XPC;EGFR;DDB2;ERCC1;ERCC6;POLD4;MC1R;MAGEF1;NEIL1;NSMCE4A;RMI2;INO80C;HMGA2;PRIMPOL;POLM;FBXO6;NSMCE1;MLH3;POLL;MGMT;CHEK2;FAAP20;MPG;TP73;ENDOV;CSNK1E;REC8;RECQL5;MTA1;MSH5
10851,GO:0044391,0.999989832312024,4.67254897219348e-05,5,182,ribosomal subunit,CC,RPL13A;EIF2D;RPL39L;RPL29;RPL12
15846,GO:0072594,0.999989925753975,2.21831546680256e-05,27,459,establishment of protein localization to organelle,BP,DDIT3;TFDP2;RPL13A;TMEM173;VPS11;MICALL2;AIP;PEX10;LRSAM1;BBC3;SORL1;LONP2;PDE2A;PEMT;BNIP3L;GAS6;AKT1;TSG101;TP73;PEX7;TMEM50B;BCL6;PEX1;RPL29;TMCO6;OSCP1;RPL12
12827,GO:0051169,0.999990408068195,2.6248406378998e-05,15,304,nuclear transport,BP,RAPGEF3;TMEM173;XPOT;RGS14;PKD1;SRSF5;PDE2A;GAS6;CAMK1;STRADB;AKT1;IFI27;CPSF4;BCL6;TMCO6
2895,GO:0006405,0.999990693416402,5.83826225439838e-05,3,133,RNA export from nucleus,BP,XPOT;SRSF5;CPSF4
2889,GO:0006399,0.999990753414293,3.88578863711459e-05,6,183,tRNA metabolic process,BP,AARS;CARS;TRPT1;RPUSD3;CPSF4;DTD1
16831,GO:0098781,0.999991152690164,0.000118980309752295,1,93,ncRNA transcription,BP,POU2F2
17611,GO:1901362,0.999992551528869,9.94395836168015e-06,348,3527,organic cyclic compound biosynthetic process,BP,TNIP1;XDH;ZC3H6;HTRA1;F2R;NT5E;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;NAPRT;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;IDH2;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;PYCR2;DHTKD1;TFDP2;MXI1;HSD17B14;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;ASH2L;SOX13;LHPP;UROS;ETV4;WWTR1;POLD4;MAP2K1;CYP27B1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;OGDHL;SOX12;HDAC11;NMRK1;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;NPR2;SALL2;NMNAT2;NME4;ETV1;ZP3;NEIL1;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;PPCS;HES2;EREG;CHD2;TEF;PSAT1;APBB3;RMI2;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;ACACB;NT5C1B;MAPK3;THRA;RGS14;MVD;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SRD5A3;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;HSD11B1;JDP2;HDAC5;IRF5;GALK1;TFB1M;PLTP;SRSF5;VLDLR;ADGRF1;NADK;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;HSD17B7;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;NOS3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;CYP2R1;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;TM7SF2;HINT2;AKT1;IGFBP7;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;TSG101;PHF2;FGFR4;ZNF217;PIAS3;TCIRG1;ZNF25;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;MPI;TAZ;BCL6;HSF4;LEMD2;SIRT2;TRPC1;GDF15;RECQL5;OSBPL1A;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;ENTPD2;FUK;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;PLPP6;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;SIX5
2900,GO:0006412,0.999992891494865,1.37416189346842e-05,43,653,translation,BP,TNIP1;EGFR;GGT1;ABTB1;ZFP36L1;RPL13A;MIF4GD;MAP2K1;GRB7;UNK;CIRBP;CAPRIN2;AARS;NEURL1;CARS;SESN2;MKNK2;IMPACT;MAPK3;EIF2D;MAP2K2;ATF4;GTPBP1;AGO4;PTAFR;PPP1R15A;RXRA;PAIP2B;AKT1;IGF2BP2;LSM14B;RPL39L;ZC3H12D;PAIP2;RPL29;EIF4EBP1;DHPS;PER1;IGF2BP3;ITGA2;ERBB2;EIF2AK4;RPL12
17643,GO:1901532,0.99999411058101,8.14627978166202e-05,1,103,regulation of hematopoietic progenitor cell differentiation,BP,TP73
3661,GO:0008152,0.999994383881304,7.3704086194044e-06,902,8273,metabolic process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;NYNRIN;APOE;BTBD2;ZMYND8;NFATC4;XPC;SERPINE2;GID4;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;ALDH7A1;TYSND1;PPP1R35;SUGCT;SLC2A3;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;THSD4;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;GPX3;GJC2;LRP1;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;NEK9;RAPGEF3;BPHL;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;DGKA;SLC16A3;RNPEPL1;IGFBP4;CD9;SLC2A9;IDH2;FKBP9;CRTAP;CST3;DNM1;MEF2D;NOS1;GPSM1;DDIT3;TSC22D1;BRSK1;DNPH1;DNAJB5;ACAD10;PGM1;CRTC1;CLCA2;PACS2;MRC2;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;MMP28;COL13A1;GRAMD4;SMARCA1;MST1R;ARRDC1;TRIM65;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;RPS6KA2;GAA;PYGL;MMP1;PYCR2;CTF1;CNTN1;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;PHYHD1;RPL13A;MSRB2;OBSL1;MDFI;TK2;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;KLF9;RNF165;MIF4GD;CDK18;NISCH;PHACTR3;CPT2;MLYCD;FBXW4;PLD3;ASH2L;SOX13;CUL7;PITPNM3;LHPP;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;NAGLU;PPP1R14A;ETV4;TXNRD3;WWTR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;COL6A1;CCDC71L;CRYL1;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MAML3;TMEM173;SNX9;FAM213A;THAP8;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;OGDHL;SOX12;HDAC11;RAB3B;PCSK1;PTMS;CYBRD1;HSD11B1L;UNK;NMRK1;PRSS8;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;GALE;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;PHYH;ELK3;STK39;PABPC1L;ERO1B;BLVRB;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;KLHL29;PHF1;GLDC;NPR2;PLCXD1;CAPNS2;NDUFA4L2;CBS;SPRY4;USP20;DHRS12;SALL2;DLG3;ITGB4;NMNAT2;DDX59;NME4;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;MARCH4;ETV5;NSUN7;ETFB;GSTO1;LCE1E;LTBP1;MUC19;PPCS;NSMCE4A;TRIB2;HES2;EREG;CHD2;GPT2;TEF;PSAT1;APBB3;PTPRE;PNPLA3;RNF44;SSH3;RMI2;PLCD3;DHRS4;PSPH;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;PPM1J;ABCG1;ESYT2;TRAPPC9;CARF;LPAR3;GSTT1;CARS;FKBP10;MTMR4;C5;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;PPP1R3E;ING4;ACOT11;RRNAD1;HMGA2;AREG;ST6GALNAC6;COL8A1;SLIT3;ECM1;B4GAT1;MARCH9;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;LAMB2;PC;FBXO27;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;RGS14;MVD;IRF2BPL;FAM20C;TDRKH;PBXIP1;CNTRL;ADAMTSL1;SNTA1;FAHD2B;PAN2;CTSB;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;ZXDC;SDC2;FBXO17;ARHGAP22;MLXIPL;TBC1D14;PTPDC1;C1RL;PLCD1;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;HIBADH;SLC50A1;PGPEP1;SDHA;TECPR1;FAM86C2P;LRSAM1;DMTN;KLHL24;LITAF;ANGPTL4;PTHLH;UBXN4;ATF4;ZFPM1;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;SSH1;LTB4R2;PCMTD2;PRIMPOL;POLM;TENM2;FBXO6;IFI6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;FLOT1;MDK;TTN;PSKH1;HLCS;AZIN2;HSD11B1;JDP2;HDAC5;GTPBP1;IRF5;SORL1;GALK1;TFB1M;NTPCR;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;PAPLN;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;CES2;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;TSTD1;WNK4;ATRAID;ALDOC;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;ACADS;FBXL16;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;MAP1LC3A;MOCOS;APOL4;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;RPUSD3;ZNF662;SHARPIN;CCS;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;ALKBH7;BCR;KLHDC8B;MAPRE3;FYCO1;MAN2C1;CHKB;NBR1;CPT1C;EXD3;HEXA;FAHD2A;TNNI2;SRR;TADA3;BOLA1;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;THNSL2;PRDM8;STRADB;CTSH;ACOX3;ACAD11;PNRC1;FBXL8;MGMT;GSTO2;ASNS;ENTPD6;TM7SF2;PAIP2B;LCE1F;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;CARD11;DGUOK;CDKN1C;MICAL1;SWT1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;LACTB2;PHYKPL;WDR45;IGFBP2;ASS1;SPDYE2;SPDYE2B;COMTD1;NFU1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;SLC6A6;ZNF25;FARP1;DNASE2;ASMTL;FAAH;UPP1;SPSB3;ATG2A;WDFY2;C9ORF72;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;SMARCD2;SPATA18;MARK4;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;NCOA7;NELFCD;TENM4;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;TPCN1;RABGGTA;TXNRD2;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;ZNF554;CPSF4;POLR2J2;ALDH1L1;HOXC5;PLB1;FAAP20;PIDD1;CAT;ZNF160;MAPK10;DPP7;MPG;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;UBOX5;CHRM3;ZNF846;APRT;TMX4;TFEB;OGFOD2;MIB2;CERS4;MPI;PEX7;SNX17;LSM14B;ENDOV;JOSD2;PHC1;SCYL3;METTL7A;CSNK1E;TAZ;HGSNAT;BCL6;HSF4;REC8;SAT2;RNF213;GSTM3;TKFC;FBXO25;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;UBXN6;SIRT2;TRPC1;MBOAT2;GDF15;PHLDA2;RECQL5;RAB13;OSBPL1A;TST;GOLGA2;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;ETNK2;NAGA;MTA1;MSH5;ENTPD2;FUK;AP2A2;CIDEA;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;CHD6;RNF170;DHPS;EPHB2;NMRAL1;POLR2J3;INPP4A;PER1;IGF2BP3;ITGA2;FGFR1;DIP2C;PIGV;WFS1;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;SH3PXD2A;CTH;XYLT2;ERBB2;KDELC2;UST;EIF2AK4;STK32B;UNC119;RGS12;SYVN1;PFKL;FRS3;SFI1;MMP17;RPL12;MPPE1;HMBOX1;TTC19;TRIM2;GRB10;TSHZ1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;KCTD13;DBP;APBA1;PEX11A;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;TEAD2;ACOT8;BTBD11;SIX5
2892,GO:0006402,0.999994450797408,1.54989135833798e-05,15,322,mRNA catabolic process,BP,ZFP36L1;RPL13A;CIRBP;PAN2;GTPBP1;PCBP4;AGO4;ERN1;PNRC1;AKT1;IGF2BP2;ZC3H12D;RPL29;IGF2BP3;RPL12
12899,GO:0051276,0.999994545107585,9.07330830800588e-06,82,1046,chromosome organization,BP,ZMYND8;XPC;H1F0;VEGFA;PADI3;DDB2;ERCC1;BAHCC1;NOS1;SMARCA1;RBL2;ASH2L;POLD4;PKN1;H2AFJ;PHF21A;TUBG2;HDAC11;PABPC1L;BRD3;KDM3A;MTHFR;PHF1;RAG1;CHD2;RMI2;FKBP10;INO80C;CHD3;SPC24;SCMH1;SATB1;ING4;HMGA2;JADE2;MAPK3;CHMP1B;TSPYL2;H1FX;ZFPM1;KDM4C;CBX7;TTN;HLCS;JDP2;HDAC5;TEP1;KDM7A;MAP3K12;NDE1;PKIB;L3MBTL1;HLTF;DNMT3A;MLH3;HMG20B;AGO4;TADA3;TERC;MBD1;TNRC18;PHF2;CHMP5;UHRF2;SMARCD2;RPS6KA5;CHMP4C;C6ORF89;MTA3;PHC1;BCL6;HSF4;REC8;LEMD2;SIRT2;RECQL5;MTA1;MSH5;HDAC8;CHD6;PER1;HMBOX1
2902,GO:0006414,0.999995300538632,4.01084319919678e-05,2,126,translational elongation,BP,ABTB1;GTPBP1
14486,GO:0065004,0.999995460177772,1.82179653763594e-05,7,213,protein-DNA complex assembly,BP,XPC;H1F0;DDB2;SOX12;THRA;TSPYL2;H1FX
6267,GO:0019866,0.999995487352486,1.0468889414546e-05,25,450,organelle inner membrane,CC,PRODH;CRAT;HADH;IDH2;CPT2;HMGCL;NDUFA4L2;NME4;NIPSNAP1;SDHA;PDE2A;ERN1;ACAD11;TM7SF2;ACADVL;IFI27;SLC25A29;SMIM20;LETMD1;TAZ;LEMD2;SLC25A42;TST;TTC19;SDHAF4
342,GO:0000956,0.999995912925247,1.78852103571193e-05,6,200,nuclear-transcribed mRNA catabolic process,BP,ZFP36L1;RPL13A;PAN2;PNRC1;RPL29;RPL12
10869,GO:0044427,0.999996410174104,6.64995811142697e-06,54,770,chromosomal part,CC,H1F0;NR1D1;ERCC1;BAHCC1;MEF2D;SMARCA1;RBL2;ASH2L;POLD4;H2AFJ;TRNP1;PHC2;APPL2;KDM3A;PHF1;SALL2;NSMCE4A;INO80C;CHD3;SPC24;SCMH1;SATB1;STAT6;HMGA2;H1FX;KDM4C;CBX7;NSMCE1;HLCS;TEP1;CEBPB;NDE1;L3MBTL1;DNMT3A;MLH3;CALCOCO1;TERC;RXRA;TNRC18;CHEK2;SEPT6;PHF2;UHRF2;CAPN2;SMARCD2;TP73;BCL6;REC8;LEMD2;SIRT2;POLR3GL;MSH5;TCF7;HMBOX1
2861,GO:0006355,0.999996623276809,4.67516983050068e-06,269,2832,regulation of transcription, DNA-templated,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;MDFI;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;SOX12;HDAC11;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IFT57;TSG101;PHF2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
2494,GO:0005743,0.999996856953131,7.85661603561335e-06,21,407,mitochondrial inner membrane,CC,PRODH;CRAT;HADH;IDH2;CPT2;HMGCL;NDUFA4L2;NME4;NIPSNAP1;SDHA;PDE2A;ACAD11;ACADVL;SLC25A29;SMIM20;LETMD1;TAZ;SLC25A42;TST;TTC19;SDHAF4
10888,GO:0044451,0.999997325213446,4.6215836043184e-06,74,974,nucleoplasm part,CC,NFATC4;H1F0;PTK6;OBSCN;NR1D1;ERCC1;BAHCC1;CRTC1;ERCC6;TCEA2;KLHDC2;ASH2L;LHPP;WWTR1;PHF21A;DGKQ;MAML3;PHF7;HDAC11;APPL2;PHF1;SALL2;NSMCE4A;RMI2;INO80C;CHD3;MKNK2;SATB1;ING4;JADE2;RGS14;EIF2D;FLYWCH1;TENM2;PSKH1;HDAC5;SRSF5;CREBRF;ISG20;SMURF2;BHLHE40;HMG20B;AGO4;BNIP3L;NBR1;TADA3;TERC;MBD1;TNRC18;WDR19;CRY2;CHEK2;ZNF217;PIAS3;LMNA;NELFCD;FOXO4;CPSF4;POLR2J2;FAAP20;UBOX5;HSF4;SIRT2;RECQL5;POLR3GL;HDAC8;TCF7;EPAS1;CHD6;POLR2J3;LRCH4;HMBOX1;KCTD13;PLEKHH2
18398,GO:1903506,0.999997444665033,3.54993213663924e-06,270,2849,regulation of nucleic acid-templated transcription,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;MDFI;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;SOX12;HDAC11;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IFT57;TSG101;PHF2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
20185,GO:2001141,0.999997619125689,3.31073110480846e-06,270,2851,regulation of RNA biosynthetic process,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;MDFI;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;SOX12;HDAC11;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IFT57;TSG101;PHF2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
2891,GO:0006401,0.999997818477882,6.14769088232733e-06,16,346,RNA catabolic process,BP,ZFP36L1;RPL13A;CIRBP;PAN2;GTPBP1;PCBP4;ISG20;AGO4;ERN1;PNRC1;AKT1;IGF2BP2;ZC3H12D;RPL29;IGF2BP3;RPL12
8845,GO:0034654,0.999998024615636,2.69753847952762e-06,328,3386,nucleobase-containing compound biosynthetic process,BP,TNIP1;XDH;ZC3H6;HTRA1;F2R;NT5E;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;NAPRT;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;IDH2;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;DHTKD1;TFDP2;MXI1;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;ASH2L;SOX13;LHPP;ETV4;WWTR1;POLD4;MAP2K1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;OGDHL;SOX12;HDAC11;NMRK1;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;NPR2;SALL2;NMNAT2;NME4;ETV1;ZP3;NEIL1;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;PPCS;HES2;EREG;CHD2;TEF;APBB3;RMI2;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;NT5C1B;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;GALK1;TFB1M;SRSF5;VLDLR;ADGRF1;NADK;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;NOS3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;TSG101;PHF2;FGFR4;ZNF217;PIAS3;TCIRG1;ZNF25;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;MPI;TAZ;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;ENTPD2;FUK;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
15452,GO:0071824,0.999998125533338,7.32064719895518e-06,8,237,protein-DNA complex subunit organization,BP,XPC;H1F0;DDB2;SOX12;THRA;TSPYL2;H1FX;SMARCD2
5903,GO:0018130,0.999998253839955,2.38474393313557e-06,333,3435,heterocycle biosynthetic process,BP,TNIP1;XDH;ZC3H6;HTRA1;F2R;NT5E;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;NAPRT;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;IDH2;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;PYCR2;DHTKD1;TFDP2;MXI1;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;ASH2L;SOX13;LHPP;UROS;ETV4;WWTR1;POLD4;MAP2K1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;OGDHL;SOX12;HDAC11;NMRK1;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;NPR2;SALL2;NMNAT2;NME4;ETV1;ZP3;NEIL1;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;PPCS;HES2;EREG;CHD2;TEF;PSAT1;APBB3;RMI2;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;NT5C1B;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;GALK1;TFB1M;PLTP;SRSF5;VLDLR;ADGRF1;NADK;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;NOS3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;TSG101;PHF2;FGFR4;ZNF217;PIAS3;TCIRG1;ZNF25;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;MPI;TAZ;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;ENTPD2;FUK;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
5562,GO:0016579,0.999998295800624,6.30890601350297e-06,9,244,protein deubiquitination,BP,TNIP1;RNF135;DDB2;USP20;INO80C;SMURF2;TADA3;FOXO4;JOSD2
2475,GO:0005694,0.999998942791827,1.93717793492615e-06,63,881,chromosome,CC,H1F0;NR1D1;ERCC1;BAHCC1;MEF2D;SMARCA1;RBL2;ASH2L;POLD4;H2AFJ;TRNP1;PHC2;APPL2;KDM3A;PHF1;SALL2;NEIL1;NSMCE4A;INO80C;CHD3;SPC24;SCMH1;SATB1;STAT6;HMGA2;H1FX;KDM4C;CBX7;NSMCE1;TTN;HLCS;TEP1;CEBPB;NDE1;L3MBTL1;DNMT3A;MLH3;CALCOCO1;HMG20B;TERC;RXRA;MBD1;TNRC18;CHEK2;SEPT6;PHF2;UHRF2;CAPN2;SMARCD2;ADD3;FAAP20;TP73;BCL6;REC8;LEMD2;SIRT2;RECQL5;POLR3GL;MSH5;HDAC8;TCF7;RGS12;HMBOX1
6144,GO:0019438,0.999998972573727,1.41328017948113e-06,331,3432,aromatic compound biosynthetic process,BP,TNIP1;XDH;ZC3H6;HTRA1;F2R;NT5E;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;NAPRT;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;IDH2;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;DHTKD1;TFDP2;MXI1;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;ASH2L;SOX13;LHPP;UROS;ETV4;WWTR1;POLD4;MAP2K1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;OGDHL;SOX12;HDAC11;NMRK1;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;NPR2;SALL2;NMNAT2;NME4;ETV1;ZP3;NEIL1;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;PPCS;HES2;EREG;CHD2;TEF;PSAT1;APBB3;RMI2;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;NT5C1B;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;GALK1;TFB1M;SRSF5;VLDLR;ADGRF1;NADK;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;NOS3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;TSG101;PHF2;FGFR4;ZNF217;PIAS3;TCIRG1;ZNF25;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;MPI;TAZ;BCL6;HSF4;LEMD2;SIRT2;TRPC1;GDF15;RECQL5;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;ENTPD2;FUK;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
18316,GO:1903311,0.999999065355265,3.54966666579314e-06,9,250,regulation of mRNA metabolic process,BP,ZFP36L1;CIRBP;GTPBP1;PCBP4;AKT1;IGF2BP2;CPSF4;ZC3H12D;IGF2BP3
10377,GO:0043226,0.999999102120522,1.25924858223892e-06,1084,9768,organelle,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;APOE;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;VWA5A;ALDH7A1;TYSND1;POSTN;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;THSD4;NAPRT;EDEM1;CRAT;GLUL;FAM210B;GPX3;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;DDB2;D2HGDH;PRNP;ZDHHC1;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;ZKSCAN1;SPTB;NPEPL1;LOXL1;TSPAN1;SLC16A3;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;ACAD10;PGM1;CRTC1;CLCA2;PACS2;ADGRB2;ERCC6;NDRG1;GGT1;ADAMTS13;FCGBP;ABTB1;TCEA2;PLEKHH1;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;ARMCX2;HEBP1;TRIM65;ZFP36L1;ADARB1;PPM1M;SYT8;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;PYCR2;CNTN1;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;LTBP4;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;PLD3;KLHDC2;ASH2L;SOX13;CUL7;LHPP;TMEM92;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;MPRIP;NAGLU;OXLD1;ETV4;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;COL6A1;PPL;SDCCAG8;CRYL1;ABCA2;PKN1;PGLS;CAPG;DDIT4;H2AFJ;LPCAT4;BTG1;TOM1L2;TRNP1;DNASE1L1;SYNGAP1;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;MAGEF1;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;NPHP4;VEGFB;R3HDM2;MARCKSL1;OGDHL;SOX12;HDAC11;RAB3B;CD68;PCSK1;PLEKHH3;PTMS;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;APPL2;PRSS8;CIRBP;CAPRIN2;TPM2;TTBK2;LY6K;PRKCZ;PPP2R3B;GALE;SERPING1;PAK1;ABCA7;ANKS6;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;PABPC1L;B4GALNT4;ERO1B;BLVRB;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;BRI3;FOXQ1;ARVCF;PHF1;GLDC;NDUFA4L2;TMEM44;CBS;TMEM187;USP20;SALL2;SYNE3;DLG3;ITGB4;NMNAT2;DDX59;WDR27;MICALL2;NME4;PDZD2;CEP250;FBXW8;ETV1;NSUN5P2;NEIL1;SHROOM4;ABHD14B;NEURL1;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;MARCH4;NID1;ETV5;ETFB;GSTO1;WDR60;LTBP1;MUC19;SYNC;PPCS;SMIM14;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;CHD2;GPT2;TEF;TNS1;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;OLFM2;DHRS4;CCDC106;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;OAF;MANF;S100A13;GSTT1;AGAP1;FKBP10;MTMR4;C5;KIF17;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;ANO1;SNX29;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;SCMH1;TCF25;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;R3HDM4;SH3TC2;ING4;NUDCD3;ACOT11;VAMP2;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;PCLO;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;PC;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;SEMA5A;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;SCARA3;RGS14;IRF2BPL;DNAL4;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;LTBP2;ADAMTSL1;SNTA1;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;ZXDC;PQLC2;KIAA0319L;SDC2;CHMP1B;NRSN2;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;TCTN1;PTPDC1;C1RL;PLCD1;ARHGEF2;SEPT10;MTMR11;FBF1;INPP5D;PDCD1LG2;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;STMN3;SLC50A1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;DMTN;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;MORN4;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;SSH1;LRRC45;LTB4R2;SV2A;FAM214B;SLC38A10;PRIMPOL;FAM193B;FRMD4B;RABGAP1;POLM;ACAP3;TENM2;MYH16;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;RALGAPA1;FLOT1;LTBP3;CEP68;TTN;PSKH1;HLCS;KCNMA1;AZIN2;HSD11B1;JDP2;HDAC5;WHAMMP3;IRF5;SORL1;MAP6;GALK1;TFB1M;NTPCR;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;GPRC5C;DHX32;DEAF1;TEP1;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;CEBPB;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;TSTD1;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;METTL23;AQP3;ACADS;CEP131;ISG20;LONP2;EPN3;MARK3;DGCR6L;HLTF;DNMT3A;TRIOBP;TRPV4;MXD3;TAGLN3;FOXL1;DIRC2;CSRNP3;TTC12;ITGA1;TMSB4X;SLFN5;MAP1LC3A;APOL4;HSD17B7;PDE2A;SMURF2;LMO7;TRIB3;RAB40B;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;MARCH2;BNIP3L;PIK3R2;RHBDF2;NICN1;ZNF558;RPUSD3;ANGEL1;ZNF662;SHARPIN;CCS;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ESRG;ALKBH7;CROCC;BCR;MAPRE3;ATP7B;FYCO1;MAN2C1;C19ORF33;CEP112;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;BCAM;TADA3;NBEAL2;BOLA1;KIF13B;SPAG16;TTYH3;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;PRDM8;SLC9A3R2;EFEMP2;STRADB;CTSH;WDR19;ACOX3;ACAD11;PNRC1;TMEM80;CCDC15;UACA;GSDMC;MGMT;GSTO2;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;MICAL1;SWT1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;GAREM2;IFT57;LACTB2;PHYKPL;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;TTC21A;CAPS;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;KIF27;FMNL3;PHF2;FGFR4;IGF2BP2;TMEM256;RASSF9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;ZNF25;FARP1;DNASE2;LMNA;FAAH;UPP1;MAB21L2;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;ARMC9;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;FOXO4;GNAL;COG7;YPEL3;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;SMIM20;TPCN1;ULBP1;ADD3;MBLAC2;MAGED2;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;ASIC1;ALDH1L1;HOXC5;GJB4;FAAP20;PIDD1;CAT;ZNF160;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;UNC119B;TIMP1;HFE;JAK3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;ZNF846;APRT;FCHSD1;TMX4;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;ENDOV;PHC1;SCYL3;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;RABAC1;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;SLC37A4;EHD3;RPL39L;FYN;ZC3H12D;EML3;ATP8B2;PJA2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;SLC25A42;SIRT2;MBOAT2;GDF15;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;FAM220A;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;CADM4;POU2F2;RCOR2;POLR3GL;RHOBTB3;NAGA;MTA1;RTN2;MSH5;ENTPD2;AP2A2;CIDEA;EPS8L2;HDAC8;MYO18A;ADIRF;RPL29;ERV3-1;RETSAT;TGFBR3;CIDEB;TCF7;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;TBC1D16;MFNG;CHD6;RNF170;LURAP1;EPHB2;NMRAL1;MAGI1;POLR2J3;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;SPATA6;SH3PXD2A;CTH;XYLT2;ERBB2;SEC31B;PLLP;KDELC2;UST;EIF2AK4;UNC119;CCDC69;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;SFI1;RPL12;MPPE1;HMBOX1;NET1;TTC19;TSHZ1;TNNI1;CREB3L4;ZNF449;IRF2BP2;BSG;ZMYM3;LYPLAL1;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTD1;KDSR;IKBKB;DMTF1;SNCB;HIP1;CYP4V2;PLEKHH2;ROBO4;TEAD2;ACOT8;TCTEX1D4;SIX5
15405,GO:0071704,0.999999167512064,1.11139340605022e-06,852,7918,organic substance metabolic process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;NYNRIN;APOE;BTBD2;ZMYND8;NFATC4;XPC;SERPINE2;GID4;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;ALDH7A1;TYSND1;PPP1R35;SLC2A3;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;THSD4;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;GJC2;LRP1;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;NEK9;RAPGEF3;BPHL;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;DGKA;SLC16A3;RNPEPL1;IGFBP4;CD9;SLC2A9;IDH2;FKBP9;CRTAP;CST3;DNM1;MEF2D;NOS1;DDIT3;TSC22D1;BRSK1;DNPH1;DNAJB5;ACAD10;PGM1;CRTC1;CLCA2;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;MMP28;GRAMD4;SMARCA1;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;RPS6KA2;GAA;PYGL;MMP1;PYCR2;CTF1;CNTN1;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;RPL13A;MSRB2;OBSL1;MDFI;TK2;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;KLF9;RNF165;MIF4GD;CDK18;NISCH;PHACTR3;CPT2;MLYCD;FBXW4;PLD3;ASH2L;SOX13;CUL7;PITPNM3;LHPP;PRSS3;HMGCL;UROS;HYAL1;NAGLU;PPP1R14A;ETV4;WWTR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;CCDC71L;CRYL1;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;OGDHL;SOX12;HDAC11;RAB3B;PCSK1;PTMS;UNK;NMRK1;PRSS8;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;GALE;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;PHYH;ELK3;STK39;PABPC1L;ERO1B;BLVRB;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;KLHL29;PHF1;GLDC;NPR2;PLCXD1;CAPNS2;CBS;SPRY4;USP20;SALL2;DLG3;NMNAT2;DDX59;NME4;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;MARCH4;ETV5;ETFB;GSTO1;LCE1E;LTBP1;MUC19;PPCS;NSMCE4A;TRIB2;HES2;EREG;CHD2;GPT2;TEF;PSAT1;APBB3;PTPRE;PNPLA3;RNF44;SSH3;RMI2;PLCD3;DHRS4;PSPH;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;PPM1J;ABCG1;ESYT2;TRAPPC9;CARF;LPAR3;GSTT1;CARS;FKBP10;MTMR4;C5;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;PPP1R3E;ING4;ACOT11;RRNAD1;HMGA2;AREG;ST6GALNAC6;SLIT3;ECM1;B4GAT1;MARCH9;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;LAMB2;PC;FBXO27;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;RGS14;MVD;IRF2BPL;FAM20C;TDRKH;PBXIP1;CNTRL;ADAMTSL1;SNTA1;PAN2;CTSB;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;ZXDC;SDC2;FBXO17;ARHGAP22;MLXIPL;PTPDC1;C1RL;PLCD1;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;HIBADH;SLC50A1;PGPEP1;SDHA;LRSAM1;DMTN;KLHL24;LITAF;ANGPTL4;PTHLH;UBXN4;ATF4;ZFPM1;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;SSH1;LTB4R2;PCMTD2;PRIMPOL;POLM;TENM2;FBXO6;IFI6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;FLOT1;MDK;TTN;PSKH1;HLCS;AZIN2;HSD11B1;JDP2;HDAC5;GTPBP1;IRF5;SORL1;GALK1;TFB1M;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;PAPLN;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;CES2;NLRP1;PEG3;ACY1;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;WNK4;ATRAID;ALDOC;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;ACADS;FBXL16;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;MOCOS;APOL4;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;RPUSD3;ZNF662;SHARPIN;GAS6;GLUD1;DNAJC6;SUCLG2;ERN1;ALKBH7;BCR;KLHDC8B;MAPRE3;MAN2C1;CHKB;NBR1;CPT1C;EXD3;HEXA;TNNI2;SRR;TADA3;BOLA1;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;THNSL2;PRDM8;STRADB;CTSH;ACOX3;ACAD11;PNRC1;FBXL8;MGMT;GSTO2;ASNS;ENTPD6;TM7SF2;PAIP2B;LCE1F;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;CARD11;DGUOK;CDKN1C;MICAL1;SWT1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;LACTB2;PHYKPL;WDR45;IGFBP2;ASS1;SPDYE2;SPDYE2B;NFU1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;HAGH;CBR4;PHLDA1;ACADVL;SLC6A6;ZNF25;DNASE2;FAAH;UPP1;SPSB3;WDFY2;C9ORF72;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;SMARCD2;SPATA18;MARK4;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;NCOA7;NELFCD;TENM4;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;ZNF554;CPSF4;POLR2J2;ALDH1L1;HOXC5;PLB1;FAAP20;PIDD1;CAT;ZNF160;MAPK10;DPP7;MPG;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;UBOX5;CHRM3;ZNF846;APRT;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;LSM14B;ENDOV;JOSD2;PHC1;SCYL3;CSNK1E;TAZ;HGSNAT;BCL6;HSF4;REC8;SAT2;RNF213;GSTM3;TKFC;FBXO25;SLC37A4;EHD3;RPL39L;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;UBXN6;SIRT2;TRPC1;MBOAT2;GDF15;PHLDA2;RECQL5;RAB13;OSBPL1A;TST;GOLGA2;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;ETNK2;NAGA;MTA1;MSH5;ENTPD2;FUK;AP2A2;CIDEA;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;CHD6;RNF170;DHPS;EPHB2;NMRAL1;POLR2J3;INPP4A;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;CTH;XYLT2;ERBB2;KDELC2;UST;EIF2AK4;STK32B;UNC119;RGS12;SYVN1;PFKL;FRS3;MMP17;RPL12;MPPE1;HMBOX1;TRIM2;TSHZ1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;KCTD13;DBP;APBA1;PEX11A;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;TEAD2;ACOT8;BTBD11;SIX5
2559,GO:0005840,0.999999376847671,2.98207900720891e-06,6,225,ribosome,CC,RPL13A;EIF2D;RPL39L;RPL29;EIF2AK4;RPL12
2869,GO:0006364,0.999999594727074,1.69014849101409e-06,8,255,rRNA processing,BP,RPL13A;NSUN5P2;RRNAD1;TFB1M;ISG20;CSNK1E;RPL29;RPL12
14843,GO:0070646,0.999999601804527,1.56595559025899e-06,9,259,protein modification by small protein removal,BP,TNIP1;RNF135;DDB2;USP20;INO80C;SMURF2;TADA3;FOXO4;JOSD2
10889,GO:0044452,0.999999668690585,2.51861564372475e-06,3,163,nucleolar part,CC,INO80C;PAK6;DEAF1
7308,GO:0031326,0.999999797245335,2.85611251425288e-07,318,3354,regulation of cellular biosynthetic process,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;ACP5;WWC3;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;HBEGF;RBL2;TFDP2;MXI1;RPL13A;MSRB2;MDFI;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;CYP27B1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;ABCA7;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;TRIB2;HES2;EREG;CHD2;TEF;APBB3;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ECM1;MAPK3;ERRFI1;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;VLDLR;ADGRF1;GABBR1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;PAIP2B;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IFT57;ASS1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ACADVL;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;LSM14B;TAZ;BCL6;HSF4;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;EIF4EBP1;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FITM2;FKBP8;CTH;ERBB2;EIF2AK4;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;SIX5
2485,GO:0005730,0.999999804119253,3.84043468806305e-07,56,836,nucleolus,CC,DOCK4;XPC;ERCC6;ABTB1;ADARB1;RBL2;MXI1;RPL13A;MIF4GD;CPT2;ETV4;POLD4;CAPG;ARL2;ITPR3;CIRBP;DDX59;NSUN5P2;ABHD14B;CHD2;SPG11;CARF;S100A13;FKBP10;INO80C;CHD3;SPC24;CTSB;TSPYL2;H1FX;SDHA;PAK6;SRSF5;DEAF1;KDM7A;ISG20;HLTF;CDK5RAP3;LDOC1;HINT2;TSG101;PHF2;PHLDA1;ACADVL;COG7;YPEL3;MAGED2;C6ORF89;ZNF554;GJB4;ENDOV;RNF213;SIRT2;FGFR1;RGS12;DTD1
2857,GO:0006351,0.999999829068958,2.45262335336581e-07,276,2977,transcription, DNA-templated,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;MDFI;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;SOX12;HDAC11;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;SRSF5;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;CDKN1C;SWT1;CRY2;CHEK2;IFT57;TSG101;PHF2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
16841,GO:0098798,0.999999846061647,8.7387785410909e-07,5,218,mitochondrial protein complex,CC,NDUFA4L2;SDHA;SUCLG2;ANKZF1;SDHAF4
16675,GO:0097659,0.999999856718411,2.05935547110196e-07,277,2991,nucleic acid-templated transcription,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;MDFI;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;SOX12;HDAC11;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;SRSF5;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;CDKN1C;SWT1;CRY2;CHEK2;IFT57;TSG101;PHF2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
8080,GO:0032774,0.999999861074805,1.99660648359676e-07,278,3001,RNA biosynthetic process,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;MDFI;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;SOX12;HDAC11;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;PRIMPOL;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;SRSF5;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;CDKN1C;SWT1;CRY2;CHEK2;IFT57;TSG101;PHF2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
4333,GO:0009889,0.999999878804544,1.71548807748857e-07,322,3404,regulation of biosynthetic process,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;ACP5;WWC3;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;HBEGF;RBL2;TFDP2;MXI1;RPL13A;MSRB2;MDFI;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;CYP27B1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;ABCA7;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;TRIB2;HES2;EREG;CHD2;TEF;APBB3;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ECM1;ACACB;MAPK3;ERRFI1;THRA;RGS14;MVD;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;VLDLR;ADGRF1;GABBR1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;TM7SF2;PAIP2B;AKT1;IGFBP7;CARD11;CDKN1C;CRY2;CHEK2;IFT57;ASS1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ACADVL;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;LSM14B;TAZ;BCL6;HSF4;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;EIF4EBP1;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FITM2;FKBP8;CTH;ERBB2;EIF2AK4;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;SIX5
10764,GO:0044238,0.999999897821752,1.39185355731423e-07,819,7704,primary metabolic process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;DLG4;ZC3H6;HTRA1;GAMT;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;NYNRIN;APOE;BTBD2;ZMYND8;NFATC4;XPC;SERPINE2;GID4;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;ALDH7A1;TYSND1;PPP1R35;SLC2A3;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;CDC42EP5;THSD4;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;GJC2;LRP1;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;PRDX5;BAHCC1;TFPI2;DUSP5;NEK9;RAPGEF3;BPHL;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;DGKA;RNPEPL1;IGFBP4;IDH2;FKBP9;CRTAP;CST3;MEF2D;NOS1;DDIT3;TSC22D1;BRSK1;DNPH1;DNAJB5;ACAD10;PGM1;CRTC1;CLCA2;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;MMP28;GRAMD4;SMARCA1;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;RPS6KA2;GAA;PYGL;MMP1;PYCR2;CTF1;CNTN1;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;RPL13A;MSRB2;OBSL1;MDFI;TK2;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;KLF9;RNF165;MIF4GD;CDK18;NISCH;PHACTR3;CPT2;MLYCD;FBXW4;PLD3;ASH2L;SOX13;CUL7;PITPNM3;LHPP;PRSS3;HMGCL;HYAL1;PPP1R14A;ETV4;WWTR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;CCDC71L;CRYL1;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;ALPK1;LPCAT4;BTG1;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;OGDHL;SOX12;HDAC11;RAB3B;PCSK1;PTMS;UNK;NMRK1;PRSS8;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;GALE;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;PHYH;ELK3;STK39;PABPC1L;ERO1B;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;KLHL29;PHF1;GLDC;NPR2;PLCXD1;CAPNS2;CBS;SPRY4;USP20;SALL2;DLG3;NMNAT2;DDX59;NME4;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;MARCH4;ETV5;ETFB;GSTO1;LCE1E;LTBP1;MUC19;PPCS;NSMCE4A;TRIB2;HES2;EREG;CHD2;GPT2;TEF;PSAT1;APBB3;PTPRE;PNPLA3;RNF44;SSH3;RMI2;PLCD3;DHRS4;PSPH;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;PPM1J;ABCG1;ESYT2;TRAPPC9;CARF;LPAR3;CARS;FKBP10;MTMR4;C5;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;PPP1R3E;ING4;ACOT11;RRNAD1;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;MARCH9;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;LAMB2;PC;FBXO27;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;RGS14;MVD;IRF2BPL;FAM20C;TDRKH;PBXIP1;CNTRL;ADAMTSL1;SNTA1;PAN2;CTSB;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;ZXDC;SDC2;FBXO17;ARHGAP22;MLXIPL;PTPDC1;C1RL;PLCD1;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;HIBADH;PGPEP1;SDHA;LRSAM1;DMTN;KLHL24;LITAF;ANGPTL4;PTHLH;UBXN4;ATF4;ZFPM1;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;SSH1;LTB4R2;PCMTD2;PRIMPOL;POLM;TENM2;FBXO6;IFI6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;FLOT1;MDK;TTN;PSKH1;HLCS;AZIN2;HSD11B1;JDP2;HDAC5;GTPBP1;IRF5;SORL1;GALK1;TFB1M;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;PAPLN;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;CES2;NLRP1;PEG3;ACY1;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;WNK4;ATRAID;ALDOC;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;ACADS;FBXL16;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;MOCOS;APOL4;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;RPUSD3;ZNF662;SHARPIN;GAS6;GLUD1;DNAJC6;SUCLG2;ERN1;ALKBH7;BCR;KLHDC8B;MAPRE3;MAN2C1;CHKB;NBR1;CPT1C;EXD3;HEXA;TNNI2;SRR;TADA3;BOLA1;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;THNSL2;PRDM8;STRADB;CTSH;ACOX3;ACAD11;PNRC1;FBXL8;MGMT;GSTO2;ASNS;ENTPD6;TM7SF2;PAIP2B;LCE1F;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;CARD11;DGUOK;CDKN1C;MICAL1;SWT1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;LACTB2;PHYKPL;WDR45;IGFBP2;ASS1;SPDYE2;SPDYE2B;NFU1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;CBR4;PHLDA1;ACADVL;SLC6A6;ZNF25;DNASE2;FAAH;UPP1;SPSB3;WDFY2;C9ORF72;UHRF2;ARSA;CAPN2;MAN2B1;SMARCD2;SPATA18;MARK4;IFI27;PTOV1;PLAU;INSR;ACSS1;NCOA7;NELFCD;TENM4;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;PLB1;FAAP20;PIDD1;CAT;ZNF160;MAPK10;DPP7;MPG;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;UBOX5;CHRM3;ZNF846;APRT;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;LSM14B;ENDOV;JOSD2;PHC1;SCYL3;CSNK1E;TAZ;BCL6;HSF4;REC8;RNF213;TKFC;FBXO25;SLC37A4;RPL39L;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;UBXN6;SIRT2;MBOAT2;GDF15;PHLDA2;RECQL5;RAB13;OSBPL1A;GOLGA2;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;ETNK2;NAGA;MTA1;MSH5;ENTPD2;FUK;AP2A2;CIDEA;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;EPAS1;LAMTOR2;MAP3K10;MFNG;STARD10;CHD6;RNF170;DHPS;EPHB2;POLR2J3;INPP4A;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;CTH;XYLT2;ERBB2;KDELC2;UST;EIF2AK4;STK32B;UNC119;RGS12;SYVN1;PFKL;FRS3;MMP17;RPL12;MPPE1;HMBOX1;TRIM2;TSHZ1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;ZMYM3;LYPLAL1;NUDT18;KCTD13;DBP;PEX11A;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;PLEKHA4;HIP1;CYP4V2;TEAD2;ACOT8;BTBD11;SIX5
12882,GO:0051252,0.999999954701743,6.60118177940974e-08,278,3026,regulation of RNA metabolic process,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;MDFI;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;SOX12;HDAC11;CIRBP;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ECM1;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;GTPBP1;IRF5;TFB1M;PCBP4;SRSF5;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IFT57;TSG101;PHF2;IGF2BP2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;BCL6;HSF4;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;PER1;IGF2BP3;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
2464,GO:0005681,0.999999955940699,3.6993386490361e-07,3,181,spliceosomal complex,CC,DHX32;TEP1;MAPKBP1
17667,GO:1901576,0.999999964175327,4.96165971224272e-08,484,4895,organic substance biosynthetic process,BP,TNIP1;XDH;ZC3H6;HTRA1;GAMT;F2R;ST6GALNAC2;NT5E;ISYNA1;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;LMF1;ALDH7A1;ZNF862;WWC3;NAPRT;GLUL;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;ZSCAN18;RBCK1;PRNP;ZDHHC1;NR1D1;ADAMTS7;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;DGKA;IDH2;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;SMARCA1;ZFP36L1;NUPR1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;PYGL;PYCR2;DHTKD1;TFDP2;MXI1;HSD17B14;RPL13A;MSRB2;MDFI;TK2;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;MLYCD;ASH2L;SOX13;PITPNM3;LHPP;HMGCL;UROS;HYAL1;ETV4;WWTR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;CRYL1;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;OPLAH;LPCAT4;BTG1;TRNP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;VEGFB;OGDHL;SOX12;HDAC11;PCSK1;PTMS;UNK;NMRK1;CIRBP;CAPRIN2;LY6K;PRKCZ;ABCA7;AARS;ELK3;PABPC1L;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;FOXQ1;PHF1;NPR2;CBS;SALL2;NMNAT2;NME4;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;GSTO1;MUC19;PPCS;TRIB2;HES2;EREG;CHD2;GPT2;TEF;PSAT1;APBB3;PNPLA3;RMI2;PSPH;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;GSTT1;CARS;MTMR4;PPARA;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;ACACB;NT5C1B;MAPK3;CSPG4;PC;ERRFI1;THRA;VANGL2;ACSS2;RGS14;MVD;IRF2BPL;PBXIP1;ADAMTSL1;ZSCAN30;EIF2D;MAPK12;LTA4H;PI4K2A;NAT14;ZXDC;SDC2;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;LITAF;PTHLH;ATF4;ZFPM1;CHST6;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;AZIN2;HSD11B1;JDP2;HDAC5;GTPBP1;IRF5;GALK1;TFB1M;PLTP;SRSF5;GSTM2;VLDLR;ADGRF1;NADK;GABBR1;DEAF1;TEP1;ST3GAL3;PEG3;GLI4;RFX2;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;HSD17B7;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;PIGZ;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;GLUD1;ERN1;MAPRE3;CHKB;HEXA;TNNI2;SRR;TADA3;BOLA1;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;THNSL2;PRDM8;PNRC1;GSTO2;ASNS;TM7SF2;PAIP2B;HINT2;AKT1;IGFBP7;CARD11;DGUOK;CDKN1C;SWT1;CRY2;B4GALT2;CHEK2;IFT57;WDR45;ASS1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;HAGH;CBR4;PHLDA1;ACADVL;ZNF25;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;ACSS1;NCOA7;NELFCD;FOXO4;COG7;RPS6KA5;PIGQ;MAP2K5;ZDHHC24;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;CERS4;MPI;PEX7;LSM14B;TAZ;BCL6;HSF4;GSTM3;SLC37A4;RPL39L;ZC3H12D;LEMD2;SIRT2;TRPC1;MBOAT2;GDF15;RECQL5;OSBPL1A;GOLGA2;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;ETNK2;MTA1;ENTPD2;FUK;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;TGFBR3;TCF7;PLPP6;MAN1B1;EPAS1;MAP3K10;MFNG;STARD10;CHD6;DHPS;NMRAL1;POLR2J3;INPP4A;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;FITM2;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;RGS12;SYVN1;PFKL;RPL12;MPPE1;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;KCTD13;DBP;ZNF667;ZNF287;DTD1;KDSR;IKBKB;NTM;DMTF1;PLEKHA4;HIP1;TEAD2;ACOT8;SIX5
17984,GO:1902494,0.999999965575195,6.17283782212499e-08,90,1229,catalytic complex,CC,BTBD2;FBXO2;RBCK1;DDB2;ERCC1;ABTB1;SMARCA1;CUL9;DHTKD1;FBXW4;ASH2L;CUL7;POLD4;ABCA2;PHC2;PHF21A;DNAH1;ULK1;OGDHL;HDAC11;APPL2;PPP2R3B;ABCA7;KLHL29;PHF1;GLDC;SALL2;ZSWIM4;FBXW8;WDR60;NSMCE4A;INO80C;CHD3;SESN2;ING4;NUDCD3;JADE2;FBXO27;DCAF10;DNAL4;FBXO17;SDHA;KLHL24;FBXO6;CBX7;NSMCE1;HDAC5;GTPBP1;TEP1;FBXL15;TGFBR2;SMURF2;LMO7;AGO4;PIK3R2;SHARPIN;SUCLG2;ERN1;KLHDC8B;TADA3;TERC;PPP1R15A;MAPKBP1;ZNF217;CBR4;SPSB3;C9ORF72;SMARCD2;INSR;GNAL;RABGGTA;PIGQ;POLR2J2;MIB2;PHC1;ATP12A;FBXO25;RECQL5;POLR3GL;HDAC8;CHD6;POLR2J3;PIGV;WFS1;SYVN1;PFKL;SDHAF4;KCTD13;IKBKB;BTBD11
10763,GO:0044237,0.999999966310924,4.65671194896941e-08,839,7899,cellular metabolic process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;DLG4;ZC3H6;HTRA1;GAMT;F2R;ST6GALNAC2;NT5E;TNFRSF6B;ISYNA1;NYNRIN;APOE;BTBD2;ZMYND8;NFATC4;XPC;SERPINE2;GID4;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;ALDH7A1;TYSND1;PPP1R35;SLC2A3;FBXO2;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;AIG1;GPX3;GJC2;LRP1;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;PRDX5;BAHCC1;TFPI2;DUSP5;NEK9;RAPGEF3;BPHL;TNFSF15;ZKSCAN1;SPTB;LOXL1;DGKA;SLC16A3;RNPEPL1;IGFBP4;CD9;SLC2A9;IDH2;FKBP9;CRTAP;CST3;DNM1;MEF2D;NOS1;GPSM1;DDIT3;TSC22D1;BRSK1;DNPH1;DNAJB5;ACAD10;PGM1;CRTC1;PACS2;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;GRAMD4;SMARCA1;MST1R;ARRDC1;TRIM65;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;RPS6KA2;GAA;PYGL;MMP1;PYCR2;CTF1;CNTN1;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;RPL13A;MSRB2;OBSL1;MDFI;TK2;PLAT;ULK2;SLC27A1;CTSF;MAPK13;KLF9;RNF165;MIF4GD;CDK18;PHACTR3;CPT2;MLYCD;FBXW4;ASH2L;SOX13;CUL7;PITPNM3;LHPP;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;PPP1R14A;ETV4;TXNRD3;WWTR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;CCDC71L;CRYL1;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TRNP1;SHC2;PLCH2;DNASE1L1;SYNGAP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;OGDHL;SOX12;HDAC11;RAB3B;PCSK1;PTMS;UNK;NMRK1;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;PHYH;ELK3;STK39;PABPC1L;ERO1B;BLVRB;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;KLHL29;PHF1;GLDC;NPR2;NDUFA4L2;CBS;SPRY4;USP20;SALL2;DLG3;ITGB4;NMNAT2;DDX59;NME4;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;MARCH4;ETV5;ETFB;GSTO1;LCE1E;LTBP1;MUC19;PPCS;NSMCE4A;TRIB2;HES2;EREG;CHD2;GPT2;TEF;PSAT1;APBB3;PTPRE;PNPLA3;RNF44;SSH3;RMI2;PLCD3;DHRS4;PSPH;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;PPM1J;ABCG1;ESYT2;TRAPPC9;CARF;LPAR3;GSTT1;CARS;FKBP10;MTMR4;C5;APOBEC3F;ACOT1;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;PPP1R3E;ING4;ACOT11;RRNAD1;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;MARCH9;PI4KAP1;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;LAMB2;PC;FBXO27;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;RGS14;MVD;IRF2BPL;FAM20C;TDRKH;PBXIP1;CNTRL;ADAMTSL1;SNTA1;PAN2;CTSB;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;ZXDC;SDC2;FBXO17;ARHGAP22;MLXIPL;TBC1D14;PTPDC1;PLCD1;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;HIBADH;SDHA;TECPR1;LRSAM1;DMTN;KLHL24;LITAF;PTHLH;UBXN4;ATF4;ZFPM1;CHST6;BBC3;KDM4C;PAK6;ZNF467;SSH1;LTB4R2;PCMTD2;PRIMPOL;POLM;TENM2;FBXO6;IFI6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;FLOT1;MDK;TTN;PSKH1;HLCS;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;SORL1;GALK1;TFB1M;NTPCR;PCBP4;IL17RD;HERPUD1;PLTP;SRSF5;GSTM2;VLDLR;PAPLN;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;CES2;NLRP1;PEG3;ACY1;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;TSTD1;WNK4;ATRAID;ALDOC;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;ACADS;FBXL16;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;MAP1LC3A;MOCOS;HSD17B7;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;PIGZ;HEXB;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;TRPV1;MARCH2;PIP5KL1;BNIP3L;PIK3R2;EPHA1;ZNF558;RPUSD3;ZNF662;SHARPIN;CCS;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;ALKBH7;BCR;KLHDC8B;MAPRE3;FYCO1;MAN2C1;CHKB;NBR1;CPT1C;EXD3;HEXA;TNNI2;SRR;TADA3;BOLA1;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;THNSL2;PRDM8;STRADB;CTSH;ACOX3;ACAD11;PNRC1;FBXL8;MGMT;GSTO2;ASNS;ENTPD6;PAIP2B;LCE1F;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;CARD11;DGUOK;CDKN1C;MICAL1;SWT1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;LACTB2;PHYKPL;WDR45;IGFBP2;ASS1;SPDYE2;SPDYE2B;NFU1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;HAGH;CBR4;PHLDA1;ACADVL;SLC6A6;ZNF25;FARP1;DNASE2;FAAH;UPP1;SPSB3;ATG2A;WDFY2;C9ORF72;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;SMARCD2;SPATA18;MARK4;IFI27;PTOV1;INSR;ACSS1;NCOA7;NELFCD;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TPCN1;RABGGTA;TXNRD2;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;ZNF554;CPSF4;POLR2J2;ALDH1L1;HOXC5;PLB1;FAAP20;PIDD1;CAT;ZNF160;MAPK10;MPG;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;UBOX5;CHRM3;ZNF846;APRT;TFEB;MIB2;CERS4;MPI;PEX7;LSM14B;ENDOV;JOSD2;PHC1;SCYL3;CSNK1E;TAZ;BCL6;HSF4;REC8;SAT2;RNF213;GSTM3;TKFC;FBXO25;EHD3;RPL39L;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;UBXN6;SIRT2;TRPC1;MBOAT2;GDF15;PHLDA2;RECQL5;RAB13;OSBPL1A;TST;GOLGA2;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;ETNK2;NAGA;MTA1;MSH5;ENTPD2;FUK;AP2A2;CIDEA;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;RETSAT;TGFBR3;CIDEB;TCF7;PLPP6;RNPEP;VAV3;MAN1B1;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;STARD10;CHD6;RNF170;DHPS;EPHB2;NMRAL1;POLR2J3;INPP4A;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;SH3PXD2A;CTH;XYLT2;ERBB2;KDELC2;UST;EIF2AK4;STK32B;UNC119;RGS12;SYVN1;PFKL;FRS3;SFI1;RPL12;MPPE1;HMBOX1;TRIM2;GRB10;TSHZ1;CREB3L4;ZNF449;IRF2BP2;KCTD11;BSG;ZMYM3;LYPLAL1;NUDT18;SDHAF4;KCTD13;DBP;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;PLEKHA4;HIP1;CYP4V2;TEAD2;ACOT8;BTBD11;SIX5
15944,GO:0080090,0.999999966394563,4.68664429922052e-08,442,4506,regulation of primary metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;ZC3H6;HTRA1;F2R;TNFRSF6B;APOE;BTBD2;ZMYND8;NFATC4;SERPINE2;FOS;GSN;CITED4;EGR1;CTNNBIP1;LMF1;TYSND1;PPP1R35;FBXO2;ZNF862;PTK6;WWC3;EDEM1;GJC2;LRP1;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;BAHCC1;TFPI2;DUSP5;RAPGEF3;TNFSF15;ZKSCAN1;IGFBP4;CRTAP;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;ABTB1;TCEA2;GRAMD4;SMARCA1;MST1R;ZFP36L1;ADARB1;NUPR1;B3GAT3;TCFL5;HBEGF;RBL2;CTF1;CNTN1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;PLAT;LTBP4;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;PHACTR3;CPT2;MLYCD;ASH2L;SOX13;PPP1R14A;ETV4;WWTR1;MAP2K1;CYP27B1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;SHC2;SYNGAP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;SHC1;VPS11;SPRY2;GRB7;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;PHF1;SPRY4;SALL2;DLG3;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;EAPP;NGFR;ELFN2;ETV5;TRIB2;HES2;EREG;CHD2;TEF;APBB3;TNFRSF25;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;LPAR3;MTMR4;C5;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ECM1;ACACB;MAPK3;CSPG4;TRPT1;ERRFI1;THRA;STK40;VANGL2;RGS14;MVD;IRF2BPL;PBXIP1;SNTA1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;DMTN;LITAF;ANGPTL4;PTHLH;ATF4;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;SSH1;LTB4R2;TENM2;IFI6;ZNF516;CBX7;PKD1;FLOT1;MDK;TTN;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;HERPUD1;SRSF5;VLDLR;PAPLN;ADGRF1;GABBR1;DEAF1;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;RHBDF1;LRP5;ATRAID;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;LONP2;HLTF;DNMT3A;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;PIK3R2;EPHA1;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;NBR1;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;STRADB;CTSH;PNRC1;MGMT;TM7SF2;PAIP2B;HINT2;AKT1;IGFBP7;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;IFT57;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ACADVL;ZNF25;WDFY2;C9ORF72;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;ZNF554;CPSF4;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;ZNF846;TFEB;LSM14B;CSNK1E;TAZ;BCL6;HSF4;FYN;ZC3H12D;SNX1;LEMD2;SIRT2;GDF15;PHLDA2;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;EPAS1;LAMTOR2;MAP3K10;CHD6;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FITM2;FKBP8;CTH;ERBB2;EIF2AK4;UNC119;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;PEX11A;ZNF667;ZNF287;CAMKK1;PNKD;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;BTBD11;SIX5
19711,GO:2000112,0.999999969816312,4.38578515541721e-08,297,3211,regulation of cellular macromolecule biosynthetic process,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;HBEGF;RBL2;TFDP2;MXI1;RPL13A;MSRB2;MDFI;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;ABCA7;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ECM1;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;PAIP2B;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IFT57;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;LSM14B;BCL6;HSF4;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;EIF4EBP1;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;SIX5
4501,GO:0010556,0.999999972402176,4.00612848952326e-08,302,3259,regulation of macromolecule biosynthetic process,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;HBEGF;RBL2;TFDP2;MXI1;RPL13A;MSRB2;MDFI;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;ABCA7;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;TRIB2;HES2;EREG;CHD2;TEF;APBB3;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ECM1;MAPK3;ERRFI1;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;IRF5;TFB1M;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;PAIP2B;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IFT57;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;LSM14B;BCL6;HSF4;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;EIF4EBP1;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;SIX5
5331,GO:0016072,0.999999976634113,1.08867812163773e-07,8,283,rRNA metabolic process,BP,RPL13A;NSUN5P2;RRNAD1;TFB1M;ISG20;CSNK1E;RPL29;RPL12
4022,GO:0009058,0.999999978634764,2.97739058038928e-08,487,4935,biosynthetic process,BP,TNIP1;XDH;ZC3H6;HTRA1;GAMT;F2R;ST6GALNAC2;NT5E;ISYNA1;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;LMF1;ALDH7A1;ZNF862;ACP5;WWC3;NAPRT;GLUL;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;ZSCAN18;RBCK1;PRNP;ZDHHC1;NR1D1;ADAMTS7;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;DGKA;IDH2;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;SMARCA1;ZFP36L1;NUPR1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;PYGL;PYCR2;DHTKD1;TFDP2;MXI1;HSD17B14;RPL13A;MSRB2;MDFI;TK2;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;MLYCD;ASH2L;SOX13;PITPNM3;LHPP;HMGCL;UROS;HYAL1;ETV4;WWTR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;CRYL1;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;OPLAH;LPCAT4;BTG1;TRNP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;VEGFB;OGDHL;SOX12;HDAC11;PCSK1;PTMS;UNK;NMRK1;CIRBP;CAPRIN2;LY6K;PRKCZ;ABCA7;AARS;ELK3;PABPC1L;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;FOXQ1;PHF1;NPR2;CBS;SALL2;NMNAT2;NME4;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;GSTO1;MUC19;PPCS;TRIB2;HES2;EREG;CHD2;GPT2;TEF;PSAT1;APBB3;PNPLA3;RMI2;PSPH;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;GSTT1;CARS;MTMR4;PPARA;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;ACACB;NT5C1B;MAPK3;CSPG4;PC;ERRFI1;THRA;VANGL2;ACSS2;RGS14;MVD;IRF2BPL;PBXIP1;ADAMTSL1;ZSCAN30;EIF2D;MAPK12;LTA4H;PI4K2A;NAT14;ZXDC;SDC2;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;LITAF;PTHLH;ATF4;ZFPM1;CHST6;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;AZIN2;HSD11B1;JDP2;HDAC5;GTPBP1;IRF5;GALK1;TFB1M;PLTP;SRSF5;GSTM2;VLDLR;ADGRF1;NADK;GABBR1;DEAF1;TEP1;ST3GAL3;PEG3;GLI4;RFX2;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;HSD17B7;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;ALDH1L2;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;PIGZ;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;GLUD1;ERN1;MAPRE3;CHKB;HEXA;TNNI2;SRR;TADA3;BOLA1;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;THNSL2;PRDM8;PNRC1;GSTO2;ASNS;TM7SF2;PAIP2B;HINT2;AKT1;IGFBP7;CARD11;DGUOK;CDKN1C;SWT1;CRY2;B4GALT2;CHEK2;IFT57;WDR45;ASS1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;HAGH;CBR4;PHLDA1;ACADVL;ZNF25;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;ACSS1;NCOA7;NELFCD;FOXO4;COG7;RPS6KA5;PIGQ;MAP2K5;ZDHHC24;EDA2R;ZNF554;CPSF4;POLR2J2;ALDH1L1;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;CERS4;MPI;PEX7;LSM14B;TAZ;BCL6;HSF4;GSTM3;SLC37A4;RPL39L;ZC3H12D;LEMD2;SIRT2;TRPC1;MBOAT2;GDF15;RECQL5;OSBPL1A;GOLGA2;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;ETNK2;MTA1;ENTPD2;FUK;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;TGFBR3;TCF7;PLPP6;MAN1B1;EPAS1;MAP3K10;MFNG;STARD10;CHD6;DHPS;NMRAL1;POLR2J3;INPP4A;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;FITM2;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;RGS12;SYVN1;PFKL;RPL12;MPPE1;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;KCTD13;DBP;ZNF667;ZNF287;DTD1;KDSR;IKBKB;NTM;DMTF1;PLEKHA4;HIP1;TEAD2;ACOT8;SIX5
10773,GO:0044260,0.999999980532348,2.68412523521455e-08,639,6240,cellular macromolecule metabolic process,BP,TNIP1;XDH;DUSP6;PTPRS;DLG4;ZC3H6;HTRA1;F2R;ST6GALNAC2;NT5E;TNFRSF6B;NYNRIN;APOE;BTBD2;ZMYND8;NFATC4;XPC;SERPINE2;GID4;FOS;H1F0;GSN;CITED4;PYGB;EGR1;CTNNBIP1;LMF1;PPP1R35;FBXO2;ZNF862;PTK6;TMEM129;CDC42EP5;WWC3;EDEM1;RNF135;GJC2;LRP1;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;ERCC1;FBLN1;ADAMTS7;PRDX5;BAHCC1;TFPI2;DUSP5;NEK9;RAPGEF3;TNFSF15;ZKSCAN1;SPTB;LOXL1;IGFBP4;CD9;FKBP9;CRTAP;CST3;DNM1;MEF2D;NOS1;DDIT3;TSC22D1;BRSK1;DNAJB5;PGM1;CRTC1;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;GRAMD4;SMARCA1;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RPS6KA2;GAA;PYGL;MMP1;CTF1;CNTN1;TFDP2;MXI1;RPL13A;MSRB2;OBSL1;MDFI;TK2;PLAT;ULK2;SLC27A1;CTSF;MAPK13;KLF9;RNF165;MIF4GD;CDK18;PHACTR3;FBXW4;ASH2L;SOX13;CUL7;LHPP;HYAL1;PPP1R14A;ETV4;WWTR1;POLD4;MAP2K1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;ALPK1;BTG1;TRNP1;SHC2;DNASE1L1;SYNGAP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;SOX12;HDAC11;RAB3B;PTMS;UNK;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;ELK3;STK39;PABPC1L;ERO1B;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;KLHL29;PHF1;NPR2;CBS;SPRY4;USP20;SALL2;DLG3;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;MARCH4;ETV5;ETFB;LCE1E;LTBP1;MUC19;NSMCE4A;TRIB2;HES2;EREG;CHD2;TEF;APBB3;PTPRE;RNF44;SSH3;RMI2;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;PPM1J;ABCG1;TRAPPC9;CARF;LPAR3;CARS;FKBP10;MTMR4;C5;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;BLMH;MKNK2;RASA4;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;PPP1R3E;ING4;RRNAD1;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;MARCH9;JADE2;MAPK3;CSPG4;TRPT1;LAMB2;FBXO27;BNIP3;ERRFI1;MACROD1;THRA;DCAF10;PEX10;STK40;VANGL2;RGS14;MVD;IRF2BPL;FAM20C;TDRKH;PBXIP1;CNTRL;ADAMTSL1;SNTA1;PAN2;CTSB;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;NAT14;ZXDC;SDC2;FBXO17;ARHGAP22;MLXIPL;PTPDC1;ARHGEF2;TSPYL2;MAP2K2;SRD5A3;LRSAM1;DMTN;KLHL24;LITAF;UBXN4;ATF4;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;SSH1;PCMTD2;PRIMPOL;POLM;TENM2;FBXO6;IFI6;ZNF516;CBX7;PKD1;NSMCE1;FLOT1;MDK;TTN;PSKH1;HLCS;JDP2;HDAC5;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;VLDLR;PAPLN;ADGRF1;DEAF1;TEP1;ST3GAL3;SULF2;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;ATRAID;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;FBXL16;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;MOCOS;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;MLH3;CALCOCO1;EDA;HMG20B;CDK5RAP3;AGO4;MINK1;PIGZ;HEXB;PROM2;ZFP90;WNT7A;TTLL11;TRPV1;MARCH2;BNIP3L;PIK3R2;EPHA1;ZNF558;ZNF662;SHARPIN;GAS6;DNAJC6;ERN1;BCR;KLHDC8B;MAPRE3;MAN2C1;NBR1;HEXA;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;POLL;TERC;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;STRADB;CTSH;PNRC1;FBXL8;MGMT;PAIP2B;LCE1F;HINT2;AKT1;IGFBP7;CARD11;DGUOK;CDKN1C;MICAL1;SWT1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;WDR45;IGFBP2;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;PHLDA1;ZNF25;DNASE2;SPSB3;WDFY2;C9ORF72;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;SMARCD2;SPATA18;MARK4;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;MPG;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;UBOX5;CHRM3;ZNF846;TFEB;MIB2;MPI;LSM14B;ENDOV;JOSD2;PHC1;SCYL3;CSNK1E;BCL6;HSF4;REC8;RNF213;FBXO25;EHD3;RPL39L;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;UBXN6;SIRT2;GDF15;PHLDA2;RECQL5;RAB13;GOLGA2;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;MSH5;AP2A2;CIDEA;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;MAN1B1;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;CHD6;RNF170;DHPS;EPHB2;POLR2J3;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;BLOC1S1;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;STK32B;UNC119;RGS12;SYVN1;FRS3;RPL12;MPPE1;HMBOX1;TRIM2;TSHZ1;CREB3L4;ZNF449;IRF2BP2;KCTD11;ZMYM3;LYPLAL1;KCTD13;DBP;ZNF667;ZNF287;CAMKK1;DTX3;DTD1;IKBKB;NTM;DMTF1;HIP1;TEAD2;ACOT8;BTBD11;SIX5
12829,GO:0051171,0.999999981829468,2.5599609041707e-08,427,4390,regulation of nitrogen compound metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;ZC3H6;HTRA1;F2R;TNFRSF6B;APOE;BTBD2;ZMYND8;NFATC4;SERPINE2;FOS;GSN;CITED4;EGR1;CTNNBIP1;PPP1R35;FBXO2;ZNF862;PTK6;ACP5;WWC3;EDEM1;GJC2;LRP1;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;BAHCC1;TFPI2;DUSP5;RAPGEF3;TNFSF15;ZKSCAN1;IGFBP4;CRTAP;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;ABTB1;TCEA2;GRAMD4;SMARCA1;MST1R;ZFP36L1;ADARB1;NUPR1;B3GAT3;TCFL5;HBEGF;RBL2;CTF1;CNTN1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;PLAT;LTBP4;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;PHACTR3;ASH2L;SOX13;PPP1R14A;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;SHC2;SYNGAP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;SHC1;VPS11;SPRY2;GRB7;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;PHF1;SPRY4;SALL2;DLG3;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;EAPP;NGFR;ELFN2;ETV5;TRIB2;HES2;EREG;CHD2;TEF;APBB3;TNFRSF25;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;LPAR3;C5;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ECM1;MAPK3;CSPG4;TRPT1;ERRFI1;THRA;STK40;VANGL2;RGS14;IRF2BPL;PBXIP1;SNTA1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;DMTN;LITAF;PTHLH;ATF4;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;SSH1;LTB4R2;TENM2;IFI6;ZNF516;CBX7;PKD1;FLOT1;MDK;TTN;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;HERPUD1;SRSF5;VLDLR;PAPLN;ADGRF1;GABBR1;DEAF1;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;RHBDF1;LRP5;ATRAID;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;PIK3R2;EPHA1;ZNF558;ZNF662;GAS6;ERN1;BCR;MAPRE3;NBR1;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;STRADB;CTSH;PNRC1;MGMT;PAIP2B;HINT2;AKT1;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;IFT57;ASS1;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ZNF25;WDFY2;C9ORF72;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;ZNF554;CPSF4;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;ZNF846;TFEB;LSM14B;CSNK1E;TAZ;BCL6;HSF4;FYN;ZC3H12D;SNX1;LEMD2;SIRT2;GDF15;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;EPAS1;LAMTOR2;MAP3K10;CHD6;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;UNC119;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;CAMKK1;PNKD;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;BTBD11;SIX5
10769,GO:0044249,0.999999984037006,2.23464741904025e-08,474,4829,cellular biosynthetic process,BP,TNIP1;XDH;ZC3H6;HTRA1;GAMT;F2R;ST6GALNAC2;NT5E;ISYNA1;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;LMF1;ALDH7A1;ZNF862;ACP5;WWC3;NAPRT;GLUL;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;ZSCAN18;RBCK1;PRNP;ZDHHC1;NR1D1;ADAMTS7;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;DGKA;IDH2;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;SMARCA1;ZFP36L1;NUPR1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;PYCR2;DHTKD1;TFDP2;MXI1;HSD17B14;RPL13A;MSRB2;MDFI;TK2;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;MLYCD;ASH2L;SOX13;PITPNM3;LHPP;HMGCL;UROS;HYAL1;ETV4;WWTR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;OPLAH;LPCAT4;BTG1;TRNP1;ITGA6;PITPNM1;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;VEGFB;OGDHL;SOX12;HDAC11;PCSK1;PTMS;UNK;NMRK1;CIRBP;CAPRIN2;LY6K;PRKCZ;ABCA7;AARS;ELK3;PABPC1L;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;FOXQ1;PHF1;NPR2;CBS;SALL2;NMNAT2;NME4;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;GSTO1;MUC19;PPCS;TRIB2;HES2;EREG;CHD2;GPT2;TEF;PSAT1;APBB3;PNPLA3;RMI2;PSPH;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;GSTT1;CARS;MTMR4;PPARA;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;ACACB;NT5C1B;MAPK3;CSPG4;ERRFI1;THRA;VANGL2;ACSS2;RGS14;MVD;IRF2BPL;PBXIP1;ADAMTSL1;ZSCAN30;EIF2D;MAPK12;LTA4H;PI4K2A;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;LITAF;PTHLH;ATF4;ZFPM1;CHST6;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;GALK1;TFB1M;PLTP;SRSF5;GSTM2;VLDLR;ADGRF1;NADK;GABBR1;DEAF1;TEP1;ST3GAL3;PEG3;GLI4;RFX2;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;HSD17B7;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;PIGZ;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;GLUD1;ERN1;MAPRE3;CHKB;TNNI2;SRR;TADA3;BOLA1;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;THNSL2;PRDM8;PNRC1;GSTO2;ASNS;PAIP2B;AKT1;CARD11;DGUOK;CDKN1C;SWT1;CRY2;B4GALT2;CHEK2;IFT57;WDR45;ASS1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;HAGH;CBR4;PHLDA1;ACADVL;ZNF25;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;ACSS1;NCOA7;NELFCD;FOXO4;COG7;RPS6KA5;PIGQ;MAP2K5;ZDHHC24;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;CERS4;MPI;PEX7;LSM14B;TAZ;BCL6;HSF4;GSTM3;RPL39L;ZC3H12D;LEMD2;SIRT2;TRPC1;MBOAT2;GDF15;RECQL5;OSBPL1A;GOLGA2;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;ETNK2;MTA1;ENTPD2;FUK;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;TGFBR3;TCF7;MAN1B1;EPAS1;MAP3K10;MFNG;STARD10;CHD6;DHPS;NMRAL1;POLR2J3;INPP4A;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;FITM2;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;RGS12;SYVN1;PFKL;RPL12;MPPE1;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;KCTD13;DBP;ZNF667;ZNF287;DTD1;KDSR;IKBKB;NTM;DMTF1;PLEKHA4;HIP1;TEAD2;ACOT8;SIX5
1445,GO:0003677,0.999999984974387,2.42609917893955e-08,158,1916,DNA binding,MF,ZC3H6;ZMYND8;NFATC4;XPC;FOS;H1F0;EGR1;EGFR;ZSCAN18;DDB2;ZDHHC1;NR1D1;ERCC1;PRDX5;BAHCC1;ZKSCAN1;MEF2D;DDIT3;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;KLF9;ASH2L;SOX13;ETV4;MXD4;H2AFJ;TRNP1;DNASE1L1;PHC2;PHF21A;ZNF76;PBX2;THAP8;SOX12;ELK3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;NEIL1;RAG1;ETV5;HES2;CHD2;TEF;RMI2;CARF;PPARA;CHD3;TCF25;SATB1;STAT6;KLF7;HMGA2;THRA;ZSCAN30;NAT14;MLXIPL;TSPYL2;H1FX;FLYWCH1;LITAF;ATF4;ZFPM1;ZNF467;POLM;ZNF516;JDP2;HDAC5;IRF5;TFB1M;PCBP4;DEAF1;GLI4;RFX2;CEBPB;CREBRF;ZNF251;HLTF;DNMT3A;MXD3;FOXL1;CSRNP3;BHLHE40;MLH3;CALCOCO1;HMG20B;ZFP90;ZNF558;ZNF662;POLL;TERC;RXRA;ZNF358;ZNF362;MBD1;TNRC18;PRDM8;MGMT;CRY2;IFT57;TSG101;ZNF217;NUCB2;ZNF25;DNASE2;UHRF2;SMARCD2;FOXO4;ZNF554;POLR2J2;HOXC5;ZNF160;MPG;ZFP28;TP73;MTA3;MNT;ZNF846;TFEB;CERS4;ENDOV;PHC1;BCL6;HSF4;LEMD2;RECQL5;POU2F2;RCOR2;MTA1;MSH5;MYO18A;TCF7;EPAS1;CHD6;POLR2J3;PER1;ZNF333;HMBOX1;TSHZ1;CREB3L4;ZNF449;ZMYM3;DBP;ZNF667;ZNF287;DTD1;DMTF1;TEAD2;SIX5
4468,GO:0010468,0.999999988845056,1.62376363566383e-08,327,3513,regulation of gene expression,BP,TNIP1;XDH;ACTA2;ZC3H6;HTRA1;BBS2;F2R;APOE;ZMYND8;NFATC4;SERPINE2;FOS;GSN;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;GJC2;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;ANK3;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;CNTN1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;SPRY2;GRB7;ADM2;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;SERPING1;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;RAG1;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;C5;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;SLIT3;ECM1;ACACB;MAPK3;PC;THRA;STK40;RGS14;IRF2BPL;TDRKH;PBXIP1;PAN2;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SLC50A1;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;TTN;JDP2;HDAC5;GTPBP1;IRF5;TFB1M;PCBP4;SRSF5;VLDLR;ADGRF1;DEAF1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;ATRAID;CREBRF;ZNF251;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;CTSH;PNRC1;PAIP2B;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IFT57;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;WNT3;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;BRAF;EDA2R;ZNF554;CPSF4;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;LSM14B;CSNK1E;BCL6;HSF4;FYN;ZC3H12D;LEMD2;SIRT2;GDF15;PHLDA2;RECQL5;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;APBA1;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
7305,GO:0031323,0.999999990201126,1.38693829669653e-08,451,4617,regulation of cellular metabolic process,BP,TNIP1;XDH;DUSP6;DLG4;ZC3H6;HTRA1;F2R;TNFRSF6B;APOE;ZMYND8;NFATC4;SERPINE2;FOS;GSN;CITED4;EGR1;CTNNBIP1;LMF1;TYSND1;PPP1R35;FBXO2;ZNF862;PTK6;ACP5;WWC3;EDEM1;GJC2;LRP1;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;BAHCC1;TFPI2;DUSP5;RAPGEF3;TNFSF15;ZKSCAN1;IGFBP4;CRTAP;CST3;MEF2D;NOS1;GPSM1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;GRAMD4;SMARCA1;MST1R;TRIM65;ZFP36L1;ADARB1;NUPR1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;CTF1;CNTN1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;PLAT;ULK2;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;PHACTR3;MLYCD;ASH2L;SOX13;EPM2A;PPP1R14A;ETV4;WWTR1;MAP2K1;CYP27B1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;SHC2;SYNGAP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;PHF1;SPRY4;SALL2;DLG3;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;EAPP;NGFR;ELFN2;ETV5;TRIB2;HES2;EREG;CHD2;TEF;APBB3;TNFRSF25;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;LPAR3;MTMR4;C5;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ECM1;ACACB;MAPK3;CSPG4;TRPT1;BNIP3;ERRFI1;THRA;STK40;VANGL2;RGS14;IRF2BPL;FAM20C;PBXIP1;SNTA1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;TBC1D14;ARHGEF2;INPP5D;TSPYL2;MAP2K2;LRSAM1;DMTN;LITAF;PTHLH;ATF4;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;SSH1;LTB4R2;TENM2;IFI6;ZNF516;CBX7;PKD1;FLOT1;MDK;TTN;JDP2;HDAC5;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;HERPUD1;SRSF5;VLDLR;PAPLN;ADGRF1;GABBR1;DEAF1;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;RHBDF1;LRP5;ATRAID;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;LONP2;HLTF;DNMT3A;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;ZNF558;ZNF662;GAS6;ERN1;BCR;MAPRE3;FYCO1;NBR1;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;STRADB;CTSH;PNRC1;MGMT;PAIP2B;HINT2;AKT1;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;IFT57;ASS1;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ACADVL;ZNF25;FARP1;WDFY2;C9ORF72;CHMP5;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;TPCN1;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;ZNF554;CPSF4;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;ZNF846;TFEB;LSM14B;CSNK1E;TAZ;BCL6;HSF4;FYN;ZC3H12D;LEMD2;SIRT2;GDF15;PHLDA2;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;EPAS1;LAMTOR2;MAP3K10;TBC1D16;CHD6;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FITM2;FKBP8;CTH;ERBB2;EIF2AK4;UNC119;SFI1;HMBOX1;GRB10;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;CAMKK1;PNKD;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;SIX5
10866,GO:0044422,0.999999993727255,8.8124019222789e-09,744,7161,organelle part,CC,TNIP1;DUSP6;H6PD;PTPRS;DLG4;DOCK4;BBS2;ST6GALNAC2;NT5E;APOE;ESPN;NFATC4;FLNC;XPC;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;VWA5A;ALDH7A1;POSTN;WIPF1;SLC2A3;FBXO2;PTK6;TMEM129;NAPRT;EDEM1;CRAT;FAM210B;LRP1;NAGS;TIMP2;CLIP2;VEGFA;OBSCN;EGFR;DDB2;D2HGDH;PRNP;SCN8A;NR1D1;ERCC1;ADAMTS7;HADH;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;SPTB;TSPAN1;SLC16A3;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;BRSK1;SHANK2;ACAD10;PGM1;CRTC1;CLCA2;ADGRB2;ERCC6;NDRG1;ADAMTS13;ABTB1;TCEA2;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARMCX2;TRIM65;ADARB1;SYT8;ARAP1;B3GAT3;HBEGF;RBL2;RPS6KA2;GAA;PYGL;PYCR2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;OBSL1;EVC;TK2;BBS1;ULK2;CERCAM;CTSF;KLF9;REEP2;MIF4GD;RAB11FIP4;PHACTR3;CPT2;MLYCD;ASAP2;PLD3;KLHDC2;ASH2L;SOX13;CUL7;LHPP;TMEM92;ATG16L2;PRSS3;HMGCL;HYAL1;NAGLU;ETV4;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;COL6A1;SDCCAG8;ABCA2;PKN1;CAPG;H2AFJ;LPCAT4;TRNP1;DNASE1L1;PHC2;PITPNM1;PHF21A;DGKQ;EML2;MAML3;TUBG2;TMEM173;SNX9;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;NPHP4;VEGFB;OGDHL;SOX12;HDAC11;RAB3B;CD68;PCSK1;MYH11;CYBRD1;ITPR3;HSD11B1L;PITPNC1;APPL2;CIRBP;CAPRIN2;TPM2;TTBK2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;SLC37A2;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;CEMIP;KDM3A;BRI3;PHF1;GLDC;NDUFA4L2;TMEM44;USP20;SALL2;SYNE3;DLG3;NMNAT2;DDX59;WDR27;MICALL2;NME4;CEP250;NSUN5P2;NEIL1;SHROOM4;ABHD14B;CCDC88B;RAG1;SPPL2B;NGFR;MARCH4;ETV5;ETFB;WDR60;LTBP1;MUC19;SYNC;SMIM14;MALL;NSMCE4A;ACTR1B;CHD2;GPT2;NIPSNAP1;SPG11;TMC6;PNPLA3;RNF44;RMI2;CYHR1;OLFM2;DHRS4;ANO8;TMED4;PLA2G6;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;FAM50A;CARF;S100A13;FKBP10;MTMR4;KIF17;APOBEC3F;PPARA;INO80C;CHD3;CHAC1;CCDC92;SPC24;AIP;MKNK2;SCMH1;IFT27;NLRX1;PKD2;SATB1;STAT6;ING4;NUDCD3;VAMP2;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SEPT5;ECM1;B4GAT1;MARCH9;JADE2;ACACB;KCNAB2;MAPK3;CSPG4;LAMB2;PC;DEF6;BNIP3;MACROD1;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;SCARA3;RGS14;IRF2BPL;DNAL4;FAM20C;MYZAP;PBXIP1;DYSF;RHOF;SLC22A18;CNTRL;ADAMTSL1;TUBE1;CTSB;HOOK2;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;PQLC2;KIAA0319L;SDC2;CHMP1B;MLXIPL;IFNGR2;TBC1D14;TCTN1;PTPDC1;ARHGEF2;SEPT10;FBF1;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;SLC50A1;SDHA;TECPR1;KIF21B;SLC48A1;DMTN;LITAF;PTHLH;UBXN4;NOL4L;MORN4;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;KDM4C;PAK6;LRRC45;LTB4R2;SV2A;PRIMPOL;FAM193B;RABGAP1;POLM;TENM2;MYH16;FBXO6;KIF26B;REEP6;CBX7;PKD1;FUCA1;NSMCE1;FLOT1;CEP68;TTN;PSKH1;HLCS;AZIN2;HSD11B1;HDAC5;WHAMMP3;SORL1;MAP6;TFB1M;IL17RD;HERPUD1;SRSF5;VLDLR;GPRC5C;DHX32;DEAF1;TEP1;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;COL4A6;KDM7A;CEBPB;NEK8;RHBDF1;ACOT7;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;DBNDD1;L3MBTL1;ACADS;CEP131;ISG20;LONP2;EPN3;HLTF;DNMT3A;TRIOBP;TRPV4;MXD3;DIRC2;TTC12;TMSB4X;MAP1LC3A;HSD17B7;PDE2A;SMURF2;RAB40B;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;PIGZ;HEXB;LDOC1;PROM2;SLC27A3;WNT7A;TTLL11;MARCH2;BNIP3L;RHBDF2;NICN1;RPUSD3;ANGEL1;GAS6;VPS39;GLUD1;SUCLG2;ERN1;CEP126;LZTS2;ALKBH7;CROCC;MAPRE3;ATP7B;MAN2C1;CEP112;NBR1;CPT1C;HEXA;GOLGA2P5;TNNI2;TADA3;NBEAL2;KIF13B;SPAG16;NECAB3;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;CTSH;WDR19;ACOX3;ACAD11;TMEM80;CCDC15;GSDMC;MGMT;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;DGUOK;REEP4;MICAL1;CRY2;MZT2B;B4GALT2;LAMB1;CHEK2;IFT57;LACTB2;PHYKPL;SBF2;SEPT6;TNNT1;NFU1;WDR66;CABYR;TSG101;KIF27;PHF2;RASSF9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;LMNA;FAAH;UPP1;COPG1;C9ORF72;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;IFI27;PLAU;INSR;WNT3;ACSS1;KRT19;NELFCD;SLC25A29;FOXO4;COG7;YPEL3;RPS6KA5;ANKZF1;CHMP4C;SMIM20;TPCN1;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;HOMER2;C6ORF89;PIGQ;MAP2K5;ZNF554;CPSF4;POLR2J2;LETMD1;HOXC5;GJB4;FAAP20;PIDD1;CAT;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;UNC119B;TIMP1;HFE;TP73;MTA3;SCNN1A;TUBGCP6;MNT;SNX33;UBOX5;APRT;CERS4;PEX7;SNX17;ENDOV;PHC1;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;HSF4;REC8;RNF213;SLC9A7;GSTM3;SLC37A4;EHD3;RPL39L;FYN;ZC3H12D;EML3;ATP8B2;PJA2;SNX1;PEX1;LEMD2;UBXN6;SLC25A42;SIRT2;MBOAT2;RECQL5;RAB13;TOM1;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;POU2F2;POLR3GL;RHOBTB3;MTA1;RTN2;MSH5;ENTPD2;AP2A2;CIDEA;EPS8L2;HDAC8;MYO18A;ADIRF;RPL29;RETSAT;TCF7;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MFNG;CHD6;RNF170;LURAP1;MAGI1;POLR2J3;PER1;LRCH4;SEPT8;MCTP2;FGFR1;PIGV;WFS1;ESYT3;BLOC1S1;FITM2;FKBP8;SPATA6;SH3PXD2A;XYLT2;ERBB2;SEC31B;KDELC2;UST;UNC119;CCDC69;RGS12;SYVN1;PFKL;HLA-G;CORO1B;SFI1;RPL12;MPPE1;HMBOX1;TTC19;TNNI1;CREB3L4;IRF2BP2;BSG;ZMYM3;SDHAF4;TRIM45;KCTD13;PEX11A;TMEM8A;DTD1;KDSR;DMTF1;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4
10779,GO:0044271,0.999999994226054,8.39322843275316e-09,372,3952,cellular nitrogen compound biosynthetic process,BP,TNIP1;XDH;ZC3H6;HTRA1;F2R;NT5E;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ALDH7A1;ZNF862;ACP5;WWC3;NAPRT;NAGS;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;IDH2;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;GGT1;ABTB1;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;DHTKD1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;LHPP;UROS;ETV4;WWTR1;POLD4;MAP2K1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;OPLAH;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;OGDHL;SOX12;HDAC11;PCSK1;UNK;NMRK1;CIRBP;CAPRIN2;PRKCZ;AARS;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;NPR2;SALL2;NMNAT2;NME4;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;PPCS;HES2;EREG;CHD2;TEF;PSAT1;APBB3;RMI2;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;CARS;PPARA;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;ST6GALNAC6;ECM1;NT5C1B;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;EIF2D;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;GALK1;TFB1M;SRSF5;VLDLR;ADGRF1;NADK;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;ASNS;PAIP2B;AKT1;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;ASS1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;HAGH;ZNF25;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;CERS4;MPI;LSM14B;TAZ;BCL6;HSF4;RPL39L;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;ENTPD2;FUK;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;DHPS;NMRAL1;POLR2J3;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
10378,GO:0043227,0.999999994588481,7.92764476436093e-09,1001,9236,membrane-bounded organelle,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;APOE;MARVELD1;SYTL1;ZMYND8;HS1BP3;NFATC4;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;VWA5A;ALDH7A1;TYSND1;POSTN;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;ACP5;THSD4;NAPRT;EDEM1;CRAT;GLUL;FAM210B;GPX3;LRP1;ALOX15B;NAGS;PDCD4;TIMP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;DDB2;D2HGDH;PRNP;ZDHHC1;SCN8A;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;RAPGEF3;BPHL;CLTCL1;FCHO1;ZKSCAN1;SPTB;NPEPL1;LOXL1;TSPAN1;SLC16A3;IGFBP4;KRT15;CD9;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;ACAD10;PGM1;CRTC1;CLCA2;PACS2;ERCC6;NDRG1;GGT1;ADAMTS13;FCGBP;ABTB1;TCEA2;COL13A1;GRAMD4;SMARCA1;MST1R;ARRDC1;ARMCX2;HEBP1;TRIM65;ZFP36L1;ADARB1;PPM1M;SYT8;NUPR1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;RPS6KA2;ARHGAP23;GAA;PYGL;PYCR2;CNTN1;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;LTBP4;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;PLD3;KLHDC2;ASH2L;SOX13;CUL7;LHPP;TMEM92;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;NAGLU;OXLD1;ETV4;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;COL6A1;PPL;CRYL1;ABCA2;PKN1;PGLS;CAPG;DDIT4;H2AFJ;LPCAT4;BTG1;TOM1L2;TRNP1;DNASE1L1;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;FAM213A;FAM110C;MAGEF1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;NPHP4;VEGFB;R3HDM2;MARCKSL1;OGDHL;SOX12;HDAC11;RAB3B;CD68;PCSK1;PTMS;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;APPL2;PRSS8;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;GALE;SERPING1;PAK1;ABCA7;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;PABPC1L;B4GALNT4;ERO1B;BLVRB;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;BRI3;FOXQ1;ARVCF;PHF1;GLDC;NDUFA4L2;TMEM44;CBS;TMEM187;SALL2;SYNE3;ITGB4;NMNAT2;DDX59;WDR27;MICALL2;NME4;PDZD2;CEP250;FBXW8;ETV1;NSUN5P2;NEIL1;ABHD14B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;MARCH4;NID1;ETV5;ETFB;GSTO1;WDR60;LTBP1;MUC19;PPCS;SMIM14;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;CHD2;GPT2;TEF;PSAT1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;OLFM2;DHRS4;CCDC106;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;OAF;MANF;S100A13;GSTT1;AGAP1;FKBP10;MTMR4;C5;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;ANO1;SNX29;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;SCMH1;TCF25;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;R3HDM4;SH3TC2;ING4;ACOT11;VAMP2;HMGA2;AREG;ST6GALNAC6;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;PCLO;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;PC;DEF6;BNIP3;ERRFI1;MACROD1;SEMA5A;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;SCARA3;RGS14;IRF2BPL;FAM20C;TDRKH;PBXIP1;DYSF;RHOF;SLC22A18;LTBP2;ADAMTSL1;PAN2;CTSB;HOOK2;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;ZXDC;PQLC2;KIAA0319L;SDC2;CHMP1B;NRSN2;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;PTPDC1;C1RL;PLCD1;ARHGEF2;MTMR11;PDCD1LG2;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;STMN3;SLC50A1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;DMTN;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;LRRC45;LTB4R2;SV2A;FAM214B;SLC38A10;PRIMPOL;FAM193B;POLM;ACAP3;TENM2;FBXO6;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;RALGAPA1;FLOT1;LTBP3;CEP68;TTN;PSKH1;HLCS;KCNMA1;AZIN2;HSD11B1;JDP2;HDAC5;WHAMMP3;IRF5;SORL1;MAP6;GALK1;TFB1M;NTPCR;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;GPRC5C;DHX32;DEAF1;TEP1;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;PEG3;ACY1;COL4A6;GLI4;RFX2;ENDOG;KDM7A;CEBPB;PTGR2;NEK8;RHBDF1;ACOT7;LRP5;TSTD1;ATRAID;ALDOC;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;METTL23;AQP3;ACADS;CEP131;ISG20;LONP2;EPN3;MARK3;DGCR6L;HLTF;DNMT3A;TRIOBP;TRPV4;MXD3;TAGLN3;FOXL1;DIRC2;CSRNP3;ITGA1;TMSB4X;SLFN5;MAP1LC3A;APOL4;HSD17B7;PDE2A;SMURF2;LMO7;TRIB3;RAB40B;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;MARCH2;BNIP3L;PIK3R2;RHBDF2;NICN1;ZNF558;RPUSD3;ANGEL1;ZNF662;CCS;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;NUDT6;LZTS2;ESRG;ALKBH7;CROCC;BCR;ATP7B;FYCO1;MAN2C1;C19ORF33;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;BCAM;TADA3;NBEAL2;BOLA1;SPAG16;TTYH3;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;PRDM8;SLC9A3R2;EFEMP2;STRADB;CTSH;WDR19;ACOX3;ACAD11;PNRC1;UACA;GSDMC;MGMT;GSTO2;TMEM9;ENTPD6;C12ORF66;TM7SF2;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;CARD11;DGUOK;REEP4;CDKN1C;SWT1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;GAREM2;IFT57;LACTB2;PHYKPL;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;CAPS;COMTD1;NFU1;CABYR;TSG101;KIF27;FMNL3;PHF2;FGFR4;IGF2BP2;TMEM256;RASSF9;ZNF217;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;ZNF25;DNASE2;LMNA;FAAH;UPP1;MAB21L2;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;ARMC9;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;FOXO4;GNAL;COG7;YPEL3;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;TNXB;SMIM20;TPCN1;ULBP1;ADD3;MBLAC2;MAGED2;RABGGTA;TXNRD2;ITGB6;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;ASIC1;ALDH1L1;HOXC5;GJB4;FAAP20;PIDD1;CAT;ZNF160;MZT2A;MYOF;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;TIMP1;HFE;JAK3;TP73;MTA3;SCNN1A;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;ZNF846;APRT;FCHSD1;TMX4;TFEB;MIB2;CERS4;MPI;PEX7;SNX17;ENDOV;PHC1;SCYL3;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;RABAC1;HSF4;REC8;SAT2;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;EPS8L1;SLC37A4;EHD3;FYN;ZC3H12D;ATP8B2;PJA2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;SLC25A42;SIRT2;MBOAT2;GDF15;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;FAM220A;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;CADM4;POU2F2;RCOR2;POLR3GL;RHOBTB3;NAGA;MTA1;RTN2;MSH5;ENTPD2;AP2A2;CIDEA;EPS8L2;HDAC8;MYO18A;ADIRF;ERV3-1;RETSAT;TGFBR3;TCF7;RNPEP;VAV3;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;TBC1D16;MFNG;CHD6;RNF170;LURAP1;EPHB2;NMRAL1;MAGI1;POLR2J3;PER1;LRCH4;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;CTH;XYLT2;ERBB2;SEC31B;PLLP;KDELC2;UST;CCDC69;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;RPL12;MPPE1;HMBOX1;NET1;TTC19;TSHZ1;CREB3L4;ZNF449;IRF2BP2;BSG;ZMYM3;LYPLAL1;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTD1;KDSR;IKBKB;DMTF1;SNCB;HIP1;CYP4V2;PLEKHH2;ROBO4;TEAD2;ACOT8;TCTEX1D4;SIX5
6066,GO:0019219,0.999999998677922,2.07431736327834e-09,296,3271,regulation of nucleobase-containing compound metabolic process,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;ERCC1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;MSRB2;MDFI;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;MAGEF1;SHC1;SOX12;HDAC11;CIRBP;CAPRIN2;PRKCZ;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;NEIL1;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ECM1;MAPK3;THRA;RGS14;IRF2BPL;PBXIP1;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;GTPBP1;IRF5;TFB1M;PCBP4;SRSF5;VLDLR;ADGRF1;GABBR1;DEAF1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;NOS3;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;MGMT;AKT1;CARD11;CDKN1C;CRY2;CHEK2;IFT57;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;TAZ;BCL6;HSF4;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;ADIRF;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;PER1;IGF2BP3;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
6069,GO:0019222,0.999999999025145,1.47392868930822e-09,477,4907,regulation of metabolic process,BP,TNIP1;XDH;DUSP6;ACTA2;DLG4;ZC3H6;HTRA1;BBS2;F2R;TNFRSF6B;APOE;BTBD2;ZMYND8;NFATC4;SERPINE2;FOS;GSN;CITED4;EGR1;CTNNBIP1;LMF1;TYSND1;PPP1R35;FBXO2;ZNF862;PTK6;ACP5;WWC3;EDEM1;GJC2;LRP1;PDCD4;TIMP2;VEGFA;NTSR1;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;RAPGEF3;TNFSF15;ZKSCAN1;IGFBP4;CRTAP;CST3;MEF2D;NOS1;GPSM1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;ABTB1;TCEA2;GRAMD4;SMARCA1;MST1R;TRIM65;ZFP36L1;ADARB1;NUPR1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;CTF1;CNTN1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;PLAT;LTBP4;ULK2;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;PHACTR3;CPT2;MLYCD;ASH2L;SOX13;EPM2A;PPP1R14A;ETV4;WWTR1;MAP2K1;CYP27B1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;SHC2;SYNGAP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;ADM2;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;PHF1;SPRY4;SALL2;DLG3;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;EAPP;NGFR;ELFN2;ETV5;TRIB2;HES2;EREG;CHD2;TEF;APBB3;TNFRSF25;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;LPAR3;MTMR4;C5;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;SLIT3;ECM1;ACACB;MAPK3;CSPG4;TRPT1;PC;BNIP3;ERRFI1;THRA;STK40;VANGL2;RGS14;MVD;IRF2BPL;FAM20C;TDRKH;PBXIP1;SNTA1;PAN2;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;TBC1D14;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SLC50A1;LRSAM1;DMTN;LITAF;ANGPTL4;PTHLH;ATF4;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;SSH1;LTB4R2;TENM2;IFI6;ZNF516;CBX7;PKD1;FLOT1;MDK;TTN;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;HERPUD1;SRSF5;VLDLR;PAPLN;ADGRF1;GABBR1;DEAF1;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;RHBDF1;LRP5;ATRAID;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;LONP2;HLTF;DNMT3A;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;BNIP3L;PIK3R2;EPHA1;ZNF558;ZNF662;CCS;GAS6;ERN1;BCR;MAPRE3;FYCO1;NBR1;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;STRADB;CTSH;PNRC1;MGMT;TM7SF2;PAIP2B;HINT2;AKT1;IGFBP7;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;IFT57;ASS1;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ACADVL;ZNF25;FARP1;WDFY2;C9ORF72;CHMP5;UHRF2;SMARCD2;IFI27;PTOV1;INSR;WNT3;NCOA7;NELFCD;FOXO4;RPS6KA5;TPCN1;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;ZNF554;CPSF4;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;ZNF846;TFEB;LSM14B;CSNK1E;TAZ;BCL6;HSF4;FYN;ZC3H12D;SNX1;LEMD2;SIRT2;GDF15;PHLDA2;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;VAV3;EPAS1;LAMTOR2;MAP3K10;TBC1D16;CHD6;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FITM2;FKBP8;CTH;ERBB2;EIF2AK4;UNC119;SFI1;RPL12;HMBOX1;GRB10;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;APBA1;PEX11A;ZNF667;ZNF287;CAMKK1;PNKD;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;BTBD11;SIX5
9900,GO:0042254,0.999999999246215,3.95131877718802e-09,8,317,ribosome biogenesis,BP,RPL13A;NSUN5P2;RRNAD1;TFB1M;ISG20;CSNK1E;RPL29;RPL12
13676,GO:0060255,0.999999999391492,9.56569571748018e-10,438,4573,regulation of macromolecule metabolic process,BP,TNIP1;XDH;DUSP6;ACTA2;DLG4;ZC3H6;HTRA1;BBS2;F2R;TNFRSF6B;APOE;BTBD2;ZMYND8;NFATC4;SERPINE2;FOS;GSN;CITED4;EGR1;CTNNBIP1;PPP1R35;FBXO2;ZNF862;PTK6;WWC3;EDEM1;GJC2;LRP1;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;ERCC1;FBLN1;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;RAPGEF3;TNFSF15;ZKSCAN1;IGFBP4;CRTAP;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;ABTB1;TCEA2;GRAMD4;SMARCA1;MST1R;ZFP36L1;ADARB1;NUPR1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;CTF1;CNTN1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;PLAT;LTBP4;SLC27A1;MAPK13;KLF9;RNF165;MIF4GD;PHACTR3;ASH2L;SOX13;PPP1R14A;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;SHC2;SYNGAP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;SHC1;VPS11;SPRY2;GRB7;ADM2;SOX12;HDAC11;UNK;CIRBP;CAPRIN2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;PHF1;SPRY4;SALL2;DLG3;ETV1;ZP3;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;EAPP;NGFR;ELFN2;ETV5;TRIB2;HES2;EREG;CHD2;TEF;APBB3;TNFRSF25;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;LPAR3;MTMR4;C5;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;SLIT3;ECM1;ACACB;MAPK3;CSPG4;TRPT1;PC;ERRFI1;THRA;STK40;VANGL2;RGS14;IRF2BPL;TDRKH;PBXIP1;SNTA1;PAN2;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SLC50A1;DMTN;LITAF;PTHLH;ATF4;ZFPM1;BBC3;KDM4C;PAK6;ZNF467;SSH1;TENM2;IFI6;ZNF516;CBX7;PKD1;FLOT1;MDK;TTN;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;HERPUD1;SRSF5;VLDLR;PAPLN;ADGRF1;DEAF1;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;RHBDF1;LRP5;ATRAID;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;AGO4;MINK1;HEXB;PROM2;ZFP90;WNT7A;TRPV1;PIK3R2;EPHA1;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;NBR1;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;STRADB;CTSH;PNRC1;MGMT;PAIP2B;HINT2;AKT1;CARD11;CDKN1C;MICAL1;CRY2;CHEK2;HMSD;IFT57;SPDYE2;SPDYE2B;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ZNF25;WDFY2;C9ORF72;CHMP5;UHRF2;SMARCD2;IFI27;PTOV1;INSR;WNT3;NCOA7;NELFCD;FOXO4;RPS6KA5;C6ORF89;CTDSPL;MAP2K5;BRAF;EDA2R;ZNF554;CPSF4;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;ZNF846;TFEB;LSM14B;CSNK1E;BCL6;HSF4;FYN;ZC3H12D;SNX1;LEMD2;SIRT2;GDF15;PHLDA2;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;EPAS1;LAMTOR2;MAP3K10;TBC1D16;CHD6;EPHB2;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;UNC119;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;APBA1;ZNF667;ZNF287;CAMKK1;IKBKB;DMTF1;HIP1;TEAD2;ACOT8;BTBD11;SIX5
8773,GO:0034470,0.999999999448623,2.23827172926952e-09,13,396,ncRNA processing,BP,RPL13A;AARS;NSUN5P2;RRNAD1;TRPT1;TFB1M;ISG20;AGO4;RPUSD3;CPSF4;CSNK1E;RPL29;RPL12
10883,GO:0044446,0.999999999668339,5.4479416665289e-10,725,7066,intracellular organelle part,CC,TNIP1;DUSP6;H6PD;PTPRS;DLG4;DOCK4;BBS2;ST6GALNAC2;NT5E;APOE;ESPN;NFATC4;XPC;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;VWA5A;ALDH7A1;POSTN;WIPF1;SLC2A3;PTK6;TMEM129;NAPRT;EDEM1;CRAT;FAM210B;LRP1;NAGS;TIMP2;CLIP2;VEGFA;OBSCN;EGFR;DDB2;D2HGDH;PRNP;NR1D1;ERCC1;ADAMTS7;HADH;PRDX5;BAHCC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;SPTB;TSPAN1;SLC16A3;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;CRTAP;CST3;DNM1;MEF2D;NOS1;GPSM1;DDIT3;BRSK1;SHANK2;ACAD10;PGM1;CRTC1;CLCA2;ADGRB2;ERCC6;NDRG1;ADAMTS13;ABTB1;TCEA2;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARMCX2;TRIM65;ADARB1;SYT8;ARAP1;B3GAT3;HBEGF;RBL2;RPS6KA2;GAA;PYGL;PYCR2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;OBSL1;EVC;TK2;BBS1;ULK2;CERCAM;CTSF;KLF9;REEP2;MIF4GD;RAB11FIP4;PHACTR3;CPT2;MLYCD;ASAP2;PLD3;KLHDC2;ASH2L;SOX13;CUL7;LHPP;TMEM92;ATG16L2;PRSS3;HMGCL;HYAL1;NAGLU;ETV4;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;COL6A1;SDCCAG8;ABCA2;PKN1;CAPG;H2AFJ;LPCAT4;TRNP1;DNASE1L1;PHC2;PITPNM1;PHF21A;DGKQ;EML2;MAML3;TUBG2;TMEM173;SNX9;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;NPHP4;VEGFB;OGDHL;SOX12;HDAC11;RAB3B;CD68;PCSK1;MYH11;CYBRD1;ITPR3;HSD11B1L;PITPNC1;APPL2;CIRBP;CAPRIN2;TPM2;TTBK2;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;SLC37A2;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;CEMIP;KDM3A;BRI3;PHF1;GLDC;NDUFA4L2;TMEM44;USP20;SALL2;SYNE3;NMNAT2;DDX59;WDR27;MICALL2;NME4;CEP250;NSUN5P2;NEIL1;SHROOM4;ABHD14B;CCDC88B;RAG1;SPPL2B;NGFR;MARCH4;ETV5;ETFB;WDR60;LTBP1;MUC19;SYNC;SMIM14;MALL;NSMCE4A;ACTR1B;CHD2;GPT2;NIPSNAP1;SPG11;TMC6;PNPLA3;RNF44;RMI2;CYHR1;OLFM2;DHRS4;ANO8;TMED4;PLA2G6;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;FAM50A;CARF;S100A13;FKBP10;MTMR4;KIF17;APOBEC3F;PPARA;INO80C;CHD3;CHAC1;CCDC92;SPC24;AIP;MKNK2;SCMH1;IFT27;NLRX1;PKD2;SATB1;STAT6;ING4;NUDCD3;VAMP2;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SEPT5;ECM1;B4GAT1;MARCH9;JADE2;ACACB;KCNAB2;MAPK3;CSPG4;LAMB2;PC;DEF6;BNIP3;MACROD1;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;SCARA3;RGS14;IRF2BPL;DNAL4;FAM20C;MYZAP;PBXIP1;DYSF;RHOF;SLC22A18;CNTRL;ADAMTSL1;TUBE1;CTSB;HOOK2;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;PQLC2;KIAA0319L;SDC2;CHMP1B;MLXIPL;IFNGR2;TBC1D14;PTPDC1;ARHGEF2;SEPT10;FBF1;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;SLC50A1;SDHA;TECPR1;KIF21B;SLC48A1;DMTN;LITAF;PTHLH;UBXN4;NOL4L;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;KDM4C;PAK6;LRRC45;LTB4R2;SV2A;PRIMPOL;FAM193B;RABGAP1;POLM;TENM2;MYH16;FBXO6;KIF26B;REEP6;CBX7;PKD1;FUCA1;NSMCE1;FLOT1;CEP68;TTN;PSKH1;HLCS;AZIN2;HSD11B1;HDAC5;SORL1;MAP6;TFB1M;IL17RD;HERPUD1;SRSF5;VLDLR;GPRC5C;DHX32;DEAF1;TEP1;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;COL4A6;KDM7A;CEBPB;NEK8;RHBDF1;ACOT7;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;DBNDD1;L3MBTL1;ACADS;CEP131;ISG20;LONP2;EPN3;HLTF;DNMT3A;TRIOBP;TRPV4;MXD3;DIRC2;TTC12;TMSB4X;MAP1LC3A;HSD17B7;PDE2A;SMURF2;RAB40B;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;PIGZ;HEXB;LDOC1;SLC27A3;WNT7A;TTLL11;MARCH2;BNIP3L;RHBDF2;NICN1;RPUSD3;ANGEL1;GAS6;VPS39;GLUD1;SUCLG2;ERN1;CEP126;LZTS2;ALKBH7;CROCC;MAPRE3;ATP7B;MAN2C1;CEP112;NBR1;CPT1C;HEXA;GOLGA2P5;TNNI2;TADA3;NBEAL2;KIF13B;SPAG16;NECAB3;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;MBD1;TNRC18;RAB43;SPATA7;CTSH;WDR19;ACOX3;ACAD11;CCDC15;GSDMC;MGMT;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;DGUOK;REEP4;MICAL1;CRY2;MZT2B;B4GALT2;LAMB1;CHEK2;IFT57;LACTB2;PHYKPL;SBF2;SEPT6;TNNT1;NFU1;WDR66;TSG101;KIF27;PHF2;RASSF9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;LMNA;FAAH;UPP1;COPG1;C9ORF72;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;IFI27;PLAU;INSR;WNT3;ACSS1;KRT19;NELFCD;SLC25A29;FOXO4;COG7;YPEL3;RPS6KA5;ANKZF1;CHMP4C;SMIM20;TPCN1;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;C6ORF89;PIGQ;MAP2K5;ZNF554;CPSF4;POLR2J2;LETMD1;HOXC5;GJB4;FAAP20;PIDD1;CAT;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;TIMP1;HFE;TP73;MTA3;TUBGCP6;MNT;SNX33;UBOX5;APRT;CERS4;PEX7;SNX17;ENDOV;PHC1;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;HSF4;REC8;RNF213;SLC9A7;SLC37A4;EHD3;RPL39L;FYN;ZC3H12D;EML3;ATP8B2;PJA2;SNX1;PEX1;LEMD2;UBXN6;SLC25A42;SIRT2;MBOAT2;RECQL5;RAB13;TOM1;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;POU2F2;POLR3GL;RHOBTB3;MTA1;RTN2;MSH5;ENTPD2;AP2A2;CIDEA;HDAC8;MYO18A;ADIRF;RPL29;RETSAT;TCF7;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MFNG;CHD6;RNF170;LURAP1;MAGI1;POLR2J3;PER1;LRCH4;SEPT8;MCTP2;FGFR1;PIGV;WFS1;ESYT3;BLOC1S1;FITM2;FKBP8;SH3PXD2A;XYLT2;ERBB2;SEC31B;KDELC2;UST;UNC119;CCDC69;RGS12;SYVN1;PFKL;HLA-G;CORO1B;SFI1;RPL12;MPPE1;HMBOX1;TTC19;TNNI1;CREB3L4;IRF2BP2;BSG;ZMYM3;SDHAF4;TRIM45;KCTD13;PEX11A;TMEM8A;DTD1;KDSR;DMTF1;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4
16450,GO:0097159,0.999999999828663,3.1795512411924e-10,440,4611,organic cyclic compound binding,MF,XDH;H6PD;ACTA2;ZC3H6;NT5E;NYNRIN;APOE;ZMYND8;NFATC4;XPC;FOS;PRODH;OSBPL5;H1F0;ACSF2;PYGB;EGR1;ZNF862;PTK6;GLUL;LRP1;PDCD4;OBSCN;EGFR;ZSCAN18;DDB2;D2HGDH;ZDHHC1;SCN8A;NR1D1;ERCC1;HADH;S100A4;PRDX5;BAHCC1;NEK9;RAPGEF3;ZKSCAN1;DGKA;SLC16A3;IDH2;FKBP9;DNM1;MEF2D;NOS1;DDIT3;BRSK1;ACAD10;ERCC6;ABTB1;TCEA2;KHNYN;ZCCHC24;MYH15;SMARCA1;MST1R;HEBP1;ZFP36L1;ADARB1;CUL9;NUPR1;TCFL5;RBL2;PHGDH;RPS6KA2;PYGL;CYP3A5;DHTKD1;TFDP2;MXI1;RPL13A;TK2;ULK2;SLC27A1;MAPK13;KLF9;MIF4GD;CDK18;ASH2L;SOX13;ETV4;TXNRD3;MAP2K1;CYP27B1;PCK2;MXD4;CRYL1;ABCA2;PKN1;H2AFJ;ALPK1;OPLAH;TRNP1;DNASE1L1;PHC2;PHF21A;DGKQ;ZNF76;PBX2;TUBG2;TMEM173;THAP8;DNAH1;ARL2;ULK1;VPS11;GRB7;R3HDM2;OGDHL;SOX12;RAB3B;MYH11;UNK;NMRK1;CIRBP;CAPRIN2;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;APOBEC3C;AARS;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;KDM3A;MTHFR;FOXQ1;PHF1;GLDC;NPR2;CBS;SALL2;NMNAT2;DDX59;NME4;ETV1;NSUN5P2;NEIL1;ACVR2B;RAG1;SPEG;ETV5;NSUN7;ACTR1B;HES2;CHD2;GPT2;TEF;TNS1;RMI2;RHOBTB2;ABCG1;XPOT;FAM50A;CARF;MANF;AGAP1;CARS;FKBP10;KIF17;SPATS2;APOBEC3F;PPARA;CHD3;MKNK2;TCF25;IFT27;NLRX1;SATB1;STAT6;KLF7;R3HDM4;HMGA2;SEPT5;ACACB;NT5C1B;MAPK3;PC;OSBPL10;THRA;STK40;ACSS2;MVD;FAM20C;TDRKH;RHOF;TUBE1;PAN2;ZSCAN30;EIF2D;MAPK12;MYH3;LTA4H;PI4K2A;NAT14;ZXDC;PAQR6;MLXIPL;SEPT10;TSPYL2;MAP2K2;H1FX;HIBADH;FLYWCH1;TWF2;SDHA;KIF21B;SLC48A1;LITAF;ATF4;ZFPM1;PAK6;ZNF467;POLM;KIF26B;ZNF516;TTN;PSKH1;HLCS;HSD11B1;JDP2;HDAC5;GTPBP1;IRF5;GALK1;TFB1M;NTPCR;PCBP4;SRSF5;NADK;DHX32;DEAF1;TEP1;NLRP1;PEG3;GLI4;RFX2;ENDOG;CEBPB;MAP3K12;NEK8;WNK4;CREBRF;PCSK9;ZNF251;PKN3;ACADS;ISG20;LONP2;MARK3;HLTF;DNMT3A;TGFBR2;TRPV4;MXD3;FOXL1;CSRNP3;TMSB4X;SLFN5;MOCOS;PDE2A;TRIB3;RAB40B;ARL10;BHLHE40;MLH3;CALCOCO1;HMG20B;NOS3;AGO4;MINK1;PROM2;ZFP90;SLC27A3;TTLL11;TRPV1;PIP5KL1;EPHA1;ZNF558;RPUSD3;ZNF662;GLUD1;SUCLG2;ERN1;NUDT6;BCR;ATP7B;FYCO1;CHKB;EXD3;SRR;KIF13B;UCKL1;CAMK1;POLL;TERC;CYP2R1;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;THNSL2;PRDM8;STRADB;ACOX3;ACAD11;MGMT;ASNS;TM7SF2;PAIP2B;HINT2;MAPKBP1;AKT1;DGUOK;MICAL1;CRY2;CHEK2;IFT57;LACTB2;PHYKPL;SEPT6;ASS1;TSG101;KIF27;FGFR4;IGF2BP2;ZNF217;CBR4;ACADVL;NUCB2;ZNF25;DNASE2;UHRF2;SMARCD2;MARK4;RAB25;INSR;ACSS1;NELFCD;FOXO4;GNAL;RPS6KA5;ANKZF1;LTB4R;TXNRD2;MAP2K5;BRAF;ZNF554;CPSF4;POLR2J2;HOXC5;CAT;ZNF160;MAPK10;MPG;LGALS1;ZFP28;JAK3;TP73;MTA3;MNT;ZNF846;APRT;TFEB;CERS4;LSM14B;ENDOV;PHC1;SCYL3;ATP12A;CSNK1E;BCL6;HSF4;TKFC;EHD3;RPL39L;FYN;MAST4;ATP8B2;PEX1;LEMD2;SIRT2;RECQL5;RAB13;TST;ADA;POU2F2;RCOR2;RHOBTB3;ETNK2;MTA1;MSH5;ENTPD2;FUK;PAIP2;MYO18A;RPL29;TCF7;EPAS1;MAP3K10;CHD6;EPHB2;MAGI1;POLR2J3;PER1;SEPT8;IGF2BP3;FGFR1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;STK32B;PFKL;RPL12;HMBOX1;HSP90AB4P;TSHZ1;CREB3L4;ZNF449;ZMYM3;DBP;ZNF667;ZNF287;CAMKK1;DTD1;IKBKB;DMTF1;CYP4V2;TEAD2;SIX5
10380,GO:0043229,0.99999999992804,1.79218333317659e-10,1001,9296,intracellular organelle,CC,TNIP1;XDH;DUSP6;H6PD;PTPRS;ACTA2;DLG4;ZC3H6;DOCK4;GAMT;BBS2;F2R;ST6GALNAC2;NT5E;APOE;MARVELD1;BTBD2;SYTL1;ESPN;ZMYND8;HS1BP3;NFATC4;FLNC;XPC;SERPINE2;FHL1;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;VWA5A;ALDH7A1;TYSND1;POSTN;SUGCT;WIPF1;SLC2A3;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;NAPRT;EDEM1;CRAT;GLUL;FAM210B;LRP1;RSPH3;ALOX15B;NAGS;PDCD4;TIMP2;CLIP2;VEGFA;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;DDB2;D2HGDH;PRNP;ZDHHC1;SCN8A;NR1D1;ERCC1;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;IFT140;RAPGEF3;BPHL;CLTCL1;FCHO1;ZKSCAN1;SPTB;NPEPL1;LOXL1;TSPAN1;SLC16A3;IGFBP4;KRT15;CD9;NINL;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;PARVB;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;SHANK2;DNAJB5;ACAD10;PGM1;CRTC1;CLCA2;PACS2;ADGRB2;ERCC6;NDRG1;ADAMTS13;ABTB1;TCEA2;PLEKHH1;COL13A1;GRAMD4;MYH15;SMARCA1;MST1R;ARRDC1;ARMCX2;TRIM65;ZFP36L1;ADARB1;PPM1M;SYT8;NUPR1;RIN1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RPS6KA2;GAA;PYGL;PYCR2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;MSRB2;OBSL1;MDFI;EVC;TK2;BBS1;PLAT;ULK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;RAB11FIP4;CDK18;NISCH;PHACTR3;CPT2;MLYCD;ASAP2;PLD3;KLHDC2;ASH2L;SOX13;CUL7;LHPP;TMEM92;EPM2A;ATG16L2;PRSS3;HMGCL;UROS;HYAL1;MPRIP;NAGLU;OXLD1;ETV4;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;COL6A1;PPL;SDCCAG8;ABCA2;PKN1;CAPG;DDIT4;H2AFJ;LPCAT4;BTG1;TRNP1;DNASE1L1;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;EML2;MAML3;TUBG2;TMEM173;SNX9;PLEKHG5;FAM110C;DNAH1;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;GRB7;NPHP4;VEGFB;R3HDM2;OGDHL;SOX12;HDAC11;RAB3B;CD68;PCSK1;PLEKHH3;PTMS;MYH11;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;APPL2;CIRBP;CAPRIN2;TPM2;TTBK2;LY6K;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;BRI3;FOXQ1;ARVCF;PHF1;GLDC;NDUFA4L2;TMEM44;CBS;TMEM187;USP20;SALL2;SYNE3;NMNAT2;DDX59;WDR27;MICALL2;NME4;PDZD2;CEP250;FBXW8;ETV1;NSUN5P2;NEIL1;SHROOM4;ABHD14B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;MARCH4;ETV5;ETFB;WDR60;LTBP1;MUC19;SYNC;SMIM14;MALL;WNT2B;NSMCE4A;ACTR1B;TRIB2;HES2;CHD2;GPT2;TEF;TNS1;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;OLFM2;DHRS4;CCDC106;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;RINL;FAM50A;CARF;MANF;S100A13;AGAP1;FKBP10;MTMR4;KIF17;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;SCMH1;TCF25;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;R3HDM4;SH3TC2;ING4;NUDCD3;VAMP2;HMGA2;AREG;ST6GALNAC6;ENKD1;COL8A1;AP1G2;SLIT3;SEPT5;ECM1;B4GAT1;MARCH9;PCLO;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;ITGB5;LAMB2;PC;DEF6;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;DCAF10;PEX10;STK40;VANGL2;ACSS2;SCARA3;RGS14;IRF2BPL;DNAL4;FAM20C;MYZAP;TDRKH;PBXIP1;DYSF;RHOF;PLEK2;SLC22A18;CNTRL;ADAMTSL1;SNTA1;TUBE1;PAN2;CTSB;HOOK2;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;PI4K2A;NAT14;ZXDC;PQLC2;KIAA0319L;SDC2;CHMP1B;NRSN2;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;TCTN1;PTPDC1;ARHGEF2;SEPT10;FBF1;INPP5D;PRAF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;TWF2;STMN3;SLC50A1;SDHA;TECPR1;KIF21B;SLC48A1;EHBP1L1;DMTN;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;ATF4;PROCR;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;SSH1;LRRC45;LTB4R2;SV2A;FAM214B;SLC38A10;PRIMPOL;FAM193B;FRMD4B;RABGAP1;POLM;ACAP3;TENM2;MYH16;FBXO6;KIF26B;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;RALGAPA1;FLOT1;CEP68;TTN;PSKH1;HLCS;AZIN2;HSD11B1;JDP2;HDAC5;WHAMMP3;IRF5;SORL1;MAP6;TFB1M;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;GPRC5C;DHX32;DEAF1;TEP1;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;PEG3;COL4A6;GLI4;RFX2;ENDOG;KDM7A;CEBPB;NEK8;RHBDF1;ACOT7;LRP5;TSTD1;ATRAID;ALDOC;NDE1;CREBRF;PCSK9;ZNF251;DBNDD1;PKIB;L3MBTL1;PKN3;METTL23;AQP3;ACADS;CEP131;ISG20;LONP2;EPN3;DGCR6L;HLTF;DNMT3A;TRIOBP;TRPV4;MXD3;TAGLN3;FOXL1;DIRC2;CSRNP3;TTC12;ITGA1;TMSB4X;SLFN5;MAP1LC3A;APOL4;HSD17B7;PDE2A;SMURF2;LMO7;TRIB3;RAB40B;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;PROM2;ZFP90;SLC27A3;WNT7A;TTLL11;MARCH2;BNIP3L;PIK3R2;RHBDF2;NICN1;ZNF558;RPUSD3;ANGEL1;ZNF662;CCS;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;CEP126;NUDT6;LZTS2;ESRG;ALKBH7;CROCC;MAPRE3;ATP7B;FYCO1;MAN2C1;C19ORF33;CEP112;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;TADA3;NBEAL2;BOLA1;KIF13B;SPAG16;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;CYP2R1;PPP1R15A;RXRA;RIMS3;ZNF358;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;PRDM8;SLC9A3R2;STRADB;CTSH;WDR19;ACOX3;ACAD11;PNRC1;CCDC15;UACA;GSDMC;MGMT;TMEM9;ENTPD6;C12ORF66;TM7SF2;PLEKHG6;STEAP2;HINT2;MAPKBP1;AKT1;ZFYVE21;IGFBP7;ITPR2;DGUOK;REEP4;CDKN1C;MICAL1;SWT1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;IFT57;LACTB2;PHYKPL;TMEM143;SBF2;IGFBP2;SEPT6;ASS1;TNNT1;COMTD1;NFU1;WDR66;CABYR;TSG101;KIF27;FMNL3;PHF2;FGFR4;IGF2BP2;RASSF9;ZNF217;TMOD2;SNN;PIAS3;TCIRG1;ASAP3;HAGH;STEAP3;CBR4;PHLDA1;ACADVL;NUCB2;ZNF25;FARP1;DNASE2;LMNA;FAAH;UPP1;MAB21L2;COPG1;ATG2A;WDFY2;C9ORF72;SGSM2;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;MARK4;ARHGAP27;RAB25;C1ORF210;IFI27;PTOV1;PLAU;INSR;WNT3;ACSS1;KRT19;NCOA7;NELFCD;TENM4;SLC25A29;FOXO4;COG7;YPEL3;RPS6KA5;ANKZF1;CHMP4C;PNPLA4;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;C6ORF89;PIGQ;LYST;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;ARHGAP44;ZNF554;CPSF4;POLR2J2;LETMD1;ASIC1;ALDH1L1;HOXC5;GJB4;FAAP20;PIDD1;CAT;ZNF160;MZT2A;MYOF;HAUS4;MAPK10;DPP7;YPEL5;MPG;LGALS1;ZFP28;TIMP1;HFE;JAK3;TP73;MTA3;TUBGCP6;MNT;FRAT1;SNX33;UBOX5;ZNF846;APRT;FCHSD1;TMX4;TFEB;MIB2;CERS4;PEX7;SNX17;ENDOV;PHC1;SCYL3;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;RABAC1;HSF4;REC8;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;SLC37A4;EHD3;RPL39L;FYN;ZC3H12D;EML3;ATP8B2;PJA2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;SLC25A42;SIRT2;MBOAT2;GDF15;RECQL5;RAB13;OSBPL1A;MPDZ;TOM1;FAM220A;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;POU2F2;RCOR2;POLR3GL;RHOBTB3;NAGA;MTA1;RTN2;MSH5;ENTPD2;AP2A2;CIDEA;HDAC8;MYO18A;ADIRF;RPL29;RETSAT;CIDEB;TCF7;RNPEP;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;TBC1D16;MFNG;CHD6;RNF170;LURAP1;EPHB2;NMRAL1;MAGI1;POLR2J3;PER1;LRCH4;SEPT8;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;SH3PXD2A;XYLT2;ERBB2;SEC31B;KDELC2;UST;EIF2AK4;UNC119;CCDC69;RGS12;SYVN1;PFKL;C15ORF62;HLA-G;CORO1B;SFI1;RPL12;MPPE1;HMBOX1;NET1;TTC19;TSHZ1;TNNI1;CREB3L4;ZNF449;IRF2BP2;BSG;ZMYM3;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTD1;KDSR;IKBKB;DMTF1;SNCB;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;SIX5
9128,GO:0035485,0.99999999997304,0.882474640171763,0,1,adenine/guanine mispair binding,MF,
14059,GO:0060907,0.999999999974201,0.687957247522227,0,3,positive regulation of macrophage cytokine production,BP,
9185,GO:0035582,0.999999999974935,0.681240313083237,0,3,sequestering of BMP in extracellular matrix,BP,
1738,GO:0004340,0.999999999975504,0.681522269862033,0,3,glucokinase activity,MF,
1779,GO:0004396,0.999999999975504,0.681522269862033,0,3,hexokinase activity,MF,
3986,GO:0008865,0.999999999975504,0.681522269862033,0,3,fructokinase activity,MF,
6041,GO:0019158,0.999999999975504,0.681522269862033,0,3,mannokinase activity,MF,
1246,GO:0002949,0.999999999975996,0.687814241011812,0,3,tRNA threonylcarbamoyladenosine modification,BP,
5973,GO:0018479,0.999999999976778,0.881174745814326,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
14333,GO:0061574,0.999999999976883,0.683370574187938,0,3,ASAP complex,CC,
19640,GO:1990930,0.999999999977215,0.884812394138858,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
14823,GO:0070602,0.99999999997749,0.693462055028696,0,3,regulation of centromeric sister chromatid cohesion,BP,
9201,GO:0035602,0.999999999978037,0.880146634461164,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9202,GO:0035603,0.999999999978037,0.880146634461164,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9203,GO:0035604,0.999999999978037,0.880146634461164,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
13906,GO:0060595,0.999999999978037,0.880146634461164,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13919,GO:0060615,0.999999999978037,0.880146634461164,0,1,mammary gland bud formation,BP,
13929,GO:0060648,0.999999999978037,0.880146634461164,0,1,mammary gland bud morphogenesis,BP,
13935,GO:0060667,0.999999999978037,0.880146634461164,0,1,branch elongation involved in salivary gland morphogenesis,BP,
14064,GO:0060915,0.999999999978037,0.880146634461164,0,1,mesenchymal cell differentiation involved in lung development,BP,
328,GO:0000917,0.999999999978305,0.882438195081014,0,1,division septum assembly,BP,
16298,GO:0090529,0.999999999978305,0.882438195081014,0,1,cell septum assembly,BP,
16024,GO:0086089,0.999999999978782,0.880331136099702,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17914,GO:1902282,0.999999999978782,0.880331136099702,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
15942,GO:0080058,0.999999999978951,0.887406475112167,0,1,protein deglutathionylation,BP,
16642,GO:0097573,0.999999999978951,0.887406475112167,0,1,glutathione oxidoreductase activity,MF,
2156,GO:0004984,0.99999999997899,0.703983445936125,0,3,olfactory receptor activity,MF,
12670,GO:0050911,0.99999999997899,0.703983445936125,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
11639,GO:0046404,0.999999999979161,0.686387524266411,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
13135,GO:0051733,0.999999999979161,0.686387524266411,0,3,polydeoxyribonucleotide kinase activity,MF,
13136,GO:0051734,0.999999999979161,0.686387524266411,0,3,ATP-dependent polynucleotide kinase activity,MF,
15907,GO:0072733,0.999999999979475,0.68614200169318,0,3,response to staurosporine,BP,
15908,GO:0072734,0.999999999979475,0.68614200169318,0,3,cellular response to staurosporine,BP,
15264,GO:0071475,0.999999999979591,0.687753808693001,0,3,cellular hyperosmotic salinity response,BP,
2821,GO:0006288,0.999999999979629,0.689275618032971,0,3,base-excision repair, DNA ligation,BP,
1961,GO:0004673,0.999999999979709,0.898023852957105,0,1,protein histidine kinase activity,MF,
5895,GO:0018106,0.999999999979709,0.898023852957105,0,1,peptidyl-histidine phosphorylation,BP,
2154,GO:0004979,0.999999999979943,0.882334570233789,0,1,beta-endorphin receptor activity,MF,
7464,GO:0031635,0.999999999979943,0.882334570233789,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7659,GO:0032097,0.999999999979943,0.882334570233789,0,1,positive regulation of response to food,BP,
7662,GO:0032100,0.999999999979943,0.882334570233789,0,1,positive regulation of appetite,BP,
9665,GO:0038047,0.999999999979943,0.882334570233789,0,1,morphine receptor activity,MF,
11699,GO:0046521,0.999999999979943,0.882334570233789,0,1,sphingoid catabolic process,BP,
14256,GO:0061358,0.999999999979943,0.882334570233789,0,1,negative regulation of Wnt protein secretion,BP,
7961,GO:0032581,0.999999999980218,0.882461338283769,0,1,ER-dependent peroxisome organization,BP,
17196,GO:0106101,0.999999999980218,0.882461338283769,0,1,ER-dependent peroxisome localization,BP,
12410,GO:0048936,0.999999999980385,0.683314414628187,0,3,peripheral nervous system neuron axonogenesis,BP,
11967,GO:0047323,0.999999999980775,0.881076779945573,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13320,GO:0052381,0.999999999980775,0.881076779945573,0,1,tRNA dimethylallyltransferase activity,MF,
11926,GO:0047021,0.999999999980949,0.889069569563658,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12433,GO:0050221,0.999999999980949,0.889069569563658,0,1,prostaglandin-E2 9-reductase activity,MF,
12413,GO:0050023,0.999999999980976,0.882353729945165,0,1,L-fuconate dehydratase activity,MF,
13064,GO:0051598,0.999999999981253,0.880123940165822,0,1,meiotic recombination checkpoint,BP,
18848,GO:1904535,0.999999999981281,0.880124247878578,0,1,positive regulation of telomeric loop disassembly,BP,
11976,GO:0047395,0.999999999981385,0.88032653238548,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
11998,GO:0047620,0.999999999981385,0.88032653238548,0,1,acylglycerol kinase activity,MF,
2265,GO:0005184,0.999999999982028,0.703709590240198,0,3,neuropeptide hormone activity,MF,
2300,GO:0005280,0.999999999982187,0.681976129371635,0,3,amino acid:proton symporter activity,MF,
19302,GO:1905643,0.999999999982247,0.880062665750648,0,1,positive regulation of DNA methylation,BP,
20099,GO:2000820,0.999999999982247,0.880062665750648,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
10690,GO:0043997,0.999999999982275,0.880300501974125,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
17189,GO:0106075,0.999999999982275,0.880300501974125,0,1,peptide N-succinyltransferase activity,MF,
17191,GO:0106078,0.999999999982275,0.880300501974125,0,1,histone succinyltransferase activity,MF,
2314,GO:0005315,0.999999999982289,0.68109419702803,0,3,inorganic phosphate transmembrane transporter activity,MF,
878,GO:0002238,0.999999999982568,0.880122665346401,0,1,response to molecule of fungal origin,BP,
940,GO:0002351,0.999999999982568,0.880122665346401,0,1,serotonin production involved in inflammatory response,BP,
985,GO:0002442,0.999999999982568,0.880122665346401,0,1,serotonin secretion involved in inflammatory response,BP,
1040,GO:0002554,0.999999999982568,0.880122665346401,0,1,serotonin secretion by platelet,BP,
6241,GO:0019814,0.999999999982568,0.880122665346401,0,1,immunoglobulin complex,CC,
6242,GO:0019815,0.999999999982568,0.880122665346401,0,1,B cell receptor complex,CC,
8063,GO:0032752,0.999999999982568,0.880122665346401,0,1,positive regulation of interleukin-3 production,BP,
9890,GO:0042223,0.999999999982568,0.880122665346401,0,1,interleukin-3 biosynthetic process,BP,
11212,GO:0045399,0.999999999982568,0.880122665346401,0,1,regulation of interleukin-3 biosynthetic process,BP,
11213,GO:0045401,0.999999999982568,0.880122665346401,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11222,GO:0045423,0.999999999982568,0.880122665346401,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11223,GO:0045425,0.999999999982568,0.880122665346401,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
15109,GO:0071226,0.999999999982568,0.880122665346401,0,1,cellular response to molecule of fungal origin,BP,
11806,GO:0046725,0.999999999982615,0.880222391459014,0,1,negative regulation by virus of viral protein levels in host cell,BP,
15638,GO:0072183,0.999999999982615,0.880222391459014,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15708,GO:0072308,0.999999999982615,0.880222391459014,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
1835,GO:0004493,0.999999999982671,0.895384681331532,0,1,methylmalonyl-CoA epimerase activity,MF,
11681,GO:0046491,0.999999999982671,0.895384681331532,0,1,L-methylmalonyl-CoA metabolic process,BP,
17092,GO:0102008,0.999999999982736,0.880122720905042,0,1,cytosolic dipeptidase activity,MF,
17153,GO:0103046,0.999999999982736,0.880122720905042,0,1,alanylglutamate dipeptidase activity,MF,
8184,GO:0032937,0.999999999982923,0.682111789860092,0,3,SREBP-SCAP-Insig complex,CC,
457,GO:0001306,0.999999999982925,0.892608526378429,0,1,age-dependent response to oxidative stress,BP,
458,GO:0001315,0.999999999982925,0.892608526378429,0,1,age-dependent response to reactive oxygen species,BP,
1272,GO:0003068,0.999999999982925,0.892608526378429,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1273,GO:0003069,0.999999999982925,0.892608526378429,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1274,GO:0003070,0.999999999982925,0.892608526378429,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
3545,GO:0007571,0.999999999982925,0.892608526378429,0,1,age-dependent general metabolic decline,BP,
7847,GO:0032416,0.999999999982934,0.881575710929826,0,1,negative regulation of sodium:proton antiporter activity,BP,
16516,GO:0097291,0.999999999982934,0.881575710929826,0,1,renal phosphate ion absorption,BP,
12375,GO:0048822,0.99999999998304,0.681685630566869,0,3,enucleate erythrocyte development,BP,
20132,GO:2000977,0.999999999983101,0.69289982467438,0,3,regulation of forebrain neuron differentiation,BP,
9113,GO:0035441,0.999999999983154,0.878886388366285,0,1,cell migration involved in vasculogenesis,BP,
7353,GO:0031404,0.999999999983224,0.689946482946412,0,3,chloride ion binding,MF,
8413,GO:0033504,0.999999999983278,0.68151778367882,0,3,floor plate development,BP,
2111,GO:0004897,0.999999999983431,0.679580666795777,0,3,ciliary neurotrophic factor receptor activity,MF,
14553,GO:0070120,0.999999999983431,0.679580666795777,0,3,ciliary neurotrophic factor-mediated signaling pathway,BP,
1832,GO:0004490,0.999999999983517,0.884633053407685,0,1,methylglutaconyl-CoA hydratase activity,MF,
12412,GO:0050011,0.999999999983517,0.884633053407685,0,1,itaconyl-CoA hydratase activity,MF,
8224,GO:0033004,0.999999999983519,0.685844937526488,0,3,negative regulation of mast cell activation,BP,
8227,GO:0033007,0.999999999983519,0.685844937526488,0,3,negative regulation of mast cell activation involved in immune response,BP,
9604,GO:0036483,0.999999999983563,0.88012450460254,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
18349,GO:1903381,0.999999999983563,0.88012450460254,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18350,GO:1903382,0.999999999983563,0.88012450460254,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
8688,GO:0034338,0.999999999983645,0.6815321609797,0,3,short-chain carboxylesterase activity,MF,
14519,GO:0070060,0.999999999983646,0.878292854887451,0,1,'de novo' actin filament nucleation,BP,
3362,GO:0007113,0.999999999983757,0.69316161227111,0,3,endomitotic cell cycle,BP,
7751,GO:0032276,0.999999999983797,0.681372242624725,0,3,regulation of gonadotropin secretion,BP,
7753,GO:0032278,0.999999999983797,0.681372242624725,0,3,positive regulation of gonadotropin secretion,BP,
11852,GO:0046880,0.999999999983797,0.681372242624725,0,3,regulation of follicle-stimulating hormone secretion,BP,
11853,GO:0046881,0.999999999983797,0.681372242624725,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
7002,GO:0030696,0.999999999983852,0.880294573587209,0,1,tRNA (m5U54) methyltransferase activity,MF,
7003,GO:0030697,0.999999999983852,0.880294573587209,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
15395,GO:0071691,0.999999999983922,0.879784144658266,0,1,cardiac muscle thin filament assembly,BP,
9788,GO:0040030,0.99999999998402,0.880184973960075,0,1,regulation of molecular function, epigenetic,BP,
10271,GO:0043035,0.99999999998402,0.880184973960075,0,1,chromatin insulator sequence binding,MF,
16619,GO:0097510,0.999999999984031,0.88136999160888,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
5944,GO:0018293,0.99999999998409,0.889628607350754,0,1,protein-FAD linkage,BP,
7053,GO:0030849,0.999999999984139,0.880122004146611,0,1,autosome,CC,
12980,GO:0051429,0.999999999984147,0.687765371374302,0,3,corticotropin-releasing hormone receptor binding,MF,
18808,GO:1904428,0.999999999984205,0.686034798301916,0,3,negative regulation of tubulin deacetylation,BP,
2223,GO:0005127,0.999999999984216,0.68162931246355,0,3,ciliary neurotrophic factor receptor binding,MF,
9287,GO:0035747,0.999999999984282,0.690133569121147,0,3,natural killer cell chemotaxis,BP,
1164,GO:0002785,0.999999999984317,0.880205707521086,0,1,negative regulation of antimicrobial peptide production,BP,
1166,GO:0002787,0.999999999984317,0.880205707521086,0,1,negative regulation of antibacterial peptide production,BP,
3781,GO:0008348,0.999999999984317,0.880205707521086,0,1,negative regulation of antimicrobial humoral response,BP,
8168,GO:0032915,0.999999999984361,0.881123031282218,0,1,positive regulation of transforming growth factor beta2 production,BP,
17449,GO:1900370,0.9999999999844,0.880116689655309,0,1,positive regulation of RNA interference,BP,
14472,GO:0061945,0.999999999984458,0.68623454644444,0,3,regulation of protein K48-linked ubiquitination,BP,
10582,GO:0043569,0.999999999984509,0.681611433559631,0,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
13506,GO:0055113,0.999999999984608,0.876103437983593,0,1,epiboly involved in gastrulation with mouth forming second,BP,
1503,GO:0003860,0.999999999984661,0.881951883358442,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
9961,GO:0042365,0.999999999984662,0.694508966002057,0,3,water-soluble vitamin catabolic process,BP,
14961,GO:0070898,0.999999999984667,0.875951615661202,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
7285,GO:0031291,0.999999999984675,0.694299868449476,0,3,Ran protein signal transduction,BP,
5802,GO:0017061,0.999999999984693,0.880122816382788,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
1424,GO:0003383,0.999999999984875,0.681392968225227,0,3,apical constriction,BP,
848,GO:0002176,0.999999999984995,0.703436210362847,0,3,male germ cell proliferation,BP,
9459,GO:0036093,0.999999999984995,0.703436210362847,0,3,germ cell proliferation,BP,
1375,GO:0003273,0.999999999985012,0.681141702866329,0,3,cell migration involved in endocardial cushion formation,BP,
2035,GO:0004778,0.999999999985115,0.884257071215388,0,1,succinyl-CoA hydrolase activity,MF,
8092,GO:0032788,0.999999999985115,0.884257071215388,0,1,saturated monocarboxylic acid metabolic process,BP,
8093,GO:0032789,0.999999999985115,0.884257071215388,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8336,GO:0033204,0.999999999985246,0.880431296912083,0,1,ribonuclease P RNA binding,MF,
3126,GO:0006710,0.999999999985255,0.882271595777292,0,1,androgen catabolic process,BP,
1551,GO:0003952,0.999999999985337,0.880464368255229,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1578,GO:0003990,0.999999999985337,0.880464368255229,0,1,acetylcholinesterase activity,MF,
4817,GO:0014016,0.999999999985337,0.880464368255229,0,1,neuroblast differentiation,BP,
11651,GO:0046448,0.999999999985337,0.880464368255229,0,1,tropane alkaloid metabolic process,BP,
12581,GO:0050783,0.999999999985337,0.880464368255229,0,1,cocaine metabolic process,BP,
5974,GO:0018585,0.999999999985385,0.880982553998135,0,1,fluorene oxygenase activity,MF,
5984,GO:0018917,0.999999999985385,0.880982553998135,0,1,fluorene metabolic process,BP,
3998,GO:0008940,0.999999999985493,0.68206716188819,0,3,nitrate reductase activity,MF,
13024,GO:0051538,0.99999999998552,0.690078151801495,0,3,3 iron, 4 sulfur cluster binding,MF,
13705,GO:0060300,0.99999999998556,0.686779340615488,0,3,regulation of cytokine activity,BP,
7541,GO:0031859,0.999999999985609,0.882090768491279,0,1,platelet activating factor receptor binding,MF,
9861,GO:0042137,0.999999999985609,0.882090768491279,0,1,sequestering of neurotransmitter,BP,
17370,GO:1900126,0.999999999985615,0.681352015115674,0,3,negative regulation of hyaluronan biosynthetic process,BP,
9946,GO:0042335,0.999999999985636,0.682163974944244,0,3,cuticle development,BP,
18532,GO:1903778,0.999999999985674,0.774696508696512,0,2,protein localization to vacuolar membrane,BP,
8610,GO:0034140,0.99999999998569,0.681916455001047,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
16174,GO:0090233,0.999999999985734,0.880352260201246,0,1,negative regulation of spindle checkpoint,BP,
17965,GO:1902426,0.999999999985734,0.880352260201246,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19193,GO:1905341,0.999999999985734,0.880352260201246,0,1,negative regulation of protein localization to kinetochore,BP,
8733,GO:0034395,0.999999999985739,0.885072539924046,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
1091,GO:0002679,0.999999999985741,0.694356084920806,0,3,respiratory burst involved in defense response,BP,
3922,GO:0008607,0.999999999985756,0.685661435550651,0,3,phosphorylase kinase regulator activity,MF,
18416,GO:1903527,0.999999999985807,0.681574809362834,0,3,positive regulation of membrane tubulation,BP,
18090,GO:1902775,0.999999999985813,0.681686108104951,0,3,mitochondrial large ribosomal subunit assembly,BP,
966,GO:0002408,0.999999999985849,0.880111879533962,0,1,myeloid dendritic cell chemotaxis,BP,
17959,GO:1902412,0.999999999985893,0.681335669282477,0,3,regulation of mitotic cytokinesis,BP,
443,GO:0001192,0.999999999985938,0.895310415097266,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
444,GO:0001193,0.999999999985938,0.895310415097266,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
16434,GO:0097129,0.99999999998594,0.693069170345854,0,3,cyclin D2-CDK4 complex,CC,
16687,GO:0097699,0.999999999985982,0.880126549037656,0,1,vascular endothelial cell response to fluid shear stress,BP,
18239,GO:1903126,0.999999999986017,0.88107354961878,0,1,negative regulation of centriole-centriole cohesion,BP,
20201,GO:2001173,0.999999999986017,0.88107354961878,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
2894,GO:0006404,0.99999999998605,0.691552578538281,0,3,RNA import into nucleus,BP,
6660,GO:0030023,0.999999999986072,0.674729923581664,0,3,extracellular matrix constituent conferring elasticity,MF,
9797,GO:0042007,0.999999999986139,0.886631227140983,0,1,interleukin-18 binding,MF,
10929,GO:0044611,0.999999999986191,0.681620641633867,0,3,nuclear pore inner ring,CC,
6807,GO:0030272,0.999999999986193,0.895125329725071,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
14089,GO:0060971,0.9999999999863,0.680761133203832,0,3,embryonic heart tube left/right pattern formation,BP,
6638,GO:0023041,0.999999999986345,0.684635125225194,0,3,neuronal signal transduction,BP,
19918,GO:2000489,0.999999999986363,0.68325413316809,0,3,regulation of hepatic stellate cell activation,BP,
12044,GO:0048014,0.999999999986403,0.88012020022815,0,1,Tie signaling pathway,BP,
12686,GO:0050928,0.999999999986403,0.88012020022815,0,1,negative regulation of positive chemotaxis,BP,
14216,GO:0061218,0.999999999986407,0.684958083367179,0,3,negative regulation of mesonephros development,BP,
7230,GO:0031151,0.999999999986458,0.879539067531658,0,1,histone methyltransferase activity (H3-K79 specific),MF,
9208,GO:0035609,0.999999999986485,0.880127186993108,0,1,C-terminal protein deglutamylation,BP,
9209,GO:0035610,0.999999999986485,0.880127186993108,0,1,protein side chain deglutamylation,BP,
9241,GO:0035662,0.999999999986494,0.719819146823806,0,3,Toll-like receptor 4 binding,MF,
9920,GO:0042284,0.999999999986499,0.882411955529387,0,1,sphingolipid delta-4 desaturase activity,MF,
327,GO:0000916,0.99999999998651,0.880929623029328,0,1,actomyosin contractile ring contraction,BP,
9503,GO:0036213,0.99999999998651,0.880929623029328,0,1,contractile ring contraction,BP,
1500,GO:0003854,0.999999999986531,0.685942195386521,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
19170,GO:1905292,0.999999999986547,0.683911208735925,0,3,regulation of neural crest cell differentiation,BP,
19171,GO:1905294,0.999999999986547,0.683911208735925,0,3,positive regulation of neural crest cell differentiation,BP,
19177,GO:1905310,0.999999999986547,0.683911208735925,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19178,GO:1905312,0.999999999986547,0.683911208735925,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
10586,GO:0043578,0.99999999998655,0.66402145884582,0,3,nuclear matrix organization,BP,
16215,GO:0090292,0.99999999998655,0.66402145884582,0,3,nuclear matrix anchoring at nuclear membrane,BP,
5423,GO:0016282,0.999999999986646,0.880125769379135,0,1,eukaryotic 43S preinitiation complex,CC,
12439,GO:0050290,0.999999999986677,0.880122950180481,0,1,sphingomyelin phosphodiesterase D activity,MF,
9584,GO:0036455,0.99999999998668,0.890929131533925,0,1,iron-sulfur transferase activity,MF,
1588,GO:0004001,0.999999999986706,0.881355828040004,0,1,adenosine kinase activity,MF,
2000,GO:0004727,0.999999999986706,0.881355828040004,0,1,prenylated protein tyrosine phosphatase activity,MF,
2756,GO:0006169,0.999999999986706,0.881355828040004,0,1,adenosine salvage,BP,
2760,GO:0006175,0.999999999986706,0.881355828040004,0,1,dATP biosynthetic process,BP,
3786,GO:0008355,0.999999999986821,0.880128089975768,0,1,olfactory learning,BP,
2074,GO:0004829,0.999999999986857,0.682327670719067,0,3,threonine-tRNA ligase activity,MF,
2922,GO:0006435,0.999999999986857,0.682327670719067,0,3,threonyl-tRNA aminoacylation,BP,
13273,GO:0052031,0.999999999986861,0.686749821554799,0,3,modulation by symbiont of host defense response,BP,
13307,GO:0052255,0.999999999986861,0.686749821554799,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13339,GO:0052552,0.999999999986861,0.686749821554799,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13340,GO:0052553,0.999999999986861,0.686749821554799,0,3,modulation by symbiont of host immune response,BP,
15932,GO:0075528,0.999999999986861,0.686749821554799,0,3,modulation by virus of host immune response,BP,
5466,GO:0016404,0.999999999986914,0.880126254783842,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
17901,GO:1902255,0.99999999998694,0.723035026598974,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
3023,GO:0006572,0.999999999986967,0.694444918780823,0,3,tyrosine catabolic process,BP,
1833,GO:0004491,0.999999999987019,0.880918585793857,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
4732,GO:0010904,0.999999999987019,0.880918585793857,0,1,regulation of UDP-glucose catabolic process,BP,
4733,GO:0010905,0.999999999987019,0.880918585793857,0,1,negative regulation of UDP-glucose catabolic process,BP,
5972,GO:0018478,0.999999999987019,0.880918585793857,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
18721,GO:1904226,0.999999999987019,0.880918585793857,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18722,GO:1904227,0.999999999987019,0.880918585793857,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
9790,GO:0040032,0.999999999987032,0.88216465258816,0,1,post-embryonic body morphogenesis,BP,
11082,GO:0045112,0.999999999987153,0.697024910594468,0,3,integrin biosynthetic process,BP,
14182,GO:0061140,0.99999999998717,0.694194985966238,0,3,lung secretory cell differentiation,BP,
19164,GO:1905277,0.999999999987179,0.88030915667929,0,1,negative regulation of epithelial tube formation,BP,
19968,GO:2000606,0.999999999987179,0.88030915667929,0,1,regulation of cell proliferation involved in mesonephros development,BP,
19969,GO:2000607,0.999999999987179,0.88030915667929,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20033,GO:2000699,0.999999999987179,0.88030915667929,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20034,GO:2000701,0.999999999987179,0.88030915667929,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20035,GO:2000702,0.999999999987179,0.88030915667929,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20036,GO:2000703,0.999999999987179,0.88030915667929,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20048,GO:2000733,0.999999999987179,0.88030915667929,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20049,GO:2000734,0.999999999987179,0.88030915667929,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
7361,GO:0031417,0.999999999987241,0.67695724551412,0,3,NatC complex,CC,
338,GO:0000939,0.999999999987277,0.687750778939252,0,3,condensed chromosome inner kinetochore,CC,
3895,GO:0008537,0.999999999987304,0.70317843496809,0,3,proteasome activator complex,CC,
3773,GO:0008331,0.999999999987314,0.683756647756777,0,3,high voltage-gated calcium channel activity,MF,
11951,GO:0047223,0.999999999987319,0.682306257469392,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
8523,GO:0033860,0.999999999987372,0.707561040970494,0,3,regulation of NAD(P)H oxidase activity,BP,
8525,GO:0033864,0.999999999987372,0.707561040970494,0,3,positive regulation of NAD(P)H oxidase activity,BP,
2150,GO:0004970,0.999999999987424,0.681145945653087,0,3,ionotropic glutamate receptor activity,MF,
2151,GO:0004972,0.999999999987424,0.681145945653087,0,3,NMDA glutamate receptor activity,MF,
17954,GO:1902396,0.999999999987445,0.880168023923437,0,1,protein localization to bicellular tight junction,BP,
14919,GO:0070836,0.999999999987446,0.682828959838989,0,3,caveola assembly,BP,
14255,GO:0061357,0.999999999987465,0.68212850444765,0,3,positive regulation of Wnt protein secretion,BP,
11918,GO:0046985,0.999999999987488,0.687452230883328,0,3,positive regulation of hemoglobin biosynthetic process,BP,
4161,GO:0009227,0.999999999987491,0.688391803404279,0,3,nucleotide-sugar catabolic process,BP,
17488,GO:1900748,0.999999999987507,0.681198018842353,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18895,GO:1904647,0.999999999987529,0.87827717144645,0,1,response to rotenone,BP,
3980,GO:0008829,0.999999999987568,0.882628194446276,0,1,dCTP deaminase activity,MF,
13653,GO:0060212,0.999999999987568,0.882628194446276,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17388,GO:1900152,0.999999999987568,0.882628194446276,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
19505,GO:1990439,0.999999999987583,0.880325166019125,0,1,MAP kinase serine/threonine phosphatase activity,MF,
1947,GO:0004654,0.999999999987619,0.880123946076517,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
16322,GO:0090616,0.999999999987619,0.880123946076517,0,1,mitochondrial mRNA 3'-end processing,BP,
16486,GO:0097222,0.999999999987619,0.880123946076517,0,1,mitochondrial mRNA polyadenylation,BP,
19827,GO:2000328,0.99999999998762,0.692526408519835,0,3,regulation of T-helper 17 cell lineage commitment,BP,
14711,GO:0070404,0.999999999987681,0.695308856500171,0,3,NADH binding,MF,
450,GO:0001224,0.999999999987687,0.67994282287777,0,3,RNA polymerase II transcription cofactor binding,MF,
13482,GO:0055077,0.999999999987725,0.682187215050824,0,3,gap junction hemi-channel activity,MF,
11629,GO:0046380,0.999999999987778,0.880184817950297,0,1,N-acetylneuraminate biosynthetic process,BP,
12421,GO:0050124,0.999999999987778,0.880184817950297,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13936,GO:0060668,0.999999999987781,0.880214054691409,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
2773,GO:0006203,0.999999999987818,0.697084724113995,0,3,dGTP catabolic process,BP,
10947,GO:0044725,0.999999999987821,0.876127087471729,0,1,chromatin reprogramming in the zygote,BP,
10948,GO:0044727,0.999999999987821,0.876127087471729,0,1,DNA demethylation of male pronucleus,BP,
9966,GO:0042374,0.999999999987821,0.891181509325531,0,1,phylloquinone metabolic process,BP,
9967,GO:0042376,0.999999999987821,0.891181509325531,0,1,phylloquinone catabolic process,BP,
17705,GO:1901662,0.999999999987821,0.891181509325531,0,1,quinone catabolic process,BP,
9331,GO:0035853,0.999999999987837,0.880125976424265,0,1,chromosome passenger complex localization to spindle midzone,BP,
19585,GO:1990758,0.999999999987865,0.882538595045754,0,1,mitotic sister chromatid biorientation,BP,
1065,GO:0002606,0.99999999998787,0.687883617248449,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
19970,GO:2000609,0.999999999987912,0.683544299657966,0,3,regulation of thyroid hormone generation,BP,
16311,GO:0090571,0.999999999987915,0.686533777370713,0,3,RNA polymerase II transcription repressor complex,CC,
15492,GO:0071898,0.999999999987945,0.686232786635638,0,3,regulation of estrogen receptor binding,BP,
15493,GO:0071899,0.999999999987945,0.686232786635638,0,3,negative regulation of estrogen receptor binding,BP,
16376,GO:0097026,0.999999999987983,0.879129562037435,0,1,dendritic cell dendrite assembly,BP,
1934,GO:0004638,0.999999999988055,0.880263562160581,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1935,GO:0004639,0.999999999988055,0.880263562160581,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
17776,GO:1901897,0.999999999988093,0.681032194091006,0,3,regulation of relaxation of cardiac muscle,BP,
16382,GO:0097037,0.999999999988121,0.880246981263134,0,1,heme export,BP,
15242,GO:0071442,0.999999999988125,0.683269839671409,0,3,positive regulation of histone H3-K14 acetylation,BP,
11430,GO:0045901,0.999999999988133,0.688045303681861,0,3,positive regulation of translational elongation,BP,
6248,GO:0019834,0.999999999988135,0.693330682841377,0,3,phospholipase A2 inhibitor activity,MF,
18278,GO:1903223,0.999999999988151,0.681791724976933,0,3,positive regulation of oxidative stress-induced neuron death,BP,
6527,GO:0021936,0.999999999988212,0.681576865033404,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
12396,GO:0048865,0.999999999988218,0.691833341791794,0,3,stem cell fate commitment,BP,
20181,GO:2001136,0.999999999988266,0.88026249097766,0,1,negative regulation of endocytic recycling,BP,
18228,GO:1903093,0.999999999988288,0.69880870925962,0,3,regulation of protein K48-linked deubiquitination,BP,
13959,GO:0060697,0.999999999988394,0.880340799810925,0,1,positive regulation of phospholipid catabolic process,BP,
17390,GO:1900161,0.999999999988394,0.880340799810925,0,1,regulation of phospholipid scramblase activity,BP,
17391,GO:1900163,0.999999999988394,0.880340799810925,0,1,positive regulation of phospholipid scramblase activity,BP,
20058,GO:2000752,0.999999999988394,0.880340799810925,0,1,regulation of glucosylceramide catabolic process,BP,
20059,GO:2000753,0.999999999988394,0.880340799810925,0,1,positive regulation of glucosylceramide catabolic process,BP,
20060,GO:2000754,0.999999999988394,0.880340799810925,0,1,regulation of sphingomyelin catabolic process,BP,
20061,GO:2000755,0.999999999988394,0.880340799810925,0,1,positive regulation of sphingomyelin catabolic process,BP,
2693,GO:0006061,0.999999999988408,0.886837109514312,0,1,sorbitol biosynthetic process,BP,
5985,GO:0018931,0.999999999988408,0.886837109514312,0,1,naphthalene metabolic process,BP,
6134,GO:0019406,0.999999999988408,0.886837109514312,0,1,hexitol biosynthetic process,BP,
10643,GO:0043795,0.999999999988408,0.886837109514312,0,1,glyceraldehyde oxidoreductase activity,MF,
16276,GO:0090420,0.999999999988408,0.886837109514312,0,1,naphthalene-containing compound metabolic process,BP,
17860,GO:1902167,0.999999999988437,0.901023646304526,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
18971,GO:1904803,0.999999999988437,0.901023646304526,0,1,regulation of translation involved in cellular response to UV,BP,
5424,GO:0016286,0.999999999988439,0.880414019430734,0,1,small conductance calcium-activated potassium channel activity,MF,
19495,GO:1990415,0.999999999988457,0.68333735778958,0,3,Pex17p-Pex14p docking complex,CC,
19503,GO:1990429,0.999999999988457,0.68333735778958,0,3,peroxisomal importomer complex,CC,
20117,GO:2000848,0.999999999988462,0.695198512505618,0,3,positive regulation of corticosteroid hormone secretion,BP,
15950,GO:0080129,0.999999999988473,0.89144461459461,0,1,proteasome core complex assembly,BP,
13524,GO:0060011,0.999999999988542,0.694481497997295,0,3,Sertoli cell proliferation,BP,
419,GO:0001112,0.99999999998858,0.880314203456582,0,1,DNA-templated transcriptional open complex formation,BP,
420,GO:0001113,0.99999999998858,0.880314203456582,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
421,GO:0001120,0.99999999998858,0.880314203456582,0,1,protein-DNA complex remodeling,BP,
5255,GO:0015889,0.999999999988581,0.692961567532782,0,3,cobalamin transport,BP,
11913,GO:0046979,0.999999999988582,0.688433039891701,0,3,TAP2 binding,MF,
17936,GO:1902338,0.999999999988605,0.681891673371852,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
18939,GO:1904746,0.999999999988605,0.681891673371852,0,3,negative regulation of apoptotic process involved in development,BP,
13564,GO:0060057,0.999999999988606,0.69441576943933,0,3,apoptotic process involved in mammary gland involution,BP,
13565,GO:0060058,0.999999999988606,0.69441576943933,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
17937,GO:1902339,0.999999999988606,0.69441576943933,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
18409,GO:1903519,0.999999999988606,0.69441576943933,0,3,regulation of mammary gland involution,BP,
18410,GO:1903521,0.999999999988606,0.69441576943933,0,3,positive regulation of mammary gland involution,BP,
18940,GO:1904747,0.999999999988606,0.69441576943933,0,3,positive regulation of apoptotic process involved in development,BP,
2077,GO:0004832,0.999999999988609,0.681810177198538,0,3,valine-tRNA ligase activity,MF,
2925,GO:0006438,0.999999999988609,0.681810177198538,0,3,valyl-tRNA aminoacylation,BP,
8149,GO:0032889,0.999999999988637,0.880403458942103,0,1,regulation of vacuole fusion, non-autophagic,BP,
1419,GO:0003366,0.999999999988638,0.880039084734687,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
8855,GO:0034669,0.999999999988638,0.880039084734687,0,1,integrin alpha4-beta7 complex,CC,
19590,GO:1990771,0.999999999988638,0.880039084734687,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
1294,GO:0003129,0.999999999988651,0.686071072464562,0,3,heart induction,BP,
5834,GO:0017126,0.999999999988687,0.880118504958618,0,1,nucleologenesis,BP,
19331,GO:1905773,0.999999999988784,0.681727975639286,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
6310,GO:0019960,0.999999999988806,0.681456386762982,0,3,C-X3-C chemokine binding,MF,
15332,GO:0071593,0.999999999988818,0.686276219895144,0,3,lymphocyte aggregation,BP,
12213,GO:0048496,0.999999999988853,0.682031727478966,0,3,maintenance of animal organ identity,BP,
6667,GO:0030035,0.99999999998886,0.681887826013565,0,3,microspike assembly,BP,
8062,GO:0032747,0.999999999988874,0.695141690565934,0,3,positive regulation of interleukin-23 production,BP,
8567,GO:0034059,0.999999999988962,0.68166303934238,0,3,response to anoxia,BP,
687,GO:0001907,0.999999999989054,0.696686071163192,0,3,killing by symbiont of host cells,BP,
10693,GO:0044004,0.999999999989054,0.696686071163192,0,3,disruption by symbiont of host cell,BP,
10906,GO:0044533,0.999999999989054,0.696686071163192,0,3,positive regulation of apoptotic process in other organism,BP,
13277,GO:0052042,0.999999999989054,0.696686071163192,0,3,positive regulation by symbiont of host programmed cell death,BP,
13313,GO:0052330,0.999999999989054,0.696686071163192,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13332,GO:0052501,0.999999999989054,0.696686071163192,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
16182,GO:0090244,0.999999999989109,0.681555823713209,0,3,Wnt signaling pathway involved in somitogenesis,BP,
18101,GO:1902822,0.999999999989141,0.692629995170779,0,3,regulation of late endosome to lysosome transport,BP,
11720,GO:0046577,0.999999999989151,0.88018900291604,0,1,long-chain-alcohol oxidase activity,MF,
4982,GO:0015112,0.999999999989175,0.880356939141342,0,1,nitrate transmembrane transporter activity,MF,
5160,GO:0015706,0.999999999989175,0.880356939141342,0,1,nitrate transport,BP,
9688,GO:0038107,0.999999999989179,0.683787186492984,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
17345,GO:1900094,0.999999999989179,0.683787186492984,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17392,GO:1900164,0.999999999989179,0.683787186492984,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
2478,GO:0005713,0.999999999989258,0.880442580064966,0,1,recombination nodule,CC,
2479,GO:0005715,0.999999999989258,0.880442580064966,0,1,late recombination nodule,CC,
5009,GO:0015173,0.999999999989258,0.880442580064966,0,1,aromatic amino acid transmembrane transporter activity,MF,
5027,GO:0015196,0.999999999989258,0.880442580064966,0,1,L-tryptophan transmembrane transporter activity,MF,
10282,GO:0043060,0.999999999989258,0.880442580064966,0,1,meiotic metaphase I plate congression,BP,
12887,GO:0051257,0.999999999989258,0.880442580064966,0,1,meiotic spindle midzone assembly,BP,
12927,GO:0051311,0.999999999989258,0.880442580064966,0,1,meiotic metaphase plate congression,BP,
18745,GO:1904271,0.999999999989258,0.880442580064966,0,1,L-proline import across plasma membrane,BP,
18852,GO:1904555,0.999999999989258,0.880442580064966,0,1,L-proline transmembrane transport,BP,
18853,GO:1904556,0.999999999989258,0.880442580064966,0,1,L-tryptophan transmembrane transport,BP,
19303,GO:1905647,0.999999999989258,0.880442580064966,0,1,proline import across plasma membrane,BP,
10700,GO:0044035,0.999999999989308,0.884163746672607,0,1,multi-organism catabolic process,BP,
10727,GO:0044115,0.999999999989308,0.884163746672607,0,1,development of symbiont involved in interaction with host,BP,
10734,GO:0044145,0.999999999989308,0.884163746672607,0,1,modulation of development of symbiont involved in interaction with host,BP,
10736,GO:0044147,0.999999999989308,0.884163746672607,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10951,GO:0044730,0.999999999989308,0.884163746672607,0,1,bone sialoprotein binding,MF,
13300,GO:0052214,0.999999999989308,0.884163746672607,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13301,GO:0052227,0.999999999989308,0.884163746672607,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13302,GO:0052229,0.999999999989308,0.884163746672607,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13314,GO:0052360,0.999999999989308,0.884163746672607,0,1,catabolism by host of symbiont macromolecule,BP,
13315,GO:0052361,0.999999999989308,0.884163746672607,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13316,GO:0052362,0.999999999989308,0.884163746672607,0,1,catabolism by host of symbiont protein,BP,
13317,GO:0052363,0.999999999989308,0.884163746672607,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13318,GO:0052364,0.999999999989308,0.884163746672607,0,1,catabolism by host of substance in symbiont,BP,
13322,GO:0052416,0.999999999989308,0.884163746672607,0,1,metabolism by host of symbiont macromolecule,BP,
13323,GO:0052417,0.999999999989308,0.884163746672607,0,1,metabolism by host of symbiont protein,BP,
13324,GO:0052418,0.999999999989308,0.884163746672607,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13325,GO:0052419,0.999999999989308,0.884163746672607,0,1,metabolism by host of substance in symbiont,BP,
19283,GO:1905581,0.999999999989308,0.884163746672607,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19288,GO:1905597,0.999999999989308,0.884163746672607,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19290,GO:1905599,0.999999999989308,0.884163746672607,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
11863,GO:0046898,0.999999999989416,0.679922291140997,0,3,response to cycloheximide,BP,
1799,GO:0004446,0.999999999989418,0.880335961319562,0,1,inositol-hexakisphosphate phosphatase activity,MF,
6866,GO:0030351,0.999999999989418,0.880335961319562,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
8516,GO:0033787,0.999999999989418,0.880335961319562,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8742,GO:0034417,0.999999999989418,0.880335961319562,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
13398,GO:0052826,0.999999999989418,0.880335961319562,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
9944,GO:0042328,0.999999999989423,0.681170043513425,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
14763,GO:0070494,0.999999999989425,0.684963638666302,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14764,GO:0070495,0.999999999989425,0.684963638666302,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
3805,GO:0008398,0.999999999989433,0.880308060241241,0,1,sterol 14-demethylase activity,MF,
8407,GO:0033488,0.999999999989433,0.880308060241241,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
1726,GO:0004322,0.999999999989457,0.688472462015368,0,3,ferroxidase activity,MF,
5634,GO:0016724,0.999999999989457,0.688472462015368,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
1667,GO:0004132,0.999999999989475,0.881457805837998,0,1,dCMP deaminase activity,MF,
18378,GO:1903434,0.999999999989497,0.880175029612389,0,1,negative regulation of constitutive secretory pathway,BP,
12074,GO:0048075,0.999999999989499,0.88013209369897,0,1,positive regulation of eye pigmentation,BP,
5149,GO:0015691,0.999999999989517,0.682958599035521,0,3,cadmium ion transport,BP,
14810,GO:0070574,0.999999999989517,0.682958599035521,0,3,cadmium ion transmembrane transport,BP,
378,GO:0001011,0.999999999989551,0.878967860971423,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
405,GO:0001087,0.999999999989551,0.878967860971423,0,1,transcription factor activity, TFIIB-class binding,MF,
232,GO:0000481,0.999999999989553,0.88021475859754,0,1,maturation of 5S rRNA,BP,
6344,GO:0021526,0.999999999989557,0.882296621569691,0,1,medial motor column neuron differentiation,BP,
18033,GO:1902616,0.999999999989557,0.882296621569691,0,1,acyl carnitine transmembrane transport,BP,
6165,GO:0019530,0.999999999989662,0.681913782379506,0,3,taurine metabolic process,BP,
6199,GO:0019694,0.999999999989662,0.681913782379506,0,3,alkanesulfonate metabolic process,BP,
842,GO:0002158,0.999999999989666,0.691477902581698,0,3,osteoclast proliferation,BP,
17295,GO:0150003,0.99999999998967,0.687670141769612,0,3,regulation of spontaneous synaptic transmission,BP,
5437,GO:0016309,0.999999999989674,0.68189187253193,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
856,GO:0002189,0.999999999989685,0.880397162198857,0,1,ribose phosphate diphosphokinase complex,CC,
6540,GO:0021960,0.999999999989704,0.68109327591163,0,3,anterior commissure morphogenesis,BP,
12024,GO:0047860,0.999999999989708,0.888642289215892,0,1,diiodophenylpyruvate reductase activity,MF,
15827,GO:0072572,0.999999999989723,0.881051208051846,0,1,poly-ADP-D-ribose binding,MF,
1753,GO:0004359,0.999999999989733,0.682188893093315,0,3,glutaminase activity,MF,
11712,GO:0046544,0.999999999989736,0.880122308305453,0,1,development of secondary male sexual characteristics,BP,
4014,GO:0009032,0.99999999998977,0.883938604899107,0,1,thymidine phosphorylase activity,MF,
5360,GO:0016154,0.99999999998977,0.883938604899107,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
8667,GO:0034271,0.999999999989774,0.6825714395586,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8668,GO:0034272,0.999999999989774,0.6825714395586,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
4602,GO:0010722,0.999999999989795,0.879684522737023,0,1,regulation of ferrochelatase activity,BP,
8931,GO:0034986,0.999999999989795,0.879684522737023,0,1,iron chaperone activity,MF,
18723,GO:1904229,0.999999999989795,0.879684522737023,0,1,regulation of succinate dehydrogenase activity,BP,
18724,GO:1904231,0.999999999989795,0.879684522737023,0,1,positive regulation of succinate dehydrogenase activity,BP,
18725,GO:1904232,0.999999999989795,0.879684522737023,0,1,regulation of aconitate hydratase activity,BP,
18726,GO:1904234,0.999999999989795,0.879684522737023,0,1,positive regulation of aconitate hydratase activity,BP,
14361,GO:0061629,0.999999999989838,0.682293723038075,0,3,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
2793,GO:0006238,0.999999999989852,0.889024920232342,0,1,CMP salvage,BP,
4158,GO:0009224,0.999999999989852,0.889024920232342,0,1,CMP biosynthetic process,BP,
11500,GO:0046035,0.999999999989852,0.889024920232342,0,1,CMP metabolic process,BP,
5969,GO:0018444,0.999999999989857,0.681623490687316,0,3,translation release factor complex,CC,
14309,GO:0061519,0.999999999989861,0.880218472109802,0,1,macrophage homeostasis,BP,
10596,GO:0043602,0.999999999989902,0.880413700712415,0,1,nitrate catabolic process,BP,
11584,GO:0046210,0.999999999989902,0.880413700712415,0,1,nitric oxide catabolic process,BP,
12012,GO:0047726,0.999999999989902,0.880413700712415,0,1,iron-cytochrome-c reductase activity,MF,
16252,GO:0090345,0.999999999989902,0.880413700712415,0,1,cellular organohalogen metabolic process,BP,
16253,GO:0090346,0.999999999989902,0.880413700712415,0,1,cellular organofluorine metabolic process,BP,
3835,GO:0008446,0.999999999989928,0.883790016659495,0,1,GDP-mannose 4,6-dehydratase activity,MF,
16634,GO:0097536,0.999999999989958,0.880349517188779,0,1,thymus epithelium morphogenesis,BP,
18713,GO:1904210,0.99999999998996,0.887059430428537,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18730,GO:1904239,0.99999999998996,0.887059430428537,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18731,GO:1904240,0.99999999998996,0.887059430428537,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
8661,GO:0034245,0.999999999989975,0.880181425605323,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
6616,GO:0022849,0.999999999989987,0.880122355603173,0,1,glutamate-gated calcium ion channel activity,MF,
18890,GO:1904631,0.999999999989988,0.88077974538336,0,1,response to glucoside,BP,
19603,GO:1990812,0.999999999990021,0.682013239565392,0,3,growth cone filopodium,CC,
8503,GO:0033699,0.99999999999006,0.88149915141797,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
17246,GO:0120108,0.99999999999006,0.88149915141797,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
19434,GO:1990165,0.99999999999006,0.88149915141797,0,1,single-strand break-containing DNA binding,MF,
8373,GO:0033290,0.999999999990069,0.880140921181297,0,1,eukaryotic 48S preinitiation complex,CC,
10744,GO:0044207,0.999999999990069,0.880140921181297,0,1,translation initiation ternary complex,CC,
1743,GO:0004346,0.999999999990101,0.884168625487028,0,1,glucose-6-phosphatase activity,MF,
12443,GO:0050309,0.999999999990101,0.884168625487028,0,1,sugar-terminal-phosphatase activity,MF,
14837,GO:0070634,0.999999999990107,0.684615917085265,0,3,transepithelial ammonium transport,BP,
7079,GO:0030882,0.999999999990136,0.880186542443602,0,1,lipid antigen binding,MF,
7080,GO:0030883,0.999999999990136,0.880186542443602,0,1,endogenous lipid antigen binding,MF,
7081,GO:0030884,0.999999999990136,0.880186542443602,0,1,exogenous lipid antigen binding,MF,
12036,GO:0048006,0.999999999990136,0.880186542443602,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
5568,GO:0016590,0.999999999990151,0.8800590262818,0,1,ACF complex,CC,
7800,GO:0032358,0.999999999990182,0.895908205030216,0,1,oxidized pyrimidine DNA binding,MF,
14295,GO:0061481,0.999999999990182,0.895908205030216,0,1,response to TNF agonist,BP,
18004,GO:1902546,0.999999999990182,0.895908205030216,0,1,positive regulation of DNA N-glycosylase activity,BP,
20262,GO:2001272,0.999999999990182,0.895908205030216,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
14424,GO:0061770,0.999999999990229,0.880992921433883,0,1,translation elongation factor binding,MF,
14594,GO:0070184,0.999999999990229,0.880992921433883,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15812,GO:0072545,0.999999999990229,0.880992921433883,0,1,tyrosine binding,MF,
18144,GO:1902937,0.999999999990229,0.880992921433883,0,1,inward rectifier potassium channel complex,CC,
18987,GO:1904842,0.999999999990229,0.880992921433883,0,1,response to nitroglycerin,BP,
18988,GO:1904843,0.999999999990229,0.880992921433883,0,1,cellular response to nitroglycerin,BP,
10242,GO:0042997,0.999999999990281,0.682169372912385,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
11785,GO:0046687,0.999999999990291,0.891403332579529,0,1,response to chromate,BP,
15119,GO:0071247,0.999999999990291,0.891403332579529,0,1,cellular response to chromate,BP,
17882,GO:1902220,0.999999999990291,0.891403332579529,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
6330,GO:0021508,0.999999999990327,0.879847754267375,0,1,floor plate formation,BP,
8414,GO:0033505,0.999999999990327,0.879847754267375,0,1,floor plate morphogenesis,BP,
13542,GO:0060032,0.999999999990327,0.879847754267375,0,1,notochord regression,BP,
1761,GO:0004367,0.999999999990367,0.880167485133863,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
11572,GO:0046168,0.999999999990367,0.880167485133863,0,1,glycerol-3-phosphate catabolic process,BP,
2769,GO:0006193,0.999999999990402,0.891304514842048,0,1,ITP catabolic process,BP,
4138,GO:0009203,0.999999999990402,0.891304514842048,0,1,ribonucleoside triphosphate catabolic process,BP,
4142,GO:0009207,0.999999999990402,0.891304514842048,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9507,GO:0036220,0.999999999990402,0.891304514842048,0,1,ITP diphosphatase activity,MF,
9508,GO:0036222,0.999999999990402,0.891304514842048,0,1,XTP diphosphatase activity,MF,
10160,GO:0042766,0.999999999990416,0.879017567824232,0,1,nucleosome mobilization,BP,
8406,GO:0033484,0.999999999990426,0.692456948704731,0,3,nitric oxide homeostasis,BP,
12895,GO:0051267,0.999999999990432,0.880280877918403,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13502,GO:0055103,0.999999999990432,0.880280877918403,0,1,ligase regulator activity,MF,
19985,GO:2000631,0.999999999990432,0.880280877918403,0,1,regulation of pre-miRNA processing,BP,
19986,GO:2000632,0.999999999990432,0.880280877918403,0,1,negative regulation of pre-miRNA processing,BP,
19521,GO:1990504,0.999999999990435,0.681585452057094,0,3,dense core granule exocytosis,BP,
1680,GO:0004148,0.999999999990438,0.880219716183886,0,1,dihydrolipoyl dehydrogenase activity,MF,
10333,GO:0043159,0.999999999990438,0.880219716183886,0,1,acrosomal matrix,CC,
10563,GO:0043544,0.999999999990438,0.880219716183886,0,1,lipoamide binding,MF,
12762,GO:0051068,0.999999999990438,0.880219716183886,0,1,dihydrolipoamide metabolic process,BP,
10640,GO:0043739,0.999999999990457,0.880280365412332,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
6004,GO:0019050,0.999999999990505,0.690902572521006,0,3,suppression by virus of host apoptotic process,BP,
9748,GO:0039526,0.999999999990505,0.690902572521006,0,3,modulation by virus of host apoptotic process,BP,
2995,GO:0006543,0.999999999990517,0.681977812773556,0,3,glutamine catabolic process,BP,
19435,GO:1990166,0.999999999990533,0.682397037507528,0,3,protein localization to site of double-strand break,BP,
18031,GO:1902612,0.99999999999055,0.88034430086244,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18032,GO:1902613,0.99999999999055,0.88034430086244,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19462,GO:1990262,0.99999999999055,0.88034430086244,0,1,anti-Mullerian hormone signaling pathway,BP,
630,GO:0001820,0.99999999999061,0.689544599580412,0,3,serotonin secretion,BP,
5917,GO:0018197,0.99999999999061,0.681574318872531,0,3,peptidyl-aspartic acid modification,BP,
4730,GO:0010899,0.999999999990635,0.70006728080687,0,3,regulation of phosphatidylcholine catabolic process,BP,
3855,GO:0008478,0.999999999990653,0.879577134610682,0,1,pyridoxal kinase activity,MF,
4240,GO:0009443,0.999999999990653,0.879577134610682,0,1,pyridoxal 5'-phosphate salvage,BP,
13982,GO:0060729,0.999999999990679,0.684915357797286,0,3,intestinal epithelial structure maintenance,BP,
13621,GO:0060154,0.999999999990737,0.690729646422021,0,3,cellular process regulating host cell cycle in response to virus,BP,
18946,GO:1904753,0.999999999990749,0.684065752317478,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
5111,GO:0015439,0.999999999990754,0.880320365837616,0,1,heme-transporting ATPase activity,MF,
17988,GO:1902504,0.999999999990754,0.880320365837616,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
13010,GO:0051490,0.999999999990755,0.684652558804716,0,3,negative regulation of filopodium assembly,BP,
11970,GO:0047341,0.999999999990761,0.880248976167128,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
407,GO:0001093,0.99999999999082,0.682759769009599,0,3,TFIIB-class transcription factor binding,MF,
11296,GO:0045636,0.999999999990846,0.681364510961179,0,3,positive regulation of melanocyte differentiation,BP,
16508,GO:0097274,0.999999999990899,0.774682620696852,0,2,urea homeostasis,BP,
9239,GO:0035658,0.999999999990916,0.68319952181696,0,3,Mon1-Ccz1 complex,CC,
9168,GO:0035553,0.999999999990925,0.685472456431783,0,3,oxidative single-stranded RNA demethylation,BP,
1659,GO:0004117,0.999999999991046,0.880348504650511,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2038,GO:0004782,0.999999999991046,0.880348504650511,0,1,sulfinoalanine decarboxylase activity,MF,
3841,GO:0008455,0.999999999991046,0.880348504650511,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3890,GO:0008531,0.999999999991046,0.880348504650511,0,1,riboflavin kinase activity,MF,
4162,GO:0009231,0.999999999991046,0.880348504650511,0,1,riboflavin biosynthetic process,BP,
4220,GO:0009398,0.999999999991046,0.880348504650511,0,1,FMN biosynthetic process,BP,
9981,GO:0042412,0.999999999991046,0.880348504650511,0,1,taurine biosynthetic process,BP,
11593,GO:0046305,0.999999999991046,0.880348504650511,0,1,alkanesulfonate biosynthetic process,BP,
11650,GO:0046444,0.999999999991046,0.880348504650511,0,1,FMN metabolic process,BP,
7777,GO:0032311,0.999999999991054,0.882137815945162,0,1,angiogenin-PRI complex,CC,
3636,GO:0008108,0.999999999991056,0.887706667626736,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
5312,GO:0016034,0.999999999991056,0.887706667626736,0,1,maleylacetoacetate isomerase activity,MF,
17088,GO:0101030,0.999999999991056,0.887706667626736,0,1,tRNA-guanine transglycosylation,BP,
6354,GO:0021541,0.999999999991063,0.880136861009255,0,1,ammon gyrus development,BP,
4303,GO:0009758,0.999999999991071,0.878615164088069,0,1,carbohydrate utilization,BP,
4869,GO:0014734,0.999999999991071,0.878615164088069,0,1,skeletal muscle hypertrophy,BP,
10600,GO:0043610,0.999999999991071,0.878615164088069,0,1,regulation of carbohydrate utilization,BP,
17982,GO:1902488,0.999999999991071,0.878615164088069,0,1,cholangiocyte apoptotic process,BP,
18642,GO:1904000,0.999999999991071,0.878615164088069,0,1,positive regulation of eating behavior,BP,
18669,GO:1904054,0.999999999991071,0.878615164088069,0,1,regulation of cholangiocyte proliferation,BP,
18670,GO:1904056,0.999999999991071,0.878615164088069,0,1,positive regulation of cholangiocyte proliferation,BP,
18701,GO:1904192,0.999999999991071,0.878615164088069,0,1,regulation of cholangiocyte apoptotic process,BP,
18702,GO:1904193,0.999999999991071,0.878615164088069,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18703,GO:1904195,0.999999999991071,0.878615164088069,0,1,regulation of granulosa cell proliferation,BP,
18704,GO:1904197,0.999999999991071,0.878615164088069,0,1,positive regulation of granulosa cell proliferation,BP,
18706,GO:1904200,0.999999999991071,0.878615164088069,0,1,iodide transmembrane transport,BP,
18707,GO:1904201,0.999999999991071,0.878615164088069,0,1,regulation of iodide transport,BP,
18708,GO:1904202,0.999999999991071,0.878615164088069,0,1,negative regulation of iodide transport,BP,
18709,GO:1904204,0.999999999991071,0.878615164088069,0,1,regulation of skeletal muscle hypertrophy,BP,
18710,GO:1904206,0.999999999991071,0.878615164088069,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18715,GO:1904212,0.999999999991071,0.878615164088069,0,1,regulation of iodide transmembrane transport,BP,
18716,GO:1904213,0.999999999991071,0.878615164088069,0,1,negative regulation of iodide transmembrane transport,BP,
19563,GO:1990705,0.999999999991071,0.878615164088069,0,1,cholangiocyte proliferation,BP,
19575,GO:1990739,0.999999999991071,0.878615164088069,0,1,granulosa cell proliferation,BP,
14693,GO:0070369,0.999999999991076,0.680964267951308,0,3,beta-catenin-TCF7L2 complex,CC,
10676,GO:0043972,0.999999999991076,0.880123022794465,0,1,histone H3-K23 acetylation,BP,
10687,GO:0043994,0.999999999991076,0.880123022794465,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
2003,GO:0004730,0.999999999991118,0.883882435648053,0,1,pseudouridylate synthase activity,MF,
14965,GO:0070902,0.999999999991118,0.883882435648053,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
2173,GO:0005010,0.999999999991133,0.676914746205063,0,3,insulin-like growth factor-activated receptor activity,MF,
14640,GO:0070267,0.999999999991139,0.880219538280632,0,1,oncosis,BP,
572,GO:0001715,0.999999999991195,0.880176781804246,0,1,ectodermal cell fate specification,BP,
10113,GO:0042665,0.999999999991195,0.880176781804246,0,1,regulation of ectodermal cell fate specification,BP,
10114,GO:0042666,0.999999999991195,0.880176781804246,0,1,negative regulation of ectodermal cell fate specification,BP,
19864,GO:2000383,0.999999999991195,0.880176781804246,0,1,regulation of ectoderm development,BP,
19865,GO:2000384,0.999999999991195,0.880176781804246,0,1,negative regulation of ectoderm development,BP,
13903,GO:0060591,0.999999999991195,0.682062186315803,0,3,chondroblast differentiation,BP,
19006,GO:1904877,0.999999999991202,0.881136601406157,0,1,positive regulation of DNA ligase activity,BP,
14292,GO:0061474,0.999999999991237,0.880393818436946,0,1,phagolysosome membrane,CC,
4793,GO:0010990,0.999999999991263,0.681019418235808,0,3,regulation of SMAD protein complex assembly,BP,
811,GO:0002085,0.999999999991268,0.684997442262972,0,3,inhibition of neuroepithelial cell differentiation,BP,
11277,GO:0045608,0.999999999991268,0.684997442262972,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
7071,GO:0030868,0.999999999991276,0.688352908373351,0,3,smooth endoplasmic reticulum membrane,CC,
16572,GO:0097425,0.999999999991276,0.688352908373351,0,3,smooth endoplasmic reticulum part,CC,
15594,GO:0072108,0.999999999991287,0.696475541796394,0,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
6020,GO:0019082,0.999999999991333,0.880139172195756,0,1,viral protein processing,BP,
16282,GO:0090472,0.999999999991333,0.880139172195756,0,1,dibasic protein processing,BP,
6381,GO:0021578,0.999999999991352,0.681093580303181,0,3,hindbrain maturation,BP,
6399,GO:0021626,0.999999999991352,0.681093580303181,0,3,central nervous system maturation,BP,
6083,GO:0019249,0.999999999991383,0.692687162363285,0,3,lactate biosynthetic process,BP,
17823,GO:1902038,0.999999999991392,0.880245710990155,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17903,GO:1902257,0.999999999991392,0.880245710990155,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
5559,GO:0016576,0.999999999991417,0.683595806343875,0,3,histone dephosphorylation,BP,
18697,GO:1904177,0.999999999991431,0.681198593767437,0,3,regulation of adipose tissue development,BP,
18698,GO:1904179,0.999999999991431,0.681198593767437,0,3,positive regulation of adipose tissue development,BP,
5977,GO:0018773,0.99999999999144,0.883762583631493,0,1,acetylpyruvate hydrolase activity,MF,
8798,GO:0034545,0.99999999999144,0.883762583631493,0,1,fumarylpyruvate hydrolase activity,MF,
11999,GO:0047621,0.99999999999144,0.883762583631493,0,1,acylpyruvate hydrolase activity,MF,
13338,GO:0052550,0.99999999999144,0.883762583631493,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13344,GO:0052567,0.99999999999144,0.883762583631493,0,1,response to defense-related host reactive oxygen species production,BP,
13840,GO:0060482,0.999999999991491,0.687776119848346,0,3,lobar bronchus development,BP,
19021,GO:1904895,0.999999999991508,0.88389175987864,0,1,ESCRT complex assembly,BP,
19023,GO:1904902,0.999999999991508,0.88389175987864,0,1,ESCRT III complex assembly,BP,
3131,GO:0006722,0.999999999991509,0.880503039715794,0,1,triterpenoid metabolic process,BP,
6211,GO:0019742,0.999999999991509,0.880503039715794,0,1,pentacyclic triterpenoid metabolic process,BP,
19032,GO:1904924,0.999999999991509,0.880503039715794,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19206,GO:1905370,0.999999999991509,0.880503039715794,0,1,serine-type endopeptidase complex,CC,
3883,GO:0008520,0.999999999991511,0.879773855958921,0,1,L-ascorbate:sodium symporter activity,MF,
5042,GO:0015229,0.999999999991511,0.879773855958921,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5250,GO:0015882,0.999999999991511,0.879773855958921,0,1,L-ascorbic acid transmembrane transport,BP,
14956,GO:0070890,0.999999999991511,0.879773855958921,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14967,GO:0070904,0.999999999991511,0.879773855958921,0,1,transepithelial L-ascorbic acid transport,BP,
19242,GO:1905458,0.999999999991523,0.880159581070793,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19738,GO:2000174,0.999999999991523,0.880159581070793,0,1,regulation of pro-T cell differentiation,BP,
19739,GO:2000176,0.999999999991523,0.880159581070793,0,1,positive regulation of pro-T cell differentiation,BP,
16427,GO:0097117,0.999999999991526,0.879686846751485,0,1,guanylate kinase-associated protein clustering,BP,
1625,GO:0004064,0.999999999991538,0.68793550542079,0,3,arylesterase activity,MF,
2270,GO:0005212,0.999999999991553,0.697141077525179,0,3,structural constituent of eye lens,MF,
2244,GO:0005157,0.999999999991576,0.880478940844894,0,1,macrophage colony-stimulating factor receptor binding,MF,
10020,GO:0042488,0.999999999991576,0.880478940844894,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
13916,GO:0060611,0.999999999991576,0.880478940844894,0,1,mammary gland fat development,BP,
17888,GO:1902228,0.999999999991576,0.880478940844894,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
18627,GO:1903971,0.999999999991576,0.880478940844894,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18630,GO:1903974,0.999999999991576,0.880478940844894,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18685,GO:1904124,0.999999999991576,0.880478940844894,0,1,microglial cell migration,BP,
18686,GO:1904139,0.999999999991576,0.880478940844894,0,1,regulation of microglial cell migration,BP,
18687,GO:1904141,0.999999999991576,0.880478940844894,0,1,positive regulation of microglial cell migration,BP,
19560,GO:1990682,0.999999999991576,0.880478940844894,0,1,CSF1-CSF1R complex,CC,
8985,GO:0035120,0.999999999991618,0.875888266594727,0,1,post-embryonic appendage morphogenesis,BP,
8986,GO:0035127,0.999999999991618,0.875888266594727,0,1,post-embryonic limb morphogenesis,BP,
8987,GO:0035128,0.999999999991618,0.875888266594727,0,1,post-embryonic forelimb morphogenesis,BP,
16559,GO:0097393,0.999999999991618,0.875888266594727,0,1,telomeric repeat-containing RNA transcription,BP,
16560,GO:0097394,0.999999999991618,0.875888266594727,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17668,GO:1901580,0.999999999991618,0.875888266594727,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17669,GO:1901581,0.999999999991618,0.875888266594727,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17670,GO:1901582,0.999999999991618,0.875888266594727,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19498,GO:1990421,0.999999999991618,0.875888266594727,0,1,subtelomeric heterochromatin,CC,
19564,GO:1990707,0.999999999991618,0.875888266594727,0,1,nuclear subtelomeric heterochromatin,CC,
19437,GO:1990168,0.999999999991644,0.684425582897958,0,3,protein K33-linked deubiquitination,BP,
2171,GO:0005008,0.999999999991663,0.879887315598504,0,1,hepatocyte growth factor-activated receptor activity,MF,
18943,GO:1904750,0.999999999991663,0.879887315598504,0,1,negative regulation of protein localization to nucleolus,BP,
1428,GO:0003404,0.99999999999168,0.880271175387623,0,1,optic vesicle morphogenesis,BP,
1432,GO:0003409,0.99999999999168,0.880271175387623,0,1,optic cup structural organization,BP,
6397,GO:0021622,0.99999999999168,0.880271175387623,0,1,oculomotor nerve morphogenesis,BP,
6398,GO:0021623,0.99999999999168,0.880271175387623,0,1,oculomotor nerve formation,BP,
14586,GO:0070172,0.99999999999168,0.880271175387623,0,1,positive regulation of tooth mineralization,BP,
11316,GO:0045660,0.999999999991702,0.881631773969314,0,1,positive regulation of neutrophil differentiation,BP,
14296,GO:0061484,0.999999999991716,0.681821015050379,0,3,hematopoietic stem cell homeostasis,BP,
9454,GO:0036085,0.999999999991761,0.880286620018899,0,1,GDP-fucose import into Golgi lumen,BP,
17607,GO:1901350,0.999999999991769,0.879731356747915,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
1515,GO:0003878,0.999999999991786,0.880129944826093,0,1,ATP citrate synthase activity,MF,
4206,GO:0009346,0.999999999991786,0.880129944826093,0,1,citrate lyase complex,CC,
11872,GO:0046912,0.999999999991796,0.681982237220847,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
11066,GO:0045084,0.999999999991797,0.682226757412888,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
16272,GO:0090403,0.999999999991821,0.682096691966322,0,3,oxidative stress-induced premature senescence,BP,
18844,GO:1904530,0.999999999991831,0.880304409181926,0,1,negative regulation of actin filament binding,BP,
18886,GO:1904617,0.999999999991831,0.880304409181926,0,1,negative regulation of actin binding,BP,
1516,GO:0003880,0.999999999991842,0.68826618720001,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2950,GO:0006481,0.999999999991842,0.68826618720001,0,3,C-terminal protein methylation,BP,
2087,GO:0004853,0.999999999991844,0.887033085365252,0,1,uroporphyrinogen decarboxylase activity,MF,
19145,GO:1905222,0.999999999991876,0.880298706175525,0,1,atrioventricular canal morphogenesis,BP,
13990,GO:0060737,0.999999999991883,0.681677505649411,0,3,prostate gland morphogenetic growth,BP,
8730,GO:0034392,0.999999999991887,0.681868314861646,0,3,negative regulation of smooth muscle cell apoptotic process,BP,
18825,GO:1904468,0.999999999991887,0.683116523190609,0,3,negative regulation of tumor necrosis factor secretion,BP,
17920,GO:1902296,0.99999999999189,0.880272927490556,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17933,GO:1902319,0.99999999999189,0.880272927490556,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
18172,GO:1902983,0.99999999999189,0.880272927490556,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
2024,GO:0004766,0.999999999991896,0.888584117528097,0,1,spermidine synthase activity,MF,
8238,GO:0033026,0.999999999991922,0.880116523459195,0,1,negative regulation of mast cell apoptotic process,BP,
13148,GO:0051771,0.999999999991926,0.693293389236656,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
17206,GO:0110025,0.999999999991937,0.880310674349606,0,1,DNA strand resection involved in replication fork processing,BP,
17207,GO:0110026,0.999999999991937,0.880310674349606,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
8,GO:0000015,0.99999999999195,0.882642194398816,0,1,phosphopyruvate hydratase complex,CC,
1932,GO:0004634,0.99999999999195,0.882642194398816,0,1,phosphopyruvate hydratase activity,MF,
12561,GO:0050757,0.999999999991974,0.880359867774533,0,1,thymidylate synthase biosynthetic process,BP,
12562,GO:0050758,0.999999999991974,0.880359867774533,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12563,GO:0050760,0.999999999991974,0.880359867774533,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
1540,GO:0003937,0.999999999991982,0.881192488948481,0,1,IMP cyclohydrolase activity,MF,
1938,GO:0004643,0.999999999991982,0.881192488948481,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
13387,GO:0052798,0.999999999991982,0.881192488948481,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
1911,GO:0004607,0.999999999991985,0.887474177987728,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
469,GO:0001512,0.999999999991985,0.89064719188478,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
18800,GO:1904408,0.999999999991985,0.89064719188478,0,1,melatonin binding,MF,
19285,GO:1905594,0.999999999991985,0.89064719188478,0,1,resveratrol binding,MF,
16405,GO:0097070,0.999999999992006,0.880089491411935,0,1,ductus arteriosus closure,BP,
16506,GO:0097272,0.999999999992006,0.880089491411935,0,1,ammonia homeostasis,BP,
16507,GO:0097273,0.999999999992006,0.880089491411935,0,1,creatinine homeostasis,BP,
16509,GO:0097275,0.999999999992006,0.880089491411935,0,1,cellular ammonia homeostasis,BP,
16510,GO:0097276,0.999999999992006,0.880089491411935,0,1,cellular creatinine homeostasis,BP,
16511,GO:0097277,0.999999999992006,0.880089491411935,0,1,cellular urea homeostasis,BP,
7602,GO:0031997,0.999999999992016,0.688480682507717,0,3,N-terminal myristoylation domain binding,MF,
12937,GO:0051343,0.999999999992016,0.688480682507717,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13794,GO:0060414,0.999999999992018,0.681364219682455,0,3,aorta smooth muscle tissue morphogenesis,BP,
6559,GO:0022012,0.999999999992027,0.879056043589829,0,1,subpallium cell proliferation in forebrain,BP,
6560,GO:0022018,0.999999999992027,0.879056043589829,0,1,lateral ganglionic eminence cell proliferation,BP,
13754,GO:0060366,0.999999999992027,0.879056043589829,0,1,lambdoid suture morphogenesis,BP,
13755,GO:0060367,0.999999999992027,0.879056043589829,0,1,sagittal suture morphogenesis,BP,
14049,GO:0060873,0.999999999992027,0.879056043589829,0,1,anterior semicircular canal development,BP,
14050,GO:0060875,0.999999999992027,0.879056043589829,0,1,lateral semicircular canal development,BP,
18549,GO:1903818,0.999999999992035,0.677087887051889,0,3,positive regulation of voltage-gated potassium channel activity,BP,
301,GO:0000811,0.999999999992043,0.689582234244,0,3,GINS complex,CC,
6234,GO:0019797,0.999999999992063,0.682220444562538,0,3,procollagen-proline 3-dioxygenase activity,MF,
8426,GO:0033557,0.999999999992063,0.682220444562538,0,3,Slx1-Slx4 complex,CC,
13430,GO:0052905,0.999999999992063,0.682220444562538,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
493,GO:0001546,0.999999999992101,0.884033410918252,0,1,preantral ovarian follicle growth,BP,
1684,GO:0004155,0.999999999992101,0.884033410918252,0,1,6,7-dihydropteridine reductase activity,MF,
12091,GO:0048162,0.999999999992101,0.884033410918252,0,1,multi-layer follicle stage,BP,
2897,GO:0006407,0.99999999999212,0.694704207543849,0,3,rRNA export from nucleus,BP,
2724,GO:0006106,0.999999999992125,0.684843008559486,0,3,fumarate metabolic process,BP,
849,GO:0002177,0.999999999992141,0.691707681845367,0,3,manchette,CC,
8328,GO:0033186,0.99999999999216,0.681597295361015,0,3,CAF-1 complex,CC,
20234,GO:2001229,0.999999999992163,0.871822431099371,0,1,negative regulation of response to gamma radiation,BP,
9215,GO:0035616,0.999999999992171,0.681859489310211,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
11151,GO:0045234,0.999999999992187,0.882881628830583,0,1,protein palmitoleylation,BP,
1556,GO:0003957,0.999999999992191,0.880123270682076,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
3959,GO:0008746,0.999999999992191,0.880123270682076,0,1,NAD(P)+ transhydrogenase activity,MF,
3961,GO:0008750,0.999999999992191,0.880123270682076,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
5604,GO:0016652,0.999999999992191,0.880123270682076,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
11346,GO:0045726,0.999999999992192,0.880121380453861,0,1,positive regulation of integrin biosynthetic process,BP,
13202,GO:0051891,0.999999999992192,0.880121380453861,0,1,positive regulation of cardioblast differentiation,BP,
18494,GO:1903701,0.999999999992192,0.880121380453861,0,1,substantia propria of cornea development,BP,
12385,GO:0048852,0.999999999992207,0.682247695454228,0,3,diencephalon morphogenesis,BP,
3849,GO:0008467,0.99999999999221,0.68541092453373,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
13968,GO:0060708,0.999999999992218,0.688464297639157,0,3,spongiotrophoblast differentiation,BP,
19869,GO:2000389,0.999999999992281,0.682027046556688,0,3,regulation of neutrophil extravasation,BP,
19870,GO:2000391,0.999999999992281,0.682027046556688,0,3,positive regulation of neutrophil extravasation,BP,
7447,GO:0031592,0.999999999992287,0.879246510668631,0,1,centrosomal corona,CC,
18819,GO:1904454,0.999999999992287,0.879246510668631,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
16217,GO:0090297,0.999999999992299,0.888555101681638,0,1,positive regulation of mitochondrial DNA replication,BP,
17761,GO:1901860,0.999999999992299,0.888555101681638,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19405,GO:1990046,0.999999999992299,0.888555101681638,0,1,stress-induced mitochondrial fusion,BP,
1729,GO:0004326,0.999999999992323,0.880425831595391,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
3982,GO:0008841,0.999999999992323,0.880425831595391,0,1,dihydrofolate synthase activity,MF,
11866,GO:0046901,0.999999999992323,0.880425831595391,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
19817,GO:2000317,0.999999999992323,0.682084791704437,0,3,negative regulation of T-helper 17 type immune response,BP,
19820,GO:2000320,0.999999999992323,0.682084791704437,0,3,negative regulation of T-helper 17 cell differentiation,BP,
17250,GO:0140009,0.999999999992324,0.880207775720073,0,1,L-aspartate import across plasma membrane,BP,
6961,GO:0030623,0.99999999999233,0.879604838556926,0,1,U5 snRNA binding,MF,
3102,GO:0006682,0.999999999992361,0.683299667153005,0,3,galactosylceramide biosynthetic process,BP,
6123,GO:0019375,0.999999999992361,0.683299667153005,0,3,galactolipid biosynthetic process,BP,
7846,GO:0032415,0.999999999992394,0.683057017807932,0,3,regulation of sodium:proton antiporter activity,BP,
10691,GO:0043998,0.999999999992394,0.880264809381731,0,1,H2A histone acetyltransferase activity,MF,
8957,GO:0035054,0.99999999999241,0.880296890406047,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
12742,GO:0051040,0.99999999999241,0.880296890406047,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12743,GO:0051042,0.99999999999241,0.880296890406047,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13607,GO:0060128,0.99999999999241,0.880296890406047,0,1,corticotropin hormone secreting cell differentiation,BP,
14022,GO:0060804,0.99999999999241,0.880296890406047,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14878,GO:0070724,0.99999999999241,0.880296890406047,0,1,BMP receptor complex,CC,
2315,GO:0005316,0.999999999992413,0.880273451597306,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
861,GO:0002194,0.999999999992439,0.880308938209175,0,1,hepatocyte cell migration,BP,
10281,GO:0043049,0.999999999992439,0.880308938209175,0,1,otic placode formation,BP,
14175,GO:0061114,0.999999999992439,0.880308938209175,0,1,branching involved in pancreas morphogenesis,BP,
14937,GO:0070858,0.999999999992439,0.880308938209175,0,1,negative regulation of bile acid biosynthetic process,BP,
16278,GO:0090425,0.999999999992439,0.880308938209175,0,1,acinar cell differentiation,BP,
18736,GO:1904252,0.999999999992439,0.880308938209175,0,1,negative regulation of bile acid metabolic process,BP,
20134,GO:2000979,0.999999999992439,0.880308938209175,0,1,positive regulation of forebrain neuron differentiation,BP,
1069,GO:0002635,0.999999999992463,0.876093680302741,0,1,negative regulation of germinal center formation,BP,
7563,GO:0031933,0.999999999992478,0.682138395889737,0,3,telomeric heterochromatin,CC,
6038,GO:0019145,0.999999999992575,0.880415628386691,0,1,aminobutyraldehyde dehydrogenase activity,MF,
8505,GO:0033737,0.999999999992575,0.880415628386691,0,1,1-pyrroline dehydrogenase activity,MF,
11935,GO:0047105,0.999999999992575,0.880415628386691,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12301,GO:0048674,0.999999999992623,0.880465303864267,0,1,collateral sprouting of injured axon,BP,
12309,GO:0048686,0.999999999992623,0.880465303864267,0,1,regulation of sprouting of injured axon,BP,
12310,GO:0048687,0.999999999992623,0.880465303864267,0,1,positive regulation of sprouting of injured axon,BP,
12311,GO:0048688,0.999999999992623,0.880465303864267,0,1,negative regulation of sprouting of injured axon,BP,
12312,GO:0048689,0.999999999992623,0.880465303864267,0,1,formation of growth cone in injured axon,BP,
12313,GO:0048693,0.999999999992623,0.880465303864267,0,1,regulation of collateral sprouting of injured axon,BP,
12314,GO:0048694,0.999999999992623,0.880465303864267,0,1,positive regulation of collateral sprouting of injured axon,BP,
19281,GO:1905578,0.999999999992623,0.880465303864267,0,1,regulation of ERBB3 signaling pathway,BP,
19282,GO:1905580,0.999999999992623,0.880465303864267,0,1,positive regulation of ERBB3 signaling pathway,BP,
19382,GO:1905942,0.999999999992623,0.880465303864267,0,1,regulation of formation of growth cone in injured axon,BP,
19383,GO:1905943,0.999999999992623,0.880465303864267,0,1,negative regulation of formation of growth cone in injured axon,BP,
6473,GO:0021822,0.999999999992627,0.881049630274607,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
18097,GO:1902809,0.999999999992638,0.685845423870337,0,3,regulation of skeletal muscle fiber differentiation,BP,
9649,GO:0038021,0.999999999992653,0.880134607858397,0,1,leptin receptor activity,MF,
8036,GO:0032696,0.999999999992662,0.683099643442674,0,3,negative regulation of interleukin-13 production,BP,
1573,GO:0003985,0.999999999992687,0.68641596166812,0,3,acetyl-CoA C-acetyltransferase activity,MF,
8776,GO:0034473,0.999999999992719,0.69828741134987,0,3,U1 snRNA 3'-end processing,BP,
8779,GO:0034476,0.999999999992719,0.69828741134987,0,3,U5 snRNA 3'-end processing,BP,
928,GO:0002326,0.999999999992747,0.67535354805262,0,3,B cell lineage commitment,BP,
9620,GO:0036502,0.999999999992783,0.880299098289789,0,1,Derlin-1-VIMP complex,CC,
9213,GO:0035614,0.999999999992809,0.69235257466087,0,3,snRNA stem-loop binding,MF,
1161,GO:0002775,0.99999999999284,0.688190453114777,0,3,antimicrobial peptide production,BP,
1162,GO:0002778,0.99999999999284,0.688190453114777,0,3,antibacterial peptide production,BP,
1163,GO:0002784,0.99999999999284,0.688190453114777,0,3,regulation of antimicrobial peptide production,BP,
1165,GO:0002786,0.99999999999284,0.688190453114777,0,3,regulation of antibacterial peptide production,BP,
16890,GO:0098885,0.999999999992852,0.879659025832043,0,1,modification of postsynaptic actin cytoskeleton,BP,
16990,GO:0099159,0.999999999992852,0.879659025832043,0,1,regulation of modification of postsynaptic structure,BP,
17385,GO:1900149,0.999999999992852,0.879659025832043,0,1,positive regulation of Schwann cell migration,BP,
18743,GO:1904266,0.999999999992852,0.879659025832043,0,1,regulation of Schwann cell chemotaxis,BP,
18744,GO:1904268,0.999999999992852,0.879659025832043,0,1,positive regulation of Schwann cell chemotaxis,BP,
19162,GO:1905274,0.999999999992852,0.879659025832043,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19581,GO:1990751,0.999999999992852,0.879659025832043,0,1,Schwann cell chemotaxis,BP,
7052,GO:0030846,0.999999999992857,0.876054534955554,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7429,GO:0031554,0.999999999992857,0.876054534955554,0,1,regulation of DNA-templated transcription, termination,BP,
13887,GO:0060566,0.999999999992857,0.876054534955554,0,1,positive regulation of DNA-templated transcription, termination,BP,
18876,GO:1904594,0.999999999992857,0.876054534955554,0,1,regulation of termination of RNA polymerase II transcription,BP,
18877,GO:1904595,0.999999999992857,0.876054534955554,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20089,GO:2000804,0.999999999992857,0.876054534955554,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20090,GO:2000806,0.999999999992857,0.876054534955554,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
4518,GO:0010585,0.999999999992866,0.881965700459053,0,1,glutamine secretion,BP,
18547,GO:1903803,0.999999999992866,0.881965700459053,0,1,L-glutamine import across plasma membrane,BP,
15804,GO:0072534,0.999999999992921,0.879084904132393,0,1,perineuronal net,CC,
11950,GO:0047220,0.999999999992928,0.880341151048717,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
16530,GO:0097338,0.999999999992948,0.88012595295578,0,1,response to clozapine,BP,
79,GO:0000160,0.999999999992958,0.880198414921359,0,1,phosphorelay signal transduction system,BP,
19128,GO:1905168,0.999999999992958,0.880198414921359,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19304,GO:1905651,0.999999999992967,0.680361000432683,0,3,regulation of artery morphogenesis,BP,
19305,GO:1905653,0.999999999992967,0.680361000432683,0,3,positive regulation of artery morphogenesis,BP,
18464,GO:1903613,0.999999999992968,0.880118024779057,0,1,regulation of protein tyrosine phosphatase activity,BP,
18465,GO:1903615,0.999999999992968,0.880118024779057,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
383,GO:0001025,0.999999999992974,0.677163355522588,0,3,RNA polymerase III transcription factor binding,MF,
429,GO:0001156,0.999999999992974,0.677163355522588,0,3,TFIIIC-class transcription factor binding,MF,
5815,GO:0017087,0.99999999999298,0.880165757381244,0,1,mitochondrial processing peptidase complex,CC,
10656,GO:0043914,0.99999999999298,0.880165757381244,0,1,NADPH:sulfur oxidoreductase activity,MF,
1613,GO:0004044,0.999999999993014,0.880191984131881,0,1,amidophosphoribosyltransferase activity,MF,
423,GO:0001129,0.999999999993028,0.683208746691831,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
424,GO:0001132,0.999999999993028,0.683208746691831,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
10644,GO:0043812,0.99999999999304,0.681615383080566,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
5587,GO:0016618,0.999999999993046,0.689120042510445,0,3,hydroxypyruvate reductase activity,MF,
6806,GO:0030267,0.999999999993046,0.689120042510445,0,3,glyoxylate reductase (NADP) activity,MF,
13162,GO:0051793,0.999999999993048,0.681555511363577,0,3,medium-chain fatty acid catabolic process,BP,
14714,GO:0070408,0.999999999993065,0.880091378804287,0,1,carbamoyl phosphate metabolic process,BP,
14715,GO:0070409,0.999999999993065,0.880091378804287,0,1,carbamoyl phosphate biosynthetic process,BP,
18501,GO:1903717,0.999999999993065,0.880091378804287,0,1,response to ammonia,BP,
18502,GO:1903718,0.999999999993065,0.880091378804287,0,1,cellular response to ammonia,BP,
4245,GO:0009449,0.999999999993066,0.682129388278251,0,3,gamma-aminobutyric acid biosynthetic process,BP,
15601,GO:0072125,0.999999999993094,0.684063957955158,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16147,GO:0090194,0.999999999993094,0.684063957955158,0,3,negative regulation of glomerulus development,BP,
3435,GO:0007228,0.999999999993094,0.774669180934915,0,2,positive regulation of hh target transcription factor activity,BP,
5048,GO:0015247,0.999999999993106,0.681707698283484,0,3,aminophospholipid transmembrane transporter activity,MF,
1052,GO:0002580,0.999999999993106,0.698766294625219,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
7940,GO:0032545,0.999999999993134,0.68932215800517,0,3,CURI complex,CC,
8765,GO:0034456,0.999999999993134,0.68932215800517,0,3,UTP-C complex,CC,
9268,GO:0035720,0.999999999993151,0.684483086073967,0,3,intraciliary anterograde transport,BP,
4878,GO:0014744,0.999999999993151,0.680720727180552,0,3,positive regulation of muscle adaptation,BP,
9804,GO:0042025,0.999999999993156,0.682160390004214,0,3,host cell nucleus,CC,
10720,GO:0044094,0.999999999993156,0.682160390004214,0,3,host cell nuclear part,CC,
19401,GO:1990034,0.999999999993205,0.683479844510637,0,3,calcium ion export across plasma membrane,BP,
4828,GO:0014038,0.999999999993223,0.681921579189542,0,3,regulation of Schwann cell differentiation,BP,
3470,GO:0007308,0.999999999993232,0.880381081519578,0,1,oocyte construction,BP,
3471,GO:0007309,0.999999999993232,0.880381081519578,0,1,oocyte axis specification,BP,
3472,GO:0007314,0.999999999993232,0.880381081519578,0,1,oocyte anterior/posterior axis specification,BP,
3473,GO:0007315,0.999999999993232,0.880381081519578,0,1,pole plasm assembly,BP,
3788,GO:0008358,0.999999999993232,0.880381081519578,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7007,GO:0030719,0.999999999993232,0.880381081519578,0,1,P granule organization,BP,
9294,GO:0035755,0.999999999993232,0.880381081519578,0,1,cardiolipin hydrolase activity,MF,
2779,GO:0006212,0.999999999993278,0.880300346628369,0,1,uracil catabolic process,BP,
2781,GO:0006214,0.999999999993278,0.880300346628369,0,1,thymidine catabolic process,BP,
4419,GO:0010232,0.999999999993278,0.880300346628369,0,1,vascular transport,BP,
5828,GO:0017113,0.999999999993278,0.880300346628369,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6154,GO:0019483,0.999999999993278,0.880300346628369,0,1,beta-alanine biosynthetic process,BP,
11553,GO:0046127,0.999999999993278,0.880300346628369,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
13623,GO:0060156,0.999999999993278,0.880300346628369,0,1,milk ejection reflex,BP,
18342,GO:1903367,0.999999999993278,0.880300346628369,0,1,positive regulation of fear response,BP,
20139,GO:2000987,0.999999999993278,0.880300346628369,0,1,positive regulation of behavioral fear response,BP,
11135,GO:0045208,0.999999999993305,0.880223106878122,0,1,MAPK phosphatase export from nucleus,BP,
11136,GO:0045209,0.999999999993305,0.880223106878122,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
4163,GO:0009233,0.999999999993311,0.880208641332061,0,1,menaquinone metabolic process,BP,
4164,GO:0009234,0.999999999993311,0.880208641332061,0,1,menaquinone biosynthetic process,BP,
7699,GO:0032194,0.999999999993311,0.880208641332061,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
9964,GO:0042371,0.999999999993311,0.880208641332061,0,1,vitamin K biosynthetic process,BP,
9163,GO:0035544,0.999999999993322,0.880126168403505,0,1,negative regulation of SNARE complex assembly,BP,
3822,GO:0008426,0.999999999993367,0.699511678541681,0,3,protein kinase C inhibitor activity,MF,
2630,GO:0005958,0.999999999993374,0.678275008987359,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
9573,GO:0036435,0.999999999993386,0.688279753200064,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
3989,GO:0008890,0.999999999993414,0.884706401225594,0,1,glycine C-acetyltransferase activity,MF,
6160,GO:0019518,0.999999999993414,0.884706401225594,0,1,L-threonine catabolic process to glycine,BP,
7320,GO:0031339,0.999999999993419,0.684846458599431,0,3,negative regulation of vesicle fusion,BP,
10466,GO:0043376,0.999999999993427,0.880214934753254,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
8167,GO:0032914,0.999999999993435,0.683521011203234,0,3,positive regulation of transforming growth factor beta1 production,BP,
16389,GO:0097051,0.999999999993473,0.681371088617282,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17897,GO:1902238,0.999999999993475,0.880138892127451,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17898,GO:1902239,0.999999999993475,0.880138892127451,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19425,GO:1990127,0.999999999993475,0.880138892127451,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
3960,GO:0008747,0.999999999993477,0.884974036563771,0,1,N-acetylneuraminate lyase activity,MF,
18047,GO:1902659,0.999999999993478,0.691340686268041,0,3,regulation of glucose mediated signaling pathway,BP,
18048,GO:1902661,0.999999999993478,0.691340686268041,0,3,positive regulation of glucose mediated signaling pathway,BP,
1826,GO:0004484,0.999999999993481,0.880126242353977,0,1,mRNA guanylyltransferase activity,MF,
12452,GO:0050355,0.999999999993481,0.880126242353977,0,1,triphosphatase activity,MF,
15903,GO:0072717,0.999999999993496,0.697763849687395,0,3,cellular response to actinomycin D,BP,
837,GO:0002144,0.999999999993501,0.881171227695359,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
7413,GO:0031515,0.999999999993502,0.684075262291133,0,3,tRNA (m1A) methyltransferase complex,CC,
834,GO:0002135,0.999999999993509,0.880393317457197,0,1,CTP binding,MF,
5819,GO:0017098,0.999999999993509,0.880393317457197,0,1,sulfonylurea receptor binding,MF,
17623,GO:1901388,0.999999999993509,0.880393317457197,0,1,regulation of transforming growth factor beta activation,BP,
17624,GO:1901389,0.999999999993509,0.880393317457197,0,1,negative regulation of transforming growth factor beta activation,BP,
18479,GO:1903659,0.999999999993509,0.880393317457197,0,1,regulation of complement-dependent cytotoxicity,BP,
18480,GO:1903660,0.999999999993509,0.880393317457197,0,1,negative regulation of complement-dependent cytotoxicity,BP,
19633,GO:1990913,0.999999999993509,0.880393317457197,0,1,sperm head plasma membrane,CC,
19634,GO:1990917,0.999999999993509,0.880393317457197,0,1,ooplasm,CC,
8486,GO:0033676,0.999999999993518,0.886785331986279,0,1,double-stranded DNA-dependent ATPase activity,MF,
13953,GO:0060689,0.999999999993526,0.683089340793465,0,3,cell differentiation involved in salivary gland development,BP,
6395,GO:0021615,0.999999999993536,0.880279337733625,0,1,glossopharyngeal nerve morphogenesis,BP,
17654,GO:1901555,0.999999999993539,0.879780869303025,0,1,response to paclitaxel,BP,
19317,GO:1905705,0.999999999993539,0.879780869303025,0,1,cellular response to paclitaxel,BP,
14988,GO:0070943,0.99999999999354,0.689478292724168,0,3,neutrophil mediated killing of symbiont cell,BP,
20261,GO:2001271,0.999999999993541,0.682669398337222,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
8607,GO:0034137,0.999999999993552,0.698607358084016,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
2359,GO:0005461,0.999999999993557,0.879949244401696,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
5192,GO:0015787,0.999999999993557,0.879949244401696,0,1,UDP-glucuronic acid transmembrane transport,BP,
16760,GO:0098619,0.999999999993571,0.882114186621164,0,1,selenocysteine-tRNA ligase activity,MF,
4649,GO:0010797,0.999999999993583,0.889506433761937,0,1,regulation of multivesicular body size involved in endosome transport,BP,
1482,GO:0003796,0.999999999993584,0.885466303841952,0,1,lysozyme activity,MF,
13946,GO:0060681,0.999999999993584,0.683850035479839,0,3,branch elongation involved in ureteric bud branching,BP,
18911,GO:1904691,0.999999999993615,0.88108652926779,0,1,negative regulation of type B pancreatic cell proliferation,BP,
7239,GO:0031204,0.99999999999362,0.698114904982381,0,3,posttranslational protein targeting to membrane, translocation,BP,
1888,GO:0004573,0.999999999993626,0.880345826947615,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
4682,GO:0010836,0.999999999993629,0.686118522885486,0,3,negative regulation of protein ADP-ribosylation,BP,
19514,GO:1990456,0.999999999993629,0.880178261681984,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
11008,GO:0044868,0.999999999993691,0.879952700770812,0,1,modulation by host of viral molecular function,BP,
19154,GO:1905255,0.999999999993691,0.879952700770812,0,1,regulation of RNA binding transcription factor activity,BP,
19649,GO:1990968,0.999999999993691,0.879952700770812,0,1,modulation by host of RNA binding by virus,BP,
19650,GO:1990969,0.999999999993691,0.879952700770812,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
3344,GO:0007066,0.999999999993694,0.894140524126868,0,1,female meiosis sister chromatid cohesion,BP,
5301,GO:0016011,0.999999999993701,0.684308546463279,0,3,dystroglycan complex,CC,
2251,GO:0005166,0.999999999993722,0.89311143572482,0,1,neurotrophin p75 receptor binding,MF,
3497,GO:0007402,0.999999999993722,0.89311143572482,0,1,ganglion mother cell fate determination,BP,
3609,GO:0008052,0.999999999993722,0.89311143572482,0,1,sensory organ boundary specification,BP,
4404,GO:0010160,0.999999999993722,0.89311143572482,0,1,formation of animal organ boundary,BP,
12398,GO:0048867,0.999999999993722,0.89311143572482,0,1,stem cell fate determination,BP,
14205,GO:0061193,0.999999999993722,0.89311143572482,0,1,taste bud development,BP,
16971,GO:0099082,0.999999999993722,0.89311143572482,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
16972,GO:0099083,0.999999999993722,0.89311143572482,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17029,GO:0099538,0.999999999993722,0.89311143572482,0,1,synaptic signaling via neuropeptide,BP,
17030,GO:0099540,0.999999999993722,0.89311143572482,0,1,trans-synaptic signaling by neuropeptide,BP,
17038,GO:0099551,0.999999999993722,0.89311143572482,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
9195,GO:0035594,0.999999999993726,0.683491967058432,0,3,ganglioside binding,MF,
2352,GO:0005432,0.999999999993731,0.682309274761702,0,3,calcium:sodium antiporter activity,MF,
7009,GO:0030729,0.99999999999374,0.880265165216637,0,1,acetoacetate-CoA ligase activity,MF,
12019,GO:0047760,0.99999999999374,0.880265165216637,0,1,butyrate-CoA ligase activity,MF,
16967,GO:0099077,0.999999999993741,0.880089885993579,0,1,histone-dependent DNA binding,MF,
19313,GO:1905687,0.999999999993741,0.880089885993579,0,1,regulation of diacylglycerol kinase activity,BP,
19314,GO:1905689,0.999999999993741,0.880089885993579,0,1,positive regulation of diacylglycerol kinase activity,BP,
4826,GO:0014036,0.999999999993746,0.880166020843083,0,1,neural crest cell fate specification,BP,
9219,GO:0035622,0.999999999993746,0.880166020843083,0,1,intrahepatic bile duct development,BP,
12397,GO:0048866,0.999999999993746,0.880166020843083,0,1,stem cell fate specification,BP,
13529,GO:0060018,0.999999999993746,0.880166020843083,0,1,astrocyte fate commitment,BP,
13660,GO:0060221,0.999999999993746,0.880166020843083,0,1,retinal rod cell differentiation,BP,
13857,GO:0060516,0.999999999993746,0.880166020843083,0,1,primary prostatic bud elongation,BP,
13858,GO:0060517,0.999999999993746,0.880166020843083,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14017,GO:0060784,0.999999999993746,0.880166020843083,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
11134,GO:0045204,0.999999999993771,0.681811760590365,0,3,MAPK export from nucleus,BP,
15826,GO:0072570,0.999999999993783,0.880281474696946,0,1,ADP-D-ribose binding,MF,
14457,GO:0061888,0.99999999999379,0.687666477942509,0,3,regulation of astrocyte activation,BP,
2030,GO:0004773,0.999999999993812,0.879973479992153,0,1,steryl-sulfatase activity,MF,
16708,GO:0097749,0.999999999993812,0.879973479992153,0,1,membrane tubulation,BP,
19146,GO:1905223,0.999999999993812,0.879978781325276,0,1,epicardium morphogenesis,BP,
2274,GO:0005219,0.999999999993825,0.893524715078632,0,1,ryanodine-sensitive calcium-release channel activity,MF,
1675,GO:0004142,0.99999999999385,0.685921420790033,0,3,diacylglycerol cholinephosphotransferase activity,MF,
3853,GO:0008475,0.999999999993861,0.682059163089922,0,3,procollagen-lysine 5-dioxygenase activity,MF,
11891,GO:0046946,0.999999999993861,0.682059163089922,0,3,hydroxylysine metabolic process,BP,
11892,GO:0046947,0.999999999993861,0.682059163089922,0,3,hydroxylysine biosynthetic process,BP,
4857,GO:0014701,0.999999999993862,0.679319512482803,0,3,junctional sarcoplasmic reticulum membrane,CC,
17822,GO:1902037,0.999999999993867,0.682250186216278,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
8453,GO:0033603,0.999999999993867,0.696562718972277,0,3,positive regulation of dopamine secretion,BP,
6011,GO:0019065,0.999999999993887,0.682040585585213,0,3,receptor-mediated endocytosis of virus by host cell,BP,
15927,GO:0075509,0.999999999993887,0.682040585585213,0,3,endocytosis involved in viral entry into host cell,BP,
16360,GO:0093001,0.999999999993892,0.880286285794871,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
2120,GO:0004915,0.999999999993907,0.774771793691853,0,2,interleukin-6 receptor activity,MF,
2598,GO:0005896,0.999999999993907,0.774771793691853,0,2,interleukin-6 receptor complex,CC,
6316,GO:0019981,0.999999999993907,0.774771793691853,0,2,interleukin-6 binding,MF,
14551,GO:0070110,0.999999999993907,0.774771793691853,0,2,ciliary neurotrophic factor receptor complex,CC,
13820,GO:0060447,0.999999999993931,0.879448130009324,0,1,bud outgrowth involved in lung branching,BP,
13991,GO:0060739,0.999999999993931,0.879448130009324,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
10361,GO:0043199,0.999999999993933,0.685008224308932,0,3,sulfate binding,MF,
4587,GO:0010700,0.999999999993935,0.880304030833152,0,1,negative regulation of norepinephrine secretion,BP,
7498,GO:0031686,0.999999999993935,0.880304030833152,0,1,A1 adenosine receptor binding,MF,
11031,GO:0045032,0.999999999993935,0.880304030833152,0,1,ADP-activated adenosine receptor activity,MF,
13390,GO:0052810,0.999999999993976,0.880194106536897,0,1,1-phosphatidylinositol-5-kinase activity,MF,
8627,GO:0034166,0.999999999993981,0.88026959210348,0,1,toll-like receptor 10 signaling pathway,BP,
10193,GO:0042825,0.99999999999403,0.682000285899494,0,3,TAP complex,CC,
13947,GO:0060683,0.999999999994058,0.880342243860746,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
19484,GO:1990401,0.999999999994058,0.880342243860746,0,1,embryonic lung development,BP,
7949,GO:0032557,0.999999999994065,0.682638331796269,0,3,pyrimidine ribonucleotide binding,MF,
19262,GO:1905524,0.999999999994067,0.879406160871913,0,1,negative regulation of protein autoubiquitination,BP,
19994,GO:2000645,0.999999999994078,0.684877397611474,0,3,negative regulation of receptor catabolic process,BP,
14933,GO:0070852,0.999999999994097,0.672321293025364,0,3,cell body fiber,CC,
8881,GO:0034711,0.999999999994114,0.68452424525713,0,3,inhibin binding,MF,
18559,GO:1903837,0.999999999994151,0.88043858057191,0,1,regulation of mRNA 3'-UTR binding,BP,
18560,GO:1903839,0.999999999994151,0.88043858057191,0,1,positive regulation of mRNA 3'-UTR binding,BP,
8564,GO:0034056,0.999999999994164,0.681909844185219,0,3,estrogen response element binding,MF,
8447,GO:0033597,0.999999999994183,0.881009443750892,0,1,mitotic checkpoint complex,CC,
19468,GO:1990298,0.999999999994183,0.881009443750892,0,1,bub1-bub3 complex,CC,
521,GO:0001609,0.999999999994206,0.684757307766046,0,3,G-protein coupled adenosine receptor activity,MF,
9543,GO:0036333,0.999999999994211,0.880361292130208,0,1,hepatocyte homeostasis,BP,
18954,GO:1904772,0.999999999994211,0.880361292130208,0,1,response to tetrachloromethane,BP,
1668,GO:0004133,0.999999999994217,0.879664754685161,0,1,glycogen debranching enzyme activity,MF,
1669,GO:0004134,0.999999999994217,0.879664754685161,0,1,4-alpha-glucanotransferase activity,MF,
1670,GO:0004135,0.999999999994217,0.879664754685161,0,1,amylo-alpha-1,6-glucosidase activity,MF,
10269,GO:0043033,0.999999999994217,0.879664754685161,0,1,isoamylase complex,CC,
17129,GO:0102500,0.999999999994217,0.879664754685161,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
660,GO:0001855,0.999999999994225,0.884701138909528,0,1,complement component C4b binding,MF,
1769,GO:0004377,0.999999999994271,0.880398489155556,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
16534,GO:0097343,0.999999999994274,0.680772798175124,0,3,ripoptosome assembly,BP,
17504,GO:1901026,0.999999999994274,0.680772798175124,0,3,ripoptosome assembly involved in necroptotic process,BP,
3434,GO:0007227,0.999999999994286,0.681819284271089,0,3,signal transduction downstream of smoothened,BP,
1883,GO:0004567,0.999999999994292,0.880267472243613,0,1,beta-mannosidase activity,MF,
4449,GO:0010412,0.999999999994292,0.880267472243613,0,1,mannan metabolic process,BP,
11619,GO:0046355,0.999999999994292,0.880267472243613,0,1,mannan catabolic process,BP,
12681,GO:0050923,0.999999999994324,0.681251743739534,0,3,regulation of negative chemotaxis,BP,
17707,GO:1901664,0.999999999994334,0.688596008325959,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17708,GO:1901666,0.999999999994334,0.688596008325959,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18191,GO:1903011,0.999999999994341,0.677811614347275,0,3,negative regulation of bone development,BP,
20223,GO:2001205,0.999999999994341,0.677811614347275,0,3,negative regulation of osteoclast development,BP,
13579,GO:0060075,0.999999999994403,0.682526676936738,0,3,regulation of resting membrane potential,BP,
11243,GO:0045519,0.999999999994423,0.892317438026769,0,1,interleukin-23 receptor binding,MF,
14889,GO:0070743,0.999999999994423,0.892317438026769,0,1,interleukin-23 complex,CC,
2415,GO:0005590,0.999999999994441,0.878148842570995,0,1,collagen type VII trimer,CC,
16778,GO:0098648,0.999999999994441,0.878148842570995,0,1,collagen anchoring fibril,CC,
16780,GO:0098652,0.999999999994441,0.878148842570995,0,1,collagen type VII anchoring fibril,CC,
7817,GO:0032379,0.999999999994444,0.690069650463234,0,3,positive regulation of intracellular lipid transport,BP,
7820,GO:0032382,0.999999999994444,0.690069650463234,0,3,positive regulation of intracellular sterol transport,BP,
7823,GO:0032385,0.999999999994444,0.690069650463234,0,3,positive regulation of intracellular cholesterol transport,BP,
12346,GO:0048752,0.999999999994445,0.683361477606318,0,3,semicircular canal morphogenesis,BP,
4640,GO:0010767,0.999999999994457,0.681236034335951,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
14115,GO:0061009,0.999999999994463,0.686786472929363,0,3,common bile duct development,BP,
8379,GO:0033301,0.999999999994466,0.880196582155897,0,1,cell cycle comprising mitosis without cytokinesis,BP,
17600,GO:1901338,0.999999999994495,0.684687047820411,0,3,catecholamine binding,MF,
14283,GO:0061444,0.999999999994496,0.880055524373291,0,1,endocardial cushion cell development,BP,
13609,GO:0060134,0.999999999994504,0.681287563508943,0,3,prepulse inhibition,BP,
2361,GO:0005464,0.999999999994514,0.879831728613104,0,1,UDP-xylose transmembrane transporter activity,MF,
5193,GO:0015790,0.999999999994514,0.879831728613104,0,1,UDP-xylose transmembrane transport,BP,
18027,GO:1902603,0.999999999994549,0.684133150639266,0,3,carnitine transmembrane transport,BP,
14985,GO:0070939,0.999999999994561,0.681648287043275,0,3,Dsl1/NZR complex,CC,
14426,GO:0061772,0.999999999994562,0.880250244618821,0,1,drug transport across blood-nerve barrier,BP,
18428,GO:1903544,0.999999999994562,0.880250244618821,0,1,response to butyrate,BP,
18429,GO:1903545,0.999999999994562,0.880250244618821,0,1,cellular response to butyrate,BP,
2059,GO:0004814,0.999999999994564,0.684754269935898,0,3,arginine-tRNA ligase activity,MF,
2907,GO:0006420,0.999999999994564,0.684754269935898,0,3,arginyl-tRNA aminoacylation,BP,
20208,GO:2001183,0.999999999994587,0.88220389349366,0,1,negative regulation of interleukin-12 secretion,BP,
9001,GO:0035189,0.999999999994624,0.682513344424353,0,3,Rb-E2F complex,CC,
2555,GO:0005833,0.999999999994625,0.880320236679832,0,1,hemoglobin complex,CC,
8524,GO:0033862,0.999999999994625,0.880320236679832,0,1,UMP kinase activity,MF,
10209,GO:0042904,0.999999999994638,0.683922677501183,0,3,9-cis-retinoic acid biosynthetic process,BP,
10210,GO:0042905,0.999999999994638,0.683922677501183,0,3,9-cis-retinoic acid metabolic process,BP,
12113,GO:0048213,0.999999999994661,0.880337066854763,0,1,Golgi vesicle prefusion complex stabilization,BP,
2090,GO:0004856,0.999999999994663,0.880200598860862,0,1,xylulokinase activity,MF,
2652,GO:0005998,0.999999999994663,0.880200598860862,0,1,xylulose catabolic process,BP,
1030,GO:0002538,0.999999999994669,0.880294653971779,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1031,GO:0002540,0.999999999994669,0.880294653971779,0,1,leukotriene production involved in inflammatory response,BP,
9129,GO:0035490,0.999999999994669,0.880294653971779,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9130,GO:0035491,0.999999999994669,0.880294653971779,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
14136,GO:0061044,0.999999999994669,0.880294653971779,0,1,negative regulation of vascular wound healing,BP,
17598,GO:1901331,0.999999999994669,0.880294653971779,0,1,positive regulation of odontoblast differentiation,BP,
18136,GO:1902913,0.999999999994669,0.880294653971779,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19702,GO:2000098,0.999999999994669,0.880294653971779,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
3816,GO:0008418,0.999999999994672,0.891083520447897,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
8533,GO:0033878,0.999999999994692,0.880182343099864,0,1,hormone-sensitive lipase activity,MF,
17915,GO:1902283,0.999999999994693,0.880154193703101,0,1,negative regulation of primary amine oxidase activity,BP,
6448,GO:0021773,0.999999999994698,0.681481540501579,0,3,striatal medium spiny neuron differentiation,BP,
11163,GO:0045272,0.999999999994702,0.705953305170135,0,3,plasma membrane respiratory chain complex I,CC,
304,GO:0000814,0.999999999994724,0.697755886603496,0,3,ESCRT II complex,CC,
121,GO:0000252,0.99999999999475,0.884539779510605,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
11922,GO:0047012,0.99999999999475,0.884539779510605,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17155,GO:0103066,0.99999999999475,0.884539779510605,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17156,GO:0103067,0.99999999999475,0.884539779510605,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
6375,GO:0021569,0.999999999994765,0.884570741677612,0,1,rhombomere 3 development,BP,
6376,GO:0021570,0.999999999994765,0.884570741677612,0,1,rhombomere 4 development,BP,
5201,GO:0015803,0.999999999994765,0.682378502699459,0,3,branched-chain amino acid transport,BP,
13007,GO:0051481,0.999999999994775,0.681640335817861,0,3,negative regulation of cytosolic calcium ion concentration,BP,
18354,GO:1903387,0.999999999994781,0.880119831173623,0,1,positive regulation of homophilic cell adhesion,BP,
1844,GO:0004506,0.999999999994791,0.880319457119249,0,1,squalene monooxygenase activity,MF,
7233,GO:0031166,0.999999999994823,0.681937876192112,0,3,integral component of vacuolar membrane,CC,
7299,GO:0031310,0.999999999994823,0.681937876192112,0,3,intrinsic component of vacuolar membrane,CC,
12477,GO:0050560,0.999999999994839,0.880260701574703,0,1,aspartate-tRNA(Asn) ligase activity,MF,
14571,GO:0070145,0.999999999994839,0.880260701574703,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
16579,GO:0097441,0.99999999999484,0.682653411500006,0,3,basal dendrite,CC,
13648,GO:0060200,0.999999999994846,0.880122836915822,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13649,GO:0060201,0.999999999994846,0.880122836915822,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
16814,GO:0098746,0.999999999994846,0.880122836915822,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18678,GO:1904098,0.999999999994878,0.684495610997934,0,3,regulation of protein O-linked glycosylation,BP,
18679,GO:1904100,0.999999999994878,0.684495610997934,0,3,positive regulation of protein O-linked glycosylation,BP,
14116,GO:0061010,0.999999999994881,0.877197256448257,0,1,gall bladder development,BP,
14428,GO:0061780,0.999999999994881,0.877197256448257,0,1,mitotic cohesin loading,BP,
14791,GO:0070550,0.999999999994881,0.877197256448257,0,1,rDNA condensation,BP,
19176,GO:1905309,0.999999999994881,0.877197256448257,0,1,positive regulation of cohesin loading,BP,
19219,GO:1905405,0.999999999994881,0.877197256448257,0,1,regulation of mitotic cohesin loading,BP,
19220,GO:1905406,0.999999999994881,0.877197256448257,0,1,positive regulation of mitotic cohesin loading,BP,
8859,GO:0034677,0.999999999994902,0.880189403007488,0,1,integrin alpha7-beta1 complex,CC,
8862,GO:0034681,0.999999999994902,0.880189403007488,0,1,integrin alpha11-beta1 complex,CC,
3516,GO:0007468,0.999999999994904,0.881372025884991,0,1,regulation of rhodopsin gene expression,BP,
11419,GO:0045872,0.999999999994904,0.881372025884991,0,1,positive regulation of rhodopsin gene expression,BP,
3876,GO:0008511,0.999999999994934,0.879807805245093,0,1,sodium:potassium:chloride symporter activity,MF,
4283,GO:0009674,0.999999999994934,0.879807805245093,0,1,potassium:sodium symporter activity,MF,
5096,GO:0015378,0.999999999994934,0.879807805245093,0,1,sodium:chloride symporter activity,MF,
11384,GO:0045795,0.999999999994934,0.879807805245093,0,1,positive regulation of cell volume,BP,
438,GO:0001179,0.999999999994941,0.882360144080681,0,1,RNA polymerase I transcription factor binding,MF,
2486,GO:0005731,0.999999999994968,0.883426901800267,0,1,nucleolus organizer region,CC,
3345,GO:0007072,0.999999999994968,0.883426901800267,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7073,GO:0030874,0.999999999994968,0.883426901800267,0,1,nucleolar chromatin,CC,
16551,GO:0097372,0.999999999994968,0.883426901800267,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
3072,GO:0006642,0.999999999994977,0.682101586687084,0,3,triglyceride mobilization,BP,
7950,GO:0032558,0.999999999995008,0.695193059389149,0,3,adenyl deoxyribonucleotide binding,MF,
7954,GO:0032564,0.999999999995008,0.695193059389149,0,3,dATP binding,MF,
5432,GO:0016300,0.999999999995044,0.682049439125725,0,3,tRNA (uracil) methyltransferase activity,MF,
20224,GO:2001206,0.999999999995048,0.682876395648853,0,3,positive regulation of osteoclast development,BP,
4266,GO:0009624,0.99999999999505,0.880367973791667,0,1,response to nematode,BP,
4284,GO:0009692,0.99999999999505,0.880367973791667,0,1,ethylene metabolic process,BP,
4285,GO:0009698,0.99999999999505,0.880367973791667,0,1,phenylpropanoid metabolic process,BP,
4314,GO:0009804,0.99999999999505,0.880367973791667,0,1,coumarin metabolic process,BP,
5626,GO:0016711,0.99999999999505,0.880367973791667,0,1,flavonoid 3'-monooxygenase activity,MF,
6101,GO:0019341,0.99999999999505,0.880367973791667,0,1,dibenzo-p-dioxin catabolic process,BP,
10505,GO:0043449,0.99999999999505,0.880367973791667,0,1,cellular alkene metabolic process,BP,
9198,GO:0035598,0.999999999995082,0.880274845633115,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
14394,GO:0061712,0.999999999995082,0.880274845633115,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
1637,GO:0004082,0.999999999995083,0.688546310533799,0,3,bisphosphoglycerate mutase activity,MF,
1922,GO:0004619,0.999999999995083,0.688546310533799,0,3,phosphoglycerate mutase activity,MF,
11708,GO:0046538,0.999999999995083,0.688546310533799,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
125,GO:0000257,0.999999999995112,0.887352535492525,0,1,nitrilase activity,MF,
5690,GO:0016815,0.999999999995112,0.887352535492525,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
9954,GO:0042356,0.999999999995112,0.887352535492525,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
12481,GO:0050577,0.999999999995112,0.887352535492525,0,1,GDP-L-fucose synthase activity,MF,
14744,GO:0070463,0.999999999995113,0.880239901045065,0,1,tubulin-dependent ATPase activity,MF,
19977,GO:2000619,0.999999999995117,0.688750916828564,0,3,negative regulation of histone H4-K16 acetylation,BP,
5531,GO:0016520,0.999999999995134,0.88012400632824,0,1,growth hormone-releasing hormone receptor activity,MF,
11817,GO:0046786,0.999999999995161,0.88012281764026,0,1,viral replication complex formation and maintenance,BP,
20008,GO:2000661,0.999999999995161,0.88012281764026,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
1365,GO:0003252,0.999999999995177,0.874469898445953,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
3426,GO:0007217,0.999999999995182,0.880382742687446,0,1,tachykinin receptor signaling pathway,BP,
1899,GO:0004587,0.999999999995196,0.88167736319271,0,1,ornithine-oxo-acid transaminase activity,MF,
4395,GO:0010121,0.999999999995196,0.88167736319271,0,1,arginine catabolic process to proline via ornithine,BP,
6155,GO:0019493,0.999999999995196,0.88167736319271,0,1,arginine catabolic process to proline,BP,
6173,GO:0019544,0.999999999995196,0.88167736319271,0,1,arginine catabolic process to glutamate,BP,
9051,GO:0035299,0.999999999995206,0.880128123151744,0,1,inositol pentakisphosphate 2-kinase activity,MF,
20001,GO:2000653,0.999999999995222,0.681951878555798,0,3,regulation of genetic imprinting,BP,
9771,GO:0039713,0.999999999995243,0.880246164716063,0,1,viral factory,CC,
9772,GO:0039714,0.999999999995243,0.880246164716063,0,1,cytoplasmic viral factory,CC,
15790,GO:0072517,0.999999999995243,0.880246164716063,0,1,host cell viral assembly compartment,CC,
17443,GO:1900276,0.999999999995243,0.880246164716063,0,1,regulation of proteinase activated receptor activity,BP,
17480,GO:1900736,0.999999999995243,0.880246164716063,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17481,GO:1900737,0.999999999995243,0.880246164716063,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
9798,GO:0042008,0.999999999995254,0.880231022114458,0,1,interleukin-18 receptor activity,MF,
19547,GO:1990613,0.999999999995254,0.880231022114458,0,1,mitochondrial membrane fusion,BP,
2351,GO:0005427,0.999999999995271,0.880297682279666,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
5080,GO:0015322,0.999999999995271,0.880297682279666,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
7459,GO:0031626,0.999999999995277,0.880121302504628,0,1,beta-endorphin binding,MF,
14867,GO:0070685,0.999999999995286,0.881145163792237,0,1,macropinocytic cup,CC,
3087,GO:0006663,0.999999999995311,0.685554210520053,0,3,platelet activating factor biosynthetic process,BP,
15916,GO:0072752,0.999999999995321,0.879907535873601,0,1,cellular response to rapamycin,BP,
5890,GO:0018094,0.999999999995323,0.880251874004383,0,1,protein polyglycylation,BP,
14883,GO:0070735,0.999999999995323,0.880251874004383,0,1,protein-glycine ligase activity,MF,
14884,GO:0070736,0.999999999995323,0.880251874004383,0,1,protein-glycine ligase activity, initiating,MF,
10751,GO:0044214,0.999999999995323,0.677604672736494,0,3,spanning component of plasma membrane,CC,
7411,GO:0031510,0.999999999995325,0.686896911616593,0,3,SUMO activating enzyme complex,CC,
7734,GO:0032252,0.999999999995355,0.677331775528567,0,3,secretory granule localization,BP,
9149,GO:0035517,0.999999999995358,0.681485304267716,0,3,PR-DUB complex,CC,
18379,GO:1903435,0.999999999995366,0.88033984824259,0,1,positive regulation of constitutive secretory pathway,BP,
14895,GO:0070773,0.999999999995385,0.887555828307338,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15301,GO:0071544,0.999999999995385,0.887555828307338,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15478,GO:0071877,0.999999999995385,0.887555828307338,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15482,GO:0071881,0.999999999995385,0.887555828307338,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16027,GO:0086096,0.999999999995385,0.887555828307338,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17290,GO:0140193,0.999999999995385,0.887555828307338,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17291,GO:0140194,0.999999999995385,0.887555828307338,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18795,GO:1904396,0.999999999995397,0.68052986122953,0,3,regulation of neuromuscular junction development,BP,
3513,GO:0007439,0.999999999995404,0.880323026405214,0,1,ectodermal digestive tract development,BP,
9504,GO:0036215,0.999999999995404,0.880323026405214,0,1,response to stem cell factor,BP,
9505,GO:0036216,0.999999999995404,0.880323026405214,0,1,cellular response to stem cell factor stimulus,BP,
9690,GO:0038109,0.999999999995404,0.880323026405214,0,1,Kit signaling pathway,BP,
12267,GO:0048611,0.999999999995404,0.880323026405214,0,1,embryonic ectodermal digestive tract development,BP,
14239,GO:0061325,0.999999999995411,0.684507057994802,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
10237,GO:0042988,0.999999999995412,0.880121488993801,0,1,X11-like protein binding,MF,
9988,GO:0042421,0.99999999999544,0.683545952107501,0,3,norepinephrine biosynthetic process,BP,
3725,GO:0008260,0.999999999995467,0.880222927948008,0,1,3-oxoacid CoA-transferase activity,MF,
10274,GO:0043041,0.999999999995467,0.880222927948008,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
1361,GO:0003247,0.999999999995471,0.884158871532153,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1555,GO:0003956,0.999999999995471,0.884158871532153,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2483,GO:0005724,0.999999999995471,0.884158871532153,0,1,nuclear telomeric heterochromatin,CC,
7410,GO:0031509,0.999999999995471,0.884158871532153,0,1,telomeric heterochromatin assembly,BP,
7568,GO:0031940,0.999999999995471,0.884158871532153,0,1,positive regulation of chromatin silencing at telomere,BP,
18072,GO:1902732,0.999999999995471,0.884158871532153,0,1,positive regulation of chondrocyte proliferation,BP,
19266,GO:1905547,0.999999999995471,0.884158871532153,0,1,regulation of telomeric heterochromatin assembly,BP,
19267,GO:1905549,0.999999999995471,0.884158871532153,0,1,positive regulation of telomeric heterochromatin assembly,BP,
8474,GO:0033633,0.999999999995477,0.880122820534433,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
16407,GO:0097086,0.999999999995492,0.880206739954075,0,1,amniotic stem cell differentiation,BP,
20038,GO:2000706,0.999999999995492,0.880206739954075,0,1,negative regulation of dense core granule biogenesis,BP,
20054,GO:2000740,0.999999999995492,0.880206739954075,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20087,GO:2000797,0.999999999995492,0.880206739954075,0,1,regulation of amniotic stem cell differentiation,BP,
20088,GO:2000798,0.999999999995492,0.880206739954075,0,1,negative regulation of amniotic stem cell differentiation,BP,
9277,GO:0035730,0.999999999995573,0.893728797600138,0,1,S-nitrosoglutathione binding,MF,
9278,GO:0035731,0.999999999995573,0.893728797600138,0,1,dinitrosyl-iron complex binding,MF,
9279,GO:0035732,0.999999999995573,0.893728797600138,0,1,nitric oxide storage,BP,
6870,GO:0030372,0.999999999995577,0.880122849850638,0,1,high molecular weight B cell growth factor receptor binding,MF,
16108,GO:0090138,0.999999999995619,0.880205364134789,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
13164,GO:0051795,0.999999999995629,0.695465757665317,0,3,positive regulation of timing of catagen,BP,
3910,GO:0008579,0.999999999995633,0.880119785603939,0,1,JUN kinase phosphatase activity,MF,
933,GO:0002332,0.999999999995642,0.880102433361515,0,1,transitional stage B cell differentiation,BP,
934,GO:0002333,0.999999999995642,0.880102433361515,0,1,transitional one stage B cell differentiation,BP,
18845,GO:1904531,0.999999999995642,0.880102433361515,0,1,positive regulation of actin filament binding,BP,
18887,GO:1904618,0.999999999995642,0.880102433361515,0,1,positive regulation of actin binding,BP,
19409,GO:1990051,0.999999999995642,0.880102433361515,0,1,activation of protein kinase C activity,BP,
13217,GO:0051908,0.999999999995677,0.880288284080934,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
8636,GO:0034191,0.999999999995691,0.68221696143462,0,3,apolipoprotein A-I receptor binding,MF,
4491,GO:0010521,0.999999999995725,0.691263979531425,0,3,telomerase inhibitor activity,MF,
862,GO:0002196,0.999999999995728,0.882128930137713,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
4975,GO:0015098,0.999999999995728,0.882128930137713,0,1,molybdate ion transmembrane transporter activity,MF,
5148,GO:0015689,0.999999999995728,0.882128930137713,0,1,molybdate ion transport,BP,
13105,GO:0051684,0.999999999995738,0.681548015196439,0,3,maintenance of Golgi location,BP,
2568,GO:0005853,0.999999999995784,0.69848330311061,0,3,eukaryotic translation elongation factor 1 complex,CC,
7719,GO:0032222,0.99999999999579,0.877668854195908,0,1,regulation of synaptic transmission, cholinergic,BP,
7720,GO:0032224,0.99999999999579,0.877668854195908,0,1,positive regulation of synaptic transmission, cholinergic,BP,
5963,GO:0018395,0.999999999995819,0.880213351954441,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6552,GO:0021998,0.999999999995819,0.880213351954441,0,1,neural plate mediolateral regionalization,BP,
8508,GO:0033746,0.999999999995819,0.880213351954441,0,1,histone demethylase activity (H3-R2 specific),MF,
8509,GO:0033749,0.999999999995819,0.880213351954441,0,1,histone demethylase activity (H4-R3 specific),MF,
12169,GO:0048338,0.999999999995819,0.880213351954441,0,1,mesoderm structural organization,BP,
12173,GO:0048352,0.999999999995819,0.880213351954441,0,1,paraxial mesoderm structural organization,BP,
14529,GO:0070077,0.999999999995819,0.880213351954441,0,1,histone arginine demethylation,BP,
14530,GO:0070078,0.999999999995819,0.880213351954441,0,1,histone H3-R2 demethylation,BP,
14531,GO:0070079,0.999999999995819,0.880213351954441,0,1,histone H4-R3 demethylation,BP,
18801,GO:1904412,0.999999999995819,0.880213351954441,0,1,regulation of cardiac ventricle development,BP,
18802,GO:1904414,0.999999999995819,0.880213351954441,0,1,positive regulation of cardiac ventricle development,BP,
19167,GO:1905285,0.999999999995819,0.880213351954441,0,1,fibrous ring of heart morphogenesis,BP,
2040,GO:0004790,0.999999999995822,0.880387577808659,0,1,thioether S-methyltransferase activity,MF,
7014,GO:0030748,0.999999999995822,0.880387577808659,0,1,amine N-methyltransferase activity,MF,
17137,GO:0102707,0.999999999995822,0.880387577808659,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
10955,GO:0044752,0.999999999995826,0.682312885247299,0,3,response to human chorionic gonadotropin,BP,
8078,GO:0032771,0.999999999995845,0.880133300579933,0,1,regulation of monophenol monooxygenase activity,BP,
8079,GO:0032773,0.999999999995845,0.880133300579933,0,1,positive regulation of monophenol monooxygenase activity,BP,
8165,GO:0032912,0.999999999995845,0.880133300579933,0,1,negative regulation of transforming growth factor beta2 production,BP,
12053,GO:0048023,0.999999999995845,0.880133300579933,0,1,positive regulation of melanin biosynthetic process,BP,
13165,GO:0051796,0.999999999995845,0.880133300579933,0,1,negative regulation of timing of catagen,BP,
14056,GO:0060901,0.999999999995845,0.880133300579933,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
18132,GO:1902908,0.999999999995845,0.880133300579933,0,1,regulation of melanosome transport,BP,
18133,GO:1902910,0.999999999995845,0.880133300579933,0,1,positive regulation of melanosome transport,BP,
13988,GO:0060735,0.99999999999585,0.887325640093477,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18040,GO:1902629,0.99999999999585,0.887325640093477,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
13500,GO:0055100,0.999999999995866,0.682544481227944,0,3,adiponectin binding,MF,
19622,GO:1990876,0.999999999995882,0.879898370663925,0,1,cytoplasmic side of nuclear pore,CC,
16309,GO:0090560,0.999999999995891,0.881000396521286,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
1378,GO:0003278,0.999999999995926,0.68225598799092,0,3,apoptotic process involved in heart morphogenesis,BP,
16588,GO:0097454,0.999999999995933,0.684882916328642,0,3,Schwann cell microvillus,CC,
3783,GO:0008352,0.999999999995962,0.88035537235257,0,1,katanin complex,CC,
4009,GO:0009007,0.999999999995966,0.880203994478396,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
8081,GO:0032775,0.999999999995966,0.880203994478396,0,1,DNA methylation on adenine,BP,
9363,GO:0035905,0.99999999999598,0.686454145484775,0,3,ascending aorta development,BP,
9366,GO:0035910,0.99999999999598,0.686454145484775,0,3,ascending aorta morphogenesis,BP,
16582,GO:0097444,0.999999999996007,0.880122073551183,0,1,spine apparatus,CC,
19199,GO:1905355,0.999999999996007,0.880122073551183,0,1,spine apparatus assembly,BP,
9598,GO:0036476,0.999999999996016,0.696065684872824,0,3,neuron death in response to hydrogen peroxide,BP,
18273,GO:1903207,0.999999999996016,0.696065684872824,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18274,GO:1903208,0.999999999996016,0.696065684872824,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
4368,GO:0009992,0.999999999996037,0.880933798978132,0,1,cellular water homeostasis,BP,
12983,GO:0051433,0.999999999996044,0.880124714018278,0,1,BH2 domain binding,MF,
118,GO:0000247,0.999999999996045,0.890423962368517,0,1,C-8 sterol isomerase activity,MF,
2027,GO:0004769,0.999999999996045,0.890423962368517,0,1,steroid delta-isomerase activity,MF,
10069,GO:0042586,0.999999999996045,0.890423962368517,0,1,peptide deformylase activity,MF,
6151,GO:0019474,0.999999999996068,0.682399251410282,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6152,GO:0019477,0.999999999996068,0.682399251410282,0,3,L-lysine catabolic process,BP,
8415,GO:0033512,0.999999999996068,0.682399251410282,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
11648,GO:0046440,0.999999999996068,0.682399251410282,0,3,L-lysine metabolic process,BP,
3966,GO:0008775,0.999999999996081,0.882600367434601,0,1,acetate CoA-transferase activity,MF,
4324,GO:0009850,0.999999999996081,0.882600367434601,0,1,auxin metabolic process,BP,
4325,GO:0009852,0.999999999996081,0.882600367434601,0,1,auxin catabolic process,BP,
4396,GO:0010124,0.999999999996081,0.882600367434601,0,1,phenylacetate catabolic process,BP,
9148,GO:0035516,0.999999999996087,0.880132887328953,0,1,oxidative DNA demethylase activity,MF,
14686,GO:0070343,0.999999999996087,0.880132887328953,0,1,white fat cell proliferation,BP,
14690,GO:0070350,0.999999999996087,0.880132887328953,0,1,regulation of white fat cell proliferation,BP,
19641,GO:1990931,0.999999999996087,0.880132887328953,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
4921,GO:0014876,0.999999999996094,0.887125513286301,0,1,response to injury involved in regulation of muscle adaptation,BP,
14119,GO:0061015,0.999999999996118,0.787966142367946,0,2,snRNA import into nucleus,BP,
3577,GO:0007624,0.999999999996121,0.880142550218319,0,1,ultradian rhythm,BP,
19190,GO:1905335,0.999999999996122,0.87183229214438,0,1,regulation of aggrephagy,BP,
19191,GO:1905337,0.999999999996122,0.87183229214438,0,1,positive regulation of aggrephagy,BP,
14829,GO:0070618,0.999999999996157,0.880350897518674,0,1,Grb2-Sos complex,CC,
8579,GO:0034092,0.999999999996158,0.688158079302863,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8629,GO:0034183,0.999999999996158,0.688158079302863,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
16370,GO:0097016,0.999999999996161,0.774607208074292,0,2,L27 domain binding,MF,
108,GO:0000225,0.999999999996172,0.890455724931176,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
18637,GO:1903984,0.999999999996174,0.682701920526972,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
14727,GO:0070427,0.999999999996176,0.685624576390628,0,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
16175,GO:0090234,0.999999999996179,0.681874310984839,0,3,regulation of kinetochore assembly,BP,
17447,GO:1900368,0.999999999996191,0.703062093412749,0,3,regulation of RNA interference,BP,
2126,GO:0004924,0.999999999996196,0.679631458585031,0,3,oncostatin-M receptor activity,MF,
9710,GO:0038165,0.999999999996196,0.679631458585031,0,3,oncostatin-M-mediated signaling pathway,BP,
10190,GO:0042822,0.999999999996216,0.682535298552836,0,3,pyridoxal phosphate metabolic process,BP,
14153,GO:0061078,0.999999999996224,0.901478119485766,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
16237,GO:0090323,0.999999999996224,0.901478119485766,0,1,prostaglandin secretion involved in immune response,BP,
18472,GO:1903636,0.999999999996224,0.901478119485766,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18473,GO:1903638,0.999999999996224,0.901478119485766,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18475,GO:1903645,0.999999999996224,0.901478119485766,0,1,negative regulation of chaperone-mediated protein folding,BP,
12051,GO:0048021,0.999999999996229,0.681479227247252,0,3,regulation of melanin biosynthetic process,BP,
7766,GO:0032299,0.999999999996233,0.693678050162332,0,3,ribonuclease H2 complex,CC,
14866,GO:0070682,0.999999999996237,0.686414955806552,0,3,proteasome regulatory particle assembly,BP,
5628,GO:0016714,0.999999999996253,0.693519033351441,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
14759,GO:0070489,0.999999999996258,0.880159340762252,0,1,T cell aggregation,BP,
1866,GO:0004534,0.999999999996259,0.678320853084275,0,3,5'-3' exoribonuclease activity,MF,
6345,GO:0021527,0.999999999996265,0.880116239835444,0,1,spinal cord association neuron differentiation,BP,
16648,GO:0097598,0.999999999996265,0.880116239835444,0,1,sperm cytoplasmic droplet,CC,
5957,GO:0018350,0.999999999996278,0.880522506969068,0,1,protein esterification,BP,
10772,GO:0044258,0.999999999996278,0.880522506969068,0,1,intestinal lipid catabolic process,BP,
9197,GO:0035597,0.999999999996295,0.881481618277983,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9381,GO:0035933,0.999999999996308,0.694900177291297,0,3,glucocorticoid secretion,BP,
20118,GO:2000849,0.999999999996308,0.694900177291297,0,3,regulation of glucocorticoid secretion,BP,
2474,GO:0005691,0.999999999996327,0.880128998444629,0,1,U6atac snRNP,CC,
6962,GO:0030624,0.999999999996327,0.880128998444629,0,1,U6atac snRNA binding,MF,
18452,GO:1903584,0.999999999996327,0.880128998444629,0,1,regulation of histone deubiquitination,BP,
18453,GO:1903586,0.999999999996327,0.880128998444629,0,1,positive regulation of histone deubiquitination,BP,
960,GO:0002384,0.999999999996328,0.88014356477258,0,1,hepatic immune response,BP,
14552,GO:0070119,0.999999999996328,0.88014356477258,0,1,ciliary neurotrophic factor binding,MF,
8383,GO:0033316,0.999999999996358,0.880314272790732,0,1,meiotic spindle assembly checkpoint,BP,
10967,GO:0044779,0.999999999996358,0.880314272790732,0,1,meiotic spindle checkpoint,BP,
10971,GO:0044785,0.999999999996358,0.880314272790732,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
17841,GO:1902102,0.999999999996358,0.880314272790732,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17842,GO:1902103,0.999999999996358,0.880314272790732,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
18231,GO:1903096,0.999999999996358,0.880314272790732,0,1,protein localization to meiotic spindle midzone,BP,
19112,GO:1905132,0.999999999996358,0.880314272790732,0,1,regulation of meiotic chromosome separation,BP,
19113,GO:1905133,0.999999999996358,0.880314272790732,0,1,negative regulation of meiotic chromosome separation,BP,
19200,GO:1905359,0.999999999996358,0.880314272790732,0,1,protein localization to meiotic spindle,BP,
15857,GO:0072616,0.999999999996361,0.880156475795604,0,1,interleukin-18 secretion,BP,
5761,GO:0016939,0.999999999996375,0.681725370606467,0,3,kinesin II complex,CC,
19513,GO:1990454,0.999999999996378,0.681961994905117,0,3,L-type voltage-gated calcium channel complex,CC,
4939,GO:0014908,0.999999999996387,0.87999921837768,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
11338,GO:0045716,0.999999999996418,0.689217515562596,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
17863,GO:1902173,0.999999999996434,0.880291412066401,0,1,negative regulation of keratinocyte apoptotic process,BP,
2078,GO:0004833,0.999999999996441,0.884833762952825,0,1,tryptophan 2,3-dioxygenase activity,MF,
8511,GO:0033754,0.999999999996441,0.884833762952825,0,1,indoleamine 2,3-dioxygenase activity,MF,
8670,GO:0034275,0.999999999996441,0.884833762952825,0,1,kynurenic acid metabolic process,BP,
8671,GO:0034276,0.999999999996441,0.884833762952825,0,1,kynurenic acid biosynthetic process,BP,
9520,GO:0036269,0.999999999996441,0.884833762952825,0,1,swimming behavior,BP,
15631,GO:0072174,0.999999999996442,0.681842191813033,0,3,metanephric tubule formation,BP,
17198,GO:0110008,0.999999999996461,0.880311318468111,0,1,ncRNA deadenylation,BP,
3643,GO:0008119,0.999999999996483,0.880280023244732,0,1,thiopurine S-methyltransferase activity,MF,
13633,GO:0060171,0.99999999999649,0.88012291669193,0,1,stereocilium membrane,CC,
2778,GO:0006211,0.999999999996504,0.675226726858748,0,3,5-methylcytosine catabolic process,BP,
6259,GO:0019857,0.999999999996504,0.675226726858748,0,3,5-methylcytosine metabolic process,BP,
16078,GO:0090086,0.999999999996507,0.700571734514383,0,3,negative regulation of protein deubiquitination,BP,
6542,GO:0021966,0.999999999996537,0.88012277778203,0,1,corticospinal neuron axon guidance,BP,
6543,GO:0021972,0.999999999996537,0.88012277778203,0,1,corticospinal neuron axon guidance through spinal cord,BP,
12682,GO:0050924,0.999999999996537,0.88012277778203,0,1,positive regulation of negative chemotaxis,BP,
12687,GO:0050929,0.999999999996537,0.88012277778203,0,1,induction of negative chemotaxis,BP,
15353,GO:0071623,0.999999999996537,0.88012277778203,0,1,negative regulation of granulocyte chemotaxis,BP,
16040,GO:0090024,0.999999999996537,0.88012277778203,0,1,negative regulation of neutrophil chemotaxis,BP,
16191,GO:0090260,0.999999999996537,0.88012277778203,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
18037,GO:1902623,0.999999999996537,0.88012277778203,0,1,negative regulation of neutrophil migration,BP,
9305,GO:0035790,0.999999999996571,0.880177076363236,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
19958,GO:2000583,0.999999999996571,0.880177076363236,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19959,GO:2000584,0.999999999996571,0.880177076363236,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
13867,GO:0060535,0.999999999996598,0.685506861316299,0,3,trachea cartilage morphogenesis,BP,
14652,GO:0070291,0.999999999996608,0.684039925686095,0,3,N-acylethanolamine metabolic process,BP,
4696,GO:0010859,0.99999999999664,0.880129221936312,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
19083,GO:1905042,0.999999999996645,0.880776350202688,0,1,negative regulation of epithelium regeneration,BP,
14396,GO:0061723,0.99999999999666,0.774691559128557,0,2,glycophagy,BP,
8925,GO:0034971,0.999999999996676,0.88032139110844,0,1,histone H3-R17 methylation,BP,
9234,GO:0035642,0.999999999996676,0.88032139110844,0,1,histone methyltransferase activity (H3-R17 specific),MF,
8522,GO:0033858,0.99999999999668,0.880293444581031,0,1,N-acetylgalactosamine kinase activity,MF,
9500,GO:0036194,0.999999999996716,0.69350398689263,0,3,muscle cell projection,CC,
9501,GO:0036195,0.999999999996716,0.69350398689263,0,3,muscle cell projection membrane,CC,
1512,GO:0003875,0.999999999996723,0.880246618380529,0,1,ADP-ribosylarginine hydrolase activity,MF,
807,GO:0002081,0.999999999996726,0.879140050997878,0,1,outer acrosomal membrane,CC,
9566,GO:0036396,0.999999999996745,0.686334998375426,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
11172,GO:0045293,0.999999999996745,0.686334998375426,0,3,mRNA editing complex,CC,
14793,GO:0070552,0.999999999996749,0.682566862340348,0,3,BRISC complex,CC,
7478,GO:0031651,0.999999999996763,0.880141148191755,0,1,negative regulation of heat generation,BP,
7505,GO:0031699,0.999999999996763,0.880141148191755,0,1,beta-3 adrenergic receptor binding,MF,
14432,GO:0061798,0.999999999996763,0.880141148191755,0,1,GTP 3',8'-cyclase activity,MF,
14433,GO:0061799,0.999999999996763,0.880141148191755,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
16241,GO:0090327,0.999999999996763,0.880141148191755,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
15314,GO:0071561,0.999999999996771,0.880122599911642,0,1,nucleus-vacuole junction,CC,
7176,GO:0031071,0.999999999996782,0.880536366430606,0,1,cysteine desulfurase activity,MF,
15334,GO:0071596,0.999999999996786,0.68043607183032,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
492,GO:0001545,0.999999999996797,0.880150690380707,0,1,primary ovarian follicle growth,BP,
15210,GO:0071393,0.999999999996797,0.880150690380707,0,1,cellular response to progesterone stimulus,BP,
16753,GO:0098592,0.999999999996838,0.682073464891742,0,3,cytoplasmic side of apical plasma membrane,CC,
2365,GO:0005483,0.999999999996848,0.683629180391344,0,3,soluble NSF attachment protein activity,MF,
10806,GO:0044316,0.999999999996852,0.8801967481779,0,1,cone cell pedicle,CC,
12779,GO:0051097,0.999999999996878,0.683735162271462,0,3,negative regulation of helicase activity,BP,
11103,GO:0045153,0.99999999999688,0.889552165439822,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
8977,GO:0035101,0.999999999996886,0.682058470214277,0,3,FACT complex,CC,
11412,GO:0045852,0.999999999996892,0.683484183377702,0,3,pH elevation,BP,
12995,GO:0051454,0.999999999996892,0.683484183377702,0,3,intracellular pH elevation,BP,
1033,GO:0002542,0.999999999996893,0.881343793858074,0,1,Factor XII activation,BP,
13220,GO:0051919,0.999999999996893,0.881343793858074,0,1,positive regulation of fibrinolysis,BP,
17534,GO:1901143,0.999999999996898,0.774709345673668,0,2,insulin catabolic process,BP,
6340,GO:0021521,0.999999999996909,0.680694659954723,0,3,ventral spinal cord interneuron specification,BP,
6449,GO:0021775,0.999999999996909,0.680694659954723,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6450,GO:0021776,0.999999999996909,0.680694659954723,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
13890,GO:0060573,0.999999999996909,0.680694659954723,0,3,cell fate specification involved in pattern specification,BP,
13896,GO:0060579,0.999999999996909,0.680694659954723,0,3,ventral spinal cord interneuron fate commitment,BP,
13897,GO:0060581,0.999999999996909,0.680694659954723,0,3,cell fate commitment involved in pattern specification,BP,
16730,GO:0098536,0.999999999996924,0.681813314064061,0,3,deuterosome,CC,
4015,GO:0009041,0.999999999996941,0.690258370747352,0,3,uridylate kinase activity,MF,
20190,GO:2001151,0.999999999996942,0.880285112397404,0,1,regulation of renal water transport,BP,
20191,GO:2001153,0.999999999996942,0.880285112397404,0,1,positive regulation of renal water transport,BP,
8692,GO:0034343,0.999999999996962,0.681978444653638,0,3,type III interferon production,BP,
8693,GO:0034344,0.999999999996962,0.681978444653638,0,3,regulation of type III interferon production,BP,
16213,GO:0090290,0.999999999996972,0.892334483735367,0,1,positive regulation of osteoclast proliferation,BP,
10552,GO:0043532,0.999999999996982,0.879862602224391,0,1,angiostatin binding,MF,
15317,GO:0071566,0.999999999996991,0.880325105890431,0,1,UFM1 activating enzyme activity,MF,
7723,GO:0032227,0.999999999996993,0.681870060641495,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
4299,GO:0009753,0.999999999997008,0.785716684191903,0,2,response to jasmonic acid,BP,
5975,GO:0018636,0.999999999997008,0.785716684191903,0,2,phenanthrene 9,10-monooxygenase activity,MF,
11927,GO:0047023,0.999999999997008,0.785716684191903,0,2,androsterone dehydrogenase activity,MF,
11934,GO:0047086,0.999999999997008,0.785716684191903,0,2,ketosteroid monooxygenase activity,MF,
11936,GO:0047115,0.999999999997008,0.785716684191903,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
15212,GO:0071395,0.999999999997008,0.785716684191903,0,2,cellular response to jasmonic acid stimulus,BP,
3204,GO:0006843,0.999999999997019,0.884508946777654,0,1,mitochondrial citrate transmembrane transport,BP,
16054,GO:0090044,0.999999999997019,0.884508946777654,0,1,positive regulation of tubulin deacetylation,BP,
19529,GO:1990546,0.999999999997019,0.884508946777654,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
11161,GO:0045263,0.999999999997026,0.88695435303225,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
1829,GO:0004487,0.999999999997048,0.682679814803639,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
14372,GO:0061649,0.999999999997072,0.682359441738536,0,3,ubiquitin modification-dependent histone binding,MF,
3862,GO:0008488,0.999999999997073,0.880293201780774,0,1,gamma-glutamyl carboxylase activity,MF,
13505,GO:0055108,0.999999999997081,0.881699334192678,0,1,Golgi to transport vesicle transport,BP,
19479,GO:1990386,0.999999999997081,0.881699334192678,0,1,mitotic cleavage furrow ingression,BP,
19539,GO:1990583,0.999999999997081,0.881699334192678,0,1,phospholipase D activator activity,MF,
3954,GO:0008709,0.999999999997082,0.893880407692088,0,1,cholate 7-alpha-dehydrogenase activity,MF,
6816,GO:0030283,0.999999999997082,0.893880407692088,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
11923,GO:0047015,0.999999999997082,0.893880407692088,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
1712,GO:0004306,0.999999999997083,0.882379469395625,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
19709,GO:2000110,0.999999999997092,0.69011473347635,0,3,negative regulation of macrophage apoptotic process,BP,
6380,GO:0021577,0.999999999997109,0.880160429634544,0,1,hindbrain structural organization,BP,
6384,GO:0021589,0.999999999997109,0.880160429634544,0,1,cerebellum structural organization,BP,
14058,GO:0060904,0.999999999997109,0.880160429634544,0,1,regulation of protein folding in endoplasmic reticulum,BP,
18761,GO:1904313,0.999999999997109,0.880160429634544,0,1,response to methamphetamine hydrochloride,BP,
1727,GO:0004324,0.999999999997123,0.882131888761596,0,1,ferredoxin-NADP+ reductase activity,MF,
4960,GO:0015039,0.999999999997123,0.882131888761596,0,1,NADPH-adrenodoxin reductase activity,MF,
5639,GO:0016730,0.999999999997123,0.882131888761596,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5640,GO:0016731,0.999999999997123,0.882131888761596,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
18773,GO:1904351,0.999999999997137,0.68238715868792,0,3,negative regulation of protein catabolic process in the vacuole,BP,
19126,GO:1905166,0.999999999997137,0.68238715868792,0,3,negative regulation of lysosomal protein catabolic process,BP,
1160,GO:0002774,0.999999999997141,0.880309592382231,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
14855,GO:0070667,0.999999999997141,0.880309592382231,0,1,negative regulation of mast cell proliferation,BP,
158,GO:0000322,0.999999999997153,0.687710913734886,0,3,storage vacuole,CC,
10056,GO:0042568,0.99999999999717,0.893622170299641,0,1,insulin-like growth factor binary complex,CC,
5525,GO:0016507,0.999999999997179,0.880311532321159,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
9475,GO:0036125,0.999999999997179,0.880311532321159,0,1,fatty acid beta-oxidation multienzyme complex,CC,
7680,GO:0032139,0.99999999999718,0.687750267265885,0,3,dinucleotide insertion or deletion binding,MF,
14731,GO:0070432,0.999999999997198,0.682239765020294,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14705,GO:0070384,0.99999999999721,0.682020559683857,0,3,Harderian gland development,BP,
17324,GO:1900039,0.99999999999723,0.89009304237129,0,1,positive regulation of cellular response to hypoxia,BP,
17831,GO:1902071,0.99999999999723,0.89009304237129,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17832,GO:1902073,0.99999999999723,0.89009304237129,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
7529,GO:0031775,0.999999999997236,0.879039270825946,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7893,GO:0032470,0.999999999997236,0.879039270825946,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
15993,GO:0086039,0.999999999997236,0.879039270825946,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
18405,GO:1903515,0.999999999997236,0.879039270825946,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19402,GO:1990036,0.999999999997236,0.879039270825946,0,1,calcium ion import into sarcoplasmic reticulum,BP,
8154,GO:0032898,0.999999999997257,0.681898547934356,0,3,neurotrophin production,BP,
14590,GO:0070180,0.999999999997261,0.90110607261802,0,1,large ribosomal subunit rRNA binding,MF,
14751,GO:0070476,0.999999999997261,0.90110607261802,0,1,rRNA (guanine-N7)-methylation,BP,
1819,GO:0004475,0.999999999997261,0.884488463641892,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
3996,GO:0008905,0.999999999997261,0.884488463641892,0,1,mannose-phosphate guanylyltransferase activity,MF,
7831,GO:0032395,0.999999999997268,0.698137533461725,0,3,MHC class II receptor activity,MF,
9310,GO:0035799,0.999999999997268,0.681996787917782,0,3,ureter maturation,BP,
6264,GO:0019863,0.999999999997298,0.886798257239081,0,1,IgE binding,MF,
1593,GO:0004013,0.999999999997311,0.682183588560899,0,3,adenosylhomocysteinase activity,MF,
5681,GO:0016802,0.999999999997311,0.682183588560899,0,3,trialkylsulfonium hydrolase activity,MF,
2599,GO:0005898,0.999999999997317,0.880155404998408,0,1,interleukin-13 receptor complex,CC,
2634,GO:0005967,0.99999999999732,0.682162877655598,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
16016,GO:0086075,0.999999999997324,0.681473452503376,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
9612,GO:0036493,0.999999999997363,0.683628862399442,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
5491,GO:0016434,0.999999999997365,0.682074394164467,0,3,rRNA (cytosine) methyltransferase activity,MF,
3749,GO:0008294,0.99999999999737,0.873735617806858,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
11073,GO:0045092,0.999999999997376,0.880216700125744,0,1,interleukin-18 receptor complex,CC,
1064,GO:0002605,0.999999999997377,0.880085374084922,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
4627,GO:0010754,0.999999999997377,0.880085374084922,0,1,negative regulation of cGMP-mediated signaling,BP,
14370,GO:0061646,0.999999999997388,0.880122809236331,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
17794,GO:1901979,0.999999999997397,0.772322686270566,0,2,regulation of inward rectifier potassium channel activity,BP,
1937,GO:0004642,0.999999999997418,0.880116046097123,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
17218,GO:0120012,0.999999999997418,0.880116046097123,0,1,intermembrane sphingolipid transfer,BP,
17220,GO:0120016,0.999999999997418,0.880116046097123,0,1,intermembrane sphingolipid transfer activity,MF,
17221,GO:0120017,0.999999999997418,0.880116046097123,0,1,intermembrane ceramide transfer activity,MF,
8502,GO:0033693,0.999999999997452,0.682028827112543,0,3,neurofilament bundle assembly,BP,
15842,GO:0072590,0.999999999997459,0.880082113690404,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15843,GO:0072591,0.999999999997459,0.880082113690404,0,1,citrate-L-glutamate ligase activity,MF,
721,GO:0001951,0.99999999999746,0.681925852275686,0,3,intestinal D-glucose absorption,BP,
17161,GO:0106001,0.99999999999746,0.681925852275686,0,3,intestinal hexose absorption,BP,
14193,GO:0061156,0.999999999997462,0.683837237680716,0,3,pulmonary artery morphogenesis,BP,
5444,GO:0016321,0.999999999997464,0.682770706454792,0,3,female meiosis chromosome segregation,BP,
16100,GO:0090119,0.999999999997467,0.880124976391344,0,1,vesicle-mediated cholesterol transport,BP,
18751,GO:1904290,0.999999999997467,0.880124976391344,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
19637,GO:1990926,0.999999999997467,0.880124976391344,0,1,short-term synaptic potentiation,BP,
491,GO:0001544,0.999999999997477,0.879607871962415,0,1,initiation of primordial ovarian follicle growth,BP,
5540,GO:0016534,0.999999999997481,0.880176341309273,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
6382,GO:0021586,0.999999999997481,0.880176341309273,0,1,pons maturation,BP,
6431,GO:0021718,0.999999999997481,0.880176341309273,0,1,superior olivary nucleus development,BP,
6432,GO:0021722,0.999999999997481,0.880176341309273,0,1,superior olivary nucleus maturation,BP,
18663,GO:1904044,0.999999999997485,0.696848194364231,0,3,response to aldosterone,BP,
9290,GO:0035750,0.9999999999975,0.880117526835649,0,1,protein localization to myelin sheath abaxonal region,BP,
4497,GO:0010533,0.999999999997514,0.705880310019584,0,3,regulation of activation of Janus kinase activity,BP,
2364,GO:0005477,0.999999999997519,0.880228135277911,0,1,pyruvate secondary active transmembrane transporter activity,MF,
14904,GO:0070782,0.999999999997525,0.881001898540612,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
3142,GO:0006740,0.99999999999753,0.682468582018954,0,3,NADPH regeneration,BP,
3840,GO:0008454,0.999999999997552,0.774741236706826,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
8388,GO:0033328,0.999999999997555,0.880214494497521,0,1,peroxisome membrane targeting sequence binding,MF,
9461,GO:0036105,0.999999999997555,0.880214494497521,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
17372,GO:1900130,0.999999999997555,0.880214494497521,0,1,regulation of lipid binding,BP,
17373,GO:1900131,0.999999999997555,0.880214494497521,0,1,negative regulation of lipid binding,BP,
452,GO:0001226,0.999999999997567,0.880273102272667,0,1,RNA polymerase II transcription corepressor binding,MF,
3820,GO:0008424,0.999999999997567,0.880273102272667,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
9450,GO:0036071,0.999999999997567,0.880273102272667,0,1,N-glycan fucosylation,BP,
11877,GO:0046921,0.999999999997567,0.880273102272667,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
5921,GO:0018201,0.999999999997578,0.681896006993965,0,3,peptidyl-glycine modification,BP,
15388,GO:0071678,0.999999999997606,0.879398693556222,0,1,olfactory bulb axon guidance,BP,
14406,GO:0061738,0.999999999997611,0.683486585191954,0,3,late endosomal microautophagy,BP,
6482,GO:0021840,0.999999999997644,0.880533792946433,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6483,GO:0021842,0.999999999997644,0.880533792946433,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
953,GO:0002373,0.999999999997663,0.894104535234895,0,1,plasmacytoid dendritic cell cytokine production,BP,
1141,GO:0002736,0.999999999997663,0.894104535234895,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1142,GO:0002737,0.999999999997663,0.894104535234895,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
17568,GO:1901253,0.999999999997663,0.894104535234895,0,1,negative regulation of intracellular transport of viral material,BP,
18035,GO:1902618,0.999999999997676,0.880061767404104,0,1,cellular response to fluoride,BP,
7343,GO:0031393,0.999999999997693,0.774811798966771,0,2,negative regulation of prostaglandin biosynthetic process,BP,
12005,GO:0047676,0.999999999997695,0.880121475735804,0,1,arachidonate-CoA ligase activity,MF,
17215,GO:0110095,0.999999999997728,0.70042629263492,0,3,cellular detoxification of aldehyde,BP,
7376,GO:0031437,0.999999999997733,0.682162439239248,0,3,regulation of mRNA cleavage,BP,
17261,GO:0140052,0.999999999997757,0.682047774413498,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
6221,GO:0019776,0.999999999997758,0.68873457016617,0,3,Atg8 ligase activity,MF,
9014,GO:0035241,0.999999999997758,0.682377143957879,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
18934,GO:1904734,0.999999999997765,0.904386824865083,0,1,positive regulation of electron transfer activity,BP,
19050,GO:1904960,0.999999999997765,0.904386824865083,0,1,positive regulation of cytochrome-c oxidase activity,BP,
1270,GO:0003064,0.999999999997771,0.88247797443553,0,1,regulation of heart rate by hormone,BP,
19372,GO:1905912,0.999999999997771,0.88247797443553,0,1,regulation of calcium ion export across plasma membrane,BP,
19373,GO:1905913,0.999999999997771,0.88247797443553,0,1,negative regulation of calcium ion export across plasma membrane,BP,
785,GO:0002046,0.999999999997784,0.893445183816173,0,1,opsin binding,MF,
9558,GO:0036372,0.999999999997784,0.893445183816173,0,1,opsin transport,BP,
516,GO:0001582,0.999999999997791,0.880386668997359,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
8249,GO:0033041,0.999999999997791,0.880386668997359,0,1,sweet taste receptor activity,MF,
10646,GO:0043843,0.999999999997791,0.880386668997359,0,1,ADP-specific glucokinase activity,MF,
18526,GO:1903767,0.999999999997791,0.880386668997359,0,1,sweet taste receptor complex,CC,
18527,GO:1903768,0.999999999997791,0.880386668997359,0,1,taste receptor complex,CC,
197,GO:0000416,0.999999999997797,0.880195588568593,0,1,positive regulation of histone H3-K36 methylation,BP,
12272,GO:0048630,0.999999999997798,0.681939040435251,0,3,skeletal muscle tissue growth,BP,
12273,GO:0048631,0.999999999997798,0.681939040435251,0,3,regulation of skeletal muscle tissue growth,BP,
12274,GO:0048633,0.999999999997798,0.681939040435251,0,3,positive regulation of skeletal muscle tissue growth,BP,
10732,GO:0044130,0.999999999997804,0.687250177798409,0,3,negative regulation of growth of symbiont in host,BP,
10735,GO:0044146,0.999999999997804,0.687250177798409,0,3,negative regulation of growth of symbiont involved in interaction with host,BP,
3774,GO:0008332,0.999999999997826,0.881921766282432,0,1,low voltage-gated calcium channel activity,MF,
5,GO:0000011,0.99999999999783,0.880332088567768,0,1,vacuole inheritance,BP,
333,GO:0000928,0.99999999999783,0.880332088567768,0,1,gamma-tubulin small complex, spindle pole body,CC,
643,GO:0001834,0.99999999999783,0.880332088567768,0,1,trophectodermal cell proliferation,BP,
1563,GO:0003972,0.99999999999783,0.880332088567768,0,1,RNA ligase (ATP) activity,MF,
1638,GO:0004083,0.99999999999783,0.880332088567768,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
2013,GO:0004743,0.99999999999783,0.880332088567768,0,1,pyruvate kinase activity,MF,
2731,GO:0006113,0.99999999999783,0.880332088567768,0,1,fermentation,BP,
2759,GO:0006174,0.99999999999783,0.880332088567768,0,1,dADP phosphorylation,BP,
2766,GO:0006186,0.99999999999783,0.880332088567768,0,1,dGDP phosphorylation,BP,
2949,GO:0006480,0.99999999999783,0.880332088567768,0,1,N-terminal protein amino acid methylation,BP,
3153,GO:0006756,0.99999999999783,0.880332088567768,0,1,AMP phosphorylation,BP,
3372,GO:0007146,0.99999999999783,0.880332088567768,0,1,meiotic recombination nodule assembly,BP,
3838,GO:0008452,0.99999999999783,0.880332088567768,0,1,RNA ligase activity,MF,
3952,GO:0008700,0.99999999999783,0.880332088567768,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4234,GO:0009436,0.99999999999783,0.880332088567768,0,1,glyoxylate catabolic process,BP,
4426,GO:0010260,0.99999999999783,0.880332088567768,0,1,animal organ senescence,BP,
4440,GO:0010348,0.99999999999783,0.880332088567768,0,1,lithium:proton antiporter activity,MF,
4812,GO:0014011,0.99999999999783,0.880332088567768,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5065,GO:0015292,0.99999999999783,0.880332088567768,0,1,uniporter activity,MF,
5489,GO:0016430,0.99999999999783,0.880332088567768,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5574,GO:0016596,0.99999999999783,0.880332088567768,0,1,thienylcyclohexylpiperidine binding,MF,
5684,GO:0016807,0.99999999999783,0.880332088567768,0,1,cysteine-type carboxypeptidase activity,MF,
5707,GO:0016843,0.99999999999783,0.880332088567768,0,1,amine-lyase activity,MF,
5708,GO:0016844,0.99999999999783,0.880332088567768,0,1,strictosidine synthase activity,MF,
5812,GO:0017082,0.99999999999783,0.880332088567768,0,1,mineralocorticoid receptor activity,MF,
5864,GO:0017178,0.99999999999783,0.880332088567768,0,1,diphthine-ammonia ligase activity,MF,
5875,GO:0018011,0.99999999999783,0.880332088567768,0,1,N-terminal peptidyl-alanine methylation,BP,
5876,GO:0018012,0.99999999999783,0.880332088567768,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5877,GO:0018013,0.99999999999783,0.880332088567768,0,1,N-terminal peptidyl-glycine methylation,BP,
5878,GO:0018016,0.99999999999783,0.880332088567768,0,1,N-terminal peptidyl-proline dimethylation,BP,
5882,GO:0018025,0.99999999999783,0.880332088567768,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5914,GO:0018194,0.99999999999783,0.880332088567768,0,1,peptidyl-alanine modification,BP,
6188,GO:0019659,0.99999999999783,0.880332088567768,0,1,glucose catabolic process to lactate,BP,
6189,GO:0019660,0.99999999999783,0.880332088567768,0,1,glycolytic fermentation,BP,
6190,GO:0019661,0.99999999999783,0.880332088567768,0,1,glucose catabolic process to lactate via pyruvate,BP,
6191,GO:0019666,0.99999999999783,0.880332088567768,0,1,nitrogenous compound fermentation,BP,
6236,GO:0019799,0.99999999999783,0.880332088567768,0,1,tubulin N-acetyltransferase activity,MF,
6320,GO:0020003,0.99999999999783,0.880332088567768,0,1,symbiont-containing vacuole,CC,
6805,GO:0030264,0.99999999999783,0.880332088567768,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6894,GO:0030474,0.99999999999783,0.880332088567768,0,1,spindle pole body duplication,BP,
6966,GO:0030629,0.99999999999783,0.880332088567768,0,1,U6 snRNA 3'-end binding,MF,
7012,GO:0030735,0.99999999999783,0.880332088567768,0,1,carnosine N-methyltransferase activity,MF,
7125,GO:0030961,0.99999999999783,0.880332088567768,0,1,peptidyl-arginine hydroxylation,BP,
7735,GO:0032253,0.99999999999783,0.880332088567768,0,1,dense core granule localization,BP,
8458,GO:0033609,0.99999999999783,0.880332088567768,0,1,oxalate metabolic process,BP,
8698,GO:0034353,0.99999999999783,0.880332088567768,0,1,RNA pyrophosphohydrolase activity,MF,
8780,GO:0034477,0.99999999999783,0.880332088567768,0,1,U6 snRNA 3'-end processing,BP,
8794,GO:0034512,0.99999999999783,0.880332088567768,0,1,box C/D snoRNA binding,MF,
8937,GO:0034998,0.99999999999783,0.880332088567768,0,1,oligosaccharyltransferase I complex,CC,
9134,GO:0035498,0.99999999999783,0.880332088567768,0,1,carnosine metabolic process,BP,
9174,GO:0035568,0.99999999999783,0.880332088567768,0,1,N-terminal peptidyl-proline methylation,BP,
9175,GO:0035570,0.99999999999783,0.880332088567768,0,1,N-terminal peptidyl-serine methylation,BP,
9176,GO:0035572,0.99999999999783,0.880332088567768,0,1,N-terminal peptidyl-serine dimethylation,BP,
9177,GO:0035573,0.99999999999783,0.880332088567768,0,1,N-terminal peptidyl-serine trimethylation,BP,
9541,GO:0036317,0.99999999999783,0.880332088567768,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9863,GO:0042140,0.99999999999783,0.880332088567768,0,1,late meiotic recombination nodule assembly,BP,
10166,GO:0042774,0.99999999999783,0.880332088567768,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10184,GO:0042806,0.99999999999783,0.880332088567768,0,1,fucose binding,MF,
10511,GO:0043465,0.99999999999783,0.880332088567768,0,1,regulation of fermentation,BP,
10817,GO:0044328,0.99999999999783,0.880332088567768,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10818,GO:0044329,0.99999999999783,0.880332088567768,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10819,GO:0044330,0.99999999999783,0.880332088567768,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10923,GO:0044599,0.99999999999783,0.880332088567768,0,1,AP-5 adaptor complex,CC,
10934,GO:0044648,0.99999999999783,0.880332088567768,0,1,histone H3-K4 dimethylation,BP,
10952,GO:0044732,0.99999999999783,0.880332088567768,0,1,mitotic spindle pole body,CC,
11575,GO:0046176,0.99999999999783,0.880332088567768,0,1,aldonic acid catabolic process,BP,
11576,GO:0046177,0.99999999999783,0.880332088567768,0,1,D-gluconate catabolic process,BP,
11594,GO:0046316,0.99999999999783,0.880332088567768,0,1,gluconokinase activity,MF,
11810,GO:0046745,0.99999999999783,0.880332088567768,0,1,viral capsid secondary envelopment,BP,
11920,GO:0046996,0.99999999999783,0.880332088567768,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11925,GO:0047017,0.99999999999783,0.880332088567768,0,1,prostaglandin-F synthase activity,MF,
12013,GO:0047734,0.99999999999783,0.880332088567768,0,1,CDP-glycerol diphosphatase activity,MF,
12415,GO:0050046,0.99999999999783,0.880332088567768,0,1,lathosterol oxidase activity,MF,
12448,GO:0050346,0.99999999999783,0.880332088567768,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12917,GO:0051300,0.99999999999783,0.880332088567768,0,1,spindle pole body organization,BP,
12925,GO:0051308,0.99999999999783,0.880332088567768,0,1,male meiosis chromosome separation,BP,
12975,GO:0051417,0.99999999999783,0.880332088567768,0,1,microtubule nucleation by spindle pole body,BP,
12996,GO:0051455,0.99999999999783,0.880332088567768,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13106,GO:0051685,0.99999999999783,0.880332088567768,0,1,maintenance of ER location,BP,
13432,GO:0052907,0.99999999999783,0.880332088567768,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13433,GO:0052909,0.99999999999783,0.880332088567768,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13727,GO:0060327,0.99999999999783,0.880332088567768,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13920,GO:0060620,0.99999999999783,0.880332088567768,0,1,regulation of cholesterol import,BP,
14052,GO:0060887,0.99999999999783,0.880332088567768,0,1,limb epidermis development,BP,
14197,GO:0061163,0.99999999999783,0.880332088567768,0,1,endoplasmic reticulum polarization,BP,
14298,GO:0061495,0.99999999999783,0.880332088567768,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14302,GO:0061508,0.99999999999783,0.880332088567768,0,1,CDP phosphorylation,BP,
14324,GO:0061565,0.99999999999783,0.880332088567768,0,1,dAMP phosphorylation,BP,
14325,GO:0061566,0.99999999999783,0.880332088567768,0,1,CMP phosphorylation,BP,
14326,GO:0061567,0.99999999999783,0.880332088567768,0,1,dCMP phosphorylation,BP,
14327,GO:0061568,0.99999999999783,0.880332088567768,0,1,GDP phosphorylation,BP,
14328,GO:0061569,0.99999999999783,0.880332088567768,0,1,UDP phosphorylation,BP,
14329,GO:0061570,0.99999999999783,0.880332088567768,0,1,dCDP phosphorylation,BP,
14330,GO:0061571,0.99999999999783,0.880332088567768,0,1,TDP phosphorylation,BP,
14332,GO:0061573,0.99999999999783,0.880332088567768,0,1,actin filament bundle retrograde transport,BP,
14383,GO:0061685,0.99999999999783,0.880332088567768,0,1,diphthine methylesterase activity,MF,
14491,GO:0065010,0.99999999999783,0.880332088567768,0,1,extracellular membrane-bounded organelle,CC,
14494,GO:0070004,0.99999999999783,0.880332088567768,0,1,cysteine-type exopeptidase activity,MF,
14562,GO:0070130,0.99999999999783,0.880332088567768,0,1,negative regulation of mitochondrial translation,BP,
14579,GO:0070165,0.99999999999783,0.880332088567768,0,1,positive regulation of adiponectin secretion,BP,
14636,GO:0070260,0.99999999999783,0.880332088567768,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14792,GO:0070551,0.99999999999783,0.880332088567768,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14794,GO:0070553,0.99999999999783,0.880332088567768,0,1,nicotinic acid receptor activity,MF,
14809,GO:0070573,0.99999999999783,0.880332088567768,0,1,metallodipeptidase activity,MF,
14834,GO:0070631,0.99999999999783,0.880332088567768,0,1,spindle pole body localization,BP,
14835,GO:0070632,0.99999999999783,0.880332088567768,0,1,establishment of spindle pole body localization,BP,
14846,GO:0070650,0.99999999999783,0.880332088567768,0,1,actin filament bundle distribution,BP,
14892,GO:0070762,0.99999999999783,0.880332088567768,0,1,nuclear pore transmembrane ring,CC,
15230,GO:0071424,0.99999999999783,0.880332088567768,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15430,GO:0071789,0.99999999999783,0.880332088567768,0,1,spindle pole body localization to nuclear envelope,BP,
15431,GO:0071790,0.99999999999783,0.880332088567768,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15483,GO:0071885,0.99999999999783,0.880332088567768,0,1,N-terminal protein N-methyltransferase activity,MF,
15509,GO:0071931,0.99999999999783,0.880332088567768,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15906,GO:0072720,0.99999999999783,0.880332088567768,0,1,response to dithiothreitol,BP,
15992,GO:0086038,0.99999999999783,0.880332088567768,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16323,GO:0090624,0.99999999999783,0.880332088567768,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16324,GO:0090625,0.99999999999783,0.880332088567768,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16523,GO:0097310,0.99999999999783,0.880332088567768,0,1,cap2 mRNA methylation,BP,
16636,GO:0097541,0.99999999999783,0.880332088567768,0,1,axonemal basal plate,CC,
16658,GO:0097630,0.99999999999783,0.880332088567768,0,1,intrinsic component of omegasome membrane,CC,
16659,GO:0097631,0.99999999999783,0.880332088567768,0,1,integral component of omegasome membrane,CC,
16674,GO:0097655,0.99999999999783,0.880332088567768,0,1,serpin family protein binding,MF,
16692,GO:0097712,0.99999999999783,0.880332088567768,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16803,GO:0098725,0.99999999999783,0.880332088567768,0,1,symmetric cell division,BP,
17016,GO:0099519,0.99999999999783,0.880332088567768,0,1,dense core granule cytoskeletal transport,BP,
17065,GO:0099627,0.99999999999783,0.880332088567768,0,1,neurotransmitter receptor cycle,BP,
17067,GO:0099630,0.99999999999783,0.880332088567768,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17132,GO:0102524,0.99999999999783,0.880332088567768,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17233,GO:0120048,0.99999999999783,0.880332088567768,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17234,GO:0120049,0.99999999999783,0.880332088567768,0,1,snRNA (adenine-N6)-methylation,BP,
17384,GO:1900148,0.99999999999783,0.880332088567768,0,1,negative regulation of Schwann cell migration,BP,
17495,GO:1901003,0.99999999999783,0.880332088567768,0,1,negative regulation of fermentation,BP,
17594,GO:1901318,0.99999999999783,0.880332088567768,0,1,negative regulation of flagellated sperm motility,BP,
17638,GO:1901523,0.99999999999783,0.880332088567768,0,1,icosanoid catabolic process,BP,
17786,GO:1901950,0.99999999999783,0.880332088567768,0,1,dense core granule transport,BP,
17853,GO:1902145,0.99999999999783,0.880332088567768,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17854,GO:1902151,0.99999999999783,0.880332088567768,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17855,GO:1902153,0.99999999999783,0.880332088567768,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17951,GO:1902387,0.99999999999783,0.880332088567768,0,1,ceramide 1-phosphate binding,MF,
17952,GO:1902388,0.99999999999783,0.880332088567768,0,1,ceramide 1-phosphate transporter activity,MF,
17953,GO:1902389,0.99999999999783,0.880332088567768,0,1,ceramide 1-phosphate transport,BP,
18057,GO:1902688,0.99999999999783,0.880332088567768,0,1,regulation of NAD metabolic process,BP,
18058,GO:1902689,0.99999999999783,0.880332088567768,0,1,negative regulation of NAD metabolic process,BP,
18135,GO:1902912,0.99999999999783,0.880332088567768,0,1,pyruvate kinase complex,CC,
18293,GO:1903259,0.99999999999783,0.880332088567768,0,1,exon-exon junction complex disassembly,BP,
18650,GO:1904023,0.99999999999783,0.880332088567768,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18651,GO:1904024,0.99999999999783,0.880332088567768,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18654,GO:1904028,0.99999999999783,0.880332088567768,0,1,positive regulation of collagen fibril organization,BP,
18922,GO:1904713,0.99999999999783,0.880332088567768,0,1,beta-catenin destruction complex binding,MF,
18956,GO:1904777,0.99999999999783,0.880332088567768,0,1,negative regulation of protein localization to cell cortex,BP,
18972,GO:1904806,0.99999999999783,0.880332088567768,0,1,regulation of protein oxidation,BP,
18973,GO:1904808,0.99999999999783,0.880332088567768,0,1,positive regulation of protein oxidation,BP,
19084,GO:1905044,0.99999999999783,0.880332088567768,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19085,GO:1905045,0.99999999999783,0.880332088567768,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19166,GO:1905279,0.99999999999783,0.880332088567768,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19182,GO:1905319,0.99999999999783,0.880332088567768,0,1,mesenchymal stem cell migration,BP,
19183,GO:1905320,0.99999999999783,0.880332088567768,0,1,regulation of mesenchymal stem cell migration,BP,
19184,GO:1905322,0.99999999999783,0.880332088567768,0,1,positive regulation of mesenchymal stem cell migration,BP,
19195,GO:1905344,0.99999999999783,0.880332088567768,0,1,prostaglandin catabolic process,BP,
19230,GO:1905435,0.99999999999783,0.880332088567768,0,1,regulation of histone H3-K4 trimethylation,BP,
19231,GO:1905437,0.99999999999783,0.880332088567768,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19301,GO:1905642,0.99999999999783,0.880332088567768,0,1,negative regulation of DNA methylation,BP,
19407,GO:1990048,0.99999999999783,0.880332088567768,0,1,anterograde neuronal dense core vesicle transport,BP,
19461,GO:1990261,0.99999999999783,0.880332088567768,0,1,pre-mRNA catabolic process,BP,
19533,GO:1990570,0.99999999999783,0.880332088567768,0,1,GDP-mannose transmembrane transport,BP,
19574,GO:1990738,0.99999999999783,0.880332088567768,0,1,pseudouridine 5'-phosphatase activity,MF,
19583,GO:1990755,0.99999999999783,0.880332088567768,0,1,mitotic spindle microtubule depolymerization,BP,
19655,GO:2000003,0.99999999999783,0.880332088567768,0,1,positive regulation of DNA damage checkpoint,BP,
20043,GO:2000722,0.99999999999783,0.880332088567768,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20044,GO:2000724,0.99999999999783,0.880332088567768,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20128,GO:2000909,0.99999999999783,0.880332088567768,0,1,regulation of sterol import,BP,
14352,GO:0061618,0.999999999997841,0.875420642955697,0,1,sublamina densa,CC,
2258,GO:0005173,0.999999999997841,0.681366061141419,0,3,stem cell factor receptor binding,MF,
13420,GO:0052858,0.999999999997862,0.880221676859937,0,1,peptidyl-lysine acetyltransferase activity,MF,
1416,GO:0003360,0.999999999997875,0.681488554621627,0,3,brainstem development,BP,
18810,GO:1904430,0.999999999997878,0.681991203225098,0,3,negative regulation of t-circle formation,BP,
4910,GO:0014852,0.999999999997884,0.880333978031462,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4911,GO:0014853,0.999999999997884,0.880333978031462,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5785,GO:0017020,0.999999999997884,0.880333978031462,0,1,myosin phosphatase regulator activity,MF,
19338,GO:1905794,0.999999999997886,0.877254872969333,0,1,response to puromycin,BP,
19339,GO:1905795,0.999999999997886,0.877254872969333,0,1,cellular response to puromycin,BP,
3021,GO:0006569,0.999999999997904,0.688642319506236,0,3,tryptophan catabolic process,BP,
6146,GO:0019441,0.999999999997904,0.688642319506236,0,3,tryptophan catabolic process to kynurenine,BP,
9994,GO:0042436,0.999999999997904,0.688642319506236,0,3,indole-containing compound catabolic process,BP,
11585,GO:0046218,0.999999999997904,0.688642319506236,0,3,indolalkylamine catabolic process,BP,
7647,GO:0032076,0.99999999999791,0.880347565385081,0,1,negative regulation of deoxyribonuclease activity,BP,
9540,GO:0036316,0.99999999999791,0.880347565385081,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
13965,GO:0060703,0.99999999999791,0.880347565385081,0,1,deoxyribonuclease inhibitor activity,MF,
14689,GO:0070346,0.99999999999791,0.880347565385081,0,1,positive regulation of fat cell proliferation,BP,
17588,GO:1901303,0.99999999999791,0.880347565385081,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
17990,GO:1902511,0.99999999999791,0.880347565385081,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18468,GO:1903625,0.99999999999791,0.880347565385081,0,1,negative regulation of DNA catabolic process,BP,
9396,GO:0035971,0.999999999997915,0.889415271765136,0,1,peptidyl-histidine dephosphorylation,BP,
2765,GO:0006185,0.999999999997916,0.893181421281488,0,1,dGDP biosynthetic process,BP,
4111,GO:0009170,0.999999999997916,0.893181421281488,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4120,GO:0009183,0.999999999997916,0.893181421281488,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
11510,GO:0046054,0.999999999997916,0.893181421281488,0,1,dGMP metabolic process,BP,
11797,GO:0046711,0.999999999997916,0.893181421281488,0,1,GDP biosynthetic process,BP,
6071,GO:0019227,0.999999999997917,0.692004505893998,0,3,neuronal action potential propagation,BP,
16881,GO:0098870,0.999999999997917,0.692004505893998,0,3,action potential propagation,BP,
18582,GO:1903893,0.999999999997923,0.880420951416507,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
14825,GO:0070611,0.999999999997936,0.88036045172903,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14826,GO:0070612,0.999999999997936,0.88036045172903,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
860,GO:0002193,0.999999999997947,0.680492733933323,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
8621,GO:0034155,0.999999999997957,0.880233011230945,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8622,GO:0034157,0.999999999997957,0.880233011230945,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
2055,GO:0004809,0.999999999997974,0.683811159728401,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
9758,GO:0039552,0.99999999999798,0.880111662681233,0,1,RIG-I binding,MF,
15358,GO:0071633,0.999999999997988,0.880335393085342,0,1,dihydroceramidase activity,MF,
5109,GO:0015432,0.999999999997989,0.880228045204521,0,1,bile acid-exporting ATPase activity,MF,
8370,GO:0033283,0.999999999997989,0.880228045204521,0,1,organic acid-transporting ATPase activity,MF,
8371,GO:0033284,0.999999999997989,0.880228045204521,0,1,carboxylic acid-transporting ATPase activity,MF,
8372,GO:0033285,0.999999999997989,0.880228045204521,0,1,monocarboxylic acid-transporting ATPase activity,MF,
11075,GO:0045098,0.999999999998015,0.883901099044746,0,1,type III intermediate filament,CC,
14026,GO:0060821,0.999999999998039,0.878668994743457,0,1,inactivation of X chromosome by DNA methylation,BP,
16455,GO:0097166,0.999999999998039,0.878668994743457,0,1,lens epithelial cell proliferation,BP,
20178,GO:2001109,0.999999999998039,0.878668994743457,0,1,regulation of lens epithelial cell proliferation,BP,
20179,GO:2001111,0.999999999998039,0.878668994743457,0,1,positive regulation of lens epithelial cell proliferation,BP,
11719,GO:0046573,0.99999999999804,0.8841491322778,0,1,lactonohydrolase activity,MF,
17091,GO:0102007,0.99999999999804,0.8841491322778,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
17554,GO:1901207,0.999999999998042,0.88015946079709,0,1,regulation of heart looping,BP,
18523,GO:1903762,0.999999999998042,0.88015946079709,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18614,GO:1903947,0.999999999998042,0.88015946079709,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18616,GO:1903952,0.999999999998042,0.88015946079709,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18617,GO:1903954,0.999999999998042,0.88015946079709,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19073,GO:1905026,0.999999999998042,0.88015946079709,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19075,GO:1905033,0.999999999998042,0.88015946079709,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
15096,GO:0071209,0.999999999998049,0.699560987561151,0,3,U7 snRNA binding,MF,
19627,GO:1990889,0.999999999998059,0.882347329602379,0,1,H4K20me3 modified histone binding,MF,
2119,GO:0004913,0.999999999998069,0.880523737351387,0,1,interleukin-4 receptor activity,MF,
9388,GO:0035948,0.999999999998094,0.682009894866538,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
11958,GO:0047275,0.999999999998095,0.880227414950412,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
3611,GO:0008057,0.999999999998103,0.879543360858052,0,1,eye pigment granule organization,BP,
526,GO:0001635,0.999999999998121,0.693207657628718,0,3,calcitonin gene-related peptide receptor activity,MF,
16667,GO:0097642,0.999999999998121,0.693207657628718,0,3,calcitonin family receptor activity,MF,
13873,GO:0060542,0.999999999998125,0.880089036642609,0,1,regulation of strand invasion,BP,
14682,GO:0070337,0.999999999998125,0.880089036642609,0,1,3'-flap-structured DNA binding,MF,
16724,GO:0098530,0.999999999998125,0.880089036642609,0,1,positive regulation of strand invasion,BP,
6955,GO:0030617,0.999999999998149,0.880306582644906,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
1762,GO:0004368,0.99999999999816,0.880068739066752,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
2740,GO:0006127,0.99999999999816,0.880068739066752,0,1,glycerophosphate shuttle,BP,
5748,GO:0016901,0.99999999999816,0.880068739066752,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
13346,GO:0052590,0.99999999999816,0.880068739066752,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13347,GO:0052591,0.99999999999816,0.880068739066752,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
5288,GO:0015960,0.999999999998163,0.682758558635508,0,3,diadenosine polyphosphate biosynthetic process,BP,
5290,GO:0015965,0.999999999998163,0.682758558635508,0,3,diadenosine tetraphosphate metabolic process,BP,
5291,GO:0015966,0.999999999998163,0.682758558635508,0,3,diadenosine tetraphosphate biosynthetic process,BP,
19883,GO:2000409,0.999999999998189,0.882431614245015,0,1,positive regulation of T cell extravasation,BP,
19901,GO:2000451,0.999999999998189,0.882431614245015,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19903,GO:2000454,0.999999999998189,0.882431614245015,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
12388,GO:0048855,0.999999999998195,0.879975080997405,0,1,adenohypophysis morphogenesis,BP,
15008,GO:0070976,0.999999999998217,0.880347909507023,0,1,TIR domain binding,MF,
2141,GO:0004955,0.999999999998234,0.684734796574109,0,3,prostaglandin receptor activity,MF,
17919,GO:1902292,0.999999999998235,0.890046156327831,0,1,cell cycle DNA replication initiation,BP,
17932,GO:1902315,0.999999999998235,0.890046156327831,0,1,nuclear cell cycle DNA replication initiation,BP,
18170,GO:1902975,0.999999999998235,0.890046156327831,0,1,mitotic DNA replication initiation,BP,
13665,GO:0060235,0.999999999998241,0.674422287808194,0,3,lens induction in camera-type eye,BP,
475,GO:0001519,0.999999999998246,0.880195175877352,0,1,peptide amidation,BP,
1842,GO:0004504,0.999999999998246,0.880195175877352,0,1,peptidylglycine monooxygenase activity,MF,
1907,GO:0004598,0.999999999998246,0.880195175877352,0,1,peptidylamidoglycolate lyase activity,MF,
5885,GO:0018032,0.999999999998246,0.880195175877352,0,1,protein amidation,BP,
7237,GO:0031179,0.999999999998246,0.880195175877352,0,1,peptide modification,BP,
16246,GO:0090336,0.999999999998248,0.687714983049958,0,3,positive regulation of brown fat cell differentiation,BP,
15516,GO:0071947,0.999999999998254,0.681613774722489,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
17632,GO:1901491,0.999999999998256,0.774652506397217,0,2,negative regulation of lymphangiogenesis,BP,
14062,GO:0060913,0.999999999998261,0.880347793749066,0,1,cardiac cell fate determination,BP,
15375,GO:0071657,0.999999999998261,0.880347793749066,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
17573,GO:1901258,0.999999999998261,0.880347793749066,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
12437,GO:0050265,0.999999999998275,0.681848866615792,0,3,RNA uridylyltransferase activity,MF,
10611,GO:0043626,0.999999999998282,0.887713559090122,0,1,PCNA complex,CC,
10979,GO:0044796,0.999999999998282,0.887713559090122,0,1,DNA polymerase processivity factor complex,CC,
9909,GO:0042270,0.999999999998283,0.687133373556718,0,3,protection from natural killer cell mediated cytotoxicity,BP,
14429,GO:0061783,0.999999999998296,0.695550437460665,0,3,peptidoglycan muralytic activity,MF,
4433,GO:0010309,0.999999999998306,0.883817584941955,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19531,GO:1990565,0.999999999998306,0.883817584941955,0,1,HSP90-CDC37 chaperone complex,CC,
18221,GO:1903070,0.999999999998314,0.687513824068351,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
1710,GO:0004304,0.99999999999832,0.882911746777107,0,1,estrone sulfotransferase activity,MF,
3084,GO:0006660,0.99999999999832,0.882911746777107,0,1,phosphatidylserine catabolic process,BP,
3127,GO:0006711,0.99999999999832,0.882911746777107,0,1,estrogen catabolic process,BP,
11201,GO:0045352,0.99999999999832,0.882911746777107,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11202,GO:0045353,0.99999999999832,0.882911746777107,0,1,interleukin-1 Type II receptor antagonist activity,MF,
16259,GO:0090370,0.999999999998337,0.880131760026402,0,1,negative regulation of cholesterol efflux,BP,
20249,GO:2001247,0.999999999998337,0.880131760026402,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
1757,GO:0004363,0.999999999998386,0.882079138320613,0,1,glutathione synthase activity,MF,
1894,GO:0004581,0.999999999998387,0.890179253217596,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
8487,GO:0033677,0.999999999998388,0.682087519507934,0,3,DNA/RNA helicase activity,MF,
1369,GO:0003257,0.999999999998388,0.88013171302245,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
4613,GO:0010736,0.999999999998388,0.88013171302245,0,1,serum response element binding,MF,
4901,GO:0014835,0.999999999998388,0.88013171302245,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
17562,GO:1901228,0.999999999998388,0.88013171302245,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
5389,GO:0016231,0.999999999998401,0.880122104542848,0,1,beta-N-acetylglucosaminidase activity,MF,
17103,GO:0102166,0.999999999998401,0.880122104542848,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17104,GO:0102167,0.999999999998401,0.880122104542848,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17135,GO:0102571,0.999999999998401,0.880122104542848,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
11483,GO:0045988,0.999999999998401,0.682803485869256,0,3,negative regulation of striated muscle contraction,BP,
13509,GO:0055118,0.999999999998401,0.682803485869256,0,3,negative regulation of cardiac muscle contraction,BP,
11477,GO:0045976,0.999999999998406,0.774757509475407,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
16257,GO:0090365,0.99999999999841,0.880926850290073,0,1,regulation of mRNA modification,BP,
16258,GO:0090367,0.99999999999841,0.880926850290073,0,1,negative regulation of mRNA modification,BP,
18277,GO:1903215,0.99999999999841,0.880926850290073,0,1,negative regulation of protein targeting to mitochondrion,BP,
20186,GO:2001144,0.99999999999841,0.880926850290073,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20187,GO:2001145,0.99999999999841,0.880926850290073,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
12441,GO:0050294,0.999999999998412,0.697908566893037,0,3,steroid sulfotransferase activity,MF,
1652,GO:0004108,0.999999999998416,0.880320880255222,0,1,citrate (Si)-synthase activity,MF,
9575,GO:0036440,0.999999999998416,0.880320880255222,0,1,citrate synthase activity,MF,
17434,GO:1900259,0.999999999998421,0.882155677119254,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17435,GO:1900260,0.999999999998421,0.882155677119254,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
778,GO:0002037,0.999999999998422,0.881102973511356,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
11960,GO:0047280,0.999999999998425,0.880124159605002,0,1,nicotinamide phosphoribosyltransferase activity,MF,
3729,GO:0008267,0.999999999998432,0.879194378928675,0,1,poly-glutamine tract binding,MF,
1948,GO:0004655,0.999999999998449,0.88029026493626,0,1,porphobilinogen synthase activity,MF,
18995,GO:1904854,0.999999999998449,0.88029026493626,0,1,proteasome core complex binding,MF,
824,GO:0002101,0.999999999998471,0.686837315082625,0,3,tRNA wobble cytosine modification,BP,
7962,GO:0032584,0.999999999998477,0.682058289434077,0,3,growth cone membrane,CC,
11707,GO:0046534,0.999999999998479,0.880126522808151,0,1,positive regulation of photoreceptor cell differentiation,BP,
18564,GO:1903847,0.999999999998523,0.772842024628126,0,2,regulation of aorta morphogenesis,BP,
18565,GO:1903849,0.999999999998523,0.772842024628126,0,2,positive regulation of aorta morphogenesis,BP,
11765,GO:0046645,0.999999999998526,0.681735758979476,0,3,positive regulation of gamma-delta T cell activation,BP,
5488,GO:0016429,0.999999999998527,0.683844833099761,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
14474,GO:0061953,0.999999999998527,0.683844833099761,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
4736,GO:0010908,0.999999999998528,0.682021356448277,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4737,GO:0010909,0.999999999998528,0.682021356448277,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
18070,GO:1902730,0.999999999998528,0.682021356448277,0,3,positive regulation of proteoglycan biosynthetic process,BP,
15025,GO:0071001,0.999999999998552,0.694671837528187,0,3,U4/U6 snRNP,CC,
6740,GO:0030167,0.999999999998558,0.684228107893632,0,3,proteoglycan catabolic process,BP,
6758,GO:0030200,0.999999999998558,0.684228107893632,0,3,heparan sulfate proteoglycan catabolic process,BP,
19270,GO:1905553,0.999999999998578,0.690747058118673,0,3,regulation of blood vessel branching,BP,
3983,GO:0008852,0.999999999998585,0.880337247057431,0,1,exodeoxyribonuclease I activity,MF,
16678,GO:0097680,0.999999999998597,0.682471516105294,0,3,double-strand break repair via classical nonhomologous end joining,BP,
1817,GO:0004471,0.99999999999862,0.682339302298103,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1818,GO:0004473,0.99999999999862,0.682339302298103,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
10647,GO:0043849,0.99999999999862,0.880328549450735,0,1,Ras palmitoyltransferase activity,MF,
2162,GO:0004998,0.999999999998622,0.88012177034477,0,1,transferrin receptor activity,MF,
4971,GO:0015091,0.999999999998622,0.88012177034477,0,1,ferric iron transmembrane transporter activity,MF,
8435,GO:0033570,0.999999999998622,0.88012177034477,0,1,transferrin transmembrane transporter activity,MF,
15786,GO:0072510,0.999999999998622,0.88012177034477,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
1409,GO:0003345,0.999999999998625,0.880173090195654,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
4719,GO:0010886,0.999999999998642,0.682011299270682,0,3,positive regulation of cholesterol storage,BP,
6934,GO:0030550,0.999999999998657,0.689592023649467,0,3,acetylcholine receptor inhibitor activity,MF,
2161,GO:0004996,0.999999999998661,0.880173303990188,0,1,thyroid-stimulating hormone receptor activity,MF,
9725,GO:0038194,0.999999999998661,0.880173303990188,0,1,thyroid-stimulating hormone signaling pathway,BP,
9730,GO:0039003,0.999999999998661,0.880173303990188,0,1,pronephric field specification,BP,
9733,GO:0039017,0.999999999998661,0.880173303990188,0,1,pattern specification involved in pronephros development,BP,
10134,GO:0042728,0.999999999998661,0.880173303990188,0,1,flavin-containing compound catabolic process,BP,
14742,GO:0070460,0.999999999998661,0.880173303990188,0,1,thyroid-stimulating hormone secretion,BP,
15531,GO:0072003,0.999999999998661,0.880173303990188,0,1,kidney rudiment formation,BP,
15532,GO:0072004,0.999999999998661,0.880173303990188,0,1,kidney field specification,BP,
15544,GO:0072025,0.999999999998661,0.880173303990188,0,1,distal convoluted tubule development,BP,
15563,GO:0072069,0.999999999998661,0.880173303990188,0,1,DCT cell differentiation,BP,
15667,GO:0072221,0.999999999998661,0.880173303990188,0,1,metanephric distal convoluted tubule development,BP,
15676,GO:0072240,0.999999999998661,0.880173303990188,0,1,metanephric DCT cell differentiation,BP,
15705,GO:0072304,0.999999999998661,0.880173303990188,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15706,GO:0072305,0.999999999998661,0.880173303990188,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15709,GO:0072309,0.999999999998661,0.880173303990188,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15758,GO:0072389,0.999999999998661,0.880173303990188,0,1,flavin adenine dinucleotide catabolic process,BP,
17405,GO:1900200,0.999999999998661,0.880173303990188,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17406,GO:1900204,0.999999999998661,0.880173303990188,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17407,GO:1900205,0.999999999998661,0.880173303990188,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17410,GO:1900211,0.999999999998661,0.880173303990188,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17411,GO:1900212,0.999999999998661,0.880173303990188,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17412,GO:1900214,0.999999999998661,0.880173303990188,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17413,GO:1900215,0.999999999998661,0.880173303990188,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17414,GO:1900217,0.999999999998661,0.880173303990188,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17415,GO:1900218,0.999999999998661,0.880173303990188,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17536,GO:1901147,0.999999999998661,0.880173303990188,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18186,GO:1903004,0.999999999998661,0.880173303990188,0,1,regulation of protein K63-linked deubiquitination,BP,
18187,GO:1903006,0.999999999998661,0.880173303990188,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18188,GO:1903007,0.999999999998661,0.880173303990188,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19965,GO:2000592,0.999999999998661,0.880173303990188,0,1,regulation of metanephric DCT cell differentiation,BP,
19966,GO:2000594,0.999999999998661,0.880173303990188,0,1,positive regulation of metanephric DCT cell differentiation,BP,
19972,GO:2000612,0.999999999998661,0.880173303990188,0,1,regulation of thyroid-stimulating hormone secretion,BP,
12784,GO:0051102,0.999999999998665,0.880150740649762,0,1,DNA ligation involved in DNA recombination,BP,
5778,GO:0017005,0.999999999998675,0.880209509130817,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6437,GO:0021757,0.999999999998675,0.880209509130817,0,1,caudate nucleus development,BP,
6438,GO:0021758,0.999999999998675,0.880209509130817,0,1,putamen development,BP,
19091,GO:1905062,0.999999999998688,0.880348263262622,0,1,positive regulation of cardioblast proliferation,BP,
3217,GO:0006867,0.999999999998692,0.880341618132179,0,1,asparagine transport,BP,
5015,GO:0015182,0.999999999998692,0.880341618132179,0,1,L-asparagine transmembrane transporter activity,MF,
5022,GO:0015190,0.999999999998692,0.880341618132179,0,1,L-leucine transmembrane transporter activity,MF,
5023,GO:0015191,0.999999999998692,0.880341618132179,0,1,L-methionine transmembrane transporter activity,MF,
5135,GO:0015658,0.999999999998692,0.880341618132179,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5215,GO:0015821,0.999999999998692,0.880341618132179,0,1,methionine transport,BP,
10648,GO:0043865,0.999999999998692,0.880341618132179,0,1,methionine transmembrane transporter activity,MF,
1417,GO:0003363,0.999999999998694,0.880059446046268,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
19311,GO:1905671,0.999999999998697,0.682941286053841,0,3,regulation of lysosome organization,BP,
16984,GO:0099122,0.999999999998698,0.682196306217653,0,3,RNA polymerase II C-terminal domain binding,MF,
18525,GO:1903764,0.999999999998727,0.880122703791077,0,1,regulation of potassium ion export across plasma membrane,BP,
4648,GO:0010796,0.999999999998729,0.691440687863473,0,3,regulation of multivesicular body size,BP,
16092,GO:0090107,0.999999999998739,0.685766713775509,0,3,regulation of high-density lipoprotein particle assembly,BP,
3685,GO:0008192,0.99999999999874,0.687986900601305,0,3,RNA guanylyltransferase activity,MF,
111,GO:0000229,0.999999999998745,0.884591454918209,0,1,cytoplasmic chromosome,CC,
126,GO:0000262,0.999999999998745,0.884591454918209,0,1,mitochondrial chromosome,CC,
1755,GO:0004361,0.999999999998755,0.883478440197709,0,1,glutaryl-CoA dehydrogenase activity,MF,
2264,GO:0005183,0.999999999998755,0.883478440197709,0,1,gonadotropin hormone-releasing hormone activity,MF,
7420,GO:0031530,0.999999999998755,0.883478440197709,0,1,gonadotropin-releasing hormone receptor binding,MF,
19394,GO:1990008,0.999999999998755,0.883478440197709,0,1,neurosecretory vesicle,CC,
15084,GO:0071163,0.999999999998757,0.69063221393064,0,3,DNA replication preinitiation complex assembly,BP,
2072,GO:0004827,0.999999999998773,0.69038938306959,0,3,proline-tRNA ligase activity,MF,
2920,GO:0006433,0.999999999998773,0.69038938306959,0,3,prolyl-tRNA aminoacylation,BP,
3844,GO:0008458,0.99999999999878,0.880279680683893,0,1,carnitine O-octanoyltransferase activity,MF,
5475,GO:0016414,0.99999999999878,0.880279680683893,0,1,O-octanoyltransferase activity,MF,
5476,GO:0016415,0.99999999999878,0.880279680683893,0,1,octanoyltransferase activity,MF,
8883,GO:0034714,0.999999999998795,0.682446572414477,0,3,type III transforming growth factor beta receptor binding,MF,
6532,GO:0021942,0.999999999998803,0.681857110431485,0,3,radial glia guided migration of Purkinje cell,BP,
13833,GO:0060465,0.999999999998805,0.880245166448417,0,1,pharynx development,BP,
12188,GO:0048388,0.999999999998816,0.780119449520844,0,2,endosomal lumen acidification,BP,
1885,GO:0004569,0.999999999998822,0.880124311206902,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
6446,GO:0021771,0.999999999998823,0.880095237522229,0,1,lateral geniculate nucleus development,BP,
9938,GO:0042320,0.999999999998823,0.880095237522229,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
13587,GO:0060084,0.999999999998823,0.880095237522229,0,1,synaptic transmission involved in micturition,BP,
2697,GO:0006065,0.999999999998845,0.682437795070574,0,3,UDP-glucuronate biosynthetic process,BP,
11637,GO:0046398,0.999999999998845,0.682437795070574,0,3,UDP-glucuronate metabolic process,BP,
1511,GO:0003874,0.999999999998861,0.89419457355249,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
4239,GO:0009441,0.999999999998861,0.89419457355249,0,1,glycolate metabolic process,BP,
5951,GO:0018323,0.999999999998861,0.89419457355249,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8675,GO:0034309,0.999999999998861,0.89419457355249,0,1,primary alcohol biosynthetic process,BP,
9593,GO:0036470,0.999999999998861,0.89419457355249,0,1,tyrosine 3-monooxygenase activator activity,MF,
9594,GO:0036471,0.999999999998861,0.89419457355249,0,1,cellular response to glyoxal,BP,
9600,GO:0036478,0.999999999998861,0.89419457355249,0,1,L-dopa decarboxylase activator activity,MF,
9635,GO:0036524,0.999999999998861,0.89419457355249,0,1,protein deglycase activity,MF,
9636,GO:0036525,0.999999999998861,0.89419457355249,0,1,protein deglycation,BP,
9637,GO:0036526,0.999999999998861,0.89419457355249,0,1,peptidyl-cysteine deglycation,BP,
9638,GO:0036527,0.999999999998861,0.89419457355249,0,1,peptidyl-arginine deglycation,BP,
9639,GO:0036528,0.999999999998861,0.89419457355249,0,1,peptidyl-lysine deglycation,BP,
9640,GO:0036529,0.999999999998861,0.89419457355249,0,1,protein deglycation, glyoxal removal,BP,
9641,GO:0036530,0.999999999998861,0.89419457355249,0,1,protein deglycation, methylglyoxal removal,BP,
9642,GO:0036531,0.999999999998861,0.89419457355249,0,1,glutathione deglycation,BP,
11190,GO:0045340,0.999999999998861,0.89419457355249,0,1,mercury ion binding,MF,
11592,GO:0046295,0.999999999998861,0.89419457355249,0,1,glycolate biosynthetic process,BP,
17175,GO:0106044,0.999999999998861,0.89419457355249,0,1,guanine deglycation,BP,
17176,GO:0106045,0.999999999998861,0.89419457355249,0,1,guanine deglycation, methylglyoxal removal,BP,
17177,GO:0106046,0.999999999998861,0.89419457355249,0,1,guanine deglycation, glyoxal removal,BP,
17260,GO:0140041,0.999999999998861,0.89419457355249,0,1,cellular detoxification of methylglyoxal,BP,
17710,GO:1901671,0.999999999998861,0.89419457355249,0,1,positive regulation of superoxide dismutase activity,BP,
18223,GO:1903072,0.999999999998861,0.89419457355249,0,1,regulation of death-inducing signaling complex assembly,BP,
18224,GO:1903073,0.999999999998861,0.89419457355249,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18238,GO:1903122,0.999999999998861,0.89419457355249,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18250,GO:1903167,0.999999999998861,0.89419457355249,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18251,GO:1903168,0.999999999998861,0.89419457355249,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18255,GO:1903176,0.999999999998861,0.89419457355249,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18256,GO:1903178,0.999999999998861,0.89419457355249,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18260,GO:1903184,0.999999999998861,0.89419457355249,0,1,L-dopa metabolic process,BP,
18261,GO:1903185,0.999999999998861,0.89419457355249,0,1,L-dopa biosynthetic process,BP,
18262,GO:1903189,0.999999999998861,0.89419457355249,0,1,glyoxal metabolic process,BP,
18263,GO:1903195,0.999999999998861,0.89419457355249,0,1,regulation of L-dopa biosynthetic process,BP,
18264,GO:1903197,0.999999999998861,0.89419457355249,0,1,positive regulation of L-dopa biosynthetic process,BP,
18265,GO:1903198,0.999999999998861,0.89419457355249,0,1,regulation of L-dopa decarboxylase activity,BP,
18266,GO:1903200,0.999999999998861,0.89419457355249,0,1,positive regulation of L-dopa decarboxylase activity,BP,
18984,GO:1904833,0.999999999998861,0.89419457355249,0,1,positive regulation of removal of superoxide radicals,BP,
19790,GO:2000277,0.999999999998861,0.89419457355249,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19796,GO:2000284,0.999999999998861,0.89419457355249,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
921,GO:0002316,0.999999999998862,0.880134327031827,0,1,follicular B cell differentiation,BP,
5948,GO:0018315,0.999999999998862,0.880134327031827,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
9810,GO:0042040,0.999999999998862,0.880134327031827,0,1,metal incorporation into metallo-molybdopterin complex,BP,
14343,GO:0061598,0.999999999998862,0.880134327031827,0,1,molybdopterin adenylyltransferase activity,MF,
14344,GO:0061599,0.999999999998862,0.880134327031827,0,1,molybdopterin molybdotransferase activity,MF,
15834,GO:0072579,0.999999999998862,0.880134327031827,0,1,glycine receptor clustering,BP,
16423,GO:0097112,0.999999999998862,0.880134327031827,0,1,gamma-aminobutyric acid receptor clustering,BP,
17578,GO:1901291,0.999999999998866,0.882035991180589,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
4167,GO:0009237,0.999999999998867,0.880327923723479,0,1,siderophore metabolic process,BP,
6091,GO:0019290,0.999999999998867,0.880327923723479,0,1,siderophore biosynthetic process,BP,
157,GO:0000320,0.999999999998872,0.774625170613186,0,2,re-entry into mitotic cell cycle,BP,
14992,GO:0070948,0.999999999998882,0.686779736342899,0,3,regulation of neutrophil mediated cytotoxicity,BP,
7546,GO:0031871,0.999999999998894,0.683718346831058,0,3,proteinase activated receptor binding,MF,
8235,GO:0033023,0.99999999999897,0.774690509903415,0,2,mast cell homeostasis,BP,
8236,GO:0033024,0.99999999999897,0.774690509903415,0,2,mast cell apoptotic process,BP,
8237,GO:0033025,0.99999999999897,0.774690509903415,0,2,regulation of mast cell apoptotic process,BP,
15443,GO:0071812,0.999999999998972,0.880299879657826,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15462,GO:0071848,0.999999999998972,0.880299879657826,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
7572,GO:0031945,0.999999999998984,0.880168838330059,0,1,positive regulation of glucocorticoid metabolic process,BP,
7575,GO:0031948,0.999999999998984,0.880168838330059,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
13998,GO:0060748,0.999999999998984,0.880168838330059,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14145,GO:0061054,0.999999999998984,0.880168838330059,0,1,dermatome development,BP,
14201,GO:0061183,0.999999999998984,0.880168838330059,0,1,regulation of dermatome development,BP,
14202,GO:0061184,0.999999999998984,0.880168838330059,0,1,positive regulation of dermatome development,BP,
14211,GO:0061205,0.999999999998984,0.880168838330059,0,1,paramesonephric duct development,BP,
14259,GO:0061369,0.999999999998984,0.880168838330059,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
19668,GO:2000019,0.999999999998984,0.880168838330059,0,1,negative regulation of male gonad development,BP,
19692,GO:2000066,0.999999999998984,0.880168838330059,0,1,positive regulation of cortisol biosynthetic process,BP,
19761,GO:2000224,0.999999999998984,0.880168838330059,0,1,regulation of testosterone biosynthetic process,BP,
19762,GO:2000225,0.999999999998984,0.880168838330059,0,1,negative regulation of testosterone biosynthetic process,BP,
11789,GO:0046695,0.999999999998988,0.689523589553024,0,3,SLIK (SAGA-like) complex,CC,
782,GO:0002041,0.999999999998997,0.880675126538892,0,1,intussusceptive angiogenesis,BP,
3924,GO:0008609,0.999999999999002,0.879413589492761,0,1,alkylglycerone-phosphate synthase activity,MF,
9557,GO:0036371,0.999999999999008,0.879127457602912,0,1,protein localization to T-tubule,BP,
15999,GO:0086046,0.999999999999008,0.879127457602912,0,1,membrane depolarization during SA node cell action potential,BP,
16902,GO:0098907,0.999999999999008,0.879127457602912,0,1,regulation of SA node cell action potential,BP,
19510,GO:1990448,0.999999999999012,0.879901994809278,0,1,exon-exon junction complex binding,MF,
8528,GO:0033867,0.999999999999029,0.884091005931518,0,1,Fas-activated serine/threonine kinase activity,MF,
7879,GO:0032455,0.999999999999032,0.681967293337704,0,3,nerve growth factor processing,BP,
19436,GO:1990167,0.999999999999033,0.684280956791931,0,3,protein K27-linked deubiquitination,BP,
9668,GO:0038052,0.999999999999047,0.774773708479089,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10498,GO:0043423,0.999999999999048,0.880130336308104,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
19935,GO:2000537,0.999999999999048,0.880130336308104,0,1,regulation of B cell chemotaxis,BP,
19936,GO:2000538,0.999999999999048,0.880130336308104,0,1,positive regulation of B cell chemotaxis,BP,
16683,GO:0097694,0.999999999999048,0.677799434630977,0,3,establishment of RNA localization to telomere,BP,
16684,GO:0097695,0.999999999999048,0.677799434630977,0,3,establishment of protein-containing complex localization to telomere,BP,
16612,GO:0097500,0.999999999999056,0.682001735058407,0,3,receptor localization to non-motile cilium,BP,
6832,GO:0030305,0.999999999999081,0.883042439996499,0,1,heparanase activity,MF,
16060,GO:0090065,0.999999999999088,0.907862002045777,0,1,regulation of production of siRNA involved in RNA interference,BP,
16790,GO:0098680,0.999999999999088,0.907862002045777,0,1,template-free RNA nucleotidyltransferase,MF,
18495,GO:1903704,0.999999999999088,0.907862002045777,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19534,GO:1990572,0.999999999999088,0.907862002045777,0,1,TERT-RMRP complex,CC,
7240,GO:0031205,0.999999999999096,0.793370837375645,0,2,endoplasmic reticulum Sec complex,CC,
7757,GO:0032286,0.999999999999109,0.682050426136416,0,3,central nervous system myelin maintenance,BP,
11959,GO:0047277,0.999999999999112,0.881846830120458,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
8164,GO:0032911,0.999999999999123,0.682252554679779,0,3,negative regulation of transforming growth factor beta1 production,BP,
14512,GO:0070050,0.999999999999126,0.682890967561388,0,3,neuron cellular homeostasis,BP,
6377,GO:0021571,0.999999999999141,0.880261775812403,0,1,rhombomere 5 development,BP,
6378,GO:0021572,0.999999999999141,0.880261775812403,0,1,rhombomere 6 development,BP,
9046,GO:0035283,0.999999999999141,0.880261775812403,0,1,central nervous system segmentation,BP,
9047,GO:0035284,0.999999999999141,0.880261775812403,0,1,brain segmentation,BP,
16156,GO:0090204,0.999999999999156,0.697751537088939,0,3,protein localization to nuclear pore,BP,
16887,GO:0098881,0.99999999999916,0.682225221035195,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16930,GO:0098967,0.99999999999916,0.682225221035195,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
15448,GO:0071818,0.99999999999917,0.683154542022954,0,3,BAT3 complex,CC,
15750,GO:0072379,0.99999999999917,0.683154542022954,0,3,ER membrane insertion complex,CC,
11734,GO:0046601,0.999999999999174,0.681994868200109,0,3,positive regulation of centriole replication,BP,
6877,GO:0030389,0.999999999999175,0.898974485832627,0,1,fructosamine metabolic process,BP,
974,GO:0002428,0.999999999999191,0.694812001108452,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
3095,GO:0006671,0.999999999999211,0.880128673052871,0,1,phytosphingosine metabolic process,BP,
14896,GO:0070774,0.999999999999211,0.880128673052871,0,1,phytoceramidase activity,MF,
15338,GO:0071602,0.999999999999211,0.880128673052871,0,1,phytosphingosine biosynthetic process,BP,
14785,GO:0070539,0.999999999999232,0.880232468432426,0,1,linoleic acid binding,MF,
13076,GO:0051615,0.999999999999233,0.880103118798251,0,1,histamine uptake,BP,
6329,GO:0021503,0.999999999999243,0.87888130288389,0,1,neural fold bending,BP,
7102,GO:0030910,0.999999999999265,0.68189564170092,0,3,olfactory placode formation,BP,
15401,GO:0071698,0.999999999999265,0.68189564170092,0,3,olfactory placode development,BP,
15402,GO:0071699,0.999999999999265,0.68189564170092,0,3,olfactory placode morphogenesis,BP,
14135,GO:0061043,0.999999999999275,0.683891644524977,0,3,regulation of vascular wound healing,BP,
4978,GO:0015105,0.999999999999285,0.888482766761265,0,1,arsenite transmembrane transporter activity,MF,
5157,GO:0015700,0.999999999999285,0.888482766761265,0,1,arsenite transport,BP,
12768,GO:0051086,0.999999999999286,0.881764179601037,0,1,chaperone mediated protein folding independent of cofactor,BP,
11262,GO:0045590,0.999999999999292,0.880224719415684,0,1,negative regulation of regulatory T cell differentiation,BP,
10411,GO:0043273,0.999999999999302,0.880116085144923,0,1,CTPase activity,MF,
2167,GO:0005004,0.999999999999343,0.879979043740368,0,1,GPI-linked ephrin receptor activity,MF,
13229,GO:0051933,0.999999999999343,0.879979043740368,0,1,amino acid neurotransmitter reuptake,BP,
13231,GO:0051935,0.999999999999343,0.879979043740368,0,1,glutamate reuptake,BP,
13235,GO:0051941,0.999999999999343,0.879979043740368,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13238,GO:0051946,0.999999999999343,0.879979043740368,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
16447,GO:0097156,0.999999999999343,0.879979043740368,0,1,fasciculation of motor neuron axon,BP,
16451,GO:0097161,0.999999999999343,0.879979043740368,0,1,DH domain binding,MF,
18828,GO:1904477,0.999999999999343,0.879979043740368,0,1,positive regulation of Ras GTPase binding,BP,
19108,GO:1905099,0.999999999999343,0.879979043740368,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20177,GO:2001108,0.999999999999343,0.879979043740368,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
10469,GO:0043382,0.999999999999343,0.692511848746904,0,3,positive regulation of memory T cell differentiation,BP,
13141,GO:0051754,0.999999999999366,0.682195294192856,0,3,meiotic sister chromatid cohesion, centromeric,BP,
1496,GO:0003844,0.999999999999367,0.880302813137971,0,1,1,4-alpha-glucan branching enzyme activity,MF,
17139,GO:0102752,0.999999999999367,0.880302813137971,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
8954,GO:0035037,0.999999999999373,0.880125202915791,0,1,sperm entry,BP,
11962,GO:0047290,0.999999999999377,0.884071748467193,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
14539,GO:0070094,0.999999999999377,0.880376395728535,0,1,positive regulation of glucagon secretion,BP,
3808,GO:0008404,0.999999999999378,0.882366572024125,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3809,GO:0008405,0.999999999999378,0.882366572024125,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15347,GO:0071614,0.999999999999378,0.882366572024125,0,1,linoleic acid epoxygenase activity,MF,
4985,GO:0015117,0.999999999999386,0.882179678372353,0,1,thiosulfate transmembrane transporter activity,MF,
4991,GO:0015131,0.999999999999386,0.882179678372353,0,1,oxaloacetate transmembrane transporter activity,MF,
5161,GO:0015709,0.999999999999386,0.882179678372353,0,1,thiosulfate transport,BP,
5171,GO:0015729,0.999999999999386,0.882179678372353,0,1,oxaloacetate transport,BP,
5177,GO:0015743,0.999999999999386,0.882179678372353,0,1,malate transport,BP,
15229,GO:0071423,0.999999999999386,0.882179678372353,0,1,malate transmembrane transport,BP,
17938,GO:1902356,0.999999999999386,0.882179678372353,0,1,oxaloacetate(2-) transmembrane transport,BP,
13053,GO:0051585,0.999999999999394,0.880293606278401,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13077,GO:0051620,0.999999999999394,0.880293606278401,0,1,norepinephrine uptake,BP,
13078,GO:0051621,0.999999999999394,0.880293606278401,0,1,regulation of norepinephrine uptake,BP,
13079,GO:0051622,0.999999999999394,0.880293606278401,0,1,negative regulation of norepinephrine uptake,BP,
13237,GO:0051945,0.999999999999394,0.880293606278401,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
18160,GO:1902957,0.999999999999394,0.880293606278401,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18299,GO:1903282,0.999999999999394,0.880293606278401,0,1,regulation of glutathione peroxidase activity,BP,
18300,GO:1903284,0.999999999999394,0.880293606278401,0,1,positive regulation of glutathione peroxidase activity,BP,
18301,GO:1903285,0.999999999999394,0.880293606278401,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19236,GO:1905447,0.999999999999394,0.880293606278401,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19800,GO:2000295,0.999999999999394,0.880293606278401,0,1,regulation of hydrogen peroxide catabolic process,BP,
19909,GO:2000468,0.999999999999394,0.880293606278401,0,1,regulation of peroxidase activity,BP,
19910,GO:2000470,0.999999999999394,0.880293606278401,0,1,positive regulation of peroxidase activity,BP,
12833,GO:0051176,0.999999999999396,0.681841994151759,0,3,positive regulation of sulfur metabolic process,BP,
6418,GO:0021688,0.999999999999402,0.880268886570726,0,1,cerebellar molecular layer formation,BP,
14045,GO:0060853,0.999999999999402,0.880268886570726,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
19060,GO:1904983,0.999999999999414,0.88109636641776,0,1,glycine import into mitochondrion,BP,
12069,GO:0048058,0.999999999999423,0.880268268328473,0,1,compound eye corneal lens development,BP,
12345,GO:0048749,0.999999999999423,0.880268268328473,0,1,compound eye development,BP,
16219,GO:0090299,0.999999999999426,0.883919822151037,0,1,regulation of neural crest formation,BP,
16220,GO:0090301,0.999999999999426,0.883919822151037,0,1,negative regulation of neural crest formation,BP,
19815,GO:2000314,0.999999999999426,0.883919822151037,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14924,GO:0070842,0.999999999999435,0.68180919669188,0,3,aggresome assembly,BP,
701,GO:0001922,0.999999999999436,0.681747470985916,0,3,B-1 B cell homeostasis,BP,
12804,GO:0051133,0.999999999999439,0.699449323771376,0,3,regulation of NK T cell activation,BP,
12805,GO:0051135,0.999999999999439,0.699449323771376,0,3,positive regulation of NK T cell activation,BP,
16375,GO:0097025,0.999999999999455,0.681732490637727,0,3,MPP7-DLG1-LIN7 complex,CC,
6505,GO:0021886,0.999999999999458,0.692388598047227,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6506,GO:0021888,0.999999999999458,0.692388598047227,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
12867,GO:0051232,0.999999999999474,0.880541585736865,0,1,meiotic spindle elongation,BP,
17433,GO:1900248,0.999999999999484,0.774555399988578,0,2,negative regulation of cytoplasmic translational elongation,BP,
4969,GO:0015086,0.999999999999488,0.880140472798768,0,1,cadmium ion transmembrane transporter activity,MF,
4970,GO:0015087,0.999999999999488,0.880140472798768,0,1,cobalt ion transmembrane transporter activity,MF,
4973,GO:0015094,0.999999999999488,0.880140472798768,0,1,lead ion transmembrane transporter activity,MF,
5150,GO:0015692,0.999999999999488,0.880140472798768,0,1,lead ion transport,BP,
14832,GO:0070627,0.999999999999488,0.880140472798768,0,1,ferrous iron import,BP,
14913,GO:0070826,0.999999999999488,0.880140472798768,0,1,paraferritin complex,CC,
16964,GO:0099073,0.999999999999494,0.774740482702217,0,2,mitochondrion-derived vesicle,CC,
8537,GO:0033897,0.999999999999506,0.888965547721986,0,1,ribonuclease T2 activity,MF,
5863,GO:0017177,0.999999999999508,0.880168430198174,0,1,glucosidase II complex,CC,
8539,GO:0033919,0.999999999999508,0.880168430198174,0,1,glucan 1,3-alpha-glucosidase activity,MF,
16318,GO:0090600,0.999999999999508,0.880168430198174,0,1,alpha-1,3-glucosidase activity,MF,
1518,GO:0003882,0.999999999999509,0.880457959518905,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
8764,GO:0034455,0.999999999999522,0.68191594691013,0,3,t-UTP complex,CC,
3778,GO:0008343,0.999999999999526,0.87920788900754,0,1,adult feeding behavior,BP,
10244,GO:0042999,0.999999999999527,0.880124062356617,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10247,GO:0043002,0.999999999999527,0.880124062356617,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10248,GO:0043004,0.999999999999527,0.880124062356617,0,1,cytoplasmic sequestering of CFTR protein,BP,
12450,GO:0050353,0.999999999999554,0.880334911778132,0,1,trimethyllysine dioxygenase activity,MF,
927,GO:0002325,0.999999999999574,0.890108692733247,0,1,natural killer cell differentiation involved in immune response,BP,
8121,GO:0032824,0.999999999999574,0.890108692733247,0,1,negative regulation of natural killer cell differentiation,BP,
8123,GO:0032826,0.999999999999574,0.890108692733247,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8124,GO:0032827,0.999999999999574,0.890108692733247,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
5410,GO:0016262,0.999999999999575,0.68357260182757,0,3,protein N-acetylglucosaminyltransferase activity,MF,
3971,GO:0008794,0.999999999999593,0.894611563542695,0,1,arsenate reductase (glutaredoxin) activity,MF,
6951,GO:0030611,0.999999999999593,0.894611563542695,0,1,arsenate reductase activity,MF,
4860,GO:0014707,0.999999999999597,0.880535076686842,0,1,branchiomeric skeletal muscle development,BP,
18866,GO:1904578,0.999999999999598,0.695665928863414,0,3,response to thapsigargin,BP,
18867,GO:1904579,0.999999999999598,0.695665928863414,0,3,cellular response to thapsigargin,BP,
7492,GO:0031673,0.999999999999604,0.861677761272093,0,1,H zone,CC,
16198,GO:0090271,0.999999999999615,0.772970620605919,0,2,positive regulation of fibroblast growth factor production,BP,
4457,GO:0010454,0.999999999999624,0.683953553426811,0,3,negative regulation of cell fate commitment,BP,
15914,GO:0072749,0.999999999999646,0.882713063514539,0,1,cellular response to cytochalasin B,BP,
16912,GO:0098918,0.999999999999646,0.882713063514539,0,1,structural constituent of synapse,MF,
16936,GO:0098973,0.999999999999646,0.882713063514539,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16937,GO:0098974,0.999999999999646,0.882713063514539,0,1,postsynaptic actin cytoskeleton organization,BP,
16998,GO:0099186,0.999999999999646,0.882713063514539,0,1,structural constituent of postsynapse,MF,
16999,GO:0099188,0.999999999999646,0.882713063514539,0,1,postsynaptic cytoskeleton organization,BP,
17596,GO:1901328,0.999999999999646,0.882713063514539,0,1,response to cytochalasin B,BP,
1717,GO:0004311,0.999999999999649,0.682854989072717,0,3,farnesyltranstransferase activity,MF,
6327,GO:0021501,0.999999999999654,0.881236118934389,0,1,prechordal plate formation,BP,
6360,GO:0021547,0.999999999999654,0.881236118934389,0,1,midbrain-hindbrain boundary initiation,BP,
20056,GO:2000742,0.999999999999654,0.881236118934389,0,1,regulation of anterior head development,BP,
20057,GO:2000744,0.999999999999654,0.881236118934389,0,1,positive regulation of anterior head development,BP,
15451,GO:0071821,0.999999999999663,0.879695161525188,0,1,FANCM-MHF complex,CC,
15321,GO:0071573,0.999999999999665,0.880326708241709,0,1,shelterin complex assembly,BP,
18963,GO:1904790,0.999999999999665,0.880326708241709,0,1,regulation of shelterin complex assembly,BP,
18964,GO:1904792,0.999999999999665,0.880326708241709,0,1,positive regulation of shelterin complex assembly,BP,
18993,GO:1904850,0.999999999999665,0.880326708241709,0,1,negative regulation of establishment of protein localization to telomere,BP,
19027,GO:1904910,0.999999999999665,0.880326708241709,0,1,regulation of establishment of RNA localization to telomere,BP,
19028,GO:1904911,0.999999999999665,0.880326708241709,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19029,GO:1904913,0.999999999999665,0.880326708241709,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19030,GO:1904914,0.999999999999665,0.880326708241709,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
10830,GO:0044343,0.999999999999668,0.880126470718754,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10832,GO:0044345,0.999999999999668,0.880126470718754,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
16184,GO:0090246,0.999999999999668,0.880126470718754,0,1,convergent extension involved in somitogenesis,BP,
19674,GO:2000040,0.999999999999668,0.880126470718754,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19675,GO:2000041,0.999999999999668,0.880126470718754,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19685,GO:2000054,0.999999999999668,0.880126470718754,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19697,GO:2000079,0.999999999999668,0.880126470718754,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19698,GO:2000080,0.999999999999668,0.880126470718754,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
2322,GO:0005332,0.999999999999675,0.881603531294133,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
5018,GO:0015185,0.999999999999675,0.881603531294133,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
15770,GO:0072429,0.999999999999707,0.682553671799521,0,3,response to intra-S DNA damage checkpoint signaling,BP,
6409,GO:0021678,0.999999999999708,0.711730607563827,0,3,third ventricle development,BP,
901,GO:0002282,0.999999999999708,0.880358411371128,0,1,microglial cell activation involved in immune response,BP,
18055,GO:1902685,0.999999999999714,0.880133941418631,0,1,positive regulation of receptor localization to synapse,BP,
6489,GO:0021855,0.999999999999732,0.682473340500327,0,3,hypothalamus cell migration,BP,
694,GO:0001915,0.999999999999737,0.683988612715671,0,3,negative regulation of T cell mediated cytotoxicity,BP,
5746,GO:0016899,0.999999999999779,0.774591681212533,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
3162,GO:0006776,0.999999999999784,0.693349662798262,0,3,vitamin A metabolic process,BP,
3915,GO:0008591,0.999999999999787,0.882756284868434,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
10111,GO:0042662,0.999999999999787,0.882756284868434,0,1,negative regulation of mesodermal cell fate specification,BP,
11388,GO:0045813,0.999999999999787,0.882756284868434,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
14410,GO:0061743,0.999999999999787,0.882756284868434,0,1,motor learning,BP,
16073,GO:0090081,0.999999999999787,0.882756284868434,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16074,GO:0090082,0.999999999999787,0.882756284868434,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16260,GO:0090381,0.999999999999787,0.882756284868434,0,1,regulation of heart induction,BP,
16888,GO:0098883,0.999999999999787,0.882756284868434,0,1,synapse disassembly,BP,
17080,GO:0100012,0.999999999999787,0.882756284868434,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17582,GO:1901296,0.999999999999787,0.882756284868434,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17595,GO:1901321,0.999999999999787,0.882756284868434,0,1,positive regulation of heart induction,BP,
18916,GO:1904701,0.999999999999787,0.882756284868434,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18921,GO:1904711,0.999999999999787,0.882756284868434,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18931,GO:1904723,0.999999999999787,0.882756284868434,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
19096,GO:1905067,0.999999999999787,0.882756284868434,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19330,GO:1905771,0.999999999999787,0.882756284868434,0,1,negative regulation of mesodermal cell differentiation,BP,
19368,GO:1905903,0.999999999999787,0.882756284868434,0,1,negative regulation of mesoderm formation,BP,
9124,GO:0035470,0.999999999999788,0.882731008341858,0,1,positive regulation of vascular wound healing,BP,
13954,GO:0060690,0.999999999999788,0.882731008341858,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13955,GO:0060691,0.999999999999788,0.882731008341858,0,1,epithelial cell maturation involved in salivary gland development,BP,
17347,GO:1900098,0.999999999999788,0.882731008341858,0,1,regulation of plasma cell differentiation,BP,
17348,GO:1900100,0.999999999999788,0.882731008341858,0,1,positive regulation of plasma cell differentiation,BP,
18395,GO:1903489,0.999999999999788,0.882731008341858,0,1,positive regulation of lactation,BP,
4867,GO:0014732,0.999999999999792,0.685646873536325,0,3,skeletal muscle atrophy,BP,
8530,GO:0033871,0.999999999999806,0.881857384655804,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
7340,GO:0031389,0.999999999999813,0.880330813856121,0,1,Rad17 RFC-like complex,CC,
12788,GO:0051107,0.999999999999813,0.880330813856121,0,1,negative regulation of DNA ligation,BP,
12946,GO:0051352,0.999999999999813,0.880330813856121,0,1,negative regulation of ligase activity,BP,
19005,GO:1904876,0.999999999999813,0.880330813856121,0,1,negative regulation of DNA ligase activity,BP,
12631,GO:0050859,0.999999999999815,0.683850001061917,0,3,negative regulation of B cell receptor signaling pathway,BP,
9670,GO:0038062,0.999999999999819,0.880178410636097,0,1,protein tyrosine kinase collagen receptor activity,MF,
16005,GO:0086056,0.999999999999825,0.88013882261368,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16907,GO:0098912,0.999999999999825,0.88013882261368,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
16682,GO:0097692,0.999999999999826,0.880005662187392,0,1,histone H3-K4 monomethylation,BP,
17774,GO:1901895,0.999999999999826,0.880005662187392,0,1,negative regulation of calcium-transporting ATPase activity,BP,
14976,GO:0070926,0.999999999999835,0.880173876195861,0,1,regulation of ATP:ADP antiporter activity,BP,
19920,GO:2000491,0.999999999999841,0.880293039744938,0,1,positive regulation of hepatic stellate cell activation,BP,
7674,GO:0032127,0.999999999999848,0.880296572633665,0,1,dense core granule membrane,CC,
15059,GO:0071065,0.999999999999848,0.880296572633665,0,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15073,GO:0071133,0.999999999999848,0.880296572633665,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
15805,GO:0072535,0.999999999999848,0.880296572633665,0,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,
15882,GO:0072680,0.999999999999848,0.880296572633665,0,1,extracellular matrix-dependent thymocyte migration,BP,
15883,GO:0072681,0.999999999999848,0.880296572633665,0,1,fibronectin-dependent thymocyte migration,BP,
19809,GO:2000307,0.999999999999848,0.880296572633665,0,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19810,GO:2000309,0.999999999999848,0.880296572633665,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19884,GO:2000410,0.999999999999848,0.880296572633665,0,1,regulation of thymocyte migration,BP,
19885,GO:2000412,0.999999999999848,0.880296572633665,0,1,positive regulation of thymocyte migration,BP,
19886,GO:2000413,0.999999999999848,0.880296572633665,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
19887,GO:2000415,0.999999999999848,0.880296572633665,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
15007,GO:0070975,0.999999999999891,0.879581802334323,0,1,FHA domain binding,MF,
12292,GO:0048664,0.999999999999897,0.693417473190298,0,3,neuron fate determination,BP,
1271,GO:0003065,0.999999999999925,0.882851750135719,0,1,positive regulation of heart rate by epinephrine,BP,
16565,GO:0097409,0.999999999999926,0.881797375280947,0,1,glial cytoplasmic inclusion,CC,
16568,GO:0097414,0.999999999999926,0.881797375280947,0,1,classical Lewy body,CC,
16591,GO:0097462,0.999999999999926,0.881797375280947,0,1,Lewy neurite,CC,
19404,GO:1990038,0.999999999999926,0.881797375280947,0,1,Lewy body corona,CC,
8488,GO:0033678,0.999999999999927,0.880354815166188,0,1,5'-3' DNA/RNA helicase activity,MF,
8492,GO:0033682,0.999999999999927,0.880354815166188,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
13392,GO:0052812,0.999999999999933,0.774669835005731,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
15838,GO:0072586,0.999999999999935,0.880125465622858,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15839,GO:0072587,0.999999999999935,0.880125465622858,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
11391,GO:0045819,0.999999999999948,0.880164712195717,0,1,positive regulation of glycogen catabolic process,BP,
855,GO:0002188,0.999999999999951,0.680016868831218,0,3,translation reinitiation,BP,
14313,GO:0061535,0.999999999999956,0.67695080908935,0,3,glutamate secretion, neurotransmission,BP,
12478,GO:0050561,0.99999999999996,0.880166683246503,0,1,glutamate-tRNA(Gln) ligase activity,MF,
519,GO:0001605,0.999999999999974,0.880122742263474,0,1,adrenomedullin receptor activity,MF,
2136,GO:0004948,0.999999999999974,0.880122742263474,0,1,calcitonin receptor activity,MF,
15161,GO:0071324,0.999999999999974,0.880122742263474,0,1,cellular response to disaccharide stimulus,BP,
15163,GO:0071329,0.999999999999974,0.880122742263474,0,1,cellular response to sucrose stimulus,BP,
18246,GO:1903143,0.999999999999974,0.880122742263474,0,1,adrenomedullin receptor complex,CC,
19492,GO:1990409,0.999999999999974,0.880122742263474,0,1,adrenomedullin binding,MF,
14565,GO:0070138,0.999999999999977,0.68189701396748,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14567,GO:0070140,0.999999999999977,0.68189701396748,0,3,SUMO-specific isopeptidase activity,MF,
6,GO:0000012,1,0.361089736121395,0,8,single strand break repair,BP,
11,GO:0000022,1,0.281815301018757,0,10,mitotic spindle elongation,BP,
15,GO:0000028,1,0.132053200527413,0,18,ribosomal small subunit assembly,BP,
29,GO:0000054,1,0.207634068110373,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.377712209809786,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.429750999367853,0,7,ribosomal small subunit export from nucleus,BP,
34,GO:0000064,1,0.600691363629274,0,4,L-ornithine transmembrane transporter activity,MF,
37,GO:0000076,1,0.150411796876643,0,15,DNA replication checkpoint,BP,
47,GO:0000099,1,0.598545280414389,0,4,sulfur amino acid transmembrane transporter activity,MF,
57,GO:0000120,1,0.535223415206829,0,5,RNA polymerase I transcription factor complex,CC,
62,GO:0000125,1,0.542616372999422,0,5,PCAF complex,CC,
64,GO:0000127,1,0.472116240690442,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000138,1,0.476042960049415,0,6,Golgi trans cisterna,CC,
73,GO:0000150,1,0.36670837387572,0,8,recombinase activity,MF,
84,GO:0000172,1,0.482396355711132,0,6,ribonuclease MRP complex,CC,
87,GO:0000176,1,0.211379394005451,0,13,nuclear exosome (RNase complex),CC,
101,GO:0000213,1,0.603388244263842,0,4,tRNA-intron endonuclease activity,MF,
102,GO:0000214,1,0.604326026804702,0,4,tRNA-intron endonuclease complex,CC,
112,GO:0000235,1,0.36006662502828,0,8,astral microtubule,CC,
114,GO:0000243,1,0.375323172583626,0,8,commitment complex,CC,
115,GO:0000244,1,0.245830168080089,0,11,spliceosomal tri-snRNP complex assembly,BP,
139,GO:0000290,1,0.32406983923605,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
140,GO:0000291,1,0.0143157594832302,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
145,GO:0000298,1,0.606378799054077,0,4,endopolyphosphatase activity,MF,
151,GO:0000307,1,0.00962070287737691,0,37,cyclin-dependent protein kinase holoenzyme complex,CC,
154,GO:0000313,1,5.43494584101407e-05,0,84,organellar ribosome,CC,
155,GO:0000314,1,0.0376601878112412,0,28,organellar small ribosomal subunit,CC,
156,GO:0000315,1,0.00260419621089061,0,51,organellar large ribosomal subunit,CC,
162,GO:0000338,1,0.28686855232719,0,10,protein deneddylation,BP,
163,GO:0000339,1,0.119361834398893,0,17,RNA cap binding,MF,
164,GO:0000340,1,0.319302230952363,0,9,RNA 7-methylguanosine cap binding,MF,
165,GO:0000346,1,0.197610428429529,0,13,transcription export complex,CC,
166,GO:0000347,1,0.477304401974197,0,6,THO complex,CC,
173,GO:0000380,1,0.00334577226504534,0,45,alternative mRNA splicing, via spliceosome,BP,
174,GO:0000381,1,0.0152480285429717,0,33,regulation of alternative mRNA splicing, via spliceosome,BP,
177,GO:0000387,1,0.0118205308902525,0,36,spliceosomal snRNP assembly,BP,
178,GO:0000389,1,0.468594151682209,0,6,mRNA 3'-splice site recognition,BP,
180,GO:0000393,1,0.532824193812463,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
182,GO:0000395,1,0.534309288905201,0,5,mRNA 5'-splice site recognition,BP,
184,GO:0000400,1,0.132839249453699,0,16,four-way junction DNA binding,MF,
185,GO:0000403,1,0.464887927104923,0,6,Y-form DNA binding,MF,
190,GO:0000408,1,0.543506949655326,0,5,EKC/KEOPS complex,CC,
195,GO:0000414,1,0.595598935989951,0,4,regulation of histone H3-K36 methylation,BP,
201,GO:0000423,1,0.0900080184979418,0,19,mitophagy,BP,
210,GO:0000439,1,0.321132188493704,0,9,core TFIIH complex,CC,
211,GO:0000444,1,0.603229666406213,0,4,MIS12/MIND type complex,CC,
212,GO:0000445,1,0.477304401974197,0,6,THO complex part of transcription export complex,CC,
213,GO:0000447,1,0.331174505793715,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
219,GO:0000459,1,0.424414971699306,0,7,exonucleolytic trimming involved in rRNA processing,BP,
220,GO:0000460,1,0.0170891253289949,0,33,maturation of 5.8S rRNA,BP,
222,GO:0000462,1,0.0108571476783905,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
223,GO:0000463,1,0.299288568032264,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000466,1,0.0652964829576327,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000467,1,0.424414971699306,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000469,1,0.0402916856637014,0,26,cleavage involved in rRNA processing,BP,
227,GO:0000470,1,0.0547354338586772,0,24,maturation of LSU-rRNA,BP,
229,GO:0000478,1,0.153742529721103,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
230,GO:0000479,1,0.174642765941514,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000480,1,0.464903053527104,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000491,1,0.327733437205783,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
234,GO:0000492,1,0.421685915965413,0,7,box C/D snoRNP assembly,BP,
243,GO:0000700,1,0.60710946547614,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000702,1,0.550268460196903,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
248,GO:0000707,1,0.366611675047405,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000712,1,0.319716887652815,0,9,resolution of meiotic recombination intermediates,BP,
260,GO:0000727,1,0.535488541611244,0,5,double-strand break repair via break-induced replication,BP,
261,GO:0000729,1,0.0604464068189478,0,22,DNA double-strand break processing,BP,
262,GO:0000730,1,0.284070506342094,0,10,DNA recombinase assembly,BP,
271,GO:0000774,1,0.253318518857933,0,11,adenyl-nucleotide exchange factor activity,MF,
279,GO:0000782,1,0.280501773678197,0,10,telomere cap complex,CC,
280,GO:0000783,1,0.280501773678197,0,10,nuclear telomere cap complex,CC,
284,GO:0000788,1,0.0389734766925692,0,31,nuclear nucleosome,CC,
291,GO:0000796,1,0.408955560996487,0,7,condensin complex,CC,
298,GO:0000805,1,0.409639382653976,0,7,X chromosome,CC,
300,GO:0000808,1,0.317576729773616,0,9,origin recognition complex,CC,
302,GO:0000812,1,0.284073677907967,0,10,Swr1 complex,CC,
314,GO:0000827,1,0.605192903984679,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
315,GO:0000828,1,0.605192903984679,0,4,inositol hexakisphosphate kinase activity,MF,
316,GO:0000829,1,0.605192903984679,0,4,inositol heptakisphosphate kinase activity,MF,
317,GO:0000832,1,0.605192903984679,0,4,inositol hexakisphosphate 5-kinase activity,MF,
325,GO:0000912,1,0.4651190081241,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
326,GO:0000915,1,0.4651190081241,0,6,actomyosin contractile ring assembly,BP,
337,GO:0000938,1,0.600166025611512,0,4,GARP complex,CC,
339,GO:0000940,1,0.190318427996708,0,13,condensed chromosome outer kinetochore,CC,
341,GO:0000942,1,0.601921937232416,0,4,condensed nuclear chromosome outer kinetochore,CC,
343,GO:0000957,1,0.528233055591361,0,5,mitochondrial RNA catabolic process,BP,
345,GO:0000959,1,0.00561205322488102,0,41,mitochondrial RNA metabolic process,BP,
346,GO:0000960,1,0.600184686683158,0,4,regulation of mitochondrial RNA catabolic process,BP,
349,GO:0000963,1,0.13354233443199,0,16,mitochondrial RNA processing,BP,
350,GO:0000964,1,0.609685187887768,0,4,mitochondrial RNA 5'-end processing,BP,
351,GO:0000965,1,0.536967297281542,0,5,mitochondrial RNA 3'-end processing,BP,
352,GO:0000966,1,0.0763795971596609,0,21,RNA 5'-end processing,BP,
354,GO:0000972,1,0.412113842008634,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000974,1,0.194698843044183,0,13,Prp19 complex,CC,
364,GO:0000983,1,0.149796740295676,0,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
368,GO:0000990,1,0.319003523332476,0,9,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000995,1,0.597055179250921,0,4,transcription factor activity, core RNA polymerase III binding,MF,
376,GO:0001007,1,0.59799731409694,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
380,GO:0001013,1,0.364572747962081,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001030,1,0.5286414607237,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
386,GO:0001031,1,0.5286414607237,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
387,GO:0001032,1,0.601809805360144,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001054,1,0.266682405956203,0,11,RNA polymerase I activity,MF,
394,GO:0001056,1,0.160564025573004,0,15,RNA polymerase III activity,MF,
398,GO:0001075,1,0.469506184462084,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
402,GO:0001083,1,0.528638870982581,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
434,GO:0001163,1,0.364572747962081,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
435,GO:0001164,1,0.364572747962081,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
440,GO:0001188,1,0.364572747962081,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
446,GO:0001206,1,0.525955777882718,0,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
461,GO:0001405,1,0.535550926457022,0,5,presequence translocase-associated import motor,CC,
470,GO:0001514,1,0.36347621367992,0,8,selenocysteine incorporation,BP,
472,GO:0001516,1,0.123314711929558,0,17,prostaglandin biosynthetic process,BP,
497,GO:0001553,1,0.528238149921391,0,5,luteinization,BP,
515,GO:0001580,1,0.390983916416464,0,8,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
527,GO:0001637,1,0.410756497765448,0,7,G-protein coupled chemoattractant receptor activity,MF,
533,GO:0001652,1,0.607514604840442,0,4,granular component,CC,
549,GO:0001671,1,0.0631646757359148,0,22,ATPase activator activity,MF,
550,GO:0001672,1,0.409806660175599,0,7,regulation of chromatin assembly or disassembly,BP,
558,GO:0001682,1,0.235715136700564,0,12,tRNA 5'-leader removal,BP,
575,GO:0001727,1,0.529202098197187,0,5,lipid kinase activity,MF,
577,GO:0001730,1,0.605544364881289,0,4,2'-5'-oligoadenylate synthetase activity,MF,
584,GO:0001739,1,0.467939834829141,0,6,sex chromatin,CC,
591,GO:0001756,1,0.00670931738771504,0,39,somitogenesis,BP,
602,GO:0001771,1,0.468486175343468,0,6,immunological synapse formation,BP,
611,GO:0001780,1,0.319359581895348,0,9,neutrophil homeostasis,BP,
612,GO:0001781,1,0.532198727181446,0,5,neutrophil apoptotic process,BP,
617,GO:0001787,1,0.543808008123244,0,5,natural killer cell proliferation,BP,
636,GO:0001826,1,0.526803835735879,0,5,inner cell mass cell differentiation,BP,
641,GO:0001832,1,0.16812016884772,0,14,blastocyst growth,BP,
642,GO:0001833,1,0.279089503633705,0,10,inner cell mass cell proliferation,BP,
651,GO:0001842,1,0.53556692888012,0,5,neural fold formation,BP,
655,GO:0001846,1,0.539375268152498,0,5,opsonin binding,MF,
656,GO:0001848,1,0.539153691176638,0,5,complement binding,MF,
662,GO:0001866,1,0.617904544626092,0,4,NK T cell proliferation,BP,
666,GO:0001871,1,0.409261338002487,0,7,pattern binding,MF,
675,GO:0001886,1,0.413366517944647,0,7,endothelial cell morphogenesis,BP,
676,GO:0001887,1,0.600835333019153,0,4,selenium compound metabolic process,BP,
689,GO:0001910,1,0.0268898269582194,0,29,regulation of leukocyte mediated cytotoxicity,BP,
690,GO:0001911,1,0.285142331567745,0,10,negative regulation of leukocyte mediated cytotoxicity,BP,
691,GO:0001912,1,0.12122691641437,0,17,positive regulation of leukocyte mediated cytotoxicity,BP,
693,GO:0001914,1,0.200085061817803,0,13,regulation of T cell mediated cytotoxicity,BP,
695,GO:0001916,1,0.373835547457928,0,8,positive regulation of T cell mediated cytotoxicity,BP,
713,GO:0001939,1,0.465931776677407,0,6,female pronucleus,CC,
714,GO:0001940,1,0.526907326684122,0,5,male pronucleus,CC,
735,GO:0001967,1,0.413696121218452,0,7,suckling behavior,BP,
743,GO:0001975,1,0.250700524901924,0,11,response to amphetamine,BP,
744,GO:0001976,1,0.606364859181369,0,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,
752,GO:0001993,1,0.602607496054932,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
759,GO:0002002,1,0.604768887886808,0,4,regulation of angiotensin levels in blood,BP,
760,GO:0002003,1,0.604768887886808,0,4,angiotensin maturation,BP,
777,GO:0002036,1,0.601054194227583,0,4,regulation of L-glutamate import across plasma membrane,BP,
786,GO:0002051,1,0.599337574331751,0,4,osteoblast fate commitment,BP,
798,GO:0002068,1,0.101547639056154,0,18,glandular epithelial cell development,BP,
799,GO:0002069,1,0.471848269090475,0,6,columnar/cuboidal epithelial cell maturation,BP,
800,GO:0002070,1,0.249575388874688,0,11,epithelial cell maturation,BP,
802,GO:0002072,1,0.463421362996883,0,6,optic cup morphogenesis involved in camera-type eye development,BP,
821,GO:0002097,1,0.132994595599025,0,16,tRNA wobble base modification,BP,
822,GO:0002098,1,0.220161994703494,0,12,tRNA wobble uridine modification,BP,
835,GO:0002138,1,0.474127866219139,0,6,retinoic acid biosynthetic process,BP,
836,GO:0002143,1,0.604399636357075,0,4,tRNA wobble position uridine thiolation,BP,
838,GO:0002151,1,0.464680921161459,0,6,G-quadruplex RNA binding,MF,
843,GO:0002159,1,0.599202086972888,0,4,desmosome assembly,BP,
845,GO:0002162,1,0.407814532349472,0,7,dystroglycan binding,MF,
847,GO:0002175,1,0.598213671961718,0,4,protein localization to paranode region of axon,BP,
850,GO:0002178,1,0.249270140754963,0,11,palmitoyltransferase complex,CC,
852,GO:0002182,1,0.246786757661446,0,11,cytoplasmic translational elongation,BP,
863,GO:0002199,1,0.412719896818812,0,7,zona pellucida receptor complex,CC,
874,GO:0002227,1,0.352159208184093,0,10,innate immune response in mucosa,BP,
884,GO:0002251,1,0.18627675529549,0,15,organ or tissue specific immune response,BP,
900,GO:0002281,1,0.465213553335183,0,6,macrophage activation involved in immune response,BP,
924,GO:0002320,1,0.191200915075358,0,13,lymphoid progenitor cell differentiation,BP,
926,GO:0002323,1,0.328091949639116,0,9,natural killer cell activation involved in immune response,BP,
930,GO:0002328,1,0.317699752891785,0,9,pro-B cell differentiation,BP,
938,GO:0002347,1,0.281679332978421,0,10,response to tumor cell,BP,
939,GO:0002349,1,0.539531990059728,0,5,histamine production involved in inflammatory response,BP,
961,GO:0002385,1,0.211673353634809,0,14,mucosal immune response,BP,
970,GO:0002418,1,0.363531980393605,0,8,immune response to tumor cell,BP,
971,GO:0002420,1,0.600548845908237,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
972,GO:0002423,1,0.600548845908237,0,4,natural killer cell mediated immune response to tumor cell,BP,
984,GO:0002441,1,0.539531990059728,0,5,histamine secretion involved in inflammatory response,BP,
999,GO:0002468,1,0.605375963049283,0,4,dendritic cell antigen processing and presentation,BP,
1001,GO:0002475,1,0.473682476160535,0,6,antigen processing and presentation via MHC class Ib,BP,
1022,GO:0002523,1,0.5560426651686,0,5,leukocyte migration involved in inflammatory response,BP,
1035,GO:0002544,1,0.259012426475816,0,11,chronic inflammatory response,BP,
1037,GO:0002548,1,0.0873853282671343,0,20,monocyte chemotaxis,BP,
1039,GO:0002553,1,0.539531990059728,0,5,histamine secretion by mast cell,BP,
1051,GO:0002579,1,0.615571879655196,0,4,positive regulation of antigen processing and presentation,BP,
1063,GO:0002604,1,0.605375963049283,0,4,regulation of dendritic cell antigen processing and presentation,BP,
1088,GO:0002676,1,0.540235476807945,0,5,regulation of chronic inflammatory response,BP,
1126,GO:0002715,1,0.105283906302014,0,18,regulation of natural killer cell mediated immunity,BP,
1127,GO:0002716,1,0.322988828132243,0,9,negative regulation of natural killer cell mediated immunity,BP,
1128,GO:0002717,1,0.288309895714631,0,10,positive regulation of natural killer cell mediated immunity,BP,
1151,GO:0002759,1,0.607302139810717,0,4,regulation of antimicrobial humoral response,BP,
1180,GO:0002827,1,0.419374097768239,0,7,positive regulation of T-helper 1 type immune response,BP,
1187,GO:0002834,1,0.465482165696462,0,6,regulation of response to tumor cell,BP,
1190,GO:0002837,1,0.465482165696462,0,6,regulation of immune response to tumor cell,BP,
1195,GO:0002855,1,0.600548845908237,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1198,GO:0002858,1,0.600548845908237,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1239,GO:0002934,1,0.316179729527216,0,9,desmosome organization,BP,
1241,GO:0002943,1,0.604103061668995,0,4,tRNA dihydrouridine synthesis,BP,
1269,GO:0003062,1,0.602774205883755,0,4,regulation of heart rate by chemical signal,BP,
1280,GO:0003084,1,0.475523443219325,0,6,positive regulation of systemic arterial blood pressure,BP,
1293,GO:0003128,1,0.533841933746138,0,5,heart field specification,BP,
1299,GO:0003139,1,0.604771117033912,0,4,secondary heart field specification,BP,
1300,GO:0003140,1,0.601844266613446,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
1307,GO:0003157,1,0.317713359888238,0,9,endocardium development,BP,
1309,GO:0003159,1,0.25065556611615,0,11,morphogenesis of an endothelium,BP,
1310,GO:0003160,1,0.602382155113473,0,4,endocardium morphogenesis,BP,
1311,GO:0003161,1,0.316543671669624,0,9,cardiac conduction system development,BP,
1323,GO:0003176,1,0.604161807340569,0,4,aortic valve development,BP,
1324,GO:0003177,1,0.462699342986426,0,6,pulmonary valve development,BP,
1326,GO:0003180,1,0.604161807340569,0,4,aortic valve morphogenesis,BP,
1329,GO:0003184,1,0.462699342986426,0,6,pulmonary valve morphogenesis,BP,
1342,GO:0003207,1,0.600036925406345,0,4,cardiac chamber formation,BP,
1345,GO:0003211,1,0.600036925406345,0,4,cardiac ventricle formation,BP,
1348,GO:0003215,1,0.215626055226442,0,12,cardiac right ventricle morphogenesis,BP,
1352,GO:0003222,1,0.243279315609897,0,11,ventricular trabecula myocardium morphogenesis,BP,
1355,GO:0003228,1,0.602105023986291,0,4,atrial cardiac muscle tissue development,BP,
1366,GO:0003253,1,0.602363341997985,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1370,GO:0003263,1,0.542004011335417,0,5,cardioblast proliferation,BP,
1371,GO:0003264,1,0.475911554881984,0,6,regulation of cardioblast proliferation,BP,
1372,GO:0003266,1,0.540624475131484,0,5,regulation of secondary heart field cardioblast proliferation,BP,
1382,GO:0003284,1,0.600241943914562,0,4,septum primum development,BP,
1393,GO:0003309,1,0.131091356474566,0,16,type B pancreatic cell differentiation,BP,
1396,GO:0003323,1,0.148934959138785,0,15,type B pancreatic cell development,BP,
1398,GO:0003334,1,0.246619866058125,0,11,keratinocyte development,BP,
1401,GO:0003337,1,0.419285275571343,0,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1403,GO:0003339,1,0.539598216417236,0,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1408,GO:0003344,1,0.461559214650096,0,6,pericardium morphogenesis,BP,
1410,GO:0003348,1,0.598005736976014,0,4,cardiac endothelial cell differentiation,BP,
1422,GO:0003376,1,0.318367515023586,0,9,sphingosine-1-phosphate signaling pathway,BP,
1444,GO:0003676,1,0,228,3236,nucleic acid binding,MF,ZC3H6;NYNRIN;ZMYND8;NFATC4;XPC;FOS;H1F0;EGR1;ZNF862;LRP1;PDCD4;EGFR;ZSCAN18;DDB2;ZDHHC1;NR1D1;ERCC1;S100A4;PRDX5;BAHCC1;ZKSCAN1;SLC16A3;DNM1;MEF2D;DDIT3;ERCC6;ABTB1;TCEA2;KHNYN;ZCCHC24;SMARCA1;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;RPL13A;KLF9;MIF4GD;ASH2L;SOX13;ETV4;MXD4;H2AFJ;TRNP1;DNASE1L1;PHC2;PHF21A;ZNF76;PBX2;THAP8;GRB7;R3HDM2;SOX12;UNK;CIRBP;CAPRIN2;APOBEC3C;AARS;ELK3;PABPC1L;KDM3A;FOXQ1;PHF1;SALL2;DDX59;ETV1;NSUN5P2;NEIL1;RAG1;ETV5;NSUN7;HES2;CHD2;TEF;TNS1;RMI2;XPOT;FAM50A;CARF;MANF;CARS;SPATS2;APOBEC3F;PPARA;CHD3;TCF25;SATB1;STAT6;KLF7;R3HDM4;HMGA2;THRA;TDRKH;PAN2;ZSCAN30;EIF2D;LTA4H;NAT14;ZXDC;MLXIPL;TSPYL2;H1FX;FLYWCH1;TWF2;LITAF;ATF4;ZFPM1;ZNF467;POLM;ZNF516;JDP2;HDAC5;GTPBP1;IRF5;TFB1M;NTPCR;PCBP4;SRSF5;DHX32;DEAF1;TEP1;PEG3;GLI4;RFX2;ENDOG;CEBPB;CREBRF;PCSK9;ZNF251;ISG20;HLTF;DNMT3A;MXD3;FOXL1;CSRNP3;TMSB4X;BHLHE40;MLH3;CALCOCO1;HMG20B;AGO4;ZFP90;ZNF558;RPUSD3;ZNF662;EXD3;POLL;TERC;RXRA;ZNF358;ZNF362;MBD1;TNRC18;PRDM8;MGMT;PAIP2B;MAPKBP1;CRY2;IFT57;LACTB2;ASS1;TSG101;IGF2BP2;ZNF217;NUCB2;ZNF25;DNASE2;UHRF2;SMARCD2;NELFCD;FOXO4;ANKZF1;ZNF554;CPSF4;POLR2J2;HOXC5;ZNF160;MPG;LGALS1;ZFP28;TP73;MTA3;MNT;ZNF846;TFEB;CERS4;LSM14B;ENDOV;PHC1;CSNK1E;BCL6;HSF4;EHD3;RPL39L;LEMD2;RECQL5;TST;POU2F2;RCOR2;MTA1;MSH5;PAIP2;MYO18A;RPL29;TCF7;EPAS1;CHD6;POLR2J3;PER1;IGF2BP3;ZNF333;EIF2AK4;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;ZMYM3;DBP;ZNF667;ZNF287;DTD1;DMTF1;TEAD2;SIX5
1450,GO:0003688,1,0.168004312242088,0,14,DNA replication origin binding,MF,
1451,GO:0003689,1,0.365659346523366,0,8,DNA clamp loader activity,MF,
1465,GO:0003723,1,0,71,1482,RNA binding,MF,H1F0;LRP1;PDCD4;S100A4;SLC16A3;DNM1;ABTB1;KHNYN;ZCCHC24;ZFP36L1;ADARB1;RPL13A;MIF4GD;GRB7;R3HDM2;UNK;CIRBP;CAPRIN2;APOBEC3C;AARS;PABPC1L;DDX59;NSUN5P2;NSUN7;CHD2;TNS1;XPOT;FAM50A;MANF;CARS;SPATS2;APOBEC3F;CHD3;THRA;TDRKH;EIF2D;LTA4H;H1FX;TWF2;GTPBP1;TFB1M;NTPCR;PCBP4;SRSF5;DHX32;TEP1;PCSK9;ISG20;HLTF;TMSB4X;AGO4;RPUSD3;MAPKBP1;LACTB2;ASS1;IGF2BP2;NELFCD;CPSF4;LGALS1;LSM14B;ENDOV;CSNK1E;RPL39L;TST;PAIP2;MYO18A;RPL29;IGF2BP3;EIF2AK4;RPL12;DTD1
1475,GO:0003747,1,0.467333002432564,0,6,translation release factor activity,MF,
1483,GO:0003810,1,0.600568319972578,0,4,protein-glutamine gamma-glutamyltransferase activity,MF,
1499,GO:0003847,1,0.616531709961775,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1527,GO:0003909,1,0.410819397769648,0,7,DNA ligase activity,MF,
1528,GO:0003910,1,0.466269680288058,0,6,DNA ligase (ATP) activity,MF,
1529,GO:0003916,1,0.465848880787676,0,6,DNA topoisomerase activity,MF,
1530,GO:0003917,1,0.601475542690973,0,4,DNA topoisomerase type I activity,MF,
1536,GO:0003923,1,0.530703387604472,0,5,GPI-anchor transamidase activity,MF,
1549,GO:0003950,1,0.114561513854769,0,17,NAD+ ADP-ribosyltransferase activity,MF,
1553,GO:0003954,1,0.0114176936154852,0,40,NADH dehydrogenase activity,MF,
1576,GO:0003988,1,0.470580786749178,0,6,acetyl-CoA C-acyltransferase activity,MF,
1596,GO:0004017,1,0.528965075857254,0,5,adenylate kinase activity,MF,
1603,GO:0004028,1,0.409976416602948,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1605,GO:0004030,1,0.528659289924157,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1614,GO:0004045,1,0.625795371981139,0,4,aminoacyl-tRNA hydrolase activity,MF,
1624,GO:0004062,1,0.615629553774384,0,4,aryl sulfotransferase activity,MF,
1643,GO:0004089,1,0.530428096175166,0,5,carbonate dehydratase activity,MF,
1654,GO:0004111,1,0.607823449503755,0,4,creatine kinase activity,MF,
1665,GO:0004128,1,0.414988558365234,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1692,GO:0004169,1,0.55182389298105,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1699,GO:0004181,1,0.318591812824279,0,9,metallocarboxypeptidase activity,MF,
1700,GO:0004185,1,0.362169361820648,0,8,serine-type carboxypeptidase activity,MF,
1706,GO:0004298,1,0.127222072619037,0,18,threonine-type endopeptidase activity,MF,
1707,GO:0004300,1,0.369970421566456,0,8,enoyl-CoA hydratase activity,MF,
1714,GO:0004308,1,0.601573293306301,0,4,exo-alpha-sialidase activity,MF,
1715,GO:0004309,1,0.596095899989321,0,4,exopolyphosphatase activity,MF,
1718,GO:0004312,1,0.323334022752394,0,9,fatty acid synthase activity,MF,
1731,GO:0004331,1,0.600211174435271,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1760,GO:0004366,1,0.52846521045848,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1796,GO:0004439,1,0.360138401074378,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1815,GO:0004468,1,0.599191745149486,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1816,GO:0004470,1,0.606336246126214,0,4,malic enzyme activity,MF,
1821,GO:0004477,1,0.600883928856116,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1830,GO:0004488,1,0.600883928856116,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
1857,GO:0004523,1,0.478398312890142,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1858,GO:0004525,1,0.600136325177009,0,4,ribonuclease III activity,MF,
1859,GO:0004526,1,0.266646408202935,0,11,ribonuclease P activity,MF,
1861,GO:0004528,1,0.604650314615826,0,4,phosphodiesterase I activity,MF,
1870,GO:0004549,1,0.141523475524612,0,16,tRNA-specific ribonuclease activity,MF,
1881,GO:0004565,1,0.600649284595771,0,4,beta-galactosidase activity,MF,
1890,GO:0004576,1,0.294039611316212,0,10,oligosaccharyl transferase activity,MF,
1893,GO:0004579,1,0.330345202456936,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1896,GO:0004583,1,0.600544467695765,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
1903,GO:0004594,1,0.602393802854105,0,4,pantothenate kinase activity,MF,
1905,GO:0004596,1,0.288279462858297,0,10,peptide alpha-N-acetyltransferase activity,MF,
1945,GO:0004652,1,0.359940275120313,0,8,polynucleotide adenylyltransferase activity,MF,
1946,GO:0004653,1,0.21617889161163,0,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,
1966,GO:0004679,1,0.409952952305565,0,7,AMP-activated protein kinase activity,MF,
1970,GO:0004689,1,0.531773087341573,0,5,phosphorylase kinase activity,MF,
1971,GO:0004690,1,0.406929420565599,0,7,cyclic nucleotide-dependent protein kinase activity,MF,
1972,GO:0004691,1,0.462356840543074,0,6,cAMP-dependent protein kinase activity,MF,
1981,GO:0004704,1,0.533960544911275,0,5,NF-kappaB-inducing kinase activity,MF,
1997,GO:0004723,1,0.409093797038939,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
1999,GO:0004726,1,0.364023283088194,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2008,GO:0004738,1,0.531420907773123,0,5,pyruvate dehydrogenase activity,MF,
2014,GO:0004745,1,0.368921472851111,0,8,retinol dehydrogenase activity,MF,
2017,GO:0004749,1,0.602446165787176,0,4,ribose phosphate diphosphokinase activity,MF,
2023,GO:0004758,1,0.529312462064911,0,5,serine C-palmitoyltransferase activity,MF,
2025,GO:0004767,1,0.532402679878174,0,5,sphingomyelin phosphodiesterase activity,MF,
2071,GO:0004826,1,0.531446820877442,0,5,phenylalanine-tRNA ligase activity,MF,
2080,GO:0004839,1,0.52827321326685,0,5,ubiquitin activating enzyme activity,MF,
2083,GO:0004844,1,0.539021623391689,0,5,uracil DNA N-glycosylase activity,MF,
2116,GO:0004908,1,0.532925573782614,0,5,interleukin-1 receptor activity,MF,
2137,GO:0004950,1,0.410756497765448,0,7,chemokine receptor activity,MF,
2140,GO:0004954,1,0.603037366450434,0,4,prostanoid receptor activity,MF,
2187,GO:0005047,1,0.531441751956959,0,5,signal recognition particle binding,MF,
2189,GO:0005049,1,0.35988102345163,0,8,nuclear export signal receptor activity,MF,
2196,GO:0005072,1,0.35817164876271,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2197,GO:0005078,1,0.404954161469132,0,7,MAP-kinase scaffold activity,MF,
2201,GO:0005087,1,0.615097274120019,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2227,GO:0005131,1,0.600495506951137,0,4,growth hormone receptor binding,MF,
2233,GO:0005138,1,0.537083876209848,0,5,interleukin-6 receptor binding,MF,
2238,GO:0005149,1,0.321113381013301,0,9,interleukin-1 receptor binding,MF,
2311,GO:0005310,1,0.0779053104995151,0,20,dicarboxylic acid transmembrane transporter activity,MF,
2312,GO:0005313,1,0.463848481977379,0,6,L-glutamate transmembrane transporter activity,MF,
2325,GO:0005338,1,0.251179115937032,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2329,GO:0005345,1,0.536515610657895,0,5,purine nucleobase transmembrane transporter activity,MF,
2342,GO:0005381,1,0.469053294578046,0,6,iron ion transmembrane transporter activity,MF,
2343,GO:0005384,1,0.600199437441192,0,4,manganese ion transmembrane transporter activity,MF,
2355,GO:0005452,1,0.216194494772217,0,12,inorganic anion exchanger activity,MF,
2378,GO:0005513,1,0.366950502511521,0,8,detection of calcium ion,BP,
2396,GO:0005542,1,0.483611664109657,0,6,folic acid binding,MF,
2418,GO:0005593,1,0.598534531228231,0,4,FACIT collagen trimer,CC,
2434,GO:0005634,1,0,522,5714,nucleus,CC,TNIP1;DUSP6;ZC3H6;DOCK4;GAMT;NT5E;APOE;MARVELD1;ZMYND8;NFATC4;XPC;FHL1;S100A6;FOS;H1F0;GSN;CITED4;EGR1;CTNNBIP1;VWA5A;ALDH7A1;ZNF862;PTK6;GLUL;LRP1;ALOX15B;PDCD4;OBSCN;EGFR;PADI3;ZSCAN18;DDB2;PRNP;NR1D1;ERCC1;HADH;S100A4;PRDX5;BAHCC1;DUSP5;NEK9;FCHO1;ZKSCAN1;NPEPL1;TSPAN1;SLC16A3;KRT15;SLC2A9;CST3;DNM1;MEF2D;NOS1;DDIT3;TSC22D1;BRSK1;DNPH1;DNAJB5;CRTC1;CLCA2;ERCC6;NDRG1;ABTB1;TCEA2;SMARCA1;TRIM65;ZFP36L1;ADARB1;PPM1M;NUPR1;ARAP1;TCFL5;RBL2;RPS6KA2;TFDP2;MXI1;RPL13A;MDFI;MAPK13;KLF9;RNF165;MIF4GD;CDK18;PHACTR3;CPT2;KLHDC2;ASH2L;SOX13;CUL7;LHPP;TMEM92;EPM2A;ATG16L2;ETV4;TXNRD3;WWTR1;POLD4;MAP2K1;MXD4;PPL;PKN1;CAPG;H2AFJ;BTG1;TRNP1;DNASE1L1;PHC2;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TUBG2;FAM110C;ARL2;PHF7;SPRY2;NPHP4;R3HDM2;SOX12;HDAC11;PTMS;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;APPL2;CIRBP;CAPRIN2;TTBK2;PRKCZ;PPP2R3B;PAK1;APOBEC3C;PRR7;ELK3;STK39;BLVRB;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;FOXQ1;ARVCF;PHF1;GLDC;CBS;SALL2;SYNE3;DDX59;WDR27;PDZD2;ETV1;NSUN5P2;NEIL1;ABHD14B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ETV5;NSMCE4A;TRIB2;HES2;CHD2;TEF;SPG11;APBB3;TMC6;PTPRE;RNF44;SSH3;RMI2;CYHR1;OLFM2;DHRS4;CCDC106;NAB2;UNKL;XPOT;FAM50A;CARF;MANF;S100A13;AGAP1;FKBP10;APOBEC3F;PPARA;INO80C;CHD3;CCDC92;SPC24;SESN2;AIP;BLMH;MKNK2;SCMH1;TCF25;SATB1;STAT6;KLF7;R3HDM4;ING4;HMGA2;AREG;JADE2;ACACB;NT5C1B;MAPK3;DEF6;BNIP3;ERRFI1;MACROD1;THRA;DCAF10;STK40;ACSS2;RGS14;IRF2BPL;PBXIP1;SLC22A18;PAN2;CTSB;ZSCAN30;EIF2D;MAPK12;MVB12B;LTA4H;NAT14;ZXDC;CHMP1B;ARHGAP22;MLXIPL;TBC1D14;PTPDC1;TSPYL2;MAP2K2;H1FX;FLYWCH1;SLC50A1;SDHA;TECPR1;LITAF;PTHLH;UBXN4;NOL4L;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LRRC45;LTB4R2;FAM214B;PRIMPOL;FAM193B;POLM;TENM2;REEP6;ZNF516;CBX7;PKD1;NSMCE1;RALGAPA1;FLOT1;CEP68;TTN;PSKH1;HLCS;AZIN2;JDP2;HDAC5;IRF5;SORL1;IL17RD;SRSF5;DHX32;DEAF1;TEP1;NLRP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;NEK8;ACOT7;ATRAID;CREBRF;ZNF251;PKIB;L3MBTL1;PKN3;METTL23;AQP3;ACADS;ISG20;LONP2;EPN3;DGCR6L;HLTF;DNMT3A;TRIOBP;MXD3;TAGLN3;FOXL1;CSRNP3;TMSB4X;SLFN5;PDE2A;SMURF2;LMO7;TRIB3;RAB40B;BHLHE40;ALDH1L2;MLH3;CALCOCO1;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;LDOC1;ZFP90;BNIP3L;PIK3R2;NICN1;ZNF558;ANGEL1;ZNF662;CCS;ERN1;NUDT6;ESRG;MAN2C1;C19ORF33;NBR1;EXD3;TNNI2;TADA3;SPAG16;UCKL1;NECAB3;CAMK1;POLL;TERC;RXRA;ZNF358;ZNF362;MBD1;TNRC18;SPATA7;PRDM8;SLC9A3R2;STRADB;WDR19;ACAD11;PNRC1;UACA;MGMT;TM7SF2;HINT2;MAPKBP1;AKT1;ITPR2;DGUOK;CDKN1C;SWT1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;CHEK2;NFU1;CABYR;TSG101;PHF2;IGF2BP2;ZNF217;PIAS3;ASAP3;PHLDA1;ACADVL;NUCB2;ZNF25;LMNA;UPP1;MAB21L2;ATG2A;C9ORF72;TBC1D20;CHMP5;UHRF2;CAPN2;NPIPA2;SMARCD2;ARHGAP27;IFI27;PTOV1;INSR;NCOA7;NELFCD;TENM4;FOXO4;COG7;YPEL3;RPS6KA5;ADD3;MAGED2;RABGGTA;ITGB6;C6ORF89;CTDSPL;MAP2K5;BRAF;ZNF554;CPSF4;POLR2J2;LETMD1;HOXC5;GJB4;FAAP20;PIDD1;ZNF160;MZT2A;MYOF;MAPK10;MPG;LGALS1;ZFP28;TP73;MTA3;MNT;UBOX5;ZNF846;APRT;TFEB;CERS4;ENDOV;PHC1;SPIRE1;CSNK1E;TAZ;BCL6;HSF4;REC8;RNF213;GSTM3;ADAP1;TKFC;FBXO25;EHD3;FYN;ZC3H12D;LEMD2;UBXN6;SLC25A42;SIRT2;GDF15;RECQL5;FAM220A;HCFC1R1;CELSR1;SH3GLB2;POU2F2;RCOR2;POLR3GL;MTA1;MSH5;CIDEA;HDAC8;ADIRF;RETSAT;TCF7;STX1A;EPAS1;CHD6;EPHB2;NMRAL1;MAGI1;POLR2J3;PER1;LRCH4;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;ZNF333;ERBB2;CCDC69;RGS12;SYVN1;MPPE1;HMBOX1;NET1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;TRIM45;KCTD13;DBP;APBA1;ZNF667;ZNF287;CAMKK1;PNKD;DTD1;IKBKB;DMTF1;HIP1;PLEKHH2;TEAD2;TCTEX1D4;SIX5
2441,GO:0005642,1,0.529806920532586,0,5,annulate lamellae,CC,
2444,GO:0005654,1,0,231,3045,nucleoplasm,CC,TNIP1;DUSP6;NT5E;NFATC4;XPC;FOS;H1F0;CITED4;EGR1;CTNNBIP1;VWA5A;PTK6;OBSCN;DDB2;NR1D1;ERCC1;HADH;BAHCC1;DUSP5;FCHO1;TSPAN1;DNM1;MEF2D;NOS1;DDIT3;BRSK1;CRTC1;ERCC6;TCEA2;SMARCA1;TRIM65;ADARB1;ARAP1;RBL2;RPS6KA2;TFDP2;KLF9;PHACTR3;CPT2;KLHDC2;ASH2L;SOX13;LHPP;TMEM92;ATG16L2;ETV4;WWTR1;POLD4;PKN1;CAPG;PHC2;PHF21A;DGKQ;MAML3;PHF7;SOX12;HDAC11;ITPR3;HSD11B1L;PITPNC1;APPL2;CIRBP;PPP2R3B;ELK3;STK39;BLVRB;KDM3A;PHF1;SALL2;WDR27;NEIL1;RAG1;SPPL2B;NGFR;ETV5;NSMCE4A;CHD2;RNF44;RMI2;CYHR1;OLFM2;XPOT;FAM50A;CARF;PPARA;INO80C;CHD3;CCDC92;AIP;MKNK2;SCMH1;SATB1;STAT6;ING4;HMGA2;JADE2;MAPK3;DEF6;BNIP3;MACROD1;THRA;DCAF10;STK40;ACSS2;RGS14;IRF2BPL;EIF2D;MAPK12;LTA4H;MLXIPL;TBC1D14;PTPDC1;TSPYL2;FLYWCH1;TECPR1;LITAF;PTHLH;NOL4L;ATF4;ZFPM1;KDM4C;LRRC45;LTB4R2;FAM193B;POLM;TENM2;CBX7;NSMCE1;PSKH1;HDAC5;IL17RD;SRSF5;NLRP1;KDM7A;CEBPB;ACOT7;CREBRF;L3MBTL1;ACADS;ISG20;EPN3;HLTF;DNMT3A;SMURF2;BHLHE40;HMG20B;AGO4;BNIP3L;NICN1;MAN2C1;NBR1;TADA3;POLL;TERC;RXRA;MBD1;TNRC18;SPATA7;WDR19;MGMT;AKT1;CRY2;MZT2B;B4GALT2;CHEK2;NFU1;PHF2;ZNF217;PIAS3;ASAP3;LMNA;UPP1;UHRF2;NPIPA2;SMARCD2;ARHGAP27;NELFCD;FOXO4;RPS6KA5;ADD3;RABGGTA;ITGB6;CPSF4;POLR2J2;LETMD1;HOXC5;FAAP20;PIDD1;MZT2A;MAPK10;MPG;TP73;MTA3;MNT;UBOX5;APRT;PHC1;SPIRE1;CSNK1E;BCL6;HSF4;ZC3H12D;SIRT2;RECQL5;HCFC1R1;CELSR1;SH3GLB2;POU2F2;POLR3GL;MTA1;HDAC8;ADIRF;TCF7;EPAS1;CHD6;MAGI1;POLR2J3;PER1;LRCH4;MCTP2;SYVN1;MPPE1;HMBOX1;CREB3L4;IRF2BP2;ZMYM3;TRIM45;KCTD13;DMTF1;PLEKHH2;TEAD2
2445,GO:0005655,1,0.390844825300883,0,8,nucleolar ribonuclease P complex,CC,
2448,GO:0005658,1,0.468472233140756,0,6,alpha DNA polymerase:primase complex,CC,
2449,GO:0005662,1,0.171542416327096,0,14,DNA replication factor A complex,CC,
2450,GO:0005663,1,0.475665896076625,0,6,DNA replication factor C complex,CC,
2451,GO:0005664,1,0.317576729773616,0,9,nuclear origin of replication recognition complex,CC,
2458,GO:0005672,1,0.613762103820302,0,4,transcription factor TFIIA complex,CC,
2461,GO:0005675,1,0.197024550282815,0,13,holo TFIIH complex,CC,
2466,GO:0005683,1,0.446131848869516,0,7,U7 snRNP,CC,
2467,GO:0005684,1,0.000769672539258377,0,58,U2-type spliceosomal complex,CC,
2468,GO:0005685,1,0.0876820357266113,0,20,U1 snRNP,CC,
2469,GO:0005686,1,0.0892607994554821,0,20,U2 snRNP,CC,
2470,GO:0005687,1,0.268698660957081,0,11,U4 snRNP,CC,
2471,GO:0005688,1,0.395838591811432,0,8,U6 snRNP,CC,
2472,GO:0005689,1,0.0446699663482768,0,26,U12-type spliceosomal complex,CC,
2484,GO:0005726,1,0.599942615010014,0,4,perichromatin fibrils,CC,
2488,GO:0005736,1,0.234686752577526,0,12,DNA-directed RNA polymerase I complex,CC,
2493,GO:0005742,1,0.385292817342589,0,8,mitochondrial outer membrane translocase complex,CC,
2495,GO:0005744,1,0.204276477984372,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2498,GO:0005747,1,0.00915483753155539,0,42,mitochondrial respiratory chain complex I,CC,
2500,GO:0005750,1,0.266130410450757,0,11,mitochondrial respiratory chain complex III,CC,
2503,GO:0005757,1,0.613625712552944,0,4,mitochondrial permeability transition pore complex,CC,
2507,GO:0005761,1,5.43494584101407e-05,0,84,mitochondrial ribosome,CC,
2508,GO:0005762,1,0.00260419621089061,0,51,mitochondrial large ribosomal subunit,CC,
2509,GO:0005763,1,0.0376601878112412,0,28,mitochondrial small ribosomal subunit,CC,
2527,GO:0005784,1,0.63245428989473,0,4,Sec61 translocon complex,CC,
2528,GO:0005785,1,0.421816251862803,0,7,signal recognition particle receptor complex,CC,
2529,GO:0005786,1,0.481598237797809,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2530,GO:0005787,1,0.54969318809181,0,5,signal peptidase complex,CC,
2539,GO:0005797,1,0.419011339789673,0,7,Golgi medial cisterna,CC,
2548,GO:0005818,1,0.36006662502828,0,8,aster,CC,
2550,GO:0005826,1,0.528554558987815,0,5,actomyosin contractile ring,CC,
2551,GO:0005827,1,0.529071040250985,0,5,polar microtubule,CC,
2552,GO:0005828,1,0.407848065755912,0,7,kinetochore microtubule,CC,
2557,GO:0005838,1,0.0752230776950688,0,21,proteasome regulatory particle,CC,
2558,GO:0005839,1,0.0984409344589469,0,20,proteasome core complex,CC,
2561,GO:0005845,1,0.254144494313133,0,11,mRNA cap binding complex,CC,
2565,GO:0005850,1,0.600285190473623,0,4,eukaryotic translation initiation factor 2 complex,CC,
2566,GO:0005851,1,0.471666312032378,0,6,eukaryotic translation initiation factor 2B complex,CC,
2567,GO:0005852,1,0.123717116255319,0,17,eukaryotic translation initiation factor 3 complex,CC,
2584,GO:0005879,1,0.531450093146202,0,5,axonemal microtubule,CC,
2590,GO:0005885,1,0.295440875509246,0,10,Arp2/3 protein complex,CC,
2594,GO:0005890,1,0.603037525793235,0,4,sodium:potassium-exchanging ATPase complex,CC,
2596,GO:0005892,1,0.600342879449305,0,4,acetylcholine-gated channel complex,CC,
2609,GO:0005915,1,0.409178992286214,0,7,zonula adherens,CC,
2610,GO:0005916,1,0.46414884868549,0,6,fascia adherens,CC,
2624,GO:0005947,1,0.532839992652443,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2625,GO:0005952,1,0.528664055662332,0,5,cAMP-dependent protein kinase complex,CC,
2628,GO:0005955,1,0.59824849598778,0,4,calcineurin complex,CC,
2632,GO:0005964,1,0.531773087341573,0,5,phosphorylase kinase complex,CC,
2644,GO:0005981,1,0.604080080618199,0,4,regulation of glycogen catabolic process,BP,
2651,GO:0005997,1,0.617834157721033,0,4,xylulose metabolic process,BP,
2657,GO:0006003,1,0.600211174435271,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2661,GO:0006011,1,0.46765655742187,0,6,UDP-glucose metabolic process,BP,
2677,GO:0006041,1,0.60268377756827,0,4,glucosamine metabolic process,BP,
2682,GO:0006047,1,0.19262175397611,0,13,UDP-N-acetylglucosamine metabolic process,BP,
2683,GO:0006048,1,0.320441826980107,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2687,GO:0006054,1,0.284239384037128,0,10,N-acetylneuraminate metabolic process,BP,
2700,GO:0006068,1,0.41741535055529,0,7,ethanol catabolic process,BP,
2703,GO:0006072,1,0.407652938190415,0,7,glycerol-3-phosphate metabolic process,BP,
2710,GO:0006086,1,0.191098664924751,0,13,acetyl-CoA biosynthetic process from pyruvate,BP,
2726,GO:0006108,1,0.475371842478872,0,6,malate metabolic process,BP,
2736,GO:0006120,1,0.00625503179589693,0,45,mitochondrial electron transport, NADH to ubiquinone,BP,
2738,GO:0006122,1,0.206738796590233,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2739,GO:0006123,1,0.214209187636558,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2741,GO:0006139,1,0,397,4613,nucleobase-containing compound metabolic process,BP,TNIP1;XDH;H6PD;DLG4;ZC3H6;HTRA1;GAMT;F2R;NT5E;NYNRIN;APOE;ZMYND8;NFATC4;XPC;FOS;H1F0;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;NAPRT;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;DDB2;PRNP;NR1D1;ERCC1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;IGFBP4;IDH2;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;DHTKD1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;ASH2L;SOX13;LHPP;ETV4;WWTR1;POLD4;MAP2K1;PCK2;MXD4;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;DNASE1L1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;MAGEF1;SHC1;OGDHL;SOX12;HDAC11;PTMS;NMRK1;CIRBP;CAPRIN2;PRKCZ;APOBEC3C;AARS;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;NPR2;CBS;SALL2;DLG3;NMNAT2;DDX59;NME4;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;ACVR2B;RAG1;EAPP;NGFR;ETV5;PPCS;NSMCE4A;HES2;EREG;CHD2;TEF;APBB3;RMI2;NAB2;UNKL;ABCG1;TRAPPC9;CARF;CARS;APOBEC3F;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;RRNAD1;HMGA2;AREG;ECM1;NT5C1B;KCNAB2;MAPK3;TRPT1;MACROD1;THRA;RGS14;IRF2BPL;FAM20C;TDRKH;PBXIP1;PAN2;ZSCAN30;MAPK12;MYH3;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SDHA;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;FBXO6;ZNF516;CBX7;PKD1;NSMCE1;MDK;JDP2;HDAC5;GTPBP1;IRF5;GALK1;TFB1M;PCBP4;SRSF5;VLDLR;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;ISG20;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;RPUSD3;ZNF662;GAS6;ERN1;MAPRE3;EXD3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;MGMT;ENTPD6;MAPKBP1;AKT1;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;LACTB2;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;ZNF25;DNASE2;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;MPG;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;MPI;ENDOV;CSNK1E;TAZ;BCL6;HSF4;REC8;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;MSH5;ENTPD2;FUK;CIDEA;HDAC8;MYO18A;ADIRF;RPL29;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;IGF2BP3;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;KCTD13;DBP;ZNF667;ZNF287;DTD1;IKBKB;DMTF1;HIP1;TEAD2;SIX5
2761,GO:0006177,1,0.535560827949015,0,5,GMP biosynthetic process,BP,
2767,GO:0006188,1,0.283715869997536,0,10,IMP biosynthetic process,BP,
2768,GO:0006189,1,0.468494685047441,0,6,'de novo' IMP biosynthetic process,BP,
2775,GO:0006207,1,0.464530453794018,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2792,GO:0006235,1,0.615946914039438,0,4,dTTP biosynthetic process,BP,
2803,GO:0006265,1,0.319779541838522,0,9,DNA topological change,BP,
2806,GO:0006268,1,0.410374510630107,0,7,DNA unwinding involved in DNA replication,BP,
2808,GO:0006270,1,0.00564136250159165,0,41,DNA replication initiation,BP,
2809,GO:0006271,1,0.0818905328258139,0,20,DNA strand elongation involved in DNA replication,BP,
2811,GO:0006273,1,0.250384862826651,0,11,lagging strand elongation,BP,
2847,GO:0006335,1,0.032348579426747,0,32,DNA replication-dependent nucleosome assembly,BP,
2848,GO:0006336,1,0.00275610370731483,0,50,DNA replication-independent nucleosome assembly,BP,
2853,GO:0006344,1,0.599277374396924,0,4,maintenance of chromatin silencing,BP,
2874,GO:0006370,1,0.0193903566684758,0,32,7-methylguanosine mRNA capping,BP,
2880,GO:0006384,1,0.414810907165182,0,7,transcription initiation from RNA polymerase III promoter,BP,
2883,GO:0006390,1,0.194440074895482,0,13,mitochondrial transcription,BP,
2886,GO:0006396,1,0,25,876,RNA processing,BP,EGFR;ZFP36L1;ADARB1;RPL13A;MAP2K1;AARS;PABPC1L;NSUN5P2;RRNAD1;TRPT1;PAN2;MAP2K2;TFB1M;SRSF5;DHX32;TEP1;ISG20;AGO4;RPUSD3;ERN1;MAPKBP1;CPSF4;CSNK1E;RPL29;RPL12
2888,GO:0006398,1,0.530612174227599,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2903,GO:0006415,1,7.21812429956581e-06,0,100,translational termination,BP,
2919,GO:0006432,1,0.531446820877442,0,5,phenylalanyl-tRNA aminoacylation,BP,
2928,GO:0006448,1,0.116753557130377,0,17,regulation of translational elongation,BP,
2929,GO:0006449,1,0.413280246443293,0,7,regulation of translational termination,BP,
2931,GO:0006451,1,0.36347621367992,0,8,translational readthrough,BP,
2943,GO:0006474,1,0.172013226512998,0,14,N-terminal protein amino acid acetylation,BP,
2960,GO:0006498,1,0.528174001687492,0,5,N-terminal protein lipidation,BP,
2961,GO:0006499,1,0.599500258046526,0,4,N-terminal protein myristoylation,BP,
2999,GO:0006547,1,0.600629436276767,0,4,histidine metabolic process,BP,
3001,GO:0006549,1,0.60350160568052,0,4,isoleucine metabolic process,BP,
3010,GO:0006558,1,0.620926742983275,0,4,L-phenylalanine metabolic process,BP,
3011,GO:0006559,1,0.620926742983275,0,4,L-phenylalanine catabolic process,BP,
3020,GO:0006568,1,0.534645673997125,0,5,tryptophan metabolic process,BP,
3022,GO:0006570,1,0.612539646684038,0,4,tyrosine metabolic process,BP,
3034,GO:0006586,1,0.534645673997125,0,5,indolalkylamine metabolic process,BP,
3036,GO:0006590,1,0.279198109626488,0,10,thyroid hormone generation,BP,
3047,GO:0006607,1,0.0772817582996969,0,20,NLS-bearing protein import into nucleus,BP,
3048,GO:0006610,1,0.368005925980641,0,8,ribosomal protein import into nucleus,BP,
3053,GO:0006616,1,0.491723854432369,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3055,GO:0006620,1,0.423250915940713,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3056,GO:0006621,1,0.365980013700111,0,8,protein retention in ER lumen,BP,
3062,GO:0006627,1,0.479122556328499,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3094,GO:0006670,1,0.289741170257059,0,10,sphingosine metabolic process,BP,
3098,GO:0006678,1,0.412119570504455,0,7,glucosylceramide metabolic process,BP,
3101,GO:0006681,1,0.466933479869622,0,6,galactosylceramide metabolic process,BP,
3105,GO:0006685,1,0.530362447297271,0,5,sphingomyelin catabolic process,BP,
3123,GO:0006705,1,0.528463716066181,0,5,mineralocorticoid biosynthetic process,BP,
3132,GO:0006725,1,0,412,4730,cellular aromatic compound metabolic process,BP,TNIP1;XDH;H6PD;DLG4;ZC3H6;HTRA1;GAMT;F2R;NT5E;NYNRIN;APOE;ZMYND8;NFATC4;XPC;FOS;H1F0;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;NAPRT;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;DDB2;PRNP;NR1D1;ERCC1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;IGFBP4;SLC2A9;IDH2;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;DHTKD1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;ASH2L;SOX13;LHPP;PRSS3;UROS;ETV4;WWTR1;POLD4;MAP2K1;PCK2;MXD4;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;DNASE1L1;ITGA6;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MAML3;TMEM173;THAP8;MAGEF1;SHC1;OGDHL;SOX12;HDAC11;PTMS;NMRK1;CIRBP;CAPRIN2;PRKCZ;APOBEC3C;AARS;ELK3;PABPC1L;BLVRB;SEC14L2;BRD3;KDM3A;MTHFR;FOXQ1;PHF1;NPR2;CBS;SALL2;DLG3;NMNAT2;DDX59;NME4;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;ACVR2B;RAG1;EAPP;NGFR;ETV5;PPCS;NSMCE4A;HES2;EREG;CHD2;TEF;PSAT1;APBB3;RMI2;NAB2;UNKL;ABCG1;TRAPPC9;CARF;CARS;APOBEC3F;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;RRNAD1;HMGA2;AREG;ECM1;NT5C1B;KCNAB2;MAPK3;TRPT1;MACROD1;THRA;RGS14;IRF2BPL;FAM20C;TDRKH;PBXIP1;PAN2;ZSCAN30;MAPK12;MYH3;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SDHA;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;FBXO6;ZNF516;CBX7;PKD1;NSMCE1;MDK;JDP2;HDAC5;GTPBP1;IRF5;GALK1;TFB1M;PCBP4;SRSF5;GSTM2;VLDLR;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;ISG20;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;RPUSD3;ZNF662;GAS6;ERN1;MAPRE3;EXD3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;MGMT;ENTPD6;MAPKBP1;AKT1;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;LACTB2;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;CBR4;ZNF25;DNASE2;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;ALDH1L1;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;MPG;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;MPI;ENDOV;CSNK1E;TAZ;BCL6;HSF4;REC8;GSTM3;ZC3H12D;LEMD2;SIRT2;TRPC1;GDF15;RECQL5;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;MSH5;ENTPD2;FUK;CIDEA;HDAC8;MYO18A;ADIRF;RPL29;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;IGF2BP3;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;KCTD13;DBP;ZNF667;ZNF287;PNKD;DTD1;IKBKB;DMTF1;SNCB;HIP1;TEAD2;SIX5
3134,GO:0006729,1,0.427389519437642,0,7,tetrahydrobiopterin biosynthetic process,BP,
3145,GO:0006743,1,0.156317347285836,0,15,ubiquinone metabolic process,BP,
3146,GO:0006744,1,0.17763565210453,0,14,ubiquinone biosynthetic process,BP,
3177,GO:0006797,1,0.524740371850358,0,5,polyphosphate metabolic process,BP,
3178,GO:0006798,1,0.596095899989321,0,4,polyphosphate catabolic process,BP,
3203,GO:0006842,1,0.603123264512943,0,4,tricarboxylic acid transport,BP,
3208,GO:0006851,1,0.0803330182854371,0,20,mitochondrial calcium ion transmembrane transport,BP,
3211,GO:0006857,1,0.362284786571871,0,8,oligopeptide transport,BP,
3214,GO:0006863,1,0.475560971971602,0,6,purine nucleobase transport,BP,
3237,GO:0006895,1,0.08717936049391,0,19,Golgi to endosome transport,BP,
3256,GO:0006925,1,0.197172884191378,0,13,inflammatory cell apoptotic process,BP,
3259,GO:0006930,1,0.361048039629723,0,8,substrate-dependent cell migration, cell extension,BP,
3294,GO:0006991,1,0.318175906178117,0,9,response to sterol depletion,BP,
3299,GO:0006999,1,0.149265992321098,0,15,nuclear pore organization,BP,
3300,GO:0007000,1,0.416700710618003,0,7,nucleolus organization,BP,
3316,GO:0007023,1,0.61687538516875,0,4,post-chaperonin tubulin folding pathway,BP,
3318,GO:0007028,1,0.35999326053663,0,8,cytoplasm organization,BP,
3329,GO:0007042,1,0.375331203739965,0,8,lysosomal lumen acidification,BP,
3343,GO:0007064,1,0.0615437380504015,0,22,mitotic sister chromatid cohesion,BP,
3352,GO:0007089,1,0.602003768380763,0,4,traversing start control point of mitotic cell cycle,BP,
3353,GO:0007091,1,0.00239222326651333,0,48,metaphase/anaphase transition of mitotic cell cycle,BP,
3355,GO:0007094,1,0.0256046314616646,0,29,mitotic spindle assembly checkpoint,BP,
3358,GO:0007097,1,0.127144880530291,0,16,nuclear migration,BP,
3360,GO:0007099,1,0.0255356679132944,0,29,centriole replication,BP,
3367,GO:0007135,1,0.4728221726196,0,6,meiosis II,BP,
3391,GO:0007172,1,0.410241240890031,0,7,signal complex assembly,BP,
3400,GO:0007183,1,0.248305200572803,0,11,SMAD protein complex assembly,BP,
3429,GO:0007220,1,0.151459113143892,0,15,Notch receptor processing,BP,
3469,GO:0007296,1,0.601279286002215,0,4,vitellogenesis,BP,
3483,GO:0007351,1,0.318535754095359,0,9,tripartite regional subdivision,BP,
3490,GO:0007379,1,0.248612116436182,0,11,segment specification,BP,
3491,GO:0007386,1,0.527987636430407,0,5,compartment pattern specification,BP,
3539,GO:0007549,1,0.21701925780689,0,12,dosage compensation,BP,
3560,GO:0007603,1,0.131194083363081,0,16,phototransduction, visible light,BP,
3595,GO:0008024,1,0.360187127431747,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3599,GO:0008035,1,0.600666786830847,0,4,high-density lipoprotein particle binding,MF,
3613,GO:0008063,1,0.60049970125611,0,4,Toll signaling pathway,BP,
3616,GO:0008066,1,0.599407935297915,0,4,glutamate receptor activity,MF,
3621,GO:0008079,1,0.467333002432564,0,6,translation termination factor activity,MF,
3627,GO:0008090,1,0.412501547883486,0,7,retrograde axonal transport,BP,
3645,GO:0008121,1,0.43844914762908,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3652,GO:0008137,1,0.014674444006657,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3654,GO:0008139,1,0.0531933442240716,0,23,nuclear localization sequence binding,MF,
3657,GO:0008143,1,0.169429558620434,0,14,poly(A) binding,MF,
3673,GO:0008174,1,0.31888807707975,0,9,mRNA methyltransferase activity,MF,
3674,GO:0008175,1,0.0287639028312928,0,28,tRNA methyltransferase activity,MF,
3677,GO:0008179,1,0.280649505627349,0,10,adenylate cyclase binding,MF,
3681,GO:0008187,1,0.0782876352950665,0,20,poly-pyrimidine tract binding,MF,
3688,GO:0008195,1,0.317156826827497,0,9,phosphatidate phosphatase activity,MF,
3701,GO:0008212,1,0.528463716066181,0,5,mineralocorticoid metabolic process,BP,
3720,GO:0008250,1,0.236763887055217,0,12,oligosaccharyltransferase complex,CC,
3728,GO:0008266,1,0.130540242839162,0,16,poly(U) RNA binding,MF,
3732,GO:0008271,1,0.527807779353325,0,5,secondary active sulfate transmembrane transporter activity,MF,
3733,GO:0008272,1,0.409819549325259,0,7,sulfate transport,BP,
3736,GO:0008275,1,0.600273583391053,0,4,gamma-tubulin small complex,CC,
3750,GO:0008295,1,0.608792020679329,0,4,spermidine biosynthetic process,BP,
3761,GO:0008309,1,0.605470165833222,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3764,GO:0008312,1,0.424204331162224,0,7,7S RNA binding,MF,
3766,GO:0008320,1,0.189805341128975,0,14,protein transmembrane transporter activity,MF,
3772,GO:0008330,1,0.604031613944301,0,4,protein tyrosine/threonine phosphatase activity,MF,
3776,GO:0008334,1,0.0524421591773754,0,24,histone mRNA metabolic process,BP,
3784,GO:0008353,1,0.134887804697302,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3785,GO:0008354,1,0.409690405696178,0,7,germ cell migration,BP,
3812,GO:0008409,1,0.129185925735244,0,16,5'-3' exonuclease activity,MF,
3815,GO:0008417,1,0.279652749343686,0,10,fucosyltransferase activity,MF,
3828,GO:0008432,1,0.369737509007596,0,8,JUN kinase binding,MF,
3830,GO:0008440,1,0.601863040036188,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
3850,GO:0008469,1,0.363540520851989,0,8,histone-arginine N-methyltransferase activity,MF,
3856,GO:0008479,1,0.616905331761112,0,4,queuine tRNA-ribosyltransferase activity,MF,
3861,GO:0008486,1,0.606378799054077,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
3868,GO:0008499,1,0.282740197360679,0,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3875,GO:0008510,1,0.527598664212179,0,5,sodium:bicarbonate symporter activity,MF,
3880,GO:0008517,1,0.600203748147708,0,4,folic acid transmembrane transporter activity,MF,
3888,GO:0008527,1,0.440063289567792,0,7,taste receptor activity,MF,
3892,GO:0008534,1,0.621892043068662,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
3896,GO:0008540,1,0.227747122125431,0,12,proteasome regulatory particle, base subcomplex,CC,
3897,GO:0008541,1,0.421306124907359,0,7,proteasome regulatory particle, lid subcomplex,CC,
3902,GO:0008553,1,0.322711935844318,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3905,GO:0008559,1,0.600055650424687,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
3907,GO:0008568,1,0.280743611428694,0,10,microtubule-severing ATPase activity,MF,
3919,GO:0008595,1,0.318535754095359,0,9,anterior/posterior axis specification, embryo,BP,
3921,GO:0008603,1,0.530574917891888,0,5,cAMP-dependent protein kinase regulator activity,MF,
3932,GO:0008622,1,0.541312185856189,0,5,epsilon DNA polymerase complex,CC,
3939,GO:0008635,1,0.324431069515888,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3941,GO:0008641,1,0.280221458638894,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3978,GO:0008821,1,0.325161415461629,0,9,crossover junction endodeoxyribonuclease activity,MF,
3984,GO:0008853,1,0.609370597394947,0,4,exodeoxyribonuclease III activity,MF,
3997,GO:0008934,1,0.603617672162802,0,4,inositol monophosphate 1-phosphatase activity,MF,
4000,GO:0008948,1,0.603005899704885,0,4,oxaloacetate decarboxylase activity,MF,
4004,GO:0008970,1,0.409961156371097,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4012,GO:0009019,1,0.600415210464477,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4016,GO:0009048,1,0.279380529409245,0,10,dosage compensation by inactivation of X chromosome,BP,
4018,GO:0009052,1,0.535828917111748,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4036,GO:0009072,1,0.258405638157518,0,11,aromatic amino acid family metabolic process,BP,
4037,GO:0009074,1,0.377409665800074,0,8,aromatic amino acid family catabolic process,BP,
4075,GO:0009133,1,0.616753813864679,0,4,nucleoside diphosphate biosynthetic process,BP,
4114,GO:0009176,1,0.535671866388653,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4115,GO:0009177,1,0.535671866388653,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4137,GO:0009202,1,0.477857643334339,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4145,GO:0009211,1,0.484187983458911,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4146,GO:0009212,1,0.615946914039438,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4155,GO:0009221,1,0.372900053266518,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4171,GO:0009249,1,0.443492924413826,0,7,protein lipoylation,BP,
4182,GO:0009263,1,0.200091048377453,0,13,deoxyribonucleotide biosynthetic process,BP,
4184,GO:0009265,1,0.29349895708449,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4192,GO:0009303,1,0.0383030450074581,0,26,rRNA transcription,BP,
4193,GO:0009304,1,0.415534824559366,0,7,tRNA transcription,BP,
4203,GO:0009328,1,0.602247920648015,0,4,phenylalanine-tRNA ligase complex,CC,
4217,GO:0009395,1,0.0294262186762589,0,28,phospholipid catabolic process,BP,
4218,GO:0009396,1,0.327698361275224,0,9,folic acid-containing compound biosynthetic process,BP,
4244,GO:0009448,1,0.600336412705983,0,4,gamma-aminobutyric acid metabolic process,BP,
4248,GO:0009452,1,0.0170613488784077,0,33,7-methylguanosine RNA capping,BP,
4255,GO:0009595,1,0.321382055117817,0,9,detection of biotic stimulus,BP,
4256,GO:0009597,1,0.529800253468021,0,5,detection of virus,BP,
4287,GO:0009713,1,0.323484125517376,0,9,catechol-containing compound biosynthetic process,BP,
4298,GO:0009750,1,0.602180661308809,0,4,response to fructose,BP,
4311,GO:0009794,1,0.604436624187372,0,4,regulation of mitotic cell cycle, embryonic,BP,
4316,GO:0009812,1,0.366995665061151,0,8,flavonoid metabolic process,BP,
4330,GO:0009886,1,0.288007840901078,0,10,post-embryonic animal morphogenesis,BP,
4343,GO:0009912,1,0.535616190522703,0,5,auditory receptor cell fate commitment,BP,
4347,GO:0009922,1,0.531814387460337,0,5,fatty acid elongase activity,MF,
4372,GO:0010002,1,0.359578808961418,0,8,cardioblast differentiation,BP,
4377,GO:0010032,1,0.527988790429964,0,5,meiotic chromosome condensation,BP,
4384,GO:0010041,1,0.536249079903094,0,5,response to iron(III) ion,BP,
4387,GO:0010044,1,0.603506983022011,0,4,response to aluminum ion,BP,
4427,GO:0010265,1,0.476738515178919,0,6,SCF complex assembly,BP,
4430,GO:0010273,1,0.580496064377757,0,5,detoxification of copper ion,BP,
4431,GO:0010286,1,0.541077536534997,0,5,heat acclimation,BP,
4434,GO:0010310,1,0.31988849630384,0,9,regulation of hydrogen peroxide metabolic process,BP,
4435,GO:0010314,1,0.282573303164626,0,10,phosphatidylinositol-5-phosphate binding,MF,
4455,GO:0010452,1,0.314000972745229,0,9,histone H3-K36 methylation,BP,
4458,GO:0010455,1,0.609481717318869,0,4,positive regulation of cell fate commitment,BP,
4461,GO:0010459,1,0.611062922164141,0,4,negative regulation of heart rate,BP,
4467,GO:0010467,1,0,367,4267,gene expression,BP,TNIP1;XDH;ACTA2;ZC3H6;HTRA1;BBS2;F2R;APOE;ZMYND8;NFATC4;SERPINE2;FOS;GSN;CITED4;EGR1;CTNNBIP1;LMF1;TYSND1;ZNF862;WWC3;GJC2;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;ANK3;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;SMARCA1;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;CNTN1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;PLAT;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;PRSS3;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;MAGEF1;SHC1;SPRY2;GRB7;ADM2;SOX12;HDAC11;PCSK1;UNK;CIRBP;CAPRIN2;PRKCZ;SERPING1;AARS;ELK3;PABPC1L;ERO1B;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;NSUN5P2;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;CARS;C5;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;RRNAD1;HMGA2;SLIT3;ECM1;ACACB;MAPK3;TRPT1;PC;THRA;STK40;RGS14;IRF2BPL;TDRKH;PBXIP1;PAN2;ZSCAN30;EIF2D;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SLC50A1;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;TENM2;ZNF516;CBX7;PKD1;MDK;TTN;JDP2;HDAC5;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;SRSF5;VLDLR;ADGRF1;DHX32;DEAF1;TEP1;PEG3;GLI4;RFX2;KDM7A;CEBPB;RHBDF1;LRP5;ATRAID;CREBRF;PCSK9;ZNF251;L3MBTL1;FBXL15;METTL23;ISG20;LONP2;HLTF;DNMT3A;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;RHBDF2;ZNF558;RPUSD3;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;CTSH;PNRC1;PAIP2B;MAPKBP1;AKT1;CARD11;CDKN1C;SWT1;CRY2;CHEK2;IFT57;NFU1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ZNF25;UHRF2;CAPN2;SMARCD2;IFI27;PTOV1;PLAU;INSR;WNT3;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;BRAF;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;LSM14B;CSNK1E;BCL6;HSF4;RPL39L;FYN;ZC3H12D;LEMD2;SIRT2;GDF15;PHLDA2;RECQL5;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;TGFBR3;CIDEB;TCF7;EPAS1;MAP3K10;CHD6;DHPS;EPHB2;POLR2J3;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;APBA1;ZNF667;ZNF287;IKBKB;DMTF1;HIP1;TEAD2;SIX5
4473,GO:0010484,1,0.597078408679805,0,4,H3 histone acetyltransferase activity,MF,
4474,GO:0010485,1,0.100511150209996,0,18,H4 histone acetyltransferase activity,MF,
4477,GO:0010499,1,0.0762472495196031,0,22,proteasomal ubiquitin-independent protein catabolic process,BP,
4483,GO:0010510,1,0.246648490347348,0,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4489,GO:0010519,1,0.472925433176042,0,6,negative regulation of phospholipase activity,BP,
4520,GO:0010587,1,0.528340564620474,0,5,miRNA catabolic process,BP,
4527,GO:0010603,1,0.408184527015377,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4530,GO:0010606,1,0.526980923065827,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4535,GO:0010613,1,0.089216523232762,0,19,positive regulation of cardiac muscle hypertrophy,BP,
4540,GO:0010623,1,0.415370924621358,0,7,programmed cell death involved in cell development,BP,
4541,GO:0010624,1,0.598058233436181,0,4,regulation of Schwann cell proliferation,BP,
4542,GO:0010626,1,0.598058233436181,0,4,negative regulation of Schwann cell proliferation,BP,
4599,GO:0010719,1,0.105094766518649,0,18,negative regulation of epithelial to mesenchymal transition,BP,
4605,GO:0010727,1,0.600414456532718,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
4606,GO:0010728,1,0.60132390552786,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4645,GO:0010792,1,0.465333476112843,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4646,GO:0010793,1,0.528063951437565,0,5,regulation of mRNA export from nucleus,BP,
4665,GO:0010818,1,0.291569692309491,0,10,T cell chemotaxis,BP,
4666,GO:0010819,1,0.425429618855936,0,7,regulation of T cell chemotaxis,BP,
4667,GO:0010820,1,0.425429618855936,0,7,positive regulation of T cell chemotaxis,BP,
4672,GO:0010825,1,0.465203238262367,0,6,positive regulation of centrosome duplication,BP,
4673,GO:0010826,1,0.223503567614166,0,12,negative regulation of centrosome duplication,BP,
4681,GO:0010835,1,0.411812709411696,0,7,regulation of protein ADP-ribosylation,BP,
4684,GO:0010838,1,0.528223611992892,0,5,positive regulation of keratinocyte proliferation,BP,
4688,GO:0010847,1,0.601109253811434,0,4,regulation of chromatin assembly,BP,
4700,GO:0010867,1,0.31946782777015,0,9,positive regulation of triglyceride biosynthetic process,BP,
4703,GO:0010870,1,0.286478837668998,0,10,positive regulation of receptor biosynthetic process,BP,
4738,GO:0010911,1,0.409605939582145,0,7,regulation of isomerase activity,BP,
4739,GO:0010912,1,0.409605939582145,0,7,positive regulation of isomerase activity,BP,
4753,GO:0010935,1,0.367100922547065,0,8,regulation of macrophage cytokine production,BP,
4754,GO:0010936,1,0.533698337410932,0,5,negative regulation of macrophage cytokine production,BP,
4759,GO:0010944,1,0.477452391667187,0,6,negative regulation of transcription by competitive promoter binding,BP,
4768,GO:0010958,1,0.601054194227583,0,4,regulation of amino acid import across plasma membrane,BP,
4774,GO:0010965,1,0.00214813157945958,0,49,regulation of mitotic sister chromatid separation,BP,
4790,GO:0010986,1,0.603136418469465,0,4,positive regulation of lipoprotein particle clearance,BP,
4795,GO:0010992,1,0.421630147075368,0,7,ubiquitin recycling,BP,
4796,GO:0010994,1,0.544375216574675,0,5,free ubiquitin chain polymerization,BP,
4798,GO:0010997,1,0.530801209542723,0,5,anaphase-promoting complex binding,MF,
4811,GO:0014010,1,0.526305659919672,0,5,Schwann cell proliferation,BP,
4813,GO:0014012,1,0.611566118448388,0,4,peripheral nervous system axon regeneration,BP,
4821,GO:0014029,1,0.283863670277277,0,10,neural crest formation,BP,
4830,GO:0014041,1,0.414986939773873,0,7,regulation of neuron maturation,BP,
4831,GO:0014042,1,0.598896069694158,0,4,positive regulation of neuron maturation,BP,
4835,GO:0014046,1,0.329726912572376,0,9,dopamine secretion,BP,
4843,GO:0014059,1,0.329726912572376,0,9,regulation of dopamine secretion,BP,
4876,GO:0014742,1,0.089216523232762,0,19,positive regulation of muscle hypertrophy,BP,
4883,GO:0014807,1,0.46638743984692,0,6,regulation of somitogenesis,BP,
4891,GO:0014821,1,0.541387889579608,0,5,phasic smooth muscle contraction,BP,
4938,GO:0014904,1,0.150282423099629,0,15,myotube cell development,BP,
4947,GO:0015014,1,0.599504942027761,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4948,GO:0015015,1,0.600945221603841,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
4974,GO:0015095,1,0.130549733218606,0,16,magnesium ion transmembrane transporter activity,MF,
4979,GO:0015106,1,0.245039854972162,0,11,bicarbonate transmembrane transporter activity,MF,
4984,GO:0015116,1,0.465595071722366,0,6,sulfate transmembrane transporter activity,MF,
4993,GO:0015137,1,0.603123264512943,0,4,citrate transmembrane transporter activity,MF,
4996,GO:0015142,1,0.603123264512943,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5004,GO:0015165,1,0.324194464378178,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5008,GO:0015172,1,0.463848481977379,0,6,acidic amino acid transmembrane transporter activity,MF,
5013,GO:0015180,1,0.528424110446669,0,5,L-alanine transmembrane transporter activity,MF,
5024,GO:0015193,1,0.528289246193819,0,5,L-proline transmembrane transporter activity,MF,
5025,GO:0015194,1,0.411927422624686,0,7,L-serine transmembrane transporter activity,MF,
5030,GO:0015205,1,0.471985931597232,0,6,nucleobase transmembrane transporter activity,MF,
5037,GO:0015220,1,0.600476576563172,0,4,choline transmembrane transporter activity,MF,
5039,GO:0015226,1,0.602122157700577,0,4,carnitine transmembrane transporter activity,MF,
5063,GO:0015288,1,0.474394796504058,0,6,porin activity,MF,
5090,GO:0015368,1,0.465085329800668,0,6,calcium:cation antiporter activity,MF,
5112,GO:0015440,1,0.600295744851906,0,4,peptide-transporting ATPase activity,MF,
5113,GO:0015450,1,0.443212815992025,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5124,GO:0015556,1,0.411523343811442,0,7,C4-dicarboxylate transmembrane transporter activity,MF,
5125,GO:0015562,1,0.599560333498475,0,4,efflux transmembrane transporter activity,MF,
5128,GO:0015616,1,0.596807754958278,0,4,DNA translocase activity,MF,
5132,GO:0015643,1,0.467736824973404,0,6,toxic substance binding,MF,
5151,GO:0015693,1,0.130549733218606,0,16,magnesium ion transport,BP,
5158,GO:0015701,1,0.0897048269783756,0,19,bicarbonate transport,BP,
5172,GO:0015732,1,0.372073854192967,0,8,prostaglandin transport,BP,
5179,GO:0015746,1,0.603123264512943,0,4,citrate transport,BP,
5188,GO:0015780,1,0.221190220334496,0,12,nucleotide-sugar transmembrane transport,BP,
5205,GO:0015808,1,0.528424110446669,0,5,L-alanine transport,BP,
5217,GO:0015824,1,0.464936630270737,0,6,proline transport,BP,
5218,GO:0015825,1,0.411927422624686,0,7,L-serine transport,BP,
5231,GO:0015851,1,0.418358086389273,0,7,nucleobase transport,BP,
5232,GO:0015853,1,0.613371049849879,0,4,adenine transport,BP,
5242,GO:0015871,1,0.465041544468818,0,6,choline transport,BP,
5247,GO:0015879,1,0.602122157700577,0,4,carnitine transport,BP,
5251,GO:0015884,1,0.537649657301994,0,5,folic acid transport,BP,
5265,GO:0015917,1,0.599608889550987,0,4,aminophospholipid transport,BP,
5282,GO:0015939,1,0.534582672154527,0,5,pantothenate metabolic process,BP,
5287,GO:0015959,1,0.413954721070931,0,7,diadenosine polyphosphate metabolic process,BP,
5289,GO:0015961,1,0.606378799054077,0,4,diadenosine polyphosphate catabolic process,BP,
5298,GO:0016004,1,0.367216984966401,0,8,phospholipase activator activity,MF,
5305,GO:0016018,1,0.290762427477923,0,10,cyclosporin A binding,MF,
5309,GO:0016024,1,0.191352778093467,0,13,CDP-diacylglycerol biosynthetic process,BP,
5317,GO:0016045,1,0.414821299510458,0,7,detection of bacterium,BP,
5326,GO:0016056,1,0.191327693687619,0,13,rhodopsin mediated signaling pathway,BP,
5329,GO:0016070,1,0,308,3763,RNA metabolic process,BP,TNIP1;ZC3H6;HTRA1;F2R;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;NR1D1;PRDX5;BAHCC1;ZKSCAN1;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;RPL13A;MSRB2;MDFI;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;SOX12;HDAC11;CIRBP;CAPRIN2;PRKCZ;APOBEC3C;AARS;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;DDX59;ETV1;ZP3;NSUN5P2;ABHD14B;ACVR2B;EAPP;NGFR;ETV5;HES2;EREG;CHD2;TEF;APBB3;NAB2;UNKL;ABCG1;TRAPPC9;CARF;CARS;APOBEC3F;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;RRNAD1;HMGA2;ECM1;MAPK3;TRPT1;THRA;RGS14;IRF2BPL;TDRKH;PBXIP1;PAN2;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;PRIMPOL;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;GTPBP1;IRF5;TFB1M;PCBP4;SRSF5;VLDLR;ADGRF1;DHX32;DEAF1;TEP1;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;L3MBTL1;FBXL15;METTL23;ISG20;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;RPUSD3;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;CAMK1;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;MAPKBP1;AKT1;CARD11;CDKN1C;SWT1;CRY2;CHEK2;IFT57;LACTB2;TSG101;PHF2;IGF2BP2;ZNF217;PIAS3;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;ENDOV;CSNK1E;BCL6;HSF4;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;CIDEA;HDAC8;ADIRF;RPL29;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;IGF2BP3;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;DBP;ZNF667;ZNF287;DTD1;IKBKB;DMTF1;HIP1;TEAD2;SIX5
5330,GO:0016071,1,0,24,737,mRNA metabolic process,BP,DDIT3;ZFP36L1;ADARB1;RPL13A;CIRBP;PABPC1L;EREG;PAN2;ATF4;GTPBP1;PCBP4;SRSF5;DHX32;AGO4;RPUSD3;ERN1;PNRC1;AKT1;IGF2BP2;CPSF4;ZC3H12D;RPL29;IGF2BP3;RPL12
5333,GO:0016074,1,0.240702959337605,0,12,snoRNA metabolic process,BP,
5334,GO:0016075,1,0.157969275159146,0,15,rRNA catabolic process,BP,
5336,GO:0016078,1,0.482089431880638,0,6,tRNA catabolic process,BP,
5345,GO:0016102,1,0.474127866219139,0,6,diterpenoid biosynthetic process,BP,
5347,GO:0016114,1,0.325370188610462,0,9,terpenoid biosynthetic process,BP,
5364,GO:0016174,1,0.600796639851524,0,4,NAD(P)H oxidase activity,MF,
5367,GO:0016180,1,0.0649413452691794,0,22,snRNA processing,BP,
5397,GO:0016240,1,0.612001840307087,0,4,autophagosome membrane docking,BP,
5401,GO:0016246,1,0.153904781124828,0,15,RNA interference,BP,
5406,GO:0016255,1,0.411983415147869,0,7,attachment of GPI anchor to protein,BP,
5408,GO:0016259,1,0.601918468588281,0,4,selenocysteine metabolic process,BP,
5412,GO:0016264,1,0.40919927650339,0,7,gap junction assembly,BP,
5416,GO:0016272,1,0.451109072165291,0,7,prefoldin complex,CC,
5417,GO:0016273,1,0.248006913077952,0,11,arginine N-methyltransferase activity,MF,
5418,GO:0016274,1,0.248006913077952,0,11,protein-arginine N-methyltransferase activity,MF,
5422,GO:0016281,1,0.325175536866684,0,9,eukaryotic translation initiation factor 4F complex,CC,
5445,GO:0016322,1,0.465238326331214,0,6,neuron remodeling,BP,
5454,GO:0016338,1,0.370892772042033,0,8,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5457,GO:0016342,1,0.188927848797676,0,13,catenin complex,CC,
5470,GO:0016408,1,0.195263731664208,0,13,C-acyltransferase activity,MF,
5484,GO:0016423,1,0.193755384213973,0,13,tRNA (guanine) methyltransferase activity,MF,
5485,GO:0016426,1,0.601990059951656,0,4,tRNA (adenine) methyltransferase activity,MF,
5486,GO:0016427,1,0.363247348611554,0,8,tRNA (cytosine) methyltransferase activity,MF,
5487,GO:0016428,1,0.604335089800649,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5492,GO:0016435,1,0.616062149043066,0,4,rRNA (guanine) methyltransferase activity,MF,
5500,GO:0016453,1,0.607256865603751,0,4,C-acetyltransferase activity,MF,
5501,GO:0016454,1,0.529312462064911,0,5,C-palmitoyltransferase activity,MF,
5505,GO:0016461,1,0.422786403810108,0,7,unconventional myosin complex,CC,
5519,GO:0016494,1,0.601661883440013,0,4,C-X-C chemokine receptor activity,MF,
5545,GO:0016556,1,0.149988088144443,0,15,mRNA modification,BP,
5549,GO:0016560,1,0.601425122459634,0,4,protein import into peroxisome matrix, docking,BP,
5561,GO:0016578,1,0.071170160236017,0,21,histone deubiquitination,BP,
5563,GO:0016580,1,0.248699161088629,0,11,Sin3 complex,CC,
5565,GO:0016584,1,0.434131727094626,0,7,nucleosome positioning,BP,
5570,GO:0016592,1,0.0126636621279692,0,35,mediator complex,CC,
5571,GO:0016593,1,0.364498495082089,0,8,Cdc73/Paf1 complex,CC,
5579,GO:0016602,1,0.608237544298861,0,4,CCAAT-binding factor complex,CC,
5612,GO:0016670,1,0.409593033809898,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5617,GO:0016679,1,0.385967956585302,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5618,GO:0016681,1,0.43844914762908,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5630,GO:0016717,1,0.528417253605535,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5661,GO:0016775,1,0.54581916312397,0,5,phosphotransferase activity, nitrogenous group as acceptor,MF,
5663,GO:0016778,1,0.602446165787176,0,4,diphosphotransferase activity,MF,
5665,GO:0016780,1,0.104401040560592,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
5683,GO:0016805,1,0.411773591742751,0,7,dipeptidase activity,MF,
5719,GO:0016863,1,0.305710830724365,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
5734,GO:0016886,1,0.280399898415052,0,10,ligase activity, forming phosphoric ester bonds,MF,
5740,GO:0016892,1,0.474612109156883,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5753,GO:0016918,1,0.553918538690556,0,5,retinal binding,MF,
5757,GO:0016926,1,0.410757350421307,0,7,protein desumoylation,BP,
5758,GO:0016929,1,0.464794170630435,0,6,SUMO-specific protease activity,MF,
5766,GO:0016972,1,0.600388378642966,0,4,thiol oxidase activity,MF,
5767,GO:0016973,1,0.286881188672842,0,10,poly(A)+ mRNA export from nucleus,BP,
5770,GO:0016997,1,0.601573293306301,0,4,alpha-sialidase activity,MF,
5791,GO:0017040,1,0.613879838311927,0,4,N-acylsphingosine amidohydrolase activity,MF,
5798,GO:0017056,1,0.0417583614421406,0,25,structural constituent of nuclear pore,MF,
5800,GO:0017059,1,0.364759431438922,0,8,serine C-palmitoyltransferase complex,CC,
5807,GO:0017070,1,0.261552171685653,0,11,U6 snRNA binding,MF,
5821,GO:0017101,1,0.222913445474212,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5823,GO:0017108,1,0.465502392472194,0,6,5'-flap endonuclease activity,MF,
5845,GO:0017146,1,0.599487736875237,0,4,NMDA selective glutamate receptor complex,CC,
5848,GO:0017150,1,0.604103061668995,0,4,tRNA dihydrouridine synthase activity,MF,
5849,GO:0017151,1,0.411027850113528,0,7,DEAD/H-box RNA helicase binding,MF,
5850,GO:0017153,1,0.600326756309402,0,4,sodium:dicarboxylate symporter activity,MF,
5858,GO:0017166,1,0.276258249418512,0,10,vinculin binding,MF,
5860,GO:0017169,1,0.418417978641537,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5865,GO:0017182,1,0.318682726626914,0,9,peptidyl-diphthamide metabolic process,BP,
5866,GO:0017183,1,0.318682726626914,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5867,GO:0017185,1,0.360482337001865,0,8,peptidyl-lysine hydroxylation,BP,
5869,GO:0017187,1,0.616959594257171,0,4,peptidyl-glutamic acid carboxylation,BP,
5870,GO:0017196,1,0.472319291021381,0,6,N-terminal peptidyl-methionine acetylation,BP,
5883,GO:0018026,1,0.318434506318423,0,9,peptidyl-lysine monomethylation,BP,
5889,GO:0018076,1,0.596958508312171,0,4,N-terminal peptidyl-lysine acetylation,BP,
5893,GO:0018103,1,0.477182578715513,0,6,protein C-linked glycosylation,BP,
5907,GO:0018158,1,0.330295115181013,0,9,protein oxidation,BP,
5910,GO:0018171,1,0.61661015516863,0,4,peptidyl-cysteine oxidation,BP,
5919,GO:0018199,1,0.603709149097758,0,4,peptidyl-glutamine modification,BP,
5922,GO:0018202,1,0.251733390282325,0,11,peptidyl-histidine modification,BP,
5924,GO:0018206,1,0.286804304589652,0,10,peptidyl-methionine modification,BP,
5928,GO:0018211,1,0.477182578715513,0,6,peptidyl-tryptophan modification,BP,
5930,GO:0018214,1,0.616959594257171,0,4,protein carboxylation,BP,
5931,GO:0018216,1,0.192109142171868,0,13,peptidyl-arginine methylation,BP,
5935,GO:0018242,1,0.190283110696471,0,13,protein O-linked glycosylation via serine,BP,
5936,GO:0018243,1,0.21617889161163,0,12,protein O-linked glycosylation via threonine,BP,
5949,GO:0018317,1,0.477182578715513,0,6,protein C-linked glycosylation via tryptophan,BP,
5952,GO:0018335,1,0.60032776036264,0,4,protein succinylation,BP,
5960,GO:0018377,1,0.599500258046526,0,4,protein myristoylation,BP,
5965,GO:0018401,1,0.528812845448518,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
5966,GO:0018406,1,0.477182578715513,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5978,GO:0018812,1,0.600559987125195,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
5998,GO:0019042,1,0.250424872880764,0,11,viral latency,BP,
5999,GO:0019043,1,0.323875520193551,0,9,establishment of viral latency,BP,
6003,GO:0019049,1,0.600620191452517,0,4,evasion or tolerance of host defenses by virus,BP,
6023,GO:0019086,1,0.604900251746743,0,4,late viral transcription,BP,
6030,GO:0019103,1,0.479753817483921,0,6,pyrimidine nucleotide binding,MF,
6052,GO:0019203,1,0.530664413386291,0,5,carbohydrate phosphatase activity,MF,
6062,GO:0019215,1,0.250414342047528,0,11,intermediate filament binding,MF,
6078,GO:0019238,1,0.466873088350837,0,6,cyclohydrolase activity,MF,
6086,GO:0019262,1,0.536701913274226,0,5,N-acetylneuraminate catabolic process,BP,
6093,GO:0019317,1,0.465010856308967,0,6,fucose catabolic process,BP,
6097,GO:0019321,1,0.259989438716614,0,11,pentose metabolic process,BP,
6098,GO:0019322,1,0.60830751451268,0,4,pentose biosynthetic process,BP,
6099,GO:0019323,1,0.613504371204945,0,4,pentose catabolic process,BP,
6100,GO:0019336,1,0.531908228686371,0,5,phenol-containing compound catabolic process,BP,
6115,GO:0019367,1,0.531814387460337,0,5,fatty acid elongation, saturated fatty acid,BP,
6116,GO:0019368,1,0.531814387460337,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6119,GO:0019371,1,0.417470529387441,0,7,cyclooxygenase pathway,BP,
6121,GO:0019373,1,0.53012090738453,0,5,epoxygenase P450 pathway,BP,
6122,GO:0019374,1,0.466933479869622,0,6,galactolipid metabolic process,BP,
6156,GO:0019509,1,0.536464348993537,0,5,L-methionine salvage from methylthioadenosine,BP,
6166,GO:0019531,1,0.527807779353325,0,5,oxalate transmembrane transporter activity,MF,
6167,GO:0019532,1,0.527807779353325,0,5,oxalate transport,BP,
6182,GO:0019614,1,0.531908228686371,0,5,catechol-containing compound catabolic process,BP,
6187,GO:0019646,1,0.214209187636558,0,14,aerobic electron transport chain,BP,
6219,GO:0019773,1,0.446896204087969,0,7,proteasome core complex, alpha-subunit complex,CC,
6220,GO:0019774,1,0.323558050940499,0,10,proteasome core complex, beta-subunit complex,CC,
6229,GO:0019784,1,0.422615970847586,0,7,NEDD8-specific protease activity,MF,
6232,GO:0019788,1,0.486047118835124,0,6,NEDD8 transferase activity,MF,
6235,GO:0019798,1,0.465634639807396,0,6,procollagen-proline dioxygenase activity,MF,
6252,GO:0019841,1,0.629281999347198,0,4,retinol binding,MF,
6258,GO:0019856,1,0.464530453794018,0,6,pyrimidine nucleobase biosynthetic process,BP,
6270,GO:0019870,1,0.530798430453913,0,5,potassium channel inhibitor activity,MF,
6281,GO:0019896,1,0.24927623573033,0,11,axonal transport of mitochondrion,BP,
6291,GO:0019907,1,0.41540847618454,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6292,GO:0019908,1,0.132506047471097,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6296,GO:0019918,1,0.600771765727391,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6297,GO:0019919,1,0.412927037498387,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6306,GO:0019956,1,0.220255435255467,0,12,chemokine binding,MF,
6308,GO:0019958,1,0.601602414853568,0,4,C-X-C chemokine binding,MF,
6314,GO:0019966,1,0.418521395862989,0,7,interleukin-1 binding,MF,
6332,GO:0021511,1,0.35959380527405,0,8,spinal cord patterning,BP,
6334,GO:0021513,1,0.408599464049147,0,7,spinal cord dorsal/ventral patterning,BP,
6335,GO:0021514,1,0.599069763797571,0,4,ventral spinal cord interneuron differentiation,BP,
6339,GO:0021520,1,0.466426403494121,0,6,spinal cord motor neuron cell fate specification,BP,
6348,GO:0021534,1,0.532285303936167,0,5,cell proliferation in hindbrain,BP,
6353,GO:0021540,1,0.615110708319042,0,4,corpus callosum morphogenesis,BP,
6361,GO:0021548,1,0.530861552112582,0,5,pons development,BP,
6386,GO:0021591,1,0.119907939873642,0,17,ventricular system development,BP,
6391,GO:0021603,1,0.600391604226062,0,4,cranial nerve formation,BP,
6407,GO:0021670,1,0.366164333024964,0,8,lateral ventricle development,BP,
6420,GO:0021692,1,0.352729689004279,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6422,GO:0021694,1,0.518199671992359,0,5,cerebellar Purkinje cell layer formation,BP,
6429,GO:0021702,1,0.518199671992359,0,5,cerebellar Purkinje cell differentiation,BP,
6447,GO:0021772,1,0.12991430012958,0,16,olfactory bulb development,BP,
6454,GO:0021781,1,0.532231735449301,0,5,glial cell fate commitment,BP,
6459,GO:0021794,1,0.408855081109084,0,7,thalamus development,BP,
6465,GO:0021800,1,0.527850110566185,0,5,cerebral cortex tangential migration,BP,
6468,GO:0021814,1,0.406721338957325,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6469,GO:0021815,1,0.524573954172875,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6472,GO:0021819,1,0.282508318970166,0,10,layer formation in cerebral cortex,BP,
6476,GO:0021825,1,0.599793090795519,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6488,GO:0021854,1,0.255515507074024,0,11,hypothalamus development,BP,
6491,GO:0021859,1,0.529878512905831,0,5,pyramidal neuron differentiation,BP,
6492,GO:0021860,1,0.529878512905831,0,5,pyramidal neuron development,BP,
6493,GO:0021861,1,0.417302680971636,0,7,forebrain radial glial cell differentiation,BP,
6499,GO:0021877,1,0.528348375359549,0,5,forebrain neuron fate commitment,BP,
6500,GO:0021879,1,0.0295425947812789,0,28,forebrain neuron differentiation,BP,
6503,GO:0021884,1,0.133789650338778,0,16,forebrain neuron development,BP,
6507,GO:0021889,1,0.468120125536659,0,6,olfactory bulb interneuron differentiation,BP,
6508,GO:0021891,1,0.528012335024087,0,5,olfactory bulb interneuron development,BP,
6512,GO:0021895,1,0.284777750173089,0,10,cerebral cortex neuron differentiation,BP,
6517,GO:0021903,1,0.531424631287183,0,5,rostrocaudal neural tube patterning,BP,
6519,GO:0021910,1,0.464201685668036,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6522,GO:0021924,1,0.532285303936167,0,5,cell proliferation in external granule layer,BP,
6523,GO:0021930,1,0.532285303936167,0,5,cerebellar granule cell precursor proliferation,BP,
6524,GO:0021932,1,0.408588671934531,0,7,hindbrain radial glia guided cell migration,BP,
6533,GO:0021943,1,0.599311685831052,0,4,formation of radial glial scaffolds,BP,
6539,GO:0021957,1,0.59992933293578,0,4,corticospinal tract morphogenesis,BP,
6544,GO:0021978,1,0.530076977182961,0,5,telencephalon regionalization,BP,
6545,GO:0021979,1,0.609400166857498,0,4,hypothalamus cell differentiation,BP,
6546,GO:0021983,1,0.101473615302364,0,18,pituitary gland development,BP,
6547,GO:0021984,1,0.532145696064609,0,5,adenohypophysis development,BP,
6549,GO:0021988,1,0.114337976113273,0,17,olfactory lobe development,BP,
6553,GO:0021999,1,0.530237271015307,0,5,neural plate anterior/posterior regionalization,BP,
6561,GO:0022027,1,0.59172470050016,0,4,interkinetic nuclear migration,BP,
6562,GO:0022028,1,0.59961163550245,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
6567,GO:0022400,1,0.246938847919692,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6589,GO:0022613,1,5.3218539035225e-11,14,447,ribonucleoprotein complex biogenesis,BP,RPL13A;GRB7;CIRBP;NSUN5P2;RRNAD1;EIF2D;TFB1M;SRSF5;ISG20;AGO4;C9ORF72;CSNK1E;RPL29;RPL12
6591,GO:0022615,1,0.606746816431435,0,4,protein to membrane docking,BP,
6592,GO:0022616,1,0.043187828155423,0,25,DNA strand elongation,BP,
6596,GO:0022624,1,0.0528611255264123,0,24,proteasome accessory complex,CC,
6603,GO:0022824,1,0.409017316044171,0,7,transmitter-gated ion channel activity,MF,
6607,GO:0022835,1,0.409017316044171,0,7,transmitter-gated channel activity,MF,
6620,GO:0022858,1,0.528424110446669,0,5,alanine transmembrane transporter activity,MF,
6621,GO:0022884,1,0.167034804670971,0,15,macromolecule transmembrane transporter activity,MF,
6622,GO:0022889,1,0.411927422624686,0,7,serine transmembrane transporter activity,MF,
6629,GO:0023019,1,0.319175394512581,0,9,signal transduction involved in regulation of gene expression,BP,
6631,GO:0023023,1,0.222861683857705,0,12,MHC protein complex binding,MF,
6634,GO:0023026,1,0.287475640579102,0,10,MHC class II protein complex binding,MF,
6635,GO:0023029,1,0.600768982439864,0,4,MHC class Ib protein binding,MF,
6646,GO:0030002,1,0.46786533215994,0,6,cellular anion homeostasis,BP,
6653,GO:0030014,1,0.148023319802674,0,15,CCR4-NOT complex,CC,
6654,GO:0030015,1,0.528609110879167,0,5,CCR4-NOT core complex,CC,
6666,GO:0030033,1,0.149700717394587,0,15,microvillus assembly,BP,
6673,GO:0030043,1,0.608758063857829,0,4,actin filament fragmentation,BP,
6678,GO:0030050,1,0.461745787706765,0,6,vesicle transport along actin filament,BP,
6684,GO:0030061,1,0.530640449999464,0,5,mitochondrial crista,CC,
6687,GO:0030071,1,0.0035141522958093,0,45,regulation of mitotic metaphase/anaphase transition,BP,
6707,GO:0030124,1,0.605283950143018,0,4,AP-4 adaptor complex,CC,
6727,GO:0030150,1,0.110702155295316,0,18,protein import into mitochondrial matrix,BP,
6745,GO:0030174,1,0.468002673053354,0,6,regulation of DNA-dependent DNA replication initiation,BP,
6793,GO:0030242,1,0.528161455725386,0,5,autophagy of peroxisome,BP,
6795,GO:0030247,1,0.409261338002487,0,7,polysaccharide binding,MF,
6800,GO:0030259,1,0.603372183331545,0,4,lipid glycosylation,BP,
6804,GO:0030263,1,0.60024314848789,0,4,apoptotic chromosome condensation,BP,
6808,GO:0030274,1,0.599974739802785,0,4,LIM domain binding,MF,
6811,GO:0030277,1,0.362899470081543,0,8,maintenance of gastrointestinal epithelium,BP,
6814,GO:0030280,1,0.230955503290477,0,12,structural constituent of epidermis,MF,
6817,GO:0030284,1,0.528437755918356,0,5,estrogen receptor activity,MF,
6820,GO:0030289,1,0.609500797458474,0,4,protein phosphatase 4 complex,CC,
6836,GO:0030309,1,0.364976504593026,0,8,poly-N-acetyllactosamine metabolic process,BP,
6837,GO:0030311,1,0.364976504593026,0,8,poly-N-acetyllactosamine biosynthetic process,BP,
6842,GO:0030318,1,0.189441858938409,0,13,melanocyte differentiation,BP,
6843,GO:0030320,1,0.46786533215994,0,6,cellular monovalent inorganic anion homeostasis,BP,
6854,GO:0030331,1,0.0152365545723129,0,33,estrogen receptor binding,MF,
6882,GO:0030422,1,0.330226937915312,0,9,production of siRNA involved in RNA interference,BP,
6883,GO:0030423,1,0.604161154072806,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
6888,GO:0030430,1,0.602272154857997,0,4,host cell cytoplasm,CC,
6893,GO:0030473,1,0.52451556408037,0,5,nuclear migration along microtubule,BP,
6898,GO:0030488,1,0.0179588619570949,0,32,tRNA methylation,BP,
6899,GO:0030490,1,0.00147450424985275,0,53,maturation of SSU-rRNA,BP,
6901,GO:0030497,1,0.28422266231167,0,10,fatty acid elongation,BP,
6926,GO:0030539,1,0.317050858795498,0,9,male genitalia development,BP,
6927,GO:0030540,1,0.283257496831974,0,10,female genitalia development,BP,
6932,GO:0030548,1,0.48053541573531,0,6,acetylcholine receptor regulator activity,MF,
6941,GO:0030575,1,0.315294851807587,0,9,nuclear body organization,BP,
6943,GO:0030578,1,0.59614751398243,0,4,PML body organization,BP,
6956,GO:0030618,1,0.597599131941107,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
6959,GO:0030621,1,0.465461551394838,0,6,U4 snRNA binding,MF,
6965,GO:0030628,1,0.484490259724433,0,6,pre-mRNA 3'-splice site binding,MF,
6969,GO:0030643,1,0.599751446086948,0,4,cellular phosphate ion homeostasis,BP,
6985,GO:0030673,1,0.315265941118352,0,9,axolemma,CC,
6988,GO:0030677,1,0.209777973096156,0,13,ribonuclease P complex,CC,
6990,GO:0030681,1,0.302913359197449,0,10,multimeric ribonuclease P complex,CC,
6993,GO:0030684,1,9.27715497127669e-05,0,74,preribosome,CC,
6994,GO:0030686,1,0.0180404705621502,0,32,90S preribosome,CC,
6995,GO:0030687,1,0.049643460365818,0,24,preribosome, large subunit precursor,CC,
6996,GO:0030688,1,0.219194026093331,0,12,preribosome, small subunit precursor,CC,
7058,GO:0030854,1,0.535728810271441,0,5,positive regulation of granulocyte differentiation,BP,
7063,GO:0030859,1,0.147492481207932,0,15,polarized epithelial cell differentiation,BP,
7070,GO:0030867,1,0.0494866939204337,0,25,rough endoplasmic reticulum membrane,CC,
7072,GO:0030870,1,0.528748548796591,0,5,Mre11 complex,CC,
7087,GO:0030891,1,0.615416433900483,0,4,VCB complex,CC,
7091,GO:0030896,1,0.601464459524029,0,4,checkpoint clamp complex,CC,
7093,GO:0030898,1,0.364588305429792,0,8,actin-dependent ATPase activity,MF,
7101,GO:0030906,1,0.608017739970848,0,4,retromer, cargo-selective complex,CC,
7107,GO:0030916,1,0.599538477540196,0,4,otic vesicle formation,BP,
7108,GO:0030917,1,0.602941786408414,0,4,midbrain-hindbrain boundary development,BP,
7116,GO:0030948,1,0.364371167371901,0,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7121,GO:0030953,1,0.408630562796089,0,7,astral microtubule organization,BP,
7122,GO:0030955,1,0.316898421230739,0,9,potassium ion binding,MF,
7124,GO:0030957,1,0.285421507942548,0,10,Tat protein binding,MF,
7126,GO:0030964,1,0.00915483753155539,0,42,NADH dehydrogenase complex,CC,
7157,GO:0031045,1,0.470005292976261,0,6,dense core granule,CC,
7163,GO:0031053,1,0.279404890110169,0,10,primary miRNA processing,BP,
7165,GO:0031055,1,0.00764307533144601,0,42,chromatin remodeling at centromere,BP,
7182,GO:0031080,1,0.283514244479525,0,10,nuclear pore outer ring,CC,
7190,GO:0031088,1,0.538498351358642,0,5,platelet dense granule membrane,CC,
7215,GO:0031118,1,0.386442491244996,0,8,rRNA pseudouridine synthesis,BP,
7217,GO:0031120,1,0.631843023661693,0,4,snRNA pseudouridine synthesis,BP,
7221,GO:0031125,1,0.241583437798998,0,12,rRNA 3'-end processing,BP,
7222,GO:0031126,1,0.434171234548412,0,7,snoRNA 3'-end processing,BP,
7228,GO:0031145,1,8.93583556016858e-05,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7242,GO:0031209,1,0.359978321316384,0,8,SCAR complex,CC,
7244,GO:0031211,1,0.364759431438922,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7269,GO:0031261,1,0.535379352210003,0,5,DNA replication preinitiation complex,CC,
7271,GO:0031264,1,0.320612979376021,0,9,death-inducing signaling complex,CC,
7272,GO:0031265,1,0.46718146946606,0,6,CD95 death-inducing signaling complex,CC,
7291,GO:0031298,1,0.324799762759426,0,9,replication fork protection complex,CC,
7295,GO:0031304,1,0.0115748918828633,0,36,intrinsic component of mitochondrial inner membrane,CC,
7296,GO:0031305,1,0.0115748918828633,0,36,integral component of mitochondrial inner membrane,CC,
7301,GO:0031313,1,0.412786374364647,0,7,extrinsic component of endosome membrane,CC,
7302,GO:0031314,1,0.528452663146716,0,5,extrinsic component of mitochondrial inner membrane,CC,
7321,GO:0031340,1,0.470466387024333,0,6,positive regulation of vesicle fusion,BP,
7322,GO:0031341,1,0.012930251502902,0,35,regulation of cell killing,BP,
7323,GO:0031342,1,0.251009181218318,0,11,negative regulation of cell killing,BP,
7324,GO:0031343,1,0.0662803213484715,0,22,positive regulation of cell killing,BP,
7332,GO:0031365,1,0.0484872612373651,0,24,N-terminal protein amino acid modification,BP,
7335,GO:0031371,1,0.365439966600441,0,8,ubiquitin conjugating enzyme complex,CC,
7339,GO:0031386,1,0.242379080848807,0,12,protein tag,MF,
7341,GO:0031390,1,0.36567671345527,0,8,Ctf18 RFC-like complex,CC,
7342,GO:0031392,1,0.604693652812847,0,4,regulation of prostaglandin biosynthetic process,BP,
7351,GO:0031402,1,0.359689724210474,0,8,sodium ion binding,MF,
7358,GO:0031414,1,0.325064877364883,0,9,N-terminal protein acetyltransferase complex,CC,
7359,GO:0031415,1,0.611928759526041,0,4,NatA complex,CC,
7363,GO:0031419,1,0.468536311282402,0,6,cobalamin binding,MF,
7364,GO:0031420,1,0.189615433947105,0,13,alkali metal ion binding,MF,
7367,GO:0031428,1,0.538999085033908,0,5,box C/D snoRNP complex,CC,
7368,GO:0031429,1,0.562763403611126,0,5,box H/ACA snoRNP complex,CC,
7380,GO:0031441,1,0.317178994084001,0,9,negative regulation of mRNA 3'-end processing,BP,
7381,GO:0031442,1,0.318473234983147,0,9,positive regulation of mRNA 3'-end processing,BP,
7392,GO:0031464,1,0.222562118921331,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7394,GO:0031466,1,0.618171370763767,0,4,Cul5-RING ubiquitin ligase complex,CC,
7417,GO:0031527,1,0.240651576542276,0,11,filopodium membrane,CC,
7424,GO:0031536,1,0.616616515441843,0,4,positive regulation of exit from mitosis,BP,
7425,GO:0031543,1,0.279620971562829,0,10,peptidyl-proline dioxygenase activity,MF,
7426,GO:0031544,1,0.60054825445255,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7427,GO:0031545,1,0.465736996302985,0,6,peptidyl-proline 4-dioxygenase activity,MF,
7450,GO:0031595,1,0.374993003568059,0,8,nuclear proteasome complex,CC,
7451,GO:0031597,1,0.225974452771123,0,12,cytosolic proteasome complex,CC,
7453,GO:0031618,1,0.360248771644339,0,8,nuclear pericentric heterochromatin,CC,
7454,GO:0031620,1,0.604890886955455,0,4,regulation of fever generation,BP,
7455,GO:0031622,1,0.604890886955455,0,4,positive regulation of fever generation,BP,
7461,GO:0031628,1,0.600733194143458,0,4,opioid receptor binding,MF,
7467,GO:0031640,1,0.102782866513878,0,20,killing of cells of other organism,BP,
7469,GO:0031642,1,0.473573608184119,0,6,negative regulation of myelination,BP,
7472,GO:0031645,1,0.418728982632485,0,7,negative regulation of neurological system process,BP,
7481,GO:0031658,1,0.42009658222617,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7484,GO:0031664,1,0.136677498001707,0,16,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7485,GO:0031665,1,0.371612009542158,0,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7486,GO:0031666,1,0.539757191293562,0,5,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7504,GO:0031698,1,0.601583392309597,0,4,beta-2 adrenergic receptor binding,MF,
7517,GO:0031730,1,0.545836219900583,0,5,CCR5 chemokine receptor binding,MF,
7518,GO:0031731,1,0.671188326088455,0,4,CCR6 chemokine receptor binding,MF,
7534,GO:0031821,1,0.468632157541753,0,6,G-protein coupled serotonin receptor binding,MF,
7540,GO:0031852,1,0.600733194143458,0,4,mu-type opioid receptor binding,MF,
7561,GO:0031931,1,0.410734225370935,0,7,TORC1 complex,CC,
7566,GO:0031937,1,0.361576607700248,0,8,positive regulation of chromatin silencing,BP,
7571,GO:0031944,1,0.600362299806592,0,4,negative regulation of glucocorticoid metabolic process,BP,
7574,GO:0031947,1,0.600362299806592,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
7579,GO:0031956,1,0.600161135096973,0,4,medium-chain fatty acid-CoA ligase activity,MF,
7592,GO:0031981,1,0,277,3521,nuclear lumen,CC,TNIP1;DUSP6;DOCK4;NT5E;NFATC4;XPC;FOS;H1F0;CITED4;EGR1;CTNNBIP1;VWA5A;PTK6;OBSCN;DDB2;NR1D1;ERCC1;HADH;BAHCC1;DUSP5;FCHO1;TSPAN1;DNM1;MEF2D;NOS1;DDIT3;BRSK1;CRTC1;ERCC6;ABTB1;TCEA2;SMARCA1;TRIM65;ADARB1;ARAP1;RBL2;RPS6KA2;TFDP2;MXI1;RPL13A;KLF9;MIF4GD;PHACTR3;CPT2;KLHDC2;ASH2L;SOX13;LHPP;TMEM92;ATG16L2;ETV4;WWTR1;POLD4;PKN1;CAPG;H2AFJ;TRNP1;PHC2;PHF21A;DGKQ;MAML3;ARL2;PHF7;SOX12;HDAC11;ITPR3;HSD11B1L;PITPNC1;APPL2;CIRBP;PRKCZ;PPP2R3B;ELK3;STK39;BLVRB;KDM3A;PHF1;SALL2;DDX59;WDR27;NSUN5P2;NEIL1;ABHD14B;RAG1;SPPL2B;NGFR;ETV5;NSMCE4A;CHD2;SPG11;RNF44;RMI2;CYHR1;OLFM2;XPOT;FAM50A;CARF;S100A13;FKBP10;PPARA;INO80C;CHD3;CCDC92;SPC24;AIP;MKNK2;SCMH1;SATB1;STAT6;ING4;HMGA2;JADE2;MAPK3;DEF6;BNIP3;MACROD1;THRA;DCAF10;STK40;ACSS2;RGS14;IRF2BPL;CTSB;EIF2D;MAPK12;LTA4H;MLXIPL;TBC1D14;PTPDC1;TSPYL2;H1FX;FLYWCH1;SDHA;TECPR1;LITAF;PTHLH;NOL4L;ATF4;ZFPM1;KDM4C;PAK6;LRRC45;LTB4R2;FAM193B;POLM;TENM2;CBX7;NSMCE1;TTN;PSKH1;HLCS;HDAC5;IL17RD;SRSF5;DEAF1;TEP1;NLRP1;KDM7A;CEBPB;ACOT7;CREBRF;L3MBTL1;ACADS;ISG20;EPN3;HLTF;DNMT3A;SMURF2;BHLHE40;MLH3;CALCOCO1;HMG20B;CDK5RAP3;AGO4;LDOC1;BNIP3L;NICN1;MAN2C1;NBR1;TADA3;POLL;TERC;RXRA;MBD1;TNRC18;SPATA7;WDR19;MGMT;HINT2;AKT1;CRY2;MZT2B;B4GALT2;CHEK2;NFU1;TSG101;PHF2;ZNF217;PIAS3;ASAP3;PHLDA1;ACADVL;LMNA;UPP1;UHRF2;NPIPA2;SMARCD2;ARHGAP27;INSR;NELFCD;FOXO4;COG7;YPEL3;RPS6KA5;ADD3;MAGED2;RABGGTA;ITGB6;C6ORF89;ZNF554;CPSF4;POLR2J2;LETMD1;HOXC5;GJB4;FAAP20;PIDD1;MZT2A;MAPK10;MPG;TP73;MTA3;MNT;UBOX5;APRT;ENDOV;PHC1;SPIRE1;CSNK1E;BCL6;HSF4;REC8;RNF213;ZC3H12D;SIRT2;RECQL5;HCFC1R1;CELSR1;SH3GLB2;POU2F2;POLR3GL;MTA1;MSH5;HDAC8;ADIRF;TCF7;EPAS1;CHD6;MAGI1;POLR2J3;PER1;LRCH4;MCTP2;FGFR1;RGS12;SYVN1;MPPE1;HMBOX1;CREB3L4;IRF2BP2;ZMYM3;TRIM45;KCTD13;DTD1;DMTF1;PLEKHH2;TEAD2
7597,GO:0031987,1,0.357860543195159,0,8,locomotion involved in locomotory behavior,BP,
7601,GO:0031996,1,0.280273853139488,0,10,thioesterase binding,MF,
7610,GO:0032009,1,0.412195987837307,0,7,early phagosome,CC,
7614,GO:0032020,1,0.484770326472695,0,6,ISG15-protein conjugation,BP,
7623,GO:0032039,1,0.189896943879313,0,13,integrator complex,CC,
7624,GO:0032040,1,0.0161878672105837,0,33,small-subunit processome,CC,
7639,GO:0032059,1,0.410804908460546,0,7,bleb,CC,
7673,GO:0032119,1,0.379595011191215,0,8,sequestering of zinc ion,BP,
7676,GO:0032133,1,0.607115882702435,0,4,chromosome passenger complex,CC,
7679,GO:0032138,1,0.6002588646149,0,4,single base insertion or deletion binding,MF,
7695,GO:0032183,1,0.187531797299444,0,13,SUMO binding,MF,
7696,GO:0032184,1,0.600084598867949,0,4,SUMO polymer binding,MF,
7704,GO:0032202,1,0.60333111701086,0,4,telomere assembly,BP,
7712,GO:0032211,1,0.0894467802119257,0,19,negative regulation of telomere maintenance via telomerase,BP,
7730,GO:0032237,1,0.60015840306541,0,4,activation of store-operated calcium channel activity,BP,
7731,GO:0032239,1,0.129268382124688,0,16,regulation of nucleobase-containing compound transport,BP,
7733,GO:0032241,1,0.40952523183423,0,7,positive regulation of nucleobase-containing compound transport,BP,
7741,GO:0032264,1,0.605752377806408,0,4,IMP salvage,BP,
7749,GO:0032274,1,0.408919155154309,0,7,gonadotropin secretion,BP,
7750,GO:0032275,1,0.527433995451837,0,5,luteinizing hormone secretion,BP,
7764,GO:0032296,1,0.600136325177009,0,4,double-stranded RNA-specific ribonuclease activity,MF,
7773,GO:0032306,1,0.545840965825363,0,5,regulation of prostaglandin secretion,BP,
7774,GO:0032308,1,0.545840965825363,0,5,positive regulation of prostaglandin secretion,BP,
7776,GO:0032310,1,0.480382794830986,0,6,prostaglandin secretion,BP,
7780,GO:0032329,1,0.362622688167652,0,8,serine transport,BP,
7783,GO:0032332,1,0.244807675596319,0,11,positive regulation of chondrocyte differentiation,BP,
7784,GO:0032341,1,0.528463716066181,0,5,aldosterone metabolic process,BP,
7785,GO:0032342,1,0.528463716066181,0,5,aldosterone biosynthetic process,BP,
7786,GO:0032344,1,0.528463716066181,0,5,regulation of aldosterone metabolic process,BP,
7789,GO:0032347,1,0.528463716066181,0,5,regulation of aldosterone biosynthetic process,BP,
7798,GO:0032356,1,0.285530389837253,0,10,oxidized DNA binding,MF,
7799,GO:0032357,1,0.324080330761078,0,9,oxidized purine DNA binding,MF,
7802,GO:0032364,1,0.535991216456296,0,5,oxygen homeostasis,BP,
7827,GO:0032389,1,0.409561021944708,0,7,MutLalpha complex,CC,
7837,GO:0032404,1,0.365445752675982,0,8,mismatch repair complex binding,MF,
7838,GO:0032405,1,0.534390104710077,0,5,MutLalpha complex binding,MF,
7839,GO:0032407,1,0.531447784829035,0,5,MutSalpha complex binding,MF,
7877,GO:0032453,1,0.462596475261836,0,6,histone demethylase activity (H3-K4 specific),MF,
7886,GO:0032463,1,0.253308346922816,0,11,negative regulation of protein homooligomerization,BP,
7887,GO:0032464,1,0.476776951871529,0,6,positive regulation of protein homooligomerization,BP,
7890,GO:0032467,1,0.0427126423017698,0,25,positive regulation of cytokinesis,BP,
7894,GO:0032471,1,0.427943347538649,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
7901,GO:0032483,1,0.600138865502291,0,4,regulation of Rab protein signal transduction,BP,
7908,GO:0032490,1,0.600204544332606,0,4,detection of molecule of bacterial origin,BP,
7928,GO:0032525,1,0.465834259792616,0,6,somite rostral/caudal axis specification,BP,
7934,GO:0032534,1,0.464917690589321,0,6,regulation of microvillus assembly,BP,
7937,GO:0032541,1,0.536542497354729,0,5,cortical endoplasmic reticulum,CC,
7939,GO:0032543,1,1.87269661869895e-07,0,129,mitochondrial translation,BP,
7944,GO:0032552,1,0.48104590032191,0,6,deoxyribonucleotide binding,MF,
7946,GO:0032554,1,0.611950431293179,0,4,purine deoxyribonucleotide binding,MF,
7963,GO:0032585,1,0.288121705245156,0,10,multivesicular body membrane,CC,
7978,GO:0032604,1,0.371719935936602,0,8,granulocyte macrophage colony-stimulating factor production,BP,
7991,GO:0032621,1,0.467146208715196,0,6,interleukin-18 production,BP,
7994,GO:0032627,1,0.539147995567924,0,5,interleukin-23 production,BP,
8004,GO:0032645,1,0.371719935936602,0,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8008,GO:0032650,1,0.540028826924258,0,5,regulation of interleukin-1 alpha production,BP,
8016,GO:0032661,1,0.530783747240926,0,5,regulation of interleukin-18 production,BP,
8018,GO:0032667,1,0.539147995567924,0,5,regulation of interleukin-23 production,BP,
8048,GO:0032725,1,0.422308648320092,0,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8052,GO:0032730,1,0.609218375154239,0,4,positive regulation of interleukin-1 alpha production,BP,
8059,GO:0032740,1,0.421725349418115,0,7,positive regulation of interleukin-17 production,BP,
8083,GO:0032777,1,0.602954335035841,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8084,GO:0032780,1,0.412148681369095,0,7,negative regulation of ATPase activity,BP,
8087,GO:0032783,1,0.605548247042487,0,4,ELL-EAF complex,CC,
8100,GO:0032797,1,0.254034882035766,0,11,SMN complex,CC,
8109,GO:0032806,1,0.0425203478172769,0,25,carboxy-terminal domain protein kinase complex,CC,
8110,GO:0032807,1,0.603444962879725,0,4,DNA ligase IV complex,CC,
8111,GO:0032808,1,0.599799722008997,0,4,lacrimal gland development,BP,
8116,GO:0032815,1,0.540696127360005,0,5,negative regulation of natural killer cell activation,BP,
8118,GO:0032817,1,0.617889991443117,0,4,regulation of natural killer cell proliferation,BP,
8119,GO:0032819,1,0.617889991443117,0,4,positive regulation of natural killer cell proliferation,BP,
8138,GO:0032875,1,0.407930958569555,0,7,regulation of DNA endoreduplication,BP,
8139,GO:0032876,1,0.59831391006435,0,4,negative regulation of DNA endoreduplication,BP,
8158,GO:0032905,1,0.466286282020791,0,6,transforming growth factor beta1 production,BP,
8159,GO:0032906,1,0.464440028143731,0,6,transforming growth factor beta2 production,BP,
8161,GO:0032908,1,0.466286282020791,0,6,regulation of transforming growth factor beta1 production,BP,
8162,GO:0032909,1,0.464440028143731,0,6,regulation of transforming growth factor beta2 production,BP,
8177,GO:0032926,1,0.414774222720763,0,7,negative regulation of activin receptor signaling pathway,BP,
8182,GO:0032933,1,0.361469321403854,0,8,SREBP signaling pathway,BP,
8197,GO:0032960,1,0.600265152363643,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8223,GO:0033003,1,0.0710615198549934,0,21,regulation of mast cell activation,BP,
8225,GO:0033005,1,0.324317333115229,0,9,positive regulation of mast cell activation,BP,
8226,GO:0033006,1,0.0916779686081015,0,19,regulation of mast cell activation involved in immune response,BP,
8228,GO:0033008,1,0.368424506637773,0,8,positive regulation of mast cell activation involved in immune response,BP,
8240,GO:0033029,1,0.532198727181446,0,5,regulation of neutrophil apoptotic process,BP,
8242,GO:0033031,1,0.604781159782504,0,4,positive regulation of neutrophil apoptotic process,BP,
8244,GO:0033033,1,0.373579425630201,0,8,negative regulation of myeloid cell apoptotic process,BP,
8245,GO:0033034,1,0.473922912596978,0,6,positive regulation of myeloid cell apoptotic process,BP,
8248,GO:0033038,1,0.499883501082689,0,6,bitter taste receptor activity,MF,
8253,GO:0033046,1,0.0107662669751928,0,36,negative regulation of sister chromatid segregation,BP,
8254,GO:0033047,1,0.000528367263088254,0,60,regulation of mitotic sister chromatid segregation,BP,
8255,GO:0033048,1,0.013910024582999,0,34,negative regulation of mitotic sister chromatid segregation,BP,
8258,GO:0033061,1,0.322710992568243,0,9,DNA recombinase mediator complex,CC,
8259,GO:0033063,1,0.41647972305249,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8275,GO:0033093,1,0.600870767294807,0,4,Weibel-Palade body,CC,
8279,GO:0033119,1,0.0643422107315516,0,22,negative regulation of RNA splicing,BP,
8288,GO:0033131,1,0.478573685497392,0,6,regulation of glucokinase activity,BP,
8290,GO:0033133,1,0.610235911302275,0,4,positive regulation of glucokinase activity,BP,
8294,GO:0033139,1,0.474815720690125,0,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8296,GO:0033141,1,0.611332349209927,0,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8302,GO:0033147,1,0.318925139827575,0,9,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8306,GO:0033152,1,0.600149733262107,0,4,immunoglobulin V(D)J recombination,BP,
8312,GO:0033162,1,0.478232446033461,0,6,melanosome membrane,CC,
8316,GO:0033170,1,0.365659346523366,0,8,protein-DNA loading ATPase activity,MF,
8320,GO:0033178,1,0.294139190106928,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8322,GO:0033180,1,0.375887802435361,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8324,GO:0033182,1,0.278698871069842,0,10,regulation of histone ubiquitination,BP,
8326,GO:0033184,1,0.528375931977648,0,5,positive regulation of histone ubiquitination,BP,
8331,GO:0033192,1,0.528029467066209,0,5,calmodulin-dependent protein phosphatase activity,MF,
8343,GO:0033220,1,0.600295744851906,0,4,amide-transporting ATPase activity,MF,
8350,GO:0033240,1,0.420716276156315,0,7,positive regulation of cellular amine metabolic process,BP,
8353,GO:0033256,1,0.412830954273342,0,7,I-kappaB/NF-kappaB complex,CC,
8357,GO:0033263,1,0.600157015102806,0,4,CORVET complex,CC,
8368,GO:0033278,1,0.600174479447687,0,4,cell proliferation in midbrain,BP,
8377,GO:0033299,1,0.532285101027998,0,5,secretion of lysosomal enzymes,BP,
8381,GO:0033313,1,0.528982462931003,0,5,meiotic cell cycle checkpoint,BP,
8382,GO:0033314,1,0.363196867928379,0,8,mitotic DNA replication checkpoint,BP,
8387,GO:0033327,1,0.472280307118391,0,6,Leydig cell differentiation,BP,
8393,GO:0033353,1,0.600486933790146,0,4,S-adenosylmethionine cycle,BP,
8403,GO:0033391,1,0.464969689591988,0,6,chromatoid body,CC,
8405,GO:0033483,1,0.371090856602567,0,8,gas homeostasis,BP,
8408,GO:0033489,1,0.607325873190038,0,4,cholesterol biosynthetic process via desmosterol,BP,
8409,GO:0033490,1,0.607325873190038,0,4,cholesterol biosynthetic process via lathosterol,BP,
8412,GO:0033503,1,0.602023796774915,0,4,HULC complex,CC,
8417,GO:0033523,1,0.218199960612191,0,12,histone H2B ubiquitination,BP,
8423,GO:0033553,1,0.60155628391488,0,4,rDNA heterochromatin,CC,
8430,GO:0033561,1,0.053383586718377,0,23,regulation of water loss via skin,BP,
8434,GO:0033567,1,0.537291117756652,0,5,DNA replication, Okazaki fragment processing,BP,
8440,GO:0033588,1,0.531404712627892,0,5,Elongator holoenzyme complex,CC,
8443,GO:0033592,1,0.528360901880761,0,5,RNA strand annealing activity,MF,
8450,GO:0033600,1,0.600883728364699,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
8451,GO:0033601,1,0.359540041970464,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8459,GO:0033612,1,0.221222690296542,0,12,receptor serine/threonine kinase binding,MF,
8464,GO:0033622,1,0.245329197146064,0,11,integrin activation,BP,
8465,GO:0033623,1,0.464773031925975,0,6,regulation of integrin activation,BP,
8470,GO:0033629,1,0.415685217376199,0,7,negative regulation of cell adhesion mediated by integrin,BP,
8471,GO:0033630,1,0.224842873079793,0,12,positive regulation of cell adhesion mediated by integrin,BP,
8478,GO:0033646,1,0.410790215353706,0,7,host intracellular part,CC,
8479,GO:0033647,1,0.530254837794985,0,5,host intracellular organelle,CC,
8480,GO:0033648,1,0.530254837794985,0,5,host intracellular membrane-bounded organelle,CC,
8482,GO:0033655,1,0.602272154857997,0,4,host cell cytoplasm part,CC,
8483,GO:0033668,1,0.608072603290401,0,4,negative regulation by symbiont of host apoptotic process,BP,
8510,GO:0033750,1,0.207634068110373,0,13,ribosome localization,BP,
8542,GO:0033962,1,0.101790251926861,0,18,cytoplasmic mRNA processing body assembly,BP,
8557,GO:0034036,1,0.465756249189603,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8563,GO:0034046,1,0.408597306708163,0,7,poly(G) binding,MF,
8573,GO:0034080,1,0.00976008802956121,0,40,CENP-A containing nucleosome assembly,BP,
8575,GO:0034086,1,0.220249721359446,0,12,maintenance of sister chromatid cohesion,BP,
8577,GO:0034088,1,0.220249721359446,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8578,GO:0034091,1,0.368112900788502,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8580,GO:0034093,1,0.535012997030266,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8582,GO:0034098,1,0.319957028913342,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
8602,GO:0034127,1,0.601102542813599,0,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8604,GO:0034134,1,0.286647533512682,0,10,toll-like receptor 2 signaling pathway,BP,
8605,GO:0034135,1,0.476296544180222,0,6,regulation of toll-like receptor 2 signaling pathway,BP,
8615,GO:0034145,1,0.532786579256783,0,5,positive regulation of toll-like receptor 4 signaling pathway,BP,
8620,GO:0034154,1,0.600743943966449,0,4,toll-like receptor 7 signaling pathway,BP,
8628,GO:0034182,1,0.368112900788502,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8630,GO:0034184,1,0.535012997030266,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8632,GO:0034186,1,0.603241485849212,0,4,apolipoprotein A-I binding,MF,
8641,GO:0034201,1,0.535114156560346,0,5,response to oleic acid,BP,
8647,GO:0034214,1,0.36084720959964,0,8,protein hexamerization,BP,
8651,GO:0034227,1,0.534931006186108,0,5,tRNA thio-modification,BP,
8676,GO:0034310,1,0.41741535055529,0,7,primary alcohol catabolic process,BP,
8677,GO:0034311,1,0.123740284629022,0,17,diol metabolic process,BP,
8678,GO:0034312,1,0.1580434606597,0,15,diol biosynthetic process,BP,
8687,GO:0034334,1,0.600212851120032,0,4,adherens junction maintenance,BP,
8718,GO:0034379,1,0.478199882076144,0,6,very-low-density lipoprotein particle assembly,BP,
8726,GO:0034388,1,0.466521743958547,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8746,GO:0034427,1,0.299627739646399,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8747,GO:0034431,1,0.606378799054077,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8748,GO:0034432,1,0.606378799054077,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
8758,GO:0034448,1,0.609352896117213,0,4,EGO complex,CC,
8761,GO:0034452,1,0.274852933457234,0,10,dynactin binding,MF,
8762,GO:0034453,1,0.0522503578642831,0,23,microtubule anchoring,BP,
8763,GO:0034454,1,0.312610792597125,0,9,microtubule anchoring at centrosome,BP,
8774,GO:0034471,1,0.098639013881557,0,19,ncRNA 5'-end processing,BP,
8775,GO:0034472,1,0.17965305667981,0,14,snRNA 3'-end processing,BP,
8778,GO:0034475,1,0.386823378720118,0,8,U4 snRNA 3'-end processing,BP,
8781,GO:0034481,1,0.600901583022095,0,4,chondroitin sulfotransferase activity,MF,
8782,GO:0034483,1,0.361515625486157,0,8,heparan sulfate sulfotransferase activity,MF,
8787,GO:0034501,1,0.13242877521845,0,16,protein localization to kinetochore,BP,
8792,GO:0034508,1,0.00272806216075269,0,50,centromere complex assembly,BP,
8795,GO:0034513,1,0.562763403611126,0,5,box H/ACA snoRNA binding,MF,
8797,GO:0034518,1,0.223704066337018,0,12,RNA cap binding complex,CC,
8813,GO:0034603,1,0.531420907773123,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8814,GO:0034604,1,0.531420907773123,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8824,GO:0034625,1,0.531814387460337,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8825,GO:0034626,1,0.531814387460337,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8828,GO:0034629,1,0.0800789054436385,0,20,cellular protein-containing complex localization,BP,
8832,GO:0034638,1,0.483446733550577,0,6,phosphatidylcholine catabolic process,BP,
8834,GO:0034641,1,0,458,5143,cellular nitrogen compound metabolic process,BP,TNIP1;XDH;H6PD;DLG4;ZC3H6;HTRA1;GAMT;F2R;NT5E;NYNRIN;APOE;ZMYND8;NFATC4;XPC;FOS;H1F0;CITED4;EGR1;CTNNBIP1;ALDH7A1;ZNF862;ACP5;WWC3;NAPRT;CRAT;NAGS;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;DDB2;PRNP;NR1D1;ERCC1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;RNPEPL1;IGFBP4;SLC2A9;IDH2;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;SMARCA1;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;CYP3A5;DHTKD1;TFDP2;MXI1;RPL13A;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;LHPP;UROS;ETV4;WWTR1;POLD4;MAP2K1;PCK2;MXD4;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;OPLAH;BTG1;TRNP1;DNASE1L1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;MAGEF1;SHC1;GRB7;OGDHL;SOX12;HDAC11;PCSK1;PTMS;UNK;NMRK1;CIRBP;CAPRIN2;PRKCZ;ABCA7;APOBEC3C;AARS;ELK3;PABPC1L;ERO1B;BLVRB;SEC14L2;BRD3;KDM3A;MTHFR;FOXQ1;PHF1;NPR2;CBS;SALL2;DLG3;NMNAT2;DDX59;NME4;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;EAPP;NGFR;ETV5;GSTO1;PPCS;NSMCE4A;HES2;EREG;CHD2;TEF;PSAT1;APBB3;RMI2;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;GSTT1;CARS;APOBEC3F;PPARA;INO80C;CHD3;CHAC1;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;RRNAD1;HMGA2;AREG;ST6GALNAC6;ECM1;ACACB;NT5C1B;KCNAB2;MAPK3;TRPT1;PC;MACROD1;THRA;RGS14;IRF2BPL;FAM20C;TDRKH;PBXIP1;PAN2;ZSCAN30;EIF2D;MAPK12;MYH3;LTA4H;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SDHA;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;FBXO6;ZNF516;CBX7;PKD1;NSMCE1;MDK;HLCS;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;SORL1;GALK1;TFB1M;PCBP4;SRSF5;GSTM2;VLDLR;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;ISG20;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;RPUSD3;ZNF662;GAS6;ERN1;MAPRE3;CPT1C;EXD3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;CTSH;PNRC1;MGMT;GSTO2;ASNS;ENTPD6;PAIP2B;MAPKBP1;AKT1;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;LACTB2;ASS1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;HAGH;ZNF25;DNASE2;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;ALDH1L1;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;MPG;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;CERS4;MPI;LSM14B;ENDOV;CSNK1E;TAZ;BCL6;HSF4;REC8;SAT2;GSTM3;RPL39L;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;TST;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;NAGA;MTA1;MSH5;ENTPD2;FUK;CIDEA;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;TGFBR3;TCF7;RNPEP;EPAS1;MAP3K10;CHD6;DHPS;NMRAL1;POLR2J3;PER1;IGF2BP3;ITGA2;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;KCTD13;DBP;ZNF667;ZNF287;PNKD;DTD1;IKBKB;DMTF1;HIP1;TEAD2;SIX5
8836,GO:0034643,1,0.0922994701578875,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
8840,GO:0034648,1,0.597388322926368,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
8848,GO:0034657,1,0.602433140052012,0,4,GID complex,CC,
8850,GO:0034661,1,0.056747755553187,0,23,ncRNA catabolic process,BP,
8851,GO:0034663,1,0.371735428422382,0,8,endoplasmic reticulum chaperone complex,CC,
8880,GO:0034709,1,0.245178804318034,0,12,methylosome,CC,
8884,GO:0034715,1,0.495384499650603,0,6,pICln-Sm protein complex,CC,
8886,GO:0034719,1,0.147023924824332,0,16,SMN-Sm protein complex,CC,
8887,GO:0034720,1,0.462596475261836,0,6,histone H3-K4 demethylation,BP,
8890,GO:0034723,1,0.032348579426747,0,32,DNA replication-dependent nucleosome organization,BP,
8891,GO:0034724,1,0.00242441962282603,0,51,DNA replication-independent nucleosome organization,BP,
8913,GO:0034770,1,0.315141533096772,0,9,histone H4-K20 methylation,BP,
8914,GO:0034773,1,0.465944630811578,0,6,histone H4-K20 trimethylation,BP,
8923,GO:0034969,1,0.281622182883246,0,10,histone arginine methylation,BP,
8929,GO:0034982,1,0.290862353118643,0,10,mitochondrial protein processing,BP,
8939,GO:0035005,1,0.463873915879025,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8944,GO:0035022,1,0.612623681761415,0,4,positive regulation of Rac protein signal transduction,BP,
8949,GO:0035032,1,0.466565975769405,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8958,GO:0035061,1,0.599936461523347,0,4,interchromatin granule,CC,
8966,GO:0035087,1,0.604304248280349,0,4,siRNA loading onto RISC involved in RNA interference,BP,
8968,GO:0035089,1,0.190569542402444,0,13,establishment of apical/basal cell polarity,BP,
8990,GO:0035145,1,0.0707479389328872,0,21,exon-exon junction complex,CC,
8996,GO:0035174,1,0.470709971690692,0,6,histone serine kinase activity,MF,
9005,GO:0035197,1,0.318482521353436,0,9,siRNA binding,MF,
9010,GO:0035234,1,0.471949380363473,0,6,ectopic germ cell programmed cell death,BP,
9011,GO:0035235,1,0.318759583947462,0,9,ionotropic glutamate receptor signaling pathway,BP,
9015,GO:0035242,1,0.412927037498387,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9016,GO:0035243,1,0.600771765727391,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9017,GO:0035246,1,0.248006913077952,0,11,peptidyl-arginine N-methylation,BP,
9018,GO:0035247,1,0.320007373616132,0,9,peptidyl-arginine omega-N-methylation,BP,
9022,GO:0035251,1,0.415128383821414,0,7,UDP-glucosyltransferase activity,MF,
9035,GO:0035267,1,0.0904281382081245,0,19,NuA4 histone acetyltransferase complex,CC,
9058,GO:0035312,1,0.465722545429047,0,6,5'-3' exodeoxyribonuclease activity,MF,
9061,GO:0035325,1,0.380329223866396,0,8,Toll-like receptor binding,MF,
9063,GO:0035327,1,0.0842209279485692,0,20,transcriptionally active chromatin,CC,
9068,GO:0035333,1,0.222137228645531,0,12,Notch receptor processing, ligand-dependent,BP,
9072,GO:0035338,1,0.193802927143919,0,13,long-chain fatty-acyl-CoA biosynthetic process,BP,
9073,GO:0035339,1,0.608052511058708,0,4,SPOTS complex,CC,
9084,GO:0035363,1,0.603252584028834,0,4,histone locus body,CC,
9085,GO:0035368,1,0.602491443223103,0,4,selenocysteine insertion sequence binding,MF,
9091,GO:0035376,1,0.533455122135415,0,5,sterol import,BP,
9111,GO:0035437,1,0.249508199609409,0,11,maintenance of protein localization in endoplasmic reticulum,BP,
9122,GO:0035461,1,0.361689179398101,0,8,vitamin transmembrane transport,BP,
9144,GO:0035511,1,0.539493894738825,0,5,oxidative DNA demethylation,BP,
9145,GO:0035513,1,0.603452852235168,0,4,oxidative RNA demethylation,BP,
9147,GO:0035515,1,0.603452852235168,0,4,oxidative RNA demethylase activity,MF,
9151,GO:0035519,1,0.62126412659059,0,4,protein K29-linked ubiquitination,BP,
9152,GO:0035520,1,0.316614830856291,0,9,monoubiquitinated protein deubiquitination,BP,
9153,GO:0035521,1,0.600376373149352,0,4,monoubiquitinated histone deubiquitination,BP,
9154,GO:0035522,1,0.600376373149352,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9155,GO:0035523,1,0.601758180289743,0,4,protein K29-linked deubiquitination,BP,
9156,GO:0035524,1,0.528289246193819,0,5,proline transmembrane transport,BP,
9164,GO:0035546,1,0.596565854326723,0,4,interferon-beta secretion,BP,
9165,GO:0035547,1,0.596565854326723,0,4,regulation of interferon-beta secretion,BP,
9166,GO:0035549,1,0.596565854326723,0,4,positive regulation of interferon-beta secretion,BP,
9212,GO:0035613,1,0.150679057219989,0,15,RNA stem-loop binding,MF,
9235,GO:0035646,1,0.288246200190994,0,10,endosome to melanosome transport,BP,
9236,GO:0035650,1,0.611300230156645,0,4,AP-1 adaptor complex binding,MF,
9249,GO:0035672,1,0.466878165519268,0,6,oligopeptide transmembrane transport,BP,
9250,GO:0035673,1,0.600066005482202,0,4,oligopeptide transmembrane transporter activity,MF,
9273,GO:0035726,1,0.612236649858781,0,4,common myeloid progenitor cell proliferation,BP,
9280,GO:0035733,1,0.601453500362586,0,4,hepatic stellate cell activation,BP,
9289,GO:0035749,1,0.534594756588647,0,5,myelin sheath adaxonal region,CC,
9316,GO:0035810,1,0.529293407745888,0,5,positive regulation of urine volume,BP,
9345,GO:0035871,1,0.317201803062899,0,9,protein K11-linked deubiquitination,BP,
9348,GO:0035877,1,0.606478998134658,0,4,death effector domain binding,MF,
9353,GO:0035883,1,0.116155281972475,0,17,enteroendocrine cell differentiation,BP,
9364,GO:0035907,1,0.528561643443205,0,5,dorsal aorta development,BP,
9367,GO:0035912,1,0.600477773192572,0,4,dorsal aorta morphogenesis,BP,
9377,GO:0035929,1,0.367229665607141,0,8,steroid hormone secretion,BP,
9378,GO:0035930,1,0.538487502383158,0,5,corticosteroid hormone secretion,BP,
9391,GO:0035964,1,0.469035362976472,0,6,COPI-coated vesicle budding,BP,
9397,GO:0035973,1,0.409832732313607,0,7,aggrephagy,BP,
9416,GO:0036002,1,0.0182637266419882,0,32,pre-mRNA binding,MF,
9432,GO:0036033,1,0.595648924984333,0,4,mediator complex binding,MF,
9437,GO:0036041,1,0.494184549515182,0,6,long-chain fatty acid binding,MF,
9445,GO:0036056,1,0.599409175163716,0,4,filtration diaphragm,CC,
9446,GO:0036057,1,0.599409175163716,0,4,slit diaphragm,CC,
9487,GO:0036149,1,0.410291707202769,0,7,phosphatidylinositol acyl-chain remodeling,BP,
9495,GO:0036158,1,0.470670612949606,0,6,outer dynein arm assembly,BP,
9516,GO:0036260,1,0.0170613488784077,0,33,RNA capping,BP,
9518,GO:0036265,1,0.622510462950245,0,4,RNA (guanine-N7)-methylation,BP,
9528,GO:0036295,1,0.194706113539976,0,13,cellular response to increased oxygen levels,BP,
9532,GO:0036302,1,0.525425885918327,0,5,atrioventricular canal development,BP,
9536,GO:0036312,1,0.314907482432483,0,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
9539,GO:0036315,1,0.188062841708509,0,13,cellular response to sterol,BP,
9546,GO:0036337,1,0.600290935279369,0,4,Fas signaling pathway,BP,
9552,GO:0036353,1,0.366334204201066,0,8,histone H2A-K119 monoubiquitination,BP,
9569,GO:0036402,1,0.482536055558787,0,6,proteasome-activating ATPase activity,MF,
9577,GO:0036444,1,0.360418189443022,0,8,calcium import into the mitochondrion,BP,
9580,GO:0036449,1,0.40643095401632,0,7,microtubule minus-end,CC,
9585,GO:0036457,1,0.592622472274561,0,4,keratohyalin granule,CC,
9589,GO:0036462,1,0.418731855631281,0,7,TRAIL-activated apoptotic signaling pathway,BP,
9601,GO:0036480,1,0.415804664093209,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9602,GO:0036481,1,0.477530529334236,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9645,GO:0038003,1,0.604737237948833,0,4,opioid receptor signaling pathway,BP,
9655,GO:0038028,1,0.600317819135479,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
9656,GO:0038030,1,0.464959861730174,0,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,
9657,GO:0038031,1,0.528292348565174,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
9660,GO:0038036,1,0.46635666620335,0,6,sphingosine-1-phosphate receptor activity,MF,
9663,GO:0038042,1,0.61530711603698,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
9671,GO:0038063,1,0.408583310903032,0,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,
9681,GO:0038092,1,0.467620992766303,0,6,nodal signaling pathway,BP,
9705,GO:0038155,1,0.472117425532717,0,6,interleukin-23-mediated signaling pathway,BP,
9711,GO:0038166,1,0.536419411925189,0,5,angiotensin-activated signaling pathway,BP,
9715,GO:0038180,1,0.367212746162031,0,8,nerve growth factor signaling pathway,BP,
9729,GO:0038203,1,0.411013272140344,0,7,TORC2 signaling,BP,
9776,GO:0040009,1,0.595788123079893,0,4,regulation of growth rate,BP,
9782,GO:0040016,1,0.410876030222112,0,7,embryonic cleavage,BP,
9789,GO:0040031,1,0.489629381651297,0,6,snRNA modification,BP,
9803,GO:0042023,1,0.359085887596656,0,8,DNA endoreduplication,BP,
9805,GO:0042026,1,0.0430400840894886,0,25,protein refolding,BP,
9813,GO:0042045,1,0.537239747448906,0,5,epithelial fluid transport,BP,
9830,GO:0042090,1,0.528416217218022,0,5,interleukin-12 biosynthetic process,BP,
9849,GO:0042117,1,0.528800778726992,0,5,monocyte activation,BP,
9850,GO:0042118,1,0.409608673284692,0,7,endothelial cell activation,BP,
9852,GO:0042126,1,0.600799095325511,0,4,nitrate metabolic process,BP,
9866,GO:0042148,1,0.3665103982045,0,8,strand invasion,BP,
9902,GO:0042256,1,0.543753686068323,0,5,mature ribosome assembly,BP,
9907,GO:0042268,1,0.489017106482346,0,6,regulation of cytolysis,BP,
9908,GO:0042269,1,0.134275491150637,0,16,regulation of natural killer cell mediated cytotoxicity,BP,
9913,GO:0042274,1,0.000210398457456551,0,70,ribosomal small subunit biogenesis,BP,
9915,GO:0042276,1,0.0955318170711143,0,19,error-prone translesion synthesis,BP,
9922,GO:0042287,1,0.133013502057532,0,16,MHC protein binding,MF,
9923,GO:0042288,1,0.32038468200684,0,9,MHC class I protein binding,MF,
9926,GO:0042296,1,0.612338464815041,0,4,ISG15 transferase activity,MF,
9927,GO:0042297,1,0.592318352385406,0,4,vocal learning,BP,
9928,GO:0042301,1,0.46592620721734,0,6,phosphate ion binding,MF,
9952,GO:0042354,1,0.465010856308967,0,6,L-fucose metabolic process,BP,
9953,GO:0042355,1,0.465010856308967,0,6,L-fucose catabolic process,BP,
9965,GO:0042373,1,0.623104439592147,0,4,vitamin K metabolic process,BP,
9969,GO:0042382,1,0.466107099412322,0,6,paraspeckles,CC,
9972,GO:0042392,1,0.534280108751832,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9977,GO:0042403,1,0.245735447580106,0,11,thyroid hormone metabolic process,BP,
9978,GO:0042405,1,0.214285734721139,0,12,nuclear inclusion body,CC,
9979,GO:0042406,1,0.603711400606339,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
9984,GO:0042416,1,0.417497564121446,0,7,dopamine biosynthetic process,BP,
9987,GO:0042420,1,0.604254934821134,0,4,dopamine catabolic process,BP,
9989,GO:0042423,1,0.323484125517376,0,9,catecholamine biosynthetic process,BP,
9990,GO:0042424,1,0.531908228686371,0,5,catecholamine catabolic process,BP,
9992,GO:0042428,1,0.598666087800626,0,4,serotonin metabolic process,BP,
9993,GO:0042430,1,0.364151655070043,0,8,indole-containing compound metabolic process,BP,
9996,GO:0042439,1,0.530077196867338,0,5,ethanolamine-containing compound metabolic process,BP,
10001,GO:0042447,1,0.470097672065483,0,6,hormone catabolic process,BP,
10016,GO:0042481,1,0.246920542219418,0,11,regulation of odontogenesis,BP,
10017,GO:0042482,1,0.529543539566922,0,5,positive regulation of odontogenesis,BP,
10019,GO:0042487,1,0.530272715081408,0,5,regulation of odontogenesis of dentin-containing tooth,BP,
10030,GO:0042501,1,0.289082448950945,0,10,serine phosphorylation of STAT protein,BP,
10033,GO:0042532,1,0.249141646457341,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10036,GO:0042535,1,0.60992319061949,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
10041,GO:0042541,1,0.469076583440528,0,6,hemoglobin biosynthetic process,BP,
10045,GO:0042551,1,0.0415383413979219,0,25,neuron maturation,BP,
10048,GO:0042555,1,0.24585728564024,0,11,MCM complex,CC,
10050,GO:0042559,1,0.180384207445306,0,14,pteridine-containing compound biosynthetic process,BP,
10058,GO:0042573,1,0.254766049624045,0,11,retinoic acid metabolic process,BP,
10059,GO:0042574,1,0.363120382255631,0,8,retinal metabolic process,BP,
10066,GO:0042583,1,0.529125381391563,0,5,chromaffin granule,CC,
10067,GO:0042584,1,0.60107670951316,0,4,chromaffin granule membrane,CC,
10070,GO:0042587,1,0.533617243128055,0,5,glycogen granule,CC,
10088,GO:0042622,1,0.465657408621285,0,6,photoreceptor outer segment membrane,CC,
10100,GO:0042635,1,0.291579336659744,0,10,positive regulation of hair cycle,BP,
10101,GO:0042636,1,0.600128458588354,0,4,negative regulation of hair cycle,BP,
10102,GO:0042637,1,0.612082573376789,0,4,catagen,BP,
10103,GO:0042640,1,0.600102553102364,0,4,anagen,BP,
10118,GO:0042693,1,0.469249618115604,0,6,muscle cell fate commitment,BP,
10128,GO:0042719,1,0.556103206613889,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10130,GO:0042721,1,0.54913424510682,0,5,mitochondrial inner membrane protein insertion complex,CC,
10136,GO:0042731,1,0.607221746828088,0,4,PH domain binding,MF,
10150,GO:0042753,1,0.463662051692142,0,6,positive regulation of circadian rhythm,BP,
10152,GO:0042755,1,0.175408066009963,0,14,eating behavior,BP,
10157,GO:0042761,1,0.28422266231167,0,10,very long-chain fatty acid biosynthetic process,BP,
10158,GO:0042762,1,0.14796423232159,0,15,regulation of sulfur metabolic process,BP,
10159,GO:0042765,1,0.530703387604472,0,5,GPI-anchor transamidase complex,CC,
10168,GO:0042776,1,0.632777036995336,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10170,GO:0042780,1,0.418063987291783,0,7,tRNA 3'-end processing,BP,
10172,GO:0042788,1,0.0388696875686525,0,29,polysomal ribosome,CC,
10174,GO:0042790,1,0.219535315568394,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10175,GO:0042791,1,0.472116240690442,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10177,GO:0042796,1,0.467365355442672,0,6,snRNA transcription by RNA polymerase III,BP,
10178,GO:0042797,1,0.472116240690442,0,6,tRNA transcription by RNA polymerase III,BP,
10179,GO:0042799,1,0.595942776304388,0,4,histone methyltransferase activity (H4-K20 specific),MF,
10192,GO:0042824,1,0.601526536318934,0,4,MHC class I peptide loading complex,CC,
10197,GO:0042834,1,0.41748051354365,0,7,peptidoglycan binding,MF,
10206,GO:0042891,1,0.412264573970205,0,7,antibiotic transport,BP,
10207,GO:0042895,1,0.468445148639473,0,6,antibiotic transmembrane transporter activity,MF,
10225,GO:0042974,1,0.0881660562091496,0,19,retinoic acid receptor binding,MF,
10227,GO:0042976,1,0.423558061846367,0,7,activation of Janus kinase activity,BP,
10241,GO:0042996,1,0.528410957748048,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10260,GO:0043023,1,0.256980961309676,0,11,ribosomal large subunit binding,MF,
10261,GO:0043024,1,0.17443440563604,0,14,ribosomal small subunit binding,MF,
10267,GO:0043031,1,0.603705924544044,0,4,negative regulation of macrophage activation,BP,
10268,GO:0043032,1,0.220010601242896,0,12,positive regulation of macrophage activation,BP,
10279,GO:0043047,1,0.247392640576423,0,11,single-stranded telomeric DNA binding,MF,
10301,GO:0043102,1,0.472932815709567,0,6,amino acid salvage,BP,
10323,GO:0043137,1,0.610374680151936,0,4,DNA replication, removal of RNA primer,BP,
10325,GO:0043139,1,0.413485077375297,0,7,5'-3' DNA helicase activity,MF,
10327,GO:0043141,1,0.533336717717719,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10328,GO:0043142,1,0.192832827091718,0,13,single-stranded DNA-dependent ATPase activity,MF,
10329,GO:0043144,1,0.385676677794778,0,8,snoRNA processing,BP,
10354,GO:0043189,1,0.0904281382081245,0,19,H4/H2A histone acetyltransferase complex,CC,
10368,GO:0043208,1,0.601664025794947,0,4,glycosphingolipid binding,MF,
10376,GO:0043225,1,0.359916306342929,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
10382,GO:0043231,1,0,839,8303,intracellular membrane-bounded organelle,CC,TNIP1;XDH;DUSP6;H6PD;DLG4;ZC3H6;DOCK4;GAMT;F2R;ST6GALNAC2;NT5E;APOE;MARVELD1;ZMYND8;HS1BP3;NFATC4;XPC;FHL1;S100A6;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;LMF1;VWA5A;ALDH7A1;TYSND1;POSTN;SUGCT;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;ACP5;NAPRT;EDEM1;CRAT;GLUL;FAM210B;LRP1;ALOX15B;NAGS;PDCD4;OBSCN;NTSR1;EGFR;PADI3;ZSCAN18;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;ERCC1;ADAMTS7;HADH;S100A4;PRDX5;ANK3;BAHCC1;DUSP5;NEK9;BPHL;CLTCL1;FCHO1;ZKSCAN1;SPTB;NPEPL1;TSPAN1;SLC16A3;IGFBP4;KRT15;SLC2A9;SNPH;IDH2;FKBP9;CRTAP;CST3;DNM1;MEF2D;NOS1;GPSM1;DDIT3;ARAP3;TSC22D1;BRSK1;DNPH1;DNAJB5;ACAD10;CRTC1;CLCA2;PACS2;ERCC6;NDRG1;ADAMTS13;ABTB1;TCEA2;COL13A1;GRAMD4;SMARCA1;MST1R;ARMCX2;TRIM65;ZFP36L1;ADARB1;PPM1M;NUPR1;ARAP1;B3GAT3;TCFL5;RBL2;RPS6KA2;GAA;PYCR2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;MSRB2;OBSL1;MDFI;TK2;CERCAM;SLC27A1;CTSF;MAPK13;KLF9;REEP2;RNF165;MIF4GD;CDK18;PHACTR3;CPT2;MLYCD;ASAP2;PLD3;KLHDC2;ASH2L;SOX13;CUL7;LHPP;TMEM92;EPM2A;ATG16L2;HMGCL;UROS;HYAL1;NAGLU;OXLD1;ETV4;TXNRD3;WWTR1;SYNGR1;ACP6;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;COL6A1;PPL;ABCA2;PKN1;CAPG;DDIT4;H2AFJ;LPCAT4;BTG1;TRNP1;DNASE1L1;PHC2;PITPNM1;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MAML3;TUBG2;TMEM173;SNX9;FAM110C;ARL2;ULK1;SHC1;VPS11;PHF7;SPRY2;NPHP4;R3HDM2;OGDHL;SOX12;HDAC11;CD68;PTMS;CYBRD1;ITPR3;LAMA5;RALGDS;HSD11B1L;PITPNC1;APPL2;CIRBP;CAPRIN2;TTBK2;PRKCZ;PPP2R3B;PAK1;ABCA7;SLC37A2;APOBEC3C;AARS;PRR7;PHYH;MCTP1;ELK3;STK39;B4GALNT4;ERO1B;BLVRB;FGFR3;SEC14L2;BRD3;CEMIP;KDM3A;BRI3;FOXQ1;ARVCF;PHF1;GLDC;NDUFA4L2;TMEM44;CBS;SALL2;SYNE3;NMNAT2;DDX59;WDR27;NME4;PDZD2;FBXW8;ETV1;NSUN5P2;NEIL1;ABHD14B;CCDC88B;RAG1;SPPL2B;EAPP;SPEG;NGFR;MARCH4;ETV5;ETFB;LTBP1;MUC19;SMIM14;MALL;WNT2B;NSMCE4A;TRIB2;HES2;CHD2;GPT2;TEF;NIPSNAP1;SPG11;APBB3;TMC6;PTPRE;PNPLA3;RNF44;SSH3;RMI2;CYHR1;OLFM2;DHRS4;CCDC106;RHOBTB2;ANO8;TMED4;TNFRSF25;NAB2;PLA2G6;UNKL;CES3;ABCG1;DNMBP;ESYT2;XPOT;TRAPPC9;FAM50A;CARF;MANF;S100A13;AGAP1;FKBP10;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;CHAC1;CCDC92;SPC24;FNDC4;SESN2;AIP;BLMH;MKNK2;SCMH1;TCF25;IFT27;NLRX1;PKD2;SATB1;STAT6;KLF7;R3HDM4;ING4;VAMP2;HMGA2;AREG;ST6GALNAC6;COL8A1;AP1G2;SLIT3;B4GAT1;MARCH9;JADE2;ACACB;NT5C1B;MAPK3;CSPG4;LAMB2;PC;DEF6;BNIP3;ERRFI1;MACROD1;THRA;DCAF10;PEX10;STK40;ACSS2;SCARA3;RGS14;IRF2BPL;FAM20C;TDRKH;PBXIP1;RHOF;SLC22A18;ADAMTSL1;PAN2;CTSB;HOOK2;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;LTA4H;PI4K2A;NAT14;ZXDC;PQLC2;KIAA0319L;SDC2;CHMP1B;ARHGAP22;MLXIPL;IFNGR2;TBC1D14;PTPDC1;ARHGEF2;TSPYL2;MAP2K2;H1FX;SRD5A3;HIBADH;FLYWCH1;STMN3;SLC50A1;SDHA;TECPR1;SLC48A1;DMTN;LITAF;SEMA3B;PTHLH;UBXN4;NOL4L;ATF4;ZFPM1;MOSPD3;CHST6;BBC3;KDM4C;PAK6;ZNF467;LRRC45;LTB4R2;SV2A;FAM214B;SLC38A10;PRIMPOL;FAM193B;POLM;ACAP3;TENM2;FBXO6;IFI6;REEP6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;RALGAPA1;FLOT1;CEP68;TTN;PSKH1;HLCS;AZIN2;HSD11B1;JDP2;HDAC5;WHAMMP3;IRF5;SORL1;MAP6;TFB1M;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;TPBG;DHX32;DEAF1;TEP1;ST3GAL3;SULF2;CES2;TMEM175;NLRP1;PEG3;COL4A6;GLI4;RFX2;ENDOG;KDM7A;CEBPB;NEK8;RHBDF1;ACOT7;LRP5;TSTD1;ATRAID;ALDOC;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;METTL23;AQP3;ACADS;CEP131;ISG20;LONP2;EPN3;DGCR6L;HLTF;DNMT3A;TRIOBP;MXD3;TAGLN3;FOXL1;DIRC2;CSRNP3;TMSB4X;SLFN5;MAP1LC3A;APOL4;HSD17B7;PDE2A;SMURF2;LMO7;TRIB3;RAB40B;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXDC;MINK1;PIGZ;HEXB;LDOC1;ZFP90;SLC27A3;WNT7A;MARCH2;BNIP3L;PIK3R2;RHBDF2;NICN1;ZNF558;RPUSD3;ANGEL1;ZNF662;CCS;GAS6;VPS39;GLUD1;DNAJC6;SUCLG2;ERN1;NUDT6;ESRG;ALKBH7;ATP7B;FYCO1;MAN2C1;C19ORF33;NBR1;CPT1C;EXD3;HEXA;GOLGA2P5;TNNI2;TADA3;NBEAL2;BOLA1;SPAG16;UCKL1;NECAB3;CAMK1;POLL;TERC;CYP2R1;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;SPATA7;PRDM8;SLC9A3R2;STRADB;CTSH;WDR19;ACOX3;ACAD11;PNRC1;UACA;GSDMC;MGMT;TMEM9;ENTPD6;C12ORF66;TM7SF2;STEAP2;HINT2;MAPKBP1;AKT1;IGFBP7;ITPR2;DGUOK;REEP4;CDKN1C;SWT1;CRY2;MZT2B;B4GALT2;BEX2;AMIGO2;LAMB1;CHEK2;IFT57;LACTB2;PHYKPL;TMEM143;SBF2;ASS1;COMTD1;NFU1;CABYR;TSG101;FMNL3;PHF2;FGFR4;IGF2BP2;ZNF217;SNN;PIAS3;TCIRG1;ASAP3;HAGH;CBR4;PHLDA1;ACADVL;NUCB2;ZNF25;DNASE2;LMNA;FAAH;UPP1;MAB21L2;COPG1;ATG2A;C9ORF72;TBC1D20;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;NPIPA2;GOLGA8A;SMARCD2;SPATA18;ICA1;ARHGAP27;IFI27;PTOV1;INSR;WNT3;ACSS1;NCOA7;NELFCD;TENM4;SLC25A29;FOXO4;COG7;YPEL3;RPS6KA5;ANKZF1;PNPLA4;SMIM20;TPCN1;ULBP1;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;YIPF3;ZNF554;CPSF4;POLR2J2;LETMD1;ASIC1;ALDH1L1;HOXC5;GJB4;FAAP20;PIDD1;CAT;ZNF160;MZT2A;MYOF;MAPK10;DPP7;MPG;LGALS1;ZFP28;TIMP1;TP73;MTA3;MNT;FRAT1;UBOX5;ZNF846;APRT;TMX4;TFEB;CERS4;PEX7;SNX17;ENDOV;PHC1;SCYL3;METTL7A;SPIRE1;TMEM50B;CSNK1E;TAZ;HGSNAT;BCL6;RABAC1;HSF4;REC8;RNF213;SLC9A7;GSTM3;ADAP1;TKFC;FBXO25;SLC37A4;EHD3;FYN;ZC3H12D;ATP8B2;PJA2;SNX1;PEX1;LEMD2;HSDL1;UBXN6;SLC25A42;SIRT2;MBOAT2;GDF15;RECQL5;RAB13;TOM1;FAM220A;TST;GOLGA2;HCFC1R1;CELSR1;SH3GLB2;ADA;POU2F2;RCOR2;POLR3GL;RHOBTB3;NAGA;MTA1;RTN2;MSH5;ENTPD2;AP2A2;CIDEA;HDAC8;MYO18A;ADIRF;RETSAT;TCF7;MAN1B1;STX1A;GALNS;EPAS1;LAMTOR2;MFNG;CHD6;RNF170;LURAP1;EPHB2;NMRAL1;MAGI1;POLR2J3;PER1;LRCH4;MCTP2;IGF2BP3;ITGA2;SLC39A11;FGFR1;PIGV;WFS1;TMEM223;ZNF333;ESYT3;BLOC1S1;FITM2;FKBP8;XYLT2;ERBB2;SEC31B;KDELC2;UST;CCDC69;RGS12;SYVN1;C15ORF62;HLA-G;MPPE1;HMBOX1;NET1;TTC19;TSHZ1;CREB3L4;ZNF449;IRF2BP2;BSG;ZMYM3;SDHAF4;TRIM45;KCTD13;DBP;APBA1;PEX11A;ZNF667;TMEM8A;ZNF287;CAMKK1;PNKD;DTD1;KDSR;IKBKB;DMTF1;SNCB;HIP1;CYP4V2;PLEKHH2;TEAD2;ACOT8;TCTEX1D4;SIX5
10430,GO:0043304,1,0.0916779686081015,0,19,regulation of mast cell degranulation,BP,
10432,GO:0043306,1,0.368424506637773,0,8,positive regulation of mast cell degranulation,BP,
10444,GO:0043320,1,0.467144182036015,0,6,natural killer cell degranulation,BP,
10449,GO:0043328,1,0.622991672248896,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10454,GO:0043353,1,0.46464350459424,0,6,enucleate erythrocyte differentiation,BP,
10506,GO:0043455,1,0.36318985426341,0,8,regulation of secondary metabolic process,BP,
10507,GO:0043456,1,0.606129129864131,0,4,regulation of pentose-phosphate shunt,BP,
10509,GO:0043461,1,0.606334512136763,0,4,proton-transporting ATP synthase complex assembly,BP,
10514,GO:0043471,1,0.322462620563707,0,9,regulation of cellular carbohydrate catabolic process,BP,
10517,GO:0043476,1,0.222053114301222,0,12,pigment accumulation,BP,
10518,GO:0043482,1,0.222053114301222,0,12,cellular pigment accumulation,BP,
10520,GO:0043485,1,0.288246200190994,0,10,endosome to pigment granule transport,BP,
10521,GO:0043486,1,0.00362662458114292,0,48,histone exchange,BP,
10528,GO:0043495,1,0.41835687037944,0,7,protein membrane anchor,MF,
10529,GO:0043496,1,0.082958141569026,0,20,regulation of protein homodimerization activity,BP,
10530,GO:0043497,1,0.324164629674272,0,9,regulation of protein heterodimerization activity,BP,
10541,GO:0043515,1,0.531038321486734,0,5,kinetochore binding,MF,
10542,GO:0043516,1,0.0444819783786373,0,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10543,GO:0043517,1,0.254671377160446,0,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10544,GO:0043518,1,0.22497008544363,0,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10550,GO:0043527,1,0.537004165024023,0,5,tRNA methyltransferase complex,CC,
10583,GO:0043570,1,0.600137550620206,0,4,maintenance of DNA repeat elements,BP,
10588,GO:0043584,1,0.24556663071412,0,11,nose development,BP,
10591,GO:0043587,1,0.363928728494465,0,8,tongue morphogenesis,BP,
10613,GO:0043628,1,0.036683302045561,0,27,ncRNA 3'-end processing,BP,
10618,GO:0043633,1,0.373073244946001,0,8,polyadenylation-dependent RNA catabolic process,BP,
10619,GO:0043634,1,0.42391987812544,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10628,GO:0043656,1,0.410790215353706,0,7,intracellular region of host,CC,
10639,GO:0043734,1,0.612892930315186,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
10645,GO:0043813,1,0.527703323293416,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10660,GO:0043923,1,0.13133392534125,0,16,positive regulation by host of viral transcription,BP,
10661,GO:0043928,1,0.0181648826132369,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10673,GO:0043968,1,0.132198560037517,0,16,histone H2A acetylation,BP,
10682,GO:0043984,1,0.0893641859410546,0,19,histone H4-K16 acetylation,BP,
10683,GO:0043985,1,0.468742102360165,0,6,histone H4-R3 methylation,BP,
10688,GO:0043995,1,0.279447924723116,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10689,GO:0043996,1,0.279447924723116,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10695,GO:0044020,1,0.605034668044033,0,4,histone methyltransferase activity (H4-R3 specific),MF,
10698,GO:0044030,1,0.167597800683932,0,14,regulation of DNA methylation,BP,
10725,GO:0044110,1,0.538354540172762,0,5,growth involved in symbiotic interaction,BP,
10728,GO:0044116,1,0.538354540172762,0,5,growth of symbiont involved in interaction with host,BP,
10729,GO:0044117,1,0.538354540172762,0,5,growth of symbiont in host,BP,
10730,GO:0044126,1,0.60484390964874,0,4,regulation of growth of symbiont in host,BP,
10733,GO:0044144,1,0.60484390964874,0,4,modulation of growth of symbiont involved in interaction with host,BP,
10738,GO:0044154,1,0.410522378589919,0,7,histone H3-K14 acetylation,BP,
10762,GO:0044233,1,0.220775582585354,0,12,ER-mitochondrion membrane contact site,CC,
10790,GO:0044294,1,0.408926518415884,0,7,dendritic growth cone,CC,
10805,GO:0044314,1,0.621464981425392,0,4,protein K27-linked ubiquitination,BP,
10836,GO:0044352,1,0.602787095453177,0,4,pinosome,CC,
10837,GO:0044354,1,0.602787095453177,0,4,macropinosome,CC,
10840,GO:0044359,1,0.474662978373984,0,6,modulation of molecular function in other organism,BP,
10841,GO:0044362,1,0.539448706670885,0,5,negative regulation of molecular function in other organism,BP,
10842,GO:0044364,1,0.102782866513878,0,20,disruption of cells of other organism,BP,
10848,GO:0044388,1,0.546436028618201,0,5,small protein activating enzyme binding,MF,
10858,GO:0044413,1,0.600620191452517,0,4,avoidance of host defenses,BP,
10860,GO:0044415,1,0.600620191452517,0,4,evasion or tolerance of host defenses,BP,
10862,GO:0044417,1,0.325621559887433,0,9,translocation of molecules into host,BP,
10870,GO:0044428,1,0,309,3801,nuclear part,CC,TNIP1;DUSP6;DOCK4;NT5E;NFATC4;XPC;S100A6;FOS;H1F0;CITED4;EGR1;CTNNBIP1;VWA5A;PTK6;OBSCN;EGFR;DDB2;PRNP;NR1D1;ERCC1;HADH;BAHCC1;DUSP5;FCHO1;TSPAN1;SLC16A3;SLC2A9;CST3;DNM1;MEF2D;NOS1;DDIT3;BRSK1;CRTC1;CLCA2;ERCC6;ABTB1;TCEA2;SMARCA1;TRIM65;ADARB1;ARAP1;RBL2;RPS6KA2;TFDP2;MXI1;RPL13A;KLF9;MIF4GD;PHACTR3;CPT2;KLHDC2;ASH2L;SOX13;CUL7;LHPP;TMEM92;ATG16L2;ETV4;WWTR1;POLD4;PKN1;CAPG;H2AFJ;TRNP1;PHC2;PHF21A;DGKQ;MAML3;ARL2;PHF7;SOX12;HDAC11;ITPR3;HSD11B1L;PITPNC1;APPL2;CIRBP;PRKCZ;PPP2R3B;PAK1;ELK3;STK39;BLVRB;KDM3A;PHF1;SALL2;SYNE3;DDX59;WDR27;NSUN5P2;NEIL1;ABHD14B;RAG1;SPPL2B;NGFR;ETV5;NSMCE4A;CHD2;SPG11;TMC6;RNF44;RMI2;CYHR1;OLFM2;XPOT;FAM50A;CARF;S100A13;FKBP10;APOBEC3F;PPARA;INO80C;CHD3;CCDC92;SPC24;AIP;MKNK2;SCMH1;SATB1;STAT6;ING4;HMGA2;JADE2;MAPK3;DEF6;BNIP3;MACROD1;THRA;DCAF10;STK40;ACSS2;RGS14;IRF2BPL;SLC22A18;CTSB;EIF2D;MAPK12;LTA4H;MLXIPL;TBC1D14;PTPDC1;TSPYL2;H1FX;FLYWCH1;SDHA;TECPR1;LITAF;PTHLH;UBXN4;NOL4L;ATF4;ZFPM1;KDM4C;PAK6;LRRC45;LTB4R2;FAM193B;POLM;TENM2;CBX7;NSMCE1;FLOT1;TTN;PSKH1;HLCS;HDAC5;SORL1;IL17RD;SRSF5;DHX32;DEAF1;TEP1;NLRP1;KDM7A;CEBPB;ACOT7;ATRAID;CREBRF;L3MBTL1;ACADS;ISG20;EPN3;HLTF;DNMT3A;MXD3;SMURF2;RAB40B;BHLHE40;MLH3;CALCOCO1;HMG20B;CDK5RAP3;AGO4;LDOC1;BNIP3L;NICN1;ERN1;MAN2C1;NBR1;TADA3;POLL;TERC;RXRA;MBD1;TNRC18;SPATA7;WDR19;MGMT;TM7SF2;HINT2;MAPKBP1;AKT1;CRY2;MZT2B;B4GALT2;CHEK2;NFU1;TSG101;PHF2;ZNF217;PIAS3;ASAP3;PHLDA1;ACADVL;NUCB2;LMNA;UPP1;C9ORF72;TBC1D20;UHRF2;NPIPA2;SMARCD2;ARHGAP27;IFI27;INSR;NELFCD;FOXO4;COG7;YPEL3;RPS6KA5;ADD3;MAGED2;RABGGTA;ITGB6;C6ORF89;ZNF554;CPSF4;POLR2J2;LETMD1;HOXC5;GJB4;FAAP20;PIDD1;MZT2A;MYOF;MAPK10;MPG;TP73;MTA3;MNT;UBOX5;APRT;CERS4;ENDOV;PHC1;SPIRE1;CSNK1E;BCL6;HSF4;REC8;RNF213;ZC3H12D;LEMD2;SIRT2;RECQL5;HCFC1R1;CELSR1;SH3GLB2;POU2F2;POLR3GL;MTA1;MSH5;HDAC8;ADIRF;RETSAT;TCF7;STX1A;EPAS1;CHD6;MAGI1;POLR2J3;PER1;LRCH4;MCTP2;FGFR1;RGS12;SYVN1;MPPE1;HMBOX1;CREB3L4;IRF2BP2;ZMYM3;TRIM45;KCTD13;DTD1;DMTF1;PLEKHH2;TEAD2
10902,GO:0044528,1,0.601691476535724,0,4,regulation of mitochondrial mRNA stability,BP,
10904,GO:0044531,1,0.47521428880165,0,6,modulation of programmed cell death in other organism,BP,
10905,GO:0044532,1,0.47521428880165,0,6,modulation of apoptotic process in other organism,BP,
10909,GO:0044545,1,0.529915579424748,0,5,NSL complex,CC,
10911,GO:0044547,1,0.528843677725321,0,5,DNA topoisomerase binding,MF,
10915,GO:0044557,1,0.541977443468532,0,5,relaxation of smooth muscle,BP,
10917,GO:0044571,1,0.623970228650211,0,4,[2Fe-2S] cluster assembly,BP,
10930,GO:0044613,1,0.224209592163984,0,12,nuclear pore central transport channel,CC,
10931,GO:0044614,1,0.596784526228527,0,4,nuclear pore cytoplasmic filaments,CC,
10932,GO:0044615,1,0.315418346069261,0,9,nuclear pore nuclear basket,CC,
10970,GO:0044784,1,0.00239222326651333,0,48,metaphase/anaphase transition of cell cycle,BP,
10985,GO:0044806,1,0.409127902938929,0,7,G-quadruplex DNA unwinding,BP,
10994,GO:0044837,1,0.409709170941914,0,7,actomyosin contractile ring organization,BP,
10997,GO:0044848,1,0.367247485171721,0,8,biological phase,BP,
10999,GO:0044851,1,0.367247485171721,0,8,hair cycle phase,BP,
11006,GO:0044860,1,0.601726151242053,0,4,protein localization to plasma membrane raft,BP,
11012,GO:0045002,1,0.41041316020575,0,7,double-strand break repair via single-strand annealing,BP,
11013,GO:0045003,1,0.284070506342094,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11019,GO:0045009,1,0.478232446033461,0,6,chitosome,CC,
11032,GO:0045039,1,0.496042111087761,0,6,protein import into mitochondrial inner membrane,BP,
11033,GO:0045040,1,0.491401497825922,0,6,protein import into mitochondrial outer membrane,BP,
11035,GO:0045046,1,0.466331286786427,0,6,protein import into peroxisome membrane,BP,
11037,GO:0045048,1,0.532104241254842,0,5,protein insertion into ER membrane,BP,
11043,GO:0045059,1,0.470884065934965,0,6,positive thymic T cell selection,BP,
11057,GO:0045075,1,0.528416217218022,0,5,regulation of interleukin-12 biosynthetic process,BP,
11080,GO:0045110,1,0.467051898244733,0,6,intermediate filament bundle assembly,BP,
11084,GO:0045116,1,0.184852117400885,0,14,protein neddylation,BP,
11086,GO:0045120,1,0.215305885694234,0,12,pronucleus,CC,
11101,GO:0045144,1,0.537198403037075,0,5,meiotic sister chromatid segregation,BP,
11106,GO:0045161,1,0.358905771491223,0,8,neuronal ion channel clustering,BP,
11107,GO:0045162,1,0.597754464147933,0,4,clustering of voltage-gated sodium channels,BP,
11130,GO:0045198,1,0.279563311799231,0,10,establishment of epithelial cell apical/basal polarity,BP,
11152,GO:0045236,1,0.374736621974214,0,8,CXCR chemokine receptor binding,MF,
11158,GO:0045254,1,0.411851396401454,0,7,pyruvate dehydrogenase complex,CC,
11162,GO:0045271,1,0.00915483753155539,0,42,respiratory chain complex I,CC,
11166,GO:0045275,1,0.266130410450757,0,11,respiratory chain complex III,CC,
11171,GO:0045292,1,0.134098027213299,0,16,mRNA cis splicing, via spliceosome,BP,
11173,GO:0045294,1,0.3606450330253,0,8,alpha-catenin binding,MF,
11174,GO:0045295,1,0.314357000046314,0,9,gamma-catenin binding,MF,
11177,GO:0045298,1,0.610981267988948,0,4,tubulin complex,CC,
11183,GO:0045329,1,0.600723502237387,0,4,carnitine biosynthetic process,BP,
11189,GO:0045338,1,0.604793425036113,0,4,farnesyl diphosphate metabolic process,BP,
11191,GO:0045341,1,0.600081236823661,0,4,MHC class I biosynthetic process,BP,
11192,GO:0045342,1,0.53204259359951,0,5,MHC class II biosynthetic process,BP,
11193,GO:0045343,1,0.600081236823661,0,4,regulation of MHC class I biosynthetic process,BP,
11194,GO:0045345,1,0.600081236823661,0,4,positive regulation of MHC class I biosynthetic process,BP,
11195,GO:0045346,1,0.53204259359951,0,5,regulation of MHC class II biosynthetic process,BP,
11198,GO:0045349,1,0.606858146611356,0,4,interferon-alpha biosynthetic process,BP,
11199,GO:0045350,1,0.470329349958182,0,6,interferon-beta biosynthetic process,BP,
11200,GO:0045351,1,0.366637207907953,0,8,type I interferon biosynthetic process,BP,
11203,GO:0045354,1,0.606858146611356,0,4,regulation of interferon-alpha biosynthetic process,BP,
11206,GO:0045357,1,0.470329349958182,0,6,regulation of interferon-beta biosynthetic process,BP,
11208,GO:0045359,1,0.600407022042154,0,4,positive regulation of interferon-beta biosynthetic process,BP,
11229,GO:0045448,1,0.604436624187372,0,4,mitotic cell cycle, embryonic,BP,
11248,GO:0045569,1,0.606885598296859,0,4,TRAIL binding,MF,
11274,GO:0045605,1,0.281002310701695,0,10,negative regulation of epidermal cell differentiation,BP,
11276,GO:0045607,1,0.535563988461521,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11279,GO:0045617,1,0.466114492581367,0,6,negative regulation of keratinocyte differentiation,BP,
11293,GO:0045631,1,0.535563988461521,0,5,regulation of mechanoreceptor differentiation,BP,
11294,GO:0045632,1,0.608392971711824,0,4,negative regulation of mechanoreceptor differentiation,BP,
11295,GO:0045634,1,0.530928444565006,0,5,regulation of melanocyte differentiation,BP,
11305,GO:0045649,1,0.246934713188385,0,11,regulation of macrophage differentiation,BP,
11307,GO:0045651,1,0.31731420886311,0,9,positive regulation of macrophage differentiation,BP,
11309,GO:0045653,1,0.173423114587879,0,17,negative regulation of megakaryocyte differentiation,BP,
11330,GO:0045683,1,0.191520730556246,0,13,negative regulation of epidermis development,BP,
11333,GO:0045686,1,0.218343268562058,0,12,negative regulation of glial cell differentiation,BP,
11335,GO:0045713,1,0.414303340753217,0,7,low-density lipoprotein particle receptor biosynthetic process,BP,
11336,GO:0045714,1,0.469559210487401,0,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11340,GO:0045719,1,0.528019394992648,0,5,negative regulation of glycogen biosynthetic process,BP,
11341,GO:0045721,1,0.41025109127278,0,7,negative regulation of gluconeogenesis,BP,
11350,GO:0045736,1,0.0374361186726097,0,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
11374,GO:0045777,1,0.198563050225651,0,13,positive regulation of blood pressure,BP,
11382,GO:0045793,1,0.319096027806232,0,9,positive regulation of cell size,BP,
11394,GO:0045822,1,0.283218570702357,0,10,negative regulation of heart contraction,BP,
11401,GO:0045835,1,0.465416307033821,0,6,negative regulation of meiotic nuclear division,BP,
11407,GO:0045841,1,0.0225295385316961,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
11408,GO:0045842,1,0.370141824868104,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11420,GO:0045875,1,0.533003627678546,0,5,negative regulation of sister chromatid cohesion,BP,
11421,GO:0045876,1,0.281791744648365,0,10,positive regulation of sister chromatid cohesion,BP,
11428,GO:0045899,1,0.288646400307911,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11429,GO:0045900,1,0.605436579029609,0,4,negative regulation of translational elongation,BP,
11440,GO:0045915,1,0.540685014479078,0,5,positive regulation of catecholamine metabolic process,BP,
11444,GO:0045919,1,0.61159108098615,0,4,positive regulation of cytolysis,BP,
11469,GO:0045953,1,0.367013057654168,0,8,negative regulation of natural killer cell mediated cytotoxicity,BP,
11470,GO:0045954,1,0.366119836006636,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11474,GO:0045964,1,0.540685014479078,0,5,positive regulation of dopamine metabolic process,BP,
11485,GO:0045990,1,0.604580371437873,0,4,carbon catabolite regulation of transcription,BP,
11486,GO:0045991,1,0.604580371437873,0,4,carbon catabolite activation of transcription,BP,
11487,GO:0045992,1,0.0890587276424842,0,19,negative regulation of embryonic development,BP,
11493,GO:0046015,1,0.607343870881165,0,4,regulation of transcription by glucose,BP,
11505,GO:0046040,1,0.219772646322203,0,12,IMP metabolic process,BP,
11524,GO:0046075,1,0.615946914039438,0,4,dTTP metabolic process,BP,
11526,GO:0046078,1,0.608433351830661,0,4,dUMP metabolic process,BP,
11536,GO:0046098,1,0.605819814107153,0,4,guanine metabolic process,BP,
11564,GO:0046146,1,0.427389519437642,0,7,tetrahydrobiopterin metabolic process,BP,
11615,GO:0046341,1,0.168801712844417,0,14,CDP-diacylglycerol metabolic process,BP,
11616,GO:0046348,1,0.366041162258138,0,8,amino sugar catabolic process,BP,
11617,GO:0046349,1,0.248182403910869,0,11,amino sugar biosynthetic process,BP,
11631,GO:0046385,1,0.29349895708449,0,10,deoxyribose phosphate biosynthetic process,BP,
11643,GO:0046426,1,0.019468992820785,0,31,negative regulation of JAK-STAT cascade,BP,
11655,GO:0046457,1,0.123314711929558,0,17,prostanoid biosynthetic process,BP,
11665,GO:0046469,1,0.532592587893676,0,5,platelet activating factor metabolic process,BP,
11670,GO:0046475,1,0.154297228222692,0,15,glycerophospholipid catabolic process,BP,
11671,GO:0046476,1,0.531709702611539,0,5,glycosylceramide biosynthetic process,BP,
11675,GO:0046483,1,0,413,4714,heterocycle metabolic process,BP,TNIP1;XDH;H6PD;DLG4;ZC3H6;HTRA1;GAMT;F2R;NT5E;NYNRIN;APOE;ZMYND8;NFATC4;XPC;FOS;PRODH;H1F0;CITED4;EGR1;CTNNBIP1;ZNF862;ACP5;WWC3;NAPRT;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;DDB2;PRNP;NR1D1;ERCC1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;IGFBP4;SLC2A9;IDH2;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;PYCR2;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;ASH2L;SOX13;LHPP;PRSS3;UROS;ETV4;WWTR1;POLD4;MAP2K1;PCK2;MXD4;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;DNASE1L1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;MAGEF1;SHC1;OGDHL;SOX12;HDAC11;PTMS;NMRK1;CIRBP;CAPRIN2;PRKCZ;APOBEC3C;AARS;ELK3;PABPC1L;BLVRB;SEC14L2;BRD3;KDM3A;MTHFR;FOXQ1;PHF1;NPR2;CBS;SALL2;DLG3;NMNAT2;DDX59;NME4;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;ACVR2B;RAG1;EAPP;NGFR;ETV5;PPCS;NSMCE4A;HES2;EREG;CHD2;TEF;PSAT1;APBB3;RMI2;NAB2;UNKL;ABCG1;TRAPPC9;CARF;CARS;APOBEC3F;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;RRNAD1;HMGA2;AREG;ECM1;ACACB;NT5C1B;KCNAB2;MAPK3;TRPT1;PC;MACROD1;THRA;RGS14;IRF2BPL;FAM20C;TDRKH;PBXIP1;PAN2;ZSCAN30;MAPK12;MYH3;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SDHA;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;FBXO6;ZNF516;CBX7;PKD1;NSMCE1;MDK;HLCS;JDP2;HDAC5;GTPBP1;IRF5;GALK1;TFB1M;PCBP4;PLTP;SRSF5;VLDLR;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;ISG20;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;RPUSD3;ZNF662;GAS6;ERN1;MAPRE3;EXD3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;MGMT;ENTPD6;MAPKBP1;AKT1;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;LACTB2;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;ZNF25;DNASE2;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;ALDH1L1;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;MPG;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;MPI;ENDOV;CSNK1E;TAZ;BCL6;HSF4;REC8;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;MSH5;ENTPD2;FUK;CIDEA;HDAC8;MYO18A;ADIRF;RPL29;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;IGF2BP3;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;KCTD13;DBP;ZNF667;ZNF287;DTD1;IKBKB;DMTF1;HIP1;TEAD2;SIX5
11694,GO:0046512,1,0.370008583350661,0,8,sphingosine biosynthetic process,BP,
11698,GO:0046520,1,0.325643614834916,0,9,sphingoid biosynthetic process,BP,
11705,GO:0046532,1,0.527525084324124,0,5,regulation of photoreceptor cell differentiation,BP,
11706,GO:0046533,1,0.599401656223195,0,4,negative regulation of photoreceptor cell differentiation,BP,
11709,GO:0046540,1,0.0530088178715846,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11732,GO:0046599,1,0.116869037055357,0,17,regulation of centriole replication,BP,
11733,GO:0046600,1,0.365861744094785,0,8,negative regulation of centriole replication,BP,
11735,GO:0046602,1,0.364326516081409,0,8,regulation of mitotic centrosome separation,BP,
11738,GO:0046606,1,0.196896786483432,0,13,negative regulation of centrosome cycle,BP,
11739,GO:0046607,1,0.320645152246894,0,9,positive regulation of centrosome cycle,BP,
11769,GO:0046654,1,0.415878132136481,0,7,tetrahydrofolate biosynthetic process,BP,
11815,GO:0046784,1,0.36985023733001,0,8,viral mRNA export from host cell nucleus,BP,
11827,GO:0046826,1,0.431356690690441,0,7,negative regulation of protein export from nucleus,BP,
11829,GO:0046831,1,0.146892135914081,0,15,regulation of RNA export from nucleus,BP,
11831,GO:0046833,1,0.40952523183423,0,7,positive regulation of RNA export from nucleus,BP,
11834,GO:0046836,1,0.538242745981412,0,5,glycolipid transport,BP,
11835,GO:0046838,1,0.280898979102072,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11844,GO:0046855,1,0.280898979102072,0,10,inositol phosphate dephosphorylation,BP,
11856,GO:0046884,1,0.599670704551517,0,4,follicle-stimulating hormone secretion,BP,
11876,GO:0046920,1,0.529354257473001,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11883,GO:0046931,1,0.151534870596815,0,15,pore complex assembly,BP,
11888,GO:0046940,1,0.534905120944294,0,5,nucleoside monophosphate phosphorylation,BP,
11901,GO:0046965,1,0.244969891198453,0,11,retinoid X receptor binding,MF,
11902,GO:0046966,1,0.0334046918939965,0,27,thyroid hormone receptor binding,MF,
11907,GO:0046972,1,0.279447924723116,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11908,GO:0046974,1,0.528307539103152,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11909,GO:0046975,1,0.46062488287276,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11910,GO:0046976,1,0.528687333525805,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11911,GO:0046977,1,0.605906468104541,0,4,TAP binding,MF,
11912,GO:0046978,1,0.605906468104541,0,4,TAP1 binding,MF,
11917,GO:0046984,1,0.605024430922453,0,4,regulation of hemoglobin biosynthetic process,BP,
11940,GO:0047134,1,0.546893928074658,0,5,protein-disulfide reductase activity,MF,
11954,GO:0047238,1,0.600252835203372,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11987,GO:0047497,1,0.0922994701578875,0,19,mitochondrion transport along microtubule,BP,
11988,GO:0047498,1,0.465185151655957,0,6,calcium-dependent phospholipase A2 activity,MF,
12049,GO:0048019,1,0.287393239052605,0,10,receptor antagonist activity,MF,
12050,GO:0048020,1,0.322432298104808,0,10,CCR chemokine receptor binding,MF,
12054,GO:0048024,1,0.000337148830698382,0,63,regulation of mRNA splicing, via spliceosome,BP,
12055,GO:0048025,1,0.116417068897593,0,17,negative regulation of mRNA splicing, via spliceosome,BP,
12056,GO:0048026,1,0.219603741641469,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12064,GO:0048039,1,0.478637675139162,0,6,ubiquinone binding,MF,
12067,GO:0048048,1,0.0521007932870113,0,23,embryonic eye morphogenesis,BP,
12068,GO:0048050,1,0.481585784849254,0,6,post-embryonic eye morphogenesis,BP,
12070,GO:0048066,1,0.0227223506446288,0,30,developmental pigmentation,BP,
12071,GO:0048069,1,0.528899110049351,0,5,eye pigmentation,BP,
12072,GO:0048070,1,0.221258729027683,0,12,regulation of developmental pigmentation,BP,
12075,GO:0048087,1,0.416556261943718,0,7,positive regulation of developmental pigmentation,BP,
12088,GO:0048149,1,0.600729743941176,0,4,behavioral response to ethanol,BP,
12105,GO:0048200,1,0.469035362976472,0,6,Golgi transport vesicle coating,BP,
12107,GO:0048205,1,0.469035362976472,0,6,COPI coating of Golgi vesicle,BP,
12114,GO:0048227,1,0.369042859548199,0,8,plasma membrane to endosome transport,BP,
12121,GO:0048245,1,0.611043594381073,0,4,eosinophil chemotaxis,BP,
12126,GO:0048254,1,0.614022496043672,0,4,snoRNA localization,BP,
12128,GO:0048256,1,0.360754630167077,0,8,flap endonuclease activity,MF,
12141,GO:0048273,1,0.468005845992481,0,6,mitogen-activated protein kinase p38 binding,MF,
12143,GO:0048280,1,0.285276576303003,0,10,vesicle fusion with Golgi apparatus,BP,
12148,GO:0048290,1,0.466310575356434,0,6,isotype switching to IgA isotypes,BP,
12149,GO:0048291,1,0.362272139983909,0,8,isotype switching to IgG isotypes,BP,
12153,GO:0048296,1,0.529769827647553,0,5,regulation of isotype switching to IgA isotypes,BP,
12155,GO:0048298,1,0.601307060349611,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12156,GO:0048302,1,0.411410848707664,0,7,regulation of isotype switching to IgG isotypes,BP,
12157,GO:0048304,1,0.531031605968375,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12161,GO:0048311,1,0.167191304967894,0,14,mitochondrion distribution,BP,
12162,GO:0048312,1,0.464617282688937,0,6,intracellular distribution of mitochondria,BP,
12164,GO:0048318,1,0.544591621340074,0,5,axial mesoderm development,BP,
12171,GO:0048340,1,0.407653262375571,0,7,paraxial mesoderm morphogenesis,BP,
12172,GO:0048341,1,0.600262273888546,0,4,paraxial mesoderm formation,BP,
12185,GO:0048385,1,0.251020554963194,0,11,regulation of retinoic acid receptor signaling pathway,BP,
12186,GO:0048386,1,0.60091051909302,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
12187,GO:0048387,1,0.530742487354554,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
12201,GO:0048476,1,0.541735891448083,0,5,Holliday junction resolvase complex,CC,
12203,GO:0048478,1,0.412951081851403,0,7,replication fork protection,BP,
12215,GO:0048500,1,0.332410251173141,0,9,signal recognition particle,CC,
12224,GO:0048520,1,0.599326027242804,0,4,positive regulation of behavior,BP,
12230,GO:0048531,1,0.220058143828357,0,12,beta-1,3-galactosyltransferase activity,MF,
12233,GO:0048535,1,0.219853928756848,0,12,lymph node development,BP,
12242,GO:0048549,1,0.600327261009,0,4,positive regulation of pinocytosis,BP,
12248,GO:0048563,1,0.423826779882348,0,7,post-embryonic animal organ morphogenesis,BP,
12253,GO:0048570,1,0.532176774618061,0,5,notochord morphogenesis,BP,
12261,GO:0048596,1,0.127104882060011,0,16,embryonic camera-type eye morphogenesis,BP,
12282,GO:0048642,1,0.411497554401345,0,7,negative regulation of skeletal muscle tissue development,BP,
12291,GO:0048663,1,0.0539573800794114,0,23,neuron fate commitment,BP,
12293,GO:0048665,1,0.410552593166198,0,7,neuron fate specification,BP,
12319,GO:0048702,1,0.408827451397607,0,7,embryonic neurocranium morphogenesis,BP,
12320,GO:0048703,1,0.409672489382856,0,7,embryonic viscerocranium morphogenesis,BP,
12328,GO:0048712,1,0.530363389779111,0,5,negative regulation of astrocyte differentiation,BP,
12331,GO:0048715,1,0.363103765403049,0,8,negative regulation of oligodendrocyte differentiation,BP,
12336,GO:0048733,1,0.524631520845182,0,5,sebaceous gland development,BP,
12340,GO:0048741,1,0.192958777364584,0,13,skeletal muscle fiber development,BP,
12341,GO:0048742,1,0.527388166311058,0,5,regulation of skeletal muscle fiber development,BP,
12349,GO:0048755,1,0.52804580171823,0,5,branching morphogenesis of a nerve,BP,
12350,GO:0048757,1,0.288246200190994,0,10,pigment granule maturation,BP,
12363,GO:0048793,1,0.599450155381879,0,4,pronephros development,BP,
12371,GO:0048818,1,0.612046517379211,0,4,positive regulation of hair follicle maturation,BP,
12372,GO:0048819,1,0.367247485171721,0,8,regulation of hair follicle maturation,BP,
12373,GO:0048820,1,0.148306483854819,0,15,hair follicle maturation,BP,
12386,GO:0048853,1,0.407984424930962,0,7,forebrain morphogenesis,BP,
12416,GO:0050072,1,0.41522299861072,0,7,m7G(5')pppN diphosphatase activity,MF,
12423,GO:0050136,1,0.014674444006657,0,38,NADH dehydrogenase (quinone) activity,MF,
12425,GO:0050145,1,0.534905120944294,0,5,nucleoside phosphate kinase activity,MF,
12432,GO:0050220,1,0.616213307848587,0,4,prostaglandin-E synthase activity,MF,
12442,GO:0050308,1,0.530664413386291,0,5,sugar-phosphatase activity,MF,
12457,GO:0050428,1,0.465756249189603,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12472,GO:0050510,1,0.600228430728774,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
12474,GO:0050542,1,0.633287341283075,0,4,icosanoid binding,MF,
12475,GO:0050543,1,0.633287341283075,0,4,icosatetraenoic acid binding,MF,
12476,GO:0050544,1,0.633287341283075,0,4,arachidonic acid binding,MF,
12492,GO:0050656,1,0.600593333497998,0,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
12500,GO:0050664,1,0.475504505973278,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12501,GO:0050665,1,0.329230292480463,0,9,hydrogen peroxide biosynthetic process,BP,
12515,GO:0050685,1,0.0698819296255564,0,21,positive regulation of mRNA processing,BP,
12516,GO:0050686,1,0.0324394024690033,0,27,negative regulation of mRNA processing,BP,
12519,GO:0050689,1,0.53606404711316,0,5,negative regulation of defense response to virus by host,BP,
12532,GO:0050705,1,0.613453588774496,0,4,regulation of interleukin-1 alpha secretion,BP,
12540,GO:0050713,1,0.539232144688672,0,5,negative regulation of interleukin-1 beta secretion,BP,
12555,GO:0050733,1,0.601632289996276,0,4,RS domain binding,MF,
12565,GO:0050765,1,0.322867949154087,0,9,negative regulation of phagocytosis,BP,
12602,GO:0050811,1,0.32806364558103,0,9,GABA receptor binding,MF,
12603,GO:0050812,1,0.217095857935205,0,12,regulation of acyl-CoA biosynthetic process,BP,
12604,GO:0050815,1,0.473314960494521,0,6,phosphoserine residue binding,MF,
12613,GO:0050829,1,0.0563931700503564,0,25,defense response to Gram-negative bacterium,BP,
12619,GO:0050847,1,0.409870584060448,0,7,progesterone receptor signaling pathway,BP,
12627,GO:0050855,1,0.217074489951223,0,12,regulation of B cell receptor signaling pathway,BP,
12633,GO:0050861,1,0.601071456040191,0,4,positive regulation of B cell receptor signaling pathway,BP,
12644,GO:0050872,1,0.318174702047659,0,9,white fat cell differentiation,BP,
12651,GO:0050882,1,0.456750435197862,0,6,voluntary musculoskeletal movement,BP,
12657,GO:0050892,1,0.191700292125315,0,13,intestinal absorption,BP,
12671,GO:0050912,1,0.344187944566715,0,9,detection of chemical stimulus involved in sensory perception of taste,BP,
12689,GO:0050931,1,0.0545264014685981,0,23,pigment cell differentiation,BP,
12690,GO:0050932,1,0.411409994677303,0,7,regulation of pigment cell differentiation,BP,
12691,GO:0050942,1,0.528004697851367,0,5,positive regulation of pigment cell differentiation,BP,
12731,GO:0051023,1,0.324026298090576,0,9,regulation of immunoglobulin secretion,BP,
12732,GO:0051024,1,0.536771943956724,0,5,positive regulation of immunoglobulin secretion,BP,
12737,GO:0051030,1,0.613206162535507,0,4,snRNA transport,BP,
12741,GO:0051036,1,0.535729960851048,0,5,regulation of endosome size,BP,
12766,GO:0051084,1,0.0174784106240807,0,32,'de novo' posttranslational protein folding,BP,
12767,GO:0051085,1,0.0329893409102413,0,27,chaperone cofactor-dependent protein refolding,BP,
12777,GO:0051095,1,0.325016492354022,0,9,regulation of helicase activity,BP,
12778,GO:0051096,1,0.475448976052788,0,6,positive regulation of helicase activity,BP,
12785,GO:0051103,1,0.251615414296315,0,11,DNA ligation involved in DNA repair,BP,
12786,GO:0051105,1,0.466032689071386,0,6,regulation of DNA ligation,BP,
12787,GO:0051106,1,0.529413744101965,0,5,positive regulation of DNA ligation,BP,
12802,GO:0051131,1,0.118849672921644,0,17,chaperone-mediated protein complex assembly,BP,
12803,GO:0051132,1,0.543858390759204,0,5,NK T cell activation,BP,
12834,GO:0051177,1,0.609959968459605,0,4,meiotic sister chromatid cohesion,BP,
12866,GO:0051231,1,0.24812198458117,0,11,spindle elongation,BP,
12872,GO:0051238,1,0.240808158877604,0,12,sequestering of metal ion,BP,
12886,GO:0051256,1,0.363994725124889,0,8,mitotic spindle midzone assembly,BP,
12911,GO:0051292,1,0.282112523445326,0,10,nuclear pore complex assembly,BP,
12922,GO:0051305,1,0.527478168247078,0,5,chromosome movement towards spindle pole,BP,
12923,GO:0051306,1,0.00166312169118623,0,51,mitotic sister chromatid separation,BP,
12924,GO:0051307,1,0.21793711825207,0,12,meiotic chromosome separation,BP,
12928,GO:0051315,1,0.191237608733802,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12934,GO:0051340,1,0.367735062967714,0,8,regulation of ligase activity,BP,
12945,GO:0051351,1,0.417756416537427,0,7,positive regulation of ligase activity,BP,
12955,GO:0051382,1,0.16987584647725,0,14,kinetochore assembly,BP,
12956,GO:0051383,1,0.0899173922910605,0,19,kinetochore organization,BP,
12961,GO:0051388,1,0.600142288312062,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
12966,GO:0051400,1,0.367261810045118,0,8,BH domain binding,MF,
12984,GO:0051434,1,0.611439699964614,0,4,BH3 domain binding,MF,
12987,GO:0051444,1,0.213269663669814,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
12991,GO:0051450,1,0.368070962076763,0,8,myoblast proliferation,BP,
13041,GO:0051569,1,0.0699055886934456,0,21,regulation of histone H3-K4 methylation,BP,
13043,GO:0051571,1,0.168973292032219,0,14,positive regulation of histone H3-K4 methylation,BP,
13046,GO:0051574,1,0.416013949036378,0,7,positive regulation of histone H3-K9 methylation,BP,
13063,GO:0051597,1,0.467376298960871,0,6,response to methylmercury,BP,
13066,GO:0051601,1,0.528627107624344,0,5,exocyst localization,BP,
13080,GO:0051639,1,0.360702365863286,0,8,actin filament network formation,BP,
13086,GO:0051646,1,0.0119231364018572,0,35,mitochondrion localization,BP,
13093,GO:0051654,1,0.0812228699972629,0,20,establishment of mitochondrion localization,BP,
13095,GO:0051657,1,0.355793708435318,0,8,maintenance of organelle location,BP,
13096,GO:0051660,1,0.600130254772078,0,4,establishment of centrosome localization,BP,
13097,GO:0051661,1,0.522128674347033,0,5,maintenance of centrosome location,BP,
13110,GO:0051697,1,0.603910429048928,0,4,protein delipidation,BP,
13118,GO:0051709,1,0.426898289619834,0,7,regulation of killing of cells of other organism,BP,
13120,GO:0051712,1,0.426898289619834,0,7,positive regulation of killing of cells of other organism,BP,
13133,GO:0051731,1,0.603910649919114,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13142,GO:0051764,1,0.245356926203517,0,11,actin crosslink formation,BP,
13144,GO:0051766,1,0.529783290588945,0,5,inositol trisphosphate kinase activity,MF,
13145,GO:0051767,1,0.322229113541859,0,9,nitric-oxide synthase biosynthetic process,BP,
13146,GO:0051769,1,0.322229113541859,0,9,regulation of nitric-oxide synthase biosynthetic process,BP,
13147,GO:0051770,1,0.464872177624078,0,6,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13163,GO:0051794,1,0.612082573376789,0,4,regulation of timing of catagen,BP,
13166,GO:0051797,1,0.119024835515127,0,17,regulation of hair follicle development,BP,
13167,GO:0051798,1,0.291579336659744,0,10,positive regulation of hair follicle development,BP,
13175,GO:0051818,1,0.480304340065597,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13179,GO:0051832,1,0.600620191452517,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13181,GO:0051834,1,0.600620191452517,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
13183,GO:0051836,1,0.325621559887433,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13185,GO:0051852,1,0.612265802041556,0,4,disruption by host of symbiont cells,BP,
13190,GO:0051873,1,0.612265802041556,0,4,killing by host of symbiont cells,BP,
13194,GO:0051880,1,0.407752964729596,0,7,G-quadruplex DNA binding,MF,
13197,GO:0051883,1,0.480304340065597,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13198,GO:0051884,1,0.600102553102364,0,4,regulation of timing of anagen,BP,
13212,GO:0051901,1,0.620056394789808,0,4,positive regulation of mitochondrial depolarization,BP,
13218,GO:0051917,1,0.46701852105293,0,6,regulation of fibrinolysis,BP,
13219,GO:0051918,1,0.601980638844242,0,4,negative regulation of fibrinolysis,BP,
13251,GO:0051964,1,0.60001791386604,0,4,negative regulation of synapse assembly,BP,
13260,GO:0051974,1,0.36618440004458,0,8,negative regulation of telomerase activity,BP,
13265,GO:0051985,1,0.0107662669751928,0,36,negative regulation of chromosome segregation,BP,
13275,GO:0052040,1,0.47521428880165,0,6,modulation by symbiont of host programmed cell death,BP,
13276,GO:0052041,1,0.608072603290401,0,4,negative regulation by symbiont of host programmed cell death,BP,
13287,GO:0052150,1,0.535154658156577,0,5,modulation by symbiont of host apoptotic process,BP,
13291,GO:0052173,1,0.470163102495038,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13296,GO:0052200,1,0.470163102495038,0,6,response to host defenses,BP,
13298,GO:0052204,1,0.539448706670885,0,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13299,GO:0052205,1,0.474662978373984,0,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13304,GO:0052248,1,0.47521428880165,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13327,GO:0052428,1,0.612680573675604,0,4,modulation by host of symbiont molecular function,BP,
13328,GO:0052433,1,0.47521428880165,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13330,GO:0052490,1,0.608072603290401,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13343,GO:0052564,1,0.534262915021963,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13345,GO:0052572,1,0.534262915021963,0,5,response to host immune response,BP,
13362,GO:0052658,1,0.465038612230746,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13367,GO:0052695,1,0.466128177782779,0,6,cellular glucuronidation,BP,
13368,GO:0052696,1,0.601662486656474,0,4,flavonoid glucuronidation,BP,
13369,GO:0052697,1,0.601662486656474,0,4,xenobiotic glucuronidation,BP,
13372,GO:0052723,1,0.605192903984679,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13373,GO:0052724,1,0.605192903984679,0,4,inositol hexakisphosphate 3-kinase activity,MF,
13388,GO:0052803,1,0.600629436276767,0,4,imidazole-containing compound metabolic process,BP,
13391,GO:0052811,1,0.600055110615227,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
13404,GO:0052832,1,0.603617672162802,0,4,inositol monophosphate 3-phosphatase activity,MF,
13405,GO:0052833,1,0.603617672162802,0,4,inositol monophosphate 4-phosphatase activity,MF,
13406,GO:0052834,1,0.603617672162802,0,4,inositol monophosphate phosphatase activity,MF,
13410,GO:0052840,1,0.606378799054077,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13411,GO:0052841,1,0.606378799054077,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13412,GO:0052842,1,0.606378799054077,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13413,GO:0052843,1,0.606378799054077,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13414,GO:0052844,1,0.606378799054077,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13415,GO:0052845,1,0.606378799054077,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13416,GO:0052846,1,0.606378799054077,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13417,GO:0052847,1,0.606378799054077,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13418,GO:0052848,1,0.606378799054077,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13448,GO:0055009,1,0.602105023986291,0,4,atrial cardiac muscle tissue morphogenesis,BP,
13503,GO:0055105,1,0.504880238193085,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13514,GO:0055131,1,0.532392814531679,0,5,C3HC4-type RING finger domain binding,MF,
13526,GO:0060013,1,0.527695058994274,0,5,righting reflex,BP,
13528,GO:0060017,1,0.531214640967587,0,5,parathyroid gland development,BP,
13530,GO:0060019,1,0.326997722699463,0,9,radial glial cell differentiation,BP,
13533,GO:0060022,1,0.528186956588342,0,5,hard palate development,BP,
13544,GO:0060037,1,0.114616946575776,0,17,pharyngeal system development,BP,
13546,GO:0060039,1,0.165327387099888,0,14,pericardium development,BP,
13559,GO:0060052,1,0.415633148451162,0,7,neurofilament cytoskeleton organization,BP,
13562,GO:0060055,1,0.194113505403162,0,13,angiogenesis involved in wound healing,BP,
13563,GO:0060056,1,0.419766839477953,0,7,mammary gland involution,BP,
13566,GO:0060059,1,0.51858543996113,0,5,embryonic retina morphogenesis in camera-type eye,BP,
13573,GO:0060068,1,0.473691214963574,0,6,vagina development,BP,
13589,GO:0060087,1,0.615875133445853,0,4,relaxation of vascular smooth muscle,BP,
13593,GO:0060091,1,0.536525007954495,0,5,kinocilium,CC,
13600,GO:0060120,1,0.535616190522703,0,5,inner ear receptor cell fate commitment,BP,
13602,GO:0060123,1,0.597751329122359,0,4,regulation of growth hormone secretion,BP,
13611,GO:0060136,1,0.602242627518517,0,4,embryonic process involved in female pregnancy,BP,
13618,GO:0060149,1,0.17497351319364,0,14,negative regulation of posttranscriptional gene silencing,BP,
13625,GO:0060158,1,0.605245775704087,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
13626,GO:0060159,1,0.604682606294431,0,4,regulation of dopamine receptor signaling pathway,BP,
13652,GO:0060211,1,0.245407641755044,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13654,GO:0060213,1,0.245407641755044,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13662,GO:0060229,1,0.367216984966401,0,8,lipase activator activity,MF,
13663,GO:0060231,1,0.195520022962911,0,13,mesenchymal to epithelial transition,BP,
13679,GO:0060261,1,0.119257248799156,0,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
13695,GO:0060287,1,0.606163285942606,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
13703,GO:0060297,1,0.59485134704598,0,4,regulation of sarcomere organization,BP,
13729,GO:0060331,1,0.473800262397287,0,6,negative regulation of response to interferon-gamma,BP,
13734,GO:0060336,1,0.473800262397287,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
13736,GO:0060338,1,0.0250870000738022,0,29,regulation of type I interferon-mediated signaling pathway,BP,
13737,GO:0060339,1,0.410838484906836,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13738,GO:0060340,1,0.317767439752935,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,
13752,GO:0060363,1,0.41077234167108,0,7,cranial suture morphogenesis,BP,
13753,GO:0060364,1,0.600397127092492,0,4,frontal suture morphogenesis,BP,
13756,GO:0060368,1,0.466612557383158,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13757,GO:0060369,1,0.601738304329159,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13761,GO:0060373,1,0.600382908181231,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
13766,GO:0060379,1,0.408588728496433,0,7,cardiac muscle cell myoblast differentiation,BP,
13776,GO:0060391,1,0.216537488562818,0,12,positive regulation of SMAD protein signal transduction,BP,
13779,GO:0060394,1,0.413162914024936,0,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
13823,GO:0060452,1,0.533307682270398,0,5,positive regulation of cardiac muscle contraction,BP,
13850,GO:0060501,1,0.600782557566572,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
13856,GO:0060513,1,0.467127191769775,0,6,prostatic bud formation,BP,
13861,GO:0060526,1,0.5997019761372,0,4,prostate glandular acinus morphogenesis,BP,
13862,GO:0060527,1,0.5997019761372,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
13866,GO:0060534,1,0.411433214424988,0,7,trachea cartilage development,BP,
13868,GO:0060536,1,0.604048122975361,0,4,cartilage morphogenesis,BP,
13871,GO:0060539,1,0.52995534961052,0,5,diaphragm development,BP,
13891,GO:0060574,1,0.608931787224556,0,4,intestinal epithelial cell maturation,BP,
13893,GO:0060576,1,0.325798819135434,0,9,intestinal epithelial cell development,BP,
13902,GO:0060590,1,0.0123485813014088,0,35,ATPase regulator activity,MF,
13904,GO:0060592,1,0.601172200591749,0,4,mammary gland formation,BP,
13918,GO:0060613,1,0.47173432808462,0,6,fat pad development,BP,
13938,GO:0060670,1,0.28329816922641,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13943,GO:0060676,1,0.614393822487079,0,4,ureteric bud formation,BP,
13948,GO:0060684,1,0.602661058521893,0,4,epithelial-mesenchymal cell signaling,BP,
13958,GO:0060696,1,0.542672396152247,0,5,regulation of phospholipid catabolic process,BP,
13961,GO:0060699,1,0.605287640573598,0,4,regulation of endoribonuclease activity,BP,
13962,GO:0060700,1,0.322585005647158,0,9,regulation of ribonuclease activity,BP,
13989,GO:0060736,1,0.40881923729355,0,7,prostate gland growth,BP,
13996,GO:0060745,1,0.599229173408512,0,4,mammary gland branching involved in pregnancy,BP,
14010,GO:0060765,1,0.0630096496975291,0,22,regulation of androgen receptor signaling pathway,BP,
14011,GO:0060766,1,0.361808702188735,0,8,negative regulation of androgen receptor signaling pathway,BP,
14012,GO:0060767,1,0.322801135899494,0,9,epithelial cell proliferation involved in prostate gland development,BP,
14013,GO:0060768,1,0.366783303422668,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14015,GO:0060770,1,0.474591248872992,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14033,GO:0060837,1,0.465389794847813,0,6,blood vessel endothelial cell differentiation,BP,
14035,GO:0060839,1,0.409698065647614,0,7,endothelial cell fate commitment,BP,
14048,GO:0060872,1,0.600692336045945,0,4,semicircular canal development,BP,
14053,GO:0060896,1,0.361072384604626,0,8,neural plate pattern specification,BP,
14054,GO:0060897,1,0.466695379715106,0,6,neural plate regionalization,BP,
14055,GO:0060900,1,0.358870073183021,0,8,embryonic camera-type eye formation,BP,
14065,GO:0060916,1,0.599429981348411,0,4,mesenchymal cell proliferation involved in lung development,BP,
14069,GO:0060923,1,0.530124590863117,0,5,cardiac muscle cell fate commitment,BP,
14081,GO:0060956,1,0.598005736976014,0,4,endocardial cell differentiation,BP,
14084,GO:0060965,1,0.219086208110508,0,12,negative regulation of gene silencing by miRNA,BP,
14086,GO:0060967,1,0.17497351319364,0,14,negative regulation of gene silencing by RNA,BP,
14091,GO:0060973,1,0.279660861923014,0,10,cell migration involved in heart development,BP,
14112,GO:0061004,1,0.415770615805786,0,7,pattern specification involved in kidney development,BP,
14129,GO:0061036,1,0.087839735549314,0,19,positive regulation of cartilage development,BP,
14134,GO:0061042,1,0.467826664836276,0,6,vascular wound healing,BP,
14142,GO:0061051,1,0.53371538638396,0,5,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14154,GO:0061081,1,0.545907087385531,0,5,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14156,GO:0061083,1,0.601510589346942,0,4,regulation of protein refolding,BP,
14157,GO:0061084,1,0.601510589346942,0,4,negative regulation of protein refolding,BP,
14161,GO:0061088,1,0.465636942140497,0,6,regulation of sequestering of zinc ion,BP,
14167,GO:0061101,1,0.608532010743468,0,4,neuroendocrine cell differentiation,BP,
14177,GO:0061133,1,0.550824503511954,0,5,endopeptidase activator activity,MF,
14191,GO:0061154,1,0.25065556611615,0,11,endothelial tube morphogenesis,BP,
14196,GO:0061162,1,0.146623937141432,0,15,establishment of monopolar cell polarity,BP,
14199,GO:0061179,1,0.43588576316885,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14206,GO:0061196,1,0.600567419935419,0,4,fungiform papilla development,BP,
14207,GO:0061197,1,0.600567419935419,0,4,fungiform papilla morphogenesis,BP,
14230,GO:0061309,1,0.469748566348549,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
14232,GO:0061312,1,0.531580426142436,0,5,BMP signaling pathway involved in heart development,BP,
14233,GO:0061314,1,0.524389295969257,0,5,Notch signaling involved in heart development,BP,
14237,GO:0061323,1,0.250864784504951,0,11,cell proliferation involved in heart morphogenesis,BP,
14243,GO:0061339,1,0.146623937141432,0,15,establishment or maintenance of monopolar cell polarity,BP,
14253,GO:0061355,1,0.601845293497027,0,4,Wnt protein secretion,BP,
14254,GO:0061356,1,0.601845293497027,0,4,regulation of Wnt protein secretion,BP,
14276,GO:0061436,1,0.0689193241100062,0,21,establishment of skin barrier,BP,
14291,GO:0061470,1,0.599250899617916,0,4,T follicular helper cell differentiation,BP,
14303,GO:0061511,1,0.609944672306424,0,4,centriole elongation,BP,
14320,GO:0061550,1,0.600195220699691,0,4,cranial ganglion development,BP,
14334,GO:0061575,1,0.630323983677308,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
14336,GO:0061578,1,0.246515569359844,0,11,Lys63-specific deubiquitinase activity,MF,
14351,GO:0061617,1,0.378967704697383,0,8,MICOS complex,CC,
14358,GO:0061626,1,0.467539779238993,0,6,pharyngeal arch artery morphogenesis,BP,
14363,GO:0061631,1,0.0388153974731709,0,26,ubiquitin conjugating enzyme activity,MF,
14364,GO:0061635,1,0.415156614179374,0,7,regulation of protein complex stability,BP,
14366,GO:0061641,1,0.00976008802956121,0,40,CENP-A containing chromatin organization,BP,
14373,GO:0061650,1,0.0345249846942372,0,27,ubiquitin-like protein conjugating enzyme activity,MF,
14377,GO:0061665,1,0.530931038777629,0,5,SUMO ligase activity,MF,
14378,GO:0061668,1,0.4687793830249,0,6,mitochondrial ribosome assembly,BP,
14380,GO:0061673,1,0.528530721002546,0,5,mitotic spindle astral microtubule,CC,
14382,GO:0061684,1,0.28029464081224,0,10,chaperone-mediated autophagy,BP,
14384,GO:0061687,1,0.450329025556641,0,7,detoxification of inorganic compound,BP,
14401,GO:0061732,1,0.467907728251795,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14403,GO:0061734,1,0.524498063729949,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
14437,GO:0061820,1,0.317137472415349,0,9,telomeric D-loop disassembly,BP,
14438,GO:0061821,1,0.600021945302467,0,4,telomeric D-loop binding,MF,
14478,GO:0061983,1,0.4728221726196,0,6,meiosis II cell cycle process,BP,
14493,GO:0070003,1,0.127222072619037,0,18,threonine-type peptidase activity,MF,
14496,GO:0070008,1,0.280531208527918,0,10,serine-type exopeptidase activity,MF,
14536,GO:0070087,1,0.461149443154056,0,6,chromo shadow domain binding,MF,
14547,GO:0070102,1,0.189562255347595,0,13,interleukin-6-mediated signaling pathway,BP,
14550,GO:0070106,1,0.360095926566526,0,8,interleukin-27-mediated signaling pathway,BP,
14558,GO:0070125,1,4.2062753941066e-05,0,86,mitochondrial translational elongation,BP,
14559,GO:0070126,1,3.27051375756958e-05,0,88,mitochondrial translational termination,BP,
14560,GO:0070127,1,0.362529304115163,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14561,GO:0070129,1,0.104249464086815,0,18,regulation of mitochondrial translation,BP,
14563,GO:0070131,1,0.251545873417681,0,11,positive regulation of mitochondrial translation,BP,
14564,GO:0070137,1,0.599854952744869,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14566,GO:0070139,1,0.599854952744869,0,4,SUMO-specific endopeptidase activity,MF,
14576,GO:0070162,1,0.531329434421259,0,5,adiponectin secretion,BP,
14577,GO:0070163,1,0.531329434421259,0,5,regulation of adiponectin secretion,BP,
14578,GO:0070164,1,0.603582982402881,0,4,negative regulation of adiponectin secretion,BP,
14595,GO:0070187,1,0.466860546101126,0,6,shelterin complex,CC,
14596,GO:0070189,1,0.606299735570447,0,4,kynurenine metabolic process,BP,
14603,GO:0070198,1,0.0366981960470199,0,26,protein localization to chromosome, telomeric region,BP,
14604,GO:0070199,1,0.0552503216522336,0,23,establishment of protein localization to chromosome,BP,
14605,GO:0070200,1,0.1684542319684,0,14,establishment of protein localization to telomere,BP,
14607,GO:0070202,1,0.248145444007905,0,11,regulation of establishment of protein localization to chromosome,BP,
14608,GO:0070203,1,0.281909065668616,0,10,regulation of establishment of protein localization to telomere,BP,
14613,GO:0070212,1,0.598833834907823,0,4,protein poly-ADP-ribosylation,BP,
14614,GO:0070213,1,0.598581508460957,0,4,protein auto-ADP-ribosylation,BP,
14619,GO:0070230,1,0.230010471459432,0,12,positive regulation of lymphocyte apoptotic process,BP,
14623,GO:0070234,1,0.329861142761307,0,9,positive regulation of T cell apoptotic process,BP,
14624,GO:0070235,1,0.531759823459213,0,5,regulation of activation-induced cell death of T cells,BP,
14625,GO:0070236,1,0.602945094076728,0,4,negative regulation of activation-induced cell death of T cells,BP,
14629,GO:0070245,1,0.532302378150219,0,5,positive regulation of thymocyte apoptotic process,BP,
14634,GO:0070257,1,0.474993468969752,0,6,positive regulation of mucus secretion,BP,
14671,GO:0070318,1,0.604436998181099,0,4,positive regulation of G0 to G1 transition,BP,
14685,GO:0070341,1,0.465026240372458,0,6,fat cell proliferation,BP,
14687,GO:0070344,1,0.465026240372458,0,6,regulation of fat cell proliferation,BP,
14688,GO:0070345,1,0.600232813904343,0,4,negative regulation of fat cell proliferation,BP,
14691,GO:0070358,1,0.539898118703544,0,5,actin polymerization-dependent cell motility,BP,
14694,GO:0070370,1,0.541077536534997,0,5,cellular heat acclimation,BP,
14707,GO:0070391,1,0.53009419597804,0,5,response to lipoteichoic acid,BP,
14716,GO:0070410,1,0.405483032480915,0,7,co-SMAD binding,MF,
14717,GO:0070411,1,0.316118367690409,0,9,I-SMAD binding,MF,
14722,GO:0070419,1,0.407908123544151,0,7,nonhomologous end joining complex,CC,
14724,GO:0070424,1,0.464476267442218,0,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14730,GO:0070431,1,0.362435259386555,0,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14756,GO:0070486,1,0.297274021656455,0,10,leukocyte aggregation,BP,
14757,GO:0070487,1,0.60387692469881,0,4,monocyte aggregation,BP,
14768,GO:0070508,1,0.533455122135415,0,5,cholesterol import,BP,
14775,GO:0070525,1,0.197014829511888,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14779,GO:0070531,1,0.528333875714236,0,5,BRCA1-A complex,CC,
14780,GO:0070534,1,0.00641236315994149,0,40,protein K63-linked ubiquitination,BP,
14781,GO:0070535,1,0.527180321904085,0,5,histone H2A K63-linked ubiquitination,BP,
14789,GO:0070545,1,0.601048942499516,0,4,PeBoW complex,CC,
14803,GO:0070567,1,0.367904192379338,0,8,cytidylyltransferase activity,MF,
14804,GO:0070568,1,0.535604792111539,0,5,guanylyltransferase activity,MF,
14805,GO:0070569,1,0.413292358163643,0,7,uridylyltransferase activity,MF,
14814,GO:0070579,1,0.594432313663011,0,4,methylcytosine dioxygenase activity,MF,
14815,GO:0070584,1,0.0755068040335181,0,21,mitochondrion morphogenesis,BP,
14822,GO:0070601,1,0.367410614264823,0,8,centromeric sister chromatid cohesion,BP,
14833,GO:0070628,1,0.109750770683224,0,18,proteasome binding,MF,
14836,GO:0070633,1,0.250783744813389,0,11,transepithelial transport,BP,
14870,GO:0070696,1,0.25072723976763,0,11,transmembrane receptor protein serine/threonine kinase binding,MF,
14873,GO:0070700,1,0.323559604392536,0,9,BMP receptor binding,MF,
14876,GO:0070717,1,0.0691751165734346,0,21,poly-purine tract binding,MF,
14887,GO:0070741,1,0.0684575361514815,0,21,response to interleukin-6,BP,
14890,GO:0070757,1,0.360102830267051,0,8,interleukin-35-mediated signaling pathway,BP,
14891,GO:0070761,1,0.476079212328659,0,6,pre-snoRNP complex,CC,
14893,GO:0070765,1,0.475690528504525,0,6,gamma-secretase complex,CC,
14897,GO:0070775,1,0.409555379635589,0,7,H3 histone acetyltransferase complex,CC,
14898,GO:0070776,1,0.409555379635589,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14900,GO:0070778,1,0.600331348844152,0,4,L-aspartate transmembrane transport,BP,
14907,GO:0070815,1,0.600336995723674,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14908,GO:0070816,1,0.150077263837659,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14912,GO:0070822,1,0.170835467003794,0,14,Sin3-type complex,CC,
14918,GO:0070831,1,0.408383778615833,0,7,basement membrane assembly,BP,
14922,GO:0070840,1,0.0992327179314544,0,18,dynein complex binding,MF,
14929,GO:0070847,1,0.374483580048326,0,8,core mediator complex,CC,
14941,GO:0070862,1,0.284750125772293,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
14944,GO:0070874,1,0.528019394992648,0,5,negative regulation of glycogen metabolic process,BP,
14946,GO:0070876,1,0.600418979753034,0,4,SOSS complex,CC,
14948,GO:0070878,1,0.358852307095009,0,8,primary miRNA binding,MF,
14949,GO:0070883,1,0.538391139228229,0,5,pre-miRNA binding,MF,
14952,GO:0070886,1,0.365790766175567,0,8,positive regulation of calcineurin-NFAT signaling cascade,BP,
14963,GO:0070900,1,0.32553979837157,0,9,mitochondrial tRNA modification,BP,
14964,GO:0070901,1,0.611144413191833,0,4,mitochondrial tRNA methylation,BP,
14980,GO:0070934,1,0.603003178854329,0,4,CRD-mediated mRNA stabilization,BP,
14981,GO:0070935,1,0.247194772742669,0,11,3'-UTR-mediated mRNA stabilization,BP,
14983,GO:0070937,1,0.53070545670332,0,5,CRD-mediated mRNA stability complex,CC,
14984,GO:0070938,1,0.244517306817752,0,11,contractile ring,CC,
14986,GO:0070940,1,0.533088673884593,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
14987,GO:0070942,1,0.606930380437178,0,4,neutrophil mediated cytotoxicity,BP,
15006,GO:0070973,1,0.602151500677308,0,4,protein localization to endoplasmic reticulum exit site,BP,
15010,GO:0070979,1,0.0361013146748407,0,27,protein K11-linked ubiquitination,BP,
15015,GO:0070986,1,0.221611405250777,0,12,left/right axis specification,BP,
15016,GO:0070987,1,0.107199149001644,0,18,error-free translesion synthesis,BP,
15019,GO:0070990,1,0.479400123308728,0,6,snRNP binding,MF,
15026,GO:0071004,1,0.122148466558671,0,17,U2-type prespliceosome,CC,
15029,GO:0071007,1,0.0283679662925166,0,29,U2-type catalytic step 2 spliceosome,CC,
15030,GO:0071008,1,0.606964639784884,0,4,U2-type post-mRNA release spliceosomal complex,CC,
15031,GO:0071010,1,0.0660128136752405,0,22,prespliceosome,CC,
15033,GO:0071012,1,0.466944616640978,0,6,catalytic step 1 spliceosome,CC,
15035,GO:0071014,1,0.323148547344402,0,9,post-mRNA release spliceosomal complex,CC,
15038,GO:0071025,1,0.158969774654931,0,15,RNA surveillance,BP,
15040,GO:0071027,1,0.205164792245181,0,13,nuclear RNA surveillance,BP,
15041,GO:0071028,1,0.205164792245181,0,13,nuclear mRNA surveillance,BP,
15042,GO:0071029,1,0.482208839492383,0,6,nuclear ncRNA surveillance,BP,
15045,GO:0071033,1,0.539025621091765,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15046,GO:0071034,1,0.607350976414036,0,4,CUT catabolic process,BP,
15047,GO:0071035,1,0.482208839492383,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15048,GO:0071038,1,0.547781913884863,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15049,GO:0071042,1,0.614559599791712,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15050,GO:0071043,1,0.607350976414036,0,4,CUT metabolic process,BP,
15051,GO:0071044,1,0.251978431067458,0,11,histone mRNA catabolic process,BP,
15053,GO:0071046,1,0.482208839492383,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15054,GO:0071047,1,0.614559599791712,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15057,GO:0071051,1,0.554043382490804,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15088,GO:0071169,1,0.373122522653065,0,8,establishment of protein localization to chromatin,BP,
15089,GO:0071173,1,0.0256046314616646,0,29,spindle assembly checkpoint,BP,
15090,GO:0071174,1,0.0256046314616646,0,29,mitotic spindle checkpoint,BP,
15091,GO:0071203,1,0.466201040130374,0,6,WASH complex,CC,
15092,GO:0071204,1,0.475179276503573,0,6,histone pre-mRNA 3'end processing complex,CC,
15093,GO:0071205,1,0.596279197805345,0,4,protein localization to juxtaparanode region of axon,BP,
15095,GO:0071208,1,0.625812373987011,0,4,histone pre-mRNA DCP binding,MF,
15097,GO:0071211,1,0.601033839067995,0,4,protein targeting to vacuole involved in autophagy,BP,
15106,GO:0071223,1,0.53009419597804,0,5,cellular response to lipoteichoic acid,BP,
15121,GO:0071253,1,0.52848510584632,0,5,connexin binding,MF,
15122,GO:0071256,1,0.63245428989473,0,4,translocon complex,CC,
15123,GO:0071257,1,0.528340329248855,0,5,cellular response to electrical stimulus,BP,
15130,GO:0071267,1,0.472932815709567,0,6,L-methionine salvage,BP,
15139,GO:0071284,1,0.599317457330138,0,4,cellular response to lead ion,BP,
15143,GO:0071294,1,0.396644933330434,0,8,cellular response to zinc ion,BP,
15155,GO:0071316,1,0.53628536470479,0,5,cellular response to nicotine,BP,
15182,GO:0071354,1,0.0684575361514815,0,21,cellular response to interleukin-6,BP,
15192,GO:0071371,1,0.190068632258355,0,13,cellular response to gonadotropin stimulus,BP,
15193,GO:0071372,1,0.359801443266042,0,8,cellular response to follicle-stimulating hormone stimulus,BP,
15207,GO:0071389,1,0.471511148813309,0,6,cellular response to mineralocorticoid stimulus,BP,
15208,GO:0071391,1,0.245969734887987,0,11,cellular response to estrogen stimulus,BP,
15211,GO:0071394,1,0.414002396450517,0,7,cellular response to testosterone stimulus,BP,
15214,GO:0071397,1,0.243862172271726,0,11,cellular response to cholesterol,BP,
15234,GO:0071428,1,0.162519845913745,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15238,GO:0071438,1,0.60444953813473,0,4,invadopodium membrane,CC,
15240,GO:0071440,1,0.529388297560969,0,5,regulation of histone H3-K14 acetylation,BP,
15243,GO:0071447,1,0.536767286562209,0,5,cellular response to hydroperoxide,BP,
15249,GO:0071455,1,0.46615405931231,0,6,cellular response to hyperoxia,BP,
15252,GO:0071459,1,0.0802493737091275,0,20,protein localization to chromosome, centromeric region,BP,
15284,GO:0071501,1,0.361469321403854,0,8,cellular response to sterol depletion,BP,
15293,GO:0071532,1,0.600051293315234,0,4,ankyrin repeat binding,MF,
15294,GO:0071535,1,0.606759568746559,0,4,RING-like zinc finger domain binding,MF,
15298,GO:0071541,1,0.425012247109138,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15300,GO:0071543,1,0.606378799054077,0,4,diphosphoinositol polyphosphate metabolic process,BP,
15307,GO:0071550,1,0.369752084779149,0,8,death-inducing signaling complex assembly,BP,
15315,GO:0071564,1,0.21893737521572,0,12,npBAF complex,CC,
15316,GO:0071565,1,0.217322340716063,0,12,nBAF complex,CC,
15323,GO:0071578,1,0.465999441345567,0,6,zinc ion import across plasma membrane,BP,
15335,GO:0071598,1,0.536387301156706,0,5,neuronal ribonucleoprotein granule,CC,
15336,GO:0071599,1,0.408772899008178,0,7,otic vesicle development,BP,
15337,GO:0071600,1,0.599538477540196,0,4,otic vesicle morphogenesis,BP,
15354,GO:0071624,1,0.114038001511985,0,18,positive regulation of granulocyte chemotaxis,BP,
15359,GO:0071634,1,0.114069069154648,0,17,regulation of transforming growth factor beta production,BP,
15360,GO:0071635,1,0.46564945418776,0,6,negative regulation of transforming growth factor beta production,BP,
15361,GO:0071636,1,0.360304962995525,0,8,positive regulation of transforming growth factor beta production,BP,
15378,GO:0071664,1,0.599404357159641,0,4,catenin-TCF7L2 complex,CC,
15387,GO:0071677,1,0.261938883355523,0,11,positive regulation of mononuclear cell migration,BP,
15390,GO:0071680,1,0.527983926771907,0,5,response to indole-3-methanol,BP,
15391,GO:0071681,1,0.527983926771907,0,5,cellular response to indole-3-methanol,BP,
15411,GO:0071712,1,0.252268773686958,0,11,ER-associated misfolded protein catabolic process,BP,
15419,GO:0071731,1,0.245696373729488,0,11,response to nitric oxide,BP,
15420,GO:0071732,1,0.279322328466004,0,10,cellular response to nitric oxide,BP,
15422,GO:0071763,1,0.46560507079717,0,6,nuclear membrane organization,BP,
15427,GO:0071782,1,0.102149154810566,0,18,endoplasmic reticulum tubular network,CC,
15429,GO:0071787,1,0.600946996655806,0,4,endoplasmic reticulum tubular network formation,BP,
15439,GO:0071803,1,0.323638720492735,0,9,positive regulation of podosome assembly,BP,
15446,GO:0071816,1,0.604874886220114,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
15447,GO:0071817,1,0.543472478992713,0,5,MMXD complex,CC,
15457,GO:0071837,1,0.363142837403151,0,8,HMG box domain binding,MF,
15459,GO:0071839,1,0.608770037953422,0,4,apoptotic process in bone marrow,BP,
15463,GO:0071850,1,0.172625459018916,0,14,mitotic cell cycle arrest,BP,
15467,GO:0071865,1,0.608560473594217,0,4,regulation of apoptotic process in bone marrow,BP,
15468,GO:0071866,1,0.608560473594217,0,4,negative regulation of apoptotic process in bone marrow,BP,
15485,GO:0071888,1,0.370650721703022,0,8,macrophage apoptotic process,BP,
15490,GO:0071896,1,0.598500611319163,0,4,protein localization to adherens junction,BP,
15527,GO:0071987,1,0.599762136684789,0,4,WD40-repeat domain binding,MF,
15553,GO:0072047,1,0.607575493261962,0,4,proximal/distal pattern formation involved in nephron development,BP,
15554,GO:0072048,1,0.415770615805786,0,7,renal system pattern specification,BP,
15555,GO:0072049,1,0.611650172105542,0,4,comma-shaped body morphogenesis,BP,
15572,GO:0072079,1,0.254437229759621,0,11,nephron tubule formation,BP,
15574,GO:0072081,1,0.607575493261962,0,4,specification of nephron tubule identity,BP,
15575,GO:0072086,1,0.607575493261962,0,4,specification of loop of Henle identity,BP,
15619,GO:0072148,1,0.219281053708856,0,12,epithelial cell fate commitment,BP,
15622,GO:0072161,1,0.602128333027406,0,4,mesenchymal cell differentiation involved in kidney development,BP,
15629,GO:0072172,1,0.614393822487079,0,4,mesonephric tubule formation,BP,
15635,GO:0072178,1,0.529731558087486,0,5,nephric duct morphogenesis,BP,
15641,GO:0072189,1,0.40948687304112,0,7,ureter development,BP,
15664,GO:0072217,1,0.52999289194586,0,5,negative regulation of metanephros development,BP,
15717,GO:0072321,1,0.298786430983865,0,10,chaperone-mediated protein transport,BP,
15724,GO:0072338,1,0.599977245044666,0,4,cellular lactam metabolic process,BP,
15727,GO:0072344,1,0.603269068221311,0,4,rescue of stalled ribosome,BP,
15731,GO:0072349,1,0.315998688758255,0,9,modified amino acid transmembrane transporter activity,MF,
15736,GO:0072357,1,0.41183884196373,0,7,PTW/PP1 phosphatase complex,CC,
15754,GO:0072385,1,0.593261243728284,0,4,minus-end-directed organelle transport along microtubule,BP,
15759,GO:0072393,1,0.242130667841487,0,11,microtubule anchoring at microtubule organizing center,BP,
15761,GO:0072396,1,0.463875844741087,0,6,response to cell cycle checkpoint signaling,BP,
15763,GO:0072402,1,0.463875844741087,0,6,response to DNA integrity checkpoint signaling,BP,
15767,GO:0072423,1,0.463875844741087,0,6,response to DNA damage checkpoint signaling,BP,
15768,GO:0072425,1,0.24458734499439,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15774,GO:0072487,1,0.528630214233712,0,5,MSL complex,CC,
15775,GO:0072488,1,0.412258629984921,0,7,ammonium transmembrane transport,BP,
15779,GO:0072501,1,0.599751446086948,0,4,cellular divalent inorganic anion homeostasis,BP,
15780,GO:0072502,1,0.599751446086948,0,4,cellular trivalent inorganic anion homeostasis,BP,
15798,GO:0072526,1,0.604715924333709,0,4,pyridine-containing compound catabolic process,BP,
15803,GO:0072531,1,0.470506576721045,0,6,pyrimidine-containing compound transmembrane transport,BP,
15807,GO:0072537,1,0.529405361833207,0,5,fibroblast activation,BP,
15808,GO:0072538,1,0.321004814446212,0,9,T-helper 17 type immune response,BP,
15809,GO:0072539,1,0.413747426769426,0,7,T-helper 17 cell differentiation,BP,
15810,GO:0072540,1,0.609488143868441,0,4,T-helper 17 cell lineage commitment,BP,
15813,GO:0072546,1,0.279371133475602,0,10,ER membrane protein complex,CC,
15820,GO:0072559,1,0.483675005188929,0,6,NLRP3 inflammasome complex,CC,
15841,GO:0072589,1,0.63421987874922,0,4,box H/ACA scaRNP complex,CC,
15849,GO:0072602,1,0.599082971291608,0,4,interleukin-4 secretion,BP,
15854,GO:0072610,1,0.601752992271195,0,4,interleukin-12 secretion,BP,
15859,GO:0072641,1,0.462165739910049,0,6,type I interferon secretion,BP,
15860,GO:0072642,1,0.462165739910049,0,6,interferon-alpha secretion,BP,
15872,GO:0072669,1,0.432711030750844,0,7,tRNA-splicing ligase complex,CC,
15874,GO:0072672,1,0.600241732823832,0,4,neutrophil extravasation,BP,
15879,GO:0072677,1,0.473439539358997,0,6,eosinophil migration,BP,
15890,GO:0072697,1,0.248064650919955,0,11,protein localization to cell cortex,BP,
15898,GO:0072710,1,0.31569843019542,0,9,response to hydroxyurea,BP,
15899,GO:0072711,1,0.358645806731245,0,8,cellular response to hydroxyurea,BP,
15902,GO:0072716,1,0.614244040960646,0,4,response to actinomycin D,BP,
15925,GO:0075136,1,0.470163102495038,0,6,response to host,BP,
15931,GO:0075525,1,0.536600965238629,0,5,viral translational termination-reinitiation,BP,
15934,GO:0075713,1,0.367361577925139,0,8,establishment of integrated proviral latency,BP,
15938,GO:0080009,1,0.281861022661035,0,10,mRNA methylation,BP,
15943,GO:0080084,1,0.5286414607237,0,5,5S rDNA binding,MF,
15959,GO:0080182,1,0.137859577190257,0,16,histone H3-K4 trimethylation,BP,
15961,GO:0085020,1,0.423633598927305,0,7,protein K6-linked ubiquitination,BP,
15967,GO:0086004,1,0.0786531070253353,0,20,regulation of cardiac muscle cell contraction,BP,
15974,GO:0086011,1,0.246518909381777,0,11,membrane repolarization during action potential,BP,
15976,GO:0086013,1,0.361495528726779,0,8,membrane repolarization during cardiac muscle cell action potential,BP,
15977,GO:0086014,1,0.278003201196252,0,10,atrial cardiac muscle cell action potential,BP,
15987,GO:0086026,1,0.278003201196252,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
15989,GO:0086028,1,0.611080965427793,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
15995,GO:0086042,1,0.464112742134753,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
15996,GO:0086043,1,0.611080965427793,0,4,bundle of His cell action potential,BP,
16007,GO:0086064,1,0.133138177687424,0,16,cell communication by electrical coupling involved in cardiac conduction,BP,
16009,GO:0086066,1,0.278003201196252,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
16012,GO:0086069,1,0.322070441743909,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16015,GO:0086073,1,0.527167359350899,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16021,GO:0086080,1,0.358255394060366,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16023,GO:0086083,1,0.527167359350899,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16032,GO:0089701,1,0.550447361146668,0,5,U2AF,CC,
16036,GO:0089720,1,0.479506586596877,0,6,caspase binding,MF,
16037,GO:0090009,1,0.598073293590011,0,4,primitive streak formation,BP,
16038,GO:0090022,1,0.0965062358296731,0,19,regulation of neutrophil chemotaxis,BP,
16039,GO:0090023,1,0.141405260636193,0,16,positive regulation of neutrophil chemotaxis,BP,
16041,GO:0090025,1,0.2289671106465,0,12,regulation of monocyte chemotaxis,BP,
16042,GO:0090026,1,0.335388257526864,0,9,positive regulation of monocyte chemotaxis,BP,
16046,GO:0090032,1,0.600362299806592,0,4,negative regulation of steroid hormone biosynthetic process,BP,
16059,GO:0090063,1,0.600396318813607,0,4,positive regulation of microtubule nucleation,BP,
16064,GO:0090069,1,0.194894113272274,0,13,regulation of ribosome biogenesis,BP,
16065,GO:0090070,1,0.369114527517264,0,8,positive regulation of ribosome biogenesis,BP,
16066,GO:0090071,1,0.600218908752343,0,4,negative regulation of ribosome biogenesis,BP,
16067,GO:0090073,1,0.367269574305126,0,8,positive regulation of protein homodimerization activity,BP,
16068,GO:0090074,1,0.534201817809203,0,5,negative regulation of protein homodimerization activity,BP,
16083,GO:0090091,1,0.599354715526533,0,4,positive regulation of extracellular matrix disassembly,BP,
16114,GO:0090151,1,0.24366966610268,0,12,establishment of protein localization to mitochondrial membrane,BP,
16117,GO:0090155,1,0.606590043420578,0,4,negative regulation of sphingolipid biosynthetic process,BP,
16119,GO:0090158,1,0.529393263426049,0,5,endoplasmic reticulum membrane organization,BP,
16125,GO:0090168,1,0.605677879804932,0,4,Golgi reassembly,BP,
16138,GO:0090185,1,0.318506929664357,0,9,negative regulation of kidney development,BP,
16160,GO:0090208,1,0.247733823317886,0,11,positive regulation of triglyceride metabolic process,BP,
16166,GO:0090219,1,0.60049417287598,0,4,negative regulation of lipid kinase activity,BP,
16171,GO:0090230,1,0.600112561185923,0,4,regulation of centromere complex assembly,BP,
16176,GO:0090235,1,0.404475784195435,0,7,regulation of metaphase plate congression,BP,
16179,GO:0090239,1,0.252831889664364,0,11,regulation of histone H4 acetylation,BP,
16180,GO:0090240,1,0.421138816981679,0,7,positive regulation of histone H4 acetylation,BP,
16181,GO:0090241,1,0.606440439269824,0,4,negative regulation of histone H4 acetylation,BP,
16183,GO:0090245,1,0.597963415618058,0,4,axis elongation involved in somitogenesis,BP,
16192,GO:0090261,1,0.610284548160767,0,4,positive regulation of inclusion body assembly,BP,
16194,GO:0090266,1,0.19419638096309,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16195,GO:0090267,1,0.412885384564223,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16204,GO:0090280,1,0.531536365896866,0,5,positive regulation of calcium ion import,BP,
16216,GO:0090296,1,0.605984258026126,0,4,regulation of mitochondrial DNA replication,BP,
16222,GO:0090304,1,0,345,4177,nucleic acid metabolic process,BP,TNIP1;ZC3H6;HTRA1;F2R;NT5E;NYNRIN;APOE;ZMYND8;NFATC4;XPC;FOS;H1F0;CITED4;EGR1;CTNNBIP1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;DDB2;PRNP;NR1D1;ERCC1;PRDX5;BAHCC1;ZKSCAN1;IGFBP4;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;TFDP2;MXI1;RPL13A;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;ASH2L;SOX13;ETV4;WWTR1;POLD4;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;DNASE1L1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;MAGEF1;SHC1;SOX12;HDAC11;PTMS;CIRBP;CAPRIN2;PRKCZ;APOBEC3C;AARS;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;CBS;SALL2;DDX59;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;ACVR2B;RAG1;EAPP;NGFR;ETV5;NSMCE4A;HES2;EREG;CHD2;TEF;APBB3;RMI2;NAB2;UNKL;ABCG1;TRAPPC9;CARF;CARS;APOBEC3F;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;RRNAD1;HMGA2;AREG;ECM1;MAPK3;TRPT1;THRA;RGS14;IRF2BPL;TDRKH;PBXIP1;PAN2;ZSCAN30;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;PRIMPOL;POLM;TENM2;FBXO6;ZNF516;CBX7;PKD1;NSMCE1;MDK;JDP2;HDAC5;GTPBP1;IRF5;TFB1M;PCBP4;SRSF5;VLDLR;ADGRF1;DHX32;DEAF1;TEP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;ISG20;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;MLH3;CALCOCO1;EDA;HMG20B;CDK5RAP3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;RPUSD3;ZNF662;GAS6;ERN1;MAPRE3;EXD3;TNNI2;TADA3;BOLA1;CAMK1;POLL;TERC;PTAFR;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;MGMT;MAPKBP1;AKT1;CARD11;CDKN1C;SWT1;CRY2;CHEK2;IFT57;LACTB2;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;ZNF25;DNASE2;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;MPG;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;ENDOV;CSNK1E;BCL6;HSF4;REC8;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;MSH5;CIDEA;HDAC8;MYO18A;ADIRF;RPL29;TGFBR3;TCF7;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;IGF2BP3;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;DTD1;IKBKB;DMTF1;HIP1;TEAD2;SIX5
16227,GO:0090309,1,0.600126417510751,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16267,GO:0090394,1,0.602173908231712,0,4,negative regulation of excitatory postsynaptic potential,BP,
16270,GO:0090400,1,0.410157729936646,0,7,stress-induced premature senescence,BP,
16280,GO:0090435,1,0.419299310096576,0,7,protein localization to nuclear envelope,BP,
16284,GO:0090481,1,0.285494592060954,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16295,GO:0090520,1,0.318367515023586,0,9,sphingolipid mediated signaling pathway,BP,
16296,GO:0090521,1,0.600262858668581,0,4,glomerular visceral epithelial cell migration,BP,
16313,GO:0090576,1,0.363958696759915,0,8,RNA polymerase III transcription factor complex,CC,
16327,GO:0090646,1,0.222087518962043,0,12,mitochondrial tRNA processing,BP,
16332,GO:0090657,1,0.245675514387121,0,11,telomeric loop disassembly,BP,
16337,GO:0090666,1,0.603224690191781,0,4,scaRNA localization to Cajal body,BP,
16340,GO:0090669,1,0.602310324023728,0,4,telomerase RNA stabilization,BP,
16341,GO:0090670,1,0.0943268850499512,0,19,RNA localization to Cajal body,BP,
16342,GO:0090671,1,0.0943268850499512,0,19,telomerase RNA localization to Cajal body,BP,
16343,GO:0090672,1,0.0943268850499512,0,19,telomerase RNA localization,BP,
16347,GO:0090685,1,0.0943268850499512,0,19,RNA localization to nucleus,BP,
16352,GO:0090723,1,0.250484816431159,0,11,growth cone part,CC,
16353,GO:0090724,1,0.601889654366602,0,4,central region of growth cone,CC,
16357,GO:0090735,1,0.284070506342094,0,10,DNA repair complex assembly,BP,
16359,GO:0090741,1,0.478232446033461,0,6,pigment granule membrane,CC,
16377,GO:0097027,1,0.416836152297312,0,7,ubiquitin-protein transferase activator activity,MF,
16392,GO:0097056,1,0.604463127686703,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
16400,GO:0097065,1,0.600885867852649,0,4,anterior head development,BP,
16411,GO:0097094,1,0.24511201806287,0,11,craniofacial suture morphogenesis,BP,
16412,GO:0097100,1,0.541327356198338,0,5,supercoiled DNA binding,MF,
16437,GO:0097136,1,0.474026077303661,0,6,Bcl-2 family protein complex,CC,
16441,GO:0097150,1,0.0998519152489094,0,18,neuronal stem cell population maintenance,BP,
16443,GO:0097152,1,0.411737777395628,0,7,mesenchymal cell apoptotic process,BP,
16444,GO:0097153,1,0.231418728185532,0,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,
16445,GO:0097154,1,0.609419897588669,0,4,GABAergic neuron differentiation,BP,
16448,GO:0097157,1,0.362222009715053,0,8,pre-mRNA intronic binding,MF,
16454,GO:0097165,1,0.532240676597709,0,5,nuclear stress granule,CC,
16459,GO:0097176,1,0.604724245387676,0,4,epoxide metabolic process,BP,
16462,GO:0097179,1,0.634864025546402,0,4,protease inhibitor complex,CC,
16473,GO:0097197,1,0.530403128970212,0,5,tetraspanin-enriched microdomain,CC,
16475,GO:0097199,1,0.540839206130281,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16476,GO:0097200,1,0.258623647806248,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
16481,GO:0097209,1,0.604716310415155,0,4,epidermal lamellar body,CC,
16503,GO:0097255,1,0.539002783477532,0,5,R2TP complex,CC,
16517,GO:0097296,1,0.223681183585623,0,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
16525,GO:0097322,1,0.469101889133984,0,6,7SK snRNA binding,MF,
16531,GO:0097340,1,0.24888855294608,0,11,inhibition of cysteine-type endopeptidase activity,BP,
16532,GO:0097341,1,0.24888855294608,0,11,zymogen inhibition,BP,
16533,GO:0097342,1,0.467061660532983,0,6,ripoptosome,CC,
16544,GO:0097361,1,0.612495211272387,0,4,CIA complex,CC,
16547,GO:0097366,1,0.061512108316781,0,22,response to bronchodilator,BP,
16554,GO:0097381,1,0.52545392776322,0,5,photoreceptor disc membrane,CC,
16566,GO:0097411,1,0.606466335600273,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
16569,GO:0097418,1,0.528354878208962,0,5,neurofibrillary tangle,CC,
16571,GO:0097422,1,0.529003570898419,0,5,tubular endosome,CC,
16573,GO:0097427,1,0.527977351096377,0,5,microtubule bundle,CC,
16576,GO:0097433,1,0.530952197163091,0,5,dense body,CC,
16584,GO:0097449,1,0.465369320727308,0,6,astrocyte projection,CC,
16600,GO:0097484,1,0.114970374547251,0,17,dendrite extension,BP,
16613,GO:0097501,1,0.45034844917733,0,7,stress response to metal ion,BP,
16616,GO:0097504,1,0.253511592440948,0,11,Gemini of coiled bodies,CC,
16618,GO:0097506,1,0.539021623391689,0,5,deaminated base DNA N-glycosylase activity,MF,
16623,GO:0097524,1,0.599284173268143,0,4,sperm plasma membrane,CC,
16625,GO:0097526,1,0.0300833039972483,0,29,spliceosomal tri-snRNP complex,CC,
16626,GO:0097527,1,0.601902337319206,0,4,necroptotic signaling pathway,BP,
16640,GO:0097550,1,0.474329483029028,0,6,transcriptional preinitiation complex,CC,
16649,GO:0097602,1,0.119714847589046,0,17,cullin family protein binding,MF,
16670,GO:0097646,1,0.61530711603698,0,4,calcitonin family receptor signaling pathway,BP,
16677,GO:0097677,1,0.479117041953675,0,6,STAT family protein binding,MF,
16701,GO:0097732,1,0.536525007954495,0,5,9+2 non-motile cilium,CC,
16713,GO:0098501,1,0.541013089264986,0,5,polynucleotide dephosphorylation,BP,
16717,GO:0098505,1,0.281134569442419,0,10,G-rich strand telomeric DNA binding,MF,
16723,GO:0098528,1,0.603533568108147,0,4,skeletal muscle fiber differentiation,BP,
16726,GO:0098532,1,0.49271483313169,0,6,histone H3-K27 trimethylation,BP,
16728,GO:0098534,1,0.0224939476288125,0,30,centriole assembly,BP,
16732,GO:0098543,1,0.414821299510458,0,7,detection of other organism,BP,
16737,GO:0098556,1,0.586101539987898,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16745,GO:0098576,1,0.601850685095904,0,4,lumenal side of membrane,CC,
16747,GO:0098581,1,0.365159755114435,0,8,detection of external biotic stimulus,BP,
16755,GO:0098596,1,0.592318352385406,0,4,imitative learning,BP,
16756,GO:0098597,1,0.517604532685009,0,5,observational learning,BP,
16757,GO:0098598,1,0.592318352385406,0,4,learned vocalization behavior or vocal learning,BP,
16771,GO:0098641,1,0.107026464632717,0,18,cadherin binding involved in cell-cell adhesion,MF,
16829,GO:0098779,1,0.366459034441851,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
16830,GO:0098780,1,0.116272079124637,0,17,response to mitochondrial depolarisation,BP,
16852,GO:0098814,1,0.532760725388895,0,5,spontaneous synaptic transmission,BP,
16857,GO:0098826,1,0.600937962599132,0,4,endoplasmic reticulum tubular network membrane,CC,
16872,GO:0098845,1,0.467045744340313,0,6,postsynaptic endosome,CC,
16873,GO:0098847,1,0.192447054109236,0,13,sequence-specific single stranded DNA binding,MF,
16898,GO:0098903,1,0.464308778166799,0,6,regulation of membrane repolarization during action potential,BP,
16904,GO:0098909,1,0.533258045681968,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16905,GO:0098910,1,0.526797070652773,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16906,GO:0098911,1,0.316327442312414,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16928,GO:0098957,1,0.602236336127489,0,4,anterograde axonal transport of mitochondrion,BP,
16929,GO:0098960,1,0.600566688342694,0,4,postsynaptic neurotransmitter receptor activity,MF,
16982,GO:0099116,1,0.144917210718333,0,16,tRNA 5'-end processing,BP,
16988,GO:0099133,1,0.359916306342929,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
17012,GO:0099515,1,0.312599059324047,0,9,actin filament-based transport,BP,
17024,GO:0099529,1,0.600566688342694,0,4,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
17054,GO:0099602,1,0.48053541573531,0,6,neurotransmitter receptor regulator activity,MF,
17059,GO:0099612,1,0.462039839134576,0,6,protein localization to axon,BP,
17102,GO:0102158,1,0.600559987125195,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17107,GO:0102336,1,0.531814387460337,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17108,GO:0102337,1,0.531814387460337,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17109,GO:0102338,1,0.531814387460337,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17114,GO:0102343,1,0.600559987125195,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17115,GO:0102344,1,0.600559987125195,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17116,GO:0102345,1,0.600559987125195,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17119,GO:0102391,1,0.600161135096973,0,4,decanoate-CoA ligase activity,MF,
17120,GO:0102420,1,0.600316902281753,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17140,GO:0102756,1,0.531814387460337,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17182,GO:0106058,1,0.365790766175567,0,8,positive regulation of calcineurin-mediated signaling,BP,
17190,GO:0106077,1,0.60032776036264,0,4,histone succinylation,BP,
17200,GO:0110011,1,0.527156652319063,0,5,regulation of basement membrane organization,BP,
17216,GO:0110096,1,0.547112613581226,0,5,cellular response to aldehyde,BP,
17217,GO:0120009,1,0.529490321577522,0,5,intermembrane lipid transfer,BP,
17219,GO:0120013,1,0.529490321577522,0,5,intermembrane lipid transfer activity,MF,
17262,GO:0140053,1,8.74983459949496e-09,0,153,mitochondrial gene expression,BP,
17265,GO:0140059,1,0.600311267052444,0,4,dendrite arborization,BP,
17285,GO:0140131,1,0.330098487414151,0,9,positive regulation of lymphocyte chemotaxis,BP,
17296,GO:0150005,1,0.286555002159087,0,10,enzyme activator complex,CC,
17318,GO:1900028,1,0.603577822172742,0,4,negative regulation of ruffle assembly,BP,
17322,GO:1900037,1,0.290471678147123,0,10,regulation of cellular response to hypoxia,BP,
17323,GO:1900038,1,0.469995637771821,0,6,negative regulation of cellular response to hypoxia,BP,
17325,GO:1900040,1,0.526936171552622,0,5,regulation of interleukin-2 secretion,BP,
17328,GO:1900044,1,0.358906755278957,0,8,regulation of protein K63-linked ubiquitination,BP,
17329,GO:1900045,1,0.526948943588808,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17333,GO:1900060,1,0.606590043420578,0,4,negative regulation of ceramide biosynthetic process,BP,
17369,GO:1900125,1,0.464656986775304,0,6,regulation of hyaluronan biosynthetic process,BP,
17423,GO:1900227,1,0.600141285215285,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17427,GO:1900242,1,0.464559551986993,0,6,regulation of synaptic vesicle endocytosis,BP,
17431,GO:1900246,1,0.527036971200834,0,5,positive regulation of RIG-I signaling pathway,BP,
17432,GO:1900247,1,0.246786757661446,0,11,regulation of cytoplasmic translational elongation,BP,
17436,GO:1900262,1,0.472009753527589,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17437,GO:1900264,1,0.472009753527589,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17444,GO:1900363,1,0.217382586665886,0,12,regulation of mRNA polyadenylation,BP,
17445,GO:1900364,1,0.360311787068946,0,8,negative regulation of mRNA polyadenylation,BP,
17453,GO:1900376,1,0.599303525897606,0,4,regulation of secondary metabolite biosynthetic process,BP,
17464,GO:1900426,1,0.42253586889384,0,7,positive regulation of defense response to bacterium,BP,
17468,GO:1900452,1,0.604814157818664,0,4,regulation of long term synaptic depression,BP,
17494,GO:1900864,1,0.32553979837157,0,9,mitochondrial RNA modification,BP,
17500,GO:1901018,1,0.319598944348934,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17506,GO:1901029,1,0.419901482331581,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17509,GO:1901032,1,0.19966324181621,0,13,negative regulation of response to reactive oxygen species,BP,
17515,GO:1901072,1,0.531135521427271,0,5,glucosamine-containing compound catabolic process,BP,
17519,GO:1901077,1,0.60036101253124,0,4,regulation of relaxation of muscle,BP,
17527,GO:1901097,1,0.6008793450614,0,4,negative regulation of autophagosome maturation,BP,
17551,GO:1901201,1,0.244706157608941,0,11,regulation of extracellular matrix assembly,BP,
17553,GO:1901203,1,0.359622988711926,0,8,positive regulation of extracellular matrix assembly,BP,
17555,GO:1901213,1,0.361689958910322,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17585,GO:1901299,1,0.536850585030921,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17593,GO:1901317,1,0.618799874951282,0,4,regulation of flagellated sperm motility,BP,
17603,GO:1901341,1,0.60015840306541,0,4,positive regulation of store-operated calcium channel activity,BP,
17612,GO:1901363,1,7.4034477899185e-11,434,4574,heterocyclic compound binding,MF,XDH;H6PD;ACTA2;ZC3H6;NT5E;NYNRIN;ZMYND8;NFATC4;XPC;FOS;PRODH;H1F0;ACSF2;PYGB;EGR1;ZNF862;PTK6;GLUL;LRP1;PDCD4;OBSCN;EGFR;ZSCAN18;DDB2;D2HGDH;ZDHHC1;SCN8A;NR1D1;ERCC1;HADH;S100A4;PRDX5;BAHCC1;NEK9;RAPGEF3;ZKSCAN1;DGKA;SLC16A3;IDH2;FKBP9;DNM1;MEF2D;NOS1;DDIT3;BRSK1;ACAD10;ERCC6;ABTB1;TCEA2;KHNYN;ZCCHC24;MYH15;SMARCA1;MST1R;HEBP1;ZFP36L1;ADARB1;CUL9;NUPR1;TCFL5;RBL2;PHGDH;RPS6KA2;PYGL;CYP3A5;DHTKD1;TFDP2;MXI1;RPL13A;TK2;ULK2;SLC27A1;MAPK13;KLF9;MIF4GD;CDK18;ASH2L;SOX13;ETV4;TXNRD3;MAP2K1;CYP27B1;PCK2;MXD4;CRYL1;ABCA2;PKN1;H2AFJ;ALPK1;OPLAH;TRNP1;DNASE1L1;PHC2;PHF21A;DGKQ;ZNF76;PBX2;TUBG2;TMEM173;THAP8;DNAH1;ARL2;ULK1;VPS11;GRB7;R3HDM2;OGDHL;SOX12;RAB3B;MYH11;UNK;NMRK1;CIRBP;CAPRIN2;TTBK2;PRKCZ;HTR7;PAK1;ABCA7;APOBEC3C;AARS;ELK3;STK39;PABPC1L;FGFR3;SEC14L2;KDM3A;MTHFR;FOXQ1;PHF1;GLDC;NPR2;CBS;SALL2;NMNAT2;DDX59;NME4;ETV1;NSUN5P2;NEIL1;ACVR2B;RAG1;SPEG;ETV5;NSUN7;ACTR1B;HES2;CHD2;GPT2;TEF;TNS1;RMI2;RHOBTB2;ABCG1;XPOT;FAM50A;CARF;MANF;AGAP1;CARS;FKBP10;KIF17;SPATS2;APOBEC3F;PPARA;CHD3;MKNK2;TCF25;IFT27;NLRX1;SATB1;STAT6;KLF7;R3HDM4;HMGA2;SEPT5;ACACB;NT5C1B;MAPK3;PC;THRA;STK40;ACSS2;MVD;FAM20C;TDRKH;RHOF;TUBE1;PAN2;ZSCAN30;EIF2D;MAPK12;MYH3;LTA4H;PI4K2A;NAT14;ZXDC;MLXIPL;SEPT10;TSPYL2;MAP2K2;H1FX;HIBADH;FLYWCH1;TWF2;SDHA;KIF21B;SLC48A1;LITAF;ATF4;ZFPM1;PAK6;ZNF467;POLM;KIF26B;ZNF516;TTN;PSKH1;HLCS;JDP2;HDAC5;GTPBP1;IRF5;GALK1;TFB1M;NTPCR;PCBP4;SRSF5;NADK;DHX32;DEAF1;TEP1;NLRP1;PEG3;GLI4;RFX2;ENDOG;CEBPB;MAP3K12;NEK8;WNK4;CREBRF;PCSK9;ZNF251;PKN3;ACADS;ISG20;LONP2;MARK3;HLTF;DNMT3A;TGFBR2;TRPV4;MXD3;FOXL1;CSRNP3;TMSB4X;SLFN5;MOCOS;PDE2A;TRIB3;RAB40B;ARL10;BHLHE40;MLH3;CALCOCO1;HMG20B;NOS3;AGO4;MINK1;ZFP90;SLC27A3;TTLL11;TRPV1;PIP5KL1;EPHA1;ZNF558;RPUSD3;ZNF662;GLUD1;SUCLG2;ERN1;NUDT6;BCR;ATP7B;FYCO1;CHKB;EXD3;SRR;KIF13B;UCKL1;CAMK1;POLL;TERC;CYP2R1;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;RAB43;ATP2B4;THNSL2;PRDM8;STRADB;ACOX3;ACAD11;MGMT;ASNS;TM7SF2;PAIP2B;HINT2;MAPKBP1;AKT1;DGUOK;MICAL1;CRY2;CHEK2;IFT57;LACTB2;PHYKPL;SEPT6;ASS1;TSG101;KIF27;FGFR4;IGF2BP2;ZNF217;CBR4;ACADVL;NUCB2;ZNF25;DNASE2;UHRF2;SMARCD2;MARK4;RAB25;INSR;ACSS1;NELFCD;FOXO4;GNAL;RPS6KA5;ANKZF1;LTB4R;TXNRD2;MAP2K5;BRAF;ZNF554;CPSF4;POLR2J2;HOXC5;CAT;ZNF160;MAPK10;MPG;LGALS1;ZFP28;JAK3;TP73;MTA3;MNT;ZNF846;APRT;TFEB;CERS4;LSM14B;ENDOV;PHC1;SCYL3;ATP12A;CSNK1E;BCL6;HSF4;TKFC;EHD3;RPL39L;FYN;MAST4;ATP8B2;PEX1;LEMD2;SIRT2;RECQL5;RAB13;TST;ADA;POU2F2;RCOR2;RHOBTB3;ETNK2;MTA1;MSH5;ENTPD2;FUK;PAIP2;MYO18A;RPL29;TCF7;EPAS1;MAP3K10;CHD6;EPHB2;MAGI1;POLR2J3;PER1;SEPT8;IGF2BP3;FGFR1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;STK32B;PFKL;RPL12;HMBOX1;HSP90AB4P;TSHZ1;CREB3L4;ZNF449;ZMYM3;DBP;ZNF667;ZNF287;CAMKK1;DTD1;IKBKB;DMTF1;CYP4V2;TEAD2;SIX5
17618,GO:1901381,1,0.247144129354489,0,11,positive regulation of potassium ion transmembrane transport,BP,
17621,GO:1901386,1,0.604261124292405,0,4,negative regulation of voltage-gated calcium channel activity,BP,
17625,GO:1901407,1,0.320359906321935,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17626,GO:1901409,1,0.413494682429644,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17629,GO:1901474,1,0.603061152975893,0,4,azole transmembrane transporter activity,MF,
17631,GO:1901490,1,0.600713794875295,0,4,regulation of lymphangiogenesis,BP,
17639,GO:1901524,1,0.17029712404238,0,14,regulation of mitophagy,BP,
17640,GO:1901525,1,0.464961209503517,0,6,negative regulation of mitophagy,BP,
17641,GO:1901526,1,0.366459034441851,0,8,positive regulation of mitophagy,BP,
17644,GO:1901533,1,0.471502194077321,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17646,GO:1901535,1,0.524293812973497,0,5,regulation of DNA demethylation,BP,
17682,GO:1901620,1,0.40951459484296,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17683,GO:1901621,1,0.528352676390082,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17685,GO:1901623,1,0.290567386358069,0,10,regulation of lymphocyte chemotaxis,BP,
17706,GO:1901663,1,0.17763565210453,0,14,quinone biosynthetic process,BP,
17729,GO:1901723,1,0.530092154124114,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17742,GO:1901797,1,0.0450912194700774,0,25,negative regulation of signal transduction by p53 class mediator,BP,
17750,GO:1901836,1,0.249319908118589,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17752,GO:1901838,1,0.320955023458505,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17753,GO:1901841,1,0.605026716302461,0,4,regulation of high voltage-gated calcium channel activity,BP,
17756,GO:1901844,1,0.413354664571013,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17758,GO:1901857,1,0.545141294793672,0,5,positive regulation of cellular respiration,BP,
17759,GO:1901858,1,0.605984258026126,0,4,regulation of mitochondrial DNA metabolic process,BP,
17778,GO:1901906,1,0.606378799054077,0,4,diadenosine pentaphosphate metabolic process,BP,
17779,GO:1901907,1,0.606378799054077,0,4,diadenosine pentaphosphate catabolic process,BP,
17780,GO:1901908,1,0.606378799054077,0,4,diadenosine hexaphosphate metabolic process,BP,
17781,GO:1901909,1,0.606378799054077,0,4,diadenosine hexaphosphate catabolic process,BP,
17782,GO:1901910,1,0.606378799054077,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17783,GO:1901911,1,0.606378799054077,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
17790,GO:1901970,1,0.370141824868104,0,8,positive regulation of mitotic sister chromatid separation,BP,
17811,GO:1902004,1,0.36248368693587,0,8,positive regulation of amyloid-beta formation,BP,
17818,GO:1902031,1,0.469543975834187,0,6,regulation of NADP metabolic process,BP,
17819,GO:1902033,1,0.530520438815655,0,5,regulation of hematopoietic stem cell proliferation,BP,
17820,GO:1902035,1,0.602652976129922,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
17838,GO:1902099,1,0.0035141522958093,0,45,regulation of metaphase/anaphase transition of cell cycle,BP,
17839,GO:1902100,1,0.0225295385316961,0,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,
17840,GO:1902101,1,0.370141824868104,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17858,GO:1902165,1,0.164331115137566,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17859,GO:1902166,1,0.20723224361498,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17867,GO:1902177,1,0.544927830828617,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17870,GO:1902187,1,0.167655266679932,0,14,negative regulation of viral release from host cell,BP,
17883,GO:1902221,1,0.620926742983275,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17884,GO:1902222,1,0.620926742983275,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
17889,GO:1902229,1,0.0174433542215981,0,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17890,GO:1902230,1,0.0407472756896326,0,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17891,GO:1902231,1,0.487246623754579,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17899,GO:1902253,1,0.069531749135433,0,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17900,GO:1902254,1,0.109320652982911,0,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17935,GO:1902337,1,0.416682866165636,0,7,regulation of apoptotic process involved in morphogenesis,BP,
17939,GO:1902358,1,0.465595071722366,0,6,sulfate transmembrane transport,BP,
17958,GO:1902410,1,0.467813095417187,0,6,mitotic cytokinetic process,BP,
17960,GO:1902414,1,0.359914724179567,0,8,protein localization to cell junction,BP,
17961,GO:1902415,1,0.323617274370461,0,9,regulation of mRNA binding,BP,
17962,GO:1902416,1,0.416277225592615,0,7,positive regulation of mRNA binding,BP,
17970,GO:1902455,1,0.60023501539603,0,4,negative regulation of stem cell population maintenance,BP,
17971,GO:1902459,1,0.527612678122831,0,5,positive regulation of stem cell population maintenance,BP,
17992,GO:1902513,1,0.466825619009372,0,6,regulation of organelle transport along microtubule,BP,
17996,GO:1902525,1,0.545334354248326,0,5,regulation of protein monoubiquitination,BP,
17997,GO:1902527,1,0.619584300585429,0,4,positive regulation of protein monoubiquitination,BP,
18017,GO:1902570,1,0.332561679026086,0,9,protein localization to nucleolus,BP,
18022,GO:1902581,1,0.540993352873189,0,5,multi-organism cellular localization,BP,
18023,GO:1902583,1,0.540993352873189,0,5,multi-organism intracellular transport,BP,
18034,GO:1902617,1,0.612038929238548,0,4,response to fluoride,BP,
18036,GO:1902622,1,0.065778383920904,0,22,regulation of neutrophil migration,BP,
18038,GO:1902624,1,0.0963913491598091,0,19,positive regulation of neutrophil migration,BP,
18062,GO:1902713,1,0.600270965417065,0,4,regulation of interferon-gamma secretion,BP,
18074,GO:1902739,1,0.462165739910049,0,6,regulation of interferon-alpha secretion,BP,
18075,GO:1902741,1,0.462165739910049,0,6,positive regulation of interferon-alpha secretion,BP,
18108,GO:1902855,1,0.284704218734898,0,10,regulation of non-motile cilium assembly,BP,
18110,GO:1902857,1,0.417534918384632,0,7,positive regulation of non-motile cilium assembly,BP,
18128,GO:1902902,1,0.250639003686508,0,11,negative regulation of autophagosome assembly,BP,
18137,GO:1902914,1,0.149088241161655,0,15,regulation of protein polyubiquitination,BP,
18138,GO:1902915,1,0.463757405112749,0,6,negative regulation of protein polyubiquitination,BP,
18139,GO:1902916,1,0.365828833813867,0,8,positive regulation of protein polyubiquitination,BP,
18164,GO:1902961,1,0.468925588573144,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18177,GO:1902993,1,0.281700898615625,0,10,positive regulation of amyloid precursor protein catabolic process,BP,
18190,GO:1903010,1,0.242842348127455,0,11,regulation of bone development,BP,
18192,GO:1903012,1,0.600995345364521,0,4,positive regulation of bone development,BP,
18217,GO:1903055,1,0.216259921170743,0,12,positive regulation of extracellular matrix organization,BP,
18218,GO:1903059,1,0.604616614727701,0,4,regulation of protein lipidation,BP,
18219,GO:1903061,1,0.604616614727701,0,4,positive regulation of protein lipidation,BP,
18226,GO:1903077,1,0.11478302526416,0,17,negative regulation of protein localization to plasma membrane,BP,
18234,GO:1903115,1,0.0692262447796728,0,21,regulation of actin filament-based movement,BP,
18237,GO:1903121,1,0.610449891476955,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
18248,GO:1903147,1,0.367314684941997,0,8,negative regulation of autophagy of mitochondrion,BP,
18272,GO:1903206,1,0.19966324181621,0,13,negative regulation of hydrogen peroxide-induced cell death,BP,
18282,GO:1903232,1,0.548161800684398,0,5,melanosome assembly,BP,
18292,GO:1903251,1,0.532543244875794,0,5,multi-ciliated epithelial cell differentiation,BP,
18294,GO:1903265,1,0.368929523535702,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18308,GO:1903297,1,0.534021138569127,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18309,GO:1903298,1,0.534021138569127,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18310,GO:1903299,1,0.421275908161529,0,7,regulation of hexokinase activity,BP,
18312,GO:1903301,1,0.537186451720023,0,5,positive regulation of hexokinase activity,BP,
18325,GO:1903332,1,0.420112766301215,0,7,regulation of protein folding,BP,
18326,GO:1903333,1,0.542228270583585,0,5,negative regulation of protein folding,BP,
18327,GO:1903335,1,0.609752290749626,0,4,regulation of vacuolar transport,BP,
18337,GO:1903361,1,0.534838509110921,0,5,protein localization to basolateral plasma membrane,BP,
18343,GO:1903371,1,0.599539688257173,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
18346,GO:1903376,1,0.415804664093209,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18347,GO:1903377,1,0.609896188144561,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18361,GO:1903405,1,0.320556134860194,0,9,protein localization to nuclear body,BP,
18397,GO:1903504,1,0.19419638096309,0,13,regulation of mitotic spindle checkpoint,BP,
18414,GO:1903525,1,0.527971696908687,0,5,regulation of membrane tubulation,BP,
18433,GO:1903553,1,0.600828003822457,0,4,positive regulation of extracellular exosome assembly,BP,
18462,GO:1903608,1,0.413228572693264,0,7,protein localization to cytoplasmic stress granule,BP,
18489,GO:1903689,1,0.462456168578025,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18490,GO:1903690,1,0.599000855444545,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
18513,GO:1903748,1,0.604008866247555,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
18515,GO:1903750,1,0.610162753004369,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18516,GO:1903751,1,0.610162753004369,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18517,GO:1903753,1,0.600609536654232,0,4,negative regulation of p38MAPK cascade,BP,
18544,GO:1903799,1,0.359799247006441,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18557,GO:1903830,1,0.130549733218606,0,16,magnesium ion transmembrane transport,BP,
18568,GO:1903859,1,0.278341003626497,0,10,regulation of dendrite extension,BP,
18570,GO:1903861,1,0.359241931948917,0,8,positive regulation of dendrite extension,BP,
18571,GO:1903862,1,0.539196029483077,0,5,positive regulation of oxidative phosphorylation,BP,
18583,GO:1903894,1,0.195922047523924,0,13,regulation of IRE1-mediated unfolded protein response,BP,
18584,GO:1903895,1,0.600563356702089,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
18585,GO:1903896,1,0.416840805892779,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
18597,GO:1903912,1,0.601654982692686,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
18634,GO:1903978,1,0.602343549873426,0,4,regulation of microglial cell activation,BP,
18643,GO:1904016,1,0.599951826504953,0,4,response to Thyroglobulin triiodothyronine,BP,
18677,GO:1904090,1,0.634864025546402,0,4,peptidase inhibitor complex,CC,
18689,GO:1904153,1,0.323484660085054,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18719,GO:1904220,1,0.602456058868971,0,4,regulation of serine C-palmitoyltransferase activity,BP,
18738,GO:1904259,1,0.527156652319063,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18739,GO:1904261,1,0.527156652319063,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18741,GO:1904263,1,0.368023315157317,0,8,positive regulation of TORC1 signaling,BP,
18749,GO:1904288,1,0.599828977635509,0,4,BAT3 complex binding,MF,
18753,GO:1904293,1,0.195943583313125,0,13,negative regulation of ERAD pathway,BP,
18762,GO:1904315,1,0.600566688342694,0,4,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
18779,GO:1904357,1,0.0364405230470745,0,26,negative regulation of telomere maintenance via telomere lengthening,BP,
18782,GO:1904376,1,0.0889115539093383,0,19,negative regulation of protein localization to cell periphery,BP,
18790,GO:1904385,1,0.173595933324574,0,14,cellular response to angiotensin,BP,
18824,GO:1904467,1,0.277797883146799,0,10,regulation of tumor necrosis factor secretion,BP,
18826,GO:1904469,1,0.406760451174295,0,7,positive regulation of tumor necrosis factor secretion,BP,
18898,GO:1904667,1,0.513363927467181,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18903,GO:1904680,1,0.0682854313532636,0,22,peptide transmembrane transporter activity,MF,
18910,GO:1904690,1,0.601557130932782,0,4,positive regulation of cytoplasmic translational initiation,BP,
18923,GO:1904714,1,0.46641966113224,0,6,regulation of chaperone-mediated autophagy,BP,
18936,GO:1904742,1,0.607236484590645,0,4,regulation of telomeric DNA binding,BP,
18941,GO:1904748,1,0.416682866165636,0,7,regulation of apoptotic process involved in development,BP,
18942,GO:1904749,1,0.609770754383936,0,4,regulation of protein localization to nucleolus,BP,
18955,GO:1904776,1,0.464802352711309,0,6,regulation of protein localization to cell cortex,BP,
18957,GO:1904778,1,0.528015432995493,0,5,positive regulation of protein localization to cell cortex,BP,
18966,GO:1904796,1,0.530639152864067,0,5,regulation of core promoter binding,BP,
18968,GO:1904798,1,0.602998710330591,0,4,positive regulation of core promoter binding,BP,
18976,GO:1904814,1,0.192739338157016,0,13,regulation of protein localization to chromosome, telomeric region,BP,
18978,GO:1904816,1,0.248298233636789,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
18994,GO:1904851,1,0.320264993809455,0,9,positive regulation of establishment of protein localization to telomere,BP,
18998,GO:1904867,1,0.320556134860194,0,9,protein localization to Cajal body,BP,
19000,GO:1904869,1,0.363317089072753,0,8,regulation of protein localization to Cajal body,BP,
19001,GO:1904871,1,0.363317089072753,0,8,positive regulation of protein localization to Cajal body,BP,
19002,GO:1904872,1,0.106921277948804,0,18,regulation of telomerase RNA localization to Cajal body,BP,
19003,GO:1904874,1,0.157140179660547,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19013,GO:1904885,1,0.525819287977059,0,5,beta-catenin destruction complex assembly,BP,
19019,GO:1904893,1,0.019468992820785,0,31,negative regulation of STAT cascade,BP,
19031,GO:1904923,1,0.219964084923714,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19033,GO:1904925,1,0.249847393186842,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19035,GO:1904929,1,0.464781854736481,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
19141,GO:1905209,1,0.149806577014089,0,15,positive regulation of cardiocyte differentiation,BP,
19142,GO:1905214,1,0.250575217072645,0,11,regulation of RNA binding,BP,
19144,GO:1905216,1,0.366343605929916,0,8,positive regulation of RNA binding,BP,
19150,GO:1905244,1,0.36067966951261,0,8,regulation of modification of synaptic structure,BP,
19153,GO:1905247,1,0.468925588573144,0,6,positive regulation of aspartic-type peptidase activity,BP,
19180,GO:1905314,1,0.315253110554342,0,9,semi-lunar valve development,BP,
19185,GO:1905323,1,0.464618341338689,0,6,telomerase holoenzyme complex assembly,BP,
19187,GO:1905331,1,0.216648222021771,0,12,negative regulation of morphogenesis of an epithelium,BP,
19192,GO:1905340,1,0.603010351969257,0,4,regulation of protein localization to kinetochore,BP,
19194,GO:1905342,1,0.603010351969257,0,4,positive regulation of protein localization to kinetochore,BP,
19235,GO:1905446,1,0.539269750815339,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19237,GO:1905448,1,0.612629095505009,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19240,GO:1905456,1,0.414120172933522,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19342,GO:1905818,1,0.00146800441599691,0,52,regulation of chromosome separation,BP,
19343,GO:1905819,1,0.0202341978907006,0,31,negative regulation of chromosome separation,BP,
19344,GO:1905820,1,0.325572587426284,0,9,positive regulation of chromosome separation,BP,
19345,GO:1905832,1,0.592958579134069,0,4,positive regulation of spindle assembly,BP,
19370,GO:1905907,1,0.614010305134131,0,4,negative regulation of amyloid fibril formation,BP,
19389,GO:1905961,1,0.364759431438922,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19391,GO:1990001,1,0.357856052721508,0,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
19396,GO:1990023,1,0.194545309542739,0,13,mitotic spindle midzone,CC,
19419,GO:1990111,1,0.62249162609913,0,4,spermatoproteasome complex,CC,
19423,GO:1990124,1,0.415374011529605,0,7,messenger ribonucleoprotein complex,CC,
19426,GO:1990130,1,0.530805714941346,0,5,GATOR1 complex,CC,
19438,GO:1990169,1,0.580496064377757,0,5,stress response to copper ion,BP,
19441,GO:1990173,1,0.282099819560065,0,10,protein localization to nucleoplasm,BP,
19451,GO:1990226,1,0.530771838487766,0,5,histone methyltransferase binding,MF,
19453,GO:1990239,1,0.606292634475231,0,4,steroid hormone binding,MF,
19454,GO:1990246,1,0.600559987125195,0,4,uniplex complex,CC,
19455,GO:1990247,1,0.409145419170113,0,7,N6-methyladenosine-containing RNA binding,MF,
19457,GO:1990254,1,0.603407136778849,0,4,keratin filament binding,MF,
19469,GO:1990314,1,0.359885355777517,0,8,cellular response to insulin-like growth factor stimulus,BP,
19476,GO:1990380,1,0.313985395019022,0,9,Lys48-specific deubiquitinase activity,MF,
19488,GO:1990405,1,0.596206406078361,0,4,protein antigen binding,MF,
19496,GO:1990416,1,0.466025941380737,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19507,GO:1990441,1,0.601894323015198,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
19509,GO:1990446,1,0.612074446333828,0,4,U1 snRNP binding,MF,
19518,GO:1990481,1,0.604428978502792,0,4,mRNA pseudouridine synthesis,BP,
19523,GO:1990511,1,0.600301793842758,0,4,piRNA biosynthetic process,BP,
19530,GO:1990564,1,0.540298982614574,0,5,protein polyufmylation,BP,
19542,GO:1990592,1,0.540298982614574,0,5,protein K69-linked ufmylation,BP,
19552,GO:1990635,1,0.600795716382649,0,4,proximal dendrite,CC,
19559,GO:1990668,1,0.470880224796991,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
19569,GO:1990726,1,0.572076853416955,0,5,Lsm1-7-Pat1 complex,CC,
19579,GO:1990745,1,0.600285137013594,0,4,EARP complex,CC,
19592,GO:1990774,1,0.244503291389231,0,11,tumor necrosis factor secretion,BP,
19593,GO:1990776,1,0.134354343539402,0,16,response to angiotensin,BP,
19602,GO:1990809,1,0.600936543197619,0,4,endoplasmic reticulum tubular network membrane organization,BP,
19607,GO:1990825,1,0.284298563128393,0,10,sequence-specific mRNA binding,MF,
19619,GO:1990868,1,0.52901214341593,0,5,response to chemokine,BP,
19620,GO:1990869,1,0.52901214341593,0,5,cellular response to chemokine,BP,
19629,GO:1990907,1,0.245110142556475,0,11,beta-catenin-TCF complex,CC,
19645,GO:1990948,1,0.57284429602682,0,5,ubiquitin ligase inhibitor activity,MF,
19647,GO:1990966,1,0.606525457079745,0,4,ATP generation from poly-ADP-D-ribose,BP,
19667,GO:2000018,1,0.529839687724369,0,5,regulation of male gonad development,BP,
19669,GO:2000020,1,0.602002457007915,0,4,positive regulation of male gonad development,BP,
19694,GO:2000074,1,0.415109268136528,0,7,regulation of type B pancreatic cell development,BP,
19699,GO:2000095,1,0.317958196944531,0,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19700,GO:2000096,1,0.466291276295271,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19707,GO:2000108,1,0.0843281162800443,0,20,positive regulation of leukocyte apoptotic process,BP,
19708,GO:2000109,1,0.476148688677255,0,6,regulation of macrophage apoptotic process,BP,
19717,GO:2000121,1,0.473330987351738,0,6,regulation of removal of superoxide radicals,BP,
19720,GO:2000136,1,0.250099680194493,0,11,regulation of cell proliferation involved in heart morphogenesis,BP,
19722,GO:2000138,1,0.529228722640391,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
19725,GO:2000144,1,0.0553273865049049,0,23,positive regulation of DNA-templated transcription, initiation,BP,
19729,GO:2000152,1,0.620228516493489,0,4,regulation of ubiquitin-specific protease activity,BP,
19751,GO:2000197,1,0.464830484302369,0,6,regulation of ribonucleoprotein complex localization,BP,
19767,GO:2000232,1,0.251610272260189,0,11,regulation of rRNA processing,BP,
19769,GO:2000234,1,0.369114527517264,0,8,positive regulation of rRNA processing,BP,
19774,GO:2000251,1,0.256530354668947,0,11,positive regulation of actin cytoskeleton reorganization,BP,
19792,GO:2000279,1,0.0321226387855058,0,27,negative regulation of DNA biosynthetic process,BP,
19798,GO:2000288,1,0.469452752495869,0,6,positive regulation of myoblast proliferation,BP,
19799,GO:2000291,1,0.412502503950649,0,7,regulation of myoblast proliferation,BP,
19816,GO:2000316,1,0.416314698281578,0,7,regulation of T-helper 17 type immune response,BP,
19818,GO:2000318,1,0.61043736571257,0,4,positive regulation of T-helper 17 type immune response,BP,
19819,GO:2000319,1,0.536568778084327,0,5,regulation of T-helper 17 cell differentiation,BP,
19839,GO:2000347,1,0.602211128736006,0,4,positive regulation of hepatocyte proliferation,BP,
19854,GO:2000370,1,0.600074720531464,0,4,positive regulation of clathrin-dependent endocytosis,BP,
19855,GO:2000371,1,0.465426684921794,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19856,GO:2000373,1,0.465426684921794,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19862,GO:2000381,1,0.60324906989922,0,4,negative regulation of mesoderm development,BP,
19878,GO:2000403,1,0.121189680779536,0,17,positive regulation of lymphocyte migration,BP,
19881,GO:2000406,1,0.156216716782835,0,15,positive regulation of T cell migration,BP,
19906,GO:2000465,1,0.464808562591974,0,6,regulation of glycogen (starch) synthase activity,BP,
19937,GO:2000542,1,0.600706975571665,0,4,negative regulation of gastrulation,BP,
19967,GO:2000601,1,0.464852591927045,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
19975,GO:2000617,1,0.470363430899761,0,6,positive regulation of histone H3-K9 acetylation,BP,
19976,GO:2000618,1,0.533186090082798,0,5,regulation of histone H4-K16 acetylation,BP,
19979,GO:2000622,1,0.599864084566986,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19980,GO:2000623,1,0.599864084566986,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19983,GO:2000628,1,0.414204385349787,0,7,regulation of miRNA metabolic process,BP,
19984,GO:2000630,1,0.534567005974192,0,5,positive regulation of miRNA metabolic process,BP,
20006,GO:2000659,1,0.47059715235163,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
20007,GO:2000660,1,0.606463507883093,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
20022,GO:2000676,1,0.603021117759943,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
20032,GO:2000698,1,0.613535849650907,0,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,
20047,GO:2000727,1,0.24973941258503,0,11,positive regulation of cardiac muscle cell differentiation,BP,
20051,GO:2000737,1,0.131120277094414,0,16,negative regulation of stem cell differentiation,BP,
20069,GO:2000767,1,0.361104104745978,0,8,positive regulation of cytoplasmic translation,BP,
20085,GO:2000794,1,0.464809414439392,0,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20095,GO:2000811,1,0.19350619404762,0,13,negative regulation of anoikis,BP,
20097,GO:2000816,1,0.0202341978907006,0,31,negative regulation of mitotic sister chromatid separation,BP,
20102,GO:2000823,1,0.624446698196193,0,4,regulation of androgen receptor activity,BP,
20103,GO:2000825,1,0.624446698196193,0,4,positive regulation of androgen receptor activity,BP,
20108,GO:2000831,1,0.473990952915585,0,6,regulation of steroid hormone secretion,BP,
20110,GO:2000833,1,0.611946134808257,0,4,positive regulation of steroid hormone secretion,BP,
20115,GO:2000846,1,0.538487502383158,0,5,regulation of corticosteroid hormone secretion,BP,
20130,GO:2000973,1,0.470537619543281,0,6,regulation of pro-B cell differentiation,BP,
20135,GO:2000980,1,0.535563988461521,0,5,regulation of inner ear receptor cell differentiation,BP,
20136,GO:2000981,1,0.608392971711824,0,4,negative regulation of inner ear receptor cell differentiation,BP,
20140,GO:2001012,1,0.602128333027406,0,4,mesenchymal cell differentiation involved in renal system development,BP,
20142,GO:2001014,1,0.246961170221515,0,11,regulation of skeletal muscle cell differentiation,BP,
20144,GO:2001016,1,0.603666860141149,0,4,positive regulation of skeletal muscle cell differentiation,BP,
20158,GO:2001034,1,0.528038687747084,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20162,GO:2001039,1,0.19966324181621,0,13,negative regulation of cellular response to drug,BP,
20167,GO:2001053,1,0.467883607617504,0,6,regulation of mesenchymal cell apoptotic process,BP,
20168,GO:2001054,1,0.531191911192264,0,5,negative regulation of mesenchymal cell apoptotic process,BP,
20196,GO:2001166,1,0.528836523931062,0,5,regulation of histone H2B ubiquitination,BP,
20197,GO:2001168,1,0.600245622191401,0,4,positive regulation of histone H2B ubiquitination,BP,
20207,GO:2001182,1,0.601752992271195,0,4,regulation of interleukin-12 secretion,BP,
20215,GO:2001197,1,0.527156652319063,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20222,GO:2001204,1,0.405141524609499,0,7,regulation of osteoclast development,BP,
20227,GO:2001214,1,0.532769060129608,0,5,positive regulation of vasculogenesis,BP,
20229,GO:2001223,1,0.466774122698343,0,6,negative regulation of neuron migration,BP,
20243,GO:2001241,1,0.225588730550926,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
20258,GO:2001268,1,0.546163550704882,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20260,GO:2001270,1,0.611590912414653,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20266,GO:2001279,1,0.604693652812847,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
17609,GO:1901360,1.00000000000001,0,442,4864,organic cyclic compound metabolic process,BP,TNIP1;XDH;H6PD;DLG4;ZC3H6;HTRA1;GAMT;F2R;NT5E;NYNRIN;APOE;ZMYND8;NFATC4;XPC;FOS;PRODH;OSBPL5;H1F0;CITED4;EGR1;CTNNBIP1;LMF1;ZNF862;ACP5;WWC3;NAPRT;PDCD4;TIMP2;VEGFA;EGFR;ZSCAN18;RBCK1;DDB2;PRNP;NR1D1;ERCC1;PRDX5;BAHCC1;RAPGEF3;ZKSCAN1;IGFBP4;SLC2A9;IDH2;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNPH1;DNAJB5;PGM1;CRTC1;ERCC6;TCEA2;SMARCA1;ZFP36L1;ADARB1;NUPR1;TCFL5;RBL2;PYCR2;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;HSD17B14;RPL13A;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;ASH2L;SOX13;LHPP;PRSS3;UROS;ETV4;WWTR1;POLD4;MAP2K1;CYP27B1;PCK2;MXD4;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;BTG1;TRNP1;DNASE1L1;ITGA6;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MAML3;TMEM173;THAP8;MAGEF1;SHC1;OGDHL;SOX12;HDAC11;PTMS;NMRK1;CIRBP;CAPRIN2;PRKCZ;APOBEC3C;AARS;ELK3;PABPC1L;BLVRB;SEC14L2;BRD3;KDM3A;MTHFR;FOXQ1;PHF1;NPR2;CBS;SALL2;DLG3;NMNAT2;DDX59;NME4;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;ACVR2B;RAG1;EAPP;NGFR;ETV5;PPCS;NSMCE4A;HES2;EREG;CHD2;TEF;PSAT1;APBB3;RMI2;DHRS4;NAB2;UNKL;ABCG1;TRAPPC9;CARF;CARS;APOBEC3F;PPARA;INO80C;CHD3;SESN2;AIP;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;RRNAD1;HMGA2;AREG;ECM1;ACACB;NT5C1B;KCNAB2;MAPK3;TRPT1;PC;MACROD1;THRA;RGS14;MVD;IRF2BPL;FAM20C;TDRKH;PBXIP1;PAN2;ZSCAN30;MAPK12;MYH3;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SRD5A3;SDHA;LITAF;PTHLH;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;LTB4R2;PRIMPOL;POLM;TENM2;FBXO6;ZNF516;CBX7;PKD1;NSMCE1;MDK;HLCS;HSD11B1;JDP2;HDAC5;GTPBP1;IRF5;SORL1;GALK1;TFB1M;PCBP4;PLTP;SRSF5;GSTM2;VLDLR;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;PEG3;GLI4;RFX2;ENDOG;KDM7A;CEBPB;ACOT7;LRP5;ALDOC;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;ISG20;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;MOCOS;HSD17B7;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;RPUSD3;ZNF662;GAS6;ERN1;MAPRE3;EXD3;TNNI2;TADA3;BOLA1;UCKL1;CAMK1;POLL;TERC;PTAFR;CYP2R1;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;MGMT;ENTPD6;TM7SF2;HINT2;MAPKBP1;AKT1;IGFBP7;CARD11;DGUOK;CDKN1C;SWT1;CRY2;CHEK2;IFT57;LACTB2;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;CBR4;ACADVL;ZNF25;DNASE2;UPP1;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;RPS6KA5;MAP2K5;EDA2R;ZNF554;CPSF4;POLR2J2;ALDH1L1;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;MPG;ZFP28;HFE;KIAA1549;TP73;MTA3;MNT;ZNF846;APRT;TFEB;MPI;SNX17;ENDOV;CSNK1E;TAZ;BCL6;HSF4;REC8;GSTM3;ZC3H12D;LEMD2;SIRT2;TRPC1;GDF15;RECQL5;OSBPL1A;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;MSH5;ENTPD2;FUK;CIDEA;HDAC8;MYO18A;ADIRF;RPL29;TGFBR3;TCF7;PLPP6;EPAS1;MAP3K10;CHD6;POLR2J3;PER1;IGF2BP3;FGFR1;WFS1;ZNF333;FKBP8;CTH;ERBB2;EIF2AK4;RGS12;PFKL;RPL12;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;NUDT18;KCTD13;DBP;ZNF667;ZNF287;PNKD;DTD1;IKBKB;DMTF1;SNCB;HIP1;CYP4V2;TEAD2;ACOT8;SIX5
2358,GO:0005459,1.00000000000001,0.786086167057286,0,2,UDP-galactose transmembrane transporter activity,MF,
2887,GO:0006397,1.00000000000001,0,9,439,mRNA processing,BP,ZFP36L1;ADARB1;PABPC1L;PAN2;SRSF5;DHX32;RPUSD3;ERN1;CPSF4
15722,GO:0072334,1.00000000000001,0.786086167057286,0,2,UDP-galactose transmembrane transport,BP,
14408,GO:0061740,1.00000000000002,0.682942034292751,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
372,GO:0000994,1.00000000000005,0.882942104955924,0,1,RNA polymerase III core binding,MF,
1685,GO:0004157,1.00000000000005,0.8801246973261,0,1,dihydropyrimidinase activity,MF,
18667,GO:1904048,1.00000000000005,0.8801246973261,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18668,GO:1904050,1.00000000000005,0.8801246973261,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19172,GO:1905301,1.00000000000005,0.8801246973261,0,1,regulation of macropinocytosis,BP,
19173,GO:1905302,1.00000000000005,0.8801246973261,0,1,negative regulation of macropinocytosis,BP,
10471,GO:0043385,1.00000000000006,0.880345018482771,0,1,mycotoxin metabolic process,BP,
10472,GO:0043387,1.00000000000006,0.880345018482771,0,1,mycotoxin catabolic process,BP,
11586,GO:0046222,1.00000000000006,0.880345018482771,0,1,aflatoxin metabolic process,BP,
11587,GO:0046223,1.00000000000006,0.880345018482771,0,1,aflatoxin catabolic process,BP,
17614,GO:1901376,1.00000000000006,0.880345018482771,0,1,organic heteropentacyclic compound metabolic process,BP,
17615,GO:1901377,1.00000000000006,0.880345018482771,0,1,organic heteropentacyclic compound catabolic process,BP,
18535,GO:1903786,1.00000000000006,0.880345018482771,0,1,regulation of glutathione biosynthetic process,BP,
18536,GO:1903788,1.00000000000006,0.880345018482771,0,1,positive regulation of glutathione biosynthetic process,BP,
3798,GO:0008380,1.00000000000007,0,7,391,RNA splicing,BP,TRPT1;SRSF5;DHX32;TEP1;ERN1;MAPKBP1;CPSF4
11494,GO:0046016,1.00000000000008,0.687204812845731,0,3,positive regulation of transcription by glucose,BP,
12611,GO:0050822,1.00000000000008,0.880234640865049,0,1,peptide stabilization,BP,
12612,GO:0050823,1.00000000000008,0.880234640865049,0,1,peptide antigen stabilization,BP,
8218,GO:0032991,1.00000000000008,0,333,3841,protein-containing complex,CC,DLG4;BBS2;APOE;BTBD2;ESPN;NFATC4;KCNG1;XPC;FOS;H1F0;GSN;CTNNBIP1;FBXO2;GJC2;LRP1;CLIP2;EGFR;RBCK1;DDB2;PRNP;SCN8A;NR1D1;ERCC1;FBLN1;BAHCC1;IFT140;CLTCL1;SPTB;CRTAP;DNM1;NOS1;GPSM1;DDIT3;SHANK2;SCN4B;ERCC6;ABTB1;TCEA2;COL13A1;MYH15;SMARCA1;MST1R;ZFP36L1;CUL9;NUPR1;RBL2;EXOC2;DHTKD1;TFDP2;MXI1;RPL13A;OBSL1;EVC;BBS1;FBXW4;ASH2L;CUL7;WWTR1;POLD4;GIGYF1;COL6A1;ABCA2;CAPG;H2AFJ;ITGA6;PHC2;PITPNM1;PHF21A;PBX2;EML2;TUBG2;DNAH1;ULK1;SHC1;VPS11;GRB7;BLOC1S4;OGDHL;SOX12;HDAC11;MYH11;ITPR3;LAMA5;UNK;APPL2;CIRBP;CAPRIN2;PRKCZ;PPP2R3B;PAK1;ABCA7;APOBEC3C;FGFR3;KLHL29;PHF1;GLDC;NPR2;PLXNB3;NDUFA4L2;SALL2;SYNE3;ZSWIM4;DLG3;ITGB4;CEP250;FBXW8;SHROOM4;ACVR2B;WDR60;LTBP1;NSMCE4A;ACTR1B;PLXNB1;OLFM2;XPOT;TRAPPC9;C5;KIF17;APOBEC3F;PPARA;INO80C;CHD3;ANO1;SPC24;SESN2;AIP;IMPACT;IFT27;PKD2;ING4;NUDCD3;VAMP2;HMGA2;COL8A1;AP1G2;SEPT5;KCNC4;JADE2;KCNAB2;ITGB5;LAMB2;FBXO27;THRA;DCAF10;SCARA3;DNAL4;TDRKH;CNTRL;SNTA1;PAN2;HOOK2;EIF2D;MVB12B;MYH3;PI4K2A;CHMP1B;FBXO17;MLXIPL;TCTN1;ARHGEF2;SEPT10;FBF1;H1FX;SDHA;KIF21B;LRRC8A;KLHL24;ATF4;ZFPM1;RABGAP1;MYH16;FBXO6;KIF26B;CBX7;PKD1;NSMCE1;FLOT1;TTN;KCNMA1;TSNARE1;HDAC5;GTPBP1;SORL1;HERPUD1;PLTP;VLDLR;GPRC5C;DHX32;GABBR1;DEAF1;TEP1;NLRP1;COL4A6;CEBPB;LRP5;TSTD1;NDE1;PCSK9;FBXL15;METTL23;TGFBR2;MXD3;ITGA1;TMSB4X;SMURF2;LMO7;MLH3;EDA;AGO4;PIK3R2;EPHA1;SHARPIN;VPS39;SUCLG2;ERN1;KLHDC8B;FYCO1;CPT1C;TNNI2;TADA3;C1QTNF6;KIF13B;TTYH3;TERC;PPP1R15A;RXRA;ADCY6;TNRC18;ATP2B4;CTSH;WDR19;PNRC1;C12ORF66;TM7SF2;MAPKBP1;AKT1;ITPR2;CARD11;MZT2B;LAMB1;IFT57;SEPT6;TTC21A;TNNT1;WDR66;TSG101;KIF27;PHF2;FGFR4;ZNF217;TCIRG1;CBR4;SPSB3;COPG1;C9ORF72;SMARCD2;INSR;WNT3;KRT19;NELFCD;GNAL;COG7;ANKZF1;CHMP4C;TNXB;RABGGTA;ITGB6;PIGQ;CPSF4;POLR2J2;GJB4;FAAP20;MZT2A;HAUS4;HFE;TP73;SCNN1A;TUBGCP6;MIB2;PHC1;ATP12A;REC8;FBXO25;EPS8L1;RPL39L;ZC3H12D;SNX1;UBXN6;SIRT2;TRPC1;RECQL5;PLXND1;RCOR2;POLR3GL;MSH5;AP2A2;EPS8L2;HDAC8;MYO18A;RPL29;TGFBR3;TCF7;STX1A;EPAS1;LAMTOR2;CHD6;EPHB2;POLR2J3;SEPT8;ITGA2;FGFR1;PIGV;WFS1;BLOC1S1;FKBP8;SH3PXD2A;ERBB2;SEC31B;EIF2AK4;SYVN1;PFKL;HLA-G;RPL12;HMBOX1;GRB10;TNNI1;SDHAF4;KCTD13;PEX11A;IKBKB;HIP1;TEAD2;BTBD11
1656,GO:0004113,1.00000000000008,0.880121027792857,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
422,GO:0001128,1.00000000000008,0.887596819387313,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
11896,GO:0046952,1.0000000000001,0.68263534478431,0,3,ketone body catabolic process,BP,
2745,GO:0006147,1.0000000000001,0.880114759440963,0,1,guanine catabolic process,BP,
3990,GO:0008892,1.0000000000001,0.880114759440963,0,1,guanine deaminase activity,MF,
9222,GO:0035625,1.00000000000011,0.880223643962814,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
16254,GO:0090360,1.00000000000011,0.683464144578949,0,3,platelet-derived growth factor production,BP,
16255,GO:0090361,1.00000000000011,0.683464144578949,0,3,regulation of platelet-derived growth factor production,BP,
14234,GO:0061316,1.00000000000014,0.684215022951075,0,3,canonical Wnt signaling pathway involved in heart development,BP,
5283,GO:0015942,1.00000000000015,0.693565031278489,0,3,formate metabolic process,BP,
296,GO:0000801,1.00000000000018,0.880141957663454,0,1,central element,CC,
3718,GO:0008240,1.00000000000018,0.774700006529894,0,2,tripeptidyl-peptidase activity,MF,
6872,GO:0030375,1.00000000000019,0.681023617372922,0,3,thyroid hormone receptor coactivator activity,MF,
13932,GO:0060664,1.0000000000002,0.774762543434045,0,2,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
1594,GO:0004014,1.0000000000002,0.880277531003205,0,1,adenosylmethionine decarboxylase activity,MF,
3009,GO:0006557,1.0000000000002,0.880277531003205,0,1,S-adenosylmethioninamine biosynthetic process,BP,
6239,GO:0019810,1.0000000000002,0.880277531003205,0,1,putrescine binding,MF,
11687,GO:0046499,1.0000000000002,0.880277531003205,0,1,S-adenosylmethioninamine metabolic process,BP,
294,GO:0000799,1.00000000000021,0.681720373164912,0,3,nuclear condensin complex,CC,
16207,GO:0090284,1.00000000000021,0.87964746038296,0,1,positive regulation of protein glycosylation in Golgi,BP,
8838,GO:0034645,1.00000000000022,0,359,4042,cellular macromolecule biosynthetic process,BP,TNIP1;ZC3H6;HTRA1;F2R;ST6GALNAC2;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;LMF1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;ZDHHC1;NR1D1;ADAMTS7;PRDX5;BAHCC1;ZKSCAN1;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;PGM1;CRTC1;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;SMARCA1;ZFP36L1;NUPR1;B3GAT3;TCFL5;HBEGF;RBL2;TFDP2;MXI1;RPL13A;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;ETV4;WWTR1;POLD4;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;VEGFB;SOX12;HDAC11;PTMS;UNK;CIRBP;CAPRIN2;LY6K;PRKCZ;ABCA7;AARS;ELK3;PABPC1L;SEC14L2;BRD3;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;MUC19;HES2;EREG;CHD2;TEF;APBB3;RMI2;NAB2;UNKL;ABCG1;TRAPPC9;CARF;CARS;PPARA;INO80C;CHD3;SESN2;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;MAPK3;CSPG4;THRA;VANGL2;RGS14;MVD;IRF2BPL;PBXIP1;ADAMTSL1;ZSCAN30;EIF2D;MAPK12;NAT14;ZXDC;ARHGAP22;MLXIPL;ARHGEF2;TSPYL2;MAP2K2;SRD5A3;LITAF;ATF4;ZFPM1;KDM4C;PAK6;ZNF467;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;GTPBP1;IRF5;TFB1M;SRSF5;VLDLR;ADGRF1;DEAF1;TEP1;ST3GAL3;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;AGO4;PIGZ;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;POLL;TERC;PTAFR;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;PAIP2B;AKT1;CARD11;CDKN1C;SWT1;CRY2;B4GALT2;CHEK2;IFT57;WDR45;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;PHLDA1;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;COG7;RPS6KA5;PIGQ;MAP2K5;ZDHHC24;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;MPI;LSM14B;BCL6;HSF4;RPL39L;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;TGFBR3;TCF7;MAN1B1;EPAS1;MAP3K10;MFNG;CHD6;DHPS;POLR2J3;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;RGS12;SYVN1;RPL12;MPPE1;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;DTD1;IKBKB;NTM;DMTF1;HIP1;TEAD2;ACOT8;SIX5
1964,GO:0004676,1.00000000000023,0.879736831858514,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
15236,GO:0071435,1.00000000000023,0.682019488875442,0,3,potassium ion export,BP,
15118,GO:0071245,1.00000000000024,0.880209943832179,0,1,cellular response to carbon monoxide,BP,
18362,GO:1903406,1.00000000000024,0.880209943832179,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18363,GO:1903408,1.00000000000024,0.880209943832179,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19275,GO:1905572,1.00000000000024,0.880336976316745,0,1,ganglioside GM1 transport to membrane,BP,
19277,GO:1905574,1.00000000000024,0.880336976316745,0,1,ganglioside GM2 binding,MF,
19278,GO:1905575,1.00000000000024,0.880336976316745,0,1,ganglioside GM3 binding,MF,
19280,GO:1905577,1.00000000000024,0.880336976316745,0,1,ganglioside GP1c binding,MF,
4276,GO:0009646,1.00000000000025,0.880272577688963,0,1,response to absence of light,BP,
6947,GO:0030586,1.00000000000025,0.880272577688963,0,1,[methionine synthase] reductase activity,MF,
7338,GO:0031380,1.00000000000025,0.880272577688963,0,1,nuclear RNA-directed RNA polymerase complex,CC,
12464,GO:0050444,1.00000000000025,0.880272577688963,0,1,aquacobalamin reductase (NADPH) activity,MF,
15274,GO:0071485,1.00000000000025,0.880272577688963,0,1,cellular response to absence of light,BP,
18661,GO:1904041,1.00000000000025,0.880272577688963,0,1,regulation of cystathionine beta-synthase activity,BP,
18662,GO:1904042,1.00000000000025,0.880272577688963,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19545,GO:1990603,1.00000000000025,0.880272577688963,0,1,dark adaptation,BP,
2122,GO:0004918,1.00000000000027,0.880433174120482,0,1,interleukin-8 receptor activity,MF,
6309,GO:0019959,1.00000000000027,0.880433174120482,0,1,interleukin-8 binding,MF,
9693,GO:0038112,1.00000000000027,0.880433174120482,0,1,interleukin-8-mediated signaling pathway,BP,
19628,GO:1990904,1.00000000000028,0,28,702,ribonucleoprotein complex,CC,BTBD2;ZFP36L1;RPL13A;PITPNM1;GRB7;UNK;CIRBP;APOBEC3C;APOBEC3F;IMPACT;TDRKH;PAN2;EIF2D;DHX32;TEP1;TSTD1;AGO4;TERC;CTSH;PNRC1;MAPKBP1;C9ORF72;RPL39L;ZC3H12D;RPL29;EIF2AK4;RPL12;HMBOX1
8849,GO:0034660,1.00000000000029,0,17,544,ncRNA metabolic process,BP,RPL13A;AARS;NSUN5P2;CARS;RRNAD1;TRPT1;TDRKH;TFB1M;ISG20;AGO4;RPUSD3;CPSF4;CSNK1E;POU2F2;RPL29;RPL12;DTD1
8323,GO:0033181,1.00000000000032,0.88382680438684,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
16373,GO:0097020,1.00000000000034,0.880259625637657,0,1,COPII adaptor activity,MF,
170,GO:0000375,1.00000000000035,0,3,301,RNA splicing, via transesterification reactions,BP,SRSF5;DHX32;CPSF4
16045,GO:0090031,1.00000000000035,0.682134940047163,0,3,positive regulation of steroid hormone biosynthetic process,BP,
6659,GO:0030021,1.00000000000036,0.880307323658759,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6862,GO:0030345,1.00000000000036,0.880307323658759,0,1,structural constituent of tooth enamel,MF,
14066,GO:0060920,1.00000000000037,0.68170488650404,0,3,cardiac pacemaker cell differentiation,BP,
14070,GO:0060926,1.00000000000037,0.68170488650404,0,3,cardiac pacemaker cell development,BP,
3649,GO:0008131,1.00000000000038,0.681965012503431,0,3,primary amine oxidase activity,MF,
14966,GO:0070903,1.00000000000039,0.881744008577241,0,1,mitochondrial tRNA thio-modification,BP,
1931,GO:0004633,1.00000000000039,0.880830433964149,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
10674,GO:0043969,1.0000000000004,0.878607395111584,0,1,histone H2B acetylation,BP,
14467,GO:0061920,1.0000000000004,0.878607395111584,0,1,protein propionyltransferase activity,MF,
14468,GO:0061921,1.0000000000004,0.878607395111584,0,1,peptidyl-lysine propionylation,BP,
17266,GO:0140064,1.0000000000004,0.878607395111584,0,1,peptide crotonyltransferase activity,MF,
17267,GO:0140065,1.0000000000004,0.878607395111584,0,1,peptide butyryltransferase activity,MF,
17269,GO:0140067,1.0000000000004,0.878607395111584,0,1,peptidyl-lysine butyrylation,BP,
17270,GO:0140068,1.0000000000004,0.878607395111584,0,1,histone crotonyltransferase activity,MF,
17271,GO:0140069,1.0000000000004,0.878607395111584,0,1,histone butyryltransferase activity,MF,
17306,GO:1900003,1.00000000000041,0.69737817533261,0,3,regulation of serine-type endopeptidase activity,BP,
17307,GO:1900004,1.00000000000041,0.69737817533261,0,3,negative regulation of serine-type endopeptidase activity,BP,
18018,GO:1902571,1.00000000000041,0.69737817533261,0,3,regulation of serine-type peptidase activity,BP,
18019,GO:1902572,1.00000000000041,0.69737817533261,0,3,negative regulation of serine-type peptidase activity,BP,
8247,GO:0033037,1.00000000000041,0.880091866193655,0,1,polysaccharide localization,BP,
13376,GO:0052735,1.00000000000041,0.681789142653818,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
6461,GO:0021796,1.00000000000042,0.682072413900248,0,3,cerebral cortex regionalization,BP,
17446,GO:1900365,1.00000000000042,0.682379297166835,0,3,positive regulation of mRNA polyadenylation,BP,
13939,GO:0060671,1.00000000000043,0.68441242517226,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13940,GO:0060672,1.00000000000043,0.68441242517226,0,3,epithelial cell morphogenesis involved in placental branching,BP,
2051,GO:0004802,1.00000000000043,0.881150331273294,0,1,transketolase activity,MF,
5139,GO:0015670,1.00000000000045,0.883873126361772,0,1,carbon dioxide transport,BP,
8131,GO:0032849,1.00000000000045,0.883873126361772,0,1,positive regulation of cellular pH reduction,BP,
9472,GO:0036122,1.00000000000046,0.678498017991818,0,3,BMP binding,MF,
18028,GO:1902605,1.00000000000046,0.880344744884158,0,1,heterotrimeric G-protein complex assembly,BP,
10708,GO:0044062,1.00000000000047,0.684152841687042,0,3,regulation of excretion,BP,
171,GO:0000377,1.00000000000049,0,3,298,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,SRSF5;DHX32;CPSF4
183,GO:0000398,1.00000000000049,0,3,298,mRNA splicing, via spliceosome,BP,SRSF5;DHX32;CPSF4
16458,GO:0097169,1.00000000000049,0.708492915070502,0,3,AIM2 inflammasome complex,CC,
1314,GO:0003164,1.00000000000049,0.774587644646916,0,2,His-Purkinje system development,BP,
3167,GO:0006781,1.00000000000054,0.880963600520801,0,1,succinyl-CoA pathway,BP,
2647,GO:0005988,1.00000000000057,0.774692901915953,0,2,lactose metabolic process,BP,
2648,GO:0005989,1.00000000000057,0.774692901915953,0,2,lactose biosynthetic process,BP,
11618,GO:0046351,1.00000000000057,0.774692901915953,0,2,disaccharide biosynthetic process,BP,
19445,GO:1990180,1.00000000000058,0.693014429757741,0,3,mitochondrial tRNA 3'-end processing,BP,
4023,GO:0009059,1.0000000000006,0,369,4112,macromolecule biosynthetic process,BP,TNIP1;ZC3H6;HTRA1;F2R;ST6GALNAC2;APOE;ZMYND8;NFATC4;FOS;CITED4;EGR1;CTNNBIP1;LMF1;ZNF862;WWC3;PDCD4;VEGFA;EGFR;ZSCAN18;RBCK1;PRNP;ZDHHC1;NR1D1;ADAMTS7;PRDX5;BAHCC1;ZKSCAN1;CST3;MEF2D;NOS1;DDIT3;TSC22D1;DNAJB5;PGM1;CRTC1;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;SMARCA1;ZFP36L1;NUPR1;B3GAT3;TCFL5;HBEGF;RBL2;TFDP2;MXI1;RPL13A;MSRB2;MDFI;TK2;MAPK13;KLF9;RNF165;MIF4GD;ASH2L;SOX13;HYAL1;ETV4;WWTR1;POLD4;MAP2K1;MXD4;ABCA2;PKN1;MC1R;H2AFJ;BTG1;TRNP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;THAP8;SHC1;GRB7;VEGFB;SOX12;HDAC11;PTMS;UNK;CIRBP;CAPRIN2;LY6K;PRKCZ;ABCA7;AARS;ELK3;PABPC1L;SEC14L2;BRD3;CEMIP;KDM3A;FOXQ1;PHF1;SALL2;ETV1;ZP3;ABHD14B;NEURL1;ACVR2B;EAPP;NGFR;ETV5;MUC19;TRIB2;HES2;EREG;CHD2;TEF;APBB3;RMI2;NAB2;PLA2G6;UNKL;ABCG1;TRAPPC9;CARF;CARS;PPARA;INO80C;CHD3;SESN2;AIP;MKNK2;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;MAPK3;CSPG4;ERRFI1;THRA;VANGL2;RGS14;MVD;IRF2BPL;PBXIP1;ADAMTSL1;ZSCAN30;EIF2D;MAPK12;NAT14;ZXDC;SDC2;ARHGAP22;MLXIPL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;LITAF;ATF4;ZFPM1;CHST6;KDM4C;PAK6;ZNF467;PRIMPOL;POLM;TENM2;ZNF516;CBX7;PKD1;MDK;JDP2;HDAC5;GTPBP1;IRF5;TFB1M;SRSF5;VLDLR;ADGRF1;DEAF1;TEP1;ST3GAL3;PEG3;GLI4;RFX2;KDM7A;CEBPB;LRP5;CREBRF;ZNF251;PKIB;L3MBTL1;FBXL15;METTL23;HLTF;DNMT3A;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;TMSB4X;PDE2A;SMURF2;APLN;TRIB3;DAP;BHLHE40;CALCOCO1;EDA;HMG20B;CDK5RAP3;AGO4;PIGZ;HEXB;ZFP90;WNT7A;TRPV1;PIK3R2;ZNF558;ZNF662;GAS6;ERN1;MAPRE3;HEXA;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;POLL;TERC;PTAFR;PPP1R15A;RXRA;ZNF358;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;PNRC1;PAIP2B;AKT1;CARD11;CDKN1C;SWT1;CRY2;B4GALT2;CHEK2;IFT57;WDR45;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;PHLDA1;ZNF25;UHRF2;SMARCD2;IFI27;PTOV1;INSR;NCOA7;NELFCD;FOXO4;COG7;RPS6KA5;PIGQ;MAP2K5;ZDHHC24;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;ZFP28;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;ZNF846;TFEB;MPI;LSM14B;BCL6;HSF4;RPL39L;ZC3H12D;LEMD2;SIRT2;GDF15;RECQL5;GOLGA2;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;CIDEA;HDAC8;PAIP2;ADIRF;RPL29;EIF4EBP1;TGFBR3;TCF7;MAN1B1;EPAS1;MAP3K10;MFNG;CHD6;DHPS;POLR2J3;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;RGS12;SYVN1;RPL12;MPPE1;HMBOX1;TSHZ1;CREB3L4;ZNF449;IRF2BP2;ZMYM3;KCTD13;DBP;ZNF667;ZNF287;DTD1;IKBKB;NTM;DMTF1;HIP1;TEAD2;ACOT8;SIX5
3993,GO:0008897,1.0000000000006,0.880334521682838,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
11503,GO:0046038,1.0000000000006,0.886656783002435,0,1,GMP catabolic process,BP,
13361,GO:0052657,1.0000000000006,0.886656783002435,0,1,guanine phosphoribosyltransferase activity,MF,
3293,GO:0006990,1.00000000000061,0.684347634395465,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
2029,GO:0004772,1.00000000000063,0.880252959182316,0,1,sterol O-acyltransferase activity,MF,
8895,GO:0034736,1.00000000000063,0.880252959182316,0,1,cholesterol O-acyltransferase activity,MF,
18439,GO:1903565,1.00000000000063,0.880252959182316,0,1,negative regulation of protein localization to cilium,BP,
18442,GO:1903568,1.00000000000063,0.880252959182316,0,1,negative regulation of protein localization to ciliary membrane,BP,
751,GO:0001992,1.00000000000065,0.880130046496582,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
2158,GO:0004990,1.00000000000065,0.880130046496582,0,1,oxytocin receptor activity,MF,
2308,GO:0005298,1.00000000000065,0.880130046496582,0,1,proline:sodium symporter activity,MF,
10053,GO:0042564,1.00000000000065,0.880130046496582,0,1,NLS-dependent protein nuclear import complex,CC,
11982,GO:0047464,1.00000000000066,0.880122637203102,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12453,GO:0050379,1.00000000000066,0.880122637203102,0,1,UDP-glucuronate 5'-epimerase activity,MF,
172,GO:0000379,1.00000000000067,0.684279783069256,0,3,tRNA-type intron splice site recognition and cleavage,BP,
10633,GO:0043686,1.00000000000069,0.690121806656413,0,3,co-translational protein modification,BP,
1622,GO:0004060,1.00000000000071,0.881516866697618,0,1,arylamine N-acetyltransferase activity,MF,
8198,GO:0032962,1.00000000000072,0.682041883084366,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
7236,GO:0031177,1.00000000000072,0.711098718326283,0,3,phosphopantetheine binding,MF,
5509,GO:0016476,1.00000000000073,0.682094120481824,0,3,regulation of embryonic cell shape,BP,
7226,GO:0031134,1.00000000000073,0.683768106183611,0,3,sister chromatid biorientation,BP,
1029,GO:0002537,1.00000000000078,0.879477291682523,0,1,nitric oxide production involved in inflammatory response,BP,
14288,GO:0061459,1.00000000000078,0.879477291682523,0,1,L-arginine transmembrane transporter activity,MF,
16654,GO:0097625,1.00000000000078,0.879477291682523,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16655,GO:0097626,1.00000000000078,0.879477291682523,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16656,GO:0097627,1.00000000000078,0.879477291682523,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16665,GO:0097639,1.00000000000078,0.879477291682523,0,1,L-lysine import across plasma membrane,BP,
16666,GO:0097640,1.00000000000078,0.879477291682523,0,1,L-ornithine import across plasma membrane,BP,
18390,GO:1903461,1.00000000000078,0.880303423307069,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
7682,GO:0032143,1.00000000000079,0.774766985207649,0,2,single thymine insertion binding,MF,
7768,GO:0032301,1.00000000000079,0.774766985207649,0,2,MutSalpha complex,CC,
1425,GO:0003400,1.0000000000008,0.880966491151423,0,1,regulation of COPII vesicle coating,BP,
2204,GO:0005090,1.0000000000008,0.880966491151423,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13930,GO:0060661,1.0000000000008,0.880966491151423,0,1,submandibular salivary gland formation,BP,
15167,GO:0071335,1.0000000000008,0.880966491151423,0,1,hair follicle cell proliferation,BP,
15168,GO:0071336,1.0000000000008,0.880966491151423,0,1,regulation of hair follicle cell proliferation,BP,
15169,GO:0071338,1.0000000000008,0.880966491151423,0,1,positive regulation of hair follicle cell proliferation,BP,
16096,GO:0090113,1.0000000000008,0.880966491151423,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
19245,GO:1905462,1.00000000000084,0.774603521970545,0,2,regulation of DNA duplex unwinding,BP,
9220,GO:0035623,1.00000000000085,0.880281559849312,0,1,renal glucose absorption,BP,
1429,GO:0003406,1.00000000000085,0.681270964936853,0,3,retinal pigment epithelium development,BP,
10297,GO:0043095,1.00000000000087,0.898398252995635,0,1,regulation of GTP cyclohydrolase I activity,BP,
10303,GO:0043105,1.00000000000087,0.898398252995635,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10913,GO:0044549,1.00000000000087,0.898398252995635,0,1,GTP cyclohydrolase binding,MF,
2267,GO:0005199,1.00000000000088,0.880259087063392,0,1,structural constituent of cell wall,MF,
15379,GO:0071665,1.00000000000088,0.880259087063392,0,1,gamma-catenin-TCF7L2 complex,CC,
8971,GO:0035092,1.00000000000089,0.681399303099753,0,3,sperm chromatin condensation,BP,
1384,GO:0003292,1.00000000000089,0.880094836505235,0,1,cardiac septum cell differentiation,BP,
14068,GO:0060922,1.00000000000089,0.880094836505235,0,1,atrioventricular node cell differentiation,BP,
14071,GO:0060928,1.00000000000089,0.880094836505235,0,1,atrioventricular node cell development,BP,
12025,GO:0047874,1.0000000000009,0.881140018859464,0,1,dolichyldiphosphatase activity,MF,
15508,GO:0071930,1.0000000000009,0.681885450811136,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
739,GO:0001971,1.0000000000009,0.879420389642192,0,1,negative regulation of activation of membrane attack complex,BP,
15227,GO:0071421,1.00000000000091,0.774665787932084,0,2,manganese ion transmembrane transport,BP,
14593,GO:0070183,1.00000000000092,0.880338432689084,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
16580,GO:0097442,1.00000000000092,0.880100019411782,0,1,CA3 pyramidal cell dendrite,CC,
7678,GO:0032137,1.00000000000093,0.682122274374361,0,3,guanine/thymine mispair binding,MF,
6850,GO:0030327,1.00000000000093,0.682070143146861,0,3,prenylated protein catabolic process,BP,
191,GO:0000409,1.00000000000098,0.879797085765802,0,1,regulation of transcription by galactose,BP,
192,GO:0000411,1.00000000000098,0.879797085765802,0,1,positive regulation of transcription by galactose,BP,
205,GO:0000431,1.00000000000098,0.879797085765802,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
207,GO:0000435,1.00000000000098,0.879797085765802,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
2413,GO:0005588,1.000000000001,0.680383699094271,0,3,collagen type V trimer,CC,
13627,GO:0060161,1.00000000000101,0.682245585637225,0,3,positive regulation of dopamine receptor signaling pathway,BP,
10572,GO:0043553,1.00000000000103,0.682171377606376,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
2049,GO:0004800,1.00000000000104,0.879972407605775,0,1,thyroxine 5'-deiodinase activity,MF,
508,GO:0001572,1.00000000000105,0.880122835423947,0,1,lactosylceramide biosynthetic process,BP,
11673,GO:0046478,1.00000000000105,0.880122835423947,0,1,lactosylceramide metabolic process,BP,
7621,GO:0032029,1.00000000000106,0.874939666333222,0,1,myosin tail binding,MF,
15475,GO:0071873,1.00000000000108,0.880239719507472,0,1,response to norepinephrine,BP,
15476,GO:0071874,1.00000000000108,0.880239719507472,0,1,cellular response to norepinephrine stimulus,BP,
12951,GO:0051377,1.00000000000108,0.681976952295889,0,3,mannose-ethanolamine phosphotransferase activity,MF,
5529,GO:0016517,1.0000000000011,0.881658036863131,0,1,interleukin-12 receptor activity,MF,
9800,GO:0042019,1.0000000000011,0.881658036863131,0,1,interleukin-23 binding,MF,
9801,GO:0042020,1.0000000000011,0.881658036863131,0,1,interleukin-23 receptor activity,MF,
9802,GO:0042022,1.0000000000011,0.881658036863131,0,1,interleukin-12 receptor complex,CC,
15806,GO:0072536,1.0000000000011,0.881658036863131,0,1,interleukin-23 receptor complex,CC,
16957,GO:0099053,1.00000000000112,0.682914762075803,0,3,activating signal cointegrator 1 complex,CC,
16338,GO:0090667,1.00000000000112,0.879296821900518,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16339,GO:0090668,1.00000000000112,0.879296821900518,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
13490,GO:0055087,1.00000000000114,0.689252931495484,0,3,Ski complex,CC,
8904,GO:0034757,1.00000000000114,0.878840644867693,0,1,negative regulation of iron ion transport,BP,
8905,GO:0034759,1.00000000000114,0.878840644867693,0,1,regulation of iron ion transmembrane transport,BP,
8906,GO:0034760,1.00000000000114,0.878840644867693,0,1,negative regulation of iron ion transmembrane transport,BP,
8074,GO:0032767,1.00000000000114,0.6984813469841,0,3,copper-dependent protein binding,MF,
8766,GO:0034457,1.00000000000115,0.6983712998203,0,3,Mpp10 complex,CC,
15414,GO:0071723,1.00000000000116,0.681848729061371,0,3,lipopeptide binding,MF,
9107,GO:0035425,1.00000000000118,0.684086763861343,0,3,autocrine signaling,BP,
14680,GO:0070335,1.00000000000119,0.879694701715706,0,1,aspartate binding,MF,
5768,GO:0016979,1.00000000000119,0.886708048861171,0,1,lipoate-protein ligase activity,MF,
1693,GO:0004170,1.0000000000012,0.882284081423058,0,1,dUTP diphosphatase activity,MF,
11527,GO:0046080,1.0000000000012,0.882284081423058,0,1,dUTP metabolic process,BP,
11528,GO:0046081,1.0000000000012,0.882284081423058,0,1,dUTP catabolic process,BP,
1736,GO:0004336,1.00000000000122,0.880329501445651,0,1,galactosylceramidase activity,MF,
3103,GO:0006683,1.00000000000122,0.880329501445651,0,1,galactosylceramide catabolic process,BP,
6124,GO:0019376,1.00000000000122,0.880329501445651,0,1,galactolipid catabolic process,BP,
6441,GO:0021763,1.00000000000124,0.880792350449513,0,1,subthalamic nucleus development,BP,
13606,GO:0060127,1.00000000000124,0.880792350449513,0,1,prolactin secreting cell differentiation,BP,
13829,GO:0060459,1.00000000000124,0.880792350449513,0,1,left lung development,BP,
13830,GO:0060460,1.00000000000124,0.880792350449513,0,1,left lung morphogenesis,BP,
13894,GO:0060577,1.00000000000124,0.880792350449513,0,1,pulmonary vein morphogenesis,BP,
13895,GO:0060578,1.00000000000124,0.880792350449513,0,1,superior vena cava morphogenesis,BP,
14125,GO:0061031,1.00000000000124,0.880792350449513,0,1,endodermal digestive tract morphogenesis,BP,
1144,GO:0002740,1.00000000000125,0.884247185334446,0,1,negative regulation of cytokine secretion involved in immune response,BP,
1208,GO:0002874,1.00000000000125,0.884247185334446,0,1,regulation of chronic inflammatory response to antigenic stimulus,BP,
1209,GO:0002875,1.00000000000125,0.884247185334446,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2234,GO:0005141,1.00000000000125,0.884247185334446,0,1,interleukin-10 receptor binding,MF,
18671,GO:1904057,1.00000000000125,0.884247185334446,0,1,negative regulation of sensory perception of pain,BP,
7701,GO:0032197,1.00000000000125,0.880165102507999,0,1,transposition, RNA-mediated,BP,
8745,GO:0034423,1.00000000000126,0.880361170419211,0,1,autophagosome lumen,CC,
19893,GO:2000422,1.00000000000126,0.880361170419211,0,1,regulation of eosinophil chemotaxis,BP,
19894,GO:2000424,1.00000000000126,0.880361170419211,0,1,positive regulation of eosinophil chemotaxis,BP,
4428,GO:0010266,1.00000000000126,0.694886495053934,0,3,response to vitamin B1,BP,
18787,GO:1904381,1.00000000000127,0.774620305228293,0,2,Golgi apparatus mannose trimming,BP,
17211,GO:0110057,1.00000000000127,0.880112409331641,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17212,GO:0110059,1.00000000000127,0.880112409331641,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
19597,GO:1990784,1.00000000000128,0.880152381350781,0,1,response to dsDNA,BP,
19599,GO:1990786,1.00000000000128,0.880152381350781,0,1,cellular response to dsDNA,BP,
3529,GO:0007518,1.00000000000129,0.880548921263343,0,1,myoblast fate determination,BP,
1542,GO:0003939,1.0000000000013,0.880401768446187,0,1,L-iditol 2-dehydrogenase activity,MF,
2694,GO:0006062,1.0000000000013,0.880401768446187,0,1,sorbitol catabolic process,BP,
6135,GO:0019407,1.0000000000013,0.880401768446187,0,1,hexitol catabolic process,BP,
6161,GO:0019519,1.0000000000013,0.880401768446187,0,1,pentitol metabolic process,BP,
6164,GO:0019527,1.0000000000013,0.880401768446187,0,1,pentitol catabolic process,BP,
7304,GO:0031320,1.0000000000013,0.880401768446187,0,1,hexitol dehydrogenase activity,MF,
11702,GO:0046526,1.0000000000013,0.880401768446187,0,1,D-xylulose reductase activity,MF,
12823,GO:0051160,1.0000000000013,0.880401768446187,0,1,L-xylitol catabolic process,BP,
12824,GO:0051164,1.0000000000013,0.880401768446187,0,1,L-xylitol metabolic process,BP,
14510,GO:0070042,1.00000000000132,0.880313646992049,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
18174,GO:1902990,1.00000000000133,0.687619371644406,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
16671,GO:0097647,1.00000000000142,0.699137654271283,0,3,amylin receptor signaling pathway,BP,
11368,GO:0045764,1.00000000000142,0.787524677818763,0,2,positive regulation of cellular amino acid metabolic process,BP,
15063,GO:0071074,1.00000000000142,0.882050292027456,0,1,eukaryotic initiation factor eIF2 binding,MF,
18485,GO:1903674,1.00000000000142,0.882050292027456,0,1,regulation of cap-dependent translational initiation,BP,
18486,GO:1903676,1.00000000000142,0.882050292027456,0,1,positive regulation of cap-dependent translational initiation,BP,
19410,GO:1990070,1.00000000000142,0.897302125325139,0,1,TRAPPI protein complex,CC,
13924,GO:0060631,1.00000000000142,0.682096347898343,0,3,regulation of meiosis I,BP,
388,GO:0001034,1.00000000000145,0.882745430070059,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
2362,GO:0005471,1.00000000000146,0.691974415720088,0,3,ATP:ADP antiporter activity,MF,
5031,GO:0015207,1.00000000000146,0.691974415720088,0,3,adenine transmembrane transporter activity,MF,
3546,GO:0007576,1.00000000000146,0.880392820020815,0,1,nucleolar fragmentation,BP,
3829,GO:0008434,1.00000000000147,0.880123056762301,0,1,calcitriol receptor activity,MF,
9716,GO:0038181,1.00000000000147,0.880123056762301,0,1,bile acid receptor activity,MF,
9717,GO:0038183,1.00000000000147,0.880123056762301,0,1,bile acid signaling pathway,BP,
9718,GO:0038186,1.00000000000147,0.880123056762301,0,1,lithocholic acid receptor activity,MF,
17837,GO:1902098,1.00000000000147,0.880123056762301,0,1,calcitriol binding,MF,
17852,GO:1902121,1.00000000000147,0.880123056762301,0,1,lithocholic acid binding,MF,
17912,GO:1902271,1.00000000000147,0.880123056762301,0,1,D3 vitamins binding,MF,
2011,GO:0004741,1.00000000000147,0.681075675222846,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
3526,GO:0007509,1.00000000000149,0.879921539650031,0,1,mesoderm migration involved in gastrulation,BP,
3620,GO:0008078,1.00000000000149,0.879921539650031,0,1,mesodermal cell migration,BP,
9423,GO:0036015,1.0000000000015,0.700922752522832,0,3,response to interleukin-3,BP,
9424,GO:0036016,1.0000000000015,0.700922752522832,0,3,cellular response to interleukin-3,BP,
5091,GO:0015369,1.00000000000152,0.880113319343264,0,1,calcium:proton antiporter activity,MF,
12808,GO:0051139,1.00000000000152,0.880113319343264,0,1,metal ion:proton antiporter activity,MF,
2411,GO:0005586,1.00000000000152,0.88010964172487,0,1,collagen type III trimer,CC,
4482,GO:0010509,1.00000000000152,0.88010964172487,0,1,polyamine homeostasis,BP,
19263,GO:1905535,1.00000000000153,0.880120810000808,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19264,GO:1905537,1.00000000000153,0.880120810000808,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19295,GO:1905610,1.00000000000153,0.880120810000808,0,1,regulation of mRNA cap binding,BP,
19296,GO:1905612,1.00000000000153,0.880120810000808,0,1,positive regulation of mRNA cap binding,BP,
4727,GO:0010896,1.00000000000154,0.683052332944354,0,3,regulation of triglyceride catabolic process,BP,
13759,GO:0060371,1.00000000000154,0.682004449155129,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
409,GO:0001096,1.00000000000155,0.880204165340268,0,1,TFIIF-class transcription factor binding,MF,
4846,GO:0014063,1.00000000000155,0.890202821965889,0,1,negative regulation of serotonin secretion,BP,
17017,GO:0099522,1.00000000000157,0.881442829663182,0,1,region of cytosol,CC,
17018,GO:0099523,1.00000000000157,0.881442829663182,0,1,presynaptic cytosol,CC,
17019,GO:0099524,1.00000000000157,0.881442829663182,0,1,postsynaptic cytosol,CC,
18951,GO:1904764,1.00000000000157,0.881442829663182,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
19610,GO:1990832,1.00000000000157,0.881442829663182,0,1,slow axonal transport,BP,
19611,GO:1990833,1.00000000000157,0.881442829663182,0,1,clathrin-uncoating ATPase activity,MF,
5452,GO:0016333,1.00000000000158,0.88032600152655,0,1,morphogenesis of follicular epithelium,BP,
5453,GO:0016334,1.00000000000158,0.88032600152655,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
9897,GO:0042247,1.00000000000158,0.88032600152655,0,1,establishment of planar polarity of follicular epithelium,BP,
10105,GO:0042643,1.00000000000158,0.88032600152655,0,1,actomyosin, actin portion,CC,
19380,GO:1905940,1.00000000000161,0.68328982237448,0,3,negative regulation of gonad development,BP,
4005,GO:0008973,1.00000000000161,0.880280536347515,0,1,phosphopentomutase activity,MF,
3973,GO:0008798,1.00000000000161,0.880093661969324,0,1,beta-aspartyl-peptidase activity,MF,
14977,GO:0070931,1.00000000000161,0.880093661969324,0,1,Golgi-associated vesicle lumen,CC,
13200,GO:0051886,1.00000000000162,0.880121841948269,0,1,negative regulation of timing of anagen,BP,
20221,GO:2001203,1.00000000000162,0.880121841948269,0,1,positive regulation of transforming growth factor-beta secretion,BP,
344,GO:0000958,1.00000000000163,0.682000633931131,0,3,mitochondrial mRNA catabolic process,BP,
3093,GO:0006669,1.00000000000163,0.880323150595692,0,1,sphinganine-1-phosphate biosynthetic process,BP,
1009,GO:0002488,1.00000000000164,0.880153545832912,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1010,GO:0002489,1.00000000000164,0.880153545832912,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
8791,GO:0034506,1.00000000000164,0.880153545832912,0,1,chromosome, centromeric core domain,CC,
11904,GO:0046968,1.00000000000164,0.880153545832912,0,1,peptide antigen transport,BP,
11914,GO:0046980,1.00000000000164,0.880153545832912,0,1,tapasin binding,MF,
15735,GO:0072356,1.00000000000164,0.880153545832912,0,1,chromosome passenger complex localization to kinetochore,BP,
2079,GO:0004835,1.00000000000164,0.880121831151562,0,1,tubulin-tyrosine ligase activity,MF,
5909,GO:0018166,1.00000000000164,0.880121831151562,0,1,C-terminal protein-tyrosinylation,BP,
5950,GO:0018322,1.00000000000164,0.880121831151562,0,1,protein tyrosinylation,BP,
17732,GO:1901726,1.00000000000164,0.876233358345505,0,1,negative regulation of histone deacetylase activity,BP,
19114,GO:1905143,1.00000000000166,0.885028620664467,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
6471,GO:0021817,1.00000000000167,0.677147796356674,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
8642,GO:0034203,1.00000000000167,0.880122328951964,0,1,glycolipid translocation,BP,
4693,GO:0010856,1.00000000000167,0.880273974978291,0,1,adenylate cyclase activator activity,MF,
10340,GO:0043170,1.00000000000169,0,689,6864,macromolecule metabolic process,BP,TNIP1;XDH;DUSP6;PTPRS;ACTA2;DLG4;ZC3H6;HTRA1;BBS2;F2R;ST6GALNAC2;NT5E;TNFRSF6B;NYNRIN;APOE;BTBD2;ZMYND8;NFATC4;XPC;SERPINE2;GID4;FOS;H1F0;GSN;CITED4;PYGB;EGR1;CTNNBIP1;LMF1;TYSND1;PPP1R35;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;CDC42EP5;THSD4;WWC3;EDEM1;RNF135;GJC2;LRP1;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;ERCC1;FBLN1;ADAMTS7;PRDX5;ANK3;BAHCC1;TFPI2;DUSP5;NEK9;RAPGEF3;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;RNPEPL1;IGFBP4;CD9;FKBP9;CRTAP;CST3;DNM1;MEF2D;NOS1;DDIT3;TSC22D1;BRSK1;DNAJB5;PGM1;CRTC1;CLCA2;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;MMP28;GRAMD4;SMARCA1;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;ARAP1;B3GAT3;TCFL5;HBEGF;RBL2;RPS6KA2;GAA;PYGL;MMP1;CTF1;CNTN1;TFDP2;MXI1;RPL13A;MSRB2;OBSL1;MDFI;TK2;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;KLF9;RNF165;MIF4GD;CDK18;PHACTR3;FBXW4;ASH2L;SOX13;CUL7;LHPP;PRSS3;HYAL1;NAGLU;PPP1R14A;ETV4;WWTR1;POLD4;MAP2K1;MXD4;ABCA2;PKN1;MC1R;DDIT4;H2AFJ;ALPK1;BTG1;TRNP1;SHC2;DNASE1L1;SYNGAP1;ITGA6;PHF21A;DGKQ;ZNF76;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;SOX12;HDAC11;RAB3B;PCSK1;PTMS;UNK;PRSS8;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;ELK3;STK39;PABPC1L;ERO1B;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;KLHL29;PHF1;NPR2;CAPNS2;CBS;SPRY4;USP20;SALL2;DLG3;DDX59;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;MARCH4;ETV5;ETFB;LCE1E;LTBP1;MUC19;NSMCE4A;TRIB2;HES2;EREG;CHD2;TEF;APBB3;PTPRE;RNF44;SSH3;RMI2;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;PPM1J;ABCG1;TRAPPC9;CARF;LPAR3;CARS;FKBP10;MTMR4;C5;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;PPP1R3E;ING4;RRNAD1;HMGA2;AREG;ST6GALNAC6;SLIT3;ECM1;B4GAT1;MARCH9;JADE2;ACACB;MAPK3;CSPG4;TRPT1;LAMB2;PC;FBXO27;BNIP3;ERRFI1;MACROD1;THRA;DCAF10;PEX10;STK40;VANGL2;RGS14;MVD;IRF2BPL;FAM20C;TDRKH;PBXIP1;CNTRL;ADAMTSL1;SNTA1;PAN2;CTSB;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;NAT14;ZXDC;SDC2;FBXO17;ARHGAP22;MLXIPL;PTPDC1;C1RL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;SLC50A1;PGPEP1;LRSAM1;DMTN;KLHL24;LITAF;PTHLH;UBXN4;ATF4;ZFPM1;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;SSH1;PCMTD2;PRIMPOL;POLM;TENM2;FBXO6;IFI6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;FLOT1;MDK;TTN;PSKH1;HLCS;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;SORL1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;VLDLR;PAPLN;ADGRF1;DHX32;DEAF1;TEP1;ST3GAL3;SULF2;NLRP1;PEG3;ACY1;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;NEK8;RHBDF1;LRP5;PTPRU;WNK4;ATRAID;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;FBXL16;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;MOCOS;APOL4;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;AGO4;MINK1;PIGZ;HEXB;PROM2;ZFP90;WNT7A;TTLL11;TRPV1;MARCH2;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;RPUSD3;ZNF662;SHARPIN;GAS6;DNAJC6;ERN1;BCR;KLHDC8B;MAPRE3;MAN2C1;NBR1;EXD3;HEXA;TNNI2;TADA3;BOLA1;NECAB3;CAMK1;POLL;TERC;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;PRDM8;STRADB;CTSH;PNRC1;FBXL8;MGMT;PAIP2B;LCE1F;HINT2;MAPKBP1;AKT1;IGFBP7;CARD11;DGUOK;CDKN1C;MICAL1;SWT1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;LACTB2;WDR45;IGFBP2;SPDYE2;SPDYE2B;NFU1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;PHLDA1;ZNF25;DNASE2;SPSB3;WDFY2;C9ORF72;CHMP5;UHRF2;ARSA;CAPN2;MAN2B1;SMARCD2;SPATA18;MARK4;IFI27;PTOV1;PLAU;INSR;WNT3;NCOA7;NELFCD;TENM4;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;ZNF554;CPSF4;POLR2J2;HOXC5;FAAP20;PIDD1;CAT;ZNF160;MAPK10;DPP7;MPG;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;UBOX5;CHRM3;ZNF846;TFEB;MIB2;MPI;LSM14B;ENDOV;JOSD2;PHC1;SCYL3;CSNK1E;HGSNAT;BCL6;HSF4;REC8;RNF213;FBXO25;EHD3;RPL39L;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;UBXN6;SIRT2;GDF15;PHLDA2;RECQL5;RAB13;GOLGA2;POU2F2;PLXND1;RCOR2;POLR3GL;MTA1;MSH5;AP2A2;CIDEA;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;RNPEP;MAN1B1;GALNS;EPAS1;LAMTOR2;MAP3K10;TBC1D16;MFNG;CHD6;RNF170;DHPS;EPHB2;POLR2J3;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;BLOC1S1;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;STK32B;UNC119;RGS12;SYVN1;FRS3;MMP17;RPL12;MPPE1;HMBOX1;TRIM2;TSHZ1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;ZMYM3;LYPLAL1;KCTD13;DBP;APBA1;ZNF667;ZNF287;CAMKK1;DTX3;DTD1;IKBKB;NTM;DMTF1;HIP1;TEAD2;ACOT8;BTBD11;SIX5
6088,GO:0019276,1.00000000000171,0.880333828310808,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
9019,GO:0035248,1.00000000000171,0.880333828310808,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
6227,GO:0019782,1.00000000000171,0.880265876177081,0,1,ISG15 activating enzyme activity,MF,
2580,GO:0005873,1.00000000000175,0.681830430299772,0,3,plus-end kinesin complex,CC,
8130,GO:0032848,1.0000000000018,0.880176855377091,0,1,negative regulation of cellular pH reduction,BP,
10465,GO:0043375,1.0000000000018,0.880176855377091,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11776,GO:0046668,1.0000000000018,0.880176855377091,0,1,regulation of retinal cell programmed cell death,BP,
11777,GO:0046671,1.0000000000018,0.880176855377091,0,1,negative regulation of retinal cell programmed cell death,BP,
14312,GO:0061534,1.0000000000018,0.873905176095449,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
18969,GO:1904799,1.0000000000018,0.8801617863076,0,1,regulation of neuron remodeling,BP,
18970,GO:1904800,1.0000000000018,0.8801617863076,0,1,negative regulation of neuron remodeling,BP,
19737,GO:2000173,1.0000000000018,0.8801617863076,0,1,negative regulation of branching morphogenesis of a nerve,BP,
17773,GO:1901894,1.00000000000182,0.686545144856458,0,3,regulation of calcium-transporting ATPase activity,BP,
13994,GO:0060743,1.00000000000184,0.88038850007763,0,1,epithelial cell maturation involved in prostate gland development,BP,
1377,GO:0003275,1.00000000000184,0.774714208532798,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
17902,GO:1902256,1.00000000000184,0.774714208532798,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
5765,GO:0016971,1.00000000000185,0.682187623766571,0,3,flavin-linked sulfhydryl oxidase activity,MF,
3666,GO:0008160,1.00000000000186,0.880365915706478,0,1,protein tyrosine phosphatase activator activity,MF,
10055,GO:0042567,1.00000000000186,0.880365915706478,0,1,insulin-like growth factor ternary complex,CC,
16472,GO:0097196,1.00000000000187,0.776349112394921,0,2,Shu complex,CC,
4894,GO:0014825,1.00000000000187,0.896399953884133,0,1,stomach fundus smooth muscle contraction,BP,
4907,GO:0014847,1.00000000000187,0.896399953884133,0,1,proximal stomach smooth muscle contraction,BP,
7536,GO:0031839,1.00000000000187,0.896399953884133,0,1,type 1 neuromedin U receptor binding,MF,
7537,GO:0031840,1.00000000000187,0.896399953884133,0,1,type 2 neuromedin U receptor binding,MF,
9127,GO:0035483,1.00000000000187,0.896399953884133,0,1,gastric emptying,BP,
10214,GO:0042922,1.00000000000187,0.896399953884133,0,1,neuromedin U receptor binding,MF,
10898,GO:0044495,1.00000000000187,0.896399953884133,0,1,modulation of blood pressure in other organism,BP,
10899,GO:0044497,1.00000000000187,0.896399953884133,0,1,positive regulation of blood pressure in other organism,BP,
17235,GO:0120060,1.00000000000187,0.896399953884133,0,1,regulation of gastric emptying,BP,
17236,GO:0120061,1.00000000000187,0.896399953884133,0,1,negative regulation of gastric emptying,BP,
17237,GO:0120063,1.00000000000187,0.896399953884133,0,1,stomach smooth muscle contraction,BP,
17238,GO:0120068,1.00000000000187,0.896399953884133,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17239,GO:0120069,1.00000000000187,0.896399953884133,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
3995,GO:0008903,1.00000000000189,0.891165152136162,0,1,hydroxypyruvate isomerase activity,MF,
8932,GO:0034987,1.00000000000189,0.878812240895624,0,1,immunoglobulin receptor binding,MF,
8933,GO:0034988,1.00000000000189,0.878812240895624,0,1,Fc-gamma receptor I complex binding,MF,
13760,GO:0060372,1.00000000000189,0.878812240895624,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
19068,GO:1905000,1.00000000000189,0.878812240895624,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
1315,GO:0003165,1.00000000000191,0.880100369122658,0,1,Purkinje myocyte development,BP,
9216,GO:0035617,1.00000000000191,0.682475764155354,0,3,stress granule disassembly,BP,
823,GO:0002100,1.00000000000191,0.880005426815327,0,1,tRNA wobble adenosine to inosine editing,BP,
2148,GO:0004968,1.00000000000191,0.880005426815327,0,1,gonadotropin-releasing hormone receptor activity,MF,
8899,GO:0034752,1.00000000000191,0.880005426815327,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8900,GO:0034753,1.00000000000191,0.880005426815327,0,1,nuclear aryl hydrocarbon receptor complex,CC,
13370,GO:0052717,1.00000000000191,0.880005426815327,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13371,GO:0052718,1.00000000000191,0.880005426815327,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
7787,GO:0032345,1.00000000000192,0.682105474382242,0,3,negative regulation of aldosterone metabolic process,BP,
7790,GO:0032348,1.00000000000192,0.682105474382242,0,3,negative regulation of aldosterone biosynthetic process,BP,
19691,GO:2000065,1.00000000000192,0.682105474382242,0,3,negative regulation of cortisol biosynthetic process,BP,
3077,GO:0006651,1.00000000000192,0.879646247388669,0,1,diacylglycerol biosynthetic process,BP,
18944,GO:1904751,1.00000000000192,0.69303294729471,0,3,positive regulation of protein localization to nucleolus,BP,
18171,GO:1902977,1.00000000000192,0.881987974385049,0,1,mitotic DNA replication preinitiation complex assembly,BP,
7590,GO:0031974,1.00000000000193,0,393,4312,membrane-enclosed lumen,CC,TNIP1;DUSP6;H6PD;DOCK4;NT5E;APOE;NFATC4;XPC;FOS;PRODH;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;VWA5A;ALDH7A1;PTK6;NAPRT;CRAT;NAGS;TIMP2;VEGFA;OBSCN;EGFR;DDB2;D2HGDH;NR1D1;ERCC1;ADAMTS7;HADH;PRDX5;BAHCC1;DUSP5;FCHO1;TSPAN1;IGFBP4;IDH2;CRTAP;CST3;DNM1;MEF2D;NOS1;DDIT3;BRSK1;ACAD10;PGM1;CRTC1;ERCC6;ADAMTS13;ABTB1;TCEA2;COL13A1;SMARCA1;TRIM65;ADARB1;ARAP1;RBL2;RPS6KA2;GAA;PYGL;PYCR2;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;TK2;CERCAM;CTSF;KLF9;MIF4GD;PHACTR3;CPT2;MLYCD;KLHDC2;ASH2L;SOX13;LHPP;TMEM92;ATG16L2;PRSS3;HMGCL;HYAL1;NAGLU;ETV4;WWTR1;ACP6;POLD4;PCK2;COL6A1;PKN1;CAPG;H2AFJ;TRNP1;DNASE1L1;PHC2;PHF21A;DGKQ;MAML3;ARL2;SHC1;PHF7;VEGFB;OGDHL;SOX12;HDAC11;PCSK1;ITPR3;HSD11B1L;PITPNC1;APPL2;CIRBP;PRKCZ;PPP2R3B;SERPING1;PHYH;ELK3;STK39;BLVRB;KDM3A;PHF1;GLDC;SALL2;DDX59;WDR27;NME4;NSUN5P2;NEIL1;ABHD14B;RAG1;SPPL2B;NGFR;ETV5;ETFB;LTBP1;MUC19;NSMCE4A;ACTR1B;CHD2;GPT2;SPG11;RNF44;RMI2;CYHR1;OLFM2;ANO8;CES3;XPOT;FAM50A;CARF;S100A13;FKBP10;PPARA;INO80C;CHD3;CCDC92;SPC24;AIP;MKNK2;SCMH1;SATB1;STAT6;ING4;HMGA2;COL8A1;ECM1;JADE2;MAPK3;CSPG4;LAMB2;PC;DEF6;BNIP3;MACROD1;THRA;DCAF10;STK40;ACSS2;RGS14;IRF2BPL;FAM20C;ADAMTSL1;CTSB;EIF2D;MXRA8;MAPK12;LTA4H;SDC2;MLXIPL;TBC1D14;PTPDC1;TSPYL2;H1FX;HIBADH;FLYWCH1;SDHA;TECPR1;LITAF;PTHLH;NOL4L;ATF4;ZFPM1;KDM4C;PAK6;LRRC45;LTB4R2;PRIMPOL;FAM193B;POLM;TENM2;CBX7;FUCA1;NSMCE1;TTN;PSKH1;HLCS;HDAC5;SORL1;TFB1M;IL17RD;SRSF5;DEAF1;TEP1;CES2;NLRP1;COL4A6;KDM7A;CEBPB;ACOT7;ALDOC;CREBRF;PCSK9;L3MBTL1;ACADS;ISG20;LONP2;EPN3;HLTF;DNMT3A;TMSB4X;PDE2A;SMURF2;BHLHE40;ALDH1L2;MLH3;CALCOCO1;HMG20B;CDK5RAP3;AGO4;HEXB;LDOC1;WNT7A;BNIP3L;NICN1;RPUSD3;GAS6;GLUD1;SUCLG2;ALKBH7;MAN2C1;NBR1;HEXA;TADA3;POLL;TERC;RXRA;MBD1;TNRC18;SPATA7;CTSH;WDR19;ACOX3;MGMT;HINT2;AKT1;IGFBP7;DGUOK;CRY2;MZT2B;B4GALT2;LAMB1;CHEK2;LACTB2;PHYKPL;NFU1;TSG101;PHF2;ZNF217;PIAS3;ASAP3;HAGH;CBR4;PHLDA1;ACADVL;LMNA;UPP1;UHRF2;ARSA;MAN2B1;NPIPA2;SMARCD2;ARHGAP27;INSR;WNT3;ACSS1;NELFCD;FOXO4;COG7;YPEL3;RPS6KA5;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;C6ORF89;ZNF554;CPSF4;POLR2J2;LETMD1;HOXC5;GJB4;FAAP20;PIDD1;CAT;MZT2A;MAPK10;DPP7;YPEL5;MPG;LGALS1;TIMP1;TP73;MTA3;MNT;UBOX5;APRT;PEX7;ENDOV;PHC1;METTL7A;SPIRE1;CSNK1E;BCL6;HSF4;REC8;RNF213;ZC3H12D;SIRT2;RECQL5;TST;HCFC1R1;CELSR1;SH3GLB2;ADA;POU2F2;POLR3GL;MTA1;MSH5;HDAC8;ADIRF;TCF7;GALNS;EPAS1;CHD6;MAGI1;POLR2J3;PER1;LRCH4;MCTP2;FGFR1;WFS1;BLOC1S1;KDELC2;RGS12;SYVN1;PFKL;MPPE1;HMBOX1;CREB3L4;IRF2BP2;ZMYM3;SDHAF4;TRIM45;KCTD13;DTD1;DMTF1;PLEKHH2;TEAD2;ACOT8
10384,GO:0043233,1.00000000000193,0,393,4312,organelle lumen,CC,TNIP1;DUSP6;H6PD;DOCK4;NT5E;APOE;NFATC4;XPC;FOS;PRODH;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;VWA5A;ALDH7A1;PTK6;NAPRT;CRAT;NAGS;TIMP2;VEGFA;OBSCN;EGFR;DDB2;D2HGDH;NR1D1;ERCC1;ADAMTS7;HADH;PRDX5;BAHCC1;DUSP5;FCHO1;TSPAN1;IGFBP4;IDH2;CRTAP;CST3;DNM1;MEF2D;NOS1;DDIT3;BRSK1;ACAD10;PGM1;CRTC1;ERCC6;ADAMTS13;ABTB1;TCEA2;COL13A1;SMARCA1;TRIM65;ADARB1;ARAP1;RBL2;RPS6KA2;GAA;PYGL;PYCR2;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;TK2;CERCAM;CTSF;KLF9;MIF4GD;PHACTR3;CPT2;MLYCD;KLHDC2;ASH2L;SOX13;LHPP;TMEM92;ATG16L2;PRSS3;HMGCL;HYAL1;NAGLU;ETV4;WWTR1;ACP6;POLD4;PCK2;COL6A1;PKN1;CAPG;H2AFJ;TRNP1;DNASE1L1;PHC2;PHF21A;DGKQ;MAML3;ARL2;SHC1;PHF7;VEGFB;OGDHL;SOX12;HDAC11;PCSK1;ITPR3;HSD11B1L;PITPNC1;APPL2;CIRBP;PRKCZ;PPP2R3B;SERPING1;PHYH;ELK3;STK39;BLVRB;KDM3A;PHF1;GLDC;SALL2;DDX59;WDR27;NME4;NSUN5P2;NEIL1;ABHD14B;RAG1;SPPL2B;NGFR;ETV5;ETFB;LTBP1;MUC19;NSMCE4A;ACTR1B;CHD2;GPT2;SPG11;RNF44;RMI2;CYHR1;OLFM2;ANO8;CES3;XPOT;FAM50A;CARF;S100A13;FKBP10;PPARA;INO80C;CHD3;CCDC92;SPC24;AIP;MKNK2;SCMH1;SATB1;STAT6;ING4;HMGA2;COL8A1;ECM1;JADE2;MAPK3;CSPG4;LAMB2;PC;DEF6;BNIP3;MACROD1;THRA;DCAF10;STK40;ACSS2;RGS14;IRF2BPL;FAM20C;ADAMTSL1;CTSB;EIF2D;MXRA8;MAPK12;LTA4H;SDC2;MLXIPL;TBC1D14;PTPDC1;TSPYL2;H1FX;HIBADH;FLYWCH1;SDHA;TECPR1;LITAF;PTHLH;NOL4L;ATF4;ZFPM1;KDM4C;PAK6;LRRC45;LTB4R2;PRIMPOL;FAM193B;POLM;TENM2;CBX7;FUCA1;NSMCE1;TTN;PSKH1;HLCS;HDAC5;SORL1;TFB1M;IL17RD;SRSF5;DEAF1;TEP1;CES2;NLRP1;COL4A6;KDM7A;CEBPB;ACOT7;ALDOC;CREBRF;PCSK9;L3MBTL1;ACADS;ISG20;LONP2;EPN3;HLTF;DNMT3A;TMSB4X;PDE2A;SMURF2;BHLHE40;ALDH1L2;MLH3;CALCOCO1;HMG20B;CDK5RAP3;AGO4;HEXB;LDOC1;WNT7A;BNIP3L;NICN1;RPUSD3;GAS6;GLUD1;SUCLG2;ALKBH7;MAN2C1;NBR1;HEXA;TADA3;POLL;TERC;RXRA;MBD1;TNRC18;SPATA7;CTSH;WDR19;ACOX3;MGMT;HINT2;AKT1;IGFBP7;DGUOK;CRY2;MZT2B;B4GALT2;LAMB1;CHEK2;LACTB2;PHYKPL;NFU1;TSG101;PHF2;ZNF217;PIAS3;ASAP3;HAGH;CBR4;PHLDA1;ACADVL;LMNA;UPP1;UHRF2;ARSA;MAN2B1;NPIPA2;SMARCD2;ARHGAP27;INSR;WNT3;ACSS1;NELFCD;FOXO4;COG7;YPEL3;RPS6KA5;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;C6ORF89;ZNF554;CPSF4;POLR2J2;LETMD1;HOXC5;GJB4;FAAP20;PIDD1;CAT;MZT2A;MAPK10;DPP7;YPEL5;MPG;LGALS1;TIMP1;TP73;MTA3;MNT;UBOX5;APRT;PEX7;ENDOV;PHC1;METTL7A;SPIRE1;CSNK1E;BCL6;HSF4;REC8;RNF213;ZC3H12D;SIRT2;RECQL5;TST;HCFC1R1;CELSR1;SH3GLB2;ADA;POU2F2;POLR3GL;MTA1;MSH5;HDAC8;ADIRF;TCF7;GALNS;EPAS1;CHD6;MAGI1;POLR2J3;PER1;LRCH4;MCTP2;FGFR1;WFS1;BLOC1S1;KDELC2;RGS12;SYVN1;PFKL;MPPE1;HMBOX1;CREB3L4;IRF2BP2;ZMYM3;SDHAF4;TRIM45;KCTD13;DTD1;DMTF1;PLEKHH2;TEAD2;ACOT8
14499,GO:0070013,1.00000000000193,0,393,4312,intracellular organelle lumen,CC,TNIP1;DUSP6;H6PD;DOCK4;NT5E;APOE;NFATC4;XPC;FOS;PRODH;H1F0;GSN;CITED4;ACSF2;PYGB;EGR1;CTNNBIP1;VWA5A;ALDH7A1;PTK6;NAPRT;CRAT;NAGS;TIMP2;VEGFA;OBSCN;EGFR;DDB2;D2HGDH;NR1D1;ERCC1;ADAMTS7;HADH;PRDX5;BAHCC1;DUSP5;FCHO1;TSPAN1;IGFBP4;IDH2;CRTAP;CST3;DNM1;MEF2D;NOS1;DDIT3;BRSK1;ACAD10;PGM1;CRTC1;ERCC6;ADAMTS13;ABTB1;TCEA2;COL13A1;SMARCA1;TRIM65;ADARB1;ARAP1;RBL2;RPS6KA2;GAA;PYGL;PYCR2;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;TK2;CERCAM;CTSF;KLF9;MIF4GD;PHACTR3;CPT2;MLYCD;KLHDC2;ASH2L;SOX13;LHPP;TMEM92;ATG16L2;PRSS3;HMGCL;HYAL1;NAGLU;ETV4;WWTR1;ACP6;POLD4;PCK2;COL6A1;PKN1;CAPG;H2AFJ;TRNP1;DNASE1L1;PHC2;PHF21A;DGKQ;MAML3;ARL2;SHC1;PHF7;VEGFB;OGDHL;SOX12;HDAC11;PCSK1;ITPR3;HSD11B1L;PITPNC1;APPL2;CIRBP;PRKCZ;PPP2R3B;SERPING1;PHYH;ELK3;STK39;BLVRB;KDM3A;PHF1;GLDC;SALL2;DDX59;WDR27;NME4;NSUN5P2;NEIL1;ABHD14B;RAG1;SPPL2B;NGFR;ETV5;ETFB;LTBP1;MUC19;NSMCE4A;ACTR1B;CHD2;GPT2;SPG11;RNF44;RMI2;CYHR1;OLFM2;ANO8;CES3;XPOT;FAM50A;CARF;S100A13;FKBP10;PPARA;INO80C;CHD3;CCDC92;SPC24;AIP;MKNK2;SCMH1;SATB1;STAT6;ING4;HMGA2;COL8A1;ECM1;JADE2;MAPK3;CSPG4;LAMB2;PC;DEF6;BNIP3;MACROD1;THRA;DCAF10;STK40;ACSS2;RGS14;IRF2BPL;FAM20C;ADAMTSL1;CTSB;EIF2D;MXRA8;MAPK12;LTA4H;SDC2;MLXIPL;TBC1D14;PTPDC1;TSPYL2;H1FX;HIBADH;FLYWCH1;SDHA;TECPR1;LITAF;PTHLH;NOL4L;ATF4;ZFPM1;KDM4C;PAK6;LRRC45;LTB4R2;PRIMPOL;FAM193B;POLM;TENM2;CBX7;FUCA1;NSMCE1;TTN;PSKH1;HLCS;HDAC5;SORL1;TFB1M;IL17RD;SRSF5;DEAF1;TEP1;CES2;NLRP1;COL4A6;KDM7A;CEBPB;ACOT7;ALDOC;CREBRF;PCSK9;L3MBTL1;ACADS;ISG20;LONP2;EPN3;HLTF;DNMT3A;TMSB4X;PDE2A;SMURF2;BHLHE40;ALDH1L2;MLH3;CALCOCO1;HMG20B;CDK5RAP3;AGO4;HEXB;LDOC1;WNT7A;BNIP3L;NICN1;RPUSD3;GAS6;GLUD1;SUCLG2;ALKBH7;MAN2C1;NBR1;HEXA;TADA3;POLL;TERC;RXRA;MBD1;TNRC18;SPATA7;CTSH;WDR19;ACOX3;MGMT;HINT2;AKT1;IGFBP7;DGUOK;CRY2;MZT2B;B4GALT2;LAMB1;CHEK2;LACTB2;PHYKPL;NFU1;TSG101;PHF2;ZNF217;PIAS3;ASAP3;HAGH;CBR4;PHLDA1;ACADVL;LMNA;UPP1;UHRF2;ARSA;MAN2B1;NPIPA2;SMARCD2;ARHGAP27;INSR;WNT3;ACSS1;NELFCD;FOXO4;COG7;YPEL3;RPS6KA5;ADD3;MAGED2;RABGGTA;TXNRD2;ITGB6;C6ORF89;ZNF554;CPSF4;POLR2J2;LETMD1;HOXC5;GJB4;FAAP20;PIDD1;CAT;MZT2A;MAPK10;DPP7;YPEL5;MPG;LGALS1;TIMP1;TP73;MTA3;MNT;UBOX5;APRT;PEX7;ENDOV;PHC1;METTL7A;SPIRE1;CSNK1E;BCL6;HSF4;REC8;RNF213;ZC3H12D;SIRT2;RECQL5;TST;HCFC1R1;CELSR1;SH3GLB2;ADA;POU2F2;POLR3GL;MTA1;MSH5;HDAC8;ADIRF;TCF7;GALNS;EPAS1;CHD6;MAGI1;POLR2J3;PER1;LRCH4;MCTP2;FGFR1;WFS1;BLOC1S1;KDELC2;RGS12;SYVN1;PFKL;MPPE1;HMBOX1;CREB3L4;IRF2BP2;ZMYM3;SDHAF4;TRIM45;KCTD13;DTD1;DMTF1;PLEKHH2;TEAD2;ACOT8
14994,GO:0070950,1.00000000000193,0.880332814420721,0,1,regulation of neutrophil mediated killing of bacterium,BP,
14995,GO:0070951,1.00000000000193,0.880332814420721,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
14999,GO:0070962,1.00000000000193,0.880332814420721,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15000,GO:0070963,1.00000000000193,0.880332814420721,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16151,GO:0090198,1.00000000000193,0.880332814420721,0,1,negative regulation of chemokine secretion,BP,
16379,GO:0097029,1.00000000000193,0.880332814420721,0,1,mature conventional dendritic cell differentiation,BP,
17376,GO:1900135,1.00000000000193,0.880332814420721,0,1,positive regulation of renin secretion into blood stream,BP,
19056,GO:1904977,1.00000000000193,0.880332814420721,0,1,lymphatic endothelial cell migration,BP,
8546,GO:0033989,1.00000000000194,0.880350469261039,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9463,GO:0036111,1.00000000000194,0.880350469261039,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10918,GO:0044594,1.00000000000194,0.880350469261039,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
120,GO:0000250,1.00000000000195,0.88013486447591,0,1,lanosterol synthase activity,MF,
7430,GO:0031559,1.00000000000195,0.88013486447591,0,1,oxidosqualene cyclase activity,MF,
19218,GO:1905404,1.00000000000196,0.885183314279393,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
9138,GO:0035504,1.00000000000196,0.885640206824591,0,1,regulation of myosin light chain kinase activity,BP,
9139,GO:0035505,1.00000000000196,0.885640206824591,0,1,positive regulation of myosin light chain kinase activity,BP,
10316,GO:0043126,1.00000000000196,0.885640206824591,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10317,GO:0043128,1.00000000000196,0.885640206824591,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11562,GO:0046136,1.00000000000196,0.885640206824591,0,1,positive regulation of vitamin metabolic process,BP,
13880,GO:0060557,1.00000000000196,0.885640206824591,0,1,positive regulation of vitamin D biosynthetic process,BP,
13882,GO:0060559,1.00000000000196,0.885640206824591,0,1,positive regulation of calcidiol 1-monooxygenase activity,BP,
4054,GO:0009107,1.00000000000197,0.883803783908153,0,1,lipoate biosynthetic process,BP,
5769,GO:0016992,1.00000000000197,0.883803783908153,0,1,lipoate synthase activity,MF,
14648,GO:0070283,1.00000000000197,0.883803783908153,0,1,radical SAM enzyme activity,MF,
18937,GO:1904743,1.00000000000199,0.772326253270105,0,2,negative regulation of telomeric DNA binding,BP,
8650,GO:0034224,1.00000000000199,0.880761846798472,0,1,cellular response to zinc ion starvation,BP,
8655,GO:0034238,1.00000000000204,0.880158036275024,0,1,macrophage fusion,BP,
8656,GO:0034239,1.00000000000204,0.880158036275024,0,1,regulation of macrophage fusion,BP,
8657,GO:0034241,1.00000000000204,0.880158036275024,0,1,positive regulation of macrophage fusion,BP,
19825,GO:2000325,1.00000000000205,0.880021509491122,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19826,GO:2000327,1.00000000000205,0.880021509491122,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19213,GO:1905394,1.00000000000205,0.682338995031207,0,3,retromer complex binding,MF,
12972,GO:0051413,1.00000000000205,0.88041243601929,0,1,response to cortisone,BP,
19908,GO:2000467,1.00000000000206,0.681907159042925,0,3,positive regulation of glycogen (starch) synthase activity,BP,
2688,GO:0006055,1.00000000000206,0.889114321456947,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11630,GO:0046381,1.00000000000206,0.889114321456947,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11980,GO:0047444,1.00000000000206,0.889114321456947,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12465,GO:0050462,1.00000000000206,0.889114321456947,0,1,N-acetylneuraminate synthase activity,MF,
6416,GO:0021685,1.00000000000207,0.879619915924691,0,1,cerebellar granular layer structural organization,BP,
2128,GO:0004931,1.00000000000207,0.881447094557363,0,1,extracellularly ATP-gated cation channel activity,MF,
5530,GO:0016519,1.00000000000207,0.881447094557363,0,1,gastric inhibitory peptide receptor activity,MF,
9092,GO:0035381,1.00000000000207,0.881447094557363,0,1,ATP-gated ion channel activity,MF,
9723,GO:0038192,1.00000000000207,0.881447094557363,0,1,gastric inhibitory peptide signaling pathway,BP,
17334,GO:1900062,1.0000000000021,0.880197413461719,0,1,regulation of replicative cell aging,BP,
15107,GO:0071224,1.0000000000021,0.682129165225536,0,3,cellular response to peptidoglycan,BP,
15607,GO:0072131,1.00000000000212,0.680927487615176,0,3,kidney mesenchyme morphogenesis,BP,
15609,GO:0072133,1.00000000000212,0.680927487615176,0,3,metanephric mesenchyme morphogenesis,BP,
13770,GO:0060383,1.00000000000213,0.880146906923468,0,1,positive regulation of DNA strand elongation,BP,
19247,GO:1905464,1.00000000000213,0.880146906923468,0,1,positive regulation of DNA duplex unwinding,BP,
19332,GO:1905774,1.00000000000213,0.880146906923468,0,1,regulation of DNA helicase activity,BP,
19333,GO:1905776,1.00000000000213,0.880146906923468,0,1,positive regulation of DNA helicase activity,BP,
19646,GO:1990955,1.00000000000213,0.880146906923468,0,1,G-rich single-stranded DNA binding,MF,
7542,GO:0031860,1.00000000000214,0.68176791890936,0,3,telomeric 3' overhang formation,BP,
4589,GO:0010705,1.00000000000216,0.880124254824979,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
15994,GO:0086040,1.00000000000216,0.880124254824979,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16026,GO:0086092,1.00000000000216,0.880124254824979,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
17377,GO:1900138,1.00000000000217,0.687886507604648,0,3,negative regulation of phospholipase A2 activity,BP,
2787,GO:0006226,1.00000000000217,0.687753881349502,0,3,dUMP biosynthetic process,BP,
3393,GO:0007174,1.00000000000219,0.880796995253123,0,1,epidermal growth factor catabolic process,BP,
7850,GO:0032419,1.00000000000219,0.880796995253123,0,1,extrinsic component of lysosome membrane,CC,
19058,GO:1904979,1.00000000000219,0.880796995253123,0,1,negative regulation of endosome organization,BP,
19202,GO:1905365,1.00000000000219,0.880796995253123,0,1,regulation of intralumenal vesicle formation,BP,
19203,GO:1905366,1.00000000000219,0.880796995253123,0,1,negative regulation of intralumenal vesicle formation,BP,
1394,GO:0003310,1.00000000000221,0.886217035956813,0,1,pancreatic A cell differentiation,BP,
6367,GO:0021558,1.00000000000221,0.886217035956813,0,1,trochlear nerve development,BP,
11478,GO:0045977,1.00000000000221,0.886217035956813,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
13628,GO:0060164,1.00000000000221,0.886217035956813,0,1,regulation of timing of neuron differentiation,BP,
14168,GO:0061102,1.00000000000221,0.886217035956813,0,1,stomach neuroendocrine cell differentiation,BP,
14169,GO:0061105,1.00000000000221,0.886217035956813,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14170,GO:0061106,1.00000000000221,0.886217035956813,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15450,GO:0071820,1.00000000000221,0.886217035956813,0,1,N-box binding,MF,
15565,GO:0072071,1.00000000000221,0.886217035956813,0,1,kidney interstitial fibroblast differentiation,BP,
15616,GO:0072141,1.00000000000221,0.886217035956813,0,1,renal interstitial fibroblast development,BP,
19763,GO:2000226,1.00000000000221,0.886217035956813,0,1,regulation of pancreatic A cell differentiation,BP,
19764,GO:2000227,1.00000000000221,0.886217035956813,0,1,negative regulation of pancreatic A cell differentiation,BP,
2328,GO:0005344,1.00000000000221,0.881841571567973,0,1,oxygen carrier activity,MF,
12026,GO:0047888,1.00000000000221,0.881841571567973,0,1,fatty acid peroxidase activity,MF,
2005,GO:0004733,1.00000000000223,0.880241535106101,0,1,pyridoxamine-phosphate oxidase activity,MF,
19007,GO:1904878,1.00000000000224,0.876824031974755,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
1350,GO:0003220,1.00000000000225,0.878616026090759,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1364,GO:0003251,1.00000000000225,0.878616026090759,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
6954,GO:0030616,1.00000000000225,0.878616026090759,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
9032,GO:0035262,1.00000000000225,0.878616026090759,0,1,gonad morphogenesis,BP,
14132,GO:0061040,1.00000000000225,0.878616026090759,0,1,female gonad morphogenesis,BP,
19174,GO:1905304,1.00000000000225,0.878616026090759,0,1,regulation of cardiac myofibril assembly,BP,
19175,GO:1905305,1.00000000000225,0.878616026090759,0,1,negative regulation of cardiac myofibril assembly,BP,
13974,GO:0060715,1.00000000000225,0.682816655833844,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
18159,GO:1902956,1.00000000000226,0.692952996322493,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18344,GO:1903373,1.00000000000226,0.681791031518562,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
13783,GO:0060398,1.00000000000227,0.681677502226638,0,3,regulation of growth hormone receptor signaling pathway,BP,
7082,GO:0030885,1.00000000000228,0.694826706838436,0,3,regulation of myeloid dendritic cell activation,BP,
7065,GO:0030862,1.00000000000228,0.880108609829283,0,1,positive regulation of polarized epithelial cell differentiation,BP,
9731,GO:0039007,1.00000000000228,0.880108609829283,0,1,pronephric nephron morphogenesis,BP,
9732,GO:0039008,1.00000000000228,0.880108609829283,0,1,pronephric nephron tubule morphogenesis,BP,
9735,GO:0039020,1.00000000000228,0.880108609829283,0,1,pronephric nephron tubule development,BP,
9736,GO:0039022,1.00000000000228,0.880108609829283,0,1,pronephric duct development,BP,
9737,GO:0039023,1.00000000000228,0.880108609829283,0,1,pronephric duct morphogenesis,BP,
14554,GO:0070121,1.00000000000228,0.880108609829283,0,1,Kupffer's vesicle development,BP,
15599,GO:0072114,1.00000000000228,0.880108609829283,0,1,pronephros morphogenesis,BP,
14422,GO:0061768,1.00000000000229,0.880122819362139,0,1,magnesium:sodium antiporter activity,MF,
4221,GO:0009400,1.00000000000231,0.88033605502884,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
8707,GO:0034366,1.00000000000231,0.88033605502884,0,1,spherical high-density lipoprotein particle,CC,
18106,GO:1902847,1.00000000000231,0.88033605502884,0,1,regulation of neuronal signal transduction,BP,
18182,GO:1902998,1.00000000000231,0.88033605502884,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19361,GO:1905891,1.00000000000231,0.88033605502884,0,1,regulation of cellular response to thapsigargin,BP,
19362,GO:1905892,1.00000000000231,0.88033605502884,0,1,negative regulation of cellular response to thapsigargin,BP,
19363,GO:1905894,1.00000000000231,0.88033605502884,0,1,regulation of cellular response to tunicamycin,BP,
19364,GO:1905895,1.00000000000231,0.88033605502884,0,1,negative regulation of cellular response to tunicamycin,BP,
18806,GO:1904426,1.00000000000231,0.774672070146732,0,2,positive regulation of GTP binding,BP,
10696,GO:0044028,1.00000000000231,0.774717453840756,0,2,DNA hypomethylation,BP,
10697,GO:0044029,1.00000000000231,0.774717453840756,0,2,hypomethylation of CpG island,BP,
15342,GO:0071606,1.00000000000232,0.881684659870001,0,1,chemokine (C-C motif) ligand 4 production,BP,
15368,GO:0071643,1.00000000000232,0.881684659870001,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15369,GO:0071644,1.00000000000232,0.881684659870001,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15856,GO:0072615,1.00000000000232,0.881684659870001,0,1,interleukin-17 secretion,BP,
19102,GO:1905076,1.00000000000232,0.881684659870001,0,1,regulation of interleukin-17 secretion,BP,
19103,GO:1905077,1.00000000000232,0.881684659870001,0,1,negative regulation of interleukin-17 secretion,BP,
19217,GO:1905403,1.00000000000232,0.881684659870001,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
16697,GO:0097726,1.00000000000233,0.890977784922709,0,1,LEM domain binding,MF,
1973,GO:0004692,1.00000000000235,0.880180665547238,0,1,cGMP-dependent protein kinase activity,MF,
13366,GO:0052692,1.00000000000236,0.886618468506371,0,1,raffinose alpha-galactosidase activity,MF,
16553,GO:0097376,1.00000000000236,0.886618468506371,0,1,interneuron axon guidance,BP,
10822,GO:0044334,1.00000000000238,0.774749606124507,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
1978,GO:0004699,1.00000000000238,0.681978471284485,0,3,calcium-independent protein kinase C activity,MF,
12028,GO:0047915,1.0000000000024,0.883744370199755,0,1,ganglioside galactosyltransferase activity,MF,
1609,GO:0004034,1.00000000000246,0.880430924822775,0,1,aldose 1-epimerase activity,MF,
9385,GO:0035945,1.00000000000246,0.880430924822775,0,1,mitochondrial ncRNA surveillance,BP,
9386,GO:0035946,1.00000000000246,0.880430924822775,0,1,mitochondrial mRNA surveillance,BP,
15039,GO:0071026,1.00000000000246,0.880430924822775,0,1,cytoplasmic RNA surveillance,BP,
20105,GO:2000827,1.00000000000246,0.880430924822775,0,1,mitochondrial RNA surveillance,BP,
16205,GO:0090281,1.00000000000246,0.683138055532053,0,3,negative regulation of calcium ion import,BP,
16976,GO:0099093,1.0000000000025,0.774783139851248,0,2,calcium export from the mitochondrion,BP,
10043,GO:0042543,1.00000000000251,0.901747947981023,0,1,protein N-linked glycosylation via arginine,BP,
17975,GO:1902464,1.00000000000251,0.88012802403962,0,1,regulation of histone H3-K27 trimethylation,BP,
17976,GO:1902466,1.00000000000251,0.88012802403962,0,1,positive regulation of histone H3-K27 trimethylation,BP,
2224,GO:0005128,1.00000000000254,0.88027658055828,0,1,erythropoietin receptor binding,MF,
2230,GO:0005135,1.00000000000254,0.88027658055828,0,1,interleukin-3 receptor binding,MF,
13629,GO:0060166,1.00000000000255,0.780424326452134,0,2,olfactory pit development,BP,
4923,GO:0014878,1.00000000000256,0.880118746479718,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5197,GO:0015798,1.00000000000257,0.674452488460699,0,3,myo-inositol transport,BP,
19061,GO:1904990,1.00000000000258,0.880468618468658,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19062,GO:1904992,1.00000000000258,0.880468618468658,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3847,GO:0008465,1.00000000000258,0.889129261507454,0,1,glycerate dehydrogenase activity,MF,
20042,GO:2000721,1.0000000000026,0.880124094231392,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
5483,GO:0016422,1.0000000000026,0.683982781740106,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
355,GO:0000973,1.0000000000026,0.684460900227979,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
1313,GO:0003163,1.00000000000264,0.774598913146585,0,2,sinoatrial node development,BP,
3965,GO:0008768,1.00000000000264,0.895459079370491,0,1,UDP-sugar diphosphatase activity,MF,
14067,GO:0060921,1.00000000000264,0.774598913146585,0,2,sinoatrial node cell differentiation,BP,
14072,GO:0060931,1.00000000000264,0.774598913146585,0,2,sinoatrial node cell development,BP,
11028,GO:0045027,1.00000000000264,0.881181812515079,0,1,DNA end binding,MF,
7972,GO:0032595,1.00000000000265,0.880943621705226,0,1,B cell receptor transport within lipid bilayer,BP,
7974,GO:0032597,1.00000000000265,0.880943621705226,0,1,B cell receptor transport into membrane raft,BP,
7975,GO:0032599,1.00000000000265,0.880943621705226,0,1,protein transport out of membrane raft,BP,
7976,GO:0032600,1.00000000000265,0.880943621705226,0,1,chemokine receptor transport out of membrane raft,BP,
8166,GO:0032913,1.00000000000265,0.880943621705226,0,1,negative regulation of transforming growth factor beta3 production,BP,
8456,GO:0033606,1.00000000000265,0.880943621705226,0,1,chemokine receptor transport within lipid bilayer,BP,
15615,GO:0072139,1.00000000000265,0.880943621705226,0,1,glomerular parietal epithelial cell differentiation,BP,
20070,GO:2000768,1.00000000000265,0.880943621705226,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
19215,GO:1905397,1.00000000000269,0.780444101672161,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19216,GO:1905402,1.00000000000269,0.780444101672161,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
14174,GO:0061113,1.0000000000027,0.77483302148888,0,2,pancreas morphogenesis,BP,
4403,GO:0010159,1.0000000000027,0.684010468814392,0,3,specification of animal organ position,BP,
7203,GO:0031104,1.00000000000272,0.880147227413096,0,1,dendrite regeneration,BP,
16796,GO:0098705,1.00000000000273,0.88012288393698,0,1,copper ion import across plasma membrane,BP,
16538,GO:0097350,1.00000000000274,0.686994285139675,0,3,neutrophil clearance,BP,
4992,GO:0015136,1.00000000000276,0.880268003115445,0,1,sialic acid transmembrane transporter activity,MF,
5123,GO:0015538,1.00000000000276,0.880268003115445,0,1,sialic acid:proton symporter activity,MF,
5174,GO:0015739,1.00000000000276,0.880268003115445,0,1,sialic acid transport,BP,
9494,GO:0036157,1.00000000000276,0.685878666874568,0,3,outer dynein arm,CC,
18900,GO:1904672,1.00000000000278,0.68179703707589,0,3,regulation of somatic stem cell population maintenance,BP,
2241,GO:0005152,1.00000000000278,0.683825329695835,0,3,interleukin-1 receptor antagonist activity,MF,
13201,GO:0051890,1.00000000000278,0.774616795429556,0,2,regulation of cardioblast differentiation,BP,
8160,GO:0032907,1.00000000000279,0.680413657496182,0,3,transforming growth factor beta3 production,BP,
8163,GO:0032910,1.00000000000279,0.680413657496182,0,3,regulation of transforming growth factor beta3 production,BP,
9456,GO:0036090,1.00000000000279,0.777078609847876,0,2,cleavage furrow ingression,BP,
19768,GO:2000233,1.00000000000281,0.774732229912609,0,2,negative regulation of rRNA processing,BP,
9086,GO:0035370,1.00000000000281,0.775287559732212,0,2,UBC13-UEV1A complex,CC,
2309,GO:0005308,1.00000000000282,0.880227594976124,0,1,creatine transmembrane transporter activity,MF,
2310,GO:0005309,1.00000000000282,0.880227594976124,0,1,creatine:sodium symporter activity,MF,
5249,GO:0015881,1.00000000000282,0.880227594976124,0,1,creatine transmembrane transport,BP,
4612,GO:0010735,1.00000000000285,0.681776291772765,0,3,positive regulation of transcription via serum response element binding,BP,
13122,GO:0051715,1.00000000000286,0.709795385305974,0,3,cytolysis in other organism,BP,
2299,GO:0005275,1.00000000000286,0.880315580584513,0,1,amine transmembrane transporter activity,MF,
5053,GO:0015265,1.00000000000286,0.880315580584513,0,1,urea channel activity,MF,
1247,GO:0002950,1.00000000000288,0.685961029666641,0,3,ceramide phosphoethanolamine synthase activity,MF,
8329,GO:0033188,1.00000000000288,0.685961029666641,0,3,sphingomyelin synthase activity,MF,
11985,GO:0047493,1.00000000000288,0.685961029666641,0,3,ceramide cholinephosphotransferase activity,MF,
19499,GO:1990423,1.00000000000289,0.681729547224313,0,3,RZZ complex,CC,
9167,GO:0035552,1.0000000000029,0.685571828468958,0,3,oxidative single-stranded DNA demethylation,BP,
11995,GO:0047578,1.00000000000291,0.880457063881472,0,1,4-hydroxyglutamate transaminase activity,MF,
13061,GO:0051595,1.00000000000292,0.697725254088931,0,3,response to methylglyoxal,BP,
3648,GO:0008127,1.00000000000292,0.888253270866355,0,1,quercetin 2,3-dioxygenase activity,MF,
8854,GO:0034667,1.00000000000294,0.774665883952374,0,2,integrin alpha3-beta1 complex,CC,
18950,GO:1904762,1.00000000000294,0.880156418870442,0,1,positive regulation of myofibroblast differentiation,BP,
2034,GO:0004777,1.00000000000294,0.880121894752099,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
4011,GO:0009013,1.00000000000294,0.880121894752099,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
10320,GO:0043131,1.00000000000294,0.880121894752099,0,1,erythrocyte enucleation,BP,
10455,GO:0043354,1.00000000000294,0.880121894752099,0,1,enucleate erythrocyte maturation,BP,
14469,GO:0061930,1.00000000000294,0.880121894752099,0,1,regulation of erythrocyte enucleation,BP,
14470,GO:0061931,1.00000000000294,0.880121894752099,0,1,positive regulation of erythrocyte enucleation,BP,
16319,GO:0090601,1.00000000000294,0.880121894752099,0,1,enucleation,BP,
18104,GO:1902838,1.00000000000294,0.880121894752099,0,1,regulation of nuclear migration along microtubule,BP,
15913,GO:0072741,1.00000000000294,0.682141755921196,0,3,protein localization to cell division site,BP,
18236,GO:1903119,1.00000000000294,0.682141755921196,0,3,protein localization to actin cytoskeleton,BP,
18832,GO:1904498,1.00000000000294,0.682141755921196,0,3,protein localization to mitotic actomyosin contractile ring,BP,
19444,GO:1990179,1.00000000000294,0.682141755921196,0,3,protein localization to actomyosin contractile ring,BP,
4438,GO:0010335,1.00000000000295,0.880125702430758,0,1,response to non-ionic osmotic stress,BP,
8540,GO:0033925,1.00000000000295,0.880125702430758,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
15261,GO:0071471,1.00000000000295,0.880125702430758,0,1,cellular response to non-ionic osmotic stress,BP,
1719,GO:0004313,1.00000000000295,0.878848590374875,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1722,GO:0004316,1.00000000000295,0.878848590374875,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1723,GO:0004317,1.00000000000295,0.878848590374875,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1724,GO:0004319,1.00000000000295,0.878848590374875,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
6043,GO:0019171,1.00000000000295,0.878848590374875,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
11937,GO:0047117,1.00000000000295,0.878848590374875,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11981,GO:0047451,1.00000000000295,0.878848590374875,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
17099,GO:0102131,1.00000000000295,0.878848590374875,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17100,GO:0102132,1.00000000000295,0.878848590374875,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
12480,GO:0050571,1.00000000000296,0.884437508360004,0,1,1,5-anhydro-D-fructose reductase activity,MF,
58,GO:0000121,1.00000000000296,0.88029925486953,0,1,glycerol-1-phosphatase activity,MF,
10322,GO:0043136,1.00000000000296,0.88029925486953,0,1,glycerol-3-phosphatase activity,MF,
7681,GO:0032142,1.00000000000297,0.681875080891093,0,3,single guanine insertion binding,MF,
14747,GO:0070471,1.00000000000297,0.681901677330215,0,3,uterine smooth muscle contraction,BP,
14748,GO:0070472,1.00000000000297,0.681901677330215,0,3,regulation of uterine smooth muscle contraction,BP,
14749,GO:0070474,1.00000000000297,0.681901677330215,0,3,positive regulation of uterine smooth muscle contraction,BP,
1690,GO:0004167,1.00000000000298,0.811105920256674,0,2,dopachrome isomerase activity,MF,
5718,GO:0016862,1.00000000000298,0.811105920256674,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
12428,GO:0050178,1.00000000000298,0.811105920256674,0,2,phenylpyruvate tautomerase activity,MF,
14755,GO:0070483,1.000000000003,0.880290921209224,0,1,detection of hypoxia,BP,
8997,GO:0035175,1.00000000000301,0.883495742337382,0,1,histone kinase activity (H3-S10 specific),MF,
15733,GO:0072354,1.00000000000301,0.883495742337382,0,1,histone kinase activity (H3-T3 specific),MF,
15734,GO:0072355,1.00000000000301,0.883495742337382,0,1,histone H3-T3 phosphorylation,BP,
17272,GO:0140074,1.00000000000301,0.880121534708815,0,1,cardiac endothelial to mesenchymal transition,BP,
3492,GO:0007387,1.00000000000305,0.880347851495128,0,1,anterior compartment pattern formation,BP,
3493,GO:0007388,1.00000000000305,0.880347851495128,0,1,posterior compartment specification,BP,
13523,GO:0060010,1.00000000000306,0.880267914677767,0,1,Sertoli cell fate commitment,BP,
1084,GO:0002669,1.00000000000306,0.879968350182077,0,1,positive regulation of T cell anergy,BP,
1230,GO:0002913,1.00000000000306,0.879968350182077,0,1,positive regulation of lymphocyte anergy,BP,
6026,GO:0019089,1.00000000000306,0.879968350182077,0,1,transmission of virus,BP,
10694,GO:0044007,1.00000000000306,0.879968350182077,0,1,dissemination or transmission of symbiont from host,BP,
13176,GO:0051821,1.00000000000306,0.879968350182077,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
4205,GO:0009331,1.00000000000308,0.774599018662386,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
15915,GO:0072750,1.00000000000309,0.888453914847143,0,1,cellular response to leptomycin B,BP,
17606,GO:1901344,1.00000000000309,0.888453914847143,0,1,response to leptomycin B,BP,
17727,GO:1901707,1.00000000000309,0.888453914847143,0,1,leptomycin B binding,MF,
19119,GO:1905152,1.0000000000031,0.880071597518701,0,1,positive regulation of voltage-gated sodium channel activity,BP,
5296,GO:0015990,1.0000000000031,0.896896960721848,0,1,electron transport coupled proton transport,BP,
19284,GO:1905590,1.00000000000311,0.880299723691358,0,1,fibronectin fibril organization,BP,
19828,GO:2000329,1.00000000000311,0.880299723691358,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
3817,GO:0008419,1.00000000000311,0.880357143537826,0,1,RNA lariat debranching enzyme activity,MF,
1359,GO:0003241,1.00000000000311,0.683439878741777,0,3,growth involved in heart morphogenesis,BP,
6658,GO:0030020,1.00000000000311,0.680098023446122,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
16000,GO:0086047,1.00000000000311,0.880148968741083,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
18705,GO:1904199,1.00000000000311,0.880148968741083,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19572,GO:1990736,1.00000000000311,0.880148968741083,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
15154,GO:0071315,1.00000000000312,0.683469336088396,0,3,cellular response to morphine,BP,
15156,GO:0071317,1.00000000000312,0.683469336088396,0,3,cellular response to isoquinoline alkaloid,BP,
13038,GO:0051563,1.00000000000312,0.774637691992377,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
9531,GO:0036301,1.00000000000312,0.682371989721302,0,3,macrophage colony-stimulating factor production,BP,
17571,GO:1901256,1.00000000000312,0.682371989721302,0,3,regulation of macrophage colony-stimulating factor production,BP,
6403,GO:0021644,1.00000000000312,0.885216817603983,0,1,vagus nerve morphogenesis,BP,
997,GO:0002461,1.00000000000316,0.880620290509034,0,1,tolerance induction dependent upon immune response,BP,
1019,GO:0002519,1.00000000000316,0.880620290509034,0,1,natural killer cell tolerance induction,BP,
1078,GO:0002652,1.00000000000316,0.880620290509034,0,1,regulation of tolerance induction dependent upon immune response,BP,
8041,GO:0032712,1.00000000000316,0.880620290509034,0,1,negative regulation of interleukin-3 production,BP,
15374,GO:0071656,1.00000000000316,0.880620290509034,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17572,GO:1901257,1.00000000000316,0.880620290509034,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
3836,GO:0008448,1.00000000000316,0.882528411926391,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
7833,GO:0032398,1.00000000000318,0.883771712931895,0,1,MHC class Ib protein complex,CC,
8000,GO:0032639,1.00000000000318,0.883771712931895,0,1,TRAIL production,BP,
8024,GO:0032679,1.00000000000318,0.883771712931895,0,1,regulation of TRAIL production,BP,
8068,GO:0032759,1.00000000000318,0.883771712931895,0,1,positive regulation of TRAIL production,BP,
19948,GO:2000566,1.00000000000318,0.883771712931895,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20212,GO:2001187,1.00000000000318,0.883771712931895,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
9439,GO:0036046,1.00000000000318,0.880296413530134,0,1,protein demalonylation,BP,
9440,GO:0036047,1.00000000000318,0.880296413530134,0,1,peptidyl-lysine demalonylation,BP,
9441,GO:0036048,1.00000000000318,0.880296413530134,0,1,protein desuccinylation,BP,
9442,GO:0036049,1.00000000000318,0.880296413530134,0,1,peptidyl-lysine desuccinylation,BP,
9443,GO:0036054,1.00000000000318,0.880296413530134,0,1,protein-malonyllysine demalonylase activity,MF,
9444,GO:0036055,1.00000000000318,0.880296413530134,0,1,protein-succinyllysine desuccinylase activity,MF,
14387,GO:0061697,1.00000000000318,0.880296413530134,0,1,protein-glutaryllysine deglutarylase activity,MF,
14388,GO:0061698,1.00000000000318,0.880296413530134,0,1,protein deglutarylation,BP,
14389,GO:0061699,1.00000000000318,0.880296413530134,0,1,peptidyl-lysine deglutarylation,BP,
5281,GO:0015938,1.00000000000319,0.892815664524746,0,1,coenzyme A catabolic process,BP,
8529,GO:0033869,1.00000000000319,0.892815664524746,0,1,nucleoside bisphosphate catabolic process,BP,
8552,GO:0034031,1.00000000000319,0.892815664524746,0,1,ribonucleoside bisphosphate catabolic process,BP,
8555,GO:0034034,1.00000000000319,0.892815664524746,0,1,purine nucleoside bisphosphate catabolic process,BP,
2232,GO:0005137,1.00000000000319,0.880969390955548,0,1,interleukin-5 receptor binding,MF,
2597,GO:0005895,1.00000000000319,0.880969390955548,0,1,interleukin-5 receptor complex,CC,
1226,GO:0002904,1.00000000000322,0.697491781958788,0,3,positive regulation of B cell apoptotic process,BP,
19428,GO:1990134,1.00000000000322,0.88012264917553,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
19054,GO:1904975,1.00000000000322,0.774642169167863,0,2,response to bleomycin,BP,
19055,GO:1904976,1.00000000000322,0.774642169167863,0,2,cellular response to bleomycin,BP,
124,GO:0000255,1.00000000000322,0.774612970569927,0,2,allantoin metabolic process,BP,
410,GO:0001097,1.00000000000322,0.685591760444536,0,3,TFIIH-class transcription factor binding,MF,
1683,GO:0004152,1.00000000000323,0.881300499046158,0,1,dihydroorotate dehydrogenase activity,MF,
18448,GO:1903576,1.00000000000323,0.881300499046158,0,1,response to L-arginine,BP,
18507,GO:1903724,1.00000000000323,0.8802567489286,0,1,positive regulation of centriole elongation,BP,
14702,GO:0070381,1.00000000000324,0.774775453083913,0,2,endosome to plasma membrane transport vesicle,CC,
5886,GO:0018057,1.00000000000324,0.68207823225664,0,3,peptidyl-lysine oxidation,BP,
11143,GO:0045218,1.00000000000325,0.682000429784318,0,3,zonula adherens maintenance,BP,
5237,GO:0015864,1.00000000000325,0.775646882409035,0,2,pyrimidine nucleoside transport,BP,
13435,GO:0052918,1.00000000000327,0.879995189753382,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13437,GO:0052926,1.00000000000327,0.879995189753382,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
15331,GO:0071586,1.00000000000327,0.779909343968623,0,2,CAAX-box protein processing,BP,
15947,GO:0080120,1.00000000000327,0.779909343968623,0,2,CAAX-box protein maturation,BP,
2336,GO:0005366,1.00000000000328,0.879756643769709,0,1,myo-inositol:proton symporter activity,MF,
640,GO:0001831,1.0000000000033,0.879840730388453,0,1,trophectodermal cellular morphogenesis,BP,
17671,GO:1901585,1.00000000000331,0.880338043462014,0,1,regulation of acid-sensing ion channel activity,BP,
4905,GO:0014843,1.00000000000331,0.879849221430843,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
10109,GO:0042660,1.00000000000331,0.879849221430843,0,1,positive regulation of cell fate specification,BP,
3740,GO:0008281,1.00000000000331,0.880123123039157,0,1,sulfonylurea receptor activity,MF,
15751,GO:0072382,1.00000000000331,0.870018218563348,0,1,minus-end-directed vesicle transport along microtubule,BP,
3644,GO:0008120,1.00000000000331,0.884207788142914,0,1,ceramide glucosyltransferase activity,MF,
17142,GO:0102769,1.00000000000331,0.884207788142914,0,1,dihydroceramide glucosyltransferase activity,MF,
9389,GO:0035962,1.00000000000333,0.880177815867423,0,1,response to interleukin-13,BP,
9390,GO:0035963,1.00000000000333,0.880177815867423,0,1,cellular response to interleukin-13,BP,
12438,GO:0050277,1.00000000000333,0.880177815867423,0,1,sedoheptulokinase activity,MF,
2121,GO:0004917,1.00000000000335,0.882741819141383,0,1,interleukin-7 receptor activity,MF,
12544,GO:0050717,1.00000000000335,0.692042965712696,0,3,positive regulation of interleukin-1 alpha secretion,BP,
1895,GO:0004582,1.00000000000337,0.713716266900297,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
8327,GO:0033185,1.00000000000337,0.713716266900297,0,3,dolichol-phosphate-mannose synthase complex,CC,
8545,GO:0033981,1.00000000000338,0.89975819588512,0,1,D-dopachrome decarboxylase activity,MF,
7113,GO:0030942,1.00000000000339,0.690804557887555,0,3,endoplasmic reticulum signal peptide binding,MF,
4749,GO:0010931,1.00000000000343,0.879036340564827,0,1,macrophage tolerance induction,BP,
4750,GO:0010932,1.00000000000343,0.879036340564827,0,1,regulation of macrophage tolerance induction,BP,
4751,GO:0010933,1.00000000000343,0.879036340564827,0,1,positive regulation of macrophage tolerance induction,BP,
19571,GO:1990730,1.00000000000343,0.77474254599315,0,2,VCP-NSFL1C complex,CC,
3637,GO:0008109,1.00000000000343,0.774719507107263,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
18492,GO:1903697,1.00000000000344,0.880261954679907,0,1,negative regulation of microvillus assembly,BP,
2104,GO:0004882,1.00000000000345,0.880275367017505,0,1,androgen receptor activity,MF,
9382,GO:0035935,1.00000000000345,0.880275367017505,0,1,androgen secretion,BP,
16452,GO:0097162,1.00000000000345,0.880275367017505,0,1,MADS box domain binding,MF,
20111,GO:2000834,1.00000000000345,0.880275367017505,0,1,regulation of androgen secretion,BP,
20112,GO:2000836,1.00000000000345,0.880275367017505,0,1,positive regulation of androgen secretion,BP,
3206,GO:0006848,1.00000000000347,0.682139871571735,0,3,pyruvate transport,BP,
12616,GO:0050833,1.00000000000347,0.682139871571735,0,3,pyruvate transmembrane transporter activity,MF,
17630,GO:1901475,1.00000000000347,0.682139871571735,0,3,pyruvate transmembrane transport,BP,
10678,GO:0043974,1.00000000000348,0.681739532468742,0,3,histone H3-K27 acetylation,BP,
17712,GO:1901674,1.00000000000348,0.681739532468742,0,3,regulation of histone H3-K27 acetylation,BP,
4269,GO:0009631,1.00000000000348,0.88012227988475,0,1,cold acclimation,BP,
11595,GO:0046317,1.00000000000348,0.88012227988475,0,1,regulation of glucosylceramide biosynthetic process,BP,
11596,GO:0046318,1.00000000000348,0.88012227988475,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
18232,GO:1903108,1.00000000000348,0.88012227988475,0,1,regulation of mitochondrial transcription,BP,
18233,GO:1903109,1.00000000000348,0.88012227988475,0,1,positive regulation of mitochondrial transcription,BP,
14057,GO:0060903,1.00000000000349,0.77486689223943,0,2,positive regulation of meiosis I,BP,
198,GO:0000417,1.0000000000035,0.880153012804012,0,1,HIR complex,CC,
7004,GO:0030702,1.0000000000035,0.880153012804012,0,1,chromatin silencing at centromere,BP,
19098,GO:1905069,1.0000000000035,0.880153012804012,0,1,allantois development,BP,
8867,GO:0034693,1.00000000000351,0.880447533924339,0,1,U11/U12 snRNP,CC,
3930,GO:0008616,1.00000000000351,0.69496408578031,0,3,queuosine biosynthetic process,BP,
11548,GO:0046116,1.00000000000351,0.69496408578031,0,3,queuosine metabolic process,BP,
1856,GO:0004522,1.00000000000351,0.88490899898667,0,1,ribonuclease A activity,MF,
3969,GO:0008785,1.00000000000351,0.88490899898667,0,1,alkyl hydroperoxide reductase activity,MF,
2010,GO:0004740,1.00000000000352,0.681769227532638,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
1391,GO:0003307,1.00000000000352,0.68425241368775,0,3,regulation of Wnt signaling pathway involved in heart development,BP,
15639,GO:0072185,1.00000000000354,0.880559225039504,0,1,metanephric cap development,BP,
15640,GO:0072186,1.00000000000354,0.880559225039504,0,1,metanephric cap morphogenesis,BP,
16085,GO:0090094,1.00000000000354,0.880559225039504,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16086,GO:0090095,1.00000000000354,0.880559225039504,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16087,GO:0090096,1.00000000000354,0.880559225039504,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
3,GO:0000009,1.00000000000354,0.880540271830666,0,1,alpha-1,6-mannosyltransferase activity,MF,
13434,GO:0052917,1.00000000000354,0.880540271830666,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
13864,GO:0060529,1.00000000000356,0.774628927183761,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
3100,GO:0006680,1.00000000000359,0.682269994645319,0,3,glucosylceramide catabolic process,BP,
2235,GO:0005142,1.00000000000362,0.880570604748996,0,1,interleukin-11 receptor binding,MF,
5838,GO:0017133,1.00000000000362,0.880570604748996,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10642,GO:0043783,1.00000000000362,0.880570604748996,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11156,GO:0045251,1.00000000000362,0.880570604748996,0,1,electron transfer flavoprotein complex,CC,
16924,GO:0098939,1.00000000000362,0.879928358721248,0,1,dendritic transport of mitochondrion,BP,
16935,GO:0098972,1.00000000000362,0.879928358721248,0,1,anterograde dendritic transport of mitochondrion,BP,
16218,GO:0090298,1.00000000000363,0.682010150041088,0,3,negative regulation of mitochondrial DNA replication,BP,
17760,GO:1901859,1.00000000000363,0.682010150041088,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
17648,GO:1901537,1.00000000000364,0.676601766776372,0,3,positive regulation of DNA demethylation,BP,
5899,GO:0018117,1.00000000000366,0.884052550106967,0,1,protein adenylylation,BP,
5911,GO:0018175,1.00000000000366,0.884052550106967,0,1,protein nucleotidylation,BP,
10924,GO:0044601,1.00000000000366,0.884052550106967,0,1,protein denucleotidylation,BP,
10925,GO:0044602,1.00000000000366,0.884052550106967,0,1,protein deadenylylation,BP,
10926,GO:0044603,1.00000000000366,0.884052550106967,0,1,protein adenylylhydrolase activity,MF,
14881,GO:0070733,1.00000000000366,0.884052550106967,0,1,protein adenylyltransferase activity,MF,
13168,GO:0051799,1.00000000000367,0.681795783728793,0,3,negative regulation of hair follicle development,BP,
18,GO:0000033,1.00000000000367,0.688606496208394,0,3,alpha-1,3-mannosyltransferase activity,MF,
16909,GO:0098915,1.00000000000368,0.681923644947985,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
8098,GO:0032795,1.00000000000369,0.891676960163241,0,1,heterotrimeric G-protein binding,MF,
1513,GO:0003876,1.0000000000037,0.77467559913168,0,2,AMP deaminase activity,MF,
12000,GO:0047623,1.0000000000037,0.77467559913168,0,2,adenosine-phosphate deaminase activity,MF,
4210,GO:0009372,1.0000000000037,0.880274671668992,0,1,quorum sensing,BP,
9567,GO:0036398,1.0000000000037,0.880274671668992,0,1,TCR signalosome,CC,
9568,GO:0036399,1.0000000000037,0.880274671668992,0,1,TCR signalosome assembly,BP,
12404,GO:0048874,1.0000000000037,0.880274671668992,0,1,homeostasis of number of cells in a free-living population,BP,
13283,GO:0052097,1.0000000000037,0.880274671668992,0,1,interspecies quorum sensing,BP,
13284,GO:0052106,1.0000000000037,0.880274671668992,0,1,quorum sensing involved in interaction with host,BP,
13983,GO:0060730,1.0000000000037,0.880274671668992,0,1,regulation of intestinal epithelial structure maintenance,BP,
13984,GO:0060731,1.0000000000037,0.880274671668992,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14875,GO:0070715,1.0000000000037,0.880274671668992,0,1,sodium-dependent organic cation transport,BP,
754,GO:0001996,1.00000000000375,0.683693271396395,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
1395,GO:0003321,1.00000000000375,0.683693271396395,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
14862,GO:0070676,1.00000000000377,0.689476878782499,0,3,intralumenal vesicle formation,BP,
14850,GO:0070662,1.00000000000377,0.774766160035905,0,2,mast cell proliferation,BP,
14854,GO:0070666,1.00000000000377,0.774766160035905,0,2,regulation of mast cell proliferation,BP,
14856,GO:0070668,1.00000000000377,0.774766160035905,0,2,positive regulation of mast cell proliferation,BP,
7006,GO:0030718,1.00000000000378,0.880178634392845,0,1,germ-line stem cell population maintenance,BP,
8802,GO:0034584,1.00000000000378,0.880178634392845,0,1,piRNA binding,MF,
8207,GO:0032977,1.00000000000378,0.880125144867762,0,1,membrane insertase activity,MF,
8208,GO:0032978,1.00000000000378,0.880125144867762,0,1,protein insertion into membrane from inner side,BP,
8209,GO:0032979,1.00000000000378,0.880125144867762,0,1,protein insertion into mitochondrial membrane from inner side,BP,
9408,GO:0035989,1.00000000000379,0.68251042186752,0,3,tendon development,BP,
2909,GO:0006422,1.00000000000379,0.880602442358664,0,1,aspartyl-tRNA aminoacylation,BP,
7993,GO:0032625,1.00000000000379,0.880223733519241,0,1,interleukin-21 production,BP,
15858,GO:0072619,1.00000000000379,0.880223733519241,0,1,interleukin-21 secretion,BP,
11188,GO:0045337,1.0000000000038,0.686385632928703,0,3,farnesyl diphosphate biosynthetic process,BP,
10903,GO:0044530,1.00000000000382,0.682489770977481,0,3,supraspliceosomal complex,CC,
15110,GO:0071228,1.00000000000384,0.880327463900073,0,1,cellular response to tumor cell,BP,
14993,GO:0070949,1.00000000000384,0.780179216947925,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
14997,GO:0070960,1.00000000000384,0.780179216947925,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
14998,GO:0070961,1.00000000000384,0.780179216947925,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
6509,GO:0021892,1.00000000000384,0.691792399662631,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
2575,GO:0005863,1.00000000000385,0.880197663431824,0,1,striated muscle myosin thick filament,CC,
3308,GO:0007014,1.00000000000385,0.880197663431824,0,1,actin ubiquitination,BP,
9565,GO:0036392,1.00000000000385,0.880197663431824,0,1,chemokine (C-C motif) ligand 20 production,BP,
18574,GO:1903881,1.00000000000385,0.880197663431824,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18575,GO:1903883,1.00000000000385,0.880197663431824,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18576,GO:1903884,1.00000000000385,0.880197663431824,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18577,GO:1903886,1.00000000000385,0.880197663431824,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
15998,GO:0086045,1.00000000000385,0.774644410227782,0,2,membrane depolarization during AV node cell action potential,BP,
2105,GO:0004883,1.00000000000387,0.879902977928799,0,1,glucocorticoid receptor activity,MF,
9667,GO:0038051,1.00000000000387,0.879902977928799,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
13785,GO:0060400,1.00000000000387,0.880123544417497,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
8777,GO:0034474,1.00000000000388,0.879751954292215,0,1,U2 snRNA 3'-end processing,BP,
3485,GO:0007354,1.00000000000388,0.684138048170186,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
18717,GO:1904217,1.00000000000389,0.684374151039219,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18718,GO:1904219,1.00000000000389,0.684374151039219,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18720,GO:1904222,1.00000000000389,0.684374151039219,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
18925,GO:1904716,1.00000000000391,0.880552317044455,0,1,positive regulation of chaperone-mediated autophagy,BP,
19241,GO:1905457,1.00000000000391,0.691167386163917,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20131,GO:2000974,1.00000000000391,0.691167386163917,0,3,negative regulation of pro-B cell differentiation,BP,
5669,GO:0016784,1.00000000000391,0.885942820614476,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6256,GO:0019853,1.00000000000391,0.885942820614476,0,1,L-ascorbic acid biosynthetic process,BP,
10199,GO:0042839,1.00000000000391,0.885942820614476,0,1,D-glucuronate metabolic process,BP,
10200,GO:0042840,1.00000000000391,0.885942820614476,0,1,D-glucuronate catabolic process,BP,
12031,GO:0047939,1.00000000000391,0.885942820614476,0,1,L-glucuronate reductase activity,MF,
14548,GO:0070103,1.00000000000395,0.883548015833297,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14549,GO:0070104,1.00000000000395,0.883548015833297,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17873,GO:1902205,1.00000000000395,0.883548015833297,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17874,GO:1902206,1.00000000000395,0.883548015833297,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17878,GO:1902215,1.00000000000395,0.883548015833297,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17887,GO:1902227,1.00000000000395,0.883548015833297,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17893,GO:1902233,1.00000000000395,0.883548015833297,0,1,negative regulation of positive thymic T cell selection,BP,
18626,GO:1903970,1.00000000000395,0.883548015833297,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18629,GO:1903973,1.00000000000395,0.883548015833297,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18353,GO:1903385,1.00000000000396,0.774708050454727,0,2,regulation of homophilic cell adhesion,BP,
2026,GO:0004768,1.00000000000397,0.682055159030382,0,3,stearoyl-CoA 9-desaturase activity,MF,
5384,GO:0016215,1.00000000000397,0.682055159030382,0,3,acyl-CoA desaturase activity,MF,
5057,GO:0015272,1.00000000000398,0.880307618826835,0,1,ATP-activated inward rectifier potassium channel activity,MF,
18734,GO:1904247,1.000000000004,0.880307766143694,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
16460,GO:0097177,1.000000000004,0.692325249581801,0,3,mitochondrial ribosome binding,MF,
12696,GO:0050957,1.00000000000401,0.880159943320065,0,1,equilibrioception,BP,
1823,GO:0004479,1.00000000000402,0.880344127097525,0,1,methionyl-tRNA formyltransferase activity,MF,
6318,GO:0019988,1.00000000000402,0.880344127097525,0,1,charged-tRNA amino acid modification,BP,
15518,GO:0071951,1.00000000000402,0.880344127097525,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
17784,GO:1901917,1.00000000000402,0.880344127097525,0,1,regulation of exoribonuclease activity,BP,
17785,GO:1901919,1.00000000000402,0.880344127097525,0,1,positive regulation of exoribonuclease activity,BP,
19336,GO:1905779,1.00000000000402,0.880344127097525,0,1,positive regulation of exonuclease activity,BP,
1059,GO:0002587,1.00000000000403,0.887245252341452,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
10243,GO:0042998,1.00000000000403,0.77465689189253,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
2019,GO:0004751,1.00000000000405,0.88251826074939,0,1,ribose-5-phosphate isomerase activity,MF,
19880,GO:2000405,1.00000000000405,0.880112357139032,0,1,negative regulation of T cell migration,BP,
5299,GO:0016005,1.00000000000406,0.774828563865112,0,2,phospholipase A2 activator activity,MF,
7705,GO:0032203,1.00000000000408,0.882382702392314,0,1,telomere formation via telomerase,BP,
13957,GO:0060694,1.00000000000408,0.882382702392314,0,1,regulation of cholesterol transporter activity,BP,
15726,GO:0072343,1.00000000000408,0.882382702392314,0,1,pancreatic stellate cell proliferation,BP,
17655,GO:1901558,1.00000000000408,0.882382702392314,0,1,response to metformin,BP,
19273,GO:1905563,1.00000000000408,0.882382702392314,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19765,GO:2000229,1.00000000000408,0.882382702392314,0,1,regulation of pancreatic stellate cell proliferation,BP,
19766,GO:2000230,1.00000000000408,0.882382702392314,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
11727,GO:0046588,1.00000000000408,0.894684550529119,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
55,GO:0000117,1.00000000000409,0.880102310775596,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
1567,GO:0003976,1.00000000000412,0.689283307344538,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1804,GO:0004454,1.00000000000412,0.880490378507417,0,1,ketohexokinase activity,MF,
3059,GO:0006624,1.00000000000413,0.79025356096175,0,2,vacuolar protein processing,BP,
176,GO:0000386,1.00000000000414,0.684028583683134,0,3,second spliceosomal transesterification activity,MF,
6435,GO:0021747,1.00000000000414,0.681775330819407,0,3,cochlear nucleus development,BP,
3881,GO:0008518,1.00000000000415,0.88033670296053,0,1,reduced folate carrier activity,MF,
16866,GO:0098838,1.00000000000415,0.88033670296053,0,1,reduced folate transmembrane transport,BP,
5107,GO:0015421,1.00000000000416,0.880228856187993,0,1,oligopeptide-transporting ATPase activity,MF,
16366,GO:0097010,1.00000000000419,0.681976742319322,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
5017,GO:0015184,1.0000000000042,0.77462715507272,0,2,L-cystine transmembrane transporter activity,MF,
5208,GO:0015811,1.0000000000042,0.77462715507272,0,2,L-cystine transport,BP,
7114,GO:0030943,1.0000000000042,0.684907350239964,0,3,mitochondrion targeting sequence binding,MF,
16118,GO:0090156,1.00000000000421,0.689234142903511,0,3,cellular sphingolipid homeostasis,BP,
17736,GO:1901740,1.00000000000422,0.881789668660817,0,1,negative regulation of myoblast fusion,BP,
18612,GO:1903943,1.00000000000422,0.881789668660817,0,1,regulation of hepatocyte apoptotic process,BP,
18613,GO:1903944,1.00000000000422,0.881789668660817,0,1,negative regulation of hepatocyte apoptotic process,BP,
19570,GO:1990729,1.00000000000422,0.881789668660817,0,1,primary miRNA modification,BP,
19578,GO:1990744,1.00000000000422,0.881789668660817,0,1,primary miRNA methylation,BP,
2050,GO:0004801,1.00000000000423,0.889039791933019,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
5954,GO:0018343,1.00000000000423,0.685469264276475,0,3,protein farnesylation,BP,
7460,GO:0031627,1.00000000000424,0.682119789722308,0,3,telomeric loop formation,BP,
13810,GO:0060435,1.00000000000424,0.887831179225189,0,1,bronchiole development,BP,
13838,GO:0060480,1.00000000000424,0.887831179225189,0,1,lung goblet cell differentiation,BP,
10198,GO:0042835,1.00000000000425,0.88012309429824,0,1,BRE binding,MF,
15412,GO:0071713,1.00000000000425,0.88012309429824,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
6387,GO:0021592,1.00000000000425,0.880119876284726,0,1,fourth ventricle development,BP,
6550,GO:0021993,1.00000000000425,0.880119876284726,0,1,initiation of neural tube closure,BP,
6462,GO:0021797,1.00000000000425,0.880253591756671,0,1,forebrain anterior/posterior pattern specification,BP,
6501,GO:0021881,1.00000000000425,0.880253591756671,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
12166,GO:0048320,1.00000000000425,0.880253591756671,0,1,axial mesoderm formation,BP,
14027,GO:0060823,1.00000000000425,0.880253591756671,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
2012,GO:0004742,1.00000000000426,0.880130211172826,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
6922,GO:0030523,1.00000000000426,0.880130211172826,0,1,dihydrolipoamide S-acyltransferase activity,MF,
1949,GO:0004656,1.00000000000426,0.682598147347577,0,3,procollagen-proline 4-dioxygenase activity,MF,
963,GO:0002396,1.00000000000427,0.882033140764831,0,1,MHC protein complex assembly,BP,
964,GO:0002397,1.00000000000427,0.882033140764831,0,1,MHC class I protein complex assembly,BP,
1012,GO:0002501,1.00000000000427,0.882033140764831,0,1,peptide antigen assembly with MHC protein complex,BP,
1013,GO:0002502,1.00000000000427,0.882033140764831,0,1,peptide antigen assembly with MHC class I protein complex,BP,
6413,GO:0021682,1.00000000000431,0.880096899120549,0,1,nerve maturation,BP,
19197,GO:1905349,1.00000000000431,0.889728396020831,0,1,ciliary transition zone assembly,BP,
2143,GO:0004960,1.00000000000431,0.880717269500371,0,1,thromboxane receptor activity,MF,
2144,GO:0004961,1.00000000000431,0.880717269500371,0,1,thromboxane A2 receptor activity,MF,
5314,GO:0016036,1.00000000000431,0.880717269500371,0,1,cellular response to phosphate starvation,BP,
7317,GO:0031335,1.00000000000431,0.880717269500371,0,1,regulation of sulfur amino acid metabolic process,BP,
7318,GO:0031337,1.00000000000431,0.880717269500371,0,1,positive regulation of sulfur amino acid metabolic process,BP,
9320,GO:0035814,1.00000000000431,0.880717269500371,0,1,negative regulation of renal sodium excretion,BP,
9724,GO:0038193,1.00000000000431,0.880717269500371,0,1,thromboxane A2 signaling pathway,BP,
12502,GO:0050666,1.00000000000431,0.880717269500371,0,1,regulation of homocysteine metabolic process,BP,
12504,GO:0050668,1.00000000000431,0.880717269500371,0,1,positive regulation of homocysteine metabolic process,BP,
19254,GO:1905502,1.00000000000432,0.88985959180935,0,1,acetyl-CoA binding,MF,
5026,GO:0015195,1.00000000000433,0.880132410877405,0,1,L-threonine transmembrane transporter activity,MF,
5219,GO:0015826,1.00000000000433,0.880132410877405,0,1,threonine transport,BP,
8804,GO:0034589,1.00000000000433,0.880132410877405,0,1,hydroxyproline transport,BP,
8805,GO:0034590,1.00000000000433,0.880132410877405,0,1,L-hydroxyproline transmembrane transporter activity,MF,
16855,GO:0098821,1.00000000000434,0.677422455231425,0,3,BMP receptor activity,MF,
18368,GO:1903422,1.00000000000434,0.681769731144236,0,3,negative regulation of synaptic vesicle recycling,BP,
19612,GO:1990834,1.00000000000435,0.682288119517777,0,3,response to odorant,BP,
12770,GO:0051088,1.00000000000437,0.68187141036545,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
14783,GO:0070537,1.00000000000438,0.682238545501336,0,3,histone H2A K63-linked deubiquitination,BP,
16995,GO:0099174,1.00000000000439,0.681980480566906,0,3,regulation of presynapse organization,BP,
19294,GO:1905606,1.00000000000439,0.681980480566906,0,3,regulation of presynapse assembly,BP,
11653,GO:0046452,1.00000000000439,0.691637040843319,0,3,dihydrofolate metabolic process,BP,
5088,GO:0015362,1.00000000000441,0.880149845015116,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
13278,GO:0052047,1.00000000000441,0.878925161724563,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
18727,GO:1904235,1.00000000000441,0.878925161724563,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18728,GO:1904237,1.00000000000441,0.878925161724563,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20220,GO:2001202,1.00000000000441,0.878925161724563,0,1,negative regulation of transforming growth factor-beta secretion,BP,
19601,GO:1990796,1.00000000000441,0.88032546576611,0,1,photoreceptor cell terminal bouton,CC,
18912,GO:1904693,1.00000000000441,0.680928983357655,0,3,midbrain morphogenesis,BP,
16720,GO:0098508,1.00000000000441,0.776264088402658,0,2,endothelial to hematopoietic transition,BP,
20096,GO:2000812,1.00000000000443,0.880171886847083,0,1,regulation of barbed-end actin filament capping,BP,
85,GO:0000173,1.00000000000443,0.884038190164378,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
6778,GO:0030222,1.00000000000445,0.880212475222992,0,1,eosinophil differentiation,BP,
11300,GO:0045643,1.00000000000445,0.880212475222992,0,1,regulation of eosinophil differentiation,BP,
11301,GO:0045645,1.00000000000445,0.880212475222992,0,1,positive regulation of eosinophil differentiation,BP,
12117,GO:0048239,1.00000000000447,0.775682815005624,0,2,negative regulation of DNA recombination at telomere,BP,
15889,GO:0072695,1.00000000000447,0.775682815005624,0,2,regulation of DNA recombination at telomere,BP,
7178,GO:0031074,1.00000000000449,0.690776622994911,0,3,nucleocytoplasmic transport complex,CC,
3520,GO:0007497,1.00000000000454,0.880122818232829,0,1,posterior midgut development,BP,
15408,GO:0071707,1.00000000000454,0.888700647117862,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
17828,GO:1902045,1.00000000000456,0.88056772177187,0,1,negative regulation of Fas signaling pathway,BP,
19923,GO:2000504,1.00000000000456,0.88056772177187,0,1,positive regulation of blood vessel remodeling,BP,
7261,GO:0031249,1.00000000000457,0.880485099217575,0,1,denatured protein binding,MF,
17950,GO:1902380,1.00000000000457,0.880485099217575,0,1,positive regulation of endoribonuclease activity,BP,
18930,GO:1904722,1.00000000000457,0.880485099217575,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
5425,GO:0016287,1.00000000000458,0.880350610625432,0,1,glycerone-phosphate O-acyltransferase activity,MF,
14374,GO:0061656,1.00000000000459,0.889705326413687,0,1,SUMO conjugating enzyme activity,MF,
18259,GO:1903182,1.00000000000459,0.889705326413687,0,1,regulation of SUMO transferase activity,BP,
18518,GO:1903755,1.00000000000459,0.889705326413687,0,1,positive regulation of SUMO transferase activity,BP,
19473,GO:1990356,1.00000000000459,0.889705326413687,0,1,sumoylated E2 ligase complex,CC,
17713,GO:1901675,1.0000000000046,0.879876681083285,0,1,negative regulation of histone H3-K27 acetylation,BP,
15569,GO:0072076,1.00000000000462,0.681061730489507,0,3,nephrogenic mesenchyme development,BP,
6333,GO:0021512,1.00000000000462,0.880134950835206,0,1,spinal cord anterior/posterior patterning,BP,
14451,GO:0061851,1.00000000000463,0.880346904433936,0,1,leading edge of lamellipodium,CC,
18768,GO:1904328,1.00000000000463,0.880346904433936,0,1,regulation of myofibroblast contraction,BP,
19588,GO:1990764,1.00000000000463,0.880346904433936,0,1,myofibroblast contraction,BP,
14224,GO:0061301,1.00000000000463,0.879580766804167,0,1,cerebellum vasculature morphogenesis,BP,
2217,GO:0005115,1.00000000000464,0.88008146697443,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
6406,GO:0021650,1.00000000000464,0.88008146697443,0,1,vestibulocochlear nerve formation,BP,
9633,GO:0036517,1.00000000000464,0.88008146697443,0,1,chemoattraction of serotonergic neuron axon,BP,
13199,GO:0051885,1.00000000000464,0.88008146697443,0,1,positive regulation of timing of anagen,BP,
13541,GO:0060031,1.00000000000464,0.88008146697443,0,1,mediolateral intercalation,BP,
13572,GO:0060067,1.00000000000464,0.88008146697443,0,1,cervix development,BP,
13909,GO:0060599,1.00000000000464,0.88008146697443,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14016,GO:0060775,1.00000000000464,0.88008146697443,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14023,GO:0060809,1.00000000000464,0.88008146697443,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14247,GO:0061347,1.00000000000464,0.88008146697443,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14248,GO:0061348,1.00000000000464,0.88008146697443,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14249,GO:0061349,1.00000000000464,0.88008146697443,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14250,GO:0061350,1.00000000000464,0.88008146697443,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14252,GO:0061354,1.00000000000464,0.88008146697443,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14367,GO:0061642,1.00000000000464,0.88008146697443,0,1,chemoattraction of axon,BP,
17949,GO:1902379,1.00000000000464,0.88008146697443,0,1,chemoattractant activity involved in axon guidance,MF,
19036,GO:1904933,1.00000000000464,0.88008146697443,0,1,regulation of cell proliferation in midbrain,BP,
19037,GO:1904934,1.00000000000464,0.88008146697443,0,1,negative regulation of cell proliferation in midbrain,BP,
19046,GO:1904955,1.00000000000464,0.88008146697443,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19232,GO:1905438,1.00000000000464,0.88008146697443,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
7463,GO:0031630,1.00000000000464,0.880166749779964,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
17171,GO:0106022,1.00000000000464,0.880166749779964,0,1,positive regulation of vesicle docking,BP,
1598,GO:0004019,1.00000000000466,0.880342879951173,0,1,adenylosuccinate synthase activity,MF,
3991,GO:0008893,1.00000000000466,0.892283375695347,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5676,GO:0016794,1.00000000000466,0.892283375695347,0,1,diphosphoric monoester hydrolase activity,MF,
16403,GO:0097068,1.00000000000466,0.681980880082131,0,3,response to thyroxine,BP,
18791,GO:1904386,1.00000000000466,0.681980880082131,0,3,response to L-phenylalanine derivative,BP,
11021,GO:0045016,1.00000000000467,0.880263026808638,0,1,mitochondrial magnesium ion transmembrane transport,BP,
14162,GO:0061091,1.00000000000469,0.880122657396453,0,1,regulation of phospholipid translocation,BP,
14163,GO:0061092,1.00000000000469,0.880122657396453,0,1,positive regulation of phospholipid translocation,BP,
8454,GO:0033604,1.0000000000047,0.774766805490719,0,2,negative regulation of catecholamine secretion,BP,
17490,GO:1900753,1.0000000000047,0.880130005713202,0,1,doxorubicin transport,BP,
1036,GO:0002545,1.00000000000471,0.882228323455765,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1210,GO:0002880,1.00000000000471,0.882228323455765,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1211,GO:0002882,1.00000000000471,0.882228323455765,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1533,GO:0003920,1.00000000000471,0.882228323455765,0,1,GMP reductase activity,MF,
5285,GO:0015950,1.00000000000471,0.882228323455765,0,1,purine nucleotide interconversion,BP,
5286,GO:0015951,1.00000000000471,0.882228323455765,0,1,purine ribonucleotide interconversion,BP,
5607,GO:0016657,1.00000000000471,0.882228323455765,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18010,GO:1902560,1.00000000000471,0.882228323455765,0,1,GMP reductase complex,CC,
2681,GO:0006046,1.00000000000471,0.685488162236102,0,3,N-acetylglucosamine catabolic process,BP,
188,GO:0000406,1.00000000000471,0.77476006274265,0,2,double-strand/single-strand DNA junction binding,MF,
7693,GO:0032181,1.00000000000471,0.77476006274265,0,2,dinucleotide repeat insertion binding,MF,
7769,GO:0032302,1.00000000000471,0.77476006274265,0,2,MutSbeta complex,CC,
11235,GO:0045485,1.00000000000472,0.880127734125797,0,1,omega-6 fatty acid desaturase activity,MF,
1788,GO:0004420,1.00000000000473,0.88012532189219,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
9919,GO:0042282,1.00000000000473,0.88012532189219,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
1261,GO:0003017,1.00000000000473,0.87826046553511,0,1,lymph circulation,BP,
4995,GO:0015141,1.00000000000474,0.683474785505111,0,3,succinate transmembrane transporter activity,MF,
5178,GO:0015744,1.00000000000474,0.683474785505111,0,3,succinate transport,BP,
15228,GO:0071422,1.00000000000474,0.683474785505111,0,3,succinate transmembrane transport,BP,
4471,GO:0010481,1.00000000000475,0.688065154159684,0,3,epidermal cell division,BP,
4472,GO:0010482,1.00000000000475,0.688065154159684,0,3,regulation of epidermal cell division,BP,
10823,GO:0044335,1.00000000000476,0.877264322978976,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
19686,GO:2000055,1.00000000000476,0.877264322978976,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
17326,GO:1900041,1.00000000000476,0.682170113710902,0,3,negative regulation of interleukin-2 secretion,BP,
11196,GO:0045347,1.00000000000476,0.684828623606494,0,3,negative regulation of MHC class II biosynthetic process,BP,
19334,GO:1905777,1.00000000000478,0.682224533517979,0,3,regulation of exonuclease activity,BP,
3977,GO:0008817,1.0000000000048,0.880143032972665,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
13126,GO:0051722,1.0000000000048,0.880449223174518,0,1,protein C-terminal methylesterase activity,MF,
13127,GO:0051723,1.0000000000048,0.880449223174518,0,1,protein methylesterase activity,MF,
15132,GO:0071275,1.00000000000481,0.881020105702772,0,1,cellular response to aluminum ion,BP,
19312,GO:1905672,1.00000000000481,0.881020105702772,0,1,negative regulation of lysosome organization,BP,
6365,GO:0021555,1.00000000000482,0.779968750363212,0,2,midbrain-hindbrain boundary morphogenesis,BP,
12262,GO:0048597,1.00000000000483,0.70143548812273,0,3,post-embryonic camera-type eye morphogenesis,BP,
13169,GO:0051800,1.00000000000484,0.880108769520536,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
20092,GO:2000808,1.00000000000484,0.880108769520536,0,1,negative regulation of synaptic vesicle clustering,BP,
16228,GO:0090310,1.00000000000484,0.772784004197122,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
10796,GO:0044301,1.00000000000485,0.880125964675561,0,1,climbing fiber,CC,
19400,GO:1990032,1.00000000000485,0.880125964675561,0,1,parallel fiber,CC,
11865,GO:0046900,1.00000000000485,0.779814782146226,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
18457,GO:1903593,1.00000000000486,0.695882077019549,0,3,regulation of histamine secretion by mast cell,BP,
18458,GO:1903595,1.00000000000486,0.695882077019549,0,3,positive regulation of histamine secretion by mast cell,BP,
15371,GO:0071650,1.00000000000486,0.686403389545493,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
9040,GO:0035276,1.00000000000487,0.880110063952059,0,1,ethanol binding,MF,
9246,GO:0035668,1.00000000000487,0.880110063952059,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9247,GO:0035669,1.00000000000487,0.880110063952059,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
20154,GO:2001029,1.00000000000487,0.880110063952059,0,1,regulation of cellular glucuronidation,BP,
20155,GO:2001031,1.00000000000487,0.880110063952059,0,1,positive regulation of cellular glucuronidation,BP,
6451,GO:0021778,1.00000000000489,0.878464637466122,0,1,oligodendrocyte cell fate specification,BP,
6452,GO:0021779,1.00000000000489,0.878464637466122,0,1,oligodendrocyte cell fate commitment,BP,
6453,GO:0021780,1.00000000000489,0.878464637466122,0,1,glial cell fate specification,BP,
8833,GO:0034640,1.00000000000489,0.880283933501188,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
16979,GO:0099098,1.00000000000489,0.880283933501188,0,1,microtubule polymerization based movement,BP,
8959,GO:0035063,1.00000000000491,0.880201359195323,0,1,nuclear speck organization,BP,
9341,GO:0035867,1.00000000000493,0.770450088443863,0,2,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
14752,GO:0070478,1.00000000000493,0.880139031758432,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
10,GO:0000019,1.00000000000495,0.682109357279439,0,3,regulation of mitotic recombination,BP,
8918,GO:0034777,1.00000000000495,0.880791194359352,0,1,recycling endosome lumen,CC,
3824,GO:0008428,1.00000000000495,0.683450941042539,0,3,ribonuclease inhibitor activity,MF,
5979,GO:0018872,1.00000000000495,0.880441770874213,0,1,arsonoacetate metabolic process,BP,
7015,GO:0030791,1.00000000000495,0.880441770874213,0,1,arsenite methyltransferase activity,MF,
7016,GO:0030792,1.00000000000495,0.880441770874213,0,1,methylarsonite methyltransferase activity,MF,
14025,GO:0060819,1.00000000000496,0.774216240328984,0,2,inactivation of X chromosome by genetic imprinting,BP,
15497,GO:0071907,1.00000000000498,0.68540035362439,0,3,determination of digestive tract left/right asymmetry,BP,
18068,GO:1902725,1.00000000000499,0.880014644372883,0,1,negative regulation of satellite cell differentiation,BP,
12426,GO:0050146,1.00000000000499,0.880118760398948,0,1,nucleoside phosphotransferase activity,MF,
8606,GO:0034136,1.00000000000499,0.681846074495845,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
10127,GO:0042713,1.00000000000501,0.681739345513233,0,3,sperm ejaculation,BP,
1918,GO:0004615,1.00000000000502,0.782365155104039,0,2,phosphomannomutase activity,MF,
17346,GO:1900095,1.00000000000502,0.876649068076287,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
4357,GO:0009957,1.00000000000503,0.774288226584069,0,2,epidermal cell fate specification,BP,
9742,GO:0039513,1.00000000000505,0.880343122713106,0,1,suppression by virus of host catalytic activity,BP,
9744,GO:0039516,1.00000000000505,0.880343122713106,0,1,modulation by virus of host catalytic activity,BP,
9762,GO:0039650,1.00000000000505,0.880343122713106,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13279,GO:0052053,1.00000000000505,0.880343122713106,0,1,negative regulation by symbiont of host catalytic activity,BP,
13286,GO:0052148,1.00000000000505,0.880343122713106,0,1,modulation by symbiont of host catalytic activity,BP,
13295,GO:0052199,1.00000000000505,0.880343122713106,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
4204,GO:0009330,1.00000000000505,0.774643483183097,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
1532,GO:0003919,1.00000000000505,0.881726518684119,0,1,FMN adenylyltransferase activity,MF,
3147,GO:0006747,1.00000000000505,0.881726518684119,0,1,FAD biosynthetic process,BP,
11649,GO:0046443,1.00000000000505,0.881726518684119,0,1,FAD metabolic process,BP,
15757,GO:0072388,1.00000000000505,0.881726518684119,0,1,flavin adenine dinucleotide biosynthetic process,BP,
6000,GO:0019045,1.00000000000507,0.773370866601866,0,2,latent virus replication,BP,
6001,GO:0019046,1.00000000000507,0.773370866601866,0,2,release from viral latency,BP,
8835,GO:0034642,1.00000000000507,0.880181121085146,0,1,mitochondrion migration along actin filament,BP,
7506,GO:0031700,1.00000000000508,0.886266484648582,0,1,adrenomedullin receptor binding,MF,
11123,GO:0045186,1.00000000000508,0.879514072283399,0,1,zonula adherens assembly,BP,
11718,GO:0046570,1.00000000000512,0.888817919422451,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
18640,GO:1903998,1.00000000000513,0.693153282233257,0,3,regulation of eating behavior,BP,
10742,GO:0044205,1.00000000000513,0.68249512358709,0,3,'de novo' UMP biosynthetic process,BP,
9266,GO:0035712,1.00000000000514,0.880276060993997,0,1,T-helper 2 cell activation,BP,
19951,GO:2000569,1.00000000000514,0.880276060993997,0,1,regulation of T-helper 2 cell activation,BP,
19952,GO:2000570,1.00000000000514,0.880276060993997,0,1,positive regulation of T-helper 2 cell activation,BP,
8616,GO:0034146,1.00000000000514,0.880127394661482,0,1,toll-like receptor 5 signaling pathway,BP,
8617,GO:0034147,1.00000000000514,0.880127394661482,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8618,GO:0034148,1.00000000000514,0.880127394661482,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
14725,GO:0070425,1.00000000000514,0.880127394661482,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14728,GO:0070428,1.00000000000514,0.880127394661482,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14729,GO:0070429,1.00000000000514,0.880127394661482,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14732,GO:0070433,1.00000000000514,0.880127394661482,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15828,GO:0072573,1.00000000000514,0.880127394661482,0,1,tolerance induction to lipopolysaccharide,BP,
16214,GO:0090291,1.00000000000514,0.880127394661482,0,1,negative regulation of osteoclast proliferation,BP,
19841,GO:2000349,1.00000000000514,0.880127394661482,0,1,negative regulation of CD40 signaling pathway,BP,
18846,GO:1904533,1.00000000000514,0.682054108992541,0,3,regulation of telomeric loop disassembly,BP,
13203,GO:0051892,1.00000000000515,0.880135037606509,0,1,negative regulation of cardioblast differentiation,BP,
20028,GO:2000690,1.00000000000515,0.880135037606509,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20029,GO:2000691,1.00000000000515,0.880135037606509,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
14417,GO:0061757,1.00000000000515,0.880327116428164,0,1,leukocyte adhesion to arterial endothelial cell,BP,
19066,GO:1904997,1.00000000000515,0.880327116428164,0,1,regulation of leukocyte adhesion to arterial endothelial cell,BP,
19067,GO:1904998,1.00000000000515,0.880327116428164,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
18235,GO:1903116,1.00000000000517,0.774662576225929,0,2,positive regulation of actin filament-based movement,BP,
18534,GO:1903781,1.00000000000517,0.774662576225929,0,2,positive regulation of cardiac conduction,BP,
18615,GO:1903949,1.00000000000517,0.774662576225929,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
3846,GO:0008460,1.00000000000517,0.882073342905574,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
11111,GO:0045168,1.00000000000518,0.780100814945881,0,2,cell-cell signaling involved in cell fate commitment,BP,
11608,GO:0046331,1.00000000000518,0.780100814945881,0,2,lateral inhibition,BP,
5760,GO:0016938,1.00000000000519,0.880324562054602,0,1,kinesin I complex,CC,
7544,GO:0031867,1.00000000000519,0.880178112902265,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
19888,GO:2000416,1.0000000000052,0.682152862934069,0,3,regulation of eosinophil migration,BP,
5105,GO:0015410,1.00000000000521,0.681959366350523,0,3,manganese-transporting ATPase activity,MF,
1776,GO:0004392,1.00000000000523,0.781710986250964,0,2,heme oxygenase (decyclizing) activity,MF,
3172,GO:0006788,1.00000000000523,0.781710986250964,0,2,heme oxidation,BP,
20141,GO:2001013,1.00000000000523,0.774605054616727,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
11506,GO:0046041,1.00000000000524,0.784660082328112,0,2,ITP metabolic process,BP,
12010,GO:0047710,1.00000000000524,0.891519081679573,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
897,GO:0002277,1.00000000000524,0.894904331110913,0,1,myeloid dendritic cell activation involved in immune response,BP,
1054,GO:0002582,1.00000000000524,0.894904331110913,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1057,GO:0002585,1.00000000000524,0.894904331110913,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1060,GO:0002588,1.00000000000524,0.894904331110913,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
5787,GO:0017024,1.00000000000524,0.894904331110913,0,1,myosin I binding,MF,
17074,GO:0099640,1.00000000000524,0.894904331110913,0,1,axo-dendritic protein transport,BP,
17075,GO:0099641,1.00000000000524,0.894904331110913,0,1,anterograde axonal protein transport,BP,
3864,GO:0008493,1.00000000000525,0.882344134598507,0,1,tetracycline transmembrane transporter activity,MF,
5258,GO:0015904,1.00000000000525,0.882344134598507,0,1,tetracycline transport,BP,
15623,GO:0072162,1.00000000000525,0.774735459544463,0,2,metanephric mesenchymal cell differentiation,BP,
9706,GO:0038158,1.00000000000526,0.778136395944275,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
18487,GO:1903677,1.00000000000528,0.684688658193372,0,3,regulation of cap-independent translational initiation,BP,
18488,GO:1903679,1.00000000000528,0.684688658193372,0,3,positive regulation of cap-independent translational initiation,BP,
11039,GO:0045054,1.00000000000529,0.68516177364072,0,3,constitutive secretory pathway,BP,
17187,GO:0106073,1.00000000000529,0.772276467826883,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
6042,GO:0019166,1.00000000000531,0.687258689059835,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
209,GO:0000438,1.00000000000531,0.689731100033399,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
2502,GO:0005753,1.00000000000532,0.880888966301419,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
4690,GO:0010849,1.00000000000532,0.880888966301419,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
19789,GO:2000276,1.00000000000532,0.880888966301419,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
8027,GO:0032685,1.00000000000533,0.880277272062353,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
11820,GO:0046811,1.00000000000533,0.880096125763407,0,1,histone deacetylase inhibitor activity,MF,
19413,GO:1990074,1.00000000000534,0.880232287549486,0,1,polyuridylation-dependent mRNA catabolic process,BP,
16676,GO:0097676,1.00000000000535,0.677432341536431,0,3,histone H3-K36 dimethylation,BP,
7186,GO:0031084,1.00000000000537,0.681920147737995,0,3,BLOC-2 complex,CC,
8155,GO:0032899,1.00000000000538,0.880170906405603,0,1,regulation of neurotrophin production,BP,
8156,GO:0032901,1.00000000000538,0.880170906405603,0,1,positive regulation of neurotrophin production,BP,
8841,GO:0034649,1.00000000000538,0.880170906405603,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
12193,GO:0048403,1.00000000000538,0.880170906405603,0,1,brain-derived neurotrophic factor binding,MF,
5415,GO:0016269,1.0000000000054,0.880424415742367,0,1,O-glycan processing, core 3,BP,
11952,GO:0047224,1.0000000000054,0.880424415742367,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
5359,GO:0016150,1.00000000000541,0.88434670087937,0,1,translation release factor activity, codon nonspecific,MF,
6040,GO:0019153,1.00000000000542,0.884560406587713,0,1,protein-disulfide reductase (glutathione) activity,MF,
15816,GO:0072555,1.00000000000542,0.884560406587713,0,1,17-beta-ketosteroid reductase activity,MF,
15835,GO:0072582,1.00000000000542,0.884560406587713,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
13107,GO:0051686,1.00000000000545,0.87423270710863,0,1,establishment of ER localization,BP,
16975,GO:0099089,1.00000000000545,0.87423270710863,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
4346,GO:0009918,1.00000000000547,0.880356436580008,0,1,sterol delta7 reductase activity,MF,
5120,GO:0015499,1.00000000000547,0.880356436580008,0,1,formate transmembrane transporter activity,MF,
5136,GO:0015660,1.00000000000547,0.880356436580008,0,1,formate efflux transmembrane transporter activity,MF,
5168,GO:0015724,1.00000000000547,0.880356436580008,0,1,formate transport,BP,
5196,GO:0015797,1.00000000000547,0.880356436580008,0,1,mannitol transport,BP,
5354,GO:0016131,1.00000000000547,0.880356436580008,0,1,brassinosteroid metabolic process,BP,
5355,GO:0016132,1.00000000000547,0.880356436580008,0,1,brassinosteroid biosynthetic process,BP,
11805,GO:0046724,1.00000000000547,0.880356436580008,0,1,oxalic acid secretion,BP,
11996,GO:0047598,1.00000000000547,0.880356436580008,0,1,7-dehydrocholesterol reductase activity,MF,
19348,GO:1905843,1.00000000000549,0.87595445195507,0,1,regulation of cellular response to gamma radiation,BP,
4557,GO:0010643,1.0000000000055,0.682155158391545,0,3,cell communication by chemical coupling,BP,
14126,GO:0061032,1.00000000000551,0.880318074093139,0,1,visceral serous pericardium development,BP,
15626,GO:0072166,1.00000000000551,0.880318074093139,0,1,posterior mesonephric tubule development,BP,
15700,GO:0072299,1.00000000000551,0.880318074093139,0,1,negative regulation of metanephric glomerulus development,BP,
15703,GO:0072302,1.00000000000551,0.880318074093139,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
4800,GO:0010999,1.00000000000552,0.880126304804228,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
11488,GO:0045993,1.00000000000552,0.880126304804228,0,1,negative regulation of translational initiation by iron,BP,
11919,GO:0046986,1.00000000000552,0.880126304804228,0,1,negative regulation of hemoglobin biosynthetic process,BP,
1744,GO:0004347,1.00000000000553,0.881228743923796,0,1,glucose-6-phosphate isomerase activity,MF,
6081,GO:0019242,1.00000000000553,0.881228743923796,0,1,methylglyoxal biosynthetic process,BP,
16860,GO:0098829,1.00000000000554,0.879943108383038,0,1,intestinal folate absorption,BP,
18816,GO:1904447,1.00000000000554,0.879943108383038,0,1,folic acid import across plasma membrane,BP,
6942,GO:0030576,1.00000000000554,0.682771289568585,0,3,Cajal body organization,BP,
3498,GO:0007403,1.00000000000555,0.880248794887828,0,1,glial cell fate determination,BP,
14014,GO:0060769,1.00000000000555,0.880248794887828,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14238,GO:0061324,1.00000000000555,0.880248794887828,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
18833,GO:1904499,1.00000000000555,0.880248794887828,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18834,GO:1904501,1.00000000000555,0.880248794887828,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18965,GO:1904793,1.00000000000555,0.880248794887828,0,1,regulation of euchromatin binding,BP,
14770,GO:0070510,1.00000000000559,0.879702256640368,0,1,regulation of histone H4-K20 methylation,BP,
14771,GO:0070512,1.00000000000559,0.879702256640368,0,1,positive regulation of histone H4-K20 methylation,BP,
9592,GO:0036466,1.00000000000559,0.774608983883225,0,2,synaptic vesicle recycling via endosome,BP,
15658,GO:0072209,1.0000000000056,0.880332865761652,0,1,metanephric mesangial cell differentiation,BP,
15681,GO:0072254,1.0000000000056,0.880332865761652,0,1,metanephric glomerular mesangial cell differentiation,BP,
15682,GO:0072255,1.0000000000056,0.880332865761652,0,1,metanephric glomerular mesangial cell development,BP,
17426,GO:1900241,1.0000000000056,0.880332865761652,0,1,positive regulation of phenotypic switching,BP,
19133,GO:1905176,1.0000000000056,0.880332865761652,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
16865,GO:0098837,1.0000000000056,0.683991267520718,0,3,postsynaptic recycling endosome,CC,
11065,GO:0045083,1.00000000000561,0.880146319194791,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
19797,GO:2000286,1.00000000000561,0.682175242214493,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
18924,GO:1904715,1.00000000000562,0.683791316806026,0,3,negative regulation of chaperone-mediated autophagy,BP,
4990,GO:0015130,1.00000000000562,0.880142911554224,0,1,mevalonate transmembrane transporter activity,MF,
5170,GO:0015728,1.00000000000562,0.880142911554224,0,1,mevalonate transport,BP,
13150,GO:0051780,1.00000000000562,0.880142911554224,0,1,behavioral response to nutrient,BP,
8040,GO:0032707,1.00000000000562,0.880548246734701,0,1,negative regulation of interleukin-23 production,BP,
12014,GO:0047747,1.00000000000562,0.880548246734701,0,1,cholate-CoA ligase activity,MF,
764,GO:0002017,1.00000000000564,0.882240619306258,0,1,regulation of blood volume by renal aldosterone,BP,
18302,GO:1903286,1.00000000000565,0.68514454244562,0,3,regulation of potassium ion import,BP,
19651,GO:1990983,1.00000000000567,0.880375656928425,0,1,tRNA demethylation,BP,
19652,GO:1990984,1.00000000000567,0.880375656928425,0,1,tRNA demethylase activity,MF,
15892,GO:0072702,1.00000000000567,0.88010291882043,0,1,response to methyl methanesulfonate,BP,
15893,GO:0072703,1.00000000000567,0.88010291882043,0,1,cellular response to methyl methanesulfonate,BP,
6495,GO:0021870,1.00000000000568,0.880040450518514,0,1,Cajal-Retzius cell differentiation,BP,
18967,GO:1904797,1.00000000000568,0.880040450518514,0,1,negative regulation of core promoter binding,BP,
13789,GO:0060406,1.0000000000057,0.774773170118048,0,2,positive regulation of penile erection,BP,
3918,GO:0008594,1.00000000000574,0.774658654588859,0,2,photoreceptor cell morphogenesis,BP,
14612,GO:0070209,1.00000000000574,0.880263740502679,0,1,ASTRA complex,CC,
18611,GO:1903939,1.00000000000574,0.880263740502679,0,1,regulation of TORC2 signaling,BP,
18839,GO:1904515,1.00000000000574,0.880263740502679,0,1,positive regulation of TORC2 signaling,BP,
9210,GO:0035611,1.00000000000575,0.880336288049801,0,1,protein branching point deglutamylation,BP,
2746,GO:0006148,1.00000000000575,0.880494699704456,0,1,inosine catabolic process,BP,
3140,GO:0006738,1.00000000000575,0.880494699704456,0,1,nicotinamide riboside catabolic process,BP,
11683,GO:0046495,1.00000000000575,0.880494699704456,0,1,nicotinamide riboside metabolic process,BP,
14838,GO:0070637,1.00000000000575,0.880494699704456,0,1,pyridine nucleoside metabolic process,BP,
14839,GO:0070638,1.00000000000575,0.880494699704456,0,1,pyridine nucleoside catabolic process,BP,
12035,GO:0048003,1.00000000000577,0.681808922640268,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12037,GO:0048007,1.00000000000577,0.681808922640268,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
2356,GO:0005456,1.00000000000578,0.882677447395639,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5189,GO:0015782,1.00000000000578,0.882677447395639,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
19535,GO:1990573,1.00000000000578,0.683591539417125,0,3,potassium ion import across plasma membrane,BP,
292,GO:0000797,1.00000000000579,0.880122826249064,0,1,condensin core heterodimer,CC,
2446,GO:0005656,1.00000000000579,0.68713398860453,0,3,nuclear pre-replicative complex,CC,
2805,GO:0006267,1.00000000000579,0.68713398860453,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
9563,GO:0036387,1.00000000000579,0.68713398860453,0,3,pre-replicative complex,CC,
9564,GO:0036388,1.00000000000579,0.68713398860453,0,3,pre-replicative complex assembly,BP,
17922,GO:1902299,1.00000000000579,0.68713398860453,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
1399,GO:0003335,1.0000000000058,0.880394322974535,0,1,corneocyte development,BP,
1400,GO:0003336,1.0000000000058,0.880394322974535,0,1,corneocyte desquamation,BP,
19321,GO:1905715,1.0000000000058,0.880394322974535,0,1,regulation of cornification,BP,
19322,GO:1905716,1.0000000000058,0.880394322974535,0,1,negative regulation of cornification,BP,
10741,GO:0044194,1.0000000000058,0.683696244325148,0,3,cytolytic granule,CC,
19718,GO:2000124,1.0000000000058,0.774958632908963,0,2,regulation of endocannabinoid signaling pathway,BP,
7545,GO:0031870,1.00000000000585,0.880042762963097,0,1,thromboxane A2 receptor binding,MF,
5016,GO:0015183,1.00000000000586,0.682057069673571,0,3,L-aspartate transmembrane transporter activity,MF,
12021,GO:0047801,1.00000000000586,0.881083269755094,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
4607,GO:0010729,1.00000000000586,0.881477263339438,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
11957,GO:0047273,1.00000000000586,0.880268533390902,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
19907,GO:2000466,1.00000000000587,0.682159422482454,0,3,negative regulation of glycogen (starch) synthase activity,BP,
3489,GO:0007371,1.00000000000588,0.880193124228099,0,1,ventral midline determination,BP,
13669,GO:0060245,1.00000000000588,0.880193124228099,0,1,detection of cell density,BP,
13670,GO:0060246,1.00000000000588,0.880193124228099,0,1,detection of cell density by contact stimulus,BP,
13671,GO:0060248,1.00000000000588,0.880193124228099,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
15548,GO:0072036,1.00000000000588,0.880193124228099,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15696,GO:0072285,1.00000000000588,0.880193124228099,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
3433,GO:0007225,1.00000000000588,0.880122955924641,0,1,patched ligand maturation,BP,
9230,GO:0035638,1.00000000000588,0.880122955924641,0,1,signal maturation,BP,
4008,GO:0009000,1.00000000000588,0.880445035751917,0,1,selenocysteine lyase activity,MF,
12135,GO:0048264,1.00000000000588,0.880317340254232,0,1,determination of ventral identity,BP,
20252,GO:2001253,1.00000000000588,0.880317340254232,0,1,regulation of histone H3-K36 trimethylation,BP,
15383,GO:0071673,1.00000000000591,0.880300268897135,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
18855,GO:1904565,1.00000000000591,0.880300268897135,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18856,GO:1904566,1.00000000000591,0.880300268897135,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
5147,GO:0015688,1.00000000000591,0.789499083305859,0,2,iron chelate transport,BP,
5256,GO:0015891,1.00000000000591,0.789499083305859,0,2,siderophore transport,BP,
7909,GO:0032493,1.00000000000592,0.683948511801105,0,3,response to bacterial lipoprotein,BP,
14683,GO:0070339,1.00000000000592,0.683948511801105,0,3,response to bacterial lipopeptide,BP,
15103,GO:0071220,1.00000000000592,0.683948511801105,0,3,cellular response to bacterial lipoprotein,BP,
15104,GO:0071221,1.00000000000592,0.683948511801105,0,3,cellular response to bacterial lipopeptide,BP,
1977,GO:0004698,1.00000000000593,0.878610850423829,0,1,calcium-dependent protein kinase C activity,MF,
9099,GO:0035403,1.00000000000593,0.878610850423829,0,1,histone kinase activity (H3-T6 specific),MF,
9104,GO:0035408,1.00000000000593,0.878610850423829,0,1,histone H3-T6 phosphorylation,BP,
20039,GO:2000707,1.00000000000593,0.878610850423829,0,1,positive regulation of dense core granule biogenesis,BP,
1837,GO:0004496,1.00000000000593,0.881283160456505,0,1,mevalonate kinase activity,MF,
13423,GO:0052894,1.00000000000593,0.881283160456505,0,1,norspermine:oxygen oxidoreductase activity,MF,
13424,GO:0052895,1.00000000000593,0.881283160456505,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
3807,GO:0008403,1.00000000000594,0.880292796439493,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
6860,GO:0030342,1.00000000000594,0.880292796439493,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
15970,GO:0086007,1.00000000000595,0.77466773248844,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17755,GO:1901843,1.00000000000595,0.77466773248844,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
6263,GO:0019862,1.00000000000595,0.884876670275464,0,1,IgA binding,MF,
19377,GO:1905937,1.00000000000596,0.894393429801871,0,1,negative regulation of germ cell proliferation,BP,
19778,GO:2000255,1.00000000000596,0.894393429801871,0,1,negative regulation of male germ cell proliferation,BP,
10927,GO:0044609,1.00000000000597,0.775620042123824,0,2,DBIRD complex,CC,
5493,GO:0016436,1.00000000000597,0.774862775296414,0,2,rRNA (uridine) methyltransferase activity,MF,
9644,GO:0038002,1.00000000000599,0.880117739647677,0,1,endocrine signaling,BP,
9544,GO:0036335,1.00000000000599,0.88012036283738,0,1,intestinal stem cell homeostasis,BP,
3373,GO:0007147,1.000000000006,0.880212125067965,0,1,female meiosis II,BP,
16206,GO:0090283,1.00000000000602,0.684230827300829,0,3,regulation of protein glycosylation in Golgi,BP,
8461,GO:0033615,1.00000000000602,0.685132361803168,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
1506,GO:0003867,1.00000000000603,0.880122816989021,0,1,4-aminobutyrate transaminase activity,MF,
4841,GO:0014053,1.00000000000603,0.880122816989021,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
7683,GO:0032144,1.00000000000603,0.880122816989021,0,1,4-aminobutyrate transaminase complex,CC,
7684,GO:0032145,1.00000000000603,0.880122816989021,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8452,GO:0033602,1.00000000000603,0.880122816989021,0,1,negative regulation of dopamine secretion,BP,
8725,GO:0034386,1.00000000000603,0.880122816989021,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
11965,GO:0047298,1.00000000000603,0.880122816989021,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
14311,GO:0061528,1.00000000000603,0.880122816989021,0,1,aspartate secretion,BP,
18817,GO:1904448,1.00000000000603,0.880122816989021,0,1,regulation of aspartate secretion,BP,
18818,GO:1904450,1.00000000000603,0.880122816989021,0,1,positive regulation of aspartate secretion,BP,
801,GO:0002071,1.00000000000604,0.774947661035824,0,2,glandular epithelial cell maturation,BP,
6989,GO:0030678,1.00000000000605,0.692749372692728,0,3,mitochondrial ribonuclease P complex,CC,
16705,GO:0097745,1.00000000000605,0.692749372692728,0,3,mitochondrial tRNA 5'-end processing,BP,
15765,GO:0072414,1.00000000000605,0.879726285145413,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15772,GO:0072432,1.00000000000605,0.879726285145413,0,1,response to G1 DNA damage checkpoint signaling,BP,
18039,GO:1902626,1.00000000000606,0.71204624163163,0,3,assembly of large subunit precursor of preribosome,BP,
5382,GO:0016212,1.00000000000607,0.775512836627618,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9480,GO:0036137,1.00000000000607,0.775512836627618,0,2,kynurenine aminotransferase activity,MF,
16390,GO:0097052,1.00000000000607,0.775512836627618,0,2,L-kynurenine metabolic process,BP,
17056,GO:0099606,1.00000000000611,0.878717698193771,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17057,GO:0099607,1.00000000000611,0.878717698193771,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
10966,GO:0044778,1.00000000000612,0.775655710856985,0,2,meiotic DNA integrity checkpoint,BP,
14672,GO:0070320,1.00000000000614,0.88035349103166,0,1,inward rectifier potassium channel inhibitor activity,MF,
17342,GO:1900085,1.00000000000614,0.88035349103166,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18459,GO:1903596,1.00000000000614,0.88035349103166,0,1,regulation of gap junction assembly,BP,
18460,GO:1903598,1.00000000000614,0.88035349103166,0,1,positive regulation of gap junction assembly,BP,
18463,GO:1903609,1.00000000000614,0.88035349103166,0,1,negative regulation of inward rectifier potassium channel activity,BP,
4213,GO:0009383,1.00000000000614,0.774809849829734,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
17684,GO:1901622,1.00000000000615,0.880376769564376,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
16381,GO:0097036,1.00000000000616,0.886391022859434,0,1,regulation of plasma membrane sterol distribution,BP,
8951,GO:0035034,1.00000000000617,0.775733267859006,0,2,histone acetyltransferase regulator activity,MF,
1892,GO:0004578,1.00000000000622,0.880163937505737,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
6046,GO:0019187,1.00000000000622,0.880163937505737,0,1,beta-1,4-mannosyltransferase activity,MF,
12739,GO:0051032,1.00000000000622,0.880163937505737,0,1,nucleic acid transmembrane transporter activity,MF,
12740,GO:0051033,1.00000000000622,0.880163937505737,0,1,RNA transmembrane transporter activity,MF,
2884,GO:0006391,1.00000000000622,0.685318175539422,0,3,transcription initiation from mitochondrial promoter,BP,
4402,GO:0010157,1.00000000000622,0.879319372442775,0,1,response to chlorate,BP,
16419,GO:0097108,1.00000000000622,0.879319372442775,0,1,hedgehog family protein binding,MF,
7535,GO:0031826,1.00000000000623,0.687368172480799,0,3,type 2A serotonin receptor binding,MF,
5106,GO:0015420,1.00000000000625,0.879965613680987,0,1,cobalamin-transporting ATPase activity,MF,
5108,GO:0015431,1.00000000000625,0.879965613680987,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
8829,GO:0034634,1.00000000000625,0.879965613680987,0,1,glutathione transmembrane transporter activity,MF,
8916,GO:0034775,1.00000000000625,0.879965613680987,0,1,glutathione transmembrane transport,BP,
9115,GO:0035443,1.00000000000625,0.879965613680987,0,1,tripeptide transmembrane transport,BP,
10216,GO:0042937,1.00000000000625,0.879965613680987,0,1,tripeptide transmembrane transporter activity,MF,
11745,GO:0046623,1.00000000000625,0.879965613680987,0,1,sphingolipid-translocating ATPase activity,MF,
15529,GO:0071997,1.00000000000625,0.879965613680987,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16954,GO:0099039,1.00000000000625,0.879965613680987,0,1,sphingolipid translocation,BP,
1189,GO:0002836,1.00000000000627,0.682286782075331,0,3,positive regulation of response to tumor cell,BP,
1192,GO:0002839,1.00000000000627,0.682286782075331,0,3,positive regulation of immune response to tumor cell,BP,
9623,GO:0036506,1.00000000000631,0.682061834200363,0,3,maintenance of unfolded protein,BP,
18784,GO:1904378,1.00000000000631,0.682061834200363,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
6829,GO:0030299,1.00000000000632,0.687458734861114,0,3,intestinal cholesterol absorption,BP,
10765,GO:0044241,1.00000000000632,0.687458734861114,0,3,lipid digestion,BP,
16875,GO:0098856,1.00000000000632,0.687458734861114,0,3,intestinal lipid absorption,BP,
6366,GO:0021557,1.00000000000633,0.780102843474682,0,2,oculomotor nerve development,BP,
15592,GO:0072106,1.00000000000635,0.696462501444853,0,3,regulation of ureteric bud formation,BP,
15593,GO:0072107,1.00000000000635,0.696462501444853,0,3,positive regulation of ureteric bud formation,BP,
19165,GO:1905278,1.00000000000635,0.696462501444853,0,3,positive regulation of epithelial tube formation,BP,
1778,GO:0004395,1.00000000000635,0.88872989573171,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3821,GO:0008425,1.00000000000635,0.88872989573171,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3951,GO:0008689,1.00000000000635,0.88872989573171,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4450,GO:0010420,1.00000000000635,0.88872989573171,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4647,GO:0010795,1.00000000000635,0.88872989573171,0,1,regulation of ubiquinone biosynthetic process,BP,
6945,GO:0030580,1.00000000000635,0.88872989573171,0,1,quinone cofactor methyltransferase activity,MF,
10919,GO:0044595,1.00000000000635,0.88872989573171,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10920,GO:0044596,1.00000000000635,0.88872989573171,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
13140,GO:0051750,1.00000000000635,0.88872989573171,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14316,GO:0061542,1.00000000000635,0.88872989573171,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
10116,GO:0042670,1.00000000000637,0.682078827707047,0,3,retinal cone cell differentiation,BP,
11716,GO:0046549,1.00000000000637,0.682078827707047,0,3,retinal cone cell development,BP,
6998,GO:0030690,1.00000000000637,0.880338984231823,0,1,Noc1p-Noc2p complex,CC,
6999,GO:0030691,1.00000000000637,0.880338984231823,0,1,Noc2p-Noc3p complex,CC,
16248,GO:0090341,1.00000000000638,0.884963161824021,0,1,negative regulation of secretion of lysosomal enzymes,BP,
9369,GO:0035915,1.00000000000638,0.881402869025683,0,1,pore formation in membrane of other organism,BP,
19857,GO:2000374,1.00000000000638,0.881402869025683,0,1,regulation of oxygen metabolic process,BP,
17836,GO:1902093,1.00000000000638,0.702938711289309,0,3,positive regulation of flagellated sperm motility,BP,
14008,GO:0060763,1.00000000000639,0.774783542327365,0,2,mammary duct terminal end bud growth,BP,
4208,GO:0009360,1.0000000000064,0.880349256767819,0,1,DNA polymerase III complex,CC,
6433,GO:0021730,1.00000000000641,0.879099186966097,0,1,trigeminal sensory nucleus development,BP,
6434,GO:0021740,1.00000000000641,0.879099186966097,0,1,principal sensory nucleus of trigeminal nerve development,BP,
14183,GO:0061141,1.00000000000641,0.879099186966097,0,1,lung ciliated cell differentiation,BP,
20086,GO:2000795,1.00000000000641,0.879099186966097,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
12488,GO:0050652,1.00000000000641,0.880196084813866,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12489,GO:0050653,1.00000000000641,0.880196084813866,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
9146,GO:0035514,1.00000000000641,0.696194694581403,0,3,DNA demethylase activity,MF,
1606,GO:0004031,1.00000000000642,0.880122799288704,0,1,aldehyde oxidase activity,MF,
5589,GO:0016623,1.00000000000642,0.880122799288704,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
17144,GO:0102797,1.00000000000642,0.880122799288704,0,1,geranial:oxygen oxidoreductase activity,MF,
17145,GO:0102798,1.00000000000642,0.880122799288704,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
9622,GO:0036505,1.00000000000642,0.880324501332042,0,1,prosaposin receptor activity,MF,
4608,GO:0010730,1.00000000000642,0.682200576892051,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
9327,GO:0035844,1.00000000000643,0.683878279430982,0,3,cloaca development,BP,
5390,GO:0016232,1.00000000000643,0.880338731247713,0,1,HNK-1 sulfotransferase activity,MF,
5989,GO:0018993,1.00000000000643,0.88032927910177,0,1,somatic sex determination,BP,
6029,GO:0019101,1.00000000000643,0.88032927910177,0,1,female somatic sex determination,BP,
13527,GO:0060014,1.00000000000643,0.88032927910177,0,1,granulosa cell differentiation,BP,
15557,GO:0072053,1.00000000000644,0.774757746259551,0,2,renal inner medulla development,BP,
15558,GO:0072054,1.00000000000644,0.774757746259551,0,2,renal outer medulla development,BP,
20109,GO:2000832,1.00000000000644,0.774631590443568,0,2,negative regulation of steroid hormone secretion,BP,
20116,GO:2000847,1.00000000000644,0.774631590443568,0,2,negative regulation of corticosteroid hormone secretion,BP,
20119,GO:2000850,1.00000000000644,0.774631590443568,0,2,negative regulation of glucocorticoid secretion,BP,
3348,GO:0007079,1.00000000000644,0.680802581375065,0,3,mitotic chromosome movement towards spindle pole,BP,
6960,GO:0030622,1.00000000000645,0.682492136074288,0,3,U4atac snRNA binding,MF,
4808,GO:0014004,1.00000000000645,0.774825559580953,0,2,microglia differentiation,BP,
4809,GO:0014005,1.00000000000645,0.774825559580953,0,2,microglia development,BP,
3418,GO:0007206,1.00000000000646,0.88013740873995,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
15423,GO:0071765,1.00000000000646,0.88013740873995,0,1,nuclear inner membrane organization,BP,
6785,GO:0030233,1.00000000000646,0.884100656806705,0,1,deoxynucleotide transmembrane transporter activity,MF,
6831,GO:0030302,1.00000000000646,0.884100656806705,0,1,deoxynucleotide transport,BP,
7131,GO:0030974,1.00000000000646,0.884100656806705,0,1,thiamine pyrophosphate transmembrane transport,BP,
15052,GO:0071045,1.00000000000646,0.884100656806705,0,1,nuclear histone mRNA catabolic process,BP,
15356,GO:0071629,1.00000000000646,0.884100656806705,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16277,GO:0090422,1.00000000000646,0.884100656806705,0,1,thiamine pyrophosphate transmembrane transporter activity,MF,
978,GO:0002432,1.00000000000647,0.880127893821335,0,1,granuloma formation,BP,
18506,GO:1903723,1.00000000000648,0.894721095418309,0,1,negative regulation of centriole elongation,BP,
1746,GO:0004349,1.0000000000065,0.880240445692833,0,1,glutamate 5-kinase activity,MF,
1747,GO:0004350,1.0000000000065,0.880240445692833,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
3038,GO:0006592,1.0000000000065,0.880240445692833,0,1,ornithine biosynthetic process,BP,
5813,GO:0017084,1.0000000000065,0.880240445692833,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6051,GO:0019202,1.0000000000065,0.880240445692833,0,1,amino acid kinase activity,MF,
9712,GO:0038171,1.00000000000651,0.682216497131679,0,3,cannabinoid signaling pathway,BP,
15506,GO:0071926,1.00000000000651,0.682216497131679,0,3,endocannabinoid signaling pathway,BP,
18742,GO:1904265,1.00000000000651,0.880003297086632,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
397,GO:0001074,1.00000000000651,0.880374570683487,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
403,GO:0001084,1.00000000000651,0.880374570683487,0,1,transcription factor activity, TFIID-class binding,MF,
8422,GO:0033552,1.00000000000651,0.880374570683487,0,1,response to vitamin B3,BP,
2664,GO:0006014,1.00000000000653,0.698498561583772,0,3,D-ribose metabolic process,BP,
16704,GO:0097742,1.00000000000653,0.681775126401946,0,3,de novo centriole assembly,BP,
16729,GO:0098535,1.00000000000653,0.681775126401946,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
3863,GO:0008489,1.00000000000653,0.880330326076963,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
11956,GO:0047263,1.00000000000653,0.880330326076963,0,1,N-acylsphingosine galactosyltransferase activity,MF,
9914,GO:0042275,1.00000000000656,0.885397602251536,0,1,error-free postreplication DNA repair,BP,
15688,GO:0072268,1.00000000000658,0.684144559605602,0,3,pattern specification involved in metanephros development,BP,
4013,GO:0009020,1.00000000000658,0.881794803328059,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13364,GO:0052666,1.00000000000658,0.881794803328059,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17179,GO:0106050,1.00000000000658,0.881794803328059,0,1,tRNA 2'-O-methyltransferase activity,MF,
5992,GO:0019002,1.00000000000658,0.778250444782553,0,2,GMP binding,MF,
14721,GO:0070418,1.00000000000659,0.880121671540085,0,1,DNA-dependent protein kinase complex,CC,
2622,GO:0005943,1.00000000000659,0.774638547445251,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
16673,GO:0097651,1.00000000000659,0.774638547445251,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
17795,GO:1901980,1.0000000000066,0.877297278092395,0,1,positive regulation of inward rectifier potassium channel activity,BP,
9864,GO:0042144,1.00000000000661,0.77485432202303,0,2,vacuole fusion, non-autophagic,BP,
16645,GO:0097576,1.00000000000661,0.77485432202303,0,2,vacuole fusion,BP,
7761,GO:0032290,1.00000000000661,0.663784156101946,0,3,peripheral nervous system myelin formation,BP,
13450,GO:0055011,1.00000000000662,0.88359199668546,0,1,atrial cardiac muscle cell differentiation,BP,
13453,GO:0055014,1.00000000000662,0.88359199668546,0,1,atrial cardiac muscle cell development,BP,
11067,GO:0045085,1.00000000000662,0.883226300904126,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
16813,GO:0098745,1.00000000000662,0.883226300904126,0,1,Dcp1-Dcp2 complex,CC,
17748,GO:1901834,1.00000000000662,0.883226300904126,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17749,GO:1901835,1.00000000000662,0.883226300904126,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18733,GO:1904246,1.00000000000662,0.883226300904126,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
3260,GO:0006931,1.00000000000664,0.690228244190247,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
16710,GO:0097753,1.00000000000665,0.880183885149212,0,1,membrane bending,BP,
19427,GO:1990131,1.00000000000666,0.690390638893914,0,3,Gtr1-Gtr2 GTPase complex,CC,
8637,GO:0034196,1.00000000000666,0.880372475757612,0,1,acylglycerol transport,BP,
8638,GO:0034197,1.00000000000666,0.880372475757612,0,1,triglyceride transport,BP,
10853,GO:0044395,1.00000000000666,0.880372475757612,0,1,protein targeting to vacuolar membrane,BP,
17471,GO:1900483,1.00000000000666,0.880372475757612,0,1,regulation of protein targeting to vacuolar membrane,BP,
13321,GO:0052405,1.00000000000667,0.69628806318586,0,3,negative regulation by host of symbiont molecular function,BP,
17093,GO:0102009,1.00000000000669,0.882149710108731,0,1,proline dipeptidase activity,MF,
2063,GO:0004818,1.0000000000067,0.774645758751163,0,2,glutamate-tRNA ligase activity,MF,
2911,GO:0006424,1.0000000000067,0.774645758751163,0,2,glutamyl-tRNA aminoacylation,BP,
1847,GO:0004513,1.00000000000671,0.880640709857806,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
11963,GO:0047291,1.00000000000671,0.880640709857806,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
17690,GO:1901631,1.00000000000672,0.879203171691555,0,1,positive regulation of presynaptic membrane organization,BP,
18793,GO:1904393,1.00000000000672,0.879203171691555,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18794,GO:1904395,1.00000000000672,0.879203171691555,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
11310,GO:0045654,1.00000000000673,0.780039555073632,0,2,positive regulation of megakaryocyte differentiation,BP,
12029,GO:0047933,1.00000000000675,0.878836662945802,0,1,glucose-1,6-bisphosphate synthase activity,MF,
9481,GO:0036138,1.00000000000676,0.879794678849584,0,1,peptidyl-histidine hydroxylation,BP,
9482,GO:0036139,1.00000000000676,0.879794678849584,0,1,peptidyl-histidine dioxygenase activity,MF,
9483,GO:0036140,1.00000000000676,0.879794678849584,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9905,GO:0042265,1.00000000000676,0.879794678849584,0,1,peptidyl-asparagine hydroxylation,BP,
17097,GO:0102113,1.00000000000676,0.879794678849584,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
6039,GO:0019150,1.00000000000677,0.881337813330745,0,1,D-ribulokinase activity,MF,
10534,GO:0043504,1.00000000000678,0.681925684185069,0,3,mitochondrial DNA repair,BP,
13143,GO:0051765,1.0000000000068,0.77712107249923,0,2,inositol tetrakisphosphate kinase activity,MF,
15986,GO:0086024,1.0000000000068,0.879121834954048,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17294,GO:0140200,1.0000000000068,0.879121834954048,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17520,GO:1901078,1.0000000000068,0.879121834954048,0,1,negative regulation of relaxation of muscle,BP,
17777,GO:1901898,1.0000000000068,0.879121834954048,0,1,negative regulation of relaxation of cardiac muscle,BP,
18607,GO:1903929,1.0000000000068,0.880294090551586,0,1,primary palate development,BP,
1789,GO:0004421,1.0000000000068,0.880238086026183,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
4275,GO:0009645,1.0000000000068,0.880238086026183,0,1,response to low light intensity stimulus,BP,
4400,GO:0010142,1.0000000000068,0.880238086026183,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
11788,GO:0046690,1.0000000000068,0.880238086026183,0,1,response to tellurium ion,BP,
18085,GO:1902767,1.0000000000068,0.880238086026183,0,1,isoprenoid biosynthetic process via mevalonate,BP,
19511,GO:1990450,1.00000000000682,0.881221410412117,0,1,linear polyubiquitin binding,MF,
5527,GO:0016509,1.00000000000683,0.682680706030191,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
2685,GO:0006050,1.00000000000684,0.884780447165906,0,1,mannosamine metabolic process,BP,
2686,GO:0006051,1.00000000000684,0.884780447165906,0,1,N-acetylmannosamine metabolic process,BP,
11091,GO:0045127,1.00000000000684,0.884780447165906,0,1,N-acetylglucosamine kinase activity,MF,
7502,GO:0031694,1.00000000000685,0.890872487500094,0,1,alpha-2A adrenergic receptor binding,MF,
14537,GO:0070091,1.00000000000685,0.681933610139388,0,3,glucagon secretion,BP,
14538,GO:0070092,1.00000000000685,0.681933610139388,0,3,regulation of glucagon secretion,BP,
18306,GO:1903294,1.00000000000685,0.77464596568178,0,2,regulation of glutamate secretion, neurotransmission,BP,
18307,GO:1903296,1.00000000000685,0.77464596568178,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
7958,GO:0032574,1.00000000000686,0.880160919711001,0,1,5'-3' RNA helicase activity,MF,
7959,GO:0032575,1.00000000000686,0.880160919711001,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
925,GO:0002322,1.00000000000687,0.774614161532435,0,2,B cell proliferation involved in immune response,BP,
2117,GO:0004909,1.00000000000687,0.776029843950505,0,2,interleukin-1, Type I, activating receptor activity,MF,
5083,GO:0015333,1.00000000000687,0.682029926695293,0,3,peptide:proton symporter activity,MF,
10115,GO:0042668,1.00000000000688,0.787126774152832,0,2,auditory receptor cell fate determination,BP,
20133,GO:2000978,1.00000000000688,0.787126774152832,0,2,negative regulation of forebrain neuron differentiation,BP,
2908,GO:0006421,1.00000000000688,0.682452129495132,0,3,asparaginyl-tRNA aminoacylation,BP,
15743,GO:0072365,1.0000000000069,0.878716448952629,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
4656,GO:0010808,1.0000000000069,0.87996725861033,0,1,positive regulation of synaptic vesicle priming,BP,
10799,GO:0044305,1.0000000000069,0.87996725861033,0,1,calyx of Held,CC,
14430,GO:0061789,1.0000000000069,0.87996725861033,0,1,dense core granule priming,BP,
11884,GO:0046933,1.00000000000691,0.705018120439206,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
11921,GO:0047006,1.00000000000691,0.887112271582629,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11930,GO:0047042,1.00000000000691,0.887112271582629,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12011,GO:0047718,1.00000000000691,0.887112271582629,0,1,indanol dehydrogenase activity,MF,
5268,GO:0015920,1.00000000000692,0.88035148838025,0,1,lipopolysaccharide transport,BP,
7913,GO:0032497,1.00000000000692,0.88035148838025,0,1,detection of lipopolysaccharide,BP,
14766,GO:0070506,1.00000000000692,0.88035148838025,0,1,high-density lipoprotein particle receptor activity,MF,
11181,GO:0045323,1.00000000000692,0.684249914475776,0,3,interleukin-1 receptor complex,CC,
1959,GO:0004671,1.00000000000692,0.88012283849187,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
15002,GO:0070966,1.00000000000693,0.68183134887821,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
18664,GO:1904045,1.00000000000694,0.880850279190715,0,1,cellular response to aldosterone,BP,
8694,GO:0034346,1.00000000000694,0.880313227566147,0,1,positive regulation of type III interferon production,BP,
5539,GO:0016533,1.00000000000694,0.783798880127725,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
16696,GO:0097724,1.00000000000695,0.882569336572607,0,1,sperm flagellum movement,BP,
19223,GO:1905419,1.00000000000695,0.882569336572607,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
5100,GO:0015389,1.00000000000696,0.880820713655479,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5101,GO:0015390,1.00000000000696,0.880820713655479,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5102,GO:0015391,1.00000000000696,0.880820713655479,0,1,nucleobase:cation symporter activity,MF,
18746,GO:1904274,1.00000000000696,0.880820713655479,0,1,tricellular tight junction assembly,BP,
18366,GO:1903420,1.00000000000697,0.879965063352005,0,1,protein localization to endoplasmic reticulum tubular network,BP,
7530,GO:0031798,1.00000000000697,0.87942979621617,0,1,type 1 metabotropic glutamate receptor binding,MF,
14441,GO:0061828,1.00000000000697,0.87942979621617,0,1,apical tubulobulbar complex,CC,
14442,GO:0061829,1.00000000000697,0.87942979621617,0,1,basal tubulobulbar complex,CC,
1140,GO:0002732,1.00000000000698,0.880125814582136,0,1,positive regulation of dendritic cell cytokine production,BP,
7914,GO:0032498,1.00000000000698,0.880125814582136,0,1,detection of muramyl dipeptide,BP,
7915,GO:0032499,1.00000000000698,0.880125814582136,0,1,detection of peptidoglycan,BP,
7916,GO:0032500,1.00000000000698,0.880125814582136,0,1,muramyl dipeptide binding,MF,
19849,GO:2000361,1.00000000000698,0.880125814582136,0,1,regulation of prostaglandin-E synthase activity,BP,
19850,GO:2000363,1.00000000000698,0.880125814582136,0,1,positive regulation of prostaglandin-E synthase activity,BP,
16816,GO:0098749,1.000000000007,0.880123715227792,0,1,cerebellar neuron development,BP,
18080,GO:1902746,1.00000000000701,0.880497998258291,0,1,regulation of lens fiber cell differentiation,BP,
2225,GO:0005129,1.00000000000701,0.897070199273826,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
8550,GO:0034021,1.00000000000701,0.897070199273826,0,1,response to silicon dioxide,BP,
7560,GO:0031930,1.00000000000703,0.886094335389674,0,1,mitochondria-nucleus signaling pathway,BP,
12513,GO:0050682,1.00000000000704,0.772177077808207,0,2,AF-2 domain binding,MF,
6328,GO:0021502,1.00000000000706,0.774663158871448,0,2,neural fold elevation formation,BP,
14713,GO:0070407,1.00000000000707,0.880300812196186,0,1,oxidation-dependent protein catabolic process,BP,
2335,GO:0005365,1.00000000000708,0.770015350418358,0,2,myo-inositol transmembrane transporter activity,MF,
15067,GO:0071105,1.00000000000711,0.880122873046248,0,1,response to interleukin-11,BP,
15176,GO:0071348,1.00000000000711,0.880122873046248,0,1,cellular response to interleukin-11,BP,
1780,GO:0004397,1.00000000000712,0.880295775678157,0,1,histidine ammonia-lyase activity,MF,
2109,GO:0004890,1.00000000000712,0.880295775678157,0,1,GABA-A receptor activity,MF,
2282,GO:0005237,1.00000000000712,0.880295775678157,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
6177,GO:0019556,1.00000000000712,0.880295775678157,0,1,histidine catabolic process to glutamate and formamide,BP,
6178,GO:0019557,1.00000000000712,0.880295775678157,0,1,histidine catabolic process to glutamate and formate,BP,
6617,GO:0022851,1.00000000000712,0.880295775678157,0,1,GABA-gated chloride ion channel activity,MF,
10599,GO:0043606,1.00000000000712,0.880295775678157,0,1,formamide metabolic process,BP,
16978,GO:0099095,1.00000000000712,0.880295775678157,0,1,ligand-gated anion channel activity,MF,
18060,GO:1902710,1.00000000000712,0.880295775678157,0,1,GABA receptor complex,CC,
18061,GO:1902711,1.00000000000712,0.880295775678157,0,1,GABA-A receptor complex,CC,
9132,GO:0035494,1.00000000000713,0.683740792088364,0,3,SNARE complex disassembly,BP,
17428,GO:1900243,1.00000000000714,0.880120556446278,0,1,negative regulation of synaptic vesicle endocytosis,BP,
19121,GO:1905154,1.00000000000714,0.880120556446278,0,1,negative regulation of membrane invagination,BP,
19123,GO:1905161,1.00000000000714,0.880120556446278,0,1,protein localization to phagocytic vesicle,BP,
19124,GO:1905162,1.00000000000714,0.880120556446278,0,1,regulation of phagosome maturation,BP,
19129,GO:1905169,1.00000000000714,0.880120556446278,0,1,regulation of protein localization to phagocytic vesicle,BP,
19130,GO:1905171,1.00000000000714,0.880120556446278,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19248,GO:1905468,1.00000000000714,0.880120556446278,0,1,regulation of clathrin-coated pit assembly,BP,
19249,GO:1905469,1.00000000000714,0.880120556446278,0,1,negative regulation of clathrin-coated pit assembly,BP,
1910,GO:0004605,1.00000000000714,0.6820721004972,0,3,phosphatidate cytidylyltransferase activity,MF,
16428,GO:0097118,1.00000000000715,0.879801872535138,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
1316,GO:0003166,1.00000000000718,0.880122930065052,0,1,bundle of His development,BP,
1317,GO:0003167,1.00000000000718,0.880122930065052,0,1,atrioventricular bundle cell differentiation,BP,
13907,GO:0060596,1.00000000000718,0.880122930065052,0,1,mammary placode formation,BP,
14073,GO:0060932,1.00000000000718,0.880122930065052,0,1,His-Purkinje system cell differentiation,BP,
779,GO:0002038,1.00000000000718,0.880726532911795,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4712,GO:0010879,1.00000000000718,0.880726532911795,0,1,cholesterol transport involved in cholesterol storage,BP,
9076,GO:0035352,1.00000000000718,0.880726532911795,0,1,NAD transmembrane transport,BP,
10321,GO:0043132,1.00000000000718,0.880726532911795,0,1,NAD transport,BP,
10928,GO:0044610,1.00000000000718,0.880726532911795,0,1,FMN transmembrane transporter activity,MF,
13128,GO:0051724,1.00000000000718,0.880726532911795,0,1,NAD transmembrane transporter activity,MF,
8060,GO:0032741,1.0000000000072,0.774723412396779,0,2,positive regulation of interleukin-18 production,BP,
12020,GO:0047800,1.0000000000072,0.880196914320055,0,1,cysteamine dioxygenase activity,MF,
585,GO:0001740,1.0000000000072,0.68267775779074,0,3,Barr body,CC,
9613,GO:0036494,1.00000000000722,0.880106281005425,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
16621,GO:0097513,1.00000000000722,0.680475828860604,0,3,myosin II filament,CC,
7995,GO:0032632,1.00000000000725,0.775045039571163,0,2,interleukin-3 production,BP,
8019,GO:0032672,1.00000000000725,0.775045039571163,0,2,regulation of interleukin-3 production,BP,
17470,GO:1900477,1.00000000000726,0.881266036371943,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
1824,GO:0004482,1.00000000000726,0.880015319369782,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
7423,GO:0031533,1.00000000000726,0.880015319369782,0,1,mRNA cap methyltransferase complex,CC,
17164,GO:0106005,1.00000000000726,0.880015319369782,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
15014,GO:0070985,1.00000000000729,0.785430485819796,0,2,TFIIK complex,CC,
8669,GO:0034274,1.00000000000729,0.681860136600492,0,3,Atg12-Atg5-Atg16 complex,CC,
12370,GO:0048817,1.00000000000731,0.774615672730182,0,2,negative regulation of hair follicle maturation,BP,
8313,GO:0033167,1.00000000000731,0.87705718532563,0,1,ARC complex,CC,
8314,GO:0033168,1.00000000000731,0.87705718532563,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
9571,GO:0036404,1.00000000000731,0.87705718532563,0,1,conversion of ds siRNA to ss siRNA,BP,
3981,GO:0008832,1.00000000000735,0.880288449829133,0,1,dGTPase activity,MF,
5675,GO:0016793,1.00000000000735,0.880288449829133,0,1,triphosphoric monoester hydrolase activity,MF,
7952,GO:0032560,1.00000000000735,0.880288449829133,0,1,guanyl deoxyribonucleotide binding,MF,
7955,GO:0032567,1.00000000000735,0.880288449829133,0,1,dGTP binding,MF,
14337,GO:0061580,1.00000000000735,0.880144443400943,0,1,colon epithelial cell migration,BP,
14925,GO:0070843,1.00000000000735,0.880144443400943,0,1,misfolded protein transport,BP,
14926,GO:0070844,1.00000000000735,0.880144443400943,0,1,polyubiquitinated protein transport,BP,
14927,GO:0070845,1.00000000000735,0.880144443400943,0,1,polyubiquitinated misfolded protein transport,BP,
14928,GO:0070846,1.00000000000735,0.880144443400943,0,1,Hsp90 deacetylation,BP,
19466,GO:1990275,1.00000000000736,0.880332140850774,0,1,preribosome binding,MF,
3866,GO:0008495,1.00000000000736,0.880318537735097,0,1,protoheme IX farnesyltransferase activity,MF,
12060,GO:0048033,1.00000000000736,0.880318537735097,0,1,heme o metabolic process,BP,
12061,GO:0048034,1.00000000000736,0.880318537735097,0,1,heme O biosynthetic process,BP,
11431,GO:0045903,1.00000000000738,0.704147570379678,0,3,positive regulation of translational fidelity,BP,
12605,GO:0050816,1.00000000000742,0.691703526169681,0,3,phosphothreonine residue binding,MF,
14407,GO:0061739,1.00000000000743,0.68196268334188,0,3,protein lipidation involved in autophagosome assembly,BP,
13921,GO:0060623,1.00000000000743,0.682813841837362,0,3,regulation of chromosome condensation,BP,
5051,GO:0015252,1.00000000000744,0.880301892994291,0,1,proton channel activity,MF,
9116,GO:0035445,1.00000000000744,0.880301892994291,0,1,borate transmembrane transport,BP,
11799,GO:0046713,1.00000000000744,0.880301892994291,0,1,borate transport,BP,
11800,GO:0046715,1.00000000000744,0.880301892994291,0,1,active borate transmembrane transporter activity,MF,
15928,GO:0075519,1.00000000000744,0.898715470712525,0,1,microtubule-dependent intracellular transport of viral material,BP,
15929,GO:0075521,1.00000000000744,0.898715470712525,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15933,GO:0075606,1.00000000000744,0.898715470712525,0,1,transport of viral material towards nucleus,BP,
9344,GO:0035870,1.00000000000745,0.784386252946306,0,2,dITP diphosphatase activity,MF,
587,GO:0001743,1.00000000000745,0.681740348743458,0,3,optic placode formation,BP,
3987,GO:0008887,1.00000000000745,0.880282070223028,0,1,glycerate kinase activity,MF,
943,GO:0002357,1.00000000000747,0.880342799612624,0,1,defense response to tumor cell,BP,
18387,GO:1903445,1.00000000000747,0.692354660105338,0,3,protein transport from ciliary membrane to plasma membrane,BP,
1822,GO:0004478,1.00000000000747,0.880338303615645,0,1,methionine adenosyltransferase activity,MF,
1900,GO:0004588,1.00000000000749,0.88035614074937,0,1,orotate phosphoribosyltransferase activity,MF,
1901,GO:0004590,1.00000000000749,0.88035614074937,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
10804,GO:0044313,1.00000000000754,0.68096440528814,0,3,protein K6-linked deubiquitination,BP,
2177,GO:0005025,1.00000000000755,0.681766539951766,0,3,transforming growth factor beta receptor activity, type I,MF,
5076,GO:0015317,1.00000000000756,0.883735286085029,0,1,phosphate:proton symporter activity,MF,
9123,GO:0035469,1.00000000000756,0.880116616156194,0,1,determination of pancreatic left/right asymmetry,BP,
15498,GO:0071908,1.00000000000756,0.880116616156194,0,1,determination of intestine left/right asymmetry,BP,
15499,GO:0071909,1.00000000000756,0.880116616156194,0,1,determination of stomach left/right asymmetry,BP,
19733,GO:2000167,1.00000000000756,0.880116616156194,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
169,GO:0000354,1.00000000000756,0.774322093867693,0,2,cis assembly of pre-catalytic spliceosome,BP,
9697,GO:0038124,1.00000000000757,0.774681614284694,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10025,GO:0042494,1.00000000000757,0.774681614284694,0,2,detection of bacterial lipoprotein,BP,
10027,GO:0042496,1.00000000000757,0.774681614284694,0,2,detection of diacyl bacterial lipopeptide,BP,
14684,GO:0070340,1.00000000000757,0.774681614284694,0,2,detection of bacterial lipopeptide,BP,
15415,GO:0071724,1.00000000000757,0.774681614284694,0,2,response to diacyl bacterial lipopeptide,BP,
15417,GO:0071726,1.00000000000757,0.774681614284694,0,2,cellular response to diacyl bacterial lipopeptide,BP,
18566,GO:1903850,1.00000000000758,0.880355184828466,0,1,regulation of cristae formation,BP,
18567,GO:1903852,1.00000000000758,0.880355184828466,0,1,positive regulation of cristae formation,BP,
18849,GO:1904542,1.00000000000758,0.880355184828466,0,1,regulation of free ubiquitin chain polymerization,BP,
18850,GO:1904544,1.00000000000758,0.880355184828466,0,1,positive regulation of free ubiquitin chain polymerization,BP,
19010,GO:1904881,1.00000000000758,0.880355184828466,0,1,cellular response to hydrogen sulfide,BP,
1770,GO:0004378,1.00000000000758,0.880329943055091,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
17136,GO:0102704,1.00000000000758,0.880329943055091,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
14412,GO:0061749,1.00000000000758,0.774579314862111,0,2,forked DNA-dependent helicase activity,MF,
14449,GO:0061849,1.00000000000758,0.774579314862111,0,2,telomeric G-quadruplex DNA binding,MF,
12582,GO:0050785,1.00000000000759,0.887665382881513,0,1,advanced glycation end-product receptor activity,MF,
18878,GO:1904596,1.00000000000759,0.887665382881513,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18879,GO:1904597,1.00000000000759,0.887665382881513,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18880,GO:1904599,1.00000000000759,0.887665382881513,0,1,advanced glycation end-product binding,MF,
18881,GO:1904603,1.00000000000759,0.887665382881513,0,1,regulation of advanced glycation end-product receptor activity,BP,
18882,GO:1904604,1.00000000000759,0.887665382881513,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19136,GO:1905204,1.00000000000759,0.887665382881513,0,1,negative regulation of connective tissue replacement,BP,
4537,GO:0010615,1.00000000000759,0.880123435575799,0,1,positive regulation of cardiac muscle adaptation,BP,
18289,GO:1903244,1.00000000000759,0.880123435575799,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19137,GO:1905205,1.00000000000759,0.880123435575799,0,1,positive regulation of connective tissue replacement,BP,
17430,GO:1900245,1.00000000000759,0.680513667934064,0,3,positive regulation of MDA-5 signaling pathway,BP,
1572,GO:0003983,1.00000000000759,0.881038652830162,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
13139,GO:0051748,1.00000000000759,0.881038652830162,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
12963,GO:0051391,1.00000000000761,0.880161973478509,0,1,tRNA acetylation,BP,
12964,GO:0051392,1.00000000000761,0.880161973478509,0,1,tRNA N-acetyltransferase activity,MF,
18974,GO:1904812,1.00000000000761,0.880161973478509,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19624,GO:1990882,1.00000000000761,0.880161973478509,0,1,rRNA acetylation,BP,
19625,GO:1990883,1.00000000000761,0.880161973478509,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19626,GO:1990884,1.00000000000761,0.880161973478509,0,1,RNA acetylation,BP,
5818,GO:0017095,1.00000000000762,0.774644948838386,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
15740,GO:0072362,1.00000000000762,0.879241232859648,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
3975,GO:0008803,1.00000000000764,0.893216469719024,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
6823,GO:0030292,1.00000000000766,0.684006231827196,0,3,protein tyrosine kinase inhibitor activity,MF,
2163,GO:0004999,1.00000000000768,0.880340208631829,0,1,vasoactive intestinal polypeptide receptor activity,MF,
4379,GO:0010034,1.00000000000769,0.880228315452033,0,1,response to acetate,BP,
12006,GO:0047685,1.00000000000769,0.885564473053463,0,1,amine sulfotransferase activity,MF,
8429,GO:0033560,1.00000000000772,0.880166816366262,0,1,folate reductase activity,MF,
13189,GO:0051870,1.00000000000772,0.880166816366262,0,1,methotrexate binding,MF,
9509,GO:0036228,1.00000000000773,0.775002213708127,0,2,protein localization to nuclear inner membrane,BP,
6307,GO:0019957,1.00000000000773,0.777463347127226,0,2,C-C chemokine binding,MF,
19672,GO:2000035,1.00000000000774,0.687672933657202,0,3,regulation of stem cell division,BP,
5335,GO:0016077,1.00000000000775,0.880052094313957,0,1,snoRNA catabolic process,BP,
9336,GO:0035862,1.00000000000775,0.880052094313957,0,1,dITP metabolic process,BP,
9337,GO:0035863,1.00000000000775,0.880052094313957,0,1,dITP catabolic process,BP,
12660,GO:0050897,1.00000000000775,0.880052094313957,0,1,cobalt ion binding,MF,
16555,GO:0097382,1.00000000000775,0.880052094313957,0,1,deoxynucleoside-diphosphatase activity,MF,
16556,GO:0097383,1.00000000000775,0.880052094313957,0,1,dIDP diphosphatase activity,MF,
17691,GO:1901639,1.00000000000775,0.880052094313957,0,1,XDP catabolic process,BP,
17692,GO:1901640,1.00000000000775,0.880052094313957,0,1,XTP binding,MF,
17693,GO:1901641,1.00000000000775,0.880052094313957,0,1,ITP binding,MF,
19392,GO:1990003,1.00000000000775,0.880052094313957,0,1,IDP phosphatase activity,MF,
1558,GO:0003960,1.00000000000775,0.689736467780477,0,3,NADPH:quinone reductase activity,MF,
17775,GO:1901896,1.00000000000775,0.780177331536673,0,2,positive regulation of calcium-transporting ATPase activity,BP,
16762,GO:0098625,1.00000000000777,0.880183575467591,0,1,methylselenol reductase activity,MF,
16763,GO:0098626,1.00000000000777,0.880183575467591,0,1,methylseleninic acid reductase activity,MF,
916,GO:0002309,1.00000000000777,0.896096707410108,0,1,T cell proliferation involved in immune response,BP,
18443,GO:1903569,1.00000000000779,0.880549597332137,0,1,positive regulation of protein localization to ciliary membrane,BP,
18789,GO:1904383,1.00000000000779,0.880995904474327,0,1,response to sodium phosphate,BP,
18870,GO:1904585,1.00000000000779,0.880995904474327,0,1,response to putrescine,BP,
18871,GO:1904586,1.00000000000779,0.880995904474327,0,1,cellular response to putrescine,BP,
19608,GO:1990828,1.00000000000779,0.880995904474327,0,1,hepatocyte dedifferentiation,BP,
19759,GO:2000211,1.00000000000779,0.880122640679605,0,1,regulation of glutamate metabolic process,BP,
19760,GO:2000212,1.00000000000779,0.880122640679605,0,1,negative regulation of glutamate metabolic process,BP,
3225,GO:0006880,1.00000000000781,0.701952438297256,0,3,intracellular sequestering of iron ion,BP,
16646,GO:0097577,1.00000000000781,0.701952438297256,0,3,sequestering of iron ion,BP,
17908,GO:1902263,1.00000000000781,0.692813475653452,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
16394,GO:0097058,1.00000000000781,0.882796369030099,0,1,CRLF-CLCF1 complex,CC,
16395,GO:0097059,1.00000000000781,0.882796369030099,0,1,CNTFR-CLCF1 complex,CC,
18633,GO:1903977,1.00000000000781,0.774512371015459,0,2,positive regulation of glial cell migration,BP,
912,GO:0002299,1.00000000000782,0.884946876053703,0,1,alpha-beta intraepithelial T cell differentiation,BP,
913,GO:0002300,1.00000000000782,0.884946876053703,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
914,GO:0002304,1.00000000000782,0.884946876053703,0,1,gamma-delta intraepithelial T cell differentiation,BP,
915,GO:0002305,1.00000000000782,0.884946876053703,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
19898,GO:2000434,1.00000000000783,0.803605583347842,0,2,regulation of protein neddylation,BP,
19899,GO:2000435,1.00000000000783,0.803605583347842,0,2,negative regulation of protein neddylation,BP,
8404,GO:0033477,1.00000000000787,0.881622312619403,0,1,S-methylmethionine metabolic process,BP,
11942,GO:0047150,1.00000000000787,0.881622312619403,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14359,GO:0061627,1.00000000000787,0.881622312619403,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
4091,GO:0009149,1.00000000000788,0.786152023408268,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4147,GO:0009213,1.00000000000788,0.786152023408268,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7948,GO:0032556,1.00000000000788,0.786152023408268,0,2,pyrimidine deoxyribonucleotide binding,MF,
19838,GO:2000346,1.00000000000788,0.774772858434217,0,2,negative regulation of hepatocyte proliferation,BP,
2421,GO:0005597,1.00000000000793,0.880101396762622,0,1,collagen type XVI trimer,CC,
5670,GO:0016785,1.00000000000793,0.880101396762622,0,1,transferase activity, transferring selenium-containing groups,MF,
16761,GO:0098621,1.00000000000793,0.880101396762622,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
20017,GO:2000670,1.00000000000794,0.774509406989629,0,2,positive regulation of dendritic cell apoptotic process,BP,
5971,GO:0018467,1.00000000000794,0.880358629724727,0,1,formaldehyde dehydrogenase activity,MF,
13214,GO:0051903,1.00000000000794,0.880358629724727,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
1620,GO:0004056,1.00000000000795,0.881627037391246,0,1,argininosuccinate lyase activity,MF,
10003,GO:0042450,1.00000000000795,0.881627037391246,0,1,arginine biosynthetic process via ornithine,BP,
6372,GO:0021563,1.00000000000798,0.771372725190276,0,2,glossopharyngeal nerve development,BP,
15886,GO:0072684,1.000000000008,0.880180969073076,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
7303,GO:0031315,1.00000000000801,0.879757493149248,0,1,extrinsic component of mitochondrial outer membrane,CC,
8518,GO:0033823,1.00000000000802,0.880319847885351,0,1,procollagen glucosyltransferase activity,MF,
13131,GO:0051728,1.00000000000802,0.880319847885351,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13132,GO:0051729,1.00000000000802,0.880319847885351,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13640,GO:0060184,1.00000000000802,0.880319847885351,0,1,cell cycle switching,BP,
9517,GO:0036261,1.00000000000802,0.880200430196627,0,1,7-methylguanosine cap hypermethylation,BP,
15085,GO:0071164,1.00000000000802,0.880200430196627,0,1,RNA trimethylguanosine synthase activity,MF,
17879,GO:1902216,1.00000000000805,0.879390284233559,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
8885,GO:0034718,1.0000000000081,0.880115233113135,0,1,SMN-Gemin2 complex,CC,
10124,GO:0042704,1.0000000000081,0.774754001910452,0,2,uterine wall breakdown,BP,
8856,GO:0034670,1.00000000000812,0.877651296276167,0,1,chemotaxis to arachidonic acid,BP,
19315,GO:1905696,1.00000000000814,0.774606300992251,0,2,regulation of polysome binding,BP,
16882,GO:0098871,1.00000000000817,0.883636357873658,0,1,postsynaptic actin cytoskeleton,CC,
17046,GO:0099571,1.00000000000817,0.883636357873658,0,1,postsynaptic cytoskeleton,CC,
11061,GO:0045079,1.00000000000818,0.883808380500232,0,1,negative regulation of chemokine biosynthetic process,BP,
14041,GO:0060846,1.00000000000819,0.682427362810139,0,3,blood vessel endothelial cell fate commitment,BP,
14042,GO:0060847,1.00000000000819,0.682427362810139,0,3,endothelial cell fate specification,BP,
16413,GO:0097101,1.00000000000819,0.682427362810139,0,3,blood vessel endothelial cell fate specification,BP,
13949,GO:0060685,1.00000000000819,0.683880068336206,0,3,regulation of prostatic bud formation,BP,
13950,GO:0060686,1.00000000000819,0.683880068336206,0,3,negative regulation of prostatic bud formation,BP,
6457,GO:0021784,1.0000000000082,0.899054409679961,0,1,postganglionic parasympathetic fiber development,BP,
8444,GO:0033593,1.0000000000082,0.87551710174956,0,1,BRCA2-MAGE-D1 complex,CC,
10756,GO:0044220,1.00000000000821,0.880122823582683,0,1,host cell perinuclear region of cytoplasm,CC,
2337,GO:0005367,1.00000000000822,0.875269950659579,0,1,myo-inositol:sodium symporter activity,MF,
2962,GO:0006500,1.00000000000823,0.881063916770039,0,1,N-terminal protein palmitoylation,BP,
5874,GO:0018009,1.00000000000823,0.881063916770039,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
4126,GO:0009189,1.00000000000823,0.700332619919782,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
10956,GO:0044753,1.00000000000824,0.880330271553801,0,1,amphisome,CC,
18680,GO:1904106,1.00000000000824,0.880330271553801,0,1,protein localization to microvillus,BP,
19051,GO:1904970,1.00000000000824,0.880330271553801,0,1,brush border assembly,BP,
8221,GO:0032996,1.00000000000828,0.882321865853488,0,1,Bcl3-Bcl10 complex,CC,
11064,GO:0045082,1.00000000000828,0.882321865853488,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
7382,GO:0031443,1.0000000000083,0.87980642599042,0,1,fast-twitch skeletal muscle fiber contraction,BP,
17327,GO:1900042,1.00000000000832,0.772494543426363,0,2,positive regulation of interleukin-2 secretion,BP,
14392,GO:0061709,1.00000000000832,0.879881685366507,0,1,reticulophagy,BP,
15589,GO:0072102,1.00000000000832,0.683128135000196,0,3,glomerulus morphogenesis,BP,
10220,GO:0042942,1.00000000000833,0.880377146377169,0,1,D-serine transport,BP,
11078,GO:0045105,1.00000000000833,0.880219894145434,0,1,intermediate filament polymerization or depolymerization,BP,
18610,GO:1903937,1.00000000000833,0.880219894145434,0,1,response to acrylamide,BP,
528,GO:0001640,1.00000000000835,0.880029592873034,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
529,GO:0001642,1.00000000000835,0.880029592873034,0,1,group III metabotropic glutamate receptor activity,MF,
3411,GO:0007196,1.00000000000835,0.880029592873034,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
9326,GO:0035841,1.00000000000835,0.880029592873034,0,1,new growing cell tip,CC,
16944,GO:0098988,1.00000000000835,0.880029592873034,0,1,G-protein coupled glutamate receptor activity,MF,
8002,GO:0032641,1.00000000000835,0.880304182298298,0,1,lymphotoxin A production,BP,
8073,GO:0032765,1.00000000000835,0.880304182298298,0,1,positive regulation of mast cell cytokine production,BP,
9845,GO:0042109,1.00000000000835,0.880304182298298,0,1,lymphotoxin A biosynthetic process,BP,
1713,GO:0004307,1.00000000000838,0.785328098745506,0,2,ethanolaminephosphotransferase activity,MF,
2810,GO:0006272,1.00000000000838,0.686954539802814,0,3,leading strand elongation,BP,
1245,GO:0002947,1.00000000000841,0.880144189882583,0,1,tumor necrosis factor receptor superfamily complex,CC,
8897,GO:0034750,1.00000000000842,0.774716736753657,0,2,Scrib-APC-beta-catenin complex,CC,
18652,GO:1904026,1.00000000000842,0.775035151451509,0,2,regulation of collagen fibril organization,BP,
18999,GO:1904868,1.00000000000842,0.769958776228821,0,2,telomerase catalytic core complex assembly,BP,
19011,GO:1904882,1.00000000000842,0.769958776228821,0,2,regulation of telomerase catalytic core complex assembly,BP,
19012,GO:1904884,1.00000000000842,0.769958776228821,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
13516,GO:0060002,1.00000000000843,0.770529473497133,0,2,plus-end directed microfilament motor activity,MF,
19877,GO:2000402,1.00000000000843,0.681891707049956,0,3,negative regulation of lymphocyte migration,BP,
7771,GO:0032304,1.00000000000847,0.880122644111325,0,1,negative regulation of icosanoid secretion,BP,
17378,GO:1900139,1.00000000000847,0.880122644111325,0,1,negative regulation of arachidonic acid secretion,BP,
99,GO:0000210,1.00000000000848,0.880237360296795,0,1,NAD+ diphosphatase activity,MF,
3144,GO:0006742,1.00000000000848,0.880237360296795,0,1,NADP catabolic process,BP,
6113,GO:0019364,1.00000000000848,0.880237360296795,0,1,pyridine nucleotide catabolic process,BP,
6195,GO:0019677,1.00000000000848,0.880237360296795,0,1,NAD catabolic process,BP,
5829,GO:0017116,1.00000000000849,0.682019257443307,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
3964,GO:0008761,1.00000000000849,0.880119404249978,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4214,GO:0009384,1.00000000000849,0.880119404249978,0,1,N-acylmannosamine kinase activity,MF,
19911,GO:2000474,1.0000000000085,0.880151043533512,0,1,regulation of opioid receptor signaling pathway,BP,
496,GO:0001552,1.00000000000851,0.881889348796181,0,1,ovarian follicle atresia,BP,
19846,GO:2000355,1.00000000000851,0.881889348796181,0,1,negative regulation of ovarian follicle development,BP,
1836,GO:0004494,1.00000000000852,0.880323274554934,0,1,methylmalonyl-CoA mutase activity,MF,
4007,GO:0008995,1.00000000000855,0.880373860983233,0,1,ribonuclease E activity,MF,
16185,GO:0090247,1.00000000000855,0.880373860983233,0,1,cell motility involved in somitogenic axis elongation,BP,
16186,GO:0090249,1.00000000000855,0.880373860983233,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17563,GO:1901229,1.00000000000855,0.880373860983233,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17564,GO:1901231,1.00000000000855,0.880373860983233,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17565,GO:1901232,1.00000000000855,0.880373860983233,0,1,regulation of convergent extension involved in axis elongation,BP,
17566,GO:1901233,1.00000000000855,0.880373860983233,0,1,negative regulation of convergent extension involved in axis elongation,BP,
6590,GO:0022614,1.00000000000857,0.681713019557862,0,3,membrane to membrane docking,BP,
6022,GO:0019085,1.00000000000859,0.774738052437492,0,2,early viral transcription,BP,
18491,GO:1903691,1.00000000000861,0.772117728354769,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
1415,GO:0003357,1.00000000000862,0.773327669592388,0,2,noradrenergic neuron differentiation,BP,
10759,GO:0044228,1.00000000000864,0.880122983842179,0,1,host cell surface,CC,
9254,GO:0035691,1.00000000000864,0.888054952254038,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9256,GO:0035693,1.00000000000864,0.888054952254038,0,1,NOS2-CD74 complex,CC,
10107,GO:0042658,1.00000000000864,0.888054952254038,0,1,MHC class II protein binding, via antigen binding groove,MF,
13826,GO:0060455,1.00000000000864,0.695518251859512,0,3,negative regulation of gastric acid secretion,BP,
1681,GO:0004149,1.00000000000867,0.880335488500576,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
5650,GO:0016751,1.00000000000867,0.880335488500576,0,1,S-succinyltransferase activity,MF,
17714,GO:1901676,1.00000000000868,0.880166949697765,0,1,positive regulation of histone H3-K27 acetylation,BP,
16620,GO:0097512,1.00000000000869,0.898834875353782,0,1,cardiac myofibril,CC,
9734,GO:0039019,1.00000000000869,0.774671561729912,0,2,pronephric nephron development,BP,
11046,GO:0045062,1.00000000000871,0.883504416370602,0,1,extrathymic T cell selection,BP,
15037,GO:0071021,1.00000000000871,0.883504416370602,0,1,U2-type post-spliceosomal complex,CC,
14458,GO:0061889,1.00000000000873,0.880120008888382,0,1,negative regulation of astrocyte activation,BP,
18635,GO:1903979,1.00000000000873,0.880120008888382,0,1,negative regulation of microglial cell activation,BP,
858,GO:0002191,1.00000000000874,0.684527794265997,0,3,cap-dependent translational initiation,BP,
2220,GO:0005124,1.00000000000876,0.880505889507798,0,1,scavenger receptor binding,MF,
5419,GO:0016277,1.00000000000876,0.880505889507798,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17746,GO:1901804,1.00000000000876,0.880505889507798,0,1,beta-glucoside metabolic process,BP,
17747,GO:1901805,1.00000000000876,0.880505889507798,0,1,beta-glucoside catabolic process,BP,
18821,GO:1904457,1.00000000000876,0.880505889507798,0,1,positive regulation of neuronal action potential,BP,
16440,GO:0097149,1.00000000000876,0.681968818310272,0,3,centralspindlin complex,CC,
4925,GO:0014886,1.00000000000877,0.774746175577782,0,2,transition between slow and fast fiber,BP,
13044,GO:0051572,1.00000000000877,0.682742420623175,0,3,negative regulation of histone H3-K4 methylation,BP,
19631,GO:1990910,1.0000000000088,0.696185083985332,0,3,response to hypobaric hypoxia,BP,
12407,GO:0048880,1.00000000000881,0.774785331051111,0,2,sensory system development,BP,
11443,GO:0045918,1.00000000000882,0.799644232038445,0,2,negative regulation of cytolysis,BP,
9226,GO:0035633,1.00000000000883,0.775144895672365,0,2,maintenance of permeability of blood-brain barrier,BP,
18767,GO:1904327,1.00000000000883,0.774568341234781,0,2,protein localization to cytosolic proteasome complex,BP,
18785,GO:1904379,1.00000000000883,0.774568341234781,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
18493,GO:1903699,1.00000000000884,0.874922325078885,0,1,tarsal gland development,BP,
18499,GO:1903709,1.00000000000884,0.874922325078885,0,1,uterine gland development,BP,
5463,GO:0016401,1.00000000000885,0.776241935129805,0,2,palmitoyl-CoA oxidase activity,MF,
1754,GO:0004360,1.00000000000885,0.878718530716284,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
14790,GO:0070548,1.00000000000885,0.878718530716284,0,1,L-glutamine aminotransferase activity,MF,
5346,GO:0016103,1.00000000000886,0.880125050228017,0,1,diterpenoid catabolic process,BP,
5348,GO:0016115,1.00000000000886,0.880125050228017,0,1,terpenoid catabolic process,BP,
8844,GO:0034653,1.00000000000886,0.880125050228017,0,1,retinoic acid catabolic process,BP,
1914,GO:0004610,1.00000000000887,0.881594211076941,0,1,phosphoacetylglucosamine mutase activity,MF,
1801,GO:0004449,1.00000000000889,0.689385802799356,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
17110,GO:0102339,1.00000000000891,0.880394831085438,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17111,GO:0102340,1.00000000000891,0.880394831085438,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17112,GO:0102341,1.00000000000891,0.880394831085438,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17113,GO:0102342,1.00000000000891,0.880394831085438,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
3976,GO:0008808,1.00000000000891,0.880183652828923,0,1,cardiolipin synthase activity,MF,
6939,GO:0030572,1.00000000000891,0.880183652828923,0,1,phosphatidyltransferase activity,MF,
10453,GO:0043337,1.00000000000891,0.880183652828923,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
19320,GO:1905711,1.00000000000891,0.880183652828923,0,1,response to phosphatidylethanolamine,BP,
4687,GO:0010845,1.00000000000892,0.880361909065105,0,1,positive regulation of reciprocal meiotic recombination,BP,
1809,GO:0004462,1.00000000000892,0.881396650900571,0,1,lactoylglutathione lyase activity,MF,
369,GO:0000991,1.00000000000895,0.779904270523857,0,2,transcription factor activity, core RNA polymerase II binding,MF,
14082,GO:0060957,1.00000000000896,0.880323583438663,0,1,endocardial cell fate commitment,BP,
14284,GO:0061445,1.00000000000896,0.880323583438663,0,1,endocardial cushion cell fate commitment,BP,
18829,GO:1904481,1.00000000000897,0.880450931604999,0,1,response to tetrahydrofolate,BP,
18830,GO:1904482,1.00000000000897,0.880450931604999,0,1,cellular response to tetrahydrofolate,BP,
9370,GO:0035921,1.000000000009,0.881199657667412,0,1,desmosome disassembly,BP,
17456,GO:1900387,1.000000000009,0.881199657667412,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
1777,GO:0004394,1.00000000000901,0.88014084592972,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
6230,GO:0019785,1.00000000000903,0.775773337952885,0,2,ISG15-specific protease activity,MF,
10336,GO:0043163,1.00000000000904,0.680280878928314,0,3,cell envelope organization,BP,
11150,GO:0045229,1.00000000000904,0.680280878928314,0,3,external encapsulating structure organization,BP,
13431,GO:0052906,1.00000000000904,0.880119920939446,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
16917,GO:0098926,1.00000000000905,0.879775926219048,0,1,postsynaptic signal transduction,BP,
17022,GO:0099527,1.00000000000905,0.879775926219048,0,1,postsynapse to nucleus signaling pathway,BP,
17371,GO:1900127,1.00000000000905,0.682033507595321,0,3,positive regulation of hyaluronan biosynthetic process,BP,
17652,GO:1901551,1.00000000000907,0.88013840973534,0,1,negative regulation of endothelial cell development,BP,
18244,GO:1903141,1.00000000000907,0.88013840973534,0,1,negative regulation of establishment of endothelial barrier,BP,
2016,GO:0004748,1.00000000000908,0.681969011588878,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2637,GO:0005971,1.00000000000908,0.681969011588878,0,3,ribonucleoside-diphosphate reductase complex,CC,
5638,GO:0016728,1.00000000000908,0.681969011588878,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
14400,GO:0061731,1.00000000000908,0.681969011588878,0,3,ribonucleoside-diphosphate reductase activity,MF,
1933,GO:0004637,1.00000000000908,0.880245075684594,0,1,phosphoribosylamine-glycine ligase activity,MF,
1936,GO:0004641,1.00000000000908,0.880245075684594,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1939,GO:0004644,1.00000000000908,0.880245075684594,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
677,GO:0001888,1.0000000000091,0.774705366924935,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
579,GO:0001732,1.0000000000091,0.776080026185879,0,2,formation of cytoplasmic translation initiation complex,BP,
6821,GO:0030290,1.0000000000091,0.880220963110833,0,1,sphingolipid activator protein activity,MF,
7858,GO:0032428,1.0000000000091,0.880220963110833,0,1,beta-N-acetylgalactosaminidase activity,MF,
7344,GO:0031394,1.00000000000911,0.780474122608412,0,2,positive regulation of prostaglandin biosynthetic process,BP,
20267,GO:2001280,1.00000000000911,0.780474122608412,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
8517,GO:0033814,1.00000000000912,0.886605722747299,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12485,GO:0050632,1.00000000000912,0.886605722747299,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14784,GO:0070538,1.00000000000912,0.886605722747299,0,1,oleic acid binding,MF,
17613,GO:1901373,1.00000000000912,0.886605722747299,0,1,lipid hydroperoxide transport,BP,
16965,GO:0099074,1.00000000000915,0.774943374509372,0,2,mitochondrion to lysosome transport,BP,
16966,GO:0099075,1.00000000000915,0.774943374509372,0,2,mitochondrion-derived vesicle mediated transport,BP,
16385,GO:0097045,1.00000000000918,0.880122869201938,0,1,phosphatidylserine exposure on blood platelet,BP,
17924,GO:1902304,1.00000000000918,0.880122869201938,0,1,positive regulation of potassium ion export,BP,
5451,GO:0016332,1.00000000000919,0.880167754111276,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
15561,GO:0072060,1.00000000000919,0.880167754111276,0,1,outer medullary collecting duct development,BP,
13603,GO:0060124,1.00000000000923,0.774752228734865,0,2,positive regulation of growth hormone secretion,BP,
9096,GO:0035400,1.00000000000926,0.880119329364216,0,1,histone tyrosine kinase activity,MF,
9097,GO:0035401,1.00000000000926,0.880119329364216,0,1,histone kinase activity (H3-Y41 specific),MF,
9102,GO:0035406,1.00000000000926,0.880119329364216,0,1,histone-tyrosine phosphorylation,BP,
9105,GO:0035409,1.00000000000926,0.880119329364216,0,1,histone H3-Y41 phosphorylation,BP,
3988,GO:0008889,1.00000000000927,0.682014520366449,0,3,glycerophosphodiester phosphodiesterase activity,MF,
17131,GO:0102522,1.00000000000927,0.880845267008461,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
2255,GO:0005170,1.00000000000928,0.88011851942321,0,1,neurotrophin TRKC receptor binding,MF,
49,GO:0000103,1.00000000000928,0.689102819490919,0,3,sulfate assimilation,BP,
11780,GO:0046680,1.00000000000928,0.881217759180834,0,1,response to DDT,BP,
20074,GO:2000775,1.00000000000928,0.881217759180834,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
16006,GO:0086057,1.00000000000929,0.880175465200692,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
19442,GO:1990174,1.00000000000929,0.880175465200692,0,1,phosphodiesterase decapping endonuclease activity,MF,
14700,GO:0070376,1.00000000000929,0.880331028947764,0,1,regulation of ERK5 cascade,BP,
14701,GO:0070377,1.00000000000929,0.880331028947764,0,1,negative regulation of ERK5 cascade,BP,
16449,GO:0097158,1.0000000000093,0.884110322432781,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
5126,GO:0015578,1.00000000000931,0.880454406485174,0,1,mannose transmembrane transporter activity,MF,
5184,GO:0015761,1.00000000000931,0.880454406485174,0,1,mannose transmembrane transport,BP,
17335,GO:1900063,1.00000000000933,0.678829721843479,0,3,regulation of peroxisome organization,BP,
19679,GO:2000048,1.00000000000935,0.786833912420142,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
16632,GO:0097534,1.00000000000935,0.774169313971004,0,2,lymphoid lineage cell migration,BP,
16633,GO:0097535,1.00000000000935,0.774169313971004,0,2,lymphoid lineage cell migration into thymus,BP,
4375,GO:0010015,1.00000000000936,0.89708948551229,0,1,root morphogenesis,BP,
4389,GO:0010053,1.00000000000936,0.89708948551229,0,1,root epidermal cell differentiation,BP,
4390,GO:0010054,1.00000000000936,0.89708948551229,0,1,trichoblast differentiation,BP,
6595,GO:0022622,1.00000000000936,0.89708948551229,0,1,root system development,BP,
7525,GO:0031763,1.00000000000936,0.89708948551229,0,1,galanin receptor binding,MF,
7526,GO:0031764,1.00000000000936,0.89708948551229,0,1,type 1 galanin receptor binding,MF,
7527,GO:0031765,1.00000000000936,0.89708948551229,0,1,type 2 galanin receptor binding,MF,
7528,GO:0031766,1.00000000000936,0.89708948551229,0,1,type 3 galanin receptor binding,MF,
12174,GO:0048364,1.00000000000936,0.89708948551229,0,1,root development,BP,
12353,GO:0048764,1.00000000000936,0.89708948551229,0,1,trichoblast maturation,BP,
12354,GO:0048765,1.00000000000936,0.89708948551229,0,1,root hair cell differentiation,BP,
12355,GO:0048767,1.00000000000936,0.89708948551229,0,1,root hair elongation,BP,
13004,GO:0051464,1.00000000000936,0.89708948551229,0,1,positive regulation of cortisol secretion,BP,
15955,GO:0080147,1.00000000000936,0.89708948551229,0,1,root hair cell development,BP,
16307,GO:0090558,1.00000000000936,0.89708948551229,0,1,plant epidermis development,BP,
16325,GO:0090627,1.00000000000936,0.89708948551229,0,1,plant epidermal cell differentiation,BP,
17002,GO:0099402,1.00000000000936,0.89708948551229,0,1,plant organ development,BP,
18029,GO:1902606,1.00000000000936,0.89708948551229,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18030,GO:1902608,1.00000000000936,0.89708948551229,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18121,GO:1902890,1.00000000000936,0.89708948551229,0,1,regulation of root hair elongation,BP,
18122,GO:1902891,1.00000000000936,0.89708948551229,0,1,negative regulation of root hair elongation,BP,
18578,GO:1903888,1.00000000000936,0.89708948551229,0,1,regulation of plant epidermal cell differentiation,BP,
18579,GO:1903889,1.00000000000936,0.89708948551229,0,1,negative regulation of plant epidermal cell differentiation,BP,
19212,GO:1905392,1.00000000000936,0.89708948551229,0,1,plant organ morphogenesis,BP,
19224,GO:1905421,1.00000000000936,0.89708948551229,0,1,regulation of plant organ morphogenesis,BP,
19225,GO:1905422,1.00000000000936,0.89708948551229,0,1,negative regulation of plant organ morphogenesis,BP,
19693,GO:2000067,1.00000000000936,0.89708948551229,0,1,regulation of root morphogenesis,BP,
19793,GO:2000280,1.00000000000936,0.89708948551229,0,1,regulation of root development,BP,
20120,GO:2000851,1.00000000000936,0.89708948551229,0,1,positive regulation of glucocorticoid secretion,BP,
18695,GO:1904170,1.00000000000936,0.880122867716085,0,1,regulation of bleb assembly,BP,
18696,GO:1904172,1.00000000000936,0.880122867716085,0,1,positive regulation of bleb assembly,BP,
12495,GO:0050659,1.00000000000938,0.774580443510239,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
18109,GO:1902856,1.00000000000939,0.774683133041646,0,2,negative regulation of non-motile cilium assembly,BP,
8619,GO:0034150,1.00000000000941,0.880076204373193,0,1,toll-like receptor 6 signaling pathway,BP,
9078,GO:0035355,1.00000000000941,0.880076204373193,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
19440,GO:1990172,1.00000000000941,0.880076204373193,0,1,G-protein coupled receptor catabolic process,BP,
10907,GO:0044539,1.00000000000942,0.681941765625889,0,3,long-chain fatty acid import,BP,
11947,GO:0047186,1.00000000000943,0.880170628054395,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
8481,GO:0033650,1.00000000000944,0.883137347466754,0,1,host cell mitochondrion,CC,
10740,GO:0044190,1.00000000000944,0.883137347466754,0,1,host cell mitochondrial envelope,CC,
15776,GO:0072492,1.00000000000944,0.883137347466754,0,1,host cell mitochondrial intermembrane space,CC,
18648,GO:1904021,1.00000000000947,0.880251150057275,0,1,negative regulation of G-protein coupled receptor internalization,BP,
2616,GO:0005927,1.00000000000947,0.885094583362764,0,1,muscle tendon junction,CC,
8646,GO:0034213,1.00000000000947,0.885094583362764,0,1,quinolinate catabolic process,BP,
11849,GO:0046874,1.00000000000947,0.885094583362764,0,1,quinolinate metabolic process,BP,
15611,GO:0072135,1.00000000000949,0.774721528548666,0,2,kidney mesenchymal cell proliferation,BP,
15612,GO:0072136,1.00000000000949,0.774721528548666,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
6076,GO:0019236,1.00000000000952,0.781701999693143,0,2,response to pheromone,BP,
8390,GO:0033342,1.00000000000952,0.880404030073403,0,1,negative regulation of collagen binding,BP,
8475,GO:0033634,1.00000000000953,0.688994602804754,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
8894,GO:0034729,1.00000000000954,0.688790634574179,0,3,histone H3-K79 methylation,BP,
2321,GO:0005330,1.00000000000958,0.880124833639613,0,1,dopamine:sodium symporter activity,MF,
2323,GO:0005335,1.00000000000958,0.880124833639613,0,1,serotonin:sodium symporter activity,MF,
4847,GO:0014064,1.00000000000958,0.880124833639613,0,1,positive regulation of serotonin secretion,BP,
6240,GO:0019811,1.00000000000958,0.880124833639613,0,1,cocaine binding,MF,
6531,GO:0021941,1.00000000000958,0.880124833639613,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
7397,GO:0031475,1.00000000000958,0.885409018266018,0,1,myosin V complex,CC,
16062,GO:0090067,1.00000000000958,0.880124833639613,0,1,regulation of thalamus size,BP,
1136,GO:0002728,1.00000000000958,0.880126457773237,0,1,negative regulation of natural killer cell cytokine production,BP,
18843,GO:1904529,1.00000000000958,0.774749193406777,0,2,regulation of actin filament binding,BP,
18885,GO:1904616,1.00000000000958,0.774749193406777,0,2,regulation of actin binding,BP,
10801,GO:0044307,1.0000000000096,0.873763449904431,0,1,dendritic branch,CC,
7554,GO:0031905,1.00000000000962,0.692449206412714,0,3,early endosome lumen,CC,
10481,GO:0043400,1.00000000000962,0.789427206064503,0,2,cortisol secretion,BP,
13002,GO:0051462,1.00000000000962,0.789427206064503,0,2,regulation of cortisol secretion,BP,
2790,GO:0006231,1.00000000000964,0.686572312590015,0,3,dTMP biosynthetic process,BP,
11523,GO:0046073,1.00000000000964,0.686572312590015,0,3,dTMP metabolic process,BP,
6337,GO:0021516,1.00000000000966,0.682047417882125,0,3,dorsal spinal cord development,BP,
8267,GO:0033082,1.00000000000968,0.880122816921333,0,1,regulation of extrathymic T cell differentiation,BP,
19556,GO:1990654,1.00000000000968,0.880122816921333,0,1,sebum secreting cell proliferation,BP,
697,GO:0001918,1.00000000000968,0.880340838926162,0,1,farnesylated protein binding,MF,
2796,GO:0006253,1.00000000000968,0.89105093991681,0,1,dCTP catabolic process,BP,
11516,GO:0046065,1.00000000000968,0.89105093991681,0,1,dCTP metabolic process,BP,
12022,GO:0047840,1.00000000000968,0.89105093991681,0,1,dCTP diphosphatase activity,MF,
5871,GO:0017198,1.00000000000968,0.895069966682932,0,1,N-terminal peptidyl-serine acetylation,BP,
5872,GO:0018002,1.00000000000968,0.895069966682932,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7109,GO:0030920,1.00000000000968,0.895069966682932,0,1,peptidyl-serine acetylation,BP,
14450,GO:0061850,1.00000000000968,0.895069966682932,0,1,growth cone leading edge,CC,
15521,GO:0071960,1.00000000000968,0.895069966682932,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19449,GO:1990190,1.00000000000968,0.895069966682932,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20040,GO:2000718,1.00000000000968,0.895069966682932,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20041,GO:2000719,1.00000000000968,0.895069966682932,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
15815,GO:0072554,1.00000000000971,0.880564153820158,0,1,blood vessel lumenization,BP,
17548,GO:1901189,1.00000000000971,0.880564153820158,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17583,GO:1901297,1.00000000000971,0.880564153820158,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19097,GO:1905068,1.00000000000971,0.880564153820158,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
15013,GO:0070984,1.00000000000971,0.880140696052913,0,1,SET domain binding,MF,
17602,GO:1901340,1.00000000000972,0.88014381333251,0,1,negative regulation of store-operated calcium channel activity,BP,
14653,GO:0070292,1.00000000000974,0.880121153654795,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
17105,GO:0102200,1.00000000000974,0.880121153654795,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
8972,GO:0035093,1.00000000000975,0.77422123118888,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
9738,GO:0039502,1.00000000000975,0.880121168959684,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9739,GO:0039503,1.00000000000975,0.880121168959684,0,1,suppression by virus of host innate immune response,BP,
9743,GO:0039514,1.00000000000975,0.880121168959684,0,1,suppression by virus of host JAK-STAT cascade,BP,
9759,GO:0039562,1.00000000000975,0.880121168959684,0,1,suppression by virus of host STAT activity,BP,
9760,GO:0039563,1.00000000000975,0.880121168959684,0,1,suppression by virus of host STAT1 activity,BP,
9761,GO:0039564,1.00000000000975,0.880121168959684,0,1,suppression by virus of host STAT2 activity,BP,
10859,GO:0044414,1.00000000000975,0.880121168959684,0,1,suppression of host defenses,BP,
13180,GO:0051833,1.00000000000975,0.880121168959684,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13272,GO:0052029,1.00000000000975,0.880121168959684,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13274,GO:0052037,1.00000000000975,0.880121168959684,0,1,negative regulation by symbiont of host defense response,BP,
13289,GO:0052167,1.00000000000975,0.880121168959684,0,1,modulation by symbiont of host innate immune response,BP,
13290,GO:0052170,1.00000000000975,0.880121168959684,0,1,negative regulation by symbiont of host innate immune response,BP,
13308,GO:0052261,1.00000000000975,0.880121168959684,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13309,GO:0052306,1.00000000000975,0.880121168959684,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13310,GO:0052309,1.00000000000975,0.880121168959684,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13331,GO:0052493,1.00000000000975,0.880121168959684,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13341,GO:0052561,1.00000000000975,0.880121168959684,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13342,GO:0052562,1.00000000000975,0.880121168959684,0,1,negative regulation by symbiont of host immune response,BP,
15921,GO:0075109,1.00000000000975,0.880121168959684,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15922,GO:0075111,1.00000000000975,0.880121168959684,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15923,GO:0075112,1.00000000000975,0.880121168959684,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15924,GO:0075114,1.00000000000975,0.880121168959684,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
16931,GO:0098968,1.00000000000975,0.880121168959684,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
3638,GO:0008111,1.00000000000977,0.881716591140179,0,1,alpha-methylacyl-CoA racemase activity,MF,
9312,GO:0035801,1.00000000000979,0.777188226746295,0,2,adrenal cortex development,BP,
9313,GO:0035802,1.00000000000979,0.777188226746295,0,2,adrenal cortex formation,BP,
11221,GO:0045416,1.00000000000983,0.774766895736695,0,2,positive regulation of interleukin-8 biosynthetic process,BP,
1546,GO:0003944,1.00000000000986,0.88086040602501,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
13704,GO:0060298,1.00000000000987,0.681999093982866,0,3,positive regulation of sarcomere organization,BP,
11701,GO:0046525,1.00000000000989,0.883359045170279,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
14573,GO:0070159,1.0000000000099,0.880529977595834,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
1766,GO:0004373,1.00000000000991,0.880245347970063,0,1,glycogen (starch) synthase activity,MF,
14317,GO:0061547,1.00000000000991,0.880245347970063,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
2636,GO:0005969,1.00000000000994,0.87919370083744,0,1,serine-pyruvate aminotransferase complex,CC,
5371,GO:0016189,1.00000000000994,0.87919370083744,0,1,synaptic vesicle to endosome fusion,BP,
8325,GO:0033183,1.00000000000994,0.680242038543402,0,3,negative regulation of histone ubiquitination,BP,
17591,GO:1901314,1.00000000000994,0.680242038543402,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17592,GO:1901315,1.00000000000994,0.680242038543402,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
15549,GO:0072038,1.00000000000997,0.774678320920421,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15550,GO:0072039,1.00000000000997,0.774678320920421,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15551,GO:0072040,1.00000000000997,0.774678320920421,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17535,GO:1901145,1.00000000000997,0.774678320920421,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18901,GO:1904673,1.00000000000997,0.774678320920421,0,2,negative regulation of somatic stem cell population maintenance,BP,
2065,GO:0004820,1.00000000000997,0.778735579621042,0,2,glycine-tRNA ligase activity,MF,
2913,GO:0006426,1.00000000000997,0.778735579621042,0,2,glycyl-tRNA aminoacylation,BP,
14572,GO:0070150,1.00000000000997,0.778735579621042,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
18750,GO:1904289,1.00000000000998,0.77478308445177,0,2,regulation of mitotic DNA damage checkpoint,BP,
11102,GO:0045145,1.00000000000999,0.774937178119199,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
1197,GO:0002857,1.00000000001001,0.774788547150492,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1200,GO:0002860,1.00000000001001,0.774788547150492,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
12981,GO:0051430,1.00000000001006,0.776404564440054,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
846,GO:0002169,1.00000000001006,0.774915094315235,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1827,GO:0004485,1.00000000001006,0.774915094315235,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
19134,GO:1905202,1.00000000001006,0.774915094315235,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
12154,GO:0048297,1.00000000001006,0.881070328990723,0,1,negative regulation of isotype switching to IgA isotypes,BP,
7709,GO:0032207,1.00000000001006,0.880330705917422,0,1,regulation of telomere maintenance via recombination,BP,
7710,GO:0032208,1.00000000001006,0.880330705917422,0,1,negative regulation of telomere maintenance via recombination,BP,
18407,GO:1903517,1.00000000001006,0.880330705917422,0,1,negative regulation of single strand break repair,BP,
18528,GO:1903770,1.00000000001006,0.880330705917422,0,1,negative regulation of beta-galactosidase activity,BP,
18550,GO:1903823,1.00000000001006,0.880330705917422,0,1,telomere single strand break repair,BP,
18551,GO:1903824,1.00000000001006,0.880330705917422,0,1,negative regulation of telomere single strand break repair,BP,
552,GO:0001674,1.00000000001007,0.775203865379159,0,2,female germ cell nucleus,CC,
10068,GO:0042585,1.00000000001007,0.775203865379159,0,2,germinal vesicle,CC,
6474,GO:0021823,1.00000000001008,0.774104052894823,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6478,GO:0021827,1.00000000001008,0.774104052894823,0,2,postnatal olfactory bulb interneuron migration,BP,
6481,GO:0021836,1.00000000001008,0.774104052894823,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
8210,GO:0032980,1.00000000001009,0.880491450614929,0,1,keratinocyte activation,BP,
17060,GO:0099617,1.00000000001011,0.880254404544506,0,1,matrix side of mitochondrial inner membrane,CC,
10721,GO:0044105,1.00000000001012,0.896077821416401,0,1,L-xylulose reductase (NAD+) activity,MF,
12414,GO:0050038,1.00000000001012,0.896077821416401,0,1,L-xylulose reductase (NADP+) activity,MF,
1811,GO:0004464,1.00000000001012,0.806503735632657,0,2,leukotriene-C4 synthase activity,MF,
15071,GO:0071109,1.00000000001012,0.771926359225492,0,2,superior temporal gyrus development,BP,
2417,GO:0005592,1.00000000001015,0.879624395418872,0,1,collagen type XI trimer,CC,
15216,GO:0071400,1.00000000001016,0.774871482273897,0,2,cellular response to oleic acid,BP,
619,GO:0001794,1.00000000001016,0.880122078032449,0,1,type IIa hypersensitivity,BP,
620,GO:0001796,1.00000000001016,0.880122078032449,0,1,regulation of type IIa hypersensitivity,BP,
621,GO:0001798,1.00000000001016,0.880122078032449,0,1,positive regulation of type IIa hypersensitivity,BP,
738,GO:0001970,1.00000000001016,0.880122078032449,0,1,positive regulation of activation of membrane attack complex,BP,
988,GO:0002445,1.00000000001016,0.880122078032449,0,1,type II hypersensitivity,BP,
1221,GO:0002892,1.00000000001016,0.880122078032449,0,1,regulation of type II hypersensitivity,BP,
1222,GO:0002894,1.00000000001016,0.880122078032449,0,1,positive regulation of type II hypersensitivity,BP,
7513,GO:0031714,1.00000000001016,0.880122078032449,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7514,GO:0031715,1.00000000001016,0.880122078032449,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
17496,GO:1901004,1.00000000001017,0.888627728815456,0,1,ubiquinone-6 metabolic process,BP,
17497,GO:1901006,1.00000000001017,0.888627728815456,0,1,ubiquinone-6 biosynthetic process,BP,
8948,GO:0035026,1.00000000001018,0.774736192759525,0,2,leading edge cell differentiation,BP,
9643,GO:0038001,1.00000000001019,0.777274278176881,0,2,paracrine signaling,BP,
4944,GO:0014916,1.00000000001022,0.678623875436476,0,3,regulation of lung blood pressure,BP,
3953,GO:0008705,1.00000000001023,0.876662682939009,0,1,methionine synthase activity,MF,
9827,GO:0042084,1.00000000001023,0.876662682939009,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
637,GO:0001827,1.00000000001023,0.77459542104532,0,2,inner cell mass cell fate commitment,BP,
638,GO:0001828,1.00000000001023,0.77459542104532,0,2,inner cell mass cellular morphogenesis,BP,
14021,GO:0060800,1.00000000001024,0.774675324886578,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
14094,GO:0060978,1.00000000001026,0.77475102128687,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
8737,GO:0034402,1.00000000001027,0.774993073738724,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
1517,GO:0003881,1.00000000001027,0.882277831794984,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
14034,GO:0060838,1.00000000001028,0.682086559584226,0,3,lymphatic endothelial cell fate commitment,BP,
8744,GO:0034421,1.00000000001031,0.682299249383224,0,3,post-translational protein acetylation,BP,
16992,GO:0099170,1.00000000001031,0.682061009145877,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17035,GO:0099547,1.00000000001031,0.682061009145877,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17048,GO:0099578,1.00000000001031,0.682061009145877,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
7611,GO:0032010,1.00000000001032,0.68244786777153,0,3,phagolysosome,CC,
9141,GO:0035508,1.00000000001032,0.880105193848304,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
17998,GO:1902528,1.00000000001032,0.878912047454885,0,1,regulation of protein linear polyubiquitination,BP,
17999,GO:1902530,1.00000000001032,0.878912047454885,0,1,positive regulation of protein linear polyubiquitination,BP,
20270,GO:2001288,1.00000000001032,0.878912047454885,0,1,positive regulation of caveolin-mediated endocytosis,BP,
9259,GO:0035697,1.00000000001033,0.778275617294781,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9260,GO:0035698,1.00000000001033,0.778275617294781,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
15885,GO:0072683,1.00000000001033,0.778275617294781,0,2,T cell extravasation,BP,
19882,GO:2000407,1.00000000001033,0.778275617294781,0,2,regulation of T cell extravasation,BP,
19900,GO:2000449,1.00000000001033,0.778275617294781,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19902,GO:2000452,1.00000000001033,0.778275617294781,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
746,GO:0001978,1.00000000001034,0.88092546728277,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
747,GO:0001983,1.00000000001034,0.88092546728277,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
748,GO:0001985,1.00000000001034,0.88092546728277,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
753,GO:0001994,1.00000000001034,0.88092546728277,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
755,GO:0001997,1.00000000001034,0.88092546728277,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1287,GO:0003099,1.00000000001034,0.88092546728277,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2130,GO:0004936,1.00000000001034,0.88092546728277,0,1,alpha-adrenergic receptor activity,MF,
2131,GO:0004937,1.00000000001034,0.88092546728277,0,1,alpha1-adrenergic receptor activity,MF,
18638,GO:1903995,1.00000000001034,0.88092546728277,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18639,GO:1903997,1.00000000001034,0.88092546728277,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
15590,GO:0072103,1.00000000001036,0.776191377048414,0,2,glomerulus vasculature morphogenesis,BP,
15591,GO:0072104,1.00000000001036,0.776191377048414,0,2,glomerular capillary formation,BP,
4376,GO:0010025,1.00000000001037,0.775536845710007,0,2,wax biosynthetic process,BP,
4407,GO:0010166,1.00000000001037,0.775536845710007,0,2,wax metabolic process,BP,
11700,GO:0046523,1.00000000001037,0.880303347179865,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
15939,GO:0080019,1.00000000001037,0.775536845710007,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17149,GO:0102965,1.00000000001037,0.775536845710007,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
1807,GO:0004459,1.0000000000104,0.690492190413459,0,3,L-lactate dehydrogenase activity,MF,
17653,GO:1901552,1.0000000000104,0.774722024285527,0,2,positive regulation of endothelial cell development,BP,
18245,GO:1903142,1.0000000000104,0.774722024285527,0,2,positive regulation of establishment of endothelial barrier,BP,
7543,GO:0031862,1.00000000001041,0.77458550724871,0,2,prostanoid receptor binding,MF,
15522,GO:0071962,1.00000000001042,0.69529524695923,0,3,mitotic sister chromatid cohesion, centromeric,BP,
6444,GO:0021768,1.00000000001047,0.880235184447407,0,1,nucleus accumbens development,BP,
1571,GO:0003980,1.00000000001047,0.771204926199461,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
16542,GO:0097359,1.00000000001047,0.771204926199461,0,2,UDP-glucosylation,BP,
7801,GO:0032361,1.00000000001049,0.881584937662504,0,1,pyridoxal phosphate catabolic process,BP,
10189,GO:0042820,1.00000000001049,0.881584937662504,0,1,vitamin B6 catabolic process,BP,
6212,GO:0019747,1.00000000001049,0.894867616032464,0,1,regulation of isoprenoid metabolic process,BP,
15461,GO:0071847,1.00000000001051,0.774765691919062,0,2,TNFSF11-mediated signaling pathway,BP,
512,GO:0001576,1.00000000001053,0.881225071988096,0,1,globoside biosynthetic process,BP,
1548,GO:0003948,1.00000000001053,0.881225071988096,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12473,GO:0050512,1.00000000001053,0.881225071988096,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
7714,GO:0032213,1.00000000001054,0.774969789327503,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7715,GO:0032214,1.00000000001054,0.774969789327503,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
18847,GO:1904534,1.00000000001054,0.774969789327503,0,2,negative regulation of telomeric loop disassembly,BP,
19335,GO:1905778,1.00000000001054,0.774969789327503,0,2,negative regulation of exonuclease activity,BP,
19346,GO:1905838,1.00000000001054,0.774969789327503,0,2,regulation of telomeric D-loop disassembly,BP,
19347,GO:1905839,1.00000000001054,0.774969789327503,0,2,negative regulation of telomeric D-loop disassembly,BP,
13560,GO:0060053,1.00000000001054,0.774683758958373,0,2,neurofilament cytoskeleton,CC,
12864,GO:0051228,1.00000000001055,0.880121665542231,0,1,mitotic spindle disassembly,BP,
12865,GO:0051230,1.00000000001055,0.880121665542231,0,1,spindle disassembly,BP,
15339,GO:0071603,1.00000000001057,0.774726470663696,0,2,endothelial cell-cell adhesion,BP,
829,GO:0002118,1.00000000001058,0.880247888253414,0,1,aggressive behavior,BP,
830,GO:0002121,1.00000000001058,0.880247888253414,0,1,inter-male aggressive behavior,BP,
9512,GO:0036250,1.00000000001058,0.88196016402832,0,1,peroxisome transport along microtubule,BP,
10946,GO:0044721,1.00000000001058,0.88196016402832,0,1,protein import into peroxisome matrix, substrate release,BP,
2261,GO:0005176,1.00000000001061,0.784117216078639,0,2,ErbB-2 class receptor binding,MF,
4323,GO:0009841,1.00000000001064,0.880563444980474,0,1,mitochondrial endopeptidase Clp complex,CC,
1351,GO:0003221,1.00000000001064,0.876803751024963,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1354,GO:0003226,1.00000000001064,0.876803751024963,0,1,right ventricular compact myocardium morphogenesis,BP,
6363,GO:0021553,1.00000000001064,0.876803751024963,0,1,olfactory nerve development,BP,
6008,GO:0019061,1.00000000001064,0.880706157895747,0,1,uncoating of virus,BP,
4731,GO:0010900,1.00000000001065,0.903555351458112,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
13730,GO:0060332,1.00000000001065,0.680826639414332,0,3,positive regulation of response to interferon-gamma,BP,
13733,GO:0060335,1.00000000001065,0.680826639414332,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
1188,GO:0002835,1.00000000001065,0.775148606962024,0,2,negative regulation of response to tumor cell,BP,
1191,GO:0002838,1.00000000001065,0.775148606962024,0,2,negative regulation of immune response to tumor cell,BP,
1196,GO:0002856,1.00000000001065,0.775148606962024,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1199,GO:0002859,1.00000000001065,0.775148606962024,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
20065,GO:2000759,1.00000000001066,0.880122818521286,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20066,GO:2000761,1.00000000001066,0.880122818521286,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
15324,GO:0071579,1.00000000001067,0.881525792941589,0,1,regulation of zinc ion transport,BP,
15325,GO:0071580,1.00000000001067,0.881525792941589,0,1,regulation of zinc ion transmembrane transport,BP,
15326,GO:0071581,1.00000000001067,0.881525792941589,0,1,regulation of zinc ion transmembrane import,BP,
15327,GO:0071582,1.00000000001067,0.881525792941589,0,1,negative regulation of zinc ion transport,BP,
15328,GO:0071583,1.00000000001067,0.881525792941589,0,1,negative regulation of zinc ion transmembrane transport,BP,
15329,GO:0071584,1.00000000001067,0.881525792941589,0,1,negative regulation of zinc ion transmembrane import,BP,
15330,GO:0071585,1.00000000001067,0.881525792941589,0,1,detoxification of cadmium ion,BP,
19439,GO:1990170,1.00000000001067,0.881525792941589,0,1,stress response to cadmium ion,BP,
3843,GO:0008457,1.00000000001067,0.880144784533107,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
11955,GO:0047256,1.00000000001067,0.880144784533107,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
2819,GO:0006286,1.00000000001068,0.787155077475812,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
18064,GO:1902715,1.00000000001068,0.774589326381232,0,2,positive regulation of interferon-gamma secretion,BP,
4626,GO:0010752,1.00000000001069,0.774580964810673,0,2,regulation of cGMP-mediated signaling,BP,
17193,GO:0106088,1.00000000001069,0.879810946295634,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17194,GO:0106089,1.00000000001069,0.879810946295634,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17240,GO:0120077,1.00000000001069,0.879810946295634,0,1,angiogenic sprout fusion,BP,
17241,GO:0120078,1.00000000001069,0.879810946295634,0,1,cell adhesion involved in sprouting angiogenesis,BP,
4224,GO:0009405,1.0000000000107,0.77454836536515,0,2,pathogenesis,BP,
5518,GO:0016493,1.0000000000107,0.775629752256017,0,2,C-C chemokine receptor activity,MF,
1418,GO:0003365,1.00000000001075,0.680206811706263,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
3555,GO:0007598,1.00000000001077,0.880573513291454,0,1,blood coagulation, extrinsic pathway,BP,
17552,GO:1901202,1.00000000001077,0.880573513291454,0,1,negative regulation of extracellular matrix assembly,BP,
18358,GO:1903394,1.00000000001077,0.880573513291454,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
6369,GO:0021560,1.00000000001077,0.775032773874532,0,2,abducens nerve development,BP,
6388,GO:0021598,1.00000000001077,0.775032773874532,0,2,abducens nerve morphogenesis,BP,
6389,GO:0021599,1.00000000001077,0.775032773874532,0,2,abducens nerve formation,BP,
11652,GO:0046449,1.00000000001083,0.681720862812386,0,3,creatinine metabolic process,BP,
8863,GO:0034683,1.00000000001083,0.879781689644495,0,1,integrin alphav-beta3 complex,CC,
11337,GO:0045715,1.00000000001083,0.879781689644495,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12558,GO:0050748,1.00000000001083,0.879781689644495,0,1,negative regulation of lipoprotein metabolic process,BP,
13282,GO:0052066,1.00000000001083,0.879781689644495,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13292,GO:0052190,1.00000000001083,0.879781689644495,0,1,modulation by symbiont of host phagocytosis,BP,
13293,GO:0052191,1.00000000001083,0.879781689644495,0,1,positive regulation by symbiont of host phagocytosis,BP,
13303,GO:0052231,1.00000000001083,0.879781689644495,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13319,GO:0052370,1.00000000001083,0.879781689644495,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13335,GO:0052522,1.00000000001083,0.879781689644495,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
19934,GO:2000536,1.00000000001083,0.879781689644495,0,1,negative regulation of entry of bacterium into host cell,BP,
15172,GO:0071344,1.00000000001085,0.785657102441652,0,2,diphosphate metabolic process,BP,
1728,GO:0004325,1.00000000001087,0.879633785850204,0,1,ferrochelatase activity,MF,
16256,GO:0090362,1.00000000001088,0.775524941061641,0,2,positive regulation of platelet-derived growth factor production,BP,
3851,GO:0008470,1.0000000000109,0.880123680118574,0,1,isovaleryl-CoA dehydrogenase activity,MF,
809,GO:0002083,1.00000000001095,0.884129697904002,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
11964,GO:0047293,1.00000000001095,0.884129697904002,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
1664,GO:0004127,1.00000000001095,0.774967964809557,0,2,cytidylate kinase activity,MF,
19537,GO:1990578,1.00000000001099,0.880084883681377,0,1,perinuclear endoplasmic reticulum membrane,CC,
1346,GO:0003213,1.00000000001099,0.772797817191479,0,2,cardiac right atrium morphogenesis,BP,
3885,GO:0008523,1.000000000011,0.880270560365298,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
5246,GO:0015878,1.000000000011,0.880270560365298,0,1,biotin transport,BP,
5253,GO:0015887,1.000000000011,0.880270560365298,0,1,pantothenate transmembrane transport,BP,
14028,GO:0060825,1.00000000001101,0.779778286306375,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19814,GO:2000313,1.00000000001101,0.779778286306375,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
1786,GO:0004418,1.00000000001102,0.886009231462449,0,1,hydroxymethylbilane synthase activity,MF,
5908,GO:0018160,1.00000000001102,0.886009231462449,0,1,peptidyl-pyrromethane cofactor linkage,BP,
775,GO:0002032,1.00000000001102,0.777492695445655,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
6615,GO:0022848,1.00000000001103,0.682256203505653,0,3,acetylcholine-gated cation-selective channel activity,MF,
14431,GO:0061792,1.00000000001107,0.880041803881207,0,1,secretory granule maturation,BP,
19520,GO:1990502,1.00000000001107,0.880041803881207,0,1,dense core granule maturation,BP,
8380,GO:0033306,1.00000000001107,0.77654608603106,0,2,phytol metabolic process,BP,
18254,GO:1903173,1.00000000001107,0.77654608603106,0,2,fatty alcohol metabolic process,BP,
892,GO:0002266,1.00000000001108,0.776707493372403,0,2,follicular dendritic cell activation,BP,
893,GO:0002268,1.00000000001108,0.776707493372403,0,2,follicular dendritic cell differentiation,BP,
8354,GO:0033257,1.00000000001108,0.776707493372403,0,2,Bcl3/NF-kappaB2 complex,CC,
6630,GO:0023021,1.00000000001108,0.682580231969664,0,3,termination of signal transduction,BP,
18588,GO:1903899,1.00000000001108,0.684010768968722,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
8839,GO:0034647,1.00000000001108,0.771047298192652,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8888,GO:0034721,1.00000000001108,0.771047298192652,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
11197,GO:0045348,1.00000000001109,0.687001794570939,0,3,positive regulation of MHC class II biosynthetic process,BP,
10096,GO:0042631,1.00000000001111,0.880221587594205,0,1,cellular response to water deprivation,BP,
16013,GO:0086070,1.00000000001111,0.680565321964721,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
13567,GO:0060060,1.00000000001116,0.879698831012288,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14821,GO:0070593,1.00000000001116,0.879698831012288,0,1,dendrite self-avoidance,BP,
19104,GO:1905089,1.00000000001117,0.874125882101384,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19105,GO:1905090,1.00000000001117,0.874125882101384,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15547,GO:0072034,1.00000000001117,0.774685840273878,0,2,renal vesicle induction,BP,
3041,GO:0006597,1.0000000000112,0.777844447876892,0,2,spermine biosynthetic process,BP,
6321,GO:0020012,1.0000000000112,0.774804287350825,0,2,evasion or tolerance of host immune response,BP,
6991,GO:0030682,1.0000000000112,0.774804287350825,0,2,evasion or tolerance of host defense response,BP,
6992,GO:0030683,1.0000000000112,0.774804287350825,0,2,evasion or tolerance by virus of host immune response,BP,
13170,GO:0051805,1.0000000000112,0.774804287350825,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13172,GO:0051807,1.0000000000112,0.774804287350825,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
117,GO:0000246,1.00000000001121,0.880133144311552,0,1,delta24(24-1) sterol reductase activity,MF,
12484,GO:0050614,1.00000000001121,0.880133144311552,0,1,delta24-sterol reductase activity,MF,
16281,GO:0090461,1.00000000001121,0.880133144311552,0,1,glutamate homeostasis,BP,
3641,GO:0008117,1.00000000001125,0.880088807730344,0,1,sphinganine-1-phosphate aldolase activity,MF,
5110,GO:0015433,1.00000000001128,0.774732779909775,0,2,peptide antigen-transporting ATPase activity,MF,
9082,GO:0035359,1.00000000001131,0.880150640172122,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
12245,GO:0048560,1.00000000001133,0.775936552891579,0,2,establishment of anatomical structure orientation,BP,
15319,GO:0071568,1.00000000001137,0.784326750111685,0,2,UFM1 transferase activity,MF,
16482,GO:0097210,1.00000000001137,0.775412829862941,0,2,response to gonadotropin-releasing hormone,BP,
16483,GO:0097211,1.00000000001137,0.775412829862941,0,2,cellular response to gonadotropin-releasing hormone,BP,
10470,GO:0043383,1.00000000001138,0.687168648137394,0,3,negative T cell selection,BP,
11044,GO:0045060,1.00000000001138,0.687168648137394,0,3,negative thymic T cell selection,BP,
428,GO:0001147,1.00000000001138,0.771131421517739,0,2,transcription termination site sequence-specific DNA binding,MF,
431,GO:0001160,1.00000000001138,0.771131421517739,0,2,transcription termination site DNA binding,MF,
2382,GO:0005519,1.00000000001138,0.880159220966679,0,1,cytoskeletal regulatory protein binding,MF,
8531,GO:0033872,1.00000000001139,0.881464266312803,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
14508,GO:0070037,1.00000000001143,0.892147515416686,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
2175,GO:0005021,1.00000000001147,0.774872795573591,0,2,vascular endothelial growth factor-activated receptor activity,MF,
19684,GO:2000053,1.0000000000115,0.772094500353536,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
17242,GO:0120092,1.00000000001151,0.88025980507428,0,1,crotonyl-CoA hydratase activity,MF,
17243,GO:0120093,1.00000000001151,0.88025980507428,0,1,regulation of peptidyl-lysine crotonylation,BP,
17244,GO:0120094,1.00000000001151,0.88025980507428,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
217,GO:0000454,1.00000000001153,0.709416671901415,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
8107,GO:0032804,1.00000000001155,0.778178539158863,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
9251,GO:0035674,1.00000000001155,0.778611851265462,0,2,tricarboxylic acid transmembrane transport,BP,
1243,GO:0002945,1.00000000001157,0.774842118832403,0,2,cyclin K-CDK13 complex,CC,
2068,GO:0004823,1.00000000001157,0.774619976599348,0,2,leucine-tRNA ligase activity,MF,
2916,GO:0006429,1.00000000001157,0.774619976599348,0,2,leucyl-tRNA aminoacylation,BP,
14542,GO:0070097,1.00000000001158,0.774596455811484,0,2,delta-catenin binding,MF,
9384,GO:0035938,1.00000000001159,0.879966985086421,0,1,estradiol secretion,BP,
20125,GO:2000864,1.00000000001159,0.879966985086421,0,1,regulation of estradiol secretion,BP,
12791,GO:0051120,1.0000000000116,0.775113466818266,0,2,hepoxilin A3 synthase activity,MF,
3640,GO:0008116,1.0000000000116,0.880104896104911,0,1,prostaglandin-I synthase activity,MF,
20247,GO:2001245,1.0000000000116,0.774649915949433,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
9709,GO:0038163,1.00000000001164,0.893392265800096,0,1,thrombopoietin-mediated signaling pathway,BP,
19378,GO:1905938,1.00000000001164,0.893392265800096,0,1,positive regulation of germ cell proliferation,BP,
19779,GO:2000256,1.00000000001164,0.893392265800096,0,1,positive regulation of male germ cell proliferation,BP,
5138,GO:0015669,1.00000000001164,0.686316811494413,0,3,gas transport,BP,
11966,GO:0047322,1.00000000001165,0.772805540779404,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12454,GO:0050405,1.00000000001165,0.772805540779404,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
518,GO:0001595,1.00000000001165,0.889999368023644,0,1,angiotensin receptor activity,MF,
2134,GO:0004945,1.00000000001165,0.889999368023644,0,1,angiotensin type II receptor activity,MF,
19297,GO:1905616,1.00000000001168,0.77478973459663,0,2,regulation of miRNA mediated inhibition of translation,BP,
19298,GO:1905618,1.00000000001168,0.77478973459663,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
4550,GO:0010636,1.00000000001168,0.774703141479501,0,2,positive regulation of mitochondrial fusion,BP,
9666,GO:0038049,1.00000000001169,0.770303115829884,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
17479,GO:1900673,1.00000000001169,0.775470243903146,0,2,olefin metabolic process,BP,
4988,GO:0015127,1.00000000001169,0.88012248506496,0,1,bilirubin transmembrane transporter activity,MF,
5152,GO:0015694,1.00000000001169,0.88012248506496,0,1,mercury ion transport,BP,
5167,GO:0015723,1.00000000001169,0.88012248506496,0,1,bilirubin transport,BP,
6972,GO:0030653,1.00000000001169,0.88012248506496,0,1,beta-lactam antibiotic metabolic process,BP,
9937,GO:0042316,1.00000000001169,0.88012248506496,0,1,penicillin metabolic process,BP,
17521,GO:1901086,1.00000000001169,0.88012248506496,0,1,benzylpenicillin metabolic process,BP,
10838,GO:0044355,1.00000000001169,0.886316143089238,0,1,clearance of foreign intracellular DNA,BP,
10839,GO:0044356,1.00000000001169,0.886316143089238,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
16956,GO:0099046,1.00000000001169,0.886316143089238,0,1,clearance of foreign intracellular nucleic acids,BP,
18888,GO:1904627,1.00000000001169,0.886316143089238,0,1,response to phorbol 13-acetate 12-myristate,BP,
18889,GO:1904628,1.00000000001169,0.886316143089238,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
16239,GO:0090325,1.00000000001172,0.774754950300568,0,2,regulation of locomotion involved in locomotory behavior,BP,
152,GO:0000308,1.00000000001174,0.774642471319496,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
11424,GO:0045887,1.00000000001175,0.879595684557988,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
18084,GO:1902766,1.00000000001176,0.783080379515863,0,2,skeletal muscle satellite cell migration,BP,
1552,GO:0003953,1.00000000001176,0.885710622876841,0,1,NAD+ nucleosidase activity,MF,
12422,GO:0050135,1.00000000001176,0.885710622876841,0,1,NAD(P)+ nucleosidase activity,MF,
14434,GO:0061809,1.00000000001176,0.885710622876841,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
2021,GO:0004756,1.00000000001177,0.775362340485596,0,2,selenide, water dikinase activity,MF,
5409,GO:0016260,1.00000000001177,0.775362340485596,0,2,selenocysteine biosynthetic process,BP,
5666,GO:0016781,1.00000000001177,0.775362340485596,0,2,phosphotransferase activity, paired acceptors,MF,
14678,GO:0070329,1.00000000001177,0.775362340485596,0,2,tRNA seleno-modification,BP,
13682,GO:0060265,1.00000000001178,0.895757978691242,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
14208,GO:0061198,1.00000000001178,0.682475026387139,0,3,fungiform papilla formation,BP,
6007,GO:0019060,1.00000000001178,0.793018022723197,0,2,intracellular transport of viral protein in host cell,BP,
6946,GO:0030581,1.00000000001178,0.793018022723197,0,2,symbiont intracellular protein transport in host,BP,
13117,GO:0051708,1.00000000001178,0.793018022723197,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
16714,GO:0098502,1.00000000001181,0.695319355859704,0,3,DNA dephosphorylation,BP,
7857,GO:0032427,1.00000000001182,0.775351686545484,0,2,GBD domain binding,MF,
16825,GO:0098770,1.00000000001183,0.770271216439485,0,2,FBXO family protein binding,MF,
4972,GO:0015093,1.00000000001183,0.774623154386525,0,2,ferrous iron transmembrane transporter activity,MF,
5146,GO:0015684,1.00000000001183,0.774623154386525,0,2,ferrous iron transport,BP,
18573,GO:1903874,1.00000000001183,0.774623154386525,0,2,ferrous iron transmembrane transport,BP,
2067,GO:0004822,1.00000000001184,0.774699578750375,0,2,isoleucine-tRNA ligase activity,MF,
2915,GO:0006428,1.00000000001184,0.774699578750375,0,2,isoleucyl-tRNA aminoacylation,BP,
19306,GO:1905661,1.00000000001185,0.775445431658641,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19307,GO:1905663,1.00000000001185,0.775445431658641,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
1368,GO:0003256,1.00000000001185,0.68052125183574,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
19207,GO:1905371,1.00000000001188,0.779349875882225,0,2,ceramide phosphoethanolamine metabolic process,BP,
19208,GO:1905373,1.00000000001188,0.779349875882225,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20143,GO:2001015,1.00000000001188,0.774651197390104,0,2,negative regulation of skeletal muscle cell differentiation,BP,
7732,GO:0032240,1.00000000001189,0.772417999482632,0,2,negative regulation of nucleobase-containing compound transport,BP,
11830,GO:0046832,1.00000000001189,0.772417999482632,0,2,negative regulation of RNA export from nucleus,BP,
1688,GO:0004164,1.0000000000119,0.882836900201696,0,1,diphthine synthase activity,MF,
1733,GO:0004333,1.0000000000119,0.882836900201696,0,1,fumarate hydratase activity,MF,
13515,GO:0060001,1.00000000001191,0.878687564992271,0,1,minus-end directed microfilament motor activity,MF,
8169,GO:0032916,1.00000000001191,0.7723868823974,0,2,positive regulation of transforming growth factor beta3 production,BP,
19890,GO:2000418,1.00000000001191,0.77497007784449,0,2,positive regulation of eosinophil migration,BP,
6933,GO:0030549,1.00000000001192,0.890511411804535,0,1,acetylcholine receptor activator activity,MF,
5946,GO:0018307,1.00000000001192,0.787290399745021,0,2,enzyme active site formation,BP,
203,GO:0000429,1.00000000001193,0.686943493920837,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000436,1.00000000001193,0.686943493920837,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
14282,GO:0061443,1.00000000001194,0.77472477185603,0,2,endocardial cushion cell differentiation,BP,
10375,GO:0043224,1.00000000001196,0.798193109375083,0,2,nuclear SCF ubiquitin ligase complex,CC,
12073,GO:0048073,1.00000000001196,0.774621832062362,0,2,regulation of eye pigmentation,BP,
15022,GO:0070993,1.00000000001196,0.774625837220465,0,2,translation preinitiation complex,CC,
214,GO:0000448,1.00000000001201,0.774742160154974,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
8099,GO:0032796,1.00000000001202,0.777716435841948,0,2,uropod organization,BP,
19082,GO:1905041,1.00000000001204,0.774639048580353,0,2,regulation of epithelium regeneration,BP,
19483,GO:1990399,1.00000000001204,0.774639048580353,0,2,epithelium regeneration,BP,
1486,GO:0003826,1.00000000001204,0.777315554127504,0,2,alpha-ketoacid dehydrogenase activity,MF,
1504,GO:0003863,1.00000000001204,0.777315554127504,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
13444,GO:0055005,1.00000000001205,0.774762763428501,0,2,ventricular cardiac myofibril assembly,BP,
168,GO:0000350,1.00000000001206,0.687374764389534,0,3,generation of catalytic spliceosome for second transesterification step,BP,
9261,GO:0035700,1.00000000001207,0.882919313761673,0,1,astrocyte chemotaxis,BP,
9484,GO:0036145,1.00000000001207,0.882919313761673,0,1,dendritic cell homeostasis,BP,
19904,GO:2000458,1.00000000001207,0.882919313761673,0,1,regulation of astrocyte chemotaxis,BP,
2410,GO:0005584,1.00000000001208,0.77454567495331,0,2,collagen type I trimer,CC,
13383,GO:0052746,1.00000000001209,0.774749439991087,0,2,inositol phosphorylation,BP,
5352,GO:0016128,1.00000000001209,0.683439284845931,0,3,phytosteroid metabolic process,BP,
5353,GO:0016129,1.00000000001209,0.683439284845931,0,3,phytosteroid biosynthetic process,BP,
16001,GO:0086048,1.00000000001211,0.77467666351067,0,2,membrane depolarization during bundle of His cell action potential,BP,
6035,GO:0019135,1.00000000001212,0.882200854874312,0,1,deoxyhypusine monooxygenase activity,MF,
12761,GO:0051066,1.00000000001213,0.779552716127643,0,2,dihydrobiopterin metabolic process,BP,
12129,GO:0048257,1.00000000001215,0.775123770052122,0,2,3'-flap endonuclease activity,MF,
5912,GO:0018192,1.00000000001216,0.880455287379495,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7872,GO:0032447,1.00000000001216,0.880455287379495,0,1,protein urmylation,BP,
9925,GO:0042292,1.00000000001216,0.880455287379495,0,1,URM1 activating enzyme activity,MF,
14345,GO:0061604,1.00000000001216,0.880455287379495,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14346,GO:0061605,1.00000000001216,0.880455287379495,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16856,GO:0098822,1.00000000001216,0.880455287379495,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
9506,GO:0036219,1.00000000001216,0.898358724199813,0,1,GTP diphosphatase activity,MF,
10941,GO:0044713,1.00000000001216,0.898358724199813,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10942,GO:0044714,1.00000000001216,0.898358724199813,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12007,GO:0047693,1.00000000001216,0.898358724199813,0,1,ATP diphosphatase activity,MF,
13865,GO:0060532,1.00000000001224,0.774653161461356,0,2,bronchus cartilage development,BP,
14184,GO:0061145,1.00000000001224,0.774653161461356,0,2,lung smooth muscle development,BP,
17645,GO:1901534,1.00000000001224,0.77474783690745,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
11974,GO:0047389,1.00000000001225,0.774746731452353,0,2,glycerophosphocholine phosphodiesterase activity,MF,
2231,GO:0005136,1.0000000000123,0.880300657163594,0,1,interleukin-4 receptor binding,MF,
4356,GO:0009956,1.0000000000123,0.880167686788652,0,1,radial pattern formation,BP,
556,GO:0001680,1.0000000000123,0.880704162284557,0,1,tRNA 3'-terminal CCA addition,BP,
2056,GO:0004810,1.0000000000123,0.880704162284557,0,1,tRNA adenylyltransferase activity,MF,
13438,GO:0052927,1.0000000000123,0.880704162284557,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13439,GO:0052928,1.0000000000123,0.880704162284557,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13440,GO:0052929,1.0000000000123,0.880704162284557,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19604,GO:1990817,1.0000000000123,0.880704162284557,0,1,RNA adenylyltransferase activity,MF,
2020,GO:0004753,1.00000000001231,0.880074507305189,0,1,saccharopine dehydrogenase activity,MF,
11938,GO:0047130,1.00000000001231,0.880074507305189,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11939,GO:0047131,1.00000000001231,0.880074507305189,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
5032,GO:0015211,1.00000000001232,0.880437013088354,0,1,purine nucleoside transmembrane transporter activity,MF,
8276,GO:0033106,1.00000000001233,0.782481346471586,0,2,cis-Golgi network membrane,CC,
19600,GO:1990791,1.00000000001233,0.774988766639949,0,2,dorsal root ganglion development,BP,
11782,GO:0046684,1.00000000001234,0.776334344189466,0,2,response to pyrethroid,BP,
16721,GO:0098518,1.00000000001236,0.687345331341864,0,3,polynucleotide phosphatase activity,MF,
937,GO:0002339,1.00000000001236,0.789695265702476,0,2,B cell selection,BP,
941,GO:0002352,1.00000000001236,0.789695265702476,0,2,B cell negative selection,BP,
16485,GO:0097213,1.00000000001238,0.880783158761143,0,1,regulation of lysosomal membrane permeability,BP,
12771,GO:0051089,1.00000000001239,0.880164194852179,0,1,constitutive protein ectodomain proteolysis,BP,
16709,GO:0097752,1.00000000001239,0.682226983624898,0,3,regulation of DNA stability,BP,
1716,GO:0004310,1.00000000001239,0.881157256410977,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
7156,GO:0031038,1.00000000001239,0.881157256410977,0,1,myosin II filament organization,BP,
10545,GO:0043519,1.00000000001239,0.881157256410977,0,1,regulation of myosin II filament organization,BP,
13269,GO:0051996,1.00000000001239,0.881157256410977,0,1,squalene synthase activity,MF,
769,GO:0002025,1.00000000001242,0.881430102046383,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
2132,GO:0004939,1.00000000001242,0.881430102046383,0,1,beta-adrenergic receptor activity,MF,
2133,GO:0004941,1.00000000001242,0.881430102046383,0,1,beta2-adrenergic receptor activity,MF,
12954,GO:0051380,1.00000000001242,0.881430102046383,0,1,norepinephrine binding,MF,
14455,GO:0061884,1.00000000001242,0.881430102046383,0,1,regulation of mini excitatory postsynaptic potential,BP,
14456,GO:0061885,1.00000000001242,0.881430102046383,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
16854,GO:0098816,1.00000000001242,0.881430102046383,0,1,mini excitatory postsynaptic potential,BP,
1564,GO:0003973,1.00000000001243,0.880038888608748,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
6312,GO:0019962,1.00000000001243,0.880038888608748,0,1,type I interferon binding,MF,
11992,GO:0047545,1.00000000001243,0.880038888608748,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
13624,GO:0060157,1.00000000001244,0.77457156756728,0,2,urinary bladder development,BP,
1651,GO:0004105,1.00000000001245,0.778641453159858,0,2,choline-phosphate cytidylyltransferase activity,MF,
7765,GO:0032298,1.00000000001245,0.880775222511012,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16431,GO:0097123,1.00000000001245,0.880775222511012,0,1,cyclin A1-CDK2 complex,CC,
13192,GO:0051877,1.00000000001245,0.77497666522415,0,2,pigment granule aggregation in cell center,BP,
7869,GO:0032440,1.00000000001246,0.888935930159617,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19300,GO:1905636,1.00000000001246,0.888935930159617,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
3133,GO:0006726,1.00000000001247,0.880122829149672,0,1,eye pigment biosynthetic process,BP,
5368,GO:0016182,1.00000000001247,0.880122829149672,0,1,synaptic vesicle budding from endosome,BP,
9998,GO:0042441,1.00000000001247,0.880122829149672,0,1,eye pigment metabolic process,BP,
10447,GO:0043324,1.00000000001247,0.880122829149672,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10516,GO:0043474,1.00000000001247,0.880122829149672,0,1,pigment metabolic process involved in pigmentation,BP,
16861,GO:0098830,1.00000000001247,0.880122829149672,0,1,presynaptic endosome,CC,
1538,GO:0003933,1.00000000001248,0.881823264631204,0,1,GTP cyclohydrolase activity,MF,
1539,GO:0003934,1.00000000001248,0.881823264631204,0,1,GTP cyclohydrolase I activity,MF,
9414,GO:0035998,1.00000000001248,0.881823264631204,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
4661,GO:0010814,1.00000000001248,0.880122130412649,0,1,substance P catabolic process,BP,
4663,GO:0010816,1.00000000001248,0.880122130412649,0,1,calcitonin catabolic process,BP,
7294,GO:0031302,1.00000000001248,0.880122130412649,0,1,intrinsic component of endosome membrane,CC,
8919,GO:0034959,1.00000000001248,0.880122130412649,0,1,endothelin maturation,BP,
5526,GO:0016508,1.0000000000125,0.682091332384881,0,3,long-chain-enoyl-CoA hydratase activity,MF,
2118,GO:0004910,1.00000000001252,0.88646637155582,0,1,interleukin-1, Type II, blocking receptor activity,MF,
8031,GO:0032690,1.00000000001252,0.88646637155582,0,1,negative regulation of interleukin-1 alpha production,BP,
12539,GO:0050712,1.00000000001252,0.88646637155582,0,1,negative regulation of interleukin-1 alpha secretion,BP,
1968,GO:0004686,1.00000000001252,0.879557204292309,0,1,elongation factor-2 kinase activity,MF,
15248,GO:0071454,1.00000000001252,0.879557204292309,0,1,cellular response to anoxia,BP,
16130,GO:0090176,1.00000000001252,0.880103905313025,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
5511,GO:0016479,1.00000000001253,0.682789070765348,0,3,negative regulation of transcription by RNA polymerase I,BP,
15957,GO:0080163,1.00000000001254,0.880518246634257,0,1,regulation of protein serine/threonine phosphatase activity,BP,
4080,GO:0009138,1.00000000001254,0.690252014680548,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
11093,GO:0045131,1.00000000001256,0.880320751983812,0,1,pre-mRNA branch point binding,MF,
2002,GO:0004729,1.00000000001257,0.883197793418595,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
14909,GO:0070818,1.00000000001257,0.883197793418595,0,1,protoporphyrinogen oxidase activity,MF,
6226,GO:0019781,1.00000000001258,0.777684300286419,0,2,NEDD8 activating enzyme activity,MF,
12271,GO:0048627,1.00000000001259,0.780794763312415,0,2,myoblast development,BP,
18933,GO:1904732,1.00000000001261,0.794804542534149,0,2,regulation of electron transfer activity,BP,
19049,GO:1904959,1.00000000001261,0.794804542534149,0,2,regulation of cytochrome-c oxidase activity,BP,
16617,GO:0097505,1.00000000001261,0.880092348519656,0,1,Rad6-Rad18 complex,CC,
14385,GO:0061689,1.00000000001261,0.682240517261773,0,3,tricellular tight junction,CC,
6037,GO:0019144,1.00000000001263,0.787504077972911,0,2,ADP-sugar diphosphatase activity,MF,
5395,GO:0016237,1.00000000001264,0.880122785040576,0,1,lysosomal microautophagy,BP,
6223,GO:0019778,1.00000000001264,0.880122785040576,0,1,Atg12 activating enzyme activity,MF,
6224,GO:0019779,1.00000000001264,0.880122785040576,0,1,Atg8 activating enzyme activity,MF,
8892,GO:0034727,1.00000000001264,0.880122785040576,0,1,piecemeal microautophagy of the nucleus,BP,
9747,GO:0039521,1.00000000001264,0.880122785040576,0,1,suppression by virus of host autophagy,BP,
19356,GO:1905878,1.00000000001264,0.87761765677899,0,1,invadopodium disassembly,BP,
19374,GO:1905927,1.00000000001264,0.87761765677899,0,1,regulation of invadopodium disassembly,BP,
19375,GO:1905929,1.00000000001264,0.87761765677899,0,1,positive regulation of invadopodium disassembly,BP,
18297,GO:1903279,1.00000000001264,0.776475347172564,0,2,regulation of calcium:sodium antiporter activity,BP,
18298,GO:1903281,1.00000000001264,0.776475347172564,0,2,positive regulation of calcium:sodium antiporter activity,BP,
18285,GO:1903237,1.00000000001264,0.896418973265087,0,1,negative regulation of leukocyte tethering or rolling,BP,
11929,GO:0047035,1.00000000001264,0.788221975970981,0,2,testosterone dehydrogenase (NAD+) activity,MF,
14379,GO:0061669,1.00000000001266,0.774602485434633,0,2,spontaneous neurotransmitter secretion,BP,
8157,GO:0032902,1.00000000001266,0.77475197537926,0,2,nerve growth factor production,BP,
6824,GO:0030294,1.00000000001267,0.880856592409095,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
11897,GO:0046958,1.0000000000127,0.880276753568899,0,1,nonassociative learning,BP,
5212,GO:0015817,1.00000000001271,0.880340682287382,0,1,histidine transport,BP,
7522,GO:0031753,1.00000000001271,0.880340682287382,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7523,GO:0031755,1.00000000001271,0.880340682287382,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
18295,GO:1903276,1.00000000001273,0.778482299399014,0,2,regulation of sodium ion export across plasma membrane,BP,
18296,GO:1903278,1.00000000001273,0.778482299399014,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18303,GO:1903288,1.00000000001273,0.778482299399014,0,2,positive regulation of potassium ion import,BP,
20173,GO:2001070,1.00000000001274,0.774895344475801,0,2,starch binding,MF,
4321,GO:0009826,1.00000000001274,0.77646764161723,0,2,unidimensional cell growth,BP,
18770,GO:1904339,1.00000000001274,0.879714247998009,0,1,negative regulation of dopaminergic neuron differentiation,BP,
13707,GO:0060302,1.00000000001274,0.780067104179725,0,2,negative regulation of cytokine activity,BP,
4729,GO:0010898,1.00000000001278,0.775615905689584,0,2,positive regulation of triglyceride catabolic process,BP,
14584,GO:0070170,1.00000000001279,0.774608180472757,0,2,regulation of tooth mineralization,BP,
12377,GO:0048840,1.0000000000128,0.681897363657854,0,3,otolith development,BP,
1843,GO:0004505,1.0000000000128,0.786243776268385,0,2,phenylalanine 4-monooxygenase activity,MF,
3646,GO:0008124,1.0000000000128,0.786243776268385,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
4888,GO:0014816,1.00000000001282,0.773673976675826,0,2,skeletal muscle satellite cell differentiation,BP,
16668,GO:0097643,1.00000000001282,0.894702818697932,0,1,amylin receptor activity,MF,
18383,GO:1903440,1.00000000001282,0.894702818697932,0,1,amylin receptor complex,CC,
19490,GO:1990407,1.00000000001282,0.894702818697932,0,1,calcitonin gene-related peptide binding,MF,
4044,GO:0009085,1.00000000001284,0.774751111364441,0,2,lysine biosynthetic process,BP,
6272,GO:0019878,1.00000000001284,0.774751111364441,0,2,lysine biosynthetic process via aminoadipic acid,BP,
9255,GO:0035692,1.00000000001285,0.781589024107448,0,2,macrophage migration inhibitory factor receptor complex,CC,
306,GO:0000818,1.00000000001286,0.77542240257314,0,2,nuclear MIS12/MIND complex,CC,
644,GO:0001835,1.00000000001286,0.880279852013118,0,1,blastocyst hatching,BP,
9000,GO:0035188,1.00000000001286,0.880279852013118,0,1,hatching,BP,
15393,GO:0071684,1.00000000001286,0.880279852013118,0,1,organism emergence from protective structure,BP,
1438,GO:0003419,1.00000000001286,0.775038175556691,0,2,growth plate cartilage chondrocyte proliferation,BP,
1439,GO:0003420,1.00000000001286,0.775038175556691,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
12017,GO:0047756,1.00000000001289,0.775633784079861,0,2,chondroitin 4-sulfotransferase activity,MF,
10677,GO:0043973,1.00000000001289,0.880866805021819,0,1,histone H3-K4 acetylation,BP,
16505,GO:0097267,1.00000000001289,0.681923292026797,0,3,omega-hydroxylase P450 pathway,BP,
8812,GO:0034602,1.0000000000129,0.880132288043848,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
14127,GO:0061034,1.0000000000129,0.880132288043848,0,1,olfactory bulb mitral cell layer development,BP,
2157,GO:0004985,1.0000000000129,0.687106622103085,0,3,opioid receptor activity,MF,
5833,GO:0017125,1.0000000000129,0.88012294597902,0,1,deoxycytidyl transferase activity,MF,
11977,GO:0047408,1.0000000000129,0.777382724402113,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
11978,GO:0047409,1.0000000000129,0.777382724402113,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
16321,GO:0090615,1.0000000000129,0.776264809381246,0,2,mitochondrial mRNA processing,BP,
1840,GO:0004499,1.00000000001294,0.881041777297724,0,1,N,N-dimethylaniline monooxygenase activity,MF,
8147,GO:0032887,1.00000000001295,0.879667605641167,0,1,regulation of spindle elongation,BP,
8148,GO:0032888,1.00000000001295,0.879667605641167,0,1,regulation of mitotic spindle elongation,BP,
13464,GO:0055028,1.00000000001295,0.879667605641167,0,1,cortical microtubule,CC,
13468,GO:0055048,1.00000000001295,0.879667605641167,0,1,anastral spindle assembly,BP,
15528,GO:0071988,1.00000000001295,0.879667605641167,0,1,protein localization to spindle pole body,BP,
17208,GO:0110028,1.00000000001295,0.879667605641167,0,1,positive regulation of mitotic spindle organization,BP,
17942,GO:1902363,1.00000000001295,0.879667605641167,0,1,regulation of protein localization to spindle pole body,BP,
17943,GO:1902365,1.00000000001295,0.879667605641167,0,1,positive regulation of protein localization to spindle pole body,BP,
18105,GO:1902846,1.00000000001295,0.879667605641167,0,1,positive regulation of mitotic spindle elongation,BP,
19324,GO:1905720,1.00000000001295,0.879667605641167,0,1,cytoplasmic microtubule bundle,CC,
19327,GO:1905767,1.00000000001296,0.879851049736037,0,1,regulation of double-stranded telomeric DNA binding,BP,
19328,GO:1905768,1.00000000001296,0.879851049736037,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
5906,GO:0018153,1.00000000001296,0.775632473811907,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5937,GO:0018262,1.00000000001296,0.775632473811907,0,2,isopeptide cross-linking,BP,
4166,GO:0009236,1.00000000001297,0.68187079245111,0,3,cobalamin biosynthetic process,BP,
3903,GO:0008555,1.00000000001297,0.880117153292568,0,1,chloride-transporting ATPase activity,MF,
13773,GO:0060386,1.00000000001297,0.880094022847856,0,1,synapse assembly involved in innervation,BP,
16283,GO:0090480,1.00000000001298,0.681797399248411,0,3,purine nucleotide-sugar transmembrane transport,BP,
6515,GO:0021898,1.00000000001298,0.682697335032592,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
17754,GO:1901842,1.000000000013,0.885978994811669,0,1,negative regulation of high voltage-gated calcium channel activity,BP,
12982,GO:0051431,1.000000000013,0.885852910517745,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
976,GO:0002430,1.00000000001301,0.88067795504059,0,1,complement receptor mediated signaling pathway,BP,
1924,GO:0004621,1.00000000001301,0.88067795504059,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2966,GO:0006507,1.00000000001301,0.88067795504059,0,1,GPI anchor release,BP,
4728,GO:0010897,1.00000000001301,0.88067795504059,0,1,negative regulation of triglyceride catabolic process,BP,
8549,GO:0034014,1.00000000001301,0.88067795504059,0,1,response to triglyceride,BP,
15217,GO:0071401,1.00000000001301,0.88067795504059,0,1,cellular response to triglyceride,BP,
1373,GO:0003270,1.00000000001302,0.878108274441977,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
14039,GO:0060843,1.00000000001302,0.878108274441977,0,1,venous endothelial cell differentiation,BP,
1602,GO:0004027,1.00000000001302,0.889309425979433,0,1,alcohol sulfotransferase activity,MF,
2306,GO:0005294,1.00000000001303,0.877764863889073,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
5081,GO:0015327,1.00000000001303,0.877764863889073,0,1,cystine:glutamate antiporter activity,MF,
5082,GO:0015328,1.00000000001303,0.877764863889073,0,1,cystine secondary active transmembrane transporter activity,MF,
17717,GO:1901680,1.00000000001303,0.877764863889073,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
1921,GO:0004618,1.00000000001303,0.880480972387534,0,1,phosphoglycerate kinase activity,MF,
5327,GO:0016062,1.00000000001306,0.8803835924149,0,1,adaptation of rhodopsin mediated signaling,BP,
9555,GO:0036367,1.00000000001306,0.8803835924149,0,1,light adaption,BP,
2601,GO:0005900,1.00000000001307,0.774829695056609,0,2,oncostatin-M receptor complex,CC,
9924,GO:0042289,1.00000000001311,0.785725581300535,0,2,MHC class II protein binding,MF,
9910,GO:0042271,1.00000000001312,0.77458949782225,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
4246,GO:0009450,1.00000000001313,0.774606491698342,0,2,gamma-aminobutyric acid catabolic process,BP,
6313,GO:0019964,1.00000000001313,0.880240990384128,0,1,interferon-gamma binding,MF,
19480,GO:1990390,1.00000000001313,0.880240990384128,0,1,protein K33-linked ubiquitination,BP,
14439,GO:0061825,1.00000000001316,0.880165363806739,0,1,podosome core,CC,
16518,GO:0097298,1.00000000001316,0.880165363806739,0,1,regulation of nucleus size,BP,
15935,GO:0075732,1.00000000001316,0.774586912343866,0,2,viral penetration into host nucleus,BP,
18024,GO:1902594,1.00000000001316,0.774586912343866,0,2,multi-organism nuclear import,BP,
7334,GO:0031370,1.00000000001317,0.88012294186755,0,1,eukaryotic initiation factor 4G binding,MF,
15275,GO:0071486,1.00000000001319,0.880120095039524,0,1,cellular response to high light intensity,BP,
16596,GO:0097473,1.00000000001319,0.880120095039524,0,1,retinal rod cell apoptotic process,BP,
19395,GO:1990009,1.00000000001319,0.880120095039524,0,1,retinal cell apoptotic process,BP,
14962,GO:0070899,1.0000000000132,0.880317874590444,0,1,mitochondrial tRNA wobble uridine modification,BP,
4399,GO:0010139,1.00000000001321,0.884376839473273,0,1,pyrimidine deoxyribonucleotide salvage,BP,
8375,GO:0033292,1.00000000001321,0.772778556140451,0,2,T-tubule organization,BP,
9224,GO:0035630,1.00000000001322,0.774760566546391,0,2,bone mineralization involved in bone maturation,BP,
2164,GO:0005000,1.00000000001323,0.774756518221791,0,2,vasopressin receptor activity,MF,
8432,GO:0033565,1.00000000001323,0.682026166573784,0,3,ESCRT-0 complex,CC,
3945,GO:0008650,1.00000000001324,0.880222212731141,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
11864,GO:0046899,1.00000000001324,0.774999697761045,0,2,nucleoside triphosphate adenylate kinase activity,MF,
6731,GO:0030156,1.00000000001326,0.897886555416205,0,1,benzodiazepine receptor binding,MF,
4701,GO:0010868,1.00000000001326,0.77466970677411,0,2,negative regulation of triglyceride biosynthetic process,BP,
7360,GO:0031416,1.0000000000133,0.784931679228041,0,2,NatB complex,CC,
7495,GO:0031682,1.00000000001331,0.88031329759338,0,1,G-protein gamma-subunit binding,MF,
18088,GO:1902773,1.00000000001331,0.88031329759338,0,1,GTPase activator complex,CC,
951,GO:0002370,1.00000000001331,0.690503301530307,0,3,natural killer cell cytokine production,BP,
1135,GO:0002727,1.00000000001331,0.690503301530307,0,3,regulation of natural killer cell cytokine production,BP,
15542,GO:0072019,1.00000000001331,0.881054370803641,0,1,proximal convoluted tubule development,BP,
15670,GO:0072229,1.00000000001331,0.881054370803641,0,1,metanephric proximal convoluted tubule development,BP,
18111,GO:1902858,1.00000000001331,0.881054370803641,0,1,propionyl-CoA metabolic process,BP,
18112,GO:1902860,1.00000000001331,0.881054370803641,0,1,propionyl-CoA biosynthetic process,BP,
12663,GO:0050904,1.00000000001332,0.774709808355836,0,2,diapedesis,BP,
3523,GO:0007500,1.00000000001333,0.777235825720799,0,2,mesodermal cell fate determination,BP,
1498,GO:0003846,1.00000000001335,0.774964701127528,0,2,2-acylglycerol O-acyltransferase activity,MF,
1677,GO:0004144,1.00000000001335,0.774964701127528,0,2,diacylglycerol O-acyltransferase activity,MF,
12434,GO:0050252,1.00000000001335,0.774964701127528,0,2,retinol O-fatty-acyltransferase activity,MF,
15636,GO:0072179,1.00000000001335,0.777219967854992,0,2,nephric duct formation,BP,
8917,GO:0034776,1.00000000001336,0.774581313845573,0,2,response to histamine,BP,
15226,GO:0071420,1.00000000001336,0.774581313845573,0,2,cellular response to histamine,BP,
8576,GO:0034087,1.00000000001337,0.772118989838322,0,2,establishment of mitotic sister chromatid cohesion,BP,
17143,GO:0102773,1.00000000001339,0.880126818173278,0,1,dihydroceramide kinase activity,MF,
2239,GO:0005150,1.00000000001339,0.77714497962519,0,2,interleukin-1, Type I receptor binding,MF,
3583,GO:0007634,1.00000000001342,0.880467190287518,0,1,optokinetic behavior,BP,
14051,GO:0060876,1.00000000001342,0.880467190287518,0,1,semicircular canal formation,BP,
3911,GO:0008582,1.00000000001343,0.774048173272125,0,2,regulation of synaptic growth at neuromuscular junction,BP,
16744,GO:0098575,1.00000000001343,0.776333443049011,0,2,lumenal side of lysosomal membrane,CC,
19057,GO:1904978,1.00000000001343,0.681942693951591,0,3,regulation of endosome organization,BP,
19039,GO:1904947,1.00000000001344,0.88031516956908,0,1,folic acid import into mitochondrion,BP,
3730,GO:0008269,1.00000000001346,0.880857861470206,0,1,JAK pathway signal transduction adaptor activity,MF,
4315,GO:0009810,1.00000000001346,0.880857861470206,0,1,stilbene metabolic process,BP,
8536,GO:0033885,1.00000000001346,0.880857861470206,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11588,GO:0046272,1.00000000001346,0.880857861470206,0,1,stilbene catabolic process,BP,
1236,GO:0002930,1.00000000001347,0.880121935597367,0,1,trabecular meshwork development,BP,
20129,GO:2000969,1.00000000001348,0.682565992859276,0,3,positive regulation of AMPA receptor activity,BP,
14601,GO:0070195,1.00000000001349,0.880129764230391,0,1,growth hormone receptor complex,CC,
1929,GO:0004631,1.00000000001349,0.888267525734107,0,1,phosphomevalonate kinase activity,MF,
311,GO:0000823,1.0000000000135,0.882822109712818,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
312,GO:0000824,1.0000000000135,0.882822109712818,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
313,GO:0000825,1.0000000000135,0.882822109712818,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
11969,GO:0047326,1.0000000000135,0.882822109712818,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
11128,GO:0045196,1.0000000000135,0.774306629800556,0,2,establishment or maintenance of neuroblast polarity,BP,
11132,GO:0045200,1.0000000000135,0.774306629800556,0,2,establishment of neuroblast polarity,BP,
6723,GO:0030144,1.00000000001351,0.682268569047101,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
11903,GO:0046967,1.00000000001355,0.774811447216234,0,2,cytosol to ER transport,BP,
11838,GO:0046848,1.00000000001358,0.887138767539597,0,1,hydroxyapatite binding,MF,
2009,GO:0004739,1.00000000001359,0.779268142731007,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
1740,GO:0004343,1.00000000001359,0.880165494781868,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
19214,GO:1905395,1.00000000001359,0.790244429758009,0,2,response to flavonoid,BP,
19340,GO:1905799,1.0000000000136,0.899154463214992,0,1,regulation of intraciliary retrograde transport,BP,
601,GO:0001770,1.00000000001362,0.879719174012967,0,1,establishment of natural killer cell polarity,BP,
11736,GO:0046604,1.00000000001364,0.689396299695966,0,3,positive regulation of mitotic centrosome separation,BP,
1734,GO:0004334,1.00000000001365,0.886167797548856,0,1,fumarylacetoacetase activity,MF,
18415,GO:1903526,1.00000000001365,0.774688236859305,0,2,negative regulation of membrane tubulation,BP,
2852,GO:0006343,1.00000000001365,0.880177297749801,0,1,establishment of chromatin silencing,BP,
10077,GO:0042595,1.00000000001365,0.880177297749801,0,1,behavioral response to starvation,BP,
15241,GO:0071441,1.00000000001365,0.880177297749801,0,1,negative regulation of histone H3-K14 acetylation,BP,
20002,GO:2000654,1.00000000001365,0.880177297749801,0,1,regulation of cellular response to testosterone stimulus,BP,
20003,GO:2000655,1.00000000001365,0.880177297749801,0,1,negative regulation of cellular response to testosterone stimulus,BP,
13124,GO:0051717,1.00000000001366,0.77478254289648,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
8861,GO:0034680,1.00000000001367,0.774664689480294,0,2,integrin alpha10-beta1 complex,CC,
16643,GO:0097574,1.00000000001367,0.774373772108682,0,2,lateral part of cell,CC,
16644,GO:0097575,1.00000000001367,0.774373772108682,0,2,lateral cell cortex,CC,
4317,GO:0009814,1.00000000001368,0.880875854248292,0,1,defense response, incompatible interaction,BP,
4318,GO:0009817,1.00000000001368,0.880875854248292,0,1,defense response to fungus, incompatible interaction,BP,
19179,GO:1905313,1.00000000001368,0.880875854248292,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19485,GO:1990402,1.00000000001368,0.880875854248292,0,1,embryonic liver development,BP,
7135,GO:0030984,1.00000000001369,0.783735222731035,0,2,kininogen binding,MF,
17299,GO:0150018,1.0000000000137,0.681954520272654,0,3,basal dendrite development,BP,
17300,GO:0150019,1.0000000000137,0.681954520272654,0,3,basal dendrite morphogenesis,BP,
17301,GO:0150020,1.0000000000137,0.681954520272654,0,3,basal dendrite arborization,BP,
8410,GO:0033499,1.00000000001371,0.781556039811341,0,2,galactose catabolic process via UDP-galactose,BP,
6153,GO:0019482,1.00000000001373,0.774851696820533,0,2,beta-alanine metabolic process,BP,
1568,GO:0003977,1.00000000001374,0.775152433131945,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1904,GO:0004595,1.00000000001374,0.880662144188039,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
237,GO:0000495,1.00000000001374,0.880378488881283,0,1,box H/ACA snoRNA 3'-end processing,BP,
2734,GO:0006117,1.00000000001374,0.880378488881283,0,1,acetaldehyde metabolic process,BP,
8544,GO:0033979,1.00000000001374,0.880378488881283,0,1,box H/ACA snoRNA metabolic process,BP,
8921,GO:0034964,1.00000000001374,0.880378488881283,0,1,box H/ACA snoRNA processing,BP,
9157,GO:0035525,1.00000000001374,0.880378488881283,0,1,NF-kappaB p50/p65 complex,CC,
12949,GO:0051365,1.00000000001375,0.880268179940794,0,1,cellular response to potassium ion starvation,BP,
4689,GO:0010848,1.00000000001375,0.880275193307792,0,1,regulation of chromatin disassembly,BP,
48,GO:0000101,1.00000000001377,0.681920935189091,0,3,sulfur amino acid transport,BP,
2473,GO:0005690,1.00000000001377,0.77547539009161,0,2,U4atac snRNP,CC,
15027,GO:0071005,1.00000000001377,0.77547539009161,0,2,U2-type precatalytic spliceosome,CC,
887,GO:0002254,1.00000000001381,0.776400495375919,0,2,kinin cascade,BP,
942,GO:0002353,1.00000000001381,0.776400495375919,0,2,plasma kallikrein-kinin cascade,BP,
11991,GO:0047536,1.00000000001382,0.880817103032652,0,1,2-aminoadipate transaminase activity,MF,
15823,GO:0072563,1.00000000001384,0.778596474812892,0,2,endothelial microparticle,CC,
15273,GO:0071484,1.00000000001384,0.774736724613336,0,2,cellular response to light intensity,BP,
129,GO:0000270,1.00000000001385,0.785535113501619,0,2,peptidoglycan metabolic process,BP,
3958,GO:0008745,1.00000000001385,0.785535113501619,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
4174,GO:0009253,1.00000000001385,0.785535113501619,0,2,peptidoglycan catabolic process,BP,
5306,GO:0016019,1.00000000001385,0.785535113501619,0,2,peptidoglycan receptor activity,MF,
13119,GO:0051710,1.00000000001385,0.785535113501619,0,2,regulation of cytolysis in other organism,BP,
13121,GO:0051714,1.00000000001385,0.785535113501619,0,2,positive regulation of cytolysis in other organism,BP,
14587,GO:0070176,1.00000000001389,0.88278539276157,0,1,DRM complex,CC,
12444,GO:0050313,1.00000000001389,0.893639918916316,0,1,sulfur dioxygenase activity,MF,
5968,GO:0018423,1.00000000001393,0.782028788957729,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
3884,GO:0008521,1.00000000001393,0.88035556169189,0,1,acetyl-CoA transmembrane transporter activity,MF,
5245,GO:0015876,1.00000000001393,0.88035556169189,0,1,acetyl-CoA transport,BP,
5264,GO:0015916,1.00000000001393,0.88035556169189,0,1,fatty-acyl-CoA transport,BP,
17599,GO:1901337,1.00000000001393,0.88035556169189,0,1,thioester transport,BP,
1845,GO:0004511,1.00000000001395,0.882084946844123,0,1,tyrosine 3-monooxygenase activity,MF,
3033,GO:0006585,1.00000000001395,0.882084946844123,0,1,dopamine biosynthetic process from tyrosine,BP,
8261,GO:0033076,1.00000000001395,0.882084946844123,0,1,isoquinoline alkaloid metabolic process,BP,
9013,GO:0035240,1.00000000001395,0.882084946844123,0,1,dopamine binding,MF,
9885,GO:0042214,1.00000000001395,0.882084946844123,0,1,terpene metabolic process,BP,
9986,GO:0042418,1.00000000001395,0.882084946844123,0,1,epinephrine biosynthetic process,BP,
13312,GO:0052314,1.00000000001395,0.882084946844123,0,1,phytoalexin metabolic process,BP,
14863,GO:0070678,1.00000000001397,0.88035194693592,0,1,preprotein binding,MF,
2022,GO:0004757,1.00000000001397,0.886155520866473,0,1,sepiapterin reductase activity,MF,
6838,GO:0030314,1.00000000001397,0.774697181189557,0,2,junctional membrane complex,CC,
10589,GO:0043585,1.00000000001399,0.773644878718969,0,2,nose morphogenesis,BP,
3767,GO:0008321,1.00000000001401,0.774482250148979,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
14453,GO:0061880,1.00000000001401,0.88356556246638,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14454,GO:0061881,1.00000000001401,0.88356556246638,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
1969,GO:0004687,1.00000000001402,0.773231010542722,0,2,myosin light chain kinase activity,MF,
14212,GO:0061209,1.00000000001403,0.684168868024599,0,3,cell proliferation involved in mesonephros development,BP,
490,GO:0001543,1.00000000001405,0.879485745852111,0,1,ovarian follicle rupture,BP,
4207,GO:0009353,1.00000000001405,0.887872901460121,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7421,GO:0031531,1.00000000001405,0.887872901460121,0,1,thyrotropin-releasing hormone receptor binding,MF,
10578,GO:0043564,1.00000000001405,0.775529809166183,0,2,Ku70:Ku80 complex,CC,
1884,GO:0004568,1.00000000001408,0.774880608218825,0,2,chitinase activity,MF,
2674,GO:0006030,1.00000000001408,0.774880608218825,0,2,chitin metabolic process,BP,
2675,GO:0006032,1.00000000001408,0.774880608218825,0,2,chitin catabolic process,BP,
3612,GO:0008061,1.00000000001408,0.774880608218825,0,2,chitin binding,MF,
8241,GO:0033030,1.00000000001408,0.880025384044881,0,1,negative regulation of neutrophil apoptotic process,BP,
14644,GO:0070274,1.00000000001411,0.780450250568297,0,2,RES complex,CC,
10352,GO:0043185,1.00000000001414,0.881254738808121,0,1,vascular endothelial growth factor receptor 3 binding,MF,
14830,GO:0070625,1.00000000001414,0.881254738808121,0,1,zymogen granule exocytosis,BP,
19561,GO:1990698,1.00000000001415,0.777070036556295,0,2,palmitoleoyltransferase activity,MF,
6865,GO:0030350,1.00000000001415,0.774564119529577,0,2,iron-responsive element binding,MF,
6873,GO:0030377,1.00000000001416,0.886378510284631,0,1,urokinase plasminogen activator receptor activity,MF,
9726,GO:0038195,1.00000000001416,0.886378510284631,0,1,urokinase plasminogen activator signaling pathway,BP,
14110,GO:0061002,1.00000000001416,0.685185957581936,0,3,negative regulation of dendritic spine morphogenesis,BP,
1689,GO:0004165,1.00000000001418,0.68209301864859,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
12110,GO:0048209,1.00000000001419,0.775348360286496,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
9796,GO:0042000,1.00000000001419,0.880493069001755,0,1,translocation of peptides or proteins into host,BP,
10704,GO:0044053,1.00000000001419,0.880493069001755,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13173,GO:0051808,1.00000000001419,0.880493069001755,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
8043,GO:0032714,1.00000000001421,0.774783890963604,0,2,negative regulation of interleukin-5 production,BP,
2179,GO:0005030,1.00000000001421,0.879745079197148,0,1,neurotrophin receptor activity,MF,
4465,GO:0010465,1.00000000001421,0.879745079197148,0,1,nerve growth factor receptor activity,MF,
6875,GO:0030379,1.00000000001421,0.879745079197148,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
12140,GO:0048270,1.00000000001425,0.881237969185436,0,1,methionine adenosyltransferase regulator activity,MF,
10861,GO:0044416,1.00000000001427,0.780307473910735,0,2,induction by symbiont of host defense response,BP,
11808,GO:0046730,1.00000000001427,0.780307473910735,0,2,induction of host immune response by virus,BP,
11809,GO:0046732,1.00000000001427,0.780307473910735,0,2,active induction of host immune response by virus,BP,
13306,GO:0052251,1.00000000001427,0.780307473910735,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13333,GO:0052509,1.00000000001427,0.780307473910735,0,2,positive regulation by symbiont of host defense response,BP,
13334,GO:0052510,1.00000000001427,0.780307473910735,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
763,GO:0002016,1.00000000001428,0.898854799654007,0,1,regulation of blood volume by renin-angiotensin,BP,
765,GO:0002019,1.00000000001428,0.898854799654007,0,1,regulation of renal output by angiotensin,BP,
1279,GO:0003083,1.00000000001428,0.898854799654007,0,1,negative regulation of renal output by angiotensin,BP,
1291,GO:0003106,1.00000000001428,0.898854799654007,0,1,negative regulation of glomerular filtration by angiotensin,BP,
4931,GO:0014895,1.00000000001428,0.898854799654007,0,1,smooth muscle hypertrophy,BP,
10090,GO:0042624,1.00000000001428,0.898854799654007,0,1,ATPase activity, uncoupled,MF,
7377,GO:0031438,1.00000000001428,0.88030820702093,0,1,negative regulation of mRNA cleavage,BP,
18929,GO:1904721,1.00000000001428,0.88030820702093,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
1543,GO:0003940,1.00000000001429,0.880894272294816,0,1,L-iduronidase activity,MF,
3834,GO:0008444,1.00000000001429,0.880894272294816,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
6767,GO:0030209,1.00000000001429,0.880894272294816,0,1,dermatan sulfate catabolic process,BP,
9586,GO:0036458,1.00000000001429,0.880894272294816,0,1,hepatocyte growth factor binding,MF,
2898,GO:0006408,1.0000000000143,0.778246677862305,0,2,snRNA export from nucleus,BP,
9292,GO:0035752,1.0000000000143,0.882093684241157,0,1,lysosomal lumen pH elevation,BP,
9548,GO:0036343,1.00000000001431,0.901872797177533,0,1,psychomotor behavior,BP,
1312,GO:0003162,1.00000000001431,0.772809557955884,0,2,atrioventricular node development,BP,
7672,GO:0032116,1.00000000001432,0.772215849909804,0,2,SMC loading complex,CC,
16348,GO:0090694,1.00000000001432,0.772215849909804,0,2,Scc2-Scc4 cohesin loading complex,CC,
268,GO:0000741,1.00000000001432,0.883185634349908,0,1,karyogamy,BP,
3480,GO:0007344,1.00000000001432,0.883185634349908,0,1,pronuclear fusion,BP,
13134,GO:0051732,1.00000000001432,0.883185634349908,0,1,polyribonucleotide kinase activity,MF,
13137,GO:0051736,1.00000000001432,0.883185634349908,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
1791,GO:0004423,1.00000000001433,0.880084636952744,0,1,iduronate-2-sulfatase activity,MF,
8361,GO:0033269,1.00000000001434,0.775163976500277,0,2,internode region of axon,CC,
10435,GO:0043309,1.00000000001436,0.780841212619822,0,2,regulation of eosinophil degranulation,BP,
10436,GO:0043311,1.00000000001436,0.780841212619822,0,2,positive regulation of eosinophil degranulation,BP,
18015,GO:1902566,1.00000000001436,0.780841212619822,0,2,regulation of eosinophil activation,BP,
18016,GO:1902568,1.00000000001436,0.780841212619822,0,2,positive regulation of eosinophil activation,BP,
10133,GO:0042727,1.00000000001437,0.776217869848641,0,2,flavin-containing compound biosynthetic process,BP,
11205,GO:0045356,1.00000000001438,0.774774857262536,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
16240,GO:0090326,1.00000000001438,0.880272227574299,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
18102,GO:1902823,1.00000000001438,0.880272227574299,0,1,negative regulation of late endosome to lysosome transport,BP,
18328,GO:1903336,1.00000000001438,0.880272227574299,0,1,negative regulation of vacuolar transport,BP,
19830,GO:2000331,1.00000000001438,0.880272227574299,0,1,regulation of terminal button organization,BP,
9686,GO:0038098,1.00000000001439,0.881432216340914,0,1,sequestering of BMP from receptor via BMP binding,BP,
11614,GO:0046340,1.00000000001439,0.774856532985971,0,2,diacylglycerol catabolic process,BP,
13987,GO:0060734,1.00000000001441,0.880123404421176,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
13033,GO:0051548,1.00000000001442,0.774051864510842,0,2,negative regulation of keratinocyte migration,BP,
3871,GO:0008506,1.00000000001443,0.774843567160759,0,2,sucrose:proton symporter activity,MF,
3879,GO:0008515,1.00000000001443,0.774843567160759,0,2,sucrose transmembrane transporter activity,MF,
4282,GO:0009669,1.00000000001443,0.774843567160759,0,2,sucrose:cation symporter activity,MF,
5002,GO:0015154,1.00000000001443,0.774843567160759,0,2,disaccharide transmembrane transporter activity,MF,
5003,GO:0015157,1.00000000001443,0.774843567160759,0,2,oligosaccharide transmembrane transporter activity,MF,
5185,GO:0015766,1.00000000001443,0.774843567160759,0,2,disaccharide transport,BP,
5186,GO:0015770,1.00000000001443,0.774843567160759,0,2,sucrose transport,BP,
5187,GO:0015772,1.00000000001443,0.774843567160759,0,2,oligosaccharide transport,BP,
14265,GO:0061386,1.00000000001445,0.77323320646169,0,2,closure of optic fissure,BP,
12429,GO:0050185,1.00000000001445,0.875916083190938,0,1,phosphatidylinositol deacylase activity,MF,
1834,GO:0004492,1.00000000001448,0.881129796436298,0,1,methylmalonyl-CoA decarboxylase activity,MF,
10503,GO:0043435,1.00000000001449,0.880372305772046,0,1,response to corticotropin-releasing hormone,BP,
15197,GO:0071376,1.00000000001449,0.880372305772046,0,1,cellular response to corticotropin-releasing hormone stimulus,BP,
16767,GO:0098633,1.00000000001451,0.880399567324861,0,1,collagen fibril binding,MF,
18653,GO:1904027,1.00000000001451,0.880399567324861,0,1,negative regulation of collagen fibril organization,BP,
16863,GO:0098833,1.00000000001452,0.88012280606856,0,1,presynaptic endocytic zone,CC,
16864,GO:0098835,1.00000000001452,0.88012280606856,0,1,presynaptic endocytic zone membrane,CC,
11363,GO:0045759,1.00000000001456,0.779957776917731,0,2,negative regulation of action potential,BP,
17154,GO:0103053,1.00000000001456,0.787060837619852,0,2,1-ethyladenine demethylase activity,MF,
19412,GO:1990072,1.00000000001458,0.789916109348266,0,2,TRAPPIII protein complex,CC,
16439,GO:0097145,1.00000000001459,0.880896938459708,0,1,BAK complex,CC,
196,GO:0000415,1.0000000000146,0.879975479828482,0,1,negative regulation of histone H3-K36 methylation,BP,
10018,GO:0042483,1.0000000000146,0.879975479828482,0,1,negative regulation of odontogenesis,BP,
14585,GO:0070171,1.0000000000146,0.879975479828482,0,1,negative regulation of tooth mineralization,BP,
7428,GO:0031547,1.00000000001461,0.774345405416528,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
5996,GO:0019034,1.00000000001463,0.774613041674218,0,2,viral replication complex,CC,
7173,GO:0031064,1.00000000001464,0.771160464065854,0,2,negative regulation of histone deacetylation,BP,
14376,GO:0061663,1.00000000001464,0.879585934500888,0,1,NEDD8 ligase activity,MF,
15146,GO:0071301,1.00000000001464,0.879585934500888,0,1,cellular response to vitamin B1,BP,
18797,GO:1904404,1.00000000001464,0.879585934500888,0,1,response to formaldehyde,BP,
13854,GO:0060510,1.00000000001466,0.781915939597299,0,2,Type II pneumocyte differentiation,BP,
10916,GO:0044565,1.00000000001466,0.780199499585283,0,2,dendritic cell proliferation,BP,
1691,GO:0004168,1.00000000001468,0.880881072927915,0,1,dolichol kinase activity,MF,
10280,GO:0043048,1.00000000001468,0.880881072927915,0,1,dolichyl monophosphate biosynthetic process,BP,
16189,GO:0090258,1.00000000001468,0.774782837488751,0,2,negative regulation of mitochondrial fission,BP,
4773,GO:0010963,1.00000000001469,0.88624173405057,0,1,regulation of L-arginine import,BP,
14991,GO:0070947,1.00000000001469,0.88624173405057,0,1,neutrophil mediated killing of fungus,BP,
14996,GO:0070953,1.00000000001469,0.88624173405057,0,1,regulation of neutrophil mediated killing of fungus,BP,
15001,GO:0070965,1.00000000001469,0.88624173405057,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
19942,GO:2000552,1.00000000001469,0.88624173405057,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
13740,GO:0060342,1.00000000001469,0.882234464629276,0,1,photoreceptor inner segment membrane,CC,
8755,GO:0034441,1.0000000000147,0.882781741384936,0,1,plasma lipoprotein particle oxidation,BP,
16610,GO:0097498,1.0000000000147,0.776228275518618,0,2,endothelial tube lumen extension,BP,
7752,GO:0032277,1.00000000001471,0.880957846720149,0,1,negative regulation of gonadotropin secretion,BP,
10538,GO:0043509,1.00000000001471,0.880957846720149,0,1,activin A complex,CC,
10539,GO:0043511,1.00000000001471,0.880957846720149,0,1,inhibin complex,CC,
10540,GO:0043512,1.00000000001471,0.880957846720149,0,1,inhibin A complex,CC,
11059,GO:0045077,1.00000000001471,0.880957846720149,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11854,GO:0046882,1.00000000001471,0.880957846720149,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
12099,GO:0048180,1.00000000001471,0.880957846720149,0,1,activin complex,CC,
13688,GO:0060278,1.00000000001471,0.880957846720149,0,1,regulation of ovulation,BP,
13689,GO:0060279,1.00000000001471,0.880957846720149,0,1,positive regulation of ovulation,BP,
19710,GO:2000111,1.00000000001471,0.78369483400151,0,2,positive regulation of macrophage apoptotic process,BP,
6045,GO:0019185,1.00000000001471,0.774812621156691,0,2,snRNA-activating protein complex,CC,
3091,GO:0006667,1.00000000001472,0.776057657542142,0,2,sphinganine metabolic process,BP,
11693,GO:0046511,1.00000000001472,0.776057657542142,0,2,sphinganine biosynthetic process,BP,
7584,GO:0031962,1.00000000001472,0.880071523471391,0,1,mineralocorticoid receptor binding,MF,
13696,GO:0060290,1.00000000001472,0.880071523471391,0,1,transdifferentiation,BP,
14421,GO:0061767,1.00000000001472,0.880071523471391,0,1,negative regulation of lung blood pressure,BP,
16669,GO:0097644,1.00000000001474,0.787440371853643,0,2,calcitonin family binding,MF,
18382,GO:1903439,1.00000000001474,0.787440371853643,0,2,calcitonin family receptor complex,CC,
19489,GO:1990406,1.00000000001474,0.787440371853643,0,2,CGRP receptor complex,CC,
19491,GO:1990408,1.00000000001474,0.787440371853643,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
4446,GO:0010387,1.00000000001475,0.880673250039745,0,1,COP9 signalosome assembly,BP,
6157,GO:0019510,1.00000000001475,0.880673250039745,0,1,S-adenosylhomocysteine catabolic process,BP,
15131,GO:0071268,1.00000000001475,0.880673250039745,0,1,homocysteine biosynthetic process,BP,
9619,GO:0036501,1.00000000001477,0.880128744349798,0,1,UFD1-NPL4 complex,CC,
7289,GO:0031296,1.00000000001477,0.889913844067684,0,1,B cell costimulation,BP,
16951,GO:0099022,1.00000000001478,0.778505046935529,0,2,vesicle tethering,BP,
16955,GO:0099044,1.00000000001478,0.778505046935529,0,2,vesicle tethering to endoplasmic reticulum,BP,
7354,GO:0031405,1.00000000001478,0.876351758293899,0,1,lipoic acid binding,MF,
10641,GO:0043754,1.00000000001478,0.876351758293899,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
563,GO:0001705,1.00000000001479,0.774726709764565,0,2,ectoderm formation,BP,
570,GO:0001712,1.00000000001479,0.774726709764565,0,2,ectodermal cell fate commitment,BP,
8014,GO:0032658,1.0000000000148,0.882896657836044,0,1,regulation of interleukin-15 production,BP,
8058,GO:0032738,1.0000000000148,0.882896657836044,0,1,positive regulation of interleukin-15 production,BP,
9243,GO:0035664,1.0000000000148,0.882896657836044,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9244,GO:0035665,1.0000000000148,0.882896657836044,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
1264,GO:0003032,1.00000000001483,0.775303475184937,0,2,detection of oxygen,BP,
19562,GO:1990700,1.00000000001484,0.880163425481822,0,1,nucleolar chromatin organization,BP,
18641,GO:1903999,1.00000000001486,0.78893274593739,0,2,negative regulation of eating behavior,BP,
19775,GO:2000252,1.00000000001486,0.78893274593739,0,2,negative regulation of feeding behavior,BP,
382,GO:0001018,1.00000000001486,0.776338146670613,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
962,GO:0002386,1.00000000001487,0.77625615151259,0,2,immune response in mucosal-associated lymphoid tissue,BP,
968,GO:0002415,1.00000000001487,0.77625615151259,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
16686,GO:0097698,1.00000000001487,0.885746013183763,0,1,telomere maintenance via base-excision repair,BP,
13261,GO:0051977,1.00000000001487,0.880906339425627,0,1,lysophospholipid transport,BP,
13262,GO:0051978,1.00000000001487,0.880906339425627,0,1,lysophospholipid transporter activity,MF,
16754,GO:0098594,1.00000000001489,0.897847391496906,0,1,mucin granule,CC,
6373,GO:0021564,1.00000000001491,0.775699725961209,0,2,vagus nerve development,BP,
16495,GO:0097232,1.00000000001492,0.880264097021035,0,1,lamellar body membrane,CC,
16496,GO:0097233,1.00000000001492,0.880264097021035,0,1,alveolar lamellar body membrane,CC,
106,GO:0000221,1.00000000001493,0.682651904705421,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
3848,GO:0008466,1.00000000001493,0.882727412064127,0,1,glycogenin glucosyltransferase activity,MF,
17138,GO:0102751,1.00000000001493,0.882727412064127,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
14800,GO:0070563,1.00000000001493,0.775554798407508,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
16662,GO:0097636,1.00000000001495,0.77480970906424,0,2,intrinsic component of autophagosome membrane,CC,
16663,GO:0097637,1.00000000001495,0.77480970906424,0,2,integral component of autophagosome membrane,CC,
8603,GO:0034128,1.00000000001498,0.681773871202563,0,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
6343,GO:0021524,1.000000000015,0.777149488367161,0,2,visceral motor neuron differentiation,BP,
17827,GO:1902044,1.00000000001501,0.775000114663233,0,2,regulation of Fas signaling pathway,BP,
16950,GO:0099011,1.00000000001503,0.774509045230331,0,2,neuronal dense core vesicle exocytosis,BP,
17020,GO:0099525,1.00000000001503,0.774509045230331,0,2,presynaptic dense core vesicle exocytosis,BP,
8866,GO:0034686,1.00000000001507,0.772976750109244,0,2,integrin alphav-beta8 complex,CC,
9340,GO:0035866,1.00000000001507,0.772976750109244,0,2,alphav-beta3 integrin-PKCalpha complex,CC,
17049,GO:0099580,1.00000000001507,0.880050297884606,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
19504,GO:1990430,1.00000000001507,0.772976750109244,0,2,extracellular matrix protein binding,MF,
13498,GO:0055095,1.00000000001508,0.880178858539369,0,1,lipoprotein particle mediated signaling,BP,
13499,GO:0055096,1.00000000001508,0.880178858539369,0,1,low-density lipoprotein particle mediated signaling,BP,
592,GO:0001757,1.00000000001508,0.77473250488056,0,2,somite specification,BP,
3128,GO:0006713,1.00000000001509,0.882859197433179,0,1,glucocorticoid catabolic process,BP,
16471,GO:0097195,1.00000000001509,0.775314910969526,0,2,pilomotor reflex,BP,
5629,GO:0016715,1.00000000001509,0.774837860389979,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
9982,GO:0042414,1.00000000001509,0.775203278924556,0,2,epinephrine metabolic process,BP,
17569,GO:1901254,1.00000000001512,0.880129335674643,0,1,positive regulation of intracellular transport of viral material,BP,
18073,GO:1902737,1.00000000001512,0.880129335674643,0,1,dendritic filopodium,CC,
17994,GO:1902523,1.00000000001514,0.774672113354437,0,2,positive regulation of protein K63-linked ubiquitination,BP,
4794,GO:0010991,1.00000000001515,0.77376595675755,0,2,negative regulation of SMAD protein complex assembly,BP,
20219,GO:2001201,1.0000000000152,0.773552285984996,0,2,regulation of transforming growth factor-beta secretion,BP,
4,GO:0000010,1.00000000001521,0.778380674698073,0,2,trans-hexaprenyltranstransferase activity,MF,
12449,GO:0050347,1.00000000001521,0.778380674698073,0,2,trans-octaprenyltranstransferase activity,MF,
13377,GO:0052739,1.00000000001523,0.88130438133434,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13378,GO:0052740,1.00000000001523,0.88130438133434,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18851,GO:1904550,1.00000000001523,0.88130438133434,0,1,response to arachidonic acid,BP,
19824,GO:2000324,1.00000000001523,0.88130438133434,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
6127,GO:0019389,1.00000000001525,0.880359297165784,0,1,glucuronoside metabolic process,BP,
6128,GO:0019391,1.00000000001525,0.880359297165784,0,1,glucuronoside catabolic process,BP,
17118,GO:0102390,1.00000000001525,0.880359297165784,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
7891,GO:0032468,1.00000000001526,0.8802353656787,0,1,Golgi calcium ion homeostasis,BP,
11497,GO:0046032,1.00000000001527,0.88524483229491,0,1,ADP catabolic process,BP,
10087,GO:0042613,1.00000000001528,0.700721693986682,0,3,MHC class II protein complex,CC,
16028,GO:0086098,1.00000000001529,0.77483487993058,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
4001,GO:0008962,1.0000000000153,0.77611699767336,0,2,phosphatidylglycerophosphatase activity,MF,
18209,GO:1903045,1.0000000000153,0.880100107177552,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
5522,GO:0016503,1.00000000001531,0.888139659734833,0,1,pheromone receptor activity,MF,
11717,GO:0046554,1.00000000001531,0.888139659734833,0,1,malate dehydrogenase (NADP+) activity,MF,
11108,GO:0045163,1.00000000001534,0.772608393044186,0,2,clustering of voltage-gated potassium channels,BP,
8274,GO:0033091,1.00000000001534,0.880374214397035,0,1,positive regulation of immature T cell proliferation,BP,
14753,GO:0070481,1.00000000001537,0.880328831353966,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14847,GO:0070651,1.00000000001537,0.880328831353966,0,1,nonfunctional rRNA decay,BP,
20010,GO:2000663,1.00000000001537,0.880211425699909,0,1,negative regulation of interleukin-5 secretion,BP,
11968,GO:0047325,1.00000000001538,0.880278994397733,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
13374,GO:0052725,1.00000000001538,0.880278994397733,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13375,GO:0052726,1.00000000001538,0.880278994397733,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13397,GO:0052825,1.00000000001538,0.880278994397733,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13402,GO:0052830,1.00000000001538,0.880278994397733,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13403,GO:0052831,1.00000000001538,0.880278994397733,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13407,GO:0052835,1.00000000001538,0.880278994397733,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14446,GO:0061845,1.00000000001538,0.880278994397733,0,1,neuron projection branch point,CC,
14447,GO:0061846,1.00000000001538,0.880278994397733,0,1,dendritic spine cytoplasm,CC,
8741,GO:0034416,1.00000000001539,0.774979152973377,0,2,bisphosphoglycerate phosphatase activity,MF,
15789,GO:0072513,1.0000000000154,0.896590496301109,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
18928,GO:1904720,1.00000000001542,0.775089424523006,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
1694,GO:0004174,1.00000000001543,0.775140784534917,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5602,GO:0016649,1.00000000001543,0.775140784534917,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
10938,GO:0044691,1.00000000001546,0.774584001469635,0,2,tooth eruption,BP,
1334,GO:0003193,1.00000000001547,0.880294412713594,0,1,pulmonary valve formation,BP,
9371,GO:0035922,1.00000000001547,0.880294412713594,0,1,foramen ovale closure,BP,
15997,GO:0086044,1.00000000001547,0.880294412713594,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16003,GO:0086054,1.00000000001547,0.880294412713594,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16004,GO:0086055,1.00000000001547,0.880294412713594,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16017,GO:0086076,1.00000000001547,0.880294412713594,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16019,GO:0086078,1.00000000001547,0.880294412713594,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16020,GO:0086079,1.00000000001547,0.880294412713594,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16901,GO:0098906,1.00000000001547,0.880294412713594,0,1,regulation of Purkinje myocyte action potential,BP,
19398,GO:1990029,1.00000000001547,0.880294412713594,0,1,vasomotion,BP,
18673,GO:1904059,1.0000000000155,0.869999810567316,0,1,regulation of locomotor rhythm,BP,
14024,GO:0060816,1.00000000001551,0.771669855166219,0,2,random inactivation of X chromosome,BP,
451,GO:0001225,1.00000000001551,0.772440433019759,0,2,RNA polymerase II transcription coactivator binding,MF,
6442,GO:0021764,1.00000000001552,0.768981144693927,0,2,amygdala development,BP,
9895,GO:0042245,1.00000000001555,0.774838716168397,0,2,RNA repair,BP,
9862,GO:0042138,1.00000000001558,0.880599284986865,0,1,meiotic DNA double-strand break formation,BP,
18691,GO:1904155,1.00000000001558,0.880263651338561,0,1,DN2 thymocyte differentiation,BP,
18692,GO:1904156,1.00000000001558,0.880263651338561,0,1,DN3 thymocyte differentiation,BP,
14404,GO:0061736,1.00000000001558,0.880095782638628,0,1,engulfment of target by autophagosome,BP,
14415,GO:0061753,1.00000000001558,0.880095782638628,0,1,substrate localization to autophagosome,BP,
19493,GO:1990410,1.00000000001559,0.780014814529868,0,2,adrenomedullin receptor signaling pathway,BP,
6513,GO:0021896,1.00000000001559,0.769130181608641,0,2,forebrain astrocyte differentiation,BP,
6514,GO:0021897,1.00000000001559,0.769130181608641,0,2,forebrain astrocyte development,BP,
5460,GO:0016361,1.00000000001559,0.777219448484619,0,2,activin receptor activity, type I,MF,
12098,GO:0048179,1.00000000001559,0.777219448484619,0,2,activin receptor complex,CC,
19111,GO:1905123,1.00000000001561,0.774636680558894,0,2,regulation of glucosylceramidase activity,BP,
9511,GO:0036245,1.00000000001562,0.779682437693848,0,2,cellular response to menadione,BP,
11943,GO:0047159,1.00000000001562,0.880162286575954,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11948,GO:0047191,1.00000000001562,0.880162286575954,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
20248,GO:2001246,1.00000000001562,0.880162286575954,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
11371,GO:0045769,1.00000000001564,0.876229243927545,0,1,negative regulation of asymmetric cell division,BP,
608,GO:0001777,1.00000000001564,0.896476077991299,0,1,T cell homeostatic proliferation,BP,
944,GO:0002358,1.00000000001564,0.896476077991299,0,1,B cell homeostatic proliferation,BP,
8206,GO:0032976,1.00000000001564,0.896476077991299,0,1,release of matrix enzymes from mitochondria,BP,
16438,GO:0097144,1.00000000001564,0.896476077991299,0,1,BAX complex,CC,
19422,GO:1990117,1.00000000001564,0.896476077991299,0,1,B cell receptor apoptotic signaling pathway,BP,
1841,GO:0004500,1.00000000001566,0.880312383426837,0,1,dopamine beta-monooxygenase activity,MF,
3035,GO:0006589,1.00000000001566,0.880312383426837,0,1,octopamine biosynthetic process,BP,
11610,GO:0046333,1.00000000001566,0.880312383426837,0,1,octopamine metabolic process,BP,
15488,GO:0071894,1.00000000001567,0.775555449135426,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
15844,GO:0072592,1.00000000001568,0.776300195568526,0,2,oxygen metabolic process,BP,
581,GO:0001735,1.00000000001568,0.774837407683222,0,2,prenylcysteine oxidase activity,MF,
6851,GO:0030328,1.00000000001568,0.774837407683222,0,2,prenylcysteine catabolic process,BP,
6852,GO:0030329,1.00000000001568,0.774837407683222,0,2,prenylcysteine metabolic process,BP,
18952,GO:1904766,1.00000000001569,0.87979748604142,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
1790,GO:0004422,1.0000000000157,0.781977840494482,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2762,GO:0006178,1.0000000000157,0.781977840494482,0,2,guanine salvage,BP,
7740,GO:0032263,1.0000000000157,0.781977840494482,0,2,GMP salvage,BP,
11537,GO:0046099,1.0000000000157,0.781977840494482,0,2,guanine biosynthetic process,BP,
3741,GO:0008282,1.00000000001571,0.774770233033485,0,2,inward rectifying potassium channel,CC,
2320,GO:0005329,1.00000000001573,0.774591740339679,0,2,dopamine transmembrane transporter activity,MF,
9409,GO:0035990,1.00000000001574,0.882904194806927,0,1,tendon cell differentiation,BP,
9410,GO:0035992,1.00000000001574,0.882904194806927,0,1,tendon formation,BP,
12189,GO:0048389,1.00000000001574,0.882904194806927,0,1,intermediate mesoderm development,BP,
12190,GO:0048390,1.00000000001574,0.882904194806927,0,1,intermediate mesoderm morphogenesis,BP,
12191,GO:0048391,1.00000000001574,0.882904194806927,0,1,intermediate mesoderm formation,BP,
12192,GO:0048392,1.00000000001574,0.882904194806927,0,1,intermediate mesodermal cell differentiation,BP,
13456,GO:0055018,1.00000000001574,0.882904194806927,0,1,regulation of cardiac muscle fiber development,BP,
13457,GO:0055020,1.00000000001574,0.882904194806927,0,1,positive regulation of cardiac muscle fiber development,BP,
13852,GO:0060503,1.00000000001574,0.882904194806927,0,1,bud dilation involved in lung branching,BP,
14186,GO:0061149,1.00000000001574,0.882904194806927,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14187,GO:0061150,1.00000000001574,0.882904194806927,0,1,renal system segmentation,BP,
14188,GO:0061151,1.00000000001574,0.882904194806927,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14192,GO:0061155,1.00000000001574,0.882904194806927,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14214,GO:0061216,1.00000000001574,0.882904194806927,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14217,GO:0061227,1.00000000001574,0.882904194806927,0,1,pattern specification involved in mesonephros development,BP,
15487,GO:0071893,1.00000000001574,0.882904194806927,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15583,GO:0072096,1.00000000001574,0.882904194806927,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15584,GO:0072097,1.00000000001574,0.882904194806927,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15585,GO:0072098,1.00000000001574,0.882904194806927,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15586,GO:0072099,1.00000000001574,0.882904194806927,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15587,GO:0072100,1.00000000001574,0.882904194806927,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15588,GO:0072101,1.00000000001574,0.882904194806927,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15644,GO:0072192,1.00000000001574,0.882904194806927,0,1,ureter epithelial cell differentiation,BP,
15648,GO:0072198,1.00000000001574,0.882904194806927,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15649,GO:0072199,1.00000000001574,0.882904194806927,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15650,GO:0072200,1.00000000001574,0.882904194806927,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
17789,GO:1901964,1.00000000001574,0.882904194806927,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19656,GO:2000004,1.00000000001574,0.882904194806927,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19657,GO:2000005,1.00000000001574,0.882904194806927,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19658,GO:2000006,1.00000000001574,0.882904194806927,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19659,GO:2000007,1.00000000001574,0.882904194806927,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
1295,GO:0003130,1.00000000001574,0.777209137140579,0,2,BMP signaling pathway involved in heart induction,BP,
1297,GO:0003133,1.00000000001574,0.777209137140579,0,2,endodermal-mesodermal cell signaling,BP,
1298,GO:0003134,1.00000000001574,0.777209137140579,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
15614,GO:0072138,1.00000000001574,0.777209137140579,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
218,GO:0000455,1.00000000001575,0.77782186833119,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
2061,GO:0004816,1.00000000001575,0.775301781554564,0,2,asparagine-tRNA ligase activity,MF,
2236,GO:0005143,1.00000000001577,0.77595550883295,0,2,interleukin-12 receptor binding,MF,
8386,GO:0033326,1.0000000000158,0.88012281646695,0,1,cerebrospinal fluid secretion,BP,
12165,GO:0048319,1.00000000001581,0.774545221692775,0,2,axial mesoderm morphogenesis,BP,
1618,GO:0004053,1.00000000001581,0.781377361694624,0,2,arginase activity,MF,
6174,GO:0019547,1.00000000001581,0.781377361694624,0,2,arginine catabolic process to ornithine,BP,
5980,GO:0018879,1.00000000001582,0.775567417893153,0,2,biphenyl metabolic process,BP,
1874,GO:0004556,1.00000000001583,0.880921331687303,0,1,alpha-amylase activity,MF,
5362,GO:0016160,1.00000000001583,0.880921331687303,0,1,amylase activity,MF,
17151,GO:0103025,1.00000000001583,0.880921331687303,0,1,alpha-amylase activity (releasing maltohexaose),MF,
6906,GO:0030505,1.00000000001584,0.773159953537618,0,2,inorganic diphosphate transport,BP,
11763,GO:0046642,1.00000000001584,0.682876975252879,0,3,negative regulation of alpha-beta T cell proliferation,BP,
9285,GO:0035744,1.00000000001584,0.890567228682478,0,1,T-helper 1 cell cytokine production,BP,
9893,GO:0042231,1.00000000001584,0.890567228682478,0,1,interleukin-13 biosynthetic process,BP,
18283,GO:1903233,1.00000000001584,0.773653573544631,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
1597,GO:0004018,1.00000000001586,0.885876813024729,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
14831,GO:0070626,1.00000000001586,0.885876813024729,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
9205,GO:0035606,1.00000000001589,0.800266907512659,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
4532,GO:0010609,1.00000000001589,0.775215794027986,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
15503,GO:0071920,1.00000000001589,0.776007991028172,0,2,cleavage body,CC,
10649,GO:0043874,1.00000000001589,0.881530273267436,0,1,acireductone synthase activity,MF,
15642,GO:0072190,1.0000000000159,0.777093583635716,0,2,ureter urothelium development,BP,
15643,GO:0072191,1.0000000000159,0.777093583635716,0,2,ureter smooth muscle development,BP,
15645,GO:0072193,1.0000000000159,0.777093583635716,0,2,ureter smooth muscle cell differentiation,BP,
15647,GO:0072197,1.0000000000159,0.777093583635716,0,2,ureter morphogenesis,BP,
17455,GO:1900378,1.00000000001591,0.774020890924012,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
14681,GO:0070336,1.00000000001591,0.774761761457292,0,2,flap-structured DNA binding,MF,
1639,GO:0004084,1.00000000001593,0.777337355434873,0,2,branched-chain-amino-acid transaminase activity,MF,
4041,GO:0009082,1.00000000001593,0.777337355434873,0,2,branched-chain amino acid biosynthetic process,BP,
4049,GO:0009098,1.00000000001593,0.777337355434873,0,2,leucine biosynthetic process,BP,
4050,GO:0009099,1.00000000001593,0.777337355434873,0,2,valine biosynthetic process,BP,
13358,GO:0052654,1.00000000001593,0.777337355434873,0,2,L-leucine transaminase activity,MF,
13359,GO:0052655,1.00000000001593,0.777337355434873,0,2,L-valine transaminase activity,MF,
13360,GO:0052656,1.00000000001593,0.777337355434873,0,2,L-isoleucine transaminase activity,MF,
3950,GO:0008670,1.00000000001593,0.786368301887213,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
6502,GO:0021882,1.00000000001593,0.775586589485443,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6510,GO:0021893,1.00000000001593,0.775586589485443,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
9352,GO:0035881,1.00000000001593,0.775586589485443,0,2,amacrine cell differentiation,BP,
14150,GO:0061074,1.00000000001593,0.775586589485443,0,2,regulation of neural retina development,BP,
14151,GO:0061075,1.00000000001593,0.775586589485443,0,2,positive regulation of neural retina development,BP,
18113,GO:1902866,1.00000000001593,0.775586589485443,0,2,regulation of retina development in camera-type eye,BP,
18114,GO:1902868,1.00000000001593,0.775586589485443,0,2,positive regulation of retina development in camera-type eye,BP,
18115,GO:1902869,1.00000000001593,0.775586589485443,0,2,regulation of amacrine cell differentiation,BP,
18116,GO:1902871,1.00000000001593,0.775586589485443,0,2,positive regulation of amacrine cell differentiation,BP,
8384,GO:0033319,1.00000000001593,0.88121048769174,0,1,UDP-D-xylose metabolic process,BP,
8385,GO:0033320,1.00000000001593,0.88121048769174,0,1,UDP-D-xylose biosynthetic process,BP,
12065,GO:0048040,1.00000000001593,0.88121048769174,0,1,UDP-glucuronate decarboxylase activity,MF,
2129,GO:0004935,1.00000000001594,0.776465489784164,0,2,adrenergic receptor activity,MF,
756,GO:0001998,1.00000000001595,0.882010454163462,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
776,GO:0002034,1.00000000001595,0.882010454163462,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1276,GO:0003072,1.00000000001595,0.882010454163462,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18484,GO:1903673,1.00000000001595,0.882010454163462,0,1,mitotic cleavage furrow formation,BP,
18914,GO:1904695,1.00000000001595,0.882010454163462,0,1,positive regulation of vascular smooth muscle contraction,BP,
14419,GO:0061762,1.00000000001597,0.774599660922588,0,2,CAMKK-AMPK signaling cascade,BP,
16948,GO:0099004,1.00000000001597,0.774599660922588,0,2,calmodulin dependent kinase signaling pathway,BP,
3340,GO:0007060,1.00000000001597,0.77507301969971,0,2,male meiosis chromosome segregation,BP,
5089,GO:0015367,1.00000000001597,0.88292689577634,0,1,oxoglutarate:malate antiporter activity,MF,
5176,GO:0015742,1.00000000001597,0.88292689577634,0,1,alpha-ketoglutarate transport,BP,
228,GO:0000472,1.00000000001597,0.68101392649127,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
353,GO:0000967,1.00000000001597,0.68101392649127,0,3,rRNA 5'-end processing,BP,
19638,GO:1990927,1.00000000001599,0.77460721441188,0,2,calcium ion regulated lysosome exocytosis,BP,
2455,GO:0005668,1.000000000016,0.782583797386939,0,2,RNA polymerase transcription factor SL1 complex,CC,
11099,GO:0045142,1.000000000016,0.774643810617136,0,2,triplex DNA binding,MF,
7567,GO:0031938,1.00000000001601,0.779808998058746,0,2,regulation of chromatin silencing at telomere,BP,
18406,GO:1903516,1.00000000001602,0.682706656834,0,3,regulation of single strand break repair,BP,
18693,GO:1904167,1.00000000001603,0.876785955572087,0,1,regulation of thyroid hormone receptor activity,BP,
18694,GO:1904168,1.00000000001603,0.876785955572087,0,1,negative regulation of thyroid hormone receptor activity,BP,
1803,GO:0004452,1.00000000001608,0.781871081197587,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12705,GO:0050992,1.00000000001608,0.781871081197587,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12706,GO:0050993,1.00000000001608,0.781871081197587,0,2,dimethylallyl diphosphate metabolic process,BP,
9007,GO:0035226,1.00000000001609,0.880307913281962,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9008,GO:0035227,1.00000000001609,0.880307913281962,0,1,regulation of glutamate-cysteine ligase activity,BP,
9009,GO:0035229,1.00000000001609,0.880307913281962,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
17923,GO:1902302,1.00000000001612,0.774607249760807,0,2,regulation of potassium ion export,BP,
17570,GO:1901255,1.00000000001612,0.778392006364607,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
6963,GO:0030626,1.00000000001613,0.776451702013761,0,2,U12 snRNA binding,MF,
2496,GO:0005745,1.00000000001613,0.774981832201641,0,2,m-AAA complex,CC,
2260,GO:0005175,1.00000000001616,0.899194530678145,0,1,CD27 receptor binding,MF,
204,GO:0000430,1.00000000001616,0.780815051142671,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
206,GO:0000432,1.00000000001616,0.780815051142671,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
12009,GO:0047708,1.00000000001617,0.881323953210366,0,1,biotinidase activity,MF,
13767,GO:0060380,1.00000000001617,0.881323953210366,0,1,regulation of single-stranded telomeric DNA binding,BP,
13768,GO:0060381,1.00000000001617,0.881323953210366,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
19478,GO:1990384,1.00000000001617,0.888540611286901,0,1,hyaloid vascular plexus regression,BP,
7895,GO:0032472,1.00000000001617,0.776146802685807,0,2,Golgi calcium ion transport,BP,
3522,GO:0007499,1.00000000001619,0.880123566715821,0,1,ectoderm and mesoderm interaction,BP,
12366,GO:0048807,1.00000000001619,0.880123566715821,0,1,female genitalia morphogenesis,BP,
18902,GO:1904674,1.00000000001619,0.880123566715821,0,1,positive regulation of somatic stem cell population maintenance,BP,
7352,GO:0031403,1.00000000001619,0.774241956411391,0,2,lithium ion binding,MF,
11468,GO:0045950,1.0000000000162,0.775071802267101,0,2,negative regulation of mitotic recombination,BP,
4429,GO:0010269,1.0000000000162,0.696146523291435,0,3,response to selenium ion,BP,
18447,GO:1903575,1.00000000001623,0.779947706233035,0,2,cornified envelope assembly,BP,
16543,GO:0097360,1.00000000001625,0.774648658336283,0,2,chorionic trophoblast cell proliferation,BP,
17619,GO:1901382,1.00000000001625,0.774648658336283,0,2,regulation of chorionic trophoblast cell proliferation,BP,
16541,GO:0097356,1.00000000001626,0.87950580801547,0,1,perinucleolar compartment,CC,
6475,GO:0021824,1.00000000001627,0.77485784798494,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6479,GO:0021828,1.00000000001627,0.77485784798494,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6490,GO:0021856,1.00000000001627,0.77485784798494,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
13772,GO:0060385,1.00000000001627,0.77485784798494,0,2,axonogenesis involved in innervation,BP,
18345,GO:1903375,1.00000000001627,0.77485784798494,0,2,facioacoustic ganglion development,BP,
16748,GO:0098582,1.00000000001629,0.77463326948935,0,2,innate vocalization behavior,BP,
6225,GO:0019780,1.00000000001632,0.879947211416708,0,1,FAT10 activating enzyme activity,MF,
8374,GO:0033291,1.00000000001634,0.905430063959589,0,1,eukaryotic 80S initiation complex,CC,
8770,GO:0034463,1.00000000001634,0.905430063959589,0,1,90S preribosome assembly,BP,
7378,GO:0031439,1.00000000001634,0.774930881184622,0,2,positive regulation of mRNA cleavage,BP,
20205,GO:2001180,1.00000000001634,0.776517216422544,0,2,negative regulation of interleukin-10 secretion,BP,
11049,GO:0045065,1.00000000001635,0.77803065295446,0,2,cytotoxic T cell differentiation,BP,
11257,GO:0045583,1.00000000001635,0.77803065295446,0,2,regulation of cytotoxic T cell differentiation,BP,
11258,GO:0045585,1.00000000001635,0.77803065295446,0,2,positive regulation of cytotoxic T cell differentiation,BP,
5656,GO:0016768,1.00000000001635,0.883645275659132,0,1,spermine synthase activity,MF,
9687,GO:0038101,1.00000000001637,0.883333853478898,0,1,sequestering of nodal from receptor via nodal binding,BP,
17355,GO:1900108,1.00000000001637,0.883333853478898,0,1,negative regulation of nodal signaling pathway,BP,
17382,GO:1900146,1.00000000001637,0.883333853478898,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17397,GO:1900176,1.00000000001637,0.883333853478898,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
1383,GO:0003289,1.00000000001637,0.681888374080607,0,3,atrial septum primum morphogenesis,BP,
7000,GO:0030692,1.00000000001639,0.778306212599638,0,2,Noc4p-Nop14p complex,CC,
2357,GO:0005457,1.00000000001639,0.774495220891772,0,2,GDP-fucose transmembrane transporter activity,MF,
5190,GO:0015783,1.00000000001639,0.774495220891772,0,2,GDP-fucose transmembrane transport,BP,
9453,GO:0036080,1.00000000001639,0.774495220891772,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
4095,GO:0009153,1.0000000000164,0.787202697046479,0,2,purine deoxyribonucleotide biosynthetic process,BP,
2149,GO:0004969,1.00000000001641,0.774791683139978,0,2,histamine receptor activity,MF,
6477,GO:0021826,1.00000000001643,0.775091563424863,0,2,substrate-independent telencephalic tangential migration,BP,
6480,GO:0021830,1.00000000001643,0.775091563424863,0,2,interneuron migration from the subpallium to the cortex,BP,
6484,GO:0021843,1.00000000001643,0.775091563424863,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
1514,GO:0003877,1.00000000001644,0.881148606270977,0,1,ATP adenylyltransferase activity,MF,
2069,GO:0004824,1.00000000001644,0.881148606270977,0,1,lysine-tRNA ligase activity,MF,
2917,GO:0006430,1.00000000001644,0.881148606270977,0,1,lysyl-tRNA aminoacylation,BP,
2048,GO:0004799,1.00000000001651,0.88469588015652,0,1,thymidylate synthase activity,MF,
6025,GO:0019088,1.00000000001651,0.88469588015652,0,1,immortalization of host cell by virus,BP,
6324,GO:0020021,1.00000000001651,0.88469588015652,0,1,immortalization of host cell,BP,
9826,GO:0042083,1.00000000001651,0.88469588015652,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
5816,GO:0017089,1.00000000001651,0.776371292873206,0,2,glycolipid transporter activity,MF,
5997,GO:0019035,1.00000000001652,0.880094431619937,0,1,viral integration complex,CC,
11418,GO:0045870,1.00000000001652,0.880094431619937,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
19246,GO:1905463,1.00000000001652,0.880094431619937,0,1,negative regulation of DNA duplex unwinding,BP,
2797,GO:0006256,1.00000000001653,0.880327000110761,0,1,UDP catabolic process,BP,
4082,GO:0009140,1.00000000001653,0.880327000110761,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4130,GO:0009193,1.00000000001653,0.880327000110761,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4131,GO:0009195,1.00000000001653,0.880327000110761,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4156,GO:0009222,1.00000000001653,0.880327000110761,0,1,pyrimidine ribonucleotide catabolic process,BP,
11507,GO:0046048,1.00000000001653,0.880327000110761,0,1,UDP metabolic process,BP,
7336,GO:0031372,1.00000000001656,0.779487875444401,0,2,UBC13-MMS2 complex,CC,
8870,GO:0034696,1.00000000001657,0.775771314363043,0,2,response to prostaglandin F,BP,
1636,GO:0004081,1.00000000001658,0.786329111591199,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
3972,GO:0008796,1.00000000001658,0.786329111591199,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
3668,GO:0008169,1.00000000001658,0.688582049890581,0,3,C-methyltransferase activity,MF,
6964,GO:0030627,1.00000000001661,0.783310291350694,0,2,pre-mRNA 5'-splice site binding,MF,
7245,GO:0031213,1.00000000001661,0.774651277432526,0,2,RSF complex,CC,
557,GO:0001681,1.00000000001665,0.880336334438817,0,1,sialate O-acetylesterase activity,MF,
3647,GO:0008126,1.00000000001665,0.880336334438817,0,1,acetylesterase activity,MF,
13511,GO:0055120,1.00000000001666,0.892215367612012,0,1,striated muscle dense body,CC,
11252,GO:0045578,1.00000000001667,0.682463412916112,0,3,negative regulation of B cell differentiation,BP,
10962,GO:0044771,1.00000000001667,0.774949282046595,0,2,meiotic cell cycle phase transition,BP,
17806,GO:1901993,1.00000000001667,0.774949282046595,0,2,regulation of meiotic cell cycle phase transition,BP,
17807,GO:1901994,1.00000000001667,0.774949282046595,0,2,negative regulation of meiotic cell cycle phase transition,BP,
15028,GO:0071006,1.00000000001668,0.682551869311036,0,3,U2-type catalytic step 1 spliceosome,CC,
9603,GO:0036482,1.00000000001669,0.7872008828255,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18161,GO:1902958,1.00000000001669,0.7872008828255,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18351,GO:1903383,1.00000000001669,0.7872008828255,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18352,GO:1903384,1.00000000001669,0.7872008828255,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19465,GO:1990269,1.00000000001671,0.775391580707817,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
10123,GO:0042701,1.00000000001673,0.774864727817364,0,2,progesterone secretion,BP,
1338,GO:0003199,1.00000000001673,0.885289835572049,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
4820,GO:0014028,1.00000000001673,0.885289835572049,0,1,notochord formation,BP,
949,GO:0002368,1.00000000001673,0.880630374924073,0,1,B cell cytokine production,BP,
1194,GO:0002842,1.00000000001673,0.880630374924073,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9550,GO:0036351,1.00000000001673,0.880630374924073,0,1,histone H2A-K13 ubiquitination,BP,
9551,GO:0036352,1.00000000001673,0.880630374924073,0,1,histone H2A-K15 ubiquitination,BP,
1404,GO:0003340,1.00000000001674,0.774805844216972,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
20031,GO:2000697,1.00000000001674,0.774805844216972,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
1828,GO:0004486,1.00000000001675,0.880240264138041,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
10442,GO:0043317,1.00000000001675,0.880240264138041,0,1,regulation of cytotoxic T cell degranulation,BP,
10443,GO:0043318,1.00000000001675,0.880240264138041,0,1,negative regulation of cytotoxic T cell degranulation,BP,
1629,GO:0004070,1.00000000001675,0.774202823970508,0,2,aspartate carbamoyltransferase activity,MF,
1641,GO:0004087,1.00000000001675,0.774202823970508,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1642,GO:0004088,1.00000000001675,0.774202823970508,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1682,GO:0004151,1.00000000001675,0.774202823970508,0,2,dihydroorotase activity,MF,
5644,GO:0016743,1.00000000001675,0.774202823970508,0,2,carboxyl- or carbamoyltransferase activity,MF,
17081,GO:0100057,1.00000000001675,0.879446105067137,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18980,GO:1904826,1.00000000001675,0.879446105067137,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
18981,GO:1904828,1.00000000001675,0.879446105067137,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
3867,GO:0008496,1.00000000001676,0.8801350086368,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
2135,GO:0004947,1.00000000001676,0.781954512462308,0,2,bradykinin receptor activity,MF,
18593,GO:1903905,1.00000000001678,0.774284854760872,0,2,positive regulation of establishment of T cell polarity,BP,
9634,GO:0036518,1.00000000001678,0.774749215462969,0,2,chemorepulsion of dopaminergic neuron axon,BP,
14368,GO:0061643,1.00000000001678,0.774749215462969,0,2,chemorepulsion of axon,BP,
13784,GO:0060399,1.00000000001678,0.774542532892749,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
14038,GO:0060842,1.00000000001679,0.680627332947139,0,3,arterial endothelial cell differentiation,BP,
8830,GO:0034635,1.00000000001684,0.775747525144249,0,2,glutathione transport,BP,
10218,GO:0042939,1.00000000001684,0.775747525144249,0,2,tripeptide transport,BP,
14409,GO:0061741,1.00000000001685,0.77595713204052,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
5837,GO:0017130,1.00000000001686,0.879828885918306,0,1,poly(C) RNA binding,MF,
16746,GO:0098577,1.00000000001686,0.879828885918306,0,1,inactive sex chromosome,CC,
18120,GO:1902889,1.00000000001686,0.879828885918306,0,1,protein localization to spindle microtubule,BP,
19467,GO:1990280,1.00000000001686,0.879828885918306,0,1,RNA localization to chromatin,BP,
16848,GO:0098808,1.00000000001688,0.776268043242878,0,2,mRNA cap binding,MF,
16925,GO:0098943,1.00000000001689,0.780369691190355,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
4829,GO:0014040,1.0000000000169,0.772133230647546,0,2,positive regulation of Schwann cell differentiation,BP,
18025,GO:1902595,1.0000000000169,0.780533750170766,0,2,regulation of DNA replication origin binding,BP,
2372,GO:0005502,1.0000000000169,0.880123203469335,0,1,11-cis retinal binding,MF,
2373,GO:0005503,1.0000000000169,0.880123203469335,0,1,all-trans retinal binding,MF,
14460,GO:0061896,1.0000000000169,0.880123203469335,0,1,all-trans retinol 3,4-desaturase activity,MF,
14461,GO:0061897,1.0000000000169,0.880123203469335,0,1,all-trans retinal 3,4-desaturase activity,MF,
14462,GO:0061898,1.0000000000169,0.880123203469335,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14463,GO:0061899,1.0000000000169,0.880123203469335,0,1,11-cis-retinal 3,4-desaturase activity,MF,
17098,GO:0102121,1.0000000000169,0.775026309630699,0,2,ceramidase activity,MF,
882,GO:0002249,1.00000000001691,0.774332272969225,0,2,lymphocyte anergy,BP,
1083,GO:0002667,1.00000000001691,0.774332272969225,0,2,regulation of T cell anergy,BP,
1207,GO:0002870,1.00000000001691,0.774332272969225,0,2,T cell anergy,BP,
1229,GO:0002911,1.00000000001691,0.774332272969225,0,2,regulation of lymphocyte anergy,BP,
1628,GO:0004069,1.00000000001693,0.775747202030275,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2985,GO:0006532,1.00000000001693,0.775747202030275,0,2,aspartate biosynthetic process,BP,
2986,GO:0006533,1.00000000001693,0.775747202030275,0,2,aspartate catabolic process,BP,
6175,GO:0019550,1.00000000001693,0.775747202030275,0,2,glutamate catabolic process to aspartate,BP,
6176,GO:0019551,1.00000000001693,0.775747202030275,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
1240,GO:0002940,1.00000000001696,0.775484887930478,0,2,tRNA N2-guanine methylation,BP,
4873,GO:0014739,1.00000000001698,0.880322339247612,0,1,positive regulation of muscle hyperplasia,BP,
18281,GO:1903231,1.00000000001698,0.880322339247612,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
19354,GO:1905867,1.00000000001698,0.688776978000747,0,3,epididymis development,BP,
17633,GO:1901492,1.00000000001699,0.775497641495996,0,2,positive regulation of lymphangiogenesis,BP,
7231,GO:0031161,1.000000000017,0.880297207595685,0,1,phosphatidylinositol catabolic process,BP,
15894,GO:0072706,1.00000000001702,0.880382113799757,0,1,response to sodium dodecyl sulfate,BP,
15895,GO:0072707,1.00000000001702,0.880382113799757,0,1,cellular response to sodium dodecyl sulfate,BP,
4292,GO:0009737,1.00000000001703,0.880130128525548,0,1,response to abscisic acid,BP,
4293,GO:0009738,1.00000000001703,0.880130128525548,0,1,abscisic acid-activated signaling pathway,BP,
4306,GO:0009787,1.00000000001703,0.880130128525548,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4307,GO:0009789,1.00000000001703,0.880130128525548,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
15099,GO:0071215,1.00000000001703,0.880130128525548,0,1,cellular response to abscisic acid stimulus,BP,
17627,GO:1901419,1.00000000001703,0.880130128525548,0,1,regulation of response to alcohol,BP,
17628,GO:1901421,1.00000000001703,0.880130128525548,0,1,positive regulation of response to alcohol,BP,
19387,GO:1905957,1.00000000001703,0.880130128525548,0,1,regulation of cellular response to alcohol,BP,
19388,GO:1905959,1.00000000001703,0.880130128525548,0,1,positive regulation of cellular response to alcohol,BP,
2842,GO:0006313,1.00000000001706,0.880152485975574,0,1,transposition, DNA-mediated,BP,
4355,GO:0009955,1.00000000001706,0.880868091283626,0,1,adaxial/abaxial pattern specification,BP,
9263,GO:0035709,1.00000000001706,0.880868091283626,0,1,memory T cell activation,BP,
16279,GO:0090427,1.00000000001706,0.880868091283626,0,1,activation of meiosis,BP,
19663,GO:2000011,1.00000000001706,0.880868091283626,0,1,regulation of adaxial/abaxial pattern formation,BP,
19949,GO:2000567,1.00000000001706,0.880868091283626,0,1,regulation of memory T cell activation,BP,
19950,GO:2000568,1.00000000001706,0.880868091283626,0,1,positive regulation of memory T cell activation,BP,
20169,GO:2001055,1.00000000001706,0.880868091283626,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
5045,GO:0015234,1.00000000001707,0.778186736688149,0,2,thiamine transmembrane transporter activity,MF,
15511,GO:0071934,1.00000000001707,0.778186736688149,0,2,thiamine transmembrane transport,BP,
11034,GO:0045041,1.00000000001707,0.779744861472897,0,2,protein import into mitochondrial intermembrane space,BP,
17477,GO:1900623,1.00000000001707,0.774741991141668,0,2,regulation of monocyte aggregation,BP,
17478,GO:1900625,1.00000000001707,0.774741991141668,0,2,positive regulation of monocyte aggregation,BP,
5086,GO:0015350,1.00000000001711,0.774637347492017,0,2,methotrexate transmembrane transporter activity,MF,
13245,GO:0051958,1.00000000001711,0.774637347492017,0,2,methotrexate transport,BP,
1003,GO:0002477,1.00000000001713,0.893269111759845,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1007,GO:0002481,1.00000000001713,0.893269111759845,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
8446,GO:0033596,1.00000000001714,0.680723126343207,0,3,TSC1-TSC2 complex,CC,
19553,GO:1990637,1.00000000001717,0.684044830392242,0,3,response to prolactin,BP,
19323,GO:1905719,1.00000000001718,0.774982464945857,0,2,protein localization to perinuclear region of cytoplasm,BP,
5805,GO:0017065,1.00000000001719,0.884865922253878,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
5236,GO:0015862,1.0000000000172,0.880605626550135,0,1,uridine transport,BP,
10794,GO:0044299,1.00000000001721,0.879933241464457,0,1,C-fiber,CC,
15297,GO:0071540,1.00000000001721,0.880118884247232,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
7627,GO:0032044,1.00000000001723,0.77964183826986,0,2,DSIF complex,CC,
5400,GO:0016243,1.00000000001723,0.880156078638331,0,1,regulation of autophagosome size,BP,
5932,GO:0018217,1.00000000001723,0.880156078638331,0,1,peptidyl-aspartic acid phosphorylation,BP,
14124,GO:0061030,1.00000000001723,0.880156078638331,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
19109,GO:1905103,1.00000000001723,0.880156078638331,0,1,integral component of lysosomal membrane,CC,
19643,GO:1990938,1.00000000001723,0.880156078638331,0,1,peptidyl-aspartic acid autophosphorylation,BP,
1616,GO:0004047,1.00000000001724,0.780439942830749,0,2,aminomethyltransferase activity,MF,
3215,GO:0006864,1.00000000001726,0.779863854327788,0,2,pyrimidine nucleotide transport,BP,
5036,GO:0015218,1.00000000001726,0.779863854327788,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19525,GO:1990519,1.00000000001726,0.779863854327788,0,2,pyrimidine nucleotide import into mitochondrion,BP,
3916,GO:0008592,1.00000000001726,0.880281900201697,0,1,regulation of Toll signaling pathway,BP,
9894,GO:0042241,1.00000000001726,0.880281900201697,0,1,interleukin-18 biosynthetic process,BP,
11211,GO:0045381,1.00000000001726,0.880281900201697,0,1,regulation of interleukin-18 biosynthetic process,BP,
11362,GO:0045751,1.00000000001726,0.880281900201697,0,1,negative regulation of Toll signaling pathway,BP,
10984,GO:0044805,1.00000000001728,0.774666944546948,0,2,late nucleophagy,BP,
5404,GO:0016250,1.00000000001728,0.880342480770818,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5695,GO:0016826,1.00000000001728,0.880342480770818,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
11961,GO:0047288,1.0000000000173,0.777306689563431,0,2,monosialoganglioside sialyltransferase activity,MF,
146,GO:0000301,1.00000000001736,0.682218467525256,0,3,retrograde transport, vesicle recycling within Golgi,BP,
17981,GO:1902480,1.00000000001738,0.880481996104458,0,1,protein localization to mitotic spindle,BP,
18093,GO:1902805,1.00000000001739,0.774472052439839,0,2,positive regulation of synaptic vesicle transport,BP,
19806,GO:2000302,1.00000000001739,0.774472052439839,0,2,positive regulation of synaptic vesicle exocytosis,BP,
1032,GO:0002541,1.00000000001739,0.776079238358158,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
9383,GO:0035936,1.0000000000174,0.879804648151191,0,1,testosterone secretion,BP,
20113,GO:2000843,1.0000000000174,0.879804648151191,0,1,regulation of testosterone secretion,BP,
20114,GO:2000845,1.0000000000174,0.879804648151191,0,1,positive regulation of testosterone secretion,BP,
19293,GO:1905602,1.00000000001741,0.778344103968938,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
11945,GO:0047179,1.00000000001741,0.793475627946784,0,2,platelet-activating factor acetyltransferase activity,MF,
460,GO:0001401,1.00000000001742,0.777307668274246,0,2,mitochondrial sorting and assembly machinery complex,CC,
3536,GO:0007538,1.00000000001744,0.774638562066067,0,2,primary sex determination,BP,
3537,GO:0007542,1.00000000001744,0.774638562066067,0,2,primary sex determination, germ-line,BP,
5988,GO:0018992,1.00000000001744,0.774638562066067,0,2,germ-line sex determination,BP,
6028,GO:0019100,1.00000000001744,0.774638562066067,0,2,male germ-line sex determination,BP,
15613,GO:0072137,1.00000000001744,0.866007033820221,0,1,condensed mesenchymal cell proliferation,BP,
14894,GO:0070772,1.00000000001744,0.880303118550968,0,1,PAS complex,CC,
7881,GO:0032458,1.00000000001745,0.88017273482608,0,1,slow endocytic recycling,BP,
19406,GO:1990047,1.00000000001746,0.880696255256318,0,1,spindle matrix,CC,
2254,GO:0005169,1.00000000001749,0.786035883996325,0,2,neurotrophin TRKB receptor binding,MF,
6633,GO:0023025,1.00000000001749,0.775409778344124,0,2,MHC class Ib protein complex binding,MF,
6636,GO:0023030,1.00000000001749,0.775409778344124,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
436,GO:0001165,1.00000000001749,0.8801241463558,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
14338,GO:0061582,1.00000000001752,0.77451454131673,0,2,intestinal epithelial cell migration,BP,
14708,GO:0070401,1.00000000001753,0.778449833396421,0,2,NADP+ binding,MF,
8769,GO:0034462,1.00000000001754,0.880758547816145,0,1,small-subunit processome assembly,BP,
16733,GO:0098547,1.00000000001754,0.880758547816145,0,1,lumenal side of Golgi membrane,CC,
12953,GO:0051379,1.00000000001755,0.776231762907044,0,2,epinephrine binding,MF,
19118,GO:1905150,1.00000000001758,0.774566144569523,0,2,regulation of voltage-gated sodium channel activity,BP,
16432,GO:0097124,1.00000000001759,0.775372888764019,0,2,cyclin A2-CDK2 complex,CC,
2070,GO:0004825,1.00000000001761,0.774967380550417,0,2,methionine-tRNA ligase activity,MF,
2918,GO:0006431,1.00000000001761,0.774967380550417,0,2,methionyl-tRNA aminoacylation,BP,
5942,GO:0018282,1.00000000001764,0.774585342223771,0,2,metal incorporation into metallo-sulfur cluster,BP,
5943,GO:0018283,1.00000000001764,0.774585342223771,0,2,iron incorporation into metallo-sulfur cluster,BP,
2052,GO:0004803,1.00000000001765,0.774635767522969,0,2,transposase activity,MF,
2114,GO:0004905,1.00000000001767,0.780317818181616,0,2,type I interferon receptor activity,MF,
4916,GO:0014858,1.00000000001768,0.774604213635589,0,2,positive regulation of skeletal muscle cell proliferation,BP,
18067,GO:1902724,1.00000000001768,0.774604213635589,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18069,GO:1902728,1.00000000001768,0.774604213635589,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
3845,GO:0008459,1.00000000001769,0.774758615670694,0,2,chondroitin 6-sulfotransferase activity,MF,
2798,GO:0006258,1.0000000000177,0.781988969263892,0,2,UDP-glucose catabolic process,BP,
18348,GO:1903378,1.0000000000177,0.77471397907716,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18505,GO:1903722,1.0000000000177,0.787576365072575,0,2,regulation of centriole elongation,BP,
17856,GO:1902162,1.0000000000177,0.793427674478722,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17857,GO:1902164,1.0000000000177,0.793427674478722,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
10235,GO:0042986,1.00000000001776,0.776230283617476,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
7133,GO:0030981,1.00000000001777,0.680889090232813,0,3,cortical microtubule cytoskeleton,CC,
11260,GO:0045588,1.00000000001777,0.774606722228837,0,2,positive regulation of gamma-delta T cell differentiation,BP,
1089,GO:0002677,1.00000000001781,0.778241567184041,0,2,negative regulation of chronic inflammatory response,BP,
14440,GO:0061827,1.00000000001784,0.779330445355967,0,2,sperm head,CC,
13535,GO:0060024,1.00000000001785,0.775538009356088,0,2,rhythmic synaptic transmission,BP,
13769,GO:0060382,1.00000000001786,0.774478768923396,0,2,regulation of DNA strand elongation,BP,
12052,GO:0048022,1.00000000001786,0.774308681929927,0,2,negative regulation of melanin biosynthetic process,BP,
17454,GO:1900377,1.00000000001786,0.774308681929927,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
12669,GO:0050910,1.00000000001788,0.774387042135569,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
13547,GO:0060040,1.00000000001789,0.775709935505801,0,2,retinal bipolar neuron differentiation,BP,
17636,GO:1901509,1.00000000001789,0.774747520190833,0,2,regulation of endothelial tube morphogenesis,BP,
8889,GO:0034722,1.0000000000179,0.885734202934831,0,1,gamma-glutamyl-peptidase activity,MF,
820,GO:0002094,1.00000000001791,0.778265518277642,0,2,polyprenyltransferase activity,MF,
9318,GO:0035812,1.00000000001793,0.776074254759563,0,2,renal sodium excretion,BP,
9319,GO:0035813,1.00000000001793,0.776074254759563,0,2,regulation of renal sodium excretion,BP,
14557,GO:0070124,1.00000000001793,0.785344110000553,0,2,mitochondrial translational initiation,BP,
13003,GO:0051463,1.00000000001794,0.879995804574943,0,1,negative regulation of cortisol secretion,BP,
13604,GO:0060125,1.00000000001794,0.879995804574943,0,1,negative regulation of growth hormone secretion,BP,
396,GO:0001069,1.00000000001794,0.774605889847438,0,2,regulatory region RNA binding,MF,
1002,GO:0002476,1.00000000001795,0.777846173574757,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
11139,GO:0045213,1.00000000001797,0.77883145560893,0,2,neurotransmitter receptor metabolic process,BP,
18600,GO:1903918,1.00000000001798,0.879494144183625,0,1,regulation of actin filament severing,BP,
18601,GO:1903919,1.00000000001798,0.879494144183625,0,1,negative regulation of actin filament severing,BP,
3193,GO:0006824,1.00000000001798,0.775469672220379,0,2,cobalt ion transport,BP,
14570,GO:0070143,1.00000000001799,0.880122852082339,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
14393,GO:0061711,1.000000000018,0.779387903299912,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
13806,GO:0060430,1.000000000018,0.772456324431462,0,2,lung saccule development,BP,
14483,GO:0065001,1.00000000001801,0.774465116339531,0,2,specification of axis polarity,BP,
15403,GO:0071701,1.00000000001801,0.880122820025216,0,1,regulation of MAPK export from nucleus,BP,
17872,GO:1902202,1.00000000001801,0.7777504070423,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
17429,GO:1900244,1.00000000001802,0.775528684884524,0,2,positive regulation of synaptic vesicle endocytosis,BP,
4895,GO:0014826,1.00000000001804,0.881194277289291,0,1,vein smooth muscle contraction,BP,
6752,GO:0030185,1.00000000001804,0.881194277289291,0,1,nitric oxide transport,BP,
7439,GO:0031583,1.00000000001804,0.881194277289291,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7510,GO:0031705,1.00000000001804,0.881194277289291,0,1,bombesin receptor binding,MF,
7511,GO:0031707,1.00000000001804,0.881194277289291,0,1,endothelin A receptor binding,MF,
7512,GO:0031708,1.00000000001804,0.881194277289291,0,1,endothelin B receptor binding,MF,
9321,GO:0035815,1.00000000001804,0.881194277289291,0,1,positive regulation of renal sodium excretion,BP,
9936,GO:0042313,1.00000000001804,0.881194277289291,0,1,protein kinase C deactivation,BP,
10348,GO:0043179,1.00000000001804,0.881194277289291,0,1,rhythmic excitation,BP,
8559,GO:0034039,1.00000000001807,0.778365795975259,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
10844,GO:0044378,1.0000000000181,0.779724023817947,0,2,non-sequence-specific DNA binding, bending,MF,
13605,GO:0060126,1.0000000000181,0.77523715621276,0,2,somatotropin secreting cell differentiation,BP,
2124,GO:0004921,1.00000000001811,0.880288946342378,0,1,interleukin-11 receptor activity,MF,
6315,GO:0019970,1.00000000001811,0.880288946342378,0,1,interleukin-11 binding,MF,
9704,GO:0038154,1.00000000001811,0.880288946342378,0,1,interleukin-11-mediated signaling pathway,BP,
11014,GO:0045004,1.00000000001814,0.773976163073756,0,2,DNA replication proofreading,BP,
15058,GO:0071062,1.00000000001815,0.880134050700553,0,1,alphav-beta3 integrin-vitronectin complex,CC,
2242,GO:0005153,1.00000000001816,0.774947934704598,0,2,interleukin-8 receptor binding,MF,
15507,GO:0071929,1.00000000001816,0.774947934704598,0,2,alpha-tubulin acetylation,BP,
8466,GO:0033624,1.00000000001816,0.774277708343477,0,2,negative regulation of integrin activation,BP,
12431,GO:0050211,1.00000000001817,0.774964966768966,0,2,procollagen galactosyltransferase activity,MF,
12419,GO:0050115,1.00000000001817,0.880122818334469,0,1,myosin-light-chain-phosphatase activity,MF,
14321,GO:0061551,1.00000000001818,0.681870641167086,0,3,trigeminal ganglion development,BP,
15791,GO:0072518,1.0000000000182,0.879960064969374,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17302,GO:0150031,1.0000000000182,0.879960064969374,0,1,regulation of protein localization to lysosome,BP,
17303,GO:0150033,1.0000000000182,0.879960064969374,0,1,negative regulation of protein localization to lysosome,BP,
12018,GO:0047757,1.00000000001822,0.772900952931684,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
5759,GO:0016936,1.00000000001826,0.780581491797316,0,2,galactoside binding,MF,
10374,GO:0043221,1.00000000001827,0.880174019719114,0,1,SMC family protein binding,MF,
4003,GO:0008967,1.00000000001828,0.775974276077222,0,2,phosphoglycolate phosphatase activity,MF,
11180,GO:0045322,1.00000000001829,0.77496743589853,0,2,unmethylated CpG binding,MF,
4053,GO:0009106,1.00000000001829,0.777932888756962,0,2,lipoate metabolic process,BP,
3305,GO:0007008,1.00000000001829,0.880256568800282,0,1,outer mitochondrial membrane organization,BP,
5310,GO:0016031,1.00000000001829,0.880256568800282,0,1,tRNA import into mitochondrion,BP,
14541,GO:0070096,1.00000000001829,0.880256568800282,0,1,mitochondrial outer membrane translocase complex assembly,BP,
19149,GO:1905242,1.00000000001829,0.880256568800282,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
1058,GO:0002586,1.00000000001831,0.79399211512591,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
11582,GO:0046208,1.00000000001832,0.693817105520934,0,3,spermine catabolic process,BP,
13436,GO:0052925,1.00000000001833,0.885426167993797,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
340,GO:0000941,1.00000000001833,0.880749837792408,0,1,condensed nuclear chromosome inner kinetochore,CC,
12997,GO:0051456,1.00000000001833,0.880749837792408,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
17931,GO:1902311,1.00000000001834,0.882988094805139,0,1,regulation of copper ion transmembrane transport,BP,
10441,GO:0043316,1.00000000001835,0.774901732425154,0,2,cytotoxic T cell degranulation,BP,
10129,GO:0042720,1.00000000001835,0.79396031703749,0,2,mitochondrial inner membrane peptidase complex,CC,
19147,GO:1905224,1.00000000001836,0.77460691087666,0,2,clathrin-coated pit assembly,BP,
11726,GO:0046587,1.00000000001839,0.880317206143478,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
18857,GO:1904567,1.00000000001839,0.880317206143478,0,1,response to wortmannin,BP,
18858,GO:1904568,1.00000000001839,0.880317206143478,0,1,cellular response to wortmannin,BP,
19555,GO:1990646,1.00000000001839,0.880317206143478,0,1,cellular response to prolactin,BP,
3721,GO:0008251,1.00000000001839,0.774700028370744,0,2,tRNA-specific adenosine deaminase activity,MF,
15562,GO:0072061,1.0000000000184,0.780556992243211,0,2,inner medullary collecting duct development,BP,
2060,GO:0004815,1.00000000001845,0.775150893719802,0,2,aspartate-tRNA ligase activity,MF,
16433,GO:0097125,1.00000000001846,0.77827026139846,0,2,cyclin B1-CDK1 complex,CC,
11924,GO:0047016,1.00000000001846,0.880913120748049,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
1566,GO:0003975,1.00000000001846,0.881035537896102,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
4002,GO:0008963,1.00000000001846,0.881035537896102,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
2627,GO:0005954,1.00000000001848,0.880436236211388,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
19639,GO:1990928,1.00000000001849,0.77446025588376,0,2,response to amino acid starvation,BP,
6405,GO:0021649,1.0000000000185,0.880430183981302,0,1,vestibulocochlear nerve structural organization,BP,
9677,GO:0038085,1.0000000000185,0.880430183981302,0,1,vascular endothelial growth factor binding,MF,
13706,GO:0060301,1.0000000000185,0.880430183981302,0,1,positive regulation of cytokine activity,BP,
14322,GO:0061552,1.0000000000185,0.880430183981302,0,1,ganglion morphogenesis,BP,
16552,GO:0097374,1.0000000000185,0.880430183981302,0,1,sensory neuron axon guidance,BP,
17948,GO:1902378,1.0000000000185,0.880430183981302,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
18985,GO:1904835,1.0000000000185,0.880430183981302,0,1,dorsal root ganglion morphogenesis,BP,
19081,GO:1905040,1.0000000000185,0.880430183981302,0,1,otic placode development,BP,
15881,GO:0072679,1.0000000000185,0.774884225889665,0,2,thymocyte migration,BP,
5225,GO:0015842,1.00000000001855,0.778070369449881,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
16794,GO:0098700,1.00000000001855,0.778070369449881,0,2,neurotransmitter loading into synaptic vesicle,BP,
9479,GO:0036135,1.00000000001855,0.774383181640212,0,2,Schwann cell migration,BP,
17383,GO:1900147,1.00000000001855,0.774383181640212,0,2,regulation of Schwann cell migration,BP,
19429,GO:1990136,1.00000000001856,0.880411809754925,0,1,linoleate 9S-lipoxygenase activity,MF,
3030,GO:0006580,1.0000000000186,0.880349985163371,0,1,ethanolamine metabolic process,BP,
18249,GO:1903165,1.0000000000186,0.880349985163371,0,1,response to polycyclic arene,BP,
18904,GO:1904681,1.0000000000186,0.880349985163371,0,1,response to 3-methylcholanthrene,BP,
15276,GO:0071492,1.0000000000186,0.776689211337829,0,2,cellular response to UV-A,BP,
1617,GO:0004052,1.00000000001863,0.775241040977124,0,2,arachidonate 12-lipoxygenase activity,MF,
9411,GO:0035993,1.00000000001864,0.777646612019091,0,2,deltoid tuberosity development,BP,
6311,GO:0019961,1.00000000001866,0.774637435539636,0,2,interferon binding,MF,
7539,GO:0031849,1.00000000001868,0.880190527924233,0,1,olfactory receptor binding,MF,
2420,GO:0005595,1.0000000000187,0.877510887841001,0,1,collagen type XII trimer,CC,
8515,GO:0033768,1.00000000001871,0.77494996010809,0,2,SUMO-targeted ubiquitin ligase complex,CC,
15138,GO:0071283,1.00000000001871,0.787156648561284,0,2,cellular response to iron(III) ion,BP,
4825,GO:0014034,1.00000000001873,0.774648547027942,0,2,neural crest cell fate commitment,BP,
7384,GO:0031445,1.00000000001874,0.775983640504503,0,2,regulation of heterochromatin assembly,BP,
7385,GO:0031453,1.00000000001874,0.775983640504503,0,2,positive regulation of heterochromatin assembly,BP,
11385,GO:0045799,1.00000000001874,0.775983640504503,0,2,positive regulation of chromatin assembly or disassembly,BP,
8129,GO:0032847,1.00000000001876,0.777956043625707,0,2,regulation of cellular pH reduction,BP,
10787,GO:0044284,1.00000000001876,0.894812607002292,0,1,mitochondrial crista junction,CC,
4452,GO:0010428,1.00000000001876,0.880072481129242,0,1,methyl-CpNpG binding,MF,
3173,GO:0006789,1.00000000001878,0.88054290572092,0,1,bilirubin conjugation,BP,
15153,GO:0071314,1.0000000000188,0.880340049102683,0,1,cellular response to cocaine,BP,
17941,GO:1902362,1.0000000000188,0.880340049102683,0,1,melanocyte apoptotic process,BP,
3763,GO:0008311,1.0000000000188,0.780957613365731,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4444,GO:0010370,1.0000000000188,0.775895336360157,0,2,perinucleolar chromocenter,CC,
17130,GO:0102521,1.00000000001882,0.775085454997254,0,2,tRNA-4-demethylwyosine synthase activity,MF,
7644,GO:0032072,1.00000000001885,0.880249157429195,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7854,GO:0032423,1.00000000001885,0.880249157429195,0,1,regulation of mismatch repair,BP,
7855,GO:0032425,1.00000000001885,0.880249157429195,0,1,positive regulation of mismatch repair,BP,
9265,GO:0035711,1.00000000001885,0.880249157429195,0,1,T-helper 1 cell activation,BP,
19896,GO:2000426,1.00000000001885,0.880249157429195,0,1,negative regulation of apoptotic cell clearance,BP,
19099,GO:1905071,1.00000000001886,0.774628464067281,0,2,occluding junction disassembly,BP,
19100,GO:1905073,1.00000000001886,0.774628464067281,0,2,regulation of occluding junction disassembly,BP,
19101,GO:1905075,1.00000000001886,0.774628464067281,0,2,positive regulation of occluding junction disassembly,BP,
8140,GO:0032877,1.00000000001887,0.774645127824259,0,2,positive regulation of DNA endoreduplication,BP,
7259,GO:0031247,1.00000000001887,0.776086254335905,0,2,actin rod assembly,BP,
20172,GO:2001069,1.00000000001888,0.775082842181274,0,2,glycogen binding,MF,
2212,GO:0005105,1.00000000001888,0.880703167313636,0,1,type 1 fibroblast growth factor receptor binding,MF,
19666,GO:2000017,1.00000000001889,0.774894924814282,0,2,positive regulation of determination of dorsal identity,BP,
973,GO:0002424,1.00000000001894,0.775165316586429,0,2,T cell mediated immune response to tumor cell,BP,
1193,GO:0002840,1.00000000001894,0.775165316586429,0,2,regulation of T cell mediated immune response to tumor cell,BP,
5959,GO:0018364,1.00000000001894,0.802174384478363,0,2,peptidyl-glutamine methylation,BP,
2680,GO:0006045,1.00000000001895,0.77465887181318,0,2,N-acetylglucosamine biosynthetic process,BP,
17516,GO:1901073,1.00000000001895,0.77465887181318,0,2,glucosamine-containing compound biosynthetic process,BP,
2015,GO:0004747,1.00000000001895,0.889736091407134,0,1,ribokinase activity,MF,
11149,GO:0045226,1.00000000001896,0.774943015284954,0,2,extracellular polysaccharide biosynthetic process,BP,
11628,GO:0046379,1.00000000001896,0.774943015284954,0,2,extracellular polysaccharide metabolic process,BP,
19276,GO:1905573,1.00000000001899,0.776482676576002,0,2,ganglioside GM1 binding,MF,
19279,GO:1905576,1.00000000001899,0.776482676576002,0,2,ganglioside GT1b binding,MF,
3877,GO:0008513,1.00000000001899,0.880891614913776,0,1,secondary active organic cation transmembrane transporter activity,MF,
8601,GO:0034124,1.000000000019,0.776089114125476,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
2304,GO:0005290,1.00000000001901,0.774991699168119,0,2,L-histidine transmembrane transporter activity,MF,
16344,GO:0090673,1.00000000001902,0.879598235426926,0,1,endothelial cell-matrix adhesion,BP,
347,GO:0000961,1.00000000001905,0.774587734159742,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
6859,GO:0030337,1.00000000001906,0.781474363442107,0,2,DNA polymerase processivity factor activity,MF,
19059,GO:1904980,1.00000000001907,0.879718280622792,0,1,positive regulation of endosome organization,BP,
1721,GO:0004315,1.00000000001907,0.780922498137566,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
9588,GO:0036461,1.00000000001912,0.788981281050718,0,2,BLOC-2 complex binding,MF,
5407,GO:0016256,1.00000000001914,0.782372979227245,0,2,N-glycan processing to lysosome,BP,
5550,GO:0016561,1.00000000001916,0.776322504609548,0,2,protein import into peroxisome matrix, translocation,BP,
235,GO:0000493,1.00000000001916,0.777317083517725,0,2,box H/ACA snoRNP assembly,BP,
3734,GO:0008273,1.00000000001917,0.774582007023495,0,2,calcium, potassium:sodium antiporter activity,MF,
5358,GO:0016149,1.00000000001917,0.880201613124708,0,1,translation release factor activity, codon specific,MF,
7187,GO:0031085,1.00000000001918,0.774817919420424,0,2,BLOC-3 complex,CC,
18977,GO:1904815,1.00000000001919,0.776433763922837,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
6970,GO:0030644,1.0000000000192,0.780168371696301,0,2,cellular chloride ion homeostasis,BP,
19802,GO:2000298,1.00000000001921,0.775074870323674,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
1570,GO:0003979,1.00000000001922,0.880289111601678,0,1,UDP-glucose 6-dehydrogenase activity,MF,
6632,GO:0023024,1.00000000001922,0.880289111601678,0,1,MHC class I protein complex binding,MF,
2317,GO:0005324,1.00000000001924,0.775149116804938,0,2,long-chain fatty acid transporter activity,MF,
5261,GO:0015910,1.00000000001924,0.775149116804938,0,2,peroxisomal long-chain fatty acid import,BP,
5995,GO:0019008,1.00000000001926,0.78029613893647,0,2,molybdopterin synthase complex,CC,
15821,GO:0072560,1.00000000001927,0.880300191126738,0,1,type B pancreatic cell maturation,BP,
7123,GO:0030956,1.00000000001928,0.700915000683071,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
12479,GO:0050567,1.00000000001928,0.700915000683071,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
14865,GO:0070681,1.00000000001928,0.700915000683071,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
13875,GO:0060545,1.00000000001931,0.776284201733979,0,2,positive regulation of necroptotic process,BP,
2947,GO:0006478,1.00000000001933,0.777231093410513,0,2,peptidyl-tyrosine sulfation,BP,
3854,GO:0008476,1.00000000001933,0.777231093410513,0,2,protein-tyrosine sulfotransferase activity,MF,
15074,GO:0071139,1.00000000001935,0.774709351175236,0,2,resolution of recombination intermediates,BP,
15075,GO:0071140,1.00000000001935,0.774709351175236,0,2,resolution of mitotic recombination intermediates,BP,
7356,GO:0031407,1.00000000001936,0.880553686189148,0,1,oxylipin metabolic process,BP,
12032,GO:0047977,1.00000000001936,0.880553686189148,0,1,hepoxilin-epoxide hydrolase activity,MF,
17740,GO:1901751,1.00000000001936,0.880553686189148,0,1,leukotriene A4 metabolic process,BP,
20274,GO:2001300,1.00000000001936,0.880553686189148,0,1,lipoxin metabolic process,BP,
20275,GO:2001301,1.00000000001936,0.880553686189148,0,1,lipoxin biosynthetic process,BP,
20276,GO:2001302,1.00000000001936,0.880553686189148,0,1,lipoxin A4 metabolic process,BP,
20277,GO:2001303,1.00000000001936,0.880553686189148,0,1,lipoxin A4 biosynthetic process,BP,
20278,GO:2001304,1.00000000001936,0.880553686189148,0,1,lipoxin B4 metabolic process,BP,
20279,GO:2001306,1.00000000001936,0.880553686189148,0,1,lipoxin B4 biosynthetic process,BP,
19089,GO:1905051,1.00000000001939,0.79108243793046,0,2,regulation of base-excision repair,BP,
19090,GO:1905053,1.00000000001939,0.79108243793046,0,2,positive regulation of base-excision repair,BP,
7375,GO:0031436,1.00000000001941,0.774455305119279,0,2,BRCA1-BARD1 complex,CC,
3819,GO:0008422,1.00000000001941,0.774616844086108,0,2,beta-glucosidase activity,MF,
7337,GO:0031379,1.00000000001941,0.79915897225329,0,2,RNA-directed RNA polymerase complex,CC,
3724,GO:0008254,1.00000000001941,0.879658067531039,0,1,3'-nucleotidase activity,MF,
6890,GO:0030432,1.00000000001943,0.791270556356905,0,2,peristalsis,BP,
1906,GO:0004597,1.00000000001945,0.880211687814378,0,1,peptide-aspartate beta-dioxygenase activity,MF,
1955,GO:0004662,1.00000000001947,0.778665229873986,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2626,GO:0005953,1.00000000001947,0.778665229873986,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
3606,GO:0008048,1.00000000001947,0.880720340015775,0,1,calcium sensitive guanylate cyclase activator activity,MF,
3484,GO:0007352,1.00000000001947,0.876837940029377,0,1,zygotic specification of dorsal/ventral axis,BP,
17420,GO:1900224,1.00000000001947,0.876837940029377,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
19863,GO:2000382,1.00000000001947,0.876837940029377,0,1,positive regulation of mesoderm development,BP,
10601,GO:0043614,1.00000000001949,0.774619776893088,0,2,multi-eIF complex,CC,
2935,GO:0006463,1.0000000000195,0.880192797828455,0,1,steroid hormone receptor complex assembly,BP,
348,GO:0000962,1.0000000000195,0.774879490075082,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
11026,GO:0045025,1.0000000000195,0.774879490075082,0,2,mitochondrial degradosome,CC,
20264,GO:2001274,1.00000000001955,0.774804651160589,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
957,GO:0002378,1.00000000001959,0.880126342636391,0,1,immunoglobulin biosynthetic process,BP,
15318,GO:0071567,1.00000000001961,0.78647715429491,0,2,UFM1 hydrolase activity,MF,
14098,GO:0060987,1.00000000001962,0.8806219539847,0,1,lipid tube,CC,
7024,GO:0030806,1.00000000001963,0.774433235633375,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7039,GO:0030821,1.00000000001963,0.774433235633375,0,2,negative regulation of cAMP catabolic process,BP,
8282,GO:0033122,1.00000000001963,0.774433235633375,0,2,negative regulation of purine nucleotide catabolic process,BP,
17892,GO:1902232,1.00000000001965,0.777822433735407,0,2,regulation of positive thymic T cell selection,BP,
455,GO:0001300,1.00000000001965,0.774913397668052,0,2,chronological cell aging,BP,
8494,GO:0033684,1.00000000001966,0.773462460233418,0,2,regulation of luteinizing hormone secretion,BP,
8495,GO:0033686,1.00000000001966,0.773462460233418,0,2,positive regulation of luteinizing hormone secretion,BP,
16363,GO:0097003,1.00000000001966,0.77547879606076,0,2,adipokinetic hormone receptor activity,MF,
16047,GO:0090034,1.00000000001968,0.778487048286692,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16048,GO:0090035,1.00000000001968,0.778487048286692,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
3617,GO:0008073,1.00000000001969,0.785510747010782,0,2,ornithine decarboxylase inhibitor activity,MF,
17910,GO:1902268,1.00000000001969,0.785510747010782,0,2,negative regulation of polyamine transmembrane transport,BP,
370,GO:0000992,1.0000000000197,0.774541767133221,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
374,GO:0001002,1.0000000000197,0.774541767133221,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
375,GO:0001003,1.0000000000197,0.774541767133221,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
5693,GO:0016822,1.00000000001976,0.783153685187628,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5694,GO:0016823,1.00000000001976,0.783153685187628,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6867,GO:0030366,1.00000000001976,0.783751368644094,0,2,molybdopterin synthase activity,MF,
16868,GO:0098840,1.00000000001977,0.787805097561566,0,2,protein transport along microtubule,BP,
16983,GO:0099118,1.00000000001977,0.787805097561566,0,2,microtubule-based protein transport,BP,
6410,GO:0021679,1.00000000001977,0.77490124898616,0,2,cerebellar molecular layer development,BP,
6417,GO:0021687,1.00000000001977,0.77490124898616,0,2,cerebellar molecular layer morphogenesis,BP,
576,GO:0001729,1.00000000001978,0.774790133667014,0,2,ceramide kinase activity,MF,
1951,GO:0004658,1.00000000001979,0.777075290899997,0,2,propionyl-CoA carboxylase activity,MF,
3872,GO:0008507,1.0000000000198,0.880220072164683,0,1,sodium:iodide symporter activity,MF,
5093,GO:0015373,1.00000000001984,0.774415606344534,0,2,anion:sodium symporter activity,MF,
1771,GO:0004379,1.00000000001986,0.774607226018189,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
5873,GO:0018008,1.00000000001986,0.774607226018189,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6032,GO:0019107,1.00000000001986,0.774607226018189,0,2,myristoyltransferase activity,MF,
10131,GO:0042723,1.00000000001988,0.686979599675131,0,3,thiamine-containing compound metabolic process,BP,
1266,GO:0003050,1.0000000000199,0.880289771400381,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
14935,GO:0070856,1.0000000000199,0.880041611304158,0,1,myosin VI light chain binding,MF,
2585,GO:0005880,1.00000000001995,0.886137130566512,0,1,nuclear microtubule,CC,
5822,GO:0017102,1.00000000001996,0.774986941156633,0,2,methionyl glutamyl tRNA synthetase complex,CC,
12765,GO:0051083,1.00000000001999,0.777674692163521,0,2,'de novo' cotranslational protein folding,BP,
1783,GO:0004408,1.00000000002,0.880680800090498,0,1,holocytochrome-c synthase activity,MF,
5776,GO:0017003,1.00000000002,0.880680800090498,0,1,protein-heme linkage,BP,
5779,GO:0017006,1.00000000002,0.880680800090498,0,1,protein-tetrapyrrole linkage,BP,
5887,GO:0018063,1.00000000002,0.880680800090498,0,1,cytochrome c-heme linkage,BP,
7675,GO:0032129,1.00000000002003,0.778207959461655,0,2,histone deacetylase activity (H3-K9 specific),MF,
11905,GO:0046969,1.00000000002003,0.778207959461655,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19549,GO:1990619,1.00000000002003,0.778207959461655,0,2,histone H3-K9 deacetylation,BP,
826,GO:0002114,1.00000000002006,0.88018241982207,0,1,interleukin-33 receptor activity,MF,
8521,GO:0033857,1.00000000002006,0.774585865713104,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
17096,GO:0102092,1.00000000002006,0.774585865713104,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
16680,GO:0097682,1.00000000002006,0.881164221844784,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
11289,GO:0045627,1.00000000002006,0.687094686110813,0,3,positive regulation of T-helper 1 cell differentiation,BP,
9330,GO:0035851,1.00000000002007,0.880322276435251,0,1,Krueppel-associated box domain binding,MF,
1392,GO:0003308,1.00000000002007,0.777078922982608,0,2,negative regulation of Wnt signaling pathway involved in heart development,BP,
12427,GO:0050152,1.00000000002009,0.888598642963297,0,1,omega-amidase activity,MF,
17321,GO:1900036,1.00000000002011,0.880597716321023,0,1,positive regulation of cellular response to heat,BP,
8740,GO:0034414,1.00000000002012,0.775256047654484,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10169,GO:0042779,1.00000000002012,0.775256047654484,0,2,tRNA 3'-trailer cleavage,BP,
10171,GO:0042781,1.00000000002012,0.775256047654484,0,2,3'-tRNA processing endoribonuclease activity,MF,
19157,GO:1905267,1.00000000002012,0.775256047654484,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
4539,GO:0010621,1.00000000002015,0.891329184917724,0,1,negative regulation of transcription by transcription factor localization,BP,
9497,GO:0036164,1.00000000002015,0.891329184917724,0,1,cell-abiotic substrate adhesion,BP,
17003,GO:0099403,1.00000000002018,0.768847455679682,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17004,GO:0099404,1.00000000002018,0.768847455679682,0,2,mitotic sister chromatid cohesion, telomeric,BP,
19025,GO:1904907,1.00000000002018,0.768847455679682,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19026,GO:1904908,1.00000000002018,0.768847455679682,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
8860,GO:0034678,1.00000000002023,0.77466703587694,0,2,integrin alpha8-beta1 complex,CC,
3968,GO:0008783,1.00000000002024,0.880883695323545,0,1,agmatinase activity,MF,
8402,GO:0033388,1.00000000002024,0.880883695323545,0,1,putrescine biosynthetic process from arginine,BP,
6845,GO:0030322,1.00000000002027,0.775580539397926,0,2,stabilization of membrane potential,BP,
9342,GO:0035868,1.00000000002028,0.774418207748853,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
17203,GO:0110021,1.00000000002032,0.775571343753237,0,2,cardiac muscle myoblast proliferation,BP,
17204,GO:0110022,1.00000000002032,0.775571343753237,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17205,GO:0110024,1.00000000002032,0.775571343753237,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
3806,GO:0008401,1.00000000002037,0.774821302662362,0,2,retinoic acid 4-hydroxylase activity,MF,
16664,GO:0097638,1.00000000002038,0.773575485621076,0,2,L-arginine import across plasma membrane,BP,
9067,GO:0035332,1.00000000002039,0.77279274375143,0,2,positive regulation of hippo signaling,BP,
14043,GO:0060849,1.00000000002043,0.7748106270557,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
1510,GO:0003873,1.00000000002048,0.681824235784927,0,3,6-phosphofructo-2-kinase activity,MF,
5738,GO:0016890,1.00000000002048,0.779560850025881,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
2256,GO:0005171,1.00000000002054,0.881400793558627,0,1,hepatocyte growth factor receptor binding,MF,
1488,GO:0003828,1.00000000002054,0.772498953592544,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
12733,GO:0051025,1.00000000002059,0.774977892062202,0,2,negative regulation of immunoglobulin secretion,BP,
17058,GO:0099609,1.0000000000206,0.774533236988482,0,2,microtubule lateral binding,MF,
685,GO:0001905,1.0000000000206,0.773988386216373,0,2,activation of membrane attack complex,BP,
737,GO:0001969,1.0000000000206,0.773988386216373,0,2,regulation of activation of membrane attack complex,BP,
4641,GO:0010768,1.00000000002061,0.77384066313225,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
1653,GO:0004109,1.00000000002063,0.775065158075132,0,2,coproporphyrinogen oxidase activity,MF,
18377,GO:1903433,1.00000000002064,0.774844299698846,0,2,regulation of constitutive secretory pathway,BP,
4305,GO:0009786,1.00000000002067,0.777098082238148,0,2,regulation of asymmetric cell division,BP,
5166,GO:0015722,1.00000000002067,0.68196456911334,0,3,canalicular bile acid transport,BP,
2044,GO:0004794,1.00000000002072,0.886876076388702,0,1,L-threonine ammonia-lyase activity,MF,
18394,GO:1903487,1.00000000002073,0.776995338003767,0,2,regulation of lactation,BP,
1431,GO:0003408,1.00000000002075,0.773598127605015,0,2,optic cup formation involved in camera-type eye development,BP,
2281,GO:0005234,1.00000000002077,0.773932640227105,0,2,extracellularly glutamate-gated ion channel activity,MF,
8192,GO:0032954,1.00000000002078,0.774613403885915,0,2,regulation of cytokinetic process,BP,
18380,GO:1903436,1.00000000002078,0.774613403885915,0,2,regulation of mitotic cytokinetic process,BP,
18381,GO:1903438,1.00000000002078,0.774613403885915,0,2,positive regulation of mitotic cytokinetic process,BP,
18396,GO:1903490,1.00000000002078,0.774613403885915,0,2,positive regulation of mitotic cytokinesis,BP,
4691,GO:0010851,1.00000000002078,0.777092551023237,0,2,cyclase regulator activity,MF,
4692,GO:0010853,1.00000000002078,0.777092551023237,0,2,cyclase activator activity,MF,
6796,GO:0030249,1.00000000002078,0.777092551023237,0,2,guanylate cyclase regulator activity,MF,
6797,GO:0030250,1.00000000002078,0.777092551023237,0,2,guanylate cyclase activator activity,MF,
18522,GO:1903760,1.00000000002078,0.774639457199187,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19072,GO:1905024,1.00000000002078,0.774639457199187,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
1541,GO:0003938,1.00000000002079,0.777946870756726,0,2,IMP dehydrogenase activity,MF,
9806,GO:0042030,1.0000000000208,0.774391269944238,0,2,ATPase inhibitor activity,MF,
3869,GO:0008503,1.00000000002081,0.790037272111646,0,2,benzodiazepine receptor activity,MF,
1507,GO:0003868,1.00000000002083,0.882807378547234,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
19074,GO:1905031,1.00000000002083,0.68074687761421,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
15036,GO:0071020,1.00000000002087,0.780170339593719,0,2,post-spliceosomal complex,CC,
175,GO:0000384,1.00000000002088,0.781772005525547,0,2,first spliceosomal transesterification activity,MF,
1797,GO:0004441,1.00000000002089,0.88121593743957,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13401,GO:0052829,1.00000000002089,0.88121593743957,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
873,GO:0002225,1.00000000002089,0.781869121246139,0,2,positive regulation of antimicrobial peptide production,BP,
1152,GO:0002760,1.00000000002089,0.781869121246139,0,2,positive regulation of antimicrobial humoral response,BP,
1171,GO:0002803,1.00000000002089,0.781869121246139,0,2,positive regulation of antibacterial peptide production,BP,
8289,GO:0033132,1.0000000000209,0.784310166696558,0,2,negative regulation of glucokinase activity,BP,
18311,GO:1903300,1.0000000000209,0.784310166696558,0,2,negative regulation of hexokinase activity,BP,
7497,GO:0031685,1.00000000002091,0.77479042720224,0,2,adenosine receptor binding,MF,
16883,GO:0098875,1.00000000002093,0.880122971009603,0,1,epididymosome,CC,
17963,GO:1902423,1.00000000002102,0.775138107345135,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17964,GO:1902425,1.00000000002102,0.775138107345135,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
5385,GO:0016222,1.00000000002108,0.775017576443145,0,2,procollagen-proline 4-dioxygenase complex,CC,
14459,GO:0061890,1.00000000002108,0.78134995085244,0,2,positive regulation of astrocyte activation,BP,
18636,GO:1903980,1.00000000002108,0.78134995085244,0,2,positive regulation of microglial cell activation,BP,
8571,GO:0034066,1.0000000000211,0.781936984427966,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
14102,GO:0060994,1.0000000000211,0.777122778083776,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
18714,GO:1904211,1.00000000002113,0.777095445211202,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
13905,GO:0060594,1.00000000002115,0.773689281956226,0,2,mammary gland specification,BP,
2313,GO:0005314,1.00000000002117,0.774876228198424,0,2,high-affinity glutamate transmembrane transporter activity,MF,
5121,GO:0015501,1.00000000002117,0.774876228198424,0,2,glutamate:sodium symporter activity,MF,
4209,GO:0009368,1.00000000002121,0.784108583446431,0,2,endopeptidase Clp complex,CC,
7415,GO:0031523,1.00000000002123,0.773650509991179,0,2,Myb complex,CC,
16526,GO:0097325,1.00000000002125,0.774762103580949,0,2,melanocyte proliferation,BP,
1759,GO:0004365,1.00000000002127,0.888040876225878,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6246,GO:0019828,1.00000000002127,0.888040876225878,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9204,GO:0035605,1.00000000002127,0.888040876225878,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10651,GO:0043891,1.00000000002127,0.888040876225878,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
1053,GO:0002581,1.00000000002127,0.780843156483882,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
18063,GO:1902714,1.00000000002127,0.774989269982993,0,2,negative regulation of interferon-gamma secretion,BP,
14955,GO:0070889,1.00000000002129,0.775226674761871,0,2,platelet alpha granule organization,BP,
8662,GO:0034247,1.00000000002132,0.888367641302089,0,1,snoRNA splicing,BP,
15432,GO:0071796,1.00000000002132,0.888367641302089,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
1534,GO:0003921,1.00000000002133,0.880445863735608,0,1,GMP synthase activity,MF,
1535,GO:0003922,1.00000000002133,0.880445863735608,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
19432,GO:1990145,1.00000000002134,0.774870173711067,0,2,maintenance of translational fidelity,BP,
2259,GO:0005174,1.00000000002135,0.880692346782869,0,1,CD40 receptor binding,MF,
2360,GO:0005462,1.00000000002135,0.775135238764564,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
19532,GO:1990569,1.00000000002135,0.775135238764564,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
2419,GO:0005594,1.00000000002135,0.775048966769981,0,2,collagen type IX trimer,CC,
13037,GO:0051562,1.00000000002136,0.774968201249667,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
1502,GO:0003858,1.00000000002137,0.774903684319037,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
12342,GO:0048743,1.00000000002139,0.774700381528664,0,2,positive regulation of skeletal muscle fiber development,BP,
19004,GO:1904875,1.0000000000214,0.775682910121183,0,2,regulation of DNA ligase activity,BP,
9950,GO:0042351,1.00000000002141,0.78422513125816,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
16800,GO:0098713,1.00000000002141,0.880728612632629,0,1,leucine import across plasma membrane,BP,
18546,GO:1903801,1.00000000002141,0.880728612632629,0,1,L-leucine import across plasma membrane,BP,
15746,GO:0072368,1.00000000002142,0.773839208341823,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
6404,GO:0021648,1.00000000002142,0.774841435396075,0,2,vestibulocochlear nerve morphogenesis,BP,
11659,GO:0046462,1.00000000002143,0.77724686468233,0,2,monoacylglycerol metabolic process,BP,
13356,GO:0052651,1.00000000002143,0.77724686468233,0,2,monoacylglycerol catabolic process,BP,
2881,GO:0006386,1.00000000002144,0.896781807999013,0,1,termination of RNA polymerase III transcription,BP,
3054,GO:0006617,1.00000000002146,0.78834557043836,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
12384,GO:0048850,1.00000000002147,0.774440878522496,0,2,hypophysis morphogenesis,BP,
16546,GO:0097363,1.00000000002147,0.774782475613316,0,2,protein O-GlcNAc transferase activity,MF,
3901,GO:0008545,1.00000000002147,0.774787013178328,0,2,JUN kinase kinase activity,MF,
18126,GO:1902896,1.00000000002148,0.774825332990904,0,2,terminal web assembly,BP,
2459,GO:0005673,1.0000000000215,0.779250563350975,0,2,transcription factor TFIIE complex,CC,
2076,GO:0004831,1.0000000000215,0.775529708526438,0,2,tyrosine-tRNA ligase activity,MF,
2924,GO:0006437,1.0000000000215,0.775529708526438,0,2,tyrosyl-tRNA aminoacylation,BP,
16374,GO:0097021,1.00000000002151,0.776989689579428,0,2,lymphocyte migration into lymphoid organs,BP,
668,GO:0001878,1.00000000002154,0.880644211064157,0,1,response to yeast,BP,
4215,GO:0009386,1.00000000002154,0.880644211064157,0,1,translational attenuation,BP,
14448,GO:0061847,1.00000000002154,0.880644211064157,0,1,response to cholecystokinin,BP,
15295,GO:0071538,1.00000000002154,0.880644211064157,0,1,SH2 domain-mediated complex assembly,BP,
19614,GO:1990839,1.00000000002154,0.880644211064157,0,1,response to endothelin,BP,
19618,GO:1990859,1.00000000002154,0.880644211064157,0,1,cellular response to endothelin,BP,
51,GO:0000105,1.00000000002157,0.77509732177688,0,2,histidine biosynthetic process,BP,
3574,GO:0007621,1.00000000002157,0.879533138236404,0,1,negative regulation of female receptivity,BP,
14297,GO:0061485,1.00000000002158,0.879519004021941,0,1,memory T cell proliferation,BP,
15350,GO:0071619,1.00000000002159,0.880709165514115,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20194,GO:2001163,1.00000000002159,0.880709165514115,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20195,GO:2001165,1.00000000002159,0.880709165514115,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
8399,GO:0033385,1.00000000002159,0.880339151382373,0,1,geranylgeranyl diphosphate metabolic process,BP,
8400,GO:0033386,1.00000000002159,0.880339151382373,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
3170,GO:0006784,1.00000000002161,0.774432225198601,0,2,heme a biosynthetic process,BP,
11567,GO:0046160,1.00000000002161,0.774432225198601,0,2,heme a metabolic process,BP,
7283,GO:0031289,1.00000000002162,0.880312100494158,0,1,actin phosphorylation,BP,
10558,GO:0043538,1.00000000002162,0.880312100494158,0,1,regulation of actin phosphorylation,BP,
2684,GO:0006049,1.00000000002163,0.880328265970583,0,1,UDP-N-acetylglucosamine catabolic process,BP,
9542,GO:0036324,1.00000000002166,0.783944143412008,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
13408,GO:0052836,1.00000000002166,0.781346231790822,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13409,GO:0052839,1.00000000002166,0.781346231790822,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
9918,GO:0042281,1.00000000002171,0.777664354544296,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
8950,GO:0035033,1.00000000002171,0.780306639370349,0,2,histone deacetylase regulator activity,MF,
657,GO:0001849,1.00000000002176,0.785249739260044,0,2,complement component C1q binding,MF,
13859,GO:0060523,1.00000000002178,0.774505154546804,0,2,prostate epithelial cord elongation,BP,
10745,GO:0044208,1.00000000002183,0.779866858904489,0,2,'de novo' AMP biosynthetic process,BP,
15900,GO:0072714,1.00000000002183,0.883242676582029,0,1,response to selenite ion,BP,
15901,GO:0072715,1.00000000002183,0.883242676582029,0,1,cellular response to selenite ion,BP,
18859,GO:1904569,1.00000000002183,0.883242676582029,0,1,regulation of selenocysteine incorporation,BP,
18860,GO:1904570,1.00000000002183,0.883242676582029,0,1,negative regulation of selenocysteine incorporation,BP,
18861,GO:1904572,1.00000000002183,0.883242676582029,0,1,negative regulation of mRNA binding,BP,
18862,GO:1904573,1.00000000002183,0.883242676582029,0,1,regulation of selenocysteine insertion sequence binding,BP,
18863,GO:1904574,1.00000000002183,0.883242676582029,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19143,GO:1905215,1.00000000002183,0.883242676582029,0,1,negative regulation of RNA binding,BP,
1944,GO:0004651,1.00000000002184,0.778128603310718,0,2,polynucleotide 5'-phosphatase activity,MF,
16719,GO:0098507,1.00000000002184,0.778128603310718,0,2,polynucleotide 5' dephosphorylation,BP,
618,GO:0001792,1.00000000002185,0.880133724985926,0,1,polymeric immunoglobulin receptor activity,MF,
8489,GO:0033679,1.00000000002186,0.88012368507692,0,1,3'-5' DNA/RNA helicase activity,MF,
8491,GO:0033681,1.00000000002186,0.88012368507692,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8768,GO:0034459,1.00000000002186,0.88012368507692,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9768,GO:0039695,1.00000000002186,0.88012368507692,0,1,DNA-templated viral transcription,BP,
19052,GO:1904971,1.00000000002186,0.88012368507692,0,1,regulation of viral translation,BP,
19053,GO:1904973,1.00000000002186,0.88012368507692,0,1,positive regulation of viral translation,BP,
19131,GO:1905172,1.00000000002186,0.88012368507692,0,1,RISC complex binding,MF,
19316,GO:1905698,1.00000000002186,0.88012368507692,0,1,positive regulation of polysome binding,BP,
19524,GO:1990518,1.00000000002186,0.88012368507692,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
1957,GO:0004666,1.00000000002187,0.774609683376508,0,2,prostaglandin-endoperoxide synthase activity,MF,
7083,GO:0030886,1.00000000002189,0.778677439603579,0,2,negative regulation of myeloid dendritic cell activation,BP,
1623,GO:0004061,1.00000000002192,0.883609695579319,0,1,arylformamidase activity,MF,
4776,GO:0010967,1.00000000002192,0.883609695579319,0,1,regulation of polyamine biosynthetic process,BP,
7145,GO:0031013,1.00000000002192,0.883609695579319,0,1,troponin I binding,MF,
13425,GO:0052899,1.00000000002192,0.883609695579319,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13427,GO:0052902,1.00000000002192,0.883609695579319,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13428,GO:0052903,1.00000000002192,0.883609695579319,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13429,GO:0052904,1.00000000002192,0.883609695579319,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
17589,GO:1901304,1.00000000002192,0.883609695579319,0,1,regulation of spermidine biosynthetic process,BP,
17590,GO:1901307,1.00000000002192,0.883609695579319,0,1,positive regulation of spermidine biosynthetic process,BP,
16301,GO:0090541,1.00000000002192,0.774796976140743,0,2,MIT domain binding,MF,
8234,GO:0033018,1.00000000002193,0.776402267004508,0,2,sarcoplasmic reticulum lumen,CC,
19463,GO:1990264,1.00000000002194,0.775310420591011,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
19919,GO:2000490,1.00000000002198,0.776184306422256,0,2,negative regulation of hepatic stellate cell activation,BP,
7606,GO:0032002,1.00000000002198,0.776365731622719,0,2,interleukin-28 receptor complex,CC,
8297,GO:0033142,1.00000000002199,0.880902297200849,0,1,progesterone receptor binding,MF,
19803,GO:2000299,1.00000000002201,0.880260343112765,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
1349,GO:0003219,1.00000000002201,0.775951033217919,0,2,cardiac right ventricle formation,BP,
2228,GO:0005132,1.00000000002206,0.789209919781047,0,2,type I interferon receptor binding,MF,
15884,GO:0072682,1.00000000002206,0.880251331079109,0,1,eosinophil extravasation,BP,
19889,GO:2000417,1.00000000002206,0.880251331079109,0,1,negative regulation of eosinophil migration,BP,
19891,GO:2000419,1.00000000002206,0.880251331079109,0,1,regulation of eosinophil extravasation,BP,
19892,GO:2000420,1.00000000002206,0.880251331079109,0,1,negative regulation of eosinophil extravasation,BP,
476,GO:0001520,1.00000000002207,0.774678749960848,0,2,outer dense fiber,CC,
12246,GO:0048561,1.00000000002208,0.880825557050907,0,1,establishment of animal organ orientation,BP,
13777,GO:0060392,1.00000000002209,0.781766284038666,0,2,negative regulation of SMAD protein signal transduction,BP,
11204,GO:0045355,1.00000000002216,0.783304695760495,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11953,GO:0047237,1.00000000002218,0.774857537672778,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
18907,GO:1904685,1.00000000002218,0.775142334135016,0,2,positive regulation of metalloendopeptidase activity,BP,
6905,GO:0030504,1.0000000000222,0.879062571481773,0,1,inorganic diphosphate transmembrane transporter activity,MF,
15502,GO:0071918,1.00000000002223,0.77479284374167,0,2,urea transmembrane transport,BP,
17886,GO:1902226,1.00000000002223,0.777936793841322,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
18625,GO:1903969,1.00000000002223,0.777936793841322,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18628,GO:1903972,1.00000000002223,0.777936793841322,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
179,GO:0000390,1.00000000002226,0.783253860160659,0,2,spliceosomal complex disassembly,BP,
2226,GO:0005130,1.00000000002226,0.885443348544239,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2207,GO:0005094,1.00000000002227,0.784810922617939,0,2,Rho GDP-dissociation inhibitor activity,MF,
12116,GO:0048237,1.0000000000223,0.779692525912495,0,2,rough endoplasmic reticulum lumen,CC,
9207,GO:0035608,1.00000000002231,0.774799045223079,0,2,protein deglutamylation,BP,
10456,GO:0043366,1.00000000002231,0.776268643325008,0,2,beta selection,BP,
15692,GO:0072278,1.00000000002231,0.777100014414363,0,2,metanephric comma-shaped body morphogenesis,BP,
7241,GO:0031208,1.00000000002232,0.774588096847182,0,2,POZ domain binding,MF,
17967,GO:1902442,1.00000000002233,0.880193451148562,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
17968,GO:1902443,1.00000000002233,0.880193451148562,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
17709,GO:1901668,1.00000000002235,0.787180228945102,0,2,regulation of superoxide dismutase activity,BP,
471,GO:0001515,1.00000000002235,0.8817042496795,0,1,opioid peptide activity,MF,
10137,GO:0042732,1.00000000002236,0.788720402852834,0,2,D-xylose metabolic process,BP,
63,GO:0000126,1.00000000002237,0.771014793443875,0,2,transcription factor TFIIIB complex,CC,
384,GO:0001026,1.00000000002237,0.771014793443875,0,2,TFIIIB-type transcription factor activity,MF,
18915,GO:1904700,1.00000000002238,0.880371135304122,0,1,granulosa cell apoptotic process,BP,
18920,GO:1904708,1.00000000002238,0.880371135304122,0,1,regulation of granulosa cell apoptotic process,BP,
11725,GO:0046586,1.00000000002238,0.787598287404852,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
4485,GO:0010512,1.00000000002239,0.774985368344361,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
9303,GO:0035788,1.00000000002239,0.774985368344361,0,2,cell migration involved in metanephros development,BP,
9304,GO:0035789,1.00000000002239,0.774985368344361,0,2,metanephric mesenchymal cell migration,BP,
9307,GO:0035793,1.00000000002239,0.774985368344361,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17424,GO:1900238,1.00000000002239,0.774985368344361,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
19963,GO:2000589,1.00000000002239,0.774985368344361,0,2,regulation of metanephric mesenchymal cell migration,BP,
19964,GO:2000591,1.00000000002239,0.774985368344361,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
13655,GO:0060214,1.00000000002241,0.7790900626476,0,2,endocardium formation,BP,
14471,GO:0061944,1.00000000002241,0.880130894887614,0,1,negative regulation of protein K48-linked ubiquitination,BP,
1137,GO:0002729,1.00000000002243,0.784567224610405,0,2,positive regulation of natural killer cell cytokine production,BP,
7716,GO:0032216,1.00000000002243,0.880754176973253,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
15971,GO:0086008,1.00000000002243,0.775115206440279,0,2,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
8691,GO:0034342,1.00000000002244,0.775648610668536,0,2,response to type III interferon,BP,
16170,GO:0090226,1.00000000002244,0.896134503132331,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
18421,GO:1903537,1.00000000002246,0.77516527378606,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18422,GO:1903538,1.00000000002246,0.77516527378606,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
511,GO:0001575,1.00000000002248,0.777314396969943,0,2,globoside metabolic process,BP,
167,GO:0000349,1.00000000002249,0.775210257568432,0,2,generation of catalytic spliceosome for first transesterification step,BP,
2506,GO:0005760,1.00000000002249,0.774614714053763,0,2,gamma DNA polymerase complex,CC,
16093,GO:0090108,1.0000000000225,0.881292766436465,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16140,GO:0090187,1.0000000000225,0.881292766436465,0,1,positive regulation of pancreatic juice secretion,BP,
16247,GO:0090340,1.0000000000225,0.881292766436465,0,1,positive regulation of secretion of lysosomal enzymes,BP,
6551,GO:0021997,1.00000000002251,0.773785164624897,0,2,neural plate axis specification,BP,
17921,GO:1902298,1.00000000002251,0.771128609699636,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19501,GO:1990426,1.00000000002251,0.771128609699636,0,2,mitotic recombination-dependent replication fork processing,BP,
19522,GO:1990505,1.00000000002251,0.771128609699636,0,2,mitotic DNA replication maintenance of fidelity,BP,
10560,GO:0043541,1.00000000002253,0.774838943890448,0,2,UDP-N-acetylglucosamine transferase complex,CC,
18470,GO:1903630,1.00000000002254,0.889460802461732,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18471,GO:1903632,1.00000000002254,0.889460802461732,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
83,GO:0000171,1.00000000002255,0.774879129297112,0,2,ribonuclease MRP activity,MF,
9713,GO:0038172,1.00000000002258,0.774867146196441,0,2,interleukin-33-mediated signaling pathway,BP,
8743,GO:0034418,1.00000000002259,0.775706069416128,0,2,urate biosynthetic process,BP,
19008,GO:1904879,1.00000000002261,0.775033258160507,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
14515,GO:0070053,1.00000000002262,0.774819430663164,0,2,thrombospondin receptor activity,MF,
5771,GO:0016998,1.00000000002262,0.779438667985153,0,2,cell wall macromolecule catabolic process,BP,
19730,GO:2000156,1.00000000002262,0.774837653062158,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
1772,GO:0004382,1.00000000002263,0.775788071777515,0,2,guanosine-diphosphatase activity,MF,
1752,GO:0004357,1.00000000002263,0.774834288825481,0,2,glutamate-cysteine ligase activity,MF,
5824,GO:0017109,1.00000000002263,0.774834288825481,0,2,glutamate-cysteine ligase complex,CC,
16404,GO:0097069,1.00000000002263,0.774834288825481,0,2,cellular response to thyroxine stimulus,BP,
18792,GO:1904387,1.00000000002263,0.774834288825481,0,2,cellular response to L-phenylalanine derivative,BP,
5143,GO:0015679,1.00000000002269,0.77347881125625,0,2,plasma membrane copper ion transport,BP,
15978,GO:0086015,1.0000000000227,0.773882066785171,0,2,SA node cell action potential,BP,
15981,GO:0086018,1.0000000000227,0.773882066785171,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
14413,GO:0061750,1.00000000002271,0.880613705149034,0,1,acid sphingomyelin phosphodiesterase activity,MF,
14735,GO:0070436,1.00000000002272,0.774753244667608,0,2,Grb2-EGFR complex,CC,
20098,GO:2000819,1.00000000002274,0.774867037497568,0,2,regulation of nucleotide-excision repair,BP,
437,GO:0001172,1.00000000002275,0.798827251914292,0,2,transcription, RNA-templated,BP,
1562,GO:0003968,1.00000000002275,0.798827251914292,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
2840,GO:0006311,1.00000000002276,0.880295615857906,0,1,meiotic gene conversion,BP,
5383,GO:0016213,1.00000000002276,0.880295615857906,0,1,linoleoyl-CoA desaturase activity,MF,
11092,GO:0045128,1.00000000002276,0.880295615857906,0,1,negative regulation of reciprocal meiotic recombination,BP,
17209,GO:0110029,1.00000000002276,0.880295615857906,0,1,negative regulation of meiosis I,BP,
6487,GO:0021849,1.00000000002278,0.774785674213809,0,2,neuroblast division in subventricular zone,BP,
14758,GO:0070488,1.00000000002278,0.815307443271298,0,2,neutrophil aggregation,BP,
14989,GO:0070944,1.00000000002279,0.777996579858496,0,2,neutrophil mediated killing of bacterium,BP,
14990,GO:0070945,1.00000000002279,0.777996579858496,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
20165,GO:2001045,1.00000000002279,0.774570162430504,0,2,negative regulation of integrin-mediated signaling pathway,BP,
1489,GO:0003829,1.00000000002282,0.774702454759908,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
5214,GO:0015820,1.00000000002282,0.775146884534087,0,2,leucine transport,BP,
2363,GO:0005476,1.00000000002286,0.77654834348137,0,2,carnitine:acyl carnitine antiporter activity,MF,
19568,GO:1990723,1.00000000002286,0.77028321076273,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
9911,GO:0042272,1.00000000002288,0.771523214254624,0,2,nuclear RNA export factor complex,CC,
5976,GO:0018738,1.00000000002289,0.889782321582306,0,1,S-formylglutathione hydrolase activity,MF,
5043,GO:0015230,1.00000000002291,0.775308108589376,0,2,FAD transmembrane transporter activity,MF,
9075,GO:0035350,1.00000000002291,0.775308108589376,0,2,FAD transmembrane transport,BP,
12929,GO:0051316,1.00000000002295,0.775343528206489,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
7651,GO:0032089,1.00000000002296,0.774787992785395,0,2,NACHT domain binding,MF,
5443,GO:0016320,1.00000000002299,0.781209216655475,0,2,endoplasmic reticulum membrane fusion,BP,
10726,GO:0044111,1.00000000002301,0.77802749390154,0,2,development involved in symbiotic interaction,BP,
16014,GO:0086072,1.00000000002301,0.88044016646064,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16022,GO:0086082,1.00000000002301,0.88044016646064,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
2369,GO:0005497,1.00000000002302,0.790826176646126,0,2,androgen binding,MF,
11083,GO:0045113,1.00000000002303,0.793129679831688,0,2,regulation of integrin biosynthetic process,BP,
4274,GO:0009644,1.00000000002304,0.775584818416241,0,2,response to high light intensity,BP,
107,GO:0000224,1.00000000002306,0.88039689955611,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
580,GO:0001733,1.00000000002306,0.88039689955611,0,1,galactosylceramide sulfotransferase activity,MF,
12524,GO:0050694,1.00000000002306,0.88039689955611,0,1,galactose 3-O-sulfotransferase activity,MF,
12525,GO:0050698,1.00000000002306,0.88039689955611,0,1,proteoglycan sulfotransferase activity,MF,
19921,GO:2000501,1.00000000002314,0.784157237687409,0,2,regulation of natural killer cell chemotaxis,BP,
19922,GO:2000503,1.00000000002314,0.784157237687409,0,2,positive regulation of natural killer cell chemotaxis,BP,
8263,GO:0033078,1.00000000002316,0.777583743306394,0,2,extrathymic T cell differentiation,BP,
593,GO:0001758,1.00000000002317,0.682754665238774,0,3,retinal dehydrogenase activity,MF,
7598,GO:0031990,1.00000000002317,0.772876277898649,0,2,mRNA export from nucleus in response to heat stress,BP,
17090,GO:0102005,1.00000000002318,0.885523931157492,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
4896,GO:0014827,1.00000000002318,0.776513286746282,0,2,intestine smooth muscle contraction,BP,
20218,GO:2001200,1.0000000000232,0.781358329140788,0,2,positive regulation of dendritic cell differentiation,BP,
3099,GO:0006679,1.00000000002323,0.778202367255306,0,2,glucosylceramide biosynthetic process,BP,
18796,GO:1904398,1.00000000002325,0.773334353247691,0,2,positive regulation of neuromuscular junction development,BP,
8535,GO:0033883,1.00000000002329,0.785443054396522,0,2,pyridoxal phosphatase activity,MF,
7370,GO:0031431,1.00000000002329,0.774836889302006,0,2,Dbf4-dependent protein kinase complex,CC,
10731,GO:0044128,1.00000000002331,0.880122405967233,0,1,positive regulation of growth of symbiont in host,BP,
10737,GO:0044148,1.00000000002331,0.880122405967233,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
16903,GO:0098908,1.00000000002331,0.774950219012314,0,2,regulation of neuronal action potential,BP,
3261,GO:0006933,1.00000000002333,0.777610134945877,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
13297,GO:0052203,1.00000000002334,0.777501305067574,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
18820,GO:1904455,1.00000000002336,0.774502063100447,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
16585,GO:0097450,1.00000000002337,0.774807440400853,0,2,astrocyte end-foot,CC,
16586,GO:0097451,1.00000000002337,0.774807440400853,0,2,glial limiting end-foot,CC,
14452,GO:0061857,1.00000000002338,0.774835950098764,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
17608,GO:1901355,1.00000000002338,0.7751861081441,0,2,response to rapamycin,BP,
14235,GO:0061317,1.00000000002338,0.777314868247908,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17581,GO:1901295,1.00000000002338,0.777314868247908,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19095,GO:1905066,1.00000000002338,0.777314868247908,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
9648,GO:0038018,1.00000000002339,0.774435472423121,0,2,Wnt receptor catabolic process,BP,
8438,GO:0033577,1.0000000000234,0.775032313192225,0,2,protein glycosylation in endoplasmic reticulum,BP,
4949,GO:0015016,1.0000000000234,0.773810874889553,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
12420,GO:0050119,1.0000000000234,0.773810874889553,0,2,N-acetylglucosamine deacetylase activity,MF,
253,GO:0000718,1.00000000002342,0.883350632487568,0,1,nucleotide-excision repair, DNA damage removal,BP,
1673,GO:0004139,1.00000000002342,0.883350632487568,0,1,deoxyribose-phosphate aldolase activity,MF,
10834,GO:0044349,1.00000000002342,0.883350632487568,0,1,DNA excision,BP,
11638,GO:0046403,1.00000000002342,0.883350632487568,0,1,polynucleotide 3'-phosphatase activity,MF,
16715,GO:0098503,1.00000000002342,0.883350632487568,0,1,DNA 3' dephosphorylation,BP,
16716,GO:0098504,1.00000000002342,0.883350632487568,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16718,GO:0098506,1.00000000002342,0.883350632487568,0,1,polynucleotide 3' dephosphorylation,BP,
15044,GO:0071031,1.00000000002342,0.784513193317965,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15056,GO:0071049,1.00000000002342,0.784513193317965,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
8260,GO:0033065,1.00000000002344,0.787165555663819,0,2,Rad51C-XRCC3 complex,CC,
3920,GO:0008597,1.00000000002346,0.778015935333636,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
1621,GO:0004057,1.00000000002347,0.88084028882315,0,1,arginyltransferase activity,MF,
11306,GO:0045650,1.0000000000235,0.77835996012933,0,2,negative regulation of macrophage differentiation,BP,
16212,GO:0090289,1.00000000002351,0.785359943758656,0,2,regulation of osteoclast proliferation,BP,
3967,GO:0008781,1.00000000002352,0.78527378985414,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
1887,GO:0004572,1.00000000002354,0.774496507366758,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
11771,GO:0046657,1.00000000002358,0.787812576146876,0,2,folic acid catabolic process,BP,
19233,GO:1905443,1.00000000002362,0.880125636502624,0,1,regulation of clathrin coat assembly,BP,
19234,GO:1905445,1.00000000002362,0.880125636502624,0,1,positive regulation of clathrin coat assembly,BP,
14307,GO:0061517,1.00000000002362,0.775002410072008,0,2,macrophage proliferation,BP,
14308,GO:0061518,1.00000000002362,0.775002410072008,0,2,microglial cell proliferation,BP,
15582,GO:0072095,1.00000000002362,0.776959923210656,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
16484,GO:0097212,1.00000000002365,0.776577198069792,0,2,lysosomal membrane organization,BP,
8767,GO:0034458,1.00000000002368,0.774879260266445,0,2,3'-5' RNA helicase activity,MF,
15346,GO:0071612,1.00000000002369,0.874977404990694,0,1,IP-10 production,BP,
15376,GO:0071658,1.00000000002369,0.874977404990694,0,1,regulation of IP-10 production,BP,
15377,GO:0071660,1.00000000002369,0.874977404990694,0,1,positive regulation of IP-10 production,BP,
4609,GO:0010731,1.00000000002369,0.88059073952845,0,1,protein glutathionylation,BP,
4610,GO:0010732,1.00000000002369,0.88059073952845,0,1,regulation of protein glutathionylation,BP,
4611,GO:0010734,1.00000000002369,0.88059073952845,0,1,negative regulation of protein glutathionylation,BP,
18229,GO:1903094,1.0000000000237,0.794366041497383,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19731,GO:2000157,1.0000000000237,0.794366041497383,0,2,negative regulation of ubiquitin-specific protease activity,BP,
144,GO:0000296,1.00000000002372,0.88067701037049,0,1,spermine transport,BP,
15363,GO:0071638,1.00000000002373,0.786586452621517,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
18732,GO:1904245,1.00000000002373,0.777502313247606,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
14947,GO:0070877,1.00000000002373,0.774795122048694,0,2,microprocessor complex,CC,
18230,GO:1903095,1.00000000002373,0.774795122048694,0,2,ribonuclease III complex,CC,
4845,GO:0014062,1.00000000002374,0.783481391290578,0,2,regulation of serotonin secretion,BP,
704,GO:0001928,1.00000000002375,0.880741253938633,0,1,regulation of exocyst assembly,BP,
13636,GO:0060178,1.00000000002375,0.880741253938633,0,1,regulation of exocyst localization,BP,
8367,GO:0033277,1.00000000002375,0.775041648590156,0,2,abortive mitotic cell cycle,BP,
14597,GO:0070191,1.00000000002376,0.776353846853911,0,2,methionine-R-sulfoxide reductase activity,MF,
14420,GO:0061763,1.00000000002378,0.775002665490817,0,2,multivesicular body-lysosome fusion,BP,
19978,GO:2000620,1.00000000002379,0.774186821498256,0,2,positive regulation of histone H4-K16 acetylation,BP,
16354,GO:0090725,1.00000000002383,0.787805282633518,0,2,peripheral region of growth cone,CC,
10614,GO:0043629,1.00000000002384,0.879179062297203,0,1,ncRNA polyadenylation,BP,
10615,GO:0043630,1.00000000002384,0.879179062297203,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
9351,GO:0035880,1.00000000002386,0.775321519019343,0,2,embryonic nail plate morphogenesis,BP,
7896,GO:0032474,1.00000000002389,0.774653833944685,0,2,otolith morphogenesis,BP,
14546,GO:0070101,1.0000000000239,0.775579700887842,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
1679,GO:0004146,1.0000000000239,0.784904530735722,0,2,dihydrofolate reductase activity,MF,
4586,GO:0010698,1.0000000000239,0.793488459042152,0,2,acetyltransferase activator activity,MF,
13960,GO:0060698,1.00000000002393,0.774784059148226,0,2,endoribonuclease inhibitor activity,MF,
13963,GO:0060701,1.00000000002393,0.774784059148226,0,2,negative regulation of ribonuclease activity,BP,
13964,GO:0060702,1.00000000002393,0.774784059148226,0,2,negative regulation of endoribonuclease activity,BP,
16545,GO:0097362,1.00000000002394,0.774957628155372,0,2,MCM8-MCM9 complex,CC,
3182,GO:0006808,1.00000000002394,0.789049687762543,0,2,regulation of nitrogen utilization,BP,
11775,GO:0046666,1.00000000002394,0.789049687762543,0,2,retinal cell programmed cell death,BP,
6385,GO:0021590,1.00000000002395,0.773832694419727,0,2,cerebellum maturation,BP,
6419,GO:0021691,1.00000000002395,0.773832694419727,0,2,cerebellar Purkinje cell layer maturation,BP,
6427,GO:0021699,1.00000000002395,0.773832694419727,0,2,cerebellar cortex maturation,BP,
9218,GO:0035621,1.00000000002396,0.775971762721861,0,2,ER to Golgi ceramide transport,BP,
2054,GO:0004807,1.00000000002397,0.88611876995987,0,1,triose-phosphate isomerase activity,MF,
1560,GO:0003963,1.00000000002397,0.775521624984145,0,2,RNA-3'-phosphate cyclase activity,MF,
14957,GO:0070893,1.000000000024,0.774793472046469,0,2,transposon integration,BP,
14958,GO:0070894,1.000000000024,0.774793472046469,0,2,regulation of transposon integration,BP,
14959,GO:0070895,1.000000000024,0.774793472046469,0,2,negative regulation of transposon integration,BP,
16463,GO:0097180,1.000000000024,0.792684970909713,0,2,serine protease inhibitor complex,CC,
13765,GO:0060378,1.00000000002401,0.879351223901547,0,1,regulation of brood size,BP,
7788,GO:0032346,1.00000000002401,0.774806786443137,0,2,positive regulation of aldosterone metabolic process,BP,
7791,GO:0032349,1.00000000002401,0.774806786443137,0,2,positive regulation of aldosterone biosynthetic process,BP,
16535,GO:0097344,1.00000000002402,0.779070351290501,0,2,Rix1 complex,CC,
8433,GO:0033566,1.00000000002408,0.775114162168929,0,2,gamma-tubulin complex localization,BP,
17995,GO:1902524,1.00000000002409,0.779713433841615,0,2,positive regulation of protein K48-linked ubiquitination,BP,
13348,GO:0052593,1.00000000002411,0.774847552798917,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13349,GO:0052594,1.00000000002411,0.774847552798917,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13350,GO:0052595,1.00000000002411,0.774847552798917,0,2,aliphatic-amine oxidase activity,MF,
13351,GO:0052596,1.00000000002411,0.774847552798917,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
18003,GO:1902544,1.00000000002412,0.788642563355526,0,2,regulation of DNA N-glycosylase activity,BP,
2992,GO:0006540,1.00000000002412,0.774980948999099,0,2,glutamate decarboxylation to succinate,BP,
5140,GO:0015671,1.00000000002412,0.776504999198573,0,2,oxygen transport,BP,
16679,GO:0097681,1.00000000002413,0.76596653501301,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
14498,GO:0070012,1.00000000002414,0.775149138310819,0,2,oligopeptidase activity,MF,
6520,GO:0021914,1.00000000002415,0.774874230429653,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7409,GO:0031508,1.0000000000242,0.783722367223683,0,2,pericentric heterochromatin assembly,BP,
4498,GO:0010536,1.00000000002425,0.793565703325037,0,2,positive regulation of activation of Janus kinase activity,BP,
13102,GO:0051673,1.00000000002427,0.780669839285167,0,2,membrane disruption in other organism,BP,
19168,GO:1905286,1.00000000002429,0.775338838776888,0,2,serine-type peptidase complex,CC,
11007,GO:0044861,1.00000000002431,0.776436437125489,0,2,protein transport into plasma membrane raft,BP,
16112,GO:0090149,1.00000000002434,0.775039613370608,0,2,mitochondrial membrane fission,BP,
19776,GO:2000253,1.00000000002434,0.773464169953599,0,2,positive regulation of feeding behavior,BP,
17356,GO:1900109,1.00000000002435,0.785526087684938,0,2,regulation of histone H3-K9 dimethylation,BP,
17357,GO:1900110,1.00000000002435,0.785526087684938,0,2,negative regulation of histone H3-K9 dimethylation,BP,
7064,GO:0030860,1.00000000002435,0.774857810586753,0,2,regulation of polarized epithelial cell differentiation,BP,
2349,GO:0005415,1.00000000002439,0.775498353424204,0,2,nucleoside:sodium symporter activity,MF,
5235,GO:0015860,1.00000000002439,0.775498353424204,0,2,purine nucleoside transmembrane transport,BP,
16869,GO:0098842,1.00000000002442,0.775740433527413,0,2,postsynaptic early endosome,CC,
6516,GO:0021902,1.00000000002443,0.773966210557913,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
14811,GO:0070576,1.00000000002444,0.774972742583323,0,2,vitamin D 24-hydroxylase activity,MF,
16135,GO:0090182,1.00000000002445,0.77990314706167,0,2,regulation of secretion of lysosomal enzymes,BP,
246,GO:0000703,1.00000000002446,0.789154639608108,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
2066,GO:0004821,1.00000000002447,0.776288939891881,0,2,histidine-tRNA ligase activity,MF,
2914,GO:0006427,1.00000000002447,0.776288939891881,0,2,histidyl-tRNA aminoacylation,BP,
906,GO:0002291,1.00000000002448,0.780924129310651,0,2,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
19929,GO:2000520,1.00000000002448,0.780924129310651,0,2,regulation of immunological synapse formation,BP,
19930,GO:2000521,1.00000000002448,0.780924129310651,0,2,negative regulation of immunological synapse formation,BP,
20213,GO:2001188,1.00000000002448,0.780924129310651,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20214,GO:2001189,1.00000000002448,0.780924129310651,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
215,GO:0000451,1.00000000002452,0.776744829542881,0,2,rRNA 2'-O-methylation,BP,
216,GO:0000453,1.00000000002452,0.776744829542881,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
14509,GO:0070039,1.00000000002452,0.776744829542881,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
1943,GO:0004649,1.00000000002453,0.777733834517462,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
3532,GO:0007525,1.00000000002453,0.730712218878516,0,2,somatic muscle development,BP,
15078,GO:0071148,1.00000000002457,0.772729182043561,0,2,TEAD-1-YAP complex,CC,
18441,GO:1903567,1.00000000002457,0.775097554880121,0,2,regulation of protein localization to ciliary membrane,BP,
2064,GO:0004819,1.00000000002457,0.774904683906992,0,2,glutamine-tRNA ligase activity,MF,
2912,GO:0006425,1.00000000002457,0.774904683906992,0,2,glutaminyl-tRNA aminoacylation,BP,
5207,GO:0015810,1.0000000000246,0.774781783848049,0,2,aspartate transmembrane transport,BP,
10525,GO:0043490,1.0000000000246,0.774781783848049,0,2,malate-aspartate shuttle,BP,
9242,GO:0035663,1.00000000002463,0.777007645064527,0,2,Toll-like receptor 2 binding,MF,
9311,GO:0035800,1.00000000002463,0.780815778359318,0,2,deubiquitinase activator activity,MF,
19732,GO:2000158,1.00000000002463,0.780815778359318,0,2,positive regulation of ubiquitin-specific protease activity,BP,
11878,GO:0046922,1.00000000002465,0.774890749996467,0,2,peptide-O-fucosyltransferase activity,MF,
9221,GO:0035624,1.00000000002468,0.773890353971647,0,2,receptor transactivation,BP,
16436,GO:0097135,1.00000000002472,0.775378021472334,0,2,cyclin E2-CDK2 complex,CC,
15345,GO:0071611,1.00000000002472,0.775243306586153,0,2,granulocyte colony-stimulating factor production,BP,
15373,GO:0071655,1.00000000002472,0.775243306586153,0,2,regulation of granulocyte colony-stimulating factor production,BP,
9196,GO:0035596,1.00000000002473,0.775937322701099,0,2,methylthiotransferase activity,MF,
9199,GO:0035600,1.00000000002473,0.775937322701099,0,2,tRNA methylthiolation,BP,
12468,GO:0050497,1.00000000002473,0.775937322701099,0,2,transferase activity, transferring alkylthio groups,MF,
19586,GO:1990761,1.00000000002475,0.774918876199375,0,2,growth cone lamellipodium,CC,
10191,GO:0042823,1.00000000002475,0.774231430354009,0,2,pyridoxal phosphate biosynthetic process,BP,
20013,GO:2000666,1.00000000002476,0.776060147726672,0,2,negative regulation of interleukin-13 secretion,BP,
5378,GO:0016206,1.00000000002477,0.775296246531826,0,2,catechol O-methyltransferase activity,MF,
17095,GO:0102084,1.00000000002477,0.775296246531826,0,2,L-dopa O-methyltransferase activity,MF,
17147,GO:0102938,1.00000000002477,0.775296246531826,0,2,orcinol O-methyltransferase activity,MF,
9125,GO:0035473,1.0000000000248,0.778746535325251,0,2,lipase binding,MF,
5987,GO:0018963,1.00000000002484,0.776537984120341,0,2,phthalate metabolic process,BP,
13288,GO:0052151,1.00000000002486,0.784536270597761,0,2,positive regulation by symbiont of host apoptotic process,BP,
13613,GO:0060139,1.00000000002486,0.784536270597761,0,2,positive regulation of apoptotic process by virus,BP,
15043,GO:0071030,1.00000000002492,0.777776587272408,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15055,GO:0071048,1.00000000002492,0.777776587272408,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
2190,GO:0005052,1.00000000002492,0.774841148151128,0,2,peroxisome matrix targeting signal-1 binding,MF,
17170,GO:0106020,1.00000000002493,0.775190339775229,0,2,regulation of vesicle docking,BP,
1730,GO:0004329,1.00000000002493,0.774791150638699,0,2,formate-tetrahydrofolate ligase activity,MF,
4176,GO:0009257,1.00000000002493,0.774791150638699,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
15165,GO:0071332,1.00000000002496,0.77710923751066,0,2,cellular response to fructose stimulus,BP,
18474,GO:1903644,1.00000000002498,0.793643921977412,0,2,regulation of chaperone-mediated protein folding,BP,
18257,GO:1903179,1.00000000002502,0.787126698124604,0,2,regulation of dopamine biosynthetic process,BP,
18258,GO:1903181,1.00000000002502,0.787126698124604,0,2,positive regulation of dopamine biosynthetic process,BP,
5479,GO:0016418,1.00000000002502,0.773492244791827,0,2,S-acetyltransferase activity,MF,
1234,GO:0002923,1.00000000002505,0.880743388126028,0,1,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1235,GO:0002924,1.00000000002505,0.880743388126028,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9842,GO:0042105,1.00000000002505,0.880743388126028,0,1,alpha-beta T cell receptor complex,CC,
5304,GO:0016015,1.00000000002506,0.778590334902378,0,2,morphogen activity,MF,
3486,GO:0007356,1.0000000000251,0.777207974951285,0,2,thorax and anterior abdomen determination,BP,
20174,GO:2001074,1.0000000000251,0.777207974951285,0,2,regulation of metanephric ureteric bud development,BP,
20175,GO:2001076,1.0000000000251,0.777207974951285,0,2,positive regulation of metanephric ureteric bud development,BP,
12027,GO:0047894,1.00000000002514,0.784791659353967,0,2,flavonol 3-sulfotransferase activity,MF,
19268,GO:1905550,1.00000000002517,0.782668962820708,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19269,GO:1905552,1.00000000002517,0.782668962820708,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
6511,GO:0021894,1.00000000002521,0.891978570474617,0,1,cerebral cortex GABAergic interneuron development,BP,
19070,GO:1905006,1.00000000002523,0.776427091987581,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
15254,GO:0071461,1.00000000002527,0.783019497339093,0,2,cellular response to redox state,BP,
16913,GO:0098920,1.0000000000253,0.880346431018357,0,1,retrograde trans-synaptic signaling by lipid,BP,
16914,GO:0098921,1.0000000000253,0.880346431018357,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
3503,GO:0007412,1.00000000002533,0.784108168461885,0,2,axon target recognition,BP,
10663,GO:0043932,1.00000000002536,0.775418206649533,0,2,ossification involved in bone remodeling,BP,
16435,GO:0097134,1.00000000002536,0.777099083264366,0,2,cyclin E1-CDK2 complex,CC,
2125,GO:0004923,1.00000000002543,0.772142680063803,0,2,leukemia inhibitory factor receptor activity,MF,
532,GO:0001651,1.00000000002545,0.78367974762185,0,2,dense fibrillar component,CC,
1863,GO:0004530,1.00000000002548,0.772068054657922,0,2,deoxyribonuclease I activity,MF,
18953,GO:1904768,1.00000000002549,0.787569690332555,0,2,all-trans-retinol binding,MF,
6997,GO:0030689,1.00000000002556,0.6851579113813,0,3,Noc complex,CC,
5648,GO:0016748,1.00000000002566,0.775208487215883,0,2,succinyltransferase activity,MF,
299,GO:0000806,1.00000000002568,0.775180826261783,0,2,Y chromosome,CC,
14040,GO:0060844,1.00000000002569,0.7751243953086,0,2,arterial endothelial cell fate commitment,BP,
15366,GO:0071641,1.0000000000257,0.776080617652694,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
17442,GO:1900275,1.00000000002571,0.774697928577263,0,2,negative regulation of phospholipase C activity,BP,
12124,GO:0048250,1.00000000002574,0.780899888443326,0,2,iron import into the mitochondrion,BP,
1385,GO:0003294,1.00000000002575,0.774914629459855,0,2,atrial ventricular junction remodeling,BP,
4559,GO:0010645,1.00000000002575,0.774914629459855,0,2,regulation of cell communication by chemical coupling,BP,
4565,GO:0010652,1.00000000002575,0.774914629459855,0,2,positive regulation of cell communication by chemical coupling,BP,
9525,GO:0036292,1.00000000002575,0.780538755797646,0,2,DNA rewinding,BP,
20152,GO:2001027,1.00000000002577,0.772801248311297,0,2,negative regulation of endothelial cell chemotaxis,BP,
18071,GO:1902731,1.00000000002578,0.76961888726051,0,2,negative regulation of chondrocyte proliferation,BP,
1745,GO:0004348,1.0000000000258,0.775024355814523,0,2,glucosylceramidase activity,MF,
18854,GO:1904562,1.00000000002581,0.773112604802821,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
9126,GO:0035482,1.00000000002582,0.792354925289306,0,2,gastric motility,BP,
19189,GO:1905333,1.00000000002582,0.792354925289306,0,2,regulation of gastric motility,BP,
3675,GO:0008176,1.00000000002582,0.785058288584198,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
17163,GO:0106004,1.00000000002582,0.785058288584198,0,2,tRNA (guanine-N7)-methylation,BP,
3507,GO:0007418,1.00000000002583,0.774427061021084,0,2,ventral midline development,BP,
6528,GO:0021937,1.00000000002583,0.774427061021084,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6529,GO:0021938,1.00000000002583,0.774427061021084,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6530,GO:0021940,1.00000000002583,0.774427061021084,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
142,GO:0000294,1.00000000002587,0.774800454493132,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
8304,GO:0033149,1.00000000002587,0.774385738732504,0,2,FFAT motif binding,MF,
7870,GO:0032444,1.00000000002588,0.770394688106551,0,2,activin responsive factor complex,CC,
9042,GO:0035279,1.0000000000259,0.774875794081657,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
16838,GO:0098795,1.0000000000259,0.774875794081657,0,2,mRNA cleavage involved in gene silencing,BP,
14103,GO:0060995,1.00000000002593,0.77476915662411,0,2,cell-cell signaling involved in kidney development,BP,
14219,GO:0061289,1.00000000002593,0.77476915662411,0,2,Wnt signaling pathway involved in kidney development,BP,
14220,GO:0061290,1.00000000002593,0.77476915662411,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15654,GO:0072204,1.00000000002593,0.77476915662411,0,2,cell-cell signaling involved in metanephros development,BP,
3831,GO:0008441,1.00000000002594,0.774483897819504,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
17751,GO:1901837,1.00000000002596,0.776963123314696,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
16393,GO:0097057,1.00000000002598,0.787092155050303,0,2,TRAF2-GSTP1 complex,CC,
9740,GO:0039506,1.000000000026,0.774799762714812,0,2,modulation by virus of host molecular function,BP,
9741,GO:0039507,1.000000000026,0.774799762714812,0,2,suppression by virus of host molecular function,BP,
13280,GO:0052055,1.000000000026,0.774799762714812,0,2,modulation by symbiont of host molecular function,BP,
13281,GO:0052056,1.000000000026,0.774799762714812,0,2,negative regulation by symbiont of host molecular function,BP,
18304,GO:1903292,1.00000000002605,0.774873671740734,0,2,protein localization to Golgi membrane,BP,
485,GO:0001537,1.00000000002607,0.775263762987366,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
11591,GO:0046294,1.00000000002608,0.783319312729767,0,2,formaldehyde catabolic process,BP,
3999,GO:0008941,1.00000000002608,0.77637666058381,0,2,nitric oxide dioxygenase activity,MF,
5624,GO:0016708,1.00000000002608,0.77637666058381,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
4771,GO:0010961,1.00000000002614,0.774174265187771,0,2,cellular magnesium ion homeostasis,BP,
17587,GO:1901301,1.00000000002615,0.774806027188084,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
13945,GO:0060678,1.00000000002616,0.880732795297523,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15603,GO:0072127,1.00000000002616,0.880732795297523,0,1,renal capsule development,BP,
15604,GO:0072128,1.00000000002616,0.880732795297523,0,1,renal capsule morphogenesis,BP,
15605,GO:0072129,1.00000000002616,0.880732795297523,0,1,renal capsule formation,BP,
15606,GO:0072130,1.00000000002616,0.880732795297523,0,1,renal capsule specification,BP,
15660,GO:0072213,1.00000000002616,0.880732795297523,0,1,metanephric capsule development,BP,
15685,GO:0072265,1.00000000002616,0.880732795297523,0,1,metanephric capsule morphogenesis,BP,
15686,GO:0072266,1.00000000002616,0.880732795297523,0,1,metanephric capsule formation,BP,
15687,GO:0072267,1.00000000002616,0.880732795297523,0,1,metanephric capsule specification,BP,
3116,GO:0006696,1.00000000002619,0.776338708187152,0,2,ergosterol biosynthetic process,BP,
3695,GO:0008204,1.00000000002619,0.776338708187152,0,2,ergosterol metabolic process,BP,
6106,GO:0019353,1.00000000002621,0.880348144248836,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8418,GO:0033526,1.00000000002621,0.880348144248836,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
18989,GO:1904844,1.00000000002621,0.791877109433721,0,2,response to L-glutamine,BP,
18990,GO:1904845,1.00000000002621,0.791877109433721,0,2,cellular response to L-glutamine,BP,
16985,GO:0099130,1.00000000002625,0.880818304489327,0,1,estrogen binding,MF,
18604,GO:1903924,1.00000000002625,0.880818304489327,0,1,estradiol binding,MF,
3726,GO:0008263,1.00000000002626,0.775024652224852,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
18665,GO:1904046,1.00000000002629,0.789546127070078,0,2,negative regulation of vascular endothelial growth factor production,BP,
19632,GO:1990911,1.00000000002631,0.776524950189809,0,2,response to psychosocial stress,BP,
19271,GO:1905555,1.00000000002631,0.778141762791131,0,2,positive regulation blood vessel branching,BP,
2291,GO:0005250,1.00000000002633,0.774931968376067,0,2,A-type (transient outward) potassium channel activity,MF,
17647,GO:1901536,1.00000000002637,0.774946915934988,0,2,negative regulation of DNA demethylation,BP,
19064,GO:1904995,1.00000000002638,0.789134127116231,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
2460,GO:0005674,1.00000000002641,0.780183503777562,0,2,transcription factor TFIIF complex,CC,
7582,GO:0031959,1.00000000002642,0.774788431050218,0,2,mineralocorticoid receptor signaling pathway,BP,
19009,GO:1904880,1.00000000002642,0.775080508993194,0,2,response to hydrogen sulfide,BP,
2032,GO:0004775,1.00000000002642,0.780619180203233,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
15980,GO:0086017,1.00000000002645,0.774781362662614,0,2,Purkinje myocyte action potential,BP,
15990,GO:0086029,1.00000000002645,0.774781362662614,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16011,GO:0086068,1.00000000002645,0.774781362662614,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
6074,GO:0019230,1.00000000002649,0.774168604612775,0,2,proprioception,BP,
14635,GO:0070259,1.0000000000265,0.774867824962207,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
14223,GO:0061300,1.0000000000265,0.778780180162624,0,2,cerebellum vasculature development,BP,
3160,GO:0006772,1.00000000002651,0.882814736722406,0,1,thiamine metabolic process,BP,
9955,GO:0042357,1.00000000002651,0.882814736722406,0,1,thiamine diphosphate metabolic process,BP,
12446,GO:0050333,1.00000000002651,0.882814736722406,0,1,thiamin-triphosphatase activity,MF,
14260,GO:0061370,1.00000000002652,0.774851008242435,0,2,testosterone biosynthetic process,BP,
2073,GO:0004828,1.00000000002657,0.777383709824196,0,2,serine-tRNA ligase activity,MF,
2921,GO:0006434,1.00000000002657,0.777383709824196,0,2,seryl-tRNA aminoacylation,BP,
2776,GO:0006208,1.00000000002661,0.775464129206166,0,2,pyrimidine nucleobase catabolic process,BP,
2777,GO:0006210,1.00000000002661,0.775464129206166,0,2,thymine catabolic process,BP,
6261,GO:0019859,1.00000000002661,0.775464129206166,0,2,thymine metabolic process,BP,
17141,GO:0102758,1.00000000002661,0.890187106771105,0,1,very-long-chain enoyl-CoA reductase activity,MF,
5458,GO:0016344,1.00000000002662,0.774842095781637,0,2,meiotic chromosome movement towards spindle pole,BP,
8924,GO:0034970,1.00000000002663,0.774991295929529,0,2,histone H3-R2 methylation,BP,
19945,GO:2000562,1.00000000002665,0.776042148079648,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
17026,GO:0099532,1.00000000002666,0.773789518311177,0,2,synaptic vesicle endosomal processing,BP,
15077,GO:0071144,1.00000000002668,0.771671018789471,0,2,heteromeric SMAD protein complex,CC,
18477,GO:1903650,1.0000000000267,0.797845698518551,0,2,negative regulation of cytoplasmic transport,BP,
19991,GO:2000642,1.0000000000267,0.797845698518551,0,2,negative regulation of early endosome to late endosome transport,BP,
9044,GO:0035281,1.00000000002679,0.784874552589661,0,2,pre-miRNA export from nucleus,BP,
10054,GO:0042565,1.00000000002679,0.784874552589661,0,2,RNA nuclear export complex,CC,
244,GO:0000701,1.00000000002681,0.783376465528566,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
15195,GO:0071374,1.00000000002686,0.773264123455001,0,2,cellular response to parathyroid hormone stimulus,BP,
13536,GO:0060025,1.0000000000269,0.774793156982605,0,2,regulation of synaptic activity,BP,
6844,GO:0030321,1.00000000002693,0.774535589580718,0,2,transepithelial chloride transport,BP,
11160,GO:0045259,1.00000000002695,0.781299920031118,0,2,proton-transporting ATP synthase complex,CC,
16939,GO:0098978,1.00000000002695,0.774138687660712,0,2,glutamatergic synapse,CC,
16943,GO:0098985,1.00000000002695,0.774138687660712,0,2,asymmetric, glutamatergic, excitatory synapse,CC,
2332,GO:0005350,1.00000000002698,0.775391385415207,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
5233,GO:0015855,1.00000000002698,0.775391385415207,0,2,pyrimidine nucleobase transport,BP,
18979,GO:1904823,1.00000000002698,0.775391385415207,0,2,purine nucleobase transmembrane transport,BP,
16899,GO:0098904,1.000000000027,0.775037721027612,0,2,regulation of AV node cell action potential,BP,
5747,GO:0016900,1.000000000027,0.796271689670228,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
11932,GO:0047057,1.000000000027,0.796271689670228,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
11207,GO:0045358,1.00000000002702,0.783419558264651,0,2,negative regulation of interferon-beta biosynthetic process,BP,
4870,GO:0014735,1.00000000002704,0.779433417998928,0,2,regulation of muscle atrophy,BP,
4871,GO:0014736,1.00000000002704,0.779433417998928,0,2,negative regulation of muscle atrophy,BP,
10993,GO:0044830,1.00000000002705,0.77479544870886,0,2,modulation by host of viral RNA genome replication,BP,
1362,GO:0003249,1.00000000002706,0.768313936353455,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1363,GO:0003250,1.00000000002706,0.768313936353455,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
20084,GO:2000793,1.00000000002706,0.768313936353455,0,2,cell proliferation involved in heart valve development,BP,
14600,GO:0070194,1.00000000002708,0.775528698643693,0,2,synaptonemal complex disassembly,BP,
221,GO:0000461,1.00000000002709,0.806267271535473,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
20082,GO:2000790,1.00000000002716,0.773754020629917,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20083,GO:2000791,1.00000000002716,0.773754020629917,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
16945,GO:0098989,1.00000000002717,0.778986233502649,0,2,NMDA selective glutamate receptor signaling pathway,BP,
1891,GO:0004577,1.00000000002717,0.785270699931509,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
13608,GO:0060129,1.0000000000272,0.774801035968856,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
15983,GO:0086020,1.00000000002723,0.774155176890347,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
15984,GO:0086021,1.00000000002723,0.774155176890347,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16002,GO:0086053,1.00000000002723,0.774155176890347,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16018,GO:0086077,1.00000000002723,0.774155176890347,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
19418,GO:1990108,1.00000000002724,0.773592269146294,0,2,protein linear deubiquitination,BP,
9556,GO:0036369,1.00000000002726,0.7735043398084,0,2,transcription factor catabolic process,BP,
6260,GO:0019858,1.00000000002726,0.786698021818611,0,2,cytosine metabolic process,BP,
4584,GO:0010693,1.00000000002727,0.774608012910806,0,2,negative regulation of alkaline phosphatase activity,BP,
2075,GO:0004830,1.00000000002729,0.774997449388196,0,2,tryptophan-tRNA ligase activity,MF,
2923,GO:0006436,1.00000000002729,0.774997449388196,0,2,tryptophanyl-tRNA aminoacylation,BP,
8490,GO:0033680,1.00000000002731,0.77481226947669,0,2,ATP-dependent DNA/RNA helicase activity,MF,
14443,GO:0061833,1.00000000002733,0.775228583012573,0,2,protein localization to tricellular tight junction,BP,
19353,GO:1905863,1.00000000002735,0.772598972243527,0,2,invadopodium organization,BP,
19695,GO:2000077,1.00000000002736,0.774947786696369,0,2,negative regulation of type B pancreatic cell development,BP,
1581,GO:0003994,1.00000000002737,0.774891039114145,0,2,aconitate hydratase activity,MF,
8467,GO:0033625,1.00000000002738,0.774816041165801,0,2,positive regulation of integrin activation,BP,
5763,GO:0016942,1.00000000002738,0.786706517351858,0,2,insulin-like growth factor binding protein complex,CC,
9583,GO:0036454,1.00000000002738,0.786706517351858,0,2,growth factor complex,CC,
17929,GO:1902309,1.00000000002739,0.776680285512242,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
17068,GO:0099631,1.00000000002741,0.792769588012465,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
1508,GO:0003870,1.00000000002746,0.880593050224629,0,1,5-aminolevulinate synthase activity,MF,
5649,GO:0016749,1.00000000002746,0.880593050224629,0,1,N-succinyltransferase activity,MF,
3933,GO:0008623,1.00000000002752,0.774866376550809,0,2,CHRAC,CC,
18623,GO:1903964,1.00000000002753,0.774820105293282,0,2,monounsaturated fatty acid metabolic process,BP,
18624,GO:1903966,1.00000000002753,0.774820105293282,0,2,monounsaturated fatty acid biosynthetic process,BP,
15610,GO:0072134,1.00000000002755,0.77330757842154,0,2,nephrogenic mesenchyme morphogenesis,BP,
10445,GO:0043321,1.00000000002758,0.774575710301532,0,2,regulation of natural killer cell degranulation,BP,
10446,GO:0043323,1.00000000002758,0.774575710301532,0,2,positive regulation of natural killer cell degranulation,BP,
1028,GO:0002536,1.00000000002758,0.788954622769449,0,2,respiratory burst involved in inflammatory response,BP,
13681,GO:0060264,1.00000000002758,0.788954622769449,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13683,GO:0060266,1.00000000002758,0.788954622769449,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
3410,GO:0007195,1.00000000002759,0.773757668558019,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
123,GO:0000254,1.0000000000276,0.774975743417861,0,2,C-4 methylsterol oxidase activity,MF,
1825,GO:0004483,1.0000000000276,0.774975743417861,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2885,GO:0006393,1.0000000000276,0.774975743417861,0,2,termination of mitochondrial transcription,BP,
3207,GO:0006850,1.0000000000276,0.774975743417861,0,2,mitochondrial pyruvate transmembrane transport,BP,
4006,GO:0008988,1.0000000000276,0.774975743417861,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
7717,GO:0032217,1.0000000000276,0.774975743417861,0,2,riboflavin transmembrane transporter activity,MF,
7718,GO:0032218,1.0000000000276,0.774975743417861,0,2,riboflavin transport,BP,
8101,GO:0032798,1.0000000000276,0.774975743417861,0,2,Swi5-Sfr1 complex,CC,
9581,GO:0036451,1.0000000000276,0.774975743417861,0,2,cap mRNA methylation,BP,
15333,GO:0071595,1.0000000000276,0.774975743417861,0,2,Nem1-Spo7 phosphatase complex,CC,
15940,GO:0080023,1.0000000000276,0.774975743417861,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
16522,GO:0097309,1.0000000000276,0.774975743417861,0,2,cap1 mRNA methylation,BP,
19420,GO:1990112,1.0000000000276,0.774975743417861,0,2,RQC complex,CC,
19421,GO:1990116,1.0000000000276,0.774975743417861,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19623,GO:1990879,1.0000000000276,0.774975743417861,0,2,CST complex,CC,
15244,GO:0071449,1.00000000002761,0.894520523244051,0,1,cellular response to lipid hydroperoxide,BP,
2047,GO:0004798,1.00000000002761,0.784103053706151,0,2,thymidylate kinase activity,MF,
2788,GO:0006227,1.00000000002761,0.784103053706151,0,2,dUDP biosynthetic process,BP,
2791,GO:0006233,1.00000000002761,0.784103053706151,0,2,dTDP biosynthetic process,BP,
4081,GO:0009139,1.00000000002761,0.784103053706151,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4132,GO:0009196,1.00000000002761,0.784103053706151,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4133,GO:0009197,1.00000000002761,0.784103053706151,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
11522,GO:0046072,1.00000000002761,0.784103053706151,0,2,dTDP metabolic process,BP,
11525,GO:0046077,1.00000000002761,0.784103053706151,0,2,dUDP metabolic process,BP,
247,GO:0000706,1.00000000002763,0.774792767406417,0,2,meiotic DNA double-strand break processing,BP,
19635,GO:1990918,1.00000000002763,0.774792767406417,0,2,double-strand break repair involved in meiotic recombination,BP,
4786,GO:0010982,1.00000000002766,0.775113449533467,0,2,regulation of high-density lipoprotein particle clearance,BP,
4787,GO:0010983,1.00000000002766,0.775113449533467,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
15449,GO:0071819,1.00000000002767,0.793323787521839,0,2,DUBm complex,CC,
19752,GO:2000199,1.00000000002768,0.880304484725762,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19753,GO:2000200,1.00000000002768,0.880304484725762,0,1,regulation of ribosomal subunit export from nucleus,BP,
19754,GO:2000202,1.00000000002768,0.880304484725762,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19755,GO:2000206,1.00000000002768,0.880304484725762,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19756,GO:2000208,1.00000000002768,0.880304484725762,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
1980,GO:0004703,1.00000000002772,0.775013013352602,0,2,G-protein coupled receptor kinase activity,MF,
12008,GO:0047696,1.00000000002772,0.775013013352602,0,2,beta-adrenergic receptor kinase activity,MF,
5411,GO:0016263,1.00000000002772,0.778478433019159,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5414,GO:0016267,1.00000000002772,0.778478433019159,0,2,O-glycan processing, core 1,BP,
1686,GO:0004161,1.00000000002773,0.779790108620714,0,2,dimethylallyltranstransferase activity,MF,
1737,GO:0004337,1.00000000002773,0.779790108620714,0,2,geranyltranstransferase activity,MF,
8397,GO:0033383,1.00000000002773,0.779790108620714,0,2,geranyl diphosphate metabolic process,BP,
8398,GO:0033384,1.00000000002773,0.779790108620714,0,2,geranyl diphosphate biosynthetic process,BP,
19135,GO:1905203,1.00000000002782,0.781246722586047,0,2,regulation of connective tissue replacement,BP,
5731,GO:0016882,1.00000000002782,0.787921771741331,0,2,cyclo-ligase activity,MF,
17906,GO:1902261,1.00000000002783,0.771806763436815,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
1360,GO:0003245,1.00000000002784,0.778327154891548,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
17268,GO:0140066,1.00000000002785,0.773393816683506,0,2,peptidyl-lysine crotonylation,BP,
11790,GO:0046696,1.00000000002787,0.775213776671119,0,2,lipopolysaccharide receptor complex,CC,
3337,GO:0007056,1.00000000002798,0.775930123825332,0,2,spindle assembly involved in female meiosis,BP,
3338,GO:0007057,1.00000000002798,0.775930123825332,0,2,spindle assembly involved in female meiosis I,BP,
3858,GO:0008482,1.00000000002798,0.880600860327708,0,1,sulfite oxidase activity,MF,
9854,GO:0042128,1.00000000002798,0.880600860327708,0,1,nitrate assimilation,BP,
14668,GO:0070315,1.00000000002804,0.774895709561756,0,2,G1 to G0 transition involved in cell differentiation,BP,
1531,GO:0003918,1.0000000000281,0.774580758375814,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
14300,GO:0061505,1.0000000000281,0.774580758375814,0,2,DNA topoisomerase II activity,MF,
1953,GO:0004660,1.00000000002812,0.778658224054641,0,2,protein farnesyltransferase activity,MF,
2633,GO:0005965,1.00000000002812,0.778658224054641,0,2,protein farnesyltransferase complex,CC,
4861,GO:0014717,1.00000000002815,0.780795142107993,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4862,GO:0014718,1.00000000002815,0.780795142107993,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4936,GO:0014901,1.00000000002815,0.780795142107993,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
6085,GO:0019255,1.00000000002817,0.776709858989243,0,2,glucose 1-phosphate metabolic process,BP,
5038,GO:0015222,1.00000000002819,0.776341247712875,0,2,serotonin transmembrane transporter activity,MF,
12584,GO:0050787,1.0000000000282,0.786992790568811,0,2,detoxification of mercury ion,BP,
5365,GO:0016175,1.00000000002827,0.791523265618542,0,2,superoxide-generating NADPH oxidase activity,MF,
10257,GO:0043020,1.00000000002827,0.791523265618542,0,2,NADPH oxidase complex,CC,
17877,GO:1902214,1.0000000000283,0.776974845434994,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
1599,GO:0004020,1.00000000002831,0.774890444623597,0,2,adenylylsulfate kinase activity,MF,
2036,GO:0004779,1.00000000002831,0.774890444623597,0,2,sulfate adenylyltransferase activity,MF,
2037,GO:0004781,1.00000000002831,0.774890444623597,0,2,sulfate adenylyltransferase (ATP) activity,MF,
8038,GO:0032701,1.00000000002831,0.778374105172818,0,2,negative regulation of interleukin-18 production,BP,
16168,GO:0090222,1.00000000002832,0.77358704430206,0,2,centrosome-templated microtubule nucleation,BP,
3639,GO:0008113,1.00000000002835,0.786395581720132,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
18054,GO:1902683,1.00000000002835,0.775127918231512,0,2,regulation of receptor localization to synapse,BP,
7110,GO:0030934,1.00000000002837,0.770576005203797,0,2,anchoring collagen complex,CC,
1585,GO:0003998,1.00000000002837,0.800265244757731,0,2,acylphosphatase activity,MF,
8285,GO:0033128,1.00000000002851,0.776464813048591,0,2,negative regulation of histone phosphorylation,BP,
11975,GO:0047391,1.00000000002851,0.777204451356245,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
1491,GO:0003835,1.00000000002854,0.77437145667728,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
20209,GO:2001184,1.00000000002854,0.774962658539719,0,2,positive regulation of interleukin-12 secretion,BP,
18827,GO:1904475,1.00000000002854,0.774267188096509,0,2,regulation of Ras GTPase binding,BP,
20176,GO:2001106,1.00000000002854,0.774267188096509,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
19576,GO:1990742,1.00000000002855,0.795232475191597,0,2,microvesicle,CC,
19376,GO:1905936,1.00000000002855,0.799036994985348,0,2,regulation of germ cell proliferation,BP,
19777,GO:2000254,1.00000000002855,0.799036994985348,0,2,regulation of male germ cell proliferation,BP,
9537,GO:0036313,1.00000000002857,0.775068264132344,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
1034,GO:0002543,1.00000000002857,0.775004046405454,0,2,activation of blood coagulation via clotting cascade,BP,
12392,GO:0048859,1.00000000002866,0.784693902894212,0,2,formation of anatomical boundary,BP,
3635,GO:0008107,1.00000000002867,0.774779804947212,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
7223,GO:0031127,1.00000000002867,0.774779804947212,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
18408,GO:1903518,1.00000000002867,0.775529233221714,0,2,positive regulation of single strand break repair,BP,
15434,GO:0071798,1.0000000000287,0.778927999348152,0,2,response to prostaglandin D,BP,
15435,GO:0071799,1.0000000000287,0.778927999348152,0,2,cellular response to prostaglandin D stimulus,BP,
9077,GO:0035354,1.00000000002876,0.880253862752975,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9696,GO:0038123,1.00000000002876,0.880253862752975,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10026,GO:0042495,1.00000000002876,0.880253862752975,0,1,detection of triacyl bacterial lipopeptide,BP,
10028,GO:0042497,1.00000000002876,0.880253862752975,0,1,triacyl lipopeptide binding,MF,
15416,GO:0071725,1.00000000002876,0.880253862752975,0,1,response to triacyl bacterial lipopeptide,BP,
15418,GO:0071727,1.00000000002876,0.880253862752975,0,1,cellular response to triacyl bacterial lipopeptide,BP,
8626,GO:0034165,1.0000000000288,0.774815512082489,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
673,GO:0001884,1.00000000002887,0.774828468744936,0,2,pyrimidine nucleoside binding,MF,
833,GO:0002134,1.00000000002887,0.774828468744936,0,2,UTP binding,MF,
7943,GO:0032551,1.00000000002887,0.774828468744936,0,2,pyrimidine ribonucleoside binding,MF,
1487,GO:0003827,1.00000000002888,0.774975329322521,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
10304,GO:0043111,1.0000000000289,0.781964738948687,0,2,replication fork arrest,BP,
13558,GO:0060051,1.00000000002892,0.777864256356316,0,2,negative regulation of protein glycosylation,BP,
16208,GO:0090285,1.00000000002892,0.777864256356316,0,2,negative regulation of protein glycosylation in Golgi,BP,
18938,GO:1904744,1.00000000002893,0.786277890564106,0,2,positive regulation of telomeric DNA binding,BP,
9267,GO:0035718,1.00000000002896,0.786604129316678,0,2,macrophage migration inhibitory factor binding,MF,
499,GO:0001555,1.000000000029,0.774973269974913,0,2,oocyte growth,BP,
7445,GO:0031590,1.000000000029,0.774973269974913,0,2,wybutosine metabolic process,BP,
7446,GO:0031591,1.000000000029,0.774973269974913,0,2,wybutosine biosynthetic process,BP,
6897,GO:0030485,1.00000000002904,0.778754947479586,0,2,smooth muscle contractile fiber,CC,
14871,GO:0070697,1.00000000002905,0.775059526719954,0,2,activin receptor binding,MF,
14872,GO:0070699,1.00000000002905,0.775059526719954,0,2,type II activin receptor binding,MF,
17165,GO:0106014,1.00000000002908,0.781423461518322,0,2,regulation of inflammatory response to wounding,BP,
17166,GO:0106015,1.00000000002908,0.781423461518322,0,2,negative regulation of inflammatory response to wounding,BP,
7548,GO:0031893,1.00000000002908,0.880871963027366,0,1,vasopressin receptor binding,MF,
7549,GO:0031896,1.00000000002908,0.880871963027366,0,1,V2 vasopressin receptor binding,MF,
1046,GO:0002572,1.00000000002909,0.77480368330368,0,2,pro-T cell differentiation,BP,
5947,GO:0018312,1.00000000002912,0.776514608304378,0,2,peptidyl-serine ADP-ribosylation,BP,
19487,GO:1990404,1.00000000002912,0.776514608304378,0,2,protein ADP-ribosylase activity,MF,
16908,GO:0098914,1.00000000002912,0.773636838474175,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
17063,GO:0099624,1.00000000002912,0.773636838474175,0,2,atrial cardiac muscle cell membrane repolarization,BP,
1913,GO:0004609,1.00000000002917,0.775654307871928,0,2,phosphatidylserine decarboxylase activity,MF,
6788,GO:0030237,1.00000000002917,0.774829545564457,0,2,female sex determination,BP,
2353,GO:0005436,1.00000000002922,0.774813922346799,0,2,sodium:phosphate symporter activity,MF,
5078,GO:0015319,1.00000000002922,0.774813922346799,0,2,sodium:inorganic phosphate symporter activity,MF,
5079,GO:0015321,1.00000000002922,0.774813922346799,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
2692,GO:0006060,1.00000000002923,0.780764539110335,0,2,sorbitol metabolic process,BP,
11627,GO:0046370,1.00000000002923,0.780764539110335,0,2,fructose biosynthetic process,BP,
3000,GO:0006548,1.00000000002924,0.774943773692018,0,2,histidine catabolic process,BP,
13389,GO:0052805,1.00000000002924,0.774943773692018,0,2,imidazole-containing compound catabolic process,BP,
19155,GO:1905258,1.00000000002927,0.791498537163616,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19156,GO:1905259,1.00000000002927,0.791498537163616,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
6864,GO:0030348,1.00000000002929,0.776373075683024,0,2,syntaxin-3 binding,MF,
982,GO:0002439,1.00000000002931,0.778724272214304,0,2,chronic inflammatory response to antigenic stimulus,BP,
9114,GO:0035442,1.00000000002932,0.778114781822749,0,2,dipeptide transmembrane transport,BP,
10217,GO:0042938,1.00000000002932,0.778114781822749,0,2,dipeptide transport,BP,
16080,GO:0090088,1.00000000002932,0.778114781822749,0,2,regulation of oligopeptide transport,BP,
16081,GO:0090089,1.00000000002932,0.778114781822749,0,2,regulation of dipeptide transport,BP,
20126,GO:2000878,1.00000000002932,0.778114781822749,0,2,positive regulation of oligopeptide transport,BP,
20127,GO:2000880,1.00000000002932,0.778114781822749,0,2,positive regulation of dipeptide transport,BP,
20188,GO:2001148,1.00000000002932,0.778114781822749,0,2,regulation of dipeptide transmembrane transport,BP,
20189,GO:2001150,1.00000000002932,0.778114781822749,0,2,positive regulation of dipeptide transmembrane transport,BP,
17757,GO:1901856,1.00000000002933,0.775216643182838,0,2,negative regulation of cellular respiration,BP,
10431,GO:0043305,1.00000000002934,0.7791006991989,0,2,negative regulation of mast cell degranulation,BP,
15698,GO:0072289,1.00000000002935,0.77468977108222,0,2,metanephric nephron tubule formation,BP,
10419,GO:0043291,1.00000000002941,0.76772098074558,0,2,RAVE complex,CC,
20192,GO:2001160,1.00000000002942,0.78314411846036,0,2,regulation of histone H3-K79 methylation,BP,
20193,GO:2001162,1.00000000002942,0.78314411846036,0,2,positive regulation of histone H3-K79 methylation,BP,
14726,GO:0070426,1.00000000002944,0.775177947559176,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14733,GO:0070434,1.00000000002944,0.775177947559176,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
6828,GO:0030298,1.00000000002947,0.88933961144842,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7515,GO:0031726,1.00000000002947,0.88933961144842,0,1,CCR1 chemokine receptor binding,MF,
7516,GO:0031729,1.00000000002947,0.88933961144842,0,1,CCR4 chemokine receptor binding,MF,
11822,GO:0046817,1.00000000002947,0.88933961144842,0,1,chemokine receptor antagonist activity,MF,
10245,GO:0043000,1.00000000002947,0.780043280957533,0,2,Golgi to plasma membrane CFTR protein transport,BP,
19981,GO:2000625,1.00000000002948,0.77480601895407,0,2,regulation of miRNA catabolic process,BP,
19982,GO:2000627,1.00000000002948,0.77480601895407,0,2,positive regulation of miRNA catabolic process,BP,
10215,GO:0042923,1.0000000000295,0.777011047305559,0,2,neuropeptide binding,MF,
5302,GO:0016012,1.00000000002951,0.77755529435835,0,2,sarcoglycan complex,CC,
18644,GO:1904017,1.00000000002952,0.774232796870314,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
16422,GO:0097111,1.00000000002957,0.774181092600221,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
9899,GO:0042253,1.00000000002959,0.783800207213733,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
19721,GO:2000137,1.00000000002959,0.772064096931178,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
3008,GO:0006556,1.0000000000296,0.775778754531776,0,2,S-adenosylmethionine biosynthetic process,BP,
12139,GO:0048269,1.0000000000296,0.775778754531776,0,2,methionine adenosyltransferase complex,CC,
13898,GO:0060584,1.0000000000296,0.775553030450508,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13899,GO:0060585,1.0000000000296,0.775553030450508,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
11439,GO:0045914,1.0000000000296,0.775280960736099,0,2,negative regulation of catecholamine metabolic process,BP,
11473,GO:0045963,1.0000000000296,0.775280960736099,0,2,negative regulation of dopamine metabolic process,BP,
3092,GO:0006668,1.00000000002965,0.774913783223351,0,2,sphinganine-1-phosphate metabolic process,BP,
11933,GO:0047066,1.00000000002966,0.894068581668566,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
16688,GO:0097707,1.00000000002966,0.894068581668566,0,1,ferroptosis,BP,
17213,GO:0110075,1.00000000002966,0.894068581668566,0,1,regulation of ferroptosis,BP,
17214,GO:0110076,1.00000000002966,0.894068581668566,0,1,negative regulation of ferroptosis,BP,
6294,GO:0019912,1.00000000002972,0.77569342759667,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
17360,GO:1900114,1.00000000002975,0.774558941972552,0,2,positive regulation of histone H3-K9 trimethylation,BP,
9433,GO:0036034,1.00000000002977,0.775213874981792,0,2,mediator complex assembly,BP,
20202,GO:2001176,1.00000000002977,0.775213874981792,0,2,regulation of mediator complex assembly,BP,
20203,GO:2001178,1.00000000002977,0.775213874981792,0,2,positive regulation of mediator complex assembly,BP,
7652,GO:0032090,1.00000000002983,0.787713354232467,0,2,Pyrin domain binding,MF,
8538,GO:0033906,1.00000000002983,0.776809336877993,0,2,hyaluronoglucuronidase activity,MF,
7159,GO:0031048,1.00000000002984,0.774793706848162,0,2,chromatin silencing by small RNA,BP,
19696,GO:2000078,1.00000000002986,0.784694393056538,0,2,positive regulation of type B pancreatic cell development,BP,
9323,GO:0035822,1.00000000002986,0.77460963529321,0,2,gene conversion,BP,
4994,GO:0015140,1.00000000002991,0.778891604702007,0,2,malate transmembrane transporter activity,MF,
669,GO:0001880,1.00000000002992,0.774361657562681,0,2,Mullerian duct regression,BP,
10665,GO:0043946,1.00000000002994,0.883189683482369,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10666,GO:0043947,1.00000000002994,0.883189683482369,0,1,positive regulation by host of symbiont catalytic activity,BP,
13326,GO:0052422,1.00000000002994,0.883189683482369,0,1,modulation by host of symbiont catalytic activity,BP,
1756,GO:0004362,1.00000000002998,0.880716249824551,0,1,glutathione-disulfide reductase activity,MF,
5191,GO:0015786,1.00000000002998,0.880716249824551,0,1,UDP-glucose transmembrane transport,BP,
2206,GO:0005093,1.00000000002999,0.775278563160275,0,2,Rab GDP-dissociation inhibitor activity,MF,
17469,GO:1900453,1.00000000003,0.781251960257125,0,2,negative regulation of long term synaptic depression,BP,
2142,GO:0004957,1.00000000003,0.776023915475027,0,2,prostaglandin E receptor activity,MF,
5456,GO:0016340,1.00000000003006,0.774151463277759,0,2,calcium-dependent cell-matrix adhesion,BP,
4740,GO:0010915,1.00000000003007,0.799479526566424,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4741,GO:0010916,1.00000000003007,0.799479526566424,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
43,GO:0000095,1.00000000003009,0.88080875102104,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
5203,GO:0015805,1.00000000003009,0.88080875102104,0,1,S-adenosyl-L-methionine transport,BP,
17787,GO:1901962,1.00000000003009,0.88080875102104,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
14149,GO:0061073,1.0000000000301,0.774746705504186,0,2,ciliary body morphogenesis,BP,
15083,GO:0071159,1.00000000003021,0.788730478544893,0,2,NF-kappaB complex,CC,
18864,GO:1904576,1.00000000003024,0.778221082431542,0,2,response to tunicamycin,BP,
18865,GO:1904577,1.00000000003024,0.778221082431542,0,2,cellular response to tunicamycin,BP,
12112,GO:0048211,1.00000000003026,0.774846775075721,0,2,Golgi vesicle docking,BP,
3814,GO:0008413,1.00000000003028,0.791898805965139,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9161,GO:0035539,1.00000000003028,0.791898805965139,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
6244,GO:0019826,1.00000000003028,0.775201499867254,0,2,oxygen sensor activity,MF,
7736,GO:0032258,1.00000000003028,0.77558147102896,0,2,protein localization by the Cvt pathway,BP,
16498,GO:0097238,1.0000000000303,0.792997359354109,0,2,cellular response to methylglyoxal,BP,
9647,GO:0038016,1.00000000003033,0.775154500834923,0,2,insulin receptor internalization,BP,
11612,GO:0046338,1.0000000000304,0.774897554407016,0,2,phosphatidylethanolamine catabolic process,BP,
17448,GO:1900369,1.00000000003049,0.798844493454766,0,2,negative regulation of RNA interference,BP,
18280,GO:1903225,1.00000000003049,0.773172886404949,0,2,negative regulation of endodermal cell differentiation,BP,
1090,GO:0002678,1.00000000003052,0.780616970971817,0,2,positive regulation of chronic inflammatory response,BP,
19265,GO:1905538,1.00000000003069,0.774792265802568,0,2,polysome binding,MF,
2562,GO:0005846,1.00000000003072,0.775570285507229,0,2,nuclear cap binding complex,CC,
11104,GO:0045155,1.00000000003081,0.782896826714524,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
6162,GO:0019520,1.00000000003098,0.776332629061766,0,2,aldonic acid metabolic process,BP,
6163,GO:0019521,1.00000000003098,0.776332629061766,0,2,D-gluconate metabolic process,BP,
3665,GO:0008158,1.00000000003103,0.786338087279254,0,2,hedgehog receptor activity,MF,
14645,GO:0070278,1.00000000003104,0.775173385176362,0,2,extracellular matrix constituent secretion,BP,
6303,GO:0019948,1.00000000003112,0.775094829090359,0,2,SUMO activating enzyme activity,MF,
15773,GO:0072434,1.00000000003118,0.771111420742864,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
5313,GO:0016035,1.00000000003118,0.780657933847491,0,2,zeta DNA polymerase complex,CC,
5601,GO:0016647,1.00000000003119,0.778701772050713,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
11728,GO:0046592,1.00000000003119,0.778701772050713,0,2,polyamine oxidase activity,MF,
13426,GO:0052901,1.00000000003119,0.778701772050713,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
5580,GO:0016603,1.00000000003125,0.778379192803895,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5868,GO:0017186,1.00000000003125,0.778379192803895,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
18569,GO:1903860,1.00000000003137,0.774943069525729,0,2,negative regulation of dendrite extension,BP,
19736,GO:2000172,1.00000000003137,0.774943069525729,0,2,regulation of branching morphogenesis of a nerve,BP,
19,GO:0000035,1.00000000003144,0.809141124897623,0,2,acyl binding,MF,
20,GO:0000036,1.00000000003144,0.809141124897623,0,2,acyl carrier activity,MF,
4169,GO:0009245,1.00000000003144,0.809141124897623,0,2,lipid A biosynthetic process,BP,
10933,GO:0044620,1.00000000003144,0.809141124897623,0,2,ACP phosphopantetheine attachment site binding,MF,
11682,GO:0046493,1.00000000003144,0.809141124897623,0,2,lipid A metabolic process,BP,
12845,GO:0051192,1.00000000003144,0.809141124897623,0,2,prosthetic group binding,MF,
17576,GO:1901269,1.00000000003144,0.809141124897623,0,2,lipooligosaccharide metabolic process,BP,
17577,GO:1901271,1.00000000003144,0.809141124897623,0,2,lipooligosaccharide biosynthetic process,BP,
9430,GO:0036022,1.00000000003147,0.776887034834541,0,2,limb joint morphogenesis,BP,
9431,GO:0036023,1.00000000003147,0.776887034834541,0,2,embryonic skeletal limb joint morphogenesis,BP,
1674,GO:0004140,1.00000000003148,0.776211217671937,0,2,dephospho-CoA kinase activity,MF,
5842,GO:0017143,1.00000000003149,0.775026330615962,0,2,insecticide metabolic process,BP,
5981,GO:0018894,1.00000000003149,0.775026330615962,0,2,dibenzo-p-dioxin metabolic process,BP,
2004,GO:0004731,1.00000000003151,0.774934629202212,0,2,purine-nucleoside phosphorylase activity,MF,
6470,GO:0021816,1.00000000003152,0.774735710012684,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
2348,GO:0005412,1.00000000003152,0.775467111731096,0,2,glucose:sodium symporter activity,MF,
119,GO:0000248,1.00000000003157,0.7747958305692,0,2,C-5 sterol desaturase activity,MF,
14874,GO:0070704,1.00000000003157,0.7747958305692,0,2,sterol desaturase activity,MF,
17547,GO:1901187,1.00000000003167,0.774867063772527,0,2,regulation of ephrin receptor signaling pathway,BP,
16414,GO:0097102,1.00000000003169,0.775006457248654,0,2,endothelial tip cell fate specification,BP,
19788,GO:2000275,1.00000000003172,0.787678218054321,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
14902,GO:0070780,1.00000000003177,0.783200325088993,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
12015,GO:0047750,1.0000000000318,0.795521876867365,0,2,cholestenol delta-isomerase activity,MF,
10421,GO:0043293,1.00000000003181,0.776833822372386,0,2,apoptosome,CC,
3802,GO:0008391,1.00000000003182,0.776794800698354,0,2,arachidonic acid monooxygenase activity,MF,
3803,GO:0008392,1.00000000003182,0.776794800698354,0,2,arachidonic acid epoxygenase activity,MF,
7989,GO:0032618,1.00000000003185,0.78026256902255,0,2,interleukin-15 production,BP,
2240,GO:0005151,1.00000000003188,0.777057933584375,0,2,interleukin-1, Type II receptor binding,MF,
13758,GO:0060370,1.00000000003197,0.88009110583513,0,1,susceptibility to T cell mediated cytotoxicity,BP,
1765,GO:0004372,1.00000000003205,0.775473542574849,0,2,glycine hydroxymethyltransferase activity,MF,
2043,GO:0004793,1.00000000003205,0.775473542574849,0,2,threonine aldolase activity,MF,
2997,GO:0006545,1.00000000003205,0.775473542574849,0,2,glycine biosynthetic process,BP,
3957,GO:0008732,1.00000000003205,0.775473542574849,0,2,L-allo-threonine aldolase activity,MF,
6087,GO:0019264,1.00000000003205,0.775473542574849,0,2,glycine biosynthetic process from serine,BP,
15756,GO:0072387,1.00000000003207,0.776063379682104,0,2,flavin adenine dinucleotide metabolic process,BP,
14360,GO:0061628,1.00000000003208,0.774463908920228,0,2,H3K27me3 modified histone binding,MF,
11620,GO:0046356,1.00000000003215,0.786611148271939,0,2,acetyl-CoA catabolic process,BP,
9700,GO:0038129,1.00000000003222,0.775270632248361,0,2,ERBB3 signaling pathway,BP,
2569,GO:0005854,1.00000000003223,0.784485579051557,0,2,nascent polypeptide-associated complex,CC,
2932,GO:0006452,1.00000000003226,0.781602176752025,0,2,translational frameshifting,BP,
11432,GO:0045905,1.00000000003226,0.781602176752025,0,2,positive regulation of translational termination,BP,
18531,GO:1903775,1.00000000003233,0.775563406823125,0,2,regulation of DNA double-strand break processing,BP,
831,GO:0002127,1.00000000003233,0.886416087077833,0,1,tRNA wobble base cytosine methylation,BP,
1244,GO:0002946,1.00000000003233,0.886416087077833,0,1,tRNA C5-cytosine methylation,BP,
4604,GO:0010726,1.00000000003236,0.775950027151596,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
18103,GO:1902824,1.00000000003237,0.786853092300082,0,2,positive regulation of late endosome to lysosome transport,BP,
18329,GO:1903337,1.00000000003237,0.786853092300082,0,2,positive regulation of vacuolar transport,BP,
15205,GO:0071386,1.00000000003239,0.77388091603467,0,2,cellular response to corticosterone stimulus,BP,
9701,GO:0038131,1.0000000000324,0.776426333150839,0,2,neuregulin receptor activity,MF,
4490,GO:0010520,1.00000000003249,0.774969885748981,0,2,regulation of reciprocal meiotic recombination,BP,
7848,GO:0032417,1.00000000003249,0.774831301548608,0,2,positive regulation of sodium:proton antiporter activity,BP,
15926,GO:0075341,1.00000000003252,0.880666739819386,0,1,host cell PML body,CC,
11242,GO:0045509,1.00000000003265,0.77488950329893,0,2,interleukin-27 receptor activity,MF,
19238,GO:1905449,1.00000000003279,0.776490838978128,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19239,GO:1905451,1.00000000003279,0.776490838978128,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19988,GO:2000638,1.00000000003284,0.774867311162439,0,2,regulation of SREBP signaling pathway,BP,
19989,GO:2000639,1.00000000003284,0.774867311162439,0,2,negative regulation of SREBP signaling pathway,BP,
15222,GO:0071409,1.00000000003286,0.772262213095631,0,2,cellular response to cycloheximide,BP,
5199,GO:0015801,1.00000000003286,0.775422161732581,0,2,aromatic amino acid transport,BP,
5220,GO:0015827,1.00000000003286,0.775422161732581,0,2,tryptophan transport,BP,
5465,GO:0016403,1.00000000003287,0.781385260852381,0,2,dimethylargininase activity,MF,
5801,GO:0017060,1.00000000003289,0.775406957544911,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
8565,GO:0034057,1.00000000003292,0.77488491751461,0,2,RNA strand-exchange activity,MF,
13835,GO:0060474,1.000000000033,0.79535959512968,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
7521,GO:0031752,1.00000000003301,0.774497778761731,0,2,D5 dopamine receptor binding,MF,
12683,GO:0050925,1.00000000003309,0.774059488311541,0,2,negative regulation of negative chemotaxis,BP,
14796,GO:0070557,1.00000000003309,0.781953650036916,0,2,PCNA-p21 complex,CC,
3019,GO:0006567,1.00000000003314,0.784616787169995,0,2,threonine catabolic process,BP,
1601,GO:0004022,1.00000000003319,0.77695076216983,0,2,alcohol dehydrogenase (NAD) activity,MF,
15194,GO:0071373,1.0000000000332,0.775001745226928,0,2,cellular response to luteinizing hormone stimulus,BP,
19448,GO:1990189,1.00000000003325,0.787890699249724,0,2,peptide-serine-N-acetyltransferase activity,MF,
19512,GO:1990452,1.0000000000333,0.774811595699392,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
12809,GO:0051140,1.00000000003336,0.794661200223615,0,2,regulation of NK T cell proliferation,BP,
12810,GO:0051142,1.00000000003336,0.794661200223615,0,2,positive regulation of NK T cell proliferation,BP,
8500,GO:0033691,1.00000000003344,0.774165662016052,0,2,sialic acid binding,MF,
13645,GO:0060197,1.00000000003348,0.777056098042976,0,2,cloacal septation,BP,
8113,GO:0032810,1.00000000003368,0.778867691108845,0,2,sterol response element binding,MF,
14706,GO:0070390,1.00000000003368,0.883469812108314,0,1,transcription export complex 2,CC,
7183,GO:0031081,1.0000000000337,0.774805962688042,0,2,nuclear pore distribution,BP,
13098,GO:0051664,1.0000000000337,0.774805962688042,0,2,nuclear pore localization,BP,
11475,GO:0045967,1.00000000003375,0.76873182147415,0,2,negative regulation of growth rate,BP,
8541,GO:0033961,1.00000000003377,0.88317351027233,0,1,cis-stilbene-oxide hydrolase activity,MF,
11030,GO:0045031,1.00000000003379,0.776185236201493,0,2,ATP-activated adenosine receptor activity,MF,
3857,GO:0008481,1.00000000003382,0.776730833757407,0,2,sphinganine kinase activity,MF,
5795,GO:0017050,1.00000000003382,0.776730833757407,0,2,D-erythro-sphingosine kinase activity,MF,
9477,GO:0036128,1.00000000003383,0.776384878502554,0,2,CatSper complex,CC,
658,GO:0001850,1.00000000003387,0.882579647976258,0,1,complement component C3a binding,MF,
659,GO:0001851,1.00000000003387,0.882579647976258,0,1,complement component C3b binding,MF,
19971,GO:2000611,1.00000000003391,0.774815764593439,0,2,positive regulation of thyroid hormone generation,BP,
16512,GO:0097278,1.00000000003396,0.775036481154851,0,2,complement-dependent cytotoxicity,BP,
7725,GO:0032229,1.00000000003398,0.783518707646958,0,2,negative regulation of synaptic transmission, GABAergic,BP,
1720,GO:0004314,1.00000000003403,0.775003319072901,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5480,GO:0016419,1.00000000003403,0.775003319072901,0,2,S-malonyltransferase activity,MF,
5481,GO:0016420,1.00000000003403,0.775003319072901,0,2,malonyltransferase activity,MF,
3686,GO:0008193,1.00000000003404,0.781708458352501,0,2,tRNA guanylyltransferase activity,MF,
4902,GO:0014839,1.00000000003406,0.782524948433402,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
18043,GO:1902636,1.00000000003409,0.786555356692374,0,2,kinociliary basal body,CC,
15818,GO:0072557,1.00000000003417,0.791711453048868,0,2,IPAF inflammasome complex,CC,
2629,GO:0005956,1.00000000003418,0.784225368409149,0,2,protein kinase CK2 complex,CC,
16051,GO:0090038,1.00000000003421,0.77480519253259,0,2,negative regulation of protein kinase C signaling,BP,
502,GO:0001560,1.00000000003429,0.774393255633231,0,2,regulation of cell growth by extracellular stimulus,BP,
19636,GO:1990923,1.00000000003431,0.774835648709141,0,2,PET complex,CC,
5576,GO:0016598,1.00000000003435,0.777366881639823,0,2,protein arginylation,BP,
16900,GO:0098905,1.00000000003436,0.788854372982107,0,2,regulation of bundle of His cell action potential,BP,
11741,GO:0046619,1.00000000003443,0.77449948503707,0,2,optic placode formation involved in camera-type eye formation,BP,
12658,GO:0050893,1.00000000003451,0.775577723745908,0,2,sensory processing,BP,
6222,GO:0019777,1.00000000003452,0.782810943568169,0,2,Atg12 transferase activity,MF,
1882,GO:0004566,1.00000000003453,0.777645402964935,0,2,beta-glucuronidase activity,MF,
1263,GO:0003025,1.00000000003455,0.771938965972904,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
13384,GO:0052794,1.00000000003455,0.775832517160388,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13385,GO:0052795,1.00000000003455,0.775832517160388,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13386,GO:0052796,1.00000000003455,0.775832517160388,0,2,exo-alpha-(2->8)-sialidase activity,MF,
1242,GO:0002944,1.00000000003455,0.774143403708517,0,2,cyclin K-CDK12 complex,CC,
16289,GO:0090500,1.00000000003458,0.779290767909559,0,2,endocardial cushion to mesenchymal transition,BP,
10815,GO:0044326,1.00000000003464,0.775891868857083,0,2,dendritic spine neck,CC,
14414,GO:0061752,1.00000000003484,0.776798625521359,0,2,telomeric repeat-containing RNA binding,MF,
17522,GO:1901090,1.0000000000349,0.77637336124981,0,2,regulation of protein tetramerization,BP,
17523,GO:1901091,1.0000000000349,0.77637336124981,0,2,negative regulation of protein tetramerization,BP,
17524,GO:1901093,1.0000000000349,0.77637336124981,0,2,regulation of protein homotetramerization,BP,
17525,GO:1901094,1.0000000000349,0.77637336124981,0,2,negative regulation of protein homotetramerization,BP,
17121,GO:0102485,1.00000000003491,0.769050499485369,0,2,dATP phosphohydrolase activity,MF,
17122,GO:0102486,1.00000000003491,0.769050499485369,0,2,dCTP phosphohydrolase activity,MF,
17123,GO:0102487,1.00000000003491,0.769050499485369,0,2,dUTP phosphohydrolase activity,MF,
17124,GO:0102488,1.00000000003491,0.769050499485369,0,2,dTTP phosphohydrolase activity,MF,
17125,GO:0102489,1.00000000003491,0.769050499485369,0,2,GTP phosphohydrolase activity,MF,
17126,GO:0102490,1.00000000003491,0.769050499485369,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17127,GO:0102491,1.00000000003491,0.769050499485369,0,2,dGTP phosphohydrolase activity,MF,
13843,GO:0060486,1.00000000003492,0.774094325099637,0,2,Clara cell differentiation,BP,
805,GO:0002079,1.00000000003493,0.773881553588092,0,2,inner acrosomal membrane,CC,
14939,GO:0070860,1.00000000003498,0.880645972277421,0,1,RNA polymerase I core factor complex,CC,
12470,GO:0050508,1.00000000003504,0.774792403022743,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12471,GO:0050509,1.00000000003504,0.774792403022743,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
8796,GO:0034515,1.00000000003505,0.774925258519274,0,2,proteasome storage granule,CC,
15253,GO:0071460,1.00000000003508,0.791282367925021,0,2,cellular response to cell-matrix adhesion,BP,
17354,GO:1900107,1.00000000003526,0.774531767909354,0,2,regulation of nodal signaling pathway,BP,
17381,GO:1900145,1.00000000003526,0.774531767909354,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17396,GO:1900175,1.00000000003526,0.774531767909354,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
3591,GO:0008020,1.00000000003545,0.774983742802359,0,2,G-protein coupled photoreceptor activity,MF,
11570,GO:0046166,1.00000000003557,0.780795426879421,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
16274,GO:0090409,1.00000000003562,0.880678901549446,0,1,malonyl-CoA synthetase activity,MF,
16275,GO:0090410,1.00000000003562,0.880678901549446,0,1,malonate catabolic process,BP,
16144,GO:0090191,1.00000000003564,0.778105602582604,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
11442,GO:0045917,1.00000000003573,0.776769121886804,0,2,positive regulation of complement activation,BP,
19782,GO:2000259,1.00000000003573,0.776769121886804,0,2,positive regulation of protein activation cascade,BP,
2102,GO:0004874,1.00000000003573,0.774504013234398,0,2,aryl hydrocarbon receptor activity,MF,
236,GO:0000494,1.00000000003588,0.890218547936547,0,1,box C/D snoRNA 3'-end processing,BP,
8543,GO:0033967,1.00000000003588,0.890218547936547,0,1,box C/D snoRNA metabolic process,BP,
8920,GO:0034963,1.00000000003588,0.890218547936547,0,1,box C/D snoRNA processing,BP,
9421,GO:0036009,1.00000000003588,0.890218547936547,0,1,protein-glutamine N-methyltransferase activity,MF,
19459,GO:1990258,1.00000000003588,0.890218547936547,0,1,histone glutamine methylation,BP,
19460,GO:1990259,1.00000000003588,0.890218547936547,0,1,histone-glutamine methyltransferase activity,MF,
15386,GO:0071676,1.00000000003591,0.775759785095186,0,2,negative regulation of mononuclear cell migration,BP,
16043,GO:0090027,1.00000000003591,0.775759785095186,0,2,negative regulation of monocyte chemotaxis,BP,
1763,GO:0004370,1.00000000003628,0.771855090857701,0,2,glycerol kinase activity,MF,
11571,GO:0046167,1.00000000003628,0.771855090857701,0,2,glycerol-3-phosphate biosynthetic process,BP,
10802,GO:0044308,1.0000000000363,0.773789847434898,0,2,axonal spine,CC,
6359,GO:0021546,1.00000000003647,0.778645236802506,0,2,rhombomere development,BP,
11899,GO:0046963,1.00000000003651,0.776792358342004,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11900,GO:0046964,1.00000000003651,0.776792358342004,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18009,GO:1902559,1.00000000003651,0.776792358342004,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
439,GO:0001181,1.00000000003651,0.77841166783466,0,2,transcription factor activity, core RNA polymerase I binding,MF,
1725,GO:0004320,1.00000000003665,0.776100264229484,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5428,GO:0016295,1.00000000003665,0.776100264229484,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5429,GO:0016296,1.00000000003665,0.776100264229484,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5430,GO:0016297,1.00000000003665,0.776100264229484,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
9379,GO:0035931,1.00000000003666,0.77496413192055,0,2,mineralocorticoid secretion,BP,
9380,GO:0035932,1.00000000003666,0.77496413192055,0,2,aldosterone secretion,BP,
20121,GO:2000855,1.00000000003666,0.77496413192055,0,2,regulation of mineralocorticoid secretion,BP,
20122,GO:2000857,1.00000000003666,0.77496413192055,0,2,positive regulation of mineralocorticoid secretion,BP,
20123,GO:2000858,1.00000000003666,0.77496413192055,0,2,regulation of aldosterone secretion,BP,
20124,GO:2000860,1.00000000003666,0.77496413192055,0,2,positive regulation of aldosterone secretion,BP,
19821,GO:2000321,1.00000000003668,0.78671084848617,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19829,GO:2000330,1.00000000003668,0.78671084848617,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
9904,GO:0042264,1.00000000003684,0.774396674342283,0,2,peptidyl-aspartic acid hydroxylation,BP,
3823,GO:0008427,1.00000000003688,0.786696177635911,0,2,calcium-dependent protein kinase inhibitor activity,MF,
4695,GO:0010858,1.00000000003688,0.786696177635911,0,2,calcium-dependent protein kinase regulator activity,MF,
16474,GO:0097198,1.00000000003689,0.773689991664278,0,2,histone H3-K36 trimethylation,BP,
13138,GO:0051747,1.0000000000369,0.791027602463911,0,2,cytosine C-5 DNA demethylase activity,MF,
17940,GO:1902359,1.00000000003698,0.77556893578288,0,2,Notch signaling pathway involved in somitogenesis,BP,
17944,GO:1902366,1.00000000003698,0.77556893578288,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17945,GO:1902367,1.00000000003698,0.77556893578288,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
4150,GO:0009216,1.00000000003698,0.775877039684068,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
6352,GO:0021539,1.00000000003703,0.779243377222104,0,2,subthalamus development,BP,
9031,GO:0035261,1.00000000003719,0.769524614014321,0,2,external genitalia morphogenesis,BP,
3002,GO:0006550,1.00000000003721,0.779135751263543,0,2,isoleucine catabolic process,BP,
15094,GO:0071207,1.00000000003726,0.77744184224673,0,2,histone pre-mRNA stem-loop binding,MF,
15148,GO:0071306,1.00000000003726,0.776542552215405,0,2,cellular response to vitamin E,BP,
13399,GO:0052827,1.00000000003734,0.774932408868648,0,2,inositol pentakisphosphate phosphatase activity,MF,
16446,GO:0097155,1.00000000003742,0.770943529695955,0,2,fasciculation of sensory neuron axon,BP,
20233,GO:2001228,1.00000000003746,0.763667059214395,0,2,regulation of response to gamma radiation,BP,
1650,GO:0004104,1.00000000003746,0.775107960396445,0,2,cholinesterase activity,MF,
8358,GO:0033265,1.00000000003746,0.775107960396445,0,2,choline binding,MF,
16653,GO:0097623,1.00000000003753,0.774931670252909,0,2,potassium ion export across plasma membrane,BP,
14173,GO:0061110,1.00000000003767,0.773350231448876,0,2,dense core granule biogenesis,BP,
20037,GO:2000705,1.00000000003767,0.773350231448876,0,2,regulation of dense core granule biogenesis,BP,
1411,GO:0003350,1.00000000003775,0.775195488528712,0,2,pulmonary myocardium development,BP,
6262,GO:0019860,1.00000000003779,0.778789525312076,0,2,uracil metabolic process,BP,
15909,GO:0072737,1.00000000003791,0.775597403569034,0,2,response to diamide,BP,
15910,GO:0072738,1.00000000003791,0.775597403569034,0,2,cellular response to diamide,BP,
8295,GO:0033140,1.00000000003805,0.776758019449956,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
14934,GO:0070853,1.00000000003808,0.773072873382426,0,2,myosin VI binding,MF,
3602,GO:0008043,1.00000000003821,0.796263667467581,0,2,intracellular ferritin complex,CC,
14650,GO:0070288,1.00000000003821,0.796263667467581,0,2,ferritin complex,CC,
9522,GO:0036284,1.00000000003829,0.778819024686057,0,2,tubulobulbar complex,CC,
2018,GO:0004750,1.00000000003834,0.880660318597243,0,1,ribulose-phosphate 3-epimerase activity,MF,
16652,GO:0097621,1.00000000003834,0.880660318597243,0,1,monoamine oxidase activity,MF,
4370,GO:0009996,1.00000000003842,0.776972888808429,0,2,negative regulation of cell fate specification,BP,
20137,GO:2000983,1.00000000003849,0.799590040139548,0,2,regulation of ATP citrate synthase activity,BP,
20138,GO:2000984,1.00000000003849,0.799590040139548,0,2,negative regulation of ATP citrate synthase activity,BP,
19411,GO:1990071,1.00000000003853,0.789407687517629,0,2,TRAPPII protein complex,CC,
9283,GO:0035740,1.00000000003879,0.777909079214831,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
19947,GO:2000564,1.00000000003879,0.777909079214831,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
4078,GO:0009136,1.0000000000388,0.786604862564715,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4117,GO:0009180,1.0000000000388,0.786604862564715,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4125,GO:0009188,1.0000000000388,0.786604862564715,0,2,ribonucleoside diphosphate biosynthetic process,BP,
5566,GO:0016586,1.00000000003888,0.774049279056688,0,2,RSC-type complex,CC,
1519,GO:0003883,1.00000000003888,0.774826805469945,0,2,CTP synthase activity,MF,
10747,GO:0044210,1.00000000003888,0.774826805469945,0,2,'de novo' CTP biosynthetic process,BP,
17418,GO:1900222,1.00000000003905,0.778752278710936,0,2,negative regulation of amyloid-beta clearance,BP,
18426,GO:1903542,1.00000000003906,0.775318681719386,0,2,negative regulation of exosomal secretion,BP,
2653,GO:0005999,1.00000000003915,0.783369473950425,0,2,xylulose biosynthetic process,BP,
5645,GO:0016744,1.00000000003915,0.783369473950425,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
10452,GO:0043335,1.00000000003933,0.78063080164026,0,2,protein unfolding,BP,
2186,GO:0005046,1.0000000000395,0.779093711987276,0,2,KDEL sequence binding,MF,
13839,GO:0060481,1.00000000004026,0.781432124311952,0,2,lobar bronchus epithelium development,BP,
5388,GO:0016230,1.00000000004083,0.780744690295207,0,2,sphingomyelin phosphodiesterase activator activity,MF,
7500,GO:0031691,1.00000000004089,0.777000330865889,0,2,alpha-1A adrenergic receptor binding,MF,
7501,GO:0031692,1.00000000004089,0.777000330865889,0,2,alpha-1B adrenergic receptor binding,MF,
7524,GO:0031762,1.00000000004089,0.777000330865889,0,2,follicle-stimulating hormone receptor binding,MF,
10121,GO:0042699,1.00000000004089,0.777000330865889,0,2,follicle-stimulating hormone signaling pathway,BP,
6092,GO:0019303,1.00000000004133,0.791499763731185,0,2,D-ribose catabolic process,BP,
9401,GO:0035981,1.00000000004139,0.779092954132216,0,2,tongue muscle cell differentiation,BP,
18098,GO:1902811,1.00000000004139,0.779092954132216,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
20159,GO:2001035,1.00000000004139,0.779092954132216,0,2,regulation of tongue muscle cell differentiation,BP,
20160,GO:2001037,1.00000000004139,0.779092954132216,0,2,positive regulation of tongue muscle cell differentiation,BP,
16529,GO:0097332,1.00000000004149,0.786523319762119,0,2,response to antipsychotic drug,BP,
2758,GO:0006172,1.00000000004185,0.880686540037386,0,1,ADP biosynthetic process,BP,
16490,GO:0097226,1.00000000004185,0.880686540037386,0,1,sperm mitochondrial sheath,CC,
19749,GO:2000195,1.00000000004244,0.776334389223707,0,2,negative regulation of female gonad development,BP,
854,GO:0002184,1.00000000004249,0.774412470800148,0,2,cytoplasmic translational termination,BP,
15021,GO:0070992,1.00000000004311,0.797051755691115,0,2,translation initiation complex,CC,
12106,GO:0048203,1.0000000000432,0.776396771948943,0,2,vesicle targeting, trans-Golgi to endosome,BP,
4832,GO:0014043,1.00000000004327,0.77695327748192,0,2,negative regulation of neuron maturation,BP,
17567,GO:1901252,1.00000000004335,0.786919665502008,0,2,regulation of intracellular transport of viral material,BP,
11794,GO:0046707,1.00000000004336,0.779053024022792,0,2,IDP metabolic process,BP,
11795,GO:0046709,1.00000000004336,0.779053024022792,0,2,IDP catabolic process,BP,
6463,GO:0021798,1.00000000004373,0.77366834340458,0,2,forebrain dorsal/ventral pattern formation,BP,
6421,GO:0021693,1.00000000004392,0.77429315163258,0,2,cerebellar Purkinje cell layer structural organization,BP,
6426,GO:0021698,1.00000000004392,0.77429315163258,0,2,cerebellar cortex structural organization,BP,
1739,GO:0004342,1.00000000004476,0.776749372634837,0,2,glucosamine-6-phosphate deaminase activity,MF,
2678,GO:0006043,1.00000000004476,0.776749372634837,0,2,glucosamine catabolic process,BP,
17255,GO:0140031,1.00000000004517,0.775318035143386,0,2,phosphorylation-dependent protein binding,MF,
2370,GO:0005499,1.00000000004759,0.775682202674342,0,2,vitamin D binding,MF,
9858,GO:0042134,1.00000000004799,0.786553087935271,0,2,rRNA primary transcript binding,MF,
15689,GO:0072272,1.0000000000481,0.776807664719214,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
19519,GO:1990498,1.00000000004841,0.773151484415221,0,2,mitotic spindle microtubule,CC,
7151,GO:0031022,1.00000000004923,0.769333484558222,0,2,nuclear migration along microfilament,BP,
16288,GO:0090498,1.00000000004962,0.774996662746882,0,2,extrinsic component of Golgi membrane,CC,
17788,GO:1901963,1.00000000005026,0.777166670385176,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
3181,GO:0006807,1.00000000006169,0,761,7389,nitrogen compound metabolic process,BP,TNIP1;XDH;DUSP6;H6PD;PTPRS;DLG4;ZC3H6;HTRA1;GAMT;F2R;ST6GALNAC2;NT5E;TNFRSF6B;NYNRIN;APOE;BTBD2;ZMYND8;NFATC4;XPC;SERPINE2;GID4;FOS;PRODH;OSBPL5;H1F0;GSN;CITED4;EGR1;CTNNBIP1;LMF1;ALDH7A1;TYSND1;PPP1R35;FBXO2;ADAM19;ZNF862;PTK6;TMEM129;CDC42EP5;ACP5;THSD4;WWC3;NAPRT;EDEM1;CRAT;RNF135;GLUL;GJC2;LRP1;NAGS;PDCD4;TIMP2;VEGFA;OBSCN;EGFR;PADI3;ZSCAN18;RBCK1;DDB2;D2HGDH;PRNP;ZDHHC1;NR1D1;ERCC1;FBLN1;SLC7A8;ADAMTS7;PRDX5;BAHCC1;TFPI2;DUSP5;NEK9;RAPGEF3;BPHL;TNFSF15;ZKSCAN1;SPTB;NPEPL1;LOXL1;RNPEPL1;IGFBP4;SLC2A9;IDH2;FKBP9;CRTAP;CST3;MEF2D;NOS1;DDIT3;TSC22D1;BRSK1;DNPH1;DNAJB5;PGM1;CRTC1;CLCA2;ERCC6;GGT1;ADAMTS13;ABTB1;TCEA2;MMP28;GRAMD4;SMARCA1;MST1R;ARRDC1;ZFP36L1;ADARB1;PPM1M;CUL9;NUPR1;B3GAT3;TCFL5;HBEGF;RBL2;PHGDH;RPS6KA2;MMP1;PYCR2;CTF1;CNTN1;CYP3A5;DHTKD1;TFDP2;MXI1;ALDH4A1;RPL13A;MSRB2;OBSL1;MDFI;TK2;PLAT;LTBP4;ULK2;SLC27A1;CTSF;MAPK13;KLF9;RNF165;MIF4GD;CDK18;PHACTR3;FBXW4;ASH2L;SOX13;CUL7;LHPP;PRSS3;HMGCL;UROS;HYAL1;NAGLU;PPP1R14A;ETV4;WWTR1;POLD4;MAP2K1;PCK2;MXD4;ABCA2;PKN1;PGLS;MC1R;DDIT4;H2AFJ;ALPK1;OPLAH;LPCAT4;BTG1;TRNP1;SHC2;DNASE1L1;SYNGAP1;ITGA6;PHF21A;DGKQ;ZNF76;AKR7A2;PBX2;MAML3;TMEM173;SNX9;THAP8;MAGEF1;ULK1;SHC1;VPS11;SPRY2;GRB7;VEGFB;ADM2;OGDHL;SOX12;HDAC11;RAB3B;PCSK1;PTMS;UNK;NMRK1;PRSS8;CIRBP;CAPRIN2;TTBK2;LY6K;PRKCZ;PPP2R3B;SERPING1;PAK1;ABCA7;APOBEC3C;AARS;ELK3;STK39;PABPC1L;ERO1B;BLVRB;FGFR3;FBXO41;SEC14L2;BRD3;CEMIP;KDM3A;MTHFR;FOXQ1;KLHL29;PHF1;GLDC;NPR2;CAPNS2;CBS;SPRY4;USP20;SALL2;DLG3;NMNAT2;DDX59;NME4;FBXW8;ETV1;ZP3;NSUN5P2;NEIL1;ABHD14B;NEURL1;ACVR2B;RAG1;SPPL2B;EAPP;SPEG;NGFR;ELFN2;MARCH4;ETV5;ETFB;GSTO1;LCE1E;LTBP1;MUC19;PPCS;NSMCE4A;TRIB2;HES2;EREG;CHD2;GPT2;TEF;PSAT1;APBB3;PTPRE;RNF44;SSH3;RMI2;PSPH;ANO8;TNFRSF25;NAB2;PLA2G6;UNKL;PPM1J;ABCG1;ESYT2;TRAPPC9;CARF;LPAR3;GSTT1;CARS;FKBP10;MTMR4;C5;APOBEC3F;PPARA;PLGRKT;INO80C;CHD3;CHAC1;SESN2;AIP;BLMH;MKNK2;RASA4;SCMH1;TCF25;IMPACT;NLRX1;PKD2;SATB1;STAT6;KLF7;ING4;RRNAD1;HMGA2;AREG;ST6GALNAC6;ECM1;B4GAT1;MARCH9;JADE2;ACACB;NT5C1B;KCNAB2;MAPK3;CSPG4;TRPT1;LAMB2;PC;FBXO27;BNIP3;ERRFI1;MACROD1;OSBPL10;THRA;DCAF10;PEX10;STK40;VANGL2;RGS14;MVD;IRF2BPL;FAM20C;TDRKH;PBXIP1;CNTRL;ADAMTSL1;SNTA1;PAN2;CTSB;ZSCAN30;EIF2D;MXRA8;MAPK12;MVB12B;MYH3;LTA4H;NAT14;ZXDC;SDC2;FBXO17;ARHGAP22;MLXIPL;PTPDC1;C1RL;ARHGEF2;INPP5D;TSPYL2;MAP2K2;SRD5A3;HIBADH;PGPEP1;SDHA;LRSAM1;DMTN;KLHL24;LITAF;PTHLH;UBXN4;ATF4;ZFPM1;CHST6;BBC3;KDM4C;PAK6;ZNF467;PRSS22;SSH1;LTB4R2;PCMTD2;PRIMPOL;POLM;TENM2;FBXO6;IFI6;ZNF516;CBX7;PKD1;FUCA1;NSMCE1;FLOT1;MDK;TTN;PSKH1;HLCS;AZIN2;JDP2;HDAC5;GTPBP1;IRF5;SORL1;GALK1;TFB1M;PCBP4;IL17RD;HERPUD1;SRSF5;GSTM2;VLDLR;PAPLN;ADGRF1;NADK;DHX32;GABBR1;DEAF1;TEP1;ST3GAL3;SULF2;NLRP1;PEG3;ACY1;GLI4;RFX2;ENDOG;KDM7A;CEBPB;MAP3K12;NEK8;RHBDF1;ACOT7;LRP5;PTPRU;WNK4;ATRAID;ALDOC;CREBRF;PCSK9;ZNF251;PKIB;L3MBTL1;PKN3;FBXL15;METTL23;FBXL16;ISG20;LONP2;MARK3;HLTF;DNMT3A;TRIOBP;TGFBR2;TRPV4;MXD3;TAGLN3;FOXL1;CSRNP3;MN1;ITGA1;TMSB4X;MOCOS;APOL4;PDE2A;SMURF2;APLN;LMO7;TRIB3;RAB40B;DAP;BHLHE40;ALDH1L2;MLH3;CALCOCO1;PEMT;EDA;HMG20B;CDK5RAP3;NOS3;AGO4;MINK1;PIGZ;HEXB;PROM2;ZFP90;WNT7A;TTLL11;TRPV1;MARCH2;BNIP3L;PIK3R2;EPHA1;RHBDF2;ZNF558;RPUSD3;ZNF662;SHARPIN;GAS6;GLUD1;DNAJC6;ERN1;BCR;KLHDC8B;MAPRE3;MAN2C1;CHKB;NBR1;CPT1C;EXD3;HEXA;TNNI2;SRR;TADA3;BOLA1;UCKL1;NECAB3;CAMK1;POLL;TERC;PTAFR;PPP1R15A;RXRA;ZNF358;ADCY6;ZNF362;MBD1;TNRC18;ATP2B4;THNSL2;PRDM8;STRADB;CTSH;PNRC1;FBXL8;MGMT;GSTO2;ASNS;ENTPD6;PAIP2B;LCE1F;HINT2;MAPKBP1;AKT1;IGFBP7;CARD11;DGUOK;CDKN1C;MICAL1;SWT1;CRY2;B4GALT2;LAMB1;CHEK2;HMSD;IFT57;LACTB2;PHYKPL;WDR45;IGFBP2;ASS1;SPDYE2;SPDYE2B;NFU1;TSG101;PHF2;FGFR4;IGF2BP2;ZNF217;PIAS3;TCIRG1;HAGH;CBR4;PHLDA1;SLC6A6;ZNF25;DNASE2;UPP1;SPSB3;WDFY2;C9ORF72;UHRF2;ARSA;CAPN2;MAN2B1;SMARCD2;SPATA18;MARK4;IFI27;PTOV1;PLAU;INSR;NCOA7;NELFCD;TENM4;FOXO4;COG7;RPS6KA5;ANKZF1;CHMP4C;RABGGTA;C6ORF89;PIGQ;CTDSPL;MAP2K5;ZDHHC24;BRAF;EDA2R;ZNF554;CPSF4;POLR2J2;ALDH1L1;HOXC5;PLB1;FAAP20;PIDD1;CAT;ZNF160;MAPK10;DPP7;MPG;LGALS1;ZFP28;TIMP1;HFE;JAK3;KIAA1549;TP73;MTA3;MNT;SNX33;UBOX5;CHRM3;ZNF846;APRT;TFEB;MIB2;CERS4;MPI;LSM14B;ENDOV;JOSD2;PHC1;SCYL3;CSNK1E;TAZ;HGSNAT;BCL6;HSF4;REC8;SAT2;RNF213;GSTM3;FBXO25;RPL39L;FYN;MAST4;ZC3H12D;PJA2;SNX1;LEMD2;UBXN6;SIRT2;MBOAT2;GDF15;RECQL5;RAB13;TST;GOLGA2;ADA;POU2F2;PLXND1;RCOR2;POLR3GL;NAGA;MTA1;MSH5;ENTPD2;FUK;AP2A2;CIDEA;HDAC8;PAIP2;MYO18A;ADIRF;RPL29;EIF4EBP1;AVPI1;TGFBR3;CIDEB;TCF7;RNPEP;MAN1B1;GALNS;EPAS1;LAMTOR2;MAP3K10;MFNG;STARD10;CHD6;RNF170;DHPS;EPHB2;NMRAL1;POLR2J3;PER1;IGF2BP3;ITGA2;FGFR1;PIGV;WFS1;ZNF333;ESYT3;BLOC1S1;FKBP8;CTH;XYLT2;ERBB2;UST;EIF2AK4;STK32B;UNC119;RGS12;SYVN1;PFKL;FRS3;MMP17;RPL12;MPPE1;HMBOX1;TRIM2;TSHZ1;CREB3L4;MMP19;ZNF449;IRF2BP2;KCTD11;ZMYM3;LYPLAL1;NUDT18;KCTD13;DBP;ZNF667;ZNF287;CAMKK1;PNKD;DTX3;DTD1;KDSR;IKBKB;NTM;DMTF1;SNCB;HIP1;TEAD2;ACOT8;BTBD11;SIX5
